Master,Protein FDR Confidence: Combined,Accession,Gene Symbol,Description,# Peptides,# PSMs,"Abundance Ratio: (BLL, Diseased) / (BLL, Normal)","Abundance Ratio: (PLL, Diseased) / (BLL, Diseased)","Abundance Ratio: (PLL, Normal) / (BLL, Normal)","Abundance Ratio: (PLL, Diseased) / (PLL, Normal)","Abundance Ratio (log2): (BLL, Diseased) / (BLL, Normal)","Abundance Ratio (log2): (PLL, Diseased) / (BLL, Diseased)","Abundance Ratio (log2): (PLL, Normal) / (BLL, Normal)","Abundance Ratio (log2): (PLL, Diseased) / (PLL, Normal)","Abundance Ratio P-Value: (BLL, Diseased) / (BLL, Normal)","Abundance Ratio P-Value: (PLL, Diseased) / (BLL, Diseased)","Abundance Ratio P-Value: (PLL, Normal) / (BLL, Normal)","Abundance Ratio P-Value: (PLL, Diseased) / (PLL, Normal)","Abundances (Grouped): BLL, Diseased","Abundances (Grouped): BLL, Normal","Abundances (Grouped): PLL, Diseased","Abundances (Grouped): PLL, Normal","Abundances (Grouped) Count: BLL, Diseased","Abundances (Grouped) Count: BLL, Normal","Abundances (Grouped) Count: PLL, Diseased","Abundances (Grouped) Count: PLL, Normal","Abundances (Normalized): F1: Sample, BLL, Diseased","Abundances (Normalized): F3: Sample, BLL, Diseased","Abundances (Normalized): F5: Sample, BLL, Diseased","Abundances (Normalized): F7: Sample, BLL, Diseased","Abundances (Normalized): F9: Sample, BLL, Diseased","Abundances (Normalized): F2: Sample, BLL, Normal","Abundances (Normalized): F4: Sample, BLL, Normal","Abundances (Normalized): F6: Sample, BLL, Normal","Abundances (Normalized): F8: Sample, BLL, Normal","Abundances (Normalized): F10: Sample, BLL, Normal","Abundances (Normalized): F11: Sample, PLL, Diseased","Abundances (Normalized): F13: Sample, PLL, Diseased","Abundances (Normalized): F15: Sample, PLL, Diseased","Abundances (Normalized): F17: Sample, PLL, Diseased","Abundances (Normalized): F19: Sample, PLL, Diseased","Abundances (Normalized): F12: Sample, PLL, Normal","Abundances (Normalized): F14: Sample, PLL, Normal","Abundances (Normalized): F16: Sample, PLL, Normal","Abundances (Normalized): F18: Sample, PLL, Normal","Abundances (Normalized): F20: Sample, PLL, Normal","Abundance: F1: Sample, BLL, Diseased","Abundance: F3: Sample, BLL, Diseased","Abundance: F5: Sample, BLL, Diseased","Abundance: F7: Sample, BLL, Diseased","Abundance: F9: Sample, BLL, Diseased","Abundance: F2: Sample, BLL, Normal","Abundance: F4: Sample, BLL, Normal","Abundance: F6: Sample, BLL, Normal","Abundance: F8: Sample, BLL, Normal","Abundance: F10: Sample, BLL, Normal","Abundance: F11: Sample, PLL, Diseased","Abundance: F13: Sample, PLL, Diseased","Abundance: F15: Sample, PLL, Diseased","Abundance: F17: Sample, PLL, Diseased","Abundance: F19: Sample, PLL, Diseased","Abundance: F12: Sample, PLL, Normal","Abundance: F14: Sample, PLL, Normal","Abundance: F16: Sample, PLL, Normal","Abundance: F18: Sample, PLL, Normal","Abundance: F20: Sample, PLL, Normal",Exp. q-value: Combined,Contaminant,Sum PEP Score,Coverage [%],# Unique Peptides,# AAs,MW [kDa],calc. pI,# Peptides (by Search Engine): Sequest HT,Biological Process,Cellular Component,Pfam IDs,Entrez Gene ID,Gene ID,Ensembl Gene ID,Reactome Pathways,WikiPathways,# Protein Pathway Groups,# Razor Peptides,"Abundances (Grouped) CV [%]: BLL, Diseased","Abundances (Grouped) CV [%]: BLL, Normal","Abundances (Grouped) CV [%]: PLL, Diseased","Abundances (Grouped) CV [%]: PLL, Normal","Found in Sample: F1: Sample, BLL, Diseased","Found in Sample: F3: Sample, BLL, Diseased","Found in Sample: F5: Sample, BLL, Diseased","Found in Sample: F7: Sample, BLL, Diseased","Found in Sample: F9: Sample, BLL, Diseased","Found in Sample: F2: Sample, BLL, Normal","Found in Sample: F4: Sample, BLL, Normal","Found in Sample: F6: Sample, BLL, Normal","Found in Sample: F8: Sample, BLL, Normal","Found in Sample: F10: Sample, BLL, Normal","Found in Sample: F11: Sample, PLL, Diseased","Found in Sample: F13: Sample, PLL, Diseased","Found in Sample: F15: Sample, PLL, Diseased","Found in Sample: F17: Sample, PLL, Diseased","Found in Sample: F19: Sample, PLL, Diseased","Found in Sample: F12: Sample, PLL, Normal","Found in Sample: F14: Sample, PLL, Normal","Found in Sample: F16: Sample, PLL, Normal","Found in Sample: F18: Sample, PLL, Normal","Found in Sample: F20: Sample, PLL, Normal",# Protein Groups,Modifications,Checked,"Abundance Ratio Variability [%]: (BLL, Diseased) / (BLL, Normal)","Abundance Ratio Variability [%]: (PLL, Diseased) / (BLL, Diseased)","Abundance Ratio Variability [%]: (PLL, Normal) / (BLL, Normal)","Abundance Ratio Variability [%]: (PLL, Diseased) / (PLL, Normal)",Score Sequest HT: Sequest HT,Molecular Function,Phospho (S; T; Y) Count,Phospho (S; T; Y) Positions
Master Protein,High,Q07812,BAX,Apoptosis regulator BAX OS=Homo sapiens OX=9606 GN=BAX PE=1 SV=1,1,5,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,2.78E+05,,,1.08E+06,1,,,3,2.78E+05,,,,,,,,,,,,,,,1.08E+06,1.12E+05,1.20E+06,,,1.10E+03,,,,,,,,,,,,,,,2.10E+03,3.15E+04,8.53E+03,,,0,FALSE,4.686,7,1,192,21.2,5.22,1,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component,Pf00452,581,A8K4W1; hsa:581; P55269; Q07812; Q07814; Q07815; Q8WZ49; Q9NR76; Q9NYG7; Q9UCZ6; Q9UCZ7; Q9UQD6,ENSG00000087088,"TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest; Transcriptional regulation by RUNX2; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; Release of apoptotic factors from the mitochondria; Pyroptosis; Activation, translocation and oligomerization of BAX; NTRK3 as a dependence receptor",miRNA regulation of DNA damage response; TP53 network; Leptin signaling pathway; TNF-alpha signaling pathway; Amyotrophic lateral sclerosis (ALS); Nanomaterial induced apoptosis; Apoptosis; Mammary gland development pathway - Involution (Stage 4 of 4); Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Overview of nanoparticle effects; RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced AP-1 survival signaling; Photodynamic therapy-induced HIF-1 survival signaling; Regulation of apoptosis by parathyroid hormone-related protein; miRNA regulation of p53 pathway in prostate cancer; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Hepatitis B infection; Melanoma; IL-18 signaling pathway; EGFR tyrosine kinase inhibitor resistance; Regucalcin in proximal tubule epithelial kidney cells; Host-pathogen interaction of human coronaviruses - apoptosis; Peroxiredoxin 2 induced ovarian failure; p53 transcriptional gene network; Pleural mesothelioma; Complement system in neuronal development and plasticity; Urotensin-II-mediated signaling pathway; TROP2 regulatory signaling; IL-26 signaling pathways; HDAC6 interactions in the central nervous system; DNA damage response; DNA damage response (only ATM dependent),48,0,,,,74.83,Peak Found,High,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,,,,,13.49,transporter activity;other molecular function,0,
Master Protein,High,Q96E11,MRRF,"Ribosome-recycling factor, mitochondrial OS=Homo sapiens OX=9606 GN=MRRF PE=1 SV=1",1,2,100,0.473,100,1.429,6.64,-1.08,6.64,0.52,1.00E-17,6.97E-01,1.00E-17,5.93E-01,7.23E+04,,5.46E+04,2.25E+04,2,,4,4,,,,1.19E+05,4.41E+04,,,,,,,5.63E+04,5.60E+04,1.84E+04,5.32E+04,,4.43E+03,1.49E+05,7.40E+03,6.86E+04,,,,1.19E+05,2.27E+03,,,,,,,2.52E+03,4.55E+02,2.48E+03,1.32E+03,,1.24E+03,1.06E+03,1.73E+02,7.30E+02,0.004,FALSE,2.562,3,1,262,29.3,9.79,1,cell organization and biogenesis;protein metabolism;other metabolic processes,mitochondrion,Pf01765,92399,A8K6D8; A8K6Z4; B7Z4X5; B7Z6P7; hsa:92399; Q5RKT1; Q5T7T0; Q5T7T1; Q5T7T2; Q5T7T3; Q5T7T4; Q5T7T5; Q96E11,ENSG00000148187,Mitochondrial translation termination,,1,0,64.86,,40.09,118.46,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,,54.86,,127.95,4.93,translation activity,0,
Master Protein,High,P18577,RHCE,Blood group Rh(CE) polypeptide OS=Homo sapiens OX=9606 GN=RHCE PE=1 SV=2,1,1,100,0.909,100,0.403,6.64,-0.14,6.64,-1.31,1.00E-17,7.95E-01,1.00E-17,5.81E-01,8.22E+04,,7.48E+04,1.85E+05,1,,4,1,,,,8.22E+04,,,,,,,1.92E+05,8.65E+04,,4.42E+04,6.46E+04,,1.85E+05,,,,,,,8.22E+04,,,,,,,1.15E+03,3.86E+03,,5.95E+03,1.61E+03,,5.21E+04,,,,0,FALSE,4.462,4,1,417,45.5,9.36,1,transport,plasma membrane;other membranes,Pf00909,,A0A220QMM7,,,,0,0,,,67.82,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,56.84,,56.84,4.2,transporter activity,0,
Master Protein,High,Q5RKV6,EXOSC6,Exosome complex component MTR3 OS=Homo sapiens OX=9606 GN=EXOSC6 PE=1 SV=1,1,1,100,0.604,,100,6.64,-0.73,,6.64,1.00E-17,8.75E-01,,1.00E-17,1.29E+05,,7.76E+04,,1,,1,,,,,1.29E+05,,,,,,,,,,7.76E+04,,,,,,,,,,1.29E+05,,,,,,,,,,1.05E+04,,,,,,,0.002,FALSE,3.033,6,1,272,28.2,6.28,1,DNA metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf01138,118460,hsa:118460; Q5RKV6,ENSG00000223496,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",,6,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.16,,0,
Master Protein,High,E9PFW3,AP2M1,AP-2 complex subunit mu OS=Homo sapiens OX=9606 GN=AP2M1 PE=1 SV=1,2,2,100,0.77,100,0.335,6.64,-0.38,6.64,-1.58,1.00E-17,9.15E-01,1.00E-17,4.45E-01,4.95E+05,,3.81E+05,1.67E+06,1,,4,1,,,,4.95E+05,,,,,,,5.66E+05,2.03E+05,,2.02E+06,2.57E+05,,1.67E+06,,,,,,,4.95E+05,,,,,,,3.38E+03,9.06E+03,,2.72E+05,6.39E+03,,4.68E+05,,,,0,FALSE,9.168,7,2,460,52.3,9.5,2,transport,plasma membrane;other membranes,Pf00928,1173,E9PFW3,ENSG00000161203,,Synaptic vesicle pathway; GABA receptor signaling; EGF/EGFR signaling pathway; Fragile X syndrome; GDNF signaling,5,0,,,112.15,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,95.9,,95.9,7.47,other molecular function,0,
Master Protein,High,Q9Y3A4,RRP7A,Ribosomal RNA-processing protein 7 homolog A OS=Homo sapiens OX=9606 GN=RRP7A PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.35E+05,,,,1,,,,,,,3.35E+05,,,,,,,,,,,,,,,,,,,,3.35E+05,,,,,,,,,,,,,,,,,0,FALSE,5.609,9,1,280,32.3,9.58,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytoskeleton;nucleus;other cell component,"Pf12923, Pf17799",27341,A4FTX2; B2RBG4; hsa:27341; Q0VAD0; Q5JZ94; Q6P4B5; Q8IVR9; Q8IVY0; Q8N5Q3; Q8NEY6; Q9Y3A4; Q9Y3H5,ENSG00000189306,rRNA modification in the nucleus and cytosol; Major pathway of rRNA processing in the nucleolus and cytosol,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.69,,0,
Master Protein,High,P42574,CASP3,Caspase-3 OS=Homo sapiens OX=9606 GN=CASP3 PE=1 SV=2,1,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.02E+06,,,,1,,,,,,,,1.02E+06,,,,,,,,,,,,,,,,,,,,5.27E+04,,,,,,,,,,,,,,,,0,FALSE,8.072,8,1,277,31.6,6.54,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf00656,836,A8K5M2; D3DP53; hsa:836; P42574; Q96AN1; Q96KP2,ENSG00000164305,Degradation of the extracellular matrix; Apoptosis induced DNA fragmentation; Signaling by Hippo; Activation of caspases through apoptosome-mediated cleavage; SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Caspase activation via Dependence Receptors in the absence of ligand; Pyroptosis; Caspase-mediated cleavage of cytoskeletal proteins; NADE modulates death signalling; Other interleukin signaling; Apoptotic cleavage of cell adhesion  proteins; Stimulation of the cell death response by PAK-2p34,miRNA regulation of DNA damage response; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; AGE/RAGE pathway; Allograft rejection; Corticotropin-releasing hormone signaling pathway; Parkinson's disease pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Amyotrophic lateral sclerosis (ALS); Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Copper homeostasis; Hepatitis C and hepatocellular carcinoma; MAPK signaling pathway; Apoptosis modulation by HSP70; ERK pathway in Huntington's disease; Oxidative damage response; miRNA regulation of p53 pathway in prostate cancer; Prion disease pathway; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; MTHFR deficiency; Acute viral myocarditis; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; Host-pathogen interaction of human coronaviruses - apoptosis; Peroxiredoxin 2 induced ovarian failure; Complement system in neuronal development and plasticity; Orexin receptor pathway; Network map of SARS-CoV-2 signaling pathway; Alzheimer's disease; Urotensin-II-mediated signaling pathway; DYRK1A involvement regarding cell proliferation in brain development; IL-26 signaling pathways; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response,60,0,,,,,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,7.22,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,C9JPP3,RBBP4,"RB binding protein 4, chromatin remodeling factor (Fragment) OS=Homo sapiens OX=9606 GN=RBBP4 PE=1 SV=2",3,6,100,1.71,100,4.01,6.64,0.77,6.64,2,1.00E-17,1.11E-01,1.00E-17,1.58E-01,7.15E+05,,1.22E+06,3.05E+05,1,,3,1,,,,7.15E+05,,,,,,,,9.54E+05,,1.22E+06,1.54E+06,,3.05E+05,,,,,,,7.15E+05,,,,,,,,4.26E+04,,1.65E+05,3.82E+04,,8.56E+04,,,,0,FALSE,17.591,84,1,87,9.7,4.94,3,,,Pf12265,,C9JPP3,ENSG00000162521,,Interactome of polycomb repressive complex 2 (PRC2) ; Tumor suppressor activity of SMARCB1; Epithelial to mesenchymal transition in colorectal cancer; Effect of progerin on genes involved in progeria; Pleural mesothelioma; DYRK1A involvement regarding cell proliferation in brain development,6,0,,,23.63,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,32.55,,32.55,20.08,,0,
Master Protein,High,Q8TDD1,DDX54,ATP-dependent RNA helicase DDX54 OS=Homo sapiens OX=9606 GN=DDX54 PE=1 SV=2,2,3,100,0.233,,100,6.64,-2.1,,6.64,1.00E-17,2.37E-01,,1.00E-17,1.57E+05,,3.66E+04,,2,,1,,,,,6.87E+04,3.59E+05,,,,,,,,,3.66E+04,,,,,,,,,,6.87E+04,1.85E+04,,,,,,,,,4.93E+03,,,,,,,0,FALSE,9.767,4,2,881,98.5,10.02,2,RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,ER/Golgi;nucleus,"Pf00270, Pf00271, Pf08147",79039,hsa:79039; Q86YT8; Q8TDD1; Q9BRZ1,ENSG00000123064,,,0,0,96.03,,,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,137.13,,,7.09,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q8TAD8,SNIP1,Smad nuclear-interacting protein 1 OS=Homo sapiens OX=9606 GN=SNIP1 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.85E+04,,,,2,,,,,,,1.00E+04,3.43E+04,,,,,,,,,,,,,,,,,,,1.00E+04,1.77E+03,,,,,,,,,,,,,,,,0.001,FALSE,3.865,4,1,396,45.8,9.99,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,cytosol;nucleus,Pf00498,79753,hsa:79753; Q8TAD8; Q96SP9; Q9H9T7,ENSG00000163877,mRNA Splicing - Major Pathway,TGF-beta signaling pathway,2,0,77.55,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.03,nucleic acid binding activity,0,
Master Protein,Medium,Q9H8H0,NOL11,Nucleolar protein 11 OS=Homo sapiens OX=9606 GN=NOL11 PE=1 SV=1,1,1,100,0.815,100,0.377,6.64,-0.29,6.64,-1.41,1.00E-17,8.76E-01,1.00E-17,5.26E-01,5.59E+04,,4.56E+04,1.21E+05,2,,1,1,,,,4.47E+04,7.00E+04,,,,,,,,,4.56E+04,,,,1.21E+05,,,,,,4.47E+04,3.61E+03,,,,,,,,,6.14E+03,,,,8.57E+02,,,0.015,FALSE,2.119,2,1,719,81.1,6.07,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf08168, Pf20998",25926,B7Z5V9; hsa:25926; Q7L5S1; Q9H8H0; Q9UG18,ENSG00000130935,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,31.22,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,33.56,,0,0,,0,
Master Protein,High,Q8WTT2,NOC3L,Nucleolar complex protein 3 homolog OS=Homo sapiens OX=9606 GN=NOC3L PE=1 SV=1,1,4,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.61E+05,,,,1,,,,,,,2.61E+05,,,,,,,,,,,,,,,,,,,,2.61E+05,,,,,,,,,,,,,,,,,0,FALSE,8.155,3,1,800,92.5,9.17,1,DNA metabolism;other metabolic processes;other biological processes,mitochondrion;nucleus,"Pf03914, Pf07540",64318,hsa:64318; Q8WTT2; Q9H5M6; Q9H9D8,ENSG00000173145,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,14.23,other molecular function,0,
Master Protein,High,Q9UI30,TRMT112,Multifunctional methyltransferase subunit TRM112-like protein OS=Homo sapiens OX=9606 GN=TRMT112 PE=1 SV=1,1,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,3.30E+05,,,9.61E+05,2,,,3,,,,1.77E+05,6.17E+05,,,,,,,,,,,9.61E+05,1.65E+05,,,1.73E+06,,,,1.77E+05,3.18E+04,,,,,,,,,,,1.87E+03,4.65E+04,,,1.84E+04,0.001,FALSE,3.716,11,1,125,14.2,5.26,1,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf03966,51504,B2R539; hsa:51504; J3KNG5; Q3MHC7; Q8N2Z4; Q9UI30,ENSG00000173113,rRNA modification in the nucleus and cytosol; tRNA modification in the nucleus and cytosol; Methylation; Eukaryotic Translation Termination,,4,0,78.42,,,82.09,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,,,,,6.87,other molecular function,0,
Master Protein,High,Q9Y3A6,TMED5,Transmembrane emp24 domain-containing protein 5 OS=Homo sapiens OX=9606 GN=TMED5 PE=1 SV=1,2,4,100,0.475,,100,6.64,-1.07,,6.64,1.00E-17,6.31E-01,,1.00E-17,1.05E+06,,5.01E+05,,1,,2,,,,,1.05E+06,,,,,,,,,4.80E+05,5.23E+05,,,,,,,,,,1.05E+06,,,,,,,,,3.90E+03,7.05E+04,,,,,,,0,FALSE,9.367,23,2,229,26,4.84,2,cell organization and biogenesis;transport,other membranes;ER/Golgi;other cell component,Pf01105,50999,B1AKT4; B2R703; D3DT38; hsa:50999; Q96AX8; Q9Y3A6,ENSG00000117500,WNT ligand biogenesis and trafficking,,1,0,,,6.19,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,6.5,,,15.74,,0,
Master Protein,High,Q6P1L8,MRPL14,"39S ribosomal protein L14, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL14 PE=1 SV=1",1,4,100,0.999,100,2.001,6.64,0,6.64,1,1.00E-17,6.56E-01,1.00E-17,3.74E-01,3.82E+05,,3.82E+05,1.71E+05,1,,4,2,,,,3.82E+05,,,,,,,,2.77E+05,1.92E+05,5.26E+05,5.33E+05,,2.65E+05,,1.11E+05,,,,,3.82E+05,,,,,,,,1.24E+04,1.56E+03,7.09E+04,1.33E+04,,7.44E+04,,2.59E+03,,0.001,FALSE,3.816,7,1,145,15.9,10.24,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf00238,64928,B2R575; hsa:64928; Q6P1L8; Q96Q72,ENSG00000180992,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,,45.54,57.95,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,49.13,,53.79,9.56,other molecular function,0,
Master Protein,High,P28906,CD34,Hematopoietic progenitor cell antigen CD34 OS=Homo sapiens OX=9606 GN=CD34 PE=1 SV=2,1,1,100,2.999,,100,6.64,1.58,,6.64,1.00E-17,6.12E-02,,1.00E-17,1.02E+05,,5.85E+05,,2,,3,,,2.09E+05,,4.94E+04,,,,,,,,6.63E+04,,5.85E+05,6.73E+05,,,,,,,7.95E+02,,4.94E+04,,,,,,,,2.96E+03,,7.88E+04,1.67E+04,,,,,,0.001,FALSE,3.287,5,1,385,40.7,7.37,1,cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf06365,947,A8K664; hsa:947; P28906; Q15970; Q15971; Q5JTA3; Q5JTA4; Q9UJB1,ENSG00000174059,,Cell lineage map for neuronal differentiation,1,0,87.38,,74.26,,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,107.27,,,3.06,other molecular function,0,
Master Protein,High,A0A994J6T1,RAC1,Rac family small GTPase 1 OS=Homo sapiens OX=9606 GN=RAC1 PE=4 SV=1,4,20,100,0.058,,100,6.64,-4.1,,6.64,1.00E-17,7.49E-03,,1.00E-17,1.78E+05,,1.04E+04,,2,,2,,,,,4.97E+05,6.40E+04,,,,,,,8.49E+03,,,1.27E+04,,,,,,,,,4.97E+05,3.30E+03,,,,,,,3.79E+02,,,3.15E+02,,,,,,0,FALSE,13.603,19,1,225,24.8,7.94,4,signal transduction,,,,A0A994J6T1,ENSG00000136238,,Nucleotide-binding oligomerization domain (NOD) pathway; Target of rapamycin signaling; Microtubule cytoskeleton regulation; Spinal cord injury; RAC1/PAK1/p38/MMP2 pathway; Hepatitis C and hepatocellular carcinoma; Chemokine signaling pathway; Microglia pathogen phagocytosis pathway; Robo4 and VEGF signaling pathways crosstalk; PI3K-Akt signaling pathway; MET in type 1 papillary renal cell carcinoma; Chromosomal and microsatellite instability in colorectal cancer ; Ebola virus infection in host; Ras signaling; Pancreatic adenocarcinoma pathway; Ciliary landscape; Cell migration and invasion through p75NTR; Melanoma; 2q13 copy number variation syndrome; 2q21.1 copy number variation syndrome; 2q37 copy number variation syndrome; Genetic causes of porto-sinusoidal vascular disease; 13q12.12 copy number variation; HDAC6 interactions in the central nervous system; GNAQ pathways in port-wine stain; DNA damage response (only ATM dependent),26,0,109.14,,28.08,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,147.14,,,45.51,other molecular function,0,
Master Protein,High,Q8NBQ5,,Estradiol 17-beta-dehydrogenase 11 OS=Homo sapiens OX=9606 GN=HSD17B11 PE=1 SV=3,2,2,100,0.268,,100,6.64,-1.9,,6.64,1.00E-17,3.03E-01,,1.00E-17,1.47E+05,,3.94E+04,,1,,3,,,,,1.47E+05,,,,,,,,4.65E+04,,3.94E+04,1.46E+04,,,,,,,,,1.47E+05,,,,,,,,2.08E+03,,5.31E+03,3.63E+02,,,,,,0,FALSE,4.388,11,2,300,32.9,9.07,2,,,,,,,,,0,0,,,49.98,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,22.65,,,4.97,,0,
Master Protein,High,E5RGU8,CA1,Carbonic anhydrase 1 (Fragment) OS=Homo sapiens OX=9606 GN=CA1 PE=1 SV=1,4,47,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,4.55E+06,,,3.25E+06,1,,,2,,,,,4.55E+06,,,,,,,,,,,,,1.25E+06,,8.49E+06,,,,,2.35E+05,,,,,,,,,,,,,8.82E+03,,9.03E+04,0,FALSE,22.933,45,1,99,11.2,6.37,4,,,Pf00194,,E5RGU8,ENSG00000133742,,,0,0,,,,105.24,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,1,,FALSE,,,,,124.68,other molecular function,0,
Master Protein,High,Q14573,ITPR3,"Inositol 1,4,5-trisphosphate receptor type 3 OS=Homo sapiens OX=9606 GN=ITPR3 PE=1 SV=2",6,13,100,0.5,,100,6.64,-1,,6.64,1.00E-17,7.17E-01,,1.00E-17,9.42E+04,,4.71E+04,,1,,1,,,,,9.42E+04,,,,,,,,4.71E+04,,,,,,,,,,,,9.42E+04,,,,,,,,2.10E+03,,,,,,,,,0,FALSE,17.762,3,4,2671,303.9,6.48,6,transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,"Pf00520, Pf01365, Pf02815, Pf08454, Pf08709",3710,hsa:3710; Q14573; Q14649; Q5TAQ2,ENSG00000096433,"Effects of PIP2 hydrolysis; Role of phospholipids in phagocytosis; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Sensory perception of sweet, bitter, and umami (glutamate) taste; Ion homeostasis; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Ca2+ pathway; VEGFR2 mediated cell proliferation; Elevation of cytosolic Ca2+ levels; PLC beta mediated events; DAG and IP3 signaling; CLEC7A (Dectin-1) induces NFAT activation",Alzheimer's disease and miRNA effects; Myometrial relaxation and contraction pathways; MFAP5-mediated ovarian cancer cell motility and invasiveness; GPR40 pathway; Vitamin D-sensitive calcium signaling in depression; Airway smooth muscle cell contraction; Pleural mesothelioma; Alzheimer's disease; GDNF signaling; Calcium regulation in cardiac cells,25,0,,,,,n/a,High,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,,29.07,transporter activity;other molecular function,0,
Master Protein,High,Q5QJE6,DNTTIP2,Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Homo sapiens OX=9606 GN=DNTTIP2 PE=1 SV=2,3,3,100,0.542,,100,6.64,-0.88,,6.64,1.00E-17,8.45E-01,,1.00E-17,4.20E+04,,2.28E+04,,1,,1,,,,,4.20E+04,,,,,,,,,,2.28E+04,,,,,,,,,,4.20E+04,,,,,,,,,,3.07E+03,,,,,,,0,FALSE,7.369,6,3,756,84.4,6.16,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf08698,30836,hsa:30836; Q12987; Q53H59; Q5QJE6; Q5TFJ4; Q6TLI0; Q76MJ8; Q86WX9,ENSG00000067334,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,0,,,9.03,,0,
Master Protein,High,Q05048,CSTF1,Cleavage stimulation factor subunit 1 OS=Homo sapiens OX=9606 GN=CSTF1 PE=1 SV=1,5,10,100,0.799,100,0.614,6.64,-0.32,6.64,-0.7,1.00E-17,8.34E-01,1.00E-17,7.75E-01,1.78E+05,,2.57E+05,3.02E+05,5,,2,3,1.38E+05,1.78E+05,4.80E+04,8.75E+05,1.11E+06,,,,,,,,1.35E+05,4.90E+05,,3.02E+05,,,2.30E+05,4.22E+05,5.47E+02,6.77E+02,4.69E+02,8.75E+05,5.72E+04,,,,,,,,1.10E+03,6.60E+04,,5.88E+02,,,5.38E+03,4.49E+03,0,FALSE,19.047,18,5,431,48.3,6.58,5,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00400, Pf16699",1477,hsa:1477; Q05048; Q5QPD8,ENSG00000101138,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,mRNA processing,5,0,103.56,,80.23,30.5,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,,54.62,,59.17,33.15,,0,
Master Protein,High,Q15061,WDR43,WD repeat-containing protein 43 OS=Homo sapiens OX=9606 GN=WDR43 PE=1 SV=3,2,4,100,2.106,100,1.508,6.64,1.07,6.64,0.59,1.00E-17,2.61E-01,1.00E-17,5.53E-01,3.11E+04,,6.59E+04,4.34E+04,2,,3,2,,,,4.98E+04,1.94E+04,,,,,,,,6.59E+04,9.97E+04,4.30E+04,,9.16E+04,,2.06E+04,,,,,4.98E+04,1.00E+03,,,,,,,,5.35E+02,1.34E+04,1.07E+03,,2.57E+04,,4.82E+02,,0,FALSE,4.599,4,2,677,74.8,5.57,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00400, Pf04003",23160,hsa:23160; Q15061; Q15395; Q92577,ENSG00000163811,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,62.14,,40.97,89.47,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,71.31,,89.77,8.2,other molecular function,0,
Master Protein,High,Q96QK1,VPS35,Vacuolar protein sorting-associated protein 35 OS=Homo sapiens OX=9606 GN=VPS35 PE=1 SV=2,1,4,100,1.118,100,0.677,6.64,0.16,6.64,-0.56,1.00E-17,5.37E-01,1.00E-17,8.55E-01,2.08E+05,,2.32E+05,3.43E+05,2,,2,2,,,,1.19E+05,3.64E+05,,,,,,,,,4.48E+05,1.20E+05,,2.55E+05,,4.61E+05,,,,,1.19E+05,1.88E+04,,,,,,,,,6.04E+04,2.99E+03,,7.18E+04,,1.08E+04,,0,FALSE,8.352,2,1,796,91.6,5.49,1,cell-cell signaling;cell organization and biogenesis;transport;signal transduction;other biological processes,other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf03635,55737,hsa:55737; Q561W2; Q96QK1; Q9H016; Q9H096; Q9H4P3; Q9H8J0; Q9NRS7; Q9NVG2; Q9NX80; Q9NZK2,ENSG00000069329,WNT ligand biogenesis and trafficking,,1,0,71.82,,81.57,40.53,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,High,n/a,1,,FALSE,,59.81,,77.95,19.22,signal transduction activity or receptor binding,0,
Master Protein,High,Q96ME1,FBXL18,F-box/LRR-repeat protein 18 OS=Homo sapiens OX=9606 GN=FBXL18 PE=1 SV=3,1,1,100,0.097,,100,6.64,-3.36,,6.64,1.00E-17,4.74E-02,,1.00E-17,7.55E+04,,7.36E+03,,3,,1,,,,1.03E+05,1.85E+04,7.55E+04,,,,,,,,,7.36E+03,,,,,,,,,1.01E+03,1.85E+04,3.89E+03,,,,,,,,,9.91E+02,,,,,,,0,FALSE,5.036,3,1,718,78.9,8.27,1,protein metabolism;other metabolic processes,cytosol;other cell component,"Pf12937, Pf19729",80028,A0A024R857; B3KTC9; B4DH63; H0Y6I6; hsa:80028; Q96ME1; Q9BR90; Q9BTC7; Q9HAK7,ENSG00000155034,Antigen processing: Ubiquitination & Proteasome degradation; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Neddylation,,3,0,65.56,,,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,53.77,,,3.01,,0,
Master Protein,High,O43676,NDUFB3,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 OS=Homo sapiens OX=9606 GN=NDUFB3 PE=1 SV=3,1,2,100,0.571,100,1.842,6.64,-0.81,6.64,0.88,1.00E-17,8.10E-01,1.00E-17,4.69E-01,4.64E+05,,2.65E+05,1.44E+05,3,,3,1,,4.64E+05,2.52E+05,1.06E+06,,,,,,,,2.65E+05,1.93E+05,,5.16E+05,,,,1.44E+05,,,1.76E+03,2.46E+03,1.06E+06,,,,,,,,1.18E+04,1.57E+03,,1.28E+04,,,,3.37E+03,,0.001,FALSE,3.907,11,1,98,11.4,9.2,1,cell organization and biogenesis;other metabolic processes;transport,other membranes;mitochondrion,Pf08122,4709,hsa:4709; O43676; Q6IB80,ENSG00000119013,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease,4,0,70.97,,52.26,,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,67.61,,40.32,4.55,transporter activity,0,
Master Protein,High,Q8WVM8,SCFD1,Sec1 family domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SCFD1 PE=1 SV=4,5,7,100,0.596,100,1.06,6.64,-0.75,6.64,0.08,1.00E-17,8.46E-01,1.00E-17,8.21E-01,2.86E+05,,2.33E+05,4.25E+05,4,,4,2,,1.38E+06,2.96E+05,2.76E+05,1.73E+05,,,,,,,3.57E+04,1.79E+05,3.03E+05,3.45E+05,2.65E+05,6.81E+05,,,,,5.23E+03,2.89E+03,2.76E+05,8.95E+03,,,,,,,1.59E+03,1.45E+03,4.09E+04,8.57E+03,5.17E+02,1.91E+05,,,,0,FALSE,21.925,13,5,642,72.3,6.27,5,stress response;transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi,Pf00995,23256,A8K2Z5; B7Z4U7; B7Z594; hsa:23256; O60754; O94990; Q7Z529; Q8WVM8; Q9BZI3; Q9UNL3; Q9Y6A8,ENSG00000092108,COPII-mediated vesicle transport; RHOA GTPase cycle,,2,0,106.75,,64.53,62.11,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,79.1,,93.19,21.11,other molecular function,0,
Master Protein,High,Q5JSP0,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FGD3 PE=1 SV=1",1,1,100,0.853,100,0.122,6.64,-0.23,6.64,-3.03,1.00E-17,7.56E-01,1.00E-17,1.02E-01,2.22E+05,,1.90E+05,1.55E+06,1,,3,1,,2.22E+05,,,,,,,,,1.90E+05,8.67E+04,,3.19E+05,,,,1.55E+06,,,,8.45E+02,,,,,,,,,1.13E+03,3.87E+03,,4.30E+04,,,,1.10E+04,,,0.002,FALSE,2.793,2,1,725,79.4,6.15,1,cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;ER/Golgi;other cell component,"Pf00169, Pf00621, Pf01363",89846,F8W7P2; hsa:89846; Q4VX84; Q5JSP0; Q7Z7D9; Q8N5G1,ENSG00000127084,CDC42 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events,,3,0,,,58.72,,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,60.22,,60.22,2.32,enzyme regulator activity;other molecular function,0,
Master Protein,High,O60220,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A OS=Homo sapiens OX=9606 GN=TIMM8A PE=1 SV=1,1,4,100,2.466,,100,6.64,1.3,,6.64,1.00E-17,8.50E-02,,1.00E-17,2.84E+05,,7.00E+05,,2,,2,,,,,4.60E+05,1.75E+05,,,,,,,2.97E+05,,1.65E+06,,,,,,,,,,4.60E+05,9.04E+03,,,,,,,1.32E+04,,2.23E+05,,,,,,,0,FALSE,8.818,15,1,97,11,5.16,1,cell organization and biogenesis;transport;developmental processes,other membranes;mitochondrion,Pf02953,1678,B2R5A6; O60220; Q6IRW6,ENSG00000126953,Mitochondrial protein import,,1,0,63.37,,98.39,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,88.65,,,16.85,other molecular function,0,
Master Protein,High,P35244,RPA3,Replication protein A 14 kDa subunit OS=Homo sapiens OX=9606 GN=RPA3 PE=1 SV=1,2,6,100,1.328,100,7.055,6.64,0.41,6.64,2.82,1.00E-17,3.34E-01,1.00E-17,3.00E-02,6.42E+05,,5.14E+05,6.83E+04,3,,5,2,,2.48E+05,,1.11E+06,6.42E+05,,,,,,4.92E+05,6.47E+05,5.60E+05,5.14E+05,3.40E+05,,5.46E+04,,8.53E+04,,,9.43E+02,,1.11E+06,3.31E+04,,,,,,2.94E+03,2.89E+04,4.55E+03,6.92E+04,8.45E+03,,1.53E+04,,2.00E+03,,0,FALSE,15.949,30,2,121,13.6,5.08,2,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf08661,6119,hsa:6119; P35244; Q549U6,ENSG00000106399,HSF1 activation; Fanconi Anemia Pathway; Regulation of HSF1-mediated heat shock response; Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Meiotic recombination; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Removal of the Flap Intermediate; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER; Removal of the Flap Intermediate from the C-strand; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),"Retinoblastoma gene in cancer; G1 to S cell cycle control; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",36,0,64.77,,22.05,31.05,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,50.17,,34.05,23.85,nucleic acid binding activity,0,
Master Protein,High,Q9Y5J1,UTP18,U3 small nucleolar RNA-associated protein 18 homolog OS=Homo sapiens OX=9606 GN=UTP18 PE=1 SV=3,1,1,100,0.984,,100,6.64,-0.02,,6.64,1.00E-17,6.71E-01,,1.00E-17,3.08E+04,,3.03E+04,,1,,1,,,,,3.08E+04,,,,,,,,,,3.03E+04,,,,,,,,,,3.08E+04,,,,,,,,,,4.09E+03,,,,,,,0.001,FALSE,3.921,4,1,556,62,8.76,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,other membranes;nucleus;other cell component,Pf00400,51096,hsa:51096; Q9H4N6; Q9Y5J1,ENSG00000011260,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.08,,0,
Master Protein,High,Q9Y221,NIP7,60S ribosome subunit biogenesis protein NIP7 homolog OS=Homo sapiens OX=9606 GN=NIP7 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,7.04E+04,,,,1,,,,,,,7.04E+04,,,,,,,,,,,,,,,,,,,,7.04E+04,,,,,,,,,,,,,,,,,0,FALSE,5.8,11,1,180,20.4,8.51,1,cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,"Pf03657, Pf17833",51388,B2RD04; hsa:51388; Q9NZZ0; Q9Y221,ENSG00000132603,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.11,,0,
Master Protein,High,P56537,EIF6,Eukaryotic translation initiation factor 6 OS=Homo sapiens OX=9606 GN=EIF6 PE=1 SV=1,1,3,100,1.751,,100,6.64,0.81,,6.64,1.00E-17,2.45E-01,,1.00E-17,1.85E+05,,3.24E+05,,1,,1,,,,,1.85E+05,,,,,,,,,,3.24E+05,,,,,,,,,,1.85E+05,,,,,,,,,,4.37E+04,,,,,,,0,FALSE,6.676,7,1,245,26.6,4.68,1,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf01912,3692,B7ZBG9; hsa:3692; P56537; Q6IBN8; Q96TD5,ENSG00000242372,,Translation factors; Genetic causes of porto-sinusoidal vascular disease,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,10.88,translation activity;nucleic acid binding activity,0,
Master Protein,High,O60244,MED14,Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2,1,2,100,0.298,,100,6.64,-1.75,,6.64,1.00E-17,3.69E-01,,1.00E-17,1.51E+05,,4.50E+04,,1,,3,,,,,1.51E+05,,,,,,,4.50E+04,,,1.11E+05,2.79E+04,,,,,,,,,1.51E+05,,,,,,,2.69E+02,,,1.49E+04,6.93E+02,,,,,,0.004,FALSE,2.585,1,1,1454,160.5,8.73,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf08638,9282,hsa:9282; O60244; Q4KMR7; Q9UNB3,ENSG00000180182,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; RSV-host interactions; Generic Transcription Pathway,Vitamin D in inflammatory diseases,5,0,,,71.51,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,88.08,,,5.18,other molecular function,0,
Master Protein,High,Q9ULU4,ZMYND8,MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,4,4,100,0.732,,100,6.64,-0.45,,6.64,1.00E-17,9.72E-01,,1.00E-17,1.27E+05,,9.29E+04,,1,,3,,,,,1.27E+05,,,,,,,,1.87E+05,,9.29E+04,4.97E+04,,,,,,,,,1.27E+05,,,,,,,,8.35E+03,,1.25E+04,1.24E+03,,,,,,0,FALSE,10.855,5,4,1186,131.6,7.2,4,cell organization and biogenesis;DNA metabolism;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf00439, Pf00628, Pf00855, Pf12064",23613,B3KVL2; B7Z2A8; B7Z3E0; B7Z680; B7ZM62; E1P5U5; F5H0X3; H7C0U2; hsa:23613; J3KPU3; Q13517; Q2HXV1; Q2HXV2; Q2HXV3; Q2HXV4; Q2HXV7; Q2HXV8; Q2HXV9; Q2HXW0; Q2HXW1; Q2HXW2; Q4JJ94; Q4JJ95; Q5TH09; Q5TH11; Q6MZM1; Q8WXC5; Q9H1F3; Q9H1F4; Q9H1F5; Q9H1L8; Q9H1L9; Q9H2G5; Q9NYN3; Q9UIX6; Q9ULU4,ENSG00000101040,,,0,0,,,63.9,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,74.63,,,11.98,other molecular function,0,
Master Protein,High,O60828,PQBP1,Polyglutamine-binding protein 1 OS=Homo sapiens OX=9606 GN=PQBP1 PE=1 SV=1,2,5,100,0.433,,100,6.64,-1.21,,6.64,1.00E-17,5.18E-01,,1.00E-17,8.62E+05,,2.60E+05,,1,,2,,,,,8.62E+05,,,,,,,,2.41E+05,,2.81E+05,,,,,,,,,,8.62E+05,,,,,,,,1.08E+04,,3.79E+04,,,,,,,0,FALSE,12.987,16,2,265,30.5,6.33,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,,10084,C9JQA1; hsa:10084; O60828; Q4VY25; Q4VY26; Q4VY27; Q4VY29; Q4VY30; Q4VY34; Q4VY35; Q4VY36; Q4VY37; Q4VY38; Q9GZP2; Q9GZU4; Q9GZZ4,ENSG00000102103; ENSG00000292208,mRNA Splicing - Major Pathway,,1,0,,,10.83,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,11.39,,,14.7,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q99081,TCF12,Transcription factor 12 OS=Homo sapiens OX=9606 GN=TCF12 PE=1 SV=1,2,2,100,0.381,,100,6.64,-1.39,,6.64,1.00E-17,5.42E-01,,1.00E-17,6.78E+04,,2.58E+04,,1,,3,,,,,6.78E+04,,,,,,,,2.58E+04,,1.65E+04,2.72E+04,,,,,,,,,6.78E+04,,,,,,,,1.15E+03,,2.23E+03,6.76E+02,,,,,,0,FALSE,8.272,4,1,682,72.9,7.02,2,other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,Pf00010,6938,B4E1W1; hsa:6938; Q7Z3D9; Q86TC1; Q86VM2; Q99081,ENSG00000140262,RUNX1 regulates transcription of genes involved in differentiation of HSCs; NGF-stimulated transcription; Myogenesis,,3,0,,,24.99,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,7.49,,,6.44,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P46734,MAP2K3,Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens OX=9606 GN=MAP2K3 PE=1 SV=2,1,1,100,0.39,100,1.348,6.64,-1.36,6.64,0.43,1.00E-17,4.02E-01,1.00E-17,6.40E-01,3.16E+06,,1.14E+06,8.42E+05,3,,2,1,4.83E+06,,3.16E+06,4.57E+04,,,,,,,1.52E+06,,8.46E+05,,,,8.42E+05,,,,1.92E+04,,3.09E+04,4.57E+04,,,,,,,9.11E+03,,6.88E+03,,,,2.37E+05,,,,0.001,FALSE,3.605,5,1,347,39.3,7.43,1,other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf00069,5606,B3KSK7; hsa:5606; P46734; Q99441; Q9UE71; Q9UE72,ENSG00000034152,Oxidative Stress Induced Senescence; activated TAK1 mediates p38 MAPK activation,"Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Endoderm differentiation; Photodynamic therapy-induced AP-1 survival signaling; TGF-beta signaling pathway; MAPK signaling pathway; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; MAPK cascade; Epithelial to mesenchymal transition in colorectal cancer; Thermogenesis; Vitamin D in inflammatory diseases; Signal transduction through IL1R; Translation inhibitors in chronically activated PDGFRA cells; Hepatitis B infection; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; 16p11.2 proximal deletion syndrome; Pleural mesothelioma; GNAQ pathways in port-wine stain; Interferon type I signaling pathways; Serotonin HTR1 group and FOS pathway; Toll-like receptor signaling pathway",34,0,90.62,,40.38,,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,106.4,,44.17,3.85,kinase activity;other molecular function,0,
Master Protein,Medium,Q96RN5,MED15,Mediator of RNA polymerase II transcription subunit 15 OS=Homo sapiens OX=9606 GN=MED15 PE=1 SV=2,1,2,100,1.562,100,6.09,6.64,0.64,6.64,2.61,1.00E-17,2.97E-01,1.00E-17,8.10E-02,2.07E+05,,3.23E+05,5.30E+04,1,,2,1,,,,2.07E+05,,,,,,,4.10E+05,,,2.55E+05,,,5.30E+04,,,,,,,2.07E+05,,,,,,,2.45E+03,,,3.43E+04,,,1.49E+04,,,,0.011,FALSE,2.228,2,1,788,86.7,9.42,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf09606, Pf21538, Pf21539",51586,D3DX31; D3DX32; hsa:51586; O15413; Q6IC31; Q8NF16; Q96CT0; Q96IH7; Q96RN5; Q9P1T3,ENSG00000099917,Generic Transcription Pathway; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; RSV-host interactions,Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; 22q11.2 copy number variation syndrome,7,0,,,32.93,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,35.5,,35.5,5.97,other molecular function,0,
Master Protein,High,H0YDT6,EIF3F,Eukaryotic translation initiation factor 3 subunit F OS=Homo sapiens OX=9606 GN=EIF3F PE=1 SV=2,2,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,2.35E+05,,,9.47E+05,2,,,1,,,5.89E+05,9.35E+04,,,,,,,,,,,,,9.47E+05,,,,,,5.75E+03,9.35E+04,,,,,,,,,,,,,2.66E+05,,,,0,FALSE,7.322,10,2,359,37.7,6.06,2,cell organization and biogenesis;protein metabolism;other metabolic processes,translational apparatus;other cell component,"Pf01398, Pf13012",,H0YDT6,ENSG00000175390,,,0,0,102.65,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,6.16,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BTT0,ANP32E,Acidic leucine-rich nuclear phosphoprotein 32 family member E OS=Homo sapiens OX=9606 GN=ANP32E PE=1 SV=1,4,25,100,0.521,100,2.096,6.64,-0.94,6.64,1.07,1.00E-17,6.76E-01,1.00E-17,3.75E-01,4.49E+06,,6.28E+05,2.28E+06,2,,3,4,,,,2.63E+06,7.65E+06,,,,,,,6.28E+05,,1.40E+06,4.95E+05,,1.13E+05,1.72E+07,4.35E+05,1.19E+07,,,,2.63E+06,3.95E+05,,,,,,,2.80E+04,,1.89E+05,1.23E+04,,3.17E+04,1.22E+05,1.02E+04,1.27E+05,0,FALSE,23.208,24,4,268,30.7,3.85,4,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,nucleus;other cell component,Pf14580,81611,B4E0I6; E9PEA6; hsa:81611; Q5TB18; Q5TB20; Q8N1S4; Q8WWW9; Q9BTT0,ENSG00000143401,,,0,0,69.07,,58.13,114.93,n/a,n/a,High,High,High,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,1,,FALSE,,80.36,,46.31,99.59,enzyme regulator activity;other molecular function,0,
Master Protein,High,A0A0A0MRF6,AKAP9,A-kinase anchoring protein 9 OS=Homo sapiens OX=9606 GN=AKAP9 PE=1 SV=2,4,6,100,0.299,100,0.643,6.64,-1.74,6.64,-0.64,1.00E-17,3.89E-01,1.00E-17,8.69E-01,7.76E+04,,2.24E+04,5.84E+04,3,,4,2,,,3.85E+05,7.76E+04,2.93E+04,,,,,,,8.44E+03,4.40E+04,6.69E+04,1.14E+04,,9.81E+04,,3.48E+04,,,,3.76E+03,7.76E+04,1.51E+03,,,,,,,3.77E+02,3.57E+02,9.01E+03,2.83E+02,,2.76E+04,,8.14E+02,,0,FALSE,16.283,2,4,3931,455.6,5,4,signal transduction,cytoskeleton;ER/Golgi;other cell component,Pf10495,,A0A0A0MRF6,ENSG00000127914,,NO/cGMP/PKG mediated neuroprotection,1,0,117.64,,85.47,67.37,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,115.03,,120.97,19.14,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O00182,LGALS9,Galectin-9 OS=Homo sapiens OX=9606 GN=LGALS9 PE=1 SV=2,3,8,100,1.374,100,1.59,6.64,0.46,6.64,0.67,1.00E-17,3.64E-01,1.00E-17,5.38E-01,2.93E+05,,2.60E+05,1.23E+05,3,,5,3,,7.34E+05,4.83E+04,2.93E+05,,,,,,,1.33E+05,2.37E+05,2.60E+05,5.15E+05,5.53E+05,,7.83E+04,1.44E+06,1.23E+05,,,2.79E+03,4.72E+02,2.93E+05,,,,,,,7.93E+02,1.06E+04,2.11E+03,6.94E+04,1.38E+04,,2.20E+04,1.02E+04,2.89E+03,,0,FALSE,14.188,13,3,355,39.5,9.17,3,stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,Pf00337,3965,A7VJG6; F8W9W4; hsa:3965; O00182; O14532; O75028; Q3B8N1; Q53FQ0; Q8WYQ7; Q9NQ58,ENSG00000168961,Interleukin-2 family signaling,Vitamin D receptor pathway; Pleural mesothelioma; Immune infiltration in pancreatic cancer,4,0,96.94,,54.33,141.26,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,,93.65,,102.33,21.39,other molecular function,0,
Master Protein,High,Q9NRA8,EIF4ENIF1,Eukaryotic translation initiation factor 4E transporter OS=Homo sapiens OX=9606 GN=EIF4ENIF1 PE=1 SV=2,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.78E+04,,,,1,,,,,,,3.78E+04,,,,,,,,,,,,,,,,,,,,3.78E+04,,,,,,,,,,,,,,,,,0,FALSE,8.281,3,2,985,108.1,8.32,2,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes,cytosol;nucleus;other cell component,Pf10477,56478,B1AKL2; B1AKL3; B2RBF1; hsa:56478; Q8NCF2; Q9H708; Q9NRA8,ENSG00000184708,,Primary ovarian insufficiency; 10q11.21q11.23 copy number variation syndrome,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,S4R369,MRPL37,Mitochondrial ribosomal protein L37 OS=Homo sapiens OX=9606 GN=MRPL37 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,8.58E+04,,,,1,,,,,,,8.58E+04,,,,,,,,,,,,,,,,,,,,8.58E+04,,,,,,,,,,,,,,,,,0.001,FALSE,4.24,5,1,483,54.9,9.42,1,protein metabolism;other metabolic processes,mitochondrion;translational apparatus,Pf07147,51253,S4R369,ENSG00000116221,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.18,other molecular function,0,
Master Protein,High,A0A994J735,ATP6V0A1,ATPase H+ transporting V0 subunit a1 OS=Homo sapiens OX=9606 GN=ATP6V0A1 PE=4 SV=1,3,3,100,0.755,100,0.592,6.64,-0.4,6.64,-0.76,1.00E-17,8.62E-01,1.00E-17,8.09E-01,7.23E+05,,5.09E+05,1.03E+06,2,,4,1,5.97E+05,,,8.76E+05,,,,,,,,4.84E+05,5.36E+05,1.07E+06,4.51E+05,,1.03E+06,,,,2.37E+03,,,8.76E+05,,,,,,,,2.16E+04,4.35E+03,1.44E+05,1.12E+04,,2.89E+05,,,,0,FALSE,7.35,5,3,865,98.8,6.58,3,transport,other membranes;other cytoplasmic organelle,,,A0A994J735,ENSG00000033627,,,0,0,26.81,,45.78,,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,44.82,,22.31,8.51,transporter activity,0,
Master Protein,High,Q96I24,FUBP3,Far upstream element-binding protein 3 OS=Homo sapiens OX=9606 GN=FUBP3 PE=1 SV=2,4,10,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.43E+05,,,,1,,,,,,,2.43E+05,,,,,,,,,,,,,,,,,,,,2.43E+05,,,,,,,,,,,,,,,,,0,FALSE,13.463,10,2,572,61.6,8.38,4,RNA metabolism OR transcription;other metabolic processes;other biological processes,translational apparatus;nucleus;other cell component,Pf00013,8939,A3KFK8; A3KFL0; hsa:8939; Q92946; Q96I24; Q9BVB6,ENSG00000107164,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,26.1,nucleic acid binding activity,0,
Master Protein,High,Q96MG7,NSMCE3,Non-structural maintenance of chromosomes element 3 homolog OS=Homo sapiens OX=9606 GN=NSMCE3 PE=1 SV=1,2,4,100,0.228,,100,6.64,-2.13,,6.64,1.00E-17,1.98E-01,,1.00E-17,1.80E+05,,4.11E+04,,2,,1,,,,4.64E+05,7.01E+04,,,,,,,,,,4.11E+04,,,,,,,,,4.54E+03,7.01E+04,,,,,,,,,,5.54E+03,,,,,,,0,FALSE,6.36,11,2,304,34.3,9.28,2,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf01454,56160,hsa:56160; Q8IW16; Q8TEI6; Q96MG7; Q9H214,ENSG00000185115; ENSG00000282130,SUMOylation of DNA damage response and repair proteins,15q11q13 copy number variation,2,0,104.33,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,162.02,,,14.34,other molecular function,0,
Master Protein,High,P20592,MX2,Interferon-induced GTP-binding protein Mx2 OS=Homo sapiens OX=9606 GN=MX2 PE=1 SV=1,2,4,100,0.894,100,1.198,6.64,-0.16,6.64,0.26,1.00E-17,7.83E-01,1.00E-17,7.38E-01,1.29E+05,,1.30E+05,9.86E+04,4,,3,4,,1.27E+05,2.19E+06,1.09E+05,1.32E+05,,,,,,1.30E+05,,,1.81E+05,8.49E+04,1.75E+05,,9.40E+04,2.78E+04,1.03E+05,,4.81E+02,2.14E+04,1.09E+05,6.82E+03,,,,,,7.78E+02,,,2.43E+04,2.11E+03,3.42E+02,,6.66E+02,6.51E+02,1.10E+03,0,FALSE,7.25,3,1,715,82,8.76,2,stress response;transport;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00350, Pf01031, Pf02212",4600,B7Z5D3; D3DSI7; hsa:4600; P20592,ENSG00000183486,ISG15 antiviral mechanism; Interferon alpha/beta signaling,Vitamin D receptor pathway,3,1,161.71,,36.27,60.31,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,87.4,,55.43,10.26,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q8NHH9,ATL2,Atlastin-2 OS=Homo sapiens OX=9606 GN=ATL2 PE=1 SV=2,2,9,100,0.526,100,0.102,6.64,-0.93,6.64,-3.29,1.00E-17,7.75E-01,1.00E-17,8.34E-02,6.82E+04,,3.59E+04,3.51E+05,2,,1,1,,,8.37E+04,5.56E+04,,,,,,,,,,3.59E+04,,,3.51E+05,,,,,,8.18E+02,5.56E+04,,,,,,,,,,4.83E+03,,,9.85E+04,,,,0,FALSE,6.311,5,1,583,66.2,5.48,2,cell organization and biogenesis,other membranes;ER/Golgi,"Pf02263, Pf02841",64225,B7Z1X2; B7Z7X8; hsa:64225; Q4ZG30; Q7Z630; Q8NHH8; Q8NHH9; Q9H5M7,ENSG00000119787,,,0,0,28.57,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,30.58,,0,21.99,other molecular function,0,
Master Protein,High,Q53H12,AGK,"Acylglycerol kinase, mitochondrial OS=Homo sapiens OX=9606 GN=AGK PE=1 SV=2",3,6,100,0.753,,100,6.64,-0.41,,6.64,1.00E-17,8.95E-01,,1.00E-17,2.26E+05,,2.43E+05,,2,,4,,,,,6.23E+05,8.22E+04,,,,,,1.15E+07,4.31E+05,,1.37E+05,3.50E+04,,,,,,,,,6.23E+05,4.24E+03,,,,,,6.90E+04,1.92E+04,,1.85E+04,8.70E+02,,,,,,0,FALSE,15.8,16,3,422,47.1,8.09,3,cell organization and biogenesis;other metabolic processes;transport,other membranes;cytosol;mitochondrion;other cell component,"Pf00781, Pf19712",55750,hsa:55750; Q53H12; Q75KN1; Q96GC3; Q9NP48,ENSG00000006530; ENSG00000262327,Signaling by BRAF and RAF1 fusions; Glycerophospholipid biosynthesis,,2,0,108.45,,186.84,,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,126.97,,,19.2,kinase activity;other molecular function,0,
Master Protein,High,A0A7I2V508,BAG6,Large proline-rich protein BAG6 OS=Homo sapiens OX=9606 GN=BAG6 PE=1 SV=1,4,9,100,0.705,100,0.706,6.64,-0.51,6.64,-0.5,1.00E-17,9.90E-01,1.00E-17,8.92E-01,2.43E+05,,8.23E+04,8.90E+04,4,,3,3,1.12E+05,,5.50E+05,3.49E+05,1.69E+05,,,,,,4.66E+05,5.45E+04,,8.23E+04,,,5.65E+05,8.90E+04,2.39E+04,,4.43E+02,,5.38E+03,3.49E+05,8.71E+03,,,,,,2.79E+03,2.43E+03,,1.11E+04,,,1.59E+05,6.31E+02,5.59E+02,,0,FALSE,17.824,6,4,1173,123.4,5.69,4,cell organization and biogenesis;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf00240, Pf12057, Pf20960",,A0A7I2V508,ENSG00000204463,,,0,0,67.16,,114.44,130.76,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,116.58,,112.6,26.18,,0,
Master Protein,High,P51948,MNAT1,CDK-activating kinase assembly factor MAT1 OS=Homo sapiens OX=9606 GN=MNAT1 PE=1 SV=1,1,2,100,0.239,,100,6.64,-2.06,,6.64,1.00E-17,2.03E-01,,1.00E-17,2.28E+05,,5.45E+04,,1,,4,,,,,2.28E+05,,,,,,,,6.38E+04,4.65E+04,1.41E+05,1.85E+04,,,,,,,,,2.28E+05,,,,,,,,2.85E+03,3.78E+02,1.90E+04,4.60E+02,,,,,,0,FALSE,4.794,5,1,309,35.8,6.09,1,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes,nucleus,"Pf06391, Pf17121",4331,G3V1U8; hsa:4331; P51948; Q15817; Q6ICQ7,ENSG00000020426,RUNX1 regulates transcription of genes involved in differentiation of HSCs; NoRC negatively regulates rRNA expression; RNA Polymerase I Promoter Escape; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Cyclin D associated events in G1; Cyclin A/B1/B2 associated events during G2/M transition; RNA Polymerase I Transcription Initiation; RNA Polymerase I Transcription Termination; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Cyclin E associated events during G1/S transition ; Cyclin A:Cdk2-associated events at S phase entry,"Eukaryotic transcription initiation; G1 to S cell cycle control; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",38,0,,,77.88,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,58.19,,,4.58,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q9H7L9,SUDS3,Sin3 histone deacetylase corepressor complex component SDS3 OS=Homo sapiens OX=9606 GN=SUDS3 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.27E+05,,,,1,,,,,,,2.27E+05,,,,,,,,,,,,,,,,,,,,2.27E+05,,,,,,,,,,,,,,,,,0.005,FALSE,2.491,5,1,328,38.1,5.66,1,cell organization and biogenesis;other biological processes,cytosol;nucleus,Pf08598,64426,hsa:64426; Q4KMQ5; Q8N6H0; Q9H7L9; Q9H8D2,ENSG00000111707,Ub-specific processing proteases; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Potential therapeutics for SARS,,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.75,other molecular function,0,
Master Protein,High,Q4VC31,MIX23,Protein MIX23 OS=Homo sapiens OX=9606 GN=MIX23 PE=1 SV=1,3,6,100,0.642,100,1.604,6.64,-0.64,6.64,0.68,1.00E-17,8.82E-01,1.00E-17,5.27E-01,5.21E+05,,2.71E+05,1.13E+05,1,,4,1,,,,5.21E+05,,,,,,,,2.57E+05,4.29E+04,4.49E+05,2.85E+05,,,,1.13E+05,,,,,5.21E+05,,,,,,,,1.15E+04,3.49E+02,6.05E+04,7.09E+03,,,,2.64E+03,,0,FALSE,12.358,28,3,144,16.6,7.81,3,,mitochondrion,Pf09774,131076,hsa:131076; Q32LY6; Q4VC31,ENSG00000160124,,,0,0,,,64.51,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,45.95,,31.84,15.63,,0,
Master Protein,High,J3KQ32,OLA1,Obg-like ATPase 1 OS=Homo sapiens OX=9606 GN=OLA1 PE=1 SV=1,1,1,100,1.299,,100,6.64,0.38,,6.64,1.00E-17,4.84E-01,,1.00E-17,2.93E+04,,3.80E+04,,1,,3,,,,,2.93E+04,,,,,,,,3.80E+04,,1.46E+04,4.04E+04,,,,,,,,,2.93E+04,,,,,,,,1.70E+03,,1.97E+03,1.00E+03,,,,,,0.001,FALSE,3.761,4,1,416,46.9,8.06,1,,cytosol;cytoskeleton;nucleus,"Pf01926, Pf06071",,J3KQ32,ENSG00000138430,,,0,0,,,46.04,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,9.4,,,3.56,translation activity;other molecular function,0,
Master Protein,High,O60306,AQR,RNA helicase aquarius OS=Homo sapiens OX=9606 GN=AQR PE=1 SV=4,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.10E+05,,,,2,,,,,,8.59E+05,1.12E+05,,,,,,,,,,,,,,,,,,,8.40E+03,1.12E+05,,,,,,,,,,,,,,,,,0,FALSE,8.356,2,2,1485,171.2,6.37,2,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf13086, Pf13087, Pf16399, Pf21143, Pf21144",9716,A0JP17; A5YKK3; hsa:9716; O60306; Q2YDX9; Q6IRU8; Q6PIC8,ENSG00000021776,mRNA Splicing - Major Pathway; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER,,5,0,108.77,,,,n/a,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.08,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O00148,DDX39A,ATP-dependent RNA helicase DDX39A OS=Homo sapiens OX=9606 GN=DDX39A PE=1 SV=2,6,24,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,6.51E+05,,,,1,,,,,,,6.51E+05,,,,,,,,,,,,,,,,,,,,6.51E+05,,,,,,,,,,,,,,,,,0,FALSE,21.179,17,1,427,49.1,5.68,6,RNA metabolism OR transcription;other metabolic processes;transport,nucleus;other cell component,"Pf00270, Pf00271",10212,B1Q2N1; hsa:10212; O00148; Q8N5M0; Q9BVP6; Q9H5W0,ENSG00000123136,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,39.56,other molecular function,0,
Master Protein,High,Q9GZS3,SKIC8,SKI8 subunit of superkiller complex protein OS=Homo sapiens OX=9606 GN=SKIC8 PE=1 SV=1,2,2,100,5.099,,100,6.64,2.35,,6.64,1.00E-17,3.60E-02,,1.00E-17,1.82E+04,,9.26E+04,,1,,2,,,,,1.82E+04,,,,,,,,,,1.12E+05,7.68E+04,,,,,,,,,1.82E+04,,,,,,,,,,1.51E+04,1.91E+03,,,,,,0,FALSE,6.515,11,2,305,33.6,5.47,2,cell-cell signaling;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf00400,80349,D3DW84; hsa:80349; Q6IA22; Q7Z4X4; Q9GZS3,ENSG00000140395,E3 ubiquitin ligases ubiquitinate target proteins; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events; mRNA decay by 3' to 5' exoribonuclease,,5,0,,,26.23,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,27.99,,,7.38,,0,
Master Protein,High,O43252,PAPSS1,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 OS=Homo sapiens OX=9606 GN=PAPSS1 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,8.21E+04,,,,1,,,,,,,8.21E+04,,,,,,,,,,,,,,,,,,,,8.21E+04,,,,,,,,,,,,,,,,,0.001,FALSE,3.286,2,1,624,70.8,6.86,1,other metabolic processes;developmental processes,cytosol,"Pf01583, Pf01747, Pf14306",9061,hsa:9061; O43252; O43841; O75332; Q6IAX6; Q96FB1; Q96TF4; Q9P1P9; Q9UE98,ENSG00000138801,Signaling by BRAF and RAF1 fusions; Transport and synthesis of PAPS; Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Sulfation biotransformation reaction,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.48,kinase activity;other molecular function,0,
Master Protein,High,P23258,TUBG1,Tubulin gamma-1 chain OS=Homo sapiens OX=9606 GN=TUBG1 PE=1 SV=2,2,4,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.55E+04,,,8.68E+04,1,,,1,,,,1.55E+04,,,,,,,,,,,,,8.68E+04,,,,,,,1.55E+04,,,,,,,,,,,,,2.44E+04,,,,0,FALSE,8.196,9,2,451,51.1,6.14,2,cell cycle OR cell proliferation;cell organization and biogenesis,cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,"Pf00091, Pf03953",7283,hsa:7283; P23258; Q53X79; Q9BW59,ENSG00000131462,Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,Alstrom syndrome,8,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,14.02,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q6P1J9,CDC73,Parafibromin OS=Homo sapiens OX=9606 GN=CDC73 PE=1 SV=1,3,3,100,0.45,,100,6.64,-1.15,,6.64,1.00E-17,6.27E-01,,1.00E-17,3.31E+05,,1.02E+05,,2,,3,,,,,3.02E+05,3.62E+05,,,,,,3.25E+05,9.28E+04,,1.02E+05,,,,,,,,,,3.02E+05,1.87E+04,,,,,,1.95E+03,4.14E+03,,1.38E+04,,,,,,,0,FALSE,14.936,6,3,531,60.5,9.61,3,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,cytosol;nucleus,"Pf05179, Pf16050",79577,A6NLZ8; B2RBR2; hsa:79577; Q6P1J9; Q6PK51; Q96A07; Q9H245; Q9H5L7,ENSG00000134371,Hedgehog 'on' state; E3 ubiquitin ligases ubiquitinate target proteins; Formation of the beta-catenin:TCF transactivating complex; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,Endoderm differentiation,7,0,12.63,,75.89,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,55.99,,,9.95,other molecular function,0,
Master Protein,High,A0A8Q3WKC8,MTCH1,Mitochondrial carrier 1 OS=Homo sapiens OX=9606 GN=MTCH1 PE=1 SV=1,2,3,100,2.131,,100,6.64,1.09,,6.64,1.00E-17,1.48E-01,,1.00E-17,2.54E+05,,3.88E+05,,1,,4,,,,,2.54E+05,,,,,,,9.75E+05,7.27E+04,,3.01E+05,5.00E+05,,,,,,,,,2.54E+05,,,,,,,5.83E+03,3.25E+03,,4.06E+04,1.24E+04,,,,,,0,FALSE,9.829,8,2,427,46.3,8.92,2,,other membranes,Pf00153,,A0A8Q3WKC8,ENSG00000137409,,,0,0,,,83.06,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,92.22,,,6.58,,0,
Master Protein,High,H3BT57,PML,PML nuclear body scaffold OS=Homo sapiens OX=9606 GN=PML PE=1 SV=1,14,40,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.15E+05,,,,1,,,,,,,1.15E+05,,,,,,,,,,,,,,,,,,,,1.15E+05,,,,,,,,,,,,,,,,,0,FALSE,56.332,35,1,568,62.9,7.55,14,,other cell component,"Pf00097, Pf00643, Pf12126",,H3BT57,ENSG00000140464,,miRNA regulation of DNA damage response; Wnt/beta-catenin signaling pathway in leukemia; p53 transcriptional gene network; Acute myeloid leukemia; DNA damage response,5,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,125.62,other molecular function,0,
Master Protein,High,H0YNN4,NDUFAF1,"Complex I intermediate-associated protein 30, mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=NDUFAF1 PE=1 SV=2",1,3,100,0.899,100,1.224,6.64,-0.15,6.64,0.29,1.00E-17,7.86E-01,1.00E-17,7.51E-01,1.17E+05,,1.06E+05,8.64E+04,1,,4,1,,,,1.17E+05,,,,,,,,5.67E+04,9.43E+04,1.18E+05,2.22E+05,,8.64E+04,,,,,,,1.17E+05,,,,,,,,2.53E+03,7.66E+02,1.60E+04,5.51E+03,,2.43E+04,,,,0,FALSE,5.823,5,1,351,40.4,8.54,1,,cytosol;mitochondrion,Pf08547,,H0YNN4,ENSG00000137806,,Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,2,0,,,57.58,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,47.79,,43.31,8.08,,0,
Master Protein,High,I3L4Q0,MCRIP1,"HCG1818442, isoform CRA_a OS=Homo sapiens OX=9606 GN=MCRIP1 PE=1 SV=1",1,1,100,0.744,,100,6.64,-0.43,,6.64,1.00E-17,9.51E-01,,1.00E-17,1.07E+05,,7.96E+04,,1,,1,,,,,1.07E+05,,,,,,,,7.96E+04,,,,,,,,,,,,1.07E+05,,,,,,,,3.56E+03,,,,,,,,,0.001,FALSE,3.216,15,1,118,12.9,9.63,1,,nucleus;other cell component,Pf14799,348262,A0A024R8W3; I3L4Q0,ENSG00000225663,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.78,,0,
Master Protein,Medium,P14550,AKR1A1,Aldo-keto reductase family 1 member A1 OS=Homo sapiens OX=9606 GN=AKR1A1 PE=1 SV=3,1,1,100,2.821,100,4.138,6.64,1.5,6.64,2.05,1.00E-17,1.54E-01,1.00E-17,1.61E-01,2.46E+04,,6.94E+04,1.68E+04,1,,3,1,,,,2.46E+04,,,,,,,,3.75E+04,,7.61E+04,6.94E+04,,,,1.68E+04,,,,,2.46E+04,,,,,,,,1.68E+03,,1.02E+04,1.73E+03,,,,3.93E+02,,0.019,FALSE,2.012,2,1,325,36.6,6.79,1,other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;other cell component,Pf00248,10327,A8KAL8; D3DQ04; hsa:10327; P14550; Q6IAZ4,ENSG00000117448,Glutathione conjugation; Formation of xylulose-5-phosphate,Benzo(a)pyrene metabolism; Metapathway biotransformation Phase I and II,4,0,,,33.79,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,14.14,,14.14,2.1,other molecular function,0,
Master Protein,High,Q96S97,MYADM,Myeloid-associated differentiation marker OS=Homo sapiens OX=9606 GN=MYADM PE=1 SV=2,1,1,100,0.279,100,0.171,6.64,-1.84,6.64,-2.55,1.00E-17,2.20E-01,1.00E-17,1.80E-01,6.46E+05,,1.80E+05,1.05E+06,2,,1,1,,2.10E+06,1.98E+05,,,,,,,,,1.80E+05,,,,,1.05E+06,,,,,7.99E+03,1.94E+03,,,,,,,,,8.05E+03,,,,,2.96E+05,,,,0.007,FALSE,2.379,3,1,322,35.3,8.15,1,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytoskeleton;other cell component,Pf01284,91663,B2RE58; hsa:91663; Q542Z1; Q7Z507; Q8N9R4; Q96CS6; Q96S97; Q96SK9,ENSG00000179820,,,0,0,117.05,,,,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,218.66,,0,1.97,,0,
Master Protein,High,Q14197,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL58 PE=1 SV=1",1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,8.41E+04,,,,1,,,,,,,8.41E+04,,,,,,,,,,,,,,,,,,,,8.41E+04,,,,,,,,,,,,,,,,,0.002,FALSE,3.084,10,1,206,23.6,10.07,1,cell organization and biogenesis;protein metabolism;other metabolic processes,plasma membrane;other membranes;mitochondrion;translational apparatus;nucleus,Pf00472,3396,B2RAD1; hsa:3396; Q14197; Q53HM7; Q53Y11,ENSG00000167862,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.29,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P62829,RPL23,60S ribosomal protein L23 OS=Homo sapiens OX=9606 GN=RPL23 PE=1 SV=1,2,6,100,0.623,100,4.04,6.64,-0.68,6.64,2.01,1.00E-17,9.08E-01,1.00E-17,1.68E-01,4.42E+05,,9.98E+04,2.47E+04,2,,1,1,,,1.49E+05,1.31E+06,,,,,,,,9.98E+04,,,,,2.47E+04,,,,,,1.45E+03,1.31E+06,,,,,,,,4.46E+03,,,,,6.94E+03,,,,0,FALSE,10.796,11,2,140,14.9,10.51,2,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf00238,9349,hsa:9349; P23131; P24048; P62829; Q29246; Q3SWV7; Q6P5S1,ENSG00000125691,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins; 17q12 copy number variation syndrome,15,0,112.64,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,11.16,,0,19.31,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y2D5,,A-kinase anchor protein 2 OS=Homo sapiens OX=9606 GN=AKAP2 PE=1 SV=3,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,8.37E+04,,,,1,,,,,,,8.37E+04,,,,,,,,,,,,,,,,,,,,8.37E+04,,,,,,,,,,,,,,,,,0.001,FALSE,3.509,2,1,859,94.6,5.11,1,,,,,,,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.84,,0,
Master Protein,High,Q9Y678,COPG1,Coatomer subunit gamma-1 OS=Homo sapiens OX=9606 GN=COPG1 PE=1 SV=1,2,5,100,0.59,100,0.243,6.64,-0.76,6.64,-2.04,1.00E-17,8.55E-01,1.00E-17,2.48E-01,1.90E+05,,1.12E+05,5.37E+05,2,,2,2,2.37E+05,,,1.53E+05,,,,,,,1.83E+05,,6.86E+04,,,,8.70E+05,,3.31E+05,,9.43E+02,,,1.53E+05,,,,,,,1.10E+03,,5.58E+02,,,,2.44E+05,,7.74E+03,,0,FALSE,5.463,3,2,874,97.7,5.47,2,transport;other biological processes,other membranes;cytosol;ER/Golgi,"Pf01602, Pf08752, Pf16381",22820,A8K6M8; B3KMF6; hsa:22820; Q54AC4; Q9Y678,ENSG00000181789,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,VEGFA-VEGFR2 signaling,3,0,30.7,,64.4,63.48,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,n/a,High,n/a,1,,FALSE,,60.82,,54.31,13.08,other molecular function,0,
Master Protein,High,Q01650,SLC7A5,Large neutral amino acids transporter small subunit 1 OS=Homo sapiens OX=9606 GN=SLC7A5 PE=1 SV=2,1,3,100,0.162,100,0.079,6.64,-2.63,6.64,-3.66,1.00E-17,1.15E-01,1.00E-17,4.95E-02,1.73E+05,,2.80E+04,3.53E+05,1,,4,1,,,,,1.73E+05,,,,,,1.33E+06,1.08E+04,7.29E+04,6.64E+03,,,3.53E+05,,,,,,,,8.93E+03,,,,,,7.95E+03,4.80E+02,5.92E+02,8.94E+02,,,9.93E+04,,,,0,FALSE,4.77,3,1,507,55,7.72,1,stress response;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf13520,8140,hsa:8140; Q01650; Q8IV97; Q9UBN8; Q9UP15; Q9UQC0,ENSG00000103257,Tryptophan catabolism; Basigin interactions; Amino acid transport across the plasma membrane,"Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; mRNA, protein, and metabolite inducation pathway by cyclosporin A; Pleural mesothelioma",7,0,,,183.24,,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,191.42,,191.42,10.06,transporter activity;other molecular function,0,
Master Protein,Medium,Q9H9Y2,RPF1,Ribosome production factor 1 OS=Homo sapiens OX=9606 GN=RPF1 PE=1 SV=2,1,1,100,0.044,100,1.081,6.64,-4.52,6.64,0.11,1.00E-17,5.26E-03,1.00E-17,8.36E-01,6.69E+04,,2.91E+03,2.70E+03,2,,1,1,,,,7.06E+04,6.33E+04,,,,,,,,,2.91E+03,,,2.70E+03,,,,,,,7.06E+04,3.27E+03,,,,,,,,,3.93E+02,,,7.57E+02,,,,0.012,FALSE,2.18,4,1,349,40.1,10.01,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf04427,80135,hsa:80135; Q5VSK7; Q6AHX1; Q8WXZ8; Q9H9Y2,ENSG00000117133,,,0,0,7.61,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,7.99,,0,2.83,nucleic acid binding activity,0,
Master Protein,High,Q96FQ6,S100A16,Protein S100-A16 OS=Homo sapiens OX=9606 GN=S100A16 PE=1 SV=1,2,2,100,0.525,100,0.819,6.64,-0.93,6.64,-0.29,1.00E-17,7.43E-01,1.00E-17,9.97E-01,4.63E+05,,2.03E+05,2.32E+05,3,,4,2,2.99E+06,,3.42E+05,4.63E+05,,,,,,,,2.76E+04,2.08E+05,1.73E+06,1.98E+05,1.05E+06,,,5.15E+04,,1.19E+04,,3.34E+03,4.63E+05,,,,,,,,1.23E+03,1.69E+03,2.33E+05,4.92E+03,2.04E+03,,,1.20E+03,,0,FALSE,7.058,30,2,103,11.8,6.79,2,other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf01023,140576,A8K439; D3DV52; hsa:140576; Q5RHS6; Q96FQ6,ENSG00000188643,,,0,0,118.2,,147.22,128.18,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,,124.7,,130.88,5.88,other molecular function,0,
Master Protein,High,Q15311,RALBP1,RalA-binding protein 1 OS=Homo sapiens OX=9606 GN=RALBP1 PE=1 SV=3,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,7.82E+04,,,,1,,,,,,,7.82E+04,,,,,,,,,,,,,,,,,,,,7.82E+04,,,,,,,,,,,,,,,,,0,FALSE,7.078,4,1,655,76,5.88,1,transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus,"Pf00620, Pf20924",10928,D3DUI0; hsa:10928; Q15311,ENSG00000017797,CDC42 GTPase cycle; RAC1 GTPase cycle,RalA downstream regulated genes; Ras signaling; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway,6,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.34,transporter activity;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q9Y520,PRRC2C,Protein PRRC2C OS=Homo sapiens OX=9606 GN=PRRC2C PE=1 SV=4,2,2,100,1.467,,100,6.64,0.55,,6.64,1.00E-17,4.13E-01,,1.00E-17,1.12E+04,,1.65E+04,,1,,1,,,,,1.12E+04,,,,,,,,,,1.65E+04,,,,,,,,,,1.12E+04,,,,,,,,,,2.22E+03,,,,,,,0,FALSE,6.949,1,2,2896,316.7,9.13,2,cell organization and biogenesis;other biological processes,cytosol;other cell component,Pf07001,23215,hsa:23215; Q05DM8; Q49A39; Q6PD54; Q9H2N2; Q9HA05; Q9NSM8; Q9NXL3; Q9UF29; Q9UPQ6; Q9Y520,ENSG00000117523,,VEGFA-VEGFR2 signaling,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,5.31,,0,
Master Protein,High,Q7L1W4,LRRC8D,Volume-regulated anion channel subunit LRRC8D OS=Homo sapiens OX=9606 GN=LRRC8D PE=1 SV=1,1,1,100,1.228,100,1.293,6.64,0.3,6.64,0.37,1.00E-17,4.68E-01,1.00E-17,6.77E-01,1.97E+05,,2.61E+05,1.88E+05,2,,4,2,6.84E+05,,,5.70E+04,,,,,,,2.53E+05,,2.68E+05,2.15E+05,2.74E+05,2.42E+05,1.45E+05,,,,2.72E+03,,,5.70E+04,,,,,,,1.52E+03,,2.18E+03,2.89E+04,6.80E+03,4.73E+02,4.08E+04,,,,0.001,FALSE,3.945,2,1,858,98.1,7.72,1,cell organization and biogenesis;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,"Pf12534, Pf13855",55144,D3DT29; hsa:55144; Q6UWB2; Q7L1W4; Q9NVW3,ENSG00000171492,Miscellaneous transport and binding events,Neuroinflammation and glutamatergic signaling,2,0,119.64,,10.53,35.41,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,,208.41,,37.44,4.65,transporter activity,0,
Master Protein,High,Q8TCU6,PREX1,"Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein OS=Homo sapiens OX=9606 GN=PREX1 PE=1 SV=3",1,1,100,1.048,100,2.407,6.64,0.07,6.64,1.27,1.00E-17,6.24E-01,1.00E-17,4.00E-01,2.37E+04,,2.48E+04,1.03E+04,1,,4,1,,,,2.37E+04,,,,,,,4.56E+04,2.15E+04,2.86E+04,3.98E+03,,,1.03E+04,,,,,,,2.37E+04,,,,,,,2.72E+02,9.61E+02,2.33E+02,5.37E+02,,,2.90E+03,,,,0.001,FALSE,3.092,1,1,1659,186.1,6.44,1,cell organization and biogenesis;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf00610, Pf00621",57580,E1P5X9; hsa:57580; Q5JS95; Q5JS96; Q69YL2; Q7Z2L9; Q8TCU6; Q9BQH0; Q9BX55; Q9H4Q6; Q9P2D2; Q9UGQ4,ENSG00000124126,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle,Chemokine signaling pathway,13,0,,,69.1,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,73.33,,73.33,3.17,enzyme regulator activity;other molecular function,0,
Master Protein,High,B4E3L3,USP28,Ubiquitin carboxyl-terminal hydrolase OS=Homo sapiens OX=9606 GN=USP28 PE=1 SV=1,2,2,100,1.389,,100,6.64,0.47,,6.64,1.00E-17,4.67E-01,,1.00E-17,3.20E+04,,5.03E+04,,2,,3,,,,,4.12E+04,2.48E+04,,,,,,5.33E+04,,3.70E+04,5.03E+04,,,,,,,,,,4.12E+04,1.28E+03,,,,,,3.19E+02,,3.00E+02,6.77E+03,,,,,,,0,FALSE,5.572,3,2,920,105.8,5.35,2,protein metabolism,,Pf00443,57646,B4E3L3,ENSG00000048028,,Warburg effect modulated by deubiquitinating enzymes and their substrates,1,0,34.94,,18.57,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,35.1,,,7.78,other molecular function,0,
Master Protein,Medium,A0A0A0MT33,SCAF8,SR-related CTD associated factor 8 OS=Homo sapiens OX=9606 GN=SCAF8 PE=1 SV=1,1,1,100,0.382,,100,6.64,-1.39,,6.64,1.00E-17,5.06E-01,,1.00E-17,1.06E+05,,4.06E+04,,1,,3,,,,,1.06E+05,,,,,,,,4.06E+04,,9.65E+04,2.38E+04,,,,,,,,,1.06E+05,,,,,,,,1.82E+03,,1.30E+04,5.93E+02,,,,,,0.015,FALSE,2.105,1,1,1349,148.8,9.06,1,,nucleus,"Pf00076, Pf04818",22828,A0A0A0MT33,ENSG00000213079,,,0,0,,,70.86,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,85.79,,,2.05,nucleic acid binding activity,0,
Master Protein,High,Q9NNW7,TXNRD2,"Thioredoxin reductase 2, mitochondrial OS=Homo sapiens OX=9606 GN=TXNRD2 PE=1 SV=3",3,5,100,0.182,100,0.13,6.64,-2.46,6.64,-2.94,1.00E-17,8.19E-02,1.00E-17,9.08E-02,5.87E+05,,1.13E+05,8.66E+05,2,,4,3,,,,1.65E+05,2.09E+06,,,,,,,2.03E+05,5.61E+04,1.13E+05,1.13E+05,4.05E+05,,,8.66E+05,3.39E+06,,,,1.65E+05,1.08E+05,,,,,,,9.05E+03,4.56E+02,1.52E+04,2.81E+03,7.90E+02,,,2.03E+04,3.61E+04,0,FALSE,8.709,10,3,524,56.5,7.5,3,stress response;other biological processes,cytosol;mitochondrion;other cell component,"Pf02852, Pf07992",10587,hsa:10587; O95840; Q96IJ2; Q9H2Z5; Q9NNW7; Q9NZV3; Q9NZV4; Q9P2Y0; Q9P2Y1; Q9UQU8,ENSG00000184470,Detoxification of Reactive Oxygen Species,Selenium micronutrient network; Selenium micronutrient network ; Selenium micronutrient network; Selenium metabolism and selenoproteins; Oxidative stress response; 22q11.2 copy number variation syndrome,7,0,120.76,,50.04,103.44,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,,127.98,,94.38,13.65,other molecular function,0,
Master Protein,High,Q9UNI6,DUSP12,Dual specificity protein phosphatase 12 OS=Homo sapiens OX=9606 GN=DUSP12 PE=1 SV=1,1,1,100,1.663,,100,6.64,0.73,,6.64,1.00E-17,3.62E-01,,1.00E-17,4.45E+04,,7.40E+04,,1,,3,,,,,4.45E+04,,,,,,,,5.99E+04,8.71E+04,7.40E+04,,,,,,,,,,4.45E+04,,,,,,,,2.67E+03,7.08E+02,9.97E+03,,,,,,,0.002,FALSE,2.912,6,1,340,37.7,6.84,1,protein metabolism;other metabolic processes,cytosol;nucleus;other cell component,Pf00782,11266,hsa:11266; Q5VXA8; Q9UNI6,ENSG00000081721,,,0,0,,,18.51,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,26.36,,,3.32,other molecular function,0,
Master Protein,High,O43264,ZW10,Centromere/kinetochore protein zw10 homolog OS=Homo sapiens OX=9606 GN=ZW10 PE=1 SV=3,2,3,100,1.345,100,0.555,6.64,0.43,6.64,-0.85,1.00E-17,4.56E-01,1.00E-17,7.38E-01,1.09E+05,,1.47E+05,2.65E+05,1,,3,1,,,,1.09E+05,,,,,,,,1.49E+05,,1.02E+05,1.47E+05,,2.65E+05,,,,,,,1.09E+05,,,,,,,,6.65E+03,,1.38E+04,3.65E+03,,7.43E+04,,,,0.001,FALSE,4.083,4,2,779,88.8,6.27,2,cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,"Pf06248, Pf20665, Pf20666",9183,A1A528; hsa:9183; O43264,ENSG00000086827,COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,7,0,,,19.95,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,1.92,,1.89,7.44,nucleic acid binding activity,0,
Master Protein,High,O43678,NDUFA2,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 OS=Homo sapiens OX=9606 GN=NDUFA2 PE=1 SV=3,2,7,100,1.084,100,0.979,6.64,0.12,6.64,-0.03,1.00E-17,4.65E-01,1.00E-17,8.62E-01,5.04E+05,,1.02E+06,1.05E+06,3,,4,1,,,2.74E+05,2.49E+06,5.04E+05,,,,,,,7.87E+05,4.43E+05,1.44E+06,1.33E+06,,,,1.05E+06,,,,2.68E+03,2.49E+06,2.60E+04,,,,,,,3.52E+04,3.60E+03,1.94E+05,3.31E+04,,,,2.45E+04,,0,FALSE,9.889,31,2,99,10.9,9.57,2,cell organization and biogenesis;other metabolic processes;transport;developmental processes,other membranes;mitochondrion,Pf05047,4695,D6RJD6; hsa:4695; O43678; Q6IAY8,ENSG00000131495,Complex I biogenesis; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,6,0,111.86,,46.82,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,124.7,,43.68,23.79,transporter activity,0,
Master Protein,High,Q9ULG1,INO80,Chromatin-remodeling ATPase INO80 OS=Homo sapiens OX=9606 GN=INO80 PE=1 SV=2,2,2,100,0.088,100,0.02,6.64,-3.51,6.64,-5.66,1.00E-17,1.29E-02,1.00E-17,6.28E-04,1.68E+05,,2.69E+05,2.31E+05,2,,1,4,,,,2.86E+05,9.86E+04,,,,,,,,,2.69E+05,,1.88E+05,6.10E+04,6.91E+05,,2.83E+05,,,,2.86E+05,5.09E+03,,,,,,,,,3.63E+04,,3.67E+02,1.72E+04,4.90E+03,,3.01E+03,0,FALSE,5.404,2,2,1556,176.6,9.5,2,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;cytoskeleton;nucleus,"Pf00176, Pf00271, Pf13892",54617,A6H8X4; hsa:54617; Q9NTG6; Q9ULG1,ENSG00000128908,UCH proteinases; DNA Damage Recognition in GG-NER,,2,0,68.98,,,89.07,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,,131.99,,71.29,6.02,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,B3KS98,EIF3H,Eukaryotic translation initiation factor 3 subunit H OS=Homo sapiens OX=9606 GN=EIF3H PE=1 SV=1,2,3,100,1.72,100,2.056,6.64,0.78,6.64,1.04,1.00E-17,2.62E-01,1.00E-17,4.44E-01,1.84E+05,,1.88E+05,9.12E+04,4,,2,2,3.17E+05,,6.90E+04,1.88E+05,1.81E+05,,,,,,2.40E+05,,,1.47E+05,,,7.47E+04,,1.11E+05,,1.26E+03,,6.74E+02,1.88E+05,9.32E+03,,,,,,1.43E+03,,,1.98E+04,,,2.10E+04,,2.60E+03,,0,FALSE,7.792,8,2,366,41.6,7.33,2,cell organization and biogenesis;protein metabolism;other metabolic processes,translational apparatus;other cell component,"Pf01398, Pf19445",,B3KS98,ENSG00000147677,,Measles virus infection,1,0,53.7,,34.05,27.82,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,78.26,,68.15,4.68,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8IWA0,WDR75,WD repeat-containing protein 75 OS=Homo sapiens OX=9606 GN=WDR75 PE=1 SV=1,1,2,100,0.621,,100,6.64,-0.69,,6.64,1.00E-17,9.01E-01,,1.00E-17,3.89E+05,,2.42E+05,,1,,2,,,,,3.89E+05,,,,,,,,1.33E+05,,4.40E+05,,,,,,,,,,3.89E+05,,,,,,,,5.93E+03,,5.92E+04,,,,,,,0.002,FALSE,3.015,2,1,830,94.4,5.96,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf00400,84128,hsa:84128; Q8IWA0; Q96J10; Q9H8U8; Q9H9U5; Q9H9V8; Q9UIX2,ENSG00000115368,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,,,75.78,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,94.09,,,6.29,,0,
Master Protein,High,Q02543,RPL18A,60S ribosomal protein L18a OS=Homo sapiens OX=9606 GN=RPL18A PE=1 SV=2,2,2,100,0.295,100,0.156,6.64,-1.76,6.64,-2.68,1.00E-17,3.22E-01,1.00E-17,1.18E-01,2.98E+05,,8.81E+04,5.63E+05,1,,3,1,,,,2.98E+05,,,,,,,3.34E+05,8.81E+04,,4.85E+04,,,,5.63E+05,,,,,,2.98E+05,,,,,,,2.00E+03,3.94E+03,,6.54E+03,,,,3.99E+03,,,0.001,FALSE,3.764,10,2,176,20.7,10.71,2,protein metabolism;other metabolic processes,cytosol;translational apparatus;other cell component,Pf01775,6142,hsa:6142; Q02543,ENSG00000105640,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),VEGFA-VEGFR2 signaling; Cytoplasmic ribosomal proteins,15,0,,,98.56,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,109.13,,109.13,4.97,other molecular function,0,
Master Protein,High,D6RE79,MFSD10,Major facilitator superfamily domain containing 10 OS=Homo sapiens OX=9606 GN=MFSD10 PE=1 SV=1,1,4,100,1.949,100,8.097,6.64,0.96,6.64,3.02,1.00E-17,1.56E-01,1.00E-17,3.42E-02,3.42E+05,,6.67E+05,8.24E+04,1,,5,1,,,,3.42E+05,,,,,,,4.66E+06,1.43E+05,7.71E+05,6.05E+05,6.67E+05,,8.24E+04,,,,,,,3.42E+05,,,,,,,2.79E+04,6.41E+03,6.26E+03,8.16E+04,1.66E+04,,2.32E+04,,,,0.004,FALSE,2.549,3,1,480,50.4,9.69,1,transport,other membranes,Pf00083,,D6RE79,ENSG00000109736,,,0,0,,,135.47,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,22.99,,22.99,12.07,transporter activity,0,
Master Protein,High,Q969Z0,TBRG4,FAST kinase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=TBRG4 PE=1 SV=1,1,2,100,2.858,100,1.141,6.64,1.52,6.64,0.19,1.00E-17,1.30E-01,1.00E-17,7.50E-01,3.76E+04,,1.53E+05,1.34E+05,2,,4,1,,,,6.86E+04,2.06E+04,,,,,,,2.18E+04,2.30E+05,1.67E+05,1.40E+05,,,,1.34E+05,,,,,6.86E+04,1.06E+03,,,,,,,9.74E+02,1.87E+03,2.26E+04,3.48E+03,,,,3.14E+03,,0.001,FALSE,3.207,2,1,631,70.7,7.42,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,mitochondrion;other cell component,"Pf06743, Pf08368, Pf08373",9238,A4D2L2; A4D2L3; D3DVL5; D3DVL6; hsa:9238; O14710; Q53GI8; Q8NDM4; Q969Z0; Q9BUC6; Q9Y2F6,ENSG00000136270,FASTK family proteins regulate processing and stability of mitochondrial RNAs,,1,0,76.11,,62.33,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,112.56,,43.92,4.97,,0,
Master Protein,High,A0A669KBL1,USP7,Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=1,7,13,100,0.86,100,0.591,6.64,-0.22,6.64,-0.76,1.00E-17,7.80E-01,1.00E-17,7.43E-01,3.20E+05,,2.79E+05,4.32E+05,4,,3,4,,5.94E+05,1.06E+05,5.14E+05,2.00E+05,,,,,,,,2.79E+05,1.08E+06,2.22E+05,9.37E+04,4.73E+05,,3.96E+05,1.19E+06,,2.26E+03,1.03E+03,5.14E+05,1.03E+04,,,,,,,,2.27E+03,1.45E+05,5.52E+03,1.83E+02,1.33E+05,,9.26E+03,1.27E+04,0,FALSE,26.663,10,7,1137,132.2,6.05,7,protein metabolism,,"Pf00443, Pf00917, Pf12436, Pf14533",,A0A669KBL1,ENSG00000187555,,Nucleotide excision repair in xeroderma pigmentosum,1,0,67.02,,90.79,86.34,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,1,,FALSE,,81.95,,49.47,37.41,other molecular function,0,
Master Protein,Medium,Q8TAG9,EXOC6,Exocyst complex component 6 OS=Homo sapiens OX=9606 GN=EXOC6 PE=1 SV=3,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.01E+03,,,6.59E+04,1,,,1,,,,1.01E+03,,,,,,,,,,,,,6.59E+04,,,,,,,1.01E+03,,,,,,,,,,,,,1.85E+04,,,,0.022,FALSE,1.957,2,1,804,93.7,6.2,1,cell cycle OR cell proliferation;cell organization and biogenesis;transport,plasma membrane;other membranes;cytosol;other cell component,"Pf04091, Pf20651",54536,E9PHI3; hsa:54536; Q5VXH8; Q8TAG9; Q9NZ24,ENSG00000138190,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing; VxPx cargo-targeting to cilium,Interactions between LOXL4 and oxidative stress pathway; Ciliary landscape,5,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,2.35,,0,
Master Protein,High,Q9HBH1,PDF,"Peptide deformylase, mitochondrial OS=Homo sapiens OX=9606 GN=PDF PE=1 SV=1",2,2,100,0.429,100,,6.64,-1.22,6.64,,1.00E-17,5.56E-01,1.00E-17,,3.55E+05,,1.18E+05,2.16E+05,1,,2,1,,,,3.55E+05,,,,,,,,3.07E+05,,4.55E+04,,,,,,2.16E+05,,,,3.55E+05,,,,,,,,1.37E+04,,6.12E+03,,,,,,2.30E+03,0,FALSE,6.632,16,2,243,27,9.16,2,protein metabolism;other metabolic processes;other biological processes,mitochondrion,Pf01327,64146,hsa:64146; Q8WUN6; Q9HBH1,ENSG00000258429,,,0,0,,,104.93,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,164.09,,,6.55,other molecular function,0,
Master Protein,Medium,Q99541,PLIN2,Perilipin-2 OS=Homo sapiens OX=9606 GN=PLIN2 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.74E+05,,,,1,,,,,,,1.74E+05,,,,,,,,,,,,,,,,,,,,1.74E+05,,,,,,,,,,,,,,,,,0.012,FALSE,2.187,3,1,437,48,6.8,1,cell organization and biogenesis;stress response;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,Pf03036,123,hsa:123; Q99541; Q9BSC3,ENSG00000147872,PPARA activates gene expression; Late endosomal microautophagy; Lipophagy; Chaperone Mediated Autophagy,Adipogenesis,5,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,1.8,,0,
Master Protein,High,A0A087X159,SSBP2,Single stranded DNA binding protein 2 OS=Homo sapiens OX=9606 GN=SSBP2 PE=1 SV=1,2,2,100,0.362,,100,6.64,-1.46,,6.64,1.00E-17,4.83E-01,,1.00E-17,1.77E+05,,9.08E+03,,1,,1,,,,,1.77E+05,,,,,,,,9.08E+03,,,,,,,,,,,,1.77E+05,,,,,,,,4.06E+02,,,,,,,,,0,FALSE,5.742,11,2,369,38.7,6.42,2,,nucleus,Pf04503,23635,A0A087X159,ENSG00000145687,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,7.8,nucleic acid binding activity,0,
Master Protein,High,O95985,TOP3B,DNA topoisomerase 3-beta-1 OS=Homo sapiens OX=9606 GN=TOP3B PE=1 SV=1,1,1,100,1.485,,100,6.64,0.57,,6.64,1.00E-17,3.98E-01,,1.00E-17,1.91E+04,,2.84E+04,,1,,1,,,,,1.91E+04,,,,,,,,,,,2.84E+04,,,,,,,,,1.91E+04,,,,,,,,,,,7.05E+02,,,,,,0.001,FALSE,3.817,2,1,862,96.6,8.12,1,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes,nucleus;other cell component,"Pf01131, Pf01751",8940,A0M8Q3; hsa:8940; O95985; Q9BUP5,ENSG00000100038,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.21,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O00268,TAF4,Transcription initiation factor TFIID subunit 4 OS=Homo sapiens OX=9606 GN=TAF4 PE=1 SV=2,1,2,100,0.488,,100,6.64,-1.04,,6.64,1.00E-17,6.67E-01,,1.00E-17,2.02E+05,,9.87E+04,,1,,1,,,,,2.02E+05,,,,,,,,,,9.87E+04,,,,,,,,,,2.02E+05,,,,,,,,,,1.33E+04,,,,,,,0,FALSE,6.263,3,1,1085,110,9.94,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf05236, Pf07531",6874,A6NGD9; hsa:6874; O00268; Q5TBP6; Q99721; Q9BR40; Q9BX42,ENSG00000130699,RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,,9,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,8.18,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,High,O15127,SCAMP2,Secretory carrier-associated membrane protein 2 OS=Homo sapiens OX=9606 GN=SCAMP2 PE=1 SV=2,2,3,100,0.697,100,2.247,6.64,-0.52,6.64,1.17,1.00E-17,9.93E-01,1.00E-17,3.87E-01,3.38E+05,,2.36E+05,1.05E+05,1,,2,1,,,,3.38E+05,,,,,,,,,,2.53E+05,2.20E+05,,1.05E+05,,,,,,,3.38E+05,,,,,,,,,,3.41E+04,5.46E+03,,2.95E+04,,,,0,FALSE,12.698,6,2,329,36.6,6.1,2,transport,other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf04144,10066,B2RDF0; hsa:10066; O15127; Q9BQE8,ENSG00000140497,,Serotonin transporter activity; Monoamine transport,2,0,,,9.98,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,10.48,,10.48,13.99,,0,
Master Protein,Medium,G3XAK1,MST1,Macrophage stimulating 1 OS=Homo sapiens OX=9606 GN=MST1 PE=1 SV=1,1,2,100,0.835,,100,6.64,-0.26,,6.64,1.00E-17,7.77E-01,,1.00E-17,2.27E+05,,1.90E+05,,1,,4,,,,,2.27E+05,,,,,,,,1.43E+05,1.90E+05,1.93E+05,1.90E+05,,,,,,,,,2.27E+05,,,,,,,,6.39E+03,1.54E+03,2.60E+04,4.71E+03,,,,,,0.015,FALSE,2.105,1,1,725,81.9,7.8,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes,other cytoplasmic organelle,"Pf00024, Pf00051, Pf00089",4485,G3XAK1; hsa:4485,ENSG00000173531,,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-YAP signaling; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Leukocyte-intrinsic Hippo pathway functions; Pleural mesothelioma; Macrophage-stimulating protein (MSP) signaling network map,7,0,,,13.41,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,1.34,,,4.69,signal transduction activity or receptor binding;kinase activity;other molecular function,0,
Master Protein,High,B8ZZA8,GLS; LOC109682737,glutaminase OS=Homo sapiens OX=9606 GN=GLS PE=1 SV=1,3,7,100,0.326,,100,6.64,-1.62,,6.64,1.00E-17,3.42E-01,,1.00E-17,4.67E+05,,1.52E+05,,1,,3,,,,,4.67E+05,,,,,,,,1.36E+05,1.92E+05,1.52E+05,,,,,,,,,,4.67E+05,,,,,,,,6.06E+03,1.56E+03,2.05E+04,,,,,,,0,FALSE,14.482,28,1,169,18.6,6.86,3,other metabolic processes,mitochondrion,Pf04960,,A0A2J8N4F2; A0A2J8WVT4; A0A5J5MKD6; A0A5N3W8W8; A0A7J7YI57; A0A7J8FST2; A0A8C0SMW8; A0A8C0XDF4; A0A8C2NE80; A0A8C9JEH0; A0A8D1LXB0; A0A8P0PE65,ENSCAFG00000009513; ENSCAFG00040014548; ENSCCNG00000023198; ENSCHIG00010002061; ENSPTIG00000005669; ENSSSCG00015079343; ENSSSCG00025054136; ENSSSCG00030041682; ENSSSCG00035011835; ENSSSCG00045023594; ENSSSCG00050025871; ENSSSCG00060030677,,,0,0,,,18.05,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,18.41,,,15.31,other molecular function,0,
Master Protein,High,P19652,ORM2,Alpha-1-acid glycoprotein 2 OS=Homo sapiens OX=9606 GN=ORM2 PE=1 SV=2,2,3,100,0.753,100,1.298,6.64,-0.41,6.64,0.38,1.00E-17,8.65E-01,1.00E-17,6.61E-01,7.10E+05,,5.35E+05,4.49E+05,1,,5,3,,7.10E+05,,,,,,,,,1.97E+05,2.91E+05,5.35E+05,1.37E+06,7.18E+05,,7.04E+05,,1.52E+05,4.49E+05,,2.70E+03,,,,,,,,,1.18E+03,1.30E+04,4.34E+03,1.85E+05,1.78E+04,,1.98E+05,,3.56E+03,4.78E+03,0,FALSE,7.629,13,2,201,23.6,5.11,2,stress response;other biological processes,non-structural extracellular;other cytoplasmic organelle;other cell component,Pf00061,5005,B2R5L2; hsa:5005; P19652; Q16571; Q5T538; Q6IB74,ENSG00000228278,Neutrophil degranulation; Platelet degranulation,Vitamin D receptor pathway,3,0,,,74.87,63.49,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,,90.46,,74.34,6.81,,0,
Master Protein,High,A0A994J7H4,NPLOC4,"NPL4 homolog, ubiquitin recognition factor OS=Homo sapiens OX=9606 GN=NPLOC4 PE=4 SV=1",2,3,100,1.207,100,1.095,6.64,0.27,6.64,0.13,1.00E-17,5.34E-01,1.00E-17,7.93E-01,7.09E+04,,1.85E+05,3.70E+04,2,,5,4,,,,7.66E+04,6.56E+04,,,,,,2.58E+05,5.87E+04,1.93E+05,1.85E+05,3.03E+04,,7.64E+04,4.13E+04,3.32E+04,3.29E+04,,,,7.66E+04,3.38E+03,,,,,,1.54E+03,2.62E+03,1.57E+03,2.49E+04,7.54E+02,,2.15E+04,2.93E+02,7.77E+02,3.50E+02,0,FALSE,7.877,4,2,651,72.4,6.76,2,protein metabolism;other metabolic processes,,,,A0A994J7H4,ENSG00000182446,,,0,0,10.99,,66.6,45.03,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,65.8,,70.69,8.81,other molecular function,0,
Master Protein,High,Q13825,AUH,"Methylglutaconyl-CoA hydratase, mitochondrial OS=Homo sapiens OX=9606 GN=AUH PE=1 SV=1",3,7,100,0.432,100,0.996,6.64,-1.21,6.64,-0.01,1.00E-17,5.52E-01,1.00E-17,8.52E-01,4.38E+05,,1.82E+05,1.32E+05,2,,4,3,,,,3.50E+05,5.48E+05,,,,,,,3.37E+04,2.62E+05,1.55E+05,2.14E+05,3.11E+05,9.89E+04,,1.32E+05,,,,,3.50E+05,2.83E+04,,,,,,,1.51E+03,2.13E+03,2.09E+04,5.31E+03,6.07E+02,2.78E+04,,3.09E+03,,0,FALSE,7.798,9,3,339,35.6,9.48,3,other metabolic processes,mitochondrion,Pf00378,549,B1ALV7; B1ALV8; hsa:549; Q13825; Q8WUE4,ENSG00000148090,Branched-chain amino acid catabolism,Amino acid metabolism,2,0,31.18,,59.3,63.25,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,89.87,,76.98,17,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75368,SH3BGRL,Adapter SH3BGRL OS=Homo sapiens OX=9606 GN=SH3BGRL PE=1 SV=1,2,6,100,6.56,,100,6.64,2.71,,6.64,1.00E-17,1.99E-02,,1.00E-17,1.02E+04,,6.66E+04,,1,,2,,,,,1.02E+04,,,,,,,,4.75E+04,,9.33E+04,,,,,,,,,,1.02E+04,,,,,,,,2.12E+03,,1.26E+04,,,,,,,0,FALSE,7.685,35,2,114,12.8,5.25,2,protein metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf04908,6451,hsa:6451; O75368; Q3SYL1; Q5JT50; Q6FIE8; Q9H0N8,ENSG00000131171,,,0,0,,,46.01,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,51,,,22.42,other molecular function,0,
Master Protein,High,A0A1B0GVF3,CPT2,Carnitine palmitoyltransferase 2 OS=Homo sapiens OX=9606 GN=CPT2 PE=1 SV=1,4,16,100,1.954,100,0.975,6.64,0.97,6.64,-0.04,1.00E-17,1.40E-01,1.00E-17,8.30E-01,3.23E+05,,8.87E+05,6.12E+05,4,,5,4,1.90E+05,,6.38E+04,5.48E+05,1.06E+06,,,,,,4.54E+05,8.07E+05,2.31E+06,8.87E+05,1.09E+06,1.09E+06,3.43E+05,2.38E+05,1.55E+06,,7.56E+02,,6.23E+02,5.48E+05,5.47E+04,,,,,,2.72E+03,3.61E+04,1.87E+04,1.19E+05,2.70E+04,2.13E+03,9.63E+04,1.68E+03,3.62E+04,,0,FALSE,17.333,8,4,670,75.2,8.5,4,other metabolic processes,mitochondrion;nucleus,Pf00755,,A0A1B0GVF3,ENSG00000157184,,PPAR-alpha pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Thermogenesis,4,0,95.85,,63.88,77.58,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,,97.56,,111.98,41.99,other molecular function,0,
Master Protein,High,Q14692,BMS1,Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens OX=9606 GN=BMS1 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,4.72E+04,,,,1,,,,,,,4.72E+04,,,,,,,,,,,,,,,,,,,,4.72E+04,,,,,,,,,,,,,,,,,0.001,FALSE,3.797,1,1,1282,145.7,6.44,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf04950, Pf08142",9790,hsa:9790; Q14692; Q5QPT5; Q86XJ9,ENSG00000165733,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.6,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75177,SS18L1,Calcium-responsive transactivator OS=Homo sapiens OX=9606 GN=SS18L1 PE=1 SV=2,1,1,100,0.363,100,0.467,6.64,-1.46,6.64,-1.1,1.00E-17,4.72E-01,1.00E-17,6.48E-01,1.09E+05,,3.95E+04,8.45E+04,1,,1,3,,,,1.09E+05,,,,,,,,,,3.95E+04,,2.86E+05,6.29E+04,,8.45E+04,,,,,1.09E+05,,,,,,,,,,5.32E+03,,5.58E+02,1.77E+04,,1.98E+03,,0,FALSE,4.593,5,1,396,43,6.44,1,cell organization and biogenesis;developmental processes;other biological processes,cytosol;nucleus;other cell component,Pf05030,26039,A6NNE3; A8K620; B3KWR8; E1P5H7; hsa:26039; O75177; Q5JXJ3; Q6MZV9; Q6NTH3; Q6XYD9; Q8NE69; Q9BR55; Q9H4K6,ENSG00000184402,,,0,0,,,,85.17,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,0,,37.91,3.01,other molecular function,0,
Master Protein,High,Q9H936,SLC25A22,Mitochondrial glutamate carrier 1 OS=Homo sapiens OX=9606 GN=SLC25A22 PE=1 SV=1,2,2,100,0.677,100,0.261,6.64,-0.56,6.64,-1.94,1.00E-17,9.95E-01,1.00E-17,3.65E-01,6.67E+04,,5.30E+04,1.90E+05,3,,4,5,4.95E+04,6.67E+04,,4.77E+05,,,,,,,5.35E+04,2.47E+05,,3.17E+04,5.25E+04,2.10E+05,6.79E+03,1.40E+05,2.92E+05,1.90E+05,1.97E+02,2.53E+02,,4.77E+05,,,,,,,3.20E+02,1.10E+04,,4.27E+03,1.31E+03,4.10E+02,1.91E+03,9.91E+02,6.84E+03,2.02E+03,0,FALSE,7.79,13,2,323,34.4,9.29,2,other metabolic processes;transport;other biological processes,other membranes;mitochondrion,Pf00153,79751,A8K366; C9J1H6; E9PJD3; E9PKB2; E9PL68; E9PN26; E9PNQ3; E9PP01; E9PR97; hsa:79751; Q8TBU8; Q9H936,ENSG00000177542,Organic anion transporters,,1,0,122.4,,104.96,62.85,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,,53.59,,55.06,5.27,transporter activity,0,
Master Protein,High,A0A140T928,HLA-DPB1,"HLA class II histocompatibility antigen, DP beta 1 chain (Fragment) OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1",5,24,100,0.357,,100,6.64,-1.49,,6.64,1.00E-17,4.06E-01,,1.00E-17,4.00E+05,,1.43E+05,,1,,1,,,,,4.00E+05,,,,,,,,,,1.43E+05,,,,,,,,,,4.00E+05,,,,,,,,,,1.92E+04,,,,,,,0,FALSE,35.084,30,1,235,27.1,7.44,5,other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00969, Pf07654",,A0A140T928,ENSG00000236693,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,69.97,,0,
Master Protein,High,Q92900,UPF1,Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1 PE=1 SV=2,4,12,100,0.311,100,1.162,6.64,-1.68,6.64,0.22,1.00E-17,3.11E-01,1.00E-17,7.81E-01,3.10E+05,,1.70E+05,2.07E+04,2,,4,1,,,,7.65E+05,1.25E+05,,,,,,,2.36E+05,4.44E+04,5.14E+05,1.22E+05,,2.07E+04,,,,,,,7.65E+05,6.47E+03,,,,,,,1.05E+04,3.61E+02,6.93E+04,3.03E+03,,5.82E+03,,,,0,FALSE,18.201,7,4,1129,124.3,6.61,4,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes,cytosol;nucleus;other cell component,"Pf09416, Pf13086, Pf13087, Pf18141",5976,hsa:5976; O00239; O43343; Q86Z25; Q92842; Q92900,ENSG00000005007,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Pathophysiological roles of DUX4 in FSHD1,3,0,101.58,,89.76,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,92.07,,69.21,36.87,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q7Z6I8,C5orf24,UPF0461 protein C5orf24 OS=Homo sapiens OX=9606 GN=C5orf24 PE=1 SV=1,3,3,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,3.37E+05,,,4.22E+05,3,,,3,,,1.73E+06,3.37E+05,9.81E+04,,,,,,,,,,,,2.09E+05,4.22E+05,,7.03E+05,,,1.69E+04,3.37E+05,5.06E+03,,,,,,,,,,,,5.88E+04,2.99E+03,,7.49E+03,0,FALSE,14.824,34,3,188,20.1,9.85,3,,,Pf17724,134553,D3DQA7; hsa:134553; Q7Z6I8; Q86Y53; Q8N1T9,ENSG00000181904,,,0,0,122.11,,,55.72,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,1,Acetyl [N-Term],FALSE,,,,,11.35,,0,
Master Protein,High,H0YI09,TMT1A,Methyltransferase like 7A (Fragment) OS=Homo sapiens OX=9606 GN=METTL7A PE=1 SV=1,1,2,100,0.917,100,2.43,6.64,-0.12,6.64,1.28,1.00E-17,6.90E-01,1.00E-17,3.62E-01,1.94E+05,,2.23E+05,9.19E+04,3,,3,1,1.94E+05,,8.61E+04,3.40E+05,,,,,,,,2.23E+05,,7.90E+04,3.07E+05,,9.19E+04,,,,7.71E+02,,8.41E+02,3.40E+05,,,,,,,,9.97E+03,,1.06E+04,7.64E+03,,2.58E+04,,,,0.001,FALSE,3.581,5,1,244,28.3,8.38,1,,other membranes,Pf08241,,H0YI09,ENSG00000185432,,,0,0,61.7,,56.86,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,62.39,,55.92,5.44,other molecular function,0,
Master Protein,High,Q9P253,VPS18,Vacuolar protein sorting-associated protein 18 homolog OS=Homo sapiens OX=9606 GN=VPS18 PE=1 SV=2,1,1,100,0.773,,100,6.64,-0.37,,6.64,1.00E-17,8.60E-01,,1.00E-17,5.54E+03,,4.28E+03,,1,,1,,,,,5.54E+03,,,,,,,,,,4.28E+03,,,,,,,,,,5.54E+03,,,,,,,,,,5.77E+02,,,,,,,0.01,FALSE,2.296,2,1,973,110.1,6.07,1,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,other membranes;cytoskeleton;other cytoplasmic organelle;other cell component,Pf05131,57617,hsa:57617; Q8TCG0; Q96DI3; Q9H268; Q9P253,ENSG00000104142,SARS-CoV-2 modulates autophagy,"Ebola virus infection in host; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins",3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.37,cytoskeletal activity;other molecular function,0,
Master Protein,Medium,Q9UBV7,B4GALT7,"Beta-1,4-galactosyltransferase 7 OS=Homo sapiens OX=9606 GN=B4GALT7 PE=1 SV=1",1,1,100,5.794,100,3.843,6.64,2.53,6.64,1.94,1.00E-17,1.70E-03,1.00E-17,2.04E-01,4.91E+06,,1.58E+07,4.11E+06,3,,2,2,,9.85E+06,4.91E+06,2.66E+05,,,,,,,,,4.03E+07,6.18E+06,,,1.28E+06,,1.32E+07,,,3.74E+04,4.79E+04,2.66E+05,,,,,,,,,3.27E+05,8.32E+05,,,3.59E+05,,3.09E+05,,0.023,FALSE,1.937,5,1,327,37.4,8.98,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi,"Pf02709, Pf13733",11285,B3KN39; hsa:11285; Q9UBV7; Q9UHN2,ENSG00000027847,"A tetrasaccharide linker sequence is required for GAG synthesis; Defective B4GALT7 causes EDS, progeroid type",Proteoglycan biosynthesis; 5q35 copy number variation; Glycosaminoglycan synthesis in fibroblasts,5,0,95.72,,103.82,116.46,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,124.13,,84.26,2.64,other molecular function,0,
Master Protein,High,O60508,CDC40,Pre-mRNA-processing factor 17 OS=Homo sapiens OX=9606 GN=CDC40 PE=1 SV=1,3,6,100,0.464,100,3.364,6.64,-1.11,6.64,1.75,1.00E-17,6.63E-01,1.00E-17,1.90E-01,3.29E+05,,7.46E+04,3.64E+04,2,,4,1,,1.85E+05,,5.87E+05,,,,,,,,1.02E+05,3.62E+04,3.85E+05,5.48E+04,,3.64E+04,,,,,7.02E+02,,5.87E+05,,,,,,,,4.54E+03,2.94E+02,5.18E+04,1.36E+03,,1.02E+04,,,,0,FALSE,13.189,9,3,579,65.5,7.06,3,RNA metabolism OR transcription;other metabolic processes;developmental processes,nucleus,Pf00400,51362,B2RBC5; hsa:51362; O60508; O75471; Q5SRN0; Q9UPG1,ENSG00000168438,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,mRNA processing,5,0,73.7,,112.62,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,69.04,,0,20.32,nucleic acid binding activity,0,
Master Protein,High,A0A8V8TM71,TRNT1,tRNA nucleotidyl transferase 1 OS=Homo sapiens OX=9606 GN=TRNT1 PE=1 SV=1,2,3,100,1.414,100,27.989,6.64,0.5,6.64,4.81,1.00E-17,3.56E-01,1.00E-17,3.52E-03,2.02E+05,,3.33E+05,1.02E+04,2,,3,2,,,,2.56E+05,1.59E+05,,,,,,,2.35E+05,,3.46E+05,3.33E+05,,5.38E+03,,1.93E+04,,,,,2.56E+05,8.20E+03,,,,,,,1.05E+04,,4.66E+04,8.27E+03,,1.51E+03,,4.51E+02,,0,FALSE,6.02,6,2,473,54,8.06,2,RNA metabolism OR transcription;other metabolic processes,,"Pf01743, Pf12627",,A0A8V8TM71,ENSG00000072756,,,0,0,32.93,,19.91,79.76,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,31.84,,83.44,2.89,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P49006,MARCKSL1,MARCKS-related protein OS=Homo sapiens OX=9606 GN=MARCKSL1 PE=1 SV=2,2,3,100,0.085,100,0.012,6.64,-3.56,6.64,-6.33,1.00E-17,1.15E-02,1.00E-17,1.74E-04,2.87E+05,,1.33E+04,1.07E+06,4,,1,1,,1.25E+06,6.56E+04,1.58E+04,3.47E+06,,,,,,,,,1.33E+04,,,,,,1.07E+06,,4.75E+03,6.41E+02,1.58E+04,1.79E+05,,,,,,,,,1.79E+03,,,,,,1.14E+04,0,FALSE,11.22,24,2,195,19.5,4.67,2,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytoskeleton;other cell component,Pf02063,65108,D3DPQ0; hsa:65108; P49006; Q5TEE6; Q6NXS5,ENSG00000175130,,,0,0,134.67,,,,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,169.88,,0,10.02,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9H0N5,PCBD2,Pterin-4-alpha-carbinolamine dehydratase 2 OS=Homo sapiens OX=9606 GN=PCBD2 PE=1 SV=4,2,7,100,1.204,100,0.88,6.64,0.27,6.64,-0.18,1.00E-17,4.65E-01,1.00E-17,9.47E-01,3.11E+05,,6.14E+05,4.25E+05,3,,5,2,1.16E+06,,,2.96E+05,3.11E+05,,,,,,6.14E+05,2.45E+05,8.16E+04,7.53E+05,6.96E+05,,1.50E+05,,1.20E+06,,4.63E+03,,,2.96E+05,1.60E+04,,,,,,3.67E+03,1.09E+04,6.63E+02,1.01E+05,1.73E+04,,4.22E+04,,2.82E+04,,0,FALSE,6.065,18,2,130,14.4,9.11,2,other metabolic processes;other biological processes,nucleus,Pf01329,84105,hsa:84105; Q8TD40; Q9H0N5,ENSG00000132570,,,0,0,84.26,,62.17,110.09,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,94.27,,116.61,17.18,other molecular function,0,
Master Protein,High,A0A3B3IUB5,HM13,Histocompatibility minor 13 OS=Homo sapiens OX=9606 GN=HM13 PE=1 SV=1,1,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,8.84E+04,,,,1,,,,,,,8.84E+04,,,,,,,,,,,,,,,,,,,,8.84E+04,,,,,,,,,,,,,,,,,0,FALSE,6.937,6,1,420,46.3,8.03,1,,other membranes;ER/Golgi,Pf04258,,A0A3B3IUB5,ENSG00000101294,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,8.73,other molecular function,0,
Master Protein,High,Q9ULV4,CORO1C,Coronin-1C OS=Homo sapiens OX=9606 GN=CORO1C PE=1 SV=1,2,3,100,0.139,100,0.236,6.64,-2.84,6.64,-2.08,1.00E-17,4.19E-02,1.00E-17,3.30E-01,4.56E+05,,5.27E+04,2.06E+05,2,,3,3,,8.57E+05,,,2.43E+05,,,,,,,,5.27E+04,1.69E+05,2.88E+04,1.22E+05,1.35E+06,,,2.06E+05,,3.25E+03,,,1.25E+04,,,,,,,,4.28E+02,2.27E+04,7.15E+02,2.38E+02,3.80E+05,,,2.19E+03,0,FALSE,9.871,7,2,474,53.2,7.08,2,cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;other cytoplasmic organelle;other cell component,"Pf00400, Pf08953, Pf16300",23603,A7MAP0; A7MAP1; B3KU12; hsa:23603; Q9NSK5; Q9ULV4,ENSG00000110880,,,0,0,79.01,,89.73,122.69,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,,53.23,,67.31,10.04,cytoskeletal activity;other molecular function,0,
Master Protein,High,P42345,MTOR,Serine/threonine-protein kinase mTOR OS=Homo sapiens OX=9606 GN=MTOR PE=1 SV=1,2,4,100,0.588,100,2.548,6.64,-0.77,6.64,1.35,1.00E-17,8.58E-01,1.00E-17,3.89E-01,2.17E+05,,1.27E+05,5.00E+04,4,,1,1,1.09E+06,,6.01E+05,7.81E+04,7.75E+04,,,,,,,,,,1.27E+05,,,,5.00E+04,,4.33E+03,,5.87E+03,7.81E+04,4.00E+03,,,,,,,,,,3.17E+03,,,,1.17E+03,,0,FALSE,7.592,1,2,2549,288.7,7.17,2,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00454, Pf02259, Pf02260, Pf08771, Pf11865",2475,hsa:2475; P42345; Q4LE76; Q5TER1; Q6LE87; Q96QG3; Q9Y4I3,ENSG00000198793,Amino acids regulate mTORC1; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; Constitutive Signaling by AKT1 E17K in Cancer; PIP3 activates AKT signaling; Regulation of TP53 Degradation; CD28 dependent PI3K/Akt signaling; VEGFR2 mediated vascular permeability; HSF1-dependent transactivation,"AMP-activated protein kinase signaling; Target of rapamycin signaling; MicroRNAs in cardiomyocyte hypertrophy; Type II diabetes mellitus; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; Thymic stromal lymphopoietin (TSLP) signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; Polycystic kidney disease pathway; Cardiac hypertrophic response; Extracellular vesicle-mediated signaling in recipient cells; TSLP signaling pathway; Ovarian infertility; MECP2 and associated Rett syndrome; Wnt signaling pathway; BDNF-TrkB signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; ATM signaling in development and disease ; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; Clear cell renal cell carcinoma pathways; PI3K/AKT/mTOR - vitamin D3 signaling; PI3K-Akt signaling pathway; Somatroph axis (GH) and its relationship to dietary restriction and aging; Caloric restriction and aging; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Thermogenesis; EGF/EGFR signaling pathway; Synaptic signaling pathways associated with autism spectrum disorder; Hippo signaling regulation pathways; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Joubert syndrome; Gastrin signaling pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Regucalcin in proximal tubule epithelial kidney cells; CAMKK2 pathway; Neuroinflammation; Autophagy; p53 transcriptional gene network; Pleural mesothelioma; Orexin receptor pathway; CCL18 signaling pathway; Network map of SARS-CoV-2 signaling pathway; Sphingolipid metabolism in senescence; Alzheimer's disease; Th17 cell differentiation pathway; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; Clock-controlled autophagy in bone metabolism; Warburg effect modulated by deubiquitinating enzymes and their substrates; Acute myeloid leukemia; Primary ovarian insufficiency; Macrophage-stimulating protein (MSP) signaling network map; JAK-STAT signaling in the regulation of beta cells; ADHD and autism (ASD) linked metabolic pathways and SNP; GNAQ pathways in port-wine stain; Artemisinin inhibition of uveal melanoma; Interferon type I signaling pathways; ErbB signaling pathway",92,0,105.28,,,,High,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,179.1,,0,12.46,translation activity;nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,Q6P1X6,C8orf82,UPF0598 protein C8orf82 OS=Homo sapiens OX=9606 GN=C8orf82 PE=1 SV=2,6,7,100,0.811,100,0.108,6.64,-0.3,6.64,-3.21,1.00E-17,8.58E-01,1.00E-17,1.06E-01,2.28E+05,,8.99E+04,2.19E+05,2,,3,2,,,1.59E+05,3.27E+05,,,,,,,1.57E+05,8.99E+04,,2.36E+04,,,9.26E+04,,5.20E+05,,,,1.55E+03,3.27E+05,,,,,,,9.37E+02,4.01E+03,,3.19E+03,,,2.60E+04,,1.22E+04,,0,FALSE,26.22,32,6,216,23.9,9.14,6,,,Pf14956,414919,hsa:414919; Q6GMR2; Q6P1X6; Q6P2Q7,ENSG00000213563,,,0,0,48.96,,73.87,98.7,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,56.59,,144.48,22.88,,0,
Master Protein,High,G5E972,TMPO,Thymopoietin OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=1,16,166,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.94E+05,,,,3,,,,,1.22E+05,,1.94E+05,7.08E+05,,,,,,,,,,,,,,,,,4.65E+02,,1.94E+05,3.65E+04,,,,,,,,,,,,,,,,0,FALSE,102.371,48,1,414,46.3,9.03,16,,other membranes;nucleus,"Pf03020, Pf08198",7112,G5E972,ENSG00000120802,,Envelope proteins and their potential roles in EDMD physiopathology; Overlap between signal transduction pathways contributing to LMNA laminopathies,2,0,93.47,,,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,Phospho [T74],FALSE,,,,,492.02,nucleic acid binding activity,1,Phospho [T74]
Master Protein,High,Q9NX14,NDUFB11,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFB11 PE=1 SV=1",2,9,100,0.149,100,1.393,6.64,-2.74,6.64,0.48,1.00E-17,4.62E-02,1.00E-17,6.21E-01,3.35E+05,,6.70E+05,5.11E+05,3,,3,2,3.35E+05,,2.06E+05,1.34E+06,,,,,,,5.00E+04,,,8.87E+05,6.70E+05,,2.51E+05,,1.04E+06,,1.33E+03,,2.02E+03,1.34E+06,,,,,,,2.99E+02,,,1.20E+05,1.66E+04,,7.06E+04,,2.43E+04,,0,FALSE,12.967,22,2,153,17.3,5.22,2,cell organization and biogenesis;other metabolic processes,other membranes;mitochondrion,Pf10183,54539,hsa:54539; Q5JRR3; Q5JRR4; Q6IAB6; Q8WZ96; Q9BXX9; Q9NX14,ENSG00000147123,Complex I biogenesis,Nonalcoholic fatty liver disease,3,0,99.1,,81.1,86.31,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,High,n/a,High,n/a,High,n/a,1,,FALSE,,93.64,,94.06,30.65,,0,
Master Protein,High,Q9Y673,ALG5,Dolichyl-phosphate beta-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG5 PE=1 SV=1,1,1,100,0.419,,100,6.64,-1.26,,6.64,1.00E-17,5.83E-01,,1.00E-17,9.97E+04,,4.18E+04,,1,,2,,,,,9.97E+04,,,,,,,,6.21E+04,,2.81E+04,,,,,,,,,,9.97E+04,,,,,,,,2.77E+03,,3.79E+03,,,,,,,0.005,FALSE,2.504,6,1,324,36.9,9.28,1,protein metabolism;other metabolic processes;developmental processes,other membranes;ER/Golgi,Pf00535,29880,B4DR37; hsa:29880; Q5TBA6; Q9Y673,ENSG00000120697,Synthesis of dolichyl-phosphate-glucose,N-glycan biosynthesis,2,0,,,53.2,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,60.2,,,2.47,other molecular function,0,
Master Protein,High,P08240,SRPRA,Signal recognition particle receptor subunit alpha OS=Homo sapiens OX=9606 GN=SRPRA PE=1 SV=2,3,9,100,0.46,100,0.961,6.64,-1.12,6.64,-0.06,1.00E-17,5.77E-01,1.00E-17,8.60E-01,1.37E+06,,6.12E+05,4.42E+05,2,,5,3,,4.63E+06,,4.06E+05,,,,,,,2.62E+06,2.84E+04,4.67E+05,1.08E+06,6.12E+05,5.36E+05,3.01E+05,,4.42E+05,,,1.76E+04,,4.06E+05,,,,,,,1.57E+04,1.27E+03,3.80E+03,1.45E+05,1.52E+04,1.04E+03,8.46E+04,,1.03E+04,,0,FALSE,9.136,7,3,638,69.8,8.95,3,cell organization and biogenesis;other biological processes,other membranes;ER/Golgi,"Pf00448, Pf02881, Pf04086",6734,A6NIB3; B2R5Z8; B4E0H3; E9PJS4; hsa:6734; P08240; Q9BVJ4,ENSG00000182934,XBP1(S) activates chaperone genes; SRP-dependent cotranslational protein targeting to membrane,,2,0,118.63,,104.05,27.69,n/a,High,n/a,High,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,139.52,,92.4,21.11,other molecular function,0,
Master Protein,High,A0A8V8TLA4,RPSA,40S ribosomal protein SA OS=Homo sapiens OX=9606 GN=RPSA PE=1 SV=1,3,11,100,0.751,100,0.59,6.64,-0.41,6.64,-0.76,1.00E-17,8.48E-01,1.00E-17,7.84E-01,6.49E+05,,9.94E+05,8.76E+05,4,,5,3,2.42E+05,,2.59E+05,2.15E+06,1.62E+06,,,,,,9.94E+05,2.34E+05,1.22E+06,2.61E+06,4.73E+05,,4.50E+06,2.20E+05,8.76E+05,,9.60E+02,,2.53E+03,2.15E+06,8.38E+04,,,,,,5.94E+03,1.04E+04,9.90E+03,3.52E+05,1.17E+04,,1.26E+06,1.56E+03,2.05E+04,,0,FALSE,22.795,15,3,331,37,5.16,3,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes,plasma membrane;other membranes;cytosol;translational apparatus;nucleus,"Pf00318, Pf16122",,A0A8V8TLA4,ENSG00000168028,,,0,0,90.64,,84.01,123.54,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,High,n/a,1,,FALSE,,104.05,,125.54,41.99,other molecular function,0,
Master Protein,High,E7EWR4,CSTF2,Cleavage stimulation factor subunit 2 OS=Homo sapiens OX=9606 GN=CSTF2 PE=1 SV=1,2,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.16E+05,,,,1,,,,,,,3.16E+05,,,,,,,,,,,,,,,,,,,,3.16E+05,,,,,,,,,,,,,,,,,0,FALSE,7.063,7,1,597,62.9,6.87,2,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00076, Pf14304, Pf14327",1478,E7EWR4,ENSG00000101811,,mRNA processing,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,12.13,nucleic acid binding activity,0,
Master Protein,High,O75691,UTP20,Small subunit processome component 20 homolog OS=Homo sapiens OX=9606 GN=UTP20 PE=1 SV=3,4,6,100,0.791,,100,6.64,-0.34,,6.64,1.00E-17,9.00E-01,,1.00E-17,1.20E+05,,1.12E+05,,2,,2,,,,,1.41E+05,1.02E+05,,,,,,,,,1.62E+05,7.71E+04,,,,,,,,,1.41E+05,5.24E+03,,,,,,,,,2.19E+04,1.92E+03,,,,,,0,FALSE,11.294,2,4,2785,318.2,7.39,4,RNA metabolism OR transcription;other metabolic processes;other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf07539, Pf20416",27340,hsa:27340; O75691; Q9H3H4,ENSG00000120800,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,23.03,,50.28,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,50.78,,,15.82,,0,
Master Protein,High,I3L0M3,MAZ,MYC associated zinc finger protein OS=Homo sapiens OX=9606 GN=MAZ PE=1 SV=1,2,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.43E+05,,,,1,,,,,,,2.43E+05,,,,,,,,,,,,,,,,,,,,2.43E+05,,,,,,,,,,,,,,,,,0,FALSE,7.719,46,1,94,10.1,8.31,2,,,"Pf00096, Pf12874",,A0A024R636; I3L0M3,ENSG00000103495,,16p11.2 proximal deletion syndrome; Sudden infant death syndrome (SIDS) susceptibility pathways,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,10.73,,0,
Master Protein,High,A0A8V8TMH9,ARHGEF1,Rho guanine nucleotide exchange factor 1 OS=Homo sapiens OX=9606 GN=ARHGEF1 PE=1 SV=1,2,3,100,1.311,100,0.821,6.64,0.39,6.64,-0.28,1.00E-17,4.18E-01,1.00E-17,9.91E-01,2.83E+05,,2.10E+05,3.08E+05,4,,2,3,1.06E+06,,2.90E+05,9.32E+04,2.75E+05,,,,,,,,1.26E+05,3.50E+05,,,3.08E+05,5.72E+05,1.15E+05,,4.20E+03,,2.84E+03,9.32E+04,1.42E+04,,,,,,,,1.02E+03,4.71E+04,,,8.66E+04,4.05E+03,2.68E+03,,0,FALSE,4.903,4,2,983,109.9,6.1,2,signal transduction,other membranes;other cell component,"Pf00621, Pf09128, Pf17838",,A0A8V8TMH9,ENSG00000076928,,,0,0,99.84,,66.51,69.22,High,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,,50.59,,79.48,7.31,signal transduction activity or receptor binding;enzyme regulator activity,0,
Master Protein,High,E7ETU7,MRPL3,Mitochondrial ribosomal protein L3 OS=Homo sapiens OX=9606 GN=MRPL3 PE=1 SV=1,1,1,100,1.098,,100,6.64,0.14,,6.64,1.00E-17,5.92E-01,,1.00E-17,2.78E+04,,3.06E+04,,2,,4,,,,,2.98E+04,2.60E+04,,,,,,8.05E+04,2.20E+04,,2.64E+04,3.55E+04,,,,,,,,,2.98E+04,1.34E+03,,,,,,4.81E+02,9.84E+02,,3.55E+03,8.82E+02,,,,,,0.002,FALSE,3.007,4,1,375,41.6,9.58,1,protein metabolism;other metabolic processes,translational apparatus;other cell component,Pf00297,,E7ETU7,ENSG00000114686,,,0,0,9.44,,65.34,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,34.86,,,2.33,other molecular function,0,
Master Protein,High,J3QTA6,CHCHD6,Coiled-coil-helix-coiled-coil-helix domain containing 6 OS=Homo sapiens OX=9606 GN=CHCHD6 PE=1 SV=1,3,7,100,0.437,100,2.861,6.64,-1.19,6.64,1.52,1.00E-17,5.32E-01,1.00E-17,2.84E-01,8.61E+05,,2.50E+05,4.16E+04,3,,4,3,,3.31E+05,,8.61E+05,1.65E+06,,,,,,,2.52E+05,2.48E+05,3.46E+05,1.18E+05,,4.11E+04,,4.16E+04,5.04E+06,,1.26E+03,,8.61E+05,8.49E+04,,,,,,,1.12E+04,2.01E+03,4.66E+04,2.92E+03,,1.16E+04,,9.73E+02,5.37E+04,0,FALSE,16.714,21,3,256,28.8,9.44,3,,other membranes;cytosol;mitochondrion,Pf05300,,J3QTA6,ENSG00000159685,,,0,0,69.91,,38.9,169.01,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,,99.4,,124.41,24.12,,0,
Master Protein,High,Q96QC0,PPP1R10,Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Homo sapiens OX=9606 GN=PPP1R10 PE=1 SV=1,1,1,100,2.147,,100,6.64,1.1,,6.64,1.00E-17,2.18E-01,,1.00E-17,6.56E+04,,1.41E+05,,1,,1,,,,,6.56E+04,,,,,,,,,,1.41E+05,,,,,,,,,,6.56E+04,,,,,,,,,,1.90E+04,,,,,,,0.009,FALSE,2.313,1,1,940,99,9.17,1,transport;other biological processes,nucleus;other cell component,"Pf00642, Pf08711",5514,hsa:5514; O00405; Q96QC0,ENSG00000204569; ENSG00000206489; ENSG00000227804; ENSG00000230995; ENSG00000231737; ENSG00000235291; ENSG00000238104,,,0,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.61,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P61163,ACTR1A,Alpha-centractin OS=Homo sapiens OX=9606 GN=ACTR1A PE=1 SV=1,3,3,100,1.546,100,0.312,6.64,0.63,6.64,-1.68,1.00E-17,2.40E-01,1.00E-17,4.39E-01,1.18E+06,,4.30E+04,1.38E+05,3,,3,3,3.57E+06,,1.18E+06,2.78E+04,,,,,,,,,3.52E+04,6.42E+04,4.30E+04,,2.86E+05,1.38E+05,1.12E+05,,1.42E+04,,1.16E+04,2.78E+04,,,,,,,,,2.86E+02,8.65E+03,1.07E+03,,8.03E+04,9.76E+02,2.63E+03,,0,FALSE,9.916,13,3,376,42.6,6.64,3,transport,cytosol;cytoskeleton;other cell component,Pf00022,10121,B2R6B0; hsa:10121; P42024; P61163,ENSG00000138107,COPI-mediated anterograde transport; MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; COPI-independent Golgi-to-ER retrograde traffic; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,HDAC6 interactions in the central nervous system,12,0,113.35,,31.58,52.39,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,26.94,,48.88,9.14,other molecular function,0,
Master Protein,High,C9J0Y3,GOLGA4,Golgin A4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=2,1,2,100,1.353,100,0.347,6.64,0.44,6.64,-1.53,1.00E-17,4.56E-01,1.00E-17,4.94E-01,2.65E+04,,3.58E+04,1.03E+05,1,,5,2,,,,2.65E+04,,,,,,,3.58E+04,6.55E+03,4.10E+04,5.12E+04,1.78E+04,,1.10E+05,,9.65E+04,,,,,2.65E+04,,,,,,,2.14E+02,2.93E+02,3.33E+02,6.89E+03,4.42E+02,,3.10E+04,,2.26E+03,,0,FALSE,4.354,1,1,2285,266.7,5.39,1,,,Pf01465,2803,C9J0Y3,ENSG00000144674,,,0,0,,,59.19,9.44,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,63.34,,44.15,6.76,,0,
Master Protein,Medium,Q15404,RSU1,Ras suppressor protein 1 OS=Homo sapiens OX=9606 GN=RSU1 PE=1 SV=3,1,3,100,0.26,100,8.949,6.64,-1.94,6.64,3.16,1.00E-17,2.44E-01,1.00E-17,3.75E-02,3.58E+05,,1.07E+05,1.20E+04,2,,4,1,,,1.20E+06,1.07E+05,,,,,,,9.46E+04,,4.53E+04,1.21E+05,1.91E+05,,1.20E+04,,,,,,1.17E+04,1.07E+05,,,,,,,5.66E+02,,3.68E+02,1.63E+04,4.74E+03,,3.36E+03,,,,0.019,FALSE,1.998,3,1,277,31.5,8.65,1,signal transduction;other biological processes,cytosol;other cell component,Pf13855,6251,A8KA46; D3DRU3; hsa:6251; Q15404; Q6FI17,ENSG00000148484,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,,1,0,118.35,,53.71,,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,120.54,,52.54,4.17,,0,
Master Protein,High,Q9NPI6,DCP1A,mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3,2,2,100,0.681,100,0.289,6.64,-0.55,6.64,-1.79,1.00E-17,1.00E+00,1.00E-17,3.24E-01,6.34E+04,,3.04E+05,3.93E+05,3,,3,4,2.54E+06,,,6.34E+04,3.28E+04,,,,,,,,3.04E+05,3.19E+05,3.46E+04,1.31E+06,,2.63E+06,1.28E+04,1.18E+05,1.01E+04,,,6.34E+04,1.69E+03,,,,,,,,2.47E+03,4.30E+04,8.59E+02,2.56E+03,,1.86E+04,3.00E+02,1.25E+03,0,FALSE,5.653,4,2,582,63.2,6.25,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf06058, Pf16741",55802,B4DHN9; hsa:55802; Q9NPI6; U3KQM8,ENSG00000272886,"mRNA decay by 5' to 3' exoribonuclease; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA",TGF-beta signaling pathway,5,0,163.74,,73.03,120.35,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,69.63,,59.37,2.9,enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9P2D1,CHD7,Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens OX=9606 GN=CHD7 PE=1 SV=3,1,1,100,0.588,,100,6.64,-0.77,,6.64,1.00E-17,8.82E-01,,1.00E-17,6.95E+04,,4.09E+04,,1,,1,,,,,6.95E+04,,,,,,,,,,4.09E+04,,,,,,,,,,6.95E+04,,,,,,,,,,5.51E+03,,,,,,,0,FALSE,4.731,1,1,2997,335.7,6.34,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,"Pf00176, Pf00271, Pf00385, Pf07533",55636,D0VBA5; E9PNZ2; hsa:55636; Q05DI5; Q2TAN4; Q66K35; Q7Z6C0; Q7Z7Q2; Q9NXA0; Q9NXA3; Q9P2D1,ENSG00000171316,,Kallmann syndrome,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.19,nucleic acid binding activity;other molecular function,0,
Master Protein,High,D9J307,HLA-B,HLA class I antigen OS=Homo sapiens OX=9606 GN=HLA-B PE=1 SV=1,9,130,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,6.41E+05,,,,1,,,,,,,6.41E+05,,,,,,,,,,,,,,,,,,,,6.41E+05,,,,,,,,,,,,,,,,,0,FALSE,64.588,40,1,362,40.4,6.3,9,other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00129, Pf06623, Pf07654",,D9J307,ENSG00000232126,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,327.12,,0,
Master Protein,Medium,Q92643,PIGK,GPI-anchor transamidase OS=Homo sapiens OX=9606 GN=PIGK PE=1 SV=2,1,1,100,1.195,100,0.939,6.64,0.26,6.64,-0.09,1.00E-17,4.66E-01,1.00E-17,8.78E-01,4.30E+05,,5.14E+05,5.47E+05,3,,2,2,1.45E+06,,,7.86E+04,4.30E+05,,,,,,5.53E+05,,,4.78E+05,,,6.40E+05,,4.68E+05,,5.78E+03,,,7.86E+04,2.22E+04,,,,,,3.31E+03,,,6.44E+04,,,1.80E+05,,1.09E+04,,0.023,FALSE,1.914,3,1,395,45.2,6.16,1,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf01650,10026,B2R7K3; B4E2M3; hsa:10026; O14822; Q5TG77; Q92643,ENSG00000142892,Attachment of GPI anchor to uPAR,,1,0,109.23,,10.27,22.04,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,104.29,,21.75,2.57,other molecular function,0,
Master Protein,High,O95625,ZBTB11,Zinc finger and BTB domain-containing protein 11 OS=Homo sapiens OX=9606 GN=ZBTB11 PE=1 SV=2,1,1,100,1.086,,100,6.64,0.12,,6.64,1.00E-17,6.33E-01,,1.00E-17,4.12E+04,,4.47E+04,,1,,2,,,,,4.12E+04,,,,,,,,,,4.69E+04,4.26E+04,,,,,,,,,4.12E+04,,,,,,,,,,6.32E+03,1.06E+03,,,,,,0,FALSE,4.433,2,1,1053,119.3,8.66,1,other biological processes,nucleus,"Pf00096, Pf00651, Pf13912, Pf17921",27107,hsa:27107; O95625; Q2NKP9,ENSG00000066422,,,0,0,,,6.75,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,7.08,,,3.39,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A6I8PTZ8,AGO1,Argonaute RISC component 1 OS=Homo sapiens OX=9606 GN=AGO1 PE=1 SV=1,3,3,100,0.638,100,0.168,6.64,-0.65,6.64,-2.57,1.00E-17,9.05E-01,1.00E-17,2.13E-01,1.65E+05,,1.10E+05,1.57E+05,3,,3,1,,,3.56E+05,1.65E+05,2.93E+04,,,,,,,8.47E+04,1.43E+05,1.10E+05,,,,,,1.57E+05,,,3.48E+03,1.65E+05,1.51E+03,,,,,,,3.78E+03,1.16E+03,1.48E+04,,,,,,1.68E+03,0,FALSE,9.353,5,2,891,101.1,9.22,3,other biological processes,cytosol;other cell component,"Pf02170, Pf02171, Pf08699, Pf16486, Pf16487, Pf16488",26523,A0A6I8PTZ8,ENSG00000092847,,Modulators of TCR signaling and T cell activation,1,0,89.37,,25.84,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,56.04,,0,6.47,nucleic acid binding activity,0,
Master Protein,High,Q86TJ2,TADA2B,Transcriptional adapter 2-beta OS=Homo sapiens OX=9606 GN=TADA2B PE=1 SV=2,1,1,100,0.585,,100,6.64,-0.77,,6.64,1.00E-17,8.36E-01,,1.00E-17,1.03E+05,,6.00E+04,,1,,2,,,,,1.03E+05,,,,,,,,2.82E+04,,1.28E+05,,,,,,,,,,1.03E+05,,,,,,,,1.26E+03,,1.72E+04,,,,,,,0.001,FALSE,4.107,5,1,420,48.4,7.83,1,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf00249,93624,A0AUJ8; A4QMR7; B3KSN0; B3KU86; hsa:93624; Q6MZG9; Q86TJ2,ENSG00000173011,Ub-specific processing proteases; HATs acetylate histones,,2,0,,,90.33,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,123.08,,,2.91,other molecular function,0,
Master Protein,High,A0A669KAX3,WFS1,Wolframin ER transmembrane glycoprotein OS=Homo sapiens OX=9606 GN=WFS1 PE=1 SV=1,2,8,100,0.927,,100,6.64,-0.11,,6.64,1.00E-17,7.14E-01,,1.00E-17,1.35E+05,,2.15E+05,,2,,5,,,,,3.91E+05,4.67E+04,,,,,,2.15E+05,1.08E+06,6.75E+04,4.89E+05,1.77E+05,,,,,,,,,3.91E+05,2.41E+03,,,,,,1.28E+03,4.82E+04,5.48E+02,6.59E+04,4.40E+03,,,,,,0,FALSE,9.173,3,2,902,101.5,8.05,2,other biological processes,other membranes;ER/Golgi,"Pf19913, Pf19914, Pf20023, Pf20053",,A0A669KAX3,ENSG00000109501,,,0,0,111.25,,100.42,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,93.64,,,19.34,,0,
Master Protein,High,Q9BX68,HINT2,Adenosine 5'-monophosphoramidase HINT2 OS=Homo sapiens OX=9606 GN=HINT2 PE=1 SV=1,5,22,100,0.642,100,1.34,6.64,-0.64,6.64,0.42,1.00E-17,9.13E-01,1.00E-17,7.37E-01,8.31E+05,,7.66E+06,4.42E+06,3,,4,3,,2.83E+05,,5.81E+06,8.31E+05,,,,,,,7.02E+06,3.22E+06,8.36E+06,9.37E+06,,5.59E+06,8.07E+04,4.42E+06,,,1.07E+03,,5.81E+06,4.29E+04,,,,,,,3.14E+05,2.61E+04,1.13E+06,2.33E+05,,1.57E+06,5.72E+02,1.04E+05,,0,FALSE,30.909,48,5,163,17.2,9.16,5,other metabolic processes;other biological processes,other membranes;mitochondrion;other cell component,Pf01230,84681,hsa:84681; Q5TCW3; Q9BX68,ENSG00000137133,RHOD GTPase cycle,,1,0,131.95,,38.56,86.3,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,High,High,High,n/a,High,Peak Found,High,n/a,1,,FALSE,,78.34,,49.8,68.34,other molecular function,0,
Master Protein,High,Q9BT40,INPP5K,Inositol polyphosphate 5-phosphatase K OS=Homo sapiens OX=9606 GN=INPP5K PE=1 SV=3,1,3,100,1.141,100,0.57,6.64,0.19,6.64,-0.81,1.00E-17,5.43E-01,1.00E-17,7.48E-01,1.57E+05,,1.79E+05,3.14E+05,1,,2,1,,,,1.57E+05,,,,,,,,,,3.43E+05,9.37E+04,,,,3.14E+05,,,,,1.57E+05,,,,,,,,,,4.62E+04,2.33E+03,,,,7.35E+03,,0.001,FALSE,3.801,2,1,448,51.1,6.54,1,cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,Pf17751,51763,B2R6I2; B2R750; D3DTH8; hsa:51763; Q15733; Q9BT40; Q9NPJ5; Q9P2R5,ENSG00000132376,Synthesis of PIPs at the plasma membrane,Notch signaling; VEGFA-VEGFR2 signaling; Effect of progerin on genes involved in progeria,4,0,,,80.69,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,103.01,,103.01,8.19,other molecular function,0,
Master Protein,High,A0A8V8TMQ1,FXR1,RNA-binding protein FXR1 OS=Homo sapiens OX=9606 GN=FXR1 PE=1 SV=1,3,8,100,0.57,100,1.058,6.64,-0.81,6.64,0.08,1.00E-17,8.29E-01,1.00E-17,8.61E-01,2.94E+05,,7.33E+04,9.62E+04,1,,4,3,,,,2.94E+05,,,,,,,3.42E+04,8.59E+04,,5.74E+05,6.25E+04,,1.71E+05,9.62E+04,8.12E+04,,,,,2.94E+05,,,,,,,2.05E+02,3.84E+03,,7.73E+04,1.55E+03,,4.82E+04,6.81E+02,1.90E+03,,0,FALSE,13.956,6,3,650,72.7,6.16,3,other biological processes,nucleus;other cell component,"Pf00013, Pf05641, Pf12235, Pf16096, Pf16097, Pf17904, Pf18336",,A0A8V8TMQ1,ENSG00000114416,,Bile acids synthesis and enterohepatic circulation,1,0,,,136.08,41.6,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,57.75,,56.88,18.44,nucleic acid binding activity,0,
Master Protein,High,Q8N9N8,EIF1AD,Probable RNA-binding protein EIF1AD OS=Homo sapiens OX=9606 GN=EIF1AD PE=1 SV=1,1,1,100,0.612,,100,6.64,-0.71,,6.64,1.00E-17,8.99E-01,,1.00E-17,6.18E+04,,3.78E+04,,1,,1,,,,,6.18E+04,,,,,,,,3.78E+04,,,,,,,,,,,,6.18E+04,,,,,,,,1.69E+03,,,,,,,,,0,FALSE,6.794,10,1,165,19,5.21,1,protein metabolism;other metabolic processes,cytosol;nucleus;other cell component,Pf01176,84285,B2R4N5; hsa:84285; Q8N9N8; Q9BSC1,ENSG00000175376,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,4.01,nucleic acid binding activity,0,
Master Protein,Medium,P25098,GRK2,Beta-adrenergic receptor kinase 1 OS=Homo sapiens OX=9606 GN=GRK2 PE=1 SV=2,1,2,100,2.016,,100,6.64,1.01,,6.64,1.00E-17,2.14E-01,,1.00E-17,9.31E+04,,1.88E+05,,2,,2,,,,,1.92E+05,4.52E+04,,,,,,,,,3.59E+05,9.80E+04,,,,,,,,,1.92E+05,2.33E+03,,,,,,,,,4.84E+04,2.44E+03,,,,,,0.03,FALSE,1.817,1,1,689,79.5,7.28,1,cell-cell signaling;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf00069, Pf00169, Pf00615",156,B0ZBE1; hsa:156; P25098; Q13837; Q6GTT3,ENSG00000173020,G alpha (q) signalling events; Activation of SMO; G alpha (s) signalling events; Cargo recognition for clathrin-mediated endocytosis; Calmodulin induced events,Chemokine signaling pathway; Hedgehog signaling pathway; Hedgehog signaling pathway; HDAC6 interactions in the central nervous system,9,0,87.56,,80.81,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,61.05,,,3.91,signal transduction activity or receptor binding;kinase activity;other molecular function,0,
Master Protein,High,A0A8V8TQ67,POGZ,Pogo transposable element derived with ZNF domain OS=Homo sapiens OX=9606 GN=POGZ PE=1 SV=1,7,12,100,1.081,100,5.089,6.64,0.11,6.64,2.35,1.00E-17,4.07E-01,1.00E-17,9.91E-02,1.54E+06,,7.53E+05,2.54E+05,4,,4,1,,8.81E+05,2.88E+05,3.67E+06,2.69E+06,,,,,,,1.69E+06,1.27E+06,4.47E+05,2.10E+05,,2.54E+05,,,,,3.35E+03,2.81E+03,3.67E+06,1.39E+05,,,,,,,7.53E+04,1.03E+04,6.03E+04,5.21E+03,,7.13E+04,,,,0,FALSE,25.116,8,7,1417,156,7.52,7,,,"Pf03184, Pf03221",,A0A8V8TQ67,ENSG00000143442,,,0,0,83.44,,76.6,,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,89.06,,24.27,40.28,nucleic acid binding activity,0,
Master Protein,High,Q96KR1,ZFR,Zinc finger RNA-binding protein OS=Homo sapiens OX=9606 GN=ZFR PE=1 SV=2,3,6,100,0.339,100,3.807,6.64,-1.56,6.64,1.93,1.00E-17,4.05E-01,1.00E-17,1.94E-01,3.65E+05,,6.79E+04,1.40E+04,2,,4,1,,,,2.53E+05,5.26E+05,,,,,,,8.63E+04,5.34E+04,3.07E+05,1.76E+04,,1.40E+04,,,,,,,2.53E+05,2.72E+04,,,,,,,3.86E+03,4.34E+02,4.13E+04,4.37E+02,,3.94E+03,,,,0,FALSE,8.327,4,3,1074,116.9,9.04,3,,nucleus;other cell component,"Pf07528, Pf12874, Pf20965",51663,B2RNR5; hsa:51663; Q05C08; Q3B7X5; Q6P5A3; Q86UA0; Q96KR1; Q9H6V4; Q9NTI1; Q9Y687,ENSG00000056097,,Exercise-induced circadian regulation,1,0,49.48,,112.23,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,75.72,,14.59,15.02,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O15511,ARPC5,Actin-related protein 2/3 complex subunit 5 OS=Homo sapiens OX=9606 GN=ARPC5 PE=1 SV=3,2,8,100,0.738,100,0.53,6.64,-0.44,6.64,-0.92,1.00E-17,8.15E-01,1.00E-17,7.32E-01,1.23E+06,,8.09E+05,3.58E+05,2,,3,1,8.52E+05,,,1.78E+06,,,,,,,,5.76E+05,,1.66E+06,8.09E+05,,3.58E+05,,,,3.38E+03,,,1.78E+06,,,,,,,,2.57E+04,,2.23E+05,2.01E+04,,1.00E+05,,,,0,FALSE,10.573,31,2,151,16.3,5.67,2,cell organization and biogenesis;other biological processes,non-structural extracellular;cytosol;cytoskeleton;nucleus;other cell component,Pf04699,10092,A6NEC4; hsa:10092; O15511; Q6PG42,ENSG00000162704,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Neutrophil degranulation; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,Pathogenic Escherichia coli infection; Regulation of actin cytoskeleton,8,0,50.03,,56.13,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,73.85,,144.5,31.98,cytoskeletal activity,0,
Master Protein,High,Q7Z478,DHX29,ATP-dependent RNA helicase DHX29 OS=Homo sapiens OX=9606 GN=DHX29 PE=1 SV=2,1,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,3.74E+04,,,1.39E+05,1,,,2,,,,,3.74E+04,,,,,,,,,,,,5.01E+04,3.85E+05,,,,,,,1.93E+03,,,,,,,,,,,,1.41E+04,2.73E+03,,,0.001,FALSE,3.373,1,1,1369,155.1,8.09,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus,"Pf00270, Pf00271, Pf04408, Pf07717, Pf21010",54505,hsa:54505; O75549; Q63HN0; Q63HN3; Q7Z478; Q8IWW2; Q8N3A1; Q9UMH2,ENSG00000067248,,VEGFA-VEGFR2 signaling,1,0,,,,108.85,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,,,,5.43,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A994J4R6,USP9X,Ubiquitin specific peptidase 9 X-linked OS=Homo sapiens OX=9606 GN=USP9X PE=4 SV=1,5,5,100,0.992,100,0.292,6.64,-0.01,6.64,-1.78,1.00E-17,6.27E-01,1.00E-17,3.67E-01,2.27E+05,,1.59E+05,9.10E+05,2,,1,3,,3.23E+05,,,1.60E+05,,,,,,1.59E+05,,,,,9.10E+05,9.33E+05,,9.08E+04,,,1.23E+03,,,8.27E+03,,,,,,9.51E+02,,,,,1.77E+03,2.62E+05,,2.13E+03,,0,FALSE,18.681,3,5,2575,292.7,5.82,5,,,,8239,A0A994J4R6,ENSG00000124486,,Ciliopathies; Bardet-Biedl syndrome,2,0,47.58,,,74.42,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,0,,0,17.83,other molecular function,0,
Master Protein,High,Q7L591,DOK3,Docking protein 3 OS=Homo sapiens OX=9606 GN=DOK3 PE=1 SV=2,2,3,100,0.847,100,1.287,6.64,-0.24,6.64,0.36,1.00E-17,8.35E-01,1.00E-17,6.68E-01,6.62E+05,,1.77E+05,3.34E+05,2,,3,1,,,,4.39E+05,9.99E+05,,,,,,,1.77E+05,,8.22E+05,1.23E+05,3.34E+05,,,,,,,,4.39E+05,5.15E+04,,,,,,,7.92E+03,,1.11E+05,3.05E+03,6.52E+02,,,,,0,FALSE,8.069,7,2,496,53.3,7.77,2,signal transduction;other biological processes,plasma membrane;other membranes;other cell component,Pf02174,79930,E9PAT0; H7BXS0; hsa:79930; Q7L591; Q8N864; Q9BQB3; Q9H666,ENSG00000146094,Neutrophil degranulation,5q35 copy number variation,2,0,55.13,,103.99,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,78.05,,0,7.38,,0,
Master Protein,High,A0A0G2JHC2,PPP1R18,PPP1R18 OS=Homo sapiens OX=9606 GN=PPP1R18 PE=1 SV=1,4,4,100,0.314,,100,6.64,-1.67,,6.64,1.00E-17,2.88E-01,,1.00E-17,7.38E+05,,2.19E+04,,3,,1,,2.87E+05,,7.42E+05,7.38E+05,,,,,,,,2.19E+04,,,,,,,,,1.14E+03,,7.25E+03,7.38E+05,,,,,,,,9.80E+02,,,,,,,,,0,FALSE,14.952,12,4,613,68,5.45,4,,,"Pf13914, Pf13916",,A0A0G2JHC2,ENSG00000231247,,,0,0,44.43,,,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,35.1,,,13.35,other molecular function,0,
Master Protein,High,J3KR72,TAF6,Transcription initiation factor TFIID subunit 6 OS=Homo sapiens OX=9606 GN=TAF6 PE=1 SV=1,4,6,100,0.825,100,0.508,6.64,-0.28,6.64,-0.98,1.00E-17,8.06E-01,1.00E-17,6.57E-01,4.54E+05,,5.11E+05,7.15E+04,4,,5,4,8.80E+05,,3.78E+05,5.45E+05,3.29E+05,,,,,,9.56E+05,6.10E+05,4.63E+05,4.41E+05,5.11E+05,,7.00E+04,5.02E+05,1.89E+04,7.30E+04,3.50E+03,,3.69E+03,5.45E+05,1.70E+04,,,,,,5.71E+03,2.72E+04,3.76E+03,5.94E+04,1.27E+04,,1.97E+04,3.56E+03,4.43E+02,7.77E+02,0,FALSE,13.992,9,4,734,78.9,8.54,4,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,"Pf02969, Pf07571",,J3KR72,ENSG00000106290,,,0,0,46.74,,35.44,135.78,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,,85.4,,128.44,18.35,other molecular function,0,
Master Protein,High,P51148,RAB5C,Ras-related protein Rab-5C OS=Homo sapiens OX=9606 GN=RAB5C PE=1 SV=2,3,11,100,1.819,100,0.726,6.64,0.86,6.64,-0.46,1.00E-17,1.11E-01,1.00E-17,8.36E-01,1.16E+06,,2.12E+06,2.91E+06,1,,2,1,,,,1.16E+06,,,,,,,1.75E+06,,,2.56E+06,,,2.91E+06,,,,,,,1.16E+06,,,,,,,1.04E+04,,,3.45E+05,,,8.19E+05,,,,0,FALSE,10.264,17,1,216,23.5,8.41,3,transport,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf00071,5878,F8W1H5; hsa:5878; P51148; Q6FH55; Q9P0Y5,ENSG00000108774,Neutrophil degranulation; RAB geranylgeranylation; RAB GEFs exchange GTP for GDP on RABs; Golgi Associated Vesicle Biogenesis; Respiratory syncytial virus (RSV) attachment and entry; Clathrin-mediated endocytosis; TBC/RABGAPs,Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Vasopressin-regulated water reabsorption,10,0,,,26.8,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,28.62,,28.62,25.51,other molecular function,0,
Master Protein,High,Q9Y232,CDYL,Chromodomain Y-like protein OS=Homo sapiens OX=9606 GN=CDYL PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.42E+05,,,,1,,,,,,,2.42E+05,,,,,,,,,,,,,,,,,,,,2.42E+05,,,,,,,,,,,,,,,,,0,FALSE,5.751,3,1,598,66.4,9.45,1,cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf00378, Pf00385",9425,A8K6D6; B4DLG4; hsa:9425; Q0VDG7; Q32NC5; Q5VX99; Q6P7T5; Q9BWZ2; Q9Y232; Q9Y424,ENSG00000153046,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.91,other molecular function,0,
Master Protein,High,Q16630,CPSF6,Cleavage and polyadenylation specificity factor subunit 6 OS=Homo sapiens OX=9606 GN=CPSF6 PE=1 SV=2,6,11,100,0.536,100,6.459,6.64,-0.9,6.64,2.69,1.00E-17,6.99E-01,1.00E-17,8.75E-02,5.81E+05,,2.13E+05,1.81E+04,2,,4,1,,,3.35E+05,1.01E+06,,,,,,,1.59E+05,1.65E+05,2.74E+05,8.01E+05,,,1.81E+04,,,,,,3.28E+03,1.01E+06,,,,,,,9.48E+02,7.38E+03,2.23E+03,1.08E+05,,,5.09E+03,,,,0,FALSE,21.764,15,6,551,59.2,7.15,6,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf00076,11052,A8K7K9; hsa:11052; Q16630; Q53ES1; Q9BSJ7; Q9BW18,ENSG00000111605,Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease,,2,0,70.79,,87.31,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,92.5,,141.89,30.12,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P00403,MT-CO2,Cytochrome c oxidase subunit 2 OS=Homo sapiens OX=9606 GN=MT-CO2 PE=1 SV=1,2,12,100,1.208,100,6.427,6.64,0.27,6.64,2.68,1.00E-17,4.10E-01,1.00E-17,5.31E-02,5.48E+06,,2.68E+06,4.17E+05,3,,5,1,,,5.72E+06,5.48E+06,2.98E+05,,,,,,1.20E+07,6.73E+06,2.68E+06,3.60E+05,1.94E+06,,4.17E+05,,,,,,5.59E+04,5.48E+06,1.54E+04,,,,,,7.17E+04,3.01E+05,2.18E+04,4.86E+04,4.81E+04,,1.17E+05,,,,0,FALSE,7.492,13,2,227,25.5,4.82,2,other metabolic processes;stress response;transport,other membranes;mitochondrion,"Pf00116, Pf02790",4513,hsa:4513; P00403; Q37526,ENSG00000198712,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Endothelin pathways; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Neuroinflammation; Mitochondrial complex IV assembly; CCL18 signaling pathway; 5q35 copy number variation,12,0,79.93,,98.86,,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,108.72,,128.3,20.56,transporter activity;other molecular function,0,
Master Protein,High,P62917,RPL8,60S ribosomal protein L8 OS=Homo sapiens OX=9606 GN=RPL8 PE=1 SV=2,3,11,100,0.332,100,0.868,6.64,-1.59,6.64,-0.2,1.00E-17,2.86E-01,1.00E-17,9.54E-01,2.36E+06,,2.47E+05,2.61E+05,5,,5,4,2.36E+06,6.28E+05,2.39E+06,4.20E+06,1.34E+06,,,,,,2.13E+06,1.61E+06,2.47E+05,1.14E+05,2.09E+05,,1.97E+05,4.03E+06,1.63E+05,3.46E+05,9.38E+03,2.39E+03,2.34E+04,4.20E+06,6.93E+04,,,,,,1.28E+04,7.20E+04,2.00E+03,1.54E+04,5.19E+03,,5.54E+04,2.86E+04,3.81E+03,3.69E+03,0,FALSE,10.812,23,3,257,28,11.03,3,protein metabolism;other metabolic processes,cytosol;translational apparatus;other cell component,"Pf00181, Pf03947",6132,A8K094; D3DWN2; hsa:6132; P25120; P62917; Q567Q7; Q969V7; Q9BWQ9,ENSG00000161016,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Protein hydroxylation,Cytoplasmic ribosomal proteins,15,0,61.64,,109.09,160.41,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,122.73,,121.05,27.96,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q7Z5J4,RAI1,Retinoic acid-induced protein 1 OS=Homo sapiens OX=9606 GN=RAI1 PE=1 SV=2,1,3,100,0.868,100,2.836,6.64,-0.2,6.64,1.5,1.00E-17,7.98E-01,1.00E-17,2.95E-01,5.91E+04,,5.13E+04,1.81E+04,1,,5,1,,,,5.91E+04,,,,,,,5.13E+04,5.99E+04,3.18E+04,8.32E+04,4.91E+04,,,,1.81E+04,,,,,5.91E+04,,,,,,,3.07E+02,2.67E+03,2.59E+02,1.12E+04,1.22E+03,,,,4.24E+02,,0,FALSE,5.387,1,1,1906,203.2,8.79,1,developmental processes;other biological processes,nucleus;other cell component,Pf13771,10743,hsa:10743; Q7Z5J4; Q8N3B4; Q8ND08; Q8WU64; Q96JK5; Q9H1C1; Q9H1C2; Q9UF69,ENSG00000108557,Heme signaling; Circadian Clock,Smith-Magenis and Potocki-Lupski syndrome copy number variation,3,0,,,34.03,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,21.18,,24.71,9.65,other molecular function,0,
Master Protein,High,Q9Y6X9,MORC2,ATPase MORC2 OS=Homo sapiens OX=9606 GN=MORC2 PE=1 SV=2,2,3,100,1.324,,100,6.64,0.41,,6.64,1.00E-17,4.45E-01,,1.00E-17,1.27E+05,,1.69E+05,,1,,1,,,,,1.27E+05,,,,,,,,1.69E+05,,,,,,,,,,,,1.27E+05,,,,,,,,7.54E+03,,,,,,,,,0,FALSE,6.764,4,2,1032,117.8,8.38,2,cell organization and biogenesis;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,"Pf07496, Pf13589, Pf17942",22880,B2RNB1; hsa:22880; Q9UF28; Q9Y6V2; Q9Y6X9,ENSG00000133422,Fatty acyl-CoA biosynthesis,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,9.51,other molecular function,0,
Master Protein,High,P02790,HPX,Hemopexin OS=Homo sapiens OX=9606 GN=HPX PE=1 SV=2,2,3,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,1.51E+05,,1.14E+06,1.42E+05,1,,1,1,,,,,1.51E+05,,,,,,,,,1.14E+06,,,1.42E+05,,,,,,,,7.78E+03,,,,,,,,,1.54E+05,,,4.00E+04,,,,0,FALSE,8.767,10,2,462,51.6,7.02,2,protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,non-structural extracellular;other cell component,Pf00045,3263,B2R957; hsa:3263; P02790,ENSG00000110169,Scavenging of heme from plasma,,1,0,,,,,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,9.55,transporter activity;other molecular function,0,
Master Protein,High,F8VXI7,DYNLL1,Dynein light chain (Fragment) OS=Homo sapiens OX=9606 GN=DYNLL1 PE=1 SV=1,2,16,100,1.227,100,1.971,6.64,0.3,6.64,0.98,1.00E-17,3.32E-01,1.00E-17,3.87E-01,2.89E+06,,3.31E+05,2.11E+05,3,,2,2,,1.82E+06,,2.89E+06,3.60E+06,,,,,,,,4.59E+04,2.38E+06,,7.46E+04,5.95E+05,,,,,6.92E+03,,2.89E+06,1.86E+05,,,,,,,,3.73E+02,3.21E+05,,1.45E+02,1.67E+05,,,,0,FALSE,20.517,79,2,42,4.8,4.72,2,other biological processes,cytoskeleton;other cell component,Pf01221,,F8VXI7,ENSG00000088986,,Ciliary landscape; Intraflagellar transport proteins binding to dynein; Genes related to primary cilium development (based on CRISPR); 3q29 copy number variation syndrome; Vasopressin-regulated water reabsorption,5,0,32.3,,136.07,109.92,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,High,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,54.68,,101.97,70.24,,0,
Master Protein,High,Q9UEG4,ZNF629,Zinc finger protein 629 OS=Homo sapiens OX=9606 GN=ZNF629 PE=1 SV=2,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,7.46E+04,,,1.11E+05,2,,,2,,,,3.75E+04,1.49E+05,,,,,,,,,,,,,9.23E+04,,1.33E+05,,,,3.75E+04,7.67E+03,,,,,,,,,,,,,6.54E+02,,1.41E+03,0.001,FALSE,3.193,2,1,869,96.6,7.93,1,other biological processes,nucleus,Pf00096,23361,hsa:23361; Q15938; Q9UEG4,ENSG00000102870,,,0,0,84.44,,,25.42,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,,,,2.03,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A804HJI2,RSRC1,Arginine and serine rich coiled-coil 1 OS=Homo sapiens OX=9606 GN=RSRC1 PE=1 SV=1,1,2,100,0.556,,100,6.64,-0.85,,6.64,1.00E-17,7.84E-01,,1.00E-17,1.52E+05,,8.44E+04,,2,,2,,,,,2.58E+05,8.93E+04,,,,,,,5.32E+04,,1.34E+05,,,,,,,,,,2.58E+05,4.60E+03,,,,,,,2.37E+03,,1.81E+04,,,,,,,0,FALSE,5.233,5,1,342,39.5,11.08,1,RNA metabolism OR transcription;other metabolic processes,,,,A0A804HJI2,ENSG00000174891,,,0,0,68.8,,61.1,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,51.99,,,9.26,,0,
Master Protein,High,Q9Y2C4,EXOG,"Nuclease EXOG, mitochondrial OS=Homo sapiens OX=9606 GN=EXOG PE=1 SV=2",1,2,100,0.92,100,0.227,6.64,-0.12,6.64,-2.14,1.00E-17,7.59E-01,1.00E-17,2.15E-01,1.07E+05,,9.84E+04,4.34E+05,2,,3,1,,,,1.41E+05,8.10E+04,,,,,,,,5.38E+04,3.41E+05,9.84E+04,,,4.34E+05,,,,,,1.41E+05,4.18E+03,,,,,,,,4.37E+02,4.59E+04,2.45E+03,,,3.08E+03,,,0.002,FALSE,3.072,3,1,368,41.1,8.27,1,cell organization and biogenesis;DNA metabolism;other metabolic processes,other membranes;mitochondrion;nucleus;other cell component,"Pf01223, Pf18026",9941,A8K242; B4DVG2; hsa:9941; Q3SXM9; Q9Y2C4; Q9Y2C8,ENSG00000157036,,,0,0,38.33,,93.95,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,74.48,,105.41,4.97,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y3B4,SF3B6,Splicing factor 3B subunit 6 OS=Homo sapiens OX=9606 GN=SF3B6 PE=1 SV=1,2,3,100,0.674,100,4.157,6.64,-0.57,6.64,2.06,1.00E-17,9.66E-01,1.00E-17,1.71E-01,1.09E+05,,7.71E+04,1.85E+04,3,,4,1,1.09E+05,,,2.41E+05,5.41E+04,,,,,,,4.12E+04,1.44E+05,4.24E+05,2.57E+04,,1.85E+04,,,,4.33E+02,,,2.41E+05,2.79E+03,,,,,,,1.84E+03,1.17E+03,5.72E+04,6.40E+02,,5.21E+03,,,,0,FALSE,6.466,22,2,125,14.6,9.38,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes,nucleus,Pf00076,51639,hsa:51639; Q53TM1; Q9Y3B4,ENSG00000115128,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,,2,0,71.39,,116.22,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,113.37,,113.8,7.84,nucleic acid binding activity,0,
Master Protein,Medium,Q9BQ15,NABP2,SOSS complex subunit B1 OS=Homo sapiens OX=9606 GN=NABP2 PE=1 SV=1,1,2,100,2.82,,100,6.64,1.5,,6.64,1.00E-17,1.55E-01,,1.00E-17,2.69E+04,,7.58E+04,,1,,1,,,,,2.69E+04,,,,,,,,,,7.58E+04,,,,,,,,,,2.69E+04,,,,,,,,,,1.02E+04,,,,,,,0.029,FALSE,1.836,11,1,211,22.3,9.06,1,cell cycle OR cell proliferation;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf21473,79035,A6NDF8; hsa:79035; Q6XYC8; Q9BQ15,ENSG00000139579,RNA polymerase II transcribes snRNA genes,Mesodermal commitment pathway,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,6.5,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UII4,HERC5,E3 ISG15--protein ligase HERC5 OS=Homo sapiens OX=9606 GN=HERC5 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.07E+04,,,,1,,,,,,,2.07E+04,,,,,,,,,,,,,,,,,,,,2.07E+04,,,,,,,,,,,,,,,,,0.001,FALSE,4.248,2,1,1024,116.8,7.65,1,protein metabolism;other metabolic processes;stress response;other biological processes,cytosol;other cell component,"Pf00415, Pf00632",51191,B2RTQ1; hsa:51191; Q69G20; Q9UII4,ENSG00000138646,Antigen processing: Ubiquitination & Proteasome degradation; RSV-host interactions; PKR-mediated signaling; ISG15 antiviral mechanism; Negative regulators of DDX58/IFIH1 signaling,,6,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.83,other molecular function,0,
Master Protein,High,Q86U86,PBRM1,Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1,9,14,100,0.858,100,1.069,6.64,-0.22,6.64,0.1,1.00E-17,6.76E-01,1.00E-17,8.10E-01,1.08E+06,,1.64E+06,5.67E+05,5,,5,4,1.17E+06,1.25E+06,2.12E+05,1.08E+06,9.08E+05,,,,,,1.64E+06,4.47E+05,1.90E+06,1.73E+06,1.60E+06,1.14E+06,1.60E+06,,2.83E+05,1.08E+05,4.64E+03,4.73E+03,2.07E+03,1.08E+06,4.69E+04,,,,,,9.82E+03,2.00E+04,1.55E+04,2.33E+05,3.98E+04,2.22E+03,4.50E+05,,6.61E+03,1.15E+03,0,FALSE,28.115,7,9,1689,192.8,6.89,9,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00439, Pf00505, Pf01426",55193,A1L381; A1L382; A4FUJ7; hsa:55193; Q1RMD1; Q1RMD2; Q86U86; Q96MS2; Q9H2T3; Q9H2T4; Q9H2T5; Q9H301; Q9H314,ENSG00000163939,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,Clear cell renal cell carcinoma pathways,3,0,45.15,,39.64,90.4,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,,81.8,,131.2,41.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q86U70,LDB1,LIM domain-binding protein 1 OS=Homo sapiens OX=9606 GN=LDB1 PE=1 SV=2,1,5,100,0.483,,100,6.64,-1.05,,6.64,1.00E-17,6.53E-01,,1.00E-17,2.24E+05,,9.95E+04,,3,,3,,,,2.24E+05,4.97E+05,4.77E+04,,,,,,9.95E+04,,,2.62E+05,2.30E+04,,,,,,,,2.19E+03,4.97E+05,2.46E+03,,,,,,5.95E+02,,,3.53E+04,5.71E+02,,,,,,0,FALSE,12.823,4,1,411,46.5,6.96,1,cell adhesion;cell-cell signaling;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf01803, Pf17916",8861,B4DUC4; hsa:8861; O75479; O96010; Q1EQX1; Q86U70; Q9UGM4,ENSG00000198728,Regulation of expression of SLITs and ROBOs; Expression and translocation of olfactory receptors; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Cardiogenesis,,4,0,88.3,,95.28,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,113.99,,,20.51,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H160,ING2,Inhibitor of growth protein 2 OS=Homo sapiens OX=9606 GN=ING2 PE=1 SV=2,1,1,100,2.264,,100,6.64,1.18,,6.64,1.00E-17,2.00E-01,,1.00E-17,1.86E+04,,4.22E+04,,1,,2,,,,,1.86E+04,,,,,,,,,,3.59E+04,4.96E+04,,,,,,,,,1.86E+04,,,,,,,,,,4.84E+03,1.23E+03,,,,,,0.008,FALSE,2.341,5,1,280,32.8,7.9,1,cell cycle OR cell proliferation;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;nucleus,Pf12998,3622,B6ZDS1; hsa:3622; O95698; Q9H160,ENSG00000168556,SUMOylation of transcription cofactors; PI5P Regulates TP53 Acetylation,Transcription co-factors SKI and SKIL protein partners,3,0,,,22.7,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,24.11,,,2.52,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q8IXQ6,PARP9,Protein mono-ADP-ribosyltransferase PARP9 OS=Homo sapiens OX=9606 GN=PARP9 PE=1 SV=2,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,4.97E+04,,,4.75E+04,1,,,3,,,,,4.97E+04,,,,,,,,,,,,2.73E+04,4.76E+04,,4.75E+04,,,,,2.56E+03,,,,,,,,,,,,7.68E+03,3.37E+02,,5.05E+02,0.03,FALSE,1.816,1,1,854,96.3,7.91,1,DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;mitochondrion;nucleus;other cell component,Pf01661,83666,A8KA94; B2R8S9; E9PFM7; hsa:83666; Q8IXQ6; Q8TCP3; Q9BZL8; Q9BZL9,ENSG00000138496,Maturation of nucleoprotein; Nicotinamide salvaging; Maturation of nucleoprotein,,3,0,,,,28.56,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,,,,,2.85,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q15797,SMAD1,Mothers against decapentaplegic homolog 1 OS=Homo sapiens OX=9606 GN=SMAD1 PE=1 SV=1,1,1,100,0.254,100,3.253,6.64,-1.98,6.64,1.7,1.00E-17,2.29E-01,1.00E-17,2.41E-01,3.49E+05,,8.86E+04,4.22E+04,1,,3,2,,,,3.49E+05,,,,,,,8.58E+04,,2.20E+05,8.86E+04,,,2.17E+04,8.22E+04,,,,,,3.49E+05,,,,,,,5.13E+02,,1.79E+03,1.19E+04,,,6.10E+03,5.83E+02,,,0,FALSE,5.415,3,1,465,52.2,7.31,1,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,other membranes;cytosol;nucleus;other cell component,"Pf03165, Pf03166",4086,A8KAJ0; D3DNZ9; hsa:4086; Q15797; Q16636; Q9UFT8,ENSG00000170365,Ub-specific processing proteases; Signaling by BMP; Cardiogenesis; RUNX2 regulates bone development,Bone morphogenic protein signaling and regulation; Angiogenesis; Heart development; Neural crest differentiation; Mesodermal commitment pathway; Differentiation of white and brown adipocyte; Mesodermal commitment pathway; BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; Neovascularization processes; Osteoblast differentiation and related diseases; TGF-beta receptor signaling in skeletal dysplasias; Development of ureteric collection system; Network map of SARS-CoV-2 signaling pathway; Clock-controlled autophagy in bone metabolism; Markers of kidney cell lineage; 10q11.21q11.23 copy number variation syndrome; Macrophage-stimulating protein (MSP) signaling network map; TGF-beta receptor signaling,24,0,,,58.35,82.36,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,4.86,,68.49,2.79,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A0A0MSV9,TAPBP,Tapasin OS=Homo sapiens OX=9606 GN=TAPBP PE=1 SV=1,2,2,100,0.491,100,2.016,6.64,-1.02,6.64,1.01,1.00E-17,6.63E-01,1.00E-17,4.03E-01,5.89E+05,,3.01E+05,6.39E+05,2,,4,2,,,,3.00E+06,1.16E+05,,,,,,1.28E+06,6.91E+04,1.30E+06,7.10E+04,,5.23E+05,,,7.81E+05,,,,,3.00E+06,5.96E+03,,,,,,7.66E+03,3.09E+03,1.05E+04,9.56E+03,,1.02E+03,,,1.83E+04,,0,FALSE,8.937,4,2,504,53.9,7.08,2,other biological processes,other membranes,Pf07654,6892,A0A0A0MSV9,ENSG00000206208; ENSG00000231925,,,0,0,130.94,,103.58,27.96,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,,141.73,,29.71,5.55,,0,
Master Protein,High,O75175,CNOT3,CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1,1,2,100,0.373,,100,6.64,-1.42,,6.64,1.00E-17,4.75E-01,,1.00E-17,3.12E+05,,1.17E+05,,1,,1,,,,,3.12E+05,,,,,,,,1.17E+05,,,,,,,,,,,,3.12E+05,,,,,,,,5.21E+03,,,,,,,,,0.001,FALSE,4.14,3,1,753,81.8,6.2,1,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf04065, Pf04153",4849,hsa:4849; O75175; Q9NZN7; Q9UF76,ENSG00000088038; ENSG00000273943; ENSG00000274176; ENSG00000274616; ENSG00000274941; ENSG00000275979; ENSG00000276082; ENSG00000277114; ENSG00000277600; ENSG00000277615,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain; M-decay: degradation of maternal mRNAs by maternally stored factors,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,6.15,,0,
Master Protein,High,Q8WXG6,MADD,MAP kinase-activating death domain protein OS=Homo sapiens OX=9606 GN=MADD PE=1 SV=2,1,1,100,0.318,,100,6.64,-1.65,,6.64,1.00E-17,4.72E-01,,1.00E-17,2.64E+04,,8.41E+03,,1,,1,,,,,2.64E+04,,,,,,,,,,8.41E+03,,,,,,,,,,2.64E+04,,,,,,,,,,1.13E+03,,,,,,,0,FALSE,5.209,1,1,1647,183.2,6.04,1,signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf02141, Pf03456",8567,A8K8S7; B5MEE5; D3DQR4; hsa:8567; O15065; O15293; Q15732; Q15741; Q8IWD7; Q8WXG3; Q8WXG4; Q8WXG5; Q8WXG6; Q8WZ63,ENSG00000110514,,Apoptosis modulation and signaling; Deregulation of Rab and Rab effector genes in bladder cancer; TNF-alpha signaling pathway,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.95,signal transduction activity or receptor binding;enzyme regulator activity,0,
Master Protein,High,P20591,MX1,Interferon-induced GTP-binding protein Mx1 OS=Homo sapiens OX=9606 GN=MX1 PE=1 SV=4,2,3,100,0.484,100,0.12,6.64,-1.05,6.64,-3.06,1.00E-17,7.55E-01,1.00E-17,1.23E-01,4.78E+04,,2.01E+04,1.68E+05,4,,3,1,6.16E+04,1.53E+06,,1.05E+04,3.70E+04,,,,,,4.47E+04,,,1.60E+04,2.01E+04,,,1.68E+05,,,2.45E+02,5.82E+03,,1.05E+04,1.91E+03,,,,,,2.67E+02,,,2.15E+03,5.00E+02,,,1.19E+03,,,0,FALSE,4.698,4,1,662,75.5,5.83,2,stress response;signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,"Pf00350, Pf01031, Pf02212",4599,B2RDA5; B3KU10; C9IYV7; C9J8D6; C9JN19; C9JN88; C9JUL1; C9JZS6; D3DSI8; hsa:4599; P20591; Q86YP5; Q96CI3,ENSG00000157601,ISG15 antiviral mechanism; Interferon alpha/beta signaling,Immune response to tuberculosis; Measles virus infection; SARS-CoV-2 innate immunity evasion and cell-specific immune response,5,0,182.33,,57.69,,Peak Found,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,105.76,,38.66,7.14,cytoskeletal activity;other molecular function,0,
Master Protein,High,P18433,PTPRA,Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,6.22E+04,,,,1,,,,,,,6.22E+04,,,,,,,,,,,,,,,,,,,,6.22E+04,,,,,,,,,,,,,,,,,0,FALSE,6.216,2,1,802,90.7,6.65,1,other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,Pf00102,5786,A8K2G8; D3DVX5; hsa:5786; P18433; Q14513; Q7Z2I2; Q96TD9,ENSG00000132670,RAF/MAP kinase cascade; NCAM signaling for neurite out-growth,Microtubule cytoskeleton regulation; Spinal cord injury,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.45,other molecular function,0,
Master Protein,High,A0A0U1RQQ9,SCYL2,SCY1 like pseudokinase 2 OS=Homo sapiens OX=9606 GN=SCYL2 PE=1 SV=1,1,1,100,0.89,,100,6.64,-0.17,,6.64,1.00E-17,7.78E-01,,1.00E-17,6.46E+04,,5.76E+04,,1,,1,,,,,6.46E+04,,,,,,,,,,5.76E+04,,,,,,,,,,6.46E+04,,,,,,,,,,7.76E+03,,,,,,,0.003,FALSE,2.714,2,1,933,104,8.22,1,,,Pf00069,55681,A0A0U1RQQ9,ENSG00000136021,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.41,kinase activity;other molecular function,0,
Master Protein,Medium,Q9NSI6,BRWD1,Bromodomain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=BRWD1 PE=1 SV=4,1,1,100,0.121,100,0.053,6.64,-3.05,6.64,-4.23,1.00E-17,3.12E-02,1.00E-17,1.17E-02,2.94E+05,,3.55E+04,6.69E+05,1,,1,2,,,,,2.94E+05,,,,,,,,,3.55E+04,,,,,6.18E+04,7.24E+06,,,,,1.51E+04,,,,,,,,,4.79E+03,,,,,1.45E+03,7.71E+04,0.027,FALSE,1.86,0,1,2320,262.8,8.46,1,cell organization and biogenesis;other biological processes,cytosol;nucleus,"Pf00400, Pf00439",54014,C9JK25; hsa:54014; O43721; Q5R2V0; Q5R2V1; Q6P2D1; Q8TCV3; Q96QG9; Q96QH0; Q9NSI6; Q9NUK1,ENSG00000185658,Interleukin-7 signaling; Chromatin modifying enzymes,,2,0,,,,139.03,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,1,,FALSE,,0,,795.91,2.72,,0,
Master Protein,High,Q5JVF3,PCID2,PCI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PCID2 PE=1 SV=2,1,1,100,2.195,,100,6.64,1.13,,6.64,1.00E-17,2.20E-01,,1.00E-17,3.78E+04,,8.30E+04,,1,,2,,,,,3.78E+04,,,,,,,,4.46E+04,,1.54E+05,,,,,,,,,,3.78E+04,,,,,,,,1.99E+03,,2.08E+04,,,,,,,0.004,FALSE,2.564,4,1,399,46,8.53,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,nucleus;other cell component,Pf01399,55795,A6NK09; hsa:55795; Q3ZCX1; Q5JVF3; Q5TC57; Q5TC58; Q9H7K1; Q9HBZ7; Q9NUK6; Q9NVY1; Q9NW44; Q9NWH3,ENSG00000126226,,,0,0,,,78.1,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,98.22,,,3.08,nucleic acid binding activity,0,
Master Protein,Medium,Q9UMZ2,SYNRG,Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.08E+04,,,,1,,,,,,,2.08E+04,,,,,,,,,,,,,,,,,,,,2.08E+04,,,,,,,,,,,,,,,,,0.012,FALSE,2.194,2,1,1314,140.6,5.03,1,transport,other membranes;ER/Golgi;other cell component,,11276,A8MWU4; B7ZKZ2; B7ZKZ3; hsa:11276; Q17RI2; Q5BKU5; Q6ZT17; Q9UMZ2,ENSG00000274047; ENSG00000275066,,17q12 copy number variation syndrome,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,0,,0,
Master Protein,High,Q9UKJ3,GPATCH8,G patch domain-containing protein 8 OS=Homo sapiens OX=9606 GN=GPATCH8 PE=1 SV=2,4,6,100,0.586,,100,6.64,-0.77,,6.64,1.00E-17,8.37E-01,,1.00E-17,1.56E+05,,1.36E+05,,2,,2,,,,,4.34E+05,5.57E+04,,,,,,,1.18E+05,,1.57E+05,,,,,,,,,,4.34E+05,2.87E+03,,,,,,,5.25E+03,,2.12E+04,,,,,,,0,FALSE,12.377,4,4,1502,164.1,8.66,4,,nucleus,Pf01585,23131,B9EGP9; hsa:23131; O60300; Q8TB99; Q9UKJ3,ENSG00000186566,,,0,0,109.25,,20.35,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,63.23,,,16.32,other molecular function,0,
Master Protein,High,Q9NS69,TOMM22,Mitochondrial import receptor subunit TOM22 homolog OS=Homo sapiens OX=9606 GN=TOMM22 PE=1 SV=3,1,14,100,0.589,100,2.005,6.64,-0.76,6.64,1,1.00E-17,8.67E-01,1.00E-17,4.19E-01,1.68E+06,,9.91E+05,4.94E+05,2,,4,1,,2.21E+06,,1.28E+06,,,,,,,,5.90E+05,7.58E+05,1.30E+06,3.05E+06,,,,4.94E+05,,,8.41E+03,,1.28E+06,,,,,,,,2.63E+04,6.16E+03,1.75E+05,7.57E+04,,,,1.16E+04,,0,FALSE,12.006,18,1,142,15.5,4.34,1,cell organization and biogenesis;transport;other biological processes,other membranes;mitochondrion,Pf04281,56993,hsa:56993; Q9NS69,ENSG00000100216,Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy,,2,0,37.94,,79,,n/a,High,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,High,n/a,n/a,n/a,High,n/a,1,,FALSE,,73.46,,52.86,65.42,transporter activity,0,
Master Protein,High,Q13363,CTBP1,C-terminal-binding protein 1 OS=Homo sapiens OX=9606 GN=CTBP1 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.05E+05,,,,1,,,,,,,3.05E+05,,,,,,,,,,,,,,,,,,,,3.05E+05,,,,,,,,,,,,,,,,,0,FALSE,6.968,4,1,440,47.5,6.77,1,protein metabolism;other metabolic processes;transport;other biological processes,nucleus;other cell component,"Pf00389, Pf02826",1487,Q13363; Q4W5N3; Q7Z2Q5,ENSG00000159692,SUMOylation of transcription cofactors; Deactivation of the beta-catenin transactivating complex; Repression of WNT target genes; Signaling by TCF7L2 mutants,Notch signaling; Ectoderm differentiation; Ectoderm differentiation; Wnt signaling pathway; Pathways affected in adenoid cystic carcinoma; Wnt signaling pathway and pluripotency; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Pleural mesothelioma,14,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.25,other molecular function,0,
Master Protein,High,Q8N2U0,TMEM256,Transmembrane protein 256 OS=Homo sapiens OX=9606 GN=TMEM256 PE=3 SV=1,1,3,100,1.444,100,2.488,6.64,0.53,6.64,1.32,1.00E-17,2.39E-01,1.00E-17,3.22E-01,6.76E+05,,9.77E+05,3.93E+05,1,,2,1,,,,6.76E+05,,,,,,,,,,1.53E+06,6.24E+05,,,,3.93E+05,,,,,6.76E+05,,,,,,,,,,2.06E+05,1.55E+04,,,,9.19E+03,,0,FALSE,6.33,25,1,113,11.7,8.94,1,,other membranes,Pf04241,254863,hsa:254863; Q8N2U0,ENSG00000205544; ENSG00000283771,,,0,0,,,59.38,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,68.59,,68.59,13.09,,0,
Master Protein,High,P17813,ENG,Endoglin OS=Homo sapiens OX=9606 GN=ENG PE=1 SV=2,4,8,100,0.612,100,3.336,6.64,-0.71,6.64,1.74,1.00E-17,8.26E-01,1.00E-17,2.37E-01,6.12E+05,,2.17E+05,8.14E+04,2,,5,1,,,,6.98E+05,5.36E+05,,,,,,2.08E+05,2.17E+05,3.38E+04,5.82E+05,6.38E+05,,,,8.14E+04,,,,,6.98E+05,2.77E+04,,,,,,1.24E+03,9.69E+03,2.74E+02,7.84E+04,1.59E+04,,,,1.90E+03,,0,FALSE,15.515,9,4,658,70.5,6.61,4,cell adhesion;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;nucleus;other cell component,,2022,hsa:2022; P17813; Q14248; Q14926; Q5T9C0,ENSG00000106991,,Hypothesized pathways in pathogenesis of cardiovascular disease; VEGFA-VEGFR2 signaling; TGF-beta receptor signaling in skeletal dysplasias; TGF-beta receptor signaling,4,0,18.55,,77.91,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,53.06,,38.7,22.74,signal transduction activity or receptor binding;kinase activity;other molecular function,0,
Master Protein,High,P55209,NAP1L1,Nucleosome assembly protein 1-like 1 OS=Homo sapiens OX=9606 GN=NAP1L1 PE=1 SV=1,1,2,100,0.964,100,5.116,6.64,-0.05,6.64,2.35,1.00E-17,6.46E-01,1.00E-17,1.35E-01,1.96E+05,,2.04E+05,4.00E+04,3,,2,1,,1.96E+05,,3.14E+05,1.43E+05,,,,,,,,7.67E+04,5.45E+05,,,4.00E+04,,,,,7.44E+02,,3.14E+05,7.40E+03,,,,,,,,6.23E+02,7.34E+04,,,1.12E+04,,,,0.001,FALSE,3.224,5,1,391,45.3,4.46,1,cell organization and biogenesis;DNA metabolism;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,Pf00956,4673,B3KNT8; B3KV44; hsa:4673; P55209,ENSG00000187109,,VEGFA-VEGFR2 signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies,2,0,40.12,,106.49,,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,114.68,,169.67,6.16,other molecular function,0,
Master Protein,High,P16219,ACADS,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADS PE=1 SV=1",2,4,100,1.034,,100,6.64,0.05,,6.64,1.00E-17,6.65E-01,,1.00E-17,1.04E+05,,1.08E+05,,1,,4,,,,,1.04E+05,,,,,,,,5.84E+05,9.06E+04,6.26E+04,1.29E+05,,,,,,,,,1.04E+05,,,,,,,,2.61E+04,7.36E+02,8.44E+03,3.19E+03,,,,,,0,FALSE,6.805,8,2,412,44.3,7.99,2,other metabolic processes,cytoskeleton;mitochondrion;nucleus,"Pf00441, Pf02770, Pf02771",35,hsa:35; P16219; P78331,ENSG00000122971,Beta oxidation of hexanoyl-CoA to butanoyl-CoA; Beta oxidation of butanoyl-CoA to acetyl-CoA,Fatty acid beta-oxidation; Mitochondrial long chain fatty acid beta-oxidation; IL-18 signaling pathway; Mitochondrial fatty acid oxidation disorders,6,0,,,113.91,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,45.25,,,7.31,other molecular function,0,
Master Protein,High,Q5GLZ8,HERC4,Probable E3 ubiquitin-protein ligase HERC4 OS=Homo sapiens OX=9606 GN=HERC4 PE=1 SV=1,1,1,100,0.742,,100,6.64,-0.43,,6.64,1.00E-17,8.99E-01,,1.00E-17,5.84E+05,,6.24E+05,,3,,3,,3.73E+05,,,5.84E+05,1.06E+06,,,,,,,2.40E+05,,7.88E+05,6.24E+05,,,,,,1.48E+03,,,5.84E+05,5.48E+04,,,,,,,1.07E+04,,1.06E+05,1.55E+04,,,,,,0.009,FALSE,2.314,1,1,1057,118.5,6.19,1,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00415, Pf00632",26091,hsa:26091; Q5GC98; Q5GC99; Q5GCA0; Q5GLZ8; Q8IXP9; Q9HCH9,ENSG00000148634,Antigen processing: Ubiquitination & Proteasome degradation,,1,0,52.46,,51.1,,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,66.74,,,2.89,other molecular function,0,
Master Protein,High,Q8IV04,TBC1D10C,Carabin OS=Homo sapiens OX=9606 GN=TBC1D10C PE=1 SV=1,2,2,100,2.78,,100,6.64,1.48,,6.64,1.00E-17,1.21E-01,,1.00E-17,6.94E+04,,1.72E+05,,1,,4,,,,,6.94E+04,,,,,,,4.59E+05,1.04E+05,,1.49E+05,1.99E+05,,,,,,,,,6.94E+04,,,,,,,2.74E+03,4.63E+03,,2.01E+04,4.94E+03,,,,,,0,FALSE,6.38,8,2,446,49.7,8.76,2,transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol,Pf00566,374403,G3V1D6; hsa:374403; Q8IV04,ENSG00000175463,Neutrophil degranulation; TBC/RABGAPs,,2,0,,,69.78,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,30.98,,,2.95,enzyme regulator activity,0,
Master Protein,High,Q9BS92,NIPSNAP3B,Protein NipSnap homolog 3B OS=Homo sapiens OX=9606 GN=NIPSNAP3B PE=2 SV=1,1,3,100,1.09,100,11.724,6.64,0.12,6.64,3.55,1.00E-17,5.88E-01,1.00E-17,1.13E-02,3.71E+05,,4.87E+05,4.16E+04,2,,4,1,,,,6.75E+05,2.04E+05,,,,,,,6.99E+05,4.73E+05,2.34E+05,5.02E+05,,,,4.16E+04,,,,,6.75E+05,1.05E+04,,,,,,,3.12E+04,3.84E+03,3.16E+04,1.25E+04,,,,9.72E+02,,0,FALSE,5.612,6,1,247,28.3,9.28,1,,mitochondrion,Pf07978,55335,hsa:55335; Q5VX30; Q9BS92; Q9NUM2,ENSG00000165028,,,0,0,75.71,,39.92,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,77.01,,34.48,4.7,,0,
Master Protein,High,A0A494C0G7,DIMT1,rRNA adenine N(6)-methyltransferase OS=Homo sapiens OX=9606 GN=DIMT1 PE=1 SV=1,1,2,100,0.392,100,0.604,6.64,-1.35,6.64,-0.73,1.00E-17,4.85E-01,1.00E-17,8.22E-01,2.26E+05,,8.86E+04,1.47E+05,1,,3,1,,,,2.26E+05,,,,,,,,,8.86E+04,1.48E+05,5.04E+04,,,,1.47E+05,,,,,2.26E+05,,,,,,,,,7.20E+02,1.99E+04,1.25E+03,,,,3.43E+03,,0,FALSE,5.597,5,1,317,35.7,10.05,1,RNA metabolism OR transcription;other metabolic processes,,Pf00398,,A0A494C0G7,ENSG00000086189,,,0,0,,,51.2,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,59.17,,59.17,7.97,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q6NXT4,SLC30A6,Zinc transporter 6 OS=Homo sapiens OX=9606 GN=SLC30A6 PE=1 SV=2,1,2,100,1.109,,100,6.64,0.15,,6.64,1.00E-17,6.37E-01,,1.00E-17,7.91E+04,,8.77E+04,,1,,4,,,,,7.91E+04,,,,,,,7.03E+04,,5.69E+04,1.33E+05,1.10E+05,,,,,,,,,7.91E+04,,,,,,,4.20E+02,,4.62E+02,1.79E+04,2.72E+03,,,,,,0.005,FALSE,2.521,3,1,461,51.1,9.16,1,transport;other biological processes,other membranes;ER/Golgi,Pf01545,55676,A5YM45; B7Z901; hsa:55676; Q6NXT4; Q8N5C9; Q96NC3,ENSG00000152683,,Zinc homeostasis,1,0,,,37.83,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,44.51,,,4.9,transporter activity,0,
Master Protein,High,Q7Z434,MAVS,Mitochondrial antiviral-signaling protein OS=Homo sapiens OX=9606 GN=MAVS PE=1 SV=2,3,6,100,2.519,,100,6.64,1.33,,6.64,1.00E-17,1.51E-01,,1.00E-17,8.97E+04,,1.42E+05,,2,,3,,,,,1.00E+05,8.02E+04,,,,,,,,1.42E+05,3.93E+05,9.22E+04,,,,,,,,,1.00E+05,4.14E+03,,,,,,,,1.15E+03,5.30E+04,2.29E+03,,,,,,0,FALSE,13.66,12,3,540,56.5,5.52,3,stress response;signal transduction;other biological processes,other membranes;mitochondrion;other cytoplasmic organelle;other cell component,Pf16739,57506,A8K6X0; B2BD33; B2BD34; F5H6C8; hsa:57506; M1P2Z0; Q2HWT5; Q3I0Y2; Q5T7I6; Q7Z434; Q86VY7; Q9H1H3; Q9H4Y1; Q9H8D3; Q9ULE9,ENSG00000088888,PKR-mediated signaling; SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses; Ovarian tumor domain proteases; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Evasion by RSV of host interferon responses,Novel intracellular components of RIG-I-like receptor pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Hepatitis B infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Network map of SARS-CoV-2 signaling pathway; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; Lung pathology of COVID-19; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,24,0,15.72,,77.27,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,65.11,,,18.4,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P08648,ITGA5,Integrin alpha-5 OS=Homo sapiens OX=9606 GN=ITGA5 PE=1 SV=2,2,2,100,0.703,,100,6.64,-0.51,,6.64,1.00E-17,9.98E-01,,1.00E-17,1.19E+05,,7.14E+04,,2,,4,,,,,1.98E+05,7.19E+04,,,,,,,6.70E+04,7.62E+04,1.18E+05,5.97E+04,,,,,,,,,1.98E+05,3.71E+03,,,,,,,2.99E+03,6.19E+02,1.58E+04,1.48E+03,,,,,,0,FALSE,5.726,3,2,1049,114.5,5.77,2,cell adhesion;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,"Pf01839, Pf08441, Pf20805, Pf20806",3678,hsa:3678; P08648; Q96HA5,ENSG00000161638,Cell surface interactions at the vascular wall; Integrin cell surface interactions; GPER1 signaling; Signal transduction by L1; RUNX2 regulates genes involved in cell migration; Fibronectin matrix formation; Elastic fibre formation,Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Epithelial to mesenchymal transition in colorectal cancer; CCL18 signaling pathway; GDNF signaling; TROP2 regulatory signaling,17,0,65.94,,32.32,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,67.21,,,6.14,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q14CX7,NAA25,"N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1",2,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.68E+06,,,6.01E+05,2,,,2,1.48E+06,1.91E+06,,,,,,,,,,,,,,1.32E+06,2.73E+05,,,,5.90E+03,7.25E+03,,,,,,,,,,,,,,2.58E+03,7.67E+04,,,,0,FALSE,6.821,3,2,972,112.2,6.64,2,,cytosol;ER/Golgi;other cell component,Pf09797,80018,A0JLU7; hsa:80018; Q14CX7; Q6MZH1; Q7Z4N6; Q9H911,ENSG00000111300,,,0,0,17.73,,,93.07,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,,,,5.87,,0,
Master Protein,High,Q6P2I3,FAHD2B,Fumarylacetoacetate hydrolase domain-containing protein 2B OS=Homo sapiens OX=9606 GN=FAHD2B PE=1 SV=1,1,2,100,2.347,,100,6.64,1.23,,6.64,1.00E-17,1.22E-01,,1.00E-17,2.01E+05,,4.72E+05,,1,,2,,,,,2.01E+05,,,,,,,,,,5.53E+05,4.02E+05,,,,,,,,,2.01E+05,,,,,,,,,,7.46E+04,1.00E+04,,,,,,0,FALSE,4.836,6,1,314,34.6,7.75,1,,,Pf01557,151313,D3DXH7; hsa:151313; Q6P2I3; Q8NDK1,ENSG00000144199; ENSG00000291581,,,0,0,,,22.33,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,23.71,,,7.09,other molecular function,0,
Master Protein,High,Q15596,NCOA2,Nuclear receptor coactivator 2 OS=Homo sapiens OX=9606 GN=NCOA2 PE=1 SV=2,1,1,100,0.459,100,2.021,6.64,-1.12,6.64,1.02,1.00E-17,6.77E-01,1.00E-17,4.88E-01,6.21E+04,,2.85E+04,1.41E+04,1,,2,1,,,,6.21E+04,,,,,,,1.23E+05,,,6.59E+03,,,1.41E+04,,,,,,,6.21E+04,,,,,,,7.38E+02,,,8.88E+02,,,3.96E+03,,,,0,FALSE,5.337,1,1,1464,159.1,6.64,1,RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,nucleus;other cell component,"Pf00989, Pf07469, Pf08815, Pf08832, Pf14598, Pf16279, Pf16665",10499,hsa:10499; Q14CD2; Q15596,ENSG00000140396,"PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Endogenous sterols; Heme signaling; SUMOylation of transcription cofactors; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Transcriptional activation of mitochondrial biogenesis; Estrogen-dependent gene expression; Cytoprotection by HMOX1; Activation of gene expression by SREBF (SREBP); Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol; HATs acetylate histones; Recycling of bile acids and salts; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; RORA activates gene expression; Synthesis of bile acids and bile salts via 27-hydroxycholesterol",Androgen receptor signaling pathway; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Constitutive androstane receptor pathway; Pregnane X receptor pathway; Nuclear receptors meta-pathway,25,0,,,127.08,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,303.57,,303.57,4.02,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,High,M0QYN0,MYDGF,Myeloid derived growth factor OS=Homo sapiens OX=9606 GN=MYDGF PE=1 SV=1,1,4,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,3.97E+05,,,1.33E+05,1,,,4,,,,,3.97E+05,,,,,,,,,,,1.64E+05,,2.17E+05,1.08E+05,9.53E+04,,,,,2.05E+04,,,,,,,,,,,3.20E+02,,1.54E+03,2.52E+03,1.01E+03,0,FALSE,5.595,8,1,189,20.4,5.3,1,,,Pf10572,,M0QYN0,ENSG00000074842,,,0,0,,,,38.37,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,,,,11.89,,0,
Master Protein,High,Q8N684,CPSF7,Cleavage and polyadenylation specificity factor subunit 7 OS=Homo sapiens OX=9606 GN=CPSF7 PE=1 SV=1,3,8,100,0.739,100,,6.64,-0.44,6.64,,1.00E-17,8.17E-01,1.00E-17,,1.14E+06,,8.28E+05,2.54E+05,2,,3,1,,,,1.05E+06,1.24E+06,,,,,,8.28E+05,,,1.33E+06,2.72E+05,,,,,2.54E+05,,,,1.05E+06,6.41E+04,,,,,,4.95E+03,,,1.79E+05,6.77E+03,,,,,2.70E+03,0,FALSE,9.461,7,3,471,52,8,3,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf00076,79869,B3KU04; C9K0Q4; hsa:79869; Q7Z3H9; Q8N684; Q9H025; Q9H9V1,ENSG00000149532,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; RHOBTB1 GTPase cycle; Processing of Intronless Pre-mRNAs,,5,0,12.13,,65.28,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,55.41,,,17.58,nucleic acid binding activity,0,
Master Protein,High,A0A7I2V409,MARK3,non-specific serine/threonine protein kinase OS=Homo sapiens OX=9606 GN=MARK3 PE=1 SV=1,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,5.56E+04,,,2.90E+05,1,,,2,,,,,5.56E+04,,,,,,,,,,,1.09E+06,7.70E+04,,,,,,,,2.87E+03,,,,,,,,,,,2.13E+03,2.16E+04,,,,0.002,FALSE,2.974,2,1,796,88.8,9.42,1,,other cell component,"Pf00069, Pf00627, Pf02149",,A0A7I2V409,ENSG00000075413,,,0,0,,,,122.77,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,,,,2.25,kinase activity;other molecular function,0,
Master Protein,High,Q9UKL0,RCOR1,REST corepressor 1 OS=Homo sapiens OX=9606 GN=RCOR1 PE=1 SV=2,4,6,100,1.807,100,0.501,6.64,0.85,6.64,-1,1.00E-17,2.22E-01,1.00E-17,6.47E-01,2.60E+05,,3.52E+05,4.87E+05,5,,2,2,7.55E+05,1.10E+05,4.70E+04,5.12E+05,2.60E+05,,,,,,,,,5.59E+05,2.22E+05,,9.35E+04,,,2.54E+06,3.00E+03,4.20E+02,4.59E+02,5.12E+05,1.34E+04,,,,,,,,,7.53E+04,5.51E+03,,2.63E+04,,,2.70E+04,0,FALSE,16.942,11,1,485,53.3,7.03,4,cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf00249, Pf01448, Pf20878",23186,hsa:23186; J3KN32; Q15044; Q6P2I9; Q86VG5; Q9UKL0,ENSG00000089902,Regulation of PTEN gene transcription; Potential therapeutics for SARS; HDACs deacetylate histones; Factors involved in megakaryocyte development and platelet production,,4,2,87.43,,61.06,131.38,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,,114.04,,372.26,19.49,other molecular function,0,
Master Protein,High,Q9HCN8,SDF2L1,Stromal cell-derived factor 2-like protein 1 OS=Homo sapiens OX=9606 GN=SDF2L1 PE=1 SV=2,4,13,100,4.639,100,3.393,6.64,2.21,6.64,1.76,1.00E-17,4.31E-03,1.00E-17,2.15E-01,2.86E+05,,1.18E+06,4.11E+05,5,,4,2,5.79E+04,5.71E+05,8.88E+04,1.02E+06,2.86E+05,,,,,,,1.61E+06,6.96E+05,1.46E+06,9.58E+05,,7.35E+05,,2.30E+05,,2.30E+02,2.17E+03,8.68E+02,1.02E+06,1.47E+04,,,,,,,7.17E+04,5.65E+03,1.97E+05,2.38E+04,,2.06E+05,,5.37E+03,,0,FALSE,21.744,29,4,221,23.6,7.03,4,protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi;other cell component,Pf02815,23753,A2RUD3; hsa:23753; Q9BRI5; Q9HCN8,ENSG00000128228,,VEGFA-VEGFR2 signaling,1,0,99.03,,36.07,74.06,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,137.13,,127.53,41.04,other molecular function,0,
Master Protein,High,Q99496,RNF2,E3 ubiquitin-protein ligase RING2 OS=Homo sapiens OX=9606 GN=RNF2 PE=1 SV=1,3,13,100,1.359,100,11.037,6.64,0.44,6.64,3.46,1.00E-17,3.76E-01,1.00E-17,1.99E-02,2.94E+05,,4.00E+05,4.21E+04,3,,5,3,,7.34E+04,,6.27E+05,2.94E+05,,,,,,5.62E+05,4.65E+05,4.00E+05,3.38E+05,2.48E+05,,4.19E+03,4.21E+04,,4.66E+04,,2.79E+02,,6.27E+05,1.52E+04,,,,,,3.36E+03,2.08E+04,3.25E+03,4.55E+04,6.17E+03,,1.18E+03,2.99E+02,,4.96E+02,0,FALSE,11.437,14,1,336,37.6,6.84,3,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,"Pf13923, Pf16207",6045,B2RBS7; B3KRH1; Q5TEN1; Q5TEN2; Q99496,ENSG00000121481,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; Pleural mesothelioma,11,0,84.07,,29.71,75.23,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,,78.68,,51.05,41.7,other molecular function,0,
Master Protein,High,Q9BRR9,ARHGAP9,Rho GTPase-activating protein 9 OS=Homo sapiens OX=9606 GN=ARHGAP9 PE=1 SV=2,1,1,100,0.354,,100,6.64,-1.5,,6.64,1.00E-17,4.90E-01,,1.00E-17,9.14E+04,,3.24E+04,,3,,3,,,2.34E+05,,9.14E+04,4.01E+04,,,,,,,3.24E+04,4.98E+04,1.99E+04,,,,,,,,8.87E+02,,9.14E+04,2.07E+03,,,,,,,1.45E+03,4.05E+02,2.68E+03,,,,,,,0,FALSE,6.217,3,1,750,83.2,8.34,1,signal transduction;other biological processes,non-structural extracellular;cytosol;other cell component,"Pf00018, Pf00169, Pf00620",64333,B4DVI3; E9PDX9; hsa:64333; Q8NAF3; Q8TCJ3; Q8WYR0; Q96EZ2; Q96S74; Q9BRR9,ENSG00000123329,RHOA GTPase cycle; Neutrophil degranulation; CDC42 GTPase cycle; RAC1 GTPase cycle,,4,0,82.35,,44.18,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,93.01,,,4.1,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q6ZRS2,SRCAP,Helicase SRCAP OS=Homo sapiens OX=9606 GN=SRCAP PE=1 SV=3,1,1,100,1.877,100,0.522,6.64,0.91,6.64,-0.94,1.00E-17,3.01E-01,1.00E-17,7.31E-01,4.55E+04,,8.54E+04,1.64E+05,1,,3,1,,,,4.55E+04,,,,,,,,8.54E+04,,8.69E+03,2.26E+05,,,,1.64E+05,,,,,4.55E+04,,,,,,,,3.82E+03,,1.17E+03,5.62E+03,,,,3.83E+03,,0.007,FALSE,2.376,0,1,3230,343.3,5.96,1,cell organization and biogenesis;other biological processes,ER/Golgi;nucleus;other cell component,"Pf00176, Pf00271, Pf07529",10847,B0JZA6; hsa:10847; O15026; Q6ZRS2; Q7Z744; Q9Y5L9,ENSG00000080603,,Pathways affected in adenoid cystic carcinoma,1,0,,,103.3,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,133.19,,92.24,2.24,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8NBM8,PCYOX1L,Prenylcysteine oxidase-like OS=Homo sapiens OX=9606 GN=PCYOX1L PE=1 SV=2,1,1,100,1.758,,100,6.64,0.81,,6.64,1.00E-17,1.25E-01,,1.00E-17,9.86E+05,,1.73E+06,,1,,1,,,,9.86E+05,,,,,,,,1.73E+06,,,,,,,,,,,,9.63E+03,,,,,,,,1.04E+04,,,,,,,,,,0.005,FALSE,2.486,5,1,494,54.6,7.31,1,protein metabolism;other metabolic processes,non-structural extracellular;other cell component,"Pf07156, Pf13450",78991,hsa:78991; Q7Z4S2; Q8NBM8; Q8NCY5; Q8NF69; Q9BTE8; Q9BWS3,ENSG00000145882,Platelet degranulation,,1,0,,,,,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,0,other molecular function,0,
Master Protein,High,Q86U44,METTL3,N6-adenosine-methyltransferase catalytic subunit OS=Homo sapiens OX=9606 GN=METTL3 PE=1 SV=2,4,6,100,0.508,100,0.291,6.64,-0.98,6.64,-1.78,1.00E-17,7.00E-01,1.00E-17,3.50E-01,2.08E+05,,1.23E+05,3.41E+05,2,,5,3,,,,7.15E+05,6.04E+04,,,,,,8.62E+04,1.01E+05,3.43E+05,6.82E+05,1.23E+05,1.10E+06,,3.41E+05,,1.87E+05,,,,7.15E+05,3.12E+03,,,,,,5.15E+02,4.50E+03,2.78E+03,9.19E+04,3.06E+03,2.15E+03,,2.42E+03,,1.99E+03,0,FALSE,14.139,10,4,580,64.4,6.42,4,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,Pf05063,56339,hsa:56339; O14736; Q86U44; Q86V05; Q9HB32,ENSG00000165819,Processing of Capped Intron-Containing Pre-mRNA,mRNA processing,2,0,119.37,,95.32,90.27,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,47.51,,76.92,21.91,nucleic acid binding activity;other molecular function,0,
Master Protein,High,F8VVM2,SLC25A3,"Phosphate carrier protein, mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A3 PE=1 SV=1",10,54,100,0.601,100,3.229,6.64,-0.73,6.64,1.69,1.00E-17,8.36E-01,1.00E-17,1.98E-01,3.96E+06,,2.38E+06,7.38E+05,4,,4,1,8.64E+06,,6.35E+06,1.34E+06,2.47E+06,,,,,,1.81E+07,,1.54E+06,7.14E+05,3.68E+06,,7.38E+05,,,,3.43E+04,,6.20E+04,1.34E+06,1.28E+05,,,,,,1.08E+05,,1.25E+04,9.62E+04,9.14E+04,,2.07E+05,,,,0,FALSE,42.722,36,1,324,36.1,9.26,10,transport,other membranes;mitochondrion,Pf00153,,F8VVM2,ENSG00000075415,,,0,0,72.1,,135.73,,High,n/a,High,High,High,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,116.35,,92.22,123.64,transporter activity,0,
Master Protein,High,Q9NRP0,OSTC,Oligosaccharyltransferase complex subunit OSTC OS=Homo sapiens OX=9606 GN=OSTC PE=1 SV=1,1,2,100,0.337,,100,6.64,-1.57,,6.64,1.00E-17,3.33E-01,,1.00E-17,1.30E+06,,4.39E+05,,1,,2,,,,,1.30E+06,,,,,,,,,,7.27E+05,2.65E+05,,,,,,,,,1.30E+06,,,,,,,,,,9.80E+04,6.58E+03,,,,,,0.002,FALSE,2.928,8,1,149,16.8,9.13,1,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf04756,58505,A8MYS2; B2R5H1; D6RH22; hsa:58505; Q9NRP0; Q9P075; Q9P1R4,ENSG00000198856,,,0,0,,,65.96,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,78.18,,,5.7,,0,
Master Protein,High,Q9NVM9,INTS13,Integrator complex subunit 13 OS=Homo sapiens OX=9606 GN=INTS13 PE=1 SV=2,2,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.49E+05,,,1.98E+05,2,,,1,,3.09E+05,,7.23E+04,,,,,,,,,,,,1.98E+05,,,,,,1.17E+03,,7.23E+04,,,,,,,,,,,,3.87E+02,,,,,0,FALSE,8.869,5,2,706,80.2,6.7,2,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf10221,55726,B4DNK1; hsa:55726; Q86WE2; Q96HM2; Q9BTX2; Q9NTB6; Q9NVM5; Q9NVM9,ENSG00000064102,RNA polymerase II transcribes snRNA genes,1p36 copy number variation syndrome,2,0,87.73,,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,,,,7.37,,0,
Master Protein,High,F5H2X7,CIZ1,CDKN1A interacting zinc finger protein 1 OS=Homo sapiens OX=9606 GN=CIZ1 PE=1 SV=2,3,4,100,0.129,100,0.033,6.64,-2.96,6.64,-4.93,1.00E-17,7.83E-02,1.00E-17,7.41E-03,1.24E+05,,3.76E+03,1.14E+05,2,,1,1,,,,7.50E+04,2.04E+05,,,,,,,,,3.76E+03,,,,,,1.14E+05,,,,7.50E+04,1.05E+04,,,,,,,,,5.07E+02,,,,,,1.22E+03,0,FALSE,9.652,4,3,954,106.2,6.74,3,,plasma membrane;other membranes;nucleus,Pf12171,25792,F5H2X7,ENSG00000148337,,,0,0,65.32,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,113.61,,0,9.29,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P40937,RFC5,Replication factor C subunit 5 OS=Homo sapiens OX=9606 GN=RFC5 PE=1 SV=1,2,3,100,26.219,,100,6.64,4.71,,6.64,1.00E-17,1.19E-04,,1.00E-17,1.20E+05,,6.42E+04,,2,,1,,,,9.48E+04,1.51E+05,,,,,,,,,,6.42E+04,,,,,,,,,9.26E+02,1.51E+05,,,,,,,,,,8.65E+03,,,,,,,0,FALSE,12.931,11,2,340,38.5,7.2,2,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00004, Pf08542",5985,A8MZ62; B3KSX8; hsa:5985; P40937,ENSG00000111445,Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,"Retinoblastoma gene in cancer; DNA replication; Nucleotide excision repair; 7q11.23 copy number variation syndrome; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",28,0,32.53,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,12.66,nucleic acid binding activity;other molecular function,0,
Master Protein,High,B7ZKJ8,ITIH4,ITIH4 protein OS=Homo sapiens OX=9606 GN=ITIH4 PE=1 SV=1,2,2,100,2.02,100,0.624,6.64,1.01,6.64,-0.68,1.00E-17,1.65E-01,1.00E-17,8.28E-01,8.46E+04,,6.45E+05,4.25E+05,3,,4,2,8.46E+04,,5.51E+05,1.96E+04,,,,,,,,3.89E+05,3.95E+04,1.07E+06,1.40E+06,1.22E+06,,1.49E+05,,,3.36E+02,,5.38E+03,1.96E+04,,,,,,,,1.74E+04,3.21E+02,1.44E+05,3.47E+04,2.37E+03,,1.05E+03,,,0,FALSE,4.525,2,2,935,103.8,6.89,2,other metabolic processes,non-structural extracellular,"Pf00092, Pf06668, Pf08487",3700,B7ZKJ8; hsa:3700,ENSG00000055955,,Network map of SARS-CoV-2 signaling pathway; HDAC6 interactions in the central nervous system,2,0,132.73,,85.65,110.63,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,,113.94,,118.16,4.19,enzyme regulator activity,0,
Master Protein,High,P0C7P0,CISD3,"CDGSH iron-sulfur domain-containing protein 3, mitochondrial OS=Homo sapiens OX=9606 GN=CISD3 PE=1 SV=1",1,1,100,0.707,,100,6.64,-0.5,,6.64,1.00E-17,9.98E-01,,1.00E-17,1.60E+05,,1.13E+05,,1,,2,,,,,1.60E+05,,,,,,,1.00E+05,1.28E+05,,,,,,,,,,,,1.60E+05,,,,,,,6.01E+02,5.71E+03,,,,,,,,,0.002,FALSE,2.882,9,1,127,14.2,10.55,1,protein metabolism;other metabolic processes,mitochondrion,Pf09360,284106,hsa:284106; P0C7P0,ENSG00000274768; ENSG00000277972,,17q12 copy number variation syndrome,1,0,,,16.92,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,17.86,,,2.45,other molecular function,0,
Master Protein,High,V9GZ56,LSM4,U6 snRNA-associated Sm-like protein LSm4 (Fragment) OS=Homo sapiens OX=9606 GN=LSM4 PE=1 SV=1,1,3,100,0.254,100,1.175,6.64,-1.98,6.64,0.23,1.00E-17,1.91E-01,1.00E-17,7.31E-01,1.08E+06,,2.73E+05,2.33E+05,2,,4,2,,,,1.51E+06,7.68E+05,,,,,,,4.12E+05,1.81E+05,1.20E+06,1.48E+05,,2.43E+05,,2.23E+05,,,,,1.51E+06,3.96E+04,,,,,,,1.84E+04,1.47E+03,1.61E+05,3.67E+03,,6.83E+04,,5.21E+03,,0,FALSE,6.312,7,1,238,25.7,10.15,1,RNA metabolism OR transcription;other metabolic processes,nucleus,Pf01423,,V9GZ56,ENSG00000130520,,Ciliary landscape,1,0,46.02,,101.04,6.3,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,89.48,,68.67,9.73,nucleic acid binding activity,0,
Master Protein,High,A0A1B0GV02,ZEB2,Zinc finger E-box binding homeobox 2 OS=Homo sapiens OX=9606 GN=ZEB2 PE=1 SV=1,1,1,100,0.275,100,0.599,6.64,-1.86,6.64,-0.74,1.00E-17,3.51E-01,1.00E-17,8.10E-01,7.19E+04,,1.98E+04,3.30E+04,2,,1,3,,,,6.93E+04,7.46E+04,,,,,,,,,1.98E+04,,,1.10E+04,,3.30E+04,1.37E+06,,,,6.93E+04,3.85E+03,,,,,,,,,2.67E+03,,,3.09E+03,,7.73E+02,1.45E+04,0.001,FALSE,3.56,1,1,1239,139.1,6.32,1,other biological processes,cytosol;nucleus,"Pf00096, Pf05605, Pf12874",,A0A1B0GV02,ENSG00000169554,,Mammary gland development pathway - Embryonic development (Stage 1 of 4); Epithelial to mesenchymal transition in colorectal cancer; Extrafollicular and follicular B cell activation by SARS-CoV-2,3,0,5.21,,,165.11,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,,5.46,,98.93,3.83,nucleic acid binding activity,0,
Master Protein,High,Q8TBC4,UBA3,NEDD8-activating enzyme E1 catalytic subunit OS=Homo sapiens OX=9606 GN=UBA3 PE=1 SV=2,1,1,100,0.188,100,0.508,6.64,-2.41,6.64,-0.98,1.00E-17,2.12E-01,1.00E-17,7.02E-01,3.50E+04,,6.57E+03,1.29E+04,2,,1,2,1.25E+05,,,9.76E+03,,,,,,,,,,6.57E+03,,,6.48E+03,,2.59E+04,,4.98E+02,,,9.76E+03,,,,,,,,,,8.85E+02,,,1.82E+03,,6.05E+02,,0,FALSE,4.66,3,1,463,51.8,5.45,1,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00899, Pf08825",9039,A6NLB5; A8K027; hsa:9039; O76088; Q8TBC4; Q9NTU3,ENSG00000144744,Neddylation; Antigen processing: Ubiquitination & Proteasome degradation; Dectin-1 mediated noncanonical NF-kB signaling; NIK-->noncanonical NF-kB signaling,Hijack of ubiquitination by SARS-CoV-2,5,0,120.98,,,84.74,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,244.87,,110.96,3.48,other molecular function,0,
Master Protein,High,P61964,WDR5,WD repeat-containing protein 5 OS=Homo sapiens OX=9606 GN=WDR5 PE=1 SV=1,2,3,100,0.401,,100,6.64,-1.32,,6.64,1.00E-17,4.96E-01,,1.00E-17,3.96E+05,,1.93E+05,,2,,5,,,,,7.50E+05,2.09E+05,,,,,,2.65E+05,1.93E+05,8.94E+04,1.26E+05,2.17E+05,,,,,,,,,7.50E+05,1.08E+04,,,,,,1.59E+03,8.61E+03,7.27E+02,1.70E+04,5.39E+03,,,,,,0,FALSE,7.403,12,2,334,36.6,8.27,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytoskeleton;nucleus;other cell component,Pf00400,11091,hsa:11091; P61964; Q91VA5; Q9NWX7; Q9UGP9,ENSG00000196363,Neddylation; Formation of WDR5-containing histone-modifying complexes; Activation of anterior HOX genes in hindbrain development during early embryogenesis; RMTs methylate histone arginines; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; HATs acetylate histones; Cardiogenesis,Pleural mesothelioma; Kleefstra syndrome,10,0,79.75,,39.59,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,76.51,,,5.31,other molecular function,0,
Master Protein,High,A0A7I2YQX2,NDUFAF2,NADH:ubiquinone oxidoreductase complex assembly factor 2 OS=Homo sapiens OX=9606 GN=NDUFAF2 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.51E+06,,,,1,,,,,,,,1.51E+06,,,,,,,,,,,,,,,,,,,,7.81E+04,,,,,,,,,,,,,,,,0.001,FALSE,3.572,11,1,177,20.8,9.33,1,cell organization and biogenesis,other membranes;mitochondrion,Pf05071,,A0A7I2YQX2,ENSG00000164182,,SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,1,0,,,,,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.82,,0,
Master Protein,High,Q9Y3B7,MRPL11,"39S ribosomal protein L11, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL11 PE=1 SV=1",2,4,100,1.368,100,1.788,6.64,0.45,6.64,0.84,1.00E-17,4.28E-01,1.00E-17,5.22E-01,1.23E+05,,1.64E+05,9.16E+04,3,,4,1,1.23E+05,,1.82E+04,3.68E+05,,,,,,,,1.11E+05,5.69E+04,2.41E+05,3.53E+05,,9.16E+04,,,,4.90E+02,,1.78E+02,3.68E+05,,,,,,,,4.97E+03,4.62E+02,3.25E+04,8.76E+03,,2.57E+04,,,,0,FALSE,5.642,11,2,192,20.7,9.91,2,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,"Pf00298, Pf03946",65003,A6NLT0; A8K219; hsa:65003; Q32P46; Q96Q73; Q9Y3B7,ENSG00000174547,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,105.65,,69.74,,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,123.49,,83.37,9.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P61244,MAX,Protein max OS=Homo sapiens OX=9606 GN=MAX PE=1 SV=1,2,2,100,0.421,100,0.21,6.64,-1.25,6.64,-2.25,1.00E-17,5.23E-01,1.00E-17,1.97E-01,3.75E+05,,1.18E+05,5.33E+05,1,,3,4,,,,3.75E+05,,,,,,,1.07E+05,1.18E+05,,,1.18E+05,3.81E+05,,7.04E+05,4.16E+05,6.84E+05,,,,3.75E+05,,,,,,,6.37E+02,5.26E+03,,,2.93E+03,7.42E+02,,4.99E+03,9.73E+03,7.28E+03,0,FALSE,9.387,19,2,160,18.3,6.3,2,other biological processes,nucleus;other cell component,Pf00010,4149,A6NH73; A8K265; A8K4G4; A8K824; hsa:4149; P25912; P52163; P61244; Q14803; Q96CY8,ENSG00000125952,Transcriptional Regulation by E2F6; Cyclin E associated events during G1/S transition ; Transcription of E2F targets under negative control by DREAM complex; Cyclin A:Cdk2-associated events at S phase entry,B cell receptor signaling pathway; Pathways affected in adenoid cystic carcinoma; MAPK signaling pathway; p38 MAPK signaling pathway; Small cell lung cancer; Pleural mesothelioma; 5q35 copy number variation,11,0,,,5.68,31.39,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,0.16,,38.11,8.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q5SW79,CEP170,Centrosomal protein of 170 kDa OS=Homo sapiens OX=9606 GN=CEP170 PE=1 SV=1,2,2,100,3.967,100,3.537,6.64,1.99,6.64,1.82,1.00E-17,2.20E-02,1.00E-17,1.84E-01,1.84E+05,,5.32E+05,4.90E+05,1,,1,2,,,,1.84E+05,,,,,,,,,,5.32E+05,,,1.51E+05,1.60E+06,,,,,,1.84E+05,,,,,,,,,,7.17E+04,,,4.23E+04,1.13E+04,,,0,FALSE,5.506,2,2,1584,175.2,7.11,2,,cytosol;cytoskeleton;other cell component,"Pf00498, Pf15308",9859,hsa:9859; O75058; Q5SW77; Q5SW78; Q5SW79; Q7LGA9; Q86W31; Q9UQ08; Q9UQ09,ENSG00000143702; ENSG00000276725,,Ciliary landscape,1,0,,,,117.06,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,0,,0,5.87,,0,
Master Protein,High,A0A5F9ZHS3,MEN1,Menin OS=Homo sapiens OX=9606 GN=MEN1 PE=1 SV=1,1,1,100,0.551,,100,6.64,-0.86,,6.64,1.00E-17,7.72E-01,,1.00E-17,2.14E+05,,1.06E+05,,3,,2,,,2.14E+05,,2.29E+04,2.51E+05,,,,,,,,,1.28E+05,8.83E+04,,,,,,,8.13E+02,,2.29E+04,1.29E+04,,,,,,,,,1.72E+04,2.19E+03,,,,,,0.007,FALSE,2.391,2,1,652,72.3,6.49,1,,nucleus,Pf05053,,A0A5F9ZHS3,ENSG00000133895,,10q11.21q11.23 copy number variation syndrome,1,0,75.23,,25.74,,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,66.64,,,3.06,nucleic acid binding activity,0,
Master Protein,High,O75822,EIF3J,Eukaryotic translation initiation factor 3 subunit J OS=Homo sapiens OX=9606 GN=EIF3J PE=1 SV=2,2,4,100,0.623,100,0.186,6.64,-0.68,6.64,-2.43,1.00E-17,9.22E-01,1.00E-17,1.84E-01,2.30E+05,,1.43E+05,7.71E+05,2,,1,2,,,,1.40E+05,3.77E+05,,,,,,,,,1.43E+05,,,8.90E+05,,6.68E+05,,,,,1.40E+05,1.95E+04,,,,,,,,,1.93E+04,,,2.50E+05,,1.56E+04,,0,FALSE,7.033,5,2,258,29,4.83,2,cell organization and biogenesis;protein metabolism;other metabolic processes,cytosol;translational apparatus;other cell component,Pf08597,8669,B4DUI3; F5H425; hsa:8669; O75822; Q9BUD2; Q9H8Q2; Q9UI65,ENSG00000104131,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,8,0,64.78,,,20.19,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,76.4,,21.38,10.03,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P62314,SNRPD1,Small nuclear ribonucleoprotein Sm D1 OS=Homo sapiens OX=9606 GN=SNRPD1 PE=1 SV=1,2,11,100,1.263,100,9.158,6.64,0.34,6.64,3.2,1.00E-17,3.03E-01,1.00E-17,2.72E-02,1.03E+06,,2.26E+06,7.10E+04,2,,5,2,,,,3.43E+06,3.07E+05,,,,,,2.26E+06,6.03E+05,4.09E+06,4.98E+06,6.40E+05,,2.78E+04,,1.81E+05,,,,,3.43E+06,1.59E+04,,,,,,1.35E+04,2.69E+04,3.32E+04,6.71E+05,1.59E+04,,7.82E+03,,4.24E+03,,0,FALSE,12.788,26,2,119,13.3,11.56,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf01423,6632,B5BTZ1; hsa:6632; P13641; P62314,ENSG00000167088,mRNA Splicing - Major Pathway; SARS-CoV-2 modulates host translation machinery; snRNP Assembly; mRNA Splicing - Minor Pathway,mRNA processing,5,0,118.19,,79.04,103.75,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,High,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,91.73,,112.74,34.01,,0,
Master Protein,High,F8W9P4,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase OS=Homo sapiens OX=9606 GN=PIK3CD PE=1 SV=1",1,1,100,1.806,100,0.497,6.64,0.85,6.64,-1.01,1.00E-17,3.20E-01,1.00E-17,6.96E-01,3.81E+04,,6.88E+04,1.38E+05,2,,1,1,,,,5.18E+04,2.80E+04,,,,,,,,,6.88E+04,,,1.38E+05,,,,,,,5.18E+04,1.45E+03,,,,,,,,,9.27E+03,,,3.89E+04,,,,0.004,FALSE,2.59,1,1,1068,121.9,7.15,1,other metabolic processes;signal transduction,,"Pf00454, Pf00613, Pf00792, Pf00794, Pf02192",,F8W9P4,ENSG00000171608,,AMP-activated protein kinase signaling; Alzheimer's disease and miRNA effects; Glioblastoma signaling pathways; Overview of nanoparticle effects; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Microglia pathogen phagocytosis pathway; Endometrial cancer; PI3K-Akt signaling pathway; MET in type 1 papillary renal cell carcinoma; Ebola virus infection in host; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Cancer immunotherapy by CTLA4 blockade; Measles virus infection; Hepatitis B infection; Melanoma; Osteoblast differentiation and related diseases; Kisspeptin/kisspeptin receptor system in the ovary; Pleural mesothelioma; Alzheimer's disease; Acute myeloid leukemia,26,0,42.06,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,46.19,,0,3.62,kinase activity;other molecular function,0,
Master Protein,High,Q8IUR7,ARMC8,Armadillo repeat-containing protein 8 OS=Homo sapiens OX=9606 GN=ARMC8 PE=1 SV=2,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,4.46E+05,,,7.15E+05,2,,,2,,7.48E+05,2.66E+05,,,,,,,,,,,,,,3.30E+05,1.55E+06,,,,2.84E+03,2.60E+03,,,,,,,,,,,,,,9.27E+04,1.10E+04,,,0.005,FALSE,2.461,1,1,673,75.5,6.73,1,protein metabolism;other metabolic processes,non-structural extracellular;cytosol;nucleus;other cell component,Pf00514,25852,A8K0L2; B7Z441; B7Z453; D3DNE6; F5GWK4; hsa:25852; Q6PIL2; Q8IUR7; Q96D19; Q96HZ5; Q9NV02; Q9NV94; Q9Y4R9,ENSG00000114098,Neutrophil degranulation,Ciliary landscape,2,0,67.27,,,91.72,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,,,,2.5,,0,
Master Protein,High,Q9UBL3,ASH2L,Set1/Ash2 histone methyltransferase complex subunit ASH2 OS=Homo sapiens OX=9606 GN=ASH2L PE=1 SV=1,1,4,100,3.1,100,4.048,6.64,1.63,6.64,2.02,1.00E-17,1.28E-01,1.00E-17,1.70E-01,2.54E+04,,6.92E+04,1.94E+04,2,,4,2,,,,5.43E+04,1.18E+04,,,,,,1.98E+05,,5.64E+04,8.50E+04,3.11E+04,,9.92E+03,3.80E+04,,,,,,5.43E+04,6.11E+02,,,,,,1.19E+03,,4.58E+02,1.15E+04,7.74E+02,,2.79E+03,2.70E+02,,,0,FALSE,4.967,3,1,628,68.7,5.69,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00622, Pf21198, Pf21257",9070,A8K7C3; D3DSW9; hsa:9070; O60659; O60660; Q96B62; Q9UBL3,ENSG00000129691,Formation of WDR5-containing histone-modifying complexes; Formation of the beta-catenin:TCF transactivating complex; Deactivation of the beta-catenin transactivating complex; Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Kleefstra syndrome,7,0,90.79,,79.61,82.92,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,88.99,,80.21,16.7,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BRR6,ADPGK,ADP-dependent glucokinase OS=Homo sapiens OX=9606 GN=ADPGK PE=1 SV=1,3,7,100,1.765,100,10.533,6.64,0.82,6.64,3.4,1.00E-17,1.49E-01,1.00E-17,1.38E-02,7.95E+05,,5.98E+05,2.70E+04,1,,5,1,,,,7.95E+05,,,,,,,1.40E+06,5.35E+05,7.38E+05,5.98E+05,2.52E+05,,2.70E+04,,,,,,,7.95E+05,,,,,,,8.36E+03,2.39E+04,6.00E+03,8.06E+04,6.27E+03,,7.58E+03,,,,0,FALSE,11.772,10,3,497,54.1,6.2,3,other metabolic processes,non-structural extracellular;other membranes;ER/Golgi,Pf04587,83440,hsa:83440; Q49AU7; Q8NBI1; Q8WZ90; Q96NF8; Q9BRR6; Q9H0A7,ENSG00000159322,Glycolysis,,1,0,,,60.5,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,High,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,84.66,,69.16,17.01,kinase activity;other molecular function,0,
Master Protein,High,A0A2R8Y602,CLPB,Caseinolytic mitochondrial matrix peptidase chaperone subunit B (Fragment) OS=Homo sapiens OX=9606 GN=CLPB PE=1 SV=1,1,6,100,4.752,100,2.308,6.64,2.25,6.64,1.21,1.00E-17,1.52E-02,1.00E-17,3.39E-01,8.79E+04,,4.18E+05,1.02E+05,3,,3,2,,8.79E+04,,3.06E+05,2.48E+04,,,,,,,4.18E+05,1.31E+05,4.19E+05,,,3.05E+05,,3.38E+04,,,3.34E+02,,3.06E+05,1.28E+03,,,,,,,1.87E+04,1.06E+03,5.65E+04,,,8.58E+04,,7.91E+02,,0.001,FALSE,3.767,3,1,382,43.3,6.96,1,,,"Pf00023, Pf07724, Pf12796",,A0A2R8Y602,ENSG00000162129,,,0,0,105.78,,51.42,113.23,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,105.55,,110.78,16.78,other molecular function,0,
Master Protein,High,P45954,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADSB PE=1 SV=1",1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.50E+05,,,,1,,,,,,,2.50E+05,,,,,,,,,,,,,,,,,,,,2.50E+05,,,,,,,,,,,,,,,,,0.001,FALSE,3.63,5,1,432,47.5,6.99,1,other metabolic processes,mitochondrion,"Pf00441, Pf02770, Pf02771",36,B4DQ51; hsa:36; P45954; Q5SQN6; Q96CX7,ENSG00000196177,Branched-chain amino acid catabolism; Mitochondrial protein degradation,Valproic acid pathway,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,0,other molecular function,0,
Master Protein,High,A0A7P0T932,ACADM,Acyl-CoA dehydrogenase medium chain OS=Homo sapiens OX=9606 GN=ACADM PE=1 SV=1,9,35,100,1.608,100,0.602,6.64,0.68,6.64,-0.73,1.00E-17,2.83E-01,1.00E-17,7.74E-01,2.23E+05,,3.59E+05,4.62E+05,2,,3,2,,,,1.99E+05,2.51E+05,,,,,,,1.59E+04,,6.14E+05,3.59E+05,7.80E+05,2.74E+05,,,,,,,1.99E+05,1.30E+04,,,,,,,7.11E+02,,8.27E+04,8.93E+03,1.52E+03,7.70E+04,,,,0,FALSE,36.517,32,1,374,41.5,8.44,9,,mitochondrion,"Pf00441, Pf02770, Pf02771",,A0A7P0T932,ENSG00000117054,,PPAR-alpha pathway; Nuclear receptors meta-pathway; Amino acid metabolism; PPAR signaling pathway; Female steroid hormones in cardiomyocyte energy metabolism,5,0,16.43,,91.03,67.89,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,,106.89,,94.3,113.85,other molecular function,0,
Master Protein,High,O95758,PTBP3,Polypyrimidine tract-binding protein 3 OS=Homo sapiens OX=9606 GN=PTBP3 PE=1 SV=2,3,12,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.20E+04,,,,1,,,,,,,2.20E+04,,,,,,,,,,,,,,,,,,,,2.20E+04,,,,,,,,,,,,,,,,,0,FALSE,9.078,9,1,552,59.7,9.04,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf11835, Pf13893",9991,B1ALY2; B1ALY3; B1ALY5; B1ALY6; B3KME7; hsa:9991; O95758; Q68DB9; Q86YB3; Q86YH9,ENSG00000119314,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,29.6,nucleic acid binding activity,0,
Master Protein,High,P40197,GP5,Platelet glycoprotein V OS=Homo sapiens OX=9606 GN=GP5 PE=1 SV=1,1,4,100,0.054,100,0.397,6.64,-4.21,6.64,-1.33,1.00E-17,8.80E-05,1.00E-17,5.68E-01,2.07E+06,,1.12E+05,2.82E+05,3,,2,2,3.48E+06,9.97E+04,2.07E+06,,,,,,,,9.87E+04,,,1.27E+05,,,3.65E+05,,2.17E+05,,1.38E+04,3.79E+02,2.02E+04,,,,,,,,5.90E+02,,,1.70E+04,,,1.03E+05,,5.09E+03,,0,FALSE,6.002,3,1,560,60.9,9.63,1,cell adhesion;protein metabolism;other metabolic processes;stress response;transport;other biological processes,plasma membrane;other membranes,"Pf01463, Pf13855",2814,D1MER9; hsa:2814; P40197,ENSG00000178732,Platelet Adhesion to exposed collagen; Intrinsic Pathway of Fibrin Clot Formation; Platelet Aggregation (Plug Formation); Defective F9 activation; GP1b-IX-V activation signalling; Enhanced binding of GP1BA variant to VWF multimer:collagen ; Defective binding of VWF variant to GPIb:IX:V,22q11.2 copy number variation syndrome,8,0,90.12,,17.47,35.84,High,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,102.6,,34.3,10.15,,0,
Master Protein,High,A0A0C4DFV9,SET,SET nuclear proto-oncogene OS=Homo sapiens OX=9606 GN=SET PE=1 SV=2,4,39,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.79E+05,,,,1,,,,,,,2.79E+05,,,,,,,,,,,,,,,,,,,,2.79E+05,,,,,,,,,,,,,,,,,0,FALSE,27.724,23,1,296,34.5,4.34,4,cell organization and biogenesis,nucleus,Pf00956,,A0A0C4DFV9,ENSG00000119335,,Histone modifications,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,112.61,,0,
Master Protein,High,A0A087WU53,MAGT1,Magnesium transporter 1 OS=Homo sapiens OX=9606 GN=MAGT1 PE=1 SV=1,1,6,100,1.062,100,0.793,6.64,0.09,6.64,-0.33,1.00E-17,5.72E-01,1.00E-17,9.79E-01,3.81E+05,,5.13E+05,6.02E+05,5,,5,2,3.26E+05,3.81E+05,1.94E+05,8.40E+05,4.83E+05,,,,,,1.48E+05,5.13E+05,3.42E+05,7.73E+05,6.09E+05,,,,5.15E+05,7.05E+05,1.30E+03,1.45E+03,1.89E+03,8.40E+05,2.49E+04,,,,,,8.87E+02,2.29E+04,2.78E+03,1.04E+05,1.51E+04,,,,1.21E+04,7.50E+03,0.004,FALSE,2.649,2,1,367,41.5,9.94,1,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf04756,84061,A0A087WU53; hsa:84061,ENSG00000102158,,,0,0,54.91,,50.55,22.02,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,,75.06,,44.94,8.03,,0,
Master Protein,High,Q9UHA4,LAMTOR3,Ragulator complex protein LAMTOR3 OS=Homo sapiens OX=9606 GN=LAMTOR3 PE=1 SV=1,2,4,100,,,100,6.64,,,6.64,1.00E-17,,,1.00E-17,1.85E+05,,8.00E+05,,2,,2,,,,,1.08E+06,3.16E+04,,,,,,,,,1.16E+06,5.51E+05,,,,,,,,,1.08E+06,1.63E+03,,,,,,,,,1.56E+05,1.37E+04,,,,,,0,FALSE,6.824,27,2,124,13.6,7.34,2,signal transduction;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf08923,8649,B2R4A1; hsa:8649; J3KMX4; Q9H364; Q9UHA4,ENSG00000109270,Neutrophil degranulation; TP53 Regulates Metabolic Genes; Regulation of PTEN gene transcription; Amino acids regulate mTORC1; mTORC1-mediated signalling; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; MAP2K and MAPK activation,MAPK signaling pathway; MAPK cascade; Gastrin signaling pathway; Melanoma,13,0,133.37,,50.38,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,10.3,enzyme regulator activity,0,
Master Protein,High,P02750,LRG1,Leucine-rich alpha-2-glycoprotein OS=Homo sapiens OX=9606 GN=LRG1 PE=1 SV=2,1,2,100,1.322,100,0.096,6.64,0.4,6.64,-3.38,1.00E-17,5.13E-01,1.00E-17,3.78E-02,4.32E+04,,5.71E+04,5.66E+05,2,,2,4,,,,3.12E+03,5.97E+05,,,,,,,,8.40E+04,3.88E+04,,5.79E+05,,5.53E+05,2.95E+05,1.72E+06,,,,3.12E+03,3.08E+04,,,,,,,,6.82E+02,5.23E+03,,1.13E+03,,3.92E+03,6.91E+03,1.83E+04,0.005,FALSE,2.535,3,1,347,38.2,6.95,1,cell adhesion;stress response;other biological processes,non-structural extracellular;other membranes;other cell component,Pf13855,116844,hsa:116844; P02750; Q8N4F5; Q96QZ4,ENSG00000171236,Neutrophil degranulation,Network map of SARS-CoV-2 signaling pathway,2,0,139.95,,52.04,80.67,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,1,,FALSE,,692.77,,59.49,4.51,signal transduction activity or receptor binding,0,
Master Protein,High,O14828,SCAMP3,Secretory carrier-associated membrane protein 3 OS=Homo sapiens OX=9606 GN=SCAMP3 PE=1 SV=3,1,1,100,0.186,,100,6.64,-2.43,,6.64,1.00E-17,1.77E-01,,1.00E-17,1.01E+05,,1.89E+04,,1,,1,,,,,1.01E+05,,,,,,,,1.89E+04,,,,,,,,,,,,1.01E+05,,,,,,,,8.42E+02,,,,,,,,,0,FALSE,5.676,4,1,347,38.3,7.64,1,transport,other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf04144,10067,A9Z1W6; B1AVS6; hsa:10067; O14828; O15128; Q96FR8; Q9BPY0,ENSG00000116521; ENSG00000263290,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.89,other molecular function,0,
Master Protein,High,Q9NV56,MRGBP,MRG/MORF4L-binding protein OS=Homo sapiens OX=9606 GN=MRGBP PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.79E+04,,,,1,,,,,,,2.79E+04,,,,,,,,,,,,,,,,,,,,2.79E+04,,,,,,,,,,,,,,,,,0.006,FALSE,2.454,7,1,204,22.4,5.83,1,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf07904,55257,A8C4L5; hsa:55257; Q9NV56,ENSG00000101189,HATs acetylate histones,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.14,,0,
Master Protein,High,A2RRP1,NBAS,NBAS subunit of NRZ tethering complex OS=Homo sapiens OX=9606 GN=NBAS PE=1 SV=2,5,7,100,0.294,100,0.662,6.64,-1.77,6.64,-0.6,1.00E-17,2.67E-01,1.00E-17,8.80E-01,1.70E+05,,5.28E+05,6.52E+05,3,,4,3,,,2.89E+05,1.70E+05,6.02E+04,,,,,,4.28E+05,4.77E+04,,8.03E+05,6.53E+05,,6.52E+05,6.55E+05,1.67E+05,,,,2.83E+03,1.70E+05,3.10E+03,,,,,,2.56E+03,2.13E+03,,1.08E+05,1.62E+04,,1.83E+05,4.64E+03,3.91E+03,,0,FALSE,19.655,3,5,2371,268.4,5.96,5,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,other membranes;cytosol;ER/Golgi,"Pf08314, Pf15492",51594,A2RRP1; hsa:51594; O95790; Q2VPJ7; Q53TK6; Q86V39; Q8NFY8; Q9Y3W5,ENSG00000151779,COPI-dependent Golgi-to-ER retrograde traffic,,1,0,66.25,,68.03,57.15,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,27.2,,101.94,17.22,other molecular function,0,
Master Protein,High,O60318,MCM3AP,Germinal-center associated nuclear protein OS=Homo sapiens OX=9606 GN=MCM3AP PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,5.76E+04,,,,1,,,,,,,5.76E+04,,,,,,,,,,,,,,,,,,,,5.76E+04,,,,,,,,,,,,,,,,,0,FALSE,6.186,1,1,1980,218.3,6.39,1,cell organization and biogenesis;other metabolic processes;transport;developmental processes,other membranes;cytosol;nucleus;other cell component,"Pf03399, Pf16766, Pf16768, Pf16769",8888,C9JL56; hsa:8888; O60318; Q2M3C1; Q6PJP6; Q9BSY5; Q9UMT4,ENSG00000160294,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P51398,DAP3,"28S ribosomal protein S29, mitochondrial OS=Homo sapiens OX=9606 GN=DAP3 PE=1 SV=1",2,5,100,2.027,,100,6.64,1.02,,6.64,1.00E-17,1.70E-01,,1.00E-17,2.09E+05,,4.24E+05,,1,,1,,,,,2.09E+05,,,,,,,,,,,4.24E+05,,,,,,,,,2.09E+05,,,,,,,,,,,1.05E+04,,,,,,0,FALSE,5.169,7,2,398,45.5,8.88,2,protein metabolism;other metabolic processes;signal transduction,other membranes;mitochondrion;translational apparatus;nucleus,Pf10236,7818,B4DP59; B4DY62; E7EM60; hsa:7818; P51398; Q13044; Q68CT7; Q96Q20,ENSG00000132676,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,,11.37,other molecular function,0,
Master Protein,High,Q9UHD9,UBQLN2,Ubiquilin-2 OS=Homo sapiens OX=9606 GN=UBQLN2 PE=1 SV=2,3,9,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.49E+04,,,,2,,,,,,,1.81E+04,6.74E+04,,,,,,,,,,,,,,,,,,,1.81E+04,3.47E+03,,,,,,,,,,,,,,,,0,FALSE,9.459,7,1,624,65.7,5.22,3,cell organization and biogenesis;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf00240, Pf00627",29978,hsa:29978; O94798; Q5D027; Q9H3W6; Q9HAZ4; Q9UHD9,ENSG00000188021,Cargo recognition for clathrin-mediated endocytosis,,1,0,81.59,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,24.95,other molecular function,0,
Master Protein,High,Q96DV4,MRPL38,"39S ribosomal protein L38, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL38 PE=1 SV=2",1,9,100,3.966,100,4.244,6.64,1.99,6.64,2.09,1.00E-17,1.24E-02,1.00E-17,1.47E-01,2.30E+05,,1.03E+06,2.39E+05,3,,4,3,,2.30E+05,,1.99E+05,3.46E+05,,,,,,,2.08E+05,8.48E+05,1.61E+06,1.25E+06,,6.31E+05,4.11E+04,2.39E+05,,,8.74E+02,,1.99E+05,1.79E+04,,,,,,,9.31E+03,6.89E+03,2.16E+05,3.10E+04,,1.77E+05,2.91E+02,5.59E+03,,0.004,FALSE,2.568,2,1,380,44.6,7.53,1,protein metabolism;other metabolic processes,other membranes;cytosol;mitochondrion;translational apparatus,Pf01161,64978,B3KN96; hsa:64978; Q96DV4; Q96Q66; Q9P0B9,ENSG00000204316,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,30.08,,61.27,98.88,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,High,n/a,1,,FALSE,,71.5,,93.93,17.23,,0,
Master Protein,High,A0A6Q8PH91,MACROD1,Mono-ADP ribosylhydrolase 1 OS=Homo sapiens OX=9606 GN=MACROD1 PE=1 SV=1,1,3,100,0.517,,100,6.64,-0.95,,6.64,1.00E-17,7.06E-01,,1.00E-17,3.25E+05,,1.68E+05,,1,,2,,,,,3.25E+05,,,,,,,,5.51E+05,,,5.12E+04,,,,,,,,,3.25E+05,,,,,,,,2.46E+04,,,1.27E+03,,,,,,0,FALSE,6.874,7,1,334,36.4,9.51,1,,nucleus,Pf01661,,A0A6Q8PH91,ENSG00000133315,,,0,0,,,117.37,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,220.55,,,10.03,,0,
Master Protein,High,Q8NF37,LPCAT1,Lysophosphatidylcholine acyltransferase 1 OS=Homo sapiens OX=9606 GN=LPCAT1 PE=1 SV=2,2,4,100,3.056,100,1.827,6.64,1.61,6.64,0.87,1.00E-17,5.50E-02,1.00E-17,4.63E-01,2.40E+05,,3.81E+05,1.19E+05,1,,4,2,,,,2.40E+05,,,,,,,,1.17E+05,2.01E+05,1.25E+06,7.22E+05,,4.10E+04,,3.45E+05,,,,,2.40E+05,,,,,,,,5.23E+03,1.63E+03,1.69E+05,1.79E+04,,1.15E+04,,8.07E+03,,0,FALSE,9.639,5,2,534,59.1,6.02,2,protein metabolism;other metabolic processes;developmental processes;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf01553, Pf13833",79888,hsa:79888; Q1HAQ1; Q7Z4G6; Q8N3U7; Q8NF37; Q8WUL8; Q9GZW6,ENSG00000153395,Neutrophil degranulation; Synthesis of PA; Acyl chain remodelling of PC; Acyl chain remodelling of PG; Synthesis of PC,,5,0,,,91.9,111.34,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,50.36,,110.87,11.05,other molecular function,0,
Master Protein,High,Q9Y639,NPTN,Neuroplastin OS=Homo sapiens OX=9606 GN=NPTN PE=1 SV=2,3,5,100,0.962,100,1.182,6.64,-0.06,6.64,0.24,1.00E-17,6.90E-01,1.00E-17,7.30E-01,1.82E+05,,5.91E+05,2.12E+05,4,,5,1,2.20E+05,5.28E+04,,7.10E+05,1.51E+05,,,,,,8.16E+05,6.11E+04,2.85E+05,1.04E+06,5.91E+05,,2.12E+05,,,,8.72E+02,2.01E+02,,7.10E+05,7.80E+03,,,,,,4.88E+03,2.73E+03,2.32E+03,1.41E+05,1.47E+04,,5.95E+04,,,,0,FALSE,7.506,9,3,398,44.4,7.99,3,cell adhesion;cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;other cell component,Pf13927,27020,B2RAL7; B7Z4D3; B7ZLL2; hsa:27020; Q17R52; Q59EJ9; Q6NVX7; Q9Y639; Q9Y640,ENSG00000156642,GABA receptor activation,,1,0,103.22,,70.66,,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,101.04,,35.54,10.61,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q6PJW8,CNST,Consortin OS=Homo sapiens OX=9606 GN=CNST PE=1 SV=3,2,2,100,0.248,,100,6.64,-2.01,,6.64,1.00E-17,2.29E-01,,1.00E-17,3.42E+05,,8.49E+04,,2,,2,,6.74E+05,,,1.73E+05,,,,,,,,6.48E+04,,1.11E+05,,,,,,,2.68E+03,,,1.73E+05,,,,,,,,2.90E+03,,1.50E+04,,,,,,,0,FALSE,4.705,3,2,725,79.5,4.53,2,other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,Pf15281,163882,hsa:163882; Q5VSY9; Q5VTM7; Q6PJW8; Q8IYA9; Q8N3L5; Q8NB09; Q8TEI2; Q96MR5,ENSG00000162852,,,0,0,83.58,,37.17,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,82.99,,,4.83,other molecular function,0,
Master Protein,High,Q8IY37,DHX37,Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens OX=9606 GN=DHX37 PE=1 SV=1,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.50E+04,,,,1,,,,,,,2.50E+04,,,,,,,,,,,,,,,,,,,,2.50E+04,,,,,,,,,,,,,,,,,0,FALSE,7.254,3,2,1157,129.5,8.1,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,other membranes;nucleus;other cell component,"Pf00270, Pf00271, Pf04408, Pf07717, Pf21010",57647,hsa:57647; Q8IY37; Q9BUI7; Q9P211,ENSG00000150990,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,H0YG38,PRPF40A,Pre-mRNA processing factor 40 homolog A (Fragment) OS=Homo sapiens OX=9606 GN=PRPF40A PE=1 SV=2,5,10,100,0.562,100,0.129,6.64,-0.83,6.64,-2.96,1.00E-17,7.93E-01,1.00E-17,1.13E-01,3.73E+05,,2.09E+05,1.63E+06,2,,2,2,,,,1.76E+05,7.88E+05,,,,,,6.33E+05,,,6.92E+04,,1.91E+06,,,,1.39E+06,,,,1.76E+05,4.07E+04,,,,,,3.79E+03,,,9.33E+03,,3.73E+03,,,,1.48E+04,0,FALSE,27.182,18,1,367,38.7,5.39,5,RNA metabolism OR transcription;other metabolic processes,nucleus,Pf00397,,H0YG38,ENSG00000196504,,,0,0,89.72,,113.55,22.5,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,,94.46,,170.11,28.33,,0,
Master Protein,High,P26440,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=IVD PE=1 SV=2",4,9,100,1.126,100,1.356,6.64,0.17,6.64,0.44,1.00E-17,4.35E-01,1.00E-17,6.25E-01,9.94E+05,,3.45E+05,2.94E+05,1,,4,1,,,,9.94E+05,,,,,,,,2.96E+05,1.94E+05,7.46E+05,4.03E+05,,2.94E+05,,,,,,,9.94E+05,,,,,,,,1.32E+04,1.58E+03,1.01E+05,1.00E+04,,8.27E+04,,,,0,FALSE,10.432,17,4,426,46.6,8.05,4,other metabolic processes,mitochondrion;nucleus,"Pf00441, Pf02770, Pf02771",3712,B2RCV5; B3KVI7; hsa:3712; J3KR54; P26440; Q53XZ9; Q96AF6,ENSG00000128928,Branched-chain amino acid catabolism,Valproic acid pathway,2,0,,,58.5,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,50.96,,0,23.59,other molecular function,0,
Master Protein,Medium,G5E977,NAPRT,Nicotinate phosphoribosyltransferase OS=Homo sapiens OX=9606 GN=NAPRT PE=1 SV=1,1,1,100,0.795,,100,6.64,-0.33,,6.64,1.00E-17,8.38E-01,,1.00E-17,2.83E+04,,2.25E+04,,1,,1,,,,,2.83E+04,,,,,,,,,,2.25E+04,,,,,,,,,,2.83E+04,,,,,,,,,,3.04E+03,,,,,,,0.012,FALSE,2.157,3,1,584,62.1,6.73,1,other metabolic processes,,"Pf17767, Pf17956",,G5E977,ENSG00000147813; ENSG00000278488,,NAD+ biosynthetic pathways,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.96,other molecular function,0,
Master Protein,High,Q9UKD2,MRTO4,mRNA turnover protein 4 homolog OS=Homo sapiens OX=9606 GN=MRTO4 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.17E+05,,,,1,,,,,,,1.17E+05,,,,,,,,,,,,,,,,,,,,1.17E+05,,,,,,,,,,,,,,,,,0,FALSE,4.571,10,1,239,27.5,8.29,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00466, Pf17777",51154,B3KNB3; hsa:51154; Q5TG55; Q96SS6; Q9BPV9; Q9UKD2,ENSG00000053372,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.41,,0,
Master Protein,High,Q8NAF0,ZNF579,Zinc finger protein 579 OS=Homo sapiens OX=9606 GN=ZNF579 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,8.28E+04,,,,1,,,,,,,8.28E+04,,,,,,,,,,,,,,,,,,,,8.28E+04,,,,,,,,,,,,,,,,,0.001,FALSE,3.486,3,1,562,60.5,8.69,1,other biological processes,nucleus,Pf00096,163033,hsa:163033; Q8NAF0,ENSG00000218891,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O43715,TRIAP1,TP53-regulated inhibitor of apoptosis 1 OS=Homo sapiens OX=9606 GN=TRIAP1 PE=1 SV=1,1,1,100,1.929,,100,6.64,0.95,,6.64,1.00E-17,1.82E-01,,1.00E-17,1.97E+05,,3.79E+05,,1,,1,,,,,1.97E+05,,,,,,,,,,3.79E+05,,,,,,,,,,1.97E+05,,,,,,,,,,5.11E+04,,,,,,,0,FALSE,6.154,18,1,76,8.8,5.48,1,cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;signal transduction;other biological processes,mitochondrion;nucleus;other cell component,Pf05254,51499,B2R4Z7; hsa:51499; O43715; Q5RKS5; Q6LCA7,ENSG00000170855,Mitochondrial protein degradation; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,5q35 copy number variation,3,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.93,other molecular function,0,
Master Protein,High,Q8IYS2,KIAA2013,Uncharacterized protein KIAA2013 OS=Homo sapiens OX=9606 GN=KIAA2013 PE=1 SV=1,2,2,100,0.481,,100,6.64,-1.06,,6.64,1.00E-17,6.59E-01,,1.00E-17,2.07E+05,,1.33E+05,,3,,4,,1.30E+05,,,2.07E+05,7.84E+05,,,,,,2.25E+05,1.06E+05,,5.62E+04,1.67E+05,,,,,,5.17E+02,,,2.07E+05,4.04E+04,,,,,,1.34E+03,4.75E+03,,7.58E+03,4.15E+03,,,,,,0,FALSE,8.172,5,2,634,69.1,8.19,2,,,Pf10222,90231,hsa:90231; Q5JXC1; Q8IVF8; Q8IYS2; Q8NDI7; Q9BSY1,ENSG00000116685,,,0,0,95.64,,52.78,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,110.39,,,5.2,,0,
Master Protein,High,Q96E39,RBMXL1,"RNA binding motif protein, X-linked-like-1 OS=Homo sapiens OX=9606 GN=RBMXL1 PE=1 SV=1",9,25,100,0.224,,100,6.64,-2.16,,6.64,1.00E-17,1.52E-01,,1.00E-17,4.05E+05,,9.07E+04,,1,,4,,,,,4.05E+05,,,,,,,,4.58E+04,8.00E+04,5.90E+05,1.03E+05,,,,,,,,,4.05E+05,,,,,,,,2.04E+03,6.50E+02,7.95E+04,2.56E+03,,,,,,0,FALSE,35.851,22,1,390,42.1,9.89,9,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00076, Pf08081",494115,hsa:494115; Q96E39,ENSG00000213516,,,0,0,,,126.03,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,72.64,,,62.78,nucleic acid binding activity,0,
Master Protein,High,Q5BJD5,TMEM41B,Transmembrane protein 41B OS=Homo sapiens OX=9606 GN=TMEM41B PE=1 SV=1,1,1,100,0.165,,100,6.64,-2.6,,6.64,1.00E-17,1.45E-01,,1.00E-17,7.40E+04,,1.22E+04,,2,,2,,,7.49E+04,,7.30E+04,,,,,,,,2.84E+04,,5.27E+03,,,,,,,,2.85E+02,,7.30E+04,,,,,,,,1.27E+03,,7.10E+02,,,,,,,0,FALSE,5.02,7,1,291,32.5,9.58,1,cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes,other membranes;ER/Golgi;other cell component,Pf09335,440026,D3DQU9; E9PP29; hsa:440026; Q15055; Q4G0P0; Q5BJD5,ENSG00000166471,,,0,0,1.78,,97.22,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,138.58,,,3.49,transporter activity,0,
Master Protein,Medium,O43933,PEX1,Peroxisomal ATPase PEX1 OS=Homo sapiens OX=9606 GN=PEX1 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.44E+04,,,,1,,,,,,,2.44E+04,,,,,,,,,,,,,,,,,,,,2.44E+04,,,,,,,,,,,,,,,,,0.012,FALSE,2.22,2,1,1283,142.8,6.33,1,cell organization and biogenesis;other metabolic processes;transport;other biological processes,other membranes;cytosol;other cytoplasmic organelle;other cell component,"Pf00004, Pf09262, Pf09263, Pf17862",5189,A4D1G3; A8KA90; B4DIM7; E9PE75; hsa:5189; O43933; Q96S71; Q96S72; Q96S73; Q99994,ENSG00000127980,Peroxisomal protein import,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.81,transporter activity;other molecular function,0,
Master Protein,High,Q01831,XPC,DNA repair protein complementing XP-C cells OS=Homo sapiens OX=9606 GN=XPC PE=1 SV=4,3,3,100,0.775,,100,6.64,-0.37,,6.64,1.00E-17,9.28E-01,,1.00E-17,3.83E+05,,4.60E+05,,2,,3,,,,5.96E+05,2.46E+05,,,,,,,,4.60E+05,,4.63E+05,1.24E+05,,,,,,,,5.83E+03,2.46E+05,,,,,,,,2.06E+04,,6.24E+04,3.08E+03,,,,,,0,FALSE,8.391,4,3,940,105.9,8.9,3,cell cycle OR cell proliferation;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component,"Pf03835, Pf10403, Pf10404, Pf10405",7508,B4DIP3; E9PB96; E9PH69; hsa:7508; Q01831; Q53GT7; Q96AX0,ENSG00000154767,SUMOylation of DNA damage response and repair proteins; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER,"Male infertility; Nucleotide excision repair; DNA repair pathways, full network; p53 transcriptional gene network; Nucleotide excision repair in xeroderma pigmentosum",8,0,58.88,,55.89,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,83.29,,,5.36,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q6PI48,DARS2,"Aspartate--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=DARS2 PE=1 SV=1",2,5,100,0.642,100,0.125,6.64,-0.64,6.64,-3,1.00E-17,9.68E-01,1.00E-17,7.05E-02,2.49E+05,,1.40E+05,4.90E+05,2,,3,2,,,,3.29E+05,1.88E+05,,,,,,,1.12E+05,,1.87E+05,1.40E+05,2.90E+05,,8.27E+05,,,,,,3.29E+05,9.70E+03,,,,,,,5.02E+03,,2.52E+04,3.47E+03,5.65E+02,,5.86E+03,,,0,FALSE,10.455,6,2,645,73.5,8.02,2,protein metabolism;RNA metabolism OR transcription;other metabolic processes,other membranes;mitochondrion;nucleus,"Pf00152, Pf01336, Pf02938",55157,hsa:55157; Q6PI48,ENSG00000117593,Mitochondrial tRNA aminoacylation,,1,0,38.45,,25.74,68.05,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,,72.28,,68.21,18.22,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y657,SPIN1,Spindlin-1 OS=Homo sapiens OX=9606 GN=SPIN1 PE=1 SV=3,6,8,100,0.699,100,1.963,6.64,-0.52,6.64,0.97,1.00E-17,9.72E-01,1.00E-17,4.31E-01,3.90E+05,,2.66E+05,9.39E+04,4,,3,2,5.71E+05,,1.10E+05,2.29E+06,2.67E+05,,,,,,,,1.52E+05,9.69E+05,2.66E+05,,,,7.73E+04,1.14E+05,2.27E+03,,1.07E+03,2.29E+06,1.38E+04,,,,,,,,1.23E+03,1.31E+05,6.61E+03,,,,1.81E+03,1.22E+03,0,FALSE,18.749,37,6,262,29.6,6.96,6,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;nucleus,Pf02513,10927,A8K0X6; B3KRQ4; hsa:10927; Q7KZJ8; Q9GZT2; Q9H0N7; Q9Y657,ENSG00000106723,,,0,0,124.2,,95.75,27.24,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,,60.83,,11.59,24.31,other molecular function,0,
Master Protein,High,Q9Y2V2,CARHSP1,Calcium-regulated heat-stable protein 1 OS=Homo sapiens OX=9606 GN=CARHSP1 PE=1 SV=2,1,9,100,0.6,100,1.016,6.64,-0.74,6.64,0.02,1.00E-17,8.64E-01,1.00E-17,8.48E-01,3.54E+05,,2.12E+05,2.09E+05,3,,4,1,1.01E+06,,1.83E+05,3.54E+05,,,,,,,2.12E+05,3.69E+05,,2.11E+05,2.13E+05,,2.09E+05,,,,4.02E+03,,1.79E+03,3.54E+05,,,,,,,1.27E+03,1.65E+04,,2.85E+04,5.29E+03,,5.87E+04,,,,0.001,FALSE,3.998,11,1,147,15.9,8.21,1,signal transduction;other biological processes,cytosol;other cytoplasmic organelle;other cell component,Pf00313,23589,B2R4C3; D3DUF5; hsa:23589; Q2YDX5; Q9BQ53; Q9Y2V2,ENSG00000153048,,,0,0,84.72,,31.24,,High,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,71.65,,0.5,25.32,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q6MZP7,LIN54,Protein lin-54 homolog OS=Homo sapiens OX=9606 GN=LIN54 PE=1 SV=3,1,1,100,0.555,,100,6.64,-0.85,,6.64,1.00E-17,7.89E-01,,1.00E-17,1.03E+05,,5.71E+04,,1,,2,,,,,1.03E+05,,,,,,,,,,4.62E+04,7.05E+04,,,,,,,,,1.03E+05,,,,,,,,,,6.23E+03,1.75E+03,,,,,,0,FALSE,5.334,3,1,749,79.4,9.01,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,nucleus,Pf03638,132660,hsa:132660; Q32M68; Q32M69; Q6MZP7; Q6N071; Q76B60,ENSG00000189308,G1/S-Specific Transcription; Polo-like kinase mediated events; Cyclin E associated events during G1/S transition ; Transcription of E2F targets under negative control by DREAM complex; Cyclin A:Cdk2-associated events at S phase entry; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,DYRK1A involvement regarding cell proliferation in brain development,8,0,,,29.38,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,31.48,,,3.46,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q9UM00,TMCO1,Calcium load-activated calcium channel OS=Homo sapiens OX=9606 GN=TMCO1 PE=1 SV=2,1,1,100,0.071,100,0.166,6.64,-3.81,6.64,-2.59,1.00E-17,7.25E-03,1.00E-17,2.06E-01,3.23E+05,,2.30E+04,1.38E+05,2,,2,1,1.74E+06,,5.98E+04,,,,,,,,,1.51E+04,,,3.50E+04,1.38E+05,,,,,6.92E+03,,5.85E+02,,,,,,,,,6.76E+02,,,8.70E+02,2.70E+02,,,,,0.03,FALSE,1.817,6,1,239,27.1,10.26,1,cell organization and biogenesis;stress response;transport;signal transduction;other biological processes,other membranes;cytosol;ER/Golgi,Pf01956,54499,B2REA0; hsa:54499; J9JIE6; O75545; Q9BZS3; Q9BZU8; Q9UM00,ENSG00000143183,,,0,0,132.03,,56.07,,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,253.86,,64.04,0,transporter activity;translation activity,0,
Master Protein,High,Q9NY97,B3GNT2,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 OS=Homo sapiens OX=9606 GN=B3GNT2 PE=1 SV=2",1,1,100,1.363,,100,6.64,0.45,,6.64,1.00E-17,4.85E-01,,1.00E-17,5.56E+04,,7.58E+04,,1,,3,,,,,5.56E+04,,,,,,,1.11E+05,1.63E+04,,7.58E+04,,,,,,,,,,5.56E+04,,,,,,,6.64E+02,7.26E+02,,1.02E+04,,,,,,,0.003,FALSE,2.675,5,1,397,46,8.54,1,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,other membranes;ER/Golgi,Pf01762,10678,hsa:10678; Q54AC1; Q9NQQ9; Q9NQR0; Q9NUT9; Q9NY97,ENSG00000170340,Keratan sulfate biosynthesis; O-linked glycosylation of mucins,,2,0,,,70.74,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,68.84,,,2.5,other molecular function,0,
Master Protein,High,Q96L91,EP400,E1A-binding protein p400 OS=Homo sapiens OX=9606 GN=EP400 PE=1 SV=4,1,1,100,0.755,100,11.099,6.64,-0.41,6.64,3.47,1.00E-17,8.97E-01,1.00E-17,4.10E-02,4.13E+04,,3.12E+04,2.81E+03,1,,3,1,,,,4.13E+04,,,,,,,,6.27E+04,,3.12E+04,1.42E+04,,2.81E+03,,,,,,,4.13E+04,,,,,,,,2.80E+03,,4.20E+03,3.53E+02,,7.90E+02,,,,0.001,FALSE,4.015,1,1,3159,343.3,9.19,1,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00176, Pf00271, Pf07529, Pf15790",57634,hsa:57634; O15411; Q6P2F5; Q8N8Q7; Q8NE05; Q96JK7; Q96L91; Q9P230,ENSG00000183495,Formation of Senescence-Associated Heterochromatin Foci (SAHF); HATs acetylate histones,HDAC6 interactions in the central nervous system,4,0,,,68.28,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,74.49,,80.73,2.88,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9P086,MED11,Mediator of RNA polymerase II transcription subunit 11 OS=Homo sapiens OX=9606 GN=MED11 PE=1 SV=2,1,1,100,0.883,100,0.298,6.64,-0.18,6.64,-1.75,1.00E-17,7.91E-01,1.00E-17,3.25E-01,1.40E+05,,1.23E+05,4.14E+05,1,,1,1,,,,1.40E+05,,,,,,,,,,1.23E+05,,4.14E+05,,,,,,,,1.40E+05,,,,,,,,,,1.66E+04,,8.08E+02,,,,,0.001,FALSE,3.967,15,1,117,13.1,5.96,1,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf10280,400569,hsa:400569; Q6NS89; Q9P086,ENSG00000161920,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; RSV-host interactions,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,0,,0,3.91,other molecular function,0,
Master Protein,High,H0Y4R2,POR,NADPH--hemoprotein reductase (Fragment) OS=Homo sapiens OX=9606 GN=POR PE=1 SV=1,1,2,100,1.439,,100,6.64,0.53,,6.64,1.00E-17,3.60E-01,,1.00E-17,1.55E+05,,2.22E+05,,1,,2,,,,,1.55E+05,,,,,,,,,,1.60E+05,3.08E+05,,,,,,,,,1.55E+05,,,,,,,,,,2.16E+04,7.66E+03,,,,,,0,FALSE,9.894,3,1,725,81.6,6.54,1,,ER/Golgi,"Pf00175, Pf00258, Pf00667",,H0Y4R2,ENSG00000127948,,Oxidation by cytochrome P450; Ferroptosis; 7q11.23 distal copy number variation,3,0,,,44.57,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,49.24,,,8.77,other molecular function,0,
Master Protein,High,B4DLN1,,"cDNA FLJ60124, highly similar to Mitochondrial dicarboxylate carrier OS=Homo sapiens OX=9606 PE=2 SV=1",1,1,100,0.998,,100,6.64,0,,6.64,1.00E-17,5.04E-01,,1.00E-17,9.19E+05,,9.18E+05,,1,,3,,,,,9.19E+05,,,,,,,,1.32E+06,,6.79E+05,9.18E+05,,,,,,,,,9.19E+05,,,,,,,,5.89E+04,,9.14E+04,2.28E+04,,,,,,0.003,FALSE,2.709,2,1,442,48.1,9.52,1,protein metabolism;other metabolic processes;transport,other membranes;mitochondrion;translational apparatus;nucleus;other cell component,"Pf00153, Pf00542, Pf16320",,,,,,0,0,,,33.28,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,45.07,,,3.57,other molecular function,0,
Master Protein,High,Q7Z4R8,C6orf120,UPF0669 protein C6orf120 OS=Homo sapiens OX=9606 GN=C6orf120 PE=1 SV=1,1,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.16E+05,,,9.61E+05,1,,,1,,,,1.16E+05,,,,,,,,,,,,,,9.61E+05,,,,,,1.16E+05,,,,,,,,,,,,,,6.81E+03,,,0.001,FALSE,4.255,14,1,191,20.8,4.84,1,other biological processes,non-structural extracellular;other cytoplasmic organelle,Pf17065,387263,B4DHE9; E1P5C9; hsa:387263; Q7Z4R8,ENSG00000185127,Neutrophil degranulation,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,,,,5.23,,0,
Master Protein,Medium,Q9UBQ5,EIF3K,Eukaryotic translation initiation factor 3 subunit K OS=Homo sapiens OX=9606 GN=EIF3K PE=1 SV=1,1,2,100,0.417,100,0.148,6.64,-1.26,6.64,-2.75,1.00E-17,5.15E-01,1.00E-17,1.51E-01,5.00E+05,,2.08E+05,1.40E+06,4,,1,3,2.21E+05,1.51E+06,,6.34E+05,3.94E+05,,,,,,,,,,2.08E+05,1.53E+06,6.89E+05,,,1.40E+06,8.76E+02,5.75E+03,,6.34E+05,2.03E+04,,,,,,,,,,5.18E+03,2.97E+03,1.94E+05,,,1.49E+04,0.011,FALSE,2.225,5,1,218,25,4.93,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf10075,27335,A8K0I9; B7ZAM9; hsa:27335; Q96IQ0; Q9UBQ5; Q9Y6D1,ENSG00000178982; ENSG00000282986,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",,6,0,83.17,,,37.47,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,,61.33,,12.76,4.34,translation activity;nucleic acid binding activity,0,
Master Protein,High,E9PHG5,CYP20A1,Cytochrome P450 family 20 subfamily A member 1 OS=Homo sapiens OX=9606 GN=CYP20A1 PE=1 SV=1,3,5,100,2.554,100,0.653,6.64,1.35,6.64,-0.62,1.00E-17,9.41E-02,1.00E-17,8.26E-01,1.36E+05,,3.17E+05,5.21E+05,3,,5,2,,,1.36E+05,2.53E+05,1.14E+05,,,,,,3.17E+05,2.95E+04,2.79E+05,4.81E+05,3.62E+05,,3.31E+05,,8.18E+05,,,,1.33E+03,2.53E+05,5.88E+03,,,,,,1.89E+03,1.32E+03,2.27E+03,6.48E+04,9.01E+03,,9.31E+04,,1.91E+04,,0,FALSE,12.209,9,3,470,53.4,6.21,3,,,Pf00067,,E9PHG5,ENSG00000119004,,Oxidation by cytochrome P450; Metapathway biotransformation Phase I and II,2,0,44.6,,56.54,59.84,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,High,n/a,1,,FALSE,,28.44,,64.91,13.13,other molecular function,0,
Master Protein,High,P21291,CSRP1,Cysteine and glycine-rich protein 1 OS=Homo sapiens OX=9606 GN=CSRP1 PE=1 SV=3,2,4,100,0.814,100,0.385,6.64,-0.3,6.64,-1.38,1.00E-17,8.76E-01,1.00E-17,5.51E-01,1.02E+05,,8.32E+04,1.49E+05,2,,2,3,,,,1.53E+04,6.83E+05,,,,,,,,,2.63E+05,2.64E+04,5.25E+05,8.89E+04,,,1.49E+05,,,,1.53E+04,3.52E+04,,,,,,,,,3.54E+04,6.56E+02,1.02E+03,2.50E+04,,,1.58E+03,0,FALSE,6.276,20,2,193,20.6,8.57,2,cell organization and biogenesis;other biological processes,cytoskeleton;nucleus;other cell component,Pf00412,1465,A8K268; hsa:1465; P21291; Q5U0J2,ENSG00000159176,MTF1 activates gene expression,MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling,3,0,135.22,,115.6,93.01,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,,153.43,,122.42,11.32,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9BVI4,NOC4L,Nucleolar complex protein 4 homolog OS=Homo sapiens OX=9606 GN=NOC4L PE=1 SV=1,1,4,100,2.315,100,17.061,6.64,1.21,6.64,4.09,1.00E-17,2.06E-01,1.00E-17,1.35E-02,5.04E+04,,5.98E+04,3.50E+03,2,,3,1,,,,1.96E+05,1.30E+04,,,,,,,5.98E+04,,2.95E+05,4.61E+04,,3.50E+03,,,,,,,1.96E+05,6.70E+02,,,,,,,2.67E+03,,3.98E+04,1.14E+03,,9.84E+02,,,,0.001,FALSE,3.155,2,1,516,58.4,7.49,1,RNA metabolism OR transcription;other metabolic processes,other membranes;nucleus;other cell component,Pf03914,79050,hsa:79050; Q8N2S5; Q96I14; Q9BVI4,ENSG00000184967; ENSG00000288146,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,123.8,,104.79,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,130.92,,33.97,6.48,,0,
Master Protein,Medium,A0A994J7J2,ZDHHC3,Zinc finger DHHC-type palmitoyltransferase 3 OS=Homo sapiens OX=9606 GN=ZDHHC3 PE=4 SV=1,1,1,100,0.247,,100,6.64,-2.02,,6.64,1.00E-17,2.96E-01,,1.00E-17,6.83E+04,,1.69E+04,,1,,1,,,,,6.83E+04,,,,,,,,,,1.69E+04,,,,,,,,,,6.83E+04,,,,,,,,,,2.27E+03,,,,,,,0.019,FALSE,2.002,4,1,357,40.7,5.99,1,,other membranes,,,A0A994J7J2,ENSG00000163812,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,0,other molecular function,0,
Master Protein,High,A0A0G2JJD3,ABHD16A,"HLA-B associated transcript 5, isoform CRA_b OS=Homo sapiens OX=9606 GN=ABHD16A PE=1 SV=1",3,5,100,1.605,100,,6.64,0.68,6.64,,1.00E-17,3.36E-01,1.00E-17,,1.04E+05,,1.67E+05,8.21E+04,1,,5,2,,,,1.04E+05,,,,,,,5.20E+04,1.67E+05,3.10E+04,3.10E+05,3.03E+05,,1.02E+05,6.59E+04,,,,,,1.04E+05,,,,,,,3.11E+02,7.48E+03,2.52E+02,4.18E+04,7.53E+03,,2.88E+04,4.67E+02,,,0,FALSE,10.357,7,3,601,67.5,8.84,3,,other membranes,Pf00561,,A0A0G2JJD3,ENSG00000224552; ENSG00000230475; ENSG00000231488; ENSG00000235676; ENSG00000236063,,,0,0,,,76.91,30.76,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,120.23,,,11.28,other molecular function,0,
Master Protein,High,Q9NRL2,BAZ1A,Bromodomain adjacent to zinc finger domain protein 1A OS=Homo sapiens OX=9606 GN=BAZ1A PE=1 SV=2,2,3,100,0.333,100,0.153,6.64,-1.58,6.64,-2.71,1.00E-17,4.94E-01,1.00E-17,1.77E-01,3.54E+04,,1.05E+04,6.88E+04,2,,3,1,,,,4.75E+04,2.64E+04,,,,,,,1.68E+04,,1.05E+04,8.26E+03,,,,,6.88E+04,,,,4.75E+04,1.36E+03,,,,,,,7.53E+02,,1.41E+03,2.05E+02,,,,,7.33E+02,0,FALSE,5.235,2,2,1556,178.6,6.6,2,cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00439, Pf00628, Pf02791, Pf10537, Pf15612, Pf15613",11177,hsa:11177; Q9NRL2; Q9NZ15; Q9P065; Q9UIG1; Q9Y3V3,ENSG00000198604,,Ectoderm differentiation,1,0,40.38,,37.53,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,47.46,,40.13,8.65,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P51665,PSMD7,26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMD7 PE=1 SV=2,2,7,100,0.692,100,0.049,6.64,-0.53,6.64,-4.37,1.00E-17,9.94E-01,1.00E-17,8.90E-03,6.58E+04,,3.62E+04,7.46E+05,3,,4,2,,,1.49E+06,2.37E+04,6.58E+04,,,,,,,6.56E+03,3.97E+04,3.30E+04,5.22E+04,,7.54E+05,,7.39E+05,,,,1.46E+04,2.37E+04,3.40E+03,,,,,,,2.93E+02,3.23E+02,4.45E+03,1.30E+03,,2.12E+05,,1.73E+04,,0,FALSE,11.596,9,2,324,37,6.77,2,protein metabolism;other metabolic processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf01398, Pf13012",5713,D3DWS9; hsa:5713; P51665; Q6PKI2; Q96E97,ENSG00000103035,Neutrophil degranulation; Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,65,0,158.57,,58.58,1.43,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,High,n/a,1,,FALSE,,80.75,,30.19,17.37,other molecular function,0,
Master Protein,High,O15270,SPTLC2,Serine palmitoyltransferase 2 OS=Homo sapiens OX=9606 GN=SPTLC2 PE=1 SV=1,2,3,100,1.796,100,5.478,6.64,0.84,6.64,2.45,1.00E-17,2.99E-01,1.00E-17,1.35E-01,7.70E+04,,1.38E+05,2.52E+04,1,,1,1,,,,7.70E+04,,,,,,,,,,1.38E+05,,,2.52E+04,,,,,,,7.70E+04,,,,,,,,,,1.86E+04,,,7.09E+03,,,,0,FALSE,5.337,7,2,562,62.9,7.78,2,other metabolic processes;other biological processes,other membranes;ER/Golgi,Pf00155,9517,hsa:9517; O15270; Q16685,ENSG00000100596,Sphingolipid de novo biosynthesis,Sphingolipid pathway; Sphingolipid metabolism: integrated pathway; Biosynthesis and turnover of 1-deoxy-sphingoid bases,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,0,,0,9.13,other molecular function,0,
Master Protein,Medium,P50454,SERPINH1,Serpin H1 OS=Homo sapiens OX=9606 GN=SERPINH1 PE=1 SV=2,1,1,100,1.772,100,1.685,6.64,0.83,6.64,0.75,1.00E-17,2.22E-01,1.00E-17,5.04E-01,2.70E+05,,4.78E+05,2.90E+05,1,,3,2,,,,2.70E+05,,,,,,,,,1.27E+06,4.78E+05,3.31E+05,,3.57E+05,,2.36E+05,,,,,2.70E+05,,,,,,,,,1.03E+04,6.44E+04,8.22E+03,,1.00E+05,,5.52E+03,,0.03,FALSE,1.817,6,1,418,46.4,8.69,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes,non-structural extracellular;other membranes;ER/Golgi,Pf00079,871,B3KVJ3; hsa:871; P29043; P50454; Q5XPB4; Q6NSJ6; Q8IY96; Q9NP88,ENSG00000149257,Collagen biosynthesis and modifying enzymes,Endochondral ossification; Type I collagen synthesis in the context of osteogenesis imperfecta; Endochondral ossification with skeletal dysplasias; 15q13.3 copy number variation syndrome; 15q11q13 copy number variation,6,0,,,72.68,28.96,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,45.58,,48.74,2.98,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q13618,CUL3,Cullin-3 OS=Homo sapiens OX=9606 GN=CUL3 PE=1 SV=2,2,5,100,12.343,,100,6.64,3.63,,6.64,1.00E-17,2.68E-03,,1.00E-17,1.24E+04,,1.54E+05,,1,,3,,,,,1.24E+04,,,,,,,,2.69E+06,1.11E+05,1.54E+05,,,,,,,,,,1.24E+04,,,,,,,,1.20E+05,9.05E+02,2.07E+04,,,,,,,0,FALSE,5.509,4,2,768,88.9,8.48,2,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,"Pf00888, Pf10557",8452,A8K536; B8ZZC3; hsa:8452; O75415; Q13618; Q569L3; Q9UBI8; Q9UET7,ENSG00000036257,Potential therapeutics for SARS; Antigen processing: Ubiquitination & Proteasome degradation; Degradation of DVL; Hedgehog 'on' state; Regulation of RAS by GAPs; Neddylation; KEAP1-NFE2L2 pathway; RHOBTB3 ATPase cycle; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,Hereditary leiomyomatosis and renal cell carcinoma pathway; Hedgehog signaling pathway; NRF2-ARE regulation; 22q11.2 copy number variation syndrome; Head and neck squamous cell carcinoma; 1p36 copy number variation syndrome,16,0,,,149.91,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,40.63,,,16.41,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P03886,MT-ND1,NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens OX=9606 GN=MT-ND1 PE=1 SV=1,1,2,100,3.048,100,3.955,6.64,1.61,6.64,1.98,1.00E-17,5.10E-02,1.00E-17,1.45E-01,1.74E+05,,5.30E+05,1.34E+05,1,,3,1,,,,1.74E+05,,,,,,,,,3.28E+05,5.78E+05,5.30E+05,,1.34E+05,,,,,,,1.74E+05,,,,,,,,,2.66E+03,7.79E+04,1.32E+04,,3.77E+04,,,,0,FALSE,4.77,6,1,318,35.6,6.55,1,cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes,other membranes;mitochondrion;other cell component,Pf00146,4535,C0JKH6; hsa:4535; P03886; Q37523,ENSG00000198888,Complex I biogenesis; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Arsenic metabolism and reactive oxygen species generation; Oxidative phosphorylation,6,0,,,27.78,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,13.42,,13.42,7.57,transporter activity,0,
Master Protein,High,Q9P0M9,MRPL27,"39S ribosomal protein L27, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL27 PE=1 SV=1",1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.09E+05,,,,1,,,,,,,1.09E+05,,,,,,,,,,,,,,,,,,,,1.09E+05,,,,,,,,,,,,,,,,,0,FALSE,6.009,10,1,148,16.1,10.42,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf01016,51264,B2RE14; hsa:51264; Q9P0M9,ENSG00000108826,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.19,other molecular function,0,
Master Protein,High,A0A7I2V4F7,PPP1CA,Serine/threonine-protein phosphatase OS=Homo sapiens OX=9606 GN=PPP1CA PE=1 SV=1,6,19,100,0.47,,100,6.64,-1.09,,6.64,1.00E-17,5.93E-01,,1.00E-17,5.98E+05,,2.81E+05,,1,,2,,,,,5.98E+05,,,,,,,,2.91E+05,,2.72E+05,,,,,,,,,,5.98E+05,,,,,,,,1.30E+04,,3.66E+04,,,,,,,0,FALSE,26.755,24,2,335,37.8,7.05,6,other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus,"Pf00149, Pf16891",,A0A7I2V4F7,ENSG00000172531,,Common pathways underlying drug addiction; Focal adhesion; Fragile X syndrome; HDAC6 interactions in the central nervous system,4,0,,,4.71,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,4.94,,,60.41,other molecular function,0,
Master Protein,High,Q9NP66,HMG20A,High mobility group protein 20A OS=Homo sapiens OX=9606 GN=HMG20A PE=1 SV=1,3,14,100,0.816,100,7.178,6.64,-0.29,6.64,2.84,1.00E-17,8.02E-01,1.00E-17,2.79E-02,6.07E+05,,4.95E+05,6.90E+04,3,,5,1,,,6.07E+05,1.05E+06,1.01E+05,,,,,,1.83E+05,4.95E+05,1.36E+05,5.79E+05,6.04E+05,,6.90E+04,,,,,,5.93E+03,1.05E+06,5.19E+03,,,,,,1.09E+03,2.21E+04,1.10E+03,7.81E+04,1.50E+04,,1.94E+04,,,,0,FALSE,13.07,13,3,347,40.1,6.49,3,cell organization and biogenesis;other biological processes,nucleus,Pf00505,10363,A6NHY3; D3DW78; hsa:10363; Q53G31; Q9NP66; Q9NSF6,ENSG00000140382,,,0,0,81.03,,55.95,,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,107.97,,32.52,48.57,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P36543,ATP6V1E1,V-type proton ATPase subunit E 1 OS=Homo sapiens OX=9606 GN=ATP6V1E1 PE=1 SV=1,1,5,100,2.618,100,0.7,6.64,1.39,6.64,-0.51,1.00E-17,4.98E-02,1.00E-17,8.97E-01,3.59E+05,,9.39E+05,1.34E+06,1,,4,2,,,,3.59E+05,,,,,,,,6.14E+05,8.33E+05,1.70E+06,1.06E+06,,1.43E+06,,1.26E+06,,,,,3.59E+05,,,,,,,,2.74E+04,6.77E+03,2.29E+05,2.63E+04,,4.02E+05,,2.95E+04,,0.002,FALSE,2.916,6,1,226,26.1,8,1,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf01991,529,A8MUE4; A8MUN4; hsa:529; P36543,ENSG00000131100,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,VEGFA-VEGFR2 signaling; Proximal tubule transport,7,0,,,44.49,8.96,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,High,n/a,High,n/a,1,,FALSE,,35.18,,45.34,16.05,transporter activity;other molecular function,0,
Master Protein,High,Q9BX67,JAM3,Junctional adhesion molecule C OS=Homo sapiens OX=9606 GN=JAM3 PE=1 SV=1,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.59E+05,,,1.01E+04,4,,,2,1.29E+05,1.69E+06,3.84E+04,,1.95E+05,,,,,,,,,,,,2.89E+03,,3.50E+04,,5.13E+02,6.44E+03,3.75E+02,,1.01E+04,,,,,,,,,,,,8.12E+02,,8.18E+02,,0.006,FALSE,2.451,3,1,310,35,7.59,1,cell adhesion;cell organization and biogenesis;stress response;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component,"Pf07686, Pf13927",83700,B3KWG9; hsa:83700; Q8WWL8; Q96FL1; Q9BX67,ENSG00000166086,Cell surface interactions at the vascular wall; Integrin cell surface interactions,,2,0,153.51,,,119.82,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,,,,1.92,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P29279,CCN2,CCN family member 2 OS=Homo sapiens OX=9606 GN=CCN2 PE=1 SV=2,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.25E+05,,,,1,,,,,,,1.25E+05,,,,,,,,,,,,,,,,,,,,1.25E+05,,,,,,,,,,,,,,,,,0,FALSE,6.682,11,2,349,38.1,8,2,cell adhesion;cell cycle OR cell proliferation;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;ER/Golgi;other cell component,"Pf00007, Pf00093, Pf00219, Pf19035",1490,E1P578; hsa:1490; P29279; Q6LCY0; Q96A79; Q96QX2; Q9UDL6,ENSG00000118523,YAP1- and WWTR1 (TAZ)-stimulated gene expression; RUNX3 regulates YAP1-mediated transcription,Lung fibrosis; Hypothesized pathways in pathogenesis of cardiovascular disease; VEGFA-VEGFR2 signaling; Envelope proteins and their potential roles in EDMD physiopathology; Hippo-Merlin signaling dysregulation; Netrin-UNC5B signaling pathway; Angiotensin II receptor type 1 pathway; Pleural mesothelioma; Orexin receptor pathway; Osteoarthritic chondrocyte hypertrophy,12,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.2,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9H2F5,EPC1,Enhancer of polycomb homolog 1 OS=Homo sapiens OX=9606 GN=EPC1 PE=1 SV=1,1,1,100,0.121,100,0.359,6.64,-3.05,6.64,-1.48,1.00E-17,4.46E-02,1.00E-17,5.18E-01,2.08E+05,,2.52E+04,7.02E+04,1,,4,1,2.08E+05,,,,,,,,,,,1.56E+04,6.89E+04,3.23E+04,1.96E+04,,,,7.02E+04,,8.28E+02,,,,,,,,,,,6.95E+02,5.60E+02,4.36E+03,4.87E+02,,,,1.64E+03,,0.005,FALSE,2.513,2,1,836,93.4,8.59,1,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,other membranes;nucleus;other cell component,"Pf06752, Pf10513",80314,B4DSC3; D3DRX7; hsa:80314; Q5VW54; Q5VW56; Q5VW58; Q8NAQ4; Q8NE21; Q96LF4; Q96RR6; Q9H2F5; Q9H7T7,ENSG00000120616,Transcriptional Regulation by E2F6; HATs acetylate histones,,2,0,,,71.18,,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,66.89,,66.89,2.85,other molecular function,0,
Master Protein,High,Q9Y2X7,GIT1,ARF GTPase-activating protein GIT1 OS=Homo sapiens OX=9606 GN=GIT1 PE=1 SV=2,2,2,100,0.408,,100,6.64,-1.29,,6.64,1.00E-17,5.60E-01,,1.00E-17,1.27E+05,,5.17E+04,,2,,2,,,4.96E+05,,3.24E+04,,,,,,,,,4.24E+04,6.30E+04,,,,,,,,1.88E+03,,3.24E+04,,,,,,,,,3.44E+02,8.49E+03,,,,,,,0,FALSE,8.498,4,2,761,84.3,6.8,2,transport;developmental processes;signal transduction;other biological processes,cytosol;cytoskeleton;mitochondrion;other cell component,"Pf01412, Pf08518, Pf12205, Pf12796, Pf16559",28964,B4DGU9; B4DSV3; hsa:28964; Q86SS0; Q9BRJ4; Q9Y2X7,ENSG00000108262,CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; Ephrin signaling; Activation of RAC1 downstream of NMDARs,CAMKK2 pathway; Regulation of actin cytoskeleton,12,0,124.08,,27.72,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,222.31,,,6,enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q8N488,RYBP,RING1 and YY1-binding protein OS=Homo sapiens OX=9606 GN=RYBP PE=1 SV=2,1,3,100,0.083,,100,6.64,-3.6,,6.64,1.00E-17,1.05E-02,,1.00E-17,3.81E+05,,3.15E+04,,1,,3,,,,,3.81E+05,,,,,,,,3.15E+04,,1.36E+05,1.18E+04,,,,,,,,,3.81E+05,,,,,,,,1.40E+03,,1.84E+04,2.92E+02,,,,,,0,FALSE,10.735,10,1,228,24.8,9.63,1,cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf00641, Pf17219",23429,hsa:23429; Q8N488; Q9P2W5; Q9UMW4,ENSG00000163602; ENSG00000281766,Transcriptional Regulation by E2F6; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,,2,0,,,111.84,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,114.02,,,14.23,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,G3V467,DMAC2L,Distal membrane arm assembly component 2 like OS=Homo sapiens OX=9606 GN=DMAC2L PE=1 SV=1,1,1,100,0.275,100,1.518,6.64,-1.86,6.64,0.6,1.00E-17,2.86E-01,1.00E-17,5.85E-01,1.91E+05,,5.26E+04,3.92E+04,1,,3,2,,,,1.91E+05,,,,,,,,5.26E+04,8.38E+04,4.23E+04,,,2.19E+04,,7.00E+04,,,,,1.91E+05,,,,,,,,2.35E+03,6.80E+02,5.70E+03,,,6.17E+03,,1.64E+03,,0.02,FALSE,1.992,4,1,219,24.5,8.02,1,,,,,G3V467,ENSG00000125375,,,0,0,,,36.28,73.88,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,36.2,,80.28,2.18,,0,
Master Protein,High,Q9BQ52,ELAC2,Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens OX=9606 GN=ELAC2 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.79E+04,,,,1,,,,,,,1.79E+04,,,,,,,,,,,,,,,,,,,,1.79E+04,,,,,,,,,,,,,,,,,0.001,FALSE,3.894,2,1,826,92.2,7.9,1,RNA metabolism OR transcription;other metabolic processes,cytosol;mitochondrion;nucleus,"Pf12706, Pf13691",60528,B4DPL9; hsa:60528; Q6IA94; Q9BQ52; Q9HAS8; Q9HAS9; Q9NVT1,ENSG00000006744,"tRNA processing in the nucleus; tRNA processing in the mitochondrion; rRNA processing in the mitochondrion; tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis",,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.44,other molecular function,0,
Master Protein,High,Q9Y266,NUDC,Nuclear migration protein nudC OS=Homo sapiens OX=9606 GN=NUDC PE=1 SV=1,1,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.13E+05,,,,1,,,,,,,2.13E+05,,,,,,,,,,,,,,,,,,,,2.13E+05,,,,,,,,,,,,,,,,,0,FALSE,5.392,5,1,331,38.2,5.38,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf04969, Pf14050, Pf16273",10726,hsa:10726; Q5QP31; Q5QP35; Q9H0N2; Q9Y266; Q9Y2B6,ENSG00000090273,RND2 GTPase cycle; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Ciliary landscape; PAFAH1B1 copy number variation,9,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.63,other molecular function,0,
Master Protein,High,P55010,EIF5,Eukaryotic translation initiation factor 5 OS=Homo sapiens OX=9606 GN=EIF5 PE=1 SV=2,2,6,100,0.679,100,0.161,6.64,-0.56,6.64,-2.63,1.00E-17,9.84E-01,1.00E-17,1.47E-01,5.93E+05,,1.08E+05,9.63E+05,3,,5,4,,1.05E+06,5.93E+05,2.12E+05,,,,,,,3.23E+05,1.05E+05,1.04E+05,4.08E+05,1.08E+05,1.08E+06,1.92E+06,2.30E+05,8.59E+05,,,3.98E+03,5.79E+03,2.12E+05,,,,,,,1.93E+03,4.69E+03,8.44E+02,5.50E+04,2.68E+03,2.11E+03,5.40E+05,1.63E+03,2.01E+04,,0,FALSE,11.414,6,2,431,49.2,5.58,2,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf01873, Pf02020",1983,hsa:1983; P55010; Q53XB3; Q9H5N2; Q9UG48,ENSG00000100664,Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,4,0,67.78,,69.44,68.39,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,n/a,1,,FALSE,,110.21,,91.62,16.61,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P22670,RFX1,MHC class II regulatory factor RFX1 OS=Homo sapiens OX=9606 GN=RFX1 PE=1 SV=2,3,4,100,0.697,,100,6.64,-0.52,,6.64,1.00E-17,9.88E-01,,1.00E-17,3.37E+05,,1.68E+05,,1,,4,,,,,3.37E+05,,,,,,,1.49E+05,9.81E+04,,2.15E+05,1.89E+05,,,,,,,,,3.37E+05,,,,,,,8.92E+02,4.38E+03,,2.90E+04,4.71E+03,,,,,,0,FALSE,12.047,5,3,979,104.7,6.29,3,other biological processes,nucleus;other cell component,"Pf02257, Pf04589",5989,hsa:5989; P22670,ENSG00000132005; ENSG00000288283,,Alstrom syndrome,1,0,,,31.35,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,92.29,,,12.76,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O00505,KPNA3,Importin subunit alpha-4 OS=Homo sapiens OX=9606 GN=KPNA3 PE=1 SV=2,3,6,100,0.111,,100,6.64,-3.17,,6.64,1.00E-17,1.99E-02,,1.00E-17,5.04E+05,,5.60E+04,,1,,3,,,,,5.04E+05,,,,,,,,5.60E+04,,3.13E+05,4.27E+04,,,,,,,,,5.04E+05,,,,,,,,2.50E+03,,4.22E+04,1.06E+03,,,,,,0,FALSE,7.299,5,1,521,57.8,4.94,3,cell organization and biogenesis;transport;other biological processes,cytosol;nucleus;other cell component,"Pf00514, Pf01749, Pf16186",3839,hsa:3839; O00191; O00505; O43195; Q5JVM9; Q8IYQ9; Q96AA7,ENSG00000102753,ISG15 antiviral mechanism; NS1 Mediated Effects on Host Pathways,,2,0,,,111.09,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,46.25,,,11.65,other molecular function,0,
Master Protein,High,Q06136,KDSR,3-ketodihydrosphingosine reductase OS=Homo sapiens OX=9606 GN=KDSR PE=1 SV=1,2,2,100,0.34,100,0.171,6.64,-1.55,6.64,-2.55,1.00E-17,4.08E-01,1.00E-17,1.57E-01,2.60E+05,,1.04E+05,3.62E+05,1,,5,3,,,,2.60E+05,,,,,,,4.43E+05,1.04E+05,7.50E+04,1.83E+05,4.82E+04,3.37E+05,,3.62E+05,,5.74E+05,,,,2.60E+05,,,,,,,2.65E+03,4.64E+03,6.10E+02,2.47E+04,1.20E+03,6.58E+02,,2.56E+03,,6.11E+03,0,FALSE,5.902,8,2,332,36.2,7.12,2,other metabolic processes,non-structural extracellular;other membranes;ER/Golgi,Pf00106,2531,B2R5Y1; B4DMX0; hsa:2531; Q06136,ENSG00000119537,Sphingolipid de novo biosynthesis,Sphingolipid pathway; Sphingolipid metabolism: integrated pathway; Biosynthesis and turnover of 1-deoxy-sphingoid bases; Synthesis of ceramides and 1-deoxyceramides,5,0,,,93.99,30.63,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,122.14,,60.45,6.63,other molecular function,0,
Master Protein,High,Q9UBG3,CRNN,Cornulin OS=Homo sapiens OX=9606 GN=CRNN PE=1 SV=1,2,3,100,6.502,100,13.226,6.64,2.7,6.64,3.73,1.00E-17,3.65E-04,1.00E-17,1.46E-02,2.28E+05,,1.58E+06,1.12E+05,2,,2,2,4.15E+05,,1.26E+05,,,,,,,,8.95E+06,,2.80E+05,,,,4.23E+04,2.98E+05,,,1.65E+03,,1.23E+03,,,,,,,,5.35E+04,,2.27E+03,,,,1.19E+04,2.11E+03,,,0,FALSE,11.583,6,2,495,53.5,6.1,2,cell adhesion;stress response;other biological processes,other membranes;other cell component,Pf01023,49860,B2RE60; hsa:49860; Q8N613; Q9UBG3,ENSG00000143536,,,0,0,75.66,,132.84,106.27,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,208.8,,142.92,10.17,other molecular function,0,
Master Protein,High,Q8WU76,SCFD2,Sec1 family domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCFD2 PE=1 SV=2,1,2,100,2.614,100,2.17,6.64,1.39,6.64,1.12,1.00E-17,1.68E-01,1.00E-17,4.63E-01,5.98E+04,,1.21E+05,5.58E+04,2,,3,1,,,8.19E+04,4.37E+04,,,,,,,8.49E+05,,1.08E+05,,1.21E+05,,5.58E+04,,,,,,8.00E+02,4.37E+04,,,,,,,5.07E+03,,8.74E+02,,3.01E+03,,1.57E+04,,,,0.001,FALSE,3.142,2,1,684,75.1,6.68,1,transport,,Pf00995,152579,hsa:152579; Q8N5F3; Q8N8H0; Q8WU76; Q96ED3,ENSG00000184178,,,0,0,43.09,,118.07,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,69.1,,16.56,3.05,,0,
Master Protein,High,P10768,ESD,S-formylglutathione hydrolase OS=Homo sapiens OX=9606 GN=ESD PE=1 SV=2,2,6,100,1.017,100,1.284,6.64,0.02,6.64,0.36,1.00E-17,6.11E-01,1.00E-17,6.45E-01,3.09E+05,,3.14E+05,2.45E+05,3,,2,4,,1.17E+06,,1.42E+05,3.09E+05,,,,,,,,,3.83E+05,2.58E+05,,1.62E+05,3.69E+05,6.31E+04,7.07E+05,,4.45E+03,,1.42E+05,1.59E+04,,,,,,,,,5.16E+04,6.40E+03,,4.55E+04,2.62E+03,1.48E+03,7.52E+03,0,FALSE,15.996,15,2,282,31.4,7.02,2,other metabolic processes,cytosol;ER/Golgi;other cell component,Pf00756,2098,hsa:2098; P10768; Q5TBU8; Q5TBV0; Q5TBV2; Q9BVJ2,ENSG00000139684,Glutathione conjugation,"Phase I biotransformations, non-P450",2,0,102.25,,27.65,87.47,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,108.44,,95.95,21.35,other molecular function,0,
Master Protein,High,Q12904,AIMP1,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens OX=9606 GN=AIMP1 PE=1 SV=2,2,8,100,0.924,100,0.291,6.64,-0.11,6.64,-1.78,1.00E-17,7.57E-01,1.00E-17,3.17E-01,1.31E+05,,1.21E+05,4.17E+05,1,,1,1,,,,1.31E+05,,,,,,,,,,1.21E+05,,,4.17E+05,,,,,,,1.31E+05,,,,,,,,,,1.63E+04,,,1.17E+05,,,,0,FALSE,6.687,12,2,312,34.3,8.43,2,cell-cell signaling;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;cytosol;ER/Golgi;nucleus;other cell component,Pf01588,9255,B3KTR2; B4E1S7; hsa:9255; Q12904; Q6FG28; Q96CQ9,ENSG00000164022,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,Ciliary landscape,3,0,,,,,High,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,Phospho [T188; S191],FALSE,,0,,0,24.23,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,2,Phospho [T188; S191]
Master Protein,High,A0A0A0MQX8,MBNL1,Muscleblind like splicing regulator 1 OS=Homo sapiens OX=9606 GN=MBNL1 PE=1 SV=1,1,4,100,0.657,,100,6.64,-0.6,,6.64,1.00E-17,9.25E-01,,1.00E-17,5.32E+05,,3.50E+05,,1,,1,,,,,5.32E+05,,,,,,,,,,3.50E+05,,,,,,,,,,5.32E+05,,,,,,,,,,4.71E+04,,,,,,,0,FALSE,6.358,6,1,400,43,8.82,1,,cytosol;nucleus,"Pf00642, Pf14608",,A0A0A0MQX8,ENSG00000152601,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,,16.81,other molecular function,0,
Master Protein,High,A0A8V8TQG7,NFIA,Nuclear factor 1 OS=Homo sapiens OX=9606 GN=NFIA PE=1 SV=1,1,4,100,0.564,100,4.296,6.64,-0.83,6.64,2.1,1.00E-17,8.42E-01,1.00E-17,1.78E-01,7.90E+04,,4.45E+04,1.04E+04,1,,5,1,,,,7.90E+04,,,,,,,1.11E+05,1.06E+04,4.45E+04,9.61E+04,3.95E+04,,1.04E+04,,,,,,,7.90E+04,,,,,,,6.66E+02,4.75E+02,3.62E+02,1.30E+04,9.83E+02,,2.91E+03,,,,0.001,FALSE,3.595,3,1,490,53.7,8.38,1,DNA metabolism;other metabolic processes;other biological processes,nucleus,"Pf00859, Pf03165, Pf10524",,A0A8V8TQG7,ENSG00000162599,,,0,0,,,69.43,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,Acetyl [N-Term],FALSE,,79.6,,112.88,12.08,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UGU5,HMGXB4,HMG domain-containing protein 4 OS=Homo sapiens OX=9606 GN=HMGXB4 PE=1 SV=2,2,3,100,3.081,100,2.971,6.64,1.62,6.64,1.57,1.00E-17,1.17E-01,1.00E-17,3.18E-01,4.31E+04,,1.40E+05,4.47E+04,2,,4,2,,,,1.15E+05,1.62E+04,,,,,,,8.52E+04,9.79E+04,2.00E+05,2.07E+05,,,7.28E+04,2.75E+04,,,,,1.15E+05,8.37E+02,,,,,,,3.80E+03,7.95E+02,2.69E+04,5.16E+03,,,5.16E+02,6.44E+02,,0,FALSE,8.3,7,2,601,65.7,9.32,2,cell-cell signaling;transport;signal transduction;other biological processes,nucleus,"Pf00505, Pf13775",10042,hsa:10042; O75672; O75673; Q9UGU5; Q9UMT5,ENSG00000100281,,,0,0,106.37,,44.07,63.89,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,,109.87,,55.29,7.37,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q92600,CNOT9,CCR4-NOT transcription complex subunit 9 OS=Homo sapiens OX=9606 GN=CNOT9 PE=1 SV=1,1,2,100,0.193,100,0.534,6.64,-2.38,6.64,-0.91,1.00E-17,1.69E-01,1.00E-17,7.62E-01,1.42E+05,,2.74E+04,5.14E+04,2,,1,1,,,,7.72E+04,2.63E+05,,,,,,,,,2.74E+04,,,,,,5.14E+04,,,,7.72E+04,1.36E+04,,,,,,,,,3.70E+03,,,,,,5.47E+02,0.004,FALSE,2.615,3,1,299,33.6,8.03,1,RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf04078,9125,B2RPI0; B5MDQ4; B7Z1E5; hsa:9125; Q92600; Q96IX4,ENSG00000144580,Activation of anterior HOX genes in hindbrain development during early embryogenesis; Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain; M-decay: degradation of maternal mRNAs by maternally stored factors,,4,0,77.24,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,96.67,,0,5.23,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9BTX1,NDC1,Nucleoporin NDC1 OS=Homo sapiens OX=9606 GN=NDC1 PE=1 SV=2,1,2,100,2.71,,100,6.64,1.44,,6.64,1.00E-17,1.58E-01,,1.00E-17,2.30E+04,,6.23E+04,,1,,2,,,,,2.30E+04,,,,,,,2.45E+05,,,1.59E+04,,,,,,,,,,2.30E+04,,,,,,,1.47E+03,,,2.14E+03,,,,,,,0.002,FALSE,2.951,3,1,674,76.3,9.09,1,cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,Pf09531,55706,B4DHA3; B4DQQ5; G3XA81; hsa:55706; Q8NB76; Q9BTX1; Q9H9T6; Q9NSG3; Q9NSG4; Q9NVZ7,ENSG00000058804,SARS-CoV-2 activates/modulates innate and adaptive immune responses; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; Postmitotic nuclear pore complex (NPC) reformation,,29,0,,,124.24,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,272.62,,,6.81,other molecular function,0,
Master Protein,High,P53396,ACLY,ATP-citrate synthase OS=Homo sapiens OX=9606 GN=ACLY PE=1 SV=3,5,13,100,0.706,100,0.409,6.64,-0.5,6.64,-1.29,1.00E-17,9.76E-01,1.00E-17,5.17E-01,4.94E+05,,3.48E+05,6.25E+05,2,,3,3,,,,9.99E+05,2.45E+05,,,,,,,3.48E+05,,7.60E+05,1.73E+05,,2.47E+06,6.25E+05,3.46E+05,,,,,9.99E+05,1.26E+04,,,,,,,1.55E+04,,1.02E+05,4.30E+03,,6.94E+05,4.43E+03,8.09E+03,,0,FALSE,25.262,8,5,1101,120.8,7.33,5,other metabolic processes,non-structural extracellular;cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf00285, Pf00549, Pf02629, Pf16114",47,B4DIM0; B4E3P0; hsa:47; P53396; Q13037; Q9BRL0,ENSG00000131473,Neutrophil degranulation; ChREBP activates metabolic gene expression; Fatty acyl-CoA biosynthesis,Sterol regulatory element-binding proteins (SREBP) signaling; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Fatty acid biosynthesis; Amino acid metabolism; Lipid metabolism pathway; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer,10,0,85.75,,70.59,100.66,High,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,111.2,,70.82,40.75,other molecular function,0,
Master Protein,High,Q9P032,NDUFAF4,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 OS=Homo sapiens OX=9606 GN=NDUFAF4 PE=1 SV=1,2,5,100,0.906,100,0.924,6.64,-0.14,6.64,-0.11,1.00E-17,5.61E-01,1.00E-17,8.95E-01,1.27E+06,,7.08E+05,8.80E+05,1,,3,1,,,,1.27E+06,,,,,,,,,6.96E+05,7.65E+05,7.08E+05,,8.80E+05,,,,,,,1.27E+06,,,,,,,,,5.66E+03,1.03E+05,1.76E+04,,2.47E+05,,,,0,FALSE,9.8,14,2,175,20.3,8.82,2,cell organization and biogenesis;stress response;other biological processes,other membranes;cytosol;mitochondrion,Pf06784,29078,B2R4J5; hsa:29078; Q9P032,ENSG00000123545,Complex I biogenesis,,1,0,,,5.11,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,2.4,,2.4,18.33,other molecular function,0,
Master Protein,High,Q9Y3D0,CIAO2B,Cytosolic iron-sulfur assembly component 2B OS=Homo sapiens OX=9606 GN=CIAO2B PE=1 SV=1,1,2,100,1.373,100,1.984,6.64,0.46,6.64,0.99,1.00E-17,4.45E-01,1.00E-17,4.81E-01,2.58E+04,,3.54E+04,1.79E+04,2,,2,1,,,,2.85E+04,2.34E+04,,,,,,,,6.79E+04,1.85E+04,,,,,1.79E+04,,,,,2.85E+04,1.20E+03,,,,,,,,5.52E+02,2.49E+03,,,,,4.18E+02,,0,FALSE,5.79,13,1,163,17.7,5.19,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes,cytosol;cytoskeleton;nucleus;other cell component,Pf01883,51647,hsa:51647; Q9Y3D0,ENSG00000166595,Cytosolic iron-sulfur cluster assembly,Iron-sulfur cluster biogenesis; 2q11.2 copy number variation syndrome,3,0,14.1,,80.85,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,93.46,,103.3,6.92,,0,
Master Protein,High,A0A087WX97,BCL2L13,BCL2 like 13 OS=Homo sapiens OX=9606 GN=BCL2L13 PE=1 SV=1,1,3,100,1.575,100,1.587,6.64,0.66,6.64,0.67,1.00E-17,2.85E-01,1.00E-17,5.54E-01,1.60E+05,,2.52E+05,1.59E+05,1,,4,1,,,,1.60E+05,,,,,,,,2.48E+05,1.64E+05,2.69E+05,2.56E+05,,1.59E+05,,,,,,,1.60E+05,,,,,,,,1.11E+04,1.33E+03,3.62E+04,6.37E+03,,4.46E+04,,,,0,FALSE,4.57,3,1,509,54.4,4.54,1,other biological processes,other membranes,Pf00452,23786,A0A087WX97,ENSG00000099968,,Regulation of apoptosis by parathyroid hormone-related protein; TAR syndrome,2,0,,,20.34,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,6.24,,6.24,11.03,,0,
Master Protein,High,Q8WUA4,GTF3C2,General transcription factor 3C polypeptide 2 OS=Homo sapiens OX=9606 GN=GTF3C2 PE=1 SV=2,3,3,100,2.597,100,0.889,6.64,1.38,6.64,-0.17,1.00E-17,1.47E-01,1.00E-17,9.34E-01,6.00E+04,,1.56E+05,1.75E+05,1,,3,1,,,,6.00E+04,,,,,,,,1.56E+05,,2.91E+05,7.20E+04,,1.75E+05,,,,,,,6.00E+04,,,,,,,,6.95E+03,,3.92E+04,1.79E+03,,4.92E+04,,,,0,FALSE,11,5,3,911,100.6,7.31,3,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf00400,2976,D6W557; hsa:2976; Q16632; Q8WUA4; Q9BWI7,ENSG00000115207,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter,,3,0,,,63.87,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,79.7,,68.86,8.75,other molecular function,0,
Master Protein,High,A0A6Q8PFE4,ACTB,Actin beta OS=Homo sapiens OX=9606 GN=ACTB PE=1 SV=1,21,628,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,4.96E+04,,,6.96E+04,1,,,2,,,,,4.96E+04,,,,,,,,,,,,4.97E+04,9.74E+04,,,,,,,2.56E+03,,,,,,,,,,,,1.40E+04,6.90E+02,,,0,FALSE,151.508,74,1,332,37.3,5.55,21,,,Pf00022,,A0A6Q8PFE4,ENSG00000075624,,Common pathways underlying drug addiction; Ebola virus infection in host; Acute viral myocarditis; Thermogenesis; Pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway,6,0,,,,45.85,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,,,,1578.15,,0,
Master Protein,High,O43776,NARS1,"Asparagine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=NARS1 PE=1 SV=1",3,7,100,2.198,100,0.211,6.64,1.14,6.64,-2.25,1.00E-17,1.33E-01,1.00E-17,2.06E-01,9.02E+04,,4.66E+05,2.50E+06,1,,4,3,,,,9.02E+04,,,,,,,,8.54E+04,5.00E+05,5.63E+05,4.34E+05,2.32E+06,2.50E+06,2.70E+06,,,,,,9.02E+04,,,,,,,,3.81E+03,4.06E+03,7.58E+04,1.08E+04,4.53E+03,7.03E+05,1.91E+04,,,0,FALSE,13.154,9,3,548,62.9,6.25,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;other cell component,"Pf00152, Pf01336, Pf20917",4677,B4DG16; hsa:4677; O43776; Q53GU6,ENSG00000134440,Cytosolic tRNA aminoacylation,Photodynamic therapy-induced unfolded protein response,2,0,,,53.94,7.48,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,,44.56,,53.84,23.49,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8WXA9,SREK1,Splicing regulatory glutamine/lysine-rich protein 1 OS=Homo sapiens OX=9606 GN=SREK1 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,9.37E+04,,,,1,,,,,,,9.37E+04,,,,,,,,,,,,,,,,,,,,9.37E+04,,,,,,,,,,,,,,,,,0.001,FALSE,4.097,4,1,508,59.3,10.39,1,RNA metabolism OR transcription;other metabolic processes,nucleus,Pf00076,140890,A4FTW3; hsa:140890; Q2M1J0; Q86X37; Q8WXA9,ENSG00000153914,,mRNA processing,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,0,,0,
Master Protein,High,G5E9W9,GIMAP4,"GTPase, IMAP family member 4 OS=Homo sapiens OX=9606 GN=GIMAP4 PE=1 SV=1",3,5,100,1.466,100,0.559,6.64,0.55,6.64,-0.84,1.00E-17,3.30E-01,1.00E-17,7.74E-01,1.99E+04,,5.65E+05,9.60E+05,1,,1,1,,,,1.99E+04,,,,,,,,,,5.65E+05,,,9.60E+05,,,,,,,1.99E+04,,,,,,,,,,7.62E+04,,,2.70E+05,,,,0,FALSE,10.56,17,3,343,39,8.1,3,,cytosol;other cell component,Pf04548,,G5E9W9,ENSG00000133574,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,0,,0,17.39,other molecular function,0,
Master Protein,High,Q02127,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial OS=Homo sapiens OX=9606 GN=DHODH PE=1 SV=3",4,4,100,0.304,,100,6.64,-1.72,,6.64,1.00E-17,3.17E-01,,1.00E-17,4.31E+05,,3.40E+04,,1,,5,,,,,4.31E+05,,,,,,,6.22E+04,2.19E+04,3.40E+04,4.97E+04,1.83E+04,,,,,,,,,4.31E+05,,,,,,,3.72E+02,9.77E+02,2.76E+02,6.70E+03,4.54E+02,,,,,,0,FALSE,15.538,18,4,395,42.8,9.67,4,other metabolic processes,other membranes;cytosol;mitochondrion;nucleus,Pf01180,1723,A8K8C8; hsa:1723; Q02127; Q6P176,ENSG00000102967,Pyrimidine biosynthesis,Pyrimidine metabolism,2,0,,,50.06,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,Phospho [S336],FALSE,,67.35,,,11.89,other molecular function,1,Phospho [S336]
Master Protein,Medium,Q13105,ZBTB17,Zinc finger and BTB domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ZBTB17 PE=1 SV=3,1,2,100,0.988,,100,6.64,-0.02,,6.64,1.00E-17,7.07E-01,,1.00E-17,1.23E+05,,1.22E+05,,1,,1,,,,,1.23E+05,,,,,,,,,,1.22E+05,,,,,,,,,,1.23E+05,,,,,,,,,,1.64E+04,,,,,,,0.011,FALSE,2.255,2,1,803,87.9,6.44,1,cell cycle OR cell proliferation;developmental processes;other biological processes,nucleus;other cell component,"Pf00096, Pf00651, Pf13894",7709,A0AV07; B4DXB4; B7ZLQ9; F5H411; hsa:7709; Q13105; Q15932; Q5JYB2; Q9NUC9,ENSG00000116809,XBP1(S) activates chaperone genes,Cell cycle; Small cell lung cancer,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,Acetyl [N-Term],FALSE,,0,,,5.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8IXM2,BAP18,Chromatin complexes subunit BAP18 OS=Homo sapiens OX=9606 GN=BAP18 PE=1 SV=1,3,7,100,0.684,100,1.009,6.64,-0.55,6.64,0.01,1.00E-17,9.49E-01,1.00E-17,8.22E-01,1.66E+06,,1.01E+06,6.44E+05,2,,3,3,,,,1.55E+06,1.78E+06,,,,,,,6.51E+05,,1.82E+06,1.01E+06,,1.79E+05,,6.44E+05,1.22E+06,,,,1.55E+06,9.17E+04,,,,,,,2.91E+04,,2.45E+05,2.50E+04,,5.02E+04,,1.51E+04,1.30E+04,0,FALSE,12.832,26,3,172,17.9,7.33,3,cell organization and biogenesis,cytosol;nucleus,,124944,B4DIV3; C9J4G0; E9PB29; hsa:124944; Q8IXM2,ENSG00000258315,,,0,0,9.44,,51.7,76.74,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,,64.8,,69.15,21.87,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H6W3,RIOX1,Ribosomal oxygenase 1 OS=Homo sapiens OX=9606 GN=RIOX1 PE=1 SV=2,1,1,100,0.474,100,1.804,6.64,-1.08,6.64,0.85,1.00E-17,7.04E-01,1.00E-17,5.36E-01,6.49E+04,,3.07E+04,1.70E+04,1,,1,1,,,,6.49E+04,,,,,,,,,,3.07E+04,,,,,1.70E+04,,,,,6.49E+04,,,,,,,,,,4.14E+03,,,,,3.99E+02,,0.001,FALSE,3.404,2,1,641,71,6.46,1,cell organization and biogenesis;other biological processes,nucleus,"Pf08007, Pf21233",79697,B4DT02; hsa:79697; Q9H6W3,ENSG00000170468,Protein hydroxylation,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,0,,0,3.34,other molecular function,0,
Master Protein,High,Q96F86,EDC3,Enhancer of mRNA-decapping protein 3 OS=Homo sapiens OX=9606 GN=EDC3 PE=1 SV=1,2,2,100,0.249,,100,6.64,-2.01,,6.64,1.00E-17,2.37E-01,,1.00E-17,1.74E+05,,4.33E+04,,1,,1,,,,,1.74E+05,,,,,,,,4.33E+04,,,,,,,,,,,,1.74E+05,,,,,,,,1.93E+03,,,,,,,,,0,FALSE,7.637,8,2,508,56,7.11,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;other cell component,"Pf03853, Pf09532, Pf12701, Pf16598",80153,B3KPH0; D3DW61; hsa:80153; Q96F86; Q9H797,ENSG00000179151,mRNA decay by 5' to 3' exoribonuclease,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,7.13,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O00151,PDLIM1,PDZ and LIM domain protein 1 OS=Homo sapiens OX=9606 GN=PDLIM1 PE=1 SV=4,1,2,100,1.961,100,0.663,6.64,0.97,6.64,-0.59,1.00E-17,1.97E-01,1.00E-17,8.37E-01,1.61E+05,,3.16E+05,4.77E+05,1,,2,2,,1.61E+05,,,,,,,,,,,,5.19E+05,1.93E+05,,3.63E+05,,6.25E+05,,,6.12E+02,,,,,,,,,,,,7.00E+04,4.78E+03,,1.02E+05,,1.46E+04,,0.001,FALSE,3.234,4,1,329,36,7.02,1,cell organization and biogenesis;stress response;developmental processes;other biological processes,cytoskeleton;other cell component,"Pf00412, Pf00595, Pf15936",9124,B2RBS6; hsa:9124; O00151; Q5VZH5; Q9BPZ9,ENSG00000107438,,,0,0,,,64.92,37.54,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,76.6,,58.37,5.53,cytoskeletal activity;other molecular function,0,
Master Protein,High,O95487,SEC24B,Protein transport protein Sec24B OS=Homo sapiens OX=9606 GN=SEC24B PE=1 SV=2,3,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.48E+04,,,,1,,,,,,,3.48E+04,,,,,,,,,,,,,,,,,,,,3.48E+04,,,,,,,,,,,,,,,,,0,FALSE,7.669,4,3,1268,137.3,6.67,3,cell organization and biogenesis;transport;developmental processes;other biological processes,other membranes;cytosol;ER/Golgi,"Pf00626, Pf04810, Pf04811, Pf04815, Pf08033",10427,B7ZKM8; B7ZKN4; hsa:10427; O95487; Q0VG08,ENSG00000138802,"MHC class II antigen presentation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; COPII-mediated vesicle transport; Cargo concentration in the ER; Regulation of cholesterol biosynthesis by SREBP (SREBF); Antigen Presentation: Folding, assembly and peptide loading of class I MHC",Sterol regulatory element-binding proteins (SREBP) signaling,7,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,9.17,other molecular function,0,
Master Protein,High,Q8N5M1,ATPAF2,ATP synthase mitochondrial F1 complex assembly factor 2 OS=Homo sapiens OX=9606 GN=ATPAF2 PE=1 SV=1,1,1,100,0.886,,100,6.64,-0.18,,6.64,1.00E-17,7.98E-01,,1.00E-17,9.92E+04,,8.78E+04,,1,,3,,,,,9.92E+04,,,,,,,,4.50E+04,,1.04E+05,8.78E+04,,,,,,,,,9.92E+04,,,,,,,,2.01E+03,,1.40E+04,2.18E+03,,,,,,0,FALSE,4.273,6,1,289,32.8,7.09,1,cell organization and biogenesis,cytosol;mitochondrion;nucleus,Pf07542,91647,A6NDE5; A8K2J2; hsa:91647; Q6XYC7; Q8N5M1,ENSG00000171953,,7q11.23 copy number variation syndrome; Smith-Magenis and Potocki-Lupski syndrome copy number variation,2,0,,,38.63,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,23.15,,,3.38,,0,
Master Protein,High,Q9BV23,ABHD6,Monoacylglycerol lipase ABHD6 OS=Homo sapiens OX=9606 GN=ABHD6 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,9.38E+04,,,,1,,,,,,,9.38E+04,,,,,,,,,,,,,,,,,,,,9.38E+04,,,,,,,,,,,,,,,,,0,FALSE,6.197,4,1,337,38.3,8.41,1,other metabolic processes;other biological processes,plasma membrane;other membranes;mitochondrion;other cytoplasmic organelle;other cell component,Pf00561,57406,B2R7Y9; hsa:57406; Q6ZMF7; Q9BV23,ENSG00000163686,Arachidonate production from DAG,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.64,other molecular function,0,
Master Protein,High,G3V3D1,NPC2,NPC intracellular cholesterol transporter 2 (Fragment) OS=Homo sapiens OX=9606 GN=NPC2 PE=1 SV=1,1,2,100,18.752,100,0.544,6.64,4.23,6.64,-0.88,1.00E-17,7.30E-08,1.00E-17,6.91E-01,1.30E+05,,1.72E+06,1.67E+06,1,,2,1,,,,1.30E+05,,,,,,,,,,3.37E+06,8.76E+05,,,,1.67E+06,,,,,1.30E+05,,,,,,,,,,4.54E+05,2.18E+04,,,,3.90E+04,,0,FALSE,7.176,10,1,221,23.7,6.73,1,transport,non-structural extracellular,Pf02221,,G3V3D1,ENSG00000119655,,TYROBP causal network in microglia; Ebola virus infection in host; Cholesterol metabolism; Fatty acids and lipoproteins transport in hepatocytes,4,0,,,83.01,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,0,,4.89,6.66,other molecular function,0,
Master Protein,High,P41240,CSK,Tyrosine-protein kinase CSK OS=Homo sapiens OX=9606 GN=CSK PE=1 SV=1,2,2,100,0.769,100,0.281,6.64,-0.38,6.64,-1.83,1.00E-17,8.83E-01,1.00E-17,3.94E-01,4.27E+04,,3.28E+04,1.17E+05,4,,1,2,,1.03E+05,2.91E+04,5.25E+04,3.47E+04,,,,,,,,,3.28E+04,,,,8.32E+04,,1.64E+05,,3.92E+02,2.84E+02,5.25E+04,1.79E+03,,,,,,,,,4.42E+03,,,,5.89E+02,,1.74E+03,0,FALSE,4.363,6,2,450,50.7,7.06,2,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf00017, Pf00018, Pf07714",1445,P41240; Q2M3N2; Q6FGZ6,ENSG00000103653,Phosphorylation of CD3 and TCR zeta chains; PD-1 signaling; Signaling by BRAF and RAF1 fusions; Negative regulation of FLT3; GAB1 signalosome; Integrin signaling; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; RHOH GTPase cycle; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants,Integrin-mediated cell adhesion; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; EGF/EGFR signaling pathway; Regulation of actin cytoskeleton,18,0,61.5,,,46.08,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,40.57,,51.1,6.18,kinase activity;other molecular function,0,
Master Protein,High,Q15853,USF2,Upstream stimulatory factor 2 OS=Homo sapiens OX=9606 GN=USF2 PE=1 SV=1,3,3,100,0.676,100,1.249,6.64,-0.57,6.64,0.32,1.00E-17,9.67E-01,1.00E-17,7.06E-01,1.99E+05,,8.52E+04,4.61E+04,2,,4,2,1.85E+05,,,2.14E+05,,,,,,,,8.46E+04,4.62E+04,2.31E+05,8.58E+04,,3.09E+04,,6.87E+04,,7.37E+02,,,2.14E+05,,,,,,,,3.78E+03,3.75E+02,3.11E+04,2.13E+03,,8.67E+03,,1.61E+03,,0,FALSE,13.327,12,2,346,36.9,5.1,3,transport;other biological processes,nucleus;other cell component,Pf00010,7392,hsa:7392; O00671; O00709; Q05750; Q07952; Q15851; Q15852; Q15853; Q6FI33; Q6YI47,ENSG00000105698,Estrogen-dependent gene expression,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),2,0,10.19,,72.76,53.78,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,25.2,,50.21,10.95,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P15880,RPS2,40S ribosomal protein S2 OS=Homo sapiens OX=9606 GN=RPS2 PE=1 SV=2,8,26,100,0.688,100,0.718,6.64,-0.54,6.64,-0.48,1.00E-17,9.48E-01,1.00E-17,9.49E-01,8.77E+05,,6.87E+05,5.84E+05,5,,5,5,6.58E+05,2.11E+06,8.77E+05,2.31E+06,5.70E+05,,,,,,1.06E+07,6.87E+05,1.98E+05,1.27E+06,5.00E+05,4.38E+06,5.84E+05,4.65E+05,7.35E+04,6.08E+05,2.62E+03,8.00E+03,8.57E+03,2.31E+06,2.94E+04,,,,,,6.33E+04,3.07E+04,1.61E+03,1.71E+05,1.24E+04,8.54E+03,1.64E+05,3.30E+03,1.72E+03,6.47E+03,0,FALSE,28.951,31,8,293,31.3,10.24,8,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,"Pf00333, Pf03719",6187,B2R5G0; D3DU82; hsa:6187; P15880; Q3MIB1,ENSG00000140988; ENSG00000291931,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; RMTs methylate histone arginines; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Protein methylation; SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,22,0,64.05,,168.29,145.52,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,102.79,,118.46,70.02,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O00487,PSMD14,26S proteasome non-ATPase regulatory subunit 14 OS=Homo sapiens OX=9606 GN=PSMD14 PE=1 SV=1,2,4,100,0.251,100,0.383,6.64,-2,6.64,-1.39,1.00E-17,2.24E-01,1.00E-17,5.51E-01,2.33E+05,,5.85E+04,1.72E+05,2,,2,2,,,,1.00E+05,5.43E+05,,,,,,,3.04E+04,,1.12E+05,,,8.27E+05,,3.58E+04,,,,,1.00E+05,2.80E+04,,,,,,,1.36E+03,,1.51E+04,,,2.32E+05,,8.37E+02,,0,FALSE,8.449,10,2,310,34.6,6.52,2,protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,Pf01398,10213,B3KNW2; hsa:10213; O00176; O00487,ENSG00000115233,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Metalloprotease DUBs,Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,64,0,97.37,,81.2,129.7,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,73.21,,155.66,13.22,enzyme regulator activity;other molecular function,0,
Master Protein,High,P15918,RAG1,V(D)J recombination-activating protein 1 OS=Homo sapiens OX=9606 GN=RAG1 PE=1 SV=2,3,3,100,0.412,100,1.285,6.64,-1.28,6.64,0.36,1.00E-17,5.61E-01,1.00E-17,6.82E-01,1.15E+05,,4.74E+04,3.69E+04,1,,2,1,,,,1.15E+05,,,,,,,,,,1.00E+05,2.24E+04,,3.69E+04,,,,,,,1.15E+05,,,,,,,,,,1.35E+04,5.57E+02,,1.04E+04,,,,0,FALSE,13.258,4,3,1043,119,8.68,3,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,"Pf00097, Pf10426, Pf12560, Pf12940",5896,E9PPC4; P15918; Q8IY72; Q8NER2,ENSG00000166349,MAPK6/MAPK4 signaling; Interleukin-7 signaling,Male infertility,3,0,,,89.69,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,121.6,,121.6,9.57,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q6B0K9,HBM,Hemoglobin subunit mu OS=Homo sapiens OX=9606 GN=HBM PE=1 SV=1,3,7,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.32E+06,,,7.36E+06,3,,,1,1.95E+06,1.32E+06,4.54E+05,,,,,,,,,,,,,,7.36E+06,,,,7.75E+03,5.00E+03,4.44E+03,,,,,,,,,,,,,,2.07E+06,,,,0,FALSE,19.398,39,3,141,15.6,6.62,3,other metabolic processes;transport;other biological processes,cytosol;other cell component,Pf00042,3042,hsa:3042; Q6B0K9,ENSG00000206177,,,0,0,60.55,,,,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,1,,FALSE,,,,,19.41,other molecular function,0,
Master Protein,High,Q8IYB8,SUPV3L1,"ATP-dependent RNA helicase SUPV3L1, mitochondrial OS=Homo sapiens OX=9606 GN=SUPV3L1 PE=1 SV=1",3,4,100,1.975,100,,6.64,0.98,6.64,,1.00E-17,1.88E-01,1.00E-17,,2.37E+05,,1.56E+05,8.99E+04,1,,2,1,,,,2.37E+05,,,,,,,,,,1.62E+05,1.50E+05,,8.99E+04,,,,,,,2.37E+05,,,,,,,,,,2.18E+04,3.73E+03,,2.53E+04,,,,0,FALSE,14.076,7,3,786,87.9,7.99,3,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,mitochondrion;nucleus;other cytoplasmic organelle,"Pf00271, Pf12513, Pf18114, Pf18147",6832,A8K301; hsa:6832; O43630; Q8IYB8,ENSG00000156502,Mitochondrial RNA degradation,,1,0,,,5.18,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,5.43,,,11.08,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O15027,SEC16A,Protein transport protein Sec16A OS=Homo sapiens OX=9606 GN=SEC16A PE=1 SV=4,3,3,100,0.22,,100,6.64,-2.19,,6.64,1.00E-17,2.07E-01,,1.00E-17,1.67E+05,,3.66E+04,,1,,1,,,,,1.67E+05,,,,,,,,3.66E+04,,,,,,,,,,,,1.67E+05,,,,,,,,1.64E+03,,,,,,,,,0,FALSE,7.395,2,3,2357,251.7,5.8,3,cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes,other membranes;cytosol;ER/Golgi;other cell component,"Pf12931, Pf12932",9919,A1YCA4; hsa:9919; J3KNL6; O15027; Q4G0D7; Q5SXP0; Q5SXP1; Q8N347; Q96HP1,ENSG00000148396,COPII-mediated vesicle transport,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.39,,0,
Master Protein,High,Q9NYI0,PSD3,PH and SEC7 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=PSD3 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,9.53E+04,,,,1,,,,,,,9.53E+04,,,,,,,,,,,,,,,,,,,,9.53E+04,,,,,,,,,,,,,,,,,0,FALSE,7.777,2,1,1048,116,5.99,1,other biological processes,plasma membrane;other membranes;other cell component,"Pf01369, Pf15410",23362,A6NFQ4; E9KL50; hsa:23362; Q6B003; Q9NYI0; Q9Y2F1,ENSG00000156011,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.4,enzyme regulator activity,0,
Master Protein,High,Q13162,PRDX4,Peroxiredoxin-4 OS=Homo sapiens OX=9606 GN=PRDX4 PE=1 SV=1,5,47,100,0.606,100,1.024,6.64,-0.72,6.64,0.03,1.00E-17,8.92E-01,1.00E-17,8.44E-01,6.00E+05,,5.85E+05,5.31E+05,1,,4,2,,,,6.00E+05,,,,,,,,1.26E+05,3.16E+05,1.08E+06,1.12E+06,,1.86E+06,,1.52E+05,,,,,6.00E+05,,,,,,,,5.62E+03,2.57E+03,1.46E+05,2.79E+04,,5.22E+05,,3.55E+03,,0,FALSE,26.557,24,3,271,30.5,6.29,5,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;cytosol;ER/Golgi;other cell component,"Pf00578, Pf10417",10549,hsa:10549; Q13162; Q6FHT3,ENSG00000123131,Neutrophil degranulation,Selenium micronutrient network,2,0,,,77.88,120.09,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,114.06,,108.01,114.85,other molecular function,0,
Master Protein,High,Q5VV89,MGST3,Microsomal glutathione S-transferase 3 OS=Homo sapiens OX=9606 GN=MGST3 PE=1 SV=1,2,3,100,2.023,100,0.314,6.64,1.02,6.64,-1.67,1.00E-17,1.76E-01,1.00E-17,4.19E-01,1.09E+05,,4.14E+05,1.36E+06,2,,2,2,,,,2.04E+05,5.81E+04,,,,,,,,,7.06E+05,2.42E+05,,1.14E+06,,1.64E+06,,,,,2.04E+05,3.00E+03,,,,,,,,,9.51E+04,6.02E+03,,3.20E+05,,3.83E+04,,0,FALSE,5.079,17,2,166,18.4,9.96,2,,other membranes,Pf01124,,Q5VV89,ENSG00000143198,,Nuclear receptors meta-pathway; NRF2 pathway; Metapathway biotransformation Phase I and II,3,0,78.82,,69.17,25.38,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,High,n/a,1,,FALSE,,83.13,,66.98,8.72,,0,
Master Protein,High,C9JJ19,MRPS34,Mitochondrial ribosomal protein S34 OS=Homo sapiens OX=9606 GN=MRPS34 PE=1 SV=2,1,1,100,0.498,,100,6.64,-1.01,,6.64,1.00E-17,7.11E-01,,1.00E-17,8.35E+04,,5.11E+04,,2,,3,,,,,1.66E+05,4.18E+04,,,,,,5.82E+04,5.11E+04,,,2.96E+04,,,,,,,,,1.66E+05,2.16E+03,,,,,,3.48E+02,2.28E+03,,,7.37E+02,,,,,,0.009,FALSE,2.301,4,1,225,26.3,9.89,1,,mitochondrion,Pf16053,65993,C9JJ19,ENSG00000074071,,,0,0,84.61,,32.08,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,89.96,,,2.11,other molecular function,0,
Master Protein,High,Q9Y2Z0,SUGT1,Protein SGT1 homolog OS=Homo sapiens OX=9606 GN=SUGT1 PE=1 SV=3,3,7,100,2.502,100,0.412,6.64,1.32,6.64,-1.28,1.00E-17,1.78E-01,1.00E-17,5.91E-01,6.78E+04,,1.18E+05,1.11E+05,1,,4,5,,,,6.78E+04,,,,,,,1.09E+05,,3.37E+04,3.27E+05,1.27E+05,2.61E+05,7.51E+04,6.46E+04,1.11E+05,1.47E+05,,,,6.78E+04,,,,,,,6.53E+02,,2.73E+02,4.41E+04,3.15E+03,5.09E+02,2.11E+04,4.58E+02,2.59E+03,1.56E+03,0,FALSE,9.236,12,3,365,41,5.16,3,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,"Pf04969, Pf05002",10910,A2A303; hsa:10910; Q5JAK5; Q5TAM6; Q6VXY6; Q9Y2Z0,ENSG00000165416,The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection,Nucleotide-binding oligomerization domain (NOD) pathway,3,0,,,84.01,60.21,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,,69.94,,84.1,20.68,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P04150,NR3C1,Glucocorticoid receptor OS=Homo sapiens OX=9606 GN=NR3C1 PE=1 SV=1,3,5,100,0.652,,100,6.64,-0.62,,6.64,1.00E-17,9.49E-01,,1.00E-17,7.70E+04,,5.02E+04,,2,,4,,,,,8.09E+04,7.33E+04,,,,,,8.30E+04,3.92E+04,,6.44E+04,3.38E+04,,,,,,,,,8.09E+04,3.78E+03,,,,,,4.96E+02,1.75E+03,,8.68E+03,8.39E+02,,,,,,0,FALSE,12.976,7,3,777,85.6,6.38,3,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component,"Pf00104, Pf00105, Pf02155",2908,A0ZXF9; B0LPG8; D3DQF4; F5ATB7; hsa:2908; P04150; P04151; Q53EP5; Q6N0A4,ENSG00000113580,"Potential therapeutics for SARS; Regulation of RUNX2 expression and activity; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Circadian Clock; SUMOylation of intracellular receptors; PTK6 Expression; Regulation of NPAS4 gene transcription",Nuclear receptors; Adipogenesis; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Endoderm differentiation; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; Transcription factor regulation in adipogenesis; White fat cell differentiation; Vitamin D in inflammatory diseases; 16p11.2 proximal deletion syndrome; HDAC6 interactions in the central nervous system; Sudden infant death syndrome (SIDS) susceptibility pathways; Serotonin receptor 4/6/7 and NR3C signaling,21,0,6.97,,41.57,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,52.71,,,15.49,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,O15162,PLSCR1,Phospholipid scramblase 1 OS=Homo sapiens OX=9606 GN=PLSCR1 PE=1 SV=1,1,1,100,0.762,100,1.315,6.64,-0.39,6.64,0.39,1.00E-17,9.40E-01,1.00E-17,6.04E-01,4.48E+05,,3.41E+05,2.59E+05,1,,4,1,,4.48E+05,,,,,,,,,9.93E+05,,4.17E+05,6.65E+04,2.79E+05,,,,2.59E+05,,,1.70E+03,,,,,,,,,5.94E+03,,3.39E+03,8.96E+03,6.93E+03,,,,6.07E+03,,0.015,FALSE,2.127,6,1,318,35,4.94,1,cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes,extracellular matrix;plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,Pf03803,5359,B2R8H8; B4DTE8; hsa:5359; O15162,ENSG00000188313,,EGF/EGFR signaling pathway; Complement system in neuronal development and plasticity,2,0,,,90.36,,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,65.24,,76.25,2.79,signal transduction activity or receptor binding;transporter activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q6Y288,B3GLCT,"Beta-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=B3GLCT PE=1 SV=2",2,2,100,0.05,,100,6.64,-4.32,,6.64,1.00E-17,6.58E-03,,1.00E-17,1.24E+05,,4.24E+03,,1,,1,,,,,1.24E+05,,,,,,,,,,4.24E+03,,,,,,,,,,1.24E+05,,,,,,,,,,5.72E+02,,,,,,,0,FALSE,11.421,8,2,498,56.5,7.5,2,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf02434,145173,A8K5F8; hsa:145173; Q5W0H2; Q6NUI3; Q6Y288,ENSG00000187676,Defective B3GALTL causes PpS; O-glycosylation of TSR domain-containing proteins,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,6.29,other molecular function,0,
Master Protein,High,A0A499FI31,SART3,"Spliceosome associated factor 3, U4/U6 recycling protein OS=Homo sapiens OX=9606 GN=SART3 PE=1 SV=1",5,10,100,0.333,,100,6.64,-1.59,,6.64,1.00E-17,3.48E-01,,1.00E-17,1.02E+06,,3.58E+05,,2,,1,,,,,7.41E+05,1.41E+06,,,,,,,,,3.58E+05,,,,,,,,,,7.41E+05,7.30E+04,,,,,,,,,4.82E+04,,,,,,,0,FALSE,32.944,11,5,981,111.9,5.5,5,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00076, Pf05391, Pf16605",,A0A499FI31,ENSG00000075856,,,0,0,44.17,,,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,66.18,,,37.08,nucleic acid binding activity,0,
Master Protein,High,P13727,PRG2,Bone marrow proteoglycan OS=Homo sapiens OX=9606 GN=PRG2 PE=1 SV=2,3,4,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,7.24E+06,,,,1,,,,,7.24E+06,,,,,,,,,,,,,,,,,,,,2.75E+04,,,,,,,,,,,,,,,,,,,0,FALSE,8.952,17,3,222,25.2,6.76,3,stress response;other biological processes,non-structural extracellular;ER/Golgi;other cell component,Pf00059,5553,A6XMW0; B2R5I1; hsa:5553; P13727; P81448; Q14227; Q6ICT2,ENSG00000186652,Neutrophil degranulation,,1,0,,,,,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,7.84,other molecular function,0,
Master Protein,High,V9GYT7,PSIP1,PC4 and SFRS1 interacting protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=PSIP1 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.12E+05,,,,2,,,,,,,6.48E+04,1.95E+05,,,,,,,,,,,,,,,,,,,6.48E+04,1.01E+04,,,,,,,,,,,,,,,,0,FALSE,4.883,26,1,65,7.8,7.52,1,,,,,V9GYT7,ENSG00000164985,,MECP2 and associated Rett syndrome,1,0,70.96,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4,,0,
Master Protein,High,Q9UIV1,CNOT7,CCR4-NOT transcription complex subunit 7 OS=Homo sapiens OX=9606 GN=CNOT7 PE=1 SV=3,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.05E+04,,,,1,,,,,,,2.05E+04,,,,,,,,,,,,,,,,,,,,2.05E+04,,,,,,,,,,,,,,,,,0,FALSE,5.554,7,1,285,32.7,4.84,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,Pf04857,29883,A8MZM5; B3KMP1; B3KN35; D3DSP6; G3V108; hsa:29883; Q7Z530; Q9UIV1,ENSG00000198791,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain; M-decay: degradation of maternal mRNAs by maternally stored factors,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.54,nucleic acid binding activity;other molecular function,0,
Master Protein,High,E7EQY1,FAM136A,Protein FAM136A OS=Homo sapiens OX=9606 GN=FAM136A PE=1 SV=1,2,3,100,0.317,100,0.506,6.64,-1.66,6.64,-0.98,1.00E-17,3.62E-01,1.00E-17,7.05E-01,3.17E+05,,4.38E+04,1.00E+05,2,,3,2,,,,2.54E+05,3.97E+05,,,,,,4.38E+04,,1.99E+05,2.15E+04,,,5.15E+04,1.95E+05,,,,,,2.54E+05,2.05E+04,,,,,,2.62E+02,,1.62E+03,2.90E+03,,,1.45E+04,1.38E+03,,,0,FALSE,4.532,8,2,245,26.8,8.24,2,,,Pf05811,84908,E7EQY1,ENSG00000035141,,,0,0,31.08,,109.71,82.23,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,75.53,,87.98,7.76,,0,
Master Protein,High,P62495,ETF1,Eukaryotic peptide chain release factor subunit 1 OS=Homo sapiens OX=9606 GN=ETF1 PE=1 SV=3,3,4,100,3.911,100,2.165,6.64,1.97,6.64,1.11,1.00E-17,5.61E-02,1.00E-17,4.07E-01,4.08E+04,,1.59E+05,7.36E+04,2,,2,2,,,1.21E+05,1.38E+04,,,,,,,,,,1.26E+05,2.02E+05,,2.55E+05,,2.13E+04,,,,1.18E+03,1.38E+04,,,,,,,,,,1.69E+04,5.03E+03,,7.15E+04,,4.98E+02,,0,FALSE,8.287,8,3,437,49,5.71,3,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,"Pf03463, Pf03464, Pf03465",2107,B2R6B4; D3DQC1; hsa:2107; P46055; P62495; Q5M7Z7; Q96CG1,ENSG00000120705,Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Protein hydroxylation,Translation factors,6,0,112.37,,33.14,119.59,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,152.83,,185.02,13.71,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BWS9,CHID1,Chitinase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CHID1 PE=1 SV=1,3,6,100,0.358,100,0.954,6.64,-1.48,6.64,-0.07,1.00E-17,4.39E-01,1.00E-17,8.99E-01,3.42E+05,,1.15E+05,5.33E+05,4,,4,5,,2.79E+06,3.44E+04,8.05E+04,1.45E+06,,,,,,3.31E+04,3.76E+04,,1.96E+06,3.50E+05,1.06E+06,5.33E+05,3.46E+05,9.42E+05,1.26E+05,,1.06E+04,3.36E+02,8.05E+04,7.49E+04,,,,,,1.98E+02,1.68E+03,,2.64E+05,8.71E+03,2.06E+03,1.50E+05,2.45E+03,2.20E+04,1.34E+03,0,FALSE,8.893,11,3,393,44.9,8.63,3,other metabolic processes;stress response;other biological processes,non-structural extracellular;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00704,66005,B3KWB0; hsa:66005; Q8NBM9; Q96CZ3; Q96S93; Q96SK0; Q9BWS9; Q9BY52,ENSG00000177830,Platelet degranulation,,1,0,120.32,,154.8,65.57,n/a,High,Peak Found,High,High,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,83.46,,137.15,16.2,other molecular function,0,
Master Protein,High,Q9NPI1,BRD7,Bromodomain-containing protein 7 OS=Homo sapiens OX=9606 GN=BRD7 PE=1 SV=1,3,4,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.81E+05,,,,1,,,,,,,2.81E+05,,,,,,,,,,,,,,,,,,,,2.81E+05,,,,,,,,,,,,,,,,,0,FALSE,14.435,9,3,651,74.1,6.39,3,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00439, Pf12024",29117,hsa:29117; Q4VC09; Q8N2L9; Q96KA4; Q9BV48; Q9NPI1; Q9UH59,ENSG00000166164,Regulation of TP53 Activity through Acetylation,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,11.02,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A7P0Z472,ADSL,Adenylosuccinate lyase OS=Homo sapiens OX=9606 GN=ADSL PE=1 SV=1,2,2,100,1.527,100,,6.64,0.61,6.64,,1.00E-17,3.96E-01,1.00E-17,,1.54E+04,,2.35E+04,8.91E+05,1,,1,1,,,,1.54E+04,,,,,,,,2.35E+04,,,,,8.91E+05,,,,,,,1.54E+04,,,,,,,,1.05E+03,,,,,2.50E+05,,,,0,FALSE,10.165,8,2,526,59.3,7.09,2,other metabolic processes,cytosol,"Pf00206, Pf10397",,A0A7P0Z472,ENSG00000239900,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,,6.05,other molecular function,0,
Master Protein,High,Q9H4A3,WNK1,Serine/threonine-protein kinase WNK1 OS=Homo sapiens OX=9606 GN=WNK1 PE=1 SV=2,2,2,100,0.389,100,0.109,6.64,-1.36,6.64,-3.2,1.00E-17,5.63E-01,1.00E-17,7.48E-02,6.64E+04,,2.58E+04,3.97E+05,2,,4,3,,9.37E+04,,,4.71E+04,,,,,,4.07E+04,,3.28E+04,1.01E+04,2.03E+04,2.32E+05,6.05E+05,,,3.97E+05,,3.56E+02,,,2.43E+03,,,,,,2.43E+02,,2.67E+02,1.36E+03,5.04E+02,4.53E+02,1.70E+05,,,4.22E+03,0,FALSE,4.372,1,2,2382,250.6,6.34,2,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00069, Pf12202",65125,A1L4B0; C5HTZ5; C5HTZ6; C5HTZ7; H6WZW3; hsa:65125; O15052; P54963; Q4VBX9; Q6IFS5; Q86WL5; Q8N673; Q96CZ6; Q9H4A3; Q9P1S9,ENSG00000060237,Stimuli-sensing channels,Ciliary landscape,2,0,46.89,,52.05,45.45,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,,73.69,,67.41,5.76,enzyme regulator activity;kinase activity;other molecular function,0,
Master Protein,High,A0A3B3ISG5,IDE,Insulin degrading enzyme OS=Homo sapiens OX=9606 GN=IDE PE=1 SV=1,1,2,100,9.072,100,0.345,6.64,3.18,6.64,-1.53,1.00E-17,6.57E-03,1.00E-17,4.94E-01,5.47E+03,,4.96E+04,1.49E+05,1,,4,2,,,,5.47E+03,,,,,,,,2.30E+04,9.18E+04,1.47E+05,2.68E+04,,3.08E+05,7.19E+04,,,,,,5.47E+03,,,,,,,,1.03E+03,7.46E+02,1.98E+04,6.66E+02,,8.67E+04,5.10E+02,,,0.005,FALSE,2.532,1,1,1019,117.9,6.92,1,protein metabolism,mitochondrion,"Pf00675, Pf05193, Pf16187",3416,A0A3B3ISG5,ENSG00000119912,,Alzheimer's disease and miRNA effects; Alzheimer's disease,2,0,,,81.82,87.94,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,102.9,,74.52,5.6,other molecular function,0,
Master Protein,High,Q15526,SURF1,Surfeit locus protein 1 OS=Homo sapiens OX=9606 GN=SURF1 PE=1 SV=1,1,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.98E+05,,,,1,,,,,,,1.98E+05,,,,,,,,,,,,,,,,,,,,1.98E+05,,,,,,,,,,,,,,,,,0.007,FALSE,2.39,3,1,300,33.3,9.6,1,cell organization and biogenesis;other metabolic processes;transport,other membranes;mitochondrion,Pf02104,6834,hsa:6834; Q15526; Q5T8T3; Q5T8T4,ENSG00000148290; ENSG00000280627,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,Electron transport chain: OXPHOS system in mitochondria; Type II diabetes mellitus; Mitochondrial complex IV assembly,6,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.7,transporter activity,0,
Master Protein,High,O94973,AP2A2,AP-2 complex subunit alpha-2 OS=Homo sapiens OX=9606 GN=AP2A2 PE=1 SV=2,5,13,100,0.906,100,0.329,6.64,-0.14,6.64,-1.6,1.00E-17,7.66E-01,1.00E-17,4.78E-01,4.97E+04,,6.38E+04,1.94E+05,2,,5,1,,1.18E+05,,2.10E+04,,,,,,,1.73E+06,1.68E+04,6.38E+04,1.77E+04,1.15E+05,,1.94E+05,,,,,4.48E+02,,2.10E+04,,,,,,,1.03E+04,7.52E+02,5.18E+02,2.38E+03,2.86E+03,,5.45E+04,,,,0,FALSE,16.412,6,1,939,103.9,6.96,5,transport,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,"Pf01602, Pf02296, Pf02883",161,hsa:161; O75403; O94973; Q53ET1; Q96SI8,ENSG00000183020,"Potential therapeutics for SARS; Recycling pathway of L1; MHC class II antigen presentation; Neutrophil degranulation; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Nef Mediated CD4 Down-regulation; Retrograde neurotrophin signalling; Nef Mediated CD8 Down-regulation; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation",Synaptic vesicle pathway; GABA receptor signaling; mBDNF and proBDNF regulation of GABA neurotransmission; Cell lineage map for neuronal differentiation,18,0,98.73,,193.18,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,113.93,,142.78,32.27,other molecular function,0,
Master Protein,High,Q96GQ5,RUSF1,RUS family member 1 OS=Homo sapiens OX=9606 GN=RUSF1 PE=1 SV=2,1,4,100,2.119,100,2.126,6.64,1.08,6.64,1.09,1.00E-17,7.41E-02,1.00E-17,3.88E-01,5.70E+05,,1.21E+06,5.68E+05,1,,1,1,,,,5.70E+05,,,,,,,,,,1.21E+06,,,5.68E+05,,,,,,,5.70E+05,,,,,,,,,,1.63E+05,,,1.60E+05,,,,0,FALSE,9.842,5,1,468,51,6.93,1,,,Pf04884,64755,hsa:64755; Q53GL8; Q8NAJ4; Q96GQ5; Q9BVY3; Q9H887,ENSG00000140688,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,0,18.27,,0,
Master Protein,High,A0A0A0MQR0,CYP4F2,Cytochrome P450 family 4 subfamily F member 2 OS=Homo sapiens OX=9606 GN=CYP4F2 PE=1 SV=1,1,1,100,1.407,100,0.112,6.64,0.49,6.64,-3.15,1.00E-17,4.73E-01,1.00E-17,4.57E-02,4.06E+04,,5.71E+04,5.09E+05,1,,2,1,,,,,4.06E+04,,,,,,,,,9.10E+04,3.59E+04,,,,5.09E+05,,,,,,2.09E+03,,,,,,,,,1.23E+04,8.91E+02,,,,1.19E+04,,0.006,FALSE,2.426,3,1,520,59.9,6.9,1,,,Pf00067,,A0A0A0MQR0,ENSG00000186115,,Oxidation by cytochrome P450; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; Eicosanoid metabolism via lipooxygenases (LOX); Metapathway biotransformation Phase I and II,5,0,,,61.46,,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,High,n/a,1,,FALSE,,71.54,,71.54,2.41,other molecular function,0,
Master Protein,High,J3KPH8,HDAC7,Histone deacetylase OS=Homo sapiens OX=9606 GN=HDAC7 PE=1 SV=1,1,1,100,0.411,,100,6.64,-1.28,,6.64,1.00E-17,5.97E-01,,1.00E-17,8.19E+04,,3.37E+04,,1,,2,,,,,8.19E+04,,,,,,,,2.33E+04,,4.87E+04,,,,,,,,,,8.19E+04,,,,,,,,1.04E+03,,6.56E+03,,,,,,,0.003,FALSE,2.761,2,1,1014,108.9,8.46,1,cell organization and biogenesis;other biological processes,cytosol;nucleus,Pf00850,,J3KPH8,ENSG00000061273,,Neural crest differentiation; Initiation of transcription and translation elongation at the HIV-1 LTR; Ethanol effects on histone modifications,3,0,,,49.89,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,55.9,,,2.03,other molecular function,0,
Master Protein,High,A0A994J6L2,MGA,MAX dimerization protein MGA OS=Homo sapiens OX=9606 GN=MGA PE=4 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.73E+04,,,,2,,,,,,,4.80E+04,1.55E+04,,,,,,,,,,,,,,,,,,,4.80E+04,8.00E+02,,,,,,,,,,,,,,,,0.001,FALSE,3.531,1,1,3114,341.2,7.08,1,other biological processes,nucleus,,,A0A994J6L2,ENSG00000174197,,Pathways affected in adenoid cystic carcinoma,1,0,72.31,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.07,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H6P5,TASP1,Threonine aspartase 1 OS=Homo sapiens OX=9606 GN=TASP1 PE=1 SV=1,2,2,100,0.348,,100,6.64,-1.52,,6.64,1.00E-17,4.11E-01,,1.00E-17,1.91E+05,,6.43E+04,,1,,5,,,,,1.91E+05,,,,,,,8.22E+04,6.43E+04,3.98E+04,2.64E+05,4.07E+04,,,,,,,,,1.91E+05,,,,,,,4.92E+02,2.87E+03,3.23E+02,3.56E+04,1.01E+03,,,,,,0,FALSE,5.419,6,2,420,44.4,7.75,2,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;other cell component,Pf01112,55617,B7Z690; B7Z963; hsa:55617; Q5TDU9; Q9BQN0; Q9H6P5; Q9NQ08; Q9NTS6; Q9NXJ2,ENSG00000089123,Formation of WDR5-containing histone-modifying complexes,,1,0,,,96.19,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,16.54,,,5.59,other molecular function,0,
Master Protein,High,Q9Y2Q0,ATP8A1,Phospholipid-transporting ATPase IA OS=Homo sapiens OX=9606 GN=ATP8A1 PE=1 SV=1,1,3,100,2.143,100,2.242,6.64,1.1,6.64,1.17,1.00E-17,2.39E-01,1.00E-17,3.99E-01,4.40E+04,,9.43E+04,4.39E+04,1,,4,2,,,,4.40E+04,,,,,,,,5.71E+04,8.10E+04,1.10E+05,1.70E+05,,8.15E+04,,2.36E+04,,,,,4.40E+04,,,,,,,,2.55E+03,6.58E+02,1.48E+04,4.21E+03,,2.29E+04,,5.52E+02,,0,FALSE,4.677,1,1,1164,131.3,6.84,1,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00122, Pf13246, Pf16209, Pf16212",10396,hsa:10396; Q32M35; Q32M36; Q4W5J7; Q4W5P2; Q9Y2Q0,ENSG00000124406,Neutrophil degranulation; Ion transport by P-type ATPases,Peptide GPCRs,3,0,,,46.49,77.91,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,41.35,,80.63,9.12,transporter activity;other molecular function,0,
Master Protein,High,Q9UBV2,SEL1L,Protein sel-1 homolog 1 OS=Homo sapiens OX=9606 GN=SEL1L PE=1 SV=3,2,3,100,11.276,100,7.002,6.64,3.5,6.64,2.81,1.00E-17,5.82E-04,1.00E-17,6.93E-02,2.68E+04,,3.02E+05,4.31E+04,1,,3,1,,,,2.68E+04,,,,,,,,,3.02E+05,5.54E+05,1.36E+05,,4.31E+04,,,,,,,2.68E+04,,,,,,,,,2.45E+03,7.47E+04,3.37E+03,,1.21E+04,,,,0,FALSE,15.207,5,2,794,88.7,5.39,2,protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,other membranes;ER/Golgi,"Pf00040, Pf08238",6400,hsa:6400; Q6UWT6; Q9P1T9; Q9UBV2; Q9UHK7,ENSG00000071537,ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis; ER Quality Control Compartment (ERQC); Pre-NOTCH Processing in Golgi,Familial  hyperlipidemia type 1; Familial hyperlipidemia type 4; Familial hyperlipidemia type 5,9,0,,,63.76,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,81.54,,81.54,11.16,,0,
Master Protein,High,Q9BUL8,PDCD10,Programmed cell death protein 10 OS=Homo sapiens OX=9606 GN=PDCD10 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.90E+05,,,,1,,,,,,,2.90E+05,,,,,,,,,,,,,,,,,,,,2.90E+05,,,,,,,,,,,,,,,,,0,FALSE,5.759,11,1,212,24.7,8.19,1,cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,"Pf06840, Pf20929",11235,A8K515; D3DNN5; hsa:11235; O14811; Q9BUL8,ENSG00000114209,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.32,other molecular function,0,
Master Protein,High,P84157,MXRA7,Matrix-remodeling-associated protein 7 OS=Homo sapiens OX=9606 GN=MXRA7 PE=1 SV=1,1,3,100,1.062,,100,6.64,0.09,,6.64,1.00E-17,5.85E-01,,1.00E-17,2.96E+05,,3.15E+05,,1,,3,,,,,2.96E+05,,,,,,,,3.15E+05,,1.41E+05,8.05E+05,,,,,,,,,2.96E+05,,,,,,,,1.41E+04,,1.91E+04,2.00E+04,,,,,,0,FALSE,7.494,14,1,204,21.5,4.26,1,,other membranes;ER/Golgi,,439921,hsa:439921; P84157; Q0P5W3,ENSG00000182534,,,0,0,,,81.84,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,81.66,,,8.45,,0,
Master Protein,High,A0A6Q8PFU3,PAFAH1B1,Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens OX=9606 GN=PAFAH1B1 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,4.50E+05,,,,2,,,,,5.44E+05,,,3.72E+05,,,,,,,,,,,,,,,,,2.07E+03,,,1.92E+04,,,,,,,,,,,,,,,,0.001,FALSE,3.308,3,1,428,48.7,7.06,1,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;other biological processes,other membranes;cytoskeleton;nucleus;other cell component,"Pf00400, Pf08513",5048,A0A6Q8PFU3,ENSG00000007168,,Wnt signaling pathway and pluripotency; Ciliary landscape; Neurogenesis regulation in the olfactory epithelium; PAFAH1B1 copy number variation,4,0,26.63,,,,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.1,other molecular function,0,
Master Protein,High,A0A7P0Z4K1,PNISR,PNN interacting serine and arginine rich protein OS=Homo sapiens OX=9606 GN=PNISR PE=1 SV=1,2,3,100,0.352,100,0.027,6.64,-1.51,6.64,-5.19,1.00E-17,4.57E-01,1.00E-17,2.84E-03,1.57E+05,,5.51E+04,2.01E+06,4,,1,1,1.38E+05,,6.27E+04,1.78E+05,1.12E+06,,,,,,,,,5.51E+04,,,,,,2.01E+06,5.48E+02,,6.13E+02,1.78E+05,5.79E+04,,,,,,,,,7.43E+03,,,,,,2.14E+04,0,FALSE,7.305,3,2,814,93.6,10.1,2,,plasma membrane;other membranes;cytosol;nucleus,Pf15996,25957,A0A7P0Z4K1,ENSG00000132424,,,0,0,133.34,,,,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,54.5,,0,9.43,,0,
Master Protein,High,E9PGZ4,SACM1L,SAC1 like phosphatidylinositide phosphatase OS=Homo sapiens OX=9606 GN=SACM1L PE=1 SV=1,6,17,100,2.104,100,8.491,6.64,1.07,6.64,3.09,1.00E-17,2.00E-01,1.00E-17,5.87E-02,9.28E+04,,1.75E+05,2.07E+04,3,,2,1,,,2.43E+04,9.28E+04,1.04E+05,,,,,,,,1.48E+05,2.07E+05,,,,,2.07E+04,,,,2.38E+02,9.28E+04,5.39E+03,,,,,,,,1.21E+03,2.79E+04,,,,,4.83E+02,,0,FALSE,17.643,14,1,484,55.5,7.2,6,other metabolic processes,other membranes,Pf02383,22908,E9PGZ4,ENSG00000211456,,,0,0,58.61,,23.34,,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,41.82,,24.81,35.28,other molecular function,0,
Master Protein,High,P82921,MRPS21,"28S ribosomal protein S21, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS21 PE=1 SV=3",1,1,100,0.715,,100,6.64,-0.48,,6.64,1.00E-17,9.67E-01,,1.00E-17,1.19E+05,,8.47E+04,,1,,1,,,,,1.19E+05,,,,,,,,8.47E+04,,,,,,,,,,,,1.19E+05,,,,,,,,3.78E+03,,,,,,,,,0.001,FALSE,3.141,16,1,87,10.7,9.92,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf01165,54460,A0A075B746; hsa:54460; P82921; Q5TB11; Q9BST6,ENSG00000266472,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.94,other molecular function,0,
Master Protein,High,P39210,MPV17,Protein Mpv17 OS=Homo sapiens OX=9606 GN=MPV17 PE=1 SV=1,1,2,100,0.504,,100,6.64,-0.99,,6.64,1.00E-17,7.38E-01,,1.00E-17,2.82E+05,,1.42E+05,,1,,1,,,,,2.82E+05,,,,,,,,,,1.42E+05,,,,,,,,,,2.82E+05,,,,,,,,,,1.92E+04,,,,,,,0.001,FALSE,3.259,13,1,176,19.7,9.47,1,cell organization and biogenesis;stress response;transport;developmental processes;other biological processes,other membranes;cytosol;mitochondrion;other cytoplasmic organelle;other cell component,Pf04117,4358,D6W555; hsa:4358; P39210; Q53SY2; Q96B08,ENSG00000115204,Peroxisomal protein import,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,7.98,transporter activity,0,
Master Protein,High,Q9P0U4,CXXC1,CXXC-type zinc finger protein 1 OS=Homo sapiens OX=9606 GN=CXXC1 PE=1 SV=2,1,1,100,0.409,,100,6.64,-1.29,,6.64,1.00E-17,5.61E-01,,1.00E-17,1.26E+05,,5.17E+04,,1,,1,,,,,1.26E+05,,,,,,,,,,5.17E+04,,,,,,,,,,1.26E+05,,,,,,,,,,6.96E+03,,,,,,,0,FALSE,5.955,2,1,656,75.7,8.24,1,other biological processes,cytosol;nucleus,"Pf00628, Pf02008, Pf12269",30827,B2RC03; hsa:30827; Q8N2W4; Q96BC8; Q9P0U4; Q9P2V7,ENSG00000154832,Formation of WDR5-containing histone-modifying complexes; XBP1(S) activates chaperone genes,Male infertility,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.46,nucleic acid binding activity;other molecular function,0,
Master Protein,High,I3L1Q2,BCL7C,BAF chromatin remodeling complex subunit BCL7C (Fragment) OS=Homo sapiens OX=9606 GN=BCL7C PE=1 SV=1,2,5,100,0.611,,100,6.64,-0.71,,6.64,1.00E-17,9.35E-01,,1.00E-17,1.73E+06,,3.52E+05,,3,,4,,2.37E+05,,,1.73E+06,1.85E+06,,,,,,,1.86E+05,2.89E+05,1.74E+06,4.30E+05,,,,,,9.42E+02,,,1.73E+06,9.54E+04,,,,,,,8.30E+03,2.35E+03,2.35E+05,1.07E+04,,,,,,0,FALSE,10.519,11,2,293,32.8,6.46,2,,nucleus,"Pf04714, Pf17906",,I3L1Q2,ENSG00000099385,,,0,0,70.61,,109.87,,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,116.12,,,20.75,,0,
Master Protein,High,Q9BU61,NDUFAF3,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 OS=Homo sapiens OX=9606 GN=NDUFAF3 PE=1 SV=1,1,1,100,1.085,,100,6.64,0.12,,6.64,1.00E-17,5.52E-01,,1.00E-17,3.14E+05,,3.41E+05,,1,,4,,,,,3.14E+05,,,,,,,7.75E+05,,4.62E+05,1.51E+05,2.51E+05,,,,,,,,,3.14E+05,,,,,,,4.64E+03,,3.75E+03,2.04E+04,6.25E+03,,,,,,0,FALSE,4.725,13,1,184,20.3,8.22,1,cell organization and biogenesis,other membranes;mitochondrion;nucleus,Pf04430,25915,hsa:25915; Q9BU61,ENSG00000178057,Complex I biogenesis,,1,0,,,67.27,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,67.6,,,3.99,,0,
Master Protein,High,Q9C005,DPY30,Protein dpy-30 homolog OS=Homo sapiens OX=9606 GN=DPY30 PE=1 SV=1,2,4,100,2.428,,100,6.64,1.28,,6.64,1.00E-17,8.67E-02,,1.00E-17,3.55E+05,,6.38E+05,,1,,2,,,,,3.55E+05,,,,,,,,,,8.24E+05,4.94E+05,,,,,,,,,3.55E+05,,,,,,,,,,1.11E+05,1.23E+04,,,,,,0,FALSE,15.762,45,2,99,11.2,4.88,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport,ER/Golgi;nucleus,Pf05186,84661,D6W578; hsa:84661; Q9C005,ENSG00000162961,Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Formation of WDR5-containing histone-modifying complexes,Kleefstra syndrome,5,0,,,35.45,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,1,Acetyl [N-Term],FALSE,,69.94,,,16.82,other molecular function,0,
Master Protein,High,P24534,EEF1B2,Elongation factor 1-beta OS=Homo sapiens OX=9606 GN=EEF1B2 PE=1 SV=3,4,8,100,0.255,100,0.089,6.64,-1.97,6.64,-3.49,1.00E-17,2.15E-01,1.00E-17,4.02E-02,5.93E+05,,7.94E+04,6.53E+05,3,,4,4,,9.58E+06,3.75E+04,5.93E+05,,,,,,,3.79E+04,,9.15E+05,1.66E+05,1.48E+04,4.76E+05,8.96E+05,1.23E+06,,3.01E+05,,3.64E+04,3.67E+02,5.93E+05,,,,,,,2.27E+02,,7.43E+03,2.24E+04,3.67E+02,9.28E+02,2.52E+05,8.72E+03,,3.21E+03,0,FALSE,13.137,24,4,225,24.7,4.67,4,protein metabolism;other metabolic processes,cytosol;other cell component,"Pf00736, Pf10587",1933,A8K795; hsa:1933; P24534; Q6IBH9,ENSG00000114942; ENSG00000283391,Eukaryotic Translation Elongation,Translation factors,2,0,157.37,,150.34,57.7,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,146.67,,90.59,22.7,enzyme regulator activity;nucleic acid binding activity,0,
Master Protein,High,P04839,CYBB,Cytochrome b-245 heavy chain OS=Homo sapiens OX=9606 GN=CYBB PE=1 SV=2,3,6,100,4.445,100,1.927,6.64,2.15,6.64,0.95,1.00E-17,8.34E-03,1.00E-17,4.40E-01,2.91E+05,,8.91E+05,3.11E+05,1,,5,2,,,,2.91E+05,,,,,,,2.69E+05,1.92E+05,1.32E+06,7.68E+06,8.91E+05,,3.13E+05,,3.09E+05,,,,,2.91E+05,,,,,,,1.61E+03,8.60E+03,1.07E+04,1.03E+06,2.21E+04,,8.79E+04,,7.23E+03,,0,FALSE,10.426,8,3,570,65.3,8.63,3,other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cell component,"Pf01794, Pf08022, Pf08030",1536,A8K138; hsa:1536; P04839; Q2PP16,ENSG00000165168,RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; Neutrophil degranulation; Detoxification of Reactive Oxygen Species; VEGFA-VEGFR2 Pathway; ROS and RNS production in phagocytes; Cross-presentation of particulate exogenous antigens (phagosomes); RHO GTPases Activate NADPH Oxidases,Alzheimer's disease and miRNA effects; VEGFA-VEGFR2 signaling; Microglia pathogen phagocytosis pathway; Oxidative stress response; Ferroptosis; Alzheimer's disease; Urotensin-II-mediated signaling pathway; Genetic causes of porto-sinusoidal vascular disease; HDAC6 interactions in the central nervous system; Type II interferon signaling,19,0,,,153.09,0.86,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,100.94,,100.94,15.4,other molecular function,0,
Master Protein,Medium,P42696,RBM34,RNA-binding protein 34 OS=Homo sapiens OX=9606 GN=RBM34 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.25E+04,,,,1,,,,,,,2.25E+04,,,,,,,,,,,,,,,,,,,,2.25E+04,,,,,,,,,,,,,,,,,0.016,FALSE,2.084,3,1,430,48.5,10.11,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf00076,23029,A8K8J7; hsa:23029; P42696; Q8N2Z8; Q9H5A1,ENSG00000188739,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.49,nucleic acid binding activity,0,
Master Protein,High,Q8N4Q1,CHCHD4,Mitochondrial intermembrane space import and assembly protein 40 OS=Homo sapiens OX=9606 GN=CHCHD4 PE=1 SV=1,2,3,100,0.394,,100,6.64,-1.34,,6.64,1.00E-17,5.13E-01,,1.00E-17,1.53E+05,,6.03E+04,,1,,2,,,,,1.53E+05,,,,,,,,,,6.33E+04,5.75E+04,,,,,,,,,1.53E+05,,,,,,,,,,8.53E+03,1.43E+03,,,,,,0,FALSE,10.876,30,2,142,16,4.31,2,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;other biological processes,mitochondrion,Pf06747,131474,A8K3Z9; hsa:131474; Q8N4Q1; Q96AI2; Q96MY6,ENSG00000163528,Mitochondrial protein import,,1,0,,,6.81,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,7.15,,,12.25,other molecular function,0,
Master Protein,High,J3KPV1,CHCHD7,Coiled-coil-helix-coiled-coil-helix domain containing 7 OS=Homo sapiens OX=9606 GN=CHCHD7 PE=1 SV=1,1,4,100,0.451,,100,6.64,-1.15,,6.64,1.00E-17,6.38E-01,,1.00E-17,3.24E+05,,6.35E+04,,3,,4,,,5.92E+04,,3.81E+05,3.24E+05,,,,,,,5.18E+04,7.53E+04,4.60E+05,5.35E+04,,,,,,,2.25E+02,,3.81E+05,1.67E+04,,,,,,,2.31E+03,6.12E+02,6.20E+04,1.33E+03,,,,,,0,FALSE,7.005,19,1,94,11.1,9.54,1,,,Pf02297,,J3KPV1,ENSG00000170791,,,0,0,67.41,,125.03,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,139.44,,,12.87,,0,
Master Protein,High,Q9BTZ2,DHRS4,Dehydrogenase/reductase SDR family member 4 OS=Homo sapiens OX=9606 GN=DHRS4 PE=1 SV=3,3,4,100,1.726,,100,6.64,0.79,,6.64,1.00E-17,2.57E-01,,1.00E-17,1.79E+05,,1.87E+05,,1,,3,,,,,1.79E+05,,,,,,,,1.87E+05,7.97E+04,4.86E+05,,,,,,,,,,1.79E+05,,,,,,,,8.37E+03,6.47E+02,6.55E+04,,,,,,,0,FALSE,7.646,20,3,278,29.5,8.56,3,other metabolic processes;other biological processes,other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle,Pf13561,10901,B2RB10; B7WNS9; D3YTB8; E2QRL8; hsa:10901; O95162; Q20CR0; Q2LC19; Q2LE81; Q58IU4; Q6E0Y1; Q6UWU3; Q71UQ6; Q8TD03; Q9BTZ2; Q9H3N5; Q9NV08,ENSG00000157326; ENSG00000284807,Peroxisomal protein import; RA biosynthesis pathway,,2,0,,,83.85,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,10.65,other molecular function,0,
Master Protein,High,A0A7I2V2B0,SLC9A6,Sodium/hydrogen exchanger OS=Homo sapiens OX=9606 GN=SLC9A6 PE=1 SV=1,2,2,100,3.206,100,1.089,6.64,1.68,6.64,0.12,1.00E-17,1.08E-01,1.00E-17,8.07E-01,1.01E+04,,3.25E+04,2.98E+04,1,,2,1,,,,,1.01E+04,,,,,,,,,7.06E+04,1.49E+04,,,,2.98E+04,,,,,,5.22E+02,,,,,,,,,9.51E+03,3.71E+02,,,,6.98E+02,,0,FALSE,6.999,4,2,731,81.4,6.54,2,transport;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,Pf00999,,A0A7I2V2B0,ENSG00000198689,,,0,0,,,92.06,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,127.14,,127.14,5.66,transporter activity,0,
Master Protein,High,A0A590UJ43,CSNK1A1,Casein kinase 1 alpha 1 OS=Homo sapiens OX=9606 GN=CSNK1A1 PE=1 SV=1,1,3,100,1.285,100,0.473,6.64,0.36,6.64,-1.08,1.00E-17,4.26E-01,1.00E-17,6.02E-01,2.23E+05,,2.19E+05,5.60E+05,2,,5,4,,,,3.13E+05,1.58E+05,,,,,,2.19E+05,5.14E+04,2.06E+05,5.78E+05,3.98E+05,3.19E+05,1.05E+06,2.27E+05,9.81E+05,,,,,3.13E+05,8.16E+03,,,,,,1.31E+03,2.30E+03,1.67E+03,7.79E+04,9.89E+03,6.23E+02,2.95E+05,1.61E+03,2.30E+04,,0,FALSE,4.509,3,1,426,48.5,9.55,1,,,Pf00069,,A0A590UJ43,ENSG00000113712,,Alzheimer's disease and miRNA effects; Complement system; Wnt/beta-catenin signaling pathway in leukemia; Regulation of Wnt / B-catenin signaling by small molecule compounds; Chromosomal and microsatellite instability in colorectal cancer ; Hedgehog signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Pleural mesothelioma; Alzheimer's disease; DYRK1A involvement regarding cell proliferation in brain development,13,0,46.53,,69.7,66.89,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,,70.08,,108.9,7.2,kinase activity;other molecular function,0,
Master Protein,High,Q7Z5K2,WAPL,Wings apart-like protein homolog OS=Homo sapiens OX=9606 GN=WAPL PE=1 SV=1,1,1,100,0.351,,100,6.64,-1.51,,6.64,1.00E-17,4.51E-01,,1.00E-17,1.08E+05,,3.80E+04,,1,,1,,,,,1.08E+05,,,,,,,,3.80E+04,,,,,,,,,,,,1.08E+05,,,,,,,,1.70E+03,,,,,,,,,0,FALSE,9.601,2,1,1190,132.9,5.44,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf07814,23063,A7E2B5; hsa:23063; Q5VSK5; Q7Z5K2; Q8IX10; Q92549,ENSG00000062650,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,Cohesin complex - Cornelia de Lange syndrome; 10q22q23 copy number variation,6,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,4.63,other molecular function,0,
Master Protein,High,Q6PI98,INO80C,INO80 complex subunit C OS=Homo sapiens OX=9606 GN=INO80C PE=1 SV=1,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.45E+05,,,,1,,,,,,,3.45E+05,,,,,,,,,,,,,,,,,,,,3.45E+05,,,,,,,,,,,,,,,,,0,FALSE,6.672,14,2,192,20.6,10.02,2,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus,Pf08265,125476,B4DUI4; E9PCS7; hsa:125476; Q6PI98; Q86WR1; Q8N994,ENSG00000153391,UCH proteinases; DNA Damage Recognition in GG-NER,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.86,,0,
Master Protein,High,Q15833,STXBP2,Syntaxin-binding protein 2 OS=Homo sapiens OX=9606 GN=STXBP2 PE=1 SV=2,1,3,100,8.485,100,0.755,6.64,3.08,6.64,-0.4,1.00E-17,3.13E-03,1.00E-17,9.74E-01,3.28E+04,,2.54E+05,3.37E+05,2,,3,1,,1.43E+05,,7.51E+03,,,,,,,,1.89E+05,,4.09E+05,2.54E+05,,3.37E+05,,,,,5.43E+02,,7.51E+03,,,,,,,,8.44E+03,,5.51E+04,6.32E+03,,9.47E+04,,,,0.001,FALSE,3.492,3,1,593,66.4,6.55,1,cell-cell signaling;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf00995,6813,B4E175; E7EQD5; hsa:6813; Q15833; Q9BU65,ENSG00000076944,Platelet degranulation ; Other interleukin signaling,Splicing factor NOVA regulated synaptic proteins; Insulin signaling,4,0,127.31,,39.8,,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,208.23,,51.43,10.33,other molecular function,0,
Master Protein,High,A0A8V8TNU3,CYFIP2,Cytoplasmic FMR1-interacting protein OS=Homo sapiens OX=9606 GN=CYFIP2 PE=1 SV=1,1,1,100,0.188,,100,6.64,-2.41,,6.64,1.00E-17,1.96E-01,,1.00E-17,5.01E+04,,9.01E+03,,3,,3,,1.27E+05,,2.78E+04,5.01E+04,,,,,,,,5.21E+03,,4.13E+04,9.01E+03,,,,,,5.04E+02,,2.71E+02,5.01E+04,,,,,,,,2.33E+02,,5.57E+03,2.24E+02,,,,,,0.007,FALSE,2.362,1,1,1300,150.8,7.46,1,cell organization and biogenesis,other cell component,"Pf05994, Pf07159",,A0A8V8TNU3,ENSG00000055163,,Fragile X syndrome,1,0,76.11,,107.2,,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,114.53,,,0,other molecular function,0,
Master Protein,Medium,Q8IXT5,RBM12B,RNA-binding protein 12B OS=Homo sapiens OX=9606 GN=RBM12B PE=1 SV=2,1,1,100,0.169,,100,6.64,-2.57,,6.64,1.00E-17,1.31E-01,,1.00E-17,1.45E+05,,2.45E+04,,1,,1,,,,,1.45E+05,,,,,,,,,,2.45E+04,,,,,,,,,,1.45E+05,,,,,,,,,,3.30E+03,,,,,,,0.026,FALSE,1.861,1,1,1001,118,6.81,1,other biological processes,nucleus;other cell component,Pf00076,389677,A8MYB5; hsa:389677; Q8IXT5,ENSG00000183808,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,1.89,,0,
Master Protein,High,Q8WXH0,SYNE2,Nesprin-2 OS=Homo sapiens OX=9606 GN=SYNE2 PE=1 SV=3,9,10,100,0.723,100,1.009,6.64,-0.47,6.64,0.01,1.00E-17,9.42E-01,1.00E-17,8.52E-01,7.56E+05,,1.89E+05,4.85E+04,1,,5,3,,,,7.56E+05,,,,,,,1.07E+05,3.44E+04,2.94E+05,1.89E+05,5.53E+05,1.06E+05,4.75E+04,,4.85E+04,,,,,7.56E+05,,,,,,,6.40E+02,1.53E+03,2.39E+03,2.54E+04,1.37E+04,2.07E+02,1.33E+04,,1.13E+03,,0,FALSE,28.836,2,9,6885,795.9,5.36,9,cell organization and biogenesis;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf00307, Pf00435, Pf10541",23224,B4DND7; B4DPR6; I6XXQ5; Q540G1; Q86YP9; Q8N1S3; Q8NF49; Q8TER7; Q8WWW3; Q8WWW4; Q8WWW5; Q8WXH0; Q8WXH1; Q9NU50; Q9UFQ4; Q9Y2L4; Q9Y4R1,ENSG00000054654,Meiotic synapsis,Ovarian infertility; Rett syndrome; Envelope proteins and their potential roles in EDMD physiopathology,4,0,,,85.84,49.88,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,69.01,,100.69,30.31,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9UPN9,TRIM33,E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens OX=9606 GN=TRIM33 PE=1 SV=3,1,2,100,1.154,100,0.555,6.64,0.21,6.64,-0.85,1.00E-17,4.38E-01,1.00E-17,7.61E-01,5.41E+05,,6.25E+05,1.13E+06,2,,2,2,,,8.91E+05,3.29E+05,,,,,,,7.03E+05,,,5.55E+05,,1.31E+06,,,,9.67E+05,,,8.70E+03,3.29E+05,,,,,,,4.20E+03,,,7.48E+04,,2.55E+03,,,,1.03E+04,0.007,FALSE,2.386,1,1,1127,122.5,6.67,1,protein metabolism;other metabolic processes;other biological processes,nucleus,"Pf00439, Pf00628, Pf00643",51592,hsa:51592; O95855; Q5TG72; Q5TG73; Q5TG74; Q9C017; Q9UJ79; Q9UPN9,ENSG00000197323,Downregulation of SMAD2/3:SMAD4 transcriptional activity; Germ layer formation at gastrulation,Ectoderm differentiation,3,0,65.11,,16.65,21.26,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,,68.31,,20.03,6.41,nucleic acid binding activity;other molecular function,0,
Master Protein,High,D6RCF4,CISD2,CDGSH iron-sulfur domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CISD2 PE=1 SV=1,2,3,100,0.373,100,0.22,6.64,-1.42,6.64,-2.18,1.00E-17,4.91E-01,1.00E-17,2.92E-01,9.01E+04,,6.34E+04,2.88E+05,3,,3,2,8.13E+06,,,9.01E+04,5.80E+04,,,,,,3.39E+05,6.34E+04,,2.16E+04,,3.33E+05,,,2.49E+05,,3.23E+04,,,9.01E+04,2.99E+03,,,,,,2.02E+03,2.83E+03,,2.92E+03,,6.49E+02,,,5.83E+03,,0,FALSE,7.086,17,2,145,16.1,9.14,2,other biological processes,other membranes;mitochondrion;ER/Golgi,"Pf09360, Pf10660",,D6RCF4,ENSG00000145354,,,0,0,168.56,,121.93,20.27,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,133.54,,120.19,4.02,other molecular function,0,
Master Protein,Medium,Q86WJ1,CHD1L,Chromodomain-helicase-DNA-binding protein 1-like OS=Homo sapiens OX=9606 GN=CHD1L PE=1 SV=3,1,1,100,1.308,,100,6.64,0.39,,6.64,1.00E-17,5.23E-01,,1.00E-17,7.13E+04,,9.33E+04,,1,,1,,,,,7.13E+04,,,,,,,,,,9.33E+04,,,,,,,,,,7.13E+04,,,,,,,,,,1.26E+04,,,,,,,0.03,FALSE,1.818,1,1,897,100.9,6.9,1,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00176, Pf00271",9557,A5YM64; B4DDE1; B5MDZ7; Q53EZ3; Q5VXX7; Q6DD94; Q6PK83; Q86WJ1; Q86XH3; Q96HF7; Q96SP3; Q9BVJ1; Q9NVV8,ENSG00000131778,Formation of Incision Complex in GG-NER; Dual Incision in GG-NER,1q21.1 copy number variation syndrome; Nucleotide excision repair in xeroderma pigmentosum,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,1.91,other molecular function,0,
Master Protein,High,O95857,TSPAN13,Tetraspanin-13 OS=Homo sapiens OX=9606 GN=TSPAN13 PE=2 SV=1,1,1,100,1.55,,100,6.64,0.63,,6.64,1.00E-17,3.76E-01,,1.00E-17,9.55E+04,,1.48E+05,,1,,1,,,,,9.55E+04,,,,,,,,,,,1.48E+05,,,,,,,,,9.55E+04,,,,,,,,,,,3.68E+03,,,,,,0,FALSE,6.771,10,1,204,22.1,7.93,1,other biological processes,plasma membrane;other membranes,Pf00335,27075,hsa:27075; O95857,ENSG00000106537,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.48,other molecular function,0,
Master Protein,High,P37198,NUP62,Nuclear pore glycoprotein p62 OS=Homo sapiens OX=9606 GN=NUP62 PE=1 SV=3,5,14,100,0.459,100,0.626,6.64,-1.12,6.64,-0.67,1.00E-17,5.75E-01,1.00E-17,7.60E-01,2.70E+06,,1.33E+06,2.18E+06,4,,4,3,2.80E+06,5.24E+06,2.41E+06,2.61E+06,,,,,,,,6.09E+05,1.71E+06,4.89E+06,1.03E+06,,3.83E+05,2.89E+06,2.18E+06,,1.11E+04,1.99E+04,2.36E+04,2.61E+06,,,,,,,,2.72E+04,1.39E+04,6.59E+05,2.55E+04,,1.08E+05,2.05E+04,5.09E+04,,0,FALSE,24.125,13,5,522,53.2,5.31,5,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes,other membranes;cytoskeleton;nucleus;other cell component,Pf05064,23636,B3KWU5; hsa:23636; P37198; Q503A4; Q6GTM2; Q96C43; Q9NSL1,ENSG00000213024,HCMV Early Events; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,7q11.23 copy number variation syndrome,30,0,40.61,,94.2,71.1,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,109.77,,79.83,47.7,other molecular function,0,
Master Protein,High,Q14684,RRP1B,Ribosomal RNA processing protein 1 homolog B OS=Homo sapiens OX=9606 GN=RRP1B PE=1 SV=3,3,4,100,0.563,,100,6.64,-0.83,,6.64,1.00E-17,7.89E-01,,1.00E-17,2.10E+05,,5.36E+04,,1,,2,,,,,2.10E+05,,,,,,,,2.28E+04,,1.26E+05,,,,,,,,,,2.10E+05,,,,,,,,1.02E+03,,1.70E+04,,,,,,,0,FALSE,10.182,6,3,758,84.4,9.76,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf05997,23076,hsa:23076; Q14684; Q8TBZ4,ENSG00000160208,,,0,0,,,98.1,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,60.87,,,12.57,other molecular function,0,
Master Protein,High,Q9ULD9,ZNF608,Zinc finger protein 608 OS=Homo sapiens OX=9606 GN=ZNF608 PE=1 SV=4,2,2,100,0.61,100,0.591,6.64,-0.71,6.64,-0.76,1.00E-17,8.68E-01,1.00E-17,7.91E-01,9.59E+04,,5.85E+04,9.90E+04,2,,2,4,,,,1.47E+05,6.25E+04,,,,,,,,,5.98E+04,5.72E+04,1.78E+05,1.83E+04,1.15E+05,,8.49E+04,,,,1.47E+05,3.23E+03,,,,,,,,,8.05E+03,1.42E+03,3.48E+02,5.15E+03,8.17E+02,,9.04E+02,0,FALSE,7.663,2,2,1512,162.1,8.79,2,other biological processes,nucleus,,57507,A7E2W9; hsa:57507; Q3SYM6; Q68D12; Q8IY05; Q9ULD9; Q9Y5A1,ENSG00000168916,,,0,0,57,,3.08,67.05,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,,63.89,,70.82,5.5,other molecular function,0,
Master Protein,High,Q9BQF6,SENP7,Sentrin-specific protease 7 OS=Homo sapiens OX=9606 GN=SENP7 PE=1 SV=4,1,1,100,0.195,,100,6.64,-2.36,,6.64,1.00E-17,2.15E-01,,1.00E-17,3.88E+04,,7.57E+03,,1,,1,,,,,3.88E+04,,,,,,,,,,7.57E+03,,,,,,,,,,3.88E+04,,,,,,,,,,1.02E+03,,,,,,,0.001,FALSE,3.519,2,1,1050,119.6,6.61,1,protein metabolism;other metabolic processes;stress response,nucleus;other cell component,Pf02902,57337,A1L3A5; A8MW39; B7WNW8; hsa:57337; Q7Z3F4; Q96PS5; Q9BQF6; Q9C0F6; Q9HBT5,ENSG00000138468,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.26,other molecular function,0,
Master Protein,High,Q9UJX3,ANAPC7,Anaphase-promoting complex subunit 7 OS=Homo sapiens OX=9606 GN=ANAPC7 PE=1 SV=5,1,3,100,2.295,,100,6.64,1.2,,6.64,1.00E-17,1.76E-01,,1.00E-17,7.60E+04,,1.74E+05,,1,,1,,,,,7.60E+04,,,,,,,,,,1.74E+05,,,,,,,,,,7.60E+04,,,,,,,,,,2.35E+04,,,,,,,0,FALSE,4.921,4,1,565,63.1,5.72,1,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;developmental processes;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf13181,,Q96AC4; Q96GF4; Q9BU24; Q9NT16; Q9UJX3,ENSG00000196510,Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,Cell cycle,19,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,11.47,other molecular function,0,
Master Protein,High,P62854,RPS26,40S ribosomal protein S26 OS=Homo sapiens OX=9606 GN=RPS26 PE=1 SV=3,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,7.63E+05,,,,2,,,,,9.85E+05,,5.91E+05,,,,,,,,,,,,,,,,,,3.74E+03,,5.91E+05,,,,,,,,,,,,,,,,,0,FALSE,4.277,10,1,115,13,11,1,protein metabolism;other metabolic processes;other biological processes,other membranes;cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf01283,6231,hsa:6231; P02383; P62854; P70394; Q06722; Q3MHD8; Q6IRY4,ENSG00000197728,"Major pathway of rRNA processing in the nucleolus and cytosol; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,35.31,,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P22033,MMUT,"Methylmalonyl-CoA mutase, mitochondrial OS=Homo sapiens OX=9606 GN=MMUT PE=1 SV=4",3,5,100,1.453,,100,6.64,0.54,,6.64,1.00E-17,3.52E-01,,1.00E-17,1.15E+05,,7.55E+05,,1,,1,,,,,1.15E+05,,,,,,,,,,7.55E+05,,,,,,,,,,1.15E+05,,,,,,,,,,1.02E+05,,,,,,,0,FALSE,17.603,7,3,750,83.1,6.93,3,other metabolic processes;developmental processes;other biological processes,mitochondrion;other cell component,"Pf01642, Pf02310",4594,A8K953; hsa:4594; P22033; Q5SYZ3; Q96B11; Q9UD64,ENSG00000146085,"Propionyl-CoA catabolism; Defective MMAA causes MMA, cblA type; Defective MUT causes MMAM; Cobalamin (Cbl) metabolism",Vitamin B12 metabolism; Amino acid metabolism,6,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,,21.86,other molecular function,0,
Master Protein,High,Q96CB9,NSUN4,5-methylcytosine rRNA methyltransferase NSUN4 OS=Homo sapiens OX=9606 GN=NSUN4 PE=1 SV=2,1,1,100,0.835,100,0.45,6.64,-0.26,6.64,-1.15,1.00E-17,8.35E-01,1.00E-17,6.31E-01,5.88E+04,,4.91E+04,1.09E+05,1,,2,1,,,,5.88E+04,,,,,,,,,,2.17E+04,1.11E+05,,,,1.09E+05,,,,,5.88E+04,,,,,,,,,,2.92E+03,2.76E+03,,,,2.55E+03,,0.003,FALSE,2.765,4,1,384,43.1,8.18,1,RNA metabolism OR transcription;other metabolic processes,mitochondrion;translational apparatus,Pf01189,387338,A8K6S6; B3KQ50; B4DHA4; hsa:387338; Q5TDF7; Q96AN8; Q96CB9; Q9HAJ8,ENSG00000117481,rRNA modification in the mitochondrion,,1,0,,,95.22,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,135.02,,135.02,3.89,nucleic acid binding activity;other molecular function,0,
Master Protein,High,D6RJ07,ZNF346,Zinc finger protein 346 OS=Homo sapiens OX=9606 GN=ZNF346 PE=1 SV=1,1,2,100,0.393,100,0.251,6.64,-1.35,6.64,-1.99,1.00E-17,5.09E-01,1.00E-17,2.89E-01,2.18E+05,,8.57E+04,3.41E+05,1,,4,1,,,,2.18E+05,,,,,,,,5.59E+04,1.64E+05,1.31E+05,3.65E+04,,,,,3.41E+05,,,,2.18E+05,,,,,,,,2.50E+03,1.33E+03,1.77E+04,9.08E+02,,,,,3.63E+03,0,FALSE,5.621,5,1,310,34.6,9.22,1,,nucleus,Pf12874,,D6RJ07,ENSG00000113761,,5q35 copy number variation,1,0,,,62.44,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,74.84,,74.84,7.1,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q7Z6I6,ARHGAP30,Rho GTPase-activating protein 30 OS=Homo sapiens OX=9606 GN=ARHGAP30 PE=1 SV=3,1,1,100,0.287,100,0.086,6.64,-1.8,6.64,-3.54,1.00E-17,3.43E-01,1.00E-17,5.80E-02,1.04E+05,,3.20E+04,3.73E+05,2,,4,4,,,,6.73E+04,1.59E+05,,,,,,,3.53E+04,2.90E+04,4.44E+04,1.99E+04,3.83E+05,,3.63E+05,4.57E+04,7.52E+05,,,,6.73E+04,8.23E+03,,,,,,,1.58E+03,2.35E+02,5.99E+03,4.94E+02,7.47E+02,,2.57E+03,1.07E+03,8.00E+03,0,FALSE,4.756,1,1,1101,118.5,4.81,1,signal transduction;other biological processes,cytosol;other cell component,Pf00620,257106,hsa:257106; Q5SY52; Q5SY53; Q5SY54; Q6ZML6; Q7Z3J8; Q7Z6I6; Q86XI7,ENSG00000186517,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOU GTPase cycle,,4,0,57.5,,32.21,74.81,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,58.3,,90.26,4.4,enzyme regulator activity,0,
Master Protein,High,Q9H974,QTRT2,Queuine tRNA-ribosyltransferase accessory subunit 2 OS=Homo sapiens OX=9606 GN=QTRT2 PE=1 SV=1,1,2,100,0.414,,100,6.64,-1.27,,6.64,1.00E-17,6.49E-01,,1.00E-17,2.34E+04,,9.69E+03,,1,,2,,,,,2.34E+04,,,,,,,,7.84E+03,,,1.20E+04,,,,,,,,,2.34E+04,,,,,,,,3.50E+02,,,2.98E+02,,,,,,0,FALSE,4.771,5,1,415,46.7,6.81,1,RNA metabolism OR transcription;other metabolic processes,other membranes;mitochondrion;other cell component,Pf01702,79691,A6NGE9; B7Z472; B7Z5R2; hsa:79691; J3KR78; Q6IA59; Q9H974,ENSG00000151576,tRNA modification in the nucleus and cytosol,,1,0,,,29.55,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,31.68,,,7.16,other molecular function,0,
Master Protein,High,P13051,UNG,Uracil-DNA glycosylase OS=Homo sapiens OX=9606 GN=UNG PE=1 SV=2,1,4,100,0.83,,100,6.64,-0.27,,6.64,1.00E-17,8.15E-01,,1.00E-17,1.86E+05,,1.55E+05,,1,,2,,,,,1.86E+05,,,,,,,,1.18E+05,,2.03E+05,,,,,,,,,,1.86E+05,,,,,,,,5.26E+03,,2.74E+04,,,,,,,0,FALSE,7.07,8,1,313,34.6,9.32,1,DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,mitochondrion;nucleus,Pf03167,7374,A8K5M6; B2R8Y1; hsa:7374; O00637; O00719; P13051; Q93028,ENSG00000076248,Chromatin modifications during the maternal to zygotic transition (MZT),"Base excision repair; DNA repair pathways, full network",3,0,,,37.65,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,40.95,,,14.57,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96IY1,NSL1,Kinetochore-associated protein NSL1 homolog OS=Homo sapiens OX=9606 GN=NSL1 PE=1 SV=3,1,1,100,0.337,,100,6.64,-1.57,,6.64,1.00E-17,4.12E-01,,1.00E-17,2.99E+05,,1.01E+05,,2,,1,,,,,2.12E+05,4.22E+05,,,,,,,,,1.01E+05,,,,,,,,,,2.12E+05,2.17E+04,,,,,,,,,1.36E+04,,,,,,,0,FALSE,5.811,8,1,281,32.1,6.79,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf08641,25936,E7ETD5; hsa:25936; Q5SY75; Q96IY1; Q9H2M5; Q9NRN8; Q9Y415,ENSG00000117697,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,6,0,46.73,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,51.9,,,4.36,,0,
Master Protein,High,P17252,PRKCA,Protein kinase C alpha type OS=Homo sapiens OX=9606 GN=PRKCA PE=1 SV=4,4,15,100,0.497,100,7.731,6.64,-1.01,6.64,2.95,1.00E-17,6.94E-01,1.00E-17,6.00E-02,1.43E+05,,7.10E+04,9.24E+03,1,,5,2,,,,1.43E+05,,,,,,,6.06E+04,1.44E+05,3.50E+04,1.45E+05,7.10E+04,,4.56E+03,,1.87E+04,,,,,1.43E+05,,,,,,,3.63E+02,6.44E+03,2.84E+02,1.96E+04,1.77E+03,,1.28E+03,,4.38E+02,,0,FALSE,19.317,6,1,672,76.7,7.05,4,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf00069, Pf00130, Pf00168, Pf00433",5578,B5BU22; hsa:5578; P17252; Q15137; Q32M72; Q96RE4,ENSG00000154229,"G alpha (z) signalling events; Disinhibition of SNARE formation; RET signaling; Regulation of KIT signaling; SHC1 events in ERBB2 signaling; Ca2+ pathway; WNT5A-dependent internalization of FZD4; Inactivation, recovery and regulation of the phototransduction cascade; Syndecan interactions; HuR (ELAVL1) binds and stabilizes mRNA; VEGFR2 mediated cell proliferation; Trafficking of GluR2-containing AMPA receptors; Depolymerization of the Nuclear Lamina; Acetylcholine regulates insulin secretion; EGFR Transactivation by Gastrin; RHO GTPases Activate NADPH Oxidases; Calmodulin induced events; ROBO receptors bind AKAP5","Target of rapamycin signaling; Thyroxine (thyroid hormone) production; Follicle stimulating hormone (FSH) signaling pathway; Microtubule cytoskeleton regulation; Endothelin pathways; Glioblastoma signaling pathways; Pathogenic Escherichia coli infection; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Spinal cord injury; Alpha 6 beta 4 signaling pathway; T cell receptor and co-stimulatory signaling; Common pathways underlying drug addiction; Cardiac hypertrophic response; Complement system; Myometrial relaxation and contraction pathways; Transcriptional activation by NRF2 in response to phytochemicals; Kit receptor signaling pathway; Focal adhesion; Melatonin metabolism and effects; G protein signaling pathways; Wnt signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling; PDGFR-beta pathway; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Ras signaling; Non-small cell lung cancer; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; NRF2-ARE regulation; EGF/EGFR signaling pathway; Hippo signaling regulation pathways; Fragile X syndrome; Overview of interferons-mediated signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Neuroinflammation and glutamatergic signaling; Orexin receptor pathway; Hippocampal synaptogenesis and neurogenesis; Chronic hyperglycemia impairment of neuron function; TROP2 regulatory signaling; Cardiomyocyte signaling pathways converging on titin; Calcium regulation in cardiac cells; Osteoarthritic chondrocyte hypertrophy; ErbB signaling pathway",75,0,,,55.44,86,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,75.2,,96.35,48.25,signal transduction activity or receptor binding;kinase activity;other molecular function,0,
Master Protein,High,J3QLS3,MRPS7,Mitochondrial ribosomal protein S7 OS=Homo sapiens OX=9606 GN=MRPS7 PE=1 SV=1,4,6,100,0.478,,100,6.64,-1.07,,6.64,1.00E-17,6.88E-01,,1.00E-17,2.69E+05,,1.46E+05,,1,,3,,,,,2.69E+05,,,,,,,,1.71E+05,,6.24E+04,1.46E+05,,,,,,,,,2.69E+05,,,,,,,,7.62E+03,,8.40E+03,3.63E+03,,,,,,0,FALSE,17.79,15,4,271,31.7,9.86,4,protein metabolism;other metabolic processes,translational apparatus,Pf00177,,J3QLS3,ENSG00000125445,,,0,0,,,44.9,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,69.21,,,18.43,,0,
Master Protein,High,Q9UMN6,KMT2B,Histone-lysine N-methyltransferase 2B OS=Homo sapiens OX=9606 GN=KMT2B PE=1 SV=1,2,4,100,1.213,100,4.603,6.64,0.28,6.64,2.2,1.00E-17,5.76E-01,1.00E-17,1.15E-01,6.53E+04,,9.54E+04,1.72E+04,2,,5,2,1.97E+05,,,2.16E+04,,,,,,,1.58E+05,3.97E+04,9.54E+04,5.44E+04,9.80E+04,,1.41E+04,,2.10E+04,,7.84E+02,,,2.16E+04,,,,,,,9.46E+02,1.77E+03,7.75E+02,7.33E+03,2.44E+03,,3.97E+03,,4.92E+02,,0,FALSE,6.429,1,2,2715,293.3,8.22,2,cell organization and biogenesis;other metabolic processes;other biological processes,nucleus,"Pf00628, Pf00856, Pf02008, Pf05964, Pf05965, Pf13771",9757,hsa:9757; O15022; O95836; Q96GP2; Q96IP3; Q9UK25; Q9UMN6; Q9Y668; Q9Y669,ENSG00000272333,PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Formation of WDR5-containing histone-modifying complexes,Histone modifications,4,0,113.53,,51.84,27.61,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,119.15,,66.96,11.84,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H0U6,MRPL18,"39S ribosomal protein L18, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL18 PE=1 SV=1",1,3,100,0.693,,100,6.64,-0.53,,6.64,1.00E-17,9.96E-01,,1.00E-17,3.62E+05,,2.51E+05,,2,,5,,3.46E+05,,,3.78E+05,,,,,,,2.13E+05,2.05E+05,2.51E+05,3.41E+05,6.26E+05,,,,,,1.38E+03,,,3.78E+05,,,,,,,1.27E+03,9.16E+03,2.04E+03,4.60E+04,1.56E+04,,,,,,0.009,FALSE,2.308,5,1,180,20.6,9.54,1,protein metabolism;other metabolic processes;transport,other membranes;mitochondrion;translational apparatus,Pf00861,29074,hsa:29074; Q5TAP9; Q9H0U6; Q9NZW8,ENSG00000112110,Mitochondrial translation elongation; Mitochondrial translation initiation; Mitochondrial translation termination,,3,0,6.25,,53.73,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,34.37,,,6.63,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8WUM4,PDCD6IP,Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1,3,5,100,1.396,,100,6.64,0.48,,6.64,1.00E-17,3.90E-01,,1.00E-17,1.84E+05,,1.87E+05,,2,,5,,6.81E+05,,,4.96E+04,,,,,,,1.78E+05,7.80E+04,8.44E+05,1.87E+05,3.64E+05,,,,,,2.71E+03,,,4.96E+04,,,,,,,1.07E+03,3.49E+03,6.86E+03,2.52E+04,9.03E+03,,,,,,0,FALSE,15.259,6,3,868,96,6.52,3,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,non-structural extracellular;plasma membrane;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf03097, Pf13949",10015,C5MQH7; E9PFU1; hsa:10015; Q6NUS1; Q8WUM4; Q9BX86; Q9NUN0; Q9P2H2; Q9UKL5,ENSG00000170248,Budding and maturation of HIV virion; Regulation of necroptotic cell death; Uptake and function of anthrax toxins,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells,5,0,122.21,,92.41,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,128.27,,,16.87,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P31689,DNAJA1,DnaJ homolog subfamily A member 1 OS=Homo sapiens OX=9606 GN=DNAJA1 PE=1 SV=2,3,6,100,0.45,100,0.622,6.64,-1.15,6.64,-0.69,1.00E-17,5.57E-01,1.00E-17,8.36E-01,1.88E+06,,7.40E+05,4.96E+05,3,,2,2,,4.44E+06,1.88E+06,1.33E+06,,,,,,,,,,1.13E+06,4.86E+05,,1.87E+05,1.32E+06,,,,1.69E+04,1.84E+04,1.33E+06,,,,,,,,,,1.52E+05,1.21E+04,,5.25E+04,9.36E+03,,,0,FALSE,13.319,16,3,397,44.8,7.08,3,protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf00226, Pf00684, Pf01556",3301,hsa:3301; P31689; Q5T7Q0; Q86TL9,ENSG00000086061,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,VEGFA-VEGFR2 signaling; Exercise-induced circadian regulation; HDAC6 interactions in the central nervous system,4,0,65.06,,56.25,106.38,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,74.81,,169.27,18.08,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,O60568,PLOD3,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 OS=Homo sapiens OX=9606 GN=PLOD3 PE=1 SV=1,1,2,100,1.952,,100,6.64,0.96,,6.64,1.00E-17,2.91E-01,,1.00E-17,3.46E+04,,6.75E+04,,2,,2,,,,,2.97E+04,4.02E+04,,,,,,,4.00E+04,,,1.14E+05,,,,,,,,,2.97E+04,2.07E+03,,,,,,,1.79E+03,,,2.83E+03,,,,,,0,FALSE,8.243,3,1,738,84.7,6.05,1,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,non-structural extracellular;extracellular matrix;other membranes;ER/Golgi,Pf03171,8985,B2R6W6; hsa:8985; O60568; Q540C3,ENSG00000106397,Collagen biosynthesis and modifying enzymes,VEGFA-VEGFR2 signaling; IL-18 signaling pathway,3,0,21.13,,67.78,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,69.65,,,7.07,other molecular function,0,
Master Protein,High,Q9BQC6,MRPL57,"Ribosomal protein 63, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL57 PE=1 SV=1",1,5,100,2.644,,100,6.64,1.4,,6.64,1.00E-17,8.16E-02,,1.00E-17,2.80E+05,,6.21E+05,,2,,3,,,,,3.72E+05,2.11E+05,,,,,,,5.00E+05,,6.21E+05,1.43E+06,,,,,,,,,3.72E+05,1.09E+04,,,,,,,2.23E+04,,8.36E+04,3.56E+04,,,,,,0,FALSE,4.401,13,1,102,12.3,11.44,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf14978,78988,A2A332; hsa:78988; Q9BQC6,ENSG00000173141,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,39.21,,59.57,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,61.12,,,8.3,other molecular function,0,
Master Protein,High,Q0ZGT2,NEXN,Nexilin OS=Homo sapiens OX=9606 GN=NEXN PE=1 SV=1,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,2.23E+06,,,1.61E+06,1,,,1,,,2.23E+06,,,,,,,,,,,,,,,,1.61E+06,,,,2.18E+04,,,,,,,,,,,,,,,,3.77E+04,,0.005,FALSE,2.502,3,1,675,80.6,5.33,1,cell adhesion;cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytoskeleton;other cell component,Pf07679,91624,A0PJ84; B4DPZ7; hsa:91624; Q0D2H2; Q0ZGT2; Q14CC2; Q14CC3; Q16081; Q7Z2X0; Q96DL0; Q9Y2V1,ENSG00000162614,,VEGFA-VEGFR2 signaling,1,0,,,,,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,,,,2.79,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9HC36,MRM3,"rRNA methyltransferase 3, mitochondrial OS=Homo sapiens OX=9606 GN=MRM3 PE=1 SV=2",1,2,100,0.399,,100,6.64,-1.33,,6.64,1.00E-17,5.74E-01,,1.00E-17,8.72E+04,,3.48E+04,,1,,2,,,,,8.72E+04,,,,,,,,3.61E+04,,,3.36E+04,,,,,,,,,8.72E+04,,,,,,,,1.61E+03,,,8.34E+02,,,,,,0.001,FALSE,3.837,3,1,420,47,8.73,1,RNA metabolism OR transcription;other metabolic processes,mitochondrion,Pf00588,55178,hsa:55178; Q53GN1; Q86VC3; Q96F76; Q9HC36; Q9NVQ5,ENSG00000171861,rRNA modification in the mitochondrion,,1,0,,,5.03,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,5.28,,,5.75,other molecular function,0,
Master Protein,High,Q16594,TAF9,Transcription initiation factor TFIID subunit 9 OS=Homo sapiens OX=9606 GN=TAF9 PE=1 SV=1,1,1,100,2.31,,100,6.64,1.21,,6.64,1.00E-17,9.01E-02,,1.00E-17,3.62E+05,,8.36E+05,,1,,3,,,,,3.62E+05,,,,,,,,,8.36E+05,1.18E+06,6.71E+05,,,,,,,,,3.62E+05,,,,,,,,,6.79E+03,1.58E+05,1.67E+04,,,,,,0.001,FALSE,3.27,4,1,264,29,8.66,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf02291,6880,D3DWA3; hsa:6880; Q16594; Q5U0D1; Q9BTS1,ENSG00000273841; ENSG00000276463,RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; HATs acetylate histones,Eukaryotic transcription initiation,12,0,,,28.77,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,29.24,,,3,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q99611,SEPHS2,"Selenide, water dikinase 2 OS=Homo sapiens OX=9606 GN=SEPHS2 PE=1 SV=3",1,1,100,1.158,100,0.351,6.64,0.21,6.64,-1.51,1.00E-17,5.78E-01,1.00E-17,5.10E-01,5.75E+04,,6.66E+04,1.90E+05,1,,2,1,,,,5.75E+04,,,,,,,,,1.24E+05,3.57E+04,,,,,1.90E+05,,,,,5.75E+04,,,,,,,,,1.01E+03,4.81E+03,,,,,4.44E+03,,0.002,FALSE,3.076,4,1,448,47.3,5.88,1,other metabolic processes,cytosol;other cell component,"Pf00586, Pf02769",22928,hsa:22928; Q99611; Q9BUQ2,ENSG00000179918,Selenocysteine synthesis,Selenium micronutrient network; Selenium metabolism and selenoproteins,3,0,,,78.36,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,98.69,,98.69,3.54,kinase activity;other molecular function,0,
Master Protein,High,A0A494C0K7,MED27,Mediator of RNA polymerase II transcription subunit 27 OS=Homo sapiens OX=9606 GN=MED27 PE=1 SV=1,1,1,100,0.795,100,0.273,6.64,-0.33,6.64,-1.87,1.00E-17,8.77E-01,1.00E-17,3.82E-01,5.21E+04,,4.02E+04,6.85E+04,3,,4,2,6.31E+04,,2.95E+04,5.21E+04,,,,,,,4.61E+04,3.51E+04,5.46E+04,6.42E+03,,2.83E+05,1.66E+04,,,,2.51E+02,,2.88E+02,5.21E+04,,,,,,,2.76E+02,1.57E+03,4.44E+02,8.65E+02,,5.52E+02,4.67E+03,,,,0.003,FALSE,2.697,5,1,326,36.4,9.32,1,,cytosol;nucleus,Pf11571,,A0A494C0K7,ENSG00000160563,,,0,0,35.58,,59.07,125.74,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,,56.44,,131.39,3.34,,0,
Master Protein,Medium,A0A7I2V2H5,ST3GAL4,"ST3 beta-galactoside alpha-2,3-sialyltransferase 4 OS=Homo sapiens OX=9606 GN=ST3GAL4 PE=1 SV=1",1,1,100,7.345,,100,6.64,2.88,,6.64,1.00E-17,4.17E-03,,1.00E-17,3.85E+04,,2.83E+05,,1,,4,,,,,3.85E+04,,,,,,,,1.53E+06,1.31E+05,1.45E+05,5.52E+05,,,,,,,,,3.85E+04,,,,,,,,6.84E+04,1.07E+03,1.96E+04,1.37E+04,,,,,,0.023,FALSE,1.922,9,1,181,20.7,9.39,1,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf00777,,A0A7I2V2H5,ENSG00000110080,,,0,0,,,111.41,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,1,Phospho [S158; S161],FALSE,,110.09,,,2.71,other molecular function,2,Phospho [S158; S161]
Master Protein,Medium,P06703,S100A6,Protein S100-A6 OS=Homo sapiens OX=9606 GN=S100A6 PE=1 SV=1,1,2,100,0.595,100,1.173,6.64,-0.75,6.64,0.23,1.00E-17,8.48E-01,1.00E-17,7.55E-01,1.94E+05,,1.18E+05,1.01E+05,5,,2,3,4.99E+05,6.13E+04,3.25E+05,1.94E+05,1.22E+05,,,,,,,,,8.88E+04,1.58E+05,1.01E+05,2.95E+05,,1.33E+04,,1.98E+03,2.33E+02,3.17E+03,1.94E+05,6.29E+03,,,,,,,,,1.20E+04,3.92E+03,1.97E+02,8.28E+04,,3.12E+02,,0.012,FALSE,2.18,9,1,90,10.2,5.48,1,cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf01023,6277,D3DV39; hsa:6277; P06703; Q5RHS4,ENSG00000197956,,Gastric cancer network 2; Vitamin D receptor pathway; Prostaglandin synthesis and regulation,3,0,72.8,,39.6,105.64,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,83.76,,95.36,2.29,transporter activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9H7B2,RPF2,Ribosome production factor 2 homolog OS=Homo sapiens OX=9606 GN=RPF2 PE=1 SV=2,1,1,100,1.444,100,10.426,6.64,0.53,6.64,3.38,1.00E-17,4.48E-01,1.00E-17,4.06E-02,4.03E+04,,5.11E+04,4.90E+03,2,,4,1,,,,8.12E+04,2.00E+04,,,,,,,6.85E+04,3.81E+04,9.63E+04,3.52E+04,,4.90E+03,,,,,,,8.12E+04,1.03E+03,,,,,,,3.06E+03,3.10E+02,1.30E+04,8.75E+02,,1.38E+03,,,,0,FALSE,6.379,6,1,306,35.6,9.99,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf04427,84154,hsa:84154; Q5VXN1; Q8N4A1; Q9H7B2,ENSG00000197498,,,0,0,85.39,,48.31,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,80.79,,48.27,4.24,nucleic acid binding activity,0,
Master Protein,High,O75569,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A OS=Homo sapiens OX=9606 GN=PRKRA PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.63E+05,,,,1,,,,,,,2.63E+05,,,,,,,,,,,,,,,,,,,,2.63E+05,,,,,,,,,,,,,,,,,0,FALSE,5.654,6,1,313,34.4,8.41,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes,cytosol;nucleus;other cell component,Pf00035,8575,A8K3I6; hsa:8575; O75569; Q53G24; Q6X7T5; Q8NDK4,ENSG00000180228,PKR-mediated signaling; MicroRNA (miRNA) biogenesis; Small interfering RNA (siRNA) biogenesis,VEGFA-VEGFR2 signaling; Ebola virus infection in host,5,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.41,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y4D7,PLXND1,Plexin-D1 OS=Homo sapiens OX=9606 GN=PLXND1 PE=1 SV=3,1,1,100,0.875,,100,6.64,-0.19,,6.64,1.00E-17,7.71E-01,,1.00E-17,3.92E+04,,3.43E+04,,1,,1,,,,,3.92E+04,,,,,,,,3.43E+04,,,,,,,,,,,,3.92E+04,,,,,,,,1.53E+03,,,,,,,,,0,FALSE,4.894,1,1,1925,211.9,7.15,1,cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,"Pf01403, Pf01437, Pf01833, Pf08337, Pf17960, Pf20170",23129,A7E2C6; C9JPZ6; hsa:23129; Q6PJS9; Q8IZJ2; Q9BTQ2; Q9Y4D7,ENSG00000004399,RND2 GTPase cycle; Other semaphorin interactions; NOTCH3 Intracellular Domain Regulates Transcription,Neurogenesis regulation in the olfactory epithelium,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.09,other molecular function,0,
Master Protein,High,P48382,RFX5,DNA-binding protein RFX5 OS=Homo sapiens OX=9606 GN=RFX5 PE=1 SV=1,7,11,100,0.167,100,3.153,6.64,-2.58,6.64,1.66,1.00E-17,1.44E-01,1.00E-17,2.70E-01,9.38E+04,,1.78E+04,4.38E+04,4,,3,2,,7.90E+04,3.36E+04,6.93E+05,1.12E+05,,,,,,,1.78E+04,,3.67E+05,1.61E+04,,5.11E+03,3.76E+05,,,,3.00E+02,3.28E+02,6.93E+05,5.75E+03,,,,,,,7.97E+02,,4.94E+04,4.00E+02,,1.44E+03,2.66E+03,,,0,FALSE,29.944,19,7,616,65.3,9.29,7,other biological processes,nucleus;other cell component,"Pf02257, Pf14621, Pf18326",5993,B7Z848; D3DV19; E9PFU4; hsa:5993; P48382; Q5VWC3,ENSG00000143390,,Prion disease pathway; IL-18 signaling pathway,2,0,135.57,,151.2,137.63,n/a,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,62.53,,15.84,30.34,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,P46087,NOP2,Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase OS=Homo sapiens OX=9606 GN=NOP2 PE=1 SV=2,1,1,100,0.3,100,7.373,6.64,-1.74,6.64,2.88,1.00E-17,2.33E-01,1.00E-17,4.38E-02,2.45E+06,,7.34E+05,9.96E+04,1,,2,1,,,,,2.45E+06,,,,,,,,5.25E+05,1.03E+06,,,,,9.96E+04,,,,,,1.26E+05,,,,,,,,4.26E+03,1.38E+05,,,,,2.33E+03,,0.019,FALSE,1.998,1,1,812,89.2,9.23,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf01189, Pf08062, Pf17125",4839,A1A4Z3; B3KPD6; hsa:4839; P46087; Q05BA7; Q0P5S5; Q3KQS4; Q58F30,ENSG00000111641,rRNA modification in the nucleus and cytosol; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,Imatinib and chronic myeloid leukemia,3,0,,,45.79,,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,50.74,,50.74,1.93,other molecular function,0,
Master Protein,High,Q9HAU5,UPF2,Regulator of nonsense transcripts 2 OS=Homo sapiens OX=9606 GN=UPF2 PE=1 SV=1,5,6,100,0.386,100,2.143,6.64,-1.37,6.64,1.1,1.00E-17,5.52E-01,1.00E-17,4.32E-01,5.98E+04,,4.64E+04,1.27E+04,5,,2,2,1.37E+05,5.98E+04,3.00E+04,3.99E+05,3.64E+04,,,,,,1.00E+05,2.15E+04,,,,,3.47E+03,4.67E+04,,,5.44E+02,2.27E+02,2.93E+02,3.99E+05,1.88E+03,,,,,,5.99E+02,9.61E+02,,,,,9.74E+02,3.31E+02,,,0,FALSE,22.729,8,5,1272,147.7,5.69,5,RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf02854, Pf04050",26019,A6NLJ5; D3DRS0; hsa:26019; Q14BM1; Q5W0J4; Q8N8U1; Q9H1J2; Q9HAU5; Q9NWL1; Q9P2D9; Q9Y4M9,ENSG00000151461,Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),,2,0,117.09,,91.39,121.89,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,114.02,,68.68,20.85,nucleic acid binding activity,0,
Master Protein,High,Q6PI47,KCTD18,BTB/POZ domain-containing protein KCTD18 OS=Homo sapiens OX=9606 GN=KCTD18 PE=2 SV=2,1,5,100,0.458,100,1.181,6.64,-1.13,6.64,0.24,1.00E-17,6.29E-01,1.00E-17,7.24E-01,1.67E+05,,4.58E+04,4.81E+04,3,,5,4,,1.94E+05,,1.67E+05,2.47E+04,,,,,,4.58E+04,8.89E+04,2.32E+04,2.08E+05,7.21E+03,8.50E+04,5.64E+03,5.51E+04,,4.20E+04,,7.39E+02,,1.67E+05,1.27E+03,,,,,,2.74E+02,3.97E+03,1.88E+02,2.80E+04,1.79E+02,1.66E+02,1.58E+03,3.90E+02,,4.47E+02,0,FALSE,5.236,4,1,426,46.7,9.1,1,cell organization and biogenesis,,"Pf02214, Pf19321",130535,hsa:130535; Q53T21; Q6NW26; Q6PCD8; Q6PI47; Q8N9B7; Q96N73,ENSG00000155729,,,0,0,70.79,,108.1,70.1,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,Acetyl [N-Term],FALSE,,111.66,,122.22,16.21,,0,
Master Protein,High,O15514,POLR2D,DNA-directed RNA polymerase II subunit RPB4 OS=Homo sapiens OX=9606 GN=POLR2D PE=1 SV=1,2,3,100,1.275,100,2.465,6.64,0.35,6.64,1.3,1.00E-17,3.64E-01,1.00E-17,3.02E-01,4.66E+05,,7.13E+05,2.43E+05,3,,3,1,,4.66E+05,,4.51E+05,6.42E+05,,,,,,,,7.13E+05,6.06E+05,1.04E+06,,,,2.43E+05,,,1.77E+03,,4.51E+05,3.31E+04,,,,,,,,5.79E+03,8.17E+04,2.59E+04,,,,5.69E+03,,0,FALSE,8.904,18,2,142,16.3,4.79,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus,Pf03874,5433,hsa:5433; O15514; Q52LT4,ENSG00000144231,Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,Pyrimidine metabolism,42,0,20.48,,28.98,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,51.6,,27.97,11.42,other molecular function,0,
Master Protein,Medium,Q9H3R5,CENPH,Centromere protein H OS=Homo sapiens OX=9606 GN=CENPH PE=1 SV=1,1,2,100,4.746,,100,6.64,2.25,,6.64,1.00E-17,3.08E-02,,1.00E-17,3.87E+04,,1.84E+05,,1,,3,,,,,3.87E+04,,,,,,,,,1.84E+05,1.77E+05,3.04E+05,,,,,,,,,3.87E+04,,,,,,,,,1.49E+03,2.39E+04,7.56E+03,,,,,,0.012,FALSE,2.221,7,1,247,28.5,5.29,1,cell cycle OR cell proliferation;cell organization and biogenesis,cytosol;nucleus;other cell component,Pf05837,64946,A8K3Y1; hsa:64946; Q9H3R5,ENSG00000153044,Deposition of new CENPA-containing nucleosomes at the centromere; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,7,0,,,32.22,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,4.98,,,5.39,other molecular function,0,
Master Protein,High,Q8N9A8,CNEP1R1,Nuclear envelope phosphatase-regulatory subunit 1 OS=Homo sapiens OX=9606 GN=CNEP1R1 PE=1 SV=1,1,1,100,0.47,,100,6.64,-1.09,,6.64,1.00E-17,6.94E-01,,1.00E-17,8.56E+04,,4.02E+04,,1,,3,,,,,8.56E+04,,,,,,,,4.02E+04,,9.03E+03,4.05E+04,,,,,,,,,8.56E+04,,,,,,,,1.80E+03,,1.22E+03,1.01E+03,,,,,,0.009,FALSE,2.316,8,1,125,14.3,8.38,1,other metabolic processes;other biological processes,other membranes;cytosol;nucleus;other cell component,Pf09771,255919,hsa:255919; Q4G1A9; Q5H9V0; Q8N9A8; Q8NE06,ENSG00000205423,Depolymerization of the Nuclear Lamina,,1,0,,,60.47,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,1.15,,,2.17,,0,
Master Protein,High,Q6ZSZ5,ARHGEF18,Rho guanine nucleotide exchange factor 18 OS=Homo sapiens OX=9606 GN=ARHGEF18 PE=1 SV=4,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.50E+05,,,,2,,,,,,,1.06E+05,2.12E+05,,,,,,,,,,,,,,,,,,,1.06E+05,1.09E+04,,,,,,,,,,,,,,,,0.003,FALSE,2.743,1,1,1361,151.5,6.33,1,cell organization and biogenesis;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00621, Pf17838",23370,A8MV62; B5ME81; hsa:23370; I3L1I5; O60274; Q6DD92; Q6ZSZ5,ENSG00000104880,RHOA GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),,5,0,47.1,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.06,enzyme regulator activity;other molecular function,0,
Master Protein,High,O75787,ATP6AP2,Renin receptor OS=Homo sapiens OX=9606 GN=ATP6AP2 PE=1 SV=2,1,1,100,0.897,,100,6.64,-0.16,,6.64,1.00E-17,7.37E-01,,1.00E-17,1.93E+05,,1.73E+05,,1,,1,,,,,1.93E+05,,,,,,,,,,1.73E+05,,,,,,,,,,1.93E+05,,,,,,,,,,2.33E+04,,,,,,,0.007,FALSE,2.399,4,1,350,39,6.1,1,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf07850,10159,B7Z9I3; hsa:10159; O75787; Q5QTQ7; Q6T7F5; Q8NBP3; Q8NG15; Q96FV6; Q96LB5; Q9H2P8; Q9UG89,ENSG00000182220,Neutrophil degranulation; Metabolism of Angiotensinogen to Angiotensins,ACE inhibitor pathway; Oxidative phosphorylation,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.64,other molecular function,0,
Master Protein,High,Q10567,AP1B1,AP-1 complex subunit beta-1 OS=Homo sapiens OX=9606 GN=AP1B1 PE=1 SV=3,8,20,100,0.321,100,0.743,6.64,-1.64,6.64,-0.43,1.00E-17,3.18E-01,1.00E-17,9.35E-01,6.13E+05,,1.33E+05,2.02E+06,2,,5,2,,,,4.19E+05,8.97E+05,,,,,,2.29E+05,1.33E+05,1.03E+05,1.03E+05,4.56E+05,,2.09E+06,,1.94E+06,,,,,4.19E+05,4.63E+04,,,,,,1.37E+03,5.93E+03,8.38E+02,1.38E+04,1.13E+04,,5.88E+05,,4.55E+04,,0,FALSE,36.293,13,3,949,104.5,5.06,8,cell organization and biogenesis;transport;developmental processes,other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf01602, Pf02883, Pf09066",162,C9JRD1; F8WDL0; hsa:162; P78436; Q10567; Q20WL3; Q86X54,ENSG00000100280,MHC class II antigen presentation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Nef mediated downregulation of MHC class I complex cell surface expression,,4,0,51.34,,73.1,5.27,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,High,n/a,1,,FALSE,,90.85,,116.31,69.66,other molecular function,0,
Master Protein,High,O75995,SASH3,SAM and SH3 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=SASH3 PE=1 SV=2,1,1,100,0.25,100,7.192,6.64,-2,6.64,2.85,1.00E-17,2.42E-01,1.00E-17,8.46E-02,1.73E+05,,4.31E+04,5.99E+03,1,,2,1,,,,1.73E+05,,,,,,,,8.16E+04,,2.28E+04,,,5.99E+03,,,,,,,1.73E+05,,,,,,,,3.64E+03,,3.07E+03,,,1.68E+03,,,,0,FALSE,4.34,5,1,380,41.6,5.27,1,cell cycle OR cell proliferation;other biological processes,nucleus;other cell component,"Pf00536, Pf07653, Pf12485",54440,A6NCH1; A8K7K8; hsa:54440; O75995; Q5JZ38,ENSG00000122122,,,0,0,,,79.65,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,101.05,,101.05,3.06,,0,
Master Protein,High,E9PGC5,PTPRK,protein-tyrosine-phosphatase OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.36E+05,,,,1,,,,,,,1.36E+05,,,,,,,,,,,,,,,,,,,,1.36E+05,,,,,,,,,,,,,,,,,0.001,FALSE,3.667,1,1,1472,165.9,5.91,1,cell adhesion;cell organization and biogenesis;other metabolic processes,plasma membrane;other membranes;other cell component,"Pf00041, Pf00102, Pf00629, Pf07679",,E9PGC5,ENSG00000152894; ENSG00000273993,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.18,other molecular function,0,
Master Protein,High,Q14574,DSC3,Desmocollin-3 OS=Homo sapiens OX=9606 GN=DSC3 PE=1 SV=3,1,1,100,0.37,,100,6.64,-1.43,,6.64,1.00E-17,4.59E-01,,1.00E-17,1.59E+05,,5.87E+04,,1,,1,,,,,1.59E+05,,,,,,,,,5.87E+04,,,,,,,,,,,1.59E+05,,,,,,,,,4.77E+02,,,,,,,,0,FALSE,6.097,2,1,896,99.9,6.1,1,cell adhesion;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf00028, Pf01049, Pf08758",1825,A6NN35; hsa:1825; Q14200; Q14574; Q9HAZ9,ENSG00000134762,Formation of the cornified envelope,Pleural mesothelioma,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,4.27,other molecular function,0,
Master Protein,High,P01860,IGHG3,Immunoglobulin heavy constant gamma 3 OS=Homo sapiens OX=9606 GN=IGHG3 PE=1 SV=3,2,9,100,8.764,100,0.989,6.64,3.13,6.64,-0.02,1.00E-17,1.19E-03,1.00E-17,8.48E-01,6.57E+04,,5.76E+05,5.82E+05,1,,2,2,,,,6.57E+04,,,,,,,,,,6.37E+05,5.21E+05,,1.01E+06,,3.37E+05,,,,,6.57E+04,,,,,,,,,,8.58E+04,1.29E+04,,2.83E+05,,7.88E+03,,0,FALSE,16.725,8,1,446,49.1,6.87,2,stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,Pf07654,,A0A075B6N8; A0A286YES1; A0A4W9A917; A2NU35; P01860,,Initial triggering of complement; Classical antibody-mediated complement activation; FCGR activation; Regulation of actin dynamics for phagocytic cup formation; Role of phospholipids in phagocytosis; FCGR3A-mediated IL10 synthesis; FCGR3A-mediated phagocytosis; Regulation of Complement cascade,,8,0,,,14.14,70.6,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,14.9,,77.26,30.24,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P30622,CLIP1,CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2,1,1,100,0.212,,100,6.64,-2.24,,6.64,1.00E-17,2.03E-01,,1.00E-17,1.53E+05,,3.24E+04,,2,,1,,,,3.65E+05,6.41E+04,,,,,,,,3.24E+04,,,,,,,,,,,3.57E+03,6.41E+04,,,,,,,,1.45E+03,,,,,,,,,0.002,FALSE,2.903,1,1,1438,162.1,5.36,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf01302, Pf16641",6249,A0AVD3; hsa:6249; P30622; Q17RS4; Q29RG0,ENSG00000130779,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Microtubule cytoskeleton regulation; PAFAH1B1 copy number variation,9,0,99.16,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,145.81,,,3.02,cytoskeletal activity;other molecular function,0,
Master Protein,High,A8MUS3,RPL23A,Ribosomal protein L23a OS=Homo sapiens OX=9606 GN=RPL23A PE=1 SV=1,3,7,100,0.487,100,0.878,6.64,-1.04,6.64,-0.19,1.00E-17,6.77E-01,1.00E-17,9.36E-01,1.08E+06,,2.01E+05,7.93E+05,3,,5,2,,,8.11E+04,2.83E+06,1.08E+06,,,,,,1.76E+05,8.72E+05,3.64E+05,9.55E+04,2.01E+05,,,2.09E+06,3.00E+05,,,,7.92E+02,2.83E+06,5.58E+04,,,,,,1.05E+03,3.89E+04,2.96E+03,1.29E+04,5.01E+03,,,1.48E+04,7.03E+03,,0,FALSE,10.24,15,3,194,21.9,10.48,3,protein metabolism;other metabolic processes,translational apparatus,"Pf00276, Pf03939",,A8MUS3,ENSG00000198242,,,0,0,104.53,,91.26,105.93,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,,121.24,,112.65,19.41,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8I5KRC6,MACROH2A1,MacroH2A.1 histone OS=Homo sapiens OX=9606 GN=MACROH2A1 PE=1 SV=1,21,469,100,1.313,100,2.163,6.64,0.39,6.64,1.11,1.00E-17,2.73E-01,1.00E-17,3.61E-01,1.06E+06,,2.63E+06,6.13E+05,5,,5,2,4.47E+05,1.47E+07,3.11E+05,1.06E+06,2.34E+07,,,,,,1.17E+07,9.46E+05,2.63E+06,1.96E+06,2.99E+06,,1.65E+05,,2.27E+06,,1.78E+03,5.60E+04,3.04E+03,1.06E+06,1.21E+06,,,,,,6.99E+04,4.23E+04,2.14E+04,2.64E+05,7.44E+04,,4.65E+04,,5.31E+04,,0,FALSE,129.269,65,2,343,36.5,9.95,21,cell organization and biogenesis,nucleus;other cell component,"Pf00125, Pf01661, Pf16211",,A0A8I5KRC6,ENSG00000113648,,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,2,0,132.29,,107.44,122.21,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,n/a,High,High,Peak Found,High,High,n/a,Peak Found,n/a,High,n/a,1,,FALSE,,138.79,,125.11,1308.34,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A6NFX8,NUDT5,Nudix hydrolase 5 OS=Homo sapiens OX=9606 GN=NUDT5 PE=1 SV=1,1,2,100,0.437,,100,6.64,-1.19,,6.64,1.00E-17,6.89E-01,,1.00E-17,2.28E+04,,9.95E+03,,2,,1,,,,,4.85E+04,1.07E+04,,,,,,,9.95E+03,,,,,,,,,,,,4.85E+04,5.51E+02,,,,,,,4.45E+02,,,,,,,,,0.001,FALSE,3.593,6,1,232,25.9,5.19,1,,,Pf00293,,A6NFX8,ENSG00000165609,,,0,0,90.36,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,123.14,,,6.52,other molecular function,0,
Master Protein,Medium,Q96S59,RANBP9,Ran-binding protein 9 OS=Homo sapiens OX=9606 GN=RANBP9 PE=1 SV=1,1,1,100,0.616,,100,6.64,-0.7,,6.64,1.00E-17,9.18E-01,,1.00E-17,2.32E+05,,1.44E+05,,2,,3,,,,,1.67E+05,3.23E+05,,,,,,,,1.58E+05,1.44E+05,1.30E+05,,,,,,,,,1.67E+05,1.67E+04,,,,,,,,1.28E+03,1.95E+04,3.23E+03,,,,,,0.024,FALSE,1.902,1,1,729,77.8,6.79,1,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00622, Pf08513, Pf10607",10048,A0PJA2; B2R8E1; hsa:10048; O94764; Q6P3T7; Q7LBR2; Q7Z7F9; Q96S59,ENSG00000010017,RAF/MAP kinase cascade; L1CAM interactions; MET activates RAS signaling,Brain-derived neurotrophic factor (BDNF) signaling pathway; Ciliary landscape,5,0,45.01,,9.68,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,47.11,,,1.89,other molecular function,0,
Master Protein,High,H0Y6G2,CAMK2G,calcium/calmodulin-dependent protein kinase OS=Homo sapiens OX=9606 GN=CAMK2G PE=1 SV=2,3,3,100,1.165,,100,6.64,0.22,,6.64,1.00E-17,4.98E-01,,1.00E-17,2.00E+05,,2.33E+05,,1,,1,,,,,2.00E+05,,,,,,,,,,2.33E+05,,,,,,,,,,2.00E+05,,,,,,,,,,3.14E+04,,,,,,,0,FALSE,10.499,9,3,588,65.2,7.94,3,other metabolic processes,other cell component,"Pf00069, Pf08332",,H0Y6G2,ENSG00000148660,,"NO/cGMP/PKG mediated neuroprotection; Splicing factor NOVA regulated synaptic proteins; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; Disruption of postsynaptic signaling by CNV",5,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,10.87,kinase activity;other molecular function,0,
Master Protein,Medium,A0A2R8YG42,ARHGEF7,Rho guanine nucleotide exchange factor 7 OS=Homo sapiens OX=9606 GN=ARHGEF7 PE=1 SV=1,1,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.28E+06,,,,1,,,,,,1.28E+06,,,,,,,,,,,,,,,,,,,,1.25E+04,,,,,,,,,,,,,,,,,,0.015,FALSE,2.095,2,1,862,97.1,6.73,1,cell organization and biogenesis;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,"Pf00169, Pf00307, Pf00621, Pf07653, Pf16523, Pf16614, Pf16615",,A0A2R8YG42,ENSG00000102606,,,0,0,,,,,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.08,enzyme regulator activity;other molecular function,0,
Master Protein,High,P15848,ARSB,Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1,1,1,100,0.97,,100,6.64,-0.04,,6.64,1.00E-17,7.35E-01,,1.00E-17,7.69E+04,,7.46E+04,,2,,1,,3.05E+05,,,1.94E+04,,,,,,,,,,7.46E+04,,,,,,,1.21E+03,,,1.94E+04,,,,,,,,,,1.00E+04,,,,,,,0.005,FALSE,2.46,4,1,533,59.6,8.21,1,cell organization and biogenesis;other metabolic processes;transport;other biological processes,non-structural extracellular;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00884,411,B2RC20; hsa:411; P15848; Q8N322; Q9UDI9,ENSG00000113273,Neutrophil degranulation; CS/DS degradation; Glycosphingolipid catabolism; The activation of arylsulfatases; MPS VI - Maroteaux-Lamy syndrome,Glycosaminoglycan degradation,6,0,124.56,,,,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,275.75,,,2.78,other molecular function,0,
Master Protein,High,Q5Y7H0,HLA-DQA1,HLA class II histocompatibility antigen DQ alpha chain OS=Homo sapiens OX=9606 GN=HLA-DQA1 PE=1 SV=1,3,29,100,7.807,,100,6.64,2.96,,6.64,1.00E-17,1.49E-03,,1.00E-17,8.07E+04,,6.30E+05,,1,,1,,,,,8.07E+04,,,,,,,,,,6.30E+05,,,,,,,,,,8.07E+04,,,,,,,,,,8.49E+04,,,,,,,0,FALSE,21.271,16,2,255,28.2,5.27,3,other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00993, Pf07654",,Q5Y7H0,ENSG00000228284,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,94.93,,0,
Master Protein,High,Q6P1N0,CC2D1A,Coiled-coil and C2 domain-containing protein 1A OS=Homo sapiens OX=9606 GN=CC2D1A PE=1 SV=1,2,2,100,0.257,100,1.28,6.64,-1.96,6.64,0.36,1.00E-17,3.36E-01,1.00E-17,7.24E-01,4.68E+04,,1.20E+04,9.40E+03,1,,1,1,,,,4.68E+04,,,,,,,,1.20E+04,,,,,9.40E+03,,,,,,,4.68E+04,,,,,,,,5.37E+02,,,,,2.64E+03,,,,0,FALSE,6.954,3,2,951,104,8.09,2,other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus,"Pf00168, Pf21528",54862,hsa:54862; Q6P1N0; Q7Z435; Q86XV0; Q8NF89; Q9H603; Q9NXI1,ENSG00000132024; ENSG00000288293,,Sudden infant death syndrome (SIDS) susceptibility pathways,1,0,,,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,0,6.22,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P42785,PRCP,Lysosomal Pro-X carboxypeptidase OS=Homo sapiens OX=9606 GN=PRCP PE=1 SV=1,1,2,100,0.451,,100,6.64,-1.15,,6.64,1.00E-17,5.84E-01,,1.00E-17,4.87E+05,,2.20E+05,,2,,2,,,3.06E+06,,7.77E+04,,,,,,,,,,3.82E+05,1.26E+05,,,,,,,1.16E+04,,7.77E+04,,,,,,,,,,5.15E+04,3.14E+03,,,,,,0.001,FALSE,4.247,4,1,496,55.8,7.21,1,protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf05577,5547,A8MU24; B2R7B7; B3KRK5; B5BU34; hsa:5547; P42785,ENSG00000137509,Neutrophil degranulation; Intrinsic Pathway of Fibrin Clot Formation,,2,0,134.41,,71.09,,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,260.68,,,7.7,other molecular function,0,
Master Protein,Medium,Q7LGA3,HS2ST1,Heparan sulfate 2-O-sulfotransferase 1 OS=Homo sapiens OX=9606 GN=HS2ST1 PE=1 SV=1,1,1,100,1.266,100,3.261,6.64,0.34,6.64,1.71,1.00E-17,4.45E-01,1.00E-17,2.27E-01,2.33E+05,,2.96E+05,9.07E+04,1,,4,2,,2.33E+05,,,,,,,,,,1.30E+05,3.62E+05,2.42E+05,4.25E+05,,1.20E+05,,6.87E+04,,,8.87E+02,,,,,,,,,,5.81E+03,2.94E+03,3.26E+04,1.06E+04,,3.36E+04,,1.61E+03,,0.03,FALSE,1.825,5,1,356,41.9,8.69,1,protein metabolism;other metabolic processes;developmental processes,other membranes;ER/Golgi,Pf03567,9653,D3DT22; hsa:9653; O75036; Q32NB5; Q7LGA3; Q8TAC5; Q9H441; Q9NUJ9,ENSG00000153936,HS-GAG biosynthesis,Glycosaminoglycan synthesis in fibroblasts; Metapathway biotransformation Phase I and II,3,0,,,45.15,38.28,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,49.05,,59.28,3.51,other molecular function,0,
Master Protein,High,Q09161,NCBP1,Nuclear cap-binding protein subunit 1 OS=Homo sapiens OX=9606 GN=NCBP1 PE=1 SV=1,3,8,100,0.585,100,,6.64,-0.77,6.64,,1.00E-17,8.42E-01,1.00E-17,,5.20E+05,,1.55E+05,1.42E+05,1,,1,1,,,,5.20E+05,,,,,,,,,,1.55E+05,,,,,,1.42E+05,,,,5.20E+05,,,,,,,,,,2.08E+04,,,,,,1.51E+03,0,FALSE,10.993,6,3,790,91.8,6.43,3,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes,cytosol;mitochondrion;nucleus;other cell component,"Pf02854, Pf09088, Pf09090",4686,B2R718; hsa:4686; Q09161; Q59G76; Q5T1V0; Q5T7X2,ENSG00000136937,Regulation of expression of SLITs and ROBOs; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; snRNP Assembly; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Abortive elongation of HIV-1 transcript in the absence of Tat; RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; mRNA Capping; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Signaling by FGFR2 IIIa TM; Processing of Intronless Pre-mRNAs; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,mRNA processing; 3q29 copy number variation syndrome,29,0,,,,,High,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,0,,,22.75,nucleic acid binding activity;other molecular function,0,
Master Protein,High,H0UI80,NELFCD,Negative elongation factor complex member C/D OS=Homo sapiens OX=9606 GN=NELFCD PE=1 SV=1,3,9,100,0.153,100,10.418,6.64,-2.71,6.64,3.38,1.00E-17,5.64E-02,1.00E-17,4.44E-02,4.98E+05,,9.83E+04,6.62E+04,4,,4,3,7.00E+05,,3.54E+05,8.70E+05,1.54E+05,,,,,,2.28E+05,,4.24E+04,3.09E+05,1.53E+04,,1.38E+04,,2.72E+05,6.62E+04,2.78E+03,,3.46E+03,8.70E+05,7.92E+03,,,,,,1.36E+03,,3.44E+02,4.16E+04,3.80E+02,,3.86E+03,,6.37E+03,7.05E+02,0,FALSE,20.79,7,3,599,67.3,5.21,3,other biological processes,nucleus,Pf04858,51497,H0UI80; H0UI81; hsa:51497,ENSG00000101158,,Initiation of transcription and translation elongation at the HIV-1 LTR; 4p16.3 copy number variation,2,0,62.53,,95.99,116.37,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,,112.96,,130.24,25.95,,0,
Master Protein,High,P82663,MRPS25,"28S ribosomal protein S25, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS25 PE=1 SV=1",1,1,100,0.648,,100,6.64,-0.63,,6.64,1.00E-17,9.52E-01,,1.00E-17,5.97E+04,,3.87E+04,,1,,1,,,,,5.97E+04,,,,,,,,3.87E+04,,,,,,,,,,,,5.97E+04,,,,,,,,1.73E+03,,,,,,,,,0,FALSE,6.098,10,1,173,20.1,8.82,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf05047,64432,B4DFJ5; B4DQG6; hsa:64432; P82663; Q9H7P5,ENSG00000131368,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.85,other molecular function,0,
Master Protein,Medium,Q15583,TGIF1,Homeobox protein TGIF1 OS=Homo sapiens OX=9606 GN=TGIF1 PE=1 SV=3,1,1,100,0.144,100,0.01,6.64,-2.79,6.64,-6.64,1.00E-17,7.08E-02,1.00E-17,1.00E-17,2.01E+05,,2.90E+04,3.97E+06,4,,2,2,2.60E+05,5.30E+06,1.54E+05,1.27E+04,,,,,,,,1.25E+04,,,6.73E+04,,,,2.45E+05,6.44E+07,1.03E+03,2.02E+04,1.51E+03,1.27E+04,,,,,,,,5.57E+02,,,1.67E+03,,,,5.73E+03,6.85E+05,0.012,FALSE,2.147,2,1,401,43,8.92,1,other biological processes,nucleus;other cell component,Pf05920,7050,A6NE42; A6NLU7; F8VZB6; hsa:7050; Q15583; Q6ICR0; Q8N5X9; Q9NRS0,ENSG00000177426,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Downregulation of SMAD2/3:SMAD4 transcriptional activity,Androgen receptor signaling pathway; TGF-beta signaling pathway; Tgif disruption of Shh signaling; TGF-beta receptor signaling in skeletal dysplasias; TGF-beta receptor signaling,7,0,180.25,,97.19,140.35,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,1,Phospho [T100],FALSE,,135.29,,515.57,1.81,nucleic acid binding activity;other molecular function,1,Phospho [T100]
Master Protein,High,Q5M775,SPECC1,Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,1,1,100,1.577,100,0.346,6.64,0.66,6.64,-1.53,1.00E-17,4.04E-01,1.00E-17,5.04E-01,5.58E+04,,8.80E+04,2.55E+05,1,,1,1,,,,5.58E+04,,,,,,,,,,8.80E+04,,,2.55E+05,,,,,,,5.58E+04,,,,,,,,,,1.19E+04,,,7.15E+04,,,,0,FALSE,5.189,1,1,1068,118.5,6.7,1,cell organization and biogenesis;developmental processes;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf00307,92521,B4DHH0; B7WNS8; hsa:92521; Q5IBP1; Q5IBP2; Q5IBP3; Q5IBP4; Q5M772; Q5M773; Q5M774; Q5M775; Q86XT8; Q8N4U4; Q8WU84; Q9HCQ3,ENSG00000128487,,,0,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,0,3.17,,0,
Master Protein,High,P13861,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR2A PE=1 SV=2,1,5,100,1.146,100,0.833,6.64,0.2,6.64,-0.26,1.00E-17,5.01E-01,1.00E-17,9.97E-01,2.58E+05,,2.96E+05,4.85E+05,2,,4,3,,,,2.78E+05,2.40E+05,,,,,,1.61E+05,2.50E+05,,6.38E+05,3.50E+05,,,6.02E+05,1.68E+05,4.85E+05,,,,2.78E+05,1.24E+04,,,,,,9.65E+02,1.12E+04,,8.60E+04,8.70E+03,,,4.27E+03,3.93E+03,5.16E+03,0,FALSE,7.039,5,1,404,45.5,5.07,1,signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00027, Pf02197",5576,hsa:5576; P13861; Q16823; Q9BUB1,ENSG00000114302,FCGR3A-mediated IL10 synthesis; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase; ROBO receptors bind AKAP5,Myometrial relaxation and contraction pathways; G protein signaling pathways; TGF-beta signaling pathway; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; GDNF signaling; Calcium regulation in cardiac cells; EPAC1 and PKA reduction of retinal inflammation; Sudden infant death syndrome (SIDS) susceptibility pathways,22,0,10.38,,59.19,53.73,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,50.9,,77.21,21.1,enzyme regulator activity;other molecular function,0,
Master Protein,High,E9PPM1,TP53I11,Tumor protein p53-inducible protein 11 OS=Homo sapiens OX=9606 GN=TP53I11 PE=1 SV=1,2,3,100,0.133,100,0.17,6.64,-2.91,6.64,-2.56,1.00E-17,2.61E-02,1.00E-17,1.36E-01,7.57E+05,,9.47E+04,5.57E+05,3,,2,2,,7.57E+05,,1.53E+05,8.90E+05,,,,,,8.24E+04,,1.09E+05,,,,,1.27E+06,2.44E+05,,,2.88E+03,,1.53E+05,4.59E+04,,,,,,4.93E+02,,8.85E+02,,,,,9.04E+03,5.70E+03,,0,FALSE,4.684,7,2,236,26,9.04,2,,other membranes,Pf14936,,E9PPM1,ENSG00000175274,,11p11.2 copy number variation syndrome,1,0,65.41,,19.63,96.04,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,,48.43,,119.29,6.29,,0,
Master Protein,High,Q9UKF6,CPSF3,Cleavage and polyadenylation specificity factor subunit 3 OS=Homo sapiens OX=9606 GN=CPSF3 PE=1 SV=1,3,4,100,1.369,100,1.504,6.64,0.45,6.64,0.59,1.00E-17,4.55E-01,1.00E-17,6.06E-01,5.75E+04,,1.86E+05,9.36E+04,4,,2,2,3.73E+04,4.99E+04,,5.05E+05,6.62E+04,,,,,,9.57E+04,,,3.63E+05,,1.34E+05,,6.55E+04,,,1.48E+02,1.90E+02,,5.05E+05,3.41E+03,,,,,,5.72E+02,,,4.89E+04,,2.61E+02,,4.64E+02,,,0,FALSE,13.312,8,3,684,77.4,5.6,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf07521, Pf10996, Pf11718, Pf16661",51692,hsa:51692; O14769; Q53RS2; Q96F36; Q9UKF6,ENSG00000119203,Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,mRNA processing,6,0,138.1,,82.39,48.52,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,,96.77,,54.16,11.82,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H4A6,GOLPH3,Golgi phosphoprotein 3 OS=Homo sapiens OX=9606 GN=GOLPH3 PE=1 SV=1,2,2,100,1.309,,100,6.64,0.39,,6.64,1.00E-17,4.77E-01,,1.00E-17,1.94E+04,,2.54E+04,,1,,2,,,,,1.94E+04,,,,,,,7.72E+04,8.38E+03,,,,,,,,,,,,1.94E+04,,,,,,,4.62E+02,3.74E+02,,,,,,,,,0,FALSE,4.952,11,2,298,33.8,6.44,2,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component,Pf05719,64083,hsa:64083; Q9H4A6; Q9UIW5,ENSG00000113384,,,0,0,,,113.73,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,200.6,,,6.02,other molecular function,0,
Master Protein,High,Q9NP92,MRPS30,"39S ribosomal protein S30, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS30 PE=1 SV=2",2,2,100,0.682,100,1.294,6.64,-0.55,6.64,0.37,1.00E-17,9.87E-01,1.00E-17,6.90E-01,1.36E+05,,3.17E+05,2.08E+04,2,,3,1,,,,4.69E+05,3.94E+04,,,,,,,1.26E+05,,3.17E+05,3.23E+05,,,,2.08E+04,,,,,4.69E+05,2.03E+03,,,,,,,5.62E+03,,4.28E+04,8.03E+03,,,,4.86E+02,,0,FALSE,7.344,6,2,439,50.3,7.97,2,protein metabolism;other metabolic processes;other biological processes,other membranes;mitochondrion;translational apparatus,Pf07147,10884,hsa:10884; Q96I91; Q96Q19; Q9H0P8; Q9NP92; Q9NSF9; Q9NZ76,ENSG00000112996,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,119.5,,43.97,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,32.58,,1.5,6.62,other molecular function,0,
Master Protein,High,A0A994J4Y8,PGAM5,"PGAM family member 5, mitochondrial serine/threonine protein phosphatase OS=Homo sapiens OX=9606 GN=PGAM5 PE=4 SV=1",4,9,100,0.702,100,2.318,6.64,-0.51,6.64,1.21,1.00E-17,9.03E-01,1.00E-17,3.02E-01,2.18E+06,,3.72E+05,1.67E+05,5,,5,4,7.59E+05,4.34E+06,1.71E+05,2.18E+06,2.85E+06,,,,,,3.61E+05,5.19E+05,4.38E+05,2.87E+05,3.72E+05,,9.56E+04,5.67E+04,2.93E+05,1.62E+06,3.02E+03,1.65E+04,1.67E+03,2.18E+06,1.47E+05,,,,,,2.16E+03,2.32E+04,3.56E+03,3.87E+04,9.24E+03,,2.69E+04,4.02E+02,6.87E+03,1.72E+04,0,FALSE,12.421,19,4,288,31.9,8.68,4,,,,192111,A0A994J4Y8,ENSG00000247077,,NRF2-ARE regulation,1,0,80.86,,22.08,143.73,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,96.75,,102.8,19.55,,0,
Master Protein,High,Q16740,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial OS=Homo sapiens OX=9606 GN=CLPP PE=1 SV=1",2,7,100,1.26,100,0.526,6.64,0.33,6.64,-0.93,1.00E-17,4.89E-01,1.00E-17,7.11E-01,1.25E+05,,1.57E+05,2.98E+05,1,,3,1,,,,1.25E+05,,,,,,,,,1.57E+05,1.22E+05,6.17E+05,,2.98E+05,,,,,,,1.25E+05,,,,,,,,,1.28E+03,1.65E+04,1.53E+04,,8.38E+04,,,,0,FALSE,11.118,13,2,277,30.2,8.09,2,protein metabolism;other metabolic processes,mitochondrion;other cell component,Pf00574,8192,B2R4W5; hsa:8192; Q16740,ENSG00000125656,Mitochondrial protein degradation,Primary ovarian insufficiency,2,0,,,92.4,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,32.7,,41.95,25.98,other molecular function,0,
Master Protein,High,I3L0M9,ELOB,Elongin B (Fragment) OS=Homo sapiens OX=9606 GN=ELOB PE=1 SV=1,1,3,100,0.105,,100,6.64,-3.26,,6.64,1.00E-17,1.33E-02,,1.00E-17,7.04E+05,,7.37E+04,,1,,2,,,,,7.04E+05,,,,,,,,1.18E+05,,4.61E+04,,,,,,,,,,7.04E+05,,,,,,,,5.26E+03,,6.22E+03,,,,,,,0,FALSE,5.49,18,1,140,15.6,5.17,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,,,I3L0M9,ENSG00000103363,,Dual hijack model of Vif in HIV infection; Type 2 papillary renal cell carcinoma; Hijack of ubiquitination by SARS-CoV-2; Modulators of TCR signaling and T cell activation,4,0,,,61.76,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,71.97,,,7.39,,0,
Master Protein,High,Q96ER9,CCDC51,Mitochondrial potassium channel OS=Homo sapiens OX=9606 GN=CCDC51 PE=1 SV=2,2,4,100,0.951,100,1.868,6.64,-0.07,6.64,0.9,1.00E-17,7.48E-01,1.00E-17,4.38E-01,7.15E+04,,6.80E+04,3.64E+04,1,,5,1,,,,7.15E+04,,,,,,,4.38E+04,5.48E+04,6.80E+04,8.21E+04,8.15E+04,,3.64E+04,,,,,,,7.15E+04,,,,,,,2.62E+02,2.45E+03,5.53E+02,1.11E+04,2.03E+03,,1.02E+04,,,,0,FALSE,6.956,8,2,411,45.8,8.19,2,cell organization and biogenesis;transport,other membranes;mitochondrion,,79714,hsa:79714; Q96ER9; Q9HA01,ENSG00000164051,,,0,0,,,25.37,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,25.39,,29.4,12.34,transporter activity,0,
Master Protein,High,Q9Y3A2,UTP11,Probable U3 small nucleolar RNA-associated protein 11 OS=Homo sapiens OX=9606 GN=UTP11 PE=1 SV=2,3,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.19E+05,,,,1,,,,,,,1.19E+05,,,,,,,,,,,,,,,,,,,,1.19E+05,,,,,,,,,,,,,,,,,0,FALSE,17.874,13,3,253,30.4,10.15,3,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,non-structural extracellular;nucleus;other cell component,Pf03998,51118,A8K785; B4DJC6; D3DPT7; hsa:51118; Q5VT93; Q9BS98; Q9NS31; Q9Y3A2,ENSG00000183520,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,11.8,,0,
Master Protein,High,E9PN81,RNASEH2C,Ribonuclease H2 subunit C OS=Homo sapiens OX=9606 GN=RNASEH2C PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.99E+05,,,,1,,,,,,,2.99E+05,,,,,,,,,,,,,,,,,,,,2.99E+05,,,,,,,,,,,,,,,,,0,FALSE,7.188,10,1,247,26.3,6.37,1,RNA metabolism OR transcription;other metabolic processes,other cell component,Pf08615,,E9PN81,ENSG00000172922,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.41,,0,
Master Protein,High,A0A994J5J9,PHC2,Polyhomeotic homolog 2 OS=Homo sapiens OX=9606 GN=PHC2 PE=4 SV=1,5,6,100,2.068,,100,6.64,1.05,,6.64,1.00E-17,1.02E-01,,1.00E-17,4.95E+05,,8.47E+05,,2,,4,,,,,1.45E+06,1.70E+05,,,,,,,1.48E+06,4.64E+05,4.83E+05,2.58E+06,,,,,,,,,1.45E+06,8.75E+03,,,,,,,6.63E+04,3.77E+03,6.51E+04,6.41E+04,,,,,,0,FALSE,19.458,10,4,881,92.9,8.76,5,,nucleus;other cell component,,,A0A994J5J9,ENSG00000134686,,,0,1,111.75,,80.25,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,99.18,,,17.48,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O95983,MBD3,Methyl-CpG-binding domain protein 3 OS=Homo sapiens OX=9606 GN=MBD3 PE=1 SV=1,4,5,100,0.457,100,0.494,6.64,-1.13,6.64,-1.02,1.00E-17,6.32E-01,1.00E-17,6.40E-01,8.03E+05,,5.01E+05,9.47E+04,3,,4,1,8.03E+05,,,3.74E+05,5.38E+06,,,,,,,1.67E+04,6.07E+05,6.07E+05,4.14E+05,,9.47E+04,,,,3.19E+03,,,3.74E+05,2.77E+05,,,,,,,7.44E+02,4.93E+03,8.17E+04,1.03E+04,,2.66E+04,,,,0,FALSE,17.456,19,4,291,32.8,5.34,4,cell organization and biogenesis;developmental processes;other biological processes,nucleus;other cell component,"Pf01429, Pf14048, Pf16564",53615,A8K4B7; D6W5Z2; hsa:53615; O95983; Q6PIL9; Q6PJZ9; Q86XF4,ENSG00000071655,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,Effect of progerin on genes involved in progeria,7,0,126.94,,67.68,,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,126.15,,70.04,16.22,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UL63,MKLN1,Muskelin OS=Homo sapiens OX=9606 GN=MKLN1 PE=1 SV=2,1,1,100,0.299,100,2.381,6.64,-1.74,6.64,1.25,1.00E-17,4.29E-01,1.00E-17,3.94E-01,3.35E+04,,1.00E+04,4.21E+03,1,,2,1,,,,3.35E+04,,,,,,,,9.89E+03,,1.02E+04,,,4.21E+03,,,,,,,3.35E+04,,,,,,,,4.42E+02,,1.37E+03,,,1.18E+03,,,,0.01,FALSE,2.297,2,1,735,84.7,6.34,1,cell adhesion;cell organization and biogenesis;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf01344, Pf06588, Pf13415",4289,A4D1M8; A6NG43; hsa:4289; Q9NSK4; Q9NUS8; Q9UL63,ENSG00000128585,,Ciliary landscape,1,0,,,2.05,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,2.15,,2.15,2.45,other molecular function,0,
Master Protein,High,Q8NI27,THOC2,THO complex subunit 2 OS=Homo sapiens OX=9606 GN=THOC2 PE=1 SV=2,8,16,100,0.826,100,1.45,6.64,-0.28,6.64,0.54,1.00E-17,7.03E-01,1.00E-17,5.83E-01,1.45E+06,,1.12E+06,1.64E+05,3,,4,3,1.48E+06,,8.07E+05,1.45E+06,,,,,,,1.44E+06,1.58E+05,,2.76E+06,8.67E+05,1.64E+05,2.86E+04,,6.85E+05,,5.88E+03,,7.89E+03,1.45E+06,,,,,,,8.59E+03,7.08E+03,,3.72E+05,2.16E+04,3.20E+02,8.03E+03,,1.60E+04,,0,FALSE,31.227,7,8,1593,182.7,8.44,8,RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,nucleus,"Pf11262, Pf11732, Pf16134",57187,A6NM50; hsa:57187; Q5JZ12; Q6IN92; Q8NI27; Q9H8I6,ENSG00000125676,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,,3,0,30.47,,84.44,118.47,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,89.29,,99.62,39.43,nucleic acid binding activity,0,
Master Protein,High,Q15397,PUM3,Pumilio homolog 3 OS=Homo sapiens OX=9606 GN=PUM3 PE=1 SV=3,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.52E+05,,,,1,,,,,,,1.52E+05,,,,,,,,,,,,,,,,,,,,1.52E+05,,,,,,,,,,,,,,,,,0.001,FALSE,3.105,4,1,648,73.5,9.64,1,other biological processes,ER/Golgi;nucleus;other cell component,Pf08144,9933,A8K804; hsa:9933; Q15397; Q547G7; Q5SZY9; Q6IB47; Q96B27; Q96L78; Q96L79; Q96L80,ENSG00000080608,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3,nucleic acid binding activity,0,
Master Protein,High,Q8NAV1,PRPF38A,Pre-mRNA-splicing factor 38A OS=Homo sapiens OX=9606 GN=PRPF38A PE=1 SV=1,2,2,100,0.571,,100,6.64,-0.81,,6.64,1.00E-17,8.48E-01,,1.00E-17,5.95E+04,,3.40E+04,,1,,2,,,,,5.95E+04,,,,,,,,2.80E+04,,4.12E+04,,,,,,,,,,5.95E+04,,,,,,,,1.25E+03,,5.55E+03,,,,,,,0,FALSE,7.418,11,2,312,37.5,9.96,2,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf03371, Pf12871",84950,hsa:84950; Q8NAV1; Q96JW1; Q9BVZ8,ENSG00000134748,mRNA Splicing - Major Pathway,MECP2 and associated Rett syndrome,2,0,,,26.88,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,28.71,,,5.07,,0,
Master Protein,High,Q16204,CCDC6,Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2,2,2,100,1.87,100,2.236,6.64,0.9,6.64,1.16,1.00E-17,2.71E-01,1.00E-17,4.04E-01,8.53E+04,,1.60E+05,7.14E+04,1,,1,1,,,,8.53E+04,,,,,,,,,,1.60E+05,,,7.14E+04,,,,,,,8.53E+04,,,,,,,,,,2.15E+04,,,2.01E+04,,,,0,FALSE,8.26,8,2,474,53.3,7.34,2,cell organization and biogenesis,cytosol;cytoskeleton,Pf09755,8030,hsa:8030; Q15250; Q16204; Q6GSG7,ENSG00000108091,,Retinoblastoma gene in cancer; Mesodermal commitment pathway; 16p11.2 proximal deletion syndrome,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,0,6.9,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q14571,ITPR2,"Inositol 1,4,5-trisphosphate receptor type 2 OS=Homo sapiens OX=9606 GN=ITPR2 PE=1 SV=2",5,15,100,1.98,100,2.992,6.64,0.99,6.64,1.58,1.00E-17,2.14E-01,1.00E-17,3.13E-01,1.44E+05,,1.55E+05,2.54E+04,2,,5,3,,,,1.08E+05,1.93E+05,,,,,,5.68E+04,1.71E+05,1.55E+05,4.12E+05,3.04E+04,5.04E+05,2.54E+04,,1.62E+04,,,,,1.08E+05,9.95E+03,,,,,,3.40E+02,7.64E+03,1.26E+03,5.55E+04,7.56E+02,9.83E+02,7.13E+03,,3.78E+02,,0,FALSE,19.837,3,3,2701,307.9,6.43,5,stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,"Pf00520, Pf01365, Pf02815, Pf08454, Pf08709",3709,hsa:3709; O94773; Q14571,ENSG00000123104,Role of phospholipids in phagocytosis; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Ion homeostasis; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Ca2+ pathway; VEGFR2 mediated cell proliferation; Elevation of cytosolic Ca2+ levels; PLC beta mediated events; DAG and IP3 signaling; CLEC7A (Dectin-1) induces NFAT activation; Effects of PIP2 hydrolysis,Alzheimer's disease and miRNA effects; Myometrial relaxation and contraction pathways; Vitamin D-sensitive calcium signaling in depression; Thyroid hormones production and peripheral downstream signaling effects; Alzheimer's disease; GDNF signaling; Calcium regulation in cardiac cells,21,0,39.95,,91.38,153.46,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,83.42,,88.87,40.33,transporter activity;other molecular function,0,
Master Protein,High,Q9NPJ6,MED4,Mediator of RNA polymerase II transcription subunit 4 OS=Homo sapiens OX=9606 GN=MED4 PE=1 SV=1,5,9,100,2.024,,100,6.64,1.02,,6.64,1.00E-17,6.13E-02,,1.00E-17,8.53E+05,,1.07E+06,,1,,1,,,,,8.53E+05,,,,,,,,,,1.07E+06,,,,,,,,,,8.53E+05,,,,,,,,,,1.44E+05,,,,,,,0,FALSE,18.382,24,5,270,29.7,5.1,5,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf10018,29079,B4DX67; hsa:29079; Q53GB4; Q53H68; Q5T912; Q6FHC4; Q6IA79; Q9BS95; Q9NPJ6; Q9NYR5,ENSG00000136146,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; RSV-host interactions; Generic Transcription Pathway,,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,91.08,,,30.56,other molecular function,0,
Master Protein,High,P09497,CLTB,Clathrin light chain B OS=Homo sapiens OX=9606 GN=CLTB PE=1 SV=1,1,5,100,0.169,100,0.103,6.64,-2.57,6.64,-3.28,1.00E-17,1.33E-01,1.00E-17,8.63E-02,1.61E+05,,3.22E+04,3.49E+05,5,,4,2,1.61E+05,5.28E+05,1.13E+05,7.40E+04,1.36E+06,,,,,,,1.81E+04,7.17E+04,3.65E+04,2.85E+04,7.49E+05,1.63E+05,,,,6.38E+02,2.01E+03,1.10E+03,7.40E+04,7.04E+04,,,,,,,8.07E+02,5.83E+02,4.91E+03,7.09E+02,1.46E+03,4.57E+04,,,,0.004,FALSE,2.63,4,1,229,25.2,4.64,1,transport,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,Pf01086,1212,hsa:1212; P09497; Q53Y37; Q6FHW1,ENSG00000175416,"Lysosome Vesicle Biogenesis; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; Formation of annular gap junctions",Ebola virus infection in host; Fragile X syndrome; 5q35 copy number variation,11,0,121.33,,60.18,90.98,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,94.9,,96.82,12.46,other molecular function,0,
Master Protein,High,Q9NQG5,RPRD1B,Regulation of nuclear pre-mRNA domain-containing protein 1B OS=Homo sapiens OX=9606 GN=RPRD1B PE=1 SV=1,2,5,100,0.842,100,0.257,6.64,-0.25,6.64,-1.96,1.00E-17,6.91E-01,1.00E-17,2.39E-01,9.24E+05,,7.78E+05,3.51E+06,4,,4,4,1.07E+06,,5.81E+05,7.96E+05,1.19E+06,,,,,,,8.11E+05,1.19E+06,7.46E+05,3.24E+05,2.67E+06,,4.66E+06,3.42E+05,4.62E+06,4.26E+03,,5.68E+03,7.96E+05,6.15E+04,,,,,,,3.62E+04,9.69E+03,1.01E+05,8.05E+03,5.20E+03,,3.31E+04,8.00E+03,4.92E+04,0,FALSE,10.34,11,2,326,36.9,5.97,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf04818, Pf16566",58490,hsa:58490; Q1WDE7; Q6PKF4; Q9NQG5,ENSG00000101413,RNA polymerase II transcribes snRNA genes,Modulators of TCR signaling and T cell activation,2,0,30.22,,46.29,66.58,High,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,51.03,,88.66,15.06,other molecular function,0,
Master Protein,High,Q9NQX4,MYO5C,Unconventional myosin-Vc OS=Homo sapiens OX=9606 GN=MYO5C PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,5.12E+05,,,,4,,,,3.90E+06,6.81E+05,,1.66E+05,3.86E+05,,,,,,,,,,,,,,,,1.55E+04,2.59E+03,,1.66E+05,1.99E+04,,,,,,,,,,,,,,,,0,FALSE,5.25,1,1,1742,202.7,7.71,1,cell organization and biogenesis;transport,cytoskeleton;other cell component,"Pf00063, Pf00612, Pf01843",55930,hsa:55930; Q6P1W8; Q9NQX4,ENSG00000128833,,,0,0,136.98,,,,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.22,cytoskeletal activity;other molecular function,0,
Master Protein,High,P78346,RPP30,Ribonuclease P protein subunit p30 OS=Homo sapiens OX=9606 GN=RPP30 PE=1 SV=1,1,1,100,0.409,,100,6.64,-1.29,,6.64,1.00E-17,5.97E-01,,1.00E-17,6.83E+04,,2.80E+04,,1,,3,,,,,6.83E+04,,,,,,,,2.80E+04,,6.84E+04,2.04E+04,,,,,,,,,6.83E+04,,,,,,,,1.25E+03,,9.21E+03,5.08E+02,,,,,,0.001,FALSE,3.167,6,1,268,29.3,8.91,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf01876,10556,B2R799; E9PB02; hsa:10556; P78346,ENSG00000148688,tRNA processing in the nucleus; Major pathway of rRNA processing in the nucleolus and cytosol,,2,0,,,66.21,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,54.56,,,2.77,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A5F9ZI63,EED,Embryonic ectoderm development OS=Homo sapiens OX=9606 GN=EED PE=1 SV=2,2,3,100,1.074,100,0.636,6.64,0.1,6.64,-0.65,1.00E-17,5.78E-01,1.00E-17,8.08E-01,2.52E+05,,2.40E+05,3.84E+05,1,,3,2,,,,2.52E+05,,,,,,,,,2.23E+05,1.12E+06,2.40E+05,,8.50E+04,1.74E+06,,,,,,2.52E+05,,,,,,,,,1.82E+03,1.51E+05,5.95E+03,,2.39E+04,1.23E+04,,,0,FALSE,6.012,4,2,501,56.3,8.29,2,,cytosol;nucleus,Pf00400,,A0A5F9ZI63,ENSG00000074266,,Histone modifications; Interactome of polycomb repressive complex 2 (PRC2) ; Tumor suppressor activity of SMARCB1; Epithelial to mesenchymal transition in colorectal cancer; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; Pleural mesothelioma; 5q35 copy number variation,7,0,,,97.08,128.23,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,149.22,,121.59,6.65,,0,
Master Protein,High,Q9BYG3,NIFK,MKI67 FHA domain-interacting nucleolar phosphoprotein OS=Homo sapiens OX=9606 GN=NIFK PE=1 SV=1,3,3,100,0.452,100,0.448,6.64,-1.15,6.64,-1.16,1.00E-17,6.41E-01,1.00E-17,6.32E-01,9.63E+04,,4.26E+04,9.51E+04,2,,4,2,6.57E+04,,,1.41E+05,,,,,,,,3.38E+05,5.49E+04,2.65E+04,3.30E+04,1.63E+05,,,5.56E+04,,2.61E+02,,,1.41E+05,,,,,,,,1.51E+04,4.46E+02,3.57E+03,8.21E+02,3.17E+02,,,1.30E+03,,0,FALSE,10.488,15,3,293,34.2,9.88,3,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00076, Pf12196",84365,A8K788; hsa:84365; Q8TB66; Q96ED4; Q9BYG3,ENSG00000155438,,,0,0,51.46,,133,69.35,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,,91.72,,98.67,8.94,nucleic acid binding activity,0,
Master Protein,Medium,P60468,SEC61B,Protein transport protein Sec61 subunit beta OS=Homo sapiens OX=9606 GN=SEC61B PE=1 SV=2,1,1,100,0.951,100,1.245,6.64,-0.07,6.64,0.32,1.00E-17,6.86E-01,1.00E-17,6.93E-01,2.63E+05,,2.50E+05,2.42E+05,1,,4,4,,,,,2.63E+05,,,,,,,2.87E+05,1.26E+05,2.17E+05,7.22E+05,,3.13E+04,9.84E+05,1.02E+05,5.75E+05,,,,,1.36E+04,,,,,,,1.28E+04,1.03E+03,2.93E+04,1.79E+04,,8.80E+03,6.98E+03,2.39E+03,6.12E+03,0.03,FALSE,1.814,10,1,96,10,11.56,1,protein metabolism;other metabolic processes;stress response;transport,other membranes;cytosol;ER/Golgi,Pf03911,10952,hsa:10952; P38390; P38391; P60468; Q6IBC1,ENSG00000106803,ER-Phagosome pathway; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; SRP-dependent cotranslational protein targeting to membrane,,3,0,,,78.14,105.18,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,,59.54,,122.03,2,translation activity;other molecular function,0,
Master Protein,High,O00566,MPHOSPH10,U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens OX=9606 GN=MPHOSPH10 PE=1 SV=2,1,4,100,1.089,100,3.185,6.64,0.12,6.64,1.67,1.00E-17,6.07E-01,1.00E-17,2.17E-01,1.84E+05,,7.99E+04,2.51E+04,2,,4,1,,,,5.52E+05,6.12E+04,,,,,,,9.23E+04,6.42E+04,6.69E+05,6.92E+04,,2.51E+04,,,,,,,5.52E+05,3.16E+03,,,,,,,4.12E+03,5.22E+02,9.01E+04,1.72E+03,,7.05E+03,,,,0,FALSE,5.724,3,1,681,78.8,4.86,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf04006,10199,A0AVJ8; hsa:10199; O00566,ENSG00000124383,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,113.19,,132.84,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,91.21,,26,9.98,,0,
Master Protein,High,G5E9T8,GOSR1,Golgi SNAP receptor complex member 1 (Fragment) OS=Homo sapiens OX=9606 GN=GOSR1 PE=1 SV=2,1,2,100,0.297,100,0.197,6.64,-1.75,6.64,-2.35,1.00E-17,3.83E-01,1.00E-17,2.53E-01,9.43E+04,,2.80E+04,1.42E+05,1,,2,1,,,,9.43E+04,,,,,,,,4.94E+04,,1.59E+04,,,,,1.42E+05,,,,,9.43E+04,,,,,,,,2.21E+03,,2.14E+03,,,,,3.33E+03,,0,FALSE,5.299,7,1,255,29.1,9.91,1,transport,other membranes;ER/Golgi,Pf12352,,G5E9T8,ENSG00000108587,,,0,0,,,72.68,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,88.81,,88.81,8.21,,0,
Master Protein,High,O15355,PPM1G,Protein phosphatase 1G OS=Homo sapiens OX=9606 GN=PPM1G PE=1 SV=1,1,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,5.00E+05,,,,3,,,,,5.00E+05,,4.09E+05,1.45E+06,,,,,,,,,,,,,,,,,1.90E+03,,4.09E+05,7.46E+04,,,,,,,,,,,,,,,,0,FALSE,9.511,5,1,546,59.2,4.36,1,protein metabolism;other metabolic processes;other biological processes,other membranes;nucleus;other cell component,Pf00481,5496,hsa:5496; O15355,ENSG00000115241,,VEGFA-VEGFR2 signaling; mRNA processing,2,0,73.12,,,,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,15.06,other molecular function,0,
Master Protein,High,Q8N1F8,STK11IP,Serine/threonine-protein kinase 11-interacting protein OS=Homo sapiens OX=9606 GN=STK11IP PE=1 SV=4,2,2,100,1.342,,100,6.64,0.42,,6.64,1.00E-17,4.98E-01,,1.00E-17,3.88E+04,,5.20E+04,,1,,1,,,,,3.88E+04,,,,,,,,,,5.20E+04,,,,,,,,,,3.88E+04,,,,,,,,,,7.01E+03,,,,,,,0,FALSE,10.473,4,2,1088,120.2,5.36,2,other biological processes,non-structural extracellular;other cytoplasmic organelle;other cell component,Pf15904,114790,C9JQV3; hsa:114790; Q8N1F8; Q8NAW9; Q8WXE4; Q96CN3; Q96PY9,ENSG00000144589,Neutrophil degranulation,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,7.15,other molecular function,0,
Master Protein,High,A1L0T0,ILVBL,2-hydroxyacyl-CoA lyase 2 OS=Homo sapiens OX=9606 GN=ILVBL PE=1 SV=2,5,5,100,1.238,100,1.726,6.64,0.31,6.64,0.79,1.00E-17,5.15E-01,1.00E-17,5.01E-01,3.40E+04,,3.38E+04,4.01E+04,4,,1,2,2.93E+04,,2.54E+04,1.20E+05,3.96E+04,,,,,,3.38E+04,,,,,,3.45E+04,,,4.67E+04,1.16E+02,,2.48E+02,1.20E+05,2.04E+03,,,,,,2.02E+02,,,,,,9.69E+03,,,4.97E+02,0,FALSE,13.393,10,5,632,67.8,8.15,5,other metabolic processes,other membranes;ER/Golgi;other cell component,"Pf00205, Pf02775, Pf02776",10994,A1L0T0; hsa:10994; O43341; Q96F08; Q99651; Q9BWN5; Q9UEB2,ENSG00000105135,,,0,0,83.5,,,21.31,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,,28.5,,146.02,11.65,other molecular function,0,
Master Protein,High,Q8NE86,MCU,"Calcium uniporter protein, mitochondrial OS=Homo sapiens OX=9606 GN=MCU PE=1 SV=1",3,7,100,0.371,100,0.808,6.64,-1.43,6.64,-0.31,1.00E-17,3.79E-01,1.00E-17,9.92E-01,2.06E+06,,2.51E+05,3.90E+05,3,,4,2,5.95E+06,,2.06E+06,8.65E+04,,,,,,,2.21E+06,9.18E+04,,3.27E+05,1.93E+05,,1.92E+05,,,7.89E+05,2.36E+04,,2.02E+04,8.65E+04,,,,,,,1.32E+04,4.10E+03,,4.41E+04,4.78E+03,,5.40E+04,,,8.40E+03,0,FALSE,10.803,14,3,351,39.8,8.65,3,cell organization and biogenesis;transport;signal transduction;other biological processes,other membranes;mitochondrion,Pf04678,90550,B2RDF3; B3KXV7; hsa:90550; Q8NE86; Q96FL3,ENSG00000156026,Processing of SMDT1,Alzheimer's disease and miRNA effects; Pleural mesothelioma; Alzheimer's disease,5,0,110.47,,142.85,85.99,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,High,Peak Found,n/a,High,n/a,n/a,Peak Found,1,,FALSE,,146.11,,123.63,19.48,transporter activity;other molecular function,0,
Master Protein,High,O14975,SLC27A2,Long-chain fatty acid transport protein 2 OS=Homo sapiens OX=9606 GN=SLC27A2 PE=1 SV=2,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,7.42E+04,,,1.74E+05,1,,,1,,,,7.42E+04,,,,,,,,,,,,,1.74E+05,,,,,,,7.42E+04,,,,,,,,,,,,,4.88E+04,,,,0.002,FALSE,2.908,3,1,620,70.3,8.51,1,other metabolic processes;transport,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle,"Pf00501, Pf13193",11001,A8K2J7; hsa:11001; O14975; Q53FY6; Q6PF09,ENSG00000140284,Peroxisomal protein import; Neutrophil degranulation; Fatty acyl-CoA biosynthesis; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol; Alpha-oxidation of phytanate; Synthesis of bile acids and bile salts via 24-hydroxycholesterol,PPAR signaling pathway; Fatty acids and lipoproteins transport in hepatocytes,8,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,3.4,transporter activity;other molecular function,0,
Master Protein,High,A0A8Q3SHZ3,PCNT,Pericentrin OS=Homo sapiens OX=9606 GN=PCNT PE=1 SV=1,2,4,100,1.307,100,0.612,6.64,0.39,6.64,-0.71,1.00E-17,4.81E-01,1.00E-17,8.46E-01,9.61E+04,,9.87E+04,1.28E+05,3,,4,3,,,1.79E+04,9.61E+04,1.90E+05,,,,,,,1.04E+05,6.59E+04,2.17E+05,9.37E+04,,1.48E+04,2.43E+05,1.28E+05,,,,1.75E+02,9.61E+04,9.80E+03,,,,,,,4.64E+03,5.35E+02,2.92E+04,2.33E+03,,4.17E+03,1.72E+03,3.01E+03,,0,FALSE,8.207,1,2,3347,378.8,5.55,2,signal transduction,cytoskeleton;other cell component,Pf10495,,A0A8Q3SHZ3,ENSG00000160299,,,0,0,85.04,,55.42,88.65,n/a,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,,100.61,,55.37,13.05,other molecular function,0,
Master Protein,High,Q96F63,CCDC97,Coiled-coil domain-containing protein 97 OS=Homo sapiens OX=9606 GN=CCDC97 PE=1 SV=1,1,1,100,0.328,,100,6.64,-1.61,,6.64,1.00E-17,4.75E-01,,1.00E-17,3.91E+04,,1.28E+04,,1,,1,,,,,3.91E+04,,,,,,,,,,1.28E+04,,,,,,,,,,3.91E+04,,,,,,,,,,1.73E+03,,,,,,,0.001,FALSE,3.802,5,1,343,38.9,4.59,1,,nucleus,Pf09747,90324,hsa:90324; Q658N6; Q96F63; Q96IF3,ENSG00000142039,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.85,,0,
Master Protein,High,P35250,RFC2,Replication factor C subunit 2 OS=Homo sapiens OX=9606 GN=RFC2 PE=1 SV=3,3,4,100,2.606,100,16.375,6.64,1.38,6.64,4.03,1.00E-17,1.72E-01,1.00E-17,9.66E-03,4.45E+04,,1.16E+05,7.09E+03,1,,5,1,,,,4.45E+04,,,,,,,1.84E+05,1.97E+04,1.42E+05,1.16E+05,6.60E+04,,7.09E+03,,,,,,,4.45E+04,,,,,,,1.10E+03,8.79E+02,1.15E+03,1.56E+04,1.64E+03,,1.99E+03,,,,0,FALSE,12.227,12,3,354,39.1,6.44,3,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00004, Pf08542",5982,B5BU07; D3DXG3; hsa:5982; P32846; P35250; Q9BU93,ENSG00000049541,Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,"DNA replication; Nucleotide excision repair; 7q11.23 copy number variation syndrome; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",27,0,,,60.86,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,63.92,,63.92,11.6,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q7Z2K6,ERMP1,Endoplasmic reticulum metallopeptidase 1 OS=Homo sapiens OX=9606 GN=ERMP1 PE=1 SV=2,1,1,100,1.325,100,2.976,6.64,0.41,6.64,1.57,1.00E-17,4.28E-01,1.00E-17,3.04E-01,1.48E+05,,2.03E+05,6.59E+04,2,,4,2,,1.09E+05,,2.01E+05,,,,,,,1.53E+05,2.10E+05,,1.95E+05,2.52E+05,,3.87E+04,,1.12E+05,,,4.14E+02,,2.01E+05,,,,,,,9.14E+02,9.40E+03,,2.63E+04,6.25E+03,,1.09E+04,,2.62E+03,,0,FALSE,4.565,1,1,904,100.2,7.52,1,protein metabolism;stress response;signal transduction,other membranes;ER/Golgi,Pf04389,79956,B2RNA4; B3KSB1; hsa:79956; Q7Z2K6; Q8N5T5; Q9H5M1,ENSG00000099219,,,0,0,41.91,,20.16,68.84,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,45.73,,71.02,3.18,other molecular function,0,
Master Protein,High,Q5K651,SAMD9,Sterile alpha motif domain-containing protein 9 OS=Homo sapiens OX=9606 GN=SAMD9 PE=1 SV=1,1,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,7.43E+03,,,6.97E+04,1,,,1,,,,7.43E+03,,,,,,,,,,,,,6.97E+04,,,,,,,7.43E+03,,,,,,,,,,,,,1.96E+04,,,,0,FALSE,5.274,1,1,1589,184.2,7.83,1,cell organization and biogenesis;stress response;transport,cytosol;other cell component,Pf00536,54809,A2RU68; hsa:54809; Q5K649; Q5K651; Q6P080; Q75N21; Q8IVG6; Q9NXS8,ENSG00000205413,,,0,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,5.95,,0,
Master Protein,High,Q9BXS5,AP1M1,AP-1 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP1M1 PE=1 SV=3,2,4,100,3.959,,100,6.64,1.99,,6.64,1.00E-17,7.04E-02,,1.00E-17,8.06E+03,,3.19E+04,,1,,1,,,,,8.06E+03,,,,,,,,,,3.19E+04,,,,,,,,,,8.06E+03,,,,,,,,,,4.30E+03,,,,,,,0,FALSE,9.014,9,2,423,48.6,7.3,2,cell organization and biogenesis;transport,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00928, Pf01217",8907,hsa:8907; Q4TTY5; Q9BXS5,ENSG00000072958,MHC class II antigen presentation; Neutrophil degranulation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Nef mediated downregulation of MHC class I complex cell surface expression,,5,0,,,,,High,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,8.7,other molecular function,0,
Master Protein,High,Q13813,SPTAN1,"Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=1 SV=3",67,204,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.53E+05,,,,5,,,,2.64E+05,1.53E+05,1.54E+05,7.74E+04,2.00E+04,,,,,,,,,,,,,,,,1.05E+03,5.81E+02,1.51E+03,7.74E+04,1.03E+03,,,,,,,,,,,,,,,,0,FALSE,310.049,37,1,2472,284.4,5.35,67,cell organization and biogenesis,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00018, Pf00435, Pf08726, Pf13499",6709,hsa:6709; Q13186; Q13813; Q15324; Q16606; Q59EF1; Q5VXV5; Q5VXV6; Q7Z6M5; Q9P0V0,ENSG00000197694,Neutrophil degranulation; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; COPI-mediated anterograde transport; RHOV GTPase cycle; RHOU GTPase cycle; Nephrin family interactions; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins; Caspase-mediated cleavage of cytoskeletal proteins,Fas ligand pathway and stress induction of heat shock proteins,12,0,68.77,,,,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,571.15,cytoskeletal activity;other molecular function,0,
Master Protein,Medium,Q5VUM1,SDHAF4,"Succinate dehydrogenase assembly factor 4, mitochondrial OS=Homo sapiens OX=9606 GN=SDHAF4 PE=1 SV=1",1,1,100,1.07,,100,6.64,0.1,,6.64,1.00E-17,6.44E-01,,1.00E-17,9.38E+04,,1.00E+05,,1,,1,,,,,9.38E+04,,,,,,,,,,1.00E+05,,,,,,,,,,9.38E+04,,,,,,,,,,1.35E+04,,,,,,,0.012,FALSE,2.211,24,1,108,12.2,9.36,1,cell organization and biogenesis;other metabolic processes;stress response,mitochondrion,Pf07896,135154,E1P532; hsa:135154; Q5VUM1,ENSG00000154079,,Mitochondrial complex II assembly,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.78,enzyme regulator activity,0,
Master Protein,Medium,A0A7P0Z426,NAXE,NAD(P)H-hydrate epimerase OS=Homo sapiens OX=9606 GN=NAXE PE=1 SV=1,1,1,100,1.693,,100,6.64,0.76,,6.64,1.00E-17,2.47E-01,,1.00E-17,1.84E+05,,3.12E+05,,1,,1,,,,,1.84E+05,,,,,,,,3.12E+05,,,,,,,,,,,,1.84E+05,,,,,,,,1.39E+04,,,,,,,,,0.01,FALSE,2.279,5,1,302,32.7,8.37,1,,non-structural extracellular;mitochondrion,Pf03853,,A0A7P0Z426,ENSG00000163382,,,0,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.53,other molecular function,0,
Master Protein,High,A0A087X266,TMEM120A,Transmembrane protein 120A OS=Homo sapiens OX=9606 GN=TMEM120A PE=1 SV=1,2,2,100,0.588,,100,6.64,-0.77,,6.64,1.00E-17,8.31E-01,,1.00E-17,1.10E+05,,4.59E+04,,3,,2,,,1.17E+06,,1.10E+05,5.56E+04,,,,,,,6.08E+04,3.47E+04,,,,,,,,,4.43E+03,,1.10E+05,2.87E+03,,,,,,,2.72E+03,2.82E+02,,,,,,,,0,FALSE,4.357,3,2,369,42.9,8.43,2,,other membranes;nucleus,Pf07851,83862,A0A087X266,ENSG00000189077,,7q11.23 distal copy number variation,1,0,141.04,,38.65,,n/a,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,38.97,,,3.72,,0,
Master Protein,High,O60907,TBL1X,F-box-like/WD repeat-containing protein TBL1X OS=Homo sapiens OX=9606 GN=TBL1X PE=1 SV=3,1,1,100,1.725,100,1.47,6.64,0.79,6.64,0.56,1.00E-17,2.43E-01,1.00E-17,6.04E-01,2.52E+05,,4.34E+05,2.95E+05,1,,1,1,,,,2.52E+05,,,,,,,,,,4.34E+05,,,2.95E+05,,,,,,,2.52E+05,,,,,,,,,,5.85E+04,,,8.29E+04,,,,0,FALSE,5.981,5,1,577,62.5,6.55,1,protein metabolism;other metabolic processes;other biological processes,cytoskeleton;nucleus;other cell component,"Pf00400, Pf08513",6907,A8K044; A8K4J7; hsa:6907; O60907; Q86UY2,ENSG00000101849,"PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; HCMV Early Events; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Heme signaling; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Transcriptional activation of mitochondrial biogenesis; HDACs deacetylate histones; Cytoprotection by HMOX1; Activation of gene expression by SREBF (SREBP); NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Loss of MECP2 binding ability to the NCoR/SMRT complex; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; RORA activates gene expression",Ectoderm differentiation; Ectoderm differentiation; Rett syndrome,22,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,0,,0,5.22,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P0C7P3,SLFN14,Protein SLFN14 OS=Homo sapiens OX=9606 GN=SLFN14 PE=1 SV=2,1,1,100,0.191,100,0.107,6.64,-2.39,6.64,-3.22,1.00E-17,2.03E-01,1.00E-17,9.48E-02,5.06E+04,,9.66E+03,9.02E+04,2,,2,1,,4.56E+05,,5.61E+03,,,,,,,,1.60E+04,,5.85E+03,,,9.02E+04,,,,,1.73E+03,,5.61E+03,,,,,,,,7.13E+02,,7.88E+02,,,2.53E+04,,,,0,FALSE,5.59,2,1,912,103.8,8.24,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf04326, Pf17057, Pf21026",342618,B2RTW9; hsa:342618; P0C7P3,ENSG00000236320,,17q12 copy number variation syndrome,1,0,137.99,,65.62,,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,399.56,,77.65,3.42,translation activity;other molecular function,0,
Master Protein,High,O00635,TRIM38,E3 ubiquitin-protein ligase TRIM38 OS=Homo sapiens OX=9606 GN=TRIM38 PE=1 SV=1,2,2,100,0.546,100,,6.64,-0.87,6.64,,1.00E-17,8.53E-01,1.00E-17,,5.05E+04,,1.33E+04,2.24E+04,2,,1,1,,,4.82E+04,5.28E+04,,,,,,,,,,1.33E+04,,,,,2.24E+04,,,,4.71E+02,5.28E+04,,,,,,,,,,1.79E+03,,,,,5.23E+02,,0,FALSE,9.759,6,2,465,53.4,7.02,2,protein metabolism;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,"Pf00622, Pf00643, Pf13765, Pf15227",10475,B2R862; hsa:10475; O00635,ENSG00000112343,Interferon gamma signaling,,1,0,6.52,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,0,,,7.48,other molecular function,0,
Master Protein,High,P61073,CXCR4,C-X-C chemokine receptor type 4 OS=Homo sapiens OX=9606 GN=CXCR4 PE=1 SV=1,1,1,100,0.245,,100,6.64,-2.03,,6.64,1.00E-17,3.09E-01,,1.00E-17,4.13E+04,,1.01E+04,,2,,3,,,,3.99E+04,4.28E+04,,,,,,,,1.01E+04,,6.13E+03,1.28E+04,,,,,,,,3.89E+02,4.28E+04,,,,,,,,4.53E+02,,8.25E+02,3.17E+02,,,,,,0.008,FALSE,2.343,3,1,352,39.7,8.21,1,cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,"Pf00001, Pf12109",7852,B2R5N0; hsa:7852; O60835; P30991; P56438; P61073; Q53S69; Q9BXA0; Q9UKN2,ENSG00000121966,G alpha (i) signalling events; Chemokine receptors bind chemokines; Signaling by ROBO receptors; Formation of definitive endoderm; Specification of primordial germ cells; Binding and entry of HIV virion,"Peptide GPCRs; Cardiac progenitor differentiation; Hematopoietic stem cell differentiation; Amplification and expansion of oncogenic pathways as metastatic traits; Chemokine signaling pathway; Acute viral myocarditis; Neovascularization processes; Selective expression of chemokine receptors during T-cell polarization; GPCRs, class A rhodopsin-like; Genes controlling nephrogenesis; CCL18 signaling pathway; Extrafollicular and follicular B cell activation by SARS-CoV-2; 2q37 copy number variation syndrome; Cell interactions of the pancreatic cancer microenvironment; TAR syndrome; 5q35 copy number variation; IL-19 signaling pathway",23,0,5.1,,34.54,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,30.37,,,2.57,cytoskeletal activity;other molecular function,0,
Master Protein,High,O95168,NDUFB4,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 OS=Homo sapiens OX=9606 GN=NDUFB4 PE=1 SV=3,1,2,100,0.763,,100,6.64,-0.39,,6.64,1.00E-17,8.88E-01,,1.00E-17,2.65E+05,,2.02E+05,,2,,3,,,,,2.53E+05,2.77E+05,,,,,,,2.02E+05,,1.84E+05,3.33E+05,,,,,,,,,2.53E+05,1.43E+04,,,,,,,9.04E+03,,2.49E+04,8.28E+03,,,,,,0.001,FALSE,3.774,14,1,129,15.2,9.85,1,cell organization and biogenesis;other metabolic processes;stress response;transport,other membranes;mitochondrion;nucleus,Pf07225,4710,B2RUY3; B9EJC7; hsa:4710; O95168,ENSG00000065518,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,5,0,6.37,,33.81,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,14.59,,,7.24,transporter activity,0,
Master Protein,High,Q9ULR0,ISY1,Pre-mRNA-splicing factor ISY1 homolog OS=Homo sapiens OX=9606 GN=ISY1 PE=1 SV=3,3,5,100,0.23,,100,6.64,-2.12,,6.64,1.00E-17,2.33E-01,,1.00E-17,1.28E+05,,1.83E+04,,1,,3,,,,,1.28E+05,,,,,,,,9.69E+03,,2.94E+04,1.83E+04,,,,,,,,,1.28E+05,,,,,,,,4.33E+02,,3.96E+03,4.54E+02,,,,,,0,FALSE,14.866,16,3,285,33,5.17,3,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf06246,100534599; 57461,hsa:100534599; hsa:57461; Q96IL2; Q9BT05; Q9ULR0,ENSG00000240682,mRNA Splicing - Major Pathway; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER,,5,0,,,51.73,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,56.14,,,17.35,,0,
Master Protein,High,Q5T2T1,MPP7,MAGUK p55 subfamily member 7 OS=Homo sapiens OX=9606 GN=MPP7 PE=1 SV=1,1,1,100,0.04,100,0.155,6.64,-4.65,6.64,-2.69,1.00E-17,9.06E-04,1.00E-17,1.83E-01,2.36E+05,,9.38E+03,6.06E+04,3,,1,3,4.54E+05,,2.36E+05,,4.55E+04,,,,,,,,,9.38E+03,,4.20E+05,6.06E+04,,1.41E+04,,1.80E+03,,2.31E+03,,2.35E+03,,,,,,,,,1.26E+03,,8.20E+02,1.70E+04,,3.31E+02,,0.001,FALSE,3.13,2,1,576,65.5,7.14,1,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf00018, Pf00595, Pf00625, Pf02828",143098,B2RCC9; B4DWL9; B5MDZ3; D3DRW3; hsa:143098; Q5T2T0; Q5T2T1; Q8IY28,ENSG00000150054,RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle,,6,0,83.35,,,134.73,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,119.7,,113.62,2.29,other molecular function,0,
Master Protein,High,P15170,GSPT1,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens OX=9606 GN=GSPT1 PE=1 SV=1,3,6,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.95E+05,,,1.27E+06,1,,,3,,,,1.95E+05,,,,,,,,,,,,,1.27E+06,1.69E+06,7.85E+04,,,,,1.95E+05,,,,,,,,,,,,,3.58E+05,1.20E+04,1.84E+03,,0,FALSE,10.433,9,3,499,55.7,5.62,3,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,"Pf00009, Pf03143, Pf03144",2935,hsa:2935; J3KQG6; P15170; Q96GF2,ENSG00000103342,Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),,4,0,,,,82.5,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,,,,18.34,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q4G176,ACSF3,"Malonate--CoA ligase ACSF3, mitochondrial OS=Homo sapiens OX=9606 GN=ACSF3 PE=1 SV=3",1,2,100,2.645,,100,6.64,1.4,,6.64,1.00E-17,5.67E-02,,1.00E-17,2.95E+05,,7.81E+05,,1,,2,,,,,2.95E+05,,,,,,,,1.04E+06,,,5.88E+05,,,,,,,,,2.95E+05,,,,,,,,4.64E+04,,,1.46E+04,,,,,,0.002,FALSE,2.929,3,1,576,64.1,8.37,1,other metabolic processes,mitochondrion;nucleus,"Pf00501, Pf13193",197322,A8K4J8; C9JQL6; hsa:197322; Q4G176; Q6INA0; Q8N2F7,ENSG00000176715,Synthesis of very long-chain fatty acyl-CoAs,,1,0,,,39.2,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,42.77,,,6.03,other molecular function,0,
Master Protein,High,Q6K0P9,PYHIN1,Pyrin and HIN domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PYHIN1 PE=1 SV=1,9,46,100,0.246,,100,6.64,-2.02,,6.64,1.00E-17,1.28E-01,,1.00E-17,1.60E+06,,2.32E+05,,2,,4,,,3.59E+06,,7.13E+05,,,,,,,2.13E+05,,2.52E+05,7.87E+05,8.81E+03,,,,,,,1.37E+04,,7.13E+05,,,,,,,1.28E+03,,2.04E+03,1.06E+05,2.19E+02,,,,,,0,FALSE,30.105,21,5,492,55,9.8,9,cell cycle OR cell proliferation;other biological processes,cytosol;nucleus;other cell component,"Pf02758, Pf02760",149628,hsa:149628; Q5T3W6; Q6K0P6; Q6K0P7; Q6K0P8; Q6K0P9; Q8WW65,ENSG00000163564,,,0,0,94.61,,105.37,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,79.48,,,111.53,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A0G2JQH2,RPS18,40S ribosomal protein S18 OS=Homo sapiens OX=9606 GN=RPS18 PE=1 SV=1,4,13,100,0.504,100,2.45,6.64,-0.99,6.64,1.29,1.00E-17,7.18E-01,1.00E-17,4.09E-01,2.46E+05,,1.24E+05,5.07E+04,1,,3,1,,,,2.46E+05,,,,,,,,4.61E+06,,5.74E+04,1.24E+05,,5.07E+04,,,,,,,2.46E+05,,,,,,,,2.06E+05,,7.74E+03,3.08E+03,,1.42E+04,,,,0,FALSE,11.918,97,1,33,3.8,11,4,,,,,A0A0G2JQH2,ENSG00000227794,,,0,0,,,163.38,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,Acetyl [N-Term],FALSE,,144.27,,79.65,29.07,,0,
Master Protein,High,Q969S9,GFM2,"Ribosome-releasing factor 2, mitochondrial OS=Homo sapiens OX=9606 GN=GFM2 PE=1 SV=1",2,4,100,1.265,100,14.307,6.64,0.34,6.64,3.84,1.00E-17,5.39E-01,1.00E-17,2.09E-02,7.15E+04,,5.89E+04,3.95E+03,3,,5,1,,,7.15E+04,2.07E+05,1.65E+04,,,,,,4.50E+04,1.90E+05,5.44E+04,7.79E+04,5.89E+04,,3.95E+03,,,,,,6.98E+02,2.07E+05,8.49E+02,,,,,,2.69E+02,8.49E+03,4.42E+02,1.05E+04,1.46E+03,,1.11E+03,,,,0,FALSE,4.844,4,2,779,86.5,6.51,2,cell organization and biogenesis;protein metabolism;other metabolic processes,mitochondrion,"Pf00009, Pf00679, Pf03144, Pf03764, Pf14492",84340,A0AR28; hsa:84340; Q8N6D8; Q8WYI0; Q969S9; Q9H6Z1,ENSG00000164347,Mitochondrial translation termination,,1,0,99.77,,70.2,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,59.12,,18.24,9.29,other molecular function,0,
Master Protein,High,P14317,HCLS1,Hematopoietic lineage cell-specific protein OS=Homo sapiens OX=9606 GN=HCLS1 PE=1 SV=3,2,5,100,1.367,,100,6.64,0.45,,6.64,1.00E-17,4.02E-01,,1.00E-17,5.56E+05,,2.51E+05,,1,,1,,,,,5.56E+05,,,,,,,,2.51E+05,,,,,,,,,,,,5.56E+05,,,,,,,,1.12E+04,,,,,,,,,0,FALSE,15.046,9,2,486,54,4.81,2,cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component,"Pf00018, Pf02218",3059,B4DQ69; hsa:3059; P14317; Q53Y93; Q6IBK9; Q9UDK0,ENSG00000180353,,Pathogenic Escherichia coli infection; B cell receptor signaling pathway; TYROBP causal network in microglia,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,17.14,cytoskeletal activity;other molecular function,0,
Master Protein,Medium,A0A2R8Y4T1,TNS1,Tensin 1 OS=Homo sapiens OX=9606 GN=TNS1 PE=1 SV=1,1,3,100,0.693,100,0.102,6.64,-0.53,6.64,-3.3,1.00E-17,9.52E-01,1.00E-17,1.03E-01,3.58E+04,,2.49E+04,2.64E+05,1,,3,3,,,,3.58E+04,,,,,,,,,2.49E+04,5.28E+04,1.45E+04,,5.19E+05,5.22E+04,2.64E+05,,,,,3.58E+04,,,,,,,,,2.02E+02,7.12E+03,3.61E+02,,1.46E+05,3.70E+02,6.17E+03,,0.012,FALSE,2.202,0,1,1860,199.4,8.34,1,,other cell component,"Pf00017, Pf00130, Pf08416, Pf10409",,A0A2R8Y4T1,ENSG00000079308,,,0,0,,,64.46,83.99,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,n/a,1,,FALSE,,78.5,,116.56,3.85,other molecular function,0,
Master Protein,High,Q9BQG0,MYBBP1A,Myb-binding protein 1A OS=Homo sapiens OX=9606 GN=MYBBP1A PE=1 SV=2,7,11,100,0.685,100,2.515,6.64,-0.55,6.64,1.33,1.00E-17,9.96E-01,1.00E-17,3.71E-01,7.31E+05,,2.08E+05,6.41E+04,5,,5,3,1.20E+06,1.73E+05,7.31E+05,1.20E+06,8.19E+04,,,,,,6.39E+05,1.66E+04,7.14E+04,1.11E+06,2.08E+05,,6.41E+04,1.45E+06,3.15E+04,,4.78E+03,6.59E+02,7.14E+03,1.20E+06,4.22E+03,,,,,,3.82E+03,7.43E+02,5.80E+02,1.49E+05,5.17E+03,,1.80E+04,1.03E+04,7.37E+02,,0,FALSE,32.055,9,7,1328,148.8,9.28,7,cell organization and biogenesis;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,Pf04931,10514,hsa:10514; Q86VM3; Q9BQG0; Q9BW49; Q9P0V5; Q9UF99,ENSG00000132382,B-WICH complex positively regulates rRNA expression,Energy metabolism; 10q11.21q11.23 copy number variation syndrome,3,0,79.48,,112.8,157.2,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,,114.46,,110.5,33.28,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8I5KQX1,IKBKG,Inhibitor of nuclear factor kappa B kinase regulatory subunit gamma OS=Homo sapiens OX=9606 GN=IKBKG PE=1 SV=1,1,3,100,2.182,100,1.585,6.64,1.13,6.64,0.66,1.00E-17,2.31E-01,1.00E-17,5.48E-01,2.59E+04,,5.64E+04,3.56E+04,2,,1,1,,,2.50E+04,2.68E+04,,,,,,,,,,5.64E+04,,,,,3.56E+04,,,,2.44E+02,2.68E+04,,,,,,,,,,7.61E+03,,,,,8.34E+02,,0.001,FALSE,3.738,3,1,438,50.3,6.01,1,,cytosol,"Pf11577, Pf16516, Pf18414",,A0A8I5KQX1,ENSG00000269335,,Nucleotide-binding oligomerization domain (NOD) pathway; Ebstein-Barr virus LMP1 signaling; RAC1/PAK1/p38/MMP2 pathway; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; Toll-like receptor signaling related to MyD88; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; ATM signaling in development and disease ; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; Fibrin complement receptor 3 signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Pancreatic adenocarcinoma pathway; miRNA role in immune response in sepsis; Canonical NF-kB pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Small cell lung cancer; Hepatitis B infection; Host-pathogen interaction of human coronaviruses - interferon induction; STING pathway in Kawasaki-like disease and COVID-19; Modulators of TCR signaling and T cell activation; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Acute myeloid leukemia; Toll-like receptor signaling pathway,27,0,4.89,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,5.13,,0,5.86,other molecular function,0,
Master Protein,Medium,A6NIV2,TOMM7,Mitochondrial import receptor subunit TOM7 homolog OS=Homo sapiens OX=9606 GN=TOMM7 PE=1 SV=2,1,1,100,0.629,100,0.422,6.64,-0.67,6.64,-1.24,1.00E-17,9.32E-01,1.00E-17,5.92E-01,5.40E+04,,3.40E+04,1.52E+05,1,,4,3,,,,,5.40E+04,,,,,,2.90E+04,,3.43E+04,3.37E+04,3.93E+05,,,1.62E+05,3.67E+04,1.52E+05,,,,,2.79E+03,,,,,,1.73E+02,,2.79E+02,4.54E+03,9.76E+03,,,1.15E+03,8.59E+02,1.62E+03,0.016,FALSE,2.085,6,1,125,14.3,9.83,1,transport,other membranes;mitochondrion,Pf08038,,A6NIV2,ENSG00000196683,,,0,0,,,147.22,59.55,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,13.38,,131.94,1.68,,0,
Master Protein,High,A0A3B3ITA3,C8orf33,Chromosome 8 open reading frame 33 OS=Homo sapiens OX=9606 GN=C8orf33 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.16E+04,,,,1,,,,,,,3.16E+04,,,,,,,,,,,,,,,,,,,,3.16E+04,,,,,,,,,,,,,,,,,0.001,FALSE,3.25,4,1,248,27.3,10.04,1,,,Pf15393,,A0A3B3ITA3,ENSG00000182307,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.4,,0,
Master Protein,High,P40425,PBX2,Pre-B-cell leukemia transcription factor 2 OS=Homo sapiens OX=9606 GN=PBX2 PE=1 SV=2,2,3,100,0.59,100,0.147,6.64,-0.76,6.64,-2.76,1.00E-17,8.50E-01,1.00E-17,1.15E-01,4.29E+05,,8.94E+04,8.85E+05,1,,2,1,,,,4.29E+05,,,,,,,,,,2.76E+05,2.90E+04,,8.85E+05,,,,,,,4.29E+05,,,,,,,,,,3.71E+04,7.21E+02,,2.49E+05,,,,0,FALSE,6.253,9,2,430,45.9,7.56,2,developmental processes;other biological processes,nucleus;other cell component,"Pf03792, Pf05920",5089,A2BFJ2; hsa:5089; P40425,ENSG00000204304; ENSG00000206315; ENSG00000224952; ENSG00000225987; ENSG00000232005; ENSG00000236353; ENSG00000237344,,,0,0,,,114.47,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,14.25,,80.02,12.95,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8IY81,FTSJ3,pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 OS=Homo sapiens OX=9606 GN=FTSJ3 PE=1 SV=2,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,2.99E+05,,,1.73E+07,2,,,2,,,,1.79E+05,4.99E+05,,,,,,,,,,,,,1.73E+07,,1.72E+07,,,,1.79E+05,2.58E+04,,,,,,,,,,,,,1.22E+05,,1.83E+05,0,FALSE,6.843,3,1,847,96.5,8.4,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf01728, Pf07780, Pf11861",117246,B2RCA5; D3DU22; hsa:117246; Q8IY81; Q8N3A3; Q8WXX1; Q9BWM4; Q9NXT6,ENSG00000108592,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,66.68,,,0.2,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,,,,4.33,other molecular function,0,
Master Protein,Medium,P78413,IRX4,Iroquois-class homeodomain protein IRX-4 OS=Homo sapiens OX=9606 GN=IRX4 PE=1 SV=2,1,1,100,1.448,,100,6.64,0.53,,6.64,1.00E-17,4.35E-01,,1.00E-17,4.88E+04,,7.06E+04,,1,,2,,,,,4.88E+04,,,,,,,4.23E+04,,,1.18E+05,,,,,,,,,,4.88E+04,,,,,,,2.53E+02,,,1.59E+04,,,,,,,0.016,FALSE,2.071,2,1,519,54.4,6.18,1,developmental processes;other biological processes,nucleus;other cell component,Pf05920,50805,B2RMW5; D3DTC5; H1AFL0; H1AFL1; hsa:50805; P78413; Q2NL64; Q9UHR2,ENSG00000113430,,Heart development; Cardiac progenitor differentiation,2,0,,,66.72,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,79.33,,,1.9,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P56270,MAZ,Myc-associated zinc finger protein OS=Homo sapiens OX=9606 GN=MAZ PE=1 SV=1,3,4,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,5.75E+05,,,3.08E+05,2,,,1,,,,1.78E+05,1.86E+06,,,,,,,,,,,,,,,3.08E+05,,,,1.78E+05,9.58E+04,,,,,,,,,,,,,,,3.28E+03,0,FALSE,16.244,9,2,477,48.6,8.95,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00096, Pf13894",4150,A8QJL9; C6G496; G5E927; H3BQD6; hsa:4150; P56270; Q15703; Q8NFN7; Q99443,ENSG00000103495,,16p11.2 proximal deletion syndrome; Sudden infant death syndrome (SIDS) susceptibility pathways,2,0,116.69,,,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,,,,12.25,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q06546,GABPA,GA-binding protein alpha chain OS=Homo sapiens OX=9606 GN=GABPA PE=1 SV=1,3,5,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.24E+06,,,,1,,,,,,,1.24E+06,,,,,,,,,,,,,,,,,,,,1.24E+06,,,,,,,,,,,,,,,,,0,FALSE,16.187,10,3,454,51.3,4.97,3,developmental processes;other biological processes,nucleus;other cell component,"Pf00178, Pf02198, Pf11620",2551,hsa:2551; Q06546; Q12939,ENSG00000154727,Transcriptional activation of mitochondrial biogenesis,Energy metabolism; Allograft rejection; Myometrial relaxation and contraction pathways; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; Mitochondrial gene expression; Pleural mesothelioma,7,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,17.78,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q5SU54,HLA-DQB1,MHC class II antigen OS=Homo sapiens OX=9606 GN=HLA-DQB1 PE=1 SV=1,5,10,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,2.14E+06,,,2.35E+06,1,,,1,,,,2.14E+06,,,,,,,,,,,,2.35E+06,,,,,,,,2.14E+06,,,,,,,,,,,,4.58E+03,,,,,0,FALSE,19.594,30,3,269,30.5,7.85,5,other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00969, Pf07654",3119,Q5SU54,ENSG00000179344,,Allograft rejection; Ebola virus infection in host,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,,,,29.91,,0,
Master Protein,High,A0A286YFF7,PPT1,Palmitoyl-protein thioesterase 1 OS=Homo sapiens OX=9606 GN=PPT1 PE=1 SV=1,1,3,100,2.64,100,3.583,6.64,1.4,6.64,1.84,1.00E-17,8.80E-02,1.00E-17,1.71E-01,1.27E+05,,5.12E+05,1.43E+05,2,,3,1,,,6.45E+04,2.48E+05,,,,,,,1.80E+05,,,6.20E+05,5.12E+05,,,,1.43E+05,,,,6.31E+02,2.48E+05,,,,,,,1.08E+03,,,8.35E+04,1.27E+04,,,,3.35E+03,,0,FALSE,5.983,5,1,335,37.1,6.52,1,other metabolic processes,ER/Golgi;other cell component,Pf02089,,A0A286YFF7,ENSG00000131238,,,0,0,83.02,,52.42,,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,69.91,,31.18,9.2,other molecular function,0,
Master Protein,High,Q13231,CHIT1,Chitotriosidase-1 OS=Homo sapiens OX=9606 GN=CHIT1 PE=1 SV=1,1,3,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.80E+06,,,8.55E+05,3,,,3,1.83E+06,1.80E+06,,2.80E+04,,,,,,,,,,,,8.55E+05,1.15E+05,,5.25E+06,,7.28E+03,6.84E+03,,2.80E+04,,,,,,,,,,,,1.67E+03,3.23E+04,,1.23E+05,,0,FALSE,4.79,5,1,466,51.6,6.96,1,other metabolic processes;other biological processes,non-structural extracellular;other cytoplasmic organelle;other cell component,"Pf00704, Pf01607",1118,B3KNW6; hsa:1118; J3KN09; Q0VGG5; Q0VGG6; Q13231; Q3ZAR1; Q6ISC2; Q9H3V8; Q9UDJ8,ENSG00000133063,Neutrophil degranulation; Digestion of dietary carbohydrate,,2,0,84.63,,,133.88,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,High,n/a,1,,FALSE,,,,,12.05,other molecular function,0,
Master Protein,High,Q9H2K0,MTIF3,"Translation initiation factor IF-3, mitochondrial OS=Homo sapiens OX=9606 GN=MTIF3 PE=1 SV=4",1,4,100,0.982,100,3.109,6.64,-0.03,6.64,1.64,1.00E-17,6.46E-01,1.00E-17,2.69E-01,3.75E+05,,2.66E+05,6.87E+04,3,,4,2,,4.08E+05,4.60E+04,3.75E+05,,,,,,,,4.83E+05,7.19E+04,2.31E+05,3.05E+05,,3.82E+04,1.23E+05,,,,1.55E+03,4.50E+02,3.75E+05,,,,,,,,2.16E+04,5.84E+02,3.12E+04,7.59E+03,,1.07E+04,8.75E+02,,,0,FALSE,6.165,6,1,278,31.7,9.69,1,cell organization and biogenesis;protein metabolism;other metabolic processes,mitochondrion,Pf05198,219402,hsa:219402; Q05BL8; Q5W0V0; Q86X68; Q9H2K0,ENSG00000122033,Mitochondrial translation initiation,,1,0,72.43,,62.47,74.57,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,97.94,,89.69,9.56,translation activity;nucleic acid binding activity,0,
Master Protein,High,O43172,PRPF4,U4/U6 small nuclear ribonucleoprotein Prp4 OS=Homo sapiens OX=9606 GN=PRPF4 PE=1 SV=2,8,8,100,0.211,,100,6.64,-2.24,,6.64,1.00E-17,1.03E-01,,1.00E-17,9.68E+05,,7.77E+04,,1,,2,,,,,9.68E+05,,,,,,,,7.21E+04,,,8.36E+04,,,,,,,,,9.68E+05,,,,,,,,3.22E+03,,,2.08E+03,,,,,,0,FALSE,31.113,26,8,522,58.4,7.42,8,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00400, Pf08799",9128,hsa:9128; O43172; O43445; O43864; Q5T1M8; Q96DG2; Q96IK4,ENSG00000136875,mRNA Splicing - Major Pathway,mRNA processing,2,0,,,10.45,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,10.98,,,25.46,nucleic acid binding activity,0,
Master Protein,High,Q8IY18,SMC5,Structural maintenance of chromosomes protein 5 OS=Homo sapiens OX=9606 GN=SMC5 PE=1 SV=2,1,4,100,1.467,100,0.632,6.64,0.55,6.64,-0.66,1.00E-17,3.45E-01,1.00E-17,8.07E-01,2.06E+05,,3.03E+05,4.79E+05,4,,5,3,1.85E+05,,3.16E+04,2.30E+05,5.98E+06,,,,,,6.98E+05,1.20E+05,1.99E+05,5.69E+05,3.03E+05,1.37E+06,,8.53E+04,4.79E+05,,7.35E+02,,3.09E+02,2.30E+05,3.09E+05,,,,,,4.18E+03,5.38E+03,1.62E+03,7.67E+04,7.52E+03,2.67E+03,,6.04E+02,1.12E+04,,0,FALSE,4.787,1,1,1101,128.7,8.38,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf02463,23137,A6NM81; hsa:23137; O60335; Q05D92; Q5VZ60; Q8IY18; Q96SB9,ENSG00000198887,SUMOylation of DNA damage response and repair proteins,,1,0,181.55,,65.23,102.03,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,1,,FALSE,,144.02,,108.2,9.83,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,O95139,NDUFB6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 OS=Homo sapiens OX=9606 GN=NDUFB6 PE=1 SV=3,1,1,100,0.469,100,0.253,6.64,-1.09,6.64,-1.98,1.00E-17,6.19E-01,1.00E-17,3.21E-01,4.95E+05,,2.31E+05,9.13E+05,2,,3,1,,,,3.99E+05,6.13E+05,,,,,,,2.31E+05,1.52E+05,3.82E+05,,9.13E+05,,,,,,,,3.99E+05,3.16E+04,,,,,,,1.03E+04,1.23E+03,5.15E+04,,1.78E+03,,,,,0.024,FALSE,1.895,8,1,128,15.5,9.63,1,cell organization and biogenesis;other metabolic processes;transport,other membranes;mitochondrion;nucleus,Pf09782,4712,A8K0Y7; hsa:4712; O95139; Q5VYT2; Q6IB84,ENSG00000165264,Complex I biogenesis; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,6,0,29.84,,45.87,,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,36.46,,58.6,2.49,transporter activity,0,
Master Protein,High,Q9UJX5,ANAPC4,Anaphase-promoting complex subunit 4 OS=Homo sapiens OX=9606 GN=ANAPC4 PE=1 SV=2,2,3,100,1.513,,100,6.64,0.6,,6.64,1.00E-17,4.14E-01,,1.00E-17,9.39E+04,,6.49E+04,,1,,2,,,,,9.39E+04,,,,,,,,2.85E+04,,1.48E+05,,,,,,,,,,9.39E+04,,,,,,,,1.27E+03,,1.99E+04,,,,,,,0,FALSE,7.939,2,2,808,92.1,5.53,2,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus,"Pf12894, Pf12896",29945,A8K8H1; E9PCR4; hsa:29945; Q6PCC6; Q9NSH6; Q9UJX5,ENSG00000053900,Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,Cell cycle,19,0,,,95.71,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,10.7,,,7.57,other molecular function,0,
Master Protein,High,H7C2C6,CCDC88A,Coiled-coil domain containing 88A (Fragment) OS=Homo sapiens OX=9606 GN=CCDC88A PE=1 SV=1,1,1,100,11.447,100,0.1,6.64,3.52,6.64,-3.33,1.00E-17,1.83E-03,1.00E-17,6.37E-02,1.68E+04,,1.92E+05,1.93E+06,1,,4,1,,,,1.68E+04,,,,,,,,2.95E+05,1.25E+05,3.31E+04,1.13E+06,,,,1.93E+06,,,,,1.68E+04,,,,,,,,1.32E+04,1.02E+03,4.45E+03,2.81E+04,,,,4.51E+04,,0.004,FALSE,2.551,1,1,1202,136.5,7.33,1,,,,,H7C2C6,ENSG00000115355,,Mesodermal commitment pathway,1,0,,,126.77,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,100.98,,101.17,2.22,,0,
Master Protein,High,Q96IX5,ATP5MK,"ATP synthase membrane subunit K, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5MK PE=1 SV=1",1,3,100,1.545,100,9.234,6.64,0.63,6.64,3.21,1.00E-17,2.17E-01,1.00E-17,2.50E-02,4.70E+05,,8.90E+05,9.63E+04,2,,4,1,2.46E+05,,,8.98E+05,,,,,,,4.05E+05,1.30E+06,,9.80E+05,8.08E+05,,9.63E+04,,,,9.77E+02,,,8.98E+05,,,,,,,2.42E+03,5.82E+04,,1.32E+05,2.01E+04,,2.71E+04,,,,0.004,FALSE,2.658,17,1,58,6.5,9.76,1,other metabolic processes,other membranes;mitochondrion,Pf14960,84833,B2R4N2; D3DR92; hsa:84833; Q96IX5,ENSG00000173915,,,0,0,80.63,,42.78,,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,83.49,,41.9,6.34,,0,
Master Protein,High,A0A087X1N8,SERPINB6,Serpin family B member 6 OS=Homo sapiens OX=9606 GN=SERPINB6 PE=1 SV=1,2,2,100,0.715,100,1.109,6.64,-0.48,6.64,0.15,1.00E-17,9.88E-01,1.00E-17,8.02E-01,1.54E+05,,1.08E+05,8.84E+04,3,,2,5,2.61E+05,,,3.82E+04,1.54E+05,,,,,,,,1.43E+05,8.07E+04,,2.03E+05,1.73E+04,1.88E+05,6.00E+04,8.84E+04,1.04E+03,,,3.82E+04,7.95E+03,,,,,,,,1.17E+03,1.09E+04,,3.97E+02,4.87E+03,1.33E+03,1.40E+03,9.41E+02,0,FALSE,7.071,9,2,395,44.8,5.68,2,,non-structural extracellular,Pf00079,5269,A0A087X1N8,ENSG00000124570,,Ectoderm differentiation,1,0,73.76,,39.58,72.88,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,,76.16,,79.87,6.11,enzyme regulator activity,0,
Master Protein,Medium,Q09472,EP300,Histone acetyltransferase p300 OS=Homo sapiens OX=9606 GN=EP300 PE=1 SV=2,1,1,100,0.554,100,1.627,6.64,-0.85,6.64,0.7,1.00E-17,8.61E-01,1.00E-17,6.02E-01,4.40E+04,,2.44E+04,1.50E+04,3,,1,1,,1.06E+05,,4.40E+04,2.59E+04,,,,,,2.44E+04,,,,,,,,1.50E+04,,,4.02E+02,,4.40E+04,1.33E+03,,,,,,1.46E+02,,,,,,,,3.50E+02,,0.03,FALSE,1.826,1,1,2414,264,8.5,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00439, Pf00569, Pf02135, Pf02172, Pf06001, Pf08214, Pf09030",2033,B1AKC2; hsa:2033; Q09472,ENSG00000100393,B-WICH complex positively regulates rRNA expression; Formation of the beta-catenin:TCF transactivating complex; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; HATs acetylate histones; Transcriptional regulation of granulopoiesis; Metalloprotease DUBs; Zygotic genome activation (ZGA); PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Formation of paraxial mesoderm; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NGF-stimulated transcription; Heme signaling; Regulation of RUNX3 expression and activity; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; SUMOylation of transcription cofactors; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of TP53 Activity through Methylation; NFE2L2 regulating anti-oxidant/detoxification enzymes; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest; NOTCH1 Intracellular Domain Regulates Transcription; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; STAT3 nuclear events downstream of ALK signaling; NFE2L2 regulating MDR associated enzymes; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Nuclear events mediated by NFE2L2; NFE2L2 regulates pentose phosphate pathway genes; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; NOTCH3 Intracellular Domain Regulates Transcription; FOXO-mediated transcription of cell death genes; Regulation of FOXO transcriptional activity by acetylation; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells; NFE2L2 regulating inflammation associated genes; NFE2L2 regulating tumorigenic genes; NFE2L2 regulating ER-stress associated genes; Regulation of NFE2L2 gene expression; RORA activates gene expression; Attenuation phase; CD209 (DC-SIGN) signaling; Polo-like kinase mediated events; Activation of the TFAP2 (AP-2) family of transcription factors; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Evasion by RSV of host interferon responses; RUNX3 regulates p14-ARF; Regulation of gene expression by Hypoxia-inducible Factor; PI5P Regulates TP53 Acetylation; NOTCH2 intracellular domain regulates transcription; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production; NOTCH4 Intracellular Domain Regulates Transcription; RUNX3 regulates NOTCH signaling,Androgen receptor signaling pathway; Energy metabolism; Cell cycle; Glioblastoma signaling pathways; Aryl hydrocarbon receptor pathway; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Kit receptor signaling pathway; Initiation of transcription and translation elongation at the HIV-1 LTR; Pathways affected in adenoid cystic carcinoma; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; TGF-beta signaling pathway; IL-4 signaling pathway; Wnt signaling pathway and pluripotency; Prion disease pathway; Clear cell renal cell carcinoma pathways; Ebola virus infection in host; Type 2 papillary renal cell carcinoma; Hepatitis B infection; Male infertility; TGF-beta receptor signaling in skeletal dysplasias; CAMKK2 pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response; CCL18 signaling pathway; Calcium mediated T-cell apoptosis involved in inclusion body myositis; Urotensin-II-mediated signaling pathway; Pathophysiological roles of DUX4 in FSHD1; HDAC6 interactions in the central nervous system; TGF-beta receptor signaling; Notch signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,91,0,71.54,,,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,61.09,,0,2.27,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UIL1,SCOC,Short coiled-coil protein OS=Homo sapiens OX=9606 GN=SCOC PE=1 SV=2,1,6,100,0.687,100,2.457,6.64,-0.54,6.64,1.3,1.00E-17,9.66E-01,1.00E-17,3.25E-01,9.65E+05,,3.07E+05,1.25E+05,5,,5,2,3.94E+05,9.65E+05,1.46E+06,1.44E+06,2.29E+05,,,,,,1.49E+06,1.24E+05,1.57E+05,1.62E+06,3.07E+05,,1.06E+05,,1.47E+05,,1.57E+03,3.67E+03,1.42E+04,1.44E+06,1.18E+04,,,,,,8.93E+03,5.55E+03,1.28E+03,2.19E+05,7.63E+03,,2.99E+04,,3.43E+03,,0,FALSE,7.133,11,1,159,18,8.85,1,other biological processes,other membranes;cytosol;ER/Golgi;nucleus,Pf10224,60592,B7WPH7; D3DNY7; E9PB65; hsa:60592; Q6P5T9; Q7L2Y0; Q7Z4P2; Q96JY9; Q9BZB2; Q9UIL1,ENSG00000153130,Retrograde transport at the Trans-Golgi-Network,,1,0,63.85,,101.31,22.63,Peak Found,Peak Found,High,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,123.55,,90.41,17.4,,0,
Master Protein,High,Q9UNS2,COPS3,COP9 signalosome complex subunit 3 OS=Homo sapiens OX=9606 GN=COPS3 PE=1 SV=3,2,6,100,0.545,100,0.223,6.64,-0.88,6.64,-2.17,1.00E-17,7.88E-01,1.00E-17,3.01E-01,1.28E+05,,4.10E+04,1.84E+05,1,,3,3,,,,1.28E+05,,,,,,,,2.24E+04,,1.85E+05,4.10E+04,,1.68E+06,5.69E+04,1.84E+05,,,,,1.28E+05,,,,,,,,1.00E+03,,2.49E+04,1.02E+03,,4.71E+05,4.03E+02,4.30E+03,,0,FALSE,10.643,10,2,423,47.8,6.65,2,protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf01399, Pf21215",8533,B2R683; B4DY81; hsa:8533; O43191; Q7LDR6; Q9UNS2,ENSG00000141030,Formation of TC-NER Pre-Incision Complex; Neddylation; Cargo recognition for clathrin-mediated endocytosis; DNA Damage Recognition in GG-NER,Ciliary landscape; Smith-Magenis and Potocki-Lupski syndrome copy number variation,6,0,,,107.51,140.93,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,115.45,,115.45,20.11,,0,
Master Protein,High,Q96S55,WRNIP1,ATPase WRNIP1 OS=Homo sapiens OX=9606 GN=WRNIP1 PE=1 SV=2,1,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,4.20E+04,,,,1,,,,,,,4.20E+04,,,,,,,,,,,,,,,,,,,,4.20E+04,,,,,,,,,,,,,,,,,0.004,FALSE,2.608,2,1,665,72.1,6.1,1,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00004, Pf12002, Pf16193, Pf18279",56897,B2RDB0; hsa:56897; Q53EP6; Q59ET8; Q5W0E2; Q5W0E4; Q8WV26; Q96S55; Q9H681; Q9NRJ6,ENSG00000124535,,,0,0,,,,,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.4,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,O60749,SNX2,Sorting nexin-2 OS=Homo sapiens OX=9606 GN=SNX2 PE=1 SV=2,1,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,4.99E+05,,,1.25E+06,2,,,2,,,,2.97E+05,8.39E+05,,,,,,,,,,,,,1.09E+06,,1.43E+06,,,,2.97E+05,4.33E+04,,,,,,,,,,,,,7.73E+03,,1.53E+04,0.002,FALSE,3.037,2,1,519,58.4,5.12,1,cell organization and biogenesis;transport,other membranes;cytosol;other cytoplasmic organelle;other cell component,"Pf00787, Pf03700, Pf09325",6643,B3KN44; B4DEK4; B7Z408; hsa:6643; O43650; O60749; P82862; Q53XK8; Q597H6; Q9BTS8,ENSG00000205302,Golgi Associated Vesicle Biogenesis,,1,0,67.42,,,19.23,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,1,,FALSE,,,,,4.63,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,D6RBW1,EIF4E,Eukaryotic translation initiation factor 4E OS=Homo sapiens OX=9606 GN=EIF4E PE=1 SV=1,1,1,100,0.477,100,0.793,6.64,-1.07,6.64,-0.33,1.00E-17,6.54E-01,1.00E-17,9.60E-01,1.58E+05,,7.56E+04,9.53E+04,1,,2,1,,,,1.58E+05,,,,,,,6.07E+04,9.42E+04,,,,,,,,9.53E+04,,,,1.58E+05,,,,,,,3.63E+02,4.21E+03,,,,,,,,1.01E+03,0.001,FALSE,3.403,6,1,245,28.5,8.12,1,protein metabolism;other metabolic processes,cytosol;other cell component,Pf01652,1977,D6RBW1,ENSG00000151247,,"Translation factors; Leptin signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Interleukin-1 (IL-1) structural pathway; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prader-Willi and Angelman syndrome; PI3K-Akt signaling pathway; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; Hypertrophy model; Interferon type I signaling pathways",20,0,,,30.65,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,32.91,,32.91,2.88,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9C0B0,UNK,RING finger protein unkempt homolog OS=Homo sapiens OX=9606 GN=UNK PE=1 SV=2,1,1,100,0.234,,100,6.64,-2.09,,6.64,1.00E-17,2.53E-01,,1.00E-17,1.04E+05,,2.45E+04,,1,,2,,,,,1.04E+05,,,,,,,,3.47E+04,,1.72E+04,,,,,,,,,,1.04E+05,,,,,,,,1.55E+03,,2.32E+03,,,,,,,0.001,FALSE,4.045,3,1,810,88,6.86,1,developmental processes;other biological processes,other cell component,"Pf00642, Pf18384",85451,hsa:85451; Q9C0B0,ENSG00000132478,,,0,0,,,47.58,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,52.97,,,3.7,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P01876,IGHA1,Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=3,1,1,100,1.422,100,4.577,6.64,0.51,6.64,2.19,1.00E-17,3.57E-01,1.00E-17,1.70E-01,1.58E+05,,2.25E+05,4.86E+04,2,,4,3,,,,1.67E+05,1.50E+05,,,,,,,2.08E+05,8.86E+04,2.44E+05,4.91E+05,,,4.86E+04,4.26E+04,8.49E+04,,,,1.67E+05,7.74E+03,,,,,,,9.30E+03,7.20E+02,3.29E+04,1.22E+04,,,3.44E+02,9.96E+02,9.04E+02,0.003,FALSE,2.724,2,1,398,42.8,5.64,1,stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf00047, Pf07654",,A0A286YEY1; P01876,ENSG00000211895; ENSG00000282633,Cell surface interactions at the vascular wall; Scavenging of heme from plasma,Inflammatory response pathway,3,0,7.64,,65.48,39,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,53.92,,62,2.11,other molecular function,0,
Master Protein,High,O75489,NDUFS3,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS3 PE=1 SV=1",5,21,100,1.621,100,2.704,6.64,0.7,6.64,1.44,1.00E-17,1.52E-01,1.00E-17,2.73E-01,8.08E+05,,2.74E+06,6.70E+05,2,,5,5,,,,3.31E+06,1.97E+05,,,,,,2.28E+06,7.56E+05,4.21E+06,2.74E+06,4.71E+06,1.89E+05,1.37E+06,6.70E+05,7.10E+05,2.59E+05,,,,3.31E+06,1.02E+04,,,,,,1.36E+04,3.38E+04,3.42E+04,3.69E+05,1.17E+05,3.68E+02,3.85E+05,4.74E+03,1.66E+04,2.75E+03,0,FALSE,19.629,23,5,264,30.2,7.5,5,cell organization and biogenesis;other metabolic processes;transport;other biological processes,other membranes;mitochondrion;nucleus,Pf00329,4722,B2R9J1; B4DFM8; hsa:4722; O75489; Q9UNQ8,ENSG00000213619,RHOG GTPase cycle; Complex I biogenesis; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,7,0,125.55,,53.78,73.71,n/a,n/a,High,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,108.94,,92.91,60.51,transporter activity;other molecular function,0,
Master Protein,High,Q13823,GNL2,Nucleolar GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=GNL2 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.04E+05,,,,1,,,,,,,1.04E+05,,,,,,,,,,,,,,,,,,,,1.04E+05,,,,,,,,,,,,,,,,,0.001,FALSE,3.304,2,1,731,83.6,9.25,1,other biological processes,nucleus,"Pf01926, Pf08153",29889,hsa:29889; Q13823; Q9BWN7,ENSG00000134697,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.38,other molecular function,0,
Master Protein,High,Q9BWU0,,Kanadaptin OS=Homo sapiens OX=9606 GN=SLC4A1AP PE=1 SV=1,1,1,100,0.432,100,0.405,6.64,-1.21,6.64,-1.3,1.00E-17,6.38E-01,1.00E-17,5.80E-01,5.97E+04,,2.58E+04,6.37E+04,3,,1,2,,,3.39E+04,6.99E+04,5.97E+04,,,,,,,,,2.58E+04,,,,,2.35E+04,1.73E+05,,,3.31E+02,6.99E+04,3.08E+03,,,,,,,,,3.48E+03,,,,,5.49E+02,1.84E+03,0,FALSE,5.249,2,1,796,88.8,5.19,1,,,,,,,,,0,0,34.05,,,107.66,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,,25.32,,174.06,2.44,,0,
Master Protein,High,Q96SI9,STRBP,Spermatid perinuclear RNA-binding protein OS=Homo sapiens OX=9606 GN=STRBP PE=1 SV=1,9,18,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,7.54E+04,,,,1,,,,,,,7.54E+04,,,,,,,,,,,,,,,,,,,,7.54E+04,,,,,,,,,,,,,,,,,0,FALSE,36.955,17,5,672,73.6,8.72,9,other biological processes,cytoskeleton;nucleus;other cell component,"Pf00035, Pf07528, Pf20965",55342,hsa:55342; Q32NB9; Q96SI9; Q9BUE1; Q9BXG4; Q9H0B4; Q9H7V1; Q9NUK4,ENSG00000165209,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,56.22,cytoskeletal activity;nucleic acid binding activity,0,
Master Protein,High,A0A0G2JH66,HLA-F,"HLA class I histocompatibility antigen, alpha chain F OS=Homo sapiens OX=9606 GN=HLA-F PE=1 SV=1",4,45,100,0.282,100,0.108,6.64,-1.83,6.64,-3.21,1.00E-17,2.50E-01,1.00E-17,6.99E-02,3.80E+05,,1.07E+05,9.92E+05,2,,1,1,,6.59E+05,,2.19E+05,,,,,,,,,,1.07E+05,,,,9.92E+05,,,,2.50E+03,,2.19E+05,,,,,,,,,,1.44E+04,,,,7.03E+03,,,0,FALSE,19.131,14,2,442,50.4,7.17,4,,other membranes,"Pf00129, Pf07654",,A0A0G2JH66,ENSG00000137403; ENSG00000206509; ENSG00000235220; ENSG00000237508,,,0,0,70.82,,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,85.78,,0,135.46,,0,
Master Protein,High,A0A0D9SEI0,MTRES1,Mitochondrial transcription rescue factor 1 OS=Homo sapiens OX=9606 GN=MTRES1 PE=1 SV=1,3,3,100,1.116,100,3.57,6.64,0.16,6.64,1.84,1.00E-17,6.10E-01,1.00E-17,2.30E-01,5.62E+04,,5.24E+04,1.47E+04,2,,5,1,,,,1.04E+05,3.03E+04,,,,,,1.72E+05,3.09E+04,5.24E+04,1.66E+05,3.71E+04,,1.47E+04,,,,,,,1.04E+05,1.56E+03,,,,,,1.03E+03,1.38E+03,4.26E+02,2.24E+04,9.21E+02,,4.12E+03,,,,0,FALSE,8.774,14,3,245,28.4,9.29,3,,,,51250,A0A0D9SEI0,ENSG00000130349,,,0,0,77.68,,77.55,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,81.41,,43.4,9.31,,0,
Master Protein,High,Q15052,ARHGEF6,Rho guanine nucleotide exchange factor 6 OS=Homo sapiens OX=9606 GN=ARHGEF6 PE=1 SV=2,1,1,100,3.372,,100,6.64,1.75,,6.64,1.00E-17,9.45E-02,,1.00E-17,4.04E+04,,1.36E+05,,1,,1,,,,,4.04E+04,,,,,,,,,,1.36E+05,,,,,,,,,,4.04E+04,,,,,,,,,,1.84E+04,,,,,,,0,FALSE,4.305,2,1,776,87.4,6.05,1,cell organization and biogenesis;signal transduction;other biological processes,cytosol;other cell component,"Pf00169, Pf00307, Pf00621, Pf07653, Pf16523, Pf16614, Pf16615",9459,A6NMW9; A8K6S7; B1AL37; hsa:9459; Q15052; Q15396; Q5JQ66; Q7Z3W1; Q86XH0,ENSG00000129675,G alpha (12/13) signalling events; G beta:gamma signalling through CDC42; CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; RHOU GTPase cycle; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Pancreatic adenocarcinoma pathway; Regulation of actin cytoskeleton,9,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.64,enzyme regulator activity,0,
Master Protein,High,Q9NTN3,SLC35D1,Nucleotide sugar transporter SLC35D1 OS=Homo sapiens OX=9606 GN=SLC35D1 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,4.19E+04,,,,1,,,,,,,4.19E+04,,,,,,,,,,,,,,,,,,,,4.19E+04,,,,,,,,,,,,,,,,,0.001,FALSE,3.434,6,1,355,39.2,8.97,1,transport,other membranes;ER/Golgi,Pf03151,23169,A8K185; B7Z3X2; hsa:23169; Q52LU5; Q92548; Q9NTN3,ENSG00000116704,"Formation of the active cofactor, UDP-glucuronate; Transport of nucleotide sugars; Defective SLC35D1 causes SCHBCKD",,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.36,transporter activity,0,
Master Protein,Medium,A0A087WWM0,TRAPPC3,Trafficking protein particle complex subunit OS=Homo sapiens OX=9606 GN=TRAPPC3 PE=1 SV=1,1,1,100,0.482,,100,6.64,-1.05,,6.64,1.00E-17,7.22E-01,,1.00E-17,5.92E+04,,2.85E+04,,2,,2,,,,,5.30E+04,6.60E+04,,,,,,,6.30E+04,,,1.29E+04,,,,,,,,,5.30E+04,3.40E+03,,,,,,,2.81E+03,,,3.21E+02,,,,,,0.017,FALSE,2.039,8,1,188,21.2,5.06,1,transport,cytosol;ER/Golgi;other cell component,Pf04051,27095,A0A087WWM0,ENSG00000054116,,,0,0,15.39,,93.22,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,116.51,,,2.36,,0,
Master Protein,High,O14893,GEMIN2,Gem-associated protein 2 OS=Homo sapiens OX=9606 GN=GEMIN2 PE=1 SV=1,1,2,100,1.873,,100,6.64,0.91,,6.64,1.00E-17,3.00E-01,,1.00E-17,6.12E+04,,1.15E+05,,1,,1,,,,,6.12E+04,,,,,,,1.15E+05,,,,,,,,,,,,,6.12E+04,,,,,,,6.85E+02,,,,,,,,,,0.001,FALSE,4.171,6,1,280,31.6,5.58,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf04938,8487,B2R9W8; hsa:8487; O14893; Q2M3B3; Q9H4F5; Q9NS77; Q9NS78; Q9NS79,ENSG00000092208,snRNP Assembly; SARS-CoV-2 modulates host translation machinery,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,6.31,,0,
Master Protein,Medium,O95243,MBD4,Methyl-CpG-binding domain protein 4 OS=Homo sapiens OX=9606 GN=MBD4 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.39E+04,,,,2,,,,,,,2.71E+04,7.14E+03,,,,,,,,,,,,,,,,,,,2.71E+04,3.68E+02,,,,,,,,,,,,,,,,0.029,FALSE,1.84,1,1,580,66,8.82,1,DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus,Pf01429,8930,B4DZN2; D3DNC3; D3DNC4; E9PEE4; hsa:8930; O95243; Q2MD36; Q7Z4T3; Q96F09,ENSG00000129071,Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Displacement of DNA glycosylase by APEX1,"Base excision repair; DNA repair pathways, full network",5,0,82.37,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O60262,GNG7,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 OS=Homo sapiens OX=9606 GN=GNG7 PE=1 SV=1,1,5,100,0.809,,100,6.64,-0.31,,6.64,1.00E-17,8.07E-01,,1.00E-17,1.57E+05,,2.43E+05,,2,,3,,,,5.37E+04,4.57E+05,,,,,,,5.63E+04,2.43E+05,,2.85E+05,,,,,,,,,5.24E+02,4.57E+05,,,,,,,3.37E+02,1.08E+04,,3.84E+04,,,,,,,0,FALSE,5.197,21,1,68,7.5,8.51,1,stress response;signal transduction;other biological processes,plasma membrane;other membranes,Pf00631,2788,B2R496; hsa:2788; O60262,ENSG00000176533,"G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation",Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells,35,0,111.7,,62.49,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,99.71,,,15.2,other molecular function,0,
Master Protein,High,Q9Y6H3,ATP23,Mitochondrial inner membrane protease ATP23 homolog OS=Homo sapiens OX=9606 GN=ATP23 PE=1 SV=3,1,1,100,0.357,100,0.745,6.64,-1.49,6.64,-0.43,1.00E-17,5.29E-01,1.00E-17,9.34E-01,5.49E+04,,1.76E+04,2.36E+04,2,,3,1,,1.31E+05,,2.30E+04,,,,,,,,1.64E+04,,2.34E+04,1.76E+04,,,,2.36E+04,,,4.98E+02,,2.30E+04,,,,,,,,7.33E+02,,3.15E+03,4.37E+02,,,,5.52E+02,,0.002,FALSE,2.96,7,1,246,28.1,8.03,1,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response,plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component,Pf09768,91419,hsa:91419; Q1RLM4; Q96E81; Q9Y6H3,ENSG00000166896; ENSG00000262145,,,0,0,99.25,,19.46,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,122.46,,10.36,2.22,kinase activity;other molecular function,0,
Master Protein,High,O15014,ZNF609,Zinc finger protein 609 OS=Homo sapiens OX=9606 GN=ZNF609 PE=1 SV=2,1,2,100,0.978,,100,6.64,-0.03,,6.64,1.00E-17,6.95E-01,,1.00E-17,3.82E+04,,3.74E+04,,1,,2,,,,,3.82E+04,,,,,,,,1.82E+04,,7.70E+04,,,,,,,,,,3.82E+04,,,,,,,,8.11E+02,,1.04E+04,,,,,,,0.001,FALSE,3.707,2,1,1411,151.1,8.03,1,other biological processes,nucleus,,23060,hsa:23060; O15014; Q0D2I2,ENSG00000180357,,,0,0,,,87.48,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,116.72,,,6.4,other molecular function,0,
Master Protein,High,C9JEJ2,PCYT1A,choline-phosphate cytidylyltransferase OS=Homo sapiens OX=9606 GN=PCYT1A PE=1 SV=1,3,4,100,3.169,,100,6.64,1.66,,6.64,1.00E-17,5.63E-02,,1.00E-17,3.86E+05,,8.10E+04,,1,,4,,,,,3.86E+05,,,,,,,,7.00E+04,9.38E+04,3.09E+05,5.36E+04,,,,,,,,,3.86E+05,,,,,,,,3.13E+03,7.62E+02,4.16E+04,1.33E+03,,,,,,0,FALSE,14.43,14,3,380,43.2,8.5,3,other metabolic processes,,Pf01467,,C9JEJ2,ENSG00000161217,,"Trans-sulfuration, one-carbon metabolism and related pathways; Kennedy pathway from sphingolipids; One-carbon metabolism and related pathways; Glycerolipids and glycerophospholipids; 3q29 copy number variation syndrome",5,0,,,90.71,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,93.6,,,15.65,other molecular function,0,
Master Protein,High,A0A8I5KWA8,ATP7A,P-type Cu(+) transporter OS=Homo sapiens OX=9606 GN=ATP7A PE=1 SV=1,1,3,100,1.157,100,0.464,6.64,0.21,6.64,-1.11,1.00E-17,5.60E-01,1.00E-17,6.82E-01,3.28E+04,,3.79E+04,7.61E+04,1,,3,3,,,,3.28E+04,,,,,,,,3.11E+04,,9.32E+04,3.79E+04,,3.88E+05,7.61E+04,6.71E+04,,,,,3.28E+04,,,,,,,,1.39E+03,,1.26E+04,9.42E+02,,1.09E+05,5.39E+02,1.57E+03,,0,FALSE,9.109,1,1,1531,166.4,6.23,1,transport,other membranes;ER/Golgi,"Pf00122, Pf00403, Pf00702",,A0A8I5KWA8,ENSG00000165240,,Copper homeostasis; Copper metabolism,2,0,,,62.93,103.17,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,26.62,,92.08,7.37,transporter activity;other molecular function,0,
Master Protein,High,P48449,LSS,Lanosterol synthase OS=Homo sapiens OX=9606 GN=LSS PE=1 SV=1,2,2,100,0.989,100,0.541,6.64,-0.02,6.64,-0.89,1.00E-17,6.95E-01,1.00E-17,7.85E-01,4.02E+04,,3.98E+04,7.36E+04,1,,2,3,,,,4.02E+04,,,,,,,,,,5.24E+04,3.03E+04,,7.43E+03,,7.36E+04,1.31E+05,,,,4.02E+04,,,,,,,,,,7.06E+03,7.52E+02,,2.09E+03,,1.72E+03,1.39E+03,0,FALSE,7.063,4,2,732,83.3,6.61,2,other metabolic processes;other biological processes,other membranes;ER/Golgi;other cell component,Pf00432,4047,B4DJZ9; D3DSN0; E9PEI9; G5E9Q9; P48449; Q8IYL6; Q9UEZ1,ENSG00000160285,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders; Cholesterol metabolism; Enterocyte cholesterol metabolism,8,0,,,37.79,87.48,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,,41.11,,90.47,6.13,other molecular function,0,
Master Protein,High,A0A2Y9D025,NDUFA6,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 OS=Homo sapiens OX=9606 GN=NDUFA6 PE=1 SV=1,2,17,100,1.092,100,13.443,6.64,0.13,6.64,3.75,1.00E-17,5.00E-01,1.00E-17,8.74E-03,1.95E+06,,2.69E+06,1.19E+05,2,,5,1,,,,3.05E+06,1.25E+06,,,,,,5.83E+05,1.50E+06,2.69E+06,2.74E+06,2.76E+06,,1.19E+05,,,,,,,3.05E+06,6.46E+04,,,,,,3.48E+03,6.71E+04,2.19E+04,3.70E+05,6.86E+04,,3.34E+04,,,,0,FALSE,7.148,16,2,154,17.9,10.14,2,,other membranes;mitochondrion,Pf13233,4700,A0A2Y9D025; hsa:4700,ENSG00000184983; ENSG00000273397; ENSG00000277365; ENSG00000281013,,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,3,0,59.04,,47.71,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,High,High,High,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,69.69,,44.85,42.99,,0,
Master Protein,High,Q6UXV4,APOOL,MICOS complex subunit MIC27 OS=Homo sapiens OX=9606 GN=APOOL PE=1 SV=1,6,10,100,0.449,100,2.45,6.64,-1.15,6.64,1.29,1.00E-17,5.82E-01,1.00E-17,3.59E-01,6.93E+05,,2.33E+05,1.07E+05,3,,5,1,1.39E+05,,,6.93E+05,9.85E+05,,,,,,2.33E+05,5.88E+05,2.25E+05,4.73E+05,2.11E+05,,1.07E+05,,,,5.51E+02,,,6.93E+05,5.08E+04,,,,,,1.39E+03,2.63E+04,1.83E+03,6.37E+04,5.25E+03,,3.00E+04,,,,0,FALSE,21.941,35,6,268,29.1,9.52,6,cell organization and biogenesis,non-structural extracellular;other membranes;mitochondrion;other cell component,Pf09769,139322,hsa:139322; Q3KNU7; Q5H9D1; Q6UXV4,ENSG00000155008,Platelet degranulation ; Cristae formation,,2,0,70.96,,50.09,,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,60.82,,87.66,28.67,,0,
Master Protein,High,B4E1C1,DAXX,Death domain-associated protein 6 OS=Homo sapiens OX=9606 GN=DAXX PE=2 SV=1,2,2,100,0.5,,100,6.64,-1,,6.64,1.00E-17,6.59E-01,,1.00E-17,7.23E+05,,3.62E+05,,1,,3,,,,,7.23E+05,,,,,,,,3.62E+05,,3.66E+05,1.30E+05,,,,,,,,,7.23E+05,,,,,,,,1.61E+04,,4.93E+04,3.22E+03,,,,,,0,FALSE,10.131,5,2,752,82.8,4.89,2,cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf03344, Pf20920",1616,B4E1C1,ENSG00000204209,,Androgen receptor signaling pathway; Amyotrophic lateral sclerosis (ALS); Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; p38 MAPK signaling pathway,5,0,,,47.33,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,1.71,,,8.25,other molecular function,0,
Master Protein,High,L7N2F9,,V-SNARE coiled-coil homology domain-containing protein (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1,2,6,100,1.085,100,2.331,6.64,0.12,6.64,1.22,1.00E-17,5.13E-01,1.00E-17,3.38E-01,4.80E+05,,5.21E+05,2.23E+05,1,,2,2,,,,4.80E+05,,,,,,,,,3.51E+05,7.74E+05,,,9.63E+04,,5.19E+05,,,,,4.80E+05,,,,,,,,,2.85E+03,1.04E+05,,,2.71E+04,,1.21E+04,,0,FALSE,11.461,33,1,121,13.1,7.96,2,transport,other membranes,Pf00957,,,,,,0,0,,,53.22,97.11,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,60.22,,94.27,24.83,,0,
Master Protein,High,Q14320,FAM50A,Protein FAM50A OS=Homo sapiens OX=9606 GN=FAM50A PE=1 SV=2,1,1,100,4.185,100,6.721,6.64,2.07,6.64,2.75,1.00E-17,6.06E-02,1.00E-17,8.51E-02,1.41E+04,,5.88E+04,8.75E+03,1,,1,1,,,,1.41E+04,,,,,,,5.88E+04,,,,,,8.75E+03,,,,,,,1.41E+04,,,,,,,3.52E+02,,,,,,2.46E+03,,,,0.003,FALSE,2.711,5,1,339,40.2,6.83,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf04921,9130,A8KAQ4; B2R997; hsa:9130; Q14320; Q5HY37; Q6PJH5,ENSG00000071859,mRNA Splicing - Major Pathway,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,0,,0,3.39,,0,
Master Protein,High,Q9NPA8,ENY2,Transcription and mRNA export factor ENY2 OS=Homo sapiens OX=9606 GN=ENY2 PE=1 SV=1,1,3,100,1.432,100,2.869,6.64,0.52,6.64,1.52,1.00E-17,2.22E-01,1.00E-17,2.58E-01,1.08E+06,,1.54E+06,5.37E+05,1,,4,1,,,,1.08E+06,,,,,,,4.01E+06,,1.16E+06,2.04E+06,7.76E+05,,,,5.37E+05,,,,,1.08E+06,,,,,,,2.40E+04,,9.42E+03,2.75E+05,1.93E+04,,,,1.26E+04,,0.001,FALSE,3.818,17,1,101,11.5,9.33,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,mitochondrion;nucleus;other cell component,Pf10163,56943,B2RE52; G3V117; hsa:56943; Q9NPA8,ENSG00000120533,HATs acetylate histones,,1,0,,,72.2,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,61.04,,61.04,9.85,other molecular function,0,
Master Protein,High,A0A087WZN1,IDH3B,"Isocitrate dehydrogenase [NAD] subunit, mitochondrial OS=Homo sapiens OX=9606 GN=IDH3B PE=1 SV=1",1,2,100,0.15,,100,6.64,-2.73,,6.64,1.00E-17,1.06E-01,,1.00E-17,1.22E+05,,1.89E+04,,3,,2,,2.71E+05,1.22E+05,,1.12E+05,,,,,,,,,,2.04E+04,1.75E+04,,,,,,1.08E+03,4.62E+02,,1.12E+05,,,,,,,,,,2.75E+03,4.36E+02,,,,,,0.001,FALSE,4.166,4,1,387,42.4,8.46,1,other metabolic processes,mitochondrion,Pf00180,3420,A0A087WZN1,ENSG00000101365,,TCA cycle (aka Krebs or citric acid cycle),1,0,53.07,,10.61,,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,20.59,,,6.15,other molecular function,0,
Master Protein,High,Q16762,TST,Thiosulfate sulfurtransferase OS=Homo sapiens OX=9606 GN=TST PE=1 SV=4,4,16,100,0.61,100,5.205,6.64,-0.71,6.64,2.38,1.00E-17,9.15E-01,1.00E-17,1.07E-01,1.33E+06,,1.26E+06,9.89E+04,3,,4,1,,5.86E+05,,2.69E+06,1.33E+06,,,,,,,4.66E+06,3.44E+05,9.94E+05,1.59E+06,,9.89E+04,,,,,2.23E+03,,2.69E+06,6.87E+04,,,,,,,2.08E+05,2.80E+03,1.34E+05,3.95E+04,,2.78E+04,,,,0,FALSE,17.19,15,4,297,33.4,7.25,4,other metabolic processes;transport;other biological processes,mitochondrion,Pf00581,7263,B3KRM1; hsa:7263; Q16762; Q6IB06,ENSG00000128311,Sulfide oxidation to sulfate,,2,0,69.47,,100.68,,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,65.62,,60.53,46.61,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P23526,AHCY,Adenosylhomocysteinase OS=Homo sapiens OX=9606 GN=AHCY PE=1 SV=4,4,8,100,1.238,100,0.742,6.64,0.31,6.64,-0.43,1.00E-17,4.76E-01,1.00E-17,9.55E-01,3.88E+05,,4.80E+05,7.43E+05,3,,3,4,,,5.38E+04,3.88E+05,5.64E+06,,,,,,,3.05E+05,,1.46E+06,4.80E+05,5.12E+05,,1.08E+06,5.02E+05,1.61E+06,,,5.26E+02,3.88E+05,2.91E+05,,,,,,,1.36E+04,,1.96E+05,1.19E+04,9.98E+02,,7.65E+03,1.17E+04,1.72E+04,0,FALSE,17.224,14,4,432,47.7,6.34,4,other metabolic processes,cytosol;ER/Golgi;nucleus;other cell component,"Pf00670, Pf05221",191,A8K307; B3KUN3; E1P5P2; F5H737; hsa:191; P23526; Q96A36,ENSG00000101444,"Methylation; Sulfur amino acid metabolism; Metabolism of ingested SeMet, Sec, MeSec into H2Se; Defective AHCY causes HMAHCHD","Folate metabolism; Trans-sulfuration pathway; One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Methionine de novo and salvage pathway; Ethanol effects on histone modifications; Spina bifida",11,0,154.56,,83.07,57.32,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,141.77,,82.89,26,other molecular function,0,
Master Protein,High,A0A0S2Z4L3,PROS1,Protein S (Fragment) OS=Homo sapiens OX=9606 GN=PROS1 PE=1 SV=1,2,3,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,2.52E+05,,,1.86E+05,1,,,2,,2.52E+05,,,,,,,,,,,,,,,1.55E+05,,2.23E+05,,,9.56E+02,,,,,,,,,,,,,,,4.35E+04,,5.21E+03,,0,FALSE,7.499,4,1,708,78.8,5.74,2,other biological processes,non-structural extracellular;ER/Golgi,"Pf00054, Pf00594, Pf02210, Pf07645, Pf12661, Pf14670",5627,A0A0S2Z4L3,ENSG00000184500,,Complement system; Dengue-2 interactions with complement and coagulation cascades; Complement system in neuronal development and plasticity; Complement and coagulation cascades,4,0,,,,25.46,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,,,7.01,other molecular function,0,
Master Protein,High,H0YFY6,NUMA1,Nuclear mitotic apparatus protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=NUMA1 PE=1 SV=1,48,199,100,1.757,100,14.566,6.64,0.81,6.64,3.86,1.00E-17,1.58E-01,1.00E-17,6.56E-03,4.55E+05,,8.18E+05,5.61E+04,4,,5,1,,4.18E+05,7.15E+04,1.29E+06,4.96E+05,,,,,,9.56E+05,1.42E+05,9.28E+05,8.18E+05,6.75E+05,,5.61E+04,,,,,1.59E+03,6.99E+02,1.29E+06,2.56E+04,,,,,,5.71E+03,6.32E+03,7.54E+03,1.10E+05,1.68E+04,,1.58E+04,,,,0,FALSE,233.887,54,1,964,107.3,9.09,48,,nucleus,,,H0YFY6,ENSG00000137497,,Ectoderm differentiation; Ectoderm differentiation; 8p23.1 copy number variation syndrome,3,0,90.51,,47.32,,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,86.64,,24.96,575.37,,0,
Master Protein,High,Q5T0B9,ZNF362,Zinc finger protein 362 OS=Homo sapiens OX=9606 GN=ZNF362 PE=1 SV=1,2,2,100,1.232,,100,6.64,0.3,,6.64,1.00E-17,4.50E-01,,1.00E-17,2.23E+05,,2.75E+05,,2,,1,,,1.96E+05,,2.54E+05,,,,,,,,2.75E+05,,,,,,,,,,7.46E+02,,2.54E+05,,,,,,,,1.23E+04,,,,,,,,,0,FALSE,5.854,9,2,420,45.8,9.64,2,other biological processes,nucleus,Pf00096,149076,hsa:149076; Q5T0B9; Q8WYU4,ENSG00000160094,,,0,0,18.03,,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,19.05,,,3.3,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96MF7,NSMCE2,E3 SUMO-protein ligase NSE2 OS=Homo sapiens OX=9606 GN=NSMCE2 PE=1 SV=2,1,2,100,0.171,,100,6.64,-2.55,,6.64,1.00E-17,9.80E-02,,1.00E-17,2.18E+05,,3.74E+04,,1,,4,,,,,2.18E+05,,,,,,,,3.92E+04,3.57E+04,2.22E+05,3.08E+04,,,,,,,,,2.18E+05,,,,,,,,1.75E+03,2.90E+02,2.99E+04,7.66E+02,,,,,,0,FALSE,4.858,5,1,247,27.9,7.74,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf11789,286053,hsa:286053; Q8N549; Q96MF7,ENSG00000156831,SUMOylation of DNA damage response and repair proteins,,1,0,,,113.98,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,19.39,,,2.32,other molecular function,0,
Master Protein,High,O00399,DCTN6,Dynactin subunit 6 OS=Homo sapiens OX=9606 GN=DCTN6 PE=1 SV=1,1,2,100,0.529,100,0.263,6.64,-0.92,6.64,-1.93,1.00E-17,7.93E-01,1.00E-17,3.65E-01,7.84E+04,,4.15E+04,1.58E+05,1,,1,1,,,,7.84E+04,,,,,,,,,,4.15E+04,,,1.58E+05,,,,,,,7.84E+04,,,,,,,,,,5.59E+03,,,4.44E+04,,,,0.001,FALSE,3.359,9,1,190,20.7,6.32,1,cell cycle OR cell proliferation;cell organization and biogenesis,cytosol;cytoskeleton;other cell component,,10671,B2RAC1; hsa:10671; O00399,ENSG00000104671,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic,Vasopressin-regulated water reabsorption,5,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,0,4.84,other molecular function,0,
Master Protein,High,Q66GS9,CEP135,Centrosomal protein of 135 kDa OS=Homo sapiens OX=9606 GN=CEP135 PE=1 SV=2,1,1,100,0.897,100,6.669,6.64,-0.16,6.64,2.74,1.00E-17,7.97E-01,1.00E-17,9.16E-02,5.28E+04,,4.74E+04,7.11E+03,3,,3,1,1.17E+05,,5.28E+04,3.15E+04,,,,,,,,3.42E+04,,6.64E+04,4.74E+04,,7.11E+03,,,,4.67E+02,,5.16E+02,3.15E+04,,,,,,,,1.53E+03,,8.94E+03,1.18E+03,,2.00E+03,,,,0.003,FALSE,2.73,1,1,1140,133.4,6.21,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;cytoskeleton,,9662,B2RMY0; hsa:9662; O75130; Q58F25; Q66GS9; Q9H8H7,ENSG00000174799,Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,,7,0,66.54,,32.73,,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,59.95,,41.15,2.3,cytoskeletal activity;other molecular function,0,
Master Protein,Medium,P56277,CMC4,Cx9C motif-containing protein 4 OS=Homo sapiens OX=9606 GN=CMC4 PE=1 SV=1,1,1,100,1.216,100,0.514,6.64,0.28,6.64,-0.96,1.00E-17,4.89E-01,1.00E-17,6.43E-01,1.61E+05,,1.73E+05,4.03E+05,2,,4,2,,2.95E+05,8.84E+04,,,,,,,,8.28E+04,2.13E+05,,5.17E+05,1.40E+05,,,,1.44E+05,1.13E+06,,1.12E+03,8.64E+02,,,,,,,,4.95E+02,9.52E+03,,6.97E+04,3.47E+03,,,,3.36E+03,1.20E+04,0.01,FALSE,2.272,25,1,68,7.7,8.18,1,,mitochondrion,Pf08991,100272147,hsa:100272147; P56277; Q5HYP9,ENSG00000182712,Mitochondrial protein import,,1,0,76.16,,81.23,109.49,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,,78.07,,112.02,2.54,,0,
Master Protein,High,P01833,PIGR,Polymeric immunoglobulin receptor OS=Homo sapiens OX=9606 GN=PIGR PE=1 SV=4,1,3,100,2.308,100,0.427,6.64,1.21,6.64,-1.23,1.00E-17,1.28E-01,1.00E-17,6.13E-01,1.24E+05,,3.80E+05,8.88E+05,2,,3,3,,,3.11E+05,4.93E+04,,,,,,,1.36E+06,,3.80E+05,3.13E+04,,,2.76E+06,,8.88E+05,6.24E+05,,,3.04E+03,4.93E+04,,,,,,,8.12E+03,,3.08E+03,4.21E+03,,,7.75E+05,,2.08E+04,6.65E+03,0.004,FALSE,2.555,2,1,764,83.2,5.74,1,transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf07686,5284,hsa:5284; P01833; Q68D81; Q8IZY7,ENSG00000162896,Neutrophil degranulation,,1,0,102.73,,116.64,81.75,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,,136.94,,119.11,8.65,other molecular function,0,
Master Protein,Medium,O00264,PGRMC1,Membrane-associated progesterone receptor component 1 OS=Homo sapiens OX=9606 GN=PGRMC1 PE=1 SV=3,1,3,100,1.098,,100,6.64,0.14,,6.64,1.00E-17,4.44E-01,,1.00E-17,6.59E+05,,7.23E+05,,1,,4,,,,,6.59E+05,,,,,,,,5.73E+05,9.13E+05,1.27E+06,3.73E+05,,,,,,,,,6.59E+05,,,,,,,,2.56E+04,7.42E+03,1.72E+05,9.27E+03,,,,,,0.011,FALSE,2.241,7,1,195,21.7,4.7,1,cell organization and biogenesis;other metabolic processes;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;mitochondrion;ER/Golgi;other cell component,Pf00173,10857,B7Z1L3; hsa:10857; O00264; Q9UGJ9,ENSG00000101856,Neutrophil degranulation,Primary ovarian insufficiency,2,0,,,50.52,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,55.35,,,7.85,other molecular function,0,
Master Protein,High,O60504,SORBS3,Vinexin OS=Homo sapiens OX=9606 GN=SORBS3 PE=1 SV=2,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,6.74E+04,,,,1,,,,,,,6.74E+04,,,,,,,,,,,,,,,,,,,,6.74E+04,,,,,,,,,,,,,,,,,0,FALSE,9.717,6,2,671,75.3,9.45,2,cell adhesion;cell organization and biogenesis;signal transduction;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf00018, Pf02208, Pf14604",10174,hsa:10174; O60504; Q5BJE4; Q6NX54; Q96FY4; Q9UQE4,ENSG00000120896,Smooth Muscle Contraction,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,9.79,cytoskeletal activity,0,
Master Protein,High,Q9NV88,INTS9,Integrator complex subunit 9 OS=Homo sapiens OX=9606 GN=INTS9 PE=1 SV=2,1,1,100,1.029,,100,6.64,0.04,,6.64,1.00E-17,6.31E-01,,1.00E-17,2.55E+04,,2.63E+04,,1,,1,,,,,2.55E+04,,,,,,,,2.63E+04,,,,,,,,,,,,2.55E+04,,,,,,,,1.17E+03,,,,,,,,,0,FALSE,4.68,3,1,658,73.8,6.33,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus,"Pf10996, Pf16661, Pf21382",55756,B7Z560; B7Z6M5; hsa:55756; O00224; Q8TB16; Q9NV88,ENSG00000104299,RNA polymerase II transcribes snRNA genes,1p36 copy number variation syndrome,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.56,,0,
Master Protein,High,A0A3B3IT47,WDR37,WD repeat domain 37 OS=Homo sapiens OX=9606 GN=WDR37 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,9.81E+04,,,,3,,,,1.82E+05,,6.58E+04,9.81E+04,,,,,,,,,,,,,,,,,7.24E+02,,6.43E+02,9.81E+04,,,,,,,,,,,,,,,,,0,FALSE,5.257,3,1,576,63.8,7.93,1,,,Pf00400,,A0A3B3IT47,ENSG00000047056,,,0,0,52.07,,,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.06,,0,
Master Protein,High,A0A8I5KUL7,FAM162A,Family with sequence similarity 162 member A OS=Homo sapiens OX=9606 GN=FAM162A PE=1 SV=1,2,5,100,7.147,100,,6.64,2.84,6.64,,1.00E-17,5.62E-04,1.00E-17,,1.01E+06,,4.35E+05,2.98E+05,1,,1,1,,,,1.01E+06,,,,,,,,4.35E+05,,,,2.98E+05,,,,,,,,1.01E+06,,,,,,,,1.94E+04,,,,5.82E+02,,,,,0,FALSE,15.97,22,2,160,18.2,9.77,2,,other membranes;cytosol;mitochondrion,Pf06388,,A0A8I5KUL7,ENSG00000114023,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,17.51,,0,
Master Protein,High,Q9NUQ2,AGPAT5,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon OS=Homo sapiens OX=9606 GN=AGPAT5 PE=1 SV=3,2,4,100,0.204,100,0.459,6.64,-2.29,6.64,-1.12,1.00E-17,1.05E-01,1.00E-17,6.21E-01,6.32E+05,,1.29E+05,2.80E+05,1,,3,1,,,,6.32E+05,,,,,,,,4.09E+05,,1.18E+05,1.29E+05,,2.80E+05,,,,,,,6.32E+05,,,,,,,,1.83E+04,,1.60E+04,3.20E+03,,7.88E+04,,,,0,FALSE,5.113,6,2,364,42,9.1,2,other metabolic processes;other biological processes,other membranes;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf01553, Pf16076",55326,hsa:55326; Q8IZ47; Q9BQG4; Q9NUQ2,ENSG00000155189; ENSG00000284980,Synthesis of PA,Triacylglyceride synthesis,2,0,,,75.34,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,12.95,,12.95,11.68,other molecular function,0,
Master Protein,Medium,Q96AZ6,ISG20,Interferon-stimulated gene 20 kDa protein OS=Homo sapiens OX=9606 GN=ISG20 PE=1 SV=2,1,1,100,1.962,,100,6.64,0.97,,6.64,1.00E-17,1.81E-01,,1.00E-17,2.95E+05,,5.78E+05,,1,,2,,,,,2.95E+05,,,,,,,1.77E+06,,,1.89E+05,,,,,,,,,,2.95E+05,,,,,,,1.06E+04,,,2.55E+04,,,,,,,0.012,FALSE,2.187,4,1,181,20.4,8.92,1,DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf00929,3669,hsa:3669; O00441; O00586; Q96AZ6,ENSG00000172183,Interferon alpha/beta signaling,,1,0,,,114.03,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,202.1,,,2.44,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NWA0,MED9,Mediator of RNA polymerase II transcription subunit 9 OS=Homo sapiens OX=9606 GN=MED9 PE=1 SV=1,1,1,100,2.183,,100,6.64,1.13,,6.64,1.00E-17,2.06E-01,,1.00E-17,6.25E+04,,1.36E+05,,1,,1,,,,,6.25E+04,,,,,,,,,,1.36E+05,,,,,,,,,,6.25E+04,,,,,,,,,,1.84E+04,,,,,,,0.003,FALSE,2.677,16,1,146,16.4,7.39,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf07544,55090,hsa:55090; Q9NWA0,ENSG00000141026,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; RSV-host interactions,Vitamin D receptor pathway; Smith-Magenis and Potocki-Lupski syndrome copy number variation,5,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.47,other molecular function,0,
Master Protein,High,Q12874,SF3A3,Splicing factor 3A subunit 3 OS=Homo sapiens OX=9606 GN=SF3A3 PE=1 SV=1,10,21,100,0.377,100,3.106,6.64,-1.41,6.64,1.64,1.00E-17,4.53E-01,1.00E-17,2.25E-01,6.81E+05,,7.33E+05,1.70E+05,3,,4,3,,,2.81E+04,6.90E+06,6.81E+05,,,,,,,1.06E+06,3.90E+05,3.55E+06,5.08E+05,1.70E+05,1.01E+04,,5.76E+05,,,,2.75E+02,6.90E+06,3.51E+04,,,,,,,4.72E+04,3.16E+03,4.78E+05,1.26E+04,3.31E+02,2.84E+03,,1.35E+04,,0,FALSE,43.032,35,10,501,58.8,5.38,10,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf11931, Pf12108, Pf13297, Pf16837",10946,D3DPT5; hsa:10946; Q12874; Q15460; Q5VT87,ENSG00000183431,mRNA Splicing - Major Pathway,Exercise-induced circadian regulation; mRNA processing,3,0,149.55,,107.38,115.76,n/a,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,115.97,,137.39,75.22,other molecular function,0,
Master Protein,High,Q6PKG0,LARP1,La-related protein 1 OS=Homo sapiens OX=9606 GN=LARP1 PE=1 SV=2,2,3,100,0.913,100,0.741,6.64,-0.13,6.64,-0.43,1.00E-17,6.38E-01,1.00E-17,9.51E-01,1.19E+06,,9.95E+04,2.92E+05,3,,2,2,1.95E+06,,1.19E+06,7.76E+04,,,,,,,,,,1.50E+05,6.62E+04,,5.24E+05,,1.63E+05,,7.76E+03,,1.17E+04,7.76E+04,,,,,,,,,,2.02E+04,1.65E+03,,1.47E+05,,3.82E+03,,0,FALSE,5.297,2,2,1096,123.4,8.82,2,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;other cell component,"Pf05383, Pf21071",23367,hsa:23367; O94836; Q6PKG0; Q8N4M2; Q8NB73; Q9UFD7,ENSG00000155506,SARS-CoV-2 activates/modulates innate and adaptive immune responses,"Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Network map of SARS-CoV-2 signaling pathway",4,0,87.82,,54.61,74.2,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,93.92,,63.97,8.1,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y4C1,KDM3A,Lysine-specific demethylase 3A OS=Homo sapiens OX=9606 GN=KDM3A PE=1 SV=4,3,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.16E+05,,,,1,,,,,,,2.16E+05,,,,,,,,,,,,,,,,,,,,2.16E+05,,,,,,,,,,,,,,,,,0,FALSE,9.877,4,3,1321,147.2,8.07,3,cell organization and biogenesis;other metabolic processes;signal transduction;other biological processes,nucleus;other cell component,Pf02373,55818,D6W5M3; hsa:55818; Q53S72; Q68D47; Q68UT9; Q6N050; Q8IY08; Q9Y4C1,ENSG00000115548,HDMs demethylate histones; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,Thermogenesis; Male infertility; Vitamin D-sensitive calcium signaling in depression,5,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,8.58,nucleic acid binding activity;other molecular function,0,
Master Protein,High,M0QZ12,GRAMD1A,GRAM domain containing 1A OS=Homo sapiens OX=9606 GN=GRAMD1A PE=1 SV=1,1,4,100,1.79,,100,6.64,0.84,,6.64,1.00E-17,2.95E-01,,1.00E-17,7.50E+04,,1.28E+05,,2,,3,,,,,1.66E+05,3.38E+04,,,,,,,1.49E+05,,1.28E+05,1.21E+05,,,,,,,,,1.66E+05,1.74E+03,,,,,,,6.66E+03,,1.73E+04,3.00E+03,,,,,,0.001,FALSE,3.224,2,1,807,89.7,6.62,1,transport,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,"Pf02893, Pf16016",57655,M0QZ12,ENSG00000089351,,,0,0,93.64,,11.04,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,117.91,,,5.67,,0,
Master Protein,High,Q92530,PSMF1,Proteasome inhibitor PI31 subunit OS=Homo sapiens OX=9606 GN=PSMF1 PE=1 SV=2,1,1,100,0.297,100,1.233,6.64,-1.75,6.64,0.3,1.00E-17,2.14E-01,1.00E-17,6.93E-01,3.19E+06,,9.49E+05,5.95E+05,1,,4,2,3.19E+06,,,,,,,,,,,5.43E+05,1.76E+06,1.05E+05,1.66E+06,,2.55E+05,,1.38E+06,,1.27E+04,,,,,,,,,,,2.42E+04,1.43E+04,1.41E+04,4.12E+04,,7.18E+04,,3.24E+04,,0.002,FALSE,2.802,4,1,271,29.8,5.74,1,protein metabolism;other metabolic processes;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,"Pf08577, Pf11566",9491,A0AVQ9; D3DVW3; hsa:9491; Q92530; Q9H4I1,ENSG00000125818,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,,59,0,,,80.69,97.36,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,89.48,,104.25,2.55,enzyme regulator activity;other molecular function,0,
Master Protein,Medium,Q9UPC5,GPR34,Probable G-protein coupled receptor 34 OS=Homo sapiens OX=9606 GN=GPR34 PE=2 SV=2,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.21E+06,,,9.62E+06,2,,,3,1.63E+06,,9.06E+05,,,,,,,,,,,,,1.41E+07,,5.11E+06,,9.62E+06,6.46E+03,,8.85E+03,,,,,,,,,,,,,2.75E+04,,3.62E+04,,1.02E+05,0.019,FALSE,2.007,6,1,381,43.8,9.86,1,signal transduction,plasma membrane;other membranes,Pf00001,2857,hsa:2857; O95853; Q9UPC5,ENSG00000171659,,"GPCRs, class A rhodopsin-like",1,0,40.24,,,46.82,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,1,Acetyl [N-Term],FALSE,,,,,3.43,other molecular function,0,
Master Protein,High,Q9NVV4,MTPAP,"Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1",2,3,100,1.17,100,0.725,6.64,0.23,6.64,-0.46,1.00E-17,4.95E-01,1.00E-17,9.00E-01,2.18E+05,,2.31E+05,3.19E+05,3,,2,1,2.18E+05,,3.75E+05,2.61E+04,,,,,,,,,3.35E+05,1.59E+05,,,3.19E+05,,,,8.68E+02,,3.66E+03,2.61E+04,,,,,,,,,2.72E+03,2.15E+04,,,8.95E+04,,,,0,FALSE,6.919,7,2,582,66.1,9.04,2,RNA metabolism OR transcription;other metabolic processes,mitochondrion;nucleus;other cell component,"Pf03828, Pf17797",55149,D3DRX0; hsa:55149; Q659E3; Q6P7E5; Q9HA74; Q9NVV4,ENSG00000107951,,,0,0,84.61,,50.2,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,75.09,,56.3,10.4,other molecular function,0,
Master Protein,High,O95373,IPO7,Importin-7 OS=Homo sapiens OX=9606 GN=IPO7 PE=1 SV=1,3,9,100,0.651,100,1.038,6.64,-0.62,6.64,0.05,1.00E-17,9.61E-01,1.00E-17,8.66E-01,8.44E+04,,1.16E+05,4.96E+04,5,,3,3,2.06E+06,6.62E+04,3.18E+05,1.36E+04,8.44E+04,,,,,,1.96E+05,,,4.31E+04,1.16E+05,,9.64E+05,4.15E+04,4.96E+04,,8.19E+03,2.51E+02,3.11E+03,1.36E+04,4.35E+03,,,,,,1.17E+03,,,5.81E+03,2.89E+03,,2.71E+05,2.94E+02,1.16E+03,,0,FALSE,14.534,5,3,1038,119.4,4.82,3,stress response;transport;other biological processes,cytosol;nucleus,"Pf03810, Pf08506",10527,A6NNM5; B2R786; hsa:10527; O95373; Q1RMF7; Q9H177; Q9NTE3,ENSG00000205339,,,0,0,172.13,,64.48,150.77,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,115.7,,136.47,23.26,enzyme regulator activity;other molecular function,0,
Master Protein,High,A0A087WYL7,MED6,Mediator of RNA polymerase II transcription subunit 6 OS=Homo sapiens OX=9606 GN=MED6 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,4.28E+04,,,,1,,,,,,,4.28E+04,,,,,,,,,,,,,,,,,,,,4.28E+04,,,,,,,,,,,,,,,,,0,FALSE,6.692,7,1,257,29.7,8.69,1,other biological processes,nucleus,Pf04934,10001,A0A087WYL7,ENSG00000133997,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.97,other molecular function,0,
Master Protein,High,Q2TB10,ZNF800,Zinc finger protein 800 OS=Homo sapiens OX=9606 GN=ZNF800 PE=1 SV=1,1,1,100,0.975,,100,6.64,-0.04,,6.64,1.00E-17,6.79E-01,,1.00E-17,2.88E+04,,2.81E+04,,1,,1,,,,,2.88E+04,,,,,,,,,,2.81E+04,,,,,,,,,,2.88E+04,,,,,,,,,,3.78E+03,,,,,,,0,FALSE,6.588,3,1,664,75.2,9.47,1,developmental processes;other biological processes,nucleus,"Pf00096, Pf12874, Pf16622, Pf16624",168850,hsa:168850; Q2TB10; Q9HBN0,ENSG00000048405,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,4.66,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q14696,MESD,LRP chaperone MESD OS=Homo sapiens OX=9606 GN=MESD PE=1 SV=2,2,8,100,1.103,100,1.249,6.64,0.14,6.64,0.32,1.00E-17,4.41E-01,1.00E-17,6.96E-01,4.57E+05,,1.13E+06,4.83E+05,2,,5,5,,,,1.35E+06,1.54E+05,,,,,,1.13E+05,1.59E+05,1.69E+06,2.07E+06,1.13E+06,1.28E+06,2.30E+05,4.83E+05,9.23E+05,3.30E+05,,,,1.35E+06,7.95E+03,,,,,,6.77E+02,7.10E+03,1.37E+04,2.78E+05,2.81E+04,2.49E+03,6.45E+04,3.43E+03,2.16E+04,3.51E+03,0,FALSE,15.384,16,2,234,26.1,7.78,2,cell-cell signaling;protein metabolism;other metabolic processes;transport;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi,Pf10185,23184,B4DW84; D3DW96; hsa:23184; Q14696; Q969U1,ENSG00000117899,,,0,0,112.52,,85.56,67.92,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,90.99,,127.84,32.66,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,Medium,E5RJD8,TBCA,Tubulin-specific chaperone A OS=Homo sapiens OX=9606 GN=TBCA PE=1 SV=1,1,1,100,0.236,100,0.584,6.64,-2.08,6.64,-0.78,1.00E-17,2.12E-01,1.00E-17,8.25E-01,1.76E+05,,4.66E+04,7.11E+04,4,,4,2,8.48E+04,,3.48E+04,5.57E+05,3.66E+05,,,,,,8.74E+04,3.71E+04,,1.97E+04,5.85E+04,,3.09E+04,,,1.64E+05,3.37E+02,,3.40E+02,5.57E+05,1.89E+04,,,,,,5.23E+02,1.66E+03,,2.66E+03,1.45E+03,,8.68E+03,,,1.74E+03,0.026,FALSE,1.869,8,1,119,14.3,5.12,1,cell organization and biogenesis;protein metabolism;other metabolic processes,cytoskeleton;nucleus;other cell component,Pf02970,,E5RJD8,ENSG00000171530,,,0,0,94.2,,57.58,96.49,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,1,,FALSE,,114.9,,98.25,2.57,cytoskeletal activity,0,
Master Protein,High,P61020,RAB5B,Ras-related protein Rab-5B OS=Homo sapiens OX=9606 GN=RAB5B PE=1 SV=1,5,14,100,0.496,100,0.78,6.64,-1.01,6.64,-0.36,1.00E-17,6.46E-01,1.00E-17,8.93E-01,2.44E+06,,1.63E+06,2.35E+06,4,,5,4,3.86E+06,,1.23E+06,1.54E+06,5.80E+06,,,,,,1.63E+06,4.81E+05,7.41E+05,5.31E+06,3.28E+06,3.54E+06,4.10E+06,,8.53E+05,1.56E+06,1.54E+04,,1.21E+04,1.54E+06,2.99E+05,,,,,,9.77E+03,2.15E+04,6.02E+03,7.15E+05,8.16E+04,6.90E+03,1.15E+06,,2.00E+04,1.66E+04,0,FALSE,19.072,32,3,215,23.7,8.13,5,cell organization and biogenesis;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,5869,A8K982; B4DKD7; hsa:5869; P35239; P35277; P61020; Q6PIK9; Q86TH0; Q8IXL2,ENSG00000111540,Neutrophil degranulation; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Respiratory syncytial virus (RSV) attachment and entry; Clathrin-mediated endocytosis; TBC/RABGAPs,Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Vasopressin-regulated water reabsorption,9,2,68.98,,87.88,61.74,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,114.8,,85.1,35.49,other molecular function,0,
Master Protein,High,Q9NTZ6,RBM12,RNA-binding protein 12 OS=Homo sapiens OX=9606 GN=RBM12 PE=1 SV=1,2,3,100,0.399,100,0.411,6.64,-1.33,6.64,-1.28,1.00E-17,5.34E-01,1.00E-17,5.98E-01,3.90E+05,,3.31E+04,3.18E+05,5,,1,2,3.90E+05,7.50E+05,2.69E+05,5.95E+05,3.14E+04,,,,,,,3.31E+04,,,,1.25E+06,,,,8.06E+04,1.55E+03,2.85E+03,2.63E+03,5.95E+05,1.62E+03,,,,,,,1.48E+03,,,,2.44E+03,,,,8.58E+02,0,FALSE,7.823,2,2,932,97.3,8.63,2,other biological processes,nucleus;other cell component,Pf00076,10137,B3KRU2; E1P5R6; hsa:10137; O94865; Q8N3B1; Q9H196; Q9NTZ6,ENSG00000244462,,,0,0,68.77,,,124.31,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,,167.76,,0,8.4,,0,
Master Protein,High,Q9BTA9,WAC,WW domain-containing adapter protein with coiled-coil OS=Homo sapiens OX=9606 GN=WAC PE=1 SV=3,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.16E+05,,,,1,,,,,,,2.16E+05,,,,,,,,,,,,,,,,,,,,2.16E+05,,,,,,,,,,,,,,,,,0,FALSE,4.91,4,1,647,70.7,9.45,1,cell cycle OR cell proliferation;cell organization and biogenesis;stress response;signal transduction;other biological processes,nucleus,Pf00397,51322,A8K2A9; C9JBT9; D3DRW5; D3DRW6; D3DRW7; hsa:51322; Q53EN9; Q5JU75; Q5JU77; Q5VXK0; Q5VXK2; Q8TCK1; Q96DP3; Q96FW6; Q96JI3; Q9BTA9,ENSG00000095787,E3 ubiquitin ligases ubiquitinate target proteins,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.53,other molecular function,0,
Master Protein,High,A0A8Q3WKF1,MRPS27,Mitochondrial ribosomal protein S27 OS=Homo sapiens OX=9606 GN=MRPS27 PE=1 SV=1,4,5,100,0.581,,100,6.64,-0.78,,6.64,1.00E-17,8.24E-01,,1.00E-17,1.77E+05,,3.93E+05,,3,,3,,1.77E+05,,6.51E+04,4.50E+05,,,,,,,,4.47E+05,,2.05E+05,3.93E+05,,,,,,7.05E+02,,6.36E+02,4.50E+05,,,,,,,,2.00E+04,,2.76E+04,9.76E+03,,,,,,0,FALSE,11.631,14,4,460,52.6,6.23,4,,mitochondrion,Pf10037,,A0A8Q3WKF1,ENSG00000113048,,,0,0,85.69,,36.48,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,15.05,,0,
Master Protein,High,Q96AB3,ISOC2,Isochorismatase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ISOC2 PE=1 SV=1,3,8,100,1.947,100,6.902,6.64,0.96,6.64,2.79,1.00E-17,8.88E-02,1.00E-17,5.09E-02,1.13E+06,,2.55E+06,1.43E+05,1,,4,1,,,,1.13E+06,,,,,,,,2.82E+06,2.30E+06,3.98E+06,1.30E+06,,1.43E+05,,,,,,,1.13E+06,,,,,,,,1.26E+05,1.87E+04,5.36E+05,3.22E+04,,4.01E+04,,,,0,FALSE,14.124,29,3,205,22.3,7.77,3,other biological processes,nucleus;other cell component,Pf00857,79763,hsa:79763; Q6ZN91; Q96AB3; Q9H5G0,ENSG00000063241,,,0,0,,,42.98,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,73.78,,110.58,28.4,,0,
Master Protein,High,E9PPP8,MTMR1,Myotubularin related protein 1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=2,2,3,100,0.392,100,1.513,6.64,-1.35,6.64,0.6,1.00E-17,5.01E-01,1.00E-17,5.88E-01,1.57E+05,,6.70E+04,2.28E+04,2,,4,1,,,2.33E+05,1.06E+05,,,,,,,7.16E+04,1.07E+05,,6.27E+04,4.11E+04,,2.28E+04,,,,,,2.27E+03,1.06E+05,,,,,,,4.28E+02,4.77E+03,,8.45E+03,1.02E+03,,6.39E+03,,,,0,FALSE,6.488,5,2,682,76.6,6.61,2,other metabolic processes,other membranes;other cell component,,,E9PPP8,ENSG00000063601,,,0,0,52.99,,38.74,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,89.53,,63.55,8.16,other molecular function,0,
Master Protein,High,O00193,SMAP,Small acidic protein OS=Homo sapiens OX=9606 GN=SMAP PE=1 SV=1,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,4.15E+05,,,,1,,,,,,,4.15E+05,,,,,,,,,,,,,,,,,,,,4.15E+05,,,,,,,,,,,,,,,,,0,FALSE,13.462,13,2,183,20.3,4.72,2,,,Pf15477,10944,B2RD28; hsa:10944; O00193,ENSG00000110696,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,9.09,,0,
Master Protein,High,Q9NVK5,FGFR1OP2,FGFR1 oncogene partner 2 OS=Homo sapiens OX=9606 GN=FGFR1OP2 PE=1 SV=1,1,1,100,0.758,,100,6.64,-0.4,,6.64,1.00E-17,9.09E-01,,1.00E-17,7.82E+04,,4.36E+04,,4,,5,,7.79E+04,,7.84E+04,2.12E+05,1.61E+04,,,,,,8.07E+04,2.95E+04,4.07E+04,2.51E+05,4.36E+04,,,,,,3.10E+02,,7.66E+02,2.12E+05,8.33E+02,,,,,,4.83E+02,1.32E+03,3.30E+02,3.38E+04,1.08E+03,,,,,,0,FALSE,5.692,6,1,253,29.4,6,1,stress response,cytosol,Pf05769,26127,hsa:26127; Q6R955; Q8N5L7; Q9NVK5; Q9P034; Q9UFK8,ENSG00000111790,Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease,,2,0,85.8,,103.85,,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,109.84,,,3.48,other molecular function,0,
Master Protein,High,Q9H4A4,RNPEP,Aminopeptidase B OS=Homo sapiens OX=9606 GN=RNPEP PE=1 SV=2,1,1,100,0.265,,100,6.64,-1.92,,6.64,1.00E-17,3.53E-01,,1.00E-17,4.29E+04,,1.14E+04,,1,,1,,,,,4.29E+04,,,,,,,,1.14E+04,,,,,,,,,,,,4.29E+04,,,,,,,,5.08E+02,,,,,,,,,0,FALSE,7.348,2,1,650,72.5,5.74,1,protein metabolism,non-structural extracellular;plasma membrane;other membranes,"Pf01433, Pf09127, Pf17900",6051,hsa:6051; Q9BVM9; Q9H1D4; Q9H4A4; Q9NPT7,ENSG00000176393,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,4.26,other molecular function,0,
Master Protein,Medium,H3BNQ7,ABAT,"4-aminobutyrate aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=ABAT PE=1 SV=1",1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.23E+05,,,,1,,,,,,,,3.23E+05,,,,,,,,,,,,,,,,,,,,1.67E+04,,,,,,,,,,,,,,,,0.01,FALSE,2.283,2,1,515,57.9,7.87,1,other metabolic processes,mitochondrion,Pf00202,,H3BNQ7,ENSG00000183044,,Valproic acid pathway; Fragile X syndrome,2,0,,,,,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,1.74,other molecular function,0,
Master Protein,High,X6RAY8,MRPL4,Mitochondrial ribosomal protein L4 OS=Homo sapiens OX=9606 GN=MRPL4 PE=1 SV=1,1,2,100,0.06,100,5.192,6.64,-4.05,6.64,2.38,1.00E-17,8.36E-03,1.00E-17,1.51E-01,1.66E+05,,9.99E+03,1.92E+03,1,,3,1,,,,1.66E+05,,,,,,,,6.31E+03,,3.89E+04,9.99E+03,,1.92E+03,,,,,,,1.66E+05,,,,,,,,2.82E+02,,5.24E+03,2.48E+02,,5.40E+02,,,,0.001,FALSE,3.627,3,1,357,39.6,10.59,1,protein metabolism;other metabolic processes,translational apparatus;other cell component,Pf00573,,X6RAY8,ENSG00000105364,,,0,0,,,96.97,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,86.43,,54.6,6.4,other molecular function,0,
Master Protein,High,Q16643,DBN1,Drebrin OS=Homo sapiens OX=9606 GN=DBN1 PE=1 SV=4,2,4,100,0.159,,100,6.64,-2.66,,6.64,1.00E-17,1.10E-01,,1.00E-17,6.84E+04,,8.10E+04,,4,,1,,7.68E+04,,6.09E+04,5.39E+04,1.20E+06,,,,,,,,,8.10E+04,,,,,,,3.05E+02,,5.95E+02,5.39E+04,6.18E+04,,,,,,,,,1.09E+04,,,,,,,0,FALSE,4.274,5,2,649,71.4,4.45,2,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf00241,1627,A8MV58; B2RBG0; hsa:1627; Q16643; Q9UFZ5,ENSG00000113758,RHOD GTPase cycle; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle; RHOH GTPase cycle,5q35 copy number variation,5,0,163.26,,,,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,9.1,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A6Q8PGG9,TRIP12,E3 ubiquitin-protein ligase OS=Homo sapiens OX=9606 GN=TRIP12 PE=1 SV=1,4,5,100,4.026,100,3.833,6.64,2.01,6.64,1.94,1.00E-17,6.09E-02,1.00E-17,1.90E-01,2.29E+04,,1.01E+05,2.63E+04,3,,4,2,,6.85E+04,,2.29E+04,1.42E+04,,,,,,2.07E+05,,5.84E+04,9.04E+04,1.13E+05,,2.97E+04,,2.34E+04,,,2.60E+02,,2.29E+04,7.32E+02,,,,,,1.24E+03,,4.74E+02,1.22E+04,2.80E+03,,8.34E+03,,5.47E+02,,0,FALSE,13.618,3,4,2068,228.4,8.6,4,protein metabolism;DNA metabolism;other metabolic processes;stress response,nucleus,"Pf00632, Pf02825",9320,A0A6Q8PGG9,ENSG00000153827,,,0,0,82.84,,54.68,16.78,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,86.84,,45.06,15.29,other molecular function,0,
Master Protein,High,Q5VSL9,STRIP1,Striatin-interacting protein 1 OS=Homo sapiens OX=9606 GN=STRIP1 PE=1 SV=1,1,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,8.48E+04,,,,1,,,,,,,8.48E+04,,,,,,,,,,,,,,,,,,,,8.48E+04,,,,,,,,,,,,,,,,,0,FALSE,4.415,3,1,837,95.5,6.29,1,cell organization and biogenesis;other biological processes,cytosol;nucleus,"Pf07923, Pf11882",85369,hsa:85369; Q0V925; Q5VSL8; Q5VSL9; Q658K2; Q6ZV31; Q8N598; Q96SN2; Q9C0A2,ENSG00000143093,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.58,other molecular function,0,
Master Protein,High,Q71DI3,H3C13; H3C14; H3C15,Histone H3.2 OS=Homo sapiens OX=9606 GN=H3C15 PE=1 SV=3,10,727,100,0.222,100,2.637,6.64,-2.17,6.64,1.4,1.00E-17,9.40E-02,1.00E-17,3.14E-01,1.55E+07,,3.22E+06,7.24E+05,4,,4,1,1.69E+07,,4.24E+07,1.43E+07,9.96E+06,,,,,,2.78E+07,1.34E+06,,1.39E+05,7.74E+06,,7.24E+05,,,,6.71E+04,,4.15E+05,1.43E+07,5.14E+05,,,,,,1.67E+05,6.00E+04,,1.87E+04,1.92E+05,,2.04E+05,,,,0,FALSE,67.505,65,1,136,15.4,11.27,10,cell organization and biogenesis,non-structural extracellular;nucleus;other cell component,Pf00125,126961; 333932; 653604,A2BDF6; A6NFS4; hsa:126961; hsa:333932; hsa:653604; Q6B053; Q71DI3,ENSG00000183598; ENSG00000203811; ENSG00000203852,Meiotic recombination; Amyloid fiber formation; HCMV Late Events; RUNX1 regulates transcription of genes involved in differentiation of HSCs; HCMV Early Events; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RMTs methylate histone arginines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; HATs acetylate histones; Chromatin modifications during the maternal to zygotic transition (MZT); RNA Polymerase I Promoter Escape; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Condensation of Prophase Chromosomes; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis; Interleukin-7 signaling; Factors involved in megakaryocyte development and platelet production; HDMs demethylate histones; PKMTs methylate histone lysines,Histone modifications; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,37,0,70.07,,138.44,,High,n/a,High,High,High,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,136.2,,125.78,1307.85,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NU22,MDN1,Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2,1,1,100,18.438,,100,6.64,4.2,,6.64,1.00E-17,2.98E-05,,1.00E-17,2.74E+04,,5.06E+05,,1,,1,,,,,2.74E+04,,,,,,,5.06E+05,,,,,,,,,,,,,2.74E+04,,,,,,,3.02E+03,,,,,,,,,,0.002,FALSE,2.963,0,1,5596,632.4,5.68,1,cell organization and biogenesis;transport,cytosol;cytoskeleton;nucleus;other cell component,"Pf07728, Pf17865, Pf17867, Pf21108",23195,hsa:23195; O15019; Q5T794; Q9NU22,ENSG00000112159,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.12,other molecular function,0,
Master Protein,High,Q9UKN8,GTF3C4,General transcription factor 3C polypeptide 4 OS=Homo sapiens OX=9606 GN=GTF3C4 PE=1 SV=2,2,3,100,1.288,100,0.698,6.64,0.36,6.64,-0.52,1.00E-17,4.75E-01,1.00E-17,9.31E-01,1.23E+05,,1.58E+05,2.27E+05,1,,2,1,,,,1.23E+05,,,,,,,,,,1.62E+05,1.55E+05,2.27E+05,,,,,,,,1.23E+05,,,,,,,,,,2.18E+04,3.86E+03,4.43E+02,,,,,0,FALSE,5.683,2,2,822,91.9,6.65,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,mitochondrion;nucleus;other cell component,"Pf12657, Pf12660, Pf19336",9329,hsa:9329; Q5VZJ7; Q9UKN8,ENSG00000125484,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter,,3,0,,,2.94,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,3.09,,3.09,7.92,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q5XPI4,RNF123,E3 ubiquitin-protein ligase RNF123 OS=Homo sapiens OX=9606 GN=RNF123 PE=1 SV=1,2,6,100,2.77,100,1.029,6.64,1.47,6.64,0.04,1.00E-17,1.27E-01,1.00E-17,8.45E-01,9.86E+04,,1.01E+05,1.14E+05,2,,5,2,,,,4.62E+05,2.11E+04,,,,,,5.47E+04,9.09E+04,1.01E+05,1.36E+06,1.77E+05,,1.40E+05,,9.30E+04,,,,,4.62E+05,1.09E+03,,,,,,3.27E+02,4.06E+03,8.19E+02,1.84E+05,4.41E+03,,3.93E+04,,2.18E+03,,0,FALSE,11.14,2,2,1314,148.4,6.74,2,protein metabolism;other metabolic processes,other membranes;cytosol;nucleus;other cell component,"Pf00622, Pf13920",63891,A1L4Q3; A6NLS5; hsa:63891; Q5I022; Q5XPI4; Q6PFW4; Q71RH0; Q8IW18; Q9H0M8; Q9H5L8; Q9H9T2,ENSG00000164068,Antigen processing: Ubiquitination & Proteasome degradation; Ub-specific processing proteases,,2,0,129.07,,157.86,28.4,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,132.13,,59.03,9.58,other molecular function,0,
Master Protein,High,H0YIV9,,"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1",1,4,100,1.202,,100,6.64,0.27,,6.64,1.00E-17,4.83E-01,,1.00E-17,2.43E+05,,2.92E+05,,2,,4,,,,2.14E+05,2.75E+05,,,,,,,,3.71E+05,1.50E+05,2.29E+05,4.69E+05,,,,,,,,2.09E+03,2.75E+05,,,,,,,,1.66E+04,1.22E+03,3.09E+04,1.16E+04,,,,,,0.002,FALSE,2.773,7,1,168,18.7,5.73,1,other biological processes,other membranes;mitochondrion,Pf02686,,,,,,0,0,17.89,,46.83,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,61.7,,,6.74,,0,
Master Protein,High,O00425,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3 OS=Homo sapiens OX=9606 GN=IGF2BP3 PE=1 SV=2,1,1,100,2.792,,100,6.64,1.48,,6.64,1.00E-17,1.07E-01,,1.00E-17,6.80E+04,,1.90E+05,,1,,1,,,,,6.80E+04,,,,,,,1.90E+05,,,,,,,,,,,,,6.80E+04,,,,,,,1.14E+03,,,,,,,,,,0.002,FALSE,2.928,2,1,579,63.7,8.87,1,protein metabolism;other metabolic processes;transport;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00013, Pf00076",10643,A0A4Z5; hsa:10643; O00425; Q63HM0; Q6MZZ2; Q86VB1,ENSG00000136231,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.07,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O95639,CPSF4,Cleavage and polyadenylation specificity factor subunit 4 OS=Homo sapiens OX=9606 GN=CPSF4 PE=1 SV=1,2,2,100,0.23,100,0.126,6.64,-2.12,6.64,-2.98,1.00E-17,1.92E-01,1.00E-17,8.40E-02,3.54E+05,,8.12E+04,6.43E+05,1,,2,1,,,,3.54E+05,,,,,,,7.70E+04,,,,8.56E+04,,,6.43E+05,,,,,,3.54E+05,,,,,,,4.60E+02,,,,2.13E+03,,,4.55E+03,,,0,FALSE,7.653,13,2,269,30.2,8.31,2,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00098, Pf00642, Pf15663",10898,D6W5S8; hsa:10898; O95639; Q6FGE6; Q86TF8; Q9BTW6,ENSG00000160917,Transport of Mature mRNA Derived from an Intronless Transcript; tRNA processing in the nucleus; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs; Inhibition of Host mRNA Processing and RNA Silencing,mRNA processing,8,0,,,7.52,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,7.89,,7.89,6.02,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A3B3IRV5,HEBP1,Heme binding protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=HEBP1 PE=1 SV=1,1,6,100,3.421,100,1.037,6.64,1.77,6.64,0.05,1.00E-17,3.81E-02,1.00E-17,8.30E-01,8.84E+04,,4.80E+05,3.77E+05,2,,4,2,,,,2.54E+05,3.07E+04,,,,,,,5.51E+05,4.18E+05,6.24E+05,1.46E+05,,5.66E+05,,2.51E+05,,,,,2.54E+05,1.59E+03,,,,,,,2.46E+04,3.40E+03,8.41E+04,3.64E+03,,1.59E+05,,5.88E+03,,0,FALSE,4.996,8,1,207,23.1,9.33,1,,other cell component,Pf04832,,A0A3B3IRV5,ENSG00000013583,,,0,0,110.9,,48.39,54.41,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,100.14,,77.19,19.38,,0,
Master Protein,High,A0A8V8TP22,WDR1,WD repeat domain 1 OS=Homo sapiens OX=9606 GN=WDR1 PE=1 SV=1,3,6,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,2.75E+06,,6.35E+05,6.23E+05,2,,2,3,7.50E+06,,,,1.01E+06,,,,,,,,5.04E+05,7.99E+05,,9.92E+06,3.35E+05,,6.23E+05,,2.98E+04,,,,5.19E+04,,,,,,,,4.10E+03,1.08E+05,,1.93E+04,9.42E+04,,1.46E+04,,0,FALSE,13.973,10,3,659,72,6.9,3,,,Pf00400,9948,A0A8V8TP22,ENSG00000071127,,Hypertrophy model,1,0,107.98,,31.98,150.38,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,,,,18.42,,0,
Master Protein,High,Q7L2J0,MEPCE,7SK snRNA methylphosphate capping enzyme OS=Homo sapiens OX=9606 GN=MEPCE PE=1 SV=1,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,7.12E+04,,,,2,,,,,,,5.91E+04,8.57E+04,,,,,,,,,,,,,,,,,,,5.91E+04,4.42E+03,,,,,,,,,,,,,,,,0,FALSE,4.488,4,2,689,74.3,9.57,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf06859,56257,B3KP86; D6W5V7; hsa:56257; Q7L2J0; Q9NPD4,ENSG00000146834,,IL-18 signaling pathway; 1p36 copy number variation syndrome,2,0,25.99,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.7,nucleic acid binding activity;other molecular function,0,
Master Protein,High,E9PL71,EEF1D,Elongation factor 1-delta (Fragment) OS=Homo sapiens OX=9606 GN=EEF1D PE=1 SV=1,4,27,100,0.794,100,0.479,6.64,-0.33,6.64,-1.06,1.00E-17,8.38E-01,1.00E-17,6.83E-01,3.22E+04,,2.56E+04,5.34E+04,1,,1,3,,,3.22E+04,,,,,,,,,,,,2.56E+04,,5.34E+04,,2.54E+04,3.32E+05,,,3.14E+02,,,,,,,,,,,,6.35E+02,,1.50E+04,,5.93E+02,3.53E+03,0,FALSE,16.796,31,1,187,20.8,5.01,4,protein metabolism;other metabolic processes,other cell component,Pf10587,,E9PL71,ENSG00000104529; ENSG00000273594,,,0,0,,,,123.8,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,,0,,77.81,76.93,nucleic acid binding activity,0,
Master Protein,High,Q9NWS0,PIH1D1,PIH1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PIH1D1 PE=1 SV=1,1,1,100,0.76,,100,6.64,-0.4,,6.64,1.00E-17,9.47E-01,,1.00E-17,8.84E+04,,6.71E+04,,2,,2,,,,,7.50E+04,1.04E+05,,,,,,,,9.71E+04,4.64E+04,,,,,,,,,,7.50E+04,5.37E+03,,,,,,,,7.89E+02,6.25E+03,,,,,,,0.001,FALSE,3.877,6,1,290,32.3,5.14,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf08190, Pf18201",55011,B4DGN7; B4E2X7; hsa:55011; Q9BVL0; Q9NWS0,ENSG00000104872,,,0,0,23.05,,49.97,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,47.5,,,3.17,other molecular function,0,
Master Protein,High,H0YDW8,GNLY,Granulysin (Fragment) OS=Homo sapiens OX=9606 GN=GNLY PE=1 SV=1,1,1,100,4.225,100,0.938,6.64,2.08,6.64,-0.09,1.00E-17,6.10E-02,1.00E-17,9.02E-01,2.80E+04,,1.18E+05,1.26E+05,1,,2,2,,,,2.80E+04,,,,,,,,4.92E+04,,2.84E+05,,,5.62E+04,,2.82E+05,,,,,2.80E+04,,,,,,,,2.20E+03,,3.82E+04,,,1.58E+04,,6.60E+03,,0.001,FALSE,3.742,10,1,187,20.9,9.38,1,stress response,,Pf03489,,H0YDW8,ENSG00000115523,,Allograft rejection,1,0,,,99.65,94.45,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,147.24,,65.71,4.05,,0,
Master Protein,High,Q7Z5L9,IRF2BP2,Interferon regulatory factor 2-binding protein 2 OS=Homo sapiens OX=9606 GN=IRF2BP2 PE=1 SV=2,3,3,100,0.545,100,0.8,6.64,-0.88,6.64,-0.32,1.00E-17,7.76E-01,1.00E-17,9.73E-01,3.06E+05,,1.67E+05,2.09E+05,1,,2,1,,,,3.06E+05,,,,,,,,1.35E+05,,2.07E+05,,,2.09E+05,,,,,,,3.06E+05,,,,,,,,6.02E+03,,2.79E+04,,,5.86E+04,,,,0,FALSE,12.597,9,2,587,61,8.69,3,other biological processes,nucleus;other cell component,Pf11261,359948,B1AM35; B1AM36; hsa:359948; Q6P083; Q7Z5L8; Q7Z5L9; Q8N351; Q8WUH8,ENSG00000168264,,,0,0,,,29.85,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,32.02,,32.02,10.22,other molecular function,0,
Master Protein,High,Q16891,IMMT,MICOS complex subunit MIC60 OS=Homo sapiens OX=9606 GN=IMMT PE=1 SV=1,28,180,100,0.544,100,1.177,6.64,-0.88,6.64,0.24,1.00E-17,8.00E-01,1.00E-17,7.21E-01,1.16E+06,,8.59E+05,4.46E+05,2,,3,3,,,,8.10E+05,1.66E+06,,,,,,,2.21E+05,,9.43E+05,8.59E+05,,1.88E+05,1.96E+06,4.46E+05,,,,,8.10E+05,8.54E+04,,,,,,,9.88E+03,,1.27E+05,2.14E+04,,5.28E+04,1.39E+04,1.04E+04,,0,FALSE,145.793,41,1,758,83.6,6.48,28,cell organization and biogenesis;other biological processes,other membranes;mitochondrion,Pf09731,10989,B1H0U5; B2R5N6; hsa:10989; Q14539; Q15092; Q16891; Q68D41; Q69HW5; Q6IBL0; Q7Z3X1; Q8TAJ5; Q9P0V2,ENSG00000132305,Cristae formation,,1,0,48.51,,58.53,110.74,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,High,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,75.65,,94.12,511.37,,0,
Master Protein,High,P62191,PSMC1,26S proteasome regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMC1 PE=1 SV=1,2,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,6.18E+04,,,5.04E+05,1,,,1,,,,6.18E+04,,,,,,,,,,,,,5.04E+05,,,,,,,6.18E+04,,,,,,,,,,,,,1.42E+05,,,,0,FALSE,7.637,6,2,440,49.2,6.21,2,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00004, Pf16450, Pf17862",5700,B4DR63; hsa:5700; P49014; P62191; Q03527; Q6IAW0; Q6NW36; Q96AZ3,ENSG00000100764,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,64,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,6.31,other molecular function,0,
Master Protein,High,F8W7T1,DPF3,Double PHD fingers 3 OS=Homo sapiens OX=9606 GN=DPF3 PE=1 SV=1,5,6,100,0.635,100,0.137,6.64,-0.66,6.64,-2.87,1.00E-17,9.17E-01,1.00E-17,1.12E-01,7.81E+05,,1.29E+05,9.42E+05,2,,1,1,,,,1.12E+06,5.47E+05,,,,,,,,,,1.29E+05,,,,,9.42E+05,,,,1.12E+06,2.82E+04,,,,,,,,,,3.20E+03,,,,,1.00E+04,0,FALSE,22.343,16,5,412,46.4,7.3,5,,,Pf14051,8110,F8W7T1,ENSG00000205683,,Tumor suppressor activity of SMARCB1; Thermogenesis,2,0,48.41,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,172.15,,0,17.37,,0,
Master Protein,High,A0A0B4J1W0,MED24,Mediator of RNA polymerase II transcription subunit 24 OS=Homo sapiens OX=9606 GN=MED24 PE=1 SV=1,1,4,100,0.379,100,0.652,6.64,-1.4,6.64,-0.62,1.00E-17,5.03E-01,1.00E-17,8.93E-01,1.26E+05,,4.76E+04,7.30E+04,2,,2,2,,9.95E+04,,1.59E+05,,,,,,,,,3.42E+04,6.63E+04,,1.47E+05,,,,3.63E+04,,3.78E+02,,1.59E+05,,,,,,,,,2.77E+02,8.93E+03,,2.87E+02,,,,3.86E+02,0,FALSE,6.929,2,1,1014,112.9,6.87,1,,nucleus,Pf11277,,A0A0B4J1W0,ENSG00000008838,,,0,0,32.39,,45.25,85.43,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,,39.66,,80.67,13.21,,0,
Master Protein,High,P14324,FDPS,Farnesyl pyrophosphate synthase OS=Homo sapiens OX=9606 GN=FDPS PE=1 SV=4,1,2,100,0.85,100,0.61,6.64,-0.23,6.64,-0.71,1.00E-17,8.43E-01,1.00E-17,8.23E-01,5.61E+04,,4.77E+04,7.82E+04,1,,3,3,,,,,5.61E+04,,,,,,,,4.77E+04,2.79E+05,1.52E+04,,3.77E+05,7.82E+04,3.67E+04,,,,,,2.89E+03,,,,,,,,3.87E+02,3.76E+04,3.78E+02,,1.06E+05,5.54E+02,8.58E+02,,0,FALSE,4.791,4,1,419,48.2,6.15,1,other metabolic processes,cytosol;nucleus;other cell component,Pf00348,2224,D3DV91; E9PCI9; hsa:2224; P14324; Q96G29,ENSG00000160752,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Mevalonate pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders; Cholesterol metabolism; Enterocyte cholesterol metabolism,9,0,,,126.18,113.18,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,122.89,,122.89,4.83,other molecular function,0,
Master Protein,High,P80511,S100A12,Protein S100-A12 OS=Homo sapiens OX=9606 GN=S100A12 PE=1 SV=2,1,5,100,19.677,100,0.219,6.64,4.3,6.64,-2.19,1.00E-17,1.76E-05,1.00E-17,1.98E-01,3.12E+04,,6.13E+05,2.80E+06,1,,3,1,,,,3.12E+04,,,,,,,,,6.92E+05,6.13E+05,3.24E+05,,,,2.80E+06,,,,,3.12E+04,,,,,,,,,5.62E+03,8.26E+04,8.04E+03,,,,6.56E+04,,0,FALSE,5.657,20,1,92,10.6,6.25,1,other metabolic processes;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf01023,6283,hsa:6283; P80511; P83219; Q5SY66; Q7M4R1,ENSG00000163221,Neutrophil degranulation; TAK1-dependent IKK and NF-kappa-B activation  ; TRAF6 mediated NF-kB activation; Advanced glycosylation endproduct receptor signaling,,4,0,,,35.74,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,High,n/a,1,,FALSE,,19.16,,16.97,16.83,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,J3KPT4,TRABD,TraB domain containing OS=Homo sapiens OX=9606 GN=TRABD PE=1 SV=1,6,11,100,1.693,100,0.87,6.64,0.76,6.64,-0.2,1.00E-17,2.44E-01,1.00E-17,9.51E-01,1.49E+05,,4.22E+05,9.36E+04,4,,5,2,1.47E+05,,5.10E+04,2.44E+05,1.51E+05,,,,,,5.16E+05,4.22E+05,4.70E+04,1.08E+06,2.23E+05,,9.87E+04,,,8.88E+04,5.84E+02,,4.98E+02,2.44E+05,7.79E+03,,,,,,3.09E+03,1.88E+04,3.82E+02,1.45E+05,5.54E+03,,2.77E+04,,,9.45E+02,0,FALSE,24.045,29,6,379,42.7,8,6,,,Pf01963,80305,J3KPT4,ENSG00000170638,,,0,0,53.13,,85.55,7.5,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,1,Acetyl [N-Term],FALSE,,105.27,,109.17,33.91,,0,
Master Protein,High,Q9UL15,BAG5,BAG family molecular chaperone regulator 5 OS=Homo sapiens OX=9606 GN=BAG5 PE=1 SV=1,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,2.21E+04,,,7.36E+04,1,,,1,,,,2.21E+04,,,,,,,,,,,,,,,7.36E+04,,,,,2.21E+04,,,,,,,,,,,,,,,1.72E+03,,0.001,FALSE,3.485,3,1,447,51.2,6.05,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;mitochondrion;nucleus;other cell component,Pf02179,9529,hsa:9529; O94950; Q86W59; Q9UL15,ENSG00000166170,Regulation of HSF1-mediated heat shock response,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,,,,3.1,other molecular function,0,
Master Protein,High,Q9BXW7,HDHD5,Haloacid dehalogenase-like hydrolase domain-containing 5 OS=Homo sapiens OX=9606 GN=HDHD5 PE=1 SV=1,3,6,100,0.397,,100,6.64,-1.33,,6.64,1.00E-17,4.91E-01,,1.00E-17,1.36E+05,,1.45E+05,,2,,3,,,,,6.65E+05,2.77E+04,,,,,,,4.92E+05,,9.47E+03,1.45E+05,,,,,,,,,6.65E+05,1.43E+03,,,,,,,2.20E+04,,1.28E+03,3.59E+03,,,,,,0,FALSE,24.571,15,3,423,46.3,8.13,3,other metabolic processes,mitochondrion,Pf13344,27440,B2RCK5; Q9BXW7; Q9BXW8; Q9NWA8; Q9NX41,ENSG00000069998,,,0,0,130.1,,115.57,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,94.4,,,24.21,,0,
Master Protein,High,P48723,HSPA13,Heat shock 70 kDa protein 13 OS=Homo sapiens OX=9606 GN=HSPA13 PE=1 SV=1,1,2,100,11.963,100,0.512,6.64,3.58,6.64,-0.97,1.00E-17,2.91E-03,1.00E-17,6.88E-01,1.29E+04,,1.54E+05,2.96E+05,1,,4,3,,,,1.29E+04,,,,,,,,1.01E+05,3.42E+05,2.30E+05,1.04E+05,2.96E+05,1.36E+05,,6.41E+06,,,,,1.29E+04,,,,,,,,4.53E+03,2.78E+03,3.09E+04,2.58E+03,5.76E+02,3.82E+04,,1.50E+05,,0.001,FALSE,3.194,3,1,471,51.9,5.76,1,protein metabolism;other metabolic processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,Pf00012,6782,B2R616; hsa:6782; P48723; Q8NE40,ENSG00000155304,Regulation of HSF1-mediated heat shock response,,1,0,,,59.46,156.85,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,61.59,,93.08,7.15,other molecular function,0,
Master Protein,High,Q96RE7,NACC1,Nucleus accumbens-associated protein 1 OS=Homo sapiens OX=9606 GN=NACC1 PE=1 SV=1,3,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,7.90E+04,,,,1,,,,,,,7.90E+04,,,,,,,,,,,,,,,,,,,,7.90E+04,,,,,,,,,,,,,,,,,0,FALSE,10.733,9,3,527,57.2,5.74,3,other biological processes,nucleus;other cell component,"Pf00651, Pf10523",112939,hsa:112939; Q96RE7,ENSG00000160877,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,10.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y5M8,SRPRB,Signal recognition particle receptor subunit beta OS=Homo sapiens OX=9606 GN=SRPRB PE=1 SV=3,2,5,100,0.695,100,0.694,6.64,-0.53,6.64,-0.53,1.00E-17,9.65E-01,1.00E-17,8.84E-01,2.73E+05,,1.90E+05,2.73E+05,1,,4,1,,,,2.73E+05,,,,,,,,1.29E+05,1.25E+05,2.78E+05,3.11E+05,,2.73E+05,,,,,,,2.73E+05,,,,,,,,5.77E+03,1.01E+03,3.75E+04,7.72E+03,,7.68E+04,,,,0,FALSE,7.909,12,2,271,29.7,9.04,2,cell organization and biogenesis;other biological processes,other membranes;cytoskeleton;ER/Golgi;other cell component,Pf09439,58477,hsa:58477; Q6P595; Q8N2D8; Q9Y5M8,ENSG00000144867,XBP1(S) activates chaperone genes; SRP-dependent cotranslational protein targeting to membrane,,2,0,,,46.35,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,63.53,,63.53,13.89,other molecular function,0,
Master Protein,High,Q8NDX5,PHC3,Polyhomeotic-like protein 3 OS=Homo sapiens OX=9606 GN=PHC3 PE=1 SV=1,3,5,100,0.724,,100,6.64,-0.47,,6.64,1.00E-17,9.79E-01,,1.00E-17,1.50E+05,,1.09E+05,,1,,1,,,,,1.50E+05,,,,,,,,1.09E+05,,,,,,,,,,,,1.50E+05,,,,,,,,4.85E+03,,,,,,,,,0,FALSE,16.455,8,2,983,106.1,6.62,3,other biological processes,nucleus,"Pf00536, Pf21319",80012,A2RRP9; hsa:80012; Q5HYF0; Q6NSG2; Q8NDX5; Q8NFT7; Q8NFZ1; Q8TBM2; Q9H971; Q9H9I4,ENSG00000173889,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6,,9,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,14.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,H0Y8P4,UTP15,U3 small nucleolar RNA-associated protein 15 homolog (Fragment) OS=Homo sapiens OX=9606 GN=UTP15 PE=1 SV=1,1,1,100,0.622,100,4.195,6.64,-0.69,6.64,2.07,1.00E-17,9.11E-01,1.00E-17,1.47E-01,1.28E+05,,7.98E+04,1.90E+04,1,,3,1,,,,1.28E+05,,,,,,,7.98E+04,,,9.54E+04,3.11E+04,,1.90E+04,,,,,,,1.28E+05,,,,,,,4.77E+02,,,1.29E+04,7.73E+02,,5.34E+03,,,,0.001,FALSE,3.662,2,1,545,61.4,9.04,1,RNA metabolism OR transcription;other metabolic processes,ER/Golgi;nucleus,"Pf00400, Pf09384",,H0Y8P4,ENSG00000164338,,,0,0,,,48.75,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,24.32,,29.09,2.48,,0,
Master Protein,Medium,Q96D71,REPS1,RalBP1-associated Eps domain-containing protein 1 OS=Homo sapiens OX=9606 GN=REPS1 PE=1 SV=3,1,1,100,0.483,,100,6.64,-1.05,,6.64,1.00E-17,7.23E-01,,1.00E-17,5.88E+04,,2.84E+04,,2,,3,,,,7.84E+04,4.41E+04,,,,,,,5.21E+04,1.51E+04,,2.84E+04,,,,,,,,,7.66E+02,4.41E+04,,,,,,,3.12E+02,6.73E+02,,3.83E+03,,,,,,,0.024,FALSE,1.907,2,1,796,86.6,5.69,1,transport,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf12763,85021,B7ZBZ8; B7ZBZ9; B7ZC00; hsa:85021; J3KP76; Q5JWJ5; Q5JWJ6; Q5JWJ7; Q8NDR7; Q8WU62; Q96D71; Q9BXY9,ENSG00000135597,Cargo recognition for clathrin-mediated endocytosis,,2,0,39.56,,58.86,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,55.49,,,2.62,other molecular function,0,
Master Protein,High,Q96PU8,QKI,KH domain-containing RNA-binding protein QKI OS=Homo sapiens OX=9606 GN=QKI PE=1 SV=1,2,3,100,0.939,100,1.499,6.64,-0.09,6.64,0.58,1.00E-17,7.43E-01,1.00E-17,5.50E-01,5.07E+04,,6.64E+04,4.43E+04,2,,3,3,,,,1.44E+05,1.79E+04,,,,,,6.64E+04,1.34E+05,,,1.69E+04,,,6.26E+04,2.38E+04,4.43E+04,,,,1.44E+05,9.23E+02,,,,,,3.97E+02,5.98E+03,,,4.21E+02,,,4.43E+02,5.57E+02,4.71E+02,0,FALSE,9.648,10,2,341,37.6,8.56,2,RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00013, Pf16544, Pf16551",9444,hsa:9444; Q2I375; Q5MJQ1; Q969L9; Q96EJ3; Q96KA3; Q96PU6; Q96PU7; Q96PU8; Q9P0X6; Q9P0X7; Q9P0X8; Q9P0X9; Q9P0Y0; Q9P0Y1,ENSG00000112531,Signaling by BRAF and RAF1 fusions,VEGFA-VEGFR2 signaling; Exercise-induced circadian regulation,3,0,110.13,,81.06,44.51,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,120.21,,110.43,6.5,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q99590,SCAF11,Protein SCAF11 OS=Homo sapiens OX=9606 GN=SCAF11 PE=1 SV=2,6,11,100,0.552,,100,6.64,-0.86,,6.64,1.00E-17,7.30E-01,,1.00E-17,1.96E+05,,5.89E+05,,2,,3,,,,3.03E+04,1.27E+06,,,,,,,,3.54E+05,,1.48E+06,5.89E+05,,,,,,,,2.96E+02,1.27E+06,,,,,,,,1.58E+04,,2.00E+05,1.46E+04,,,,,,0,FALSE,28.492,7,6,1463,164.6,8.41,6,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus,Pf13639,9169,A6NEU9; A6NLW5; hsa:9169; Q8IW59; Q99590,ENSG00000139218,,Apoptosis,1,0,134.81,,73.7,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,41.29,,,42.49,other molecular function,0,
Master Protein,High,Q9NXH8,TOR4A,Torsin-4A OS=Homo sapiens OX=9606 GN=TOR4A PE=1 SV=2,1,1,100,1.247,100,0.419,6.64,0.32,6.64,-1.25,1.00E-17,4.67E-01,1.00E-17,5.19E-01,1.58E+05,,1.96E+05,4.69E+05,1,,1,1,,,,1.58E+05,,,,,,,,,,1.96E+05,,,4.69E+05,,,,,,,1.58E+05,,,,,,,,,,2.65E+04,,,1.32E+05,,,,0.004,FALSE,2.617,2,1,423,46.9,9.94,1,,non-structural extracellular;other membranes;ER/Golgi;nucleus;other cell component,Pf06309,54863,A2BFA4; hsa:54863; Q9NXH8,ENSG00000198113,Platelet degranulation,,1,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,0,2.28,other molecular function,0,
Master Protein,High,Q9Y6I4,USP3,Ubiquitin carboxyl-terminal hydrolase 3 OS=Homo sapiens OX=9606 GN=USP3 PE=1 SV=2,3,4,100,5.293,100,6.624,6.64,2.4,6.64,2.73,1.00E-17,1.53E-02,1.00E-17,7.69E-02,4.80E+04,,2.54E+05,3.83E+04,1,,1,1,,,,4.80E+04,,,,,,,2.54E+05,,,,,,3.83E+04,,,,,,,4.80E+04,,,,,,,1.52E+03,,,,,,1.08E+04,,,,0,FALSE,12.041,7,3,520,58.9,8.18,3,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00443, Pf02148",9960,B4DVU5; F5H1A6; hsa:9960; Q8WVD0; Q9Y6I4,ENSG00000140455,Ub-specific processing proteases,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,0,,0,13.37,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,G3XAN8,TIMM8B,Mitochondrial import inner membrane translocase subunit OS=Homo sapiens OX=9606 GN=TIMM8B PE=1 SV=1,1,1,100,1.223,,100,6.64,0.29,,6.64,1.00E-17,5.45E-01,,1.00E-17,3.59E+04,,4.38E+04,,1,,2,,,,3.59E+04,,,,,,,,,,,1.28E+05,1.50E+04,,,,,,,,3.50E+02,,,,,,,,,,,1.72E+04,3.73E+02,,,,,,0.026,FALSE,1.869,17,1,98,11.1,8.1,1,transport,other membranes;mitochondrion,Pf02953,26521,G3XAN8; hsa:26521,ENSG00000150779,,,0,0,,,111.69,,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,190.9,,,2.86,,0,
Master Protein,High,P48960,ADGRE5,Adhesion G protein-coupled receptor E5 OS=Homo sapiens OX=9606 GN=ADGRE5 PE=1 SV=4,9,32,100,1.004,,100,6.64,0.01,,6.64,1.00E-17,5.82E-01,,1.00E-17,2.92E+06,,4.22E+06,,2,,5,,2.84E+06,,,3.00E+06,,,,,,,4.86E+06,2.39E+06,5.45E+05,4.22E+06,6.06E+06,,,,,,1.13E+04,,,3.00E+06,,,,,,,2.90E+04,1.07E+05,4.43E+03,5.69E+05,1.51E+05,,,,,,0,FALSE,53.484,17,9,835,91.8,6.87,9,cell adhesion;cell-cell signaling;stress response;signal transduction;other biological processes,plasma membrane;other membranes,"Pf00002, Pf01825, Pf07645",976,A8K7Z4; B2RBJ9; hsa:976; O00718; O76101; P48960; Q8NG72; Q8TBQ7,ENSG00000123146,Neutrophil degranulation; Class B/2 (Secretin family receptors),"Vitamin D receptor pathway; GPCRs, class B secretin-like",4,0,4.08,,60.03,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,High,n/a,n/a,High,High,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,,78.32,,,101.67,other molecular function,0,
Master Protein,High,Q86VY4,TSPYL5,Testis-specific Y-encoded-like protein 5 OS=Homo sapiens OX=9606 GN=TSPYL5 PE=1 SV=2,3,3,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,2.66E+05,,,6.56E+05,1,,,1,,,,2.66E+05,,,,,,,,,,,,6.56E+05,,,,,,,,2.66E+05,,,,,,,,,,,,1.28E+03,,,,,0,FALSE,12.762,13,3,417,45.1,9.54,3,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf00956,85453,B3KRF0; hsa:85453; Q86VY4; Q9C0B3,ENSG00000180543,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,,,,11.6,other molecular function,0,
Master Protein,High,P62070,RRAS2,Ras-related protein R-Ras2 OS=Homo sapiens OX=9606 GN=RRAS2 PE=1 SV=1,1,1,100,2.481,,100,6.64,1.31,,6.64,1.00E-17,1.26E-01,,1.00E-17,8.96E+04,,2.22E+05,,2,,1,,,,,3.40E+04,2.37E+05,,,,,,,,,2.22E+05,,,,,,,,,,3.40E+04,1.22E+04,,,,,,,,,3.00E+04,,,,,,,0.002,FALSE,2.929,6,1,204,23.4,6.01,1,developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi,Pf00071,22800,B2R9Z3; B7Z5Z2; B7Z6C4; B7Z7H6; hsa:22800; P17082; P62070,ENSG00000133818,RND1 GTPase cycle,MAPK signaling pathway; Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; EGFR tyrosine kinase inhibitor resistance; Regulation of actin cytoskeleton,6,0,105.93,,,,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,167.63,,,2.49,other molecular function,0,
Master Protein,High,P51689,ARSD,Arylsulfatase D OS=Homo sapiens OX=9606 GN=ARSD PE=1 SV=2,2,4,100,4.961,100,2.247,6.64,2.31,6.64,1.17,1.00E-17,1.77E-02,1.00E-17,3.77E-01,4.37E+04,,2.56E+05,9.65E+04,1,,3,1,,,,4.37E+04,,,,,,,2.56E+05,2.63E+04,,4.92E+05,,9.65E+04,,,,,,,,4.37E+04,,,,,,,1.53E+03,1.17E+03,,6.63E+04,,1.88E+02,,,,,0,FALSE,8.186,6,2,593,64.8,7.23,2,,ER/Golgi;other cytoplasmic organelle,"Pf00884, Pf14707",414,hsa:414; P51689; Q9UHJ8,ENSG00000006756,Glycosphingolipid catabolism; The activation of arylsulfatases,Estrogen metabolism,3,0,,,90.24,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,0,,0,14.91,other molecular function,0,
Master Protein,High,Q13627,DYRK1A,Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens OX=9606 GN=DYRK1A PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,6.63E+04,,,,1,,,,,,,6.63E+04,,,,,,,,,,,,,,,,,,,,6.63E+04,,,,,,,,,,,,,,,,,0,FALSE,5.372,2,1,763,85.5,8.75,1,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,cytoskeleton;nucleus;other cell component,Pf00069,1859,hsa:1859; O60769; Q13627; Q92582; Q92810; Q9UNM5,ENSG00000157540,G0 and Early G1,T cell receptor and co-stimulatory signaling; DYRK1A involvement regarding cell proliferation in brain development,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.41,cytoskeletal activity;kinase activity;other molecular function,0,
Master Protein,High,A0A8I5KUR0,MED12,Mediator complex subunit 12 OS=Homo sapiens OX=9606 GN=MED12 PE=1 SV=1,2,2,100,0.903,100,,6.64,-0.15,6.64,,1.00E-17,7.72E-01,1.00E-17,,6.66E+04,,4.35E+04,9.11E+05,3,,1,2,,6.25E+04,,6.66E+04,3.61E+05,,,,,,,,,4.35E+04,,,,5.91E+05,,1.41E+06,,2.38E+02,,6.66E+04,1.86E+04,,,,,,,,,5.86E+03,,,,4.19E+03,,1.50E+04,0,FALSE,8.607,1,2,2179,243.1,7.09,2,other biological processes,nucleus,"Pf09497, Pf12144, Pf12145",,A0A8I5KUR0,ENSG00000184634,,,0,0,104.68,,,57.73,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,39.12,,,6.06,other molecular function,0,
Master Protein,High,Q14562,DHX8,ATP-dependent RNA helicase DHX8 OS=Homo sapiens OX=9606 GN=DHX8 PE=1 SV=1,1,3,100,2.037,100,6.885,6.64,1.03,6.64,2.78,1.00E-17,2.50E-01,1.00E-17,6.16E-02,3.99E+04,,8.14E+04,1.18E+04,2,,2,2,,,,4.79E+04,3.33E+04,,,,,,,,,2.47E+05,2.68E+04,,1.82E+04,,7.69E+03,,,,,4.79E+04,1.72E+03,,,,,,,,,3.33E+04,6.65E+02,,5.10E+03,,1.80E+02,,0.002,FALSE,3.035,1,1,1220,139.2,8.32,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus,"Pf00270, Pf00271, Pf00575, Pf04408, Pf07717, Pf21010",1659,hsa:1659; Q14562,ENSG00000067596,mRNA Splicing - Major Pathway,mRNA processing,2,0,25.45,,113.78,57.28,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,167.45,,130.7,7.24,other molecular function,0,
Master Protein,High,Q8NBU5,ATAD1,Outer mitochondrial transmembrane helix translocase OS=Homo sapiens OX=9606 GN=ATAD1 PE=1 SV=1,1,1,100,0.398,,100,6.64,-1.33,,6.64,1.00E-17,5.34E-01,,1.00E-17,1.05E+05,,4.17E+04,,1,,1,,,,,1.05E+05,,,,,,,,4.17E+04,,,,,,,,,,,,1.05E+05,,,,,,,,1.86E+03,,,,,,,,,0.001,FALSE,4.027,7,1,361,40.7,6.9,1,other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;other cytoplasmic organelle;other cell component,"Pf00004, Pf17862",84896,D3DR26; hsa:84896; Q6DKG1; Q6P4B9; Q8N3G1; Q8NBU5; Q8WYR9; Q969Y3,ENSG00000138138,Class I peroxisomal membrane protein import,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.38,transporter activity;other molecular function,0,
Master Protein,High,Q8IXI2,RHOT1,Mitochondrial Rho GTPase 1 OS=Homo sapiens OX=9606 GN=RHOT1 PE=1 SV=2,2,4,100,1,100,2.236,6.64,0,6.64,1.16,1.00E-17,6.65E-01,1.00E-17,3.92E-01,1.01E+05,,2.19E+05,1.26E+05,4,,5,2,1.06E+05,,2.92E+04,9.23E+05,9.63E+04,,,,,,8.76E+04,2.19E+05,1.12E+05,8.27E+05,4.11E+05,,3.94E+05,,4.03E+04,,4.20E+02,,2.85E+02,9.23E+05,4.97E+03,,,,,,5.24E+02,9.76E+03,9.09E+02,1.11E+05,1.02E+04,,1.11E+05,,9.43E+02,,0,FALSE,5.452,3,2,618,70.7,6.27,2,cell organization and biogenesis;transport;signal transduction;other biological processes,other membranes;mitochondrion,"Pf00071, Pf08355, Pf08356",55288,A4FVB6; A6NFV0; B4DG48; hsa:55288; J9JIH9; Q6NUR3; Q6P9F8; Q6PJG1; Q6YMW8; Q86UB0; Q8IW28; Q8IXI2; Q8IXJ7; Q9H067; Q9H9N8; Q9NUZ2,ENSG00000126858,Ub-specific processing proteases; RHOT1 GTPase cycle,HDAC6 interactions in the central nervous system,3,0,147.05,,92.15,115.16,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,106.13,,122.88,8.78,other molecular function,0,
Master Protein,High,Q6NZY4,ZCCHC8,Zinc finger CCHC domain-containing protein 8 OS=Homo sapiens OX=9606 GN=ZCCHC8 PE=1 SV=2,1,2,100,2.419,100,1.285,6.64,1.27,6.64,0.36,1.00E-17,4.01E-02,1.00E-17,7.44E-01,8.59E+05,,2.26E+06,1.76E+06,4,,4,1,2.99E+06,1.75E+06,,4.22E+05,3.05E+05,,,,,,,7.03E+05,4.76E+06,4.91E+06,1.07E+06,,,,,1.76E+06,1.19E+04,6.64E+03,,4.22E+05,1.57E+04,,,,,,,3.14E+04,3.87E+04,6.62E+05,2.66E+04,,,,,1.87E+04,0,FALSE,4.325,3,1,707,78.5,4.87,1,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00098, Pf04046",55596,hsa:55596; Q6NZY4; Q7L2P6; Q8N2K5; Q96SK7; Q9NSS2; Q9NSS3,ENSG00000033030,,,0,0,92.57,,79.9,,Peak Found,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,88.79,,133.29,7.29,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A994J7M6,PIGS,Phosphatidylinositol glycan anchor biosynthesis class S OS=Homo sapiens OX=9606 GN=PIGS PE=4 SV=1,2,4,100,1.603,100,5.993,6.64,0.68,6.64,2.58,1.00E-17,2.76E-01,1.00E-17,8.15E-02,3.43E+05,,3.48E+05,3.21E+04,3,,5,1,,,3.43E+05,3.77E+05,5.34E+04,,,,,,2.50E+06,1.73E+05,1.93E+05,3.48E+05,7.64E+05,,,,3.21E+04,,,,3.35E+03,3.77E+05,2.75E+03,,,,,,1.49E+04,7.72E+03,1.56E+03,4.69E+04,1.90E+04,,,,7.52E+02,,0,FALSE,8.371,6,2,594,65.5,6.77,2,protein metabolism;other metabolic processes,other membranes;ER/Golgi,,,A0A994J7M6,ENSG00000087111,,,0,0,68.99,,123.34,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,104.42,,59.71,11.63,,0,
Master Protein,High,X6R3N0,SLC27A3,Long-chain fatty acid transport protein 3 OS=Homo sapiens OX=9606 GN=SLC27A3 PE=1 SV=1,3,10,100,0.71,,100,6.64,-0.49,,6.64,1.00E-17,9.56E-01,,1.00E-17,5.39E+05,,5.88E+05,,2,,4,,,,,6.44E+05,4.52E+05,,,,,,3.61E+06,2.32E+05,,7.55E+05,4.57E+05,,,,,,,,,6.44E+05,2.33E+04,,,,,,2.16E+04,1.03E+04,,1.02E+05,1.14E+04,,,,,,0,FALSE,19.233,8,3,811,87.3,8.4,3,other metabolic processes,ER/Golgi,"Pf00501, Pf13193",11000,X6R3N0,ENSG00000143554; ENSG00000263163,,,0,0,24.84,,124.91,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,High,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,129.47,,,37.78,,0,
Master Protein,High,P23497,SP100,Nuclear autoantigen Sp-100 OS=Homo sapiens OX=9606 GN=SP100 PE=1 SV=3,3,10,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,9.46E+04,,,,1,,,,,,,9.46E+04,,,,,,,,,,,,,,,,,,,,9.46E+04,,,,,,,,,,,,,,,,,0,FALSE,10.512,2,1,879,100.4,8.22,3,cell organization and biogenesis;DNA metabolism;stress response;signal transduction;other biological processes,nucleus;other cell component,"Pf00505, Pf01342, Pf03172, Pf09011",6672,B4DDX5; B8ZZD8; E7EUA7; E9PH61; F8WFE2; hsa:6672; O75450; P23497; Q13343; Q8TE34; Q96F70; Q96T24; Q96T95; Q9NP33; Q9UE32,ENSG00000067066,SUMOylation of DNA damage response and repair proteins; Interferon gamma signaling,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,26.79,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UMX0,UBQLN1,Ubiquilin-1 OS=Homo sapiens OX=9606 GN=UBQLN1 PE=1 SV=2,3,12,100,4.931,100,0.775,6.64,2.3,6.64,-0.37,1.00E-17,1.31E-02,1.00E-17,9.61E-01,1.37E+05,,3.96E+05,2.39E+05,2,,4,2,,,,4.86E+05,3.86E+04,,,,,,,5.13E+04,3.03E+05,1.68E+06,5.17E+05,,2.45E+05,,2.34E+05,,,,,4.86E+05,1.99E+03,,,,,,,2.29E+03,2.46E+03,2.27E+05,1.29E+04,,6.90E+04,,5.47E+03,,0,FALSE,11.444,7,1,589,62.5,5.11,3,cell organization and biogenesis;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00240, Pf00627",29979,A0A024R284; hsa:29979; Q5T6J5; Q5T6J9; Q8IXS9; Q8N2Q3; Q9H0T8; Q9H3R4; Q9HAZ5; Q9UMX0,ENSG00000135018,Cargo recognition for clathrin-mediated endocytosis,,1,1,120.62,,112.94,3.53,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,127.6,,79.56,31.54,other molecular function,0,
Master Protein,High,P10155,RO60,RNA-binding protein RO60 OS=Homo sapiens OX=9606 GN=RO60 PE=1 SV=2,4,6,100,0.277,100,0.634,6.64,-1.85,6.64,-0.66,1.00E-17,3.40E-01,1.00E-17,8.46E-01,7.98E+04,,4.74E+04,9.55E+04,2,,3,2,,,,3.14E+05,2.03E+04,,,,,,,4.74E+04,,1.09E+05,2.03E+04,,1.07E+05,,8.52E+04,,,,,3.14E+05,1.05E+03,,,,,,,2.12E+03,,1.47E+04,5.04E+02,,3.00E+04,,1.99E+03,,0,FALSE,12.436,10,4,538,60.6,8.03,4,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf05731,6738,B2RBB9; hsa:6738; P10155; Q5LJ98; Q5LJ99; Q5LJA0; Q86WL3; Q86WL4; Q92787; Q9H1W6,ENSG00000116747,,,0,0,124.22,,77.03,15.97,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,83.62,,83.09,16.58,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P28838,LAP3,Cytosol aminopeptidase OS=Homo sapiens OX=9606 GN=LAP3 PE=1 SV=3,4,15,100,1.861,100,0.775,6.64,0.9,6.64,-0.37,1.00E-17,8.42E-02,1.00E-17,9.24E-01,6.37E+05,,1.87E+06,1.69E+06,5,,5,5,3.50E+06,6.37E+05,1.13E+06,4.23E+05,1.12E+05,,,,,,4.84E+05,7.17E+05,1.87E+06,2.17E+06,3.07E+06,1.44E+06,1.69E+06,1.03E+07,2.60E+06,2.95E+05,1.39E+04,2.42E+03,1.10E+04,4.23E+05,5.78E+03,,,,,,2.89E+03,3.20E+04,1.52E+04,2.93E+05,7.63E+04,2.82E+03,4.76E+05,7.27E+04,6.09E+04,3.14E+03,0,FALSE,12.487,10,4,519,56.1,7.93,4,protein metabolism,other cell component,"Pf00883, Pf02789",51056,B3KMQ3; hsa:51056; P28838; Q6IAM6; Q6P0L6; Q9UQE3,ENSG00000002549,,,0,0,117.18,,64.27,122.68,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,,121.28,,87.9,30.24,other molecular function,0,
Master Protein,High,Q8WW12,PCNP,PEST proteolytic signal-containing nuclear protein OS=Homo sapiens OX=9606 GN=PCNP PE=1 SV=2,2,5,100,0.149,100,0.185,6.64,-2.75,6.64,-2.43,1.00E-17,1.01E-01,1.00E-17,2.54E-01,1.07E+05,,2.64E+04,2.72E+05,5,,4,3,8.11E+04,1.07E+05,7.61E+04,1.54E+05,1.63E+06,,,,,,9.44E+04,8.09E+03,,4.99E+04,1.39E+04,2.72E+05,,,4.32E+04,3.85E+05,3.22E+02,4.08E+02,7.43E+02,1.54E+05,8.42E+04,,,,,,5.65E+02,3.61E+02,,6.73E+03,3.46E+02,5.30E+02,,,1.01E+03,4.10E+03,0,FALSE,7.766,17,2,178,18.9,7.49,2,cell cycle OR cell proliferation;protein metabolism;other metabolic processes,nucleus,Pf15473,57092,B2RBE7; D3DN52; hsa:57092; Q53GF3; Q6AI44; Q8WW12; Q96CU3; Q9NS81,ENSG00000081154,,,0,0,166.7,,95.68,74.64,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,,113.46,,96.81,14.32,,0,
Master Protein,High,O43719,HTATSF1,HIV Tat-specific factor 1 OS=Homo sapiens OX=9606 GN=HTATSF1 PE=1 SV=1,3,6,100,0.42,100,0.361,6.64,-1.25,6.64,-1.47,1.00E-17,5.38E-01,1.00E-17,5.05E-01,2.14E+05,,4.69E+04,7.91E+04,3,,4,4,,,9.13E+04,2.48E+05,2.14E+05,,,,,,,3.64E+04,5.14E+04,9.16E+04,4.28E+04,7.65E+05,8.10E+03,8.34E+04,,7.50E+04,,,8.93E+02,2.48E+05,1.10E+04,,,,,,,1.63E+03,4.18E+02,1.23E+04,1.06E+03,1.49E+03,2.28E+03,5.91E+02,,7.99E+02,0,FALSE,11.138,5,3,755,85.8,4.4,3,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf00076,27336,D3DWG9; hsa:27336; O43719; Q59G06; Q99730,ENSG00000102241,mRNA Splicing - Major Pathway,,1,0,44.72,,44.67,153.02,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,,103.91,,135.6,17.52,other molecular function,0,
Master Protein,High,Q4G0N4,NADK2,"NAD kinase 2, mitochondrial OS=Homo sapiens OX=9606 GN=NADK2 PE=1 SV=2",1,1,100,5.997,,100,6.64,2.58,,6.64,1.00E-17,1.06E-02,,1.00E-17,4.17E+04,,2.50E+05,,1,,1,,,,,4.17E+04,,,,,,,,2.50E+05,,,,,,,,,,,,4.17E+04,,,,,,,,1.12E+04,,,,,,,,,0.002,FALSE,2.916,3,1,442,49.4,8.18,1,other metabolic processes,mitochondrion,Pf01513,133686,B5MC93; hsa:133686; Q4G0N4; Q6UTX5; Q96NM0,ENSG00000152620,Mitochondrial protein degradation; Nicotinate metabolism,,2,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.67,kinase activity;other molecular function,0,
Master Protein,High,H7C0G7,NHEJ1,Non-homologous end joining factor 1 OS=Homo sapiens OX=9606 GN=NHEJ1 PE=1 SV=2,2,2,100,0.367,100,3.913,6.64,-1.44,6.64,1.97,1.00E-17,4.21E-01,1.00E-17,1.87E-01,3.99E+05,,2.26E+05,7.70E+04,1,,2,1,,,,3.99E+05,,,,,,,,,,5.19E+05,9.89E+04,,7.70E+04,,,,,,,3.99E+05,,,,,,,,,,6.99E+04,2.46E+03,,2.16E+04,,,,0,FALSE,11.227,13,2,304,33.8,5.99,2,DNA metabolism;other metabolic processes;stress response,nucleus,Pf09302,,H7C0G7,ENSG00000187736,,"Non-homologous end joining; DNA repair pathways, full network",2,0,,,96.13,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,59.9,,0,7.46,,0,
Master Protein,High,Q9BX59,TAPBPL,Tapasin-related protein OS=Homo sapiens OX=9606 GN=TAPBPL PE=1 SV=2,1,2,100,0.856,100,17.062,6.64,-0.22,6.64,4.09,1.00E-17,8.37E-01,1.00E-17,1.55E-02,5.61E+04,,4.80E+04,2.82E+03,1,,3,1,,,,5.61E+04,,,,,,,,3.40E+04,,8.25E+04,4.80E+04,,2.82E+03,,,,,,,5.61E+04,,,,,,,,1.52E+03,,1.11E+04,1.19E+03,,7.91E+02,,,,0.001,FALSE,3.386,4,1,468,50.2,5.26,1,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;ER/Golgi,"Pf07654, Pf07686",55080,hsa:55080; Q9BX59; Q9NWB8,ENSG00000139192,,,0,0,,,45.57,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,61.47,,43.45,6.54,other molecular function,0,
Master Protein,High,Q9NXF1,TEX10,Testis-expressed protein 10 OS=Homo sapiens OX=9606 GN=TEX10 PE=1 SV=2,3,12,100,0.459,,100,6.64,-1.12,,6.64,1.00E-17,5.96E-01,,1.00E-17,5.90E+05,,1.14E+05,,3,,5,,4.34E+06,,5.90E+05,3.30E+05,,,,,,,5.72E+06,1.14E+05,1.22E+05,6.18E+04,7.02E+04,,,,,,1.72E+04,,5.77E+03,3.30E+05,,,,,,,3.42E+04,5.09E+03,9.92E+02,8.32E+03,1.74E+03,,,,,,0,FALSE,16.791,5,3,929,105.6,9.36,3,,mitochondrion;nucleus,Pf12333,54881,B4DYV2; hsa:54881; Q5T722; Q5T723; Q8NCN8; Q8TDY0; Q9NXF1,ENSG00000136891,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,127.95,,206.71,,High,n/a,High,High,High,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,98.79,,,42.05,,0,
Master Protein,High,Q96T23,RSF1,Remodeling and spacing factor 1 OS=Homo sapiens OX=9606 GN=RSF1 PE=1 SV=2,4,7,100,0.22,100,2.701,6.64,-2.19,6.64,1.43,1.00E-17,1.50E-01,1.00E-17,2.92E-01,5.54E+05,,8.56E+04,1.16E+04,2,,2,1,,,,5.47E+05,5.61E+05,,,,,,,1.28E+04,,5.71E+05,,,1.16E+04,,,,,,,5.47E+05,2.90E+04,,,,,,,5.73E+02,,7.70E+04,,,3.27E+03,,,,0,FALSE,9.529,4,4,1441,163.7,5.01,4,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00628, Pf15612",51773,hsa:51773; Q86X86; Q96T23; Q9H3L8; Q9NVZ8; Q9NYU0,ENSG00000048649,Deposition of new CENPA-containing nucleosomes at the centromere,,1,0,1.82,,135.21,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,116.21,,151.44,16.62,other molecular function,0,
Master Protein,High,O96008,TOMM40,Mitochondrial import receptor subunit TOM40 homolog OS=Homo sapiens OX=9606 GN=TOMM40 PE=1 SV=1,4,14,100,2.508,100,2.06,6.64,1.33,6.64,1.04,1.00E-17,9.29E-02,1.00E-17,3.99E-01,1.30E+05,,5.65E+05,1.86E+05,2,,2,1,1.40E+05,,,1.20E+05,,,,,,,,,,6.77E+05,4.72E+05,,1.86E+05,,,,5.57E+02,,,1.20E+05,,,,,,,,,,9.12E+04,1.17E+04,,5.24E+04,,,,0,FALSE,30.162,21,4,361,37.9,7.25,4,cell organization and biogenesis;transport;other biological processes,other membranes;cytosol;mitochondrion;other cell component,Pf01459,10452,A0A024R0P9; hsa:10452; O96008; Q86VW4; Q8WY09; Q8WY10; Q8WY11; Q9BR95,ENSG00000130204,Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy,IL-18 signaling pathway,3,0,11.02,,25.11,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,40.93,,3.75,55.11,transporter activity,0,
Master Protein,High,Q96CB8,INTS12,Integrator complex subunit 12 OS=Homo sapiens OX=9606 GN=INTS12 PE=1 SV=1,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.23E+04,,,,1,,,,,,,1.23E+04,,,,,,,,,,,,,,,,,,,,1.23E+04,,,,,,,,,,,,,,,,,0,FALSE,8.335,7,2,462,48.8,9.69,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf00628,57117,B2RC48; hsa:57117; Q3B6Z3; Q96CB8; Q9HD71,ENSG00000138785,RNA polymerase II transcribes snRNA genes,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.99,other molecular function,0,
Master Protein,High,I3L0U5,CCDC137,Coiled-coil domain containing 137 (Fragment) OS=Homo sapiens OX=9606 GN=CCDC137 PE=1 SV=1,1,1,100,0.461,100,2.465,6.64,-1.12,6.64,1.3,1.00E-17,7.22E-01,1.00E-17,3.79E-01,3.35E+04,,1.27E+04,6.26E+03,2,,4,2,,,,6.32E+04,1.77E+04,,,,,,3.31E+04,1.02E+04,,7.19E+03,1.60E+04,,3.00E+03,,1.30E+04,,,,,6.32E+04,9.15E+02,,,,,,1.98E+02,4.54E+02,,9.69E+02,3.97E+02,,8.44E+02,,3.05E+02,,0.001,FALSE,3.482,4,1,292,33.5,11,1,,nucleus;other cell component,,,I3L0U5,ENSG00000185298,,,0,0,79.41,,69.77,88.51,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,92.02,,88.01,3.44,,0,
Master Protein,High,Q96I25,RBM17,Splicing factor 45 OS=Homo sapiens OX=9606 GN=RBM17 PE=1 SV=1,4,7,100,0.49,,100,6.64,-1.03,,6.64,1.00E-17,6.68E-01,,1.00E-17,4.83E+05,,1.63E+05,,1,,3,,,,,4.83E+05,,,,,,,1.63E+05,2.23E+04,,2.13E+05,,,,,,,,,,4.83E+05,,,,,,,9.76E+02,9.95E+02,,2.87E+04,,,,,,,0,FALSE,16.865,15,4,401,44.9,5.97,4,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00076, Pf01585",84991,hsa:84991; Q96GY6; Q96I25,ENSG00000134453,mRNA Splicing - Major Pathway,mRNA processing,2,0,,,74.5,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,34.74,,,22.28,nucleic acid binding activity,0,
Master Protein,High,Q96N66,MBOAT7,Lysophospholipid acyltransferase 7 OS=Homo sapiens OX=9606 GN=MBOAT7 PE=1 SV=2,4,8,100,0.836,100,0.126,6.64,-0.26,6.64,-2.99,1.00E-17,6.76E-01,1.00E-17,1.08E-01,1.36E+06,,4.84E+05,1.32E+06,2,,4,2,,,2.09E+06,8.92E+05,,,,,,,4.52E+05,9.08E+05,,4.49E+05,5.19E+05,1.57E+06,,,,1.11E+06,,,2.04E+04,8.92E+05,,,,,,,2.70E+03,4.05E+04,,6.05E+04,1.29E+04,3.05E+03,,,,1.18E+04,0,FALSE,15.554,13,4,472,52.7,8.97,4,other metabolic processes;developmental processes;other biological processes,other membranes;ER/Golgi;other cell component,Pf03062,79143,A9C4B6; B0V3I5; B4DQ87; hsa:79143; Q05DF0; Q7L5N2; Q96N66; Q99908; Q9BPV2; Q9BRE9,ENSG00000125505; ENSG00000273592; ENSG00000274194; ENSG00000275118; ENSG00000276935; ENSG00000277025; ENSG00000277733; ENSG00000277923; ENSG00000278322; ENSG00000278519,Acyl chain remodelling of PI,,1,0,56.77,,37.72,24.36,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,High,High,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,,27.07,,25.27,22.46,other molecular function,0,
Master Protein,High,A0A8I5KV92,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3 OS=Homo sapiens OX=9606 GN=EIF4G3 PE=1 SV=1,3,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.40E+04,,,,1,,,,,,,2.40E+04,,,,,,,,,,,,,,,,,,,,2.40E+04,,,,,,,,,,,,,,,,,0,FALSE,8.299,2,1,1895,207.8,6.54,3,protein metabolism;other metabolic processes,,"Pf02020, Pf02847, Pf02854",,A0A8I5KV92,ENSG00000075151,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,7.77,nucleic acid binding activity,0,
Master Protein,High,A0A5H1ZRP4,NELFB,Negative elongation factor B OS=Homo sapiens OX=9606 GN=NELFB PE=1 SV=1,3,3,100,0.421,100,0.614,6.64,-1.25,6.64,-0.7,1.00E-17,5.65E-01,1.00E-17,8.28E-01,7.64E+04,,7.83E+04,1.27E+05,3,,4,4,,,7.64E+04,2.83E+05,5.93E+04,,,,,,,9.81E+03,7.76E+04,3.21E+05,7.89E+04,1.40E+05,,1.22E+05,1.33E+05,9.47E+04,,,7.47E+02,2.83E+05,3.06E+03,,,,,,,4.38E+02,6.31E+02,4.33E+04,1.96E+03,2.72E+02,,8.64E+02,3.12E+03,1.01E+03,0,FALSE,6.972,6,3,628,70,6.04,3,cell cycle OR cell proliferation;other biological processes,nucleus,Pf06209,,A0A5H1ZRP4,ENSG00000188986,,Initiation of transcription and translation elongation at the HIV-1 LTR; 4p16.3 copy number variation; 5q35 copy number variation,3,0,89.28,,112.17,16.2,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,123.15,,72.74,7.75,,0,
Master Protein,High,Q3L8U1,CHD9,Chromodomain-helicase-DNA-binding protein 9 OS=Homo sapiens OX=9606 GN=CHD9 PE=1 SV=2,1,2,100,0.871,,100,6.64,-0.2,,6.64,1.00E-17,7.83E-01,,1.00E-17,3.88E+04,,3.37E+04,,1,,1,,,,,3.88E+04,,,,,,,,,,3.37E+04,,,,,,,,,,3.88E+04,,,,,,,,,,4.55E+03,,,,,,,0,FALSE,6.261,1,1,2897,325.8,7.01,1,cell organization and biogenesis,cytosol;nucleus,"Pf00176, Pf00271, Pf00385, Pf07533",80205,B2RTU2; B9ZVQ0; hsa:80205; O15025; Q1WF12; Q3L8U1; Q6DTK9; Q9H9V7; Q9UHM2,ENSG00000177200,"Activation of gene expression by SREBF (SREBP); PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Heme signaling; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Transcriptional activation of mitochondrial biogenesis; Cytoprotection by HMOX1; RORA activates gene expression",,10,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,4.18,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q9Y3D9,MRPS23,"28S ribosomal protein S23, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS23 PE=1 SV=2",1,2,100,0.457,,100,6.64,-1.13,,6.64,1.00E-17,5.71E-01,,1.00E-17,7.78E+05,,3.56E+05,,1,,4,,,,,7.78E+05,,,,,,,,5.75E+05,2.20E+05,1.34E+05,7.07E+05,,,,,,,,,7.78E+05,,,,,,,,2.57E+04,1.79E+03,1.80E+04,1.76E+04,,,,,,0.02,FALSE,1.987,5,1,190,21.8,8.9,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus;nucleus,Pf10484,51649,B2R6V3; hsa:51649; Q96Q24; Q9BWH8; Q9P053; Q9Y3D9,ENSG00000181610,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,,67.37,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,82.46,,,3.84,other molecular function,0,
Master Protein,High,Q14137,BOP1,Ribosome biogenesis protein BOP1 OS=Homo sapiens OX=9606 GN=BOP1 PE=1 SV=2,3,3,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.83E+05,,,5.67E+05,1,,,1,,,,1.83E+05,,,,,,,,,,,,,5.67E+05,,,,,,,1.83E+05,,,,,,,,,,,,,1.59E+05,,,,0,FALSE,13.443,7,3,746,83.6,6.19,3,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00400, Pf08145",23246,hsa:23246; Q14137; Q969Z6; Q96IS8; Q96Q25; Q9BSA7; Q9BVM0,ENSG00000261236,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,,,,11.22,other molecular function,0,
Master Protein,High,P26640,VARS1,Valine--tRNA ligase OS=Homo sapiens OX=9606 GN=VARS1 PE=1 SV=4,7,13,100,0.441,100,0.417,6.64,-1.18,6.64,-1.26,1.00E-17,5.92E-01,1.00E-17,5.02E-01,9.05E+04,,1.50E+05,3.91E+05,3,,5,4,1.30E+06,,8.08E+04,9.05E+04,,,,,,,1.40E+05,1.15E+05,2.36E+05,1.97E+05,1.50E+05,,2.50E+06,2.84E+05,5.38E+05,7.63E+04,5.15E+03,,7.90E+02,9.05E+04,,,,,,,8.38E+02,5.13E+03,1.92E+03,2.66E+04,3.73E+03,,7.04E+05,2.02E+03,1.26E+04,8.13E+02,0,FALSE,28.227,8,7,1264,140.4,7.59,7,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol,"Pf00043, Pf00133, Pf08264",7407,B0V1N1; B4DZ61; hsa:7407; P26640; Q5JQ90; Q96E77; Q9UQM2,ENSG00000096171; ENSG00000204394; ENSG00000224264; ENSG00000226589; ENSG00000231116,Cytosolic tRNA aminoacylation,Amino acid metabolism,2,0,142.89,,28.92,131.45,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,84.33,,86.96,37.26,other molecular function,0,
Master Protein,High,P61513,RPL37A,60S ribosomal protein L37a OS=Homo sapiens OX=9606 GN=RPL37A PE=1 SV=2,2,2,100,0.339,,100,6.64,-1.56,,6.64,1.00E-17,4.71E-01,,1.00E-17,7.15E+04,,2.78E+04,,3,,3,,,,5.98E+04,2.33E+05,7.15E+04,,,,,,,7.63E+04,,2.78E+04,2.03E+04,,,,,,,,5.84E+02,2.33E+05,3.69E+03,,,,,,,3.41E+03,,3.75E+03,5.04E+02,,,,,,0,FALSE,9.03,29,2,92,10.3,10.43,2,protein metabolism;other metabolic processes,cytosol;translational apparatus;other cell component,Pf01780,6168,hsa:6168; P12751; P61513; Q6FGF5,ENSG00000197756,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,79.71,,73.31,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,40.12,,,6.42,other molecular function,0,
Master Protein,Medium,Q9H6K4,OPA3,Optic atrophy 3 protein OS=Homo sapiens OX=9606 GN=OPA3 PE=1 SV=1,1,2,100,0.993,100,7.096,6.64,-0.01,6.64,2.83,1.00E-17,5.36E-01,1.00E-17,4.57E-02,7.20E+05,,7.15E+05,7.52E+04,1,,5,2,,,,7.20E+05,,,,,,,2.32E+05,2.94E+05,7.15E+05,8.64E+05,1.23E+06,,1.93E+04,,2.93E+05,,,,,7.20E+05,,,,,,,1.39E+03,1.31E+04,5.81E+03,1.16E+05,3.05E+04,,5.42E+03,,6.86E+03,,0.022,FALSE,1.955,4,1,179,20,8.91,1,other biological processes,mitochondrion,Pf07047,80207,hsa:80207; Q6P384; Q8N784; Q9H6K4,ENSG00000125741,,,0,0,,,61.95,123.95,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,61.79,,129.5,3.23,,0,
Master Protein,High,O60234,GMFG,Glia maturation factor gamma OS=Homo sapiens OX=9606 GN=GMFG PE=1 SV=1,1,4,100,0.3,100,0.281,6.64,-1.74,6.64,-1.83,1.00E-17,3.15E-01,1.00E-17,4.10E-01,2.26E+05,,6.77E+04,2.41E+05,2,,2,3,3.44E+05,,,1.48E+05,,,,,,,,2.79E+04,,1.64E+05,,2.41E+05,9.52E+03,2.65E+06,,,1.37E+03,,,1.48E+05,,,,,,,,1.25E+03,,2.21E+04,,4.69E+02,2.68E+03,1.88E+04,,,0.001,FALSE,3.381,7,1,142,16.8,5.26,1,protein metabolism;other metabolic processes;signal transduction;other biological processes,non-structural extracellular;other cell component,Pf00241,9535,hsa:9535; O60234; Q6IB37,ENSG00000130755; ENSG00000291873,Neutrophil degranulation,,1,0,56.15,,100.35,151.26,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,,98.08,,178.65,6.77,signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9BRJ6,C7orf50,Uncharacterized protein C7orf50 OS=Homo sapiens OX=9606 GN=C7orf50 PE=1 SV=1,2,3,100,2.431,,100,6.64,1.28,,6.64,1.00E-17,1.10E-01,,1.00E-17,1.78E+05,,4.34E+05,,1,,2,,,,,1.78E+05,,,,,,,,,,6.46E+05,2.91E+05,,,,,,,,,1.78E+05,,,,,,,,,,8.71E+04,7.23E+03,,,,,,0,FALSE,8.567,18,2,194,22.1,9.64,2,,,Pf10180,84310,Q9BRJ6,ENSG00000146540,,,0,0,,,53.62,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,60.74,,,11.76,,0,
Master Protein,High,P18615,NELFE,Negative elongation factor E OS=Homo sapiens OX=9606 GN=NELFE PE=1 SV=3,3,4,100,0.277,100,0.085,6.64,-1.85,6.64,-3.56,1.00E-17,2.93E-01,1.00E-17,2.89E-02,3.34E+05,,6.94E+04,5.38E+05,2,,1,1,,,,3.17E+05,3.51E+05,,,,,,,,,6.94E+04,,,,,,5.38E+05,,,,3.17E+05,1.81E+04,,,,,,,,,9.36E+03,,,,,,5.73E+03,0,FALSE,17.592,15,3,380,43.2,9.33,3,other biological processes,plasma membrane;other membranes;nucleus;other cell component,Pf00076,7936,A2BE08; B4DUN1; B4DYX9; hsa:7936; P18615; Q5JP74; Q5JP75; Q96F56; Q9NPK2,ENSG00000204356; ENSG00000206268; ENSG00000206357; ENSG00000229363; ENSG00000231044; ENSG00000233801,Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes,Initiation of transcription and translation elongation at the HIV-1 LTR; 4p16.3 copy number variation,16,0,7.2,,,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,77.33,,0,17.92,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13952,NFYC,Nuclear transcription factor Y subunit gamma OS=Homo sapiens OX=9606 GN=NFYC PE=1 SV=3,3,4,100,0.423,,100,6.64,-1.24,,6.64,1.00E-17,5.49E-01,,1.00E-17,8.03E+04,,2.04E+05,,3,,2,,8.03E+04,,2.82E+04,1.03E+06,,,,,,,,1.14E+05,,3.65E+05,,,,,,,3.19E+02,,2.76E+02,1.03E+06,,,,,,,,5.09E+03,,4.92E+04,,,,,,,0,FALSE,8.553,7,3,458,50.3,6.1,3,protein metabolism;other metabolic processes;other biological processes,nucleus;other cell component,Pf00125,4802,B4DUS6; B4DW63; D3DPV9; F8VWM3; hsa:4802; Q13952; Q59GY4; Q5T6K8; Q5T6K9; Q5T6L1; Q5TZR6; Q92869; Q9HBX1; Q9NXB5; Q9UM67; Q9UML0; Q9UMT7,ENSG00000066136,PPARA activates gene expression; Activation of gene expression by SREBF (SREBP); FOXO-mediated transcription of cell death genes; ATF4 activates genes in response to endoplasmic reticulum  stress; ATF6 (ATF6-alpha) activates chaperone genes,,5,0,148.7,,74.2,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,123.4,,,10.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P32942,ICAM3,Intercellular adhesion molecule 3 OS=Homo sapiens OX=9606 GN=ICAM3 PE=1 SV=2,3,9,100,0.498,100,0.949,6.64,-1.01,6.64,-0.08,1.00E-17,6.94E-01,1.00E-17,8.90E-01,5.66E+05,,4.39E+05,4.43E+05,1,,5,3,,,,5.66E+05,,,,,,,9.37E+04,1.86E+06,1.02E+05,4.39E+05,7.35E+05,2.00E+05,4.43E+05,,1.04E+06,,,,,5.66E+05,,,,,,,5.60E+02,8.29E+04,8.31E+02,5.92E+04,1.83E+04,3.91E+02,1.25E+05,,2.43E+04,,0,FALSE,12.848,7,3,547,59.5,5.43,3,cell adhesion;transport,plasma membrane;other membranes,"Pf03921, Pf21146",3385,hsa:3385; P32942; Q6PD68,ENSG00000076662,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Integrin cell surface interactions; CD209 (DC-SIGN) signaling,Ebola virus infection in host,4,0,,,112.74,76.89,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,73.66,,126.12,19.17,signal transduction activity or receptor binding,0,
Master Protein,High,O00186,STXBP3,Syntaxin-binding protein 3 OS=Homo sapiens OX=9606 GN=STXBP3 PE=1 SV=2,2,2,100,0.713,100,3.127,6.64,-0.49,6.64,1.64,1.00E-17,9.65E-01,1.00E-17,2.69E-01,3.42E+05,,2.43E+05,7.78E+04,1,,1,1,,,,3.42E+05,,,,,,,,2.43E+05,,,,,7.78E+04,,,,,,,3.42E+05,,,,,,,,1.09E+04,,,,,2.19E+04,,,,0.001,FALSE,4.223,3,2,592,67.7,7.8,2,cell adhesion;cell-cell signaling;stress response;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;other cell component,Pf00995,6814,A8K269; A8K5K7; hsa:6814; O00186; Q53FW1; Q86YJ3; Q9UPD7,ENSG00000116266,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Disinhibition of SNARE formation,Insulin signaling,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,0,,0,4.05,other molecular function,0,
Master Protein,High,Q9H078,CLPB,Caseinolytic peptidase B protein homolog OS=Homo sapiens OX=9606 GN=CLPB PE=1 SV=1,2,4,100,2.047,100,1.115,6.64,1.03,6.64,0.16,1.00E-17,2.54E-01,1.00E-17,7.33E-01,7.94E+04,,3.99E+04,6.72E+04,3,,3,1,,1.14E+05,,7.94E+04,5.28E+04,,,,,,3.99E+04,2.83E+05,,1.37E+04,,,,6.72E+04,,,,4.33E+02,,7.94E+04,2.72E+03,,,,,,2.38E+02,1.26E+04,,1.85E+03,,,,4.77E+02,,,0,FALSE,6.253,4,2,707,78.7,9.01,2,stress response;signal transduction;other biological processes,mitochondrion;other cell component,"Pf07724, Pf10431, Pf12796",81570,B4DXJ7; B4DXP7; B4DXW4; E7EWN6; F8W7P6; hsa:81570; Q8ND11; Q9H078; Q9H8Y0,ENSG00000162129,,,0,0,37.32,,132.29,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,114.71,,100.06,9.28,other molecular function,0,
Master Protein,High,Q8ND56,LSM14A,Protein LSM14 homolog A OS=Homo sapiens OX=9606 GN=LSM14A PE=1 SV=3,1,1,100,1.237,100,0.594,6.64,0.31,6.64,-0.75,1.00E-17,5.22E-01,1.00E-17,8.16E-01,9.48E+04,,1.17E+05,1.97E+05,1,,2,2,,,,9.48E+04,,,,,,,,,,1.29E+05,1.07E+05,1.02E+06,3.83E+04,,,,,,,9.48E+04,,,,,,,,,,1.73E+04,2.66E+03,1.98E+03,1.08E+04,,,,0.001,FALSE,3.289,4,1,463,50.5,9.52,1,cell cycle OR cell proliferation;cell organization and biogenesis;stress response;signal transduction;other biological processes,cytosol;cytoskeleton;other cell component,"Pf09532, Pf12701",26065,B4DTG6; hsa:26065; Q76LX7; Q8ND56; Q96AR3; Q96K73; Q96SN5; Q9UFR3,ENSG00000257103; ENSG00000262860,,,0,0,,,13.08,131.14,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,,13.77,,334.76,2.87,nucleic acid binding activity,0,
Master Protein,High,O14734,ACOT8,Acyl-coenzyme A thioesterase 8 OS=Homo sapiens OX=9606 GN=ACOT8 PE=1 SV=1,1,2,100,6.919,100,3.673,6.64,2.79,6.64,1.88,1.00E-17,1.53E-02,1.00E-17,1.82E-01,8.83E+03,,6.11E+04,1.66E+04,1,,1,1,,,,8.83E+03,,,,,,,,,,6.11E+04,,,1.66E+04,,,,,,,8.83E+03,,,,,,,,,,8.23E+03,,,4.67E+03,,,,0.005,FALSE,2.542,6,1,319,35.9,7.56,1,cell organization and biogenesis;other metabolic processes;other biological processes,cytosol;other cytoplasmic organelle,"Pf02551, Pf13622",10005,hsa:10005; O14734; O15261; Q17RX4,ENSG00000101473,Peroxisomal protein import; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol; alpha-linolenic acid (ALA) metabolism; Beta-oxidation of pristanoyl-CoA; Beta-oxidation of very long chain fatty acids,,5,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,0,5.58,other molecular function,0,
Master Protein,High,P19971,TYMP,Thymidine phosphorylase OS=Homo sapiens OX=9606 GN=TYMP PE=1 SV=2,1,1,100,0.321,,100,6.64,-1.64,,6.64,1.00E-17,2.92E-01,,1.00E-17,6.31E+05,,2.03E+05,,2,,1,,7.36E+05,,5.40E+05,,,,,,,,2.03E+05,,,,,,,,,,2.93E+03,,5.28E+03,,,,,,,,1.21E+03,,,,,,,,,,0.001,FALSE,3.808,3,1,482,49.9,5.53,1,cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes,cytosol,"Pf00591, Pf02885, Pf07831",1890,A8MW15; H9KVA0; hsa:1890; P19971; Q13390; Q8WVB7,ENSG00000025708,Pyrimidine salvage; Pyrimidine catabolism,Fluoropyrimidine activity; Bladder cancer; Pyrimidine metabolism,5,0,21.74,,,,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,23.06,,,2.14,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P27708,CAD,CAD protein OS=Homo sapiens OX=9606 GN=CAD PE=1 SV=3,4,9,100,1.355,100,0.409,6.64,0.44,6.64,-1.29,1.00E-17,3.87E-01,1.00E-17,5.89E-01,7.42E+05,,1.48E+05,2.38E+05,2,,1,2,2.23E+06,,,2.46E+05,,,,,,,,,,1.48E+05,,,1.07E+06,,5.30E+04,,8.87E+03,,,2.46E+05,,,,,,,,,,2.00E+04,,,3.00E+05,,1.24E+03,,0,FALSE,20.13,3,4,2225,242.8,6.46,4,protein metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00117, Pf00185, Pf00988, Pf01979, Pf02142, Pf02729, Pf02786, Pf02787",790,D6W552; hsa:790; P27708; Q6P0Q0; Q96CK3,ENSG00000084774,Pyrimidine biosynthesis,Endothelin pathways; Amino acid metabolism; Pyrimidine metabolism,4,0,113.33,,,128.04,High,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,0,,0,21.75,kinase activity;other molecular function,0,
Master Protein,High,A0A8Q3WK80,MAT2B,Methionine adenosyltransferase 2 subunit beta OS=Homo sapiens OX=9606 GN=MAT2B PE=1 SV=1,2,4,100,0.978,,100,6.64,-0.03,,6.64,1.00E-17,6.36E-01,,1.00E-17,1.99E+05,,1.95E+05,,1,,1,,,,,1.99E+05,,,,,,,,,,1.95E+05,,,,,,,,,,1.99E+05,,,,,,,,,,2.63E+04,,,,,,,0,FALSE,12.616,11,2,341,38.3,7.15,2,other metabolic processes,,Pf04321,,A0A8Q3WK80,ENSG00000038274,,Methionine de novo and salvage pathway; Methylation pathways,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,15.97,,0,
Master Protein,High,D6RBQ9,HNRNPD,Heterogeneous nuclear ribonucleoprotein D OS=Homo sapiens OX=9606 GN=HNRNPD PE=1 SV=1,9,42,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.45E+04,,,,1,,,,,,,1.45E+04,,,,,,,,,,,,,,,,,,,,1.45E+04,,,,,,,,,,,,,,,,,0,FALSE,29.402,40,1,155,15.6,4.91,9,other biological processes,nucleus;other cell component,"Pf00076, Pf08143",,D6RBQ9,ENSG00000138668,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,90.28,nucleic acid binding activity,0,
Master Protein,High,Q9H0C8,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C OS=Homo sapiens OX=9606 GN=ILKAP PE=1 SV=1,2,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,6.29E+04,,,,1,,,,,,,6.29E+04,,,,,,,,,,,,,,,,,,,,6.29E+04,,,,,,,,,,,,,,,,,0,FALSE,10.747,9,2,392,42.9,7.09,2,,other cell component,Pf00481,80895,B3KM39; hsa:80895; Q9H0C8,ENSG00000132323,,2q37 copy number variation syndrome,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,9.64,other molecular function,0,
Master Protein,High,Q9GZL7,WDR12,Ribosome biogenesis protein WDR12 OS=Homo sapiens OX=9606 GN=WDR12 PE=1 SV=2,1,1,100,0.402,,100,6.64,-1.32,,6.64,1.00E-17,4.46E-01,,1.00E-17,5.66E+05,,2.27E+05,,2,,1,,,,,1.91E+05,1.67E+06,,,,,,,,,2.27E+05,,,,,,,,,,1.91E+05,8.62E+04,,,,,,,,,3.06E+04,,,,,,,0.001,FALSE,3.959,5,1,423,47.7,5.9,1,RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,nucleus;other cell component,"Pf00400, Pf08154",55759,B3KPA9; hsa:55759; Q96HU0; Q9GZL7; Q9NV80; Q9NYI8,ENSG00000138442,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,112.35,,,,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,193.91,,,3.65,other molecular function,0,
Master Protein,High,O15031,PLXNB2,Plexin-B2 OS=Homo sapiens OX=9606 GN=PLXNB2 PE=1 SV=3,5,10,100,4.081,100,7.788,6.64,2.03,6.64,2.96,1.00E-17,3.01E-02,1.00E-17,5.09E-02,3.05E+04,,3.46E+05,2.01E+04,3,,4,1,,,2.57E+05,1.43E+04,3.05E+04,,,,,,1.21E+06,,4.37E+04,2.99E+05,4.00E+05,,,,2.01E+04,,,,2.51E+03,1.43E+04,1.57E+03,,,,,,7.23E+03,,3.55E+02,4.03E+04,9.94E+03,,,,4.70E+02,,0,FALSE,16.013,4,5,1838,205,6.24,5,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,"Pf01403, Pf01437, Pf01833, Pf08337, Pf17960, Pf20170",23654,A6QRH0; hsa:23654; O15031; Q7KZU3; Q9BSU7,ENSG00000196576,,2q11.2 copy number variation syndrome,1,0,134.85,,103.15,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,High,High,Peak Found,High,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,113.78,,55.95,25.02,other molecular function,0,
Master Protein,High,Q15050,RRS1,Ribosome biogenesis regulatory protein homolog OS=Homo sapiens OX=9606 GN=RRS1 PE=1 SV=2,1,2,100,1.179,100,0.915,6.64,0.24,6.64,-0.13,1.00E-17,5.96E-01,1.00E-17,9.19E-01,6.49E+04,,9.90E+04,1.00E+05,3,,5,2,1.60E+05,,6.49E+04,5.62E+04,,,,,,,2.00E+05,4.22E+04,1.25E+05,9.90E+04,6.63E+04,,,1.79E+05,,5.64E+04,6.36E+02,,6.34E+02,5.62E+04,,,,,,,1.20E+03,1.88E+03,1.02E+03,1.33E+04,1.65E+03,,,1.27E+03,,6.00E+02,0,FALSE,5.206,5,1,365,41.2,10.7,1,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,ER/Golgi;nucleus;other cell component,Pf04939,23212,hsa:23212; Q15050; Q9BUX8,ENSG00000179041,,,0,0,61.5,,57.28,73.66,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,70.56,,79.14,7.02,nucleic acid binding activity,0,
Master Protein,High,Q92526,CCT6B,T-complex protein 1 subunit zeta-2 OS=Homo sapiens OX=9606 GN=CCT6B PE=1 SV=5,2,3,100,1.646,100,0.688,6.64,0.72,6.64,-0.54,1.00E-17,2.75E-01,1.00E-17,8.75E-01,1.99E+05,,3.28E+05,4.76E+05,1,,2,2,,,,1.99E+05,,,,,,,,,,4.70E+05,2.28E+05,,9.41E+05,,2.41E+05,,,,,1.99E+05,,,,,,,,,,6.34E+04,5.67E+03,,2.64E+05,,5.64E+03,,0,FALSE,5.083,4,1,530,57.8,7.24,2,protein metabolism;other metabolic processes,cytosol,Pf00118,10693,B4DX20; B4DYB0; hsa:10693; Q8TC34; Q92526,ENSG00000132141,Formation of tubulin folding intermediates by CCT/TriC; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,16p11.2 proximal deletion syndrome; 17q12 copy number variation syndrome,7,0,,,49.02,83.76,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,54.79,,75.91,7.92,other molecular function,0,
Master Protein,High,O15264,MAPK13,Mitogen-activated protein kinase 13 OS=Homo sapiens OX=9606 GN=MAPK13 PE=1 SV=1,1,1,100,0.31,,100,6.64,-1.69,,6.64,1.00E-17,4.59E-01,,1.00E-17,2.43E+04,,7.52E+03,,1,,2,,,,,2.43E+04,,,,,,,,,,6.94E+03,8.16E+03,,,,,,,,,2.43E+04,,,,,,,,,,9.35E+02,2.03E+02,,,,,,0.001,FALSE,3.249,4,1,365,42.1,8.38,1,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf00069,5603,hsa:5603; O14739; O15124; O15264; Q5U4A5; Q6FI46; Q9UNU0,ENSG00000156711,VEGFA-VEGFR2 Pathway; NOD1/2 Signaling Pathway; p38MAPK events; DSCAM interactions,"Parkinson's disease pathway; Retinoblastoma gene in cancer; RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced AP-1 survival signaling; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; MAPK signaling pathway; Novel intracellular components of RIG-I-like receptor pathway; Angiopoietin-like protein 8 regulatory pathway; Oxidative damage response; Epithelial to mesenchymal transition in colorectal cancer; Thermogenesis; Non-genomic actions of 1,25 dihydroxyvitamin D3; Regulatory circuits of the STAT3 signaling pathway; Hepatitis B infection; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; Insulin signaling; Host-pathogen interaction of human coronaviruses - apoptosis; Host-pathogen interaction of human coronaviruses - MAPK signaling; Toll-like receptor signaling pathway",24,0,,,11.42,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,12.01,,,3.28,kinase activity;other molecular function,0,
Master Protein,High,Q2NL82,TSR1,Pre-rRNA-processing protein TSR1 homolog OS=Homo sapiens OX=9606 GN=TSR1 PE=1 SV=1,2,2,100,0.855,100,2.485,6.64,-0.23,6.64,1.31,1.00E-17,8.32E-01,1.00E-17,3.59E-01,1.81E+05,,4.80E+04,1.54E+04,1,,3,2,,,,1.81E+05,,,,,,,,3.05E+04,4.80E+04,1.11E+05,,,7.56E+03,,3.14E+04,,,,,1.81E+05,,,,,,,,1.36E+03,3.90E+02,1.49E+04,,,2.12E+03,,7.34E+02,,0,FALSE,5.309,3,2,804,91.8,7.42,2,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,"Pf04950, Pf08142",55720,hsa:55720; Q2NL82; Q8WUY5; Q9NVT0; Q9P2E6,ENSG00000167721,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,,,66.9,86.47,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,12.53,,91.3,5.06,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,E7EV75,ZMYND11,Zinc finger MYND-type containing 11 OS=Homo sapiens OX=9606 GN=ZMYND11 PE=1 SV=2,1,1,100,0.213,,100,6.64,-2.23,,6.64,1.00E-17,2.64E-01,,1.00E-17,2.13E+04,,4.54E+03,,1,,1,,,,,2.13E+04,,,,,,,,,,4.54E+03,,,,,,,,,,2.13E+04,,,,,,,,,,6.12E+02,,,,,,,0.012,FALSE,2.184,3,1,617,72.6,8.62,1,cell organization and biogenesis;other biological processes,nucleus,"Pf00439, Pf00855, Pf21524",,E7EV75,ENSG00000015171,,10q22q23 copy number variation,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.31,other molecular function,0,
Master Protein,High,A0A8J9AUI2,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP1 PE=1 SV=1,2,4,100,,100,0.202,6.64,,6.64,-2.31,1.00E-17,,1.00E-17,2.85E-01,4.58E+04,,5.05E+04,2.50E+05,2,,2,1,,,,1.04E+05,2.02E+04,,,,,,,,,4.51E+04,5.66E+04,,2.50E+05,,,,,,,1.04E+05,1.04E+03,,,,,,,,,6.07E+03,1.41E+03,,7.02E+04,,,,0,FALSE,6.413,3,2,1024,114.9,5.71,2,,ER/Golgi,"Pf13890, Pf19533",22930,A0A8J9AUI2,ENSG00000115839,,,0,0,95.38,,16.11,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,16.99,11.33,enzyme regulator activity,0,
Master Protein,High,Q92520,FAM3C,Protein FAM3C OS=Homo sapiens OX=9606 GN=FAM3C PE=1 SV=1,2,2,100,0.067,,100,6.64,-3.91,,6.64,1.00E-17,3.38E-03,,1.00E-17,4.49E+05,,2.99E+04,,3,,1,,,4.49E+05,,2.39E+05,1.00E+06,,,,,,,,,2.99E+04,,,,,,,,1.71E+03,,2.39E+05,5.17E+04,,,,,,,,,4.03E+03,,,,,,,0,FALSE,7.613,13,2,227,24.7,8.29,2,signal transduction,non-structural extracellular;ER/Golgi;other cell component,Pf15711,10447,A6NDN2; A8K3R7; hsa:10447; Q92520,ENSG00000196937,Platelet degranulation,,1,0,69.99,,,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,69.28,,,5.99,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9BYB0,SHANK3,SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens OX=9606 GN=SHANK3 PE=1 SV=3,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.34E+05,,,,1,,,,,,,1.34E+05,,,,,,,,,,,,,,,,,,,,1.34E+05,,,,,,,,,,,,,,,,,0,FALSE,10.734,2,1,1731,184.6,8.88,1,cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf00536, Pf07653, Pf12796, Pf17820",,D7UT47; Q8TET3; Q9BYB0,,RET signaling; Neurexins and neuroligins,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.65,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q8WXX7,AUTS2,Autism susceptibility gene 2 protein OS=Homo sapiens OX=9606 GN=AUTS2 PE=1 SV=1,1,2,100,0.627,,100,6.64,-0.67,,6.64,1.00E-17,9.31E-01,,1.00E-17,6.78E+04,,4.25E+04,,1,,4,,,,,6.78E+04,,,,,,,,2.79E+04,6.48E+04,1.19E+05,1.46E+04,,,,,,,,,6.78E+04,,,,,,,,1.24E+03,5.26E+02,1.60E+04,3.64E+02,,,,,,0,FALSE,5.048,2,1,1259,138.9,9.38,1,cell organization and biogenesis;developmental processes;other biological processes,cytoskeleton;nucleus;other cell component,Pf15336,26053,A4D1Y9; L7QET3; L7QF75; Q5D049; Q6PJU5; Q8WXX7; Q9Y4F2,ENSG00000158321,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,,1,0,,,82.5,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,86.56,,,3.19,other molecular function,0,
Master Protein,High,O60573,EIF4E2,Eukaryotic translation initiation factor 4E type 2 OS=Homo sapiens OX=9606 GN=EIF4E2 PE=1 SV=1,1,2,100,1.147,,100,6.64,0.2,,6.64,1.00E-17,5.76E-01,,1.00E-17,1.18E+05,,1.35E+05,,1,,1,,,,,1.18E+05,,,,,,,,,,1.35E+05,,,,,,,,,,1.18E+05,,,,,,,,,,1.82E+04,,,,,,,0.002,FALSE,3.007,9,1,245,28.3,8.88,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,Pf01652,9470,B8ZZJ9; hsa:9470; O60573; O75349,ENSG00000135930,ISG15 antiviral mechanism,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; EGFR tyrosine kinase inhibitor resistance,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,5.78,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,A0A6Q8PGB1,CEP290,Centrosomal protein 290 OS=Homo sapiens OX=9606 GN=CEP290 PE=1 SV=1,1,1,100,0.79,100,0.09,6.64,-0.34,6.64,-3.47,1.00E-17,8.41E-01,1.00E-17,5.70E-02,2.13E+05,,1.68E+05,1.87E+06,2,,4,2,,3.18E+05,,1.42E+05,,,,,,,2.91E+05,7.86E+04,4.16E+05,9.68E+04,,3.42E+06,1.02E+06,,,,,1.21E+03,,1.42E+05,,,,,,,1.74E+03,3.51E+03,3.38E+03,1.30E+04,,6.67E+03,2.86E+05,,,,0.025,FALSE,1.89,0,1,2766,323,5.96,1,cell organization and biogenesis,cytoskeleton;other cell component,Pf16574,80184,A0A6Q8PGB1,ENSG00000198707,,Clear cell renal cell carcinoma pathways; Ciliary landscape; Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome,5,0,54.07,,73.36,76.51,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,77.14,,70.1,2.3,,0,
Master Protein,High,Q9P1F3,ABRACL,Costars family protein ABRACL OS=Homo sapiens OX=9606 GN=ABRACL PE=1 SV=1,2,6,100,3.051,,100,6.64,1.61,,6.64,1.00E-17,2.84E-02,,1.00E-17,1.19E+06,,3.64E+06,,3,,1,,5.04E+06,,1.19E+06,1.04E+06,,,,,,,,,,3.64E+06,,,,,,,2.00E+04,,1.17E+04,1.04E+06,,,,,,,,,,4.91E+05,,,,,,,0,FALSE,11.683,36,2,81,9.1,6.29,2,other biological processes,,Pf14705,58527,hsa:58527; Q5SZC8; Q9P0A1; Q9P1F3,ENSG00000146386,,,0,0,93.35,,,,High,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,1,Acetyl [N-Term],FALSE,,21.23,,,23.44,,0,
Master Protein,High,Q9UHL4,DPP7,Dipeptidyl peptidase 2 OS=Homo sapiens OX=9606 GN=DPP7 PE=1 SV=3,3,8,100,0.51,100,0.861,6.64,-0.97,6.64,-0.22,1.00E-17,7.25E-01,1.00E-17,9.54E-01,2.07E+05,,2.33E+05,9.46E+04,3,,5,3,,2.07E+05,,6.49E+05,1.79E+05,,,,,,8.15E+04,2.33E+05,1.64E+05,7.63E+05,2.89E+05,3.07E+05,3.85E+04,,9.46E+04,,,7.85E+02,,6.49E+05,9.21E+03,,,,,,4.87E+02,1.04E+04,1.33E+03,1.03E+05,7.18E+03,5.98E+02,1.08E+04,,2.21E+03,,0,FALSE,9.863,9,3,492,54.3,6.32,3,protein metabolism;other metabolic processes,non-structural extracellular;ER/Golgi;other cytoplasmic organelle;other cell component,Pf05577,29952,A8K7U7; hsa:29952; Q5VSF1; Q969X4; Q9UHL4,ENSG00000176978,Neutrophil degranulation,,1,0,76.58,,87.2,96.49,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,65.79,,98.12,17.52,other molecular function,0,
Master Protein,High,A0A087WUT6,EIF5B,Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=1,6,14,100,0.559,100,0.345,6.64,-0.84,6.64,-1.54,1.00E-17,7.93E-01,1.00E-17,4.56E-01,4.27E+05,,7.87E+04,3.28E+05,4,,4,4,,7.16E+04,7.26E+06,7.02E+05,2.60E+05,,,,,,,1.11E+05,5.58E+04,3.68E+05,3.69E+04,,1.77E+06,4.59E+05,1.40E+05,2.34E+05,,2.72E+02,7.09E+04,7.02E+05,1.34E+04,,,,,,,4.96E+03,4.54E+02,4.96E+04,9.17E+02,,4.98E+05,3.26E+03,3.27E+03,2.49E+03,0,FALSE,26.068,8,6,1220,138.6,5.58,6,protein metabolism;other metabolic processes,,"Pf00009, Pf11987, Pf14578",,A0A087WUT6,ENSG00000158417,,Ciliary landscape,1,0,167.26,,107.28,116.6,n/a,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,93.44,,84.39,44.95,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8I5KXU4,KDM1A,Lysine-specific histone demethylase OS=Homo sapiens OX=9606 GN=KDM1A PE=1 SV=1,3,6,100,0.876,100,0.519,6.64,-0.19,6.64,-0.95,1.00E-17,7.61E-01,1.00E-17,6.55E-01,3.47E+05,,2.70E+05,3.77E+05,4,,5,3,1.29E+05,1.16E+06,,5.06E+05,2.39E+05,,,,,,2.70E+05,6.67E+05,1.71E+05,2.89E+05,1.78E+05,3.77E+05,5.86E+04,,,3.33E+06,5.14E+02,4.41E+03,,5.06E+05,1.23E+04,,,,,,1.61E+03,2.98E+04,1.39E+03,3.89E+04,4.43E+03,7.35E+02,1.65E+04,,,3.54E+04,0,FALSE,9.572,4,3,878,95.3,6.25,3,cell organization and biogenesis;other biological processes,nucleus,"Pf01593, Pf04433",,A0A8I5KXU4,ENSG00000004487,,Effect of progerin on genes involved in progeria; Thermogenesis; Vitamin D-sensitive calcium signaling in depression; Thyroid hormones production and peripheral downstream signaling effects; Neurogenesis regulation in the olfactory epithelium,5,0,90.93,,64.65,143.73,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,,35.9,,21.15,11.15,other molecular function,0,
Master Protein,High,Q8TF76,HASPIN,Serine/threonine-protein kinase haspin OS=Homo sapiens OX=9606 GN=HASPIN PE=1 SV=3,1,1,100,0.682,,100,6.64,-0.55,,6.64,1.00E-17,9.61E-01,,1.00E-17,8.77E+04,,5.98E+04,,3,,4,,,4.05E+05,8.77E+04,6.27E+04,,,,,,,4.88E+05,3.58E+04,,6.46E+04,5.53E+04,,,,,,,1.54E+03,8.57E+02,6.27E+04,,,,,,,2.92E+03,1.60E+03,,8.71E+03,1.37E+03,,,,,,0.001,FALSE,4.004,3,1,798,88.4,9.16,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes,cytoskeleton;nucleus;other cell component,Pf12330,83903,hsa:83903; Q5U5K3; Q8TF76; Q96MN1; Q9BXS7,ENSG00000177602,,,0,0,103.04,,135.65,,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,81.97,,,3.66,kinase activity;other molecular function,0,
Master Protein,High,Q86XP3,DDX42,ATP-dependent RNA helicase DDX42 OS=Homo sapiens OX=9606 GN=DDX42 PE=1 SV=1,7,10,100,0.451,100,0.079,6.64,-1.15,6.64,-3.65,1.00E-17,5.81E-01,1.00E-17,3.00E-02,4.36E+05,,2.72E+05,8.16E+06,3,,2,2,,2.39E+05,,1.51E+06,4.36E+05,,,,,,,7.49E+04,,9.85E+05,,5.36E+06,,,,1.24E+07,,9.09E+02,,1.51E+06,2.25E+04,,,,,,,3.35E+03,,1.33E+05,,1.04E+04,,,,1.32E+05,0,FALSE,34.965,13,7,938,102.9,7.02,7,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00270, Pf00271",11325,A6NML1; A8KA43; hsa:11325; O75619; Q68G51; Q86XP3; Q96BK1; Q96HR7; Q9Y3V8,ENSG00000198231,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,,2,0,93.84,,121.42,56.23,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,,40.41,,173.99,37.45,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13405,MRPL49,"39S ribosomal protein L49, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL49 PE=1 SV=1",3,5,100,3.305,100,0.142,6.64,1.72,6.64,-2.81,1.00E-17,1.70E-02,1.00E-17,9.10E-02,4.98E+05,,1.16E+06,3.05E+06,2,,4,3,,,1.94E+05,1.28E+06,,,,,,,,6.08E+05,2.18E+06,9.65E+05,1.40E+06,,4.51E+05,3.05E+06,,4.41E+06,,,1.90E+03,1.28E+06,,,,,,,,2.72E+04,1.77E+04,1.30E+05,3.47E+04,,1.27E+05,2.16E+04,,4.69E+04,0,FALSE,12.182,23,3,166,19.2,9.45,3,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf05046,740,B2R4G6; hsa:740; Q13405,ENSG00000149792,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,104.07,,52.48,76.26,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,,111.62,,136.13,13.88,other molecular function,0,
Master Protein,High,P61758,VBP1,Prefoldin subunit 3 OS=Homo sapiens OX=9606 GN=VBP1 PE=1 SV=4,1,2,100,0.649,100,0.513,6.64,-0.62,6.64,-0.96,1.00E-17,9.60E-01,1.00E-17,7.20E-01,6.96E+04,,4.52E+04,8.81E+04,1,,4,1,,,,6.96E+04,,,,,,,,2.63E+04,7.77E+04,1.72E+04,8.00E+04,,8.81E+04,,,,,,,6.96E+04,,,,,,,,1.17E+03,6.31E+02,2.31E+03,1.99E+03,,2.47E+04,,,,0.001,FALSE,3.516,10,1,197,22.6,7.11,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf02996,7411,B2R8L5; B4DWR3; F5H2A7; hsa:7411; O55228; P61758; Q15765; Q5JT81; Q86X96,ENSG00000155959,Prefoldin mediated transfer of substrate  to CCT/TriC,Cellular proteostasis,2,0,,,66.07,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,85.71,,85.71,7.29,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q6PIJ6,FBXO38,F-box only protein 38 OS=Homo sapiens OX=9606 GN=FBXO38 PE=1 SV=3,1,2,100,0.565,,100,6.64,-0.82,,6.64,1.00E-17,8.83E-01,,1.00E-17,3.44E+04,,1.94E+04,,2,,3,,,,,2.43E+04,4.86E+04,,,,,,4.33E+04,,,6.59E+03,1.94E+04,,,,,,,,,2.43E+04,2.51E+03,,,,,,2.59E+02,,,8.88E+02,4.83E+02,,,,,,0.001,FALSE,3.397,1,1,1188,133.9,6.33,1,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf00646,81545,hsa:81545; Q6PIJ6; Q6PK72; Q7Z2U0; Q86VN3; Q9BXY6; Q9H837; Q9HC40,ENSG00000145868,,,0,0,47.05,,80.6,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,81.21,,,4.99,,0,
Master Protein,High,Q96T58,SPEN,Msx2-interacting protein OS=Homo sapiens OX=9606 GN=SPEN PE=1 SV=1,4,6,100,0.396,100,0.406,6.64,-1.34,6.64,-1.3,1.00E-17,5.14E-01,1.00E-17,6.15E-01,2.62E+05,,2.08E+05,9.23E+04,4,,3,1,,2.55E+05,7.54E+05,2.69E+05,1.98E+05,,,,,,,5.80E+04,,2.08E+05,2.40E+05,9.23E+04,,,,,,9.68E+02,7.37E+03,2.69E+05,1.02E+04,,,,,,,2.59E+03,,2.80E+04,5.97E+03,1.80E+02,,,,,0,FALSE,14.296,2,4,3664,402,7.64,4,signal transduction;other biological processes,nucleus;other cell component,"Pf00076, Pf07744, Pf20808, Pf20809, Pf20810",23013,hsa:23013; Q96T58; Q9H9A8; Q9NWH5; Q9UQ01; Q9Y556,ENSG00000065526,RHOBTB1 GTPase cycle,Notch signaling pathway,2,0,70.12,,57.6,,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,92.44,,0,15.89,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8NEF9,SRFBP1,Serum response factor-binding protein 1 OS=Homo sapiens OX=9606 GN=SRFBP1 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.73E+05,,,,1,,,,,,,1.73E+05,,,,,,,,,,,,,,,,,,,,1.73E+05,,,,,,,,,,,,,,,,,0.001,FALSE,4.007,3,1,429,48.6,9.58,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf09073,153443,hsa:153443; Q5QFI2; Q8NEF9; Q96AH4; Q96DK2,ENSG00000151304,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.76,,0,
Master Protein,High,Q9H0D6,XRN2,5'-3' exoribonuclease 2 OS=Homo sapiens OX=9606 GN=XRN2 PE=1 SV=1,2,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,3.58E+05,,,1.36E+05,2,,,3,,,,4.46E+05,2.88E+05,,,,,,,,,,,,,4.82E+05,9.12E+03,1.36E+05,,,,4.46E+05,1.48E+04,,,,,,,,,,,,,3.41E+03,2.13E+02,1.45E+03,0,FALSE,7.161,3,2,950,108.5,7.47,2,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,"Pf03159, Pf17846",22803,hsa:22803; Q3L8N4; Q6KGZ9; Q9BQL1; Q9H0D6; Q9NTW0; Q9NXS6; Q9UL53,ENSG00000088930,Major pathway of rRNA processing in the nucleolus and cytosol; Association of TriC/CCT with target proteins during biosynthesis,mRNA processing,3,0,30.54,,,116.98,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,,,,5.42,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8NCN5,PDPR,"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2",1,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.39E+05,,,,1,,,,,,,2.39E+05,,,,,,,,,,,,,,,,,,,,2.39E+05,,,,,,,,,,,,,,,,,0,FALSE,4.355,3,1,879,99.3,6.35,1,,mitochondrion;other cell component,"Pf01266, Pf01571, Pf08669, Pf16350",55066,A7E298; A8K8Y7; B3KSE1; Q6AI20; Q6AWC9; Q8NCN5,ENSG00000090857,Regulation of pyruvate dehydrogenase (PDH) complex,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,7.27,other molecular function,0,
Master Protein,High,P36959,GMPR,GMP reductase 1 OS=Homo sapiens OX=9606 GN=GMPR PE=1 SV=1,4,5,100,,100,0.404,6.64,,6.64,-1.31,1.00E-17,,1.00E-17,5.00E-01,2.33E+06,,1.69E+05,5.56E+05,1,,1,2,,,,,2.33E+06,,,,,,,,,1.69E+05,,,5.83E+05,,5.30E+05,,,,,,1.20E+05,,,,,,,,,2.27E+04,,,1.64E+05,,1.24E+04,,0,FALSE,12.74,19,4,345,37.4,7.06,4,other metabolic processes;stress response,cytosol;other cell component,Pf00478,2766,hsa:2766; P36959; Q96HQ6,ENSG00000137198,Purine salvage,,1,0,,,,6.76,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,,0.47,17.24,other molecular function,0,
Master Protein,High,Q9NTG7,SIRT3,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial OS=Homo sapiens OX=9606 GN=SIRT3 PE=1 SV=2",1,1,100,1.291,,100,6.64,0.37,,6.64,1.00E-17,4.87E-01,,1.00E-17,9.08E+04,,1.17E+05,,1,,1,,,,,9.08E+04,,,,,,,,1.17E+05,,,,,,,,,,,,9.08E+04,,,,,,,,5.24E+03,,,,,,,,,0,FALSE,4.541,7,1,399,43.5,8.7,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,mitochondrion;nucleus;other cell component,Pf02146,23410,B7Z5U6; hsa:23410; Q9NTG7; Q9Y6E8,ENSG00000142082,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Transcriptional activation of mitochondrial biogenesis; Regulation of FOXO transcriptional activity by acetylation","Energy metabolism; NAD metabolism, sirtuins and aging; NAD+ metabolism; NAD+ biosynthetic pathways; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence",8,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.87,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UBE0,SAE1,SUMO-activating enzyme subunit 1 OS=Homo sapiens OX=9606 GN=SAE1 PE=1 SV=1,3,8,100,0.464,100,5.757,6.64,-1.11,6.64,2.53,1.00E-17,6.51E-01,1.00E-17,1.19E-01,2.72E+05,,1.71E+05,1.43E+04,2,,5,1,,,,8.86E+05,8.35E+04,,,,,,7.16E+04,2.05E+05,3.87E+04,9.93E+05,1.71E+05,,,,1.43E+04,,,,,8.86E+05,4.31E+03,,,,,,4.28E+02,9.14E+03,3.14E+02,1.34E+05,4.26E+03,,,,3.35E+02,,0,FALSE,14.246,13,3,346,38.4,5.3,3,protein metabolism;other metabolic processes;other biological processes,nucleus;other cell component,Pf00899,10055,B2RDP5; B3KMQ2; F5GXX7; G3XAK6; hsa:10055; O95717; Q9P020; Q9UBE0,ENSG00000142230,"SUMO is conjugated to E1 (UBA2:SAE1); SUMO is transferred from E1 to E2 (UBE2I, UBC9)",,2,0,117.07,,133.77,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,132.9,,34.85,24.64,enzyme regulator activity;other molecular function,0,
Master Protein,High,A0A8Z5A536,LAMTOR5,Ragulator complex protein LAMTOR5 OS=Homo sapiens OX=9606 GN=LAMTOR5 PE=1 SV=1,2,7,100,1.162,100,1.042,6.64,0.22,6.64,0.06,1.00E-17,4.90E-01,1.00E-17,8.22E-01,4.74E+05,,2.40E+05,2.10E+05,2,,2,2,,8.99E+05,,2.50E+05,,,,,,,,1.45E+05,,3.95E+05,,,1.41E+05,3.11E+05,,,,3.42E+03,,2.50E+05,,,,,,,,6.48E+03,,5.33E+04,,,3.96E+04,2.21E+03,,,0,FALSE,13.58,25,2,173,18.1,5.5,2,other biological processes,other membranes;other cytoplasmic organelle,,10542,A0A8Z5A536; hsa:10542,ENSG00000134248,,,0,0,79.86,,65.52,53.28,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,57.74,,60.29,30.65,,0,
Master Protein,High,A0A087WYR3,TPD52L2,TPD52 like 2 OS=Homo sapiens OX=9606 GN=TPD52L2 PE=1 SV=1,1,2,100,17.459,100,6.429,6.64,4.13,6.64,2.68,1.00E-17,1.88E-06,1.00E-17,8.41E-02,5.44E+05,,9.50E+06,1.48E+06,1,,1,1,,,,5.44E+05,,,,,,,9.50E+06,,,,,,,1.48E+06,,,,,,5.44E+05,,,,,,,5.68E+04,,,,,,,1.05E+04,,,0.001,FALSE,4.017,14,1,222,23.8,6.55,1,,other cell component,Pf04201,7165,A0A087WYR3,ENSG00000101150,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,0,,0,8.71,,0,
Master Protein,High,O15160,POLR1C,DNA-directed RNA polymerases I and III subunit RPAC1 OS=Homo sapiens OX=9606 GN=POLR1C PE=1 SV=1,1,2,100,0.405,,100,6.64,-1.3,,6.64,1.00E-17,5.45E-01,,1.00E-17,2.94E+05,,1.19E+05,,1,,3,,,,,2.94E+05,,,,,,,,1.19E+05,,2.84E+05,6.58E+04,,,,,,,,,2.94E+05,,,,,,,,5.32E+03,,3.82E+04,1.64E+03,,,,,,0,FALSE,5.486,5,1,346,39.2,5.5,1,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,"Pf01000, Pf01193",9533,hsa:9533; O15160; O75395; Q5JTE3,ENSG00000171453,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination,Pyrimidine metabolism; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,15,0,,,72.72,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,86.04,,,6.23,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P20585,MSH3,DNA mismatch repair protein Msh3 OS=Homo sapiens OX=9606 GN=MSH3 PE=1 SV=4,2,2,100,5.352,100,3.689,6.64,2.42,6.64,1.88,1.00E-17,3.48E-02,1.00E-17,2.00E-01,1.41E+04,,7.55E+04,2.05E+04,1,,3,1,,,,1.41E+04,,,,,,,,,6.18E+04,2.24E+05,7.55E+04,,,,2.05E+04,,,,,1.41E+04,,,,,,,,,5.02E+02,3.02E+04,1.88E+03,,,,4.79E+02,,0,FALSE,4.831,2,2,1137,127.3,8.02,2,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus,"Pf00488, Pf01624, Pf05188, Pf05192",4437,A1L480; A1L482; A6NMM6; hsa:4437; P20585; Q6PJT5; Q86UQ6; Q92867,ENSG00000113318,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta); Defective Mismatch Repair Associated With MSH3; Defective Mismatch Repair Associated With MSH2,"Chromosomal and microsatellite instability in colorectal cancer ; DNA repair pathways, full network",5,0,,,74.77,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,26.88,,26.88,5.06,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P23511,NFYA,Nuclear transcription factor Y subunit alpha OS=Homo sapiens OX=9606 GN=NFYA PE=1 SV=2,1,2,100,0.809,100,1.514,6.64,-0.31,6.64,0.6,1.00E-17,7.92E-01,1.00E-17,5.65E-01,6.55E+05,,5.30E+05,3.50E+05,1,,1,1,,,,6.55E+05,,,,,,,,,5.30E+05,,,,,,3.50E+05,,,,,6.55E+05,,,,,,,,,4.31E+03,,,,,,8.19E+03,,0,FALSE,14.277,7,1,347,36.9,8.94,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf02045,4800,hsa:4800; P23511; Q8IXU0,ENSG00000001167,PPARA activates gene expression; Activation of gene expression by SREBF (SREBP); FOXO-mediated transcription of cell death genes; ATF4 activates genes in response to endoplasmic reticulum  stress; ATF6 (ATF6-alpha) activates chaperone genes,Sterol regulatory element-binding proteins (SREBP) signaling; Wnt signaling pathway and pluripotency; Sudden infant death syndrome (SIDS) susceptibility pathways,8,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,0,,0,9.38,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BU23,LMF2,Lipase maturation factor 2 OS=Homo sapiens OX=9606 GN=LMF2 PE=1 SV=2,1,3,100,0.671,,100,6.64,-0.57,,6.64,1.00E-17,9.65E-01,,1.00E-17,3.20E+05,,1.89E+05,,2,,3,,1.13E+06,,,9.06E+04,,,,,,,3.95E+05,,,1.17E+05,1.89E+05,,,,,,4.50E+03,,,9.06E+04,,,,,,,2.36E+03,,,1.58E+04,4.69E+03,,,,,,0,FALSE,4.461,3,1,707,79.6,10.1,1,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf06762,91289,A6NEZ0; hsa:91289; Q13392; Q6ZNR2; Q8WU74; Q96C62; Q9BU23,ENSG00000100258,Assembly of active LPL and LIPC lipase complexes,,1,0,120.48,,61.74,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,131.33,,,9.84,,0,
Master Protein,High,Q92954,PRG4,Proteoglycan 4 OS=Homo sapiens OX=9606 GN=PRG4 PE=1 SV=3,1,1,100,0.93,,100,6.64,-0.1,,6.64,1.00E-17,7.21E-01,,1.00E-17,3.33E+04,,3.10E+04,,1,,5,,,,,3.33E+04,,,,,,,8.51E+04,5.52E+04,3.10E+04,1.32E+04,2.64E+04,,,,,,,,,3.33E+04,,,,,,,5.09E+02,2.47E+03,2.51E+02,1.78E+03,6.56E+02,,,,,,0.002,FALSE,2.889,1,1,1404,151,9.51,1,transport;other biological processes,non-structural extracellular,"Pf00045, Pf01033",10216,hsa:10216; Q6DNC4; Q6DNC5; Q6ZMZ5; Q92954; Q9BX49,ENSG00000116690,,,0,0,,,67.33,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,65.13,,,2.74,other molecular function,0,
Master Protein,High,Q13445,TMED1,Transmembrane emp24 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TMED1 PE=1 SV=1,2,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.07E+05,,,1.38E+05,2,,,2,,,,4.14E+04,2.75E+05,,,,,,,,,,,,,,6.74E+04,2.81E+05,,,,4.14E+04,1.42E+04,,,,,,,,,,,,,,1.58E+03,2.99E+03,0,FALSE,6.703,13,2,227,25.2,4.48,2,cell-cell signaling;cell organization and biogenesis;stress response;transport;signal transduction,plasma membrane;other membranes;ER/Golgi;other cell component,Pf01105,11018,hsa:11018; Q13445,ENSG00000099203,,Ciliary landscape,1,0,104.43,,,86.71,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,,,,,7.31,signal transduction activity or receptor binding,0,
Master Protein,High,A0A8V8TL82,ROCK2,Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=1,2,2,100,3.249,100,0.75,6.64,1.7,6.64,-0.41,1.00E-17,1.02E-01,1.00E-17,9.89E-01,1.56E+04,,5.06E+04,6.75E+04,1,,2,2,,,,1.56E+04,,,,,,,,,1.40E+05,,1.83E+04,,2.05E+05,,2.22E+04,,,,,1.56E+04,,,,,,,,,1.14E+03,,4.55E+02,,5.76E+04,,5.20E+02,,0,FALSE,5.348,2,2,1445,167.1,5.88,2,cell organization and biogenesis;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;other cell component,"Pf00069, Pf08912",,A0A8V8TL82,ENSG00000134318,,Spinal cord injury; Physico-chemical features and toxicity-associated pathways; Chemokine signaling pathway; Wnt signaling; Airway smooth muscle cell contraction,5,0,,,108.7,113.81,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,178.12,,72.7,6.29,kinase activity;other molecular function,0,
Master Protein,High,P37802,TAGLN2,Transgelin-2 OS=Homo sapiens OX=9606 GN=TAGLN2 PE=1 SV=3,3,5,100,11.125,100,3.967,6.64,3.48,6.64,1.99,1.00E-17,3.03E-04,1.00E-17,1.46E-01,7.82E+04,,6.76E+05,3.86E+05,1,,5,2,,,,7.82E+04,,,,,,,1.47E+05,6.76E+05,9.34E+05,8.90E+04,1.19E+06,,6.78E+05,,2.19E+05,,,,,7.82E+04,,,,,,,8.81E+02,3.02E+04,7.59E+03,1.20E+04,2.95E+04,,1.91E+05,,5.13E+03,,0,FALSE,10.422,19,3,199,22.4,8.25,3,cell organization and biogenesis;other biological processes,non-structural extracellular;cytosol;cytoskeleton,"Pf00307, Pf00402",8407,E9KL39; hsa:8407; P37802; Q5JRQ6; Q5JRQ7; Q6FGI1; Q9BUH5; Q9H4P0,ENSG00000158710,Platelet degranulation,,1,0,,,79.41,72.32,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,32.93,,32.93,12.42,cytoskeletal activity,0,
Master Protein,High,Q96JJ7,TMX3,Protein disulfide-isomerase TMX3 OS=Homo sapiens OX=9606 GN=TMX3 PE=1 SV=2,4,11,100,2.677,100,0.922,6.64,1.42,6.64,-0.12,1.00E-17,4.65E-02,1.00E-17,8.92E-01,7.67E+05,,5.74E+05,3.80E+05,3,,4,2,,7.67E+05,,9.67E+05,1.01E+05,,,,,,,5.16E+05,3.29E+05,6.38E+05,7.68E+05,,3.25E+05,,4.43E+05,,,2.91E+03,,9.67E+05,5.22E+03,,,,,,,2.31E+04,2.67E+03,8.59E+04,1.91E+04,,9.14E+04,,1.04E+04,,0,FALSE,22.234,16,4,454,51.8,4.91,4,protein metabolism;other metabolic processes,plasma membrane;other membranes;ER/Golgi;other cell component,"Pf00085, Pf13848",54495,B3KV75; hsa:54495; Q52LT7; Q8N5J0; Q96JJ7; Q9NWJ9,ENSG00000166479,Platelet degranulation,,1,0,74.11,,33.17,21.68,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,76.92,,67.48,31.03,other molecular function,0,
Master Protein,High,Q53GS9,USP39,U4/U6.U5 tri-snRNP-associated protein 2 OS=Homo sapiens OX=9606 GN=USP39 PE=1 SV=2,3,9,100,1.009,,100,6.64,0.01,,6.64,1.00E-17,5.06E-01,,1.00E-17,1.31E+06,,1.44E+06,,1,,3,,,,,1.31E+06,,,,,,,3.17E+06,,,1.44E+06,1.61E+05,,,,,,,,,1.31E+06,,,,,,,1.90E+04,,,1.95E+05,3.99E+03,,,,,,0,FALSE,10.822,9,3,565,65.3,8.91,3,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00443, Pf02148",10713,A8K086; B3KM40; B4DHT4; D6W5L4; G5E9H0; hsa:10713; Q53GS9; Q6NX47; Q96RK9; Q9BV89; Q9H381; Q9P050; Q9Y310,ENSG00000168883,mRNA Splicing - Major Pathway,,1,0,,,94.92,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,67.22,,,26.55,other molecular function,0,
Master Protein,High,Q01826,SATB1,DNA-binding protein SATB1 OS=Homo sapiens OX=9606 GN=SATB1 PE=1 SV=1,3,4,100,1.17,,100,6.64,0.23,,6.64,1.00E-17,5.17E-01,,1.00E-17,1.67E+05,,1.96E+05,,1,,1,,,,,1.67E+05,,,,,,,,1.96E+05,,,,,,,,,,,,1.67E+05,,,,,,,,8.75E+03,,,,,,,,,0,FALSE,8.886,7,3,763,85.9,6.54,3,cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf00046, Pf02376, Pf16534, Pf16557",6304,B3KXF1; C9JTR6; hsa:6304; Q01826; Q59EQ0,ENSG00000182568,SUMOylation of chromatin organization proteins; Apoptotic cleavage of cellular proteins,Vitamin D receptor pathway,3,0,,,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,0,,,12.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15723,ELF2,ETS-related transcription factor Elf-2 OS=Homo sapiens OX=9606 GN=ELF2 PE=1 SV=2,1,1,100,0.369,100,0.023,6.64,-1.44,6.64,-5.46,1.00E-17,5.55E-01,1.00E-17,9.17E-04,4.99E+04,,1.84E+04,8.13E+05,1,,4,1,,,,4.99E+04,,,,,,,9.45E+04,2.14E+04,,1.01E+04,1.59E+04,,,,,8.13E+05,,,,4.99E+04,,,,,,,5.65E+02,9.54E+02,,1.36E+03,3.95E+02,,,,,8.65E+03,0.004,FALSE,2.607,2,1,593,63.9,6.57,1,other biological processes,cytosol;nucleus;other cell component,"Pf00178, Pf12310",1998,E9PCX3; hsa:1998; Q15723; Q15724; Q15725; Q6P1K5,ENSG00000109381,RUNX1 regulates transcription of genes involved in BCR signaling,,1,0,,,111.73,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,71.41,,71.41,2.66,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A3B3IUC4,GLA,Alpha-galactosidase OS=Homo sapiens OX=9606 GN=GLA PE=1 SV=1,1,1,100,2.222,,100,6.64,1.15,,6.64,1.00E-17,1.59E-01,,1.00E-17,1.09E+05,,2.41E+05,,2,,1,,,,,1.08E+05,1.09E+05,,,,,,,2.41E+05,,,,,,,,,,,,1.08E+05,5.63E+03,,,,,,,1.08E+04,,,,,,,,,0.003,FALSE,2.745,4,1,470,53.2,5.86,1,other metabolic processes,other cytoplasmic organelle,"Pf16499, Pf17450",,A0A3B3IUC4,ENSG00000102393,,Ciliary landscape,1,0,0.61,,,,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0.64,,,2.23,other molecular function,0,
Master Protein,High,H0Y886,NDUFB5,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=NDUFB5 PE=1 SV=1",1,5,100,1.248,,100,6.64,0.32,,6.64,1.00E-17,4.59E-01,,1.00E-17,2.14E+05,,4.02E+05,,2,,3,,,,,3.77E+05,1.22E+05,,,,,,,5.49E+05,,4.02E+05,1.28E+05,,,,,,,,,3.77E+05,6.28E+03,,,,,,,2.45E+04,,5.42E+04,3.17E+03,,,,,,0,FALSE,4.942,7,1,206,23.5,9.6,1,,other membranes;mitochondrion;nucleus,Pf09781,,H0Y886,ENSG00000136521,,,0,0,72.35,,59.52,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,66.52,,,13.89,,0,
Master Protein,High,P20340,RAB6A,Ras-related protein Rab-6A OS=Homo sapiens OX=9606 GN=RAB6A PE=1 SV=3,2,33,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.74E+05,,,,4,,,,1.41E+05,4.12E+05,,3.08E+05,2.44E+05,,,,,,,,,,,,,,,,5.58E+02,1.57E+03,,3.08E+05,1.26E+04,,,,,,,,,,,,,,,,0,FALSE,8.554,12,1,208,23.6,5.54,2,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,Pf00071,5870,A8K133; B7Z772; F5H668; hsa:5870; P20340; Q1W5D8; Q5U0A8; Q9UBE4,ENSG00000175582,Neutrophil degranulation; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; COPI-independent Golgi-to-ER retrograde traffic; Pre-NOTCH Processing in Golgi; Retrograde transport at the Trans-Golgi-Network; TBC/RABGAPs,,7,0,41.25,,,,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,77.76,cytoskeletal activity;other molecular function,0,
Master Protein,High,H0YLU7,ETFA,Electron transfer flavoprotein subunit alpha OS=Homo sapiens OX=9606 GN=ETFA PE=1 SV=2,7,34,100,1.235,100,2.137,6.64,0.3,6.64,1.1,1.00E-17,3.90E-01,1.00E-17,4.53E-01,1.01E+06,,3.80E+06,1.32E+06,2,,5,2,,,,3.62E+06,2.82E+05,,,,,,1.11E+05,2.57E+06,4.86E+06,4.54E+06,3.80E+06,,1.81E+06,,9.58E+05,,,,,3.62E+06,1.45E+04,,,,,,6.64E+02,1.15E+05,3.95E+04,6.12E+05,9.45E+04,,5.08E+05,,2.24E+04,,0,FALSE,43.997,29,7,406,42.4,7.46,7,,mitochondrion,"Pf00766, Pf01012",,H0YLU7,ENSG00000140374,,,0,0,120.98,,60.65,43.49,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,High,High,High,High,n/a,High,n/a,High,n/a,1,,FALSE,,104.39,,54.89,110.49,other molecular function,0,
Master Protein,Medium,O94864,SUPT7L,STAGA complex 65 subunit gamma OS=Homo sapiens OX=9606 GN=SUPT7L PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.39E+05,,,,1,,,,,,,2.39E+05,,,,,,,,,,,,,,,,,,,,2.39E+05,,,,,,,,,,,,,,,,,0.016,FALSE,2.083,7,1,414,46.2,5.12,1,other biological processes,nucleus;other cell component,Pf07524,9913,B4E3W3; hsa:9913; O94864; Q6IB21; Q9H2T6,ENSG00000119760,HATs acetylate histones,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.51,other molecular function,0,
Master Protein,High,Q5VT06,CEP350,Centrosome-associated protein 350 OS=Homo sapiens OX=9606 GN=CEP350 PE=1 SV=1,1,1,100,0.106,,100,6.64,-3.23,,6.64,1.00E-17,5.82E-02,,1.00E-17,5.48E+04,,5.83E+03,,3,,1,,5.48E+04,,,7.19E+04,2.48E+04,,,,,,,,,5.83E+03,,,,,,,2.18E+02,,,7.19E+04,1.28E+03,,,,,,,,,7.85E+02,,,,,,,0.001,FALSE,3.674,0,1,3117,350.7,6.33,1,cell organization and biogenesis;other biological processes,cytoskeleton;nucleus;other cell component,"Pf01302, Pf14309",9857,hsa:9857; O75068; Q5VT06; Q8TDK3; Q8WY20,ENSG00000135837,,3q29 copy number variation syndrome,1,0,47.15,,,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,46.2,,,2.66,cytoskeletal activity,0,
Master Protein,High,A0A3F2YNX6,KAT6A,Histone acetyltransferase OS=Homo sapiens OX=9606 GN=KAT6A PE=1 SV=1,2,2,100,1.857,,100,6.64,0.89,,6.64,1.00E-17,2.90E-01,,1.00E-17,4.64E+04,,7.80E+04,,2,,2,,,,,1.08E+05,2.00E+04,,,,,,5.92E+04,,,1.03E+05,,,,,,,,,,1.08E+05,1.03E+03,,,,,,3.54E+02,,,1.39E+04,,,,,,,0,FALSE,8.288,2,2,2006,225.1,5.71,2,cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,"Pf00628, Pf01853, Pf17772, Pf21524",,A0A3F2YNX6,ENSG00000083168,,Pathways affected in adenoid cystic carcinoma,1,0,96.97,,38.06,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,37.18,,,6.75,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H444,CHMP4B,Charged multivesicular body protein 4b OS=Homo sapiens OX=9606 GN=CHMP4B PE=1 SV=1,1,4,100,1.137,100,2.536,6.64,0.18,6.64,1.34,1.00E-17,5.10E-01,1.00E-17,3.67E-01,2.00E+05,,1.87E+05,8.07E+04,3,,4,2,,2.93E+05,9.05E+04,2.00E+05,,,,,,,,1.37E+05,2.48E+05,3.06E+05,1.41E+05,,3.36E+04,,1.93E+05,,,1.11E+03,8.84E+02,2.00E+05,,,,,,,,6.11E+03,2.02E+03,4.12E+04,3.49E+03,,9.45E+03,,4.52E+03,,0,FALSE,6.338,6,1,224,24.9,4.82,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf03357,128866,E1P5N4; hsa:128866; Q53ZD6; Q9H444,ENSG00000101421,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex,,9,0,52.12,,40.03,99.5,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,55.55,,100.9,13.07,other molecular function,0,
Master Protein,High,Q9UI09,NDUFA12,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 OS=Homo sapiens OX=9606 GN=NDUFA12 PE=1 SV=1,2,4,100,0.331,,100,6.64,-1.6,,6.64,1.00E-17,4.18E-01,,1.00E-17,1.58E+05,,5.22E+04,,1,,1,,,,,1.58E+05,,,,,,,,,,5.22E+04,,,,,,,,,,1.58E+05,,,,,,,,,,7.03E+03,,,,,,,0,FALSE,8.973,24,2,145,17.1,9.63,2,cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes,other membranes;cytosol;mitochondrion,Pf05071,55967,F8VQS7; hsa:55967; Q53XX0; Q9BRV6; Q9UI09,ENSG00000184752,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,13.57,transporter activity,0,
Master Protein,High,A0A994J5K1,PMPCA,"Peptidase, mitochondrial processing subunit alpha OS=Homo sapiens OX=9606 GN=PMPCA PE=4 SV=1",2,6,100,0.587,100,0.839,6.64,-0.77,6.64,-0.25,1.00E-17,8.30E-01,1.00E-17,9.97E-01,7.89E+05,,2.66E+05,4.33E+05,2,,3,2,,,,6.51E+05,9.57E+05,,,,,,,1.62E+06,1.12E+05,,2.66E+05,4.23E+05,4.43E+05,,,,,,,6.51E+05,4.94E+04,,,,,,,7.22E+04,9.09E+02,,6.62E+03,8.25E+02,1.24E+05,,,,0,FALSE,10.383,8,2,548,60.7,6.98,2,protein metabolism,mitochondrion,,,A0A994J5K1,ENSG00000165688,,,0,0,26.97,,124.45,3.17,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,123.81,,116.1,19.83,other molecular function,0,
Master Protein,High,A0A8J8YVX4,ODF2,Outer dense fiber of sperm tails 2 OS=Homo sapiens OX=9606 GN=ODF2 PE=1 SV=1,1,1,100,0.301,,100,6.64,-1.73,,6.64,1.00E-17,3.16E-01,,1.00E-17,1.97E+05,,5.93E+04,,1,,3,,,,,1.97E+05,,,,,,,,5.93E+04,,9.51E+04,4.94E+04,,,,,,,,,1.97E+05,,,,,,,,2.65E+03,,1.28E+04,1.23E+03,,,,,,0.003,FALSE,2.74,2,1,912,105.1,8.68,1,,cytoskeleton;other cell component,,,A0A8J8YVX4,ENSG00000136811,,,0,0,,,35.34,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,29.72,,,2.51,,0,
Master Protein,High,Q86T03,PIP4P1,"Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase OS=Homo sapiens OX=9606 GN=PIP4P1 PE=1 SV=1",2,8,100,1.079,100,0.974,6.64,0.11,6.64,-0.04,1.00E-17,6.03E-01,1.00E-17,8.70E-01,5.86E+05,,2.33E+05,2.38E+05,1,,3,1,,,,5.86E+05,,,,,,,,6.24E+05,,2.33E+05,2.01E+05,,2.38E+05,,,,,,,5.86E+05,,,,,,,,2.79E+04,,3.13E+04,4.98E+03,,6.68E+04,,,,0,FALSE,12.266,12,2,277,29.5,8.91,2,cell organization and biogenesis;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;nucleus;other cytoplasmic organelle,Pf09788,90809,B2RA35; hsa:90809; Q86T03; Q86U09; Q8WUC0; Q9BU67; Q9NSU8,ENSG00000165782; ENSG00000291802,PI5P Regulates TP53 Acetylation; Synthesis of PIPs in the nucleus,,2,0,,,66.95,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,142.93,,0.64,25.86,other molecular function,0,
Master Protein,High,P55199,ELL,RNA polymerase II elongation factor ELL OS=Homo sapiens OX=9606 GN=ELL PE=1 SV=1,1,2,100,1.365,100,0.726,6.64,0.45,6.64,-0.46,1.00E-17,4.73E-01,1.00E-17,9.87E-01,3.51E+04,,4.79E+04,6.60E+04,1,,1,2,,,,3.51E+04,,,,,,,,,,4.79E+04,,,2.07E+05,,2.11E+04,,,,,3.51E+04,,,,,,,,,,6.46E+03,,,5.81E+04,,4.93E+02,,0,FALSE,4.341,3,1,621,68.2,9.33,1,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf07303, Pf10390",8178,hsa:8178; P55199,ENSG00000105656,Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; Transcription-Coupled Nucleotide Excision Repair (TC-NER),Interactome of polycomb repressive complex 2 (PRC2),14,0,,,,115.28,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,0,,208.63,5.81,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NXE4,SMPD4,Sphingomyelin phosphodiesterase 4 OS=Homo sapiens OX=9606 GN=SMPD4 PE=1 SV=3,1,1,100,0.229,100,0.097,6.64,-2.13,6.64,-3.36,1.00E-17,2.80E-01,1.00E-17,8.21E-02,5.22E+04,,1.19E+04,1.23E+05,3,,1,1,,,1.02E+05,4.51E+04,5.22E+04,,,,,,,1.19E+04,,,,,,,,1.23E+05,,,9.98E+02,4.51E+04,2.69E+03,,,,,,,5.33E+02,,,,,,,,1.30E+03,0,FALSE,4.515,2,1,866,97.7,8.27,1,cell organization and biogenesis;other metabolic processes;other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus,Pf14724,55627,B1PBA3; B4DM23; B4DQ31; B4DRB8; B4DWK7; B4E0L6; E7ESA2; E9PCE6; hsa:55627; Q6FI76; Q6P1P7; Q6ZT43; Q9H0M2; Q9NW20; Q9NWL2; Q9NXE4; Q9P2C9,ENSG00000136699; ENSG00000292130,Glycosphingolipid catabolism,,1,0,46.78,,,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,20.17,,0,3.3,other molecular function,0,
Master Protein,High,Q8N3X1,FNBP4,Formin-binding protein 4 OS=Homo sapiens OX=9606 GN=FNBP4 PE=1 SV=3,1,1,100,0.357,,100,6.64,-1.48,,6.64,1.00E-17,5.00E-01,,1.00E-17,7.94E+04,,2.84E+04,,1,,3,,,,,7.94E+04,,,,,,,,2.84E+04,,2.98E+04,1.66E+04,,,,,,,,,7.94E+04,,,,,,,,1.27E+03,,4.01E+03,4.12E+02,,,,,,0,FALSE,4.267,2,1,1017,110.2,4.74,1,,nucleus,Pf00397,23360,hsa:23360; Q8N3X1; Q9H985; Q9NT81; Q9Y2L7,ENSG00000109920; ENSG00000285182,,,0,0,,,29.09,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,6.88,,,3.51,,0,
Master Protein,High,Q01196,RUNX1,Runt-related transcription factor 1 OS=Homo sapiens OX=9606 GN=RUNX1 PE=1 SV=3,3,4,100,0.606,100,1.493,6.64,-0.72,6.64,0.58,1.00E-17,8.71E-01,1.00E-17,6.28E-01,4.13E+05,,8.96E+04,5.87E+04,1,,4,3,,,,4.13E+05,,,,,,,,8.62E+04,4.09E+04,9.31E+04,1.17E+05,,,7.69E+04,5.41E+04,5.87E+04,,,,4.13E+05,,,,,,,,3.85E+03,3.32E+02,1.25E+04,2.90E+03,,,5.45E+02,1.27E+03,6.25E+02,0,FALSE,10.681,8,3,453,48.7,9.35,3,cell cycle OR cell proliferation;developmental processes;other biological processes,nucleus;other cell component,"Pf00853, Pf08504",861,A8MV94; B2RMS4; D3DSG1; hsa:861; O60472; O60473; O76047; O76089; Q01196; Q13081; Q13755; Q13756; Q13757; Q13758; Q13759; Q15341; Q15343; Q16122; Q16284; Q16285; Q16286; Q16346; Q16347; Q92479,ENSG00000159216,RUNX1 regulates transcription of genes involved in differentiation of HSCs; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Estrogen-dependent gene expression; RUNX1 regulates expression of components of tight junctions; Pre-NOTCH Transcription and Translation; RUNX1 regulates transcription of genes involved in differentiation of keratinocytes; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; RUNX1 regulates estrogen receptor mediated transcription; RUNX1 regulates transcription of genes involved in WNT signaling; Organic cation transport; SARS-CoV-1 activates/modulates innate immune responses; Transcriptional regulation of granulopoiesis; RUNX3 regulates p14-ARF; RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs); RUNX1 regulates transcription of genes involved in differentiation of myeloid cells; RUNX1 regulates transcription of genes involved in interleukin signaling; Regulation of RUNX1 Expression and Activity; RUNX2 regulates genes involved in differentiation of myeloid cells; RUNX1 regulates transcription of genes involved in BCR signaling,Hematopoietic stem cell differentiation; Dual hijack model of Vif in HIV infection; Orexin receptor pathway; Th17 cell differentiation pathway; Acute myeloid leukemia,24,0,,,37.63,19.07,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,20.11,,32.49,11.21,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UH92,MLX,Max-like protein X OS=Homo sapiens OX=9606 GN=MLX PE=1 SV=2,1,1,100,0.811,100,0.577,6.64,-0.3,6.64,-0.79,1.00E-17,8.78E-01,1.00E-17,7.89E-01,1.23E+05,,9.95E+04,1.72E+05,1,,3,1,,,,1.23E+05,,,,,,,,7.01E+04,,1.76E+05,9.95E+04,,1.72E+05,,,,,,,1.23E+05,,,,,,,,3.13E+03,,2.37E+04,2.47E+03,,4.84E+04,,,,0.005,FALSE,2.545,3,1,298,33.3,8.06,1,other biological processes,other membranes;cytosol;nucleus;other cell component,Pf00010,6945,A8K2J3; B2RAV8; B2RD73; hsa:6945; Q53XM6; Q96FL2; Q9H2V0; Q9H2V1; Q9H2V2; Q9NXN3; Q9UH92,ENSG00000108788,ChREBP activates metabolic gene expression,Nonalcoholic fatty liver disease,2,0,,,47.46,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,62.21,,62.21,0,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8NF50,DOCK8,Dedicator of cytokinesis protein 8 OS=Homo sapiens OX=9606 GN=DOCK8 PE=1 SV=3,2,2,100,2.398,100,4.213,6.64,1.26,6.64,2.07,1.00E-17,1.67E-01,1.00E-17,1.74E-01,9.52E+04,,1.13E+05,2.69E+04,2,,2,1,,,4.21E+04,2.16E+05,,,,,,,1.43E+05,,,8.97E+04,,,,,2.69E+04,,,,4.11E+02,2.16E+05,,,,,,,8.53E+02,,,1.21E+04,,,,,6.28E+02,,0,FALSE,8.138,2,2,2099,238.4,6.87,2,cell cycle OR cell proliferation;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf06920, Pf11878, Pf14429, Pf20421, Pf20422",81704,A2A350; A2BDF2; A4FU78; B7ZLP0; E9PH09; hsa:81704; Q3MV16; Q5JPJ1; Q8NF50; Q8TEP1; Q8WUY2; Q9BYJ5; Q9H1Q2; Q9H1Q3; Q9H308; Q9H7P2,ENSG00000107099,CDC42 GTPase cycle; RHOJ GTPase cycle; RAC1 GTPase cycle; Factors involved in megakaryocyte development and platelet production,,4,0,95.21,,32.16,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,30.89,,34.63,6.04,enzyme regulator activity,0,
Master Protein,High,Q15717,ELAVL1,ELAV-like protein 1 OS=Homo sapiens OX=9606 GN=ELAVL1 PE=1 SV=2,5,12,100,0.291,100,4.444,6.64,-1.78,6.64,2.15,1.00E-17,2.65E-01,1.00E-17,1.11E-01,2.72E+05,,4.71E+05,3.62E+04,4,,5,2,,1.92E+05,1.20E+05,4.12E+05,3.85E+05,,,,,,4.97E+05,1.20E+05,5.30E+05,4.71E+05,5.31E+04,,6.42E+04,,2.04E+04,,,7.29E+02,1.17E+03,4.12E+05,1.99E+04,,,,,,2.97E+03,5.38E+03,4.30E+03,6.35E+04,1.32E+03,,1.80E+04,,4.77E+02,,0,FALSE,19.881,21,5,326,36.1,9.17,5,cell organization and biogenesis;transport;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,Pf00076,1994,B4DVB8; hsa:1994; Q15717; Q53XN6; Q9BTT1,ENSG00000066044,HuR (ELAVL1) binds and stabilizes mRNA,AMP-activated protein kinase signaling; Endoderm differentiation; Pre-implantation embryo; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Gastrin signaling pathway; IL-18 signaling pathway; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; 1p36 copy number variation syndrome,10,0,51.88,,68.24,73.25,High,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,88.46,,98.94,30.35,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75964,ATP5MG,"ATP synthase subunit g, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5MG PE=1 SV=3",2,4,100,1.267,100,1.326,6.64,0.34,6.64,0.41,1.00E-17,2.97E-01,1.00E-17,6.54E-01,1.12E+06,,2.39E+06,6.99E+05,2,,5,2,,,,3.89E+06,3.23E+05,,,,,,3.31E+05,4.82E+06,4.11E+05,2.39E+06,2.57E+06,,1.92E+06,,2.54E+05,,,,,3.89E+06,1.66E+04,,,,,,1.98E+03,2.15E+05,3.34E+03,3.22E+05,6.39E+04,,5.39E+05,,5.95E+03,,0,FALSE,8.262,23,2,103,11.4,9.64,2,other metabolic processes;transport,other membranes;mitochondrion,Pf04718,10632,A8K0K3; hsa:10632; O75964; Q96BV6; Q9UBZ7,ENSG00000167283,Mitochondrial protein degradation; Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,5,0,119.78,,87.91,108.29,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,136.82,,112.08,10.66,transporter activity,0,
Master Protein,High,Q01085,TIAL1,Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1,1,5,100,0.28,100,0.455,6.64,-1.83,6.64,-1.14,1.00E-17,2.92E-01,1.00E-17,6.39E-01,1.69E+05,,4.74E+04,1.04E+05,2,,3,1,,2.57E+05,,1.11E+05,,,,,,,,7.99E+03,,3.14E+05,4.74E+04,,1.04E+05,,,,,9.78E+02,,1.11E+05,,,,,,,,3.57E+02,,4.24E+04,1.18E+03,,2.93E+04,,,,0,FALSE,6.497,5,1,375,41.6,7.74,1,cell cycle OR cell proliferation;stress response;other biological processes,cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf00076,7073,A8K3T0; A8K4L9; hsa:7073; Q01085,ENSG00000151923,FGFR2 alternative splicing,,1,0,56.28,,135.25,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,123.91,,125.92,16.69,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q5T1J5,CHCHD2P9,"Putative coiled-coil-helix-coiled-coil-helix domain-containing protein CHCHD2P9, mitochondrial OS=Homo sapiens OX=9606 GN=CHCHD2P9 PE=5 SV=1",1,8,100,0.387,,100,6.64,-1.37,,6.64,1.00E-17,3.97E-01,,1.00E-17,2.94E+06,,1.14E+06,,1,,1,,,,,2.94E+06,,,,,,,,1.14E+06,,,,,,,,,,,,2.94E+06,,,,,,,,5.09E+04,,,,,,,,,0,FALSE,15.996,19,1,151,15.5,9.89,1,cell organization and biogenesis;other biological processes,mitochondrion;nucleus,,,Q5T1J5,,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,27.08,nucleic acid binding activity,0,
Master Protein,High,Q8NHP8,PLBD2,Putative phospholipase B-like 2 OS=Homo sapiens OX=9606 GN=PLBD2 PE=1 SV=2,1,2,100,0.578,100,1.255,6.64,-0.79,6.64,0.33,1.00E-17,8.69E-01,1.00E-17,6.72E-01,6.91E+04,,4.00E+04,3.74E+04,2,,4,4,,6.11E+04,,7.81E+04,,,,,,,,3.73E+04,4.27E+04,7.56E+04,2.92E+04,1.18E+05,1.58E+04,6.53E+04,2.14E+04,,,2.32E+02,,7.81E+04,,,,,,,,1.67E+03,3.47E+02,1.02E+04,7.25E+02,2.30E+02,4.44E+03,4.63E+02,5.01E+02,,0.002,FALSE,2.874,2,1,589,65.4,6.8,1,other metabolic processes,non-structural extracellular;other cytoplasmic organelle,Pf04916,196463,F5H5E2; hsa:196463; Q8NHP8,ENSG00000151176,,,0,0,17.22,,44.03,85.89,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,,31.17,,91.4,5.54,other molecular function,0,
Master Protein,High,Q86X55,CARM1,Histone-arginine methyltransferase CARM1 OS=Homo sapiens OX=9606 GN=CARM1 PE=1 SV=3,2,2,100,0.08,100,0.072,6.64,-3.64,6.64,-3.8,1.00E-17,2.24E-02,1.00E-17,5.17E-02,1.53E+05,,1.23E+04,1.72E+05,2,,1,2,3.76E+05,,,6.25E+04,,,,,,,,,,1.23E+04,,,3.90E+04,7.57E+05,,,1.49E+03,,,6.25E+04,,,,,,,,,,1.66E+03,,,1.10E+04,5.37E+03,,,0,FALSE,10.17,6,2,608,65.8,6.73,2,cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf06325, Pf11531",10498,A6NN38; hsa:10498; Q86X55,ENSG00000142453,"Estrogen-dependent gene expression; Heme signaling; Transcriptional activation of mitochondrial biogenesis; Cytoprotection by HMOX1; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Activation of gene expression by SREBF (SREBP); RMTs methylate histone arginines; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest; RORA activates gene expression",Androgen receptor signaling pathway; Nitric oxide metabolism in cystic fibrosis,15,0,101.1,,,127.56,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,151.58,,309.77,6.81,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15555,MAPRE2,Microtubule-associated protein RP/EB family member 2 OS=Homo sapiens OX=9606 GN=MAPRE2 PE=1 SV=1,5,6,100,1.321,,100,6.64,0.4,,6.64,1.00E-17,3.55E-01,,1.00E-17,4.15E+05,,6.57E+05,,2,,1,,,,,4.62E+05,3.72E+05,,,,,,,,,6.57E+05,,,,,,,,,,4.62E+05,1.92E+04,,,,,,,,,8.85E+04,,,,,,,0,FALSE,18.707,33,5,327,37,5.57,5,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytoskeleton;other cell component,"Pf00307, Pf03271",10982,B2RE21; B3KR39; B4DJV4; B7Z2L3; E9PHR3; F5H1V8; G5E9I6; hsa:10982; Q15555; Q9UQ33,ENSG00000166974,,Ciliary landscape,1,0,15.31,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,85.81,,,16.64,cytoskeletal activity;other molecular function,0,
Master Protein,High,P22415,USF1,Upstream stimulatory factor 1 OS=Homo sapiens OX=9606 GN=USF1 PE=1 SV=1,2,4,100,0.727,100,3.347,6.64,-0.46,6.64,1.74,1.00E-17,9.19E-01,1.00E-17,1.44E-01,6.89E+05,,4.57E+05,1.36E+05,2,,5,1,,2.17E+06,,2.19E+05,,,,,,,6.84E+05,3.08E+05,8.16E+05,4.57E+05,3.32E+05,,,,1.36E+05,,,8.26E+03,,2.19E+05,,,,,,,4.09E+03,1.37E+04,6.63E+03,6.15E+04,8.26E+03,,,,3.19E+03,,0,FALSE,6.981,10,1,310,33.5,5.54,2,stress response;other biological processes,ER/Golgi;nucleus;other cell component,Pf00010,7391,B2RBZ4; hsa:7391; P22415; Q5SY46; Q7Z5Y1,ENSG00000158773,Estrogen-dependent gene expression,7q11.23 copy number variation syndrome; Familial hyperlipidemia type 2,3,0,115.57,,42.91,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,129.09,,48.41,13.85,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UIQ6,LNPEP,Leucyl-cystinyl aminopeptidase OS=Homo sapiens OX=9606 GN=LNPEP PE=1 SV=3,3,7,100,2.434,100,1.859,6.64,1.28,6.64,0.89,1.00E-17,1.11E-01,1.00E-17,3.86E-01,2.23E+05,,3.95E+05,1.91E+05,5,,5,3,2.80E+05,1.29E+05,3.92E+04,2.62E+05,2.23E+05,,,,,,4.98E+04,1.02E+05,3.95E+05,6.32E+05,5.30E+05,,1.91E+05,,2.76E+04,4.92E+05,1.11E+03,4.89E+02,3.83E+02,2.62E+05,1.15E+04,,,,,,2.98E+02,4.55E+03,3.21E+03,8.51E+04,1.32E+04,,5.36E+04,,6.45E+02,5.24E+03,0,FALSE,18.407,5,3,1025,117.3,5.73,3,cell-cell signaling;protein metabolism;other metabolic processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,"Pf01433, Pf11838, Pf17900",4012,hsa:4012; O00769; Q15145; Q59H76; Q9TNQ2; Q9TNQ3; Q9UIQ6; Q9UIQ7,ENSG00000113441,Antigen processing: Ubiquitination & Proteasome degradation; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Endosomal/Vacuolar pathway,,3,0,54.14,,75.34,99.57,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,,118.3,,132.84,25.94,other molecular function,0,
Master Protein,High,B8ZWD1,DBI,"Diazepam binding inhibitor, acyl-CoA binding protein OS=Homo sapiens OX=9606 GN=DBI PE=1 SV=1",1,4,100,1.954,100,0.415,6.64,0.97,6.64,-1.27,1.00E-17,1.82E-01,1.00E-17,5.93E-01,2.20E+05,,3.99E+05,9.62E+05,3,,2,2,2.20E+05,,,1.09E+05,3.84E+05,,,,,,,1.97E+05,,8.10E+05,,5.52E+05,,1.68E+06,,,8.75E+02,,,1.09E+05,1.98E+04,,,,,,,8.78E+03,,1.09E+05,,1.08E+03,,1.19E+04,,,0.001,FALSE,3.544,21,1,97,11.1,8.32,1,,,Pf00887,1622,B8ZWD1,ENSG00000155368,,Sterol regulatory element-binding proteins (SREBP) signaling; PPAR-alpha pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Fatty acid transporters,5,0,58.26,,86.18,71.36,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,,94.98,,65.38,12.41,other molecular function,0,
Master Protein,Medium,Q9P1Z2,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CALCOCO1 PE=1 SV=2,1,2,100,7.116,100,1.377,6.64,2.83,6.64,0.46,1.00E-17,1.00E-02,1.00E-17,6.23E-01,2.98E+04,,2.12E+05,1.54E+05,1,,2,1,,,,2.98E+04,,,,,,,,2.67E+05,,,1.68E+05,,1.54E+05,,,,,,,2.98E+04,,,,,,,,1.19E+04,,,4.18E+03,,4.32E+04,,,,0.012,FALSE,2.177,3,1,691,77.3,4.82,1,cell-cell signaling;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf07888, Pf17751, Pf18112",57658,B3KVA8; hsa:57658; Q6FI59; Q71RC3; Q86WF8; Q96JU3; Q9H090; Q9P1Z2,ENSG00000012822,,,0,0,,,31.97,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,34.41,,34.41,7.48,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BQ75,CMSS1,Protein CMSS1 OS=Homo sapiens OX=9606 GN=CMSS1 PE=1 SV=2,1,2,100,0.567,,100,6.64,-0.82,,6.64,1.00E-17,8.39E-01,,1.00E-17,5.99E+04,,3.40E+04,,1,,4,,,,,5.99E+04,,,,,,,,3.33E+04,3.47E+04,1.44E+05,2.79E+04,,,,,,,,,5.99E+04,,,,,,,,1.49E+03,2.82E+02,1.94E+04,6.93E+02,,,,,,0.001,FALSE,3.289,5,1,279,31.9,9.19,1,,,Pf14617,84319,A8K5S7; B4DUM1; E9PHS3; hsa:84319; Q9BQ75,ENSG00000184220,,,0,0,,,93.37,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,17.77,,,3.38,,0,
Master Protein,High,Q8IWA5,SLC44A2,Choline transporter-like protein 2 OS=Homo sapiens OX=9606 GN=SLC44A2 PE=1 SV=3,4,5,100,1.239,100,3.598,6.64,0.31,6.64,1.85,1.00E-17,4.93E-01,1.00E-17,2.32E-01,1.33E+05,,1.64E+05,4.57E+04,1,,4,1,,,,1.33E+05,,,,,,,,6.07E+04,1.77E+05,3.99E+05,1.53E+05,,4.57E+04,,,,,,,1.33E+05,,,,,,,,2.71E+03,1.44E+03,5.37E+04,3.79E+03,,1.28E+04,,,,0,FALSE,12.915,8,4,706,80.1,8.57,4,other metabolic processes;transport,plasma membrane;other membranes;mitochondrion,Pf04515,57153,B2RBB1; B3KNH3; B4DFJ0; F2Q9D7; hsa:57153; Q658V1; Q658Z2; Q6PJV7; Q8IWA5; Q8N2F0; Q9NY68,ENSG00000129353,"Neutrophil degranulation; Synthesis of PC; Transport of bile salts and organic acids, metal ions and amine compounds",,3,0,,,72.61,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,52.57,,52.57,15.5,transporter activity,0,
Master Protein,High,Q9BRX8,PRXL2A,Peroxiredoxin-like 2A OS=Homo sapiens OX=9606 GN=PRXL2A PE=1 SV=3,2,4,100,1.38,,100,6.64,0.46,,6.64,1.00E-17,2.63E-01,,1.00E-17,7.18E+05,,9.92E+05,,1,,4,,,,,7.18E+05,,,,,,,1.62E+06,,8.62E+05,8.11E+05,1.14E+06,,,,,,,,,7.18E+05,,,,,,,9.67E+03,,7.00E+03,1.09E+05,2.83E+04,,,,,,0,FALSE,5.974,10,2,229,25.7,8.84,2,other biological processes,non-structural extracellular;other cell component,Pf13911,84293,B2RD81; Q6UW08; Q8N2K3; Q8NBK9; Q96JR0; Q9BRX8,ENSG00000122378,,10q22q23 copy number variation,1,0,,,33.32,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,24.65,,,9.95,other molecular function,0,
Master Protein,High,Q86YP4,GATAD2A,Transcriptional repressor p66-alpha OS=Homo sapiens OX=9606 GN=GATAD2A PE=1 SV=1,3,3,100,0.147,100,0.016,6.64,-2.76,6.64,-5.97,1.00E-17,6.78E-02,1.00E-17,7.22E-04,2.41E+05,,6.30E+04,1.13E+06,2,,2,2,,,,3.10E+05,1.87E+05,,,,,,,4.49E+04,,8.85E+04,,,,1.75E+06,,7.26E+05,,,,3.10E+05,9.64E+03,,,,,,,2.00E+03,,1.19E+04,,,,1.24E+04,,7.72E+03,0,FALSE,11.601,7,3,633,68,9.94,3,cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes,nucleus,"Pf00320, Pf16563",54815,B5MC40; hsa:54815; Q7L3J2; Q86YP4; Q96F28; Q9NPU2; Q9NXS1,ENSG00000167491,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,,6,0,34.95,,46.27,58.51,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,51.93,,51.07,9.95,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O15164,TRIM24,Transcription intermediary factor 1-alpha OS=Homo sapiens OX=9606 GN=TRIM24 PE=1 SV=3,1,1,100,0.447,,100,6.64,-1.16,,6.64,1.00E-17,6.46E-01,,1.00E-17,1.39E+05,,6.19E+04,,1,,1,,,,,1.39E+05,,,,,,,,,,6.19E+04,,,,,,,,,,1.39E+05,,,,,,,,,,8.34E+03,,,,,,,0.005,FALSE,2.491,1,1,1050,116.8,7.11,1,cell cycle OR cell proliferation;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;mitochondrion;nucleus;other cell component,"Pf00439, Pf00628, Pf00643",8805,A4D1R7; A4D1R8; hsa:8805; O15164; O95854,ENSG00000122779,Signaling by BRAF and RAF1 fusions; Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.44,signal transduction activity or receptor binding;nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,Q8N983,MRPL43,"39S ribosomal protein L43, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL43 PE=1 SV=1",1,2,100,0.885,,100,6.64,-0.18,,6.64,1.00E-17,7.76E-01,,1.00E-17,1.60E+05,,1.41E+05,,1,,2,,,,,1.60E+05,,,,,,,,2.34E+05,8.55E+04,,,,,,,,,,,1.60E+05,,,,,,,,1.04E+04,6.95E+02,,,,,,,,0.001,FALSE,3.861,6,1,215,23.4,8.65,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf05047,84545,B1AL06; B1AL07; B1AL09; B1AL10; C9J5Q3; D3DR71; hsa:84545; Q5JW06; Q7Z719; Q7Z7H6; Q86XN1; Q8N983; Q9BYC7,ENSG00000055950,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,,65.72,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,77.81,,,3.5,other molecular function,0,
Master Protein,High,Q9Y5S1,TRPV2,Transient receptor potential cation channel subfamily V member 2 OS=Homo sapiens OX=9606 GN=TRPV2 PE=1 SV=1,1,1,100,2.403,100,0.185,6.64,1.26,6.64,-2.44,1.00E-17,1.86E-01,1.00E-17,2.37E-01,2.02E+04,,4.86E+04,2.63E+05,1,,1,2,,,,2.02E+04,,,,,,,,,,,4.86E+04,,,,1.33E+05,5.20E+05,,,,2.02E+04,,,,,,,,,,,1.21E+03,,,,3.11E+03,5.53E+03,0.001,FALSE,3.973,2,1,764,85.9,5.83,1,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;other cell component,"Pf00520, Pf12796",51393,A6NML2; A8K0Z0; hsa:51393; Q9Y5S1; Q9Y670,ENSG00000187688,TRP channels,,1,0,,,,83.8,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,,0,,109.06,2.65,transporter activity,0,
Master Protein,High,O00217,NDUFS8,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS8 PE=1 SV=1",1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,4.32E+05,,,1.04E+06,1,,,1,,,,4.32E+05,,,,,,,,,,,,,,,,1.04E+06,,,,4.32E+05,,,,,,,,,,,,,,,,1.11E+04,0,FALSE,4.827,9,1,210,23.7,6.34,1,cell organization and biogenesis;other metabolic processes;stress response;transport,other membranes;mitochondrion,Pf12838,4728,B2RB86; hsa:4728; O00217; Q0VDA8,ENSG00000110717,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,5,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,,,,3.08,transporter activity;other molecular function,0,
Master Protein,High,Q6PCB7,SLC27A1,Long-chain fatty acid transport protein 1 OS=Homo sapiens OX=9606 GN=SLC27A1 PE=1 SV=1,2,3,100,0.862,,100,6.64,-0.21,,6.64,1.00E-17,7.73E-01,,1.00E-17,1.69E+05,,1.95E+05,,2,,4,,,,2.35E+05,1.22E+05,,,,,,,3.36E+05,1.41E+05,2.70E+05,7.49E+04,,,,,,,,,2.30E+03,1.22E+05,,,,,,,2.01E+03,6.30E+03,2.19E+03,1.01E+04,,,,,,,0,FALSE,12.358,6,2,646,71.1,8.53,2,other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi,"Pf00501, Pf13193",376497,A6NIH2; B7Z662; hsa:376497; Q6PCB7,ENSG00000130304,PPARA activates gene expression; Transport of fatty acids,PPAR-alpha pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Fatty acids and lipoproteins transport in hepatocytes,6,0,44.89,,57.8,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,99.02,,,9.18,transporter activity;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q15067,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens OX=9606 GN=ACOX1 PE=1 SV=3,7,11,100,0.895,100,0.367,6.64,-0.16,6.64,-1.44,1.00E-17,7.82E-01,1.00E-17,5.31E-01,1.79E+05,,9.03E+04,2.34E+05,2,,4,2,,,,4.14E+05,7.76E+04,,,,,,2.69E+04,,1.28E+05,9.94E+05,6.37E+04,,7.33E+04,,7.50E+05,,,,,4.14E+05,4.00E+03,,,,,,1.61E+02,,1.04E+03,1.34E+05,1.58E+03,,2.06E+04,,1.76E+04,,0,FALSE,20.153,18,7,660,74.4,8.16,7,cell organization and biogenesis;other metabolic processes;other biological processes,other membranes;cytosol;other cytoplasmic organelle,"Pf01756, Pf02770, Pf14749",51,A8K6X8; A8KAA0; B4DK61; F5GYQ8; hsa:51; Q12863; Q15067; Q15068; Q15101; Q16131; Q7Z3W5; Q9UD31,ENSG00000161533,TYSND1 cleaves peroxisomal proteins,Estrogen receptor pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX); Omega-3 / omega-6 fatty acid synthesis,8,0,96.74,,152.57,116.25,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,89.79,,47.46,28.77,other molecular function,0,
Master Protein,High,P15927,RPA2,Replication protein A 32 kDa subunit OS=Homo sapiens OX=9606 GN=RPA2 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,9.26E+05,,,,2,,,,1.65E+06,,,5.21E+05,,,,,,,,,,,,,,,,,6.55E+03,,,5.21E+05,,,,,,,,,,,,,,,,,0,FALSE,4.93,10,1,270,29.2,6.15,1,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,Pf08784,6118,hsa:6118; P15927; Q52II0; Q5TEI9; Q5TEJ5,ENSG00000117748,Fanconi Anemia Pathway; Regulation of HSF1-mediated heat shock response; Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Meiotic recombination; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; HSF1 activation; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Removal of the Flap Intermediate; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER; Removal of the Flap Intermediate from the C-strand; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),"miRNA regulation of DNA damage response; Retinoblastoma gene in cancer; G1 to S cell cycle control; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair; DNA damage response",38,0,73.5,,,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8J9C4H3,GOLGB1,Golgin B1 OS=Homo sapiens OX=9606 GN=GOLGB1 PE=1 SV=1,2,2,100,0.719,100,0.912,6.64,-0.48,6.64,-0.13,1.00E-17,9.18E-01,1.00E-17,9.33E-01,2.92E+04,,2.10E+04,2.30E+04,1,,3,1,,,,2.92E+04,,,,,,,5.56E+04,1.20E+04,,2.10E+04,,,,,2.30E+04,,,,,2.92E+04,,,,,,,3.32E+02,5.34E+02,,2.83E+03,,,,,5.38E+02,,0,FALSE,10.431,1,2,3264,376.3,5,2,cell cycle OR cell proliferation;other biological processes,other membranes;ER/Golgi,,,A0A8J9C4H3,ENSG00000173230,,,0,0,,,78.05,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,92.31,,92.31,7.65,nucleic acid binding activity,0,
Master Protein,High,G5E975,SMARCB1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 OS=Homo sapiens OX=9606 GN=SMARCB1 PE=1 SV=1,2,3,100,0.264,,100,6.64,-1.92,,6.64,1.00E-17,2.15E-01,,1.00E-17,5.14E+05,,2.32E+05,,1,,3,,,,,5.14E+05,,,,,,,,2.32E+05,,2.68E+05,3.89E+04,,,,,,,,,5.14E+05,,,,,,,,1.04E+04,,3.61E+04,9.67E+02,,,,,,0,FALSE,8.344,13,2,394,45,5.76,2,cell organization and biogenesis,nucleus;other cell component,"Pf04855, Pf21459",6598,G5E975,ENSG00000099956; ENSG00000275837,,Tumor suppressor activity of SMARCB1; Thermogenesis; Modulators of TCR signaling and T cell activation; DYRK1A involvement regarding cell proliferation in brain development; Kleefstra syndrome; 10q11.21q11.23 copy number variation syndrome,6,0,,,68.56,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,168.92,,,10.31,nucleic acid binding activity,0,
Master Protein,High,Q92930,RAB8B,Ras-related protein Rab-8B OS=Homo sapiens OX=9606 GN=RAB8B PE=1 SV=2,6,62,100,2.191,100,2.286,6.64,1.13,6.64,1.19,1.00E-17,5.24E-02,1.00E-17,3.42E-01,6.84E+05,,1.50E+06,6.19E+05,1,,4,2,,,,6.84E+05,,,,,,,,1.11E+06,1.55E+06,1.81E+06,1.45E+06,,2.24E+05,,1.71E+06,,,,,6.84E+05,,,,,,,,4.96E+04,1.26E+04,2.43E+05,3.60E+04,,6.29E+04,,4.01E+04,,0,FALSE,20.289,28,2,207,23.6,9.07,6,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,51762,hsa:51762; Q5JPC4; Q92930; Q9P293,ENSG00000166128,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; TBC/RABGAPs,Ectoderm differentiation; Ectoderm differentiation,5,0,,,19.47,108.76,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,High,n/a,High,High,High,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,17.75,,139.85,139.9,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q92620,DHX38,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Homo sapiens OX=9606 GN=DHX38 PE=1 SV=2,2,4,100,2.142,100,1.742,6.64,1.1,6.64,0.8,1.00E-17,2.47E-01,1.00E-17,5.71E-01,5.13E+04,,1.10E+05,6.31E+04,1,,1,1,,,,5.13E+04,,,,,,,1.10E+05,,,,,,,,,6.31E+04,,,,5.13E+04,,,,,,,6.57E+02,,,,,,,,,6.72E+02,0,FALSE,6.462,2,2,1227,140.4,6.54,2,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00270, Pf00271, Pf04408, Pf07717, Pf21010",9785,B4DVG8; D3DWS7; hsa:9785; O75212; Q92620; Q96HN7,ENSG00000140829,mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,mRNA processing,5,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,0,,0,12.11,other molecular function,0,
Master Protein,High,P53701,HCCS,Holocytochrome c-type synthase OS=Homo sapiens OX=9606 GN=HCCS PE=1 SV=1,1,6,100,1.207,100,3.206,6.64,0.27,6.64,1.68,1.00E-17,5.76E-01,1.00E-17,2.04E-01,8.56E+04,,7.40E+04,3.90E+04,4,,3,4,8.76E+04,,8.37E+04,2.44E+05,2.97E+04,,,,,,,4.89E+04,,4.11E+05,7.40E+04,,6.95E+03,8.09E+04,1.88E+04,3.52E+05,3.48E+02,,8.18E+02,2.44E+05,1.53E+03,,,,,,,2.19E+03,,5.54E+04,1.84E+03,,1.95E+03,5.74E+02,4.39E+02,3.74E+03,0,FALSE,7.991,6,1,268,30.6,6.68,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,other membranes;cytosol;mitochondrion,Pf01265,3052,B3KUS1; hsa:3052; P53701; Q502X8,ENSG00000004961,,,0,0,83.01,,113.64,140.82,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,95.31,,129.41,19.68,other molecular function,0,
Master Protein,High,P80217,IFI35,Interferon-induced 35 kDa protein OS=Homo sapiens OX=9606 GN=IFI35 PE=1 SV=5,1,1,100,1.217,100,1.543,6.64,0.28,6.64,0.63,1.00E-17,5.42E-01,1.00E-17,5.60E-01,5.04E+04,,6.14E+04,3.98E+04,1,,5,1,,,,5.04E+04,,,,,,,2.92E+05,9.78E+03,6.14E+04,4.42E+04,1.03E+05,,,,3.98E+04,,,,,5.04E+04,,,,,,,1.75E+03,4.37E+02,4.99E+02,5.96E+03,2.57E+03,,,,9.31E+02,,0.002,FALSE,2.973,6,1,286,31.5,6.09,1,stress response;other biological processes,non-structural extracellular;other membranes;cytosol;nucleus;other cell component,"Pf07292, Pf07334",3430,C9JGX1; hsa:3430; P80217; Q92984; Q99537; Q9BV98,ENSG00000068079,Interferon alpha/beta signaling,Immune response to tuberculosis,2,0,,,109.01,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,101.42,,101.42,2.82,other molecular function,0,
Master Protein,High,Q8NDT2,RBM15B,Putative RNA-binding protein 15B OS=Homo sapiens OX=9606 GN=RBM15B PE=1 SV=3,2,3,100,1.303,,100,6.64,0.38,,6.64,1.00E-17,5.03E-01,,1.00E-17,4.81E+04,,3.60E+04,,2,,4,,,,,9.94E+04,2.32E+04,,,,,,,3.88E+04,3.35E+04,1.64E+05,2.74E+04,,,,,,,,,9.94E+04,1.20E+03,,,,,,,1.73E+03,2.72E+02,2.21E+04,6.80E+02,,,,,,0,FALSE,12.783,4,2,890,97.1,9.85,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,nucleus;other cell component,"Pf00076, Pf07744",29890,A4QPG7; hsa:29890; Q6QE19; Q8NDT2; Q9BV96,ENSG00000259956,,,0,0,87.82,,99.43,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,72.68,,,11.12,nucleic acid binding activity,0,
Master Protein,High,A0A8Q3SHN7,LARP7,La-related protein 7 OS=Homo sapiens OX=9606 GN=LARP7 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.99E+04,,,,1,,,,,,,3.99E+04,,,,,,,,,,,,,,,,,,,,3.99E+04,,,,,,,,,,,,,,,,,0.002,FALSE,2.965,2,1,595,68.4,9.51,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00076, Pf05383, Pf08777",,A0A8Q3SHN7,ENSG00000174720,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.56,nucleic acid binding activity,0,
Master Protein,High,Q9UIB8,CD84,SLAM family member 5 OS=Homo sapiens OX=9606 GN=CD84 PE=1 SV=1,1,2,100,0.246,100,0.614,6.64,-2.02,6.64,-0.7,1.00E-17,2.24E-01,1.00E-17,8.26E-01,3.09E+05,,7.60E+04,1.24E+05,2,,2,2,1.46E+05,,6.51E+05,,,,,,,,3.19E+05,1.81E+04,,,,,9.79E+04,,1.56E+05,,5.81E+02,,6.36E+03,,,,,,,,1.91E+03,8.09E+02,,,,,2.75E+04,,3.66E+03,,0.002,FALSE,2.961,5,1,345,38.8,7.06,1,cell adhesion;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;other cell component,Pf13927,8832,B2R8T1; B7Z3R8; hsa:8832; O15430; O95266; O95660; Q5H9R1; Q6FHA8; Q8WLP1; Q8WWI8; Q9UF04; Q9UIB6; Q9UIB7; Q9UIB8; Q9UIT7,ENSG00000066294,Cell surface interactions at the vascular wall,TYROBP causal network in microglia,2,0,89.54,,126.21,32.49,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,138.98,,232.06,5.98,other molecular function,0,
Master Protein,High,H0Y9X1,TMA16,Translation machinery-associated protein 16 (Fragment) OS=Homo sapiens OX=9606 GN=TMA16 PE=1 SV=1,2,6,100,0.856,,100,6.64,-0.22,,6.64,1.00E-17,7.95E-01,,1.00E-17,4.36E+05,,3.22E+05,,5,,4,,3.12E+05,2.50E+05,6.08E+06,8.31E+05,4.36E+05,,,,,,1.49E+05,3.69E+05,,1.52E+06,2.80E+05,,,,,,1.24E+03,9.50E+02,5.94E+04,8.31E+05,2.25E+04,,,,,,8.92E+02,1.65E+04,,2.05E+05,6.96E+03,,,,,,0,FALSE,8.557,11,2,242,27.7,9.57,2,,nucleus,Pf11176,,H0Y9X1,ENSG00000198498,,,0,0,159.58,,109.3,,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,102.4,,,17.39,,0,
Master Protein,High,Q9UJW0,DCTN4,Dynactin subunit 4 OS=Homo sapiens OX=9606 GN=DCTN4 PE=1 SV=1,1,2,100,0.265,100,0.514,6.64,-1.91,6.64,-0.96,1.00E-17,3.56E-01,1.00E-17,7.15E-01,4.64E+04,,1.23E+04,2.40E+04,2,,1,3,,,,1.76E+04,1.23E+05,,,,,,,,,1.23E+04,,,1.06E+04,,2.40E+04,1.06E+05,,,,1.76E+04,6.32E+03,,,,,,,,,1.66E+03,,,2.98E+03,,5.61E+02,1.13E+03,0,FALSE,5.417,4,1,460,52.3,7.34,1,,cytosol;cytoskeleton;nucleus;other cell component,Pf05502,51164,B3KWW0; D3DQH0; E5RGT5; hsa:51164; Q8TAN8; Q9UJW0,ENSG00000132912,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic,Vasopressin-regulated water reabsorption,5,0,105.95,,,110.19,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,,167.69,,82.56,6,,0,
Master Protein,High,Q03701,CEBPZ,CCAAT/enhancer-binding protein zeta OS=Homo sapiens OX=9606 GN=CEBPZ PE=1 SV=3,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.47E+05,,,,1,,,,,,,1.47E+05,,,,,,,,,,,,,,,,,,,,1.47E+05,,,,,,,,,,,,,,,,,0,FALSE,6.35,2,2,1054,120.9,5.94,2,other biological processes,nucleus,Pf03914,10153,hsa:10153; Q03701; Q8NE75,ENSG00000115816,,Gastric cancer network 2,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.42,other molecular function,0,
Master Protein,High,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.89E+05,,,5.11E+05,2,,,1,,,,1.79E+05,2.00E+05,,,,,,,,,,,,,,,5.11E+05,,,,1.79E+05,1.03E+04,,,,,,,,,,,,,,,5.44E+03,0,FALSE,5.127,1,1,1649,178.6,8.95,1,protein metabolism;other metabolic processes,,"Pf00628, Pf13639",57661,A6H8W1; B7ZM64; B9EGP0; C9JS82; hsa:57661; Q6PJP2; Q8IVY2; Q8N2Y7; Q9BSM2; Q9P1Y6,ENSG00000070047; ENSG00000274780,,,0,0,7.8,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,,,,3.05,other molecular function,0,
Master Protein,High,Q96T51,RUFY1,RUN and FYVE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RUFY1 PE=1 SV=2,4,8,100,0.957,100,0.799,6.64,-0.06,6.64,-0.32,1.00E-17,6.66E-01,1.00E-17,9.73E-01,4.58E+05,,1.32E+05,2.43E+05,1,,3,2,,,,4.58E+05,,,,,,,,1.32E+05,,4.06E+05,1.30E+05,,5.05E+05,,1.17E+05,,,,,4.58E+05,,,,,,,,5.89E+03,,5.47E+04,3.23E+03,,1.42E+05,,2.75E+03,,0,FALSE,18.493,11,4,708,79.8,5.74,4,transport;signal transduction;other biological processes,other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf01363, Pf02759",80230,hsa:80230; Q59FF3; Q71S93; Q96T51; Q9H6I3,ENSG00000176783; ENSG00000284260,Synthesis of PIPs at the plasma membrane,,1,0,,,71.35,88.08,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,75.06,,76.18,28.88,other molecular function,0,
Master Protein,High,Q9BWJ5,SF3B5,Splicing factor 3B subunit 5 OS=Homo sapiens OX=9606 GN=SF3B5 PE=1 SV=1,1,1,100,0.147,,100,6.64,-2.77,,6.64,1.00E-17,1.35E-01,,1.00E-17,3.59E+04,,5.27E+03,,3,,1,,,,3.31E+04,5.67E+04,3.59E+04,,,,,,,,,5.27E+03,,,,,,,,,3.23E+02,5.67E+04,1.85E+03,,,,,,,,,7.10E+02,,,,,,,0.009,FALSE,2.329,13,1,86,10.1,6.35,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf07189,83443,B2R568; hsa:83443; Q7RTV1; Q9BWJ5,ENSG00000169976,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing,3,0,30.87,,,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,11.64,,,2.28,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15293,RCN1,Reticulocalbin-1 OS=Homo sapiens OX=9606 GN=RCN1 PE=1 SV=1,2,4,100,0.81,100,2.104,6.64,-0.3,6.64,1.07,1.00E-17,8.82E-01,1.00E-17,3.48E-01,4.55E+05,,3.68E+05,1.75E+05,2,,2,1,,,,1.62E+05,1.28E+06,,,,,,,4.77E+05,,,2.84E+05,,,,1.75E+05,,,,,1.62E+05,6.60E+04,,,,,,,2.13E+04,,,7.07E+03,,,,4.10E+03,,0,FALSE,8.747,14,2,331,38.9,5,2,developmental processes,ER/Golgi,Pf13202,5954,B7Z1M1; D3DR00; hsa:5954; Q15293,ENSG00000049449,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,VEGFA-VEGFR2 signaling,3,0,109.73,,35.79,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,140.77,,38.78,14.35,other molecular function,0,
Master Protein,High,E9PAU2,RAVER1,"Ribonucleoprotein, PTB binding 1 OS=Homo sapiens OX=9606 GN=RAVER1 PE=1 SV=1",6,11,100,0.772,100,2.482,6.64,-0.37,6.64,1.31,1.00E-17,8.03E-01,1.00E-17,3.06E-01,2.53E+06,,3.62E+05,1.06E+05,5,,5,2,3.00E+06,8.90E+05,2.79E+06,2.50E+06,2.53E+06,,,,,,2.70E+06,7.96E+05,6.62E+04,3.62E+05,1.88E+05,,2.72E+05,,4.15E+04,,1.19E+04,3.38E+03,2.72E+04,2.50E+06,1.31E+05,,,,,,1.62E+04,3.56E+04,5.38E+02,4.88E+04,4.66E+03,,7.63E+04,,9.71E+02,,0,FALSE,24.674,13,6,756,79.5,8.92,6,,other cell component,Pf00076,100979766; 101057136,A0A2R8ZDL0; H2QFB5; K7DLH7; pps:100979766; ptr:101057136,ENSPPAG00000002611; ENSPTRG00000010466,,,0,0,35.71,,132.06,103.93,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,High,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,113.13,,58.84,34.77,nucleic acid binding activity,0,
Master Protein,Medium,Q05823,RNASEL,2-5A-dependent ribonuclease OS=Homo sapiens OX=9606 GN=RNASEL PE=1 SV=2,1,1,100,0.1,100,0.166,6.64,-3.33,6.64,-2.59,1.00E-17,5.47E-02,1.00E-17,1.99E-01,5.43E+04,,1.35E+04,8.11E+04,5,,3,1,1.30E+06,5.43E+04,6.60E+05,3.97E+04,5.31E+04,,,,,,4.37E+04,1.35E+04,,5.29E+03,,8.11E+04,,,,,5.16E+03,2.06E+02,6.45E+03,3.97E+04,2.74E+03,,,,,,2.61E+02,6.03E+02,,7.12E+02,,1.58E+02,,,,,0.01,FALSE,2.283,1,1,741,83.5,6.65,1,protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;mitochondrion;nucleus,"Pf00023, Pf00069, Pf06479",6041,hsa:6041; Q05823; Q5W0L2; Q6AI46,ENSG00000135828,OAS antiviral response; Interferon alpha/beta signaling,,2,0,132.37,,97.08,,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,129.91,,102.42,2.13,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,B4DEE8,MGMT,Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens OX=9606 GN=MGMT PE=1 SV=1,1,5,100,1.094,100,17.042,6.64,0.13,6.64,4.09,1.00E-17,5.39E-01,1.00E-17,1.11E-02,1.99E+05,,2.14E+05,1.25E+04,2,,3,2,,,,4.48E+05,8.87E+04,,,,,,,2.14E+05,,6.45E+05,7.37E+04,,8.27E+03,,1.90E+04,,,,,4.48E+05,4.58E+03,,,,,,,9.55E+03,,8.69E+04,1.83E+03,,2.32E+03,,4.45E+02,,0,FALSE,7.86,8,1,238,25,8.66,1,DNA metabolism;other metabolic processes;stress response,nucleus,"Pf01035, Pf02870",4255,B4DEE8,ENSG00000170430,,"Direct reversal repair; DNA repair pathways, full network; p53 transcriptional gene network",3,0,94.65,,95.77,55.74,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,104.74,,95.6,20.2,other molecular function,0,
Master Protein,High,Q96JP5,ZFP91,E3 ubiquitin-protein ligase ZFP91 OS=Homo sapiens OX=9606 GN=ZFP91 PE=1 SV=1,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.13E+05,,,,1,,,,,,,1.13E+05,,,,,,,,,,,,,,,,,,,,1.13E+05,,,,,,,,,,,,,,,,,0,FALSE,14.173,8,2,570,63.4,7.36,2,protein metabolism;other metabolic processes;signal transduction;other biological processes,nucleus,Pf00096,80829,A6NHC4; A8MSG7; Q86V47; Q96JP4; Q96JP5; Q96QA3,ENSG00000186660,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,8.54,other molecular function,0,
Master Protein,High,Q8WXI9,GATAD2B,Transcriptional repressor p66-beta OS=Homo sapiens OX=9606 GN=GATAD2B PE=1 SV=1,5,10,100,0.402,100,0.033,6.64,-1.31,6.64,-4.91,1.00E-17,4.62E-01,1.00E-17,4.79E-03,4.16E+05,,6.29E+05,1.34E+06,3,,5,2,,,6.70E+04,1.81E+06,4.16E+05,,,,,,1.71E+05,7.96E+05,1.15E+05,6.29E+05,7.28E+05,5.78E+05,,3.12E+06,,,,,6.55E+02,1.81E+06,2.14E+04,,,,,,1.02E+03,3.56E+04,9.36E+02,8.48E+04,1.81E+04,1.13E+03,,2.21E+04,,,0,FALSE,35.055,15,5,593,65.2,9.7,5,cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf00320, Pf16563",57459,D3DUZ2; hsa:57459; Q5VUR2; Q7LG68; Q8WXI9; Q9ULS0,ENSG00000143614; ENSG00000261992,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,,6,0,120.75,,65.81,97.13,n/a,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,,48.67,,140.09,35.16,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O15235,MRPS12,"28S ribosomal protein S12, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS12 PE=1 SV=1",1,1,100,0.326,,100,6.64,-1.62,,6.64,1.00E-17,3.54E-01,,1.00E-17,2.41E+05,,7.87E+04,,1,,1,,,,,2.41E+05,,,,,,,,,,,7.87E+04,,,,,,,,,2.41E+05,,,,,,,,,,,1.96E+03,,,,,,0,FALSE,4.647,18,1,138,15.2,10.29,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf00164,6183,hsa:6183; O15235; Q53X98,ENSG00000128626; ENSG00000283018,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.9,other molecular function,0,
Master Protein,High,A0A494BZV2,MPRIP,Myosin phosphatase Rho interacting protein OS=Homo sapiens OX=9606 GN=MPRIP PE=1 SV=1,1,1,100,1.046,,100,6.64,0.06,,6.64,1.00E-17,6.29E-01,,1.00E-17,1.42E+05,,1.49E+05,,1,,4,,,,,1.42E+05,,,,,,,,9.80E+04,1.45E+05,1.53E+05,2.64E+05,,,,,,,,,1.42E+05,,,,,,,,4.38E+03,1.18E+03,2.06E+04,6.56E+03,,,,,,0,FALSE,4.56,1,1,2425,274.2,5.6,1,,cytosol;cytoskeleton,Pf00169,,A0A494BZV2,ENSG00000133030,,Smith-Magenis and Potocki-Lupski syndrome copy number variation,1,0,,,42.68,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,27.33,,,2.63,,0,
Master Protein,High,Q9BS16,CENPK,Centromere protein K OS=Homo sapiens OX=9606 GN=CENPK PE=1 SV=1,1,3,100,0.423,100,0.986,6.64,-1.24,6.64,-0.02,1.00E-17,4.97E-01,1.00E-17,8.62E-01,5.75E+05,,2.43E+05,2.45E+05,3,,3,2,5.75E+05,1.15E+06,,8.11E+04,,,,,,,,,2.65E+05,2.43E+05,2.20E+05,3.36E+05,,,1.78E+05,,2.28E+03,4.38E+03,,8.11E+04,,,,,,,,,2.15E+03,3.27E+04,5.47E+03,6.56E+02,,,4.17E+03,,0.008,FALSE,2.348,7,1,269,31.6,4.89,1,cell cycle OR cell proliferation;cell organization and biogenesis,cytosol;nucleus;other cell component,Pf11802,64105,hsa:64105; Q9BS16; Q9H4L0,ENSG00000123219,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Deposition of new CENPA-containing nucleosomes at the centromere; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,7,0,88.95,,9.14,43.53,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,,125.18,,45.48,5.08,,0,
Master Protein,Medium,Q8N573,OXR1,Oxidation resistance protein 1 OS=Homo sapiens OX=9606 GN=OXR1 PE=1 SV=2,1,1,100,1.258,,100,6.64,0.33,,6.64,1.00E-17,4.46E-01,,1.00E-17,2.06E+05,,2.59E+05,,2,,1,,,,,1.18E+05,3.61E+05,,,,,,,,,2.59E+05,,,,,,,,,,1.18E+05,1.86E+04,,,,,,,,,3.49E+04,,,,,,,0.019,FALSE,2.013,2,1,874,97.9,5.47,1,stress response;other biological processes,mitochondrion;nucleus,"Pf01476, Pf07534",55074,A6NK11; A8KA34; B3KXL1; B7Z402; B7Z8N5; D3HIS6; hsa:55074; Q3LIB5; Q6ZVK9; Q8N573; Q8N8V0; Q9H266; Q9NWC7,ENSG00000164830,,,0,0,71.98,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,Phospho [T228; S230],FALSE,,87.66,,,3.07,other molecular function,2,Phospho [T228; S230]
Master Protein,High,Q92575,UBXN4,UBX domain-containing protein 4 OS=Homo sapiens OX=9606 GN=UBXN4 PE=1 SV=2,2,5,100,0.718,100,1.657,6.64,-0.48,6.64,0.73,1.00E-17,9.99E-01,1.00E-17,4.52E-01,2.55E+05,,5.50E+05,3.89E+04,2,,5,1,,,,5.68E+05,1.14E+05,,,,,,5.76E+05,8.22E+05,2.59E+05,4.57E+05,5.50E+05,,3.89E+04,,,,,,,5.68E+05,5.90E+03,,,,,,3.45E+03,3.67E+04,2.11E+03,6.15E+04,1.37E+04,,1.09E+04,,,,0,FALSE,10.723,11,2,508,56.7,6.38,2,stress response,other membranes;cytosol;ER/Golgi;nucleus,Pf00789,23190,A8K9W4; hsa:23190; Q4ZG56; Q8IYM5; Q92575,ENSG00000144224,,,0,0,94.03,,38.31,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,56.04,,81.28,14.52,,0,
Master Protein,High,O95747,OXSR1,Serine/threonine-protein kinase OSR1 OS=Homo sapiens OX=9606 GN=OXSR1 PE=1 SV=1,1,6,100,0.265,100,0.71,6.64,-1.91,6.64,-0.49,1.00E-17,2.31E-01,1.00E-17,9.20E-01,4.28E+05,,7.81E+04,1.76E+05,4,,3,2,4.89E+05,,9.60E+05,3.74E+05,3.74E+04,,,,,,3.24E+05,7.81E+04,,,4.80E+04,,4.79E+05,6.43E+04,,,1.94E+03,,9.38E+03,3.74E+05,1.93E+03,,,,,,1.94E+03,3.49E+03,,,1.19E+03,,1.35E+05,4.56E+02,,,0.005,FALSE,2.526,2,1,527,58,6.43,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,cytosol;other cell component,"Pf00069, Pf12202",9943,hsa:9943; O95747; Q3LR53; Q7Z501; Q9UPQ1,ENSG00000172939,,,0,0,81.99,,100.88,107.98,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,123.54,,94.49,5.55,kinase activity;other molecular function,0,
Master Protein,High,P36954,POLR2I,DNA-directed RNA polymerase II subunit RPB9 OS=Homo sapiens OX=9606 GN=POLR2I PE=1 SV=1,1,6,100,0.808,,100,6.64,-0.31,,6.64,1.00E-17,6.94E-01,,1.00E-17,1.10E+06,,8.88E+05,,2,,2,,,,2.20E+06,5.49E+05,,,,,,,,,,8.82E+05,8.93E+05,,,,,,,,2.15E+04,5.49E+05,,,,,,,,,,1.19E+05,2.22E+04,,,,,,0,FALSE,9.51,18,1,125,14.5,5.14,1,DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response,nucleus,"Pf01096, Pf02150",5438,B2R5J2; hsa:5438; P36954; Q6NW05,ENSG00000105258,Processing of Capped Intron-Containing Pre-mRNA; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,Pyrimidine metabolism; Eukaryotic transcription initiation,43,0,84.9,,0.86,,High,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,110.62,,,21.96,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O14976,GAK,Cyclin-G-associated kinase OS=Homo sapiens OX=9606 GN=GAK PE=1 SV=2,2,4,100,0.316,,100,6.64,-1.66,,6.64,1.00E-17,3.60E-01,,1.00E-17,2.04E+05,,1.72E+04,,1,,1,,,,,2.04E+05,,,,,,,,1.72E+04,,,,,,,,,,,,2.04E+05,,,,,,,,7.67E+02,,,,,,,,,0,FALSE,11.87,3,2,1311,143.1,5.73,2,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,cytosol;ER/Golgi;other cell component,"Pf00069, Pf10409",2580,hsa:2580; O14976; Q5U4P5; Q9BVY6,ENSG00000178950,Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,,13.1,kinase activity;other molecular function,0,
Master Protein,High,Q14258,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25 OS=Homo sapiens OX=9606 GN=TRIM25 PE=1 SV=2,3,3,100,0.561,100,0.886,6.64,-0.83,6.64,-0.17,1.00E-17,8.27E-01,1.00E-17,9.37E-01,3.08E+05,,1.36E+05,3.53E+05,3,,3,2,2.44E+06,,3.08E+05,2.20E+05,,,,,,,,1.30E+05,,2.59E+05,1.36E+05,,2.30E+05,,5.43E+05,,9.68E+03,,3.01E+03,2.20E+05,,,,,,,,5.83E+03,,3.49E+04,3.37E+03,,6.46E+04,,1.27E+04,,0,FALSE,10.716,8,3,630,70.9,8.09,3,protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00622, Pf13445, Pf13765",7706,hsa:7706; Q14258,ENSG00000121060,Interferon gamma signaling; RSV-host interactions; PKR-mediated signaling; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Termination of translesion DNA synthesis; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses; Ovarian tumor domain proteases; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Evasion by RSV of host interferon responses,Novel intracellular components of RIG-I-like receptor pathway; Cytosolic DNA-sensing pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response; 1p36 copy number variation syndrome,19,0,127.03,,41.54,57.3,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,85.1,,43.96,10.01,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P09486,SPARC,SPARC OS=Homo sapiens OX=9606 GN=SPARC PE=1 SV=1,1,2,100,0.237,100,0.332,6.64,-2.08,6.64,-1.59,1.00E-17,1.50E-01,1.00E-17,3.91E-01,8.40E+05,,1.99E+05,5.98E+05,3,,3,1,6.59E+06,3.02E+05,8.40E+05,,,,,,,,3.61E+05,,,1.63E+05,1.99E+05,,5.98E+05,,,,2.62E+04,1.15E+03,8.20E+03,,,,,,,,2.16E+03,,,2.20E+04,4.94E+03,,1.68E+05,,,,0.002,FALSE,2.99,6,1,303,34.6,4.84,1,other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;nucleus;other cell component,"Pf00050, Pf09289, Pf10591",6678,D3DQH9; hsa:6678; P09486; Q6IBK4,ENSG00000113140,ECM proteoglycans; Platelet degranulation ; Nuclear signaling by ERBB4; Scavenging by Class H Receptors,miR-509-3p alteration of YAP1/ECM axis; Epithelial to mesenchymal transition in colorectal cancer; Burn wound healing; Pleural mesothelioma,8,0,135.24,,43.73,,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,95,,32.37,6.11,other molecular function,0,
Master Protein,High,Q9BRZ2,TRIM56,E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3,2,5,100,0.364,100,0.328,6.64,-1.46,6.64,-1.61,1.00E-17,4.67E-01,1.00E-17,4.69E-01,3.70E+05,,3.20E+04,2.83E+05,3,,5,2,,1.18E+06,,2.21E+05,3.70E+05,,,,,,7.16E+04,1.34E+04,3.20E+04,1.95E+05,2.62E+04,9.05E+05,8.83E+04,,,,,4.49E+03,,2.21E+05,1.91E+04,,,,,,4.28E+02,5.99E+02,2.60E+02,2.62E+04,6.52E+02,1.77E+03,2.48E+04,,,,0,FALSE,15.249,5,2,755,81.4,7.74,2,protein metabolism;other metabolic processes;stress response;other biological processes,cytosol;other cell component,"Pf00643, Pf13445",81844,hsa:81844; Q6PJS5; Q86VT6; Q8N2H8; Q8NAC0; Q9BRZ2; Q9H031,ENSG00000169871,Regulation of innate immune responses to cytosolic DNA,,1,0,87.51,,109.96,116.28,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,78.65,,84.06,19.84,other molecular function,0,
Master Protein,High,Q9ULL5,PRR12,Proline-rich protein 12 OS=Homo sapiens OX=9606 GN=PRR12 PE=1 SV=3,3,4,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.63E+05,,,,1,,,,,,,1.63E+05,,,,,,,,,,,,,,,,,,,,1.63E+05,,,,,,,,,,,,,,,,,0,FALSE,19.161,4,3,2036,210.9,7.87,3,,nucleus;other cell component,Pf13926,57479,E9PB06; hsa:57479; Q8N4J6; Q9ULL5,ENSG00000126464,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,15.92,,0,
Master Protein,High,Q8N8A6,DDX51,ATP-dependent RNA helicase DDX51 OS=Homo sapiens OX=9606 GN=DDX51 PE=1 SV=3,1,1,100,0.564,100,1.005,6.64,-0.83,6.64,0.01,1.00E-17,8.16E-01,1.00E-17,8.65E-01,1.31E+05,,7.36E+04,7.32E+04,1,,1,1,,,,1.31E+05,,,,,,,,,,7.36E+04,,,7.32E+04,,,,,,,1.31E+05,,,,,,,,,,9.92E+03,,,2.06E+04,,,,0.006,FALSE,2.443,3,1,666,72.4,8.16,1,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00270, Pf00271",317781,A8MPT9; hsa:317781; Q5CZ71; Q8IXK5; Q8N8A6; Q96ED1,ENSG00000185163; ENSG00000288503,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,0,,0,3.34,other molecular function,0,
Master Protein,High,Q9Y3I1,FBXO7,F-box only protein 7 OS=Homo sapiens OX=9606 GN=FBXO7 PE=1 SV=1,1,3,100,0.15,100,1.012,6.64,-2.74,6.64,0.02,1.00E-17,4.61E-02,1.00E-17,8.82E-01,6.08E+05,,9.09E+04,8.98E+04,2,,2,1,1.20E+06,,3.08E+05,,,,,,,,,,9.40E+04,,8.79E+04,,8.98E+04,,,,4.76E+03,,3.01E+03,,,,,,,,,,7.64E+02,,2.18E+03,,2.52E+04,,,,0.001,FALSE,3.519,3,1,522,58.5,6.55,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;mitochondrion;nucleus;other cell component,"Pf00646, Pf11566",25793,B4DNB3; B4DWX5; hsa:25793; Q5TGC4; Q5TI86; Q96HM6; Q9UF21; Q9UKT2; Q9Y3I1,ENSG00000100225,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation,,2,0,83.49,,4.73,,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,104.88,,4.96,8.76,other molecular function,0,
Master Protein,High,Q9NTM9,CUTC,Copper homeostasis protein cutC homolog OS=Homo sapiens OX=9606 GN=CUTC PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,2.17E+05,,,,1,,,,,,,2.17E+05,,,,,,,,,,,,,,,,,,,,2.17E+05,,,,,,,,,,,,,,,,,0,FALSE,4.547,10,1,273,29.3,8.18,1,cell organization and biogenesis;transport;other biological processes,cytosol;nucleus;other cell component,Pf03932,51076,hsa:51076; Q5TCZ8; Q9NTM9; Q9Y321,ENSG00000119929,Ion transport by P-type ATPases,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.25,other molecular function,0,
Master Protein,High,Q9H147,DNTTIP1,Deoxynucleotidyltransferase terminal-interacting protein 1 OS=Homo sapiens OX=9606 GN=DNTTIP1 PE=1 SV=2,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,8.57E+05,,,,2,,,,,,,2.21E+05,3.32E+06,,,,,,,,,,,,,,,,,,,2.21E+05,1.71E+05,,,,,,,,,,,,,,,,0.004,FALSE,2.614,4,1,329,37,8.97,1,,nucleus;other cell component,"Pf18192, Pf21229",116092,B2RA18; hsa:116092; Q96DE3; Q9BQP2; Q9H147; Q9H148,ENSG00000101457,,,0,0,123.77,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.39,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O14562,UBFD1,Ubiquitin domain-containing protein UBFD1 OS=Homo sapiens OX=9606 GN=UBFD1 PE=1 SV=2,1,1,100,0.826,,100,6.64,-0.27,,6.64,1.00E-17,8.12E-01,,1.00E-17,2.26E+04,,1.87E+04,,1,,1,,,,,2.26E+04,,,,,,,,,,1.87E+04,,,,,,,,,,2.26E+04,,,,,,,,,,2.52E+03,,,,,,,0.003,FALSE,2.677,5,1,309,33.4,5.77,1,,,Pf00240,56061,A8MW58; D3DWF2; hsa:56061; O14562,ENSG00000103353,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,2.89,,0,
Master Protein,High,P36969,GPX4,Phospholipid hydroperoxide glutathione peroxidase OS=Homo sapiens OX=9606 GN=GPX4 PE=1 SV=3,1,2,100,2.465,100,0.288,6.64,1.3,6.64,-1.8,1.00E-17,5.08E-02,1.00E-17,3.11E-01,4.29E+05,,1.06E+06,3.67E+06,1,,2,2,,,,4.29E+05,,,,,,,,,1.42E+06,7.88E+05,,,1.48E+06,,9.09E+06,,,,,4.29E+05,,,,,,,,,1.15E+04,1.06E+05,,,4.16E+05,,2.13E+05,,0.001,FALSE,3.468,6,1,197,22.2,8.37,1,cell organization and biogenesis;other metabolic processes;stress response;other biological processes,cytosol;mitochondrion;nucleus;other cell component,Pf00255,2879,hsa:2879; O43381; P36969; Q6PJ59; Q9UPK2,ENSG00000167468,Synthesis of 15-eicosatetraenoic acid derivatives; Synthesis of 12-eicosatetraenoic acid derivatives; Synthesis of 5-eicosatetraenoic acids,"Glutathione metabolism; Selenium micronutrient network; Folate metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Selenium metabolism and selenoproteins; One-carbon metabolism and related pathways; Ferroptosis; Metapathway biotransformation Phase I and II",11,0,,,40.33,101.81,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,44.11,,114.7,4.83,other molecular function,0,
Master Protein,High,Q14814,MEF2D,Myocyte-specific enhancer factor 2D OS=Homo sapiens OX=9606 GN=MEF2D PE=1 SV=1,2,3,100,0.525,,100,6.64,-0.93,,6.64,1.00E-17,7.22E-01,,1.00E-17,6.25E+05,,3.28E+05,,4,,1,,1.71E+05,3.97E+06,,3.00E+05,1.30E+06,,,,,,3.28E+05,,,,,,,,,,6.78E+02,1.51E+04,,3.00E+05,6.72E+04,,,,,,1.96E+03,,,,,,,,,,0.001,FALSE,4.139,4,1,521,55.9,7.88,2,developmental processes;other biological processes,nucleus;other cell component,"Pf00319, Pf12347",4209,D3DVC0; hsa:4209; Q14814; Q14815; Q5T9U5; Q5T9U6,ENSG00000116604; ENSG00000291761,NGF-stimulated transcription; Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; Myogenesis,Energy metabolism; SRF and miRs in smooth muscle differentiation and proliferation; Cell differentiation - expanded index; Cell differentiation - index; B cell receptor signaling pathway; Adipogenesis; p38 MAPK signaling pathway; Epithelial to mesenchymal transition in colorectal cancer; EGF/EGFR signaling pathway; Gastrin signaling pathway; Modulators of TCR signaling and T cell activation; Pleural mesothelioma; Calcium mediated T-cell apoptosis involved in inclusion body myositis,18,0,122.87,,,,Peak Found,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,134.29,,,6.45,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75477,ERLIN1,Erlin-1 OS=Homo sapiens OX=9606 GN=ERLIN1 PE=1 SV=2,3,11,100,9.179,100,,6.64,3.2,6.64,,1.00E-17,5.83E-03,1.00E-17,,2.52E+04,,3.28E+04,1.09E+04,1,,2,1,,,,2.52E+04,,,,,,,,1.10E+04,,,9.74E+04,,1.09E+04,,,,,,,2.52E+04,,,,,,,,4.92E+02,,,2.42E+03,,3.06E+03,,,,0,FALSE,16.424,12,1,348,39.1,7.87,3,other metabolic processes;stress response;signal transduction;other biological processes,other membranes;ER/Golgi;other cell component,Pf01145,10613,B0QZ42; D3DR65; hsa:10613; O75477; Q53HV0,ENSG00000107566,ABC-family proteins mediated transport; Defective CFTR causes cystic fibrosis,,2,0,,,112.67,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,195.46,,,21.94,other molecular function,0,
Master Protein,High,M0QZQ2,MED25,Mediator of RNA polymerase II transcription subunit 25 OS=Homo sapiens OX=9606 GN=MED25 PE=1 SV=3,1,1,100,0.369,,100,6.64,-1.44,,6.64,1.00E-17,5.42E-01,,1.00E-17,5.98E+04,,2.20E+04,,2,,1,,,,,1.31E+05,2.74E+04,,,,,,,2.20E+04,,,,,,,,,,,,1.31E+05,1.41E+03,,,,,,,9.85E+02,,,,,,,,,0,FALSE,6.264,3,1,796,84.5,9.07,1,,nucleus;other cell component,"Pf11232, Pf11235, Pf11265, Pf18658",,M0QZQ2,ENSG00000104973,,,0,0,92.44,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,128.05,,,3.42,,0,
Master Protein,Medium,A0A2R8Y7R8,RNASEH2B,Ribonuclease H2 subunit B OS=Homo sapiens OX=9606 GN=RNASEH2B PE=1 SV=1,1,1,100,1.48,,100,6.64,0.57,,6.64,1.00E-17,3.97E-01,,1.00E-17,2.06E+04,,3.05E+04,,1,,1,,,,,2.06E+04,,,,,,,,,,3.05E+04,,,,,,,,,,2.06E+04,,,,,,,,,,4.11E+03,,,,,,,0.015,FALSE,2.108,6,1,355,40.1,8.88,1,,nucleus;other cell component,"Pf09468, Pf17745",,A0A2R8Y7R8,ENSG00000136104,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.87,,0,
Master Protein,High,Q8IXM6,NRM,Nurim OS=Homo sapiens OX=9606 GN=NRM PE=1 SV=1,1,7,100,1.186,,100,6.64,0.25,,6.64,1.00E-17,4.88E-01,,1.00E-17,3.81E+05,,3.04E+05,,3,,5,,,,4.40E+05,3.81E+05,9.97E+04,,,,,,2.57E+05,5.64E+05,7.21E+04,3.04E+05,5.21E+05,,,,,,,,4.30E+03,3.81E+05,5.14E+03,,,,,,1.54E+03,2.52E+04,5.85E+02,4.10E+04,1.30E+04,,,,,,0.002,FALSE,2.77,8,1,262,29.4,8.63,1,,other membranes;nucleus,,11270,B0S7R0; B0S7R1; hsa:11270; I3XIE2; I3XIE3; Q5JP57; Q5JP58; Q5JP59; Q5JP60; Q8IXM6; Q8WU45; Q9BSX3; Q9UN92,ENSG00000137404; ENSG00000206484; ENSG00000228854; ENSG00000228867; ENSG00000234809; ENSG00000235773; ENSG00000236843,,,0,0,59.23,,58.67,,n/a,n/a,High,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,63.71,,,18.86,,0,
Master Protein,High,Q9NV31,IMP3,U3 small nucleolar ribonucleoprotein protein IMP3 OS=Homo sapiens OX=9606 GN=IMP3 PE=1 SV=1,1,2,100,0.664,,100,6.64,-0.59,,6.64,1.00E-17,9.33E-01,,1.00E-17,4.66E+05,,3.09E+05,,1,,1,,,,,4.66E+05,,,,,,,,,,3.09E+05,,,,,,,,,,4.66E+05,,,,,,,,,,4.17E+04,,,,,,,0.004,FALSE,2.621,8,1,184,21.8,9.5,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,translational apparatus;nucleus;other cell component,"Pf00163, Pf01479",55272,B3KQ67; hsa:55272; Q53G10; Q9NV31,ENSG00000177971,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,IL-18 signaling pathway,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,5.38,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13561,DCTN2,Dynactin subunit 2 OS=Homo sapiens OX=9606 GN=DCTN2 PE=1 SV=4,2,3,100,0.218,100,1.001,6.64,-2.2,6.64,0,1.00E-17,1.33E-01,1.00E-17,8.11E-01,9.25E+05,,2.68E+04,7.21E+04,2,,2,2,5.50E+06,,,1.56E+05,,,,,,,,2.24E+04,,3.20E+04,,,2.33E+05,,2.24E+04,,2.18E+04,,,1.56E+05,,,,,,,,1.00E+03,,4.31E+03,,,6.54E+04,,5.23E+02,,0,FALSE,6.935,6,2,401,44.2,5.21,2,cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes,other membranes;cytosol;cytoskeleton;other cell component,Pf04912,10540,B2RBK5; hsa:10540; Q13561; Q86YN2; Q9BW17,ENSG00000175203,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,Vasopressin-regulated water reabsorption,12,0,133.64,,24.94,116.62,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,94.57,,127.64,9.51,cytoskeletal activity;other molecular function,0,
Master Protein,High,P63096,GNAI1,Guanine nucleotide-binding protein G(i) subunit alpha-1 OS=Homo sapiens OX=9606 GN=GNAI1 PE=1 SV=2,9,104,100,0.918,100,2.351,6.64,-0.12,6.64,1.23,1.00E-17,7.60E-01,1.00E-17,3.86E-01,6.24E+04,,4.57E+04,1.62E+04,4,,5,3,1.31E+05,4.94E+04,2.53E+04,7.89E+04,,,,,,,3.80E+04,7.70E+03,4.57E+04,1.41E+05,1.19E+05,,7.57E+03,1.50E+05,1.62E+04,,5.19E+02,1.88E+02,2.47E+02,7.89E+04,,,,,,,2.27E+02,3.44E+02,3.71E+02,1.90E+04,2.96E+03,,2.13E+03,1.07E+03,3.78E+02,,0,FALSE,39.163,28,2,354,40.3,5.97,9,cell cycle OR cell proliferation;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,Pf00503,2770,A8KA88; B4E2V1; C9J3A4; hsa:2770; P04898; P11015; P31871; P63096; Q5U074; Q8TAN5; Q9UGA4,ENSG00000127955,"G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Adrenaline,noradrenaline inhibits insulin secretion",Nicotine effect on dopaminergic neurons; Thyroid stimulating hormone (TSH) signaling pathway; Endothelin pathways; Corticotropin-releasing hormone signaling pathway; S1P receptor signal transduction; Common pathways underlying drug addiction; G protein signaling pathways; Cell-type dependent selectivity of CCK2R signaling; Chemokine signaling pathway; Purinergic signaling; Prostaglandin and leukotriene metabolism in senescence ; Prostaglandin and leukotriene metabolism in senescence ; Calcium regulation in cardiac cells; 5q35 copy number variation; Serotonin HTR1 group and FOS pathway,25,0,63.88,,80.86,138.02,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,,96.13,,132.35,274.34,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q5T5C7,SARS1,serine--tRNA ligase OS=Homo sapiens OX=9606 GN=SARS1 PE=1 SV=1,3,6,100,0.658,100,0.058,6.64,-0.6,6.64,-4.1,1.00E-17,9.32E-01,1.00E-17,8.98E-03,1.84E+05,,7.38E+04,4.65E+05,2,,4,2,,3.02E+05,,,1.12E+05,,,,,,2.25E+05,,8.10E+04,6.73E+04,5.37E+04,,2.39E+06,,9.04E+04,,,1.15E+03,,,5.79E+03,,,,,,1.35E+03,,6.58E+02,9.06E+03,1.33E+03,,6.72E+05,,2.12E+03,,0,FALSE,14.159,8,3,536,61.3,7.06,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol,"Pf00587, Pf02403",6301,Q5T5C7,ENSG00000031698,,VEGFA-VEGFR2 signaling,1,0,64.77,,74.65,131.12,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,57.07,,30.38,19.46,other molecular function,0,
Master Protein,High,Q02083,NAAA,N-acylethanolamine-hydrolyzing acid amidase OS=Homo sapiens OX=9606 GN=NAAA PE=1 SV=3,1,3,100,1.951,100,2.157,6.64,0.96,6.64,1.11,1.00E-17,1.94E-01,1.00E-17,3.91E-01,1.28E+05,,2.51E+05,1.06E+05,5,,5,2,1.85E+05,2.30E+05,3.87E+04,4.10E+04,1.28E+05,,,,,,7.86E+05,4.90E+04,2.01E+05,2.51E+05,2.60E+05,,8.63E+04,,1.30E+05,,7.35E+02,8.74E+02,3.78E+02,4.10E+04,6.63E+03,,,,,,4.70E+03,2.19E+03,1.63E+03,3.38E+04,6.47E+03,,2.42E+04,,3.05E+03,,0.001,FALSE,3.428,5,1,359,40,8.75,1,other metabolic processes,other membranes;other cytoplasmic organelle;other cell component,"Pf02275, Pf15508",27163,hsa:27163; Q02083; Q5KTF2; Q96EY2; Q9BRA8,ENSG00000138744,Neurotransmitter release cycle,,1,0,68.5,,90.41,28.75,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,119.28,,55.25,9.46,other molecular function,0,
Master Protein,Medium,Q15542,TAF5,Transcription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3,1,1,100,1.413,,100,6.64,0.5,,6.64,1.00E-17,3.62E-01,,1.00E-17,1.59E+05,,2.25E+05,,1,,3,,,,,1.59E+05,,,,,,,1.03E+06,,,1.64E+05,2.25E+05,,,,,,,,,1.59E+05,,,,,,,6.14E+03,,,2.20E+04,5.58E+03,,,,,,0.015,FALSE,2.103,1,1,800,86.8,5.64,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytoskeleton;nucleus;other cell component,"Pf00400, Pf04494",6877,A8K5B4; B2RMR0; B7ZKJ6; hsa:6877; Q15542; Q53EM4; Q5SYD5; Q86UZ7; Q9Y4K5,ENSG00000148835,RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Regulation of TP53 Activity through Phosphorylation,Eukaryotic transcription initiation,11,0,,,102.17,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,40.23,,,2.88,other molecular function,0,
Master Protein,High,A0A075B7B8,IGHV3OR16-12,Immunoglobulin heavy variable 3/OR16-12 (non-functional) (Fragment) OS=Homo sapiens OX=9606 GN=IGHV3OR16-12 PE=1 SV=1,1,3,100,0.519,,100,6.64,-0.95,,6.64,1.00E-17,7.50E-01,,1.00E-17,9.07E+05,,8.23E+05,,3,,2,,9.07E+05,7.24E+06,8.85E+05,,,,,,,,,,4.65E+05,1.46E+06,,,,,,,3.60E+03,2.75E+04,8.65E+03,,,,,,,,,,3.78E+03,1.96E+05,,,,,,,0.007,FALSE,2.366,9,1,117,12.9,6.51,1,other biological processes,,Pf07686,,A0A075B7B8,ENSG00000270467,,,0,0,121.65,,72.93,,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,100.89,,,8.99,other molecular function,0,
Master Protein,High,H0Y5K5,ERGIC3,Endoplasmic reticulum-Golgi intermediate compartment protein (Fragment) OS=Homo sapiens OX=9606 GN=ERGIC3 PE=1 SV=1,1,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.90E+05,,,,1,,,,,,,1.90E+05,,,,,,,,,,,,,,,,,,,,1.90E+05,,,,,,,,,,,,,,,,,0,FALSE,5.367,7,1,397,44.6,6.47,1,transport,other membranes;ER/Golgi;other cell component,"Pf07970, Pf13850",,H0Y5K5,ENSG00000125991,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,9.66,,0,
Master Protein,High,O94927,HAUS5,HAUS augmin-like complex subunit 5 OS=Homo sapiens OX=9606 GN=HAUS5 PE=1 SV=2,1,2,100,0.561,100,0.396,6.64,-0.83,6.64,-1.34,1.00E-17,8.80E-01,1.00E-17,5.66E-01,2.07E+04,,1.16E+04,2.85E+04,1,,3,2,,,,2.07E+04,,,,,,,,1.16E+04,,1.16E+04,9.07E+03,,2.77E+04,2.94E+04,,,,,,2.07E+04,,,,,,,,5.20E+02,,1.57E+03,2.25E+02,,7.78E+03,2.08E+02,,,0.001,FALSE,3.141,2,1,633,71.6,8.51,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;cytoskeleton,Pf14817,23354,B2RXK1; hsa:23354; O94927; Q6P2P7; Q7L3D5; Q96CT8,ENSG00000249115,Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,,7,0,,,13.71,4.18,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,0.32,,8.51,2.77,,0,
Master Protein,Medium,O75528,TADA3,Transcriptional adapter 3 OS=Homo sapiens OX=9606 GN=TADA3 PE=1 SV=1,1,2,100,0.934,,100,6.64,-0.1,,6.64,1.00E-17,7.53E-01,,1.00E-17,4.74E+04,,4.43E+04,,2,,1,,,,2.47E+04,9.12E+04,,,,,,,,4.43E+04,,,,,,,,,,,2.41E+02,9.12E+04,,,,,,,,1.98E+03,,,,,,,,,0.012,FALSE,2.192,2,1,432,48.9,6.27,1,cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes,cytoskeleton;nucleus;other cell component,Pf10198,10474,hsa:10474; O75528; Q6FI83; Q9UFS2,ENSG00000171148,Ub-specific processing proteases; Formation of WDR5-containing histone-modifying complexes; HATs acetylate histones,,3,0,81.14,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,103.85,,,3.66,other molecular function,0,
Master Protein,High,Q14331,FRG1,Protein FRG1 OS=Homo sapiens OX=9606 GN=FRG1 PE=1 SV=1,2,2,100,0.398,100,0.074,6.64,-1.33,6.64,-3.76,1.00E-17,4.54E-01,1.00E-17,5.97E-02,9.40E+05,,1.12E+05,1.73E+05,2,,2,5,,,,5.62E+05,1.57E+06,,,,,,,,,9.77E+05,1.28E+04,1.73E+05,1.59E+05,2.47E+05,2.48E+04,1.61E+06,,,,5.62E+05,8.11E+04,,,,,,,,,1.32E+05,3.18E+02,3.37E+02,4.48E+04,1.75E+03,5.79E+02,1.71E+04,0,FALSE,6.448,10,2,258,29.2,9.01,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytoskeleton;nucleus,Pf06229,2483,A8K775; hsa:2483; Q14331,ENSG00000109536; ENSG00000275145; ENSG00000283153; ENSG00000283630,,,0,0,66.97,,137.76,148.31,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,,115.75,,127.01,5.35,cytoskeletal activity,0,
Master Protein,High,Q641Q2,WASHC2A,WASH complex subunit 2A OS=Homo sapiens OX=9606 GN=WASHC2A PE=1 SV=3,3,3,100,0.332,,100,6.64,-1.59,,6.64,1.00E-17,4.48E-01,,1.00E-17,7.67E+04,,2.55E+04,,1,,2,,,,,7.67E+04,,,,,,,,6.02E+04,,1.08E+04,,,,,,,,,,7.67E+04,,,,,,,,2.69E+03,,1.45E+03,,,,,,,0,FALSE,13.203,4,3,1341,147.1,4.81,3,transport;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf15255,387680,A2A3S2; A2A3U6; hsa:387680; Q5SNT6; Q641Q2; Q6DHY0,ENSG00000099290,,,0,0,,,98.45,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,143.76,,,7.32,other molecular function,0,
Master Protein,High,Q9BPX5,ARPC5L,Actin-related protein 2/3 complex subunit 5-like protein OS=Homo sapiens OX=9606 GN=ARPC5L PE=1 SV=1,2,4,100,2.131,100,1.895,6.64,1.09,6.64,0.92,1.00E-17,1.36E-01,1.00E-17,4.47E-01,3.84E+05,,5.65E+05,4.42E+05,2,,3,2,,,,2.54E+05,5.79E+05,,,,,,,,1.64E+06,5.65E+05,5.19E+05,,2.86E+05,,6.82E+05,,,,,2.54E+05,2.99E+04,,,,,,,,1.33E+04,7.62E+04,1.29E+04,,8.03E+04,,1.60E+04,,0,FALSE,7.369,33,2,153,16.9,6.6,2,cell organization and biogenesis;other biological processes,cytoskeleton;other cell component,Pf04699,81873,hsa:81873; Q7Z523; Q9BPX5,ENSG00000136950,,Pathogenic Escherichia coli infection; VEGFA-VEGFR2 signaling,2,0,55.1,,69.77,57.89,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,64.5,,61.53,12.85,cytoskeletal activity,0,
Master Protein,High,Q9NRX1,PNO1,RNA-binding protein PNO1 OS=Homo sapiens OX=9606 GN=PNO1 PE=1 SV=1,1,5,100,2.645,,100,6.64,1.4,,6.64,1.00E-17,9.97E-02,,1.00E-17,9.67E+04,,2.75E+05,,2,,4,,,,,1.49E+05,6.29E+04,,,,,,,7.43E+04,2.19E+05,4.47E+05,3.46E+05,,,,,,,,,1.49E+05,3.24E+03,,,,,,,3.32E+03,1.78E+03,6.03E+04,8.60E+03,,,,,,0.001,FALSE,3.376,6,1,252,27.9,9.73,1,other biological processes,cytosol;nucleus;other cell component,,56902,A8K6Q0; hsa:56902; Q53G13; Q8WVB8; Q9NRX1,ENSG00000115946,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,57.4,,59.42,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,73.9,,,10.44,,0,
Master Protein,Medium,Q9NVU7,SDAD1,Protein SDA1 homolog OS=Homo sapiens OX=9606 GN=SDAD1 PE=1 SV=3,1,1,100,0.731,,100,6.64,-0.45,,6.64,1.00E-17,9.58E-01,,1.00E-17,5.80E+04,,4.24E+04,,1,,2,,,,,5.80E+04,,,,,,,,6.74E+04,,2.67E+04,,,,,,,,,,5.80E+04,,,,,,,,3.01E+03,,3.59E+03,,,,,,,0.015,FALSE,2.117,2,1,687,79.8,9.25,1,transport;other biological processes,nucleus,"Pf05285, Pf08158, Pf21638",55153,hsa:55153; Q32Q11; Q68D52; Q7Z5U4; Q9H831; Q9H9P6; Q9NVU7,ENSG00000198301,,,0,0,,,61.17,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,71.13,,,3.56,,0,
Master Protein,High,Q8N201,INTS1,Integrator complex subunit 1 OS=Homo sapiens OX=9606 GN=INTS1 PE=1 SV=2,3,5,100,1.239,,100,6.64,0.31,,6.64,1.00E-17,4.67E-01,,1.00E-17,4.19E+05,,1.04E+05,,2,,2,,,,,2.06E+05,8.50E+05,,,,,,,,,1.38E+05,7.79E+04,,,,,,,,,2.06E+05,4.39E+04,,,,,,,,,1.87E+04,1.94E+03,,,,,,0,FALSE,8.865,2,3,2190,244.1,6.13,3,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,other membranes;nucleus,Pf12432,26173,A6NJ44; hsa:26173; Q6NT70; Q6UX74; Q8N201; Q8WV40; Q96D36; Q9NTD1; Q9P2A8; Q9Y3W8,ENSG00000164880,RNA polymerase II transcribes snRNA genes,,1,0,86.23,,39.55,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,33.63,,,14.34,,0,
Master Protein,High,Q9BRT2,UQCC2,Ubiquinol-cytochrome-c reductase complex assembly factor 2 OS=Homo sapiens OX=9606 GN=UQCC2 PE=1 SV=1,1,4,100,1.077,100,1.049,6.64,0.11,6.64,0.07,1.00E-17,5.69E-01,1.00E-17,8.21E-01,2.25E+05,,2.43E+05,2.31E+05,2,,3,2,,1.92E+05,,2.64E+05,,,,,,,,,8.92E+04,6.31E+05,2.43E+05,,3.41E+05,,1.57E+05,,,7.30E+02,,2.64E+05,,,,,,,,,7.25E+02,8.50E+04,6.03E+03,,9.57E+04,,3.67E+03,,0.003,FALSE,2.713,13,1,126,14.9,7.37,1,cell organization and biogenesis;other biological processes,other membranes;mitochondrion;nucleus,Pf20180,84300,B2R4I0; Q9BRT2,ENSG00000137288,,Mitochondrial complex III assembly,1,0,22.16,,87.01,52.3,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,93.05,,90.8,11.85,,0,
Master Protein,High,Q8NF91,SYNE1,Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4,4,5,100,1.658,100,0.844,6.64,0.73,6.64,-0.24,1.00E-17,2.87E-01,1.00E-17,9.71E-01,1.86E+05,,1.53E+05,5.16E+04,1,,4,1,,,,1.86E+05,,,,,,,,1.41E+05,1.67E+05,5.29E+05,2.89E+04,,,,5.16E+04,,,,,1.86E+05,,,,,,,,6.29E+03,1.36E+03,7.12E+04,7.18E+02,,,,1.21E+03,,0,FALSE,12.595,1,4,8797,1010.5,5.53,4,cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component,"Pf00307, Pf00435, Pf10541",23345,B3W695; E7EQI5; H0Y4C0; O94890; Q3ZCV0; Q5JV19; Q5JV22; Q8N9P7; Q8NF91; Q8TCP1; Q8WWW6; Q8WWW7; Q8WXF6; Q96N17; Q9C0A7; Q9H525; Q9H526; Q9NS36; Q9NU50; Q9UJ06; Q9UJ07; Q9ULF8,ENSG00000131018,Meiotic synapsis,Envelope proteins and their potential roles in EDMD physiopathology,2,0,,,100.11,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,7.29,,75.34,16.21,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q6ZT21,TMPPE,Transmembrane protein with metallophosphoesterase domain OS=Homo sapiens OX=9606 GN=TMPPE PE=1 SV=2,1,4,100,2.675,100,2.399,6.64,1.42,6.64,1.26,1.00E-17,1.52E-01,1.00E-17,3.53E-01,3.51E+04,,8.56E+04,3.91E+04,2,,4,2,,,,1.13E+05,1.09E+04,,,,,,,1.18E+05,4.12E+04,2.14E+05,6.18E+04,,1.03E+05,,1.49E+04,,,,,1.13E+05,5.60E+02,,,,,,,5.29E+03,3.35E+02,2.88E+04,1.54E+03,,2.89E+04,,3.48E+02,,0.001,FALSE,3.409,3,1,453,49.4,6.92,1,,other membranes,Pf00149,643853,B2RNG5; hsa:643853; Q6ZRG1; Q6ZT21,ENSG00000188167,,,0,0,116.72,,70.9,105.75,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,123.07,,110.04,7.58,other molecular function,0,
Master Protein,High,P18065,IGFBP2,Insulin-like growth factor-binding protein 2 OS=Homo sapiens OX=9606 GN=IGFBP2 PE=1 SV=2,2,2,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,1.87E+04,,,,1,,,,,,,1.87E+04,,,,,,,,,,,,,,,,,,,,1.87E+04,,,,,,,,,,,,,,,,,0,FALSE,7.767,8,2,325,34.8,7.5,2,other biological processes,non-structural extracellular;plasma membrane;other membranes,"Pf00086, Pf00219",3485,hsa:3485; P18065; Q14619; Q9UCL3,ENSG00000115457,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Myometrial relaxation and contraction pathways; Photodynamic therapy-induced HIF-1 survival signaling,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.74,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9Y2T2,AP3M1,AP-3 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP3M1 PE=1 SV=1,2,3,100,0.677,100,1.501,6.64,-0.56,6.64,0.59,1.00E-17,9.77E-01,1.00E-17,5.92E-01,2.16E+05,,1.86E+05,1.01E+05,2,,1,1,,2.87E+05,,1.63E+05,,,,,,,,,,1.86E+05,,,1.01E+05,,,,,1.09E+03,,1.63E+05,,,,,,,,,,2.51E+04,,,2.85E+04,,,,0,FALSE,10.517,11,2,418,46.9,6.93,2,cell organization and biogenesis;transport,other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00928, Pf01217",26985,hsa:26985; Q5JQ12; Q9H5L2; Q9Y2T2,ENSG00000185009,Association of TriC/CCT with target proteins during biosynthesis,,1,0,39.05,,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,73.77,,0,12.14,other molecular function,0,
Master Protein,High,E7EUC7,UGP2,UTP--glucose-1-phosphate uridylyltransferase OS=Homo sapiens OX=9606 GN=UGP2 PE=1 SV=1,2,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,3.56E+04,,,1.32E+05,3,,,3,,7.51E+04,,1.94E+04,3.56E+04,,,,,,,,,,,,,7.27E+04,2.01E+05,1.32E+05,,2.85E+02,,1.94E+04,1.84E+03,,,,,,,,,,,,,5.15E+02,4.70E+03,1.41E+03,0,FALSE,4.545,6,2,517,57.8,8.13,2,other metabolic processes,,Pf01704,,E7EUC7,ENSG00000169764,,Glucuronidation,1,0,66,,,47.48,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,,,,5.31,other molecular function,0,
Master Protein,Medium,Q9HA77,CARS2,"Probable cysteine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=CARS2 PE=1 SV=1",1,2,100,1.239,100,3.603,6.64,0.31,6.64,1.85,1.00E-17,4.45E-01,1.00E-17,1.71E-01,4.14E+05,,5.14E+05,1.35E+05,1,,4,2,,,,4.14E+05,,,,,,,,3.54E+05,6.68E+05,5.14E+05,5.13E+05,,8.56E+04,,2.13E+05,,,,,4.14E+05,,,,,,,,1.58E+04,5.43E+03,6.93E+04,1.28E+04,,2.40E+04,,4.99E+03,,0.025,FALSE,1.876,3,1,564,62.2,8.34,1,protein metabolism;RNA metabolism OR transcription;other metabolic processes,mitochondrion;other cell component,Pf01406,79587,hsa:79587; Q8NI84; Q96IV4; Q9HA77,ENSG00000134905,Mitochondrial tRNA aminoacylation,,1,0,,,25.01,60.39,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,22.38,,64.52,5.49,other molecular function,0,
Master Protein,High,P62942,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A OS=Homo sapiens OX=9606 GN=FKBP1A PE=1 SV=2,1,1,100,1.585,,100,6.64,0.66,,6.64,1.00E-17,2.99E-01,,1.00E-17,1.86E+05,,2.96E+05,,1,,1,,,,,1.86E+05,,,,,,,,,,,2.96E+05,,,,,,,,,1.86E+05,,,,,,,,,,,7.34E+03,,,,,,0.003,FALSE,2.741,13,1,108,11.9,8.16,1,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component,Pf00254,2280,D3DVW6; hsa:2280; P20071; P62942; Q4VC47; Q6FGD9; Q6LEU3; Q9H103; Q9H566,ENSG00000088832,Potential therapeutics for SARS; mTORC1-mediated signalling; SARS-CoV-1 activates/modulates innate immune responses; TGF-beta receptor signaling activates SMADs; Calcineurin activates NFAT; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); TGFBR1 LBD Mutants in Cancer,Target of rapamycin signaling; Spinal cord injury; Head and neck squamous cell carcinoma; TGF-beta receptor signaling in skeletal dysplasias; Affected pathways in Duchenne muscular dystrophy; Calcium regulation in cardiac cells; TGF-beta receptor signaling,14,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.32,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q15046,KARS1,Lysine--tRNA ligase OS=Homo sapiens OX=9606 GN=KARS1 PE=1 SV=3,4,9,100,1.158,100,0.412,6.64,0.21,6.64,-1.28,1.00E-17,4.81E-01,1.00E-17,5.69E-01,3.65E+05,,6.18E+05,1.22E+06,1,,4,3,,,,3.65E+05,,,,,,,1.71E+05,,6.61E+05,6.23E+05,6.13E+05,3.44E+05,1.97E+06,,1.22E+06,,,,,3.65E+05,,,,,,,1.03E+03,,5.37E+03,8.40E+04,1.52E+04,6.72E+02,5.53E+05,,2.85E+04,,0,FALSE,25.068,11,4,597,68,6.35,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component,"Pf00152, Pf01336",3735,A8MSK1; D3DUK4; hsa:3735; O14946; Q15046; Q96J25; Q9HB23,ENSG00000065427,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation; Mitochondrial tRNA aminoacylation,,3,0,,,44.75,69.1,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,5.78,,73.06,36.93,nucleic acid binding activity;other molecular function,0,
Master Protein,High,J3KQL8,APOL2,Apolipoprotein L2 OS=Homo sapiens OX=9606 GN=APOL2 PE=1 SV=2,2,2,100,0.189,100,0.441,6.64,-2.4,6.64,-1.18,1.00E-17,1.43E-01,1.00E-17,6.27E-01,1.49E+05,,6.39E+04,1.37E+05,4,,4,2,1.38E+05,,1.28E+05,2.62E+05,1.61E+05,,,,,,,1.91E+04,3.15E+04,1.30E+05,2.82E+05,,4.24E+05,,,4.42E+04,5.47E+02,,1.25E+03,2.62E+05,8.32E+03,,,,,,,8.53E+02,2.56E+02,1.75E+04,7.01E+03,,1.19E+05,,,4.71E+02,0,FALSE,6.326,5,2,449,48.9,6,2,protein metabolism;other metabolic processes;transport,non-structural extracellular;other membranes,Pf05461,,J3KQL8,ENSG00000128335,,,0,0,35.55,,105.16,114.7,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,,128.5,,102.96,5.06,other molecular function,0,
Master Protein,High,Q15031,LARS2,"Leucine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=LARS2 PE=1 SV=2",3,3,100,1.328,100,47.983,6.64,0.41,6.64,5.58,1.00E-17,3.94E-01,1.00E-17,1.09E-03,2.09E+05,,1.93E+05,4.02E+03,3,,4,1,2.65E+05,,,2.09E+05,1.63E+05,,,,,,,1.26E+05,2.95E+05,1.08E+05,3.32E+05,,4.02E+03,,,,1.05E+03,,,2.09E+05,8.43E+03,,,,,,,5.63E+03,2.40E+03,1.46E+04,8.25E+03,,1.13E+03,,,,0,FALSE,12.187,4,3,903,101.9,8.22,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes,mitochondrion,"Pf00133, Pf08264, Pf13603",23395,hsa:23395; Q15031,ENSG00000011376,Mitochondrial tRNA aminoacylation,Amino acid metabolism; IL-18 signaling pathway; Primary ovarian insufficiency,4,0,23.89,,53.28,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,70.43,,71.88,9.97,other molecular function,0,
Master Protein,High,Q9H0S4,DDX47,Probable ATP-dependent RNA helicase DDX47 OS=Homo sapiens OX=9606 GN=DDX47 PE=1 SV=1,1,1,100,0.447,,100,6.64,-1.16,,6.64,1.00E-17,6.55E-01,,1.00E-17,6.51E+04,,2.91E+04,,1,,3,,,,,6.51E+04,,,,,,,6.18E+05,1.32E+04,,2.91E+04,,,,,,,,,,6.51E+04,,,,,,,3.70E+03,5.91E+02,,3.92E+03,,,,,,,0.006,FALSE,2.435,4,1,455,50.6,9.1,1,RNA metabolism OR transcription;other metabolic processes;signal transduction,nucleus,"Pf00270, Pf00271",51202,B3KXP4; G5E955; hsa:51202; Q96GM0; Q96NV8; Q9H0S4; Q9UI98,ENSG00000213782,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,,,156.59,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,141.28,,,2.77,other molecular function,0,
Master Protein,High,Q9NYJ1,COA4,"Cytochrome c oxidase assembly factor 4 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=COA4 PE=1 SV=2",2,10,100,1.923,100,2.038,6.64,0.94,6.64,1.03,1.00E-17,1.83E-01,1.00E-17,3.93E-01,2.06E+05,,6.96E+05,6.53E+04,3,,3,3,1.49E+05,,,2.06E+05,4.53E+05,,,,,,,6.96E+05,,1.50E+06,4.91E+05,,2.25E+04,,7.63E+04,6.53E+04,5.90E+02,,,2.06E+05,2.34E+04,,,,,,,3.11E+04,,2.02E+05,1.22E+04,,6.31E+03,,1.78E+03,6.95E+02,0,FALSE,9.599,20,2,87,10.1,6.04,2,cell organization and biogenesis,mitochondrion,Pf06747,51287,B2RAA0; hsa:51287; Q69YU4; Q9NYJ1,ENSG00000181924,Mitochondrial protein import,,1,0,60.16,,59.37,52,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,,124.41,,104.6,31.12,,0,
Master Protein,High,B8ZZS0,BET1L,Bet1 golgi vesicular membrane trafficking protein like OS=Homo sapiens OX=9606 GN=BET1L PE=1 SV=1,1,2,100,0.27,100,1.297,6.64,-1.89,6.64,0.38,1.00E-17,3.12E-01,1.00E-17,7.11E-01,1.12E+05,,3.02E+04,2.33E+04,1,,1,2,,,,1.12E+05,,,,,,,,,3.02E+04,,,,1.61E+04,,3.37E+04,,,,,1.12E+05,,,,,,,,,2.45E+02,,,,4.51E+03,,7.89E+02,,0.002,FALSE,2.805,10,1,152,17.1,8.88,1,transport,other membranes;ER/Golgi,,,B8ZZS0,ENSG00000177951,,,0,0,,,,50.19,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,0,,56.27,4.6,,0,
Master Protein,High,Q96CV9,OPTN,Optineurin OS=Homo sapiens OX=9606 GN=OPTN PE=1 SV=3,1,2,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,1.24E+05,,,3.38E+05,1,,,1,,1.24E+05,,,,,,,,,,,,,,,3.38E+05,,,,,4.73E+02,,,,,,,,,,,,,,,9.49E+04,,,,0,FALSE,6.125,2,1,577,65.9,5.17,1,cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf11577, Pf16516, Pf18414",10133,B3KP00; D3DRS4; D3DRS8; hsa:10133; Q5T672; Q5T673; Q5T674; Q5T675; Q7LDL9; Q8N562; Q96CV9; Q9UET9; Q9UEV4; Q9Y218,ENSG00000123240,Regulation of PLK1 Activity at G2/M Transition; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; TBC/RABGAPs; TNFR1-induced proapoptotic signaling,HDAC6 interactions in the central nervous system,6,0,,,,,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,8.45,other molecular function,0,
Master Protein,High,Q01658,DR1,Protein Dr1 OS=Homo sapiens OX=9606 GN=DR1 PE=1 SV=1,1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,4.08E+05,,,,1,,,,,,,4.08E+05,,,,,,,,,,,,,,,,,,,,4.08E+05,,,,,,,,,,,,,,,,,0.001,FALSE,4.027,14,1,176,19.4,4.75,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytoskeleton;nucleus;other cell component,Pf00808,1810,hsa:1810; Q01658,ENSG00000117505,Formation of WDR5-containing histone-modifying complexes; HATs acetylate histones,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,4.29,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P41970,ELK3,ETS domain-containing protein Elk-3 OS=Homo sapiens OX=9606 GN=ELK3 PE=1 SV=2,2,3,100,0.847,100,0.176,6.64,-0.24,6.64,-2.51,1.00E-17,8.29E-01,1.00E-17,1.61E-01,1.43E+05,,1.21E+05,6.90E+05,1,,1,1,,,,1.43E+05,,,,,,,,,,1.21E+05,,,,,,6.90E+05,,,,1.43E+05,,,,,,,,,,1.63E+04,,,,,,7.34E+03,0,FALSE,8.966,8,2,407,44.2,8.95,2,stress response;developmental processes;signal transduction;other biological processes,mitochondrion;nucleus;other cell component,Pf00178,2004,B2R6S6; hsa:2004; P41970; Q6FG57; Q6GU29; Q9UD17,ENSG00000111145,,ID signaling pathway,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,0,,0,8.79,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P62875,POLR2L,"DNA-directed RNA polymerases I, II, and III subunit RPABC5 OS=Homo sapiens OX=9606 GN=POLR2L PE=1 SV=1",1,2,100,6.109,,100,6.64,2.61,,6.64,1.00E-17,7.12E-03,,1.00E-17,6.25E+04,,3.82E+05,,1,,2,,,,,6.25E+04,,,,,,,,,2.36E+05,6.19E+05,,,,,,,,,,6.25E+04,,,,,,,,,1.92E+03,8.34E+04,,,,,,,0.004,FALSE,2.557,16,1,67,7.6,7.77,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus,Pf01194,5441,hsa:5441; P52436; P62875; Q6FHX3,ENSG00000177700,Activation of anterior HOX genes in hindbrain development during early embryogenesis; RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; mRNA Splicing - Major Pathway; Estrogen-dependent gene expression; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,Pyrimidine metabolism; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,56,0,,,63.37,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,74.31,,,5.27,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O00330,PDHX,"Pyruvate dehydrogenase protein X component, mitochondrial OS=Homo sapiens OX=9606 GN=PDHX PE=1 SV=3",2,5,100,0.818,,100,6.64,-0.29,,6.64,1.00E-17,7.27E-01,,1.00E-17,8.36E+05,,6.23E+05,,1,,4,,,,,8.36E+05,,,,,,,,9.66E+05,1.43E+05,7.83E+05,4.95E+05,,,,,,,,,8.36E+05,,,,,,,,4.31E+04,1.16E+03,1.06E+05,1.23E+04,,,,,,0,FALSE,8.875,6,2,501,54.1,8.66,2,other metabolic processes,mitochondrion;other cell component,"Pf00198, Pf00364, Pf02817",8050,B4DW62; D3DR11; E9PB14; E9PBP7; hsa:8050; O00330; O60221; Q96FV8; Q99783,ENSG00000110435,Glyoxylate metabolism and glycine degradation; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid,Amino acid metabolism,5,0,,,60.21,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,21.02,,,16.26,other molecular function,0,
Master Protein,High,Q9BRX9,WDR83,WD repeat domain-containing protein 83 OS=Homo sapiens OX=9606 GN=WDR83 PE=1 SV=1,1,1,100,0.982,100,0.64,6.64,-0.03,6.64,-0.64,1.00E-17,7.26E-01,1.00E-17,8.54E-01,6.48E+04,,6.36E+04,1.43E+05,1,,4,2,,,,6.48E+04,,,,,,,5.17E+04,,7.83E+04,1.89E+05,4.41E+04,2.81E+05,,,,7.25E+04,,,,6.48E+04,,,,,,,3.09E+02,,6.36E+02,2.55E+04,1.10E+03,5.47E+02,,,,7.72E+02,0.009,FALSE,2.322,4,1,315,34.3,5.58,1,RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,other membranes;nucleus;other cytoplasmic organelle,Pf00400,84292,B2RAF1; hsa:84292; Q53FT6; Q9BRX9,ENSG00000123154,MAP2K and MAPK activation,,1,0,,,73.92,83.34,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,,49.85,,86.1,3.56,,0,
Master Protein,High,P60866,RPS20,40S ribosomal protein S20 OS=Homo sapiens OX=9606 GN=RPS20 PE=1 SV=1,3,13,100,1.076,100,7.202,6.64,0.11,6.64,2.85,1.00E-17,5.12E-01,1.00E-17,5.12E-02,1.04E+06,,3.62E+06,3.13E+05,3,,5,3,1.04E+06,,,5.94E+06,6.51E+05,,,,,,3.03E+06,9.61E+06,2.87E+06,4.46E+06,3.62E+06,2.72E+05,3.13E+05,,3.37E+05,,4.14E+03,,,5.94E+06,3.36E+04,,,,,,1.81E+04,4.29E+05,2.34E+04,6.01E+05,8.99E+04,5.31E+02,8.78E+04,,7.89E+03,,0,FALSE,11.459,23,3,119,13.4,9.94,3,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf00338,6224,B2R4F4; B4DW28; hsa:6224; P17075; P60866; Q5M8S9,ENSG00000008988,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,115.89,,59.39,10.68,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,High,High,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,82.3,,96.81,31.85,enzyme regulator activity;other molecular function,0,
Master Protein,Medium,Q5W0V3,FHIP2A,FHF complex subunit HOOK interacting protein 2A OS=Homo sapiens OX=9606 GN=FHIP2A PE=1 SV=1,1,1,100,0.48,100,0.229,6.64,-1.06,6.64,-2.13,1.00E-17,6.99E-01,1.00E-17,2.96E-01,1.57E+05,,5.24E+04,3.29E+05,2,,4,2,4.75E+05,,,5.18E+04,,,,,,,,4.27E+04,1.33E+05,5.65E+04,4.85E+04,1.91E+06,5.65E+04,,,,1.89E+03,,,5.18E+04,,,,,,,,1.91E+03,1.08E+03,7.61E+03,1.21E+03,3.73E+03,1.59E+04,,,,0.023,FALSE,1.914,2,1,765,86.5,5.29,1,,,"Pf10257, Pf19311, Pf19314",57700,Q5H9P7; Q5W0V2; Q5W0V3; Q8IY76; Q9HCH2,ENSG00000151553,,,0,0,113.6,,60.16,133.31,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,,113.34,,237.25,2.91,,0,
Master Protein,High,P18887,XRCC1,DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=3,2,2,100,0.379,,100,6.64,-1.4,,6.64,1.00E-17,5.70E-01,,1.00E-17,4.38E+04,,1.66E+04,,2,,2,,,,2.78E+04,6.90E+04,,,,,,,3.72E+04,,,,7.40E+03,,,,,,,,2.72E+02,6.90E+04,,,,,,,2.22E+02,,,,1.84E+02,,,,,,0,FALSE,6.36,5,2,633,69.5,6.28,2,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf00533, Pf01834",7515,hsa:7515; P18887; Q6IBS4; Q9HCB1,ENSG00000073050,Gap-filling DNA repair synthesis and ligation in TC-NER; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway; HDR through MMEJ (alt-NHEJ); Resolution of AP sites via the single-nucleotide replacement pathway; Gap-filling DNA repair synthesis and ligation in GG-NER,"Base excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",8,0,60.14,,94.51,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,84.57,,,3.85,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P0DPB6,POLR1D,DNA-directed RNA polymerases I and III subunit RPAC2 OS=Homo sapiens OX=9606 GN=POLR1D PE=1 SV=1,1,2,100,0.402,,100,6.64,-1.31,,6.64,1.00E-17,5.31E-01,,1.00E-17,1.49E+05,,6.49E+04,,3,,2,,4.85E+05,,1.49E+05,9.95E+04,,,,,,,8.61E+04,,,4.90E+04,,,,,,,1.92E+03,,1.45E+03,9.95E+04,,,,,,,5.15E+02,,,6.60E+03,,,,,,,0,FALSE,7.007,14,1,133,15.2,5.8,1,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf01193, Pf13656",51082,hsa:51082; P0DPB6; Q5TBX2; Q96BR3; Q9Y2S0,ENSG00000186184,,Pyrimidine metabolism; Eukaryotic transcription initiation; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,4,0,85.76,,38.87,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,62.22,,,7.75,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96JQ2,CLMN,Calmin OS=Homo sapiens OX=9606 GN=CLMN PE=1 SV=1,2,3,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,5.29E+04,,,,1,,,,,,,5.29E+04,,,,,,,,,,,,,,,,,,,,5.29E+04,,,,,,,,,,,,,,,,,0,FALSE,13.381,5,2,1002,111.6,4.94,2,cell organization and biogenesis;transport;developmental processes;other biological processes,other membranes;nucleus;other cell component,Pf00307,79789,B2RAR7; hsa:79789; Q96JQ2; Q9H713; Q9HA23; Q9HA57; Q9UFP4; Q9ULN2,ENSG00000165959,,Vitamin D receptor pathway,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,9.35,cytoskeletal activity,0,
Master Protein,High,Q9C0J8,WDR33,pre-mRNA 3' end processing protein WDR33 OS=Homo sapiens OX=9606 GN=WDR33 PE=1 SV=2,4,4,100,0.568,,100,6.64,-0.82,,6.64,1.00E-17,8.03E-01,,1.00E-17,1.87E+05,,2.87E+04,,1,,1,,,,,1.87E+05,,,,,,,,,,,2.87E+04,,,,,,,,,1.87E+05,,,,,,,,,,,7.13E+02,,,,,,0,FALSE,27.737,7,4,1336,145.8,9.17,4,DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00400, Pf01391",55339,hsa:55339; Q05DP8; Q53FG9; Q587J1; Q69YF7; Q6NUQ0; Q9C0J8; Q9NUL1,ENSG00000136709,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Transport of Mature mRNA Derived from an Intronless Transcript; Processing of Intronless Pre-mRNAs,,5,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,16.3,,0,
Master Protein,High,Q13111,CHAF1A,Chromatin assembly factor 1 subunit A OS=Homo sapiens OX=9606 GN=CHAF1A PE=1 SV=3,1,1,100,0.7,,100,6.64,-0.51,,6.64,1.00E-17,9.41E-01,,1.00E-17,3.09E+04,,2.16E+04,,1,,2,,,,,3.09E+04,,,,,,,,2.36E+04,,1.98E+04,,,,,,,,,,3.09E+04,,,,,,,,1.05E+03,,2.67E+03,,,,,,,0,FALSE,4.535,2,1,956,106.8,5.94,1,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response,nucleus;other cell component,"Pf11600, Pf12253, Pf15539, Pf15557",10036,hsa:10036; Q13111; Q6NXG5; Q7Z7K3; Q9UJY8,ENSG00000167670,,Nanoparticle triggered autophagic cell death,1,0,,,12.31,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,12.96,,,3.76,other molecular function,0,
Master Protein,Medium,Q8N9M1,C19orf47,Uncharacterized protein C19orf47 OS=Homo sapiens OX=9606 GN=C19orf47 PE=1 SV=1,1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,5.33E+04,,,1.42E+04,2,,,1,,,,4.66E+04,6.08E+04,,,,,,,,,,,,1.42E+04,,,,,,,4.66E+04,3.14E+03,,,,,,,,,,,,3.99E+03,,,,0.012,FALSE,2.216,4,1,422,44.7,10.11,1,,nucleus,"Pf17740, Pf18017",126526,Q8IZ33; Q8N0V9; Q8N9M1,ENSG00000160392,,,0,0,18.69,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,,,,3.17,,0,
Master Protein,High,Q9Y676,MRPS18B,"28S ribosomal protein S18b, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS18B PE=1 SV=1",1,2,100,0.267,,100,6.64,-1.9,,6.64,1.00E-17,2.74E-01,,1.00E-17,1.86E+05,,4.98E+04,,2,,1,,,,,1.15E+05,3.03E+05,,,,,,,4.98E+04,,,,,,,,,,,,1.15E+05,1.56E+04,,,,,,,2.22E+03,,,,,,,,,0,FALSE,5.508,7,1,258,29.4,9.38,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus;nucleus;other cell component,Pf01084,28973,A6NDQ0; hsa:28973; Q659G4; Q9BS27; Q9Y676,ENSG00000203624; ENSG00000204568; ENSG00000223775; ENSG00000226111; ENSG00000227420; ENSG00000229861; ENSG00000233813,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,63.65,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,74.72,,,7.92,other molecular function,0,
Master Protein,High,A0A8V8TQI8,OS9,Endoplasmic reticulum lectin OS=Homo sapiens OX=9606 GN=OS9 PE=1 SV=1,1,2,100,1.275,,100,6.64,0.35,,6.64,1.00E-17,4.36E-01,,1.00E-17,2.75E+05,,3.51E+05,,1,,1,,,,,2.75E+05,,,,,,,,,,3.51E+05,,,,,,,,,,2.75E+05,,,,,,,,,,4.73E+04,,,,,,,0,FALSE,6.965,3,1,668,75.6,4.87,1,stress response;signal transduction,ER/Golgi,Pf07915,,A0A8V8TQI8,ENSG00000135506,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,8.45,other molecular function,0,
Master Protein,High,Q9H0V9,LMAN2L,VIP36-like protein OS=Homo sapiens OX=9606 GN=LMAN2L PE=1 SV=1,2,2,100,0.611,100,2.827,6.64,-0.71,6.64,1.5,1.00E-17,8.83E-01,1.00E-17,3.01E-01,4.14E+05,,1.62E+05,6.14E+04,2,,2,1,,,,3.40E+05,5.04E+05,,,,,,1.73E+05,1.52E+05,,,,,6.14E+04,,,,,,,3.40E+05,2.60E+04,,,,,,1.04E+03,6.80E+03,,,,,1.72E+04,,,,0,FALSE,9.144,11,2,348,39.7,8.38,2,protein metabolism;other metabolic processes;transport,other membranes;ER/Golgi;other cell component,Pf03388,81562,B4DSH3; D3DXH6; hsa:81562; Q53GV3; Q53S67; Q63HN6; Q8NBQ6; Q9BQ14; Q9H0V9,ENSG00000114988,COPII-mediated vesicle transport; Cargo concentration in the ER,2q11.2 copy number variation syndrome,3,0,27.53,,9.24,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,100.75,,0,8.21,other molecular function,0,
Master Protein,High,Q96CW5,TUBGCP3,Gamma-tubulin complex component 3 OS=Homo sapiens OX=9606 GN=TUBGCP3 PE=1 SV=2,1,4,100,1.57,100,1.407,6.64,0.65,6.64,0.49,1.00E-17,3.14E-01,1.00E-17,6.08E-01,8.63E+04,,2.82E+05,9.63E+04,2,,5,2,,,,2.68E+05,2.78E+04,,,,,,5.04E+04,3.64E+05,5.26E+04,3.40E+05,2.82E+05,,3.43E+05,,2.70E+04,,,,,2.68E+05,1.43E+03,,,,,,3.01E+02,1.63E+04,4.27E+02,4.58E+04,7.01E+03,,9.64E+04,,6.33E+02,,0.001,FALSE,3.954,2,1,907,103.5,8.12,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;other cell component,"Pf04130, Pf17681",10426,hsa:10426; O43631; O60852; O60853; Q5T8L2; Q7Z4K1; Q96CW5; Q96I79,ENSG00000126216,Recruitment of NuMA to mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes,Prader-Willi and Angelman syndrome; 15q11.2 copy number variation syndrome,4,0,114.89,,71.04,120.75,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,89.35,,96.85,10.02,cytoskeletal activity;other molecular function,0,
Master Protein,High,M0R019,HNRNPM,Heterogeneous nuclear ribonucleoprotein M (Fragment) OS=Homo sapiens OX=9606 GN=HNRNPM PE=1 SV=8,16,53,100,0.101,,100,6.64,-3.31,,6.64,1.00E-17,7.18E-03,,1.00E-17,1.16E+06,,1.17E+05,,2,,1,,5.74E+06,,,2.33E+05,,,,,,,,,,1.17E+05,,,,,,,2.28E+04,,,2.33E+05,,,,,,,,,,1.57E+04,,,,,,,0,FALSE,61.895,56,1,352,37.6,9.03,16,,,"Pf00076, Pf11532",,M0R019,ENSG00000099783,,,0,0,130.4,,,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,353.23,,,154.54,nucleic acid binding activity,0,
Master Protein,High,A0A494C0A9,CBFB,Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=1,1,2,100,0.943,100,0.509,6.64,-0.08,6.64,-0.97,1.00E-17,6.79E-01,1.00E-17,6.74E-01,3.38E+05,,3.19E+05,6.26E+05,4,,4,1,2.16E+05,1.60E+06,,2.41E+04,5.29E+05,,,,,,3.84E+05,7.60E+05,,1.52E+05,2.65E+05,,,6.26E+05,,,8.58E+02,6.10E+03,,2.41E+04,2.73E+04,,,,,,2.30E+03,3.39E+04,,2.05E+04,6.58E+03,,,4.44E+03,,,0.001,FALSE,3.132,7,1,223,26.4,7.21,1,other biological processes,nucleus,Pf02312,,A0A494C0A9,ENSG00000067955,,Dual hijack model of Vif in HIV infection; Hijack of ubiquitination by SARS-CoV-2,2,0,118.87,,67.66,,Peak Found,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,133.46,,58.21,5.66,other molecular function,0,
Master Protein,High,Q6P9B9,INTS5,Integrator complex subunit 5 OS=Homo sapiens OX=9606 GN=INTS5 PE=1 SV=1,3,4,100,0.34,,100,6.64,-1.55,,6.64,1.00E-17,3.48E-01,,1.00E-17,9.77E+05,,2.76E+05,,2,,5,,1.12E+06,,,8.51E+05,,,,,,,2.76E+05,1.65E+05,1.05E+05,6.08E+05,3.10E+05,,,,,,4.46E+03,,,8.51E+05,,,,,,,1.65E+03,7.37E+03,8.53E+02,8.20E+04,7.71E+03,,,,,,0,FALSE,13.514,4,3,1019,107.9,7.05,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,other membranes;cytosol;nucleus;other cell component,"Pf14837, Pf14838",80789,hsa:80789; Q6P9B9; Q8N6W5; Q9C0G5,ENSG00000185085,RNA polymerase II transcribes snRNA genes,,1,0,19.39,,66.51,,High,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,79.23,,,11.77,,0,
Master Protein,Medium,Q13574,DGKZ,Diacylglycerol kinase zeta OS=Homo sapiens OX=9606 GN=DGKZ PE=1 SV=4,1,1,100,0.865,100,0.415,6.64,-0.21,6.64,-1.27,1.00E-17,7.78E-01,1.00E-17,6.11E-01,3.82E+04,,3.30E+04,7.96E+04,3,,3,1,4.87E+04,,3.82E+04,2.66E+04,,,,,,,3.30E+04,,1.26E+05,2.94E+03,,,7.96E+04,,,,1.93E+02,,3.73E+02,2.66E+04,,,,,,,1.98E+02,,1.02E+03,3.97E+02,,,2.24E+04,,,,0.029,FALSE,1.839,1,1,928,103.9,8.05,1,cell cycle OR cell proliferation;other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00023, Pf00130, Pf00609, Pf00781",8525,B7Z2M9; B7Z6M3; E9PPW4; F6UCU9; G3V0F6; hsa:8525; J3KNJ6; O00542; Q13574; Q6ZVG7; Q8IVW9,ENSG00000149091,Effects of PIP2 hydrolysis,Myometrial relaxation and contraction pathways; Leptin-insulin signaling overlap; Glycerolipids and glycerophospholipids; Modulators of TCR signaling and T cell activation,5,0,29.27,,118.68,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,109.26,,109.26,1.93,kinase activity;other molecular function,0,
Master Protein,High,Q15554,TERF2,Telomeric repeat-binding factor 2 OS=Homo sapiens OX=9606 GN=TERF2 PE=1 SV=3,8,27,100,1.205,100,0.036,6.64,0.27,6.64,-4.8,1.00E-17,2.99E-01,1.00E-17,3.32E-03,5.94E+05,,1.37E+06,1.54E+06,4,,4,1,,1.24E+05,9.83E+04,3.70E+06,2.85E+06,,,,,,,1.24E+06,5.09E+05,1.51E+06,1.88E+06,,,,,1.54E+06,,4.71E+02,9.61E+02,3.70E+06,1.47E+05,,,,,,,5.54E+04,4.14E+03,2.03E+05,4.66E+04,,,,,1.64E+04,0,FALSE,33.487,19,8,542,59.6,9.35,8,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes,nucleus;other cell component,"Pf00249, Pf08558, Pf16772",7014,hsa:7014; Q15554,ENSG00000132604,Meiotic synapsis; Telomere Extension By Telomerase; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; Packaging Of Telomere Ends; DNA Damage/Telomere Stress Induced Senescence; Polymerase switching on the C-strand of the telomere; Telomere C-strand synthesis initiation; Removal of the Flap Intermediate from the C-strand,"Hematopoietic stem cell gene regulation by GABP alpha/beta complex; DNA repair pathways, full network; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",17,0,109.79,,45.05,,n/a,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,High,High,High,High,n/a,n/a,High,n/a,High,1,,FALSE,,112.25,,26.57,77.04,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P61962,DCAF7,DDB1- and CUL4-associated factor 7 OS=Homo sapiens OX=9606 GN=DCAF7 PE=1 SV=1,1,1,100,0.722,,100,6.64,-0.47,,6.64,1.00E-17,9.91E-01,,1.00E-17,8.67E+04,,6.23E+04,,2,,3,,,,8.84E+04,8.50E+04,,,,,,,,6.06E+04,,1.31E+05,6.23E+04,,,,,,,,8.64E+02,8.50E+04,,,,,,,,2.71E+03,,1.76E+04,1.55E+03,,,,,,0,FALSE,4.473,5,1,342,38.9,5.52,1,protein metabolism;other metabolic processes,cytosol;nucleus;other cell component,Pf00400,10238,B4E039; D3DU14; hsa:10238; O15491; P61962; Q9DAE4,ENSG00000136485,Neddylation; Association of TriC/CCT with target proteins during biosynthesis,Ciliary landscape; DYRK1A involvement regarding cell proliferation in brain development,4,0,2.75,,47.39,,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,5.89,,,2.43,other molecular function,0,
Master Protein,High,K7ELC2,RPS15,40S ribosomal protein S15 OS=Homo sapiens OX=9606 GN=RPS15 PE=1 SV=1,3,5,100,,100,3.545,6.64,,6.64,1.83,1.00E-17,,1.00E-17,1.63E-01,5.84E+05,,2.23E+06,9.40E+05,3,,1,4,,4.16E+05,,2.23E+06,5.84E+05,,,,,,,,,,2.23E+06,1.40E+06,1.21E+05,6.88E+06,6.29E+05,,,1.58E+03,,2.23E+06,3.01E+04,,,,,,,,,,5.54E+04,2.74E+03,3.39E+04,4.88E+04,1.47E+04,,0,FALSE,14.303,40,3,152,17.7,10.39,3,protein metabolism;other metabolic processes,translational apparatus,Pf00203,6209,K7ELC2,ENSG00000115268,,Cytoplasmic ribosomal proteins,1,0,93.02,,,138.41,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,High,n/a,1,,FALSE,,,,0,19.3,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P83436,COG7,Conserved oligomeric Golgi complex subunit 7 OS=Homo sapiens OX=9606 GN=COG7 PE=1 SV=1,1,1,100,0.618,100,8.558,6.64,-0.69,6.64,3.1,1.00E-17,9.58E-01,1.00E-17,6.49E-02,3.60E+04,,2.22E+04,2.60E+03,2,,1,1,,,4.44E+04,2.92E+04,,,,,,,,2.22E+04,,,,,2.60E+03,,,,,,4.33E+02,2.92E+04,,,,,,,,9.94E+02,,,,,7.30E+02,,,,0.001,FALSE,4.019,2,1,770,86.3,5.47,1,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,other membranes;ER/Golgi;nucleus;other cell component,Pf10191,91949,hsa:91949; P83436; Q6UWU7,ENSG00000168434,COPI-mediated anterograde transport; Intra-Golgi traffic; Retrograde transport at the Trans-Golgi-Network,,3,0,29.13,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,31.21,,0,3.05,,0,
Master Protein,High,A0A1B0GW05,DPY19L1,Dpy-19 like C-mannosyltransferase 1 OS=Homo sapiens OX=9606 GN=DPY19L1 PE=1 SV=1,2,4,100,1.163,100,0.887,6.64,0.22,6.64,-0.17,1.00E-17,5.56E-01,1.00E-17,9.35E-01,1.30E+05,,1.51E+05,1.70E+05,2,,1,3,,,,7.71E+04,2.18E+05,,,,,,,,,1.51E+05,,6.92E+05,7.45E+04,,,1.70E+05,,,,7.71E+04,1.13E+04,,,,,,,,,2.03E+04,,1.35E+03,2.09E+04,,,1.81E+03,0,FALSE,10.03,5,2,748,84.5,9.25,2,,other membranes,Pf10034,,A0A1B0GW05,ENSG00000173852,,,0,0,67.59,,,106.48,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,,80.67,,83.3,14.55,other molecular function,0,
Master Protein,High,Q15291,RBBP5,Retinoblastoma-binding protein 5 OS=Homo sapiens OX=9606 GN=RBBP5 PE=1 SV=2,1,6,100,0.576,100,4.665,6.64,-0.8,6.64,2.22,1.00E-17,8.54E-01,1.00E-17,1.18E-01,1.02E+06,,5.88E+05,1.26E+05,1,,4,1,,,,1.02E+06,,,,,,,,5.80E+05,1.70E+05,8.58E+05,5.97E+05,,1.26E+05,,,,,,,1.02E+06,,,,,,,,2.59E+04,1.38E+03,1.16E+05,1.48E+04,,3.54E+04,,,,0,FALSE,4.92,4,1,538,59.1,5.1,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus,Pf00400,5929,A8K272; hsa:5929; Q15291; Q7Z6D8; Q8NDZ7,ENSG00000117222,Neddylation; Formation of WDR5-containing histone-modifying complexes; Formation of the beta-catenin:TCF transactivating complex; Deactivation of the beta-catenin transactivating complex; Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Kleefstra syndrome,8,0,,,51.52,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,24.35,,35.01,18.21,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8V8TKY5,NBN,Nibrin OS=Homo sapiens OX=9606 GN=NBN PE=1 SV=1,2,2,100,0.22,,100,6.64,-2.19,,6.64,1.00E-17,1.49E-01,,1.00E-17,4.41E+05,,9.70E+04,,1,,1,,,,,4.41E+05,,,,,,,,,,9.70E+04,,,,,,,,,,4.41E+05,,,,,,,,,,1.31E+04,,,,,,,0,FALSE,7.249,4,2,782,88.5,7.74,2,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction,nucleus;other cell component,"Pf00498, Pf00533, Pf08599, Pf16508",,A0A8V8TKY5,ENSG00000104320,,"Homologous recombination; DDX1 as a regulatory component of the Drosha microprocessor; ATM signaling in development and disease ; Breast cancer pathway; DNA repair pathways, full network; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; Primary ovarian insufficiency",7,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,3.53,,0,
Master Protein,High,Q5TEZ5,C6orf163,Uncharacterized protein C6orf163 OS=Homo sapiens OX=9606 GN=C6orf163 PE=4 SV=2,1,2,74.102,0.026,18.77,0.101,6.21,-5.29,4.23,-3.31,4.40E-06,4.50E-07,5.33E-03,3.82E-02,2.20E+06,2.96E+04,5.63E+04,5.56E+05,1,1,3,5,,,,,2.20E+06,,,2.96E+04,,,,5.63E+04,3.02E+04,7.20E+04,,4.04E+05,9.53E+03,5.56E+05,6.55E+05,1.37E+06,,,,,1.13E+05,,,2.73E+02,,,,2.51E+03,2.46E+02,9.70E+03,,7.88E+02,2.68E+03,3.94E+03,1.53E+04,1.46E+04,0.001,FALSE,3.628,4,1,329,38.5,6.96,1,,,,206412,Q5TEZ5,ENSG00000203872,,,0,0,,,39.93,82.73,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,0,32.45,40.57,127.56,4.55,,0,
Master Protein,Medium,Q76L83,ASXL2,Putative Polycomb group protein ASXL2 OS=Homo sapiens OX=9606 GN=ASXL2 PE=1 SV=1,1,6,70.984,0.01,0.486,0.4,6.15,-6.64,-1.04,-1.32,2.71E-06,1.00E-17,2.93E-01,4.62E-01,8.91E+08,1.25E+07,2.44E+06,6.10E+06,1,5,2,3,,,,,8.91E+08,7.20E+06,9.23E+06,1.37E+08,1.37E+08,1.25E+07,,,1.10E+07,5.40E+05,,6.10E+06,,,2.75E+05,3.88E+08,,,,,4.59E+07,2.56E+04,1.64E+05,1.26E+06,3.87E+06,1.33E+05,,,8.95E+04,7.28E+04,,1.19E+04,,,6.42E+03,4.13E+06,0.021,FALSE,1.967,1,1,1435,153.7,8.81,1,other biological processes,nucleus,"Pf05066, Pf13919, Pf13922",55252,hsa:55252; Q53TC9; Q5H9U4; Q76L81; Q76L83; Q86XM1; Q9C0H8; Q9NV67,ENSG00000143970,UCH proteinases,,1,0,,115.14,128.2,169.03,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,1,,FALSE,110.22,318.33,146.92,334,14.67,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,A6NMQ1,POLA1,DNA polymerase OS=Homo sapiens OX=9606 GN=POLA1 PE=1 SV=1,1,1,31.595,0.01,1.266,0.01,4.98,-6.64,0.34,-6.64,6.76E-05,1.00E-17,9.07E-01,1.00E-17,3.81E+06,1.21E+05,,1.53E+05,1,1,,4,,3.81E+06,,,,,,,,1.21E+05,,,,,,,4.29E+04,5.43E+05,3.67E+04,4.30E+06,,1.45E+04,,,,,,,,1.28E+03,,,,,,,1.21E+04,3.85E+03,8.58E+02,4.58E+04,0.024,FALSE,1.913,1,1,1468,166.4,5.81,1,cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response,cytosol;nucleus,"Pf00136, Pf03104, Pf08996, Pf12254",5422,A6NMQ1,ENSG00000101868,,Retinoblastoma gene in cancer; Pyrimidine metabolism; DNA replication,3,0,,,,167.4,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,Phospho [S1371],FALSE,0,,245.85,,2.03,nucleic acid binding activity;other molecular function,1,Phospho [S1371]
Master Protein,High,P62701,RPS4X,"40S ribosomal protein S4, X isoform OS=Homo sapiens OX=9606 GN=RPS4X PE=1 SV=2",6,53,30.403,0.808,7.243,2.093,4.93,-0.31,2.86,1.07,1.86E-04,8.18E-01,3.89E-02,4.64E-01,5.70E+06,1.69E+05,5.32E+06,1.43E+06,4,1,5,3,9.84E+06,,3.30E+06,1.22E+07,3.60E+05,,,,,1.69E+05,1.26E+07,5.32E+06,4.37E+06,7.53E+06,4.73E+06,,9.80E+06,5.10E+05,1.43E+06,,3.91E+04,,3.22E+04,1.22E+07,1.86E+04,,,,,1.80E+03,7.56E+04,2.37E+05,3.55E+04,1.02E+06,1.18E+05,,2.75E+06,3.61E+03,3.33E+04,,0,FALSE,21.803,22,4,263,29.6,10.15,6,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,"Pf00467, Pf00900, Pf08071, Pf16121",6191,hsa:6191; P12631; P12750; P27576; P55831; P62701; Q14727; Q6IPY4,ENSG00000198034,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,2,85.96,,49.54,130.87,High,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,High,High,High,High,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,80.71,72.91,86.59,114.24,141.83,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9C0I1,MTMR12,Myotubularin-related protein 12 OS=Homo sapiens OX=9606 GN=MTMR12 PE=1 SV=2,1,2,28.41,0.048,100,0.013,4.83,-4.39,6.64,-6.27,2.51E-04,7.91E-05,1.00E-17,1.56E-04,5.49E+06,1.93E+05,2.62E+05,2.03E+07,1,4,3,1,,,,,5.49E+06,2.68E+06,2.08E+05,1.79E+05,1.35E+05,,3.02E+06,,2.62E+05,3.38E+04,,,,,,2.03E+07,,,,,2.83E+05,9.52E+03,3.70E+03,1.65E+03,3.79E+03,,1.81E+04,,2.13E+03,4.55E+03,,,,,,2.16E+05,0.001,FALSE,3.292,1,1,747,86.1,6.62,1,,cytosol;cytoskeleton;ER/Golgi;other cell component,"Pf06602, Pf12578",54545,hsa:54545; Q69YJ4; Q6PFW3; Q96QU2; Q9C0I1; Q9NX27,ENSG00000150712,Synthesis of PIPs at the early endosome membrane,,1,0,,156.52,150.4,,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,38.01,135.41,38.01,135.41,5.42,,0,
Master Protein,High,Q6ZWC4,,Putative uncharacterized protein LOC100128429 OS=Homo sapiens OX=9606 PE=5 SV=1,1,1,26.796,0.01,0.197,0.01,4.74,-6.64,-2.34,-6.64,2.85E-04,1.00E-17,1.41E-01,1.00E-17,2.65E+06,9.88E+04,,1.95E+04,1,2,,2,,2.65E+06,,,,9.32E+04,1.05E+05,,,,,,,,,,7.83E+03,,4.85E+04,,,1.01E+04,,,,3.31E+02,1.86E+03,,,,,,,,,,2.20E+03,,1.13E+03,,0.005,FALSE,2.53,8,1,215,23,9.03,1,,,,,,,,,0,0,,8.31,,102.07,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,Phospho [T171],FALSE,8.72,,145.78,,2.59,,1,Phospho [T171]
Master Protein,High,Q01081,U2AF1,Splicing factor U2AF 35 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF1 PE=1 SV=3,5,26,24.453,0.135,0.65,3.557,4.61,-2.89,-0.62,1.83,1.48E-03,1.30E-02,6.40E-01,1.42E-01,1.52E+06,9.96E+04,5.12E+05,6.82E+04,4,1,5,3,2.44E+06,,8.05E+05,5.23E+06,9.48E+05,,,,,9.96E+04,5.12E+05,6.37E+05,2.43E+05,7.65E+05,2.84E+04,,9.61E+04,6.14E+04,,6.82E+04,9.68E+03,,7.87E+03,5.23E+06,4.89E+04,,,,,1.06E+03,3.06E+03,2.84E+04,1.97E+03,1.03E+05,7.05E+02,,2.70E+04,4.35E+02,,7.26E+02,0,FALSE,49.055,33,5,240,27.9,8.81,5,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00076, Pf00642",102724594; 7307,hsa:102724594; hsa:7307; Q01081; Q701P4; Q71RF1,ENSG00000160201,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,mRNA processing,5,0,87.16,,68.44,24.4,Peak Found,n/a,High,High,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,73.56,138.98,7.81,8.94,91.91,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BQA9,CYBC1,Cytochrome b-245 chaperone 1 OS=Homo sapiens OX=9606 GN=CYBC1 PE=1 SV=1,1,4,23.559,0.149,3.86,0.519,4.56,-2.74,1.95,-0.95,2.80E-03,3.83E-02,2.73E-01,7.10E-01,1.21E+06,5.13E+04,2.30E+05,1.76E+05,4,2,3,5,,1.94E+06,4.62E+05,1.02E+06,1.43E+06,,6.86E+04,,3.83E+04,,,6.42E+04,,2.65E+05,2.30E+05,5.10E+05,3.16E+03,1.76E+06,1.76E+05,1.25E+05,,7.38E+03,4.51E+03,1.02E+06,7.36E+04,,1.22E+03,,1.08E+03,,,2.87E+03,,3.57E+04,5.70E+03,9.95E+02,8.87E+02,1.25E+04,4.11E+03,1.33E+03,0.005,FALSE,2.52,4,1,187,20.8,6.8,1,other metabolic processes;stress response,other membranes;ER/Golgi,Pf15169,79415,E1B6X3; hsa:79415; Q96NR1; Q9BQA9,ENSG00000178927,,Genetic causes of porto-sinusoidal vascular disease,1,0,51.67,40.01,57.57,140.08,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,63.45,56.24,141.41,112.07,6.71,,0,
Master Protein,High,P42766,RPL35,60S ribosomal protein L35 OS=Homo sapiens OX=9606 GN=RPL35 PE=1 SV=2,4,27,22.559,1.293,4.998,3.149,4.5,0.37,2.32,1.65,2.80E-03,3.35E-01,1.23E-01,2.41E-01,1.33E+06,9.67E+04,3.04E+06,9.93E+05,3,3,5,4,,,1.73E+05,1.19E+07,1.33E+06,1.57E+05,,9.67E+04,,2.62E+04,2.76E+05,5.97E+06,7.89E+05,4.72E+06,3.04E+06,,1.05E+06,9.41E+05,1.10E+06,1.32E+05,,,1.69E+03,1.19E+07,6.84E+04,5.59E+02,,8.93E+02,,2.79E+02,1.65E+03,2.66E+05,6.41E+03,6.36E+05,7.55E+04,,2.95E+05,6.67E+03,2.57E+04,1.40E+03,0,FALSE,14.168,29,4,123,14.5,11.05,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;translational apparatus;nucleus;other cell component,Pf00831,11224,A8K4V7; hsa:11224; P42766; Q4VBY5; Q5JTN5; Q6IBC7; Q96QJ7; Q9BYF4,ENSG00000136942,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,144.79,70.19,82.91,56.35,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.47,125.59,81.86,87.8,57.21,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P68032,ACTC1,"Actin, alpha cardiac muscle 1 OS=Homo sapiens OX=9606 GN=ACTC1 PE=1 SV=1",13,643,22.254,1.086,5.983,5.704,4.48,0.12,2.58,2.51,7.09E-04,5.06E-01,2.53E-02,1.05E-01,1.01E+08,7.32E+05,3.59E+07,2.73E+06,5,5,5,5,3.33E+08,7.86E+05,1.01E+08,1.02E+08,9.39E+06,3.40E+06,3.47E+05,9.61E+05,7.32E+05,5.63E+05,3.59E+07,1.06E+07,2.82E+07,1.04E+08,6.33E+07,2.73E+06,7.77E+07,1.25E+07,1.80E+06,9.57E+05,1.32E+06,2.98E+03,9.90E+05,1.02E+08,4.84E+05,1.21E+04,6.17E+03,8.87E+03,2.06E+04,5.99E+03,2.15E+05,4.72E+05,2.29E+05,1.41E+07,1.57E+06,5.32E+03,2.18E+07,8.83E+04,4.22E+04,1.02E+04,0,FALSE,85.884,33,1,377,42,5.39,13,cell organization and biogenesis;developmental processes;other biological processes,cytosol;cytoskeleton;other cell component,Pf00022,70,hsa:70; P04270; P68032,ENSG00000159251,RHOA GTPase cycle; RHOB GTPase cycle; Striated Muscle Contraction,Cardiac progenitor differentiation; Myometrial relaxation and contraction pathways; Striated muscle contraction pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; 22q11.2 copy number variation syndrome; Pleural mesothelioma,9,0,122.66,104.02,75.45,172.87,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,High,Peak Found,Peak Found,1,,FALSE,138.97,144.93,118.03,125.89,1448.73,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A3B3IUA2,SNU13,Ribonucloprotein OS=Homo sapiens OX=9606 GN=SNU13 PE=1 SV=1,3,8,19.684,1.057,6.78,3.922,4.3,0.08,2.76,1.97,1.59E-03,5.21E-01,1.12E-01,1.50E-01,5.17E+05,4.66E+04,7.46E+05,1.89E+05,3,2,4,3,,5.17E+05,,7.16E+06,1.57E+05,9.62E+04,,,2.26E+04,,,1.36E+06,2.34E+05,2.08E+06,4.11E+05,,,5.29E+05,1.23E+05,1.89E+05,,1.96E+03,,7.16E+06,8.08E+03,3.42E+02,,,6.36E+02,,,6.06E+04,1.90E+03,2.80E+05,1.02E+04,,,3.75E+03,2.88E+03,2.01E+03,0,FALSE,12.372,15,3,272,30.1,9.55,3,other biological processes,nucleus;other cell component,Pf01248,,A0A3B3IUA2,ENSG00000100138,,,0,0,151.01,87.69,84.45,77.75,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,148.66,121.43,31.38,93.58,19.69,nucleic acid binding activity,0,
Master Protein,High,P41217,CD200,OX-2 membrane glycoprotein OS=Homo sapiens OX=9606 GN=CD200 PE=1 SV=4,3,14,18.313,0.61,2.184,4.204,4.19,-0.71,1.13,2.07,2.21E-03,8.93E-01,5.39E-01,1.30E-01,5.64E+05,3.08E+04,5.98E+05,6.72E+04,5,1,5,3,2.58E+06,7.10E+04,5.64E+05,1.35E+06,1.53E+05,,3.08E+04,,,,8.72E+05,2.04E+05,5.61E+04,5.98E+05,7.25E+05,,2.88E+04,6.72E+04,,1.08E+05,1.03E+04,2.70E+02,5.51E+03,1.35E+06,7.89E+03,,5.47E+02,,,,5.21E+03,9.10E+03,4.56E+02,8.05E+04,1.80E+04,,8.09E+03,4.76E+02,,1.15E+03,0,FALSE,14.956,18,3,278,31.2,8.51,3,cell adhesion;other biological processes,plasma membrane;other membranes;other cell component,Pf00047,4345,B3KQI1; B4DLW9; D3DN65; hsa:4345; P41217; Q6J2Q6; Q6PIQ4; Q8TB85; Q9H3J3,ENSG00000091972,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Vitamin D receptor pathway,2,0,110.83,,70.78,58.25,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,108.02,117.79,84.75,101.18,34.48,other molecular function,0,
Master Protein,High,Q8IUE6,H2AC21,Histone H2A type 2-B OS=Homo sapiens OX=9606 GN=H2AC21 PE=1 SV=3,10,739,17.878,0.396,2.207,16.734,4.16,-1.34,1.14,4.06,1.69E-03,4.10E-01,5.37E-01,1.00E-02,9.31E+06,2.00E+05,2.15E+07,1.49E+05,4,4,5,5,,2.22E+05,1.08E+07,1.03E+08,8.05E+06,,8.37E+05,9.29E+04,4.32E+05,1.85E+04,8.69E+06,6.08E+07,1.92E+07,2.75E+07,2.15E+07,3.63E+06,4.21E+04,4.09E+04,1.49E+05,2.70E+06,,8.44E+02,1.05E+05,1.03E+08,4.15E+05,,1.49E+04,8.58E+02,1.22E+04,1.97E+02,5.20E+04,2.72E+06,1.56E+05,3.70E+06,5.34E+05,7.09E+03,1.18E+04,2.90E+02,3.49E+03,2.87E+04,0,FALSE,92.306,75,2,130,14,10.89,10,,other cell component,"Pf00125, Pf16211",317772,hsa:317772; Q8IUE6,ENSG00000184270,UCH proteinases; Ub-specific processing proteases; HCMV Late Events; HCMV Early Events; HDACs deacetylate histones; Metalloprotease DUBs; RMTs methylate histone arginines; HATs acetylate histones,,8,0,159.05,108.39,71.91,131.33,n/a,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,136.77,133.5,143.57,148.25,1919.13,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O60869,EDF1,Endothelial differentiation-related factor 1 OS=Homo sapiens OX=9606 GN=EDF1 PE=1 SV=1,2,11,17.766,0.989,3.484,1.902,4.15,-0.02,1.8,0.93,3.48E-03,6.31E-01,3.41E-01,4.28E-01,6.32E+04,7.09E+04,6.43E+05,1.34E+05,3,2,3,5,,6.32E+04,4.81E+04,1.71E+06,,,,1.46E+05,3.45E+04,,,6.43E+05,,1.33E+06,6.07E+05,8.13E+04,3.10E+05,7.95E+04,1.34E+05,4.55E+05,,2.40E+02,4.70E+02,1.71E+06,,,,1.34E+03,9.71E+02,,,2.87E+04,,1.79E+05,1.51E+04,1.59E+02,8.71E+04,5.63E+02,3.14E+03,4.84E+03,0,FALSE,7.284,16,2,148,16.4,9.95,2,other biological processes,cytosol;nucleus;other cell component,"Pf01381, Pf08523",8721,hsa:8721; O60869; Q5T5T2; Q9UIM1,ENSG00000107223,,,0,0,157.35,87.29,47.27,77.99,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,High,n/a,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,116.31,87.21,86.5,75.27,31.2,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P25787,PSMA2,Proteasome subunit alpha type-2 OS=Homo sapiens OX=9606 GN=PSMA2 PE=1 SV=2,4,22,17.614,0.36,14.073,0.549,4.14,-1.47,3.81,-0.87,4.48E-03,3.52E-01,4.78E-03,7.09E-01,1.47E+06,6.22E+04,6.49E+05,1.70E+06,4,1,5,2,7.15E+06,,2.77E+06,7.85E+05,1.74E+05,,6.22E+04,,,,2.57E+06,1.49E+05,8.40E+04,8.62E+05,6.49E+05,,2.45E+06,,1.17E+06,,2.84E+04,,2.71E+04,7.85E+05,8.97E+03,,1.11E+03,,,,1.54E+04,6.68E+03,6.82E+02,1.16E+05,1.61E+04,,6.89E+05,,2.74E+04,,0,FALSE,23.366,33,4,234,25.9,7.43,4,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf00227, Pf10584",5683,hsa:5683; P25787; Q6ICS6; Q9BU45,ENSG00000106588,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,63,0,115.97,,117.05,49.91,High,n/a,High,High,High,n/a,Peak Found,n/a,n/a,n/a,High,High,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,175.58,127.19,81.02,116.7,75.35,,0,
Master Protein,High,P62805,H4C1; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9,Histone H4 OS=Homo sapiens OX=9606 GN=H4C1 PE=1 SV=2,18,1685,17.008,1.271,2.799,11.643,4.09,0.35,1.48,3.54,2.04E-03,3.69E-01,2.37E-01,2.42E-02,9.63E+08,1.38E+08,3.13E+09,4.73E+08,5,5,5,5,9.57E+08,7.51E+08,3.69E+09,2.78E+09,9.63E+08,7.70E+08,9.60E+07,1.38E+08,1.01E+08,9.04E+08,2.39E+09,3.30E+09,3.13E+09,2.43E+09,4.49E+09,4.73E+08,7.04E+08,1.78E+08,7.51E+08,8.05E+07,3.80E+06,2.85E+06,3.61E+07,2.78E+09,4.97E+07,2.74E+06,1.71E+06,1.27E+06,2.85E+06,9.61E+06,1.43E+07,1.47E+08,2.54E+07,3.28E+08,1.12E+08,9.23E+05,1.98E+08,1.26E+06,1.76E+07,8.57E+05,0,FALSE,164.037,62,18,103,11.4,11.36,18,cell organization and biogenesis;other biological processes,non-structural extracellular;nucleus;other cell component,Pf15511,121504; 554313; 8294; 8359; 8360; 8361; 8362; 8363; 8364; 8365; 8366; 8367; 8368; 8370,A2VCL0; hsa:121504; hsa:554313; hsa:8294; hsa:8359; hsa:8360; hsa:8361; hsa:8362; hsa:8363; hsa:8364; hsa:8365; hsa:8366; hsa:8367; hsa:8368; hsa:8370; P02304; P02305; P62805; Q6DRA9; Q6FGB8; Q6NWP7,ENSG00000158406; ENSG00000197061; ENSG00000197238; ENSG00000197837; ENSG00000270276; ENSG00000270882; ENSG00000273542; ENSG00000274618; ENSG00000275126; ENSG00000276180; ENSG00000276966; ENSG00000277157; ENSG00000278637; ENSG00000278705,SUMOylation of chromatin organization proteins; HCMV Late Events; Amyloid fiber formation; Meiotic synapsis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; HCMV Early Events; Transcriptional regulation by small RNAs; Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RMTs methylate histone arginines; HDMs demethylate histones; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; HATs acetylate histones; Chromatin modifications during the maternal to zygotic transition (MZT); RNA Polymerase I Promoter Escape; Meiotic recombination; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Packaging Of Telomere Ends; Condensation of Prophase Chromosomes; DNA Damage/Telomere Stress Induced Senescence; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; Nonhomologous End-Joining (NHEJ); RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis; Replacement of protamines by nucleosomes in the male pronucleus,Gastric cancer network 1; Histone modifications; 22q11.2 copy number variation syndrome; Male infertility; Type II interferon signaling,52,0,72.61,99.67,27.07,69.14,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,138.75,141.1,129.58,130.97,4309.34,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O95777,LSM8,U6 snRNA-associated Sm-like protein LSm8 OS=Homo sapiens OX=9606 GN=LSM8 PE=1 SV=3,2,6,16.866,0.181,2.748,0.473,4.08,-2.46,1.46,-1.08,5.19E-03,6.56E-02,4.12E-01,6.59E-01,1.39E+06,3.69E+04,7.55E+04,8.01E+04,3,3,5,5,4.75E+04,,,1.39E+06,6.74E+06,5.66E+04,2.13E+04,3.69E+04,,,7.55E+04,3.48E+04,1.90E+04,1.64E+06,2.09E+05,8.01E+04,1.36E+05,5.86E+04,6.75E+04,1.48E+06,1.89E+02,,,1.39E+06,3.48E+05,2.01E+02,3.79E+02,3.40E+02,,,4.51E+02,1.55E+03,1.55E+02,2.21E+05,5.18E+03,1.56E+02,3.83E+04,4.15E+02,1.58E+03,1.58E+04,0,FALSE,7.982,24,2,96,10.4,4.48,2,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf01423,51691,hsa:51691; O95777,ENSG00000128534,mRNA Splicing - Major Pathway,,1,0,129.83,46.2,176.87,171.37,Peak Found,n/a,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,136.94,138.49,62.6,113.57,13,nucleic acid binding activity,0,
Master Protein,High,O95218,ZRANB2,Zinc finger Ran-binding domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ZRANB2 PE=1 SV=2,2,4,15.948,0.312,0.01,100,4,-1.68,-6.64,6.64,2.99E-03,3.14E-01,1.00E-17,1.00E-17,3.78E+05,2.37E+04,1.18E+05,,2,1,2,,,,,1.03E+06,1.38E+05,,,,2.37E+04,,,4.93E+04,,2.83E+05,,,,,,,,,,1.03E+06,7.14E+03,,,,6.68E+02,,,2.20E+03,,3.81E+04,,,,,,,0,FALSE,8.775,8,2,330,37.4,10.01,2,RNA metabolism OR transcription;other metabolic processes,nucleus,Pf00641,9406,D3DQ75; hsa:9406; O95218; Q53GS3; Q59F92; Q5VV33; Q5VV34; Q8IXN6; Q9UP63,ENSG00000132485,,,0,0,108.03,,99.45,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,175.47,73.25,,,12.97,other molecular function,0,
Master Protein,High,H0YKD8,RPL28,60S ribosomal protein L28 OS=Homo sapiens OX=9606 GN=RPL28 PE=1 SV=1,2,4,15.722,0.632,3.933,2.527,3.97,-0.66,1.98,1.34,3.58E-03,9.09E-01,2.69E-01,3.20E-01,6.15E+05,2.48E+04,2.81E+05,1.16E+05,3,3,2,2,,,9.36E+04,6.15E+05,7.14E+05,,2.48E+04,,3.32E+04,2.40E+04,8.72E+05,,,9.02E+04,,,3.33E+05,,,4.01E+04,,,9.15E+02,6.15E+05,3.68E+04,,4.40E+02,,9.36E+02,2.55E+02,5.21E+03,,,1.22E+04,,,9.36E+04,,,4.26E+02,0,FALSE,7.135,11,2,170,19.1,11.46,2,protein metabolism;other metabolic processes,translational apparatus,Pf01778,,H0YKD8,ENSG00000108107,,,0,0,70.27,18.76,114.89,111.08,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,Peak Found,1,,FALSE,21.32,177.74,151.86,74.53,9.42,other molecular function,0,
Master Protein,High,F5H5D3,TUBA1C,Tubulin alpha chain OS=Homo sapiens OX=9606 GN=TUBA1C PE=1 SV=1,21,405,15.66,0.16,1.461,1.833,3.97,-2.64,0.55,0.87,2.78E-03,3.09E-02,7.00E-01,4.88E-01,9.40E+06,8.56E+05,1.67E+06,2.47E+06,5,2,5,4,1.67E+08,2.76E+06,1.79E+07,9.40E+06,7.24E+06,2.56E+06,2.85E+05,,,,8.94E+07,4.22E+05,8.95E+05,1.67E+06,7.94E+06,2.03E+05,4.90E+06,2.86E+06,2.13E+06,,6.64E+05,1.05E+04,1.75E+05,9.40E+06,3.73E+05,9.12E+03,5.08E+03,,,,5.34E+05,1.88E+04,7.27E+03,2.25E+05,1.97E+05,3.97E+02,1.38E+06,2.03E+04,4.99E+04,,0,FALSE,134.44,52,1,519,57.7,5.07,21,cell organization and biogenesis;other biological processes,cytoskeleton;other cell component,"Pf00091, Pf03953",84790,F5H5D3,ENSG00000167553,,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; VEGFA-VEGFR2 signaling; Alzheimer's disease; HDAC6 interactions in the central nervous system,6,1,173.1,113.09,193.74,76.89,n/a,n/a,High,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,126.12,142.09,108.07,134.92,1026.28,cytoskeletal activity;other molecular function,0,
Master Protein,High,F8W930,IGF2BP2,Insulin like growth factor 2 mRNA binding protein 2 OS=Homo sapiens OX=9606 GN=IGF2BP2 PE=1 SV=1,1,1,15.107,0.018,0.227,0.713,3.92,-5.78,-2.14,-0.49,1.94E-03,3.26E-08,1.70E-01,9.26E-01,3.89E+06,1.29E+05,2.29E+04,3.21E+04,4,3,3,2,3.53E+06,4.28E+06,5.25E+06,8.52E+04,,6.28E+05,1.29E+05,,,5.21E+04,2.67E+05,2.29E+04,,6.28E+03,,,5.53E+04,,1.86E+04,,1.40E+04,1.63E+04,5.13E+04,8.52E+04,,2.23E+03,2.29E+03,,,5.54E+02,1.59E+03,1.02E+03,,8.47E+02,,,1.55E+04,,4.36E+02,,0.005,FALSE,2.533,2,1,605,66.7,8.46,1,transport,other cell component,"Pf00013, Pf00076",10644,F8W930,ENSG00000073792,,,0,0,68.38,115.95,147.82,70.12,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,144.35,207,100.75,133.6,2.45,nucleic acid binding activity,0,
Master Protein,High,P01911,HLA-DRB1,"HLA class II histocompatibility antigen, DRB1 beta chain OS=Homo sapiens OX=9606 GN=HLA-DRB1 PE=1 SV=2",8,59,14.427,0.38,6.041,1.233,3.85,-1.4,2.59,0.3,3.75E-03,3.76E-01,3.08E-02,7.93E-01,1.32E+07,5.71E+05,5.24E+06,1.94E+06,5,5,5,5,1.32E+07,8.02E+06,1.77E+07,2.56E+07,1.21E+07,4.18E+05,5.71E+05,1.19E+06,8.99E+05,4.61E+05,5.24E+06,6.02E+06,1.51E+06,3.44E+06,8.56E+06,1.94E+06,3.49E+05,1.89E+06,1.01E+07,2.68E+07,5.26E+04,3.05E+04,1.73E+05,2.56E+07,6.25E+05,1.49E+03,1.02E+04,1.10E+04,2.53E+04,4.90E+03,3.13E+04,2.69E+05,1.23E+04,4.64E+05,2.13E+05,3.78E+03,9.82E+04,1.34E+04,2.37E+05,2.86E+05,0,FALSE,62.217,42,2,266,29.9,7.74,8,cell organization and biogenesis;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00969, Pf07654",3123,A0MWF2; A0N0W1; A2ICT1; A2TGX3; A4F5N0; A4ZXA5; A4ZXA6; A4ZY86; A5H000; A5HKN8; A7DZP9; A7LA26; A7UHG2; A7X5B1; A7X5B7; A7X5E0; A7X5E6; A7X5H8; A7X5J4; A7X5K7; A8K098; A8YQE9; A9JPG0; B0BK85; B0LUZ6; B0UYW1; B1GWE7; B2CR03; B2LVF9; B2NJ29; B2ZCY1; B3VTP8; B3VTQ3; B5A8Y2; B5A8Y3; B5B8U0; B5B9V5; B5B9V6; B5LZ25; B5QSK8; B6VCX2; B6VEL9; B7UDB2; B9VRA4; B9X248; C0LAB5; hsa:3123; O02876; O02930; O19585; O19717; O19718; O19739; O19788; O46699; O46793; O46872; O62869; O62889; O77969; O78047; O78210; O98212; P01911; P01912; P01914; P04229; P13758; P13759; P13760; P13761; P20039; P79545; Q06662; Q0PGR5; Q0PQ39; Q14280; Q14QT2; Q155F7; Q19AF2; Q19K86; Q1AP33; Q1G0Z9; Q1JRP3; Q1KLJ6; Q27PR6; Q27PR7; Q29673; Q29720; Q29722; Q29734; Q29770; Q29771; Q29772; Q29790; Q29792; Q29800; Q29806; Q29833; Q29874; Q29875; Q29886; Q29968; Q29974; Q29975; Q2A120; Q2HZE5; Q2L9H4; Q2LE76; Q2MF40; Q2MJA6; Q2MZ92; Q2VQU1; Q2YHQ2; Q30006; Q30108; Q30112; Q30115; Q30116; Q30117; Q30120; Q30134; Q30142; Q30145; Q30149; Q30159; Q30166; Q30167; Q30200; Q307W5; Q31636; Q32MY7; Q3HUP9; Q3KTM1; Q3LA84; Q3LA87; Q3LA88; Q3LA89; Q3LA90; Q3LA91; Q3LA92; Q3LA93; Q3LA94; Q3LA95; Q3LA96; Q3LA97; Q3LA98; Q3LA99; Q3LAA0; Q3LAA1; Q3LAA2; Q3MQ60; Q3T919; Q4PRC3; Q4PRC5; Q4VZY7; Q53IG1; Q56FN9; Q56FP1; Q56FP2; Q56FP3; Q58F52; Q5BM92; Q5EER6; Q5K3W2; Q5NDB9; Q5U9W6; Q5UBA2; Q5UT58; Q5W3L4; Q5Y7A7; Q5Y7B0; Q5Y7B9; Q5Y7E9; Q5Y7G0; Q683P7; Q6REE2; Q6T865; Q6U387; Q701T1; Q70GL2; Q70Q85; Q768U2; Q768U4; Q7M2H4; Q7YNY9; Q7YP03; Q7YP04; Q7YQ26; Q7YQA3; Q7YQA5; Q860D8; Q860D9; Q860E5; Q860H8; Q860S0; Q860Z3; Q861G6; Q861H0; Q861H4; Q861H5; Q861H7; Q861H8; Q8HWQ6; Q8MH59; Q8MH60; Q8WLU3; Q8WMA0; Q95348; Q95383; Q95389; Q95461; Q95HK1; Q95HL0; Q95HL1; Q95IE3; Q95IG2; Q95IT6; Q96HZ9; Q9BCL7; Q9BCP0; Q9BCP1; Q9BCP2; Q9BCP5; Q9BD21; Q9BD33; Q9BD40; Q9GIK5; Q9GIL5; Q9GIL6; Q9GIP3; Q9GIX8; Q9GIX9; Q9GIY0; Q9GIY1; Q9GIY2; Q9GIY3; Q9GIY4; Q9GJ25; Q9GJ56; Q9GJ57; Q9GJ58; Q9GJ60; Q9GJF8; Q9GJF9; Q9GJG0; Q9MXZ0; Q9MXZ5; Q9MY13; Q9MY45; Q9MY56; Q9MYF5; Q9TPB6; Q9TPW1; Q9TPW3; Q9TPW9; Q9TPX4; Q9TQ37; Q9TQ91; Q9TQE0; Q9UBY1; Q9UIM9; Q9UIN0; Q9XRX1; Q9XRY4; Q9XRY5; Q9Y453; Q9Y4H7,ENSG00000196126,Downstream TCR signaling; Phosphorylation of CD3 and TCR zeta chains; Translocation of ZAP-70 to Immunological synapse; Generation of second messenger molecules; PD-1 signaling; MHC class II antigen presentation; Interferon gamma signaling,Allograft rejection; Vitamin D receptor pathway; Ebola virus infection in host; Cancer immunotherapy by PD-1 blockade; Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; Genes associated with the development of rheumatoid arthritis; Network map of SARS-CoV-2 signaling pathway; Cell interactions of the pancreatic cancer microenvironment; Cytokines and inflammatory response; Primary ovarian insufficiency,17,3,43.66,46.52,53.75,134.68,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,99.91,85.05,133.9,113.07,168.75,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,Medium,Q8IY92,SLX4,Structure-specific endonuclease subunit SLX4 OS=Homo sapiens OX=9606 GN=SLX4 PE=1 SV=3,1,3,14.315,1.617,2.284,10.133,3.84,0.69,1.19,3.34,7.59E-03,1.93E-01,4.97E-01,1.87E-02,1.67E+06,1.16E+05,2.69E+06,2.66E+05,5,3,3,2,3.93E+06,2.52E+05,1.01E+07,1.67E+06,5.31E+04,1.96E+05,,,4.45E+04,1.16E+05,1.67E+06,,3.68E+06,,2.69E+06,,,,2.83E+05,2.50E+05,1.56E+04,9.56E+02,9.82E+04,1.67E+06,2.74E+03,6.98E+02,,,1.25E+03,1.24E+03,9.97E+03,,2.99E+04,,6.70E+04,,,,6.62E+03,2.66E+03,0.017,FALSE,2.052,0,1,1834,199.9,6.06,1,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,"Pf00651, Pf09494",84464,hsa:84464; Q69YT8; Q8IY92; Q8TF15; Q96JP1,ENSG00000188827,Resolution of D-loop Structures through Holliday Junction Intermediates; Fanconi Anemia Pathway,Nucleotide excision repair in xeroderma pigmentosum,3,0,129.63,63.76,37.55,8.72,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,143.54,123.67,60.12,46.4,5.44,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P63173,RPL38,60S ribosomal protein L38 OS=Homo sapiens OX=9606 GN=RPL38 PE=1 SV=2,3,43,14.204,0.931,7.259,1.825,3.83,-0.1,2.86,0.87,2.99E-03,6.61E-01,1.59E-02,5.42E-01,4.05E+06,2.85E+05,3.39E+06,2.97E+06,4,3,5,5,3.52E+06,,4.67E+06,8.27E+06,1.92E+06,2.31E+06,,3.01E+04,,2.85E+05,3.27E+06,7.26E+06,1.66E+06,9.79E+06,3.39E+06,6.19E+05,1.04E+07,2.97E+06,4.58E+06,2.19E+05,1.40E+04,,4.56E+04,8.27E+06,9.91E+04,8.23E+03,,2.78E+02,,3.03E+03,1.96E+04,3.24E+05,1.35E+04,1.32E+06,8.42E+04,1.21E+03,2.93E+06,2.11E+04,1.07E+05,2.33E+03,0,FALSE,17.082,36,3,70,8.2,10.1,3,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,cytosol;translational apparatus;other cell component,Pf01781,6169,B2R5A8; hsa:6169; P23411; P63173,ENSG00000172809,L13a-mediated translational silencing of Ceruloplasmin expression; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Response of EIF2AK4 (GCN2) to amino acid deficiency; Formation of a pool of free 40S subunits; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Mesodermal commitment pathway; Mesodermal commitment pathway; Cytoplasmic ribosomal proteins,16,0,58.71,142.78,65.94,109.64,High,n/a,High,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,High,High,High,High,High,Peak Found,High,High,High,Peak Found,1,,FALSE,129.79,72.04,132.59,101.69,128.98,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P07305,H1-0,Histone H1.0 OS=Homo sapiens OX=9606 GN=H1-0 PE=1 SV=3,7,108,13.958,0.301,0.836,7.416,3.8,-1.73,-0.26,2.89,4.22E-03,2.20E-01,7.19E-01,6.37E-02,4.42E+07,2.75E+06,2.54E+07,3.34E+06,5,5,5,5,8.14E+06,3.57E+07,9.63E+07,2.29E+08,4.42E+07,6.00E+06,8.74E+05,2.75E+06,1.48E+06,8.83E+06,1.17E+07,5.41E+07,4.56E+07,6.55E+06,2.54E+07,3.85E+06,3.34E+06,2.52E+06,1.44E+06,5.78E+06,3.24E+04,1.36E+05,9.41E+05,2.29E+08,2.28E+06,2.13E+04,1.55E+04,2.54E+04,4.16E+04,9.39E+04,6.97E+04,2.42E+06,3.71E+05,8.82E+05,6.31E+05,7.50E+03,9.38E+05,1.78E+04,3.36E+04,6.15E+04,0,FALSE,26.399,26,7,194,20.9,10.84,7,cell organization and biogenesis;other biological processes,cytoskeleton;ER/Golgi;nucleus;other cell component,Pf00538,3005,B2R6I0; B4DRD6; hsa:3005; P07305; Q6FG88; Q8N6R3,ENSG00000189060,Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF),,2,0,106.2,84.18,72.42,47.9,Peak Found,High,High,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,123.9,134.4,123.17,124.15,255.91,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q7L5N1,COPS6,COP9 signalosome complex subunit 6 OS=Homo sapiens OX=9606 GN=COPS6 PE=1 SV=1,2,2,13.203,0.01,5.427,0.01,3.72,-6.64,2.44,-6.64,1.10E-02,1.00E-17,1.26E-01,1.00E-17,8.45E+05,6.40E+04,,4.95E+05,1,4,,5,,,,,8.45E+05,1.09E+05,4.37E+04,9.36E+04,2.44E+04,,,,,,,8.79E+05,4.95E+05,4.29E+05,2.81E+05,1.14E+06,,,,,4.36E+04,3.89E+02,7.78E+02,8.64E+02,6.88E+02,,,,,,,1.71E+03,1.39E+05,3.04E+03,6.58E+03,1.22E+04,0,FALSE,4.678,9,2,327,36.1,5.73,2,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf01398, Pf13012",10980,A4D2A3; hsa:10980; O15387; Q7L5N1,ENSG00000168090,Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; DNA Damage Recognition in GG-NER,Nucleotide-binding oligomerization domain (NOD) pathway; Ciliary landscape,6,0,,59.32,,54.97,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,65.04,,113.64,,6.1,,0,
Master Protein,High,P15531,NME1,Nucleoside diphosphate kinase A OS=Homo sapiens OX=9606 GN=NME1 PE=1 SV=1,6,29,12.507,0.244,15.253,0.295,3.64,-2.04,3.93,-1.76,6.51E-03,1.87E-01,9.71E-03,3.21E-01,4.18E+05,3.34E+04,1.42E+05,4.80E+05,2,2,5,5,,,,1.62E+05,1.08E+06,,,2.62E+04,4.26E+04,,4.10E+04,4.70E+04,1.42E+05,2.29E+05,2.53E+05,2.16E+05,4.48E+05,5.80E+05,4.80E+05,7.31E+05,,,,1.62E+05,5.56E+04,,,2.42E+02,1.20E+03,,2.45E+02,2.10E+03,1.15E+03,3.09E+04,6.30E+03,4.21E+02,1.26E+05,4.11E+03,1.12E+04,7.78E+03,0,FALSE,25.924,46,1,152,17.1,6.19,6,DNA metabolism;other metabolic processes;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf00334,4830,hsa:4830; P15531; Q6FGK3; Q86XQ2; Q9UDJ6,ENSG00000239672,Interconversion of nucleotide di- and triphosphates; Azathioprine ADME; Ribavirin ADME,Pyrimidine metabolism,4,0,104.42,33.56,69.55,38.55,n/a,n/a,n/a,High,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.45,114.82,42.29,77.31,67.49,translation activity;kinase activity;other molecular function,0,
Master Protein,High,F5H2F4,MTHFD1,"C-1-tetrahydrofolate synthase, cytoplasmic OS=Homo sapiens OX=9606 GN=MTHFD1 PE=1 SV=2",3,4,11.899,0.228,6.959,0.39,3.57,-2.13,2.8,-1.36,7.71E-03,1.88E-01,9.95E-02,5.89E-01,3.66E+05,3.08E+04,8.35E+04,2.14E+05,3,1,3,5,3.66E+05,,,1.25E+05,9.51E+05,,,,,3.08E+04,,8.35E+04,,8.73E+04,7.57E+04,1.62E+05,5.39E+05,2.14E+05,2.62E+05,1.45E+05,1.46E+03,,,1.25E+05,4.91E+04,,,,,3.27E+02,,3.73E+03,,1.18E+04,1.88E+03,3.15E+02,1.51E+05,1.52E+03,6.12E+03,1.54E+03,0,FALSE,9.92,4,3,964,104.6,7.59,3,other metabolic processes,cytosol,"Pf00763, Pf01268, Pf02882",,F5H2F4,ENSG00000100714,,Male infertility,1,0,88.41,,7.2,60.59,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,97.83,97.83,36.4,37.57,10.54,other molecular function,0,
Master Protein,High,E2QRJ6,POLR2J3,RNA polymerase II subunit J3 OS=Homo sapiens OX=9606 GN=POLR2J3 PE=3 SV=1,2,10,11.632,0.25,,3.201,3.54,-2,,1.68,1.89E-02,1.76E-01,,2.48E-01,1.20E+06,9.80E+04,2.43E+05,4.63E+04,5,1,4,1,2.67E+06,1.05E+05,2.09E+06,1.20E+06,3.60E+04,,,,9.80E+04,,,2.43E+05,1.15E+05,1.04E+06,2.43E+05,,,,,4.63E+04,1.06E+04,3.99E+02,2.04E+04,1.20E+06,1.86E+03,,,,2.76E+03,,,1.09E+04,9.34E+02,1.40E+05,6.03E+03,,,,,4.93E+02,0,FALSE,12.786,23,2,158,17.2,5.52,2,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf01193, Pf13656",,E2QRJ6,ENSG00000168255,,,0,0,96.13,,103.3,,High,Peak Found,High,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,69.13,110.98,,112.52,27.92,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96FJ2,DYNLL2,"Dynein light chain 2, cytoplasmic OS=Homo sapiens OX=9606 GN=DYNLL2 PE=1 SV=1",3,26,11.614,0.675,3.597,1.723,3.54,-0.57,1.85,0.78,5.22E-03,9.70E-01,2.54E-01,4.97E-01,3.84E+06,1.59E+05,7.98E+05,3.61E+05,2,4,5,3,,,,7.75E+06,1.90E+06,1.01E+06,,4.41E+04,1.40E+04,5.74E+05,4.72E+04,1.92E+06,7.98E+05,9.03E+06,6.51E+05,,1.34E+06,,3.61E+05,3.32E+05,,,,7.75E+06,9.82E+04,3.58E+03,,4.07E+02,3.96E+02,6.10E+03,2.82E+02,8.59E+04,6.48E+03,1.22E+06,1.62E+04,,3.76E+05,,8.44E+03,3.53E+03,0,FALSE,19.465,51,3,89,10.3,7.37,3,other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf01221,140735,B2R5B4; hsa:140735; Q96FJ2,ENSG00000264364,Separation of Sister Chromatids; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; MHC class II antigen presentation; Intraflagellar transport; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; HCMV Early Events; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Macroautophagy; Activation of BMF and translocation to mitochondria,Ciliary landscape; Intraflagellar transport proteins binding to dynein; 3q29 copy number variation syndrome; Vasopressin-regulated water reabsorption,19,0,85.65,115.7,149.34,84.64,n/a,n/a,n/a,High,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,138.13,124.89,148.28,121.54,69.56,other molecular function,0,
Master Protein,High,Q9BYD2,MRPL9,"39S ribosomal protein L9, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL9 PE=1 SV=2",2,3,11.368,3.043,0.297,4.304,3.51,1.61,-1.75,2.11,8.34E-03,5.16E-02,2.58E-01,8.60E-02,3.94E+05,1.88E+04,5.50E+05,3.79E+04,3,2,1,2,,,1.12E+06,3.94E+05,3.06E+04,,,4.04E+04,8.76E+03,,,,,,5.50E+05,,1.31E+05,,1.10E+04,,,,1.10E+04,3.94E+05,1.58E+03,,,3.72E+02,2.47E+02,,,,,,1.37E+04,,3.67E+04,,2.58E+02,,0,FALSE,4.727,9,2,267,30.2,10.08,2,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf01281,65005,B2RD99; hsa:65005; Q5SZR2; Q9BSW8; Q9BYD2,ENSG00000143436,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,107.84,90.95,,119.42,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,154.13,0,63.22,0,8.19,other molecular function,0,
Master Protein,Medium,P12724,RNASE3,Eosinophil cationic protein OS=Homo sapiens OX=9606 GN=RNASE3 PE=1 SV=2,1,1,10.442,0.103,3.027,0.356,3.38,-3.28,1.6,-1.49,1.80E-02,7.70E-03,3.35E-01,4.26E-01,1.35E+06,1.29E+05,1.39E+05,3.91E+05,3,5,2,2,1.35E+06,1.48E+07,4.03E+05,,,1.29E+05,7.99E+05,1.20E+05,9.16E+05,1.03E+05,,,1.92E+05,1.01E+05,,3.86E+05,,,3.97E+05,,5.36E+03,5.64E+04,3.93E+03,,,4.59E+02,1.42E+04,1.11E+03,2.58E+04,1.10E+03,,,1.56E+03,1.36E+04,,7.52E+02,,,9.29E+03,,0.011,FALSE,2.241,4,1,160,18.4,10.02,1,RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,non-structural extracellular;other cytoplasmic organelle,Pf00074,6037,hsa:6037; P12724; Q4VBC1; Q8WTP7; Q8WZ62; Q9GZN9,ENSG00000169397,Neutrophil degranulation; Antimicrobial peptides,,2,0,146.01,98.56,44.31,2.01,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,115.52,101.67,37.29,48.22,0,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q6SPF0,SAMD1,Sterile alpha motif domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SAMD1 PE=1 SV=1,1,2,10.257,0.613,0.01,100,3.36,-0.71,-6.64,6.64,1.67E-02,9.13E-01,1.00E-17,1.00E-17,2.71E+05,2.64E+04,1.66E+05,,2,1,2,,,4.31E+05,,1.71E+05,,,,,2.64E+04,,,,,1.72E+05,1.61E+05,,,,,,,1.64E+03,,1.71E+05,,,,,7.45E+02,,,,,2.32E+04,3.99E+03,,,,,,0.02,FALSE,1.99,1,1,538,56,7.58,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;nucleus;other cell component,"Pf00536, Pf21524",90378,hsa:90378; Q6P0R3; Q6PIS7; Q6SPF0; Q96IM4,ENSG00000288488,,,0,0,61.17,,5.08,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,71.12,68.62,,,4.26,other molecular function,0,
Master Protein,High,A0A087WYV9,SYNJ2BP-COX16,"Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=SYNJ2BP-COX16 PE=3 SV=1",2,11,10.202,1.483,3.051,3.725,3.35,0.57,1.61,1.9,1.74E-02,2.10E-01,3.87E-01,1.79E-01,7.42E+05,7.28E+04,1.04E+06,2.22E+05,3,1,4,1,,7.42E+05,,1.22E+06,1.41E+05,,,,,7.28E+04,,8.70E+05,3.99E+05,2.48E+06,1.24E+06,,,2.22E+05,,,,2.82E+03,,1.22E+06,7.25E+03,,,,,7.74E+02,,3.89E+04,3.24E+03,3.35E+05,3.09E+04,,,1.57E+03,,,0,FALSE,11.443,22,2,182,20.5,6.1,2,,other membranes;mitochondrion,"Pf00595, Pf14138",100529257,A0A087WYV9,ENSG00000258644,,,0,0,77.23,,71.46,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,High,n/a,High,Peak Found,n/a,n/a,1,,FALSE,45.58,85.44,0,42.25,33.93,,0,
Master Protein,High,P22087,FBL,rRNA 2'-O-methyltransferase fibrillarin OS=Homo sapiens OX=9606 GN=FBL PE=1 SV=2,11,93,9.788,0.49,2.48,3.784,3.29,-1.03,1.31,1.92,1.38E-02,6.11E-01,4.24E-01,2.09E-01,2.13E+07,2.81E+05,6.44E+06,5.79E+05,5,4,5,5,3.75E+07,6.94E+06,2.13E+07,1.76E+07,3.94E+07,6.14E+05,,3.16E+04,1.29E+05,2.94E+06,1.52E+07,6.44E+06,2.97E+06,1.48E+07,3.84E+06,1.65E+06,1.17E+05,1.55E+06,5.79E+05,5.71E+05,1.49E+05,2.64E+04,2.08E+05,1.76E+07,2.03E+06,2.18E+03,,2.91E+02,3.63E+03,3.13E+04,9.10E+04,2.88E+05,2.41E+04,1.99E+06,9.55E+04,3.22E+03,3.28E+04,1.10E+04,1.35E+04,6.08E+03,0,FALSE,81.977,38,11,321,33.8,10.18,11,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf01269,2091,B5BUE8; hsa:2091; O75259; P22087; Q6IAT5; Q9UPI6,ENSG00000105202; ENSG00000280548,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,Rubinstein-Taybi syndrome 1,3,0,56.03,147.01,68.61,75.31,High,Peak Found,High,High,High,Peak Found,n/a,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,141.53,129.22,112.5,139.19,246.44,other molecular function,0,
Master Protein,High,Q9NRQ2,PLSCR4,Phospholipid scramblase 4 OS=Homo sapiens OX=9606 GN=PLSCR4 PE=1 SV=2,1,1,9.643,0.01,0.361,0.01,3.27,-6.64,-1.47,-6.64,1.45E-02,1.00E-17,2.25E-01,1.00E-17,8.91E+06,9.24E+05,,3.33E+05,1,1,,1,,8.91E+06,,,,,9.24E+05,,,,,,,,,,3.33E+05,,,,,3.39E+04,,,,,1.64E+04,,,,,,,,,,9.36E+04,,,,0.003,FALSE,2.736,4,1,329,37,5.82,1,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes,Pf03803,57088,A8K2E9; hsa:57088; Q2TTR3; Q658L3; Q6ZR73; Q7Z505; Q9NRQ2,ENSG00000114698,,Complement system in neuronal development and plasticity,1,0,,,,,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,0,,0,,2.83,signal transduction activity or receptor binding;transporter activity;other molecular function,0,
Master Protein,High,Q1KMD3,HNRNPUL2,Heterogeneous nuclear ribonucleoprotein U-like protein 2 OS=Homo sapiens OX=9606 GN=HNRNPUL2 PE=1 SV=1,14,33,9.64,0.214,2.567,0.491,3.27,-2.22,1.36,-1.03,1.45E-02,8.37E-02,2.84E-01,5.79E-01,8.54E+06,7.15E+05,4.49E+05,1.14E+07,5,5,5,5,8.02E+05,8.54E+06,3.78E+05,1.53E+07,1.36E+07,1.63E+05,7.15E+05,1.20E+05,1.73E+06,4.03E+06,1.33E+05,4.49E+05,3.81E+05,8.57E+06,7.68E+05,1.74E+07,8.13E+05,1.53E+07,6.99E+05,1.14E+07,3.18E+03,3.25E+04,3.69E+03,1.53E+07,7.01E+05,5.81E+02,1.27E+04,1.11E+03,4.87E+04,4.28E+04,7.94E+02,2.00E+04,3.09E+03,1.15E+06,1.91E+04,3.39E+04,2.28E+05,1.09E+05,1.64E+04,1.21E+05,0,FALSE,55.762,26,14,747,85.1,4.91,14,,nucleus;other cell component,"Pf00622, Pf02037, Pf13671",221092,hsa:221092; Q1KMD3; Q8N3B3,ENSG00000214753,,,0,0,90.23,120.68,177.01,87.02,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,139.85,112.81,117.88,135.35,109.59,,0,
Master Protein,High,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RPRD2 PE=1 SV=1,4,6,9.414,0.546,0.01,100,3.23,-0.87,-6.64,6.64,2.33E-02,7.67E-01,1.00E-17,1.00E-17,2.52E+05,1.74E+04,7.89E+04,,1,1,2,,,,,2.52E+05,,,,,1.74E+04,,,8.93E+04,,6.97E+04,,,,,,,,,,2.52E+05,,,,,4.90E+02,,,3.99E+03,,9.39E+03,,,,,,,0,FALSE,12.981,5,4,1461,155.9,7.42,4,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf04818,23248,A8K6N8; B3KPT1; B4E2Q6; hsa:23248; O75048; Q5VT51; Q5VT52; Q5VT53; Q6MZL4; Q86XD2; Q9P0D7,ENSG00000163125,RNA polymerase II transcribes snRNA genes,,1,0,,,17.47,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,5.95,,,18.53,other molecular function,0,
Master Protein,High,O75880,SCO1,"Protein SCO1 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=SCO1 PE=1 SV=1",4,8,9.166,0.643,6.724,3.27,3.2,-0.64,2.75,1.71,3.30E-02,9.79E-01,1.11E-01,2.16E-01,1.30E+06,7.72E+04,1.29E+06,2.62E+05,4,1,5,3,1.55E+05,5.57E+06,,2.07E+06,8.11E+05,,,,,7.72E+04,5.69E+05,2.88E+06,1.29E+06,1.32E+06,9.07E+05,,2.62E+05,,6.05E+04,4.46E+06,6.17E+02,2.12E+04,,2.07E+06,4.18E+04,,,,,8.21E+02,3.40E+03,1.28E+05,1.05E+04,1.78E+05,2.26E+04,,7.36E+04,,1.42E+03,4.75E+04,0,FALSE,12.045,20,4,301,33.8,8.88,4,cell organization and biogenesis;other biological processes,other membranes;cytoskeleton;mitochondrion,Pf02630,6341,B2RDM0; hsa:6341; O75880,ENSG00000133028,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,Electron transport chain: OXPHOS system in mitochondria; Copper homeostasis,5,0,112.18,,63.44,155.82,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,61.32,116.46,628.07,100.69,13.8,other molecular function,0,
Master Protein,High,P04275,VWF,von Willebrand factor OS=Homo sapiens OX=9606 GN=VWF PE=1 SV=4,3,4,9.138,0.01,0.01,,3.19,-6.64,-6.64,,3.49E-02,1.00E-17,1.00E-17,,1.17E+06,1.04E+05,,,1,3,,,,1.17E+06,,,,,,3.89E+05,1.04E+05,4.24E+04,,,,,,,,,,,,4.46E+03,,,,,,3.59E+03,2.94E+03,4.50E+02,,,,,,,,,,,0,FALSE,6.952,2,3,2813,309.1,5.48,3,cell adhesion;stress response;other biological processes,non-structural extracellular;extracellular matrix;ER/Golgi;other cell component,"Pf00092, Pf00093, Pf00094, Pf01826, Pf08742, Pf16164",7450,hsa:7450; P04275; Q8TCE8; Q99806,ENSG00000110799,Integrin cell surface interactions; Platelet degranulation ; Signaling by BRAF and RAF1 fusions; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Platelet Adhesion to exposed collagen; Intrinsic Pathway of Fibrin Clot Formation; Defective F8 cleavage by thrombin; Defective F8 binding to von Willebrand factor; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GP1b-IX-V activation signalling; Enhanced cleavage of VWF variant by ADAMTS13; Enhanced binding of GP1BA variant to VWF multimer:collagen ; Defective VWF cleavage by ADAMTS13 variant; Defective VWF binding to collagen type I ; Defective binding of VWF variant to GPIb:IX:V; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins,Blood clotting cascade; Focal adhesion; Dengue-2 interactions with complement and coagulation cascades; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; 22q11.2 copy number variation syndrome; Complement and coagulation cascades,30,0,,103.51,,,n/a,High,n/a,n/a,n/a,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,200.15,,,,4.37,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q13148,TARDBP,TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1,2,3,8.921,0.158,0.01,100,3.16,-2.66,-6.64,6.64,2.93E-02,1.14E-01,1.00E-17,1.00E-17,1.18E+05,1.03E+04,1.45E+04,,4,1,1,,8.90E+04,,9.52E+04,3.22E+05,1.46E+05,,,,1.03E+04,,,,,1.45E+04,,,,,,,3.53E+02,,9.30E+02,3.22E+05,7.52E+03,,,,2.91E+02,,,,,1.96E+03,,,,,,,0,FALSE,9.571,10,2,414,44.7,6.19,2,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,mitochondrion;nucleus;other cell component,"Pf00076, Pf18694, Pf20910",23435,A4GUK4; A4GUK5; A4GUK6; B2R629; B4DJ45; E2PU12; hsa:23435; Q13148; Q53H27; Q6FI92; Q96DJ0,ENSG00000120948,,MECP2 and associated Rett syndrome; HDAC6 interactions in the central nervous system,2,0,67,,,,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,28.94,28.94,,,10.16,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y4W2,LAS1L,Ribosomal biogenesis protein LAS1L OS=Homo sapiens OX=9606 GN=LAS1L PE=1 SV=2,1,4,8.812,0.298,0.01,100,3.14,-1.75,-6.64,6.64,1.99E-02,3.06E-01,1.00E-17,1.00E-17,3.49E+05,3.96E+04,1.04E+05,,1,1,5,,,,,3.49E+05,,,,,,3.96E+04,5.81E+04,1.04E+05,1.52E+05,4.86E+05,1.02E+05,,,,,,,,,3.49E+05,,,,,,4.21E+02,3.47E+02,4.64E+03,1.23E+03,6.55E+04,2.53E+03,,,,,,0.003,FALSE,2.729,2,1,734,83,4.73,1,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf04031,81887,A9X410; hsa:81887; Q5JXQ0; Q8TEN5; Q9H9V5; Q9Y4W2,ENSG00000001497,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,,,96.55,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,46.74,,,10.74,other molecular function,0,
Master Protein,High,O94925,GLS,"Glutaminase kidney isoform, mitochondrial OS=Homo sapiens OX=9606 GN=GLS PE=1 SV=1",12,29,8.807,0.863,3.308,2.619,3.14,-0.21,1.73,1.39,2.29E-02,7.44E-01,2.81E-01,3.18E-01,2.12E+06,2.87E+04,3.25E+06,7.52E+05,5,3,5,5,3.52E+05,4.72E+06,1.11E+05,4.79E+06,2.12E+06,,,1.11E+06,2.49E+04,2.87E+04,3.33E+05,1.88E+06,6.16E+06,3.25E+06,4.74E+06,7.52E+05,6.75E+05,7.88E+05,4.97E+05,1.07E+06,1.40E+03,1.79E+04,1.09E+03,4.79E+06,1.09E+05,,,1.02E+04,7.01E+02,3.05E+02,1.99E+03,8.39E+04,5.00E+04,4.38E+05,1.18E+05,1.47E+03,1.90E+05,5.58E+03,1.16E+04,1.14E+04,0,FALSE,57.41,26,10,669,73.4,7.77,12,cell-cell signaling;cell organization and biogenesis;other metabolic processes;other biological processes,cytosol;mitochondrion;other cell component,"Pf04960, Pf12796, Pf17959",2744,hsa:2744; O94925; Q9UL05; Q9UL06; Q9UL07; Q9UN40,ENSG00000115419,Glutamate Neurotransmitter Release Cycle; TP53 Regulates Metabolic Genes; Glutamate and glutamine metabolism,Amino acid metabolism; Metabolic reprogramming in colon cancer; Neuroinflammation and glutamatergic signaling; Amino acid metabolism in triple-negative breast cancer cells; Cell lineage map for neuronal differentiation,8,2,93.8,161.22,70.13,27.65,n/a,Peak Found,n/a,High,High,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,82.99,104.46,22.16,126.61,85.22,other molecular function,0,
Master Protein,High,P35606,COPB2,Coatomer subunit beta' OS=Homo sapiens OX=9606 GN=COPB2 PE=1 SV=2,3,8,8.767,0.141,12.043,0.118,3.13,-2.83,3.59,-3.08,2.06E-02,5.81E-02,2.26E-02,8.05E-02,3.24E+05,3.87E+04,3.06E+04,4.66E+05,3,1,3,5,,,5.54E+04,3.24E+05,8.15E+05,,,3.87E+04,,,,2.49E+04,,1.63E+05,3.06E+04,4.66E+05,1.78E+05,6.67E+05,2.69E+04,7.78E+05,,,5.42E+02,3.24E+05,4.20E+04,,,3.57E+02,,,,1.11E+03,,2.20E+04,7.60E+02,9.10E+02,4.99E+04,4.73E+03,6.30E+02,8.29E+03,0,FALSE,12.036,5,3,906,102.4,5.27,3,transport,other membranes;cytosol;ER/Golgi,"Pf00400, Pf04053",9276,B4DZI8; hsa:9276; P35606,ENSG00000184432,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,,2,0,96.72,,107.38,75.16,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,121.57,114.8,91.8,143.14,17.37,other molecular function,0,
Master Protein,High,A0A024R1R8,TMA7B,Translation machinery-associated protein 7B OS=Homo sapiens OX=9606 GN=TMA7B PE=3 SV=1,1,1,8.617,1.219,0.01,100,3.11,0.29,-6.64,6.64,3.41E-02,3.42E-01,1.00E-17,1.00E-17,8.29E+05,9.62E+04,8.91E+05,,5,3,4,,3.07E+05,8.29E+05,3.44E+05,1.74E+06,1.66E+06,,9.62E+04,,1.93E+05,7.34E+04,,2.75E+05,2.18E+05,2.89E+06,4.36E+06,,,,,,1.22E+03,3.15E+03,3.36E+03,1.74E+06,8.57E+04,,1.71E+03,,5.42E+03,7.80E+02,,1.23E+04,1.77E+03,3.89E+05,1.08E+05,,,,,,0.004,FALSE,2.672,14,1,64,7.1,9.99,1,,,Pf09072,,A0A024R1R8,ENSG00000225528,,,0,0,71.05,52.39,105.46,,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,86.76,130.68,,,1.92,,0,
Master Protein,High,Q9Y2R0,COA3,"Cytochrome c oxidase assembly factor 3 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=COA3 PE=1 SV=1",1,1,8.488,0.114,1.284,0.719,3.09,-3.14,0.36,-0.48,3.59E-02,2.05E-02,9.39E-01,9.31E-01,8.46E+05,9.97E+04,9.61E+04,2.24E+05,2,2,4,3,,,,5.71E+05,1.25E+06,,,,1.56E+04,6.38E+05,,1.63E+05,5.66E+04,5.67E+05,2.20E+04,,,2.30E+05,7.13E+04,2.24E+05,,,,5.71E+05,6.46E+04,,,,4.38E+02,6.79E+03,,7.29E+03,4.60E+02,7.64E+04,5.46E+02,,,1.63E+03,1.67E+03,2.39E+03,0.007,FALSE,2.353,9,1,106,11.7,9.6,1,cell organization and biogenesis;other biological processes,other membranes;mitochondrion,Pf09813,28958,A8K498; hsa:28958; Q9Y2R0,ENSG00000183978,,Mitochondrial complex IV assembly; Arsenic metabolism and reactive oxygen species generation,2,0,52.82,134.69,123.92,51.37,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,312.77,121.18,258.03,120.47,2.54,,0,
Master Protein,High,A0A994J7I5,KHDRBS3,"KH RNA binding domain containing, signal transduction associated 3 OS=Homo sapiens OX=9606 GN=KHDRBS3 PE=4 SV=1",6,10,8.467,0.171,0.01,100,3.08,-2.55,-6.64,6.64,2.22E-02,6.33E-02,1.00E-17,1.00E-17,4.23E+05,2.22E+05,9.26E+05,,5,2,3,,1.78E+05,3.39E+06,1.44E+05,4.05E+06,4.23E+05,,2.84E+05,,,1.74E+05,,1.39E+05,,9.26E+05,1.75E+06,,,,,,7.08E+02,1.29E+04,1.41E+03,4.05E+06,2.18E+04,,5.05E+03,,,1.85E+03,,6.22E+03,,1.25E+05,4.35E+04,,,,,,0,FALSE,24.744,17,6,470,50.7,9.63,6,,,,,A0A994J7I5,ENSG00000131773,,,0,0,117.21,34.12,85.81,,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,36.86,94.02,,,31.34,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q08945,SSRP1,FACT complex subunit SSRP1 OS=Homo sapiens OX=9606 GN=SSRP1 PE=1 SV=1,7,22,8.387,0.539,3.419,2.037,3.07,-0.89,1.77,1.03,2.36E-02,7.56E-01,3.10E-01,4.07E-01,5.30E+05,6.43E+04,3.76E+05,2.93E+05,5,5,5,3,5.30E+05,4.38E+05,6.11E+05,2.63E+06,4.11E+05,3.49E+05,1.56E+07,6.43E+04,2.14E+04,2.29E+04,1.35E+07,3.45E+05,5.37E+04,1.95E+06,3.76E+05,3.26E+05,2.65E+05,,2.93E+05,,2.11E+03,1.67E+03,5.97E+03,2.63E+06,2.12E+04,1.24E+03,2.77E+05,5.94E+02,6.02E+02,2.44E+02,8.07E+04,1.54E+04,4.36E+02,2.63E+05,9.33E+03,6.37E+02,7.45E+04,,6.85E+03,,0,FALSE,33.71,15,7,709,81,6.87,7,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus,"Pf00505, Pf03531, Pf08512, Pf17292, Pf21092, Pf21103",6749,hsa:6749; Q08945; Q5BJG8,ENSG00000149136,Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Regulation of TP53 Activity through Phosphorylation,,12,0,103.45,215.66,178.08,10.39,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,146.17,126.61,128.14,125.69,54.17,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BZZ5,API5,Apoptosis inhibitor 5 OS=Homo sapiens OX=9606 GN=API5 PE=1 SV=3,8,12,8.358,0.782,3.914,2.608,3.06,-0.35,1.97,1.38,4.22E-02,7.47E-01,2.07E-01,2.89E-01,1.22E+06,1.13E+05,8.74E+05,6.34E+05,5,1,4,5,5.02E+05,3.48E+06,6.30E+04,3.89E+06,1.22E+06,,,,,1.13E+05,,5.02E+05,5.59E+05,5.63E+06,1.37E+06,8.30E+05,9.77E+04,6.51E+05,5.89E+05,6.34E+05,1.99E+03,1.32E+04,6.16E+02,3.89E+06,6.30E+04,,,,,1.20E+03,,2.24E+04,4.54E+03,7.58E+05,3.40E+04,1.62E+03,2.75E+04,4.61E+03,1.38E+04,6.74E+03,0,FALSE,25.311,22,8,524,59,7.34,8,other biological processes,nucleus;other cell component,Pf05918,8539,B4DGR0; B4DRJ2; B4E283; D3DR21; G3V1C3; hsa:8539; O15441; Q9BZZ5; Q9Y4J7,ENSG00000166181,,,0,0,95.42,,121.2,48.98,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,44.26,111.51,114.81,111.55,37.39,other molecular function,0,
Master Protein,High,P11234,RALB,Ras-related protein Ral-B OS=Homo sapiens OX=9606 GN=RALB PE=1 SV=1,6,17,8.345,1.233,1.551,1.369,3.06,0.3,0.63,0.45,1.96E-02,3.24E-01,7.72E-01,6.50E-01,2.53E+06,2.73E+05,1.13E+06,7.89E+05,5,2,5,4,5.58E+06,4.98E+06,2.53E+06,2.52E+05,2.86E+05,2.33E+05,,3.20E+05,,,3.51E+05,1.13E+06,3.79E+05,3.92E+06,3.16E+06,4.95E+05,1.59E+06,2.77E+05,1.26E+06,,2.22E+04,1.89E+04,2.47E+04,2.52E+05,1.47E+04,8.27E+02,,2.95E+03,,,2.10E+03,5.05E+04,3.08E+03,5.28E+05,7.85E+04,9.65E+02,4.47E+05,1.96E+03,2.95E+04,,0,FALSE,16.423,37,6,206,23.4,6.62,6,cell cycle OR cell proliferation;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,Pf00071,5899,B4E040; hsa:5899; P11234; Q53T32; Q6ZS74,ENSG00000144118,p38MAPK events,Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Pancreatic adenocarcinoma pathway; Ciliary landscape; EGF/EGFR signaling pathway,6,0,92.34,22.3,92.35,68.64,Peak Found,High,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,134.81,130.15,47.56,100.8,32.74,other molecular function,0,
Master Protein,High,P20036,HLA-DPA1,"HLA class II histocompatibility antigen, DP alpha 1 chain OS=Homo sapiens OX=9606 GN=HLA-DPA1 PE=1 SV=1",3,38,8.28,0.47,1.597,1.882,3.05,-1.09,0.68,0.91,2.30E-02,5.68E-01,7.04E-01,4.97E-01,6.92E+06,4.53E+05,3.41E+06,9.84E+05,5,2,5,1,2.93E+06,7.72E+06,6.92E+06,5.12E+06,1.62E+07,,5.36E+05,3.82E+05,,,3.41E+06,4.81E+05,4.37E+05,1.54E+07,8.20E+06,,,,,9.84E+05,1.17E+04,2.93E+04,6.76E+04,5.12E+06,8.36E+05,,9.54E+03,3.53E+03,,,2.04E+04,2.15E+04,3.55E+03,2.08E+06,2.04E+05,,,,,1.05E+04,0,FALSE,22.685,18,3,260,29.4,5.21,3,cell organization and biogenesis;stress response;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00993, Pf07654",3113,A9YWH7; B9UKH4; O19722; O46883; P01905; P20036; P79554; Q2Q060; Q2Q061; Q5EY03; Q5STP1; Q6DQK4; Q9BCQ1; Q9TPX3; Q9XS10,ENSG00000168384; ENSG00000206291; ENSG00000224103; ENSG00000228163; ENSG00000229685; ENSG00000231389; ENSG00000235844; ENSG00000236177,Downstream TCR signaling; Phosphorylation of CD3 and TCR zeta chains; Translocation of ZAP-70 to Immunological synapse; Generation of second messenger molecules; PD-1 signaling; MHC class II antigen presentation; Interferon gamma signaling,Allograft rejection; Ebola virus infection in host,9,0,65.04,23.74,113.5,,High,High,High,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,High,High,High,High,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,116.56,132.26,0,138.07,130.57,other molecular function,0,
Master Protein,High,P17612,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens OX=9606 GN=PRKACA PE=1 SV=2,2,3,8.164,0.406,2.427,0.513,3.03,-1.3,1.28,-0.96,3.44E-02,5.08E-01,4.92E-01,7.21E-01,1.74E+05,4.47E+04,1.42E+05,1.08E+05,4,1,5,4,1.36E+05,1.39E+05,,2.18E+05,9.79E+05,4.47E+04,,,,,1.42E+05,1.14E+05,3.12E+05,4.51E+05,1.07E+05,9.78E+04,1.20E+05,,1.93E+04,1.07E+06,5.40E+02,5.27E+02,,2.18E+05,5.05E+04,1.59E+02,,,,,8.52E+02,5.07E+03,2.53E+03,6.08E+04,2.65E+03,1.91E+02,3.38E+04,,4.51E+02,1.14E+04,0.001,FALSE,4.183,6,2,351,40.6,8.79,2,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component,Pf00069,5566,hsa:5566; P17612; Q32P54; Q9H2Y0; Q9NRB4; Q9NRH9,ENSG00000072062; ENSG00000288516,"FCGR3A-mediated IL10 synthesis; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; MAPK6/MAPK4 signaling; Triglyceride catabolism; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Ion homeostasis; Interleukin-3, Interleukin-5 and GM-CSF signaling; RET signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; Mitochondrial protein degradation; Regulation of MECP2 expression and activity; PKA activation; PKA activation in glucagon signalling; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; CD209 (DC-SIGN) signaling; Rap1 signalling; HDL assembly; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase; Loss of phosphorylation of MECP2 at T308; ROBO receptors bind AKAP5; PKA-mediated phosphorylation of key metabolic factors",Nicotine effect on dopaminergic neurons; Sterol regulatory element-binding proteins (SREBP) signaling; Follicle stimulating hormone (FSH) signaling pathway; Microtubule cytoskeleton regulation; Dopamine metabolism; Common pathways underlying drug addiction; Complement system; Mesodermal commitment pathway; IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Mesodermal commitment pathway; G protein signaling pathways; MAPK signaling pathway; Cannabinoid receptor signaling; Lipid metabolism pathway; Phosphodiesterases in neuronal function; Ras signaling; Hedgehog signaling pathway; Thermogenesis; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Endochondral ossification; Endochondral ossification with skeletal dysplasias; GPR143 in melanocytes and retinal pigment epithelium cells; Neuroinflammation and glutamatergic signaling; Vasopressin-regulated water reabsorption; GDNF signaling; Urotensin-II-mediated signaling pathway; Calcium regulation in cardiac cells; KCNQ2-related epilepsies; ADHD and autism (ASD) linked metabolic pathways and SNP; EPAC1 and PKA reduction of retinal inflammation; Sudden infant death syndrome (SIDS) susceptibility pathways; Estrogen signaling pathway,75,0,111.29,,67.33,152.13,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,171.36,110.74,69.09,132.18,4.25,kinase activity;other molecular function,0,
Master Protein,High,P42285,MTREX,Exosome RNA helicase MTR4 OS=Homo sapiens OX=9606 GN=MTREX PE=1 SV=3,5,5,8.094,0.037,0.01,100,3.02,-4.76,-6.64,6.64,4.00E-02,1.07E-04,1.00E-17,1.00E-17,7.63E+05,9.43E+04,2.82E+04,,2,1,1,,1.92E+05,,,,3.03E+06,,,,,9.43E+04,2.82E+04,,,,,,,,,,7.64E+02,,,,1.56E+05,,,,,1.00E+03,1.69E+02,,,,,,,,,,0,FALSE,17.716,7,5,1042,117.7,6.52,5,RNA metabolism OR transcription;other metabolic processes;stress response,nucleus,"Pf00270, Pf00271, Pf08148, Pf13234, Pf21408",23517,hsa:23517; P42285; Q2M386; Q6MZZ8; Q6P170; Q8N5R0; Q8TAG2,ENSG00000039123,mRNA Splicing - Major Pathway; Major pathway of rRNA processing in the nucleolus and cytosol,,2,0,124.52,,,,Peak Found,n/a,n/a,High,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,275.41,275.41,,,15.5,other molecular function,0,
Master Protein,High,Q15022,SUZ12,Polycomb protein SUZ12 OS=Homo sapiens OX=9606 GN=SUZ12 PE=1 SV=3,5,8,7.578,0.36,,0.14,2.92,-1.47,,-2.84,2.87E-02,4.14E-01,,1.16E-01,3.66E+05,2.71E+04,1.50E+05,2.95E+05,1,1,4,1,,,,3.66E+05,,,2.71E+04,,,,,1.10E+05,4.35E+04,3.35E+05,2.04E+05,,,,2.95E+05,,,,,3.66E+05,,,4.82E+02,,,,,4.92E+03,3.53E+02,4.51E+04,5.06E+03,,,,6.91E+03,,0,FALSE,18.014,10,5,739,83,8.81,5,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes,nucleus;other cell component,Pf09733,23512,hsa:23512; Q15022; Q96BD9,ENSG00000178691,HCMV Early Events; SUMOylation of chromatin organization proteins; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6; Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; PRC2 methylates histones and DNA; Defective pyroptosis,Interactome of polycomb repressive complex 2 (PRC2) ; Tumor suppressor activity of SMARCB1; Epithelial to mesenchymal transition in colorectal cancer; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; Pleural mesothelioma; NF1 copy number variation syndrome,15,0,,,72.96,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,80.71,,42.69,23.94,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,B7Z4M1,RTN3,Reticulon OS=Homo sapiens OX=9606 GN=RTN3 PE=1 SV=1,1,9,7.463,0.24,1.572,1.313,2.9,-2.06,0.65,0.39,2.84E-02,1.85E-01,7.40E-01,7.16E-01,4.86E+05,4.51E+04,1.14E+05,7.09E+04,3,3,5,3,4.86E+05,,1.31E+05,5.51E+05,,,2.68E+04,,4.51E+04,7.38E+04,9.31E+04,1.14E+05,3.50E+04,5.17E+05,1.17E+05,,1.18E+06,,3.43E+04,7.09E+04,1.93E+03,,1.28E+03,5.51E+05,,,4.76E+02,,1.27E+03,7.85E+02,5.57E+02,5.09E+03,2.84E+02,6.97E+04,2.91E+03,,3.30E+05,,8.04E+02,7.55E+02,0,FALSE,6.53,12,1,123,12.7,7.83,1,,other membranes;ER/Golgi,Pf02453,,B7Z4M1,ENSG00000133318,,Alzheimer's disease and miRNA effects; Alzheimer's disease,2,0,58.05,48.79,110.71,151.91,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,90.54,98.08,101.34,137.31,24.1,,0,
Master Protein,High,Q07021,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial OS=Homo sapiens OX=9606 GN=C1QBP PE=1 SV=1",8,73,7.41,1.206,0.213,2.963,2.89,0.27,-2.23,1.57,3.17E-02,4.12E-01,3.53E-02,2.98E-01,8.91E+06,6.16E+05,2.89E+07,7.98E+06,2,3,4,4,,,,2.01E+07,3.95E+06,6.19E+07,6.16E+05,,,2.84E+05,,3.19E+07,2.46E+07,2.62E+07,3.38E+07,,6.38E+06,1.50E+06,1.81E+07,9.97E+06,,,,2.01E+07,2.04E+05,2.20E+05,1.10E+04,,,3.02E+03,,1.43E+06,2.00E+05,3.53E+06,8.40E+05,,1.79E+06,1.07E+04,4.23E+05,1.06E+05,0,FALSE,62.586,46,8,282,31.3,4.84,8,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component,Pf02330,708,hsa:708; Q07021; Q2HXR8; Q9NNY8,ENSG00000108561,RHOC GTPase cycle; RHOA GTPase cycle; Intrinsic Pathway of Fibrin Clot Formation; Apoptotic factor-mediated response; Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,Complement system; Mesodermal commitment pathway; Ebola virus infection in host,8,0,94.97,169.48,15.16,77.79,n/a,n/a,n/a,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,High,High,High,n/a,High,Peak Found,High,Peak Found,1,,FALSE,83.37,116.71,88.45,117.11,306.49,signal transduction activity or receptor binding;translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P21589,NT5E,5'-nucleotidase OS=Homo sapiens OX=9606 GN=NT5E PE=1 SV=1,4,8,7.397,0.3,0.088,10.457,2.89,-1.74,-3.5,3.39,4.27E-02,2.32E-01,2.76E-02,1.12E-02,1.46E+06,9.18E+04,5.68E+05,8.50E+03,5,3,5,2,1.83E+05,1.52E+06,1.76E+06,1.46E+06,3.54E+05,9.18E+04,1.41E+05,,,6.59E+04,2.16E+06,5.68E+05,7.58E+05,9.19E+04,2.06E+05,,5.74E+03,,1.26E+04,,7.28E+02,5.76E+03,1.72E+04,1.46E+06,1.83E+04,3.26E+02,2.51E+03,,,7.01E+02,1.29E+04,2.54E+04,6.16E+03,1.24E+04,5.13E+03,,1.61E+03,,2.94E+02,,0,FALSE,15.012,9,4,574,63.3,7.03,4,cell adhesion;DNA metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus,"Pf00149, Pf02872",4907,B3KQI8; hsa:4907; O75520; P21589; Q5W116,ENSG00000135318,Purinergic signaling in leishmaniasis infection; Purine catabolism; Pyrimidine catabolism; Nicotinate metabolism,Pluripotent stem cell differentiation pathway; NAD+ metabolism; Markers of kidney cell lineage,7,0,69.1,38.34,109.63,52.85,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,67.24,140.67,56.86,91.36,16.62,other molecular function,0,
Master Protein,Medium,P62312,LSM6,U6 snRNA-associated Sm-like protein LSm6 OS=Homo sapiens OX=9606 GN=LSM6 PE=1 SV=1,1,2,7.378,0.179,6.272,0.272,2.88,-2.48,2.65,-1.88,4.52E-02,1.06E-01,1.30E-01,3.82E-01,2.25E+05,4.32E+04,7.36E+04,2.71E+05,3,2,2,4,,2.25E+05,,1.71E+05,2.61E+06,7.02E+04,2.66E+04,,,,,,3.51E+04,1.54E+05,,1.14E+05,1.32E+04,6.45E+05,,8.98E+05,,8.54E+02,,1.71E+05,1.35E+05,2.50E+02,4.72E+02,,,,,,2.85E+02,2.08E+04,,2.22E+02,3.72E+03,4.57E+03,,9.56E+03,0.02,FALSE,1.989,9,1,80,9.1,9.58,1,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf01423,11157,hsa:11157; P62312; Q4W5J5; Q9Y4Y8,ENSG00000164167,mRNA Splicing - Major Pathway; mRNA decay by 5' to 3' exoribonuclease,,2,0,139.04,63.8,89.03,101.46,n/a,Peak Found,n/a,High,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,91.65,114.24,140.14,125.81,4.3,other molecular function,0,
Master Protein,High,P50148,GNAQ,Guanine nucleotide-binding protein G(q) subunit alpha OS=Homo sapiens OX=9606 GN=GNAQ PE=1 SV=4,4,9,7.263,1.386,17.166,1.461,2.86,0.47,4.1,0.55,5.77E-02,3.16E-01,6.51E-03,5.51E-01,9.93E+05,2.02E+04,1.49E+05,4.22E+05,3,2,5,3,2.34E+06,,9.93E+05,1.82E+05,,,,2.28E+04,1.80E+04,,1.10E+05,1.10E+04,1.49E+05,9.55E+05,6.16E+05,,4.22E+05,6.03E+04,7.13E+05,,9.29E+03,,9.70E+03,1.82E+05,,,,2.10E+02,5.06E+02,,6.59E+02,4.91E+02,1.21E+03,1.29E+05,1.53E+04,,1.18E+05,4.27E+02,1.67E+04,,0,FALSE,10.349,12,4,359,42.1,5.68,4,cell-cell signaling;stress response;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cell component,Pf00503,2776,hsa:2776; O15108; P50148; Q13462; Q6NT27; Q92471; Q9BZB9,ENSG00000156052,G alpha (q) signalling events; Thrombin signalling through proteinase activated receptors (PARs); G-protein activation; ADP signalling through P2Y purinoceptor 1; Thromboxane signalling through TP receptor; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion; PLC beta mediated events; Acetylcholine regulates insulin secretion,Thyroid stimulating hormone (TSH) signaling pathway; Microtubule cytoskeleton regulation; Alzheimer's disease and miRNA effects; Corticotropin-releasing hormone signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; Circadian rhythm genes; Cell-type dependent selectivity of CCK2R signaling; Hippo signaling regulation pathways; Gastrin signaling pathway; PKC-gamma calcium signaling pathway in ataxia; GPR143 in melanocytes and retinal pigment epithelium cells; Airway smooth muscle cell contraction; Prostaglandin and leukotriene metabolism in senescence ; Alzheimer's disease; Prostaglandin and leukotriene metabolism in senescence ; Calcium regulation in cardiac cells; GNAQ pathways in port-wine stain; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling,29,0,93,16.8,109.28,82.07,High,n/a,High,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,63.05,134.91,40.49,117.43,16.79,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,P04406,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens OX=9606 GN=GAPDH PE=1 SV=3,18,154,6.984,0.275,2.695,1.029,2.8,-1.86,1.43,0.04,3.73E-02,1.74E-01,2.57E-01,9.19E-01,4.47E+07,2.79E+06,1.59E+07,6.86E+06,5,5,5,5,3.84E+08,5.80E+06,9.16E+07,4.47E+07,1.21E+07,2.79E+06,6.40E+05,3.45E+06,4.01E+06,2.57E+06,6.99E+07,1.59E+07,2.87E+06,1.90E+07,8.67E+06,3.88E+06,1.86E+07,4.72E+06,6.86E+06,9.98E+06,1.53E+06,2.20E+04,8.95E+05,4.47E+07,6.23E+05,9.92E+03,1.14E+04,3.19E+04,1.13E+05,2.73E+04,4.18E+05,7.09E+05,2.33E+04,2.56E+06,2.15E+05,7.57E+03,5.23E+06,3.35E+04,1.61E+05,1.06E+05,0,FALSE,133.296,76,18,335,36,8.46,18,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00044, Pf02800",2597,E7EUT4; hsa:2597; P00354; P04406; Q53X65,ENSG00000111640,Glycolysis; Gluconeogenesis,Cori cycle; Alzheimer's disease and miRNA effects; HIF1A and PPARG regulation of glycolysis; VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; 7q11.23 copy number variation syndrome; Glycolysis in senescence; Alzheimer's disease; Sildenafil treatment; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; Sudden infant death syndrome (SIDS) susceptibility pathways,16,0,147.03,47.58,115.29,67.62,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,126.98,133.81,125.6,112.7,400.86,enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,Medium,L0R8M2,ZNF83,Alternative protein ZNF83 OS=Homo sapiens OX=9606 GN=ZNF83 PE=1 SV=1,1,2,6.778,0.481,1.117,1.88,2.76,-1.05,0.16,0.91,3.88E-02,6.07E-01,9.91E-01,3.89E-01,5.62E+05,8.30E+04,3.14E+05,2.69E+05,2,4,5,4,,8.36E+05,,3.78E+05,,2.41E+05,2.86E+04,2.84E+04,3.69E+05,,5.17E+05,6.97E+04,3.14E+05,9.22E+05,8.30E+04,2.78E+05,2.72E+05,2.66E+05,3.14E+04,,,3.18E+03,,3.78E+05,,8.56E+02,5.09E+02,2.62E+02,1.04E+04,,3.09E+03,3.11E+03,2.55E+03,1.24E+05,2.06E+03,5.42E+02,7.63E+04,1.88E+03,7.34E+02,,0.027,FALSE,1.855,14,1,105,12.5,5.49,1,other biological processes,,Pf01352,,L0R8M2,ENSG00000167766,,,0,0,53.32,100.78,92.91,56.84,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,133.44,107.48,91.82,121.57,4.36,,0,
Master Protein,High,P63244,RACK1,Receptor of activated protein C kinase 1 OS=Homo sapiens OX=9606 GN=RACK1 PE=1 SV=3,5,16,6.703,0.378,1.87,1.005,2.74,-1.4,0.9,0.01,6.86E-02,4.11E-01,6.13E-01,8.25E-01,1.15E+06,5.86E+04,4.73E+05,8.02E+05,5,2,5,4,2.23E+06,1.15E+06,6.97E+05,1.95E+06,1.67E+05,,5.30E+04,6.48E+04,,,4.73E+05,2.70E+06,1.07E+05,6.50E+05,4.30E+05,,5.31E+05,3.42E+06,3.68E+04,1.21E+06,8.88E+03,4.36E+03,6.81E+03,1.95E+06,8.63E+03,,9.42E+02,5.98E+02,,,2.83E+03,1.21E+05,8.71E+02,8.75E+04,1.07E+04,,1.49E+05,2.42E+04,8.60E+02,1.29E+04,0,FALSE,26.438,29,5,317,35.1,7.69,5,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,plasma membrane;cytosol;mitochondrion;translational apparatus;nucleus;other cell component,Pf00400,10399,B3KTJ0; D3DWS0; hsa:10399; P25388; P63244; P99049; Q53HU2; Q5J8M6; Q5VLR4; Q6FH47,ENSG00000204628,Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; TNFR1-mediated ceramide production,Androgen receptor signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; VEGFA-VEGFR2 signaling; Measles virus infection; Angiotensin II receptor type 1 pathway; TROP2 regulatory signaling; Interferon type I signaling pathways,10,0,69.25,14.14,119.34,114.89,High,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,71.91,79.09,98.26,117.51,39.84,signal transduction activity or receptor binding;enzyme regulator activity;translation activity;other molecular function,0,
Master Protein,High,P34096,RNASE4,Ribonuclease 4 OS=Homo sapiens OX=9606 GN=RNASE4 PE=1 SV=3,1,7,6.634,1.058,1.233,5.335,2.73,0.08,0.3,2.42,4.39E-02,5.96E-01,9.10E-01,1.34E-01,3.02E+05,4.55E+04,2.21E+05,5.61E+04,2,2,5,2,,,,6.12E+05,1.49E+05,,,,1.88E+04,1.10E+05,1.90E+06,1.22E+05,2.21E+05,8.03E+05,1.27E+05,,1.00E+05,,3.14E+04,,,,,6.12E+05,7.68E+03,,,,5.31E+02,1.17E+03,1.13E+04,5.43E+03,1.80E+03,1.08E+05,3.15E+03,,2.82E+04,,7.35E+02,,0,FALSE,5.172,9,1,147,16.8,9.03,1,stress response,non-structural extracellular,Pf00074,6038,hsa:6038; P34096,ENSG00000258818,,,0,0,86.04,100.04,119.93,74.04,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,73.22,108.4,82.98,100.1,19.37,nucleic acid binding activity;other molecular function,0,
Master Protein,High,H0YKD0,IDH3A,Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha (Fragment) OS=Homo sapiens OX=9606 GN=IDH3A PE=1 SV=1,6,22,6.606,0.116,1.495,0.417,2.72,-3.11,0.58,-1.26,4.67E-02,6.76E-03,7.89E-01,5.27E-01,1.97E+06,2.98E+05,2.28E+05,5.48E+05,1,3,1,2,,,,,1.97E+06,,2.34E+05,2.98E+05,,1.16E+06,,,2.28E+05,,,,3.94E+05,7.61E+05,,,,,,,1.01E+05,,4.16E+03,2.75E+03,,1.23E+04,,,1.86E+03,,,,1.11E+05,5.39E+03,,,0,FALSE,22.958,61,1,109,12.1,8.12,6,other metabolic processes,mitochondrion,Pf00180,,H0YKD0,ENSG00000166411,,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Metabolic reprogramming in colon cancer,2,0,,91.64,,44.86,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,40.44,0,94.17,49.58,49.19,,0,
Master Protein,High,A0A1W2PPZ5,TCEA1,Transcription elongation factor OS=Homo sapiens OX=9606 GN=TCEA1 PE=1 SV=1,4,6,6.573,0.817,,7.118,2.72,-0.29,,2.83,4.11E-02,8.06E-01,,4.94E-02,6.56E+05,2.37E+04,4.04E+05,5.55E+04,2,3,1,1,,,,6.96E+05,6.19E+05,7.23E+04,2.37E+04,,1.72E+04,,,,,4.04E+05,,,5.55E+04,,,,,,,6.96E+05,3.19E+04,2.57E+02,4.21E+02,,4.83E+02,,,,,5.44E+04,,,1.56E+04,,,,0,FALSE,12.761,15,4,301,33.9,8.38,4,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf01096, Pf07500, Pf08711",,A0A2I3HKY3; A0A2I3MHW4; A0A2K5VWC8; A0A2K5Y4M2; A0A2K6CEX7; A0A8D2FCK3; G3SGM3,ENSGGOG00000023652; ENSMFAG00000041675; ENSMLEG00000029357; ENSMNEG00000034707; ENSNLEG00000000981; ENSPANG00000018453; ENSTGEG00000016198,,,0,0,8.28,79.96,,,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,58.12,12.28,,0,16.97,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A5F9ZHN9,ALDH3A2,Aldehyde dehydrogenase OS=Homo sapiens OX=9606 GN=ALDH3A2 PE=1 SV=1,1,2,6.571,0.113,0.792,0.95,2.72,-3.14,-0.34,-0.07,7.10E-02,1.72E-02,7.70E-01,8.96E-01,9.20E+05,1.40E+05,1.04E+05,1.07E+05,3,2,4,5,9.20E+05,,2.41E+06,,2.52E+05,1.10E+05,,1.77E+05,,,1.06E+05,,1.07E+05,8.01E+04,1.02E+05,2.51E+05,8.45E+04,7.34E+04,1.07E+05,1.45E+05,3.65E+03,,2.36E+04,,1.30E+04,3.92E+02,,1.64E+03,,,6.36E+02,,8.67E+02,1.08E+04,2.53E+03,4.89E+02,2.38E+04,5.20E+02,2.50E+03,1.55E+03,0.001,FALSE,3.93,3,1,521,58.6,8.13,1,other metabolic processes,,Pf00171,,A0A5F9ZHN9,ENSG00000072210,,Fragile X syndrome; Fluoroacetic acid toxicity,2,0,92.64,32.95,12.8,54.35,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,106.5,107.63,52.9,43.8,5.65,other molecular function,0,
Master Protein,High,P08579,SNRPB2,U2 small nuclear ribonucleoprotein B'' OS=Homo sapiens OX=9606 GN=SNRPB2 PE=1 SV=1,6,20,6.394,0.16,4.889,1.098,2.68,-2.64,2.29,0.14,5.44E-02,2.43E-02,1.58E-01,7.98E-01,1.64E+06,1.90E+05,8.85E+05,2.21E+05,5,2,5,4,3.34E+05,1.64E+06,4.55E+05,5.01E+06,1.80E+06,1.73E+05,,,,2.08E+05,2.33E+06,6.23E+05,2.02E+06,4.10E+05,8.85E+05,,8.55E+04,5.73E+05,4.48E+04,2.00E+06,1.33E+03,6.22E+03,4.45E+03,5.01E+06,9.26E+04,6.16E+02,,,,2.21E+03,1.39E+04,2.78E+04,1.64E+04,5.53E+04,2.20E+04,,2.40E+04,4.06E+03,1.05E+03,2.13E+04,0,FALSE,29.159,35,5,225,25.5,9.72,6,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf00076,6629,B2R7J3; D3DW21; hsa:6629; P08579; Q9UJD4,ENSG00000125870,mRNA Splicing - Major Pathway,mRNA processing; Ciliary landscape,3,1,102.27,12.95,68.97,135.26,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,Acetyl [N-Term],FALSE,125.84,128.75,140.63,120.95,52.63,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O15212,PFDN6,Prefoldin subunit 6 OS=Homo sapiens OX=9606 GN=PFDN6 PE=1 SV=1,1,2,6.375,0.256,4.015,0.406,2.67,-1.97,2.01,-1.3,6.37E-02,2.82E-01,2.54E-01,5.78E-01,1.58E+05,2.48E+04,4.05E+04,9.97E+04,2,1,1,4,,,,6.70E+04,3.74E+05,,,,,2.48E+04,,,4.05E+04,,,3.96E+05,1.14E+05,,4.85E+04,8.72E+04,,,,6.70E+04,1.93E+04,,,,,2.64E+02,,,3.29E+02,,,7.73E+02,3.21E+04,,1.13E+03,9.28E+02,0.004,FALSE,2.594,9,1,129,14.6,8.88,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,other cell component,Pf01920,10471,hsa:10471; O15212,ENSG00000204220; ENSG00000206283; ENSG00000224782; ENSG00000235692; ENSG00000237335,Prefoldin mediated transfer of substrate  to CCT/TriC,Cellular proteostasis,2,0,98.45,,,98.33,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,143.76,143.76,48.77,48.77,6.3,other molecular function,0,
Master Protein,High,P84090,ERH,Enhancer of rudimentary homolog OS=Homo sapiens OX=9606 GN=ERH PE=1 SV=1,3,17,6.374,0.276,1.903,0.712,2.67,-1.86,0.93,-0.49,4.84E-02,1.85E-01,6.16E-01,9.31E-01,3.04E+06,3.29E+05,4.13E+05,7.53E+05,3,4,3,5,,1.78E+05,,3.51E+06,3.04E+06,,4.31E+05,1.10E+06,5.93E+04,2.51E+05,,4.13E+05,,1.47E+06,1.82E+05,7.53E+05,3.07E+04,1.33E+06,1.60E+05,2.05E+06,,6.74E+02,,3.51E+06,1.57E+05,,7.67E+03,1.02E+04,1.67E+03,2.67E+03,,1.85E+04,,1.98E+05,4.52E+03,1.47E+03,8.63E+03,9.43E+03,3.75E+03,2.18E+04,0,FALSE,14.033,44,3,104,12.3,5.92,3,cell cycle OR cell proliferation;other metabolic processes,nucleus;other cell component,Pf01133,2079,B2R5H2; hsa:2079; P70659; P84090; Q14259,ENSG00000100632,,,0,0,80.45,98.56,99.71,97.14,n/a,Peak Found,n/a,High,High,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,114.11,104.36,135.19,126.41,48.22,nucleic acid binding activity,0,
Master Protein,High,Q06413,MEF2C,Myocyte-specific enhancer factor 2C OS=Homo sapiens OX=9606 GN=MEF2C PE=1 SV=1,3,8,6.289,0.432,0.139,6.478,2.65,-1.21,-2.85,2.7,4.54E-02,5.44E-01,7.32E-02,8.88E-02,3.77E+05,1.85E+05,1.93E+05,2.57E+04,5,3,4,1,1.88E+05,5.26E+06,1.08E+05,3.77E+05,3.18E+06,1.85E+05,6.86E+04,2.20E+05,,,7.71E+05,,7.86E+04,1.53E+05,2.43E+05,,2.57E+04,,,,7.47E+02,2.00E+04,1.06E+03,3.77E+05,1.64E+05,6.57E+02,1.22E+03,2.03E+03,,,4.61E+03,,6.38E+02,2.06E+04,6.03E+03,,7.21E+03,,,,0,FALSE,7.662,7,2,473,51.2,8.03,3,cell-cell signaling;cell cycle OR cell proliferation;stress response;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00319, Pf12347",4208,C9JMZ0; D7F7N5; F8W7V7; hsa:4208; Q06413,ENSG00000081189,Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; Myogenesis; Cardiogenesis; ERK/MAPK targets; MECP2 regulates transcription factors,Energy metabolism; Heart development; SRF and miRs in smooth muscle differentiation and proliferation; Cell differentiation - expanded index; Cell differentiation - index; B cell receptor signaling pathway; Adipogenesis; Brain-derived neurotrophic factor (BDNF) signaling pathway; Cardiac progenitor differentiation; MECP2 and associated Rett syndrome; TGF-beta signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling; Prion disease pathway; Rett syndrome; EGF/EGFR signaling pathway; Gastrin signaling pathway; Endochondral ossification; Endochondral ossification with skeletal dysplasias; GDNF signaling; 2q37 copy number variation syndrome; Neurogenesis regulation in the olfactory epithelium; Sudden infant death syndrome (SIDS) susceptibility pathways,30,1,126.77,50.28,100.82,,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,164.19,115.87,28.49,68.22,20.57,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13409,DYNC1I2,Cytoplasmic dynein 1 intermediate chain 2 OS=Homo sapiens OX=9606 GN=DYNC1I2 PE=1 SV=3,5,6,6.276,0.386,4.312,,2.65,-1.37,2.11,,5.58E-02,4.77E-01,1.96E-01,,2.45E+05,1.01E+05,2.80E+04,4.33E+05,3,1,2,3,8.68E+04,,,2.45E+05,6.31E+05,,,,,1.01E+05,4.64E+04,,,1.68E+04,,,,1.54E+06,1.00E+05,4.33E+05,3.45E+02,,,2.45E+05,3.25E+04,,,,,1.07E+03,2.78E+02,,,2.27E+03,,,,1.09E+04,2.34E+03,4.61E+03,0,FALSE,17.763,10,5,638,71.4,5.2,5,transport;other biological processes,cytosol;cytoskeleton;other cell component,"Pf00400, Pf11540",1781,B7ZA04; D3DPD4; D3DPD5; D3DPD6; hsa:1781; Q13409; Q32LY9; Q53S84; Q5BJF8; Q7Z4X1; Q96NG7; Q96S87; Q9BXZ5; Q9NT58,ENSG00000077380; ENSG00000292102,Separation of Sister Chromatids; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; HCMV Early Events; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Ciliary landscape; Intraflagellar transport proteins binding to dynein; Vasopressin-regulated water reabsorption; HDAC6 interactions in the central nervous system,23,0,87.24,,66.2,108.94,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,Peak Found,1,,FALSE,0,65.53,114.06,,14.55,cytoskeletal activity;other molecular function,0,
Master Protein,High,P27216,ANXA13,Annexin A13 OS=Homo sapiens OX=9606 GN=ANXA13 PE=1 SV=3,1,7,6.272,0.016,6.996,0.015,2.65,-5.92,2.81,-6.08,4.74E-02,1.01E-05,8.54E-02,3.51E-04,3.92E+05,6.25E+04,6.47E+03,4.37E+05,1,2,2,5,,,,,3.92E+05,1.15E+05,3.41E+04,,,,,,,6.03E+03,6.94E+03,4.37E+05,1.19E+03,1.32E+07,3.87E+04,3.80E+06,,,,,2.02E+04,4.08E+02,6.06E+02,,,,,,,8.12E+02,1.72E+02,8.53E+02,3.35E+02,9.38E+04,9.07E+02,4.05E+04,0.009,FALSE,2.312,3,1,316,35.4,5.6,1,other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cell component,Pf00191,312,hsa:312; P27216; Q9BQR5,ENSG00000104537,,,0,0,,76.63,9.95,161.79,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,95.59,10.46,147.78,147.86,12.25,other molecular function,0,
Master Protein,High,P62879,GNB2,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 OS=Homo sapiens OX=9606 GN=GNB2 PE=1 SV=3,7,49,6.229,0.533,1.946,2.115,2.64,-0.91,0.96,1.08,4.46E-02,7.40E-01,6.38E-01,3.95E-01,2.67E+06,6.67E+04,1.36E+06,5.77E+05,4,4,5,5,4.52E+06,,3.83E+06,1.86E+06,1.26E+05,1.96E+05,4.39E+04,1.01E+05,,2.97E+04,2.69E+06,1.36E+06,1.00E+06,2.20E+06,5.58E+05,5.77E+05,6.59E+05,3.99E+05,1.11E+06,1.89E+05,1.80E+04,,3.74E+04,1.86E+06,6.49E+03,6.98E+02,7.81E+02,9.35E+02,,3.16E+02,1.61E+04,6.09E+04,8.14E+03,2.96E+05,1.39E+04,1.13E+03,1.85E+05,2.83E+03,2.59E+04,2.01E+03,0,FALSE,29.277,27,2,340,37.3,6,7,signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,Pf00400,2783,B3KPU1; hsa:2783; P11016; P54312; P62879,ENSG00000172354,"G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation",Corticotropin-releasing hormone signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells,36,1,76.93,81.5,55.74,58.44,High,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,125.84,108.65,132.28,89.99,123.47,other molecular function,0,
Master Protein,High,Q02413,DSG1,Desmoglein-1 OS=Homo sapiens OX=9606 GN=DSG1 PE=1 SV=2,3,9,6.092,0.281,0.246,2.686,2.61,-1.83,-2.02,1.43,4.98E-02,2.11E-01,1.97E-01,2.64E-01,3.68E+05,9.20E+04,7.32E+05,4.22E+04,4,3,2,2,1.19E+05,1.25E+06,1.14E+06,,2.95E+04,9.20E+04,,1.46E+05,2.50E+04,,4.30E+06,1.24E+05,,,,,,,2.26E+04,7.88E+04,4.71E+02,4.73E+03,1.11E+04,,1.52E+03,3.27E+02,,1.34E+03,7.05E+02,,2.57E+04,5.56E+03,,,,,,,5.30E+02,8.39E+02,0,FALSE,8.887,5,3,1049,113.7,5.03,3,cell adhesion;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00028, Pf01049",1828,B7Z845; hsa:1828; Q02413,ENSG00000134760,Neutrophil degranulation; Formation of the cornified envelope; RND2 GTPase cycle; RND3 GTPase cycle; Apoptotic cleavage of cell adhesion  proteins,,6,0,102.35,69,133.47,78.32,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,134.44,223.84,86.44,82.5,16.33,other molecular function,0,
Master Protein,High,O15347,HMGB3,High mobility group protein B3 OS=Homo sapiens OX=9606 GN=HMGB3 PE=1 SV=4,8,43,6.028,1.147,2.409,2.444,2.59,0.2,1.27,1.29,5.62E-02,4.08E-01,4.58E-01,3.40E-01,2.02E+06,2.22E+05,1.98E+06,6.07E+05,5,5,5,5,1.43E+06,1.28E+07,4.15E+05,1.12E+07,2.02E+06,2.75E+06,8.28E+05,1.45E+05,2.22E+05,1.58E+05,6.37E+05,1.98E+06,4.69E+05,1.33E+07,2.69E+06,1.86E+06,3.69E+05,4.65E+05,6.07E+05,1.60E+06,5.69E+03,4.87E+04,4.05E+03,1.12E+07,1.04E+05,9.78E+03,1.47E+04,1.34E+03,6.25E+03,1.68E+03,3.81E+03,8.83E+04,3.81E+03,1.80E+06,6.68E+04,3.63E+03,1.04E+05,3.30E+03,1.42E+04,1.71E+04,0,FALSE,63.774,30,8,200,23,8.37,8,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00505, Pf09011",3149,hsa:3149; O15347; O95556; Q6NS40,ENSG00000029993,,,0,0,106.3,135.99,141.27,71.04,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,108.32,123.29,132.89,124.88,142.56,nucleic acid binding activity,0,
Master Protein,High,P49321,NASP,Nuclear autoantigenic sperm protein OS=Homo sapiens OX=9606 GN=NASP PE=1 SV=2,10,20,6.02,0.311,4.502,0.239,2.59,-1.69,2.17,-2.07,7.08E-02,2.64E-01,1.46E-01,2.76E-01,1.38E+06,1.56E+05,2.43E+05,8.47E+05,4,2,5,5,2.68E+05,7.48E+05,,2.68E+06,2.56E+06,,1.99E+05,,1.22E+05,,1.25E+05,3.47E+05,1.12E+05,1.50E+06,2.43E+05,8.47E+05,2.45E+04,6.33E+06,4.83E+05,1.19E+06,1.06E+03,2.84E+03,,2.68E+06,1.32E+05,,3.54E+03,,3.44E+03,,7.50E+02,1.55E+04,9.08E+02,2.03E+05,6.04E+03,1.65E+03,6.87E+03,4.49E+04,1.13E+04,1.27E+04,0,FALSE,49.501,21,10,788,85.2,4.3,10,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;transport;developmental processes;other biological processes,nucleus;other cell component,Pf10516,4678,A8K6H2; B4DQP3; D3DQ07; F5H3J2; hsa:4678; P49321; Q53GW5; Q5T622; Q5T625; Q96A69; Q9BTW2,ENSG00000132780,,,0,0,79.02,33.73,126.07,145.5,Peak Found,Peak Found,n/a,High,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,42.58,76.34,41.95,117.5,67.44,other molecular function,0,
Master Protein,High,P09917,ALOX5,Polyunsaturated fatty acid 5-lipoxygenase OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2,10,26,5.868,1.571,1.62,1.202,2.55,0.65,0.7,0.26,5.93E-02,2.26E-01,6.28E-01,7.99E-01,1.66E+06,3.57E+06,3.15E+06,1.42E+06,4,5,4,5,4.03E+05,1.62E+06,,2.83E+06,1.70E+06,3.57E+06,5.04E+06,6.39E+06,4.14E+05,7.28E+05,,2.79E+06,2.61E+06,2.17E+07,3.56E+06,3.52E+06,7.66E+05,6.11E+05,1.42E+06,3.85E+06,1.60E+03,6.16E+03,,2.83E+06,8.75E+04,1.27E+04,8.97E+04,5.90E+04,1.17E+04,7.74E+03,,1.25E+05,2.12E+04,2.92E+06,8.84E+04,6.86E+03,2.15E+05,4.33E+03,3.32E+04,4.10E+04,0,FALSE,43.028,20,10,674,77.9,5.77,10,other metabolic processes;stress response;other biological processes,non-structural extracellular;other membranes;cytosol;nucleus;other cell component,"Pf00305, Pf01477",240,B7ZLS0; E5FPY5; E5FPY7; E5FPY8; hsa:240; P09917; Q5JQ14,ENSG00000012779; ENSG00000275565,Neutrophil degranulation; Interleukin-4 and Interleukin-13 signaling; Interleukin-18 signaling; Synthesis of 5-eicosatetraenoic acids; Synthesis of Leukotrienes (LT) and Eoxins (EX); Synthesis of Lipoxins (LX); Biosynthesis of D-series resolvins; Biosynthesis of maresins; Biosynthesis of E-series 18(S)-resolvins; Biosynthesis of aspirin-triggered D-series resolvins; Biosynthesis of E-series 18(R)-resolvins; Biosynthesis of DPAn-3-derived protectins and resolvins; Biosynthesis of DPAn-3-derived maresins; Biosynthesis of DPAn-3-derived 13-series resolvins; Biosynthesis of electrophilic ?-3 PUFA oxo-derivatives,Selenium micronutrient network; Vitamin D receptor pathway; Eicosanoid metabolism via lipooxygenases (LOX); Prostaglandin and leukotriene metabolism in senescence ; ALA oxylipin metabolism; Linoleic acid oxylipin metabolism; Lipid metabolism in senescent cells; Urotensin-II-mediated signaling pathway; Leukotriene metabolic pathway; Prostaglandin and leukotriene metabolism in senescence ; Omega-6-fatty acids in senescence,26,0,60.57,81.32,122.19,75.83,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,53.36,132.35,128.86,124.56,72.42,other molecular function,0,
Master Protein,High,Q8WXD2,SCG3,Secretogranin-3 OS=Homo sapiens OX=9606 GN=SCG3 PE=1 SV=3,1,2,5.795,0.01,0.017,1.003,2.53,-6.64,-5.9,0,6.12E-02,1.00E-17,8.78E-08,8.24E-01,6.28E+07,1.08E+07,1.82E+05,1.81E+05,1,1,1,2,,,,,6.28E+07,,,,,1.08E+07,,,,1.82E+05,,,1.25E+05,,2.63E+05,,,,,,3.24E+06,,,,,1.15E+05,,,,2.45E+04,,,3.51E+04,,6.15E+03,,0.005,FALSE,2.483,2,1,468,53,5.03,1,other biological processes,non-structural extracellular;other membranes;ER/Golgi;other cell component,Pf15467,29106,A8K2B0; B3KQP6; B4DK99; F5H3R8; hsa:29106; Q8WXD2; Q96C83; Q96GE8; Q9Y6G7,ENSG00000104112,Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,,3,0,,,,50.35,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,Phospho [Y380],FALSE,0,0,56.49,56.49,5.38,,1,Phospho [Y380]
Master Protein,High,Q96PK6,RBM14,RNA-binding protein 14 OS=Homo sapiens OX=9606 GN=RBM14 PE=1 SV=2,4,11,5.73,0.093,0.615,0.702,2.52,-3.42,-0.7,-0.51,7.90E-02,1.54E-02,6.64E-01,8.82E-01,1.49E+05,2.60E+04,1.52E+05,1.60E+04,3,1,2,1,9.67E+04,,1.49E+05,1.42E+06,,,2.60E+04,,,,,2.68E+05,,8.57E+04,,,,,1.60E+04,,3.84E+02,,1.46E+03,1.42E+06,,,4.63E+02,,,,,1.20E+04,,1.16E+04,,,,,3.75E+02,,0,FALSE,26.103,12,4,669,69.4,9.67,4,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,Pf00076,100526737; 10432,B0LM41; B3KMN4; D6RGD8; hsa:100526737; hsa:10432; O75932; Q2PYN1; Q53GV1; Q68DQ9; Q96PK5; Q96PK6,ENSG00000239306,RUNX2 regulates bone development,Ciliary landscape,2,0,134.9,,72.9,,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,15.52,72.3,0,39.88,40.43,other molecular function,0,
Master Protein,High,P10412,H1-4,Histone H1.4 OS=Homo sapiens OX=9606 GN=H1-4 PE=1 SV=2,22,763,5.693,1.031,0.947,5.702,2.51,0.04,-0.08,2.51,6.40E-02,5.55E-01,8.41E-01,1.05E-01,3.38E+08,3.10E+07,6.73E+08,1.15E+08,5,5,5,5,1.60E+08,1.71E+08,3.38E+08,1.22E+09,5.16E+08,2.77E+07,3.10E+07,8.48E+07,1.64E+07,9.40E+08,2.62E+08,6.68E+08,6.73E+08,9.08E+08,9.50E+08,3.72E+07,1.15E+08,1.30E+08,5.64E+07,2.82E+08,6.36E+05,6.49E+05,3.30E+06,1.22E+09,2.66E+07,9.84E+04,5.52E+05,7.82E+05,4.61E+05,1.00E+07,1.57E+06,2.98E+07,5.47E+06,1.22E+08,2.36E+07,7.25E+04,3.22E+07,9.18E+05,1.32E+06,3.01E+06,0,FALSE,125.814,52,4,219,21.9,11.03,22,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf00538,3008,hsa:3008; P10412; Q4VB25,ENSG00000168298,Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF),Pathways affected in adenoid cystic carcinoma,3,17,91,183.38,39.49,77.88,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,144.36,134.07,139.79,136.59,1864.72,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BQ39,DDX50,ATP-dependent RNA helicase DDX50 OS=Homo sapiens OX=9606 GN=DDX50 PE=1 SV=1,2,6,5.607,0.153,0.527,1.626,2.49,-2.71,-0.92,0.7,8.23E-02,8.05E-02,5.51E-01,5.88E-01,1.96E+05,3.50E+04,3.00E+04,1.85E+04,2,2,3,1,,,,1.85E+05,2.08E+05,,,2.98E+04,,4.11E+04,,3.00E+04,,1.13E+05,2.59E+04,,,,1.85E+04,,,,,1.85E+05,1.07E+04,,,2.75E+02,,4.37E+02,,1.34E+03,,1.53E+04,6.43E+02,,,,4.32E+02,,0,FALSE,6.609,4,1,737,82.5,9.17,2,,plasma membrane;other membranes;nucleus,"Pf00270, Pf00271, Pf08152",79009,hsa:79009; Q5VX37; Q8WV76; Q9BQ39; Q9BWI8,ENSG00000107625,,,0,0,8.02,22.5,87.44,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,22.57,23.94,23.89,20.41,18.67,other molecular function,0,
Master Protein,High,Q8WWC4,MAIP1,"m-AAA protease-interacting protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=MAIP1 PE=1 SV=1",1,5,5.435,2.191,9.395,1.2,2.44,1.13,3.23,0.26,8.51E-02,1.38E-01,4.43E-02,7.18E-01,2.05E+05,3.77E+04,4.49E+05,3.54E+05,5,1,4,4,1.58E+06,7.14E+04,2.05E+05,2.73E+05,7.38E+04,,,3.77E+04,,,,4.59E+05,2.61E+05,5.18E+05,4.39E+05,,3.08E+05,7.94E+04,4.07E+05,6.12E+05,6.29E+03,2.71E+02,2.00E+03,2.73E+05,3.80E+03,,,3.48E+02,,,,2.05E+04,2.12E+03,6.98E+04,1.09E+04,,8.67E+04,5.63E+02,9.52E+03,6.51E+03,0,FALSE,4.737,5,1,291,32.5,9.17,1,cell organization and biogenesis;transport;other biological processes,other membranes;mitochondrion,,79568,hsa:79568; Q658V9; Q8WWC4; Q9H671,ENSG00000162972,Processing of SMDT1,,1,0,146.01,,26.39,62.88,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,94.9,112.77,64.86,57.45,12.35,translation activity,0,
Master Protein,High,Q99873,PRMT1,Protein arginine N-methyltransferase 1 OS=Homo sapiens OX=9606 GN=PRMT1 PE=1 SV=3,1,3,5.424,1.267,0.805,6.551,2.44,0.34,-0.31,2.71,9.07E-02,5.11E-01,8.52E-01,8.19E-02,1.18E+05,2.18E+04,1.15E+05,1.75E+04,3,1,2,2,,,4.41E+04,1.18E+05,1.86E+05,,,,2.18E+04,,,,,3.14E+05,4.19E+04,,7.99E+03,,3.84E+04,,,,4.31E+02,1.18E+05,9.59E+03,,,,6.13E+02,,,,,4.23E+04,1.04E+03,,2.25E+03,,8.98E+02,,0.001,FALSE,4.015,4,1,371,42.4,5.35,1,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf13649,3276,A0A087X1W2; B4E3C3; G5E9B6; H7C2I1; hsa:3276; Q15529; Q2VP93; Q6LEU5; Q8WUW5; Q99872; Q99873; Q99874; Q9NZ04; Q9NZ05; Q9NZ06,ENSG00000126457,Estrogen-dependent gene expression; Extra-nuclear estrogen signaling; RMTs methylate histone arginines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest; Maturation of nucleoprotein,Energy metabolism; mRNA processing; Nitric oxide metabolism in cystic fibrosis; 16p11.2 distal deletion syndrome; Interferon type I signaling pathways,11,0,61.11,,108.08,92.69,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,85.29,114.25,128.66,80.15,10.01,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0AVT1,UBA6,Ubiquitin-like modifier-activating enzyme 6 OS=Homo sapiens OX=9606 GN=UBA6 PE=1 SV=1,2,2,5.333,0.347,0.464,3.766,2.42,-1.52,-1.11,1.91,6.95E-02,4.21E-01,2.66E-01,2.10E-01,3.03E+05,8.81E+04,1.48E+05,5.34E+06,2,2,3,1,3.86E+05,,,2.38E+05,,,,2.22E+05,,3.50E+04,,,3.42E+05,1.48E+05,5.22E+04,,,,5.34E+06,,1.53E+03,,,2.38E+05,,,,2.05E+03,,3.72E+02,,,2.78E+03,1.99E+04,1.30E+03,,,,1.25E+05,,0,FALSE,6.258,2,2,1052,117.9,6.14,2,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,cytosol;other cell component,"Pf00899, Pf09358, Pf10585, Pf16190, Pf16191",55236,A0AVT1; A6N8M7; B2RAV3; hsa:55236; Q4W5K0; Q6UV21; Q86T78; Q86TC7; Q8N5T3; Q8N9E4; Q9H3T7; Q9NVC9,ENSG00000033178,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,,2,0,33.47,102.97,81.69,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,136.92,64.6,24.92,136.67,4.63,other molecular function,0,
Master Protein,High,Q6JBY9,RCSD1,CapZ-interacting protein OS=Homo sapiens OX=9606 GN=RCSD1 PE=1 SV=1,7,12,5.305,0.144,1.018,0.226,2.41,-2.8,0.03,-2.15,6.74E-02,4.39E-02,8.54E-01,2.13E-01,4.41E+05,1.36E+05,1.31E+05,4.55E+05,5,2,4,4,7.18E+04,4.41E+05,9.09E+04,1.03E+06,7.58E+06,,,,4.03E+04,4.60E+05,,3.61E+05,2.90E+04,3.72E+05,4.74E+04,1.40E+05,,9.43E+05,2.20E+05,1.57E+06,2.85E+02,1.68E+03,8.88E+02,1.03E+06,3.91E+05,,,,1.13E+03,4.89E+03,,1.61E+04,2.36E+02,5.01E+04,1.18E+03,2.72E+02,,6.69E+03,5.14E+03,1.68E+04,0,FALSE,30.994,30,7,416,44.5,5.4,7,stress response;transport;other biological processes,cytosol;cytoskeleton;other cytoplasmic organelle;other cell component,"Pf05177, Pf15255",92241,B1AK48; hsa:92241; Q4G0E7; Q6IN93; Q6JBY9; Q8IZM2; Q96DX0; Q9NST4,ENSG00000198771,,,0,0,175.36,118.64,93.78,93.86,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,88.99,103.67,133.94,138.22,33.78,cytoskeletal activity;other molecular function,0,
Master Protein,High,P30084,ECHS1,"Enoyl-CoA hydratase, mitochondrial OS=Homo sapiens OX=9606 GN=ECHS1 PE=1 SV=4",9,91,5.226,1.092,14.121,0.772,2.39,0.13,3.82,-0.37,7.92E-02,5.00E-01,1.17E-03,8.78E-01,4.52E+06,7.04E+05,1.57E+07,4.49E+07,5,5,5,5,1.38E+06,4.52E+06,9.91E+05,2.16E+07,6.63E+06,6.18E+06,3.20E+05,6.74E+04,7.60E+05,7.04E+05,6.05E+06,1.57E+07,2.19E+07,2.12E+07,1.53E+07,4.49E+07,3.18E+06,8.85E+07,1.07E+07,8.99E+07,5.48E+03,1.72E+04,9.68E+03,2.16E+07,3.42E+05,2.20E+04,5.69E+03,6.22E+02,2.14E+04,7.48E+03,3.62E+04,7.02E+05,1.78E+05,2.86E+06,3.80E+05,8.76E+04,8.93E+05,6.27E+05,2.49E+05,9.57E+05,0,FALSE,54.552,35,9,290,31.4,8.07,9,other metabolic processes,mitochondrion,Pf00378,1892,hsa:1892; O00739; P30084; Q5VWY1; Q96H54,ENSG00000127884,Branched-chain amino acid catabolism; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA; Beta oxidation of octanoyl-CoA to hexanoyl-CoA; Beta oxidation of hexanoyl-CoA to butanoyl-CoA; Beta oxidation of butanoyl-CoA to acetyl-CoA; Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,Fatty acid beta-oxidation; Fatty acid biosynthesis; Ciliary landscape; Tryptophan metabolism,10,0,120.74,160.15,39.68,86.99,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,122.27,114.41,125.79,134.17,296.03,other molecular function,0,
Master Protein,High,Q07954,LRP1,Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2,2,3,5.17,0.282,0.501,2.201,2.37,-1.83,-1,1.14,8.15E-02,1.91E-01,4.40E-01,3.51E-01,2.37E+06,1.76E+05,6.69E+05,3.04E+05,1,3,3,3,,,,,2.37E+06,1.66E+05,,1.20E+06,,1.76E+05,,,6.69E+05,1.15E+06,3.31E+05,3.04E+05,2.74E+05,,5.12E+05,,,,,,1.22E+05,5.89E+02,,1.10E+04,,1.87E+03,,,5.44E+03,1.54E+05,8.21E+03,5.93E+02,7.68E+04,,1.20E+04,,0,FALSE,7.373,1,2,4544,504.3,5.39,2,other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00057, Pf00058, Pf07645, Pf12662, Pf14670, Pf16472",4035,hsa:4035; Q07954; Q2PP12; Q86SW0; Q8IVG8,ENSG00000123384,Scavenging of heme from plasma; Retinoid metabolism and transport,Alzheimer's disease and miRNA effects; Regulation of Wnt / B-catenin signaling by small molecule compounds; Statin inhibition of cholesterol production; Familial  hyperlipidemia type 1; Familial hyperlipidemia type 3; Familial hyperlipidemia type 4; Familial hyperlipidemia type 5; Alzheimer's disease; Cholesterol metabolism,11,0,,115.45,57.28,35.78,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,164.62,61.68,105.22,75.04,9.11,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9H0A0,NAT10,RNA cytidine acetyltransferase OS=Homo sapiens OX=9606 GN=NAT10 PE=1 SV=2,2,3,5.13,0.01,0.01,,2.36,-6.64,-6.64,,1.02E-01,1.00E-17,1.00E-17,,1.53E+05,2.99E+04,,,2,1,,,,,,3.43E+05,6.85E+04,,,2.99E+04,,,,,,,,,,,,,,,,3.43E+05,3.54E+03,,,2.76E+02,,,,,,,,,,,,,0,FALSE,9.347,3,2,1025,115.7,8.27,2,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf05127, Pf08351, Pf13718, Pf13725",55226,B4DFD5; E7ESU4; E9PMN9; hsa:55226; Q86WK5; Q9C0F4; Q9H0A0; Q9HA61; Q9NVF2,ENSG00000135372,rRNA modification in the nucleus and cytosol,Metapathway biotransformation Phase I and II,2,0,94.37,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,132.83,,,,10.9,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P01024,C3,Complement C3 OS=Homo sapiens OX=9606 GN=C3 PE=1 SV=2,13,35,5.113,0.799,1.213,0.784,2.35,-0.32,0.28,-0.35,9.01E-02,8.45E-01,9.69E-01,9.60E-01,9.85E+04,2.45E+05,6.25E+05,2.13E+05,4,1,4,2,1.56E+05,1.19E+06,,6.23E+04,4.25E+04,,,,2.45E+05,,,1.49E+05,3.07E+05,1.27E+06,4.84E+06,,1.52E+05,,,2.98E+05,6.18E+02,4.53E+03,,6.23E+04,2.19E+03,,,,6.91E+03,,,6.66E+03,2.49E+03,1.71E+05,1.20E+05,,4.28E+04,,,3.17E+03,0,FALSE,47.973,13,10,1663,187,6.4,13,cell organization and biogenesis;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00207, Pf01759, Pf01821, Pf01835, Pf07677, Pf07678, Pf07703, Pf17789, Pf17790, Pf17791, Pf21308, Pf21406",718,A7E236; hsa:718; P01024,ENSG00000125730,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Regulation of Complement cascade; G alpha (i) signalling events; Neutrophil degranulation; Peptide ligand-binding receptors; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Purinergic signaling in leishmaniasis infection; Alternative complement activation; Activation of C3 and C5,Allograft rejection; Complement system; Dengue-2 interactions with complement and coagulation cascades; TYROBP causal network in microglia; Cells and molecules involved in local acute inflammatory response ; 16p11.2 distal deletion syndrome; Complement system in neuronal development and plasticity; Acquired partial lipodystrophy / Barraquer-Simons syndrome; Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); Chronic hyperglycemia impairment of neuron function; Complement activation; Complement and coagulation cascades,22,0,152.77,,133.33,45.77,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,High,n/a,High,n/a,n/a,Peak Found,1,,FALSE,11.04,118.55,81.8,133.81,92.63,signal transduction activity or receptor binding;enzyme regulator activity,0,
Master Protein,High,E7ERS3,ZC3H18,Zinc finger CCCH-type containing 18 OS=Homo sapiens OX=9606 GN=ZC3H18 PE=1 SV=1,4,6,5.035,0.01,1.436,0.01,2.33,-6.64,0.52,-6.64,9.25E-02,1.00E-17,8.11E-01,1.00E-17,2.44E+05,4.71E+04,,3.97E+04,4,2,,2,,1.02E+05,3.17E+04,5.83E+05,1.47E+06,,,,2.77E+04,8.03E+04,,,,,,,,,2.69E+04,5.87E+04,,3.88E+02,3.10E+02,5.83E+05,7.59E+04,,,,7.80E+02,8.54E+02,,,,,,,,,6.30E+02,6.25E+02,0,FALSE,21.201,7,4,977,108.9,8.44,4,,nucleus,Pf18044,124245,E7ERS3,ENSG00000158545,,,0,0,121.22,68.95,,52.55,n/a,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,116.88,,59.34,,19.9,,0,
Master Protein,High,Q12905,ILF2,Interleukin enhancer-binding factor 2 OS=Homo sapiens OX=9606 GN=ILF2 PE=1 SV=2,9,24,4.935,0.397,2.309,0.96,2.3,-1.33,1.21,-0.06,7.69E-02,4.47E-01,3.32E-01,8.85E-01,2.09E+06,1.40E+06,1.22E+06,7.04E+05,4,1,5,5,1.13E+06,,1.10E+06,7.18E+06,3.85E+06,,,,,1.40E+06,1.29E+06,1.22E+06,7.36E+05,8.28E+06,7.43E+05,7.04E+05,3.59E+05,9.37E+04,1.31E+06,2.00E+06,4.49E+03,,1.07E+04,7.18E+06,1.99E+05,,,,,1.49E+04,7.71E+03,5.47E+04,5.98E+03,1.12E+06,1.85E+04,1.37E+03,1.01E+05,6.64E+02,3.06E+04,2.12E+04,0,FALSE,34.846,35,9,390,43,5.26,9,other biological processes,cytosol;nucleus;other cell component,"Pf07528, Pf20965",3608,A6NDB0; B2R8G7; hsa:3608; Q12905; Q5SR10; Q5SR11; Q7L7R3; Q9BWD4; Q9P1N0,ENSG00000143621,Neutrophil degranulation; PKR-mediated signaling,B cell receptor signaling pathway,3,0,86.94,,133.11,85.89,Peak Found,n/a,High,High,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,340.92,118.71,115.83,140.48,69.76,nucleic acid binding activity,0,
Master Protein,High,Q9H9F9,ACTR5,Actin-related protein 5 OS=Homo sapiens OX=9606 GN=ACTR5 PE=1 SV=2,2,7,4.916,0.353,4.316,0.341,2.3,-1.5,2.11,-1.55,9.81E-02,4.29E-01,2.37E-01,4.97E-01,2.74E+05,5.58E+04,8.22E+04,2.41E+05,2,1,4,1,,,3.37E+05,2.23E+05,,,5.58E+04,,,,,8.36E+04,7.68E+04,2.63E+05,8.09E+04,2.41E+05,,,,,,,3.29E+03,2.23E+05,,,9.93E+02,,,,,3.73E+03,6.24E+02,3.55E+04,2.01E+03,4.70E+02,,,,,0,FALSE,13.161,6,2,607,68.3,5.27,2,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf00022,79913,hsa:79913; Q86WF7; Q8IUY5; Q8N724; Q9BRN0; Q9BVB7; Q9H9F9,ENSG00000101442,UCH proteinases; DNA Damage Recognition in GG-NER,,2,0,28.64,,72.49,,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,30.66,66.06,0,6.46,25.06,,0,
Master Protein,High,Q02978,SLC25A11,Mitochondrial 2-oxoglutarate/malate carrier protein OS=Homo sapiens OX=9606 GN=SLC25A11 PE=1 SV=3,9,53,4.875,0.827,1.274,3.397,2.29,-0.27,0.35,1.76,9.35E-02,7.93E-01,8.03E-01,2.46E-01,4.24E+06,4.84E+05,5.81E+06,2.09E+06,5,4,5,5,3.02E+06,1.80E+07,4.24E+06,2.78E+06,1.93E+07,3.44E+05,3.90E+05,1.21E+06,,5.99E+05,1.32E+07,2.06E+06,3.29E+06,8.57E+06,5.81E+06,2.09E+06,3.61E+05,7.36E+06,2.20E+06,2.10E+05,1.20E+04,6.85E+04,4.14E+04,2.78E+06,9.98E+05,1.22E+03,6.94E+03,1.12E+04,,6.37E+03,7.88E+04,9.21E+04,2.67E+04,1.16E+06,1.44E+05,4.08E+03,1.01E+05,5.22E+04,5.14E+04,2.24E+03,0,FALSE,35.17,32,9,314,34,9.91,9,other metabolic processes;transport,plasma membrane;other membranes;mitochondrion,Pf00153,8402,F5GY65; hsa:8402; O75537; Q02978; Q969P7,ENSG00000108528,Gluconeogenesis,VEGFA-VEGFR2 signaling,2,0,88.94,62.64,67.62,118.74,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,n/a,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.64,135.01,118.56,133,139.6,transporter activity,0,
Master Protein,High,Q15287,RNPS1,RNA-binding protein with serine-rich domain 1 OS=Homo sapiens OX=9606 GN=RNPS1 PE=1 SV=1,2,8,4.874,0.725,0.01,100,2.29,-0.46,-6.64,6.64,9.65E-02,9.13E-01,1.00E-17,1.00E-17,6.65E+05,1.30E+05,3.44E+05,,5,1,3,,1.66E+05,7.52E+05,6.65E+05,2.40E+06,5.79E+05,,,,,1.30E+05,8.17E+05,3.44E+05,,6.01E+04,,,,,,,6.58E+02,2.86E+03,6.49E+03,2.40E+06,2.98E+04,,,,,1.38E+03,4.89E+03,1.54E+04,,8.09E+03,,,,,,,0,FALSE,14.053,5,2,305,34.2,11.84,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf00076,10921,A8K1P0; B4DDU8; B4DZU7; B7ZA17; hsa:10921; O75308; Q15287; Q32P25; Q8WY42; Q9NYG3,ENSG00000205937,Regulation of expression of SLITs and ROBOs; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),mRNA processing,7,0,94.48,,93.93,,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,29.13,99.71,,,25.47,nucleic acid binding activity,0,
Master Protein,High,O95926,SYF2,Pre-mRNA-splicing factor SYF2 OS=Homo sapiens OX=9606 GN=SYF2 PE=1 SV=1,2,2,4.851,0.251,1.462,,2.28,-2,0.55,,9.17E-02,3.04E-01,7.30E-01,,6.53E+04,1.35E+04,2.26E+04,1.97E+04,3,1,2,2,6.53E+04,,3.98E+04,1.59E+05,,,,,1.35E+04,,,2.17E+04,,2.35E+04,,,1.65E+04,,2.35E+04,,2.60E+02,,3.89E+02,1.59E+05,,,,,3.80E+02,,,9.68E+02,,3.17E+03,,,4.64E+03,,5.49E+02,,0,FALSE,14.303,17,2,243,28.7,8.4,2,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,nucleus;other cell component,Pf08231,25949,hsa:25949; O95926; Q5TH73,ENSG00000117614,mRNA Splicing - Major Pathway,,1,0,71.43,,5.77,24.59,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,8.98,6.06,26.17,,8.25,,0,
Master Protein,High,Q30154,HLA-DRB5,"HLA class II histocompatibility antigen, DR beta 5 chain OS=Homo sapiens OX=9606 GN=HLA-DRB5 PE=1 SV=1",8,70,4.811,0.433,0.469,4.306,2.27,-1.21,-1.09,2.11,9.65E-02,4.89E-01,2.72E-01,1.70E-01,1.40E+07,1.16E+06,7.44E+06,3.26E+06,5,4,5,5,6.07E+06,3.94E+07,4.62E+06,3.83E+07,1.40E+07,1.56E+06,2.74E+05,,8.66E+05,3.01E+06,9.97E+05,7.44E+06,1.40E+06,4.46E+07,1.51E+07,3.62E+06,4.34E+05,3.26E+06,7.66E+05,3.79E+06,2.41E+04,1.50E+05,4.52E+04,3.83E+07,7.21E+05,5.56E+03,4.88E+03,,2.44E+04,3.21E+04,5.96E+03,3.33E+05,1.14E+04,6.01E+06,3.74E+05,7.05E+03,1.22E+05,2.31E+04,1.79E+04,4.04E+04,0,FALSE,67.415,38,3,266,30,6.93,8,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle,"Pf00969, Pf07654",3127,B2RBV6; C7C4X3; hsa:3127; O00157; O00283; O46700; Q29703; Q29787; Q29788; Q30126; Q30150; Q30154; Q30199; Q6SJR2; Q7M2H9; Q8HWS7; Q8WLR5; Q9MY54; Q9XRX6,ENSG00000198502,MHC class II antigen presentation; Downstream TCR signaling; Phosphorylation of CD3 and TCR zeta chains; Translocation of ZAP-70 to Immunological synapse; Generation of second messenger molecules; PD-1 signaling; Interferon gamma signaling,Allograft rejection; Ebola virus infection in host; Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; Network map of SARS-CoV-2 signaling pathway,11,5,83.78,82.58,130.07,68.87,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,103.92,117.55,131.66,123.35,194.31,other molecular function,0,
Master Protein,High,P04792,HSPB1,Heat shock protein beta-1 OS=Homo sapiens OX=9606 GN=HSPB1 PE=1 SV=2,7,61,4.789,0.087,1.521,1.779,2.26,-3.53,0.61,0.83,9.75E-02,2.18E-03,6.50E-01,4.65E-01,2.27E+07,1.19E+06,1.32E+06,1.87E+06,5,5,5,5,6.94E+07,2.27E+07,3.37E+07,1.71E+07,8.76E+06,4.84E+05,2.61E+05,1.31E+06,1.71E+06,1.19E+06,4.85E+06,1.32E+06,2.12E+06,6.74E+05,1.25E+06,5.31E+05,7.87E+05,1.94E+06,1.95E+06,1.87E+06,2.76E+05,8.63E+04,3.30E+05,1.71E+07,4.52E+05,1.72E+03,4.64E+03,1.21E+04,4.83E+04,1.27E+04,2.90E+04,5.91E+04,1.73E+04,9.09E+04,3.12E+04,1.04E+03,2.21E+05,1.37E+04,4.56E+04,1.99E+04,0,FALSE,38.823,42,7,205,22.8,6.4,7,protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;cytosol;cytoskeleton;nucleus;other cell component,Pf00011,3315,B2R4N8; hsa:3315; P04792; Q6FI47; Q96C20; Q96EI7; Q9UC31; Q9UC34; Q9UC35; Q9UC36,ENSG00000106211,AUF1 (hnRNP D0) binds and destabilizes mRNA; MAPK6/MAPK4 signaling; Extra-nuclear estrogen signaling; VEGFA-VEGFR2 Pathway,Apoptosis-related network due to altered Notch3 in ovarian cancer; Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling; p38 MAPK signaling pathway; Extracellular vesicles in the crosstalk of cardiac cells; Ferroptosis; IL-18 signaling pathway; Intracellular trafficking proteins involved in CMT neuropathy; GDNF signaling; Macrophage-stimulating protein (MSP) signaling network map; 7q11.23 distal copy number variation; HDAC6 interactions in the central nervous system,18,0,77.98,60.75,80.73,49.19,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,128.83,116.67,103.9,137.76,139.98,enzyme regulator activity;other molecular function,0,
Master Protein,High,P68400,CSNK2A1,Casein kinase II subunit alpha OS=Homo sapiens OX=9606 GN=CSNK2A1 PE=1 SV=1,6,20,4.785,0.194,0.766,1.363,2.26,-2.36,-0.38,0.45,1.28E-01,7.98E-02,6.48E-01,6.30E-01,1.10E+06,2.28E+05,1.98E+05,3.09E+05,4,1,4,2,,1.09E+06,1.10E+06,1.31E+06,6.19E+05,,,,2.28E+05,,,1.84E+05,9.74E+04,1.40E+06,2.13E+05,,1.34E+06,7.15E+04,,,,4.14E+03,1.08E+04,1.31E+06,3.19E+04,,,,6.43E+03,,,8.21E+03,7.92E+02,1.89E+05,5.29E+03,,3.76E+05,5.07E+02,,,0,FALSE,31.496,27,6,391,45.1,7.74,6,cell-cell signaling;cell cycle OR cell proliferation;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf00069,1457,B4DYS6; D3DVV8; hsa:1457; P19138; P20426; P68400; Q14013; Q5U065,ENSG00000101266,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN stability and activity; KEAP1-NFE2L2 pathway; Regulation of TP53 Activity through Phosphorylation; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; WNT mediated activation of DVL; Signal transduction by L1; Maturation of hRSV A proteins; Receptor Mediated Mitophagy; Condensation of Prometaphase Chromosomes; Synthesis of PC,Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Translation inhibitors in chronically activated PDGFRA cells; Measles virus infection; Pleural mesothelioma; Alzheimer's disease,22,0,28.5,,130.9,127.08,n/a,Peak Found,High,High,High,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,0.81,64.48,151.05,101.51,65.39,kinase activity;other molecular function,0,
Master Protein,High,P61247,RPS3A,40S ribosomal protein S3a OS=Homo sapiens OX=9606 GN=RPS3A PE=1 SV=2,8,42,4.784,1.18,4.404,1.324,2.26,0.24,2.14,0.41,8.27E-02,4.31E-01,7.77E-02,7.45E-01,3.67E+06,4.73E+05,6.46E+06,1.94E+06,5,4,5,5,3.67E+06,1.06E+07,1.01E+06,1.05E+07,3.00E+06,1.01E+06,,2.54E+06,1.16E+04,2.22E+05,4.38E+06,9.34E+06,6.46E+06,8.81E+06,4.52E+06,1.94E+06,7.44E+06,2.18E+06,1.86E+06,2.87E+05,1.46E+04,4.04E+04,9.83E+03,1.05E+07,1.55E+05,3.59E+03,,2.35E+04,3.26E+02,2.36E+03,2.62E+04,4.17E+05,5.25E+04,1.19E+06,1.12E+05,3.78E+03,2.09E+06,1.54E+04,4.36E+04,3.05E+03,0,FALSE,33.078,34,8,264,29.9,9.73,8,protein metabolism;other metabolic processes;other biological processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf01015,6189,B2R4D4; D3DP05; hsa:6189; P33443; P49241; P61247,ENSG00000145425; ENSG00000292158,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,78.04,121.31,34.71,99.63,High,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,140.96,93.69,129.76,82.2,102.57,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O60506,SYNCRIP,Heterogeneous nuclear ribonucleoprotein Q OS=Homo sapiens OX=9606 GN=SYNCRIP PE=1 SV=2,16,51,4.754,0.384,0.655,2.245,2.25,-1.38,-0.61,1.17,8.44E-02,3.85E-01,5.28E-01,3.82E-01,4.10E+06,3.75E+05,3.80E+06,2.69E+05,3,2,4,3,,4.10E+06,,1.17E+07,2.28E+05,,,5.65E+05,,2.49E+05,,3.28E+06,4.41E+06,9.71E+06,1.32E+06,2.69E+05,1.59E+06,,9.92E+04,,,1.56E+04,,1.17E+07,1.18E+04,,,5.21E+03,,2.65E+03,,1.47E+05,3.58E+04,1.31E+06,3.29E+04,5.24E+02,4.46E+05,,2.32E+03,,0,FALSE,64.072,34,11,623,69.6,8.59,16,RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,"Pf00076, Pf18360",10492,E1P501; E1P502; hsa:10492; O60506; Q53H05; Q5TCG2; Q5TCG3; Q8IW78; Q8N599; Q96LC1; Q96LC2; Q9Y583,ENSG00000135316,,,0,0,109.12,54.83,76.63,124.97,n/a,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,113.62,110.01,76.91,68.27,155.12,nucleic acid binding activity,0,
Master Protein,High,P62280,RPS11,40S ribosomal protein S11 OS=Homo sapiens OX=9606 GN=RPS11 PE=1 SV=3,3,20,4.682,0.579,1.375,1.127,2.23,-0.79,0.46,0.17,1.06E-01,8.46E-01,8.82E-01,7.51E-01,1.63E+06,2.98E+05,1.28E+06,4.09E+05,5,1,5,4,1.63E+06,1.05E+06,1.06E+06,3.59E+06,1.71E+06,2.98E+05,,,,,6.10E+05,1.52E+06,3.63E+05,1.96E+06,1.28E+06,2.54E+05,1.95E+06,1.12E+05,6.60E+05,,6.46E+03,3.99E+03,1.03E+04,3.59E+06,8.81E+04,1.06E+03,,,,,3.65E+03,6.78E+04,2.95E+03,2.64E+05,3.17E+04,4.95E+02,5.47E+05,7.93E+02,1.54E+04,,0,FALSE,10.124,23,3,158,18.4,10.3,3,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,"Pf00366, Pf16205",6205,B2R4F5; hsa:6205; P04643; P62280; Q498Y6; Q6IRY0,ENSG00000142534,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",VEGFA-VEGFR2 signaling; IL-18 signaling pathway; Cytoplasmic ribosomal proteins,21,0,57.84,,57.18,112.43,Peak Found,Peak Found,High,High,High,Peak Found,n/a,n/a,n/a,n/a,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,36.17,73.26,99.24,97.94,51.13,nucleic acid binding activity;other molecular function,0,
Master Protein,High,E9PB61,ALYREF,Aly/REF export factor OS=Homo sapiens OX=9606 GN=ALYREF PE=1 SV=1,8,50,4.674,1.036,3.938,7.597,2.22,0.05,1.98,2.93,9.95E-02,5.51E-01,2.07E-01,6.07E-02,1.71E+06,1.34E+05,1.21E+07,6.30E+05,3,5,5,5,,3.46E+05,,2.45E+07,1.71E+06,7.77E+05,7.41E+04,8.03E+05,1.34E+05,1.32E+05,1.33E+06,1.52E+07,1.53E+07,1.21E+07,1.12E+07,1.86E+05,7.88E+05,4.21E+06,1.41E+05,6.30E+05,,1.32E+03,,2.45E+07,8.85E+04,2.76E+03,1.32E+03,7.41E+03,3.77E+03,1.40E+03,7.94E+03,6.79E+05,1.24E+05,1.63E+06,2.78E+05,3.64E+02,2.21E+05,2.98E+04,3.29E+03,6.70E+03,0,FALSE,52.45,48,8,264,27.5,11.05,8,,nucleus,"Pf00076, Pf13865",10189,E9PB61; hsa:10189,ENSG00000183684,,,0,0,153.25,96.79,51.85,143.58,n/a,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,81.67,131.67,112,139.69,150.73,nucleic acid binding activity,0,
Master Protein,High,Q9H4G4,GLIPR2,Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,4,6,4.671,0.13,2.172,0.385,2.22,-2.95,1.12,-1.38,1.30E-01,2.16E-02,5.01E-01,5.10E-01,8.97E+05,1.92E+05,3.34E+05,7.38E+05,1,3,3,3,,,,,8.97E+05,,1.92E+05,2.91E+05,1.24E+05,,3.93E+05,3.06E+05,3.34E+05,,,8.00E+05,7.38E+05,6.23E+05,,,,,,,4.63E+04,,3.41E+03,2.69E+03,3.49E+03,,2.35E+03,1.37E+04,2.71E+03,,,1.56E+03,2.07E+05,4.42E+03,,,0,FALSE,17.332,42,4,154,17.2,9.41,4,other biological processes,non-structural extracellular;other membranes;ER/Golgi,Pf00188,152007,hsa:152007; Q5VZR1; Q8N2S6; Q8WWC9; Q8WX36; Q9H4G4,ENSG00000122694,,,0,0,,41.61,12.96,12.45,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,n/a,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,0,102.58,74.8,86.83,16.22,other molecular function,0,
Master Protein,High,Q13123,IK,Protein Red OS=Homo sapiens OX=9606 GN=IK PE=1 SV=3,6,10,4.611,0.119,1.29,0.199,2.21,-3.08,0.37,-2.33,1.27E-01,1.78E-02,8.97E-01,2.59E-01,1.31E+06,9.58E+04,3.59E+04,1.80E+05,4,2,3,5,2.07E+06,,8.33E+05,2.12E+06,4.13E+05,,1.92E+05,,4.79E+04,,,,3.59E+04,1.42E+06,3.53E+04,3.81E+05,9.55E+04,1.80E+05,4.81E+04,2.76E+05,8.23E+03,,8.14E+03,2.12E+06,2.13E+04,,3.41E+03,,1.35E+03,,,,2.91E+02,1.91E+05,8.78E+02,7.44E+02,2.68E+04,1.27E+03,1.12E+03,2.94E+03,0,FALSE,26.685,17,6,557,65.6,6.64,6,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,cytoskeleton;nucleus;other cell component,"Pf07807, Pf07808",3550,hsa:3550; Q13123; Q6IPD8,ENSG00000113141,mRNA Splicing - Major Pathway,,1,0,63.79,84.97,160.8,68.88,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,104.22,81.88,97.65,102.65,31.54,other molecular function,0,
Master Protein,High,Q69YN4,VIRMA,Protein virilizer homolog OS=Homo sapiens OX=9606 GN=VIRMA PE=1 SV=2,4,12,4.558,0.245,1.071,2.081,2.19,-2.03,0.1,1.06,1.27E-01,1.74E-01,9.00E-01,4.01E-01,1.14E+06,5.49E+05,2.72E+05,1.26E+05,4,2,4,2,6.74E+06,2.86E+06,3.97E+05,4.54E+05,,,1.02E+06,,,2.94E+05,5.23E+05,3.44E+04,,7.61E+05,1.42E+05,1.48E+05,,,1.07E+05,,2.68E+04,1.09E+04,3.88E+03,4.54E+05,,,1.82E+04,,,3.13E+03,3.13E+03,1.54E+03,,1.03E+05,3.53E+03,2.89E+02,,,2.49E+03,,0,FALSE,21.042,4,4,1812,201.9,5.01,4,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf15912,25962,hsa:25962; Q2M1N0; Q69YN4; Q6AHX9; Q6NT78; Q7Z6C7; Q8IXH4; Q9BTH4; Q9H9C9; Q9NWR3; Q9P2B8; Q9UFW1,ENSG00000164944,,,0,0,114.13,78.33,92.34,22.98,High,Peak Found,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,104.87,120.86,132.77,114.34,42.56,,0,
Master Protein,High,P00558,PGK1,Phosphoglycerate kinase 1 OS=Homo sapiens OX=9606 GN=PGK1 PE=1 SV=3,10,36,4.551,0.694,0.613,1.088,2.19,-0.53,-0.71,0.12,9.69E-02,9.97E-01,4.91E-01,8.68E-01,4.08E+06,2.17E+05,3.85E+06,7.64E+05,5,3,5,5,2.00E+07,2.45E+05,4.08E+06,6.23E+06,3.12E+06,,1.56E+05,,2.17E+05,6.31E+05,3.64E+06,4.95E+06,2.42E+06,9.77E+06,3.85E+06,8.86E+05,2.56E+05,7.64E+05,4.07E+05,2.87E+06,7.93E+04,9.32E+02,3.99E+04,6.23E+06,1.61E+05,,2.78E+03,,6.11E+03,6.71E+03,2.17E+04,2.21E+05,1.96E+04,1.32E+06,9.56E+04,1.73E+03,7.20E+04,5.41E+03,9.52E+03,3.06E+04,0,FALSE,42.443,37,10,417,44.6,8.1,10,protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;other membranes;cytosol,Pf00162,5230,A8K4W6; B7Z7A9; hsa:5230; P00558; Q5J7W1; Q6IBT6; Q8NI87,ENSG00000102144,Glycolysis; Gluconeogenesis; Manipulation of host energy metabolism,Cori cycle; Photodynamic therapy-induced HIF-1 survival signaling; VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Glycolysis in senescence; Warburg effect modulated by deubiquitinating enzymes and their substrates; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,13,0,114.56,77.15,58,101.97,High,Peak Found,High,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,96.91,120.77,71.07,133.29,104.66,kinase activity;other molecular function,0,
Master Protein,High,Q07666,KHDRBS1,"KH domain-containing, RNA-binding, signal transduction-associated protein 1 OS=Homo sapiens OX=9606 GN=KHDRBS1 PE=1 SV=1",8,37,4.478,0.646,6.699,1.519,2.16,-0.63,2.74,0.6,1.10E-01,9.21E-01,1.87E-02,6.55E-01,1.94E+06,4.45E+05,9.05E+06,2.93E+06,5,5,5,5,6.00E+05,1.94E+06,3.25E+05,1.54E+07,8.74E+06,5.66E+05,4.45E+05,3.29E+05,2.70E+05,8.38E+05,1.18E+06,9.54E+06,7.40E+06,1.13E+07,9.05E+06,2.81E+06,2.31E+06,5.53E+06,2.93E+06,3.78E+06,2.39E+03,7.36E+03,3.17E+03,1.54E+07,4.51E+05,2.01E+03,7.91E+03,3.03E+03,7.61E+03,8.92E+03,7.04E+03,4.26E+05,6.01E+04,1.52E+06,2.25E+05,5.47E+03,6.49E+05,3.92E+04,6.86E+04,4.03E+04,0,FALSE,44.281,25,8,443,48.2,8.66,8,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00013, Pf16274, Pf16568",10657,D3DPP3; hsa:10657; Q07666; Q6PJX7; Q8NB97; Q99760,ENSG00000121774,PTK6 Regulates Proteins Involved in RNA Processing,Leptin signaling pathway; Primary ovarian insufficiency,3,0,121.38,46.08,50.68,36.47,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,124.12,138.17,73.85,141.52,108.55,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P27635,RPL10,60S ribosomal protein L10 OS=Homo sapiens OX=9606 GN=RPL10 PE=1 SV=5,4,10,4.471,0.363,4.924,0.328,2.16,-1.46,2.3,-1.61,1.46E-01,3.72E-01,1.10E-01,4.39E-01,1.11E+06,2.31E+05,5.35E+05,1.33E+06,5,3,5,3,1.11E+06,4.90E+05,1.27E+06,2.17E+06,9.68E+05,,,2.31E+05,3.08E+05,2.15E+05,5.36E+05,9.22E+05,5.01E+05,5.35E+05,6.33E+04,1.58E+06,1.33E+06,,,3.20E+05,4.41E+03,1.86E+03,1.24E+04,2.17E+06,4.99E+04,,,2.13E+03,8.68E+03,2.29E+03,3.21E+03,4.12E+04,4.07E+03,7.21E+04,1.57E+03,3.08E+03,3.73E+05,,,3.40E+03,0,FALSE,13.835,25,4,214,24.6,10.08,4,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf00252,6134,A3KQT0; D3DWW6; hsa:6134; P27635; Q16470; Q2HXT7; Q53FH7; Q6FGN8; Q8TDA5,ENSG00000147403,L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins; Primary ovarian insufficiency,15,0,51.12,19.79,59.51,61.99,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,49.29,89.76,32.41,80.16,33.79,other molecular function,0,
Master Protein,High,P01903,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain OS=Homo sapiens OX=9606 GN=HLA-DRA PE=1 SV=2",8,150,4.452,0.436,0.921,3.642,2.15,-1.2,-0.12,1.86,1.15E-01,4.96E-01,8.13E-01,2.21E-01,7.01E+07,6.40E+06,1.98E+07,3.54E+06,5,5,5,5,6.16E+07,7.68E+07,4.60E+07,7.01E+07,7.46E+07,1.07E+07,6.34E+05,6.40E+06,7.21E+05,1.90E+07,1.87E+07,1.98E+07,7.64E+06,1.04E+08,5.62E+07,7.74E+06,2.73E+06,2.95E+06,3.54E+06,5.36E+06,2.45E+05,2.92E+05,4.49E+05,7.01E+07,3.85E+06,3.81E+04,1.13E+04,5.91E+04,2.03E+04,2.02E+05,1.12E+05,8.83E+05,6.21E+04,1.40E+07,1.40E+06,1.51E+04,7.66E+05,2.09E+04,8.27E+04,5.70E+04,0,FALSE,67.629,33,7,254,28.6,5,8,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00993, Pf07654",3122,A2BET4; hsa:3122; P01903; Q30160; Q6IAZ1; Q861I2; Q9TP70,ENSG00000204287; ENSG00000206308; ENSG00000226260; ENSG00000227993; ENSG00000228987; ENSG00000230726; ENSG00000234794; ENSG00000277263,Downstream TCR signaling; Phosphorylation of CD3 and TCR zeta chains; Translocation of ZAP-70 to Immunological synapse; Generation of second messenger molecules; PD-1 signaling; MHC class II antigen presentation; Interferon gamma signaling,Allograft rejection; PI3K/AKT/mTOR - vitamin D3 signaling; Ebola virus infection in host; Male infertility; Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; Network map of SARS-CoV-2 signaling pathway; Cell interactions of the pancreatic cancer microenvironment; Cytokines and inflammatory response; 11p11.2 copy number variation syndrome,16,1,19.02,102.73,95.85,47.17,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,127.98,113.67,95.81,128.2,474.47,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q06323,PSME1,Proteasome activator complex subunit 1 OS=Homo sapiens OX=9606 GN=PSME1 PE=1 SV=1,6,26,4.431,0.348,0.605,1.908,2.15,-1.52,-0.72,0.93,1.16E-01,3.10E-01,4.94E-01,4.53E-01,6.58E+06,5.32E+05,1.55E+06,3.81E+05,5,2,5,4,5.01E+06,1.26E+07,3.91E+06,6.58E+06,9.45E+06,1.59E+06,,,1.78E+05,,5.41E+05,1.55E+06,1.40E+06,4.17E+06,3.06E+06,,8.55E+05,1.70E+05,1.16E+06,9.06E+04,1.99E+04,4.78E+04,3.82E+04,6.58E+06,4.88E+05,5.65E+03,,,5.01E+03,,3.24E+03,6.94E+04,1.14E+04,5.62E+05,7.60E+04,,2.40E+05,1.20E+03,2.72E+04,9.64E+02,0,FALSE,38.122,24,6,249,28.7,6.02,6,other biological processes,cytosol;nucleus;other cell component,"Pf02251, Pf02252",5720,A6NJG9; H0YNE3; hsa:5720; Q06323; Q6IBM2; Q9UEF4,ENSG00000092010; ENSG00000284916,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation,60,0,46.93,112.98,67.61,91.91,High,High,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,109.98,99.47,0,68.18,80.06,enzyme regulator activity,0,
Master Protein,High,P62244,RPS15A,40S ribosomal protein S15a OS=Homo sapiens OX=9606 GN=RPS15A PE=1 SV=2,3,29,4.414,2.245,4.221,1.242,2.14,1.17,2.08,0.31,1.19E-01,8.22E-02,9.01E-02,7.88E-01,1.70E+06,3.58E+05,3.32E+06,2.02E+06,5,4,5,5,3.73E+06,5.61E+05,1.70E+06,3.04E+06,7.68E+05,6.13E+05,8.23E+05,,1.97E+05,2.09E+05,1.08E+07,4.41E+06,2.70E+06,2.89E+06,3.32E+06,2.02E+06,4.31E+06,1.05E+06,1.86E+06,3.00E+06,1.48E+04,2.13E+03,1.66E+04,3.04E+06,3.96E+04,2.18E+03,1.46E+04,,5.54E+03,2.22E+03,6.45E+04,1.97E+05,2.20E+04,3.90E+05,8.25E+04,3.94E+03,1.21E+06,7.46E+03,4.35E+04,3.20E+04,0,FALSE,10.621,20,3,130,14.8,10.13,3,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf00410,6210,hsa:6210; P39027; P39031; P62244; Q3MHD9; Q8C023; Q9BV24,ENSG00000134419,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-2 modulates host translation machinery; SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,71.07,67.23,70.44,51.04,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,117.45,118.9,94.16,83.82,62.83,other molecular function,0,
Master Protein,High,P23396,RPS3,40S ribosomal protein S3 OS=Homo sapiens OX=9606 GN=RPS3 PE=1 SV=2,13,88,4.359,0.804,4.136,0.798,2.12,-0.31,2.05,-0.33,1.21E-01,8.24E-01,9.30E-02,9.01E-01,1.36E+07,1.34E+06,7.36E+06,6.28E+06,5,5,5,5,1.60E+07,1.92E+07,1.16E+07,6.81E+06,1.36E+07,3.59E+06,1.16E+06,1.34E+06,3.81E+05,1.44E+06,2.85E+07,5.58E+06,7.36E+06,9.83E+06,7.10E+06,8.79E+06,1.62E+07,1.65E+06,6.28E+06,4.59E+06,6.37E+04,7.29E+04,1.13E+05,6.81E+06,7.00E+05,1.28E+04,2.07E+04,1.23E+04,1.07E+04,1.53E+04,1.70E+05,2.49E+05,5.98E+04,1.32E+06,1.76E+05,1.71E+04,4.56E+06,1.17E+04,1.47E+05,4.89E+04,0,FALSE,53.364,51,13,243,26.7,9.66,13,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;translational apparatus;nucleus;other cell component,"Pf00189, Pf07650",6188,B2R7N5; hsa:6188; J3KN86; P23396; Q498B5; Q8NI95,ENSG00000149273,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,34.78,75.69,81.51,73.58,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,111.48,113.94,117.32,80.55,223.49,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y4W6,AFG3L2,AFG3-like protein 2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,7,10,4.241,1.023,1.806,2.749,2.08,0.03,0.85,1.46,1.41E-01,4.77E-01,6.37E-01,2.67E-01,1.06E+06,6.96E+05,2.10E+06,2.24E+05,5,4,5,3,2.68E+05,9.92E+05,1.20E+06,2.55E+06,1.06E+06,,8.79E+05,6.92E+05,7.00E+05,4.33E+05,1.99E+06,2.10E+06,4.53E+05,2.24E+06,2.73E+06,2.24E+05,7.85E+04,,3.36E+05,,1.06E+03,3.77E+03,1.17E+04,2.55E+06,5.45E+04,,1.56E+04,6.39E+03,1.97E+04,4.61E+03,1.19E+04,9.36E+04,3.68E+03,3.01E+05,6.78E+04,4.37E+02,2.21E+04,,7.85E+03,,0,FALSE,24.711,14,7,797,88.5,8.66,7,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes,other membranes;mitochondrion,"Pf00004, Pf01434, Pf06480, Pf17862",10939,hsa:10939; Q6P1L0; Q9Y4W6,ENSG00000141385,Mitochondrial protein degradation; Processing of SMDT1,Ciliary landscape; 10q22q23 copy number variation,4,0,68.41,27.15,45.1,60.58,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,77.14,71.69,53.14,75.8,25.7,other molecular function,0,
Master Protein,High,P29966,MARCKS,Myristoylated alanine-rich C-kinase substrate OS=Homo sapiens OX=9606 GN=MARCKS PE=1 SV=4,2,7,4.235,0.123,5.563,0.099,2.08,-3.02,2.48,-3.33,1.31E-01,2.93E-02,1.05E-01,4.40E-02,5.82E+05,2.48E+05,6.95E+04,5.72E+05,4,5,4,3,8.27E+05,,7.60E+04,4.10E+05,5.45E+06,9.42E+05,2.88E+05,2.48E+05,1.37E+05,7.29E+04,,3.85E+04,5.67E+04,3.27E+05,8.50E+04,4.49E+05,,,5.72E+05,2.24E+06,3.28E+03,,7.42E+02,4.10E+05,2.81E+05,3.35E+03,5.12E+03,2.29E+03,3.85E+03,7.75E+02,,1.72E+03,4.61E+02,4.41E+04,2.11E+03,8.75E+02,,,1.34E+04,2.39E+04,0,FALSE,5.727,7,2,332,31.5,4.45,2,cell organization and biogenesis;stress response;developmental processes;other biological processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,Pf02063,4082,E1P560; hsa:4082; P29966; Q2LA83; Q5TDB7,ENSG00000277443,Acetylcholine regulates insulin secretion,Brain-derived neurotrophic factor (BDNF) signaling pathway,2,0,149.32,103.32,106.32,92.16,Peak Found,n/a,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,High,Peak Found,1,,FALSE,137.64,121.07,58.85,83.93,6.74,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9Y2X3,NOP58,Nucleolar protein 58 OS=Homo sapiens OX=9606 GN=NOP58 PE=1 SV=1,13,64,4.184,0.314,1.526,1.541,2.06,-1.67,0.61,0.62,1.32E-01,2.43E-01,7.46E-01,5.65E-01,8.07E+06,5.11E+05,1.31E+06,8.83E+05,5,4,5,5,1.92E+06,8.26E+06,1.58E+06,8.07E+06,1.49E+07,6.33E+05,4.12E+05,8.59E+04,,1.70E+06,5.61E+05,1.31E+06,5.38E+05,6.62E+06,1.65E+06,8.31E+05,1.31E+05,1.86E+06,8.83E+05,1.09E+06,7.64E+03,3.14E+04,1.55E+04,8.07E+06,7.70E+05,2.25E+03,7.33E+03,7.92E+02,,1.81E+04,3.35E+03,5.86E+04,4.37E+03,8.93E+05,4.10E+04,1.62E+03,3.69E+04,1.32E+04,2.07E+04,1.16E+04,0,FALSE,78.067,26,13,529,59.5,8.92,13,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf01798, Pf08156",51602,hsa:51602; Q53SA4; Q6PK08; Q9P036; Q9UFN3; Q9Y2X3,ENSG00000055044,Major pathway of rRNA processing in the nucleolus and cytosol; SUMOylation of RNA binding proteins; rRNA modification in the nucleus and cytosol,,3,0,79,98.67,119.53,64.68,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,122.88,114.61,112.86,136.71,201.53,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P16152,CBR1,Carbonyl reductase [NADPH] 1 OS=Homo sapiens OX=9606 GN=CBR1 PE=1 SV=3,2,8,4.179,0.297,0.481,2.541,2.06,-1.75,-1.06,1.35,1.20E-01,2.78E-01,4.65E-01,3.57E-01,4.96E+05,1.10E+05,1.99E+05,5.27E+04,3,2,5,2,1.07E+06,,4.96E+05,1.93E+05,,,,6.91E+04,,1.74E+05,2.36E+05,3.16E+05,1.45E+05,1.99E+05,3.88E+04,1.07E+05,2.59E+04,,,,4.23E+03,,4.85E+03,1.93E+05,,,,6.37E+02,,1.85E+03,1.41E+03,1.41E+04,1.18E+03,2.69E+04,9.64E+02,2.10E+02,7.27E+03,,,,0,FALSE,8,16,2,277,30.4,8.32,2,other metabolic processes;other biological processes,cytosol,Pf00106,873,B2RBZ7; B4DFK7; hsa:873; P16152; Q3LHW8,ENSG00000159228,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Nuclear receptors meta-pathway; NRF2 pathway; Omega-6-fatty acids in senescence; Prostaglandin synthesis and regulation,5,0,75.67,61.01,55.36,86.54,Peak Found,n/a,High,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,87.71,86.89,72.3,98.27,24.53,other molecular function,0,
Master Protein,High,P14678,SNRPB,Small nuclear ribonucleoprotein-associated proteins B and B' OS=Homo sapiens OX=9606 GN=SNRPB PE=1 SV=2,4,111,4.169,0.357,0.756,2.191,2.06,-1.49,-0.4,1.13,1.33E-01,3.28E-01,6.25E-01,4.40E-01,2.79E+07,3.68E+06,6.21E+06,2.61E+06,5,5,5,5,1.14E+07,5.49E+07,8.70E+06,2.79E+07,8.94E+07,6.50E+05,3.68E+06,9.85E+06,4.89E+05,3.83E+07,6.21E+06,6.10E+06,5.83E+06,2.30E+07,8.48E+06,2.61E+06,1.66E+05,5.13E+06,1.47E+06,1.58E+07,4.54E+04,2.09E+05,8.50E+04,2.79E+07,4.61E+06,2.31E+03,6.55E+04,9.09E+04,1.38E+04,4.07E+05,3.71E+04,2.72E+05,4.73E+04,3.11E+06,2.11E+05,5.10E+03,4.66E+04,3.63E+04,3.45E+04,1.68E+05,0,FALSE,18.992,21,4,240,24.6,11.19,4,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf01423,6628,hsa:6628; P14678; Q15490; Q6IB35; Q9UIS5,ENSG00000125835,snRNP Assembly; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Minor Pathway; SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,mRNA processing,8,0,88.14,150.52,74.57,124.74,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,1,,FALSE,142.95,136.3,137.58,114.97,157.98,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O15379,HDAC3,Histone deacetylase 3 OS=Homo sapiens OX=9606 GN=HDAC3 PE=1 SV=2,1,1,4.162,0.607,0.01,100,2.06,-0.72,-6.64,6.64,1.40E-01,9.06E-01,1.00E-17,1.00E-17,7.30E+04,1.76E+04,4.44E+04,,2,1,4,,,1.39E+05,,3.83E+04,,,,,1.76E+04,,7.36E+04,1.01E+05,,8.52E+03,2.68E+04,,,,,,,5.29E+02,,3.83E+04,,,,,4.95E+02,,4.40E+02,4.49E+03,,1.15E+03,6.65E+02,,,,,,0.005,FALSE,2.526,4,1,428,48.8,5.16,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,Pf00850,8841,D3DQE1; hsa:8841; O15379; O43268; Q9UEI5; Q9UEV0,ENSG00000171720,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; HCMV Early Events; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Heme signaling; Regulation of PTEN gene transcription; Transcriptional activation of mitochondrial biogenesis; HDACs deacetylate histones; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Cytoprotection by HMOX1; Association of TriC/CCT with target proteins during biosynthesis; NR1D1 (REV-ERBA) represses gene expression; p75NTR negatively regulates cell cycle via SC1; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; RUNX2 regulates osteoblast differentiation; Loss of MECP2 binding ability to the NCoR/SMRT complex; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; STAT3 nuclear events downstream of ALK signaling,Neural crest differentiation; Initiation of transcription and translation elongation at the HIV-1 LTR; Ethanol effects on histone modifications; Transcription co-factors SKI and SKIL protein partners; 22q11.2 copy number variation syndrome; IL-18 signaling pathway; 7q11.23 copy number variation syndrome; 16p11.2 proximal deletion syndrome,31,0,80.31,,80.68,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,102.28,107.62,,,2.51,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,O75718,CRTAP,Cartilage-associated protein OS=Homo sapiens OX=9606 GN=CRTAP PE=1 SV=1,1,2,4.157,1.031,1.744,1.71,2.06,0.04,0.8,0.77,1.36E-01,6.13E-01,7.00E-01,4.96E-01,2.32E+05,1.03E+05,2.94E+05,2.08E+05,5,2,4,3,2.30E+06,9.58E+04,1.63E+06,2.03E+05,2.32E+05,,,,5.22E+04,2.02E+05,,2.24E+05,4.47E+05,3.86E+05,2.23E+05,1.13E+05,2.08E+05,,,2.84E+05,9.16E+03,3.64E+02,1.59E+04,2.03E+05,1.20E+04,,,,1.47E+03,2.15E+03,,1.00E+04,3.63E+03,5.19E+04,5.54E+03,2.20E+02,5.83E+04,,,3.02E+03,0.027,FALSE,1.859,2,1,401,46.5,5.73,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;ER/Golgi;other cell component,,10491,B2RBL6; hsa:10491; O75718,ENSG00000170275,Collagen biosynthesis and modifying enzymes,Type I collagen synthesis in the context of osteogenesis imperfecta,2,0,113.18,83.41,35.66,42.49,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,121.96,127.02,80.86,46.56,3.98,,0,
Master Protein,High,Q9H3N1,TMX1,Thioredoxin-related transmembrane protein 1 OS=Homo sapiens OX=9606 GN=TMX1 PE=1 SV=1,4,14,4.155,1.19,1.707,1.12,2.05,0.25,0.77,0.16,1.12E-01,3.29E-01,6.73E-01,8.09E-01,4.26E+05,2.17E+05,1.43E+06,1.09E+06,4,2,5,2,2.79E+05,,6.52E+05,8.62E+05,1.14E+05,4.57E+05,,,1.03E+05,,2.57E+06,6.37E+05,1.45E+06,1.43E+06,9.56E+05,2.10E+06,5.68E+05,,,,1.11E+03,,6.37E+03,8.62E+05,5.86E+03,1.63E+03,,,2.89E+03,,1.54E+04,2.85E+04,1.18E+04,1.92E+05,2.38E+04,4.10E+03,1.59E+05,,,,0,FALSE,11.233,15,4,280,31.8,4.98,4,stress response;other biological processes,other membranes;ER/Golgi;other cell component,Pf00085,81542,B2R7A4; hsa:81542; Q8N487; Q8NBN5; Q9H3N1; Q9Y4T6,ENSG00000139921,,,0,0,71.71,89.61,52.15,81.29,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,High,Peak Found,High,High,Peak Found,High,n/a,n/a,n/a,1,,FALSE,93.6,102.67,104.38,95.03,28.29,other molecular function,0,
Master Protein,High,P08473,MME,Neprilysin OS=Homo sapiens OX=9606 GN=MME PE=1 SV=2,24,217,4.136,1.015,0.901,5.863,2.05,0.02,-0.15,2.55,1.36E-01,5.71E-01,7.92E-01,9.99E-02,3.71E+07,7.00E+06,4.05E+07,2.57E+06,5,5,5,5,8.49E+07,6.55E+07,2.92E+07,3.71E+07,2.87E+07,7.89E+06,1.27E+06,2.48E+06,7.00E+06,1.07E+07,2.17E+08,2.04E+07,2.46E+07,4.84E+07,4.05E+07,6.02E+06,2.09E+06,2.57E+06,2.86E+06,1.01E+06,3.37E+05,2.49E+05,2.85E+05,3.71E+07,1.48E+06,2.81E+04,2.26E+04,2.29E+04,1.97E+05,1.14E+05,1.30E+06,9.13E+05,2.00E+05,6.52E+06,1.01E+06,1.17E+04,5.88E+05,1.82E+04,6.70E+04,1.07E+04,0,FALSE,142.981,43,24,750,85.5,5.73,24,protein metabolism;other metabolic processes;developmental processes;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf01431, Pf05649",4311,A8K6U6; D3DNJ9; hsa:4311; P08473; Q3MIX4,ENSG00000196549,Neutrophil degranulation; Metabolism of Angiotensinogen to Angiotensins; Physiological factors,Alzheimer's disease and miRNA effects; Primary focal segmental glomerulosclerosis (FSGS); Alzheimer's disease,6,0,50.99,66.66,118.07,64.43,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,125.41,103.4,119.51,109.25,591.72,other molecular function,0,
Master Protein,High,Q92905,COPS5,COP9 signalosome complex subunit 5 OS=Homo sapiens OX=9606 GN=COPS5 PE=1 SV=4,3,9,4.132,0.434,2.29,1.094,2.05,-1.2,1.2,0.13,1.50E-01,5.77E-01,5.11E-01,8.19E-01,1.42E+05,4.48E+04,8.30E+04,6.93E+04,2,2,5,4,,,,1.65E+05,1.23E+05,,,,2.96E+04,6.77E+04,8.54E+04,3.97E+04,6.03E+04,1.03E+05,8.30E+04,,8.37E+05,9.09E+04,5.28E+04,2.99E+04,,,,1.65E+05,6.34E+03,,,,8.34E+02,7.19E+02,5.11E+02,1.77E+03,4.90E+02,1.39E+04,2.06E+03,,2.35E+05,6.44E+02,1.24E+03,3.18E+02,0,FALSE,11.084,9,3,334,37.6,6.54,3,protein metabolism;other metabolic processes;transport;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,"Pf01398, Pf18323",10987,hsa:10987; O15386; Q6AW95; Q86WQ4; Q92905; Q9BQ17,ENSG00000121022,Cargo recognition for clathrin-mediated endocytosis; Neddylation; Formation of TC-NER Pre-Incision Complex; DNA Damage Recognition in GG-NER,TGF-beta signaling pathway,5,0,20.52,55.31,33.2,154.51,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,42.22,42.2,67.78,68.68,20.84,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q93077,H2AC6,Histone H2A type 1-C OS=Homo sapiens OX=9606 GN=H2AC6 PE=1 SV=3,12,1249,4.117,0.92,0.382,14.006,2.04,-0.12,-1.39,3.81,1.37E-01,6.73E-01,1.74E-01,1.56E-02,8.12E+08,2.49E+08,3.04E+09,2.62E+08,5,5,5,5,7.14E+08,8.12E+08,3.50E+09,3.93E+09,7.10E+08,6.71E+08,1.83E+08,2.49E+08,7.70E+07,4.29E+08,1.70E+09,3.63E+09,2.97E+09,3.04E+09,3.79E+09,1.80E+08,4.69E+08,2.62E+08,1.72E+08,3.62E+08,2.84E+06,3.09E+06,3.42E+07,3.93E+09,3.66E+07,2.39E+06,3.25E+06,2.30E+06,2.17E+06,4.56E+06,1.02E+07,1.62E+08,2.41E+07,4.10E+08,9.42E+07,3.52E+05,1.32E+08,1.86E+06,4.04E+06,3.86E+06,0,FALSE,125.045,69,2,130,14.1,11.05,12,other biological processes,nucleus;other cell component,"Pf00125, Pf16211",8334,B2R4F7; hsa:8334; O00775; O00776; O00777; O00778; Q540R1; Q93077,ENSG00000180573,Transcriptional regulation by small RNAs; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Inhibition of DNA recombination at telomere; HCMV Late Events; Ub-specific processing proteases; HCMV Early Events; HDACs deacetylate histones; HATs acetylate histones; Amyloid fiber formation; Meiotic synapsis; UCH proteinases; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; NoRC negatively regulates rRNA expression; Metalloprotease DUBs; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RMTs methylate histone arginines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Chromatin modifications during the maternal to zygotic transition (MZT); RNA Polymerase I Promoter Escape; Meiotic recombination; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Packaging Of Telomere Ends; Condensation of Prophase Chromosomes; DNA Damage/Telomere Stress Induced Senescence; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis,,42,10,84.56,72.58,27.17,43.67,n/a,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,140.03,141.85,136.17,142.56,3189.89,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P09669,COX6C,Cytochrome c oxidase subunit 6C OS=Homo sapiens OX=9606 GN=COX6C PE=1 SV=2,2,11,4.096,1.198,5.115,1.146,2.03,0.26,2.35,0.2,1.27E-01,4.01E-01,1.07E-01,7.54E-01,1.80E+06,8.24E+05,2.59E+06,6.27E+05,5,4,5,5,1.77E+05,1.80E+06,1.93E+05,1.97E+06,3.66E+06,1.90E+06,3.56E+05,2.08E+05,,5.05E+06,1.39E+05,2.59E+06,4.15E+06,2.40E+06,5.05E+06,5.64E+05,6.27E+05,3.16E+05,1.20E+06,1.01E+07,7.04E+02,6.83E+03,1.89E+03,1.97E+06,1.89E+05,6.77E+03,6.34E+03,1.92E+03,,5.37E+04,8.33E+02,1.16E+05,3.37E+04,3.23E+05,1.26E+05,1.10E+03,1.76E+05,2.24E+03,2.82E+04,1.08E+05,0,FALSE,5.544,27,2,75,8.8,10.39,2,other metabolic processes,other membranes;mitochondrion,Pf02937,1345,B2R4D7; hsa:1345; P09669,ENSG00000164919,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,Electron transport chain: OXPHOS system in mitochondria; Ciliary landscape; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly; 5q35 copy number variation,8,0,93.03,119.67,65.65,164.98,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,131.7,137.77,144.52,142.03,24.53,,0,
Master Protein,High,Q9Y3C6,PPIL1,Peptidyl-prolyl cis-trans isomerase-like 1 OS=Homo sapiens OX=9606 GN=PPIL1 PE=1 SV=1,2,2,4.093,0.144,0.919,0.363,2.03,-2.8,-0.12,-1.46,1.51E-01,8.87E-02,8.91E-01,5.28E-01,1.73E+05,4.23E+04,2.49E+04,6.86E+04,3,3,1,3,,3.36E+05,,1.73E+05,6.52E+04,1.68E+05,,4.23E+04,1.36E+04,,,,,2.49E+04,,1.54E+05,4.90E+03,6.86E+04,,,,1.28E+03,,1.73E+05,3.36E+03,5.98E+02,,3.90E+02,3.82E+02,,,,,3.35E+03,,3.01E+02,1.38E+03,4.86E+02,,,0,FALSE,7.918,16,2,166,18.2,7.99,2,protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes,nucleus,Pf00160,51645,hsa:51645; O15001; Q5TDC9; Q9Y3C6,ENSG00000137168,mRNA Splicing - Major Pathway,,1,0,71.28,110.11,,98.8,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,1,,FALSE,110.97,92.38,136.3,137.67,5.88,other molecular function,0,
Master Protein,High,Q969G3,SMARCE1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 OS=Homo sapiens OX=9606 GN=SMARCE1 PE=1 SV=2,15,39,4.091,0.734,1.612,2.127,2.03,-0.45,0.69,1.09,1.44E-01,9.31E-01,5.88E-01,4.56E-01,1.20E+06,2.42E+05,4.51E+06,2.20E+06,5,4,5,5,1.20E+06,8.93E+05,7.45E+04,4.71E+06,3.95E+06,6.74E+05,,1.33E+05,5.70E+04,4.37E+05,4.52E+05,3.05E+06,4.77E+06,6.57E+06,4.51E+06,2.20E+06,7.07E+05,2.74E+06,8.39E+05,8.32E+06,4.76E+03,3.39E+03,7.27E+02,4.71E+06,2.04E+05,2.40E+03,,1.23E+03,1.61E+03,4.65E+03,2.70E+03,1.36E+05,3.87E+04,8.86E+05,1.12E+05,4.28E+03,1.99E+05,1.94E+04,1.96E+04,8.85E+04,0,FALSE,76.984,46,15,411,46.6,4.88,15,cell organization and biogenesis;developmental processes;other biological processes,nucleus;other cell component,Pf00505,6605,B3KMC1; B4DFR4; C0IMW4; C0IMW5; C0IMW7; H7C3F6; hsa:6605; O43539; Q969G3,ENSG00000073584,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,Androgen receptor signaling pathway; Pathways affected in adenoid cystic carcinoma; Tumor suppressor activity of SMARCB1; Thermogenesis,6,0,94.06,87.45,59.04,105.35,High,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,118.05,121.23,72.22,103.2,119.54,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A7P0T871,ACAD9,Acyl-CoA dehydrogenase family member 9 OS=Homo sapiens OX=9606 GN=ACAD9 PE=1 SV=1,10,30,4.089,1.219,12.033,0.763,2.03,0.29,3.59,-0.39,1.71E-01,3.23E-01,1.13E-02,8.70E-01,1.05E+06,2.65E+04,2.51E+06,1.48E+06,5,2,5,5,1.03E+05,1.44E+06,1.88E+05,1.21E+06,1.05E+06,,,3.55E+04,1.98E+04,,3.42E+05,9.16E+05,3.95E+06,2.51E+06,4.13E+06,4.35E+05,1.48E+06,7.80E+06,9.51E+05,2.10E+06,4.07E+02,5.46E+03,1.84E+03,1.21E+06,5.41E+04,,,3.28E+02,5.58E+02,,2.04E+03,4.09E+04,3.21E+04,3.38E+05,1.03E+05,8.49E+02,4.16E+05,5.53E+04,2.22E+04,2.24E+04,0,FALSE,42.792,21,10,660,72.5,7.4,10,,mitochondrion,"Pf00441, Pf02770, Pf02771, Pf21343",,A0A7P0T871,ENSG00000177646,,Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,2,0,76.69,40.22,72.63,117.35,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,High,High,High,Peak Found,High,High,Peak Found,Peak Found,1,,FALSE,118.38,145.49,140.97,114.92,89.53,other molecular function,0,
Master Protein,High,Q7RTV0,PHF5A,PHD finger-like domain-containing protein 5A OS=Homo sapiens OX=9606 GN=PHF5A PE=1 SV=1,2,3,4.082,0.173,0.28,2.509,2.03,-2.53,-1.84,1.33,1.21E-01,8.04E-02,2.39E-01,3.20E-01,4.48E+05,1.00E+05,7.05E+04,3.19E+04,2,3,5,2,,3.67E+05,,5.46E+05,,1.00E+05,,1.82E+05,,7.11E+04,4.74E+04,2.93E+04,2.18E+05,1.26E+05,7.05E+04,,5.90E+03,1.72E+05,,,,1.40E+03,,5.46E+05,,3.56E+02,,1.68E+03,,7.56E+02,2.83E+02,1.31E+03,1.77E+03,1.70E+04,1.75E+03,,1.66E+03,1.22E+03,,,0,FALSE,10.891,25,2,110,12.4,8.41,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf03660,84844,hsa:84844; Q7RTV0; Q9UH06,ENSG00000100410,mRNA Splicing - Major Pathway,mRNA processing,2,0,27.58,48.98,77.49,132.05,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,48.57,84.28,241.39,141.87,8.02,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A2R8YEA7,ACTB,Actin beta (Fragment) OS=Homo sapiens OX=9606 GN=ACTB PE=1 SV=1,10,183,4.072,0.386,1.521,1.032,2.03,-1.38,0.61,0.05,1.30E-01,4.05E-01,7.04E-01,8.29E-01,2.73E+06,6.71E+05,1.05E+06,1.02E+06,2,1,1,3,1.22E+07,,,6.10E+05,,,,,6.71E+05,,,,,1.05E+06,,,2.25E+06,1.02E+06,,5.66E+05,4.86E+04,,,6.10E+05,,,,,1.89E+04,,,,,1.42E+05,,,6.32E+05,7.23E+03,,6.03E+03,0,FALSE,57.697,80,2,157,17.5,4.73,10,,,Pf00022,,A0A2R8YEA7,ENSG00000075624,,Common pathways underlying drug addiction; Ebola virus infection in host; Acute viral myocarditis; Thermogenesis; Pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway,6,0,127.98,,,68.11,High,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,315.38,315.38,65.99,81.01,415.48,,0,
Master Protein,High,O75367,MACROH2A1,Core histone macro-H2A.1 OS=Homo sapiens OX=9606 GN=MACROH2A1 PE=1 SV=5,22,519,4.059,2.964,1.378,12.619,2.02,1.57,0.46,3.66,1.41E-01,3.17E-02,7.82E-01,2.00E-02,6.47E+07,1.31E+07,2.24E+08,1.30E+07,5,5,5,5,4.99E+07,1.01E+08,6.47E+07,1.33E+08,3.48E+07,1.37E+07,4.71E+06,1.31E+07,1.67E+06,4.94E+07,3.10E+08,2.24E+08,2.50E+08,1.52E+08,1.62E+08,2.56E+07,6.92E+06,2.16E+07,1.14E+07,1.30E+07,1.98E+05,3.84E+05,6.32E+05,1.33E+08,1.80E+06,4.88E+04,8.38E+04,1.21E+05,4.70E+04,5.26E+05,1.86E+06,1.00E+07,2.03E+06,2.05E+07,4.04E+06,4.99E+04,1.94E+06,1.53E+05,2.66E+05,1.38E+05,0,FALSE,132.391,60,3,369,39.2,9.83,22,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00125, Pf01661, Pf16211",9555,hsa:9555; O75367; O75377; Q503A8; Q7Z5E3; Q96D41; Q9H8P3; Q9UP96,ENSG00000113648,,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,2,16,51.94,115.75,29.61,48.9,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,131.41,109.86,120.22,114.15,1420.98,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UI08,EVL,Ena/VASP-like protein OS=Homo sapiens OX=9606 GN=EVL PE=1 SV=2,3,11,4.033,1.196,1.841,1.417,2.01,0.26,0.88,0.5,1.73E-01,3.87E-01,6.65E-01,6.19E-01,8.75E+05,2.05E+05,4.41E+05,4.07E+05,3,3,4,3,3.01E+06,8.75E+05,,1.30E+05,,2.05E+05,2.29E+05,1.89E+05,,,,1.57E+05,2.76E+05,8.68E+05,7.05E+05,,,4.07E+05,2.14E+05,7.94E+05,1.19E+04,3.32E+03,,1.30E+05,,7.29E+02,4.08E+03,1.74E+03,,,,7.02E+03,2.24E+03,1.17E+05,1.75E+04,,,2.89E+03,5.01E+03,8.45E+03,0,FALSE,16.237,11,3,416,44.6,8.84,3,cell organization and biogenesis;developmental processes;signal transduction;other biological processes,cytosol;cytoskeleton;other cell component,"Pf00568, Pf08776",51466,A8K105; B7Z3I5; hsa:51466; O95884; Q7Z522; Q8TBV1; Q9UF25; Q9UI08; Q9UIC2,ENSG00000196405,Generation of second messenger molecules; RHO GTPases Activate Formins; Signaling by ROBO receptors,,3,0,111.64,9.88,67.64,62.58,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,High,Peak Found,High,High,n/a,n/a,Peak Found,High,Peak Found,1,,FALSE,69.71,131.35,22.96,63.51,28.59,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q14103,HNRNPD,Heterogeneous nuclear ribonucleoprotein D0 OS=Homo sapiens OX=9606 GN=HNRNPD PE=1 SV=1,13,54,4.003,0.518,1.99,6.079,2,-0.95,0.99,2.6,1.46E-01,6.70E-01,4.35E-01,9.34E-02,1.11E+07,7.56E+05,3.11E+07,2.38E+06,5,5,5,5,1.27E+07,1.96E+06,1.11E+07,4.79E+07,9.37E+06,1.57E+05,2.85E+05,1.20E+06,7.56E+05,5.06E+06,4.58E+06,3.31E+07,4.66E+07,3.05E+07,3.11E+07,3.67E+06,6.12E+05,2.38E+06,3.20E+06,1.77E+06,5.05E+04,7.44E+03,1.09E+05,4.79E+07,4.84E+05,5.60E+02,5.07E+03,1.11E+04,2.13E+04,5.38E+04,2.74E+04,1.48E+06,3.79E+05,4.10E+06,7.72E+05,7.16E+03,1.72E+05,1.69E+04,7.49E+04,1.89E+04,0,FALSE,57.113,29,5,355,38.4,7.81,13,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00076, Pf08143",3184,A8K9J2; hsa:3184; P07029; Q01858; Q14100; Q14101; Q14102; Q14103; Q4W5A1; Q9UCE8; Q9UCE9,ENSG00000138668,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,mRNA processing,3,9,108.2,136.52,52.27,51.85,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,134.2,128.05,99.61,142.77,127.36,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P62266,RPS23,40S ribosomal protein S23 OS=Homo sapiens OX=9606 GN=RPS23 PE=1 SV=3,2,9,3.991,0.476,,1.016,2,-1.07,,0.02,1.32E-01,6.32E-01,,8.26E-01,2.58E+06,1.28E+05,5.47E+05,7.76E+05,3,2,2,1,5.02E+06,,2.58E+06,6.67E+05,,,,8.05E+04,,2.04E+05,,,3.79E+05,7.88E+05,,,7.76E+05,,,,1.99E+04,,2.52E+04,6.67E+05,,,,7.43E+02,,2.17E+03,,,3.08E+03,1.06E+05,,,2.18E+05,,,,0,FALSE,12.646,28,2,143,15.8,10.49,2,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf00164,6228,hsa:6228; P39028; P62266; Q6IB08,ENSG00000186468,"Regulation of expression of SLITs and ROBOs; Protein hydroxylation; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,20,0,79.11,61.28,49.55,,High,n/a,High,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,Peak Found,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,71.28,108.59,,0,37,other molecular function,0,
Master Protein,High,P12235,SLC25A4,ADP/ATP translocase 1 OS=Homo sapiens OX=9606 GN=SLC25A4 PE=1 SV=4,8,71,3.988,0.046,1.392,0.22,2,-4.45,0.48,-2.19,1.38E-01,4.72E-05,8.58E-01,2.04E-01,2.39E+06,1.62E+05,1.84E+06,7.12E+05,2,3,4,5,,,,1.18E+06,4.85E+06,1.31E+05,1.10E+06,1.62E+05,,,1.01E+07,,8.87E+05,6.38E+04,3.80E+06,7.12E+05,2.85E+05,5.45E+05,7.54E+06,3.15E+06,,,,1.18E+06,2.50E+05,4.65E+02,1.95E+04,1.50E+03,,,6.07E+04,,7.21E+03,8.60E+03,9.45E+04,1.39E+03,8.00E+04,3.86E+03,1.76E+05,3.36E+04,0,FALSE,32.507,33,3,298,33,9.76,8,cell organization and biogenesis;other metabolic processes;transport;other biological processes,plasma membrane;other membranes;mitochondrion,Pf00153,291,D3DP59; hsa:291; P12235,ENSG00000151729,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane; Mitochondrial protein import; Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,Electron transport chain: OXPHOS system in mitochondria; Alzheimer's disease and miRNA effects; Synaptic vesicle pathway; Alzheimer's disease; Sudden infant death syndrome (SIDS) susceptibility pathways,8,0,86.19,118.47,122.71,125.51,n/a,n/a,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,114.46,57.55,142.56,145.83,134.25,transporter activity,0,
Master Protein,High,Q5TH30,NDRG3,NDRG family member 3 OS=Homo sapiens OX=9606 GN=NDRG3 PE=1 SV=1,1,1,3.985,0.202,1.048,0.922,1.99,-2.31,0.07,-0.12,1.21E-01,1.41E-01,9.58E-01,9.46E-01,3.75E+05,9.41E+04,7.58E+04,9.86E+04,1,1,3,2,,,,,3.75E+05,9.41E+04,,,,,,5.47E+04,,1.51E+05,7.58E+04,,,,6.92E+04,1.41E+05,,,,,1.93E+04,3.35E+02,,,,,,2.44E+03,,2.04E+04,1.88E+03,,,,1.62E+03,1.50E+03,0.002,FALSE,3.018,4,1,388,42.8,5.33,1,,,Pf03096,57446,Q5TH30,ENSG00000101079,,,0,0,,,54.06,48.17,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,0,57.23,53.71,55.2,2.34,,0,
Master Protein,High,Q9Y6C9,MTCH2,Mitochondrial carrier homolog 2 OS=Homo sapiens OX=9606 GN=MTCH2 PE=1 SV=1,4,23,3.981,0.752,1.927,1.152,1.99,-0.41,0.95,0.2,1.13E-01,9.01E-01,4.88E-01,8.28E-01,3.40E+06,4.24E+05,3.27E+06,1.34E+06,3,5,5,4,,3.40E+06,,3.47E+06,2.02E+06,6.70E+05,4.24E+05,2.16E+06,1.77E+05,2.11E+05,4.38E+06,2.24E+06,2.35E+06,3.31E+06,3.27E+06,6.42E+06,1.56E+06,8.48E+05,1.16E+06,,,1.29E+04,,3.47E+06,1.04E+05,2.38E+03,7.55E+03,1.99E+04,4.98E+03,2.24E+03,2.62E+04,9.98E+04,1.91E+04,4.46E+05,8.11E+04,1.25E+04,4.38E+05,6.01E+03,2.70E+04,,0,FALSE,31.592,22,4,303,33.3,7.97,4,cell organization and biogenesis;transport;other biological processes,other membranes;mitochondrion,Pf00153,23788,B2R7L8; hsa:23788; Q9Y6C9,ENSG00000109919; ENSG00000285121,,,0,0,27.56,113.12,27.92,105.44,n/a,High,n/a,High,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,Peak Found,n/a,1,,FALSE,89.59,52.62,114.29,93.31,63.09,other molecular function,0,
Master Protein,High,P09874,PARP1,Poly [ADP-ribose] polymerase 1 OS=Homo sapiens OX=9606 GN=PARP1 PE=1 SV=4,47,418,3.969,1.121,1.214,4.784,1.99,0.16,0.28,2.26,1.48E-01,4.76E-01,9.07E-01,1.43E-01,4.35E+07,1.21E+07,1.31E+08,1.83E+07,5,5,5,5,1.13E+07,4.35E+07,1.56E+07,1.66E+08,8.12E+07,1.63E+07,3.86E+06,1.21E+07,5.37E+06,4.65E+07,1.79E+08,8.09E+07,7.89E+07,1.43E+08,1.31E+08,2.16E+07,3.84E+06,1.83E+07,1.44E+07,2.22E+07,4.51E+04,1.65E+05,1.52E+05,1.66E+08,4.19E+06,5.78E+04,6.86E+04,1.12E+05,1.51E+05,4.95E+05,1.07E+06,3.61E+06,6.41E+05,1.93E+07,3.25E+06,4.20E+04,1.08E+06,1.30E+05,3.37E+05,2.36E+05,0,FALSE,308.334,49,47,1014,113,8.88,47,cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;mitochondrion;nucleus;other cell component,"Pf00533, Pf00644, Pf00645, Pf02877, Pf05406, Pf08063, Pf21728",142,B1ANJ4; hsa:142; P09874; Q8IUZ9,ENSG00000143799,SUMOylation of DNA damage response and repair proteins; Downregulation of SMAD2/3:SMAD4 transcriptional activity; HDR through MMEJ (alt-NHEJ); Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER; vRNA Synthesis; POLB-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER,"Corticotropin-releasing hormone signaling pathway; Nanoparticle triggered regulated necrosis; Fas ligand pathway and stress induction of heat shock proteins; NAD metabolism, sirtuins and aging; NAD+ metabolism; NAD+ biosynthetic pathways; Breast cancer pathway; Acute viral myocarditis; Joubert syndrome; Male infertility; Base excision repair; IL-18 signaling pathway; DNA repair pathways, full network; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Progeria-associated lipodystrophy; Primary ovarian insufficiency; Macrophage-stimulating protein (MSP) signaling network map",25,0,100.13,103.17,34.99,46.69,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,124.62,128.2,126.98,131.82,1074.9,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8I5KUM4,SPTLC1,Serine palmitoyltransferase long chain base subunit 1 OS=Homo sapiens OX=9606 GN=SPTLC1 PE=1 SV=1,1,11,3.955,1.427,1.991,2.907,1.98,0.51,0.99,1.54,1.25E-01,3.42E-01,6.07E-01,2.33E-01,3.74E+05,9.44E+04,5.65E+05,1.88E+05,2,1,4,3,,,,7.12E+05,1.96E+05,,,9.44E+04,,,,5.85E+05,3.78E+05,5.45E+05,7.51E+05,,4.15E+05,1.88E+05,1.30E+05,,,,,7.12E+05,1.01E+04,,,8.71E+02,,,,2.61E+04,3.07E+03,7.34E+04,1.87E+04,,1.17E+05,1.33E+03,3.04E+03,,0,FALSE,7.927,4,1,504,56.3,7.06,1,other metabolic processes,other membranes;ER/Golgi,Pf00155,,A0A8I5KUM4,ENSG00000090054,,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Sphingolipid metabolism: integrated pathway; Biosynthesis and turnover of 1-deoxy-sphingoid bases,3,0,80.33,,27.12,61.77,n/a,n/a,n/a,High,High,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,102.32,80.88,46.01,61.01,30.09,other molecular function,0,
Master Protein,High,P08567,PLEK,Pleckstrin OS=Homo sapiens OX=9606 GN=PLEK PE=1 SV=3,1,4,3.917,1.208,1.771,2.881,1.97,0.27,0.82,1.53,1.71E-01,5.03E-01,6.67E-01,2.94E-01,1.32E+05,3.36E+04,1.71E+05,5.95E+04,2,2,4,2,5.52E+05,,,3.14E+04,,,3.08E+04,3.67E+04,,,7.36E+04,1.44E+05,,3.44E+05,2.03E+05,,,4.89E+04,7.24E+04,,2.19E+03,,,3.14E+04,,,5.47E+02,3.39E+02,,,4.40E+02,6.45E+03,,4.63E+04,5.06E+03,,,3.47E+02,1.69E+03,,0,FALSE,5.606,4,1,350,40.1,8.28,1,cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;other cell component,"Pf00169, Pf00610",5341,B2R9E8; hsa:5341; P08567; Q53SU8; Q6FGM8; Q6FGQ1; Q8WV81,ENSG00000115956,Platelet degranulation,Serotonin and anxiety-related events; TYROBP causal network in microglia; Serotonin and anxiety,4,0,126.23,12.48,59.89,27.29,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,High,n/a,High,High,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,268.61,135.84,26.69,68.26,6.83,other molecular function,0,
Master Protein,High,P07738,BPGM,Bisphosphoglycerate mutase OS=Homo sapiens OX=9606 GN=BPGM PE=1 SV=2,4,9,3.853,0.413,2.029,0.095,1.95,-1.28,1.02,-3.4,1.58E-01,5.35E-01,5.78E-01,3.82E-02,1.61E+05,1.53E+05,6.77E+04,5.72E+05,2,2,3,5,,,,4.40E+04,5.88E+05,,,,7.31E+04,3.18E+05,,6.77E+04,6.51E+04,1.74E+05,,5.51E+05,2.94E+06,7.65E+05,3.86E+05,5.72E+05,,,,4.40E+04,3.03E+04,,,,2.06E+03,3.39E+03,,3.02E+03,5.29E+02,2.35E+04,,1.07E+03,8.26E+05,5.42E+03,9.02E+03,6.09E+03,0,FALSE,18.138,20,4,259,30,6.54,4,other metabolic processes;stress response;transport;developmental processes;other biological processes,cytosol,Pf00300,669,A4D1N9; hsa:669; P07738,ENSG00000172331,Glycolysis,IL-18 signaling pathway,2,0,121.73,88.62,60.9,102.54,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,119.22,268.3,94.14,117.2,33.19,other molecular function,0,
Master Protein,High,A0A8I5KW61,,C-X-C motif chemokine OS=Homo sapiens OX=9606 PE=3 SV=1,9,63,3.836,0.561,10.001,0.182,1.94,-0.83,3.32,-2.46,1.59E-01,7.58E-01,5.01E-03,1.51E-01,4.20E+06,1.72E+06,2.56E+06,2.11E+07,5,5,5,4,1.21E+07,3.12E+07,5.95E+05,9.91E+04,4.20E+06,1.21E+06,6.94E+04,2.38E+06,1.80E+07,1.72E+06,1.91E+06,7.06E+05,2.56E+06,5.49E+06,4.59E+06,6.51E+07,4.55E+07,9.79E+06,5.86E+06,,4.81E+04,1.19E+05,5.81E+03,9.91E+04,2.17E+05,4.29E+03,1.23E+03,2.19E+04,5.06E+05,1.83E+04,1.14E+04,3.15E+04,2.08E+04,7.40E+05,1.14E+05,1.27E+05,1.28E+07,6.94E+04,1.37E+05,,0,FALSE,41.065,39,9,193,21.1,9.13,9,stress response;signal transduction;other biological processes,non-structural extracellular,Pf00048,,,,,,0,0,134.63,160.3,64.24,90.61,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,1,,FALSE,145.87,133.12,140.61,126.57,167.32,signal transduction activity or receptor binding,0,
Master Protein,High,P56381,ATP5F1E,"ATP synthase subunit epsilon, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1E PE=1 SV=2",1,12,3.817,3.876,0.685,19.487,1.93,1.95,-0.54,4.28,1.33E-01,3.66E-03,6.71E-01,5.95E-03,4.06E+05,1.14E+05,1.60E+06,8.23E+04,4,5,4,4,3.35E+05,,1.08E+05,2.11E+06,4.93E+05,6.83E+05,1.27E+05,8.94E+04,2.53E+04,1.14E+05,,2.18E+06,6.49E+05,1.54E+06,1.67E+06,2.59E+05,1.13E+04,,7.91E+04,8.56E+04,1.33E+03,,1.06E+03,2.11E+06,2.54E+04,2.43E+03,2.25E+03,8.25E+02,7.14E+02,1.21E+03,,9.75E+04,5.27E+03,2.08E+05,4.15E+04,5.05E+02,3.17E+03,,1.85E+03,9.11E+02,0.004,FALSE,2.666,16,1,51,5.8,9.92,1,other metabolic processes;transport,other membranes;mitochondrion,Pf04627,514,B2RDD0; E1P5H6; hsa:514; P56381; Q53XU6,ENSG00000124172,Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,5,0,119.75,129.36,42.24,97.21,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,113.18,99.4,114.47,88.17,17.22,transporter activity;other molecular function,0,
Master Protein,High,P61313,RPL15,60S ribosomal protein L15 OS=Homo sapiens OX=9606 GN=RPL15 PE=1 SV=2,4,27,3.782,0.491,19.263,0.197,1.92,-1.03,4.27,-2.34,1.63E-01,6.62E-01,1.63E-04,1.72E-01,1.84E+06,2.10E+05,1.24E+06,3.79E+06,5,5,5,5,8.54E+06,1.71E+06,4.71E+06,1.76E+06,1.84E+06,7.99E+05,5.02E+04,2.10E+05,6.01E+04,2.17E+06,7.76E+06,5.95E+05,1.02E+06,1.67E+06,1.24E+06,5.23E+06,3.79E+06,2.02E+06,2.15E+06,4.92E+06,3.39E+04,6.49E+03,4.60E+04,1.76E+06,9.51E+04,2.84E+03,8.92E+02,1.94E+03,1.69E+03,2.31E+04,4.64E+04,2.66E+04,8.27E+03,2.25E+05,3.08E+04,1.02E+04,1.06E+06,1.43E+04,5.03E+04,5.24E+04,0,FALSE,18.273,24,4,204,24.1,11.62,4,protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;translational apparatus;nucleus;other cell component,Pf00827,6138,hsa:6138; P39030; P41051; P61313; Q5U0C0; Q642I1; Q6IPX6; Q8WYP2; Q96C44; Q9H2E5,ENSG00000174748,Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,80.39,136.73,121.81,41.55,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,High,High,High,1,,FALSE,123.96,115.56,113.5,102.96,58.84,other molecular function,0,
Master Protein,High,P21796,VDAC1,Voltage-dependent anion-selective channel protein 1 OS=Homo sapiens OX=9606 GN=VDAC1 PE=1 SV=2,18,455,3.719,2.97,1.316,7.747,1.89,1.57,0.4,2.95,1.70E-01,3.14E-02,8.26E-01,5.84E-02,2.82E+07,3.88E+06,9.66E+07,1.16E+07,5,5,5,5,3.29E+07,2.82E+07,1.98E+07,6.20E+07,2.06E+07,5.22E+06,3.88E+06,1.90E+06,1.98E+06,1.09E+07,2.87E+08,9.07E+07,1.39E+08,9.66E+07,8.18E+07,3.49E+07,1.94E+07,1.09E+07,7.07E+06,1.16E+07,1.31E+05,1.07E+05,1.93E+05,6.20E+07,1.06E+06,1.86E+04,6.91E+04,1.75E+04,5.59E+04,1.16E+05,1.72E+06,4.05E+06,1.13E+06,1.30E+07,2.03E+06,6.81E+04,5.45E+06,7.73E+04,1.65E+05,1.23E+05,0,FALSE,117.344,80,17,283,30.8,8.54,18,cell-cell signaling;other metabolic processes;stress response;transport;other biological processes,plasma membrane;other membranes;mitochondrion;other cell component,Pf01459,7416,B3KVK4; D3DQ93; P21796; Q5FVE7; Q9UIQ5; Q9UPL0,ENSG00000213585,Ub-specific processing proteases; Pyruvate metabolism; Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy; Mitochondrial calcium ion transport,Alzheimer's disease and miRNA effects; Alzheimer's disease; Arsenic metabolism and reactive oxygen species generation; Cholesterol metabolism; Fatty acids and lipoproteins transport in hepatocytes,10,1,52.9,77.27,61.54,66.11,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,132.55,107.44,119.8,113.42,1400.95,transporter activity;other molecular function,0,
Master Protein,High,P30050,RPL12,60S ribosomal protein L12 OS=Homo sapiens OX=9606 GN=RPL12 PE=1 SV=1,7,27,3.7,0.113,5.379,0.268,1.89,-3.14,2.43,-1.9,1.83E-01,5.05E-03,4.39E-02,2.75E-01,1.46E+06,2.03E+05,4.40E+05,6.63E+06,5,3,5,5,2.09E+05,1.46E+06,1.54E+05,6.39E+06,1.04E+07,1.00E+06,1.82E+05,2.03E+05,,,1.98E+05,1.73E+06,3.11E+05,3.72E+06,4.40E+05,6.61E+06,9.10E+06,6.63E+06,3.11E+05,2.03E+07,8.29E+02,5.54E+03,1.51E+03,6.39E+06,5.37E+05,3.57E+03,3.24E+03,1.87E+03,,,1.19E+03,7.71E+04,2.52E+03,5.01E+05,1.09E+04,1.29E+04,2.56E+06,4.70E+04,7.29E+03,2.16E+05,0,FALSE,25.178,59,7,165,17.8,9.42,7,protein metabolism;other metabolic processes,cytosol;translational apparatus;nucleus;other cell component,"Pf00298, Pf03946",6136,hsa:6136; P30050; Q5VVV2; Q6PB27,ENSG00000197958,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,121.63,101.21,116.99,85.04,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,95.5,114.56,95.83,133.36,81.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P19338,NCL,Nucleolin OS=Homo sapiens OX=9606 GN=NCL PE=1 SV=3,24,209,3.691,0.324,0.776,1.853,1.88,-1.63,-0.37,0.89,1.73E-01,2.63E-01,6.49E-01,5.33E-01,4.02E+07,9.18E+06,2.14E+07,1.18E+07,5,5,5,5,4.02E+07,1.46E+07,6.72E+07,1.07E+08,3.25E+07,6.02E+06,9.18E+06,7.93E+06,1.25E+07,1.29E+07,1.93E+08,2.14E+07,1.07E+07,3.77E+07,9.64E+06,1.28E+07,3.54E+06,1.18E+07,2.95E+06,2.97E+07,1.60E+05,5.56E+04,6.57E+05,1.07E+08,1.68E+06,2.14E+04,1.63E+05,7.32E+04,3.52E+05,1.37E+05,1.15E+06,9.56E+05,8.73E+04,5.08E+06,2.40E+05,2.50E+04,9.93E+05,8.39E+04,6.90E+04,3.16E+05,0,FALSE,101.465,32,24,710,76.6,4.7,24,developmental processes;other biological processes,plasma membrane;nucleus;other cell component,Pf00076,4691,hsa:4691; P19338; Q53SK1; Q8NB06; Q9UCF0; Q9UDG1,ENSG00000115053,Respiratory syncytial virus (RSV) attachment and entry; Major pathway of rRNA processing in the nucleolus and cytosol,Pathogenic Escherichia coli infection; VEGFA-VEGFR2 signaling,4,0,68.85,30.54,143.54,88.78,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,High,Peak Found,High,1,,FALSE,121.39,116.89,129.69,134.96,548.24,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O14497,ARID1A,AT-rich interactive domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ARID1A PE=1 SV=3,18,37,3.691,0.883,0.3,3.135,1.88,-0.18,-1.74,1.65,1.94E-01,6.88E-01,1.35E-01,2.43E-01,1.23E+06,1.69E+05,3.04E+06,1.00E+06,5,4,5,5,1.23E+06,6.63E+05,1.15E+05,4.94E+06,1.95E+06,6.06E+05,9.98E+04,2.86E+05,8.88E+04,,2.03E+06,1.86E+06,3.42E+06,3.56E+06,3.04E+06,1.22E+06,1.35E+05,1.00E+06,1.12E+05,1.26E+06,4.88E+03,2.52E+03,1.12E+03,4.94E+06,1.00E+05,2.15E+03,1.78E+03,2.64E+03,2.50E+03,,1.21E+04,8.32E+04,2.78E+04,4.80E+05,7.55E+04,2.38E+03,3.80E+04,7.09E+03,2.62E+03,1.34E+04,0,FALSE,78.485,12,17,2285,241.9,6.7,18,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf01388, Pf12031",8289,D3DPL1; hsa:8289; O14497; Q53FK9; Q5T0W1; Q5T0W2; Q5T0W3; Q8NFD6; Q96T89; Q9BY33; Q9HBJ5; Q9UPZ1,ENSG00000117713,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,Androgen receptor network in prostate cancer; Pathways affected in adenoid cystic carcinoma; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome,7,1,106.51,89.35,28.4,77.25,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,76.14,95.38,88.7,125.69,122.04,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q14008,CKAP5,Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3,9,12,3.664,0.595,1.275,1.774,1.87,-0.75,0.35,0.83,1.85E-01,8.84E-01,9.40E-01,4.67E-01,1.07E+06,6.31E+05,1.52E+06,2.02E+05,4,3,5,3,2.03E+06,,5.60E+05,4.15E+05,3.73E+06,1.18E+06,,,2.03E+05,6.31E+05,2.20E+06,4.98E+05,1.52E+06,1.48E+06,2.63E+06,,1.46E+05,,2.02E+05,8.07E+05,8.07E+03,,5.47E+03,4.15E+05,1.92E+05,4.18E+03,,,5.71E+03,6.71E+03,1.32E+04,2.22E+04,1.23E+04,2.00E+05,6.53E+04,,4.10E+04,,4.73E+03,8.59E+03,0,FALSE,26.519,7,9,2032,225.4,7.8,9,cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf02985, Pf12348, Pf21041",9793,hsa:9793; Q05D70; Q0VAX7; Q0VAX8; Q14008; Q14668; Q2TA89; Q6NSH4,ENSG00000175216,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,4p16.3 copy number variation,14,0,91.85,72.77,48.69,95.23,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,1403.08,143.66,117.94,111.15,30.94,cytoskeletal activity;other molecular function,0,
Master Protein,High,O75494,SRSF10,Serine/arginine-rich splicing factor 10 OS=Homo sapiens OX=9606 GN=SRSF10 PE=1 SV=1,2,2,3.655,0.151,10.089,0.058,1.87,-2.72,3.33,-4.12,1.59E-01,5.58E-02,3.23E-02,1.01E-02,5.96E+05,1.31E+05,7.08E+04,4.66E+05,2,1,2,3,,,,1.01E+06,3.50E+05,,1.31E+05,,,,,2.68E+04,,1.87E+05,,4.66E+05,1.10E+05,3.74E+06,,,,,,1.01E+06,1.81E+04,,2.33E+03,,,,,1.20E+03,,2.51E+04,,9.08E+02,3.10E+04,2.65E+04,,,0,FALSE,7.678,9,2,262,31.3,11.27,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,cytosol;nucleus;other cell component,Pf00076,10772,A6NFM6; A6NI42; A6NIU7; B4DJP9; hsa:10772; O60572; O75494; Q5JRH9; Q5JRI0; Q5JRI2; Q5JRI3; Q5JRI4; Q96G09; Q96P17,ENSG00000188529,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,mRNA processing,3,0,68.79,,105.86,139.11,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,1,,FALSE,46.89,68.7,184.07,137.5,6.17,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15056,EIF4H,Eukaryotic translation initiation factor 4H OS=Homo sapiens OX=9606 GN=EIF4H PE=1 SV=5,3,7,3.64,0.649,6.359,0.445,1.86,-0.62,2.67,-1.17,1.93E-01,9.20E-01,1.32E-01,6.32E-01,1.64E+05,2.28E+04,5.86E+04,1.45E+05,4,1,2,4,,6.96E+04,3.08E+04,4.47E+05,3.87E+05,,,,2.28E+04,,,3.00E+04,,1.14E+05,,1.50E+05,5.07E+05,7.00E+04,,1.40E+05,,2.64E+02,3.00E+02,4.47E+05,2.00E+04,,,,6.42E+02,,,1.34E+03,,1.54E+04,,2.93E+02,1.43E+05,4.96E+02,,1.49E+03,0,FALSE,11.798,27,3,248,27.4,7.23,3,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,Pf00076,7458,A8K3R1; D3DXF6; D3DXF8; hsa:7458; Q15056,ENSG00000106682,L13a-mediated translational silencing of Ceruloplasmin expression; GTP hydrolysis and joining of the 60S ribosomal subunit; Translation initiation complex formation; Ribosomal scanning and start codon recognition,Translation factors; 7q11.23 copy number variation syndrome,7,0,91.5,,82.6,90.81,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,60.88,106.04,41.14,87.71,23.59,nucleic acid binding activity,0,
Master Protein,High,Q9NX58,LYAR,Cell growth-regulating nucleolar protein OS=Homo sapiens OX=9606 GN=LYAR PE=1 SV=3,3,8,3.635,0.219,1.869,0.199,1.86,-2.19,0.9,-2.33,1.49E-01,1.37E-01,6.17E-01,2.61E-01,5.17E+05,1.26E+05,5.56E+04,2.75E+05,3,4,3,5,,5.17E+05,,1.19E+05,6.91E+05,,1.02E+05,1.55E+05,9.67E+03,4.21E+05,5.56E+04,5.27E+03,,1.75E+05,,2.75E+05,9.45E+03,6.80E+05,7.15E+04,8.87E+05,,1.97E+03,,1.19E+05,3.57E+04,,1.82E+03,1.43E+03,2.72E+02,4.47E+03,3.33E+02,2.36E+02,,2.36E+04,,5.37E+02,2.65E+03,4.82E+03,1.67E+03,9.44E+03,0,FALSE,14.698,11,3,379,43.6,9.57,3,RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf08790, Pf17848",55646,D3DVS4; hsa:55646; Q6FI78; Q9NX58; Q9NYS1,ENSG00000145220,,,0,0,66.28,102.65,110.92,99.88,n/a,Peak Found,n/a,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,107.28,128.88,142.18,137.85,14.23,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P04114,,Apolipoprotein B-100 OS=Homo sapiens OX=9606 GN=APOB PE=1 SV=2,4,11,3.634,0.287,1.774,3.719,1.86,-1.8,0.83,1.89,1.78E-01,1.93E-01,5.15E-01,1.50E-01,6.81E+06,2.57E+06,2.80E+06,4.94E+05,2,2,4,3,4.35E+06,1.07E+07,,,,,4.46E+05,1.48E+07,,,6.17E+06,1.28E+06,,7.58E+05,7.82E+06,4.56E+06,1.75E+05,,4.94E+05,,1.73E+04,4.05E+04,,,,,7.94E+03,1.37E+05,,,3.69E+04,5.70E+04,,1.02E+05,1.94E+05,8.90E+03,4.93E+04,,1.16E+04,,0,FALSE,14.732,1,3,4563,515.3,7.05,4,,,,,,,,,0,1,59.5,133.16,87.95,140.26,n/a,High,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,High,High,High,High,n/a,n/a,n/a,1,,FALSE,414.46,123.55,414.46,142.68,32.95,,0,
Master Protein,High,P50914,RPL14,60S ribosomal protein L14 OS=Homo sapiens OX=9606 GN=RPL14 PE=1 SV=4,2,11,3.632,0.56,10.315,0.671,1.86,-0.84,3.37,-0.58,1.82E-01,8.05E-01,1.81E-02,8.66E-01,1.68E+06,6.48E+04,9.66E+05,1.11E+06,4,4,4,3,2.79E+06,1.36E+06,6.31E+05,2.09E+06,,3.67E+06,6.28E+04,,3.64E+04,6.69E+04,9.55E+05,1.39E+06,,9.78E+05,5.97E+05,1.11E+06,1.02E+06,,,2.35E+06,1.11E+04,5.16E+03,6.17E+03,2.09E+06,,1.30E+04,1.12E+03,,1.03E+03,7.11E+02,5.71E+03,6.19E+04,,1.32E+05,1.48E+04,2.16E+03,2.85E+05,,,2.50E+04,0,FALSE,9.437,11,2,215,23.4,10.93,2,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,Pf01929,9045,hsa:9045; P50914; Q45RF0; Q53G20; Q8TBD5; Q8WUT0; Q92579; Q96GR0; Q9BSB8; Q9BW65; Q9BYF6,ENSG00000188846,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,54.21,188.44,32.98,49.9,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,350.08,61.29,144.86,92.73,28.8,other molecular function,0,
Master Protein,High,U3KQK0,H2BC15,Histone H2B OS=Homo sapiens OX=9606 GN=H2BC15 PE=1 SV=1,13,1511,3.632,1.357,0.721,10.97,1.86,0.44,-0.47,3.46,1.78E-01,3.20E-01,5.83E-01,2.77E-02,1.65E+09,6.91E+08,2.36E+09,3.14E+08,5,5,5,5,6.30E+08,9.65E+08,3.20E+09,2.38E+09,1.65E+09,6.91E+08,3.43E+08,8.68E+08,1.56E+08,1.77E+09,2.23E+09,3.71E+09,2.36E+09,1.23E+09,3.07E+09,3.14E+08,2.13E+08,4.79E+08,1.98E+08,1.04E+09,2.50E+06,3.67E+06,3.13E+07,2.38E+09,8.50E+07,2.46E+06,6.10E+06,8.01E+06,4.38E+06,1.89E+07,1.33E+07,1.65E+08,1.92E+07,1.65E+08,7.62E+07,6.12E+05,5.98E+07,3.39E+06,4.63E+06,1.11E+07,0,FALSE,120.835,49,13,166,18.8,10.54,13,,cytosol;nucleus;other cell component,Pf00125,,U3KQK0,ENSG00000233822,,,0,0,59.35,82.09,37.1,77.68,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,126.37,121.51,115.12,131.14,3780.68,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P48047,ATP5PO,"ATP synthase subunit O, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PO PE=1 SV=1",7,36,3.617,1.089,4.175,1.452,1.85,0.12,2.06,0.54,1.59E-01,5.02E-01,8.44E-02,6.84E-01,3.41E+06,1.07E+06,1.18E+07,2.29E+06,5,4,5,5,4.18E+06,1.28E+06,3.41E+06,1.12E+07,1.58E+06,1.54E+06,,1.50E+06,2.39E+05,7.60E+05,6.08E+06,1.18E+07,1.52E+07,1.78E+07,1.04E+07,2.29E+06,9.74E+05,2.64E+06,3.40E+06,1.48E+05,1.66E+04,4.87E+03,3.34E+04,1.12E+07,8.14E+04,5.48E+03,,1.38E+04,6.73E+03,8.08E+03,3.64E+04,5.25E+05,1.24E+05,2.40E+06,2.57E+05,4.46E+03,2.74E+05,1.87E+04,7.96E+04,1.58E+03,0,FALSE,34.457,37,7,213,23.3,9.96,7,other metabolic processes;transport,plasma membrane;other membranes;mitochondrion,Pf00213,539,B2R4E2; hsa:539; P48047; Q5U042; Q6IBI2,ENSG00000241837,Mitochondrial protein degradation; Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,6,0,93.07,62.06,36.87,69.38,High,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,145.08,124.72,111.91,132.63,89.74,transporter activity,0,
Master Protein,High,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens OX=9606 GN=ACIN1 PE=1 SV=2,20,56,3.611,0.247,4.34,0.749,1.85,-2.01,2.12,-0.42,1.80E-01,1.29E-01,1.17E-01,9.31E-01,4.46E+06,3.41E+05,1.70E+06,1.46E+06,5,3,5,5,4.46E+06,5.32E+05,3.63E+06,1.86E+07,8.35E+06,,3.41E+05,,1.15E+05,8.38E+05,1.21E+06,3.55E+06,1.32E+06,7.04E+06,1.70E+06,1.46E+06,1.70E+05,3.65E+06,1.03E+06,7.59E+06,1.77E+04,2.02E+03,3.55E+04,1.86E+07,4.31E+05,,6.06E+03,,3.24E+03,8.91E+03,7.21E+03,1.59E+05,1.07E+04,9.48E+05,4.22E+04,2.85E+03,4.78E+04,2.58E+04,2.40E+04,8.08E+04,0,FALSE,106.998,23,20,1341,151.8,6.43,20,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf02037, Pf16294",22985,B2RTT4; D3DS45; hsa:22985; O75158; Q9UG91; Q9UKV1; Q9UKV2; Q9UKV3,ENSG00000100813,mRNA Splicing - Major Pathway; Apoptotic cleavage of cellular proteins,,2,0,98.5,85.78,83.19,107.23,Peak Found,Peak Found,High,High,High,n/a,Peak Found,n/a,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,102.57,122.25,529.13,131.08,172.95,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P52434,POLR2H,"DNA-directed RNA polymerases I, II, and III subunit RPABC3 OS=Homo sapiens OX=9606 GN=POLR2H PE=1 SV=4",3,6,3.6,0.478,0.464,5.045,1.85,-1.06,-1.11,2.33,1.53E-01,6.37E-01,4.57E-01,1.34E-01,5.28E+05,1.10E+05,1.87E+05,4.85E+04,5,4,4,4,5.28E+05,1.05E+05,5.81E+05,3.53E+05,8.06E+05,2.27E+05,7.59E+04,1.59E+05,,4.83E+04,,1.26E+05,1.13E+05,6.15E+05,2.79E+05,4.57E+05,1.07E+04,1.07E+05,2.20E+04,,2.10E+03,3.97E+02,5.67E+03,3.53E+05,4.16E+04,8.06E+02,1.35E+03,1.47E+03,,5.13E+02,,5.61E+03,9.16E+02,8.28E+04,6.93E+03,8.91E+02,3.00E+03,7.58E+02,5.15E+02,,0,FALSE,14.322,39,3,150,17.1,4.68,3,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf03870,5437,C9J413; C9JBJ6; C9JCU7; C9JUA8; hsa:5437; P52434; P53802; Q969R0,ENSG00000163882,Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; Estrogen-dependent gene expression; RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; Formation of the Early Elongation Complex; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Abortive elongation of HIV-1 transcript in the absence of Tat; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; mRNA Splicing - Major Pathway; Activation of anterior HOX genes in hindbrain development during early embryogenesis; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,Pyrimidine metabolism; Eukaryotic transcription initiation; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,57,0,55.32,63.68,82.57,140.57,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,90.88,89.31,130.57,135.67,13.67,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q08378,GOLGA3,Golgin subfamily A member 3 OS=Homo sapiens OX=9606 GN=GOLGA3 PE=1 SV=2,13,17,3.574,0.801,0.968,1.372,1.84,-0.32,-0.05,0.46,2.13E-01,7.48E-01,8.36E-01,6.38E-01,1.04E+06,2.15E+05,3.53E+05,3.10E+05,3,3,4,5,,2.02E+06,,1.04E+06,5.05E+05,2.15E+05,,3.52E+05,,8.81E+04,,1.09E+06,1.16E+05,2.86E+05,4.36E+05,2.01E+05,1.09E+06,2.90E+05,3.10E+05,8.29E+06,,7.66E+03,,1.04E+06,2.61E+04,7.64E+02,,3.25E+03,,9.37E+02,,4.89E+04,9.41E+02,3.85E+04,1.08E+04,3.91E+02,3.05E+05,2.06E+03,7.25E+03,8.82E+04,0,FALSE,40.171,11,13,1498,167.3,5.44,13,,other membranes;cytosol;ER/Golgi;nucleus,,2802,A5PKX6; hsa:2802; O43241; Q08378; Q6P9C7; Q86XW3; Q8TDA9; Q8WZA3,ENSG00000090615,RND2 GTPase cycle,,1,0,64.49,60.46,88.59,172.67,n/a,High,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,89.19,72.24,85.32,59.99,45.33,,0,
Master Protein,High,Q8IWB1,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein OS=Homo sapiens OX=9606 GN=ITPRIP PE=1 SV=1",4,4,3.573,2.83,0.01,100,1.84,1.5,-6.64,6.64,1.96E-01,1.00E-01,1.00E-17,1.00E-17,1.70E+05,4.51E+04,9.24E+04,,1,1,4,,,,,1.70E+05,,,,,4.51E+04,,,3.99E+04,1.03E+05,6.77E+05,8.33E+04,,,,,,,,,1.70E+05,,,,,1.27E+03,,,1.78E+03,8.33E+02,9.13E+04,2.07E+03,,,,,,0,FALSE,11.168,6,4,547,62,5.88,4,signal transduction;other biological processes,plasma membrane;other membranes;nucleus,Pf20266,85450,D3DRA5; hsa:85450; Q5JU17; Q8IWB1; Q96MS8; Q9C0A9,ENSG00000148841,,Calcium mediated T-cell apoptosis involved in inclusion body myositis,1,0,,,133.85,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,130.77,,,10.12,enzyme regulator activity,0,
Master Protein,High,Q9Y5B9,SUPT16H,FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,13,53,3.573,0.566,2.13,0.615,1.84,-0.82,1.09,-0.7,1.63E-01,7.66E-01,3.89E-01,7.23E-01,3.15E+06,5.87E+05,2.98E+06,1.70E+06,5,5,5,5,5.27E+05,9.98E+06,3.48E+05,3.15E+06,1.09E+07,1.65E+06,5.87E+05,5.31E+05,3.97E+05,6.35E+05,1.45E+07,2.57E+05,2.98E+06,3.27E+06,4.23E+05,4.07E+05,1.70E+06,6.65E+06,4.89E+05,8.68E+06,2.09E+03,3.79E+04,3.40E+03,3.15E+06,5.63E+05,5.87E+03,1.04E+04,4.90E+03,1.12E+04,6.75E+03,8.67E+04,1.15E+04,2.42E+04,4.40E+05,1.05E+04,7.93E+02,4.78E+05,4.71E+04,1.14E+04,9.24E+04,0,FALSE,52.579,16,13,1047,119.8,5.66,13,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus,"Pf00557, Pf08512, Pf08644, Pf14826, Pf21091",11198,hsa:11198; Q6GMT8; Q6P2F1; Q6PJM1; Q9NRX0; Q9Y5B9,ENSG00000092201,Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Regulation of TP53 Activity through Phosphorylation,,12,0,102.74,66.57,137.21,106.74,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,106.63,107.74,122.23,121.47,157.79,other molecular function,0,
Master Protein,High,R4GMX3,COMMD3-BMI1,COMMD3-BMI1 readthrough OS=Homo sapiens OX=9606 GN=COMMD3-BMI1 PE=4 SV=1,1,2,3.571,0.218,0.876,0.784,1.84,-2.2,-0.19,-0.35,1.96E-01,2.38E-01,9.03E-01,9.73E-01,8.29E+04,2.32E+04,1.69E+04,2.03E+04,4,1,4,3,1.99E+05,,2.93E+04,3.79E+05,3.46E+04,,,,,2.32E+04,,1.31E+04,2.50E+04,2.04E+04,1.40E+04,,1.47E+04,3.48E+05,2.03E+04,,7.89E+02,,2.87E+02,3.79E+05,1.78E+03,,,,,2.47E+02,,5.83E+02,2.03E+02,2.74E+03,3.49E+02,,4.12E+03,2.47E+03,4.76E+02,,0.002,FALSE,2.99,2,1,469,53.3,7.93,1,,cytosol;nucleus,"Pf13923, Pf16207",100532731,hsa:100532731; R4GMX3,ENSG00000269897,,,0,0,103.24,,31.09,149.48,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,151.35,109.32,57.42,59.23,4.7,other molecular function,0,
Master Protein,High,A0A7I2V5M7,G3BP1,G3BP stress granule assembly factor 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1,2,3,3.558,0.233,1.123,0.738,1.83,-2.1,0.17,-0.44,1.86E-01,1.92E-01,9.69E-01,9.88E-01,2.11E+05,5.92E+04,4.91E+04,6.65E+04,2,1,4,1,2.91E+05,,1.53E+05,,,,,,5.92E+04,,6.98E+04,3.12E+04,,1.07E+05,3.45E+04,,6.65E+04,,,,1.15E+03,,1.49E+03,,,,,,1.67E+03,,4.17E+02,1.39E+03,,1.44E+04,8.58E+02,,1.87E+04,,,,0,FALSE,7.47,6,2,476,53.3,5.66,2,,cytosol;other cell component,"Pf00076, Pf02136",,A0A7I2V5M7,ENSG00000145907,,7q11.23 distal copy number variation; HDAC6 interactions in the central nervous system,2,0,44,,58.35,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,48.54,63.36,0,71.25,8.61,nucleic acid binding activity,0,
Master Protein,High,P62318,SNRPD3,Small nuclear ribonucleoprotein Sm D3 OS=Homo sapiens OX=9606 GN=SNRPD3 PE=1 SV=1,5,54,3.502,0.459,0.737,1.172,1.81,-1.12,-0.44,0.23,1.92E-01,5.45E-01,6.03E-01,8.28E-01,2.19E+07,4.87E+06,5.44E+06,9.20E+06,5,5,5,5,8.30E+06,3.20E+07,9.12E+06,2.19E+07,1.15E+08,9.24E+05,1.21E+07,1.49E+05,4.87E+06,9.55E+07,7.98E+06,5.44E+06,2.11E+06,2.44E+07,4.27E+06,9.20E+06,7.97E+05,4.23E+07,1.61E+06,5.57E+07,3.30E+04,1.22E+05,8.91E+04,2.19E+07,5.92E+06,3.29E+03,2.15E+05,1.38E+03,1.37E+05,1.01E+06,4.77E+04,2.43E+05,1.71E+04,3.28E+06,1.06E+05,1.79E+04,2.24E+05,3.00E+05,3.77E+04,5.93E+05,0,FALSE,49.187,49,5,126,13.9,10.32,5,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf01423,6634,B4DJP7; B5BU13; hsa:6634; P43331; P62318,ENSG00000100028,snRNP Assembly; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Minor Pathway; SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,mRNA processing,8,0,119.36,180.4,101.18,115.77,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,High,Peak Found,High,1,,FALSE,126.95,124.18,113.62,125.64,165.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,F6TER3,LILRB1,Leukocyte immunoglobulin like receptor B1 OS=Homo sapiens OX=9606 GN=LILRB1 PE=1 SV=2,1,1,3.482,0.256,6.656,0.207,1.8,-1.96,2.73,-2.27,1.56E-01,2.61E-01,6.04E-02,1.99E-01,1.14E+05,3.62E+05,9.96E+04,6.42E+05,3,3,4,4,1.44E+06,,,1.06E+05,1.14E+05,4.13E+05,3.62E+05,,2.25E+04,,,2.82E+04,3.52E+05,6.63E+05,2.08E+04,2.91E+06,2.74E+06,1.50E+05,1.54E+04,,5.71E+03,,,1.06E+05,5.89E+03,1.47E+03,6.43E+03,,6.34E+02,,,1.26E+03,2.86E+03,8.93E+04,5.17E+02,5.68E+03,7.69E+05,1.07E+03,3.61E+02,,0.009,FALSE,2.309,2,1,701,76,6.61,1,,other membranes,"Pf00047, Pf13895",,F6TER3,ENSG00000104972,,,0,0,138.67,79.84,115.22,109.06,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,134.81,100.87,135.99,133.32,2.46,,0,
Master Protein,High,Q969Q0,RPL36AL,60S ribosomal protein L36a-like OS=Homo sapiens OX=9606 GN=RPL36AL PE=1 SV=3,3,5,3.469,0.051,1.041,0.079,1.79,-4.29,0.06,-3.66,1.75E-01,6.91E-05,9.53E-01,6.24E-02,2.61E+06,1.25E+05,6.53E+04,2.62E+05,2,3,3,4,,,,9.08E+05,7.49E+06,,1.25E+05,1.03E+05,,3.83E+06,,1.52E+05,4.56E+04,6.53E+04,,,8.50E+03,5.22E+05,1.32E+05,9.85E+06,,,,9.08E+05,3.86E+05,,2.22E+03,9.53E+02,,4.07E+04,,6.78E+03,3.70E+02,8.80E+03,,,2.39E+03,3.70E+03,3.09E+03,1.05E+05,0,FALSE,7.966,25,3,106,12.5,10.65,3,protein metabolism;other metabolic processes,plasma membrane;other membranes;cytosol;ER/Golgi;translational apparatus;nucleus,Pf00935,6166,hsa:6166; Q3B7A5; Q969Q0,ENSG00000165502,Major pathway of rRNA processing in the nucleolus and cytosol; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),,13,0,110.84,158.59,64.5,183.4,n/a,n/a,n/a,High,High,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,123.48,114.63,132.69,146.77,11.89,other molecular function,0,
Master Protein,High,G3V2S9,SLIRP,SRA stem-loop interacting RNA binding protein OS=Homo sapiens OX=9606 GN=SLIRP PE=1 SV=1,4,7,3.465,1.416,3.502,6.102,1.79,0.5,1.81,2.61,2.25E-01,2.30E-01,3.05E-01,7.40E-02,1.09E+06,8.19E+04,2.12E+06,2.64E+05,3,3,4,4,,1.09E+06,,4.01E+06,2.37E+05,,8.19E+04,1.02E+05,,7.25E+04,,2.92E+06,1.98E+06,1.77E+06,2.28E+06,,1.99E+05,1.15E+06,2.42E+05,2.87E+05,,4.14E+03,,4.01E+06,1.22E+04,,1.46E+03,9.44E+02,,7.71E+02,,1.31E+05,1.61E+04,2.39E+05,5.66E+04,,5.60E+04,8.16E+03,5.67E+03,3.05E+03,0,FALSE,12.629,39,4,124,13.9,11.09,4,,mitochondrion,Pf00076,,G3V2S9,ENSG00000119705,,,0,0,111.26,17.84,22.38,96.97,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,169.11,96.27,134.88,112.32,19.53,nucleic acid binding activity,0,
Master Protein,High,Q9P016,THYN1,Thymocyte nuclear protein 1 OS=Homo sapiens OX=9606 GN=THYN1 PE=1 SV=1,4,7,3.451,0.651,3.425,1.472,1.79,-0.62,1.78,0.56,1.57E-01,9.59E-01,2.84E-01,5.95E-01,5.66E+05,9.21E+04,4.51E+05,3.84E+05,4,4,4,4,,4.33E+05,4.43E+04,2.07E+06,7.40E+05,,1.05E+05,8.07E+04,3.53E+04,1.06E+05,1.56E+06,9.83E+04,,1.20E+06,1.70E+05,,1.90E+05,4.99E+05,3.71E+05,3.98E+05,,1.65E+03,4.32E+02,2.07E+06,3.82E+04,,1.87E+03,7.44E+02,9.94E+02,1.13E+03,9.31E+03,4.39E+03,,1.61E+05,4.23E+03,,5.34E+04,3.54E+03,8.68E+03,4.23E+03,0,FALSE,10.978,26,4,225,25.7,9.25,4,,,Pf01878,29087,hsa:29087; Q567Q2; Q9H3L4; Q9HC20; Q9P016,ENSG00000151500,,,0,0,107.13,40.54,96.99,35.35,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,79.76,112.02,106.58,137.78,16.85,,0,
Master Protein,High,A0A1C7CYX9,DPYSL2,Dihydropyrimidinase like 2 OS=Homo sapiens OX=9606 GN=DPYSL2 PE=1 SV=1,7,31,3.428,0.474,1.851,1.888,1.78,-1.08,0.89,0.92,2.00E-01,5.78E-01,4.74E-01,5.22E-01,9.29E+06,5.59E+05,5.72E+06,1.75E+06,5,3,5,5,1.11E+07,1.69E+06,9.29E+06,5.79E+06,1.75E+07,3.90E+05,5.59E+05,,,1.06E+06,1.99E+06,2.54E+06,1.89E+07,9.09E+06,5.72E+06,2.51E+06,6.78E+04,2.97E+06,1.87E+05,1.75E+06,4.41E+04,6.43E+03,9.07E+04,5.79E+06,9.02E+05,1.39E+03,9.94E+03,,,1.13E+04,1.19E+04,1.13E+05,1.53E+05,1.22E+06,1.42E+05,4.90E+03,1.91E+04,2.11E+04,4.38E+03,1.87E+04,0,FALSE,34.865,17,6,677,73.5,6.35,7,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;other cell component,Pf01979,1808,A0A1C7CYX9,ENSG00000092964,,Microtubule cytoskeleton regulation; Brain-derived neurotrophic factor (BDNF) signaling pathway,2,1,65.25,52.29,90.15,88.47,High,n/a,High,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,108.68,136.14,69.22,108.09,75.05,other molecular function,0,
Master Protein,High,O75323,NIPSNAP2,Protein NipSnap homolog 2 OS=Homo sapiens OX=9606 GN=NIPSNAP2 PE=1 SV=1,2,6,3.421,1.179,2.053,1.964,1.77,0.24,1.04,0.97,2.29E-01,3.30E-01,5.69E-01,4.47E-01,9.16E+05,2.55E+05,1.38E+06,5.23E+05,4,2,5,4,7.30E+05,,1.92E+05,1.15E+06,1.32E+06,3.10E+05,,,,2.10E+05,8.17E+05,6.27E+05,2.20E+06,1.53E+06,1.38E+06,1.16E+06,,4.85E+05,3.55E+05,5.65E+05,2.90E+03,,1.87E+03,1.15E+06,6.79E+04,1.10E+03,,,,2.23E+03,4.89E+03,2.80E+04,1.79E+04,2.07E+05,3.44E+04,2.27E+03,,3.43E+03,8.31E+03,6.01E+03,0,FALSE,6.705,9,2,286,33.7,9.36,2,cell organization and biogenesis;other metabolic processes;other biological processes,other membranes;mitochondrion,Pf07978,2631,C9IYJ3; hsa:2631; O43801; O75323; Q53X96,ENSG00000146729,RHOJ GTPase cycle; RHOH GTPase cycle,,2,0,59.25,27.26,47.62,55.72,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,56.52,67.54,52.58,65.72,15.61,,0,
Master Protein,High,Q68CZ6,HAUS3,HAUS augmin-like complex subunit 3 OS=Homo sapiens OX=9606 GN=HAUS3 PE=1 SV=1,1,2,3.421,0.082,0.549,0.513,1.77,-3.6,-0.86,-0.96,2.00E-01,3.35E-03,4.24E-01,7.16E-01,1.32E+06,3.86E+05,1.09E+05,2.12E+05,1,1,2,2,1.32E+06,,,,,,,3.86E+05,,,1.72E+05,,6.91E+04,,,,3.05E+05,,1.47E+05,,5.25E+03,,,,,,,3.56E+03,,,1.03E+03,,5.61E+02,,,,8.57E+04,,3.45E+03,,0.001,FALSE,3.546,2,1,603,69.6,5.55,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;cytoskeleton,Pf14932,79441,B4DF64; hsa:79441; O43606; Q68CZ6; Q8TAZ5; Q9BTJ9,ENSG00000214367,Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,,7,0,,,60.24,49.33,Peak Found,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,69.8,55.18,48.5,6.64,,0,
Master Protein,High,P52888,THOP1,Thimet oligopeptidase OS=Homo sapiens OX=9606 GN=THOP1 PE=1 SV=2,2,3,3.417,0.796,10.753,0.131,1.77,-0.33,3.43,-2.94,1.76E-01,8.39E-01,2.52E-02,7.96E-02,3.18E+05,6.63E+04,5.60E+04,5.99E+05,4,2,2,2,,4.09E+05,2.54E+04,2.48E+05,4.60E+05,,,,7.72E+04,5.70E+04,,1.96E+04,,1.60E+05,,5.84E+05,,6.13E+05,,,,1.55E+03,2.48E+02,2.48E+05,2.37E+04,,,,2.18E+03,6.06E+02,,8.77E+02,,2.15E+04,,1.14E+03,,4.34E+03,,,0,FALSE,9.963,5,2,689,78.8,6.05,2,protein metabolism;other metabolic processes,cytosol;mitochondrion,Pf01432,7064,B3KSE2; hsa:7064; P52888; Q9UCB3,ENSG00000172009,Antigen processing: Ubiquitination & Proteasome degradation,,1,0,68.51,21.28,110.46,3.38,n/a,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,104.06,68.95,73.28,129.72,9.24,other molecular function,0,
Master Protein,High,Q8N4T8,CBR4,3-oxoacyl-[acyl-carrier-protein] reductase OS=Homo sapiens OX=9606 GN=CBR4 PE=1 SV=3,1,1,3.4,0.01,0.775,0.01,1.77,-6.64,-0.37,-6.64,2.21E-01,1.00E-17,7.95E-01,1.00E-17,1.07E+05,3.15E+04,,2.44E+04,3,1,,1,,,4.01E+04,1.07E+05,4.67E+05,,,,3.15E+04,,,,,,,,,,2.44E+04,,,,3.92E+02,1.07E+05,2.41E+04,,,,8.87E+02,,,,,,,,,,5.70E+02,,0,FALSE,5.349,8,1,237,25.3,9.33,1,cell organization and biogenesis;other metabolic processes,mitochondrion;other cell component,Pf13561,84869,hsa:84869; Q8N4T8; Q8WTW8; Q96K93,ENSG00000145439,Fatty acyl-CoA biosynthesis,,1,0,112.21,,,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,92.72,,0,,2.91,other molecular function,0,
Master Protein,High,F5H578,PRPF40A,Pre-mRNA processing factor 40 homolog A OS=Homo sapiens OX=9606 GN=PRPF40A PE=1 SV=4,10,19,3.4,0.882,0.738,2.384,1.77,-0.18,-0.44,1.25,2.24E-01,6.52E-01,6.93E-01,3.15E-01,9.94E+05,1.21E+05,4.96E+05,3.66E+05,4,4,5,4,5.37E+05,,1.61E+05,4.33E+06,1.84E+06,,2.82E+04,6.27E+05,2.15E+04,5.16E+05,4.70E+05,4.96E+05,7.94E+04,3.16E+06,1.27E+06,8.97E+05,6.30E+05,,2.12E+05,8.25E+04,2.13E+03,,1.57E+03,4.33E+06,9.48E+04,,5.02E+02,5.79E+03,6.05E+02,5.49E+03,2.81E+03,2.22E+04,6.45E+02,4.26E+05,3.15E+04,1.75E+03,1.77E+05,,4.97E+03,8.79E+02,0,FALSE,45.379,12,6,972,110.3,7.96,10,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00397, Pf01846",,F5H578,ENSG00000196504,,,0,3,109.84,106.94,112.66,82.51,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,97.47,93.52,79.09,112.49,57.8,,0,
Master Protein,High,Q9UIG0,BAZ1B,Tyrosine-protein kinase BAZ1B OS=Homo sapiens OX=9606 GN=BAZ1B PE=1 SV=2,15,32,3.389,0.863,,5.412,1.76,-0.21,,2.44,1.89E-01,7.14E-01,,7.74E-02,1.70E+06,7.35E+05,2.56E+06,4.52E+05,4,1,5,3,7.17E+05,,6.66E+05,6.61E+06,4.04E+06,,,,,7.35E+05,2.56E+06,2.15E+06,4.00E+05,7.66E+06,3.94E+06,6.30E+05,1.37E+04,,4.52E+05,,2.85E+03,,6.51E+03,6.61E+06,2.09E+05,,,,,7.82E+03,1.53E+04,9.61E+04,3.25E+03,1.03E+06,9.78E+04,1.23E+03,3.85E+03,,1.06E+04,,0,FALSE,50.196,15,15,1483,170.8,8.48,15,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00439, Pf00628, Pf10537, Pf15612, Pf15613",9031,B9EGK3; D3DXE9; hsa:9031; O95039; O95247; O95277; Q6P1K4; Q86UJ6; Q9UIG0,ENSG00000009954,B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,IL-18 signaling pathway; 7q11.23 copy number variation syndrome; 10q11.21q11.23 copy number variation syndrome,5,0,95.49,,81.48,86.82,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,107.05,106.76,,139.82,85.71,kinase activity;other molecular function,0,
Master Protein,High,P10809,HSPD1,"60 kDa heat shock protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPD1 PE=1 SV=2",39,808,3.373,1.618,2.216,2.29,1.75,0.69,1.15,1.2,2.07E-01,2.10E-01,3.77E-01,4.17E-01,1.18E+08,2.36E+07,2.05E+08,1.09E+08,5,5,5,5,1.18E+08,7.57E+07,5.38E+07,2.07E+08,1.68E+08,3.37E+07,1.31E+07,2.36E+07,1.49E+07,1.29E+08,1.25E+08,2.05E+08,2.58E+08,2.03E+08,3.42E+08,1.09E+08,1.12E+08,1.11E+08,8.07E+07,7.72E+07,4.68E+05,2.88E+05,5.26E+05,2.07E+08,8.67E+06,1.20E+05,2.33E+05,2.17E+05,4.21E+05,1.37E+06,7.49E+05,9.15E+06,2.09E+06,2.73E+07,8.51E+06,2.13E+05,3.16E+07,7.84E+05,1.89E+06,8.22E+05,0,FALSE,301.957,65,39,573,61,5.87,39,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;other cytoplasmic organelle;other cell component,Pf00118,3329,B2R5M6; B7Z712; hsa:3329; P10809; Q38L19; Q9UCR6,ENSG00000144381,Mitochondrial protein import; Mitochondrial protein degradation; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,Apoptosis-related network due to altered Notch3 in ovarian cancer; 8p23.1 copy number variation syndrome; Sudden infant death syndrome (SIDS) susceptibility pathways,6,0,51.02,114.05,35.34,17.83,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,128.88,124.86,134.31,127.09,2484.73,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13573,SNW1,SNW domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SNW1 PE=1 SV=1,3,4,3.369,2.453,0.918,3.093,1.75,1.29,-0.12,1.63,1.66E-01,4.10E-02,8.64E-01,2.39E-01,4.66E+05,3.40E+04,1.34E+06,3.50E+05,4,1,4,2,2.74E+05,,1.65E+05,1.56E+06,7.92E+05,,,,,3.40E+04,,2.43E+04,2.38E+06,1.02E+06,1.77E+06,,3.18E+05,,3.85E+05,,1.09E+03,,1.61E+03,1.56E+06,4.08E+04,,,,,3.62E+02,,1.08E+03,1.93E+04,1.37E+05,4.41E+04,,8.93E+04,,9.01E+03,,0,FALSE,17.065,10,3,536,61.5,9.52,3,RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,nucleus,Pf02731,22938,A8K8A9; hsa:22938; Q13483; Q13573; Q32N03; Q5D0D6,ENSG00000100603,Formation of paraxial mesoderm; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; mRNA Splicing - Major Pathway; Pre-NOTCH Transcription and Translation; Downregulation of SMAD2/3:SMAD4 transcriptional activity; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; NOTCH3 Intracellular Domain Regulates Transcription; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells; NOTCH4 Intracellular Domain Regulates Transcription; RUNX3 regulates NOTCH signaling,TGF-beta signaling pathway; Novel intracellular components of RIG-I-like receptor pathway; Splicing factor NOVA regulated synaptic proteins; Notch signaling pathway,16,0,91.13,,78.16,13.5,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,0,116.36,109.17,101.31,14.97,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,Medium,O43181,NDUFS4,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS4 PE=1 SV=1",1,2,3.366,0.01,0.01,,1.75,-6.64,-6.64,,1.74E-01,1.00E-17,1.00E-17,,4.78E+05,1.42E+05,,,1,1,,,,,,4.78E+05,,,1.42E+05,,,,,,,,,,,,,,,,,4.78E+05,,,2.53E+03,,,,,,,,,,,,,,0.021,FALSE,1.963,9,1,175,20.1,10.3,1,cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes,other membranes;mitochondrion,Pf04800,4724,hsa:4724; O43181; Q9BS69,ENSG00000164258,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,5,0,,,,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,,,,5.83,transporter activity,0,
Master Protein,High,H0YNJ6,GMPR2,GMP reductase OS=Homo sapiens OX=9606 GN=GMPR2 PE=1 SV=1,1,1,3.358,0.099,0.344,0.814,1.75,-3.34,-1.54,-0.3,1.74E-01,1.42E-02,3.04E-01,9.76E-01,5.61E+05,1.34E+05,3.75E+04,4.60E+04,3,2,2,1,,5.61E+05,,1.06E+05,5.87E+05,1.71E+05,,1.05E+05,,,,5.67E+04,,2.48E+04,,,,,4.60E+04,,,2.13E+03,,1.06E+05,3.03E+04,6.08E+02,,9.66E+02,,,,2.53E+03,,3.34E+03,,,,,1.08E+03,,0.004,FALSE,2.553,4,1,427,46.9,8.51,1,other metabolic processes,other cell component,Pf00478,51292,H0YNJ6,ENSG00000100938,,,0,0,64.76,34.01,55.34,,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,93.96,103.36,36.74,63.05,2.68,other molecular function,0,
Master Protein,High,Q6DN03,H2BC20P,Putative histone H2B type 2-C OS=Homo sapiens OX=9606 GN=H2BC20P PE=5 SV=3,5,171,3.355,1.343,1.223,6.853,1.75,0.43,0.29,2.78,2.09E-01,3.27E-01,9.00E-01,7.44E-02,1.06E+08,1.26E+07,1.75E+08,2.05E+07,5,5,5,5,1.09E+07,2.52E+08,1.06E+08,1.80E+08,3.48E+07,8.72E+06,1.26E+07,3.81E+07,1.24E+07,1.26E+08,4.20E+07,1.56E+08,1.75E+08,1.99E+08,1.85E+08,1.85E+07,1.83E+07,2.20E+07,3.00E+07,2.05E+07,4.35E+04,9.58E+05,1.03E+06,1.80E+08,1.80E+06,3.10E+04,2.24E+05,3.51E+05,3.49E+05,1.34E+06,2.51E+05,6.95E+06,1.42E+06,2.68E+07,4.60E+06,3.61E+04,5.14E+06,1.56E+05,7.03E+05,2.18E+05,0,FALSE,22.156,16,5,193,21.5,10.7,5,,nucleus;other cell component,Pf00125,,B7Z677; Q6DN03,,,,0,0,86.02,125.64,41.69,22.02,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,140.09,96.07,116.98,95.98,445.67,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P06576,ATP5F1B,"ATP synthase subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1B PE=1 SV=3",26,641,3.349,1.489,1.423,3.488,1.74,0.57,0.51,1.8,2.10E-01,2.58E-01,7.50E-01,2.36E-01,9.06E+07,2.15E+07,2.03E+08,5.02E+07,5,5,5,5,8.20E+07,5.57E+07,9.21E+07,1.78E+08,9.06E+07,5.45E+07,9.09E+06,3.04E+07,8.02E+06,2.15E+07,1.75E+08,2.73E+08,2.03E+08,1.77E+08,2.18E+08,5.02E+07,5.32E+07,4.84E+07,1.27E+07,5.68E+07,3.26E+05,2.12E+05,9.00E+05,1.78E+08,4.67E+06,1.94E+05,1.62E+05,2.80E+05,2.26E+05,2.29E+05,1.05E+06,1.22E+07,1.65E+06,2.39E+07,5.41E+06,9.78E+04,1.50E+07,3.43E+05,2.98E+05,6.05E+05,0,FALSE,288.82,69,26,529,56.5,5.4,26,other metabolic processes;transport;developmental processes;other biological processes,plasma membrane;other membranes;mitochondrion;other cell component,"Pf00006, Pf02874",506,A8K4X0; hsa:506; P06576; Q14283,ENSG00000110955,Transcriptional activation of mitochondrial biogenesis; Mitochondrial protein import; Mitochondrial protein degradation; Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,8,0,46.23,77.15,19.08,40.48,High,High,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,112.81,111.22,126.01,125.53,1834.44,signal transduction activity or receptor binding;transporter activity;other molecular function,0,
Master Protein,High,P51991,HNRNPA3,Heterogeneous nuclear ribonucleoprotein A3 OS=Homo sapiens OX=9606 GN=HNRNPA3 PE=1 SV=2,16,80,3.31,0.246,1.404,1.02,1.73,-2.02,0.49,0.03,2.14E-01,1.27E-01,7.63E-01,9.25E-01,2.62E+06,2.04E+06,3.01E+06,3.53E+06,5,5,5,5,6.01E+05,2.62E+06,6.38E+04,4.65E+07,2.92E+07,1.99E+06,7.29E+06,5.86E+06,2.44E+05,2.04E+06,5.84E+05,4.70E+06,1.97E+06,2.32E+07,3.01E+06,3.53E+06,2.35E+05,1.49E+07,5.12E+05,1.30E+07,2.39E+03,9.97E+03,6.23E+02,4.65E+07,1.50E+06,7.09E+03,1.30E+05,5.40E+04,6.87E+03,2.16E+04,3.49E+03,2.10E+05,1.60E+04,3.13E+06,7.48E+04,6.89E+03,6.60E+04,1.06E+05,1.20E+04,1.39E+05,0,FALSE,102.008,41,16,378,39.6,9.01,16,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf00076,220988,D3DPF4; hsa:220988; P51991; Q53RW7; Q6URK5,ENSG00000170144,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,,2,0,133.32,84.84,139.71,108.97,Peak Found,High,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,High,Peak Found,High,1,Acetyl [N-Term],FALSE,140.26,132.68,139.26,145.8,232.7,nucleic acid binding activity,0,
Master Protein,High,Q9NV96,TMEM30A,Cell cycle control protein 50A OS=Homo sapiens OX=9606 GN=TMEM30A PE=1 SV=1,2,4,3.309,0.806,5.391,0.827,1.73,-0.31,2.43,-0.27,1.83E-01,8.87E-01,1.04E-01,9.57E-01,5.50E+05,4.91E+04,3.05E+05,9.98E+05,4,4,5,3,,2.79E+06,8.82E+04,4.77E+05,6.34E+05,1.73E+05,2.10E+04,8.07E+04,,2.99E+04,1.17E+05,3.05E+05,5.85E+04,9.14E+05,6.23E+05,1.01E+06,3.35E+04,,9.98E+05,,,1.06E+04,8.61E+02,4.77E+05,3.27E+04,6.16E+02,3.73E+02,7.45E+02,,3.18E+02,6.97E+02,1.36E+04,4.75E+02,1.23E+05,1.55E+04,1.96E+03,9.42E+03,,2.34E+04,,0,FALSE,4.959,6,2,361,40.7,8.59,2,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf03381,55754,A8K9V8; E1P539; hsa:55754; Q658Z3; Q96H09; Q9NSL9; Q9NV96,ENSG00000112697,Neutrophil degranulation,,1,0,121.99,91.59,89.38,82.33,n/a,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,119.41,115.88,87.84,120.29,7.78,transporter activity;other molecular function,0,
Master Protein,High,Q9UDT6,CLIP2,CAP-Gly domain-containing linker protein 2 OS=Homo sapiens OX=9606 GN=CLIP2 PE=1 SV=1,3,4,3.309,0.456,0.326,0.86,1.73,-1.13,-1.62,-0.22,1.79E-01,5.94E-01,2.97E-01,9.68E-01,5.11E+05,5.75E+04,6.58E+04,8.37E+04,3,4,4,3,5.56E+05,6.56E+04,,5.11E+05,,9.91E+04,2.45E+04,1.36E+05,,3.34E+04,8.52E+04,2.16E+05,,5.08E+04,1.65E+04,,4.24E+03,8.37E+04,,3.60E+05,2.21E+03,2.49E+02,,5.11E+05,,3.52E+02,4.36E+02,1.25E+03,,3.55E+02,5.10E+02,9.66E+03,,6.85E+03,4.10E+02,,1.19E+03,5.93E+02,,3.83E+03,0,FALSE,13.718,5,3,1046,115.8,6.73,3,cell organization and biogenesis,cytoskeleton;nucleus;other cell component,Pf01302,7461,hsa:7461; O14527; O43611; Q9UDT6,ENSG00000106665,,7q11.23 copy number variation syndrome,1,0,71.81,72.94,94.68,125.05,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,101.79,91.45,132.72,141.91,11.28,cytoskeletal activity,0,
Master Protein,High,Q92797,SYMPK,Symplekin OS=Homo sapiens OX=9606 GN=SYMPK PE=1 SV=2,2,2,3.307,0.01,0.01,,1.73,-6.64,-6.64,,2.24E-01,1.00E-17,1.00E-17,,1.30E+05,3.94E+04,,,2,1,,,,,,4.57E+04,3.71E+05,,,,3.94E+04,,,,,,,,,,,,,,,4.57E+04,1.91E+04,,,,1.11E+03,,,,,,,,,,,,0,FALSE,7.814,4,2,1274,141.1,6.13,2,cell adhesion;RNA metabolism OR transcription;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf11935, Pf12295",8189,hsa:8189; O00521; O00689; O00733; Q59GT5; Q8N2U5; Q92797,ENSG00000125755,Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,,5,0,110.4,,,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,185.17,,,,6.62,,0,
Master Protein,High,F8W727,RPL32,Ribosomal protein L32 OS=Homo sapiens OX=9606 GN=RPL32 PE=1 SV=1,2,15,3.256,1.139,3.474,1.09,1.7,0.19,1.8,0.12,1.77E-01,5.17E-01,2.87E-01,7.38E-01,4.05E+05,1.01E+05,3.37E+05,2.69E+05,5,4,5,4,4.84E+04,4.40E+05,4.05E+05,1.13E+06,1.39E+05,,9.81E+04,1.03E+05,2.23E+04,1.27E+05,4.55E+05,4.61E+05,1.86E+05,3.37E+05,1.62E+05,,4.02E+05,1.80E+05,6.42E+04,8.85E+05,1.92E+02,1.67E+03,3.96E+03,1.13E+06,7.15E+03,,1.74E+03,9.51E+02,6.30E+02,1.35E+03,2.72E+03,2.06E+04,1.51E+03,4.54E+04,4.02E+03,,1.13E+05,1.27E+03,1.50E+03,9.43E+03,0,FALSE,8.969,19,2,153,18,10.59,2,protein metabolism;other metabolic processes,translational apparatus;other cell component,Pf01655,,F8W727,ENSG00000144713,,,0,0,98.43,51.69,44.55,94.88,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,112.18,88.45,121.02,101.84,33.63,other molecular function,0,
Master Protein,High,B7Z4C8,RPL31,60S ribosomal protein L31 OS=Homo sapiens OX=9606 GN=RPL31 PE=1 SV=1,1,4,3.243,0.823,3.894,0.563,1.7,-0.28,1.96,-0.83,2.51E-01,7.19E-01,1.64E-01,7.59E-01,7.85E+05,2.42E+05,6.24E+05,1.38E+06,4,4,4,3,2.50E+05,,1.17E+06,2.00E+06,5.28E+05,,2.45E+05,2.39E+05,4.16E+04,1.23E+06,1.63E+06,8.88E+05,,4.39E+05,3.59E+05,3.31E+06,5.27E+04,,,1.38E+06,9.94E+02,,1.14E+04,2.00E+06,2.72E+04,,4.36E+03,2.21E+03,1.17E+03,1.31E+04,9.74E+03,3.97E+04,,5.91E+04,8.92E+03,6.45E+03,1.48E+04,,,1.47E+04,0.008,FALSE,2.345,7,1,130,15.1,10.37,1,protein metabolism;other metabolic processes,translational apparatus;other cell component,Pf01198,,B7Z4C8,ENSG00000071082,,,0,0,78.81,122.05,70.23,103.54,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,115.66,93.74,139.98,140.78,6.07,other molecular function,0,
Master Protein,High,P15498,VAV1,Proto-oncogene vav OS=Homo sapiens OX=9606 GN=VAV1 PE=1 SV=4,2,4,3.24,0.35,0.01,100,1.7,-1.52,-6.64,6.64,2.37E-01,4.53E-01,1.00E-17,1.00E-17,1.28E+05,2.32E+04,4.71E+04,,3,1,4,,1.15E+06,,,1.28E+05,1.11E+05,,,,2.32E+04,,,2.67E+04,5.02E+04,9.42E+04,4.42E+04,,,,,,4.55E+03,,,1.28E+05,5.74E+03,,,,6.55E+02,,,1.19E+03,4.08E+02,1.27E+04,1.10E+03,,,,,,0,FALSE,5.812,3,2,845,98.3,6.62,2,cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf00017, Pf00018, Pf00130, Pf00169, Pf00307, Pf00621",7409,B4DVK9; hsa:7409; M0QXX6; P15498; Q15860,ENSG00000141968,"Regulation of actin dynamics for phagocytic cup formation; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; FCGR3A-mediated phagocytosis; Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; RHOA GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOG GTPase cycle; RAC2 GTPase cycle; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Regulation of signaling by CBL; GPVI-mediated activation cascade; Signaling by SCF-KIT; Azathioprine ADME; VEGFR2 mediated vascular permeability; Erythropoietin activates RAS; CD28 dependent Vav1 pathway",Prolactin signaling pathway; B cell receptor signaling pathway; Hematopoietic stem cell differentiation; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; IL6 signaling pathway; Chemokine signaling pathway; Microglia pathogen phagocytosis pathway; EGF/EGFR signaling pathway; Modulators of TCR signaling and T cell activation; Regulation of actin cytoskeleton; Interferon type I signaling pathways; T-cell receptor signaling pathway,38,0,128.26,,53.32,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,80.58,,,11.87,enzyme regulator activity;other molecular function,0,
Master Protein,High,A0A8Q3SHT5,NARS2,"Asparaginyl-tRNA synthetase 2, mitochondrial OS=Homo sapiens OX=9606 GN=NARS2 PE=1 SV=1",3,9,3.238,1.441,3.069,1.502,1.7,0.53,1.62,0.59,2.34E-01,3.63E-01,3.66E-01,5.82E-01,1.29E+05,5.10E+04,6.67E+05,8.25E+04,3,2,4,5,,,1.29E+05,6.59E+05,1.08E+05,,2.69E+04,,,9.66E+04,,5.07E+05,4.93E+05,1.42E+06,8.77E+05,1.03E+05,9.22E+04,4.80E+04,4.42E+04,8.25E+04,,,1.26E+03,6.59E+05,5.59E+03,,4.78E+02,,,1.03E+03,,2.26E+04,4.01E+03,1.91E+05,2.18E+04,2.01E+02,2.59E+04,3.40E+02,1.04E+03,8.78E+02,0,FALSE,8.043,7,3,509,57.5,7.71,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes,,"Pf00152, Pf01336",,A0A8Q3SHT5,ENSG00000137513,,Ectoderm differentiation,1,0,104.6,79.85,52.69,35.86,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,49.67,57.4,37.26,112.27,23.99,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P68366,TUBA4A,Tubulin alpha-4A chain OS=Homo sapiens OX=9606 GN=TUBA4A PE=1 SV=1,20,314,3.237,0.545,1.45,1.979,1.69,-0.88,0.54,0.98,2.18E-01,7.87E-01,8.37E-01,4.43E-01,1.90E+06,3.12E+05,1.39E+06,4.96E+05,5,3,5,2,7.82E+06,9.19E+05,1.00E+07,1.90E+06,3.03E+05,3.12E+05,,,3.99E+05,2.92E+05,2.34E+06,1.45E+06,6.01E+05,1.29E+06,1.39E+06,,1.21E+05,,2.03E+06,,3.11E+04,3.49E+03,9.79E+04,1.90E+06,1.56E+04,1.11E+03,,,1.13E+04,3.11E+03,1.40E+04,6.49E+04,4.88E+03,1.74E+05,3.45E+04,,3.40E+04,,4.76E+04,,0,FALSE,143.241,53,3,448,49.9,5.06,20,cell cycle OR cell proliferation;cell organization and biogenesis,non-structural extracellular;cytosol;cytoskeleton;other cell component,"Pf00091, Pf03953",7277,A8MUB1; B3KNQ6; hsa:7277; P05215; P68366,ENSG00000127824,Platelet degranulation ; Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; PKR-mediated signaling; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease; HDAC6 interactions in the central nervous system,43,0,105.47,17.03,43.73,125.54,High,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,1,,FALSE,103.75,129.02,244.65,160.23,932.7,cytoskeletal activity;other molecular function,0,
Master Protein,High,O43583,DENR,Density-regulated protein OS=Homo sapiens OX=9606 GN=DENR PE=1 SV=2,2,11,3.232,0.304,7.381,0.502,1.69,-1.72,2.88,-0.99,1.88E-01,3.31E-01,5.27E-02,6.45E-01,3.23E+05,1.00E+05,1.14E+05,7.39E+05,4,1,4,3,2.80E+05,3.74E+05,,2.28E+05,1.84E+06,,,,1.00E+05,,,6.57E+04,1.78E+05,8.56E+05,7.32E+04,,6.29E+04,,7.39E+05,8.09E+05,1.11E+03,1.42E+03,,2.28E+05,9.47E+04,,,,2.82E+03,,,2.94E+03,1.45E+03,1.15E+05,1.82E+03,,1.77E+04,,1.73E+04,8.61E+03,0,FALSE,14.333,20,2,198,22.1,5.3,2,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,,"Pf01253, Pf21023",8562,hsa:8562; O43583; Q9H3U6; Q9UKZ0,ENSG00000139726,,,0,0,113.76,,129.06,76.74,Peak Found,Peak Found,n/a,High,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,33.43,86.29,14.1,151.49,46.68,nucleic acid binding activity,0,
Master Protein,High,A2BFX2,HLA-DRB1,HLA class II histocompatibility antigen DR beta chain OS=Homo sapiens OX=9606 GN=HLA-DRB1 PE=1 SV=1,8,57,3.222,0.584,1.039,2.156,1.69,-0.78,0.05,1.11,1.83E-01,8.26E-01,8.79E-01,3.61E-01,3.59E+06,3.01E+05,5.24E+05,4.50E+05,4,3,5,4,1.38E+05,1.77E+07,,1.61E+07,8.01E+05,2.05E+05,2.36E+06,,,3.01E+05,5.24E+05,7.12E+06,2.87E+05,2.14E+07,3.88E+05,5.24E+05,3.86E+05,5.24E+06,4.05E+04,,5.47E+02,6.73E+04,,1.61E+07,4.13E+04,7.31E+02,4.20E+04,,,3.20E+03,3.13E+03,3.18E+05,2.33E+03,2.88E+06,9.64E+03,1.02E+03,1.08E+05,3.72E+04,9.47E+02,,0,FALSE,58.501,43,4,266,30.2,6.93,8,other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00969, Pf07654",,A2BFX2,ENSG00000228080,,,0,1,109.54,127.43,153.38,159.63,Peak Found,High,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,139.11,121.53,130.85,142.28,162.33,,0,
Master Protein,High,O95197,RTN3,Reticulon-3 OS=Homo sapiens OX=9606 GN=RTN3 PE=1 SV=2,3,10,3.187,0.578,11.249,0.279,1.67,-0.79,3.49,-1.84,1.90E-01,8.13E-01,7.34E-03,3.23E-01,4.91E+05,1.41E+05,5.84E+05,1.72E+06,3,5,4,5,,4.91E+05,,1.54E+06,2.72E+05,3.10E+05,1.41E+05,1.47E+05,9.97E+04,5.41E+04,,5.29E+05,3.45E+05,6.45E+05,1.63E+06,3.64E+06,1.72E+06,6.99E+05,2.89E+06,5.29E+05,,1.86E+03,,1.54E+06,1.40E+04,1.10E+03,2.50E+03,1.36E+03,2.81E+03,5.76E+02,,2.36E+04,2.80E+03,8.69E+04,4.04E+04,7.09E+03,4.84E+05,4.96E+03,6.76E+04,5.63E+03,0,FALSE,10.645,2,3,1032,112.5,4.96,3,cell organization and biogenesis;transport;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component,Pf02453,10313,B3KQS2; B7Z308; B7Z4M0; F5H774; hsa:10313; O95197; Q147U9; Q496K2; Q53GN3; Q59EP0; Q5UEP2; Q6T930; Q7RTM7; Q7RTM8; Q7RTN3,ENSG00000133318,Synaptic adhesion-like molecules,Alzheimer's disease and miRNA effects; Alzheimer's disease,3,0,88.14,64.36,72.94,71.51,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,1,,FALSE,101.26,100.91,125.1,73.42,23.9,,0,
Master Protein,High,Q10570,CPSF1,Cleavage and polyadenylation specificity factor subunit 1 OS=Homo sapiens OX=9606 GN=CPSF1 PE=1 SV=2,4,7,3.175,1.01,1.093,1.194,1.67,0.01,0.13,0.26,2.38E-01,5.29E-01,9.50E-01,7.22E-01,6.92E+05,2.04E+05,6.46E+05,2.54E+05,5,4,4,4,8.55E+06,6.44E+05,3.80E+06,6.92E+05,1.64E+05,,5.31E+05,2.26E+05,8.59E+04,1.83E+05,9.05E+05,,1.61E+06,4.61E+05,2.70E+04,1.22E+06,1.04E+05,6.18E+05,3.34E+04,,3.39E+04,2.45E+03,3.72E+04,6.92E+05,8.46E+03,,9.45E+03,2.09E+03,2.42E+03,1.95E+03,5.41E+03,,1.30E+04,6.22E+04,6.71E+02,2.38E+03,2.93E+04,4.38E+03,7.82E+02,,0,FALSE,13.935,4,4,1443,160.8,6.4,4,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf03178, Pf10433",29894,hsa:29894; Q10570; Q96AF0,ENSG00000071894; ENSG00000285049,Transport of Mature mRNA Derived from an Intronless Transcript; tRNA processing in the nucleus; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,mRNA processing,7,0,127.72,74.94,89.85,111.28,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,120.87,135.64,103.71,122.22,19.81,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A6Q8PH84,RAB7A,"RAB7A, member RAS oncogene family OS=Homo sapiens OX=9606 GN=RAB7A PE=1 SV=1",8,36,3.172,1.484,0.947,1.993,1.67,0.57,-0.08,0.99,1.93E-01,2.60E-01,8.54E-01,4.91E-01,3.56E+06,2.32E+05,9.78E+06,3.69E+06,5,4,5,5,3.56E+06,4.06E+05,7.94E+06,7.91E+06,7.75E+05,1.22E+05,,3.40E+06,4.38E+05,8.36E+04,6.27E+06,7.41E+06,9.78E+06,1.05E+07,1.33E+07,6.06E+06,3.69E+06,1.98E+06,4.49E+06,3.08E+06,1.41E+04,1.54E+03,7.75E+04,7.91E+06,4.00E+04,4.35E+02,,3.13E+04,1.23E+04,8.89E+02,3.75E+04,3.31E+05,7.94E+04,1.42E+06,3.30E+05,1.18E+04,1.04E+06,1.40E+04,1.05E+05,3.28E+04,0,FALSE,36.634,41,8,217,24.6,8.31,8,,other cytoplasmic organelle,Pf00071,,A0A6Q8PH84,ENSG00000075785,,Ebola virus infection in host; Autosomal recessive osteopetrosis pathways; Intracellular trafficking proteins involved in CMT neuropathy,3,0,89.45,158.28,29.12,39.7,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,141.61,101.72,249.46,125.67,98.6,other molecular function,0,
Master Protein,High,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 OS=Homo sapiens OX=9606 GN=CHAMP1 PE=1 SV=2,7,16,3.169,0.583,0.691,0.638,1.66,-0.78,-0.53,-0.65,2.03E-01,8.51E-01,7.00E-01,8.70E-01,3.10E+05,5.24E+04,1.21E+06,7.07E+04,3,4,4,4,,3.10E+05,,2.10E+06,2.32E+05,1.28E+06,2.41E+04,,6.49E+03,1.14E+05,,1.37E+06,7.70E+04,1.92E+06,1.08E+06,2.24E+06,6.51E+03,,2.01E+04,2.49E+05,,1.18E+03,,2.10E+06,1.20E+04,4.55E+03,4.29E+02,,1.83E+02,1.21E+03,,6.10E+04,6.26E+02,2.59E+05,2.68E+04,4.37E+03,1.83E+03,,4.69E+02,2.65E+03,0,FALSE,26.686,13,7,812,89,8.44,7,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytoskeleton;nucleus;other cell component,,283489,B3KU06; hsa:283489; Q6P181; Q8NC88; Q96JM3; Q9BST0,ENSG00000198824,,,0,0,119.97,173.43,69.6,171.68,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,High,High,Peak Found,Peak Found,n/a,High,Peak Found,1,,FALSE,127.63,77.56,115.14,85.71,42.79,other molecular function,0,
Master Protein,High,P62888,RPL30,60S ribosomal protein L30 OS=Homo sapiens OX=9606 GN=RPL30 PE=1 SV=2,3,16,3.162,0.93,6.351,0.606,1.66,-0.1,2.67,-0.72,2.44E-01,5.80E-01,7.99E-02,7.58E-01,1.58E+05,4.63E+04,1.61E+06,8.49E+05,4,2,4,2,,5.77E+04,1.41E+05,1.45E+06,1.77E+05,,3.01E+04,7.13E+04,,,2.13E+06,3.04E+04,,1.93E+06,1.34E+06,,1.64E+06,,,4.39E+05,,2.19E+02,1.38E+03,1.45E+06,9.13E+03,,5.36E+02,6.58E+02,,,1.27E+04,1.36E+03,,2.60E+05,3.32E+04,,4.61E+05,,,4.67E+03,0,FALSE,11.483,37,3,115,12.8,9.63,3,protein metabolism;other metabolic processes;stress response;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf01248,6156,B2R591; hsa:6156; P04645; P62888; Q502Z6,ENSG00000156482,L13a-mediated translational silencing of Ceruloplasmin expression; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Formation of a pool of free 40S subunits; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Selenium metabolism and selenoproteins; Cytoplasmic ribosomal proteins,15,0,145.42,57.4,69.7,81.71,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,n/a,n/a,Peak Found,1,,FALSE,84.41,115.86,44.13,87.26,47.61,other molecular function,0,
Master Protein,High,P37108,SRP14,Signal recognition particle 14 kDa protein OS=Homo sapiens OX=9606 GN=SRP14 PE=1 SV=2,5,22,3.162,0.939,0.97,9.45,1.66,-0.09,-0.04,3.24,2.20E-01,5.66E-01,8.99E-01,3.46E-02,2.08E+06,3.24E+05,1.26E+06,7.10E+04,5,4,5,2,2.45E+05,2.69E+06,5.66E+05,6.44E+06,2.08E+06,2.83E+05,,3.72E+05,1.53E+05,5.30E+05,1.26E+06,4.25E+06,6.50E+05,1.32E+06,1.13E+06,,6.10E+04,,8.28E+04,,9.75E+02,1.02E+04,5.53E+03,6.44E+06,1.07E+05,1.00E+03,,3.43E+03,4.32E+03,5.63E+03,7.51E+03,1.90E+05,5.28E+03,1.78E+05,2.81E+04,,1.71E+04,,1.94E+03,,0,FALSE,22.584,35,5,136,14.6,10.04,5,other biological processes,non-structural extracellular;cytosol;translational apparatus;nucleus;other cell component,Pf02290,6727,B5BUF5; hsa:6727; P37108; Q6B0K5; Q96Q14,ENSG00000140319,Neutrophil degranulation; SRP-dependent cotranslational protein targeting to membrane,,2,0,102.97,47.33,83.6,21.45,Peak Found,High,High,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,108.84,122.44,91.47,100.68,64.38,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P45973,CBX5,Chromobox protein homolog 5 OS=Homo sapiens OX=9606 GN=CBX5 PE=1 SV=1,9,40,3.16,0.204,3.284,0.705,1.66,-2.29,1.72,-0.5,2.34E-01,7.13E-02,1.46E-01,8.28E-01,4.53E+06,7.66E+05,1.34E+06,2.63E+06,5,5,5,5,4.53E+06,5.55E+05,2.55E+05,1.27E+07,1.46E+07,7.66E+05,2.36E+06,1.15E+06,3.62E+04,6.15E+05,3.35E+04,1.71E+06,1.34E+06,9.58E+06,1.23E+06,8.20E+06,1.48E+05,2.63E+06,1.10E+07,6.64E+05,1.80E+04,2.11E+03,2.50E+03,1.27E+07,7.53E+05,2.72E+03,4.20E+04,1.06E+04,1.02E+03,6.54E+03,2.00E+02,7.66E+04,1.09E+04,1.29E+06,3.06E+04,1.60E+04,4.15E+04,1.86E+04,2.57E+05,7.07E+03,0,FALSE,47.071,53,8,191,22.2,5.86,9,cell organization and biogenesis;stress response;other biological processes,nucleus;other cell component,"Pf00385, Pf01393",23468,B2R8T9; hsa:23468; P45973,ENSG00000094916,SUMOylation of chromatin organization proteins; Transcriptional Regulation by E2F6; Factors involved in megakaryocyte development and platelet production,Effect of progerin on genes involved in progeria; 22q11.2 copy number variation syndrome,5,1,103.42,87.98,138.61,106.53,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,137.06,117.81,84.65,131.31,126.56,other molecular function,0,
Master Protein,High,Q01130,SRSF2,Serine/arginine-rich splicing factor 2 OS=Homo sapiens OX=9606 GN=SRSF2 PE=1 SV=4,5,13,3.159,0.154,1.354,0.268,1.66,-2.7,0.44,-1.9,2.34E-01,2.68E-02,9.03E-01,2.63E-01,5.28E+06,4.20E+05,3.56E+05,1.98E+05,5,5,5,4,9.35E+05,5.28E+06,6.74E+05,9.37E+06,6.28E+06,4.20E+05,3.79E+04,2.83E+05,6.24E+05,3.85E+06,1.72E+05,4.53E+05,9.29E+04,1.42E+06,3.56E+05,1.13E+05,,3.47E+05,1.05E+04,5.82E+05,3.71E+03,2.01E+04,6.58E+03,9.37E+06,3.24E+05,1.49E+03,6.74E+02,2.61E+03,1.76E+04,4.09E+04,1.03E+03,2.02E+04,7.55E+02,1.91E+05,8.83E+03,2.20E+02,,2.46E+03,2.45E+02,6.20E+03,0,FALSE,13.45,23,5,221,25.5,11.85,5,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus,Pf00076,6427,B3KWD5; B4DN89; H0YG49; hsa:6427; Q01130,ENSG00000161547,mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Minor Pathway,mRNA processing,7,0,82.16,151.84,107.01,96.95,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,139.22,117.58,134.68,116.59,28.67,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UJ68,MSRA,Mitochondrial peptide methionine sulfoxide reductase OS=Homo sapiens OX=9606 GN=MSRA PE=1 SV=1,2,4,3.121,0.59,1.842,0.425,1.64,-0.76,0.88,-1.23,2.42E-01,8.46E-01,6.55E-01,5.29E-01,1.30E+05,6.29E+04,5.64E+05,1.16E+05,4,3,5,4,,6.98E+04,7.06E+04,8.55E+05,2.40E+05,8.40E+04,,4.85E+04,6.29E+04,,4.12E+04,8.78E+05,7.75E+05,2.36E+05,5.64E+05,1.21E+05,1.69E+04,1.11E+05,,2.26E+05,,2.65E+02,6.90E+02,8.55E+05,1.24E+04,2.99E+02,,4.48E+02,1.77E+03,,2.46E+02,3.92E+04,6.30E+03,3.18E+04,1.40E+04,2.36E+02,4.76E+03,7.86E+02,,2.41E+03,0,FALSE,7.014,12,2,235,26.1,8.09,2,protein metabolism;other metabolic processes;stress response,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component,Pf01625,4482,E9PAS8; hsa:4482; Q52TC4; Q549N4; Q66MI7; Q9UJ68,ENSG00000175806; ENSG00000285250,Protein repair,Sulindac metabolic pathway; Methionine de novo and salvage pathway; 8p23.1 copy number variation syndrome,4,0,120.71,27.44,71.07,72.06,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,79.91,99.22,60.35,102.72,9.28,other molecular function,0,
Master Protein,High,Q92544,TM9SF4,Transmembrane 9 superfamily member 4 OS=Homo sapiens OX=9606 GN=TM9SF4 PE=1 SV=2,3,8,3.114,0.523,,38.507,1.64,-0.94,,5.27,1.97E-01,7.25E-01,,1.79E-03,3.76E+05,6.31E+04,3.18E+05,6.70E+03,2,1,5,1,,,,6.05E+05,2.34E+05,6.31E+04,,,,,1.95E+06,3.02E+05,3.18E+05,2.76E+05,3.61E+05,,6.70E+03,,,,,,,6.05E+05,1.21E+04,2.24E+02,,,,,1.17E+04,1.35E+04,2.59E+03,3.71E+04,8.97E+03,,1.88E+03,,,,0,FALSE,14.772,8,3,642,74.5,6.54,3,cell adhesion;cell organization and biogenesis;stress response;transport;other biological processes,other membranes;ER/Golgi;other cytoplasmic organelle,Pf02990,9777,B0QYT7; hsa:9777; Q92544; Q9NUA3,ENSG00000101337,,,0,0,62.52,,114.26,,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,26.01,123.9,,104.54,21.34,,0,
Master Protein,High,A0A590UK80,,RRM domain-containing protein (Fragment) OS=Homo sapiens OX=9606 PE=4 SV=1,5,11,3.104,0.333,0.625,1.388,1.63,-1.59,-0.68,0.47,2.10E-01,3.19E-01,4.96E-01,6.28E-01,1.37E+06,5.91E+05,4.30E+05,3.95E+05,5,4,5,5,1.37E+06,7.81E+05,1.29E+06,1.53E+07,4.94E+06,7.20E+05,1.79E+05,4.86E+05,,9.06E+05,1.26E+05,1.65E+06,1.67E+05,3.48E+06,4.30E+05,3.95E+05,2.34E+05,1.21E+06,1.88E+05,7.13E+06,5.43E+03,2.97E+03,1.26E+04,1.53E+07,2.55E+05,2.56E+03,3.18E+03,4.48E+03,,9.63E+03,7.54E+02,7.39E+04,1.36E+03,4.69E+05,1.07E+04,7.70E+02,6.57E+04,8.57E+03,4.41E+03,7.59E+04,0,FALSE,13.614,4,3,1090,121,6.84,5,other biological processes,nucleus,"Pf00076, Pf01530, Pf02820",,,,,,0,2,129.71,54.84,122.38,163.29,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,95.94,98.27,137.3,143,24.63,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O43684,BUB3,Mitotic checkpoint protein BUB3 OS=Homo sapiens OX=9606 GN=BUB3 PE=1 SV=1,2,4,3.102,0.344,3.942,0.157,1.63,-1.54,1.98,-2.67,1.99E-01,3.88E-01,1.93E-01,1.15E-01,4.11E+05,1.19E+05,6.33E+04,8.05E+05,2,1,2,2,,,,6.18E+05,2.73E+05,,,,,1.19E+05,,4.12E+04,,9.71E+04,,7.25E+05,,,,8.94E+05,,,,6.18E+05,1.41E+04,,,,,1.26E+03,,1.84E+03,,1.31E+04,,1.41E+03,,,,9.51E+03,0,FALSE,23.053,10,2,328,37.1,6.84,2,cell cycle OR cell proliferation;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf00400,9184,A6NJ42; B2R6E7; D3DRE9; hsa:9184; O43684; O43685,ENSG00000154473,Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of mitotic proteins; APC-Cdc20 mediated degradation of Nek2A,Cell cycle; Regulation of sister chromatid separation at the metaphase-anaphase transition,12,0,54.83,,57.07,14.75,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,45.38,4.7,17.66,37.12,16.89,other molecular function,0,
Master Protein,High,Q08211,DHX9,ATP-dependent RNA helicase A OS=Homo sapiens OX=9606 GN=DHX9 PE=1 SV=4,27,92,3.094,0.311,0.592,1.295,1.63,-1.68,-0.76,0.37,2.44E-01,2.38E-01,4.82E-01,7.60E-01,1.73E+07,1.12E+06,3.49E+06,1.54E+06,5,5,5,5,5.07E+07,4.77E+05,2.14E+07,1.73E+07,5.29E+06,1.12E+06,4.19E+05,1.77E+06,2.31E+05,1.35E+06,1.57E+07,9.46E+05,3.49E+06,1.79E+07,2.44E+06,1.83E+06,1.31E+06,1.49E+06,1.54E+06,3.12E+06,2.02E+05,1.81E+03,2.09E+05,1.73E+07,2.73E+05,4.00E+03,7.45E+03,1.63E+04,6.52E+03,1.44E+04,9.42E+04,4.22E+04,2.83E+04,2.42E+06,6.06E+04,3.57E+03,3.68E+05,1.06E+04,3.60E+04,3.32E+04,0,FALSE,137.907,31,27,1270,140.9,6.84,27,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf00035, Pf00270, Pf00271, Pf04408, Pf07717, Pf21010",1660,B2RNV4; hsa:1660; Q05CI5; Q08211; Q12803; Q32Q22; Q5VY62; Q6PD69; Q99556,ENSG00000135829,mRNA Splicing - Major Pathway; PKR-mediated signaling; RIP-mediated NFkB activation via ZBP1; DEx/H-box helicases activate type I IFN and inflammatory cytokines production,MECP2 and associated Rett syndrome; mRNA processing,6,0,103.29,65.72,99.34,39.24,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,129.76,131.73,103.66,132.47,288.76,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A6Q8PH57,KIF2A,Kinesin-like protein OS=Homo sapiens OX=9606 GN=KIF2A PE=1 SV=1,4,5,3.093,0.094,5.932,0.056,1.63,-3.41,2.57,-4.16,2.34E-01,1.73E-02,1.07E-01,7.24E-03,2.11E+05,8.03E+04,7.63E+04,4.76E+05,3,2,5,4,2.11E+05,1.13E+06,,2.11E+05,,,,,5.73E+04,1.13E+05,7.63E+04,1.66E+05,2.25E+04,1.56E+05,9.35E+03,2.55E+06,2.99E+04,,1.18E+05,1.93E+06,8.38E+02,4.29E+03,,2.11E+05,,,,,1.61E+03,1.20E+03,4.56E+02,7.41E+03,1.83E+02,2.10E+04,2.32E+02,4.96E+03,8.40E+03,,2.75E+03,2.05E+04,0,FALSE,12.851,7,4,725,82.1,6.37,4,other biological processes,cytoskeleton;nucleus;other cell component,Pf00225,,A0A6Q8PH57,ENSG00000068796,,,0,0,102.52,45.98,84.79,110.32,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,71.61,109.01,210.88,140.36,11.42,cytoskeletal activity;other molecular function,0,
Master Protein,High,P62913,RPL11,60S ribosomal protein L11 OS=Homo sapiens OX=9606 GN=RPL11 PE=1 SV=2,1,6,3.089,0.939,1.786,1.635,1.63,-0.09,0.84,0.71,2.17E-01,6.51E-01,5.08E-01,6.08E-01,3.25E+06,8.55E+05,3.16E+06,2.17E+06,4,2,5,5,5.06E+06,,1.28E+05,2.81E+06,3.75E+06,1.41E+06,,,,5.18E+05,4.10E+06,1.17E+06,1.69E+06,3.92E+06,3.16E+06,2.17E+06,2.31E+06,9.71E+05,2.40E+06,1.51E+06,2.01E+04,,1.25E+03,2.81E+06,1.93E+05,5.01E+03,,,,5.51E+03,2.45E+04,5.21E+04,1.37E+04,5.29E+05,7.84E+04,4.23E+03,6.49E+05,6.88E+03,5.61E+04,1.61E+04,0.002,FALSE,2.856,5,1,178,20.2,9.6,1,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,"Pf00281, Pf00673",6135,hsa:6135; P25121; P39026; P62913; Q8TDH2; Q9Y674,ENSG00000142676,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),MET in type 1 papillary renal cell carcinoma; Cytoplasmic ribosomal proteins,15,0,71.07,65.4,47.02,32.74,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,124.38,108.34,75.24,46.74,13.03,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UDW1,UQCR10,Cytochrome b-c1 complex subunit 9 OS=Homo sapiens OX=9606 GN=UQCR10 PE=1 SV=3,2,26,3.088,2.277,8.498,1.346,1.63,1.19,3.09,0.43,2.49E-01,7.19E-02,9.36E-03,7.34E-01,1.44E+06,2.53E+05,3.08E+06,4.03E+06,4,1,5,5,,3.45E+06,5.82E+05,1.18E+06,1.77E+06,2.53E+05,,,,,1.97E+06,2.03E+06,3.08E+06,4.97E+06,1.14E+07,4.03E+06,4.38E+06,4.60E+05,8.95E+06,2.83E+05,,1.31E+04,5.69E+03,1.18E+06,9.11E+04,9.00E+02,,,,,1.18E+04,9.07E+04,2.50E+04,6.70E+05,2.83E+05,7.86E+03,1.23E+06,3.26E+03,2.09E+05,3.01E+03,0,FALSE,8.938,38,2,63,7.3,9.47,2,other metabolic processes;transport,other membranes;mitochondrion,Pf05365,29796,B5MCM5; hsa:29796; Q9T2V6; Q9UDW1,ENSG00000184076,Respiratory electron transport,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,4,0,70.78,,84.11,97.91,n/a,High,Peak Found,High,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,81.98,106.41,87,107.95,59.15,transporter activity,0,
Master Protein,High,Q9UFN0,NIPSNAP3A,Protein NipSnap homolog 3A OS=Homo sapiens OX=9606 GN=NIPSNAP3A PE=1 SV=2,5,19,3.082,5.089,1.724,4.412,1.62,2.35,0.79,2.14,2.15E-01,3.22E-03,5.28E-01,1.64E-01,3.44E+06,4.01E+04,2.86E+06,2.04E+06,4,1,5,4,2.35E+07,6.60E+07,,5.04E+05,1.24E+05,,,,,4.01E+04,1.02E+05,2.86E+06,6.97E+06,2.37E+06,6.04E+06,,2.99E+05,3.05E+06,1.36E+06,4.33E+06,9.33E+04,2.51E+05,,5.04E+05,6.38E+03,,,,,4.27E+02,6.07E+02,1.28E+05,5.66E+04,3.19E+05,1.50E+05,,8.41E+04,2.16E+04,3.19E+04,4.61E+04,0,FALSE,20.809,31,5,247,28.4,9.16,5,,cytosol;mitochondrion,Pf07978,25934,A6NM55; hsa:25934; Q5VX32; Q9BRV7; Q9H843; Q9P083; Q9UFN0,ENSG00000136783,,,0,0,137.47,,76.58,78.99,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,High,High,High,High,n/a,Peak Found,High,High,High,1,,FALSE,38.84,146.59,41.87,138.72,48.39,,0,
Master Protein,High,P32519,ELF1,ETS-related transcription factor Elf-1 OS=Homo sapiens OX=9606 GN=ELF1 PE=1 SV=2,4,10,3.081,0.583,11.504,0.085,1.62,-0.78,3.52,-3.55,1.99E-01,8.28E-01,1.17E-02,5.02E-02,4.08E+05,1.78E+05,3.27E+05,1.40E+06,3,2,5,1,4.06E+05,,,1.02E+06,4.08E+05,,,1.32E+05,,2.40E+05,1.64E+05,7.05E+05,7.87E+05,2.69E+05,3.27E+05,,,,,1.40E+06,1.61E+03,,,1.02E+06,2.10E+04,,,1.22E+03,,2.55E+03,9.82E+02,3.15E+04,6.39E+03,3.63E+04,8.13E+03,,,,,1.49E+04,0,FALSE,25.113,13,4,619,67.5,5.21,4,other biological processes,nucleus;other cell component,"Pf00178, Pf12310",1997,B4E2I5; E9PDQ9; hsa:1997; P32519; Q8N6F6; Q9UDE1,ENSG00000120690,RUNX1 regulates transcription of genes involved in interleukin signaling; RUNX1 regulates transcription of genes involved in BCR signaling,,2,0,57.98,41.22,61.56,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,26.15,113.64,11.69,109.68,34.34,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P08621,SNRNP70,U1 small nuclear ribonucleoprotein 70 kDa OS=Homo sapiens OX=9606 GN=SNRNP70 PE=1 SV=2,4,21,3.044,0.202,1.877,0.302,1.61,-2.31,0.91,-1.73,2.61E-01,9.03E-02,5.28E-01,4.00E-01,7.80E+05,1.95E+05,2.81E+05,1.56E+06,5,2,4,4,5.56E+04,7.80E+05,1.03E+05,2.89E+06,5.03E+06,,1.32E+05,,2.90E+05,,2.81E+05,2.80E+05,,6.73E+05,1.70E+04,1.01E+06,3.86E+04,2.40E+06,,3.19E+06,2.21E+02,2.97E+03,1.01E+03,2.89E+06,2.60E+05,,2.34E+03,,8.16E+03,,1.68E+03,1.25E+04,,9.07E+04,4.22E+02,1.98E+03,1.09E+04,1.70E+04,,3.39E+04,0,FALSE,36.227,16,4,437,51.5,9.94,4,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00076, Pf12220",6625,B3KUA3; hsa:6625; P08621; P78493; P78494; Q15364; Q15686; Q15687; Q15689; Q99377; Q9UE45; Q9UE46; Q9UE47; Q9UE48; Q9UFQ6,ENSG00000104852,mRNA Splicing - Major Pathway,mRNA processing,2,0,121.64,53.05,86.46,84.66,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,133.27,77.11,88.78,118.85,75.63,nucleic acid binding activity,0,
Master Protein,High,O94888,UBXN7,UBX domain-containing protein 7 OS=Homo sapiens OX=9606 GN=UBXN7 PE=1 SV=2,1,1,3.038,0.01,0.779,0.01,1.6,-6.64,-0.36,-6.64,2.55E-01,1.00E-17,8.13E-01,1.00E-17,7.56E+04,2.49E+04,,1.94E+04,2,1,,2,,,,9.67E+04,5.92E+04,,,,,2.49E+04,,,,,,,1.04E+04,,3.62E+04,,,,,9.67E+04,3.05E+03,,,,,2.65E+02,,,,,,,2.92E+03,,8.47E+02,,0.004,FALSE,2.619,3,1,489,54.8,5.16,1,protein metabolism;other metabolic processes,other membranes;cytosol;ER/Golgi;nucleus,"Pf00789, Pf13899, Pf14555",26043,D3DXB3; hsa:26043; O94888; Q6ZP77; Q86X20; Q8N327,ENSG00000163960,Neddylation; KEAP1-NFE2L2 pathway,3q29 copy number variation syndrome,3,0,34.09,,,78.31,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,36.82,,98.6,,3.56,other molecular function,0,
Master Protein,High,Q92922,SMARCC1,SWI/SNF complex subunit SMARCC1 OS=Homo sapiens OX=9606 GN=SMARCC1 PE=1 SV=3,15,40,3.036,1.046,0.558,8.499,1.6,0.06,-0.84,3.09,2.77E-01,4.42E-01,5.05E-01,3.80E-02,8.72E+05,2.91E+05,1.36E+06,1.92E+05,2,1,5,2,,,2.39E+05,3.18E+06,,,,,,2.91E+05,1.01E+06,1.36E+06,1.27E+06,5.36E+06,3.22E+06,,1.74E+05,,2.13E+05,,,,2.34E+03,3.18E+06,,,,,,3.10E+03,6.06E+03,6.09E+04,1.03E+04,7.22E+05,7.99E+04,,4.88E+04,,4.99E+03,,0,FALSE,62.728,21,7,1105,122.8,5.76,15,cell organization and biogenesis;developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf00249, Pf04433, Pf16495, Pf16496, Pf16498",6599,hsa:6599; Q17RS0; Q6P172; Q8IWH2; Q92922,ENSG00000173473,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,Androgen receptor network in prostate cancer; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome,6,0,121.6,,75.65,14.46,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,0,89.92,29.73,114.03,123.49,other molecular function,0,
Master Protein,High,Q9UIJ7,AK3,"GTP:AMP phosphotransferase AK3, mitochondrial OS=Homo sapiens OX=9606 GN=AK3 PE=1 SV=4",4,15,3.034,1.033,3.02,0.938,1.6,0.05,1.59,-0.09,2.42E-01,4.82E-01,3.07E-01,8.89E-01,1.58E+06,2.60E+05,1.18E+06,8.82E+05,3,2,5,5,3.02E+05,,,1.58E+06,1.81E+06,3.49E+05,,1.94E+05,,,1.77E+05,1.61E+06,1.46E+06,1.11E+06,1.18E+06,3.17E+06,2.18E+05,8.82E+05,2.26E+05,1.39E+06,1.20E+03,,,1.58E+06,9.31E+04,1.24E+03,,1.79E+03,,,1.06E+03,7.21E+04,1.19E+04,1.50E+05,2.93E+04,6.17E+03,6.13E+04,6.25E+03,5.29E+03,1.48E+04,0,FALSE,17.525,25,4,227,25.6,9.16,4,other metabolic processes;stress response,mitochondrion;other cell component,"Pf00406, Pf05191",50808,B4DP58; D3DRI1; E7ET30; hsa:50808; Q5VYW6; Q9H576; Q9HC01; Q9NPB4; Q9UIJ7,ENSG00000147853,Factors involved in megakaryocyte development and platelet production,,1,0,65.98,40.21,50.47,103.41,Peak Found,n/a,n/a,High,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,62.15,90.49,39.18,104.26,39.98,kinase activity;other molecular function,0,
Master Protein,High,O00422,SAP18,Histone deacetylase complex subunit SAP18 OS=Homo sapiens OX=9606 GN=SAP18 PE=1 SV=1,4,6,3.02,0.133,1.955,0.319,1.59,-2.91,0.97,-1.65,2.22E-01,3.91E-02,6.22E-01,4.60E-01,5.92E+05,1.80E+05,7.22E+04,1.53E+05,5,3,5,5,3.81E+05,1.38E+06,3.82E+05,1.44E+06,5.92E+05,2.11E+05,,,1.80E+05,5.79E+04,4.21E+05,5.15E+04,7.22E+04,1.48E+05,1.04E+04,1.53E+05,1.74E+04,8.38E+05,5.07E+04,3.60E+05,1.51E+03,5.26E+03,3.73E+03,1.44E+06,3.05E+04,7.50E+02,,,5.08E+03,6.16E+02,2.52E+03,2.30E+03,5.87E+02,1.99E+04,2.60E+02,2.98E+02,4.88E+03,5.94E+03,1.19E+03,3.83E+03,0,FALSE,21.439,26,4,153,17.6,9.35,4,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf06487,10284,B2R494; hsa:10284; O00422; Q2TTR4; Q6IAW9; Q8N606; Q9UF14; X6RAL5,ENSG00000150459,Potential therapeutics for SARS; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; mRNA Splicing - Major Pathway,Hedgehog signaling pathway,5,0,63.77,54.08,117.01,118.92,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,74.58,135.65,126.73,134.01,18.75,other molecular function,0,
Master Protein,High,Q9H6R4,NOL6,Nucleolar protein 6 OS=Homo sapiens OX=9606 GN=NOL6 PE=1 SV=2,2,5,3.01,0.837,1.009,2.287,1.59,-0.26,0.01,1.19,2.62E-01,8.29E-01,9.85E-01,3.91E-01,8.80E+04,1.91E+04,2.02E+05,1.93E+04,3,2,5,1,,8.80E+04,,2.60E+05,1.67E+04,,2.78E+04,,1.31E+04,,1.54E+06,1.43E+05,1.86E+05,2.15E+05,2.02E+05,,,,1.93E+04,,,3.34E+02,,2.60E+05,8.60E+02,,4.94E+02,,3.69E+02,,9.24E+03,6.40E+03,1.51E+03,2.90E+04,5.02E+03,,,,4.51E+02,,0,FALSE,9.243,2,2,1146,127.5,7.64,2,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,mitochondrion;nucleus;other cell component,"Pf03813, Pf17403, Pf17404, Pf17405, Pf17406, Pf17407",65083,hsa:65083; Q5T5M3; Q5T5M4; Q7L4G6; Q8N6I0; Q8TEY9; Q8TEZ0; Q8TEZ1; Q9H675; Q9H6R4,ENSG00000165271,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,102.88,50.86,132.67,,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,102.14,93.86,57.14,36.74,12.78,,0,
Master Protein,High,Q9H488,POFUT1,GDP-fucose protein O-fucosyltransferase 1 OS=Homo sapiens OX=9606 GN=POFUT1 PE=1 SV=1,1,11,3.008,2.545,3.29,2.434,1.59,1.35,1.72,1.28,2.61E-01,9.48E-02,3.50E-01,2.54E-01,1.56E+05,5.20E+04,4.40E+05,1.54E+05,4,2,5,4,,8.05E+04,7.77E+04,3.04E+05,1.13E+06,7.85E+04,,,,3.45E+04,8.73E+05,2.01E+05,5.87E+05,4.40E+05,3.20E+05,1.09E+05,2.01E+05,1.18E+05,5.79E+05,,,3.06E+02,7.59E+02,3.04E+05,5.83E+04,2.79E+02,,,,3.67E+02,5.22E+03,8.99E+03,4.77E+03,5.94E+04,7.96E+03,2.12E+02,5.65E+04,8.40E+02,1.36E+04,,0,FALSE,8.63,4,1,388,43.9,8.53,1,protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,other membranes;ER/Golgi,Pf10250,23509,A8K4R8; E1P5M4; hsa:23509; Q14685; Q5W185; Q9BW76; Q9H488,ENSG00000101346,Pre-NOTCH Processing in the Endoplasmic Reticulum,,1,0,125.45,55.09,53.68,88.21,n/a,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,n/a,1,,FALSE,98.6,113.87,83.06,86.9,32.45,other molecular function,0,
Master Protein,High,P53999,SUB1,Activated RNA polymerase II transcriptional coactivator p15 OS=Homo sapiens OX=9606 GN=SUB1 PE=1 SV=3,7,27,2.995,0.166,1.873,0.27,1.58,-2.59,0.91,-1.89,2.39E-01,3.38E-02,5.82E-01,3.47E-01,4.01E+06,3.16E+05,6.12E+05,1.14E+06,4,4,4,5,,2.90E+06,8.12E+05,2.90E+07,5.54E+06,,2.74E+05,3.64E+05,8.22E+04,2.32E+06,,1.41E+05,7.08E+05,5.76E+06,5.29E+05,1.14E+06,2.16E+05,4.41E+06,1.65E+05,2.22E+06,,1.10E+04,7.93E+03,2.90E+07,2.86E+05,,4.88E+03,3.35E+03,2.32E+03,2.47E+04,,6.28E+03,5.75E+03,7.77E+05,1.31E+04,2.22E+03,6.07E+04,3.13E+04,3.85E+03,2.36E+04,0,FALSE,32.846,38,7,127,14.4,9.6,7,RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,nucleus;other cell component,Pf02229,10923,hsa:10923; P53999; Q96L29,ENSG00000113387,,,0,0,136.9,137.75,149.16,108.35,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,115.87,117.44,109.49,134.34,80.36,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BPW8,NIPSNAP1,Protein NipSnap homolog 1 OS=Homo sapiens OX=9606 GN=NIPSNAP1 PE=1 SV=1,4,14,2.992,0.685,3.771,1.33,1.58,-0.55,1.92,0.41,2.46E-01,9.33E-01,2.06E-01,6.39E-01,1.69E+06,5.48E+05,1.64E+06,4.68E+05,4,5,5,5,7.86E+05,1.13E+06,,5.70E+06,2.54E+06,1.24E+06,1.35E+05,5.48E+05,7.52E+05,2.68E+05,1.64E+06,2.86E+06,1.30E+06,4.51E+06,1.26E+06,2.20E+06,6.97E+04,6.73E+06,4.68E+05,4.50E+05,3.12E+03,4.28E+03,,5.70E+06,1.31E+05,4.42E+03,2.40E+03,5.06E+03,2.12E+04,2.85E+03,9.82E+03,1.28E+05,1.06E+04,6.07E+05,3.14E+04,4.29E+03,1.96E+04,4.77E+04,1.09E+04,4.79E+03,0,FALSE,18.21,20,4,284,33.3,9.31,4,other biological processes,plasma membrane;other membranes;mitochondrion,Pf07978,8508,B2RAY3; hsa:8508; O43800; Q9BPW8,ENSG00000184117,,,0,0,88.3,74.21,59.89,140.09,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,115.65,113.53,91.57,136.83,46.34,,0,
Master Protein,High,K7ER00,FARSA,Phenylalanine--tRNA ligase alpha subunit OS=Homo sapiens OX=9606 GN=FARSA PE=1 SV=1,2,15,2.992,0.594,3.112,0.552,1.58,-0.75,1.64,-0.86,2.56E-01,9.05E-01,2.43E-01,7.46E-01,1.26E+06,3.88E+05,7.47E+05,1.35E+06,5,2,5,5,3.51E+06,6.45E+05,1.26E+06,7.98E+04,1.93E+06,2.89E+05,,,,5.21E+05,1.64E+06,1.25E+05,7.47E+05,5.77E+05,8.46E+05,3.83E+05,1.35E+06,1.40E+06,1.33E+06,1.88E+06,1.40E+04,2.45E+03,1.23E+04,7.98E+04,9.96E+04,1.03E+03,,,,5.54E+03,9.81E+03,5.57E+03,6.07E+03,7.77E+04,2.10E+04,7.47E+02,3.80E+05,9.89E+03,3.11E+04,2.00E+04,0,FALSE,9.307,8,2,548,62.4,7.84,2,protein metabolism;RNA metabolism OR transcription;other metabolic processes,other cell component,"Pf01409, Pf18552, Pf18553, Pf18554",,K7ER00,ENSG00000179115,,,0,0,89.38,40.59,70.06,42.96,High,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,110.74,113.66,73.17,78.59,47.82,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P17858,PFKL,"ATP-dependent 6-phosphofructokinase, liver type OS=Homo sapiens OX=9606 GN=PFKL PE=1 SV=6",5,21,2.979,0.25,0.232,3.821,1.57,-2,-2.11,1.93,2.75E-01,1.57E-01,1.22E-01,1.09E-01,7.93E+05,2.08E+05,3.40E+05,2.53E+05,5,4,5,3,9.02E+06,7.93E+05,2.48E+06,4.21E+05,9.73E+03,1.24E+06,5.75E+04,1.74E+05,,2.49E+05,3.40E+05,3.78E+05,1.33E+05,4.83E+05,2.62E+05,,2.87E+05,3.74E+04,2.53E+05,,3.58E+04,3.01E+03,2.43E+04,4.21E+05,5.02E+02,4.39E+03,1.02E+03,1.61E+03,,2.64E+03,2.03E+03,1.69E+04,1.08E+03,6.50E+04,6.52E+03,,8.07E+04,2.65E+02,5.93E+03,,0,FALSE,21.764,10,5,780,85,7.5,5,other metabolic processes;other biological processes,non-structural extracellular;cytosol;other cell component,Pf00365,5211,hsa:5211; P17858; Q96A64; Q96IH4; Q9BR91,ENSG00000141959,Neutrophil degranulation; Glycolysis,Photodynamic therapy-induced HIF-1 survival signaling; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Insulin signaling; Disorders of fructose metabolism; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,9,0,146.93,126.71,40.94,70.34,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,High,n/a,1,,FALSE,139.84,138.28,129.64,125.85,52.54,kinase activity;other molecular function,0,
Master Protein,High,P31944,CASP14,Caspase-14 OS=Homo sapiens OX=9606 GN=CASP14 PE=1 SV=2,1,3,2.976,0.264,0.458,1.713,1.57,-1.92,-1.13,0.78,2.29E-01,1.60E-01,3.40E-01,5.06E-01,2.81E+06,9.43E+05,7.40E+05,4.32E+05,1,1,1,3,,2.81E+06,,,,,9.43E+05,,,,7.40E+05,,,,,4.32E+05,,4.22E+05,,6.66E+05,,1.07E+04,,,,,1.68E+04,,,,4.43E+03,,,,,8.43E+02,,2.99E+03,,7.09E+03,0.001,FALSE,3.815,6,1,242,27.7,5.58,1,protein metabolism;other biological processes,plasma membrane;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component,Pf00656,23581,O95823; P31944; Q3SYC9,ENSG00000105141,Formation of the cornified envelope,Vitamin D receptor pathway,2,0,,,,27.25,n/a,High,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,1,,FALSE,0,0,3.64,3.64,8.62,other molecular function,0,
Master Protein,High,P35443,THBS4,Thrombospondin-4 OS=Homo sapiens OX=9606 GN=THBS4 PE=1 SV=2,1,1,2.974,0.01,4.631,0.01,1.57,-6.64,2.21,-6.64,2.44E-01,1.00E-17,2.05E-01,1.00E-17,4.32E+04,1.64E+04,,7.61E+04,3,2,,1,,6.30E+04,,3.79E+04,4.32E+04,,2.63E+04,,1.03E+04,,,,,,,,,,7.61E+04,,,2.40E+02,,3.79E+04,2.23E+03,,4.67E+02,,2.90E+02,,,,,,,,,,1.78E+03,,0,FALSE,5.252,1,1,961,105.8,4.68,1,cell adhesion;stress response;signal transduction;other biological processes,non-structural extracellular;extracellular matrix;cytosol;ER/Golgi,"Pf00008, Pf02412, Pf05735, Pf11598",7060,B2R909; hsa:7060; P35443; Q86TG2,ENSG00000113296,Signaling by PDGF,Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway,4,0,27.58,61.91,,,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,63.8,,72.19,,3.69,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q96SB8,SMC6,Structural maintenance of chromosomes protein 6 OS=Homo sapiens OX=9606 GN=SMC6 PE=1 SV=2,5,8,2.973,0.895,1.334,2.501,1.57,-0.16,0.42,1.32,2.21E-01,7.33E-01,8.50E-01,3.18E-01,3.10E+05,5.35E+04,3.61E+05,7.14E+04,2,1,5,2,,,,6.92E+05,1.38E+05,5.35E+04,,,,,4.81E+04,1.46E+05,3.61E+05,1.50E+06,1.49E+06,,,,4.48E+04,1.14E+05,,,,6.92E+05,7.14E+03,1.90E+02,,,,,2.87E+02,6.51E+03,2.93E+03,2.02E+05,3.71E+04,,,,1.05E+03,1.21E+03,0,FALSE,16.258,6,5,1091,126.2,6.99,5,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,cytoskeleton;nucleus;other cell component,Pf13476,79677,A8K8Q6; D6W518; hsa:79677; Q05BV4; Q96SB8; Q9H0X3; Q9H6M0,ENSG00000163029,SUMOylation of DNA damage response and repair proteins,,1,0,94.3,,102.49,61.48,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,37.88,91.35,71.57,54.84,20.42,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A994J6W3,SPTAN1,"Spectrin alpha, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=4 SV=1",67,205,2.97,0.325,1.091,1.275,1.57,-1.62,0.13,0.35,2.63E-01,2.64E-01,9.83E-01,7.70E-01,5.09E+07,5.88E+06,5.38E+06,9.63E+06,5,5,5,5,5.09E+07,5.70E+07,1.08E+08,2.08E+07,4.09E+07,1.73E+07,2.05E+06,1.04E+07,4.43E+06,5.88E+06,6.91E+07,3.33E+06,5.38E+06,1.60E+07,3.77E+06,1.46E+07,1.58E+06,1.23E+07,3.13E+06,9.63E+06,2.02E+05,2.17E+05,1.05E+06,2.08E+07,2.11E+06,6.15E+04,3.65E+04,9.56E+04,1.25E+05,6.25E+04,4.13E+05,1.49E+05,4.37E+04,2.16E+06,9.36E+04,2.85E+04,4.43E+05,8.70E+04,7.32E+04,1.03E+05,0,FALSE,315.34,37,1,2506,288.1,5.39,67,cell organization and biogenesis,cytoskeleton;other cell component,,,A0A994J6W3,ENSG00000197694,,,0,59,58.26,75.12,144.46,69.02,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,114.92,118.33,120.19,131.65,572.64,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q14980,NUMA1,Nuclear mitotic apparatus protein 1 OS=Homo sapiens OX=9606 GN=NUMA1 PE=1 SV=2,107,542,2.968,0.712,1.886,3.03,1.57,-0.49,0.92,1.6,2.63E-01,9.65E-01,4.98E-01,2.89E-01,4.06E+07,8.39E+06,8.10E+07,3.17E+07,5,5,5,5,4.06E+07,1.43E+07,3.09E+07,1.48E+08,1.20E+08,1.45E+07,4.62E+06,8.39E+06,2.31E+06,3.35E+07,9.88E+07,4.27E+07,6.45E+07,9.11E+07,8.10E+07,3.99E+07,3.37E+06,3.17E+07,8.30E+06,8.50E+07,1.61E+05,5.43E+04,3.02E+05,1.48E+08,6.20E+06,5.17E+04,8.22E+04,7.74E+04,6.51E+04,3.57E+05,5.91E+05,1.91E+06,5.24E+05,1.23E+07,2.01E+06,7.78E+04,9.48E+05,2.25E+05,1.94E+05,9.04E+05,0,FALSE,587.038,60,60,2115,238.1,5.78,107,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf21670,4926,H0YH75; hsa:4926; Q14980; Q14981; Q9BTE9,ENSG00000137497,Recruitment of NuMA to mitotic centrosomes; Mitotic Prophase,Ectoderm differentiation; Ectoderm differentiation; 8p23.1 copy number variation syndrome,5,40,83.9,98.91,29.65,96.69,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,130.72,117.06,127.41,137.82,1585.83,cytoskeletal activity;other molecular function,0,
Master Protein,High,P17026,ZNF22,Zinc finger protein 22 OS=Homo sapiens OX=9606 GN=ZNF22 PE=1 SV=3,2,7,2.965,1.011,4.001,2.106,1.57,0.02,2,1.07,2.34E-01,5.02E-01,2.11E-01,4.00E-01,6.29E+05,1.33E+05,2.33E+06,3.85E+05,3,4,5,5,,6.29E+05,,4.88E+06,4.24E+05,1.94E+05,4.50E+05,9.12E+04,,4.03E+04,4.52E+05,1.25E+06,2.33E+06,2.78E+06,2.89E+06,9.11E+05,1.61E+05,1.28E+06,8.16E+04,3.85E+05,,2.39E+03,,4.88E+06,2.19E+04,6.89E+02,8.00E+03,8.41E+02,,4.29E+02,2.70E+03,5.57E+04,1.89E+04,3.75E+05,7.19E+04,1.78E+03,4.53E+04,9.08E+03,1.91E+03,4.10E+03,0,FALSE,7.639,11,2,224,25.9,10.04,2,other biological processes,nucleus,Pf00096,7570,hsa:7570; P17026; Q5T741; Q96FM4,ENSG00000165512,,,0,0,127.14,94.06,54.44,91.31,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,82.88,103.74,82.66,106.79,19.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P16402,H1-3,Histone H1.3 OS=Homo sapiens OX=9606 GN=H1-3 PE=1 SV=2,21,718,2.959,0.207,0.559,2.081,1.57,-2.27,-0.84,1.06,2.65E-01,7.55E-02,3.82E-01,4.23E-01,1.77E+07,6.65E+06,3.84E+06,3.19E+05,5,5,5,5,3.18E+06,6.85E+07,1.03E+07,1.77E+07,8.61E+07,1.52E+05,6.65E+06,2.66E+07,3.49E+06,2.25E+08,3.91E+05,3.84E+06,3.50E+05,4.15E+06,7.60E+06,1.42E+05,9.62E+04,3.19E+05,2.97E+06,8.07E+07,1.27E+04,2.60E+05,1.01E+05,1.77E+07,4.44E+06,5.41E+02,1.18E+05,2.46E+05,9.83E+04,2.39E+06,2.34E+03,1.71E+05,2.84E+03,5.59E+05,1.89E+05,2.77E+02,2.70E+04,2.26E+03,6.95E+04,8.59E+05,0,FALSE,119.228,50,4,221,22.3,11.02,21,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf00538,3007,B2R751; hsa:3007; P16402; Q2M2I2,ENSG00000124575,Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF),,2,0,100.91,185.2,92.69,212.03,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,141.62,132.45,145.28,147.5,1789.23,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y2U8,LEMD3,Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,5,6,2.955,0.045,0.374,0.321,1.56,-4.47,-1.42,-1.64,2.52E-01,1.13E-03,3.67E-01,4.55E-01,2.72E+05,3.65E+04,4.38E+03,1.36E+04,2,3,1,1,,2.00E+05,,3.71E+05,,,,3.65E+04,1.48E+04,7.29E+04,,4.38E+03,,,,,,,1.36E+04,,,7.58E+02,,3.71E+05,,,,3.37E+02,4.18E+02,7.75E+02,,1.96E+02,,,,,,,3.19E+02,,0,FALSE,24.523,11,5,911,99.9,7.55,5,other biological processes,other membranes;nucleus,"Pf03020, Pf09402",23592,hsa:23592; Q9NT47; Q9NYA5; Q9Y2U8,ENSG00000174106,RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RND2 GTPase cycle; RHOG GTPase cycle; RHOD GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina,Envelope proteins and their potential roles in EDMD physiopathology,12,0,42.48,70.82,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,99.4,116.08,87.91,0,24.37,nucleic acid binding activity;other molecular function,0,
Master Protein,High,C9JSZ1,FUBP1,Far upstream element binding protein 1 OS=Homo sapiens OX=9606 GN=FUBP1 PE=1 SV=2,11,31,2.941,0.334,1.49,1.865,1.56,-1.58,0.58,0.9,2.68E-01,2.82E-01,7.86E-01,4.55E-01,5.15E+06,5.59E+05,7.78E+05,6.40E+05,5,3,5,5,4.99E+05,7.12E+06,2.85E+06,5.15E+06,8.48E+06,2.74E+06,,,1.28E+05,5.59E+05,4.74E+05,7.78E+05,1.29E+05,4.07E+06,1.26E+06,6.40E+05,8.13E+04,5.04E+06,8.96E+03,3.93E+06,1.98E+03,2.71E+04,2.78E+04,5.15E+06,4.37E+05,9.75E+03,,,3.61E+03,5.95E+03,2.84E+03,3.48E+04,1.05E+03,5.48E+05,3.13E+04,1.25E+03,2.29E+04,3.57E+04,2.10E+02,4.18E+04,0,FALSE,44.433,24,9,687,72,7.59,11,other biological processes,nucleus,Pf00013,,C9JSZ1,ENSG00000162613,,,0,2,66.71,122.59,117.65,122.12,Peak Found,Peak Found,Peak Found,High,High,High,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,114.71,132.32,118.84,136.07,84.9,nucleic acid binding activity,0,
Master Protein,High,P55795,HNRNPH2,Heterogeneous nuclear ribonucleoprotein H2 OS=Homo sapiens OX=9606 GN=HNRNPH2 PE=1 SV=1,6,17,2.922,0.184,0.01,100,1.55,-2.44,-6.64,6.64,2.56E-01,1.17E-01,1.00E-17,1.00E-17,2.57E+05,8.78E+04,4.73E+04,,1,1,2,,,,,2.57E+05,,,8.78E+04,,,,,2.23E+04,,1.00E+05,,,,,,,,,,2.57E+05,,,1.56E+03,,,,,9.95E+02,,1.35E+04,,,,,,,0,FALSE,28.556,22,3,449,49.2,6.3,6,other biological processes,cytosol;nucleus;other cell component,"Pf00076, Pf08080",3188,A1L400; P55795; Q9HHA7,ENSG00000126945,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,mRNA processing,3,0,,,90.07,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,122.47,,,57.31,,0,
Master Protein,High,P78316,NOP14,Nucleolar protein 14 OS=Homo sapiens OX=9606 GN=NOP14 PE=1 SV=3,5,6,2.917,0.42,3.944,0.167,1.54,-1.25,1.98,-2.58,2.28E-01,5.30E-01,2.19E-01,1.51E-01,5.50E+05,5.62E+04,6.59E+04,3.94E+05,2,5,3,5,,,,4.72E+05,6.41E+05,6.33E+05,5.62E+04,3.12E+04,2.42E+05,4.20E+04,,4.87E+04,1.91E+06,6.59E+04,,1.66E+05,3.29E+05,4.27E+06,5.76E+06,3.94E+05,,,,4.72E+05,3.31E+04,2.25E+03,1.00E+03,2.88E+02,6.81E+03,4.46E+02,,2.18E+03,1.55E+04,8.88E+03,,3.23E+02,9.23E+04,3.03E+04,1.35E+05,4.19E+03,0,FALSE,18.403,7,5,857,97.6,7.58,5,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf04147,8602,D3DVR6; hsa:8602; P78316; Q7LGI5; Q7Z6K0; Q8TBR6,ENSG00000087269,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,21.56,127.72,158.51,120.86,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,82.03,49.74,139.82,108.55,17.82,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P14923,JUP,Junction plakoglobin OS=Homo sapiens OX=9606 GN=JUP PE=1 SV=3,3,20,2.911,0.509,0.567,1.882,1.54,-0.97,-0.82,0.91,2.55E-01,7.40E-01,5.77E-01,4.20E-01,1.36E+06,8.37E+04,6.44E+04,4.74E+04,5,4,5,2,2.21E+06,1.36E+06,1.69E+06,5.41E+04,2.88E+04,7.69E+05,,3.72E+04,1.84E+04,1.88E+05,3.41E+07,2.75E+04,1.77E+05,6.44E+04,3.60E+04,,1.35E+05,,1.67E+04,,8.80E+03,5.18E+03,1.65E+04,5.41E+04,1.49E+03,2.73E+03,,3.44E+02,5.18E+02,2.00E+03,2.04E+05,1.23E+03,1.44E+03,8.67E+03,8.95E+02,,3.78E+04,,3.92E+02,,0,FALSE,17.951,6,3,745,81.7,6.14,3,cell adhesion;cell-cell signaling;cell organization and biogenesis;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf00514,3728,hsa:3728; P14923; Q15093; Q15151; Q7L3S5; Q86W21; Q9BWC4; Q9HCX9,ENSG00000173801,RHOC GTPase cycle; Formation of the cornified envelope; RHOA GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle; Neutrophil degranulation; VEGFR2 mediated vascular permeability; Adherens junctions interactions; Regulation of CDH11 function; Regulation of CDH19 Expression and Function; CDH11 homotypic and heterotypic interactions; RHOH GTPase cycle,Arrhythmogenic right ventricular cardiomyopathy; Corticotropin-releasing hormone signaling pathway; Ectoderm differentiation; Ectoderm differentiation; Epithelial to mesenchymal transition in colorectal cancer; Opioid receptor pathways; Acute myeloid leukemia,22,0,92.24,139.08,221.13,110.12,High,High,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,142.57,147.76,130.89,129.65,35.16,other molecular function,0,
Master Protein,High,P62851,RPS25,40S ribosomal protein S25 OS=Homo sapiens OX=9606 GN=RPS25 PE=1 SV=1,5,22,2.909,0.427,0.444,1.715,1.54,-1.23,-1.17,0.78,2.45E-01,4.77E-01,2.61E-01,5.79E-01,2.56E+06,6.19E+05,6.13E+06,2.22E+06,4,2,5,2,7.46E+05,1.62E+06,,1.97E+07,4.06E+06,,7.69E+05,4.98E+05,,,1.54E+06,1.75E+07,4.29E+06,6.13E+06,1.11E+07,,2.27E+06,,2.18E+06,,2.97E+03,6.15E+03,,1.97E+07,2.09E+05,,1.37E+04,4.60E+03,,,9.21E+03,7.82E+05,3.49E+04,8.26E+05,2.75E+05,,6.39E+05,,5.09E+04,,0,FALSE,12.29,26,5,125,13.7,10.11,5,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf03297,6230,B2R4M7; hsa:6230; P25111; P62851,ENSG00000118181; ENSG00000280831,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,136.23,30.23,77.68,3.15,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,High,High,High,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,29.15,80.06,68.62,84.15,46.99,other molecular function,0,
Master Protein,High,H3BPK7,AARS1,Alanine--tRNA ligase OS=Homo sapiens OX=9606 GN=AARS1 PE=1 SV=4,5,8,2.874,0.203,0.334,0.401,1.52,-2.3,-1.58,-1.32,2.34E-01,1.41E-01,2.74E-01,5.73E-01,2.26E+05,2.13E+05,3.92E+04,1.55E+05,5,3,4,2,2.26E+05,1.42E+06,4.54E+04,5.09E+04,7.34E+05,,7.52E+05,2.13E+05,1.89E+04,,,2.81E+04,2.44E+04,1.61E+05,5.47E+04,,6.71E+05,3.56E+04,,,8.98E+02,5.41E+03,4.43E+02,5.09E+04,3.79E+04,,1.34E+04,1.96E+03,5.34E+02,,,1.25E+03,1.99E+02,2.17E+04,1.36E+03,,1.88E+05,2.53E+02,,,0,FALSE,16.741,7,5,999,110.1,5.67,5,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol,"Pf01411, Pf02272, Pf07973",,H3BPK7,ENSG00000090861,,,0,0,118.95,115.81,95.65,127.15,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,140.24,129.7,0,106.51,24.73,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P62241,RPS8,40S ribosomal protein S8 OS=Homo sapiens OX=9606 GN=RPS8 PE=1 SV=2,4,26,2.874,0.713,2.361,0.813,1.52,-0.49,1.24,-0.3,2.55E-01,8.59E-01,3.35E-01,9.99E-01,1.25E+06,3.05E+06,8.05E+05,1.43E+06,5,4,4,5,7.25E+05,1.25E+06,1.23E+06,2.26E+06,1.50E+06,1.01E+05,2.31E+06,7.82E+06,,4.04E+06,4.51E+05,1.51E+06,,1.26E+06,5.16E+05,1.43E+06,1.27E+06,1.51E+06,8.88E+05,2.71E+06,2.88E+03,4.75E+03,1.20E+04,2.26E+06,7.75E+04,3.61E+02,4.11E+04,7.22E+04,,4.30E+04,2.70E+03,6.74E+04,,1.69E+05,1.28E+04,2.79E+03,3.58E+05,1.07E+04,2.08E+04,2.88E+04,0,FALSE,14.614,24,4,208,24.2,10.32,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf01201,6202,hsa:6202; P09058; P62241; Q6IRL7,ENSG00000142937,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,40.32,91.41,56.8,43.82,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,102.61,60.31,91,93.6,59.11,other molecular function,0,
Master Protein,High,Q9P0L0,VAPA,Vesicle-associated membrane protein-associated protein A OS=Homo sapiens OX=9606 GN=VAPA PE=1 SV=3,6,40,2.869,0.831,3.804,1.253,1.52,-0.27,1.93,0.33,2.95E-01,7.75E-01,2.06E-01,7.63E-01,1.03E+06,5.32E+04,3.44E+06,8.63E+05,4,2,5,2,1.20E+06,,1.30E+05,6.77E+06,8.88E+05,,3.67E+04,,7.69E+04,,3.44E+06,7.85E+06,8.18E+05,3.62E+06,2.54E+06,,1.10E+06,6.78E+05,,,4.75E+03,,1.27E+03,6.77E+06,4.58E+04,,6.53E+02,,2.17E+03,,2.06E+04,3.51E+05,6.65E+03,4.88E+05,6.32E+04,,3.09E+05,4.81E+03,,,0,FALSE,42.543,41,6,249,27.9,8.62,6,cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf00635,9218,A6NDZ0; D3DUI3; hsa:9218; O75453; Q5U0E7; Q9P0L0; Q9UBZ2,ENSG00000101558,Neutrophil degranulation; Sphingolipid de novo biosynthesis; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,Exercise-induced circadian regulation; Cholesterol metabolism,5,0,135.72,49.98,70.96,33.42,High,n/a,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,High,n/a,High,Peak Found,n/a,n/a,1,,FALSE,163.58,123.01,46.63,133.53,120.05,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q3ZCQ8,TIMM50,Mitochondrial import inner membrane translocase subunit TIM50 OS=Homo sapiens OX=9606 GN=TIMM50 PE=1 SV=2,3,16,2.858,1.616,1.762,3.069,1.52,0.69,0.82,1.62,2.69E-01,2.10E-01,6.35E-01,2.84E-01,1.79E+06,3.07E+05,5.01E+06,1.08E+06,4,2,5,3,7.69E+06,,3.49E+06,9.16E+05,4.44E+05,,1.60E+05,5.90E+05,,,7.57E+06,4.41E+05,5.01E+06,3.57E+06,5.38E+06,,1.70E+06,2.72E+05,1.08E+06,,3.06E+04,,3.41E+04,9.16E+05,2.29E+04,,2.85E+03,5.44E+03,,,4.53E+04,1.97E+04,4.07E+04,4.81E+05,1.34E+05,,4.76E+05,1.93E+03,2.52E+04,,0,FALSE,10.957,12,3,353,39.6,8.37,3,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;signal transduction,other membranes;mitochondrion;nucleus,Pf03031,92609,hsa:92609; Q330K1; Q3ZCQ8; Q6QA00; Q96FJ5; Q96GY2; Q9H370,ENSG00000105197,Mitochondrial protein import,,1,0,105.88,80.98,59.93,70.31,Peak Found,n/a,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,94.22,101.88,12.23,58.21,39.48,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P51649,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH5A1 PE=1 SV=2",3,11,2.857,0.492,2.256,0.684,1.51,-1.02,1.17,-0.55,2.29E-01,6.77E-01,5.33E-01,8.65E-01,4.48E+05,4.29E+04,7.59E+05,9.67E+04,4,2,5,1,9.92E+04,1.24E+06,1.62E+05,3.04E+06,,,3.92E+04,,,4.69E+04,2.70E+05,3.05E+06,7.06E+05,7.99E+05,7.59E+05,,,,,9.67E+04,3.94E+02,4.70E+03,1.59E+03,3.04E+06,,,6.97E+02,,,4.99E+02,1.61E+03,1.36E+05,5.74E+03,1.08E+05,1.89E+04,,,,,1.03E+03,0,FALSE,11.566,7,3,535,57.2,8.28,3,cell-cell signaling;other metabolic processes;developmental processes,mitochondrion;other cell component,Pf00171,7915,B2RD26; G5E949; hsa:7915; P51649; Q546H9; Q8N3W6,ENSG00000112294,Degradation of GABA,Fragile X syndrome,2,0,120.97,12.71,98.67,,Peak Found,Peak Found,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,24.09,113.83,13.38,261.71,33.46,other molecular function,0,
Master Protein,High,Q15424,SAFB,Scaffold attachment factor B1 OS=Homo sapiens OX=9606 GN=SAFB PE=1 SV=4,12,38,2.856,0.205,0.348,1.691,1.51,-2.29,-1.52,0.76,2.82E-01,7.25E-02,1.62E-01,5.19E-01,1.39E+07,5.68E+05,1.22E+06,2.21E+06,3,5,5,5,,1.97E+06,,1.39E+07,1.40E+07,5.68E+05,4.55E+05,1.59E+06,4.37E+05,8.47E+06,8.46E+05,2.33E+06,1.79E+05,1.12E+07,1.22E+06,2.21E+06,7.76E+05,4.12E+06,2.52E+05,4.44E+06,,7.48E+03,,1.39E+07,7.21E+05,2.02E+03,8.09E+03,1.46E+04,1.23E+04,9.01E+04,5.06E+03,1.04E+05,1.45E+03,1.51E+06,3.03E+04,4.30E+03,2.18E+05,2.92E+04,5.90E+03,4.72E+04,0,FALSE,70.779,17,6,915,102.6,5.47,12,cell organization and biogenesis;signal transduction;other biological processes,nucleus;other cell component,"Pf00076, Pf02037",6294,A0AV56; B7Z5B6; B7ZLP6; F5H0H3; hsa:6294; O60406; Q15424; Q59HH8,ENSG00000160633,SUMOylation of transcription cofactors,Interleukin-1 (IL-1) structural pathway,2,5,69.46,151.1,144.74,80.43,n/a,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,107.99,102.17,136.22,88.89,122.5,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P07437,TUBB,Tubulin beta chain OS=Homo sapiens OX=9606 GN=TUBB PE=1 SV=2,27,626,2.85,0.291,0.961,1.722,1.51,-1.78,-0.06,0.78,2.83E-01,2.02E-01,8.55E-01,5.76E-01,1.92E+08,4.93E+07,4.07E+07,2.51E+07,5,5,5,5,8.18E+08,3.19E+07,4.79E+08,1.92E+08,5.04E+07,2.78E+07,6.30E+07,2.65E+07,4.93E+07,5.15E+07,3.31E+08,4.07E+07,2.48E+07,3.53E+07,4.26E+07,2.51E+07,2.53E+07,2.27E+07,1.20E+07,5.95E+07,3.25E+06,1.21E+05,4.68E+06,1.92E+08,2.60E+06,9.88E+04,1.12E+06,2.44E+05,1.39E+06,5.48E+05,1.98E+06,1.82E+06,2.01E+05,4.75E+06,1.06E+06,4.90E+04,7.11E+06,1.61E+05,2.82E+05,6.33E+05,0,FALSE,259.777,69,6,444,49.6,4.89,27,cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;other biological processes,non-structural extracellular;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,"Pf00091, Pf03953",203068,hsa:203068; P05218; P07437; Q8WUC1; Q9CY33,ENSG00000183311; ENSG00000196230; ENSG00000224156; ENSG00000227739; ENSG00000229684; ENSG00000232421; ENSG00000232575; ENSG00000235067,Potential therapeutics for SARS; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Neutrophil degranulation,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Opioid receptor pathways; Alzheimer's disease; HDAC6 interactions in the central nervous system,15,27,106.2,36.52,139.37,61.98,High,Peak Found,High,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,High,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,118.69,134.09,119.2,129.75,1742.4,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q16881,TXNRD1,"Thioredoxin reductase 1, cytoplasmic OS=Homo sapiens OX=9606 GN=TXNRD1 PE=1 SV=3",3,8,2.848,0.504,1.477,0.956,1.51,-0.99,0.56,-0.07,2.88E-01,6.86E-01,8.14E-01,8.74E-01,2.02E+05,3.57E+04,4.23E+05,1.55E+05,2,1,4,4,,,,8.57E+05,4.74E+04,,,,,3.57E+04,,3.26E+05,3.18E+05,5.49E+05,7.00E+05,,5.08E+05,5.27E+04,3.69E+05,6.50E+04,,,,8.57E+05,2.44E+03,,,,,3.80E+02,,1.46E+04,2.58E+03,7.40E+04,1.74E+04,,1.43E+05,3.74E+02,8.65E+03,6.92E+02,0,FALSE,21.149,9,3,649,70.9,7.39,3,cell cycle OR cell proliferation;developmental processes;signal transduction;other biological processes,cytosol;mitochondrion;nucleus;other cell component,"Pf00462, Pf02852, Pf07992",7296,B7Z1F4; B7Z3Y8; B7Z904; E9PMY9; F5H780; hsa:7296; Q16881; Q6FI31; Q6VB40; Q6VB41; Q6VB42; Q6VBP2; Q6VBP3; Q6VBP4; Q6VBP5; Q6VBP9; Q6VBQ0; Q6YNQ1; Q76P53; Q7LA96; Q8WVC8; Q99475; Q9UES8; Q9UH79,ENSG00000198431,PPARA activates gene expression; Detoxification of Reactive Oxygen Species; TP53 Regulates Metabolic Genes; Interconversion of nucleotide di- and triphosphates; NFE2L2 regulating anti-oxidant/detoxification enzymes; Metabolism of ingested H2SeO4 and H2SeO3 into H2Se; Uptake and function of diphtheria toxin; Metabolism of ingested MeSeO2H into MeSeH,Selenium micronutrient network; Selenium micronutrient network ; Selenium micronutrient network; Selenium metabolism and selenoproteins; Nuclear receptors meta-pathway; NRF2 pathway; Oxidative stress response; Ferroptosis,16,0,126.61,,39.17,91.06,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,High,n/a,High,Peak Found,High,Peak Found,1,,FALSE,124.52,56.37,34.7,72.67,31.62,other molecular function,0,
Master Protein,High,P42167,TMPO,"Lamina-associated polypeptide 2, isoforms beta/gamma OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2",19,201,2.848,0.788,0.684,3.338,1.51,-0.34,-0.55,1.74,2.53E-01,8.48E-01,5.75E-01,2.52E-01,3.38E+06,2.86E+05,7.79E+06,5.87E+05,5,3,5,5,1.70E+06,1.34E+05,3.38E+06,2.41E+07,7.17E+06,1.02E+05,,2.86E+05,,2.13E+06,7.79E+06,8.92E+06,4.48E+06,9.73E+06,5.69E+06,1.20E+06,1.74E+05,1.44E+06,5.87E+05,9.36E+04,6.76E+03,5.09E+02,3.30E+04,2.41E+07,3.70E+05,3.62E+02,,2.63E+03,,2.26E+04,4.66E+04,3.98E+05,3.64E+04,1.31E+06,1.41E+05,2.35E+03,4.89E+04,1.02E+04,1.37E+04,9.97E+02,0,FALSE,131.916,50,4,454,50.6,9.38,19,,other membranes;nucleus;other cell component,"Pf03020, Pf08198",7112,A2T926; hsa:7112; P42167; Q14861,ENSG00000120802,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOG GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle,Envelope proteins and their potential roles in EDMD physiopathology; Overlap between signal transduction pathways contributing to LMNA laminopathies,12,4,133.74,133.65,30,86.22,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,n/a,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,Phospho [T74],FALSE,137.78,129.45,102.4,145.58,584.91,nucleic acid binding activity;other molecular function,1,Phospho [T74]
Master Protein,High,P49959,MRE11,Double-strand break repair protein MRE11 OS=Homo sapiens OX=9606 GN=MRE11 PE=1 SV=3,9,14,2.844,1.35,2.712,1.045,1.51,0.43,1.44,0.06,2.37E-01,4.04E-01,3.53E-01,7.99E-01,4.44E+05,1.55E+05,3.34E+05,1.16E+06,4,2,5,5,,4.19E+05,4.71E+05,1.08E+06,1.04E+05,,,4.61E+05,,5.20E+04,1.40E+06,1.09E+05,3.34E+05,4.42E+05,3.15E+05,3.11E+06,1.16E+06,8.07E+06,1.84E+04,5.79E+05,,1.59E+03,4.61E+03,1.08E+06,5.39E+03,,,4.25E+03,,5.52E+02,8.36E+03,4.88E+03,2.71E+03,5.95E+04,7.83E+03,6.06E+03,3.26E+05,5.72E+04,4.31E+02,6.16E+03,0,FALSE,29.253,17,9,708,80.5,5.9,9,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00149, Pf04152",4361,B3KTC7; hsa:4361; O43475; P49959,ENSG00000020922,Resolution of D-loop Structures through Holliday Junction Intermediates; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Regulation of TP53 Activity through Phosphorylation; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Cytosolic sensors of pathogen-associated DNA ; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA); Defective homologous recombination repair (HRR) due to BRCA1 loss of function; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function; Impaired BRCA2 binding to PALB2; Meiotic recombination; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; DNA Damage/Telomere Stress Induced Senescence; Nonhomologous End-Joining (NHEJ); HDR through MMEJ (alt-NHEJ); Sensing of DNA Double Strand Breaks; IRF3-mediated induction of type I IFN,"miRNA regulation of DNA damage response; Homologous recombination; DDX1 as a regulatory component of the Drosha microprocessor; Breast cancer pathway; Joubert syndrome; DNA repair pathways, full network; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; Neurogenesis regulation in the olfactory epithelium; DNA damage response",31,0,78.81,112.76,97.27,126.74,n/a,Peak Found,High,High,High,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,115.43,79.12,38.06,109.85,42.02,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P22695,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial OS=Homo sapiens OX=9606 GN=UQCRC2 PE=1 SV=3",11,91,2.843,1.391,1.225,1.197,1.51,0.48,0.29,0.26,2.84E-01,3.02E-01,8.99E-01,8.13E-01,5.45E+06,1.15E+06,1.26E+07,6.85E+06,5,5,5,5,1.07E+07,4.92E+06,8.33E+05,1.19E+07,5.45E+06,5.93E+06,1.33E+08,1.15E+06,6.61E+04,7.80E+05,1.26E+07,8.58E+06,7.82E+06,1.28E+07,2.01E+07,1.07E+06,7.76E+06,5.75E+06,9.54E+06,6.85E+06,4.24E+04,1.87E+04,8.14E+03,1.19E+07,2.81E+05,2.11E+04,2.37E+06,1.06E+04,1.86E+03,8.29E+03,7.52E+04,3.83E+05,6.35E+04,1.73E+06,4.99E+05,2.08E+03,2.18E+06,4.07E+04,2.23E+05,7.29E+04,0,FALSE,70.175,39,11,453,48.4,8.63,11,protein metabolism;other metabolic processes,other membranes;mitochondrion;nucleus,"Pf00675, Pf05193",7385,B3KSN4; hsa:7385; P22695; Q9BQ05,ENSG00000140740,Respiratory electron transport; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,5,0,66.98,208.07,39.31,51.42,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,110.75,126.61,94.76,123.23,239.05,other molecular function,0,
Master Protein,High,O95251,KAT7,Histone acetyltransferase KAT7 OS=Homo sapiens OX=9606 GN=KAT7 PE=1 SV=1,2,2,2.843,1.595,3.079,0.324,1.51,0.67,1.62,-1.63,2.89E-01,1.99E-01,2.89E-01,4.35E-01,5.89E+05,3.51E+05,6.93E+05,1.08E+06,3,1,3,1,5.89E+05,3.97E+06,,3.57E+05,,,,3.51E+05,,,2.32E+06,,6.93E+05,5.41E+05,,1.08E+06,,,,,2.34E+03,1.51E+04,,3.57E+05,,,,3.24E+03,,,1.39E+04,,5.63E+03,7.29E+04,,2.11E+03,,,,,0,FALSE,7.433,5,2,611,70.6,8.85,2,cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf01530, Pf01853, Pf17772",11143,B3KN74; B4DF85; B4DFB4; B4DFE0; B4DGY4; E7ER15; G5E9K7; hsa:11143; O95251,ENSG00000136504,HATs acetylate histones,Androgen receptor signaling pathway,2,0,123.44,,83.22,,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,276.46,138.08,0,109.59,5.69,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 OS=Homo sapiens OX=9606 GN=SCAF1 PE=1 SV=3",4,5,2.838,0.284,1.487,0.287,1.5,-1.82,0.57,-1.8,2.50E-01,1.91E-01,8.04E-01,3.27E-01,1.83E+06,1.07E+05,4.44E+04,7.77E+05,2,3,4,3,,2.64E+06,,1.27E+06,,,1.07E+05,,4.06E+04,1.61E+05,7.09E+04,6.62E+03,8.37E+04,2.78E+04,,,1.81E+04,1.47E+06,,7.77E+05,,1.00E+04,,1.27E+06,,,1.90E+03,,1.14E+03,1.71E+03,4.24E+02,2.96E+02,6.80E+02,3.74E+03,,,5.08E+03,1.04E+04,,8.27E+03,0,FALSE,13.784,4,4,1312,139.2,9.25,4,RNA metabolism OR transcription;other metabolic processes,nucleus,,58506,hsa:58506; Q7Z5V7; Q8WVA1; Q9H7N4; Q9NR59,ENSG00000126461,,,0,0,49.34,58.6,76.47,96.18,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,68.24,76.74,235.45,129,12.4,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P11171,EPB41,Protein 4.1 OS=Homo sapiens OX=9606 GN=EPB41 PE=1 SV=4,18,120,2.832,0.443,3.44,0.303,1.5,-1.18,1.78,-1.72,2.89E-01,5.10E-01,1.37E-01,3.10E-01,3.89E+06,6.26E+05,1.97E+06,2.26E+06,5,5,5,5,6.07E+07,1.56E+06,3.97E+07,3.89E+06,3.33E+06,2.69E+06,3.90E+04,7.75E+04,6.26E+05,3.08E+06,2.07E+07,7.65E+04,2.71E+06,1.42E+06,1.97E+06,6.06E+06,2.76E+07,1.54E+06,2.26E+06,1.76E+06,2.41E+05,5.94E+03,3.88E+05,3.89E+06,1.72E+05,9.56E+03,6.94E+02,7.15E+02,1.76E+04,3.28E+04,1.24E+05,3.42E+03,2.20E+04,1.92E+05,4.90E+04,1.18E+04,7.75E+06,1.09E+04,5.29E+04,1.88E+04,0,FALSE,85.03,25,5,864,97,5.58,18,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00373, Pf04382, Pf05902, Pf08736, Pf09379, Pf09380",2035,B1ALH8; B1ALH9; D3DPM9; D3DPN0; hsa:2035; P11171; P11176; Q14245; Q5TB35; Q5VXN8; Q8IXV9; Q9Y578; Q9Y579,ENSG00000159023,Neurexins and neuroligins,VEGFA-VEGFR2 signaling; Splicing factor NOVA regulated synaptic proteins; IL-18 signaling pathway,4,10,123.4,112.84,160.37,142.7,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,139.46,145.38,134.28,121.9,383.51,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A2R8YEH1,RHAG,Rh associated glycoprotein OS=Homo sapiens OX=9606 GN=RHAG PE=1 SV=1,1,3,2.831,0.01,1.158,0.01,1.5,-6.64,0.21,-6.64,2.60E-01,1.00E-17,9.20E-01,1.00E-17,2.30E+06,8.12E+05,,9.40E+05,3,1,,1,2.66E+06,2.30E+06,4.48E+05,,,,,,,8.12E+05,,,,,,,,,,9.40E+05,1.06E+04,8.74E+03,4.38E+03,,,,,,,8.64E+03,,,,,,,,,,1.00E+04,0,FALSE,4.621,5,1,433,46.9,6.6,1,transport,plasma membrane;other membranes,Pf00909,,A0A2R8YEH1,ENSG00000112077,,,0,0,65.79,,,,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,1,,FALSE,22.97,,0,,9.15,transporter activity,0,
Master Protein,High,A0A7I2V370,COMT,Catechol O-methyltransferase OS=Homo sapiens OX=9606 GN=COMT PE=1 SV=1,7,27,2.829,0.54,1.644,0.74,1.5,-0.89,0.72,-0.43,2.51E-01,7.71E-01,7.27E-01,9.27E-01,4.64E+05,2.59E+05,5.70E+05,1.85E+05,5,3,5,4,4.64E+05,5.51E+04,7.61E+05,5.27E+06,1.43E+05,,2.59E+05,,2.79E+05,3.40E+04,5.70E+05,1.76E+06,9.68E+04,4.27E+05,6.06E+05,,6.18E+05,6.14E+05,2.20E+04,5.60E+04,1.84E+03,2.09E+02,7.44E+03,5.27E+06,7.38E+03,,4.61E+03,,7.87E+03,3.62E+02,3.41E+03,7.85E+04,7.86E+02,5.76E+04,1.50E+04,,1.74E+05,4.35E+03,5.16E+02,5.96E+02,0,FALSE,37.171,40,7,302,33.5,5.97,7,other metabolic processes,plasma membrane;other membranes;other cell component,Pf01596,,A0A7I2V370,ENSG00000093010,,Flavan-3-ol metabolic pathway; MTHFR deficiency; 22q11.2 copy number variation syndrome; Primary ovarian insufficiency; Estrogen metabolism; Metapathway biotransformation Phase I and II; Methylation pathways,7,0,165.48,71.35,90.96,101.8,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,133.61,133.56,141.14,119.21,61.62,other molecular function,0,
Master Protein,High,Q8WU39,MZB1,Marginal zone B- and B1-cell-specific protein OS=Homo sapiens OX=9606 GN=MZB1 PE=1 SV=1,4,60,2.825,4.069,1.048,8.654,1.5,2.02,0.07,3.11,2.80E-01,8.89E-03,9.43E-01,4.65E-02,2.16E+06,5.30E+04,9.96E+06,2.56E+05,4,4,5,5,1.71E+06,,9.87E+05,1.32E+07,2.73E+06,,2.51E+04,1.15E+05,8.17E+04,3.43E+04,6.06E+04,1.27E+07,7.54E+06,9.96E+06,1.14E+07,1.94E+06,3.81E+05,2.56E+05,1.73E+04,1.56E+05,6.81E+03,,9.64E+03,1.32E+07,1.41E+05,,4.46E+02,1.06E+03,2.30E+03,3.65E+02,3.62E+02,5.67E+05,6.13E+04,1.34E+06,2.84E+05,3.79E+03,1.07E+05,1.81E+03,4.05E+02,1.66E+03,0,FALSE,56.407,42,4,189,20.7,5.57,4,cell organization and biogenesis;other biological processes,non-structural extracellular;ER/Golgi;other cell component,Pf11938,51237,D2IYS0; hsa:51237; Q7Z6N2; Q8WU39; Q96RL5; Q9P0T3,ENSG00000170476,,,0,0,123.1,65.85,60.06,143.42,High,n/a,High,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,121.3,114.74,116.06,108.73,242.77,,0,
Master Protein,High,Q6ZMZ3,SYNE3,Nesprin-3 OS=Homo sapiens OX=9606 GN=SYNE3 PE=1 SV=2,20,59,2.821,0.637,1.11,1.225,1.5,-0.65,0.15,0.29,2.88E-01,9.03E-01,9.78E-01,7.98E-01,4.75E+06,6.43E+05,3.92E+06,1.06E+06,5,5,5,5,1.38E+05,7.68E+06,1.23E+06,4.75E+06,7.27E+06,2.17E+06,6.43E+05,2.66E+05,1.94E+05,2.96E+06,7.68E+06,3.17E+06,2.07E+06,1.01E+07,3.92E+06,5.05E+06,1.13E+04,9.65E+06,5.72E+05,1.06E+06,5.49E+02,2.92E+04,1.20E+04,4.75E+06,3.75E+05,7.73E+03,1.14E+04,2.46E+03,5.46E+03,3.15E+04,4.59E+04,1.42E+05,1.68E+04,1.36E+06,9.73E+04,9.85E+03,3.18E+03,6.84E+04,1.34E+04,1.13E+04,0,FALSE,79.729,27,20,975,112.1,6.23,20,cell organization and biogenesis;transport;other biological processes,other membranes;ER/Golgi;nucleus;other cell component,"Pf00435, Pf10541",161176,A6H8H3; Q6ZMZ3; Q86SX5; Q8N7G8,ENSG00000176438,,Envelope proteins and their potential roles in EDMD physiopathology,1,0,81.45,100.04,62.56,124.9,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,115.87,102.91,141.28,144.69,151.04,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A087WT44,HMOX2,heme oxygenase (biliverdin-producing) OS=Homo sapiens OX=9606 GN=HMOX2 PE=1 SV=1,5,13,2.821,1.053,2.34,0.674,1.5,0.07,1.23,-0.57,2.87E-01,4.38E-01,3.64E-01,8.64E-01,5.36E+05,8.89E+05,1.30E+06,9.27E+05,3,4,5,3,2.41E+05,,,2.07E+06,5.36E+05,6.33E+05,1.25E+06,,1.78E+06,5.68E+05,5.38E+04,1.13E+06,1.30E+06,1.57E+06,1.42E+06,9.27E+05,1.91E+05,,1.48E+06,,9.58E+02,,,2.07E+06,2.77E+04,2.25E+03,2.22E+04,,5.00E+04,6.04E+03,3.22E+02,5.07E+04,1.06E+04,2.11E+05,3.54E+04,1.81E+03,5.37E+04,,3.47E+04,,0,FALSE,24.599,21,5,370,41.6,5.44,5,other metabolic processes,other membranes,Pf01126,3163,A0A087WT44,ENSG00000103415; ENSG00000277424,,,0,0,103.49,53.89,55.1,74.7,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,91.73,118.99,120.43,104.55,37.39,other molecular function,0,
Master Protein,High,P02730,SLC4A1,Band 3 anion transport protein OS=Homo sapiens OX=9606 GN=SLC4A1 PE=1 SV=3,27,1000,2.817,0.459,3.33,0.224,1.49,-1.12,1.74,-2.16,2.89E-01,5.45E-01,1.61E-01,2.10E-01,7.02E+08,4.35E+08,6.76E+07,7.36E+08,5,5,5,5,3.21E+09,7.02E+08,1.13E+09,6.24E+06,1.23E+08,1.89E+09,2.25E+08,8.67E+08,4.35E+08,1.77E+08,1.14E+09,2.57E+07,1.46E+08,6.76E+07,1.96E+07,7.66E+08,1.05E+09,4.48E+08,7.36E+08,5.24E+08,1.27E+07,2.67E+06,1.10E+07,6.24E+06,6.32E+06,6.73E+06,4.00E+06,8.00E+06,1.23E+07,1.88E+06,6.79E+06,1.15E+06,1.18E+06,9.10E+06,4.87E+05,1.49E+06,2.96E+08,3.17E+06,1.72E+07,5.58E+06,0,FALSE,217.391,39,27,911,101.7,5.19,27,cell organization and biogenesis;stress response;transport;other biological processes,plasma membrane;other membranes;cytoskeleton,"Pf00955, Pf07565",6521,G4V2I6; hsa:6521; P02730; P78487; Q1ZZ45; Q4KKW9; Q4VB84; Q9UCY7; Q9UDJ1,ENSG00000004939,"Erythrocytes take up carbon dioxide and release oxygen; Erythrocytes take up oxygen and release carbon dioxide; Bicarbonate transporters; Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",,4,0,125.57,98.77,172.77,33.63,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,145.33,146.05,129.81,139.36,2388.14,transporter activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q13838,DDX39B,Spliceosome RNA helicase DDX39B OS=Homo sapiens OX=9606 GN=DDX39B PE=1 SV=1,9,31,2.804,0.647,2.185,0.955,1.49,-0.63,1.13,-0.07,2.92E-01,9.22E-01,3.87E-01,9.72E-01,8.17E+06,2.14E+06,2.53E+06,2.91E+06,5,5,5,5,1.83E+07,8.17E+06,7.00E+06,1.72E+07,4.80E+06,8.85E+06,1.19E+06,2.14E+06,8.43E+05,4.20E+06,2.10E+06,7.53E+06,1.81E+06,1.56E+07,2.53E+06,4.84E+06,9.71E+04,4.07E+06,5.12E+05,2.91E+06,7.25E+04,3.11E+04,6.84E+04,1.72E+07,2.48E+05,3.14E+04,2.11E+04,1.98E+04,2.38E+04,4.47E+04,1.26E+04,3.37E+05,1.47E+04,2.10E+06,6.28E+04,9.43E+03,2.73E+04,2.88E+04,1.20E+04,3.10E+04,0,FALSE,35.57,25,4,428,49,5.67,9,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,nucleus;other cell component,"Pf00270, Pf00271",7919,B0S8C0; hsa:7919; O43496; Q0EFA1; Q13838; Q2L6F9; Q53GL9; Q5RJ64; Q5RJ66; Q5ST94; Q5STB4; Q5STB5; Q5STB7; Q5STB8; Q5STU4; Q5STU5; Q5STU6; Q5STU8; Q71V76,ENSG00000198563; ENSG00000215425; ENSG00000225073; ENSG00000225859; ENSG00000229496; ENSG00000230624; ENSG00000235439,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; RHOBTB2 GTPase cycle,,5,5,55.84,95.54,99.79,84.91,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,128.36,108.38,116.76,122.44,59.7,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q71U36,TUBA1A,Tubulin alpha-1A chain OS=Homo sapiens OX=9606 GN=TUBA1A PE=1 SV=1,23,446,2.797,0.175,1.084,1.074,1.48,-2.52,0.12,0.1,2.93E-01,4.21E-02,9.77E-01,8.89E-01,2.84E+08,3.16E+07,2.36E+07,2.91E+07,5,5,5,5,5.38E+08,2.84E+08,3.67E+08,1.22E+08,1.29E+08,8.47E+07,3.16E+07,2.98E+07,2.80E+07,8.35E+07,1.85E+08,2.33E+07,2.09E+07,3.34E+07,2.36E+07,1.38E+08,2.91E+07,2.21E+07,1.70E+07,3.02E+07,2.14E+06,1.08E+06,3.59E+06,1.22E+08,6.64E+06,3.01E+05,5.61E+05,2.75E+05,7.88E+05,8.88E+05,1.11E+06,1.04E+06,1.69E+05,4.49E+06,5.87E+05,2.69E+05,8.19E+06,1.57E+05,3.98E+05,3.21E+05,0,FALSE,165.091,68,2,451,50.1,5.06,23,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component,"Pf00091, Pf03953",7846,A8K0B8; G3V1U9; hsa:7846; P04687; P05209; Q71U36,ENSG00000167552,Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; PKR-mediated signaling; Recycling pathway of L1; MHC class II antigen presentation; COPI-mediated anterograde transport; Intraflagellar transport; COPI-dependent Golgi-to-ER retrograde traffic; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; Resolution of Sister Chromatid Cohesion; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease; PAFAH1B1 copy number variation,42,24,60.52,57.85,125.14,107.72,High,High,High,High,High,High,n/a,n/a,Peak Found,High,Peak Found,n/a,High,High,High,n/a,High,n/a,High,n/a,1,,FALSE,128.95,129.29,122.08,137.67,1284.13,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A494C1K3,GTF2I,General transcription factor IIi OS=Homo sapiens OX=9606 GN=GTF2I PE=1 SV=1,20,42,2.796,0.453,0.78,0.887,1.48,-1.14,-0.36,-0.17,2.93E-01,5.33E-01,6.75E-01,9.45E-01,3.40E+06,2.43E+06,2.16E+06,6.69E+05,5,4,5,5,1.68E+06,3.97E+06,3.40E+06,1.27E+07,2.96E+06,9.36E+06,8.99E+05,,1.78E+06,3.30E+06,2.16E+06,1.97E+06,3.29E+06,2.20E+06,1.83E+06,5.55E+05,6.69E+05,5.04E+06,3.80E+05,1.71E+06,6.66E+03,1.51E+04,3.32E+04,1.27E+07,1.53E+05,3.33E+04,1.60E+04,,5.02E+04,3.51E+04,1.29E+04,8.79E+04,2.67E+04,2.97E+05,4.56E+04,1.08E+03,1.88E+05,3.57E+04,8.89E+03,1.83E+04,0,FALSE,82.581,22,20,1159,131,8.69,20,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf02946, Pf03221, Pf04218",,A0A494C1K3,ENSG00000263001,,7q11.23 copy number variation syndrome; Genetic causes of porto-sinusoidal vascular disease,2,0,89.55,99.41,25.12,116.85,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,124.18,119.72,122.57,136.35,139.14,nucleic acid binding activity,0,
Master Protein,High,Q9H0L4,CSTF2T,Cleavage stimulation factor subunit 2 tau variant OS=Homo sapiens OX=9606 GN=CSTF2T PE=1 SV=1,4,4,2.794,0.065,2.153,0.085,1.48,-3.94,1.11,-3.56,2.81E-01,6.20E-04,4.00E-01,5.87E-02,1.63E+06,5.84E+05,1.06E+05,1.26E+06,3,4,1,5,,9.87E+06,,6.32E+05,1.63E+06,6.25E+05,2.35E+05,5.45E+05,,7.70E+05,,1.06E+05,,,,1.26E+06,4.09E+04,2.99E+06,1.94E+05,2.66E+06,,3.75E+04,,6.32E+05,8.42E+04,2.22E+03,4.18E+03,5.03E+03,,8.19E+03,,4.75E+03,,,,2.45E+03,1.15E+04,2.12E+04,4.53E+03,2.83E+04,0,FALSE,13.293,14,3,616,64.4,7.25,4,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00076, Pf14304, Pf14327",23283,B2RAR9; hsa:23283; O75174; Q53HK6; Q7LGE8; Q8N6T1; Q9H0L4,ENSG00000177613,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,mRNA processing,5,1,125.35,41.54,,95.46,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,116.33,110.53,139.69,143.44,12.25,nucleic acid binding activity,0,
Master Protein,High,P10109,FDX1,"Adrenodoxin, mitochondrial OS=Homo sapiens OX=9606 GN=FDX1 PE=1 SV=1",1,1,2.791,0.133,1.91,0.195,1.48,-2.91,0.93,-2.36,3.11E-01,9.21E-02,6.22E-01,2.49E-01,9.65E+04,3.46E+04,1.29E+04,6.60E+04,2,1,1,2,,7.30E+04,,1.27E+05,,,3.46E+04,,,,,1.29E+04,,,,,4.21E+04,1.04E+05,,,,2.77E+02,,1.27E+05,,,6.15E+02,,,,,5.74E+02,,,,,1.18E+04,7.34E+02,,,0,FALSE,4.646,8,1,184,19.4,5.83,1,other metabolic processes;other biological processes,mitochondrion,Pf00111,2230,B0YJ14; hsa:2230; P10109; Q53YD6,ENSG00000137714,Endogenous sterols; Pregnenolone biosynthesis; Defective CYP11A1 causes AICSR; Electron transport from NADPH to Ferredoxin,Iron-sulfur cluster biogenesis,6,0,38.41,,,59.62,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,41.84,41.84,68.93,68.93,2.74,other molecular function,0,
Master Protein,High,O14773,TPP1,Tripeptidyl-peptidase 1 OS=Homo sapiens OX=9606 GN=TPP1 PE=1 SV=2,4,21,2.79,3.392,1.353,6.314,1.48,1.76,0.44,2.66,2.57E-01,1.89E-02,9.15E-01,8.70E-02,5.74E+05,1.91E+05,5.71E+06,4.38E+05,4,1,5,5,1.98E+05,3.23E+05,,7.36E+06,1.02E+06,,,1.91E+05,,,1.15E+06,1.17E+07,2.53E+06,6.24E+06,5.71E+06,4.09E+06,2.00E+05,4.28E+05,4.38E+05,5.41E+05,7.87E+02,1.23E+03,,7.36E+06,5.26E+04,,,1.76E+03,,,6.89E+03,5.24E+05,2.06E+04,8.41E+05,1.42E+05,7.98E+03,5.62E+04,3.03E+03,1.02E+04,5.76E+03,0,FALSE,19.229,14,4,563,61.2,6.48,4,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00082, Pf09286",1200,hsa:1200; O14773; Q53HT1; Q5JAK6; Q6UX56; Q71JP6; Q96C37,ENSG00000166340,XBP1(S) activates chaperone genes,VEGFA-VEGFR2 signaling,2,0,154.71,,74.84,145.19,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,94.7,110.85,79.64,107.99,47.04,other molecular function,0,
Master Protein,High,Q9BV79,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial OS=Homo sapiens OX=9606 GN=MECR PE=1 SV=2",2,6,2.788,3.626,,18.699,1.48,1.86,,4.22,3.05E-01,3.37E-02,,1.27E-03,1.11E+05,3.15E+04,5.80E+05,2.07E+04,2,1,3,2,,,2.83E+04,4.33E+05,,,,,,3.15E+04,,,1.80E+05,5.80E+05,8.29E+05,,5.63E+03,,7.60E+04,,,,2.76E+02,4.33E+05,,,,,,3.35E+02,,,1.47E+03,7.82E+04,2.06E+04,,1.58E+03,,1.78E+03,,0,FALSE,13.062,6,2,373,40.4,8.76,2,other metabolic processes,mitochondrion;nucleus,"Pf00107, Pf08240",51102,B3KT72; Q5SYU0; Q5SYU1; Q5SYU2; Q6IBU9; Q9BV79; Q9Y373,ENSG00000116353,Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,Fatty acid biosynthesis; Mitochondrial fatty acid synthesis pathway,3,0,124.08,,61.75,121.91,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,206.44,63.52,,117.63,14.79,other molecular function,0,
Master Protein,High,P61956,SUMO2,Small ubiquitin-related modifier 2 OS=Homo sapiens OX=9606 GN=SUMO2 PE=1 SV=3,3,15,2.783,1.165,0.514,3.272,1.48,0.22,-0.96,1.71,3.11E-01,3.79E-01,3.84E-01,1.87E-01,9.94E+05,2.48E+05,2.81E+06,3.20E+05,5,3,4,5,6.10E+05,9.94E+05,4.71E+05,4.21E+06,8.32E+06,,1.00E+05,2.48E+05,,3.36E+06,,2.34E+06,1.93E+06,3.56E+06,3.37E+06,3.20E+05,7.21E+04,1.27E+05,1.06E+06,4.45E+05,2.42E+03,3.78E+03,4.60E+03,4.21E+06,4.29E+05,,1.78E+03,2.29E+03,,3.57E+04,,1.04E+05,1.57E+04,4.80E+05,8.39E+04,6.23E+02,2.02E+04,9.02E+02,2.49E+04,4.73E+03,0,FALSE,15.353,27,3,95,10.9,5.5,3,protein metabolism;other metabolic processes;other biological processes,nucleus,Pf11976,6613,B2R4I2; hsa:6613; P55855; P61956; Q32Q42; Q6IPZ6; Q96HK1,ENSG00000188612,"Formation of Incision Complex in GG-NER; SUMOylation of chromatin organization proteins; SUMOylation of intracellular receptors; SUMOylation of DNA damage response and repair proteins; SUMOylation of SUMOylation proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; SUMOylation of transcription cofactors; Processing of DNA double-strand break ends; Vitamin D (calciferol) metabolism; SUMOylation of transcription factors; SUMO is conjugated to E1 (UBA2:SAE1); SUMO is transferred from E1 to E2 (UBE2I, UBC9); SUMO is proteolytically processed",TAR syndrome,15,0,115.91,148.94,28.27,97.95,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,132.49,129.52,133.17,103.25,45.42,other molecular function,0,
Master Protein,High,Q9Y265,RUVBL1,RuvB-like 1 OS=Homo sapiens OX=9606 GN=RUVBL1 PE=1 SV=1,13,105,2.776,0.696,0.907,3.452,1.47,-0.52,-0.14,1.79,2.97E-01,9.92E-01,8.08E-01,2.40E-01,1.24E+07,1.46E+06,1.06E+07,2.57E+06,5,5,5,5,1.92E+07,3.04E+06,5.65E+06,2.22E+07,1.24E+07,4.81E+06,2.35E+05,1.45E+06,1.46E+06,2.32E+06,8.71E+06,1.40E+07,8.01E+06,1.92E+07,1.06E+07,7.73E+06,2.57E+06,1.34E+06,1.58E+06,3.96E+06,7.63E+04,1.15E+04,5.52E+04,2.22E+07,6.41E+05,1.71E+04,4.17E+03,1.34E+04,4.10E+04,2.46E+04,5.21E+04,6.26E+05,6.51E+04,2.59E+06,2.65E+05,1.51E+04,7.23E+05,9.53E+03,3.70E+04,4.21E+04,0,FALSE,72.356,49,13,456,50.2,6.42,13,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf06068, Pf17856",8607,B2R5S0; hsa:8607; P82276; Q1KMR0; Q53HK5; Q53HL7; Q53Y27; Q9BSX9; Q9Y265,ENSG00000175792,UCH proteinases; Ub-specific processing proteases; Deposition of new CENPA-containing nucleosomes at the centromere; Formation of the beta-catenin:TCF transactivating complex; Telomere Extension By Telomerase; HATs acetylate histones; DNA Damage Recognition in GG-NER,Gastric cancer network 1; lncRNA in canonical Wnt signaling and colorectal cancer,9,0,66.35,83.17,37.9,75.98,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,118.09,99.51,107.54,122.64,329.81,other molecular function,0,
Master Protein,High,A0A994J4I1,HEPACAM,Hepatic and glial cell adhesion molecule OS=Homo sapiens OX=9606 GN=HEPACAM PE=4 SV=1,1,8,2.774,0.128,0.184,2.505,1.47,-2.96,-2.44,1.33,2.97E-01,1.28E-02,2.18E-02,3.73E-01,4.31E+07,1.17E+07,4.34E+06,8.16E+05,3,4,5,4,,4.31E+07,,1.29E+06,4.54E+07,1.16E+06,9.23E+06,1.70E+07,,1.50E+07,4.43E+05,4.85E+05,1.78E+07,5.52E+06,4.34E+06,3.20E+06,1.10E+05,6.60E+06,2.08E+05,,,1.64E+05,,1.29E+06,2.34E+06,4.13E+03,1.64E+05,1.57E+05,,1.59E+05,2.65E+03,2.16E+04,1.44E+05,7.44E+05,1.08E+05,6.24E+03,3.09E+04,4.67E+04,4.87E+03,,0.004,FALSE,2.551,2,1,468,51.7,9.2,1,,other membranes,,,A0A994J4I1,ENSG00000165478,,,0,0,82.95,66.97,124.61,121.3,n/a,Peak Found,n/a,Peak Found,High,High,Peak Found,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,Phospho [Y363],FALSE,107.99,102.25,139.03,139.69,20.28,,1,Phospho [Y363]
Master Protein,Medium,O75874,IDH1,Isocitrate dehydrogenase [NADP] cytoplasmic OS=Homo sapiens OX=9606 GN=IDH1 PE=1 SV=2,1,1,2.77,0.098,1.277,0.212,1.47,-3.36,0.35,-2.24,3.01E-01,3.60E-02,8.74E-01,2.77E-01,1.34E+05,4.83E+04,1.31E+04,6.17E+04,2,2,2,2,2.02E+05,,8.85E+04,,,,4.58E+04,,5.09E+04,,,,2.88E+04,5.91E+03,,,5.00E+04,7.60E+04,,,8.04E+02,,8.64E+02,,,,8.15E+02,,1.43E+03,,,,2.34E+02,7.97E+02,,,1.41E+04,5.39E+02,,,0.03,FALSE,1.818,4,1,414,46.6,7.01,1,other metabolic processes;stress response;developmental processes;other biological processes,non-structural extracellular;cytosol;mitochondrion;other cytoplasmic organelle;other cell component,Pf00180,3417,hsa:3417; O75874; Q567U4; Q6FHQ6; Q7Z3V0; Q93090; Q9NTJ9; Q9UKW8,ENSG00000138413,Peroxisomal protein import; Neutrophil degranulation; Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate; NADPH regeneration; NFE2L2 regulating TCA cycle genes,Glutathione metabolism; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism,8,0,55.35,7.38,93.28,29.14,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,59.85,86.05,29.62,105.57,2.46,other molecular function,0,
Master Protein,High,Q96EV2,RBM33,RNA-binding protein 33 OS=Homo sapiens OX=9606 GN=RBM33 PE=1 SV=3,3,5,2.768,0.171,0.01,100,1.47,-2.55,-6.64,6.64,2.98E-01,1.36E-01,1.00E-17,1.00E-17,1.64E+05,5.92E+04,2.80E+04,,2,1,2,,,2.55E+05,,1.05E+05,,,,5.92E+04,,,,4.91E+04,,,1.59E+04,,,,,,,9.68E+02,,1.05E+05,,,,5.46E+02,,,,2.19E+03,,,3.95E+02,,,,,,0,FALSE,14.346,5,3,1170,129.9,6.93,3,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,nucleus;other cell component,,155435,A4D244; B5MC24; hsa:155435; Q52LF5; Q75LN9; Q75ML5; Q96EV2; Q9NSV0,ENSG00000184863,,,0,0,58.61,,72.22,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,67.52,56.66,,,14.91,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P45880,VDAC2,Voltage-dependent anion-selective channel protein 2 OS=Homo sapiens OX=9606 GN=VDAC2 PE=1 SV=2,13,144,2.761,1.954,1.275,2.466,1.47,0.97,0.35,1.3,3.00E-01,1.25E-01,8.58E-01,3.80E-01,1.76E+07,2.87E+06,3.74E+07,9.88E+06,5,5,5,5,7.27E+06,3.88E+07,7.93E+06,2.81E+07,1.76E+07,2.62E+06,2.25E+06,9.47E+06,2.87E+06,1.84E+07,4.25E+07,2.00E+07,1.76E+07,4.36E+07,3.74E+07,9.03E+06,1.22E+07,9.88E+06,6.92E+06,1.01E+07,2.89E+04,1.47E+05,7.75E+04,2.81E+07,9.10E+05,9.33E+03,3.99E+04,8.74E+04,8.08E+04,1.96E+05,2.54E+05,8.95E+05,1.43E+05,5.88E+06,9.29E+05,1.76E+04,3.43E+06,7.00E+04,1.62E+05,1.08E+05,0,FALSE,62.748,54,13,294,31.5,7.56,13,cell organization and biogenesis;transport;signal transduction;other biological processes,other membranes;cytoskeleton;mitochondrion;other cell component,Pf01459,7417,hsa:7417; P45880; Q5VWK1; Q5VWK3; Q6IB40; Q7L3J5; Q9BWK8; Q9Y5I6,ENSG00000165637,Mitochondrial calcium ion transport; Ub-specific processing proteases,Alzheimer's disease and miRNA effects; Ferroptosis; Alzheimer's disease,5,0,67.81,98.1,38.8,19.88,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,127.73,105.4,121.23,102.41,399.12,transporter activity;other molecular function,0,
Master Protein,High,P68431,H3C1; H3C10; H3C11; H3C12; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8,Histone H3.1 OS=Homo sapiens OX=9606 GN=H3C1 PE=1 SV=2,10,734,2.749,1.372,1.349,4.574,1.46,0.46,0.43,2.19,3.02E-01,3.12E-01,8.02E-01,1.54E-01,8.15E+08,1.95E+08,1.65E+09,3.73E+08,5,5,5,5,9.28E+08,3.93E+08,1.44E+09,8.15E+08,4.24E+08,1.95E+08,1.36E+08,2.16E+08,4.21E+07,4.19E+08,1.48E+09,1.33E+09,2.67E+09,1.65E+09,2.27E+09,1.66E+08,3.73E+08,6.16E+08,3.57E+08,6.94E+08,3.69E+06,1.49E+06,1.41E+07,8.15E+08,2.19E+07,6.95E+05,2.42E+06,1.99E+06,1.19E+06,4.46E+06,8.87E+06,5.95E+07,2.17E+07,2.22E+08,5.64E+07,3.23E+05,1.05E+08,4.37E+06,8.37E+06,7.39E+06,0,FALSE,82.029,65,1,136,15.4,11.12,10,cell organization and biogenesis;other metabolic processes,non-structural extracellular;nucleus;other cell component,Pf00125,8350; 8351; 8352; 8353; 8354; 8355; 8356; 8357; 8358; 8968,A0PJT7; A5PLR1; hsa:8350; hsa:8351; hsa:8352; hsa:8353; hsa:8354; hsa:8355; hsa:8356; hsa:8357; hsa:8358; hsa:8968; P02295; P02296; P16106; P68431; Q6ISV8; Q6NWP8; Q6NWP9; Q6NXU4; Q71DJ3; Q93081,ENSG00000197153; ENSG00000197409; ENSG00000273983; ENSG00000274750; ENSG00000275379; ENSG00000275714; ENSG00000277775; ENSG00000278828; ENSG00000286522; ENSG00000287080,Amyloid fiber formation; HCMV Late Events; RUNX1 regulates transcription of genes involved in differentiation of HSCs; HCMV Early Events; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Interleukin-7 signaling; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); Factors involved in megakaryocyte development and platelet production; RMTs methylate histone arginines; HDMs demethylate histones; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; HATs acetylate histones; Chromatin modifications during the maternal to zygotic transition (MZT); RNA Polymerase I Promoter Escape; Meiotic recombination; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Condensation of Prophase Chromosomes; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis,Histone modifications; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,37,9,53.6,68.96,30.19,48.34,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.58,136.92,135.8,142.51,1342.36,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13200,PSMD2,26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiens OX=9606 GN=PSMD2 PE=1 SV=3,8,11,2.747,3.293,1.133,0.293,1.46,1.72,0.18,-1.77,3.14E-01,4.35E-02,9.53E-01,3.43E-01,1.03E+05,1.22E+06,4.44E+05,1.92E+06,2,4,5,5,,1.24E+05,,8.61E+04,,3.97E+06,7.05E+05,1.36E+06,,1.09E+06,7.58E+05,4.44E+05,2.24E+05,1.46E+06,7.31E+04,2.13E+06,2.44E+06,4.50E+04,5.42E+04,1.92E+06,,4.71E+02,,8.61E+04,,1.41E+04,1.25E+04,1.26E+04,,1.15E+04,4.53E+03,1.98E+04,1.82E+03,1.97E+05,1.82E+03,4.16E+03,6.85E+05,3.19E+02,1.27E+03,2.04E+04,0,FALSE,24.172,15,8,908,100.1,5.2,8,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf01851, Pf17781, Pf18051",5708,B4DX07; B4DXY1; E7EW34; E9PCS3; hsa:5708; Q12932; Q13200; Q15321; Q53XQ4; Q96I12,ENSG00000175166,Antigen processing: Ubiquitination & Proteasome degradation; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Neddylation; Dectin-1 mediated noncanonical NF-kB signaling; NIK-->noncanonical NF-kB signaling; FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,65,0,25.5,83.42,92.88,88.96,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,17.87,118.07,83.85,81.28,32.5,enzyme regulator activity,0,
Master Protein,High,O60613,SELENOF,Selenoprotein F OS=Homo sapiens OX=9606 GN=SELENOF PE=1 SV=4,3,6,2.734,0.397,0.125,6.538,1.45,-1.33,-3,2.71,2.71E-01,4.91E-01,5.91E-02,5.46E-02,6.31E+05,1.69E+05,8.22E+05,3.46E+04,3,1,3,2,,4.62E+05,,1.05E+06,6.31E+05,,,,,1.69E+05,,3.70E+05,,1.12E+06,8.22E+05,,2.12E+04,,5.66E+04,,,1.76E+03,,1.05E+06,3.25E+04,,,,,1.80E+03,,1.65E+04,,1.51E+05,2.04E+04,,5.95E+03,,1.32E+03,,0,FALSE,8.466,22,3,165,18.1,5.03,3,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,ER/Golgi,Pf08806,9403,A0A0B4J1S4; hsa:9403; O60613; Q4GZG7; Q8WU00; Q9BS64; Q9GZW0; Q9NR01,ENSG00000183291,,Selenium metabolism / selenoproteins; Selenium micronutrient network,2,0,42.65,,49,64.34,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,High,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,54.05,95.73,0,67.18,16.3,other molecular function,0,
Master Protein,High,Q16576,RBBP7,Histone-binding protein RBBP7 OS=Homo sapiens OX=9606 GN=RBBP7 PE=1 SV=1,13,103,2.721,0.27,0.745,0.901,1.44,-1.89,-0.42,-0.15,2.50E-01,2.10E-01,6.34E-01,9.43E-01,4.27E+05,2.28E+05,3.52E+05,3.01E+05,5,3,5,2,6.53E+05,7.78E+04,1.69E+05,2.50E+06,4.27E+05,,,6.34E+04,2.72E+05,2.28E+05,3.52E+05,2.75E+05,2.97E+04,3.90E+06,8.37E+05,,,,1.21E+05,7.47E+05,2.59E+03,2.96E+02,1.65E+03,2.50E+06,2.20E+04,,,5.85E+02,7.66E+03,2.42E+03,2.10E+03,1.23E+04,2.41E+02,5.26E+05,2.08E+04,,,,2.84E+03,7.95E+03,0,FALSE,60.419,47,6,425,47.8,5.05,13,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00400, Pf12265",5931,hsa:5931; Q16576; Q5JP00,ENSG00000102054,Potential therapeutics for SARS; Neddylation; HCMV Early Events; Deposition of new CENPA-containing nucleosomes at the centromere; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6; HDACs deacetylate histones; Activation of anterior HOX genes in hindbrain development during early embryogenesis; RMTs methylate histone arginines; PKMTs methylate histone lysines; HATs acetylate histones; RNA Polymerase I Transcription Initiation; PRC2 methylates histones and DNA; Defective pyroptosis; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,Retinoblastoma gene in cancer; Interactome of polycomb repressive complex 2 (PRC2) ; Effect of progerin on genes involved in progeria,20,0,129.99,58.51,148.78,101.95,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,80.58,103.84,101.77,83.89,263.01,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P50416,CPT1A,"Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2",11,59,2.721,0.72,1.799,1.279,1.44,-0.47,0.85,0.36,3.07E-01,9.52E-01,6.32E-01,7.68E-01,4.54E+06,1.73E+05,5.73E+06,1.12E+06,5,5,5,4,9.07E+06,1.03E+06,5.91E+06,4.54E+06,3.91E+05,1.29E+05,4.05E+05,1.73E+05,1.23E+05,1.56E+06,2.01E+07,5.73E+06,2.55E+06,3.61E+06,6.47E+06,8.47E+05,1.49E+06,1.69E+05,1.56E+06,,3.60E+04,3.90E+03,5.78E+04,4.54E+06,2.01E+04,4.59E+02,7.20E+03,1.60E+03,3.47E+03,1.66E+04,1.20E+05,2.56E+05,2.07E+04,4.87E+05,1.61E+05,1.65E+03,4.18E+05,1.20E+03,3.66E+04,,0,FALSE,50.467,19,11,773,88.3,8.65,11,other metabolic processes;stress response;transport;developmental processes;other biological processes,other membranes;mitochondrion,"Pf00755, Pf16484",1374,hsa:1374; P50416; Q8TCU0; Q9BWK0,ENSG00000110090,PPARA activates gene expression; Signaling by Retinoic Acid; Carnitine metabolism; RORA activates gene expression,AMP-activated protein kinase signaling; Fatty acid beta-oxidation; PPAR-alpha pathway; Nuclear receptors meta-pathway; Mitochondrial long chain fatty acid beta-oxidation; Leptin and adiponectin; PPAR signaling pathway; Thermogenesis; Fragile X syndrome; IL-18 signaling pathway; Mitochondrial fatty acid oxidation disorders; Sudden infant death syndrome (SIDS) susceptibility pathways,16,0,85.56,128.8,92.29,63.95,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,112.6,121.99,58.37,87.54,127.97,other molecular function,0,
Master Protein,High,Q12846,STX4,Syntaxin-4 OS=Homo sapiens OX=9606 GN=STX4 PE=1 SV=2,4,15,2.718,3.078,3.602,1.837,1.44,1.62,1.85,0.88,3.18E-01,4.89E-02,3.08E-01,4.63E-01,1.01E+05,6.45E+04,6.04E+05,2.51E+05,5,2,5,2,1.87E+05,1.01E+05,6.80E+04,5.67E+05,3.28E+04,,,3.65E+04,,1.14E+05,2.72E+05,7.36E+05,4.65E+05,8.82E+05,6.04E+05,,4.81E+05,,1.31E+05,,7.42E+02,3.82E+02,6.65E+02,5.67E+05,1.69E+03,,,3.37E+02,,1.21E+03,1.62E+03,3.29E+04,3.78E+03,1.19E+05,1.50E+04,,1.35E+05,,3.07E+03,,0,FALSE,21.079,16,4,297,34.2,6.28,4,cell organization and biogenesis;stress response;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00804, Pf05739",6810,A8MXY0; hsa:6810; Q12846; Q15525; Q6FHE8,ENSG00000103496,Translocation of SLC2A4 (GLUT4) to the plasma membrane; ER-Phagosome pathway; trans-Golgi Network Vesicle Budding; Disinhibition of SNARE formation; Other interleukin signaling,Insulin signaling; Vasopressin-regulated water reabsorption,7,0,113.99,72.89,39.93,80.7,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,99.84,105.93,116.62,76.35,52.43,enzyme regulator activity;other molecular function,0,
Master Protein,High,P30049,ATP5F1D,"ATP synthase subunit delta, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1D PE=1 SV=2",3,35,2.716,1.744,2.152,1.758,1.44,0.8,1.11,0.81,2.79E-01,1.72E-01,3.97E-01,5.64E-01,3.01E+06,1.08E+06,6.37E+06,3.37E+06,5,5,5,5,2.07E+06,6.33E+06,6.38E+05,9.06E+06,3.01E+06,2.19E+06,1.22E+05,6.15E+05,1.08E+06,3.08E+06,8.96E+06,4.99E+06,4.98E+06,6.37E+06,1.06E+07,3.43E+06,3.37E+06,8.02E+05,5.44E+06,7.76E+05,8.22E+03,2.40E+04,6.24E+03,9.06E+06,1.55E+05,7.80E+03,2.17E+03,5.68E+03,3.04E+04,3.28E+04,5.36E+04,2.23E+05,4.04E+04,8.59E+05,2.62E+05,6.70E+03,9.46E+05,5.68E+03,1.27E+05,8.26E+03,0,FALSE,16.362,38,3,168,17.5,5.49,3,cell organization and biogenesis;other metabolic processes;transport;other biological processes,other membranes;mitochondrion,"Pf02823, Pf21335",513,D6W5Y3; hsa:513; P30049; Q6FG90,ENSG00000099624,Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,5,0,81.02,84.97,34.77,71.83,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,115.11,92.03,123.8,67.01,99.05,transporter activity,0,
Master Protein,High,A0A994J7V4,SRRM1,Serine and arginine repetitive matrix 1 OS=Homo sapiens OX=9606 GN=SRRM1 PE=4 SV=1,6,27,2.71,0.271,1.852,0.793,1.44,-1.88,0.89,-0.33,2.66E-01,1.71E-01,6.25E-01,9.74E-01,3.52E+06,4.15E+05,3.52E+05,7.52E+05,5,5,5,5,2.38E+05,5.53E+06,6.78E+05,3.66E+06,3.52E+06,7.54E+05,3.57E+05,7.81E+04,4.15E+05,6.37E+05,4.09E+05,2.58E+05,2.37E+05,2.14E+06,3.52E+05,7.83E+05,1.86E+05,4.96E+06,1.34E+05,7.52E+05,9.47E+02,2.10E+04,6.63E+03,3.66E+06,1.82E+05,2.68E+03,6.34E+03,7.21E+02,1.17E+04,6.78E+03,2.45E+03,1.15E+04,1.92E+03,2.88E+05,8.74E+03,1.53E+03,5.22E+04,3.51E+04,3.13E+03,8.01E+03,0,FALSE,34.249,9,6,917,103.8,11.85,6,RNA metabolism OR transcription;other metabolic processes,nucleus,,,A0A994J7V4,ENSG00000133226,,,0,0,81.51,58.57,120.75,149.18,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,1,Phospho [S260],FALSE,127.29,111.23,76.86,111.44,91.77,,1,Phospho [S260]
Master Protein,High,Q99623,PHB2,Prohibitin-2 OS=Homo sapiens OX=9606 GN=PHB2 PE=1 SV=2,16,164,2.697,1.259,1.883,2.889,1.43,0.33,0.91,1.53,3.12E-01,3.76E-01,4.99E-01,3.09E-01,2.02E+07,6.78E+06,2.76E+07,7.16E+06,5,5,5,5,3.23E+07,1.91E+07,1.36E+07,3.16E+07,2.02E+07,1.82E+07,2.53E+06,6.78E+06,7.08E+05,1.62E+07,8.98E+07,2.76E+07,1.33E+07,3.19E+07,2.72E+07,4.97E+06,9.51E+06,7.73E+06,5.57E+06,7.16E+06,1.28E+05,7.26E+04,1.33E+05,3.16E+07,1.04E+06,6.49E+04,4.49E+04,6.26E+04,1.99E+04,1.72E+05,5.37E+05,1.23E+06,1.08E+05,4.30E+06,6.75E+05,9.69E+03,2.67E+06,5.48E+04,1.30E+05,7.62E+04,0,FALSE,77.28,61,16,299,33.3,9.83,16,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;mitochondrion;nucleus;other cell component,Pf01145,11331,B4DP75; hsa:11331; Q2YDA4; Q7KYU3; Q92978; Q99623,ENSG00000215021,Processing of SMDT1; Cellular response to mitochondrial stress,,2,0,35.17,89.43,78.56,25.82,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,114.86,114.13,134.43,127.25,404.57,other molecular function,0,
Master Protein,High,P62072,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10 OS=Homo sapiens OX=9606 GN=TIMM10 PE=1 SV=1,4,12,2.682,0.859,6.232,1.471,1.42,-0.22,2.64,0.56,2.55E-01,7.25E-01,9.01E-02,6.00E-01,3.95E+05,7.46E+04,7.56E+05,4.23E+05,4,1,4,4,3.69E+05,,2.17E+05,1.41E+06,4.22E+05,,,,7.46E+04,,,8.58E+05,6.66E+05,1.24E+06,6.04E+05,2.96E+05,6.53E+04,6.03E+05,6.15E+05,,1.47E+03,,2.13E+03,1.41E+06,2.18E+04,,,,2.10E+03,,,3.83E+04,5.41E+03,1.68E+05,1.50E+04,5.78E+02,1.83E+04,4.27E+03,1.44E+04,,0,FALSE,15.794,32,4,90,10.3,6.29,4,cell organization and biogenesis;transport;other biological processes,other membranes;mitochondrion,Pf02953,26519,A8K136; hsa:26519; P62072; Q9WV99; Q9WVA0; Q9Y5J8,ENSG00000134809,Mitochondrial protein degradation; Mitochondrial protein import,,2,0,89.93,,34.16,67.02,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,45.77,59.31,39.07,85.18,37.31,other molecular function,0,
Master Protein,High,Q04760,GLO1,Lactoylglutathione lyase OS=Homo sapiens OX=9606 GN=GLO1 PE=1 SV=4,2,5,2.68,0.555,2.75,0.541,1.42,-0.85,1.46,-0.89,2.52E-01,8.12E-01,3.87E-01,7.09E-01,2.94E+05,1.10E+05,1.63E+05,3.02E+05,1,1,1,2,2.94E+05,,,,,,,,,1.10E+05,,,1.63E+05,,,,3.49E+05,,2.60E+05,,1.17E+03,,,,,,,,,1.17E+03,,,1.33E+03,,,,9.81E+04,,6.09E+03,,0,FALSE,7.824,20,2,184,20.8,5.31,2,other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf00903,2739,B2R6P7; B4DDV0; hsa:2739; P78375; Q04760; Q59EL0; Q5TZW3; Q96FC0; Q96J41,ENSG00000124767,Pyruvate metabolism,,1,0,,,,20.6,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,0,21.83,21.83,15.59,other molecular function,0,
Master Protein,High,Q9Y5S9,RBM8A,RNA-binding protein 8A OS=Homo sapiens OX=9606 GN=RBM8A PE=1 SV=1,5,22,2.676,0.176,2.462,0.477,1.42,-2.5,1.3,-1.07,3.24E-01,5.92E-02,4.67E-01,6.02E-01,1.17E+06,2.45E+05,3.11E+05,3.72E+05,4,5,5,4,,3.22E+05,4.84E+05,2.97E+06,2.85E+06,2.45E+05,4.09E+04,8.21E+05,2.90E+04,1.59E+06,5.67E+04,6.14E+04,3.11E+05,3.09E+06,7.77E+05,,1.26E+05,3.54E+05,3.91E+05,4.69E+06,,1.22E+03,4.73E+03,2.97E+06,1.47E+05,8.69E+02,7.27E+02,7.57E+03,8.17E+02,1.69E+04,3.39E+02,2.74E+03,2.52E+03,4.17E+05,1.93E+04,,3.53E+04,2.51E+03,9.16E+03,4.99E+04,0,FALSE,30.554,41,5,174,19.9,5.72,5,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,cytosol;nucleus;other cell component,Pf00076,9939,B3KQI9; hsa:9939; Q6FHD1; Q6IQ40; Q9GZX8; Q9NZI4; Q9Y5S9,ENSG00000265241,mRNA Splicing - Major Pathway; Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,,6,0,87.51,122.44,149.18,158.44,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,132,120.24,127.25,137.26,74.3,nucleic acid binding activity,0,
Master Protein,High,P08238,HSP90AB1,Heat shock protein HSP 90-beta OS=Homo sapiens OX=9606 GN=HSP90AB1 PE=1 SV=4,16,106,2.669,0.092,0.96,0.356,1.42,-3.44,-0.06,-1.49,3.18E-01,2.41E-03,8.54E-01,4.01E-01,3.34E+06,2.33E+06,1.11E+06,5.86E+06,5,5,5,5,1.09E+07,3.34E+06,1.52E+06,2.23E+06,2.56E+07,4.89E+06,1.16E+06,2.46E+05,2.33E+06,1.09E+07,1.20E+05,1.11E+06,8.57E+06,2.26E+06,8.13E+05,3.70E+05,4.01E+05,9.59E+07,5.86E+06,1.35E+07,4.33E+04,1.27E+04,1.49E+04,2.23E+06,1.32E+06,1.74E+04,2.06E+04,2.27E+03,6.55E+04,1.15E+05,7.20E+02,4.95E+04,6.96E+04,3.05E+05,2.02E+04,7.22E+02,1.13E+05,6.80E+05,1.37E+05,1.43E+05,0,FALSE,71.117,26,6,724,83.2,5.03,16,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00183, Pf13589",3326,B2R5P0; hsa:3326; P08238; Q5T9W7; Q9NQW0; Q9NTK6,ENSG00000096384,Regulation of actin dynamics for phagocytic cup formation; Potential therapeutics for SARS; The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Aryl hydrocarbon receptor signalling; Neutrophil degranulation; Estrogen-dependent gene expression; Sema3A PAK dependent Axon repulsion; DDX58/IFIH1-mediated induction of interferon-alpha/beta; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; RHOBTB2 GTPase cycle; Chaperone Mediated Autophagy; HSF1 activation; Attenuation phase; Uptake and function of diphtheria toxin; Assembly and release of respiratory syncytial virus (RSV) virions; Respiratory syncytial virus genome replication,Nuclear receptors meta-pathway; NRF2 pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway,25,0,116.5,109.45,133.55,176.69,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,1,,FALSE,103.45,145.93,147.84,139.08,274.48,enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P16401,H1-5,Histone H1.5 OS=Homo sapiens OX=9606 GN=H1-5 PE=1 SV=3,18,517,2.666,2.373,1,8.688,1.41,1.25,0,3.12,3.18E-01,6.87E-02,8.95E-01,4.61E-02,8.22E+07,1.10E+07,3.70E+08,1.11E+07,5,5,5,5,7.03E+07,2.43E+07,1.24E+08,4.80E+08,8.22E+07,1.10E+07,3.24E+06,1.20E+07,4.27E+06,4.92E+07,6.77E+07,3.70E+08,2.67E+08,6.72E+08,4.92E+08,1.11E+07,3.71E+07,5.36E+06,2.07E+07,9.51E+06,2.79E+05,9.21E+04,1.21E+06,4.80E+08,4.24E+06,3.90E+04,5.76E+04,1.11E+05,1.20E+05,5.23E+05,4.05E+05,1.65E+07,2.17E+06,9.06E+07,1.22E+07,2.17E+04,1.04E+07,3.80E+04,4.84E+05,1.01E+05,0,FALSE,89.064,42,12,226,22.6,10.92,18,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf00538,3009,hsa:3009; P16401; Q14529; Q3MJ42,ENSG00000184357,Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF),,2,0,118.28,119.18,61.06,75.62,High,High,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,137.57,131.85,126.89,116.65,1235.45,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,H0Y2M6,CLCN7,"Chloride channel 7, isoform CRA_c OS=Homo sapiens OX=9606 GN=CLCN7 PE=1 SV=1",1,2,2.659,0.482,1.953,0.76,1.41,-1.05,0.97,-0.4,3.16E-01,6.61E-01,6.22E-01,9.43E-01,1.57E+05,6.08E+04,7.91E+04,1.04E+05,4,3,3,3,7.09E+04,1.42E+05,,1.72E+05,1.96E+06,6.90E+04,,6.08E+04,,3.13E+04,,3.59E+04,,1.11E+05,7.91E+04,,1.04E+05,6.12E+04,1.40E+05,,2.82E+02,5.40E+02,,1.72E+05,1.01E+05,2.46E+02,,5.61E+02,,3.33E+02,,1.60E+03,,1.50E+04,1.96E+03,,2.92E+04,4.33E+02,3.28E+03,,0.023,FALSE,1.918,1,1,901,97.2,8.27,1,transport,other membranes,Pf00654,,H0Y2M6,ENSG00000103249,,Autosomal recessive osteopetrosis pathways,1,0,156.44,36.92,50.07,38.86,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,87.14,93.4,33.93,51.58,3.88,transporter activity,0,
Master Protein,High,A0A494C028,DEK,DEK proto-oncogene OS=Homo sapiens OX=9606 GN=DEK PE=1 SV=1,11,49,2.656,0.24,1.082,1.353,1.41,-2.06,0.11,0.44,3.20E-01,1.18E-01,9.75E-01,7.30E-01,1.64E+07,2.68E+06,5.01E+06,2.00E+06,5,5,5,5,1.62E+06,1.64E+07,8.90E+05,5.57E+07,2.31E+07,8.89E+05,1.25E+06,2.68E+06,4.64E+06,7.64E+06,2.57E+06,6.21E+06,1.08E+06,2.49E+07,5.01E+06,2.00E+06,9.26E+05,2.32E+06,2.55E+06,1.04E+06,6.42E+03,6.25E+04,8.70E+03,5.57E+07,1.19E+06,3.16E+03,2.22E+04,2.47E+04,1.31E+05,8.12E+04,1.54E+04,2.78E+05,8.80E+03,3.36E+06,1.24E+05,3.90E+03,2.60E+05,1.65E+04,5.96E+04,1.11E+04,0,FALSE,43.088,32,5,380,43.2,8.57,11,cell organization and biogenesis,nucleus,Pf08766,,A0A494C028,ENSG00000124795,,10q11.21q11.23 copy number variation syndrome,1,6,114.33,81.35,121.78,42,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,136.56,130.65,110.62,108.09,135.43,nucleic acid binding activity,0,
Master Protein,High,Q03188,CENPC,Centromere protein C OS=Homo sapiens OX=9606 GN=CENPC PE=1 SV=2,2,3,2.64,0.107,1.05,0.509,1.4,-3.23,0.07,-0.97,2.95E-01,1.42E-02,9.26E-01,7.09E-01,6.75E+05,1.55E+05,7.22E+04,1.42E+05,3,2,3,3,,7.28E+05,,2.56E+05,6.75E+05,,,2.65E+05,9.09E+04,,,3.40E+04,,7.22E+04,7.45E+04,7.96E+05,1.42E+05,,6.44E+04,,,2.77E+03,,2.56E+05,3.48E+04,,,2.45E+03,2.56E+03,,,1.52E+03,,9.72E+03,1.85E+03,1.55E+03,3.98E+04,,1.51E+03,,0,FALSE,8.512,3,2,943,106.8,9.39,2,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,"Pf11699, Pf15620, Pf15622",1060,hsa:1060; Q03188; Q6PIR0; Q8IW27; Q9P0M5,ENSG00000145241,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Deposition of new CENPA-containing nucleosomes at the centromere; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,7,0,46.79,69.26,37.71,120.36,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,75.1,66.1,93.47,83.07,9.63,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P09543,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Homo sapiens OX=9606 GN=CNP PE=1 SV=2",2,11,2.64,1.04,1.244,0.753,1.4,0.06,0.31,-0.41,3.24E-01,5.47E-01,8.42E-01,9.44E-01,5.06E+06,1.92E+06,1.21E+06,1.05E+06,4,1,4,3,2.19E+07,2.10E+06,1.22E+07,3.59E+05,,,,,1.92E+06,,3.17E+07,,1.53E+05,1.58E+06,9.30E+05,5.43E+06,1.05E+06,,6.86E+05,,8.69E+04,7.99E+03,1.19E+05,3.59E+05,,,,,5.40E+04,,1.90E+05,,1.24E+03,2.13E+05,2.31E+04,1.06E+04,2.94E+05,,1.60E+04,,0,FALSE,10.183,9,2,421,47.5,9.07,2,cell-cell signaling;cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes,non-structural extracellular;other membranes;cytoskeleton;mitochondrion;other cell component,"Pf05881, Pf13671",1267,hsa:1267; P09543,ENSG00000173786,,Glial cell differentiation; MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Cell lineage map for neuronal differentiation,5,0,109.2,,179.49,110.65,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,High,Peak Found,High,n/a,High,n/a,1,,FALSE,176.19,141.51,136.35,136.86,47.02,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P09429,HMGB1,High mobility group protein B1 OS=Homo sapiens OX=9606 GN=HMGB1 PE=1 SV=3,17,513,2.637,0.418,1.621,0.737,1.4,-1.26,0.7,-0.44,3.24E-01,4.57E-01,6.28E-01,8.46E-01,1.42E+08,3.64E+07,2.68E+07,5.07E+07,5,5,5,5,1.02E+07,5.83E+08,1.85E+07,1.42E+08,2.74E+08,3.64E+07,9.47E+06,1.10E+08,2.36E+07,2.40E+08,9.47E+06,2.51E+07,4.33E+07,1.55E+08,2.68E+07,1.43E+08,1.46E+07,3.10E+07,5.07E+07,5.30E+07,4.05E+04,2.21E+06,1.81E+05,1.42E+08,1.41E+07,1.29E+05,1.68E+05,1.02E+06,6.66E+05,2.56E+06,5.66E+04,1.12E+06,3.52E+05,2.09E+07,6.67E+05,2.80E+05,4.11E+06,2.19E+05,1.19E+06,5.65E+05,0,FALSE,176.085,65,13,215,24.9,5.74,17,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00505, Pf09011",3146,A5D8W9; hsa:3146; P09429; Q14321; Q5T7C3; Q6IBE1,ENSG00000189403,ER-Phagosome pathway; Neutrophil degranulation; MyD88 deficiency (TLR2/4); IRAK4 deficiency (TLR2/4); Regulation of TLR by endogenous ligand; Apoptosis induced DNA fragmentation; TAK1-dependent IKK and NF-kappa-B activation  ; TRAF6 mediated NF-kB activation; Pyroptosis; Advanced glycosylation endproduct receptor signaling,"Retinoblastoma gene in cancer; VEGFA-VEGFR2 signaling; Supression of HMGB1 mediated inflammation by THBD; Base excision repair; DNA repair pathways, full network; Pleural mesothelioma; Clock-controlled autophagy in bone metabolism; Autophagy in pancreatic ductal adenocarcinoma; DNA damage response (only ATM dependent)",20,5,115.16,113.86,113.23,85.35,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,137.92,136.55,128.79,130.73,1709.94,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,A0A7I2V4I5,ZC3H13,Zinc finger CCCH-type containing 13 OS=Homo sapiens OX=9606 GN=ZC3H13 PE=1 SV=1,1,1,2.636,0.337,0.01,100,1.4,-1.57,-6.64,6.64,3.14E-01,4.83E-01,1.00E-17,1.00E-17,6.06E+04,2.48E+04,2.13E+04,,4,4,3,,6.15E+04,5.97E+04,,1.32E+05,4.43E+04,,2.69E+04,2.30E+04,8.93E+03,3.28E+04,,2.13E+04,,4.34E+04,8.05E+03,,,,,,2.44E+02,2.27E+02,,1.32E+05,2.29E+03,,4.78E+02,2.12E+02,2.51E+02,3.49E+02,,9.50E+02,,5.85E+03,2.00E+02,,,,,,0.023,FALSE,1.94,0,1,1669,196.6,9.42,1,,nucleus,Pf00642,23091,A0A7I2V4I5,ENSG00000123200,,,0,0,52.76,44.34,73.69,,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,63.85,88.41,,,2.78,other molecular function,0,
Master Protein,High,P16150,SPN,Leukosialin OS=Homo sapiens OX=9606 GN=SPN PE=1 SV=1,3,12,2.63,0.493,0.436,0.545,1.39,-1.02,-1.2,-0.88,2.87E-01,6.69E-01,2.69E-01,6.79E-01,2.19E+06,1.37E+06,1.09E+06,1.38E+06,5,5,5,5,2.19E+06,5.72E+06,1.74E+06,2.84E+06,1.52E+05,1.37E+06,1.37E+06,1.02E+07,4.01E+06,6.86E+05,3.00E+06,4.40E+05,3.11E+06,1.09E+06,7.64E+05,5.87E+05,1.38E+06,1.49E+06,3.48E+05,1.71E+06,8.70E+03,2.17E+04,1.70E+04,2.84E+06,7.86E+03,4.89E+03,2.44E+04,9.43E+04,1.13E+05,7.30E+03,1.80E+04,1.96E+04,2.53E+04,1.46E+05,1.90E+04,1.15E+03,3.87E+05,1.06E+04,8.14E+03,1.83E+04,0,FALSE,7.421,7,3,400,40.3,5.1,3,cell adhesion;cell cycle OR cell proliferation;stress response;signal transduction;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;nucleus;other cell component,,6693,A8K9B1; hsa:6693; P16150,ENSG00000197471,Basigin interactions,16p11.2 proximal deletion syndrome,3,0,80.74,111.77,76.01,54.29,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,129.34,100.87,117.16,121.97,28.68,other molecular function,0,
Master Protein,High,Q9UKM9,RALY,RNA-binding protein Raly OS=Homo sapiens OX=9606 GN=RALY PE=1 SV=1,10,51,2.626,0.412,0.842,0.756,1.39,-1.28,-0.25,-0.4,3.27E-01,4.43E-01,7.26E-01,8.64E-01,1.55E+07,1.15E+07,3.08E+06,4.94E+06,5,5,5,5,5.87E+05,3.94E+07,2.20E+06,1.55E+07,6.31E+07,1.37E+07,8.90E+06,2.36E+07,2.12E+06,1.15E+07,3.08E+06,1.82E+06,4.89E+06,2.01E+07,2.38E+06,1.35E+07,6.54E+05,4.94E+06,2.58E+06,8.16E+06,2.33E+03,1.50E+05,2.15E+04,1.55E+07,3.26E+06,4.89E+04,1.58E+05,2.18E+05,5.96E+04,1.22E+05,1.84E+04,8.11E+04,3.97E+04,2.70E+06,5.91E+04,2.63E+04,1.84E+05,3.50E+04,6.03E+04,8.69E+04,0,FALSE,29.499,38,1,306,32.4,9.17,10,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf00076,22913,hsa:22913; Q14621; Q2M365; Q5QPL8; Q9BQX6; Q9UJE3; Q9UKM9,ENSG00000125970,,,0,8,110.68,65.44,119.46,84.69,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,118.94,130.04,92.11,127.13,114.82,other molecular function,0,
Master Protein,High,Q15758,SLC1A5,Neutral amino acid transporter B(0) OS=Homo sapiens OX=9606 GN=SLC1A5 PE=1 SV=2,3,7,2.626,0.468,4.088,0.251,1.39,-1.09,2.03,-2,2.99E-01,6.05E-01,9.59E-02,2.50E-01,9.14E+05,1.10E+06,1.54E+06,5.09E+06,4,5,4,5,,7.03E+06,2.44E+05,8.51E+04,3.42E+06,7.76E+05,1.10E+06,4.43E+06,9.54E+05,1.68E+07,,8.24E+04,1.03E+07,1.26E+06,1.89E+06,1.23E+07,5.09E+06,5.75E+05,1.44E+07,6.63E+05,,2.67E+04,2.39E+03,8.51E+04,1.77E+05,2.76E+03,1.96E+04,4.08E+04,2.69E+04,1.79E+05,,3.68E+03,8.33E+04,1.70E+05,4.70E+04,2.40E+04,1.43E+06,4.08E+03,3.38E+05,7.06E+03,0,FALSE,8.291,8,3,541,56.6,5.48,3,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;other cell component,Pf00375,6510,A8K9H5; B4DR77; B4DWS4; B7ZB81; D0EYG6; E9PC01; hsa:6510; O95720; Q15758; Q96RL9; Q9BWQ3; Q9UNP2,ENSG00000105281,RAC1 GTPase cycle; RHOQ GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOH GTPase cycle; Amino acid transport across the plasma membrane,"TYROBP causal network in microglia; mRNA, protein, and metabolite inducation pathway by cyclosporin A; Metabolic reprogramming in colon cancer; Ferroptosis; Amino acid metabolism in triple-negative breast cancer cells",11,0,121.41,142.88,137.88,97.91,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,119.29,99.42,121.72,110.87,18.15,transporter activity;other molecular function,0,
Master Protein,High,Q9Y3Y2,CHTOP,Chromatin target of PRMT1 protein OS=Homo sapiens OX=9606 GN=CHTOP PE=1 SV=2,1,4,2.626,0.444,0.736,2.215,1.39,-1.17,-0.44,1.15,3.02E-01,6.13E-01,7.31E-01,4.24E-01,2.28E+05,8.67E+04,1.46E+05,6.38E+04,3,2,4,2,,2.28E+05,,1.53E+06,6.64E+04,,7.27E+04,1.04E+05,,,5.64E+04,3.80E+05,,6.68E+05,2.99E+04,,8.41E+03,,,4.84E+05,,8.65E+02,,1.53E+06,3.42E+03,,1.29E+03,9.55E+02,,,3.37E+02,1.70E+04,,9.00E+04,7.44E+02,,2.36E+03,,,5.16E+03,0,FALSE,7.092,6,1,248,26.4,12.23,1,cell organization and biogenesis;other metabolic processes;transport;other biological processes,nucleus,Pf13865,26097,D3DV55; hsa:26097; Q0VAQ8; Q2VPI9; Q5T7Y8; Q5T7Y9; Q5T7Z0; Q6NSM4; Q6PB28; Q8WYT9; Q9BUC5; Q9H034; Q9H2L0; Q9Y3Y2,ENSG00000160679,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,,3,0,131.92,24.76,106.39,136.59,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,104.37,121.78,463.11,142.3,15.58,nucleic acid binding activity,0,
Master Protein,High,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 OS=Homo sapiens OX=9606 GN=SRRM2 PE=1 SV=2,10,21,2.619,0.316,,0.131,1.39,-1.66,,-2.94,3.30E-01,2.98E-01,,7.63E-02,9.43E+05,5.12E+04,2.99E+05,2.38E+06,4,2,5,3,,7.91E+04,8.31E+05,6.05E+06,1.07E+06,,3.39E+04,,,7.73E+04,6.21E+04,2.99E+05,9.71E+04,2.51E+06,7.41E+05,2.60E+05,,2.38E+06,,4.41E+06,,3.00E+02,8.12E+03,6.05E+06,5.52E+04,,6.03E+02,,,8.22E+02,3.72E+02,1.33E+04,7.89E+02,3.38E+05,1.84E+04,5.07E+02,,1.69E+04,,4.70E+04,0,FALSE,60.137,6,10,2752,299.4,12.06,10,RNA metabolism OR transcription;other metabolic processes,nucleus,Pf08312,23524,A6NKB9; D3DU97; hsa:23524; O15038; O94803; Q6NSL3; Q6PIM3; Q6PK40; Q8IW17; Q96GY7; Q9P0G1; Q9UHA8; Q9UQ35; Q9UQ36; Q9UQ37; Q9UQ38; Q9UQ40,ENSG00000167978,mRNA Splicing - Major Pathway,,1,0,135.91,55.14,138.11,88.28,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,41.69,117.96,,112.26,64.31,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O43395,PRPF3,U4/U6 small nuclear ribonucleoprotein Prp3 OS=Homo sapiens OX=9606 GN=PRPF3 PE=1 SV=2,8,12,2.611,0.642,2.87,0.57,1.38,-0.64,1.52,-0.81,3.15E-01,9.73E-01,3.68E-01,7.73E-01,7.64E+05,7.87E+04,7.59E+05,3.85E+05,3,3,3,4,,3.07E+05,,1.36E+06,7.64E+05,,1.22E+05,7.87E+04,6.17E+04,,,2.18E+05,,7.59E+05,8.12E+05,,5.19E+03,4.66E+05,3.18E+05,4.81E+05,,1.17E+03,,1.36E+06,3.94E+04,,2.17E+03,7.27E+02,1.74E+03,,,9.72E+03,,1.02E+05,2.02E+04,,1.46E+03,3.30E+03,7.44E+03,5.12E+03,0,FALSE,33.974,17,8,683,77.5,9.5,8,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus,"Pf01480, Pf06544, Pf08572",9129,B4DSY9; hsa:9129; O43395; O43446; Q5VT54,ENSG00000117360,mRNA Splicing - Major Pathway,mRNA processing,2,0,65.08,35.49,55.18,69.56,n/a,Peak Found,n/a,High,High,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,113.66,69.44,107.79,135.79,36.68,other molecular function,0,
Master Protein,High,P35268,RPL22,60S ribosomal protein L22 OS=Homo sapiens OX=9606 GN=RPL22 PE=1 SV=2,4,19,2.607,0.762,1.246,0.984,1.38,-0.39,0.32,-0.02,2.96E-01,8.02E-01,9.02E-01,8.42E-01,2.09E+06,7.50E+05,4.82E+05,7.73E+05,4,3,5,4,2.32E+06,,4.17E+06,1.88E+06,1.64E+06,,3.22E+06,2.45E+05,7.50E+05,,4.97E+06,3.00E+05,4.82E+05,2.27E+06,3.14E+05,,2.04E+06,1.12E+06,3.05E+05,5.32E+05,9.21E+03,,4.08E+04,1.88E+06,8.46E+04,,5.72E+04,2.26E+03,2.11E+04,,2.97E+04,1.34E+04,3.92E+03,3.05E+05,7.81E+03,,5.74E+05,7.95E+03,7.13E+03,5.67E+03,0,FALSE,18.143,40,4,128,14.8,9.19,4,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf01776,6146,B2R495; hsa:6146; P35268; Q6IBD1,ENSG00000116251,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,45.9,113.3,121.37,77.53,Peak Found,n/a,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,148.82,134.89,110.71,100.49,58.94,other molecular function,0,
Master Protein,High,Q9P258,RCC2,Protein RCC2 OS=Homo sapiens OX=9606 GN=RCC2 PE=1 SV=2,10,33,2.597,0.572,0.588,2.509,1.38,-0.81,-0.77,1.33,3.33E-01,7.79E-01,4.63E-01,3.19E-01,6.86E+06,1.21E+06,1.21E+06,1.47E+06,5,5,5,4,1.56E+06,6.86E+06,4.97E+05,1.27E+07,1.31E+07,2.95E+06,1.48E+06,3.67E+05,3.02E+05,1.21E+06,1.21E+06,2.44E+05,2.23E+05,1.48E+07,2.67E+06,2.65E+06,3.21E+05,,1.48E+06,1.47E+06,6.21E+03,2.61E+04,4.85E+03,1.27E+07,6.75E+05,1.05E+04,2.63E+04,3.38E+03,8.50E+03,1.29E+04,7.22E+03,1.09E+04,1.81E+03,1.99E+06,6.63E+04,5.16E+03,9.02E+04,,3.46E+04,1.56E+04,0,FALSE,48.787,24,10,522,56,8.78,10,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf00415,55920,hsa:55920; Q8IVL9; Q9BSN6; Q9NPV8; Q9P258,ENSG00000179051; ENSG00000281540,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,6,0,85.69,85.18,162.24,64.19,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,131.45,133.99,134.38,106.43,96.62,enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,P46781,RPS9,40S ribosomal protein S9 OS=Homo sapiens OX=9606 GN=RPS9 PE=1 SV=3,5,24,2.56,1.485,5.791,0.331,1.36,0.57,2.53,-1.6,3.13E-01,2.58E-01,3.49E-02,3.66E-01,1.97E+06,4.44E+05,2.79E+06,9.33E+06,4,3,5,5,1.22E+06,,3.23E+05,4.77E+06,3.18E+06,,,4.44E+05,4.09E+05,4.58E+06,2.10E+06,2.81E+06,1.56E+06,6.90E+06,2.79E+06,6.19E+06,9.08E+06,2.99E+07,9.33E+06,1.73E+07,4.86E+03,,3.16E+03,4.77E+06,1.64E+05,,,4.09E+03,1.15E+04,4.87E+04,1.25E+04,1.26E+05,1.27E+04,9.30E+05,6.93E+04,1.21E+04,2.55E+06,2.12E+05,2.18E+05,1.85E+05,0,FALSE,14.159,22,5,194,22.6,10.65,5,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,"Pf00163, Pf01479",6203,A9C4C1; hsa:6203; P46781; Q4QRK7; Q9BVZ0,ENSG00000170889; ENSG00000274005; ENSG00000274626; ENSG00000274646; ENSG00000274950; ENSG00000275323; ENSG00000277079; ENSG00000277359; ENSG00000278081; ENSG00000278270,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,20,0,83.98,132.47,65.47,66.99,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,Peak Found,1,,FALSE,112.92,118.91,86.64,102.98,51.45,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O43464,HTRA2,"Serine protease HTRA2, mitochondrial OS=Homo sapiens OX=9606 GN=HTRA2 PE=1 SV=2",3,5,2.559,0.29,0.309,1.227,1.36,-1.79,-1.69,0.3,3.23E-01,2.43E-01,1.61E-01,7.08E-01,9.68E+05,1.08E+06,2.48E+05,2.29E+05,2,4,3,2,,,,2.73E+05,3.43E+06,8.99E+05,,1.30E+06,1.06E+05,1.35E+06,,1.94E+05,,4.06E+05,2.48E+05,,4.10E+05,,1.28E+05,,,,,2.73E+05,1.77E+05,3.20E+03,,1.20E+04,2.98E+03,1.44E+04,,8.68E+03,,5.47E+04,6.16E+03,,1.15E+05,,2.99E+03,,0,FALSE,7.393,8,3,458,48.8,10.07,3,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf13365, Pf17820",27429,hsa:27429; O43464; Q9HBZ4; Q9P0Y3; Q9P0Y4,ENSG00000115317,Mitochondrial protein degradation,Apoptosis modulation and signaling; Parkinson's disease pathway; Nanomaterial induced apoptosis; Ciliary landscape; Complement system in neuronal development and plasticity,6,0,120.54,62.99,38.88,74.34,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,High,Peak Found,High,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,101.69,167.18,123.33,80.93,8.8,other molecular function,0,
Master Protein,High,Q8TEM1,NUP210,Nuclear pore membrane glycoprotein 210 OS=Homo sapiens OX=9606 GN=NUP210 PE=1 SV=3,10,31,2.545,0.854,0.946,2.135,1.35,-0.23,-0.08,1.09,2.62E-01,6.84E-01,8.39E-01,3.98E-01,2.26E+05,4.47E+05,2.67E+06,8.32E+05,5,3,5,2,8.93E+05,1.81E+05,9.07E+04,8.98E+05,2.26E+05,,1.35E+05,,4.47E+05,1.07E+06,2.16E+06,2.67E+06,3.94E+06,1.05E+06,4.36E+06,,9.84E+05,,7.04E+05,,3.55E+03,6.89E+02,8.87E+02,8.98E+05,1.16E+04,,2.40E+03,,1.26E+04,1.13E+04,1.29E+04,1.19E+05,3.20E+04,1.41E+05,1.08E+05,,2.76E+05,,1.65E+04,,0,FALSE,44.264,9,10,1887,205,6.81,10,transport,other membranes;ER/Golgi;nucleus,Pf02368,23225,A6NN56; hsa:23225; O94980; Q6NXG6; Q8NBJ1; Q8TEM1; Q9H6C8; Q9UFP3,ENSG00000132182,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses,,28,0,87.96,86.27,47.44,23.47,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,High,High,High,High,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,118.9,134.6,92.41,94.66,79.92,,0,
Master Protein,High,P14209,CD99,CD99 antigen OS=Homo sapiens OX=9606 GN=CD99 PE=1 SV=1,2,15,2.542,0.661,0.924,0.932,1.35,-0.6,-0.11,-0.1,2.90E-01,1.00E+00,8.74E-01,8.73E-01,2.83E+05,1.02E+05,1.37E+05,1.53E+05,5,2,4,2,3.08E+05,8.08E+04,3.81E+05,2.83E+05,4.65E+04,,,,9.00E+04,1.16E+05,,2.49E+05,3.11E+04,9.36E+04,2.00E+05,,6.13E+04,3.84E+05,,,1.23E+03,3.07E+02,3.73E+03,2.83E+05,2.40E+03,,,,2.53E+03,1.24E+03,,1.11E+04,2.53E+02,1.26E+04,4.97E+03,,1.72E+04,2.72E+03,,,0,FALSE,11.209,13,2,185,18.8,4.75,2,cell adhesion;other biological processes,plasma membrane;other membranes;other cell component,Pf12301,4267,A6NIW1; hsa:4267; O00518; P14209; Q6ICV7,ENSG00000002586; ENSG00000292348,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Cell surface interactions at the vascular wall,,2,0,67.14,18.01,69.08,102.46,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,73.77,107.43,248.66,124.41,29.61,,0,
Master Protein,High,Q16099,GRIK4,"Glutamate receptor ionotropic, kainate 4 OS=Homo sapiens OX=9606 GN=GRIK4 PE=2 SV=2",1,1,2.541,0.01,2.485,0.01,1.35,-6.64,1.31,-6.64,2.74E-01,1.00E-17,4.73E-01,1.00E-17,2.76E+05,1.31E+05,,4.48E+05,4,2,,4,2.69E+05,8.84E+05,,1.25E+05,2.82E+05,,2.29E+04,7.51E+05,,,,,,,,4.28E+05,,1.56E+05,4.70E+05,6.81E+05,1.07E+03,3.36E+03,,1.25E+05,1.46E+04,,4.07E+02,6.93E+03,,,,,,,,8.34E+02,,1.10E+03,1.10E+04,7.25E+03,0.005,FALSE,2.474,1,1,956,107.2,6.73,1,cell-cell signaling;transport;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,"Pf00060, Pf01094, Pf10613",2900,A8K9L1; hsa:2900; Q16099,ENSG00000149403,Activation of Ca-permeable Kainate Receptor,Neuroinflammation and glutamatergic signaling,2,0,86.36,133.07,,49.79,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,1,,FALSE,155.1,,196.96,,0,transporter activity,0,
Master Protein,High,Q9UBW7,ZMYM2,Zinc finger MYM-type protein 2 OS=Homo sapiens OX=9606 GN=ZMYM2 PE=1 SV=1,4,6,2.537,0.201,0.01,100,1.34,-2.32,-6.64,6.64,3.52E-01,2.07E-01,1.00E-17,1.00E-17,1.07E+05,2.71E+04,1.24E+04,,5,1,3,,1.96E+05,1.07E+05,2.59E+04,2.30E+05,4.25E+04,,,,2.71E+04,,,5.07E+03,,9.39E+04,1.24E+04,,,,,,7.80E+02,4.05E+02,2.54E+02,2.30E+05,2.19E+03,,,,7.64E+02,,,2.26E+02,,1.27E+04,3.08E+02,,,,,,0,FALSE,18.913,5,4,1377,154.8,6.34,4,other biological processes,cytosol;nucleus,"Pf06467, Pf12012",7750,A6NDG0; A6NI02; hsa:7750; O43212; O43434; O60898; Q5W0Q4; Q5W0T3; Q63HP0; Q8NE39; Q9H0V5; Q9H538; Q9UBW7; Q9UEU2,ENSG00000121741,Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease; Signaling by FLT3 fusion proteins,,3,0,75.47,,132.82,,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,111.48,,,18.56,other molecular function,0,
Master Protein,High,D6REX3,SEC31A,"SEC31 homolog A, COPII coat complex component OS=Homo sapiens OX=9606 GN=SEC31A PE=1 SV=1",2,6,2.537,1.024,4.567,0.4,1.34,0.03,2.19,-1.32,3.40E-01,6.55E-01,1.65E-01,5.02E-01,1.37E+05,6.27E+04,1.47E+05,4.54E+05,3,3,4,3,,5.40E+05,,1.37E+05,7.03E+04,,9.42E+04,6.27E+04,,5.35E+04,,1.19E+05,1.06E+05,3.59E+05,1.81E+05,,4.54E+05,6.85E+05,3.06E+05,,,2.05E+03,,1.37E+05,3.63E+03,,1.67E+03,5.78E+02,,5.69E+02,,5.32E+03,8.58E+02,4.84E+04,4.49E+03,,1.28E+05,4.85E+03,7.16E+03,,0,FALSE,7.837,2,2,1251,136.1,6.98,2,transport,other membranes;cytosol;ER/Golgi;other cell component,Pf12931,,D6REX3,ENSG00000138674,,Sterol regulatory element-binding proteins (SREBP) signaling,1,0,101.93,30.4,61.06,39.58,n/a,Peak Found,n/a,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,148.9,97.57,78.79,70.75,13.65,,0,
Master Protein,High,H3BNX8,COX5A,"Cytochrome c oxidase subunit 5A, mitochondrial OS=Homo sapiens OX=9606 GN=COX5A PE=1 SV=1",6,46,2.536,3.662,2.86,2.338,1.34,1.87,1.52,1.23,3.03E-01,1.39E-02,2.27E-01,4.07E-01,2.75E+06,1.01E+06,1.28E+07,3.97E+06,5,5,5,5,7.05E+05,2.75E+06,2.46E+06,1.29E+07,3.46E+06,2.73E+06,1.17E+06,1.01E+06,9.36E+05,5.05E+05,8.81E+06,5.88E+06,2.19E+07,1.28E+07,1.51E+07,3.67E+06,6.66E+06,3.97E+06,4.18E+06,1.14E+06,2.80E+03,1.04E+04,2.40E+04,1.29E+07,1.79E+05,9.69E+03,2.08E+04,9.31E+03,2.64E+04,5.37E+03,5.27E+04,2.63E+05,1.78E+05,1.73E+06,3.74E+05,7.15E+03,1.87E+06,2.81E+04,9.79E+04,1.21E+04,0,FALSE,21.209,32,6,153,17.2,6,6,other metabolic processes,other membranes;mitochondrion,Pf02284,,H3BNX8,ENSG00000178741,,Mitochondrial complex IV assembly; 5q35 copy number variation,2,0,108.33,67.01,47.8,49.99,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,128.68,128.27,111.12,129.42,106.31,other molecular function,0,
Master Protein,High,Q99549,MPHOSPH8,M-phase phosphoprotein 8 OS=Homo sapiens OX=9606 GN=MPHOSPH8 PE=1 SV=2,3,4,2.536,0.5,0.27,4.675,1.34,-1,-1.89,2.23,2.81E-01,7.10E-01,2.23E-01,1.41E-01,3.34E+05,8.33E+04,1.05E+05,2.25E+04,1,1,5,1,,,,3.34E+05,,8.33E+04,,,,,2.82E+04,6.26E+05,3.85E+04,1.05E+05,1.06E+05,,,,2.25E+04,,,,,3.34E+05,,2.96E+02,,,,,1.69E+02,2.80E+04,3.13E+02,1.42E+04,2.63E+03,,,,5.27E+02,,0,FALSE,10.131,4,3,860,97.1,6.06,3,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00385, Pf12796",54737,B7Z6F9; hsa:54737; Q5JPE5; Q5JTQ0; Q86TK3; Q96MK4; Q99549; Q9BTP1,ENSG00000196199,,,0,0,,,139.16,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,90.09,0,74.61,4.96,other molecular function,0,
Master Protein,High,Q9UQR0,SCML2,Sex comb on midleg-like protein 2 OS=Homo sapiens OX=9606 GN=SCML2 PE=1 SV=1,13,33,2.533,0.592,0.438,0.903,1.34,-0.76,-1.19,-0.15,3.26E-01,8.87E-01,3.08E-01,9.09E-01,1.82E+06,4.23E+05,1.51E+06,1.13E+05,4,3,5,4,,1.59E+05,2.21E+06,6.27E+06,1.49E+06,,4.23E+05,,5.35E+05,2.77E+05,1.89E+06,1.51E+06,1.10E+06,6.84E+06,6.25E+05,1.09E+06,3.99E+04,7.47E+04,,1.72E+05,,6.05E+02,2.16E+04,6.27E+06,7.71E+04,,7.52E+03,,1.51E+04,2.95E+03,1.13E+04,6.75E+04,8.97E+03,9.22E+05,1.55E+04,2.12E+03,1.12E+04,5.29E+02,,1.83E+03,0,FALSE,69.957,29,13,700,77.2,8.54,13,other biological processes,nucleus,"Pf00536, Pf02820, Pf12140, Pf17208",10389,hsa:10389; Q5JXE6; Q86U98; Q8IWD0; Q8NDP2; Q9UGC5; Q9UQR0,ENSG00000102098,,,0,0,103.91,31.4,105.62,145.31,n/a,Peak Found,High,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,84.37,109.08,331.32,138.92,106.8,other molecular function,0,
Master Protein,High,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTBN1 PE=1 SV=2",50,137,2.533,0.459,0.831,1.554,1.34,-1.12,-0.27,0.64,3.47E-01,5.45E-01,7.13E-01,6.40E-01,1.67E+07,3.16E+06,4.60E+06,2.71E+06,5,5,5,5,1.11E+07,1.54E+07,2.26E+07,1.67E+07,4.90E+07,1.17E+07,8.04E+05,3.16E+06,1.35E+06,5.18E+06,3.57E+07,2.38E+06,4.23E+06,1.23E+07,4.60E+06,5.60E+06,2.05E+06,2.28E+06,2.71E+06,4.97E+06,4.41E+04,5.86E+04,2.21E+05,1.67E+07,2.53E+06,4.17E+04,1.43E+04,2.92E+04,3.81E+04,5.50E+04,2.14E+05,1.06E+05,3.43E+04,1.66E+06,1.14E+05,1.09E+04,5.76E+05,1.62E+04,6.35E+04,5.29E+04,0,FALSE,246.945,30,46,2364,274.4,5.57,50,cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00169, Pf00307, Pf00435",6711,B2RP63; hsa:6711; O60837; Q01082; Q16057; Q53R99; Q59ER3; Q8IX99,ENSG00000115306,Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; COPI-mediated anterograde transport; RHOV GTPase cycle; RHOU GTPase cycle; Nephrin family interactions; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins; Signaling by FLT3 fusion proteins,TGF-beta signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,12,0,65.89,99.36,117.09,46.56,High,High,High,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,114.98,123.49,95.7,125.6,389.82,cytoskeletal activity;other molecular function,0,
Master Protein,High,P31942,HNRNPH3,Heterogeneous nuclear ribonucleoprotein H3 OS=Homo sapiens OX=9606 GN=HNRNPH3 PE=1 SV=2,4,11,2.524,0.163,0.01,100,1.34,-2.62,-6.64,6.64,3.59E-01,5.05E-02,1.00E-17,1.00E-17,9.23E+05,3.17E+05,5.04E+05,,5,4,5,,5.84E+05,1.96E+06,4.26E+05,9.23E+05,2.10E+06,3.16E+05,,3.17E+05,1.03E+05,6.41E+05,6.22E+05,3.15E+05,5.04E+05,6.82E+05,4.75E+04,,,,,,2.32E+03,7.46E+03,4.16E+03,9.23E+05,1.08E+05,1.12E+03,,2.93E+03,2.91E+03,6.82E+03,3.72E+03,1.41E+04,4.09E+03,9.19E+04,1.18E+03,,,,,,0,FALSE,14.993,18,4,346,36.9,6.87,4,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf00076,3189,A8K682; B3KRE1; hsa:3189; P31942; Q9BSX1; Q9NP53; Q9NP96; Q9NPA7; Q9NPI4; Q9UFU4; Q9Y4J5,ENSG00000096746,,,0,0,65.2,64.44,59.32,,Peak Found,Peak Found,High,High,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,94.17,124.44,,,29.65,,0,
Master Protein,High,Q9Y2W2,WBP11,WW domain-binding protein 11 OS=Homo sapiens OX=9606 GN=WBP11 PE=1 SV=1,4,5,2.522,0.111,2.007,0.117,1.33,-3.17,1,-3.1,2.79E-01,2.96E-02,5.68E-01,1.21E-01,2.34E+05,2.36E+05,3.20E+04,1.63E+05,4,1,5,4,2.97E+05,1.85E+05,,4.62E+05,1.81E+05,,,,,2.36E+05,1.51E+05,3.20E+04,4.22E+04,1.53E+04,1.97E+04,6.32E+05,1.80E+05,1.47E+05,6.99E+04,,1.18E+03,7.02E+02,,4.62E+05,9.35E+03,,,,,2.51E+03,9.01E+02,1.43E+03,3.43E+02,2.06E+03,4.90E+02,1.23E+03,5.07E+04,1.04E+03,1.64E+03,,0,FALSE,17.8,10,4,641,70,8.38,4,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf09429,51729,hsa:51729; Q96AY8; Q9Y2W2,ENSG00000084463,mRNA Splicing - Major Pathway,,1,0,46.96,,108.05,98.75,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,89.86,115.84,77.8,131.34,14.94,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O43242,PSMD3,26S proteasome non-ATPase regulatory subunit 3 OS=Homo sapiens OX=9606 GN=PSMD3 PE=1 SV=2,2,3,2.514,1.485,3.864,0.14,1.33,0.57,1.95,-2.84,3.41E-01,4.40E-01,2.41E-01,9.57E-02,6.44E+04,2.98E+04,8.23E+04,5.93E+05,2,3,3,4,,,7.48E+04,5.54E+04,,,3.04E+04,,1.83E+04,2.98E+04,,3.23E+04,,2.13E+05,8.23E+04,4.66E+05,4.54E+05,7.55E+05,,1.11E+06,,,7.31E+02,5.54E+04,,,5.40E+02,,5.16E+02,3.16E+02,,1.44E+03,,2.87E+04,2.05E+03,9.09E+02,1.27E+05,5.35E+03,,1.18E+04,0.001,FALSE,4.235,4,2,534,60.9,8.44,2,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf01399, Pf08375",5709,B3KMW9; B4DT72; hsa:5709; O43242; Q96EI2; Q9BQA4,ENSG00000108344,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,64,0,21.07,25.96,85.51,44.52,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,2.91,90.04,70.42,89,4.32,enzyme regulator activity,0,
Master Protein,High,P48735,IDH2,"Isocitrate dehydrogenase [NADP], mitochondrial OS=Homo sapiens OX=9606 GN=IDH2 PE=1 SV=2",23,251,2.51,1.154,1.703,2.082,1.33,0.21,0.77,1.06,3.52E-01,4.50E-01,5.84E-01,4.67E-01,7.50E+07,3.22E+07,7.53E+07,2.64E+07,5,5,5,5,9.95E+07,1.49E+07,3.57E+07,1.10E+08,7.50E+07,9.61E+07,1.87E+07,3.22E+07,1.05E+06,7.11E+07,3.16E+07,6.71E+07,7.53E+07,1.35E+08,1.31E+08,1.09E+07,4.28E+07,2.64E+07,3.63E+07,1.51E+07,3.95E+05,5.65E+04,3.49E+05,1.10E+08,3.87E+06,3.42E+05,3.33E+05,2.97E+05,2.95E+04,7.56E+05,1.89E+05,3.00E+06,6.12E+05,1.82E+07,3.25E+06,2.12E+04,1.20E+07,1.87E+05,8.48E+05,1.61E+05,0,FALSE,144.943,49,23,452,50.9,8.69,23,other metabolic processes,cytosol;mitochondrion;other cytoplasmic organelle,Pf00180,3418,B2R6L6; B4DFL2; hsa:3418; P48735; Q96GT3,ENSG00000182054,Transcriptional activation of mitochondrial biogenesis; Citric acid cycle (TCA cycle); Mitochondrial protein degradation,"VEGFA-VEGFR2 signaling; Metabolic reprogramming in colon cancer; Cerebral organic acidurias, including diseases; TCA cycle (aka Krebs or citric acid cycle)",7,0,60.85,88.88,50.31,51.54,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,118.91,121.87,132.7,120.4,715.92,other molecular function,0,
Master Protein,High,P20700,LMNB1,Lamin-B1 OS=Homo sapiens OX=9606 GN=LMNB1 PE=1 SV=2,52,982,2.504,0.915,1.031,2.624,1.32,-0.13,0.04,1.39,3.54E-01,6.80E-01,9.26E-01,3.51E-01,3.14E+08,5.55E+07,2.00E+08,1.02E+08,5,5,5,5,6.95E+07,3.81E+08,7.97E+07,3.14E+08,3.75E+08,5.55E+07,8.67E+07,4.43E+07,2.87E+07,1.86E+08,4.39E+08,9.47E+07,2.39E+08,2.00E+08,1.63E+08,1.02E+08,1.57E+07,7.59E+08,6.35E+07,3.08E+08,2.76E+05,1.45E+06,7.79E+05,3.14E+08,1.94E+07,1.97E+05,1.54E+06,4.09E+05,8.08E+05,1.98E+06,2.62E+06,4.23E+06,1.94E+06,2.69E+07,4.04E+06,1.99E+05,4.40E+06,5.38E+06,1.49E+06,3.28E+06,0,FALSE,372.453,70,50,586,66.4,5.16,52,cell organization and biogenesis;transport;other biological processes,other membranes;cytoskeleton;nucleus,"Pf00038, Pf00932",4001,B2R6J6; hsa:4001; P20700; Q3SYN7; Q96EI6,ENSG00000113368,Meiotic synapsis; RHOD GTPase cycle; RHOF GTPase cycle; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina; Breakdown of the nuclear lamina; Formation of Senescence-Associated Heterochromatin Foci (SAHF),Fas ligand pathway and stress induction of heat shock proteins; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome,14,2,64.31,78.23,57.18,122.46,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,120.17,127.08,127.83,130.9,2638.34,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P52565,ARHGDIA,Rho GDP-dissociation inhibitor 1 OS=Homo sapiens OX=9606 GN=ARHGDIA PE=1 SV=3,4,7,2.497,0.668,1.09,1.121,1.32,-0.58,0.12,0.16,3.12E-01,9.51E-01,9.29E-01,7.56E-01,1.59E+06,3.58E+05,4.93E+05,5.92E+05,2,2,3,3,,,,5.57E+05,4.56E+06,,,1.04E+06,1.23E+05,,,3.65E+05,,1.29E+06,4.93E+05,8.23E+05,1.85E+05,,5.92E+05,,,,,5.57E+05,2.35E+05,,,9.64E+03,3.45E+03,,,1.63E+04,,1.74E+05,1.22E+04,1.60E+03,5.19E+04,,1.39E+04,,0,FALSE,12.288,25,4,204,23.2,5.11,4,signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf02115,396,A8MXW0; B2R5X1; B4DDD3; B4DUV9; hsa:396; P52565; Q6IBM5,ENSG00000141522,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RHOH GTPase cycle; Axonal growth stimulation; Axonal growth inhibition (RHOA activation),Ciliary landscape; Nephrotic syndrome; Vasopressin-regulated water reabsorption,12,0,110.6,111.73,70.1,60.58,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,124.55,119.73,111.73,104.86,20.76,enzyme regulator activity,0,
Master Protein,High,Q9P035,HACD3,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 OS=Homo sapiens OX=9606 GN=HACD3 PE=1 SV=2,3,21,2.496,1.437,0.408,3.183,1.32,0.52,-1.29,1.67,3.56E-01,2.80E-01,2.13E-01,2.70E-01,4.88E+06,6.63E+05,6.31E+06,2.38E+06,4,5,5,1,1.23E+07,4.39E+06,5.43E+06,1.87E+06,,6.63E+05,5.67E+04,2.61E+05,9.02E+05,6.40E+06,1.11E+07,3.34E+05,1.42E+07,6.31E+06,5.25E+06,,2.38E+06,,,,4.88E+04,1.67E+04,5.30E+04,1.87E+06,,2.36E+03,1.01E+03,2.41E+03,2.54E+04,6.81E+04,6.65E+04,1.49E+04,1.15E+05,8.50E+05,1.30E+05,,6.70E+05,,,,0,FALSE,17.316,15,3,362,43.1,8.94,3,other metabolic processes;signal transduction;other biological processes,other membranes;ER/Golgi;nucleus,Pf04387,51495,A0PJA1; B4DRF4; hsa:51495; Q280Z3; Q6PD63; Q8IUI5; Q8NC86; Q8NCB1; Q96T12; Q9NQA7; Q9P035,ENSG00000074696,Synthesis of very long-chain fatty acyl-CoAs,,1,0,74.28,161.36,72.22,,High,High,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,109.02,116.55,53.55,92.91,73.08,enzyme regulator activity;other molecular function,0,
Master Protein,High,P10644,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR1A PE=1 SV=1,4,9,2.486,0.306,1.267,0.417,1.31,-1.71,0.34,-1.26,3.09E-01,2.74E-01,8.97E-01,6.06E-01,6.44E+05,1.50E+05,1.26E+05,2.48E+05,5,2,4,5,2.90E+06,2.98E+05,1.07E+06,6.44E+05,1.33E+05,,1.08E+05,2.08E+05,,,,9.55E+04,8.74E+04,1.97E+05,1.67E+05,2.48E+05,4.92E+05,2.18E+05,6.66E+04,3.95E+05,1.15E+04,1.13E+03,1.04E+04,6.44E+05,6.86E+03,,1.92E+03,1.91E+03,,,,4.26E+03,7.10E+02,2.65E+04,4.15E+03,4.83E+02,1.38E+05,1.54E+03,1.56E+03,4.21E+03,0,FALSE,12.106,13,4,381,43,5.35,4,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component,"Pf00027, Pf02197",5573,hsa:5573; K7ER48; P10644; Q567S7,ENSG00000108946,FCGR3A-mediated IL10 synthesis; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase,Mesodermal commitment pathway; Myometrial relaxation and contraction pathways; Mesodermal commitment pathway; G protein signaling pathways; Cannabinoid receptor signaling; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Fragile X syndrome; Cardiomyocyte signaling pathways converging on titin; Calcium regulation in cardiac cells; ADHD and autism (ASD) linked metabolic pathways and SNP; EPAC1 and PKA reduction of retinal inflammation; Sudden infant death syndrome (SIDS) susceptibility pathways,27,0,110.8,44.56,39.34,58.05,High,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,129.22,108.03,72.15,82.73,24.41,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q15459,SF3A1,Splicing factor 3A subunit 1 OS=Homo sapiens OX=9606 GN=SF3A1 PE=1 SV=1,13,32,2.48,0.375,0.816,1.058,1.31,-1.42,-0.29,0.08,3.59E-01,3.66E-01,7.62E-01,8.00E-01,7.41E+06,1.10E+06,7.78E+05,4.73E+05,5,5,5,5,5.89E+06,7.41E+06,8.67E+05,9.86E+06,4.32E+07,1.30E+06,3.41E+05,1.10E+06,3.10E+05,3.93E+06,9.17E+05,3.39E+05,7.78E+05,5.56E+06,3.80E+05,1.05E+06,6.95E+05,4.73E+05,4.49E+05,4.03E+05,2.34E+04,2.81E+04,8.47E+03,9.86E+06,2.23E+06,4.61E+03,6.07E+03,1.02E+04,8.73E+03,4.18E+04,5.48E+03,1.51E+04,6.32E+03,7.49E+05,9.44E+03,2.05E+03,1.95E+05,3.35E+03,1.05E+04,4.29E+03,0,FALSE,57.576,23,13,793,88.8,5.22,13,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00240, Pf01805, Pf12230",10291,E9PAW1; hsa:10291; Q15459,ENSG00000099995,mRNA Splicing - Major Pathway,mRNA processing,2,0,126.1,106.31,139.89,43.79,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,117.3,135.06,116.21,124.23,96.59,nucleic acid binding activity,0,
Master Protein,High,A0A994J6A8,DPF2,Double PHD fingers 2 OS=Homo sapiens OX=9606 GN=DPF2 PE=4 SV=1,6,14,2.477,1.475,0.053,9.515,1.31,0.56,-4.25,3.25,3.43E-01,2.05E-01,1.66E-03,2.74E-02,1.69E+06,4.24E+05,1.54E+06,8.87E+04,3,1,5,3,,1.65E+05,,1.73E+06,1.69E+06,,4.24E+05,,,,1.56E+05,7.83E+05,1.54E+06,4.96E+06,1.74E+06,,6.82E+04,2.22E+05,8.87E+04,,,6.28E+02,,1.73E+06,8.70E+04,,7.54E+03,,,,9.30E+02,3.50E+04,1.25E+04,6.68E+05,4.33E+04,,1.92E+04,1.58E+03,2.08E+03,,0,FALSE,30.208,18,6,575,63.7,7.28,6,,,,,A0A994J6A8,ENSG00000133884,,Tumor suppressor activity of SMARCB1,1,0,74.64,,101.06,66.23,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,0,112.34,67.44,105.83,46.07,other molecular function,0,
Master Protein,High,Q9BUJ2,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Homo sapiens OX=9606 GN=HNRNPUL1 PE=1 SV=2,10,22,2.477,0.641,3.454,0.905,1.31,-0.64,1.79,-0.14,3.59E-01,9.56E-01,3.15E-01,9.21E-01,9.14E+05,2.00E+05,3.24E+05,1.37E+05,3,1,4,5,1.28E+05,,,2.50E+06,9.14E+05,,,,,2.00E+05,,4.23E+05,2.19E+05,1.31E+06,2.48E+05,1.90E+05,5.14E+04,1.37E+05,7.39E+04,1.50E+05,5.09E+02,,,2.50E+06,4.71E+04,,,,,2.12E+03,,1.89E+04,1.78E+03,1.77E+05,6.17E+03,3.70E+02,1.44E+04,9.72E+02,1.73E+03,1.60E+03,0,FALSE,40.355,16,10,856,95.7,6.92,10,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00622, Pf02037, Pf13671",11100,B3KMW7; hsa:11100; O76022; Q6ZSZ0; Q7L8P4; Q8N6Z4; Q96G37; Q9BUJ2; Q9HAL3; Q9UG75,ENSG00000105323,,,0,0,102.27,,93.68,47.17,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,81.39,59.45,105.6,117.16,58.03,other molecular function,0,
Master Protein,High,P50213,IDH3A,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=IDH3A PE=1 SV=1",8,38,2.476,0.996,3.947,2.101,1.31,-0.01,1.98,1.07,3.47E-01,5.90E-01,1.09E-01,4.62E-01,1.20E+06,4.57E+05,9.65E+06,1.88E+06,5,1,5,4,1.51E+05,1.20E+06,5.22E+06,6.30E+06,8.71E+05,,,,4.57E+05,,2.95E+05,6.62E+06,9.65E+06,1.13E+07,1.20E+07,,2.80E+06,7.77E+05,1.26E+06,4.22E+06,5.99E+02,4.56E+03,5.10E+04,6.30E+06,4.49E+04,,,,1.29E+04,,1.76E+03,2.96E+05,7.84E+04,1.52E+06,2.98E+05,,7.86E+05,5.51E+03,2.95E+04,4.49E+04,0,FALSE,34.581,27,3,366,39.6,6.92,8,other metabolic processes,mitochondrion,Pf00180,3419,D3DW83; hsa:3419; P50213; Q9H3X0,ENSG00000166411,Citric acid cycle (TCA cycle); Mitochondrial protein degradation,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Metabolic reprogramming in colon cancer; TCA cycle (aka Krebs or citric acid cycle),5,5,101.94,,59.78,69.02,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,High,High,High,n/a,High,n/a,High,Peak Found,1,,FALSE,115.78,98.26,12.1,76.7,92.74,other molecular function,0,
Master Protein,High,A0A994J846,SYPL1,Synaptophysin like 1 OS=Homo sapiens OX=9606 GN=SYPL1 PE=4 SV=1,1,5,2.475,0.402,1.357,0.733,1.31,-1.31,0.44,-0.45,3.33E-01,4.56E-01,7.16E-01,9.26E-01,2.31E+06,9.33E+05,9.29E+05,1.27E+06,1,2,4,2,,,,2.31E+06,,,5.99E+05,1.45E+06,,,,2.96E+05,4.21E+05,2.65E+06,2.05E+06,,,1.32E+06,,1.21E+06,,,,2.31E+06,,,1.07E+04,1.34E+04,,,,1.32E+04,3.42E+03,3.58E+05,5.09E+04,,,9.38E+03,,1.29E+04,0.007,FALSE,2.416,4,1,285,31.4,8.34,1,,other membranes;ER/Golgi,,,A0A994J846,ENSG00000008282,,,0,0,,58.92,86.96,6.26,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,67.95,137.66,65.01,131.7,13.81,,0,
Master Protein,High,B0QZ18,CPNE1,Copine 1 OS=Homo sapiens OX=9606 GN=CPNE1 PE=1 SV=1,9,28,2.474,0.494,3.719,0.668,1.31,-1.02,1.89,-0.58,3.22E-01,6.19E-01,1.26E-01,7.79E-01,2.14E+06,4.41E+05,5.82E+06,1.78E+06,5,4,5,5,1.57E+05,2.14E+06,2.29E+06,7.71E+06,5.40E+05,6.23E+04,,6.17E+05,3.99E+06,3.15E+05,1.61E+07,5.82E+06,2.88E+06,3.35E+06,6.17E+06,6.31E+06,1.76E+06,4.13E+06,1.78E+06,9.59E+05,6.25E+02,8.14E+03,2.23E+04,7.71E+06,2.79E+04,2.21E+02,,5.69E+03,1.12E+05,3.35E+03,9.60E+04,2.60E+05,2.34E+04,4.51E+05,1.53E+05,1.23E+04,4.94E+05,2.93E+04,4.17E+04,1.02E+04,0,FALSE,36.281,25,9,542,59.7,6.04,9,,other membranes;nucleus,"Pf00168, Pf07002",8904,B0QZ18,ENSG00000214078,,,0,0,117.84,147.89,78.04,73.8,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,51.19,114.97,80.86,108.79,83.09,other molecular function,0,
Master Protein,High,Q9NWW5,CLN6,Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens OX=9606 GN=CLN6 PE=1 SV=1,1,6,2.472,0.796,0.745,2.642,1.31,-0.33,-0.43,1.4,3.57E-01,8.67E-01,7.43E-01,3.51E-01,1.89E+05,7.66E+04,1.51E+05,5.71E+04,1,1,4,1,,,,1.89E+05,,,,,,7.66E+04,,4.90E+05,1.30E+05,1.13E+05,1.75E+05,,5.71E+04,,,,,,,1.89E+05,,,,,,8.15E+02,,2.19E+04,1.05E+03,1.52E+04,4.35E+03,,1.60E+04,,,,0,FALSE,7.727,7,1,311,35.9,8.87,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf15156,54982,A8K560; B4DDH6; hsa:54982; Q6IAB1; Q96SR0; Q9NWW5,ENSG00000128973,,,0,0,,,78.15,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,0,36.68,0,30.53,19.88,other molecular function,0,
Master Protein,High,O00483,NDUFA4,Cytochrome c oxidase subunit NDUFA4 OS=Homo sapiens OX=9606 GN=NDUFA4 PE=1 SV=1,1,6,2.47,1.331,0.01,100,1.3,0.41,-6.64,6.64,3.47E-01,2.70E-01,1.00E-17,1.00E-17,1.04E+06,4.93E+05,2.21E+06,,4,3,4,,6.47E+05,5.83E+06,,1.66E+06,4.76E+05,,,5.76E+05,4.93E+05,3.06E+05,2.68E+05,2.23E+06,3.91E+06,,2.20E+06,,,,,,2.57E+03,2.22E+04,,1.66E+06,2.45E+04,,,5.31E+03,1.39E+04,3.25E+03,1.60E+03,9.94E+04,3.18E+04,,5.46E+04,,,,,,0.001,FALSE,3.231,12,1,81,9.4,9.38,1,other metabolic processes;transport;other biological processes,other membranes;mitochondrion,Pf06522,4697,A4D109; hsa:4697; O00483; Q6FHN5,ENSG00000189043,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly; Oxidative phosphorylation,7,0,116.42,30.19,69.28,,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,85.59,122.23,,,12.26,transporter activity;other molecular function,0,
Master Protein,High,P18754,RCC1,Regulator of chromosome condensation OS=Homo sapiens OX=9606 GN=RCC1 PE=1 SV=1,9,26,2.464,1.114,2.456,2.428,1.3,0.16,1.3,1.28,3.62E-01,4.31E-01,4.44E-01,3.04E-01,1.10E+06,2.83E+05,2.90E+06,4.74E+05,4,2,5,4,6.05E+05,2.01E+06,,3.64E+06,2.60E+05,8.27E+05,,,9.71E+04,,4.72E+06,2.28E+06,2.68E+06,3.07E+06,2.90E+06,,1.25E+06,5.77E+04,4.18E+05,5.38E+05,2.40E+03,7.62E+03,,3.64E+06,1.34E+04,2.94E+03,,,2.73E+03,,2.82E+04,1.02E+05,2.18E+04,4.14E+05,7.20E+04,,3.50E+05,4.09E+02,9.79E+03,5.73E+03,0,FALSE,48.695,40,9,421,44.9,7.52,9,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf00415,1104,hsa:1104; P18754; Q16269; Q6NT97,ENSG00000180198,Rev-mediated nuclear export of HIV RNA; Nuclear import of Rev protein; Postmitotic nuclear pore complex (NPC) reformation,22q11.2 copy number variation syndrome,4,0,94.54,111.71,29.89,88.06,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,High,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,141.74,88.63,122.1,111.39,81.96,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A994J4R3,H1-10,H1.10 linker histone OS=Homo sapiens OX=9606 GN=H1-10 PE=4 SV=1,9,71,2.458,0.341,0.5,3.54,1.3,-1.55,-1,1.82,3.65E-01,2.97E-01,3.10E-01,2.31E-01,1.71E+07,3.70E+06,2.56E+07,5.94E+06,5,5,5,5,2.89E+06,1.86E+07,9.65E+06,9.81E+07,1.71E+07,3.70E+06,7.18E+06,3.15E+06,1.62E+05,8.26E+06,3.19E+06,2.56E+07,1.06E+07,4.53E+07,2.88E+07,1.49E+07,6.59E+05,5.94E+06,1.39E+06,7.53E+06,1.15E+04,7.09E+04,9.43E+04,9.81E+07,8.81E+05,1.32E+04,1.28E+05,2.91E+04,4.57E+03,8.78E+04,1.91E+04,1.14E+06,8.65E+04,6.10E+06,7.15E+05,2.91E+04,1.85E+05,4.21E+04,3.25E+04,8.01E+04,0,FALSE,46.165,27,9,264,27.8,11.27,9,cell organization and biogenesis,nucleus;other cell component,,,A0A994J4R3,ENSG00000184897,,,0,0,133.2,72.66,72.44,94.2,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,1,,FALSE,116.76,135.47,141.79,142.77,172.79,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 OS=Homo sapiens OX=9606 GN=THRAP3 PE=1 SV=2,17,66,2.455,0.265,2.239,0.493,1.3,-1.92,1.16,-1.02,3.42E-01,1.66E-01,3.47E-01,6.19E-01,2.67E+06,6.52E+05,5.60E+05,1.90E+06,5,5,5,5,1.06E+06,2.67E+06,2.18E+06,1.87E+07,1.63E+07,6.96E+05,3.89E+05,6.52E+05,3.84E+05,5.84E+06,5.60E+05,1.84E+06,5.51E+05,5.63E+06,4.52E+05,1.90E+06,4.24E+05,2.82E+07,6.78E+05,2.13E+07,4.21E+03,1.01E+04,2.13E+04,1.87E+07,8.43E+05,2.48E+03,6.91E+03,6.01E+03,1.08E+04,6.21E+04,3.35E+03,8.24E+04,4.47E+03,7.59E+05,1.12E+04,3.70E+03,1.19E+05,2.00E+05,1.59E+04,2.26E+05,0,FALSE,88.578,23,16,955,108.6,10.15,17,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf15440,9967,D3DPS5; hsa:9967; Q5VTK6; Q9Y2W1,ENSG00000054118,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation,Interactome of polycomb repressive complex 2 (PRC2),3,1,104.74,149.45,122.45,126.22,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,120.43,117.25,133.85,140.1,188.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,G8JLA2,MYL6,Myosin light chain 6 OS=Homo sapiens OX=9606 GN=MYL6 PE=1 SV=1,9,178,2.453,0.716,1.749,1.277,1.29,-0.48,0.81,0.35,3.66E-01,9.59E-01,5.60E-01,7.69E-01,3.90E+07,1.16E+07,2.47E+07,1.25E+07,5,5,5,5,1.21E+08,2.56E+07,5.51E+07,3.90E+07,1.06E+07,2.84E+07,1.16E+07,4.97E+07,7.60E+06,4.63E+06,8.66E+06,2.47E+07,1.51E+07,2.80E+07,3.88E+07,4.93E+07,1.60E+07,1.08E+07,1.25E+07,3.23E+06,4.81E+05,9.71E+04,5.38E+05,3.90E+07,5.48E+05,1.01E+05,2.06E+05,4.58E+05,2.14E+05,4.92E+04,5.18E+04,1.10E+06,1.22E+05,3.78E+06,9.65E+05,9.61E+04,4.50E+06,7.67E+04,2.92E+05,3.44E+04,0,FALSE,82.601,76,8,152,17.1,4.55,9,,,,,G8JLA2,ENSG00000092841,,Ciliary landscape,1,2,85.28,92.21,50.76,97.43,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,128.48,129.13,123.26,124.87,525.13,other molecular function,0,
Master Protein,High,Q6UXH1,CRELD2,Protein disulfide isomerase CRELD2 OS=Homo sapiens OX=9606 GN=CRELD2 PE=1 SV=1,1,2,2.452,0.174,9.356,0.046,1.29,-2.53,3.23,-4.46,3.57E-01,1.71E-01,6.04E-02,2.27E-02,6.57E+04,2.68E+04,1.14E+04,2.51E+05,2,2,1,1,,9.87E+04,,4.37E+04,,,,,1.73E+04,4.15E+04,,1.14E+04,,,,,,2.51E+05,,,,3.75E+02,,4.37E+04,,,,,4.87E+02,4.41E+02,,5.10E+02,,,,,,1.78E+03,,,0,FALSE,7.19,5,1,353,38.2,4.59,1,,non-structural extracellular;ER/Golgi,Pf07645,79174,A5GZA2; A5GZA3; A5GZA4; A5GZA5; A5GZA6; hsa:79174; Q4W0V0; Q6UXH1; Q86UC0; Q9BU47,ENSG00000184164,,,0,0,54.56,58.19,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,44.55,62,66.93,0,7.12,other molecular function,0,
Master Protein,High,Q15363,TMED2,Transmembrane emp24 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=TMED2 PE=1 SV=1,2,11,2.45,0.211,0.702,1.004,1.29,-2.25,-0.51,0.01,3.32E-01,7.59E-02,6.01E-01,8.30E-01,2.29E+06,7.53E+05,5.31E+05,5.29E+05,2,2,5,3,,2.52E+06,,2.07E+06,,6.79E+05,,,8.35E+05,,2.45E+05,1.59E+05,5.31E+05,2.46E+06,5.49E+05,2.23E+06,5.29E+05,,7.36E+04,,,9.58E+03,,2.07E+06,,2.42E+03,,,2.35E+04,,1.46E+03,7.09E+03,4.31E+03,3.31E+05,1.37E+04,4.35E+03,1.49E+05,,1.72E+03,,0,FALSE,28.216,20,2,201,22.7,5.17,2,cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,other membranes;ER/Golgi;other cell component,Pf01105,10959,hsa:10959; Q15363,ENSG00000086598,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Pre-NOTCH Processing in Golgi; COPII-mediated vesicle transport; Cargo concentration in the ER,5q35 copy number variation,6,0,13.74,14.54,120.33,120.36,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,42.43,105.64,112.9,132.04,42.52,signal transduction activity or receptor binding,0,
Master Protein,High,Q6DD87,ZNF787,Zinc finger protein 787 OS=Homo sapiens OX=9606 GN=ZNF787 PE=1 SV=4,4,7,2.45,0.588,0.162,3.968,1.29,-0.77,-2.63,1.99,3.40E-01,8.38E-01,8.47E-02,1.45E-01,2.62E+05,6.54E+04,6.66E+05,1.91E+05,4,1,5,3,2.62E+05,2.61E+05,1.01E+05,8.94E+05,,6.54E+04,,,,,8.33E+05,1.74E+05,6.66E+05,1.19E+06,4.31E+05,1.91E+05,9.69E+04,,,3.26E+05,1.04E+03,9.93E+02,9.84E+02,8.94E+05,,2.33E+02,,,,,4.98E+03,7.76E+03,5.41E+03,1.60E+05,1.07E+04,3.72E+02,2.72E+04,,,3.47E+03,0,FALSE,17.086,15,4,382,40.4,7.96,4,other biological processes,nucleus,"Pf00096, Pf13465, Pf13912",126208,A0A087WUD1; hsa:126208; O00455; Q6DD87,ENSG00000142409,,,0,0,92.51,,58.64,56.31,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,1.11,119.17,0,99.52,22.04,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75915,ARL6IP5,PRA1 family protein 3 OS=Homo sapiens OX=9606 GN=ARL6IP5 PE=1 SV=1,3,58,2.446,0.799,0.858,7.107,1.29,-0.32,-0.22,2.83,3.39E-01,8.31E-01,7.27E-01,6.93E-02,2.80E+06,5.86E+05,4.98E+06,3.78E+05,5,2,5,2,1.09E+07,9.31E+04,6.89E+06,2.80E+06,7.28E+05,,,,4.50E+05,7.62E+05,8.22E+06,4.91E+06,4.98E+06,1.17E+06,5.14E+06,,6.66E+05,,2.15E+05,,4.33E+04,3.54E+02,6.74E+04,2.80E+06,3.76E+04,,,,1.27E+04,8.10E+03,4.92E+04,2.19E+05,4.05E+04,1.58E+05,1.28E+05,,1.87E+05,,5.02E+03,,0,FALSE,38.551,15,3,188,21.6,9.77,3,other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi,Pf03208,10550,B2R6V5; hsa:10550; O75915; Q53ES3; Q5KU08,ENSG00000144746,Glutamate Neurotransmitter Release Cycle,,1,0,106.36,36.35,51.18,72.5,High,Peak Found,High,High,High,n/a,n/a,n/a,Peak Found,Peak Found,High,High,High,High,High,n/a,High,n/a,Peak Found,n/a,1,Acetyl [N-Term],FALSE,96.78,131.06,0,127.52,225.72,,0,
Master Protein,High,O43390,HNRNPR,Heterogeneous nuclear ribonucleoprotein R OS=Homo sapiens OX=9606 GN=HNRNPR PE=1 SV=1,20,80,2.446,0.426,0.843,1.937,1.29,-1.23,-0.25,0.95,3.26E-01,4.74E-01,8.41E-01,5.07E-01,2.34E+06,1.28E+06,8.90E+06,1.12E+06,5,5,5,5,3.83E+05,1.37E+06,2.34E+06,4.12E+07,8.61E+06,2.94E+06,8.19E+05,1.28E+06,1.20E+06,5.41E+06,1.56E+06,1.58E+07,8.90E+06,4.01E+07,5.34E+06,1.12E+06,3.58E+05,7.15E+06,5.94E+05,6.35E+06,1.52E+03,5.19E+03,2.28E+04,4.12E+07,4.44E+05,1.05E+04,1.46E+04,1.18E+04,3.38E+04,5.75E+04,9.34E+03,7.07E+05,7.23E+04,5.40E+06,1.33E+05,2.19E+03,1.00E+05,5.07E+04,1.39E+04,6.76E+04,0,FALSE,84.695,36,15,633,70.9,8.13,20,RNA metabolism OR transcription;other metabolic processes,ER/Golgi;nucleus;other cell component,"Pf00076, Pf18360",10236,hsa:10236; O43390; Q2L7G6; Q5TEH1; Q9BV64; S4R3J4,ENSG00000125944; ENSG00000282958,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,mRNA processing,3,4,160.58,81.74,106.79,107.32,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,High,1,,FALSE,113.53,109.46,117.09,129.89,223.92,nucleic acid binding activity,0,
Master Protein,High,Q8N4C6,NIN,Ninein OS=Homo sapiens OX=9606 GN=NIN PE=1 SV=4,1,1,2.444,1.005,3.963,0.669,1.29,0.01,1.99,-0.58,2.86E-01,6.53E-01,1.88E-01,8.78E-01,4.73E+05,1.94E+05,3.03E+05,7.67E+05,2,1,5,2,2.32E+06,,,9.66E+04,,,1.94E+05,,,,1.67E+06,1.35E+05,8.70E+05,3.03E+05,3.03E+05,1.32E+06,4.47E+05,,,,9.20E+03,,,9.66E+04,,,3.44E+03,,,,9.98E+03,6.04E+03,7.07E+03,4.08E+04,7.53E+03,2.57E+03,1.26E+05,,,,0.009,FALSE,2.325,1,1,2090,243.1,5.03,1,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,,51199,A6NDB8; B7WPA3; C9JSB6; C9JSG2; C9JXL2; hsa:51199; Q5BKU3; Q6P0P6; Q8N4C6; Q9BWU6; Q9C012; Q9C013; Q9C014; Q9H5I6; Q9HAT7; Q9HBY5; Q9HCK7; Q9UH61,ENSG00000100503,,,0,0,130.09,,96.16,69.76,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,347.75,134.3,84.08,109.5,4.03,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q96NA2,RILP,Rab-interacting lysosomal protein OS=Homo sapiens OX=9606 GN=RILP PE=1 SV=1,2,5,2.435,0.01,2.626,0.01,1.28,-6.64,1.39,-6.64,3.00E-01,1.00E-17,4.34E-01,1.00E-17,4.06E+05,9.08E+04,,5.69E+05,2,1,,3,,2.21E+05,7.44E+05,,,,9.08E+04,,,,,,,,,5.69E+05,8.69E+05,,2.62E+04,,,8.40E+02,7.27E+03,,,,1.62E+03,,,,,,,,,1.11E+03,2.44E+05,,6.14E+02,,0,FALSE,6.806,6,2,401,44.2,5.59,2,cell organization and biogenesis;transport;other biological processes,other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component,"Pf09744, Pf11461",83547,B2RBQ8; hsa:83547; Q71RE6; Q96NA2; Q9BSL3; Q9BYS3,ENSG00000167705; ENSG00000274145,MHC class II antigen presentation,,1,0,76.63,,,87.52,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,0,,131.95,,14.25,other molecular function,0,
Master Protein,High,P30626,SRI,Sorcin OS=Homo sapiens OX=9606 GN=SRI PE=1 SV=1,3,13,2.434,0.991,1.569,0.152,1.28,-0.01,0.65,-2.72,3.56E-01,6.32E-01,6.17E-01,1.49E-01,5.82E+05,1.24E+06,3.43E+05,1.70E+06,3,5,4,5,,,1.48E+05,5.82E+05,3.40E+06,1.39E+06,1.24E+06,1.03E+06,4.81E+05,3.06E+06,,7.09E+05,1.08E+05,4.89E+05,2.41E+05,1.25E+06,1.70E+06,1.70E+07,5.11E+05,2.22E+07,,,1.44E+03,5.82E+05,1.75E+05,4.96E+03,2.20E+04,9.46E+03,1.35E+04,3.25E+04,,3.17E+04,8.76E+02,6.58E+04,5.98E+03,2.43E+03,4.78E+05,1.20E+05,1.20E+04,2.36E+05,0,FALSE,14.329,21,3,198,21.7,5.59,3,transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,"Pf13499, Pf13833",6717,A8MTH6; B4DKK2; D6W5Q0; hsa:6717; P30626,ENSG00000075142,Stimuli-sensing channels; Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels; Sodium/Calcium exchangers,,5,0,128.2,67.27,69,120.45,n/a,n/a,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,1,,FALSE,80.6,113.8,127.43,114.88,35.27,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9H9B4,SFXN1,Sideroflexin-1 OS=Homo sapiens OX=9606 GN=SFXN1 PE=1 SV=4,11,45,2.431,0.66,1.77,1.336,1.28,-0.6,0.82,0.42,3.71E-01,9.45E-01,5.21E-01,7.39E-01,5.46E+06,8.11E+05,4.93E+06,2.94E+06,5,5,5,5,2.88E+06,9.50E+06,2.26E+06,1.64E+07,5.46E+06,8.11E+05,9.76E+05,1.52E+06,6.17E+05,7.85E+05,4.89E+06,6.44E+06,7.38E+06,4.56E+06,4.93E+06,2.60E+06,2.94E+06,8.86E+06,1.23E+06,3.13E+06,1.14E+04,3.61E+04,2.21E+04,1.64E+07,2.81E+05,2.89E+03,1.74E+04,1.40E+04,1.74E+04,8.35E+03,2.93E+04,2.88E+05,5.99E+04,6.14E+05,1.22E+05,5.08E+03,8.26E+05,6.28E+04,2.88E+04,3.33E+04,0,FALSE,43.138,36,9,322,35.6,9.07,11,other metabolic processes;transport;other biological processes,other membranes;mitochondrion,Pf03820,94081,B3KPW3; D3DQN2; hsa:94081; Q9H9B4; Q9HA53,ENSG00000164466,,Metabolic Epileptic Disorders,1,2,79.7,36.93,21.52,78.66,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,108.34,102.02,145.92,134.25,119.34,transporter activity,0,
Master Protein,High,A0A8I5KT93,SETDB1,SET domain bifurcated histone lysine methyltransferase 1 OS=Homo sapiens OX=9606 GN=SETDB1 PE=1 SV=1,2,2,2.428,0.436,9.238,0.144,1.28,-1.2,3.21,-2.8,3.66E-01,5.83E-01,5.75E-02,1.55E-01,1.69E+05,3.38E+04,6.44E+04,3.12E+05,4,1,4,3,9.30E+04,3.33E+05,,3.06E+05,4.00E+04,,,,,3.38E+04,,9.24E+04,4.49E+04,1.03E+05,3.60E+04,3.12E+05,,8.07E+04,,8.23E+05,3.69E+02,1.27E+03,,3.06E+05,2.07E+03,,,,,3.59E+02,,4.13E+03,3.65E+02,1.38E+04,8.95E+02,6.09E+02,,5.72E+02,,8.76E+03,0,FALSE,4.493,2,2,1292,143.2,6.02,2,cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf00856, Pf01429, Pf05033, Pf18300, Pf18358, Pf18359",,A0A8I5KT93,ENSG00000143379,,Histone modifications; Pleural mesothelioma,2,0,76.75,,48.44,93.68,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,47.82,45.09,0,100.43,5.55,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P17987,TCP1,T-complex protein 1 subunit alpha OS=Homo sapiens OX=9606 GN=TCP1 PE=1 SV=1,9,39,2.426,0.439,2.293,0.583,1.28,-1.19,1.2,-0.78,3.72E-01,5.01E-01,3.54E-01,6.88E-01,7.07E+06,1.25E+06,1.43E+06,1.01E+07,5,5,5,5,1.43E+07,1.27E+07,4.23E+06,7.07E+05,7.07E+06,8.27E+06,1.25E+06,4.08E+06,3.24E+05,7.17E+05,6.52E+06,5.19E+05,1.43E+06,1.59E+06,4.13E+05,5.36E+06,1.08E+07,1.01E+07,1.19E+06,1.09E+07,5.67E+04,4.83E+04,4.13E+04,7.07E+05,3.65E+05,2.94E+04,2.22E+04,3.77E+04,9.14E+03,7.62E+03,3.90E+04,2.32E+04,1.16E+04,2.14E+05,1.03E+04,1.05E+04,3.05E+06,7.17E+04,2.78E+04,1.16E+05,0,FALSE,35.373,21,9,556,60.3,6.11,9,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;ER/Golgi;other cell component,Pf00118,6950,E1P5B2; hsa:6950; P17987; Q15556; Q5TCM3,ENSG00000120438,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,16p11.2 proximal deletion syndrome,8,0,72.97,113.66,120.8,55.89,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,1,,FALSE,128.22,126.49,125.1,132.39,82.69,other molecular function,0,
Master Protein,High,Q9BV40,VAMP8,Vesicle-associated membrane protein 8 OS=Homo sapiens OX=9606 GN=VAMP8 PE=1 SV=1,2,10,2.413,0.617,1.89,0.784,1.27,-0.7,0.92,-0.35,3.44E-01,9.32E-01,4.70E-01,9.36E-01,1.84E+06,1.28E+06,1.72E+06,2.10E+06,5,5,5,5,8.47E+05,4.15E+06,9.26E+05,1.84E+06,3.65E+06,1.32E+06,1.91E+05,9.72E+05,1.68E+06,1.28E+06,4.91E+05,1.72E+06,3.92E+05,1.76E+06,1.78E+06,2.52E+06,1.72E+05,6.77E+06,1.13E+06,2.10E+06,3.37E+03,1.58E+04,9.05E+03,1.84E+06,1.88E+05,4.69E+03,3.39E+03,8.97E+03,4.75E+04,1.36E+04,2.94E+03,7.68E+04,3.19E+03,2.37E+05,4.42E+04,4.92E+03,4.83E+04,4.80E+04,2.66E+04,2.24E+04,0,FALSE,5.137,24,2,100,11.4,7.34,2,cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf00957,8673,hsa:8673; O60625; Q53SP9; Q6IB09; Q9BV40,ENSG00000118640,Cargo recognition for clathrin-mediated endocytosis; ER-Phagosome pathway; Neutrophil degranulation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis,"Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins",8,0,67.32,51.63,58.56,99.74,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,100.61,56.46,101.88,91.33,19.23,other molecular function,0,
Master Protein,High,O60287,URB1,Nucleolar pre-ribosomal-associated protein 1 OS=Homo sapiens OX=9606 GN=URB1 PE=1 SV=4,3,6,2.412,0.332,0.985,1.291,1.27,-1.59,-0.02,0.37,3.17E-01,3.88E-01,9.33E-01,6.79E-01,3.07E+05,7.17E+04,5.69E+04,3.13E+04,4,3,5,3,,1.94E+06,3.09E+04,1.67E+05,5.67E+05,,2.33E+04,,2.38E+05,7.17E+04,4.30E+04,1.01E+04,7.98E+04,2.26E+05,5.69E+04,1.72E+05,4.40E+03,,3.13E+04,,,7.38E+03,3.02E+02,1.67E+05,2.92E+04,,4.14E+02,,6.71E+03,7.63E+02,2.57E+02,4.51E+02,6.48E+02,3.04E+04,1.41E+03,3.35E+02,1.24E+03,,7.33E+02,,0,FALSE,11.204,2,3,2271,254.2,6.47,3,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf11707, Pf16201",9875,D3DSE5; hsa:9875; O60287; Q96NX1; Q9NYQ1,ENSG00000142207,,,0,0,129.14,101.49,100.67,129.92,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,136.94,132.2,107.84,121.33,19.89,,0,
Master Protein,High,P09651,HNRNPA1,Heterogeneous nuclear ribonucleoprotein A1 OS=Homo sapiens OX=9606 GN=HNRNPA1 PE=1 SV=5,21,158,2.411,0.452,1.973,0.989,1.27,-1.15,0.98,-0.02,3.76E-01,5.29E-01,4.62E-01,9.47E-01,9.01E+06,6.46E+06,9.57E+06,1.45E+07,5,5,5,5,4.18E+06,9.01E+06,2.51E+06,8.57E+07,7.73E+07,9.97E+06,6.46E+06,7.68E+06,1.99E+06,6.43E+06,8.20E+06,9.57E+06,3.71E+06,9.50E+07,1.19E+07,1.45E+07,2.66E+06,4.94E+07,2.78E+06,4.13E+07,1.66E+04,3.43E+04,2.46E+04,8.57E+07,3.99E+06,3.54E+04,1.15E+05,7.08E+04,5.60E+04,6.84E+04,4.90E+04,4.27E+05,3.02E+04,1.28E+07,2.96E+05,2.82E+04,7.47E+05,3.50E+05,6.50E+04,4.40E+05,0,FALSE,144.532,51,18,372,38.7,9.13,21,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes,cytosol;nucleus;other cell component,"Pf00076, Pf11627",3178,A8K4Z8; hsa:3178; P09651; Q3MIB7; Q6PJZ7,ENSG00000135486,mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA; SARS-CoV-1-host interactions; SARS-CoV-1 modulates host translation machinery,mRNA processing,6,3,117.36,44.68,151.38,99.12,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,1,,FALSE,136.49,133.1,131.57,141.67,474.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q12872,SFSWAP,"Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3",1,1,2.403,0.195,0.01,100,1.26,-2.36,-6.64,6.64,3.68E-01,2.12E-01,1.00E-17,1.00E-17,6.53E+04,2.72E+04,1.27E+04,,2,1,1,,9.15E+04,,,4.66E+04,,,,,2.72E+04,,,1.27E+04,,,,,,,,,3.64E+02,,,4.66E+04,,,,,7.65E+02,,,5.69E+02,,,,,,,,,0,FALSE,5.771,1,1,951,104.8,8.05,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf01805, Pf09750",6433,B2RN45; B7ZM97; F5H6B8; hsa:6433; Q12872; Q6PJF7,ENSG00000061936,,mRNA processing,1,0,46.07,,,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,51.08,51.08,,,3.89,nucleic acid binding activity,0,
Master Protein,High,B0I1T2,MYO1G,Unconventional myosin-Ig OS=Homo sapiens OX=9606 GN=MYO1G PE=1 SV=2,10,18,2.403,0.587,0.32,5.588,1.26,-0.77,-1.64,2.48,3.70E-01,8.82E-01,2.88E-01,9.50E-02,9.59E+05,1.41E+05,1.42E+06,5.75E+04,4,3,5,2,,9.85E+05,9.34E+05,2.91E+06,3.92E+05,,,1.41E+05,1.07E+05,3.84E+05,7.26E+05,1.42E+06,2.90E+05,2.74E+06,1.80E+06,,1.23E+05,,2.69E+04,,,3.74E+03,9.13E+03,2.91E+06,2.02E+04,,,1.30E+03,3.02E+03,4.08E+03,4.34E+03,6.36E+04,2.35E+03,3.69E+05,4.48E+04,,3.45E+04,,6.30E+02,,0,FALSE,33.828,15,10,1018,116.4,8.73,10,cell adhesion;cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,"Pf00063, Pf06017",64005,B0I1T2; hsa:64005; Q8TEI9; Q8TES2; Q96BE2; Q96RI5; Q96RI6,ENSG00000136286,,,0,0,84.53,71.54,68.32,90.59,n/a,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,118.09,119.24,40.87,15.11,44.87,cytoskeletal activity;other molecular function,0,
Master Protein,High,P49711,CTCF,Transcriptional repressor CTCF OS=Homo sapiens OX=9606 GN=CTCF PE=1 SV=1,7,14,2.395,0.253,,0.857,1.26,-1.98,,-0.22,3.57E-01,1.61E-01,,9.68E-01,1.33E+06,1.36E+05,3.63E+05,1.86E+05,2,2,4,2,,4.42E+05,,4.03E+06,,,,9.74E+04,,1.90E+05,,6.04E+05,2.30E+05,5.18E+05,2.55E+05,,,4.16E+05,,8.28E+04,,1.68E+03,,4.03E+06,,,,8.98E+02,,2.02E+03,,2.70E+04,1.87E+03,6.99E+04,6.33E+03,,,2.95E+03,,8.81E+02,0,FALSE,43.126,16,7,727,82.7,6.96,7,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes,nucleus;other cell component,Pf00096,10664,B5MC38; hsa:10664; P49711; Q53XI7; Q59EL8,ENSG00000102974,Activation of anterior HOX genes in hindbrain development during early embryogenesis,MECP2 and associated Rett syndrome; Prion disease pathway; Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors; Sudden infant death syndrome (SIDS) susceptibility pathways,5,0,113.43,45.59,46.75,94.45,n/a,Peak Found,n/a,High,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,37.2,102.05,,14.77,44.54,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A7P0T824,VRK1,VRK serine/threonine kinase 1 OS=Homo sapiens OX=9606 GN=VRK1 PE=1 SV=1,4,20,2.395,1.3,0.292,3.817,1.26,0.38,-1.78,1.93,3.41E-01,2.87E-01,1.47E-01,1.66E-01,7.24E+05,1.00E+05,1.93E+06,4.86E+05,3,4,5,3,,,7.24E+05,2.76E+06,5.73E+05,5.32E+04,,1.88E+05,2.14E+05,3.75E+04,4.23E+06,1.73E+04,4.19E+05,4.96E+06,1.93E+06,9.43E+05,4.86E+05,,3.87E+05,,,,7.07E+03,2.76E+06,2.96E+04,1.89E+02,,1.74E+03,6.02E+03,3.99E+02,2.53E+04,7.71E+02,3.40E+03,6.68E+05,4.80E+04,1.84E+03,1.37E+05,,9.06E+03,,0,FALSE,25.672,16,4,444,50.3,7.52,4,,,Pf00069,,A0A7P0T824,ENSG00000100749,,,0,0,90.33,73.64,95.99,49.01,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,97.14,121.36,84.59,88.38,67.15,kinase activity;other molecular function,0,
Master Protein,High,P26583,HMGB2,High mobility group protein B2 OS=Homo sapiens OX=9606 GN=HMGB2 PE=1 SV=2,14,293,2.393,0.56,1.924,0.955,1.26,-0.84,0.94,-0.07,3.81E-01,7.54E-01,4.82E-01,9.72E-01,1.20E+08,2.47E+07,3.12E+07,6.08E+07,5,5,5,5,3.45E+06,1.86E+08,6.46E+06,1.20E+08,1.43E+08,2.47E+07,1.58E+07,8.07E+07,9.75E+06,6.38E+07,1.13E+07,3.46E+07,3.12E+07,1.43E+08,3.04E+07,1.60E+08,1.07E+07,6.08E+07,2.63E+07,1.12E+08,1.37E+04,7.07E+05,6.31E+04,1.20E+08,7.35E+06,8.78E+04,2.82E+05,7.44E+05,2.75E+05,6.78E+05,6.73E+04,1.55E+06,2.54E+05,1.93E+07,7.54E+05,3.12E+05,3.01E+06,4.31E+05,6.16E+05,1.19E+06,0,FALSE,156.141,51,12,209,24,7.81,14,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;nucleus;other cell component,"Pf00505, Pf09011",3148,B2R4K8; D3DP37; hsa:3148; P26583; Q5U072,ENSG00000164104,Apoptosis induced DNA fragmentation,Retinoblastoma gene in cancer; Ectoderm differentiation; Ectoderm differentiation,4,0,90.17,80.65,105.31,83.62,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,146.13,141.2,141.7,139.81,916.41,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P30044,PRDX5,"Peroxiredoxin-5, mitochondrial OS=Homo sapiens OX=9606 GN=PRDX5 PE=1 SV=4",5,17,2.375,0.786,0.744,1.14,1.25,-0.35,-0.43,0.19,3.66E-01,8.19E-01,7.37E-01,8.34E-01,9.92E+05,8.32E+05,3.14E+06,1.49E+06,4,3,5,3,1.23E+06,,5.48E+05,6.72E+06,7.99E+05,,8.32E+05,,4.79E+05,8.48E+05,2.95E+05,4.84E+06,2.43E+06,6.54E+06,3.14E+06,,1.32E+05,,2.05E+06,1.49E+06,4.89E+03,,5.36E+03,6.72E+06,4.12E+04,,1.48E+04,,1.35E+04,9.02E+03,1.76E+03,2.16E+05,1.98E+04,8.81E+05,7.80E+04,,3.72E+04,,4.80E+04,1.58E+04,0,FALSE,15.831,32,5,214,22.1,8.7,5,other metabolic processes;stress response;other biological processes,cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,Pf08534,25824,A6NC19; A6NG06; B7ZLJ4; B7ZVW3; hsa:25824; P30044; Q14CK0; Q6IAF2; Q9UBU5; Q9UJU4; Q9UKX4,ENSG00000126432,,Selenium micronutrient network,1,0,126.64,29.04,68.84,80.59,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,n/a,Peak Found,n/a,High,Peak Found,1,,FALSE,96.7,108.09,193.75,122.48,45.4,signal transduction activity or receptor binding;enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P18077,RPL35A,60S ribosomal protein L35a OS=Homo sapiens OX=9606 GN=RPL35A PE=1 SV=2,2,6,2.373,0.624,2.652,0.607,1.25,-0.68,1.41,-0.72,3.16E-01,9.14E-01,3.88E-01,7.83E-01,3.21E+05,2.27E+05,3.41E+05,6.73E+05,2,3,5,5,2.28E+05,,,4.53E+05,,,,2.27E+05,1.93E+05,2.71E+05,1.32E+06,2.16E+05,7.72E+04,1.43E+06,3.41E+05,1.25E+06,1.61E+06,5.40E+05,4.93E+05,6.73E+05,9.05E+02,,,4.53E+05,,,,2.09E+03,5.42E+03,2.88E+03,7.88E+03,9.63E+03,6.27E+02,1.93E+05,8.49E+03,2.43E+03,4.52E+05,3.83E+03,1.15E+04,7.16E+03,0,FALSE,4.294,15,2,110,12.5,11.06,2,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,Pf01247,6165,hsa:6165; P18077; Q08ES9; Q9BVN7,ENSG00000182899,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,46.72,17.13,95.36,53.92,Peak Found,n/a,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,74,105.29,83.21,122.2,9.85,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8TCS8,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PNPT1 PE=1 SV=2",3,10,2.371,1.746,0.693,2.002,1.25,0.8,-0.53,1,3.32E-01,1.86E-01,5.96E-01,4.01E-01,6.04E+05,1.59E+05,5.28E+05,3.39E+05,5,2,5,2,2.18E+06,8.88E+05,6.04E+05,2.12E+05,7.03E+04,1.19E+06,,,2.13E+04,,5.28E+05,4.30E+05,1.31E+06,2.48E+05,5.71E+05,,5.25E+05,,2.19E+05,,8.65E+03,3.37E+03,5.90E+03,2.12E+05,3.63E+03,4.23E+03,,,6.01E+02,,3.16E+03,1.92E+04,1.06E+04,3.34E+04,1.42E+04,,1.47E+05,,5.12E+03,,0,FALSE,15.862,6,3,783,85.9,7.77,3,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;other biological processes,other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00013, Pf00575, Pf01138, Pf03725, Pf03726",87178,hsa:87178; Q53SU0; Q68CN1; Q7Z7D1; Q8IWX1; Q8TCS8; Q96T05; Q9BRU3; Q9BVX0,ENSG00000138035,Mitochondrial RNA degradation,Pyrimidine metabolism; miRNA degrading enzymes,3,0,106.26,136.44,65.89,58.21,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,137.25,117.55,65.74,59.63,32.89,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P52272,HNRNPM,Heterogeneous nuclear ribonucleoprotein M OS=Homo sapiens OX=9606 GN=HNRNPM PE=1 SV=3,34,151,2.353,0.392,0.871,1.076,1.23,-1.35,-0.2,0.11,3.91E-01,4.03E-01,7.58E-01,8.87E-01,2.30E+07,9.06E+06,1.64E+07,5.46E+06,5,5,5,5,2.30E+07,1.79E+07,1.19E+07,1.07E+08,4.66E+07,5.56E+06,9.06E+06,1.01E+07,1.28E+07,8.49E+06,1.64E+07,2.22E+07,1.20E+07,3.48E+07,1.46E+07,5.46E+06,7.97E+04,1.32E+07,4.32E+06,2.26E+07,9.13E+04,6.81E+04,1.17E+05,1.07E+08,2.40E+06,1.98E+04,1.61E+05,9.32E+04,3.61E+05,9.03E+04,9.80E+04,9.91E+05,9.77E+04,4.68E+06,3.64E+05,1.07E+04,2.24E+04,9.39E+04,1.01E+05,2.40E+05,0,FALSE,175.919,55,19,730,77.5,8.7,34,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00076, Pf11532",4670,hsa:4670; P52272; Q15584; Q8WZ44; Q96H56; Q9BWL9; Q9Y492,ENSG00000099783,mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA,mRNA processing,4,15,94.4,28.51,45.29,97.26,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,119.55,115.49,132.44,139.53,433.96,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P30876,POLR2B,DNA-directed RNA polymerase II subunit RPB2 OS=Homo sapiens OX=9606 GN=POLR2B PE=1 SV=1,14,45,2.353,0.483,1.994,1.487,1.23,-1.05,1,0.57,3.50E-01,6.28E-01,5.97E-01,5.82E-01,2.55E+06,3.57E+05,1.44E+06,3.27E+05,5,5,5,5,4.62E+06,8.65E+05,2.55E+06,5.70E+06,3.14E+05,3.88E+05,5.51E+05,2.48E+05,1.98E+05,3.57E+05,1.44E+06,8.10E+05,8.73E+05,3.11E+06,2.19E+06,1.03E+05,4.12E+05,1.90E+05,3.27E+05,3.49E+05,1.83E+04,3.29E+03,2.49E+04,5.70E+06,1.62E+04,1.38E+03,9.80E+03,2.28E+03,5.58E+03,3.79E+03,8.62E+03,3.62E+04,7.09E+03,4.19E+05,5.45E+04,2.02E+02,1.16E+05,1.35E+03,7.66E+03,3.71E+03,0,FALSE,50.499,17,14,1174,133.8,6.87,14,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00562, Pf04560, Pf04561, Pf04563, Pf04565, Pf04566, Pf04567",5431,A8K1A8; hsa:5431; P30876; Q8IZ61,ENSG00000047315,mRNA Splicing - Major Pathway; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,Pyrimidine metabolism; Eukaryotic transcription initiation,43,0,82.87,39.46,57.58,45.63,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,94.26,114.84,81.51,69.34,134.36,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O00231,PSMD11,26S proteasome non-ATPase regulatory subunit 11 OS=Homo sapiens OX=9606 GN=PSMD11 PE=1 SV=3,4,12,2.346,0.769,2.293,0.117,1.23,-0.38,1.2,-3.09,3.15E-01,8.98E-01,4.04E-01,1.02E-01,4.83E+05,1.57E+05,1.42E+05,1.57E+06,4,4,4,3,5.80E+05,4.02E+05,,2.65E+05,7.93E+05,6.80E+05,,1.76E+05,4.06E+04,1.39E+05,,1.30E+05,1.56E+05,1.56E+05,6.70E+04,,1.57E+06,2.04E+06,2.19E+05,,2.30E+03,1.53E+03,,2.65E+05,4.09E+04,2.42E+03,,1.63E+03,1.14E+03,1.48E+03,,5.80E+03,1.26E+03,2.11E+04,1.67E+03,,4.41E+05,1.44E+04,5.13E+03,,0,FALSE,12.067,14,4,422,47.4,6.48,4,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf01399, Pf18055, Pf18503",5717,A8K3I7; E1P663; hsa:5717; O00231; O00495; Q53FT5,ENSG00000108671,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Parkin-ubiquitin proteasomal system pathway; VEGFA-VEGFR2 signaling,63,0,44.76,110.6,32.99,74.02,Peak Found,Peak Found,n/a,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,114.18,74.39,126.21,71.63,32.56,other molecular function,0,
Master Protein,High,Q6FI13,H2AC18; H2AC19,Histone H2A type 2-A OS=Homo sapiens OX=9606 GN=H2AC18 PE=1 SV=3,11,1476,2.346,0.953,0.465,5.498,1.23,-0.07,-1.11,2.46,3.93E-01,6.36E-01,2.68E-01,1.12E-01,1.15E+08,1.94E+07,2.48E+07,2.72E+07,5,5,5,5,2.69E+07,3.51E+07,1.15E+08,2.23E+08,1.34E+08,8.22E+07,1.74E+07,1.94E+07,7.26E+06,3.60E+07,1.05E+07,5.44E+08,7.41E+07,2.42E+07,2.48E+07,2.72E+07,1.30E+06,5.95E+07,1.46E+06,1.49E+08,1.07E+05,1.34E+05,1.13E+06,2.23E+08,6.92E+06,2.92E+05,3.09E+05,1.79E+05,2.05E+05,3.83E+05,6.26E+04,2.43E+07,6.02E+05,3.26E+06,6.16E+05,5.30E+04,3.65E+05,4.22E+05,3.43E+04,1.59E+06,0,FALSE,126.257,66,3,130,14.1,10.9,11,,nucleus;other cell component,"Pf00125, Pf16211",723790; 8337,B2R5F0; hsa:723790; hsa:8337; P20670; Q6FI13,ENSG00000288825; ENSG00000288859,UCH proteinases; Ub-specific processing proteases; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Formation of the beta-catenin:TCF transactivating complex; Activation of anterior HOX genes in hindbrain development during early embryogenesis; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Oxidative Stress Induced Senescence; Amyloid fiber formation; Meiotic synapsis; HCMV Late Events; HCMV Early Events; Transcriptional regulation by small RNAs; Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Estrogen-dependent gene expression; Metalloprotease DUBs; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RMTs methylate histone arginines; HATs acetylate histones; Chromatin modifications during the maternal to zygotic transition (MZT); RNA Polymerase I Promoter Escape; Meiotic recombination; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Packaging Of Telomere Ends; Condensation of Prophase Chromosomes; DNA Damage/Telomere Stress Induced Senescence; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis,,42,0,75.27,91.42,169.4,128.99,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,Peak Found,High,1,,FALSE,111.82,144.13,141.11,144.46,3702.15,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q14677,CLINT1,Clathrin interactor 1 OS=Homo sapiens OX=9606 GN=CLINT1 PE=1 SV=1,6,13,2.344,0.753,2.709,0.282,1.23,-0.41,1.44,-1.83,3.17E-01,9.19E-01,3.90E-01,3.40E-01,4.06E+05,1.63E+05,4.80E+05,5.63E+05,5,3,5,4,8.08E+04,4.36E+05,7.37E+04,4.06E+05,1.58E+06,3.92E+06,,,4.76E+04,1.63E+05,6.80E+05,2.12E+05,4.08E+05,6.01E+05,4.80E+05,3.75E+06,5.62E+05,5.64E+05,3.45E+05,,3.21E+02,1.65E+03,7.20E+02,4.06E+05,8.15E+04,1.39E+04,,,1.34E+03,1.74E+03,4.07E+03,9.48E+03,3.31E+03,8.10E+04,1.19E+04,7.31E+03,1.58E+05,3.99E+03,8.07E+03,,0,FALSE,21.596,15,6,625,68.2,6.42,6,cell organization and biogenesis;transport,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf01417,9685,B7Z6F8; D3DQJ6; hsa:9685; Q14677; Q8NAF1; Q96E05,ENSG00000113282,Golgi Associated Vesicle Biogenesis,,1,0,120.3,159.99,38.09,125.1,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,119.57,107.41,129.19,122.9,36.35,other molecular function,0,
Master Protein,High,A0A7P0T9U7,SF1,Splicing factor 1 OS=Homo sapiens OX=9606 GN=SF1 PE=1 SV=1,7,17,2.341,0.18,0.685,0.531,1.23,-2.47,-0.55,-0.91,3.55E-01,5.47E-02,5.49E-01,6.85E-01,1.62E+06,3.05E+05,1.35E+05,4.79E+05,5,4,5,4,3.77E+05,1.62E+06,5.50E+05,4.72E+06,4.78E+06,,3.48E+05,2.67E+05,1.33E+05,3.68E+06,3.07E+04,1.35E+05,2.19E+05,9.33E+05,4.30E+04,,2.93E+03,4.04E+06,6.41E+04,3.58E+06,1.50E+03,6.16E+03,5.37E+03,4.72E+06,2.47E+05,,6.19E+03,2.46E+03,3.75E+03,3.91E+04,1.83E+02,6.02E+03,1.78E+03,1.26E+05,1.07E+03,,8.24E+02,2.86E+04,1.50E+03,3.81E+04,0,FALSE,30.849,13,7,764,80.3,9.2,7,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00013, Pf00098, Pf16275",,A0A7P0T9U7,ENSG00000168066,,,0,0,90.87,155.12,138.69,113.89,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,120.78,100.1,142.78,142.89,55.92,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13151,HNRNPA0,Heterogeneous nuclear ribonucleoprotein A0 OS=Homo sapiens OX=9606 GN=HNRNPA0 PE=1 SV=1,8,33,2.338,0.276,2.624,0.29,1.23,-1.86,1.39,-1.79,3.69E-01,1.75E-01,2.43E-01,2.83E-01,1.70E+06,5.76E+05,1.11E+06,3.24E+06,5,4,5,5,2.32E+05,6.20E+05,1.70E+06,7.18E+06,1.48E+07,1.59E+06,1.57E+05,4.19E+05,,7.94E+05,3.65E+05,1.11E+06,8.36E+05,7.95E+06,2.02E+06,9.18E+05,1.53E+05,4.60E+06,3.24E+06,9.06E+06,9.23E+02,2.36E+03,1.66E+04,7.18E+06,7.61E+05,5.66E+03,2.79E+03,3.86E+03,,8.44E+03,2.18E+03,4.95E+04,6.79E+03,1.07E+06,5.02E+04,1.79E+03,4.29E+04,3.26E+04,7.58E+04,9.65E+04,0,FALSE,46.886,36,8,305,30.8,9.29,8,RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf00076,10949,hsa:10949; Q13151; Q6IB18,ENSG00000177733,,,0,0,126.14,84.46,127.48,98.43,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,121.43,102.15,138.51,145.48,102.76,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P21281,ATP6V1B2,"V-type proton ATPase subunit B, brain isoform OS=Homo sapiens OX=9606 GN=ATP6V1B2 PE=1 SV=3",4,15,2.334,0.364,1.387,0.975,1.22,-1.46,0.47,-0.04,3.15E-01,4.27E-01,8.44E-01,8.67E-01,3.99E+05,8.64E+04,2.72E+05,1.90E+05,5,3,5,4,2.28E+06,3.99E+05,8.26E+05,3.58E+05,2.61E+04,,,8.64E+04,5.64E+04,2.11E+05,6.01E+05,2.72E+05,2.24E+05,1.92E+05,3.19E+05,,4.67E+05,1.20E+05,3.02E+05,4.82E+04,9.06E+03,1.52E+03,8.07E+03,3.58E+05,1.35E+03,,,7.97E+02,1.59E+03,2.25E+03,3.59E+03,1.21E+04,1.82E+03,2.59E+04,7.93E+03,,1.31E+05,8.49E+02,7.07E+03,5.13E+02,0,FALSE,15.689,13,4,511,56.5,5.81,4,cell organization and biogenesis;other metabolic processes;transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00006, Pf02874",526,B2R5Z3; D3DSQ5; hsa:526; P21281; Q14544; Q15859; Q96IR0,ENSG00000147416,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,,5,0,113.96,69.57,50.79,80.44,High,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,127.94,122.45,87.61,76.75,31.45,transporter activity;other molecular function,0,
Master Protein,High,P12956,XRCC6,X-ray repair cross-complementing protein 6 OS=Homo sapiens OX=9606 GN=XRCC6 PE=1 SV=2,17,93,2.328,0.349,1.028,1.149,1.22,-1.52,0.04,0.2,3.98E-01,3.12E-01,9.23E-01,8.42E-01,1.64E+07,3.79E+06,4.77E+06,4.72E+06,5,5,5,5,1.64E+07,1.22E+07,1.22E+07,2.25E+07,4.27E+07,7.56E+06,1.76E+06,3.79E+06,8.19E+05,5.34E+06,1.23E+07,4.77E+06,3.77E+06,2.28E+07,3.58E+06,7.36E+06,1.38E+06,7.88E+06,4.72E+06,4.71E+06,6.51E+04,4.62E+04,1.19E+05,2.25E+07,2.20E+06,2.69E+04,3.13E+04,3.49E+04,2.31E+04,5.68E+04,7.33E+04,2.13E+05,3.06E+04,3.07E+06,8.90E+04,1.44E+04,3.87E+05,5.58E+04,1.11E+05,5.02E+04,0,FALSE,75.281,33,17,609,69.8,6.64,17,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf02037, Pf02735, Pf03730, Pf03731",2547,B1AHC8; hsa:2547; P12956; Q6FG89; Q9UCQ2; Q9UCQ3,ENSG00000196419,Neutrophil degranulation; Cytosolic sensors of pathogen-associated DNA ; Nonhomologous End-Joining (NHEJ); 2-LTR circle formation; IRF3-mediated induction of type I IFN,"Non-homologous end joining; DNA repair pathways, full network; Primary ovarian insufficiency; HDAC6 interactions in the central nervous system",9,0,60.26,70.56,87.81,49.81,High,High,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,113.54,125.43,123.26,121.61,264.41,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P67812,SEC11A,Signal peptidase complex catalytic subunit SEC11A OS=Homo sapiens OX=9606 GN=SEC11A PE=1 SV=1,1,5,2.328,0.374,0.393,1.534,1.22,-1.42,-1.35,0.62,3.82E-01,4.14E-01,2.57E-01,5.74E-01,9.99E+05,4.29E+05,2.59E+05,1.69E+05,5,3,5,1,1.31E+06,9.99E+05,3.73E+05,1.62E+06,2.44E+05,1.41E+06,,4.29E+05,5.20E+04,,2.77E+06,1.70E+04,2.59E+05,1.26E+06,9.12E+04,1.69E+05,,,,,5.19E+03,3.80E+03,3.64E+03,1.62E+06,1.26E+04,5.00E+03,,3.96E+03,1.47E+03,,1.65E+04,7.61E+02,2.10E+03,1.70E+05,2.27E+03,3.29E+02,,,,,0.001,FALSE,3.238,7,1,179,20.6,9.48,1,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf00717,23478,B2RAD7; B4DUL4; H0YK72; H0YK83; hsa:23478; O75957; P21378; P67812; Q53FQ8,ENSG00000140612,"SRP-dependent cotranslational protein targeting to membrane; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP); Maturation of hRSV A proteins; Synthesis, secretion, and deacylation of Ghrelin",15q25 copy number variation,6,0,65.15,111.1,132.88,,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,112.01,131.9,130.28,138.49,7.26,other molecular function,0,
Master Protein,High,Q16543,CDC37,Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1,2,3,2.322,0.134,1.399,0.222,1.22,-2.9,0.48,-2.17,3.89E-01,8.82E-02,8.25E-01,3.08E-01,1.15E+05,6.41E+04,7.29E+03,3.28E+04,5,1,1,3,3.75E+04,1.18E+05,5.45E+04,1.15E+05,9.68E+05,,,,,6.41E+04,,,,,7.29E+03,,6.79E+03,,3.28E+04,7.58E+04,1.49E+02,4.49E+02,5.33E+02,1.15E+05,5.00E+04,,,,,6.81E+02,,,,,1.81E+02,,1.91E+03,,7.68E+02,8.07E+02,0,FALSE,5.036,5,2,378,44.4,5.25,2,protein metabolism;other metabolic processes;stress response;other biological processes,cytosol;other cell component,"Pf03234, Pf08564, Pf08565",11140,hsa:11140; Q16543; Q53YA2,ENSG00000105401,RHOBTB2 GTPase cycle; Regulation of necroptotic cell death; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; Constitutive Signaling by Overexpressed ERBB2; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants,TNF-alpha signaling pathway; Aryl hydrocarbon receptor pathway; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Interactions between LOXL4 and oxidative stress pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway,27,0,154.03,,,90.57,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,46.16,46.16,117.6,117.6,7.05,enzyme regulator activity;other molecular function,0,
Master Protein,High,P40227,CCT6A,T-complex protein 1 subunit zeta OS=Homo sapiens OX=9606 GN=CCT6A PE=1 SV=3,10,33,2.315,0.639,2.258,0.593,1.21,-0.65,1.18,-0.75,4.01E-01,9.07E-01,3.64E-01,6.99E-01,3.61E+06,2.80E+06,2.26E+06,1.11E+07,5,5,5,5,1.56E+07,3.61E+06,6.04E+06,1.66E+06,3.50E+06,6.43E+06,8.84E+04,2.89E+06,6.44E+04,2.80E+06,8.79E+06,6.38E+05,1.67E+06,3.45E+06,2.26E+06,1.01E+07,1.11E+07,2.05E+07,1.18E+07,2.33E+06,6.22E+04,1.37E+04,5.90E+04,1.66E+06,1.81E+05,2.29E+04,1.57E+03,2.66E+04,1.81E+03,2.98E+04,5.26E+04,2.85E+04,1.36E+04,4.64E+05,5.61E+04,1.96E+04,3.11E+06,1.45E+05,2.77E+05,2.48E+04,0,FALSE,48.907,25,9,531,58,6.68,10,protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;other cell component,Pf00118,908,A6NCD2; hsa:908; P40227; Q3KP28; Q75LP4; Q96S46,ENSG00000146731,Formation of tubulin folding intermediates by CCT/TriC; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; RHOBTB2 GTPase cycle; Folding of actin by CCT/TriC,16p11.2 proximal deletion syndrome,7,1,91.37,106.72,95.24,57.78,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,133.45,120.02,133.38,119.64,77.3,other molecular function,0,
Master Protein,High,Q9NQC3,RTN4,Reticulon-4 OS=Homo sapiens OX=9606 GN=RTN4 PE=1 SV=2,6,41,2.309,0.766,3.314,0.707,1.21,-0.38,1.73,-0.5,3.78E-01,8.80E-01,1.62E-01,8.17E-01,2.67E+06,1.59E+06,3.79E+06,4.35E+06,5,5,5,5,1.25E+06,2.67E+06,1.85E+06,5.20E+06,7.02E+06,2.97E+05,2.45E+05,1.59E+06,3.82E+06,3.16E+06,1.55E+06,2.00E+06,5.64E+06,4.07E+06,3.79E+06,4.41E+06,4.65E+06,1.95E+06,4.34E+06,4.35E+06,4.96E+03,1.01E+04,1.81E+04,5.20E+06,3.62E+05,1.06E+03,4.36E+03,1.46E+04,1.08E+05,3.36E+04,9.25E+03,8.94E+04,4.58E+04,5.48E+05,9.42E+04,8.61E+03,1.31E+06,1.38E+04,1.02E+05,4.63E+04,0,FALSE,41.58,10,6,1192,129.9,4.5,6,cell adhesion;cell organization and biogenesis;stress response;developmental processes;other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cell component,Pf02453,57142,O94962; Q7L7Q5; Q7L7Q6; Q7L7Q8; Q8IUA4; Q96B16; Q9BXG5; Q9H212; Q9H3I3; Q9NQC3; Q9UQ42; Q9Y293; Q9Y2Y7; Q9Y5U6,ENSG00000115310,Axonal growth inhibition (RHOA activation),Alzheimer's disease and miRNA effects; Spinal cord injury; 22q11.2 copy number variation syndrome; Alzheimer's disease; Neurogenesis regulation in the olfactory epithelium; 13q12.12 copy number variation,7,0,67.67,89.56,48.64,28.44,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,Acetyl [N-Term],FALSE,132.12,123.27,139.23,91.47,129.35,other molecular function,0,
Master Protein,High,O43852,CALU,Calumenin OS=Homo sapiens OX=9606 GN=CALU PE=1 SV=2,9,24,2.309,0.438,10.298,1.042,1.21,-1.19,3.36,0.06,4.03E-01,5.01E-01,4.46E-03,8.43E-01,2.36E+06,8.11E+06,2.27E+06,1.12E+06,4,3,5,3,2.10E+06,2.99E+05,,5.60E+06,2.65E+06,,,6.78E+06,8.11E+06,1.95E+07,2.11E+05,1.69E+04,2.27E+06,2.53E+06,5.57E+06,1.20E+06,1.12E+06,,3.81E+05,,8.35E+03,1.14E+03,,5.60E+06,1.37E+05,,,6.26E+04,2.28E+05,2.07E+05,1.26E+03,7.54E+02,1.85E+04,3.41E+05,1.39E+05,2.34E+03,3.15E+05,,8.91E+03,,0,FALSE,72.964,41,9,315,37.1,4.64,9,,non-structural extracellular;other membranes;cytosol;ER/Golgi;other cell component,Pf13202,813,B3KPG9; D6QS48; D6QS49; D6QS50; D6QS51; D6QS52; D6QS53; D6QS54; D6QS55; D6QS56; D6QS57; D6QS58; D6QS59; F5H1Q9; F5H879; hsa:813; O43852; O60456; Q6FHB9; Q96RL3; Q9NR43,ENSG00000128595,Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,NOTCH1 regulation of endothelial cell calcification; VEGFA-VEGFR2 signaling,5,0,82.64,60.87,105.93,50.18,Peak Found,Peak Found,n/a,High,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,n/a,Peak Found,n/a,1,Phospho [S44; Y47],FALSE,145.1,98.78,53.34,96,78.19,other molecular function,2,Phospho [S44; Y47]
Master Protein,High,P14174,MIF,Macrophage migration inhibitory factor OS=Homo sapiens OX=9606 GN=MIF PE=1 SV=4,1,3,2.289,1.043,1.574,1.603,1.19,0.06,0.65,0.68,3.71E-01,4.63E-01,7.22E-01,5.58E-01,1.19E+06,5.21E+05,1.87E+06,8.21E+05,3,1,3,4,,5.76E+05,,1.19E+06,1.11E+07,,,,,5.21E+05,,2.88E+06,,1.87E+06,6.01E+05,1.80E+06,1.30E+05,,3.75E+05,1.57E+07,,2.19E+03,,1.19E+06,5.71E+05,,,,,5.54E+03,,1.28E+05,,2.52E+05,1.49E+04,3.50E+03,3.64E+04,,8.77E+03,1.67E+05,0.002,FALSE,2.979,8,1,115,12.5,7.88,1,cell organization and biogenesis;other metabolic processes;stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf01187,4282,A5Z1R8; B2R4S3; hsa:4282; P14174; Q2V4Y5; Q6FHV0,ENSG00000240972; ENSG00000276701,Neutrophil degranulation; Cell surface interactions at the vascular wall; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Adipogenesis; Spinal cord injury; HDAC6 interactions in the central nervous system,6,0,137.58,,63.92,166.78,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,76.68,124.22,150.53,140.99,6.59,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P16104,H2AX,Histone H2AX OS=Homo sapiens OX=9606 GN=H2AX PE=1 SV=2,11,1061,2.278,0.426,0.672,0.508,1.19,-1.23,-0.57,-0.98,4.12E-01,4.75E-01,5.86E-01,6.55E-01,2.66E+07,4.13E+05,4.51E+05,4.36E+05,5,5,5,5,2.59E+07,8.99E+06,1.54E+08,3.05E+07,2.66E+07,1.04E+07,4.13E+05,3.32E+05,4.65E+04,1.46E+06,9.61E+07,1.24E+07,1.11E+05,8.85E+04,4.51E+05,2.02E+06,1.50E+04,5.43E+05,2.20E+05,4.36E+05,1.03E+05,3.41E+04,1.51E+06,3.05E+07,1.37E+06,3.71E+04,7.34E+03,3.07E+03,1.31E+03,1.55E+04,5.74E+05,5.54E+05,9.05E+02,1.19E+04,1.12E+04,3.94E+03,4.23E+03,3.85E+03,5.15E+03,4.65E+03,0,FALSE,100.31,64,2,143,15.1,10.74,11,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytoskeleton;nucleus;other cell component,"Pf00125, Pf16211",3014,hsa:3014; P16104; Q4ZGJ7; Q6IAS5,ENSG00000188486,RUNX1 regulates transcription of genes involved in differentiation of HSCs; RMTs methylate histone arginines; Amyloid fiber formation; Meiotic synapsis; Transcriptional regulation by small RNAs; Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Chromatin modifications during the maternal to zygotic transition (MZT); RNA Polymerase I Promoter Escape; Meiotic recombination; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Packaging Of Telomere Ends; Condensation of Prophase Chromosomes; DNA Damage/Telomere Stress Induced Senescence; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; Nonhomologous End-Joining (NHEJ); RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis; Replacement of protamines by nucleosomes in the male pronucleus,"miRNA regulation of DNA damage response; miRNAs involved in DNA damage response; Proteasome degradation; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; DNA repair pathways, full network; 5q35 copy number variation; DNA damage response",47,2,120.26,175.31,191.68,122.67,Peak Found,High,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,120.27,105.95,138.68,143.15,2578.61,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NZ01,TECR,Very-long-chain enoyl-CoA reductase OS=Homo sapiens OX=9606 GN=TECR PE=1 SV=1,4,6,2.274,1.134,3.493,1.908,1.19,0.18,1.8,0.93,3.74E-01,3.66E-01,2.78E-01,4.43E-01,1.23E+06,2.04E+05,1.30E+06,3.28E+05,4,2,5,4,,9.36E+05,4.59E+05,1.62E+06,1.85E+06,9.00E+05,,4.60E+04,,,1.94E+05,7.73E+05,1.30E+06,1.49E+06,1.72E+06,7.91E+05,5.12E+03,,5.33E+05,2.02E+05,,3.56E+03,4.48E+03,1.62E+06,9.54E+04,3.20E+03,,4.25E+02,,,1.16E+03,3.45E+04,1.06E+04,2.01E+05,4.28E+04,1.54E+03,1.44E+03,,1.25E+04,2.15E+03,0,FALSE,11.65,14,4,308,36,9.45,4,other metabolic processes,other membranes;ER/Golgi,"Pf02544, Pf21696",9524,B2RD55; hsa:9524; O75350; Q6IBB2; Q9BWK3; Q9NZ01; Q9Y6P0,ENSG00000099797,Synthesis of very long-chain fatty acyl-CoAs,Fragile X syndrome,2,0,52.35,127.65,56.04,91.1,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,109.03,98.4,114.15,107.99,11.45,other molecular function,0,
Master Protein,High,F6VRR5,POLDIP3,DNA polymerase delta interacting protein 3 OS=Homo sapiens OX=9606 GN=POLDIP3 PE=1 SV=1,4,8,2.274,0.443,0.999,2.25,1.19,-1.17,0,1.17,4.04E-01,5.87E-01,9.26E-01,3.55E-01,1.09E+06,2.81E+05,3.94E+05,8.79E+04,4,4,5,5,7.52E+05,1.58E+06,2.69E+05,1.88E+06,,2.07E+06,8.79E+04,6.17E+05,1.28E+05,,3.94E+05,1.09E+06,7.69E+04,3.36E+05,5.76E+05,1.22E+06,2.81E+04,8.79E+04,2.53E+04,1.33E+05,2.99E+03,6.01E+03,2.63E+03,1.88E+06,,7.35E+03,1.56E+03,5.69E+03,3.61E+03,,2.35E+03,4.87E+04,6.25E+02,4.52E+04,1.43E+04,2.38E+03,7.90E+03,6.23E+02,5.92E+02,1.41E+03,0,FALSE,19.553,15,4,438,48.1,9.92,4,,nucleus;other cell component,Pf00076,84271,F6VRR5,ENSG00000100227,,,0,0,66.17,127.77,76.42,172.99,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,117.73,79.29,127.2,114.32,25.93,nucleic acid binding activity,0,
Master Protein,High,O75937,DNAJC8,DnaJ homolog subfamily C member 8 OS=Homo sapiens OX=9606 GN=DNAJC8 PE=1 SV=2,7,18,2.274,0.877,1.192,1.55,1.19,-0.19,0.25,0.63,3.70E-01,7.25E-01,9.56E-01,5.87E-01,2.91E+06,5.69E+05,1.76E+06,7.59E+05,5,4,5,4,1.09E+06,2.91E+06,1.57E+05,5.28E+06,5.36E+06,8.75E+05,,7.66E+05,4.23E+05,2.99E+05,2.58E+06,1.48E+06,4.47E+05,7.04E+06,1.76E+06,3.41E+05,4.97E+05,,1.16E+06,1.51E+06,4.34E+03,1.11E+04,1.54E+03,5.28E+06,2.77E+05,3.11E+03,,7.07E+03,1.19E+04,3.18E+03,1.54E+04,6.62E+04,3.63E+03,9.49E+05,4.37E+04,6.64E+02,1.40E+05,,2.71E+04,1.61E+04,0,FALSE,24.688,35,7,253,29.8,9.06,7,,cytosol;nucleus;other cell component,Pf00226,22826,B4DUU4; D3DPM0; hsa:22826; O75937; Q6IBA4; Q8N4Z5; Q9P051; Q9P067,ENSG00000126698,mRNA Splicing - Major Pathway,mRNA processing,2,0,80.12,46.38,96.36,62.96,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,88.44,125.8,138.36,86.61,49.25,other molecular function,0,
Master Protein,Medium,A0A8V8TND4,CAMK2D,calcium/calmodulin-dependent protein kinase OS=Homo sapiens OX=9606 GN=CAMK2D PE=1 SV=1,1,2,2.253,0.394,3.236,0.156,1.17,-1.34,1.69,-2.68,4.19E-01,5.71E-01,3.45E-01,1.87E-01,6.90E+04,5.37E+04,2.72E+04,1.74E+05,4,3,1,1,3.99E+04,9.14E+04,,5.22E+04,6.62E+05,,,5.37E+04,1.34E+04,1.40E+05,,,,2.72E+04,,,,,,1.74E+05,1.59E+02,3.47E+02,,5.22E+04,3.42E+04,,,4.96E+02,3.77E+02,1.49E+03,,,,3.66E+03,,,,,,1.85E+03,0.01,FALSE,2.273,2,1,523,59,7.27,1,other metabolic processes,other cell component,"Pf00069, Pf08332",,A0A8V8TND4,ENSG00000145349,,"SRF and miRs in smooth muscle differentiation and proliferation; NO/cGMP/PKG mediated neuroprotection; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; Disruption of postsynaptic signaling by CNV; Affected pathways in Duchenne muscular dystrophy",6,0,142.53,93.7,,,Peak Found,Peak Found,n/a,High,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,116.03,55.22,91.37,0,4.58,kinase activity;other molecular function,0,
Master Protein,High,Q9HB58,SP110,Sp110 nuclear body protein OS=Homo sapiens OX=9606 GN=SP110 PE=1 SV=5,1,1,2.253,0.326,0.01,100,1.17,-1.62,-6.64,6.64,4.18E-01,4.39E-01,1.00E-17,1.00E-17,9.27E+04,4.11E+04,2.93E+04,,2,1,3,,1.25E+05,,,6.88E+04,,,,,4.11E+04,,,2.93E+04,,4.42E+04,2.06E+04,,,,,,4.96E+02,,,6.88E+04,,,,,1.16E+03,,,1.31E+03,,5.96E+03,5.12E+02,,,,,,0.002,FALSE,2.872,2,1,689,78.3,8.87,1,other biological processes,nucleus,"Pf01342, Pf03172",3431,B4DVI4; F5H1M1; hsa:3431; Q14976; Q14977; Q53TG2; Q8WUZ6; Q9HB58; Q9HCT8,ENSG00000135899,,,0,0,40.86,,38.01,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,44.74,46.1,,,4.55,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NWH9,SLTM,SAFB-like transcription modulator OS=Homo sapiens OX=9606 GN=SLTM PE=1 SV=2,6,10,2.252,0.13,0.278,,1.17,-2.94,-1.84,,3.94E-01,1.67E-02,2.34E-01,,1.46E+06,1.48E+05,7.40E+04,6.96E+04,3,4,3,2,,1.46E+06,,1.76E+06,3.29E+05,8.63E+05,1.56E+05,,1.41E+05,1.11E+05,,7.40E+04,,2.52E+05,6.03E+04,,4.13E+04,,,1.17E+05,,5.54E+03,,1.76E+06,1.70E+04,3.07E+03,2.77E+03,,3.98E+03,1.18E+03,,3.30E+03,,3.39E+04,1.50E+03,,1.16E+04,,,1.25E+03,0,FALSE,31.597,8,6,1034,117.1,7.87,6,other biological processes,nucleus,"Pf00076, Pf02037",79811,A8K5V8; B2RTX3; hsa:79811; Q2VPK7; Q52MB3; Q658J7; Q6ZNF2; Q86TK6; Q9H7C3; Q9H8U9; Q9NWH9,ENSG00000137776,,,0,0,63.8,114.47,82.98,67.72,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,84.83,84.51,7.32,,29.91,nucleic acid binding activity,0,
Master Protein,High,Q9Y3B3,TMED7,Transmembrane emp24 domain-containing protein 7 OS=Homo sapiens OX=9606 GN=TMED7 PE=1 SV=2,4,8,2.247,,1.545,1.061,1.17,,0.63,0.09,3.64E-01,,6.86E-01,8.16E-01,2.42E+06,1.37E+06,4.87E+05,3.61E+05,1,3,3,2,,2.42E+06,,,,,,1.51E+06,1.76E+05,1.37E+06,,2.85E+05,,9.95E+05,4.87E+05,2.84E+05,,,,4.58E+05,,9.19E+03,,,,,,1.40E+04,4.95E+03,1.46E+04,,1.27E+04,,1.34E+05,1.21E+04,5.53E+02,,,,4.88E+03,0,FALSE,10.958,19,4,224,25.2,6.89,4,cell organization and biogenesis;transport,other membranes;ER/Golgi;other cell component,Pf01105,100302736; 51014,hsa:100302736; hsa:51014; Q8NBU8; Q8WUU6; Q96K51; Q9Y3B3,ENSG00000134970,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,,2,0,,72.03,62.08,33.33,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,n/a,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,21.35,,23.26,61.35,17.13,,0,
Master Protein,High,H0Y8C2,RPL22L1,"HCG15121, isoform CRA_a (Fragment) OS=Homo sapiens OX=9606 GN=RPL22L1 PE=1 SV=1",1,1,2.245,1.261,0.239,8.56,1.17,0.33,-2.06,3.1,3.92E-01,5.19E-01,1.99E-01,7.05E-02,4.01E+04,1.78E+04,3.65E+04,4.27E+03,2,2,4,1,,,1.83E+04,8.75E+04,,,,2.34E+04,1.36E+04,,1.36E+05,4.88E+04,,2.74E+04,1.95E+04,,4.27E+03,,,,,,1.79E+02,8.75E+04,,,,2.16E+02,3.83E+02,,8.14E+02,2.18E+03,,3.69E+03,4.86E+02,,1.20E+03,,,,0.004,FALSE,2.631,8,1,142,16.9,9.25,1,protein metabolism;other metabolic processes,translational apparatus;other cell component,Pf01776,,H0Y8C2,ENSG00000163584,,,0,0,92.39,37.66,92.41,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,97.37,97.09,40.96,59.26,2.95,other molecular function,0,
Master Protein,High,Q9H1E5,TMX4,Thioredoxin-related transmembrane protein 4 OS=Homo sapiens OX=9606 GN=TMX4 PE=1 SV=1,3,14,2.241,1.246,0.767,3.797,1.16,0.32,-0.38,1.92,4.14E-01,2.82E-01,6.35E-01,1.66E-01,1.05E+06,2.74E+05,1.37E+06,3.50E+05,5,4,5,4,1.05E+06,6.80E+05,7.19E+05,1.51E+06,2.42E+06,5.68E+05,4.69E+04,4.74E+05,,1.58E+05,2.31E+06,8.59E+04,8.08E+05,1.37E+06,1.49E+06,2.37E+05,5.18E+05,,5.17E+05,1.24E+05,4.19E+03,2.58E+03,7.03E+03,1.51E+06,1.25E+05,2.02E+03,8.34E+02,4.37E+03,,1.68E+03,1.38E+04,3.84E+03,6.57E+03,1.84E+05,3.71E+04,4.61E+02,1.46E+05,,1.21E+04,1.32E+03,0,FALSE,14.472,21,3,349,38.9,4.37,3,,other membranes;ER/Golgi;nucleus;other cell component,Pf00085,56255,hsa:56255; Q8N4P7; Q8NCC1; Q9H1E5; Q9UJA1; Q9ULQ8,ENSG00000125827,,,0,0,56.48,79.75,68.22,57.41,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,102.47,99.57,101.46,90.99,46.56,other molecular function,0,
Master Protein,High,P49368,CCT3,T-complex protein 1 subunit gamma OS=Homo sapiens OX=9606 GN=CCT3 PE=1 SV=4,9,27,2.24,0.261,1.867,0.419,1.16,-1.94,0.9,-1.25,3.96E-01,1.52E-01,4.80E-01,4.67E-01,1.37E+06,4.56E+05,8.30E+05,3.17E+06,5,3,5,3,3.39E+06,2.16E+06,1.08E+06,1.07E+06,1.37E+06,7.64E+05,,,4.56E+05,2.28E+05,2.35E+06,8.30E+05,6.16E+05,2.33E+06,4.27E+05,,5.02E+06,3.17E+06,1.79E+06,,1.35E+04,8.21E+03,1.05E+04,1.07E+06,7.08E+04,2.72E+03,,,1.28E+04,2.43E+03,1.41E+04,3.70E+04,5.01E+03,3.13E+05,1.06E+04,,1.41E+06,2.24E+04,4.19E+04,,0,FALSE,45.912,26,9,545,60.5,6.49,9,protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;other cell component,Pf00118,7203,A6NE14; hsa:7203; P49368; Q5SZY1; Q9BR64,ENSG00000163468,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,16p11.2 proximal deletion syndrome,7,0,54.34,55.67,72.5,48.73,High,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,High,High,High,Peak Found,n/a,High,Peak Found,High,n/a,1,,FALSE,129.76,132.97,75.71,116.64,75.59,other molecular function,0,
Master Protein,High,Q08170,SRSF4,Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2,4,5,2.24,0.081,0.01,100,1.16,-3.63,-6.64,6.64,4.09E-01,2.27E-02,1.00E-17,1.00E-17,1.21E+05,5.42E+04,9.79E+03,,4,1,2,,,1.03E+05,3.62E+04,3.10E+05,1.43E+05,,,,,5.42E+04,,8.20E+03,,1.17E+04,,,,,,,,3.92E+02,3.53E+02,3.10E+05,7.36E+03,,,,,5.76E+02,,3.66E+02,,1.57E+03,,,,,,,0,FALSE,11.344,8,2,494,56.6,11.52,4,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf00076,6429,hsa:6429; Q08170; Q5VXP1; Q9BUA4; Q9UEB5,ENSG00000116350,mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,mRNA processing,6,0,78.86,,24.82,,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,65.02,77.64,,,11.15,nucleic acid binding activity,0,
Master Protein,High,Q92665,MRPS31,"28S ribosomal protein S31, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS31 PE=1 SV=3",1,2,2.239,1.148,2.168,1.185,1.16,0.2,1.12,0.25,3.43E-01,5.16E-01,5.31E-01,7.49E-01,3.21E+05,1.43E+05,3.68E+05,3.11E+05,1,2,4,1,,,,3.21E+05,,,,,1.15E+05,1.79E+05,,4.33E+05,1.57E+05,3.13E+05,4.51E+05,,,,3.11E+05,,,,,3.21E+05,,,,,3.23E+03,1.91E+03,,1.94E+04,1.27E+03,4.22E+04,1.12E+04,,,,7.28E+03,,0.005,FALSE,2.519,4,1,395,45.3,9.29,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus;nucleus,Pf15433,10240,B2RCS3; hsa:10240; Q5VYC8; Q8WTV8; Q92665,ENSG00000102738,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,31.04,40.1,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,33.35,29.63,33.35,29.63,5.33,other molecular function,0,
Master Protein,High,A0A0A0MRR7,SNRPC,U1 small nuclear ribonucleoprotein C OS=Homo sapiens OX=9606 GN=SNRPC PE=1 SV=1,2,7,2.232,0.606,1.843,0.734,1.16,-0.72,0.88,-0.45,3.92E-01,9.25E-01,5.88E-01,9.60E-01,1.54E+06,5.24E+05,7.09E+05,9.66E+05,2,1,1,2,,,,1.76E+06,1.34E+06,,,5.24E+05,,,,,,7.09E+05,,7.93E+05,,,,1.18E+06,,,,1.76E+06,6.93E+04,,,4.84E+03,,,,,,9.55E+04,,1.55E+03,,,,1.25E+04,0,FALSE,10.845,17,2,180,19.7,9.58,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus,Pf06220,,A0A0A0MRR7,ENSG00000124562,,,0,0,18.99,,,27.64,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,20.59,20.59,29.55,29.55,23.85,nucleic acid binding activity;other molecular function,0,
Master Protein,High,H0YAH3,GALNT7,Polypeptide N-acetylgalactosaminyltransferase OS=Homo sapiens OX=9606 GN=GALNT7 PE=1 SV=2,4,6,2.217,0.558,,,1.15,-0.84,,,3.46E-01,7.85E-01,,,5.66E+05,8.60E+04,5.72E+04,1.50E+07,4,1,5,3,1.19E+06,,2.26E+04,4.57E+05,7.00E+05,,8.60E+04,,,,5.72E+04,3.96E+04,3.94E+04,2.72E+05,1.22E+05,,1.83E+05,1.50E+07,,1.72E+07,4.72E+03,,2.21E+02,4.57E+05,3.61E+04,,1.53E+03,,,,3.42E+02,1.77E+03,3.20E+02,3.67E+04,3.04E+03,,5.15E+04,1.06E+05,,1.83E+05,0,FALSE,15.769,8,4,657,75.4,7.05,4,protein metabolism;other metabolic processes,other membranes;ER/Golgi,"Pf00535, Pf00652",,H0YAH3,ENSG00000109586,,,0,0,82.17,,93.19,85.73,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,109.47,99.45,,,18.01,other molecular function,0,
Master Protein,High,E9PK25,CFL1,Cofilin 1 OS=Homo sapiens OX=9606 GN=CFL1 PE=1 SV=1,8,34,2.216,0.673,1.603,1.393,1.15,-0.57,0.68,0.48,3.90E-01,9.68E-01,5.89E-01,6.71E-01,2.67E+06,4.84E+05,2.52E+06,1.54E+06,4,3,5,3,3.16E+06,,2.26E+06,5.72E+06,1.02E+06,,2.92E+05,1.00E+06,,4.84E+05,1.07E+06,2.52E+06,1.24E+06,4.43E+06,2.74E+06,1.73E+06,1.54E+06,,1.28E+06,,1.26E+04,,2.21E+04,5.72E+06,5.28E+04,,5.19E+03,9.24E+03,,5.15E+03,6.42E+03,1.12E+05,1.00E+04,5.97E+05,6.82E+04,3.37E+03,4.33E+05,,2.98E+04,,0,FALSE,62.057,44,8,204,22.7,8.34,8,cell organization and biogenesis,cytoskeleton,Pf00241,,E9PK25,ENSG00000172757,,7q11.23 copy number variation syndrome,1,0,65.41,61.98,56.53,15.1,High,n/a,High,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,105.72,76.22,43.87,67.87,119.54,cytoskeletal activity,0,
Master Protein,High,P12829,MYL4,Myosin light chain 4 OS=Homo sapiens OX=9606 GN=MYL4 PE=1 SV=3,10,23,2.216,0.398,1.212,0.165,1.15,-1.33,0.28,-2.6,3.41E-01,4.98E-01,9.50E-01,1.84E-01,2.53E+05,1.58E+05,4.11E+05,1.06E+06,4,2,4,5,,2.39E+05,2.67E+05,1.86E+05,5.14E+05,1.25E+06,,,2.01E+04,,1.51E+06,,5.60E+05,3.02E+05,2.82E+05,1.37E+05,1.23E+07,1.06E+06,3.06E+06,1.04E+06,,9.10E+02,2.60E+03,1.86E+05,2.65E+04,4.45E+03,,,5.65E+02,,9.01E+03,,4.55E+03,4.07E+04,7.01E+03,2.66E+02,3.47E+06,7.49E+03,7.17E+04,1.11E+04,0,FALSE,46.165,81,9,197,21.6,5.03,10,other biological processes,cytosol;cytoskeleton,,4635,D3DXJ7; P11783; P12829,ENSG00000198336,Striated Muscle Contraction,Myometrial relaxation and contraction pathways; Striated muscle contraction pathway,3,1,48.25,136.96,87.04,142.9,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,385.72,89,81.65,84.76,65.8,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9H7Z7,PTGES2,Prostaglandin E synthase 2 OS=Homo sapiens OX=9606 GN=PTGES2 PE=1 SV=1,8,15,2.212,1.014,1.66,0.88,1.15,0.02,0.73,-0.18,3.55E-01,5.31E-01,7.30E-01,9.18E-01,3.30E+05,9.88E+04,9.63E+05,7.01E+05,4,3,5,4,8.45E+04,2.65E+05,4.10E+05,1.89E+06,,,3.38E+04,9.88E+04,1.01E+05,,5.86E+05,1.28E+06,3.47E+05,9.95E+05,9.63E+05,7.27E+05,6.75E+05,,2.13E+04,2.77E+06,3.36E+02,1.01E+03,4.01E+03,1.89E+06,,,6.01E+02,9.12E+02,2.83E+03,,3.50E+03,5.73E+04,2.82E+03,1.34E+05,2.39E+04,1.42E+03,1.90E+05,,4.98E+02,2.95E+04,0,FALSE,37.204,33,8,377,41.9,9.16,8,other metabolic processes;transport;other biological processes,non-structural extracellular;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf13410, Pf13417",80142,hsa:80142; Q53EW9; Q5SYV6; Q96GI0; Q96GL2; Q9H7Z7,ENSG00000148334,Neutrophil degranulation; Synthesis of Prostaglandins (PG) and Thromboxanes (TX),"Relationship between inflammation, COX-2 and EGFR; Omega-6-fatty acids in senescence",4,0,125.24,48.95,44.14,113.68,Peak Found,Peak Found,Peak Found,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,44.18,58.28,185.98,107.01,51.03,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y2K7,KDM2A,Lysine-specific demethylase 2A OS=Homo sapiens OX=9606 GN=KDM2A PE=1 SV=3,1,2,2.208,0.365,4.011,0.224,1.14,-1.45,2,-2.16,4.25E-01,5.19E-01,2.84E-01,3.04E-01,7.94E+04,4.00E+04,3.60E+04,1.60E+05,2,3,4,3,,,,2.26E+04,2.79E+05,,3.16E+04,4.08E+04,,4.00E+04,,1.66E+04,4.67E+04,2.78E+04,5.05E+04,,,1.60E+05,1.94E+04,5.80E+05,,,,2.26E+04,1.44E+04,,5.62E+02,3.77E+02,,4.25E+02,,7.41E+02,3.79E+02,3.74E+03,1.26E+03,,,1.14E+03,4.54E+02,6.17E+03,0.01,FALSE,2.294,1,1,1162,132.7,7.58,1,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00646, Pf02008, Pf16866, Pf17811",22992,D4QA03; E9PIL6; hsa:22992; I3VM55; Q49A21; Q4G0M3; Q69YY8; Q9BVH5; Q9H7H5; Q9UK66; Q9Y2K7,ENSG00000173120,HDMs demethylate histones,,1,0,120.18,13.61,45.19,115.1,n/a,n/a,n/a,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,210.27,136.97,130.31,134.94,4.92,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P38159,RBMX,"RNA-binding motif protein, X chromosome OS=Homo sapiens OX=9606 GN=RBMX PE=1 SV=3",11,57,2.207,0.214,0.885,1.205,1.14,-2.22,-0.18,0.27,4.00E-01,8.09E-02,8.97E-01,7.90E-01,1.19E+06,1.15E+06,3.08E+06,9.37E+05,5,5,5,5,2.21E+05,1.19E+06,1.09E+06,3.00E+07,9.96E+06,1.15E+06,7.61E+05,1.99E+06,3.98E+05,2.13E+06,1.19E+06,3.08E+06,1.83E+06,2.33E+07,4.14E+06,8.71E+05,2.72E+05,2.85E+06,9.37E+05,5.92E+06,8.78E+02,4.54E+03,1.06E+04,3.00E+07,5.14E+05,4.08E+03,1.35E+04,1.84E+04,1.12E+04,2.27E+04,7.11E+03,1.38E+05,1.48E+04,3.14E+06,1.03E+05,1.70E+03,7.65E+04,2.02E+04,2.19E+04,6.31E+04,0,FALSE,48.622,27,3,391,42.3,10.05,11,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,non-structural extracellular;nucleus;other cell component,"Pf00076, Pf08081",27316,B4E3U4; D3DWH0; E9PG86; hsa:27316; P38159; Q5JQ67; Q8N8Y7; Q969R3,ENSG00000147274,RND2 GTPase cycle; mRNA Splicing - Major Pathway; RND3 GTPase cycle; RND1 GTPase cycle; Processing of Capped Intron-Containing Pre-mRNA; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,mRNA processing,8,9,149.08,58.87,139.33,106.47,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,97.65,137.91,139.99,144.99,133.57,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NTJ3,SMC4,Structural maintenance of chromosomes protein 4 OS=Homo sapiens OX=9606 GN=SMC4 PE=1 SV=2,5,8,2.199,1.562,3.483,0.965,1.14,0.64,1.8,-0.05,4.22E-01,3.69E-01,2.29E-01,8.49E-01,1.25E+05,1.03E+05,1.25E+05,1.14E+06,3,1,2,4,,9.49E+04,,1.25E+05,5.41E+05,,,1.03E+05,,,7.96E+04,,,1.96E+05,,,4.82E+05,2.69E+06,2.50E+05,6.61E+06,,3.61E+02,,1.25E+05,2.79E+04,,,9.50E+02,,,4.76E+02,,,2.63E+04,,,1.35E+05,1.91E+04,5.86E+03,7.03E+04,0,FALSE,15.707,6,5,1288,147.1,6.79,5,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,"Pf02463, Pf06470",10051,A6NLT9; D3DNL8; hsa:10051; O95752; Q8NDL4; Q9NTJ3; Q9UNT9,ENSG00000113810,Condensation of Prophase Chromosomes; Condensation of Prometaphase Chromosomes,Ciliary landscape,3,0,98.23,,59.58,117.45,n/a,Peak Found,n/a,High,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,High,Peak Found,Peak Found,High,1,,FALSE,145.9,0,551,11.09,22.67,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P17028,ZNF24,Zinc finger protein 24 OS=Homo sapiens OX=9606 GN=ZNF24 PE=1 SV=4,1,1,2.189,0.098,0.01,100,1.13,-3.36,-6.64,6.64,3.50E-01,1.28E-02,1.00E-17,1.00E-17,4.73E+05,2.16E+05,4.62E+04,,2,1,2,,,9.78E+05,,2.28E+05,,,,2.16E+05,,,,,,5.86E+04,3.64E+04,,,,,,,3.71E+03,,2.28E+05,,,,1.99E+03,,,,,,7.90E+03,9.03E+02,,,,,,0.001,FALSE,3.336,3,1,368,42.1,6.21,1,developmental processes;other biological processes,nucleus,"Pf00096, Pf02023",7572,hsa:7572; O14754; P17028; Q53YE4; Q6ICR5; Q8IZN4,ENSG00000172466,,,0,0,87.86,,33.15,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,117.54,92.57,,,3.17,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q9UI12,ATP6V1H,V-type proton ATPase subunit H OS=Homo sapiens OX=9606 GN=ATP6V1H PE=1 SV=1,1,2,2.187,1.473,3.244,0.993,1.13,0.56,1.7,-0.01,4.29E-01,3.79E-01,3.45E-01,8.54E-01,1.15E+05,5.26E+04,1.69E+05,1.71E+05,1,1,3,2,,,,,1.15E+05,5.26E+04,,,,,,,1.69E+05,1.10E+05,2.61E+05,,2.38E+04,,1.22E+06,,,,,,5.93E+03,1.87E+02,,,,,,,1.38E+03,1.48E+04,6.49E+03,,6.68E+03,,2.87E+04,,0.027,FALSE,1.859,1,1,483,55.8,6.48,1,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle,"Pf03224, Pf11698",51606,B3KMR0; hsa:51606; Q6PK44; Q9H3E3; Q9UI12; Q9Y300,ENSG00000047249,Nef Mediated CD4 Down-regulation; Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport; Nef Mediated CD8 Down-regulation; Blockage of phagosome acidification,Proximal tubule transport,9,0,,,42.22,136.04,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,1,,FALSE,0,51.92,521.78,338.82,0,transporter activity;enzyme regulator activity,0,
Master Protein,High,A0A7I2V327,NDUFA10,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFA10 PE=1 SV=1",4,16,2.184,0.85,0.94,2.375,1.13,-0.23,-0.09,1.25,3.56E-01,7.85E-01,9.07E-01,3.76E-01,4.31E+05,5.30E+04,2.41E+05,7.85E+04,2,3,5,4,,,,1.01E+06,1.84E+05,,5.30E+04,,3.95E+04,2.50E+05,1.49E+05,7.59E+04,2.41E+05,4.51E+05,9.30E+05,,9.75E+04,1.10E+05,2.02E+04,6.32E+04,,,,1.01E+06,9.48E+03,,9.42E+02,,1.11E+03,2.66E+03,8.89E+02,3.39E+03,1.96E+03,6.07E+04,2.31E+04,,2.74E+04,7.83E+02,4.72E+02,6.73E+02,0,FALSE,24.959,18,4,393,44.2,7.55,4,other metabolic processes,other membranes;mitochondrion,Pf01712,,A0A7I2V327,ENSG00000130414,,2q37 copy number variation syndrome,1,0,97.87,103.23,93.05,55.41,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,113.02,118.95,108.23,126.76,29.16,,0,
Master Protein,High,Q5VTR2,RNF20,E3 ubiquitin-protein ligase BRE1A OS=Homo sapiens OX=9606 GN=RNF20 PE=1 SV=2,6,10,2.182,0.747,0.707,2.739,1.13,-0.42,-0.5,1.45,3.55E-01,9.10E-01,7.14E-01,3.24E-01,5.23E+05,5.46E+04,1.94E+05,1.89E+04,3,1,4,2,7.97E+06,,,5.23E+05,2.82E+04,,,,,5.46E+04,1.25E+05,1.23E+05,,4.84E+05,3.01E+05,,9.26E+03,,3.86E+04,,3.16E+04,,,5.23E+05,1.45E+03,,,,,5.81E+02,7.50E+02,5.51E+03,,6.53E+04,7.47E+03,,2.60E+03,,9.04E+02,,0,FALSE,23.263,10,6,975,113.6,5.94,6,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,nucleus;other cell component,Pf00097,56254,A7MCT5; hsa:56254; Q2TB34; Q5VTR2; Q69YL5; Q6P527; Q8N3J4; Q96JD3; Q9H9Y7; Q9HA51; Q9NUR4; Q9NWQ3; Q9NX83,ENSG00000155827,E3 ubiquitin ligases ubiquitinate target proteins; RHOBTB1 GTPase cycle,ATM signaling in development and disease,3,0,156.65,,66.54,86.69,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,0,118.94,0,86.06,33.58,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q92925,SMARCD2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 OS=Homo sapiens OX=9606 GN=SMARCD2 PE=1 SV=3,9,28,2.18,1.622,1.757,3.711,1.12,0.7,0.81,1.89,3.54E-01,1.43E-01,6.78E-01,1.72E-01,5.13E+05,6.43E+04,1.76E+06,2.86E+05,5,4,5,5,5.00E+04,5.13E+05,1.95E+05,4.00E+06,2.78E+06,6.12E+05,6.83E+04,,1.63E+04,6.06E+04,1.19E+06,2.45E+06,1.57E+06,1.76E+06,1.84E+06,8.61E+05,1.44E+03,2.86E+05,4.76E+05,1.12E+05,1.99E+02,1.95E+03,1.91E+03,4.00E+06,1.43E+05,2.18E+03,1.21E+03,,4.58E+02,6.44E+02,7.09E+03,1.10E+05,1.28E+04,2.38E+05,4.56E+04,1.68E+03,4.05E+02,2.02E+03,1.11E+04,1.20E+03,0,FALSE,44.749,28,9,531,58.9,9.64,9,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf02201,6603,A5PLL5; A6NNQ7; B4DV56; B4E1R6; hsa:6603; Q7L2I6; Q92925; Q9UHZ1,ENSG00000108604,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,Androgen receptor network in prostate cancer; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome,6,0,118.03,149.36,26.18,97.55,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,107.18,115.79,127.13,133.88,99.01,other molecular function,0,
Master Protein,High,Q15006,EMC2,ER membrane protein complex subunit 2 OS=Homo sapiens OX=9606 GN=EMC2 PE=1 SV=1,2,3,2.174,0.543,0.923,1.175,1.12,-0.88,-0.12,0.23,3.83E-01,7.55E-01,8.10E-01,7.38E-01,1.98E+05,5.98E+05,7.40E+05,2.78E+05,3,1,5,3,1.30E+06,1.98E+05,,1.26E+05,,,,,,5.98E+05,1.13E+06,7.94E+04,7.40E+05,6.56E+05,9.48E+05,1.10E+06,6.14E+04,,2.78E+05,,5.16E+03,7.54E+02,,1.26E+05,,,,,,6.36E+03,6.74E+03,3.55E+03,6.01E+03,8.84E+04,2.35E+04,2.14E+03,1.72E+04,,6.50E+03,,0,FALSE,8.173,10,2,297,34.8,6.57,2,cell organization and biogenesis,other membranes;ER/Golgi;other cell component,Pf14559,9694,hsa:9694; Q15006; Q8WUE1,ENSG00000104412,,,0,0,121.46,,55.98,114.05,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,0,33.43,109.88,71.72,10.48,,0,
Master Protein,High,A0A804HJK8,ETFDH,Electron transfer flavoprotein-ubiquinone oxidoreductase OS=Homo sapiens OX=9606 GN=ETFDH PE=1 SV=1,6,9,2.162,0.967,0.731,0.949,1.11,-0.05,-0.45,-0.08,3.59E-01,6.00E-01,5.99E-01,8.66E-01,5.75E+05,5.50E+04,6.83E+05,9.69E+05,5,2,5,4,2.62E+06,3.37E+05,2.88E+04,5.75E+05,7.15E+05,,1.09E+05,,2.76E+04,,9.32E+05,4.72E+05,2.08E+05,1.85E+06,6.83E+05,2.05E+06,6.02E+05,1.56E+06,2.65E+05,,1.04E+04,1.28E+03,2.82E+02,5.75E+05,3.69E+04,,1.94E+03,,7.79E+02,,5.57E+03,2.11E+04,1.69E+03,2.49E+05,1.70E+04,3.99E+03,1.69E+05,1.11E+04,6.20E+03,,0,FALSE,18.643,16,6,618,68.7,7.97,6,other metabolic processes,mitochondrion,"Pf01946, Pf05187, Pf21162",,A0A804HJK8,ENSG00000171503,,Riboflavin and CoQ disorders,1,0,119.28,84.32,76,73.96,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,103.45,116.77,68.67,110.21,26.62,other molecular function,0,
Master Protein,High,P49458,SRP9,Signal recognition particle 9 kDa protein OS=Homo sapiens OX=9606 GN=SRP9 PE=1 SV=2,3,17,2.16,0.274,1.397,0.307,1.11,-1.87,0.48,-1.7,4.47E-01,1.71E-01,7.68E-01,3.32E-01,9.04E+06,1.26E+06,4.27E+06,6.61E+07,5,4,5,5,1.47E+06,9.04E+06,6.01E+05,1.64E+07,1.66E+08,1.80E+06,,1.21E+06,5.71E+05,1.31E+06,2.38E+06,5.21E+06,4.27E+06,1.58E+07,2.24E+06,8.78E+07,2.31E+06,6.61E+07,3.99E+06,1.32E+08,5.83E+03,3.44E+04,5.87E+03,1.64E+07,8.55E+06,6.41E+03,,1.11E+04,1.61E+04,1.40E+04,1.42E+04,2.33E+05,3.47E+04,2.12E+06,5.58E+04,1.71E+05,6.49E+05,4.68E+05,9.33E+04,1.41E+06,0,FALSE,10.472,33,3,86,10.1,7.97,3,other biological processes,other membranes;cytosol;ER/Golgi;translational apparatus,Pf05486,6726,A8K0N0; hsa:6726; P49458; Q6NVX0; Q8WTW0,ENSG00000143742,SRP-dependent cotranslational protein targeting to membrane,,1,0,184.6,41.34,94.02,95.57,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,118.22,135.68,62.32,142.03,45.04,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P52597,HNRNPF,Heterogeneous nuclear ribonucleoprotein F OS=Homo sapiens OX=9606 GN=HNRNPF PE=1 SV=3,7,38,2.159,0.627,0.268,3.068,1.11,-0.67,-1.9,1.62,4.47E-01,8.85E-01,1.41E-01,2.48E-01,4.09E+06,1.59E+06,1.49E+06,4.16E+05,5,5,5,5,9.39E+06,5.42E+06,2.94E+06,4.09E+06,3.46E+06,4.31E+06,7.71E+05,1.65E+06,5.97E+05,1.59E+06,2.22E+06,1.40E+06,1.35E+06,5.41E+06,1.49E+06,1.77E+06,2.75E+05,4.16E+05,3.51E+05,9.73E+05,3.73E+04,2.06E+04,2.87E+04,4.09E+06,1.79E+05,1.53E+04,1.37E+04,1.52E+04,1.68E+04,1.70E+04,1.33E+04,6.27E+04,1.10E+04,7.30E+05,3.70E+04,3.45E+03,7.73E+04,2.95E+03,8.23E+03,1.04E+04,0,FALSE,46.037,26,5,415,45.6,5.58,7,RNA metabolism OR transcription;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00076, Pf08080",3185,B3KM84; hsa:3185; P52597; Q5T0N2; Q96AU2,ENSG00000169813,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA,MECP2 and associated Rett syndrome,5,0,51.23,83.51,73.04,83.08,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,100.19,85.73,121.6,125.95,135.36,nucleic acid binding activity,0,
Master Protein,High,Q9NRX2,MRPL17,"39S ribosomal protein L17, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL17 PE=1 SV=1",2,4,2.157,0.232,0.607,0.379,1.11,-2.11,-0.72,-1.4,3.63E-01,1.61E-01,5.99E-01,5.52E-01,4.91E+05,7.70E+04,5.23E+04,1.69E+05,4,2,3,3,5.90E+05,,4.09E+05,6.09E+04,7.16E+05,3.01E+05,1.97E+04,,,,,1.11E+04,,5.23E+04,2.28E+05,,1.69E+05,,2.40E+05,7.01E+04,2.35E+03,,3.99E+03,6.09E+04,3.69E+04,1.07E+03,3.50E+02,,,,,4.97E+02,,7.04E+03,5.67E+03,,4.75E+04,,5.62E+03,7.46E+02,0,FALSE,7.479,9,2,175,20,10.11,2,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf01196,63875,D3DQU3; hsa:63875; Q6IAH8; Q96Q53; Q9C066; Q9NRX2,ENSG00000158042,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,64.14,124.1,118.62,53.43,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,124.3,140.18,180.78,75.33,9.54,other molecular function,0,
Master Protein,High,P32969,RPL9; RPL9P7; RPL9P8; RPL9P9,60S ribosomal protein L9 OS=Homo sapiens OX=9606 GN=RPL9 PE=1 SV=1,6,40,2.156,0.575,3.258,0.925,1.11,-0.8,1.7,-0.11,4.17E-01,8.40E-01,2.49E-01,9.48E-01,2.39E+06,1.67E+05,1.35E+06,1.34E+06,5,4,5,5,2.73E+06,8.53E+05,5.65E+06,2.39E+06,4.14E+05,2.83E+05,9.19E+04,,9.81E+04,3.21E+06,1.28E+07,7.49E+05,3.20E+05,3.40E+06,1.35E+06,1.34E+06,1.71E+06,2.26E+06,1.07E+06,1.02E+06,1.08E+04,3.24E+03,5.52E+04,2.39E+06,2.14E+04,1.00E+03,1.63E+03,,2.76E+03,3.41E+04,7.65E+04,3.35E+04,2.60E+03,4.58E+05,3.36E+04,2.62E+03,4.80E+05,1.60E+04,2.51E+04,1.09E+04,0,FALSE,26.176,36,6,192,21.9,9.95,6,protein metabolism;other metabolic processes,cytosol;translational apparatus;other cell component,Pf00347,6133,hsa:6133; P32969,ENSG00000163682,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,85.65,166.01,139.89,34.74,High,Peak Found,High,High,High,Peak Found,Peak Found,n/a,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,135.99,113.88,135.45,122.47,132.28,nucleic acid binding activity;other molecular function,0,
Master Protein,High,X6R4W8,ZNF207,Zinc finger protein 207 OS=Homo sapiens OX=9606 GN=ZNF207 PE=1 SV=1,3,21,2.154,0.585,0.882,2.073,1.11,-0.77,-0.18,1.05,4.39E-01,8.54E-01,7.47E-01,3.83E-01,7.80E+05,2.42E+05,4.79E+05,3.20E+05,5,5,4,4,7.31E+04,7.80E+05,5.21E+05,2.90E+06,1.23E+06,2.42E+05,1.27E+05,5.00E+04,3.81E+05,9.97E+05,,6.92E+05,1.23E+05,1.41E+06,3.32E+05,5.07E+05,,6.44E+05,2.02E+05,9.25E+04,2.90E+02,2.96E+03,5.09E+03,2.90E+06,6.32E+04,8.60E+02,2.26E+03,4.61E+02,1.07E+04,1.06E+04,,3.09E+04,9.99E+02,1.91E+05,8.25E+03,9.89E+02,,4.56E+03,4.72E+03,9.85E+02,0,FALSE,18.867,9,3,497,52.6,8.47,3,,nucleus,,,X6R4W8,ENSG00000010244,,,0,0,99.01,105.07,88.58,71.24,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.44,109.65,88.32,81.32,72.57,,0,
Master Protein,High,P21912,SDHB,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial OS=Homo sapiens OX=9606 GN=SDHB PE=1 SV=3",8,38,2.153,0.836,0.875,1.199,1.11,-0.26,-0.19,0.26,4.21E-01,7.79E-01,9.06E-01,8.12E-01,1.73E+06,4.94E+05,7.42E+06,1.65E+06,5,3,5,5,2.44E+05,1.73E+06,3.02E+05,2.10E+07,7.50E+06,4.27E+05,4.94E+05,,,1.48E+06,1.69E+06,8.45E+06,7.39E+06,1.75E+07,7.42E+06,4.76E+06,3.12E+06,9.39E+05,1.65E+06,1.05E+06,9.70E+02,6.56E+03,2.95E+03,2.10E+07,3.87E+05,1.52E+03,8.78E+03,,,1.57E+04,1.01E+04,3.77E+05,6.01E+04,2.36E+06,1.84E+05,9.29E+03,8.78E+05,6.65E+03,3.87E+04,1.12E+04,0,FALSE,53.447,31,8,280,31.6,8.76,8,other metabolic processes,plasma membrane;other membranes;mitochondrion;nucleus,"Pf13085, Pf13534",6390,B2R545; hsa:6390; P21912; Q0QEY7; Q9NQ12,ENSG00000117118,Respiratory electron transport; Citric acid cycle (TCA cycle),Electron transport chain: OXPHOS system in mitochondria; Metabolic reprogramming in colon cancer; Nonalcoholic fatty liver disease; Mitochondrial complex II assembly; TCA cycle (aka Krebs or citric acid cycle),7,0,143.34,73.56,67.16,70.51,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,106.21,118.07,63,110.35,104.73,other molecular function,0,
Master Protein,High,A0A0C4DG89,DDX46,RNA helicase OS=Homo sapiens OX=9606 GN=DDX46 PE=1 SV=1,7,9,2.153,0.297,1.288,0.287,1.11,-1.75,0.36,-1.8,4.24E-01,2.76E-01,8.98E-01,3.13E-01,8.82E+05,6.47E+05,5.38E+04,5.88E+05,3,3,4,5,2.45E+05,,,8.82E+05,1.39E+06,,,6.47E+05,9.11E+04,6.50E+05,1.12E+05,,1.21E+05,5.15E+03,2.59E+04,5.88E+05,9.23E+04,6.13E+05,5.13E+04,1.48E+07,9.75E+02,,,8.82E+05,7.18E+04,,,5.96E+03,2.57E+03,6.91E+03,6.68E+02,,9.82E+02,6.94E+02,6.45E+02,1.15E+03,2.59E+04,4.34E+03,1.20E+03,1.58E+05,0,FALSE,20.992,8,7,1032,117.4,9.29,7,,nucleus,"Pf00270, Pf00271",9879,A0A0C4DG89,ENSG00000145833,,,0,0,68.4,69.54,89.36,200.57,Peak Found,n/a,n/a,High,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,107.8,54.51,122.31,135.96,24.92,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P41091,EIF2S3,Eukaryotic translation initiation factor 2 subunit 3 OS=Homo sapiens OX=9606 GN=EIF2S3 PE=1 SV=3,3,12,2.153,1.206,2.197,0.541,1.11,0.27,1.14,-0.89,4.37E-01,3.45E-01,4.66E-01,6.97E-01,8.39E+05,2.02E+05,9.71E+05,1.35E+06,4,4,5,4,1.17E+05,4.04E+06,,5.24E+05,1.34E+06,5.03E+05,1.47E+05,1.75E+05,2.34E+05,,1.15E+06,6.66E+05,9.71E+05,1.25E+06,8.74E+05,9.24E+05,2.85E+06,4.33E+05,1.98E+06,,4.64E+02,1.54E+04,,5.24E+05,6.92E+04,1.79E+03,2.61E+03,1.61E+03,6.60E+03,,6.90E+03,2.97E+04,7.89E+03,1.68E+05,2.17E+04,1.80E+03,7.99E+05,3.07E+03,4.64E+04,,0,FALSE,17.013,10,3,472,51.1,8.4,3,cell organization and biogenesis;protein metabolism;other metabolic processes,cytosol;other cell component,"Pf00009, Pf03144, Pf09173",1968,A0A024RBY4; A8K2Y2; B2R5N2; B5BTZ4; hsa:1968; P41091; Q53HK3,ENSG00000130741,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; ABC-family proteins mediated transport; PKR-mediated signaling; Formation of the ternary complex, and subsequently, the 43S complex; Response of EIF2AK1 (HRI) to heme deficiency; PERK regulates gene expression; Recycling of eIF2:GDP; Response of EIF2AK4 (GCN2) to amino acid deficiency; Cellular response to mitochondrial stress",Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,14,0,117.22,61.62,23.43,69.9,Peak Found,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,n/a,1,,FALSE,123.11,117.35,54.87,60.05,30.53,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A0B4J2D5,GATD3B,"Putative glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial OS=Homo sapiens OX=9606 GN=GATD3B PE=5 SV=1",10,54,2.152,1.128,1.2,0.767,1.11,0.17,0.26,-0.38,4.28E-01,4.70E-01,8.62E-01,8.74E-01,1.94E+06,2.28E+05,7.37E+06,2.36E+06,4,5,5,4,2.02E+05,1.61E+06,,7.69E+06,2.33E+06,2.58E+07,2.28E+05,8.92E+04,2.13E+04,2.28E+06,4.79E+05,1.45E+07,7.37E+06,7.95E+06,2.62E+06,7.35E+06,1.89E+06,,2.84E+06,1.96E+06,8.04E+02,6.13E+03,,7.69E+06,1.20E+05,9.16E+04,4.05E+03,8.23E+02,6.00E+02,2.42E+04,2.86E+03,6.49E+05,5.99E+04,1.07E+06,6.52E+04,1.43E+04,5.32E+05,,6.64E+04,2.08E+04,0,FALSE,65.979,52,10,268,28.1,8.27,10,,mitochondrion,,8209,A0A0B4J2D5; A6NFJ6; A6NJY7; hsa:8209; O00650; O00660; O15011; O15012; P30042; P55346; P78474; Q92505; Q92507,,,Gastric cancer network 1,1,0,110.64,198.53,82.62,73.95,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,128.24,113.61,143.37,113.32,183.28,,0,
Master Protein,High,Q12906,ILF3,Interleukin enhancer-binding factor 3 OS=Homo sapiens OX=9606 GN=ILF3 PE=1 SV=3,27,62,2.15,0.438,2.014,0.549,1.1,-1.19,1.01,-0.87,4.50E-01,4.99E-01,4.46E-01,6.49E-01,3.81E+06,2.51E+06,1.41E+06,7.35E+06,5,5,5,5,2.37E+06,3.81E+06,8.18E+05,2.16E+07,1.21E+07,2.51E+06,1.80E+06,8.02E+06,5.51E+05,4.46E+06,2.91E+06,1.41E+06,6.97E+05,1.43E+07,1.18E+06,7.35E+06,7.92E+05,2.44E+07,9.18E+05,2.66E+07,9.42E+03,1.45E+04,7.99E+03,2.16E+07,6.23E+05,8.93E+03,3.20E+04,7.40E+04,1.55E+04,4.74E+04,1.74E+04,6.31E+04,5.66E+03,1.92E+06,2.94E+04,1.43E+04,2.23E+05,1.73E+05,2.15E+04,2.83E+05,0,FALSE,161.861,47,23,894,95.3,8.76,27,protein metabolism;other metabolic processes;stress response;other biological processes,mitochondrion;nucleus;other cell component,"Pf00035, Pf07528, Pf20965",3609,A8K6F2; G5E9M5; hsa:3609; O43409; Q12906; Q6P1X1; Q86XY7; Q99544; Q99545; Q9BZH4; Q9BZH5; Q9NQ95; Q9NQ96; Q9NQ97; Q9NQ98; Q9NQ99; Q9NQA0; Q9NQA1; Q9NQA2; Q9NRN2; Q9NRN3; Q9NRN4; Q9UMZ9; Q9UN00; Q9UN84; Q9UNA2,ENSG00000129351,PKR-mediated signaling; Regulation of CDH11 gene transcription,,2,4,106.8,83.95,140.35,105.03,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,118.54,118.44,128.68,117.06,206.56,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A0C4DGQ5,CAPNS1,Calpain small subunit 1 OS=Homo sapiens OX=9606 GN=CAPNS1 PE=1 SV=1,7,34,2.14,0.634,10.475,0.301,1.1,-0.66,3.39,-1.73,4.19E-01,9.61E-01,4.17E-03,3.23E-01,2.13E+06,2.34E+05,1.58E+06,7.11E+06,5,3,5,5,7.81E+06,3.17E+05,6.40E+06,1.72E+06,2.13E+06,2.34E+05,,,6.10E+04,3.42E+05,5.76E+05,1.58E+06,7.32E+05,3.08E+06,2.62E+06,7.11E+06,4.39E+06,1.03E+07,1.43E+06,1.02E+07,3.10E+04,1.21E+03,6.25E+04,1.72E+06,1.10E+05,8.33E+02,,,1.72E+03,3.64E+03,3.45E+03,7.06E+04,5.94E+03,4.15E+05,6.50E+04,1.39E+04,1.23E+06,7.27E+04,3.34E+04,1.08E+05,0,FALSE,39.414,26,7,322,33.8,6.23,7,,,,826,A0A0C4DGQ5,ENSG00000126247,,Integrin-mediated cell adhesion,1,0,88.15,66.75,64.83,57.04,High,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,Acetyl [N-Term],FALSE,131.99,115.55,95.03,112.79,100.15,other molecular function,0,
Master Protein,High,Q9Y5Q0,FADS3,Fatty acid desaturase 3 OS=Homo sapiens OX=9606 GN=FADS3 PE=1 SV=1,1,2,2.131,0.5,1.715,0.854,1.09,-1,0.78,-0.23,4.51E-01,6.96E-01,6.89E-01,9.06E-01,1.04E+05,4.32E+04,5.15E+04,6.03E+04,3,5,3,5,,1.34E+05,3.60E+04,1.04E+05,,6.76E+04,3.35E+04,4.32E+04,2.21E+04,4.86E+04,,,6.68E+04,5.15E+04,3.94E+04,2.31E+05,2.43E+04,1.16E+05,4.42E+04,6.03E+04,,5.08E+02,3.52E+02,1.04E+05,,2.40E+02,5.95E+02,3.99E+02,6.23E+02,5.17E+02,,,5.43E+02,6.93E+03,9.78E+02,4.50E+02,6.83E+03,8.22E+02,1.03E+03,6.42E+02,0,FALSE,4.56,3,1,445,51.1,7.77,1,other metabolic processes,other membranes;ER/Golgi,"Pf00173, Pf00487",3995,hsa:3995; O60426; Q9Y5Q0,ENSG00000221968,,,0,0,54.92,39.65,26.21,87.41,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,66.98,46.59,85.55,71.36,5.89,other molecular function,0,
Master Protein,High,P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2",23,180,2.124,0.902,0.802,4.716,1.09,-0.15,-0.32,2.24,4.58E-01,6.95E-01,6.79E-01,1.46E-01,1.70E+07,1.04E+06,4.69E+07,4.26E+06,5,4,5,5,1.24E+07,7.43E+06,1.70E+07,7.47E+07,4.28E+07,9.29E+05,1.16E+06,,2.89E+05,4.20E+07,2.58E+07,2.61E+07,4.88E+07,5.43E+07,4.69E+07,2.49E+06,3.44E+06,4.26E+06,8.42E+06,5.16E+06,4.93E+04,2.82E+04,1.66E+05,7.47E+07,2.21E+06,3.30E+03,2.06E+04,,8.14E+03,4.47E+05,1.54E+05,1.17E+06,3.96E+05,7.31E+06,1.17E+06,4.85E+03,9.68E+05,3.02E+04,1.97E+05,5.50E+04,0,FALSE,131.534,39,12,694,75.4,7.66,23,,nucleus;other cell component,"Pf03020, Pf08198, Pf11560",7112,P08918; P08919; P42166; Q14860; Q16295,ENSG00000120802,,Envelope proteins and their potential roles in EDMD physiopathology; Overlap between signal transduction pathways contributing to LMNA laminopathies,2,10,90.83,185.76,33.31,47.81,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,Phospho [T74],FALSE,122.96,105.51,135.11,120.28,541.5,nucleic acid binding activity;other molecular function,1,Phospho [T74]
Master Protein,High,P39687,ANP32A,Acidic leucine-rich nuclear phosphoprotein 32 family member A OS=Homo sapiens OX=9606 GN=ANP32A PE=1 SV=1,6,17,2.114,0.441,3.074,0.183,1.08,-1.18,1.62,-2.45,4.61E-01,5.05E-01,1.85E-01,1.69E-01,3.12E+06,1.78E+06,1.53E+06,7.77E+05,5,5,5,5,3.12E+06,1.67E+06,1.25E+06,1.15E+07,1.18E+07,1.22E+07,3.51E+07,2.12E+05,1.78E+06,4.86E+05,1.36E+06,3.05E+06,1.70E+06,1.53E+06,6.99E+04,6.41E+07,5.83E+04,7.77E+05,5.66E+05,4.23E+07,1.24E+04,6.36E+03,1.22E+04,1.15E+07,6.11E+05,4.34E+04,6.25E+05,1.96E+03,5.01E+04,5.17E+03,8.16E+03,1.36E+05,1.38E+04,2.06E+05,1.74E+03,1.25E+05,1.64E+04,5.51E+03,1.32E+04,4.50E+05,0,FALSE,25.944,26,5,249,28.6,4.09,6,transport;signal transduction;other biological processes,ER/Golgi;nucleus;other cell component,Pf14580,8125,B2R6T4; hsa:8125; P39687; Q53FK4; Q5J8L8; Q7M4N6,ENSG00000140350,HuR (ELAVL1) binds and stabilizes mRNA,IL-18 signaling pathway,2,1,90.8,149.72,68.68,138.67,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,140.79,107.68,94.27,145.04,51.31,other molecular function,0,
Master Protein,High,A0A8Q3WMA7,SFPQ,Splicing factor proline and glutamine rich OS=Homo sapiens OX=9606 GN=SFPQ PE=1 SV=1,19,166,2.101,1.045,0.582,3.684,1.07,0.06,-0.78,1.88,4.65E-01,5.42E-01,4.12E-01,2.17E-01,2.76E+07,1.83E+07,2.46E+07,5.41E+06,5,5,5,5,2.76E+07,2.66E+07,2.73E+07,6.92E+07,5.18E+07,1.83E+07,1.58E+07,2.31E+07,2.26E+06,2.22E+07,1.39E+08,2.46E+07,1.46E+07,5.97E+07,1.69E+07,1.58E+07,2.50E+06,4.19E+07,4.85E+06,5.41E+06,1.10E+05,1.01E+05,2.67E+05,6.92E+07,2.67E+06,6.49E+04,2.81E+05,2.13E+05,6.38E+04,2.36E+05,8.30E+05,1.10E+06,1.19E+05,8.04E+06,4.19E+05,3.08E+04,7.03E+05,2.97E+05,1.14E+05,5.76E+04,0,FALSE,134.591,34,18,728,78.6,9.39,19,other biological processes,nucleus,"Pf00076, Pf08075",,A0A8Q3WMA7,ENSG00000116560,,Type 2 papillary renal cell carcinoma,1,1,47.51,51.46,102.81,116.14,High,High,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,137.22,125.2,142.06,127.43,486.39,nucleic acid binding activity,0,
Master Protein,High,Q66K74,MAP1S,Microtubule-associated protein 1S OS=Homo sapiens OX=9606 GN=MAP1S PE=1 SV=2,5,14,2.101,1.313,,3.167,1.07,0.39,,1.66,4.28E-01,3.35E-01,,2.39E-01,2.20E+05,5.30E+04,9.50E+05,1.65E+05,5,1,5,5,2.12E+05,5.44E+05,5.11E+04,5.04E+05,2.20E+05,,,,,5.30E+04,1.02E+06,8.40E+05,6.60E+05,1.04E+06,9.50E+05,4.36E+05,1.03E+04,1.65E+05,8.35E+04,3.36E+05,8.44E+02,2.07E+03,4.99E+02,5.04E+05,1.13E+04,,,,,5.64E+02,6.11E+03,3.75E+04,5.36E+03,1.40E+05,2.36E+04,8.51E+02,2.88E+03,1.17E+03,1.95E+03,3.58E+03,0,FALSE,22.534,7,5,1059,112.1,7.3,5,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,,55201,B4DH53; hsa:55201; Q27QB1; Q66K74; Q6NXF1; Q8N3L8; Q8N3W5; Q8NI88; Q96H94; Q96IT4; Q96SP8; Q9BRC6; Q9H928; Q9NVK7,ENSG00000130479,,,0,0,68.67,,17.3,85.74,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,107.32,127.59,,109.34,39.37,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75396,SEC22B,Vesicle-trafficking protein SEC22b OS=Homo sapiens OX=9606 GN=SEC22B PE=1 SV=5,8,20,2.097,1.458,2.387,1.945,1.07,0.54,1.26,0.96,3.77E-01,1.91E-01,4.88E-01,4.41E-01,4.01E+05,1.75E+05,1.44E+06,1.82E+05,4,2,5,4,3.25E+05,,3.05E+05,2.30E+06,4.94E+05,,,,3.91E+04,7.84E+05,1.44E+06,1.35E+06,1.48E+06,1.43E+06,2.07E+06,,4.44E+05,6.05E+04,2.19E+05,1.51E+05,1.29E+03,,2.98E+03,2.30E+06,2.55E+04,,,,1.10E+03,8.34E+03,8.62E+03,6.03E+04,1.20E+04,1.93E+05,5.14E+04,,1.25E+05,4.28E+02,5.13E+03,1.61E+03,0,FALSE,29.577,36,8,215,24.7,8.51,8,cell organization and biogenesis;transport;other biological processes,other membranes;ER/Golgi;other cell component,"Pf00957, Pf13774",9554,A8K1G0; hsa:9554; O75396,ENSG00000265808,COPI-dependent Golgi-to-ER retrograde traffic; ER-Phagosome pathway; COPII-mediated vesicle transport; Cargo concentration in the ER,,4,0,112.77,127.98,18.79,74.88,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,25.97,76.11,52.27,78.1,53.58,other molecular function,0,
Master Protein,High,Q96A33,CCDC47,PAT complex subunit CCDC47 OS=Homo sapiens OX=9606 GN=CCDC47 PE=1 SV=1,7,15,2.094,0.998,2.374,1.192,1.07,0,1.25,0.25,4.17E-01,6.37E-01,4.89E-01,7.11E-01,2.39E+05,1.07E+05,3.89E+05,5.49E+05,4,2,4,5,,4.32E+05,1.32E+05,1.26E+06,3.75E+04,9.86E+04,1.16E+05,,,,,7.12E+05,2.13E+05,7.55E+05,2.01E+05,9.46E+05,5.49E+05,8.19E+05,1.77E+05,4.33E+05,,1.64E+03,1.29E+03,1.26E+06,1.93E+03,3.51E+02,2.06E+03,,,,,3.18E+04,1.73E+03,1.02E+05,4.99E+03,1.84E+03,1.54E+05,5.80E+03,4.13E+03,4.61E+03,0,FALSE,26.606,23,7,483,55.8,4.87,7,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,other membranes;cytosol;ER/Golgi;other cell component,Pf07946,57003,B2RAS8; D3DU20; hsa:57003; Q96A33; Q96D00; Q96JZ7; Q9H3E4; Q9NRG3,ENSG00000108588,,,0,0,119.39,11.24,64.79,52.44,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,118.63,112.3,54.21,82.07,52.31,translation activity;other molecular function,0,
Master Protein,High,Q8N163,CCAR2,Cell cycle and apoptosis regulator protein 2 OS=Homo sapiens OX=9606 GN=CCAR2 PE=1 SV=2,8,15,2.091,0.344,0.783,0.232,1.06,-1.54,-0.35,-2.11,4.28E-01,3.51E-01,6.57E-01,2.54E-01,1.45E+06,1.78E+05,2.70E+05,5.41E+05,5,3,5,1,1.45E+06,1.12E+06,8.63E+05,3.89E+06,2.07E+06,,2.57E+04,,1.78E+05,6.90E+05,2.25E+06,2.70E+05,1.68E+05,3.67E+06,1.98E+05,,,,,5.41E+05,5.78E+03,4.26E+03,8.43E+03,3.89E+06,1.07E+05,,4.58E+02,,5.02E+03,7.34E+03,1.35E+04,1.20E+04,1.37E+03,4.94E+05,4.92E+03,,,,,5.76E+03,0,FALSE,29.158,13,8,923,102.8,5.22,8,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,cytoskeleton;mitochondrion;nucleus;other cell component,"Pf14443, Pf14444, Pf19256, Pf19257",57805,A6NL03; B2RB79; D3DSR6; hsa:57805; Q6P0Q9; Q8N163; Q8N3G7; Q8N8M1; Q8TF34; Q9H9Q9; Q9HD12; Q9NT55,ENSG00000158941,Regulation of HSF1-mediated heat shock response,TAR syndrome,2,0,64.49,116.77,120.98,,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,107.34,99.61,0,75.82,40.18,enzyme regulator activity;other molecular function,0,
Master Protein,Medium,Q5JXI8,FHL1,Four and a half LIM domains 1 (Fragment) OS=Homo sapiens OX=9606 GN=FHL1 PE=1 SV=1,1,1,2.09,0.01,0.79,0.01,1.06,-6.64,-0.34,-6.64,4.48E-01,1.00E-17,7.85E-01,1.00E-17,1.07E+05,6.29E+04,,4.96E+04,4,2,,2,1.20E+05,9.52E+04,,3.50E+05,4.93E+04,,,,2.35E+04,1.68E+05,,,,,,,1.12E+04,,,2.20E+05,4.79E+02,3.62E+02,,3.50E+05,2.54E+03,,,,6.62E+02,1.79E+03,,,,,,,3.15E+03,,,2.34E+03,0.011,FALSE,2.251,3,1,257,29.1,8.27,1,other biological processes,plasma membrane;other membranes;cytosol,Pf00412,,Q5JXI8,ENSG00000022267,,,0,0,87.22,106.75,,127.7,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,117.78,,116.48,,2.3,other molecular function,0,
Master Protein,High,P17174,GOT1,"Aspartate aminotransferase, cytoplasmic OS=Homo sapiens OX=9606 GN=GOT1 PE=1 SV=3",2,2,2.089,0.417,,1.264,1.06,-1.26,,0.34,4.42E-01,4.91E-01,,6.71E-01,1.59E+06,6.32E+05,5.70E+05,1.17E+06,2,2,4,3,,,2.32E+05,,1.08E+07,,,5.81E+05,,6.86E+05,1.15E+06,1.17E+05,1.90E+06,,2.81E+05,1.17E+06,1.92E+05,2.42E+06,,,,,2.27E+03,,5.59E+05,,,5.36E+03,,7.30E+03,6.90E+03,5.21E+03,1.54E+04,,6.98E+03,2.28E+03,5.39E+04,1.72E+04,,,0.001,FALSE,3.939,5,2,413,46.2,7.01,2,other metabolic processes;signal transduction;other biological processes,cytosol;other cell component,Pf00155,2805,B2R6R7; B7Z7E9; hsa:2805; P17174; Q5VW80,ENSG00000120053,Gluconeogenesis; Aspartate and asparagine metabolism; Methionine salvage pathway,Alanine and aspartate metabolism; Trans-sulfuration pathway; Amino acid metabolism; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; TCA cycle in senescence; Neuroinflammation and glutamatergic signaling; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,11,0,135.5,11.69,95.84,88.66,n/a,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,1,,FALSE,376.02,68.26,,74.48,5.6,other molecular function,0,
Master Protein,High,P29590,PML,Protein PML OS=Homo sapiens OX=9606 GN=PML PE=1 SV=3,17,45,2.086,0.473,0.967,0.543,1.06,-1.08,-0.05,-0.88,4.70E-01,5.75E-01,8.62E-01,6.41E-01,7.15E+06,2.33E+06,2.94E+06,2.57E+06,5,5,5,5,1.75E+07,1.05E+07,3.32E+06,7.15E+06,6.25E+06,4.53E+05,3.28E+06,5.23E+06,2.88E+05,2.33E+06,5.85E+05,4.23E+06,9.99E+05,4.86E+06,2.94E+06,8.41E+05,5.71E+05,3.27E+06,2.57E+06,4.33E+06,6.96E+04,3.99E+04,3.24E+04,7.15E+06,3.23E+05,1.61E+03,5.83E+04,4.83E+04,8.12E+03,2.47E+04,3.50E+03,1.89E+05,8.11E+03,6.54E+05,7.32E+04,1.64E+03,1.60E+05,2.32E+04,6.02E+04,4.61E+04,0,FALSE,66.603,27,4,882,97.5,6.21,17,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00097, Pf00643, Pf12126",5371,E9PBR7; hsa:5371; P29590; P29591; P29592; P29593; Q00755; Q15959; Q59FP9; Q8WUA0; Q96S41; Q9BPW2; Q9BWP7; Q9BZX6; Q9BZX7; Q9BZX8; Q9BZX9; Q9BZY0; Q9BZY2; Q9BZY3,ENSG00000140464,HCMV Early Events; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Interferon gamma signaling; Regulation of TP53 Activity through Acetylation; Regulation of PTEN localization; Regulation of RUNX1 Expression and Activity,miRNA regulation of DNA damage response; Wnt/beta-catenin signaling pathway in leukemia; TGF-beta signaling pathway; p53 transcriptional gene network; Acute myeloid leukemia; DNA damage response,13,11,60.74,89.05,69.72,69.12,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,105.16,87.06,121.85,128.22,140.86,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8V8TRH9,PPP1CB,Serine/threonine-protein phosphatase OS=Homo sapiens OX=9606 GN=PPP1CB PE=1 SV=1,6,21,2.077,0.442,1.201,0.926,1.05,-1.18,0.26,-0.11,4.26E-01,5.21E-01,9.19E-01,9.16E-01,2.79E+06,1.91E+05,1.39E+06,1.37E+06,4,5,5,5,,5.58E+06,1.32E+05,5.59E+06,1.40E+06,5.67E+05,9.55E+04,1.66E+06,1.51E+05,1.91E+05,5.04E+05,1.39E+06,1.50E+06,3.99E+06,1.22E+06,2.75E+05,1.02E+06,1.74E+06,1.37E+06,2.38E+06,,2.12E+04,1.29E+03,5.59E+06,7.21E+04,2.02E+03,1.70E+03,1.53E+04,4.26E+03,2.03E+03,3.02E+03,6.21E+04,1.22E+04,5.38E+05,3.04E+04,5.36E+02,2.87E+05,1.23E+04,3.21E+04,2.54E+04,0,FALSE,28.028,18,2,368,41.3,6.54,6,other metabolic processes;other biological processes,nucleus,"Pf00149, Pf16891",,A0A8V8TRH9,ENSG00000213639,,Common pathways underlying drug addiction; Focal adhesion; 22q11.2 copy number variation syndrome; Airway smooth muscle cell contraction,4,4,89.13,123.34,77.03,57.99,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,117.65,107.63,120.19,90.9,65.51,other molecular function,0,
Master Protein,High,Q9H3K2,GHITM,Growth hormone-inducible transmembrane protein OS=Homo sapiens OX=9606 GN=GHITM PE=1 SV=2,4,9,2.075,0.346,1.103,0.59,1.05,-1.53,0.14,-0.76,4.26E-01,3.10E-01,9.68E-01,7.64E-01,1.66E+06,2.13E+05,2.52E+05,2.27E+05,5,5,4,4,5.01E+05,1.66E+06,3.55E+05,1.71E+06,1.79E+06,1.65E+06,2.13E+05,1.50E+05,7.76E+05,1.36E+05,,3.96E+04,2.31E+05,1.20E+06,2.76E+05,,2.06E+05,2.50E+05,6.87E+04,4.46E+06,1.99E+03,6.32E+03,3.47E+03,1.71E+06,9.21E+04,5.85E+03,3.79E+03,1.38E+03,2.19E+04,1.45E+03,,1.77E+03,1.88E+03,1.62E+05,6.85E+03,,5.78E+04,1.77E+03,1.61E+03,4.75E+04,0,FALSE,9.604,12,4,345,37.2,9.94,4,cell organization and biogenesis;transport;other biological processes,other membranes;mitochondrion,Pf01027,27069,A8K9Z9; D3DWE0; hsa:27069; O95894; Q5VT95; Q9H0P2; Q9H3K2,ENSG00000165678,,10q22q23 copy number variation,1,0,59.08,111.29,119.01,172.04,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,110.65,112.99,120.46,125.02,21.44,transporter activity,0,
Master Protein,High,Q9Y3U8,RPL36,60S ribosomal protein L36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3,3,16,2.068,0.141,0.431,0.275,1.05,-2.82,-1.21,-1.86,4.53E-01,2.27E-02,3.62E-01,3.75E-01,1.53E+06,6.71E+05,2.07E+05,1.31E+06,3,3,4,3,,,2.05E+05,3.09E+06,1.53E+06,5.31E+06,,6.71E+05,,6.62E+05,,2.33E+05,1.22E+05,1.42E+06,1.84E+05,1.31E+06,1.89E+06,,4.69E+05,,,,2.00E+03,3.09E+06,7.87E+04,1.89E+04,,6.19E+03,,7.04E+03,,1.04E+04,9.90E+02,1.91E+05,4.57E+03,2.56E+03,5.32E+05,,1.10E+04,,0,FALSE,10.356,21,3,105,12.2,11.59,3,protein metabolism;other metabolic processes,cytosol;translational apparatus;nucleus;other cell component,Pf01158,25873,B2R4Y1; D6W634; hsa:25873; Q6FIG1; Q9UQF6; Q9Y3U8,ENSG00000130255,Major pathway of rRNA processing in the nucleolus and cytosol; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,89.89,121.05,126.9,58.48,n/a,n/a,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,19.15,58.75,115.58,125.25,45.61,other molecular function,0,
Master Protein,High,Q32P28,P3H1,Prolyl 3-hydroxylase 1 OS=Homo sapiens OX=9606 GN=P3H1 PE=1 SV=2,1,2,2.067,0.298,0.296,2.081,1.05,-1.75,-1.76,1.06,4.45E-01,3.40E-01,2.55E-01,4.20E-01,1.64E+05,7.93E+04,4.88E+04,2.34E+04,2,1,2,2,,,1.27E+05,,2.12E+05,,,,,7.93E+04,,2.63E+04,,9.04E+04,,,1.52E+04,,3.63E+04,,,,1.24E+03,,1.09E+04,,,,,8.43E+02,,1.18E+03,,1.22E+04,,,4.26E+03,,8.49E+02,,0.001,FALSE,3.502,2,1,736,83.3,5.14,1,protein metabolism;other metabolic processes;developmental processes;other biological processes,ER/Golgi;nucleus;other cell component,Pf13640,64175,hsa:64175; Q32P28; Q7KZR4; Q96BR8; Q96SK8; Q96SL5; Q96SN3; Q9H6K3; Q9HC86; Q9HC87,ENSG00000117385,Collagen biosynthesis and modifying enzymes,Type I collagen synthesis in the context of osteogenesis imperfecta,2,0,35.48,,77.6,58.09,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,38.43,75.31,66.8,62.89,4.34,other molecular function,0,
Master Protein,High,Q9HC52,CBX8,Chromobox protein homolog 8 OS=Homo sapiens OX=9606 GN=CBX8 PE=1 SV=3,3,5,2.053,0.861,0.01,100,1.04,-0.22,-6.64,6.64,4.35E-01,7.51E-01,1.00E-17,1.00E-17,1.34E+05,1.60E+05,4.20E+05,,4,2,5,,,3.98E+05,3.47E+04,5.68E+05,4.49E+04,,1.96E+05,,1.32E+05,,4.63E+04,4.20E+05,4.37E+05,5.92E+05,4.13E+05,,,,,,,1.51E+03,3.39E+02,5.68E+05,2.32E+03,,3.48E+03,,3.71E+03,,2.77E+02,1.88E+04,3.55E+03,7.98E+04,1.03E+04,,,,,,0,FALSE,10.589,11,3,389,43.4,9.91,3,cell organization and biogenesis;stress response;other biological processes,nucleus;other cell component,"Pf00385, Pf17218",57332,hsa:57332; Q96H39; Q9HC52; Q9NR07,ENSG00000141570,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription,,8,0,101.42,27.63,52.76,,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,131.67,46.8,,,11.42,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9HBD4,SMARCA4,SMARCA4 isoform 2 OS=Homo sapiens OX=9606 GN=SMARCA4 PE=1 SV=1,20,47,2.052,0.679,0.278,2.79,1.04,-0.56,-1.85,1.48,4.82E-01,9.77E-01,1.44E-01,3.13E-01,9.18E+06,2.96E+05,3.58E+06,1.10E+06,5,5,5,4,1.25E+08,2.68E+06,2.10E+07,9.18E+06,3.58E+06,9.68E+06,2.96E+05,7.58E+04,1.89E+05,7.23E+05,4.59E+05,2.50E+06,3.58E+06,9.40E+06,5.85E+06,1.45E+06,1.82E+05,,9.81E+05,1.24E+06,4.97E+05,1.02E+04,2.05E+05,9.18E+06,1.85E+05,3.44E+04,5.27E+03,6.99E+02,5.33E+03,7.69E+03,2.74E+03,1.12E+05,2.91E+04,1.27E+06,1.45E+05,2.83E+03,5.11E+04,,2.30E+04,1.32E+04,0,FALSE,76.67,13,11,1679,188,8.19,20,cell organization and biogenesis;other biological processes,nucleus,"Pf00176, Pf00271, Pf00439, Pf07529, Pf07533, Pf08880, Pf14619",6597,Q9HBD4,ENSG00000127616,,Androgen receptor network in prostate cancer; Pre-implantation embryo; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; Tumor suppressor activity of SMARCB1; Rett syndrome; Thermogenesis; Kleefstra syndrome,7,8,162.06,191.19,78.54,57.61,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,128.01,105.95,119.58,100.87,134.23,other molecular function,0,
Master Protein,High,B0YIW2,APOC3,Apolipoprotein C-III OS=Homo sapiens OX=9606 GN=APOC3 PE=1 SV=1,1,18,2.05,0.708,0.652,3.419,1.04,-0.5,-0.62,1.77,4.41E-01,9.13E-01,6.50E-01,1.97E-01,2.22E+06,1.08E+06,1.57E+06,7.07E+05,1,1,4,2,,,,2.22E+06,,,,,,1.08E+06,,1.76E+06,5.18E+06,1.13E+06,1.41E+06,,2.24E+05,,2.23E+06,,,,,2.22E+06,,,,,,1.15E+04,,7.85E+04,4.20E+04,1.52E+05,3.50E+04,,6.28E+04,,5.23E+04,,0,FALSE,8.454,14,1,117,12.8,8.18,1,protein metabolism;other metabolic processes;transport,non-structural extracellular,Pf05778,,B0YIW2,ENSG00000110245,,PPAR-alpha pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Cholesterol metabolism,4,0,,,79.8,115.69,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,High,n/a,High,High,High,High,n/a,High,n/a,High,n/a,1,,FALSE,0,37.82,210.87,122.99,62.98,other molecular function,0,
Master Protein,High,O43809,NUDT21,Cleavage and polyadenylation specificity factor subunit 5 OS=Homo sapiens OX=9606 GN=NUDT21 PE=1 SV=1,3,10,2.046,1.6,3.532,1.34,1.03,0.68,1.82,0.42,3.99E-01,1.65E-01,2.32E-01,6.46E-01,5.55E+05,2.23E+05,2.10E+06,7.87E+05,4,1,4,4,2.34E+05,,5.75E+04,1.32E+06,1.40E+06,2.23E+05,,,,,4.03E+06,,1.26E+06,3.51E+06,5.63E+05,8.75E+05,1.01E+05,1.01E+06,7.07E+05,,9.28E+02,,5.61E+02,1.32E+06,7.21E+04,7.92E+02,,,,,2.41E+04,,1.02E+04,4.73E+05,1.40E+04,1.71E+03,2.82E+04,7.15E+03,1.66E+04,,0,FALSE,13.693,20,3,227,26.2,8.82,3,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytoskeleton;nucleus;other cell component,Pf13869,11051,hsa:11051; O43809; Q6IB85; Q6NE84,ENSG00000167005,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,mRNA processing,5,0,93.71,,72.16,59.6,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,n/a,1,,FALSE,135.3,110.37,29.26,99.86,29.97,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A0A0MRM9,NOLC1,Nucleolar and coiled-body phosphoprotein 1 (Fragment) OS=Homo sapiens OX=9606 GN=NOLC1 PE=1 SV=1,2,8,2.043,1.25,0.01,100,1.03,0.32,-6.64,6.64,4.25E-01,3.39E-01,1.00E-17,1.00E-17,7.77E+05,3.65E+04,8.84E+05,,1,2,4,,,,,7.77E+05,,,2.54E+04,,,5.23E+04,2.18E+06,,3.20E+05,8.85E+05,8.82E+05,,,,,,,,,7.77E+05,,,4.52E+02,,,5.57E+02,1.31E+04,,2.60E+03,1.19E+05,2.19E+04,,,,,,0,FALSE,11.756,4,2,708,74.6,9.47,2,,nucleus,Pf05022,,A0A0A0MRM9,ENSG00000166197,,,0,0,,49.02,74.01,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,54.79,94.26,,,22.63,,0,
Master Protein,High,P11387,TOP1,DNA topoisomerase 1 OS=Homo sapiens OX=9606 GN=TOP1 PE=1 SV=2,19,66,2.042,0.624,1.348,0.913,1.03,-0.68,0.43,-0.13,4.85E-01,8.79E-01,7.79E-01,9.97E-01,1.04E+07,1.94E+06,7.94E+06,1.71E+06,5,5,5,5,1.60E+06,2.68E+07,2.04E+06,1.04E+07,1.41E+07,1.94E+06,1.26E+06,3.65E+06,4.95E+05,5.25E+06,7.94E+06,5.90E+06,6.90E+06,1.61E+07,1.12E+07,1.33E+06,1.71E+06,9.23E+06,6.08E+05,3.14E+06,6.37E+03,1.02E+05,2.00E+04,1.04E+07,7.26E+05,6.90E+03,2.23E+04,3.37E+04,1.39E+04,5.59E+04,4.74E+04,2.63E+05,5.61E+04,2.17E+06,2.79E+05,2.60E+03,4.80E+05,6.54E+04,1.42E+04,3.34E+04,0,FALSE,71.241,27,19,765,90.7,9.31,19,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,"Pf01028, Pf02919, Pf14370",7150,A8KA78; E1P5W3; hsa:7150; O43256; P11387; Q12855; Q12856; Q15610; Q5TFY3; Q9UJN0,ENSG00000198900,SUMOylation of DNA replication proteins,Ebola virus infection in host; 15q25 copy number variation,3,0,94.04,76.33,42.99,109.06,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,131.61,121.86,126.56,134.94,174.53,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,A2A274,ACO2,Aconitase 2 OS=Homo sapiens OX=9606 GN=ACO2 PE=1 SV=1,28,150,2.041,1.585,1.543,1.446,1.03,0.66,0.63,0.53,4.86E-01,2.21E-01,6.73E-01,6.87E-01,5.17E+06,6.75E+06,1.78E+07,6.46E+06,5,5,5,5,5.17E+06,2.63E+06,3.27E+05,2.56E+07,1.58E+07,1.63E+06,1.47E+07,6.75E+06,1.51E+06,2.95E+07,2.37E+06,2.75E+07,1.76E+07,1.78E+07,1.81E+07,1.50E+07,6.29E+06,1.61E+07,5.56E+06,6.46E+06,2.05E+04,9.98E+03,3.19E+03,2.56E+07,8.16E+05,5.79E+03,2.62E+05,6.23E+04,4.25E+04,3.14E+05,1.42E+04,1.23E+06,1.43E+05,2.40E+06,4.51E+05,2.93E+04,1.77E+06,1.14E+05,1.30E+05,6.88E+04,0,FALSE,140.448,41,28,805,87.8,7.37,28,,,"Pf00330, Pf00694",,A2A274,ENSG00000100412,,Amino acid metabolism; Metabolic reprogramming in colon cancer; Fluoroacetic acid toxicity,3,0,106.85,108.53,54.09,52.7,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,139.93,114,135.42,115.48,435.67,other molecular function,0,
Master Protein,High,Q92499,DDX1,ATP-dependent RNA helicase DDX1 OS=Homo sapiens OX=9606 GN=DDX1 PE=1 SV=2,8,25,2.036,0.866,1.129,1.627,1.03,-0.21,0.17,0.7,4.47E-01,7.40E-01,8.84E-01,5.88E-01,3.01E+06,6.94E+05,3.17E+06,1.22E+06,5,3,5,5,2.76E+06,1.38E+06,3.01E+06,3.01E+06,4.06E+06,3.01E+06,,6.94E+05,6.51E+05,,1.00E+07,3.17E+06,4.41E+06,2.35E+06,9.01E+05,1.92E+06,1.55E+06,1.30E+05,1.22E+06,3.45E+05,1.10E+04,5.23E+03,2.94E+04,3.01E+06,2.09E+05,1.07E+04,,6.41E+03,1.83E+04,,6.00E+04,1.42E+05,3.59E+04,3.17E+05,2.24E+04,3.75E+03,4.36E+05,9.22E+02,2.84E+04,3.67E+03,0,FALSE,40.097,17,8,740,82.4,7.23,8,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;mitochondrion;nucleus;other cell component,"Pf00270, Pf00271, Pf00622",1653,B4DME8; B4DPN6; hsa:1653; Q92499,ENSG00000079785,tRNA processing in the nucleus,DDX1 as a regulatory component of the Drosha microprocessor; mRNA processing,3,0,33.79,93.04,84.13,74.71,High,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,59.6,101.18,83.75,102.24,80.33,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P14770,GP9,Platelet glycoprotein IX OS=Homo sapiens OX=9606 GN=GP9 PE=1 SV=3,2,6,2.028,0.681,3.38,0.286,1.02,-0.55,1.76,-1.81,4.69E-01,9.36E-01,1.62E-01,3.31E-01,7.76E+05,3.12E+05,5.29E+05,1.80E+06,5,2,5,5,1.27E+06,7.76E+05,1.03E+06,7.31E+03,3.88E+05,5.51E+05,,,1.77E+05,,5.29E+05,1.27E+05,1.57E+05,5.30E+05,1.07E+06,1.80E+06,1.87E+06,1.68E+06,5.51E+05,1.85E+06,5.03E+03,2.95E+03,1.01E+04,7.31E+03,2.00E+04,1.96E+03,,,4.99E+03,,3.16E+03,5.69E+03,1.28E+03,7.14E+04,2.67E+04,3.50E+03,5.27E+05,1.19E+04,1.29E+04,1.97E+04,0,FALSE,7.272,13,2,177,19,6.34,2,cell adhesion;protein metabolism;other metabolic processes;stress response;transport;other biological processes,plasma membrane;other membranes,"Pf01462, Pf13855",2815,hsa:2815; P14770; Q14445; Q8N1D1; Q92525,ENSG00000169704,Intrinsic Pathway of Fibrin Clot Formation; Platelet Adhesion to exposed collagen; Platelet Aggregation (Plug Formation); Defective F9 activation; GP1b-IX-V activation signalling; Enhanced binding of GP1BA variant to VWF multimer:collagen ; Defective binding of VWF variant to GPIb:IX:V,Hematopoietic stem cell differentiation; 22q11.2 copy number variation syndrome,9,0,72.55,72.68,79.12,36.37,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,121.02,111.74,59.37,77.37,15,,0,
Master Protein,Medium,Q8WUA2,PPIL4,Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1,1,2,2.024,0.453,5.104,0.18,1.02,-1.14,2.35,-2.48,4.42E-01,6.03E-01,1.46E-01,1.44E-01,2.14E+05,1.06E+05,9.70E+04,5.40E+05,3,2,1,4,,,5.85E+04,2.14E+05,1.47E+06,,7.22E+04,1.55E+05,,,,,,9.70E+04,,3.89E+05,,7.50E+05,8.61E+04,1.54E+06,,,5.72E+02,2.14E+05,7.60E+04,,1.28E+03,1.43E+03,,,,,,1.31E+04,,7.59E+02,,5.31E+03,2.02E+03,1.64E+04,0.025,FALSE,1.876,3,1,492,57.2,5.92,1,,cytosol;nucleus,"Pf00076, Pf00160",85313,B2RD34; hsa:85313; Q7Z3Q5; Q8WUA2,ENSG00000131013,mRNA Splicing - Major Pathway,,1,0,133.29,51.68,,90.67,n/a,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,104.75,107.76,122.87,91.07,3.22,other molecular function,0,
Master Protein,High,P05141,SLC25A5,ADP/ATP translocase 2 OS=Homo sapiens OX=9606 GN=SLC25A5 PE=1 SV=7,10,118,2.019,1.965,2.048,3.58,1.01,0.97,1.03,1.84,4.93E-01,1.23E-01,4.34E-01,2.27E-01,6.95E+07,2.05E+07,9.51E+07,4.63E+07,5,5,5,5,1.48E+07,8.23E+07,1.61E+07,6.95E+07,7.73E+07,6.37E+07,7.80E+06,2.05E+07,1.24E+07,8.85E+07,9.51E+07,3.58E+07,4.76E+07,1.41E+08,9.55E+07,5.90E+07,3.82E+07,1.31E+08,1.26E+07,4.63E+07,5.87E+04,3.13E+05,1.57E+05,6.95E+07,3.99E+06,2.26E+05,1.39E+05,1.89E+05,3.49E+05,9.41E+05,5.69E+05,1.60E+06,3.87E+05,1.90E+07,2.37E+06,1.15E+05,1.07E+07,9.30E+05,2.94E+05,4.93E+05,0,FALSE,33.342,29,5,298,32.8,9.69,10,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;other biological processes,plasma membrane;other membranes;cytoskeleton;mitochondrion,Pf00153,292,B2RCV1; hsa:292; O43350; P05141,ENSG00000005022,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane; Mitochondrial protein degradation; Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,Electron transport chain: OXPHOS system in mitochondria; Alzheimer's disease and miRNA effects; Alzheimer's disease,6,5,64.8,92.44,50.94,77.63,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,121.67,131.87,133.14,125.38,211.34,transporter activity;other molecular function,0,
Master Protein,High,P05455,SSB,Lupus La protein OS=Homo sapiens OX=9606 GN=SSB PE=1 SV=2,9,18,2.016,0.421,5.063,0.453,1.01,-1.25,2.34,-1.14,4.36E-01,5.35E-01,1.28E-01,5.88E-01,6.90E+05,1.55E+05,3.13E+05,6.50E+05,4,5,5,5,,2.70E+05,5.05E+04,1.76E+06,4.93E+06,1.34E+05,2.01E+05,1.67E+05,6.99E+04,1.55E+05,5.74E+04,3.13E+05,6.90E+04,1.85E+06,4.10E+05,4.74E+05,5.80E+04,1.61E+06,6.50E+05,1.16E+06,,1.03E+03,4.93E+02,1.76E+06,2.54E+05,4.75E+02,3.58E+03,1.54E+03,1.97E+03,1.64E+03,3.43E+02,1.40E+04,5.61E+02,2.49E+05,1.02E+04,9.24E+02,1.63E+04,1.14E+04,1.52E+04,1.23E+04,0,FALSE,30.378,21,9,408,46.8,7.12,9,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,cytosol;nucleus;other cell component,"Pf00076, Pf05383, Pf08777",6741,hsa:6741; P05455; Q15367; Q53XJ4,ENSG00000138385,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination,,2,0,128.37,33.54,138.46,76.64,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,129.73,115.42,50.41,137.28,42.72,nucleic acid binding activity,0,
Master Protein,High,A0A7I2V5Q7,BCL2,Apoptosis regulator Bcl-2 OS=Homo sapiens OX=9606 GN=BCL2 PE=1 SV=1,2,8,2.012,0.875,5.082,3.552,1.01,-0.19,2.35,1.83,4.70E-01,6.22E-01,1.49E-01,1.93E-01,1.04E+06,4.87E+04,8.31E+05,3.48E+05,2,2,5,3,,,,9.30E+05,1.17E+06,,,6.45E+04,,3.67E+04,7.15E+04,4.45E+05,4.88E+06,2.13E+06,8.31E+05,,1.87E+05,,5.06E+05,3.48E+05,,,,9.30E+05,6.03E+04,,,5.95E+02,,3.91E+02,4.27E+02,1.99E+04,3.96E+04,2.86E+05,2.07E+04,,5.25E+04,,1.18E+04,3.70E+03,0,FALSE,11.265,10,2,268,29.3,7.09,2,stress response;other biological processes,other membranes;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf00452, Pf02180",,A0A7I2V5Q7,ENSG00000171791,,TP53 network; Nanomaterial induced apoptosis; Nanoparticle triggered autophagic cell death; Overview of nanoparticle effects; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; Regulation of apoptosis by parathyroid hormone-related protein; Oxidative damage response; miRNA regulation of prostate cancer signaling pathways; Prion disease pathway; NO/cGMP/PKG mediated neuroprotection; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Hedgehog signaling pathway; Acute viral myocarditis; MicroRNA network associated with chronic lymphocytic leukemia; Measles virus infection; 22q11.2 copy number variation syndrome; Small cell lung cancer; Hepatitis B infection; Male infertility; Vitamin D-sensitive calcium signaling in depression; EGFR tyrosine kinase inhibitor resistance; Endoplasmic reticulum stress response in coronavirus infection; Host-pathogen interaction of human coronaviruses - apoptosis; Host-pathogen interaction of human coronaviruses - MAPK signaling; Unfolded protein response; Pleural mesothelioma; Clock-controlled autophagy in bone metabolism; Hippocampal synaptogenesis and neurogenesis; 10q11.21q11.23 copy number variation syndrome; NF1 copy number variation syndrome ; HDAC6 interactions in the central nervous system; DNA damage response (only ATM dependent),33,0,16.14,38.75,116.96,45.99,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,42.24,109.16,42.24,132.32,22.56,,0,
Master Protein,High,P36542,ATP5F1C,"ATP synthase subunit gamma, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1C PE=1 SV=1",9,53,2.007,1.204,1.492,2.444,1.01,0.27,0.58,1.29,4.97E-01,4.13E-01,7.04E-01,3.85E-01,5.67E+06,3.86E+06,1.33E+07,5.10E+06,5,5,5,5,4.00E+06,5.67E+06,6.43E+06,9.04E+06,5.49E+06,9.74E+06,5.31E+05,3.86E+06,1.53E+06,1.45E+07,1.33E+07,1.08E+07,1.07E+07,1.70E+07,2.42E+07,5.10E+06,5.27E+06,3.59E+06,5.23E+06,5.02E+06,1.59E+04,2.16E+04,6.28E+04,9.04E+06,2.83E+05,3.46E+04,9.45E+03,3.56E+04,4.31E+04,1.54E+05,7.94E+04,4.82E+05,8.73E+04,2.29E+06,6.03E+05,9.95E+03,1.48E+06,2.55E+04,1.22E+05,5.35E+04,0,FALSE,38.29,24,9,298,33,9.22,9,other metabolic processes;transport,other membranes;mitochondrion,Pf00231,509,A8KA31; hsa:509; P36542; Q5VYP3; Q6I9V2; Q96AS8,ENSG00000165629,Mitochondrial protein degradation; Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria,4,0,30.22,98.31,37.2,14.56,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,118.36,112.04,135.79,124.35,110.03,transporter activity,0,
Master Protein,High,Q96HY6,DDRGK1,DDRGK domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DDRGK1 PE=1 SV=2,2,11,2,3.25,2.182,2.904,1,1.7,1.13,1.54,4.73E-01,4.57E-02,5.68E-01,2.50E-01,1.33E+05,5.98E+04,7.63E+05,2.60E+05,3,2,5,3,1.07E+05,,,2.74E+05,1.33E+05,9.11E+04,,3.93E+04,,,7.63E+05,5.72E+05,9.95E+05,4.75E+05,1.30E+06,2.60E+05,2.79E+05,,8.20E+03,,4.24E+02,,,2.74E+05,6.85E+03,3.24E+02,,3.63E+02,,,4.56E+03,2.56E+04,8.08E+03,6.41E+04,3.23E+04,5.07E+02,7.85E+04,,1.92E+02,,0,FALSE,9.347,11,2,314,35.6,5.12,2,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes,other membranes;ER/Golgi;nucleus;other cell component,Pf09756,65992,A6NIU5; C9JSZ5; hsa:65992; Q96HY6; Q9BW47,ENSG00000198171,RHOA GTPase cycle,,1,0,52.64,56.16,40.63,82.89,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,High,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,57.19,91.5,124.33,89.35,21.42,other molecular function,0,
Master Protein,High,P49790,NUP153,Nuclear pore complex protein Nup153 OS=Homo sapiens OX=9606 GN=NUP153 PE=1 SV=2,6,10,2,0.522,1.981,0.835,1,-0.94,0.99,-0.26,4.63E-01,7.21E-01,5.51E-01,9.64E-01,6.69E+05,2.75E+05,4.75E+05,1.13E+06,4,1,4,3,,1.51E+06,2.00E+05,8.71E+05,5.14E+05,,,,2.75E+05,,,4.68E+05,3.67E+05,4.82E+05,4.97E+05,,2.02E+05,,1.13E+06,1.65E+06,,5.72E+03,1.95E+03,8.71E+05,2.65E+04,,,,7.76E+03,,,2.09E+04,2.98E+03,6.49E+04,1.24E+04,,5.67E+04,,2.65E+04,1.76E+04,0,FALSE,24.289,6,6,1475,153.8,8.73,6,cell organization and biogenesis;transport;other biological processes,other membranes;cytosol;nucleus;other cell component,"Pf00641, Pf08604, Pf10599",9972,B4DIK2; E7EPX5; F6QR24; hsa:9972; P49790; Q4LE47; Q5T9I7; Q7Z743,ENSG00000124789,HCMV Late Events; HCMV Early Events; Transcriptional regulation by small RNAs; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses,TGF-beta signaling pathway,29,0,72.53,,12.94,73.86,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,70.94,73.46,108.8,66.64,30.23,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P36776,LONP1,"Lon protease homolog, mitochondrial OS=Homo sapiens OX=9606 GN=LONP1 PE=1 SV=2",11,56,1.993,1.042,1.121,1.108,0.99,0.06,0.16,0.15,5.03E-01,5.45E-01,9.89E-01,8.67E-01,6.91E+06,2.00E+06,4.92E+06,3.29E+06,5,4,5,5,7.26E+06,1.12E+06,4.25E+04,6.91E+06,7.06E+06,5.58E+05,,4.69E+06,9.71E+05,4.12E+06,2.74E+06,7.24E+06,1.46E+06,6.58E+06,4.92E+06,3.29E+06,1.72E+06,3.62E+06,2.35E+05,9.78E+06,2.88E+04,4.27E+03,4.15E+02,6.91E+06,3.64E+05,1.99E+03,,4.32E+04,2.74E+04,4.38E+04,1.64E+04,3.23E+05,1.19E+04,8.87E+05,1.22E+05,6.41E+03,4.83E+05,2.57E+04,5.50E+03,1.04E+05,0,FALSE,54.205,18,11,959,106.4,6.39,11,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;mitochondrion;nucleus,"Pf00004, Pf02190, Pf05362",9361,B3KPH8; D6W635; E5KMH8; F5GZ27; hsa:9361; P36776; P36777; Q8N8K8; Q9UQ95,ENSG00000196365,Mitochondrial protein degradation,,1,0,79.91,82.05,53.72,97.66,Peak Found,High,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,111.88,121.95,137.16,143.86,170.65,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P62906,RPL10A,60S ribosomal protein L10a OS=Homo sapiens OX=9606 GN=RPL10A PE=1 SV=2,7,23,1.986,0.451,1.903,0.417,0.99,-1.15,0.93,-1.26,5.05E-01,5.28E-01,4.91E-01,4.84E-01,5.66E+06,7.30E+05,2.94E+06,5.20E+06,5,3,5,5,1.24E+06,6.70E+06,1.08E+06,9.41E+06,5.66E+06,2.16E+06,,7.30E+05,1.01E+05,,3.01E+06,2.94E+06,2.01E+06,6.78E+06,1.53E+06,2.80E+06,6.67E+06,1.20E+07,4.82E+06,5.20E+06,4.93E+03,2.55E+04,1.05E+04,9.41E+06,2.92E+05,7.67E+03,,6.74E+03,2.84E+03,,1.80E+04,1.31E+05,1.63E+04,9.13E+05,3.79E+04,5.45E+03,1.87E+06,8.51E+04,1.13E+05,5.54E+04,0,FALSE,26.764,37,7,217,24.8,9.94,7,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;translational apparatus;other cell component,Pf00687,4736,B2R801; hsa:4736; P52859; P53025; P62906; Q5TZT6; Q8J013,ENSG00000198755,SRP-dependent cotranslational protein targeting to membrane; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),VEGFA-VEGFR2 signaling; Cytoplasmic ribosomal proteins,15,0,74.94,105.79,63.6,55.18,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,83.67,89.6,39.71,74.37,63.27,other molecular function,0,
Master Protein,Medium,A0A8I5KXY7,GK,glycerol kinase OS=Homo sapiens OX=9606 GN=GK PE=1 SV=1,1,1,1.983,0.716,0.01,100,0.99,-0.48,-6.64,6.64,4.09E-01,9.97E-01,1.00E-17,1.00E-17,3.67E+05,1.85E+05,4.46E+05,,5,1,3,,3.67E+05,9.85E+05,6.74E+05,2.31E+05,2.86E+05,,,,1.85E+05,,4.46E+05,,,7.05E+05,1.27E+05,,,,,,1.46E+03,3.74E+03,6.58E+03,2.31E+05,1.48E+04,,,,5.22E+03,,2.67E+03,,,9.50E+04,3.15E+03,,,,,,0.017,FALSE,2.03,2,1,581,63,6.32,1,other metabolic processes,other membranes;mitochondrion,"Pf00370, Pf02782",2710,A0A8I5KXY7,ENSG00000198814,,Fatty acid beta-oxidation; Type II diabetes mellitus; Triacylglyceride synthesis,3,0,62.25,,68,,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,55.17,91.13,,,2.8,kinase activity;other molecular function,0,
Master Protein,High,Q9BTC0,DIDO1,Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,17,30,1.973,0.522,0.386,1.145,0.98,-0.94,-1.37,0.2,4.75E-01,7.28E-01,2.30E-01,7.63E-01,1.40E+06,3.74E+05,1.14E+06,7.06E+05,5,4,5,5,4.80E+05,1.40E+06,1.21E+06,2.89E+06,2.00E+06,1.48E+05,,4.57E+05,3.06E+05,1.39E+06,1.22E+06,4.58E+05,1.14E+06,1.52E+06,8.71E+05,7.70E+05,9.62E+04,9.21E+05,1.52E+05,7.06E+05,1.91E+03,5.32E+03,1.18E+04,2.89E+06,1.03E+05,5.27E+02,,4.21E+03,8.63E+03,1.48E+04,7.29E+03,2.05E+04,9.25E+03,2.05E+05,2.16E+04,1.50E+03,2.70E+04,6.53E+03,3.56E+03,7.51E+03,0,FALSE,80.435,14,17,2240,243.7,7.88,17,RNA metabolism OR transcription;other metabolic processes;signal transduction,cytoskeleton;nucleus;other cell component,"Pf00628, Pf07500, Pf07744",11083,A8MY65; B9EH82; E1P5I1; hsa:11083; O15043; Q3ZTL7; Q3ZTL8; Q4VXS1; Q4VXS2; Q4VXV8; Q4VXV9; Q96D72; Q9BQW0; Q9BTC0; Q9BW03; Q9H4G6; Q9H4G7; Q9NTU8; Q9NUM8; Q9UFB6,ENSG00000101191,,,0,0,56.78,96.99,38.44,71.51,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,Acetyl [N-Term],FALSE,91.79,91.67,116.38,127.14,101.39,other molecular function,0,
Master Protein,High,P06213,INSR,Insulin receptor OS=Homo sapiens OX=9606 GN=INSR PE=1 SV=4,4,5,1.969,0.306,2.026,0.337,0.98,-1.71,1.02,-1.57,4.21E-01,3.42E-01,5.79E-01,4.09E-01,4.05E+05,3.25E+04,2.34E+04,7.33E+05,3,2,3,4,,5.51E+04,,5.05E+05,4.05E+05,,2.37E+04,4.45E+04,,,,2.34E+04,,5.33E+04,1.40E+04,,4.30E+04,5.42E+06,1.29E+05,4.18E+06,,2.09E+02,,5.05E+05,2.09E+04,,4.21E+02,4.10E+02,,,,1.04E+03,,7.18E+03,3.47E+02,,1.21E+04,3.84E+04,3.01E+03,4.45E+04,0,FALSE,11.429,5,4,1382,156.2,6.2,4,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,"Pf00041, Pf00757, Pf01030, Pf07714, Pf17870",3643,hsa:3643; P06213; Q17RW0; Q59H98; Q9UCB7; Q9UCB8; Q9UCB9,ENSG00000171105,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Insulin receptor recycling; IRS activation; Signal attenuation",AMP-activated protein kinase signaling; Selenium micronutrient network; Vitamin B12 metabolism; Type II diabetes mellitus; Folate metabolism; Alzheimer's disease and miRNA effects; AGE/RAGE pathway; Nanoparticle triggered autophagic cell death; Transcription factor regulation in adipogenesis; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin-insulin signaling overlap; PI3K-Akt signaling pathway; Ras signaling; NRF2-ARE regulation; Nonalcoholic fatty liver disease; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Male infertility; Insulin signaling; 16p11.2 distal deletion syndrome; Neuroinflammation and glutamatergic signaling; Pleural mesothelioma; Alzheimer's disease; 6q16 copy number variation; DNA damage response (only ATM dependent),32,0,73.44,43.19,67.95,113.35,n/a,Peak Found,n/a,High,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,66.08,30.03,47.16,99.59,12.61,signal transduction activity or receptor binding;kinase activity;other molecular function,0,
Master Protein,Medium,Q9Y6I3,EPN1,Epsin-1 OS=Homo sapiens OX=9606 GN=EPN1 PE=1 SV=2,1,1,1.966,3.898,8.186,0.922,0.98,1.96,3.03,-0.12,5.01E-01,3.21E-02,6.72E-02,9.28E-01,8.90E+04,4.53E+04,3.47E+05,3.21E+05,3,2,5,4,,8.90E+04,,5.92E+05,1.92E+04,,2.35E+04,8.74E+04,,,3.47E+05,9.82E+04,2.83E+05,5.68E+05,4.62E+05,,4.35E+05,1.56E+05,1.25E+06,2.37E+05,,3.38E+02,,5.92E+05,9.90E+02,,4.17E+02,8.06E+02,,,2.08E+03,4.39E+03,2.30E+03,7.65E+04,1.15E+04,,1.22E+05,1.10E+03,2.91E+04,2.52E+03,0.026,FALSE,1.863,1,1,576,60.3,4.83,1,transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle,Pf01417,29924,hsa:29924; Q86ST3; Q9HA18; Q9Y6I3,ENSG00000063245,Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation,VEGFA-VEGFR2 signaling; EGF/EGFR signaling pathway,5,0,133.86,81.54,50.82,96.24,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,134.77,118.56,104.45,89.08,1.93,other molecular function,0,
Master Protein,High,Q01844,EWSR1,RNA-binding protein EWS OS=Homo sapiens OX=9606 GN=EWSR1 PE=1 SV=1,7,58,1.965,1.563,0.873,6.193,0.97,0.64,-0.2,2.63,4.87E-01,1.77E-01,7.35E-01,6.35E-02,8.22E+05,4.42E+05,2.04E+06,6.80E+05,4,5,5,5,5.94E+04,1.24E+05,,1.10E+07,5.44E+06,4.42E+05,1.37E+05,1.19E+06,8.21E+04,1.16E+06,2.15E+05,6.75E+06,2.04E+06,1.29E+07,1.66E+06,2.11E+06,2.28E+05,6.80E+05,3.62E+05,5.71E+06,2.36E+02,4.72E+02,,1.10E+07,2.81E+05,1.57E+03,2.44E+03,1.09E+04,2.31E+03,1.23E+04,1.29E+03,3.01E+05,1.66E+04,1.74E+06,4.13E+04,4.12E+03,6.39E+04,4.82E+03,8.47E+03,6.08E+04,0,FALSE,50.107,14,7,656,68.4,9.33,7,,plasma membrane;other membranes;nucleus;other cell component,"Pf00076, Pf00641",2130,B0QYK1; hsa:2130; Q01844; Q5THL0; Q92635; Q96FE8; Q96MN4; Q96MX4; Q9BWA2,ENSG00000182944,,VEGFA-VEGFR2 signaling,1,0,125.51,89.63,110.32,126.53,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,133.48,137.96,131.85,123.96,167.39,other molecular function,0,
Master Protein,High,P05114,HMGN1,Non-histone chromosomal protein HMG-14 OS=Homo sapiens OX=9606 GN=HMGN1 PE=1 SV=3,8,45,1.958,0.114,0.746,0.773,0.97,-3.13,-0.42,-0.37,4.72E-01,1.07E-02,7.54E-01,9.85E-01,1.33E+06,1.09E+06,3.85E+05,7.84E+05,5,4,4,4,1.49E+05,5.31E+06,2.35E+05,1.33E+06,1.11E+07,,5.88E+05,2.01E+06,2.83E+05,1.62E+07,,2.04E+05,3.59E+05,5.04E+05,4.14E+05,,1.56E+04,2.99E+06,2.06E+05,1.48E+07,5.91E+02,2.02E+04,2.30E+03,1.33E+06,5.71E+05,,1.05E+04,1.85E+04,7.99E+03,1.72E+05,,9.12E+03,2.92E+03,6.79E+04,1.03E+04,,4.38E+03,2.12E+04,4.82E+03,1.57E+05,0,FALSE,35.665,51,8,100,10.7,9.6,8,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf01101,3150,hsa:3150; P05114; Q3KQR8,ENSG00000205581,Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER,ATM signaling in development and disease ; p38 MAPK signaling pathway; Pleural mesothelioma; Nucleotide excision repair in xeroderma pigmentosum,8,0,128.97,160.47,33.97,155.35,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,High,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,High,Peak Found,High,1,,FALSE,144.87,104.07,146.06,138.96,108.83,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O76094,SRP72,Signal recognition particle subunit SRP72 OS=Homo sapiens OX=9606 GN=SRP72 PE=1 SV=3,3,3,1.951,0.408,0.01,100,0.96,-1.29,-6.64,6.64,4.12E-01,4.99E-01,1.00E-17,1.00E-17,3.46E+05,1.77E+05,1.74E+05,,3,1,4,,2.68E+06,3.46E+05,,3.01E+05,,,,1.77E+05,,,9.33E+05,1.65E+05,,1.84E+05,5.88E+04,,,,,,1.06E+04,1.31E+03,,3.01E+05,,,,1.63E+03,,,5.58E+03,7.38E+03,,2.48E+04,1.46E+03,,,,,,0,FALSE,9.741,10,3,671,74.6,9.26,3,other biological processes,cytosol;ER/Golgi;translational apparatus;other cell component,"Pf08492, Pf13181, Pf17004",6731,G5E9Z8; hsa:6731; O76094; Q7Z3C0,ENSG00000174780,SRP-dependent cotranslational protein targeting to membrane,,1,0,122.65,,119.98,,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,19.11,127.28,,,9.44,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H9B1,EHMT1,Histone-lysine N-methyltransferase EHMT1 OS=Homo sapiens OX=9606 GN=EHMT1 PE=1 SV=4,4,6,1.947,0.668,3.448,0.86,0.96,-0.58,1.79,-0.22,4.94E-01,9.63E-01,3.21E-01,9.55E-01,1.41E+05,3.75E+04,1.98E+05,1.20E+05,4,3,5,3,,2.20E+05,4.87E+04,4.72E+05,9.03E+04,1.87E+05,,3.75E+04,8.01E+03,,1.98E+05,1.62E+05,8.84E+04,3.37E+05,2.65E+05,,,1.20E+05,9.09E+04,3.81E+05,,8.37E+02,4.76E+02,4.72E+05,4.66E+03,6.64E+02,,3.46E+02,2.26E+02,,1.18E+03,7.22E+03,7.18E+02,4.55E+04,6.59E+03,,,8.53E+02,2.13E+03,4.06E+03,0,FALSE,12.479,6,4,1298,141.4,5.76,4,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00856, Pf05033, Pf12796, Pf21533",79813,B1AQ58; B1AQ59; hsa:79813; Q86X08; Q8TCN7; Q96F53; Q96JF1; Q96KH4; Q9H9B1,ENSG00000181090,Senescence-Associated Secretory Phenotype (SASP); Regulation of TP53 Activity through Methylation; Transcriptional Regulation by E2F6; Transcriptional Regulation by VENTX; PKMTs methylate histone lysines,Histone modifications; MTHFR deficiency; Kleefstra syndrome,8,0,91.73,123.74,45.48,80.87,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,58.39,79.47,108.85,106.25,16.28,other molecular function,0,
Master Protein,High,Q9ULX6,AKAP8L,A-kinase anchor protein 8-like OS=Homo sapiens OX=9606 GN=AKAP8L PE=1 SV=4,5,7,1.944,0.231,2.515,1.064,0.96,-2.11,1.33,0.09,4.31E-01,1.68E-01,4.24E-01,8.13E-01,5.90E+05,1.58E+05,7.77E+04,7.08E+05,3,4,4,4,5.90E+05,,,1.54E+06,2.47E+05,3.73E+05,2.75E+05,,9.09E+04,8.13E+04,,1.32E+05,4.57E+04,7.44E+05,4.57E+04,,5.95E+05,1.04E+06,4.29E+04,8.43E+05,2.34E+03,,,1.54E+06,1.28E+04,1.32E+03,4.90E+03,,2.56E+03,8.65E+02,,5.91E+03,3.71E+02,1.00E+05,1.13E+03,,1.67E+05,7.38E+03,1.00E+03,8.97E+03,0,FALSE,18.841,12,5,646,71.6,5.05,5,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf04988,26993,B4DJ74; B5BU90; hsa:26993; O94792; Q96J58; Q9NRQ0; Q9UGM0; Q9ULX6,ENSG00000011243,Formation of WDR5-containing histone-modifying complexes,,1,0,84.61,69.73,139.41,68.58,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,74.27,91.99,69.07,84.46,22.48,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8WXF1,PSPC1,Paraspeckle component 1 OS=Homo sapiens OX=9606 GN=PSPC1 PE=1 SV=1,6,16,1.943,1.854,1.098,5.553,0.96,0.89,0.13,2.47,4.66E-01,1.45E-01,9.32E-01,7.04E-02,2.47E+06,3.97E+05,2.90E+06,3.16E+05,5,5,5,4,3.33E+05,2.47E+06,9.36E+05,5.03E+06,8.41E+06,1.07E+06,1.39E+05,6.82E+05,3.97E+05,1.45E+05,6.23E+06,2.66E+06,2.90E+06,5.34E+06,1.15E+06,,5.34E+04,2.61E+05,2.20E+07,3.83E+05,1.32E+03,9.37E+03,9.15E+03,5.03E+06,4.34E+05,3.82E+03,2.47E+03,6.29E+03,1.12E+04,1.54E+03,3.73E+04,1.19E+05,2.35E+04,7.20E+05,2.86E+04,,1.50E+04,1.85E+03,5.14E+05,4.08E+03,0,FALSE,24.627,19,6,523,58.7,6.67,6,cell organization and biogenesis;stress response;other biological processes,nucleus;other cell component,"Pf00076, Pf08075",55269,hsa:55269; Q5JTQ3; Q8NCZ9; Q8WXE8; Q8WXF1; Q9NV36,ENSG00000121390,,,0,0,96.66,81.33,56.94,191.81,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,88.21,124.94,105.03,109.95,49,nucleic acid binding activity,0,
Master Protein,High,O94906,PRPF6,Pre-mRNA-processing factor 6 OS=Homo sapiens OX=9606 GN=PRPF6 PE=1 SV=1,15,25,1.936,0.282,1.764,0.834,0.95,-1.82,0.82,-0.26,4.75E-01,1.80E-01,6.33E-01,9.60E-01,2.26E+06,3.16E+05,1.58E+05,1.10E+06,5,5,5,5,3.31E+05,3.12E+06,3.49E+05,2.60E+06,2.26E+06,7.25E+05,2.97E+05,8.15E+05,1.11E+05,3.16E+05,4.71E+05,5.07E+04,1.58E+05,5.89E+05,3.61E+04,1.10E+06,3.02E+04,1.50E+06,1.53E+05,2.73E+06,1.31E+03,1.19E+04,3.41E+03,2.60E+06,1.17E+05,2.58E+03,5.29E+03,7.52E+03,3.14E+03,3.36E+03,2.81E+03,2.26E+03,1.28E+03,7.94E+04,8.96E+02,2.14E+03,8.49E+03,1.06E+04,3.58E+03,2.91E+04,0,FALSE,56.499,19,15,941,106.9,8.25,15,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf06424, Pf13181, Pf14559",24148,B2RAR5; B3KMC6; hsa:24148; O94906; O95109; Q5VXS5; Q9H3Z1; Q9H4T9; Q9H4U8; Q9NTE6,ENSG00000101161,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing,3,0,75.51,66.66,97.17,100.12,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,95.58,109.11,127.71,144.96,67.47,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P11766,ADH5,Alcohol dehydrogenase class-3 OS=Homo sapiens OX=9606 GN=ADH5 PE=1 SV=4,1,3,1.935,0.024,0.83,0.055,0.95,-5.4,-0.27,-4.18,4.76E-01,2.82E-04,7.99E-01,2.58E-02,1.91E+05,9.88E+04,4.53E+03,8.20E+04,1,1,1,1,,,,1.91E+05,,,,9.88E+04,,,,,,4.53E+03,,,8.20E+04,,,,,,,1.91E+05,,,,9.12E+02,,,,,,6.10E+02,,,2.30E+04,,,,0,FALSE,6.207,5,1,374,39.7,7.49,1,other metabolic processes;stress response;other biological processes,cytosol;mitochondrion,"Pf00107, Pf08240",128,hsa:128; P11766; Q6FHR2,ENSG00000197894,Ethanol oxidation,Folate-alcohol and cancer pathway hypotheses; Amino acid metabolism,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,0,0,0,0,10.99,other molecular function,0,
Master Protein,High,Q9HCK8,CHD8,Chromodomain-helicase-DNA-binding protein 8 OS=Homo sapiens OX=9606 GN=CHD8 PE=1 SV=5,4,6,1.934,0.225,0.574,0.449,0.95,-2.15,-0.8,-1.16,4.56E-01,1.75E-01,5.82E-01,6.46E-01,2.73E+05,7.28E+04,3.34E+04,4.10E+04,2,4,4,4,,,,3.48E+05,2.15E+05,8.36E+04,,6.34E+04,2.78E+04,1.97E+05,,2.45E+04,4.56E+04,2.07E+05,1.24E+04,1.11E+05,,4.52E+04,3.73E+04,2.84E+04,,,,3.48E+05,1.11E+04,2.97E+02,,5.85E+02,7.82E+02,2.10E+03,,1.10E+03,3.70E+02,2.79E+04,3.07E+02,2.16E+02,,3.20E+02,8.72E+02,3.03E+02,0,FALSE,16.286,3,4,2581,290.3,6.47,4,cell-cell signaling;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf00176, Pf00271, Pf00385, Pf07533",57680,hsa:57680; Q4G0D8; Q68DQ0; Q6DKH9; Q6P440; Q6ZNL7; Q8N3Z9; Q8NCY4; Q8TBR9; Q96F26; Q9HCK8,ENSG00000100888,Deactivation of the beta-catenin transactivating complex,lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Pleural mesothelioma,5,0,33.53,78.71,125.54,67.61,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,85.82,103.27,84.36,94.49,20.68,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UHN1,POLG2,"DNA polymerase subunit gamma-2, mitochondrial OS=Homo sapiens OX=9606 GN=POLG2 PE=1 SV=1",1,5,1.931,0.876,0.665,3.849,0.95,-0.19,-0.59,1.94,5.09E-01,8.10E-01,6.65E-01,1.78E-01,1.01E+05,5.24E+04,8.87E+04,3.48E+04,1,1,4,2,,,,1.01E+05,,,,,,5.24E+04,,6.56E+04,1.19E+05,2.74E+05,6.62E+04,,9.33E+04,,1.30E+04,,,,,1.01E+05,,,,,,5.57E+02,,2.93E+03,9.65E+02,3.69E+04,1.64E+03,,2.62E+04,,3.04E+02,,0.001,FALSE,4.106,4,1,485,54.9,8.35,1,cell organization and biogenesis;DNA metabolism;other metabolic processes;developmental processes;other biological processes,mitochondrion;other cell component,Pf03129,11232,hsa:11232; O00419; Q0IJ81; Q96GW2; Q9UHN1; Q9UK35; Q9UK94,ENSG00000256525,Transcriptional activation of mitochondrial biogenesis,,1,0,,,74.99,106.83,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,51.22,170.94,110.07,9.96,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P14866,HNRNPL,Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2,10,78,1.929,0.491,1.422,0.888,0.95,-1.03,0.51,-0.17,5.26E-01,6.12E-01,7.50E-01,9.77E-01,5.78E+06,3.84E+06,1.83E+06,9.31E+06,5,5,5,5,3.21E+05,5.78E+06,5.90E+05,2.12E+07,2.38E+07,5.00E+06,2.75E+06,3.84E+06,8.15E+05,1.46E+07,3.31E+05,1.83E+06,2.04E+06,1.21E+07,1.18E+06,9.31E+06,4.70E+05,1.31E+07,1.26E+06,2.78E+07,1.27E+03,2.19E+04,5.76E+03,2.12E+07,1.23E+06,1.78E+04,4.89E+04,3.55E+04,2.30E+04,1.55E+05,1.98E+03,8.16E+04,1.66E+04,1.63E+06,2.93E+04,1.82E+04,1.32E+05,9.31E+04,2.96E+04,2.96E+05,0,FALSE,76.874,31,1,589,64.1,8.22,10,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00076, Pf11835, Pf13893",3191,A6ND69; A6NIT8; hsa:3191; P14866; Q9H3P3,ENSG00000104824; ENSG00000282947,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,mRNA processing; Hippocampal synaptogenesis and neurogenesis,4,12,109.81,99.39,138.96,106.85,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,1,,FALSE,134.93,125.97,143.34,132.64,292.44,nucleic acid binding activity,0,
Master Protein,High,O75369,FLNB,Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2,11,89,1.924,1.262,3.042,1.032,0.94,0.34,1.61,0.05,4.75E-01,4.43E-01,3.84E-01,8.40E-01,2.51E+05,6.64E+04,4.98E+05,1.49E+05,3,4,5,4,,1.61E+05,,6.44E+05,2.51E+05,2.64E+06,8.37E+04,5.27E+04,2.75E+04,,4.91E+04,1.16E+06,1.03E+05,2.22E+06,4.98E+05,,1.71E+04,1.22E+05,2.65E+05,1.82E+05,,6.12E+02,,6.44E+05,1.30E+04,9.40E+03,1.49E+03,4.86E+02,7.74E+02,,2.93E+02,5.17E+04,8.40E+02,2.99E+05,1.24E+04,,4.80E+03,8.66E+02,6.21E+03,1.93E+03,0,FALSE,33.413,6,8,2602,278,5.73,11,cell organization and biogenesis;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00307, Pf00630",2317,B2ZZ83; B2ZZ84; B2ZZ85; C9JKE6; C9JMC4; hsa:2317; O75369; Q13706; Q59EC2; Q60FE7; Q6MZJ1; Q8WXS9; Q8WXT0; Q8WXT1; Q8WXT2; Q8WXT3; Q9NRB5; Q9NT26; Q9UEV9,ENSG00000136068,ISG15 antiviral mechanism,Focal adhesion; MAPK signaling pathway; VEGFA-VEGFR2 signaling; Ebola virus infection in host; NPHP1 deletion syndrome,6,0,72.9,184.47,112.43,71.23,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,51.5,111.9,47.71,81.3,182.39,cytoskeletal activity;other molecular function,0,
Master Protein,High,P04921,GYPC,Glycophorin-C OS=Homo sapiens OX=9606 GN=GYPC PE=1 SV=1,1,13,1.924,0.628,4.871,0.278,0.94,-0.67,2.28,-1.85,4.86E-01,9.71E-01,5.60E-02,2.89E-01,1.36E+06,7.05E+05,7.62E+05,3.43E+06,4,1,5,3,1.46E+06,1.27E+06,3.27E+06,2.81E+05,,,7.05E+05,,,,5.37E+05,7.62E+05,2.46E+06,6.76E+05,9.54E+05,,3.62E+06,,3.43E+06,8.82E+05,5.78E+03,4.81E+03,3.20E+04,2.81E+05,,,1.25E+04,,,,3.21E+03,3.40E+04,2.00E+04,9.12E+04,2.37E+04,,1.02E+06,,8.04E+04,9.39E+03,0,FALSE,11.226,20,1,128,13.8,4.84,1,,plasma membrane;other membranes;cytoskeleton,,2995,B2R522; P04921; Q53SV9; Q92642,ENSG00000136732,Cell surface interactions at the vascular wall,,1,0,79.55,,72.94,57.84,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,High,n/a,High,Peak Found,1,,FALSE,64.19,99.95,8.03,87.56,51.11,,0,
Master Protein,High,A0A7I2YQG7,NDUFS2,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS2 PE=1 SV=1",7,9,1.922,0.206,,0.966,0.94,-2.28,,-0.05,4.82E-01,6.33E-02,,8.71E-01,1.14E+06,4.54E+05,9.19E+05,4.87E+04,1,1,5,2,,,,1.14E+06,,,4.54E+05,,,,2.59E+06,1.96E+05,9.37E+05,4.70E+05,9.19E+05,,4.12E+04,,5.76E+04,,,,,1.14E+06,,,8.08E+03,,,,1.55E+04,8.77E+03,7.61E+03,6.33E+04,2.28E+04,,1.16E+04,,1.35E+03,,0,FALSE,32.217,30,7,484,54.7,7.77,7,transport,other membranes;mitochondrion,Pf00346,,A0A7I2YQG7,ENSG00000158864,,,0,0,,,90.93,23.46,n/a,n/a,High,High,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,71.17,,72.99,32.47,transporter activity;other molecular function,0,
Master Protein,High,A0A7P0T8N8,TCERG1,Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1 PE=1 SV=1,10,32,1.922,0.508,0.983,1.348,0.94,-0.98,-0.02,0.43,4.81E-01,6.58E-01,8.49E-01,6.55E-01,2.96E+06,1.73E+05,1.37E+06,8.18E+05,4,5,5,5,,1.31E+06,6.84E+05,6.80E+06,6.68E+06,5.43E+07,1.73E+05,8.26E+05,1.62E+04,1.16E+05,8.98E+04,2.73E+05,3.92E+06,3.77E+06,1.37E+06,1.06E+07,1.82E+05,7.99E+05,8.18E+05,7.22E+06,,4.99E+03,6.68E+03,6.80E+06,3.45E+05,1.93E+05,3.07E+03,7.62E+03,4.55E+02,1.23E+03,5.37E+02,1.22E+04,3.19E+04,5.08E+05,3.40E+04,2.08E+04,5.11E+04,5.66E+03,1.91E+04,7.69E+04,0,FALSE,45.773,11,10,1115,125.9,8.92,10,,nucleus,"Pf00397, Pf01846",,A0A7P0T8N8,ENSG00000113649,,,0,0,85.95,217.92,98.51,120.24,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,131.73,108.24,109.54,132.94,96.37,other molecular function,0,
Master Protein,High,O75909,CCNK,Cyclin-K OS=Homo sapiens OX=9606 GN=CCNK PE=1 SV=2,3,3,1.92,0.881,100,0.015,0.94,-0.18,6.64,-6.04,4.78E-01,7.77E-01,1.00E-17,2.76E-04,2.07E+05,9.83E+04,1.13E+05,5.67E+06,2,4,5,3,5.13E+04,,,8.38E+05,,1.54E+05,9.92E+04,9.73E+04,2.03E+04,,6.60E+04,5.39E+05,1.13E+05,5.47E+05,1.11E+05,5.67E+06,2.02E+05,,,4.75E+07,2.04E+02,,,8.38E+05,,5.49E+02,1.76E+03,8.98E+02,5.71E+02,,3.95E+02,2.41E+04,9.17E+02,7.38E+04,2.76E+03,1.11E+04,5.67E+04,,,5.06E+05,0,FALSE,11.039,12,3,580,64.2,8.41,3,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00134, Pf21797",8812,hsa:8812; O75909; Q59FT6; Q86U16; Q96B63; Q9NNY9,ENSG00000090061,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes,Male infertility,10,0,125.12,59.43,89.08,145.44,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,77.36,92.59,108.64,147.45,11.43,enzyme regulator activity;kinase activity;other molecular function,0,
Master Protein,High,Q12907,LMAN2,Vesicular integral-membrane protein VIP36 OS=Homo sapiens OX=9606 GN=LMAN2 PE=1 SV=1,11,59,1.911,0.457,1.265,1.156,0.93,-1.13,0.34,0.21,5.33E-01,5.42E-01,8.06E-01,8.25E-01,3.65E+06,1.24E+06,3.36E+06,1.30E+06,5,5,5,5,6.97E+06,9.79E+05,3.65E+06,5.21E+06,8.01E+05,3.28E+06,3.80E+05,1.24E+06,2.48E+04,2.22E+06,1.47E+07,6.02E+05,1.51E+06,6.25E+06,3.36E+06,1.63E+06,3.66E+06,1.10E+05,7.17E+04,1.30E+06,2.77E+04,3.72E+03,3.57E+04,5.21E+06,4.13E+04,1.17E+04,6.76E+03,1.15E+04,7.00E+02,2.37E+04,8.81E+04,2.69E+04,1.23E+04,8.43E+05,8.35E+04,3.17E+03,1.03E+06,7.79E+02,1.68E+03,1.39E+04,0,FALSE,90.356,50,11,356,40.2,6.95,11,transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component,Pf03388,10960,hsa:10960; Q12907; Q53HH1,ENSG00000169223,COPII-mediated vesicle transport; Cargo concentration in the ER,5q35 copy number variation,3,0,75.97,93.57,107.74,108.23,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,97.88,124.22,72.08,106.97,222.31,other molecular function,0,
Master Protein,High,P26641,EEF1G,Elongation factor 1-gamma OS=Homo sapiens OX=9606 GN=EEF1G PE=1 SV=3,12,85,1.902,0.553,1.603,0.184,0.93,-0.86,0.68,-2.44,5.37E-01,7.41E-01,6.38E-01,1.55E-01,6.05E+06,2.15E+06,4.66E+06,1.46E+07,5,5,5,5,6.05E+06,9.19E+06,2.40E+06,1.87E+06,1.67E+07,2.15E+06,4.09E+05,3.12E+06,5.27E+05,6.16E+06,7.09E+06,1.40E+06,4.66E+06,5.76E+06,2.94E+06,3.49E+06,4.01E+07,1.46E+07,1.90E+07,4.03E+06,2.40E+04,3.49E+04,2.34E+04,1.87E+06,8.62E+05,7.64E+03,7.28E+03,2.88E+04,1.49E+04,6.55E+04,4.24E+04,6.28E+04,3.79E+04,7.76E+05,7.31E+04,6.80E+03,1.13E+07,1.03E+05,4.46E+05,4.29E+04,0,FALSE,79.515,33,12,437,50.1,6.67,12,protein metabolism;other metabolic processes;other biological processes,cytosol;other cell component,"Pf00043, Pf00647, Pf02798",1937,B4DTG2; hsa:1937; P26641; Q6PJ62; Q6PK31; Q96CU2; Q9P196,ENSG00000254772,Signaling by ALK fusions and activated point mutants; Eukaryotic Translation Elongation,Translation factors,3,0,83.75,95.16,51.47,91.85,Peak Found,High,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,107.01,122.44,110.64,67.7,306.18,nucleic acid binding activity,0,
Master Protein,High,Q5T4S7,UBR4,E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens OX=9606 GN=UBR4 PE=1 SV=1,6,8,1.895,0.375,0.833,0.852,0.92,-1.42,-0.26,-0.23,5.09E-01,4.05E-01,7.02E-01,9.66E-01,8.24E+05,4.35E+05,3.09E+05,5.87E+05,2,2,2,1,1.73E+06,,3.91E+05,,,,4.67E+05,,4.05E+05,,5.30E+05,,,,1.80E+05,,5.87E+05,,,,6.89E+03,,3.83E+03,,,,8.30E+03,,1.14E+04,,3.17E+03,,,,4.46E+03,,1.65E+05,,,,0,FALSE,23.829,2,6,5183,573.5,6.04,6,protein metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus,"Pf02207, Pf13764, Pf19423",23352,A8MPT2; A8MQ33; A8MQB1; O60646; O75050; Q4QRK5; Q5T4S7; Q5T4S8; Q5T4S9; Q5TBN8; Q5TBP2; Q6DKH8; Q6P4A4; Q7L8P7; Q8IXJ4; Q8TDN5; Q8WV67; Q9HA46; Q9P2N9; Q9UG82,ENSG00000127481,Antigen processing: Ubiquitination & Proteasome degradation; Neutrophil degranulation,,2,0,89.31,10.01,69.82,,High,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,112.48,70.3,10.53,84.17,23.61,other molecular function,0,
Master Protein,High,P14868,DARS1,"Aspartate--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=DARS1 PE=1 SV=2",5,18,1.893,0.842,2.876,0.624,0.92,-0.25,1.52,-0.68,4.42E-01,8.27E-01,3.49E-01,8.45E-01,4.18E+05,7.29E+04,3.63E+05,8.01E+05,5,4,5,5,4.64E+05,4.18E+05,1.59E+05,3.07E+05,1.74E+06,8.01E+04,,5.91E+04,6.64E+04,2.15E+05,3.63E+05,2.66E+05,5.88E+05,6.29E+05,3.46E+05,8.82E+05,5.73E+05,2.27E+06,3.19E+05,8.01E+05,1.84E+03,1.59E+03,1.55E+03,3.07E+05,8.99E+04,2.85E+02,,5.45E+02,1.87E+03,2.28E+03,2.17E+03,1.19E+04,4.78E+03,8.48E+04,8.61E+03,1.72E+03,1.61E+05,1.61E+04,7.47E+03,8.53E+03,0,FALSE,20.238,14,5,501,57.1,6.55,5,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;other cell component,"Pf00152, Pf01336",1615,A8K3J2; D3DP77; hsa:1615; P14868; Q2TNI3; Q32Q69; Q53HV4; Q53YC5; Q68CR9; Q9BW52,ENSG00000115866,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,Alanine and aspartate metabolism,3,0,103.43,70.07,36.58,78.33,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,90.54,111.95,35.24,99.36,49.06,other molecular function,0,
Master Protein,High,P84103,SRSF3,Serine/arginine-rich splicing factor 3 OS=Homo sapiens OX=9606 GN=SRSF3 PE=1 SV=1,5,13,1.893,0.298,3.214,1.366,0.92,-1.75,1.68,0.45,4.94E-01,2.15E-01,2.26E-01,6.35E-01,1.76E+06,5.90E+05,1.80E+06,1.09E+06,5,5,5,4,1.69E+05,1.76E+06,4.43E+05,2.63E+07,3.28E+06,8.82E+04,4.11E+05,6.78E+05,7.48E+05,5.90E+05,1.71E+06,6.52E+06,1.80E+06,7.37E+06,1.38E+06,1.19E+06,,1.00E+06,3.71E+05,2.72E+06,6.71E+02,6.68E+03,4.33E+03,2.63E+07,1.69E+05,3.14E+02,7.31E+03,6.25E+03,2.11E+04,6.28E+03,1.02E+04,2.91E+05,1.46E+04,9.93E+05,3.43E+04,2.31E+03,,7.11E+03,8.67E+03,2.90E+04,0,FALSE,15.292,34,4,164,19.3,11.65,5,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,nucleus;other cell component,Pf00076,6428,B4E241; hsa:6428; O08831; P23152; P84103; Q5R3K0,ENSG00000112081,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,mRNA processing,6,0,175.19,52.46,78.07,75.57,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,117.86,123.3,97.78,130.11,30.06,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q9BUP3,HTATIP2,Oxidoreductase HTATIP2 OS=Homo sapiens OX=9606 GN=HTATIP2 PE=1 SV=2,1,1,1.885,0.683,0.01,100,0.91,-0.55,-6.64,6.64,5.16E-01,9.32E-01,1.00E-17,1.00E-17,8.06E+05,4.28E+05,5.51E+05,,2,1,4,,8.74E+05,,,7.44E+05,,,,,,4.28E+05,,2.78E+05,4.96E+05,7.11E+05,6.12E+05,,,,,,3.47E+03,,,7.44E+05,,,,,,4.55E+03,,1.24E+04,4.03E+03,9.57E+04,1.52E+04,,,,,,0.016,FALSE,2.072,5,1,242,27,8.38,1,protein metabolism;other metabolic processes;transport;developmental processes;other biological processes,cytosol;nucleus;other cell component,Pf13460,10553,A8K7S7; D3DQY8; hsa:10553; O15383; O60520; O95345; Q53GC1; Q53GG2; Q6IBI3; Q9BUP3,ENSG00000109854,,,0,0,11.4,,35.49,,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,11.99,27.72,,,2.59,kinase activity;other molecular function,0,
Master Protein,High,B4DUQ1,HNRNPK,Heterogeneous nuclear ribonucleoprotein K OS=Homo sapiens OX=9606 GN=HNRNPK PE=2 SV=1,18,233,1.882,0.387,2.416,0.841,0.91,-1.37,1.27,-0.25,5.44E-01,3.91E-01,3.20E-01,9.38E-01,6.69E+07,1.30E+07,1.59E+07,1.41E+07,5,5,5,5,9.37E+07,1.84E+07,6.15E+07,6.69E+07,8.93E+07,2.24E+07,7.87E+06,1.30E+07,1.36E+07,1.01E+07,3.64E+07,1.59E+07,7.05E+06,5.70E+07,1.37E+07,1.41E+07,9.86E+06,1.13E+08,1.10E+07,9.33E+07,3.72E+05,6.97E+04,6.01E+05,6.69E+07,4.61E+06,7.96E+04,1.40E+05,1.20E+05,3.82E+05,1.07E+05,2.18E+05,7.09E+05,5.73E+04,7.68E+06,3.41E+05,2.76E+04,2.77E+06,8.02E+05,2.57E+05,9.94E+05,0,FALSE,115.104,41,18,439,48.5,5.92,18,,cytoskeleton;nucleus;other cell component,"Pf00013, Pf08067",3190,B4DUQ1,ENSG00000165119,,mRNA processing; lncRNA in canonical Wnt signaling and colorectal cancer,2,0,45.49,41.34,78.82,104.92,High,High,High,High,High,High,High,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,1,Acetyl [N-Term],FALSE,128.75,118.47,137.86,136.01,654.92,nucleic acid binding activity,0,
Master Protein,High,Q14739,LBR,Delta(14)-sterol reductase LBR OS=Homo sapiens OX=9606 GN=LBR PE=1 SV=2,8,38,1.882,0.79,,2.18,0.91,-0.34,,1.12,5.11E-01,8.45E-01,,4.16E-01,1.01E+06,7.33E+04,3.85E+06,5.40E+05,5,3,5,5,1.41E+05,2.92E+05,1.30E+06,1.36E+07,1.01E+06,,,7.33E+04,4.35E+04,2.93E+05,3.85E+06,5.54E+06,5.17E+05,9.99E+05,4.26E+06,7.07E+05,1.36E+06,2.71E+05,5.40E+05,8.97E+04,5.59E+02,1.11E+03,1.27E+04,1.36E+07,5.23E+04,,,6.76E+02,1.23E+03,3.12E+03,2.30E+04,2.47E+05,4.20E+03,1.35E+05,1.06E+05,1.38E+03,3.82E+05,1.92E+03,1.26E+04,9.55E+02,0,FALSE,45.843,14,8,615,70.7,9.36,8,other metabolic processes;other biological processes,other membranes;ER/Golgi;nucleus;other cell component,"Pf01222, Pf09465",3930,B2R5P3; hsa:3930; Q14739; Q14740; Q53GU7; Q59FE6,ENSG00000143815,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Regulation of MECP2 expression and activity; Initiation of Nuclear Envelope (NE) Reformation; Cholesterol biosynthesis,Gastric cancer network 2; Envelope proteins and their potential roles in EDMD physiopathology; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders; Cholesterol metabolism; Enterocyte cholesterol metabolism,18,0,177.31,99.82,71.71,82.59,Peak Found,Peak Found,High,High,High,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,117.88,131.66,,92.91,92.04,nucleic acid binding activity;other molecular function,0,
Master Protein,High,K7EM85,ARHGAP45,Rho GTPase activating protein 45 OS=Homo sapiens OX=9606 GN=ARHGAP45 PE=1 SV=1,2,3,1.88,0.384,0.01,100,0.91,-1.38,-6.64,6.64,5.28E-01,5.26E-01,1.00E-17,1.00E-17,9.40E+04,5.00E+04,3.61E+04,,1,1,3,,,,,9.40E+04,,,,,5.00E+04,,,2.40E+04,,7.64E+04,3.61E+04,,,,,,,,,9.40E+04,,,,,1.41E+03,,,1.07E+03,,1.03E+04,8.97E+02,,,,,,0,FALSE,8.13,3,2,1163,127.5,6,2,signal transduction;other biological processes,plasma membrane;other membranes;cytosol,Pf00620,,K7EM85,ENSG00000180448,,,0,0,,,60.36,,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,74.91,,,8.99,other molecular function,0,
Master Protein,High,Q9Y6K1,DNMT3A,DNA (cytosine-5)-methyltransferase 3A OS=Homo sapiens OX=9606 GN=DNMT3A PE=1 SV=4,3,4,1.879,0.633,1.565,1.02,0.91,-0.66,0.65,0.03,5.06E-01,8.99E-01,7.88E-01,8.58E-01,1.43E+05,7.63E+04,9.07E+04,1.19E+05,1,2,4,4,,,,1.43E+05,,,,6.42E+04,9.05E+04,,,2.68E+04,2.35E+05,2.03E+05,4.05E+04,1.26E+05,,1.13E+05,1.60E+05,4.95E+04,,,,1.43E+05,,,,5.93E+02,2.55E+03,,,1.20E+03,1.91E+03,2.74E+04,1.01E+03,2.45E+02,,8.04E+02,3.74E+03,5.27E+02,0,FALSE,11.704,6,3,912,101.8,6.57,3,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf00145, Pf00855, Pf17980, Pf21255",1788,E9PEB8; hsa:1788; Q86TE8; Q86XF5; Q8IZV0; Q8WXU9; Q9Y6K1,ENSG00000119772,RMTs methylate histone arginines; PRC2 methylates histones and DNA; Defective pyroptosis; DNA methylation; SUMOylation of DNA methylation proteins,"One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; One-carbon metabolism and related pathways; MTHFR deficiency; Opioid receptor pathways; Spina bifida",12,0,,24.01,85.41,41.1,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,25.54,137.32,33.4,111.69,14.32,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y2B0,CNPY2,Protein canopy homolog 2 OS=Homo sapiens OX=9606 GN=CNPY2 PE=1 SV=1,4,24,1.878,0.369,0.596,1.152,0.91,-1.44,-0.75,0.2,5.46E-01,3.54E-01,4.27E-01,8.40E-01,6.23E+06,1.29E+06,2.87E+06,2.19E+06,5,2,5,5,6.23E+06,6.48E+06,3.24E+05,1.95E+06,9.20E+06,,,,4.91E+05,3.36E+06,5.58E+05,8.51E+05,3.36E+06,3.26E+06,2.87E+06,2.30E+06,2.19E+06,1.38E+06,2.58E+06,2.55E+05,2.47E+04,2.46E+04,3.17E+03,1.95E+06,4.75E+05,,,,1.38E+04,3.58E+04,3.34E+03,3.80E+04,2.73E+04,4.39E+05,7.14E+04,4.48E+03,6.15E+05,9.77E+03,6.03E+04,2.72E+03,0,FALSE,13.809,31,4,182,20.6,4.92,4,other biological processes,ER/Golgi,Pf11938,10330,B2R7B9; Q9UHE9; Q9Y2B0,ENSG00000257727,,,0,0,74.84,105.38,62.52,54.13,Peak Found,High,Peak Found,High,High,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,111.23,117.4,92.07,61.73,75.23,,0,
Master Protein,Medium,A0A804HIC2,TAF1,Transcription initiation factor TFIID subunit OS=Homo sapiens OX=9606 GN=TAF1 PE=1 SV=1,1,1,1.876,0.01,3.285,0.01,0.91,-6.64,1.72,-6.64,5.04E-01,1.00E-17,2.97E-01,1.00E-17,2.71E+04,1.24E+04,,4.08E+04,2,3,,1,,,,4.38E+04,1.68E+04,,1.24E+04,2.68E+04,7.80E+03,,,,,,,,,,,4.08E+04,,,,4.38E+04,8.68E+02,,2.21E+02,2.47E+02,2.20E+02,,,,,,,,,,,4.34E+02,0.017,FALSE,2.033,0,1,1907,216.4,5.02,1,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00439, Pf09247, Pf12157, Pf15288",,A0A804HIC2,ENSG00000147133,,MECP2 and associated Rett syndrome,1,0,62.88,63.25,,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,69.89,,79.62,,0,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,Q8WUD1,RAB2B,Ras-related protein Rab-2B OS=Homo sapiens OX=9606 GN=RAB2B PE=1 SV=1,2,4,1.872,1.36,2.482,1.022,0.9,0.44,1.31,0.03,5.30E-01,4.40E-01,4.69E-01,8.55E-01,8.14E+04,3.76E+04,1.79E+05,9.33E+04,4,1,4,3,1.10E+05,6.05E+04,,1.19E+05,9.34E+03,,3.76E+04,,,,,4.05E+04,1.00E+05,3.20E+05,3.25E+05,,9.33E+04,1.67E+06,3.59E+04,,4.35E+02,2.30E+02,,1.19E+05,4.82E+02,,6.69E+02,,,,,1.81E+03,8.12E+02,4.32E+04,8.07E+03,,2.62E+04,1.18E+04,8.40E+02,,0,FALSE,6.585,13,1,216,24.2,7.83,2,cell organization and biogenesis;stress response;transport;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,Pf00071,84932,B2RD03; D3DS24; hsa:84932; Q6NZ33; Q8WUD1,ENSG00000129472,RAB geranylgeranylation,,1,1,67.7,,75.21,154.57,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,53.43,66.18,91.26,139.58,10.1,other molecular function,0,
Master Protein,High,M0R0R2,RPS5,Ribosomal protein S5 OS=Homo sapiens OX=9606 GN=RPS5 PE=1 SV=1,5,30,1.871,0.973,2.6,0.909,0.9,-0.04,1.38,-0.14,4.98E-01,6.14E-01,3.32E-01,9.93E-01,2.01E+06,4.31E+05,4.10E+06,1.22E+06,5,3,5,5,2.87E+06,1.72E+06,2.01E+06,3.10E+06,4.50E+05,,2.90E+05,,4.31E+05,1.38E+06,1.26E+06,4.15E+06,4.10E+06,4.30E+06,3.54E+06,6.36E+05,2.92E+06,1.51E+06,1.22E+06,3.90E+05,1.14E+04,6.55E+03,1.96E+04,3.10E+06,2.32E+04,,5.16E+03,,1.21E+04,1.47E+04,7.51E+03,1.85E+05,3.33E+04,5.79E+05,8.81E+04,1.24E+03,8.19E+05,1.07E+04,2.86E+04,4.15E+03,0,FALSE,26.924,21,5,225,25.3,9.76,5,protein metabolism;other metabolic processes,translational apparatus,Pf00177,,M0R0R2,ENSG00000083845,,,0,0,51.9,84.74,36.6,74.17,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,110.25,105.95,88.45,106.53,91.68,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P35232,PHB1,Prohibitin 1 OS=Homo sapiens OX=9606 GN=PHB1 PE=1 SV=1,14,159,1.864,1.15,1.584,2.575,0.9,0.2,0.66,1.36,5.52E-01,4.53E-01,6.49E-01,3.60E-01,3.27E+07,1.05E+07,4.08E+07,7.67E+06,5,5,5,5,3.47E+07,2.18E+07,2.77E+07,3.79E+07,3.27E+07,3.50E+07,1.05E+07,1.16E+07,5.02E+06,9.05E+06,7.81E+07,5.10E+07,2.77E+07,2.77E+07,4.08E+07,8.32E+06,1.01E+07,7.67E+06,5.19E+06,6.03E+06,1.38E+05,8.30E+04,2.70E+05,3.79E+07,1.69E+06,1.25E+05,1.86E+05,1.07E+05,1.41E+05,9.62E+04,4.67E+05,2.28E+06,2.25E+05,3.73E+06,1.01E+06,1.62E+04,2.84E+06,5.43E+04,1.21E+05,6.42E+04,0,FALSE,76.981,68,14,272,29.8,5.76,14,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,Pf01145,5245,B4DY47; hsa:5245; P35232; Q4VBQ0,ENSG00000167085,RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Processing of SMDT1,,5,0,20.35,83.46,46.46,25.99,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,109.74,128.07,116.72,126.35,416.33,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9UJS0,SLC25A13,"Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A13 PE=1 SV=2",2,3,1.86,0.384,1.927,0.764,0.9,-1.38,0.95,-0.39,4.48E-01,4.51E-01,6.32E-01,9.65E-01,3.84E+05,7.86E+04,1.07E+05,8.95E+04,1,3,5,4,,,,3.84E+05,,5.90E+05,,,1.42E+04,7.86E+04,1.07E+05,2.33E+05,4.79E+04,1.23E+05,1.07E+05,,2.77E+04,1.49E+05,5.36E+04,1.26E+06,,,,3.84E+05,,2.10E+03,,,4.00E+02,8.35E+02,6.38E+02,1.04E+04,3.89E+02,1.65E+04,2.66E+03,,7.79E+03,1.06E+03,1.25E+03,1.34E+04,0,FALSE,8.499,5,2,675,74.1,8.62,2,other metabolic processes;transport;other biological processes,plasma membrane;other membranes;mitochondrion,Pf00153,10165,hsa:10165; O14566; O14575; Q546F9; Q9NZW1; Q9UJS0; Q9UNI7,ENSG00000004864,Gluconeogenesis; Mitochondrial protein import; Aspartate and asparagine metabolism,,3,0,,138.63,54.64,159.33,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,128.52,52.67,135.03,104.84,9.67,transporter activity;other molecular function,0,
Master Protein,High,Q01105,SET,Protein SET OS=Homo sapiens OX=9606 GN=SET PE=1 SV=3,5,41,1.858,0.329,2.224,0.176,0.89,-1.6,1.15,-2.51,5.54E-01,2.72E-01,3.74E-01,1.42E-01,6.56E+06,3.69E+06,1.17E+06,7.26E+06,5,5,5,5,1.05E+06,6.86E+06,7.04E+05,6.56E+06,1.33E+07,4.03E+06,3.69E+06,3.76E+06,1.25E+05,2.30E+06,1.44E+06,5.21E+05,1.17E+06,2.26E+06,6.84E+05,8.95E+06,1.61E+05,2.10E+07,1.68E+06,7.26E+06,4.17E+03,2.61E+04,6.88E+03,6.56E+06,6.86E+05,1.43E+04,6.57E+04,3.47E+04,3.53E+03,2.44E+04,8.64E+03,2.32E+04,9.48E+03,3.04E+05,1.70E+04,1.75E+04,4.53E+04,1.48E+05,3.94E+04,7.73E+04,0,FALSE,30.117,19,2,290,33.5,4.32,5,cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,Pf00956,6418,A5A5H4; A6NGV1; B4DUE2; hsa:6418; Q01105; Q15541; Q5VXV1; Q5VXV2; Q6FHZ5,ENSG00000119335,HuR (ELAVL1) binds and stabilizes mRNA; Condensation of Prophase Chromosomes,Histone modifications; VEGFA-VEGFR2 signaling,4,3,90.56,58.64,56.79,105.37,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,124.33,123.49,126.46,131.53,115.9,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15545,TAF7,Transcription initiation factor TFIID subunit 7 OS=Homo sapiens OX=9606 GN=TAF7 PE=1 SV=1,5,6,1.857,2.563,,1.297,0.89,1.36,,0.38,5.23E-01,6.48E-02,,6.76E-01,7.47E+05,2.93E+05,3.15E+05,3.45E+05,3,1,4,4,8.32E+04,1.43E+06,,7.47E+05,,,,,2.93E+05,,3.66E+05,,2.72E+05,3.56E+05,2.79E+05,1.17E+06,1.19E+05,7.07E+05,1.69E+05,,3.30E+02,5.45E+03,,7.47E+05,,,,,8.26E+03,,2.19E+03,,2.21E+03,4.80E+04,6.92E+03,2.27E+03,3.33E+04,5.01E+03,3.95E+03,,0,FALSE,18.652,19,5,349,40.2,5.2,5,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;signal transduction;other biological processes,nucleus;other cell component,Pf04658,6879,B2RBV9; hsa:6879; Q13036; Q15545,ENSG00000178913,RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,Eukaryotic transcription initiation,10,0,89.47,,15.66,91.7,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,129.39,51.01,,26.72,21.3,nucleic acid binding activity;other molecular function,0,
Master Protein,High,K7EQD6,NSF,Vesicle-fusing ATPase OS=Homo sapiens OX=9606 GN=NSF PE=1 SV=2,4,18,1.851,0.997,3.078,2.154,0.89,0,1.62,1.11,4.61E-01,5.11E-01,3.11E-01,3.75E-01,6.61E+05,7.67E+04,1.12E+06,8.18E+05,5,4,5,3,5.33E+06,9.11E+04,2.23E+06,6.61E+05,2.00E+05,,9.45E+04,4.98E+04,6.23E+04,4.80E+05,1.15E+06,6.91E+04,4.31E+05,3.87E+06,1.12E+06,8.18E+05,2.01E+06,,2.94E+05,,2.12E+04,3.46E+02,2.18E+04,6.61E+05,1.03E+04,,1.68E+03,4.59E+02,1.76E+03,5.11E+03,6.90E+03,3.09E+03,3.50E+03,5.21E+05,2.79E+04,1.60E+03,5.64E+05,,6.88E+03,,0,FALSE,18.253,8,4,769,85.1,7.62,4,cell organization and biogenesis;transport,cytosol;ER/Golgi,,,K7EQD6,ENSG00000073969,,Synaptic vesicle pathway; Vasopressin-regulated water reabsorption,2,0,129.25,120.31,112.26,84.43,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,128.75,125.9,98.89,115.93,29.6,other molecular function,0,
Master Protein,High,A0A8V8TM04,FLI1,"Fli-1 proto-oncogene, ETS transcription factor OS=Homo sapiens OX=9606 GN=FLI1 PE=1 SV=1",3,4,1.849,0.916,2.332,0.726,0.89,-0.13,1.22,-0.46,5.11E-01,7.64E-01,5.01E-01,9.67E-01,4.47E+04,2.42E+04,4.10E+04,5.64E+04,1,1,3,1,,,,4.47E+04,,,2.42E+04,,,,6.44E+04,4.10E+04,,,2.55E+04,,,,,5.64E+04,,,,4.47E+04,,,4.30E+02,,,,3.85E+02,1.83E+03,,,6.34E+02,,,,,6.01E+02,0,FALSE,15.948,10,2,459,51.8,7.06,3,other biological processes,nucleus,"Pf00178, Pf02198",,A0A8V8TM04,ENSG00000151702,,Hematopoietic stem cell differentiation,1,0,,,44.86,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,0,53.95,0,53.95,9.98,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8TCJ2,STT3B,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B OS=Homo sapiens OX=9606 GN=STT3B PE=1 SV=1,7,23,1.848,0.247,1.421,0.294,0.89,-2.02,0.51,-1.76,5.58E-01,1.28E-01,7.51E-01,3.13E-01,3.62E+06,3.08E+06,1.87E+06,3.50E+06,4,5,5,5,3.26E+05,2.10E+07,,2.57E+06,5.11E+06,5.52E+06,3.08E+06,7.34E+06,1.13E+06,5.28E+05,1.87E+06,8.10E+05,1.20E+06,2.15E+06,1.96E+06,9.58E+06,8.41E+05,3.50E+06,8.03E+05,2.82E+07,1.29E+03,7.97E+04,,2.57E+06,2.64E+05,1.96E+04,5.47E+04,6.77E+04,3.17E+04,5.61E+03,1.12E+04,3.62E+04,9.73E+03,2.90E+05,4.86E+04,1.87E+04,2.36E+05,2.48E+04,1.88E+04,3.00E+05,0,FALSE,18.488,10,7,826,93.6,8.91,7,protein metabolism;other metabolic processes;stress response,other membranes;ER/Golgi;other cell component,"Pf02516, Pf21436",201595,hsa:201595; Q8TCJ2; Q96JZ4; Q96KY7,ENSG00000163527,,N-glycan biosynthesis,1,0,129.17,82.2,35.58,134.39,Peak Found,High,n/a,High,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,Peak Found,1,,FALSE,109.51,115.11,128.27,138.27,54.61,other molecular function,0,
Master Protein,High,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 OS=Homo sapiens OX=9606 GN=RBBP6 PE=1 SV=1,4,4,1.846,0.01,0.01,,0.88,-6.64,-6.64,,5.36E-01,1.00E-17,1.00E-17,,1.15E+05,4.69E+04,,,1,2,,,,,,1.15E+05,,,4.48E+04,,4.92E+04,,,,,,,,,,,,,,,1.15E+05,,,7.96E+02,,1.39E+03,,,,,,,,,,,,0,FALSE,10.927,3,4,1792,201.4,9.64,4,protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf04564, Pf08783, Pf13696",5930,Q147T5; Q15290; Q6DKH4; Q6P4C2; Q6YNC9; Q7Z6E8; Q7Z6E9; Q8N0V2; Q96PH3; Q9H3I8; Q9H5M5; Q9NPX4,ENSG00000122257,Antigen processing: Ubiquitination & Proteasome degradation; RHOBTB1 GTPase cycle,,2,0,,6.71,,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,7.04,,,,9.95,other molecular function,0,
Master Protein,High,P57772,EEFSEC,Selenocysteine-specific elongation factor OS=Homo sapiens OX=9606 GN=EEFSEC PE=1 SV=4,1,3,1.846,0.585,1.645,0.968,0.88,-0.77,0.72,-0.05,5.30E-01,8.65E-01,7.22E-01,8.64E-01,6.10E+04,3.31E+04,3.57E+04,5.44E+04,3,1,3,2,,2.61E+05,3.35E+04,6.10E+04,,,,,,3.31E+04,,3.57E+04,,9.36E+04,2.96E+04,,1.36E+05,,,2.17E+04,,9.93E+02,3.27E+02,6.10E+04,,,,,,3.52E+02,,1.59E+03,,1.26E+04,7.36E+02,,3.83E+04,,,2.31E+02,0,FALSE,4.812,2,1,596,65.3,8.35,1,protein metabolism;other metabolic processes,nucleus;other cell component,"Pf00009, Pf03144, Pf21131, Pf21208",60678,hsa:60678; P57772; Q96HZ6,ENSG00000132394; ENSG00000284869,Selenocysteine synthesis,Selenium metabolism and selenoproteins,2,0,104.85,,66.7,102.65,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,High,n/a,n/a,Peak Found,1,,FALSE,66.96,91.77,156.44,88.01,8.83,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q6NUK1,SLC25A24,Mitochondrial adenyl nucleotide antiporter SLC25A24 OS=Homo sapiens OX=9606 GN=SLC25A24 PE=1 SV=2,8,16,1.845,0.374,2.136,0.268,0.88,-1.42,1.1,-1.9,5.16E-01,3.77E-01,5.40E-01,3.46E-01,8.23E+05,1.80E+05,1.51E+06,3.00E+05,5,3,5,4,8.23E+05,4.34E+06,4.13E+05,2.81E+06,5.14E+05,,1.80E+05,,1.81E+05,3.77E+04,1.93E+06,4.44E+05,1.51E+06,2.29E+06,1.22E+05,6.93E+05,1.76E+05,5.13E+05,1.33E+05,,3.27E+03,1.65E+04,4.04E+03,2.81E+06,2.65E+04,,3.20E+03,,5.10E+03,4.00E+02,1.16E+04,1.98E+04,1.23E+04,3.09E+05,3.04E+03,1.35E+03,4.95E+04,3.63E+03,3.12E+03,,0,FALSE,30.379,28,8,477,53.3,6.33,8,stress response;transport;other biological processes,other membranes;mitochondrion,"Pf00153, Pf13499",29957,B7ZAI9; hsa:29957; Q5T331; Q5T485; Q6NUK1; Q6PJJ9; Q705K4; Q9P129,ENSG00000085491; ENSG00000284468,,,0,0,97.26,62.06,74.66,71.15,Peak Found,High,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,135.56,116.71,74.45,89.28,50.74,transporter activity;other molecular function,0,
Master Protein,High,Q9UQR1,ZNF148,Zinc finger protein 148 OS=Homo sapiens OX=9606 GN=ZNF148 PE=1 SV=2,3,3,1.841,0.319,0.01,100,0.88,-1.65,-6.64,6.64,5.31E-01,4.40E-01,1.00E-17,1.00E-17,6.23E+04,3.39E+04,1.99E+04,,1,1,3,,,,,6.23E+04,,,,,,3.39E+04,,1.25E+04,,6.47E+04,1.99E+04,,,,,,,,,6.23E+04,,,,,,3.60E+02,,5.58E+02,,8.72E+03,4.94E+02,,,,,,0,FALSE,8.517,7,3,794,88.9,6.48,3,stress response;other biological processes,ER/Golgi;nucleus,Pf00096,7707,D3DN27; O00389; O43591; Q58EY5; Q6PJ98; Q9UQR1,ENSG00000163848,,,0,0,,,87.3,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,87.54,,,10.75,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A494C0X0,TBCB,Tubulin folding cofactor B OS=Homo sapiens OX=9606 GN=TBCB PE=1 SV=1,1,1,1.841,0.472,4.641,0.187,0.88,-1.08,2.21,-2.42,4.58E-01,6.70E-01,1.54E-01,1.79E-01,2.55E+05,1.38E+05,1.20E+05,6.42E+05,5,1,1,4,8.54E+04,2.21E+06,4.94E+04,2.55E+05,1.86E+06,1.38E+05,,,,,,1.20E+05,,,,3.25E+05,,1.27E+06,1.41E+05,3.01E+06,3.39E+02,8.40E+03,4.83E+02,2.55E+05,9.62E+04,4.92E+02,,,,,,5.37E+03,,,,6.34E+02,,8.99E+03,3.31E+03,3.20E+04,0.007,FALSE,2.388,3,1,282,31.1,5.74,1,cell organization and biogenesis;protein metabolism;other metabolic processes,cytosol,"Pf01302, Pf14560",,A0A494C0X0,ENSG00000105254,,,0,0,118.14,,,110.64,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,119.49,119.49,130.12,130.12,1.7,cytoskeletal activity,0,
Master Protein,High,Q8N335,GPD1L,Glycerol-3-phosphate dehydrogenase 1-like protein OS=Homo sapiens OX=9606 GN=GPD1L PE=1 SV=1,1,1,1.84,0.325,0.01,100,0.88,-1.62,-6.64,6.64,5.44E-01,4.36E-01,1.00E-17,1.00E-17,7.76E+04,3.87E+04,2.37E+04,,4,4,2,,9.14E+04,,2.68E+04,6.60E+04,1.16E+05,9.47E+04,2.68E+04,,9.75E+03,5.60E+04,3.35E+04,1.68E+04,,,,,,,,,3.63E+02,,2.62E+02,6.60E+04,5.98E+03,3.37E+02,4.76E+02,,2.75E+02,5.95E+02,2.00E+02,7.48E+02,,,,,,,,,0.005,FALSE,2.536,2,1,351,38.4,7.02,1,other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf01210, Pf07479",23171,A8K9U3; hsa:23171; Q14702; Q8N335; Q9BRM5,ENSG00000152642,Synthesis of PA,Sudden infant death syndrome (SIDS) susceptibility pathways,2,0,50.77,79.5,47.09,,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,82.59,62.22,,,2.14,other molecular function,0,
Master Protein,High,O43396,TXNL1,Thioredoxin-like protein 1 OS=Homo sapiens OX=9606 GN=TXNL1 PE=1 SV=3,2,3,1.834,0.01,0.35,0.01,0.88,-6.64,-1.52,-6.64,4.54E-01,1.00E-17,3.04E-01,1.00E-17,2.84E+05,1.55E+05,,1.03E+05,1,1,,2,,,,,2.84E+05,,,,,1.55E+05,,,,,,,1.89E+05,,5.59E+04,,,,,,1.47E+04,,,,,1.65E+03,,,,,,,5.32E+04,,1.31E+03,,0,FALSE,13.679,13,2,289,32.2,4.96,2,,cytosol;nucleus;other cell component,"Pf00085, Pf06201",9352,hsa:9352; O43396,ENSG00000091164,RND2 GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,,7,0,,,,76.97,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,,4.57,,10.6,other molecular function,0,
Master Protein,High,P12270,TPR,Nucleoprotein TPR OS=Homo sapiens OX=9606 GN=TPR PE=1 SV=3,48,110,1.833,0.279,2.427,1.175,0.87,-1.84,1.28,0.23,5.65E-01,1.81E-01,3.17E-01,8.26E-01,7.77E+06,9.82E+05,3.54E+06,3.80E+06,5,5,5,5,1.50E+06,7.77E+06,5.88E+05,2.37E+07,2.00E+07,3.12E+05,7.82E+05,2.60E+06,9.82E+05,3.14E+06,4.28E+06,3.54E+06,2.16E+06,1.63E+07,2.93E+06,4.18E+06,6.39E+05,1.42E+07,9.84E+05,3.80E+06,5.96E+03,2.95E+04,5.75E+03,2.37E+07,1.03E+06,1.11E+03,1.39E+04,2.40E+04,2.77E+04,3.34E+04,2.56E+04,1.58E+05,1.75E+04,2.20E+06,7.28E+04,8.15E+03,1.80E+05,1.01E+05,2.30E+04,4.05E+04,0,FALSE,227.277,28,48,2363,267.1,5.02,48,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes,other membranes;cytoskeleton;nucleus;other cell component,Pf07926,7175,hsa:7175; P12270; Q15624; Q15655; Q5SWY0; Q99968,ENSG00000047410,Transport of Mature mRNA derived from an Intron-Containing Transcript; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Signaling by ALK fusions and activated point mutants,,29,0,99.15,78.84,101,115.88,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,106.71,115.75,137.91,143.56,352.72,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P48634,PRRC2A,Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,3,4,1.824,0.21,1.222,0.65,0.87,-2.25,0.29,-0.62,5.33E-01,1.55E-01,9.17E-01,8.66E-01,1.84E+05,4.39E+04,7.40E+04,5.36E+04,4,2,3,4,,1.74E+05,1.35E+04,1.95E+05,5.50E+05,,,4.43E+04,,4.35E+04,,1.65E+04,,8.43E+04,7.40E+04,,2.61E+04,9.70E+04,2.97E+04,2.77E+05,,6.62E+02,1.32E+02,1.95E+05,2.83E+04,,,4.09E+02,,4.62E+02,,7.37E+02,,1.14E+04,1.84E+03,,7.33E+03,6.87E+02,6.94E+02,2.95E+03,0,FALSE,14.844,3,3,2157,228.7,9.45,3,other biological processes,plasma membrane;other membranes;cytosol;nucleus,Pf07001,7916,B0UX77; B0UZE9; B0UZL3; hsa:7916; O95875; P48634; Q05BK4; Q4LE37; Q5SQ29; Q5SQ30; Q5ST84; Q5STX6; Q5STX7; Q68DW9; Q6P9P7; Q6PIN1; Q8MGQ9; Q96QC6,ENSG00000204469; ENSG00000206427; ENSG00000225164; ENSG00000225748; ENSG00000226618; ENSG00000231370; ENSG00000231825,,,0,0,96.95,1.34,62.69,109.52,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,71.46,116.33,97.04,108.37,12.34,,0,
Master Protein,High,P07910,HNRNPC,Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens OX=9606 GN=HNRNPC PE=1 SV=4,9,140,1.823,0.756,0.978,1.123,0.87,-0.4,-0.03,0.17,5.68E-01,8.95E-01,8.73E-01,8.58E-01,4.34E+07,2.17E+07,1.83E+07,1.52E+07,5,5,5,5,2.29E+06,1.17E+08,6.32E+05,5.69E+07,4.34E+07,2.17E+07,6.50E+06,3.56E+07,4.15E+04,3.86E+07,8.94E+06,1.83E+07,3.20E+07,8.35E+07,1.57E+07,2.15E+07,4.62E+06,1.22E+07,3.26E+07,1.52E+07,9.08E+03,4.46E+05,6.17E+03,5.69E+07,2.24E+06,7.70E+04,1.16E+05,3.28E+05,1.17E+03,4.11E+05,5.34E+04,8.20E+05,2.60E+05,1.12E+07,3.90E+05,4.19E+04,1.30E+06,8.65E+04,7.62E+05,1.62E+05,0,FALSE,61.758,24,9,306,33.7,5.08,9,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf00076,3183,D3DS19; D3DS22; hsa:3183; P07910; P22628; Q53EX2; Q59FD3; Q5FWE8; Q86SF8; Q86U45; Q96HK7; Q96HM4; Q96IY5; Q9BTS3,ENSG00000092199,SUMOylation of RNA binding proteins; mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,mRNA processing,6,0,108.6,83.58,95.08,61.03,Peak Found,High,Peak Found,High,High,High,Peak Found,High,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,137.08,141.81,134.1,127.36,410.71,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P42765,ACAA2,"3-ketoacyl-CoA thiolase, mitochondrial OS=Homo sapiens OX=9606 GN=ACAA2 PE=1 SV=2",17,70,1.821,1.098,2.929,1.746,0.86,0.13,1.55,0.8,5.12E-01,4.95E-01,1.94E-01,5.68E-01,1.97E+06,8.82E+05,1.07E+07,2.81E+06,5,5,5,5,1.12E+06,1.97E+06,1.12E+06,9.41E+06,1.32E+07,8.82E+05,1.05E+06,7.03E+05,9.78E+04,5.22E+06,3.74E+06,5.83E+06,2.99E+07,1.27E+07,1.07E+07,1.62E+06,2.81E+06,1.37E+07,1.02E+06,4.00E+06,4.45E+03,7.50E+03,1.10E+04,9.41E+06,6.80E+05,3.14E+03,1.87E+04,6.48E+03,2.76E+03,5.55E+04,2.23E+04,2.60E+05,2.43E+05,1.71E+06,2.65E+05,3.15E+03,7.88E+05,9.69E+04,2.38E+04,4.25E+04,0,FALSE,84.675,66,17,397,41.9,8.09,17,cell organization and biogenesis;other metabolic processes;stress response;transport,mitochondrion,"Pf00108, Pf02803",10449,hsa:10449; P42765; Q9BUT6,ENSG00000167315,Mitochondrial Fatty Acid Beta-Oxidation,Fatty acid biosynthesis,2,0,104.28,129.52,82.25,112.21,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,High,Peak Found,High,1,,FALSE,126.12,109.3,130.94,99.54,184.22,other molecular function,0,
Master Protein,High,P52948,NUP98,Nuclear pore complex protein Nup98-Nup96 OS=Homo sapiens OX=9606 GN=NUP98 PE=1 SV=4,10,15,1.803,0.719,,,0.85,-0.48,,,4.99E-01,8.80E-01,,,1.45E+06,5.16E+05,6.81E+04,5.23E+05,2,1,3,2,,,,8.45E+05,2.49E+06,5.16E+05,,,,,,3.67E+04,4.22E+05,6.81E+04,,1.48E+06,,,1.85E+05,,,,,8.45E+05,1.28E+05,1.83E+03,,,,,,1.64E+03,3.43E+03,9.18E+03,,2.89E+03,,,4.32E+03,,0,FALSE,40.485,8,10,1817,197.5,6.4,10,cell organization and biogenesis;protein metabolism;transport;other biological processes,other membranes;cytosol;nucleus;other cell component,"Pf04096, Pf12110, Pf21240",4928,hsa:4928; P52948; Q8IUT2; Q8WYB0; Q96E54; Q9H3Q4; Q9NT02; Q9UF57; Q9UHX0; Q9Y6J4; Q9Y6J5,ENSG00000110713,,SARS-CoV-2 innate immunity evasion and cell-specific immune response,1,0,69.71,,121.85,110.08,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,125.87,46.62,,,46.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96HE7,ERO1A,ERO1-like protein alpha OS=Homo sapiens OX=9606 GN=ERO1A PE=1 SV=2,8,21,1.803,0.536,1.182,0.643,0.85,-0.9,0.24,-0.64,5.28E-01,7.51E-01,9.00E-01,8.44E-01,2.29E+05,1.30E+06,6.78E+05,1.39E+06,4,5,5,5,1.49E+05,2.17E+05,,7.01E+05,2.42E+05,1.47E+06,5.57E+05,4.24E+06,9.85E+04,1.30E+06,2.07E+05,5.67E+05,6.78E+05,1.88E+06,1.46E+06,1.39E+06,8.68E+05,1.39E+06,1.76E+06,1.51E+06,5.91E+02,8.25E+02,,7.01E+05,1.25E+04,5.23E+03,9.90E+03,3.91E+04,2.78E+03,1.38E+04,1.24E+03,2.53E+04,5.51E+03,2.54E+05,3.62E+04,2.72E+03,2.44E+05,9.86E+03,4.13E+04,1.61E+04,0,FALSE,49.208,23,8,468,54.4,5.68,8,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,non-structural extracellular;other membranes;ER/Golgi;other cell component,Pf04137,30001,A8K9X4; A8MYW1; hsa:30001; Q7LD45; Q96HE7; Q9P1Q9; Q9UKV6,ENSG00000197930,Detoxification of Reactive Oxygen Species,,1,0,77.12,105.16,71.9,23.57,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,74.77,112.44,109.65,104.14,54.05,other molecular function,0,
Master Protein,High,P61586,RHOA,Transforming protein RhoA OS=Homo sapiens OX=9606 GN=RHOA PE=1 SV=1,7,46,1.802,0.298,1.349,0.568,0.85,-1.75,0.43,-0.82,5.78E-01,2.14E-01,8.02E-01,6.71E-01,5.36E+06,4.73E+06,4.22E+06,6.43E+06,5,5,5,5,2.82E+07,3.62E+06,5.36E+06,3.22E+06,6.41E+06,7.60E+06,4.73E+06,1.99E+06,7.95E+05,1.15E+07,9.05E+06,1.55E+06,4.22E+06,5.94E+06,3.07E+06,6.43E+06,2.47E+06,7.10E+06,3.83E+06,8.38E+06,1.12E+05,1.38E+04,5.24E+04,3.22E+06,3.31E+05,2.70E+04,8.41E+04,1.84E+04,2.24E+04,1.22E+05,5.41E+04,6.93E+04,3.43E+04,8.00E+05,7.64E+04,1.25E+04,6.93E+05,5.03E+04,8.96E+04,8.92E+04,0,FALSE,26.761,60,7,193,21.8,6.1,7,cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf00071,387,hsa:387; P06749; P61586; Q53HM4; Q5U024; Q9UDJ0; Q9UEJ4,ENSG00000067560,"Neutrophil degranulation; RHOC GTPase cycle; RHOA GTPase cycle; G alpha (12/13) signalling events; RHO GTPases Activate Formins; EPHB-mediated forward signaling; GPVI-mediated activation cascade; PI3K/AKT activation; VEGFA-VEGFR2 Pathway; ERBB2 Regulates Cell Motility; RHO GTPases activate CIT; G beta:gamma signalling through PI3Kgamma; PCP/CE pathway; RHO GTPases Activate Rhotekin and Rhophilins; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; Sema4D mediated inhibition of cell attachment and migration; Ovarian tumor domain proteases; SLIT2:ROBO1 increases RHOA activity; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); Axonal growth stimulation; Axonal growth inhibition (RHOA activation); RHO GTPases activate KTN1","Androgen receptor signaling pathway; Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Leptin signaling pathway; Pathogenic Escherichia coli infection; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Spinal cord injury; Alpha 6 beta 4 signaling pathway; Focal adhesion; G protein signaling pathways; Wnt signaling pathway; Hypothetical craniofacial development pathway; TGF-beta signaling pathway; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling; Wnt signaling pathway and pluripotency; Fibrin complement receptor 3 signaling pathway; Wnt signaling in kidney disease; Chromosomal and microsatellite instability in colorectal cancer ; Ebola virus infection in host; Ras signaling; Pancreatic adenocarcinoma pathway; Wnt signaling; Envelope proteins and their potential roles in EDMD physiopathology; Hippo signaling regulation pathways; Leukocyte-intrinsic Hippo pathway functions; Cell migration and invasion through p75NTR; Neural crest cell migration during development; Neural crest cell migration in cancer; Joubert syndrome; Gastrin signaling pathway; Netrin-UNC5B signaling pathway; mBDNF and proBDNF regulation of GABA neurotransmission; MAP3K1 role in promoting and blocking gonadal determination; Airway smooth muscle cell contraction; RAS and bradykinin pathways in COVID-19; Regulation of actin cytoskeleton; GDNF signaling; PtdIns(4,5)P2 in cytokinesis pathway; 2q11.2 copy number variation syndrome; 2q21.1 copy number variation syndrome; G13 signaling pathway; 13q12.12 copy number variation; GNAQ pathways in port-wine stain; DNA damage response (only ATM dependent); Serotonin HTR1 group and FOS pathway",73,0,113.29,81.39,60.47,43.06,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,120.03,123.36,131.34,137.21,119.57,cytoskeletal activity;other molecular function,0,
Master Protein,High,J3KN66,TOR1AIP1,Torsin 1A interacting protein 1 OS=Homo sapiens OX=9606 GN=TOR1AIP1 PE=1 SV=1,9,19,1.797,0.365,1.263,0.749,0.85,-1.45,0.34,-0.42,5.32E-01,3.55E-01,9.50E-01,9.57E-01,1.81E+06,7.18E+05,6.49E+05,4.07E+05,4,4,5,5,,3.26E+05,1.44E+06,2.47E+06,2.26E+06,,1.13E+06,4.55E+05,1.49E+05,1.66E+06,5.27E+05,5.35E+05,6.49E+05,2.70E+06,1.19E+06,3.10E+06,2.46E+05,2.23E+06,4.07E+05,3.42E+05,,1.24E+03,1.41E+04,2.47E+06,1.17E+05,,2.01E+04,4.19E+03,4.20E+03,1.76E+04,3.15E+03,2.39E+04,5.27E+03,3.64E+05,2.96E+04,6.04E+03,6.92E+04,1.58E+04,9.53E+03,3.64E+03,0,FALSE,48.757,23,8,599,67.8,7.9,9,,other membranes;nucleus,"Pf05609, Pf20443",,J3KN66,ENSG00000143337,,,0,1,59.85,79.9,82.57,104.01,n/a,n/a,Peak Found,High,High,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,90.9,100.77,109.77,120.02,61.36,other molecular function,0,
Master Protein,High,Q15631,TSN,Translin OS=Homo sapiens OX=9606 GN=TSN PE=1 SV=1,3,4,1.789,,,2.961,0.84,,,1.57,4.69E-01,,,2.50E-01,4.09E+05,4.37E+04,1.50E+06,5.08E+05,1,1,1,1,,,,4.09E+05,,,4.37E+04,,,,1.50E+06,,,,,,5.08E+05,,,,,,,4.09E+05,,,7.76E+02,,,,9.00E+03,,,,,,1.43E+05,,,,0,FALSE,10.278,27,3,228,26.2,6.44,3,DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,Pf01997,7247,B7Z3X8; hsa:7247; Q15631; Q5U0K7,ENSG00000211460,Small interfering RNA (siRNA) biogenesis,,1,0,,,,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,,,0,12.87,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75151,PHF2,Lysine-specific demethylase PHF2 OS=Homo sapiens OX=9606 GN=PHF2 PE=1 SV=4,3,3,1.787,1.802,1.401,2.297,0.84,0.85,0.49,1.2,4.78E-01,2.39E-01,8.19E-01,3.47E-01,2.97E+05,1.66E+05,5.34E+05,2.33E+05,2,1,1,1,2.62E+05,,,3.36E+05,,,,,1.66E+05,,5.34E+05,,,,,,,,2.33E+05,,1.04E+03,,,3.36E+05,,,,,4.68E+03,,3.20E+03,,,,,,,,5.44E+03,,0,FALSE,10.257,5,2,1096,120.7,9.17,3,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,"Pf00628, Pf02373, Pf17811",5253,hsa:5253; O75151; Q4VXG0; Q8N3K2; Q9Y6N4,ENSG00000197724,HDMs demethylate histones,,1,1,17.4,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,18.38,18.38,0,0,11.03,other molecular function,0,
Master Protein,High,O15042,U2SURP,U2 snRNP-associated SURP motif-containing protein OS=Homo sapiens OX=9606 GN=U2SURP PE=1 SV=2,10,15,1.784,0.423,2.434,0.383,0.84,-1.24,1.28,-1.38,5.45E-01,5.39E-01,4.43E-01,5.37E-01,1.01E+06,1.84E+05,2.77E+05,9.00E+05,5,1,4,5,2.23E+05,1.98E+06,7.84E+04,4.26E+06,1.01E+06,,,1.84E+05,,,1.01E+05,3.40E+05,,1.20E+06,2.25E+05,9.00E+05,9.35E+04,3.08E+06,7.88E+04,1.31E+06,8.84E+02,7.53E+03,7.66E+02,4.26E+06,5.21E+04,,,1.70E+03,,,6.01E+02,1.52E+04,,1.61E+05,5.59E+03,1.75E+03,2.63E+04,2.18E+04,1.84E+03,1.39E+04,0,FALSE,40.802,16,10,1029,118.2,8.47,10,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00076, Pf01805, Pf04818, Pf08312",23350,A0PJ60; hsa:23350; O15042; Q0D2M1; Q2NKQ7; Q9BR70,ENSG00000163714,mRNA Splicing - Major Pathway,,1,0,113.5,,106.82,112.77,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,5.32,94.07,73.32,593.73,40.28,,0,
Master Protein,High,A0A087X0H9,RBM26,RNA binding motif protein 26 OS=Homo sapiens OX=9606 GN=RBM26 PE=1 SV=1,3,3,1.782,0.171,1.006,0.252,0.83,-2.55,0.01,-1.99,5.32E-01,5.85E-02,9.29E-01,3.49E-01,8.07E+05,1.37E+05,4.95E+04,2.82E+05,3,2,4,3,,1.66E+06,,2.91E+05,8.07E+05,1.31E+05,,,,1.45E+05,6.15E+04,2.30E+04,,8.91E+04,3.98E+04,3.41E+05,,,1.08E+05,2.82E+05,,6.32E+03,,2.91E+05,4.16E+04,4.64E+02,,,,1.54E+03,3.68E+02,1.03E+03,,1.20E+04,9.88E+02,6.66E+02,,,2.53E+03,3.00E+03,0,FALSE,9.92,4,3,1009,113.7,9.16,3,RNA metabolism OR transcription;other metabolic processes,nucleus,Pf01480,64062,A0A087X0H9; hsa:64062,ENSG00000139746,,,0,0,75.36,7.19,53.63,49.77,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,99.24,72.69,123.15,95.8,9.07,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y3C4,TPRKB,EKC/KEOPS complex subunit TPRKB OS=Homo sapiens OX=9606 GN=TPRKB PE=1 SV=1,1,1,1.78,0.68,0.01,100,0.83,-0.56,-6.64,6.64,5.71E-01,9.58E-01,1.00E-17,1.00E-17,8.92E+04,5.01E+04,6.07E+04,,2,1,3,,7.63E+04,,,1.04E+05,,,,,,5.01E+04,,6.07E+04,3.81E+04,1.65E+05,,,,,,,3.03E+02,,,1.04E+05,,,,,,5.33E+02,,2.71E+03,3.09E+02,2.22E+04,,,,,,,0,FALSE,5.188,8,1,175,19.6,6.79,1,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf08617,51002,D6W5H6; hsa:51002; Q8IWR6; Q8IWR7; Q9H3K4; Q9Y3C4,ENSG00000144034; ENSG00000291480,tRNA modification in the nucleus and cytosol,,1,0,21.86,,76.88,,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,23.2,69.17,,,3.73,other molecular function,0,
Master Protein,High,Q14566,MCM6,DNA replication licensing factor MCM6 OS=Homo sapiens OX=9606 GN=MCM6 PE=1 SV=1,10,29,1.779,0.196,0.913,0.279,0.83,-2.35,-0.13,-1.84,5.32E-01,6.27E-02,7.99E-01,3.62E-01,2.35E+06,2.42E+05,1.08E+06,6.81E+05,5,4,4,4,1.48E+07,2.10E+06,8.06E+04,2.35E+06,3.67E+06,3.11E+06,5.21E+05,1.12E+05,8.11E+04,,,1.84E+06,1.40E+05,4.30E+06,6.36E+05,2.24E+06,,1.02E+06,2.03E+05,4.55E+05,5.86E+04,7.97E+03,7.88E+02,2.35E+06,1.90E+05,1.10E+04,9.26E+03,1.04E+03,2.28E+03,,,8.20E+04,1.14E+03,5.80E+05,1.58E+04,4.38E+03,,7.23E+03,4.75E+03,4.84E+03,0,FALSE,47.167,16,10,821,92.8,5.41,10,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00493, Pf14551, Pf17207, Pf17855, Pf18263",4175,B2R6H2; hsa:4175; Q13504; Q14566; Q99859,ENSG00000076003,Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA,Cell cycle; Retinoblastoma gene in cancer; Ciliary landscape; G1 to S cell cycle control; DNA replication,11,0,126.86,151.61,107.46,92.71,High,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,1,Acetyl [N-Term],FALSE,116.45,119.3,100.19,100.02,89.01,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P49750,YLPM1,YLP motif-containing protein 1 OS=Homo sapiens OX=9606 GN=YLPM1 PE=1 SV=4,5,5,1.778,0.147,0.197,0.459,0.83,-2.77,-2.35,-1.12,5.39E-01,5.06E-02,6.70E-02,6.48E-01,5.99E+05,4.98E+05,8.69E+04,4.94E+04,4,5,4,4,3.64E+05,6.35E+05,,5.65E+05,2.22E+06,7.73E+05,8.56E+04,5.82E+05,4.14E+05,4.98E+05,,3.91E+04,1.51E+05,1.36E+05,5.56E+04,1.80E+05,3.13E+03,,1.36E+04,3.48E+05,1.44E+03,2.41E+03,,5.65E+05,1.14E+05,2.75E+03,1.52E+03,5.37E+03,1.17E+04,5.30E+03,,1.75E+03,1.23E+03,1.83E+04,1.38E+03,3.51E+02,8.80E+02,,3.17E+02,3.70E+03,0,FALSE,18.494,4,5,2146,241.5,6.55,5,other biological processes,nucleus,Pf13671,56252,hsa:56252; P49750; P49752; Q96I64; Q9P1V7,ENSG00000119596,,,0,0,90.51,53.74,58.93,119.53,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,110.13,94.62,134.4,141.15,17.2,,0,
Master Protein,High,Q6IQ49,SDE2,Splicing regulator SDE2 OS=Homo sapiens OX=9606 GN=SDE2 PE=1 SV=1,1,2,1.775,0.303,0.01,100,0.83,-1.72,-6.64,6.64,5.63E-01,3.78E-01,1.00E-17,1.00E-17,9.97E+04,5.61E+04,3.02E+04,,2,1,2,,,1.40E+05,,7.08E+04,,,,5.61E+04,,,,2.53E+04,3.60E+04,,,,,,,,,5.33E+02,,7.08E+04,,,,5.18E+02,,,,1.13E+03,2.93E+02,,,,,,,,0,FALSE,6.711,5,1,451,49.7,6.05,1,cell cycle OR cell proliferation;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,"Pf13019, Pf13297",163859,A8K4P3; hsa:163859; Q5TD36; Q6IQ49; Q6ZS26; Q8NAG7,ENSG00000143751,mRNA Splicing - Major Pathway,,1,0,46.53,,24.78,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,51.65,43.27,,,8.45,nucleic acid binding activity,0,
Master Protein,High,H3BVG0,NUP93,Nuclear pore complex protein Nup93 OS=Homo sapiens OX=9606 GN=NUP93 PE=1 SV=1,6,10,1.775,0.713,0.916,1.581,0.83,-0.49,-0.13,0.66,5.53E-01,8.81E-01,7.81E-01,5.50E-01,8.16E+05,2.01E+05,5.72E+05,3.43E+05,4,4,4,3,8.32E+05,,5.33E+05,1.35E+06,8.00E+05,,1.36E+05,2.04E+05,1.97E+05,2.97E+05,1.77E+06,8.78E+04,,8.84E+05,3.71E+05,,1.20E+05,,3.43E+05,1.06E+06,3.30E+03,,5.21E+03,1.35E+06,4.13E+04,,2.41E+03,1.89E+03,5.56E+03,3.16E+03,1.06E+04,3.92E+03,,1.19E+05,9.21E+03,,3.39E+04,,8.04E+03,1.13E+04,0,FALSE,20.413,10,6,880,99.5,5.73,6,transport,other membranes;nucleus,Pf04097,,H3BVG0,ENSG00000102900,,,0,0,38.68,31.85,95.03,96.57,Peak Found,n/a,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,35.88,64.87,132.22,127.99,28.96,other molecular function,0,
Master Protein,High,P04350,TUBB4A,Tubulin beta-4A chain OS=Homo sapiens OX=9606 GN=TUBB4A PE=1 SV=2,19,477,1.772,1.516,0.774,0.56,0.83,0.6,-0.37,-0.84,5.31E-01,1.89E-01,6.48E-01,7.21E-01,2.29E+06,4.37E+05,3.32E+05,2.82E+05,4,3,2,2,5.03E+06,,2.80E+06,2.11E+05,1.87E+06,4.37E+05,,1.84E+05,9.43E+05,,1.27E+06,,,,8.69E+04,,5.11E+05,,1.55E+05,,2.00E+04,,2.74E+04,2.11E+05,9.64E+04,1.56E+03,,1.70E+03,2.66E+04,,7.59E+03,,,,2.16E+03,,1.44E+05,,3.63E+03,,0,FALSE,159.622,56,3,444,49.6,4.88,19,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;other cell component,"Pf00091, Pf03953",10382,B3KQP4; hsa:10382; P04350; Q969E5,ENSG00000104833,Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; PKR-mediated signaling; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,41,0,81.07,74.11,123.31,75.6,High,n/a,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,137.11,245.64,85.91,16.78,1274.07,cytoskeletal activity;other molecular function,0,
Master Protein,High,P39019,RPS19,40S ribosomal protein S19 OS=Homo sapiens OX=9606 GN=RPS19 PE=1 SV=2,8,22,1.77,0.379,0.39,0.752,0.82,-1.4,-1.36,-0.41,5.41E-01,4.07E-01,1.83E-01,8.60E-01,1.45E+06,3.86E+05,8.25E+05,8.20E+06,5,5,5,5,6.59E+05,5.00E+06,3.86E+05,1.45E+06,2.17E+06,2.19E+05,4.73E+05,2.55E+05,1.39E+06,3.86E+05,1.59E+06,8.42E+05,2.19E+05,8.25E+05,5.83E+05,5.39E+06,8.20E+06,1.25E+07,9.68E+06,7.57E+06,2.62E+03,1.90E+04,3.77E+03,1.45E+06,1.12E+05,7.78E+02,8.42E+03,2.36E+03,3.93E+04,4.11E+03,9.54E+03,3.76E+04,1.78E+03,1.11E+05,1.45E+04,1.05E+04,2.31E+06,8.84E+04,2.27E+05,8.06E+04,0,FALSE,22.699,45,4,145,16.1,10.32,8,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf01090,6223,hsa:6223; P39019,ENSG00000105372,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Complement system; Cytoplasmic ribosomal proteins,20,3,95.87,88.91,62.06,30.36,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,112.49,106.35,130.1,137.62,51.51,other molecular function,0,
Master Protein,High,A0A0A0MTC1,RNF213,Ring finger protein 213 OS=Homo sapiens OX=9606 GN=RNF213 PE=1 SV=1,9,18,1.767,0.263,0.881,0.616,0.82,-1.93,-0.18,-0.7,4.72E-01,2.13E-01,8.42E-01,8.02E-01,5.88E+05,9.82E+04,3.23E+05,1.37E+05,5,5,5,4,1.43E+07,2.36E+05,8.37E+06,2.53E+05,5.88E+05,5.91E+06,6.26E+04,1.19E+05,2.07E+04,9.82E+04,9.88E+05,9.03E+04,1.94E+06,2.32E+05,3.23E+05,,8.14E+04,9.39E+04,2.16E+05,1.99E+05,5.68E+04,8.98E+02,8.18E+04,2.53E+05,3.03E+04,2.10E+04,1.11E+03,1.10E+03,5.83E+02,1.04E+03,5.91E+03,4.03E+03,1.58E+04,3.12E+04,8.04E+03,,2.29E+04,6.65E+02,5.06E+03,2.12E+03,0,FALSE,27.958,3,9,5256,596.1,6.42,9,,cytosol;nucleus,"Pf00097, Pf20173",,A0A0A0MTC1,ENSG00000173821,,,0,0,134.09,210.11,107.37,47.29,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,124.94,132.08,117.02,134.24,40.13,other molecular function,0,
Master Protein,High,P25705,ATP5F1A,"ATP synthase subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1A PE=1 SV=1",26,441,1.765,1.527,1.159,2.748,0.82,0.61,0.21,1.46,5.93E-01,2.42E-01,9.55E-01,3.30E-01,4.57E+07,1.46E+07,1.24E+08,3.77E+07,5,5,5,5,5.37E+07,4.44E+07,3.83E+07,1.07E+08,4.57E+07,1.87E+07,1.86E+06,1.44E+07,1.46E+07,8.08E+07,5.52E+07,1.20E+08,2.28E+08,1.24E+08,1.66E+08,3.77E+07,8.45E+07,2.87E+07,2.00E+08,1.40E+07,2.13E+05,1.69E+05,3.74E+05,1.07E+08,2.36E+06,6.64E+04,3.31E+04,1.33E+05,4.11E+05,8.59E+05,3.30E+05,5.38E+06,1.85E+06,1.67E+07,4.11E+06,7.35E+04,2.37E+07,2.03E+05,4.69E+06,1.49E+05,0,FALSE,166.599,56,26,553,59.7,9.13,26,other metabolic processes;transport;other biological processes,plasma membrane;other membranes;mitochondrion;other cell component,"Pf00006, Pf00306, Pf02874",498,A8K092; B4DY56; hsa:498; K7ENP3; P25705; Q53XX6; Q8IXV2; Q96FB4; Q96HW2; Q96IR6; Q9BTV8,ENSG00000152234,Mitochondrial protein import; Mitochondrial protein degradation; Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,7,0,48.43,119.81,45.87,103.92,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,1,,FALSE,117.28,124.02,128.14,134.2,1320.88,signal transduction activity or receptor binding;transporter activity;other molecular function,0,
Master Protein,High,Q8IU81,IRF2BP1,Interferon regulatory factor 2-binding protein 1 OS=Homo sapiens OX=9606 GN=IRF2BP1 PE=1 SV=1,2,8,1.763,0.011,0.016,1.664,0.82,-6.47,-5.98,0.73,5.94E-01,1.21E-09,5.85E-08,5.68E-01,2.40E+07,4.60E+06,1.21E+05,7.27E+04,5,5,5,4,2.40E+07,8.61E+07,1.74E+08,9.18E+05,3.00E+05,5.58E+07,4.60E+06,1.12E+07,3.65E+06,4.51E+05,1.21E+05,6.79E+04,2.66E+05,7.78E+04,1.93E+06,2.48E+05,1.26E+04,7.81E+04,6.76E+04,,9.52E+04,3.27E+05,1.70E+06,9.18E+05,1.55E+04,1.98E+05,8.19E+04,1.04E+05,1.03E+05,4.80E+03,7.23E+02,3.03E+03,2.16E+03,1.05E+04,4.80E+04,4.83E+02,3.54E+03,5.54E+02,1.58E+03,,0,FALSE,6.833,7,2,584,61.6,8.18,2,protein metabolism;other metabolic processes;other biological processes,nucleus,Pf11261,26145,Q53EL7; Q6DC95; Q8IU81; Q9BRZ9; Q9Y4P4,ENSG00000170604,,,0,0,130.02,152.2,163.94,100.06,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,Phospho [Y130; T131],FALSE,146.02,147.24,139.37,144.11,13.95,other molecular function,2,Phospho [Y130; T131]
Master Protein,High,Q02548,PAX5,Paired box protein Pax-5 OS=Homo sapiens OX=9606 GN=PAX5 PE=1 SV=1,3,8,1.754,0.81,0.846,2.133,0.81,-0.3,-0.24,1.09,5.58E-01,7.58E-01,7.23E-01,3.64E-01,7.72E+05,3.01E+05,7.91E+05,2.55E+05,3,3,5,3,,1.09E+06,,7.72E+05,5.29E+05,3.01E+05,7.67E+05,,,1.40E+05,3.13E+05,1.18E+06,1.98E+05,1.40E+06,7.91E+05,,5.94E+04,,2.55E+05,7.07E+05,,4.15E+03,,7.72E+05,2.73E+04,1.07E+03,1.36E+04,,,1.49E+03,1.87E+03,5.27E+04,1.61E+03,1.88E+05,1.96E+04,,1.67E+04,,5.97E+03,7.53E+03,0,FALSE,12.158,16,3,391,42.1,9,3,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,"Pf00292, Pf12403",5079,A3QVP6; A3QVP7; A3QVP8; C0KTF6; C0KTF7; C0KTF8; C0KTF9; C0KTG0; hsa:5079; O75933; Q02548; Q5SFM2; Q6S728; Q6S729; Q6S730; Q6S731; Q6S732,ENSG00000196092,RUNX1 regulates transcription of genes involved in BCR signaling,Prion disease pathway; Extrafollicular and follicular B cell activation by SARS-CoV-2; ID signaling pathway,4,0,35.41,80.79,67.48,97.58,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,89.98,80.05,123.42,101.33,19.64,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13724,MOGS,Mannosyl-oligosaccharide glucosidase OS=Homo sapiens OX=9606 GN=MOGS PE=1 SV=5,9,48,1.751,1.14,0.684,2.195,0.81,0.19,-0.55,1.13,5.54E-01,4.60E-01,6.64E-01,4.39E-01,2.92E+06,8.10E+05,6.60E+06,1.46E+06,5,5,5,5,1.56E+06,6.13E+06,2.92E+06,4.58E+06,1.84E+06,1.30E+06,5.72E+05,2.60E+05,8.10E+05,8.27E+06,8.46E+06,1.56E+06,6.60E+06,8.28E+06,3.17E+06,2.97E+05,1.46E+06,1.93E+06,2.99E+06,3.48E+05,6.19E+03,2.33E+04,2.85E+04,4.58E+06,9.50E+04,4.62E+03,1.02E+04,2.40E+03,2.28E+04,8.80E+04,5.06E+04,6.99E+04,5.37E+04,1.12E+06,7.88E+04,5.80E+02,4.11E+05,1.37E+04,7.00E+04,3.71E+03,0,FALSE,49.419,19,9,837,91.9,8.9,9,protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi,"Pf03200, Pf16923",7841,A8K938; F5H6D0; hsa:7841; Q13724; Q17RN9; Q8TCT5,ENSG00000115275,Maturation of spike protein; N-glycan trimming in the ER and Calnexin/Calreticulin cycle; Maturation of spike protein; Defective MOGS causes CDG-2b,N-glycan biosynthesis,5,0,56.65,151.21,55.3,80.63,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,131.99,111.4,116.9,101.98,149.34,other molecular function,0,
Master Protein,High,P04899,GNAI2,Guanine nucleotide-binding protein G(i) subunit alpha-2 OS=Homo sapiens OX=9606 GN=GNAI2 PE=1 SV=3,17,161,1.743,1.114,1.616,2.007,0.8,0.16,0.69,1,6.03E-01,4.82E-01,6.30E-01,4.87E-01,3.05E+07,6.54E+06,3.85E+07,1.07E+07,5,5,5,5,4.29E+07,3.10E+07,3.05E+07,2.90E+07,1.64E+07,1.09E+07,6.54E+06,5.15E+06,1.31E+07,5.27E+06,5.96E+07,1.41E+07,1.96E+07,3.85E+07,3.86E+07,2.34E+07,7.03E+06,3.28E+07,6.54E+06,1.07E+07,1.70E+05,1.18E+05,2.98E+05,2.90E+07,8.44E+05,3.88E+04,1.16E+05,4.75E+04,3.69E+05,5.61E+04,3.56E+05,6.28E+05,1.59E+05,5.19E+06,9.60E+05,4.56E+04,1.97E+06,2.32E+05,1.53E+05,1.14E+05,0,FALSE,82.909,57,10,355,40.4,5.54,17,cell-cell signaling;cell cycle OR cell proliferation;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf00503,2771,B3KTZ0; B4DYA0; B4E2X5; hsa:2771; P04899; Q6B6N3; Q8IZ71,ENSG00000114353,"G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Adrenaline,noradrenaline inhibits insulin secretion",Thyroid stimulating hormone (TSH) signaling pathway; Corticotropin-releasing hormone signaling pathway; S1P receptor signal transduction; Complement system; G protein signaling pathways; Chemokine signaling pathway; Hippo signaling regulation pathways; Purinergic signaling; Opioid receptor pathways; Calcium regulation in cardiac cells; 5q35 copy number variation; Serotonin HTR1 group and FOS pathway,22,7,31.42,43.98,52.91,71.82,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,136.82,100.18,126.14,124,426.22,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,O14949,UQCRQ,Cytochrome b-c1 complex subunit 8 OS=Homo sapiens OX=9606 GN=UQCRQ PE=1 SV=4,2,8,1.743,0.304,1.949,0.338,0.8,-1.72,0.96,-1.56,4.89E-01,3.03E-01,6.18E-01,4.94E-01,4.35E+05,5.03E+04,9.60E+04,2.15E+05,2,1,3,1,,,,5.70E+05,3.32E+05,,,,5.03E+04,,,1.57E+06,,1.58E+04,9.60E+04,,2.15E+05,,,,,,,5.70E+05,1.71E+04,,,,1.42E+03,,,7.03E+04,,2.13E+03,2.39E+03,,6.04E+04,,,,0,FALSE,6.791,28,2,82,9.9,10.08,2,other metabolic processes;developmental processes,other membranes;mitochondrion,Pf02939,27089,hsa:27089; O14949; Q5FVE2; Q9BV88; Q9T2V7,ENSG00000164405,Respiratory electron transport; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,5,0,37.24,,156.13,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,70.64,103.21,0,126.45,20.2,,0,
Master Protein,High,Q5JRA6,MIA3,Transport and Golgi organization protein 1 homolog OS=Homo sapiens OX=9606 GN=MIA3 PE=1 SV=1,2,2,1.743,0.294,0.753,0.68,0.8,-1.77,-0.41,-0.56,5.67E-01,3.54E-01,7.65E-01,9.01E-01,5.79E+04,3.32E+04,1.06E+05,2.51E+04,3,1,4,2,,7.06E+04,,5.79E+04,2.80E+04,,,3.32E+04,,,,1.23E+05,9.28E+04,1.06E+05,1.07E+05,,4.12E+03,,,1.52E+05,,2.68E+02,,5.79E+04,1.45E+03,,,3.07E+02,,,,5.47E+03,7.54E+02,1.43E+04,2.65E+03,,1.16E+03,,,1.62E+03,0,FALSE,4.428,1,2,1907,213.6,4.84,2,cell organization and biogenesis;stress response;transport;developmental processes;other biological processes,other membranes;ER/Golgi;other cell component,Pf07653,375056,A8K2S0; A8MT05; A8MT13; B7Z430; hsa:375056; Q14083; Q3S4X3; Q5JRA5; Q5JRA6; Q5JRB0; Q5JRB1; Q5JRB2; Q6UVY8; Q86Y60; Q8N8M5; Q92580,ENSG00000154305,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Cargo concentration in the ER,Type I collagen synthesis in the context of osteogenesis imperfecta,4,0,41.91,,11.39,133.98,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,32.44,32.44,438.77,438.77,6.26,other molecular function,0,
Master Protein,High,O15446,POLR1G,DNA-directed RNA polymerase I subunit RPA34 OS=Homo sapiens OX=9606 GN=POLR1G PE=1 SV=1,2,4,1.742,0.288,1.78,0.298,0.8,-1.8,0.83,-1.74,5.62E-01,3.13E-01,6.58E-01,4.19E-01,1.49E+05,3.39E+04,8.68E+04,6.03E+04,2,3,2,1,,9.06E+04,,2.44E+05,,,,5.21E+04,2.67E+04,3.39E+04,,1.24E+04,,6.08E+05,,,,,,6.03E+04,,3.44E+02,,2.44E+05,,,,4.80E+02,7.53E+02,3.60E+02,,5.54E+02,,8.19E+04,,,,,,6.42E+02,0,FALSE,8.499,8,2,510,55,8.51,2,RNA metabolism OR transcription;other metabolic processes;signal transduction,cytosol;mitochondrion;nucleus;other cell component,Pf08208,10849,hsa:10849; O15446; Q32N11; Q7Z5U2; Q9UPF6,ENSG00000117877,B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination,2q13 copy number variation syndrome,6,0,64.72,34.79,135.76,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,51.64,72.06,39.59,56.36,13.98,,0,
Master Protein,High,Q969V5,MUL1,Mitochondrial ubiquitin ligase activator of NFKB 1 OS=Homo sapiens OX=9606 GN=MUL1 PE=1 SV=1,1,3,1.74,0.724,0.081,15.271,0.8,-0.47,-3.63,3.93,5.75E-01,9.53E-01,2.34E-02,2.01E-02,6.71E+04,3.86E+04,4.76E+04,3.12E+03,2,2,3,1,,7.96E+04,,5.66E+04,,,,4.52E+04,3.30E+04,,,4.76E+04,,9.18E+04,3.53E+04,,3.12E+03,,,,,3.02E+02,,5.66E+04,,,,4.17E+02,9.29E+02,,,2.13E+03,,1.24E+04,8.77E+02,,8.76E+02,,,,0.001,FALSE,3.392,6,1,352,39.8,8.13,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,other membranes;mitochondrion;other cytoplasmic organelle;other cell component,"Pf12483, Pf13920",79594,B5M497; Q7Z431; Q969V5; Q9H9B5,ENSG00000090432,Ub-specific processing proteases; Neddylation; KEAP1-NFE2L2 pathway,,3,0,23.84,22.12,51.05,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,21.66,43.2,23.47,38.36,7.85,other molecular function,0,
Master Protein,High,P11308,ERG,Transcriptional regulator ERG OS=Homo sapiens OX=9606 GN=ERG PE=1 SV=3,9,30,1.737,0.592,0.628,1.85,0.8,-0.76,-0.67,0.89,5.49E-01,8.19E-01,5.37E-01,5.03E-01,2.27E+06,4.12E+05,3.44E+06,9.36E+05,5,5,5,4,7.15E+05,2.93E+05,2.65E+06,6.34E+06,2.27E+06,4.12E+05,1.64E+05,1.09E+06,3.66E+05,3.69E+06,2.13E+06,3.77E+06,6.89E+04,9.51E+06,3.44E+06,,1.33E+05,1.27E+06,7.37E+05,1.19E+06,2.84E+03,1.11E+03,2.59E+04,6.34E+06,1.17E+05,1.46E+03,2.91E+03,1.00E+04,1.03E+04,3.92E+04,1.27E+04,1.69E+05,5.59E+02,1.28E+06,8.54E+04,,3.75E+04,8.99E+03,1.72E+04,1.27E+04,0,FALSE,55.273,28,8,479,53.8,7.65,9,protein metabolism;other metabolic processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00178, Pf02198",2078,B4DTW5; B4E0T4; hsa:2078; P11308; Q16113; Q6XXX4; Q6XXX5; Q8IXK9,ENSG00000157554,,Genes targeted by miRNAs in adipocytes; Androgen receptor network in prostate cancer; VEGFA-VEGFR2 signaling; HDAC6 interactions in the central nervous system,4,1,97.41,128.15,92.94,62.65,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,105.98,100.86,66.63,91.18,106.49,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P20273,CD22,B-cell receptor CD22 OS=Homo sapiens OX=9606 GN=CD22 PE=1 SV=2,7,10,1.735,0.926,4.346,0.426,0.79,-0.11,2.12,-1.23,5.00E-01,7.34E-01,1.93E-01,6.35E-01,1.27E+05,3.00E+05,1.74E+05,1.08E+05,5,2,5,3,1.43E+05,7.42E+04,1.27E+05,1.43E+06,2.89E+04,,,6.60E+05,1.36E+05,,1.74E+05,8.52E+04,4.30E+04,1.12E+06,3.18E+05,2.46E+06,1.08E+05,7.44E+04,,,5.70E+02,2.82E+02,1.24E+03,1.43E+06,1.49E+03,,,6.09E+03,3.84E+03,,1.04E+03,3.81E+03,3.49E+02,1.51E+05,7.91E+03,4.80E+03,3.05E+04,5.28E+02,,,0,FALSE,36.698,15,7,847,95.3,6.65,7,cell adhesion;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,"Pf08205, Pf13895, Pf13927",933,F5GYU4; F5H7U3; hsa:933; O95699; O95701; O95702; O95703; P20273; Q01665; Q32M46; Q92872; Q92873; Q9UQA6; Q9UQA7; Q9UQA8; Q9UQA9; Q9UQB0; Q9Y2A6,ENSG00000012124,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; CD22 mediated BCR regulation; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,B cell receptor signaling pathway; Extrafollicular and follicular B cell activation by SARS-CoV-2,5,0,166.17,93.05,127.78,155.26,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,1,,FALSE,77.63,81.11,130.35,266.26,35.92,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,A0A804HJE2,ZNF384,Zinc finger protein 384 OS=Homo sapiens OX=9606 GN=ZNF384 PE=1 SV=1,1,1,1.733,0.112,0.01,100,0.79,-3.16,-6.64,6.64,5.52E-01,1.62E-02,1.00E-17,1.00E-17,6.93E+05,2.31E+05,7.74E+04,,3,4,1,,,7.24E+05,,6.93E+05,1.66E+05,1.31E+05,7.47E+04,4.09E+05,4.85E+05,,,,7.74E+04,,,,,,,,,2.75E+03,,6.93E+05,8.58E+03,4.66E+02,1.33E+03,3.77E+03,1.37E+04,,,,6.29E+02,,,,,,,,0.006,FALSE,2.445,2,1,608,66.1,8.72,1,,,Pf00096,171017,A0A804HJE2,ENSG00000126746,,,0,0,59.39,73.63,,,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,77.86,6.77,,,2.46,,0,
Master Protein,High,P83731,RPL24,60S ribosomal protein L24 OS=Homo sapiens OX=9606 GN=RPL24 PE=1 SV=1,5,22,1.732,0.406,0.258,0.771,0.79,-1.3,-1.96,-0.37,5.47E-01,4.37E-01,1.15E-01,9.14E-01,2.04E+06,8.72E+05,2.73E+06,1.43E+06,5,5,5,4,2.44E+06,2.04E+06,9.94E+05,6.27E+06,1.02E+06,5.64E+05,1.73E+05,8.72E+05,1.08E+06,1.19E+06,6.31E+05,2.91E+06,8.40E+05,4.34E+06,2.73E+06,8.85E+05,4.48E+06,5.56E+05,2.31E+06,,9.68E+03,7.75E+03,9.71E+03,6.27E+06,5.25E+04,2.00E+03,3.07E+03,8.05E+03,3.06E+04,1.26E+04,3.77E+03,1.30E+05,6.82E+03,5.85E+05,6.77E+04,1.73E+03,1.26E+06,3.94E+03,5.41E+04,,0,FALSE,18.929,32,5,157,17.8,11.25,5,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes,cytosol;ER/Golgi;translational apparatus;other cell component,Pf01246,6152,B2R4Y3; hsa:6152; P38663; P83731; Q6IBS3,ENSG00000114391,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,85.13,53.24,67.81,86.75,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,110.11,131.14,141.41,90.11,47.67,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A0J9YXC7,LIMS3,LIM and senescent cell antigen-like-containing domain protein OS=Homo sapiens OX=9606 GN=LIMS3 PE=4 SV=1,2,3,1.73,0.335,0.305,1.458,0.79,-1.58,-1.71,0.54,5.50E-01,2.79E-01,1.68E-01,5.98E-01,1.65E+06,1.83E+06,3.39E+05,5.07E+05,2,3,2,1,6.73E+05,4.02E+06,,,,3.86E+06,,1.83E+06,,6.35E+05,5.52E+05,,,2.08E+05,,,5.07E+05,,,,2.68E+03,1.53E+04,,,,1.37E+04,,1.69E+04,,6.75E+03,3.30E+03,,,2.81E+04,,,1.42E+05,,,,0,FALSE,5.247,6,2,398,45.7,7.88,2,,plasma membrane;other membranes;other cell component,Pf00412,,A0A0J9YXC7,ENSG00000256671; ENSG00000256977,,,0,0,100.84,77.23,63.94,,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,100.69,150.77,50.41,10.06,7.56,other molecular function,0,
Master Protein,High,Q00839,HNRNPU,Heterogeneous nuclear ribonucleoprotein U OS=Homo sapiens OX=9606 GN=HNRNPU PE=1 SV=6,29,152,1.728,0.396,1.807,3.318,0.79,-1.34,0.85,1.73,6.10E-01,4.10E-01,5.33E-01,2.54E-01,5.62E+07,5.16E+06,2.31E+07,4.09E+06,5,5,5,5,7.46E+07,3.79E+06,5.62E+07,1.10E+08,2.36E+07,5.26E+06,9.88E+05,8.32E+06,3.42E+06,5.16E+06,1.26E+08,2.31E+07,1.10E+07,3.60E+07,9.40E+06,1.02E+07,7.16E+05,4.09E+06,2.03E+06,1.28E+07,2.96E+05,1.44E+04,5.49E+05,1.10E+08,1.22E+06,1.87E+04,1.76E+04,7.68E+04,9.62E+04,5.49E+04,7.55E+05,1.03E+06,8.91E+04,4.85E+06,2.34E+05,2.00E+04,2.01E+05,2.90E+04,4.74E+04,1.36E+05,0,FALSE,178.791,49,29,825,90.5,6,29,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf00622, Pf02037, Pf13671",3192,hsa:3192; O75507; Q00839; Q8N174; Q96HY9; Q9BQ09,ENSG00000153187,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,mRNA processing; lncRNA in canonical Wnt signaling and colorectal cancer,4,0,78.15,58.21,118.54,88.4,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,144.59,125.21,116.35,130.21,418.69,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P54920,NAPA,Alpha-soluble NSF attachment protein OS=Homo sapiens OX=9606 GN=NAPA PE=1 SV=3,7,19,1.723,0.448,2.614,0.376,0.78,-1.16,1.39,-1.41,5.65E-01,6.15E-01,2.93E-01,5.06E-01,9.73E+05,3.82E+05,4.37E+05,1.45E+06,4,5,5,5,9.42E+05,1.69E+06,,1.00E+06,3.84E+05,1.10E+06,1.00E+06,1.73E+05,3.82E+05,3.25E+05,4.37E+05,4.41E+04,3.93E+05,6.28E+05,4.97E+05,1.09E+07,1.45E+06,4.46E+06,1.32E+06,2.68E+05,3.74E+03,6.43E+03,,1.00E+06,1.98E+04,3.90E+03,1.78E+04,1.60E+03,1.08E+04,3.45E+03,2.61E+03,1.97E+03,3.19E+03,8.47E+04,1.24E+04,2.13E+04,4.09E+05,3.16E+04,3.10E+04,2.85E+03,0,FALSE,31.362,32,7,295,33.2,5.36,7,cell-cell signaling;cell organization and biogenesis;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;other cell component,Pf14938,8775,A8K879; hsa:8775; P54920; Q96IK3; Q9BVJ3,ENSG00000105402,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Golgi Associated Vesicle Biogenesis; Intra-Golgi traffic; COPII-mediated vesicle transport; Retrograde transport at the Trans-Golgi-Network,Synaptic vesicle pathway; VEGFA-VEGFR2 signaling,8,0,53.32,70.87,54.44,117.73,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,74.38,76.81,79.26,119.21,55.75,other molecular function,0,
Master Protein,High,H0YHG0,,DnaJ homolog subfamily C member 14 (Fragment) OS=Homo sapiens OX=9606 PE=1 SV=1,5,8,1.719,0.397,3.308,2.291,0.78,-1.33,1.73,1.2,5.67E-01,4.72E-01,1.86E-01,3.43E-01,9.92E+05,9.27E+05,6.83E+05,1.02E+06,5,5,5,5,1.66E+05,9.92E+05,4.06E+05,9.86E+06,3.56E+06,7.02E+04,1.18E+06,9.27E+05,7.47E+05,1.12E+06,1.08E+06,1.61E+06,8.70E+04,3.54E+05,6.83E+05,4.23E+05,1.02E+06,1.33E+06,2.34E+05,2.27E+06,6.58E+02,3.77E+03,3.97E+03,9.86E+06,1.83E+05,2.50E+02,2.10E+04,8.56E+03,2.10E+04,1.19E+04,6.48E+03,7.20E+04,7.07E+02,4.77E+04,1.70E+04,8.26E+02,2.86E+05,9.41E+03,5.47E+03,2.42E+04,0,FALSE,16.322,10,5,523,59.1,8.59,5,,nucleus;other cell component,"Pf00226, Pf02037, Pf14901",,,,,,0,0,135.74,55.22,78.93,76.85,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,127.62,123.31,141.82,140.51,21.22,,0,
Master Protein,High,A0A7I2YQG2,RPL19,Ribosomal protein L19 OS=Homo sapiens OX=9606 GN=RPL19 PE=1 SV=1,2,6,1.712,0.308,1.028,0.846,0.78,-1.7,0.04,-0.24,5.70E-01,2.78E-01,8.75E-01,9.99E-01,9.73E+05,1.55E+05,2.99E+05,4.01E+05,4,3,5,5,7.20E+04,,7.21E+05,1.31E+06,3.76E+06,1.55E+05,,1.16E+05,,4.53E+06,7.93E+04,1.64E+05,6.35E+05,4.13E+05,2.99E+05,2.30E+05,1.54E+05,5.67E+05,4.01E+05,1.13E+06,2.86E+02,,7.04E+03,1.31E+06,1.94E+05,5.52E+02,,1.07E+03,,4.82E+04,4.74E+02,7.33E+03,5.15E+03,5.56E+04,7.43E+03,4.49E+02,4.32E+04,4.02E+03,9.39E+03,1.21E+04,0,FALSE,9.598,13,2,216,25.7,11.27,2,protein metabolism;other metabolic processes,cytosol;translational apparatus;nucleus,Pf01280,,A0A7I2YQG2,ENSG00000108298,,,0,0,109.82,158.55,68.6,78.41,Peak Found,n/a,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,200.26,132.72,139.85,108.2,15.15,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q92820,GGH,Gamma-glutamyl hydrolase OS=Homo sapiens OX=9606 GN=GGH PE=1 SV=2,3,16,1.71,0.937,0.33,3.46,0.77,-0.09,-1.6,1.79,5.38E-01,5.94E-01,1.85E-01,1.96E-01,9.83E+05,5.01E+05,6.31E+05,9.05E+04,3,3,5,3,,9.83E+05,,5.24E+05,2.58E+06,2.74E+05,,5.01E+05,,7.87E+05,1.20E+05,3.02E+05,6.31E+05,2.45E+06,1.58E+06,3.08E+05,9.05E+04,,4.14E+04,,,3.73E+03,,5.24E+05,1.33E+05,9.75E+02,,4.62E+03,,8.37E+03,7.18E+02,1.35E+04,5.13E+03,3.30E+05,3.92E+04,6.01E+02,2.54E+04,,9.69E+02,,0,FALSE,12.52,13,3,318,35.9,7.11,3,other metabolic processes,non-structural extracellular;other cytoplasmic organelle;other cell component,"Pf00117, Pf07722",8836,hsa:8836; Q92820,ENSG00000137563,Neutrophil degranulation,Fluoropyrimidine activity,2,0,79.17,49.35,96.34,96.8,Peak Found,High,n/a,High,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,110.92,129.48,104.73,102.26,52.48,other molecular function,0,
Master Protein,High,M0R0C6,KHSRP,KH-type splicing regulatory protein OS=Homo sapiens OX=9606 GN=KHSRP PE=1 SV=2,12,43,1.703,0.223,1.754,0.287,0.77,-2.16,0.81,-1.8,6.21E-01,9.49E-02,5.22E-01,3.04E-01,5.69E+06,5.50E+05,9.50E+05,2.47E+06,5,5,5,5,5.69E+06,3.71E+06,1.97E+05,8.42E+06,1.30E+07,5.09E+06,5.29E+05,2.89E+05,5.50E+05,1.38E+06,9.50E+05,5.67E+05,9.68E+05,6.89E+06,9.11E+05,1.05E+06,2.26E+05,6.57E+06,2.47E+06,2.20E+07,2.26E+04,1.41E+04,1.92E+03,8.42E+06,6.71E+05,1.81E+04,9.41E+03,2.67E+03,1.55E+04,1.47E+04,5.68E+03,2.53E+04,7.86E+03,9.28E+05,2.26E+04,2.05E+03,6.34E+04,4.66E+04,5.78E+04,2.34E+05,0,FALSE,51.309,21,12,747,76.6,7.33,12,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00013, Pf09005",,M0R0C6,ENSG00000088247,,Pre-implantation embryo,1,0,78.04,128.27,131.52,139.58,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,High,1,,FALSE,116.87,106.1,131.07,123.1,113.29,nucleic acid binding activity,0,
Master Protein,High,P61106,RAB14,Ras-related protein Rab-14 OS=Homo sapiens OX=9606 GN=RAB14 PE=1 SV=4,10,81,1.703,1.142,2.341,0.8,0.77,0.19,1.23,-0.32,6.22E-01,4.59E-01,3.40E-01,9.04E-01,8.37E+06,3.50E+06,5.71E+06,1.21E+07,5,5,5,5,1.11E+07,1.55E+07,5.06E+06,6.55E+06,8.37E+06,4.56E+06,1.03E+06,1.30E+07,2.64E+06,3.50E+06,2.29E+06,3.96E+06,5.71E+06,1.54E+07,9.45E+06,2.66E+07,1.86E+07,1.21E+07,1.04E+07,1.13E+07,4.42E+04,5.89E+04,4.95E+04,6.55E+06,4.32E+05,1.62E+04,1.83E+04,1.20E+05,7.44E+04,3.73E+04,1.37E+04,1.77E+05,4.64E+04,2.08E+06,2.35E+05,5.18E+04,5.21E+06,8.61E+04,2.44E+05,1.20E+05,0,FALSE,57.514,54,8,215,23.9,6.21,10,cell organization and biogenesis;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,51552,B3KR31; hsa:51552; P35287; P61106; Q5JVD4; Q6Q7K5; Q969L0; Q9UI11,ENSG00000119396,Neutrophil degranulation; RAB geranylgeranylation; RAB GEFs exchange GTP for GDP on RABs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Synthesis of PIPs at the plasma membrane,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Ciliary landscape,7,1,44.31,94.52,71.06,43.08,High,High,Peak Found,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,98.03,98.31,103.84,99.84,212.41,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A994J7C7,SIN3A,SIN3 transcription regulator family member A OS=Homo sapiens OX=9606 GN=SIN3A PE=4 SV=1,13,21,1.702,0.523,2.638,0.351,0.77,-0.94,1.4,-1.51,5.57E-01,7.32E-01,4.11E-01,4.32E-01,2.61E+06,1.56E+05,6.05E+05,2.39E+05,3,2,5,2,,3.72E+06,8.98E+04,2.61E+06,,,1.61E+05,,,1.50E+05,1.48E+06,1.56E+05,9.99E+04,2.32E+06,6.05E+05,,,,1.38E+05,4.11E+05,,1.41E+04,8.77E+02,2.61E+06,,,2.87E+03,,,1.60E+03,8.86E+03,6.96E+03,8.12E+02,3.12E+05,1.50E+04,,,,3.24E+03,4.37E+03,0,FALSE,53.217,17,13,1278,145.7,7.25,13,other biological processes,nucleus,,,A0A994J7C7,ENSG00000169375,,MECP2 and associated Rett syndrome; Transcription co-factors SKI and SKIL protein partners; 15q11q13 copy number variation,3,0,86.94,5.06,102.13,70.12,n/a,Peak Found,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,9.06,86.17,5.31,115.62,68.04,other molecular function,0,
Master Protein,High,Q96I99,SUCLG2,"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=SUCLG2 PE=1 SV=2",12,27,1.699,0.369,0.187,1.339,0.76,-1.44,-2.42,0.42,5.75E-01,3.76E-01,5.24E-02,6.48E-01,5.16E+05,6.84E+05,2.13E+06,9.09E+05,5,5,4,5,4.32E+04,3.03E+06,1.14E+05,4.20E+06,5.16E+05,4.97E+04,9.11E+05,6.84E+05,3.22E+05,2.27E+06,,2.49E+04,2.07E+06,2.19E+06,4.51E+06,3.77E+06,1.49E+05,9.09E+05,1.55E+06,2.91E+04,1.72E+02,1.15E+04,1.12E+03,4.20E+06,2.66E+04,1.77E+02,1.62E+04,6.31E+03,9.06E+03,2.41E+04,,1.11E+03,1.68E+04,2.95E+05,1.12E+05,7.35E+03,4.20E+04,6.44E+03,3.63E+04,3.09E+02,0,FALSE,43.734,40,12,432,46.5,6.39,12,other metabolic processes,plasma membrane;other membranes;mitochondrion;other cell component,"Pf00549, Pf08442",8801,C9JVT2; hsa:8801; O95195; Q6NUH7; Q86VX8; Q8WUQ1; Q96I99,ENSG00000172340,Mitochondrial protein degradation; Citric acid cycle (TCA cycle),TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Metabolic reprogramming in colon cancer; TCA cycle (aka Krebs or citric acid cycle),5,0,120.87,101.57,83.44,118.67,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,104,104.16,130.27,122.27,79.39,other molecular function,0,
Master Protein,High,A0A7I2V535,NONO,Non-POU domain containing octamer binding OS=Homo sapiens OX=9606 GN=NONO PE=1 SV=1,17,103,1.697,0.475,1.195,0.859,0.76,-1.07,0.26,-0.22,6.24E-01,5.79E-01,9.24E-01,9.53E-01,5.62E+06,1.14E+07,6.72E+06,9.75E+06,5,5,5,5,3.28E+06,5.62E+06,1.36E+06,2.00E+07,4.71E+07,9.96E+06,1.19E+07,1.14E+07,5.30E+06,1.98E+07,2.92E+07,6.72E+06,4.71E+06,1.58E+07,3.62E+06,1.27E+07,6.47E+05,1.66E+07,6.81E+06,9.75E+06,1.30E+04,2.13E+04,1.33E+04,2.00E+07,2.43E+06,3.54E+04,2.11E+05,1.06E+05,1.49E+05,2.11E+05,1.74E+05,3.00E+05,3.83E+04,2.13E+06,9.01E+04,2.48E+04,1.82E+05,1.17E+05,1.59E+05,1.04E+05,0,FALSE,92.577,32,16,501,57.6,9.33,17,other biological processes,nucleus,"Pf00076, Pf08075",,A0A7I2V535,ENSG00000147140,,,0,0,123.71,44.94,89.38,64.91,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,129.37,128.65,137.65,122.95,253.92,nucleic acid binding activity,0,
Master Protein,High,Q99442,SEC62,Translocation protein SEC62 OS=Homo sapiens OX=9606 GN=SEC62 PE=1 SV=1,4,7,1.697,0.403,2.548,0.397,0.76,-1.31,1.35,-1.33,5.40E-01,4.54E-01,3.25E-01,5.51E-01,5.59E+05,3.32E+05,3.13E+05,1.43E+06,5,2,5,5,5.59E+05,4.67E+05,7.92E+04,1.53E+06,1.46E+06,,2.25E+05,,,4.89E+05,1.80E+05,3.13E+05,3.86E+05,4.63E+05,1.94E+05,1.98E+06,6.78E+04,1.44E+07,4.39E+05,1.43E+06,2.22E+03,1.77E+03,7.74E+02,1.53E+06,7.51E+04,,4.00E+03,,,5.20E+03,1.08E+03,1.40E+04,3.13E+03,6.24E+04,4.82E+03,3.85E+03,1.90E+04,1.02E+05,1.03E+04,1.52E+04,0,FALSE,13.477,13,4,399,45.8,7.12,4,transport;other biological processes,other membranes;ER/Golgi,Pf03839,7095,D3DNQ0; hsa:7095; O00682; O00729; Q99442,ENSG00000008952,,,0,0,78.49,52.19,39.73,165.21,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,48.84,47.43,58.87,143.99,17.91,other molecular function,0,
Master Protein,High,P10515,DLAT,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial OS=Homo sapiens OX=9606 GN=DLAT PE=1 SV=3",10,47,1.697,0.958,1.605,2.184,0.76,-0.06,0.68,1.13,6.24E-01,6.30E-01,6.10E-01,4.42E-01,3.59E+06,1.22E+06,5.02E+06,1.87E+06,5,5,5,4,5.53E+05,4.79E+06,1.38E+05,9.58E+06,3.59E+06,2.45E+05,1.22E+06,1.57E+06,3.43E+05,2.34E+06,3.63E+06,5.02E+06,3.82E+06,8.85E+06,7.69E+06,2.00E+06,2.13E+06,4.85E+05,1.76E+06,,2.20E+03,1.82E+04,1.34E+03,9.58E+06,1.85E+05,8.72E+02,2.17E+04,1.44E+04,9.65E+03,2.49E+04,2.17E+04,2.24E+05,3.10E+04,1.19E+06,1.91E+05,3.89E+03,5.99E+05,3.44E+03,4.12E+04,,0,FALSE,49.255,20,10,647,69,7.84,10,other metabolic processes,mitochondrion;other cell component,"Pf00198, Pf00364, Pf02817",1737,hsa:1737; P10515; Q16783; Q53EP3,ENSG00000150768,Glyoxylate metabolism and glycine degradation; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Neuroinflammation and glutamatergic signaling; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,8,0,102.41,76.64,40.5,47.35,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,107.13,104.01,91.33,109.19,123.24,other molecular function,0,
Master Protein,High,A0A8V8TP51,PTPRJ,protein-tyrosine-phosphatase OS=Homo sapiens OX=9606 GN=PTPRJ PE=1 SV=1,3,20,1.693,1.639,15.606,0.135,0.76,0.71,3.96,-2.89,5.60E-01,2.75E-01,2.58E-03,1.15E-01,2.83E+05,4.28E+04,2.33E+05,1.82E+06,4,5,4,4,5.42E+05,,1.48E+05,1.14E+05,6.97E+05,2.22E+05,2.51E+04,4.28E+04,1.57E+05,2.87E+04,,3.47E+04,4.02E+05,1.95E+05,2.79E+05,3.99E+06,2.57E+05,,1.38E+06,2.40E+06,2.15E+03,,1.44E+03,1.14E+05,3.59E+04,7.88E+02,4.46E+02,3.95E+02,4.43E+03,3.06E+02,,1.55E+03,3.26E+03,2.63E+04,6.93E+03,7.79E+03,7.22E+04,,3.23E+04,2.55E+04,0,FALSE,15.005,4,3,1451,157.7,6.84,3,protein metabolism;other metabolic processes,other membranes,"Pf00041, Pf00102, Pf18861",,A0A8V8TP51,ENSG00000149177,,,0,0,77.08,93.94,67.66,79.06,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,1,,FALSE,117.72,131.52,100.82,122.74,61.71,other molecular function,0,
Master Protein,High,A0A8J9BZL8,GOLGA2,Golgin A2 OS=Homo sapiens OX=9606 GN=GOLGA2 PE=1 SV=1,7,21,1.692,0.356,0.279,0.94,0.76,-1.49,-1.84,-0.09,6.02E-01,3.38E-01,1.70E-01,8.77E-01,2.89E+06,1.59E+06,6.62E+05,4.02E+05,4,5,5,3,,7.97E+06,4.34E+06,1.92E+06,1.78E+06,7.79E+04,1.59E+06,3.69E+06,6.41E+05,3.89E+06,1.31E+05,5.71E+05,1.47E+06,2.42E+06,6.62E+05,8.98E+05,1.18E+05,,,4.02E+05,,3.03E+04,4.24E+04,1.92E+06,9.20E+04,2.77E+02,2.84E+04,3.40E+04,1.81E+04,4.14E+04,7.81E+02,2.55E+04,1.19E+04,3.26E+05,1.65E+04,1.75E+03,3.30E+04,,,4.28E+03,0,FALSE,32.084,10,7,1029,116,5.05,7,,ER/Golgi,"Pf15070, Pf19046",,A0A8J9BZL8,ENSG00000167110,,,0,0,72.2,88.01,86.1,83.6,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,100.66,98.17,126.4,108.54,62.98,,0,
Master Protein,High,P04181,OAT,"Ornithine aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=OAT PE=1 SV=1",5,36,1.692,0.959,6.194,0.084,0.76,-0.06,2.63,-3.57,5.56E-01,6.70E-01,3.12E-02,2.88E-02,2.37E+05,5.76E+04,2.59E+05,2.37E+06,4,2,4,5,,4.06E+05,1.13E+05,1.39E+05,1.19E+06,,,,2.56E+04,1.29E+05,,5.23E+04,7.87E+05,3.42E+05,1.96E+05,5.75E+05,1.31E+07,2.37E+06,1.62E+06,6.98E+06,,1.54E+03,1.10E+03,1.39E+05,6.16E+04,,,,7.22E+02,1.38E+03,,2.34E+03,6.40E+03,4.61E+04,4.87E+03,1.12E+03,3.67E+06,1.68E+04,3.79E+04,7.43E+04,0,FALSE,19.548,14,5,439,48.5,7.03,5,other metabolic processes;other biological processes,mitochondrion;nucleus;other cell component,Pf00202,4942,D3DRF0; hsa:4942; P04181; Q16068; Q16069; Q68CS0; Q6IAV9; Q9UD03,ENSG00000065154,Glutamate and glutamine metabolism,Amino acid metabolism; 22q11.2 copy number variation syndrome; Creatine pathway,4,0,109.09,94.65,92.36,105.05,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,188.33,129.55,120.05,137.66,95.98,other molecular function,0,
Master Protein,High,P04843,RPN1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Homo sapiens OX=9606 GN=RPN1 PE=1 SV=1,21,191,1.69,1.038,1.154,1.63,0.76,0.05,0.21,0.7,6.28E-01,5.49E-01,9.59E-01,6.10E-01,2.17E+07,1.08E+07,2.48E+07,1.58E+07,5,5,5,5,2.02E+07,4.16E+07,8.17E+06,2.17E+07,2.53E+07,7.57E+06,9.95E+06,1.24E+07,1.08E+07,1.56E+07,6.95E+07,1.93E+07,2.34E+07,2.48E+07,2.51E+07,1.58E+07,1.15E+07,4.10E+07,1.24E+07,2.92E+07,8.02E+04,1.58E+05,7.98E+04,2.17E+07,1.31E+06,2.69E+04,1.77E+05,1.15E+05,3.05E+05,1.66E+05,4.16E+05,8.61E+05,1.90E+05,3.34E+06,6.23E+05,3.08E+04,3.22E+06,2.91E+05,2.91E+05,3.11E+05,0,FALSE,101.979,48,21,607,68.5,6.38,21,protein metabolism;other metabolic processes,other membranes;cytosol;ER/Golgi;other cell component,Pf04597,6184,B2R5Z0; D3DNB6; hsa:6184; P04843; Q68DT1,ENSG00000163902,SRP-dependent cotranslational protein targeting to membrane; Asparagine N-linked glycosylation; Maturation of spike protein,Proteasome degradation; N-glycan biosynthesis,5,0,51.56,26.43,64.41,58.26,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,142.21,117.03,122.12,126.65,562.75,,0,
Master Protein,High,Q9UGP8,SEC63,Translocation protein SEC63 homolog OS=Homo sapiens OX=9606 GN=SEC63 PE=1 SV=2,3,5,1.684,0.64,0.338,2.483,0.75,-0.64,-1.56,1.31,5.81E-01,9.54E-01,2.60E-01,2.76E-01,7.70E+05,3.19E+05,4.52E+05,8.27E+04,1,1,4,2,,,,7.70E+05,,,,,,3.19E+05,,3.14E+05,2.17E+05,7.00E+05,6.52E+05,,1.08E+05,,6.34E+04,,,,,7.70E+05,,,,,,3.39E+03,,1.40E+04,1.76E+03,9.43E+04,1.62E+04,,3.03E+04,,1.48E+03,,0,FALSE,8.166,6,3,760,87.9,5.31,3,other metabolic processes;transport;developmental processes;other biological processes,other membranes;ER/Golgi,"Pf00226, Pf02889",11231,hsa:11231; O95380; Q5THN4; Q86VS9; Q8IWL0; Q9NTE0; Q9UGP8,ENSG00000025796,,,0,0,,,51.18,36.71,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,46.24,0,60.23,13.77,transporter activity;other molecular function,0,
Master Protein,High,Q13263,TRIM28,Transcription intermediary factor 1-beta OS=Homo sapiens OX=9606 GN=TRIM28 PE=1 SV=5,22,122,1.683,0.791,1.485,3.845,0.75,-0.34,0.57,1.94,6.31E-01,8.43E-01,7.09E-01,2.04E-01,7.05E+06,2.78E+06,1.30E+07,2.84E+06,5,5,5,5,9.71E+06,7.05E+06,4.22E+06,6.68E+07,6.20E+06,4.36E+06,7.73E+05,2.78E+06,2.13E+06,7.76E+06,1.01E+07,1.30E+07,9.67E+06,5.14E+07,1.40E+07,3.86E+06,6.00E+05,4.98E+06,2.84E+06,2.29E+06,3.86E+04,2.68E+04,4.13E+04,6.68E+07,3.20E+05,1.55E+04,1.37E+04,2.57E+04,5.99E+04,8.25E+04,6.05E+04,5.80E+05,7.86E+04,6.93E+06,3.49E+05,7.53E+03,1.68E+05,3.53E+04,6.66E+04,2.43E+04,0,FALSE,155.52,45,22,835,88.5,5.77,22,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf00628, Pf00643, Pf14634",10155,hsa:10155; O00677; Q13263; Q7Z632; Q93040; Q96IM1,ENSG00000130726,Generic Transcription Pathway; HCMV Early Events; SUMOylation of transcription cofactors,Corticotropin-releasing hormone signaling pathway; Mesodermal commitment pathway; ATM signaling in development and disease,6,0,143.19,75.26,90.9,56.72,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,119.6,125.44,137.48,125.33,361.03,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,A6NHB5,ZMYM3,Zinc finger MYM-type containing 3 OS=Homo sapiens OX=9606 GN=ZMYM3 PE=1 SV=1,6,7,1.683,0.707,0.255,1.018,0.75,-0.5,-1.97,0.03,5.18E-01,9.51E-01,1.10E-01,8.34E-01,2.21E+05,2.41E+05,2.20E+05,2.99E+05,4,3,5,4,9.05E+04,,4.96E+04,5.39E+05,1.09E+06,1.02E+06,,5.31E+04,,2.41E+05,3.86E+05,9.78E+04,1.37E+05,4.66E+05,2.20E+05,,7.77E+04,1.15E+06,1.36E+04,3.23E+06,3.59E+02,,4.85E+02,5.39E+05,5.61E+04,3.63E+03,,4.90E+02,,2.56E+03,2.31E+03,4.37E+03,1.12E+03,6.29E+04,5.47E+03,,2.18E+04,8.15E+03,3.18E+02,3.44E+04,0,FALSE,22.683,6,6,1372,152.5,6.35,6,,nucleus,"Pf06467, Pf12012",,A6NHB5,ENSG00000147130,,,0,0,109.68,117.12,60.86,134.34,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,47.88,85.8,139.85,145.43,20.47,other molecular function,0,
Master Protein,High,Q01469,FABP5,Fatty acid-binding protein 5 OS=Homo sapiens OX=9606 GN=FABP5 PE=1 SV=3,2,4,1.682,5.533,1.63,1.909,0.75,2.47,0.7,0.93,5.86E-01,7.44E-03,7.20E-01,4.28E-01,1.27E+05,7.88E+04,4.66E+05,2.90E+05,3,4,4,4,,,4.80E+04,1.27E+05,6.65E+05,2.63E+05,2.59E+04,5.57E+04,1.12E+05,,7.23E+05,3.33E+05,6.52E+05,2.08E+05,,,1.61E+05,1.17E+06,2.97E+04,5.21E+05,,,4.69E+02,1.27E+05,3.43E+04,9.36E+02,4.61E+02,5.14E+02,3.14E+03,,4.32E+03,1.49E+04,5.30E+03,2.80E+04,,,4.54E+04,8.32E+03,6.96E+02,5.55E+03,0,FALSE,7.39,19,2,135,15.2,7.01,2,other metabolic processes;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf00061,2171,B2R4K0; hsa:2171; Q01469,ENSG00000164687,Neutrophil degranulation; Triglyceride catabolism; Signaling by Retinoic Acid,PPAR signaling pathway; Fatty acid transporters,5,0,119.99,92.51,51.71,108.63,n/a,n/a,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,117.05,110.68,99.71,102.78,10.94,transporter activity;other molecular function,0,
Master Protein,High,P53007,SLC25A1,"Tricarboxylate transport protein, mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A1 PE=1 SV=2",2,4,1.678,0.05,2.367,0.03,0.75,-4.31,1.24,-5.05,5.61E-01,4.03E-04,4.40E-01,2.15E-03,9.46E+05,6.05E+05,9.43E+04,5.90E+05,5,4,3,2,9.21E+05,1.08E+06,6.63E+05,1.26E+06,9.46E+05,,8.28E+05,1.54E+06,1.40E+05,4.43E+05,,,9.43E+04,2.31E+05,2.24E+04,3.74E+05,,9.30E+05,,,3.66E+03,4.09E+03,6.48E+03,1.26E+06,4.88E+04,,1.47E+04,1.42E+04,3.95E+03,4.71E+03,,,7.66E+02,3.12E+04,5.57E+02,7.29E+02,,6.59E+03,,,0,FALSE,10.745,7,2,311,34,9.89,2,other metabolic processes;transport,other membranes;mitochondrion,Pf00153,6576,A8K8E8; hsa:6576; P53007; Q9BSK6,ENSG00000100075,Gluconeogenesis; Fatty acyl-CoA biosynthesis,22q11.2 copy number variation syndrome,3,0,22.42,82.06,91.46,60.33,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,128.22,140.08,64.88,55.5,12.56,transporter activity,0,
Master Protein,High,K4DIA4,IRF2,Interferon regulatory factor 2 OS=Homo sapiens OX=9606 GN=IRF2 PE=1 SV=2,3,7,1.673,0.182,0.047,4.878,0.74,-2.46,-4.42,2.29,5.84E-01,1.16E-01,5.07E-03,1.30E-01,1.72E+05,4.78E+04,8.35E+04,1.37E+04,4,2,3,1,1.52E+05,,3.91E+04,3.81E+05,1.95E+05,,3.82E+04,5.99E+04,,,,8.35E+04,,2.41E+05,3.00E+04,,1.37E+04,,,,6.03E+02,,3.82E+02,3.81E+05,1.00E+04,,6.80E+02,5.52E+02,,,,3.73E+03,,3.25E+04,7.46E+02,,3.85E+03,,,,0,FALSE,13.838,8,3,384,43.3,6.65,3,other biological processes,cytosol;nucleus,Pf00605,,K4DIA4,ENSG00000168310,,Rubinstein-Taybi syndrome 1,1,0,74.2,31.21,92.79,,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,82.66,122.27,33.54,76.96,22.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A140T9L8,MPIG6B,C6orf25 OS=Homo sapiens OX=9606 GN=MPIG6B PE=1 SV=1,3,12,1.673,0.343,1.787,0.264,0.74,-1.54,0.84,-1.92,5.85E-01,4.09E-01,6.62E-01,2.96E-01,1.68E+05,1.01E+05,7.55E+04,7.40E+05,4,2,3,5,2.60E+05,5.11E+05,1.09E+05,2.67E+04,,6.10E+04,,,1.66E+05,,,2.12E+04,,1.05E+05,7.55E+04,7.79E+05,7.40E+05,6.64E+05,1.03E+05,9.79E+05,1.03E+03,1.94E+03,1.06E+03,2.67E+04,,2.17E+02,,,4.68E+03,,,9.47E+02,,1.42E+04,1.88E+03,1.52E+03,2.08E+05,4.71E+03,2.40E+03,1.04E+04,0,FALSE,13.562,22,3,237,24.9,9.91,3,,other membranes,Pf15096,,A0A140T9L8,ENSG00000228090,,,0,0,93.89,65.47,63.37,50.37,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,117.04,105.79,94.44,95.18,29.88,,0,
Master Protein,High,Q9NTI5,PDS5B,Sister chromatid cohesion protein PDS5 homolog B OS=Homo sapiens OX=9606 GN=PDS5B PE=1 SV=1,28,86,1.672,0.722,1.393,2.563,0.74,-0.47,0.48,1.36,6.36E-01,9.49E-01,7.05E-01,3.62E-01,5.28E+06,1.18E+06,6.30E+06,8.84E+05,5,5,5,5,5.28E+06,6.64E+05,5.11E+04,1.41E+07,9.00E+06,1.38E+06,3.52E+05,1.18E+06,5.34E+04,4.56E+06,1.48E+07,3.03E+06,2.97E+06,1.36E+07,6.30E+06,8.84E+05,2.24E+05,5.08E+06,4.20E+05,5.63E+06,2.10E+04,2.52E+03,4.99E+02,1.41E+07,4.64E+05,4.89E+03,6.25E+03,1.08E+04,1.51E+03,4.85E+04,8.86E+04,1.36E+05,2.41E+04,1.83E+06,1.56E+05,1.72E+03,6.30E+04,3.60E+04,9.84E+03,5.99E+04,0,FALSE,135.068,25,19,1447,164.6,8.47,28,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,Pf20168,23047,hsa:23047; Q5R3S3; Q5W0K8; Q6NSC3; Q8IXT6; Q9H5N8; Q9NTI5; Q9Y2I5; Q9Y451,ENSG00000083642,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,Cohesin complex - Cornelia de Lange syndrome; 10q22q23 copy number variation,6,4,101.22,119.46,70.11,109.13,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,1,,FALSE,122.69,125.68,93.25,130.65,224.12,nucleic acid binding activity,0,
Master Protein,High,O75390,CS,"Citrate synthase, mitochondrial OS=Homo sapiens OX=9606 GN=CS PE=1 SV=2",12,63,1.671,1.598,1.704,2.066,0.74,0.68,0.77,1.05,6.37E-01,2.16E-01,5.83E-01,4.71E-01,1.62E+07,2.75E+06,4.68E+07,1.71E+07,5,5,5,5,1.62E+07,4.66E+06,7.11E+05,1.94E+07,4.99E+07,1.12E+07,2.10E+04,1.26E+07,7.93E+05,2.75E+06,5.81E+06,2.85E+07,6.71E+07,4.68E+07,5.34E+07,1.71E+07,2.88E+07,5.42E+06,1.12E+08,1.20E+06,6.42E+04,1.77E+04,6.95E+03,1.94E+07,2.58E+06,4.00E+04,3.73E+02,1.17E+05,2.23E+04,2.92E+04,3.47E+04,1.27E+06,5.45E+05,6.31E+06,1.33E+06,3.33E+04,8.09E+06,3.84E+04,2.61E+06,1.28E+04,0,FALSE,45.404,34,12,466,51.7,8.32,12,other metabolic processes,mitochondrion,Pf00285,1431,hsa:1431; O75390; Q71UT9; Q7KZH0; Q96FZ8; Q9BWN8,ENSG00000062485,Citric acid cycle (TCA cycle); Mitochondrial protein import; Mitochondrial protein degradation,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Fluoroacetic acid toxicity; TCA cycle (aka Krebs or citric acid cycle),7,0,106.64,109.22,58.96,138.22,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,140.27,118.69,132.57,127.22,147.79,other molecular function,0,
Master Protein,High,P49821,NDUFV1,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFV1 PE=1 SV=4",8,18,1.671,0.944,1.435,1.444,0.74,-0.08,0.52,0.53,5.82E-01,5.92E-01,7.06E-01,6.27E-01,3.81E+05,1.69E+06,1.17E+06,1.22E+06,4,5,5,4,,2.94E+05,1.17E+05,6.02E+06,4.96E+05,3.42E+06,1.32E+07,1.10E+06,1.69E+06,5.13E+05,5.06E+05,1.17E+06,7.90E+05,3.53E+06,2.75E+06,1.71E+07,6.54E+05,1.97E+06,7.51E+05,,,1.12E+03,1.15E+03,6.02E+06,2.56E+04,1.21E+04,2.34E+05,1.01E+04,4.76E+04,5.46E+03,3.02E+03,5.22E+04,6.42E+03,4.76E+05,6.83E+04,3.34E+04,1.84E+05,1.40E+04,1.76E+04,,0,FALSE,30.14,19,8,464,50.8,8.21,8,other metabolic processes;transport,other membranes;cytosol;mitochondrion,"Pf01512, Pf10589",4723,hsa:4723; O60924; O60940; P49821; Q16104; Q6IBR3; Q96BF8; Q96HS7,ENSG00000167792,Complex I biogenesis; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; HDAC6 interactions in the central nervous system; Oxidative phosphorylation,7,0,165.35,132.04,75.53,156.56,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,140.74,97.5,137.33,124.9,53.83,transporter activity;other molecular function,0,
Master Protein,High,P11717,IGF2R,Cation-independent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=IGF2R PE=1 SV=3,7,10,1.669,0.701,2.182,1.014,0.74,-0.51,1.13,0.02,5.71E-01,9.58E-01,5.49E-01,8.48E-01,2.00E+05,8.35E+04,1.77E+05,1.45E+05,4,4,4,3,2.81E+05,,1.42E+05,4.87E+05,1.40E+05,6.53E+04,8.01E+05,,9.77E+04,7.13E+04,,9.83E+03,1.11E+05,5.65E+05,2.82E+05,,,7.55E+04,1.45E+05,2.39E+05,1.12E+03,,1.39E+03,4.87E+05,7.21E+03,2.32E+02,1.42E+04,,2.75E+03,7.59E+02,,4.39E+02,9.02E+02,7.62E+04,7.02E+03,,,5.35E+02,3.39E+03,2.54E+03,0,FALSE,24.768,5,7,2491,274.2,5.94,7,transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00040, Pf00878",3482,hsa:3482; P11717; Q7Z7G9; Q96PT5,ENSG00000197081,Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Cargo recognition for clathrin-mediated endocytosis; Retrograde transport at the Trans-Golgi-Network,TROP2 regulatory signaling,6,0,62.31,139.74,100.38,53.53,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,74.65,94.24,56.58,123.35,30.61,kinase activity;other molecular function,0,
Master Protein,High,Q16666,IFI16,Gamma-interferon-inducible protein 16 OS=Homo sapiens OX=9606 GN=IFI16 PE=1 SV=3,29,231,1.668,1.143,1.571,2.884,0.74,0.19,0.65,1.53,6.39E-01,4.58E-01,6.56E-01,3.10E-01,3.60E+07,5.58E+06,5.31E+07,9.66E+06,5,5,5,5,3.60E+07,2.54E+07,2.35E+07,3.67E+07,5.69E+07,1.54E+07,5.58E+06,5.19E+06,1.32E+06,1.81E+07,1.27E+08,3.01E+07,3.37E+07,9.34E+07,5.31E+07,1.46E+07,1.24E+06,7.46E+06,1.30E+07,9.66E+06,1.43E+05,9.66E+04,2.30E+05,3.67E+07,2.93E+06,5.46E+04,9.92E+04,4.79E+04,3.72E+04,1.93E+05,7.58E+05,1.34E+06,2.74E+05,1.26E+07,1.32E+06,2.84E+04,3.49E+05,5.28E+04,3.03E+05,1.03E+05,0,FALSE,159.607,40,25,785,88.2,9.28,29,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf02758, Pf02760",3428,A0A346JEQ3; B4DJT8; H3BLV7; hsa:3428; Q16666; Q59GX0; Q5T3W7; Q5T3W8; Q5T3X0; Q5T3X1; Q5T3X2; Q8N9E5; Q8NEQ7; Q96AJ5; Q9UH78,ENSG00000163565,IRF3-mediated induction of type I IFN,,2,4,37.15,79.22,61.74,57,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,109.71,119.98,118.62,129.32,668.94,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8WUM0,NUP133,Nuclear pore complex protein Nup133 OS=Homo sapiens OX=9606 GN=NUP133 PE=1 SV=2,5,8,1.667,0.484,1.325,0.388,0.74,-1.05,0.41,-1.36,5.75E-01,6.51E-01,7.58E-01,5.57E-01,1.80E+06,1.08E+06,7.23E+04,1.44E+06,4,1,3,3,3.28E+06,,2.43E+06,1.03E+06,1.33E+06,,,,1.08E+06,,4.32E+04,,,7.23E+04,1.15E+05,,1.87E+05,1.44E+06,1.47E+06,,1.30E+04,,2.38E+04,1.03E+06,6.88E+04,,,,3.03E+04,,2.59E+02,,,9.74E+03,2.87E+03,,5.25E+04,1.02E+04,3.44E+04,,0,FALSE,22.437,6,5,1156,128.9,5.1,5,cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes,other membranes;cytosol;nucleus;other cell component,Pf03177,55746,B2RAZ8; hsa:55746; Q5T8N0; Q8WUM0; Q9H9W2; Q9NV71; Q9NVC4,ENSG00000069248,Regulation of HSF1-mediated heat shock response; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,Ciliary landscape,36,0,51.11,,47.2,70.93,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,77.09,135.37,1.5,108.82,27.71,other molecular function,0,
Master Protein,High,P02042,HBD,Hemoglobin subunit delta OS=Homo sapiens OX=9606 GN=HBD PE=1 SV=2,13,1066,1.665,1.05,4.844,0.108,0.74,0.07,2.28,-3.21,6.02E-01,4.85E-01,5.99E-02,5.79E-02,1.74E+06,4.03E+05,2.26E+06,4.73E+06,5,5,5,5,1.74E+06,1.94E+06,2.85E+06,5.44E+05,1.53E+06,1.92E+06,2.23E+05,4.03E+05,1.96E+05,1.75E+06,1.79E+05,3.27E+06,3.72E+06,2.26E+06,2.44E+05,1.87E+06,7.17E+07,4.73E+06,1.41E+07,2.63E+06,6.92E+03,7.37E+03,2.78E+04,5.44E+05,7.89E+04,6.81E+03,3.96E+03,3.72E+03,5.53E+03,1.86E+04,1.07E+03,1.46E+05,3.02E+04,3.05E+05,6.06E+03,3.66E+03,2.01E+07,3.35E+04,3.30E+05,2.80E+04,0,FALSE,131.71,77,7,147,16,8.05,13,other metabolic processes;transport;other biological processes,cytosol;other cell component,Pf00042,3045,hsa:3045; P02042; Q3Y5H3; Q8WXT7,ENSG00000223609,Factors involved in megakaryocyte development and platelet production,VEGFA-VEGFR2 signaling,2,0,48.07,95.74,85.77,157.08,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,High,High,Peak Found,1,,FALSE,119.96,128.55,117.4,127.09,3363.57,other molecular function,0,
Master Protein,High,P68104,EEF1A1,Elongation factor 1-alpha 1 OS=Homo sapiens OX=9606 GN=EEF1A1 PE=1 SV=1,17,295,1.662,0.675,1.837,0.556,0.73,-0.57,0.88,-0.85,6.41E-01,9.71E-01,5.19E-01,6.57E-01,4.40E+07,1.29E+07,3.43E+07,6.90E+07,5,5,5,5,7.29E+07,3.02E+07,4.40E+07,3.84E+07,5.84E+07,1.29E+07,8.80E+06,1.36E+07,4.41E+06,1.15E+08,3.49E+07,3.10E+07,2.16E+07,4.05E+07,3.43E+07,1.58E+07,6.90E+07,8.12E+07,4.16E+07,1.44E+08,2.90E+05,1.15E+05,4.30E+05,3.84E+07,3.01E+06,4.59E+04,1.56E+05,1.26E+05,1.24E+05,1.23E+06,2.09E+05,1.38E+06,1.75E+05,5.46E+06,8.53E+05,3.09E+04,1.94E+07,5.75E+05,9.74E+05,1.54E+06,0,FALSE,111.787,48,17,462,50.1,9.01,17,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;translational apparatus;nucleus;other cytoplasmic organelle;other cell component,"Pf00009, Pf03143, Pf03144",1915,hsa:1915; P04719; P04720; P68104; Q6IQ15,ENSG00000156508,Neutrophil degranulation; Chaperone Mediated Autophagy; Protein methylation; HSF1 activation; Peptide chain elongation; SARS-CoV-1 modulates host translation machinery,Translation factors; Fragile X syndrome; 2q37 copy number variation syndrome,10,0,34.8,152.44,21.53,68.82,High,High,High,High,High,Peak Found,Peak Found,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,135.98,111.59,137.04,132.27,827.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P54098,POLG,DNA polymerase subunit gamma-1 OS=Homo sapiens OX=9606 GN=POLG PE=1 SV=1,1,2,1.658,0.895,0.01,100,0.73,-0.16,-6.64,6.64,6.14E-01,8.01E-01,1.00E-17,1.00E-17,8.85E+04,5.34E+04,7.92E+04,,1,2,4,,,,,8.85E+04,,,6.92E+04,4.12E+04,,,,7.43E+04,8.44E+04,1.07E+05,1.82E+04,,,,,,,,,8.85E+04,,,1.23E+03,3.80E+02,,,,3.32E+03,6.86E+02,1.44E+04,4.52E+02,,,,,,0,FALSE,4.963,2,1,1239,139.5,6.9,1,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response,mitochondrion;other cell component,Pf18136,5428,hsa:5428; P54098; Q8NFM2; Q92515,ENSG00000140521,,Male infertility; Primary ovarian insufficiency,2,0,,35.91,53.2,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,38.92,24.17,,,8.33,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q9Y3Q8,TSC22D4,Sperm acrosome developmental regulator OS=Homo sapiens OX=9606 GN=SPACDR PE=1 SV=2,1,1,1.652,1.269,0.227,9.952,0.72,0.34,-2.14,3.32,6.17E-01,5.31E-01,1.72E-01,2.68E-02,7.54E+04,4.56E+04,9.57E+04,1.04E+04,3,2,4,2,,,4.15E+05,7.54E+04,9.42E+03,8.12E+04,,,,2.57E+04,,1.24E+05,5.82E+04,1.83E+05,7.40E+04,,3.60E+03,,2.99E+04,,,,4.05E+03,7.54E+04,4.86E+02,2.89E+02,,,,2.73E+02,,5.53E+03,4.73E+02,2.47E+04,1.84E+03,,1.01E+03,,6.99E+02,,0.023,FALSE,1.932,4,1,395,41,7.21,1,cell organization and biogenesis;stress response;developmental processes;other biological processes,nucleus;other cell component,Pf01166,81628,A4D2C3; A8MWR6; D6W5V9; hsa:81628; Q9Y3Q8,ENSG00000166925,,,0,0,130.59,73.49,51.27,111.03,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,126.64,129.64,105.67,115.31,3.09,,0,
Master Protein,High,A0A0U1RRM4,PTBP1,Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1,10,31,1.652,0.142,1.392,0.143,0.72,-2.81,0.48,-2.81,6.46E-01,1.97E-02,7.71E-01,9.89E-02,1.35E+07,1.54E+06,7.11E+05,8.51E+06,5,5,4,5,3.22E+07,1.18E+07,1.76E+07,9.33E+06,1.35E+07,1.14E+05,1.73E+06,2.85E+06,8.32E+04,1.54E+06,1.57E+07,2.25E+05,,1.18E+06,4.27E+05,8.97E+06,4.41E+05,8.51E+06,8.03E+05,2.20E+07,1.28E+05,4.48E+04,1.72E+05,9.33E+06,6.98E+05,4.06E+02,3.08E+04,2.63E+04,2.34E+03,1.64E+04,9.38E+04,1.00E+04,,1.60E+05,1.06E+04,1.75E+04,1.24E+05,6.03E+04,1.88E+04,2.35E+05,0,FALSE,36.451,26,8,588,62.4,9.1,10,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00076, Pf11835, Pf13893",,A0A0U1RRM4,ENSG00000011304,,mir-124 predicted interactions with cell cycle and differentiation,1,2,53.81,92.94,172.32,107.47,High,Peak Found,High,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,117.93,107.73,147.68,136.88,86.65,nucleic acid binding activity,0,
Master Protein,High,Q9BVC6,TMEM109,Transmembrane protein 109 OS=Homo sapiens OX=9606 GN=TMEM109 PE=1 SV=1,2,26,1.646,1.999,2.417,4.693,0.72,1,1.27,2.23,6.49E-01,1.17E-01,3.07E-01,1.48E-01,4.58E+06,3.77E+05,8.30E+06,1.77E+06,5,5,5,5,1.95E+06,1.16E+07,4.58E+06,1.30E+07,1.93E+06,2.15E+05,1.70E+05,1.25E+06,3.77E+05,4.25E+06,6.24E+06,8.42E+06,7.23E+06,8.30E+06,8.60E+06,4.99E+05,1.77E+06,4.36E+06,5.73E+04,3.16E+06,7.74E+03,4.42E+04,4.47E+04,1.30E+07,9.97E+04,7.63E+02,3.02E+03,1.15E+04,1.06E+04,4.52E+04,3.73E+04,3.76E+05,5.87E+04,1.12E+06,2.14E+05,9.73E+02,4.97E+05,3.09E+04,1.34E+03,3.36E+04,0,FALSE,9.036,9,2,243,26.2,10.48,2,stress response;transport;signal transduction;other biological processes,other membranes;cytosol;ER/Golgi;nucleus,Pf14965,79073,hsa:79073; Q9BVC6,ENSG00000110108,,,0,0,80.63,138.44,12.93,91.53,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,121.48,102.7,129.11,5.21,62.45,transporter activity,0,
Master Protein,High,A0A8V8TM48,RHOT2,Mitochondrial Rho GTPase OS=Homo sapiens OX=9606 GN=RHOT2 PE=1 SV=1,4,14,1.644,2.228,7.016,0.678,0.72,1.16,2.81,-0.56,6.06E-01,8.18E-02,7.02E-02,9.00E-01,1.06E+05,6.42E+04,1.20E+06,4.51E+05,4,4,5,4,5.25E+04,,5.93E+04,8.49E+05,1.88E+05,1.11E+05,3.73E+04,2.08E+05,3.00E+04,,1.73E+06,4.25E+05,1.20E+06,1.23E+06,5.27E+05,2.40E+05,1.12E+05,8.47E+05,,8.91E+06,2.09E+02,,5.80E+02,8.49E+05,9.69E+03,3.93E+02,6.63E+02,1.92E+03,8.44E+02,,1.04E+04,1.90E+04,9.74E+03,1.66E+05,1.31E+04,4.67E+02,3.16E+04,6.01E+03,,9.49E+04,0,FALSE,18.656,11,4,619,68.2,5.86,4,cell organization and biogenesis;signal transduction,other membranes;mitochondrion,"Pf00071, Pf08355, Pf08356",,A0A8V8TM48,ENSG00000140983,,,0,0,132.24,85.89,53.15,168.85,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,100.96,98.3,125.37,107.81,51.88,other molecular function,0,
Master Protein,High,Q5TB53,TM9SF3,Transmembrane 9 superfamily member (Fragment) OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=8,3,7,1.644,0.539,1.344,0.638,0.72,-0.89,0.43,-0.65,6.02E-01,8.44E-01,8.22E-01,8.55E-01,4.16E+04,2.53E+04,2.17E+04,3.40E+04,3,1,2,1,,4.16E+04,,4.41E+04,3.66E+04,,,,,2.53E+04,4.29E+04,,,1.09E+04,,,,,,3.40E+04,,1.58E+02,,4.41E+04,1.89E+03,,,,,2.69E+02,2.57E+02,,,1.47E+03,,,,,,3.62E+02,0,FALSE,22.456,23,1,253,29.9,5.82,3,,other membranes,Pf02990,,Q5TB53,ENSG00000077147,,,0,0,9.4,,84.02,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,9.17,99.71,0,109.5,25.63,,0,
Master Protein,High,G8JLB6,HNRNPH1,Heterogeneous nuclear ribonucleoprotein H1 OS=Homo sapiens OX=9606 GN=HNRNPH1 PE=1 SV=1,12,52,1.643,0.636,0.447,2.205,0.72,-0.65,-1.16,1.14,5.83E-01,9.02E-01,3.27E-01,3.60E-01,3.01E+06,7.87E+05,2.10E+06,8.33E+05,5,5,5,5,1.67E+05,1.29E+06,3.01E+06,1.50E+07,5.21E+06,1.43E+06,7.87E+05,7.72E+05,5.82E+05,2.30E+06,2.10E+06,3.86E+06,1.93E+06,6.81E+06,1.69E+06,8.33E+05,1.06E+06,1.32E+07,7.04E+05,1.54E+05,6.65E+02,4.92E+03,2.94E+04,1.50E+07,2.69E+05,5.09E+03,1.40E+04,7.12E+03,1.64E+04,2.45E+04,1.26E+04,1.72E+05,1.57E+04,9.18E+05,4.20E+04,1.62E+03,2.97E+05,9.35E+04,1.65E+04,1.64E+03,0,FALSE,80.648,42,8,472,51.2,6.8,12,,cytosol;nucleus,"Pf00076, Pf08080",,G8JLB6,ENSG00000169045,,MECP2 and associated Rett syndrome; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells,2,4,120.23,60.22,65.67,175.73,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,108.46,125.91,132.09,102.41,174.95,nucleic acid binding activity,0,
Master Protein,High,A0A8V8TNX9,PKM,Pyruvate kinase OS=Homo sapiens OX=9606 GN=PKM PE=1 SV=1,13,59,1.638,0.584,1.267,2.035,0.71,-0.78,0.34,1.02,6.53E-01,8.02E-01,8.65E-01,4.80E-01,1.22E+07,5.19E+06,8.96E+06,1.03E+07,5,5,5,5,1.16E+08,1.22E+07,1.59E+07,6.34E+06,9.88E+06,5.19E+06,5.85E+06,5.99E+06,2.90E+05,1.12E+06,2.06E+07,4.35E+06,7.78E+06,8.96E+06,1.86E+07,1.64E+06,7.28E+05,1.62E+07,6.47E+07,1.03E+07,4.60E+05,4.62E+04,1.55E+05,6.34E+06,5.10E+05,1.85E+04,1.04E+05,5.52E+04,8.16E+03,1.19E+04,1.23E+05,1.94E+05,6.32E+04,1.21E+06,4.63E+05,3.19E+03,2.05E+05,1.15E+05,1.51E+06,1.09E+05,0,FALSE,60.169,31,13,605,65.8,7.99,13,other metabolic processes,,"Pf00224, Pf02887",,A0A8V8TNX9,ENSG00000067225,,Amino acid metabolism; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Glycolysis in senescence,4,0,146.73,74.69,59.04,141.55,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,121.43,116.9,142.51,138.6,145.18,kinase activity;other molecular function,0,
Master Protein,High,P62316,SNRPD2,Small nuclear ribonucleoprotein Sm D2 OS=Homo sapiens OX=9606 GN=SNRPD2 PE=1 SV=1,5,41,1.638,0.239,3.888,0.212,0.71,-2.06,1.96,-2.24,6.53E-01,1.14E-01,1.09E-01,1.94E-01,3.48E+06,1.12E+06,1.13E+06,5.33E+06,5,5,5,5,6.45E+05,3.48E+06,4.96E+05,1.17E+07,4.05E+07,9.60E+05,3.11E+06,1.12E+06,4.45E+04,2.25E+07,7.02E+05,1.85E+06,3.35E+05,7.88E+06,1.13E+06,5.33E+06,4.30E+05,4.78E+07,7.31E+05,2.73E+07,2.56E+03,1.32E+04,4.85E+03,1.17E+07,2.09E+06,3.41E+03,5.52E+04,1.03E+04,1.25E+03,2.39E+05,4.20E+03,8.28E+04,2.73E+03,1.06E+06,2.80E+04,1.04E+04,1.21E+05,3.39E+05,1.71E+04,2.90E+05,0,FALSE,27.237,49,5,118,13.5,9.91,5,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf01423,6633,A8K797; hsa:6633; J3KPM5; P43330; P62316,ENSG00000125743,mRNA Splicing - Major Pathway; SARS-CoV-2 modulates host translation machinery; snRNP Assembly; mRNA Splicing - Minor Pathway,mRNA processing,5,0,148.88,172.08,131.32,127.4,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,134.83,120.04,144.92,138.56,126.49,,0,
Master Protein,High,M0QXF9,BCAT2,Branched-chain-amino-acid aminotransferase (Fragment) OS=Homo sapiens OX=9606 GN=BCAT2 PE=1 SV=1,10,38,1.637,0.719,0.776,2.135,0.71,-0.48,-0.37,1.09,5.84E-01,8.96E-01,6.97E-01,3.98E-01,7.59E+05,6.56E+05,8.87E+05,7.04E+05,5,5,5,3,5.46E+05,7.59E+05,4.39E+05,6.04E+06,8.84E+06,6.56E+05,4.10E+05,8.06E+05,1.99E+05,1.49E+06,4.77E+05,7.38E+05,8.87E+05,4.14E+06,3.32E+06,,7.04E+05,,9.96E+05,1.54E+05,2.17E+03,2.88E+03,4.29E+03,6.04E+06,4.56E+05,2.33E+03,7.30E+03,7.44E+03,5.60E+03,1.59E+04,2.85E+03,3.30E+04,7.20E+03,5.58E+05,8.26E+04,,1.98E+05,,2.33E+04,1.64E+03,0,FALSE,55.493,35,10,445,49.9,7.46,10,other metabolic processes,mitochondrion;nucleus,Pf01063,,M0QXF9,ENSG00000105552,,"Trans-sulfuration, one-carbon metabolism and related pathways; One-carbon metabolism and related pathways",2,0,116.93,69.34,88.41,69.23,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,107.39,100.77,106.27,74.16,123.82,other molecular function,0,
Master Protein,High,P48643,CCT5,T-complex protein 1 subunit epsilon OS=Homo sapiens OX=9606 GN=CCT5 PE=1 SV=1,5,14,1.631,0.813,2.732,0.152,0.71,-0.3,1.45,-2.72,5.33E-01,8.26E-01,4.12E-01,1.15E-01,3.79E+05,1.03E+05,2.89E+05,5.45E+05,5,2,5,5,9.09E+05,9.12E+04,3.79E+05,4.14E+05,2.13E+05,,1.06E+05,9.98E+04,,,2.89E+05,2.71E+06,2.57E+05,1.99E+05,3.76E+05,3.23E+05,6.13E+06,5.45E+05,1.17E+05,8.96E+06,3.61E+03,3.46E+02,3.70E+03,4.14E+05,1.10E+04,,1.88E+03,9.21E+02,,,1.73E+03,1.21E+05,2.09E+03,2.68E+04,9.35E+03,6.29E+02,1.72E+06,3.86E+03,2.74E+03,9.53E+04,0,FALSE,16.731,10,4,541,59.6,5.66,5,protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;other cell component,Pf00118,22948,A8JZY8; A8K2X8; B4DYD8; hsa:22948; P48643,ENSG00000150753,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,16p11.2 proximal deletion syndrome,7,1,77.85,4,141.94,126.89,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,High,n/a,1,,FALSE,79.96,50.35,4.2,125.9,33.88,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A087WTW0,UHRF1,E3 ubiquitin-protein ligase UHRF OS=Homo sapiens OX=9606 GN=UHRF1 PE=1 SV=1,27,120,1.625,0.915,0.676,3.227,0.7,-0.13,-0.56,1.69,6.59E-01,6.80E-01,5.28E-01,2.65E-01,1.20E+07,4.29E+06,1.51E+07,3.28E+06,5,5,5,5,1.73E+06,1.52E+07,1.42E+06,1.89E+07,1.20E+07,8.29E+06,1.20E+06,4.29E+06,4.96E+05,8.12E+06,1.01E+07,2.41E+06,1.93E+07,3.71E+07,1.51E+07,6.95E+05,3.28E+06,4.24E+06,1.96E+06,4.56E+06,6.88E+03,5.76E+04,1.39E+04,1.89E+07,6.21E+05,2.95E+04,2.13E+04,3.96E+04,1.40E+04,8.63E+04,6.07E+04,1.08E+05,1.57E+05,5.00E+06,3.74E+05,1.35E+03,9.22E+05,3.01E+04,4.58E+04,4.85E+04,0,FALSE,135.369,37,27,857,96.6,8.34,27,cell cycle OR cell proliferation;protein metabolism;other metabolic processes,nucleus,"Pf00240, Pf00628, Pf02182, Pf12148",,A0A087WTW0,ENSG00000276043,,Pathways affected in adenoid cystic carcinoma; Pleural mesothelioma,2,0,80.59,82.38,77.22,54.81,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,133.23,128.39,142.2,131.01,332.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8V8TMZ5,SEC61A1,SEC61 translocon subunit alpha 1 OS=Homo sapiens OX=9606 GN=SEC61A1 PE=1 SV=1,5,10,1.622,0.641,3.196,1.006,0.7,-0.64,1.68,0.01,5.58E-01,9.34E-01,3.08E-01,8.00E-01,4.52E+05,3.42E+05,2.36E+05,3.74E+05,5,3,4,3,4.52E+05,1.06E+06,9.21E+04,2.13E+06,3.18E+05,3.42E+05,,5.28E+05,,1.17E+05,,2.24E+05,8.00E+04,6.97E+05,2.48E+05,3.74E+05,,,8.55E+04,2.60E+06,1.80E+03,4.02E+03,9.00E+02,2.13E+06,1.64E+04,1.22E+03,,4.87E+03,,1.24E+03,,9.99E+03,6.50E+02,9.40E+04,6.16E+03,7.28E+02,,,2.00E+03,2.76E+04,0,FALSE,31.3,13,5,485,53.2,8.02,5,transport,other membranes;ER/Golgi,"Pf00344, Pf10559",,A0A8V8TMZ5,ENSG00000058262,,,0,0,101.15,62.55,85.59,134.9,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,109.69,105.36,107.31,137.66,27.98,,0,
Master Protein,High,O43615,TIMM44,Mitochondrial import inner membrane translocase subunit TIM44 OS=Homo sapiens OX=9606 GN=TIMM44 PE=1 SV=2,7,23,1.619,1.099,2.521,1.989,0.69,0.14,1.33,0.99,6.08E-01,4.95E-01,2.96E-01,4.92E-01,1.65E+06,6.34E+05,3.25E+06,2.03E+06,4,1,5,4,1.41E+06,1.27E+06,1.94E+06,2.72E+06,,,6.34E+05,,,,3.89E+06,8.82E+05,3.11E+06,4.40E+06,3.25E+06,1.66E+06,2.73E+06,,2.47E+06,6.80E+05,5.60E+03,4.82E+03,1.89E+04,2.72E+06,,,1.13E+04,,,,2.32E+04,3.94E+04,2.53E+04,5.93E+05,8.08E+04,3.24E+03,7.68E+05,,5.78E+04,7.24E+03,0,FALSE,26.928,18,7,452,51.3,8.32,7,transport;other biological processes,other membranes;mitochondrion;nucleus,Pf04280,10469,A8K0R9; D6W664; hsa:10469; O43615; Q8N193,ENSG00000104980,Mitochondrial protein import,,1,0,35.89,,43.33,48.97,Peak Found,Peak Found,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,n/a,High,High,Peak Found,High,Peak Found,Peak Found,High,n/a,High,Peak Found,1,,FALSE,93.39,59.46,50.1,83.8,65.76,other molecular function,0,
Master Protein,High,Q5JPT2,SH3KBP1,SH3 domain containing kinase binding protein 1 OS=Homo sapiens OX=9606 GN=SH3KBP1 PE=1 SV=2,2,5,1.618,1,0.413,3.224,0.69,0,-1.28,1.69,5.30E-01,6.25E-01,3.65E-01,2.19E-01,3.57E+05,2.21E+05,2.94E+05,9.12E+04,2,1,4,1,,8.35E+05,,1.53E+05,,,,2.21E+05,,,,2.95E+05,2.94E+05,6.06E+05,2.11E+05,,9.12E+04,,,,,3.17E+03,,1.53E+05,,,,2.04E+03,,,,1.32E+04,2.38E+03,8.16E+04,5.24E+03,,2.56E+04,,,,0,FALSE,6.046,5,2,709,77.9,7.58,2,,,Pf14604,,Q5JPT2,ENSG00000147010,,,0,0,97.64,,49.57,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,141.5,103.48,0,21.11,17.44,,0,
Master Protein,High,P46109,CRKL,Crk-like protein OS=Homo sapiens OX=9606 GN=CRKL PE=1 SV=1,1,4,1.617,1.102,2.217,0.807,0.69,0.14,1.15,-0.31,6.29E-01,5.99E-01,5.63E-01,9.96E-01,9.96E+04,6.16E+04,1.01E+05,1.37E+05,3,2,4,3,1.46E+05,9.96E+04,,5.73E+04,,,5.70E+04,6.65E+04,,,,9.33E+03,4.25E+04,2.85E+05,2.38E+05,,2.87E+05,5.42E+04,1.37E+05,,5.78E+02,3.78E+02,,5.73E+04,,,1.01E+03,6.14E+02,,,,4.17E+02,3.45E+02,3.84E+04,5.92E+03,,8.06E+04,3.84E+02,3.20E+03,,0.001,FALSE,3.915,6,1,303,33.8,6.74,1,cell-cell signaling;cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00017, Pf00018, Pf07653",1399,A8KA44; D3DX35; hsa:1399; P46109,ENSG00000099942,Regulation of signaling by CBL; Downstream signal transduction; Erythropoietin activates RAS; Frs2-mediated activation; MET activates RAP1 and RAC1; MET receptor recycling,Androgen receptor network in prostate cancer; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; MAPK signaling pathway; Chemokine signaling pathway; MET in type 1 papillary renal cell carcinoma; EGF/EGFR signaling pathway; 22q11.2 copy number variation syndrome; IL-2 signaling pathway; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways; ErbB signaling pathway; T-cell receptor signaling pathway,22,0,43.78,10.85,96.04,74.1,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,54.26,131,89.18,123.26,10.06,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P61604,HSPE1,"10 kDa heat shock protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPE1 PE=1 SV=2",9,132,1.614,1.547,1.594,2.338,0.69,0.63,0.67,1.23,6.65E-01,2.35E-01,6.43E-01,4.07E-01,1.38E+07,1.15E+07,6.33E+07,2.59E+07,5,5,5,5,1.38E+07,1.82E+06,4.77E+06,9.64E+07,3.32E+07,3.32E+07,1.15E+07,3.86E+06,2.45E+06,3.45E+07,5.09E+06,1.03E+08,9.03E+07,2.47E+07,6.33E+07,2.59E+07,2.55E+07,2.36E+08,1.10E+07,2.60E+07,5.50E+04,6.90E+03,4.66E+04,9.64E+07,1.71E+06,1.18E+05,2.04E+05,3.56E+04,6.91E+04,3.67E+05,3.05E+04,4.60E+06,7.34E+05,3.33E+06,1.57E+06,5.05E+04,7.17E+06,1.67E+06,2.57E+05,2.77E+05,0,FALSE,30.653,67,9,102,10.9,8.92,9,protein metabolism;other metabolic processes;stress response;other biological processes,mitochondrion,Pf00166,3336,hsa:3336; O95421; P61604; Q04984; Q53X54; Q9UDH0,ENSG00000115541,RHOG GTPase cycle,,1,0,130.26,91.72,73.04,147.7,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,139.6,145.75,107.38,140.78,318.2,other molecular function,0,
Master Protein,High,P06746,POLB,DNA polymerase beta OS=Homo sapiens OX=9606 GN=POLB PE=1 SV=3,4,4,1.611,0.319,0.339,0.762,0.69,-1.65,-1.56,-0.39,6.13E-01,3.25E-01,2.55E-01,9.33E-01,8.72E+05,3.64E+05,5.25E+05,1.23E+05,4,2,3,1,9.49E+05,1.41E+06,,8.00E+05,3.62E+05,,,,5.12E+05,2.58E+05,,5.25E+05,5.18E+05,6.85E+05,,,1.23E+05,,,,3.77E+03,5.35E+03,,8.00E+05,1.87E+04,,,,1.44E+04,2.74E+03,,2.35E+04,4.21E+03,9.22E+04,,,3.46E+04,,,,0,FALSE,12.21,20,4,335,38.2,8.95,4,DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytoskeleton;nucleus;other cell component,"Pf10391, Pf14716, Pf14791, Pf14792",5423,B2RC78; hsa:5423; P06746; Q3KP48; Q6FI34,ENSG00000070501,Ub-specific processing proteases; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway; POLB-Dependent Long Patch Base Excision Repair; PCNA-Dependent Long Patch Base Excision Repair; Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,"Male infertility; Base excision repair; DNA repair pathways, full network",10,0,49.05,46.73,16.32,,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,100.16,92.95,51.9,103.26,12.72,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96CS3,FAF2,FAS-associated factor 2 OS=Homo sapiens OX=9606 GN=FAF2 PE=1 SV=2,6,23,1.611,0.602,1.591,0.818,0.69,-0.73,0.67,-0.29,5.93E-01,8.63E-01,7.60E-01,9.96E-01,2.22E+05,1.08E+05,7.17E+05,2.30E+05,5,4,5,5,8.54E+04,5.36E+05,3.58E+04,1.34E+06,2.22E+05,3.62E+05,1.02E+05,4.30E+04,,1.15E+05,8.26E+06,5.55E+05,2.11E+05,9.01E+05,7.17E+05,2.30E+05,4.94E+05,3.92E+05,5.58E+04,2.07E+05,3.39E+02,2.04E+03,3.50E+02,1.34E+06,1.14E+04,1.29E+03,1.81E+03,3.97E+02,,1.23E+03,4.94E+04,2.48E+04,1.72E+03,1.21E+05,1.78E+04,4.48E+02,1.39E+05,2.78E+03,1.31E+03,2.21E+03,0,FALSE,36.526,22,6,445,52.6,5.62,6,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport,non-structural extracellular;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00789, Pf14555, Pf21021",23197,hsa:23197; O94963; Q8IUF2; Q96CS3; Q9BRP2; Q9BVM7,ENSG00000113194,RHOA GTPase cycle; Neutrophil degranulation,5q35 copy number variation,3,0,121.08,90.69,161.46,61.84,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,74.5,80.25,99.39,95.2,69.35,enzyme regulator activity;other molecular function,0,
Master Protein,High,P48507,GCLM,Glutamate--cysteine ligase regulatory subunit OS=Homo sapiens OX=9606 GN=GCLM PE=1 SV=1,1,7,1.608,0.616,11.394,0.107,0.69,-0.7,3.51,-3.22,6.12E-01,9.39E-01,3.47E-02,9.46E-02,4.68E+04,2.91E+04,2.89E+04,3.32E+05,1,1,4,3,,,,4.68E+04,,,,,2.91E+04,,,2.60E+04,3.20E+04,9.73E+04,1.26E+04,,8.12E+05,8.60E+04,3.32E+05,,,,,4.68E+04,,,,,8.20E+02,,,1.16E+03,2.60E+02,1.31E+04,3.14E+02,,2.28E+05,6.10E+02,7.76E+03,,0,FALSE,4.697,5,1,274,30.7,6.02,1,cell organization and biogenesis;other metabolic processes;stress response;other biological processes,cytosol;other cell component,Pf00248,2730,A8K334; D3DT45; hsa:2730; M5A959; P48507; Q6FHC1; Q9NPX9; Q9NU74,ENSG00000023909,Glutathione synthesis and recycling; NFE2L2 regulating anti-oxidant/detoxification enzymes; Defective GCLC causes HAGGSD,"Glutathione metabolism; Trans-sulfuration pathway; Trans-sulfuration, one-carbon metabolism and related pathways; Nuclear receptors meta-pathway; NRF2 pathway; Transcriptional activation by NRF2 in response to phytochemicals; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Amino acid metabolism; One-carbon metabolism and related pathways; Ferroptosis; NRF2-ARE regulation; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway",15,0,,,89.88,90.09,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,High,n/a,1,,FALSE,0,60.21,109.81,100.5,18.48,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q15836,VAMP3,Vesicle-associated membrane protein 3 OS=Homo sapiens OX=9606 GN=VAMP3 PE=1 SV=3,3,8,1.605,0.462,0.542,0.864,0.68,-1.12,-0.88,-0.21,6.07E-01,6.04E-01,4.56E-01,9.32E-01,1.16E+06,6.48E+05,8.55E+05,7.76E+05,4,1,4,4,1.65E+05,,1.35E+06,9.91E+05,1.37E+06,,,,,6.48E+05,,1.15E+06,3.28E+05,1.01E+06,7.20E+05,,1.09E+06,4.32E+05,5.53E+05,1.38E+06,6.57E+02,,1.32E+04,9.91E+05,7.08E+04,,,,,6.89E+03,,5.12E+04,2.67E+03,1.37E+05,1.79E+04,,3.06E+05,3.06E+03,1.29E+04,1.47E+04,0,FALSE,13.924,41,2,100,11.3,8.79,3,cell adhesion;cell organization and biogenesis;stress response;transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00957,9341,hsa:9341; Q15836; Q9BRV4,ENSG00000049245,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; ER-Phagosome pathway; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; Cargo recognition for clathrin-mediated endocytosis; Retrograde transport at the Trans-Golgi-Network; RHOH GTPase cycle,,17,1,58.18,,45.21,51.84,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,0,55.15,8.09,37.89,32.52,other molecular function,0,
Master Protein,High,P13747,HLA-E,"HLA class I histocompatibility antigen, alpha chain E OS=Homo sapiens OX=9606 GN=HLA-E PE=1 SV=4",3,44,1.602,0.685,0.01,100,0.68,-0.55,-6.64,6.64,6.44E-01,9.75E-01,1.00E-17,1.00E-17,8.38E+04,5.23E+04,5.74E+04,,2,1,2,,9.73E+04,,,7.22E+04,,,,,,5.23E+04,1.03E+05,3.21E+04,,,,,,,,,3.86E+02,,,7.22E+04,,,,,,5.56E+02,6.14E+02,1.43E+03,,,,,,,,,0,FALSE,14.54,13,1,358,40,5.83,3,stress response;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00129, Pf06623, Pf07654",3133,E2G051; hsa:3133; P13747; Q30169; Q6DU44; Q9BT83; Q9GIY7; Q9GIY8,ENSG00000204592; ENSG00000206493; ENSG00000225201; ENSG00000229252; ENSG00000230254; ENSG00000233904; ENSG00000236632,"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; ER-Phagosome pathway; SARS-CoV-2 activates/modulates innate and adaptive immune responses; DAP12 signaling; Interferon gamma signaling; Interferon alpha/beta signaling; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Endosomal/Vacuolar pathway",Proteasome degradation; Allograft rejection; Ebola virus infection in host; TAR syndrome,13,0,20.9,,74.08,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,22.15,78.56,,,132.12,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q13885,TUBB2A,Tubulin beta-2A chain OS=Homo sapiens OX=9606 GN=TUBB2A PE=1 SV=1,18,417,1.601,0.387,0.564,0.708,0.68,-1.37,-0.83,-0.5,5.76E-01,4.63E-01,4.72E-01,9.28E-01,5.09E+05,3.18E+05,1.37E+05,1.79E+05,2,1,4,4,,,2.13E+06,1.21E+05,,,,,,3.18E+05,1.85E+06,2.88E+05,,6.54E+04,3.38E+04,4.36E+05,9.75E+04,,3.29E+05,8.73E+04,,,2.08E+04,1.21E+05,,,,,,3.38E+03,1.11E+04,1.29E+04,,8.81E+03,8.39E+02,8.50E+02,2.74E+04,,7.70E+03,9.30E+02,0,FALSE,172.86,45,1,445,49.9,4.89,18,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes,cytoskeleton;other cell component,"Pf00091, Pf03953",7280,hsa:7280; Q13885; Q6FGZ8; Q8IWR2,ENSG00000137267,The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Aggrephagy; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; PKR-mediated signaling; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,35,0,126.15,,155.26,72.88,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,292.61,134.29,105.72,126.59,1149.31,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q13428,TCOF1,Treacle protein OS=Homo sapiens OX=9606 GN=TCOF1 PE=1 SV=3,17,34,1.599,0.26,0.581,0.276,0.68,-1.94,-0.78,-1.85,6.16E-01,1.50E-01,4.36E-01,2.92E-01,2.84E+06,3.91E+05,9.72E+05,2.42E+06,5,5,5,5,2.53E+05,2.84E+06,5.07E+05,6.34E+06,9.02E+06,2.59E+05,3.91E+05,8.25E+05,1.25E+05,3.56E+06,7.35E+05,9.72E+05,8.03E+05,3.05E+06,1.82E+06,2.42E+06,1.18E+05,5.43E+06,6.97E+05,6.02E+06,1.00E+03,1.08E+04,4.95E+03,6.34E+06,4.65E+05,9.19E+02,6.95E+03,7.62E+03,3.53E+03,3.78E+04,4.40E+03,4.34E+04,6.52E+03,4.11E+05,4.52E+04,4.72E+03,3.33E+04,3.85E+04,1.63E+04,6.40E+04,0,FALSE,65.862,16,17,1488,152,9.04,17,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus,Pf03546,6949,A0JLU0; B4E111; hsa:6949; Q13428; Q6SC72; Q7Z5W9; Q96A52; Q99408; Q99860,ENSG00000070814,,,0,0,100.42,139.24,66.54,91.58,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,110.58,104.19,126.65,117.35,87.5,other molecular function,0,
Master Protein,High,Q92614,MYO18A,Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,38,172,1.597,0.317,1.266,0.756,0.68,-1.66,0.34,-0.4,6.73E-01,2.49E-01,8.65E-01,8.64E-01,5.01E+07,8.11E+06,1.21E+07,7.91E+06,5,5,5,5,6.50E+07,1.34E+08,1.44E+07,2.36E+07,5.01E+07,6.76E+06,7.63E+06,1.07E+07,8.66E+06,8.11E+06,1.63E+07,5.20E+06,5.00E+06,3.37E+07,1.21E+07,2.28E+07,1.68E+06,7.58E+06,7.91E+06,1.97E+07,2.58E+05,5.09E+05,1.40E+05,2.36E+07,2.58E+06,2.40E+04,1.36E+05,9.87E+04,2.44E+05,8.62E+04,9.78E+04,2.32E+05,4.06E+04,4.53E+06,3.01E+05,4.45E+04,4.71E+05,5.37E+04,1.85E+05,2.09E+05,0,FALSE,197.149,25,38,2054,233,6.3,38,cell organization and biogenesis;DNA metabolism;other metabolic processes;transport;other biological processes,other membranes;cytoskeleton;ER/Golgi;other cell component,"Pf00063, Pf00595, Pf01576",399687,hsa:399687; Q5H9U3; Q5QD01; Q5W9F9; Q5W9G1; Q8IXP8; Q92614,ENSG00000196535,Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease; Signaling by FLT3 fusion proteins,,3,0,82.55,17.62,81.25,74.82,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,Peak Found,High,High,Peak Found,High,1,,FALSE,118.6,122.88,126.95,130.5,533.44,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P27487,DPP4,Dipeptidyl peptidase 4 OS=Homo sapiens OX=9606 GN=DPP4 PE=1 SV=2,3,5,1.593,0.01,0.075,0.01,0.67,-6.64,-3.75,-6.64,6.19E-01,1.00E-17,4.19E-03,1.00E-17,4.69E+05,5.52E+05,,2.19E+04,1,4,,1,,,,,4.69E+05,1.04E+06,,2.61E+04,2.94E+05,1.22E+07,,,,,,,,,,2.19E+04,,,,,2.42E+04,3.69E+03,,2.41E+02,8.29E+03,1.30E+05,,,,,,,,,,2.34E+02,0,FALSE,7.392,5,3,766,88.2,6.04,3,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf00326, Pf00930",1803,hsa:1803; P27487; Q53TN1,ENSG00000197635,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",Ferroptosis,3,0,,173.83,,,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,141.03,,135.09,,13.15,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q5JPU2,PDHA1,Pyruvate dehydrogenase E1 component subunit alpha OS=Homo sapiens OX=9606 GN=PDHA1 PE=1 SV=2,8,50,1.586,0.859,1.364,0.914,0.67,-0.22,0.45,-0.13,6.79E-01,7.48E-01,7.91E-01,9.97E-01,4.38E+06,1.09E+06,7.44E+06,3.63E+06,5,5,5,4,2.56E+06,1.70E+07,4.38E+06,9.69E+06,1.72E+06,6.73E+05,1.09E+06,1.61E+06,4.82E+05,4.60E+06,6.63E+05,6.01E+06,7.44E+06,1.49E+07,1.37E+07,1.37E+06,4.25E+06,,4.82E+06,3.10E+06,1.02E+04,6.44E+04,4.28E+04,9.69E+06,8.88E+04,2.39E+03,1.94E+04,1.49E+04,1.36E+04,4.89E+04,3.96E+03,2.69E+05,6.05E+04,2.01E+06,3.41E+05,2.67E+03,1.19E+06,,1.13E+05,3.30E+04,0,FALSE,49.285,33,8,418,46.4,8.29,8,other metabolic processes,mitochondrion;nucleus,Pf00676,,Q5JPU2,ENSG00000131828,,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Lipid metabolism pathway; PI3K/AKT/mTOR - vitamin D3 signaling; Hereditary leiomyomatosis and renal cell carcinoma pathway; Metabolic reprogramming in colon cancer; Thiamine metabolic pathways; TCA cycle in senescence,8,0,89.76,99.44,68.46,45,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,n/a,High,Peak Found,1,,FALSE,132.8,111.15,83.39,118.09,146.73,other molecular function,0,
Master Protein,High,Q15907,RAB11B,Ras-related protein Rab-11B OS=Homo sapiens OX=9606 GN=RAB11B PE=1 SV=4,6,43,1.58,1.309,2.155,1.499,0.66,0.39,1.11,0.58,6.80E-01,3.46E-01,3.96E-01,6.63E-01,4.02E+06,4.98E+05,7.78E+06,6.20E+06,5,4,5,5,8.44E+06,4.50E+06,3.65E+06,3.05E+06,4.02E+06,4.36E+05,4.76E+05,5.21E+05,,8.07E+05,1.15E+07,3.57E+06,4.31E+06,7.78E+06,8.42E+06,1.97E+06,6.50E+06,8.98E+06,2.65E+06,6.20E+06,3.35E+04,1.71E+04,3.57E+04,3.05E+06,2.08E+05,1.55E+03,8.47E+03,4.81E+03,,8.58E+03,6.89E+04,1.60E+05,3.50E+04,1.05E+06,2.09E+05,3.85E+03,1.83E+06,6.37E+04,6.20E+04,6.60E+04,0,FALSE,26.306,27,6,218,24.5,5.94,6,cell-cell signaling;other metabolic processes;transport;other biological processes,other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,9230,A5YM50; B2R7I4; B4DMK0; D6W671; hsa:9230; Q15907; Q2YDT2; Q5U0I1; Q6FHR0; Q6FI42; Q8NI07,ENSG00000185236,RAB geranylgeranylation; TBC/RABGAPs,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Intracellular trafficking proteins involved in CMT neuropathy; Vasopressin-regulated water reabsorption,5,0,45.18,30,45.49,55.31,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,99.11,94.02,50.45,74.33,99.15,cytoskeletal activity;other molecular function,0,
Master Protein,High,P0C0S5,H2AZ1,Histone H2A.Z OS=Homo sapiens OX=9606 GN=H2AZ1 PE=1 SV=2,6,833,1.58,1.057,1.119,3.7,0.66,0.08,0.16,1.89,6.82E-01,5.31E-01,9.91E-01,2.16E-01,4.14E+07,3.07E+07,8.76E+07,2.13E+07,5,5,5,5,7.50E+06,4.14E+07,1.48E+07,1.54E+08,1.00E+08,1.50E+07,3.07E+07,4.06E+07,6.88E+06,3.18E+07,1.12E+07,1.07E+08,5.82E+07,8.76E+07,1.29E+08,2.13E+07,9.38E+06,1.88E+08,1.06E+07,1.23E+08,2.98E+04,1.57E+05,1.44E+05,1.54E+08,5.18E+06,5.34E+04,5.46E+05,3.74E+05,1.94E+05,3.39E+05,6.71E+04,4.79E+06,4.73E+05,1.18E+07,3.20E+06,4.16E+04,2.64E+06,1.33E+06,2.49E+05,1.31E+06,0,FALSE,58.117,54,4,128,13.5,10.58,6,cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf00125, Pf16211",3015,B2RD56; hsa:3015; P0C0S5; P17317; Q6I9U0,ENSG00000164032,Amyloid fiber formation,Proteasome degradation; Retinoblastoma gene in cancer; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,4,0,98.08,54.76,58.25,115.06,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,130.21,135.54,122.88,144.79,2017.41,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P39748,FEN1,Flap endonuclease 1 OS=Homo sapiens OX=9606 GN=FEN1 PE=1 SV=1,8,11,1.579,0.412,1.232,0.815,0.66,-1.28,0.3,-0.29,6.13E-01,4.73E-01,9.22E-01,9.83E-01,1.24E+06,2.65E+05,8.82E+05,1.14E+06,5,5,5,5,1.24E+06,8.58E+05,3.83E+05,5.66E+06,1.74E+06,7.01E+04,5.03E+04,2.77E+05,9.28E+05,2.65E+05,1.97E+05,8.82E+05,8.78E+05,4.97E+06,1.52E+06,1.14E+06,2.23E+05,4.95E+05,1.30E+06,1.76E+06,4.93E+03,3.26E+03,3.74E+03,5.66E+06,8.96E+04,2.49E+02,8.94E+02,2.56E+03,2.61E+04,2.81E+03,1.18E+03,3.94E+04,7.13E+03,6.69E+05,3.78E+04,2.23E+03,6.26E+04,3.51E+03,3.05E+04,1.88E+04,0,FALSE,30.229,30,8,380,42.6,8.62,8,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,mitochondrion;nucleus;other cell component,"Pf00752, Pf00867",2237,hsa:2237; P39748,ENSG00000168496,HDR through MMEJ (alt-NHEJ); Early Phase of HIV Life Cycle; POLB-Dependent Long Patch Base Excision Repair; PCNA-Dependent Long Patch Base Excision Repair; Removal of the Flap Intermediate; Removal of the Flap Intermediate from the C-strand,"Base excision repair; DNA repair pathways, full network",8,0,107.22,112.26,111.94,63.21,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,58.43,108.31,103,124.61,34.27,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P41250,GARS1,Glycine--tRNA ligase OS=Homo sapiens OX=9606 GN=GARS1 PE=1 SV=3,3,4,1.572,0.653,4.51,0.239,0.65,-0.61,2.17,-2.06,6.53E-01,9.31E-01,2.21E-01,3.27E-01,8.26E+04,2.91E+04,9.23E+04,1.15E+05,2,4,5,3,,,,2.08E+05,3.28E+04,,3.89E+04,9.87E+04,2.01E+04,2.17E+04,4.23E+04,9.23E+04,1.02E+05,1.82E+05,2.36E+04,6.79E+05,1.15E+05,,7.68E+04,,,,,2.08E+05,1.69E+03,,6.92E+02,9.11E+02,5.65E+02,2.31E+02,2.53E+02,4.12E+03,8.27E+02,2.45E+04,5.87E+02,1.32E+03,3.24E+04,,1.80E+03,,0,FALSE,7.697,5,3,739,83.1,7.03,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes,non-structural extracellular;cytosol;mitochondrion;other cell component,"Pf00458, Pf00587, Pf03129",2617,A0A090N8G0; B3KQA2; B4DIA0; hsa:2617; P41250; Q969Y1,ENSG00000106105,Cytosolic tRNA aminoacylation; Mitochondrial tRNA aminoacylation,HDAC6 interactions in the central nervous system,3,0,102.87,82.29,69.91,116.13,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,91.21,73.15,80.7,62.97,10.24,other molecular function,0,
Master Protein,High,Q8N8J7,FAM241A,Uncharacterized protein FAM241A OS=Homo sapiens OX=9606 GN=FAM241A PE=2 SV=2,2,2,1.571,0.18,2.769,0.242,0.65,-2.47,1.47,-2.04,6.17E-01,6.09E-02,4.38E-01,3.49E-01,9.47E+05,2.98E+04,1.21E+05,1.63E+05,3,1,3,2,9.47E+05,1.93E+07,,3.07E+05,,,,,2.98E+04,,,1.21E+05,,5.69E+05,9.39E+04,,,8.24E+04,,3.21E+05,3.76E+03,7.33E+04,,3.07E+05,,,,,8.39E+02,,,5.40E+03,,7.66E+04,2.33E+03,,,5.84E+02,,3.42E+03,0,FALSE,7.283,20,2,132,14.6,4.7,2,,other membranes;ER/Golgi;other cell component,Pf15378,132720,Q49A91; Q4W5C7; Q8N8J7; Q8TBF9,ENSG00000174749,,,0,0,157.43,,102.1,83.63,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,88.12,115.16,0,88.36,5.66,,0,
Master Protein,High,P11142,HSPA8,Heat shock cognate 71 kDa protein OS=Homo sapiens OX=9606 GN=HSPA8 PE=1 SV=1,31,258,1.567,0.678,2.135,0.834,0.65,-0.56,1.09,-0.26,6.89E-01,9.76E-01,4.03E-01,9.33E-01,2.17E+07,1.05E+07,1.87E+07,2.89E+07,5,5,5,5,1.55E+07,2.17E+07,1.20E+07,6.52E+07,4.80E+07,2.05E+07,3.63E+06,1.05E+07,6.07E+06,4.56E+07,1.60E+07,3.00E+07,1.41E+07,4.95E+07,1.87E+07,3.80E+07,4.01E+07,2.89E+07,1.35E+07,2.77E+07,6.15E+04,8.26E+04,1.18E+05,6.52E+07,2.48E+06,7.29E+04,6.45E+04,9.71E+04,1.71E+05,4.85E+05,9.54E+04,1.34E+06,1.14E+05,6.66E+06,4.64E+05,7.41E+04,1.13E+07,2.05E+05,3.16E+05,2.95E+05,0,FALSE,178.704,51,29,646,70.9,5.52,31,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf00012,3312,hsa:3312; P11142; Q9H3R6,ENSG00000109971,"AUF1 (hnRNP D0) binds and destabilizes mRNA; Neutrophil degranulation; Late endosomal microautophagy; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; PKR-mediated signaling; Regulation of HSF1-mediated heat shock response; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis; mRNA Splicing - Major Pathway; CHL1 interactions; Interleukin-4 and Interleukin-13 signaling; GABA synthesis, release, reuptake and degradation; Lipophagy; Chaperone Mediated Autophagy; Protein methylation; Attenuation phase; Respiratory syncytial virus genome transcription",Parkin-ubiquitin proteasomal system pathway; MAPK signaling pathway; Exercise-induced circadian regulation; Measles virus infection; Opioid receptor pathways; Extrafollicular and follicular B cell activation by SARS-CoV-2; 1p36 copy number variation syndrome; HDAC6 interactions in the central nervous system,27,0,71.11,99.04,57.28,35.53,High,Peak Found,High,High,High,Peak Found,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,124.34,122.92,126.37,118.45,667.49,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,O94826,TOMM70,Mitochondrial import receptor subunit TOM70 OS=Homo sapiens OX=9606 GN=TOMM70 PE=1 SV=1,10,42,1.567,0.849,1.247,1.121,0.65,-0.24,0.32,0.16,6.38E-01,7.62E-01,8.56E-01,8.55E-01,1.91E+06,1.43E+06,2.91E+06,1.85E+06,5,5,5,5,5.43E+05,1.91E+06,1.04E+06,6.23E+06,3.35E+06,3.37E+06,3.64E+05,1.43E+06,9.04E+05,6.61E+06,1.95E+06,2.28E+06,2.91E+06,9.99E+06,5.40E+06,1.52E+06,1.85E+06,1.55E+06,2.48E+06,2.73E+06,2.16E+03,7.27E+03,1.01E+04,6.23E+06,1.73E+05,1.20E+04,6.47E+03,1.32E+04,2.55E+04,7.03E+04,1.17E+04,1.02E+05,2.37E+04,1.35E+06,1.34E+05,2.97E+03,5.19E+05,1.10E+04,5.79E+04,2.91E+04,0,FALSE,60.316,25,10,608,67.4,7.12,10,cell organization and biogenesis;transport;other biological processes,other membranes;mitochondrion,"Pf00515, Pf13181",9868,D3DN48; hsa:9868; O94826,ENSG00000154174,Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Mitochondrial protein import; DDX58/IFIH1-mediated induction of interferon-alpha/beta; SARS-CoV-1 activates/modulates innate immune responses; PINK1-PRKN Mediated Mitophagy,Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,9,0,87.34,100.41,74.3,27.15,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,112.28,109.82,103.42,109.42,112.35,transporter activity;other molecular function,0,
Master Protein,High,P16109,,P-selectin OS=Homo sapiens OX=9606 GN=SELP PE=1 SV=3,7,15,1.564,0.24,1.357,0.241,0.65,-2.06,0.44,-2.05,6.29E-01,2.56E-01,7.22E-01,3.19E-01,1.42E+05,1.03E+06,5.91E+04,1.26E+06,3,5,2,4,1.42E+05,5.91E+06,,,6.04E+04,5.28E+05,1.03E+06,1.12E+06,2.51E+06,1.06E+05,,,,5.68E+04,6.14E+04,1.57E+07,6.88E+05,,2.20E+05,2.32E+06,5.63E+02,2.24E+04,,,3.12E+03,1.88E+03,1.83E+04,1.03E+04,7.07E+04,1.13E+03,,,,7.66E+03,1.53E+03,3.07E+04,1.93E+05,,5.14E+03,2.47E+04,0,FALSE,26.04,11,7,830,90.8,6.6,7,,,,,,,,,0,0,164.62,85.81,5.52,155.78,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,1,,FALSE,100.62,93.52,141.62,70.83,32.05,,0,
Master Protein,High,Q8NBJ5,COLGALT1,Procollagen galactosyltransferase 1 OS=Homo sapiens OX=9606 GN=COLGALT1 PE=1 SV=1,3,3,1.559,0.727,2.626,0.816,0.64,-0.46,1.39,-0.29,6.64E-01,9.72E-01,4.51E-01,9.87E-01,7.52E+04,4.82E+04,5.47E+04,1.27E+05,2,1,2,4,,,,7.56E+04,7.48E+04,,,4.82E+04,,,,1.83E+05,,,1.64E+04,1.74E+05,,1.07E+05,2.58E+04,1.50E+05,,,,7.56E+04,3.86E+03,,,4.45E+02,,,,8.15E+03,,,4.08E+02,3.39E+02,,7.60E+02,6.05E+02,1.59E+03,0,FALSE,11.251,6,3,622,71.6,7.31,3,cell organization and biogenesis;other biological processes,ER/Golgi,"Pf01755, Pf13704",79709,hsa:79709; Q8NBJ5; Q8NC64,ENSG00000130309,Collagen biosynthesis and modifying enzymes,Type I collagen synthesis in the context of osteogenesis imperfecta,2,0,0.7,,118.11,56.93,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,0.73,223.99,41.04,104.15,6.98,other molecular function,0,
Master Protein,High,Q7Z4V5,HDGFL2,Hepatoma-derived growth factor-related protein 2 OS=Homo sapiens OX=9606 GN=HDGFL2 PE=1 SV=1,5,7,1.556,0.048,0.748,0.093,0.64,-4.39,-0.42,-3.42,5.67E-01,1.16E-03,7.43E-01,7.46E-02,3.40E+05,5.74E+04,4.24E+03,8.43E+04,3,4,1,2,,8.92E+04,,3.40E+05,2.05E+06,,6.91E+04,1.91E+05,4.76E+04,1.94E+04,,,,4.24E+03,,,,,1.87E+04,3.79E+05,,3.39E+02,,3.40E+05,1.06E+05,,1.23E+03,1.76E+03,1.34E+03,2.06E+02,,,,5.72E+02,,,,,4.38E+02,4.04E+03,0,FALSE,24.315,10,4,671,74.3,7.49,5,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00855, Pf11467",84717,I3L080; K7EQZ6; Q7Z4V5; Q96GI5; Q9BW08,ENSG00000167674,,,0,0,129.09,92.32,,128.12,n/a,Peak Found,n/a,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,111.58,52.75,114.66,149.65,21.33,other molecular function,0,
Master Protein,High,P49189,ALDH9A1,4-trimethylaminobutyraldehyde dehydrogenase OS=Homo sapiens OX=9606 GN=ALDH9A1 PE=1 SV=3,6,14,1.554,0.614,1.787,0.915,0.64,-0.7,0.84,-0.13,6.06E-01,9.39E-01,5.86E-01,8.96E-01,9.76E+05,5.87E+05,9.21E+05,1.05E+06,4,1,5,5,2.56E+05,4.93E+05,,2.21E+06,1.93E+06,,,,,5.87E+05,2.46E+05,1.73E+06,5.97E+05,1.20E+06,9.21E+05,1.05E+06,5.52E+05,1.89E+06,4.45E+05,2.07E+06,1.02E+03,1.87E+03,,2.21E+06,9.96E+04,,,,,6.24E+03,1.47E+03,7.72E+04,4.85E+03,1.62E+05,2.29E+04,2.05E+03,1.55E+05,1.34E+04,1.04E+04,2.21E+04,0,FALSE,19.729,17,6,494,53.8,5.87,6,cell organization and biogenesis;other metabolic processes,cytosol;other cell component,Pf00171,223,B2R6X1; B4DXY7; B9EKV4; hsa:223; P49189; Q5VV90; Q6LCL1; Q9NZT7,ENSG00000143149,Carnitine synthesis,GABA receptor signaling; Fluoroacetic acid toxicity; Opioid receptor pathways,4,0,81.02,,60.49,62.44,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,116.48,103.32,76.07,88.62,37.01,other molecular function,0,
Master Protein,High,O43818,RRP9,U3 small nucleolar RNA-interacting protein 2 OS=Homo sapiens OX=9606 GN=RRP9 PE=1 SV=1,4,6,1.554,0.145,1.716,,0.64,-2.78,0.78,,5.51E-01,6.04E-02,7.35E-01,,3.70E+05,2.76E+05,8.71E+04,3.07E+05,4,4,2,4,5.09E+05,,2.69E+05,2.08E+05,1.14E+06,3.24E+05,,2.58E+05,9.88E+04,2.94E+05,8.03E+04,,,9.46E+04,,6.67E+05,3.38E+04,,1.41E+05,1.41E+06,2.02E+03,,2.63E+03,2.08E+05,5.87E+04,1.15E+03,,2.38E+03,2.78E+03,3.13E+03,4.80E+02,,,1.27E+04,,1.30E+03,9.50E+03,,3.30E+03,1.51E+04,0,FALSE,15.134,12,4,475,51.8,7.85,4,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf00400,9136,B2R996; hsa:9136; O43818; Q8IZ30,ENSG00000114767,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,80.02,41.17,11.55,111.8,Peak Found,n/a,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,55.06,63.07,127.8,,16.47,nucleic acid binding activity,0,
Master Protein,High,P49411,TUFM,"Elongation factor Tu, mitochondrial OS=Homo sapiens OX=9606 GN=TUFM PE=1 SV=3",24,142,1.552,1.468,1.146,2.458,0.63,0.55,0.2,1.3,6.97E-01,2.67E-01,9.66E-01,3.82E-01,1.78E+07,4.78E+06,4.95E+07,7.88E+06,5,5,5,5,1.78E+07,7.47E+06,9.67E+06,3.31E+07,2.17E+07,2.44E+06,4.78E+06,1.31E+07,3.65E+06,1.42E+07,1.89E+07,4.95E+07,2.18E+07,5.41E+07,7.21E+07,8.52E+06,7.03E+06,7.88E+06,5.14E+06,1.57E+07,7.07E+04,2.84E+04,9.44E+04,3.31E+07,1.12E+06,8.67E+03,8.50E+04,1.21E+05,1.03E+05,1.52E+05,1.13E+05,2.21E+06,1.77E+05,7.29E+06,1.79E+06,1.66E+04,1.97E+06,5.58E+04,1.20E+05,1.68E+05,0,FALSE,129.935,61,24,455,49.8,7.61,24,protein metabolism;other metabolic processes;other biological processes,other membranes;mitochondrion;other cell component,"Pf00009, Pf03143, Pf03144",7284,hsa:7284; O15276; P49411,ENSG00000178952,Mitochondrial translation elongation; SARS-CoV-2 modulates autophagy,16p11.2 distal deletion syndrome,3,0,57.2,73.03,52.21,45.69,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,114.77,109.11,118.57,134.21,360.84,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P04233,CD74,HLA class II histocompatibility antigen gamma chain OS=Homo sapiens OX=9606 GN=CD74 PE=1 SV=3,10,52,1.543,0.658,1.153,1.783,0.63,-0.6,0.21,0.83,6.23E-01,9.41E-01,9.58E-01,5.56E-01,1.54E+06,1.27E+05,5.56E+06,1.43E+06,5,5,4,5,1.42E+06,1.54E+06,2.67E+05,1.32E+07,3.95E+06,6.59E+05,8.74E+04,4.87E+04,1.27E+05,2.30E+06,,1.29E+07,5.35E+05,6.32E+06,4.89E+06,1.47E+05,2.51E+05,1.43E+06,1.48E+06,5.63E+06,5.66E+03,5.86E+03,2.61E+03,1.32E+07,2.04E+05,2.34E+03,1.55E+03,4.49E+02,3.59E+03,2.45E+04,,5.76E+05,4.35E+03,8.52E+05,1.22E+05,2.87E+02,7.04E+04,1.01E+04,3.46E+04,6.00E+04,0,FALSE,68.793,37,10,296,33.5,8.44,10,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00086, Pf08831, Pf09307",972,A8K7R1; B4DNE8; D3DQG3; D3DQG4; hsa:972; P04233; Q14597; Q29832; Q5U0J8; Q8SNA0; Q8WLP6,ENSG00000019582,MHC class II antigen presentation; Cell surface interactions at the vascular wall,Macrophage markers,3,0,129.44,148.74,83.07,125.24,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,114.44,122.8,142.13,120.26,160.24,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q8WVM7,STAG1,Cohesin subunit SA-1 OS=Homo sapiens OX=9606 GN=STAG1 PE=1 SV=3,6,7,1.539,0.899,0.01,100,0.62,-0.15,-6.64,6.64,6.42E-01,7.13E-01,1.00E-17,1.00E-17,2.11E+05,4.14E+04,1.84E+05,,2,1,4,,,,,2.74E+05,1.62E+05,,,,,4.14E+04,,1.43E+04,1.60E+05,2.10E+05,3.20E+05,,,,,,,,,2.74E+05,8.35E+03,,,,,4.40E+02,,6.38E+02,1.30E+03,2.84E+04,7.95E+03,,,,,,0,FALSE,16.903,6,4,1258,144.3,5.59,6,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf08514, Pf21581",10274,hsa:10274; O00539; Q6P275; Q8WVM7,ENSG00000118007,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Meiotic synapsis; Estrogen-dependent gene expression; SUMOylation of DNA damage response and repair proteins; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,Cell cycle; Regulation of sister chromatid separation at the metaphase-anaphase transition; 10q22q23 copy number variation,10,0,36.39,,72,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,80.87,,,16.68,other molecular function,0,
Master Protein,High,A0A140T9T7,TAP1,ABC-type antigen peptide transporter OS=Homo sapiens OX=9606 GN=TAP1 PE=1 SV=1,5,9,1.536,0.247,0.281,0.334,0.62,-2.02,-1.83,-1.58,5.78E-01,1.96E-01,1.94E-01,4.79E-01,5.22E+05,1.95E+05,9.08E+04,2.26E+05,4,3,4,2,,5.03E+05,2.56E+05,2.47E+06,5.41E+05,3.13E+06,1.74E+05,,1.95E+05,,1.22E+05,1.23E+06,,3.26E+04,6.74E+04,1.25E+06,4.09E+04,,,,,1.91E+03,2.50E+03,2.47E+06,2.79E+04,1.11E+04,3.10E+03,,5.51E+03,,7.31E+02,5.50E+04,,4.40E+03,1.68E+03,2.43E+03,1.15E+04,,,,0,FALSE,27.831,11,5,808,87.1,8.02,5,transport;other biological processes,other membranes,"Pf00005, Pf00664",,A0A140T9T7,ENSG00000224748,,,0,0,108.76,145.79,159.54,132.44,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,61.77,100.8,20.03,118.26,36.76,transporter activity;other molecular function,0,
Master Protein,High,K7ELL7,PRKCSH,Glucosidase 2 subunit beta OS=Homo sapiens OX=9606 GN=PRKCSH PE=1 SV=1,16,129,1.533,0.687,1.926,0.479,0.62,-0.54,0.95,-1.06,7.08E-01,9.92E-01,4.81E-01,5.64E-01,3.00E+07,3.62E+07,2.05E+07,4.59E+07,5,5,5,5,5.19E+06,1.13E+08,9.67E+05,3.00E+07,7.70E+07,2.40E+07,6.46E+07,1.49E+08,1.12E+07,3.62E+07,4.15E+06,1.55E+07,2.97E+07,3.25E+07,2.05E+07,4.59E+07,1.61E+07,5.89E+07,3.18E+07,6.78E+07,2.06E+04,4.30E+05,9.45E+03,3.00E+07,3.97E+06,8.54E+04,1.15E+06,1.37E+06,3.15E+05,3.85E+05,2.48E+04,6.93E+05,2.41E+05,4.38E+06,5.10E+05,8.95E+04,4.52E+06,4.17E+05,7.44E+05,7.22E+05,0,FALSE,100.462,44,16,535,60.2,4.41,16,other metabolic processes;developmental processes;other biological processes,ER/Golgi,"Pf12999, Pf13015, Pf13202",5589,K7ELL7,ENSG00000130175,,,0,0,107.2,96.64,55.75,47.01,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,High,Peak Found,1,,FALSE,126.15,119.32,124.83,108.2,356.21,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O14979,HNRNPDL,Heterogeneous nuclear ribonucleoprotein D-like OS=Homo sapiens OX=9606 GN=HNRNPDL PE=1 SV=3,7,30,1.532,1.287,3.041,0.401,0.62,0.36,1.6,-1.32,6.34E-01,3.77E-01,2.06E-01,5.53E-01,3.97E+05,5.39E+05,6.72E+05,1.37E+06,3,3,4,3,1.93E+05,,,2.20E+06,3.97E+05,,1.09E+06,5.39E+05,,4.70E+05,,5.60E+05,8.06E+05,3.47E+06,4.78E+05,6.41E+05,,2.04E+06,,1.37E+06,7.66E+02,,,2.20E+06,2.05E+04,,1.94E+04,4.97E+03,,5.00E+03,,2.50E+04,6.55E+03,4.68E+05,1.19E+04,1.25E+03,,1.44E+04,,1.46E+04,0,FALSE,18.762,13,5,420,46.4,9.57,7,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus,Pf00076,9987,hsa:9987; O14979; Q6SPF2; Q7KZ74; Q7KZ75; Q96IM0; Q96S43,ENSG00000152795,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,,1,0,118.86,48.68,108.04,51.75,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,162.84,54.75,0,45.3,64.82,nucleic acid binding activity,0,
Master Protein,High,Q14676,MDC1,Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens OX=9606 GN=MDC1 PE=1 SV=3,14,30,1.526,0.971,2.089,4.384,0.61,-0.04,1.06,2.13,6.83E-01,6.03E-01,5.23E-01,1.30E-01,3.62E+06,5.71E+05,9.72E+05,6.58E+05,3,4,4,2,,3.62E+06,1.02E+07,1.64E+06,,,1.04E+06,1.44E+06,3.13E+05,1.35E+04,,8.38E+05,6.06E+05,1.13E+06,1.51E+06,,,,1.44E+05,3.01E+06,,1.38E+04,9.96E+04,1.64E+06,,,1.85E+04,1.33E+04,8.82E+03,1.44E+02,,3.74E+04,4.92E+03,1.52E+05,3.75E+04,,,,3.37E+03,3.20E+04,0,FALSE,76.818,15,14,2089,226.5,5.47,14,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,"Pf00498, Pf16589, Pf16770",9656,A2AB04; A2BF04; A2RRA8; A7YY86; B0S8A2; hsa:9656; Q0EFC2; Q14676; Q2L6H7; Q2TAZ4; Q5JP55; Q5JP56; Q5ST83; Q68CQ3; Q86Z06; Q96QC2,ENSG00000137337; ENSG00000206481; ENSG00000224587; ENSG00000225589; ENSG00000228575; ENSG00000231135; ENSG00000234012; ENSG00000237095,SUMOylation of DNA damage response and repair proteins; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; TP53 Regulates Transcription of DNA Repair Genes; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ),ATM signaling in development and disease ; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; NIPBL role in DNA damage - Cornelia de Lange syndrome,9,0,86.85,93.25,38.16,128.51,n/a,Peak Found,Peak Found,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,High,High,High,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,101.06,45.13,0,18.4,107.5,other molecular function,0,
Master Protein,High,Q9Y383,LUC7L2,Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=1 SV=2,7,22,1.517,0.143,1.985,0.951,0.6,-2.81,0.99,-0.07,7.16E-01,1.78E-02,4.57E-01,8.98E-01,4.24E+06,4.21E+06,1.29E+05,9.96E+05,4,3,3,5,,1.21E+07,5.35E+05,3.87E+06,4.64E+06,,,4.21E+06,1.22E+06,1.09E+08,,1.29E+05,,4.55E+05,1.29E+05,9.96E+05,2.44E+04,1.12E+06,4.72E+05,1.06E+06,,4.59E+04,5.22E+03,3.87E+06,2.39E+05,,,3.88E+04,3.45E+04,1.16E+06,,5.77E+03,,6.14E+04,3.19E+03,1.94E+03,6.86E+03,7.95E+03,1.10E+04,1.13E+04,0,FALSE,36.642,24,5,392,46.5,10.01,7,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus,Pf03194,51631,B7Z500; hsa:51631; Q8IUP9; Q9NVL3; Q9NVN7; Q9UQN1; Q9Y383,ENSG00000146963,,,0,2,92.18,160.93,79.31,64.48,n/a,Peak Found,High,High,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,146.6,94.09,123.07,117.7,64.94,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A1B0GVH5,FTO,Alpha-ketoglutarate-dependent dioxygenase FTO OS=Homo sapiens OX=9606 GN=FTO PE=1 SV=1,2,4,1.514,0.445,0.792,,0.6,-1.17,-0.34,,6.77E-01,6.05E-01,8.10E-01,,1.10E+05,3.02E+04,4.54E+04,2.39E+04,2,2,3,1,9.75E+04,,,1.24E+05,,,,,3.26E+04,2.80E+04,1.12E+05,,,4.54E+04,2.64E+04,,,,2.39E+04,,3.87E+02,,,1.24E+05,,,,,9.20E+02,2.98E+02,6.67E+02,,,6.12E+03,6.56E+02,,,,5.60E+02,,0,FALSE,8.555,5,2,559,64.1,5.38,2,DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf12933, Pf12934",,A0A1B0GVH5,ENSG00000140718,,,0,0,16.69,10.81,73.13,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,113.94,87.93,11.37,,11.52,other molecular function,0,
Master Protein,High,O14657,TOR1B,Torsin-1B OS=Homo sapiens OX=9606 GN=TOR1B PE=1 SV=2,1,1,1.505,0.01,0.01,,0.59,-6.64,-6.64,,6.19E-01,1.00E-17,1.00E-17,,2.09E+05,1.39E+05,,,4,2,,,1.41E+06,,5.91E+05,7.37E+04,6.18E+04,,1.93E+05,,9.95E+04,,,,,,,,,,,,5.59E+03,,5.77E+03,7.37E+04,3.19E+03,,3.43E+03,,2.80E+03,,,,,,,,,,,,0.001,FALSE,3.315,4,1,336,38,8.54,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,other membranes;ER/Golgi;nucleus,"Pf06309, Pf21376",27348,hsa:27348; O14657,ENSG00000136816,Cargo recognition for clathrin-mediated endocytosis,,1,0,118.58,45.27,,,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,134.89,,,,2.64,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q8IX12,CCAR1,Cell division cycle and apoptosis regulator protein 1 OS=Homo sapiens OX=9606 GN=CCAR1 PE=1 SV=2,9,19,1.5,0.261,1.06,1.143,0.58,-1.94,0.08,0.19,6.55E-01,1.59E-01,8.86E-01,7.47E-01,2.32E+06,2.81E+05,1.04E+06,3.55E+05,4,3,5,5,3.97E+06,,9.99E+05,3.66E+06,1.47E+06,,1.03E+05,2.81E+05,1.33E+06,,1.04E+06,1.74E+05,1.04E+06,1.29E+06,3.61E+05,2.50E+05,6.90E+04,3.55E+05,3.62E+05,3.76E+05,1.58E+04,,9.76E+03,3.66E+06,7.60E+04,,1.83E+03,2.59E+03,3.76E+04,,6.22E+03,7.77E+03,8.44E+03,1.74E+05,8.98E+03,4.88E+02,1.94E+04,2.51E+03,8.47E+03,4.01E+03,0,FALSE,37.246,11,9,1150,132.7,5.76,9,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes,nucleus;other cell component,"Pf02037, Pf14443, Pf14444, Pf19256, Pf19257",55749,A0JLT7; A1L4P7; A8K9D4; B4DNP8; B4DRK8; hsa:55749; Q32NE3; Q5EBM3; Q5VUP6; Q6PIZ0; Q6X935; Q8IX12; Q9H8N4; Q9NVA7; Q9NVQ0; Q9NWM6,ENSG00000060339,mRNA Splicing - Major Pathway,,1,0,59.67,116.16,61.99,45.8,Peak Found,n/a,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,122.72,110.01,84.21,114.16,65.81,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y5Q8,GTF3C5,General transcription factor 3C polypeptide 5 OS=Homo sapiens OX=9606 GN=GTF3C5 PE=1 SV=2,1,3,1.498,0.395,0.56,1.292,0.58,-1.34,-0.84,0.37,7.07E-01,5.71E-01,5.56E-01,7.04E-01,7.74E+04,5.02E+04,3.06E+04,2.81E+04,3,2,5,4,,8.51E+04,,6.66E+04,7.74E+04,7.92E+04,,,,3.19E+04,7.47E+04,3.06E+04,2.46E+04,9.10E+04,1.95E+04,,1.61E+03,1.16E+05,2.12E+04,3.73E+04,,3.23E+02,,6.66E+04,3.99E+03,2.82E+02,,,,3.39E+02,4.47E+02,1.37E+03,2.00E+02,1.23E+04,4.85E+02,,4.54E+02,8.22E+02,4.97E+02,3.97E+02,0.001,FALSE,3.517,3,1,519,59.5,6.9,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf09734, Pf17682",9328,A6NI44; A6NJB9; hsa:9328; Q5T7U2; Q5T7U3; Q8N2U7; Q8N857; Q96GD9; Q9H4P2; Q9Y5Q8,ENSG00000148308,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter,,3,0,12.15,60.22,67.58,113.88,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,61.74,81.6,108.51,120.95,6.44,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P16157,ANK1,Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3,63,466,1.495,0.632,2.011,0.421,0.58,-0.66,1.01,-1.25,7.29E-01,8.93E-01,4.47E-01,4.90E-01,1.44E+07,1.63E+07,1.57E+07,3.48E+07,5,5,5,5,5.40E+08,1.29E+07,2.35E+08,3.40E+06,1.44E+07,2.46E+07,2.99E+07,1.06E+07,9.84E+06,1.63E+07,2.89E+08,5.30E+06,3.12E+07,1.57E+07,1.29E+07,2.05E+07,1.89E+08,3.48E+07,5.10E+07,2.04E+07,2.15E+06,4.91E+04,2.30E+06,3.40E+06,7.43E+05,8.76E+04,5.32E+05,9.82E+04,2.77E+05,1.73E+05,1.73E+06,2.37E+05,2.53E+05,2.12E+06,3.21E+05,4.00E+04,5.31E+07,2.47E+05,1.19E+06,2.17E+05,0,FALSE,432.744,49,63,1881,206.1,6.01,63,cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component,"Pf00023, Pf00531, Pf00791, Pf17809",286,A0PJN8; A6NJ23; E5RFL7; hsa:286; O43400; P16157; Q13768; Q53ER1; Q59FP2; Q8N604; Q99407,ENSG00000029534,COPI-mediated anterograde transport; CHL1 interactions; Neurofascin interactions; Interaction between L1 and Ankyrins; NrCAM interactions,,5,0,144.7,48.15,172.66,113.15,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,High,High,High,Peak Found,Peak Found,High,High,High,Peak Found,1,,FALSE,128.09,139.26,122.34,132.24,1231.26,cytoskeletal activity;other molecular function,0,
Master Protein,High,P43304,GPD2,"Glycerol-3-phosphate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=GPD2 PE=1 SV=3",5,10,1.492,0.295,0.793,1.182,0.58,-1.76,-0.34,0.24,6.67E-01,2.14E-01,7.03E-01,7.65E-01,2.68E+06,6.34E+05,2.04E+06,6.68E+05,5,5,5,5,5.39E+06,4.06E+06,2.68E+06,1.12E+06,5.35E+04,8.53E+05,5.04E+04,6.34E+05,3.65E+05,9.96E+05,4.00E+06,1.02E+05,1.24E+06,2.79E+06,2.04E+06,2.80E+06,2.77E+05,2.17E+06,2.89E+05,6.68E+05,2.14E+04,1.54E+04,2.61E+04,1.12E+06,2.76E+03,3.03E+03,8.97E+02,5.85E+03,1.03E+04,1.06E+04,2.39E+04,4.55E+03,1.00E+04,3.76E+05,5.08E+04,5.46E+03,7.78E+04,1.54E+04,6.77E+03,7.11E+03,0,FALSE,18.343,10,5,727,80.8,7.69,5,other metabolic processes,other membranes;mitochondrion;other cell component,"Pf01266, Pf16901",2820,A8K4V0; B3KSA9; hsa:2820; P43304; Q59FR1; Q9HAP9,ENSG00000115159,Triglyceride catabolism; Synthesis of PA,Fatty acid beta-oxidation,3,0,80.99,65.52,72.88,94.14,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,133.09,134.6,115.62,123.28,31.23,other molecular function,0,
Master Protein,High,P09110,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal OS=Homo sapiens OX=9606 GN=ACAA1 PE=1 SV=2",2,3,1.486,0.411,0.933,0.654,0.57,-1.28,-0.1,-0.61,6.74E-01,5.61E-01,8.89E-01,8.68E-01,1.21E+05,8.14E+04,4.97E+04,7.59E+04,1,1,1,2,,,,1.21E+05,,,,8.14E+04,,,,,4.97E+04,,,,1.97E+05,,2.92E+04,,,,,1.21E+05,,,,7.51E+02,,,,,4.03E+02,,,,5.54E+04,,6.84E+02,,0,FALSE,10.654,9,2,424,44.3,8.44,2,other metabolic processes,non-structural extracellular;cytosol;other cytoplasmic organelle;other cell component,"Pf00108, Pf02803",30,G5E935; hsa:30; P09110; Q96CA6,ENSG00000060971,Neutrophil degranulation; TYSND1 cleaves peroxisomal proteins; alpha-linolenic acid (ALA) metabolism; Beta-oxidation of very long chain fatty acids,PPAR-alpha pathway; Nuclear receptors meta-pathway; Amino acid metabolism; PPAR signaling pathway; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX),11,0,,,,104.89,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,0,163.93,163.93,9.09,other molecular function,0,
Master Protein,High,O43290,SART1,U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens OX=9606 GN=SART1 PE=1 SV=1,10,16,1.486,0.242,0.9,0.582,0.57,-2.04,-0.15,-0.78,6.52E-01,1.50E-01,7.59E-01,7.64E-01,8.87E+05,5.52E+04,2.72E+05,7.27E+05,3,2,5,4,,1.12E+05,,2.79E+06,8.87E+05,,,,1.27E+04,2.39E+05,3.11E+04,3.71E+05,5.75E+04,6.05E+05,2.72E+05,,5.00E+05,9.85E+05,5.37E+05,1.00E+06,,4.26E+02,,2.79E+06,4.57E+04,,,,3.59E+02,2.55E+03,1.86E+02,1.66E+04,4.67E+02,8.15E+04,6.76E+03,,1.40E+05,6.98E+03,1.26E+04,1.06E+04,0,FALSE,32.646,18,10,800,90.2,6.13,10,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,"Pf03343, Pf19252",9092,A6NDN1; hsa:9092; O43290; Q53GB5,ENSG00000175467,mRNA Splicing - Major Pathway,,1,0,109.17,127.13,88.64,36.29,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,2.5,72.95,19.24,123.58,46.47,,0,
Master Protein,High,P50453,SERPINB9,Serpin B9 OS=Homo sapiens OX=9606 GN=SERPINB9 PE=1 SV=1,8,19,1.48,0.49,0.256,2.468,0.57,-1.03,-1.97,1.3,6.77E-01,6.64E-01,1.07E-01,3.17E-01,2.61E+06,5.18E+05,5.61E+05,1.72E+05,5,5,5,4,2.03E+05,5.68E+06,2.61E+06,3.04E+06,1.12E+06,6.77E+05,2.04E+05,5.18E+05,2.76E+04,6.48E+05,5.61E+05,2.96E+05,1.78E+05,1.16E+06,9.34E+05,,1.09E+05,3.50E+06,2.72E+05,5.46E+04,8.05E+02,2.16E+04,2.55E+04,3.04E+06,5.78E+04,2.41E+03,3.64E+03,4.78E+03,7.78E+02,6.90E+03,3.35E+03,1.32E+04,1.44E+03,1.57E+05,2.32E+04,,3.07E+04,2.48E+04,6.36E+03,5.81E+02,0,FALSE,42.615,29,8,376,42.4,5.86,8,other biological processes,non-structural extracellular;cytosol;ER/Golgi;nucleus;other cell component,Pf00079,5272,B2RBW3; hsa:5272; P50453; Q5TD03,ENSG00000170542,,Glucocorticoid receptor pathway; Nuclear receptors meta-pathway,2,0,82.83,69,66.61,170.75,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,109.05,88.23,77.59,88.57,57.99,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q86TM6,SYVN1,E3 ubiquitin-protein ligase synoviolin OS=Homo sapiens OX=9606 GN=SYVN1 PE=1 SV=2,2,4,1.476,0.354,0.521,0.45,0.56,-1.5,-0.94,-1.15,6.86E-01,4.74E-01,5.16E-01,6.43E-01,1.02E+05,6.72E+04,2.58E+04,3.50E+04,4,1,5,3,,1.66E+05,6.26E+04,4.76E+05,2.60E+04,,,,,6.72E+04,3.35E+04,1.66E+04,4.91E+04,2.58E+04,1.50E+04,1.31E+05,7.02E+03,,3.50E+04,,,6.30E+02,6.12E+02,4.76E+05,1.34E+03,,,,,7.15E+02,2.00E+02,7.41E+02,3.99E+02,3.47E+03,3.72E+02,2.56E+02,1.97E+03,,8.19E+02,,0,FALSE,5.909,3,2,617,67.6,6.95,2,protein metabolism;other metabolic processes;stress response;transport;other biological processes,other membranes;ER/Golgi;nucleus;other cell component,Pf13639,84447,hsa:84447; Q86TM6; Q8N3K3; Q8N6E8; Q96JL5; Q96PK3,ENSG00000162298,Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; ER Quality Control Compartment (ERQC); XBP1(S) activates chaperone genes,,4,0,111.92,,49.89,112.75,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,95.17,106.63,108.66,118.48,7.55,other molecular function,0,
Master Protein,High,P09012,SNRPA,U1 small nuclear ribonucleoprotein A OS=Homo sapiens OX=9606 GN=SNRPA PE=1 SV=3,5,13,1.471,0.183,1.108,0.301,0.56,-2.45,0.15,-1.73,6.02E-01,9.37E-02,9.29E-01,3.58E-01,4.41E+05,1.69E+05,5.72E+04,4.25E+05,4,4,4,2,2.33E+05,,3.32E+05,1.62E+06,5.85E+05,,9.34E+04,5.31E+05,1.48E+05,1.92E+05,,1.89E+05,3.71E+04,8.81E+04,1.55E+04,,,2.10E+05,,8.63E+05,9.26E+02,,3.24E+03,1.62E+06,3.02E+04,,1.66E+03,4.90E+03,4.18E+03,2.05E+03,,8.46E+03,3.01E+02,1.19E+04,3.85E+02,,,1.49E+03,,9.19E+03,0,FALSE,38.085,30,4,282,31.3,9.83,5,RNA metabolism OR transcription;other metabolic processes,nucleus,Pf00076,6626,hsa:6626; P09012,ENSG00000077312,mRNA Splicing - Major Pathway,mRNA processing,2,0,91.82,81.79,93.93,86.13,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,106.89,98.5,68.63,110.85,38.55,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A494C1N0,FKBP2,peptidylprolyl isomerase OS=Homo sapiens OX=9606 GN=FKBP2 PE=1 SV=1,3,15,1.471,1.32,3.054,1.064,0.56,0.4,1.61,0.09,6.60E-01,2.87E-01,3.38E-01,8.23E-01,8.28E+05,1.61E+05,8.73E+05,2.32E+05,3,2,5,5,,2.69E+05,,8.28E+05,8.95E+05,,,,5.39E+05,4.83E+04,5.49E+04,8.73E+05,5.14E+06,1.14E+06,3.13E+05,2.32E+05,9.42E+05,2.85E+05,1.89E+05,3.29E+04,,1.02E+03,,8.28E+05,4.62E+04,,,,1.52E+04,5.13E+02,3.28E+02,3.90E+04,4.17E+04,1.54E+05,7.78E+03,4.53E+02,2.65E+05,2.02E+03,4.43E+03,3.50E+02,0,FALSE,8.43,16,3,171,18.6,8.88,3,protein metabolism;other metabolic processes,other membranes,Pf00254,,A0A494C1N0,ENSG00000173486,,Complement system,1,0,51.73,118.17,138.11,104.55,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,68.87,125.38,79.47,118.38,28.57,other molecular function,0,
Master Protein,High,Q13435,SF3B2,Splicing factor 3B subunit 2 OS=Homo sapiens OX=9606 GN=SF3B2 PE=1 SV=2,14,23,1.469,0.266,3.983,0.097,0.55,-1.91,1.99,-3.36,6.53E-01,1.58E-01,1.03E-01,4.64E-02,1.01E+06,4.17E+05,1.04E+06,7.20E+06,5,2,3,3,3.98E+05,1.01E+06,2.38E+05,6.07E+06,2.67E+06,,4.03E+05,,,4.32E+05,6.13E+05,2.99E+06,,1.04E+06,,,,7.87E+06,1.75E+05,7.20E+06,1.58E+03,3.85E+03,2.33E+03,6.07E+06,1.38E+05,,7.16E+03,,,4.59E+03,3.66E+03,1.34E+05,,1.40E+05,,,,5.58E+04,4.10E+03,7.66E+04,0,FALSE,75.95,27,14,895,100.2,5.67,14,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf02037, Pf04037, Pf04046",10992,A8K485; B4DT19; hsa:10992; Q13435; Q7L4T5; Q7Z627; Q969K1; Q96CM6; Q9BWD2,ENSG00000087365,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing,3,0,116.98,4.87,81.86,83.88,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,57.5,116.94,21.31,123.85,82.44,,0,
Master Protein,High,Q8WWY3,PRPF31,U4/U6 small nuclear ribonucleoprotein Prp31 OS=Homo sapiens OX=9606 GN=PRPF31 PE=1 SV=2,4,7,1.466,0.304,0.443,0.802,0.55,-1.72,-1.18,-0.32,6.73E-01,2.70E-01,4.35E-01,9.55E-01,1.22E+06,7.13E+04,3.84E+04,6.95E+04,4,1,4,2,5.12E+06,,2.57E+06,5.77E+05,2.83E+04,7.13E+04,,,,,,3.10E+04,3.53E+04,4.81E+05,4.18E+04,8.86E+04,,,5.46E+04,,2.04E+04,,2.51E+04,5.77E+05,1.46E+03,2.54E+02,,,,,,1.38E+03,2.86E+02,6.48E+04,1.04E+03,1.73E+02,,,1.28E+03,,0,FALSE,14.759,12,4,499,55.4,5.78,4,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf01798, Pf09785",26121,E7ESA8; F1T0A4; F1T0A5; hsa:26121; Q17RB4; Q8N7F9; Q8WWY3; Q9H271; Q9Y439,ENSG00000105618; ENSG00000274144; ENSG00000274651; ENSG00000274894; ENSG00000275117; ENSG00000275885; ENSG00000276421; ENSG00000277154; ENSG00000277707; ENSG00000277953,mRNA Splicing - Major Pathway,,1,0,111.21,,151.07,33.63,Peak Found,n/a,High,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,56,107.11,0,62.46,21.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P42677,RPS27,40S ribosomal protein S27 OS=Homo sapiens OX=9606 GN=RPS27 PE=1 SV=3,2,12,1.465,0.465,3.566,0.269,0.55,-1.1,1.83,-1.89,6.84E-01,6.05E-01,1.28E-01,2.91E-01,1.82E+06,1.77E+06,3.30E+05,2.41E+06,5,5,5,5,8.74E+05,1.82E+06,7.57E+05,1.91E+06,5.40E+06,1.77E+06,2.06E+06,6.16E+05,2.26E+05,2.50E+06,1.75E+06,3.30E+05,2.74E+05,7.11E+05,1.70E+05,2.41E+06,8.72E+05,1.55E+07,5.78E+05,1.54E+07,3.47E+03,6.90E+03,7.39E+03,1.91E+06,2.79E+05,6.31E+03,3.65E+04,5.69E+03,6.37E+03,2.65E+04,1.04E+04,1.47E+04,2.22E+03,9.58E+04,4.22E+03,4.71E+03,2.45E+05,1.10E+05,1.35E+04,1.64E+05,0,FALSE,8.712,23,2,84,9.5,9.45,2,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf01667,6232,hsa:6232; P42677; Q5T4L6,ENSG00000177954,"Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,25,0,87.95,67.6,100.26,112.03,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,1,,FALSE,136.7,115.32,137.16,118.19,30.91,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P13073,COX4I1,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial OS=Homo sapiens OX=9606 GN=COX4I1 PE=1 SV=1",8,40,1.464,0.403,2.303,1.032,0.55,-1.31,1.2,0.05,7.47E-01,4.26E-01,3.51E-01,9.17E-01,7.57E+06,2.86E+06,1.12E+07,3.13E+06,5,5,5,5,1.82E+06,7.57E+06,1.33E+05,2.89E+07,8.76E+06,3.86E+06,4.89E+05,2.86E+06,1.91E+06,3.89E+06,1.54E+06,1.38E+07,7.78E+06,1.12E+07,1.37E+07,1.60E+06,9.96E+06,3.13E+06,1.83E+06,4.62E+06,7.22E+03,2.88E+04,1.30E+03,2.89E+07,4.52E+05,1.37E+04,8.69E+03,2.64E+04,5.38E+04,4.13E+04,9.18E+03,6.16E+05,6.32E+04,1.50E+06,3.42E+05,3.13E+03,2.80E+06,2.22E+04,4.27E+04,4.92E+04,0,FALSE,37.111,36,8,169,19.6,9.51,8,other metabolic processes;transport,other membranes;cytosol;mitochondrion;nucleus,Pf02936,1327,B2R4J2; D3DUM7; hsa:1327; P13073; Q6P666,ENSG00000131143,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly; 5q35 copy number variation,8,0,121.72,55.19,53.49,80.98,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,130.01,114.79,112.44,120.77,109.8,transporter activity,0,
Master Protein,High,P49748,ACADVL,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADVL PE=1 SV=1",16,86,1.463,1.024,1.408,1.571,0.55,0.03,0.49,0.65,7.47E-01,5.63E-01,7.60E-01,6.33E-01,8.16E+06,4.80E+06,9.21E+06,1.42E+07,5,5,5,5,6.18E+05,8.16E+06,6.71E+05,9.45E+06,2.32E+07,1.41E+06,4.80E+06,1.19E+07,2.21E+06,3.17E+07,1.71E+06,4.21E+06,9.21E+06,2.84E+07,2.06E+07,1.42E+07,3.80E+06,6.54E+06,1.98E+07,3.59E+08,2.46E+03,3.10E+04,6.55E+03,9.45E+06,1.20E+06,5.01E+03,8.54E+04,1.10E+05,6.23E+04,3.37E+05,1.02E+04,1.88E+05,7.48E+04,3.82E+06,5.12E+05,2.76E+04,1.07E+06,4.63E+04,4.65E+05,3.82E+06,0,FALSE,78.027,29,16,655,70.3,8.75,16,other metabolic processes;stress response;other biological processes,other membranes;mitochondrion;nucleus,"Pf00441, Pf02770, Pf02771, Pf21343",37,B4DEB6; F5H2A9; hsa:37; O76056; P49748; Q8WUL0,ENSG00000072778,XBP1(S) activates chaperone genes; Beta oxidation of palmitoyl-CoA to myristoyl-CoA,Fatty acid beta-oxidation; Mitochondrial long chain fatty acid beta-oxidation,4,0,109.62,121.22,88.33,193.03,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,1,,FALSE,127.41,105.04,126.05,116.25,248.63,other molecular function,0,
Master Protein,High,Q9Y450,HBS1L,HBS1-like protein OS=Homo sapiens OX=9606 GN=HBS1L PE=1 SV=1,1,1,1.456,0.01,1.207,0.01,0.54,-6.64,0.27,-6.64,7.05E-01,1.00E-17,9.20E-01,1.00E-17,8.48E+04,5.83E+04,,7.16E+04,2,2,,3,,1.01E+05,7.11E+04,,,1.05E+05,3.23E+04,,,,,,,,,,7.50E+04,7.16E+04,,6.59E+04,,3.85E+02,6.95E+02,,,3.73E+02,5.75E+02,,,,,,,,,,2.11E+04,5.07E+02,,7.02E+02,0.001,FALSE,3.245,3,1,684,75.4,6.61,1,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;signal transduction,cytosol;translational apparatus;other cell component,"Pf00009, Pf03143, Pf03144, Pf08938",10767,B7Z365; hsa:10767; Q4VX89; Q4VX90; Q5T7G3; Q8NDW9; Q9UPW3; Q9Y450,ENSG00000112339,mRNA decay by 3' to 5' exoribonuclease,,1,0,24.67,74.81,,6.48,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,77.48,,86.64,,2.15,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A8MXP9,MATR3,Matrin 3 OS=Homo sapiens OX=9606 GN=MATR3 PE=1 SV=1,16,48,1.455,0.214,0.955,0.955,0.54,-2.22,-0.07,-0.07,7.52E-01,8.36E-02,8.49E-01,9.71E-01,7.56E+06,2.92E+06,1.59E+06,5.58E+06,5,5,5,5,5.34E+05,9.74E+06,7.56E+06,6.49E+06,1.43E+07,2.92E+06,1.90E+06,5.35E+06,1.18E+06,4.72E+06,2.23E+06,5.50E+05,1.59E+06,4.05E+06,1.15E+06,6.20E+06,1.51E+05,5.58E+06,1.92E+06,6.99E+06,2.12E+03,3.70E+04,7.39E+04,6.49E+06,7.37E+05,1.04E+04,3.37E+04,4.93E+04,3.32E+04,5.02E+04,1.33E+04,2.46E+04,1.29E+04,5.45E+05,2.86E+04,1.21E+04,4.24E+04,3.95E+04,4.50E+04,7.44E+04,0,FALSE,64.861,26,16,895,99.9,6.04,16,,nucleus,,,A8MXP9,ENSG00000280987,,,0,0,64.89,55.64,70.08,71.22,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,123.21,109.39,133.47,123,138.33,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UBN7,HDAC6,Histone deacetylase 6 OS=Homo sapiens OX=9606 GN=HDAC6 PE=1 SV=2,2,2,1.454,0.374,0.953,0.273,0.54,-1.42,-0.07,-1.87,6.21E-01,4.61E-01,8.17E-01,3.35E-01,1.86E+05,2.52E+05,6.96E+04,3.63E+05,3,3,1,4,,2.74E+06,1.86E+05,8.29E+04,,1.04E+05,2.52E+05,1.04E+06,,,,6.96E+04,,,,3.91E+05,2.47E+05,9.89E+05,,3.37E+05,,1.04E+04,1.82E+03,8.29E+04,,3.69E+02,4.49E+03,9.57E+03,,,,3.11E+03,,,,7.62E+02,6.93E+04,7.01E+03,,3.59E+03,0,FALSE,10.726,4,2,1215,131.3,5.3,2,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,"Pf00850, Pf02148",10013,hsa:10013; O94975; Q6NT75; Q7L3E5; Q96CY0; Q9UBN7,ENSG00000094631,Late endosomal microautophagy; Cilium Assembly; Aggrephagy; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Transcriptional regulation by RUNX2; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; RUNX2 regulates osteoblast differentiation; Chaperone Mediated Autophagy; HSF1 activation,Neural crest differentiation; Ectoderm differentiation; Ectoderm differentiation; Ethanol effects on histone modifications; 7q11.23 copy number variation syndrome; HDAC6 interactions in the central nervous system,17,0,150.11,108.03,,68.74,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,130.79,0,124.84,41.8,7.57,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,D6RH30,NFKB1,Nuclear factor NF-kappa-B p105 subunit OS=Homo sapiens OX=9606 GN=NFKB1 PE=1 SV=2,3,5,1.453,0.269,0.798,0.47,0.54,-1.9,-0.33,-1.09,6.85E-01,2.56E-01,7.72E-01,6.69E-01,1.31E+05,1.02E+05,1.63E+05,8.46E+04,4,4,3,2,9.45E+04,3.70E+05,,1.06E+05,1.62E+05,,3.44E+04,2.29E+05,4.53E+04,3.26E+05,,2.16E+05,,1.63E+05,1.29E+05,,,2.64E+05,2.71E+04,,3.75E+02,1.41E+03,,1.06E+05,8.36E+03,,6.12E+02,2.11E+03,1.28E+03,3.47E+03,,9.63E+03,,2.19E+04,3.20E+03,,,1.87E+03,6.34E+02,,0,FALSE,6.909,5,3,977,106.4,5.5,3,signal transduction;other biological processes,cytosol;mitochondrion;nucleus,"Pf00531, Pf00554, Pf12796, Pf16179",,D6RH30,ENSG00000109320,,"Alzheimer's disease and miRNA effects; Neural crest differentiation; Quercetin and Nf-kB / AP-1 induced apoptosis; Ebstein-Barr virus LMP1 signaling; Melatonin metabolism and effects; RAC1/PAK1/p38/MMP2 pathway; Initiation of transcription and translation elongation at the HIV-1 LTR; NAD metabolism, sirtuins and aging; Hepatitis C and hepatocellular carcinoma; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; TLR4 signaling and tolerance; Toll-like receptor signaling related to MyD88; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; MYD88 distinct input-output pathway; ATM signaling in development and disease ; Chemokine signaling pathway; Oxidative damage response; miRNA regulation of prostate cancer signaling pathways; Prion disease pathway; NO/cGMP/PKG mediated neuroprotection; Fibrin complement receptor 3 signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Ras signaling; Pancreatic adenocarcinoma pathway; miRNA role in immune response in sepsis; ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; Non-genomic actions of 1,25 dihydroxyvitamin D3; Ciliary landscape; Interactions between immune cells and microRNAs in tumor microenvironment; Canonical NF-kB pathway; Cancer immunotherapy by PD-1 blockade; Head and neck squamous cell carcinoma; Aspirin and miRNAs; Autosomal recessive osteopetrosis pathways; FGF23 signaling in hypophosphatemic rickets and related disorders; Kisspeptin/kisspeptin receptor system in the ovary; Activation of NLRP3 inflammasome by SARS-CoV-2; Host-pathogen interaction of human coronaviruses - interferon induction; 16p11.2 proximal deletion syndrome; STING pathway in Kawasaki-like disease and COVID-19; RAS and bradykinin pathways in COVID-19; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Modulators of TCR signaling and T cell activation; Pleural mesothelioma; Prostaglandin signaling; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Inclusion body myositis; Alzheimer's disease; Th17 cell differentiation pathway; Lung pathology of COVID-19; Ulcerative colitis signaling; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction; Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; Inflammatory bowel disease signaling; Role of ROS in COVID-19 endothelial dysfunction; Genetic causes of porto-sinusoidal vascular disease; Acute myeloid leukemia; Autophagy in pancreatic ductal adenocarcinoma; Affected pathways in Duchenne muscular dystrophy; TAR syndrome; Osteoarthritic chondrocyte hypertrophy; 10q22q23 copy number variation; GNAQ pathways in port-wine stain; Sudden infant death syndrome (SIDS) susceptibility pathways",68,0,70.02,90.07,25.9,115.1,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,112.46,129.45,88.72,91.31,13.24,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P29401,TKT,Transketolase OS=Homo sapiens OX=9606 GN=TKT PE=1 SV=3,11,126,1.451,0.263,0.927,0.423,0.54,-1.93,-0.11,-1.24,7.54E-01,1.53E-01,8.19E-01,4.92E-01,2.24E+07,1.04E+07,4.33E+06,1.48E+07,5,5,5,5,3.99E+07,8.68E+06,2.24E+07,5.92E+06,6.72E+07,1.25E+07,6.45E+06,1.04E+07,4.33E+06,5.60E+07,7.67E+06,2.81E+06,2.81E+06,2.12E+07,4.33E+06,7.61E+06,4.44E+06,1.85E+07,1.48E+07,4.57E+07,1.58E+05,3.30E+04,2.19E+05,5.92E+06,3.47E+06,4.45E+04,1.15E+05,9.58E+04,1.22E+05,5.95E+05,4.59E+04,1.26E+05,2.28E+04,2.86E+06,1.07E+05,1.48E+04,1.25E+06,1.31E+05,3.45E+05,4.87E+05,0,FALSE,69.265,24,11,623,67.8,7.66,11,other metabolic processes;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle,"Pf00456, Pf02779, Pf02780",7086,A8K089; B4DE31; E7EPA7; hsa:7086; P29401; Q8TBA3; Q96HH3,ENSG00000163931,NFE2L2 regulates pentose phosphate pathway genes; Pentose phosphate pathway; Insulin effects increased synthesis of Xylulose-5-Phosphate,Pentose phosphate metabolism; VEGFA-VEGFR2 signaling; Metabolic reprogramming in colon cancer; Thiamine metabolic pathways,7,0,87.88,119.93,100.1,89.93,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,139.07,132.66,119.46,128.66,333.46,other molecular function,0,
Master Protein,High,A0A804HKI2,LRPPRC,Leucine rich pentatricopeptide repeat containing OS=Homo sapiens OX=9606 GN=LRPPRC PE=1 SV=1,32,117,1.451,1.052,2.061,0.983,0.54,0.07,1.04,-0.02,7.54E-01,5.36E-01,4.29E-01,9.51E-01,7.95E+06,3.23E+06,1.47E+07,1.01E+07,5,5,5,5,3.30E+07,3.38E+06,2.69E+06,1.60E+07,7.95E+06,3.54E+05,6.93E+06,3.23E+06,5.95E+05,9.70E+06,2.51E+06,8.44E+06,1.47E+07,1.78E+07,2.35E+07,8.10E+06,8.75E+06,1.79E+07,1.37E+07,1.01E+07,1.31E+05,1.28E+04,2.63E+04,1.60E+07,4.10E+05,1.26E+03,1.23E+05,2.98E+04,1.68E+04,1.03E+05,1.50E+04,3.77E+05,1.20E+05,2.40E+06,5.83E+05,1.58E+04,2.46E+06,1.27E+05,3.20E+05,1.08E+05,0,FALSE,129.779,29,32,1430,161.6,6.21,32,,mitochondrion,"Pf01535, Pf13812, Pf17177",,A0A804HKI2,ENSG00000138095,,Ciliary landscape,1,0,99.83,97.92,60.82,34.88,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,108.86,109.97,127.12,124.5,316.69,,0,
Master Protein,High,Q13201,MMRN1,Multimerin-1 OS=Homo sapiens OX=9606 GN=MMRN1 PE=1 SV=3,10,20,1.449,0.488,1.924,0.416,0.54,-1.03,0.94,-1.26,7.00E-01,6.41E-01,5.67E-01,5.68E-01,1.70E+06,5.50E+05,1.12E+06,8.72E+05,5,5,4,5,6.27E+06,2.28E+06,1.70E+06,4.31E+05,6.96E+05,1.08E+06,7.99E+04,5.50E+05,1.22E+05,7.72E+05,7.09E+05,1.38E+06,,1.13E+06,1.10E+06,2.24E+06,5.58E+06,8.72E+05,3.27E+05,6.90E+04,2.49E+04,8.67E+03,1.66E+04,4.31E+05,3.59E+04,3.82E+03,1.42E+03,5.07E+03,3.44E+03,8.20E+03,4.24E+03,6.15E+04,,1.52E+05,2.74E+04,4.37E+03,1.57E+06,6.18E+03,7.64E+03,7.35E+02,0,FALSE,43.258,12,10,1228,138,7.93,10,cell adhesion;stress response;other biological processes,non-structural extracellular;extracellular matrix;other cell component,"Pf00008, Pf00386, Pf07546",22915,hsa:22915; Q13201; Q4W5L1; Q6P3T8; Q6ZUL9,ENSG00000138722,Platelet degranulation,,1,0,103.51,81.88,25.61,124.6,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,74.34,144.91,98.06,102.69,52.5,extracellular structural activity;other molecular function,0,
Master Protein,High,P55145,MANF,Mesencephalic astrocyte-derived neurotrophic factor OS=Homo sapiens OX=9606 GN=MANF PE=1 SV=3,5,27,1.449,2.149,3.287,1.208,0.53,1.1,1.72,0.27,6.09E-01,6.83E-02,2.59E-01,7.59E-01,2.36E+05,2.40E+05,1.56E+06,9.92E+05,5,2,5,4,2.36E+05,3.03E+05,1.63E+05,1.25E+06,2.22E+05,,,1.74E+05,3.31E+05,,3.13E+05,1.54E+06,1.56E+06,2.88E+06,3.28E+06,3.18E+05,1.18E+06,1.12E+06,8.79E+05,,9.37E+02,1.15E+03,1.60E+03,1.25E+06,1.15E+04,,,1.60E+03,9.31E+03,,1.87E+03,6.88E+04,1.27E+04,3.87E+05,8.16E+04,6.20E+02,3.31E+05,7.93E+03,2.06E+04,,0,FALSE,19.724,32,5,182,20.7,8.69,5,cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;cytosol;ER/Golgi,"Pf10208, Pf20145",7873,hsa:7873; P55145; Q14CX4; Q86U67; Q96IS4,ENSG00000145050,Platelet degranulation,Orexin receptor pathway,2,0,105.21,43.94,61.94,44.88,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,53.72,61.27,99.08,65.95,89.09,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G OS=Homo sapiens OX=9606 GN=PPIG PE=1 SV=2,3,3,1.449,0.219,0.576,3.128,0.53,-2.19,-0.8,1.65,7.09E-01,2.04E-01,5.70E-01,2.58E-01,1.27E+05,3.19E+04,2.16E+04,4.88E+04,4,4,4,4,,2.03E+05,2.34E+05,7.98E+04,3.54E+04,,1.68E+04,6.04E+04,1.05E+04,1.01E+05,,2.41E+04,2.66E+04,9.11E+03,1.94E+04,1.07E+05,2.81E+03,,6.47E+04,3.68E+04,,7.71E+02,2.28E+03,7.98E+04,1.83E+03,,2.99E+02,5.58E+02,2.95E+02,1.07E+03,,1.08E+03,2.16E+02,1.23E+03,4.82E+02,2.08E+02,7.90E+02,,1.52E+03,3.92E+02,0,FALSE,7.023,4,3,754,88.6,10.29,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf00160,9360,D3DPC5; D3DPC6; hsa:9360; O00706; Q13427; Q53R40; Q53SN4; Q96DG9,ENSG00000138398,mRNA Splicing - Major Pathway; SARS-CoV-1 activates/modulates innate immune responses,,2,0,69.12,89.41,39.06,83.42,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,74.86,92.26,111.48,139.45,5.03,other molecular function,0,
Master Protein,High,P07737,PFN1,Profilin-1 OS=Homo sapiens OX=9606 GN=PFN1 PE=1 SV=2,5,20,1.446,2.902,3.835,1.583,0.53,1.54,1.94,0.66,6.19E-01,3.07E-02,2.09E-01,5.43E-01,4.63E+05,3.15E+05,9.91E+05,7.75E+05,4,2,5,3,3.34E+05,,1.26E+05,6.43E+05,2.18E+06,7.01E+05,,,,1.42E+05,1.38E+05,6.31E+05,1.85E+06,6.47E+06,9.91E+05,,3.15E+06,7.75E+05,4.66E+05,,1.33E+03,,1.23E+03,6.43E+05,1.13E+05,2.49E+03,,,,1.51E+03,8.26E+02,2.82E+04,1.50E+04,8.72E+05,2.46E+04,,8.85E+05,5.49E+03,1.09E+04,,0,FALSE,14.746,39,5,140,15,8.27,5,cell organization and biogenesis;developmental processes;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf00235,5216,hsa:5216; P07737; Q53Y44,ENSG00000108518,RHO GTPases Activate Formins; Platelet degranulation ; PCP/CE pathway; Signaling by ROBO receptors,Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling; Burn wound healing; Regulation of actin cytoskeleton; G13 signaling pathway,9,0,113.49,93.91,127.39,100.34,High,n/a,Peak Found,High,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,114.69,127.11,84.5,119.91,34.89,cytoskeletal activity;other molecular function,0,
Master Protein,High,O00273,DFFA,DNA fragmentation factor subunit alpha OS=Homo sapiens OX=9606 GN=DFFA PE=1 SV=1,1,1,1.442,3.293,1.199,4.382,0.53,1.72,0.26,2.13,7.02E-01,4.97E-02,9.40E-01,1.28E-01,1.03E+05,7.17E+04,3.77E+05,8.60E+04,2,2,3,2,,,,1.83E+05,5.85E+04,1.09E+05,,,,4.70E+04,9.60E+05,,,3.77E+05,9.18E+04,,6.34E+04,,1.17E+05,,,,,1.83E+05,3.02E+03,3.89E+02,,,,4.99E+02,5.74E+03,,,5.08E+04,2.28E+03,,1.78E+04,,2.73E+03,,0.001,FALSE,3.65,4,1,331,36.5,4.79,1,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf02017, Pf09033",1676,hsa:1676; O00273; Q5T6G5; Q5T6G6; Q96I97; Q9Y6C6,ENSG00000160049,Apoptosis induced DNA fragmentation,Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Acute viral myocarditis,4,0,72.75,56.49,92.93,41.74,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,58.26,107.01,47.65,110.46,3.37,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q7Z3D6,DGLUCY,"D-glutamate cyclase, mitochondrial OS=Homo sapiens OX=9606 GN=DGLUCY PE=1 SV=2",5,10,1.441,0.673,0.389,4.492,0.53,-0.57,-1.36,2.17,6.69E-01,9.42E-01,3.16E-01,1.14E-01,1.25E+06,1.63E+05,6.35E+05,1.59E+05,3,3,5,3,,,1.25E+05,2.11E+06,1.25E+06,,1.63E+05,,1.84E+05,1.13E+05,1.89E+05,6.35E+05,1.10E+06,6.36E+05,6.34E+05,,1.59E+05,1.46E+06,1.52E+05,,,,1.22E+03,2.11E+06,6.46E+04,,2.89E+03,,5.19E+03,1.20E+03,1.13E+03,2.84E+04,8.90E+03,8.57E+04,1.58E+04,,4.45E+04,1.03E+04,3.55E+03,,0,FALSE,21.039,13,5,616,66.4,6.79,5,other metabolic processes,mitochondrion,"Pf07286, Pf14336",80017,B3KUI7; hsa:80017; Q7Z3D6; Q86SW3; Q86SX8; Q86SX9; Q86T08; Q86TV5; Q96GW5; Q9H7G0; Q9H8Y9; Q9H9W6,ENSG00000133943,,,0,0,85.66,23.85,50.24,127.57,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,47.28,78.1,91.18,48.75,29.18,other molecular function,0,
Master Protein,High,A0A0G2JJQ8,HLA-DRB4,"HLA class II histocompatibility antigen, DR beta 4 chain OS=Homo sapiens OX=9606 GN=HLA-DRB4 PE=1 SV=1",3,15,1.441,0.426,1.511,0.16,0.53,-1.23,0.6,-2.65,7.60E-01,4.74E-01,6.50E-01,1.17E-01,4.62E+06,7.88E+05,1.36E+06,1.19E+06,1,1,3,1,,,,4.62E+06,,,7.88E+05,,,,,1.52E+06,,1.36E+06,1.90E+05,,,1.19E+06,,,,,,4.62E+06,,,1.40E+04,,,,,6.78E+04,,1.83E+05,4.72E+03,,,8.44E+03,,,0,FALSE,40.148,29,2,266,30,7.33,3,other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00969, Pf07654",,A0A0G2JJQ8,ENSG00000227826,,,0,0,,,70.93,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,0,15.21,0,0,67.19,,0,
Master Protein,High,P30048,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial OS=Homo sapiens OX=9606 GN=PRDX3 PE=1 SV=3",9,93,1.438,1.307,0.71,1.276,0.52,0.39,-0.49,0.35,7.62E-01,3.47E-01,5.70E-01,7.70E-01,3.42E+07,6.58E+06,2.21E+07,1.05E+07,5,5,5,5,6.63E+06,4.78E+07,5.49E+06,3.85E+07,3.42E+07,5.62E+06,2.80E+06,6.58E+06,8.68E+06,8.04E+07,2.06E+06,3.19E+07,2.21E+07,3.77E+07,2.15E+07,2.69E+07,1.05E+07,1.54E+06,2.02E+07,5.88E+06,2.63E+04,1.82E+05,5.36E+04,3.85E+07,1.76E+06,2.00E+04,4.98E+04,6.07E+04,2.45E+05,8.55E+05,1.23E+04,1.42E+06,1.80E+05,5.08E+06,5.34E+05,5.24E+04,2.94E+06,1.09E+04,4.73E+05,6.26E+04,0,FALSE,73.377,48,9,256,27.7,7.78,9,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,"Pf00578, Pf10417",10935,B2R7Z0; D3DRC9; E9PH29; hsa:10935; P30048; P35690; Q0D2H1; Q13776; Q5T5V2; Q96HK4,ENSG00000165672,Detoxification of Reactive Oxygen Species,Selenium micronutrient network,2,0,72.85,160.36,58.88,80.06,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,136.8,122.23,126.86,93.43,276.48,enzyme regulator activity;other molecular function,0,
Master Protein,High,K7EIK6,ZNF285,Zinc finger protein 285 OS=Homo sapiens OX=9606 GN=ZNF285 PE=1 SV=2,1,2,1.435,0.391,0.01,100,0.52,-1.36,-6.64,6.64,7.63E-01,3.99E-01,1.00E-17,1.00E-17,1.89E+07,2.65E+07,7.37E+06,,3,3,1,,4.09E+08,,1.89E+07,,4.16E+06,2.65E+07,,2.90E+06,2.78E+07,,7.37E+06,,,,,,,,,,1.63E+06,,1.84E+05,,2.15E+05,9.41E+04,,2.67E+04,7.82E+05,,4.41E+04,,,,,,,,,,0.007,FALSE,2.369,4,1,597,68.9,8.21,1,other biological processes,,"Pf00096, Pf01352",26974,K7EIK6,ENSG00000267508,,,0,0,159.45,73.5,,,High,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,132.78,115.57,,,5.88,other molecular function,0,
Master Protein,High,O00567,NOP56,Nucleolar protein 56 OS=Homo sapiens OX=9606 GN=NOP56 PE=1 SV=4,11,51,1.435,0.697,0.453,0.974,0.52,-0.52,-1.14,-0.04,6.98E-01,9.91E-01,3.13E-01,9.50E-01,2.88E+06,3.73E+05,3.71E+06,6.10E+05,5,4,5,3,2.09E+06,2.11E+06,2.88E+06,1.03E+07,6.64E+06,,1.65E+05,8.47E+05,6.38E+04,4.05E+06,4.27E+06,3.71E+06,1.66E+05,6.06E+06,2.31E+06,,1.36E+05,,6.10E+05,2.19E+06,8.31E+03,8.02E+03,2.82E+04,1.03E+07,3.42E+05,,2.93E+03,7.81E+03,1.80E+03,4.30E+04,2.55E+04,1.66E+05,1.35E+03,8.16E+05,5.75E+04,,3.82E+04,,1.43E+04,2.33E+04,0,FALSE,46.724,20,11,594,66,9.19,11,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf01798, Pf08156",10528,hsa:10528; O00567; Q2M3T6; Q9NQ05,ENSG00000101361,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; Association of TriC/CCT with target proteins during biosynthesis,,3,0,75.16,146.57,66.87,109.93,High,High,High,High,High,n/a,Peak Found,High,Peak Found,High,High,High,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,High,1,,FALSE,129.2,116.61,139.49,132.22,105.61,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q92769,HDAC2,Histone deacetylase 2 OS=Homo sapiens OX=9606 GN=HDAC2 PE=1 SV=2,6,33,1.435,1.27,2.156,1.156,0.52,0.34,1.11,0.21,6.99E-01,3.02E-01,3.98E-01,7.79E-01,1.31E+06,6.07E+05,1.67E+06,2.14E+06,5,4,5,4,1.64E+06,3.46E+05,1.31E+06,6.45E+06,1.04E+06,,2.18E+05,7.35E+05,1.36E+06,5.01E+05,6.04E+05,1.50E+06,1.67E+06,8.63E+06,4.61E+06,1.42E+06,,5.83E+05,3.99E+06,3.24E+06,6.51E+03,1.31E+03,1.28E+04,6.45E+06,5.37E+04,,3.87E+03,6.79E+03,3.83E+04,5.33E+03,3.61E+03,6.70E+04,1.36E+04,1.16E+06,1.14E+05,2.76E+03,,4.13E+03,9.33E+04,3.45E+04,0,FALSE,38.356,17,3,488,55.3,5.91,6,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,Pf00850,3066,B3KRS5; B4DL58; E1P561; hsa:3066; Q5SRI8; Q5SZ86; Q8NEH4; Q92769,ENSG00000196591,"Potential therapeutics for SARS; SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Regulation of PTEN gene transcription; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Factors involved in megakaryocyte development and platelet production; RNA Polymerase I Transcription Initiation; p75NTR negatively regulates cell cycle via SC1; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation; EGR2 and SOX10-mediated initiation of Schwann cell myelination; MECP2 regulates neuronal receptors and channels",Cell cycle; Neural crest differentiation; Notch signaling; Initiation of transcription and translation elongation at the HIV-1 LTR; Ethanol effects on histone modifications; Effect of progerin on genes involved in progeria; Ciliary landscape; 7q11.23 copy number variation syndrome; SARS-CoV-2 innate immunity evasion and cell-specific immune response; TAR syndrome; Notch signaling pathway,30,4,113.4,69.05,96.62,68.36,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,121.12,106.57,87.16,114.31,109.93,other molecular function,0,
Master Protein,High,Q86SX6,GLRX5,"Glutaredoxin-related protein 5, mitochondrial OS=Homo sapiens OX=9606 GN=GLRX5 PE=1 SV=2",4,13,1.433,1.03,5.174,0.483,0.52,0.04,2.37,-1.05,6.26E-01,5.08E-01,6.89E-02,6.11E-01,2.76E+05,1.41E+05,1.36E+06,1.73E+06,4,4,4,5,1.46E+05,,2.52E+05,1.35E+06,3.03E+05,5.53E+05,7.64E+04,1.57E+05,,1.26E+05,,1.14E+06,1.79E+05,1.63E+06,2.91E+06,1.36E+05,3.67E+06,1.73E+06,2.39E+05,2.39E+06,5.79E+02,,2.46E+03,1.35E+06,1.56E+04,1.97E+03,1.36E+03,1.45E+03,,1.34E+03,,5.09E+04,1.45E+03,2.20E+05,7.23E+04,2.65E+02,1.03E+06,1.23E+04,5.59E+03,2.54E+04,0,FALSE,19.291,24,4,157,16.6,6.79,4,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;mitochondrion;other cell component,Pf00462,51218,hsa:51218; Q0X088; Q3YML0; Q86SX6; Q86WY3; Q8IZ54,ENSG00000182512,Mitochondrial iron-sulfur cluster biogenesis,Iron-sulfur cluster biogenesis,2,0,109.84,95.98,77.54,91.34,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,64.78,82.41,138.55,136.66,37.26,other molecular function,0,
Master Protein,High,Q9BSW2,CRACR2A,EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens OX=9606 GN=CRACR2A PE=1 SV=2,1,2,1.432,0.483,0.202,3.487,0.52,-1.05,-2.31,1.8,6.52E-01,6.43E-01,6.61E-02,2.46E-01,3.24E+05,4.87E+05,1.57E+05,5.17E+04,3,5,4,2,,2.68E+06,,3.43E+04,3.24E+05,4.87E+05,9.37E+03,1.08E+06,2.27E+05,5.53E+05,1.51E+05,5.66E+04,,1.63E+05,5.73E+05,1.56E+05,,,1.71E+04,,,1.02E+04,,3.43E+04,1.67E+04,1.73E+03,1.67E+02,9.92E+03,6.38E+03,5.88E+03,9.03E+02,2.53E+03,,2.19E+04,1.42E+04,3.04E+02,,,4.01E+02,,0,FALSE,4.579,2,1,731,83.1,5.24,1,transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component,"Pf00071, Pf13499",84766,B4E1X0; B9EK63; hsa:84766; Q9BSW2,ENSG00000130038,Neutrophil degranulation,Vitamin D receptor pathway,2,0,143.26,85.36,97.44,113.42,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,141.83,138.56,139.16,119.95,6.46,other molecular function,0,
Master Protein,High,Q02880,TOP2B,DNA topoisomerase 2-beta OS=Homo sapiens OX=9606 GN=TOP2B PE=1 SV=3,59,254,1.427,1.25,0.634,4.346,0.51,0.32,-0.66,2.12,7.68E-01,3.83E-01,4.76E-01,1.68E-01,4.68E+07,7.70E+06,7.08E+07,1.51E+07,5,5,5,5,4.68E+07,4.17E+07,2.00E+07,9.06E+07,4.87E+07,5.07E+07,3.83E+06,7.70E+06,1.81E+06,2.93E+07,1.39E+08,2.35E+07,5.43E+07,1.29E+08,7.08E+07,1.51E+07,2.62E+06,1.62E+07,1.04E+07,1.94E+07,1.86E+05,1.58E+05,1.95E+05,9.06E+07,2.51E+06,1.80E+05,6.80E+04,7.11E+04,5.10E+04,3.12E+05,8.31E+05,1.05E+06,4.41E+05,1.74E+07,1.76E+06,2.95E+04,7.37E+05,1.15E+05,2.43E+05,2.07E+05,0,FALSE,279.667,43,52,1626,183.2,8,59,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00204, Pf00521, Pf01751, Pf02518, Pf08070, Pf16898",7155,hsa:7155; Q02880; Q13600; Q9UMG8; Q9UQP8,ENSG00000077097,SUMOylation of DNA replication proteins,,1,7,51.78,112.48,59.28,51.19,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,121.01,123.96,137.02,134.47,743.7,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96G03,PGM2,Phosphopentomutase OS=Homo sapiens OX=9606 GN=PGM2 PE=1 SV=4,2,4,1.424,0.542,0.965,0.71,0.51,-0.88,-0.05,-0.49,6.79E-01,7.54E-01,8.16E-01,9.02E-01,5.62E+05,3.95E+05,1.90E+05,3.81E+05,5,3,5,5,1.34E+06,1.58E+05,5.62E+05,8.42E+04,1.35E+06,1.55E+06,3.90E+04,,,3.95E+05,8.36E+05,1.90E+05,4.96E+05,5.50E+04,8.58E+04,3.81E+05,7.59E+04,9.08E+05,2.65E+05,6.99E+05,5.34E+03,6.02E+02,5.49E+03,8.42E+04,6.98E+04,5.49E+03,6.94E+02,,,4.20E+03,5.00E+03,8.48E+03,4.03E+03,7.42E+03,2.13E+03,7.43E+02,2.13E+04,6.43E+03,6.21E+03,7.44E+03,0,FALSE,8.369,5,2,612,68.2,6.73,2,other metabolic processes,non-structural extracellular;cytosol;other cell component,"Pf02878, Pf02879, Pf02880",55276,B4E0G8; hsa:55276; Q53FP5; Q5QTR0; Q96G03; Q9H0P9; Q9NV22,ENSG00000169299,Neutrophil degranulation; Pentose phosphate pathway,Clear cell renal cell carcinoma pathways; Glucuronidation,4,0,88.39,119.35,99.56,71.93,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,137.6,112.6,133.61,114.86,11.08,other molecular function,0,
Master Protein,High,J3KN36,NOMO3,Nodal modulator 3 OS=Homo sapiens OX=9606 GN=NOMO3 PE=1 SV=1,7,22,1.423,0.778,0.518,2.135,0.51,-0.36,-0.95,1.09,6.87E-01,8.32E-01,3.83E-01,3.72E-01,6.59E+05,4.63E+05,5.12E+05,2.40E+05,2,1,3,1,1.44E+06,,3.02E+05,,,,,4.63E+05,,,3.69E+06,,5.12E+05,7.36E+04,,,,,2.40E+05,,5.72E+03,,2.95E+03,,,,,4.27E+03,,,2.21E+04,,4.16E+03,9.92E+03,,,,,5.62E+03,,0,FALSE,20.44,7,1,1267,139.3,5.67,7,,,"Pf13620, Pf17802",408050,J3KN36,ENSG00000103226; ENSG00000278087,,,0,0,92.45,,138.48,,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,128.08,157.29,0,126.95,46.11,other molecular function,0,
Master Protein,High,O75131,CPNE3,Copine-3 OS=Homo sapiens OX=9606 GN=CPNE3 PE=1 SV=1,11,21,1.419,0.664,0.451,1.539,0.5,-0.59,-1.15,0.62,6.26E-01,9.67E-01,3.20E-01,5.91E-01,3.18E+05,1.79E+05,2.80E+06,7.06E+05,5,3,5,5,2.67E+05,3.18E+05,1.59E+05,3.52E+06,3.07E+06,,1.79E+05,9.32E+04,,3.19E+06,9.73E+06,2.20E+06,2.27E+06,3.10E+06,2.80E+06,7.06E+05,5.43E+05,3.55E+06,5.71E+05,1.73E+07,1.06E+03,1.21E+03,1.56E+03,3.52E+06,1.58E+05,,3.19E+03,8.60E+02,,3.39E+04,5.82E+04,9.82E+04,1.84E+04,4.18E+05,6.95E+04,1.38E+03,1.53E+05,2.52E+04,1.34E+04,1.84E+05,0,FALSE,37.669,30,10,537,60.1,5.85,11,signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,"Pf00168, Pf07002",8895,A8KA47; hsa:8895; O75131; Q8IYA1,ENSG00000085719,Neutrophil degranulation; Glycerophospholipid biosynthesis,,2,1,114.34,152.81,79.97,159.92,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,136.61,84.37,137.04,136.75,57.89,signal transduction activity or receptor binding;kinase activity;other molecular function,0,
Master Protein,High,Q00688,FKBP3,Peptidyl-prolyl cis-trans isomerase FKBP3 OS=Homo sapiens OX=9606 GN=FKBP3 PE=1 SV=1,2,6,1.418,0.588,0.907,0.408,0.5,-0.77,-0.14,-1.29,6.76E-01,8.78E-01,8.46E-01,5.82E-01,1.14E+06,8.03E+05,4.76E+05,8.99E+05,3,5,4,2,,,1.14E+06,1.42E+06,8.38E+05,1.31E+06,2.20E+05,8.03E+05,2.65E+06,5.62E+05,6.69E+05,9.97E+03,,1.07E+06,3.39E+05,,9.36E+05,,,8.64E+05,,,1.11E+04,1.42E+06,4.32E+04,4.67E+03,3.92E+03,7.41E+03,7.47E+04,5.97E+03,4.00E+03,4.46E+02,,1.45E+05,8.42E+03,,2.63E+05,,,9.20E+03,0,FALSE,9.021,13,2,224,25.2,9.28,2,,nucleus,"Pf00254, Pf18410",2287,B2R4Q9; hsa:2287; Q00688; Q14317,ENSG00000100442,,,0,0,25.6,85.47,87.11,5.68,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,81.58,56,86.79,95.83,18.5,other molecular function,0,
Master Protein,High,A0A7I2V5D0,DNMT1,DNA (cytosine-5)-methyltransferase OS=Homo sapiens OX=9606 GN=DNMT1 PE=1 SV=1,11,22,1.418,0.967,1.272,1.487,0.5,-0.05,0.35,0.57,6.47E-01,6.09E-01,9.29E-01,5.77E-01,2.91E+05,6.88E+04,8.99E+05,3.78E+05,5,5,5,5,3.77E+05,1.55E+05,2.07E+05,2.05E+06,2.91E+05,7.03E+05,4.25E+04,6.88E+04,4.00E+05,5.98E+04,8.99E+05,5.93E+05,6.83E+05,3.66E+06,1.95E+06,4.17E+05,1.40E+05,4.71E+05,2.04E+05,3.78E+05,1.50E+03,5.90E+02,2.02E+03,2.05E+06,1.50E+04,2.50E+03,7.56E+02,6.35E+02,1.13E+04,6.36E+02,5.37E+03,2.65E+04,5.55E+03,4.94E+05,4.85E+04,8.13E+02,3.95E+04,3.34E+03,4.77E+03,4.02E+03,0,FALSE,42.357,9,11,1655,187,7.9,11,DNA metabolism;other metabolic processes,nucleus,"Pf00145, Pf01426, Pf02008, Pf06464, Pf12047",,A0A7I2V5D0,ENSG00000130816,,Hematopoietic stem cell gene regulation by GABP alpha/beta complex; MTHFR deficiency,2,0,130.89,114.4,83.2,44.26,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,86.21,89.72,120.53,107.02,64.17,nucleic acid binding activity;other molecular function,0,
Master Protein,High,J3QQ67,RPL18,Ribosomal protein L18 (Fragment) OS=Homo sapiens OX=9606 GN=RPL18 PE=1 SV=1,4,18,1.411,0.67,9.723,0.192,0.5,-0.58,3.28,-2.38,7.13E-01,9.83E-01,4.99E-03,1.71E-01,2.02E+06,2.90E+05,1.77E+06,3.07E+06,5,3,5,5,1.99E+06,2.02E+06,2.65E+06,3.79E+06,1.03E+06,,,2.90E+05,1.29E+05,9.07E+05,3.16E+06,2.09E+06,2.12E+05,1.48E+06,1.77E+06,2.89E+06,3.92E+06,1.22E+06,3.90E+06,3.07E+06,7.91E+03,7.66E+03,2.59E+04,3.79E+06,5.34E+04,,,2.67E+03,3.63E+03,9.65E+03,1.89E+04,9.35E+04,1.72E+03,1.99E+05,4.39E+04,5.63E+03,1.10E+06,8.66E+03,9.12E+04,3.27E+04,0,FALSE,12.561,22,4,190,21.8,11.72,4,protein metabolism;other metabolic processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf17135,,J3QQ67,ENSG00000063177,,,0,0,44.22,92.97,61.21,36.64,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,85.94,81.68,65.74,111.8,42.85,other molecular function,0,
Master Protein,High,P50402,EMD,Emerin OS=Homo sapiens OX=9606 GN=EMD PE=1 SV=1,3,7,1.41,1.175,0.916,1.536,0.5,0.23,-0.13,0.62,6.64E-01,4.25E-01,7.83E-01,5.84E-01,6.02E+05,2.29E+05,6.54E+05,4.78E+05,3,3,5,3,,1.02E+06,,6.02E+05,3.22E+05,,,2.76E+05,2.75E+04,2.29E+05,6.35E+05,6.54E+05,2.45E+05,1.52E+06,1.14E+06,4.78E+05,,,3.14E+05,2.72E+06,,3.86E+03,,6.02E+05,1.66E+04,,,2.55E+03,7.74E+02,2.43E+03,3.80E+03,2.92E+04,1.99E+03,2.05E+05,2.83E+04,9.32E+02,,,7.35E+03,2.90E+04,0,FALSE,10.176,9,3,254,29,5.5,3,cell organization and biogenesis;other biological processes,other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,Pf03020,2010,hsa:2010; P50402; Q6FI02,ENSG00000102119,RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina,Arrhythmogenic right ventricular cardiomyopathy; Envelope proteins and their potential roles in EDMD physiopathology; Influence of laminopathies on Wnt signaling,12,0,53.94,74.43,59.05,114.86,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,16.56,117.04,24.34,125.18,17.93,cytoskeletal activity,0,
Master Protein,High,B7Z2R2,UQCRB,Cytochrome b-c1 complex subunit 7 OS=Homo sapiens OX=9606 GN=UQCRB PE=1 SV=1,3,8,1.409,0.568,0.759,0.87,0.49,-0.82,-0.4,-0.2,7.11E-01,8.22E-01,6.47E-01,9.60E-01,2.01E+06,5.70E+05,6.74E+05,4.33E+05,3,2,4,4,,7.41E+05,,2.01E+06,3.14E+06,3.55E+05,,9.16E+05,,,,1.57E+06,4.47E+05,7.24E+05,6.28E+05,,1.67E+05,8.39E+05,2.24E+05,3.46E+06,,2.82E+03,,2.01E+06,1.62E+05,1.26E+03,,8.45E+03,,,,6.99E+04,3.63E+03,9.76E+04,1.56E+04,,4.71E+04,5.94E+03,5.23E+03,3.69E+04,0,FALSE,17.011,18,3,161,18.7,8.95,3,other metabolic processes,other membranes;mitochondrion,Pf02271,,B7Z2R2,ENSG00000156467,,Mitochondrial complex III assembly,1,0,61.21,62.42,59.03,132.68,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,67.26,31.13,127.6,113.34,26.51,,0,
Master Protein,High,Q06265,EXOSC9,Exosome complex component RRP45 OS=Homo sapiens OX=9606 GN=EXOSC9 PE=1 SV=3,1,2,1.408,0.555,2.274,0.344,0.49,-0.85,1.19,-1.54,6.29E-01,7.80E-01,4.95E-01,4.09E-01,3.36E+05,2.38E+05,1.86E+05,5.42E+05,3,1,2,1,7.48E+05,,,1.44E+05,3.36E+05,,,,,2.38E+05,,,1.96E+05,1.77E+05,,,,,5.42E+05,,2.97E+03,,,1.44E+05,1.73E+04,,,,,2.53E+03,,,1.59E+03,2.39E+04,,,,,1.27E+04,,0.002,FALSE,2.82,2,1,439,48.9,5.29,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf01138, Pf03725",5393,hsa:5393; Q06265; Q12883; Q4W5P5; Q86Y41; Q86Y48,ENSG00000123737,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",Ciliary landscape,7,0,75.4,,7.04,,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,84.53,84.45,0,7.39,4.98,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P08236,GUSB,Beta-glucuronidase OS=Homo sapiens OX=9606 GN=GUSB PE=1 SV=2,8,76,1.407,0.518,2.141,0.31,0.49,-0.95,1.1,-1.69,7.81E-01,6.70E-01,4.01E-01,3.36E-01,3.32E+06,4.86E+06,2.27E+06,9.42E+06,5,5,5,5,5.33E+05,9.70E+06,1.78E+05,3.32E+06,3.24E+07,7.11E+06,1.90E+06,4.86E+06,8.08E+05,6.19E+07,8.22E+05,1.65E+06,2.27E+06,8.38E+06,2.81E+06,2.70E+07,1.08E+06,6.45E+06,9.42E+06,4.77E+07,2.12E+03,3.68E+04,1.74E+03,3.32E+06,1.67E+06,2.53E+04,3.38E+04,4.48E+04,2.28E+04,6.58E+05,4.92E+03,7.35E+04,1.84E+04,1.13E+06,6.98E+04,5.26E+04,3.02E+05,4.57E+04,2.20E+05,5.08E+05,0,FALSE,33.307,18,8,651,74.7,7.02,8,protein metabolism;other metabolic processes,non-structural extracellular;other cytoplasmic organelle;other cell component,"Pf00703, Pf02836, Pf02837",2990,B4E1F6; E9PCV0; hsa:2990; P08236; Q549U0; Q96CL9,ENSG00000169919,Neutrophil degranulation; HS-GAG degradation; Hyaluronan uptake and degradation; MPS VII - Sly syndrome,Glycosaminoglycan degradation,5,0,146.33,170.81,94.11,104.14,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,139.59,120.73,139.76,112.79,146.32,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q04837,SSBP1,"Single-stranded DNA-binding protein, mitochondrial OS=Homo sapiens OX=9606 GN=SSBP1 PE=1 SV=1",7,29,1.406,0.659,1.368,0.83,0.49,-0.6,0.45,-0.27,7.81E-01,9.44E-01,7.89E-01,9.29E-01,6.00E+06,4.94E+06,4.49E+06,5.96E+06,5,4,5,5,1.30E+06,6.00E+06,4.59E+05,9.18E+06,1.37E+07,,1.69E+06,5.24E+06,4.65E+06,5.86E+06,3.32E+06,6.89E+06,3.22E+06,5.34E+06,4.49E+06,2.46E+07,1.88E+06,1.63E+07,1.47E+06,5.96E+06,5.17E+03,2.28E+04,4.49E+03,9.18E+06,7.06E+05,,3.01E+04,4.84E+04,1.31E+05,6.23E+04,1.99E+04,3.08E+05,2.61E+04,7.20E+05,1.12E+05,4.79E+04,5.29E+05,1.16E+05,3.43E+04,6.34E+04,0,FALSE,32.185,47,7,148,17.2,9.6,7,cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes,mitochondrion,Pf00436,6742,hsa:6742; Q04837,ENSG00000106028; ENSG00000262771,Mitochondrial protein degradation; Transcriptional activation of mitochondrial biogenesis,,2,0,90.13,42.31,32.86,100.51,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,124.36,107.96,118.07,130.05,73.75,nucleic acid binding activity;other molecular function,0,
Master Protein,High,J3KQE5,RAN,GTP-binding nuclear protein Ran (Fragment) OS=Homo sapiens OX=9606 GN=RAN PE=1 SV=1,5,18,1.405,1.108,0.259,5.464,0.49,0.15,-1.95,2.45,6.96E-01,3.75E-01,9.97E-02,8.52E-02,7.81E+05,6.11E+05,1.60E+06,5.03E+05,5,4,5,5,3.61E+06,6.71E+05,7.81E+05,1.84E+06,3.19E+05,,1.71E+05,4.54E+05,8.22E+05,2.17E+06,3.29E+06,1.60E+06,9.01E+05,2.43E+06,1.53E+06,5.83E+05,5.03E+05,5.30E+05,7.22E+04,2.86E+04,1.43E+04,2.55E+03,7.63E+03,1.84E+06,1.65E+04,,3.04E+03,4.19E+03,2.32E+04,2.31E+04,1.96E+04,7.13E+04,7.32E+03,3.28E+05,3.80E+04,1.14E+03,1.41E+05,3.76E+03,1.69E+03,3.05E+02,0,FALSE,17.774,24,5,234,26.8,9.58,5,transport,nucleus,Pf00071,,J3KQE5,ENSG00000132341,,22q11.2 copy number variation syndrome,1,0,92.63,97.95,47.46,78.45,High,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,105.6,78.1,115.86,111.7,50.29,other molecular function,0,
Master Protein,High,P00450,CP,Ceruloplasmin OS=Homo sapiens OX=9606 GN=CP PE=1 SV=1,8,23,1.402,1.119,0.251,0.956,0.49,0.16,-1.99,-0.07,7.13E-01,5.42E-01,7.58E-02,9.05E-01,7.20E+05,2.14E+06,1.64E+05,5.60E+05,3,5,2,2,,4.70E+06,,6.35E+04,7.20E+05,5.22E+06,3.90E+05,2.14E+06,1.61E+06,5.72E+06,,,,3.43E+05,7.81E+04,,,5.84E+05,5.38E+05,,,1.79E+04,,6.35E+04,3.72E+04,1.86E+04,6.94E+03,1.97E+04,4.54E+04,6.08E+04,,,,4.62E+04,1.94E+03,,,4.14E+03,1.26E+04,,0,FALSE,28.157,11,6,1065,122.1,5.72,8,transport,,"Pf00394, Pf07731, Pf07732",1356,A5PL27; hsa:1356,,,,0,0,137.24,77.41,88.95,5.82,n/a,Peak Found,n/a,High,High,High,Peak Found,High,High,High,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,145.01,182.92,106.33,0.83,51.81,other molecular function,0,
Master Protein,High,P07766,CD3E,T-cell surface glycoprotein CD3 epsilon chain OS=Homo sapiens OX=9606 GN=CD3E PE=1 SV=2,1,4,1.4,0.807,0.914,1.403,0.49,-0.31,-0.13,0.49,6.81E-01,8.24E-01,7.79E-01,6.11E-01,5.03E+05,3.59E+05,4.69E+05,3.34E+05,4,4,3,5,1.71E+05,4.81E+06,,7.15E+04,1.48E+06,1.57E+05,2.09E+04,,8.19E+05,1.57E+07,,,4.69E+05,5.04E+05,3.27E+05,1.30E+06,1.06E+05,6.94E+05,1.55E+05,3.34E+05,6.80E+02,1.83E+04,,7.15E+04,7.62E+04,5.60E+02,3.72E+02,,2.31E+04,1.67E+05,,,3.81E+03,6.79E+04,8.12E+03,2.53E+03,2.98E+04,4.92E+03,3.63E+03,3.56E+03,0.001,FALSE,3.877,7,1,207,23.1,6.76,1,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,"Pf02189, Pf16681",916,A8K997; hsa:916; P07766,ENSG00000198851,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Downstream TCR signaling; Phosphorylation of CD3 and TCR zeta chains; Translocation of ZAP-70 to Immunological synapse; Generation of second messenger molecules; PD-1 signaling,Cancer immunotherapy by PD-1 blockade; Measles virus infection; Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; Modulators of TCR signaling and T cell activation; Network map of SARS-CoV-2 signaling pathway; Th17 cell differentiation pathway; T-cell receptor signaling pathway,13,0,135.57,184.25,21.62,95.27,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,High,High,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,147.44,166.9,141.97,107.16,12.67,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9BZL6,PRKD2,Serine/threonine-protein kinase D2 OS=Homo sapiens OX=9606 GN=PRKD2 PE=1 SV=3,1,4,1.398,0.634,0.302,3.92,0.48,-0.66,-1.73,1.97,7.07E-01,8.99E-01,2.56E-01,2.04E-01,1.41E+05,1.07E+05,1.40E+05,6.30E+04,5,4,2,3,1.21E+06,1.41E+05,1.99E+05,7.44E+04,6.47E+04,9.43E+05,4.44E+04,2.35E+05,,4.83E+04,,4.40E+04,,4.48E+05,,9.18E+04,6.30E+04,,1.40E+04,,4.82E+03,5.34E+02,1.94E+03,7.44E+04,3.34E+03,3.35E+03,7.89E+02,2.17E+03,,5.14E+02,,1.97E+03,,6.04E+04,,1.79E+02,1.77E+04,,3.27E+02,,0,FALSE,4.581,2,1,878,96.7,6.84,1,cell adhesion;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,"Pf00069, Pf00130, Pf00169",25865,B4DTS2; hsa:25865; M0QZW1; M0R2R2; Q8NCK8; Q8TB08; Q9BZL6; Q9P0T6; Q9Y3X8,ENSG00000105287,Sphingolipid de novo biosynthesis,VEGFA-VEGFR2 signaling; Gastrin signaling pathway,3,0,145.44,134.17,116.11,69.93,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,129.18,125.7,120.68,121.37,12.45,kinase activity;other molecular function,0,
Master Protein,High,P50502,ST13,Hsc70-interacting protein OS=Homo sapiens OX=9606 GN=ST13 PE=1 SV=2,4,10,1.395,1.029,0.74,0.884,0.48,0.04,-0.43,-0.18,7.37E-01,4.50E-01,6.66E-01,9.14E-01,1.26E+06,8.67E+05,1.05E+06,6.60E+05,5,5,2,5,1.26E+06,1.92E+06,6.92E+05,2.40E+05,1.95E+06,1.06E+06,6.12E+05,8.67E+05,1.97E+05,1.28E+06,,,,7.83E+05,1.42E+06,3.01E+06,1.49E+06,1.87E+05,6.60E+05,4.63E+05,5.00E+03,7.31E+03,6.76E+03,2.40E+05,1.00E+05,3.78E+03,1.09E+04,8.00E+03,5.55E+03,1.36E+04,,,,1.05E+05,3.53E+04,5.88E+03,4.18E+05,1.32E+03,1.54E+04,4.93E+03,0,FALSE,11.136,14,4,369,41.3,5.27,4,protein metabolism;other metabolic processes;other biological processes,cytosol;other cell component,"Pf17830, Pf18253",6767,hsa:6767; O14999; P50502; Q2TU77,ENSG00000100380,Regulation of HSF1-mediated heat shock response,,1,0,62.03,52.17,40.95,98.37,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,130.85,86.82,106.73,98.39,22.38,other molecular function,0,
Master Protein,High,P36957,DLST,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial OS=Homo sapiens OX=9606 GN=DLST PE=1 SV=4",12,147,1.389,1.193,1.214,1.2,0.47,0.25,0.28,0.26,7.92E-01,4.21E-01,9.07E-01,8.12E-01,1.96E+07,1.01E+07,1.50E+07,1.45E+07,5,5,5,5,4.02E+06,1.96E+07,1.65E+06,2.45E+07,5.35E+07,1.01E+07,2.79E+06,1.25E+07,4.32E+06,6.17E+07,3.26E+06,1.28E+07,2.40E+07,3.22E+07,1.50E+07,2.41E+07,1.45E+07,1.02E+07,7.53E+06,2.68E+07,1.60E+04,7.45E+04,1.61E+04,2.45E+07,2.76E+06,3.61E+04,4.95E+04,1.15E+05,1.22E+05,6.56E+05,1.95E+04,5.70E+05,1.95E+05,4.34E+06,3.73E+05,4.69E+04,4.08E+06,7.23E+04,1.76E+05,2.86E+05,0,FALSE,72.125,31,12,453,48.7,8.95,12,protein metabolism;other metabolic processes,cytosol;mitochondrion;nucleus;other cell component,"Pf00198, Pf00364",1743,B7Z5W8; E7ESY5; hsa:1743; P36957; Q7LDY7; Q9BQ32,ENSG00000119689,Lysine catabolism; Glyoxylate metabolism and glycine degradation; Citric acid cycle (TCA cycle),TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Metabolic reprogramming in colon cancer; 7q11.23 copy number variation syndrome; 1p36 copy number variation syndrome; 10q11.21q11.23 copy number variation syndrome; TCA cycle (aka Krebs or citric acid cycle),10,0,100.74,134.52,63.42,51.02,Peak Found,High,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,138.61,133.51,136.47,110.71,417.05,other molecular function,0,
Master Protein,High,Q14498,RBM39,RNA-binding protein 39 OS=Homo sapiens OX=9606 GN=RBM39 PE=1 SV=2,10,35,1.388,0.707,5.997,1.125,0.47,-0.5,2.58,0.17,6.95E-01,9.00E-01,8.68E-02,7.57E-01,1.40E+06,3.15E+05,1.68E+06,4.28E+05,5,5,5,5,1.40E+06,9.30E+05,1.33E+06,7.37E+06,3.27E+06,7.59E+05,3.15E+05,2.47E+05,3.31E+05,2.61E+05,8.51E+06,1.21E+06,1.68E+06,5.00E+06,7.07E+05,1.97E+05,3.20E+05,4.31E+06,4.28E+05,3.02E+06,5.56E+03,3.53E+03,1.30E+04,7.37E+06,1.69E+05,2.70E+03,5.60E+03,2.28E+03,9.34E+03,2.77E+03,5.09E+04,5.42E+04,1.36E+04,6.74E+05,1.76E+04,3.83E+02,8.99E+04,3.06E+04,1.00E+04,3.21E+04,0,FALSE,43.651,24,10,530,59.3,10.1,10,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytoskeleton;nucleus;other cell component,"Pf00076, Pf15519",9584,A2RRD3; A5D8W2; B0BLV3; E1P5S0; E1P5S1; hsa:9584; Q14498; Q14499,ENSG00000131051,mRNA Splicing - Major Pathway,VEGFA-VEGFR2 signaling; mRNA processing,3,0,93.67,55.77,96.58,114.39,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,110.7,128.48,127.83,121.98,89.58,other molecular function,0,
Master Protein,High,P30041,PRDX6,Peroxiredoxin-6 OS=Homo sapiens OX=9606 GN=PRDX6 PE=1 SV=3,5,18,1.386,0.647,2.852,0.344,0.47,-0.63,1.51,-1.54,7.18E-01,9.83E-01,2.28E-01,3.85E-01,1.04E+06,8.02E+05,1.92E+06,5.16E+06,5,4,5,4,5.64E+06,7.98E+05,9.63E+05,1.43E+06,1.04E+06,5.12E+06,8.44E+05,5.17E+05,,7.61E+05,7.05E+05,4.42E+05,2.04E+06,4.70E+06,1.92E+06,4.26E+06,7.46E+06,8.03E+05,6.25E+06,,2.24E+04,3.03E+03,9.41E+03,1.43E+06,5.38E+04,1.82E+04,1.50E+04,4.77E+03,,8.10E+03,4.22E+03,1.98E+04,1.66E+04,6.33E+05,4.77E+04,8.31E+03,2.10E+06,5.69E+03,1.46E+05,,0,FALSE,18.146,29,5,224,25,6.38,5,other metabolic processes;stress response;other biological processes,non-structural extracellular;cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,"Pf00578, Pf10417",9588,A8JZY7; hsa:9588; P30041; P32077; Q5TAH4; Q5ZEZ8,ENSG00000117592,Neutrophil degranulation; Detoxification of Reactive Oxygen Species,Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling,5,0,104.4,122.08,86.07,61.98,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,n/a,1,,FALSE,96.74,118.57,91.97,93.08,45.26,other molecular function,0,
Master Protein,High,P22626,HNRNPA2B1,Heterogeneous nuclear ribonucleoproteins A2/B1 OS=Homo sapiens OX=9606 GN=HNRNPA2B1 PE=1 SV=2,19,183,1.381,0.556,1.544,1.961,0.47,-0.85,0.63,0.97,7.96E-01,7.47E-01,6.73E-01,5.00E-01,2.44E+07,1.16E+07,1.37E+07,1.78E+07,5,5,5,5,3.52E+06,2.44E+07,1.04E+07,6.97E+07,4.37E+07,2.09E+07,7.49E+06,2.21E+07,1.23E+06,1.16E+07,1.95E+07,1.37E+07,5.79E+06,2.68E+07,7.34E+06,3.61E+07,2.14E+06,1.78E+07,2.14E+06,2.82E+07,1.40E+04,9.28E+04,1.02E+05,6.97E+07,2.26E+06,7.45E+04,1.33E+05,2.04E+05,3.46E+04,1.24E+05,1.16E+05,6.12E+05,4.71E+04,3.61E+06,1.82E+05,7.04E+04,6.02E+05,1.26E+05,5.02E+04,3.00E+05,0,FALSE,152.535,65,16,353,37.4,8.95,19,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,non-structural extracellular;nucleus;other cell component,"Pf00076, Pf11627",3181,A0A024RA27; A0A024RA61; A8K064; hsa:3181; P22626; P22627; Q9UC98; Q9UDJ2,ENSG00000122566,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,mRNA processing,4,0,88.33,70.12,59.59,88.31,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,Peak Found,High,High,High,High,High,High,High,1,,FALSE,124.89,117.35,136.3,142.74,481.99,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UJU2,LEF1,Lymphoid enhancer-binding factor 1 OS=Homo sapiens OX=9606 GN=LEF1 PE=1 SV=1,3,11,1.379,2.599,2.932,1.654,0.46,1.38,1.55,0.73,7.25E-01,3.98E-02,3.76E-01,5.05E-01,1.26E+05,9.11E+04,1.45E+06,2.67E+05,3,2,5,2,,,6.46E+04,1.09E+06,1.26E+05,,7.11E+04,1.17E+05,,,1.42E+05,9.68E+05,1.66E+06,1.45E+06,2.64E+06,,,8.74E+04,,8.16E+05,,,6.31E+02,1.09E+06,6.48E+03,,1.26E+03,1.08E+03,,,8.50E+02,4.33E+04,1.35E+04,1.96E+05,6.56E+04,,,6.19E+02,,8.69E+03,0,FALSE,12.971,11,3,399,44.2,7.42,3,cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf00505, Pf08347",51176,B4DG38; B7Z8E2; E9PDK3; hsa:51176; Q3ZCU4; Q9HAZ0; Q9UJU2,ENSG00000138795,Ca2+ pathway; Formation of paraxial mesoderm; Somitogenesis; Formation of axial mesoderm; Deactivation of the beta-catenin transactivating complex; Transcriptional Regulation by VENTX; Cardiogenesis; Germ layer formation at gastrulation; Transcriptional regulation of granulopoiesis; Binding of TCF/LEF:CTNNB1 to target gene promoters; RUNX3 regulates WNT signaling; Repression of WNT target genes,Arrhythmogenic right ventricular cardiomyopathy; Endoderm differentiation; Mesodermal commitment pathway; Mesodermal commitment pathway; Wnt signaling pathway; Hepatitis C and hepatocellular carcinoma; Wnt/beta-catenin signaling pathway in leukemia; Regulation of Wnt / B-catenin signaling by small molecule compounds; Amplification and expansion of oncogenic pathways as metastatic traits; Canonical and non-canonical Notch signaling; Wnt signaling pathway and pluripotency; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; Effect of progerin on genes involved in progeria; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Hippo signaling regulation pathways; TGF-beta receptor signaling in skeletal dysplasias; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Pleural mesothelioma; Acute myeloid leukemia; 11p11.2 copy number variation syndrome ; Cell lineage map for neuronal differentiation; TGF-beta receptor signaling; DNA damage response (only ATM dependent),41,0,134.71,34.33,66.87,114.05,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,High,High,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,69.74,99.81,157.85,111.66,30.27,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P53621,COPA,Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=2,6,16,1.379,0.557,2.399,1.773,0.46,-0.84,1.26,0.83,7.15E-01,8.10E-01,4.63E-01,4.73E-01,9.71E+05,1.61E+05,3.17E+05,6.06E+05,3,1,5,3,,,1.05E+06,9.71E+05,5.85E+04,,,,1.61E+05,,1.71E+06,2.18E+05,1.80E+05,5.63E+05,3.17E+05,,8.70E+05,6.69E+04,6.06E+05,,,,1.02E+04,9.71E+05,3.02E+03,,,,4.55E+03,,1.02E+04,9.75E+03,1.46E+03,7.58E+04,7.88E+03,,2.44E+05,4.74E+02,1.42E+04,,0,FALSE,21.115,8,6,1224,138.3,7.66,6,transport;signal transduction,non-structural extracellular;other membranes;cytosol;ER/Golgi;other cell component,"Pf00400, Pf04053, Pf06957",1314,hsa:1314; P53621; Q5T201; Q8IXZ9,ENSG00000122218,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,,2,0,79.46,,107.14,79.57,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,0,107.55,53.53,130.91,46.1,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q14194,CRMP1,Dihydropyrimidinase-related protein 1 OS=Homo sapiens OX=9606 GN=CRMP1 PE=1 SV=1,5,9,1.377,1.487,1.919,3.073,0.46,0.57,0.94,1.62,7.99E-01,1.96E-01,4.54E-01,2.32E-01,2.88E+06,2.70E+06,8.28E+05,8.92E+05,4,2,4,3,1.03E+07,,6.27E+06,1.23E+06,1.32E+06,,1.25E+06,5.84E+06,,,1.59E+07,,5.66E+05,1.89E+05,1.21E+06,5.19E+06,4.67E+04,,8.92E+05,,4.10E+04,,6.13E+04,1.23E+06,6.81E+04,,2.22E+04,5.39E+04,,,9.53E+04,,4.60E+03,2.55E+04,3.01E+04,1.01E+04,1.31E+04,,2.09E+04,,0,FALSE,15.576,12,4,572,62.1,7.03,5,other metabolic processes;developmental processes;other biological processes,cytosol;cytoskeleton;other cell component,Pf01979,1400,A0EJG6; hsa:1400; Q13024; Q14194; Q4W5F1; Q96TC8,ENSG00000072832,CRMPs in Sema3A signaling,,1,0,91.49,91.56,170.97,134.98,Peak Found,n/a,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,122.14,82.97,125.95,117.64,26.05,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A7P0Z494,DBT,Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex OS=Homo sapiens OX=9606 GN=DBT PE=1 SV=1,5,20,1.377,0.534,0.277,2.027,0.46,-0.9,-1.85,1.02,7.46E-01,7.62E-01,1.28E-01,4.08E-01,2.41E+06,1.32E+06,1.06E+06,3.74E+05,2,2,5,3,,,,2.79E+06,2.07E+06,,,,5.91E+05,2.93E+06,7.75E+04,1.62E+06,7.06E+05,1.29E+06,1.06E+06,3.74E+05,5.63E+05,,3.03E+05,,,,,2.79E+06,1.07E+05,,,,1.67E+04,3.12E+04,4.63E+02,7.24E+04,5.74E+03,1.73E+05,2.63E+04,7.29E+02,1.58E+05,,7.09E+03,,0,FALSE,17.405,12,5,524,58.2,9.04,5,other metabolic processes,cytosol;cytoskeleton;mitochondrion;other cell component,"Pf00198, Pf00364, Pf02817",,A0A7P0Z494,ENSG00000137992,,,0,0,20.88,93.96,62.18,32.48,n/a,n/a,n/a,High,High,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,127.45,42.21,109.56,60.6,65.05,other molecular function,0,
Master Protein,High,P39656,DDOST,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens OX=9606 GN=DDOST PE=1 SV=4,8,52,1.375,1.085,11.326,4.624,0.46,0.12,3.5,2.21,8.01E-01,5.07E-01,1.89E-03,1.51E-01,9.54E+06,3.18E+06,1.28E+07,6.24E+05,5,4,5,5,1.12E+07,3.05E+07,9.54E+06,9.34E+06,4.48E+06,,4.62E+05,5.75E+06,1.76E+06,2.11E+07,2.08E+07,8.38E+06,9.74E+06,1.45E+07,1.28E+07,2.40E+05,6.24E+05,3.43E+05,2.36E+06,8.37E+06,4.46E+04,1.16E+05,9.32E+04,9.34E+06,2.31E+05,,8.22E+03,5.31E+04,4.96E+04,2.24E+05,1.24E+05,3.74E+05,7.92E+04,1.95E+06,3.19E+05,4.67E+02,1.75E+05,2.43E+03,5.53E+04,8.91E+04,0,FALSE,40.627,25,8,456,50.8,6.55,8,protein metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf03345,1650,B2RDQ4; B4DJE3; B4DLI2; hsa:1650; O43244; P39656; Q5VWA5; Q8NI93; Q9BUI2,ENSG00000244038,Neutrophil degranulation; SRP-dependent cotranslational protein targeting to membrane; Advanced glycosylation endproduct receptor signaling; Asparagine N-linked glycosylation; Maturation of spike protein,AGE/RAGE pathway; N-glycan biosynthesis,7,0,77.59,130.53,36.67,144.62,Peak Found,High,High,High,High,n/a,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,102.76,124.01,32.01,124.56,152.26,enzyme regulator activity,0,
Master Protein,High,O96028,NSD2,Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens OX=9606 GN=NSD2 PE=1 SV=1,4,5,1.375,0.937,0.886,1.028,0.46,-0.09,-0.17,0.04,6.44E-01,6.88E-01,8.42E-01,8.38E-01,4.04E+05,1.90E+05,2.48E+05,1.68E+05,1,1,4,2,,,,4.04E+05,,1.90E+05,,,,,,2.34E+05,2.63E+05,4.76E+05,1.48E+05,,,3.37E+05,8.43E+04,,,,,4.04E+05,,6.76E+02,,,,,,1.04E+04,2.14E+03,6.42E+04,3.68E+03,,,2.39E+03,1.97E+03,,0,FALSE,10.505,5,4,1365,152.2,8.69,4,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf00505, Pf00628, Pf00855, Pf00856, Pf17907, Pf17982",7468,A2A2T2; A2A2T3; A2A2T4; A7MCZ1; D3DVQ2; hsa:7468; O96028; O96031; Q4VBY8; Q672J1; Q6IS00; Q86V01; Q9BZB4; Q9UI92; Q9UPR2,ENSG00000109685,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; PKMTs methylate histone lysines; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ),4p16.3 copy number variation,6,0,,,49.73,84.76,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,0,79.08,111.01,105.89,15.88,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15652,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens OX=9606 GN=JMJD1C PE=1 SV=2,2,2,1.372,0.724,,0.521,0.46,-0.47,,-0.94,7.21E-01,9.48E-01,,7.06E-01,1.11E+05,7.80E+04,8.31E+04,8.20E+04,4,1,3,3,5.16E+04,1.07E+05,,1.16E+05,7.09E+05,,,,7.80E+04,,2.36E+05,,8.31E+04,,9.95E+03,1.21E+05,4.94E+04,,,8.20E+04,2.05E+02,4.07E+02,,1.16E+05,3.66E+04,,,,2.20E+03,,1.41E+03,,6.75E+02,,2.47E+02,2.36E+02,1.39E+04,,,8.73E+02,0,FALSE,5.88,1,2,2540,284.3,7.87,2,cell organization and biogenesis;stress response;other biological processes,nucleus;other cell component,Pf02373,221037,A0T124; hsa:221037; Q15652; Q5SQZ8; Q5SQZ9; Q5SR00; Q7Z3E7; Q8N3U0; Q96KB9; Q9P2G7,ENSG00000171988,Factors involved in megakaryocyte development and platelet production,Pathways affected in adenoid cystic carcinoma,2,0,126.14,,105.1,42.57,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,45.63,117.62,,180.33,5.26,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8NBX0,SCCPDH,Saccharopine dehydrogenase-like oxidoreductase OS=Homo sapiens OX=9606 GN=SCCPDH PE=1 SV=1,9,37,1.37,0.572,0.097,2.259,0.45,-0.81,-3.37,1.18,8.04E-01,7.79E-01,1.61E-03,3.70E-01,6.69E+06,3.44E+06,3.07E+06,6.39E+05,4,1,5,3,8.68E+06,5.15E+06,,1.16E+07,2.27E+06,,,,,3.44E+06,1.80E+06,3.66E+06,3.44E+06,3.07E+06,2.17E+06,,2.94E+05,,6.39E+05,6.87E+05,3.45E+04,1.96E+04,,1.16E+07,1.17E+05,,,,,3.66E+04,1.08E+04,1.64E+05,2.80E+04,4.13E+05,5.38E+04,,8.26E+04,,1.49E+04,7.31E+03,0,FALSE,52.71,32,9,429,47.1,9.14,9,other metabolic processes,non-structural extracellular;other cell component,Pf03435,51097,hsa:51097; Q8NBX0; Q8TAR0; Q9Y363,ENSG00000143653,Platelet degranulation,,1,0,58.72,,28.64,39.68,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,High,High,High,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,54.79,99.94,17.99,76.78,102.34,other molecular function,0,
Master Protein,High,A0A8I5KT88,PDIA3,Protein disulfide-isomerase OS=Homo sapiens OX=9606 GN=PDIA3 PE=1 SV=1,25,362,1.369,1.032,2.458,1.159,0.45,0.05,1.3,0.21,8.04E-01,5.54E-01,3.10E-01,8.36E-01,2.54E+07,2.43E+07,5.41E+07,6.49E+07,5,5,5,5,2.54E+07,2.48E+07,1.87E+07,6.41E+07,9.77E+07,2.43E+07,1.68E+07,3.52E+07,9.10E+06,4.24E+07,1.14E+07,6.63E+07,5.41E+07,4.46E+07,7.17E+07,6.49E+07,1.93E+07,1.86E+08,2.23E+07,1.77E+08,1.01E+05,9.42E+04,1.82E+05,6.41E+07,5.04E+06,8.65E+04,2.99E+05,3.25E+05,2.56E+05,4.51E+05,6.80E+04,2.96E+06,4.40E+05,6.01E+06,1.78E+06,1.27E+05,5.43E+06,1.31E+06,5.23E+05,1.89E+06,0,FALSE,152.338,51,25,512,57.7,6.49,25,,ER/Golgi,"Pf00085, Pf13848",,A0A8I5KT88,ENSG00000167004,,Prion disease pathway,1,0,73.67,52.63,48.06,87.27,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,126.75,129.19,121.75,138.66,1053.25,other molecular function,0,
Master Protein,High,P25786,PSMA1,Proteasome subunit alpha type-1 OS=Homo sapiens OX=9606 GN=PSMA1 PE=1 SV=1,8,38,1.369,0.504,2.115,0.211,0.45,-0.99,1.08,-2.25,7.39E-01,6.70E-01,4.10E-01,1.80E-01,5.72E+05,1.74E+06,5.37E+05,4.12E+06,5,5,5,5,2.84E+05,6.16E+06,5.29E+05,5.72E+05,5.62E+07,1.74E+06,6.37E+05,1.87E+06,6.54E+05,2.54E+07,7.06E+05,5.03E+05,4.31E+05,5.37E+05,7.88E+05,1.91E+06,2.72E+06,1.68E+07,4.12E+06,1.21E+07,1.13E+03,2.34E+04,5.17E+03,5.72E+05,2.90E+06,6.20E+03,1.13E+04,1.72E+04,1.84E+04,2.70E+05,4.22E+03,2.25E+04,3.50E+03,7.23E+04,1.96E+04,3.72E+03,7.65E+05,1.19E+05,9.65E+04,1.29E+05,0,FALSE,37.437,32,8,263,29.5,6.61,8,protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf00227, Pf10584",5682,A8K400; hsa:5682; P25786; Q53YE8; Q9BRV9,ENSG00000129084,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,62,0,191.51,178.7,25.09,87.34,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,136.82,130.28,135.41,106.5,98.32,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8NEW0,SLC30A7,Zinc transporter 7 OS=Homo sapiens OX=9606 GN=SLC30A7 PE=1 SV=1,1,4,1.364,1.367,1.077,1.088,0.45,0.45,0.11,0.12,7.27E-01,4.52E-01,9.79E-01,8.34E-01,1.08E+05,7.93E+04,9.30E+04,8.54E+04,3,1,4,1,1.70E+05,,,1.08E+05,1.14E+04,,,,,7.93E+04,,4.21E+04,7.08E+04,2.81E+05,1.22E+05,,8.54E+04,,,,6.74E+02,,,1.08E+05,5.88E+02,,,,,8.43E+02,,1.88E+03,5.75E+02,3.79E+04,3.03E+03,,2.40E+04,,,,0,FALSE,4.542,4,1,376,41.6,6.95,1,transport;other biological processes,other membranes;cytosol;mitochondrion;ER/Golgi;other cell component,Pf01545,148867,B2R949; D3DT61; hsa:148867; Q8NEW0; Q8TCH2,ENSG00000162695,,Zinc homeostasis,1,0,82.74,,82.67,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,84.18,113.68,0,63.7,10.22,transporter activity,0,
Master Protein,High,Q92626,PXDN,Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2,9,18,1.364,0.558,,,0.45,-0.84,,,7.39E-01,8.31E-01,,,1.24E+06,7.97E+05,4.87E+05,1.93E+04,3,2,5,1,,2.84E+06,,1.24E+06,6.53E+05,,,5.89E+05,,1.08E+06,4.87E+05,8.31E+04,5.22E+04,7.78E+05,6.41E+05,,1.93E+04,,,,,1.08E+04,,1.24E+06,3.37E+04,,,5.43E+03,,1.15E+04,2.91E+03,3.71E+03,4.24E+02,1.05E+05,1.59E+04,,5.43E+03,,,,0,FALSE,33.215,9,9,1479,165.2,7.17,9,cell adhesion;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;other biological processes,non-structural extracellular;extracellular matrix;ER/Golgi;other cell component,"Pf00093, Pf03098, Pf07679, Pf13855",7837,A8QM65; D6W4Y0; Q4KMG2; Q92626,ENSG00000130508,Crosslinking of collagen fibrils,EGF/EGFR signaling pathway,2,0,71.9,41.67,80.28,,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,88.7,63.37,,,60.93,signal transduction activity or receptor binding;extracellular structural activity;other molecular function,0,
Master Protein,High,H0UI06,COX7A2,Cytochrome c oxidase subunit 7A2 OS=Homo sapiens OX=9606 GN=COX7A2 PE=1 SV=1,2,42,1.364,1.482,0.693,3.433,0.45,0.57,-0.53,1.78,8.08E-01,2.60E-01,5.49E-01,2.42E-01,3.27E+06,3.35E+06,9.98E+06,2.57E+06,5,4,5,5,2.78E+06,3.27E+06,2.61E+06,3.83E+06,9.17E+06,5.35E+06,2.10E+06,1.56E+06,,6.52E+06,3.19E+06,4.39E+06,9.98E+06,1.38E+07,1.50E+07,2.57E+06,4.11E+06,1.58E+06,3.82E+06,1.05E+06,1.10E+04,1.24E+04,2.55E+04,3.83E+06,4.73E+05,1.90E+04,3.74E+04,1.44E+04,,6.93E+04,1.90E+04,1.96E+05,8.11E+04,1.86E+06,3.74E+05,5.01E+03,1.16E+06,1.12E+04,8.93E+04,1.12E+04,0,FALSE,7.88,22,2,115,12.8,9.13,2,other metabolic processes,other membranes;mitochondrion,Pf02238,1347,H0UI06; hsa:1347,ENSG00000112695,,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly,3,0,63.38,62.43,57.83,51.14,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,n/a,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,80.36,108.83,75.56,87.57,96.87,,0,
Master Protein,High,Q9NYL9,TMOD3,Tropomodulin-3 OS=Homo sapiens OX=9606 GN=TMOD3 PE=1 SV=1,1,1,1.363,0.801,0.01,100,0.45,-0.32,-6.64,6.64,6.56E-01,8.43E-01,1.00E-17,1.00E-17,2.97E+05,2.18E+05,2.38E+05,,2,1,2,,,4.23E+05,,2.08E+05,,,,2.18E+05,,,,,,2.77E+05,2.04E+05,,,,,,,1.61E+03,,2.08E+05,,,,2.01E+03,,,,,,3.73E+04,5.07E+03,,,,,,0,FALSE,4.477,5,1,352,39.6,5.19,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytoskeleton,Pf03250,29766,B2R6G7; hsa:29766; Q9NT43; Q9NYL9; Q9NZR0,ENSG00000138594,RND3 GTPase cycle; Striated Muscle Contraction; RHOBTB2 GTPase cycle,VEGFA-VEGFR2 signaling,4,0,48.04,,21.41,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,53.55,45.98,,,3.4,cytoskeletal activity,0,
Master Protein,High,Q9NRR5,UBQLN4,Ubiquilin-4 OS=Homo sapiens OX=9606 GN=UBQLN4 PE=1 SV=2,5,7,1.36,0.717,0.773,0.545,0.44,-0.48,-0.37,-0.88,7.18E-01,9.34E-01,7.51E-01,7.88E-01,1.70E+05,1.03E+05,2.13E+05,7.95E+04,3,2,4,1,5.89E+04,,,1.19E+06,1.70E+05,1.87E+05,5.65E+04,,,,,1.46E+05,4.33E+04,1.61E+06,3.10E+05,,,7.95E+04,,,2.34E+02,,,1.19E+06,8.79E+03,6.66E+02,1.00E+03,,,,,6.53E+03,3.52E+02,2.17E+05,7.70E+03,,,5.63E+02,,,0,FALSE,22.45,11,4,601,63.8,5.22,5,protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00240, Pf00627",56893,A6ND44; B2RAY7; hsa:56893; Q5VYA0; Q5VYA1; Q9BR98; Q9NRR5; Q9UHX4,ENSG00000160803,,,0,1,131.84,75.86,138.4,,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,81.51,103.16,94.23,4.75,23.76,other molecular function,0,
Master Protein,High,Q13769,THOC5,THO complex subunit 5 homolog OS=Homo sapiens OX=9606 GN=THOC5 PE=1 SV=2,4,5,1.359,0.129,,1.269,0.44,-2.95,,0.34,6.72E-01,4.46E-02,,6.91E-01,1.47E+05,2.16E+05,1.22E+05,1.60E+05,3,1,1,3,,6.40E+04,1.47E+05,3.90E+05,,,2.16E+05,,,,,,,1.22E+05,,,1.60E+05,7.29E+05,7.07E+04,,,2.43E+02,1.44E+03,3.90E+05,,,3.84E+03,,,,,,,1.64E+04,,,4.50E+04,5.17E+03,1.65E+03,,0,FALSE,17.327,10,4,683,78.5,6.87,4,RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,nucleus;other cell component,Pf09766,8563,hsa:8563; O60839; Q13769; Q9UPZ5,ENSG00000100296,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Signaling by CSF1 (M-CSF) in myeloid cells,,4,0,84.55,,,111.58,n/a,Peak Found,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,0,100.46,,0,16.91,nucleic acid binding activity,0,
Master Protein,High,P33176,KIF5B,Kinesin-1 heavy chain OS=Homo sapiens OX=9606 GN=KIF5B PE=1 SV=1,4,4,1.359,0.241,0.191,0.713,0.44,-2.05,-2.39,-0.49,7.43E-01,2.58E-01,1.30E-01,9.46E-01,1.14E+05,5.90E+04,2.16E+04,7.33E+04,3,3,4,2,,2.81E+05,,4.03E+04,1.14E+05,5.90E+04,7.26E+04,,1.88E+04,,3.51E+04,4.87E+03,,3.71E+04,1.32E+04,1.19E+05,,,4.50E+04,,,1.07E+03,,4.03E+04,5.89E+03,2.10E+02,1.29E+03,,5.29E+02,,2.10E+02,2.18E+02,,5.01E+03,3.29E+02,2.33E+02,,,1.05E+03,,0,FALSE,15.508,6,3,963,109.6,6.51,4,cell organization and biogenesis;stress response;transport;developmental processes;other biological processes,other membranes;cytosol;cytoskeleton;mitochondrion;other cytoplasmic organelle;other cell component,Pf00225,3799,A0AVB2; hsa:3799; P33176; Q5VZ85,ENSG00000170759,COPI-dependent Golgi-to-ER retrograde traffic; MHC class II antigen presentation; Kinesins; Signaling by ALK fusions and activated point mutants; Insulin processing; RHO GTPases activate KTN1,Alzheimer's disease and miRNA effects; Envelope proteins and their potential roles in EDMD physiopathology; Insulin signaling; CCL18 signaling pathway; Alzheimer's disease,11,0,84.83,55.82,70.88,64.01,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,118.41,127.26,34.21,111.1,12.93,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q06587,RING1,E3 ubiquitin-protein ligase RING1 OS=Homo sapiens OX=9606 GN=RING1 PE=1 SV=2,7,13,1.355,0.224,0.551,0.683,0.44,-2.16,-0.86,-0.55,6.92E-01,1.81E-01,5.39E-01,9.03E-01,2.19E+05,1.31E+05,1.48E+05,7.22E+04,4,3,3,1,1.94E+05,2.47E+05,,1.39E+06,1.93E+05,1.82E+05,1.31E+05,,1.26E+05,,5.22E+04,1.48E+05,,1.67E+05,,,,,7.22E+04,,7.73E+02,9.38E+02,,1.39E+06,9.96E+03,6.47E+02,2.33E+03,,3.54E+03,,3.12E+02,6.61E+03,,2.26E+04,,,,,1.69E+03,,0,FALSE,29.082,24,5,406,42.4,5.62,7,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00097, Pf16207",6015,A8JZZ0; Q06587; Q5JP96; Q5SQW2; Q86V19,ENSG00000204227; ENSG00000206287; ENSG00000226788; ENSG00000228520; ENSG00000231115; ENSG00000235107,Oxidative Stress Induced Senescence; SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6,Pleural mesothelioma; Notch signaling pathway,11,2,116.38,21.31,50.32,,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,87.47,58.9,57.97,8.36,43.23,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q5SS57,HLA-B,HLA class I antigen OS=Homo sapiens OX=9606 GN=HLA-B PE=1 SV=1,10,123,1.354,0.432,0.531,1.012,0.44,-1.21,-0.91,0.02,8.14E-01,4.87E-01,3.48E-01,9.31E-01,3.05E+06,3.22E+06,1.58E+06,4.74E+06,5,5,5,5,5.33E+06,3.02E+07,2.80E+06,3.05E+06,2.10E+06,4.07E+06,1.35E+06,3.35E+06,3.22E+06,2.80E+06,2.95E+06,8.98E+05,9.70E+05,1.58E+06,7.82E+06,5.01E+06,5.28E+05,4.74E+06,5.32E+05,1.07E+07,2.12E+04,1.15E+05,2.73E+04,3.05E+06,1.08E+05,1.45E+04,2.39E+04,3.09E+04,9.07E+04,2.98E+04,1.76E+04,4.01E+04,7.88E+03,2.13E+05,1.94E+05,9.77E+03,1.48E+05,3.36E+04,1.24E+04,1.14E+05,0,FALSE,59.015,35,1,362,40.3,5.71,10,other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00129, Pf06623, Pf07654",,Q5SS57,ENSG00000223532,,,0,5,138.99,34.18,102.05,97.24,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,80.8,133.51,139.69,143.42,324.03,,0,
Master Protein,High,P28331,NDUFS1,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS1 PE=1 SV=3",17,58,1.353,0.551,2.014,0.85,0.44,-0.86,1.01,-0.23,7.39E-01,7.38E-01,4.36E-01,9.46E-01,1.39E+06,4.42E+05,4.03E+06,2.36E+06,5,3,5,5,6.17E+05,1.39E+06,7.74E+05,9.08E+06,5.75E+06,5.20E+05,3.01E+05,,,4.42E+05,4.81E+06,2.40E+06,1.67E+06,6.96E+06,4.03E+06,2.36E+06,1.88E+06,3.07E+06,1.01E+06,3.49E+06,2.45E+03,5.26E+03,7.57E+03,9.08E+06,2.96E+05,1.85E+03,5.36E+03,,,4.70E+03,2.88E+04,1.07E+05,1.35E+04,9.38E+05,1.00E+05,4.61E+03,5.27E+05,2.17E+04,2.36E+04,3.72E+04,0,FALSE,80.796,34,17,727,79.4,6.23,17,cell organization and biogenesis;other metabolic processes;transport;other biological processes,other membranes;mitochondrion,"Pf00384, Pf09326, Pf10588, Pf13510",4719,B4DIN9; B4DJA0; B4DPG1; B4DUC1; E7ENF3; hsa:4719; P28331; Q53TR8; Q8N1C4; Q8TCC9,ENSG00000023228; ENSG00000283447,Complex I biogenesis; Mitochondrial protein degradation,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,6,0,106.64,26.33,52.51,41.49,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,53.04,129.53,95.31,124.77,172.47,transporter activity;other molecular function,0,
Master Protein,High,A0A7P0TAT8,HSP90B1,Heat shock protein 90 beta family member 1 OS=Homo sapiens OX=9606 GN=HSP90B1 PE=1 SV=1,30,301,1.352,1.092,1.768,1.03,0.44,0.13,0.82,0.04,8.15E-01,5.00E-01,5.52E-01,9.18E-01,3.64E+07,2.96E+07,3.70E+07,4.88E+07,5,5,5,5,1.28E+07,5.70E+07,5.40E+06,3.64E+07,5.46E+07,2.96E+07,1.76E+07,5.24E+07,1.62E+07,4.99E+07,8.96E+06,3.46E+07,3.70E+07,8.53E+07,7.25E+07,1.18E+08,4.88E+07,8.28E+07,4.26E+07,3.67E+07,5.08E+04,2.17E+05,5.27E+04,3.64E+07,2.81E+06,1.05E+05,3.12E+05,4.83E+05,4.56E+05,5.30E+05,5.36E+04,1.55E+06,3.00E+05,1.15E+07,1.80E+06,2.30E+05,1.37E+07,5.87E+05,9.98E+05,3.91E+05,0,FALSE,177.424,40,29,814,93.7,4.91,30,protein metabolism;other metabolic processes;other biological processes,ER/Golgi;other cell component,"Pf00183, Pf13589",,A0A7P0TAT8,ENSG00000166598,,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; PI3K-Akt signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,4,1,70.93,52.16,64.79,51.93,Peak Found,High,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,120.91,121.81,128.02,121.29,837.62,other molecular function,0,
Master Protein,High,Q7Z7H8,MRPL10,"39S ribosomal protein L10, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL10 PE=1 SV=3",1,2,1.346,0.238,0.01,100,0.43,-2.07,-6.64,6.64,7.31E-01,1.68E-01,1.00E-17,1.00E-17,7.20E+05,5.35E+05,1.72E+05,,3,1,2,,2.66E+06,,7.20E+05,5.16E+04,,,,5.35E+05,,,,,,1.66E+05,1.78E+05,,,,,,1.06E+04,,7.03E+03,5.16E+04,,,,4.93E+03,,,,,,2.23E+04,4.42E+03,,,,,,0,FALSE,7.195,7,1,261,29.3,9.58,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus;nucleus;other cell component,Pf00466,124995,A6NGJ4; hsa:124995; Q7Z7H8; Q96B80; Q96Q55,ENSG00000159111,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,118.51,,5.05,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,137.64,137.63,,,8.08,other molecular function,0,
Master Protein,High,A0A804HL01,ADD1,Adducin 1 OS=Homo sapiens OX=9606 GN=ADD1 PE=1 SV=1,9,30,1.346,0.437,0.97,0.352,0.43,-1.19,-0.04,-1.51,6.72E-01,5.61E-01,9.76E-01,4.73E-01,2.60E+05,5.21E+05,3.63E+05,1.51E+06,2,4,5,4,,9.94E+05,,6.81E+04,,9.97E+05,1.92E+05,1.34E+06,2.72E+05,,2.31E+06,9.84E+04,4.40E+05,3.63E+05,1.78E+05,1.08E+06,1.08E+07,,2.12E+06,3.04E+05,,3.78E+03,,6.81E+04,,3.55E+03,3.41E+03,1.24E+04,7.65E+03,,1.38E+04,4.39E+03,3.58E+03,4.89E+04,4.43E+03,2.11E+03,3.03E+06,,4.96E+04,3.24E+03,0,FALSE,48.604,15,8,799,87.6,5.76,9,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,Pf00596,118,A0A804HL01,ENSG00000087274,,,0,0,123.28,79.92,136.14,136.13,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,n/a,High,Peak Found,1,,FALSE,66.53,145.72,100.05,100.68,93.41,cytoskeletal activity,0,
Master Protein,High,P49593,PPM1F,Protein phosphatase 1F OS=Homo sapiens OX=9606 GN=PPM1F PE=1 SV=3,2,3,1.343,1.296,3.605,0.32,0.43,0.37,1.85,-1.64,7.73E-01,4.96E-01,2.70E-01,3.95E-01,5.75E+04,8.43E+04,1.71E+05,3.03E+05,4,3,4,3,1.26E+05,,7.05E+04,3.93E+04,4.70E+04,9.60E+04,,8.43E+04,5.14E+04,,1.25E+05,2.98E+05,,2.34E+05,1.12E+05,,5.64E+03,,3.03E+05,3.95E+05,5.02E+02,,6.89E+02,3.93E+04,2.42E+03,3.41E+02,,7.78E+02,1.45E+03,,7.49E+02,1.33E+04,,3.15E+04,2.78E+03,,1.58E+03,,7.09E+03,4.21E+03,0,FALSE,7.377,8,2,454,49.8,5.1,2,protein metabolism;other metabolic processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf00481,9647,A8K6G3; B7Z2C3; hsa:9647; P49593; Q96PM2,ENSG00000100034,Negative regulation of NMDA receptor-mediated neuronal transmission,,1,0,55.54,29.95,46.39,86.78,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,83.56,59.38,143.01,142.8,6.74,other molecular function,0,
Master Protein,High,A4D1P6,WDR91,WD repeat-containing protein 91 OS=Homo sapiens OX=9606 GN=WDR91 PE=1 SV=2,4,10,1.343,0.703,1.872,0.269,0.43,-0.51,0.9,-1.89,6.72E-01,9.73E-01,6.29E-01,3.26E-01,4.84E+05,2.39E+05,2.28E+05,8.66E+05,3,4,5,4,,7.63E+05,,4.84E+05,3.26E+05,2.07E+05,7.90E+04,2.76E+05,,1.57E+06,5.09E+04,2.28E+05,1.17E+05,6.64E+05,4.30E+05,8.22E+05,1.90E+06,5.81E+05,9.12E+05,,,2.90E+03,,4.84E+05,1.68E+04,7.38E+02,1.41E+03,2.54E+03,,1.67E+04,3.04E+02,1.02E+04,9.49E+02,8.95E+04,1.07E+04,1.60E+03,5.33E+05,4.12E+03,2.13E+04,,0,FALSE,13.643,7,4,747,83.3,6.58,4,transport;other biological processes,other membranes;cytosol;other cytoplasmic organelle,"Pf00400, Pf12894",29062,A4D1P6; A6NK54; C9JMI4; hsa:29062; Q6FI65; Q6MZQ1; Q6P4I1; Q96AE5; Q96G63; Q9H062; Q9H9B6; Q9NVG7; Q9NZY6,ENSG00000105875,CDC42 GTPase cycle,,1,0,42.18,130.73,83.91,55.11,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,n/a,1,,FALSE,139.71,92.49,90.99,67.56,24.95,enzyme regulator activity,0,
Master Protein,High,Q8N9R8,SCAI,Protein SCAI OS=Homo sapiens OX=9606 GN=SCAI PE=1 SV=2,1,1,1.343,0.01,0.495,0.01,0.42,-6.64,-1.01,-6.64,7.69E-01,1.00E-17,4.92E-01,1.00E-17,8.16E+04,6.07E+04,,3.01E+04,1,3,,3,,,,8.16E+04,,2.82E+05,6.07E+04,,,3.51E+04,,,,,,4.07E+05,7.25E+03,,3.01E+04,,,,,8.16E+04,,1.00E+03,1.08E+03,,,3.73E+02,,,,,,7.93E+02,2.04E+03,,7.04E+02,,0,FALSE,4.595,2,1,606,70.4,8.6,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,other membranes;nucleus;other cell component,Pf12070,286205,hsa:286205; Q3SXZ1; Q3SXZ2; Q5T163; Q8N1I4; Q8N9R8,ENSG00000173611,RHO GTPases Activate Formins,,1,0,,107.72,,151.55,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,108.38,,141.92,,4.11,other molecular function,0,
Master Protein,High,P08754,GNAI3,Guanine nucleotide-binding protein G(i) subunit alpha-3 OS=Homo sapiens OX=9606 GN=GNAI3 PE=1 SV=3,10,106,1.342,0.231,1.892,0.092,0.42,-2.11,0.92,-3.45,7.12E-01,1.24E-01,4.51E-01,5.54E-02,9.69E+05,5.10E+05,1.50E+05,1.84E+06,5,5,4,5,5.35E+06,9.69E+05,4.06E+06,3.64E+05,7.42E+05,5.42E+05,5.52E+05,5.10E+05,1.69E+05,3.14E+05,,1.79E+05,8.85E+04,2.55E+05,1.26E+05,1.84E+06,1.36E+05,2.73E+06,1.09E+05,2.84E+06,2.13E+04,3.68E+03,3.96E+04,3.64E+05,3.83E+04,1.93E+03,9.82E+03,4.70E+03,4.77E+03,3.34E+03,,8.01E+03,7.19E+02,3.44E+04,3.12E+03,3.59E+03,3.83E+04,1.93E+04,2.54E+03,3.02E+04,0,FALSE,45.855,34,3,354,40.5,5.69,10,cell cycle OR cell proliferation;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component,Pf00503,2773,hsa:2773; P08754; P17539; Q5TZX1,ENSG00000065135,G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production,Thyroid stimulating hormone (TSH) signaling pathway; S1P receptor signal transduction; Complement system; G protein signaling pathways; Chemokine signaling pathway; Hippo signaling regulation pathways; Purinergic signaling; Calcium regulation in cardiac cells; 5q35 copy number variation; Serotonin HTR1 group and FOS pathway,18,0,98.23,40.55,44.6,87.7,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,1,,FALSE,67.5,110.6,132.54,138.54,282.61,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q15651,HMGN3,High mobility group nucleosome-binding domain-containing protein 3 OS=Homo sapiens OX=9606 GN=HMGN3 PE=1 SV=2,2,3,1.342,0.674,4.854,0.072,0.42,-0.57,2.28,-3.79,6.68E-01,9.79E-01,1.95E-01,4.97E-02,4.50E+05,5.48E+04,5.35E+04,2.66E+05,2,1,2,1,,,,2.27E+05,8.91E+05,,,,,5.48E+04,,1.49E+05,,1.92E+04,,,,,,2.66E+05,,,,2.27E+05,4.60E+04,,,,,5.82E+02,,6.67E+03,,2.59E+03,,,,,,2.83E+03,0,FALSE,6.566,30,2,99,10.7,9.66,2,cell organization and biogenesis,cytosol;nucleus;other cell component,Pf01101,9324,B2RD37; hsa:9324; Q15651; Q5HYD3; Q7RTT0; Q969M5; Q9BZT7,ENSG00000118418,,,0,0,83.94,,109.19,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,893.14,116.71,0,0,5.66,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P19388,POLR2E,"DNA-directed RNA polymerases I, II, and III subunit RPABC1 OS=Homo sapiens OX=9606 GN=POLR2E PE=1 SV=4",1,2,1.341,0.988,1.814,0.816,0.42,-0.02,0.86,-0.29,6.56E-01,6.69E-01,6.61E-01,9.98E-01,3.90E+05,2.91E+05,3.85E+05,4.72E+05,1,4,4,2,,3.90E+05,,,,2.74E+05,,3.56E+05,1.45E+05,3.09E+05,1.80E+05,,2.72E+05,6.91E+05,5.47E+05,3.70E+05,,,,6.02E+05,,1.48E+03,,,,9.74E+02,,3.29E+03,4.09E+03,3.29E+03,1.08E+03,,2.21E+03,9.31E+04,1.36E+04,7.22E+02,,,,6.41E+03,0.004,FALSE,2.575,4,1,210,24.5,5.95,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf01191, Pf03871",5434,B2R6L4; D6W5Y1; hsa:5434; O43380; P19388; Q6PIH5; Q9BT06,ENSG00000099817,mRNA Splicing - Major Pathway; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,Pyrimidine metabolism; Eukaryotic transcription initiation; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,57,0,,33.37,56.18,33.72,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,18.2,63.78,44.09,74.83,5.34,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O15126,SCAMP1,Secretory carrier-associated membrane protein 1 OS=Homo sapiens OX=9606 GN=SCAMP1 PE=1 SV=2,1,3,1.34,1.005,1.177,0.988,0.42,0.01,0.23,-0.02,6.64E-01,6.21E-01,9.71E-01,8.81E-01,3.32E+05,2.48E+05,3.34E+05,3.95E+05,3,3,5,5,9.29E+04,1.26E+06,,3.32E+05,,,1.74E+05,4.86E+05,,2.48E+05,3.34E+05,1.89E+05,4.49E+05,5.07E+05,2.63E+05,3.95E+05,1.66E+05,5.72E+05,2.26E+05,4.55E+05,3.69E+02,4.80E+03,,3.32E+05,,,3.10E+03,4.48E+03,,2.63E+03,2.00E+03,8.45E+03,3.65E+03,6.83E+04,6.54E+03,7.70E+02,4.66E+04,4.05E+03,5.29E+03,4.84E+03,0.001,FALSE,4.245,3,1,338,37.9,7.42,1,transport;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf04144,9522,hsa:9522; O15126; O43587; Q6FG23; Q96BX1; Q96QK5,ENSG00000085365,Neutrophil degranulation,,1,0,109.93,53.78,37.46,45.84,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,106.76,109.34,63.85,55.89,8.05,other molecular function,0,
Master Protein,High,Q6YN16,HSDL2,Hydroxysteroid dehydrogenase-like protein 2 OS=Homo sapiens OX=9606 GN=HSDL2 PE=1 SV=1,6,14,1.338,1.804,2.21,0.854,0.42,0.85,1.14,-0.23,6.76E-01,1.60E-01,5.14E-01,9.37E-01,3.85E+05,1.69E+05,7.59E+05,5.82E+05,5,2,3,3,1.33E+05,1.19E+06,4.81E+04,4.37E+05,3.85E+05,,,3.40E+05,,8.40E+04,,4.16E+05,,1.15E+06,7.59E+05,1.04E+06,1.87E+05,,5.82E+05,,5.29E+02,4.50E+03,4.70E+02,4.37E+05,1.98E+04,,,3.14E+03,,8.93E+02,,1.86E+04,,1.55E+05,1.89E+04,2.03E+03,5.26E+04,,1.36E+04,,0,FALSE,29.849,26,6,418,45.4,7.99,6,,mitochondrion;other cytoplasmic organelle,"Pf00106, Pf02036",84263,A8K1L4; A8K8X1; A8MSV3; hsa:84263; Q658M8; Q6YN16; Q9BT58,ENSG00000119471,,,0,0,102.6,85.44,47.33,70.92,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,118.76,100.17,87.88,65.59,47.6,other molecular function,0,
Master Protein,High,A0A0C4DFZ2,ARSA,Arylsulfatase A OS=Homo sapiens OX=9606 GN=ARSA PE=1 SV=1,1,3,1.337,0.593,0.611,1.22,0.42,-0.75,-0.71,0.29,7.53E-01,8.45E-01,6.12E-01,7.26E-01,1.00E+05,7.66E+04,5.94E+04,7.65E+04,3,4,3,5,,1.00E+05,,1.36E+05,7.71E+04,1.26E+05,3.09E+04,,4.67E+04,1.60E+06,,,4.32E+04,2.29E+05,5.94E+04,9.61E+04,7.72E+04,7.65E+04,1.79E+04,4.87E+04,,3.80E+02,,1.36E+05,3.98E+03,4.47E+02,5.49E+02,,1.31E+03,1.70E+04,,,3.51E+02,3.09E+04,1.48E+03,1.87E+02,2.17E+04,5.42E+02,4.18E+02,5.18E+02,0.001,FALSE,4.119,3,1,509,53.8,6.07,1,other metabolic processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle;other cell component,"Pf00884, Pf14707",410,A0A0C4DFZ2; hsa:410,ENSG00000100299,,"Degradation pathway of sphingolipids, including diseases",1,0,28.51,170.22,93.15,48.22,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,133.65,55.23,98.93,93.6,8.33,other molecular function,0,
Master Protein,High,Q9Y287,ITM2B,Integral membrane protein 2B OS=Homo sapiens OX=9606 GN=ITM2B PE=1 SV=1,2,6,1.336,4.129,3.994,0.867,0.42,2.05,2,-0.21,7.59E-01,2.27E-02,2.15E-01,9.55E-01,4.10E+04,2.83E+04,5.00E+05,4.07E+05,5,3,3,2,8.54E+04,4.84E+04,4.10E+04,1.34E+04,3.78E+04,1.42E+05,2.35E+04,2.83E+04,,,,,1.00E+05,5.46E+05,5.00E+05,,2.24E+05,,7.37E+05,,3.39E+02,1.84E+02,4.00E+02,1.34E+04,1.95E+03,5.04E+02,4.18E+02,2.61E+02,,,,,8.13E+02,7.36E+04,1.24E+04,,6.31E+04,,1.73E+04,,0,FALSE,7.232,9,2,266,30.3,5.14,2,developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf04089,9445,Q5W0A3; Q96B24; Q9NYH1; Q9Y287,ENSG00000136156,Amyloid fiber formation,,1,0,57.57,103.71,64.2,75.4,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,High,n/a,High,n/a,High,n/a,1,,FALSE,85,60.49,96.82,62.35,16.82,other molecular function,0,
Master Protein,High,P62873,GNB1,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Homo sapiens OX=9606 GN=GNB1 PE=1 SV=3,10,56,1.334,0.577,0.913,3.603,0.42,-0.79,-0.13,1.85,8.27E-01,7.90E-01,8.13E-01,2.25E-01,6.62E+06,2.14E+06,9.02E+06,1.77E+06,5,4,5,5,8.41E+06,4.01E+06,6.62E+06,9.36E+06,4.52E+06,,1.60E+06,1.16E+06,2.85E+06,6.89E+06,1.58E+07,3.24E+06,2.78E+06,1.50E+07,9.02E+06,4.43E+06,3.86E+06,2.27E+05,1.45E+06,1.77E+06,3.34E+04,1.52E+04,6.47E+04,9.36E+06,2.33E+05,,2.85E+04,1.07E+04,8.03E+04,7.33E+04,9.46E+04,1.45E+05,2.26E+04,2.03E+06,2.24E+05,8.63E+03,1.09E+06,1.61E+03,3.39E+04,1.88E+04,0,FALSE,49.396,38,6,340,37.4,6,10,cell-cell signaling;cell cycle OR cell proliferation;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,Pf00400,2782,B1AJZ7; hsa:2782; P04697; P04901; P62873; Q1RMY8,ENSG00000078369,"G alpha (12/13) signalling events; Olfactory Signaling Pathway; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Sensory perception of sweet, bitter, and umami (glutamate) taste; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Inactivation, recovery and regulation of the phototransduction cascade; Glucagon signaling in metabolic regulation; Activation of the phototransduction cascade",Nicotine effect on dopaminergic neurons; Thyroid stimulating hormone (TSH) signaling pathway; Corticotropin-releasing hormone signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; 1p36 copy number variation syndrome; Calcium regulation in cardiac cells; Estrogen signaling pathway,45,4,35.57,83.56,67.76,74.56,High,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,113.53,112.96,112.56,131.44,160.28,other molecular function,0,
Master Protein,High,Q8WU90,ZC3H15,Zinc finger CCCH domain-containing protein 15 OS=Homo sapiens OX=9606 GN=ZC3H15 PE=1 SV=1,1,1,1.332,0.01,2.006,0.01,0.41,-6.64,1,-6.64,7.76E-01,1.00E-17,6.03E-01,1.00E-17,7.40E+04,4.63E+04,,9.30E+04,2,3,,2,,1.42E+05,,,3.87E+04,1.25E+05,4.63E+04,,2.47E+04,,,,,,,,6.93E+04,,,1.25E+05,,5.38E+02,,,2.00E+03,4.45E+02,8.24E+02,,6.95E+02,,,,,,,,1.95E+04,,,1.33E+03,0.002,FALSE,2.837,4,1,426,48.6,5.31,1,protein metabolism;other metabolic processes;signal transduction;other biological processes,cytosol;nucleus,"Pf00642, Pf16543",55854,B4DMW2; D3DPG7; hsa:55854; Q5QTQ4; Q8WU90; Q8WZ06; Q9NUZ3; Q9NZ37; Q9P079,ENSG00000065548,Protein hydroxylation,VEGFA-VEGFR2 signaling,2,0,80.71,80.88,,40.43,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,1,,FALSE,84.59,,66.94,,2.93,other molecular function,0,
Master Protein,High,Q9NVP1,DDX18,ATP-dependent RNA helicase DDX18 OS=Homo sapiens OX=9606 GN=DDX18 PE=1 SV=2,5,14,1.331,0.872,0.472,1.236,0.41,-0.2,-1.08,0.31,7.60E-01,6.27E-01,3.36E-01,7.04E-01,1.85E+06,6.04E+04,2.89E+05,6.58E+05,4,4,5,4,,1.16E+07,5.29E+05,2.55E+06,1.34E+06,9.63E+04,3.80E+04,,2.63E+04,1.62E+06,3.06E+06,2.77E+05,2.28E+05,2.95E+06,2.89E+05,2.02E+06,2.87E+05,1.23E+06,3.51E+05,,,4.41E+04,5.17E+03,2.55E+06,6.90E+04,3.42E+02,6.75E+02,,7.42E+02,1.73E+04,1.83E+04,1.24E+04,1.85E+03,3.98E+05,7.18E+03,3.93E+03,8.06E+04,8.74E+03,8.21E+03,,0,FALSE,20.671,10,5,670,75.4,9.5,5,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00270, Pf00271, Pf13959",8886,hsa:8886; Q6GTZ9; Q6IAU4; Q92732; Q9BQB7; Q9NVP1,ENSG00000088205,,,0,0,128.21,176.12,110.36,84.32,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,113.97,126.62,129.65,131.94,31.95,other molecular function,0,
Master Protein,High,P04440,HLA-DPB1,"HLA class II histocompatibility antigen, DP beta 1 chain OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1",6,35,1.327,0.448,0.928,1.362,0.41,-1.16,-0.11,0.45,7.61E-01,5.52E-01,8.44E-01,6.77E-01,1.41E+06,1.87E+06,1.33E+06,1.23E+06,5,5,5,5,2.98E+05,1.73E+07,2.03E+05,3.83E+06,1.41E+06,1.23E+06,3.12E+06,4.30E+06,2.91E+05,1.87E+06,1.33E+06,2.69E+05,6.73E+05,6.82E+06,4.86E+06,3.04E+06,2.28E+05,8.01E+05,1.23E+06,2.14E+06,1.19E+03,6.59E+04,1.98E+03,3.83E+06,7.27E+04,4.36E+03,5.55E+04,3.96E+04,8.21E+03,1.98E+04,7.93E+03,1.20E+04,5.47E+03,9.20E+05,1.21E+05,5.92E+03,6.41E+04,5.68E+03,2.88E+04,2.28E+04,0,FALSE,34.812,31,2,258,29.1,8.57,6,cell organization and biogenesis;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00969, Pf07654",3115,A0PFJ7; A5I886; A8YPB3; B5U8B4; B7VF80; B7VF87; B8ZX68; B8ZYT0; B9W5S8; B9W6F7; B9W6F9; C0MPP5; C0MPQ2; C0MPQ3; C0MPQ5; C0MPQ6; C0MPQ7; C4R9J5; C5IZL1; hsa:3115; O00259; O19698; O19700; O19702; O19749; O46884; O77952; O98215; O98216; O98217; O98218; O98219; O98222; O98223; P01916; P04232; P04440; P13763; P79493; P79608; Q0P0L4; Q0ZFN3; Q14279; Q27S71; Q29682; Q29684; Q29698; Q29714; Q29775; Q29776; Q29778; Q29779; Q29781; Q29827; Q29828; Q29879; Q29880; Q29898; Q29977; Q2MGW3; Q30015; Q30031; Q30032; Q30033; Q30034; Q30050; Q30051; Q30052; Q30053; Q30054; Q30055; Q30174; Q4GY31; Q4JHD8; Q5ENE0; Q5ENE1; Q5ENW3; Q5EP46; Q5EP47; Q5EP49; Q5EP51; Q5EP52; Q5EP53; Q5EP56; Q5I4H8; Q5I4H9; Q5ISH4; Q5ISH5; Q5SQ73; Q5STP2; Q5YLA6; Q6IVX1; Q6LBX2; Q6LBX3; Q6LBX4; Q6LBX5; Q6LBX6; Q6LBX7; Q6PWX6; Q6TAS4; Q714U1; Q714U2; Q7YQ10; Q860Z7; Q8HWL7; Q8HWT5; Q8SNC4; Q95HC1; Q95IT7; Q95IT8; Q9BD13; Q9GIM2; Q9GIM4; Q9GIX6; Q9GJ41; Q9MY67; Q9TNT7; Q9TQE2; Q9XS11; Q9XS12,ENSG00000215048; ENSG00000223865; ENSG00000226826; ENSG00000230763; ENSG00000236693; ENSG00000237710,MHC class II antigen presentation; Downstream TCR signaling; Phosphorylation of CD3 and TCR zeta chains; Translocation of ZAP-70 to Immunological synapse; Generation of second messenger molecules; PD-1 signaling; Interferon gamma signaling,Allograft rejection; Ebola virus infection in host,9,4,157.31,72.95,103.79,74.82,Peak Found,High,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,134.88,125.11,49.96,122.46,96.18,other molecular function,0,
Master Protein,High,O60832,DKC1,H/ACA ribonucleoprotein complex subunit DKC1 OS=Homo sapiens OX=9606 GN=DKC1 PE=1 SV=3,7,15,1.324,0.704,2.018,0.204,0.41,-0.51,1.01,-2.29,8.33E-01,9.79E-01,4.12E-01,2.36E-01,4.53E+06,2.29E+06,1.15E+06,7.40E+05,5,3,5,2,6.75E+06,4.53E+06,7.14E+05,4.85E+06,1.84E+06,,8.88E+05,2.29E+06,,3.38E+06,9.50E+06,1.15E+06,1.26E+05,4.74E+06,9.64E+05,,,5.65E+05,,9.70E+05,2.68E+04,1.72E+04,6.98E+03,4.85E+06,9.51E+04,,1.58E+04,2.11E+04,,3.60E+04,5.68E+04,5.13E+04,1.03E+03,6.39E+05,2.40E+04,,,4.00E+03,,1.03E+04,0,FALSE,44.46,21,7,514,57.6,9.42,7,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf01472, Pf01509, Pf08068, Pf16198",1736,F5BSB3; hsa:1736; O43845; O60832; Q96G67; Q9Y505,ENSG00000130826,rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase,,2,0,65.09,57.22,118.19,37.37,Peak Found,High,High,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,120.74,116.1,48.71,104.11,41.72,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P13639,EEF2,Elongation factor 2 OS=Homo sapiens OX=9606 GN=EEF2 PE=1 SV=4,14,75,1.322,0.644,2.229,0.422,0.4,-0.64,1.16,-1.24,8.35E-01,9.16E-01,3.73E-01,4.91E-01,4.65E+06,3.67E+06,3.93E+06,1.80E+07,5,5,5,5,2.01E+07,4.56E+06,2.83E+06,4.65E+06,2.69E+07,3.67E+06,1.84E+06,3.92E+06,2.99E+05,7.10E+06,9.29E+06,2.67E+06,3.93E+06,9.30E+06,3.18E+06,9.64E+06,1.80E+07,1.61E+08,8.01E+06,4.11E+07,7.97E+04,1.73E+04,2.76E+04,4.65E+06,1.39E+06,1.31E+04,3.27E+04,3.61E+04,8.41E+03,7.55E+04,5.56E+04,1.19E+05,3.19E+04,1.25E+06,7.91E+04,1.88E+04,5.04E+06,1.14E+06,1.87E+05,4.38E+05,0,FALSE,65.212,23,14,858,95.3,6.83,14,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;other cell component,"Pf00009, Pf00679, Pf03144, Pf03764, Pf14492",1938,A0A384N6H1; B2RMP5; D6W618; hsa:1938; P13639; Q58J86,ENSG00000167658,Neutrophil degranulation; Protein methylation; Uptake and function of diphtheria toxin; Peptide chain elongation; Synthesis of diphthamide-EEF2,Translation factors; AMP-activated protein kinase signaling; Brain-derived neurotrophic factor (BDNF) signaling pathway; IL-18 signaling pathway,9,0,92.92,75.88,58.81,136.31,High,High,High,High,High,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,High,High,High,1,,FALSE,133.48,123.65,127.18,124.27,228.79,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UMS4,PRPF19,Pre-mRNA-processing factor 19 OS=Homo sapiens OX=9606 GN=PRPF19 PE=1 SV=1,8,19,1.321,0.279,0.545,2.59,0.4,-1.84,-0.88,1.37,8.36E-01,1.79E-01,3.86E-01,2.95E-01,4.06E+06,2.61E+06,1.15E+06,5.54E+05,5,4,4,3,7.31E+05,4.06E+06,2.55E+05,8.78E+06,1.42E+07,,8.63E+05,1.92E+06,3.55E+06,4.39E+06,7.72E+06,2.76E+05,,4.82E+06,5.01E+04,,5.54E+05,2.32E+06,1.62E+05,,2.90E+03,1.54E+04,2.49E+03,8.78E+06,7.33E+05,,1.53E+04,1.78E+04,1.00E+05,4.67E+04,4.62E+04,1.23E+04,,6.49E+05,1.25E+03,,1.56E+05,1.64E+04,3.78E+03,,0,FALSE,33.096,21,8,504,55.1,6.61,8,cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,cytoskeleton;nucleus;other cell component,"Pf00400, Pf04564, Pf08606",27339,Q9UMS4,ENSG00000110107,mRNA Splicing - Major Pathway; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER,,5,0,105.12,59.22,115.67,113.63,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,109.8,112.22,95.07,130.6,60.84,other molecular function,0,
Master Protein,High,O95674,CDS2,Phosphatidate cytidylyltransferase 2 OS=Homo sapiens OX=9606 GN=CDS2 PE=1 SV=1,6,14,1.321,0.58,1.446,0.498,0.4,-0.79,0.53,-1.01,7.44E-01,8.61E-01,8.20E-01,6.37E-01,9.60E+05,3.32E+05,2.12E+06,6.51E+05,5,2,5,4,1.61E+06,5.01E+05,9.60E+05,1.43E+06,2.38E+05,,,1.17E+05,,9.41E+05,2.70E+06,5.18E+04,2.12E+06,7.43E+05,3.73E+06,,4.60E+05,4.30E+05,1.41E+06,9.21E+05,6.40E+03,1.90E+03,9.38E+03,1.43E+06,1.23E+04,,,1.08E+03,,1.00E+04,1.62E+04,2.31E+03,1.73E+04,1.00E+05,9.27E+04,,1.29E+05,3.05E+03,3.29E+04,9.80E+03,0,FALSE,40.088,20,6,445,51.4,7.09,6,cell organization and biogenesis;other metabolic processes,other membranes;mitochondrion;ER/Golgi,Pf01148,8760,B2RDC6; D3DW04; hsa:8760; O95674; Q5TDY2; Q5TDY3; Q5TDY4; Q5TDY5; Q9BYK5; Q9NTT2,ENSG00000101290,Synthesis of PG,,1,0,61.88,110.2,79.3,57.24,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,High,Peak Found,1,,FALSE,84.53,132.55,107.45,135.42,35.78,other molecular function,0,
Master Protein,High,Q9NPH3,IL1RAP,Interleukin-1 receptor accessory protein OS=Homo sapiens OX=9606 GN=IL1RAP PE=1 SV=2,1,1,1.32,0.628,0.747,1.571,0.4,-0.67,-0.42,0.65,6.92E-01,8.99E-01,7.27E-01,5.78E-01,2.68E+05,1.56E+05,2.12E+05,1.27E+05,2,3,3,2,,3.48E+05,,2.06E+05,,,1.56E+05,1.56E+05,,2.86E+05,,2.25E+05,,1.24E+05,2.12E+05,,1.17E+05,,1.39E+05,,,1.32E+03,,2.06E+05,,,2.77E+03,1.44E+03,,3.04E+03,,1.01E+04,,1.67E+04,5.27E+03,,3.28E+04,,3.25E+03,,0.006,FALSE,2.429,2,1,570,65.4,8.12,1,cell adhesion;cell-cell signaling;cell organization and biogenesis;stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf01582, Pf18452",3556,B1NLD0; D3DNW0; hsa:3556; O14915; Q86WJ7; Q9NPH3,ENSG00000196083,,IL-1 signaling pathway; Interleukin-1 (IL-1) structural pathway; Signal transduction through IL1R; 2q13 copy number variation syndrome,4,0,36.2,37.63,29.42,12.44,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,39.52,32.17,23.97,28.68,1.76,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,O15047,SETD1A,Histone-lysine N-methyltransferase SETD1A OS=Homo sapiens OX=9606 GN=SETD1A PE=1 SV=3,4,6,1.316,0.458,0.761,0.531,0.4,-1.13,-0.39,-0.91,6.80E-01,5.89E-01,7.59E-01,6.96E-01,5.84E+05,5.39E+04,4.53E+05,4.10E+04,4,2,4,2,7.05E+05,,4.84E+05,7.29E+05,1.12E+05,,7.47E+04,,,3.89E+04,3.85E+05,5.33E+05,,7.46E+05,2.96E+05,,,1.38E+05,1.22E+04,,2.80E+03,,4.73E+03,7.29E+05,5.79E+03,,1.33E+03,,,4.14E+02,2.30E+03,2.38E+04,,1.00E+05,7.36E+03,,,9.80E+02,2.85E+02,,0,FALSE,18.558,3,4,1707,185.9,5.14,4,cell organization and biogenesis;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf00076, Pf00856, Pf11764",9739,A6NP62; hsa:9739; O15047; Q6PIF3; Q8TAJ6,ENSG00000099381,Formation of WDR5-containing histone-modifying complexes; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Histone modifications,4,0,56.29,44.55,40.11,118.54,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,50.87,76.89,164.44,147.65,21.17,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P11388,TOP2A,DNA topoisomerase 2-alpha OS=Homo sapiens OX=9606 GN=TOP2A PE=1 SV=3,16,68,1.315,0.331,1.235,0.33,0.39,-1.59,0.3,-1.6,7.37E-01,3.58E-01,9.34E-01,3.91E-01,3.94E+05,5.92E+05,1.63E+05,7.10E+05,5,3,5,4,3.94E+05,1.50E+05,3.34E+05,8.46E+05,1.70E+06,1.36E+05,1.48E+06,,,5.92E+05,9.29E+04,8.32E+04,1.63E+05,3.03E+06,1.19E+06,,8.62E+05,4.30E+05,8.09E+05,6.23E+05,1.56E+03,5.68E+02,3.26E+03,8.46E+05,8.76E+04,4.85E+02,2.64E+04,,,6.29E+03,5.55E+02,3.72E+03,1.32E+03,4.08E+05,2.96E+04,,2.42E+05,3.05E+03,1.89E+04,6.63E+03,0,FALSE,72.825,14,9,1531,174.3,8.72,16,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf00204, Pf00521, Pf01751, Pf02518, Pf08070, Pf16898",7153,B2RTS1; hsa:7153; P11388; Q71UN1; Q71UQ5; Q9HB24; Q9HB25; Q9HB26; Q9UP44; Q9UQP9,ENSG00000131747,SUMOylation of DNA replication proteins; Transcription of E2F targets under negative control by DREAM complex,Gastric cancer network 1; Gastric cancer network 2; Retinoblastoma gene in cancer,5,0,90.87,92.91,139.67,28.84,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,High,Peak Found,1,,FALSE,99.12,124,113.02,129.58,188.13,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P21127,CDK11B,Cyclin-dependent kinase 11B OS=Homo sapiens OX=9606 GN=CDK11B PE=1 SV=4,2,3,1.315,0.382,0.01,100,0.39,-1.39,-6.64,6.64,7.12E-01,4.25E-01,1.00E-17,1.00E-17,5.66E+05,2.85E+05,1.90E+05,,1,1,4,,,,,5.66E+05,,,,,,2.85E+05,1.87E+05,,1.58E+05,4.64E+05,1.93E+05,,,,,,,,,5.66E+05,,,,,,3.03E+03,1.12E+03,,1.28E+03,6.25E+04,4.79E+03,,,,,,0,FALSE,4.524,3,2,795,92.6,5.54,2,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes,nucleus;other cell component,Pf00069,984,B7ZVY7; hsa:984; J3KTL7; J3QR29; J3QR44; O95265; P21127; Q12817; Q12818; Q12819; Q12820; Q12822; Q8N530; Q9NZS5; Q9UBJ0; Q9UBQ1; Q9UBR0; Q9UNY2; Q9UP57; Q9UP58; Q9UP59,ENSG00000248333,Recruitment of mitotic centrosome proteins and complexes,1p36 copy number variation syndrome,2,0,,,57.01,,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,27,,,4.71,kinase activity;other molecular function,0,
Master Protein,Medium,Q9UPT5,EXOC7,Exocyst complex component 7 OS=Homo sapiens OX=9606 GN=EXOC7 PE=1 SV=3,1,1,1.312,0.01,1.23,0.01,0.39,-6.64,0.3,-6.64,7.84E-01,1.00E-17,9.17E-01,1.00E-17,6.06E+04,4.62E+04,,5.68E+04,1,1,,1,,6.06E+04,,,,,,,4.62E+04,,,,,,,,5.68E+04,,,,,2.30E+02,,,,,,,1.30E+03,,,,,,,,1.59E+04,,,,0.023,FALSE,1.92,1,1,735,83.3,6.79,1,cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf03081, Pf20669",23265,B5MC69; B8XXP2; hsa:23265; Q8ND93; Q8WV91; Q96FF0; Q9H8C3; Q9H9X3; Q9HA32; Q9UPT5,ENSG00000182473,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing; VxPx cargo-targeting to cilium,Angiopoietin-like protein 8 regulatory pathway; Ciliary landscape,5,0,,,,,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,0,,0,,1.8,other molecular function,0,
Master Protein,High,A0A0C4DFM2,ZNF574,"HCG1643764, isoform CRA_b OS=Homo sapiens OX=9606 GN=ZNF574 PE=1 SV=1",5,7,1.312,0.498,0.01,100,0.39,-1.01,-6.64,6.64,7.87E-01,7.31E-01,1.00E-17,1.00E-17,8.30E+04,5.96E+04,1.16E+05,,3,2,4,,,8.30E+04,,2.12E+05,6.23E+04,1.01E+05,,,3.50E+04,,,2.32E+04,2.46E+05,3.85E+05,5.51E+04,,,,,,,3.15E+02,,2.12E+05,3.21E+03,3.60E+02,,,9.87E+02,,,1.04E+03,2.00E+03,5.18E+04,1.37E+03,,,,,,0,FALSE,21.087,9,5,986,108.6,8.41,5,,,"Pf00096, Pf12874, Pf13912",64763,A0A0C4DFM2,ENSG00000105732,,,0,0,68.13,68.75,95.72,,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,67.24,85.65,,,21.79,,0,
Master Protein,High,P08574,CYC1,"Cytochrome c1, heme protein, mitochondrial OS=Homo sapiens OX=9606 GN=CYC1 PE=1 SV=3",4,86,1.31,1.337,0.76,1.881,0.39,0.42,-0.4,0.91,8.43E-01,3.31E-01,6.30E-01,5.24E-01,6.34E+06,6.88E+06,9.32E+06,4.19E+06,4,5,5,4,6.02E+06,2.75E+07,,6.68E+06,1.80E+06,7.32E+06,4.97E+05,8.56E+06,3.11E+06,6.88E+06,4.24E+05,4.27E+06,9.32E+06,1.29E+07,9.84E+06,1.07E+07,1.64E+06,,1.41E+07,4.11E+04,2.39E+04,1.04E+05,,6.68E+06,9.28E+04,2.60E+04,8.83E+03,7.90E+04,8.76E+04,7.32E+04,2.54E+03,1.91E+05,7.57E+04,1.73E+06,2.45E+05,2.09E+04,4.60E+05,,3.31E+05,4.37E+02,0,FALSE,38.091,23,4,325,35.4,9,4,other metabolic processes;transport;other biological processes,other membranes;mitochondrion,Pf02167,1537,hsa:1537; P08574; Q5U062; Q6FHS7,ENSG00000179091,Respiratory electron transport; Mitochondrial protein import,Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,4,0,109.8,63.66,67.35,103.49,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,High,n/a,High,Peak Found,1,,FALSE,116.91,97.35,125.57,120.18,275.38,transporter activity;other molecular function,0,
Master Protein,High,P49755,TMED10,Transmembrane emp24 domain-containing protein 10 OS=Homo sapiens OX=9606 GN=TMED10 PE=1 SV=2,7,44,1.31,1.206,5.519,0.762,0.39,0.27,2.46,-0.39,8.43E-01,4.12E-01,4.06E-02,8.69E-01,3.33E+06,1.82E+06,5.94E+06,4.74E+06,5,1,5,4,3.33E+06,5.69E+06,9.84E+05,7.48E+06,3.74E+05,1.82E+06,,,,,5.94E+06,5.81E+06,5.26E+06,1.40E+07,9.56E+06,3.46E+06,6.49E+06,,8.38E+06,3.01E+06,1.32E+04,2.16E+04,9.62E+03,7.48E+06,1.93E+04,6.46E+03,,,,,3.55E+04,2.59E+05,4.27E+04,1.88E+06,2.37E+05,6.75E+03,1.82E+06,,1.96E+05,3.21E+04,0,FALSE,42.822,34,7,219,25,7.44,7,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,Pf01105,10972,B2R605; hsa:10972; P49755; Q15602; Q16536; Q86TC2; Q86TS5,ENSG00000170348,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; COPII-mediated vesicle transport; Cargo concentration in the ER,mRNA processing; 5q35 copy number variation,6,0,84.86,,45.63,47.81,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,High,Peak Found,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,146.01,105.11,47.47,81.05,135.99,transporter activity;other molecular function,0,
Master Protein,High,Q969X5,ERGIC1,Endoplasmic reticulum-Golgi intermediate compartment protein 1 OS=Homo sapiens OX=9606 GN=ERGIC1 PE=1 SV=1,9,36,1.308,0.446,0.608,0.439,0.39,-1.16,-0.72,-1.19,8.44E-01,5.17E-01,4.43E-01,5.13E-01,5.89E+06,1.73E+06,1.26E+07,8.35E+06,5,4,5,5,1.06E+07,4.02E+06,5.89E+06,3.12E+07,5.46E+06,9.89E+05,,4.48E+06,1.16E+06,2.58E+06,1.68E+07,1.27E+07,6.07E+06,6.25E+06,1.26E+07,8.35E+06,1.08E+06,1.14E+07,4.05E+05,2.50E+07,4.23E+04,1.53E+04,5.75E+04,3.12E+07,2.82E+05,3.52E+03,,4.13E+04,3.28E+04,2.75E+04,1.00E+05,5.66E+05,4.93E+04,8.42E+05,3.13E+05,1.63E+04,3.03E+05,8.05E+04,9.49E+03,2.66E+05,0,FALSE,43.635,42,9,290,32.6,7.06,9,transport,other membranes;ER/Golgi;nucleus;other cell component,"Pf07970, Pf13850",57222,hsa:57222; Q969X5; Q9H0L0; Q9H2J2; Q9ULN9,ENSG00000113719,,,0,0,98.88,70.17,42.56,108.02,High,Peak Found,High,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,129.63,114.4,143.76,144.58,109.14,,0,
Master Protein,High,P37837,TALDO1,Transaldolase OS=Homo sapiens OX=9606 GN=TALDO1 PE=1 SV=2,8,22,1.306,0.34,2.985,0.168,0.38,-1.56,1.58,-2.57,8.46E-01,3.08E-01,2.06E-01,1.32E-01,2.40E+06,3.06E+06,1.50E+06,5.32E+06,5,5,5,5,1.78E+06,3.10E+06,5.26E+05,2.40E+06,2.75E+07,7.95E+06,1.00E+06,3.06E+06,9.08E+04,3.39E+06,9.15E+05,1.74E+06,9.06E+05,3.61E+06,1.50E+06,5.32E+06,1.20E+06,1.20E+07,4.04E+06,3.06E+07,7.06E+03,1.18E+04,5.14E+03,2.40E+06,1.42E+06,2.83E+04,1.79E+04,2.83E+04,2.56E+03,3.60E+04,5.47E+03,7.75E+04,7.36E+03,4.87E+05,3.74E+04,1.04E+04,3.38E+05,8.51E+04,9.45E+04,3.25E+05,0,FALSE,27.3,23,8,337,37.5,6.81,8,other metabolic processes,cytosol;other cell component,Pf00923,6888,B2R8M2; hsa:6888; O00751; P37837; Q8WV32; Q8WZ45,ENSG00000177156,"Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; NFE2L2 regulates pentose phosphate pathway genes; Pentose phosphate pathway; Insulin effects increased synthesis of Xylulose-5-Phosphate; TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P; TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P",Pentose phosphate metabolism; Cori cycle; Metabolic reprogramming in colon cancer,9,0,162.43,98.23,64.05,111.28,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,139.2,139.6,139.89,126.09,49.27,other molecular function,0,
Master Protein,High,P26368,U2AF2,Splicing factor U2AF 65 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF2 PE=1 SV=4,9,15,1.302,0.46,0.643,3.559,0.38,-1.12,-0.64,1.83,7.55E-01,5.91E-01,5.24E-01,2.02E-01,1.13E+06,1.93E+05,9.82E+05,3.59E+05,5,2,4,3,7.58E+05,1.69E+06,2.69E+05,8.36E+06,1.13E+06,,,6.36E+05,,5.83E+04,7.66E+05,6.79E+05,,5.58E+06,1.26E+06,8.73E+05,,,2.16E+05,3.59E+05,3.01E+03,6.44E+03,2.63E+03,8.36E+06,5.84E+04,,,5.87E+03,,6.20E+02,4.58E+03,3.03E+04,,7.52E+05,3.13E+04,1.70E+03,,,5.06E+03,3.82E+03,0,FALSE,27.656,28,9,475,53.5,9.09,9,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf00076,11338,hsa:11338; P26368; Q96HC5,ENSG00000063244,Protein hydroxylation; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,mRNA processing; Warburg effect modulated by deubiquitinating enzymes and their substrates,7,0,137.13,117.67,113.62,71.52,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,35.85,106.44,123.59,110.25,43.4,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,P46821,MAP1B,Microtubule-associated protein 1B OS=Homo sapiens OX=9606 GN=MAP1B PE=1 SV=2,1,1,1.289,0.01,0.553,0.01,0.37,-6.64,-0.86,-6.64,8.04E-01,1.00E-17,5.10E-01,1.00E-17,9.09E+05,1.24E+06,,6.83E+05,2,4,,1,,3.18E+05,,,2.60E+06,,7.91E+05,2.10E+06,1.93E+05,1.93E+06,,,,,,,,,,6.83E+05,,1.21E+03,,,1.34E+05,,1.41E+04,1.94E+04,5.45E+03,2.05E+04,,,,,,,,,,7.27E+03,0.022,FALSE,1.951,1,1,2468,270.5,4.81,1,cell organization and biogenesis;stress response;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf00414,4131,A2BDK5; hsa:4131; P46821,ENSG00000131711,RSV-host interactions,Microtubule cytoskeleton regulation; Fragile X syndrome; Neurogenesis regulation in the olfactory epithelium; HDAC6 interactions in the central nervous system,5,0,110.56,73.04,,,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,Phospho [T2345],FALSE,115.64,,93.77,,2.06,cytoskeletal activity;other molecular function,1,Phospho [T2345]
Master Protein,High,P82650,MRPS22,"28S ribosomal protein S22, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS22 PE=1 SV=1",4,7,1.288,1.192,1.543,1.211,0.37,0.25,0.63,0.28,6.97E-01,4.14E-01,7.51E-01,7.34E-01,2.38E+05,2.31E+05,9.30E+05,1.80E+05,5,2,5,2,2.54E+06,1.05E+05,1.15E+05,5.50E+05,2.38E+05,,,,4.68E+04,1.14E+06,9.30E+05,2.39E+05,2.84E+05,1.15E+06,9.87E+05,,2.69E+05,,1.21E+05,,1.01E+04,4.01E+02,1.13E+03,5.50E+05,1.23E+04,,,,1.32E+03,1.21E+04,5.56E+03,1.07E+04,2.31E+03,1.55E+05,2.45E+04,,7.54E+04,,2.83E+03,,0,FALSE,17.439,18,4,360,41.3,7.9,4,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf10245,56945,hsa:56945; P82650; Q9H3I1,ENSG00000175110,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,Primary ovarian insufficiency,4,0,146.36,130.28,59.24,53.61,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,High,High,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,119.01,100.18,112.39,18.1,other molecular function,0,
Master Protein,High,P49903,SEPHS1,"Selenide, water dikinase 1 OS=Homo sapiens OX=9606 GN=SEPHS1 PE=1 SV=2",3,13,1.287,0.633,1.064,1.512,0.36,-0.66,0.09,0.6,7.10E-01,9.20E-01,9.67E-01,5.83E-01,2.87E+05,1.63E+05,2.47E+05,1.74E+05,4,4,5,3,,3.58E+05,9.46E+04,1.85E+06,2.31E+05,,1.26E+05,2.83E+05,9.96E+04,2.11E+05,2.05E+05,2.68E+05,2.11E+05,4.86E+05,2.47E+05,1.74E+05,3.92E+04,,4.47E+05,,,1.36E+03,9.24E+02,1.85E+06,1.19E+04,,2.24E+03,2.61E+03,2.81E+03,2.24E+03,1.22E+03,1.20E+04,1.71E+03,6.55E+04,6.13E+03,3.39E+02,1.10E+04,,1.05E+04,,0,FALSE,17.2,14,3,392,42.9,5.97,3,protein metabolism;other metabolic processes,plasma membrane;other membranes;nucleus;other cell component,"Pf00586, Pf02769",22929,B4DWK0; D3DRS9; D6PSQ9; hsa:22929; P49903; Q5T5U8; Q5T5U9; Q9BVT4,ENSG00000086475,,,0,0,129.25,46.4,41.04,94.52,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,95.91,99.72,143.81,110.9,42.72,kinase activity;other molecular function,0,
Master Protein,High,P47755,CAPZA2,F-actin-capping protein subunit alpha-2 OS=Homo sapiens OX=9606 GN=CAPZA2 PE=1 SV=3,4,12,1.284,0.439,0.149,0.663,0.36,-1.19,-2.75,-0.59,7.66E-01,5.89E-01,7.28E-02,8.84E-01,1.85E+05,8.70E+04,5.01E+04,1.71E+05,5,2,5,3,1.38E+06,1.85E+05,7.57E+05,1.84E+05,1.81E+05,,,,1.28E+05,5.92E+04,1.20E+06,3.46E+04,4.21E+04,2.72E+05,5.01E+04,3.06E+05,4.36E+04,,1.71E+05,,5.50E+03,7.02E+02,7.39E+03,1.84E+05,9.33E+03,,,,3.60E+03,6.30E+02,7.20E+03,1.55E+03,3.42E+02,3.66E+04,1.24E+03,5.97E+02,1.23E+04,,3.99E+03,,0,FALSE,19.896,23,3,286,32.9,5.85,4,cell organization and biogenesis,non-structural extracellular;other membranes;cytosol;cytoskeleton;other cell component,Pf01267,830,B4DG50; hsa:830; P47755,ENSG00000198898,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Sensory processing of sound by inner hair cells of the cochlea; Factors involved in megakaryocyte development and platelet production; Advanced glycosylation endproduct receptor signaling,,7,0,99.28,51.86,157.17,75.65,High,Peak Found,High,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,52.91,90.42,58.44,133.39,32.24,cytoskeletal activity,0,
Master Protein,Medium,Q9BSF4,TIMM29,Mitochondrial import inner membrane translocase subunit Tim29 OS=Homo sapiens OX=9606 GN=TIMM29 PE=1 SV=2,1,1,1.283,1.584,21.333,0.085,0.36,0.66,4.42,-3.55,7.91E-01,3.90E-01,2.71E-03,3.45E-02,3.86E+04,3.01E+04,5.45E+04,6.41E+05,3,1,2,1,,,2.47E+04,3.94E+04,3.86E+04,,,,,3.01E+04,,6.17E+04,,,4.82E+04,,,,,6.41E+05,,,2.41E+02,3.94E+04,1.99E+03,,,,,3.20E+02,,2.76E+03,,,1.20E+03,,,,,6.82E+03,0.012,FALSE,2.168,5,1,260,29.2,8.09,1,cell organization and biogenesis;transport,other membranes;mitochondrion,Pf10171,90580,Q96EY6; Q96IT8; Q9BSF4,ENSG00000142444,,,0,0,24.14,,17.45,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,3.16,32.56,0,18.43,2.08,transporter activity,0,
Master Protein,High,P46063,RECQL,ATP-dependent DNA helicase Q1 OS=Homo sapiens OX=9606 GN=RECQL PE=1 SV=3,13,27,1.282,0.529,0.472,2.961,0.36,-0.92,-1.08,1.57,7.87E-01,7.31E-01,3.20E-01,2.52E-01,2.13E+06,5.35E+05,1.83E+06,5.78E+05,4,5,5,3,5.91E+05,1.53E+06,,4.93E+06,2.97E+06,7.26E+05,2.10E+05,2.76E+05,5.35E+05,1.78E+07,1.83E+06,6.64E+05,2.55E+06,4.33E+06,1.55E+06,9.89E+05,5.78E+05,,4.78E+05,,2.35E+03,5.83E+03,,4.93E+06,1.53E+05,2.58E+03,3.73E+03,2.55E+03,1.51E+04,1.89E+05,1.09E+04,2.97E+04,2.08E+04,5.83E+05,3.85E+04,1.93E+03,1.62E+05,,1.12E+04,,0,FALSE,58.071,28,13,649,73.4,7.88,13,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response,nucleus;other cell component,"Pf00270, Pf00271, Pf16124",5965,A8K6G2; P46063,ENSG00000004700,,Progeria-associated lipodystrophy,1,0,75.39,198.68,62.99,39.67,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,128.31,115.45,85.7,108.16,81.1,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P49756,RBM25,RNA-binding protein 25 OS=Homo sapiens OX=9606 GN=RBM25 PE=1 SV=3,9,48,1.28,0.225,2.264,0.308,0.36,-2.15,1.18,-1.7,8.63E-01,9.74E-02,3.62E-01,3.38E-01,5.37E+06,1.47E+06,6.60E+05,4.20E+06,5,5,5,5,1.81E+05,6.87E+06,5.74E+05,5.37E+06,8.26E+06,1.47E+06,1.36E+06,3.51E+06,2.10E+05,4.13E+06,6.60E+05,8.77E+05,2.24E+05,2.07E+06,1.83E+05,4.28E+06,3.84E+03,4.20E+06,9.02E+05,7.88E+06,7.18E+02,2.61E+04,5.61E+03,5.37E+06,4.26E+05,5.23E+03,2.42E+04,3.24E+04,5.90E+03,4.39E+04,3.95E+03,3.92E+04,1.82E+03,2.79E+05,4.54E+03,8.35E+03,1.08E+03,2.98E+04,2.11E+04,8.39E+04,0,FALSE,60.02,17,9,843,100.1,6.32,9,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00076, Pf01480",58517,A0PJL9; B2RNA8; B3KT03; hsa:58517; P49756; Q2TA72; Q5XJ17; Q6P665; Q9H6A1; Q9UEQ5; Q9UIE9,ENSG00000119707,mRNA Splicing - Major Pathway,,1,0,86.67,76.29,95.6,90.7,Peak Found,High,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,1,,FALSE,134.07,132.9,120.9,147.22,122.65,nucleic acid binding activity,0,
Master Protein,High,P62277,RPS13,40S ribosomal protein S13 OS=Homo sapiens OX=9606 GN=RPS13 PE=1 SV=2,6,30,1.28,0.546,0.765,0.664,0.36,-0.87,-0.39,-0.59,8.63E-01,7.27E-01,6.36E-01,7.74E-01,6.92E+06,7.19E+06,4.04E+06,5.18E+06,5,5,5,5,6.92E+06,4.55E+07,2.90E+06,5.09E+06,3.33E+07,5.86E+06,3.31E+05,7.19E+06,8.54E+06,4.76E+07,4.50E+06,3.64E+06,4.04E+06,6.08E+06,2.53E+06,5.18E+06,1.16E+07,2.53E+06,1.41E+07,7.83E+05,2.75E+04,1.73E+05,2.84E+04,5.09E+06,1.72E+06,2.08E+04,5.88E+03,6.63E+04,2.41E+05,5.06E+05,2.69E+04,1.62E+05,3.28E+04,8.19E+05,6.28E+04,1.01E+04,3.25E+06,1.80E+04,3.30E+05,8.34E+03,0,FALSE,30.852,32,6,151,17.2,10.54,6,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,"Pf00312, Pf08069",6207,B2R549; hsa:6207; P19116; P62277; Q02546; Q29200; Q498Y0,ENSG00000110700,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,103.47,137.3,31.23,84.42,High,High,High,High,High,High,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,125.91,112.14,133.47,133.52,82.24,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P11166,SLC2A1,"Solute carrier family 2, facilitated glucose transporter member 1 OS=Homo sapiens OX=9606 GN=SLC2A1 PE=1 SV=2",8,152,1.28,0.342,1.117,0.308,0.36,-1.55,0.16,-1.7,8.64E-01,2.99E-01,9.92E-01,3.33E-01,8.55E+07,3.71E+07,9.24E+06,3.01E+07,5,5,5,5,4.71E+08,9.56E+07,8.55E+07,1.03E+06,4.32E+06,6.48E+07,3.35E+06,1.74E+07,3.71E+07,5.82E+07,1.11E+08,6.14E+06,1.37E+07,9.24E+06,3.66E+06,1.63E+07,1.22E+08,3.01E+07,1.10E+08,1.20E+07,1.87E+06,3.63E+05,8.35E+05,1.03E+06,2.23E+05,2.30E+05,5.96E+04,1.60E+05,1.05E+06,6.19E+05,6.63E+05,2.74E+05,1.11E+05,1.24E+06,9.09E+04,3.18E+04,3.42E+07,2.13E+05,2.57E+06,1.28E+05,0,FALSE,38.204,13,8,492,54,8.72,8,cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,Pf00083,6513,A8K9S6; B2R620; D3DPX0; hsa:6513; O75535; P11166; Q0P512; Q147X2,ENSG00000117394,Cellular hexose transport; Regulation of insulin secretion; Vitamin C (ascorbate) metabolism; Lactose synthesis; Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),Cori cycle; HIF1A and PPARG regulation of glycolysis; Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced HIF-1 survival signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; Hereditary leiomyomatosis and renal cell carcinoma pathway; Type 2 papillary renal cell carcinoma; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Insulin signaling; Proximal tubule transport; p53 transcriptional gene network; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Neuroinflammation and glutamatergic signaling; Pleural mesothelioma; Orexin receptor pathway; CCL18 signaling pathway; Glucose metabolism in triple-negative breast cancer cells; Amino acid metabolism in triple-negative breast cancer cells; Warburg effect modulated by deubiquitinating enzymes and their substrates; Chronic hyperglycemia impairment of neuron function; Glycolysis and gluconeogenesis; Macrophage-stimulating protein (MSP) signaling network map; Metabolic Epileptic Disorders; Pancreatic cancer subtypes; 15q25 copy number variation,34,0,148.13,72.31,160.46,92.01,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,139.41,144.05,123.37,132.8,337.58,transporter activity;other molecular function,0,
Master Protein,High,P60604,UBE2G2,Ubiquitin-conjugating enzyme E2 G2 OS=Homo sapiens OX=9606 GN=UBE2G2 PE=1 SV=1,1,1,1.276,1.911,0.01,100,0.35,0.93,-6.64,6.64,7.88E-01,2.28E-01,1.00E-17,1.00E-17,1.03E+05,8.11E+04,1.98E+05,,1,1,3,,,,,1.03E+05,,,,,8.11E+04,,1.98E+05,,3.00E+06,8.73E+04,,,,,,,,,,1.03E+05,,,,,2.29E+03,,1.18E+03,,2.44E+04,1.18E+04,,,,,,,0.003,FALSE,2.739,9,1,165,18.6,4.7,1,protein metabolism;other metabolic processes;other biological processes,ER/Golgi;other cell component,Pf00179,7327,A6NMQ7; A8K3L4; D3DSL7; hsa:7327; P56554; P60604,ENSG00000184787,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway,4,0,,,150.75,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,82.85,,,2.53,other molecular function,0,
Master Protein,High,P63104,YWHAZ,14-3-3 protein zeta/delta OS=Homo sapiens OX=9606 GN=YWHAZ PE=1 SV=1,15,181,1.275,0.361,2.03,0.592,0.35,-1.47,1.02,-0.76,8.67E-01,3.37E-01,4.40E-01,6.98E-01,7.41E+07,8.12E+07,3.11E+07,3.19E+07,5,5,5,5,7.41E+07,1.20E+08,3.48E+07,3.58E+07,2.30E+08,4.68E+07,2.34E+07,2.06E+08,1.54E+08,8.12E+07,2.78E+07,3.73E+07,1.89E+07,4.90E+07,3.11E+07,3.00E+08,3.89E+07,3.19E+07,2.65E+07,1.88E+07,2.94E+05,4.57E+05,3.40E+05,3.58E+07,1.19E+07,1.66E+05,4.17E+05,1.90E+06,4.33E+06,8.63E+05,1.66E+05,1.66E+06,1.54E+05,6.60E+06,7.73E+05,5.85E+05,1.09E+07,2.26E+05,6.19E+05,2.00E+05,0,FALSE,81.655,57,13,245,27.7,4.79,15,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf00244,7534,A8K1N0; B7Z465; hsa:7534; P29213; P29312; P63104; Q32P43; Q5XJ08; Q6GPI2; Q6IN74; Q6NUR9; Q6P3U9; Q86V33,ENSG00000164924,"Deactivation of the beta-catenin transactivating complex; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; Negative regulation of NOTCH4 signaling; Interleukin-3, Interleukin-5 and GM-CSF signaling; TP53 Regulates Metabolic Genes; NOTCH4 Activation and Transmission of Signal to the Nucleus; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Rap1 signalling; KSRP (KHSRP) binds and destabilizes mRNA; GP1b-IX-V activation signalling; Activation of BAD and translocation to mitochondria",Cell cycle; Prolactin signaling pathway; Pathogenic Escherichia coli infection; Myometrial relaxation and contraction pathways; Hepatitis B infection; GDNF signaling; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,23,2,82.07,74.36,34.18,145.83,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,Acetyl [N-Term],FALSE,116.05,120.31,134.32,130.41,484.24,other molecular function,0,
Master Protein,High,P10606,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial OS=Homo sapiens OX=9606 GN=COX5B PE=1 SV=2",5,29,1.274,1.034,0.828,0.918,0.35,0.05,-0.27,-0.12,8.67E-01,5.53E-01,7.09E-01,1.00E+00,1.24E+07,6.36E+06,1.43E+07,3.96E+06,5,5,5,5,1.74E+06,2.59E+07,1.02E+06,1.24E+07,2.76E+07,6.36E+06,3.08E+06,1.18E+07,5.92E+06,1.35E+07,1.85E+06,5.82E+06,1.43E+07,1.44E+07,1.66E+07,1.46E+07,4.43E+06,1.91E+06,3.96E+06,2.86E+06,6.91E+03,9.83E+04,1.00E+04,1.24E+07,1.43E+06,2.26E+04,5.47E+04,1.09E+05,1.67E+05,1.44E+05,1.11E+04,2.60E+05,1.16E+05,1.95E+06,4.13E+05,2.84E+04,1.24E+06,1.36E+04,9.28E+04,3.05E+04,0,FALSE,13.124,31,5,129,13.7,8.81,5,other metabolic processes;transport;other biological processes,other membranes;mitochondrion,Pf01215,1329,hsa:1329; P10606; Q53YB7; Q96J18; Q99610,ENSG00000135940; ENSG00000291596,Mitochondrial protein degradation; Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly; 5q35 copy number variation,8,0,92.68,53.68,60.38,92.55,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,111.66,115.84,112.01,101.14,63.77,transporter activity;other molecular function,0,
Master Protein,High,P20618,PSMB1,Proteasome subunit beta type-1 OS=Homo sapiens OX=9606 GN=PSMB1 PE=1 SV=2,3,20,1.274,0.549,2.17,0.315,0.35,-0.87,1.12,-1.66,7.76E-01,8.02E-01,3.99E-01,3.83E-01,1.53E+06,2.47E+05,5.78E+05,1.71E+06,5,5,5,5,8.24E+05,2.10E+06,3.08E+05,1.53E+06,1.22E+07,2.47E+05,1.30E+05,8.35E+05,9.84E+04,1.05E+07,5.08E+05,5.15E+05,5.78E+05,2.15E+06,8.03E+05,6.97E+05,3.08E+06,7.69E+05,3.48E+06,1.71E+06,3.27E+03,7.97E+03,3.01E+03,1.53E+06,6.27E+05,8.77E+02,2.31E+03,7.71E+03,2.77E+03,1.12E+05,3.04E+03,2.30E+04,4.70E+03,2.89E+05,2.00E+04,1.36E+03,8.66E+05,5.45E+03,8.14E+04,1.82E+04,0,FALSE,13.665,18,3,241,26.5,8.13,3,protein metabolism;other metabolic processes,non-structural extracellular;cytosol;nucleus;other cell component,Pf00227,5689,B5BU76; hsa:5689; P20618; Q9BWA8,ENSG00000008018,Neutrophil degranulation; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,63,0,146.29,193.1,77.05,66.16,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,126.57,106.57,120.42,111.52,57.71,,0,
Master Protein,High,Q96LW7,CARD19,Caspase recruitment domain-containing protein 19 OS=Homo sapiens OX=9606 GN=CARD19 PE=1 SV=1,2,2,1.271,0.986,0.387,2.811,0.35,-0.02,-1.37,1.49,7.70E-01,6.78E-01,3.59E-01,3.30E-01,1.60E+05,1.26E+05,1.37E+05,4.87E+04,3,1,2,1,,,7.50E+04,2.57E+05,1.60E+05,,,,,1.26E+05,,4.07E+05,4.60E+04,,,,,,4.87E+04,,,,7.33E+02,2.57E+05,8.25E+03,,,,,1.34E+03,,1.82E+04,3.74E+02,,,,,,1.14E+03,,0,FALSE,5.544,10,2,228,25.6,9.2,2,other biological processes,other membranes;cytosol;mitochondrion;ER/Golgi;nucleus,,84270,hsa:84270; Q5BJH8; Q96LW7; Q9BSY2,ENSG00000165233,,,0,0,55.49,,112.72,,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,78.78,106.07,0,195.67,5.31,other molecular function,0,
Master Protein,High,Q9BXP5,SRRT,Serrate RNA effector molecule homolog OS=Homo sapiens OX=9606 GN=SRRT PE=1 SV=1,15,26,1.267,0.247,3.724,0.072,0.34,-2.02,1.9,-3.8,7.72E-01,1.68E-01,2.02E-01,3.82E-02,1.01E+06,2.17E+05,4.68E+05,1.24E+06,5,4,5,2,1.88E+05,1.01E+06,3.76E+05,5.97E+06,7.76E+06,,2.33E+05,2.02E+05,1.24E+05,1.20E+06,5.55E+04,5.83E+04,6.35E+05,2.37E+06,4.68E+05,,,2.40E+06,,6.47E+05,7.48E+02,3.84E+03,3.67E+03,5.97E+06,4.00E+05,,4.15E+03,1.86E+03,3.49E+03,1.27E+04,3.32E+02,2.60E+03,5.16E+03,3.19E+05,1.16E+04,,,1.70E+04,,6.89E+03,0,FALSE,78.44,21,15,876,100.6,5.96,15,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf04959, Pf12066",51593,A4D2E5; A4D2E6; A6NK22; B4DJL4; B4DZA6; hsa:51593; O95808; Q32MI4; Q6NT74; Q8TDQ5; Q9BWP6; Q9BXP4; Q9BXP5; Q9Y4S4,ENSG00000087087,mRNA Splicing - Major Pathway; RNA polymerase II transcribes snRNA genes,,2,0,115.77,115.54,133.44,81.31,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,High,n/a,Peak Found,1,,FALSE,78.05,100.03,50.47,48.69,85,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NZI8,IGF2BP1,Insulin-like growth factor 2 mRNA-binding protein 1 OS=Homo sapiens OX=9606 GN=IGF2BP1 PE=1 SV=2,3,4,1.267,0.21,0.596,0.191,0.34,-2.25,-0.75,-2.39,6.82E-01,1.48E-01,5.75E-01,2.49E-01,4.62E+05,2.06E+05,7.71E+03,5.42E+04,5,3,1,2,3.64E+05,4.62E+05,7.07E+04,1.13E+06,2.49E+06,4.56E+05,,2.06E+05,7.28E+04,,,,,,7.71E+03,,,,7.29E+04,4.03E+04,1.45E+03,1.76E+03,6.90E+02,1.13E+06,1.28E+05,1.62E+03,,1.90E+03,2.05E+03,,,,,,1.92E+02,,,,1.71E+03,4.29E+02,0,FALSE,15.788,7,3,577,63.4,9.2,3,cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00013, Pf00076",10642,C9JT33; hsa:10642; Q9NZI8,ENSG00000159217,MAPK6/MAPK4 signaling; Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,Brain-derived neurotrophic factor (BDNF) signaling pathway; eIF5A regulation in response to inhibition of the nuclear export system,4,0,107.21,79.43,,40.77,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,103.25,28.42,80.6,0,13.1,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q92556,ELMO1,Engulfment and cell motility protein 1 OS=Homo sapiens OX=9606 GN=ELMO1 PE=1 SV=2,6,8,1.266,0.447,0.892,2.264,0.34,-1.16,-0.17,1.18,7.74E-01,5.71E-01,7.76E-01,3.62E-01,1.01E+06,6.16E+04,7.96E+05,4.36E+05,4,2,5,1,3.22E+05,,1.55E+05,3.17E+06,1.38E+07,,1.21E+04,,3.13E+05,,1.16E+05,5.05E+05,7.96E+05,1.41E+06,1.57E+06,,,,4.36E+05,,1.28E+03,,1.52E+03,3.17E+06,7.10E+05,,2.15E+02,,8.82E+03,,6.93E+02,2.26E+04,6.47E+03,1.90E+05,3.89E+04,,,,1.02E+04,,0,FALSE,14.39,10,6,727,83.8,6.28,6,cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf04727, Pf11841, Pf16457",9844,A4D1X6; hsa:9844; Q29R79; Q6ZTJ0; Q92556; Q96PB0; Q9H0I1,ENSG00000155849,"Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; VEGFA-VEGFR2 Pathway; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases; Nef and signal transduction",Chemokine signaling pathway; CCL18 signaling pathway,7,0,147.6,130.88,69.33,,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,4.66,109.57,0,66.14,17.46,other molecular function,0,
Master Protein,High,H0YFD6,HADHA,enoyl-CoA hydratase OS=Homo sapiens OX=9606 GN=HADHA PE=1 SV=2,23,142,1.266,0.903,0.829,1.489,0.34,-0.15,-0.27,0.57,8.73E-01,6.93E-01,7.11E-01,6.68E-01,1.48E+07,5.08E+06,2.00E+07,9.25E+06,5,5,5,5,1.34E+07,1.81E+07,1.48E+07,2.28E+07,1.11E+07,5.86E+06,4.38E+06,8.31E+06,3.70E+06,5.08E+06,2.18E+07,1.36E+07,1.62E+07,2.00E+07,2.15E+07,9.25E+06,3.14E+06,1.21E+07,8.02E+06,1.51E+07,5.34E+04,6.87E+04,1.45E+05,2.28E+07,5.70E+05,2.08E+04,7.79E+04,7.66E+04,1.04E+05,5.40E+04,1.30E+05,6.09E+05,1.31E+05,2.69E+06,5.33E+05,1.80E+04,8.82E+05,8.59E+04,1.88E+05,1.61E+05,0,FALSE,131.433,39,23,792,86.3,9.1,23,other metabolic processes,mitochondrion,"Pf00378, Pf00725, Pf02737",,H0YFD6,ENSG00000084754,,Valproic acid pathway,1,0,28.45,32.55,19.16,47.23,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,126.43,111.41,112.63,120.47,409.94,other molecular function,0,
Master Protein,High,Q93084,ATP2A3,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens OX=9606 GN=ATP2A3 PE=1 SV=3,25,124,1.265,0.529,1.993,1.285,0.34,-0.92,0.99,0.36,8.74E-01,6.91E-01,4.54E-01,7.65E-01,1.82E+07,1.68E+07,1.78E+07,2.86E+07,5,5,5,5,8.63E+06,4.06E+07,6.38E+06,2.09E+07,1.82E+07,8.27E+06,9.96E+07,1.68E+07,6.25E+07,4.42E+06,1.78E+07,1.96E+07,9.82E+06,1.87E+07,1.24E+07,8.04E+07,3.05E+06,4.39E+07,4.00E+06,2.86E+07,3.43E+04,1.54E+05,6.24E+04,2.09E+07,9.38E+05,2.94E+04,1.77E+06,1.55E+05,1.76E+06,4.70E+04,1.07E+05,8.77E+05,7.98E+04,2.52E+06,3.09E+05,1.57E+05,8.58E+05,3.11E+05,9.35E+04,3.05E+05,0,FALSE,117.289,28,21,999,109.2,5.52,25,stress response;transport;signal transduction;other biological processes,other membranes;cytosol;ER/Golgi;nucleus,"Pf00122, Pf00689, Pf00690, Pf00702, Pf13246",489,A8MZG0; D3DTJ8; hsa:489; O60900; O60901; O75501; O75502; Q16115; Q6JHX1; Q8TEX5; Q8TEX6; Q93084,ENSG00000074370,Ion homeostasis; Ion transport by P-type ATPases; Pre-NOTCH Processing in Golgi; Reduction of cytosolic Ca++ levels,Alzheimer's disease and miRNA effects; Myometrial relaxation and contraction pathways; Alzheimer's disease; Calcium regulation in cardiac cells,8,5,71.66,108.02,27.46,100.28,High,High,High,High,High,Peak Found,High,High,High,Peak Found,High,High,High,High,High,High,High,High,Peak Found,High,1,Acetyl [N-Term],FALSE,113.95,95.76,133.09,132.66,341.61,transporter activity;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q7Z7K0,CMC1,COX assembly mitochondrial protein homolog OS=Homo sapiens OX=9606 GN=CMC1 PE=1 SV=1,1,4,1.264,0.448,0.401,0.98,0.34,-1.16,-1.32,-0.03,7.17E-01,6.06E-01,3.68E-01,9.07E-01,2.52E+05,1.99E+05,8.90E+04,7.99E+04,4,2,5,2,1.70E+05,,1.77E+04,5.00E+05,3.75E+05,2.74E+05,,,,1.45E+05,8.90E+04,9.48E+04,3.89E+04,9.75E+05,6.47E+04,,1.20E+05,5.34E+04,,,6.74E+02,,1.73E+02,5.00E+05,1.93E+04,9.76E+02,,,,1.54E+03,5.32E+02,4.24E+03,3.16E+02,1.31E+05,1.61E+03,,3.36E+04,3.79E+02,,,0.002,FALSE,3.054,8,1,106,12.5,8.63,1,,mitochondrion,Pf08583,152100,hsa:152100; Q68DJ7; Q7Z7K0,ENSG00000187118,,Mitochondrial complex IV assembly,1,0,80.65,43.69,160.2,54.05,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,104.86,135.44,44.56,63.71,10.31,other molecular function,0,
Master Protein,High,Q9UHD8,SEPTIN9,Septin-9 OS=Homo sapiens OX=9606 GN=SEPTIN9 PE=1 SV=2,12,31,1.264,0.863,5.999,0.705,0.34,-0.21,2.58,-0.5,8.74E-01,7.44E-01,9.53E-02,8.85E-01,4.93E+06,2.72E+05,2.55E+06,6.17E+05,5,3,5,5,1.57E+07,8.72E+05,4.01E+06,4.93E+06,5.63E+06,,2.72E+05,,6.10E+04,2.82E+05,2.26E+06,2.55E+06,1.74E+05,1.30E+07,4.60E+06,6.17E+05,1.17E+05,1.76E+06,7.03E+04,1.67E+06,6.23E+04,3.31E+03,3.91E+04,4.93E+06,2.91E+05,,4.83E+03,,1.72E+03,3.00E+03,1.35E+04,1.14E+05,1.41E+03,1.75E+06,1.14E+05,1.20E+03,3.30E+04,1.25E+04,1.65E+03,1.78E+04,0,FALSE,47.291,30,12,586,65.4,8.97,12,cell cycle OR cell proliferation;other biological processes,cytoskeleton;other cell component,Pf00735,10801,A8K2V3; B3KPM0; B4DTL9; B4E0N2; B4E274; B7Z654; hsa:10801; Q96QF3; Q96QF4; Q96QF5; Q9HA04; Q9UG40; Q9UHD8; Q9Y5W4,ENSG00000184640,,,0,0,89.82,60.9,110.54,96.98,High,Peak Found,High,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,18.51,94.18,120.34,111.83,81.83,other molecular function,0,
Master Protein,High,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 OS=Homo sapiens OX=9606 GN=RANBP2 PE=1 SV=2,24,38,1.261,0.649,1.663,0.463,0.33,-0.62,0.73,-1.11,8.00E-01,9.55E-01,6.33E-01,5.92E-01,2.02E+06,8.51E+05,2.09E+06,8.56E+05,5,5,5,4,1.42E+05,2.97E+06,8.54E+05,4.11E+06,2.02E+06,8.51E+05,5.25E+05,1.31E+06,3.38E+05,1.54E+06,2.72E+06,1.48E+06,1.00E+06,4.18E+06,2.09E+06,,2.11E+05,1.69E+06,4.33E+05,2.79E+06,5.64E+02,1.13E+04,8.35E+03,4.11E+06,1.04E+05,3.03E+03,9.33E+03,1.21E+04,9.51E+03,1.64E+04,1.63E+04,6.62E+04,8.16E+03,5.63E+05,5.18E+04,,5.93E+04,1.20E+04,1.01E+04,2.97E+04,0,FALSE,125.721,12,24,3224,358,6.2,24,protein metabolism;other metabolic processes;transport;other biological processes,other membranes;cytosol;nucleus;other cell component,"Pf00160, Pf00638, Pf00641, Pf12185",5903,hsa:5903; P49792; Q13074; Q15280; Q53TE2; Q59FH7,ENSG00000153201,SARS-CoV-2 activates/modulates innate and adaptive immune responses; tRNA processing in the nucleus; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Signaling by ALK fusions and activated point mutants,,35,0,78.92,55.81,53.82,93.49,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,105.8,91.56,51.43,102.03,121.94,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A0G2JN29,NOMO1,Nodal modulator 1 OS=Homo sapiens OX=9606 GN=NOMO1 PE=1 SV=1,7,22,1.26,0.495,1.288,0.499,0.33,-1.01,0.36,-1,8.14E-01,6.67E-01,9.34E-01,7.10E-01,1.56E+06,6.90E+05,9.74E+05,4.13E+05,5,5,5,5,1.56E+06,2.32E+06,3.61E+05,1.84E+06,1.38E+06,6.90E+05,5.93E+05,2.44E+06,5.55E+05,9.22E+05,1.21E+06,5.83E+06,9.74E+05,6.88E+05,5.68E+05,1.21E+07,1.35E+05,3.72E+06,3.74E+05,4.13E+05,6.20E+03,8.82E+03,3.52E+03,1.84E+06,7.12E+04,2.45E+03,1.05E+04,2.26E+04,1.56E+04,9.80E+03,7.22E+03,2.60E+05,7.91E+03,9.27E+04,1.41E+04,2.36E+04,3.80E+04,2.64E+04,8.76E+03,4.40E+03,0,FALSE,21.868,7,1,1267,139.5,5.8,7,,,"Pf13620, Pf17802",,A0A0G2JN29,ENSG00000274779,,,0,6,48.63,76.6,120.63,152.55,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,109.74,137.73,100.85,134.47,46.61,other molecular function,0,
Master Protein,High,Q5T4U5,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADM PE=1 SV=1",10,47,1.26,1.394,1.324,2.447,0.33,0.48,0.4,1.29,8.78E-01,3.01E-01,8.21E-01,3.84E-01,2.89E+06,2.97E+06,9.47E+06,1.98E+06,5,4,5,5,2.45E+06,3.76E+06,2.52E+05,1.22E+07,2.89E+06,5.78E+06,,9.88E+06,3.12E+05,1.53E+06,2.17E+06,9.47E+06,7.87E+06,1.04E+07,9.54E+06,1.70E+06,1.09E+06,1.98E+06,2.02E+06,3.52E+06,9.74E+03,1.43E+04,2.47E+03,1.22E+07,1.49E+05,2.06E+04,,9.11E+04,8.80E+03,1.62E+04,1.30E+04,4.23E+05,6.40E+04,1.40E+06,2.37E+05,3.31E+03,3.06E+05,1.40E+04,4.72E+04,3.75E+04,0,FALSE,39.518,29,2,454,50.2,7.8,10,other metabolic processes,mitochondrion,"Pf00441, Pf02770, Pf02771",34,Q5T4U5,ENSG00000117054,,Fatty acid beta-oxidation; PPAR-alpha pathway; Nuclear receptors meta-pathway; Mitochondrial long chain fatty acid beta-oxidation; Amino acid metabolism; PPAR signaling pathway; Mitochondrial fatty acid oxidation disorders; Female steroid hormones in cardiomyocyte energy metabolism; Sudden infant death syndrome (SIDS) susceptibility pathways,9,7,106.67,99.5,42.18,43.53,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,119.58,82.72,119.57,86.53,144.42,other molecular function,0,
Master Protein,High,Q5SSJ5,HP1BP3,Heterochromatin protein 1-binding protein 3 OS=Homo sapiens OX=9606 GN=HP1BP3 PE=1 SV=1,19,153,1.257,1.67,1.161,4.233,0.33,0.74,0.22,2.08,8.80E-01,1.93E-01,9.53E-01,1.75E-01,2.33E+07,2.00E+07,2.90E+07,1.44E+07,5,5,5,5,1.81E+07,2.33E+07,1.64E+07,6.09E+07,2.78E+07,1.01E+07,2.48E+07,7.60E+06,7.84E+07,2.00E+07,3.52E+07,2.90E+07,2.15E+07,4.10E+07,2.83E+07,1.44E+07,2.30E+06,1.67E+07,6.95E+06,3.27E+07,7.18E+04,8.85E+04,1.60E+05,6.09E+07,1.43E+06,3.57E+04,4.41E+05,7.02E+04,2.21E+06,2.12E+05,2.11E+05,1.30E+06,1.75E+05,5.53E+06,7.04E+05,2.80E+04,6.47E+05,1.18E+05,1.63E+05,3.48E+05,0,FALSE,122.048,35,19,553,61.2,9.67,19,cell organization and biogenesis;stress response;other biological processes,nucleus;other cell component,Pf00538,50809,A6NI71; A8K5D7; B3KMZ8; B4E210; hsa:50809; Q05BI0; Q5SSJ5; Q5SSJ6; Q5SWC6; Q6PIM9; Q8NDF0; Q9UHY0,ENSG00000127483,,,0,0,62.28,102.76,23.89,79.69,High,High,High,High,High,High,High,High,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,137.26,127.74,141.06,136.85,385.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P40926,MDH2,"Malate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=MDH2 PE=1 SV=3",19,325,1.255,1.18,1.883,1.488,0.33,0.24,0.91,0.57,8.81E-01,4.30E-01,4.99E-01,6.68E-01,3.40E+07,1.81E+07,7.96E+07,5.67E+07,5,5,5,5,9.65E+06,3.40E+07,6.38E+06,9.61E+07,1.44E+08,2.72E+07,5.62E+06,1.81E+07,6.61E+06,1.99E+08,1.17E+07,7.96E+07,1.01E+08,9.46E+07,6.35E+07,5.67E+07,3.32E+07,1.23E+08,2.32E+07,8.08E+07,3.83E+04,1.29E+05,6.23E+04,9.61E+07,7.44E+06,9.66E+04,1.00E+05,1.67E+05,1.86E+05,2.12E+06,7.02E+04,3.56E+06,8.18E+05,1.27E+07,1.58E+06,1.11E+05,9.33E+06,8.72E+05,5.43E+05,8.61E+05,0,FALSE,112.876,66,19,338,35.5,8.68,19,other metabolic processes,other membranes;mitochondrion;other cell component,"Pf00056, Pf02866",4191,A8K414; B2RE78; B4DE44; E9PDB2; O43682; P40926,ENSG00000146701,Mitochondrial protein degradation; Gluconeogenesis; Citric acid cycle (TCA cycle),Amino acid metabolism; Metabolic reprogramming in colon cancer; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; 7q11.23 distal copy number variation; TCA cycle (aka Krebs or citric acid cycle),10,0,103.53,161.95,50.86,63.28,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,137.98,117.45,139.29,125.29,881.24,other molecular function,0,
Master Protein,High,P02749,APOH,Beta-2-glycoprotein 1 OS=Homo sapiens OX=9606 GN=APOH PE=1 SV=3,4,49,1.255,0.243,0.098,1.406,0.33,-2.04,-3.35,0.49,8.81E-01,1.23E-01,3.40E-03,5.86E-01,5.18E+06,2.37E+06,2.34E+05,3.43E+05,3,2,5,3,,5.50E+06,5.18E+06,1.21E+05,,2.21E+06,,2.54E+06,,,8.85E+05,2.26E+05,2.34E+05,5.90E+05,1.71E+05,1.64E+05,3.95E+05,,3.43E+05,,,2.09E+04,5.07E+04,1.21E+05,,7.85E+03,,2.34E+04,,,5.29E+03,1.01E+04,1.90E+03,7.95E+04,4.25E+03,3.19E+02,1.11E+05,,8.03E+03,,0,FALSE,18.091,16,2,345,38.3,7.97,4,protein metabolism;other metabolic processes;stress response;transport;other biological processes,non-structural extracellular;other cell component,"Pf00084, Pf09014",350,B2R9M3; hsa:350; P02749; Q9UCN7,ENSG00000091583,Platelet degranulation,Cholesterol metabolism,2,0,83.81,9.79,73.1,40.42,n/a,High,High,High,n/a,Peak Found,n/a,High,High,n/a,High,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,90.64,129.32,77.07,35.46,102.73,enzyme regulator activity;other molecular function,0,
Master Protein,Medium,Q92917,GPKOW,G-patch domain and KOW motifs-containing protein OS=Homo sapiens OX=9606 GN=GPKOW PE=1 SV=2,1,1,1.254,0.442,0.938,0.589,0.33,-1.18,-0.09,-0.76,7.86E-01,5.94E-01,8.95E-01,7.98E-01,1.96E+05,7.36E+04,4.63E+04,7.86E+04,3,3,2,2,,1.96E+05,,5.53E+04,1.98E+05,,4.43E+04,1.58E+05,,7.36E+04,,,,1.00E+05,2.14E+04,,,,3.17E+04,1.95E+05,,7.46E+02,,5.53E+04,1.02E+04,,7.89E+02,1.46E+03,,7.82E+02,,,,1.35E+04,5.33E+02,,,,7.41E+02,2.08E+03,0.029,FALSE,1.845,4,1,476,52.2,6.15,1,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00467, Pf12656",27238,hsa:27238; Q59EK5; Q92917; Q9BQA8,ENSG00000068394; ENSG00000292204,mRNA Splicing - Major Pathway,,1,0,54.67,64.26,91.45,101.9,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,106.91,66.38,106.21,71.37,2.66,nucleic acid binding activity,0,
Master Protein,High,Q9BVL2,NUP58,Nucleoporin p58/p45 OS=Homo sapiens OX=9606 GN=NUP58 PE=1 SV=1,4,6,1.251,1.401,1.659,1.626,0.32,0.49,0.73,0.7,8.84E-01,2.98E-01,6.07E-01,6.12E-01,1.23E+07,8.11E+06,1.35E+06,1.42E+07,5,4,5,5,4.69E+07,2.03E+07,1.23E+07,1.46E+06,5.73E+06,,5.49E+06,1.04E+07,6.30E+06,1.53E+07,5.92E+07,3.30E+05,2.39E+06,1.35E+06,3.21E+05,1.97E+07,1.08E+05,1.42E+07,4.60E+05,2.27E+07,1.86E+05,7.72E+04,1.20E+05,1.46E+06,2.96E+05,,9.76E+04,9.63E+04,1.78E+05,1.62E+05,3.54E+05,1.47E+04,1.95E+04,1.82E+05,7.97E+03,3.85E+04,3.04E+04,1.01E+05,1.08E+04,2.41E+05,0,FALSE,12.263,11,4,599,60.9,9.33,4,transport;other biological processes,other membranes;nucleus,Pf15967,9818,A6NI12; B4DZJ1; hsa:9818; O43160; Q5JRG2; Q5JRG5; Q9BVL2,ENSG00000139496,,,0,0,103.78,47.84,204.39,92.89,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.64,115.81,107.59,115.1,18,other molecular function,0,
Master Protein,High,Q9NVH1,DNAJC11,DnaJ homolog subfamily C member 11 OS=Homo sapiens OX=9606 GN=DNAJC11 PE=1 SV=2,6,14,1.25,1.225,0.218,1.256,0.32,0.29,-2.2,0.33,8.29E-01,3.27E-01,4.30E-02,7.33E-01,2.53E+06,1.38E+06,7.65E+05,1.80E+06,3,5,5,3,,5.44E+07,,2.53E+06,4.71E+05,1.74E+06,1.14E+06,4.55E+06,3.19E+05,1.38E+06,2.14E+05,1.57E+05,7.65E+05,2.83E+06,2.26E+06,1.04E+06,3.61E+06,,1.80E+06,,,2.07E+05,,2.53E+06,2.43E+04,6.20E+03,2.03E+04,4.20E+04,8.99E+03,1.47E+04,1.28E+03,7.00E+03,6.21E+03,3.81E+05,5.61E+04,2.02E+03,1.02E+06,,4.22E+04,,0,FALSE,25.814,16,6,559,63.2,8.4,6,cell organization and biogenesis,other membranes;mitochondrion;nucleus,"Pf00226, Pf11875",55735,hsa:55735; Q4VWF5; Q5VZN0; Q6PK20; Q6PK70; Q8NDM2; Q96CL7; Q9NVH1,ENSG00000007923,Cristae formation,,1,0,159.74,88.2,98.52,61.48,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,116.23,119.96,95.75,90.56,45.75,,0,
Master Protein,High,Q14527,HLTF,Helicase-like transcription factor OS=Homo sapiens OX=9606 GN=HLTF PE=1 SV=2,2,6,1.248,0.552,4.38,0.157,0.32,-0.86,2.13,-2.67,8.24E-01,8.40E-01,2.31E-01,1.93E-01,5.10E+04,4.08E+04,2.81E+04,1.79E+05,1,1,4,1,,,,5.10E+04,,,,,,4.08E+04,,1.03E+04,2.40E+04,1.92E+05,3.30E+04,,1.79E+05,,,,,,,5.10E+04,,,,,,4.34E+02,,4.60E+02,1.95E+02,2.58E+04,8.20E+02,,5.03E+04,,,,0,FALSE,8.327,3,2,1009,113.9,8.6,2,cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf00176, Pf00271, Pf08797, Pf13923",6596,D3DNH3; Q14527; Q14536; Q16051; Q7KYJ6; Q86YA5; Q92652; Q96KM9,ENSG00000071794,E3 ubiquitin ligases ubiquitinate target proteins,Retinoblastoma gene in cancer,2,0,,,131.53,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,0,76.11,0,76.11,13.05,nucleic acid binding activity;other molecular function,0,
Master Protein,High,U3KQ56,GRHPR,Glyoxylate and hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1,3,8,1.244,0.797,0.01,100,0.31,-0.33,-6.64,6.64,7.45E-01,8.30E-01,1.00E-17,1.00E-17,6.50E+05,2.19E+05,4.76E+05,,2,1,2,,,,,8.70E+05,4.85E+05,,2.19E+05,,,,,3.68E+05,,6.17E+05,,,,,,,,,,8.70E+05,2.50E+04,,3.89E+03,,,,,1.64E+04,,8.31E+04,,,,,,,0,FALSE,12.024,18,3,358,38.7,8.02,3,,,"Pf00389, Pf02826",,U3KQ56,ENSG00000137106,,,0,0,40.13,,35.77,,n/a,n/a,n/a,High,High,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,90.59,78.75,,,24.11,other molecular function,0,
Master Protein,High,Q9NR28,DIABLO,Diablo IAP-binding mitochondrial protein OS=Homo sapiens OX=9606 GN=DIABLO PE=1 SV=1,6,20,1.237,0.446,1.409,0.931,0.31,-1.16,0.5,-0.1,7.90E-01,5.63E-01,8.23E-01,9.02E-01,8.95E+05,1.53E+05,6.81E+05,2.07E+05,4,1,4,3,,5.32E+05,6.22E+04,1.85E+06,1.51E+06,1.53E+05,,,,,,1.03E+06,1.47E+05,1.96E+06,4.52E+05,2.07E+05,6.67E+04,,3.07E+05,,,2.02E+03,6.08E+02,1.85E+06,7.77E+04,5.45E+02,,,,,,4.58E+04,1.19E+03,2.64E+05,1.12E+04,4.04E+02,1.87E+04,,7.18E+03,,0,FALSE,26.111,36,6,239,27.1,5.9,6,signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion,Pf09057,56616,B2RDQ0; hsa:56616; Q6W3F3; Q96LV0; Q9BT11; Q9HAV6; Q9NR28,ENSG00000184047,SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Regulation of the apoptosome activity; Release of apoptotic factors from the mitochondria,Apoptosis modulation and signaling; TNF-alpha signaling pathway; Nanomaterial induced apoptosis; Apoptosis; Complement system in neuronal development and plasticity,10,0,84.23,,88.98,62.32,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,94.42,130.28,6.23,106.17,59.29,,0,
Master Protein,High,K7EJJ5,CLTC,Clathrin heavy chain OS=Homo sapiens OX=9606 GN=CLTC PE=1 SV=2,39,125,1.237,0.789,1.673,0.305,0.31,-0.34,0.74,-1.71,8.93E-01,8.46E-01,5.99E-01,3.29E-01,5.14E+06,4.85E+06,9.17E+06,1.40E+07,5,5,5,5,1.23E+07,9.31E+06,5.03E+06,5.14E+06,4.08E+06,1.01E+07,7.55E+06,4.85E+06,1.12E+06,1.74E+06,9.52E+06,4.86E+06,1.27E+07,9.17E+06,4.11E+06,1.25E+07,5.71E+07,1.40E+07,2.28E+07,1.19E+07,4.88E+04,3.54E+04,4.91E+04,5.14E+06,2.11E+05,3.58E+04,1.34E+05,4.47E+04,3.16E+04,1.85E+04,5.69E+04,2.17E+05,1.03E+05,1.24E+06,1.02E+05,2.44E+04,1.61E+07,9.94E+04,5.34E+05,1.27E+05,0,FALSE,162.143,30,39,1682,192.3,5.69,39,transport,plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle,"Pf00637, Pf01394, Pf09268, Pf13838",,K7EJJ5,ENSG00000141367,,Synaptic vesicle pathway; Ebola virus infection in host; Fragile X syndrome; 7q11.23 copy number variation syndrome,4,0,48.83,75.06,44.16,81.11,High,Peak Found,High,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,1,,FALSE,121.25,113.56,135.77,122.94,348.08,other molecular function,0,
Master Protein,High,E7EVA0,MAP4,Microtubule-associated protein OS=Homo sapiens OX=9606 GN=MAP4 PE=1 SV=1,4,6,1.234,0.43,,0.742,0.3,-1.22,,-0.43,7.49E-01,5.50E-01,,9.64E-01,2.38E+05,1.38E+05,3.77E+05,1.26E+06,2,2,3,2,,1.97E+05,,2.88E+05,,,,1.31E+05,,1.45E+05,,3.77E+05,,6.32E+04,9.33E+05,3.44E+06,,,4.60E+05,,,7.50E+02,,2.88E+05,,,,1.21E+03,,1.55E+03,,1.68E+04,,8.51E+03,2.32E+04,6.70E+03,,,1.08E+04,,0,FALSE,9.151,3,4,2297,245.3,6.23,4,,plasma membrane;other membranes;cytosol;cytoskeleton,Pf00418,,E7EVA0,ENSG00000047849,,Splicing factor NOVA regulated synaptic proteins; 2q37 copy number variation syndrome,2,0,26.38,7.4,96.24,108.01,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,High,n/a,1,,FALSE,20.8,50.79,,175.41,15.53,cytoskeletal activity,0,
Master Protein,High,A0A494C1V2,ZNF891,Zinc finger protein 891 OS=Homo sapiens OX=9606 GN=ZNF891 PE=4 SV=1,2,2,1.232,0.133,1.828,0.09,0.3,-2.91,0.87,-3.48,8.04E-01,7.89E-02,6.91E-01,7.57E-02,1.43E+05,1.16E+05,1.90E+04,2.12E+05,2,2,2,1,,,,6.20E+04,3.28E+05,,,5.76E+04,,2.33E+05,,,,2.56E+04,1.42E+04,,,,,2.12E+05,,,,6.20E+04,1.69E+04,,,5.31E+02,,2.48E+03,,,,3.45E+03,3.52E+02,,,,,2.25E+03,0,FALSE,4.662,5,2,548,64,8.73,2,other biological processes,,"Pf00096, Pf01352, Pf13465",,A0A494C1V2,ENSG00000214029,,,0,0,96.46,85.37,40.74,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,1,Phospho [T90],FALSE,68.75,102.81,112.26,44.6,5.47,other molecular function,1,Phospho [T90]
Master Protein,High,J3QRS3,MYL12A,Myosin light chain 12A OS=Homo sapiens OX=9606 GN=MYL12A PE=1 SV=1,8,122,1.232,0.509,1.257,0.671,0.3,-0.97,0.33,-0.57,8.97E-01,6.50E-01,8.73E-01,7.82E-01,3.19E+07,4.89E+07,1.08E+07,1.72E+07,5,5,5,5,3.19E+07,4.92E+07,9.29E+06,1.31E+07,6.60E+07,4.21E+07,7.98E+06,4.89E+07,6.35E+07,4.98E+07,1.09E+06,6.63E+06,1.08E+07,3.27E+07,2.44E+07,2.07E+07,3.24E+07,8.99E+06,1.72E+07,1.44E+07,1.27E+05,1.87E+05,9.08E+04,1.31E+07,3.40E+06,1.50E+05,1.42E+05,4.51E+05,1.79E+06,5.29E+05,6.53E+03,2.96E+05,8.75E+04,4.41E+06,6.06E+05,4.03E+04,9.09E+06,6.37E+04,4.04E+05,1.53E+05,0,FALSE,65.161,49,2,177,20.4,4.75,8,,,"Pf08976, Pf13499",10627,J3QRS3,ENSG00000101608,,Focal adhesion,1,10,70.8,48.96,86.42,46.64,High,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,118.35,118.64,130.91,128.49,352.52,other molecular function,0,
Master Protein,High,Q9UL26,RAB22A,Ras-related protein Rab-22A OS=Homo sapiens OX=9606 GN=RAB22A PE=1 SV=2,1,3,1.232,0.636,0.01,100,0.3,-0.65,-6.64,6.64,8.34E-01,9.08E-01,1.00E-17,1.00E-17,7.07E+04,7.22E+04,8.36E+04,,3,2,5,,,2.57E+05,,7.07E+04,3.08E+04,,3.44E+04,1.52E+05,,,8.36E+04,1.53E+05,1.09E+05,4.50E+04,1.36E+04,,,,,,,9.76E+02,,7.07E+04,1.59E+03,,6.12E+02,1.40E+03,,,5.00E+02,6.85E+03,8.87E+02,6.06E+03,3.39E+02,,,,,,0,FALSE,6.421,10,1,194,21.8,8.15,1,cell organization and biogenesis;transport,plasma membrane;other membranes;cytoskeleton;other cytoplasmic organelle;other cell component,Pf00071,57403,B3KR86; E1P605; hsa:57403; Q8TF12; Q9H4E6; Q9UL26,ENSG00000124209,RAB geranylgeranylation,,1,0,101.04,89.11,67.27,,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,95.64,104.74,,,6.23,other molecular function,0,
Master Protein,High,P60174,TPI1,Triosephosphate isomerase OS=Homo sapiens OX=9606 GN=TPI1 PE=1 SV=4,10,50,1.232,0.453,1.757,0.812,0.3,-1.14,0.81,-0.3,7.95E-01,5.64E-01,5.15E-01,9.17E-01,1.45E+06,5.60E+05,2.29E+06,1.98E+06,5,5,5,5,1.08E+06,1.45E+06,1.29E+05,1.27E+07,2.93E+07,1.21E+06,2.75E+05,5.60E+05,2.73E+05,6.95E+06,7.13E+04,4.93E+06,2.14E+06,5.12E+06,2.29E+06,2.26E+06,3.86E+06,5.47E+05,7.30E+05,1.98E+06,4.28E+03,5.51E+03,1.26E+03,1.27E+07,1.51E+06,4.31E+03,4.89E+03,5.16E+03,7.68E+03,7.39E+04,4.26E+02,2.20E+05,1.74E+04,6.90E+05,5.69E+04,4.42E+03,1.09E+06,3.88E+03,1.71E+04,2.11E+04,0,FALSE,51.022,55,10,249,26.7,6.9,10,other metabolic processes,cytosol,Pf00121,7167,B7Z5D8; D3DUS9; hsa:7167; P00938; P60174; Q6FHP9; Q6IS07; Q8WWD0; Q96AG5,ENSG00000111669,Glycolysis; Gluconeogenesis,Fatty acid beta-oxidation; Cori cycle; HIF1A and PPARG regulation of glycolysis; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; Disorders of fructose metabolism; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,10,0,140,155.02,72.83,71.43,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,128.81,125.95,139.21,106.13,158.55,other molecular function,0,
Master Protein,High,Q13451,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5 OS=Homo sapiens OX=9606 GN=FKBP5 PE=1 SV=2,5,7,1.231,0.709,4.816,0.132,0.3,-0.5,2.27,-2.92,7.92E-01,9.84E-01,1.32E-01,1.01E-01,1.60E+05,1.36E+05,1.37E+05,7.72E+05,3,3,3,3,,1.06E+05,,3.80E+05,1.60E+05,,9.02E+04,,1.36E+05,4.19E+05,9.57E+05,1.86E+04,,1.37E+05,,,2.11E+04,7.72E+05,,3.88E+06,,4.04E+02,,3.80E+05,8.23E+03,,1.60E+03,,3.83E+03,4.46E+03,5.72E+03,8.32E+02,,1.84E+04,,,5.93E+03,5.47E+03,,4.13E+04,0,FALSE,13.858,17,5,457,51.2,5.9,5,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00254, Pf00515",2289,F5H7R1; hsa:2289; Q13451; Q59EB8; Q5TGM6,ENSG00000096060,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; ESR-mediated signaling; MECP2 regulates neuronal receptors and channels,Androgen receptor network in prostate cancer; Farnesoid X receptor pathway; Nuclear receptors meta-pathway; MECP2 and associated Rett syndrome,7,0,67.39,82.8,137.84,131.35,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,High,1,,FALSE,44.51,59.15,143.51,144.2,19.01,other molecular function,0,
Master Protein,High,Q6P2Q9,PRPF8,Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2,23,49,1.23,0.982,2.143,1.815,0.3,-0.03,1.1,0.86,8.99E-01,6.05E-01,4.00E-01,5.45E-01,5.83E+06,3.45E+06,1.15E+07,4.48E+06,5,5,5,5,5.53E+06,7.70E+06,4.52E+06,2.91E+07,5.83E+06,1.98E+07,1.58E+06,3.45E+06,2.82E+06,3.98E+06,6.97E+06,1.20E+07,2.06E+06,1.15E+07,4.78E+07,4.48E+06,3.21E+06,1.17E+08,2.00E+06,4.91E+07,2.20E+04,2.92E+04,4.41E+04,2.91E+07,3.01E+05,7.05E+04,2.81E+04,3.19E+04,7.94E+04,4.23E+04,4.17E+04,5.35E+05,1.67E+04,1.55E+06,1.19E+06,8.74E+03,9.02E+05,8.27E+05,4.69E+04,5.22E+05,0,FALSE,106.82,14,23,2335,273.4,8.84,23,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf01398, Pf08082, Pf08083, Pf08084, Pf10596, Pf10597, Pf10598, Pf12134",10594,hsa:10594; O14547; O75965; Q6P2Q9,ENSG00000174231; ENSG00000274442,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing,3,0,99.14,119.97,113.27,141.8,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,109.64,131.38,125.79,139.65,154.32,nucleic acid binding activity;other molecular function,0,
Master Protein,High,J3QQK4,BPTF,Bromodomain PHD finger transcription factor OS=Homo sapiens OX=9606 GN=BPTF PE=1 SV=2,7,13,1.23,0.711,0.219,0.784,0.3,-0.49,-2.19,-0.35,7.26E-01,9.69E-01,1.55E-01,9.87E-01,4.59E+05,1.63E+05,8.16E+04,4.48E+04,5,3,3,1,6.45E+04,4.59E+05,2.34E+04,5.62E+05,2.51E+06,1.63E+05,3.38E+04,,,3.91E+05,,8.16E+04,,8.67E+04,2.72E+04,,,,4.48E+04,,2.56E+02,1.75E+03,2.29E+02,5.62E+05,1.30E+05,5.79E+02,6.02E+02,,,4.15E+03,,3.65E+03,,1.17E+04,6.75E+02,,,,1.05E+03,,0,FALSE,25.583,3,7,3158,350,6.49,7,other biological processes,nucleus,,2186,J3QQK4,ENSG00000171634,,Endoderm differentiation; 16p11.2 proximal deletion syndrome,2,0,141.78,92.25,50.67,,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,104.76,87.06,47.02,27.86,36.44,other molecular function,0,
Master Protein,High,P32119,PRDX2,Peroxiredoxin-2 OS=Homo sapiens OX=9606 GN=PRDX2 PE=1 SV=5,14,219,1.228,0.711,2.146,0.373,0.3,-0.49,1.1,-1.42,9.00E-01,9.68E-01,3.99E-01,4.24E-01,3.11E+07,2.53E+07,3.14E+07,5.18E+07,5,5,5,5,1.46E+08,3.48E+07,1.46E+07,2.34E+06,3.11E+07,2.76E+07,2.53E+07,1.62E+07,1.33E+07,5.71E+07,4.29E+07,5.44E+06,4.95E+07,3.14E+07,9.61E+06,1.67E+07,2.75E+08,1.77E+07,1.90E+08,5.18E+07,5.79E+05,1.32E+05,1.43E+05,2.34E+06,1.60E+06,9.83E+04,4.50E+05,1.49E+05,3.75E+05,6.07E+05,2.57E+05,2.43E+05,4.02E+05,4.24E+06,2.39E+05,3.26E+04,7.73E+07,1.25E+05,4.46E+06,5.51E+05,0,FALSE,79.599,71,13,198,21.9,5.97,14,cell cycle OR cell proliferation;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;other cell component,"Pf00578, Pf10417",7001,A8K0C0; hsa:7001; P31945; P32118; P32119; P35701; Q6FHG4; Q92763; Q9UC23,ENSG00000167815,Detoxification of Reactive Oxygen Species; TP53 Regulates Metabolic Genes; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,Selenium micronutrient network; VEGFA-VEGFR2 signaling; HDAC6 interactions in the central nervous system,6,0,125.66,62.31,70.69,105.64,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,Peak Found,High,High,High,Peak Found,1,,FALSE,135.79,126.75,139.45,136.75,536.33,other molecular function,0,
Master Protein,High,Q01518,CAP1,Adenylyl cyclase-associated protein 1 OS=Homo sapiens OX=9606 GN=CAP1 PE=1 SV=5,5,6,1.228,0.169,1.111,1.132,0.3,-2.56,0.15,0.18,8.66E-01,3.57E-02,9.24E-01,7.74E-01,3.96E+06,1.37E+05,2.92E+05,4.93E+05,3,4,5,1,3.96E+06,4.68E+06,,1.75E+05,,,1.43E+05,2.90E+06,1.17E+05,1.32E+05,2.92E+05,1.03E+05,8.85E+04,3.78E+05,6.83E+05,,4.93E+05,,,,1.57E+04,1.78E+04,,1.75E+05,,,2.54E+03,2.68E+04,3.31E+03,1.40E+03,1.75E+03,4.60E+03,7.19E+02,5.10E+04,1.70E+04,,1.39E+05,,,,0,FALSE,15.02,17,5,475,51.9,8.06,5,cell organization and biogenesis;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytoskeleton;other cytoplasmic organelle;other cell component,"Pf01213, Pf08603",10487,hsa:10487; Q01518; Q53HR7; Q5T0S1; Q5T0S2; Q6I9U6,ENSG00000131236,Neutrophil degranulation; Platelet degranulation ; Role of ABL in ROBO-SLIT signaling,Angiopoietin-like protein 8 regulatory pathway; Insulin signaling; Complement system in neuronal development and plasticity; Opioid receptor pathways,7,0,82.33,168.23,78.6,,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,22.41,105.48,12.17,75.29,17.27,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog OS=Homo sapiens OX=9606 GN=PRPF4B PE=1 SV=3,4,5,1.225,0.392,11.54,1.195,0.29,-1.35,3.53,0.26,7.97E-01,4.56E-01,1.83E-02,6.72E-01,1.08E+06,2.83E+05,1.95E+05,4.00E+05,2,4,4,2,,,,1.47E+06,7.88E+05,,3.70E+04,5.57E+05,1.44E+05,2.99E+06,2.91E+05,1.39E+05,7.53E+04,2.74E+05,,5.61E+06,,,2.85E+04,,,,,1.47E+06,4.06E+04,,6.58E+02,5.14E+03,4.05E+03,3.18E+04,1.74E+03,6.21E+03,6.11E+02,3.70E+04,,1.09E+04,,,6.67E+02,,0,FALSE,12.94,5,4,1007,116.9,10.26,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf00069,8899,A8K5C9; hsa:8899; Q13523; Q5D0F6; Q5TAY8; Q8IVC3; Q8TDP2; Q96QT7; Q9UEE6,ENSG00000112739,mRNA Splicing - Major Pathway,mRNA processing,2,0,42.68,149.18,53.8,139.99,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,91.69,82.81,138.36,35.42,11.8,kinase activity;other molecular function,0,
Master Protein,High,O75821,EIF3G,Eukaryotic translation initiation factor 3 subunit G OS=Homo sapiens OX=9606 GN=EIF3G PE=1 SV=2,5,13,1.224,0.722,0.954,0.488,0.29,-0.47,-0.07,-1.03,7.99E-01,8.69E-01,8.83E-01,6.80E-01,8.03E+05,5.16E+05,6.49E+05,1.08E+06,5,4,4,3,4.37E+05,1.92E+06,8.03E+05,8.48E+05,1.86E+05,1.03E+06,2.53E+04,,5.54E+05,4.81E+05,,1.74E+05,8.80E+05,1.07E+06,4.79E+05,,4.18E+06,1.08E+06,7.74E+05,,1.74E+03,7.30E+03,7.85E+03,8.48E+05,9.58E+03,3.65E+03,4.51E+02,,1.56E+04,5.12E+03,,7.79E+03,7.15E+03,1.44E+05,1.19E+04,,1.18E+06,7.64E+03,1.81E+04,,0,FALSE,17.313,17,5,320,35.6,6.13,5,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,"Pf00076, Pf12353",8666,hsa:8666; O14801; O75821; Q969U5,ENSG00000130811,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,8,0,79.08,78.59,61.71,93.81,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,110.9,98.19,117.15,130.49,36.71,nucleic acid binding activity,0,
Master Protein,High,P62081,RPS7,40S ribosomal protein S7 OS=Homo sapiens OX=9606 GN=RPS7 PE=1 SV=1,4,38,1.223,1.209,0.703,2.101,0.29,0.27,-0.51,1.07,8.73E-01,4.10E-01,5.86E-01,4.62E-01,2.55E+06,1.76E+06,5.50E+06,1.38E+06,5,5,5,4,2.16E+06,6.83E+06,1.88E+06,2.55E+06,3.43E+06,2.34E+05,1.34E+06,4.36E+06,1.76E+06,5.63E+06,7.35E+07,3.67E+06,5.50E+06,2.41E+06,7.38E+06,1.22E+06,1.94E+06,,1.26E+06,1.52E+06,8.56E+03,2.60E+04,1.84E+04,2.55E+06,1.77E+05,8.31E+02,2.39E+04,4.02E+04,4.97E+04,5.98E+04,4.39E+05,1.64E+05,4.46E+04,3.25E+05,1.83E+05,2.38E+03,5.45E+05,,2.95E+04,1.62E+04,0,FALSE,21.112,40,4,194,22.1,10.1,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;cytoskeleton;ER/Golgi;translational apparatus;nucleus;other cell component,Pf01251,6201,hsa:6201; P23821; P24818; P62081; Q57Z92; Q6IPH1,ENSG00000171863,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,20,0,59.94,84.12,166.58,22.29,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,96.65,80.86,127.17,55.53,99.72,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75947,ATP5PD,"ATP synthase subunit d, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PD PE=1 SV=3",9,75,1.222,0.952,1.256,1.231,0.29,-0.07,0.33,0.3,9.04E-01,6.37E-01,8.73E-01,7.94E-01,1.25E+07,1.08E+07,1.79E+07,1.42E+07,5,5,5,5,1.25E+07,4.94E+07,4.96E+06,1.25E+07,1.41E+07,1.08E+07,5.84E+06,1.57E+07,3.85E+06,2.09E+07,4.79E+06,9.30E+06,2.58E+07,1.79E+07,2.12E+07,2.52E+07,6.34E+06,1.66E+07,1.15E+07,1.42E+07,4.95E+04,1.88E+05,4.84E+04,1.25E+07,7.27E+05,3.85E+04,1.04E+05,1.45E+05,1.08E+05,2.22E+05,2.87E+04,4.15E+05,2.09E+05,2.41E+06,5.26E+05,4.91E+04,1.78E+06,1.18E+05,2.68E+05,1.52E+05,0,FALSE,47.983,70,9,161,18.5,5.3,9,other metabolic processes;transport,other membranes;mitochondrion,Pf05873,10476,B2R5L6; hsa:10476; O75947; Q9H3J4,ENSG00000167863,Mitochondrial protein degradation; Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,5,0,93.8,61.42,54.47,47.12,High,High,High,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,High,1,,FALSE,116.27,121.22,109.17,113.52,207.11,transporter activity,0,
Master Protein,High,A0A0D9SF53,DDX3X,RNA helicase OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=1,8,54,1.22,0.493,0.442,0.918,0.29,-1.02,-1.18,-0.12,9.06E-01,6.17E-01,2.41E-01,9.99E-01,7.84E+06,2.30E+07,2.28E+06,4.69E+06,5,5,5,5,7.84E+06,3.57E+07,3.20E+06,1.08E+06,2.25E+07,6.35E+07,2.46E+06,2.90E+07,1.90E+07,2.30E+07,1.28E+07,1.13E+04,1.82E+06,3.63E+06,2.28E+06,9.29E+06,2.11E+06,3.86E+06,4.69E+06,1.58E+07,3.11E+04,1.36E+05,3.13E+04,1.08E+06,1.16E+06,2.26E+05,4.37E+04,2.67E+05,5.36E+05,2.44E+05,7.63E+04,5.03E+02,1.48E+04,4.89E+05,5.67E+04,1.81E+04,5.93E+05,2.74E+04,1.10E+05,1.69E+05,0,FALSE,37.607,16,7,733,81.4,8.07,8,,cytosol;nucleus,"Pf00270, Pf00271",,A0A0D9SF53,ENSG00000215301,,Novel intracellular components of RIG-I-like receptor pathway; Hepatitis B infection,2,0,104.5,82.02,122.21,77.26,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,134.26,125.49,141.53,95.86,141.56,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P18085,ARF4,ADP-ribosylation factor 4 OS=Homo sapiens OX=9606 GN=ARF4 PE=1 SV=3,4,8,1.217,0.067,1.738,0.053,0.28,-3.9,0.8,-4.24,7.90E-01,3.34E-03,6.59E-01,1.02E-02,4.75E+05,4.74E+05,4.32E+04,8.19E+05,4,4,2,4,5.77E+05,2.29E+06,2.78E+05,,3.91E+05,2.19E+05,,1.01E+06,4.86E+05,4.63E+05,,,8.43E+04,,2.21E+04,2.43E+06,1.37E+05,2.57E+06,2.76E+05,,2.29E+03,8.69E+03,2.72E+03,,2.02E+04,7.80E+02,,9.35E+03,1.37E+04,4.93E+03,,,6.85E+02,,5.50E+02,4.73E+03,3.86E+04,1.82E+04,6.47E+03,,0,FALSE,9.805,24,1,180,20.5,7.14,4,cell organization and biogenesis;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,Pf00025,378,B2R7J7; hsa:378; P18085; P21371,ENSG00000168374,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; VxPx cargo-targeting to cilium,VEGFA-VEGFR2 signaling,4,0,106.81,61.31,82.58,98.01,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,78.68,106.64,124.56,111.18,19.83,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q9P2K3,RCOR3,REST corepressor 3 OS=Homo sapiens OX=9606 GN=RCOR3 PE=1 SV=2,4,5,1.216,0.361,0.377,0.92,0.28,-1.47,-1.41,-0.12,8.43E-01,4.84E-01,3.56E-01,8.84E-01,1.04E+05,5.33E+04,3.63E+04,3.95E+04,4,3,2,2,,7.33E+04,3.87E+04,1.48E+05,2.62E+05,,3.60E+04,5.33E+04,,3.04E+05,,1.07E+04,1.23E+05,,,,9.05E+03,1.72E+05,,,,2.79E+02,3.78E+02,1.48E+05,1.35E+04,,6.41E+02,4.91E+02,,3.23E+03,,4.78E+02,1.00E+03,,,,2.54E+03,1.22E+03,,,0,FALSE,16.666,11,1,495,55.5,8.27,4,other biological processes,cytosol;nucleus;other cell component,"Pf00249, Pf01448, Pf20878",55758,B3KYA2; B4DYY7; hsa:55758; Q5VT47; Q7L9I5; Q8N5U3; Q9NV83; Q9P2K3,ENSG00000117625,,,0,0,75.61,114.37,118.85,127.3,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,109.34,123.95,133.75,90.21,17.2,other molecular function,0,
Master Protein,High,Q14257,RCN2,Reticulocalbin-2 OS=Homo sapiens OX=9606 GN=RCN2 PE=1 SV=1,5,9,1.213,1.614,1.604,1.741,0.28,0.69,0.68,0.8,7.48E-01,2.17E-01,7.56E-01,4.77E-01,3.49E+05,1.18E+05,8.91E+05,9.66E+04,5,4,4,3,3.30E+04,3.49E+05,2.15E+04,7.38E+05,1.71E+06,,3.51E+04,3.04E+05,4.86E+05,4.58E+04,,4.42E+05,6.93E+05,1.15E+06,3.46E+06,,7.52E+04,,4.45E+05,9.66E+04,1.31E+02,1.33E+03,2.10E+02,7.38E+05,8.82E+04,,6.24E+02,2.81E+03,1.37E+04,4.87E+02,,1.97E+04,5.63E+03,1.54E+05,8.60E+04,,2.11E+04,,1.04E+04,1.03E+03,0,FALSE,22.832,31,5,317,36.9,4.4,5,,ER/Golgi;nucleus,"Pf13202, Pf13499",5955,A8MTG6; F8WCY5; hsa:5955; Q14257; Q53XN8,ENSG00000117906,,,0,0,122.94,100.01,96.26,100.91,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,89.83,80.45,82.42,122.14,30.24,other molecular function,0,
Master Protein,High,Q9Y305,ACOT9,"Acyl-coenzyme A thioesterase 9, mitochondrial OS=Homo sapiens OX=9606 GN=ACOT9 PE=1 SV=2",6,18,1.211,1.013,0.222,8.508,0.28,0.02,-2.17,3.09,8.25E-01,4.87E-01,1.51E-01,3.59E-02,2.56E+06,4.33E+04,1.01E+06,2.12E+05,3,1,4,1,,2.29E+07,,2.56E+06,2.94E+05,,,,,4.33E+04,,9.57E+05,2.06E+05,4.94E+06,1.06E+06,,2.12E+05,,,,,8.72E+04,,2.56E+06,1.52E+04,,,,,4.61E+02,,4.28E+04,1.68E+03,6.66E+05,2.64E+04,,5.97E+04,,,,0,FALSE,27.907,22,6,439,49.9,8.6,6,other metabolic processes,mitochondrion,,23597,B3KNC9; B7ZM94; hsa:23597; Q9Y305,ENSG00000123130,Mitochondrial Fatty Acid Beta-Oxidation,VEGFA-VEGFR2 signaling,2,0,145.04,,119.09,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,15.07,130.46,0,72.6,57.32,other molecular function,0,
Master Protein,High,P98179,RBM3,RNA-binding protein 3 OS=Homo sapiens OX=9606 GN=RBM3 PE=1 SV=1,2,8,1.21,0.37,0.363,0.684,0.28,-1.43,-1.46,-0.55,8.30E-01,4.49E-01,2.82E-01,8.79E-01,1.27E+05,5.10E+04,1.62E+05,2.70E+05,3,1,5,5,,,6.17E+04,1.99E+06,1.27E+05,,,5.10E+04,,,4.65E+04,1.64E+06,3.58E+04,1.62E+05,5.67E+05,2.70E+05,2.22E+05,2.51E+05,4.07E+05,3.78E+05,,,6.03E+02,1.99E+06,6.55E+03,,,4.71E+02,,,2.78E+02,7.32E+04,2.91E+02,2.19E+04,1.41E+04,5.27E+02,6.23E+04,1.78E+03,9.51E+03,4.02E+03,0,FALSE,14.175,21,2,157,17.2,8.91,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf00076,5935,hsa:5935; P98179,ENSG00000102317,,,0,0,150.81,,138.22,26.74,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,105.43,64.5,238.51,121.95,26.07,translation activity,0,
Master Protein,High,Q96TC7,RMDN3,Regulator of microtubule dynamics protein 3 OS=Homo sapiens OX=9606 GN=RMDN3 PE=1 SV=2,5,17,1.207,2.235,0.954,2.664,0.27,1.16,-0.07,1.41,8.29E-01,1.30E-01,8.25E-01,2.90E-01,7.97E+04,9.17E+04,8.59E+05,4.21E+05,3,2,5,4,7.97E+04,,,1.06E+06,3.09E+04,,,,3.22E+04,2.61E+05,1.86E+05,8.59E+05,7.39E+05,1.33E+06,1.70E+06,7.66E+05,5.71E+06,8.75E+04,2.31E+05,,3.17E+02,,,1.06E+06,1.60E+03,,,,9.07E+02,2.78E+03,1.11E+03,3.84E+04,6.00E+03,1.79E+05,4.21E+04,1.49E+03,1.61E+06,6.20E+02,5.41E+03,,0,FALSE,24.536,13,5,470,52.1,5.1,5,other biological processes,other membranes;cytoskeleton;mitochondrion;nucleus;other cell component,Pf21033,55177,A9UMZ9; B3KRR3; hsa:55177; Q6ZWE9; Q96H23; Q96SD6; Q96TC7; Q9H6G1; Q9NVQ6,ENSG00000137824,,,0,0,148.79,110.37,60.09,158.39,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,122.22,100.82,209.4,144.06,47.98,cytoskeletal activity,0,
Master Protein,High,P49207,RPL34,60S ribosomal protein L34 OS=Homo sapiens OX=9606 GN=RPL34 PE=1 SV=3,2,4,1.204,0.962,2.532,0.413,0.27,-0.06,1.34,-1.28,7.37E-01,7.05E-01,3.88E-01,5.93E-01,3.81E+05,3.22E+05,4.23E+05,1.02E+06,5,5,4,4,3.80E+05,7.80E+05,5.14E+04,1.41E+06,3.81E+05,1.49E+06,6.38E+05,3.21E+05,2.18E+05,3.22E+05,,4.88E+05,1.59E+05,1.02E+06,3.66E+05,6.54E+05,1.88E+06,,1.39E+06,7.55E+05,1.51E+03,2.96E+03,5.02E+02,1.41E+06,1.96E+04,5.31E+03,1.13E+04,2.96E+03,6.14E+03,3.42E+03,,2.18E+04,1.29E+03,1.37E+05,9.10E+03,1.28E+03,5.28E+05,,3.25E+04,8.04E+03,0,FALSE,4.656,15,2,117,13.3,11.47,2,protein metabolism;other metabolic processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf01199,6164,hsa:6164; P49207; Q6FG66; Q9BUZ2,ENSG00000109475,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,86.69,87.71,72.2,49.15,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,116.9,115.24,83.58,85.74,7.59,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O14980,XPO1,Exportin-1 OS=Homo sapiens OX=9606 GN=XPO1 PE=1 SV=1,5,19,1.204,0.825,0.378,1.543,0.27,-0.28,-1.4,0.63,8.43E-01,6.93E-01,2.73E-01,5.52E-01,1.28E+06,1.28E+06,9.72E+05,4.66E+05,5,5,5,3,8.57E+06,8.31E+05,3.27E+06,1.28E+06,3.70E+05,1.83E+06,4.80E+06,9.98E+05,4.58E+05,1.28E+06,3.45E+06,1.81E+05,4.56E+05,2.17E+06,9.72E+05,2.02E+05,4.66E+05,,6.55E+05,,3.41E+04,3.16E+03,3.19E+04,1.28E+06,1.91E+04,6.50E+03,8.54E+04,9.21E+03,1.29E+04,1.36E+04,2.06E+04,8.07E+03,3.70E+03,2.93E+05,2.42E+04,3.93E+02,1.31E+05,,1.53E+04,,0,FALSE,20.414,6,5,1071,123.3,6.06,5,other metabolic processes;transport;other biological processes,other membranes;cytosol;nucleus;other cell component,"Pf03810, Pf08389, Pf08767, Pf18777, Pf18784, Pf18787",7514,A6NL14; A8K1K5; D6W5E2; hsa:7514; O14980; Q63HP8; Q68CP3; Q99433,ENSG00000082898,Separation of Sister Chromatids; MAPK6/MAPK4 signaling; NPAS4 regulates expression of target genes; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Rev-mediated nuclear export of HIV RNA; NEP/NS2 Interacts with the Cellular Export Machinery; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Heme signaling; Deactivation of the beta-catenin transactivating complex; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; Downregulation of TGF-beta receptor signaling; HuR (ELAVL1) binds and stabilizes mRNA; Cyclin A/B1/B2 associated events during G2/M transition; Maturation of hRSV A proteins,eIF5A regulation in response to inhibition of the nuclear export system; 22q11.2 copy number variation syndrome,19,0,117.97,91.29,93.68,51.68,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,129.74,119.82,111,104.11,48.11,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P00367,GLUD1,"Glutamate dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=GLUD1 PE=1 SV=2",19,178,1.201,2.305,2.299,1.963,0.26,1.2,1.2,0.97,9.20E-01,7.55E-02,3.52E-01,5.00E-01,4.98E+06,3.56E+06,3.15E+07,7.15E+06,5,5,5,5,4.98E+06,2.55E+06,3.37E+06,2.10E+07,1.10E+07,3.56E+06,6.28E+06,1.36E+06,2.34E+06,1.61E+07,6.67E+06,5.20E+07,3.15E+07,3.57E+07,2.34E+07,7.15E+06,6.47E+06,1.16E+07,1.32E+07,1.51E+06,1.98E+04,9.70E+03,3.29E+04,2.10E+07,5.66E+05,1.27E+04,1.12E+05,1.25E+04,6.59E+04,1.71E+05,3.99E+04,2.32E+06,2.56E+05,4.81E+06,5.81E+05,1.40E+04,1.82E+06,8.24E+04,3.09E+05,1.61E+04,0,FALSE,109.306,42,19,558,61.4,7.8,19,other metabolic processes;other biological processes,mitochondrion;ER/Golgi;other cell component,"Pf00208, Pf02812",2746,B3KV55; B4DGN5; hsa:2746; P00367; Q5TBU3,ENSG00000148672,Transcriptional activation of mitochondrial biogenesis; Mitochondrial protein degradation; Glutamate and glutamine metabolism,VEGFA-VEGFR2 signaling; Amino acid metabolism; Metabolic reprogramming in colon cancer; 22q11.2 copy number variation syndrome; Amino acid metabolism pathway excerpt: histidine catabolism extension; 10q22q23 copy number variation,9,0,89.65,100.69,55.7,57.83,High,Peak Found,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,High,Peak Found,High,High,High,Peak Found,1,,FALSE,127.56,127.94,118.85,127.08,566.56,other molecular function,0,
Master Protein,High,P05387,RPLP2,60S acidic ribosomal protein P2 OS=Homo sapiens OX=9606 GN=RPLP2 PE=1 SV=1,4,77,1.2,0.499,1.388,0.234,0.26,-1,0.47,-2.09,9.21E-01,6.30E-01,7.75E-01,2.26E-01,1.13E+07,1.48E+07,4.67E+06,2.71E+07,5,5,5,5,4.77E+06,2.34E+07,9.51E+06,1.13E+07,4.48E+07,3.67E+07,3.82E+06,1.76E+07,4.10E+06,1.48E+07,4.25E+06,4.38E+06,3.02E+07,1.31E+07,4.67E+06,2.93E+07,3.49E+07,1.04E+06,2.71E+07,1.09E+06,1.90E+04,8.88E+04,9.30E+04,1.13E+07,2.31E+06,1.31E+05,6.79E+04,1.62E+05,1.16E+05,1.58E+05,2.54E+04,1.96E+05,2.45E+05,1.77E+06,1.16E+05,5.72E+04,9.80E+06,7.39E+03,6.35E+05,1.16E+04,0,FALSE,27.368,42,4,115,11.7,4.54,4,protein metabolism;other metabolic processes,cytosol;translational apparatus;other cell component,Pf00428,6181,hsa:6181; P05387; Q6FG96,ENSG00000177600,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),VEGFA-VEGFR2 signaling; Cytoplasmic ribosomal proteins; Opioid receptor pathways,16,0,85.84,87.12,98.82,87.4,Peak Found,High,High,High,High,High,Peak Found,High,High,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,124.39,94.58,113.97,109.88,217,other molecular function,0,
Master Protein,High,Q02539,H1-1,Histone H1.1 OS=Homo sapiens OX=9606 GN=H1-1 PE=1 SV=3,11,305,1.2,1.654,0.01,100,0.26,0.73,-6.64,6.64,7.42E-01,1.79E-01,1.00E-17,1.00E-17,4.92E+05,1.94E+05,9.20E+05,,4,2,5,,,2.53E+05,3.53E+05,4.26E+06,6.87E+05,2.28E+05,,,,1.65E+05,4.19E+05,3.61E+05,1.66E+06,2.02E+06,9.20E+05,,,,,,,9.62E+02,3.45E+03,4.26E+06,3.54E+04,8.10E+02,,,,1.75E+03,2.50E+03,1.61E+04,1.35E+04,2.72E+05,2.29E+04,,,,,,0,FALSE,67.866,35,2,215,21.8,10.99,11,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf00538,3024,hsa:3024; Q02539; Q3MJ34,ENSG00000124610,Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF),,2,0,138.54,22.65,68.84,,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,67.86,118.29,,,714.87,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q5SRN5,HLA-A,"Major histocompatibility complex, class I, A OS=Homo sapiens OX=9606 GN=HLA-A PE=1 SV=2",15,195,1.199,0.393,0.393,1.193,0.26,-1.35,-1.35,0.25,9.21E-01,4.04E-01,1.86E-01,8.16E-01,2.75E+07,3.69E+07,1.48E+07,2.33E+07,5,5,5,5,2.75E+07,1.67E+08,1.49E+07,4.04E+07,2.54E+07,4.03E+07,1.37E+07,3.69E+07,3.29E+07,3.88E+07,2.39E+07,1.43E+07,9.01E+06,1.48E+07,3.39E+07,1.28E+08,6.73E+06,2.33E+07,9.41E+06,4.27E+07,1.09E+05,6.34E+05,1.45E+05,4.04E+07,1.31E+06,1.43E+05,2.44E+05,3.40E+05,9.26E+05,4.13E+05,1.43E+05,6.39E+05,7.32E+04,2.00E+06,8.43E+05,2.50E+05,1.89E+06,1.65E+05,2.20E+05,4.54E+05,0,FALSE,98.503,49,8,371,41.3,6,15,other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00129, Pf06623, Pf07654",,Q5SRN5,ENSG00000206503,,Ebola virus infection in host; Cancer immunotherapy by PD-1 blockade; TAR syndrome,3,7,114.82,33.42,51.17,119.32,n/a,High,n/a,High,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,1,,FALSE,103.23,107.11,139.56,135.59,571.72,,0,
Master Protein,High,P52566,ARHGDIB,Rho GDP-dissociation inhibitor 2 OS=Homo sapiens OX=9606 GN=ARHGDIB PE=1 SV=3,8,99,1.198,0.792,3.135,1.075,0.26,-0.34,1.65,0.1,9.22E-01,8.41E-01,1.85E-01,8.88E-01,4.43E+06,2.47E+06,3.99E+06,9.58E+06,5,5,5,5,4.43E+06,3.21E+06,1.20E+06,1.02E+07,1.29E+07,2.47E+06,1.31E+06,2.57E+06,1.08E+06,3.55E+06,3.99E+06,3.50E+06,2.23E+06,1.67E+07,5.96E+06,9.58E+06,4.08E+06,1.59E+07,2.70E+06,1.17E+07,1.76E+04,1.22E+04,1.17E+04,1.02E+07,6.63E+05,8.77E+03,2.32E+04,2.38E+04,3.05E+04,3.78E+04,2.39E+04,1.57E+05,1.81E+04,2.25E+06,1.48E+05,1.87E+04,1.15E+06,1.13E+05,6.33E+04,1.24E+05,0,FALSE,65.916,61,8,201,23,5.21,8,signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;other cell component,Pf02115,397,B5BU79; hsa:397; P52566,ENSG00000111348,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC3 GTPase cycle; RHOH GTPase cycle,Fas ligand pathway and stress induction of heat shock proteins; Vasopressin-regulated water reabsorption; G13 signaling pathway,9,0,77.31,45.98,90.53,62.09,High,High,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,122.46,117.6,120.96,140.86,302.49,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q13243,SRSF5,Serine/arginine-rich splicing factor 5 OS=Homo sapiens OX=9606 GN=SRSF5 PE=1 SV=1,5,6,1.198,0.692,0.01,100,0.26,-0.53,-6.64,6.64,7.59E-01,9.74E-01,1.00E-17,1.00E-17,6.72E+05,1.09E+05,9.05E+04,,1,1,1,,,,,6.72E+05,,,,,1.09E+05,,,9.05E+04,,,,,,,,,,,,6.72E+05,,,,,3.07E+03,,,4.04E+03,,,,,,,,,0,FALSE,14.604,27,4,272,31.2,11.59,5,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus,Pf00076,6430,hsa:6430; O14797; Q13243; Q16662; Q49AD6; Q6FGE0,ENSG00000100650,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,mRNA processing,6,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,0,,,14.91,,0,
Master Protein,High,Q16629,SRSF7,Serine/arginine-rich splicing factor 7 OS=Homo sapiens OX=9606 GN=SRSF7 PE=1 SV=1,5,20,1.196,0.512,1.198,0.472,0.26,-0.97,0.26,-1.08,8.49E-01,6.59E-01,9.89E-01,5.73E-01,2.36E+06,7.74E+05,2.28E+06,2.85E+05,4,2,5,5,1.05E+05,4.70E+06,,1.48E+07,1.18E+06,3.97E+06,,,1.51E+05,,1.41E+07,2.28E+06,1.26E+06,5.46E+06,1.25E+06,1.56E+06,7.31E+04,2.85E+05,6.11E+04,4.03E+06,4.17E+02,1.79E+04,,1.48E+07,6.09E+04,1.41E+04,,,4.24E+03,,8.44E+04,1.02E+05,1.03E+04,7.36E+05,3.11E+04,3.05E+03,2.05E+04,2.02E+03,1.43E+03,4.29E+04,0,FALSE,17.589,21,4,238,27.4,11.82,5,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,nucleus;other cell component,Pf00076,6432,B4DLU6; G5E9M3; hsa:6432; Q16629; Q564D3,ENSG00000115875,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing,7,1,128.92,131.09,111.75,141.25,Peak Found,High,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,109.7,117.73,135.88,147.94,45.63,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P11277,SPTB,"Spectrin beta chain, erythrocytic OS=Homo sapiens OX=9606 GN=SPTB PE=1 SV=5",122,1263,1.196,0.388,1.716,0.277,0.26,-1.37,0.78,-1.85,9.24E-01,3.94E-01,5.77E-01,2.89E-01,2.97E+08,1.70E+08,7.98E+07,2.99E+08,5,5,5,5,9.80E+08,4.59E+08,2.97E+08,8.02E+06,1.03E+08,3.41E+08,4.73E+07,1.59E+08,3.07E+08,1.70E+08,3.47E+08,2.54E+07,1.08E+08,7.98E+07,1.34E+07,2.99E+08,8.54E+08,2.68E+08,3.75E+08,1.52E+08,3.89E+06,1.75E+06,2.90E+06,8.02E+06,5.29E+06,1.21E+06,8.42E+05,1.46E+06,8.65E+06,1.81E+06,2.08E+06,1.14E+06,8.76E+05,1.08E+07,3.32E+05,5.83E+05,2.40E+08,1.90E+06,8.78E+06,1.62E+06,0,FALSE,871.45,65,118,2137,246.3,5.27,122,cell organization and biogenesis,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00307, Pf00435",6710,hsa:6710; P11277; Q15510; Q15519,ENSG00000070182,COPI-mediated anterograde transport; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins,,4,5,103.82,58.35,118.19,69.72,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,139,141.28,123.83,128.69,3790.29,cytoskeletal activity,0,
Master Protein,High,Q14C86,GAPVD1,GTPase-activating protein and VPS9 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GAPVD1 PE=1 SV=2,3,6,1.196,0.266,2.573,0.124,0.26,-1.91,1.36,-3.02,7.56E-01,3.03E-01,4.22E-01,1.30E-01,2.65E+04,3.72E+05,1.18E+05,6.58E+04,3,1,1,4,,,4.44E+05,2.65E+04,1.28E+04,3.72E+05,,,,,,,,1.18E+05,,,1.77E+06,9.16E+04,4.29E+04,4.73E+04,,,4.34E+03,2.65E+04,6.63E+02,1.32E+03,,,,,,,,1.59E+04,,,4.98E+05,6.49E+02,1.00E+03,5.03E+02,0,FALSE,12.026,3,3,1478,164.9,5.22,3,transport;other biological processes,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,"Pf00616, Pf02204, Pf18151",26130,A8MYK3; B0QZ62; B0QZ63; B0QZ64; hsa:26130; Q14C76; Q14C86; Q2Q1W1; Q8ND92; Q8WU86; Q96CZ4; Q9NXQ1; Q9P207; Q9Y4N0,ENSG00000165219,RAB GEFs exchange GTP for GDP on RABs; Clathrin-mediated endocytosis,,2,0,152.15,,,175.27,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,0,0,0,0,17.45,enzyme regulator activity;other molecular function,0,
Master Protein,High,A0A8J8YWN6,CYB5R3,cytochrome-b5 reductase OS=Homo sapiens OX=9606 GN=CYB5R3 PE=1 SV=1,9,53,1.195,1.312,1.652,1.285,0.26,0.39,0.72,0.36,9.25E-01,3.44E-01,6.11E-01,7.65E-01,1.19E+07,2.12E+06,1.08E+07,6.12E+06,5,4,5,5,1.19E+07,1.17E+07,4.62E+06,1.26E+07,1.43E+07,9.57E+05,,2.10E+06,2.15E+06,1.95E+07,3.10E+07,4.82E+06,8.61E+06,1.51E+07,1.08E+07,1.16E+07,6.12E+06,1.44E+06,8.89E+06,5.60E+06,4.72E+04,4.44E+04,4.52E+04,1.26E+07,7.37E+05,3.40E+03,,1.94E+04,6.05E+04,2.07E+05,1.85E+05,2.15E+05,6.99E+04,2.04E+06,2.69E+05,2.25E+04,1.72E+06,1.02E+04,2.08E+05,5.96E+04,0,FALSE,56.417,41,9,345,38.8,7.33,9,,other membranes;ER/Golgi,"Pf00175, Pf00970",,A0A8J8YWN6,ENSG00000100243,,Oxidation by cytochrome P450,1,0,33.76,144.06,72.31,56.4,High,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,77.22,101.33,100.91,102.72,150.46,other molecular function,0,
Master Protein,High,Q9NYB0,TERF2IP,Telomeric repeat-binding factor 2-interacting protein 1 OS=Homo sapiens OX=9606 GN=TERF2IP PE=1 SV=1,8,26,1.194,0.668,0.543,1.794,0.26,-0.58,-0.88,0.84,7.69E-01,9.50E-01,4.03E-01,4.76E-01,3.06E+05,2.43E+05,1.82E+06,4.89E+05,5,5,5,5,3.06E+05,1.59E+05,1.44E+05,5.32E+06,4.49E+06,1.65E+06,1.07E+05,1.58E+05,2.43E+05,6.04E+05,5.11E+05,1.82E+06,1.41E+06,3.17E+06,3.20E+06,2.71E+06,2.36E+05,6.91E+04,5.32E+05,4.89E+05,1.21E+03,6.04E+02,1.41E+03,5.32E+06,2.31E+05,5.88E+03,1.91E+03,1.46E+03,6.86E+03,6.42E+03,3.06E+03,8.14E+04,1.15E+04,4.27E+05,7.96E+04,5.28E+03,6.64E+04,4.90E+02,1.25E+04,5.21E+03,0,FALSE,39.11,29,8,399,44.2,4.73,8,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,"Pf08914, Pf11626, Pf16589",54386,B4DQN4; hsa:54386; Q4W4Y2; Q8WYZ3; Q9NWR2; Q9NYB0,ENSG00000166848,Polymerase switching on the C-strand of the telomere; Meiotic synapsis; Telomere Extension By Telomerase; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; Packaging Of Telomere Ends; DNA Damage/Telomere Stress Induced Senescence; Telomere C-strand synthesis initiation; Removal of the Flap Intermediate from the C-strand,Splicing factor NOVA regulated synaptic proteins; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,16,0,124.43,116.59,57.42,133.77,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,91.51,110.86,141.89,141.05,98.9,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UH99,SUN2,SUN domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUN2 PE=1 SV=3,22,148,1.192,1.056,0.612,2.649,0.25,0.08,-0.71,1.41,9.27E-01,5.32E-01,4.48E-01,3.47E-01,1.06E+07,3.99E+06,3.22E+07,4.11E+06,5,5,5,5,7.81E+06,3.42E+07,8.91E+06,3.20E+07,1.06E+07,3.56E+06,2.63E+06,6.74E+06,3.99E+06,1.39E+07,4.73E+07,1.88E+07,2.92E+07,3.70E+07,3.22E+07,8.39E+06,3.74E+06,2.31E+06,1.50E+07,4.11E+06,3.10E+04,1.30E+05,8.70E+04,3.20E+07,5.46E+05,1.26E+04,4.67E+04,6.22E+04,1.12E+05,1.48E+05,2.83E+05,8.40E+05,2.37E+05,4.98E+06,8.00E+05,1.64E+04,1.05E+06,1.63E+04,3.50E+05,4.37E+04,0,FALSE,106.143,42,22,717,80.3,6.73,22,cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes,other membranes;nucleus;other cytoplasmic organelle;other cell component,"Pf07738, Pf18580",25777,B0QY62; hsa:25777; O75156; Q2NKN8; Q2T9F7; Q504T5; Q6B4H1; Q7Z3E3; Q9UH99,ENSG00000100242,Meiotic synapsis,,1,0,70.59,74.56,31.72,76.81,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,122.56,108.97,125.31,121.44,480.95,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A0G2JPD3,HLA-A,"HLA class I histocompatibility antigen, A alpha chain OS=Homo sapiens OX=9606 GN=HLA-A PE=1 SV=1",11,107,1.191,0.359,0.973,0.243,0.25,-1.48,-0.04,-2.04,8.87E-01,3.63E-01,8.68E-01,2.60E-01,8.88E+05,3.22E+06,7.55E+05,2.14E+06,5,5,5,5,8.88E+05,2.02E+07,9.67E+04,1.84E+05,2.18E+06,3.62E+06,3.80E+06,9.22E+05,2.10E+06,3.22E+06,8.42E+05,1.72E+06,2.56E+05,6.11E+05,7.55E+05,1.64E+07,1.52E+06,2.14E+06,4.43E+05,7.51E+06,3.53E+03,7.68E+04,9.45E+02,1.84E+05,1.13E+05,1.29E+04,6.75E+04,8.51E+03,5.91E+04,3.42E+04,5.03E+03,7.69E+04,2.08E+03,8.24E+04,1.88E+04,3.20E+04,4.27E+05,1.52E+04,1.04E+04,7.99E+04,0,FALSE,64.108,37,4,394,44.4,6.2,11,other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00129, Pf06623, Pf07654",,A0A0G2JPD3,ENSG00000206505,,,0,3,184.68,44.24,64.79,118.26,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,123.79,129.91,132.68,115.35,280.16,,0,
Master Protein,High,P22234,PAICS,Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase OS=Homo sapiens OX=9606 GN=PAICS PE=1 SV=3,7,18,1.189,0.704,1.033,0.205,0.25,-0.51,0.05,-2.28,8.19E-01,8.96E-01,9.29E-01,1.84E-01,8.67E+05,8.32E+05,6.11E+05,6.83E+06,5,3,5,5,1.91E+06,8.67E+05,7.55E+04,3.23E+05,2.62E+06,1.17E+06,8.32E+05,,,3.07E+05,7.81E+05,3.94E+04,1.03E+06,6.11E+05,3.90E+05,9.94E+05,6.83E+06,1.26E+07,7.92E+05,9.40E+06,7.59E+03,3.30E+03,7.38E+02,3.23E+05,1.35E+05,4.17E+03,1.48E+04,,,3.26E+03,4.67E+03,1.76E+03,8.38E+03,8.23E+04,9.70E+03,1.94E+03,1.92E+06,8.91E+04,1.85E+04,1.00E+05,0,FALSE,28.662,23,7,425,47,7.23,7,other metabolic processes,cytosol;other cell component,"Pf00731, Pf01259",10606,E9PDH9; hsa:10606; P22234; Q68CQ5,ENSG00000128050,Purine ribonucleoside monophosphate biosynthesis,Metabolic reprogramming in colon cancer,2,0,93.03,56.57,66.36,84.76,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,1,,FALSE,46.74,133.61,91.12,121.84,53.87,other molecular function,0,
Master Protein,High,P05023,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1 OS=Homo sapiens OX=9606 GN=ATP1A1 PE=1 SV=1,12,74,1.189,0.953,1.3,0.516,0.25,-0.07,0.38,-0.95,9.29E-01,6.36E-01,8.39E-01,6.10E-01,2.63E+06,6.99E+06,5.78E+06,1.31E+07,5,5,5,5,2.63E+06,1.40E+07,1.00E+06,1.75E+06,8.21E+06,9.68E+06,6.99E+06,1.94E+07,6.78E+06,6.10E+06,8.84E+06,2.31E+06,4.52E+06,6.69E+06,5.78E+06,1.67E+07,5.81E+06,1.85E+07,7.09E+06,1.31E+07,1.04E+04,5.34E+04,9.80E+03,1.75E+06,4.24E+05,3.44E+04,1.24E+05,1.79E+05,1.91E+05,6.49E+04,5.29E+04,1.03E+05,3.67E+04,9.01E+05,1.44E+05,3.25E+04,1.63E+06,1.31E+05,1.66E+05,1.40E+05,0,FALSE,48.881,15,12,1023,112.8,5.49,12,transport;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component,"Pf00122, Pf00689, Pf00690, Pf13246",476,B2RBR6; B7Z2T5; B7Z3U6; F5H3A1; hsa:476; P05023; Q16689; Q6LDM4; Q9UCN1; Q9UJ20; Q9UJ21,ENSG00000163399,Potential therapeutics for SARS; Ion homeostasis; Ion transport by P-type ATPases,Pre-implantation embryo; Proximal tubule transport; Arsenic metabolism and reactive oxygen species generation,6,0,100.26,56.76,43.28,46.08,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,140.29,116.02,106.27,97.61,202.84,transporter activity;other molecular function,0,
Master Protein,High,O00629,KPNA4,Importin subunit alpha-3 OS=Homo sapiens OX=9606 GN=KPNA4 PE=1 SV=1,4,8,1.187,0.321,1.154,0.489,0.25,-1.64,0.21,-1.03,8.14E-01,3.20E-01,9.69E-01,6.90E-01,8.80E+05,1.04E+05,8.69E+04,1.20E+05,2,1,5,5,,,,9.60E+05,8.07E+05,1.04E+05,,,,,4.05E+04,8.69E+04,4.85E+04,9.21E+05,1.44E+05,1.20E+05,5.80E+04,4.38E+05,1.07E+05,8.64E+05,,,,9.60E+05,4.16E+04,3.69E+02,,,,,2.42E+02,3.88E+03,3.94E+02,1.24E+05,3.57E+03,2.33E+02,1.63E+04,3.10E+03,2.50E+03,9.19E+03,0,FALSE,11.899,9,2,521,57.9,4.96,4,cell-cell signaling;other metabolic processes;transport,other membranes;cytosol;nucleus;other cell component,"Pf00514, Pf01749, Pf16186",3840,A8K4S6; D3DNM2; hsa:3840; O00190; O00629,ENSG00000186432,ISG15 antiviral mechanism; NS1 Mediated Effects on Host Pathways,Leptin signaling pathway,3,2,12.28,,152.5,107.34,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,14.34,62.81,93.84,128.02,22.32,other molecular function,0,
Master Protein,High,E9PF18,HADH,Hydroxyacyl-CoA dehydrogenase OS=Homo sapiens OX=9606 GN=HADH PE=1 SV=2,11,86,1.187,2.174,1.238,0.973,0.25,1.12,0.31,-0.04,9.31E-01,9.08E-02,8.87E-01,9.58E-01,5.17E+06,1.53E+06,2.73E+07,1.61E+07,5,5,5,5,2.78E+06,3.64E+06,5.17E+06,1.55E+07,2.24E+07,1.53E+06,8.17E+05,2.86E+06,1.47E+06,1.54E+07,8.65E+06,2.17E+07,5.26E+07,2.81E+07,2.73E+07,1.88E+07,4.69E+06,2.21E+07,4.90E+06,1.61E+07,1.10E+04,1.38E+04,5.05E+04,1.55E+07,1.16E+06,5.45E+03,1.45E+04,2.64E+04,4.13E+04,1.63E+05,5.17E+04,9.68E+05,4.27E+05,3.79E+06,6.79E+05,3.66E+04,1.32E+06,1.57E+05,1.15E+05,1.71E+05,0,FALSE,69.141,52,11,390,42.1,9.26,11,other metabolic processes,mitochondrion;nucleus,"Pf00725, Pf02737",,E9PF18,ENSG00000138796,,Amino acid metabolism,1,0,87.55,139.92,57.68,60.54,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,84.52,111.12,103.97,131.8,243.25,other molecular function,0,
Master Protein,High,Q5SNT2,TMEM201,Transmembrane protein 201 OS=Homo sapiens OX=9606 GN=TMEM201 PE=1 SV=1,2,2,1.186,0.713,1.395,0.659,0.25,-0.49,0.48,-0.6,8.23E-01,9.90E-01,8.40E-01,8.70E-01,1.67E+05,1.13E+05,1.14E+05,1.57E+05,3,3,4,1,,1.67E+05,,3.02E+05,7.47E+04,2.29E+05,1.13E+05,8.61E+04,,,,6.97E+04,2.17E+05,1.88E+05,5.87E+04,1.57E+05,,,,,,6.35E+02,,3.02E+05,3.85E+03,8.14E+02,2.01E+03,7.95E+02,,,,3.12E+03,1.76E+03,2.53E+04,1.46E+03,3.07E+02,,,,,0,FALSE,10.265,5,2,666,72.2,9.22,2,cell organization and biogenesis;transport;other biological processes,other membranes;cytoskeleton;nucleus;other cell component,"Pf09779, Pf10476",199953,B9EH90; hsa:199953; Q5SNT2; Q5SNT3,ENSG00000188807,,,0,0,62.99,53.23,60.62,,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,65.47,97.12,45.94,95.53,5.95,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q8TAQ2,SMARCC2,SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1,24,80,1.184,0.701,0.684,1.065,0.24,-0.51,-0.55,0.09,9.32E-01,9.84E-01,5.38E-01,8.95E-01,5.49E+06,3.12E+06,1.16E+07,3.02E+06,5,5,5,5,4.74E+06,5.49E+06,8.42E+05,1.62E+07,1.47E+07,3.12E+06,3.83E+06,2.60E+06,2.19E+05,6.62E+06,5.02E+06,8.08E+06,1.16E+07,2.85E+07,1.43E+07,6.36E+05,5.41E+05,6.61E+06,3.02E+06,2.92E+07,1.88E+04,2.09E+04,8.23E+03,1.62E+07,7.60E+05,1.11E+04,6.80E+04,2.40E+04,6.16E+03,7.04E+04,3.00E+04,3.61E+05,9.45E+04,3.84E+06,3.55E+05,1.24E+03,1.52E+05,4.68E+04,7.07E+04,3.11E+05,0,FALSE,111.667,26,16,1214,132.8,5.69,24,cell organization and biogenesis;developmental processes;other biological processes,nucleus;other cell component,"Pf00249, Pf04433, Pf16495, Pf16496, Pf16498",6601,F8VTJ5; hsa:6601; Q59GV3; Q8TAQ2; Q92923; Q96E12; Q96GY4,ENSG00000139613,RMTs methylate histone arginines; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,Androgen receptor network in prostate cancer; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome; 10q11.21q11.23 copy number variation syndrome,7,7,79.83,70.42,67.37,151.34,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,High,High,Peak Found,1,,FALSE,125.63,129.5,126.03,137.33,264.95,other molecular function,0,
Master Protein,High,A0A0U5Q247,HLA-DQB1,"HLA class II histocompatibility antigen, DQ beta 1 chain OS=Homo sapiens OX=9606 GN=HLA-DQB1 PE=1 SV=1",5,8,1.184,0.213,,0.591,0.24,-2.23,,-0.76,8.96E-01,7.79E-02,,7.56E-01,3.20E+06,8.78E+05,4.38E+05,2.55E+06,4,2,4,5,,5.67E+06,1.30E+05,3.29E+06,3.11E+06,,9.87E+05,7.81E+05,,,,1.05E+06,8.29E+04,1.38E+06,1.83E+05,2.55E+06,1.56E+05,3.87E+06,1.67E+05,3.32E+06,,2.15E+04,1.27E+03,3.29E+06,1.61E+05,,1.76E+04,7.21E+03,,,,4.68E+04,6.74E+02,1.86E+05,4.56E+03,4.98E+03,4.38E+04,2.74E+04,3.90E+03,3.53E+04,0,FALSE,19.679,26,3,261,29.8,8.18,5,other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00969, Pf07654",,A0A0U5Q247,ENSG00000231939,,,0,2,74.37,16.49,95.02,87.14,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,17.4,125.25,,133.89,21.32,,0,
Master Protein,High,Q9NVI7,ATAD3A,ATPase family AAA domain-containing protein 3A OS=Homo sapiens OX=9606 GN=ATAD3A PE=1 SV=2,10,74,1.181,1.564,1.671,0.938,0.24,0.65,0.74,-0.09,8.71E-01,2.28E-01,6.00E-01,9.84E-01,2.50E+06,1.32E+06,4.52E+06,3.06E+06,5,5,5,5,2.39E+05,4.14E+06,4.90E+05,4.07E+06,2.50E+06,1.99E+06,3.42E+05,4.01E+05,1.32E+06,2.33E+06,3.82E+06,4.55E+06,4.41E+06,4.52E+06,7.63E+06,5.54E+06,3.06E+06,6.94E+06,2.31E+06,2.50E+06,9.48E+02,1.57E+04,4.79E+03,4.07E+06,1.29E+05,7.09E+03,6.08E+03,3.70E+03,3.71E+04,2.48E+04,2.28E+04,2.03E+05,3.58E+04,6.10E+05,1.90E+05,1.08E+04,8.61E+05,4.92E+04,5.40E+04,2.66E+04,0,FALSE,47.262,21,10,634,71.3,8.98,10,cell organization and biogenesis;stress response;other biological processes,other membranes;mitochondrion,"Pf00004, Pf12037",55210,B3KPB3; D2K8Q1; G3V1I6; Q5SV23; Q8N275; Q96A50; Q9NVI7,ENSG00000197785,,1p36 copy number variation syndrome,1,0,82.01,70.79,30.25,50.62,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,1,,FALSE,74.18,108.9,93.7,103.7,192.14,other molecular function,0,
Master Protein,High,A0A8I5KSY8,CYB5B,Cytochrome b5 type B OS=Homo sapiens OX=9606 GN=CYB5B PE=1 SV=1,4,14,1.181,0.922,,1.31,0.24,-0.12,,0.39,8.57E-01,6.71E-01,,6.90E-01,2.83E+06,3.88E+05,3.55E+06,1.97E+05,4,4,5,1,1.34E+06,,1.85E+05,6.01E+06,6.42E+06,1.18E+06,,2.34E+05,2.12E+05,6.44E+05,2.59E+05,6.11E+06,3.55E+06,2.75E+06,5.22E+06,1.97E+05,,,,,5.31E+03,,1.81E+03,6.01E+06,3.31E+05,4.19E+03,,2.16E+03,5.96E+03,6.85E+03,1.55E+03,2.73E+05,2.88E+04,3.71E+05,1.30E+05,3.84E+02,,,,,0,FALSE,25.849,38,4,174,19,5.24,4,,,Pf00173,,A0A8I5KSY8,ENSG00000103018,,Oxidation by cytochrome P450,1,0,91.41,80,63.73,,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,80.45,82.78,,123.83,55.47,other molecular function,0,
Master Protein,High,E7EX59,PCCB,Propionyl-CoA carboxylase subunit beta OS=Homo sapiens OX=9606 GN=PCCB PE=1 SV=1,2,3,1.179,0.551,0.83,0.565,0.24,-0.86,-0.27,-0.82,8.50E-01,7.99E-01,8.11E-01,8.09E-01,9.60E+04,8.14E+04,4.40E+04,6.76E+04,5,1,4,3,9.63E+04,1.39E+05,1.93E+04,9.60E+04,8.20E+04,8.14E+04,,,,,5.30E+04,1.17E+04,7.82E+04,3.66E+04,,,9.06E+04,6.69E+04,6.76E+04,,3.83E+02,5.27E+02,1.89E+02,9.60E+04,4.23E+03,2.89E+02,,,,,3.17E+02,5.24E+02,6.35E+02,4.93E+03,,,2.55E+04,4.74E+02,1.58E+03,,0,FALSE,10.188,6,2,570,61.6,7.99,2,,,Pf01039,,E7EX59,ENSG00000114054,,Primary ovarian insufficiency,1,0,49.88,,62.32,17.97,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,21.64,66.04,1.45,55.33,10.59,other molecular function,0,
Master Protein,High,P16671,CD36,Platelet glycoprotein 4 OS=Homo sapiens OX=9606 GN=CD36 PE=1 SV=2,5,51,1.178,0.023,1.725,0.042,0.24,-5.41,0.79,-4.56,9.37E-01,8.18E-08,5.72E-01,6.34E-03,2.03E+06,4.44E+06,8.67E+04,5.70E+06,3,5,4,3,2.03E+06,1.21E+07,1.55E+06,,,4.44E+06,1.50E+05,1.62E+07,1.01E+07,2.37E+06,3.52E+05,,1.89E+05,3.97E+04,2.92E+04,2.48E+07,5.70E+06,2.17E+05,,,8.06E+03,4.58E+04,1.51E+04,,,1.58E+04,2.67E+03,1.50E+05,2.84E+05,2.52E+04,2.11E+03,,1.54E+03,5.36E+03,7.26E+02,4.83E+04,1.60E+06,1.54E+03,,,0,FALSE,21.442,11,5,472,53,7.96,5,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,Pf01130,948,D9IX66; D9IX67; D9IX68; D9IX69; hsa:948; P16671; Q13966; Q16093; Q8TCV7; Q9BPZ8; Q9BQC2; Q9BZM8; Q9BZN3; Q9BZN4; Q9BZN5,ENSG00000135218,Neutrophil degranulation; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Scavenging by Class B Receptors; ER-Phagosome pathway; Platelet degranulation ; MyD88:MAL(TIRAP) cascade initiated on plasma membrane; MyD88 deficiency (TLR2/4); IRAK4 deficiency (TLR2/4); Regulation of TLR by endogenous ligand; Interleukin-4 and Interleukin-13 signaling; Intracellular metabolism of fatty acids regulates insulin secretion; Cross-presentation of particulate exogenous antigens (phagosomes),Aryl hydrocarbon receptor pathway; PPAR signaling pathway; IL-18 signaling pathway; Genes controlling nephrogenesis; Fatty acid transporters; Cholesterol metabolism; Enterocyte cholesterol metabolism; Vitamin A and carotenoid metabolism,22,0,113.87,97.68,99.51,125.95,High,High,High,n/a,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,n/a,1,,FALSE,143.65,118.38,109.53,110.79,95.57,signal transduction activity or receptor binding;transporter activity;other molecular function,0,
Master Protein,High,A0A2R8Y6Y7,SUCLA2,"Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=SUCLA2 PE=1 SV=1",6,24,1.178,0.882,3.247,4.304,0.24,-0.18,1.7,2.11,8.48E-01,6.56E-01,2.80E-01,1.25E-01,1.55E+06,3.15E+05,2.26E+06,8.10E+05,4,3,5,4,1.45E+06,,3.99E+05,3.69E+06,1.67E+06,,3.28E+05,,3.15E+05,1.64E+05,4.38E+05,2.39E+06,1.39E+06,3.04E+06,2.26E+06,1.82E+06,3.62E+05,1.90E+06,1.82E+05,,5.75E+03,,3.90E+03,3.69E+06,8.60E+04,,5.83E+03,,8.87E+03,1.75E+03,2.62E+03,1.07E+05,1.13E+04,4.10E+05,5.63E+04,3.54E+03,1.02E+05,1.34E+04,4.26E+03,,0,FALSE,21.777,14,6,484,52.6,7.49,6,other metabolic processes,mitochondrion,"Pf00549, Pf08442",,A0A2R8Y6Y7,ENSG00000136143,,,0,0,76.33,33.76,52.96,86.3,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,23.61,69.08,107.53,115.48,59.43,other molecular function,0,
Master Protein,High,O75152,ZC3H11A,Zinc finger CCCH domain-containing protein 11A OS=Homo sapiens OX=9606 GN=ZC3H11A PE=1 SV=3,8,14,1.177,0.316,3.031,0.236,0.24,-1.66,1.6,-2.08,7.96E-01,3.35E-01,3.79E-01,3.20E-01,2.33E+05,1.25E+05,8.27E+04,9.78E+04,4,3,3,2,,1.06E+05,2.27E+04,5.11E+05,6.64E+05,,3.44E+04,1.25E+05,,2.56E+05,,8.27E+04,,2.13E+05,2.60E+04,,,8.22E+04,,1.16E+05,,4.03E+02,2.21E+02,5.11E+05,3.43E+04,,6.11E+02,1.15E+03,,2.72E+03,,3.69E+03,,2.87E+04,6.47E+02,,,5.83E+02,,1.24E+03,0,FALSE,41.619,16,8,810,89.1,8.37,8,other metabolic processes;transport,nucleus,Pf15663,9877,hsa:9877; O75152; Q6AHY4; Q6AHY9; Q6AW79; Q6AWA1; Q6PJK4; Q86XZ7,ENSG00000058673,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,,3,0,95.21,80.44,89.32,24.35,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,74.77,89.94,24.34,25.91,38.95,other molecular function,0,
Master Protein,High,P50750,CDK9,Cyclin-dependent kinase 9 OS=Homo sapiens OX=9606 GN=CDK9 PE=1 SV=3,3,3,1.174,0.312,16.217,0.018,0.23,-1.68,4.02,-5.83,8.46E-01,3.83E-01,4.73E-03,1.05E-03,1.77E+05,7.73E+04,3.07E+04,1.25E+06,5,2,3,4,1.88E+05,1.77E+05,1.34E+05,2.57E+05,3.75E+04,,,,5.15E+04,1.16E+05,,1.60E+04,,4.61E+04,3.07E+04,1.72E+06,1.94E+05,3.96E+06,,9.12E+05,7.48E+02,6.72E+02,1.31E+03,2.57E+05,1.93E+03,,,,1.45E+03,1.23E+03,,7.14E+02,,6.21E+03,7.62E+02,3.36E+03,5.46E+04,2.81E+04,,9.71E+03,0,FALSE,9.829,12,3,372,42.8,8.79,3,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf00069,1025,hsa:1025; P50750; Q5JU24; Q5JU25; Q5U006; Q96TF1,ENSG00000136807,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; Estrogen-dependent gene expression; Interactions of Tat with host cellular proteins,MicroRNAs in cardiomyocyte hypertrophy; IL-9 signaling pathway; Cardiac hypertrophic response; Initiation of transcription and translation elongation at the HIV-1 LTR; Male infertility,20,0,50.9,54.36,48.68,96.21,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,81.97,73.4,124.53,131.83,8.38,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,P05204,HMGN2,Non-histone chromosomal protein HMG-17 OS=Homo sapiens OX=9606 GN=HMGN2 PE=1 SV=3,2,23,1.171,0.172,0.302,0.3,0.23,-2.54,-1.73,-1.74,8.33E-01,6.84E-02,1.54E-01,3.33E-01,7.88E+05,4.62E+05,1.35E+05,4.51E+05,4,5,4,5,,8.25E+05,4.47E+04,7.53E+05,6.84E+06,5.33E+04,4.62E+05,1.71E+06,2.50E+05,1.08E+07,,1.46E+05,1.26E+05,1.45E+05,8.19E+04,4.51E+05,1.61E+04,2.49E+06,7.18E+03,1.78E+07,,3.13E+03,4.37E+02,7.53E+05,3.53E+05,1.89E+02,8.21E+03,1.58E+04,7.03E+03,1.15E+05,,6.53E+03,1.03E+03,1.95E+04,2.04E+03,8.80E+02,4.51E+03,1.76E+04,1.68E+02,1.90E+05,0,FALSE,11.723,29,2,90,9.4,9.99,2,cell organization and biogenesis;stress response;other biological processes,non-structural extracellular;nucleus;other cell component,Pf01101,3151,hsa:3151; P05204; Q0VGD5; Q6FGI5; Q96C64,ENSG00000198830,,,0,0,149.81,173.25,24.05,185.39,n/a,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,142.19,121.08,147.3,145.9,53.74,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8WUY1,THEM6,Protein THEM6 OS=Homo sapiens OX=9606 GN=THEM6 PE=1 SV=2,1,9,1.169,0.176,0.495,0.322,0.22,-2.5,-1.01,-1.64,8.16E-01,7.47E-02,3.56E-01,3.90E-01,8.34E+05,7.14E+05,1.14E+05,3.54E+05,5,3,4,2,8.34E+05,1.18E+06,1.73E+05,6.30E+05,2.37E+06,,,9.35E+04,7.14E+05,4.89E+06,,5.94E+04,2.12E+05,4.10E+05,6.11E+04,,5.15E+05,,2.43E+05,,3.31E+03,4.49E+03,1.69E+03,6.30E+05,1.22E+05,,,8.63E+02,2.01E+04,5.19E+04,,2.65E+03,1.72E+03,5.53E+04,1.52E+03,,1.45E+05,,5.68E+03,,0,FALSE,6.144,8,1,208,23.9,9.55,1,,non-structural extracellular,Pf13279,51337,B2RDN6; hsa:51337; Q8NBN2; Q8WUY1; Q9NYI2,ENSG00000130193,,,0,0,79.87,137.34,89.43,50.85,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,126.6,123.95,127.45,91.01,29.32,,0,
Master Protein,High,O94919,ENDOD1,Endonuclease domain-containing 1 protein OS=Homo sapiens OX=9606 GN=ENDOD1 PE=1 SV=2,7,24,1.165,0.483,1.182,0.196,0.22,-1.05,0.24,-2.35,7.53E-01,6.46E-01,1.00E+00,2.05E-01,3.01E+05,3.54E+05,2.74E+05,8.21E+05,5,5,5,5,3.01E+05,1.24E+07,1.33E+05,3.67E+05,2.13E+05,3.54E+05,3.80E+04,8.25E+04,1.50E+07,1.90E+06,5.45E+04,2.79E+04,7.47E+05,6.58E+05,2.74E+05,3.28E+07,2.59E+06,2.61E+05,3.14E+05,8.21E+05,1.19E+03,4.70E+04,1.30E+03,3.67E+05,1.10E+04,1.26E+03,6.76E+02,7.62E+02,4.23E+05,2.02E+04,3.26E+02,1.24E+03,6.07E+03,8.86E+04,6.82E+03,6.40E+04,7.27E+05,1.85E+03,7.36E+03,8.74E+03,0,FALSE,24.07,17,7,500,55,5.71,7,stress response,non-structural extracellular;cytosol,Pf01223,23052,A8K6K8; hsa:23052; O94919; Q6GQY5; Q8TAQ8,ENSG00000149218,Platelet degranulation,,1,0,202.48,186.73,95.12,193.79,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,1,,FALSE,118.86,133.34,128.18,117.4,63.74,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96KP4,CNDP2,Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2,2,5,1.163,1.001,0.511,1.926,0.22,0,-0.97,0.95,8.40E-01,6.43E-01,5.18E-01,4.54E-01,2.07E+05,7.98E+04,3.04E+05,4.08E+04,3,2,4,1,6.01E+04,,,2.07E+05,2.58E+05,,4.01E+04,,1.59E+05,,,1.73E+05,6.01E+04,6.15E+05,5.33E+05,,4.08E+04,,,,2.39E+02,,,2.07E+05,1.33E+04,,7.13E+02,,4.48E+03,,,7.74E+03,4.88E+02,8.29E+04,1.32E+04,,1.15E+04,,,,0,FALSE,7.659,8,2,475,52.8,5.97,2,protein metabolism,cytosol;nucleus,"Pf01546, Pf07687",55748,B3KUG4; hsa:55748; Q8WY59; Q96KP4; Q9BQ94; Q9NVB4; V9HWE5,ENSG00000133313,Glutathione synthesis and recycling; Paracetamol ADME,,2,0,58.72,84.46,78.2,,Peak Found,n/a,n/a,High,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,79.37,104.8,110.39,67.73,14.63,other molecular function,0,
Master Protein,High,Q99729,HNRNPAB,Heterogeneous nuclear ribonucleoprotein A/B OS=Homo sapiens OX=9606 GN=HNRNPAB PE=1 SV=2,6,24,1.163,2.69,0.907,3.038,0.22,1.43,-0.14,1.6,9.49E-01,4.50E-02,7.98E-01,2.88E-01,2.47E+06,4.48E+06,1.02E+07,3.51E+06,5,5,5,5,1.28E+07,2.30E+06,5.39E+06,2.19E+06,2.47E+06,4.37E+05,4.48E+06,4.78E+06,1.79E+06,1.24E+07,5.91E+07,1.02E+07,6.41E+06,1.18E+07,3.86E+06,1.14E+06,4.08E+05,2.08E+07,3.51E+06,1.13E+07,5.08E+04,8.74E+03,5.26E+04,2.19E+06,1.28E+05,1.55E+03,7.97E+04,4.41E+04,5.03E+04,1.32E+05,3.53E+05,4.55E+05,5.21E+04,1.59E+06,9.60E+04,2.23E+03,1.15E+05,1.47E+05,8.20E+04,1.20E+05,0,FALSE,24.763,20,5,332,36.2,8.21,6,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00076, Pf08143",3182,B3KNN5; D3DWP7; hsa:3182; Q04150; Q8N7U3; Q99729; Q9BQ99,ENSG00000197451,,Pre-implantation embryo; mRNA processing,2,0,90.26,97.24,126.1,116.17,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,93.06,100.61,126.98,129.24,59.46,nucleic acid binding activity,0,
Master Protein,High,Q9BSJ8,ESYT1,Extended synaptotagmin-1 OS=Homo sapiens OX=9606 GN=ESYT1 PE=1 SV=1,14,69,1.161,0.876,0.644,2.014,0.22,-0.19,-0.63,1.01,9.50E-01,7.28E-01,5.07E-01,4.86E-01,5.11E+06,2.59E+06,9.24E+06,6.95E+05,5,2,5,4,1.02E+07,1.12E+06,5.11E+06,8.13E+06,1.71E+06,,,1.34E+06,,5.00E+06,1.98E+07,9.24E+06,8.42E+06,7.34E+06,9.33E+06,3.53E+05,1.26E+06,6.55E+06,3.82E+05,,4.07E+04,4.24E+03,4.99E+04,8.13E+06,8.82E+04,,,1.24E+04,,5.32E+04,1.18E+05,4.13E+05,6.84E+04,9.88E+05,2.32E+05,6.89E+02,3.55E+05,4.64E+04,8.94E+03,,0,FALSE,83.25,21,14,1104,122.8,5.83,14,cell organization and biogenesis;transport,plasma membrane;other membranes;ER/Golgi,"Pf00168, Pf17047",23344,A0FGR7; A8K2S2; hsa:23344; O94848; Q6PJN4; Q9BSJ8; Q9H6J1; Q9H6W2; Q9Y416,ENSG00000139641,RHOG GTPase cycle; Glycosphingolipid transport; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle,,7,0,75.32,81.65,46.96,139.1,High,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,86.91,102.75,124.95,110.39,227.63,transporter activity;other molecular function,0,
Master Protein,High,Q9BS26,ERP44,Endoplasmic reticulum resident protein 44 OS=Homo sapiens OX=9606 GN=ERP44 PE=1 SV=1,5,14,1.159,0.979,0.92,0.498,0.21,-0.03,-0.12,-1.01,8.76E-01,4.98E-01,8.39E-01,6.09E-01,1.01E+06,1.65E+06,1.29E+06,1.26E+06,4,4,5,4,,2.84E+07,2.72E+04,1.17E+06,8.71E+05,6.39E+05,2.30E+06,4.99E+06,,1.18E+06,1.29E+06,8.23E+05,4.70E+04,2.79E+06,1.99E+06,1.33E+06,1.20E+06,,4.41E+05,2.14E+06,,1.08E+05,2.66E+02,1.17E+06,4.49E+04,2.27E+03,4.09E+04,4.60E+04,,1.26E+04,7.71E+03,3.68E+04,3.82E+02,3.76E+05,4.96E+04,2.59E+03,3.37E+05,,1.03E+04,2.28E+04,0,FALSE,28.358,20,5,406,46.9,5.26,5,protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;other membranes;ER/Golgi;other cell component,"Pf00085, Pf13848",23071,hsa:23071; O60319; Q4VXC1; Q5VWZ7; Q6UW14; Q8WX67; Q9BS26,ENSG00000023318,Neutrophil degranulation,,1,0,182.04,85.01,76.06,54.48,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,129.93,109.44,103.47,107.79,44.51,other molecular function,0,
Master Protein,High,P16383,GCFC2,Intron Large complex component GCFC2 OS=Homo sapiens OX=9606 GN=GCFC2 PE=1 SV=2,2,2,1.159,0.084,2.927,0.029,0.21,-3.58,1.55,-5.11,9.06E-01,3.12E-02,4.08E-01,7.59E-03,7.97E+04,5.17E+04,4.08E+03,1.64E+05,3,4,1,3,,7.97E+04,,2.80E+05,4.89E+04,,5.68E+04,4.70E+04,1.04E+04,6.17E+04,,,,4.08E+03,,,1.64E+05,1.15E+05,,1.73E+05,,3.03E+02,,2.80E+05,2.52E+03,,1.01E+03,4.34E+02,2.94E+02,6.56E+02,,,,5.50E+02,,,4.60E+04,8.17E+02,,1.85E+03,0,FALSE,7.159,3,2,781,89.3,5.99,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus,Pf07842,6936,A4UHQ8; A4UHQ9; hsa:6936; O95032; P16383; Q53TY0; Q6P2F2,ENSG00000005436,mRNA Splicing - Major Pathway,,1,0,92.09,52.73,,20.65,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,68.1,58.24,42.03,30.48,6.58,nucleic acid binding activity,0,
Master Protein,High,P46776,RPL27A,60S ribosomal protein L27a OS=Homo sapiens OX=9606 GN=RPL27A PE=1 SV=2,7,19,1.158,0.685,2.471,0.331,0.21,-0.55,1.3,-1.6,8.37E-01,9.55E-01,3.07E-01,3.65E-01,1.16E+06,5.00E+05,2.67E+06,1.52E+07,4,2,5,5,8.39E+05,7.95E+05,,8.30E+06,1.61E+06,4.74E+06,,,,5.27E+04,8.66E+05,3.77E+06,1.81E+06,4.89E+06,2.67E+06,6.42E+06,2.18E+07,1.52E+07,2.51E+06,2.61E+07,3.33E+03,3.02E+03,,8.30E+06,8.31E+04,1.68E+04,,,,5.60E+02,5.18E+03,1.68E+05,1.47E+04,6.59E+05,6.63E+04,1.25E+04,6.12E+06,1.08E+05,5.87E+04,2.77E+05,0,FALSE,29.112,33,7,148,16.6,11,7,protein metabolism;other metabolic processes,cytosol;ER/Golgi;translational apparatus;other cell component,Pf00828,6157,B2R4B3; hsa:6157; P46776,ENSG00000166441,Regulation of expression of SLITs and ROBOs; Protein hydroxylation; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,15,0,125.7,138.31,56.53,69.16,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,66.17,73.41,82.71,110.48,50.64,other molecular function,0,
Master Protein,High,A0A0A6YYL4,PAM16,Coronin OS=Homo sapiens OX=9606 GN=CORO7-PAM16 PE=1 SV=1,3,3,1.157,0.958,3.296,0.212,0.21,-0.06,1.72,-2.23,8.35E-01,6.09E-01,2.73E-01,2.73E-01,6.72E+05,2.59E+05,5.03E+05,8.52E+05,2,3,5,1,,,5.28E+05,8.55E+05,,,2.59E+05,,1.00E+05,8.48E+05,3.87E+06,2.67E+05,1.23E+05,7.65E+05,5.03E+05,,,,,8.52E+05,,,5.16E+03,8.55E+05,,,4.60E+03,,2.83E+03,9.01E+03,2.31E+04,1.19E+04,1.00E+03,1.03E+05,1.25E+04,,,,,9.07E+03,0,FALSE,9.408,5,3,1048,114.1,6.33,3,,,"Pf00400, Pf03656, Pf08953, Pf16300",100529144,A0A0A6YYL4; hsa:100529144,ENSG00000103426; ENSG00000278760,,,0,0,33.42,97.89,141.45,,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,103.03,91.28,103.03,6.14,7.88,,0,
Master Protein,High,P61026,RAB10,Ras-related protein Rab-10 OS=Homo sapiens OX=9606 GN=RAB10 PE=1 SV=1,7,65,1.157,0.448,0.728,0.966,0.21,-1.16,-0.46,-0.05,9.54E-01,5.22E-01,5.92E-01,9.64E-01,1.31E+07,5.30E+06,7.33E+06,6.47E+06,5,5,5,5,1.31E+07,4.70E+07,4.80E+06,2.79E+06,2.25E+07,4.01E+06,4.29E+05,1.23E+07,5.30E+06,1.23E+07,1.60E+07,3.86E+06,5.83E+06,1.41E+07,7.33E+06,2.03E+07,8.56E+06,2.46E+06,6.47E+06,2.42E+06,5.22E+04,1.79E+05,4.69E+04,2.79E+06,1.16E+06,1.43E+04,7.63E+03,1.14E+05,1.49E+05,1.31E+05,9.58E+04,1.72E+05,4.73E+04,1.90E+06,1.82E+05,3.95E+04,2.40E+06,1.74E+04,1.51E+05,2.57E+04,0,FALSE,38.442,36,4,200,22.5,8.38,7,cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,10890,D6W538; hsa:10890; O88386; P61026; Q6IA52; Q9D7X6; Q9H0T3,ENSG00000084733,Neutrophil degranulation; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Translocation of SLC2A4 (GLUT4) to the plasma membrane,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,5,1,99.53,76.86,56.61,91.3,High,Peak Found,High,High,High,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,121.97,130.49,117.27,92.53,161.55,cytoskeletal activity;other molecular function,0,
Master Protein,High,H3BPE7,FUS,FUS RNA binding protein OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1,8,60,1.156,0.361,1.187,0.847,0.21,-1.47,0.25,-0.24,8.73E-01,3.64E-01,9.95E-01,9.72E-01,2.47E+06,2.69E+05,2.69E+05,2.30E+05,4,2,5,4,,8.37E+05,3.89E+04,7.26E+06,9.12E+06,,,4.19E+05,,1.72E+05,1.59E+05,4.78E+06,5.95E+04,2.72E+06,2.69E+05,3.02E+05,6.04E+04,,1.75E+05,8.92E+06,,3.18E+03,3.80E+02,7.26E+06,4.71E+05,,,3.87E+03,,1.83E+03,9.52E+02,2.14E+05,4.83E+02,3.67E+05,6.70E+03,5.89E+02,1.70E+04,,4.10E+03,9.49E+04,0,FALSE,66.293,17,6,527,53.5,9.36,8,other biological processes,nucleus,"Pf00076, Pf00641",,H3BPE7,ENSG00000089280,,MECP2 and associated Rett syndrome; HDAC6 interactions in the central nervous system,2,0,105.51,59,131.27,184.88,n/a,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,1,,FALSE,108.11,111.97,75.37,135.59,170.4,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8NC51,SERBP1,Plasminogen activator inhibitor 1 RNA-binding protein OS=Homo sapiens OX=9606 GN=SERBP1 PE=1 SV=2,8,24,1.153,0.484,2.984,0.371,0.21,-1.05,1.58,-1.43,7.70E-01,6.43E-01,2.07E-01,3.89E-01,3.51E+05,3.31E+05,2.01E+06,2.34E+06,4,5,5,4,,2.18E+05,5.63E+04,5.65E+05,3.58E+06,3.31E+05,2.38E+05,6.16E+05,1.24E+05,2.81E+06,4.33E+06,1.13E+06,1.68E+06,2.01E+06,4.47E+06,,6.89E+05,2.14E+06,2.56E+06,1.20E+07,,8.27E+02,5.51E+02,5.65E+05,1.85E+05,1.18E+03,4.22E+03,5.68E+03,3.49E+03,2.99E+04,2.59E+04,5.05E+04,1.36E+04,2.71E+05,1.11E+05,,1.94E+05,1.51E+04,5.99E+04,1.28E+05,0,FALSE,28.5,22,8,408,44.9,8.65,8,cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,"Pf04774, Pf16174",26135,hsa:26135; Q5VU19; Q5VU20; Q5VU22; Q8NC51; Q8WUH0; Q96SE2; Q9BTY3; Q9BUM4; Q9Y367; Q9Y4S3,ENSG00000142864,,Apoptosis-related network due to altered Notch3 in ovarian cancer,1,0,150.64,136.59,57.35,118.92,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,High,1,Phospho [S330],FALSE,120.31,118.29,123.51,119.79,61.04,translation activity;nucleic acid binding activity;other molecular function,1,Phospho [S330]
Master Protein,High,E7EX17,EIF4B,Eukaryotic translation initiation factor 4B OS=Homo sapiens OX=9606 GN=EIF4B PE=1 SV=1,2,3,1.152,0.119,1.338,0.102,0.2,-3.08,0.42,-3.29,7.98E-01,3.84E-02,8.89E-01,1.06E-01,2.25E+05,1.95E+05,2.67E+04,2.61E+05,2,2,2,2,,,,4.17E+04,1.22E+06,,,,6.81E+04,5.61E+05,7.18E+04,,,9.92E+03,,,,,4.69E+04,1.46E+06,,,,4.17E+04,6.27E+04,,,,1.92E+03,5.96E+03,4.29E+02,,,1.34E+03,,,,,1.10E+03,1.55E+04,0,FALSE,6.536,6,2,616,69.7,5.67,2,,cytosol,Pf00076,1975,E7EX17,ENSG00000063046,,"Translation factors; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; Pleural mesothelioma; Interferon type I signaling pathways",7,0,132.05,110.77,107.06,132.62,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,High,1,,FALSE,134.81,143.82,139.56,148.89,6.22,nucleic acid binding activity,0,
Master Protein,Medium,Q96K76,USP47,Ubiquitin carboxyl-terminal hydrolase 47 OS=Homo sapiens OX=9606 GN=USP47 PE=1 SV=3,1,2,1.15,1.131,2.566,0.507,0.2,0.18,1.36,-0.98,8.86E-01,5.91E-01,4.48E-01,7.04E-01,3.65E+04,3.17E+04,4.08E+04,8.13E+04,4,1,3,2,5.72E+04,,2.33E+04,1.07E+04,6.51E+04,,,,3.17E+04,,3.56E+04,,,4.77E+04,4.08E+04,,6.07E+04,,1.09E+05,,2.27E+02,,2.27E+02,1.07E+04,3.36E+03,,,,8.93E+02,,2.13E+02,,,6.43E+03,1.01E+03,,1.70E+04,,2.55E+03,,0.011,FALSE,2.253,1,1,1375,157.2,5.08,1,protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00443, Pf19718",55031,B3KXF5; E9PM46; hsa:55031; Q658U0; Q86Y73; Q8TEP6; Q96K76; Q9BWI0; Q9NWN1,ENSG00000170242,Ub-specific processing proteases,,1,0,67.03,,14.65,40.29,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,94.39,71.52,44.07,44.52,1.67,other molecular function,0,
Master Protein,High,P15311,EZR,Ezrin OS=Homo sapiens OX=9606 GN=EZR PE=1 SV=4,11,36,1.15,0.393,0.519,1.939,0.2,-1.35,-0.95,0.96,9.59E-01,4.04E-01,4.02E-01,4.44E-01,6.14E+06,8.53E+05,2.06E+06,1.67E+06,5,4,5,3,6.14E+06,2.25E+06,8.80E+06,1.57E+06,7.15E+06,6.53E+05,,1.11E+06,4.57E+05,2.85E+06,5.11E+06,1.88E+05,2.06E+06,2.24E+06,1.69E+06,,1.67E+06,,1.41E+06,1.10E+07,2.44E+04,8.57E+03,8.59E+04,1.57E+06,3.69E+05,2.32E+03,,1.03E+04,1.29E+04,3.04E+04,3.05E+04,8.41E+03,1.68E+04,3.01E+05,4.21E+04,,4.69E+05,,3.29E+04,1.17E+05,0,FALSE,32.499,19,6,586,69.4,6.27,11,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,"Pf00373, Pf00769, Pf09379, Pf09380, Pf20492",7430,E1P5A8; hsa:7430; P15311; P23714; Q4VX75; Q96CU8; Q9NSJ4,ENSG00000092820,Sensory processing of sound by outer hair cells of the cochlea; Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Netrin-1 signaling,Pathogenic Escherichia coli infection; AGE/RAGE pathway; VEGFA-VEGFR2 signaling; 16p11.2 proximal deletion syndrome; CCL18 signaling pathway; Regulation of actin cytoskeleton; GDNF signaling,11,0,60.64,86.01,79.13,116.57,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,80.19,111.77,136.87,89.69,81.56,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9Y696,CLIC4,Chloride intracellular channel protein 4 OS=Homo sapiens OX=9606 GN=CLIC4 PE=1 SV=4,1,3,1.15,0.205,0.01,100,0.2,-2.29,-6.64,6.64,8.68E-01,1.87E-01,1.00E-17,1.00E-17,1.40E+05,1.27E+05,3.01E+04,,5,4,4,,1.40E+05,3.00E+05,3.56E+04,2.92E+04,6.48E+05,,3.01E+04,1.95E+05,1.29E+05,1.25E+05,,6.90E+03,6.31E+04,3.24E+04,2.80E+04,,,,,,5.57E+02,1.14E+03,3.48E+02,2.92E+04,3.34E+04,,5.35E+02,1.80E+03,3.64E+03,1.33E+03,,3.08E+02,5.12E+02,4.36E+03,6.95E+02,,,,,,0.002,FALSE,2.872,5,1,253,28.8,5.59,1,transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component,Pf13409,25932,hsa:25932; Q9UFW9; Q9UQJ6; Q9Y696,ENSG00000169504,,,0,0,111.77,56.65,71.13,,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,121.95,126.05,,,5.46,transporter activity,0,
Master Protein,High,Q13011,ECH1,"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial OS=Homo sapiens OX=9606 GN=ECH1 PE=1 SV=2",11,89,1.149,0.685,0.358,2.104,0.2,-0.55,-1.48,1.07,9.60E-01,9.89E-01,1.41E-01,4.61E-01,7.78E+06,2.42E+06,1.07E+07,1.46E+06,5,5,5,5,8.92E+06,1.82E+05,9.10E+05,1.62E+07,7.78E+06,2.42E+06,1.60E+06,2.72E+06,1.36E+05,6.22E+06,1.31E+07,1.07E+07,6.09E+06,2.57E+07,1.03E+07,4.39E+06,3.87E+06,8.28E+05,1.46E+06,9.56E+05,3.54E+04,6.93E+02,8.89E+03,1.62E+07,4.01E+05,8.59E+03,2.84E+04,2.51E+04,3.84E+03,6.62E+04,7.84E+04,4.80E+05,4.94E+04,3.47E+06,2.56E+05,8.56E+03,1.09E+06,5.87E+03,3.41E+04,1.02E+04,0,FALSE,93.891,45,11,328,35.8,8,11,other metabolic processes,cytosol;mitochondrion;other cytoplasmic organelle,Pf00378,1891,A8K745; hsa:1891; Q13011; Q8WVX0; Q96EZ9,ENSG00000104823; ENSG00000282853,Mitochondrial protein degradation; Peroxisomal protein import,Fatty acid biosynthesis; IL-18 signaling pathway,4,0,96.49,85.9,56.45,73.74,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,97.2,112.81,89.75,78.15,305.47,other molecular function,0,
Master Protein,High,P62424,RPL7A,60S ribosomal protein L7a OS=Homo sapiens OX=9606 GN=RPL7A PE=1 SV=2,8,56,1.149,1.168,1.14,0.985,0.2,0.22,0.19,-0.02,9.60E-01,4.39E-01,9.72E-01,9.50E-01,6.18E+06,2.74E+06,3.62E+06,5.59E+06,5,4,5,5,1.84E+06,9.54E+05,6.18E+06,7.94E+06,9.03E+06,3.38E+06,,7.15E+04,2.23E+06,1.03E+07,1.50E+07,3.62E+06,5.75E+05,4.95E+06,1.92E+06,2.80E+06,5.59E+06,1.34E+07,2.25E+06,1.30E+07,7.32E+03,3.63E+03,6.04E+04,7.94E+06,4.66E+05,1.20E+04,,6.59E+02,6.28E+04,1.10E+05,8.97E+04,1.62E+05,4.67E+03,6.68E+05,4.76E+04,5.45E+03,1.57E+06,9.50E+04,5.26E+04,1.39E+05,0,FALSE,47.485,35,8,266,30,10.61,8,protein metabolism;RNA metabolism OR transcription;other metabolic processes,other membranes;cytosol;translational apparatus;nucleus;other cell component,Pf01248,6130,hsa:6130; P11518; P62424; Q5T8U4,ENSG00000148303; ENSG00000280858,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,69.78,110.87,109.67,73.48,High,High,High,High,High,Peak Found,n/a,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,139.1,107.89,121.37,125.72,202.57,other molecular function,0,
Master Protein,High,Q9UQE7,SMC3,Structural maintenance of chromosomes protein 3 OS=Homo sapiens OX=9606 GN=SMC3 PE=1 SV=2,34,100,1.148,0.64,1.196,1.629,0.2,-0.64,0.26,0.7,9.60E-01,9.09E-01,9.22E-01,6.10E-01,1.14E+07,4.91E+06,3.93E+06,2.38E+06,5,5,5,5,1.14E+06,2.46E+07,7.50E+05,1.52E+07,1.14E+07,2.96E+06,4.91E+06,8.54E+06,2.97E+06,7.33E+06,3.93E+06,2.16E+06,3.83E+06,1.22E+07,6.94E+06,2.38E+06,1.29E+06,7.38E+06,1.88E+06,8.79E+06,4.53E+03,9.36E+04,7.33E+03,1.52E+07,5.86E+05,1.05E+04,8.73E+04,7.88E+04,8.36E+04,7.79E+04,2.35E+04,9.64E+04,3.11E+04,1.64E+06,1.72E+05,4.65E+03,3.63E+05,5.23E+04,4.41E+04,9.35E+04,0,FALSE,134.491,37,34,1217,141.5,7.18,34,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf02463, Pf06470",9126,A8K156; hsa:9126; O60464; Q5T482; Q9UQE7,ENSG00000108055,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Meiotic synapsis; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,Cell cycle; Retinoblastoma gene in cancer; MECP2 and associated Rett syndrome; Prion disease pathway; Regulation of sister chromatid separation at the metaphase-anaphase transition; Cohesin complex - Cornelia de Lange syndrome; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; 10q22q23 copy number variation,15,0,94.75,47.44,68.03,79.87,Peak Found,High,High,High,High,Peak Found,High,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,High,Peak Found,High,1,,FALSE,123.45,126.09,126.35,133.58,298.45,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q14152,EIF3A,Eukaryotic translation initiation factor 3 subunit A OS=Homo sapiens OX=9606 GN=EIF3A PE=1 SV=1,12,27,1.148,0.574,1.852,0.404,0.2,-0.8,0.89,-1.31,8.99E-01,8.54E-01,5.13E-01,4.67E-01,1.38E+06,8.16E+05,6.98E+05,4.88E+06,3,5,3,5,,2.08E+06,,1.38E+06,9.55E+05,2.06E+06,5.92E+05,1.15E+06,3.98E+05,8.16E+05,,6.98E+05,4.90E+05,7.02E+05,,1.32E+06,5.08E+06,4.88E+06,2.17E+06,5.14E+06,,7.90E+03,,1.38E+06,4.92E+04,7.32E+03,1.05E+04,1.06E+04,1.12E+04,8.67E+03,,3.12E+04,3.98E+03,9.46E+04,,2.57E+03,1.43E+06,3.46E+04,5.08E+04,5.47E+04,0,FALSE,50.655,13,12,1382,166.5,6.79,12,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf01399,8661,B1AMV5; B4DYS1; F5H335; hsa:8661; O00653; Q14152; Q15778,ENSG00000107581,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell; NF1 copy number variation syndrome,9,0,38.68,65.11,19.24,49.16,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,n/a,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,107.77,106.46,119.59,107.13,84.08,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A7I2YQC0,NPM1,Nucleophosmin OS=Homo sapiens OX=9606 GN=NPM1 PE=1 SV=1,9,141,1.148,0.656,0.888,0.71,0.2,-0.61,-0.17,-0.49,9.61E-01,9.37E-01,7.77E-01,8.21E-01,2.38E+07,3.39E+07,1.18E+07,1.35E+07,5,5,5,5,2.38E+07,4.50E+07,1.49E+07,2.04E+07,1.20E+08,3.39E+07,1.50E+07,3.60E+07,3.00E+06,1.08E+08,3.07E+07,1.18E+07,9.03E+06,2.85E+07,6.16E+06,2.27E+07,3.90E+06,3.23E+07,1.35E+07,1.12E+07,9.44E+04,1.71E+05,1.46E+05,2.04E+07,6.19E+06,1.21E+05,2.67E+05,3.33E+05,8.46E+04,1.14E+06,1.84E+05,5.27E+05,7.33E+04,3.84E+06,1.53E+05,4.42E+04,1.10E+06,2.29E+05,3.17E+05,1.19E+05,0,FALSE,83.678,48,9,323,35.7,4.82,9,,nucleus,"Pf03066, Pf16276",,A0A7I2YQC0,ENSG00000181163,,,0,0,97.19,103.92,66.68,65.72,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,Acetyl [N-Term],FALSE,128.86,122.54,126.32,111.59,470.8,nucleic acid binding activity,0,
Master Protein,High,Q13547,HDAC1,Histone deacetylase 1 OS=Homo sapiens OX=9606 GN=HDAC1 PE=1 SV=1,6,25,1.147,0.516,1.253,0.524,0.2,-0.95,0.32,-0.93,8.90E-01,7.11E-01,9.42E-01,7.32E-01,2.19E+06,3.15E+05,4.56E+05,8.71E+05,2,4,3,5,,,,1.48E+06,3.24E+06,1.51E+06,7.20E+05,8.75E+04,,1.38E+05,4.56E+05,,,2.67E+06,1.70E+05,8.71E+05,3.34E+03,1.08E+06,1.42E+05,1.06E+06,,,,1.48E+06,1.67E+05,5.38E+03,1.28E+04,8.08E+02,,1.46E+03,2.73E+03,,,3.60E+05,4.23E+03,1.70E+03,9.38E+02,7.69E+03,3.32E+03,1.13E+04,0,FALSE,29.322,17,3,482,55.1,5.48,6,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,Pf00850,3065,hsa:3065; Q13547; Q92534,ENSG00000116478,"Potential therapeutics for SARS; SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Formation of the beta-catenin:TCF transactivating complex; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Deactivation of the beta-catenin transactivating complex; Regulation of PTEN gene transcription; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Estrogen-dependent gene expression; MECP2 regulates transcription of neuronal ligands; Factors involved in megakaryocyte development and platelet production; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Downregulation of SMAD2/3:SMAD4 transcriptional activity; RNA Polymerase I Transcription Initiation; p75NTR negatively regulates cell cycle via SC1; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; G1/S-Specific Transcription; Regulation of TP53 Activity through Acetylation; Transcription of E2F targets under negative control by DREAM complex; Nuclear events stimulated by ALK signaling in cancer; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1; MECP2 regulates neuronal receptors and channels; Repression of WNT target genes; Loss of MECP2 binding ability to 5mC-DNA",Androgen receptor signaling pathway; Energy metabolism; Cell cycle; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Neural crest differentiation; Retinoblastoma gene in cancer; Notch signaling; Apoptosis-related network due to altered Notch3 in ovarian cancer; Initiation of transcription and translation elongation at the HIV-1 LTR; MECP2 and associated Rett syndrome; IL6 signaling pathway; TGF-beta signaling pathway; Valproic acid pathway; VEGFA-VEGFR2 signaling; Ethanol effects on histone modifications; Rett syndrome; Effect of progerin on genes involved in progeria; Ciliary landscape; Transcription co-factors SKI and SKIL protein partners; Overlap between signal transduction pathways contributing to LMNA laminopathies; Opioid receptor pathways; 15q11q13 copy number variation; Notch signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,56,0,52.6,108.06,124.59,82.24,n/a,n/a,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,140.89,86.63,94.56,101.69,73.42,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P62249,RPS16,40S ribosomal protein S16 OS=Homo sapiens OX=9606 GN=RPS16 PE=1 SV=2,6,32,1.147,1.072,1.527,1.068,0.2,0.1,0.61,0.09,9.61E-01,5.18E-01,6.83E-01,8.93E-01,7.24E+06,1.59E+06,4.28E+06,3.12E+06,5,5,5,5,2.02E+07,9.60E+05,1.98E+07,7.24E+06,5.13E+06,3.25E+06,1.34E+06,7.35E+05,1.59E+06,8.05E+06,2.42E+07,6.76E+06,4.28E+06,4.25E+06,3.80E+06,3.12E+06,3.16E+06,4.05E+07,1.82E+06,5.38E+05,8.04E+04,3.65E+03,1.93E+05,7.24E+06,2.64E+05,1.15E+04,2.38E+04,6.78E+03,4.47E+04,8.56E+04,1.45E+05,3.02E+05,3.48E+04,5.73E+05,9.43E+04,6.08E+03,8.89E+05,2.87E+05,4.25E+04,5.73E+03,0,FALSE,19.169,36,6,146,16.4,10.21,6,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf00380,6217,B2RDD5; hsa:6217; P17008; P62249,ENSG00000105193,"Major pathway of rRNA processing in the nucleolus and cytosol; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,82.71,99.51,101.19,174.78,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,119.37,103.33,116.19,130.56,61.86,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P82933,MRPS9,"28S ribosomal protein S9, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS9 PE=1 SV=2",4,5,1.147,1.089,0.01,100,0.2,0.12,-6.64,6.64,8.58E-01,5.76E-01,1.00E-17,1.00E-17,1.67E+05,1.02E+05,1.62E+05,,2,1,1,,,,,2.94E+05,9.54E+04,,,,1.02E+05,,,,,1.62E+05,,,,,,,,,,2.94E+05,4.92E+03,,,,2.88E+03,,,,,2.19E+04,,,,,,,0,FALSE,15.449,15,4,396,45.8,9.51,4,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus;nucleus,Pf00380,64965,hsa:64965; P82933; Q6PG40,ENSG00000135972,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,72.02,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,30.91,0,,,19.97,other molecular function,0,
Master Protein,High,Q15365,PCBP1,Poly(rC)-binding protein 1 OS=Homo sapiens OX=9606 GN=PCBP1 PE=1 SV=2,7,31,1.146,0.37,2.017,0.545,0.2,-1.44,1.01,-0.88,9.62E-01,3.55E-01,4.45E-01,6.44E-01,4.25E+06,2.34E+06,2.02E+06,5.57E+06,5,5,5,5,6.59E+06,2.04E+06,4.25E+06,8.16E+06,2.01E+06,1.99E+06,2.85E+06,2.83E+06,4.14E+05,2.34E+06,1.11E+06,5.23E+05,2.59E+06,4.52E+06,2.02E+06,5.86E+06,4.73E+06,1.98E+07,2.17E+06,5.57E+06,2.62E+04,7.77E+03,4.15E+04,8.16E+06,1.04E+05,7.07E+03,5.07E+04,2.61E+04,1.17E+04,2.49E+04,6.64E+03,2.34E+04,2.11E+04,6.10E+05,5.02E+04,1.14E+04,1.33E+06,1.40E+05,5.08E+04,5.93E+04,0,FALSE,33.105,31,6,356,37.5,7.09,7,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf00013,5093,hsa:5093; Q13157; Q14975; Q15365,ENSG00000169564,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,Ferroptosis,3,1,59.4,48,71.84,91.18,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,92.52,85.61,122.57,102.83,86.01,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15532,SS18,Protein SSXT OS=Homo sapiens OX=9606 GN=SS18 PE=1 SV=3,1,6,1.146,0.927,0.955,1.112,0.2,-0.11,-0.07,0.15,7.91E-01,7.11E-01,8.41E-01,7.74E-01,2.66E+05,2.32E+05,2.47E+05,2.22E+05,2,1,2,1,,,,8.71E+05,8.15E+04,,,2.32E+05,,,,9.56E+04,,6.38E+05,,2.22E+05,,,,,,,,8.71E+05,4.20E+03,,,2.15E+03,,,,4.27E+03,,8.59E+04,,4.33E+02,,,,,0,FALSE,10.769,4,1,418,45.9,6.46,1,cell organization and biogenesis;signal transduction;other biological processes,cytoskeleton;nucleus;other cell component,Pf05030,6760,B0YJ95; hsa:6760; Q15532; Q16404; Q4VAX1; Q9BXC6,ENSG00000141380,,,0,0,117.23,,104.55,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,219.71,85.07,0,162.76,24,other molecular function,0,
Master Protein,High,Q5JTJ3,COA6,Cytochrome c oxidase assembly factor 6 homolog OS=Homo sapiens OX=9606 GN=COA6 PE=1 SV=1,1,2,1.144,0.999,0.737,1.55,0.19,0,-0.44,0.63,8.51E-01,6.44E-01,7.14E-01,5.71E-01,1.82E+05,1.59E+05,1.81E+05,1.17E+05,1,2,3,1,1.82E+05,,,,,,,,8.51E+04,2.96E+05,1.80E+05,,,2.10E+05,1.81E+05,,1.17E+05,,,,7.21E+02,,,,,,,,2.40E+03,3.15E+03,1.07E+03,,,2.83E+04,4.51E+03,,3.29E+04,,,,0,FALSE,5.036,11,1,125,14.1,8.25,1,cell organization and biogenesis;other metabolic processes,plasma membrane;other membranes;mitochondrion;nucleus,Pf02297,388753,hsa:388753; Q5JTJ2; Q5JTJ3; Q5JTJ4; Q8TA88,ENSG00000168275,Mitochondrial protein import,Mitochondrial complex IV assembly,2,0,,78.24,8.9,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,98.46,1.35,98.46,1.34,6.12,other molecular function,0,
Master Protein,High,A0A8V8TN34,SLC44A1,Choline transporter-like protein OS=Homo sapiens OX=9606 GN=SLC44A1 PE=1 SV=1,2,3,1.144,0.814,2.629,,0.19,-0.3,1.39,,8.51E-01,8.37E-01,4.06E-01,,3.07E+05,1.69E+04,2.34E+05,4.44E+04,1,1,2,1,,,,3.07E+05,,,1.69E+04,,,,,2.96E+05,,,1.85E+05,,,,4.44E+04,,,,,3.07E+05,,,3.00E+02,,,,,1.32E+04,,,4.60E+03,,,,1.04E+03,,0,FALSE,7.485,4,2,726,81.3,8.22,2,other metabolic processes;transport,plasma membrane;other membranes,Pf04515,,A0A8V8TN34,ENSG00000070214,,Diet-dependent trimethylamine/trimethylamine N-oxide metabolism,1,0,,,32.48,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,34.99,0,,8.13,transporter activity,0,
Master Protein,High,P30086,PEBP1,Phosphatidylethanolamine-binding protein 1 OS=Homo sapiens OX=9606 GN=PEBP1 PE=1 SV=3,2,6,1.142,0.573,,0.751,0.19,-0.8,,-0.41,8.12E-01,8.30E-01,,9.37E-01,6.51E+05,1.82E+05,6.08E+05,4.21E+05,2,2,4,1,,5.74E+05,,7.39E+05,,,1.53E+05,2.18E+05,,,,8.75E+05,8.32E+04,7.37E+05,5.02E+05,4.21E+05,,,,,,2.18E+03,,7.39E+05,,,2.71E+03,2.01E+03,,,,3.91E+04,6.76E+02,9.93E+04,1.25E+04,8.22E+02,,,,,0,FALSE,10.407,24,2,187,21,7.53,2,other biological processes,cytosol,Pf01161,5037,B2R4S1; hsa:5037; P30086,ENSG00000089220,Signaling by BRAF and RAF1 fusions; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants,Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway,9,0,17.84,24.89,63.15,,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,High,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,26.51,67.89,,24.69,19.89,enzyme regulator activity;other molecular function,0,
Master Protein,High,A0A0C4DGG9,CHD4,DNA helicase OS=Homo sapiens OX=9606 GN=CHD4 PE=1 SV=1,36,101,1.141,0.574,0.635,1.036,0.19,-0.8,-0.65,0.05,9.66E-01,7.83E-01,4.78E-01,9.14E-01,8.31E+06,3.21E+06,5.24E+06,2.00E+06,5,5,5,5,1.59E+06,1.19E+07,1.66E+06,2.24E+07,8.31E+06,1.68E+06,1.77E+06,1.44E+07,7.71E+06,3.21E+06,5.24E+06,4.40E+06,4.61E+06,2.12E+07,7.51E+06,2.00E+06,5.74E+05,2.96E+06,1.75E+06,9.03E+06,6.32E+03,4.52E+04,1.62E+04,2.24E+07,4.29E+05,5.99E+03,3.15E+04,1.33E+05,2.17E+05,3.41E+04,3.14E+04,1.97E+05,3.74E+04,2.85E+06,1.87E+05,3.91E+03,1.61E+05,2.10E+04,4.10E+04,9.61E+04,0,FALSE,183.892,27,30,1937,220.3,6.02,36,cell organization and biogenesis,nucleus,"Pf00176, Pf00271, Pf00385, Pf00628, Pf06461, Pf06465, Pf08073, Pf08074",,A0A0C4DGG9,ENSG00000111642,,Rett syndrome; Effect of progerin on genes involved in progeria,2,6,93.95,94.07,83.14,102.12,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,1,,FALSE,141.4,113.26,135.45,131.33,315.27,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UJZ1,STOML2,"Stomatin-like protein 2, mitochondrial OS=Homo sapiens OX=9606 GN=STOML2 PE=1 SV=1",12,45,1.141,0.863,1.086,1.425,0.19,-0.21,0.12,0.51,9.66E-01,7.44E-01,9.79E-01,6.96E-01,3.83E+06,3.37E+06,3.51E+06,2.83E+06,5,5,5,5,3.43E+06,4.71E+06,4.18E+05,3.83E+06,1.09E+07,1.80E+06,2.39E+05,3.37E+06,3.58E+06,5.56E+06,2.57E+06,3.51E+06,1.62E+06,3.91E+06,4.26E+06,7.19E+06,1.68E+06,2.83E+06,1.94E+06,5.90E+06,1.36E+04,1.79E+04,4.08E+03,3.83E+06,5.64E+05,6.40E+03,4.25E+03,3.11E+04,1.01E+05,5.91E+04,1.54E+04,1.57E+05,1.32E+04,5.27E+05,1.06E+05,1.40E+04,4.72E+05,2.00E+04,4.55E+04,6.28E+04,0,FALSE,52.558,42,12,356,38.5,7.39,12,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;mitochondrion,"Pf01145, Pf16200",30968,B4E1K7; D3DRN3; hsa:30968; O60376; Q53G29; Q96FY2; Q9P042; Q9UJZ1,ENSG00000165283,Processing of SMDT1; Cellular response to mitochondrial stress,,2,0,82.71,68.84,33.79,63.64,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,121.26,119.23,115.2,79.17,129.18,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P49257,LMAN1,Protein ERGIC-53 OS=Homo sapiens OX=9606 GN=LMAN1 PE=1 SV=2,11,52,1.139,0.801,0.773,0.704,0.19,-0.32,-0.37,-0.51,9.67E-01,8.29E-01,6.46E-01,8.14E-01,4.16E+06,4.03E+06,3.71E+06,4.91E+06,5,5,5,5,2.75E+06,2.86E+06,1.86E+07,8.59E+06,4.16E+06,1.73E+07,2.81E+06,1.15E+06,6.47E+06,4.03E+06,1.72E+06,2.69E+06,6.18E+06,8.19E+06,3.71E+06,1.21E+07,7.50E+06,4.91E+06,4.46E+06,3.21E+06,1.09E+04,1.09E+04,1.81E+05,8.59E+06,2.15E+05,6.14E+04,5.00E+04,1.06E+04,1.82E+05,4.28E+04,1.03E+04,1.20E+05,5.02E+04,1.10E+06,9.23E+04,2.37E+04,2.11E+06,3.48E+04,1.04E+05,3.42E+04,0,FALSE,60.963,34,11,510,57.5,6.77,11,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,other membranes;cytoskeleton;ER/Golgi;other cell component,Pf03388,3998,hsa:3998; P49257; Q12895; Q8N5I7; Q9UQG1; Q9UQG2; Q9UQG3; Q9UQG4; Q9UQG5; Q9UQG6; Q9UQG7; Q9UQG8; Q9UQG9; Q9UQH0; Q9UQH1; Q9UQH2,ENSG00000074695,RHOC GTPase cycle; RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; COPII-mediated vesicle transport; Cargo concentration in the ER; Transport to the Golgi and subsequent modification,VEGFA-VEGFR2 signaling; Dengue-2 interactions with complement and coagulation cascades; Complement and coagulation cascades,12,0,90.54,101,58.91,55.01,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,134.05,113.34,132.23,115.7,180.35,other molecular function,0,
Master Protein,High,P62995,TRA2B,Transformer-2 protein homolog beta OS=Homo sapiens OX=9606 GN=TRA2B PE=1 SV=1,4,7,1.134,0.282,1.383,1.636,0.18,-1.83,0.47,0.71,8.90E-01,2.43E-01,8.73E-01,5.37E-01,1.26E+06,8.37E+05,1.55E+05,2.74E+05,4,4,2,2,,1.35E+06,7.80E+04,1.18E+06,3.63E+06,,9.19E+05,7.63E+05,2.58E+05,9.91E+05,,,1.11E+05,2.16E+05,,,,,6.76E+04,1.11E+06,,5.11E+03,7.62E+02,1.18E+06,1.87E+05,,1.63E+04,7.04E+03,7.27E+03,1.05E+04,,,9.02E+02,2.91E+04,,,,,1.58E+03,1.18E+04,0,FALSE,9.166,18,4,288,33.6,11.25,4,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,other membranes;nucleus;other cell component,Pf00076,6434,B4DVK2; D3DNU3; hsa:6434; O15449; P62995; Q15815; Q64283,ENSG00000136527,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,mRNA processing,5,0,95.65,45.11,45.29,125.14,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,134.9,99.59,13.21,0.72,15.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q53GQ0,HSD17B12,Very-long-chain 3-oxoacyl-CoA reductase OS=Homo sapiens OX=9606 GN=HSD17B12 PE=1 SV=2,4,7,1.133,1.426,1.417,1.481,0.18,0.51,0.5,0.57,8.31E-01,1.94E-01,8.63E-01,5.74E-01,5.87E+05,2.80E+05,1.31E+06,3.97E+05,2,1,4,3,,,,1.26E+06,2.73E+05,2.80E+05,,,,,,3.47E+05,2.88E+06,1.62E+06,1.07E+06,3.97E+05,1.40E+05,,5.37E+05,,,,,1.26E+06,1.41E+04,9.95E+02,,,,,,1.55E+04,2.34E+04,2.18E+05,2.66E+04,7.74E+02,3.93E+04,,1.26E+04,,0,FALSE,13.767,20,4,312,34.3,9.32,4,cell organization and biogenesis;other metabolic processes;other biological processes,extracellular matrix;other membranes;ER/Golgi,Pf00106,51144,A8K9B0; D3DR23; hsa:51144; Q53GQ0; Q96EA9; Q96JU2; Q9Y6G8,ENSG00000149084,Synthesis of very long-chain fatty acyl-CoAs; Androgen biosynthesis,Mitochondrial fatty acid synthesis pathway,3,0,90.93,,72.42,56.29,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,22.07,119.13,52.5,99.76,21.28,other molecular function,0,
Master Protein,High,P07900,HSP90AA1,Heat shock protein HSP 90-alpha OS=Homo sapiens OX=9606 GN=HSP90AA1 PE=1 SV=5,21,132,1.131,0.481,0.743,0.798,0.18,-1.06,-0.43,-0.33,9.74E-01,5.92E-01,6.10E-01,9.01E-01,1.21E+07,4.02E+06,8.44E+06,6.95E+06,5,4,5,5,2.66E+07,2.44E+06,2.93E+06,1.21E+07,2.25E+07,5.71E+06,,1.30E+06,2.82E+06,1.33E+07,8.44E+06,8.63E+06,5.31E+06,1.33E+07,7.22E+06,3.49E+06,1.84E+07,1.14E+07,5.87E+06,6.95E+06,1.06E+05,9.28E+03,2.86E+04,1.21E+07,1.16E+06,2.03E+04,,1.20E+04,7.95E+04,1.41E+05,5.05E+04,3.86E+05,4.32E+04,1.79E+06,1.80E+05,6.81E+03,5.16E+06,8.07E+04,1.37E+05,7.40E+04,0,FALSE,90.128,30,12,732,84.6,5.02,21,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,"Pf00183, Pf13589",3320,A8K500; B3KPJ9; hsa:3320; P07900; Q2PP14; Q5CAQ6; Q5CAQ7; Q9BVQ5,ENSG00000080824,"Regulation of actin dynamics for phagocytic cup formation; Potential therapeutics for SARS; The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Aggrephagy; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Extra-nuclear estrogen signaling; Neutrophil degranulation; vRNP Assembly; Estrogen-dependent gene expression; Regulation of necroptotic cell death; Interleukin-4 and Interleukin-13 signaling; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Sema3A PAK dependent Axon repulsion; DDX58/IFIH1-mediated induction of interferon-alpha/beta; PIWI-interacting RNA (piRNA) biogenesis; VEGFR2 mediated vascular permeability; RHOBTB2 GTPase cycle; Chaperone Mediated Autophagy; HSF1 activation; Attenuation phase; eNOS activation; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; Uptake and function of diphtheria toxin; Constitutive Signaling by Overexpressed ERBB2; Assembly and release of respiratory syncytial virus (RSV) virions; Respiratory syncytial virus genome replication; Scavenging by Class F Receptors; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants",Nucleotide-binding oligomerization domain (NOD) pathway; TNF-alpha signaling pathway; Corticotropin-releasing hormone signaling pathway; Aryl hydrocarbon receptor pathway; Ebstein-Barr virus LMP1 signaling; Aryl hydrocarbon receptor pathway; Constitutive androstane receptor pathway; Pregnane X receptor pathway; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced AP-1 survival signaling; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Th17 cell differentiation pathway; HDAC6 interactions in the central nervous system,71,9,83,92.24,34.25,63.6,High,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,94.01,92.7,131.51,125.78,340.48,signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q12849,GRSF1,G-rich sequence factor 1 OS=Homo sapiens OX=9606 GN=GRSF1 PE=1 SV=3,3,4,1.129,0.522,,1.674,0.18,-0.94,,0.74,7.99E-01,7.31E-01,,5.31E-01,4.94E+05,7.01E+04,4.14E+04,4.99E+04,5,2,4,2,2.53E+05,3.02E+06,1.49E+06,4.94E+05,1.51E+04,,4.57E+04,,1.08E+05,,,4.18E+04,2.89E+05,4.09E+04,2.41E+04,,,6.29E+04,,3.95E+04,1.00E+03,1.15E+04,1.46E+04,4.94E+05,7.80E+02,,8.12E+02,,3.03E+03,,,1.87E+03,2.35E+03,5.52E+03,5.99E+02,,,4.46E+02,,4.21E+02,0,FALSE,14.376,11,3,480,53.1,6.19,3,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,mitochondrion;nucleus;other cell component,Pf00076,2926,B3KPW0; hsa:2926; Q12849; Q4W5S5; Q6ZST3; Q8IWD6; Q8NBD2,ENSG00000132463,Viral mRNA Translation; Mitochondrial RNA degradation,VEGFA-VEGFR2 signaling,3,0,117.04,57.2,128.33,32.3,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,65.57,126.9,,186.54,14.48,nucleic acid binding activity,0,
Master Protein,High,P27348,YWHAQ,14-3-3 protein theta OS=Homo sapiens OX=9606 GN=YWHAQ PE=1 SV=1,10,55,1.129,0.575,1.187,0.347,0.17,-0.8,0.25,-1.53,9.76E-01,8.36E-01,9.30E-01,3.88E-01,1.46E+06,3.42E+06,1.24E+06,4.83E+06,5,3,4,5,1.18E+06,5.77E+06,3.40E+05,1.46E+06,2.80E+06,4.32E+06,,,1.53E+05,3.42E+06,,2.48E+05,2.07E+06,2.85E+06,7.41E+05,4.83E+06,4.87E+06,6.38E+06,4.55E+06,3.17E+06,4.67E+03,2.19E+04,3.32E+03,1.46E+06,1.44E+05,1.54E+04,,,4.31E+03,3.64E+04,,1.11E+04,1.69E+04,3.84E+05,1.84E+04,9.42E+03,1.37E+06,4.52E+04,1.06E+05,3.38E+04,0,FALSE,39.182,46,7,245,27.7,4.78,10,signal transduction;other biological processes,cytosol;other cell component,Pf00244,10971,D6W4Z5; hsa:10971; P27348; Q567U5; Q5TZU8; Q9UP48,ENSG00000134308,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; TP53 Regulates Metabolic Genes; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Activation of BAD and translocation to mitochondria,Cell cycle; Pathogenic Escherichia coli infection; Primary focal segmental glomerulosclerosis (FSGS); IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Leukocyte-intrinsic Hippo pathway functions; Hepatitis B infection; Opioid receptor pathways; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,19,0,92.09,83.33,80.93,23.96,Peak Found,High,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,132.35,106.72,134.81,116.38,111.59,other molecular function,0,
Master Protein,High,P26373,RPL13,60S ribosomal protein L13 OS=Homo sapiens OX=9606 GN=RPL13 PE=1 SV=4,5,16,1.128,0.222,0.932,0.179,0.17,-2.17,-0.1,-2.48,9.77E-01,9.11E-02,8.25E-01,1.48E-01,3.03E+06,2.42E+06,7.20E+05,4.34E+06,5,5,5,5,7.94E+05,9.00E+06,1.97E+05,3.03E+06,9.39E+06,4.14E+06,9.25E+05,2.42E+06,2.15E+06,1.52E+07,2.22E+05,9.99E+05,7.20E+05,7.20E+05,3.68E+05,4.34E+06,8.11E+05,1.25E+07,4.66E+05,1.31E+07,3.15E+03,3.42E+04,1.93E+03,3.03E+06,4.84E+05,1.47E+04,1.64E+04,2.23E+04,6.07E+04,1.62E+05,1.33E+03,4.46E+04,5.85E+03,9.70E+04,9.15E+03,8.46E+03,2.28E+05,8.87E+04,1.09E+04,1.40E+05,0,FALSE,14.638,25,5,211,24.2,11.65,5,protein metabolism;other metabolic processes;developmental processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf01294,6137,B4DLX3; F5H1S2; hsa:6137; P26373; Q3KQT8; Q567Q8; Q9BPX0,ENSG00000167526,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,98.87,117.39,51.14,99.03,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,129.43,100.05,145.67,126.53,43.74,other molecular function,0,
Master Protein,High,P16403,H1-2,Histone H1.2 OS=Homo sapiens OX=9606 GN=H1-2 PE=1 SV=2,20,714,1.126,0.21,0.848,0.577,0.17,-2.25,-0.24,-0.79,9.78E-01,7.82E-02,7.33E-01,7.76E-01,5.73E+06,3.75E+06,1.17E+06,8.28E+05,5,5,5,5,3.45E+05,7.10E+06,1.85E+06,5.73E+06,1.39E+07,3.97E+05,3.75E+06,7.82E+06,3.13E+05,2.23E+07,2.00E+05,7.90E+05,1.56E+06,1.17E+06,1.62E+06,8.28E+05,2.47E+04,6.63E+06,5.15E+05,2.67E+07,1.37E+03,2.70E+04,1.81E+04,5.73E+06,7.15E+05,1.41E+03,6.68E+04,7.22E+04,8.82E+03,2.37E+05,1.19E+03,3.53E+04,1.27E+04,1.57E+05,4.03E+04,1.61E+03,6.95E+03,4.70E+04,1.20E+04,2.84E+05,0,FALSE,115.398,48,3,213,21.4,10.93,20,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf00538,3006,A8K4I2; hsa:3006; P16403,ENSG00000187837,Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF),,2,0,91.58,132.07,55.21,163.8,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,142.44,125.66,146.81,146.91,1786.63,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q14683,SMC1A,Structural maintenance of chromosomes protein 1A OS=Homo sapiens OX=9606 GN=SMC1A PE=1 SV=2,33,89,1.122,0.503,1.851,0.644,0.17,-0.99,0.89,-0.64,9.81E-01,6.38E-01,5.13E-01,7.53E-01,2.13E+07,2.33E+07,7.75E+06,1.83E+07,5,5,5,5,3.84E+06,7.12E+07,1.30E+06,2.13E+07,3.00E+07,2.25E+07,7.95E+07,2.33E+07,7.32E+06,4.76E+07,6.82E+06,2.82E+06,7.75E+06,1.47E+07,1.00E+07,1.83E+07,1.19E+06,2.96E+07,3.74E+06,9.43E+07,1.53E+04,2.71E+05,1.27E+04,2.13E+07,1.55E+06,7.98E+04,1.41E+06,2.15E+05,2.06E+05,5.06E+05,4.08E+04,1.26E+05,6.30E+04,1.98E+06,2.49E+05,3.58E+04,3.34E+05,2.10E+05,8.75E+04,1.00E+06,0,FALSE,140.717,30,33,1233,143.1,7.64,33,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf02463, Pf06470",8243,hsa:8243; O14995; Q14683; Q16351; Q2M228,ENSG00000072501,Meiotic synapsis; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,miRNA regulation of DNA damage response; Cell cycle; Retinoblastoma gene in cancer; Constitutive androstane receptor pathway; Nuclear receptors meta-pathway; Pathways affected in adenoid cystic carcinoma; ATM signaling in development and disease ; mRNA processing; Regulation of sister chromatid separation at the metaphase-anaphase transition; Rett syndrome; CAMKK2 pathway; Cohesin complex - Cornelia de Lange syndrome; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; 10q22q23 copy number variation; DNA damage response,22,0,110.52,78.4,51.83,129.29,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,High,High,High,High,High,High,High,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,126.63,115.83,141.79,133.74,251.55,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O14672,ADAM10,Disintegrin and metalloproteinase domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ADAM10 PE=1 SV=1,3,3,1.122,1.418,5.397,0.274,0.17,0.5,2.43,-1.87,8.77E-01,3.59E-01,6.97E-02,3.44E-01,1.56E+05,1.01E+05,2.87E+05,1.72E+06,3,4,4,5,,8.51E+04,,1.56E+05,6.61E+05,2.78E+06,8.05E+04,1.26E+05,,7.14E+04,8.73E+05,,5.77E+05,1.30E+05,1.43E+05,9.15E+06,1.89E+05,3.69E+06,4.09E+05,1.72E+06,,3.23E+02,,1.56E+05,3.41E+04,9.88E+03,1.43E+03,1.16E+03,,7.60E+02,5.22E+03,,4.69E+03,1.75E+04,3.54E+03,1.78E+04,5.32E+04,2.62E+04,9.58E+03,1.83E+04,0,FALSE,14.522,9,3,748,84.1,7.77,3,cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cell component,"Pf00200, Pf13574, Pf21299",102,B4DU28; hsa:102; O14672; Q10742; Q92650,ENSG00000137845,Amyloid fiber formation; Collagen degradation; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; NOTCH3 Activation and Transmission of Signal to the Nucleus; Neutrophil degranulation; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant; Signaling by EGFR; EPH-ephrin mediated repulsion of cells; NOTCH4 Activation and Transmission of Signal to the Nucleus,Alzheimer's disease and miRNA effects; Copper homeostasis; Canonical and non-canonical Notch signaling; VEGFA-VEGFR2 signaling; 3q29 copy number variation syndrome; Interactions of natural killer cells in pancreatic cancer; Alzheimer's disease; Hypertrophy model; TROP2 regulatory signaling; 5q35 copy number variation; 10q22q23 copy number variation,27,0,104.38,175.79,83.81,121.84,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,130.53,91.35,145.3,132.09,6.11,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,O00194,RAB27B,Ras-related protein Rab-27B OS=Homo sapiens OX=9606 GN=RAB27B PE=1 SV=4,1,9,1.122,0.09,0.711,0.146,0.17,-3.47,-0.49,-2.77,9.81E-01,2.61E-03,5.71E-01,1.03E-01,1.26E+07,7.52E+06,8.10E+05,5.54E+06,3,3,2,2,1.26E+07,2.01E+07,3.71E+06,,,3.30E+06,,1.84E+07,7.52E+06,,,,1.43E+06,4.59E+05,,1.43E+07,2.14E+06,,,,5.00E+04,7.64E+04,3.62E+04,,,1.17E+04,,1.69E+05,2.12E+05,,,,1.16E+04,6.18E+04,,2.80E+04,6.01E+05,,,,0.001,FALSE,4.07,5,1,218,24.6,5.52,1,transport;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,5874,B2RAB0; hsa:5874; O00194; Q9BZB6,ENSG00000041353,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Platelet degranulation,Deregulation of Rab and Rab effector genes in bladder cancer,4,0,67.69,79.88,72.81,104.69,Peak Found,High,High,n/a,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,High,n/a,n/a,n/a,1,,FALSE,83.08,77.04,108.48,92.38,21.62,cytoskeletal activity;other molecular function,0,
Master Protein,High,O60664,PLIN3,Perilipin-3 OS=Homo sapiens OX=9606 GN=PLIN3 PE=1 SV=3,7,10,1.12,0.457,4.976,0.18,0.16,-1.13,2.31,-2.47,7.92E-01,6.05E-01,1.19E-01,1.73E-01,4.14E+05,2.29E+05,2.31E+05,6.97E+05,5,3,4,5,7.17E+05,2.41E+05,4.14E+05,2.01E+06,3.23E+05,,2.29E+05,4.07E+05,2.09E+05,,1.26E+05,2.98E+05,3.06E+05,1.80E+05,,6.97E+05,1.40E+05,8.78E+05,4.65E+05,1.56E+06,2.85E+03,9.16E+02,4.05E+03,2.01E+06,1.67E+04,,4.08E+03,3.76E+03,5.89E+03,,7.51E+02,1.33E+04,2.48E+03,2.42E+04,,1.36E+03,3.93E+04,6.22E+03,1.09E+04,1.66E+04,0,FALSE,29.217,27,7,434,47,5.44,7,cell organization and biogenesis;stress response;transport;other biological processes,other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf03036,10226,A8K4Y9; hsa:10226; K7EQF4; O60664; Q53G77; Q9BS03; Q9UBD7; Q9UP92,ENSG00000105355,Late endosomal microautophagy; Triglyceride catabolism; Retrograde transport at the Trans-Golgi-Network; RHOBTB3 ATPase cycle; Lipophagy; Chaperone Mediated Autophagy,,6,0,98.74,38.7,39.19,70.92,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,62.19,89.22,128.29,97.82,32.8,,0,
Master Protein,High,P38606,ATP6V1A,V-type proton ATPase catalytic subunit A OS=Homo sapiens OX=9606 GN=ATP6V1A PE=1 SV=2,3,7,1.117,0.776,0.716,1.219,0.16,-0.37,-0.48,0.29,8.12E-01,8.75E-01,5.87E-01,7.22E-01,4.21E+05,3.33E+05,2.83E+05,4.68E+05,3,2,5,5,1.75E+06,,4.21E+05,1.97E+05,,,1.34E+05,,8.29E+05,,1.50E+05,1.08E+05,5.93E+05,4.33E+05,2.83E+05,3.51E+05,6.90E+05,5.03E+05,1.25E+05,4.68E+05,6.95E+03,,4.11E+03,1.97E+05,,,2.38E+03,,2.34E+04,,8.95E+02,4.82E+03,4.82E+03,5.83E+04,7.03E+03,6.84E+02,1.94E+05,3.56E+03,2.92E+03,4.98E+03,0,FALSE,11.399,7,3,617,68.3,5.52,3,cell organization and biogenesis;other metabolic processes;transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00006, Pf02874, Pf16886",523,B2RBR8; B7Z1R5; D3DN75; hsa:523; P38606; Q53YD9; Q96DY6; Q9UHY3,ENSG00000114573,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,Proximal tubule transport,6,0,106.39,102.1,64.32,48.78,Peak Found,n/a,High,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,133.66,131.83,106.13,88.15,20.64,transporter activity;other molecular function,0,
Master Protein,High,Q00765,REEP5,Receptor expression-enhancing protein 5 OS=Homo sapiens OX=9606 GN=REEP5 PE=1 SV=3,2,8,1.117,0.251,0.731,0.374,0.16,-1.99,-0.45,-1.42,7.95E-01,2.29E-01,6.94E-01,5.36E-01,4.02E+05,2.80E+05,5.81E+04,1.41E+05,5,3,5,5,2.88E+05,5.57E+05,1.70E+05,5.62E+05,4.02E+05,,,2.57E+05,2.80E+05,5.90E+05,9.24E+04,2.07E+04,8.21E+04,5.81E+04,4.49E+04,1.41E+05,1.23E+05,6.78E+05,3.88E+04,3.22E+05,1.14E+03,2.12E+03,1.66E+03,5.62E+05,2.08E+04,,,2.37E+03,7.89E+03,6.28E+03,5.52E+02,9.25E+02,6.67E+02,7.83E+03,1.12E+03,2.75E+02,3.47E+04,4.80E+03,9.07E+02,3.43E+03,0,FALSE,4.362,10,2,189,21.5,8.1,2,cell organization and biogenesis;other biological processes,other membranes;cytosol;ER/Golgi,Pf03134,7905,B7Z681; D3DT04; hsa:7905; Q00765; Q04198; Q5QGT0; Q9BWH9,ENSG00000129625,,,0,0,43.09,49.5,48.25,97.87,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,77.93,81.63,86.52,111.7,16.72,,0,
Master Protein,High,E9PRY8,EEF1D,Eukaryotic translation elongation factor 1 delta OS=Homo sapiens OX=9606 GN=EEF1D PE=1 SV=1,6,36,1.117,0.986,3.633,0.155,0.16,-0.02,1.86,-2.69,8.60E-01,5.19E-01,1.30E-01,1.14E-01,1.14E+06,5.30E+05,2.47E+06,1.03E+07,3,1,5,2,1.14E+06,,,2.37E+06,4.63E+05,,5.30E+05,,,,3.00E+06,2.22E+06,2.47E+06,4.29E+06,1.40E+06,,2.60E+07,,4.05E+06,,4.53E+03,,,2.37E+06,2.39E+04,,9.42E+03,,,,1.79E+04,9.91E+04,2.01E+04,5.78E+05,3.47E+04,,7.31E+06,,9.48E+04,,0,FALSE,40.247,16,3,697,76.5,7.05,6,protein metabolism;other metabolic processes,cytosol;nucleus;other cell component,"Pf00736, Pf10587",,E9PRY8,ENSG00000104529,,,0,2,73.11,,40.11,103.34,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,32.28,39.59,164.12,91.9,114.29,nucleic acid binding activity,0,
Master Protein,Medium,A0A0A6YYG9,ARPC4-TTLL3,Protein ARPC4-TTLL3 OS=Homo sapiens OX=9606 GN=ARPC4-TTLL3 PE=3 SV=1,1,6,1.114,0.698,1.938,0.602,0.16,-0.52,0.95,-0.73,9.03E-01,9.24E-01,4.60E-01,7.32E-01,1.09E+06,9.39E+05,1.60E+06,1.90E+06,4,4,4,4,,2.63E+06,2.66E+05,4.56E+05,2.68E+06,9.30E+05,9.01E+05,1.07E+06,,9.49E+05,,2.76E+05,1.68E+06,1.85E+06,1.51E+06,1.37E+06,5.39E+05,,2.65E+06,2.43E+07,,9.98E+03,2.59E+03,4.56E+05,1.38E+05,3.31E+03,1.60E+04,9.89E+03,,1.01E+04,,1.23E+04,1.37E+04,2.50E+05,3.76E+04,2.67E+03,1.51E+05,,6.21E+04,2.58E+05,0.011,FALSE,2.231,1,1,625,71.7,5.88,1,cell organization and biogenesis;protein metabolism;other metabolic processes,cytoskeleton;other cell component,"Pf03133, Pf05856",100526693,A0A0A6YYG9; hsa:100526693,ENSG00000250151,,,0,0,88,7.83,53.85,158.26,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,n/a,High,Peak Found,1,,FALSE,146.59,82.94,89.76,118.09,12.92,,0,
Master Protein,High,Q06547,GABPB1,GA-binding protein subunit beta-1 OS=Homo sapiens OX=9606 GN=GABPB1 PE=1 SV=2,3,9,1.112,0.178,0.516,0.594,0.15,-2.49,-0.95,-0.75,8.66E-01,7.12E-02,4.43E-01,8.41E-01,9.34E+05,2.52E+05,9.02E+04,2.11E+05,2,1,2,2,,,,1.34E+06,6.51E+05,,,,,2.52E+05,,1.48E+04,,5.49E+05,,,6.92E+04,,,6.41E+05,,,,1.34E+06,3.36E+04,,,,,2.68E+03,,6.62E+02,,7.40E+04,,,1.94E+04,,,6.82E+03,0,FALSE,13.585,10,3,395,42.5,4.86,3,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf12796,2553,A8IE52; hsa:2553; Q06545; Q06547; Q12940; Q12941; Q12942; Q8IYD0,ENSG00000104064,,Myometrial relaxation and contraction pathways; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; Mitochondrial gene expression,3,0,49.02,,133.99,113.87,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,97.6,90.34,350.3,123.14,27.24,nucleic acid binding activity,0,
Master Protein,High,O75533,SF3B1,Splicing factor 3B subunit 1 OS=Homo sapiens OX=9606 GN=SF3B1 PE=1 SV=3,31,63,1.111,0.317,2.608,0.782,0.15,-1.66,1.38,-0.35,9.90E-01,2.50E-01,2.68E-01,8.88E-01,5.83E+06,1.21E+06,3.99E+06,1.62E+06,5,4,5,5,8.00E+06,4.47E+06,2.71E+06,1.36E+07,5.83E+06,,1.56E+06,8.79E+05,9.33E+05,2.05E+06,2.63E+07,1.27E+06,3.99E+06,6.22E+06,8.29E+05,1.44E+06,7.36E+05,4.86E+06,1.62E+06,6.89E+06,3.18E+04,1.70E+04,2.65E+04,1.36E+07,3.01E+05,,2.77E+04,8.11E+03,2.63E+04,2.18E+04,1.57E+05,5.69E+04,3.24E+04,8.39E+05,2.06E+04,2.81E+03,2.07E+05,3.45E+04,3.79E+04,7.33E+04,0,FALSE,157.05,30,31,1304,145.7,7.09,31,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf08920,23451,E9PCH3; hsa:23451; O75533,ENSG00000115524,B-WICH complex positively regulates rRNA expression; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing; 10q11.21q11.23 copy number variation syndrome,5,0,60.64,41.15,137.29,85.06,High,Peak Found,High,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,1,,FALSE,106.3,125.99,129.39,129.54,194.42,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8N3U4,STAG2,Cohesin subunit SA-2 OS=Homo sapiens OX=9606 GN=STAG2 PE=1 SV=3,15,51,1.108,0.658,0.364,2.091,0.15,-0.6,-1.46,1.06,9.92E-01,9.51E-01,1.52E-01,4.02E-01,3.28E+06,3.01E+06,1.13E+06,1.06E+06,4,5,5,5,,3.74E+06,1.24E+06,2.87E+06,9.29E+06,3.97E+06,2.32E+06,3.01E+06,4.51E+05,8.98E+06,1.90E+06,5.49E+05,7.30E+05,5.67E+06,1.13E+06,1.06E+06,1.64E+05,1.61E+06,3.45E+05,7.92E+06,,1.42E+04,1.21E+04,2.87E+06,4.79E+05,1.41E+04,4.12E+04,2.78E+04,1.27E+04,9.55E+04,1.14E+04,2.45E+04,5.93E+03,7.64E+05,2.81E+04,2.07E+03,4.62E+04,1.14E+04,8.08E+03,8.43E+04,0,FALSE,57.931,18,13,1231,141.2,5.43,15,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf08514, Pf21581",10735,B1AMT5; D3DTF5; hsa:10735; O00540; Q5JTI6; Q68DE9; Q8N3U4; Q9H1N8,ENSG00000101972,Meiotic synapsis; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,Cell cycle; Cohesin complex - Cornelia de Lange syndrome,9,1,81.52,85.37,106.13,145.81,n/a,High,High,High,High,High,High,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,High,Peak Found,High,1,,FALSE,132.04,116.58,137.98,131.41,132.81,other molecular function,0,
Master Protein,High,Q9NW13,RBM28,RNA-binding protein 28 OS=Homo sapiens OX=9606 GN=RBM28 PE=1 SV=3,1,1,1.107,0.369,3.4,0.12,0.15,-1.44,1.77,-3.06,8.74E-01,4.68E-01,2.96E-01,5.71E-02,1.57E+05,1.42E+05,5.80E+04,4.83E+05,1,1,2,2,,,,1.57E+05,,,,,,1.42E+05,,6.27E+04,,5.37E+04,,,,2.59E+05,,8.99E+05,,,,1.57E+05,,,,,,1.51E+03,,2.80E+03,,7.23E+03,,,,1.84E+03,,9.57E+03,0,FALSE,5.261,3,1,759,85.7,9.22,1,RNA metabolism OR transcription;other metabolic processes,nucleus,Pf00076,55131,A4D100; B4DU52; E9PDD9; hsa:55131; Q53H65; Q96CV3; Q9NW13,ENSG00000106344,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,,,10.89,78.16,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,0,11.45,98.32,91.02,3.62,,0,
Master Protein,High,Q9NUB1,ACSS1,"Acetyl-coenzyme A synthetase 2-like, mitochondrial OS=Homo sapiens OX=9606 GN=ACSS1 PE=1 SV=2",13,40,1.104,0.842,0.809,1.835,0.14,-0.25,-0.31,0.88,9.17E-01,7.72E-01,6.95E-01,5.39E-01,6.79E+05,2.32E+06,4.49E+06,1.37E+06,5,5,5,5,4.16E+05,6.79E+05,2.51E+05,1.47E+07,2.20E+06,2.32E+06,4.28E+06,4.38E+05,1.31E+05,7.92E+06,9.03E+05,4.49E+06,2.75E+06,8.05E+06,8.00E+06,3.12E+06,1.24E+06,1.37E+06,1.12E+06,2.02E+07,1.65E+03,2.58E+03,2.45E+03,1.47E+07,1.13E+05,8.26E+03,7.61E+04,4.04E+03,3.69E+03,8.42E+04,5.40E+03,2.00E+05,2.23E+04,1.08E+06,1.99E+05,6.07E+03,3.50E+05,9.72E+03,2.62E+04,2.15E+05,0,FALSE,49.275,24,13,689,74.8,7.11,13,other metabolic processes,mitochondrion,"Pf00501, Pf13193, Pf16177",84532,B3KXL2; B4DJZ3; D3DW48; F5H6F4; F8W7Y1; hsa:84532; Q5TF42; Q8IV99; Q8N234; Q96JI1; Q96JX6; Q9NU28; Q9NUB1,ENSG00000154930,Ethanol oxidation,Sterol regulatory element-binding proteins (SREBP) signaling; Amino acid metabolism; Statin inhibition of cholesterol production; Familial hyperlipidemia type 4,5,0,170.61,106.19,65.6,153.56,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,136.44,127.05,116.15,130.35,94.22,other molecular function,0,
Master Protein,High,J3KTL2,SRSF1,Serine/arginine-rich splicing factor 1 OS=Homo sapiens OX=9606 GN=SRSF1 PE=1 SV=1,12,40,1.104,0.166,0.938,0.673,0.14,-2.59,-0.09,-0.57,9.96E-01,3.49E-02,8.65E-01,7.78E-01,4.98E+06,1.72E+06,3.24E+06,1.29E+06,5,5,5,5,1.72E+06,6.87E+06,5.91E+05,3.40E+07,4.98E+06,1.72E+06,9.06E+05,3.85E+06,3.48E+06,1.57E+06,3.51E+05,3.24E+06,5.65E+06,5.49E+06,1.05E+06,1.74E+06,7.80E+04,3.56E+06,1.29E+06,3.64E+05,6.83E+03,2.61E+04,5.78E+03,3.40E+07,2.57E+05,6.13E+03,1.61E+04,3.55E+04,9.81E+04,1.67E+04,2.10E+03,1.45E+05,4.59E+04,7.39E+05,2.61E+04,3.39E+03,2.19E+04,2.53E+04,3.03E+04,3.87E+03,0,FALSE,48.838,50,12,253,28.3,10.08,12,,nucleus,Pf00076,,J3KTL2,ENSG00000136450,,,0,0,143.76,55.76,77.57,98.1,High,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,1,,FALSE,125.01,99.64,110.87,87.02,103.67,nucleic acid binding activity,0,
Master Protein,High,H3BNC9,,40S ribosomal protein S17 OS=Homo sapiens OX=9606 PE=3 SV=2,5,15,1.102,1.597,1.355,1.299,0.14,0.68,0.44,0.38,8.41E-01,2.32E-01,9.02E-01,6.69E-01,5.29E+05,3.38E+05,5.85E+05,4.27E+05,4,3,5,5,,9.37E+05,6.23E+04,5.95E+06,2.99E+05,4.68E+05,,3.33E+05,,3.38E+05,2.89E+05,1.06E+06,3.14E+05,3.71E+06,5.85E+05,4.76E+05,6.46E+06,2.82E+05,6.22E+04,4.27E+05,,3.56E+03,6.09E+02,5.95E+06,1.54E+04,1.66E+03,,3.07E+03,,3.59E+03,1.73E+03,4.73E+04,2.55E+03,5.00E+05,1.45E+04,9.27E+02,1.82E+06,2.00E+03,1.46E+03,4.55E+03,0,FALSE,21.498,11,5,584,64.5,8.78,5,protein metabolism;other metabolic processes;other biological processes,translational apparatus;other cell component,"Pf00833, Pf16366, Pf16367, Pf16368",,,,,,0,0,153.59,20.25,121.06,178.71,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,130.36,137.93,105.11,128.7,47.66,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15418,RPS6KA1,Ribosomal protein S6 kinase alpha-1 OS=Homo sapiens OX=9606 GN=RPS6KA1 PE=1 SV=2,3,4,1.101,1.313,1.251,1.155,0.14,0.39,0.32,0.21,9.20E-01,5.14E-01,9.06E-01,7.36E-01,4.11E+04,3.73E+04,5.39E+04,4.67E+04,1,5,4,1,,,,4.11E+04,,7.14E+04,3.73E+04,5.88E+04,1.80E+04,2.18E+04,5.87E+04,3.91E+04,,1.10E+05,4.95E+04,,,,4.67E+04,,,,,4.11E+04,,2.54E+02,6.63E+02,5.42E+02,5.07E+02,2.32E+02,3.51E+02,1.74E+03,,1.48E+04,1.23E+03,,,,1.09E+03,,0,FALSE,7.629,7,3,735,82.7,7.83,3,cell-cell signaling;cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00069, Pf00433",6195,A6NGG4; A8K9K7; B2RDY8; B7Z5J0; E9PRI4; hsa:6195; Q15418; Q5SVM5; Q5SVM8; Q5SVM9; Q96C05; Q9BQK2,ENSG00000117676; ENSG00000281877,Recycling pathway of L1; Senescence-Associated Secretory Phenotype (SASP); RSK activation; ERK/MAPK targets; CREB phosphorylation; Gastrin-CREB signalling pathway via PKC and MAPK,IL-5 signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Kit receptor signaling pathway; BDNF-TrkB signaling; Angiopoietin-like protein 8 regulatory pathway; TYROBP causal network in microglia; Thermogenesis; EGF/EGFR signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Cytoplasmic ribosomal proteins; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; Pleural mesothelioma; Hippocampal synaptogenesis and neurogenesis; Macrophage-stimulating protein (MSP) signaling network map,26,0,,55.93,49.08,,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,70.79,27.08,70.79,27.08,5.34,enzyme regulator activity;kinase activity;other molecular function,0,
Master Protein,High,A0A7P0T9C4,DYNC1H1,Dynein cytoplasmic 1 heavy chain 1 OS=Homo sapiens OX=9606 GN=DYNC1H1 PE=1 SV=1,18,28,1.097,0.572,0.423,0.442,0.13,-0.81,-1.24,-1.18,9.16E-01,8.60E-01,3.59E-01,5.54E-01,1.21E+06,1.42E+06,2.94E+05,3.83E+05,5,4,4,4,1.22E+06,8.73E+05,5.27E+05,1.21E+06,2.60E+06,2.40E+06,,2.99E+06,2.00E+05,8.37E+05,4.15E+05,7.22E+04,,8.03E+05,2.09E+05,5.05E+05,5.37E+05,,2.90E+05,1.26E+05,4.83E+03,3.32E+03,5.14E+03,1.21E+06,1.34E+05,8.53E+03,,2.76E+04,5.65E+03,8.90E+03,2.48E+03,3.22E+03,,1.08E+05,5.19E+03,9.85E+02,1.51E+05,,6.80E+03,1.34E+03,0,FALSE,69.012,6,18,4672,534.7,6.51,18,other biological processes,cytoskeleton;other cell component,"Pf03028, Pf08385, Pf08393, Pf12774, Pf12775, Pf12777, Pf12780, Pf12781, Pf17852, Pf18198, Pf18199",,A0A7P0T9C4,ENSG00000197102,,Ciliary landscape; Intraflagellar transport proteins binding to dynein; Vasopressin-regulated water reabsorption; PAFAH1B1 copy number variation,4,0,61.35,81.29,84.94,53.01,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,100.85,95.04,132.09,85.47,86.64,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A0C4DFX9,NELFA,Negative elongation factor complex member A OS=Homo sapiens OX=9606 GN=NELFA PE=1 SV=1,2,4,1.094,0.29,0.74,,0.13,-1.78,-0.43,,8.11E-01,2.77E-01,7.03E-01,,4.70E+05,2.37E+05,6.13E+04,1.75E+05,1,1,3,2,,,,4.70E+05,,,2.37E+05,,,,,6.03E+04,,1.47E+05,6.13E+04,1.02E+06,3.01E+04,,,,,,,4.70E+05,,,4.21E+03,,,,,2.69E+03,,1.98E+04,1.52E+03,1.99E+03,8.45E+03,,,,0,FALSE,7.516,6,2,539,58.5,9.26,2,,cytosol;nucleus,,7469,A0A0C4DFX9; hsa:7469,ENSG00000185049,,Initiation of transcription and translation elongation at the HIV-1 LTR; 4p16.3 copy number variation,2,0,,,55.71,133.34,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,0,2.39,419.43,,13.27,,0,
Master Protein,High,Q9NY12,GAR1,H/ACA ribonucleoprotein complex subunit 1 OS=Homo sapiens OX=9606 GN=GAR1 PE=1 SV=1,4,12,1.094,0.29,0.337,1.435,0.13,-1.78,-1.57,0.52,9.23E-01,2.01E-01,2.34E-01,6.09E-01,1.47E+06,1.74E+06,6.56E+05,3.78E+05,4,2,5,4,6.61E+04,7.83E+05,,3.48E+06,2.75E+06,1.44E+06,,,,2.10E+06,8.09E+04,6.13E+05,6.56E+05,2.62E+06,6.68E+05,1.71E+06,2.35E+05,,6.08E+05,4.81E+04,2.63E+02,2.97E+03,,3.48E+06,1.42E+05,5.13E+03,,,,2.23E+04,4.84E+02,2.74E+04,5.33E+03,3.53E+05,1.66E+04,3.34E+03,6.62E+04,,1.42E+04,5.12E+02,0,FALSE,20.478,24,4,217,22.3,10.92,4,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes,nucleus,Pf04410,54433,hsa:54433; Q5MJQ2; Q9NY12,ENSG00000109534,rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase,,2,0,90.93,26.13,105.41,114.37,Peak Found,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,31.68,83.73,88.66,116.81,37.52,nucleic acid binding activity,0,
Master Protein,High,Q15084,PDIA6,Protein disulfide-isomerase A6 OS=Homo sapiens OX=9606 GN=PDIA6 PE=1 SV=1,15,211,1.093,1.314,0.942,2.667,0.13,0.39,-0.09,1.42,9.96E-01,3.44E-01,8.36E-01,3.44E-01,1.66E+07,9.29E+06,4.01E+07,1.59E+07,5,5,5,5,2.26E+07,1.08E+07,7.81E+06,4.56E+07,1.66E+07,5.78E+06,9.29E+06,9.56E+06,1.09E+07,3.60E+06,8.27E+06,3.78E+07,4.55E+07,4.87E+07,4.01E+07,5.20E+06,2.22E+07,1.95E+06,1.59E+07,2.67E+07,8.97E+04,4.12E+04,7.64E+04,4.56E+07,8.55E+05,2.06E+04,1.65E+05,8.82E+04,3.07E+05,3.83E+04,4.94E+04,1.69E+06,3.70E+05,6.56E+06,9.96E+05,1.01E+04,6.23E+06,1.38E+04,3.73E+05,2.84E+05,0,FALSE,109.618,42,15,440,48.1,5.08,15,protein metabolism;other metabolic processes;stress response,non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,Pf00085,10130,B3KY95; B5MCQ5; B7Z254; B7Z4M8; F8WA83; hsa:10130; Q15084; Q53RC7; Q6ZSH5; Q99778,ENSG00000143870,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; XBP1(S) activates chaperone genes,Photodynamic therapy-induced unfolded protein response; VEGFA-VEGFR2 signaling,5,0,72.62,38.66,44.7,73.99,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,139.57,124.72,138.42,119.9,638.77,other molecular function,0,
Master Protein,High,Q8IZQ5,SELENOH,Selenoprotein H OS=Homo sapiens OX=9606 GN=SELENOH PE=1 SV=2,3,9,1.089,1.037,0.468,4.34,0.12,0.05,-1.09,2.12,8.82E-01,5.91E-01,4.40E-01,1.02E-01,1.41E+05,1.76E+05,4.46E+05,8.26E+04,5,2,5,2,1.41E+05,1.92E+05,8.49E+04,2.47E+06,6.37E+04,2.22E+05,,1.40E+05,,,4.14E+05,1.44E+06,3.17E+05,4.46E+05,7.46E+05,5.17E+05,1.32E+04,,,,5.59E+02,7.29E+02,8.30E+02,2.47E+06,3.28E+03,7.90E+02,,1.29E+03,,,2.48E+03,6.44E+04,2.57E+03,6.01E+04,1.85E+04,1.01E+03,3.71E+03,,,,0,FALSE,12.693,25,3,122,13.4,9.74,3,,ER/Golgi,Pf10262,280636,hsa:280636; Q8IZQ5; Q8N672,ENSG00000211450,,Selenium micronutrient network; Selenium metabolism and selenoproteins,2,0,178.24,32.15,68.17,134.39,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,80.89,111.5,358.98,251.32,24.32,,0,
Master Protein,High,O75475,PSIP1,PC4 and SFRS1-interacting protein OS=Homo sapiens OX=9606 GN=PSIP1 PE=1 SV=1,12,29,1.086,0.652,0.513,0.785,0.12,-0.62,-0.96,-0.35,9.90E-01,9.31E-01,3.91E-01,8.98E-01,3.46E+06,1.13E+06,2.52E+06,1.42E+06,5,5,5,5,2.51E+06,3.46E+06,3.32E+06,7.59E+06,9.78E+06,1.13E+06,4.83E+05,4.95E+05,1.67E+06,9.89E+06,1.42E+07,2.52E+06,1.97E+06,2.31E+06,4.65E+06,1.76E+06,3.47E+05,2.34E+06,1.32E+06,1.42E+06,9.96E+03,1.31E+04,3.25E+04,7.59E+06,5.04E+05,4.02E+03,8.59E+03,4.57E+03,4.70E+04,1.05E+05,8.50E+04,1.12E+05,1.60E+04,3.11E+05,1.16E+05,3.43E+03,9.75E+04,1.66E+04,3.08E+04,1.52E+04,0,FALSE,55.751,27,11,530,60.1,9.13,12,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,"Pf00855, Pf11467",11168,D3DRI9; hsa:11168; O00256; O75475; O95368; Q6P391; Q86YB9; Q9NZI3; Q9UER6,ENSG00000164985,Vpr-mediated nuclear import of PICs; Formation of WDR5-containing histone-modifying complexes; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection,MECP2 and associated Rett syndrome,8,1,59.58,147.46,101.08,50.6,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,110.67,121.18,134.43,142.27,76.96,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P30038,ALDH4A1,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH4A1 PE=1 SV=3",6,25,1.086,1.938,0.502,1.897,0.12,0.95,-0.99,0.92,8.85E-01,9.29E-02,3.78E-01,4.47E-01,9.40E+05,1.69E+05,1.90E+06,3.87E+05,5,3,5,4,4.41E+06,9.40E+05,1.65E+06,9.21E+05,4.90E+05,6.93E+05,,,6.08E+04,1.69E+05,6.88E+05,2.75E+06,1.90E+06,1.78E+06,3.82E+06,,5.03E+05,2.36E+05,5.13E+05,2.98E+05,1.75E+04,3.57E+03,1.61E+04,9.21E+05,2.53E+04,2.46E+03,,,1.71E+03,1.79E+03,4.11E+03,1.23E+05,1.54E+04,2.40E+05,9.48E+04,,1.41E+05,1.67E+03,1.20E+04,3.17E+03,0,FALSE,24.529,13,6,563,61.7,8.07,6,other metabolic processes,cytosol;mitochondrion,Pf00171,8659,A8K1Q7; B4DGE4; D2D4A3; hsa:8659; P30038; Q16882; Q53HU4; Q5JNV6; Q8IZ38; Q96IF0; Q9UDI6,ENSG00000159423,Glyoxylate metabolism and glycine degradation; Proline catabolism,22q11.2 copy number variation syndrome; p53 transcriptional gene network,4,0,94.03,109.97,53.44,36.52,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,110.41,98.39,106.07,70.32,67.78,other molecular function,0,
Master Protein,High,Q14141,SEPTIN6,Septin-6 OS=Homo sapiens OX=9606 GN=SEPTIN6 PE=1 SV=4,5,10,1.084,0.534,,3.421,0.12,-0.91,,1.77,8.59E-01,7.94E-01,,1.84E-01,7.09E+05,1.10E+05,5.93E+05,6.05E+04,2,1,4,2,,,,1.22E+06,4.13E+05,,1.10E+05,,,,,5.27E+05,8.54E+04,2.03E+06,6.66E+05,,6.06E+04,,6.03E+04,,,,,1.22E+06,2.13E+04,,1.96E+03,,,,,2.35E+04,6.94E+02,2.73E+05,1.66E+04,,1.70E+04,,1.41E+03,,0,FALSE,18.277,16,5,434,49.7,6.67,5,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component,Pf00735,23157,hsa:23157; Q14141; Q5JTK0; Q969W5; Q96A13; Q96GR1; Q96P86; Q96P87,ENSG00000125354,,2q37 copy number variation syndrome,1,0,69.76,,101.34,0.32,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,82.49,,107.04,33.16,other molecular function,0,
Master Protein,High,Q09028,RBBP4,Histone-binding protein RBBP4 OS=Homo sapiens OX=9606 GN=RBBP4 PE=1 SV=3,16,143,1.082,0.499,0.472,1.527,0.11,-1,-1.08,0.61,9.86E-01,6.29E-01,2.76E-01,6.51E-01,8.86E+06,4.04E+06,1.22E+07,5.90E+06,5,5,5,5,2.01E+06,8.86E+06,1.13E+06,5.13E+07,5.74E+07,4.04E+06,7.18E+05,1.58E+07,6.80E+05,5.27E+07,1.22E+07,8.27E+06,1.11E+07,4.18E+07,2.37E+07,5.90E+06,1.97E+06,3.14E+06,8.53E+06,1.05E+07,7.99E+03,3.37E+04,1.10E+04,5.13E+07,2.96E+06,1.44E+04,1.28E+04,1.46E+05,1.92E+04,5.61E+05,7.32E+04,3.69E+05,9.06E+04,5.64E+06,5.88E+05,1.15E+04,5.54E+05,2.22E+04,2.00E+05,1.12E+05,0,FALSE,111.218,61,7,425,47.6,4.89,16,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00400, Pf12265",5928,B2R6G9; B4DRH0; D3DPQ3; hsa:5928; P31149; Q09028; Q53H02; Q96BV9,ENSG00000162521,Potential therapeutics for SARS; HCMV Early Events; Deposition of new CENPA-containing nucleosomes at the centromere; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6; HDACs deacetylate histones; Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; RNA Polymerase I Transcription Initiation; PRC2 methylates histones and DNA; Defective pyroptosis; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; G1/S-Specific Transcription; Regulation of TP53 Activity through Acetylation; Polo-like kinase mediated events; Cyclin E associated events during G1/S transition ; Transcription of E2F targets under negative control by DREAM complex; Cyclin A:Cdk2-associated events at S phase entry; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,Retinoblastoma gene in cancer; Interactome of polycomb repressive complex 2 (PRC2) ; Tumor suppressor activity of SMARCB1; Epithelial to mesenchymal transition in colorectal cancer; Effect of progerin on genes involved in progeria; Pleural mesothelioma; DYRK1A involvement regarding cell proliferation in brain development,28,9,115.25,149.37,71.19,59.64,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,n/a,High,n/a,Peak Found,High,1,,FALSE,138.93,121.86,134.28,139.81,403.81,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q92878,RAD50,DNA repair protein RAD50 OS=Homo sapiens OX=9606 GN=RAD50 PE=1 SV=1,13,26,1.081,0.603,12.899,0.422,0.11,-0.73,3.69,-1.24,8.87E-01,9.04E-01,2.11E-03,4.78E-01,1.12E+06,1.67E+05,1.62E+06,2.31E+06,5,4,5,5,1.12E+06,1.37E+06,2.81E+04,2.38E+06,9.35E+05,4.55E+05,1.50E+04,7.79E+04,,3.57E+05,2.02E+06,3.26E+05,2.10E+06,1.62E+06,1.56E+06,2.31E+06,1.28E+06,3.55E+06,1.77E+06,3.21E+06,4.43E+03,5.20E+03,2.75E+02,2.38E+06,4.82E+04,1.62E+03,2.66E+02,7.19E+02,,3.80E+03,1.21E+04,1.45E+04,1.71E+04,2.18E+05,3.89E+04,4.50E+03,3.59E+05,2.52E+04,4.14E+04,3.41E+04,0,FALSE,45.152,12,13,1312,153.8,6.89,13,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,"Pf04423, Pf13476, Pf13558",10111,B9EGF5; hsa:10111; O43254; Q6GMT7; Q6P5X3; Q92878; Q9UP86,ENSG00000113522,Resolution of D-loop Structures through Holliday Junction Intermediates; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Regulation of TP53 Activity through Phosphorylation; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA); Defective homologous recombination repair (HRR) due to BRCA1 loss of function; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function; Impaired BRCA2 binding to PALB2; Meiotic recombination; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; DNA Damage/Telomere Stress Induced Senescence; Nonhomologous End-Joining (NHEJ); HDR through MMEJ (alt-NHEJ); Sensing of DNA Double Strand Breaks,"miRNA regulation of DNA damage response; Homologous recombination; DDX1 as a regulatory component of the Drosha microprocessor; ATM signaling in development and disease ; Breast cancer pathway; Joubert syndrome; DNA repair pathways, full network; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; DNA damage response",29,0,72.67,94.16,46.66,39.37,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,126.47,97.35,146.08,135.52,78.86,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A3B3IT92,MCM4,DNA replication licensing factor MCM4 OS=Homo sapiens OX=9606 GN=MCM4 PE=1 SV=1,15,43,1.079,0.24,1.435,0.152,0.11,-2.06,0.52,-2.72,9.84E-01,1.18E-01,6.99E-01,1.39E-01,7.25E+06,7.75E+05,1.07E+06,9.94E+05,5,5,5,5,8.60E+07,8.74E+06,7.25E+06,3.15E+06,1.54E+06,1.54E+06,3.10E+05,9.18E+05,3.62E+05,7.75E+05,5.15E+06,4.01E+05,6.77E+05,7.00E+06,1.07E+06,1.71E+06,1.41E+05,1.14E+07,9.94E+05,4.71E+05,3.42E+05,3.32E+04,7.08E+04,3.15E+06,7.93E+04,5.46E+03,5.51E+03,8.47E+03,1.02E+04,8.24E+03,3.08E+04,1.79E+04,5.50E+03,9.43E+05,2.66E+04,3.34E+03,3.97E+04,8.06E+04,2.33E+04,5.02E+03,0,FALSE,60.852,23,15,904,100.7,6.95,15,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes,nucleus;other cell component,"Pf00493, Pf14551, Pf17207, Pf17855, Pf21128",,A0A3B3IT92,ENSG00000104738,,Cell cycle; Ciliary landscape,2,0,169.99,63.67,105.47,161.75,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,1,,FALSE,116.16,133.5,134.63,122.71,116.93,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A994J749,IMPDH,Uncharacterized protein OS=Homo sapiens OX=9606 PE=4 SV=1,3,7,1.075,0.179,0.027,6.716,0.1,-2.48,-5.19,2.75,9.68E-01,4.23E-02,8.23E-05,6.43E-02,1.95E+06,1.80E+06,3.32E+05,4.95E+04,3,3,3,1,,1.95E+06,,6.64E+05,3.00E+06,5.42E+05,1.80E+06,1.81E+06,,,,3.32E+05,,4.24E+05,1.53E+05,,4.95E+04,,,,,7.40E+03,,6.64E+05,1.55E+05,1.93E+03,3.20E+04,1.67E+04,,,,1.48E+04,,5.72E+04,3.79E+03,,1.39E+04,,,,0,FALSE,9.611,4,3,1194,131.6,6.46,3,other metabolic processes,nucleus;other cell component,,,A0A994J749,ENSG00000290315,,,0,0,62.51,52.68,45.59,,n/a,Peak Found,n/a,High,High,Peak Found,High,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,81.83,90.33,0.61,7.39,20.73,other molecular function,0,
Master Protein,High,P83916,CBX1,Chromobox protein homolog 1 OS=Homo sapiens OX=9606 GN=CBX1 PE=1 SV=1,6,38,1.075,0.483,0.964,0.687,0.1,-1.05,-0.05,-0.54,8.89E-01,6.37E-01,8.23E-01,8.91E-01,1.52E+06,2.19E+05,3.98E+05,6.00E+05,4,4,4,4,1.44E+06,,6.69E+04,4.46E+06,1.59E+06,,8.31E+04,1.86E+06,1.02E+05,4.68E+05,,1.79E+05,6.06E+05,3.12E+06,2.61E+05,7.64E+05,,1.96E+06,2.56E+05,4.71E+05,5.74E+03,,6.54E+02,4.46E+06,8.22E+04,,1.48E+03,1.72E+04,2.89E+03,4.97E+03,,8.01E+03,4.92E+03,4.21E+05,6.48E+03,1.49E+03,,1.39E+04,5.99E+03,5.02E+03,0,FALSE,46.12,32,5,185,21.4,4.93,6,cell organization and biogenesis;stress response;other biological processes,cytoskeleton;nucleus;other cell component,"Pf00385, Pf01393",10951,hsa:10951; P23197; P83916,ENSG00000108468,HCMV Early Events,Effect of progerin on genes involved in progeria,2,0,97.63,133.7,134.28,88.12,Peak Found,n/a,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,132.19,87.85,121.87,125.27,142.06,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A5F9ZHL1,ACAT1,Acetyl-CoA acetyltransferase 1 OS=Homo sapiens OX=9606 GN=ACAT1 PE=1 SV=1,9,32,1.075,2.133,0.526,3.114,0.1,1.09,-0.93,1.64,8.28E-01,9.63E-02,3.98E-01,2.78E-01,2.85E+05,3.02E+05,4.70E+06,6.32E+05,4,3,5,4,2.09E+05,,9.00E+04,3.92E+06,3.90E+05,,3.53E+04,6.09E+05,,3.02E+05,9.60E+05,1.29E+07,3.31E+06,5.45E+06,4.70E+06,5.26E+05,1.06E+06,,7.60E+05,6.43E+04,8.30E+02,,8.79E+02,3.92E+06,2.01E+04,,6.27E+02,5.61E+03,,3.21E+03,5.74E+03,5.75E+05,2.69E+04,7.35E+05,1.17E+05,1.03E+03,2.97E+05,,1.78E+04,6.85E+02,0,FALSE,36.15,28,3,434,46.1,8.97,9,,mitochondrion,"Pf00108, Pf02803",,A0A5F9ZHL1,ENSG00000075239,,SARS-CoV-2 and COVID-19 pathway,1,6,160.46,90.98,82.1,69.61,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,High,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,69.26,101.52,110.53,76.53,85.59,other molecular function,0,
Master Protein,High,A0A5H1ZRQ2,DDX17,RNA helicase OS=Homo sapiens OX=9606 GN=DDX17 PE=1 SV=2,27,163,1.073,1.054,0.752,1.948,0.1,0.08,-0.41,0.96,9.79E-01,5.34E-01,6.21E-01,5.04E-01,9.77E+06,8.40E+06,3.12E+07,5.96E+06,5,5,5,5,9.77E+06,2.52E+06,6.79E+06,6.56E+07,2.35E+07,9.85E+06,5.50E+06,6.18E+06,1.17E+07,8.40E+06,3.12E+07,3.19E+07,1.23E+07,3.83E+07,1.87E+07,8.68E+06,5.33E+06,6.98E+06,2.21E+06,5.96E+06,3.88E+04,9.58E+03,6.64E+04,6.56E+07,1.21E+06,3.50E+04,9.78E+04,5.70E+04,3.28E+05,8.93E+04,1.87E+05,1.43E+06,9.98E+04,5.16E+06,4.66E+05,1.69E+04,1.50E+06,4.95E+04,5.18E+04,6.34E+04,0,FALSE,124.396,49,21,731,80.4,8.37,27,,nucleus,"Pf00270, Pf00271",10521,A0A5H1ZRQ2,ENSG00000100201,,Novel intracellular components of RIG-I-like receptor pathway,1,8,119.28,30.64,40.21,40.94,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,115.71,113.52,126.81,133.2,410.56,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8I5KX04,PCF11,PCF11 cleavage and polyadenylation factor subunit OS=Homo sapiens OX=9606 GN=PCF11 PE=1 SV=1,2,2,1.071,0.115,0.01,100,0.1,-3.12,-6.64,6.64,8.77E-01,2.74E-02,1.00E-17,1.00E-17,3.23E+05,2.95E+04,3.64E+03,,1,1,1,,,,,3.23E+05,,,,,,2.95E+04,,,,3.64E+03,,,,,,,,,,3.23E+05,,,,,,3.13E+02,,,,4.90E+02,,,,,,,0,FALSE,5.434,2,2,1686,187.9,8.66,2,RNA metabolism OR transcription;other metabolic processes,mitochondrion;nucleus,"Pf04818, Pf11526, Pf20827, Pf20844, Pf20845",51585,A0A8I5KX04,ENSG00000165494,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,0,,,2.41,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P27695,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease OS=Homo sapiens OX=9606 GN=APEX1 PE=1 SV=2,19,86,1.071,0.733,1.16,0.893,0.1,-0.45,0.21,-0.16,9.77E-01,9.32E-01,9.54E-01,9.81E-01,1.61E+07,1.00E+07,1.53E+07,8.99E+06,5,5,5,5,2.41E+07,1.57E+07,2.21E+06,1.61E+07,3.80E+07,8.22E+07,3.83E+06,1.00E+07,9.48E+05,1.19E+07,1.96E+07,5.14E+06,1.53E+07,2.30E+07,1.31E+07,1.48E+08,2.29E+06,8.99E+06,3.15E+06,2.76E+07,9.57E+04,5.96E+04,2.16E+04,1.61E+07,1.96E+06,2.92E+05,6.81E+04,9.26E+04,2.67E+04,1.27E+05,1.17E+05,2.30E+05,1.25E+05,3.10E+06,3.26E+05,2.89E+05,6.43E+05,6.37E+04,7.38E+04,2.94E+05,0,FALSE,107.123,59,19,318,35.5,8.12,19,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,cytoskeleton;mitochondrion;ER/Golgi;translational apparatus;nucleus;other cell component,Pf03372,328,hsa:328; P27695; Q969L5; Q99775,ENSG00000100823; ENSG00000291796,Displacement of DNA glycosylase by APEX1; POLB-Dependent Long Patch Base Excision Repair; PCNA-Dependent Long Patch Base Excision Repair; Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,"Thyroid stimulating hormone (TSH) signaling pathway; Spinal cord injury; Base excision repair; DNA repair pathways, full network",10,0,68.2,156.43,44.68,164.01,Peak Found,High,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,High,High,High,Peak Found,High,High,1,,FALSE,138.86,122.23,138.16,131.15,266.56,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NSE4,IARS2,"Isoleucine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=IARS2 PE=1 SV=2",11,23,1.071,0.643,,0.919,0.1,-0.64,,-0.12,8.72E-01,9.90E-01,,9.58E-01,9.53E+05,4.94E+05,2.33E+06,1.83E+06,4,5,5,5,1.76E+05,5.59E+05,,4.29E+06,1.62E+06,1.03E+06,8.73E+05,4.94E+05,2.46E+05,1.99E+05,8.82E+05,2.13E+06,3.67E+06,2.33E+06,2.66E+06,4.36E+05,2.16E+05,4.57E+06,1.83E+06,3.64E+06,6.99E+02,2.13E+03,,4.29E+06,8.37E+04,3.65E+03,1.55E+04,4.56E+03,6.93E+03,2.12E+03,5.27E+03,9.50E+04,2.98E+04,3.14E+05,6.61E+04,8.51E+02,6.07E+04,3.24E+04,4.27E+04,3.88E+04,0,FALSE,37.492,14,11,1012,113.7,7.2,11,protein metabolism;RNA metabolism OR transcription;other metabolic processes,mitochondrion,"Pf00133, Pf06827, Pf08264",55699,B2RPG8; hsa:55699; Q1M2P9; Q6PI85; Q7L439; Q86WU9; Q96D91; Q9H9Q8; Q9NSE4; Q9NW42,ENSG00000067704,Mitochondrial protein degradation; Mitochondrial tRNA aminoacylation,,2,0,111.66,65.22,43.1,90.15,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,47.56,72.88,,97.11,65.2,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O14787,TNPO2,Transportin-2 OS=Homo sapiens OX=9606 GN=TNPO2 PE=1 SV=3,2,3,1.071,0.063,0.099,0.681,0.1,-3.99,-3.34,-0.56,8.68E-01,3.37E-03,1.88E-02,8.97E-01,4.25E+05,3.97E+05,2.68E+04,3.93E+04,1,3,2,1,4.25E+05,,,,,,1.21E+06,3.97E+05,,1.17E+05,,,6.92E+04,,1.03E+04,,3.93E+04,,,,1.69E+03,,,,,,2.15E+04,3.66E+03,,1.24E+03,,,5.62E+02,,2.57E+02,,1.10E+04,,,,0,FALSE,6.338,3,1,897,101.3,5.01,2,transport,nucleus;other cell component,"Pf02985, Pf03810",30000,hsa:30000; O14655; O14787; Q6IN77,ENSG00000105576,,,0,0,,98.79,104.63,,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,99.62,163.06,104.55,163.06,5.49,other molecular function,0,
Master Protein,High,Q15029,EFTUD2,116 kDa U5 small nuclear ribonucleoprotein component OS=Homo sapiens OX=9606 GN=EFTUD2 PE=1 SV=1,17,36,1.069,0.585,0.257,0.86,0.1,-0.77,-1.96,-0.22,9.47E-01,8.58E-01,1.20E-01,9.93E-01,1.68E+06,6.80E+05,1.09E+06,1.48E+06,5,5,5,5,2.23E+06,1.08E+05,9.24E+05,1.06E+07,1.68E+06,1.21E+06,6.80E+05,7.28E+05,6.92E+04,3.49E+05,7.18E+06,1.09E+06,1.06E+06,4.60E+06,4.55E+05,1.48E+06,2.54E+05,2.19E+06,5.42E+05,2.02E+06,8.85E+03,4.09E+02,9.03E+03,1.06E+07,8.69E+04,4.29E+03,1.21E+04,6.71E+03,1.95E+03,3.71E+03,4.29E+04,4.85E+04,8.62E+03,6.21E+05,1.13E+04,2.89E+03,7.15E+04,1.55E+04,1.27E+04,2.15E+04,0,FALSE,73.704,27,17,972,109.4,5,17,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00009, Pf00679, Pf03144, Pf03764, Pf14492, Pf16004",9343,B4DK30; B4DMC0; D3DX58; hsa:9343; K7EJ81; Q15029; Q9BUR0,ENSG00000108883,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing; Ciliary landscape,4,0,137.06,70.63,101.12,66.88,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,119.31,123.43,76.68,106.53,117.3,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q9HD33,MRPL47,"39S ribosomal protein L47, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL47 PE=1 SV=2",1,2,1.069,1.676,0.586,3.277,0.1,0.75,-0.77,1.71,9.51E-01,3.61E-01,5.95E-01,2.08E-01,4.93E+04,4.61E+04,8.26E+04,2.70E+04,2,2,4,4,,5.12E+04,,4.74E+04,,,2.80E+04,7.59E+04,,,1.34E+05,1.58E+05,4.95E+04,5.10E+04,,9.92E+04,3.01E+03,5.12E+04,1.43E+04,,,1.95E+02,,4.74E+04,,,4.98E+02,7.01E+02,,,8.00E+02,7.07E+03,4.02E+02,6.87E+03,,1.93E+02,8.46E+02,3.63E+02,3.34E+02,,0.017,FALSE,2.028,6,1,250,29.4,10.37,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf06984,57129,hsa:57129; Q6XRG1; Q8N5D1; Q9HD33,ENSG00000136522,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,5.46,65.23,57.29,103.51,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,74.16,72.76,112.25,114.77,5.09,other molecular function,0,
Master Protein,High,P42126,ECI1,"Enoyl-CoA delta isomerase 1, mitochondrial OS=Homo sapiens OX=9606 GN=ECI1 PE=1 SV=1",3,21,1.065,0.484,0.815,0.816,0.09,-1.05,-0.3,-0.29,9.72E-01,5.98E-01,7.03E-01,9.17E-01,3.18E+06,1.45E+06,2.53E+06,2.48E+06,3,2,4,4,5.70E+05,,,9.18E+06,3.18E+06,7.35E+05,,,,2.85E+06,,1.41E+06,1.76E+06,5.34E+06,3.63E+06,,2.48E+06,5.05E+06,2.16E+06,2.47E+06,2.26E+03,,,9.18E+06,1.64E+05,2.61E+03,,,,3.03E+04,,6.30E+04,1.43E+04,7.19E+05,9.01E+04,,6.98E+05,3.58E+04,5.06E+04,2.63E+04,0,FALSE,18.545,17,3,302,32.8,8.54,3,other metabolic processes,mitochondrion,Pf00378,1632,A8K512; hsa:1632; P42126; Q13290; Q7Z2L6; Q7Z2L7; Q9BUB8; Q9BW05; Q9UDG6,ENSG00000167969,Mitochondrial protein degradation; mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,Fatty acid beta-oxidation; Mitochondrial long chain fatty acid beta-oxidation; Mitochondrial fatty acid oxidation disorders,5,0,102.39,83.37,59.9,44.28,Peak Found,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,High,n/a,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,80.34,86.24,96.2,59.55,62.49,other molecular function,0,
Master Protein,High,P25398,RPS12,40S ribosomal protein S12 OS=Homo sapiens OX=9606 GN=RPS12 PE=1 SV=3,5,20,1.064,0.653,1.952,0.407,0.09,-0.62,0.96,-1.3,9.71E-01,9.32E-01,4.70E-01,4.70E-01,3.91E+06,2.31E+06,2.19E+06,7.36E+06,3,5,4,4,,2.18E+06,,6.71E+06,3.91E+06,2.31E+06,3.00E+06,5.40E+06,1.58E+06,1.80E+06,,2.07E+06,2.31E+06,4.54E+06,1.77E+06,,9.53E+06,8.29E+06,1.90E+06,6.53E+06,,8.28E+03,,6.71E+06,2.02E+05,8.22E+03,5.33E+04,4.99E+04,4.47E+04,1.91E+04,,9.26E+04,1.88E+04,6.12E+05,4.40E+04,,2.68E+06,5.87E+04,4.45E+04,6.95E+04,0,FALSE,31.073,48,5,132,14.5,7.21,5,protein metabolism;other metabolic processes;other biological processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf01248,6206,hsa:6206; P25398; Q76M58,ENSG00000112306,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,53.57,54.79,47.32,50.9,n/a,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,83.52,76.44,94.65,101.2,69.35,other molecular function,0,
Master Protein,High,Q9Y224,RTRAF,"RNA transcription, translation and transport factor protein OS=Homo sapiens OX=9606 GN=RTRAF PE=1 SV=1",4,10,1.061,1.664,0.528,1.253,0.09,0.73,-0.92,0.33,9.15E-01,3.60E-01,5.19E-01,7.30E-01,1.24E+05,1.20E+05,5.90E+04,9.02E+04,4,2,5,4,1.16E+05,,1.33E+05,4.75E+05,7.93E+03,2.39E+05,,6.05E+04,,,9.80E+04,5.43E+03,3.05E+04,2.92E+05,5.90E+04,1.13E+05,1.67E+05,7.24E+04,2.34E+04,,4.61E+02,,1.30E+03,4.75E+05,4.09E+02,8.51E+02,,5.58E+02,,,5.86E+02,2.43E+02,2.48E+02,3.94E+04,1.47E+03,2.19E+02,4.68E+04,5.13E+02,5.47E+02,,0,FALSE,26.897,26,4,244,28.1,6.65,4,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf10036,51637,hsa:51637; Q9Y224,ENSG00000087302,tRNA processing in the nucleus,,1,0,110.57,84.35,117.88,64.78,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,100.17,127.8,70.21,112.37,34.25,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NYH9,UTP6,U3 small nucleolar RNA-associated protein 6 homolog OS=Homo sapiens OX=9606 GN=UTP6 PE=1 SV=2,1,5,1.059,0.741,0.539,1.344,0.08,-0.43,-0.89,0.43,9.22E-01,9.62E-01,5.24E-01,7.06E-01,1.29E+05,1.22E+05,9.57E+04,6.58E+04,2,1,3,3,,,,1.07E+05,1.56E+05,1.22E+05,,,,,,9.57E+04,3.45E+04,2.27E+05,,,2.57E+04,6.58E+04,,1.03E+06,,,,1.07E+05,8.02E+03,4.34E+02,,,,,,4.28E+03,2.80E+02,3.05E+04,,,7.22E+03,4.67E+02,,1.09E+04,0.003,FALSE,2.697,2,1,597,70.1,7.28,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf08640,55813,hsa:55813; Q8IX96; Q96BL2; Q9NQ91; Q9NYH9,ENSG00000108651,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,25.88,,82.51,152.04,n/a,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,27.6,84.58,138.76,137.98,14.39,nucleic acid binding activity,0,
Master Protein,High,Q99459,CDC5L,Cell division cycle 5-like protein OS=Homo sapiens OX=9606 GN=CDC5L PE=1 SV=2,10,22,1.058,0.563,1.186,2.095,0.08,-0.83,0.25,1.07,8.54E-01,8.02E-01,9.49E-01,4.00E-01,2.50E+05,3.07E+05,3.53E+05,7.99E+04,5,5,5,5,2.18E+05,2.50E+05,1.10E+05,4.87E+06,1.29E+06,7.67E+05,3.07E+05,2.49E+05,2.61E+04,4.14E+05,1.43E+05,6.92E+05,3.53E+05,1.50E+06,1.21E+05,7.99E+04,4.38E+04,5.78E+06,4.05E+04,1.24E+06,8.64E+02,9.51E+02,1.07E+03,4.87E+06,6.63E+04,2.73E+03,5.46E+03,2.30E+03,7.37E+02,4.40E+03,8.56E+02,3.09E+04,2.87E+03,2.02E+05,3.01E+03,1.56E+02,1.23E+04,4.09E+04,9.48E+02,1.31E+04,0,FALSE,44.698,24,10,802,92.2,8.18,10,cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,"Pf11831, Pf13921",988,hsa:988; Q76N46; Q99459; Q99974,ENSG00000096401,mRNA Splicing - Major Pathway,,1,0,150.5,76.99,101.75,172.82,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,123.73,131.26,122.01,139.18,72.2,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O14561,NDUFAB1,"Acyl carrier protein, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFAB1 PE=1 SV=3",3,13,1.058,0.864,2.155,0.333,0.08,-0.21,1.11,-1.59,9.66E-01,7.43E-01,3.96E-01,3.69E-01,2.86E+06,2.21E+06,2.24E+06,5.35E+06,3,2,5,5,,9.98E+06,,2.86E+06,9.41E+05,,3.61E+06,,,1.35E+06,1.51E+05,3.77E+05,2.36E+06,1.35E+07,2.24E+06,2.19E+06,5.35E+06,7.56E+06,4.99E+05,1.25E+07,,3.79E+04,,2.86E+06,4.85E+04,,6.42E+04,,,1.43E+04,9.00E+02,1.68E+04,1.92E+04,1.82E+06,5.56E+04,4.26E+03,1.50E+06,5.36E+04,1.17E+04,1.33E+05,0,FALSE,16.86,21,3,156,17.4,4.93,3,cell organization and biogenesis;protein metabolism;other metabolic processes,other membranes;cytosol;mitochondrion;nucleus,Pf00550,4706,B2R4M1; O14561; Q9UNV1,ENSG00000004779,Glyoxylate metabolism and glycine degradation; Mitochondrial Fatty Acid Beta-Oxidation; Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,7,0,103.65,64.5,149.09,84.11,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,106.7,102.68,123.66,133.05,42.84,translation activity;other molecular function,0,
Master Protein,High,Q99613,EIF3C,Eukaryotic translation initiation factor 3 subunit C OS=Homo sapiens OX=9606 GN=EIF3C PE=1 SV=1,10,22,1.057,0.241,0.845,0.161,0.08,-2.05,-0.24,-2.63,9.97E-01,1.57E-01,7.29E-01,1.43E-01,6.12E+05,3.50E+06,2.14E+05,1.94E+06,5,5,5,5,2.85E+05,2.25E+05,1.07E+06,6.12E+05,3.59E+08,9.43E+05,7.74E+04,3.50E+06,1.36E+07,5.85E+06,5.59E+04,7.21E+04,1.02E+06,2.35E+05,2.14E+05,2.47E+05,7.86E+06,3.00E+06,1.94E+06,1.38E+06,1.13E+03,8.55E+02,1.04E+04,6.12E+05,1.85E+07,3.35E+03,1.38E+03,3.23E+04,3.82E+05,6.22E+04,3.34E+02,3.22E+03,8.25E+03,3.16E+04,5.32E+03,4.82E+02,2.21E+06,2.13E+04,4.55E+04,1.47E+04,0,FALSE,42.832,14,10,913,105.3,5.68,10,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,"Pf01399, Pf05470",8663,A8K7Z0; B2RXG3; B4E1D5; H3BRV0; hsa:8663; O00215; Q99613; Q9BW98,ENSG00000184110,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,8,0,221.92,112.83,124.98,102.3,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,123.56,72.03,99.26,65.94,74.74,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96DZ1,ERLEC1,Endoplasmic reticulum lectin 1 OS=Homo sapiens OX=9606 GN=ERLEC1 PE=1 SV=1,2,3,1.057,0.351,2.056,0.032,0.08,-1.51,1.04,-4.95,9.03E-01,4.00E-01,5.46E-01,3.34E-03,1.76E+05,1.70E+05,1.61E+05,8.47E+05,4,3,4,4,1.09E+06,1.23E+05,,2.18E+05,1.42E+05,5.29E+06,,,4.24E+04,1.70E+05,6.03E+05,9.35E+04,,2.56E+05,1.02E+05,1.39E+07,,2.88E+06,6.85E+04,2.49E+05,4.34E+03,4.67E+02,,2.18E+05,7.32E+03,1.88E+04,,,1.20E+03,1.81E+03,3.60E+03,4.17E+03,,3.44E+04,2.53E+03,2.70E+04,,2.04E+04,1.60E+03,2.65E+03,0,FALSE,12.469,6,2,483,54.8,6.28,2,protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,ER/Golgi,Pf07915,27248,B2RDB4; B5MC72; hsa:27248; O95901; Q6UWN7; Q96DZ1; Q9NUY7; Q9UQL4,ENSG00000068912,ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis,,4,0,118.73,163.21,90.46,153.02,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,147.39,77.38,128.77,147.71,9.77,other molecular function,0,
Master Protein,High,P50395,GDI2,Rab GDP dissociation inhibitor beta OS=Homo sapiens OX=9606 GN=GDI2 PE=1 SV=2,8,20,1.057,0.737,1.767,1.181,0.08,-0.44,0.82,0.24,9.56E-01,9.25E-01,5.87E-01,7.75E-01,2.64E+06,2.06E+05,2.60E+06,1.47E+06,5,4,5,4,3.26E+06,4.18E+06,2.64E+06,2.07E+06,9.04E+05,4.46E+06,2.06E+04,,9.94E+04,4.28E+05,2.51E+06,7.00E+04,4.83E+06,3.75E+06,2.60E+06,3.48E+06,1.55E+06,,1.40E+06,1.15E+06,1.30E+04,1.59E+04,2.58E+04,2.07E+06,4.66E+04,1.58E+04,3.67E+02,,2.80E+03,4.55E+03,1.50E+04,3.13E+03,3.92E+04,5.05E+05,6.46E+04,6.78E+03,4.35E+05,,3.27E+04,1.23E+04,0,FALSE,34.805,25,8,445,50.6,6.47,8,transport;signal transduction;other biological processes,non-structural extracellular;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00996,2665,hsa:2665; O43928; P50395; Q5SX88; Q9UQM6,ENSG00000057608,RAB GEFs exchange GTP for GDP on RABs; Neutrophil degranulation,,2,0,47.28,171.39,64.43,56.38,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,101.92,84.63,132.8,82.74,63.56,enzyme regulator activity;other molecular function,0,
Master Protein,High,H7C1Z7,,protein-serine/threonine phosphatase (Fragment) OS=Homo sapiens OX=9606 GN=CTDSP1 PE=1 SV=1,2,4,1.057,1.252,5.793,0.352,0.08,0.32,2.53,-1.51,9.81E-01,5.45E-01,1.41E-01,5.12E-01,7.34E+04,5.34E+04,6.67E+04,1.90E+05,2,3,4,5,,,,7.97E+04,6.75E+04,,2.52E+04,5.34E+04,,6.66E+04,,1.15E+04,3.02E+04,1.73E+05,1.48E+05,4.68E+05,1.90E+05,1.15E+05,3.86E+05,5.90E+04,,,,7.97E+04,3.48E+03,,4.49E+02,4.92E+02,,7.08E+02,,5.13E+02,2.45E+02,2.33E+04,3.67E+03,9.12E+02,5.33E+04,8.14E+02,9.02E+03,6.28E+02,0,FALSE,7.887,10,2,262,29.2,5.99,2,,,,,,,,,0,0,11.67,43.6,90.01,72.35,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,123.61,89.82,88.43,125.57,12.36,,0,
Master Protein,High,Q9Y4D1,DAAM1,Disheveled-associated activator of morphogenesis 1 OS=Homo sapiens OX=9606 GN=DAAM1 PE=1 SV=2,1,1,1.056,0.16,1.177,0.144,0.08,-2.64,0.23,-2.8,9.49E-01,1.38E-01,9.59E-01,1.55E-01,7.98E+04,7.55E+04,1.28E+04,8.89E+04,2,1,1,3,,,,4.69E+04,1.36E+05,7.55E+04,,,,,,,,1.28E+04,,6.16E+05,8.89E+04,,1.65E+04,,,,,4.69E+04,7.00E+03,2.69E+02,,,,,,,,1.72E+03,,1.20E+03,2.50E+04,,3.87E+02,,0.009,FALSE,2.313,1,1,1078,123.4,7.23,1,cell-cell signaling;cell organization and biogenesis;signal transduction,plasma membrane;other membranes;cytosol;cytoskeleton,"Pf02181, Pf06367, Pf06371",23002,hsa:23002; Q86U34; Q8N1Z8; Q8TB39; Q9Y4D1,ENSG00000100592,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RHO GTPases Activate Formins; RHOB GTPase cycle; PCP/CE pathway,Physico-chemical features and toxicity-associated pathways; Wnt signaling,8,0,68.82,,,136.1,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,82.58,82.58,120.68,120.68,2.93,cytoskeletal activity;other molecular function,0,
Master Protein,High,B7ZM99,MTHFD1L,formate--tetrahydrofolate ligase OS=Homo sapiens OX=9606 GN=MTHFD1L PE=1 SV=1,1,1,1.056,2.839,0.01,100,0.08,1.51,-6.64,6.64,9.66E-01,1.47E-01,1.00E-17,1.00E-17,2.32E+04,2.20E+04,6.59E+04,,2,1,1,,,,,2.35E+04,2.30E+04,,,,2.20E+04,,,6.59E+04,,,,,,,,,,,,2.35E+04,1.18E+03,,,,6.19E+02,,,2.94E+03,,,,,,,,,0.005,FALSE,2.482,2,1,979,105.8,8.06,1,other metabolic processes,mitochondrion,"Pf00763, Pf01268, Pf02882",25902,B7ZM99,ENSG00000120254,,"One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways",2,0,1.48,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,1.55,1.55,,,2.89,other molecular function,0,
Master Protein,High,Q13029,PRDM2,PR domain zinc finger protein 2 OS=Homo sapiens OX=9606 GN=PRDM2 PE=1 SV=3,2,2,1.053,0.685,2.261,0.301,0.08,-0.55,1.18,-1.73,9.60E-01,9.86E-01,5.35E-01,4.26E-01,4.58E+04,5.06E+04,3.45E+04,1.14E+05,3,4,2,3,,,2.48E+04,4.58E+04,3.05E+05,,6.82E+04,1.52E+05,2.73E+04,3.76E+04,,,,5.15E+04,2.31E+04,,9.37E+03,1.14E+05,,4.70E+05,,,2.42E+02,4.58E+04,1.57E+04,,1.21E+03,1.40E+03,7.68E+02,4.00E+02,,,,6.94E+03,5.74E+02,,2.63E+03,8.11E+02,,5.00E+03,0,FALSE,6.022,2,2,1718,188.8,7.31,2,cell organization and biogenesis;other metabolic processes;other biological processes,ER/Golgi;nucleus,"Pf00096, Pf13912, Pf21549",7799,B1AJZ4; B5MC68; hsa:7799; Q13029; Q13149; Q14550; Q5THJ1; Q5VUL9,ENSG00000116731,,Histone modifications,1,0,124.64,79.18,53.86,121.94,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,101.36,78.63,129.47,135.13,6.86,nucleic acid binding activity;other molecular function,0,
Master Protein,High,J3KQ48,PTRH2,aminoacyl-tRNA hydrolase OS=Homo sapiens OX=9606 GN=PTRH2 PE=1 SV=1,1,2,1.051,0.01,0.519,0.01,0.07,-6.64,-0.95,-6.64,8.94E-01,1.00E-17,3.95E-01,1.00E-17,7.61E+05,8.02E+05,,4.17E+05,4,4,,1,2.20E+06,1.47E+06,,2.14E+04,3.94E+05,6.75E+05,5.41E+05,9.54E+05,9.69E+05,,,,,,,,4.17E+05,,,,8.75E+03,5.58E+03,,2.14E+04,2.03E+04,2.40E+03,9.62E+03,8.80E+03,2.73E+04,,,,,,,,1.17E+05,,,,0,FALSE,5.108,8,1,180,19.3,8.73,1,,other membranes;mitochondrion,Pf01981,51651,J3KQ48,ENSG00000141378,,Apoptosis modulation and signaling,1,0,97.67,26.94,,,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,144.44,,29.4,,3.42,other molecular function,0,
Master Protein,High,Q92610,ZNF592,Zinc finger protein 592 OS=Homo sapiens OX=9606 GN=ZNF592 PE=1 SV=2,3,7,1.051,1.583,1.7,1.273,0.07,0.66,0.77,0.35,9.66E-01,3.62E-01,7.03E-01,7.24E-01,5.87E+04,5.58E+04,1.69E+05,9.49E+04,3,2,3,1,,,5.87E+04,1.77E+05,3.38E+04,,,6.57E+04,4.75E+04,,,1.40E+05,,2.26E+05,1.69E+05,,,,9.49E+04,,,,5.73E+02,1.77E+05,1.74E+03,,,6.06E+02,1.34E+03,,,6.24E+03,,3.05E+04,4.19E+03,,,,2.22E+03,,0,FALSE,18.124,5,3,1267,137.4,7.84,3,other biological processes,nucleus,Pf16622,9640,hsa:9640; Q2M1T2; Q504Y9; Q92610,ENSG00000166716,,15q25 copy number variation,1,0,85.33,22.81,24.63,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,High,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,60.31,61.35,24.23,14.73,20.24,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O94776,MTA2,Metastasis-associated protein MTA2 OS=Homo sapiens OX=9606 GN=MTA2 PE=1 SV=1,11,41,1.049,0.679,1.423,1.189,0.07,-0.56,0.51,0.25,9.47E-01,9.86E-01,7.97E-01,7.59E-01,1.57E+06,1.04E+06,3.03E+06,4.99E+05,5,5,5,5,8.87E+05,1.57E+06,2.64E+05,5.49E+06,2.56E+06,1.75E+06,9.47E+05,1.04E+06,6.20E+04,1.72E+06,9.14E+05,3.03E+06,1.62E+06,3.58E+06,3.93E+06,1.68E+05,3.95E+05,5.71E+06,4.99E+05,4.73E+06,3.53E+03,5.96E+03,2.58E+03,5.49E+06,1.32E+05,6.22E+03,1.68E+04,9.62E+03,1.75E+03,1.83E+04,5.46E+03,1.35E+05,1.31E+04,4.82E+05,9.78E+04,3.28E+02,1.11E+05,4.05E+04,1.17E+04,5.03E+04,0,FALSE,36.502,21,10,668,75,9.66,11,cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00249, Pf00320, Pf01426, Pf01448, Pf17226",9219,hsa:9219; O94776; Q68DB1; Q9UQB5,ENSG00000149480,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,Effect of progerin on genes involved in progeria,7,1,95.17,62.56,49.59,116.95,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,125.43,121.71,146.54,130.73,95.84,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O43920,NDUFS5,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 OS=Homo sapiens OX=9606 GN=NDUFS5 PE=1 SV=3,2,6,1.049,1.383,0.463,2.095,0.07,0.47,-1.11,1.07,8.98E-01,2.53E-01,3.10E-01,3.83E-01,1.04E+06,3.77E+05,6.96E+05,3.77E+05,3,2,4,2,,2.08E+06,4.05E+05,1.04E+06,,1.00E+06,1.42E+05,,,,,1.48E+05,7.33E+05,1.85E+06,6.60E+05,,4.41E+05,3.22E+05,,,,7.90E+03,3.96E+03,1.04E+06,,3.57E+03,2.52E+03,,,,,6.59E+03,5.95E+03,2.49E+05,1.64E+04,,1.24E+05,2.28E+03,,,0,FALSE,8.658,25,2,106,12.5,9.14,2,cell organization and biogenesis;other metabolic processes;transport,other membranes;mitochondrion,Pf10200,4725,hsa:4725; O43920,ENSG00000168653,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,5,0,71.97,106.43,84.58,22.16,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,126.08,113.4,91.91,78.86,16.92,transporter activity,0,
Master Protein,High,A0A804HHR9,KMT2D,[histone H3]-lysine(4) N-methyltransferase OS=Homo sapiens OX=9606 GN=KMT2D PE=1 SV=1,5,5,1.048,0.353,2.709,0.142,0.07,-1.5,1.44,-2.82,9.64E-01,4.93E-01,4.30E-01,1.53E-01,8.17E+04,2.46E+04,3.22E+04,6.66E+04,2,1,3,1,,,,1.35E+05,4.93E+04,,2.46E+04,,,,,2.73E+04,,3.22E+04,3.74E+04,,,6.66E+04,,,,,,1.35E+05,2.54E+03,,4.37E+02,,,,,1.22E+03,,4.34E+03,9.30E+02,,,4.72E+02,,,0,FALSE,17.509,2,5,5553,594.9,5.59,5,cell organization and biogenesis;other metabolic processes,nucleus,"Pf00628, Pf00856, Pf05964, Pf05965, Pf13771, Pf13832",,A0A804HHR9,ENSG00000167548,,Histone modifications; 16p11.2 proximal deletion syndrome,2,0,65.87,,15.68,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,102.94,73.58,0,0,9.01,other molecular function,0,
Master Protein,High,Q9Y3I0,RTCB,RNA-splicing ligase RtcB homolog OS=Homo sapiens OX=9606 GN=RTCB PE=1 SV=1,7,12,1.048,0.867,5.201,0.189,0.07,-0.21,2.38,-2.4,9.09E-01,6.93E-01,4.86E-02,1.62E-01,4.67E+05,5.97E+05,1.06E+06,4.67E+06,5,5,5,5,3.10E+05,4.67E+05,7.14E+04,1.23E+06,3.46E+06,2.80E+06,5.97E+05,8.43E+05,1.91E+05,1.95E+05,2.70E+06,1.18E+06,3.21E+05,1.06E+06,3.97E+05,4.67E+06,1.23E+05,5.04E+06,4.50E+05,1.14E+07,1.23E+03,1.78E+03,6.98E+02,1.23E+06,1.78E+05,9.96E+03,1.06E+04,7.78E+03,5.39E+03,2.08E+03,1.62E+04,5.25E+04,2.61E+03,1.43E+05,9.86E+03,9.10E+03,3.44E+04,3.58E+04,1.05E+04,1.21E+05,0,FALSE,25.218,21,7,505,55.2,7.23,7,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cell component,Pf01139,51493,B2R6A8; hsa:51493; Q6IAI0; Q9BWL4; Q9NTH1; Q9P037; Q9P0J3; Q9Y3I0,ENSG00000100220,tRNA processing in the nucleus,Unfolded protein response,2,0,124.83,117.2,84.75,105.12,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,116.45,129.67,138.86,115.58,40.15,cytoskeletal activity;other molecular function,0,
Master Protein,High,P31040,SDHA,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial OS=Homo sapiens OX=9606 GN=SDHA PE=1 SV=2",19,94,1.048,0.732,0.652,1.863,0.07,-0.45,-0.62,0.9,9.58E-01,9.34E-01,4.99E-01,5.30E-01,1.21E+07,5.14E+06,6.37E+06,3.07E+06,5,5,5,5,1.77E+06,1.21E+07,1.20E+06,1.68E+07,3.50E+07,4.45E+06,1.18E+06,5.87E+06,5.14E+06,5.35E+07,6.37E+06,4.14E+06,3.12E+06,1.67E+07,1.01E+07,5.27E+06,3.07E+06,1.32E+06,2.56E+06,1.72E+07,7.04E+03,4.60E+04,1.18E+04,1.68E+07,1.80E+06,1.58E+04,2.10E+04,5.42E+04,1.45E+05,5.69E+05,3.81E+04,1.85E+05,2.53E+04,2.25E+06,2.51E+05,1.03E+04,8.63E+05,9.37E+03,5.99E+04,1.83E+05,0,FALSE,96.219,36,19,664,72.6,7.39,19,other metabolic processes;developmental processes,other membranes;mitochondrion;nucleus,"Pf00890, Pf02910",6389,A8K5J6; B4DJ60; E9PBJ5; hsa:6389; P31040; Q16395; Q59GW8; Q8IW48; Q9UMY5,ENSG00000073578,Respiratory electron transport; Citric acid cycle (TCA cycle),Electron transport chain: OXPHOS system in mitochondria; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Nonalcoholic fatty liver disease; Mitochondrial complex II assembly; Arsenic metabolism and reactive oxygen species generation; TCA cycle (aka Krebs or citric acid cycle),9,0,103.3,157.85,68.15,110.08,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,135.58,125.16,130.6,108.29,265.25,other molecular function,0,
Master Protein,High,P24666,ACP1,Low molecular weight phosphotyrosine protein phosphatase OS=Homo sapiens OX=9606 GN=ACP1 PE=1 SV=3,1,4,1.048,7.482,3.315,2.012,0.07,2.9,1.73,1.01,9.64E-01,3.87E-03,3.52E-01,4.13E-01,4.95E+04,4.77E+04,3.18E+05,1.58E+05,2,3,4,3,,,,1.86E+04,1.32E+05,,5.76E+04,4.77E+04,,3.87E+04,,3.20E+05,3.16E+05,5.35E+05,2.57E+05,,4.42E+05,7.12E+04,1.58E+05,,,,,1.86E+04,6.81E+03,,1.02E+03,4.40E+02,,4.12E+02,,1.43E+04,2.57E+03,7.21E+04,6.37E+03,,1.24E+05,5.05E+02,3.70E+03,,0.007,FALSE,2.37,6,1,158,18,6.74,1,,plasma membrane;other membranes;cytosol;other cell component,Pf01451,52,A8K1L9; B5MCC7; hsa:52; P24666; P24667; Q16035; Q16036; Q16725; Q3KQX8; Q53RU0,ENSG00000143727,,VEGFA-VEGFR2 signaling,1,0,106.59,19.64,34.2,86.69,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,139.47,117.77,81.52,98.2,8.62,other molecular function,0,
Master Protein,High,P05388,RPLP0,60S acidic ribosomal protein P0 OS=Homo sapiens OX=9606 GN=RPLP0 PE=1 SV=1,5,18,1.048,0.433,2.421,0.571,0.07,-1.21,1.28,-0.81,9.06E-01,5.48E-01,2.89E-01,6.78E-01,8.98E+05,5.01E+05,6.21E+05,3.36E+06,4,5,5,4,4.40E+05,,7.83E+05,3.77E+06,1.03E+06,6.92E+05,3.53E+05,3.72E+05,5.01E+05,5.85E+05,3.92E+05,9.46E+05,1.90E+05,2.21E+06,6.21E+05,,8.13E+05,4.99E+06,3.07E+06,3.67E+06,1.75E+03,,7.65E+03,3.77E+06,5.31E+04,2.46E+03,6.28E+03,3.43E+03,1.41E+04,6.22E+03,2.35E+03,4.23E+04,1.55E+03,2.98E+05,1.54E+04,,2.28E+05,3.53E+04,7.19E+04,3.91E+04,0,FALSE,20.93,21,5,317,34.3,5.97,5,cell organization and biogenesis;protein metabolism;other metabolic processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,"Pf00428, Pf00466, Pf17777",6175,hsa:6175; P05388; Q3B7A4; Q9BVK4,ENSG00000089157,Regulation of expression of SLITs and ROBOs; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,15,0,101.47,28.63,91.76,55.56,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,Peak Found,High,1,,FALSE,71.86,101.59,140.92,124.53,51.89,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96CM8,ACSF2,"Medium-chain acyl-CoA ligase ACSF2, mitochondrial OS=Homo sapiens OX=9606 GN=ACSF2 PE=1 SV=2",6,9,1.045,1.148,2.196,0.637,0.06,0.2,1.13,-0.65,8.61E-01,4.06E-01,5.21E-01,8.82E-01,1.82E+05,5.33E+05,1.27E+06,2.40E+05,5,4,5,5,8.96E+04,3.57E+05,5.55E+04,2.39E+06,1.82E+05,8.32E+04,1.28E+06,,3.96E+05,7.16E+05,6.44E+04,1.47E+06,7.57E+05,1.41E+06,1.27E+06,1.77E+05,2.40E+05,2.23E+06,1.13E+05,1.79E+06,3.56E+02,1.36E+03,5.43E+02,2.39E+06,9.39E+03,2.96E+02,2.27E+04,,1.12E+04,7.62E+03,3.85E+02,6.59E+04,6.15E+03,1.90E+05,3.15E+04,3.46E+02,6.74E+04,1.58E+04,2.65E+03,1.90E+04,0,FALSE,18.185,14,6,615,68.1,7.55,6,other metabolic processes,mitochondrion,"Pf00501, Pf13193",80221,B4DFQ6; B4DHT5; B4DUF5; hsa:80221; Q96CM8; Q9H7G2,ENSG00000167107,Mitochondrial Fatty Acid Beta-Oxidation,Mitochondrial long chain fatty acid beta-oxidation; Mitochondrial fatty acid oxidation disorders,3,0,162.51,82.48,59.44,111.74,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,107.6,122.2,73.86,130.73,28.74,other molecular function,0,
Master Protein,High,Q00325,SLC25A3,"Phosphate carrier protein, mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A3 PE=1 SV=2",11,50,1.043,2.327,1.751,1.439,0.06,1.22,0.81,0.52,9.53E-01,7.32E-02,5.59E-01,6.90E-01,8.24E+06,4.48E+06,1.64E+07,8.70E+06,5,5,5,5,5.02E+06,3.25E+07,2.31E+06,8.24E+06,1.46E+07,3.37E+06,1.60E+06,4.64E+06,4.48E+06,9.70E+06,4.49E+07,7.69E+06,1.46E+07,1.64E+07,2.50E+07,4.75E+07,4.46E+06,8.70E+06,1.66E+07,4.87E+06,1.99E+04,1.23E+05,2.25E+04,8.24E+06,7.53E+05,1.20E+04,2.85E+04,4.29E+04,1.26E+05,1.03E+05,2.68E+05,3.44E+05,1.19E+05,2.21E+06,6.22E+05,9.27E+04,1.25E+06,6.17E+04,3.89E+05,5.19E+04,0,FALSE,38.338,28,2,362,40.1,9.38,11,transport,plasma membrane;other membranes;mitochondrion,Pf00153,5250,B3KS34; hsa:5250; Q00325; Q7Z7N7; Q96A03,ENSG00000075415,,,0,8,96.27,63.38,66.06,109.81,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,112.01,126.62,92.57,110.17,100.61,transporter activity;other molecular function,0,
Master Protein,High,O96011,PEX11B,Peroxisomal membrane protein 11B OS=Homo sapiens OX=9606 GN=PEX11B PE=1 SV=1,2,2,1.04,1.132,4.383,0.151,0.06,0.18,2.13,-2.72,9.32E-01,5.40E-01,1.72E-01,1.13E-01,1.33E+05,1.37E+05,2.27E+05,5.64E+05,3,3,4,3,1.33E+05,,,1.28E+05,3.16E+05,,1.43E+05,,1.37E+05,1.23E+05,,4.96E+04,1.16E+05,5.74E+05,4.46E+05,,,5.14E+06,5.38E+05,5.64E+05,5.28E+02,,,1.28E+05,1.63E+04,,2.54E+03,,3.86E+03,1.31E+03,,2.22E+03,9.40E+02,7.74E+04,1.11E+04,,,3.64E+04,1.26E+04,6.01E+03,0,FALSE,4.702,17,2,259,28.4,9.85,2,cell organization and biogenesis;signal transduction,other membranes;cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,Pf05648,8799,B3KN85; B4DXH9; hsa:8799; O96011; Q96ET2,ENSG00000131779,Class I peroxisomal membrane protein import,TAR syndrome,2,0,55.79,7.74,85.58,127.28,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,15.61,99.83,15.52,114.95,6.49,other molecular function,0,
Master Protein,High,J3KTA4,DDX5,Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1,19,115,1.039,1.104,1.291,3.516,0.06,0.14,0.37,1.81,9.75E-01,4.90E-01,7.83E-01,2.33E-01,3.01E+06,1.37E+06,5.87E+06,1.06E+06,5,4,5,5,7.71E+06,6.95E+05,2.30E+06,1.06E+07,3.01E+06,3.22E+05,6.55E+06,,5.85E+06,2.36E+05,5.87E+06,7.49E+06,1.39E+06,5.88E+06,3.95E+06,1.70E+06,1.06E+05,9.39E+05,1.06E+06,3.77E+06,3.06E+04,2.64E+03,2.25E+04,1.06E+07,1.55E+05,1.15E+03,1.17E+05,,1.65E+05,2.51E+03,3.51E+04,3.35E+05,1.13E+04,7.92E+05,9.81E+04,3.31E+03,2.96E+04,6.65E+03,2.48E+04,4.01E+04,0,FALSE,73.955,39,13,614,69,8.85,19,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00270, Pf00271, Pf08061",1655,J3KTA4,ENSG00000108654,,Ciliary landscape,1,0,85.12,105.9,47.54,91.22,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,124.81,102.03,122.26,135.13,286.22,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P00742,F10,Coagulation factor X OS=Homo sapiens OX=9606 GN=F10 PE=1 SV=2,3,12,1.038,1.242,0.19,3.535,0.05,0.31,-2.39,1.82,8.67E-01,2.80E-01,5.43E-02,1.82E-01,2.46E+05,2.68E+05,1.72E+06,4.51E+05,5,4,5,2,2.46E+05,2.00E+05,1.98E+05,3.53E+06,2.65E+06,3.75E+05,6.71E+05,1.41E+05,1.91E+05,,4.95E+05,1.72E+06,1.94E+06,1.81E+06,6.34E+05,,4.89E+05,,4.16E+05,,9.78E+02,7.59E+02,1.93E+03,3.53E+06,1.36E+05,1.33E+03,1.19E+04,1.30E+03,5.40E+03,,2.96E+03,7.67E+04,1.58E+04,2.44E+05,1.58E+04,,1.37E+05,,9.73E+03,,0,FALSE,9.512,8,3,488,54.7,5.94,3,protein metabolism;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi,"Pf00008, Pf00089, Pf00594, Pf14670",2159,hsa:2159; P00742; Q14340,ENSG00000126218,Intrinsic Pathway of Fibrin Clot Formation; Common Pathway of Fibrin Clot Formation; Defective factor IX causes thrombophilia; Defective cofactor function of FVIIIa variant; Defective F9 variant does not activate FX; Gamma-carboxylation of protein precursors; Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus; Removal of aminoterminal propeptides from gamma-carboxylated proteins; Extrinsic Pathway of Fibrin Clot Formation,Blood clotting cascade; Complement system; Dengue-2 interactions with complement and coagulation cascades; Complement and coagulation cascades,13,0,117.63,69.59,52.7,11.38,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,84.73,116.87,137.28,58.24,31.41,other molecular function,0,
Master Protein,High,P54819,AK2,"Adenylate kinase 2, mitochondrial OS=Homo sapiens OX=9606 GN=AK2 PE=1 SV=2",11,111,1.036,1.125,1.337,4.16,0.05,0.17,0.42,2.06,9.48E-01,4.72E-01,7.90E-01,1.80E-01,5.01E+06,8.49E+05,1.88E+07,3.16E+06,5,5,5,4,1.29E+07,2.53E+06,1.19E+05,3.47E+07,5.01E+06,3.23E+05,3.91E+06,1.69E+06,3.46E+05,8.49E+05,8.26E+05,3.95E+07,1.68E+07,1.88E+07,2.26E+07,3.85E+06,1.50E+06,,1.07E+07,2.59E+06,5.12E+04,9.62E+03,1.16E+03,3.47E+07,2.58E+05,1.15E+03,6.95E+04,1.56E+04,9.76E+03,9.03E+03,4.94E+03,1.76E+06,1.36E+05,2.54E+06,5.61E+05,7.52E+03,4.22E+05,,2.49E+05,2.76E+04,0,FALSE,113.196,62,11,239,26.5,7.81,11,other metabolic processes,cytoskeleton;mitochondrion;other cell component,"Pf00406, Pf05191",204,A8K6L1; B4DHH7; B4DL64; hsa:204; P54819; Q16856; Q5EB54; Q5TIF7; Q8TCY2; Q8TCY3,ENSG00000004455,Interconversion of nucleotide di- and triphosphates,,1,0,127.29,105.04,70.19,88.47,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,101.55,123.01,140.47,136.93,360.04,kinase activity;other molecular function,0,
Master Protein,High,O14618,CCS,Copper chaperone for superoxide dismutase OS=Homo sapiens OX=9606 GN=CCS PE=1 SV=1,1,2,1.036,0.803,3.162,0.263,0.05,-0.32,1.66,-1.93,8.70E-01,8.36E-01,2.59E-01,3.72E-01,3.91E+05,3.77E+05,3.14E+05,1.19E+06,2,1,1,1,,,,2.24E+05,6.82E+05,,3.77E+05,,,,,,,3.14E+05,,1.19E+06,,,,,,,,2.24E+05,3.52E+04,,6.71E+03,,,,,,,4.23E+04,,2.33E+03,,,,,0.001,FALSE,3.175,5,1,274,29,5.58,1,protein metabolism;other metabolic processes;stress response,cytosol;nucleus;other cell component,"Pf00080, Pf00403",9973,hsa:9973; O14618; Q2M366; Q8NEV0,ENSG00000173992,Detoxification of Reactive Oxygen Species,Amyotrophic lateral sclerosis (ALS); Copper homeostasis,3,0,71.51,,,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,86.89,86.89,0,0,6.1,other molecular function,0,
Master Protein,High,H0Y9Y2,BOD1L1,Biorientation of chromosomes in cell division 1 like 1 OS=Homo sapiens OX=9606 GN=BOD1L1 PE=1 SV=2,15,19,1.035,0.31,3.641,0.073,0.05,-1.69,1.86,-3.77,9.01E-01,3.31E-01,2.58E-01,3.44E-02,1.55E+05,1.98E+05,1.28E+05,2.92E+05,5,2,4,3,5.61E+04,1.55E+05,4.84E+04,1.33E+06,1.31E+06,,1.05E+05,,,3.75E+05,7.41E+04,1.08E+05,,2.83E+05,1.51E+05,2.68E+05,,2.92E+05,,2.04E+06,2.23E+02,5.90E+02,4.73E+02,1.33E+06,6.75E+04,,1.87E+03,,,3.98E+03,4.43E+02,4.80E+03,,3.82E+04,3.76E+03,5.22E+02,,2.07E+03,,2.17E+04,0,FALSE,70.181,8,15,3098,335.3,5.14,15,,nucleus,Pf05205,259282,H0Y9Y2,ENSG00000038219,,,0,0,116.74,79.52,59.6,117.3,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,101.7,102.84,0,131.23,60.78,,0,
Master Protein,High,Q9BT09,CNPY3,Protein canopy homolog 3 OS=Homo sapiens OX=9606 GN=CNPY3 PE=1 SV=1,3,9,1.035,0.291,0.839,0.222,0.05,-1.78,-0.25,-2.17,9.74E-01,2.00E-01,7.62E-01,2.17E-01,2.04E+06,1.03E+06,2.92E+05,3.85E+05,3,4,4,5,,2.42E+06,,2.71E+05,2.04E+06,,8.51E+05,1.25E+06,8.47E+04,1.86E+06,,1.63E+05,3.62E+05,2.35E+05,3.96E+05,2.02E+05,6.52E+04,6.22E+06,3.85E+05,5.88E+06,,9.20E+03,,2.71E+05,1.05E+05,,1.51E+04,1.15E+04,2.39E+03,1.98E+04,,7.30E+03,2.94E+03,3.16E+04,9.85E+03,3.93E+02,1.83E+04,4.41E+04,9.02E+03,6.26E+04,0,FALSE,10.074,10,3,278,30.7,5.49,3,stress response,ER/Golgi,Pf11938,10695,hsa:10695; O15412; Q0P6I2; Q8NF54; Q8WTU8; Q9BT09; Q9P0F2,ENSG00000137161,Trafficking and processing of endosomal TLR,,1,0,72.72,73.71,37.65,125.42,n/a,Peak Found,n/a,High,High,n/a,Peak Found,High,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,1,,FALSE,101.66,92.06,106.81,137.68,24.51,signal transduction activity or receptor binding,0,
Master Protein,High,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 OS=Homo sapiens OX=9606 GN=LEO1 PE=1 SV=1,3,5,1.032,0.271,0.231,0.649,0.05,-1.88,-2.12,-0.62,9.23E-01,2.66E-01,7.52E-02,8.66E-01,3.01E+05,1.00E+06,1.63E+05,8.20E+04,5,4,4,3,3.01E+05,6.10E+05,4.35E+04,1.24E+06,1.22E+05,,1.68E+06,3.47E+06,6.01E+05,3.85E+05,,5.58E+04,2.60E+05,2.25E+05,1.17E+05,3.03E+05,,,8.20E+04,6.52E+04,1.20E+03,2.32E+03,4.25E+02,1.24E+06,6.30E+03,,2.98E+04,3.21E+04,1.69E+04,4.09E+03,,2.49E+03,2.11E+03,3.03E+04,2.91E+03,5.90E+02,,,1.92E+03,6.94E+02,0,FALSE,16.111,9,3,666,75.4,4.51,3,cell-cell signaling;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,cytoskeleton;nucleus,Pf04004,123169,hsa:123169; Q8WVC0; Q96N99,ENSG00000166477,E3 ubiquitin ligases ubiquitinate target proteins; Formation of the beta-catenin:TCF transactivating complex; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,Endoderm differentiation,6,0,104.9,91.99,57.53,88.35,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,88.71,105.64,104.66,91.66,15.27,other molecular function,0,
Master Protein,High,O75934,BCAS2,Pre-mRNA-splicing factor SPF27 OS=Homo sapiens OX=9606 GN=BCAS2 PE=1 SV=1,3,4,1.031,0.861,1.102,0.843,0.04,-0.22,0.14,-0.25,9.43E-01,7.98E-01,9.40E-01,9.82E-01,8.60E+04,1.73E+05,1.12E+05,8.91E+05,5,1,5,5,8.60E+04,2.70E+05,4.12E+04,4.90E+05,2.31E+04,,,,,1.73E+05,9.60E+04,4.60E+04,5.90E+05,5.38E+05,1.12E+05,1.46E+06,3.66E+04,7.71E+06,1.23E+05,8.91E+05,3.42E+02,1.03E+03,4.03E+02,4.90E+05,1.19E+03,,,,,1.84E+03,5.74E+02,2.05E+03,4.80E+03,7.25E+04,2.78E+03,2.85E+03,1.03E+04,5.46E+04,2.88E+03,9.48E+03,0,FALSE,7.523,14,3,225,26.1,5.66,3,RNA metabolism OR transcription;other metabolic processes,cytoskeleton;nucleus;other cell component,Pf05700,10286,hsa:10286; O75934; Q6FGS0,ENSG00000116752,mRNA Splicing - Major Pathway,,1,0,108.83,,95.67,157.49,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,31.88,91.94,75.65,121.49,9.65,,0,
Master Protein,High,B4DUA7,MED29,Mediator of RNA polymerase II transcription subunit 29 OS=Homo sapiens OX=9606 GN=MED29 PE=1 SV=1,1,1,1.03,0.044,3.117,0.016,0.04,-4.52,1.64,-5.99,9.87E-01,5.50E-03,3.68E-01,1.22E-03,4.69E+04,4.17E+04,2.05E+03,1.30E+05,3,2,1,1,,4.83E+04,,3.82E+04,4.69E+04,8.53E+04,2.04E+04,,,,,,,2.05E+03,,,,1.30E+05,,,,1.84E+02,,3.82E+04,2.42E+03,3.03E+02,3.62E+02,,,,,,,2.76E+02,,,,9.21E+02,,,0.003,FALSE,2.676,6,1,221,23.5,8.16,1,,nucleus,Pf11568,55588,B4DUA7; hsa:55588,ENSG00000063322,,,0,0,12.33,86.89,,,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,102.65,4.37,115.45,0,2.79,,0,
Master Protein,High,Q9UPP1,PHF8,Histone lysine demethylase PHF8 OS=Homo sapiens OX=9606 GN=PHF8 PE=1 SV=3,2,2,1.025,0.472,0.01,100,0.04,-1.08,-6.64,6.64,9.86E-01,7.34E-01,1.00E-17,1.00E-17,4.86E+04,4.74E+04,2.29E+04,,1,1,2,,,,,4.86E+04,,,,,,4.74E+04,,,,2.75E+04,1.92E+04,,,,,,,,,4.86E+04,,,,,,5.04E+02,,,,3.70E+03,4.76E+02,,,,,,0,FALSE,6.619,3,1,1060,117.8,8.72,2,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes,other membranes;nucleus,"Pf00628, Pf02373, Pf17811",23133,B3KMV4; B7Z911; hsa:23133; Q5H9U5; Q5JPR9; Q5JPS0; Q5JPS2; Q5JPS3; Q5VUJ4; Q7Z6D4; Q9HAH2; Q9UPP1,ENSG00000172943,HDMs demethylate histones,Ectoderm differentiation,2,0,,,25.27,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,26.93,,,7.18,other molecular function,0,
Master Protein,High,P13667,PDIA4,Protein disulfide-isomerase A4 OS=Homo sapiens OX=9606 GN=PDIA4 PE=1 SV=2,18,88,1.024,1.364,1.764,1.584,0.03,0.45,0.82,0.66,9.37E-01,3.16E-01,5.53E-01,6.28E-01,3.28E+06,1.40E+06,7.67E+06,6.12E+06,5,5,5,5,3.25E+06,3.28E+06,4.85E+05,2.46E+07,4.82E+06,8.88E+05,1.71E+06,1.08E+06,1.40E+06,2.78E+06,3.02E+05,7.67E+06,5.24E+06,9.39E+06,7.91E+06,6.12E+06,4.41E+06,9.99E+06,1.96E+06,8.85E+06,1.29E+04,1.25E+04,4.74E+03,2.46E+07,2.49E+05,3.16E+03,3.04E+04,9.97E+03,3.95E+04,2.96E+04,1.80E+03,3.43E+05,4.26E+04,1.26E+06,1.96E+05,1.19E+04,1.24E+06,7.08E+04,4.58E+04,9.42E+04,0,FALSE,104.584,38,18,645,72.9,5.07,18,protein metabolism;other metabolic processes;stress response;transport,non-structural extracellular;ER/Golgi;other cell component,"Pf00085, Pf13848",9601,A8K4K6; hsa:9601; P13667; Q549T6,ENSG00000155660,,,0,0,134.6,47.37,58.45,52.09,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,High,Peak Found,High,1,,FALSE,120.77,124.26,123.58,100.53,274.57,other molecular function,0,
Master Protein,High,P51858,HDGF,Hepatoma-derived growth factor OS=Homo sapiens OX=9606 GN=HDGF PE=1 SV=1,11,51,1.02,0.662,1.439,0.85,0.03,-0.6,0.53,-0.23,9.92E-01,9.48E-01,7.10E-01,9.53E-01,2.50E+06,1.33E+06,2.60E+06,2.09E+06,5,5,5,5,2.32E+06,2.16E+06,2.50E+06,7.38E+06,6.48E+06,1.36E+06,2.17E+05,1.33E+06,3.42E+04,1.00E+07,1.45E+06,2.60E+06,2.20E+06,1.03E+07,4.59E+06,4.64E+06,1.13E+06,1.43E+06,2.09E+06,6.67E+06,9.22E+03,8.22E+03,2.44E+04,7.38E+06,3.34E+05,4.84E+03,3.85E+03,1.23E+04,9.64E+02,1.07E+05,8.67E+03,1.16E+05,1.79E+04,1.39E+06,1.14E+05,9.04E+03,3.18E+05,1.01E+04,4.89E+04,7.10E+04,0,FALSE,53.398,58,10,240,26.8,4.73,11,cell organization and biogenesis;signal transduction;other biological processes,nucleus;other cell component,Pf00855,3068,B3KU21; D3DVC9; P51858; Q5SZ07; Q5SZ08; Q5SZ09,ENSG00000143321,XBP1(S) activates chaperone genes,IL-18 signaling pathway,2,0,61.01,161.85,85.15,74.69,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,114.87,106.5,107.05,90.92,154.97,signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P55084,HADHB,"Trifunctional enzyme subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=HADHB PE=1 SV=3",11,38,1.02,0.665,0.45,1.38,0.03,-0.59,-1.15,0.46,9.33E-01,9.53E-01,2.50E-01,7.17E-01,3.57E+06,1.98E+06,1.99E+06,4.50E+06,5,5,5,5,3.03E+06,2.96E+06,3.72E+06,1.02E+07,3.57E+06,6.57E+06,2.21E+06,8.06E+05,4.48E+05,1.98E+06,1.99E+06,1.39E+07,1.34E+06,1.69E+06,3.26E+06,4.50E+06,2.76E+05,1.29E+07,5.99E+05,1.05E+07,1.21E+04,1.12E+04,3.64E+04,1.02E+07,1.84E+05,2.34E+04,3.93E+04,7.44E+03,1.26E+04,2.10E+04,1.19E+04,6.21E+05,1.09E+04,2.27E+05,8.11E+04,8.77E+03,7.75E+04,9.15E+04,1.40E+04,1.12E+05,0,FALSE,57.995,43,11,474,51.3,9.41,11,other metabolic processes;other biological processes,other membranes;mitochondrion;ER/Golgi,"Pf00108, Pf02803",3032,B2RB16; B4E2W0; hsa:3032; O14969; P55084; Q53TA6; Q96C77; Q9H3F5; Q9T2V8,ENSG00000138029,Acyl chain remodeling of CL; mitochondrial fatty acid beta-oxidation of unsaturated fatty acids; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA; Beta oxidation of octanoyl-CoA to hexanoyl-CoA; Beta oxidation of hexanoyl-CoA to butanoyl-CoA; Beta oxidation of myristoyl-CoA to lauroyl-CoA; Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA; Beta oxidation of palmitoyl-CoA to myristoyl-CoA,Fatty acid beta-oxidation; Valproic acid pathway; Female steroid hormones in cardiomyocyte energy metabolism; Sudden infant death syndrome (SIDS) susceptibility pathways,12,0,65.74,101.89,120.44,99.77,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,123.79,128.11,122.82,135.06,106.24,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NPE3,NOP10,H/ACA ribonucleoprotein complex subunit 3 OS=Homo sapiens OX=9606 GN=NOP10 PE=1 SV=1,1,1,1.018,0.01,0.01,,0.03,-6.64,-6.64,,9.52E-01,1.00E-17,1.00E-17,,9.55E+04,9.38E+04,,,1,1,,,,,,9.55E+04,,,9.38E+04,,,,,,,,,,,,,,,,,9.55E+04,,,1.67E+03,,,,,,,,,,,,,,0.001,FALSE,3.092,25,1,64,7.7,9.99,1,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf04135,55505,hsa:55505; Q9NPE3,ENSG00000182117; ENSG00000291996,rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,,,,3.83,nucleic acid binding activity,0,
Master Protein,High,P00338,LDHA,L-lactate dehydrogenase A chain OS=Homo sapiens OX=9606 GN=LDHA PE=1 SV=2,9,37,1.017,0.365,0.764,0.353,0.02,-1.46,-0.39,-1.5,9.31E-01,3.45E-01,6.35E-01,4.22E-01,4.69E+06,2.55E+06,1.40E+06,1.70E+06,5,5,5,5,4.69E+06,8.94E+05,1.99E+04,4.95E+06,1.27E+07,7.05E+06,7.83E+05,2.55E+06,1.94E+06,6.34E+06,9.35E+05,1.49E+06,5.86E+05,4.49E+06,1.40E+06,4.84E+06,1.91E+06,1.08E+06,1.70E+06,1.69E+06,1.86E+04,3.40E+03,1.94E+02,4.95E+06,6.58E+05,2.51E+04,1.39E+04,2.35E+04,5.47E+04,6.74E+04,5.59E+03,6.63E+04,4.76E+03,6.05E+05,3.47E+04,9.43E+03,5.37E+05,7.67E+03,3.97E+04,1.80E+04,0,FALSE,34.067,31,8,332,36.7,8.27,9,other metabolic processes,cytosol;mitochondrion;other cell component,"Pf00056, Pf02866",3939,B4DKQ2; B7Z5E3; D3DQY3; F8W819; hsa:3939; P00338; Q53G53; Q6IBM7; Q6ZNV1; Q9UDE8; Q9UDE9,ENSG00000134333; ENSG00000288299,Pyruvate metabolism,Cori cycle; HIF1A and PPARG regulation of glycolysis; Photodynamic therapy-induced HIF-1 survival signaling; VEGFA-VEGFR2 signaling; Amino acid metabolism; Clear cell renal cell carcinoma pathways; PI3K/AKT/mTOR - vitamin D3 signaling; Hereditary leiomyomatosis and renal cell carcinoma pathway; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Glycolysis in senescence; Orexin receptor pathway; CCL18 signaling pathway; Glucose metabolism in triple-negative breast cancer cells; Warburg effect modulated by deubiquitinating enzymes and their substrates; Lactate shuttle in glial cells; Glycolysis and gluconeogenesis; Macrophage-stimulating protein (MSP) signaling network map; Metabolic Epileptic Disorders,20,0,107.94,74.74,87.61,66.04,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.85,129.04,113.07,119.53,83.26,other molecular function,0,
Master Protein,High,Q92947,GCDH,"Glutaryl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=GCDH PE=1 SV=1",5,15,1.017,2.007,9.277,1.546,0.02,1.01,3.21,0.63,9.34E-01,6.33E-02,3.13E-02,5.65E-01,9.49E+05,6.07E+04,1.55E+06,6.32E+05,2,2,4,2,,,,1.68E+06,5.38E+05,,,6.15E+04,,5.99E+04,,3.34E+05,2.32E+06,1.04E+06,2.92E+06,,7.09E+05,,5.63E+05,,,,,1.68E+06,2.77E+04,,,5.67E+02,,6.37E+02,,1.49E+04,1.88E+04,1.40E+05,7.27E+04,,1.99E+05,,1.32E+04,,0,FALSE,35.671,24,5,438,48.1,8.06,5,other metabolic processes,mitochondrion,"Pf00441, Pf02770, Pf02771",2639,A8K2Z2; O14719; Q92947,ENSG00000105607,Lysine catabolism,Fatty acid beta-oxidation; Tryptophan metabolism,3,0,72.72,1.77,71.34,16.25,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,High,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,70.72,129.85,1.86,119.2,59.95,other molecular function,0,
Master Protein,High,A0A804HHW6,RMND1,Required for meiotic nuclear division 1 homolog OS=Homo sapiens OX=9606 GN=RMND1 PE=1 SV=1,2,2,1.015,0.564,0.322,1.462,0.02,-0.83,-1.63,0.55,9.44E-01,8.16E-01,2.78E-01,5.89E-01,2.28E+05,9.92E+04,3.35E+05,1.25E+05,3,2,2,4,,2.80E+06,2.18E+04,2.28E+05,,1.49E+05,,6.60E+04,,,,,3.77E+05,2.98E+05,,3.93E+05,7.67E+03,6.89E+04,2.26E+05,,,1.07E+04,2.13E+02,2.28E+05,,5.30E+02,,6.09E+02,,,,,3.07E+03,4.02E+04,,7.67E+02,2.15E+03,4.88E+02,5.29E+03,,0,FALSE,5.381,4,2,521,59.3,8.65,2,,mitochondrion,Pf02582,,A0A804HHW6,ENSG00000155906,,,0,0,152.3,54.61,16.61,99.28,n/a,Peak Found,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,113.52,116.22,135.2,99.16,5.38,,0,
Master Protein,High,Q03252,LMNB2,Lamin-B2 OS=Homo sapiens OX=9606 GN=LMNB2 PE=1 SV=4,31,265,1.014,0.836,0.666,1.116,0.02,-0.26,-0.59,0.16,9.28E-01,7.80E-01,5.15E-01,8.62E-01,5.12E+07,4.70E+07,3.07E+07,3.70E+07,5,5,5,5,2.02E+07,8.52E+07,9.86E+06,5.12E+07,6.65E+07,5.02E+07,4.70E+07,4.99E+07,2.52E+07,4.09E+07,3.85E+07,2.44E+07,2.24E+07,5.07E+07,3.07E+07,3.70E+07,5.29E+06,1.25E+08,1.64E+07,7.10E+07,8.02E+04,3.24E+05,9.63E+04,5.12E+07,3.43E+06,1.79E+05,8.35E+05,4.60E+05,7.09E+05,4.35E+05,2.30E+05,1.09E+06,1.82E+05,6.83E+06,7.63E+05,7.21E+04,1.49E+06,8.87E+05,3.83E+05,7.56E+05,0,FALSE,152.563,53,29,620,69.9,5.59,31,cell organization and biogenesis;transport;other biological processes,other membranes;cytoskeleton;nucleus,"Pf00038, Pf00932",84823,hsa:84823; O75292; Q03252; Q14734; Q96DF6,ENSG00000176619,,Gastric cancer network 2; Fas ligand pathway and stress induction of heat shock proteins; IL-18 signaling pathway; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome,6,0,67.47,24.54,34.64,95.07,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,129.75,123.17,134.33,117.12,639.88,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q8WV22,NSMCE1,Non-structural maintenance of chromosomes element 1 homolog OS=Homo sapiens OX=9606 GN=NSMCE1 PE=1 SV=5,2,3,1.014,0.01,0.01,,0.02,-6.64,-6.64,,9.95E-01,1.00E-17,1.00E-17,,3.44E+04,3.39E+04,,,2,1,,,7.74E+04,,,1.53E+04,,,,,3.39E+04,,,,,,,,,,,,3.08E+02,,,1.53E+04,,,,,9.55E+02,,,,,,,,,,,,0,FALSE,9.822,15,2,266,30.8,7.47,2,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf07574, Pf08746",197370,D3DWF6; hsa:197370; Q8WV22; Q9P045; Q9P049,ENSG00000169189,SUMOylation of DNA damage response and repair proteins,,1,0,94.85,,,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,134.05,,,,8.09,other molecular function,0,
Master Protein,High,Q9H307,PNN,Pinin OS=Homo sapiens OX=9606 GN=PNN PE=1 SV=5,12,23,1.012,0.27,1.953,0.347,0.02,-1.89,0.97,-1.53,9.27E-01,1.64E-01,4.37E-01,4.42E-01,6.11E+06,1.99E+06,6.54E+05,2.97E+05,5,5,5,4,2.67E+05,3.00E+07,3.62E+05,6.11E+06,1.22E+07,1.72E+06,7.73E+05,1.99E+06,6.57E+06,1.16E+07,1.35E+06,6.54E+05,9.74E+04,4.20E+06,4.29E+05,3.97E+05,2.23E+05,,1.82E+05,1.91E+07,1.06E+03,1.14E+05,3.54E+03,6.11E+06,6.28E+05,6.11E+03,1.37E+04,1.84E+04,1.85E+05,1.24E+05,8.06E+03,2.92E+04,7.91E+02,5.66E+05,1.07E+04,7.74E+02,6.26E+04,,4.27E+03,2.03E+05,0,FALSE,38.362,16,12,717,81.6,7.14,12,cell adhesion;RNA metabolism OR transcription;other metabolic processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,"Pf04696, Pf04697",5411,B4DZX8; hsa:5411; O60899; Q53EM7; Q6P5X4; Q7KYL1; Q99738; Q9H307; Q9UHZ9; Q9UQR9,ENSG00000100941,mRNA Splicing - Major Pathway,,1,0,125.88,100.42,123.42,189.24,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,128.3,115.56,143.5,133,59.32,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75081,CBFA2T3,Protein CBFA2T3 OS=Homo sapiens OX=9606 GN=CBFA2T3 PE=1 SV=2,1,4,1.012,1.29,0.774,1.686,0.02,0.37,-0.37,0.75,9.90E-01,5.22E-01,7.65E-01,5.74E-01,7.78E+04,7.68E+04,1.00E+05,5.95E+04,2,3,1,1,,,,8.72E+04,6.94E+04,,3.23E+04,7.68E+04,4.12E+05,,,,,1.00E+05,,,,,5.95E+04,,,,,8.72E+04,3.58E+03,,5.74E+02,7.09E+02,1.16E+04,,,,,1.35E+04,,,,,1.39E+03,,0.001,FALSE,3.632,2,1,653,71.1,8.18,1,RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,other membranes;ER/Golgi;nucleus,"Pf01753, Pf07531, Pf08788",863,D3DX78; hsa:863; O60615; O60616; O60617; O75081; O75082; O75107; O75108; Q0P5Z6; Q6P5W6,ENSG00000129993,,Hematopoietic stem cell differentiation,1,0,16.06,119.55,,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,120.46,16.95,86.02,0,13.82,other molecular function,0,
Master Protein,High,P00492,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens OX=9606 GN=HPRT1 PE=1 SV=2,2,4,1.012,1.096,1.199,1.857,0.02,0.13,0.26,0.89,9.14E-01,4.88E-01,9.95E-01,4.69E-01,4.65E+05,3.48E+05,7.62E+05,4.17E+05,5,2,4,4,2.47E+06,2.77E+05,8.85E+05,2.49E+05,4.65E+05,,2.26E+05,5.34E+05,,,7.95E+05,1.88E+06,6.77E+05,7.31E+05,,1.73E+06,8.82E+04,,4.11E+05,4.24E+05,9.81E+03,1.05E+03,8.65E+03,2.49E+05,2.40E+04,,4.02E+03,4.93E+03,,,4.75E+03,8.41E+04,5.50E+03,9.85E+04,,3.38E+03,2.48E+04,,9.61E+03,4.51E+03,0,FALSE,6.573,10,2,218,24.6,6.68,2,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;other biological processes,cytosol;other cell component,Pf00156,3251,A6NHF0; B2R8M9; hsa:3251; P00492,ENSG00000165704,Azathioprine ADME; Purine salvage; Defective HPRT1 disrupts guanine and hypoxanthine salvage,Mesodermal commitment pathway,4,0,107.05,57.28,56.48,109.91,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,78.44,107.76,105.54,115.85,8.24,other molecular function,0,
Master Protein,High,E7EPT4,NDUFV2,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFV2 PE=1 SV=1",5,27,1.01,0.521,1.034,0.594,0.01,-0.94,0.05,-0.75,9.25E-01,6.76E-01,9.30E-01,6.99E-01,1.48E+07,1.06E+07,4.59E+06,1.27E+07,3,5,5,5,,1.48E+07,,3.92E+06,1.66E+07,3.29E+07,9.23E+06,1.06E+07,8.55E+06,1.57E+07,2.56E+06,1.28E+06,6.53E+06,4.59E+06,5.59E+06,3.04E+07,3.11E+06,1.27E+07,6.57E+06,1.51E+07,,5.61E+04,,3.92E+06,8.58E+05,1.17E+05,1.64E+05,9.76E+04,2.41E+05,1.67E+05,1.53E+04,5.70E+04,5.31E+04,6.18E+05,1.39E+05,5.93E+04,8.73E+05,9.03E+04,1.54E+05,1.61E+05,0,FALSE,23.202,21,5,252,27.9,8,5,,,Pf01257,,E7EPT4,ENSG00000178127,,,0,0,58.31,66.2,52.63,77.66,n/a,Peak Found,n/a,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,116.37,103.32,92.81,96.05,80.1,other molecular function,0,
Master Protein,High,P36578,RPL4,60S ribosomal protein L4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,8,25,1.009,0.272,1.083,0.28,0.01,-1.88,0.11,-1.84,9.24E-01,1.70E-01,9.76E-01,2.92E-01,1.80E+06,4.05E+06,1.08E+06,3.13E+06,5,5,4,5,3.68E+05,1.80E+06,1.03E+06,6.14E+06,2.69E+07,1.69E+06,4.65E+06,3.19E+06,4.05E+06,5.31E+06,8.26E+05,1.09E+06,,3.71E+06,1.08E+06,1.22E+06,5.98E+06,2.31E+06,3.13E+06,1.84E+07,1.46E+03,6.85E+03,1.01E+04,6.14E+06,1.39E+06,6.01E+03,8.26E+04,2.94E+04,1.14E+05,5.65E+04,4.94E+03,4.87E+04,,5.00E+05,2.68E+04,2.37E+03,1.68E+06,1.64E+04,7.31E+04,1.96E+05,0,FALSE,32.527,18,8,427,47.7,11.06,8,protein metabolism;other metabolic processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,"Pf00573, Pf14374",6124,A8K502; hsa:6124; P36578; P39029; Q4VBR0; Q969Z9,ENSG00000174444,L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,154.64,37.17,81.29,113.33,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,n/a,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,115.52,123.75,122.25,123.24,74.42,other molecular function,0,
Master Protein,High,P20042,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2,7,24,1.009,0.769,2.843,0.276,0.01,-0.38,1.51,-1.86,9.24E-01,8.81E-01,2.29E-01,2.64E-01,3.31E+05,1.18E+07,3.80E+05,3.93E+06,3,5,3,4,,3.31E+05,,2.68E+05,1.22E+06,1.38E+05,9.61E+04,1.00E+08,1.18E+07,2.91E+07,1.19E+05,,,3.80E+05,5.35E+05,,2.44E+06,6.35E+06,1.44E+06,1.11E+07,,1.26E+03,,2.68E+05,6.31E+04,4.91E+02,1.71E+03,9.23E+05,3.32E+05,3.10E+05,7.13E+02,,,5.13E+04,1.33E+04,,6.85E+05,4.50E+04,3.36E+04,1.18E+05,0,FALSE,33.454,24,7,333,38.4,5.8,7,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes,cytosol;other cell component,Pf01873,8894,hsa:8894; P20042; Q9BVU0; Q9UJE4,ENSG00000125977,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; ABC-family proteins mediated transport; PKR-mediated signaling; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Response of EIF2AK1 (HRI) to heme deficiency; PERK regulates gene expression; Recycling of eIF2:GDP; Response of EIF2AK4 (GCN2) to amino acid deficiency; Cellular response to mitochondrial stress",Translation factors; Brain-derived neurotrophic factor (BDNF) signaling pathway; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell; Primary ovarian insufficiency,16,0,87.99,148.28,60.91,82.31,n/a,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,High,High,n/a,High,High,High,High,1,,FALSE,141.4,120.7,93.44,52.94,66.37,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q00403,GTF2B,Transcription initiation factor IIB OS=Homo sapiens OX=9606 GN=GTF2B PE=1 SV=1,4,7,1.009,0.391,0.188,0.658,0.01,-1.36,-2.41,-0.6,9.41E-01,4.66E-01,5.25E-02,8.51E-01,8.03E+05,4.50E+05,1.95E+05,2.41E+05,4,2,5,4,4.85E+05,8.11E+06,,8.44E+05,7.64E+05,,,5.56E+05,,3.64E+05,5.35E+04,1.47E+05,3.89E+05,6.55E+05,1.95E+05,6.82E+05,9.51E+03,,8.48E+04,1.20E+06,1.93E+03,3.08E+04,,8.44E+05,3.94E+04,,,5.13E+03,,3.88E+03,3.20E+02,6.58E+03,3.16E+03,8.83E+04,4.84E+03,1.33E+03,2.67E+03,,1.98E+03,1.28E+04,0,FALSE,15.626,20,4,316,34.8,8.35,4,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00382, Pf08271",2959,A8K1A7; hsa:2959; Q00403; Q5JS30,ENSG00000137947,RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,Eukaryotic transcription initiation,10,0,145.44,29.44,82.98,113.06,Peak Found,Peak Found,n/a,High,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,84.79,108.59,97.8,143.86,24.32,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NUJ1,ABHD10,"Palmitoyl-protein thioesterase ABHD10, mitochondrial OS=Homo sapiens OX=9606 GN=ABHD10 PE=1 SV=1",9,43,1.008,1.123,0.802,2.048,0.01,0.17,-0.32,1.03,9.22E-01,4.74E-01,8.30E-01,4.76E-01,4.52E+06,1.21E+06,7.23E+06,9.42E+05,5,3,5,5,4.52E+06,5.31E+05,2.17E+05,1.02E+07,1.45E+07,,5.54E+05,1.73E+06,,1.21E+06,1.65E+06,3.77E+06,1.18E+07,1.20E+07,7.23E+06,9.97E+05,6.94E+05,9.42E+05,3.21E+04,1.18E+06,1.79E+04,2.02E+03,2.12E+03,1.02E+07,7.46E+05,,9.85E+03,1.60E+04,,1.28E+04,9.84E+03,1.68E+05,9.61E+04,1.62E+06,1.80E+05,1.94E+03,1.95E+05,6.68E+03,7.51E+02,1.26E+04,0,FALSE,40.198,41,9,306,33.9,8.57,9,protein metabolism;other metabolic processes,cytosol;mitochondrion,Pf00561,55347,B7Z6A8; C9IZX5; D3DN63; hsa:55347; Q8TCF9; Q9NUJ1,ENSG00000144827,Glucuronidation,,1,0,103.95,50.62,64.02,58.13,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,101.27,129.93,64.14,68.38,112.26,other molecular function,0,
Master Protein,High,P41252,IARS1,"Isoleucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=IARS1 PE=1 SV=2",4,9,1.003,1.496,1.543,0.682,0,0.58,0.63,-0.55,9.08E-01,3.53E-01,7.96E-01,8.67E-01,2.23E+05,2.68E+05,9.20E+04,3.82E+05,3,5,5,4,,1.13E+07,,8.43E+04,2.23E+05,6.22E+06,2.68E+05,1.42E+06,4.65E+04,1.70E+05,1.62E+06,5.19E+04,4.62E+04,9.20E+04,1.10E+05,4.30E+05,9.53E+05,,3.40E+05,1.21E+05,,4.28E+04,,8.43E+04,1.15E+04,2.21E+04,4.76E+03,1.31E+04,1.31E+03,1.80E+03,9.71E+03,2.32E+03,3.75E+02,1.24E+04,2.74E+03,8.38E+02,2.68E+05,,7.95E+03,1.28E+03,0,FALSE,15.998,4,4,1262,144.4,6.15,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,"Pf00133, Pf08264, Pf19302",3376,A8KAE9; hsa:3376; P41252; Q5TCD0; Q7Z3T4; Q9H588,ENSG00000196305; ENSG00000291356,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,Amino acid metabolism,3,0,166.32,161.62,180.12,76.62,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,131.14,63.62,135.04,120.05,27.09,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P00505,GOT2,"Aspartate aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=GOT2 PE=1 SV=3",21,200,1.003,0.755,0.914,0.972,0,-0.4,-0.13,-0.04,9.18E-01,8.97E-01,8.06E-01,9.59E-01,2.19E+07,1.00E+07,1.95E+07,1.72E+07,5,5,5,5,4.01E+06,2.19E+07,2.85E+06,3.91E+07,1.23E+08,9.91E+06,2.18E+06,1.00E+07,1.47E+07,1.22E+08,2.50E+06,1.95E+07,1.26E+07,5.00E+07,2.36E+07,1.35E+07,7.20E+06,3.52E+07,1.72E+07,6.25E+07,1.59E+04,8.32E+04,2.79E+04,3.91E+07,6.33E+06,3.52E+04,3.87E+04,9.27E+04,4.14E+05,1.29E+06,1.50E+04,8.70E+05,1.02E+05,6.73E+06,5.87E+05,2.64E+04,2.02E+06,2.50E+05,4.03E+05,6.65E+05,0,FALSE,107.771,63,21,430,47.5,9.01,21,other metabolic processes;transport;other biological processes,plasma membrane;other membranes;mitochondrion,Pf00155,2806,B4DJA6; E7ERW2; hsa:2806; P00505; Q53FL3; Q9BWA3,ENSG00000125166,Glyoxylate metabolism and glycine degradation; Gluconeogenesis; Aspartate and asparagine metabolism; Glutamate and glutamine metabolism; Degradation of cysteine and homocysteine,Alanine and aspartate metabolism; Amino acid metabolism; Metabolic reprogramming in colon cancer; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,11,0,130.07,159.27,82.07,82.31,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,138.52,116.17,136.01,124.89,585.92,other molecular function,0,
Master Protein,High,Q8IWZ8,SUGP1,SURP and G-patch domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SUGP1 PE=1 SV=2,1,1,1.003,0.572,0.01,100,0,-0.81,-6.64,6.64,9.68E-01,8.25E-01,1.00E-17,1.00E-17,1.35E+05,1.34E+05,7.72E+04,,1,1,1,,,,,1.35E+05,,1.34E+05,,,,,,,,7.72E+04,,,,,,,,,,1.35E+05,,4.78E+02,,,,,,,,1.04E+04,,,,,,,0.002,FALSE,2.92,2,1,645,72.4,7.61,1,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf01585, Pf01805",57794,hsa:57794; O60378; Q6P3X9; Q8IWZ8; Q8TCQ4; Q8WWT4; Q8WWT5; Q9NTG3,ENSG00000105705,mRNA Splicing - Major Pathway,mRNA processing,2,0,,,,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,0,,,3.82,,0,
Master Protein,High,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens OX=9606 GN=LRRFIP1 PE=1 SV=2,2,4,1.003,0.01,3.288,0.01,0,-6.64,1.72,-6.64,9.74E-01,1.00E-17,3.07E-01,1.00E-17,9.14E+04,9.12E+04,,3.00E+05,2,2,,1,,,,1.79E+04,4.67E+05,,,,3.05E+04,2.73E+05,,,,,,,,,,3.00E+05,,,,1.79E+04,2.41E+04,,,,8.58E+02,2.90E+03,,,,,,,,,,3.19E+03,0,FALSE,11.385,5,2,808,89.2,4.65,2,other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf09738,9208,E9PGZ2; hsa:9208; O75766; O75799; Q32MZ4; Q32MZ5; Q53T49; Q6PKG2; Q9Y607,ENSG00000124831,Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,IL-18 signaling pathway; 2q37 copy number variation syndrome,5,0,130.97,113.03,,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,121.56,,197.17,,12.4,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P50990,CCT8,T-complex protein 1 subunit theta OS=Homo sapiens OX=9606 GN=CCT8 PE=1 SV=4,11,34,1.003,0.642,2.557,0.553,0,-0.64,1.35,-0.86,9.90E-01,9.89E-01,2.86E-01,6.53E-01,1.52E+06,5.14E+05,1.62E+06,5.30E+06,5,5,5,5,4.15E+06,9.81E+05,1.52E+06,1.27E+06,4.02E+06,2.28E+06,1.02E+06,5.14E+05,1.32E+05,1.16E+05,1.26E+06,1.62E+06,7.53E+04,2.81E+06,2.02E+06,5.23E+06,8.09E+06,6.82E+06,3.89E+06,5.30E+06,1.65E+04,3.73E+03,1.48E+04,1.27E+06,2.07E+05,8.10E+03,1.81E+04,4.74E+03,3.71E+03,1.23E+03,7.56E+03,7.23E+04,6.11E+02,3.78E+05,5.02E+04,1.02E+04,2.27E+06,4.83E+04,9.11E+04,5.64E+04,0,FALSE,46.159,27,11,548,59.6,5.6,11,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf00118,10694,A6NN54; B4DEM7; B4DQH4; hsa:10694; P50990; Q4VBP8,ENSG00000156261; ENSG00000291533,Neutrophil degranulation; Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,16p11.2 proximal deletion syndrome,8,0,65.37,110.72,64.73,27.61,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,129.46,107.63,95.7,94.85,101.33,other molecular function,0,
Master Protein,High,P20073,ANXA7,Annexin A7 OS=Homo sapiens OX=9606 GN=ANXA7 PE=1 SV=3,13,56,1.002,1.092,2.063,0.47,0,0.13,1.04,-1.09,9.17E-01,5.00E-01,4.28E-01,5.53E-01,6.44E+06,3.40E+06,8.07E+06,1.80E+07,5,5,5,5,1.27E+06,2.92E+07,1.51E+06,6.44E+06,6.81E+06,1.13E+07,3.64E+07,1.77E+06,3.14E+06,3.40E+06,2.41E+06,9.00E+06,8.07E+06,9.65E+06,5.26E+06,4.59E+06,1.80E+07,1.89E+07,1.91E+06,2.30E+07,5.05E+03,1.11E+05,1.48E+04,6.44E+06,3.51E+05,4.00E+04,6.48E+05,1.64E+04,8.86E+04,3.61E+04,1.44E+04,4.02E+05,6.56E+04,1.30E+06,1.31E+05,8.95E+03,5.06E+06,1.34E+05,4.47E+04,2.44E+05,0,FALSE,58.882,29,13,488,52.7,5.68,13,other metabolic processes;other biological processes,other membranes;ER/Golgi;nucleus;other cell component,Pf00191,310,hsa:310; P20073; Q5F2H3; Q5T0M6; Q5T0M7,ENSG00000138279,,,0,0,127.91,130.26,43.72,70.72,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,117.53,97.3,130.51,95.55,129.8,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9UQ80,PA2G4,Proliferation-associated protein 2G4 OS=Homo sapiens OX=9606 GN=PA2G4 PE=1 SV=3,14,43,1.001,0.492,0.914,0.228,0,-1.02,-0.13,-2.13,9.17E-01,6.15E-01,8.05E-01,2.17E-01,2.56E+06,4.19E+06,2.53E+06,1.07E+07,5,5,5,5,3.46E+05,4.75E+06,1.00E+05,2.56E+06,1.30E+07,5.75E+06,2.38E+05,4.19E+06,1.26E+06,1.12E+07,2.53E+06,9.14E+05,2.72E+06,2.81E+06,7.83E+05,1.01E+07,1.07E+07,2.55E+07,3.43E+06,1.62E+07,1.37E+03,1.80E+04,9.81E+02,2.56E+06,6.69E+05,2.04E+04,4.23E+03,3.86E+04,3.54E+04,1.19E+05,1.51E+04,4.08E+04,2.21E+04,3.79E+05,1.95E+04,1.97E+04,3.02E+06,1.81E+05,8.03E+04,1.73E+05,0,FALSE,47.4,47,14,394,43.8,6.55,14,RNA metabolism OR transcription;other metabolic processes;other biological processes,non-structural extracellular;nucleus;other cytoplasmic organelle;other cell component,Pf00557,5036,hsa:5036; O43846; Q9UM59; Q9UQ80,ENSG00000170515,Neutrophil degranulation,,1,0,127.42,95.87,51.89,62.4,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,136.15,127.12,106.69,105.74,119.6,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q7L0Y3,TRMT10C,tRNA methyltransferase 10 homolog C OS=Homo sapiens OX=9606 GN=TRMT10C PE=1 SV=2,3,7,1,1.577,3.295,1.27,0,0.66,1.72,0.34,8.95E-01,2.18E-01,2.87E-01,6.72E-01,4.83E+05,2.35E+05,7.90E+05,4.67E+05,3,2,4,5,,,4.57E+05,6.53E+05,4.83E+05,,,4.57E+05,,1.21E+05,,8.12E+05,1.88E+05,1.02E+06,7.69E+05,4.03E+05,4.67E+05,1.97E+05,6.06E+05,6.42E+05,,,4.47E+03,6.53E+05,2.49E+04,,,4.22E+03,,1.28E+03,,3.63E+04,1.53E+03,1.37E+05,1.91E+04,7.86E+02,1.31E+05,1.39E+03,1.42E+04,6.84E+03,0,FALSE,8.749,9,3,403,47.3,9.36,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,mitochondrion;nucleus;other cell component,Pf01746,54931,hsa:54931; Q7L0Y3; Q9NRG5; Q9NX54; Q9Y596,ENSG00000174173,tRNA processing in the mitochondrion; tRNA modification in the mitochondrion; rRNA processing in the mitochondrion,,3,0,20.01,82.42,51.1,38.5,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,94.71,62.41,76.35,81.21,10.64,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15059,BRD3,Bromodomain-containing protein 3 OS=Homo sapiens OX=9606 GN=BRD3 PE=1 SV=1,7,11,1,0.458,0.184,0.237,0,-1.13,-2.44,-2.08,9.94E-01,6.39E-01,1.03E-01,3.17E-01,4.89E+04,4.37E+04,9.60E+04,2.69E+05,3,1,3,3,4.37E+04,,,4.80E+05,4.89E+04,,,,,4.37E+04,,1.61E+04,,1.02E+05,9.60E+04,2.69E+05,,,4.16E+04,6.51E+05,1.74E+02,,,4.80E+05,2.52E+03,,,,,4.65E+02,,7.20E+02,,1.37E+04,2.39E+03,5.24E+02,,,9.74E+02,6.93E+03,0,FALSE,29.439,13,5,726,79.5,9.36,7,cell organization and biogenesis;other biological processes,nucleus,"Pf00439, Pf17035",8019,B1APD9; hsa:8019; Q15059; Q4G5Y3; Q5T1R7; Q8N5M3; Q92645,ENSG00000169925,,,0,0,131.21,,67.18,96.09,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,15.8,75.89,0,145.53,29.41,other molecular function,0,
Master Protein,High,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 OS=Homo sapiens OX=9606 GN=BCLAF1 PE=1 SV=2,10,29,0.997,0.112,1.803,0.068,0,-3.16,0.85,-3.88,9.13E-01,7.26E-03,5.03E-01,1.91E-02,4.92E+06,1.55E+06,1.76E+05,2.29E+06,5,4,4,4,2.04E+05,6.65E+06,1.31E+05,9.87E+06,4.92E+06,,3.14E+06,3.59E+06,7.56E+04,7.67E+05,6.80E+04,2.12E+05,,1.51E+06,1.46E+05,8.69E+05,9.14E+04,6.05E+06,,1.08E+07,8.09E+02,2.53E+04,1.28E+03,9.87E+06,2.54E+05,,5.59E+04,3.31E+04,2.13E+03,8.16E+03,4.07E+02,9.48E+03,,2.03E+05,3.63E+03,1.70E+03,2.57E+04,4.29E+04,,1.15E+05,0,FALSE,58.856,13,9,920,106.1,9.98,10,stress response;other biological processes,nucleus;other cell component,Pf15440,9774,A2RU75; B7ZM58; E1P586; hsa:9774; Q14673; Q86WU6; Q86WY0; Q9NYF8,ENSG00000029363,,Interactome of polycomb repressive complex 2 (PRC2),1,0,96.82,91.51,141.78,112.1,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,128.33,118.53,88.04,146.95,87.1,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,A0A2R8Y6V7,SLC12A1,Solute carrier family 12 member 1 OS=Homo sapiens OX=9606 GN=SLC12A1 PE=1 SV=1,1,1,0.997,0.425,27.591,0.015,0,-1.23,4.79,-6.03,8.89E-01,5.84E-01,4.12E-05,2.84E-04,2.89E+05,2.90E+05,1.23E+05,8.00E+06,1,3,4,2,,2.89E+05,,,,,1.94E+06,,8.36E+04,2.90E+05,,1.19E+04,5.75E+05,1.28E+06,2.62E+04,,,,8.26E+06,7.75E+06,,1.10E+03,,,,,3.46E+04,,2.36E+03,3.08E+03,,5.32E+02,4.67E+03,1.72E+05,6.52E+02,,,,1.93E+05,8.25E+04,0.03,FALSE,1.816,1,1,1145,126.1,7.28,1,transport,plasma membrane;other membranes,"Pf00324, Pf03522, Pf08403",,A0A2R8Y6V7,ENSG00000074803,,,0,0,,131.99,126.34,4.58,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,Phospho [T946],FALSE,105.49,339.99,126.13,329.15,1.77,transporter activity,1,Phospho [T946]
Master Protein,High,P22830,FECH,"Ferrochelatase, mitochondrial OS=Homo sapiens OX=9606 GN=FECH PE=1 SV=2",5,28,0.993,0.701,3.909,0.087,-0.01,-0.51,1.97,-3.52,9.69E-01,9.49E-01,1.08E-01,2.89E-02,5.94E+05,1.20E+06,4.09E+05,3.93E+06,3,5,5,5,3.96E+05,,,1.20E+06,5.94E+05,2.12E+06,7.31E+05,1.20E+06,5.11E+05,1.86E+06,2.99E+05,4.09E+05,2.78E+05,1.36E+06,6.52E+05,3.93E+06,2.00E+07,2.45E+06,1.01E+07,3.01E+06,1.57E+03,,,1.20E+06,3.07E+04,7.55E+03,1.30E+04,1.11E+04,1.44E+04,1.98E+04,1.79E+03,1.83E+04,2.26E+03,1.83E+05,1.62E+04,7.67E+03,5.62E+06,1.73E+04,2.36E+05,3.20E+04,0,FALSE,48.693,20,5,423,47.8,8.73,5,cell organization and biogenesis;other metabolic processes;other biological processes,other membranes;mitochondrion,Pf00762,2235,A8KA72; hsa:2235; P22830; Q8IXN1; Q8NAN0,ENSG00000066926,Mitochondrial protein degradation; Heme biosynthesis,Hemesynthesis defects and porphyrias; Heme biosynthesis,4,0,57.14,54.26,75.04,94.06,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,74.14,47.76,78.51,70.5,97.72,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P28907,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 OS=Homo sapiens OX=9606 GN=CD38 PE=1 SV=2,4,9,0.992,0.423,3.236,0.645,-0.01,-1.24,1.69,-0.63,9.55E-01,5.25E-01,2.84E-01,8.59E-01,8.55E+05,2.99E+05,3.96E+05,7.76E+05,5,5,5,4,3.35E+05,1.04E+06,1.55E+05,8.55E+05,1.20E+06,2.99E+05,1.88E+05,6.50E+06,5.12E+04,8.15E+05,1.34E+06,1.29E+05,8.68E+05,3.32E+05,3.96E+05,9.68E+05,,8.92E+05,2.46E+05,6.75E+05,1.33E+03,3.94E+03,1.51E+03,8.55E+05,6.17E+04,1.06E+03,3.33E+03,6.00E+04,1.44E+03,8.66E+03,8.00E+03,5.75E+03,7.05E+03,4.47E+04,9.83E+03,1.89E+03,,6.32E+03,5.75E+03,7.19E+03,0,FALSE,12.715,15,4,300,34.3,7.66,4,cell cycle OR cell proliferation;other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,Pf02267,952,hsa:952; O00121; O00122; P28907; Q96HY4,ENSG00000004468,Nicotinate metabolism,NAD+ metabolism; NAD+ biosynthetic pathways; Cell-type dependent selectivity of CCK2R signaling; Airway smooth muscle cell contraction,5,0,63.04,176.42,79.62,46.67,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,89.4,126.43,117.38,135.7,17.3,other molecular function,0,
Master Protein,High,P18124,RPL7,60S ribosomal protein L7 OS=Homo sapiens OX=9606 GN=RPL7 PE=1 SV=1,4,23,0.992,0.751,0.758,0.221,-0.01,-0.41,-0.4,-2.18,9.94E-01,8.30E-01,6.28E-01,2.03E-01,2.00E+06,5.92E+05,9.69E+05,3.71E+06,4,1,5,5,3.49E+05,,3.64E+06,2.60E+06,1.53E+06,,,,,5.92E+05,5.09E+06,5.68E+05,5.01E+05,1.35E+06,9.69E+05,5.55E+06,5.01E+06,4.49E+05,3.71E+06,1.48E+06,1.39E+03,,3.55E+04,2.60E+06,7.92E+04,,,,,6.30E+03,3.04E+04,2.54E+04,4.07E+03,1.82E+05,2.41E+04,1.08E+04,1.41E+06,3.18E+03,8.68E+04,1.58E+04,0,FALSE,16.895,23,4,248,29.2,10.65,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,"Pf00327, Pf08079",6129,A8K504; hsa:6129; P18124; Q15289; Q3KQU0; Q5I0X1; Q6IBM9,ENSG00000147604,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),VEGFA-VEGFR2 signaling; Cytoplasmic ribosomal proteins,15,0,69.53,,113.76,68.26,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,69.23,91.76,103.37,106.16,61.61,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75531,BANF1,Barrier-to-autointegration factor OS=Homo sapiens OX=9606 GN=BANF1 PE=1 SV=1,2,24,0.991,0.956,0.438,1.156,-0.01,-0.06,-1.19,0.21,9.08E-01,6.33E-01,2.36E-01,8.37E-01,9.20E+06,4.86E+06,5.61E+06,3.28E+06,2,1,4,2,,1.95E+07,,4.33E+06,,,,,,4.86E+06,,1.76E+06,7.81E+06,5.40E+06,5.83E+06,,2.13E+06,,5.04E+06,,,7.41E+04,,4.33E+06,,,,,,5.17E+04,,7.84E+04,6.34E+04,7.27E+05,1.45E+05,,5.98E+05,,1.18E+05,,0,FALSE,28.397,29,2,89,10.1,6.09,2,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,Pf02961,8815,hsa:8815; O60558; O75531; Q6FGG7,ENSG00000175334,Vpr-mediated nuclear import of PICs; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection; Nuclear Envelope Breakdown; Initiation of Nuclear Envelope (NE) Reformation,Envelope proteins and their potential roles in EDMD physiopathology; Familial partial lipodystrophy; Progeria-associated lipodystrophy,11,0,90,,48.55,57.48,n/a,High,n/a,High,n/a,n/a,n/a,n/a,High,High,n/a,High,High,High,High,n/a,High,n/a,High,n/a,1,,FALSE,142.9,111.84,0,103.62,83.35,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9ULZ3,PYCARD,Apoptosis-associated speck-like protein containing a CARD OS=Homo sapiens OX=9606 GN=PYCARD PE=1 SV=2,1,2,0.99,0.368,1.012,0.398,-0.01,-1.44,0.02,-1.33,9.76E-01,3.83E-01,9.85E-01,5.58E-01,1.07E+06,1.08E+06,4.90E+05,1.08E+06,4,2,4,3,1.44E+06,,7.95E+05,8.34E+04,7.26E+06,,,8.33E+05,,1.41E+06,4.93E+05,2.44E+05,,5.74E+05,4.86E+05,,,1.62E+06,7.40E+05,1.08E+06,5.74E+03,,7.77E+03,8.34E+04,3.74E+05,,,7.68E+03,,1.50E+04,2.95E+03,1.09E+04,,7.73E+04,1.21E+04,,,1.15E+04,1.73E+04,1.15E+04,0,FALSE,5.924,9,1,195,21.6,6.34,1,cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes,non-structural extracellular;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00619, Pf02758",29108,hsa:29108; Q96D12; Q9BSZ5; Q9HBD0; Q9NXJ8; Q9ULZ3,ENSG00000103490,Neutrophil degranulation; The AIM2 inflammasome; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; SARS-CoV-1 activates/modulates innate immune responses; CLEC7A/inflammasome pathway,Nucleotide-binding oligomerization domain (NOD) pathway; Nanomaterial-induced inflammasome activation; TYROBP causal network in microglia; Acute viral myocarditis; Cytosolic DNA-sensing pathway; Activation of NLRP3 inflammasome by SARS-CoV-2; Prostaglandin signaling,13,0,137.31,36.27,31.72,38.71,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,115.67,134.26,38.9,47.46,6.54,signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,P51608,MECP2,Methyl-CpG-binding protein 2 OS=Homo sapiens OX=9606 GN=MECP2 PE=1 SV=1,11,29,0.987,0.801,1.556,0.473,-0.02,-0.32,0.64,-1.08,9.80E-01,7.46E-01,6.37E-01,5.74E-01,1.34E+06,5.14E+05,1.25E+06,1.45E+06,5,4,5,5,1.34E+06,8.25E+05,9.42E+05,5.55E+06,1.59E+06,1.18E+06,,5.38E+05,4.62E+05,4.91E+05,8.57E+05,4.13E+06,3.53E+05,1.86E+06,1.25E+06,2.80E+06,2.68E+05,1.41E+06,1.45E+06,2.67E+06,5.32E+03,3.13E+03,9.20E+03,5.55E+06,8.22E+04,4.21E+03,,4.97E+03,1.30E+04,5.22E+03,5.13E+03,1.84E+05,2.86E+03,2.50E+05,3.11E+04,5.45E+03,7.53E+04,1.00E+04,3.38E+04,2.84E+04,0,FALSE,46.306,29,11,486,52.4,9.95,11,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf01429,4204,hsa:4204; O15233; P51608; Q6QHH9; Q7Z384,ENSG00000169057,,Ectoderm differentiation; MECP2 and associated Rett syndrome; Lung fibrosis; Rett syndrome; Transcription co-factors SKI and SKIL protein partners; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Neurogenesis regulation in the olfactory epithelium; ADHD and autism (ASD) linked metabolic pathways and SNP; Sudden infant death syndrome (SIDS) susceptibility pathways,10,0,96.62,51.59,87.01,60.64,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,80.31,118.15,140.95,105.57,75.61,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BQ61,TRIR,Telomerase RNA component interacting RNase OS=Homo sapiens OX=9606 GN=TRIR PE=1 SV=1,3,7,0.986,0.342,0.027,6.206,-0.02,-1.55,-5.21,2.63,9.03E-01,3.86E-01,4.40E-04,9.98E-02,2.21E+05,3.89E+05,5.75E+04,4.70E+03,4,3,4,1,1.16E+05,1.62E+05,,3.03E+05,1.89E+06,3.89E+05,,,4.99E+04,1.24E+06,4.08E+04,2.92E+04,8.29E+04,8.10E+04,,,4.70E+03,,,,4.61E+02,6.16E+02,,3.03E+05,9.77E+04,1.38E+03,,,1.40E+03,1.32E+04,2.44E+02,1.30E+03,6.73E+02,1.09E+04,,,1.32E+03,,,,0,FALSE,7.257,14,3,176,18.4,9.44,3,RNA metabolism OR transcription;other metabolic processes,,,79002,hsa:79002; Q9BQ61,ENSG00000123144,,,0,0,138,109.46,47.1,,Peak Found,Peak Found,n/a,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,131.64,70.95,0,58.93,13.95,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96KM6,ZNF512B,Zinc finger protein 512B OS=Homo sapiens OX=9606 GN=ZNF512B PE=1 SV=1,5,7,0.984,0.144,7.215,0.046,-0.02,-2.8,2.85,-4.43,9.81E-01,9.70E-02,6.12E-02,3.54E-03,6.84E+04,1.82E+05,7.30E+04,4.93E+05,3,2,4,3,,6.84E+04,,4.25E+05,6.73E+04,,8.52E+04,,,3.91E+05,3.52E+04,6.36E+03,2.36E+05,1.51E+05,,4.93E+05,,7.61E+05,1.95E+04,,,2.60E+02,,4.25E+05,3.47E+03,,1.52E+03,,,4.15E+03,2.11E+02,2.84E+02,1.92E+03,2.04E+04,,9.62E+02,,5.39E+03,4.57E+02,,0,FALSE,14.43,9,5,892,97.2,9.83,5,other biological processes,nucleus,"Pf00096, Pf21276",57473,hsa:57473; Q08AK9; Q96KM6; Q9ULM4,ENSG00000196700,RHOV GTPase cycle,,1,0,110.31,90.77,99.11,88.42,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,67,80.82,80.39,144.46,20,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O60264,SMARCA5,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Homo sapiens OX=9606 GN=SMARCA5 PE=1 SV=1,17,72,0.983,0.521,0.575,1.051,-0.02,-0.94,-0.8,0.07,9.01E-01,6.75E-01,4.02E-01,9.04E-01,7.18E+06,7.67E+06,2.63E+06,4.52E+06,5,5,5,5,1.60E+07,1.24E+07,5.95E+06,7.18E+06,5.12E+06,1.12E+07,1.12E+06,7.67E+06,9.35E+05,1.05E+07,2.01E+06,2.63E+06,2.23E+06,8.88E+06,5.32E+06,1.35E+07,1.11E+06,1.33E+07,1.55E+06,4.52E+06,6.35E+04,4.70E+04,5.81E+04,7.18E+06,2.64E+05,3.99E+04,1.99E+04,7.07E+04,2.64E+04,1.12E+05,1.20E+04,1.17E+05,1.81E+04,1.20E+06,1.32E+05,2.64E+04,3.11E+05,9.42E+04,3.62E+04,4.81E+04,0,FALSE,72.615,19,17,1052,121.8,8.09,17,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00176, Pf00271, Pf09110, Pf09111",8467,hsa:8467; O60264,ENSG00000153147,Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; NoRC negatively regulates rRNA expression,10q11.21q11.23 copy number variation syndrome,5,0,50.13,79.23,69.44,90.89,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,1,,FALSE,123.12,124.33,131.4,133.38,200.86,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O95881,TXNDC12,Thioredoxin domain-containing protein 12 OS=Homo sapiens OX=9606 GN=TXNDC12 PE=1 SV=1,2,3,0.98,0.487,2.412,0.216,-0.03,-1.04,1.27,-2.21,8.96E-01,6.50E-01,4.47E-01,2.27E-01,3.19E+05,3.25E+05,1.69E+05,7.85E+05,4,1,4,1,4.61E+05,,3.17E+05,3.21E+05,2.62E+05,,,,3.25E+05,,,3.63E+05,2.76E+05,8.57E+04,1.04E+05,,,,,7.85E+05,1.83E+03,,3.10E+03,3.21E+05,1.35E+04,,,,9.17E+03,,,1.62E+04,2.24E+03,1.15E+04,2.57E+03,,,,,8.35E+03,0,FALSE,5.31,17,2,172,19.2,5.4,2,other biological processes,ER/Golgi,Pf13899,51060,B3KQS0; hsa:51060; O95881; Q5T1T4; Q96H50,ENSG00000117862,,,0,0,24.99,,65.06,,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,16.64,77.58,0,86.49,7.59,other molecular function,0,
Master Protein,High,P54709,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3 OS=Homo sapiens OX=9606 GN=ATP1B3 PE=1 SV=1,2,13,0.977,0.335,1.36,0.532,-0.03,-1.58,0.44,-0.91,9.22E-01,3.15E-01,8.09E-01,6.86E-01,1.47E+05,2.99E+05,1.66E+06,1.32E+06,5,4,5,4,1.47E+05,9.85E+05,1.46E+05,1.36E+05,5.74E+05,,4.07E+04,1.79E+05,5.02E+05,6.88E+05,6.75E+05,6.26E+05,1.66E+06,2.19E+06,1.75E+06,7.83E+04,1.74E+06,,2.60E+06,9.95E+05,5.86E+02,3.74E+03,1.43E+03,1.36E+05,2.96E+04,,7.24E+02,1.65E+03,1.41E+04,7.31E+03,4.04E+03,2.80E+04,1.35E+04,2.95E+05,4.35E+04,1.53E+02,4.90E+05,,6.09E+04,1.06E+04,0,FALSE,7.996,8,2,279,31.5,8.35,2,transport;other biological processes,plasma membrane;other membranes;cytoskeleton;other cell component,Pf00287,483,B7Z1N7; hsa:483; P54709,ENSG00000069849,Potential therapeutics for SARS; Ion homeostasis; Ion transport by P-type ATPases; Basigin interactions,Calcium regulation in cardiac cells,5,0,94.89,83.93,50.44,79.36,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,n/a,High,Peak Found,1,,FALSE,108.14,11.21,104.85,78.65,41.48,other molecular function,0,
Master Protein,High,O00541,PES1,Pescadillo homolog OS=Homo sapiens OX=9606 GN=PES1 PE=1 SV=1,5,9,0.974,0.627,3.62,1.531,-0.04,-0.67,1.86,0.61,9.67E-01,8.59E-01,1.86E-01,5.54E-01,6.75E+05,4.86E+05,1.28E+05,1.16E+06,3,5,4,5,,6.75E+05,,8.76E+05,5.33E+05,4.86E+05,7.50E+05,5.76E+05,2.70E+05,3.45E+05,,1.06E+05,7.85E+04,6.77E+05,1.54E+05,1.17E+06,3.83E+04,1.16E+06,4.43E+04,3.12E+06,,2.56E+03,,8.76E+05,2.75E+04,1.73E+03,1.33E+04,5.32E+03,7.61E+03,3.67E+03,,4.75E+03,6.38E+02,9.13E+04,3.83E+03,2.27E+03,1.08E+04,8.21E+03,1.04E+03,3.32E+04,0,FALSE,20.532,12,5,588,68,7.33,5,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf06732, Pf16589",23481,hsa:23481; O00541; Q6IC29,ENSG00000100029,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,24.8,39.13,111.73,113.81,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,69.13,131.59,46.84,130.96,25.48,other molecular function,0,
Master Protein,High,P21854,CD72,B-cell differentiation antigen CD72 OS=Homo sapiens OX=9606 GN=CD72 PE=1 SV=1,1,2,0.973,0.292,0.305,1.552,-0.04,-1.78,-1.71,0.63,9.70E-01,4.10E-01,2.72E-01,6.26E-01,4.12E+04,4.23E+04,2.00E+04,1.29E+04,5,1,3,1,9.70E+04,4.77E+05,2.53E+04,1.99E+04,4.12E+04,,,,,4.23E+04,,5.82E+03,,4.21E+04,2.00E+04,,,,1.29E+04,,3.85E+02,1.81E+03,2.48E+02,1.99E+04,2.12E+03,,,,,4.50E+02,,2.60E+02,,5.67E+03,4.98E+02,,,,3.02E+02,,0,FALSE,4.798,4,1,359,40.2,8.28,1,cell adhesion,plasma membrane;other membranes,Pf00059,971,hsa:971; P21854,ENSG00000137101,Other semaphorin interactions,,1,0,147.77,,80.66,,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,92.63,105.89,0,105.16,6.35,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P62269,RPS18,40S ribosomal protein S18 OS=Homo sapiens OX=9606 GN=RPS18 PE=1 SV=3,7,62,0.972,0.54,3.438,0.216,-0.04,-0.89,1.78,-2.21,8.91E-01,7.14E-01,1.49E-01,1.99E-01,1.24E+07,4.86E+06,6.70E+06,1.58E+07,5,5,5,5,3.58E+06,1.24E+07,2.90E+06,1.41E+07,1.71E+07,1.31E+07,5.53E+06,4.86E+06,1.09E+06,3.23E+06,3.64E+06,7.00E+06,6.70E+06,8.51E+06,5.99E+06,1.58E+07,9.05E+06,7.00E+07,6.31E+06,5.98E+07,1.42E+04,4.69E+04,2.84E+04,1.41E+07,8.83E+05,4.64E+04,9.83E+04,4.48E+04,3.07E+04,3.43E+04,2.17E+04,3.13E+05,5.44E+04,1.15E+06,1.49E+05,3.08E+04,2.54E+06,4.96E+05,1.48E+05,6.36E+05,0,FALSE,22.927,32,4,152,17.7,10.99,7,protein metabolism;other metabolic processes,cytosol;translational apparatus;nucleus;other cell component,Pf00416,6222,hsa:6222; P25232; P62269; Q5SUJ3; Q6IPF8,ENSG00000096150; ENSG00000223367; ENSG00000226225; ENSG00000231500; ENSG00000235650,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,3,64.06,81.61,28,94.06,Peak Found,High,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,High,High,1,,FALSE,121.84,96.54,130.7,117.83,158.87,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q99470,SDF2,Stromal cell-derived factor 2 OS=Homo sapiens OX=9606 GN=SDF2 PE=1 SV=2,2,2,0.972,0.42,0.117,4.359,-0.04,-1.25,-3.1,2.12,9.90E-01,5.38E-01,5.14E-02,1.44E-01,1.49E+05,8.78E+04,1.11E+05,1.02E+04,3,3,2,1,4.10E+04,1.49E+05,,6.65E+05,,8.78E+04,7.36E+04,2.12E+05,,,,3.19E+04,,3.88E+05,,,1.02E+04,,,,1.63E+02,5.66E+02,,6.65E+05,,3.12E+02,1.31E+03,1.96E+03,,,,1.42E+03,,5.22E+04,,,2.88E+03,,,,0,FALSE,6.996,14,2,211,23,7.33,2,protein metabolism;other metabolic processes,ER/Golgi;other cell component,Pf02815,6388,hsa:6388; Q99470; Q9BQ79,ENSG00000132581,,,0,0,117.03,61.3,119.93,,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,86.98,68.15,23.98,50.85,6.56,other molecular function,0,
Master Protein,High,P04053,DNTT,DNA nucleotidylexotransferase OS=Homo sapiens OX=9606 GN=DNTT PE=1 SV=3,15,44,0.97,1.236,2.195,0.935,-0.04,0.31,1.13,-0.1,8.89E-01,3.91E-01,3.86E-01,9.87E-01,5.22E+06,7.47E+05,1.11E+07,1.11E+06,5,5,5,5,1.04E+07,2.52E+06,1.00E+07,5.22E+06,1.29E+06,2.12E+05,7.47E+05,3.07E+06,7.26E+06,3.16E+05,3.44E+07,1.58E+06,3.05E+06,1.90E+07,1.11E+07,3.99E+06,7.29E+04,1.11E+06,5.23E+05,1.69E+06,4.15E+04,9.58E+03,9.77E+04,5.22E+06,6.64E+04,7.55E+02,1.33E+04,2.83E+04,2.05E+05,3.36E+03,2.06E+05,7.06E+04,2.48E+04,2.56E+06,2.76E+05,7.78E+03,2.05E+04,7.86E+03,1.22E+04,1.80E+04,0,FALSE,59.857,33,15,509,58.5,8.43,15,DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,"Pf00533, Pf01909, Pf10391, Pf14716, Pf14791",1791,hsa:1791; P04053; Q53FH1; Q5W103; Q96E50,ENSG00000107447,,,0,0,71.26,129.1,97.26,103.68,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,90.97,114.45,115.49,121.36,136.79,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q14149,MORC3,MORC family CW-type zinc finger protein 3 OS=Homo sapiens OX=9606 GN=MORC3 PE=1 SV=3,6,9,0.969,1.473,0.291,1.687,-0.04,0.56,-1.78,0.75,9.34E-01,3.31E-01,2.61E-01,5.44E-01,4.79E+05,5.56E+04,1.61E+05,7.44E+04,2,1,4,2,,,,5.75E+05,3.99E+05,,,,,5.56E+04,2.67E+05,2.26E+04,,1.51E+06,9.73E+04,,3.42E+05,,1.62E+04,,,,,5.75E+05,2.06E+04,,,,,5.92E+02,1.60E+03,1.01E+03,,2.04E+05,2.42E+03,,9.60E+04,,3.79E+02,,0,FALSE,28.09,11,6,939,107,5.6,6,protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf07496, Pf13589, Pf17942",23515,A8KA92; hsa:23515; Q14149; Q9UEZ2,ENSG00000159256,,Interactome of polycomb repressive complex 2 (PRC2),1,0,25.49,,147.33,128.62,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,73.58,107.92,0,33.6,30.71,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P78527,PRKDC,DNA-dependent protein kinase catalytic subunit OS=Homo sapiens OX=9606 GN=PRKDC PE=1 SV=3,62,162,0.968,0.601,0.708,1.212,-0.05,-0.74,-0.5,0.28,8.87E-01,8.35E-01,5.67E-01,8.05E-01,2.22E+07,3.31E+06,9.24E+06,8.30E+06,5,5,5,5,3.68E+07,1.76E+07,1.45E+07,2.22E+07,3.76E+07,7.12E+06,5.19E+05,1.97E+06,6.28E+06,3.31E+06,2.61E+07,7.05E+06,7.17E+06,2.84E+07,9.24E+06,7.29E+06,6.48E+06,8.30E+06,1.05E+07,7.02E+07,1.46E+05,6.69E+04,1.42E+05,2.22E+07,1.94E+06,2.53E+04,9.23E+03,1.82E+04,1.77E+05,3.52E+04,1.56E+05,3.15E+05,5.82E+04,3.83E+06,2.30E+05,1.42E+04,1.82E+06,5.88E+04,2.45E+05,7.47E+05,0,FALSE,230.737,20,62,4128,468.8,7.12,62,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00454, Pf02259, Pf02260, Pf08163, Pf19704, Pf20502",5591,hsa:5591; P78527; P78528; Q13327; Q13337; Q14175; Q59H99; Q7Z611; Q96SE6; Q9UME3,ENSG00000253729,E3 ubiquitin ligases ubiquitinate target proteins; Cytosolic sensors of pathogen-associated DNA ; Nonhomologous End-Joining (NHEJ); IRF3-mediated induction of type I IFN,"miRNA regulation of DNA damage response; Cell cycle; Retinoblastoma gene in cancer; Fas ligand pathway and stress induction of heat shock proteins; Pathways affected in adenoid cystic carcinoma; Non-homologous end joining; Osteoblast differentiation and related diseases; DNA repair pathways, full network; DNA damage response",13,0,41.95,73.11,68.69,135.26,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,108.63,113.58,137.46,129.48,451.74,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,B5MDU6,LDAH,Lipid droplet-associated hydrolase OS=Homo sapiens OX=9606 GN=LDAH PE=1 SV=1,1,1,0.967,1.595,1.745,2.009,-0.05,0.67,0.8,1.01,9.74E-01,1.42E-01,5.11E-01,4.31E-01,8.41E+05,8.70E+05,1.19E+06,1.52E+06,2,2,4,3,,,,2.09E+06,3.39E+05,,,9.61E+05,,7.87E+05,,7.89E+06,3.17E+05,1.54E+06,9.22E+05,,4.52E+04,1.52E+06,1.99E+06,,,,,2.09E+06,1.75E+04,,,8.87E+03,,8.37E+03,,3.52E+05,2.57E+03,2.08E+05,2.29E+04,,1.27E+04,1.08E+04,4.65E+04,,0.001,FALSE,3.167,4,1,370,42.6,6.93,1,other biological processes,other cell component,Pf10230,,B5MDU6,ENSG00000118961,,,0,0,101.91,14.06,131.82,85.63,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,139.48,120.67,46.93,140.55,2.83,other molecular function,0,
Master Protein,Medium,Q14181,POLA2,DNA polymerase alpha subunit B OS=Homo sapiens OX=9606 GN=POLA2 PE=1 SV=2,1,1,0.967,3.383,2.595,1.26,-0.05,1.76,1.38,0.33,9.83E-01,4.08E-02,4.32E-01,6.83E-01,1.48E+05,1.53E+05,4.99E+05,3.96E+05,1,1,1,2,,,,1.48E+05,,,,,1.53E+05,,,,4.99E+05,,,,6.48E+05,,2.42E+05,,,,,1.48E+05,,,,,4.30E+03,,,,4.05E+03,,,,1.82E+05,,5.66E+03,,0.012,FALSE,2.195,3,1,598,65.9,5.24,1,DNA metabolism;RNA metabolism OR transcription;other metabolic processes;transport,cytosol;nucleus,"Pf04042, Pf08418",23649,B4DNB4; hsa:23649; Q14181; Q9BPV3,ENSG00000014138,Activation of the pre-replicative complex; Defective pyroptosis; Inhibition of replication initiation of damaged DNA by RB1/E2F1; Polymerase switching on the C-strand of the telomere; Telomere C-strand synthesis initiation; DNA replication initiation; Polymerase switching; Removal of the Flap Intermediate,Pyrimidine metabolism; G1 to S cell cycle control; DNA replication,12,0,,,,64.57,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,0,76.09,76.09,2.58,nucleic acid binding activity,0,
Master Protein,High,Q14699,RFTN1,Raftlin OS=Homo sapiens OX=9606 GN=RFTN1 PE=1 SV=4,8,19,0.966,0.902,1.244,1.89,-0.05,-0.15,0.31,0.92,9.65E-01,5.93E-01,9.34E-01,4.62E-01,8.16E+05,1.38E+05,1.72E+06,1.62E+05,5,3,5,4,4.63E+04,2.98E+06,1.98E+04,8.16E+05,1.12E+06,1.16E+06,1.38E+05,,5.02E+04,,1.96E+06,9.01E+05,4.23E+05,3.45E+06,1.72E+06,1.17E+05,1.65E+05,8.09E+05,,1.60E+05,1.84E+02,1.13E+04,1.94E+02,8.16E+05,5.78E+04,4.14E+03,2.46E+03,,1.42E+03,,1.17E+04,4.02E+04,3.44E+03,4.65E+05,4.29E+04,2.27E+02,4.63E+04,5.73E+03,,1.70E+03,0,FALSE,44.66,27,8,578,63.1,5.67,8,cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf15250,23180,hsa:23180; Q0D2G0; Q14699; Q496Y2; Q4QQI7; Q5JB48; Q7Z7P2,ENSG00000131378,,,0,0,121.34,137.33,68.71,106.09,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,89.9,117.05,100.63,93.33,47.96,nucleic acid binding activity,0,
Master Protein,High,P09525,ANXA4,Annexin A4 OS=Homo sapiens OX=9606 GN=ANXA4 PE=1 SV=4,10,28,0.965,2.196,1.457,1.427,-0.05,1.14,0.54,0.51,9.73E-01,7.56E-02,7.07E-01,6.95E-01,1.16E+05,1.02E+06,4.20E+06,2.08E+06,5,4,5,5,1.16E+05,7.01E+04,5.00E+04,3.22E+06,2.82E+06,,5.20E+05,1.05E+06,9.91E+05,1.58E+06,2.47E+05,3.36E+06,1.47E+07,4.20E+06,1.36E+07,3.95E+06,8.40E+05,1.57E+06,1.82E+07,2.08E+06,4.62E+02,2.66E+02,4.89E+02,3.22E+06,1.45E+05,,9.25E+03,9.66E+03,2.79E+04,1.68E+04,1.48E+03,1.50E+05,1.20E+05,5.67E+05,3.37E+05,7.70E+03,2.36E+05,1.11E+04,4.26E+05,2.22E+04,0,FALSE,34.135,37,10,319,35.9,6.13,10,signal transduction;other biological processes,plasma membrane;other membranes;nucleus;other cell component,Pf00191,307,B4DDF9; hsa:307; P09525; Q6LES2; Q96F33; Q9BWK1,ENSG00000196975,,Prostaglandin synthesis and regulation,1,0,128.83,42,90.07,136.75,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,70.41,107.31,113.39,107.91,72.27,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q96DB5,RMDN1,Regulator of microtubule dynamics protein 1 OS=Homo sapiens OX=9606 GN=RMDN1 PE=1 SV=1,2,3,0.962,1.029,0.66,3.077,-0.06,0.04,-0.6,1.62,9.72E-01,5.11E-01,5.36E-01,2.28E-01,7.02E+05,4.73E+05,5.97E+05,1.47E+05,3,1,3,3,2.22E+06,,,5.32E+05,7.02E+05,,,,4.73E+05,,,2.28E+05,,1.04E+06,5.97E+05,,1.22E+05,8.58E+05,1.47E+05,,8.84E+03,,,5.32E+05,3.62E+04,,,,1.33E+04,,,1.02E+04,,1.40E+05,1.48E+04,,3.43E+04,6.08E+03,3.43E+03,,0,FALSE,4.455,6,2,314,35.8,8.5,2,cell cycle OR cell proliferation;cell organization and biogenesis,cytoskeleton;mitochondrion;other cell component,Pf21033,51115,A9UMZ8; B4DNF5; B4DZW6; B5MC61; C9JSC6; E7EVI2; hsa:51115; Q96DB5; Q9Y398,ENSG00000176623,,,0,0,80.83,,65.25,111.24,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,81.09,47.92,176.78,97.05,6.95,cytoskeletal activity,0,
Master Protein,High,Q9HD20,ATP13A1,Endoplasmic reticulum transmembrane helix translocase OS=Homo sapiens OX=9606 GN=ATP13A1 PE=1 SV=2,3,4,0.961,0.898,0.531,1.734,-0.06,-0.15,-0.91,0.79,9.84E-01,7.23E-01,5.11E-01,4.94E-01,1.92E+05,1.23E+05,5.14E+05,1.37E+05,4,2,5,3,4.37E+05,,8.46E+04,6.02E+05,7.62E+04,,1.72E+05,,,8.80E+04,5.14E+05,3.20E+05,5.23E+05,5.45E+05,4.20E+05,,1.37E+05,,9.16E+04,2.94E+05,1.74E+03,,8.26E+02,6.02E+05,3.93E+03,,3.06E+03,,,9.36E+02,3.07E+03,1.43E+04,4.25E+03,7.34E+04,1.04E+04,,3.85E+04,,2.14E+03,3.13E+03,0,FALSE,14.26,5,3,1204,132.9,8.13,3,transport;other biological processes,other membranes;ER/Golgi,Pf00122,57130,B3KPJ2; B3KTA7; hsa:57130; Q6NT90; Q6ZMG7; Q9H6C6; Q9HD20,ENSG00000105726,Ion transport by P-type ATPases,,1,0,87.47,45.78,20.21,61.04,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,75.89,95.87,55.78,81.49,13.59,transporter activity;other molecular function,0,
Master Protein,Medium,Q16769,QPCT,Glutaminyl-peptide cyclotransferase OS=Homo sapiens OX=9606 GN=QPCT PE=1 SV=1,1,1,0.959,0.01,0.01,,-0.06,-6.64,-6.64,,9.34E-01,1.00E-17,1.00E-17,,2.74E+05,2.86E+05,,,2,3,,,2.32E+05,,,,3.24E+05,1.03E+05,,,2.86E+05,8.31E+05,,,,,,,,,,,9.21E+02,,,,1.67E+04,3.68E+02,,,8.05E+03,8.84E+03,,,,,,,,,,,0.012,FALSE,2.176,4,1,361,40.9,6.61,1,protein metabolism;other metabolic processes,non-structural extracellular;other cell component,Pf04389,25797,hsa:25797; Q16769; Q16770; Q3KRG6; Q53TR4,ENSG00000115828,Neutrophil degranulation,,1,0,23.48,93.09,,,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,93.86,,,,3.04,other molecular function,0,
Master Protein,High,C9IZQ1,SSR1,Translocon-associated protein subunit alpha OS=Homo sapiens OX=9606 GN=SSR1 PE=1 SV=1,3,23,0.958,3.208,1.36,3.331,-0.06,1.68,0.44,1.74,8.78E-01,2.35E-02,7.94E-01,2.53E-01,3.39E+06,1.40E+06,7.83E+06,4.30E+06,4,4,5,5,1.33E+06,2.16E+06,,1.30E+07,5.33E+06,1.20E+07,,1.73E+06,1.86E+05,1.13E+06,4.42E+06,4.00E+06,7.83E+06,1.00E+07,1.14E+07,4.80E+06,3.02E+06,4.63E+06,3.29E+06,4.30E+06,5.28E+03,8.22E+03,,1.30E+07,2.75E+05,4.25E+04,,1.60E+04,5.24E+03,1.20E+04,2.65E+04,1.78E+05,6.36E+04,1.35E+06,2.82E+05,9.35E+03,8.49E+05,3.28E+04,7.70E+04,4.58E+04,0,FALSE,8.73,11,3,298,33.9,4.69,3,,other membranes;ER/Golgi,Pf03896,,C9IZQ1,ENSG00000124783,,,0,0,97.45,146.86,43.61,20.07,Peak Found,High,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,141.6,125.58,135.99,100.7,51.21,,0,
Master Protein,High,A0A8Q3WKZ1,ADA,Adenosine deaminase OS=Homo sapiens OX=9606 GN=ADA PE=1 SV=1,3,8,0.958,1.245,0.01,100,-0.06,0.32,-6.64,6.64,9.99E-01,4.59E-01,1.00E-17,1.00E-17,1.43E+05,1.07E+05,3.61E+05,,3,1,4,,,8.78E+04,,2.95E+05,1.43E+05,,,,1.07E+05,,,2.57E+05,1.38E+05,6.28E+05,5.05E+05,,,,,,,3.34E+02,,2.95E+05,7.39E+03,,,,3.01E+03,,,1.15E+04,1.12E+03,8.46E+04,1.25E+04,,,,,,0,FALSE,14.582,10,3,441,49.3,6.83,3,other metabolic processes,plasma membrane;other membranes;other cell component,Pf00962,,A0A8Q3WKZ1,ENSG00000196839,,,0,0,61.1,,58.62,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,47.91,77.56,,,21.1,other molecular function,0,
Master Protein,High,Q9HAV0,GNB4,Guanine nucleotide-binding protein subunit beta-4 OS=Homo sapiens OX=9606 GN=GNB4 PE=1 SV=3,6,34,0.957,0.047,0.154,0.225,-0.06,-4.41,-2.7,-2.15,9.11E-01,6.05E-04,7.19E-02,2.96E-01,3.89E+05,3.16E+05,9.72E+04,4.86E+04,3,2,2,2,3.89E+05,,1.77E+05,6.34E+05,,,2.90E+05,3.44E+05,,,,1.09E+04,,8.66E+05,,,2.45E+04,,9.61E+04,,1.55E+03,,1.73E+03,6.34E+05,,,5.16E+03,3.18E+03,,,,4.87E+02,,1.17E+05,,,6.90E+03,,2.25E+03,,0,FALSE,22.335,23,2,340,37.5,6,6,signal transduction,plasma membrane;other membranes;cytosol;other cell component,Pf00400,59345,B3KMH5; D3DNR8; hsa:59345; Q9HAV0,ENSG00000114450,"G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; G alpha (12/13) signalling events; G alpha (q) signalling events; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation",Myometrial relaxation and contraction pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells,34,0,57.1,12.04,137.9,83.9,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,32.44,72.92,100.32,109.26,71.85,other molecular function,0,
Master Protein,High,Q9Y230,RUVBL2,RuvB-like 2 OS=Homo sapiens OX=9606 GN=RUVBL2 PE=1 SV=3,18,43,0.955,0.696,0.617,1.212,-0.07,-0.52,-0.7,0.28,8.75E-01,9.93E-01,4.70E-01,7.45E-01,3.13E+06,1.62E+06,2.34E+06,1.42E+06,5,5,5,5,6.44E+06,1.13E+06,2.44E+06,7.80E+06,3.13E+06,4.53E+06,5.95E+05,2.45E+06,1.00E+05,1.62E+06,2.34E+06,2.25E+06,1.17E+06,5.81E+06,2.69E+06,1.42E+06,1.19E+06,2.12E+06,1.30E+06,4.51E+06,2.56E+04,4.29E+03,2.38E+04,7.80E+06,1.62E+05,1.61E+04,1.06E+04,2.26E+04,2.82E+03,1.73E+04,1.40E+04,1.01E+05,9.55E+03,7.83E+05,6.68E+04,2.77E+03,3.34E+05,1.50E+04,3.03E+04,4.80E+04,0,FALSE,75.84,56,18,463,51.1,5.64,18,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf06068, Pf17856",10856,B3KQ59; E7ETE5; hsa:10856; Q6FIB9; Q6PK27; Q9Y230; Q9Y361,ENSG00000183207,HATs acetylate histones; Telomere Extension By Telomerase,,2,0,67.16,94.02,61.27,66.05,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,Phospho [S339],FALSE,109.44,87.23,109.95,118.13,128.1,nucleic acid binding activity;other molecular function,1,Phospho [S339]
Master Protein,High,P61225,RAP2B,Ras-related protein Rap-2b OS=Homo sapiens OX=9606 GN=RAP2B PE=1 SV=1,3,12,0.955,0.627,0.834,0.913,-0.07,-0.67,-0.26,-0.13,9.65E-01,9.64E-01,8.42E-01,8.89E-01,9.47E+05,1.49E+06,8.22E+05,5.87E+05,4,3,4,2,9.97E+06,4.51E+05,1.99E+06,3.76E+04,,,,1.68E+06,1.49E+06,7.17E+05,3.89E+06,,6.92E+04,5.84E+05,1.16E+06,,1.71E+05,,2.01E+06,,3.96E+04,1.71E+03,1.94E+04,3.76E+04,,,,1.55E+04,4.19E+04,7.63E+03,2.32E+04,,5.62E+02,7.87E+04,2.87E+04,,4.81E+04,,4.71E+04,,0,FALSE,25.537,21,3,183,20.5,4.81,3,cell adhesion;stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf00071,5912,hsa:5912; P17964; P61225; Q96EG5; Q9CXG0,ENSG00000181467,Neutrophil degranulation,,1,0,149.43,39.28,119.43,119.24,High,Peak Found,Peak Found,High,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,High,High,n/a,High,n/a,High,n/a,1,,FALSE,110.47,124.29,18.94,82.83,41.02,other molecular function,0,
Master Protein,High,Q9BWF3,RBM4,RNA-binding protein 4 OS=Homo sapiens OX=9606 GN=RBM4 PE=1 SV=1,6,8,0.953,0.219,4.585,0.041,-0.07,-2.19,2.2,-4.61,9.73E-01,1.49E-01,8.70E-02,9.52E-03,6.04E+05,3.85E+05,8.46E+04,1.67E+06,2,5,2,2,,,,7.36E+05,4.96E+05,5.65E+05,1.69E+05,3.85E+05,4.79E+05,2.78E+05,,,,1.67E+05,4.28E+04,,,2.05E+06,,1.37E+06,,,,7.36E+05,2.56E+04,2.01E+03,3.01E+03,3.55E+03,1.35E+04,2.96E+03,,,,2.26E+04,1.06E+03,,,1.45E+04,,1.46E+04,0,FALSE,26.638,24,6,364,40.3,7.08,6,cell-cell signaling;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes,cytosol;nucleus;other cell component,"Pf00076, Pf00098",5936,B3KUN0; B4E1U0; E7EQS3; hsa:5936; O02916; Q4VC48; Q6P1P2; Q8WU85; Q9BWF3,ENSG00000173933,Circadian Clock,,1,0,27.65,41.86,83.88,28.14,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,53.74,28.28,44.55,58.89,24.34,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P46060,RANGAP1,Ran GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RANGAP1 PE=1 SV=1,5,9,0.953,1.999,,1.941,-0.07,1,,0.96,9.82E-01,9.70E-02,,4.22E-01,7.07E+05,3.82E+05,8.65E+05,8.40E+04,4,1,5,2,1.08E+06,6.57E+05,,7.62E+05,8.11E+04,,,,,3.82E+05,1.67E+05,3.93E+06,7.21E+05,1.57E+06,8.65E+05,,6.50E+04,,1.09E+05,,4.28E+03,2.50E+03,,7.62E+05,4.19E+03,,,,,4.06E+03,9.97E+02,1.75E+05,5.86E+03,2.11E+05,2.15E+04,,1.83E+04,,2.54E+03,,0,FALSE,16.817,8,5,587,63.5,4.68,5,protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf07834, Pf13516",5905,hsa:5905; P46060; Q96JJ2,ENSG00000100401,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Rev-mediated nuclear export of HIV RNA; SUMOylation of DNA replication proteins; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation; SUMOylation of nuclear envelope proteins,22q11.2 copy number variation syndrome; IL-18 signaling pathway,12,0,64.51,,101.63,35.43,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,111.06,111.14,,59.22,24.67,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,H7C2Q8,EBNA1BP2,EBNA1 binding protein 2 OS=Homo sapiens OX=9606 GN=EBNA1BP2 PE=1 SV=1,2,3,0.952,0.587,2.701,0.027,-0.07,-0.77,1.43,-5.23,9.57E-01,8.81E-01,2.47E-01,1.32E-03,1.84E+06,6.30E+05,5.19E+05,2.48E+06,3,5,3,3,,1.86E+06,,9.54E+05,1.84E+06,3.65E+05,9.17E+05,2.48E+06,4.01E+05,6.30E+05,8.89E+05,5.19E+05,,6.61E+04,,,,2.48E+06,8.76E+04,4.02E+06,,7.08E+03,,9.54E+05,9.47E+04,1.30E+03,1.63E+04,2.29E+04,1.13E+04,6.70E+03,5.32E+03,2.32E+04,,8.91E+03,,,,1.76E+04,2.05E+03,4.28E+04,0,FALSE,4.523,7,2,361,40.7,9.98,2,other biological processes,nucleus;other cell component,Pf05890,10969,H7C2Q8,ENSG00000117395,,,0,0,33.36,91.73,83.88,90.26,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,84.77,96.98,140.63,92.27,7.02,,0,
Master Protein,High,P62304,SNRPE,Small nuclear ribonucleoprotein E OS=Homo sapiens OX=9606 GN=SNRPE PE=1 SV=1,2,3,0.95,0.572,0.909,0.639,-0.07,-0.81,-0.14,-0.65,8.70E-01,8.01E-01,8.00E-01,7.74E-01,2.97E+06,2.81E+06,1.25E+06,2.66E+06,5,5,4,4,2.97E+06,6.36E+06,3.68E+06,2.97E+06,1.63E+06,6.70E+06,2.05E+06,3.76E+06,1.06E+06,2.81E+06,4.40E+06,1.70E+06,9.23E+05,7.69E+04,,7.20E+06,,2.78E+06,3.88E+05,2.55E+06,1.18E+04,2.42E+04,3.60E+04,2.97E+06,8.41E+04,2.38E+04,3.65E+04,3.47E+04,2.98E+04,2.99E+04,2.63E+04,7.59E+04,7.50E+03,1.04E+04,,1.40E+04,,1.97E+04,9.07E+03,2.71E+04,0,FALSE,6.898,39,2,92,10.8,9.44,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf01423,6635,B2R5B9; hsa:6635; P08578; P62304; Q15498; Q5BKT2,ENSG00000182004,snRNP Assembly; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Minor Pathway; SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,mRNA processing,8,0,49.73,65.77,105.43,88.51,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,78.07,87.84,93.41,110.2,10.8,nucleic acid binding activity,0,
Master Protein,High,A0A024R6I7,SERPINA1,Alpha-1-antitrypsin OS=Homo sapiens OX=9606 GN=SERPINA1 PE=1 SV=1,3,6,0.95,9.085,1.866,1.267,-0.07,3.18,0.9,0.34,9.45E-01,5.10E-05,6.16E-01,6.81E-01,1.51E+05,2.47E+05,2.58E+06,6.01E+05,4,2,3,3,,2.54E+05,2.22E+05,3.03E+04,1.02E+05,,,,7.49E+04,8.13E+05,,,2.58E+06,3.13E+06,8.09E+05,7.69E+05,6.01E+05,,2.53E+05,,,9.65E+02,2.17E+03,3.03E+04,5.27E+03,,,,2.11E+03,8.65E+03,,,2.10E+04,4.22E+05,2.01E+04,1.50E+03,1.69E+05,,5.93E+03,,0,FALSE,16.292,9,3,418,46.7,5.59,3,,non-structural extracellular,,,A0A024R6N5,ENSG00000277377,,,0,0,68.53,117.59,55.85,48.6,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,88.59,117.86,61.72,99.74,17.68,enzyme regulator activity,0,
Master Protein,High,Q92466,DDB2,DNA damage-binding protein 2 OS=Homo sapiens OX=9606 GN=DDB2 PE=1 SV=1,2,6,0.95,1.925,1.758,1.775,-0.07,0.95,0.81,0.83,9.44E-01,1.22E-01,6.59E-01,4.77E-01,3.83E+05,1.49E+05,8.98E+05,2.62E+05,4,3,5,3,1.68E+05,1.81E+05,,8.10E+05,1.06E+06,1.49E+05,,1.49E+05,,7.59E+04,6.05E+05,4.11E+04,9.16E+05,1.67E+06,8.98E+05,,,2.62E+05,8.19E+04,2.82E+05,6.66E+02,6.87E+02,,8.10E+05,5.49E+04,5.29E+02,,1.38E+03,,8.07E+02,3.62E+03,1.84E+03,7.44E+03,2.25E+05,2.23E+04,,,1.86E+03,1.92E+03,3.00E+03,0,FALSE,4.905,4,2,427,47.8,9.47,2,protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf00400,1643,B2R875; hsa:1643; Q76E54; Q76E55; Q76E56; Q76E57; Q92466,ENSG00000134574,Dual Incision in GG-NER; Neddylation; Ub-specific processing proteases; TP53 Regulates Transcription of DNA Repair Genes; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER,"miRNA regulation of DNA damage response; miRNA regulation of p53 pathway in prostate cancer; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Small cell lung cancer; Hepatitis B infection; Melanoma; Nucleotide excision repair; DNA repair pathways, full network; p53 transcriptional gene network; Nucleotide excision repair in xeroderma pigmentosum ; DNA damage response",21,0,81.45,33.87,71.36,52.83,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,111.7,114.43,57.29,118.4,11,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P49406,MRPL19,"39S ribosomal protein L19, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL19 PE=1 SV=2",3,10,0.949,2.893,1.559,2.656,-0.08,1.53,0.64,1.41,9.31E-01,3.79E-02,7.61E-01,2.90E-01,6.22E+04,6.50E+04,1.10E+06,1.98E+05,5,1,5,4,6.22E+04,1.96E+05,2.28E+04,2.55E+05,6.05E+04,,,,,6.50E+04,1.25E+06,9.32E+04,1.10E+06,1.04E+06,1.12E+06,2.07E+05,4.24E+05,1.20E+05,1.90E+05,,2.47E+02,7.44E+02,2.22E+02,2.55E+05,3.12E+03,,,,,6.91E+02,7.48E+03,4.16E+03,8.95E+03,1.40E+05,2.78E+04,4.03E+02,1.19E+05,8.47E+02,4.44E+03,,0,FALSE,10.152,10,3,292,33.5,9.5,3,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus;nucleus,Pf01245,9801,hsa:9801; P49406; Q53TX9; Q96Q52,ENSG00000115364,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,Cytoplasmic ribosomal proteins,4,0,84.14,,50.94,56.02,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,1.16,131.98,0,136.04,25.82,other molecular function,0,
Master Protein,High,A0A1B0GTJ8,ARID1B,AT-rich interaction domain 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=2,6,9,0.948,1.612,,4.388,-0.08,0.69,,2.13,9.83E-01,2.75E-01,,1.80E-01,1.82E+05,4.59E+04,2.25E+05,5.13E+04,1,1,4,1,,,,1.82E+05,,,4.59E+04,,,,5.71E+04,,2.22E+05,1.55E+06,2.28E+05,,,,5.13E+04,,,,,1.82E+05,,,8.17E+02,,,,3.42E+02,,1.81E+03,2.09E+05,5.67E+03,,,,1.20E+03,,0,FALSE,32.035,5,5,2415,253.8,6.87,6,cell organization and biogenesis,plasma membrane;other membranes;cytosol;nucleus,"Pf01388, Pf12031",,A0A1B0GTJ8,ENSG00000049618,,Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome,3,0,,,135.21,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,68.92,,56.26,32.05,nucleic acid binding activity,0,
Master Protein,Medium,Q16658,FSCN1,Fascin OS=Homo sapiens OX=9606 GN=FSCN1 PE=1 SV=3,1,1,0.947,0.01,0.357,0.01,-0.08,-6.64,-1.49,-6.64,9.95E-01,1.00E-17,3.23E-01,1.00E-17,1.20E+05,1.27E+05,,4.51E+04,5,1,,1,7.64E+04,1.20E+05,3.95E+04,1.39E+05,2.04E+05,,,1.27E+05,,,,,,,,,,,4.51E+04,,3.04E+02,4.56E+02,3.86E+02,1.39E+05,1.05E+04,,,1.17E+03,,,,,,,,,,,1.06E+03,,0.02,FALSE,1.988,2,1,493,54.5,7.24,1,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf06268,6624,A6NI89; B2RE97; hsa:6624; Q16658; Q96IC5; Q96IH1; Q9BRF1,ENSG00000075618,Interleukin-4 and Interleukin-13 signaling,VEGFA-VEGFR2 signaling; Urotensin-II-mediated signaling pathway,3,0,54.04,,,,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,60.93,,0,,2.7,cytoskeletal activity;other molecular function,0,
Master Protein,High,P17096,HMGA1,High mobility group protein HMG-I/HMG-Y OS=Homo sapiens OX=9606 GN=HMGA1 PE=1 SV=3,5,68,0.947,0.197,0.63,0.269,-0.08,-2.34,-0.67,-1.9,8.67E-01,6.39E-02,4.71E-01,2.83E-01,1.66E+07,4.74E+06,1.46E+06,3.34E+06,5,5,5,5,5.83E+05,6.59E+07,1.74E+06,1.66E+07,2.71E+07,8.72E+05,4.50E+06,2.09E+07,4.74E+06,5.05E+07,4.77E+05,4.85E+06,1.15E+06,1.46E+06,1.09E+07,3.34E+06,1.99E+05,2.55E+06,1.10E+07,1.83E+07,2.32E+03,2.50E+05,1.70E+04,1.66E+07,1.40E+06,3.10E+03,8.00E+04,1.92E+05,1.34E+05,5.37E+05,2.85E+03,2.16E+05,9.32E+03,1.96E+05,2.71E+05,6.52E+03,5.59E+04,1.81E+04,2.57E+05,1.95E+05,0,FALSE,36.184,49,5,107,11.7,10.32,5,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,,3159,hsa:3159; P10910; P17096; Q5T6U9; Q9UKB0,ENSG00000137309,Vpr-mediated nuclear import of PICs; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection; Formation of Senescence-Associated Heterochromatin Foci (SAHF),Adipogenesis; Pre-implantation embryo; Male infertility; 7q11.23 copy number variation syndrome; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Orexin receptor pathway,13,0,119.23,126.6,114.97,105.47,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,143.04,132.26,129.31,133.71,170.45,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P57088,TMEM33,Transmembrane protein 33 OS=Homo sapiens OX=9606 GN=TMEM33 PE=1 SV=2,3,9,0.946,0.584,0.276,1.164,-0.08,-0.78,-1.86,0.22,8.97E-01,8.64E-01,8.41E-02,7.43E-01,1.77E+06,2.23E+06,1.20E+06,8.86E+05,4,4,4,4,3.08E+06,4.13E+06,1.01E+06,8.47E+04,,3.73E+06,,3.21E+06,1.74E+05,1.55E+06,,5.28E+06,3.16E+05,1.04E+06,1.40E+06,3.69E+06,6.51E+05,1.21E+06,4.53E+05,,1.22E+04,1.57E+04,9.88E+03,8.47E+04,,1.33E+04,,2.96E+04,4.89E+03,1.65E+04,,2.36E+05,2.56E+03,1.40E+05,3.47E+04,7.19E+03,1.83E+05,8.54E+03,1.06E+04,,0,FALSE,9.861,11,3,247,28,9.7,3,cell organization and biogenesis;stress response;other biological processes,other membranes;ER/Golgi;nucleus;other cell component,Pf03661,55161,B3KSS8; hsa:55161; P57088; Q9H953,ENSG00000109133,,,0,0,89.35,74.84,110.98,99.56,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,n/a,1,,FALSE,42.36,109.32,93.57,107.44,24.06,,0,
Master Protein,High,A0A499FJK2,TGFB1,Transforming growth factor beta OS=Homo sapiens OX=9606 GN=TGFB1 PE=1 SV=1,1,3,0.944,2.233,5.018,0.31,-0.08,1.16,2.33,-1.69,9.40E-01,2.26E-01,1.57E-01,3.87E-01,6.12E+04,6.49E+04,1.01E+05,3.26E+05,3,1,4,3,6.12E+04,,7.22E+04,5.20E+03,,,,,,6.49E+04,1.13E+05,,4.90E+04,1.96E+05,9.08E+04,1.16E+06,5.27E+03,,3.26E+05,,2.43E+02,,7.05E+02,5.20E+03,,,,,,6.90E+02,6.73E+02,,3.98E+02,2.64E+04,2.26E+03,2.26E+03,1.48E+03,,7.62E+03,,0.007,FALSE,2.393,3,1,390,44.3,8.53,1,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;extracellular matrix;other cell component,"Pf00019, Pf00688",7040,A0A499FJK2; hsa:7040,ENSG00000105329,,MicroRNAs in cardiomyocyte hypertrophy; Transcription factors regulate miRNAs related to cardiac hypertrophy; Cell cycle; Allograft rejection; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Cardiac progenitor differentiation; Spinal cord injury; Primary focal segmental glomerulosclerosis (FSGS); Cardiac hypertrophic response; Mammary gland development pathway - Embryonic development (Stage 1 of 4); Pluripotent stem cell differentiation pathway; Endoderm differentiation; Dopaminergic neurogenesis; IL-3 signaling pathway; Extracellular vesicle-mediated signaling in recipient cells; Aryl hydrocarbon receptor pathway; Vitamin D receptor pathway; Nuclear receptors meta-pathway; NRF2 pathway; Lung fibrosis; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; Interactions between LOXL4 and oxidative stress pathway; MAPK signaling pathway; Canonical and non-canonical TGF-B signaling; Clear cell renal cell carcinoma pathways; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; Type 2 papillary renal cell carcinoma; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Neovascularization processes; Nonalcoholic fatty liver disease; Platelet-mediated interactions with vascular and circulating cells; Control of immune tolerance by vasoactive intestinal peptide; Selective expression of chemokine receptors during T-cell polarization; Signal transduction through IL1R; Envelope proteins and their potential roles in EDMD physiopathology; Interactions between immune cells and microRNAs in tumor microenvironment; Hepatitis B infection; Endochondral ossification; Endochondral ossification with skeletal dysplasias; TGF-beta receptor signaling in skeletal dysplasias; Regucalcin in proximal tubule epithelial kidney cells; Overlap between signal transduction pathways contributing to LMNA laminopathies; 3q29 copy number variation syndrome; Angiotensin II receptor type 1 pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response; T cell modulation in pancreatic cancer; Neuroinflammation and glutamatergic signaling; Pleural mesothelioma; Complement system in neuronal development and plasticity; Overview of proinflammatory and profibrotic mediators; CCL18 signaling pathway; Progeria-associated lipodystrophy; Th17 cell differentiation pathway; Urotensin-II-mediated signaling pathway; Ulcerative colitis signaling; Inflammatory bowel disease signaling; Clock-controlled autophagy in bone metabolism; Markers of kidney cell lineage; Comprehensive IL-17A signaling; Cell interactions of the pancreatic cancer microenvironment; Immune infiltration in pancreatic cancer; Cytokines and inflammatory response; 1p36 copy number variation syndrome; Macrophage-stimulating protein (MSP) signaling network map; Affected pathways in Duchenne muscular dystrophy; IL-19 signaling pathway; ACE inhibitor pathway; TGF-beta receptor signaling; T-cell receptor signaling pathway; DNA damage response (only ATM dependent),75,0,77.75,,55.13,119.89,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,22.47,79.94,145.86,145.85,6.1,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,D6RFN0,COPS4,COP9 signalosome complex subunit 4 OS=Homo sapiens OX=9606 GN=COPS4 PE=1 SV=1,2,2,0.943,1.323,0.453,2.754,-0.09,0.4,-1.14,1.46,9.57E-01,4.18E-01,4.22E-01,2.89E-01,2.18E+05,2.31E+05,2.88E+05,1.05E+05,1,2,1,1,,2.18E+05,,,,4.96E+05,,,1.08E+05,,2.88E+05,,,,,,1.05E+05,,,,,8.28E+02,,,,1.77E+03,,,3.03E+03,,1.72E+03,,,,,,2.94E+04,,,,0,FALSE,6.566,6,2,438,49.7,5.81,2,,ER/Golgi;nucleus;other cell component,"Pf01399, Pf18420",,D6RFN0,ENSG00000138663,,Ciliary landscape,1,0,,91.03,,,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,Phospho [Y139],FALSE,124.7,0,124.7,0,6.25,,1,Phospho [Y139]
Master Protein,High,A0A499FHX9,MCM3,DNA replication licensing factor MCM3 OS=Homo sapiens OX=9606 GN=MCM3 PE=1 SV=1,11,35,0.942,0.758,0.72,1.315,-0.09,-0.4,-0.47,0.39,8.63E-01,8.93E-01,7.19E-01,6.57E-01,6.01E+06,1.40E+06,2.60E+06,5.25E+05,5,5,5,4,1.27E+07,7.02E+06,8.50E+05,6.01E+06,8.16E+05,3.37E+06,4.61E+05,1.40E+06,4.34E+05,7.41E+06,3.72E+06,2.11E+06,7.96E+05,1.30E+07,2.60E+06,2.43E+05,,1.13E+06,1.30E+06,8.29E+04,5.04E+04,2.67E+04,8.31E+03,6.01E+06,4.21E+04,1.20E+04,8.20E+03,1.29E+04,1.22E+04,7.87E+04,2.23E+04,9.43E+04,6.46E+03,1.75E+06,6.46E+04,4.74E+02,,8.03E+03,3.03E+04,8.83E+02,0,FALSE,35.862,19,11,818,91.9,6.33,11,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes,cytoskeleton;nucleus;other cell component,"Pf00493, Pf17207, Pf17855",4172,A0A499FHX9,ENSG00000112118,,Cell cycle; Retinoblastoma gene in cancer; Ciliary landscape; G1 to S cell cycle control; DNA replication,5,0,90.23,112.23,109.96,89.18,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,118.51,122.6,93.75,101.28,99.41,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q99757,TXN2,"Thioredoxin, mitochondrial OS=Homo sapiens OX=9606 GN=TXN2 PE=1 SV=2",3,28,0.941,0.593,5.811,1.524,-0.09,-0.75,2.54,0.61,9.47E-01,8.89E-01,7.85E-02,5.98E-01,1.68E+06,6.28E+05,1.68E+06,8.60E+05,3,4,4,5,,1.04E+06,,1.91E+06,1.68E+06,,1.23E+06,2.94E+06,6.85E+04,3.21E+05,,8.38E+05,1.46E+06,1.94E+06,3.34E+06,3.60E+05,2.06E+06,8.60E+05,2.52E+06,8.84E+04,,3.95E+03,,1.91E+06,8.66E+04,,2.18E+04,2.71E+04,1.93E+03,3.41E+03,,3.74E+04,1.18E+04,2.62E+05,8.29E+04,7.02E+02,5.79E+05,6.10E+03,5.89E+04,9.41E+02,0,FALSE,17.156,37,3,166,18.4,8.29,3,stress response;other biological processes,mitochondrion;nucleus;other cell component,Pf00085,25828,hsa:25828; Q5JZA0; Q6FH60; Q99757; Q9UH29,ENSG00000100348,Detoxification of Reactive Oxygen Species; Degradation of cysteine and homocysteine,Oxidative stress response,3,0,29.14,114.13,56.1,90.36,n/a,Peak Found,n/a,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,136.19,92.71,117.47,109.79,87.31,other molecular function,0,
Master Protein,High,F5H5P2,,2-oxoisovalerate dehydrogenase subunit alpha OS=Homo sapiens OX=9606 PE=3 SV=1,1,2,0.941,0.41,0.01,100,-0.09,-1.29,-6.64,6.64,9.89E-01,4.57E-01,1.00E-17,1.00E-17,5.97E+05,6.35E+05,2.45E+05,,1,1,3,,,,,5.97E+05,,,,,,6.35E+05,,3.22E+05,,2.23E+05,2.45E+05,,,,,,,,,5.97E+05,,,,,,6.75E+03,,1.44E+04,,3.00E+04,6.08E+03,,,,,,0.002,FALSE,3.048,3,1,479,54.2,6.43,1,,mitochondrion,Pf00676,,,,,,0,0,,,19.79,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,14.68,,,4.54,other molecular function,0,
Master Protein,High,Q16698,DECR1,"2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial OS=Homo sapiens OX=9606 GN=DECR1 PE=1 SV=1",5,31,0.94,2.101,0.291,4.539,-0.09,1.07,-1.78,2.18,9.63E-01,7.52E-02,1.48E-01,1.29E-01,2.25E+05,2.12E+05,3.68E+06,4.31E+05,5,3,5,4,1.72E+05,2.25E+05,1.99E+05,4.88E+06,2.01E+06,,3.05E+04,,2.12E+05,1.94E+06,6.50E+05,1.03E+07,3.68E+06,2.77E+06,4.09E+06,2.04E+05,6.86E+05,,3.30E+05,5.63E+05,6.83E+02,8.55E+02,1.94E+03,4.88E+06,1.04E+05,,5.43E+02,,5.96E+03,2.07E+04,3.89E+03,4.61E+05,2.99E+04,3.74E+05,1.02E+05,3.97E+02,1.93E+05,,7.73E+03,5.99E+03,0,FALSE,30.076,25,5,335,36,9.28,5,other metabolic processes;other biological processes,cytosol;mitochondrion;nucleus;other cell component,Pf13561,1666,B7Z6B8; hsa:1666; Q16698; Q2M304; Q93085,ENSG00000104325,mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,Fatty acid beta-oxidation; Fatty acid biosynthesis; VEGFA-VEGFR2 signaling; Omega-6-fatty acids in senescence,5,0,136.73,144.95,84.05,49.03,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,126.88,97.29,143.85,116.62,110.19,other molecular function,0,
Master Protein,High,P16949,STMN1,Stathmin OS=Homo sapiens OX=9606 GN=STMN1 PE=1 SV=3,3,20,0.938,0.428,1.787,0.19,-0.09,-1.22,0.84,-2.4,9.94E-01,5.35E-01,5.69E-01,2.22E-01,8.62E+05,5.28E+05,3.17E+05,1.22E+06,4,4,4,4,,1.27E+06,1.25E+05,5.88E+05,1.41E+07,,6.08E+05,4.59E+05,2.57E+05,1.45E+06,,9.05E+04,2.87E+05,5.60E+05,3.51E+05,,9.26E+04,7.05E+06,2.43E+05,6.12E+06,,4.81E+03,1.22E+03,5.88E+05,7.30E+05,,1.08E+04,4.24E+03,7.23E+03,1.55E+04,,4.04E+03,2.33E+03,7.54E+04,8.73E+03,,2.60E+04,4.99E+04,5.69E+03,6.51E+04,0,FALSE,9.221,25,3,149,17.3,5.97,3,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;other cell component,Pf00836,3925,A2A2D1; B2R4E7; B7Z8N4; D3DPJ5; hsa:3925; P16949,ENSG00000117632,Nuclear signaling by ERBB4,Microtubule cytoskeleton regulation; Retinoblastoma gene in cancer; RAC1/PAK1/p38/MMP2 pathway; MAPK signaling pathway; EGF/EGFR signaling pathway; IL-18 signaling pathway,7,0,167.69,75.81,60.05,110.32,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,High,Peak Found,High,1,,FALSE,139.61,100.08,139.3,138.53,52.53,cytoskeletal activity,0,
Master Protein,High,Q9H4B7,TUBB1,Tubulin beta-1 chain OS=Homo sapiens OX=9606 GN=TUBB1 PE=1 SV=1,15,184,0.938,0.134,1.492,0.967,-0.09,-2.9,0.58,-0.05,8.59E-01,1.55E-02,7.05E-01,9.63E-01,9.30E+06,2.54E+06,1.30E+06,4.12E+06,5,4,5,5,9.05E+07,9.30E+06,4.97E+07,1.48E+06,8.69E+06,1.73E+06,,6.29E+06,3.73E+06,4.63E+05,1.05E+06,2.33E+05,1.30E+06,1.40E+06,4.09E+06,2.39E+07,6.55E+05,8.38E+06,8.99E+05,4.12E+06,3.60E+05,3.53E+04,4.85E+05,1.48E+06,4.48E+05,6.14E+03,,5.81E+04,1.05E+05,4.92E+03,6.30E+03,1.04E+04,1.06E+04,1.89E+05,1.02E+05,4.66E+04,1.84E+05,5.94E+04,2.10E+04,4.39E+04,0,FALSE,74.838,51,12,451,50.3,5.17,15,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes,cytoskeleton;other cell component,"Pf00091, Pf03953",81027,hsa:81027; Q9H4B7,ENSG00000101162,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; PKR-mediated signaling; Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,35,0,118.5,83.33,90.1,126.92,High,High,High,Peak Found,High,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,1,,FALSE,118.17,143.15,135.34,121.9,479.48,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A0G2JLV7,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1 OS=Homo sapiens OX=9606 GN=LAIR1 PE=1 SV=1,2,4,0.938,0.48,2.268,,-0.09,-1.06,1.18,,8.57E-01,6.81E-01,3.61E-01,,2.64E+05,4.23E+06,1.82E+05,3.03E+05,4,2,1,3,,8.47E+05,5.61E+04,6.07E+05,1.15E+05,,3.55E+07,5.04E+05,,,,1.82E+05,,,,3.03E+05,,,6.92E+04,4.61E+05,,3.22E+03,5.48E+02,6.07E+05,5.91E+03,,6.32E+05,4.65E+03,,,,8.14E+03,,,,5.90E+02,,,1.62E+03,4.91E+03,0,FALSE,11.817,13,2,287,31.5,5.78,2,,other membranes,Pf13895,,A0A0G2JLV7,ENSG00000276163,,,0,0,94.55,137.47,,70.99,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,96.6,0,77.57,,10.45,,0,
Master Protein,High,P39880,CUX1,Homeobox protein cut-like 1 OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=3,10,17,0.937,0.487,0.485,1.015,-0.09,-1.04,-1.04,0.02,9.22E-01,6.51E-01,3.40E-01,8.32E-01,4.22E+05,2.28E+05,7.45E+05,8.42E+05,5,2,5,4,5.92E+04,3.35E+05,4.22E+05,2.49E+06,3.41E+06,,,5.67E+04,,9.15E+05,4.49E+05,8.51E+05,3.67E+05,1.04E+06,7.45E+05,,1.81E+05,3.12E+06,3.18E+05,2.23E+06,2.35E+02,1.27E+03,4.12E+03,2.49E+06,1.76E+05,,,5.23E+02,,9.73E+03,2.69E+03,3.80E+04,2.98E+03,1.40E+05,1.85E+04,,5.08E+04,2.21E+04,7.44E+03,2.38E+04,0,FALSE,42.427,10,10,1505,164.1,5.9,10,other biological processes,cytosol;ER/Golgi;nucleus;other cell component,"Pf00046, Pf02376",1523,B3KV79; J3KQV9; P39880; Q6NYH4; Q75LE5; Q75MT2; Q75MT3; Q86UJ7; Q9UEV5,ENSG00000257923,Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease,,2,0,112.27,124.91,40.62,98.98,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,106.34,83.29,127.03,122.64,53.68,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P47985,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial OS=Homo sapiens OX=9606 GN=UQCRFS1 PE=1 SV=2",4,10,0.935,0.808,1.728,0.487,-0.1,-0.31,0.79,-1.04,9.84E-01,7.10E-01,6.74E-01,6.74E-01,1.34E+06,4.58E+05,1.03E+06,7.21E+05,5,3,5,3,1.34E+06,5.65E+06,1.79E+05,1.59E+06,6.07E+05,1.94E+06,1.03E+05,,4.58E+05,,3.38E+05,5.69E+06,7.24E+05,1.03E+06,1.51E+06,,7.21E+05,1.01E+06,7.18E+05,,5.34E+03,2.15E+04,1.75E+03,1.59E+06,3.13E+04,6.89E+03,1.83E+03,,1.29E+04,,2.02E+03,2.54E+05,5.88E+03,1.39E+05,3.76E+04,,2.03E+05,7.14E+03,1.68E+04,,0,FALSE,14.756,20,4,274,29.6,8.32,4,cell organization and biogenesis;other metabolic processes;transport,other membranes;mitochondrion,"Pf00355, Pf02921, Pf09165",7386,A8K519; hsa:7386; P47985; Q6NVX5; Q9UPH2,ENSG00000169021,Respiratory electron transport,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly; Iron metabolism disorders; Arsenic metabolism and reactive oxygen species generation,6,0,116.68,116.78,117.4,20.36,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,137.02,104.61,68.4,60.52,28.22,transporter activity;other molecular function,0,
Master Protein,High,P49916,LIG3,DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2,7,12,0.934,0.508,0.237,1.496,-0.1,-0.98,-2.08,0.58,9.35E-01,7.29E-01,1.00E-01,5.68E-01,9.94E+05,1.12E+06,7.10E+05,2.64E+05,4,3,5,3,1.04E+06,1.07E+06,,9.48E+05,1.13E+05,,1.18E+07,,3.43E+05,1.12E+06,7.10E+05,5.91E+05,2.29E+05,7.83E+05,7.43E+05,1.72E+06,1.90E+05,,2.64E+05,,4.14E+03,4.08E+03,,9.48E+05,5.81E+03,,2.10E+05,,9.65E+03,1.19E+04,4.24E+03,2.64E+04,1.86E+03,1.05E+05,1.85E+04,3.35E+03,5.34E+04,,6.18E+03,,0,FALSE,34.221,12,7,1009,112.8,9.01,7,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,mitochondrion;nucleus,"Pf00645, Pf01068, Pf04675, Pf04679, Pf16759",3980,E5KLB5; E5KLB6; hsa:3980; P49916; Q16714; Q6NVK3,ENSG00000005156,Gap-filling DNA repair synthesis and ligation in TC-NER; Gap-filling DNA repair synthesis and ligation in GG-NER; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway; HDR through MMEJ (alt-NHEJ); Resolution of AP sites via the single-nucleotide replacement pathway,"Base excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; 17q12 copy number variation syndrome",9,0,57.61,144.87,36.84,119.04,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,102.75,71.3,102.75,57.58,38.77,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P02765,AHSG,Alpha-2-HS-glycoprotein OS=Homo sapiens OX=9606 GN=AHSG PE=1 SV=2,4,177,0.933,2.955,3.658,0.695,-0.1,1.56,1.87,-0.53,9.79E-01,6.28E-02,2.51E-01,8.84E-01,1.26E+05,1.35E+05,3.71E+05,5.35E+05,2,2,2,4,,2.46E+05,,6.42E+04,,,,,9.39E+04,1.93E+05,,,,3.02E+05,4.57E+05,5.96E+05,8.39E+05,,1.23E+05,4.80E+05,,9.34E+02,,6.42E+04,,,,,2.64E+03,2.05E+03,,,,4.06E+04,1.14E+04,1.16E+03,2.36E+05,,2.89E+03,5.11E+03,0,FALSE,24.968,9,1,367,39.3,5.72,4,stress response;transport;developmental processes;other biological processes,extracellular matrix;ER/Golgi;other cell component,Pf00031,197,A8K9N6; B2R7G1; hsa:197; O14961; O14962; P02765; Q9P152,ENSG00000145192,Neutrophil degranulation; Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,,4,0,82.84,48.96,29.01,58.45,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,74.67,87.02,76.95,47.94,465.18,enzyme regulator activity,0,
Master Protein,High,A0A8V8TQJ0,MSH6,DNA mismatch repair protein OS=Homo sapiens OX=9606 GN=MSH6 PE=1 SV=1,7,8,0.933,0.451,1.538,0.617,-0.1,-1.15,0.62,-0.7,9.73E-01,6.19E-01,7.58E-01,8.47E-01,2.75E+05,1.14E+05,6.93E+04,2.71E+05,4,5,4,4,,1.69E+05,6.46E+05,3.21E+05,2.36E+05,5.63E+05,1.14E+05,2.71E+05,2.56E+04,1.61E+04,8.90E+04,,3.21E+04,2.52E+05,5.40E+04,2.65E+05,4.91E+03,1.25E+06,2.77E+05,,,6.42E+02,6.32E+03,3.21E+05,1.22E+04,2.00E+03,2.03E+03,2.50E+03,7.22E+02,1.71E+02,5.32E+02,,2.61E+02,3.40E+04,1.34E+03,5.17E+02,1.38E+03,8.89E+03,6.48E+03,,0,FALSE,22.195,7,7,1362,152.9,6.92,7,DNA metabolism;other metabolic processes;stress response,other cell component,"Pf00488, Pf00855, Pf01624, Pf05188, Pf05190, Pf05192",,A0A8V8TQJ0,ENSG00000116062,,"Glioblastoma signaling pathways; Chromosomal and microsatellite instability in colorectal cancer ; DNA repair pathways, full network; DNA mismatch repair",4,0,61.65,115.35,93.4,122.25,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,92.01,79.37,145.24,112.89,22.26,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y483,MTF2,Metal-response element-binding transcription factor 2 OS=Homo sapiens OX=9606 GN=MTF2 PE=1 SV=3,4,10,0.932,0.878,0.857,1.926,-0.1,-0.19,-0.22,0.95,9.97E-01,6.59E-01,7.63E-01,4.36E-01,7.89E+05,8.79E+05,5.70E+05,4.38E+05,5,4,4,5,7.89E+05,5.90E+05,4.32E+05,8.74E+05,2.49E+06,,2.68E+06,1.24E+06,6.23E+05,4.24E+05,,4.15E+04,6.18E+05,1.14E+06,5.27E+05,1.01E+06,1.89E+04,1.19E+05,4.38E+05,3.33E+06,3.14E+03,2.24E+03,4.22E+03,8.74E+05,1.29E+05,,4.77E+04,1.14E+04,1.76E+04,4.51E+03,,1.85E+03,5.02E+03,1.53E+05,1.31E+04,1.96E+03,5.31E+03,8.40E+02,1.03E+04,3.55E+04,0,FALSE,13.008,7,4,593,67,8.75,4,cell organization and biogenesis;developmental processes;other biological processes,nucleus;other cell component,"Pf00628, Pf14061, Pf18104",22823,A6NGQ9; A8K2Q3; B1AKT5; B1AKT6; hsa:22823; Q96G26; Q9UES9; Q9UP40; Q9Y483,ENSG00000143033,PRC2 methylates histones and DNA,Mesodermal commitment pathway; Interactome of polycomb repressive complex 2 (PRC2) ; Copper homeostasis,4,0,80.42,82.19,77.35,139.26,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,110.57,103.45,113.63,124.66,25.15,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q29RF7,PDS5A,Sister chromatid cohesion protein PDS5 homolog A OS=Homo sapiens OX=9606 GN=PDS5A PE=1 SV=1,22,54,0.931,0.693,0.477,1.94,-0.1,-0.53,-1.07,0.96,9.95E-01,9.07E-01,3.54E-01,4.32E-01,1.01E+06,4.77E+05,1.15E+06,3.82E+05,5,4,5,5,1.01E+06,4.99E+05,2.48E+05,5.21E+06,1.18E+06,1.39E+06,,1.64E+05,2.49E+05,9.13E+05,1.15E+06,1.01E+06,6.81E+05,4.74E+06,1.64E+06,1.20E+06,1.12E+05,3.82E+05,2.77E+05,1.05E+06,4.01E+03,1.90E+03,2.42E+03,5.21E+06,6.09E+04,4.95E+03,,1.51E+03,7.01E+03,9.71E+03,6.88E+03,4.49E+04,5.53E+03,6.39E+05,4.07E+04,2.35E+03,3.14E+04,2.71E+03,6.49E+03,1.12E+04,0,FALSE,103.88,25,21,1337,150.7,7.91,22,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf20168,23244,hsa:23244; Q29RF7; Q2TTR5; Q68DF7; Q8N7J4; Q8NG14; Q9Y4D4,ENSG00000121892,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,Cohesin complex - Cornelia de Lange syndrome; 10q22q23 copy number variation,6,0,124.96,85.53,89.83,80.86,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,105.01,121.94,104.46,142.17,156.28,,0,
Master Protein,High,P39023,RPL3,60S ribosomal protein L3 OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=2,6,30,0.93,0.51,2.143,0.512,-0.1,-0.97,1.1,-0.97,9.28E-01,6.99E-01,3.96E-01,6.76E-01,2.87E+06,6.12E+05,7.63E+05,1.38E+06,5,4,5,4,2.66E+06,1.44E+06,3.70E+06,4.12E+06,2.87E+06,,7.93E+05,4.73E+05,2.61E+05,1.63E+06,1.14E+07,6.67E+05,3.94E+04,1.48E+06,7.63E+05,,1.27E+06,1.51E+06,1.01E+05,4.23E+06,1.06E+04,5.45E+03,3.61E+04,4.12E+06,1.48E+05,,1.41E+04,4.36E+03,7.35E+03,1.73E+04,6.84E+04,2.98E+04,3.20E+02,2.00E+05,1.90E+04,,3.56E+05,1.07E+04,2.37E+03,4.51E+04,0,FALSE,33.246,23,6,403,46.1,10.18,6,protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf00297,6122,B2RDV9; hsa:6122; P39023; Q15548; Q5I0G0,ENSG00000100316,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,35.06,76.2,167.17,98.31,Peak Found,Peak Found,High,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,High,1,,FALSE,120.3,111.03,127.8,137.59,75.52,other molecular function,0,
Master Protein,High,Q9BV38,WDR18,WD repeat-containing protein 18 OS=Homo sapiens OX=9606 GN=WDR18 PE=1 SV=2,2,4,0.93,0.562,1.607,0.735,-0.11,-0.83,0.68,-0.44,9.71E-01,7.93E-01,7.42E-01,9.41E-01,1.77E+05,9.25E+04,6.52E+04,1.39E+05,4,4,4,4,2.24E+05,,1.40E+05,3.21E+05,1.16E+05,2.39E+05,2.57E+04,5.53E+04,,1.55E+05,6.37E+04,1.14E+04,,1.63E+05,6.67E+04,3.23E+05,,2.96E+05,6.49E+04,5.25E+04,8.88E+02,,1.37E+03,3.21E+05,5.98E+03,8.49E+02,4.57E+02,5.10E+02,,1.65E+03,3.81E+02,5.08E+02,,2.20E+04,1.66E+03,6.30E+02,,2.10E+03,1.52E+03,5.59E+02,0,FALSE,10.237,6,2,432,47.4,6.7,2,DNA metabolism;RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00400, Pf14077",57418,hsa:57418; O60390; Q9BV38; Q9BWR2,ENSG00000065268,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,46.38,82.02,82.92,78.91,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,115.28,118.9,97.17,86.3,12.17,,0,
Master Protein,Medium,O95602,POLR1A,DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens OX=9606 GN=POLR1A PE=1 SV=2,1,1,0.929,0.142,0.01,100,-0.11,-2.82,-6.64,6.64,9.35E-01,1.21E-01,1.00E-17,1.00E-17,3.83E+04,4.13E+04,5.43E+03,,3,1,1,,,,3.83E+04,5.08E+04,2.48E+04,,,,,4.13E+04,,,,5.43E+03,,,,,,,,,3.74E+02,5.08E+04,1.28E+03,,,,,4.39E+02,,,,7.32E+02,,,,,,,0.015,FALSE,2.121,0,1,1720,194.7,7.03,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00623, Pf04983, Pf04997, Pf04998, Pf05000",25885,B7Z7T0; D6W5M0; hsa:25885; O95602; Q0VG05; Q9UEH0; Q9UFT9,ENSG00000068654,B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination,Pyrimidine metabolism; Eukaryotic transcription initiation; 2q13 copy number variation syndrome,8,0,34.16,,,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,36.37,48.19,,,2.75,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q07065,CKAP4,Cytoskeleton-associated protein 4 OS=Homo sapiens OX=9606 GN=CKAP4 PE=1 SV=2,10,13,0.928,0.548,0.656,0.588,-0.11,-0.87,-0.61,-0.77,9.50E-01,7.99E-01,6.21E-01,7.16E-01,1.32E+06,5.94E+05,8.98E+05,1.78E+06,5,3,5,5,4.05E+05,1.32E+06,2.45E+05,2.13E+06,1.49E+06,8.55E+05,1.17E+05,,,5.94E+05,2.32E+05,1.00E+06,8.98E+05,1.37E+06,8.52E+05,1.64E+06,6.13E+04,3.64E+06,2.30E+06,1.78E+06,1.61E+03,5.01E+03,2.40E+03,2.13E+06,7.67E+04,3.04E+03,2.07E+03,,,6.31E+03,1.39E+03,4.47E+04,7.30E+03,1.84E+05,2.12E+04,3.19E+03,1.72E+04,2.58E+04,5.39E+04,1.89E+04,0,FALSE,40.106,23,10,602,66,5.92,10,,plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component,,10970,hsa:10970; Q07065; Q504S5; Q53ES6,ENSG00000136026,Neutrophil degranulation; RND2 GTPase cycle; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; RND3 GTPase cycle; Surfactant metabolism,,6,0,70.3,71.77,47.11,68.47,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,1,,FALSE,95.36,67.58,135.22,115.11,45.7,,0,
Master Protein,High,Q96ME7,ZNF512,Zinc finger protein 512 OS=Homo sapiens OX=9606 GN=ZNF512 PE=1 SV=2,14,29,0.925,0.56,1.619,0.568,-0.11,-0.84,0.69,-0.82,9.29E-01,8.18E-01,6.29E-01,6.71E-01,7.40E+05,1.78E+06,2.37E+06,4.14E+06,5,5,5,5,1.00E+05,7.40E+05,1.70E+05,3.47E+06,5.55E+06,2.49E+06,9.92E+05,1.78E+06,5.98E+05,2.78E+06,4.25E+04,2.37E+06,6.16E+05,4.42E+06,2.88E+06,2.94E+07,1.88E+05,4.14E+06,2.22E+05,4.25E+06,3.98E+02,2.81E+03,1.67E+03,3.47E+06,2.86E+05,8.84E+03,1.76E+04,1.64E+04,1.69E+04,2.96E+04,2.54E+02,1.06E+05,5.00E+03,5.96E+05,7.16E+04,5.74E+04,5.28E+04,2.93E+04,5.19E+03,4.53E+04,0,FALSE,59.092,37,14,567,64.6,9.76,14,other biological processes,nucleus,"Pf00096, Pf21276, Pf21367",84450,B4DSM5; hsa:84450; Q53RZ7; Q86XK6; Q96JM0; Q96ME7,ENSG00000243943,,,0,0,120.37,54.18,85.57,161.41,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,1,,FALSE,112.53,106.13,135.54,104.83,83.37,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P55884,EIF3B,Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=3,6,15,0.925,0.244,1.413,0.21,-0.11,-2.03,0.5,-2.25,9.99E-01,1.62E-01,6.98E-01,2.20E-01,5.14E+05,4.16E+05,2.53E+05,1.89E+06,5,2,5,4,1.14E+05,9.34E+05,1.22E+06,5.14E+05,2.04E+05,1.16E+05,,1.49E+06,,,3.11E+05,8.29E+04,3.26E+05,2.53E+05,8.35E+04,2.37E+06,3.32E+06,1.51E+06,1.97E+05,,4.54E+02,3.55E+03,1.19E+04,5.14E+05,1.05E+04,4.13E+02,,1.37E+04,,,1.86E+03,3.70E+03,2.65E+03,3.41E+04,2.07E+03,4.62E+03,9.32E+05,1.07E+04,4.62E+03,,0,FALSE,33.283,15,6,814,92.4,5,6,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,"Pf00076, Pf08662",8662,A4D208; hsa:8662; P55884; Q2NL77; Q9UMF9,ENSG00000106263,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,8,0,79.25,120.88,56.85,71.69,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,56.71,112.84,49.69,105.97,55.65,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13098,GPS1,COP9 signalosome complex subunit 1 OS=Homo sapiens OX=9606 GN=GPS1 PE=1 SV=4,3,3,0.925,0.349,1.623,0.038,-0.11,-1.52,0.7,-4.73,9.93E-01,3.89E-01,7.30E-01,3.83E-03,1.24E+06,3.92E+05,1.26E+05,7.66E+05,3,1,4,3,,1.24E+06,,6.30E+04,1.45E+06,,3.92E+05,,,,,1.34E+05,1.18E+05,3.72E+05,1.17E+05,,1.27E+05,9.06E+06,,7.66E+05,,4.72E+03,,6.30E+04,7.49E+04,,6.98E+03,,,,,6.00E+03,9.60E+02,5.01E+04,2.90E+03,,3.56E+04,6.42E+04,,8.16E+03,0,FALSE,7.988,9,3,491,55.5,6.74,3,protein metabolism;other metabolic processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf01399, Pf10602, Pf21151",2873,hsa:2873; Q13098; Q8NA10; Q9BWL1,ENSG00000169727,Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; RHOBTB1 GTPase cycle; DNA Damage Recognition in GG-NER,,5,0,81.46,,67.29,150.21,n/a,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,0,127.3,417.07,95.48,5.53,enzyme regulator activity,0,
Master Protein,High,P27797,CALR,Calreticulin OS=Homo sapiens OX=9606 GN=CALR PE=1 SV=1,20,715,0.921,0.72,2.177,0.355,-0.12,-0.47,1.12,-1.49,8.43E-01,9.53E-01,3.89E-01,4.00E-01,5.06E+07,2.33E+08,5.35E+07,3.26E+08,5,5,5,5,5.02E+06,1.62E+08,6.09E+06,5.06E+07,1.55E+08,5.16E+07,2.76E+08,2.33E+08,6.17E+07,2.41E+08,7.48E+06,2.65E+07,5.35E+07,1.04E+08,5.83E+07,3.26E+08,6.43E+07,8.64E+08,9.13E+07,1.17E+09,1.99E+04,6.15E+05,5.95E+04,5.06E+07,7.99E+06,1.83E+05,4.91E+06,2.15E+06,1.74E+06,2.56E+06,4.47E+04,1.18E+06,4.35E+05,1.40E+07,1.45E+06,6.36E+05,1.81E+07,6.12E+06,2.14E+06,1.24E+07,0,FALSE,176.213,55,5,417,48.1,4.44,20,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf00262,811,hsa:811; P27797; Q6IAT4; Q9UDG2,ENSG00000179218,"ER-Phagosome pathway; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Scavenging by Class A Receptors; Assembly of Viral Components at the Budding Site; Scavenging by Class F Receptors; ATF6 (ATF6-alpha) activates chaperone genes; Calnexin/calreticulin cycle",Androgen receptor signaling pathway; Complement system; Photodynamic therapy-induced unfolded protein response; VEGFA-VEGFR2 signaling; GDNF signaling; Calcium regulation in cardiac cells,13,16,102.69,62.09,73.29,97.7,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,135.47,127.08,123.81,128.17,2554.63,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,High,G3V5M2,PNP,Purine nucleoside phosphorylase OS=Homo sapiens OX=9606 GN=PNP PE=1 SV=2,8,15,0.919,1.161,0.498,1.112,-0.12,0.22,-1.01,0.15,9.49E-01,3.75E-01,3.62E-01,7.56E-01,1.64E+06,3.81E+05,1.03E+06,2.57E+05,5,3,3,2,2.83E+06,1.64E+06,2.37E+06,2.35E+05,4.99E+05,3.81E+05,3.65E+05,,,1.03E+06,1.03E+06,2.45E+05,,1.14E+06,,,1.67E+06,,3.94E+04,,1.12E+04,6.24E+03,2.32E+04,2.35E+05,2.57E+04,1.35E+03,6.49E+03,,,1.09E+04,6.19E+03,1.10E+04,,1.53E+05,,,4.71E+05,,9.23E+02,,0,FALSE,26.227,34,8,328,36.1,8.18,8,other metabolic processes,cytosol,Pf01048,,G3V5M2,ENSG00000198805,,,0,0,74.85,63.86,60.58,134.91,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,77.79,93.22,83.97,110.99,44.87,other molecular function,0,
Master Protein,High,A0A5F9YFS9,SPCS1,Signal peptidase complex subunit 1 OS=Homo sapiens OX=9606 GN=SPCS1 PE=1 SV=1,1,6,0.919,1.118,0.957,1.083,-0.12,0.16,-0.06,0.12,9.59E-01,6.13E-01,8.98E-01,8.12E-01,9.78E+04,1.04E+05,9.34E+04,1.19E+05,4,3,3,4,,1.18E+05,4.08E+04,2.82E+05,8.09E+04,2.06E+05,7.44E+04,1.04E+05,,,,9.34E+04,8.77E+04,1.88E+05,,,2.21E+05,2.10E+05,6.69E+04,5.67E+04,,4.49E+02,3.99E+02,2.82E+05,4.17E+03,7.34E+02,1.32E+03,9.62E+02,,,,4.17E+03,7.12E+02,2.54E+04,,,6.20E+04,1.49E+03,1.57E+03,6.03E+02,0,FALSE,4.85,15,1,102,11.8,9.31,1,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf06645,,A0A5F9YFS9,ENSG00000114902,,15q25 copy number variation,1,0,81.18,53.96,45.91,64.16,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,93.87,83.72,79.57,82.37,17.31,translation activity,0,
Master Protein,High,P61353,RPL27,60S ribosomal protein L27 OS=Homo sapiens OX=9606 GN=RPL27 PE=1 SV=2,3,11,0.918,0.939,1.841,1.127,-0.12,-0.09,0.88,0.17,9.19E-01,5.38E-01,5.04E-01,7.70E-01,1.53E+06,6.89E+05,9.52E+05,1.29E+06,5,4,5,5,9.42E+05,5.69E+05,1.53E+06,2.91E+06,1.82E+06,5.32E+05,4.34E+05,9.48E+05,,8.93E+05,3.15E+05,2.25E+06,5.07E+05,2.53E+06,9.52E+05,1.06E+06,1.29E+06,1.16E+07,1.64E+05,1.32E+07,3.74E+03,2.16E+03,1.49E+04,2.91E+06,9.38E+04,1.89E+03,7.73E+03,8.74E+03,,9.50E+03,1.89E+03,1.01E+05,4.12E+03,3.41E+05,2.37E+04,2.06E+03,3.63E+05,8.24E+04,3.84E+03,1.41E+05,0,FALSE,11.308,28,3,136,15.8,10.56,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,other membranes;cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,"Pf00467, Pf01777",6155,hsa:6155; P08526; P61353; Q4G0A9,ENSG00000131469,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),VEGFA-VEGFR2 signaling; Cytoplasmic ribosomal proteins,15,0,58.07,36.57,77.58,116.68,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,69.94,121.52,134.97,145.57,20.22,other molecular function,0,
Master Protein,High,Q9BVJ6,UTP14A,U3 small nucleolar RNA-associated protein 14 homolog A OS=Homo sapiens OX=9606 GN=UTP14A PE=1 SV=1,2,3,0.917,0.01,0.256,0.01,-0.12,-6.64,-1.96,-6.64,9.92E-01,1.00E-17,1.08E-01,1.00E-17,4.33E+05,5.74E+05,,1.47E+05,2,3,,1,6.47E+05,,,2.89E+05,,5.74E+05,,8.68E+05,,1.73E+05,,,,,,,,1.47E+05,,,2.57E+03,,,2.89E+05,,2.04E+03,,8.01E+03,,1.84E+03,,,,,,,,1.04E+03,,,0,FALSE,9.809,3,2,771,87.9,7.87,2,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf04615,10813,A8K7A3; A8MVQ1; B4DQ08; E9PEL7; hsa:10813; Q5JYF1; Q9BVJ6,ENSG00000156697,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,54.12,64.76,,,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,89.25,,76.03,,9.06,,0,
Master Protein,High,P23284,PPIB,Peptidyl-prolyl cis-trans isomerase B OS=Homo sapiens OX=9606 GN=PPIB PE=1 SV=2,11,137,0.917,1.894,1.242,1.561,-0.13,0.92,0.31,0.64,8.39E-01,1.37E-01,8.85E-01,6.37E-01,9.10E+06,4.28E+06,3.41E+07,1.63E+07,5,5,5,5,6.26E+06,3.39E+07,4.82E+06,1.88E+07,9.10E+06,3.28E+06,4.28E+06,4.44E+06,1.46E+06,1.85E+07,1.28E+07,2.42E+07,3.41E+07,3.41E+07,4.46E+07,1.17E+07,3.01E+07,1.63E+07,2.84E+07,1.04E+07,2.49E+04,1.29E+05,4.71E+04,1.88E+07,4.69E+05,1.17E+04,7.62E+04,4.10E+04,4.10E+04,1.97E+05,7.63E+04,1.08E+06,2.77E+05,4.59E+06,1.11E+06,2.27E+04,8.46E+06,1.16E+05,6.64E+05,1.11E+05,0,FALSE,54.228,49,11,216,23.7,9.41,11,protein metabolism;other metabolic processes;developmental processes;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,Pf00160,5479,A8K534; hsa:5479; P23284; Q6IBH5; Q9BVK5,ENSG00000166794,Collagen biosynthesis and modifying enzymes; SARS-CoV-1 activates/modulates innate immune responses,Prolactin signaling pathway; Type I collagen synthesis in the context of osteogenesis imperfecta,4,0,83.02,107.5,40.1,47.95,Peak Found,High,High,High,High,Peak Found,Peak Found,High,High,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,133.4,108.1,127.18,125.8,288.35,other molecular function,0,
Master Protein,High,Q6N043,ZNF280D,Zinc finger protein 280D OS=Homo sapiens OX=9606 GN=ZNF280D PE=1 SV=3,1,1,0.916,0.587,0.078,6.905,-0.13,-0.77,-3.68,2.79,9.16E-01,8.68E-01,1.88E-02,1.07E-01,5.97E+04,6.51E+04,3.50E+04,5.08E+03,1,2,3,1,,,,5.97E+04,,,,1.13E+05,,3.74E+04,,3.50E+04,,7.93E+04,3.50E+04,,5.08E+03,,,,,,,5.97E+04,,,,1.05E+03,,3.98E+02,,1.56E+03,,1.07E+04,8.71E+02,,1.43E+03,,,,0.001,FALSE,3.38,1,1,979,109.2,8.19,1,other biological processes,nucleus,Pf13836,54816,A1L495; B2RMT6; hsa:54816; Q6MZM6; Q6N043; Q6N085; Q6P2R6; Q7Z6J5; Q9H0U5; Q9HCI8; Q9NXS0,ENSG00000137871,,,0,0,,71.31,51.28,,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,86.57,0.05,86.57,0.05,2.82,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P51572,BCAP31,B-cell receptor-associated protein 31 OS=Homo sapiens OX=9606 GN=BCAP31 PE=1 SV=3,10,58,0.916,0.445,0.645,0.801,-0.13,-1.17,-0.63,-0.32,8.38E-01,5.14E-01,4.90E-01,9.04E-01,1.52E+07,1.12E+07,4.32E+06,1.25E+07,5,5,5,5,4.36E+06,6.82E+07,1.20E+06,1.52E+07,2.35E+07,2.34E+07,4.51E+06,2.10E+07,1.07E+07,1.12E+07,2.37E+06,6.08E+06,3.24E+06,2.60E+07,4.32E+06,4.05E+07,3.05E+06,4.57E+07,3.29E+06,1.25E+07,1.73E+04,2.59E+05,1.17E+04,1.52E+07,1.21E+06,8.32E+04,8.02E+04,1.94E+05,3.01E+05,1.19E+05,1.42E+04,2.72E+05,2.63E+04,3.50E+06,1.07E+05,7.89E+04,8.58E+05,3.24E+05,7.70E+04,1.33E+05,0,FALSE,44.01,34,10,246,28,8.44,10,stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;other cell component,"Pf05529, Pf18035",10134,B3KQ79; D3DWV5; hsa:10134; P51572; Q13836; Q96CF0,ENSG00000185825,"RSV-host interactions; RHOA GTPase cycle; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Apoptotic cleavage of cellular proteins",,5,0,120.22,55.43,118.15,98.08,Peak Found,High,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,126.89,130.4,133.11,132.18,142.8,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,Medium,Q6Q0C0,TRAF7,E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1,1,3,0.915,0.111,1.383,0.063,-0.13,-3.17,0.47,-3.98,8.37E-01,6.85E-03,7.78E-01,1.77E-02,2.15E+07,3.38E+07,2.38E+06,3.76E+07,2,5,2,2,,7.44E+07,,,6.19E+06,1.62E+08,8.16E+06,4.87E+07,5.60E+06,3.38E+07,,,4.14E+06,1.37E+06,,5.61E+07,,,2.52E+07,,,2.83E+05,,,3.19E+05,5.75E+05,1.45E+05,4.49E+05,1.58E+05,3.59E+05,,,3.36E+04,1.84E+05,,1.09E+05,,,5.89E+05,,0.01,FALSE,2.27,4,1,670,74.6,7.15,1,cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf00400, Pf13445",84231,hsa:84231; Q6Q0C0; Q9H073,ENSG00000131653,Antigen processing: Ubiquitination & Proteasome degradation,,1,0,119.72,124.4,71.29,53.81,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,1,Phospho [S108],FALSE,135.72,135.4,121.36,57.97,10.28,other molecular function,1,Phospho [S108]
Master Protein,High,Q53EL6,PDCD4,Programmed cell death protein 4 OS=Homo sapiens OX=9606 GN=PDCD4 PE=1 SV=2,2,6,0.915,0.325,2.823,0.63,-0.13,-1.62,1.5,-0.67,9.46E-01,3.12E-01,3.40E-01,8.31E-01,4.86E+05,1.67E+05,2.71E+05,8.02E+05,4,4,4,3,,7.12E+05,4.39E+04,6.28E+05,3.76E+05,9.64E+04,,5.58E+04,2.90E+05,4.44E+05,,3.50E+05,1.72E+05,7.58E+05,2.11E+05,8.02E+05,8.58E+04,8.53E+05,,,,2.71E+03,4.29E+02,6.28E+05,1.94E+04,3.43E+02,,5.15E+02,8.18E+03,4.72E+03,,1.56E+04,1.40E+03,1.02E+05,5.24E+03,1.56E+03,2.41E+04,6.05E+03,,,0,FALSE,10.819,8,2,469,51.7,5.21,2,developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf02847,27250,B2RCV4; B5ME91; hsa:27250; O15501; Q53EL6; Q5VZS6; Q6PJI5; Q8TAR5; Q99834,ENSG00000150593,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Translation inhibitors in chronically activated PDGFRA cells; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways,4,0,68.21,81.23,71.86,73.93,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,86.13,88.64,115.33,117.63,19.96,nucleic acid binding activity,0,
Master Protein,High,G3V180,DPP3,Dipeptidyl peptidase 3 OS=Homo sapiens OX=9606 GN=DPP3 PE=1 SV=1,1,2,0.914,0.112,0.732,0.168,-0.13,-3.16,-0.45,-2.58,9.23E-01,6.91E-02,7.24E-01,2.14E-01,4.37E+04,4.78E+04,5.86E+03,3.50E+04,5,1,3,4,1.09E+05,4.37E+04,1.85E+05,3.18E+04,2.96E+04,,,4.78E+04,,,,5.86E+03,,3.31E+03,1.25E+04,,1.14E+05,4.04E+04,1.20E+04,3.03E+04,4.35E+02,1.66E+02,1.81E+03,3.18E+04,1.53E+03,,,4.41E+02,,,,2.62E+02,,4.46E+02,3.11E+02,,3.20E+04,2.86E+02,2.80E+02,3.23E+02,0.002,FALSE,2.784,3,1,757,84.3,5.03,1,protein metabolism;other metabolic processes,cytosol,Pf03571,,G3V180,ENSG00000254986,,,0,0,84.05,,65.77,91.08,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,70.18,90.5,62.79,83.61,5.28,other molecular function,0,
Master Protein,Medium,P55061,TMBIM6,Bax inhibitor 1 OS=Homo sapiens OX=9606 GN=TMBIM6 PE=1 SV=2,1,1,0.912,1.127,1.247,0.91,-0.13,0.17,0.32,-0.14,9.68E-01,5.82E-01,9.60E-01,9.17E-01,1.34E+05,1.46E+05,1.32E+05,1.82E+05,2,1,3,2,,1.05E+05,,1.70E+05,,,,,,1.46E+05,,,1.05E+05,2.61E+05,1.32E+05,1.26E+05,,,2.65E+05,,,3.98E+02,,1.70E+05,,,,,,1.56E+03,,,8.57E+02,3.52E+04,3.29E+03,2.45E+02,,,6.21E+03,,0.016,FALSE,2.065,3,1,237,26.5,8.54,1,other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;mitochondrion;ER/Golgi;nucleus;other cell component,Pf01027,7009,B2R5M4; F8W034; hsa:7009; O14938; P55061; Q643A7; Q96J50,ENSG00000139644,,,0,0,33.66,,50.1,50.53,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,36.33,49.84,56.72,51.87,2.48,enzyme regulator activity;other molecular function,0,
Master Protein,High,P61011,SRP54,Signal recognition particle subunit SRP54 OS=Homo sapiens OX=9606 GN=SRP54 PE=1 SV=1,4,6,0.912,0.371,0.504,0.539,-0.13,-1.43,-0.99,-0.89,9.68E-01,5.01E-01,4.90E-01,7.42E-01,1.36E+05,1.48E+05,5.03E+04,9.34E+04,3,3,2,2,2.38E+05,,,9.18E+04,1.36E+05,1.48E+05,,1.32E+05,,2.61E+05,,,,5.12E+04,4.95E+04,,6.52E+04,1.34E+05,,,9.45E+02,,,9.18E+04,7.00E+03,5.26E+02,,1.22E+03,,2.77E+03,,,,6.89E+03,1.23E+03,,1.83E+04,9.48E+02,,,0,FALSE,15.323,12,4,504,55.7,8.75,4,cell organization and biogenesis;transport;developmental processes;other biological processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,"Pf00448, Pf02881, Pf02978",6729,B2R759; B4DUW6; hsa:6729; P13624; P61011,ENSG00000100883,SRP-dependent cotranslational protein targeting to membrane,VEGFA-VEGFR2 signaling; mRNA processing,3,0,48.34,39.03,2.28,48.74,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,73.39,95.53,43.45,53.57,21.43,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P05198,EIF2S1,Eukaryotic translation initiation factor 2 subunit 1 OS=Homo sapiens OX=9606 GN=EIF2S1 PE=1 SV=3,8,40,0.91,0.924,1.639,0.332,-0.14,-0.11,0.71,-1.59,9.29E-01,6.72E-01,5.94E-01,4.10E-01,5.69E+05,1.51E+06,4.64E+05,1.83E+06,5,5,5,5,3.54E+05,4.93E+06,1.63E+05,5.69E+05,3.89E+06,1.60E+06,2.20E+05,1.51E+06,1.31E+06,4.01E+06,1.11E+06,2.55E+05,8.58E+05,3.27E+05,4.64E+05,1.83E+06,1.43E+06,6.25E+06,1.23E+06,5.31E+06,1.41E+03,1.87E+04,1.60E+03,5.69E+05,2.01E+05,5.69E+03,3.92E+03,1.40E+04,3.70E+04,4.26E+04,6.62E+03,1.14E+04,6.97E+03,4.41E+04,1.15E+04,3.57E+03,4.01E+05,4.43E+04,2.88E+04,5.65E+04,0,FALSE,42.253,31,8,315,36.1,5.08,8,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;translational apparatus;nucleus;other cell component,"Pf00575, Pf07541",1965,hsa:1965; P05198,ENSG00000134001,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; ABC-family proteins mediated transport; PKR-mediated signaling; Response of EIF2AK1 (HRI) to heme deficiency; PERK regulates gene expression; Recycling of eIF2:GDP; Response of EIF2AK4 (GCN2) to amino acid deficiency; Cellular response to mitochondrial stress",Translation factors; Alzheimer's disease and miRNA effects; Brain-derived neurotrophic factor (BDNF) signaling pathway; Ebola virus infection in host; Nonalcoholic fatty liver disease; Measles virus infection; Unfolded protein response; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell; Alzheimer's disease,21,0,113.63,80.2,60.68,74.13,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,1,,FALSE,129.31,116.86,109.98,92.39,110.09,translation activity;nucleic acid binding activity,0,
Master Protein,High,A0A5F9ZHN7,SACM1L,SAC1 like phosphatidylinositide phosphatase OS=Homo sapiens OX=9606 GN=SACM1L PE=1 SV=1,6,17,0.91,0.621,1.298,0.634,-0.14,-0.69,0.38,-0.66,8.32E-01,8.73E-01,8.18E-01,7.51E-01,3.30E+06,1.97E+06,1.88E+06,2.04E+06,5,5,5,5,3.93E+05,3.30E+06,4.96E+05,3.84E+06,4.32E+06,2.89E+06,2.06E+06,1.97E+06,7.48E+05,6.85E+05,2.36E+06,1.66E+06,1.25E+06,3.39E+06,1.88E+06,1.04E+07,2.04E+06,4.67E+05,1.81E+06,4.99E+06,1.56E+03,1.25E+04,4.85E+03,3.84E+06,2.23E+05,1.03E+04,3.67E+04,1.82E+04,2.11E+04,7.29E+03,1.41E+04,7.42E+04,1.02E+04,4.57E+05,4.67E+04,2.02E+04,5.74E+05,3.31E+03,4.23E+04,5.31E+04,0,FALSE,19.155,11,1,609,69.4,7.12,6,other metabolic processes,other membranes,Pf02383,,A0A5F9ZHN7,ENSG00000211456,,,0,5,76.29,56.34,38.94,100.63,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,111.6,104.92,119.17,103.95,35.54,other molecular function,0,
Master Protein,Medium,P33241,LSP1,Lymphocyte-specific protein 1 OS=Homo sapiens OX=9606 GN=LSP1 PE=1 SV=1,1,1,0.909,0.874,0.183,4.14,-0.14,-0.19,-2.45,2.05,9.32E-01,8.25E-01,1.18E-01,1.69E-01,7.65E+04,8.85E+04,6.69E+04,1.62E+04,2,4,2,3,,1.86E+05,,,3.14E+04,1.63E+05,,4.34E+04,1.33E+05,5.87E+04,,4.60E+04,,9.73E+04,,,3.94E+03,1.06E+05,1.62E+04,,,7.09E+02,,,1.62E+03,5.79E+02,,4.01E+02,3.76E+03,6.24E+02,,2.06E+03,,1.31E+04,,,1.11E+03,7.49E+02,3.78E+02,,0.023,FALSE,1.942,4,1,339,37.2,4.74,1,stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton,Pf02029,4046,B3KPP1; B3KRR6; E9PBV6; E9PFP3; hsa:4046; P33241; Q16096; Q53H48; Q6FHM3; Q9BUY8,ENSG00000130592; ENSG00000288199,,,0,0,100.68,57.91,50.6,132.5,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,104.9,103.36,128.94,123.99,2.97,cytoskeletal activity,0,
Master Protein,High,P17480,UBTF,Nucleolar transcription factor 1 OS=Homo sapiens OX=9606 GN=UBTF PE=1 SV=1,8,26,0.906,0.989,2.189,1.315,-0.14,-0.02,1.13,0.39,9.90E-01,5.23E-01,4.83E-01,6.70E-01,7.65E+05,1.92E+05,9.70E+05,1.22E+06,4,4,5,5,,2.11E+05,2.02E+05,4.45E+06,2.78E+06,2.90E+05,2.25E+05,1.59E+05,,1.64E+05,4.05E+05,2.52E+06,6.00E+05,4.35E+06,9.70E+05,2.69E+05,3.35E+05,7.14E+06,1.26E+06,1.22E+06,,8.01E+02,1.97E+03,4.45E+06,1.43E+05,1.03E+03,4.00E+03,1.46E+03,,1.75E+03,2.42E+03,1.12E+05,4.87E+03,5.86E+05,2.41E+04,5.25E+02,9.42E+04,5.06E+04,2.95E+04,1.30E+04,0,FALSE,32.019,15,8,764,89.4,5.81,8,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00505, Pf09011, Pf14887",7343,A8K6R8; hsa:7343; P17480,ENSG00000108312,NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; RNA Polymerase I Promoter Opening,Ectoderm differentiation,6,0,109.04,29.45,94.13,141.2,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,44.39,106.01,130.69,124.38,75.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P62306,SNRPF,Small nuclear ribonucleoprotein F OS=Homo sapiens OX=9606 GN=SNRPF PE=1 SV=1,1,25,0.905,0.337,1.111,0.178,-0.14,-1.57,0.15,-2.49,9.88E-01,3.50E-01,9.02E-01,2.08E-01,7.12E+05,8.63E+05,2.06E+05,1.15E+06,5,3,2,4,1.75E+05,7.81E+05,1.26E+05,7.12E+05,1.14E+07,,,8.63E+05,1.04E+05,4.49E+06,1.68E+05,,,2.52E+05,,5.40E+05,2.17E+04,2.47E+06,,8.86E+06,6.94E+02,2.97E+03,1.23E+03,7.12E+05,5.88E+05,,,7.96E+03,2.92E+03,4.77E+04,1.00E+03,,,3.39E+04,,1.05E+03,6.08E+03,1.75E+04,,9.43E+04,0,FALSE,6.953,15,1,86,9.7,4.67,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf01423,6636,A2VCR2; B2R498; hsa:6636; P62306; Q15356; Q6IBQ1; Q6P4I0,ENSG00000139343,mRNA Splicing - Major Pathway; snRNP Assembly; RNA Polymerase II Transcription Termination; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Minor Pathway; SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,mRNA processing,8,0,185.92,128.86,28.15,136.76,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,High,Peak Found,High,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,High,n/a,High,1,,FALSE,138.09,103.52,146.26,145.42,66.47,nucleic acid binding activity,0,
Master Protein,High,Q12888,TP53BP1,TP53-binding protein 1 OS=Homo sapiens OX=9606 GN=TP53BP1 PE=1 SV=2,17,25,0.905,0.496,0.783,1.645,-0.14,-1.01,-0.35,0.72,9.09E-01,6.40E-01,6.50E-01,5.23E-01,2.82E+06,2.17E+05,1.39E+06,4.05E+05,5,5,4,5,1.74E+06,5.23E+06,3.76E+06,2.82E+06,1.71E+06,1.86E+05,2.25E+04,6.03E+05,2.49E+05,2.17E+05,,1.38E+06,1.05E+05,2.48E+06,1.41E+06,4.05E+05,8.91E+04,6.31E+04,1.00E+06,5.57E+05,6.91E+03,1.99E+04,3.68E+04,2.82E+06,8.82E+04,6.61E+02,4.00E+02,5.56E+03,7.03E+03,2.30E+03,,6.15E+04,8.51E+02,3.34E+05,3.50E+04,7.90E+02,2.50E+04,4.47E+02,2.34E+04,5.92E+03,0,FALSE,67.919,15,17,1972,213.4,4.7,17,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,"Pf09038, Pf18428",7158,F8VY86; hsa:7158; Q12888; Q2M1Z7; Q4LE46; Q5FWZ3; Q7Z3U4,ENSG00000067369,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ); SUMOylation of transcription factors,ATM signaling pathway; ATM signaling in development and disease,7,0,48.68,83.34,72.3,91.04,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,124.76,90.08,98.75,183.86,80.32,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P80303,NUCB2,Nucleobindin-2 OS=Homo sapiens OX=9606 GN=NUCB2 PE=1 SV=3,7,25,0.903,0.993,1.123,1.08,-0.15,-0.01,0.17,0.11,9.06E-01,5.35E-01,9.62E-01,8.04E-01,1.05E+06,1.19E+06,6.01E+05,1.63E+06,4,2,5,4,3.32E+06,,8.71E+05,1.27E+06,7.74E+05,,,1.43E+06,,9.94E+05,6.01E+05,2.57E+05,4.77E+06,2.10E+06,2.91E+05,,1.87E+06,8.09E+05,1.43E+06,5.81E+06,1.32E+04,,8.51E+03,1.27E+06,3.99E+04,,,1.32E+04,,1.06E+04,3.59E+03,1.15E+04,3.88E+04,2.83E+05,7.23E+03,,5.24E+05,5.74E+03,3.34E+04,6.19E+04,0,FALSE,31.92,21,7,420,50.2,5.12,7,signal transduction,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus,Pf13499,4925,A8K642; D3DQX5; hsa:4925; P80303; Q8NFT5; V9HW75,ENSG00000070081,,,0,0,76.56,25.4,120.05,91.37,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,High,n/a,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,79.94,93.55,94.7,108.48,77.75,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A0G2JIW1,HSPA1B,Heat shock 70 kDa protein 1B OS=Homo sapiens OX=9606 GN=HSPA1B PE=1 SV=1,16,84,0.899,0.594,1.269,0.824,-0.15,-0.75,0.34,-0.28,8.22E-01,8.23E-01,8.63E-01,9.24E-01,6.54E+06,6.74E+06,5.09E+06,5.98E+06,5,5,5,5,2.43E+06,6.54E+06,1.06E+06,1.02E+07,9.52E+06,6.74E+06,7.77E+06,1.11E+07,4.09E+06,5.70E+06,2.05E+06,4.64E+06,5.09E+06,1.63E+07,6.40E+06,1.11E+07,2.28E+06,1.30E+07,2.75E+06,5.98E+06,9.65E+03,2.48E+04,1.03E+04,1.02E+07,4.91E+05,2.40E+04,1.38E+05,1.02E+05,1.15E+05,6.06E+04,1.23E+04,2.07E+05,4.14E+04,2.20E+06,1.59E+05,2.17E+04,6.41E+05,9.24E+04,6.45E+04,6.36E+04,0,FALSE,73.602,32,10,642,70.1,5.66,16,protein metabolism;other metabolic processes,,Pf00012,,A0A0G2JIW1,ENSG00000212866; ENSG00000224501; ENSG00000232804,,,0,5,68.96,37.07,79.77,69.2,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,1,,FALSE,99.78,84.41,121.41,122.94,207.98,other molecular function,0,
Master Protein,High,P05160,F13B,Coagulation factor XIII B chain OS=Homo sapiens OX=9606 GN=F13B PE=1 SV=3,3,10,0.899,0.618,0.01,100,-0.15,-0.7,-6.64,6.64,9.61E-01,8.95E-01,1.00E-17,1.00E-17,3.28E+05,3.65E+05,2.03E+05,,2,4,2,,2.30E+05,,,,4.69E+05,,1.83E+05,5.67E+05,3.67E+06,2.35E+05,2.18E+05,,,1.88E+05,,,,,,,9.13E+02,,,,2.42E+04,,3.26E+03,5.23E+03,1.03E+05,2.50E+03,1.31E+03,,,2.54E+04,,,,,,,0,FALSE,10.308,7,3,661,75.5,6.39,3,protein metabolism;other metabolic processes;stress response,non-structural extracellular;other cell component,Pf00084,2165,A8K3E5; hsa:2165; P05160; Q5VYL5,ENSG00000143278; ENSG00000291998,Common Pathway of Fibrin Clot Formation,Androgen receptor network in prostate cancer; Blood clotting cascade; Dengue-2 interactions with complement and coagulation cascades; Steroid biosynthesis; Complement and coagulation cascades,6,0,48.46,144.23,10.36,,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,88.85,50.25,,,29.16,,0,
Master Protein,High,Q9Y2L9,LRCH1,Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LRCH1 PE=1 SV=3,1,1,0.899,0.819,1.473,0.487,-0.15,-0.29,0.56,-1.04,9.01E-01,8.68E-01,8.05E-01,6.82E-01,5.80E+04,6.45E+04,4.75E+04,1.01E+05,1,2,4,4,,,,5.80E+04,,,,6.98E+04,,5.96E+04,4.91E+04,5.31E+04,4.59E+04,,3.71E+04,,1.04E+05,1.02E+05,2.59E+04,9.99E+04,,,,5.80E+04,,,,6.44E+02,,6.34E+02,2.94E+02,2.37E+03,3.73E+02,,9.23E+02,,2.92E+04,7.20E+02,6.07E+02,1.06E+03,0,FALSE,7.558,2,1,728,80.8,5.94,1,other biological processes,other cell component,"Pf00307, Pf13855",23143,B7ZLL5; F8W6F0; hsa:23143; Q17R43; Q2KHR1; Q5TBU9; Q7Z5F6; Q7Z5F7; Q9Y2L9,ENSG00000136141,,,0,0,,11.13,14.64,45.83,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,11.7,10.31,21.97,13.69,5.07,,0,
Master Protein,High,Q8TDN6,BRIX1,Ribosome biogenesis protein BRX1 homolog OS=Homo sapiens OX=9606 GN=BRIX1 PE=1 SV=2,4,4,0.898,0.669,0.225,3.39,-0.16,-0.58,-2.15,1.76,9.91E-01,9.76E-01,1.58E-01,2.42E-01,3.34E+05,2.21E+05,1.68E+05,4.97E+04,2,2,3,1,,,,7.63E+05,1.46E+05,6.09E+05,,,,8.03E+04,,1.34E+05,,1.02E+06,1.68E+05,,,,4.97E+04,,,,,7.63E+05,7.53E+03,2.16E+03,,,,8.54E+02,,6.00E+03,,1.37E+05,4.19E+03,,,,1.16E+03,,0,FALSE,12.571,20,4,353,41.4,9.92,4,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf04427,55299,A8K0P5; hsa:55299; Q3ZTT4; Q8N453; Q8TDN6; Q96DH1,ENSG00000113460,,Gastric cancer network 2,1,0,95.95,108.45,113.74,,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,High,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,84.16,97.98,177.13,48.42,7.88,nucleic acid binding activity,0,
Master Protein,High,Q96GM8,TOE1,Target of EGR1 protein 1 OS=Homo sapiens OX=9606 GN=TOE1 PE=1 SV=1,2,2,0.898,2.63,1.354,1.013,-0.16,1.39,0.44,0.02,9.38E-01,1.44E-01,8.73E-01,8.51E-01,8.43E+04,8.75E+04,1.20E+05,1.19E+05,4,2,2,2,8.43E+04,8.43E+04,,8.94E+04,2.33E+04,,,7.92E+04,9.67E+04,,8.51E+05,,,1.69E+04,,1.40E+05,,,1.00E+05,,3.35E+02,3.20E+02,,8.94E+04,1.20E+03,,,7.31E+02,2.72E+03,,5.09E+03,,,2.28E+03,,2.73E+02,,,2.34E+03,,0,FALSE,8.299,8,2,510,56.5,7.18,2,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00642, Pf04857",114034,B4DEM6; hsa:114034; Q6IA35; Q8IWN5; Q96GM8; Q9H846,ENSG00000132773,,,0,0,44.68,14.07,135.9,23.54,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,23.22,263.06,22.65,435.21,8.1,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NX40,OCIAD1,OCIA domain-containing protein 1 OS=Homo sapiens OX=9606 GN=OCIAD1 PE=1 SV=1,5,12,0.896,0.512,2.092,0.414,-0.16,-0.97,1.06,-1.27,8.84E-01,6.95E-01,4.04E-01,5.16E-01,3.21E+06,4.29E+05,6.91E+05,2.68E+06,3,5,4,5,,1.18E+07,,3.21E+06,1.22E+06,4.29E+05,2.21E+05,4.19E+06,2.08E+05,1.98E+06,,8.10E+05,5.89E+05,1.98E+06,5.07E+05,2.68E+06,9.42E+05,2.81E+06,4.18E+05,4.91E+06,,4.48E+04,,3.21E+06,6.31E+04,1.52E+03,3.92E+03,3.86E+04,5.86E+03,2.10E+04,,3.62E+04,4.79E+03,2.67E+05,1.26E+04,5.23E+03,2.65E+05,1.99E+04,9.78E+03,5.22E+04,0,FALSE,22.92,33,5,245,27.6,7.49,5,transport;other biological processes,ER/Golgi;other cytoplasmic organelle,Pf07051,54940,C9K030; G8JLN7; hsa:54940; Q9BZE8; Q9NX40,ENSG00000109180,,,0,0,103.86,122.56,70.57,75.39,n/a,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,135.73,123.89,137.89,124.82,38.23,,0,
Master Protein,High,O75955,FLOT1,Flotillin-1 OS=Homo sapiens OX=9606 GN=FLOT1 PE=1 SV=3,13,47,0.894,0.515,0.677,0.566,-0.16,-0.96,-0.56,-0.82,8.17E-01,6.64E-01,5.29E-01,6.68E-01,4.73E+06,3.12E+06,2.52E+06,7.90E+06,5,5,5,5,2.04E+07,2.55E+06,1.21E+07,4.62E+06,4.73E+06,4.67E+06,2.59E+06,5.70E+06,9.74E+05,3.12E+06,1.82E+07,2.51E+06,1.26E+06,3.41E+06,2.52E+06,7.90E+06,2.84E+06,1.76E+07,1.55E+06,1.29E+07,8.10E+04,9.70E+03,1.18E+05,4.62E+06,2.44E+05,1.66E+04,4.60E+04,5.26E+04,2.74E+04,3.32E+04,1.09E+05,1.12E+05,1.02E+04,4.59E+05,6.27E+04,1.54E+04,7.98E+05,1.25E+05,3.63E+04,1.37E+05,0,FALSE,61.739,42,13,427,47.3,7.49,13,cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;other cytoplasmic organelle;other cell component,Pf01145,10211,B4DVY7; hsa:10211; O75955; Q969J8; Q9UHW1; Q9UNV8,ENSG00000137312; ENSG00000206379; ENSG00000206480; ENSG00000230143; ENSG00000232280,RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; Regulation of necroptotic cell death; Synaptic adhesion-like molecules,Angiopoietin-like protein 8 regulatory pathway; Insulin signaling,8,0,83.15,53.95,127.15,78.95,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,99.64,96.03,128.22,114.14,139.94,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q8NI36,WDR36,WD repeat-containing protein 36 OS=Homo sapiens OX=9606 GN=WDR36 PE=1 SV=1,2,4,0.894,1.036,1.192,1.622,-0.16,0.05,0.25,0.7,9.32E-01,6.67E-01,9.45E-01,5.74E-01,1.17E+05,6.25E+04,1.26E+05,7.44E+04,3,2,2,2,,,2.32E+04,1.58E+05,1.17E+05,,,8.78E+04,4.44E+04,,,8.27E+04,,1.90E+05,,,1.60E+04,3.45E+05,,,,,2.27E+02,1.58E+05,6.01E+03,,,8.10E+02,1.25E+03,,,3.70E+03,,2.57E+04,,,4.51E+03,2.45E+03,,,0,FALSE,7.991,4,2,951,105.3,7.53,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00400, Pf04192, Pf12894",134430,A2RUS4; hsa:134430; Q68E02; Q8N1Q2; Q8NI36,,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,69.56,46.37,55.76,128.86,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,78.92,50.63,233.24,327.84,8.08,,0,
Master Protein,High,O96019,ACTL6A,Actin-like protein 6A OS=Homo sapiens OX=9606 GN=ACTL6A PE=1 SV=1,10,35,0.892,0.738,4.897,0.685,-0.17,-0.44,2.29,-0.55,9.89E-01,8.25E-01,1.18E-01,8.66E-01,3.29E+05,4.89E+05,1.96E+06,9.61E+05,4,2,5,5,,1.49E+05,3.75E+05,4.32E+06,2.88E+05,,2.40E+05,,,9.95E+05,3.29E+06,1.96E+06,7.32E+05,2.75E+06,1.66E+06,9.61E+05,1.85E+05,1.79E+06,7.63E+04,2.70E+06,,5.66E+02,3.67E+03,4.32E+06,1.49E+04,,4.27E+03,,,1.06E+04,1.97E+04,8.76E+04,5.94E+03,3.71E+05,4.13E+04,1.87E+03,5.19E+04,1.27E+04,1.79E+03,2.87E+04,0,FALSE,50.739,34,10,429,47.4,5.6,10,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;nucleus;other cell component,Pf00022,86,B3KMN1; D3DNR9; hsa:86; O96019; Q8TAE5; Q9BVS8; Q9H0W6,ENSG00000136518,UCH proteinases; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines; HATs acetylate histones; DNA Damage Recognition in GG-NER,Androgen receptor network in prostate cancer; Gastric cancer network 1; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome,10,0,157.96,86.46,47.64,97.18,n/a,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,119.78,101.02,16.92,131.91,116.22,other molecular function,0,
Master Protein,High,Q13242,SRSF9,Serine/arginine-rich splicing factor 9 OS=Homo sapiens OX=9606 GN=SRSF9 PE=1 SV=1,2,2,0.888,0.281,0.01,100,-0.17,-1.83,-6.64,6.64,9.38E-01,3.15E-01,1.00E-17,1.00E-17,1.21E+05,1.36E+05,3.39E+04,,1,1,1,,,,,1.21E+05,,1.36E+05,,,,,,,,3.39E+04,,,,,,,,,,1.21E+05,,4.83E+02,,,,,,,,4.57E+03,,,,,,,0,FALSE,6.017,10,2,221,25.5,8.65,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf00076,8683,hsa:8683; Q13242; Q52LD1,ENSG00000111786,mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,mRNA processing,6,0,,,,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,0,,,6.54,other molecular function,0,
Master Protein,High,O43143,DHX15,ATP-dependent RNA helicase DHX15 OS=Homo sapiens OX=9606 GN=DHX15 PE=1 SV=2,9,20,0.885,1.078,0.406,1.064,-0.18,0.11,-1.3,0.09,9.71E-01,4.13E-01,2.65E-01,8.13E-01,1.11E+06,4.64E+05,1.09E+06,7.60E+05,3,2,5,4,,1.11E+06,,2.74E+06,1.65E+05,8.94E+05,,2.41E+05,,,7.61E+06,2.32E+05,7.36E+05,3.59E+06,1.09E+06,7.53E+05,1.75E+05,,1.16E+06,7.67E+05,,4.22E+03,,2.74E+06,8.49E+03,3.18E+03,,2.23E+03,,,4.55E+04,1.04E+04,5.98E+03,4.84E+05,2.71E+04,1.47E+03,4.93E+04,,2.71E+04,8.17E+03,0,FALSE,42.834,18,9,795,90.9,7.46,9,RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus,"Pf00270, Pf00271, Pf04408, Pf07717, Pf21010",1665,hsa:1665; O43143; Q9NQT7,ENSG00000109606,mRNA Splicing - Major Pathway,mRNA processing,2,0,97.38,81.34,115.39,56.8,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,5.12,118.22,118.47,62.71,64.29,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A590UJA9,TMUB1,Transmembrane and ubiquitin like domain containing 1 OS=Homo sapiens OX=9606 GN=TMUB1 PE=1 SV=1,1,1,0.885,0.084,5.443,0.014,-0.18,-3.57,2.44,-6.19,9.99E-01,1.28E-02,7.65E-02,5.23E-04,2.39E+05,2.70E+05,2.01E+04,1.47E+06,3,2,1,1,,4.08E+05,,8.12E+04,2.39E+05,,2.52E+05,2.90E+05,,,,2.01E+04,,,,,,1.47E+06,,,,1.55E+03,,8.12E+04,1.23E+04,,4.48E+03,2.68E+03,,,,9.00E+02,,,,,,1.04E+04,,,0.003,FALSE,2.681,3,1,367,37.3,9.54,1,,,,,A0A590UJA9,ENSG00000164897,,,0,0,67.27,10.04,,,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,61.06,97.92,10.55,0,2.48,,0,
Master Protein,High,O75558,STX11,Syntaxin-11 OS=Homo sapiens OX=9606 GN=STX11 PE=1 SV=1,1,3,0.883,0.212,0.899,0.102,-0.18,-2.24,-0.15,-3.29,9.70E-01,1.37E-01,7.65E-01,3.85E-02,4.47E+05,5.06E+05,9.49E+04,4.55E+05,2,1,4,3,,8.41E+05,,,2.37E+05,5.06E+05,,,,,2.27E+05,3.80E+04,,4.06E+04,2.22E+05,1.14E+07,3.24E+05,,4.55E+05,,,3.20E+03,,,1.22E+04,1.80E+03,,,,,1.36E+03,1.70E+03,,5.48E+03,5.51E+03,2.23E+04,9.11E+04,,1.07E+04,,0.004,FALSE,2.622,3,1,287,33.2,6.55,1,cell-cell signaling;cell organization and biogenesis;transport,plasma membrane;other membranes;ER/Golgi;other cell component,Pf00804,8676,E1P598; hsa:8676; O75378; O75558; O95148; Q5TCL6,ENSG00000135604,,,0,0,79.14,,81.02,156.6,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,1,,FALSE,100.1,81.41,59.82,121.94,5.09,other molecular function,0,
Master Protein,High,Q9NZB2,FAM120A,Constitutive coactivator of PPAR-gamma-like protein 1 OS=Homo sapiens OX=9606 GN=FAM120A PE=1 SV=2,1,1,0.883,0.185,1.613,0.083,-0.18,-2.43,0.69,-3.59,8.96E-01,1.94E-01,7.42E-01,5.87E-02,4.27E+04,6.89E+04,7.91E+03,9.50E+04,3,2,1,3,,4.51E+05,,1.10E+04,4.27E+04,1.93E+05,,,2.45E+04,,,,,7.91E+03,,3.67E+05,9.50E+04,,3.36E+04,,,1.71E+03,,1.10E+04,2.20E+03,6.87E+02,,,6.91E+02,,,,,1.07E+03,,7.15E+02,2.67E+04,,7.87E+02,,0.003,FALSE,2.756,2,1,1118,121.8,8.88,1,,plasma membrane;other membranes;cytosol;nucleus,,23196,A6NGU0; C4AMC6; hsa:23196; O60649; Q14688; Q4VXF4; Q4VXF5; Q4VXG2; Q86V69; Q96I21; Q9NZB1; Q9NZB2,ENSG00000048828,,VEGFA-VEGFR2 signaling,1,0,145.9,109.57,,107.36,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,142.52,110.08,117.67,95.77,2.59,,0,
Master Protein,High,Q6QNY0,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3 OS=Homo sapiens OX=9606 GN=BLOC1S3 PE=1 SV=1,1,1,0.881,1.072,6.379,0.148,-0.18,0.1,2.67,-2.76,9.94E-01,5.68E-01,3.34E-02,1.26E-01,2.50E+05,2.84E+05,2.68E+05,1.81E+06,1,3,2,3,,,,2.50E+05,,,1.92E+05,3.78E+05,,2.84E+05,1.93E+05,,3.73E+05,,,,9.14E+04,1.36E+07,1.81E+06,,,,,2.50E+05,,,3.42E+03,3.49E+03,,3.02E+03,1.15E+03,,3.03E+03,,,,2.57E+04,9.60E+04,4.24E+04,,0.001,FALSE,3.167,8,1,202,21.2,5.15,1,cell organization and biogenesis;stress response;transport;developmental processes;other biological processes,cytosol;ER/Golgi;other cell component,Pf15753,388552,B2RXB8; hsa:388552; Q6QNY0,ENSG00000189114,Golgi Associated Vesicle Biogenesis,,1,0,,32.56,44.88,142.2,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,47.79,49.62,140.78,140.37,2.57,transporter activity,0,
Master Protein,High,O00299,CLIC1,Chloride intracellular channel protein 1 OS=Homo sapiens OX=9606 GN=CLIC1 PE=1 SV=4,3,10,0.88,0.57,2.18,0.406,-0.18,-0.81,1.12,-1.3,9.66E-01,8.00E-01,4.56E-01,5.79E-01,7.25E+05,4.96E+05,3.91E+05,1.08E+06,5,3,4,5,4.36E+05,8.38E+05,7.33E+04,7.25E+05,3.46E+06,,,4.96E+05,4.27E+05,5.11E+05,,1.49E+05,1.38E+05,1.63E+06,1.03E+06,1.80E+06,4.94E+05,5.35E+06,5.65E+05,1.08E+06,1.73E+03,3.19E+03,7.16E+02,7.25E+05,1.78E+05,,,4.58E+03,1.20E+04,5.44E+03,,6.64E+03,1.12E+03,2.20E+05,2.56E+04,3.52E+03,1.39E+05,3.79E+04,1.32E+04,1.15E+04,0,FALSE,16.192,24,3,241,26.9,5.17,3,transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf13409, Pf13410",1192,hsa:1192; O00299; Q15089; Q502X1,ENSG00000206394; ENSG00000213719; ENSG00000223639; ENSG00000226248; ENSG00000226417; ENSG00000226651; ENSG00000230685,,VEGFA-VEGFR2 signaling,1,0,121.79,9.42,98.79,108.69,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,116.49,104.22,107.71,126.26,32.35,transporter activity,0,
Master Protein,High,Q96NT0,CCDC115,Coiled-coil domain-containing protein 115 OS=Homo sapiens OX=9606 GN=CCDC115 PE=1 SV=1,2,6,0.879,5.771,0.919,7.129,-0.19,2.53,-0.12,2.83,8.98E-01,7.87E-03,8.90E-01,5.92E-02,8.47E+04,6.29E+04,3.34E+05,6.09E+04,4,4,5,4,9.60E+04,7.48E+04,2.01E+04,3.33E+05,,2.04E+05,2.18E+04,1.14E+05,3.47E+04,,1.16E+05,1.31E+05,1.20E+06,1.32E+06,3.34E+05,,2.21E+04,3.90E+04,9.52E+04,1.29E+05,3.81E+02,2.84E+02,1.96E+02,3.33E+05,,7.27E+02,3.89E+02,1.05E+03,9.77E+02,,6.92E+02,5.86E+03,9.77E+03,1.78E+05,8.31E+03,,6.22E+03,2.76E+02,2.23E+03,1.37E+03,0,FALSE,9.742,23,2,180,19.7,6.95,2,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi;other cytoplasmic organelle,Pf21730,84317,B4DJ47; hsa:84317; Q96NT0; Q9BR88,ENSG00000136710,RHOA GTPase cycle,,1,0,105.74,89.93,95.51,69.47,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,105.68,117.26,105.14,107.68,18.35,other molecular function,0,
Master Protein,High,Q9NX24,NHP2,H/ACA ribonucleoprotein complex subunit 2 OS=Homo sapiens OX=9606 GN=NHP2 PE=1 SV=1,5,18,0.877,0.342,2.127,0.092,-0.19,-1.55,1.09,-3.44,9.58E-01,3.54E-01,5.41E-01,3.93E-02,9.73E+05,1.19E+05,5.19E+05,3.56E+05,4,3,5,3,,1.09E+06,1.14E+05,3.83E+06,8.66E+05,1.19E+05,3.09E+05,9.10E+04,,,5.19E+05,1.27E+06,3.84E+04,9.21E+05,3.07E+05,,,3.56E+05,3.05E+04,6.57E+05,,4.15E+03,1.11E+03,3.83E+06,4.47E+04,4.24E+02,5.49E+03,8.39E+02,,,3.10E+03,5.68E+04,3.12E+02,1.24E+05,7.64E+03,,,2.52E+03,7.14E+02,6.99E+03,0,FALSE,31.179,54,5,153,17.2,8.22,5,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;translational apparatus;nucleus;other cell component,Pf01248,55651,A6NKY8; hsa:55651; Q9NX24; Q9P095,ENSG00000145912,rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase,,2,0,110.1,68.47,80.14,90.06,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,65.34,73.9,124.87,109.5,54.9,nucleic acid binding activity,0,
Master Protein,High,O75165,DNAJC13,DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5,2,7,0.876,0.796,1.93,0.694,-0.19,-0.33,0.95,-0.53,9.83E-01,8.33E-01,6.09E-01,8.84E-01,2.00E+05,1.67E+05,2.56E+05,3.16E+05,3,5,4,5,2.14E+05,,,2.00E+05,1.38E+05,1.67E+05,2.94E+04,1.73E+05,1.15E+05,3.94E+05,,3.87E+04,5.58E+05,2.30E+05,2.85E+05,2.98E+05,1.17E+06,3.16E+05,1.32E+06,3.02E+05,8.48E+02,,,2.00E+05,7.11E+03,5.92E+02,5.24E+02,1.59E+03,3.24E+03,4.19E+03,,1.73E+03,4.53E+03,3.10E+04,7.08E+03,5.81E+02,3.28E+05,2.24E+03,3.09E+04,3.21E+03,0,FALSE,6.114,1,2,2243,254.3,6.74,2,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,"Pf00226, Pf14237, Pf19432",23317,hsa:23317; O75165; Q3L0T1; Q6PI82; Q6UJ77; Q6ZSW1; Q6ZUT5; Q86XG3; Q96DC1; Q9BWK9,ENSG00000138246,Neutrophil degranulation,,1,0,21.94,76.85,77.17,76,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,127.35,102.42,97.04,121.67,15.56,,0,
Master Protein,High,P67809,YBX1,Y-box-binding protein 1 OS=Homo sapiens OX=9606 GN=YBX1 PE=1 SV=3,5,10,0.876,0.283,0.54,,-0.19,-1.82,-0.89,,9.86E-01,2.68E-01,4.70E-01,,5.45E+05,1.66E+05,4.33E+04,2.92E+05,2,1,2,1,,,,3.44E+05,8.62E+05,,,,,1.66E+05,,1.33E+05,,1.41E+04,,,2.92E+05,,,,,,,3.44E+05,4.45E+04,,,,,1.77E+03,,5.96E+03,,1.90E+03,,,8.21E+04,,,,0,FALSE,25.484,19,5,324,35.9,9.88,5,RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,Pf00313,4904,hsa:4904; P16990; P16991; P67809; Q14972; Q15325; Q5FVF0,ENSG00000065978,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; mRNA Splicing - Major Pathway; Interferon gamma signaling; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Noncanonical activation of NOTCH3,Brain-derived neurotrophic factor (BDNF) signaling pathway; MECP2 and associated Rett syndrome; mRNA processing; Sudden infant death syndrome (SIDS) susceptibility pathways,10,0,60.74,,114.41,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,n/a,High,1,,FALSE,426.36,204.08,0,,22.82,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P06733,ENO1,Alpha-enolase OS=Homo sapiens OX=9606 GN=ENO1 PE=1 SV=2,17,81,0.875,0.663,1.243,0.422,-0.19,-0.59,0.31,-1.24,7.98E-01,9.50E-01,8.83E-01,4.91E-01,4.23E+06,1.25E+07,8.45E+06,1.05E+07,5,5,5,5,4.23E+06,3.01E+06,1.78E+06,1.35E+07,3.17E+07,1.25E+07,3.78E+06,1.44E+07,1.19E+06,1.25E+07,2.25E+06,8.45E+06,7.07E+06,1.40E+07,1.17E+07,1.05E+07,6.55E+06,5.98E+07,5.59E+06,3.18E+07,1.68E+04,1.14E+04,1.74E+04,1.35E+07,1.63E+06,4.45E+04,6.73E+04,1.33E+05,3.35E+04,1.33E+05,1.34E+04,3.77E+05,5.74E+04,1.88E+06,2.90E+05,2.05E+04,1.84E+06,4.24E+05,1.31E+05,3.39E+05,0,FALSE,79.754,35,16,434,47.1,7.39,17,other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00113, Pf03952",2023,B2RD59; hsa:2023; P06733; P22712; Q16704; Q4TUS4; Q53FT9; Q53HR3; Q658M5; Q6GMP2; Q71V37; Q7Z3V6; Q8WU71; Q96GV1; Q9BT62; Q9UCH6; Q9UM55,ENSG00000074800,Glycolysis; Gluconeogenesis; Manipulation of host energy metabolism,Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; IL-18 signaling pathway; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,9,1,115.66,67.13,51.81,101.72,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,High,High,Peak Found,High,High,High,High,1,,FALSE,126.98,122.01,142.22,135.53,207.72,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A0G2JK64,EHMT2,Histone-lysine N-methyltransferase EHMT2 OS=Homo sapiens OX=9606 GN=EHMT2 PE=1 SV=1,4,9,0.875,3.506,0.491,3.049,-0.19,1.81,-1.03,1.61,9.84E-01,1.31E-02,4.66E-01,2.13E-01,7.08E+05,1.84E+05,7.91E+05,7.88E+04,5,4,5,5,1.10E+06,7.08E+05,8.40E+04,9.05E+04,8.47E+05,7.67E+05,3.93E+05,3.02E+04,,8.60E+04,3.17E+06,2.56E+04,4.23E+04,7.91E+05,1.04E+06,2.48E+06,9.67E+02,5.64E+05,1.08E+04,7.88E+04,4.37E+03,2.69E+03,8.21E+02,9.05E+04,4.37E+04,2.73E+03,6.98E+03,2.78E+02,,9.15E+02,1.90E+04,1.14E+03,3.44E+02,1.07E+05,2.59E+04,4.85E+03,2.72E+02,3.99E+03,2.53E+02,8.39E+02,0,FALSE,17.039,5,4,1267,138.7,6.04,4,cell organization and biogenesis,nucleus;other cell component,"Pf00856, Pf05033, Pf12796, Pf21533",,A0A0G2JK64,ENSG00000232045; ENSG00000238134,,,0,0,81.11,106.15,126.87,169.46,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,71.01,116.84,132.73,130.16,28.36,other molecular function,0,
Master Protein,High,Q99714,HSD17B10,3-hydroxyacyl-CoA dehydrogenase type-2 OS=Homo sapiens OX=9606 GN=HSD17B10 PE=1 SV=3,13,48,0.875,1.039,2.896,1.363,-0.19,0.05,1.53,0.45,8.18E-01,5.48E-01,2.01E-01,7.25E-01,2.32E+06,1.96E+06,5.38E+06,1.55E+06,5,5,5,5,2.32E+06,9.61E+05,1.93E+05,6.42E+06,2.52E+06,1.96E+06,8.96E+05,2.68E+06,2.90E+04,2.85E+06,3.55E+06,5.85E+06,2.54E+06,1.30E+07,5.38E+06,9.13E+05,1.77E+06,2.73E+06,6.59E+05,1.55E+06,9.21E+03,3.65E+03,1.88E+03,6.42E+06,1.30E+05,6.96E+03,1.59E+04,2.47E+04,8.17E+02,3.03E+04,2.12E+04,2.61E+05,2.06E+04,1.75E+06,1.34E+05,1.78E+03,4.98E+05,1.93E+04,1.54E+04,1.65E+04,0,FALSE,72.784,69,13,261,26.9,7.78,13,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,plasma membrane;other membranes;mitochondrion;other cell component,Pf00106,3028,hsa:3028; Q5H927; Q6IBS9; Q8TCV9; Q96HD5; Q99714,ENSG00000072506,Branched-chain amino acid catabolism; Mitochondrial protein degradation; tRNA processing in the mitochondrion; tRNA modification in the mitochondrion; rRNA processing in the mitochondrion,Alzheimer's disease and miRNA effects; Valproic acid pathway; Alzheimer's disease,8,0,96.74,71.49,67.59,53.27,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,114.34,119.52,136.79,117.02,146.66,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q969V3,NCLN,BOS complex subunit NCLN OS=Homo sapiens OX=9606 GN=NCLN PE=1 SV=2,2,8,0.871,1.566,1.107,1.557,-0.2,0.65,0.15,0.64,9.90E-01,2.44E-01,9.38E-01,5.46E-01,4.51E+05,1.81E+05,6.36E+05,6.31E+05,4,5,5,4,3.70E+05,7.39E+05,,5.49E+05,3.09E+05,3.36E+05,7.24E+04,2.86E+05,1.09E+05,1.81E+05,6.28E+04,4.04E+05,6.36E+05,1.32E+06,9.02E+05,,3.95E+05,9.32E+05,1.20E+06,4.27E+05,1.47E+03,2.81E+03,,5.49E+05,1.59E+04,1.20E+03,1.29E+03,2.64E+03,3.07E+03,1.93E+03,3.75E+02,1.80E+04,5.17E+03,1.78E+05,2.24E+04,,1.11E+05,6.61E+03,2.80E+04,4.54E+03,0,FALSE,5.445,3,2,563,62.9,6.89,2,cell organization and biogenesis;developmental processes;other biological processes,other membranes;cytosol;ER/Golgi;other cell component,Pf04389,56926,D6W613; hsa:56926; O75252; Q6FI60; Q6ZMB7; Q8TAT7; Q969V3; Q96H48; Q96IS7; Q9BQH9; Q9BTX4; Q9NPP2,ENSG00000125912,,,0,0,39.42,57.23,72.01,53.24,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,116.58,85.7,135.65,126.59,14.34,translation activity,0,
Master Protein,High,A0A7I2YQF8,EIF3I,Eukaryotic translation initiation factor 3 subunit I OS=Homo sapiens OX=9606 GN=EIF3I PE=1 SV=1,4,11,0.868,1.384,1.241,1.409,-0.2,0.47,0.31,0.5,9.88E-01,3.80E-01,9.50E-01,6.14E-01,3.22E+05,1.95E+05,2.77E+05,8.01E+05,3,2,4,4,,,3.39E+04,3.22E+05,3.60E+05,5.67E+05,,,,6.70E+04,1.24E+05,,6.71E+05,2.96E+05,2.60E+05,9.29E+05,9.44E+05,,8.79E+04,6.91E+05,,,3.31E+02,3.22E+05,1.86E+04,2.02E+03,,,,7.12E+02,7.41E+02,,5.45E+03,3.98E+04,6.47E+03,1.81E+03,2.65E+05,,2.06E+03,7.36E+03,0,FALSE,8.764,12,4,362,40.5,5.64,4,cell organization and biogenesis;protein metabolism;other metabolic processes,translational apparatus;other cell component,Pf00400,,A0A7I2YQF8,ENSG00000084623,,,0,0,74.72,111.55,69.37,60.41,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,190.27,12.21,102.39,128.7,26.37,nucleic acid binding activity,0,
Master Protein,High,Q9Y679,AUP1,Lipid droplet-regulating VLDL assembly factor AUP1 OS=Homo sapiens OX=9606 GN=AUP1 PE=1 SV=2,1,2,0.864,1.095,0.01,100,-0.21,0.13,-6.64,6.64,9.10E-01,6.09E-01,1.00E-17,1.00E-17,1.24E+05,1.43E+05,1.34E+05,,2,2,4,,2.29E+05,,,6.69E+04,,,,,4.00E+04,5.12E+05,4.62E+05,4.37E+04,,1.23E+05,1.45E+05,,,,,,9.09E+02,,,6.69E+04,,,,,1.13E+03,5.44E+03,2.76E+03,1.95E+03,,1.65E+04,3.61E+03,,,,,,0.001,FALSE,3.136,3,1,410,45.8,8.65,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf02845,550,C0H5W8; hsa:550; Q9H866; Q9UNQ6; Q9Y679; Q9Y685,ENSG00000115307,,,0,0,77.43,120.9,95.29,,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,132.09,111.28,,,2.7,other molecular function,0,
Master Protein,High,P05109,S100A8,Protein S100-A8 OS=Homo sapiens OX=9606 GN=S100A8 PE=1 SV=1,2,18,0.864,0.291,1.071,0.394,-0.21,-1.78,0.1,-1.34,7.87E-01,2.01E-01,9.65E-01,4.53E-01,6.74E+06,6.87E+06,2.19E+06,5.79E+06,5,5,4,3,8.19E+05,3.27E+07,6.74E+06,6.96E+04,7.56E+06,1.22E+07,4.39E+06,2.71E+07,6.52E+05,6.87E+06,,6.95E+05,2.79E+06,1.73E+06,3.21E+06,1.11E+07,9.98E+04,,5.79E+06,,3.26E+03,1.24E+05,6.58E+04,6.96E+04,3.90E+05,4.33E+04,7.80E+04,2.50E+05,1.84E+04,7.30E+04,,3.11E+04,2.27E+04,2.33E+05,7.99E+04,2.16E+04,2.80E+04,,1.35E+05,,0,FALSE,7.168,24,2,93,10.8,7.03,2,cell adhesion;cell-cell signaling;protein metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf01023,6279,A8K5L3; D3DV37; hsa:6279; P05109; Q5SY70; Q9UC84; Q9UC92; Q9UCJ0; Q9UCM6,ENSG00000143546,ER-Phagosome pathway; Neutrophil degranulation; MyD88:MAL(TIRAP) cascade initiated on plasma membrane; MyD88 deficiency (TLR2/4); IRAK4 deficiency (TLR2/4); Regulation of TLR by endogenous ligand; Metal sequestration by antimicrobial proteins; RHO GTPases Activate NADPH Oxidases,Vitamin D receptor pathway,9,0,139.46,100.81,53.65,97.03,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,High,n/a,1,,FALSE,134.08,144.49,88.54,100.92,31.31,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A494C0B6,ACSL6,Long-chain-fatty-acid--CoA ligase OS=Homo sapiens OX=9606 GN=ACSL6 PE=1 SV=1,4,6,0.864,0.01,0.343,0.01,-0.21,-6.64,-1.54,-6.64,8.73E-01,1.00E-17,1.41E-01,1.00E-17,1.23E+06,1.53E+06,,1.53E+06,3,2,,1,,1.23E+06,,2.83E+05,1.34E+06,2.17E+06,,1.09E+06,,,,,,,,,1.53E+06,,,,,4.69E+03,,2.83E+05,6.89E+04,7.70E+03,,1.00E+04,,,,,,,,,4.31E+05,,,,0,FALSE,15.023,8,4,720,80.3,7.28,4,other metabolic processes,other membranes;mitochondrion;ER/Golgi,Pf00501,,A0A494C0B6,ENSG00000164398,,PPAR signaling pathway; Ferroptosis; Thermogenesis; Fatty acid transporters; Primary ovarian insufficiency; Fatty acids and lipoproteins transport in hepatocytes,6,0,61.1,46.95,,,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,45.48,,128.4,,18.18,other molecular function,0,
Master Protein,High,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A OS=Homo sapiens OX=9606 GN=PPP1R12A PE=1 SV=1,6,7,0.863,0.225,5.619,0.023,-0.21,-2.15,2.49,-5.47,9.84E-01,1.59E-01,8.84E-02,1.79E-03,5.99E+05,1.59E+05,8.93E+04,1.03E+06,3,2,1,1,,5.99E+05,,9.22E+05,1.16E+05,,,,1.38E+05,1.83E+05,,,,8.93E+04,,,,,,1.03E+06,,2.28E+03,,9.22E+05,5.96E+03,,,,3.89E+03,1.95E+03,,,,1.20E+04,,,,,,1.10E+04,0,FALSE,19.291,8,6,1030,115.2,5.4,6,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00023, Pf15898",4659,B4DZ09; F8VWB4; hsa:4659; O14974; Q2NKL4; Q569H0; Q86WU3; Q8NFR6; Q9BYH0,ENSG00000058272,Regulation of PLK1 Activity at G2/M Transition; RHO GTPases activate CIT; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs,Focal adhesion; Hippo-Merlin signaling dysregulation; Regulation of actin cytoskeleton,8,0,74.38,19.93,,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,26.39,88.11,0,0,19.62,enzyme regulator activity;other molecular function,0,
Master Protein,High,P02549,SPTA1,"Spectrin alpha chain, erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTA1 PE=1 SV=5",136,1260,0.863,0.42,1.923,0.219,-0.21,-1.25,0.94,-2.19,7.85E-01,4.61E-01,4.82E-01,2.04E-01,2.91E+08,2.05E+08,5.96E+07,2.99E+08,5,5,5,5,9.51E+08,2.94E+08,2.91E+08,6.86E+06,9.49E+07,2.05E+08,3.29E+08,2.84E+08,1.48E+08,1.76E+08,2.91E+08,3.18E+07,1.24E+08,5.96E+07,1.81E+07,2.54E+08,8.11E+08,1.61E+08,2.99E+08,3.35E+08,3.78E+06,1.12E+06,2.84E+06,6.86E+06,4.89E+06,7.28E+05,5.85E+06,2.62E+06,4.18E+06,1.87E+06,1.74E+06,1.42E+06,1.01E+06,8.03E+06,4.51E+05,4.95E+05,2.28E+08,1.14E+06,7.01E+06,3.57E+06,0,FALSE,1040.026,64,136,2419,279.8,5.05,136,cell organization and biogenesis;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00018, Pf00435, Pf08726",6708,hsa:6708; P02549; Q15514; Q5VYL1; Q5VYL2; Q6LDY5,ENSG00000163554,COPI-mediated anterograde transport; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins,,4,0,113.02,33.1,106.46,68.25,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,136.34,140.24,125.98,132.17,3755.32,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9UNK0,STX8,Syntaxin-8 OS=Homo sapiens OX=9606 GN=STX8 PE=1 SV=2,1,4,0.862,1.292,0.17,3.757,-0.21,0.37,-2.56,1.91,9.99E-01,4.36E-01,7.48E-02,1.31E-01,2.84E+05,3.41E+05,4.81E+05,5.78E+04,4,3,3,3,2.62E+05,1.02E+05,4.95E+05,3.07E+05,,3.73E+05,,2.82E+05,,3.41E+05,5.28E+05,,4.81E+05,9.28E+03,,,1.04E+04,,1.41E+05,5.78E+04,1.04E+03,3.87E+02,4.84E+03,3.07E+05,,1.33E+03,,2.60E+03,,3.63E+03,3.16E+03,,3.91E+03,1.25E+03,,,2.93E+03,,3.29E+03,6.16E+02,0.003,FALSE,2.698,3,1,236,26.9,4.98,1,cell organization and biogenesis;stress response;transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf05739,9482,hsa:9482; O60712; Q53XT8; Q9UNK0,ENSG00000170310,,,0,0,55.45,13.88,84.52,94.62,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,42.83,110.39,87.24,145.65,3.81,other molecular function,0,
Master Protein,High,P04075,ALDOA,Fructose-bisphosphate aldolase A OS=Homo sapiens OX=9606 GN=ALDOA PE=1 SV=2,10,36,0.862,0.866,1.038,0.521,-0.21,-0.21,0.05,-0.94,7.85E-01,7.40E-01,9.33E-01,6.16E-01,3.66E+06,4.58E+06,4.86E+06,8.02E+06,5,5,5,5,1.80E+06,2.55E+07,3.28E+05,3.66E+06,3.82E+07,3.51E+06,4.58E+06,9.08E+06,1.29E+06,1.19E+07,9.04E+05,1.82E+06,4.86E+06,7.87E+06,5.32E+06,7.76E+06,8.02E+06,4.31E+06,8.41E+06,4.69E+07,7.15E+03,9.67E+04,3.21E+03,3.66E+06,1.97E+06,1.25E+04,8.14E+04,8.37E+04,3.64E+04,1.27E+05,5.41E+03,8.13E+04,3.95E+04,1.06E+06,1.32E+05,1.51E+04,2.25E+06,3.06E+04,1.97E+05,5.00E+05,0,FALSE,47.966,45,8,364,39.4,8.09,10,cell organization and biogenesis;other metabolic processes;other biological processes,non-structural extracellular;cytosol;cytoskeleton;other cell component,Pf00274,226,B4DXI7; hsa:226; P04075; Q6FH76; Q6FI10; Q96B15; Q9BWD9; Q9UCN2,ENSG00000149925,Glycolysis; Gluconeogenesis; Neutrophil degranulation; Platelet degranulation,VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; 16p11.2 proximal deletion syndrome; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; Sudden infant death syndrome (SIDS) susceptibility pathways,11,2,122.55,71.14,67.74,118.51,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,133.88,123.76,127.83,125.56,99.46,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q96T60,PNKP,Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens OX=9606 GN=PNKP PE=1 SV=1,4,6,0.861,0.486,,,-0.22,-1.04,,,9.71E-01,6.39E-01,,,5.96E+05,2.33E+05,1.53E+05,2.15E+04,1,1,3,1,,,,5.96E+05,,,2.33E+05,,,,,1.32E+05,,4.37E+05,1.53E+05,,2.15E+04,,,,,,,5.96E+05,,,4.15E+03,,,,,5.89E+03,,5.89E+04,3.80E+03,,6.03E+03,,,,0,FALSE,12.071,12,4,521,57,8.46,4,DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf08645, Pf13671, Pf17913",11284,hsa:11284; Q96T60; Q9BUL2; Q9P1V2; Q9UKU8; Q9UNF8; Q9UNI0,ENSG00000039650,APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,"Base excision repair; DNA repair pathways, full network",3,0,,,70.77,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,0,14.19,,,19.39,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,A0A087X1Z3,PSME2,Proteasome activator subunit 2 OS=Homo sapiens OX=9606 GN=PSME2 PE=1 SV=1,6,28,0.861,0.345,0.11,1.272,-0.22,-1.54,-3.19,0.35,7.84E-01,3.04E-01,3.16E-03,6.85E-01,8.12E+06,4.47E+06,1.69E+06,1.16E+06,5,2,5,5,3.48E+06,8.63E+06,8.12E+06,2.37E+06,8.16E+06,5.99E+06,,,,3.34E+06,1.53E+06,6.14E+05,1.72E+06,2.29E+06,1.69E+06,7.06E+06,1.05E+06,1.16E+06,1.11E+06,1.82E+06,1.38E+04,3.28E+04,7.94E+04,2.37E+06,4.21E+05,2.13E+04,,,,3.55E+04,9.17E+03,2.74E+04,1.40E+04,3.08E+05,4.20E+04,1.38E+04,2.95E+05,8.22E+03,2.61E+04,1.94E+04,0,FALSE,38.696,38,6,254,29.1,6.71,6,,other cell component,"Pf02251, Pf02252",,A0A087X1Z3,ENSG00000100911,,,0,0,48.4,40.22,38.61,106.51,High,Peak Found,High,High,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,115.72,143.96,101.2,114.19,76.73,,0,
Master Protein,High,P24539,ATP5PB,"ATP synthase F(0) complex subunit B1, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PB PE=1 SV=2",11,52,0.86,1.017,0.929,1.048,-0.22,0.02,-0.11,0.07,7.83E-01,5.69E-01,8.22E-01,9.06E-01,6.05E+06,1.38E+07,5.79E+06,1.17E+07,5,5,5,5,2.20E+06,3.96E+07,1.40E+06,6.05E+06,3.20E+07,1.38E+07,7.14E+06,1.85E+07,1.09E+07,2.08E+07,2.19E+06,5.79E+06,5.22E+06,9.94E+06,7.93E+06,1.17E+07,5.07E+06,2.30E+07,3.24E+06,1.21E+07,8.76E+03,1.50E+05,1.36E+04,6.05E+06,1.65E+06,4.90E+04,1.27E+05,1.70E+05,3.08E+05,2.21E+05,1.31E+04,2.59E+05,4.24E+04,1.34E+06,1.97E+05,2.29E+04,1.43E+06,1.63E+05,7.57E+04,1.28E+05,0,FALSE,39.344,36,11,256,28.9,9.36,11,other metabolic processes;transport,other membranes;mitochondrion,Pf05405,515,hsa:515; P24539; Q9BQ68; Q9BRU8,ENSG00000116459,Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,5,0,111.59,38.8,47.07,70.44,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,127.24,137.47,98.15,124.17,140.65,transporter activity,0,
Master Protein,High,Q08257,CRYZ,Quinone oxidoreductase OS=Homo sapiens OX=9606 GN=CRYZ PE=1 SV=1,5,7,0.86,0.294,0.471,2.3,-0.22,-1.77,-1.09,1.2,9.45E-01,2.71E-01,3.20E-01,3.04E-01,5.24E+05,5.78E+05,3.67E+05,1.89E+05,5,2,4,3,3.71E+05,1.55E+06,5.24E+05,1.44E+06,2.89E+05,,,5.92E+05,,5.65E+05,,5.55E+04,1.38E+05,9.81E+05,1.64E+06,,4.49E+05,,1.89E+05,7.39E+04,1.48E+03,5.91E+03,5.12E+03,1.44E+06,1.49E+04,,,5.46E+03,,6.00E+03,,2.48E+03,1.12E+03,1.32E+05,4.07E+04,,1.26E+05,,4.41E+03,7.87E+02,0,FALSE,16.407,28,5,329,35.2,8.44,5,cell organization and biogenesis;other metabolic processes;other biological processes,cytosol,"Pf08240, Pf13602",1429,A6NN60; D3DQ76; hsa:1429; Q08257; Q53FT0; Q59EU7; Q5HYE7; Q6NSK9,ENSG00000116791,,,0,0,73.08,3.3,106.75,81.07,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,51.41,105.75,54.27,59.03,25.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UG22,GIMAP2,GTPase IMAP family member 2 OS=Homo sapiens OX=9606 GN=GIMAP2 PE=1 SV=2,1,1,0.859,0.01,0.175,0.01,-0.22,-6.64,-2.51,-6.64,8.47E-01,1.00E-17,4.32E-02,1.00E-17,1.68E+06,1.96E+06,,3.43E+05,3,1,,1,1.68E+06,,,4.38E+05,5.60E+06,,,,1.96E+06,,,,,,,,,,3.43E+05,,6.68E+03,,,4.38E+05,2.89E+05,,,,5.51E+04,,,,,,,,,,8.02E+03,,0,FALSE,4.355,7,1,337,38,8.24,1,,ER/Golgi;nucleus;other cell component,Pf04548,26157,hsa:26157; Q96L25; Q9UG22,ENSG00000106560,,TYROBP causal network in microglia,1,0,104.73,,,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,103.76,,0,,3.98,other molecular function,0,
Master Protein,High,O60313,OPA1,"Dynamin-like 120 kDa protein, mitochondrial OS=Homo sapiens OX=9606 GN=OPA1 PE=1 SV=3",12,36,0.859,0.727,1.609,1.033,-0.22,-0.46,0.69,0.05,7.85E-01,9.42E-01,6.35E-01,9.16E-01,3.47E+06,1.02E+06,3.22E+06,3.57E+06,4,4,5,5,1.90E+05,4.45E+06,,6.08E+06,2.71E+06,1.92E+06,3.16E+06,,5.45E+05,3.61E+04,5.46E+05,3.22E+06,2.51E+06,8.30E+06,3.73E+06,1.24E+07,1.70E+06,7.82E+04,3.57E+06,1.11E+07,7.55E+02,1.69E+04,,6.08E+06,1.40E+05,6.81E+03,5.61E+04,,1.54E+04,3.84E+02,3.26E+03,1.44E+05,2.04E+04,1.12E+06,9.27E+04,2.41E+04,4.78E+05,5.54E+02,8.35E+04,1.19E+05,0,FALSE,37.777,17,12,960,111.6,7.87,12,cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes,other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component,"Pf00350, Pf19434",4976,D3DNW4; E5KLJ5; E5KLJ6; E5KLJ7; E5KLK1; E5KLK2; hsa:4976; O60313,ENSG00000198836,Mitochondrial protein degradation; Regulation of Apoptosis,Orexin receptor pathway,3,0,75.06,99.59,78.16,97.31,Peak Found,High,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,112.67,100.45,123.74,108.08,97.36,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q8IYS1,PM20D2,Xaa-Arg dipeptidase OS=Homo sapiens OX=9606 GN=PM20D2 PE=1 SV=2,1,1,0.859,0.01,0.548,0.01,-0.22,-6.64,-0.87,-6.64,8.66E-01,1.00E-17,5.68E-01,1.00E-17,2.88E+04,3.35E+04,,1.84E+04,1,1,,1,,,,2.88E+04,,,3.35E+04,,,,,,,,,,,,1.84E+04,,,,,2.88E+04,,,5.96E+02,,,,,,,,,,,,4.30E+02,,0.002,FALSE,3.031,5,1,436,47.7,5.85,1,protein metabolism;other biological processes,nucleus,"Pf01546, Pf07687",135293,B4DYJ2; hsa:135293; Q5T7J9; Q6MZV2; Q86XD9; Q8IYS1,ENSG00000146281,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,,0,,3.31,other molecular function,0,
Master Protein,High,M0R2Z9,SUGP2,SURP and G-patch domain containing 2 OS=Homo sapiens OX=9606 GN=SUGP2 PE=1 SV=1,3,5,0.858,0.4,0.01,100,-0.22,-1.32,-6.64,6.64,9.84E-01,5.17E-01,1.00E-17,1.00E-17,2.75E+05,3.27E+05,9.44E+04,,4,4,3,,2.59E+05,2.93E+05,,2.50E+05,3.84E+05,6.15E+05,3.18E+05,3.37E+05,,6.24E+04,,,3.45E+04,2.60E+05,9.44E+04,,,,,,1.03E+03,1.11E+03,,2.50E+05,1.98E+04,2.18E+03,5.66E+03,3.11E+03,,6.64E+02,,,2.80E+02,3.51E+04,2.35E+03,,,,,,0,FALSE,9.492,4,3,1096,121.5,7.4,3,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf01585, Pf01805",10147,M0R2Z9,ENSG00000064607,,mRNA processing,1,0,20.68,67.75,90.2,,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,97.47,49.36,,,13.24,nucleic acid binding activity,0,
Master Protein,High,P28062,PSMB8,Proteasome subunit beta type-8 OS=Homo sapiens OX=9606 GN=PSMB8 PE=1 SV=3,4,19,0.858,0.526,0.19,1.862,-0.22,-0.93,-2.4,0.9,8.05E-01,7.26E-01,2.56E-02,4.58E-01,1.86E+06,2.46E+06,7.35E+05,8.03E+05,4,5,5,3,,1.77E+06,4.45E+05,1.95E+06,2.58E+07,1.48E+06,3.41E+06,2.46E+06,4.49E+05,5.42E+06,2.25E+05,3.34E+05,7.35E+05,2.61E+06,1.24E+06,1.11E+06,8.97E+04,,8.03E+05,,,6.72E+03,4.34E+03,1.95E+06,1.33E+06,5.28E+03,6.07E+04,2.27E+04,1.26E+04,5.76E+04,1.35E+03,1.49E+04,5.97E+03,3.51E+05,3.08E+04,2.16E+03,2.52E+04,,1.88E+04,,0,FALSE,24.069,18,4,276,30.3,7.43,4,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf00227,5696,B0UZC0; hsa:5696; P28062; Q29824; Q5JNW6; Q5QNR8; Q96J48,ENSG00000204264; ENSG00000206298; ENSG00000226201; ENSG00000230034; ENSG00000230669; ENSG00000231631; ENSG00000235715; ENSG00000236443,Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Interferon alpha/beta signaling,Proteasome degradation; Immune response to tuberculosis,62,0,163.2,71.93,94.16,78.41,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,100.47,81.14,133.24,127.31,53.19,other molecular function,0,
Master Protein,High,P38646,HSPA9,"Stress-70 protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPA9 PE=1 SV=2",32,218,0.857,0.926,1.337,0.968,-0.22,-0.11,0.42,-0.05,7.80E-01,6.66E-01,8.11E-01,9.62E-01,2.40E+07,9.94E+06,2.31E+07,1.38E+07,5,5,5,5,2.21E+06,2.59E+07,3.17E+06,3.90E+07,2.40E+07,1.29E+07,3.48E+06,9.94E+06,6.36E+06,2.32E+07,5.78E+06,2.13E+07,2.31E+07,3.25E+07,2.64E+07,2.00E+07,1.63E+07,1.18E+07,1.10E+07,1.38E+07,8.80E+03,9.86E+04,3.10E+04,3.90E+07,1.24E+06,4.59E+04,6.19E+04,9.17E+04,1.79E+05,2.47E+05,3.46E+04,9.52E+05,1.88E+05,4.38E+06,6.56E+05,3.91E+04,4.59E+06,8.33E+04,2.56E+05,1.47E+05,0,FALSE,181.899,57,32,679,73.6,6.16,32,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,other membranes;mitochondrion;nucleus;other cell component,Pf00012,3313,B2RCM1; hsa:3313; P30036; P31932; P38646; Q1HB43; Q53H23; Q6GU03; Q9BWB7; Q9UC56,ENSG00000113013,Mitochondrial protein degradation; Regulation of HSF1-mediated heat shock response; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Mitochondrial protein import; Cristae formation,Parkin-ubiquitin proteasomal system pathway; Iron-sulfur cluster biogenesis,7,0,84.04,68.11,45.53,25.37,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,132.73,116.23,118.21,110.21,588.6,other molecular function,0,
Master Protein,High,Q9BTV4,TMEM43,Transmembrane protein 43 OS=Homo sapiens OX=9606 GN=TMEM43 PE=1 SV=1,10,36,0.856,1.071,0.649,1.26,-0.22,0.1,-0.62,0.33,8.54E-01,5.19E-01,6.48E-01,7.78E-01,1.30E+06,8.86E+05,5.48E+06,1.11E+06,4,4,5,5,6.04E+05,,2.61E+04,1.53E+07,2.82E+06,1.05E+06,2.95E+05,7.51E+05,,5.60E+06,1.50E+07,8.02E+06,5.48E+06,4.74E+06,2.09E+06,2.19E+06,3.90E+05,1.05E+06,1.11E+06,8.64E+06,2.40E+03,,2.55E+02,1.53E+07,1.45E+05,3.72E+03,5.25E+03,6.93E+03,,5.95E+04,8.97E+04,3.58E+05,4.45E+04,6.38E+05,5.18E+04,4.28E+03,1.10E+05,7.46E+03,2.60E+04,9.20E+04,0,FALSE,65.078,43,10,400,44.8,8.13,10,cell organization and biogenesis;other metabolic processes;stress response,plasma membrane;other membranes;ER/Golgi;nucleus,Pf07787,79188,hsa:79188; Q7L4N5; Q8NC30; Q96A63; Q96F19; Q96JX0; Q9BTV4; Q9H076,ENSG00000170876,,Envelope proteins and their potential roles in EDMD physiopathology,1,0,153.19,128.47,69.59,126.79,Peak Found,n/a,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,145.08,107.61,94.18,142.25,112.06,other molecular function,0,
Master Protein,High,P05067,APP,Amyloid-beta precursor protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3,1,3,0.854,0.01,1.087,0.01,-0.23,-6.64,0.12,-6.64,8.64E-01,1.00E-17,9.21E-01,1.00E-17,1.07E+06,1.25E+06,,7.81E+05,1,3,,4,,,,,1.07E+06,,,1.25E+06,7.96E+04,3.33E+06,,,,,,4.19E+06,7.48E+04,3.08E+06,1.98E+05,,,,,,5.50E+04,,,1.15E+04,2.24E+03,3.54E+04,,,,,,8.17E+03,2.10E+04,2.18E+04,4.64E+03,,0.001,FALSE,3.148,2,1,770,86.9,4.82,1,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00014, Pf02177, Pf03494, Pf10515, Pf12924, Pf12925",351,B2R5V1; B4DII8; D3DSD1; D3DSD2; D3DSD3; hsa:351; P05067; P09000; P78438; Q13764; Q13778; Q13793; Q16011; Q16014; Q16019; Q16020; Q6GSC0; Q8WZ99; Q9BT38; Q9UC33; Q9UCA9; Q9UCB6; Q9UCC8; Q9UCD1; Q9UQ58,ENSG00000142192,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Amyloid fiber formation; G alpha (q) signalling events; G alpha (i) signalling events; ECM proteoglycans; Lysosome Vesicle Biogenesis; Platelet degranulation ; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; TAK1-dependent IKK and NF-kappa-B activation  ; TRAF6 mediated NF-kB activation; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; Formyl peptide receptors bind formyl peptides and many other ligands; Advanced glycosylation endproduct receptor signaling,Alzheimer's disease and miRNA effects; Endoderm differentiation; Apoptosis-related network due to altered Notch3 in ovarian cancer; Copper homeostasis; TGF-beta signaling pathway; Fragile X syndrome; Inclusion body myositis; Alzheimer's disease; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; Neurogenesis regulation in the olfactory epithelium; 15q11q13 copy number variation,28,0,,106.01,,109.83,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,High,High,Peak Found,Peak Found,n/a,1,,FALSE,138.81,,142.67,,7.77,signal transduction activity or receptor binding;enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H2U2,PPA2,"Inorganic pyrophosphatase 2, mitochondrial OS=Homo sapiens OX=9606 GN=PPA2 PE=1 SV=2",8,20,0.854,1.679,0.474,1.315,-0.23,0.75,-1.08,0.4,8.59E-01,1.79E-01,3.61E-01,7.44E-01,1.53E+06,7.28E+05,3.02E+06,1.68E+06,5,3,4,3,3.52E+05,2.18E+06,2.31E+05,1.53E+06,2.08E+07,,,6.06E+05,4.15E+06,7.28E+05,,1.99E+06,2.73E+06,3.34E+06,3.62E+06,,1.68E+06,5.26E+05,2.90E+06,,1.40E+03,8.27E+03,2.26E+03,1.53E+06,1.07E+06,,,5.59E+03,1.17E+05,7.74E+03,,8.90E+04,2.22E+04,4.50E+05,8.98E+04,,4.73E+05,3.73E+03,6.78E+04,,0,FALSE,31.072,29,7,334,37.9,7.39,8,other metabolic processes;other biological processes,mitochondrion;other cell component,Pf00719,27068,B4DLP7; F8WDN9; hsa:27068; I6L9B6; Q4W5E9; Q6PG51; Q8TBW0; Q96E55; Q9H0T0; Q9H2U2; Q9NX37; Q9P033; Q9ULX0,ENSG00000138777,Mitochondrial tRNA aminoacylation; Pyrophosphate hydrolysis,,2,1,176.52,110.1,24.69,69.6,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,High,High,High,n/a,High,Peak Found,High,n/a,1,,FALSE,130.92,113.95,95.52,91.77,59.33,other molecular function,0,
Master Protein,High,P38117,ETFB,Electron transfer flavoprotein subunit beta OS=Homo sapiens OX=9606 GN=ETFB PE=1 SV=3,13,88,0.853,1.374,0.762,2.554,-0.23,0.46,-0.39,1.35,8.06E-01,3.11E-01,6.32E-01,3.64E-01,1.04E+06,3.00E+06,1.09E+07,2.03E+06,5,5,5,5,3.66E+05,1.04E+06,6.28E+05,1.50E+07,9.70E+06,4.87E+06,3.59E+05,3.00E+06,7.52E+05,4.41E+06,6.66E+05,1.89E+07,1.09E+07,7.28E+06,1.37E+07,1.94E+06,3.83E+06,2.03E+06,3.41E+06,1.94E+06,1.45E+03,3.97E+03,6.14E+03,1.50E+07,5.00E+05,1.73E+04,6.39E+03,2.77E+04,2.12E+04,4.69E+04,3.98E+03,8.42E+05,8.89E+04,9.81E+05,3.41E+05,3.79E+03,1.07E+06,1.44E+04,7.98E+04,2.07E+04,0,FALSE,52.1,49,13,255,27.8,8.1,13,other metabolic processes,mitochondrion;other cell component,Pf01012,2109,A8K766; B3KNY2; hsa:2109; P38117; Q6IBH7; Q71RF6; Q9Y3S7,ENSG00000105379,Respiratory electron transport; Protein methylation,,2,0,124.75,76.95,66.46,34.73,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,117.15,126.32,96.77,110.69,209.83,other molecular function,0,
Master Protein,High,Q9HD45,TM9SF3,Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2,3,8,0.851,0.241,0.01,100,-0.23,-2.05,-6.64,6.64,9.38E-01,1.54E-01,1.00E-17,1.00E-17,3.35E+05,6.78E+05,4.49E+05,,5,4,2,,1.91E+05,1.71E+06,6.81E+04,8.56E+05,3.35E+05,,2.33E+05,1.97E+06,1.69E+05,2.25E+06,4.36E+06,,,4.61E+04,,,,,,,7.61E+02,6.48E+03,6.66E+02,8.56E+05,1.73E+04,,4.15E+03,1.82E+04,4.77E+03,2.39E+04,2.61E+04,,,6.22E+03,,,,,,,0,FALSE,22.706,10,1,589,67.8,7.21,3,other biological processes,other membranes,Pf02990,56889,hsa:56889; Q5TB57; Q6UWE7; Q9HD45; Q9NWL8; Q9P0G9; Q9UHW8,ENSG00000077147,,,0,2,106.35,95.85,138.46,,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,68.64,137.96,,,28.85,,0,
Master Protein,High,O00160,MYO1F,Unconventional myosin-If OS=Homo sapiens OX=9606 GN=MYO1F PE=1 SV=3,1,1,0.85,1.763,5.383,0.279,-0.23,0.82,2.43,-1.84,9.06E-01,2.58E-01,1.13E-01,3.13E-01,1.10E+05,1.29E+05,1.94E+05,6.95E+05,1,1,1,3,,,,,1.10E+05,,1.29E+05,,,,,,1.94E+05,,,9.32E+05,,,6.95E+05,3.10E+05,,,,,5.66E+03,,2.30E+03,,,,,,1.57E+03,,,1.82E+03,,,1.63E+04,3.31E+03,0.001,FALSE,3.107,1,1,1098,124.8,9.11,1,cell organization and biogenesis;transport,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00018, Pf00063, Pf06017",4542,O00160; Q8WWN7,ENSG00000142347,,,0,0,,,,48.57,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,1,,FALSE,0,0,50.57,50.57,2.4,cytoskeletal activity;other molecular function,0,
Master Protein,High,O75340,PDCD6,Programmed cell death protein 6 OS=Homo sapiens OX=9606 GN=PDCD6 PE=1 SV=1,5,22,0.848,1.719,,1.78,-0.24,0.78,,0.83,8.58E-01,1.79E-01,,5.57E-01,2.69E+06,6.22E+05,3.45E+06,2.12E+06,3,3,5,5,,3.53E+06,,2.69E+06,9.23E+05,,6.22E+05,,4.77E+06,3.36E+05,2.88E+05,2.66E+06,4.24E+06,6.52E+06,3.45E+06,1.33E+06,2.12E+06,1.88E+06,3.45E+06,6.43E+06,,1.34E+04,,2.69E+06,4.76E+04,,1.11E+04,,1.34E+05,3.57E+03,1.72E+03,1.19E+05,3.44E+04,8.78E+05,8.58E+04,2.59E+03,5.96E+05,1.33E+04,8.08E+04,6.85E+04,0,FALSE,19.682,41,5,191,21.9,5.4,5,cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf13499,10016,B2RD16; E7ESR3; hsa:10016; O75340; Q2YDC2; Q5TZS0,ENSG00000249915,,Epithelial to mesenchymal transition in colorectal cancer,1,0,55.91,129.96,66.2,67.35,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,95.95,131.25,,68.08,64.68,other molecular function,0,
Master Protein,High,A0A0D9SGE8,PHF6,PHD finger protein 6 OS=Homo sapiens OX=9606 GN=PHF6 PE=1 SV=1,4,9,0.846,1.177,2.18,0.654,-0.24,0.23,1.12,-0.61,9.39E-01,3.88E-01,5.50E-01,8.16E-01,9.13E+05,8.73E+04,5.11E+05,1.85E+05,4,1,5,4,1.94E+06,1.15E+06,,7.23E+05,3.85E+05,,,,,8.73E+04,5.97E+04,2.07E+04,5.11E+05,2.15E+06,7.04E+05,,2.88E+04,3.82E+05,8.98E+04,6.99E+05,7.73E+03,4.38E+03,,7.23E+05,1.99E+04,,,,,9.28E+02,3.57E+02,9.25E+02,4.15E+03,2.90E+05,1.75E+04,,8.09E+03,2.71E+03,2.10E+03,7.44E+03,0,FALSE,22.388,16,4,366,41.3,8.68,4,,nucleus,Pf13771,,A0A0D9SGE8,ENSG00000156531,,Mesodermal commitment pathway,1,0,64.03,,125.84,102.53,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,66.91,111.61,25.79,135.06,27.19,other molecular function,0,
Master Protein,High,P15153,RAC2,Ras-related C3 botulinum toxin substrate 2 OS=Homo sapiens OX=9606 GN=RAC2 PE=1 SV=1,5,21,0.845,0.739,0.69,1.804,-0.24,-0.44,-0.54,0.85,7.70E-01,8.89E-01,5.60E-01,4.63E-01,2.45E+06,2.05E+06,1.63E+06,1.27E+06,5,3,5,5,4.72E+06,1.49E+06,2.08E+06,3.85E+06,2.45E+06,3.22E+06,2.05E+06,,5.04E+05,,1.60E+06,6.75E+06,1.63E+06,1.35E+06,4.21E+06,1.27E+06,9.68E+04,3.52E+06,3.00E+06,5.92E+05,1.87E+04,5.65E+03,2.04E+04,3.85E+06,1.26E+05,1.15E+04,3.64E+04,,1.42E+04,,9.57E+03,3.02E+05,1.32E+04,1.81E+05,1.05E+05,2.48E+03,2.72E+04,2.50E+04,7.01E+04,6.30E+03,0,FALSE,14.356,27,2,192,21.4,7.61,5,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component,Pf00071,5880,hsa:5880; P15153; Q9UDJ4,ENSG00000128340,"RAC2 GTPase cycle; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; GPVI-mediated activation cascade; PCP/CE pathway; ROS and RNS production in phagocytes; RHO GTPases Activate NADPH Oxidases",Integrin-mediated cell adhesion; RalA downstream regulated genes; B cell receptor signaling pathway; Focal adhesion; MAPK signaling pathway; Chemokine signaling pathway; Microglia pathogen phagocytosis pathway; Macrophage markers; Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Insulin signaling; Regulation of actin cytoskeleton; Pathways in cancer; DNA damage response (only ATM dependent),24,2,45.6,70.83,75.61,88.36,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,94.36,93.34,109.28,115.43,43.16,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q8TDW0,LRRC8C,Volume-regulated anion channel subunit LRRC8C OS=Homo sapiens OX=9606 GN=LRRC8C PE=1 SV=2,8,15,0.844,0.261,1.023,0.893,-0.24,-1.94,0.03,-0.16,9.13E-01,1.53E-01,8.95E-01,9.08E-01,1.47E+06,2.73E+05,7.65E+05,6.31E+05,5,2,4,5,6.43E+05,6.63E+04,3.07E+06,1.47E+06,1.65E+06,8.15E+05,,,,9.17E+04,,3.48E+04,4.26E+05,2.28E+06,1.37E+06,7.41E+05,6.31E+05,3.30E+05,1.18E+06,7.80E+04,2.55E+03,2.52E+02,2.99E+04,1.47E+06,8.50E+04,2.90E+03,,,,9.75E+02,,1.56E+03,3.46E+03,3.08E+05,3.41E+04,1.45E+03,1.77E+05,2.34E+03,2.76E+04,8.30E+02,0,FALSE,29.338,14,8,803,92.4,7.62,8,cell organization and biogenesis;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,"Pf12534, Pf13855",84230,B3KXS9; hsa:84230; Q29RV6; Q8TDW0; Q9H075,ENSG00000171488,Miscellaneous transport and binding events,Neuroinflammation and glutamatergic signaling; Orexin receptor pathway,3,0,82.66,112.8,97.85,70.73,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,217.1,133.93,157.71,90.23,42.91,transporter activity,0,
Master Protein,High,O75521,ECI2,Enoyl-CoA delta isomerase 2 OS=Homo sapiens OX=9606 GN=ECI2 PE=1 SV=4,6,11,0.844,0.373,3.029,0.926,-0.24,-1.42,1.6,-0.11,9.56E-01,4.02E-01,2.97E-01,8.91E-01,4.48E+05,4.44E+05,3.71E+05,8.56E+05,4,5,5,4,2.56E+05,7.80E+05,2.57E+05,2.89E+06,,8.75E+05,6.52E+04,4.25E+05,5.74E+05,4.44E+05,6.44E+05,3.58E+05,1.97E+05,1.10E+06,3.71E+05,,4.97E+05,1.47E+06,2.34E+05,6.05E+06,1.02E+03,2.96E+03,2.51E+03,2.89E+06,,3.11E+03,1.16E+03,3.93E+03,1.62E+04,4.72E+03,3.85E+03,1.60E+04,1.60E+03,1.49E+05,9.22E+03,,1.40E+05,1.04E+04,5.47E+03,6.44E+04,0,FALSE,23.306,24,6,394,43.6,9,6,other metabolic processes,cytosol;mitochondrion;other cytoplasmic organelle;other cell component,"Pf00378, Pf00887",10455,hsa:10455; O75521; Q5JYK5; Q5JYK7; Q7L124; Q8N0X0; Q9BUE9; Q9H0T9; Q9NQH1; Q9NYH7; Q9UN55,ENSG00000198721,,,0,0,119.89,61.25,66.56,131.32,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,71.27,88.28,120.19,94.66,35.91,other molecular function,0,
Master Protein,High,P19387,POLR2C,DNA-directed RNA polymerase II subunit RPB3 OS=Homo sapiens OX=9606 GN=POLR2C PE=1 SV=2,4,13,0.844,0.49,0.01,100,-0.25,-1.03,-6.64,6.64,9.35E-01,6.89E-01,1.00E-17,1.00E-17,1.17E+06,4.02E+05,3.20E+05,,5,1,4,,3.40E+06,1.17E+06,1.55E+06,7.43E+05,3.90E+05,,,,,4.02E+05,,3.37E+05,6.77E+04,5.30E+05,3.03E+05,,,,,,1.35E+04,4.44E+03,1.52E+04,7.43E+05,2.01E+04,,,,,4.28E+03,,1.51E+04,5.50E+02,7.15E+04,7.53E+03,,,,,,0,FALSE,22.178,26,4,275,31.4,4.92,4,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus,"Pf01000, Pf01193",5432,hsa:5432; O15161; P19387,ENSG00000102978,Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,Pyrimidine metabolism; Eukaryotic transcription initiation; Primary ovarian insufficiency,44,0,80.98,,61.3,,Peak Found,High,High,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,20.51,83.66,,,40.54,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P23919,DTYMK,Thymidylate kinase OS=Homo sapiens OX=9606 GN=DTYMK PE=1 SV=4,4,6,0.843,0.979,1.12,0.774,-0.25,-0.03,0.16,-0.37,9.18E-01,5.51E-01,9.93E-01,9.99E-01,9.18E+05,7.54E+05,6.63E+05,7.15E+05,3,1,5,4,,,1.82E+06,5.00E+05,9.18E+05,,,,,7.54E+05,6.90E+05,3.03E+04,8.16E+05,5.71E+05,6.63E+05,,2.09E+05,8.45E+05,6.06E+05,1.26E+06,,,1.78E+04,5.00E+05,4.73E+04,,,,,8.02E+03,4.13E+03,1.35E+03,6.63E+03,7.69E+04,1.65E+04,,5.87E+04,5.99E+03,1.42E+04,1.35E+04,0,FALSE,11.381,16,4,212,23.8,8.27,4,other metabolic processes;other biological processes,cytosol;mitochondrion;nucleus;other cell component,Pf02223,1841,B7ZW70; hsa:1841; P23919; Q6FGX1; Q9BUX4,ENSG00000168393,Interconversion of nucleotide di- and triphosphates,Pyrimidine metabolism; 2q37 copy number variation syndrome,3,0,62.5,,55.15,60.45,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,96.51,67.64,24.54,25.14,16.61,kinase activity;other molecular function,0,
Master Protein,High,P31946,YWHAB,14-3-3 protein beta/alpha OS=Homo sapiens OX=9606 GN=YWHAB PE=1 SV=3,10,82,0.842,0.208,0.687,0.273,-0.25,-2.27,-0.54,-1.87,7.65E-01,7.59E-02,5.41E-01,2.82E-01,9.36E+06,8.45E+06,1.99E+06,5.45E+06,5,5,5,5,9.36E+06,1.81E+07,1.10E+06,1.66E+06,1.05E+07,8.45E+06,4.04E+06,8.73E+06,1.33E+06,1.16E+07,1.18E+06,4.24E+05,2.49E+06,4.43E+06,1.99E+06,9.87E+06,3.89E+06,5.45E+06,3.54E+06,1.50E+07,3.72E+04,6.87E+04,1.08E+04,1.66E+06,5.39E+05,3.00E+04,7.19E+04,8.06E+04,3.74E+04,1.24E+05,7.07E+03,1.89E+04,2.02E+04,5.96E+05,4.94E+04,1.92E+04,1.09E+06,3.86E+04,8.29E+04,1.60E+05,0,FALSE,45.652,45,6,246,28.1,4.83,10,signal transduction;other biological processes,other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf00244,7529,A8K9K2; E1P616; hsa:7529; P31946,ENSG00000166913,"TP53 Regulates Metabolic Genes; Signaling by BRAF and RAF1 fusions; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; mTORC1-mediated signalling; Signaling by Hippo; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Rap1 signalling; Negative regulation of MAPK pathway; Frs2-mediated activation; ARMS-mediated activation; Activation of BAD and translocation to mitochondria ; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA",Cell cycle; IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Hepatitis B infection; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,33,2,86.36,60.05,72.26,64.45,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,High,1,,FALSE,105.7,103.42,114.98,113.71,182.44,enzyme regulator activity;other molecular function,0,
Master Protein,High,P43897,TSFM,"Elongation factor Ts, mitochondrial OS=Homo sapiens OX=9606 GN=TSFM PE=1 SV=2",3,6,0.841,0.738,0.774,0.265,-0.25,-0.44,-0.37,-1.92,9.55E-01,9.29E-01,7.48E-01,3.07E-01,1.90E+05,2.27E+05,3.87E+05,1.37E+05,5,2,3,3,8.85E+04,1.90E+05,3.00E+04,6.34E+05,3.38E+05,,,1.69E+05,,3.04E+05,,3.02E+05,,3.87E+05,7.16E+05,,1.37E+05,2.25E+06,1.21E+05,,3.52E+02,7.21E+02,2.93E+02,6.34E+05,1.75E+04,,,1.56E+03,,3.24E+03,,1.35E+04,,5.21E+04,1.78E+04,,3.85E+04,1.60E+04,2.82E+03,,0,FALSE,18.896,16,3,325,35.4,8.38,3,protein metabolism;other metabolic processes;other biological processes,mitochondrion;nucleus,Pf00889,10102,B4E391; F5H2T7; hsa:10102; P43897; Q561V7; Q8TBC2; Q9UQK0,ENSG00000123297,Mitochondrial translation elongation,,1,0,94.31,40.31,46.71,146.52,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,High,High,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,85.86,116.29,20.34,109.83,21.64,nucleic acid binding activity,0,
Master Protein,High,A0A5F9ZHM4,LDHB,L-lactate dehydrogenase OS=Homo sapiens OX=9606 GN=LDHB PE=1 SV=1,11,65,0.839,0.311,1.068,0.336,-0.25,-1.69,0.09,-1.57,7.62E-01,2.38E-01,9.62E-01,3.73E-01,1.12E+07,3.03E+06,3.00E+06,9.60E+06,5,5,5,5,4.43E+07,1.12E+07,5.42E+06,3.81E+06,1.21E+07,2.40E+06,1.46E+06,4.80E+06,3.03E+06,3.13E+07,5.19E+06,1.40E+06,3.00E+06,9.17E+06,2.47E+06,1.30E+07,1.13E+07,3.26E+06,6.70E+06,9.60E+06,1.76E+05,4.26E+04,5.30E+04,3.81E+06,6.25E+05,8.53E+03,2.59E+04,4.43E+04,8.55E+04,3.33E+05,3.10E+04,6.24E+04,2.44E+04,1.24E+06,6.14E+04,2.53E+04,3.19E+06,2.31E+04,1.57E+05,1.02E+05,0,FALSE,48.54,35,10,341,37.4,6.25,11,other metabolic processes,cytosol,"Pf00056, Pf02866",3945,A0A5F9ZHM4,ENSG00000111716,,Clear cell renal cell carcinoma pathways; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,3,1,107.76,148.34,72.56,44.03,High,High,High,High,High,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,120.42,120.46,118.55,111.13,154.3,other molecular function,0,
Master Protein,High,Q6DD88,ATL3,Atlastin-3 OS=Homo sapiens OX=9606 GN=ATL3 PE=1 SV=1,12,50,0.839,1.02,0.501,1.486,-0.25,0.03,-1,0.57,7.62E-01,5.66E-01,3.11E-01,6.69E-01,6.98E+06,5.34E+06,7.72E+06,4.23E+06,5,4,5,5,8.93E+04,1.28E+07,5.10E+05,6.98E+06,8.61E+06,7.25E+05,3.96E+06,,7.20E+06,2.57E+07,3.06E+06,1.37E+06,7.72E+06,8.25E+06,7.90E+06,9.13E+06,4.23E+06,1.80E+06,2.92E+06,1.80E+07,3.55E+02,4.88E+04,4.98E+03,6.98E+06,4.44E+05,2.58E+03,7.04E+04,,2.03E+05,2.74E+05,1.83E+04,6.12E+04,6.27E+04,1.11E+06,1.96E+05,1.78E+04,1.19E+06,1.28E+04,6.84E+04,1.91E+05,0,FALSE,64.372,37,11,541,60.5,5.66,12,cell organization and biogenesis;other biological processes,other membranes;ER/Golgi,"Pf02263, Pf02841",25923,hsa:25923; Q6DD88; Q8N7W5; Q9H8Q5; Q9UFL1,ENSG00000184743,,,0,1,94.14,119.1,56.66,92.02,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,102.04,120.5,131.74,120.02,156.06,other molecular function,0,
Master Protein,High,E7EMK3,FLOT2,Flotillin OS=Homo sapiens OX=9606 GN=FLOT2 PE=1 SV=1,12,50,0.838,0.396,1.628,0.357,-0.26,-1.34,0.7,-1.49,7.60E-01,4.11E-01,6.24E-01,4.02E-01,7.53E+06,3.53E+06,3.46E+06,7.42E+06,5,5,5,5,2.32E+08,7.53E+06,8.33E+07,3.33E+06,4.42E+06,5.71E+06,1.52E+06,5.27E+06,2.92E+06,3.53E+06,3.46E+07,3.46E+06,1.25E+06,4.87E+06,1.23E+06,8.35E+06,5.59E+06,7.42E+06,1.45E+06,8.64E+06,9.22E+05,2.86E+04,8.14E+05,3.33E+06,2.28E+05,2.03E+04,2.71E+04,4.86E+04,8.22E+04,3.76E+04,2.07E+05,1.55E+05,1.02E+04,6.56E+05,3.05E+04,1.63E+04,1.57E+06,5.26E+04,3.39E+04,9.20E+04,0,FALSE,46.564,28,12,483,53.1,5.24,12,,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,"Pf01145, Pf15975",,E7EMK3,ENSG00000132589,,,0,0,149.36,45.37,157.98,47.01,High,Peak Found,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,1,,FALSE,118.57,131.14,125.36,130.08,121.54,,0,
Master Protein,High,H7BXI1,ESYT2,Extended synaptotagmin 2 OS=Homo sapiens OX=9606 GN=ESYT2 PE=1 SV=2,11,28,0.837,0.716,2.727,2.158,-0.26,-0.48,1.45,1.11,8.65E-01,8.93E-01,2.47E-01,3.94E-01,1.66E+06,2.51E+05,2.09E+06,1.81E+06,4,5,5,5,,8.20E+05,8.05E+05,3.34E+06,5.65E+06,1.42E+05,2.29E+05,9.61E+05,2.51E+05,5.03E+05,1.18E+07,2.04E+06,2.22E+06,2.09E+06,1.94E+06,1.81E+06,2.80E+06,9.60E+05,7.21E+05,3.13E+06,,3.12E+03,7.87E+03,3.34E+06,2.92E+05,5.04E+02,4.06E+03,8.87E+03,7.08E+03,5.34E+03,7.07E+04,9.10E+04,1.81E+04,2.82E+05,4.83E+04,3.54E+03,7.86E+05,6.80E+03,1.69E+04,3.33E+04,0,FALSE,45.788,19,11,866,96.3,8.43,11,cell organization and biogenesis;transport,plasma membrane;other membranes;cytosol;ER/Golgi,"Pf00168, Pf17047",,H7BXI1,ENSG00000117868,,,0,0,87.65,79.69,108.33,56.84,n/a,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,122.94,113.13,110.52,139.05,78.36,other molecular function,0,
Master Protein,High,P11274,BCR,Breakpoint cluster region protein OS=Homo sapiens OX=9606 GN=BCR PE=1 SV=2,1,2,0.836,0.465,0.244,1.596,-0.26,-1.1,-2.04,0.67,8.51E-01,7.30E-01,1.88E-01,6.01E-01,4.59E+04,5.50E+04,2.14E+04,1.34E+04,2,1,2,2,,,,7.55E+04,2.79E+04,,,5.50E+04,,,4.63E+04,,,9.87E+03,,,3.65E+03,,,4.91E+04,,,,7.55E+04,1.44E+03,,,5.07E+02,,,2.77E+02,,,1.33E+03,,,1.03E+03,,,5.23E+02,0.007,FALSE,2.363,1,1,1271,142.7,7.03,1,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf00168, Pf00620, Pf00621, Pf09036, Pf19057",613,hsa:613; P11274; P78501; Q12842; Q4LE80; Q6NZI3,ENSG00000186716,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease,Imatinib and chronic myeloid leukemia; Extrafollicular and follicular B cell activation by SARS-CoV-2,11,0,65.07,,91.76,121.84,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,76.83,76.87,251.6,116.12,4.65,enzyme regulator activity;kinase activity;other molecular function,0,
Master Protein,High,J3KPD3,RBM7,RNA binding motif protein 7 OS=Homo sapiens OX=9606 GN=RBM7 PE=1 SV=1,3,3,0.836,0.183,0.616,0.603,-0.26,-2.45,-0.7,-0.73,9.37E-01,1.02E-01,4.86E-01,7.64E-01,2.27E+05,5.82E+05,4.31E+05,1.47E+05,2,5,4,4,,,,2.50E+05,2.06E+05,2.06E+05,6.89E+05,7.35E+05,5.82E+05,2.95E+05,1.20E+06,,8.95E+05,2.07E+05,1.16E+04,1.52E+05,1.43E+05,6.37E+05,2.48E+04,,,,,2.50E+05,1.06E+04,7.33E+02,1.22E+04,6.78E+03,1.64E+04,3.14E+03,7.20E+03,,7.27E+03,2.79E+04,2.88E+02,2.96E+02,4.01E+04,4.52E+03,5.81E+02,,0,FALSE,11.657,14,3,267,30.6,9.57,3,,nucleus,Pf00076,10179,J3KPD3,ENSG00000076053,,,0,0,13.69,47.4,97.15,113.56,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,113.46,142.97,123.97,136.97,8.81,nucleic acid binding activity,0,
Master Protein,High,P46199,MTIF2,"Translation initiation factor IF-2, mitochondrial OS=Homo sapiens OX=9606 GN=MTIF2 PE=1 SV=2",1,3,0.836,0.361,0.201,0.92,-0.26,-1.47,-2.32,-0.12,8.87E-01,4.80E-01,1.41E-01,9.11E-01,1.01E+05,1.21E+05,3.65E+04,2.43E+04,1,1,3,2,,,,1.01E+05,,1.21E+05,,,,,,4.55E+04,3.65E+04,1.09E+04,,1.00E+05,5.88E+03,,,,,,,1.01E+05,,4.30E+02,,,,,,2.03E+03,2.96E+02,1.48E+03,,1.95E+02,1.65E+03,,,,0,FALSE,7.516,2,1,727,81.3,7.15,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,mitochondrion;nucleus;other cell component,"Pf00009, Pf11987",4528,D6W5D0; hsa:4528; P46199,ENSG00000085760,Mitochondrial translation initiation,,1,0,,,57.86,125.76,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,0,29.39,288.22,141.37,9.29,translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A024RBG1,NUDT4B,Diphosphoinositol polyphosphate phosphohydrolase NUDT4B OS=Homo sapiens OX=9606 GN=NUDT4B PE=3 SV=1,1,1,0.835,0.01,0.01,,-0.26,-6.64,-6.64,,9.43E-01,1.00E-17,1.00E-17,,1.95E+05,2.33E+05,,,1,1,,,,,,,1.95E+05,,,2.33E+05,,,,,,,,,,,,,,,,,1.00E+04,,,2.15E+03,,,,,,,,,,,,,0.001,FALSE,3.417,13,1,181,20.4,6.35,1,other metabolic processes,cytosol;nucleus;other cell component,Pf00293,11163,A0A024RBG1,ENSG00000177144,,,0,0,,,,,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,,,,2.56,nucleic acid binding activity;other molecular function,0,
Master Protein,High,E7ESC6,XPO7,Exportin 7 OS=Homo sapiens OX=9606 GN=XPO7 PE=1 SV=1,13,20,0.834,0.593,1.464,0.221,-0.26,-0.75,0.55,-2.18,9.42E-01,8.81E-01,7.86E-01,2.95E-01,1.15E+05,3.63E+05,3.33E+05,1.02E+06,4,4,5,5,8.18E+04,,2.58E+05,1.62E+05,5.31E+04,1.30E+06,6.95E+05,,1.89E+05,5.59E+04,6.23E+05,2.08E+05,5.98E+04,3.45E+05,3.33E+05,4.12E+05,1.10E+07,2.23E+06,1.02E+06,9.46E+05,3.25E+02,,2.53E+03,1.62E+05,2.74E+03,4.64E+03,1.24E+04,,5.33E+03,5.94E+02,3.73E+03,9.29E+03,4.86E+02,4.65E+04,8.29E+03,8.03E+02,3.10E+06,1.58E+04,2.38E+04,1.01E+04,0,FALSE,66.977,17,13,1088,124,6.48,13,transport,nucleus;other cell component,Pf03810,,E7ESC6,ENSG00000130227,,,0,0,66.3,100.99,66.2,142.79,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,92.51,75.22,103.17,110.5,62.79,other molecular function,0,
Master Protein,High,H7C2N1,PTMA,Prothymosin alpha (Fragment) OS=Homo sapiens OX=9606 GN=PTMA PE=1 SV=1,6,86,0.834,0.162,0.81,0.409,-0.26,-2.63,-0.3,-1.29,7.55E-01,5.08E-02,6.96E-01,4.85E-01,1.25E+06,3.28E+06,1.78E+05,3.75E+05,5,5,5,5,2.32E+05,2.26E+06,2.06E+05,1.25E+06,6.86E+07,1.67E+06,3.28E+06,3.29E+06,5.36E+05,1.56E+07,1.38E+05,6.54E+04,1.78E+05,4.40E+05,3.65E+05,3.75E+05,3.24E+04,1.44E+07,2.96E+05,2.51E+07,9.23E+02,8.58E+03,2.01E+03,1.25E+06,3.54E+06,5.92E+03,5.83E+04,3.04E+04,1.51E+04,1.66E+05,8.28E+02,2.92E+03,1.44E+03,5.93E+04,9.07E+03,7.32E+02,9.09E+03,1.02E+05,6.93E+03,2.67E+05,0,FALSE,47.454,18,6,148,15.8,4.23,6,,cytosol;nucleus,Pf03247,,H7C2N1,ENSG00000187514,,,0,0,208.5,125.38,66.74,141.04,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,143,131.8,145.12,132.56,229.03,,0,
Master Protein,High,Q14697,GANAB,Neutral alpha-glucosidase AB OS=Homo sapiens OX=9606 GN=GANAB PE=1 SV=3,31,192,0.833,1.248,1.385,1.053,-0.26,0.32,0.47,0.07,7.55E-01,3.83E-01,7.76E-01,9.03E-01,8.43E+06,1.05E+07,3.31E+07,3.07E+07,5,5,5,5,5.22E+06,8.43E+06,2.77E+06,2.72E+07,1.78E+07,5.49E+06,1.05E+07,1.08E+07,8.94E+06,1.38E+07,7.94E+06,3.00E+07,3.31E+07,5.21E+07,4.99E+07,3.07E+07,1.91E+07,3.25E+07,1.76E+07,5.57E+07,2.07E+04,3.20E+04,2.70E+04,2.72E+07,9.17E+05,1.95E+04,1.86E+05,9.95E+04,2.52E+05,1.47E+05,4.75E+04,1.34E+06,2.69E+05,7.03E+06,1.24E+06,5.99E+04,5.38E+06,2.30E+05,4.13E+05,5.93E+05,0,FALSE,174.534,40,31,944,106.8,6.14,31,protein metabolism;other metabolic processes,ER/Golgi;other cell component,"Pf01055, Pf13802, Pf21365",23193,A6NC20; hsa:23193; Q14697; Q8WTS9; Q9P0X0,ENSG00000089597,Maturation of spike protein; Calnexin/calreticulin cycle; Maturation of spike protein,N-glycan biosynthesis,5,0,82.2,30.58,51.57,48.99,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,High,1,,FALSE,119.93,128.19,130.04,135.81,558.39,other molecular function,0,
Master Protein,High,O75643,SNRNP200,U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens OX=9606 GN=SNRNP200 PE=1 SV=2,37,73,0.833,0.378,0.615,0.908,-0.26,-1.4,-0.7,-0.14,7.55E-01,3.72E-01,4.52E-01,9.93E-01,9.26E+06,6.74E+06,2.14E+06,3.74E+06,5,5,5,5,1.57E+07,3.31E+06,9.26E+06,1.48E+07,7.76E+06,6.74E+06,2.09E+07,7.36E+06,3.30E+06,5.73E+06,9.27E+06,5.17E+05,2.14E+06,6.46E+06,1.47E+06,6.72E+06,9.50E+05,3.74E+06,1.58E+06,5.99E+06,6.25E+04,1.26E+04,9.05E+04,1.48E+07,4.00E+05,2.40E+04,3.72E+05,6.79E+04,9.29E+04,6.09E+04,5.54E+04,2.31E+04,1.74E+04,8.71E+05,3.65E+04,1.31E+04,2.67E+05,2.65E+04,3.71E+04,6.37E+04,0,FALSE,144.741,22,37,2136,244.4,6.06,37,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00270, Pf00271, Pf02889, Pf18149, Pf21188",23020,hsa:23020; O75643; O94884; Q6NZY0; Q6PX59; Q8NBE6; Q96IF2; Q9H7S0,ENSG00000144028,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,2q11.2 copy number variation syndrome,3,0,50.64,78.8,94.07,67.61,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,128.37,109.6,133.11,132.44,210.27,other molecular function,0,
Master Protein,High,Q86W42,THOC6,THO complex subunit 6 homolog OS=Homo sapiens OX=9606 GN=THOC6 PE=1 SV=1,3,5,0.831,1.664,0.636,2.405,-0.27,0.74,-0.65,1.27,9.22E-01,2.08E-01,4.99E-01,3.35E-01,3.81E+05,6.45E+05,7.42E+05,4.10E+05,5,5,5,4,3.81E+05,1.23E+05,1.42E+05,1.23E+06,9.83E+06,1.91E+06,6.72E+04,1.71E+05,1.30E+06,6.45E+05,2.46E+05,9.05E+04,1.31E+06,2.83E+06,7.42E+05,3.24E+06,1.66E+04,3.05E+05,5.52E+05,,1.52E+03,4.66E+02,1.39E+03,1.23E+06,5.07E+05,6.79E+03,1.19E+03,1.58E+03,3.67E+04,6.86E+03,1.47E+03,4.04E+03,1.07E+04,3.82E+05,1.84E+04,6.31E+03,4.67E+03,2.16E+03,1.29E+04,,0,FALSE,17.269,15,3,341,37.5,7.43,3,RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,nucleus,Pf00400,79228,B2RA85; hsa:79228; Q86W42; Q8NBR1; Q9BTV9,ENSG00000131652,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Transport of Mature mRNA derived from an Intron-Containing Transcript,,3,0,179.77,95.29,106,144.9,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,134.55,137.48,140.03,128.7,17.43,nucleic acid binding activity,0,
Master Protein,High,P30040,ERP29,Endoplasmic reticulum resident protein 29 OS=Homo sapiens OX=9606 GN=ERP29 PE=1 SV=4,7,39,0.831,0.763,0.91,1.148,-0.27,-0.39,-0.14,0.2,9.44E-01,8.86E-01,8.23E-01,8.43E-01,4.97E+05,3.46E+05,8.83E+06,2.74E+06,5,4,5,5,4.97E+05,2.41E+05,4.70E+05,1.01E+07,8.68E+05,1.88E+06,2.09E+05,2.48E+05,,4.81E+05,1.19E+06,1.17E+07,7.83E+06,8.83E+06,9.94E+06,7.60E+05,4.44E+06,2.74E+06,6.47E+06,8.30E+05,1.97E+03,9.15E+02,4.59E+03,1.01E+07,4.48E+04,6.70E+03,3.72E+03,2.29E+03,,5.12E+03,7.10E+03,5.22E+05,6.36E+04,1.19E+06,2.47E+05,1.48E+03,1.25E+06,1.94E+04,1.52E+05,8.83E+03,0,FALSE,23.707,24,7,261,29,7.31,7,protein metabolism;other metabolic processes;transport;other biological processes,ER/Golgi;other cell component,"Pf07749, Pf07912",10961,C9J183; hsa:10961; P30040; Q3MJC3; Q6FHT4,ENSG00000089248,,,0,0,176.3,112.64,50.85,80.2,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,61.21,88.46,137.01,122.12,104.24,other molecular function,0,
Master Protein,High,P62753,RPS6,40S ribosomal protein S6 OS=Homo sapiens OX=9606 GN=RPS6 PE=1 SV=1,7,19,0.829,0.267,1.068,0.288,-0.27,-1.9,0.09,-1.8,7.52E-01,1.63E-01,9.62E-01,3.03E-01,3.65E+06,7.98E+06,1.18E+06,6.59E+06,4,5,5,5,,1.05E+07,7.63E+05,2.34E+06,5.68E+06,9.67E+06,5.10E+06,7.98E+06,3.96E+04,1.13E+07,7.16E+05,1.89E+06,4.81E+05,1.38E+06,1.18E+06,6.59E+06,4.60E+06,4.00E+07,2.40E+06,1.97E+07,,3.99E+04,7.46E+03,2.34E+06,2.93E+05,3.44E+04,9.08E+04,7.36E+04,1.12E+03,1.20E+05,4.28E+03,8.43E+04,3.91E+03,1.86E+05,2.94E+04,1.29E+04,1.29E+06,2.83E+05,5.62E+04,2.10E+05,0,FALSE,22.921,18,7,249,28.7,10.84,7,protein metabolism;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf01092,6194,hsa:6194; P08227; P10660; P62753; Q4VBY7; Q8N6Z7,ENSG00000137154,"SRP-dependent cotranslational protein targeting to membrane; Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Protein hydroxylation; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; SARS-CoV-2 modulates host translation machinery; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Nuclear events stimulated by ALK signaling in cancer; SARS-CoV-1 modulates host translation machinery",IL-5 signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Kit receptor signaling pathway; MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Hereditary leiomyomatosis and renal cell carcinoma pathway; Thermogenesis; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Cytoplasmic ribosomal proteins; EGFR tyrosine kinase inhibitor resistance; IL-2 signaling pathway; Pleural mesothelioma; 2q37 copy number variation syndrome; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways,49,0,89.27,64.93,49.17,106.92,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,142.14,107.76,113.17,131.41,42.32,other molecular function,0,
Master Protein,High,Q9NZ08,ERAP1,Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens OX=9606 GN=ERAP1 PE=1 SV=3,10,23,0.826,1.654,,3.005,-0.28,0.73,,1.59,9.25E-01,1.47E-01,,2.46E-01,4.26E+05,9.96E+05,3.11E+06,5.41E+05,4,3,5,5,,1.75E+05,1.37E+05,3.25E+06,1.04E+06,2.68E+06,,5.74E+05,,9.96E+05,3.11E+06,9.97E+05,2.95E+06,4.66E+06,7.75E+06,1.37E+06,1.24E+05,5.41E+05,4.69E+05,1.03E+06,,6.66E+02,1.34E+03,3.25E+06,5.35E+04,9.54E+03,,5.29E+03,,1.06E+04,1.86E+04,4.45E+04,2.39E+04,6.28E+05,1.93E+05,2.67E+03,3.49E+04,3.83E+03,1.10E+04,1.10E+04,0,FALSE,36.434,16,10,941,107.2,6.46,10,protein metabolism;other metabolic processes;developmental processes;other biological processes,non-structural extracellular;other membranes;cytosol;ER/Golgi;other cell component,"Pf01433, Pf11838, Pf17900",51752,hsa:51752; O60278; Q6UWY6; Q8NEL4; Q8TAD0; Q9NZ08; Q9UHF8; Q9UKY2,ENSG00000164307,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",,1,0,127.06,78.74,64.72,69.54,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,62.87,100.8,,96.26,63.04,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q8IYM9,TRIM22,E3 ubiquitin-protein ligase TRIM22 OS=Homo sapiens OX=9606 GN=TRIM22 PE=1 SV=1,5,6,0.826,0.655,1.767,0.372,-0.28,-0.61,0.82,-1.43,8.69E-01,9.88E-01,6.74E-01,4.38E-01,1.86E+06,1.54E+05,1.53E+06,9.69E+05,5,4,4,3,3.18E+06,1.86E+06,3.34E+06,1.31E+06,8.58E+05,7.25E+06,,2.24E+05,4.48E+04,1.06E+05,4.57E+06,,7.11E+05,1.77E+06,1.33E+06,9.69E+05,,8.35E+05,2.78E+06,,1.26E+04,7.06E+03,3.26E+04,1.31E+06,4.43E+04,2.58E+04,,2.07E+03,1.26E+03,1.13E+03,2.74E+04,,5.77E+03,2.38E+05,3.30E+04,1.89E+03,,5.92E+03,6.50E+04,,0,FALSE,14.221,13,5,498,56.9,7.72,5,protein metabolism;other metabolic processes;stress response;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,"Pf00622, Pf00643, Pf13445",10346,hsa:10346; Q05CQ0; Q15521; Q8IYM9,ENSG00000132274,Interferon gamma signaling,,1,0,52.6,186.93,81.56,71.05,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,1,,FALSE,103.01,89.99,335.99,70.26,14.38,other molecular function,0,
Master Protein,High,P15954,COX7C,"Cytochrome c oxidase subunit 7C, mitochondrial OS=Homo sapiens OX=9606 GN=COX7C PE=1 SV=1",1,6,0.826,0.168,1.406,0.126,-0.28,-2.57,0.49,-2.98,9.61E-01,8.99E-02,8.69E-01,1.16E-01,2.61E+05,3.28E+05,4.39E+04,3.47E+05,3,5,3,5,,2.61E+05,,4.53E+04,1.48E+06,5.49E+04,3.28E+05,8.33E+05,2.09E+05,1.31E+06,4.39E+04,7.71E+04,,,1.40E+04,3.47E+05,8.07E+03,2.16E+06,7.72E+04,4.50E+06,,9.93E+02,,4.53E+04,7.64E+04,1.95E+02,5.83E+03,7.68E+03,5.89E+03,1.39E+04,2.63E+02,3.45E+03,,,3.47E+02,6.77E+02,2.27E+03,1.53E+04,1.81E+03,4.79E+04,0.001,FALSE,3.844,14,1,63,7.2,10.27,1,other metabolic processes,other membranes;mitochondrion,Pf02935,1350,hsa:1350; P15954; Q6NR81,ENSG00000127184,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly; 5q35 copy number variation,7,0,129.91,94.45,70.22,136.46,n/a,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,130.99,133.61,144.19,146.3,12.14,,0,
Master Protein,High,F5H423,,ADP-ribosylation factor 3 OS=Homo sapiens OX=9606 PE=3 SV=1,5,6,0.824,0.409,0.512,1.438,-0.28,-1.29,-0.96,0.52,7.46E-01,4.39E-01,4.40E-01,6.11E-01,6.86E+06,1.20E+06,9.02E+05,9.63E+05,5,4,4,5,1.31E+07,1.80E+06,8.15E+06,2.29E+05,6.86E+06,1.64E+06,8.43E+05,8.87E+05,,8.68E+06,1.37E+06,,3.18E+05,2.15E+06,5.95E+05,9.63E+05,3.17E+05,1.47E+06,4.22E+05,4.92E+06,5.20E+04,6.85E+03,7.96E+04,2.29E+05,3.54E+05,5.82E+03,1.50E+04,8.19E+03,,9.23E+04,8.18E+03,,2.59E+03,2.90E+05,1.48E+04,1.88E+03,8.91E+04,1.04E+04,9.86E+03,5.23E+04,0,FALSE,12.122,25,2,210,23.3,8.6,5,,,Pf00025,,,,,,0,3,85.65,126.06,74.48,117.52,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,119.77,122.21,108.05,116.21,13.61,other molecular function,0,
Master Protein,High,A0A5H1ZRQ3,IGKC,Immunoglobulin kappa constant (Fragment) OS=Homo sapiens OX=9606 GN=IGKC PE=1 SV=1,2,7,0.823,0.162,0.272,0.527,-0.28,-2.63,-1.88,-0.92,8.20E-01,4.41E-02,1.38E-01,6.64E-01,9.87E+05,1.20E+06,1.60E+05,3.81E+05,3,5,2,2,,1.97E+06,3.08E+04,,9.87E+05,2.24E+06,9.41E+05,1.26E+06,5.53E+05,1.20E+06,,,,1.27E+05,2.00E+05,7.74E+05,1.87E+05,,,,,7.47E+03,3.01E+02,,5.09E+04,7.97E+03,1.67E+04,1.17E+04,1.56E+04,1.27E+04,,,,1.72E+04,4.97E+03,1.51E+03,5.26E+04,,,,0,FALSE,9.868,35,2,107,11.7,5.87,2,,,Pf07654,,A0A5H1ZRQ3,ENSG00000211592,,,0,0,97.31,50.49,31.36,86.34,n/a,Peak Found,Peak Found,n/a,High,High,High,High,Peak Found,High,n/a,n/a,n/a,High,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,89.86,115.02,109.37,128.2,20.69,,0,
Master Protein,High,O75695,RP2,Protein XRP2 OS=Homo sapiens OX=9606 GN=RP2 PE=1 SV=4,3,6,0.821,1.232,0.435,3.129,-0.29,0.3,-1.2,1.65,9.21E-01,2.91E-01,2.99E-01,2.21E-01,1.20E+06,2.17E+05,1.29E+06,3.44E+05,4,3,4,5,,1.08E+07,9.39E+05,1.53E+06,4.13E+05,2.17E+05,2.60E+06,,5.16E+04,,1.05E+06,4.31E+05,,6.79E+06,1.58E+06,1.16E+06,9.74E+04,3.44E+05,3.41E+05,1.65E+06,,4.12E+04,9.17E+03,1.53E+06,2.13E+04,7.73E+02,4.63E+04,,1.45E+03,,6.30E+03,1.93E+04,,9.16E+05,3.92E+04,2.26E+03,2.74E+04,2.43E+03,7.98E+03,1.76E+04,0,FALSE,13.319,9,3,350,39.6,5.12,3,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component,Pf07986,6102,hsa:6102; O75695; Q86XJ7; Q9NU67,ENSG00000102218,Trafficking of myristoylated proteins to the cilium,Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome,4,0,144.57,149.13,118.71,91.57,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,140.73,123.85,107.46,105.16,15.55,enzyme regulator activity;other molecular function,0,
Master Protein,High,P55072,VCP,Transitional endoplasmic reticulum ATPase OS=Homo sapiens OX=9606 GN=VCP PE=1 SV=4,26,97,0.821,0.481,0.999,0.47,-0.29,-1.05,0,-1.09,7.43E-01,5.93E-01,8.95E-01,5.52E-01,1.90E+07,3.39E+07,8.47E+06,2.94E+07,5,5,5,5,1.18E+07,7.55E+07,4.41E+06,1.90E+07,2.80E+07,2.40E+07,4.31E+07,9.49E+07,3.39E+07,3.10E+07,1.91E+06,4.26E+06,1.40E+07,1.76E+07,8.47E+06,1.61E+07,1.97E+07,2.94E+07,3.01E+07,4.79E+07,4.69E+04,2.87E+05,4.30E+04,1.90E+07,1.44E+06,8.55E+04,7.67E+05,8.76E+05,9.56E+05,3.29E+05,1.14E+04,1.90E+05,1.14E+05,2.38E+06,2.10E+05,3.15E+04,5.54E+06,2.08E+05,7.04E+05,5.10E+05,0,FALSE,103.662,44,4,806,89.3,5.26,26,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,non-structural extracellular;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00004, Pf02359, Pf02933, Pf17862",7415,B2R5T8; P55072; Q0V924; Q2TAI5; Q969G7; Q9UCD5; V9HW80,ENSG00000165280,Neutrophil degranulation; RHOH GTPase cycle; E3 ubiquitin ligases ubiquitinate target proteins; ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis; Neddylation; KEAP1-NFE2L2 pathway; Aggrephagy; Attachment and Entry; Attachment and Entry; Ovarian tumor domain proteases; Josephin domain DUBs; Protein methylation; HSF1 activation; Translesion Synthesis by POLH; N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Alstrom syndrome; Clock-controlled autophagy in bone metabolism; HDAC6 interactions in the central nervous system,21,20,101.2,62.82,70.93,43.13,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,n/a,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,123.15,121.48,111.31,122.64,282.75,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 OS=Homo sapiens OX=9606 GN=NUCKS1 PE=1 SV=1,5,12,0.82,0.169,1.503,0.017,-0.29,-2.56,0.59,-5.91,9.07E-01,6.68E-02,7.72E-01,1.85E-03,9.00E+05,1.88E+05,7.78E+04,2.48E+05,4,2,4,1,,6.78E+05,1.82E+05,2.81E+06,1.20E+06,,,4.25E+04,,8.29E+05,7.23E+04,8.37E+04,,8.66E+04,5.14E+04,,,,,2.48E+05,,2.58E+03,1.78E+03,2.81E+06,6.17E+04,,,3.92E+02,,8.81E+03,4.32E+02,3.74E+03,,1.17E+04,1.28E+03,,,,,2.64E+03,0,FALSE,24.421,26,5,243,27.3,5.08,5,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,,64710,hsa:64710; Q54AC0; Q5PXE7; Q9H1D6; Q9H1E3; Q9H723,ENSG00000069275,,,0,0,93.69,127.63,21.74,,n/a,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,100.21,97.53,268.96,0,29.46,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q16595,FXN,"Frataxin, mitochondrial OS=Homo sapiens OX=9606 GN=FXN PE=1 SV=2",2,8,0.819,3.388,3.961,0.623,-0.29,1.76,1.99,-0.68,8.66E-01,5.08E-02,2.24E-01,7.98E-01,8.06E+04,9.84E+04,2.96E+05,5.49E+05,4,1,4,4,,7.42E+04,5.10E+04,8.75E+04,3.03E+05,9.84E+04,,,,,,2.99E+05,5.18E+05,2.94E+05,1.68E+05,4.81E+05,6.27E+05,1.13E+06,2.69E+05,,,2.82E+02,4.98E+02,8.75E+04,1.56E+04,3.50E+02,,,,,,1.33E+04,4.20E+03,3.96E+04,4.17E+03,9.38E+02,1.76E+05,7.99E+03,6.29E+03,,0,FALSE,12.469,18,2,210,23.1,8.69,2,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes,cytosol;mitochondrion,Pf01491,2395,A8MXJ6; C9JJ89; hsa:2395; O15545; O95656; Q15294; Q16595; Q5VZ01,ENSG00000165060,Mitochondrial protein import; Mitochondrial iron-sulfur cluster biogenesis,Iron-sulfur cluster biogenesis,3,0,90.76,,45.44,58.3,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,49.32,88.82,40.32,63.17,27.7,other molecular function,0,
Master Protein,High,P67936,TPM4,Tropomyosin alpha-4 chain OS=Homo sapiens OX=9606 GN=TPM4 PE=1 SV=3,10,59,0.818,1.057,1.695,0.432,-0.29,0.08,0.76,-1.21,8.24E-01,4.52E-01,5.88E-01,5.04E-01,2.01E+06,8.27E+05,1.21E+06,4.02E+06,5,5,4,5,2.01E+06,4.09E+06,4.53E+05,4.36E+05,2.86E+06,8.00E+05,3.86E+05,4.45E+06,1.21E+06,8.27E+05,,8.18E+05,1.07E+06,1.84E+06,1.38E+06,8.92E+06,1.71E+06,8.86E+05,4.02E+06,6.82E+06,7.97E+03,1.56E+04,4.43E+03,4.36E+05,1.48E+05,2.84E+03,6.87E+03,4.10E+04,3.42E+04,8.79E+03,,3.65E+04,8.69E+03,2.48E+05,3.43E+04,1.74E+04,4.80E+05,6.28E+03,9.41E+04,7.26E+04,0,FALSE,35.589,35,4,248,28.5,4.69,10,cell organization and biogenesis;other biological processes,cytosol;cytoskeleton,Pf00261,7171,hsa:7171; P07226; P67936; Q15659; Q5U0D9; Q9BU85; Q9H8Q3; Q9UCS1; Q9UCS2; Q9UCS3; Q9UCS4,ENSG00000167460,RHOV GTPase cycle; Signaling by ALK fusions and activated point mutants; Smooth Muscle Contraction; Striated Muscle Contraction,Striated muscle contraction pathway,5,0,80.08,107.77,34.4,75.86,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,n/a,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,139.55,123.68,119.9,107.11,161.32,cytoskeletal activity;other molecular function,0,
Master Protein,High,C9J406,IMMT,MICOS complex subunit MIC60 OS=Homo sapiens OX=9606 GN=IMMT PE=1 SV=1,29,184,0.818,0.851,1.039,1.083,-0.29,-0.23,0.05,0.12,7.40E-01,7.59E-01,9.34E-01,8.83E-01,2.70E+07,1.44E+07,1.91E+07,1.95E+07,5,5,5,5,3.95E+06,4.44E+07,5.64E+06,2.70E+07,7.31E+07,1.44E+07,4.91E+06,2.08E+07,6.19E+06,2.63E+07,7.41E+06,1.86E+07,2.32E+07,3.54E+07,1.91E+07,2.29E+07,1.07E+07,1.95E+07,1.47E+07,2.76E+07,1.57E+04,1.69E+05,5.51E+04,2.70E+07,3.77E+06,5.10E+04,8.73E+04,1.92E+05,1.75E+05,2.79E+05,4.43E+04,8.33E+05,1.89E+05,4.77E+06,4.74E+05,4.46E+04,3.01E+06,1.38E+05,3.44E+05,2.93E+05,0,FALSE,146.349,51,2,659,73.2,6.07,29,,other membranes;mitochondrion,Pf09731,,C9J406,ENSG00000132305,,,0,25,93.81,63.48,48.52,34.74,n/a,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,High,n/a,High,n/a,High,n/a,1,,FALSE,125.54,120.79,115.19,99.09,526.33,,0,
Master Protein,High,Q9UJA5,TRMT6,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Homo sapiens OX=9606 GN=TRMT6 PE=1 SV=1,1,2,0.816,0.173,1.203,0.117,-0.29,-2.54,0.27,-3.1,8.72E-01,1.57E-01,9.39E-01,1.14E-01,8.60E+04,1.05E+05,1.48E+04,1.27E+05,3,1,3,1,,8.60E+04,,3.47E+04,3.01E+05,1.05E+05,,,,,,1.16E+04,,3.03E+04,1.48E+04,,,,,1.27E+05,,3.27E+02,,3.47E+04,1.55E+04,3.75E+02,,,,,,5.17E+02,,4.08E+03,3.69E+02,,,,,1.35E+03,0,FALSE,5.221,3,1,497,55.8,7.55,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf04189,51605,B4DUV6; hsa:51605; Q76P92; Q9BQV5; Q9UJA5; Q9ULR7; Q9Y2Z8,ENSG00000089195,tRNA modification in the nucleus and cytosol,,1,0,100.52,,52.85,,n/a,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,105.91,88.43,0,41.78,5.42,,0,
Master Protein,High,P35269,GTF2F1,General transcription factor IIF subunit 1 OS=Homo sapiens OX=9606 GN=GTF2F1 PE=1 SV=2,3,3,0.814,0.136,0.902,0.123,-0.3,-2.87,-0.15,-3.02,8.25E-01,9.97E-02,8.81E-01,1.32E-01,7.68E+04,5.82E+04,6.46E+03,5.25E+04,2,1,2,1,,,,8.99E+04,6.56E+04,,,,,5.82E+04,,4.54E+03,,9.21E+03,,,,,,5.25E+04,,,,8.99E+04,3.38E+03,,,,,6.19E+02,,2.03E+02,,1.24E+03,,,,,,5.59E+02,0,FALSE,11.634,9,3,517,58.2,7.49,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf05793,2962,B2RCS0; hsa:2962; P35269; Q9BWN0,ENSG00000125651,Viral Messenger RNA Synthesis; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; Estrogen-dependent gene expression; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM,,32,0,22.13,,48.11,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,49.03,38.76,0,53.64,11.46,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,V9GYM3,APOA2,Apolipoprotein A-II OS=Homo sapiens OX=9606 GN=APOA2 PE=1 SV=1,1,2,0.812,1.506,2.265,0.612,-0.3,0.59,1.18,-0.71,9.17E-01,3.34E-01,4.92E-01,7.82E-01,1.64E+05,2.59E+05,2.10E+05,5.86E+05,4,2,5,2,7.57E+04,5.83E+05,1.39E+05,,1.94E+05,9.52E+05,,,,7.04E+04,7.70E+04,1.62E+05,2.10E+05,1.27E+06,8.77E+05,1.14E+06,,,3.01E+05,,3.01E+02,2.21E+03,1.36E+03,,1.00E+04,3.38E+03,,,,7.48E+02,4.61E+02,7.24E+03,1.71E+03,1.71E+05,2.18E+04,2.22E+03,,,7.05E+03,,0,FALSE,4.379,8,1,133,14.9,8.27,1,protein metabolism;other metabolic processes;transport,non-structural extracellular,Pf04711,,V9GYM3,ENSG00000158874,,PPAR-alpha pathway; Nuclear receptors meta-pathway; Dengue-2 interactions with complement and coagulation cascades; PPAR signaling pathway; Familial  hyperlipidemia type 1; Familial hyperlipidemia type 2; Familial hyperlipidemia type 3; Familial hyperlipidemia type 4; Familial hyperlipidemia type 5; Cholesterol metabolism,10,0,92.09,121.95,101.42,82.31,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,119.17,110.97,129.75,121.88,4.51,other molecular function,0,
Master Protein,High,Q9UNF0,PACSIN2,Protein kinase C and casein kinase substrate in neurons protein 2 OS=Homo sapiens OX=9606 GN=PACSIN2 PE=1 SV=2,2,2,0.812,0.01,0.357,0.01,-0.3,-6.64,-1.49,-6.64,8.68E-01,1.00E-17,3.22E-01,1.00E-17,1.17E+05,1.44E+05,,5.14E+04,3,1,,4,,4.09E+05,,1.17E+05,6.72E+04,1.44E+05,,,,,,,,,,8.92E+05,1.09E+04,,3.84E+04,6.87E+04,,1.55E+03,,1.17E+05,3.47E+03,5.11E+02,,,,,,,,,,1.74E+03,3.05E+03,,8.98E+02,7.32E+02,0,FALSE,6.011,6,2,486,55.7,5.2,2,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,"Pf00611, Pf14604",11252,hsa:11252; O95921; Q96HV9; Q9H0D3; Q9NPN1; Q9UNF0; Q9Y4V2,ENSG00000100266,Clathrin-mediated endocytosis,,1,0,93.48,,,169.09,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,105.97,,94.92,,4.94,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q02818,NUCB1,Nucleobindin-1 OS=Homo sapiens OX=9606 GN=NUCB1 PE=1 SV=4,10,23,0.811,0.99,0.988,0.737,-0.3,-0.01,-0.02,-0.44,7.93E-01,5.96E-01,9.09E-01,8.51E-01,2.41E+06,1.27E+06,2.81E+06,1.87E+06,5,5,5,5,4.40E+06,1.94E+06,1.54E+06,2.41E+06,4.30E+06,3.51E+05,1.27E+06,3.07E+06,1.06E+06,5.71E+06,9.09E+06,1.40E+06,2.81E+06,2.24E+06,3.74E+06,9.98E+05,3.35E+05,1.91E+06,1.87E+06,2.25E+06,1.75E+04,7.39E+03,1.50E+04,2.41E+06,2.22E+05,1.25E+03,2.26E+04,2.83E+04,2.99E+04,6.08E+04,5.44E+04,6.24E+04,2.28E+04,3.02E+05,9.30E+04,1.95E+03,9.41E+04,1.36E+04,4.38E+04,2.40E+04,0,FALSE,50.388,34,10,461,53.8,5.25,10,signal transduction,ER/Golgi,,4924,B2RD64; hsa:4924; Q02818; Q15838; Q7Z4J7; Q9BUR1,ENSG00000104805,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,,2,0,46.06,94.11,79.07,53.44,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,100.2,100.56,109.2,101.93,67.41,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q5STZ8,ABCF1,ATP binding cassette subfamily F member 1 OS=Homo sapiens OX=9606 GN=ABCF1 PE=1 SV=10,3,10,0.811,0.107,1.96,0.705,-0.3,-3.23,0.97,-0.5,8.48E-01,1.48E-02,4.60E-01,8.88E-01,7.18E+05,1.11E+06,2.32E+05,8.73E+05,5,5,3,5,7.18E+05,2.54E+06,4.26E+05,2.95E+05,1.86E+06,8.03E+04,7.53E+05,3.02E+06,1.11E+06,1.67E+06,2.32E+05,2.64E+04,,3.60E+05,,4.46E+05,8.73E+05,2.37E+06,3.58E+05,2.46E+06,2.85E+03,9.66E+03,4.16E+03,2.95E+05,9.59E+04,2.86E+02,1.34E+04,2.78E+04,3.14E+04,1.78E+04,1.39E+03,1.18E+03,,4.85E+04,,8.71E+02,2.45E+05,1.68E+04,8.37E+03,2.62E+04,0,FALSE,12.216,5,3,846,96,6.8,3,,cytosol,Pf00005,,Q5STZ8,ENSG00000204574,,,0,0,84.33,83.41,81.59,79.58,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,High,High,Peak Found,High,1,,FALSE,96.84,131.04,145.98,87.92,29.86,other molecular function,0,
Master Protein,High,Q92804,TAF15,TATA-binding protein-associated factor 2N OS=Homo sapiens OX=9606 GN=TAF15 PE=1 SV=1,11,44,0.811,0.593,0.768,0.847,-0.3,-0.75,-0.38,-0.24,8.08E-01,8.69E-01,7.26E-01,9.82E-01,1.87E+06,1.64E+06,1.90E+06,7.82E+05,4,5,5,5,,1.22E+06,3.59E+05,1.49E+07,2.88E+06,7.59E+05,2.41E+06,2.71E+06,1.97E+05,1.64E+06,4.62E+05,6.34E+06,1.04E+06,8.66E+06,1.90E+06,1.31E+06,1.73E+05,7.82E+05,1.20E+05,1.89E+06,,4.62E+03,3.50E+03,1.49E+07,1.49E+05,2.70E+03,4.28E+04,2.50E+04,5.55E+03,1.74E+04,2.77E+03,2.83E+05,8.41E+03,1.17E+06,4.72E+04,2.55E+03,4.87E+04,5.54E+03,2.81E+03,2.01E+04,0,FALSE,55.043,21,9,592,61.8,8.02,11,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf00076,8148,B2R837; hsa:8148; Q86X94; Q92751; Q92804,ENSG00000270647; ENSG00000276833,Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,17q12 copy number variation syndrome,10,2,140.28,69.1,98.37,88.53,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,122.2,127.29,121.53,119.56,119.1,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O75380,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS6 PE=1 SV=1",5,15,0.811,0.478,1.155,1.666,-0.3,-1.06,0.21,0.74,8.17E-01,6.24E-01,9.58E-01,5.59E-01,1.24E+06,1.83E+06,1.33E+06,2.62E+06,5,3,5,4,9.13E+04,3.18E+06,4.70E+04,3.41E+06,1.24E+06,9.36E+06,,1.83E+06,,8.60E+05,2.41E+05,1.76E+06,1.33E+06,2.19E+06,1.17E+06,1.01E+07,6.80E+05,2.66E+07,6.42E+05,,3.63E+02,1.21E+04,4.59E+02,3.41E+06,6.38E+04,3.33E+04,,1.69E+04,,9.14E+03,1.44E+03,7.86E+04,1.08E+04,2.95E+05,2.91E+04,1.97E+04,1.91E+05,1.89E+05,1.50E+04,,0,FALSE,22.911,60,5,124,13.7,8.28,5,other metabolic processes;transport,other membranes;mitochondrion,Pf10276,4726,hsa:4726; O75380,ENSG00000145494,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,5,0,102.16,115.84,54.54,128.65,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,115.1,78.77,137.59,103.13,47.58,transporter activity;other molecular function,0,
Master Protein,High,A0A8V8TMF3,IKZF1,IKAROS family zinc finger 1 OS=Homo sapiens OX=9606 GN=IKZF1 PE=1 SV=1,6,13,0.81,0.347,,2.342,-0.3,-1.53,,1.23,8.76E-01,3.95E-01,,3.07E-01,2.06E+05,1.16E+05,4.59E+05,9.21E+04,5,3,5,4,2.06E+05,6.31E+04,7.89E+05,3.92E+06,1.45E+05,2.94E+05,4.23E+04,,,1.16E+05,4.59E+05,5.40E+05,2.83E+05,1.94E+06,3.18E+05,,4.47E+04,1.32E+05,2.70E+05,6.42E+04,8.18E+02,2.40E+02,7.71E+03,3.92E+06,7.49E+03,1.04E+03,7.53E+02,,,1.23E+03,2.74E+03,2.41E+04,2.30E+03,2.62E+05,7.90E+03,,1.26E+04,9.35E+02,6.32E+03,6.84E+02,0,FALSE,36.871,27,5,345,38.4,6.23,6,,,Pf00096,,A0A8V8TMF3,ENSG00000185811,,Hematopoietic stem cell differentiation; Development of pulmonary dendritic cells and macrophage subsets,2,1,160.38,85.74,98.49,79.85,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,91.86,85.6,,114.23,47.89,,0,
Master Protein,High,E7EMB3,CALM2,Calmodulin 2 OS=Homo sapiens OX=9606 GN=CALM2 PE=1 SV=1,8,280,0.81,0.509,0.921,0.568,-0.3,-0.97,-0.12,-0.82,7.32E-01,6.50E-01,8.13E-01,6.71E-01,1.51E+07,2.46E+07,9.96E+06,2.99E+07,5,5,5,5,2.40E+06,6.44E+07,1.00E+07,1.51E+07,9.71E+07,1.80E+07,2.46E+07,4.81E+07,1.23E+07,7.13E+07,1.79E+06,4.75E+06,9.96E+06,3.11E+07,1.39E+07,6.77E+07,1.31E+07,3.24E+07,2.17E+07,2.99E+07,9.52E+03,2.45E+05,9.79E+04,1.51E+07,5.01E+06,6.41E+04,4.37E+05,4.44E+05,3.46E+05,7.58E+05,1.07E+04,2.12E+05,8.09E+04,4.20E+06,3.46E+05,1.32E+05,3.69E+06,2.30E+05,5.07E+05,3.18E+05,0,FALSE,49.529,40,8,196,21.7,4.56,8,,,Pf13499,,E7EMB3,ENSG00000143933,,Alzheimer's disease and miRNA effects; Ras signaling; Melanoma; Alzheimer's disease,4,0,108.77,70.33,93.57,63.23,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,131.11,135.69,115.87,121.18,831.13,other molecular function,0,
Master Protein,High,Q96FN4,CPNE2,Copine-2 OS=Homo sapiens OX=9606 GN=CPNE2 PE=1 SV=3,7,13,0.808,0.71,,1.033,-0.31,-0.5,,0.05,9.43E-01,9.81E-01,,8.52E-01,6.69E+05,5.41E+04,1.87E+05,7.89E+04,2,3,4,1,,,,1.10E+06,4.09E+05,,1.42E+05,5.41E+04,,4.28E+04,,2.58E+04,8.21E+04,4.73E+05,4.25E+05,,,,7.89E+04,,,,,1.10E+06,2.11E+04,,2.53E+03,4.99E+02,,4.55E+02,,1.15E+03,6.67E+02,6.37E+04,1.06E+04,,,,1.85E+03,,0,FALSE,19.894,16,6,548,61.2,6.07,7,other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf00168, Pf07002",221184,hsa:221184; Q68D19; Q719H8; Q86XP9; Q96FN4,ENSG00000140848,,,0,0,64.56,68.37,91.48,,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,55.18,84.23,,89.08,33.39,other molecular function,0,
Master Protein,High,A0A8C8L3F5,ACSL5,Long-chain-fatty-acid--CoA ligase OS=Homo sapiens OX=9606 GN=ACSL5 PE=1 SV=1,4,5,0.807,0.777,1.5,0.45,-0.31,-0.36,0.58,-1.15,8.58E-01,9.15E-01,7.92E-01,6.69E-01,1.03E+05,1.21E+05,1.44E+05,1.59E+05,4,2,3,2,,6.08E+05,6.01E+04,1.64E+05,6.52E+04,1.06E+05,1.38E+05,,,,,,5.06E+04,1.44E+05,1.48E+05,2.04E+05,,,,1.24E+05,,2.31E+03,5.87E+02,1.64E+05,3.36E+03,3.78E+02,2.45E+03,,,,,,4.11E+02,1.94E+04,3.67E+03,3.98E+02,,,,1.32E+03,0,FALSE,15.902,9,4,715,79.5,7.53,4,other metabolic processes,other membranes;mitochondrion;ER/Golgi;nucleus,Pf00501,,A0A8C8L3F5,ENSG00000197142,,PPAR signaling pathway; Ferroptosis; Thermogenesis; Fatty acid transporters; Fatty acids and lipoproteins transport in hepatocytes,5,0,116.06,18.36,48.2,34.39,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,55.24,80.32,37.16,36.23,14.87,other molecular function,0,
Master Protein,High,P46940,IQGAP1,Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,16,45,0.806,1.485,1.336,3.102,-0.31,0.57,0.42,1.63,7.28E-01,2.59E-01,8.12E-01,2.80E-01,2.83E+06,2.39E+06,5.96E+06,2.79E+06,5,5,5,5,1.02E+07,1.36E+06,2.83E+06,2.43E+06,5.57E+06,2.39E+06,4.03E+06,4.86E+06,9.88E+05,1.76E+06,1.05E+07,3.92E+06,5.65E+06,9.24E+06,5.96E+06,6.37E+06,2.55E+06,1.98E+06,2.79E+06,8.94E+06,4.05E+04,5.19E+03,2.77E+04,2.43E+06,2.87E+05,8.50E+03,7.16E+04,4.49E+04,2.78E+04,1.87E+04,6.26E+04,1.75E+05,4.59E+04,1.25E+06,1.48E+05,1.24E+04,7.17E+05,1.40E+04,6.52E+04,9.51E+04,0,FALSE,67.569,16,16,1657,189.1,6.48,16,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00307, Pf00612, Pf00616, Pf03836",8826,A7MBM3; hsa:8826; P46940,ENSG00000140575,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHO GTPases activate IQGAPs; RAC2 GTPase cycle; RHOV GTPase cycle; Neutrophil degranulation; Signaling by BRAF and RAF1 fusions; RHOU GTPase cycle; Nephrin family interactions; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants,VEGFA-VEGFR2 signaling; Ebola virus infection in host; Ciliary landscape; EGF/EGFR signaling pathway; Regulation of actin cytoskeleton; G13 signaling pathway,25,0,79.23,57.22,38.47,66.53,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,123.81,109.23,99.2,113.98,151.38,enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q13423,NNT,"NAD(P) transhydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=NNT PE=1 SV=3",16,45,0.806,1.166,1.459,1.348,-0.31,0.22,0.55,0.43,7.27E-01,4.41E-01,7.26E-01,7.33E-01,9.99E+06,3.19E+06,1.31E+07,3.30E+06,5,5,5,5,5.91E+06,1.02E+07,1.17E+07,9.99E+06,7.56E+06,5.49E+07,1.01E+06,3.26E+06,1.74E+06,3.19E+06,3.33E+07,1.04E+07,2.78E+07,7.81E+06,1.31E+07,5.06E+07,3.30E+06,2.27E+06,8.50E+05,7.12E+06,2.35E+04,3.89E+04,1.14E+05,9.99E+06,3.90E+05,1.95E+05,1.79E+04,3.00E+04,4.91E+04,3.39E+04,1.99E+05,4.64E+05,2.26E+05,1.05E+06,3.26E+05,9.86E+04,9.28E+05,1.61E+04,1.99E+04,7.58E+04,0,FALSE,67.376,20,16,1086,113.8,8.09,16,other metabolic processes;transport;other biological processes,other membranes;mitochondrion,"Pf01262, Pf02233, Pf05222, Pf12769",23530,hsa:23530; Q13423; Q16796; Q2TB60; Q8N3V4,ENSG00000112992,Citric acid cycle (TCA cycle),,1,0,25.35,183.66,61.34,165.54,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,122.46,125.17,142.29,145.51,121.52,transporter activity;other molecular function,0,
Master Protein,High,Q96A65,EXOC4,Exocyst complex component 4 OS=Homo sapiens OX=9606 GN=EXOC4 PE=1 SV=1,2,3,0.805,0.909,1.195,0.625,-0.31,-0.14,0.26,-0.68,8.16E-01,7.68E-01,9.26E-01,8.34E-01,5.36E+04,4.05E+04,6.32E+04,8.04E+04,5,2,4,4,1.32E+05,8.46E+04,4.53E+04,5.36E+04,1.68E+04,,2.53E+04,,,6.48E+04,9.23E+04,,4.33E+04,1.92E+05,4.03E+04,7.75E+04,1.39E+05,8.35E+04,7.98E+03,,5.24E+02,3.22E+02,4.43E+02,5.36E+04,8.68E+02,,4.50E+02,,,6.89E+02,5.52E+02,,3.52E+02,2.59E+04,1.00E+03,1.51E+02,3.89E+04,5.92E+02,1.87E+02,,0,FALSE,8.361,3,2,974,110.4,6.49,2,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf04048, Pf20652",60412,E9PED2; hsa:60412; Q541U8; Q96A65; Q9C0G4; Q9H9K0; Q9P102,ENSG00000131558,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing; VxPx cargo-targeting to cilium,Ciliary landscape,4,0,65.94,62,77.08,69.64,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,100.13,87.2,109.12,75.93,8.9,other molecular function,0,
Master Protein,High,Q92793,CREBBP,CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3,1,2,0.804,0.092,1.374,0.054,-0.32,-3.44,0.46,-4.22,8.33E-01,4.44E-02,8.80E-01,2.22E-02,6.92E+04,8.61E+04,6.36E+03,1.18E+05,2,1,1,2,,,,2.03E+04,2.36E+05,,,,,8.61E+04,,,,6.36E+03,,,,9.00E+04,,1.56E+05,,,,2.03E+04,1.22E+04,,,,,9.16E+02,,,,8.57E+02,,,,6.38E+02,,1.66E+03,0,FALSE,6.118,1,1,2442,265.2,8.53,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00439, Pf00569, Pf02135, Pf02172, Pf06001, Pf08214, Pf09030",1387,D3DUC9; O00147; Q16376; Q4LE28; Q92793,ENSG00000005339,"SARS-CoV-2 activates/modulates innate and adaptive immune responses; Zygotic genome activation (ZGA); PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; NPAS4 regulates expression of target genes; Formation of paraxial mesoderm; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Heme signaling; Formation of the beta-catenin:TCF transactivating complex; SUMOylation of transcription cofactors; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Transcriptional activation of mitochondrial biogenesis; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Cytoprotection by HMOX1; Pre-NOTCH Transcription and Translation; Activation of gene expression by SREBF (SREBP); NFE2L2 regulating anti-oxidant/detoxification enzymes; HATs acetylate histones; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; NFE2L2 regulating MDR associated enzymes; Nuclear events mediated by NFE2L2; NFE2L2 regulates pentose phosphate pathway genes; NOTCH3 Intracellular Domain Regulates Transcription; FOXO-mediated transcription of cell death genes; Regulation of FOXO transcriptional activity by acetylation; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells; NFE2L2 regulating inflammation associated genes; NFE2L2 regulating tumorigenic genes; NFE2L2 regulating ER-stress associated genes; Regulation of NFE2L2 gene expression; RORA activates gene expression; Attenuation phase; CD209 (DC-SIGN) signaling; Activation of the TFAP2 (AP-2) family of transcription factors; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Evasion by RSV of host interferon responses; Regulation of gene expression by Hypoxia-inducible Factor; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production; NOTCH4 Intracellular Domain Regulates Transcription; RUNX3 regulates NOTCH signaling",Androgen receptor signaling pathway; Angiogenesis; TNF-alpha signaling pathway; Notch signaling; Initiation of transcription and translation elongation at the HIV-1 LTR; IL6 signaling pathway; Pathways affected in adenoid cystic carcinoma; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; TGF-beta signaling pathway; VEGFA-VEGFR2 signaling; miRNA regulation of prostate cancer signaling pathways; Wnt signaling pathway and pluripotency; Clear cell renal cell carcinoma pathways; Ebola virus infection in host; Type 2 papillary renal cell carcinoma; Ciliary landscape; Hepatitis B infection; Male infertility; TGF-beta receptor signaling in skeletal dysplasias; Overlap between signal transduction pathways contributing to LMNA laminopathies; 15q13.3 copy number variation syndrome; Urotensin-II-mediated signaling pathway; Rubinstein-Taybi syndrome 1; 15q11q13 copy number variation; TGF-beta receptor signaling; Sudden infant death syndrome (SIDS) susceptibility pathways,74,0,119.05,,,37.74,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,231.22,231.22,41.06,41.06,6.67,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O95365,ZBTB7A,Zinc finger and BTB domain-containing protein 7A OS=Homo sapiens OX=9606 GN=ZBTB7A PE=1 SV=1,3,6,0.799,1.327,9.299,0.298,-0.32,0.41,3.22,-1.75,9.19E-01,4.03E-01,2.47E-02,4.19E-01,2.96E+05,1.18E+05,1.67E+05,1.09E+06,3,1,5,4,,,2.96E+05,3.13E+05,6.02E+04,,,1.18E+05,,,7.34E+04,2.54E+05,4.97E+05,9.55E+04,1.67E+05,2.29E+05,8.60E+05,2.00E+06,1.39E+06,,,,2.89E+03,3.13E+05,3.10E+03,,,1.09E+03,,,4.39E+02,1.14E+04,4.04E+03,1.29E+04,4.16E+03,4.46E+02,2.42E+05,1.42E+04,3.26E+04,,0,FALSE,12.173,9,3,584,61.4,5.19,3,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00096, Pf00651",51341,D6W619; hsa:51341; O00456; O95365; Q14D41; Q5XG86,ENSG00000178951,,IL-18 signaling pathway,1,0,63.36,,78.87,67.38,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,160.81,82.6,78.78,99.86,17.61,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P62263,RPS14,40S ribosomal protein S14 OS=Homo sapiens OX=9606 GN=RPS14 PE=1 SV=3,4,30,0.799,0.686,0.8,1.107,-0.32,-0.54,-0.32,0.15,8.91E-01,9.15E-01,6.70E-01,7.77E-01,9.29E+05,2.62E+05,1.38E+06,7.53E+05,5,4,5,4,6.26E+05,9.29E+05,2.63E+05,2.89E+06,2.36E+06,9.40E+04,2.08E+05,3.29E+05,,5.93E+06,1.07E+06,1.94E+06,3.89E+05,1.38E+06,1.39E+06,2.64E+05,1.31E+06,1.66E+06,4.32E+05,,2.49E+03,3.53E+03,2.57E+03,2.89E+06,1.22E+05,3.34E+02,3.69E+03,3.04E+03,,6.31E+04,6.40E+03,8.66E+04,3.16E+03,1.86E+05,3.44E+04,5.14E+02,3.69E+05,1.17E+04,1.01E+04,,0,FALSE,27.11,31,4,151,16.3,10.05,4,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf00411,6208,B2R5G5; D3DQG5; hsa:6208; P06366; P62263; Q5BJI0,ENSG00000164587,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,20,0,81.05,174.45,45.94,73.64,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,130.48,85.04,124.66,86.38,90.76,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P05771,PRKCB,Protein kinase C beta type OS=Homo sapiens OX=9606 GN=PRKCB PE=1 SV=4,9,23,0.799,1.266,0.506,1.73,-0.32,0.34,-0.98,0.79,7.41E-01,3.72E-01,3.58E-01,5.10E-01,2.62E+06,1.74E+06,2.90E+06,9.44E+05,5,4,5,5,5.87E+06,9.00E+04,2.62E+06,4.44E+06,1.68E+06,,2.84E+06,7.46E+04,2.51E+06,1.21E+06,1.58E+06,2.13E+06,2.90E+06,7.10E+06,6.44E+06,1.27E+05,9.44E+05,3.80E+04,2.24E+06,1.22E+06,2.33E+04,3.42E+02,2.56E+04,4.44E+06,8.68E+04,,5.04E+04,6.88E+02,7.08E+04,1.29E+04,9.46E+03,9.53E+04,2.36E+04,9.56E+05,1.60E+05,2.48E+02,2.65E+05,2.70E+02,5.25E+04,1.30E+04,0,FALSE,39.731,19,6,671,76.8,7.01,9,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf00069, Pf00130, Pf00168, Pf00433",5579,C5IFJ8; D3DWF5; hsa:5579; O43744; P05127; P05771; Q15138; Q93060; Q9UE49; Q9UE50; Q9UEH8; Q9UJ30; Q9UJ33,ENSG00000166501,Activation of NF-kappaB in B cells; G alpha (z) signalling events; Disinhibition of SNARE formation; WNT5A-dependent internalization of FZD4; VEGFR2 mediated cell proliferation; Trafficking of GluR2-containing AMPA receptors; Depolymerization of the Nuclear Lamina; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells; RHO GTPases Activate NADPH Oxidases,"Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Glioblastoma signaling pathways; B cell receptor signaling pathway; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; Kit receptor signaling pathway; Focal adhesion; G protein signaling pathways; Wnt signaling pathway; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; Serotonin and anxiety-related events; Serotonin and anxiety; PDGFR-beta pathway; Wnt signaling pathway and pluripotency; Ras signaling; Non-small cell lung cancer; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Hippo signaling regulation pathways; Hepatitis B infection; IL-18 signaling pathway; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; GPR143 in melanocytes and retinal pigment epithelium cells; Neuroinflammation and glutamatergic signaling; Orexin receptor pathway; Chronic hyperglycemia impairment of neuron function; Macrophage-stimulating protein (MSP) signaling network map; Calcium regulation in cardiac cells; ErbB signaling pathway",48,3,77.28,76.5,63.33,98.58,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,91.18,107.43,104.32,110.27,76.1,kinase activity;other molecular function,0,
Master Protein,High,A0A804HJ08,TUBGCP2,Gamma-tubulin complex component OS=Homo sapiens OX=9606 GN=TUBGCP2 PE=1 SV=1,5,5,0.798,1.285,1.318,1.167,-0.33,0.36,0.4,0.22,9.06E-01,4.25E-01,9.30E-01,7.51E-01,2.96E+05,2.45E+05,3.41E+05,3.19E+05,4,1,5,3,4.64E+05,,5.18E+05,1.88E+05,8.25E+04,,,2.45E+05,,,7.68E+05,5.98E+04,2.86E+05,3.98E+05,3.41E+05,,3.19E+05,,1.08E+05,3.23E+05,1.84E+03,,5.06E+03,1.88E+05,4.26E+03,,,2.26E+03,,,4.59E+03,2.67E+03,2.33E+03,5.36E+04,8.47E+03,,8.97E+04,,2.52E+03,3.44E+03,0,FALSE,18.647,9,5,913,103.5,6.92,5,cell organization and biogenesis,cytosol;cytoskeleton;nucleus,"Pf04130, Pf17681",,A0A804HJ08,ENSG00000130640,,Prader-Willi and Angelman syndrome; 15q11.2 copy number variation syndrome,2,0,67.31,,69.24,49.3,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,145.09,114.66,0,103.14,14.73,cytoskeletal activity,0,
Master Protein,High,Q8N4Q0,PTGR3,Prostaglandin reductase 3 OS=Homo sapiens OX=9606 GN=PTGR3 PE=1 SV=1,1,1,0.797,0.677,0.01,100,-0.33,-0.56,-6.64,6.64,9.06E-01,9.71E-01,1.00E-17,1.00E-17,1.61E+05,2.03E+05,1.60E+05,,2,2,3,,,3.33E+05,,,7.82E+04,,,3.41E+05,,1.20E+05,,,6.10E+04,1.96E+05,1.60E+05,,,,,,,1.27E+03,,,4.03E+03,,,3.14E+03,,1.28E+03,,,4.96E+02,2.63E+04,3.96E+03,,,,,,0.006,FALSE,2.453,4,1,377,40.1,8.18,1,other metabolic processes;other biological processes,other cytoplasmic organelle,"Pf00107, Pf08240",284273,A8KA15; B4DZ91; hsa:284273; Q8N4Q0,ENSG00000180011,,,0,0,87.64,67.52,50.2,,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,69.63,80.17,,,2.62,other molecular function,0,
Master Protein,Medium,Q04759,PRKCQ,Protein kinase C theta type OS=Homo sapiens OX=9606 GN=PRKCQ PE=1 SV=3,1,2,0.791,1.788,1.275,1.009,-0.34,0.84,0.35,0.01,8.11E-01,3.16E-01,9.14E-01,8.23E-01,6.66E+04,8.42E+04,1.19E+05,1.07E+05,2,1,4,3,7.62E+04,,,5.83E+04,,,,,,8.42E+04,,4.46E+04,1.61E+05,1.57E+05,9.06E+04,1.65E+05,1.07E+05,,4.28E+04,,3.03E+02,,,5.83E+04,,,,,,8.96E+02,,1.99E+03,1.30E+03,2.11E+04,2.25E+03,3.21E+02,3.02E+04,,1.00E+03,,0.011,FALSE,2.244,1,1,706,81.8,7.61,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00069, Pf00130, Pf00433, Pf21494",5588,B4DF52; hsa:5588; Q04759; Q14DH6; Q3MJF1; Q64FY5; Q9H508; Q9H549,ENSG00000065675,"FCERI mediated NF-kB activation; Downstream TCR signaling; G alpha (z) signalling events; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Inactivation, recovery and regulation of the phototransduction cascade; Netrin-1 signaling; RAS processing; Effects of PIP2 hydrolysis; Apoptotic cleavage of cellular proteins","Glioblastoma signaling pathways; Corticotropin-releasing hormone signaling pathway; Vitamin D receptor pathway; Myometrial relaxation and contraction pathways; MFAP5-mediated ovarian cancer cell motility and invasiveness; G protein signaling pathways; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Wnt signaling pathway and pluripotency; Non-genomic actions of 1,25 dihydroxyvitamin D3; Hippo signaling regulation pathways; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; Osteoblast differentiation and related diseases; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Modulators of TCR signaling and T cell activation; Th17 cell differentiation pathway; Chronic hyperglycemia impairment of neuron function; Calcium regulation in cardiac cells; T-cell receptor signaling pathway",29,0,18.76,,49.36,58.07,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,19.84,62.13,78.86,69.37,5.31,kinase activity;other molecular function,0,
Master Protein,High,Q9UII2,ATP5IF1,"ATPase inhibitor, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5IF1 PE=1 SV=1",4,10,0.79,0.539,1.95,0.788,-0.34,-0.89,0.96,-0.34,8.89E-01,7.72E-01,4.60E-01,8.93E-01,5.06E+05,4.87E+05,2.00E+06,3.67E+06,4,5,5,5,6.93E+04,4.61E+06,,7.65E+04,3.35E+06,4.87E+05,8.02E+04,6.83E+04,2.53E+06,3.10E+06,9.36E+06,1.74E+06,2.00E+06,2.10E+06,6.62E+05,3.67E+06,5.33E+05,8.74E+06,1.31E+06,2.17E+07,2.76E+02,1.75E+04,,7.65E+04,1.73E+05,1.73E+03,1.43E+03,6.30E+02,7.13E+04,3.30E+04,5.60E+04,7.77E+04,1.62E+04,2.83E+05,1.64E+04,7.16E+03,1.50E+05,6.20E+04,3.07E+04,2.31E+05,0,FALSE,9.502,26,4,106,12.2,9.35,4,cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes,mitochondrion;other cell component,Pf04568,93974,hsa:93974; Q5JXL8; Q6IAQ7; Q9BSL9; Q9UII2,ENSG00000130770; ENSG00000285390,,Electron transport chain: OXPHOS system in mitochondria,1,0,114.16,115.71,110.62,121.31,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,84.46,141.62,125.64,129.73,26.29,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q02790,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Homo sapiens OX=9606 GN=FKBP4 PE=1 SV=3,3,9,0.789,0.594,,0.35,-0.34,-0.75,,-1.52,9.16E-01,8.51E-01,,4.99E-01,3.96E+05,1.79E+05,1.42E+05,2.38E+05,3,1,3,3,3.96E+05,,,4.61E+05,2.56E+05,,,,,1.79E+05,,2.06E+05,5.90E+04,,1.42E+05,,1.89E+05,3.28E+05,,2.38E+05,1.57E+03,,,4.61E+05,1.32E+04,,,,,1.90E+03,,9.21E+03,4.79E+02,,3.54E+03,,5.31E+04,2.33E+03,,2.54E+03,0,FALSE,11.918,10,3,459,51.8,5.43,3,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,cytosol;cytoskeleton;mitochondrion;nucleus;other cell component,"Pf00254, Pf00515",2288,D3DUQ1; hsa:2288; Q02790; Q9UCP1; Q9UCV7,ENSG00000004478,Potential therapeutics for SARS; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Estrogen-dependent gene expression; Attenuation phase,Androgen receptor signaling pathway,6,0,28.3,,54.35,28.06,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,28.55,70.31,,35.14,27.75,cytoskeletal activity;other molecular function,0,
Master Protein,High,O94905,ERLIN2,Erlin-2 OS=Homo sapiens OX=9606 GN=ERLIN2 PE=1 SV=1,4,11,0.789,2.896,2.821,1.065,-0.34,1.53,1.5,0.09,9.08E-01,1.95E-02,2.98E-01,8.59E-01,3.41E+05,1.69E+05,2.74E+06,1.47E+06,4,4,5,3,1.81E+05,,5.33E+04,1.75E+06,6.41E+05,1.52E+06,3.33E+04,4.03E+04,7.12E+05,,2.08E+06,1.82E+06,3.10E+06,3.42E+06,2.74E+06,1.47E+06,1.12E+05,,3.17E+06,,7.19E+02,,5.21E+02,1.75E+06,3.31E+04,5.41E+03,5.93E+02,3.72E+02,2.01E+04,,1.24E+04,8.15E+04,2.52E+04,4.61E+05,6.80E+04,2.86E+03,3.14E+04,,7.41E+04,,0,FALSE,14.607,19,2,339,37.8,5.62,4,other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,Pf01145,11160,A0JLQ1; A8K5S9; B4DM38; D3DSW0; hsa:11160; O94905; Q6NW21; Q86VS6; Q86W49,ENSG00000147475,ABC-family proteins mediated transport; Defective CFTR causes cystic fibrosis; Signaling by FGFR1 in disease; Signaling by plasma membrane FGFR1 fusions,,4,2,117.67,122.38,25.57,96.79,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,122.88,124.05,96.28,69.26,23.82,other molecular function,0,
Master Protein,High,P60891,PRPS1,Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens OX=9606 GN=PRPS1 PE=1 SV=2,3,3,0.788,0.184,0.148,1.353,-0.34,-2.45,-2.76,0.44,8.87E-01,8.59E-02,2.77E-02,6.38E-01,4.38E+05,5.56E+05,1.11E+05,2.85E+05,2,2,3,2,1.60E+06,,1.20E+05,,,,,,2.91E+05,1.06E+06,2.21E+05,,1.11E+05,2.92E+04,,,8.88E+05,,9.14E+04,,6.34E+03,,1.17E+03,,,,,,8.21E+03,1.13E+04,1.32E+03,,9.01E+02,3.94E+03,,,2.50E+05,,2.14E+03,,0,FALSE,7.403,13,3,318,34.8,6.98,3,other metabolic processes;developmental processes,cytosol;other cell component,"Pf13793, Pf14572",5631,B1ALA8; B2R6T7; B4DNL6; D3DUX6; hsa:5631; P09329; P60891,ENSG00000147224,5-Phosphoribose 1-diphosphate biosynthesis,,1,0,121.65,80.49,79.89,115.04,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,131.04,126.15,92.07,108.95,7.71,kinase activity;other molecular function,0,
Master Protein,High,Q92621,NUP205,Nuclear pore complex protein Nup205 OS=Homo sapiens OX=9606 GN=NUP205 PE=1 SV=3,6,7,0.787,0.963,0.669,0.656,-0.35,-0.05,-0.58,-0.61,8.81E-01,6.59E-01,5.60E-01,8.20E-01,5.66E+05,4.11E+05,1.44E+05,5.22E+05,2,3,4,2,,,3.52E+05,9.11E+05,,4.11E+05,,2.21E+05,,4.38E+05,,6.18E+04,5.07E+04,1.30E+06,3.36E+05,7.50E+05,,,3.63E+05,,,,3.44E+03,9.11E+05,,1.46E+03,,2.04E+03,,4.65E+03,,2.76E+03,4.12E+02,1.76E+05,8.36E+03,1.46E+03,,,8.49E+03,,0,FALSE,18.861,4,6,2012,227.8,6.19,6,cell organization and biogenesis;transport,other membranes;cytosol;nucleus,Pf11894,23165,A6H8X3; hsa:23165; Q86YC1; Q92621,ENSG00000155561,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,,29,0,62.66,33.07,135.1,49.17,n/a,n/a,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,9.45,91.33,9.45,93.46,16.65,other molecular function,0,
Master Protein,High,E9PI68,SPCS2,Signal peptidase complex subunit 2 OS=Homo sapiens OX=9606 GN=SPCS2 PE=1 SV=1,3,9,0.786,0.721,0.79,0.794,-0.35,-0.47,-0.34,-0.33,8.81E-01,9.13E-01,7.92E-01,9.95E-01,2.36E+05,1.10E+06,1.01E+06,8.04E+05,4,3,5,4,,2.05E+05,6.01E+04,4.51E+05,2.73E+05,1.13E+06,5.75E+05,,,1.10E+06,1.68E+05,6.49E+05,1.01E+06,1.17E+06,1.36E+06,8.30E+05,2.33E+05,7.78E+05,1.51E+06,,,7.78E+02,5.87E+02,4.51E+05,1.41E+04,4.01E+03,1.02E+04,,,1.17E+04,1.00E+03,2.90E+04,8.18E+03,1.58E+05,3.37E+04,1.62E+03,6.55E+04,5.51E+03,3.54E+04,,0,FALSE,13.672,19,3,257,28.5,8.79,3,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf06703,,E9PI68,ENSG00000118363,,15q25 copy number variation,1,0,65.65,33.35,54.15,62.58,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,n/a,1,,FALSE,71.57,84.62,104.75,119.6,29.3,other molecular function,0,
Master Protein,High,O95182,NDUFA7,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 OS=Homo sapiens OX=9606 GN=NDUFA7 PE=1 SV=3,3,3,0.785,0.178,,0.01,-0.35,-2.49,,-6.64,8.75E-01,7.94E-02,,1.00E-17,6.87E+05,4.60E+05,6.49E+04,2.77E+07,2,2,3,3,,,,6.62E+05,7.14E+05,1.19E+06,,,,1.77E+05,,1.86E+05,,6.49E+04,6.40E+04,2.77E+07,,2.83E+07,7.39E+05,,,,,6.62E+05,3.68E+04,4.25E+03,,,,1.89E+03,,8.29E+03,,8.74E+03,1.59E+03,5.40E+04,,2.01E+05,1.73E+04,,0,FALSE,7.982,25,3,113,12.5,10.18,3,protein metabolism;other metabolic processes;transport,other membranes;mitochondrion;translational apparatus,Pf07347,4701,hsa:4701; O95182,ENSG00000267855,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,5,0,5.36,104.85,66.7,83.24,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,1,,FALSE,163.81,21.3,,3.25,9.4,transporter activity;other molecular function,0,
Master Protein,High,Q14643,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1 OS=Homo sapiens OX=9606 GN=ITPR1 PE=1 SV=3",23,54,0.783,0.481,0.974,0.825,-0.35,-1.06,-0.04,-0.28,7.92E-01,6.42E-01,9.08E-01,9.86E-01,2.28E+06,8.60E+05,1.20E+06,1.87E+06,5,5,5,5,2.02E+05,2.28E+06,1.34E+05,9.53E+06,3.29E+06,1.03E+06,8.60E+05,1.05E+06,4.09E+05,4.65E+05,6.89E+05,6.99E+05,2.77E+06,3.93E+06,1.20E+06,4.97E+06,3.64E+05,7.65E+06,1.87E+06,4.87E+05,8.03E+02,8.66E+03,1.30E+03,9.53E+06,1.70E+05,3.66E+03,1.53E+04,9.73E+03,1.15E+04,4.94E+03,4.12E+03,3.12E+04,2.25E+04,5.29E+05,2.97E+04,9.70E+03,1.02E+05,5.42E+04,4.38E+04,5.18E+03,0,FALSE,105.071,14,21,2758,313.7,6.04,23,cell-cell signaling;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,"Pf00520, Pf01365, Pf02815, Pf08454, Pf08709",3708,E7EPX7; E9PDE9; hsa:3708; Q14643; Q14660; Q99897,ENSG00000150995,Ca2+ pathway; VEGFR2 mediated cell proliferation; Role of phospholipids in phagocytosis; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Ion homeostasis; cGMP effects; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Elevation of cytosolic Ca2+ levels; PLC beta mediated events; DAG and IP3 signaling; CLEC7A (Dectin-1) induces NFAT activation; Effects of PIP2 hydrolysis,Alzheimer's disease and miRNA effects; Myometrial relaxation and contraction pathways; G protein signaling pathways; Cell-type dependent selectivity of CCK2R signaling; Resistin as a regulator of inflammation; Fragile X syndrome; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Vitamin D-sensitive calcium signaling in depression; PKC-gamma calcium signaling pathway in ataxia; Type I collagen synthesis in the context of osteogenesis imperfecta; GPR143 in melanocytes and retinal pigment epithelium cells; STING pathway in Kawasaki-like disease and COVID-19; Alzheimer's disease; GDNF signaling; Calcium regulation in cardiac cells; KCNQ2-related epilepsies; 15q25 copy number variation; T-cell receptor signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling,35,2,124.66,40.35,77.39,103.08,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,134.24,112.95,134.37,131.19,169.89,transporter activity;other molecular function,0,
Master Protein,Medium,P50876,RNF144A,E3 ubiquitin-protein ligase RNF144A OS=Homo sapiens OX=9606 GN=RNF144A PE=1 SV=2,1,2,0.781,0.507,0.527,0.736,-0.36,-0.98,-0.92,-0.44,7.01E-01,6.46E-01,3.43E-01,8.71E-01,4.33E+06,5.55E+06,1.57E+06,2.63E+06,5,5,4,5,1.07E+07,5.51E+06,4.33E+06,1.89E+05,2.22E+06,8.59E+06,2.29E+06,5.55E+06,3.00E+06,6.73E+06,8.82E+06,1.10E+06,,2.25E+06,6.66E+05,7.42E+06,3.54E+06,2.63E+06,2.03E+05,2.30E+06,4.25E+04,2.10E+04,4.23E+04,1.89E+05,1.15E+05,3.05E+04,4.08E+04,5.12E+04,8.45E+04,7.16E+04,5.28E+04,4.91E+04,,3.03E+05,1.65E+04,1.45E+04,9.96E+05,1.87E+04,4.74E+03,2.45E+04,0.015,FALSE,2.103,3,1,292,32.9,6.28,1,protein metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf01485,9781,D6W4Y6; P50876; Q585H5,ENSG00000151692,E3 ubiquitin ligases ubiquitinate target proteins,,1,0,86.62,49.86,118.47,82.24,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,86.98,132.36,80.43,124.01,4.06,other molecular function,0,
Master Protein,High,P55265,ADAR,Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens OX=9606 GN=ADAR PE=1 SV=4,10,15,0.78,0.574,0.817,0.538,-0.36,-0.8,-0.29,-0.89,7.88E-01,8.53E-01,7.49E-01,6.95E-01,1.49E+06,1.04E+06,4.29E+05,4.55E+05,4,3,4,4,3.06E+06,6.04E+04,,3.94E+06,7.26E+05,2.13E+06,4.44E+04,,,1.04E+06,4.78E+05,2.86E+05,,1.83E+06,3.86E+05,7.27E+05,2.85E+05,,2.47E+05,8.47E+05,1.22E+04,2.30E+02,,3.94E+06,3.75E+04,7.56E+03,7.89E+02,,,1.10E+04,2.86E+03,1.28E+04,,2.46E+05,9.60E+03,1.42E+03,8.00E+04,,5.77E+03,9.02E+03,0,FALSE,31.102,11,10,1226,136,8.65,10,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;other biological processes,nucleus;other cell component,"Pf00035, Pf02137, Pf02295",103,B1AQQ9; B1AQR0; D3DV76; hsa:103; O15223; O43859; O43860; P55265; Q9BYM3; Q9BYM4,ENSG00000160710,PKR-mediated signaling; Interferon alpha/beta signaling; C6 deamination of adenosine; Formation of editosomes by ADAR proteins,Measles virus infection; Cytosolic DNA-sensing pathway,6,0,95,97.35,97.6,58.04,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,63.33,95.08,77.42,86.47,41.59,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P08670,VIM,Vimentin OS=Homo sapiens OX=9606 GN=VIM PE=1 SV=4,44,1169,0.779,0.789,0.89,0.953,-0.36,-0.34,-0.17,-0.07,6.99E-01,8.46E-01,7.79E-01,9.73E-01,1.10E+08,2.63E+08,1.32E+08,1.90E+08,5,5,5,5,8.11E+07,1.10E+08,8.16E+07,4.63E+08,2.12E+08,2.63E+08,3.47E+08,4.21E+08,2.13E+07,2.02E+08,1.79E+08,6.21E+07,1.07E+08,2.52E+08,1.32E+08,1.90E+08,2.42E+07,2.54E+08,7.89E+07,3.39E+08,3.22E+05,4.20E+05,7.97E+05,4.63E+08,1.10E+07,9.37E+05,6.16E+06,3.89E+06,6.00E+05,2.14E+06,1.07E+06,2.78E+06,8.71E+05,3.40E+07,3.27E+06,3.71E+05,6.79E+06,1.80E+06,1.85E+06,3.61E+06,0,FALSE,327.07,82,43,466,53.6,5.12,44,cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,"Pf00038, Pf04732",7431,B0YJC2; D3DRU4; hsa:7431; P08670; Q15867; Q15868; Q15869; Q548L2; Q6LER9; Q8N850; Q96ML2; Q9NTM3,ENSG00000026025,Late endosomal microautophagy; Aggrephagy; Interleukin-4 and Interleukin-13 signaling; Striated Muscle Contraction; RHOBTB1 GTPase cycle; Caspase-mediated cleavage of cytoskeletal proteins; Chaperone Mediated Autophagy,Allograft rejection; Spinal cord injury; Primary focal segmental glomerulosclerosis (FSGS); Mammary gland development pathway - Puberty (Stage 2 of 4); Apoptosis-related network due to altered Notch3 in ovarian cancer; Striated muscle contraction pathway; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Ciliary landscape; Burn wound healing; CCL18 signaling pathway; TROP2 regulatory signaling; Macrophage-stimulating protein (MSP) signaling network map; HDAC6 interactions in the central nervous system; T-cell receptor signaling pathway,21,1,85.46,60.94,49.57,72.13,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,139.92,122.69,135.91,136.93,3153.34,cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P54886,ALDH18A1,Delta-1-pyrroline-5-carboxylate synthase OS=Homo sapiens OX=9606 GN=ALDH18A1 PE=1 SV=2,11,28,0.778,0.666,0.894,1.096,-0.36,-0.59,-0.16,0.13,9.04E-01,9.48E-01,7.74E-01,7.76E-01,4.69E+05,2.74E+05,1.54E+06,2.48E+05,5,5,5,5,2.86E+05,4.69E+05,1.16E+05,2.30E+06,1.03E+06,7.25E+05,2.74E+05,3.66E+04,8.90E+04,8.31E+05,4.18E+05,6.25E+05,1.58E+06,1.54E+06,2.29E+06,5.07E+05,1.25E+06,3.42E+04,2.48E+05,5.58E+04,1.14E+03,1.78E+03,1.13E+03,2.30E+06,5.32E+04,2.58E+03,4.86E+03,3.37E+02,2.51E+03,8.83E+03,2.50E+03,2.79E+04,1.29E+04,2.07E+05,5.70E+04,9.88E+02,3.53E+05,2.43E+02,5.79E+03,5.94E+02,0,FALSE,48.739,19,11,795,87.2,7.12,11,other metabolic processes;other biological processes,other membranes;mitochondrion,"Pf00171, Pf00696",5832,B2R5Q4; B7Z350; B7Z5X8; B7ZLP1; D3DR44; hsa:5832; O95952; P54886; Q3KQU2; Q5T566; Q5T567; Q9UM72,ENSG00000059573,Mitochondrial protein degradation,Amino acid metabolism,2,0,105.35,93.59,59.42,120.02,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,120.21,99.82,93.76,88.46,82.13,kinase activity;other molecular function,0,
Master Protein,High,Q16656,NRF1,Nuclear respiratory factor 1 OS=Homo sapiens OX=9606 GN=NRF1 PE=1 SV=1,5,7,0.774,0.418,,0.058,-0.37,-1.26,,-4.11,8.64E-01,4.71E-01,,2.29E-02,7.43E+05,3.87E+05,1.09E+05,1.09E+06,4,5,5,3,,1.35E+06,4.10E+05,1.60E+06,3.00E+05,2.89E+06,3.87E+05,5.21E+05,1.78E+05,7.33E+04,4.76E+05,3.47E+04,1.09E+05,1.29E+05,6.40E+04,9.30E+05,,1.09E+06,,1.70E+06,,5.13E+03,4.00E+03,1.60E+06,1.55E+04,1.03E+04,6.88E+03,4.81E+03,5.03E+03,7.79E+02,2.84E+03,1.55E+03,8.89E+02,1.73E+04,1.59E+03,1.81E+03,,7.74E+03,,1.81E+04,0,FALSE,18.61,18,5,503,53.5,5.05,5,other biological processes,cytosol;nucleus,Pf10491,4899,A8K4C6; B4DDV6; hsa:4899; Q15305; Q16656; Q96AN2,ENSG00000106459,PPARA activates gene expression; Transcriptional activation of mitochondrial biogenesis,Energy metabolism; Interactions between LOXL4 and oxidative stress pathway; Mitochondrial gene expression; Sildenafil treatment,6,0,71.82,145.24,110.1,32.61,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,112.79,111.85,,81.02,24.2,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P07203,GPX1,Glutathione peroxidase 1 OS=Homo sapiens OX=9606 GN=GPX1 PE=1 SV=4,8,23,0.773,0.708,,1.531,-0.37,-0.5,,0.61,7.81E-01,9.73E-01,,6.49E-01,9.34E+05,1.59E+06,5.51E+06,4.82E+05,4,4,5,3,6.28E+05,1.09E+06,,4.99E+06,8.01E+05,3.04E+06,,1.39E+06,5.04E+05,1.83E+06,2.61E+05,1.13E+07,1.80E+06,5.51E+06,5.85E+06,,4.82E+05,,9.78E+04,1.06E+06,2.49E+03,4.14E+03,,4.99E+06,4.13E+04,1.08E+04,,1.28E+04,1.42E+04,1.95E+04,1.56E+03,5.04E+05,1.46E+04,7.42E+05,1.45E+05,,1.35E+05,,2.29E+03,1.13E+04,0,FALSE,31.234,45,8,203,22.1,6.55,8,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;mitochondrion;other cell component,Pf00255,2876,E9PAS1; hsa:2876; P07203; Q7Z5H1; Q9BW12,ENSG00000233276,Detoxification of Reactive Oxygen Species; Synthesis of 15-eicosatetraenoic acid derivatives; Synthesis of 12-eicosatetraenoic acid derivatives; Synthesis of 5-eicosatetraenoic acids,"Glutathione metabolism; Selenium micronutrient network; Folate metabolism; Amyotrophic lateral sclerosis (ALS); Trans-sulfuration, one-carbon metabolism and related pathways; Selenium metabolism and selenoproteins; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling; One-carbon metabolism and related pathways; TYROBP causal network in microglia; Oxidative stress response; Male infertility; p53 transcriptional gene network; Omega-6-fatty acids in senescence",18,0,111.04,62.49,86.6,88.55,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,106.18,108.13,,124.78,61.79,other molecular function,0,
Master Protein,High,Q14344,GNA13,Guanine nucleotide-binding protein subunit alpha-13 OS=Homo sapiens OX=9606 GN=GNA13 PE=1 SV=2,4,48,0.773,0.643,6.268,0.365,-0.37,-0.64,2.65,-1.45,8.64E-01,9.95E-01,5.07E-02,4.53E-01,1.25E+06,1.10E+05,8.46E+05,1.55E+06,4,3,5,5,1.31E+06,3.46E+06,,1.20E+06,6.23E+05,1.78E+06,1.10E+05,,,1.03E+05,3.37E+06,4.92E+05,4.78E+05,8.46E+05,2.67E+06,6.60E+06,7.19E+05,5.09E+06,5.36E+05,1.55E+06,5.19E+03,1.32E+04,,1.20E+06,3.21E+04,6.31E+03,1.96E+03,,,1.09E+03,2.02E+04,2.20E+04,3.88E+03,1.14E+05,6.64E+04,1.29E+04,2.02E+05,3.60E+04,1.25E+04,1.65E+04,0,FALSE,11.87,16,3,377,44,8,4,stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf00503,10672,B2R977; B7Z7R0; F5H1G8; hsa:10672; Q14344; Q8TD70,ENSG00000120063,CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; Thrombin signalling through proteinase activated receptors (PARs); Thromboxane signalling through TP receptor,Thyroid stimulating hormone (TSH) signaling pathway; G protein signaling pathways; Modulators of TCR signaling and T cell activation; Regulation of actin cytoskeleton; G13 signaling pathway,11,0,75.58,145.42,86.19,95.48,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,104.35,84.57,165.96,110.6,107.9,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,M0R2C6,,serine--tRNA ligase (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1,4,10,0.772,0.748,0.098,1.6,-0.37,-0.42,-3.34,0.68,9.18E-01,9.11E-01,1.08E-02,5.27E-01,1.56E+05,5.48E+05,3.81E+05,1.08E+05,4,1,4,4,,8.95E+04,2.13E+04,9.92E+05,2.70E+05,,,,,5.48E+05,,4.60E+05,1.97E+05,3.86E+05,3.75E+05,,1.27E+05,1.53E+05,4.48E+04,9.22E+04,,3.40E+02,2.08E+02,9.92E+05,1.39E+04,,,,,5.83E+03,,2.06E+04,1.60E+03,5.21E+04,9.33E+03,,3.58E+04,1.08E+03,1.05E+03,9.82E+02,0,FALSE,15.224,11,4,588,65.7,6.54,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes,,"Pf00587, Pf04300",,,,,,0,0,129.64,,31.56,44.87,n/a,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,112.99,102.99,699.99,75.68,21.62,other molecular function,0,
Master Protein,High,Q96PU4,UHRF2,E3 ubiquitin-protein ligase UHRF2 OS=Homo sapiens OX=9606 GN=UHRF2 PE=1 SV=1,3,3,0.771,0.691,0.837,0.834,-0.38,-0.53,-0.26,-0.26,7.91E-01,9.79E-01,7.82E-01,9.74E-01,6.37E+04,7.69E+04,1.11E+05,1.28E+05,2,2,3,3,,,,2.28E+05,1.78E+04,,,4.54E+04,1.30E+05,,,1.11E+05,,2.20E+05,9.08E+04,1.28E+05,,9.27E+04,,1.31E+05,,,,2.28E+05,9.18E+02,,,4.19E+02,3.67E+03,,,4.94E+03,,2.97E+04,2.26E+03,2.49E+02,,6.57E+02,,1.40E+03,0,FALSE,9.076,6,3,802,89.9,8.21,3,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00240, Pf00628, Pf02182, Pf12148",115426,hsa:115426; Q5VYR1; Q5VYR3; Q659C8; Q8TAG7; Q96PU4,ENSG00000147854,SUMOylation of transcription cofactors,,1,0,120.98,68.23,49.61,18.18,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,107.7,75.93,37.09,47.96,8.22,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q92599,SEPTIN8,Septin-8 OS=Homo sapiens OX=9606 GN=SEPTIN8 PE=1 SV=4,5,6,0.771,1.035,0.644,2.931,-0.38,0.05,-0.63,1.55,7.75E-01,5.36E-01,5.12E-01,2.67E-01,2.19E+06,1.14E+06,2.26E+06,1.78E+06,2,2,1,3,1.73E+06,,2.76E+06,,,4.57E+05,,,,2.84E+06,2.26E+06,,,,,,1.78E+06,,1.83E+06,1.16E+05,6.88E+03,,2.70E+04,,,1.62E+03,,,,3.02E+04,1.35E+04,,,,,,5.00E+05,,4.28E+04,1.24E+03,0,FALSE,24.522,22,5,483,55.7,6.28,5,cell cycle OR cell proliferation;other biological processes,other membranes;cytoskeleton;ER/Golgi;other cell component,Pf00735,23176,A6NC65; A6NKP6; F6W7K9; hsa:23176; Q8IX36; Q8IX37; Q92599; Q9BVB3,ENSG00000164402,,22q11.2 copy number variation syndrome,1,0,32.31,102.2,,78.52,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,34.79,34.79,89.46,144.11,25.36,other molecular function,0,
Master Protein,High,Q9Y277,VDAC3,Voltage-dependent anion-selective channel protein 3 OS=Homo sapiens OX=9606 GN=VDAC3 PE=1 SV=1,7,116,0.77,0.499,0.422,0.694,-0.38,-1,-1.25,-0.53,6.90E-01,6.30E-01,2.17E-01,8.04E-01,1.17E+07,6.95E+06,6.50E+06,5.14E+06,4,5,5,5,9.93E+06,2.64E+07,,4.23E+06,1.39E+07,6.95E+06,2.28E+06,2.73E+07,4.61E+06,4.38E+07,2.71E+06,1.97E+06,1.07E+07,1.06E+07,6.50E+06,1.96E+07,3.79E+06,2.60E+06,5.14E+06,1.01E+07,3.94E+04,1.00E+05,,4.23E+06,7.16E+05,2.47E+04,4.06E+04,2.52E+05,1.30E+05,4.66E+05,1.62E+04,8.81E+04,8.72E+04,1.43E+06,1.62E+05,3.82E+04,1.07E+06,1.84E+04,1.20E+05,1.08E+05,0,FALSE,36.372,26,6,283,30.6,8.66,7,cell-cell signaling;cell organization and biogenesis;stress response;transport;other biological processes,other membranes;mitochondrion;other cell component,Pf01459,7419,hsa:7419; Q9UIS0; Q9Y277,ENSG00000078668,Ub-specific processing proteases; Mitochondrial calcium ion transport,Alzheimer's disease and miRNA effects; Ferroptosis; Hepatitis B infection; Alzheimer's disease,6,0,69.17,105.92,64.22,84.32,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,128.85,115.24,80.3,107.21,311.31,transporter activity;other molecular function,0,
Master Protein,High,A0A6Q8PGS2,GDAP1,Ganglioside induced differentiation associated protein 1 OS=Homo sapiens OX=9606 GN=GDAP1 PE=1 SV=1,2,2,0.77,0.402,0.16,2.076,-0.38,-1.31,-2.65,1.05,8.41E-01,5.49E-01,9.13E-02,4.66E-01,1.32E+05,1.64E+05,3.21E+04,1.54E+04,4,3,4,1,9.85E+04,1.76E+05,1.96E+05,8.92E+04,,3.36E+05,4.07E+04,1.64E+05,,,1.52E+05,1.38E+04,7.47E+04,6.02E+03,,,1.54E+04,,,,3.91E+02,6.67E+02,1.91E+03,8.92E+04,,1.19E+03,7.23E+02,1.52E+03,,,9.07E+02,6.15E+02,6.06E+02,8.11E+02,,,4.34E+03,,,,0,FALSE,4.268,7,2,384,44.2,8.51,2,,other membranes;cytosol;mitochondrion,"Pf13410, Pf13417",,A0A6Q8PGS2,ENSG00000104381,,Intracellular trafficking proteins involved in CMT neuropathy,1,0,38.52,82.23,109.65,,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,109.9,129.41,145.24,158.63,5.05,,0,
Master Protein,High,C9JPK5,ITGB1,Integrin beta OS=Homo sapiens OX=9606 GN=ITGB1 PE=1 SV=2,10,140,0.768,0.464,0.912,0.867,-0.38,-1.11,-0.13,-0.21,6.88E-01,5.55E-01,8.04E-01,9.60E-01,3.47E+06,6.29E+06,3.53E+06,4.31E+06,5,5,5,5,2.54E+06,2.72E+07,3.06E+06,3.47E+06,4.17E+06,2.63E+06,4.56E+06,2.53E+07,1.14E+07,6.29E+06,3.98E+06,2.48E+06,3.21E+06,5.64E+06,3.53E+06,4.29E+07,6.44E+06,4.31E+06,3.08E+06,4.13E+06,1.01E+04,1.04E+05,2.99E+04,3.47E+06,2.15E+05,9.36E+03,8.10E+04,2.34E+05,3.20E+05,6.69E+04,2.38E+04,1.11E+05,2.61E+04,7.60E+05,8.78E+04,8.37E+04,1.81E+06,3.06E+04,7.20E+04,4.40E+04,0,FALSE,49.925,19,10,809,90,5.59,10,cell adhesion;signal transduction,plasma membrane;other membranes;other cell component,"Pf00362, Pf07965, Pf07974, Pf08725, Pf17205, Pf18372",,C9JPK5,ENSG00000150093,,Neural crest differentiation; Primary focal segmental glomerulosclerosis (FSGS); Mammary gland development pathway - Embryonic development (Stage 1 of 4); RAC1/PAK1/p38/MMP2 pathway; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Genes controlling nephrogenesis; Development of ureteric collection system; Pleural mesothelioma; 11p11.2 copy number variation syndrome ; TAR syndrome; Cell lineage map for neuronal differentiation,15,0,132.37,91.1,31.34,141.51,Peak Found,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,122.34,127.45,130.07,89.07,408.34,other molecular function,0,
Master Protein,High,O00161,SNAP23,Synaptosomal-associated protein 23 OS=Homo sapiens OX=9606 GN=SNAP23 PE=1 SV=1,3,11,0.768,1.018,2.802,0.607,-0.38,0.03,1.49,-0.72,8.68E-01,4.82E-01,3.35E-01,7.92E-01,5.81E+05,4.10E+05,1.26E+06,1.01E+06,5,2,3,5,1.16E+06,5.81E+05,1.53E+06,4.11E+05,2.48E+05,8.77E+05,,,,1.92E+05,,4.49E+05,,1.26E+06,1.45E+06,5.82E+06,9.36E+05,3.02E+06,3.16E+05,1.01E+06,4.63E+03,2.21E+03,1.50E+04,4.11E+05,1.28E+04,3.12E+03,,,,2.04E+03,,2.01E+04,,1.69E+05,3.61E+04,1.14E+04,2.63E+05,2.14E+04,7.40E+03,1.07E+04,0,FALSE,15.884,23,3,211,23.3,5.01,3,cell-cell signaling;cell organization and biogenesis;stress response;transport,plasma membrane;other membranes;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,Pf00835,8773,hsa:8773; O00161; O00162; Q13602; Q6IAE3,ENSG00000092531,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; ER-Phagosome pathway; Translocation of SLC2A4 (GLUT4) to the plasma membrane; RAC3 GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; Neutrophil degranulation; trans-Golgi Network Vesicle Budding,Insulin signaling,13,0,68.77,90.7,50.47,101.64,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,85.42,78.25,122.34,123.16,32.2,other molecular function,0,
Master Protein,High,Q7Z7K6,CENPV,Centromere protein V OS=Homo sapiens OX=9606 GN=CENPV PE=1 SV=1,1,1,0.768,0.146,0.814,0.138,-0.38,-2.77,-0.3,-2.86,8.25E-01,1.14E-01,7.82E-01,1.49E-01,8.25E+04,1.07E+05,1.21E+04,8.75E+04,3,1,1,1,,8.25E+04,,1.45E+04,3.89E+05,,,,,1.07E+05,,,,,1.21E+04,,,,,8.75E+04,,3.14E+02,,1.45E+04,2.01E+04,,,,,1.14E+03,,,,,3.00E+02,,,,,9.32E+02,0.002,FALSE,3.029,5,1,275,29.9,9.73,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf04828,201161,B2RPK2; hsa:201161; Q3L8N5; Q7Z7K6; Q8NFH6,ENSG00000166582,,,0,0,123.12,,,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,116.79,122.2,0,0,2.33,other molecular function,0,
Master Protein,High,P15923,TCF3,Transcription factor E2-alpha OS=Homo sapiens OX=9606 GN=TCF3 PE=1 SV=1,6,7,0.765,0.274,0.108,0.053,-0.39,-1.87,-3.21,-4.24,8.18E-01,3.51E-01,4.04E-02,2.44E-02,8.37E+04,1.79E+05,1.45E+04,7.28E+04,3,4,3,4,,8.37E+04,,7.70E+04,2.43E+05,2.07E+05,1.55E+05,,9.90E+04,3.02E+05,,,4.13E+04,6.69E+03,1.45E+04,2.27E+05,6.91E+03,3.30E+05,2.34E+04,,,3.18E+02,,7.70E+04,1.26E+04,7.38E+02,2.76E+03,,2.79E+03,3.21E+03,,,3.35E+02,9.02E+02,3.60E+02,4.42E+02,1.94E+03,2.34E+03,5.47E+02,,0,FALSE,22.479,19,6,654,67.6,6.47,6,DNA metabolism;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,Pf00010,6929,hsa:6929; P15883; P15923; Q14208; Q14635; Q14636; Q2TB39; Q2TB40; Q9UPI9,ENSG00000071564,RUNX1 regulates transcription of genes involved in differentiation of HSCs; Myogenesis,Ectoderm differentiation; Ectoderm differentiation; Wnt signaling pathway; Wnt/beta-catenin signaling pathway in leukemia; lncRNA in canonical Wnt signaling and colorectal cancer; Neurogenesis regulation in the olfactory epithelium; Sudden infant death syndrome (SIDS) susceptibility pathways,9,0,69.91,45.21,87.13,107.58,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,98.14,79.77,124.22,95.3,22.17,nucleic acid binding activity;other molecular function,0,
Master Protein,High,X6RAB3,USP6NL,USP6 N-terminal like OS=Homo sapiens OX=9606 GN=USP6NL PE=1 SV=1,1,1,0.765,0.579,3.926,0.093,-0.39,-0.79,1.97,-3.42,8.56E-01,7.91E-01,9.51E-02,3.86E-02,4.91E+05,6.42E+05,2.84E+05,3.04E+06,2,2,2,5,,3.43E+06,,7.03E+04,,,8.06E+05,,5.11E+05,,,2.92E+05,2.76E+05,,,1.61E+06,6.42E+04,3.04E+06,1.62E+07,3.29E+06,,1.30E+04,,7.03E+04,,,1.43E+04,,1.44E+04,,,1.31E+04,2.24E+03,,,3.14E+03,1.80E+04,2.15E+04,3.79E+05,3.51E+04,0.005,FALSE,2.514,1,1,851,96.6,9.1,1,,,Pf00566,,X6RAB3,ENSG00000148429,,,0,0,135.73,31.72,3.98,133.86,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,403.5,492.85,85.92,69.74,2.28,,0,
Master Protein,Medium,P42575,CASP2,Caspase-2 OS=Homo sapiens OX=9606 GN=CASP2 PE=1 SV=2,1,1,0.764,1.063,4.967,0.264,-0.39,0.09,2.31,-1.92,7.78E-01,6.48E-01,1.92E-01,3.73E-01,6.16E+04,5.00E+04,6.55E+04,2.48E+05,4,3,2,5,,1.17E+05,3.25E+04,2.40E+04,3.41E+05,,,5.00E+04,1.39E+05,4.67E+04,6.06E+04,,,7.08E+04,,7.24E+05,4.87E+03,5.77E+04,2.48E+05,7.83E+05,,4.44E+02,3.18E+02,2.40E+04,1.76E+04,,,4.61E+02,3.92E+03,4.97E+02,3.62E+02,,,9.54E+03,,1.41E+03,1.37E+03,4.09E+02,5.81E+03,8.34E+03,0.015,FALSE,2.098,3,1,452,50.7,6.81,1,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00619, Pf00656",835,A8K5F9; D3DXD6; E9PDN0; hsa:835; P42575; P42576; Q59F21; Q7KZL6; Q86UJ3; Q9BUP7; Q9BZK9; Q9BZL0,ENSG00000106144,TP53 Regulates Transcription of Caspase Activators and Caspases; NOD1/2 Signaling Pathway; NADE modulates death signalling,Apoptosis modulation and signaling; Parkinson's disease pathway; Apoptosis; Apoptosis modulation by HSP70; Acute viral myocarditis,8,0,114.85,66.75,10.95,101.2,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,100.91,121.38,135.89,145.35,2.35,other molecular function,0,
Master Protein,High,O15294,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Homo sapiens OX=9606 GN=OGT PE=1 SV=3,2,4,0.764,0.404,1.484,0.281,-0.39,-1.31,0.57,-1.83,9.05E-01,4.89E-01,8.10E-01,3.06E-01,3.48E+05,3.38E+05,1.41E+05,5.01E+05,4,2,1,1,5.30E+05,7.57E+05,2.29E+05,8.79E+04,,1.09E+06,,,1.05E+05,,,1.41E+05,,,,5.01E+05,,,,,2.11E+03,2.88E+03,2.23E+03,8.79E+04,,3.87E+03,,,2.95E+03,,,6.28E+03,,,,9.77E+02,,,,,0,FALSE,7.492,4,2,1046,116.9,6.7,2,cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component,"Pf00515, Pf13181, Pf13414, Pf13424, Pf13844",8473,hsa:8473; O15294; Q7Z3K0; Q8WWM8; Q96CC1; Q9UG57,ENSG00000147162,UCH proteinases; Formation of WDR5-containing histone-modifying complexes; Regulation of necroptotic cell death; HATs acetylate histones,Ectoderm differentiation; Ectoderm differentiation; Pleural mesothelioma,8,0,74.97,116.56,,,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,111.1,94.17,215.78,0,11.5,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q08J23,NSUN2,RNA cytosine C(5)-methyltransferase NSUN2 OS=Homo sapiens OX=9606 GN=NSUN2 PE=1 SV=2,2,5,0.763,0.01,2.627,0.01,-0.39,-6.64,1.39,-6.64,8.20E-01,1.00E-17,4.11E-01,1.00E-17,7.66E+04,1.86E+05,,2.29E+05,4,4,,2,4.13E+04,1.42E+05,,2.00E+04,3.17E+05,,2.00E+05,3.48E+05,2.14E+04,1.73E+05,,,,,,,,7.57E+04,,6.93E+05,1.64E+02,5.40E+02,,2.00E+04,1.63E+04,,3.56E+03,3.21E+03,6.02E+02,1.84E+03,,,,,,,,5.36E+02,,7.37E+03,0,FALSE,6.242,4,2,767,86.4,6.77,2,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,non-structural extracellular;cytoskeleton;mitochondrion;nucleus;other cell component,Pf01189,54888,A8K529; B2RNR4; B3KP09; B4DQW2; G3V1R4; hsa:54888; Q08J23; Q9BVN4; Q9H858; Q9NXD9,ENSG00000037474,tRNA modification in the nucleus and cytosol,,1,0,104.1,72.02,,113.57,Peak Found,Peak Found,n/a,High,High,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,1,,FALSE,129.91,,100.53,,9.33,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q14974,KPNB1,Importin subunit beta-1 OS=Homo sapiens OX=9606 GN=KPNB1 PE=1 SV=2,13,39,0.763,0.93,1.087,0.783,-0.39,-0.1,0.12,-0.35,8.55E-01,5.81E-01,9.49E-01,9.46E-01,9.46E+05,1.26E+05,1.69E+06,7.38E+05,5,4,5,5,9.46E+05,1.00E+06,8.01E+05,2.49E+06,7.72E+05,1.83E+05,8.67E+04,,2.05E+04,4.63E+05,2.42E+06,1.25E+06,1.47E+06,3.33E+06,1.69E+06,1.11E+05,4.24E+06,7.38E+05,2.23E+06,3.80E+05,3.76E+03,3.82E+03,7.82E+03,2.49E+06,3.98E+04,6.49E+02,1.54E+03,,5.79E+02,4.92E+03,1.45E+04,5.58E+04,1.20E+04,4.48E+05,4.19E+04,2.17E+02,1.19E+06,5.23E+03,5.21E+04,4.04E+03,0,FALSE,58.097,21,13,876,97.1,4.78,13,cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes,non-structural extracellular;other membranes;cytosol;ER/Golgi;nucleus;other cell component,"Pf00514, Pf03810",3837,B7ZAV6; D3DTT3; hsa:3837; Q14637; Q14974; Q53XN2; Q96J27,ENSG00000108424,Neutrophil degranulation; Apoptosis induced DNA fragmentation; Interferon alpha/beta signaling; ISG15 antiviral mechanism; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Nuclear import of Rev protein; Regulation of cholesterol biosynthesis by SREBP (SREBF); SARS-CoV-1 activates/modulates innate immune responses; Assembly of the ORC complex at the origin of replication; Initiation of Nuclear Envelope (NE) Reformation; Postmitotic nuclear pore complex (NPC) reformation; Inhibition of nitric oxide production,Sterol regulatory element-binding proteins (SREBP) signaling; 22q11.2 copy number variation syndrome,15,0,60.45,103.55,41.69,111.56,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,91.06,91.14,89.13,95.19,106.03,other molecular function,0,
Master Protein,High,Q8N1G4,LRRC47,Leucine-rich repeat-containing protein 47 OS=Homo sapiens OX=9606 GN=LRRC47 PE=1 SV=1,3,9,0.762,0.584,0.683,3.273,-0.39,-0.78,-0.55,1.71,8.97E-01,8.67E-01,6.46E-01,2.91E-01,3.21E+05,2.74E+05,1.09E+05,6.53E+04,5,4,5,4,3.21E+05,1.41E+05,6.18E+05,1.49E+05,4.22E+05,,3.69E+05,3.32E+05,3.29E+04,2.25E+05,4.82E+05,1.41E+05,1.09E+05,7.68E+04,9.93E+04,4.33E+05,1.19E+04,1.41E+05,3.03E+04,,1.27E+03,5.37E+02,6.03E+03,1.49E+05,2.17E+04,,6.56E+03,3.06E+03,9.28E+02,2.40E+03,2.88E+03,6.29E+03,8.82E+02,1.03E+04,2.47E+03,8.44E+02,3.33E+03,9.96E+02,7.10E+02,,0,FALSE,9.845,5,3,583,63.4,8.28,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes,,"Pf00560, Pf13855",57470,hsa:57470; Q8N1G4; Q9ULN5,ENSG00000130764,,,0,0,60.55,62.87,93.46,126.33,Peak Found,Peak Found,High,High,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,138.21,112.89,116.98,137.87,22.64,other molecular function,0,
Master Protein,High,Q9NPL8,TIMMDC1,"Complex I assembly factor TIMMDC1, mitochondrial OS=Homo sapiens OX=9606 GN=TIMMDC1 PE=1 SV=2",1,4,0.762,0.597,0.026,12.181,-0.39,-0.74,-5.25,3.61,8.19E-01,8.56E-01,1.32E-03,2.37E-02,1.10E+05,1.23E+05,6.54E+04,6.06E+03,3,3,5,2,,1.10E+05,,7.55E+04,1.87E+05,,1.23E+05,,5.36E+05,9.91E+04,4.45E+04,6.54E+04,6.28E+04,1.22E+05,9.52E+04,,2.15E+03,,1.71E+04,,,4.16E+02,,7.55E+04,9.62E+03,,2.19E+03,,1.51E+04,1.05E+03,2.66E+02,2.92E+03,5.10E+02,1.65E+04,2.36E+03,,6.03E+02,,4.00E+02,,0.001,FALSE,3.143,6,1,285,32.2,8.5,1,,other membranes;mitochondrion;nucleus,Pf02466,51300,D3DN81; hsa:51300; Q6IAJ7; Q6UWU6; Q9NPL8; Q9NPR3; Q9NPS5; Q9P0Y6,ENSG00000113845,Complex I biogenesis,,1,0,45.96,97.09,39.27,109.81,n/a,Peak Found,n/a,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,73.61,46.4,97.82,110.31,12.33,,0,
Master Protein,High,P09622,DLD,"Dihydrolipoyl dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=DLD PE=1 SV=2",15,175,0.761,0.646,0.856,0.72,-0.39,-0.63,-0.22,-0.47,6.79E-01,9.20E-01,7.42E-01,8.30E-01,1.20E+07,9.34E+06,1.20E+07,1.73E+07,5,5,5,5,6.58E+06,1.20E+07,1.14E+06,1.90E+07,8.52E+07,1.19E+07,3.67E+06,9.34E+06,2.16E+06,1.45E+08,8.16E+06,1.12E+07,1.48E+07,2.23E+07,1.20E+07,2.71E+07,1.03E+07,1.76E+07,8.81E+06,1.73E+07,2.61E+04,4.57E+04,1.11E+04,1.90E+07,4.39E+06,4.23E+04,6.53E+04,8.62E+04,6.10E+04,1.54E+06,4.88E+04,4.99E+05,1.20E+05,3.01E+06,2.98E+05,5.28E+04,2.89E+06,1.25E+05,2.06E+05,1.84E+05,0,FALSE,75.135,36,15,509,54.1,7.85,15,protein metabolism;other metabolic processes;developmental processes;other biological processes,cytoskeleton;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,"Pf02852, Pf07992",1738,B2R5X0; B4DHG0; B4DT69; hsa:1738; P09622; Q14131; Q14167; Q59EV8; Q8WTS4,ENSG00000091140,Lysine catabolism; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid; Citric acid cycle (TCA cycle); Branched-chain amino acid catabolism; Mitochondrial protein degradation; Glycine degradation,Fatty acid beta-oxidation; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Tryptophan metabolism; 7q11.23 copy number variation syndrome; Neuroinflammation and glutamatergic signaling; Glycolysis and gluconeogenesis; 10q11.21q11.23 copy number variation syndrome; Metabolic Epileptic Disorders; TCA cycle (aka Krebs or citric acid cycle),19,0,138.81,180.06,39.29,44.83,Peak Found,High,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,High,1,,FALSE,138.29,120.81,121.88,109.73,475.9,other molecular function,0,
Master Protein,High,Q9UFW8,CGGBP1,CGG triplet repeat-binding protein 1 OS=Homo sapiens OX=9606 GN=CGGBP1 PE=1 SV=2,4,6,0.76,1.067,1.452,0.814,-0.4,0.09,0.54,-0.3,8.52E-01,5.96E-01,8.28E-01,9.92E-01,4.41E+05,4.74E+05,3.30E+05,6.65E+05,5,3,5,3,4.41E+05,2.84E+05,2.98E+04,2.04E+06,6.46E+05,5.55E+05,,,4.74E+05,2.04E+05,3.30E+05,1.63E+05,2.98E+06,5.05E+05,2.96E+05,,1.36E+05,7.30E+05,,6.65E+05,1.75E+03,1.08E+03,2.91E+02,2.04E+06,3.33E+04,1.97E+03,,,1.34E+04,2.17E+03,1.97E+03,7.26E+03,2.42E+04,6.81E+04,7.37E+03,,3.81E+04,5.17E+03,,7.08E+03,0,FALSE,14.983,34,4,167,18.8,8.95,4,cell organization and biogenesis;other biological processes,nucleus,,8545,D3DU38; hsa:8545; O15183; Q9UFW8,ENSG00000163320,,,0,0,114.69,44.74,139.61,63.89,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,78.24,115.85,57.27,112.32,17.96,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O14818,PSMA7,Proteasome subunit alpha type-7 OS=Homo sapiens OX=9606 GN=PSMA7 PE=1 SV=1,6,23,0.76,0.385,2.365,0.155,-0.4,-1.38,1.24,-2.69,7.03E-01,4.00E-01,3.34E-01,1.14E-01,2.55E+06,1.55E+06,1.12E+06,4.42E+06,5,5,5,5,1.19E+06,2.55E+06,2.73E+05,3.01E+06,3.92E+07,3.02E+06,8.19E+05,1.55E+06,7.99E+05,1.45E+07,3.37E+05,2.29E+05,1.12E+06,3.68E+06,3.29E+06,4.71E+06,4.42E+06,1.48E+07,3.87E+06,4.06E+06,4.74E+03,9.69E+03,2.66E+03,3.01E+06,2.02E+06,1.07E+04,1.46E+04,1.43E+04,2.25E+04,1.54E+05,2.02E+03,1.02E+04,9.06E+03,4.96E+05,8.18E+04,9.19E+03,1.24E+06,1.05E+05,9.05E+04,4.33E+04,0,FALSE,19.917,30,6,248,27.9,8.46,6,protein metabolism;other metabolic processes,cytosol;nucleus;other cell component,"Pf00227, Pf10584",5688,B2R515; hsa:5688; O14818; Q5JXJ2; Q9BR53; Q9H4K5; Q9UEU8,ENSG00000101182,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,62,0,181.5,141.6,95,74.05,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,143.37,120.93,122.05,121.67,56.93,other molecular function,0,
Master Protein,High,P63010,AP2B1,AP-2 complex subunit beta OS=Homo sapiens OX=9606 GN=AP2B1 PE=1 SV=1,13,25,0.76,1.041,1.989,0.297,-0.4,0.06,0.99,-1.75,7.64E-01,4.74E-01,4.56E-01,3.17E-01,2.32E+06,9.09E+05,6.50E+05,5.59E+06,5,2,5,4,2.32E+06,2.61E+06,2.42E+06,7.67E+04,4.78E+05,2.09E+06,,,,3.95E+05,5.76E+05,6.50E+05,3.98E+06,1.50E+06,5.06E+05,,8.89E+06,3.20E+06,5.00E+06,6.24E+06,9.20E+03,9.91E+03,2.36E+04,7.67E+04,2.46E+04,7.45E+03,,,,4.20E+03,3.44E+03,2.90E+04,3.24E+04,2.03E+05,1.26E+04,,2.50E+06,2.27E+04,1.17E+05,6.65E+04,0,FALSE,57.887,20,8,937,104.5,5.38,13,transport;developmental processes,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,"Pf01602, Pf02883, Pf09066",163,A6NJP3; hsa:163; P21851; P63010; Q7Z451; Q96J19,ENSG00000006125,"Potential therapeutics for SARS; Recycling pathway of L1; MHC class II antigen presentation; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Nef Mediated CD4 Down-regulation; Retrograde neurotrophin signalling; Nef Mediated CD8 Down-regulation; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation",Synaptic vesicle pathway; GABA receptor signaling; EGF/EGFR signaling pathway; Fragile X syndrome; mBDNF and proBDNF regulation of GABA neurotransmission; Markers of kidney cell lineage; 17q12 copy number variation syndrome,20,3,76.08,96.57,102.24,41.01,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,98.55,119.08,130.07,109.56,83.08,other molecular function,0,
Master Protein,High,A0A0B4J2C3,TPT1,"Tumor protein, translationally-controlled 1 OS=Homo sapiens OX=9606 GN=TPT1 PE=1 SV=1",4,10,0.758,1.493,,0.543,-0.4,0.58,,-0.88,8.06E-01,3.75E-01,,7.00E-01,9.35E+04,1.23E+05,1.79E+05,6.10E+05,2,2,4,3,,,,2.52E+05,3.47E+04,7.74E+04,,,,1.97E+05,1.97E+05,9.89E+04,,4.09E+05,1.63E+05,,1.39E+06,2.40E+05,6.10E+05,,,,,2.52E+05,1.79E+03,2.75E+02,,,,2.09E+03,1.18E+03,4.42E+03,,5.51E+04,4.06E+03,,3.90E+05,1.70E+03,1.43E+04,,0,FALSE,17.983,21,4,197,22.6,5.24,4,,cytosol,Pf00838,7178,A0A0B4J2C3,ENSG00000133112,,,0,0,107.22,61.57,61.87,78.51,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,108.12,122.08,,61.28,30.54,,0,
Master Protein,High,A0A7P0Q1F0,ZNF423,Zinc finger protein 423 OS=Homo sapiens OX=9606 GN=ZNF423 PE=1 SV=1,2,2,0.757,0.657,0.01,100,-0.4,-0.61,-6.64,6.64,8.20E-01,9.28E-01,1.00E-17,1.00E-17,1.55E+05,1.69E+05,8.40E+04,,1,1,1,,,,,1.55E+05,,,,,,1.69E+05,,,,8.40E+04,,,,,,,,,,1.55E+05,,,,,,1.80E+03,,,,1.13E+04,,,,,,,0,FALSE,6.542,3,2,1292,145.4,6.95,2,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,nucleus,"Pf00096, Pf13912",,A0A7P0Q1F0,ENSG00000102935,,Differentiation of white and brown adipocyte; White fat cell differentiation; Joubert syndrome; Ciliopathies,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,0,,,6.14,nucleic acid binding activity,0,
Master Protein,High,P49327,FASN,Fatty acid synthase OS=Homo sapiens OX=9606 GN=FASN PE=1 SV=3,7,10,0.755,0.165,0.649,0.217,-0.41,-2.6,-0.62,-2.21,8.59E-01,1.20E-01,5.24E-01,2.18E-01,1.16E+05,3.21E+05,4.37E+04,7.46E+05,3,4,4,4,1.16E+05,1.84E+05,,,2.20E+04,9.51E+05,2.25E+05,1.79E+05,,4.57E+05,9.87E+04,,2.29E+04,4.83E+03,8.34E+04,7.53E+05,1.44E+06,7.39E+05,1.11E+05,,4.60E+02,7.00E+02,,,1.13E+03,3.38E+03,4.01E+03,1.65E+03,,4.86E+03,5.90E+02,,1.86E+02,6.51E+02,2.07E+03,1.47E+03,4.04E+05,5.24E+03,2.59E+03,,0,FALSE,21.607,3,7,2511,273.3,6.44,7,other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,"Pf00107, Pf00109, Pf00550, Pf00698, Pf00975, Pf02801, Pf08242, Pf08659, Pf16197, Pf21089, Pf21149",2194,hsa:2194; P49327; Q13479; Q16702; Q4LE83; Q6P4U5; Q6SS02; Q969R1; Q96C68; Q96IT0,ENSG00000169710,ChREBP activates metabolic gene expression; Activation of gene expression by SREBF (SREBP); Fatty acyl-CoA biosynthesis; NR1H2 & NR1H3 regulate gene expression linked to lipogenesis; Vitamin B5 (pantothenate) metabolism,AMP-activated protein kinase signaling; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Liver X receptor pathway; Nuclear receptors meta-pathway; Fatty acid biosynthesis; Angiopoietin-like protein 8 regulatory pathway; Lipid metabolism pathway; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-9 fatty acid synthesis; FOXA2 pathway,18,0,75.88,78.05,86.91,71.27,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,51.05,455.8,104.69,110.47,21.55,other molecular function,0,
Master Protein,High,Q32Q12,NME1-NME2,Nucleoside diphosphate kinase OS=Homo sapiens OX=9606 GN=NME1-NME2 PE=1 SV=1,7,35,0.755,1.142,3.433,0.773,-0.41,0.19,1.78,-0.37,8.50E-01,3.62E-01,1.49E-01,8.79E-01,6.76E+05,5.91E+05,1.18E+06,8.37E+06,4,4,5,5,5.46E+05,2.21E+05,,8.36E+05,6.39E+06,7.84E+04,,1.36E+06,2.37E+07,2.57E+05,2.45E+05,6.25E+05,1.52E+06,2.00E+06,1.18E+06,8.15E+07,8.37E+06,1.24E+07,8.59E+05,9.39E+04,2.17E+03,8.39E+02,,8.36E+05,3.30E+05,2.79E+02,,1.25E+04,6.69E+05,2.73E+03,1.47E+03,2.79E+04,1.24E+04,2.69E+05,2.92E+04,1.59E+05,2.35E+06,8.75E+04,2.01E+04,9.99E+02,0,FALSE,27.852,41,2,292,32.6,8.48,7,other metabolic processes,cytosol,Pf00334,,Q32Q12,ENSG00000011052,,,0,6,147.05,182.46,62.6,166.75,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,114.87,127.79,83.2,114.39,77.7,kinase activity;other molecular function,0,
Master Protein,High,A2A288,ZC3H12D,Probable ribonuclease ZC3H12D OS=Homo sapiens OX=9606 GN=ZC3H12D PE=1 SV=3,1,3,0.754,1.67,0.118,8.953,-0.41,0.74,-3.08,3.16,7.59E-01,3.54E-01,4.88E-02,4.77E-02,4.50E+04,5.97E+04,6.32E+04,7.06E+03,2,1,5,1,,,,6.35E+04,3.19E+04,,,,,5.97E+04,1.91E+05,5.07E+04,5.60E+04,6.32E+04,8.17E+04,,,,7.06E+03,,,,,6.35E+04,1.65E+03,,,,,6.34E+02,1.14E+03,2.26E+03,4.55E+02,8.51E+03,2.03E+03,,,,1.65E+02,,0,FALSE,6.472,3,1,527,58,8.68,1,other biological processes,nucleus;other cell component,"Pf11977, Pf18039",340152,A1L178; A2A288; B2RXF4; B7WNU7; B9ZZP9; B9ZZQ0; hsa:340152; Q6ZRW2,ENSG00000178199,,,0,0,46.89,,66.02,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,52.11,65.03,0,29.28,10.14,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O60216,RAD21,Double-strand-break repair protein rad21 homolog OS=Homo sapiens OX=9606 GN=RAD21 PE=1 SV=2,11,23,0.754,0.725,0.658,0.839,-0.41,-0.46,-0.6,-0.25,8.46E-01,8.77E-01,5.22E-01,9.81E-01,9.95E+05,2.99E+05,1.63E+06,8.75E+05,4,5,5,5,,1.01E+06,9.80E+05,5.26E+06,7.88E+05,1.07E+06,2.08E+05,1.58E+06,2.99E+05,2.25E+05,1.63E+06,4.99E+05,1.37E+06,3.32E+06,2.85E+06,5.31E+05,9.66E+04,2.24E+06,8.75E+05,1.35E+06,,3.84E+03,9.57E+03,5.26E+06,4.06E+04,3.79E+03,3.70E+03,1.45E+04,8.43E+03,2.40E+03,9.76E+03,2.23E+04,1.11E+04,4.48E+05,7.07E+04,1.03E+03,2.71E+04,1.59E+04,2.05E+04,1.44E+04,0,FALSE,43.627,28,11,631,71.6,4.65,11,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf04824, Pf04825",5885,A8K0E0; hsa:5885; O60216; Q15001; Q99568,ENSG00000164754,Meiotic synapsis; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,Cell cycle; Prion disease pathway; Regulation of sister chromatid separation at the metaphase-anaphase transition; Cohesin complex - Cornelia de Lange syndrome; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; 10q22q23 copy number variation,13,0,107.97,91.53,59.09,80.81,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,114.7,105.38,126.03,129.45,64.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P25325,MPST,3-mercaptopyruvate sulfurtransferase OS=Homo sapiens OX=9606 GN=MPST PE=1 SV=3,2,2,0.753,0.137,1.534,0.067,-0.41,-2.87,0.62,-3.9,8.14E-01,9.87E-02,7.70E-01,4.31E-02,1.04E+05,1.38E+05,1.42E+04,2.11E+05,2,1,1,4,,,,6.10E+04,1.76E+05,,,1.38E+05,,,,,,1.42E+04,,1.46E+05,6.38E+03,3.05E+05,,5.38E+05,,,,6.10E+04,9.10E+03,,,1.27E+03,,,,,,1.91E+03,,2.86E+02,1.79E+03,2.16E+03,,5.73E+03,0,FALSE,7.16,9,2,297,33.2,6.6,2,other metabolic processes;developmental processes;other biological processes,mitochondrion;other cell component,Pf00581,4357,A8MZ34; B3KP52; hsa:4357; J3KPV7; O75750; P25325; Q6FHN9,ENSG00000128309,Degradation of cysteine and homocysteine,Trans-sulfuration pathway; Amino acid metabolism,3,0,68.75,,,91.66,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,82.47,82.47,104.7,104.7,5.67,other molecular function,0,
Master Protein,High,P46013,MKI67,Proliferation marker protein Ki-67 OS=Homo sapiens OX=9606 GN=MKI67 PE=1 SV=2,16,22,0.753,0.524,0.375,3.158,-0.41,-0.93,-1.42,1.66,8.92E-01,7.27E-01,2.54E-01,1.84E-01,4.25E+05,2.11E+05,2.93E+05,2.45E+05,4,3,5,4,1.01E+05,1.18E+06,,7.50E+05,2.41E+05,2.11E+05,,5.63E+04,,1.04E+06,4.43E+04,6.36E+04,2.93E+05,6.79E+05,7.44E+05,,1.43E+05,4.19E+05,4.59E+05,6.85E+04,4.01E+02,4.48E+03,,7.50E+05,1.24E+04,7.50E+02,,5.19E+02,,1.11E+04,2.65E+02,2.84E+03,2.38E+03,9.15E+04,1.85E+04,,4.02E+04,2.97E+03,1.08E+04,7.29E+02,0,FALSE,58.171,9,16,3256,358.5,9.45,16,cell cycle OR cell proliferation;other biological processes,nucleus;other cell component,"Pf00498, Pf08065, Pf15276",4288,hsa:4288; P46013; Q5VWH2,ENSG00000148773,,Primary focal segmental glomerulosclerosis (FSGS),1,0,87.01,121.53,91.01,71.8,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,108.69,101.97,109.89,123.19,53.24,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P04424,ASL,Argininosuccinate lyase OS=Homo sapiens OX=9606 GN=ASL PE=1 SV=4,1,1,0.753,0.01,0.185,0.01,-0.41,-6.64,-2.43,-6.64,7.50E-01,1.00E-17,1.30E-01,1.00E-17,2.25E+04,2.99E+04,,5.54E+03,2,1,,2,,,,7.01E+03,7.21E+04,,,,,2.99E+04,,,,,,,2.96E+03,,1.04E+04,,,,,7.01E+03,3.72E+03,,,,,3.17E+02,,,,,,,8.31E+02,,2.42E+02,,0.004,FALSE,2.555,3,1,464,51.6,6.48,1,other metabolic processes;developmental processes;other biological processes,cytosol;other cell component,"Pf00206, Pf14698",435,E7EMI0; E9PE48; hsa:435; P04424; Q6LDS5; Q96HS2,ENSG00000126522,Urea cycle,Alanine and aspartate metabolism,2,0,116.35,,,78.59,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,214.56,,99.1,,0,other molecular function,0,
Master Protein,High,Q9H4L7,SMARCAD1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens OX=9606 GN=SMARCAD1 PE=1 SV=2,1,2,0.752,0.682,0.131,3.914,-0.41,-0.55,-2.93,1.97,7.57E-01,9.64E-01,6.53E-02,2.18E-01,3.35E+04,4.45E+04,2.29E+04,5.84E+03,2,3,3,1,,,,3.38E+04,3.32E+04,,,3.88E+04,1.02E+06,4.45E+04,,2.19E+04,,8.76E+04,2.29E+04,,5.84E+03,,,,,,,3.38E+04,1.71E+03,,,3.58E+02,2.88E+04,4.74E+02,,9.76E+02,,1.18E+04,5.68E+02,,1.64E+03,,,,0.001,FALSE,4.205,2,1,1026,117.3,5.55,1,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;stress response;other biological processes,nucleus;other cell component,"Pf00176, Pf00271",56916,B7Z799; hsa:56916; Q05D56; Q96SX1; Q9H017; Q9H4L7; Q9H860; Q9NPU9; Q9ULU7,ENSG00000163104,,,0,0,1.13,153.61,85.45,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,19.02,6.8,19.02,6.5,5.69,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BYC5,FUT8,"Alpha-(1,6)-fucosyltransferase OS=Homo sapiens OX=9606 GN=FUT8 PE=1 SV=2",1,1,0.751,0.566,1.304,0.326,-0.41,-0.82,0.38,-1.62,8.47E-01,8.02E-01,8.76E-01,4.04E-01,4.49E+05,5.98E+05,2.54E+05,7.80E+05,2,1,1,1,,8.55E+05,,2.36E+05,,5.98E+05,,,,,,,,2.54E+05,,7.80E+05,,,,,,3.25E+03,,2.36E+05,,2.13E+03,,,,,,,,3.43E+04,,1.52E+03,,,,,0.001,FALSE,3.29,2,1,575,66.5,7.66,1,protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,other membranes;ER/Golgi,"Pf14604, Pf19745",2530,B4DFS7; G3V5N0; hsa:2530; O00235; Q8IUA5; Q9BYC5; Q9BYC6; Q9P2U5; Q9P2U6,ENSG00000033170,Reactions specific to the complex N-glycan synthesis pathway; Maturation of spike protein,MECP2 and associated Rett syndrome; N-glycan biosynthesis,4,0,80.18,,,,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,102.04,102.04,0,0,2.45,other molecular function,0,
Master Protein,High,P34897,SHMT2,"Serine hydroxymethyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=SHMT2 PE=1 SV=3",9,32,0.751,1.111,1.092,1.549,-0.41,0.15,0.13,0.63,6.69E-01,4.84E-01,9.85E-01,6.42E-01,3.05E+06,2.76E+06,2.96E+06,2.03E+06,5,4,5,4,3.05E+06,4.84E+06,8.21E+05,5.81E+06,1.81E+06,4.74E+06,3.00E+06,,7.73E+05,2.53E+06,8.07E+05,2.80E+06,6.24E+06,4.19E+06,2.96E+06,7.04E+05,2.55E+06,5.46E+06,1.62E+06,,1.21E+04,1.84E+04,8.02E+03,5.81E+06,9.31E+04,1.69E+04,5.33E+04,,2.18E+04,2.69E+04,4.82E+03,1.25E+05,5.07E+04,5.65E+05,7.34E+04,1.37E+03,7.17E+05,3.87E+04,3.78E+04,,0,FALSE,39.195,25,9,504,56,8.53,9,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component,Pf00464,6472,B7Z9F1; E7EQ19; E7EU43; hsa:6472; O00740; P34897; Q8N1A5,ENSG00000182199,RHOG GTPase cycle; Mitochondrial protein degradation; Metabolism of folate and pterines,"Glycine metabolism; Vitamin B12 metabolism; Folate metabolism; One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; One-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Neuroinflammation and glutamatergic signaling; Metabolic Epileptic Disorders",13,0,63.3,59.06,58.79,79.78,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,115.28,123.35,108.45,88.44,87.31,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P19256,CD58,Lymphocyte function-associated antigen 3 OS=Homo sapiens OX=9606 GN=CD58 PE=1 SV=1,1,1,0.751,0.524,1.052,0.374,-0.41,-0.93,0.07,-1.42,8.44E-01,6.95E-01,9.42E-01,4.83E-01,4.98E+05,6.63E+05,2.61E+05,6.98E+05,1,1,3,1,,,,,4.98E+05,6.63E+05,,,,,,2.21E+05,,3.10E+05,2.61E+05,6.98E+05,,,,,,,,,2.57E+04,2.36E+03,,,,,,9.89E+03,,4.18E+04,6.48E+03,1.36E+03,,,,,0.002,FALSE,2.99,4,1,250,28.1,6.76,1,cell adhesion;stress response;other biological processes,plasma membrane;other membranes;other cell component,,965,A8K7G5; hsa:965; P19256; Q5U053; Q6IB65; Q96KI9,ENSG00000116815,Cell surface interactions at the vascular wall; Neutrophil degranulation,,2,0,,,16.84,,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,0,23.64,0,23.64,3.06,signal transduction activity or receptor binding,0,
Master Protein,High,Q15393,SF3B3,Splicing factor 3B subunit 3 OS=Homo sapiens OX=9606 GN=SF3B3 PE=1 SV=4,18,33,0.747,0.48,0.829,0.641,-0.42,-1.06,-0.27,-0.64,6.64E-01,5.90E-01,7.44E-01,7.43E-01,6.06E+06,9.65E+05,2.38E+06,2.03E+06,5,4,5,5,2.34E+06,6.06E+06,1.71E+06,1.36E+07,1.13E+07,1.24E+07,,5.49E+05,2.29E+05,1.70E+06,2.38E+06,2.93E+06,2.75E+05,7.36E+06,2.29E+05,2.03E+06,2.78E+05,8.15E+06,1.59E+06,5.73E+06,9.31E+03,2.30E+04,1.67E+04,1.36E+07,5.85E+05,4.42E+04,,5.06E+03,6.46E+03,1.80E+04,1.43E+04,1.31E+05,2.23E+03,9.91E+05,5.69E+03,3.96E+03,7.81E+04,5.78E+04,3.72E+04,6.10E+04,0,FALSE,73.461,23,18,1217,135.5,5.26,18,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf03178, Pf10433",23450,hsa:23450; Q15393; Q6NTI8; Q96GC0; Q9BPY2; Q9UFX7; Q9UJ29,ENSG00000189091,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing,3,0,75.72,156.66,110.35,91.93,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,104.19,97.79,96.12,95.32,101.77,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q00059,TFAM,"Transcription factor A, mitochondrial OS=Homo sapiens OX=9606 GN=TFAM PE=1 SV=1",6,35,0.747,1.965,1.048,2.355,-0.42,0.97,0.07,1.24,7.82E-01,1.23E-01,9.57E-01,4.03E-01,1.38E+06,4.51E+05,6.77E+06,1.35E+06,5,5,5,5,3.66E+05,1.38E+06,3.82E+05,9.03E+06,2.38E+06,3.10E+05,4.51E+05,1.50E+06,3.62E+05,3.38E+06,7.94E+05,6.77E+06,3.76E+06,7.66E+06,7.60E+06,1.35E+06,1.00E+06,2.42E+06,9.30E+05,2.97E+06,1.45E+03,5.23E+03,3.74E+03,9.03E+06,1.23E+05,1.10E+03,8.03E+03,1.38E+04,1.02E+04,3.60E+04,4.75E+03,3.03E+05,3.05E+04,1.03E+06,1.89E+05,2.62E+03,2.81E+05,1.72E+04,2.18E+04,3.16E+04,0,FALSE,27.574,26,6,246,29.1,9.72,6,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;mitochondrion;other cell component,"Pf00505, Pf09011",7019,A8MRB2; A9QXC6; B5BU05; hsa:7019; Q00059; Q5U0C6,ENSG00000108064,Mitochondrial transcription initiation; Transcriptional activation of mitochondrial biogenesis; Mitochondrial protein degradation,"Energy metabolism; NAD metabolism, sirtuins and aging; VEGFA-VEGFR2 signaling; Mitochondrial gene expression; Orexin receptor pathway; Sildenafil treatment",9,0,134.17,109.44,56.21,52.65,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,72.2,105.64,124.15,126.7,96.99,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O76021,RSL1D1,Ribosomal L1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RSL1D1 PE=1 SV=3,7,11,0.744,0.653,1.049,1.743,-0.43,-0.62,0.07,0.8,8.55E-01,9.39E-01,8.79E-01,4.92E-01,1.96E+05,1.97E+05,5.52E+05,3.71E+05,5,3,3,4,1.55E+05,1.96E+05,2.53E+04,1.20E+06,5.58E+05,4.94E+05,,4.55E+04,,1.97E+05,1.15E+05,1.89E+06,,5.52E+05,,,1.72E+05,6.67E+05,1.96E+06,2.06E+05,6.16E+02,7.46E+02,2.47E+02,1.20E+06,2.88E+04,1.76E+03,,4.20E+02,,2.09E+03,6.90E+02,8.46E+04,,7.43E+04,,,4.85E+04,4.72E+03,4.59E+04,2.20E+03,0,FALSE,23.115,17,7,490,54.9,10.13,7,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,Pf00687,26156,B4DJ58; D3DUG7; hsa:26156; O76021; Q2M1T7; Q6PL22; Q8IWS7; Q8WUZ1; Q9HDA9; Q9Y3Z9,ENSG00000171490,,,0,0,111.34,92.98,108.59,111.38,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,82.2,141.38,0,119.47,32.93,nucleic acid binding activity,0,
Master Protein,High,O95573,ACSL3,Fatty acid CoA ligase Acsl3 OS=Homo sapiens OX=9606 GN=ACSL3 PE=1 SV=3,3,5,0.743,0.202,0.399,0.578,-0.43,-2.31,-1.32,-0.79,8.35E-01,1.23E-01,2.42E-01,7.58E-01,3.19E+05,8.13E+05,3.57E+05,2.41E+05,3,1,4,2,,3.19E+05,,6.05E+05,2.43E+05,,,,,8.13E+05,,1.62E+04,2.88E+05,5.42E+05,4.44E+05,,3.25E+05,,1.79E+05,,,1.21E+03,,6.05E+05,1.25E+04,,,,,8.65E+03,,7.23E+02,2.34E+03,7.30E+04,1.10E+04,,9.13E+04,,4.19E+03,,0,FALSE,8.569,7,3,720,80.4,8.38,3,cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes,plasma membrane;other membranes;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00501,2181,hsa:2181; O95573; Q60I92; Q8IUM9,ENSG00000123983,Synthesis of very long-chain fatty acyl-CoAs; Intracellular metabolism of fatty acids regulates insulin secretion,Fatty acid beta-oxidation; Fatty acid biosynthesis; Mitochondrial long chain fatty acid beta-oxidation; PPAR signaling pathway; Ferroptosis; Thermogenesis; Ciliary landscape; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-3 / omega-6 fatty acid synthesis; Omega-9 fatty acid synthesis; Fatty acid transporters; Mitochondrial fatty acid oxidation disorders,14,0,49.03,,71.14,40.93,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,125.61,0,97.68,16.31,other molecular function,0,
Master Protein,High,Q9BZE4,GTPBP4,GTP-binding protein 4 OS=Homo sapiens OX=9606 GN=GTPBP4 PE=1 SV=3,2,2,0.743,0.358,0.488,0.545,-0.43,-1.48,-1.04,-0.88,8.48E-01,4.34E-01,4.52E-01,7.43E-01,1.84E+05,2.48E+05,6.58E+04,1.21E+05,2,1,1,1,,,,2.02E+05,1.67E+05,,,,,2.48E+05,,,,,6.58E+04,,,,1.21E+05,,,,,2.02E+05,8.63E+03,,,,,2.63E+03,,,,,1.63E+03,,,,2.82E+03,,0,FALSE,10.612,6,2,634,73.9,9.5,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,other membranes;cytosol;nucleus;other cell component,"Pf06858, Pf08155, Pf17835",23560,B3KMC5; B4DY13; B7Z7A3; hsa:23560; O95446; Q5T3R8; Q9BZE4; Q9NVJ8,ENSG00000107937,,,0,0,13.36,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,14.07,14.07,0,0,7.27,other molecular function,0,
Master Protein,High,Q96FI4,NEIL1,Endonuclease 8-like 1 OS=Homo sapiens OX=9606 GN=NEIL1 PE=1 SV=3,6,8,0.743,1.491,0.01,100,-0.43,0.58,-6.64,6.64,8.31E-01,2.85E-01,1.00E-17,1.00E-17,1.41E+05,2.09E+05,8.87E+05,,4,4,2,,,1.46E+05,9.57E+04,9.32E+05,1.36E+05,,1.83E+05,5.73E+05,2.38E+05,1.01E+05,,7.38E+05,,1.07E+06,,,,,,,,5.55E+02,9.35E+02,9.32E+05,7.03E+03,,3.26E+03,5.28E+03,6.70E+03,1.07E+03,,3.30E+04,,1.44E+05,,,,,,,0,FALSE,25.252,26,6,390,43.7,9.92,6,DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf01149, Pf09292",79661,D3DW75; hsa:79661; Q6ZRA7; Q86XW7; Q96FI4; Q9H6C3,ENSG00000140398,Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway; Defective Base Excision Repair Associated with NEIL1,,4,0,123.2,75.66,25.66,,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,83.21,81.29,,,25.06,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P07686,HEXB,Beta-hexosaminidase subunit beta OS=Homo sapiens OX=9606 GN=HEXB PE=1 SV=4,5,20,0.743,3.668,0.702,2.711,-0.43,1.87,-0.51,1.44,8.37E-01,1.40E-02,6.11E-01,2.88E-01,4.35E+05,6.93E+05,8.63E+05,5.54E+05,4,4,5,5,,6.41E+05,2.95E+05,7.83E+05,1.04E+05,6.93E+06,,3.81E+05,5.93E+05,8.10E+05,7.61E+04,8.63E+05,7.59E+05,4.12E+06,1.56E+06,1.72E+05,3.39E+05,9.22E+05,5.54E+05,1.64E+06,,2.43E+03,2.88E+03,7.83E+05,5.35E+03,2.46E+04,,3.52E+03,1.67E+04,8.62E+03,4.55E+02,3.85E+04,6.17E+03,5.55E+05,3.88E+04,3.36E+02,9.51E+04,6.53E+03,1.30E+04,1.75E+04,0,FALSE,18.091,13,5,556,63.1,6.76,5,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,non-structural extracellular;other cytoplasmic organelle;other cell component,"Pf00728, Pf14845",3074,hsa:3074; P07686,ENSG00000049860,Neutrophil degranulation; CS/DS degradation; Hyaluronan uptake and degradation; Glycosphingolipid catabolism; Keratan sulfate degradation; Defective HEXB causes GM2G2,Glycosaminoglycan degradation,7,0,68.36,145.63,106.32,80.43,n/a,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,74.28,72.87,115.96,112.31,45.92,other molecular function,0,
Master Protein,High,P49753,ACOT2,"Acyl-coenzyme A thioesterase 2, mitochondrial OS=Homo sapiens OX=9606 GN=ACOT2 PE=1 SV=6",3,7,0.741,1.674,2.188,3.869,-0.43,0.74,1.13,1.95,8.92E-01,2.53E-01,5.28E-01,1.26E-01,3.57E+05,3.04E+05,1.38E+05,4.03E+05,2,5,2,4,,,,4.72E+05,2.71E+05,2.64E+05,3.04E+05,5.55E+05,1.28E+05,3.76E+05,,4.68E+05,,,4.05E+04,,8.15E+03,1.22E+06,1.90E+05,8.56E+05,,,,4.72E+05,1.40E+04,9.39E+02,5.41E+03,5.13E+03,3.62E+03,4.00E+03,,2.09E+04,,,1.01E+03,,2.29E+03,8.62E+03,4.44E+03,9.11E+03,0,FALSE,13.158,8,3,483,53.2,8.47,3,other metabolic processes,cytosol;mitochondrion;other cytoplasmic organelle,"Pf04775, Pf08840",10965,hsa:10965; P49753; Q3I5F8; Q53EK4; Q9NUX4,ENSG00000119673,Mitochondrial protein degradation; Peroxisomal protein import; Mitochondrial Fatty Acid Beta-Oxidation,Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-3 / omega-6 fatty acid synthesis; Omega-9 fatty acid synthesis; Linoleic acid metabolism affected by SARS-CoV-2,7,0,38.25,48.19,118.87,99.64,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,39.24,72.32,99.53,90.21,17.63,other molecular function,0,
Master Protein,High,E9PAV3,NACA,"Nascent polypeptide-associated complex subunit alpha, muscle-specific form OS=Homo sapiens OX=9606 GN=NACA PE=1 SV=1",3,14,0.741,0.651,1.267,0.426,-0.43,-0.62,0.34,-1.23,8.36E-01,8.93E-01,7.91E-01,6.08E-01,4.51E+05,8.80E+05,3.97E+05,1.11E+06,2,2,5,4,6.52E+05,,,3.11E+05,,1.70E+06,,,,4.56E+05,3.97E+05,8.92E+05,2.24E+05,1.53E+06,1.06E+05,8.31E+05,1.74E+06,1.50E+06,6.52E+05,,2.59E+03,,,3.11E+05,,6.04E+03,,,,4.85E+03,2.38E+03,3.99E+04,1.82E+03,2.06E+05,2.63E+03,1.62E+03,4.90E+05,1.06E+04,1.53E+04,,0,FALSE,15.19,2,3,2078,205.3,9.58,3,other biological processes,translational apparatus;nucleus;other cell component,"Pf01849, Pf19026",,E9PAV3,ENSG00000196531,,,0,0,50.02,81.56,92.97,44.25,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,n/a,1,,FALSE,104.67,83.99,78,76.17,44.7,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8Q3WL20,CYBA,Cytochrome b-245 light chain OS=Homo sapiens OX=9606 GN=CYBA PE=1 SV=1,1,13,0.74,0.49,11.632,0.033,-0.43,-1.03,3.54,-4.91,8.24E-01,6.74E-01,2.71E-03,3.25E-03,6.82E+05,9.22E+05,3.34E+05,1.07E+07,1,1,2,3,,,,,6.82E+05,9.22E+05,,,,,,1.11E+05,,1.01E+06,,7.79E+06,,1.30E+07,,1.07E+07,,,,,3.52E+04,3.28E+03,,,,,,4.94E+03,,1.36E+05,,1.52E+04,,9.19E+04,,1.14E+05,0.001,FALSE,3.84,6,1,204,22.1,9.54,1,,plasma membrane;other membranes,Pf05038,,A0A8Q3WL20,ENSG00000051523,,Microglia pathogen phagocytosis pathway; Genetic causes of porto-sinusoidal vascular disease,2,0,,,113.46,24.73,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,High,n/a,High,1,,FALSE,0,199.26,31.06,154.46,33.99,other molecular function,0,
Master Protein,High,O43829,ZBTB14,Zinc finger and BTB domain-containing protein 14 OS=Homo sapiens OX=9606 GN=ZBTB14 PE=1 SV=2,1,1,0.738,0.225,0.325,0.512,-0.44,-2.15,-1.62,-0.97,7.54E-01,2.73E-01,2.88E-01,7.12E-01,4.70E+04,6.37E+04,1.06E+04,2.07E+04,2,1,1,2,,,,6.74E+04,3.28E+04,6.37E+04,,,,,,,,,1.06E+04,,6.42E+03,6.67E+04,,,,,,6.74E+04,1.69E+03,2.26E+02,,,,,,,,,2.63E+02,,1.80E+03,4.72E+02,,,0,FALSE,4.807,3,1,449,50.9,6.04,1,developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00096, Pf00651",7541,hsa:7541; O00403; O43829; Q2TB80,ENSG00000198081,,,0,0,48.92,,,116.56,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,54.66,54.66,215.81,215.81,2.35,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P40938,RFC3,Replication factor C subunit 3 OS=Homo sapiens OX=9606 GN=RFC3 PE=1 SV=2,4,16,0.737,0.911,0.639,2.326,-0.44,-0.13,-0.65,1.22,8.39E-01,7.24E-01,6.07E-01,2.93E-01,1.90E+05,2.46E+05,4.16E+05,1.45E+05,5,3,5,3,1.90E+05,1.24E+05,5.57E+05,9.09E+05,1.29E+05,,2.46E+05,,8.88E+04,5.18E+05,1.40E+06,2.72E+05,3.09E+05,1.07E+06,4.16E+05,,1.45E+05,6.00E+05,1.01E+05,,7.56E+02,4.70E+02,5.44E+03,9.09E+05,6.66E+03,,4.38E+03,,2.50E+03,5.51E+03,8.35E+03,1.22E+04,2.51E+03,1.44E+05,1.03E+04,,4.06E+04,4.26E+03,2.36E+03,,0,FALSE,16.253,19,4,356,40.5,8.34,4,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf13177,5983,C9JU95; hsa:5983; O15252; P40938; Q5W0E8,ENSG00000133119,Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,"Gastric cancer network 2; Retinoblastoma gene in cancer; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",28,0,90.34,76.36,73.52,98.14,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,High,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,130.93,132.05,74.85,140.69,40.19,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A5K1VW95,MDH1,Malate dehydrogenase OS=Homo sapiens OX=9606 GN=MDH1 PE=1 SV=1,2,5,0.736,2.297,2.055,0.699,-0.44,1.2,1.04,-0.52,7.57E-01,1.94E-01,5.76E-01,9.48E-01,7.37E+04,8.06E+04,1.21E+05,1.76E+05,5,2,4,4,7.37E+04,7.58E+04,2.10E+04,2.43E+05,4.78E+04,,8.80E+04,7.39E+04,,,7.34E+04,,1.18E+05,4.33E+05,1.23E+05,,1.73E+05,6.50E+04,1.82E+05,1.79E+05,2.93E+02,2.88E+02,2.05E+02,2.43E+05,2.47E+03,,1.56E+03,6.82E+02,,,4.39E+02,,9.59E+02,5.84E+04,3.06E+03,,4.86E+04,4.61E+02,4.27E+03,1.91E+03,0,FALSE,10.927,9,2,353,38.6,7.3,2,other metabolic processes,cytosol;cytoskeleton,"Pf00056, Pf02866",4190,A0A5K1VW95,ENSG00000014641,,Sterol regulatory element-binding proteins (SREBP) signaling; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Clear cell renal cell carcinoma pathways; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; TCA cycle in senescence; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; HDAC6 interactions in the central nervous system,9,0,94.48,12.3,88.63,37.85,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,40.31,49.25,23.7,43.51,12.93,other molecular function,0,
Master Protein,High,E9PQ57,RAE1,Ribonucleic acid export 1 OS=Homo sapiens OX=9606 GN=RAE1 PE=1 SV=1,8,15,0.736,0.409,0.01,100,-0.44,-1.29,-6.64,6.64,8.51E-01,5.32E-01,1.00E-17,1.00E-17,1.91E+05,2.62E+05,1.14E+05,,4,4,5,,5.54E+04,2.53E+05,1.45E+05,1.92E+06,,5.27E+05,,6.01E+06,6.03E+04,1.31E+05,1.14E+05,2.39E+05,4.03E+04,2.81E+05,7.62E+04,,,,,,2.20E+02,9.61E+02,1.41E+03,1.92E+06,,1.87E+03,,5.54E+04,1.70E+03,1.39E+03,6.80E+02,1.07E+04,3.28E+02,3.79E+04,1.89E+03,,,,,,0,FALSE,40.637,23,8,437,47.8,8.07,8,,,Pf00400,,E9PQ57,ENSG00000101146,,SARS-CoV-2 innate immunity evasion and cell-specific immune response,1,0,149.66,171.97,69.83,,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,124.58,87.68,,,49.15,,0,
Master Protein,High,Q9Y6Y8,SEC23IP,SEC23-interacting protein OS=Homo sapiens OX=9606 GN=SEC23IP PE=1 SV=1,1,1,0.734,0.623,0.731,0.625,-0.45,-0.68,-0.45,-0.68,7.29E-01,9.66E-01,7.64E-01,8.27E-01,1.95E+04,2.66E+04,1.22E+04,1.95E+04,2,2,3,1,,,2.22E+04,1.72E+04,,,1.98E+04,3.59E+04,,,1.18E+05,1.22E+04,,9.45E+03,,,1.95E+04,,,,,,2.17E+02,1.72E+04,,,3.52E+02,3.31E+02,,,7.04E+02,5.43E+02,,1.27E+03,,,5.47E+03,,,,0.001,FALSE,3.835,2,1,1000,111,5.54,1,cell organization and biogenesis;transport,other membranes;cytosol;ER/Golgi;other cell component,"Pf00536, Pf02825, Pf02862",11196,D3DRD2; hsa:11196; Q8IXH5; Q9BUK5; Q9Y6Y8,ENSG00000107651,COPII-mediated vesicle transport,,1,0,17.89,40.91,132.91,,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,39.46,44.47,44.81,42.49,3.53,other molecular function,0,
Master Protein,High,P16444,DPEP1,Dipeptidase 1 OS=Homo sapiens OX=9606 GN=DPEP1 PE=1 SV=3,6,44,0.731,1.197,1.307,1.02,-0.45,0.26,0.39,0.03,6.47E-01,4.18E-01,8.34E-01,9.25E-01,3.33E+06,2.69E+06,8.08E+06,2.68E+06,5,5,5,5,2.63E+06,2.48E+07,3.33E+06,3.11E+06,2.53E+07,2.69E+06,1.31E+06,2.81E+06,2.68E+05,2.87E+06,1.66E+07,5.23E+06,1.23E+06,1.95E+07,8.08E+06,5.43E+06,2.81E+05,2.68E+06,1.42E+06,4.61E+06,1.05E+04,9.41E+04,3.25E+04,3.11E+06,1.30E+06,9.58E+03,2.33E+04,2.59E+04,7.54E+03,3.05E+04,9.94E+04,2.34E+05,9.99E+03,2.62E+06,2.01E+05,1.06E+04,7.90E+04,1.90E+04,3.33E+04,4.90E+04,0,FALSE,39.31,22,6,411,45.6,6.15,6,protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;nucleus;other cell component,Pf01244,1800,D3DX80; hsa:1800; P16444; Q96AK2,ENSG00000015413,Aflatoxin activation and detoxification; Synthesis of Leukotrienes (LT) and Eoxins (EX); LTC4-CYSLTR mediated IL4 production,Eicosanoid metabolism via lipooxygenases (LOX); Leukotriene metabolic pathway; Omega-6-fatty acids in senescence,6,0,101.95,58.22,76,74.39,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,128.18,133.47,132.28,121.38,140.98,enzyme regulator activity;other molecular function,0,
Master Protein,High,P16452,EPB42,Protein 4.2 OS=Homo sapiens OX=9606 GN=EPB42 PE=1 SV=3,22,100,0.73,0.189,1.047,0.098,-0.45,-2.41,0.07,-3.35,6.46E-01,5.51E-02,9.42E-01,4.71E-02,2.52E+07,2.24E+07,1.21E+06,2.12E+07,5,5,5,5,6.27E+07,2.52E+07,3.46E+07,8.20E+04,8.70E+05,2.24E+07,4.20E+06,2.44E+07,2.31E+07,6.60E+06,2.46E+07,4.74E+05,1.21E+06,1.23E+06,4.29E+05,2.16E+07,2.12E+07,2.68E+07,9.07E+06,1.22E+07,2.49E+05,9.58E+04,3.39E+05,8.20E+04,4.49E+04,7.98E+04,7.47E+04,2.25E+05,6.51E+05,7.02E+04,1.47E+05,2.12E+04,9.83E+03,1.66E+05,1.07E+04,4.22E+04,5.97E+06,1.90E+05,2.12E+05,1.29E+05,0,FALSE,101.513,42,21,691,77,8.09,22,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,plasma membrane;other membranes;cytoskeleton,"Pf00868, Pf00927, Pf01841",2038,hsa:2038; P16452; Q4KKX0; Q4VB97,ENSG00000166947,,,0,1,105.5,61.16,190.24,40.29,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,129.67,143.65,119.11,108.39,242.22,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9Y2Q3,GSTK1,Glutathione S-transferase kappa 1 OS=Homo sapiens OX=9606 GN=GSTK1 PE=1 SV=3,6,24,0.729,0.865,,0.339,-0.46,-0.21,,-1.56,7.28E-01,7.36E-01,,3.62E-01,1.85E+06,3.02E+05,2.84E+06,1.37E+06,4,4,5,4,2.08E+06,1.64E+06,,4.45E+06,1.34E+06,7.72E+05,2.79E+05,3.27E+05,,1.41E+05,4.79E+05,3.15E+06,1.57E+06,2.84E+06,3.08E+06,,8.77E+05,2.83E+06,4.61E+05,2.15E+06,8.26E+03,6.25E+03,,4.45E+06,6.89E+04,2.74E+03,4.97E+03,3.02E+03,,1.50E+03,2.87E+03,1.41E+05,1.27E+04,3.83E+05,7.64E+04,,2.47E+05,2.01E+04,1.08E+04,2.29E+04,0,FALSE,28.102,39,6,226,25.5,8.41,6,other metabolic processes;other biological processes,cytosol;mitochondrion;other cytoplasmic organelle,Pf01323,373156,B4DIH1; B4DSY2; hsa:373156; Q6P4H0; Q7Z520; Q9P1S4; Q9Y2Q3,ENSG00000197448,Peroxisomal protein import; Glutathione conjugation,Metapathway biotransformation Phase I and II,3,0,59.51,71.82,52.48,69.69,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,69.81,91.33,,93.76,59.63,other molecular function,0,
Master Protein,High,Q52LJ0,FAM98B,Protein FAM98B OS=Homo sapiens OX=9606 GN=FAM98B PE=1 SV=2,7,19,0.728,0.51,0.926,0.971,-0.46,-0.97,-0.11,-0.04,8.17E-01,6.96E-01,8.39E-01,8.84E-01,7.83E+05,7.14E+05,1.74E+05,6.77E+05,4,4,4,4,,5.19E+05,2.42E+04,1.18E+06,2.00E+06,5.66E+05,6.18E+05,1.34E+06,,8.24E+05,,7.34E+04,5.79E+04,7.36E+05,4.12E+05,,3.24E+04,5.80E+06,1.77E+05,2.58E+06,,1.97E+03,2.36E+02,1.18E+06,1.03E+05,2.01E+03,1.10E+04,1.24E+04,,8.76E+03,,3.28E+03,4.71E+02,9.91E+04,1.02E+04,,9.11E+03,4.11E+04,4.15E+03,2.75E+04,0,FALSE,31.694,25,7,433,45.5,8.69,7,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf10239,283742,A8MUW5; hsa:283742; Q52LJ0; Q8N935,ENSG00000171262,tRNA processing in the nucleus,,1,0,91.94,42.4,100.63,125.72,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,1,,FALSE,73.62,89.4,82.77,83.2,56.87,other molecular function,0,
Master Protein,High,Q92608,DOCK2,Dedicator of cytokinesis protein 2 OS=Homo sapiens OX=9606 GN=DOCK2 PE=1 SV=2,10,18,0.728,1.189,0.613,0.705,-0.46,0.25,-0.71,-0.51,7.72E-01,3.31E-01,5.00E-01,9.36E-01,1.12E+06,8.47E+05,1.06E+06,3.75E+05,5,3,4,5,8.60E+05,1.12E+06,1.34E+06,1.51E+06,7.64E+05,1.50E+06,,8.47E+05,,3.11E+05,1.60E+06,1.79E+05,,2.63E+06,7.03E+05,3.75E+05,1.90E+05,1.84E+06,3.65E+05,9.62E+05,3.42E+03,4.24E+03,1.31E+04,1.51E+06,3.94E+04,5.35E+03,,7.81E+03,,3.30E+03,9.56E+03,7.98E+03,,3.54E+05,1.75E+04,7.31E+02,5.35E+04,1.31E+04,8.55E+03,1.02E+04,0,FALSE,38.733,9,10,1830,211.8,6.87,10,cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf06920, Pf07653, Pf14429, Pf16172, Pf20421, Pf20422",1794,hsa:1794; Q2M3I0; Q92608; Q96AK7,ENSG00000134516,Neutrophil degranulation; RHOA GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; Factors involved in megakaryocyte development and platelet production; Nef and signal transduction,Chemokine signaling pathway,8,0,28.21,67.38,84.17,90.85,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,68.46,103.31,115.96,135.04,53.07,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q86XI2,NCAPG2,Condensin-2 complex subunit G2 OS=Homo sapiens OX=9606 GN=NCAPG2 PE=1 SV=1,2,2,0.726,0.01,0.62,0.01,-0.46,-6.64,-0.69,-6.64,7.90E-01,1.00E-17,6.03E-01,1.00E-17,1.26E+05,1.73E+05,,1.08E+05,3,1,,1,,1.41E+05,1.26E+05,2.66E+04,,1.73E+05,,,,,,,,,,1.08E+05,,,,,,5.37E+02,1.23E+03,2.66E+04,,6.17E+02,,,,,,,,,,2.10E+02,,,,,0,FALSE,6.805,2,2,1143,130.9,6.87,2,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,Pf12422,54892,A4D228; hsa:54892; Q7Z3J9; Q86XI2; Q8WUG8; Q9BRX6; Q9H8S2; Q9H9K6,ENSG00000146918,Condensation of Prophase Chromosomes,Mesodermal commitment pathway,2,0,63.56,,,,n/a,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,1,Phospho [S12],FALSE,15.96,,0,,4.87,other molecular function,1,Phospho [S12]
Master Protein,High,O14656,TOR1A,Torsin-1A OS=Homo sapiens OX=9606 GN=TOR1A PE=1 SV=1,2,2,0.726,0.958,1.285,0.472,-0.46,-0.06,0.36,-1.08,8.58E-01,6.91E-01,9.42E-01,6.08E-01,8.25E+04,4.97E+05,2.62E+05,2.45E+05,4,1,2,5,,1.93E+05,2.75E+04,3.87E+05,3.53E+04,,,,,4.97E+05,,,1.85E+05,3.72E+05,,1.17E+06,1.16E+04,4.87E+04,2.45E+05,1.07E+06,,7.33E+02,2.68E+02,3.87E+05,1.82E+03,,,,,5.28E+03,,,1.50E+03,5.01E+04,,2.27E+03,3.27E+03,3.45E+02,5.73E+03,1.14E+04,0,FALSE,5.745,7,2,332,37.8,6.99,2,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes,other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,"Pf06309, Pf21376",1861,B2RB58; hsa:1861; O14656; Q53Y64; Q96CA0,ENSG00000136827,Cargo recognition for clathrin-mediated endocytosis,,1,0,105.22,,47.51,111.1,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,42.34,127.17,101.38,124.59,4.97,cytoskeletal activity;other molecular function,0,
Master Protein,High,H7C1E4,AP1S1,Adaptor related protein complex 1 subunit sigma 1 (Fragment) OS=Homo sapiens OX=9606 GN=AP1S1 PE=1 SV=1,1,1,0.726,0.139,0.01,100,-0.46,-2.85,-6.64,6.64,7.73E-01,1.02E-01,1.00E-17,1.00E-17,8.89E+04,1.23E+05,1.23E+04,,2,1,1,,6.90E+04,,,1.15E+05,,1.23E+05,,,,,,,,1.23E+04,,,,,,,2.74E+02,,,1.15E+05,,4.36E+02,,,,,,,,1.66E+03,,,,,,,0.008,FALSE,2.347,5,1,191,22.2,9.16,1,transport,other membranes;ER/Golgi,Pf01217,,H7C1E4,ENSG00000106367,,,0,0,35.19,,,,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,38.09,38.09,,,2.91,other molecular function,0,
Master Protein,High,Q9H2K8,TAOK3,Serine/threonine-protein kinase TAO3 OS=Homo sapiens OX=9606 GN=TAOK3 PE=1 SV=2,3,5,0.725,0.71,0.863,1.273,-0.46,-0.49,-0.21,0.35,8.49E-01,9.79E-01,7.24E-01,6.77E-01,3.54E+05,4.81E+05,2.71E+05,6.23E+05,1,5,4,4,,,,,3.54E+05,1.67E+05,9.73E+05,4.81E+05,4.95E+05,2.17E+05,3.24E+06,,3.43E+05,2.12E+05,2.14E+05,3.80E+06,3.47E+05,1.12E+06,1.30E+05,,,,,,1.82E+04,5.95E+02,1.73E+04,4.44E+03,1.39E+04,2.31E+03,1.94E+04,,2.79E+03,2.85E+04,5.31E+03,7.40E+03,9.76E+04,7.92E+03,3.04E+03,,0,FALSE,9.622,4,3,898,105.3,7.3,3,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,Pf00069,51347,hsa:51347; Q658N1; Q8IUM4; Q9H2K8; Q9HC79; Q9NZM9; Q9UHG7,ENSG00000135090,RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle,MAPK signaling pathway,4,0,,68.55,149.05,125.12,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,42.2,26.87,126.76,117.24,14.57,enzyme regulator activity;kinase activity;other molecular function,0,
Master Protein,High,P19367,HK1,Hexokinase-1 OS=Homo sapiens OX=9606 GN=HK1 PE=1 SV=3,13,37,0.725,0.931,2.082,0.629,-0.46,-0.1,1.06,-0.67,7.28E-01,6.61E-01,4.15E-01,7.37E-01,1.32E+06,1.04E+06,4.93E+06,3.06E+06,5,5,5,5,2.37E+05,2.50E+06,2.75E+05,2.42E+06,1.32E+06,1.04E+06,5.40E+06,5.11E+06,1.03E+05,8.64E+05,2.39E+06,2.21E+06,4.93E+06,7.96E+06,6.04E+06,2.48E+06,3.06E+06,4.56E+05,7.39E+06,3.15E+06,9.43E+02,9.50E+03,2.69E+03,2.42E+06,6.83E+04,3.70E+03,9.60E+04,4.71E+04,2.90E+03,9.19E+03,1.43E+04,9.86E+04,4.01E+04,1.07E+06,1.50E+05,4.84E+03,8.60E+05,3.23E+03,1.73E+05,3.35E+04,0,FALSE,52.673,19,13,917,102.4,6.8,13,other metabolic processes;stress response;other biological processes,other membranes;cytosol;mitochondrion,"Pf00349, Pf03727",3098,E9PCK0; hsa:3098; O43443; O43444; O75574; P19367; Q5VTC3; Q96HC8; Q9NNZ4; Q9NNZ5,ENSG00000156515,Glycolysis; Defective HK1 causes hexokinase deficiency (HK deficiency),Cori cycle; Photodynamic therapy-induced HIF-1 survival signaling; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; Disorders of fructose metabolism; Glucose metabolism in triple-negative breast cancer cells; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; UDP-derived sugars synthesis in fibroblasts; Glucuronidation,12,0,81.59,101.39,52.08,76.41,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,84.88,131.85,118.11,106.44,91.78,kinase activity;other molecular function,0,
Master Protein,High,P28066,PSMA5,Proteasome subunit alpha type-5 OS=Homo sapiens OX=9606 GN=PSMA5 PE=1 SV=3,4,25,0.723,0.702,1.127,0.353,-0.47,-0.51,0.17,-1.5,6.64E-01,9.08E-01,9.83E-01,3.77E-01,2.05E+06,1.90E+06,9.66E+05,3.38E+06,5,5,4,5,1.77E+06,2.05E+06,4.69E+06,1.34E+06,2.06E+07,1.90E+06,1.04E+06,2.50E+06,7.11E+04,1.13E+07,8.50E+05,1.75E+05,,2.40E+06,1.10E+06,1.17E+06,2.23E+06,1.52E+07,3.38E+06,1.53E+07,7.02E+03,7.80E+03,4.58E+04,1.34E+06,1.06E+06,6.74E+03,1.84E+04,2.31E+04,2.00E+03,1.20E+05,5.08E+03,7.81E+03,,3.24E+05,2.73E+04,2.29E+03,6.26E+05,1.07E+05,7.90E+04,1.63E+05,0,FALSE,19.26,25,4,241,26.4,4.79,4,protein metabolism;other metabolic processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf00227, Pf10584",5686,B2R8F6; B4E2V4; hsa:5686; P28066; Q3T1C1; Q6IBF7,ENSG00000143106,Neutrophil degranulation; ER-Phagosome pathway; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,63,0,134.84,134.87,82.46,95.95,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,High,High,Peak Found,1,,FALSE,134.82,99.33,141.02,137.65,86.46,,0,
Master Protein,High,Q7L2H7,EIF3M,Eukaryotic translation initiation factor 3 subunit M OS=Homo sapiens OX=9606 GN=EIF3M PE=1 SV=1,3,13,0.72,0.477,0.743,0.163,-0.47,-1.07,-0.43,-2.62,8.49E-01,6.52E-01,6.07E-01,1.31E-01,1.49E+05,4.88E+05,9.94E+04,6.07E+05,4,3,3,4,2.79E+06,,1.64E+05,1.35E+05,4.24E+04,7.04E+05,,1.79E+05,,4.88E+05,,,9.94E+04,3.58E+05,1.84E+04,6.11E+05,6.90E+06,6.03E+05,9.48E+04,,1.11E+04,,1.60E+03,1.35E+05,2.19E+03,2.50E+03,,1.65E+03,,5.19E+03,,,8.07E+02,4.82E+04,4.58E+02,1.19E+03,1.94E+06,4.27E+03,2.22E+03,,0,FALSE,15.622,13,3,374,42.5,5.63,3,cell organization and biogenesis;protein metabolism;other metabolic processes,cytosol;translational apparatus;other cell component,"Pf01399, Pf18005",10480,A8K7X4; B4E2Q4; hsa:10480; O60735; Q2F836; Q53HL6; Q7L2H7; Q9BXW1,ENSG00000149100,"L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Translation initiation complex formation; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition",,6,0,171.09,57.75,111.81,157.96,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,138.15,140.59,119.2,127.91,37.7,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P08514,ITGA2B,Integrin alpha-IIb OS=Homo sapiens OX=9606 GN=ITGA2B PE=1 SV=3,21,236,0.72,0.248,0.754,0.355,-0.47,-2.01,-0.41,-1.5,6.34E-01,1.31E-01,6.23E-01,3.99E-01,6.09E+07,2.20E+07,7.49E+06,2.47E+07,5,5,5,5,1.12E+08,1.48E+08,6.09E+07,6.78E+06,1.20E+07,2.20E+07,1.37E+07,1.48E+08,9.77E+07,6.79E+06,7.45E+06,7.49E+06,4.79E+06,1.12E+07,1.44E+07,4.99E+08,2.82E+07,2.08E+07,2.47E+07,2.17E+07,4.45E+05,5.64E+05,5.95E+05,6.78E+06,6.18E+05,7.81E+04,2.43E+05,1.37E+06,2.75E+06,7.22E+04,4.45E+04,3.35E+05,3.89E+04,1.51E+06,3.59E+05,9.73E+05,7.94E+06,1.48E+05,5.78E+05,2.31E+05,0,FALSE,82.125,29,21,1039,113.3,5.38,21,cell adhesion;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf00357, Pf01839, Pf08441, Pf20805, Pf20806",3674,B2RCY8; hsa:3674; O95366; P08514; Q14443; Q17R67,ENSG00000005961,Platelet degranulation ; Integrin cell surface interactions; ECM proteoglycans; Signaling by BRAF and RAF1 fusions; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Signal transduction by L1; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins,Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; Complement system; Hematopoietic stem cell differentiation; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Small cell lung cancer; IL-18 signaling pathway,24,0,91.04,108.24,41.52,178.74,High,High,High,Peak Found,High,High,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,High,Peak Found,1,,FALSE,131.16,137.31,143.98,110.61,573,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q8WWM7,ATXN2L,Ataxin-2-like protein OS=Homo sapiens OX=9606 GN=ATXN2L PE=1 SV=2,4,4,0.719,0.218,2.874,0.078,-0.48,-2.2,1.52,-3.69,7.16E-01,1.07E-01,2.78E-01,5.86E-02,1.11E+06,1.57E+06,9.03E+03,1.55E+05,3,5,2,3,,1.11E+06,,7.66E+04,3.40E+06,1.66E+05,1.88E+06,2.00E+06,2.32E+05,1.57E+06,,,,8.23E+03,9.89E+03,,,1.55E+05,8.72E+04,1.03E+06,,4.21E+03,,7.66E+04,1.75E+05,5.90E+02,3.35E+04,1.85E+04,6.53E+03,1.67E+04,,,,1.11E+03,2.46E+02,,,1.10E+03,2.04E+03,1.10E+04,0,FALSE,13.035,5,4,1075,113.3,8.59,4,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,other membranes;cytosol;nucleus;other cell component,"Pf06741, Pf07145, Pf14438",11273,A8K1R6; B9EGM2; E9PAR9; hsa:11273; O95135; Q63ZY4; Q6NVJ8; Q6PJW6; Q8IU61; Q8IU95; Q8WWM3; Q8WWM4; Q8WWM5; Q8WWM6; Q8WWM7; Q99703,ENSG00000168488,,16p11.2 distal deletion syndrome,1,0,111.29,76.98,12.94,124,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,125.97,155.37,114.95,39.35,10.28,nucleic acid binding activity,0,
Master Protein,High,O15400,STX7,Syntaxin-7 OS=Homo sapiens OX=9606 GN=STX7 PE=1 SV=4,4,12,0.718,0.383,1.31,0.263,-0.48,-1.39,0.39,-1.93,8.62E-01,4.60E-01,7.66E-01,3.35E-01,3.29E+05,3.77E+05,1.69E+05,1.59E+06,5,3,3,4,3.91E+05,3.29E+05,7.83E+04,1.05E+06,2.97E+05,2.49E+06,,,3.09E+05,3.77E+05,,3.05E+04,,7.10E+05,1.69E+05,5.68E+06,4.74E+05,5.30E+06,1.55E+05,,1.55E+03,1.25E+03,7.65E+02,1.05E+06,1.53E+04,8.84E+03,,,8.71E+03,4.00E+03,,1.36E+03,,9.57E+04,4.20E+03,1.11E+04,1.33E+05,3.76E+04,3.62E+03,,0,FALSE,18.11,21,4,261,29.8,5.55,4,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf05739, Pf14523",8417,E1P579; hsa:8417; O15400; Q5SZW2; Q96ES9,ENSG00000079950,,,0,0,85.55,117.05,118.45,103.19,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,93.83,89.55,118.03,128.93,35.16,other molecular function,0,
Master Protein,High,P81605,DCD,Dermcidin OS=Homo sapiens OX=9606 GN=DCD PE=1 SV=2,3,72,0.717,0.321,0.394,0.487,-0.48,-1.64,-1.34,-1.04,6.31E-01,2.57E-01,1.87E-01,5.74E-01,8.29E+06,2.44E+07,3.73E+06,3.58E+06,5,5,5,5,8.29E+06,2.25E+07,4.65E+07,7.91E+05,2.81E+06,2.44E+07,3.21E+07,3.45E+07,1.27E+07,1.01E+07,6.24E+06,7.47E+06,3.73E+06,1.36E+06,1.37E+06,1.77E+07,1.09E+05,3.58E+06,3.27E+06,2.23E+07,3.30E+04,8.55E+04,4.54E+05,7.91E+05,1.45E+05,8.67E+04,5.72E+05,3.18E+05,3.59E+05,1.07E+05,3.73E+04,3.34E+05,3.03E+04,1.84E+05,3.41E+04,3.45E+04,3.07E+04,2.54E+04,7.66E+04,2.38E+05,0,FALSE,18.727,23,3,110,11.3,6.54,3,protein metabolism;stress response;transport,non-structural extracellular;other membranes,Pf15291,117159,A5JHP2; A5JHP3; hsa:117159; P58461; P81605; Q53YJ2,ENSG00000161634,Antimicrobial peptides,,1,0,117.14,48.6,68.99,105.57,High,High,High,High,Peak Found,High,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,High,High,High,1,,FALSE,129.08,130.22,117.3,123.53,146.23,transporter activity;other molecular function,0,
Master Protein,High,G3V5Z7,PSMA6,Proteasome subunit alpha type OS=Homo sapiens OX=9606 GN=PSMA6 PE=1 SV=1,5,25,0.716,0.874,0.87,0.354,-0.48,-0.19,-0.2,-1.5,6.32E-01,7.02E-01,7.57E-01,3.98E-01,2.29E+06,2.14E+06,2.02E+06,3.66E+06,5,5,5,5,1.25E+06,4.14E+06,2.61E+05,2.29E+06,1.78E+07,1.98E+06,5.64E+05,3.44E+06,2.14E+06,3.38E+06,4.71E+05,1.05E+06,2.23E+06,3.68E+06,2.02E+06,4.08E+06,2.36E+06,8.44E+06,1.80E+06,3.66E+06,4.96E+03,1.57E+04,2.55E+03,2.29E+06,9.20E+05,7.05E+03,1.00E+04,3.17E+04,6.02E+04,3.60E+04,2.82E+03,4.68E+04,1.81E+04,4.96E+05,5.01E+04,7.96E+03,6.64E+05,5.98E+04,4.20E+04,3.90E+04,0,FALSE,14.033,21,5,252,28.1,6.76,5,protein metabolism;other metabolic processes,nucleus;other cell component,"Pf00227, Pf10584",,G3V5Z7,ENSG00000100902,,,0,0,140.23,51.45,65.16,64.28,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,131.53,101.37,63.49,93.34,58.04,,0,
Master Protein,High,P26447,S100A4,Protein S100-A4 OS=Homo sapiens OX=9606 GN=S100A4 PE=1 SV=1,3,11,0.715,0.329,0.913,0.254,-0.48,-1.61,-0.13,-1.98,6.81E-01,3.38E-01,8.19E-01,2.80E-01,5.07E+05,3.19E+06,1.90E+05,6.58E+05,5,5,5,5,2.25E+05,3.79E+06,7.82E+04,5.07E+05,1.09E+07,1.29E+06,3.19E+06,4.30E+06,1.02E+05,6.64E+06,1.66E+05,1.90E+05,6.80E+05,3.93E+05,3.53E+04,1.04E+06,6.58E+05,1.17E+07,4.72E+05,1.84E+05,8.93E+02,1.44E+04,7.64E+02,5.07E+05,5.63E+05,4.58E+03,5.68E+04,3.97E+04,2.88E+03,7.06E+04,9.95E+02,8.51E+03,5.53E+03,5.29E+04,8.78E+02,2.03E+03,1.85E+05,8.29E+04,1.10E+04,1.96E+03,0,FALSE,6.313,20,3,101,11.7,6.11,3,signal transduction;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,Pf01023,6275,A8K7R8; D3DV46; hsa:6275; P26447; Q6ICP8,ENSG00000196154,,Vitamin D receptor pathway,1,0,149.1,82.53,85.79,177.13,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,129.93,133.32,132.47,109.9,25.62,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,P31323,PRKAR2B,cAMP-dependent protein kinase type II-beta regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR2B PE=1 SV=3,2,4,0.714,0.01,2.256,0.01,-0.49,-6.64,1.17,-6.64,8.13E-01,1.00E-17,5.01E-01,1.00E-17,1.53E+05,2.33E+05,,5.27E+05,4,2,,2,2.29E+05,,1.86E+05,1.21E+05,1.26E+05,,,5.55E+05,9.83E+04,,,,,,,3.13E+05,,8.86E+05,,,9.12E+02,,1.82E+03,1.21E+05,6.48E+03,,,5.12E+03,2.77E+03,,,,,,,6.11E+02,,6.28E+03,,,0,FALSE,9.318,9,2,418,46.3,4.92,2,other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00027, Pf02197",5577,A4D0R9; hsa:5577; P31323,ENSG00000005249,FCGR3A-mediated IL10 synthesis; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase,Myometrial relaxation and contraction pathways; G protein signaling pathways; Cannabinoid receptor signaling; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Calcium regulation in cardiac cells; ADHD and autism (ASD) linked metabolic pathways and SNP; Sudden infant death syndrome (SIDS) susceptibility pathways,27,0,31.37,98.85,,67.58,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,105.22,,86.13,,15.83,enzyme regulator activity;other molecular function,0,
Master Protein,High,O75208,COQ9,"Ubiquinone biosynthesis protein COQ9, mitochondrial OS=Homo sapiens OX=9606 GN=COQ9 PE=1 SV=1",3,13,0.713,0.508,2.577,0.154,-0.49,-0.98,1.37,-2.7,7.12E-01,7.07E-01,2.56E-01,1.60E-01,6.39E+05,1.57E+06,3.59E+05,1.35E+06,4,3,3,5,,4.27E+05,9.48E+05,4.31E+05,1.57E+06,,,1.97E+06,4.99E+05,1.57E+06,,5.84E+04,,1.01E+06,3.59E+05,1.35E+06,6.11E+04,6.16E+06,3.78E+05,2.95E+06,,1.62E+03,9.26E+03,4.31E+05,8.07E+04,,,1.82E+04,1.41E+04,1.67E+04,,2.61E+03,,1.36E+05,8.92E+03,2.64E+03,1.72E+04,4.37E+04,8.86E+03,3.14E+04,0,FALSE,19.471,15,3,318,35.5,5.94,3,other metabolic processes,other membranes;mitochondrion;other cell component,"Pf08511, Pf21392",57017,A8K3L2; hsa:57017; O75208; Q7L5V7; Q7Z5T6; Q8NBL4; Q9NTJ2; Q9P056,ENSG00000088682,Ubiquinol biosynthesis,,1,0,64.09,56.58,102.31,114.3,n/a,Peak Found,Peak Found,High,High,n/a,n/a,High,Peak Found,High,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,High,Peak Found,High,1,,FALSE,89.95,113.63,124.8,133.77,35.57,other molecular function,0,
Master Protein,High,Q15369,ELOC,Elongin-C OS=Homo sapiens OX=9606 GN=ELOC PE=1 SV=1,2,6,0.712,0.47,1.183,0.215,-0.49,-1.09,0.24,-2.22,8.08E-01,6.33E-01,8.58E-01,2.64E-01,5.42E+05,4.64E+05,1.37E+05,1.49E+06,3,4,3,5,,5.42E+05,,4.55E+05,1.17E+07,,8.13E+05,2.11E+06,2.65E+05,1.49E+05,,5.74E+04,,5.43E+05,1.37E+05,3.28E+05,3.88E+05,1.66E+06,1.49E+06,7.38E+06,,2.06E+03,,4.55E+05,6.03E+05,,1.45E+04,1.94E+04,7.47E+03,1.58E+03,,2.57E+03,,7.31E+04,3.40E+03,6.40E+02,1.09E+05,1.18E+04,3.48E+04,7.86E+04,0,FALSE,11.762,30,2,112,12.5,4.78,2,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf03931,6921,E5RGD9; hsa:6921; Q15369; Q567Q6,ENSG00000154582,Antigen processing: Ubiquitination & Proteasome degradation; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Vif-mediated degradation of APOBEC3G; Neddylation; Regulation of expression of SLITs and ROBOs; Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Inactivation of CSF3 (G-CSF) signaling; Evasion by RSV of host interferon responses,Dual hijack model of Vif in HIV infection; VEGFA-VEGFR2 signaling; Type 2 papillary renal cell carcinoma; Hijack of ubiquitination by SARS-CoV-2,22,0,152.8,107.6,105.95,130.42,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,116.95,92.74,102.85,92.16,21.09,other molecular function,0,
Master Protein,High,Q9NZ45,CISD1,CDGSH iron-sulfur domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CISD1 PE=1 SV=1,2,19,0.712,1.189,1.102,2.092,-0.49,0.25,0.14,1.07,7.41E-01,3.49E-01,9.47E-01,4.00E-01,1.58E+06,4.48E+05,1.69E+06,5.46E+05,3,4,4,5,,1.58E+06,,1.84E+06,1.06E+06,6.37E+05,1.94E+05,3.15E+05,,2.56E+06,,1.53E+06,6.97E+05,2.82E+06,1.86E+06,5.46E+05,1.06E+06,6.86E+05,3.91E+04,1.28E+05,,6.00E+03,,1.84E+06,5.47E+04,2.26E+03,3.44E+03,2.90E+03,,2.72E+04,,6.82E+04,5.66E+03,3.81E+05,4.62E+04,1.06E+03,2.97E+05,4.86E+03,9.15E+02,1.36E+03,0,FALSE,14.5,26,2,108,12.2,9.09,2,protein metabolism;other metabolic processes;other biological processes,other membranes;mitochondrion,"Pf09360, Pf10660",55847,hsa:55847; Q1X902; Q9NZ45,ENSG00000122873,,Adipogenesis; Ferroptosis,2,0,26.66,119.27,50.95,84.99,n/a,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,140.92,112.79,128.65,123.09,60.11,other molecular function,0,
Master Protein,High,A0A8V8TQZ3,PHIP,Pleckstrin homology domain interacting protein OS=Homo sapiens OX=9606 GN=PHIP PE=1 SV=1,8,10,0.71,0.781,1.949,0.27,-0.5,-0.36,0.96,-1.89,8.60E-01,8.82E-01,5.60E-01,3.56E-01,2.34E+05,4.64E+05,6.53E+05,9.05E+05,5,4,5,3,8.64E+04,4.52E+05,1.10E+05,5.81E+05,2.34E+05,,9.15E+05,9.12E+05,2.36E+05,1.88E+05,4.23E+04,3.29E+05,1.13E+06,7.14E+05,6.53E+05,2.75E+06,,,1.05E+05,9.05E+05,3.43E+02,1.72E+03,1.08E+03,5.81E+05,1.21E+04,,1.63E+04,8.42E+03,6.66E+03,2.00E+03,2.53E+02,1.47E+04,9.15E+03,9.62E+04,1.62E+04,5.36E+03,,,2.46E+03,9.64E+03,0,FALSE,32.158,6,8,1834,208,8.87,8,,nucleus,"Pf00400, Pf00439",,A0A8V8TQZ3,ENSG00000146247,,,0,0,74,71.99,71.62,108.19,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,93.27,86.55,140.73,135.78,30.22,,0,
Master Protein,High,P11021,HSPA5,Endoplasmic reticulum chaperone BiP OS=Homo sapiens OX=9606 GN=HSPA5 PE=1 SV=2,32,512,0.708,0.917,1.143,0.889,-0.5,-0.13,0.19,-0.17,6.21E-01,6.77E-01,9.68E-01,9.78E-01,4.87E+07,7.00E+07,5.82E+07,1.75E+08,5,5,5,5,7.58E+06,1.32E+08,6.43E+06,4.87E+07,1.12E+08,6.68E+07,7.00E+07,9.45E+07,3.39E+07,2.40E+08,6.16E+06,4.46E+07,6.20E+07,6.97E+07,5.82E+07,1.75E+08,4.33E+07,2.01E+08,5.89E+07,3.13E+08,3.01E+04,5.00E+05,6.28E+04,4.87E+07,5.79E+06,2.37E+05,1.24E+06,8.72E+05,9.56E+05,2.56E+06,3.68E+04,1.99E+06,5.04E+05,9.40E+06,1.45E+06,3.41E+05,1.22E+07,1.43E+06,1.38E+06,3.33E+06,0,FALSE,173.145,47,30,654,72.3,5.16,32,protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component,Pf00012,3309,B0QZ61; hsa:3309; P11021; Q2EF78; Q9NPF1; Q9UK02,ENSG00000044574,"Regulation of HSF1-mediated heat shock response; Platelet degranulation ; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; ATF6B (ATF6-beta) activates chaperones; IRE1alpha activates chaperones; PERK regulates gene expression; ATF6 (ATF6-alpha) activates chaperone genes",Parkin-ubiquitin proteasomal system pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Photodynamic therapy-induced unfolded protein response; Prion disease pathway; Unfolded protein response; Orexin receptor pathway,14,1,95.08,79.88,52.28,69.99,Peak Found,High,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,130.64,117.83,132.81,118.74,1562.94,translation activity;other molecular function,0,
Master Protein,High,P01871,IGHM,Immunoglobulin heavy constant mu OS=Homo sapiens OX=9606 GN=IGHM PE=1 SV=5,6,18,0.708,1.047,0.324,3.282,-0.5,0.07,-1.63,1.71,7.07E-01,4.65E-01,1.63E-01,2.15E-01,1.39E+06,7.42E+05,2.27E+06,2.05E+05,5,5,5,4,8.35E+05,2.44E+06,1.57E+06,1.39E+06,1.32E+06,2.52E+05,7.50E+05,1.35E+06,5.76E+05,7.42E+05,2.67E+06,1.25E+06,7.73E+05,3.63E+06,2.27E+06,1.50E+05,6.51E+04,1.10E+06,2.82E+05,,3.32E+03,9.28E+03,1.53E+04,1.39E+06,6.79E+04,8.97E+02,1.33E+04,1.25E+04,1.62E+04,7.89E+03,1.60E+04,5.58E+04,6.28E+03,4.89E+05,5.63E+04,2.92E+02,1.83E+04,7.80E+03,6.60E+03,,0,FALSE,18.531,13,6,474,51.9,6.15,6,stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,Pf07654,,A0A075B6N9; A0A0G2JQL4; P01871; P04220; P20769,ENSG00000211899; ENSG00000282657,Cell surface interactions at the vascular wall; CD22 mediated BCR regulation; Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,,4,0,38.88,54.36,53.7,119.21,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,121.54,93.69,116.57,124.88,35.87,other molecular function,0,
Master Protein,High,Q70J99,UNC13D,Protein unc-13 homolog D OS=Homo sapiens OX=9606 GN=UNC13D PE=1 SV=1,5,7,0.706,0.848,0.517,0.921,-0.5,-0.24,-0.95,-0.12,7.45E-01,6.99E-01,3.94E-01,9.25E-01,1.07E+06,7.85E+05,2.31E+05,4.26E+05,3,2,5,2,2.49E+06,,1.91E+05,,1.07E+06,1.81E+05,,,,3.41E+06,2.31E+05,3.08E+06,6.78E+04,1.62E+05,6.63E+05,,8.12E+05,,2.23E+05,,9.90E+03,,1.86E+03,,5.53E+04,6.42E+02,,,,3.63E+04,1.38E+03,1.38E+05,5.50E+02,2.18E+04,1.65E+04,,2.28E+05,,5.22E+03,,0,FALSE,19.953,8,5,1090,123.2,6.65,5,stress response;transport;other biological processes,non-structural extracellular;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00168, Pf06292",201294,B4DWG9; hsa:201294; Q70J99; Q9H7K5,ENSG00000092929,Neutrophil degranulation,Deregulation of Rab and Rab effector genes in bladder cancer,2,0,92.73,127.21,151.36,80.46,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,49.16,43.95,146.1,130.51,24.22,other molecular function,0,
Master Protein,High,Q14766,LTBP1,Latent-transforming growth factor beta-binding protein 1 OS=Homo sapiens OX=9606 GN=LTBP1 PE=1 SV=4,4,19,0.706,0.804,0.609,0.684,-0.5,-0.31,-0.72,-0.55,8.00E-01,8.43E-01,5.99E-01,9.07E-01,4.60E+05,6.76E+05,4.65E+05,1.19E+06,5,5,3,3,4.60E+05,3.37E+06,3.30E+04,1.05E+05,7.47E+05,6.76E+05,4.10E+05,4.97E+06,7.01E+05,2.51E+05,1.67E+05,,,4.65E+05,6.05E+05,2.10E+07,1.19E+06,,1.31E+05,,1.83E+03,1.28E+04,3.23E+02,1.05E+05,3.85E+04,2.40E+03,7.29E+03,4.58E+04,1.97E+04,2.67E+03,1.00E+03,,,6.26E+04,1.50E+04,4.10E+04,3.33E+05,,3.07E+03,,0,FALSE,20.918,4,4,1721,186.7,5.96,4,signal transduction;other biological processes,extracellular matrix;ER/Golgi;other cell component,"Pf00683, Pf07645, Pf12662",4052,A1L3V1; hsa:4052; P22064; Q14766; Q53SD8; Q53SF3; Q53SG1; Q59HF7; Q8TD95,ENSG00000049323,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Molecules associated with elastic fibres; TGF-beta receptor signaling activates SMADs,Hypothesized pathways in pathogenesis of cardiovascular disease; TGF-beta receptor signaling in skeletal dysplasias; TGF-beta receptor signaling,7,0,147.06,142.95,54.19,158.06,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,High,Peak Found,Peak Found,n/a,n/a,High,Peak Found,High,High,n/a,Peak Found,n/a,1,,FALSE,121.23,124.75,134.18,74.65,50.45,kinase activity;other molecular function,0,
Master Protein,High,O15145,ARPC3,Actin-related protein 2/3 complex subunit 3 OS=Homo sapiens OX=9606 GN=ARPC3 PE=1 SV=3,2,3,0.706,0.028,,16.796,-0.5,-5.16,,4.07,7.04E-01,1.38E-06,,9.48E-03,1.65E+06,8.39E+05,1.59E+05,2.43E+05,5,5,2,1,3.18E+05,7.74E+06,2.19E+05,1.65E+06,4.86E+06,3.11E+05,8.39E+05,1.29E+06,2.53E+05,1.58E+06,4.08E+06,6.19E+03,,,,,,,2.43E+05,,1.26E+03,2.94E+04,2.14E+03,1.65E+06,2.51E+05,1.10E+03,1.49E+04,1.19E+04,7.12E+03,1.68E+04,2.44E+04,2.77E+02,,,,,,,5.68E+03,,0,FALSE,6.439,12,2,178,20.5,8.59,2,cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf04062,10094,hsa:10094; O00554; O15145,ENSG00000111229,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,Pathogenic Escherichia coli infection,6,0,110.45,68.56,140.99,,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,127.4,143.85,,0,6.28,cytoskeletal activity,0,
Master Protein,High,Q9UHG3,PCYOX1,Prenylcysteine oxidase 1 OS=Homo sapiens OX=9606 GN=PCYOX1 PE=1 SV=3,2,5,0.705,0.01,2.934,0.01,-0.5,-6.64,1.55,-6.64,7.17E-01,1.00E-17,3.88E-01,1.00E-17,7.43E+04,6.44E+04,,1.89E+05,3,3,,1,8.19E+04,,3.20E+04,7.43E+04,,1.33E+05,,6.44E+04,,4.53E+04,,,,,,,,1.89E+05,,,3.25E+02,,3.12E+02,7.43E+04,,4.74E+02,,5.95E+02,,4.82E+02,,,,,,,,1.34E+03,,,0,FALSE,7.43,6,2,505,56.6,6.18,2,protein metabolism;other metabolic processes,non-structural extracellular;other cytoplasmic organelle,"Pf07156, Pf13450",51449,B2RB14; B7Z9P8; hsa:51449; O94982; Q8N4N5; Q96QM8; Q9UHG3,ENSG00000116005,,,0,0,42.91,57.08,,,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,62.44,,62.44,,11.64,other molecular function,0,
Master Protein,High,A0A804HL12,MYCBP2,RCR-type E3 ubiquitin transferase OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=1,4,5,0.703,0.605,0.656,0.804,-0.51,-0.72,-0.61,-0.31,8.00E-01,8.70E-01,5.19E-01,9.99E-01,4.12E+05,5.00E+05,3.10E+05,7.89E+04,5,3,5,2,4.27E+05,5.68E+04,3.17E+04,4.12E+05,4.30E+05,5.94E+05,,4.01E+04,,5.00E+05,1.14E+06,4.01E+04,4.60E+05,3.10E+05,5.84E+04,,,,9.71E+04,6.41E+04,1.70E+03,2.16E+02,3.10E+02,4.12E+05,2.22E+04,2.11E+03,,3.70E+02,,5.32E+03,6.82E+03,1.79E+03,3.73E+03,4.18E+04,1.45E+03,,,,2.27E+03,6.83E+02,0,FALSE,14.291,1,4,4772,523.3,7.12,4,protein metabolism;other metabolic processes,cytosol;nucleus;other cell component,"Pf00415, Pf03256, Pf08005, Pf13540",,A0A804HL12,ENSG00000005810,,3q29 copy number variation syndrome,1,0,76.51,78.41,111.75,28.97,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,65.55,90.97,99.95,93.6,16.09,other molecular function,0,
Master Protein,High,Q9Y512,SAMM50,Sorting and assembly machinery component 50 homolog OS=Homo sapiens OX=9606 GN=SAMM50 PE=1 SV=3,7,47,0.702,1.005,0.702,2.081,-0.51,0.01,-0.51,1.06,6.14E-01,5.81E-01,5.36E-01,4.68E-01,2.38E+06,2.51E+06,3.84E+06,1.57E+06,5,3,5,5,2.23E+05,6.07E+06,5.45E+04,2.38E+06,6.42E+06,2.51E+06,,5.86E+05,,3.18E+06,3.34E+06,1.93E+06,3.84E+06,7.61E+06,4.24E+06,1.80E+06,1.94E+06,1.44E+06,1.57E+06,6.42E+05,8.86E+02,2.31E+04,5.33E+02,2.38E+06,3.31E+05,8.94E+03,,5.41E+03,,3.38E+04,2.00E+04,8.62E+04,3.12E+04,1.03E+06,1.05E+05,3.50E+03,5.46E+05,1.02E+04,3.67E+04,6.83E+03,0,FALSE,36.32,25,7,469,51.9,6.9,7,cell organization and biogenesis;transport,other membranes;mitochondrion,Pf01103,25813,hsa:25813; Q53HC4; Q56VW7; Q969Y9; Q96I46; Q9NW85; Q9UQM9; Q9Y512,ENSG00000100347,RAC2 GTPase cycle; Mitochondrial protein import; Cristae formation,,3,0,101.57,64.39,50.12,34.25,Peak Found,High,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,134,97.32,81.9,93.07,141.69,,0,
Master Protein,High,Q13510,ASAH1,Acid ceramidase OS=Homo sapiens OX=9606 GN=ASAH1 PE=1 SV=5,3,4,0.701,1.466,0.777,1.784,-0.51,0.55,-0.36,0.84,7.01E-01,3.18E-01,6.63E-01,4.74E-01,6.63E+05,2.09E+06,3.02E+05,1.37E+06,5,4,2,5,1.07E+05,1.48E+06,1.14E+06,5.74E+04,6.63E+05,,1.57E+06,2.79E+06,3.47E+05,3.27E+06,,,8.81E+05,,1.03E+05,1.41E+06,1.70E+05,1.88E+06,6.41E+05,1.37E+06,4.24E+02,5.64E+03,1.11E+04,5.74E+04,3.42E+04,,2.79E+04,2.58E+04,9.77E+03,3.48E+04,,,7.16E+03,,2.57E+03,2.75E+03,4.78E+04,1.33E+04,1.50E+04,1.46E+04,0,FALSE,10.484,9,3,395,44.6,7.62,3,other metabolic processes;other biological processes,non-structural extracellular;nucleus;other cytoplasmic organelle;other cell component,"Pf02275, Pf15508",427,E9PDS0; hsa:427; Q13510; Q6W898; Q96AS2,ENSG00000104763,Neutrophil degranulation; Glycosphingolipid catabolism,Sphingolipid pathway; S1P receptor signal transduction; Sphingolipid metabolism: integrated pathway; Sphingolipid metabolism in senescence; Biosynthesis and turnover of 1-deoxy-sphingoid bases; Synthesis of ceramides and 1-deoxyceramides,8,0,90.86,65.76,111.75,62.2,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,94.88,73.57,118.46,107.24,11.11,other molecular function,0,
Master Protein,High,O60884,DNAJA2,DnaJ homolog subfamily A member 2 OS=Homo sapiens OX=9606 GN=DNAJA2 PE=1 SV=1,3,5,0.7,0.91,1.238,1.806,-0.51,-0.14,0.31,0.85,7.48E-01,7.81E-01,9.24E-01,5.22E-01,1.27E+05,9.69E+04,8.90E+04,1.20E+05,5,2,4,4,3.67E+04,1.35E+05,5.18E+04,1.27E+05,3.64E+05,,5.24E+04,,,1.79E+05,2.47E+05,,3.95E+04,9.22E+04,8.59E+04,,6.96E+03,4.63E+05,3.71E+04,3.87E+05,1.46E+02,5.12E+02,5.06E+02,1.27E+05,1.88E+04,,9.31E+02,,,1.91E+03,1.48E+03,,3.21E+02,1.24E+04,2.14E+03,,1.96E+03,3.28E+03,8.69E+02,4.12E+03,0,FALSE,14.907,14,3,412,45.7,6.48,3,protein metabolism;other metabolic processes;stress response;other biological processes,other membranes;cytosol;other cell component,"Pf00226, Pf00684, Pf01556",10294,B2R7L7; hsa:10294; O14711; O60884,ENSG00000069345,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,,1,0,91.7,77.51,77.72,105.13,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,133.31,107.96,440.65,147.53,16.35,other molecular function,0,
Master Protein,High,Q92896,GLG1,Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,12,38,0.697,0.407,0.374,0.528,-0.52,-1.3,-1.42,-0.92,6.09E-01,4.34E-01,1.66E-01,6.17E-01,5.18E+06,4.81E+06,1.77E+06,2.86E+06,5,5,4,5,4.78E+06,3.01E+07,2.49E+06,5.18E+06,1.19E+07,1.20E+06,4.81E+06,1.11E+07,2.71E+06,2.15E+07,,5.41E+05,1.76E+06,6.75E+06,1.77E+06,1.65E+06,4.91E+04,5.60E+06,2.86E+06,6.91E+06,1.90E+04,1.15E+05,2.43E+04,5.18E+06,6.16E+05,4.27E+03,8.56E+04,1.03E+05,7.64E+04,2.28E+05,,2.42E+04,1.43E+04,9.09E+05,4.39E+04,3.23E+03,1.38E+04,3.97E+04,6.69E+04,7.36E+04,0,FALSE,60.583,16,12,1179,134.5,6.9,12,protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,extracellular matrix;plasma membrane;other membranes;cytoskeleton;ER/Golgi,Pf00839,2734,B7Z8Y4; D3DUJ7; hsa:2734; Q13221; Q6P9D1; Q92896,ENSG00000090863,Cell surface interactions at the vascular wall,,1,0,103.78,100.35,101.9,82.48,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,119.48,106.5,100.95,102.14,121.59,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P19878,NCF2,Neutrophil cytosol factor 2 OS=Homo sapiens OX=9606 GN=NCF2 PE=1 SV=2,1,2,0.696,0.01,20.863,0.01,-0.52,-6.64,4.38,-6.64,7.13E-01,1.00E-17,7.03E-04,1.00E-17,6.51E+04,9.35E+04,,1.95E+06,1,2,,1,,,,,6.51E+04,,2.27E+05,,3.86E+04,,,,,,,,,,,1.95E+06,,,,,3.36E+03,,4.03E+03,,1.09E+03,,,,,,,,,,,2.08E+04,0.002,FALSE,3.038,2,1,526,59.7,6.16,1,other metabolic processes;stress response;transport,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,"Pf00018, Pf00564, Pf13181",4688,B2R6Q1; B4DKQ7; B4DQA7; E9PHJ2; E9PHX3; hsa:4688; P19878; Q2PP06; Q8NFC7; Q9BV51,ENSG00000116701,RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; Detoxification of Reactive Oxygen Species; VEGFA-VEGFR2 Pathway; ROS and RNS production in phagocytes; Cross-presentation of particulate exogenous antigens (phagosomes); RHO GTPases Activate NADPH Oxidases,Brain-derived neurotrophic factor (BDNF) signaling pathway; VEGFA-VEGFR2 signaling; Microglia pathogen phagocytosis pathway; TYROBP causal network in microglia; IL-18 signaling pathway; p53 transcriptional gene network; Urotensin-II-mediated signaling pathway; Genetic causes of porto-sinusoidal vascular disease,16,0,,100.29,,,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,1,,FALSE,149.14,,149.14,,2.26,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q9BW27,NUP85,Nuclear pore complex protein Nup85 OS=Homo sapiens OX=9606 GN=NUP85 PE=1 SV=1,6,15,0.694,0.711,10.741,11.335,-0.53,-0.49,3.43,3.5,7.79E-01,9.46E-01,1.93E-02,1.55E-02,6.48E+05,2.70E+05,3.53E+05,4.81E+05,2,1,4,4,,,,7.92E+05,5.29E+05,,,2.70E+05,,,,2.01E+05,1.62E+05,1.22E+06,6.21E+05,,7.05E+03,2.90E+06,7.97E+04,4.97E+06,,,,7.92E+05,2.73E+04,,,2.49E+03,,,,8.97E+03,1.32E+03,1.64E+05,1.54E+04,,1.98E+03,2.06E+04,1.87E+03,5.29E+04,0,FALSE,26.387,13,6,656,75,5.55,6,cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf07575,79902,B4DMQ3; B4DPW1; hsa:79902; Q8NDI4; Q9BW27; Q9H9U1,ENSG00000125450,Separation of Sister Chromatids; HCMV Late Events; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,,35,0,28.13,,89.15,120.65,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,154.4,131.94,105.51,146.57,55.79,other molecular function,0,
Master Protein,High,P18669,PGAM1,Phosphoglycerate mutase 1 OS=Homo sapiens OX=9606 GN=PGAM1 PE=1 SV=2,4,26,0.694,0.365,0.088,1.558,-0.53,-1.45,-3.51,0.64,6.21E-01,3.66E-01,2.63E-03,5.47E-01,2.04E+06,2.26E+06,1.04E+06,3.42E+05,4,3,3,4,,1.42E+06,4.92E+05,2.94E+06,9.26E+06,,1.08E+06,2.26E+06,,5.61E+06,,1.04E+06,,2.57E+06,2.73E+05,2.89E+05,4.45E+05,,9.03E+04,4.05E+05,,5.39E+03,4.81E+03,2.94E+06,4.78E+05,,1.93E+04,2.09E+04,,5.97E+04,,4.63E+04,,3.47E+05,6.79E+03,5.63E+02,1.25E+05,,2.11E+03,4.31E+03,0,FALSE,19.009,28,4,254,28.8,7.18,4,other metabolic processes;other biological processes,non-structural extracellular;cytosol;other cell component,Pf00300,5223,hsa:5223; P18669; Q9BWC0,ENSG00000171314,Neutrophil degranulation; Glycolysis; Gluconeogenesis,Cori cycle; Metabolic reprogramming in colon cancer; Warburg effect modulated by deubiquitinating enzymes and their substrates; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,8,0,112.11,78.67,90.48,51.78,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,High,n/a,High,n/a,High,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,104.88,87.29,106.05,77.88,86.27,other molecular function,0,
Master Protein,High,P24557,TBXAS1,Thromboxane-A synthase OS=Homo sapiens OX=9606 GN=TBXAS1 PE=1 SV=3,7,21,0.694,1.225,0.737,2.935,-0.53,0.29,-0.44,1.55,6.05E-01,3.99E-01,6.90E-01,2.54E-01,4.14E+06,1.12E+06,1.31E+06,1.31E+06,5,5,5,5,7.01E+06,4.14E+06,2.67E+06,3.63E+05,4.46E+06,9.88E+04,4.20E+05,3.22E+06,2.22E+06,1.12E+06,2.94E+06,1.10E+05,9.30E+05,1.31E+06,3.61E+06,7.50E+06,4.09E+05,1.31E+06,4.65E+05,2.32E+06,2.78E+04,1.57E+04,2.61E+04,3.63E+05,2.30E+05,3.51E+02,7.46E+03,2.97E+04,6.26E+04,1.19E+04,1.76E+04,4.89E+03,7.56E+03,1.77E+05,8.97E+04,1.46E+04,1.15E+05,9.30E+03,1.09E+04,2.47E+04,0,FALSE,33.884,20,7,533,60.5,7.62,7,other metabolic processes;other biological processes,other membranes;cytosol;ER/Golgi,Pf00067,6916,B4DJG6; E7EMU9; E7EP08; E7ESB5; hsa:6916; O14987; P24557; Q16843; Q16844; Q8IUN1; Q96CN2; Q9GZW4; Q9HD77; Q9HD78; Q9HD79; Q9HD80; Q9HD81; Q9HD82; Q9HD83; Q9HD84,ENSG00000059377,Synthesis of Prostaglandins (PG) and Thromboxanes (TX); Eicosanoids; Defective TBXAS1 causes GHDD,"Eicosanoid metabolism via cyclooxygenases (COX); Prostaglandin and leukotriene metabolism in senescence ; Arachidonic acid (AA, ARA) oxylipin metabolism; Prostaglandin and leukotriene metabolism in senescence ; Omega-6-fatty acids in senescence; Prostaglandin synthesis and regulation",9,0,65.58,91.47,81.53,123.07,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,1,,FALSE,135.22,108.25,122.87,109.51,54.66,other molecular function,0,
Master Protein,High,Q9GZY8,MFF,Mitochondrial fission factor OS=Homo sapiens OX=9606 GN=MFF PE=1 SV=1,3,5,0.691,2.289,0.359,0.913,-0.53,1.19,-1.48,-0.13,7.43E-01,1.32E-01,2.86E-01,9.33E-01,1.06E+05,9.39E+04,3.43E+05,3.06E+05,4,3,5,4,6.49E+04,5.63E+05,,1.72E+05,3.59E+04,,9.39E+04,4.15E+05,,3.40E+04,8.33E+04,3.59E+05,2.83E+05,3.43E+05,4.20E+05,3.07E+05,3.05E+05,,3.98E+05,1.89E+05,2.58E+02,2.14E+03,,1.72E+05,1.85E+03,,1.67E+03,3.83E+03,,3.62E+02,4.98E+02,1.60E+04,2.30E+03,4.62E+04,1.04E+04,5.98E+02,8.58E+04,,9.32E+03,2.02E+03,0,FALSE,11.652,9,3,342,38.4,8.95,3,cell organization and biogenesis;signal transduction;other biological processes,other membranes;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component,Pf05644,56947,hsa:56947; Q567U1; Q658R6; Q9BVZ1; Q9GZY8; Q9H690; Q9NRG8,ENSG00000168958,,,0,0,116.33,113.22,43.49,28.52,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,102.79,81.26,121.86,50.28,11.08,other molecular function,0,
Master Protein,High,Q96QD9,FYTTD1,UAP56-interacting factor OS=Homo sapiens OX=9606 GN=FYTTD1 PE=1 SV=3,2,4,0.691,0.552,1.132,0.488,-0.53,-0.86,0.18,-1.03,7.44E-01,7.91E-01,9.89E-01,6.76E-01,1.18E+05,1.14E+05,9.41E+04,9.54E+04,2,3,4,4,,,5.68E+04,2.45E+05,,2.21E+05,3.21E+04,1.14E+05,,,,1.36E+05,4.09E+04,1.27E+05,6.95E+04,2.77E+05,3.40E+03,3.90E+05,3.29E+04,,,,5.55E+02,2.45E+05,,7.85E+02,5.71E+02,1.05E+03,,,,6.08E+03,3.32E+02,1.72E+04,1.73E+03,5.40E+02,9.56E+02,2.77E+03,7.70E+02,,0,FALSE,9.917,8,2,318,35.8,11.78,2,other metabolic processes;transport,nucleus,Pf07078,84248,A8MY74; B2RCB2; B7Z3R4; B7Z7V1; B7Z8I0; B7ZAJ3; C9J7P6; C9JNG6; C9JTH3; C9JY50; hsa:84248; Q96QD9; Q96SL9; Q9BQI8,ENSG00000122068,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,,3,0,88.25,77.46,49.06,107.09,n/a,n/a,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,75.21,73.89,139.37,138.02,13.65,nucleic acid binding activity,0,
Master Protein,High,Q9P0J0,NDUFA13,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 OS=Homo sapiens OX=9606 GN=NDUFA13 PE=1 SV=3,3,9,0.69,1.733,,2.949,-0.53,0.79,,1.56,7.88E-01,2.49E-01,,1.83E-01,2.01E+05,2.91E+05,5.81E+05,1.17E+04,5,3,5,1,2.01E+05,5.55E+05,9.24E+04,1.49E+06,1.47E+05,,2.16E+05,2.91E+05,,4.07E+05,5.10E+05,5.81E+05,3.48E+05,9.30E+05,1.50E+06,,1.17E+04,,,,7.97E+02,2.11E+03,9.03E+02,1.49E+06,7.56E+03,,3.84E+03,2.68E+03,,4.33E+03,3.05E+03,2.59E+04,2.83E+03,1.25E+05,3.74E+04,,3.29E+03,,,,0,FALSE,13.027,28,3,144,16.7,8.43,3,cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes,other membranes;mitochondrion;nucleus;other cell component,Pf06212,51079,B4DF76; hsa:51079; K7EK58; Q6PKI0; Q9H2L3; Q9P0J0; Q9Y327,ENSG00000186010,Complex I biogenesis; Mitochondrial protein degradation,Nucleotide-binding oligomerization domain (NOD) pathway; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease,6,0,117.52,31.64,59.39,,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,99.93,114.37,,15.54,27.85,other molecular function,0,
Master Protein,High,A0A6Q8PFJ0,LMNA,Lamin A/C OS=Homo sapiens OX=9606 GN=LMNA PE=1 SV=1,16,74,0.69,0.233,0.579,0.114,-0.54,-2.1,-0.79,-3.13,6.00E-01,1.09E-01,4.08E-01,6.43E-02,9.42E+06,3.84E+07,1.62E+06,3.09E+07,5,5,5,5,3.28E+06,4.94E+07,3.95E+06,9.42E+06,2.22E+07,4.80E+06,1.04E+08,2.90E+07,1.92E+08,3.84E+07,7.30E+05,4.17E+05,1.62E+06,3.79E+06,3.34E+06,3.09E+07,3.91E+06,3.52E+07,1.35E+07,3.55E+07,1.30E+04,1.88E+05,3.86E+04,9.42E+06,1.15E+06,1.71E+04,1.86E+06,2.68E+05,5.41E+06,4.09E+05,4.37E+03,1.86E+04,1.32E+04,5.11E+05,8.30E+04,6.02E+04,1.10E+06,2.50E+05,3.15E+05,3.78E+05,0,FALSE,62.757,25,15,729,80.9,8.27,16,,cytoskeleton;nucleus,"Pf00038, Pf00932",,A0A6Q8PFJ0,ENSG00000160789,,Lamin A processing pathway; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome; Primary ovarian insufficiency; 7q11.23 distal copy number variation,6,0,109.4,102.65,76.86,60.15,Peak Found,High,High,High,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,1,,FALSE,132.07,112.36,105.54,121.04,162.27,,0,
Master Protein,High,Q8N1G0,ZNF687,Zinc finger protein 687 OS=Homo sapiens OX=9606 GN=ZNF687 PE=1 SV=1,1,2,0.686,0.01,0.47,0.01,-0.54,-6.64,-1.09,-6.64,7.42E-01,1.00E-17,4.65E-01,1.00E-17,1.80E+05,9.84E+04,,4.62E+04,3,3,,1,,2.66E+05,,5.11E+04,1.80E+05,3.87E+05,,9.84E+04,,9.32E+04,,,,,,,4.62E+04,,,,,1.01E+03,,5.11E+04,9.30E+03,1.38E+03,,9.08E+02,,9.91E+02,,,,,,,1.30E+04,,,,0.001,FALSE,3.32,1,1,1237,129.4,8.19,1,other biological processes,cytosol;nucleus,"Pf00096, Pf16622",57592,D3DV17; hsa:57592; Q68DQ8; Q8N1G0; Q9H937; Q9P2A7,ENSG00000143373,,,0,0,65.17,87.19,,,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,92.76,,7.8,,6.07,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P15814,IGLL1,Immunoglobulin lambda-like polypeptide 1 OS=Homo sapiens OX=9606 GN=IGLL1 PE=1 SV=1,2,3,0.686,0.588,3.55,1.075,-0.54,-0.77,1.83,0.1,7.77E-01,8.40E-01,2.72E-01,8.41E-01,8.17E+05,4.91E+05,1.15E+05,6.39E+04,2,3,3,1,,1.50E+06,,4.46E+05,,,,2.18E+06,1.80E+04,4.91E+05,1.15E+05,4.88E+05,,6.86E+04,,,6.39E+04,,,,,5.68E+03,,4.46E+05,,,,2.01E+04,5.07E+02,5.22E+03,6.90E+02,2.18E+04,,9.25E+03,,,1.79E+04,,,,0,FALSE,12.608,17,2,213,22.9,10.07,2,other biological processes,non-structural extracellular;other membranes;ER/Golgi;other cell component,Pf07654,3543,hsa:3543; P15814; Q0P681,ENSG00000128322,Cell surface interactions at the vascular wall,Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; Network map of SARS-CoV-2 signaling pathway,3,0,76.44,126.82,102.59,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,114.88,60.01,0,28.62,12.62,other molecular function,0,
Master Protein,High,A0A494C039,HYOU1,Hypoxia up-regulated 1 OS=Homo sapiens OX=9606 GN=HYOU1 PE=1 SV=1,15,59,0.683,0.6,3.456,0.515,-0.55,-0.74,1.79,-0.96,5.93E-01,8.34E-01,1.47E-01,6.09E-01,4.09E+06,2.15E+06,4.24E+06,1.15E+07,5,5,5,5,8.08E+06,2.85E+06,1.15E+06,4.09E+06,1.04E+07,1.13E+06,1.93E+07,1.51E+06,2.15E+06,7.32E+06,1.31E+06,2.93E+06,4.24E+06,9.46E+06,5.98E+06,1.15E+07,3.86E+06,2.25E+07,3.65E+06,8.23E+07,3.21E+04,1.08E+04,1.13E+04,4.09E+06,5.34E+05,4.02E+03,3.43E+05,1.39E+04,6.05E+04,7.78E+04,7.83E+03,1.31E+05,3.45E+04,1.27E+06,1.49E+05,2.25E+04,1.09E+06,1.59E+05,8.55E+04,8.76E+05,0,FALSE,65.172,18,15,1000,111.3,5.22,15,protein metabolism;other metabolic processes,,Pf00012,10525,A0A494C039,ENSG00000149428,,VEGFA-VEGFR2 signaling,1,0,71.75,122.54,65.35,133.51,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,129.46,118.03,140.82,120.67,158.62,other molecular function,0,
Master Protein,High,Q7L592,NDUFAF7,"Protein arginine methyltransferase NDUFAF7, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFAF7 PE=1 SV=1",1,2,0.682,3.545,0.136,14.279,-0.55,1.83,-2.88,3.84,6.77E-01,8.92E-02,6.55E-02,1.10E-02,3.48E+04,5.10E+04,9.92E+04,6.95E+03,2,1,4,1,,,,6.56E+04,1.85E+04,,,5.10E+04,,,,7.82E+04,1.26E+05,6.13E+04,2.48E+05,,6.95E+03,,,,,,,6.56E+04,9.53E+02,,,4.71E+02,,,,3.49E+03,1.02E+03,8.27E+03,6.17E+03,,1.95E+03,,,,0.001,FALSE,3.316,2,1,441,49.2,8.34,1,cell organization and biogenesis;protein metabolism;other metabolic processes,mitochondrion,Pf02636,55471,hsa:55471; Q7L592; Q7Z399; Q9P1G3,ENSG00000003509,Complex I biogenesis,,1,0,79.3,,65.78,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,100.41,83.25,0,48.21,4.23,other molecular function,0,
Master Protein,High,O60610,DIAPH1,Protein diaphanous homolog 1 OS=Homo sapiens OX=9606 GN=DIAPH1 PE=1 SV=2,5,10,0.681,0.764,1.262,1.298,-0.55,-0.39,0.34,0.38,7.68E-01,8.29E-01,8.33E-01,6.64E-01,8.05E+05,6.98E+05,4.92E+05,1.06E+06,5,4,5,4,8.85E+05,5.43E+05,8.21E+05,2.09E+05,8.05E+05,,2.95E+05,7.07E+05,6.88E+05,7.60E+05,4.10E+04,3.45E+05,4.92E+05,9.45E+05,5.36E+05,,2.07E+06,2.55E+04,8.45E+05,1.33E+06,3.52E+03,2.06E+03,8.02E+03,2.09E+05,4.15E+04,,5.24E+03,6.53E+03,1.94E+04,8.08E+03,2.45E+02,1.54E+04,4.00E+03,1.27E+05,1.33E+04,,5.83E+05,1.80E+02,1.98E+04,1.41E+04,0,FALSE,17.185,5,5,1272,141.3,5.41,5,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,"Pf02181, Pf06346, Pf06367, Pf06371",1729,A6NF18; B7ZKW2; E9PEZ2; hsa:1729; O60610; Q17RN4; Q59FH8; Q9UC76,ENSG00000131504,RHOC GTPase cycle; RHOA GTPase cycle; RHO GTPases Activate Formins; RHOB GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle; Neutrophil degranulation; ERBB2 Regulates Cell Motility,Microtubule cytoskeleton regulation; AGE/RAGE pathway; Focal adhesion; Type 2 papillary renal cell carcinoma; Regulation of actin cytoskeleton; G13 signaling pathway,14,0,42.99,34.95,69.48,80.51,High,Peak Found,High,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,128.64,123.31,106.33,130.86,26.91,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,P46777,RPL5,60S ribosomal protein L5 OS=Homo sapiens OX=9606 GN=RPL5 PE=1 SV=3,9,25,0.68,0.236,1.234,0.258,-0.56,-2.08,0.3,-1.95,5.89E-01,1.11E-01,8.91E-01,2.60E-01,2.97E+06,3.84E+06,8.01E+05,7.06E+06,5,5,5,5,1.17E+06,2.97E+06,1.07E+06,4.67E+06,4.24E+06,4.03E+06,5.29E+06,3.22E+06,1.98E+06,3.84E+06,1.30E+06,4.94E+05,8.01E+05,1.85E+06,4.10E+05,9.68E+06,3.32E+06,7.06E+06,1.83E+06,9.36E+06,4.64E+03,1.13E+04,1.05E+04,4.67E+06,2.19E+05,1.43E+04,9.41E+04,2.97E+04,5.58E+04,4.09E+04,7.79E+03,2.20E+04,6.51E+03,2.49E+05,1.02E+04,1.89E+04,9.34E+05,5.00E+04,4.28E+04,9.97E+04,0,FALSE,35.532,33,9,297,34.3,9.72,9,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,"Pf14204, Pf17144",6125,hsa:6125; P46777; Q32LZ3; Q53HH6; Q9H3F4,ENSG00000122406,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),VEGFA-VEGFR2 signaling; Cytoplasmic ribosomal proteins,15,0,59.42,32.93,62.02,56.68,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,1,,FALSE,130.12,135.32,124.61,115.33,70.79,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q9UBV8,PEF1,Peflin OS=Homo sapiens OX=9606 GN=PEF1 PE=1 SV=1,1,1,0.678,0.01,0.01,,-0.56,-6.64,-6.64,,6.97E-01,1.00E-17,1.00E-17,,5.86E+04,8.65E+04,,,3,1,,,1.22E+05,,5.86E+04,1.57E+04,,,,,8.65E+04,,,,,,,,,,,,4.84E+02,,5.73E+02,1.57E+04,,,,,2.44E+03,,,,,,,,,,,,0.017,FALSE,2.062,4,1,284,30.4,6.54,1,cell organization and biogenesis;transport;developmental processes;other biological processes,other membranes;ER/Golgi;other cell component,"Pf13405, Pf13499",553115,hsa:553115; Q9UBV8,ENSG00000162517,,,0,0,81.71,,,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,76.96,,,,2.32,other molecular function,0,
Master Protein,High,Q13185,CBX3,Chromobox protein homolog 3 OS=Homo sapiens OX=9606 GN=CBX3 PE=1 SV=4,7,41,0.678,0.479,0.457,0.369,-0.56,-1.06,-1.13,-1.44,6.06E-01,5.87E-01,2.58E-01,4.19E-01,3.05E+06,9.22E+05,1.78E+06,7.71E+06,5,4,5,5,8.04E+05,2.79E+06,1.11E+07,7.66E+06,3.05E+06,5.65E+05,8.46E+05,,4.91E+06,1.00E+06,3.44E+05,1.78E+06,9.97E+05,8.57E+06,2.46E+06,1.16E+07,3.55E+05,7.71E+06,4.50E+05,1.41E+07,3.19E+03,1.06E+04,1.09E+05,7.66E+06,1.57E+05,2.01E+03,1.50E+04,,1.38E+05,1.07E+04,2.06E+03,7.95E+04,8.10E+03,1.15E+06,6.10E+04,2.26E+04,9.96E+04,5.46E+04,1.05E+04,1.50E+05,0,FALSE,54.933,38,5,183,20.8,5.33,7,cell organization and biogenesis;stress response;other biological processes,other membranes;cytoskeleton;nucleus;other cell component,"Pf00385, Pf01393",11335,hsa:11335; Q13185; Q96CD7; Q99409; Q9BVS3; Q9P0Z6,ENSG00000122565,RNA Polymerase I Promoter Escape; Transcriptional Regulation by E2F6; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Exercise-induced circadian regulation; Effect of progerin on genes involved in progeria; NIPBL role in DNA damage - Cornelia de Lange syndrome,6,3,82.8,112.53,116.83,92.13,n/a,n/a,Peak Found,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,130.95,115.14,215.34,142.72,143.56,other molecular function,0,
Master Protein,High,Q99575,POP1,Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens OX=9606 GN=POP1 PE=1 SV=2,2,2,0.677,0.663,,11.059,-0.56,-0.59,,3.47,8.11E-01,9.89E-01,,3.17E-02,2.34E+05,3.93E+05,2.30E+05,2.77E+03,3,3,3,1,,7.82E+05,,2.34E+05,1.47E+04,,4.49E+05,3.93E+05,,3.34E+05,,1.18E+04,2.44E+05,2.30E+05,,,2.77E+03,,,,,2.97E+03,,2.34E+05,7.58E+02,,7.98E+03,3.62E+03,,3.56E+03,,5.28E+02,1.98E+03,3.09E+04,,,7.80E+02,,,,0,FALSE,9.069,3,2,1024,114.6,9.22,2,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf06978, Pf08170",10940,A8K5W9; Q15037; Q99575,ENSG00000104356,tRNA processing in the nucleus,,1,0,115.08,14.55,80.4,,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,169.34,121.46,,163.98,5.55,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96D96,HVCN1,Voltage-gated hydrogen channel 1 OS=Homo sapiens OX=9606 GN=HVCN1 PE=1 SV=1,3,7,0.677,0.252,0.453,0.414,-0.56,-1.99,-1.14,-1.27,6.75E-01,1.72E-01,3.91E-01,5.36E-01,9.12E+05,1.62E+06,3.02E+05,5.07E+05,5,4,4,4,9.12E+05,3.25E+06,3.26E+05,4.22E+05,4.08E+06,,1.15E+06,2.27E+06,3.70E+05,4.46E+06,6.03E+05,7.79E+04,4.74E+05,1.93E+05,,3.70E+05,,6.94E+05,2.37E+05,3.31E+06,3.62E+03,1.24E+04,3.18E+03,4.22E+05,2.11E+05,,2.05E+04,2.10E+04,1.04E+04,4.75E+04,3.61E+03,3.48E+03,3.85E+03,2.60E+04,,7.22E+02,,4.92E+03,5.55E+03,3.53E+04,0,FALSE,12.607,21,3,273,31.7,6.8,3,transport;other biological processes,plasma membrane;other membranes,"Pf00520, Pf16799",84329,A8MQ37; B4DEB3; F8WCH5; hsa:84329; Q6UW11; Q96D96; Q96IS5,ENSG00000122986,Neutrophil degranulation; Sperm Motility And Taxes; ROS and RNS production in phagocytes,,3,0,97.01,86.17,72.2,125.89,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,128.35,115.08,132.79,120.89,19.44,transporter activity;other molecular function,0,
Master Protein,High,P08575,PTPRC,Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens OX=9606 GN=PTPRC PE=1 SV=3,18,83,0.675,0.827,1.224,0.519,-0.57,-0.27,0.29,-0.95,5.83E-01,7.92E-01,8.99E-01,6.13E-01,2.99E+06,6.88E+06,3.96E+06,8.24E+06,5,5,5,5,1.67E+06,1.35E+07,8.01E+05,2.99E+06,1.06E+07,6.88E+06,3.00E+06,7.88E+06,1.77E+06,8.36E+06,5.70E+05,3.96E+06,3.74E+06,1.30E+07,8.66E+06,2.47E+07,2.91E+06,1.64E+07,8.24E+06,7.31E+06,6.64E+03,5.15E+04,7.83E+03,2.99E+06,5.44E+05,2.45E+04,5.34E+04,7.27E+04,4.98E+04,8.89E+04,3.41E+03,1.77E+05,3.04E+04,1.75E+06,2.15E+05,4.82E+04,8.19E+05,1.16E+05,1.93E+05,7.78E+04,0,FALSE,59.405,17,18,1306,147.4,6.15,18,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,"Pf00041, Pf00102, Pf12453, Pf12567",5788,A0A0A0MT22; A8K7W6; hsa:5788; P08575; Q16614; Q9H0Y6; X6R433,ENSG00000081237; ENSG00000262418,Phosphorylation of CD3 and TCR zeta chains; Neutrophil degranulation; Other semaphorin interactions,B cell receptor signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Regulatory circuits of the STAT3 signaling pathway; Extrafollicular and follicular B cell activation by SARS-CoV-2; EPO receptor signaling; Interferon type I signaling pathways,9,0,97.33,53.71,81.3,72.62,Peak Found,High,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,127.21,112.69,121.78,121,225.19,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,P78371,CCT2,T-complex protein 1 subunit beta OS=Homo sapiens OX=9606 GN=CCT2 PE=1 SV=4,15,51,0.674,0.663,0.959,0.412,-0.57,-0.59,-0.06,-1.28,5.83E-01,9.50E-01,8.54E-01,4.78E-01,8.95E+06,1.58E+06,1.61E+06,9.74E+06,5,5,5,5,1.67E+07,1.17E+07,5.76E+06,1.46E+06,8.95E+06,8.93E+06,2.00E+06,2.45E+05,1.54E+06,1.58E+06,6.14E+06,5.47E+05,1.61E+06,2.58E+06,1.11E+06,1.32E+07,9.74E+06,3.70E+07,2.72E+06,5.74E+06,6.63E+04,4.43E+04,5.63E+04,1.46E+06,4.62E+05,3.18E+04,3.55E+04,2.26E+03,4.33E+04,1.68E+04,3.67E+04,2.44E+04,1.31E+04,3.48E+05,2.75E+04,2.57E+04,2.74E+06,2.62E+05,6.36E+04,6.11E+04,0,FALSE,68.803,47,15,535,57.5,6.46,15,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component,Pf00118,10576,A8K402; B5BTY7; B7Z243; B7Z7K4; B7ZAT2; hsa:10576; P78371; Q14D36; Q6IAT3,ENSG00000166226,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Neutrophil degranulation; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle; Folding of actin by CCT/TriC,16p11.2 proximal deletion syndrome,10,0,64.9,120.98,92.75,99.66,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,125.98,122.49,131.28,121.05,159.51,other molecular function,0,
Master Protein,High,P26196,DDX6,Probable ATP-dependent RNA helicase DDX6 OS=Homo sapiens OX=9606 GN=DDX6 PE=1 SV=2,3,8,0.674,0.66,,1.426,-0.57,-0.6,,0.51,6.68E-01,9.82E-01,,6.10E-01,1.08E+06,1.26E+06,7.34E+05,9.12E+04,2,1,4,1,,,1.19E+06,9.75E+05,,,,1.26E+06,,,8.00E+05,1.35E+06,6.73E+05,5.85E+05,,,9.12E+04,,,,,,1.17E+04,9.75E+05,,,,1.16E+04,,,4.78E+03,6.02E+04,5.47E+03,7.89E+04,,,2.56E+04,,,,0,FALSE,17.335,12,3,483,54.4,8.66,3,cell organization and biogenesis;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00270, Pf00271",1656,hsa:1656; P26196; Q5D048,ENSG00000110367,mRNA decay by 5' to 3' exoribonuclease,,1,0,14.26,,40.23,,n/a,n/a,High,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,51.86,58.29,,61.42,30.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q16531,DDB1,DNA damage-binding protein 1 OS=Homo sapiens OX=9606 GN=DDB1 PE=1 SV=1,19,57,0.672,1.014,0.453,0.947,-0.57,0.02,-1.14,-0.08,5.80E-01,5.72E-01,2.53E-01,9.78E-01,3.91E+06,5.52E+06,3.51E+06,1.90E+06,5,5,5,4,5.95E+06,3.91E+06,7.95E+05,7.80E+06,2.47E+06,5.52E+06,6.09E+05,1.07E+07,3.92E+05,3.95E+07,3.51E+06,9.12E+05,3.01E+06,1.12E+07,4.50E+06,1.26E+06,8.80E+06,4.77E+05,2.88E+06,,2.36E+04,1.49E+04,7.77E+03,7.80E+06,1.28E+05,1.96E+04,1.08E+04,9.91E+04,1.11E+04,4.20E+05,2.10E+04,4.08E+04,2.45E+04,1.52E+06,1.12E+05,2.46E+03,2.47E+06,3.38E+03,6.74E+04,,0,FALSE,81.473,22,19,1140,126.9,5.26,19,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,"Pf03178, Pf10433",1642,A6NG77; B2R648; B4DG00; hsa:1642; O15176; Q13289; Q16531; Q58F96,ENSG00000167986,Neddylation; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; DNA Damage Recognition in GG-NER; Dual Incision in GG-NER,"Hippo-Merlin signaling dysregulation; Hepatitis B infection; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",14,0,66.18,143.57,84.54,112.28,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,n/a,1,,FALSE,119.76,105.89,132.79,105.95,162.63,nucleic acid binding activity;other molecular function,0,
Master Protein,High,B1AK88,CAPZB,F-actin-capping protein subunit beta OS=Homo sapiens OX=9606 GN=CAPZB PE=1 SV=1,7,25,0.671,0.803,1.26,0.435,-0.57,-0.32,0.33,-1.2,7.42E-01,7.43E-01,8.50E-01,5.27E-01,9.37E+05,7.22E+05,8.11E+05,2.83E+06,4,5,5,5,9.79E+04,3.19E+05,,2.75E+06,5.39E+06,2.64E+06,4.91E+05,3.16E+05,7.22E+05,3.54E+06,1.49E+05,8.11E+05,8.74E+05,4.38E+06,7.68E+05,2.18E+05,2.53E+06,1.08E+07,3.73E+06,2.83E+06,3.89E+02,1.21E+03,,2.75E+06,2.78E+05,9.39E+03,8.74E+03,2.92E+03,2.03E+04,3.76E+04,8.91E+02,3.62E+04,7.10E+03,5.90E+05,1.91E+04,4.25E+02,7.11E+05,7.68E+04,8.73E+04,3.01E+04,0,FALSE,45.029,32,7,301,33.8,6.43,7,cell organization and biogenesis,cytoskeleton,Pf01115,832,B1AK88,ENSG00000077549,,VEGFA-VEGFR2 signaling,1,0,115.82,94.41,121.25,99.79,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,126.87,109.92,107.54,103.83,96.85,cytoskeletal activity,0,
Master Protein,High,Q9Y606,PUS1,Pseudouridylate synthase 1 homolog OS=Homo sapiens OX=9606 GN=PUS1 PE=1 SV=3,4,8,0.669,2.37,0.868,0.833,-0.58,1.25,-0.2,-0.26,7.60E-01,6.11E-02,7.31E-01,9.54E-01,3.77E+05,7.91E+05,1.08E+06,3.12E+05,3,3,4,3,3.77E+05,,1.61E+05,6.99E+05,,7.91E+05,8.96E+05,,2.31E+05,,,1.04E+06,7.06E+05,1.11E+06,1.69E+06,1.31E+05,,,4.77E+05,3.12E+05,1.50E+03,,1.57E+03,6.99E+05,,2.81E+03,1.59E+04,,6.51E+03,,,4.65E+04,5.73E+03,1.50E+05,4.19E+04,2.55E+02,,,1.12E+04,3.32E+03,0,FALSE,16.153,11,4,427,47.4,8.41,4,RNA metabolism OR transcription;other metabolic processes,mitochondrion;nucleus;other cell component,Pf01416,80324,A8K877; B3KQC1; hsa:80324; Q8WYT2; Q9BU44; Q9Y606,ENSG00000177192,,,0,0,65.65,55.92,35.8,56.52,Peak Found,n/a,Peak Found,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,16.71,88.73,66.19,56.86,23.34,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96AQ6,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1 OS=Homo sapiens OX=9606 GN=PBXIP1 PE=1 SV=1,9,12,0.668,0.83,2.061,0.308,-0.58,-0.27,1.04,-1.7,7.75E-01,7.69E-01,4.26E-01,4.00E-01,3.73E+05,5.19E+05,6.29E+05,1.34E+06,5,3,4,1,1.53E+05,2.23E+05,3.73E+05,1.44E+06,1.32E+06,1.20E+06,,2.93E+05,,5.19E+05,,4.02E+05,5.21E+05,7.60E+05,9.46E+05,1.34E+06,,,,,6.09E+02,8.47E+02,3.65E+03,1.44E+06,6.80E+04,4.28E+03,,2.71E+03,,5.52E+03,,1.79E+04,4.24E+03,1.02E+05,2.35E+04,2.62E+03,,,,,0,FALSE,23.942,17,9,731,80.6,5.33,9,cell adhesion;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cell component,,57326,hsa:57326; Q5T174; Q5T176; Q96AQ6; Q9H8X6; Q9HA02; Q9HD85,ENSG00000163346,,VEGFA-VEGFR2 signaling,1,0,89.12,70.47,37.04,,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,n/a,n/a,n/a,1,,FALSE,62.72,67.14,34.17,58.69,33.5,other molecular function,0,
Master Protein,High,P51124,GZMM,Granzyme M OS=Homo sapiens OX=9606 GN=GZMM PE=1 SV=2,3,4,0.668,0.427,0.638,0.962,-0.58,-1.23,-0.65,-0.06,6.63E-01,5.51E-01,5.56E-01,8.78E-01,1.33E+06,1.06E+06,1.57E+05,3.55E+05,1,2,3,2,,1.33E+06,,,,1.27E+06,,8.93E+05,,,,1.57E+05,,9.68E+05,1.18E+05,,1.50E+05,,8.42E+05,,,5.04E+03,,,,4.51E+03,,8.24E+03,,,,7.01E+03,,1.30E+05,2.93E+03,,4.22E+04,,1.97E+04,,0,FALSE,9.572,16,3,257,27.5,10.13,3,protein metabolism;stress response;other biological processes,non-structural extracellular,Pf00089,3004,hsa:3004; P51124,ENSG00000197540,Alternative complement activation,,1,0,,24.47,115.83,98.62,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,High,n/a,1,,FALSE,26.04,81.46,26.04,35.08,11.5,other molecular function,0,
Master Protein,High,E7EPK1,SEPTIN7,Septin OS=Homo sapiens OX=9606 GN=SEPTIN7 PE=1 SV=2,10,34,0.668,0.623,1.101,0.579,-0.58,-0.68,0.14,-0.79,6.45E-01,9.43E-01,9.05E-01,7.60E-01,2.89E+06,6.40E+05,7.43E+05,1.45E+06,5,4,5,5,1.09E+07,4.63E+05,2.62E+06,2.89E+06,5.09E+06,,4.43E+05,1.04E+06,2.66E+05,9.25E+05,5.21E+05,7.43E+05,4.41E+05,7.45E+06,2.19E+06,2.88E+05,4.00E+06,1.45E+06,1.18E+06,3.17E+06,4.35E+04,1.76E+03,2.56E+04,2.89E+06,2.62E+05,,7.87E+03,9.60E+03,7.51E+03,9.83E+03,3.12E+03,3.32E+04,3.58E+03,1.00E+06,5.45E+04,5.61E+02,1.12E+06,1.03E+04,2.75E+04,3.37E+04,0,FALSE,44.188,37,10,437,50.7,8.63,10,other biological processes,plasma membrane;other membranes;cytoskeleton;other cell component,Pf00735,,E7EPK1,ENSG00000122545,,,0,0,91.06,55.74,131.43,75.49,High,Peak Found,High,High,High,n/a,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,98.66,98.54,74.22,72.24,99.31,other molecular function,0,
Master Protein,High,A0A0G2JPR0,C4A,Complement C4-A OS=Homo sapiens OX=9606 GN=C4A PE=1 SV=1,7,12,0.667,1.415,0.484,1.952,-0.58,0.5,-1.05,0.97,7.30E-01,2.91E-01,4.43E-01,4.30E-01,1.22E+05,2.15E+05,1.15E+06,8.82E+04,2,2,5,2,1.35E+05,,,1.10E+05,,,2.54E+05,,1.82E+05,,1.06E+05,1.23E+06,2.60E+06,5.19E+05,1.15E+06,,6.25E+04,,1.24E+05,,5.35E+02,,,1.10E+05,,,4.51E+03,,5.14E+03,,6.34E+02,5.48E+04,2.12E+04,7.00E+04,2.85E+04,,1.76E+04,,2.91E+03,,0,FALSE,23.031,5,3,1744,192.8,7.03,7,stress response;other biological processes,non-structural extracellular,"Pf00207, Pf01759, Pf01821, Pf01835, Pf07677, Pf07678, Pf07703, Pf17789, Pf17791, Pf21145",,A0A0G2JPR0,ENSG00000244207,,,0,0,14.46,23.14,84.72,46.8,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,15.24,79.12,51.99,91.5,32.41,enzyme regulator activity,0,
Master Protein,High,P61009,SPCS3,Signal peptidase complex subunit 3 OS=Homo sapiens OX=9606 GN=SPCS3 PE=1 SV=1,1,15,0.665,0.797,2.787,0.094,-0.59,-0.33,1.48,-3.41,5.72E-01,7.27E-01,2.39E-01,4.31E-02,9.67E+05,4.45E+06,1.16E+06,1.24E+07,5,5,5,5,9.67E+05,4.68E+06,6.66E+05,7.60E+05,8.46E+06,4.95E+06,3.14E+06,4.45E+06,1.00E+06,4.89E+06,3.00E+06,5.31E+05,1.80E+06,1.16E+06,1.02E+06,1.24E+07,4.14E+05,4.47E+07,1.01E+06,3.31E+07,3.84E+03,1.78E+04,6.51E+03,7.60E+05,4.37E+05,1.76E+04,5.58E+04,4.11E+04,2.82E+04,5.20E+04,1.79E+04,2.37E+04,1.47E+04,1.57E+05,2.54E+04,2.42E+04,1.16E+05,3.17E+05,2.36E+04,3.53E+05,0.001,FALSE,3.747,5,1,180,20.3,8.62,1,protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi,Pf04573,60559,hsa:60559; P12280; P61009; Q9H0S7,ENSG00000129128,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP); Maturation of hRSV A proteins; Synthesis, secretion, and deacylation of Ghrelin; SRP-dependent cotranslational protein targeting to membrane",15q25 copy number variation,6,0,110.55,45.28,63.23,108.07,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,1,,FALSE,136.59,104.64,143.76,142.62,25.12,,0,
Master Protein,High,O75844,ZMPSTE24,CAAX prenyl protease 1 homolog OS=Homo sapiens OX=9606 GN=ZMPSTE24 PE=1 SV=2,4,18,0.665,0.367,1.043,0.633,-0.59,-1.45,0.06,-0.66,6.58E-01,3.59E-01,9.45E-01,8.65E-01,1.31E+06,1.07E+06,6.37E+05,1.09E+06,4,4,5,3,5.02E+05,2.25E+06,,1.62E+06,1.07E+06,,9.64E+04,2.11E+06,1.25E+06,9.10E+05,1.27E+06,6.37E+05,1.31E+05,1.22E+06,1.41E+05,1.74E+06,3.29E+03,,,1.09E+06,1.99E+03,8.56E+03,,1.62E+06,5.51E+04,,1.71E+03,1.94E+04,3.53E+04,9.67E+03,7.61E+03,2.85E+04,1.07E+03,1.64E+05,3.50E+03,3.38E+03,9.24E+02,,,1.16E+04,0,FALSE,26.202,12,4,475,54.8,7.49,4,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf01435, Pf16491",10269,B3KQI7; D3DPU7; hsa:10269; O75844; Q8NDZ8; Q9UBQ2,ENSG00000084073,,Adipogenesis; Lamin A processing pathway; Nephrotic syndrome; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Familial partial lipodystrophy; Progeria-associated lipodystrophy,7,0,55.09,76.25,81.72,92.9,Peak Found,Peak Found,n/a,High,High,n/a,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,107.57,120.28,28.02,245.22,57.05,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P55735,SEC13,Protein SEC13 homolog OS=Homo sapiens OX=9606 GN=SEC13 PE=1 SV=3,1,1,0.665,0.553,1.472,0.25,-0.59,-0.85,0.56,-2,7.95E-01,8.15E-01,8.12E-01,2.71E-01,2.85E+05,4.28E+05,1.57E+05,6.30E+05,1,1,1,3,,,,2.85E+05,,4.28E+05,,,,,,,,1.57E+05,,,6.30E+05,8.07E+06,1.65E+05,,,,,2.85E+05,,1.52E+03,,,,,,,,2.12E+04,,,1.77E+05,5.72E+04,3.86E+03,,0.006,FALSE,2.439,3,1,322,35.5,5.48,1,cell organization and biogenesis;transport;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf00400,6396,A8MV37; B4DXJ1; hsa:6396; P55735; Q5BJF0; Q9BRM6; Q9BUG7,ENSG00000157020,"ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; snRNP Assembly; Separation of Sister Chromatids; HCMV Late Events; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; Amino acids regulate mTORC1; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; COPII-mediated vesicle transport; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Postmitotic nuclear pore complex (NPC) reformation",Sterol regulatory element-binding proteins (SREBP) signaling,40,0,,,,150.09,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,0,0,109.42,109.42,2.35,other molecular function,0,
Master Protein,High,A0A669KBH5,SNCA,Alpha-synuclein OS=Homo sapiens OX=9606 GN=SNCA PE=1 SV=1,6,10,0.663,0.395,6.379,0.04,-0.59,-1.34,2.67,-4.65,7.53E-01,4.88E-01,1.09E-01,1.45E-02,3.10E+05,2.39E+05,2.52E+04,1.19E+05,4,3,2,5,,7.81E+05,4.43E+05,5.72E+04,2.17E+05,,3.16E+04,4.48E+05,,2.39E+05,,,,3.04E+04,2.09E+04,1.19E+05,2.30E+06,4.12E+05,8.42E+03,1.05E+05,,2.97E+03,4.33E+03,5.72E+04,1.12E+04,,5.63E+02,4.13E+03,,2.54E+03,,,,4.09E+03,5.21E+02,2.32E+02,6.47E+05,2.92E+03,1.97E+02,1.12E+03,0,FALSE,22.913,39,6,159,16.4,4.64,6,other biological processes,non-structural extracellular;other membranes;nucleus;other cell component,Pf01387,,A0A669KBH5,ENSG00000145335,,Alzheimer's disease and miRNA effects; Ectoderm differentiation; Ectoderm differentiation; Alzheimer's disease; 5q35 copy number variation; HDAC6 interactions in the central nervous system,6,0,83.8,86.91,25.96,164.45,n/a,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,129.71,418.65,69.19,27.69,28.67,,0,
Master Protein,High,Q13895,BYSL,Bystin OS=Homo sapiens OX=9606 GN=BYSL PE=1 SV=3,3,4,0.662,6.283,0.095,1.339,-0.6,2.65,-3.4,0.42,7.74E-01,6.81E-03,1.76E-02,6.30E-01,3.55E+05,4.05E+05,4.36E+04,6.06E+04,2,2,4,2,,,,2.62E+05,4.83E+05,,2.57E+05,,,6.36E+05,5.58E+05,,2.33E+04,2.50E+04,7.61E+04,,5.25E+04,,7.01E+04,,,,,2.62E+05,2.49E+04,,4.58E+03,,,6.77E+03,3.34E+03,,1.90E+02,3.37E+03,1.89E+03,,1.47E+04,,1.64E+03,,0,FALSE,8.882,10,3,437,49.6,8.12,3,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,Pf05291,705,hsa:705; Q13895; Q6P5W4; Q86W44; Q96IP8,ENSG00000112578,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,42.02,59.95,152.08,20.29,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,44.71,117.86,69.39,78.2,8.29,nucleic acid binding activity,0,
Master Protein,High,P69892,HBG2,Hemoglobin subunit gamma-2 OS=Homo sapiens OX=9606 GN=HBG2 PE=1 SV=2,12,122,0.662,0.387,4.644,0.133,-0.6,-1.37,2.22,-2.91,7.67E-01,4.73E-01,6.54E-02,9.56E-02,3.37E+05,5.17E+05,3.45E+05,2.00E+06,2,2,5,4,,,1.46E+06,7.79E+04,,2.27E+06,,,1.18E+05,,2.81E+05,1.90E+05,5.19E+05,3.45E+05,4.21E+05,9.14E+05,2.40E+07,2.25E+06,1.78E+06,,,,1.43E+04,7.79E+04,,8.09E+03,,,3.32E+03,,1.68E+03,8.47E+03,4.22E+03,4.65E+04,1.05E+04,1.78E+03,6.75E+06,1.60E+04,4.17E+04,,0,FALSE,81.393,84,1,147,16.1,7.2,12,other metabolic processes;transport;other biological processes,cytosol;other cell component,Pf00042,3048,A8MZE0; hsa:3048; P02096; P62027; P69892; Q14491; Q68NH9; Q96FH6; Q96FH7,ENSG00000196565,Factors involved in megakaryocyte development and platelet production,,1,0,127.11,127.5,36.1,154.67,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,65.68,59.3,117.31,63.27,347.39,other molecular function,0,
Master Protein,High,O00479,HMGN4,High mobility group nucleosome-binding domain-containing protein 4 OS=Homo sapiens OX=9606 GN=HMGN4 PE=1 SV=3,1,3,0.662,0.54,4.677,0.127,-0.6,-0.89,2.23,-2.97,7.10E-01,7.72E-01,1.62E-01,8.26E-02,1.07E+05,9.23E+04,5.50E+04,4.32E+05,3,3,4,1,,1.44E+05,5.10E+04,1.07E+05,,,7.71E+04,9.23E+04,,2.45E+06,,2.37E+04,7.42E+04,4.07E+04,8.15E+04,,,,,4.32E+05,,5.46E+02,4.98E+02,1.07E+05,,,1.37E+03,8.52E+02,,2.61E+04,,1.06E+03,6.02E+02,5.49E+03,2.02E+03,,,,,4.60E+03,0.004,FALSE,2.611,10,1,90,9.5,10.48,1,cell organization and biogenesis,nucleus;other cell component,Pf01101,10473,B2R4I6; hsa:10473; O00479; Q53XL9,ENSG00000182952; ENSG00000292175,,,0,0,46.46,156.41,49.78,,n/a,Peak Found,Peak Found,High,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,85.26,55.01,29.35,50.01,6.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P23219,PTGS1,Prostaglandin G/H synthase 1 OS=Homo sapiens OX=9606 GN=PTGS1 PE=1 SV=2,3,7,0.658,0.402,0.442,0.788,-0.6,-1.32,-1.18,-0.34,7.61E-01,4.99E-01,3.76E-01,9.82E-01,2.21E+05,3.36E+05,1.17E+05,1.48E+05,2,1,3,3,,1.10E+05,,,4.41E+05,3.36E+05,,,,,,,5.08E+04,1.17E+05,1.55E+05,1.48E+05,2.74E+05,,3.62E+04,,,4.19E+02,,,2.28E+04,1.19E+03,,,,,,,4.12E+02,1.57E+04,3.85E+03,2.89E+02,7.69E+04,,8.46E+02,,0,FALSE,9.974,9,3,599,68.6,7.23,3,other metabolic processes;stress response;other biological processes,other membranes;ER/Golgi;other cell component,Pf03098,5742,A8K1V7; B4DHQ2; B4E2S5; hsa:5742; P23219; Q15122; Q3HY28; Q3HY29; Q5T7T6; Q5T7T7; Q5T7T8,ENSG00000095303,Synthesis of Prostaglandins (PG) and Thromboxanes (TX); COX reactions,"Selenium micronutrient network; Overview of nanoparticle effects; Aspirin and miRNAs; Eicosanoid metabolism via cyclooxygenases (COX); Prostaglandin and leukotriene metabolism in senescence ; Arachidonic acid (AA, ARA) oxylipin metabolism; Prostaglandin and leukotriene metabolism in senescence ; Omega-6-fatty acids in senescence; Acetaminophen in analgesia and antipyresis; Prostaglandin synthesis and regulation",12,0,84.8,,49.04,77.82,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,High,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,111.09,84.41,67.98,112.06,25.26,other molecular function,0,
Master Protein,High,Q9NX18,SDHAF2,"Succinate dehydrogenase assembly factor 2, mitochondrial OS=Homo sapiens OX=9606 GN=SDHAF2 PE=1 SV=1",2,2,0.657,2.763,1.079,1.564,-0.61,1.47,0.11,0.65,6.96E-01,8.65E-02,9.80E-01,5.62E-01,8.51E+04,1.30E+05,2.92E+05,1.40E+05,2,1,5,2,,,,1.11E+05,6.52E+04,,,,,1.30E+05,7.70E+05,2.52E+04,3.23E+05,1.48E+05,2.92E+05,,,2.92E+05,6.68E+04,,,,,1.11E+05,3.36E+03,,,,,1.38E+03,4.61E+03,1.12E+03,2.63E+03,1.99E+04,7.26E+03,,,2.07E+03,1.56E+03,,0,FALSE,6.937,8,2,166,19.6,6.8,2,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;mitochondrion;nucleus,Pf03937,54949,hsa:54949; Q9NX18,ENSG00000167985,,Mitochondrial complex II assembly,1,0,36.89,,90.71,88.81,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,40.06,104.95,119.63,107.06,6.14,,0,
Master Protein,High,P60953,CDC42,Cell division control protein 42 homolog OS=Homo sapiens OX=9606 GN=CDC42 PE=1 SV=2,6,26,0.656,0.541,0.249,1.99,-0.61,-0.89,-2.01,0.99,5.62E-01,7.16E-01,5.14E-02,4.92E-01,4.75E+06,2.92E+06,4.63E+06,5.97E+05,5,4,5,4,1.85E+07,3.83E+06,7.47E+06,2.24E+06,4.75E+06,1.06E+06,,8.79E+06,9.70E+05,8.04E+06,1.67E+07,2.33E+06,4.72E+06,1.90E+06,4.63E+06,8.63E+05,4.80E+05,3.21E+05,7.42E+05,,7.34E+04,1.46E+04,7.30E+04,2.24E+06,2.45E+05,3.77E+03,,8.11E+04,2.73E+04,8.55E+04,9.96E+04,1.04E+05,3.84E+04,2.56E+05,1.15E+05,1.68E+03,1.35E+05,2.28E+03,1.74E+04,,0,FALSE,21.902,37,5,191,21.2,6.55,6,cell-cell signaling;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,998,hsa:998; P21181; P25763; P60953; Q7L8R5; Q9UDI2,ENSG00000070831,RHO GTPases Activate Formins; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; MAPK6/MAPK4 signaling; RHO GTPases Activate WASPs and WAVEs; RHO GTPases activate IQGAPs; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; RHOU GTPase cycle; EPHB-mediated forward signaling; DCC mediated attractive signaling; GPVI-mediated activation cascade; VEGFA-VEGFR2 Pathway; Myogenesis; Factors involved in megakaryocyte development and platelet production; G beta:gamma signalling through CDC42; EGFR downregulation; RHO GTPases activate PAKs; Inactivation of CDC42 and RAC1; CD28 dependent Vav1 pathway; RHO GTPases activate KTN1,Androgen receptor signaling pathway; Target of rapamycin signaling; Integrin-mediated cell adhesion; RANKL/RANK signaling pathway; Leptin signaling pathway; Microtubule cytoskeleton regulation; Metastatic brain tumor; Pathogenic Escherichia coli infection; RalA downstream regulated genes; B cell receptor signaling pathway; AGE/RAGE pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Focal adhesion; TGF-beta signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; Oxidative damage response; p38 MAPK signaling pathway; MET in type 1 papillary renal cell carcinoma; Ebola virus infection in host; Ras signaling; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Hippo signaling regulation pathways; 22q11.2 copy number variation syndrome; Gastrin signaling pathway; Regulation of actin cytoskeleton; G13 signaling pathway; Genetic causes of porto-sinusoidal vascular disease; 13q12.12 copy number variation; T-cell receptor signaling pathway; DNA damage response (only ATM dependent),63,1,88.4,90.84,100.37,40.89,High,High,High,High,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,129.43,96.48,87.15,89.34,82.5,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P27694,RPA1,Replication protein A 70 kDa DNA-binding subunit OS=Homo sapiens OX=9606 GN=RPA1 PE=1 SV=2,4,5,0.656,0.631,0.24,1.677,-0.61,-0.67,-2.06,0.75,7.48E-01,9.08E-01,1.29E-01,5.11E-01,6.01E+05,3.72E+05,3.34E+05,1.20E+05,3,3,4,3,9.63E+04,2.55E+06,,6.01E+05,,7.65E+05,,,3.72E+05,1.84E+05,7.09E+05,3.16E+05,,3.53E+05,1.65E+05,,2.31E+04,2.81E+05,1.20E+05,,3.83E+02,9.70E+03,,6.01E+05,,2.72E+03,,,1.05E+04,1.95E+03,4.24E+03,1.41E+04,,4.76E+04,4.11E+03,,6.49E+03,1.99E+03,2.81E+03,,0,FALSE,11.877,10,4,616,68.1,7.21,4,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf01336, Pf04057, Pf08646, Pf16900",6117,A8K0Y9; hsa:6117; P27694; Q59ES9,ENSG00000132383,Fanconi Anemia Pathway; SUMOylation of DNA damage response and repair proteins; Regulation of HSF1-mediated heat shock response; Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Meiotic recombination; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; HSF1 activation; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Removal of the Flap Intermediate; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER; Removal of the Flap Intermediate from the C-strand; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),"Homologous recombination; Retinoblastoma gene in cancer; G1 to S cell cycle control; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",38,0,119.73,67.36,59.59,92.13,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,119.11,121.96,109.42,95.32,14.58,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P55899,FCGRT,IgG receptor FcRn large subunit p51 OS=Homo sapiens OX=9606 GN=FCGRT PE=1 SV=1,1,8,0.655,0.316,1.608,0.187,-0.61,-1.66,0.68,-2.42,7.74E-01,3.60E-01,7.03E-01,1.73E-01,2.85E+05,4.35E+05,7.79E+04,9.24E+05,4,5,5,4,1.48E+05,3.00E+05,,2.71E+05,7.33E+05,7.58E+05,9.08E+04,1.99E+06,4.35E+05,2.66E+05,5.16E+04,1.06E+04,7.79E+04,4.04E+05,2.65E+05,1.26E+06,1.86E+04,,1.59E+06,6.75E+05,5.88E+02,1.14E+03,,2.71E+05,3.78E+04,2.70E+03,1.61E+03,1.84E+04,1.23E+04,2.83E+03,3.09E+02,4.75E+02,6.33E+02,5.44E+04,6.58E+03,2.46E+03,5.22E+03,,3.71E+04,7.19E+03,0.006,FALSE,2.453,2,1,365,39.7,6.54,1,transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle,"Pf00129, Pf07654",2217,hsa:2217; P55899; Q5HYM5; Q9HBV7; Q9NZ19,ENSG00000104870,,,0,0,70.27,107.06,103.1,77.93,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,114.35,115.09,135.61,143.98,5.57,other molecular function,0,
Master Protein,High,Q16822,PCK2,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homo sapiens OX=9606 GN=PCK2 PE=1 SV=4",6,9,0.655,1.136,1.309,0.689,-0.61,0.18,0.39,-0.54,7.43E-01,4.15E-01,8.84E-01,9.16E-01,5.85E+05,3.28E+05,8.42E+05,8.77E+05,5,4,5,5,3.05E+05,5.85E+05,9.06E+05,1.46E+06,5.68E+05,2.74E+05,3.93E+05,,6.59E+04,6.62E+05,4.38E+05,1.03E+06,4.60E+05,8.42E+05,1.32E+06,8.77E+05,7.57E+05,2.18E+06,2.36E+05,6.20E+06,1.21E+03,2.22E+03,8.85E+03,1.46E+06,2.93E+04,9.73E+02,7.00E+03,,1.86E+03,7.04E+03,2.62E+03,4.59E+04,3.74E+03,1.14E+05,3.29E+04,1.71E+03,2.13E+05,1.54E+04,5.53E+03,6.60E+04,0,FALSE,19.974,13,6,640,70.7,7.62,6,other metabolic processes;stress response;developmental processes;other biological processes,cytosol;mitochondrion,"Pf00821, Pf17297",5106,B4DW73; hsa:5106; O43253; Q16822; Q86U01; Q9BV62,ENSG00000100889; ENSG00000285241,Gluconeogenesis,Adipogenesis; Transcription factor regulation in adipogenesis; PPAR signaling pathway; PI3K-Akt signaling pathway; Krebs cycle disorders; DNA damage response (only ATM dependent),7,0,57.78,71.33,46.22,118.42,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,62.34,74.17,109.31,99.7,26.44,other molecular function,0,
Master Protein,High,A0A087WV05,,c-Myc-binding protein OS=Homo sapiens OX=9606 PE=3 SV=1,2,5,0.654,0.788,0.671,0.762,-0.61,-0.34,-0.58,-0.39,7.39E-01,8.41E-01,5.92E-01,9.69E-01,6.31E+05,9.65E+05,4.93E+05,6.47E+05,3,1,4,1,,1.63E+06,,6.31E+05,2.11E+05,,,,,9.65E+05,,3.07E+05,4.75E+05,1.25E+06,5.12E+05,,6.47E+05,,,,,6.21E+03,,6.31E+05,1.09E+04,,,,,1.03E+04,,1.37E+04,3.86E+03,1.69E+05,1.27E+04,,1.82E+05,,,,0,FALSE,6.983,26,2,110,12.7,6.02,2,other biological processes,mitochondrion;nucleus,,,,,,,0,0,88.62,,66.01,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,91.01,94.38,0,47.75,10.9,other molecular function,0,
Master Protein,High,Q8IY17,PNPLA6,Patatin-like phospholipase domain-containing protein 6 OS=Homo sapiens OX=9606 GN=PNPLA6 PE=1 SV=3,4,6,0.653,1,0.661,0.53,-0.61,0,-0.6,-0.92,7.60E-01,6.97E-01,5.26E-01,6.94E-01,1.41E+05,6.60E+05,9.39E+04,5.09E+05,3,3,4,3,1.08E+06,,1.03E+05,1.41E+05,,,4.36E+05,,6.60E+05,1.65E+06,1.58E+06,3.67E+04,,1.34E+04,2.40E+05,,7.77E+05,1.05E+05,5.09E+05,,4.28E+03,,1.01E+03,1.41E+05,,,7.75E+03,,1.86E+04,1.75E+04,9.46E+03,1.64E+03,,1.80E+03,5.97E+03,,2.18E+05,7.41E+02,1.19E+04,,0,FALSE,15.323,6,4,1375,150.9,7.74,4,other metabolic processes,other membranes;cytosol;ER/Golgi,"Pf00027, Pf01734",10908,A6NGQ0; B4DFB9; B7Z7T2; F5H5K9; hsa:10908; J3KQS3; O60859; Q86W58; Q8IY17; Q9UG58,ENSG00000032444,Glycerophospholipid catabolism,,1,0,125.16,70.55,160.11,73.05,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,128.44,137.56,103.85,133.82,19.6,other molecular function,0,
Master Protein,High,Q14165,MLEC,Malectin OS=Homo sapiens OX=9606 GN=MLEC PE=1 SV=1,6,24,0.653,1.15,1.433,0.264,-0.62,0.2,0.52,-1.92,5.85E-01,4.39E-01,7.43E-01,2.70E-01,1.94E+06,1.91E+06,2.55E+06,3.35E+06,5,4,5,5,1.69E+06,3.55E+06,1.83E+06,1.94E+06,2.56E+06,,7.35E+05,1.79E+06,2.04E+06,3.95E+06,1.11E+06,1.37E+04,5.90E+06,4.49E+06,2.55E+06,8.88E+06,9.69E+05,9.76E+06,1.39E+06,3.35E+06,6.72E+03,1.35E+04,1.79E+04,1.94E+06,1.32E+05,,1.31E+04,1.65E+04,5.74E+04,4.20E+04,6.64E+03,6.12E+02,4.79E+04,6.06E+05,6.33E+04,1.73E+04,2.72E+05,6.92E+04,3.25E+04,3.56E+04,0,FALSE,30.196,34,6,292,32.2,5.41,6,protein metabolism;other metabolic processes,plasma membrane;other membranes;ER/Golgi,Pf11721,9761,hsa:9761; Q14165,ENSG00000110917,Neutrophil degranulation; N-glycan trimming in the ER and Calnexin/Calreticulin cycle,,2,0,33.08,62.9,85.5,85.72,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,1,,FALSE,87.9,118.39,134.7,133.31,74.48,other molecular function,0,
Master Protein,High,Q9UNW1,MINPP1,Multiple inositol polyphosphate phosphatase 1 OS=Homo sapiens OX=9606 GN=MINPP1 PE=1 SV=1,2,5,0.65,0.289,0.123,0.692,-0.62,-1.79,-3.02,-0.53,6.25E-01,2.50E-01,4.94E-03,8.73E-01,8.04E+05,2.73E+06,2.32E+05,6.40E+05,2,4,1,2,,,2.07E+05,,3.13E+06,4.19E+06,1.77E+06,,6.61E+04,5.52E+06,,,2.32E+05,,,,1.35E+06,,3.03E+05,,,,2.02E+03,,1.61E+05,1.49E+04,3.16E+04,,1.86E+03,5.87E+04,,,1.89E+03,,,,3.80E+05,,7.08E+03,,0,FALSE,8.377,5,2,487,55,7.81,2,other metabolic processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi,Pf00328,9562,F5H683; hsa:9562; O95172; O95286; Q59EJ2; Q9UGA3; Q9UNW1,ENSG00000107789,Synthesis of IPs in the ER lumen,,1,0,123.9,84.44,,89.7,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,131.82,269.37,112.13,0,17.49,other molecular function,0,
Master Protein,High,Q86U38,NOP9,Nucleolar protein 9 OS=Homo sapiens OX=9606 GN=NOP9 PE=1 SV=1,3,5,0.649,1.696,,14.142,-0.62,0.76,,3.82,7.35E-01,2.46E-01,,3.82E-03,3.78E+05,1.65E+05,5.30E+05,4.15E+04,1,1,5,1,,,,3.78E+05,,,1.65E+05,,,,1.27E+06,4.93E+04,5.30E+05,8.81E+05,3.71E+05,,4.15E+04,,,,,,,3.78E+05,,,2.94E+03,,,,7.61E+03,2.20E+03,4.30E+03,1.19E+05,9.21E+03,,1.17E+04,,,,0,FALSE,16.425,9,3,636,69.4,7.28,3,RNA metabolism OR transcription;other metabolic processes;transport,nucleus;other cell component,,161424,A8MY76; hsa:161424; Q86U38; Q8IVF0; Q8TBS6,ENSG00000196943; ENSG00000285326,,,0,0,,,76.03,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,0,63.53,,35.44,15.19,,0,
Master Protein,High,P13010,XRCC5,X-ray repair cross-complementing protein 5 OS=Homo sapiens OX=9606 GN=XRCC5 PE=1 SV=3,18,61,0.645,0.42,0.558,0.642,-0.63,-1.25,-0.84,-0.64,5.49E-01,4.60E-01,3.82E-01,7.50E-01,1.11E+07,4.90E+06,3.31E+06,1.35E+06,5,5,5,5,3.22E+07,7.96E+06,1.11E+07,1.49E+07,1.03E+07,4.90E+06,3.92E+06,5.43E+06,1.67E+04,4.91E+06,2.31E+07,3.31E+06,5.71E+05,1.15E+07,3.18E+06,1.05E+07,1.03E+06,1.35E+06,9.81E+05,1.80E+07,1.28E+05,3.02E+04,1.08E+05,1.49E+07,5.30E+05,1.74E+04,6.97E+04,5.01E+04,4.71E+02,5.22E+04,1.38E+05,1.48E+05,4.64E+03,1.54E+06,7.91E+04,2.04E+04,2.89E+05,9.57E+03,2.30E+04,1.92E+05,0,FALSE,95.026,35,18,732,82.7,5.81,18,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf02735, Pf03730, Pf03731, Pf08785",7520,A8K3X5; hsa:7520; P13010; Q0Z7V0; Q4VBQ5; Q53HH7; Q7M4N0; Q9UCQ0; Q9UCQ1,ENSG00000079246,Neutrophil degranulation; Cytosolic sensors of pathogen-associated DNA ; Nonhomologous End-Joining (NHEJ); 2-LTR circle formation; IRF3-mediated induction of type I IFN,"Non-homologous end joining; Male infertility; DNA repair pathways, full network; p53 transcriptional gene network",9,0,63.95,57.44,110.64,120.43,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,109.77,122.22,139.45,125.7,203.78,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NRG9,AAAS,Aladin OS=Homo sapiens OX=9606 GN=AAAS PE=1 SV=1,3,8,0.644,1.149,0.916,1.143,-0.63,0.2,-0.13,0.19,7.14E-01,5.59E-01,8.72E-01,7.91E-01,2.16E+05,1.32E+05,7.00E+04,1.20E+05,4,2,4,3,3.14E+06,,2.55E+04,4.33E+05,1.08E+05,,,1.83E+05,9.43E+04,,5.03E+04,4.79E+04,9.73E+04,4.31E+05,,,1.20E+05,2.66E+05,1.49E+04,,1.25E+04,,2.49E+02,4.33E+05,5.58E+03,,,1.69E+03,2.66E+03,,3.01E+02,2.14E+03,7.91E+02,5.81E+04,,,3.38E+04,1.89E+03,3.50E+02,,0,FALSE,16.385,8,3,546,59.5,7.5,3,cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes,other membranes;cytosol;cytoskeleton;nucleus,Pf00400,8086,hsa:8086; Q5JB47; Q9NRG9; Q9NWI6; Q9UG19,ENSG00000094914; ENSG00000291836,HCMV Early Events; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; tRNA processing in the nucleus; RHOA GTPase cycle; HCMV Late Events; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),,29,0,160.36,45.32,117.66,94.25,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,88.04,99.02,79.28,124.35,28.25,,0,
Master Protein,High,P11940,PABPC1,Polyadenylate-binding protein 1 OS=Homo sapiens OX=9606 GN=PABPC1 PE=1 SV=2,14,52,0.644,0.999,2.961,0.48,-0.63,0,1.57,-1.06,5.48E-01,5.87E-01,2.10E-01,5.66E-01,3.34E+06,2.45E+06,2.02E+06,1.54E+07,5,5,5,5,1.04E+06,3.50E+06,2.03E+06,3.34E+06,4.64E+06,1.08E+07,2.45E+06,4.05E+06,3.85E+04,1.25E+06,2.02E+06,1.39E+06,1.71E+06,5.47E+06,2.04E+06,3.45E+07,1.54E+07,3.74E+07,4.89E+06,9.90E+06,4.11E+03,1.33E+04,1.98E+04,3.34E+06,2.39E+05,3.82E+04,4.36E+04,3.74E+04,1.08E+03,1.33E+04,1.21E+04,6.21E+04,1.39E+04,7.36E+05,5.07E+04,6.73E+04,4.32E+06,2.65E+05,1.14E+05,1.05E+05,0,FALSE,77.215,25,9,636,70.6,9.5,14,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00076, Pf00658",26986,hsa:26986; P11940; Q15097; Q93004,ENSG00000070756,AUF1 (hnRNP D0) binds and destabilizes mRNA; Regulation of expression of SLITs and ROBOs; Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Z-decay: degradation of maternal mRNAs by zygotically expressed factors,Translation factors; Endoderm differentiation; VEGFA-VEGFR2 signaling; Acute viral myocarditis,13,5,48.03,113.41,65.88,72,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,109.68,102.73,122.12,106.51,147.72,nucleic acid binding activity,0,
Master Protein,High,Q96J01,THOC3,THO complex subunit 3 OS=Homo sapiens OX=9606 GN=THOC3 PE=1 SV=1,2,2,0.643,0.834,0.01,100,-0.64,-0.26,-6.64,6.64,7.57E-01,8.13E-01,1.00E-17,1.00E-17,2.43E+05,5.29E+05,2.71E+05,,3,1,4,,1.73E+05,,,2.43E+05,6.69E+05,,,,,5.29E+05,1.58E+05,1.53E+05,,4.66E+05,5.28E+05,,,,,,6.88E+02,,,2.43E+05,3.45E+04,,,,,5.62E+03,9.44E+02,6.81E+03,,6.28E+04,1.31E+04,,,,,,0,FALSE,7.401,10,2,351,38.7,6.09,2,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,nucleus,"Pf00400, Pf07676, Pf12894",84321,hsa:84321; Q6NZ53; Q96J01,ENSG00000051596,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,,3,0,74.28,,61.02,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,108.09,65.89,,,6.69,nucleic acid binding activity,0,
Master Protein,High,P46783,RPS10,40S ribosomal protein S10 OS=Homo sapiens OX=9606 GN=RPS10 PE=1 SV=1,3,34,0.643,0.981,0.946,0.716,-0.64,-0.03,-0.08,-0.48,5.47E-01,6.06E-01,8.40E-01,8.26E-01,4.08E+06,4.20E+06,8.57E+06,4.98E+06,5,1,5,5,1.68E+07,2.33E+06,2.28E+07,4.08E+06,3.48E+06,4.20E+06,,,,,8.57E+06,6.05E+06,9.35E+06,2.86E+06,1.38E+07,4.98E+06,1.36E+07,8.50E+06,1.55E+06,1.38E+06,6.68E+04,8.85E+03,2.23E+05,4.08E+06,1.80E+05,1.49E+04,,,,,5.13E+04,2.70E+05,7.60E+04,3.85E+05,3.42E+05,9.71E+03,3.83E+06,6.03E+04,3.62E+04,1.47E+04,0,FALSE,21.848,15,3,165,18.9,10.15,3,protein metabolism;other metabolic processes,cytosol;translational apparatus;nucleus;other cell component,Pf03501,6204,B2R4E3; hsa:6204; P46783; Q5TZC0,ENSG00000124614,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,94.04,,49.91,85.99,High,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,74.04,89.51,29.98,101.72,95.06,other molecular function,0,
Master Protein,High,P35249,RFC4,Replication factor C subunit 4 OS=Homo sapiens OX=9606 GN=RFC4 PE=1 SV=2,6,6,0.641,0.431,0.01,100,-0.64,-1.21,-6.64,6.64,7.24E-01,5.49E-01,1.00E-17,1.00E-17,5.23E+05,3.94E+05,4.06E+05,,4,4,4,,2.80E+05,9.79E+05,,9.76E+05,2.22E+04,1.16E+05,,3.07E+06,1.66E+05,9.35E+05,,3.91E+05,3.06E+04,1.02E+06,4.22E+05,,,,,,1.11E+03,3.72E+03,,9.76E+05,1.15E+03,4.13E+02,,2.84E+04,4.69E+03,9.94E+03,,1.75E+04,2.48E+02,1.38E+05,1.05E+04,,,,,,0,FALSE,18.563,24,6,363,39.7,8.02,6,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00004, Pf08542",5984,B4DM41; D3DNV2; hsa:5984; P35249; Q6FHX7,ENSG00000163918,Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,"Gastric cancer network 2; Retinoblastoma gene in cancer; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",28,0,86.54,129.14,88.03,,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,116.75,101.74,,,17.88,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P07814,EPRS1,Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens OX=9606 GN=EPRS1 PE=1 SV=5,9,14,0.638,0.345,1.224,0.215,-0.65,-1.54,0.29,-2.22,6.92E-01,3.36E-01,8.55E-01,2.31E-01,9.61E+05,8.10E+05,1.23E+05,2.16E+06,5,5,5,4,1.76E+06,1.53E+06,7.85E+05,2.68E+04,9.61E+05,6.17E+05,8.31E+05,6.01E+05,3.75E+06,8.10E+05,1.23E+05,3.83E+04,5.53E+05,2.00E+05,2.84E+04,1.33E+05,2.19E+06,2.12E+06,,3.65E+06,6.98E+03,5.80E+03,7.67E+03,2.68E+04,4.96E+04,2.19E+03,1.48E+04,5.54E+03,1.06E+05,8.61E+03,7.36E+02,1.71E+03,4.49E+03,2.69E+04,7.05E+02,2.59E+02,6.16E+05,1.51E+04,,3.89E+04,0,FALSE,36.656,9,9,1512,170.5,7.33,9,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf00458, Pf00587, Pf00749, Pf03129, Pf03950, Pf09180, Pf20974",2058,A0AVA9; B9EGH3; hsa:2058; P07814; Q05BP6; Q05DF8; Q5DSM1; Q5H9S5; Q6PD57; Q86X73,ENSG00000136628,tRNA modification in the nucleus and cytosol; Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,Parkinson's disease pathway; VEGFA-VEGFR2 signaling; Amino acid metabolism,6,0,67.12,103,114.2,71.33,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,118.86,114.56,77.85,125.03,44.1,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P08133,ANXA6,Annexin A6 OS=Homo sapiens OX=9606 GN=ANXA6 PE=1 SV=3,26,228,0.638,2.6,1.542,1.218,-0.65,1.38,0.62,0.28,5.41E-01,5.06E-02,6.74E-01,8.02E-01,4.71E+06,9.28E+06,5.37E+07,3.63E+07,5,5,5,5,4.71E+06,1.06E+06,3.22E+06,2.50E+07,2.34E+07,9.28E+06,5.62E+06,1.45E+07,1.27E+06,7.60E+07,6.68E+06,8.72E+06,6.16E+07,8.47E+07,5.37E+07,4.09E+07,2.96E+07,2.63E+07,4.59E+07,3.63E+07,1.87E+04,4.02E+03,3.15E+04,2.50E+07,1.21E+06,3.30E+04,1.00E+05,1.34E+05,3.57E+04,8.08E+05,3.99E+04,3.89E+05,5.01E+05,1.14E+07,1.33E+06,7.98E+04,8.31E+06,1.87E+05,1.07E+06,3.86E+05,0,FALSE,135.915,45,2,673,75.8,5.6,26,cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;mitochondrion;other cytoplasmic organelle;other cell component,Pf00191,309,B7Z8A7; D3DQH4; E9PGK1; hsa:309; P08133; Q6ZT79,ENSG00000197043,Smooth Muscle Contraction,Calcium regulation in cardiac cells; Prostaglandin synthesis and regulation,3,26,101.95,144.97,79.52,22.37,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,128.8,130.79,118.82,127.57,646.58,transporter activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A8V8TR54,CHD3,DNA helicase OS=Homo sapiens OX=9606 GN=CHD3 PE=1 SV=1,11,19,0.637,0.831,2.336,,-0.65,-0.27,1.22,,7.35E-01,8.39E-01,4.72E-01,,4.25E+05,3.77E+05,3.54E+05,4.95E+05,3,2,1,2,,1.04E+06,,4.25E+05,1.35E+05,2.12E+05,6.71E+05,,,,,,,3.54E+05,,2.66E+05,,9.20E+05,,,,3.94E+03,,4.25E+05,6.96E+03,7.53E+02,1.19E+04,,,,,,,4.77E+04,,5.19E+02,,6.52E+03,,,0,FALSE,36.223,7,5,2114,238.4,6.86,11,cell organization and biogenesis,nucleus,"Pf00176, Pf00271, Pf00385, Pf00628, Pf06461, Pf06465, Pf08073, Pf08074",1107,A0A8V8TR54,ENSG00000170004,,Effect of progerin on genes involved in progeria,1,0,86.54,73.59,,77.97,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,133.16,112.34,97.98,,53.26,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P16615,ATP2A2,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens OX=9606 GN=ATP2A2 PE=1 SV=1,15,55,0.636,0.691,1.21,0.563,-0.65,-0.53,0.28,-0.83,5.39E-01,9.98E-01,9.11E-01,6.64E-01,2.71E+06,4.36E+06,3.88E+06,1.10E+07,5,5,5,5,8.01E+05,9.40E+06,2.71E+06,2.56E+06,1.07E+07,2.10E+06,2.77E+06,2.08E+07,4.85E+06,4.36E+06,4.78E+06,1.96E+06,2.76E+06,3.88E+06,4.63E+06,2.32E+07,3.01E+06,1.24E+07,1.70E+06,1.10E+07,3.18E+03,3.57E+04,2.64E+04,2.56E+06,5.51E+05,7.48E+03,4.93E+04,1.92E+05,1.37E+05,4.63E+04,2.86E+04,8.77E+04,2.24E+04,5.22E+05,1.15E+05,4.52E+04,8.47E+05,8.77E+04,3.97E+04,1.17E+05,0,FALSE,74.382,15,11,1042,114.7,5.34,15,cell adhesion;cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,"Pf00122, Pf00689, Pf00690, Pf00702, Pf13246",488,A6NDN7; B4DF05; hsa:488; P16614; P16615; Q86VJ2,ENSG00000174437,Ion homeostasis; Ion transport by P-type ATPases; Pre-NOTCH Processing in Golgi; Reduction of cytosolic Ca++ levels,Alzheimer's disease and miRNA effects; Arrhythmogenic right ventricular cardiomyopathy; Endothelin pathways; Myometrial relaxation and contraction pathways; Alzheimer's disease; Calcium regulation in cardiac cells,10,0,85.66,112.01,33.8,84.22,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,1,,FALSE,110.37,104.67,127.62,106.05,157.45,transporter activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,B0YIW6,ARCN1,Coatomer subunit delta OS=Homo sapiens OX=9606 GN=ARCN1 PE=1 SV=1,2,5,0.635,1.064,0.743,1.305,-0.65,0.09,-0.43,0.38,6.74E-01,6.65E-01,7.33E-01,7.16E-01,8.70E+04,1.25E+05,6.37E+04,9.26E+04,3,2,5,4,,,8.70E+04,1.05E+05,5.96E+04,,9.98E+04,1.55E+05,,,8.24E+05,6.34E+04,6.37E+04,1.67E+05,2.66E+04,,1.98E+05,1.76E+05,1.03E+04,4.87E+04,,,8.50E+02,1.05E+05,3.08E+03,,1.77E+03,1.43E+03,,,4.92E+03,2.83E+03,5.17E+02,2.25E+04,6.61E+02,,5.56E+04,1.25E+03,2.42E+02,5.19E+02,0,FALSE,7.865,5,2,552,61.6,5.85,2,transport,other membranes;ER/Golgi,"Pf00928, Pf01217",,B0YIW6,ENSG00000095139,,miR-517 relationship with ARCN1 and USP1,1,0,27.22,30.84,147.04,85.63,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,30.12,86.14,89.25,132.04,15.14,,0,
Master Protein,High,Q9HDC9,APMAP,Adipocyte plasma membrane-associated protein OS=Homo sapiens OX=9606 GN=APMAP PE=1 SV=2,12,64,0.633,0.885,0.654,0.835,-0.66,-0.18,-0.61,-0.26,5.35E-01,7.16E-01,5.00E-01,9.33E-01,9.35E+06,2.63E+07,1.37E+07,1.31E+07,5,5,5,5,9.35E+06,3.89E+07,1.94E+06,1.15E+07,7.15E+06,2.63E+07,4.89E+06,2.76E+07,6.85E+06,2.89E+07,1.96E+07,2.81E+06,1.37E+07,1.75E+07,9.46E+06,3.18E+07,4.23E+06,1.76E+06,2.35E+07,1.31E+07,3.71E+04,1.48E+05,1.89E+04,1.15E+07,3.69E+05,9.36E+04,8.70E+04,2.54E+05,1.93E+05,3.08E+05,1.17E+05,1.25E+05,1.11E+05,2.36E+06,2.35E+05,6.20E+04,1.19E+06,1.25E+04,5.50E+05,1.39E+05,0,FALSE,47.036,39,12,416,46.5,6.16,12,other metabolic processes,other membranes;other cell component,"Pf03088, Pf20067",57136,A8K514; B4DXG1; hsa:57136; Q6UVZ8; Q9GZS8; Q9HDC9; Q9NUB2,ENSG00000101474,,Ciliary landscape,1,0,105.2,63.25,53.17,85.71,High,High,Peak Found,High,Peak Found,High,High,High,High,High,High,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,124.68,118.98,121.93,110.81,167.12,other molecular function,0,
Master Protein,High,E7ETB3,DNPEP,Aspartyl aminopeptidase OS=Homo sapiens OX=9606 GN=DNPEP PE=1 SV=2,5,5,0.633,0.197,2.235,,-0.66,-2.35,1.16,,7.46E-01,8.77E-02,3.50E-01,,5.37E+05,6.27E+04,3.08E+05,2.01E+06,5,5,4,2,5.37E+05,6.66E+04,3.74E+06,4.88E+05,4.92E+06,1.62E+06,2.35E+04,4.12E+04,6.27E+04,5.21E+05,2.41E+06,,5.22E+05,1.81E+05,1.16E+05,2.03E+06,,1.98E+06,,,2.13E+03,2.53E+02,3.65E+04,4.88E+05,2.54E+05,5.78E+03,4.18E+02,3.80E+02,1.77E+03,5.54E+03,1.44E+04,,4.24E+03,2.44E+04,2.88E+03,3.97E+03,,1.40E+04,,,0,FALSE,13.339,11,5,493,54.5,7.74,5,protein metabolism,cytosol,Pf02127,23549,E7ETB3,ENSG00000123992,,Ciliary landscape,1,0,113.84,150.93,134.13,1.89,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,89.94,103.51,83.62,,14.54,other molecular function,0,
Master Protein,High,O95571,ETHE1,"Persulfide dioxygenase ETHE1, mitochondrial OS=Homo sapiens OX=9606 GN=ETHE1 PE=1 SV=2",5,32,0.632,1.785,0.497,7.952,-0.66,0.84,-1.01,2.99,6.19E-01,1.62E-01,3.86E-01,5.54E-02,2.02E+06,4.57E+05,4.09E+06,9.05E+05,5,2,5,1,2.02E+06,4.96E+05,9.50E+04,2.49E+06,4.68E+06,1.04E+05,,2.02E+06,,,1.29E+05,4.44E+06,4.09E+06,6.08E+06,3.40E+06,,,,9.05E+05,,8.01E+03,1.88E+03,9.28E+02,2.49E+06,2.41E+05,3.69E+02,,1.86E+04,,,7.71E+02,1.98E+05,3.32E+04,8.20E+05,8.45E+04,,,,2.12E+04,,0,FALSE,27.929,39,5,254,27.9,6.83,5,other metabolic processes,mitochondrion;nucleus;other cell component,Pf00753,23474,hsa:23474; O95571; Q96HR0; Q9H001,ENSG00000105755,Sulfide oxidation to sulfate,,1,0,93.28,127.58,60.38,,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,High,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,65.2,127.38,68.11,123.41,91.22,other molecular function,0,
Master Protein,Medium,Q6IN84,MRM1,"rRNA methyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=MRM1 PE=1 SV=1",1,1,0.632,2.203,0.514,2.517,-0.66,1.14,-0.96,1.33,6.22E-01,2.34E-01,5.18E-01,3.24E-01,3.05E+04,4.82E+04,6.23E+04,2.48E+04,2,1,4,3,,,,2.01E+04,4.61E+04,,,,,4.82E+04,,8.86E+04,5.14E+04,5.08E+04,7.56E+04,,2.48E+04,,1.37E+04,4.46E+04,,,,2.01E+04,2.38E+03,,,,,5.13E+02,,3.96E+03,4.17E+02,6.84E+03,1.88E+03,,6.96E+03,,3.20E+02,4.74E+02,0.011,FALSE,2.265,2,1,353,38.6,7.94,1,RNA metabolism OR transcription;other metabolic processes,mitochondrion,"Pf00588, Pf08032",79922,A8K8E2; hsa:79922; Q6IN84; Q96GK2; Q9H664,ENSG00000274853; ENSG00000278619,rRNA modification in the mitochondrion,17q12 copy number variation syndrome,2,0,55.61,,28.06,56.54,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,63.4,55.65,65.88,66.45,0,other molecular function,0,
Master Protein,High,O95202,LETM1,Mitochondrial proton/calcium exchanger protein OS=Homo sapiens OX=9606 GN=LETM1 PE=1 SV=1,10,29,0.629,0.685,0.199,0.886,-0.67,-0.55,-2.33,-0.18,6.02E-01,9.31E-01,3.83E-02,9.81E-01,2.14E+06,1.33E+06,1.27E+06,1.42E+06,3,3,5,5,,2.82E+06,,2.14E+06,1.26E+06,,3.58E+06,,2.73E+05,1.33E+06,4.66E+04,8.65E+06,1.15E+06,3.22E+06,1.27E+06,6.41E+06,1.42E+06,6.07E+05,6.47E+05,2.84E+07,,1.07E+04,,2.14E+06,6.49E+04,,6.37E+04,,7.68E+03,1.42E+04,2.79E+02,3.87E+05,9.35E+03,4.34E+05,3.16E+04,1.25E+04,3.98E+05,4.30E+03,1.52E+04,3.02E+05,0,FALSE,54.519,18,10,739,83.3,6.7,10,cell organization and biogenesis;transport;other biological processes,other membranes;mitochondrion,Pf07766,3954,B4DED2; hsa:3954; O95202; Q9UF65,ENSG00000168924,RHOG GTPase cycle; Mitochondrial calcium ion transport,4p16.3 copy number variation,3,0,37.85,97.71,119.58,159.1,n/a,High,n/a,High,High,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,119.7,95.88,136.27,105.89,98.17,transporter activity;translation activity;other molecular function,0,
Master Protein,High,P22307,SCP2,Sterol carrier protein 2 OS=Homo sapiens OX=9606 GN=SCP2 PE=1 SV=2,5,35,0.628,0.802,1.322,0.458,-0.67,-0.32,0.4,-1.13,6.18E-01,7.72E-01,8.22E-01,5.38E-01,1.60E+06,1.70E+06,2.37E+06,9.22E+06,4,5,5,5,8.16E+05,,2.99E+04,5.55E+06,3.13E+06,5.69E+06,5.38E+05,1.15E+06,1.70E+06,6.13E+06,7.34E+05,5.77E+05,7.38E+06,1.28E+07,2.37E+06,7.60E+06,4.51E+06,1.57E+07,1.54E+07,9.22E+06,3.24E+03,,2.93E+02,5.55E+06,1.61E+05,2.02E+04,9.57E+03,1.06E+04,4.80E+04,6.52E+04,4.39E+03,2.58E+04,5.99E+04,1.72E+06,5.88E+04,1.48E+04,1.27E+06,1.11E+05,3.60E+05,9.82E+04,0,FALSE,15.598,5,5,547,59,6.89,5,cell organization and biogenesis;other metabolic processes;transport;other biological processes,cytosol;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00108, Pf02036, Pf02803",6342,A6NM69; B4DGJ9; B4DHP6; C9JC79; D3DQ37; E1B6W5; F2Z3J1; hsa:6342; P22307; Q15432; Q16622; Q5VVZ1; Q6NXF4; Q99430,ENSG00000116171,TYSND1 cleaves peroxisomal proteins; alpha-linolenic acid (ALA) metabolism,PPAR-alpha pathway; Nuclear receptors meta-pathway; Mitochondrial long chain fatty acid beta-oxidation; PPAR signaling pathway; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Mitochondrial fatty acid oxidation disorders; DNA damage response (only ATM dependent),10,0,104.51,87.22,110.25,46.87,Peak Found,n/a,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,High,High,High,1,,FALSE,121.66,135.08,120.7,119.59,71.08,signal transduction activity or receptor binding;transporter activity;other molecular function,0,
Master Protein,High,P29350,PTPN6,Tyrosine-protein phosphatase non-receptor type 6 OS=Homo sapiens OX=9606 GN=PTPN6 PE=1 SV=1,2,5,0.626,0.493,0.852,0.768,-0.68,-1.02,-0.23,-0.38,7.13E-01,6.69E-01,7.82E-01,9.89E-01,4.35E+05,6.95E+05,6.01E+05,7.27E+05,2,2,3,3,,8.74E+05,,2.16E+05,,,,8.54E+05,,5.66E+05,,,3.55E+05,6.01E+05,8.68E+05,7.27E+05,2.14E+05,,1.13E+06,,,3.32E+03,,2.16E+05,,,,7.88E+03,,6.02E+03,,,2.88E+03,8.09E+04,2.16E+04,1.42E+03,6.03E+04,,2.64E+04,,0,FALSE,8.142,5,2,595,67.5,7.78,2,cell adhesion;cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00017, Pf00102",5777,A8K306; G3V0F8; hsa:5777; P29350; Q969V8; Q9UK67,ENSG00000111679,Neutrophil degranulation; CD22 mediated BCR regulation; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; PD-1 signaling; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Signal regulatory protein family interactions; Interleukin receptor SHC signaling; GPVI-mediated activation cascade; Signaling by ALK; Regulation of KIT signaling; Growth hormone receptor signaling; Regulation of IFNG signaling; Regulation of IFNA/IFNB signaling; Interleukin-37 signaling; Platelet sensitization by LDL; PECAM1 interactions; Nuclear events stimulated by ALK signaling in cancer,Prolactin signaling pathway; B cell receptor signaling pathway; T cell receptor and co-stimulatory signaling; IL-3 signaling pathway; Kit receptor signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling; Microglia pathogen phagocytosis pathway; IL-4 signaling pathway; Cancer immunotherapy by CTLA4 blockade; Modulators of TCR signaling and T cell activation; Interferon type I signaling pathways,33,0,85.28,28.65,42.2,66.41,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,76,44.05,52.76,85.25,15.26,other molecular function,0,
Master Protein,High,P00846,MT-ATP6,ATP synthase subunit a OS=Homo sapiens OX=9606 GN=MT-ATP6 PE=1 SV=1,1,4,0.622,1.012,0.273,2.007,-0.68,0.02,-1.88,1.01,5.22E-01,5.74E-01,7.35E-02,4.87E-01,4.07E+06,7.23E+06,3.88E+06,2.03E+06,4,5,3,5,5.11E+06,1.59E+07,,8.09E+05,3.24E+06,2.47E+07,3.23E+06,7.23E+06,3.53E+06,8.52E+06,6.41E+06,,,3.88E+06,2.78E+06,2.03E+06,1.72E+06,2.32E+06,4.20E+05,3.19E+06,2.03E+04,6.05E+04,,8.09E+05,1.67E+05,8.77E+04,5.75E+04,6.67E+04,9.95E+04,9.06E+04,3.83E+04,,,5.22E+05,6.91E+04,3.95E+03,4.83E+05,1.65E+04,9.82E+03,3.40E+04,0.002,FALSE,3.045,4,1,226,24.8,10.1,1,other metabolic processes;stress response;transport,other membranes;mitochondrion,Pf00119,4508,hsa:4508; P00846; Q34772; Q5S8W5; Q5S9E7; Q5S9I6; Q5SA31; Q6RPB7; Q6VHC0; Q6VHE0; Q6WQF4; Q7YCC1; Q7YCF8; Q7YCG1; Q85KU8; Q85KX1; Q85L05; Q8HNQ4; Q8HNQ8; Q8WCX6; Q9B2U5; Q9B2Z2,ENSG00000198899,Mitochondrial protein degradation; Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,6,0,106.38,93.43,42.74,52.21,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,102.64,100.94,86.78,58.61,9.75,transporter activity,0,
Master Protein,High,P36551,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial OS=Homo sapiens OX=9606 GN=CPOX PE=1 SV=3",17,97,0.622,0.489,1.149,0.192,-0.69,-1.03,0.2,-2.38,5.22E-01,6.09E-01,9.64E-01,1.65E-01,3.18E+06,9.30E+06,3.57E+06,1.51E+07,5,5,5,5,1.30E+06,1.68E+07,2.41E+06,3.18E+06,1.15E+07,6.08E+06,9.30E+06,6.30E+07,3.26E+06,9.97E+07,7.49E+05,4.35E+06,3.57E+06,6.75E+06,2.66E+06,2.77E+06,5.15E+07,1.51E+07,2.43E+07,7.31E+06,5.17E+03,6.39E+04,2.36E+04,3.18E+06,5.96E+05,2.16E+04,1.65E+05,5.81E+05,9.17E+04,1.06E+06,4.48E+03,1.94E+05,2.90E+04,9.09E+05,6.61E+04,5.40E+03,1.45E+07,1.07E+05,5.68E+05,7.78E+04,0,FALSE,78.894,43,17,454,50.1,8.25,17,other metabolic processes,other membranes;cytosol;mitochondrion;other cell component,Pf01218,1371,A8K275; B4DSD5; hsa:1371; P36551; Q14060; Q53F08; Q8IZ45; Q96AF3,ENSG00000080819,Heme biosynthesis,Hemesynthesis defects and porphyrias; Heme biosynthesis,3,0,96.48,119.12,61.04,95.64,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,128.17,96.63,138.46,102.46,272.24,other molecular function,0,
Master Protein,High,P02751,FN1,Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,4,8,0.622,0.342,0.038,1.879,-0.69,-1.55,-4.72,0.91,5.84E-01,3.39E-01,1.67E-05,4.97E-01,6.63E+05,2.92E+06,1.21E+05,9.49E+04,2,4,4,2,,2.14E+06,,2.05E+05,,,5.24E+06,6.26E+06,1.39E+06,1.63E+06,,1.28E+05,1.13E+05,7.61E+04,1.66E+05,,1.46E+05,,6.19E+04,,,8.14E+03,,2.05E+05,,,9.32E+04,5.78E+04,3.92E+04,1.73E+04,,5.73E+03,9.21E+02,1.03E+04,4.12E+03,,4.09E+04,,1.45E+03,,0,FALSE,19.441,3,4,2477,272.2,5.5,4,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;ER/Golgi;other cell component,"Pf00039, Pf00040, Pf00041",2335,B7ZLF0; E9PE77; E9PG29; hsa:2335; O95609; O95610; P02751; Q14312; Q14325; Q14326; Q17RV7; Q53S27; Q564H7; Q585T2; Q59EH1; Q60FE4; Q68DP8; Q68DP9; Q68DT4; Q6LDP6; Q6MZS0; Q6MZU5; Q6N025; Q6N0A6; Q7Z391; Q86T27; Q8IVI8; Q96KP7; Q96KP8; Q96KP9; Q9H1B8; Q9HAP3; Q9UMK2,ENSG00000115414,Cell surface interactions at the vascular wall; Degradation of the extracellular matrix; Integrin cell surface interactions; ECM proteoglycans; GPER1 signaling; Platelet degranulation ; Signaling by BRAF and RAF1 fusions; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; Interleukin-4 and Interleukin-13 signaling; Syndecan interactions; MET activates PTK2 signaling; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Molecules associated with elastic fibres; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins; Fibronectin matrix formation,Mammary gland development pathway - Puberty (Stage 2 of 4); miRNA targets in ECM and membrane receptors; Focal adhesion; Overview of nanoparticle effects; RAC1/PAK1/p38/MMP2 pathway; TGF-beta signaling pathway; Interactions between LOXL4 and oxidative stress pathway; Physico-chemical features and toxicity-associated pathways; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miR-509-3p alteration of YAP1/ECM axis; PI3K-Akt signaling pathway; Epithelial to mesenchymal transition in colorectal cancer; Inflammatory response pathway; Small cell lung cancer; IL-18 signaling pathway; Burn wound healing; Pleural mesothelioma; CCL18 signaling pathway; Regulation of actin cytoskeleton; Urotensin-II-mediated signaling pathway; TROP2 regulatory signaling; Macrophage-stimulating protein (MSP) signaling network map,51,0,116.71,68.48,30.67,57.06,n/a,Peak Found,n/a,High,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,86.89,94.86,50.84,204.28,22.29,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2,32,112,0.621,0.679,1.497,0.33,-0.69,-0.56,0.58,-1.6,5.21E-01,9.78E-01,7.02E-01,3.64E-01,8.31E+06,1.01E+07,4.81E+06,1.06E+08,5,5,5,5,3.69E+06,1.03E+07,4.27E+06,8.31E+06,9.17E+07,4.79E+07,1.01E+07,9.45E+06,1.06E+06,3.33E+07,7.58E+06,3.22E+06,4.81E+06,1.03E+07,2.52E+06,1.48E+08,8.58E+06,1.06E+08,1.07E+07,1.71E+08,1.47E+04,3.91E+04,4.17E+04,8.31E+06,4.73E+06,1.70E+05,1.80E+05,8.72E+04,2.99E+04,3.54E+05,4.53E+04,1.44E+05,3.91E+04,1.39E+06,6.27E+04,2.89E+05,2.41E+06,7.49E+05,2.49E+05,1.82E+06,0,FALSE,107.869,19,32,5890,628.7,6.15,32,other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,,79026,A1A586; hsa:79026; Q09666,ENSG00000124942,,,0,0,161.25,95.78,56.83,85.57,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,120.7,94.09,128.8,108.94,274.29,other molecular function,0,
Master Protein,High,O94880,PHF14,PHD finger protein 14 OS=Homo sapiens OX=9606 GN=PHF14 PE=1 SV=3,4,7,0.62,0.167,0.663,0.117,-0.69,-2.58,-0.59,-3.1,7.15E-01,6.65E-02,5.28E-01,7.37E-02,5.21E+05,9.05E+05,3.62E+05,1.16E+05,3,3,4,2,,6.07E+06,,5.21E+05,2.55E+05,9.05E+05,,1.08E+06,,1.75E+05,,3.30E+05,3.06E+04,5.77E+05,3.97E+05,4.09E+05,,,3.29E+04,,,2.31E+04,,5.21E+05,1.31E+04,3.22E+03,,9.98E+03,,1.86E+03,,1.47E+04,2.49E+02,7.77E+04,9.87E+03,7.97E+02,,,7.70E+02,,0,FALSE,13.38,6,4,948,106.9,5.34,4,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes,nucleus;other cell component,"Pf00628, Pf13831, Pf13832",9678,A0A0U1RRH6; A7MCZ3; B4DI82; hsa:9678; O94880,ENSG00000106443,,,0,0,143.88,66.72,68.11,120.35,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,131.59,128.94,240.22,217.88,18.83,other molecular function,0,
Master Protein,High,P25789,PSMA4,Proteasome subunit alpha type-4 OS=Homo sapiens OX=9606 GN=PSMA4 PE=1 SV=1,4,49,0.619,0.493,0.255,0.842,-0.69,-1.02,-1.97,-0.25,5.70E-01,6.74E-01,8.02E-02,9.61E-01,1.37E+06,2.30E+06,7.82E+05,3.67E+05,5,5,5,5,5.84E+05,7.27E+05,1.37E+06,1.93E+06,5.96E+07,2.30E+06,1.65E+06,2.32E+06,2.10E+05,3.10E+07,1.88E+05,5.20E+05,7.82E+05,3.91E+06,1.06E+06,5.85E+05,1.17E+05,8.50E+04,4.71E+06,3.67E+05,2.32E+03,2.76E+03,1.34E+04,1.93E+06,3.08E+06,8.17E+03,2.93E+04,2.14E+04,5.92E+03,3.30E+05,1.12E+03,2.32E+04,6.35E+03,5.27E+05,2.62E+04,1.14E+03,3.30E+04,6.02E+02,1.10E+05,3.90E+03,0,FALSE,11.094,18,4,261,29.5,7.72,4,protein metabolism;other metabolic processes,cytosol;nucleus;other cell component,"Pf00227, Pf10584",5685,D3DW86; hsa:5685; P25789; Q53XP2; Q567Q5; Q8TBD1,ENSG00000041357,Downstream TCR signaling; FCERI mediated NF-kB activation; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Exercise-induced circadian regulation; Alzheimer's disease,63,0,203.58,175.71,116.1,169.45,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,146.34,111.64,136.41,129.95,91.18,,0,
Master Protein,Medium,Q9BYD1,MRPL13,"39S ribosomal protein L13, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL13 PE=1 SV=1",1,1,0.619,0.779,0.01,100,-0.69,-0.36,-6.64,6.64,7.10E-01,8.73E-01,1.00E-17,1.00E-17,2.69E+05,7.36E+05,3.59E+05,,3,2,3,,1.11E+06,,,2.58E+05,2.69E+05,,4.26E+05,1.27E+06,,,,,2.01E+05,3.59E+05,4.77E+05,,,,,,4.39E+03,,,2.58E+05,1.39E+04,,7.58E+03,1.17E+04,,,,,1.63E+03,4.84E+04,1.19E+04,,,,,,0.03,FALSE,1.812,5,1,178,20.7,9.16,1,protein metabolism;other metabolic processes;other biological processes,other membranes;mitochondrion;translational apparatus,Pf00572,28998,B2R4R8; hsa:28998; Q9BYD1; Q9UI04,ENSG00000172172,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,89.33,70.37,40.17,,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,77.92,83.11,,,2.16,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P69891,HBG1,Hemoglobin subunit gamma-1 OS=Homo sapiens OX=9606 GN=HBG1 PE=1 SV=2,12,106,0.618,0.771,7.825,0.121,-0.69,-0.38,2.97,-3.05,5.39E-01,7.93E-01,1.27E-02,7.22E-02,1.86E+06,2.03E+06,1.42E+06,7.69E+06,5,5,5,5,1.75E+06,1.86E+06,4.00E+06,1.44E+06,2.49E+06,5.37E+06,7.04E+05,1.75E+06,2.03E+06,4.94E+06,1.56E+06,1.42E+06,8.10E+05,8.24E+06,6.00E+05,6.97E+06,1.10E+08,7.69E+06,3.80E+07,1.97E+06,6.94E+03,7.07E+03,3.91E+04,1.44E+06,1.28E+05,1.91E+04,1.25E+04,1.61E+04,5.72E+04,5.25E+04,9.34E+03,6.33E+04,6.58E+03,1.11E+06,1.49E+04,1.36E+04,3.09E+07,5.45E+04,8.88E+05,2.10E+04,0,FALSE,77.603,84,1,147,16.1,7.2,12,other metabolic processes;transport;other biological processes,cytosol;other cell component,Pf00042,736917,P02096; P61920; ptr:736917,,,,0,9,44.23,70.01,127.45,137.78,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,High,n/a,1,,FALSE,128.93,125.05,116.94,120.75,300.97,other molecular function,0,
Master Protein,High,P52756,RBM5,RNA-binding protein 5 OS=Homo sapiens OX=9606 GN=RBM5 PE=1 SV=2,1,1,0.617,0.01,0.306,0.01,-0.7,-6.64,-1.71,-6.64,7.10E-01,1.00E-17,1.46E-01,1.00E-17,3.61E+05,5.85E+05,,1.79E+05,1,1,,1,,,,3.61E+05,,,,,,5.85E+05,,,,,,,1.79E+05,,,,,,,3.61E+05,,,,,,6.22E+03,,,,,,,5.04E+04,,,,0.001,FALSE,3.504,1,1,815,92.1,6.28,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00076, Pf00641, Pf01585, Pf17780",10181,B2RA45; B4DM16; B4DMF9; B4DZ63; hsa:10181; P52756; Q93021; Q9BU14; Q9HDA6; Q9UKY8; Q9UL24,ENSG00000003756,mRNA Splicing - Major Pathway,mRNA processing,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,0,,0,,2.35,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H553,ALG2,"Alpha-1,3/1,6-mannosyltransferase ALG2 OS=Homo sapiens OX=9606 GN=ALG2 PE=1 SV=1",1,5,0.615,3.057,0.03,66.663,-0.7,1.61,-5.04,6.06,6.25E-01,1.03E-01,1.70E-03,4.27E-04,5.61E+04,9.12E+04,1.85E+05,2.77E+03,2,2,4,1,8.44E+04,,,3.72E+04,,1.14E+05,,,7.30E+04,,4.18E+04,,3.16E+05,2.10E+05,1.62E+05,,2.77E+03,,,,3.35E+02,,,3.72E+04,,4.05E+02,,,2.06E+03,,2.50E+02,,2.57E+03,2.83E+04,4.03E+03,,7.79E+02,,,,0,FALSE,5.301,3,1,416,47.1,7.05,1,protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi;nucleus;other cell component,"Pf00534, Pf13439",85365,A2A2Y0; hsa:85365; Q8NBX2; Q8NC39; Q9H553,ENSG00000119523,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein; Defective ALG2 causes CDG-1i",N-glycan biosynthesis,3,0,54.8,30.92,62.32,,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,High,n/a,High,n/a,n/a,n/a,1,,FALSE,49.9,78.51,33.22,63,16.39,other molecular function,0,
Master Protein,High,P84095,RHOG,Rho-related GTP-binding protein RhoG OS=Homo sapiens OX=9606 GN=RHOG PE=1 SV=1,2,9,0.612,1.457,1.427,0.572,-0.71,0.54,0.51,-0.81,7.37E-01,3.33E-01,8.24E-01,7.21E-01,1.53E+05,4.90E+05,2.55E+05,4.46E+05,5,2,5,3,1.50E+05,1.29E+06,6.07E+04,1.53E+05,6.00E+05,1.15E+06,,,2.08E+05,,2.55E+05,2.23E+05,1.96E+05,5.53E+05,4.10E+05,3.12E+06,1.98E+05,,4.46E+05,,5.96E+02,4.89E+03,5.93E+02,1.53E+05,3.10E+04,4.10E+03,,,5.87E+03,,1.53E+03,9.95E+03,1.59E+03,7.45E+04,1.02E+04,6.08E+03,5.57E+04,,1.04E+04,,0,FALSE,11.223,16,1,191,21.3,8.12,2,cell organization and biogenesis;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component,Pf00071,391,hsa:391; P35238; P84095; Q8NI04,ENSG00000177105,"Neutrophil degranulation; RHOG GTPase cycle; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; GPVI-mediated activation cascade; RHO GTPases activate KTN1",Brain-derived neurotrophic factor (BDNF) signaling pathway,8,0,113.94,98.08,46.14,129.07,Peak Found,High,Peak Found,High,High,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,125.14,115.82,119.19,82.39,20.83,other molecular function,0,
Master Protein,High,Q92973,TNPO1,Transportin-1 OS=Homo sapiens OX=9606 GN=TNPO1 PE=1 SV=2,5,7,0.612,1.88,0.926,1.839,-0.71,0.91,-0.11,0.88,6.57E-01,2.02E-01,8.73E-01,4.67E-01,1.66E+05,1.10E+05,2.86E+05,1.61E+05,3,2,4,4,,1.66E+05,,7.89E+04,1.86E+05,,2.43E+05,,,4.96E+04,,4.17E+05,1.24E+05,1.03E+06,1.96E+05,9.26E+04,2.80E+05,,2.97E+05,5.92E+04,,6.30E+02,,7.89E+04,9.62E+03,,4.32E+03,,,5.27E+02,,1.86E+04,1.01E+03,1.39E+05,4.87E+03,1.81E+02,7.87E+04,,6.94E+03,6.30E+02,0,FALSE,20.3,9,4,898,102.3,4.98,5,transport,cytosol;nucleus;other cell component,"Pf02985, Pf03810, Pf13513",3842,B4DVC6; hsa:3842; Q92957; Q92973; Q92975,ENSG00000083312,"Intraflagellar transport; Postmitotic nuclear pore complex (NPC) reformation; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",22q11.2 copy number variation syndrome,4,1,39.71,93.49,93.3,67.87,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,High,n/a,Peak Found,High,1,,FALSE,15.3,85.51,56.48,77.72,16.99,other molecular function,0,
Master Protein,High,Q8NC56,LEMD2,LEM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=LEMD2 PE=1 SV=1,4,6,0.611,1.33,0.215,3.523,-0.71,0.41,-2.22,1.82,6.97E-01,3.82E-01,8.20E-02,1.72E-01,3.12E+05,5.06E+05,6.48E+05,1.09E+05,5,3,3,1,1.42E+05,1.45E+06,1.70E+05,1.30E+06,3.12E+05,5.15E+05,,5.06E+05,,2.60E+05,4.65E+05,,6.48E+05,1.41E+06,,,1.09E+05,,,,5.65E+02,5.52E+03,1.66E+03,1.30E+06,1.61E+04,1.83E+03,,4.67E+03,,2.76E+03,2.78E+03,,5.27E+03,1.91E+05,,,3.06E+04,,,,0,FALSE,13.828,10,4,503,56.9,9,4,cell organization and biogenesis;developmental processes;other biological processes,other membranes;cytoskeleton;nucleus;other cell component,"Pf03020, Pf09402",221496,B4DVH5; E7EVT2; Q5T972; Q5T974; Q8NC56,ENSG00000161904,Sealing of the nuclear envelope (NE) by ESCRT-III; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina,,4,0,95.57,33.95,59.78,,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,44.97,64.85,2.53,28.59,14.39,,0,
Master Protein,High,P33527,ABCC1,Multidrug resistance-associated protein 1 OS=Homo sapiens OX=9606 GN=ABCC1 PE=1 SV=3,1,2,0.61,2.196,2.812,0.422,-0.71,1.13,1.49,-1.25,6.54E-01,2.10E-01,3.75E-01,5.42E-01,7.28E+04,1.19E+05,1.41E+05,3.35E+05,2,1,4,1,,,,3.62E+04,1.46E+05,,,,1.19E+05,,,7.03E+04,3.64E+05,1.06E+05,1.89E+05,,,3.35E+05,,,,,,3.62E+04,7.55E+03,,,,3.36E+03,,,3.14E+03,2.95E+03,1.43E+04,4.69E+03,,,2.38E+03,,,0,FALSE,4.831,1,1,1531,171.5,7.11,1,cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes,plasma membrane;other membranes,"Pf00005, Pf00664",4363,A3RJX2; C9JPJ4; hsa:4363; O14819; O43333; P33527; P78419; Q59GI9; Q9UQ97; Q9UQ99; Q9UQA0,ENSG00000103222; ENSG00000278183,ABC-family proteins mediated transport; Sphingolipid de novo biosynthesis; Paracetamol ADME; Cytoprotection by HMOX1; Transport of RCbl within the body; NFE2L2 regulating MDR associated enzymes; Heme degradation; Synthesis of Leukotrienes (LT) and Eoxins (EX),Irinotecan pathway; Leukotriene metabolic pathway; TROP2 regulatory signaling,11,0,85.36,,71.78,,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,112.24,80.28,0,70.15,5.82,transporter activity;other molecular function,0,
Master Protein,Medium,P17900,GM2A,Ganglioside GM2 activator OS=Homo sapiens OX=9606 GN=GM2A PE=1 SV=4,1,3,0.609,6.782,2.263,2.252,-0.72,2.76,1.18,1.17,5.93E-01,9.13E-03,5.30E-01,4.01E-01,3.42E+04,4.28E+04,2.20E+05,9.78E+04,2,3,5,2,,,,5.70E+04,2.06E+04,7.67E+04,,,4.28E+04,4.13E+04,2.62E+05,1.38E+05,1.41E+05,4.61E+05,2.20E+05,,1.01E+05,,9.51E+04,,,,,5.70E+04,1.06E+03,2.73E+02,,,1.20E+03,4.39E+02,1.56E+03,6.18E+03,1.14E+03,6.21E+04,5.47E+03,,2.83E+04,,2.22E+03,,0.012,FALSE,2.201,4,1,193,20.8,5.31,1,other metabolic processes;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf02221,2760,B2R699; D3DQH6; hsa:2760; P17900; Q14426; Q14428; Q6LBL5,ENSG00000196743,Neutrophil degranulation; Glycosphingolipid catabolism,"Degradation pathway of sphingolipids, including diseases",3,0,66.38,37.43,54,4.09,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,59.88,74.76,8.85,51.59,6.71,transporter activity;enzyme regulator activity;other molecular function,0,
Master Protein,High,A0A8V8TP41,FERMT3,FERM domain containing kindlin 3 OS=Homo sapiens OX=9606 GN=FERMT3 PE=1 SV=1,7,17,0.608,0.42,0.66,0.859,-0.72,-1.25,-0.6,-0.22,6.85E-01,4.88E-01,6.43E-01,9.65E-01,1.28E+06,2.22E+05,1.26E+06,1.71E+06,4,5,5,4,4.70E+06,4.00E+05,4.10E+06,3.61E+05,,1.96E+05,2.22E+05,2.99E+06,1.30E+06,2.95E+04,1.26E+06,7.15E+05,1.85E+07,2.19E+06,7.87E+05,8.26E+05,4.55E+06,,1.94E+06,1.50E+06,1.87E+04,1.52E+03,4.01E+04,3.61E+05,,6.97E+02,3.94E+03,2.76E+04,3.65E+04,3.14E+02,7.52E+03,3.19E+04,1.50E+05,2.95E+05,1.96E+04,1.61E+03,1.28E+06,,4.55E+04,1.59E+04,0,FALSE,27.889,16,7,670,76.1,6.77,7,cell adhesion;signal transduction,other cell component,"Pf00169, Pf00373, Pf18124",,A0A8V8TP41,ENSG00000149781,,,0,0,97.65,131.74,165.02,73.96,High,Peak Found,High,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,High,Peak Found,1,,FALSE,113.01,132.32,88.02,129.19,52.62,,0,
Master Protein,High,O95831,AIFM1,"Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens OX=9606 GN=AIFM1 PE=1 SV=1",14,73,0.607,0.676,0.436,1.225,-0.72,-0.56,-1.2,0.29,5.05E-01,9.73E-01,2.33E-01,7.97E-01,4.02E+06,1.87E+06,6.99E+06,1.60E+06,5,4,5,5,2.09E+06,4.02E+06,1.53E+06,6.63E+06,6.32E+06,,1.22E+06,2.73E+06,1.28E+06,2.11E+07,6.99E+06,9.10E+06,2.47E+06,1.62E+07,5.35E+06,1.50E+06,9.69E+05,1.98E+06,1.60E+06,1.89E+06,8.31E+03,1.53E+04,1.49E+04,6.63E+06,3.26E+05,,2.16E+04,2.52E+04,3.59E+04,2.24E+05,4.18E+04,4.07E+05,2.01E+04,2.18E+06,1.33E+05,2.93E+03,2.72E+05,1.40E+04,3.75E+04,2.01E+04,0,FALSE,72.985,34,14,613,66.9,8.95,14,cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,other membranes;cytosol;mitochondrion;nucleus;other cell component,"Pf00070, Pf14721",9131,A4QPB4; B1ALN1; B2RB08; D3DTE9; E9PRR0; O95831; Q1L6K4; Q1L6K6; Q2QKE4; Q5JUZ7; Q6I9X6; Q9Y3I3; Q9Y3I4,ENSG00000156709,,Apoptosis modulation and signaling; Nanomaterial induced apoptosis; Apoptosis modulation by HSP70,3,0,56.95,147.49,64.47,25.07,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,High,High,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.46,111.26,132.63,138.91,205.98,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P31930,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial OS=Homo sapiens OX=9606 GN=UQCRC1 PE=1 SV=3",14,139,0.607,1.554,0.635,2.615,-0.72,0.64,-0.66,1.39,5.04E-01,2.32E-01,4.77E-01,3.53E-01,5.51E+06,8.18E+06,1.97E+07,3.60E+06,5,5,5,5,5.51E+06,9.96E+06,3.26E+06,1.70E+07,2.27E+06,2.94E+07,4.25E+06,3.18E+07,6.21E+06,8.18E+06,4.63E+07,1.58E+07,1.89E+07,2.04E+07,1.97E+07,3.91E+06,7.54E+06,2.69E+06,3.60E+06,1.77E+06,2.19E+04,3.79E+04,3.18E+04,1.70E+07,1.17E+05,1.05E+05,7.56E+04,2.93E+05,1.75E+05,8.70E+04,2.77E+05,7.06E+05,1.54E+05,2.76E+06,4.89E+05,7.62E+03,2.12E+06,1.91E+04,8.43E+04,1.88E+04,0,FALSE,83.563,45,14,480,52.6,6.37,14,other metabolic processes;transport;other biological processes,other membranes;mitochondrion,"Pf00675, Pf05193",7384,B2R7R8; hsa:7384; P31930; Q96DD2,ENSG00000010256,Respiratory electron transport,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,4,0,79.39,84.26,51.4,56.37,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,117.94,116.82,134.45,114.04,370.91,transporter activity;other molecular function,0,
Master Protein,High,P54725,RAD23A,UV excision repair protein RAD23 homolog A OS=Homo sapiens OX=9606 GN=RAD23A PE=1 SV=1,2,3,0.605,0.337,2.42,0.346,-0.72,-1.57,1.28,-1.53,6.93E-01,3.67E-01,3.81E-01,4.90E-01,4.66E+05,4.83E+05,1.76E+05,1.12E+06,5,3,3,4,2.35E+05,7.20E+05,1.13E+05,4.66E+05,1.12E+06,4.83E+05,,,2.93E+05,1.85E+06,,6.59E+04,,4.79E+05,1.76E+05,,2.54E+04,4.47E+06,4.79E+05,2.61E+06,9.34E+02,2.74E+03,1.10E+03,4.66E+05,5.77E+04,1.72E+03,,,8.25E+03,1.96E+04,,2.95E+03,,6.45E+04,4.38E+03,,7.12E+03,3.17E+04,1.12E+04,2.77E+04,0.001,FALSE,3.754,5,2,363,39.6,4.58,2,protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,"Pf00240, Pf00627, Pf09280",5886,hsa:5886; K7ESE3; P54725; Q59EU8; Q5M7Z1,ENSG00000179262,Josephin domain DUBs; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER,"Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",6,0,75.8,96.95,88.93,108.28,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,88.1,104.6,134.63,139.02,2.16,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q92541,RTF1,RNA polymerase-associated protein RTF1 homolog OS=Homo sapiens OX=9606 GN=RTF1 PE=1 SV=4,4,5,0.605,0.485,1.184,0.154,-0.72,-1.04,0.24,-2.69,6.91E-01,6.63E-01,9.62E-01,1.08E-01,3.69E+05,7.94E+05,1.31E+05,4.81E+05,4,2,2,3,,3.17E+05,7.30E+04,4.31E+05,5.86E+05,1.39E+06,,,,4.55E+05,1.40E+05,,,1.22E+05,,4.81E+05,5.34E+04,,,8.30E+06,,1.20E+03,7.13E+02,4.31E+05,3.03E+04,4.93E+03,,,,4.84E+03,8.37E+02,,,1.65E+04,,9.38E+02,1.50E+04,,,8.83E+04,0,FALSE,11.627,7,4,710,80.3,8.15,4,cell-cell signaling;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,nucleus,Pf03126,23168,hsa:23168; Q92541; Q96BX6,ENSG00000137815,E3 ubiquitin ligases ubiquitinate target proteins; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,Endoderm differentiation,5,0,61.47,71.52,9.57,157.66,n/a,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,76.69,64.68,133.57,135.37,15.74,nucleic acid binding activity,0,
Master Protein,High,O96005,CLPTM1,Putative lipid scramblase CLPTM1 OS=Homo sapiens OX=9606 GN=CLPTM1 PE=1 SV=1,2,2,0.603,1.195,4.031,0.179,-0.73,0.26,2.01,-2.48,6.03E-01,5.83E-01,2.56E-01,2.33E-01,6.04E+04,5.44E+04,3.92E+04,2.19E+05,2,1,2,2,,,,5.03E+04,7.26E+04,,,,5.44E+04,,,1.08E+04,,,1.43E+05,,,4.74E+05,1.01E+05,,,,,5.03E+04,3.74E+03,,,,1.53E+03,,,4.82E+02,,,3.54E+03,,,3.36E+03,2.37E+03,,0,FALSE,10.541,7,2,669,76,6.3,2,other biological processes,plasma membrane;other membranes;other cell component,Pf05602,1209,B3KQH2; B4DDS3; B4E2X9; B7Z9X9; F5H8J3; hsa:1209; O96005; Q53ET6; Q9BSS5,ENSG00000104853,,,0,0,25.63,,121.52,91.62,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,130.42,112.62,126.09,115.14,6.8,signal transduction activity or receptor binding,0,
Master Protein,High,Q8NCG7,DAGLB,Diacylglycerol lipase-beta OS=Homo sapiens OX=9606 GN=DAGLB PE=1 SV=2,3,5,0.601,0.628,0.165,0.086,-0.73,-0.67,-2.6,-3.54,6.92E-01,9.25E-01,7.05E-02,6.21E-02,2.53E+05,1.59E+05,1.19E+05,2.60E+05,4,4,2,2,,1.78E+05,2.93E+04,4.56E+05,3.59E+05,1.28E+05,1.99E+05,4.43E+05,,5.88E+04,,5.10E+04,,2.76E+05,,3.21E+06,,,2.11E+04,,,6.77E+02,2.86E+02,4.56E+05,1.85E+04,4.55E+02,3.53E+03,4.09E+03,,6.25E+02,,2.28E+03,,3.72E+04,,6.26E+03,,,4.94E+02,,0,FALSE,12.174,7,3,672,73.7,6.55,3,cell cycle OR cell proliferation;other metabolic processes;developmental processes;other biological processes,plasma membrane;other membranes;nucleus,Pf01764,221955,A4D2P3; B3KV90; B4DQU0; hsa:221955; Q6PIX3; Q8N2N2; Q8N9S1; Q8NCG7; Q8TED3; Q8WXE6,ENSG00000164535,Arachidonate production from DAG,Cannabinoid receptor signaling; ADHD and autism (ASD) linked metabolic pathways and SNP,3,0,74.26,80.77,97.33,139.58,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,116.54,58.4,80.07,0,19.67,other molecular function,0,
Master Protein,High,P01591,JCHAIN,Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,2,12,0.594,1.091,0.01,100,-0.75,0.13,-6.64,6.64,6.98E-01,5.85E-01,1.00E-17,1.00E-17,3.84E+05,4.69E+05,4.82E+05,,4,5,4,,,1.90E+06,4.64E+04,1.08E+05,1.37E+06,1.02E+06,7.02E+05,4.69E+05,4.11E+05,4.30E+05,2.20E+05,7.99E+05,,4.89E+05,4.75E+05,,,,,,,7.20E+03,4.54E+02,1.08E+05,7.07E+04,3.61E+03,1.25E+04,4.32E+03,1.16E+04,4.57E+03,1.32E+03,3.57E+04,,6.58E+04,1.18E+04,,,,,,0,FALSE,9.028,14,2,159,18.1,5.24,2,cell organization and biogenesis;stress response;other biological processes,non-structural extracellular,Pf15097,3512,hsa:3512; P01591,ENSG00000132465,Cell surface interactions at the vascular wall; Scavenging of heme from plasma,,2,0,108.04,42.54,47.81,,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,158.66,130.95,,,24.29,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q13867,BLMH,Bleomycin hydrolase OS=Homo sapiens OX=9606 GN=BLMH PE=1 SV=1,2,8,0.592,0.483,0.059,10.071,-0.76,-1.05,-4.07,3.33,6.25E-01,7.23E-01,1.17E-02,2.75E-02,1.00E+05,1.09E+05,1.16E+04,9.12E+04,4,3,3,1,5.11E+05,,3.16E+05,3.16E+04,3.19E+04,1.94E+05,5.46E+04,,,1.09E+05,1.61E+06,,,9.40E+03,1.16E+04,,9.12E+04,,,,2.03E+03,,3.09E+03,3.16E+04,1.65E+03,6.90E+02,9.71E+02,,,1.16E+03,9.60E+03,,,1.27E+03,2.89E+02,,2.56E+04,,,,0,FALSE,8.895,7,2,455,52.5,6.27,2,protein metabolism;other metabolic processes;other biological processes,cytosol;other cell component,Pf03051,642,B2R796; hsa:642; Q13867; Q53F86; Q9UER9,ENSG00000108578,Antigen processing: Ubiquitination & Proteasome degradation,,1,0,105.23,58.9,169.85,,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,141.39,123.68,127.88,216.92,12.04,other molecular function,0,
Master Protein,High,P80723,BASP1,Brain acid soluble protein 1 OS=Homo sapiens OX=9606 GN=BASP1 PE=1 SV=2,6,75,0.592,0.03,0.565,0.01,-0.76,-5.07,-0.82,-6.64,4.86E-01,5.29E-06,3.90E-01,1.00E-17,1.57E+06,8.27E+06,3.06E+04,4.98E+06,4,5,1,5,4.53E+05,1.30E+07,2.25E+04,,5.47E+06,8.60E+06,8.27E+06,1.35E+07,3.18E+06,3.19E+06,,,,3.06E+04,,1.20E+07,5.70E+04,4.98E+06,2.68E+05,9.89E+06,1.80E+03,4.92E+04,2.20E+02,,2.82E+05,3.06E+04,1.47E+05,1.25E+05,8.97E+04,3.39E+04,,,,4.12E+03,,2.34E+04,1.60E+04,3.53E+04,6.27E+03,1.05E+05,0,FALSE,24.186,47,6,227,22.7,4.63,6,developmental processes;other biological processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,Pf05466,10409,B4DJA8; D3DTD5; hsa:10409; O43596; P80723; Q5U0S0; Q9BWA5,ENSG00000176788,RHOF GTPase cycle,,1,0,127.37,58.98,,100.2,Peak Found,High,Peak Found,n/a,High,High,High,High,High,High,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,High,High,1,,FALSE,113.23,213.51,119.11,137.28,179.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UJC5,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2 OS=Homo sapiens OX=9606 GN=SH3BGRL2 PE=1 SV=2,1,1,0.59,0.379,0.801,0.421,-0.76,-1.4,-0.32,-1.25,6.73E-01,4.09E-01,6.74E-01,5.36E-01,6.40E+05,4.84E+05,2.29E+05,5.75E+05,4,4,3,2,1.51E+06,1.43E+06,,8.92E+04,2.86E+05,2.78E+06,4.61E+05,,2.25E+05,5.07E+05,,2.29E+05,2.00E+05,,2.93E+05,1.28E+06,2.58E+05,,,,6.00E+03,5.45E+03,,8.92E+04,1.47E+04,9.87E+03,8.20E+03,,6.34E+03,5.39E+03,,1.02E+04,1.63E+03,,7.28E+03,2.50E+03,7.25E+04,,,,0.001,FALSE,3.635,13,1,107,12.3,6.71,1,,other membranes;nucleus;other cell component,Pf04908,83699,A8MQU2; hsa:83699; Q2VPC2; Q5VV96; Q6NSK8; Q6P9E8; Q7Z734; Q8IWD3; Q9BPY5; Q9UJC5,ENSG00000198478,,,0,0,90.01,120.49,19.66,94.02,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,119.5,128.92,103.4,109.18,2.5,other molecular function,0,
Master Protein,High,Q15428,SF3A2,Splicing factor 3A subunit 2 OS=Homo sapiens OX=9606 GN=SF3A2 PE=1 SV=2,5,9,0.59,0.357,2.059,0.1,-0.76,-1.49,1.04,-3.33,5.69E-01,3.85E-01,4.04E-01,4.45E-02,1.40E+06,9.50E+05,3.21E+05,2.83E+06,2,3,2,2,,,,1.14E+06,1.70E+06,,,9.50E+05,5.37E+05,9.91E+05,,1.90E+05,,5.44E+05,,,,1.90E+06,,4.20E+06,,,,1.14E+06,8.78E+04,,,8.77E+03,1.51E+04,1.05E+04,,8.47E+03,,7.33E+04,,,,1.35E+04,,4.47E+04,0,FALSE,18.639,17,5,464,49.2,9.64,5,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf12874, Pf16835",8175,B2RBU1; D6W605; hsa:8175; O75245; Q15428,ENSG00000104897,mRNA Splicing - Major Pathway,mRNA processing,2,0,27.7,30.43,68.36,53.2,n/a,n/a,n/a,High,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,Acetyl [N-Term],FALSE,59.89,43.91,32.22,55.72,24.74,other molecular function,0,
Master Protein,High,P84243,H3-3A; H3-3B,Histone H3.3 OS=Homo sapiens OX=9606 GN=H3-3A PE=1 SV=2,9,697,0.589,0.302,0.642,0.134,-0.76,-1.73,-0.64,-2.9,4.83E-01,2.33E-01,5.49E-01,9.60E-02,2.88E+06,1.86E+06,1.44E+05,7.53E+05,5,5,4,5,2.01E+05,1.80E+06,1.19E+07,2.88E+06,4.24E+06,3.22E+06,3.65E+05,1.86E+06,1.11E+06,1.32E+07,7.28E+04,2.86E+05,,6.27E+04,1.97E+06,6.99E+05,7.53E+05,4.75E+06,4.63E+05,6.34E+06,7.97E+02,6.83E+03,1.17E+05,2.88E+06,2.19E+05,1.14E+04,6.49E+03,1.71E+04,3.14E+04,1.40E+05,4.35E+02,1.28E+04,,8.45E+03,4.90E+04,1.36E+03,2.12E+05,3.37E+04,1.08E+04,6.75E+04,0,FALSE,42.057,64,2,136,15.3,11.27,9,cell organization and biogenesis;other biological processes,non-structural extracellular;nucleus;other cell component,Pf00125,3020; 3021,hsa:3020; hsa:3021; P06351; P33155; P84243; Q5VV55; Q5VV56; Q66I33; Q9V3W4,ENSG00000132475; ENSG00000163041,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; RNA Polymerase I Promoter Escape; Inhibition of DNA recombination at telomere; Amyloid fiber formation; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); Factors involved in megakaryocyte development and platelet production; Chromatin modifications during the maternal to zygotic transition (MZT); Meiotic recombination; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Condensation of Prophase Chromosomes; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis; Replacement of protamines by nucleosomes in the male pronucleus,Gastric cancer network 1; Histone modifications; Tumor suppressor activity of SMARCB1; Ciliary landscape; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; DYRK1A involvement regarding cell proliferation in brain development; 4p16.3 copy number variation; 5q35 copy number variation,36,0,108.47,133.35,153.99,105.65,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,132.39,109.32,126.47,147.5,1220.49,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A087WUB9,CTNNBL1,Catenin beta like 1 OS=Homo sapiens OX=9606 GN=CTNNBL1 PE=1 SV=1,4,9,0.588,0.394,,1.923,-0.77,-1.34,,0.94,4.81E-01,4.35E-01,,4.25E-01,1.87E+06,4.82E+06,1.07E+06,2.13E+05,5,2,5,1,2.24E+07,1.72E+06,7.08E+06,1.87E+06,2.47E+05,1.26E+07,,1.85E+06,,,1.44E+07,1.48E+05,8.35E+05,1.37E+06,1.07E+06,,,,2.13E+05,,8.89E+04,6.55E+03,6.92E+04,1.87E+06,1.27E+04,4.46E+04,,1.71E+04,,,8.61E+04,6.61E+03,6.79E+03,1.84E+05,2.65E+04,,,,4.98E+03,,0,FALSE,20.546,11,4,568,65.7,5.02,4,,cytosol;cytoskeleton;nucleus,Pf08216,,A0A087WUB9,ENSG00000132792,,,0,0,137.55,105.04,170.46,,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,129.1,125.72,,111.75,32.35,,0,
Master Protein,High,O60885,BRD4,Bromodomain-containing protein 4 OS=Homo sapiens OX=9606 GN=BRD4 PE=1 SV=2,8,14,0.587,0.332,0.649,1.462,-0.77,-1.59,-0.62,0.55,6.74E-01,3.45E-01,5.38E-01,5.35E-01,6.73E+05,2.11E+05,2.73E+05,3.09E+05,5,3,5,5,2.16E+05,6.73E+05,1.92E+05,2.67E+06,2.00E+06,8.33E+04,,1.04E+06,2.11E+05,,2.73E+05,1.99E+05,2.33E+05,1.41E+06,3.41E+05,6.10E+05,3.09E+05,6.36E+05,1.53E+05,1.35E+05,8.56E+02,2.56E+03,1.88E+03,2.67E+06,1.03E+05,2.96E+02,,9.60E+03,5.93E+03,,1.63E+03,8.90E+03,1.90E+03,1.90E+05,8.48E+03,1.19E+03,8.68E+04,4.51E+03,3.58E+03,1.44E+03,0,FALSE,29.383,7,5,1362,152.1,9.19,8,cell organization and biogenesis;stress response;other biological processes,nucleus;other cell component,"Pf00439, Pf17035, Pf17105",23476,hsa:23476; O60433; O60885; Q4G0X8; Q86YS8; Q96PD3,ENSG00000141867,Potential therapeutics for SARS,VEGFA-VEGFR2 signaling; 7q11.23 copy number variation syndrome,3,3,97.77,116.86,105.01,65.68,n/a,Peak Found,Peak Found,High,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,101.2,112.57,89.63,97.08,36.62,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,Q9UBU9,NXF1,Nuclear RNA export factor 1 OS=Homo sapiens OX=9606 GN=NXF1 PE=1 SV=1,1,3,0.587,1.114,1.052,0.621,-0.77,0.16,0.07,-0.69,6.87E-01,5.30E-01,8.88E-01,7.91E-01,2.15E+05,3.66E+05,2.39E+05,3.85E+05,2,1,2,1,,,4.96E+05,9.29E+04,,,3.66E+05,,,,3.14E+05,,,1.83E+05,,3.85E+05,,,,,,,4.85E+03,9.29E+04,,,6.51E+03,,,,1.88E+03,,,2.46E+04,,7.51E+02,,,,,0,FALSE,4.787,4,1,619,70.1,8.51,1,other metabolic processes;transport,cytosol;nucleus;other cell component,"Pf02136, Pf03943, Pf09162",10482,B4E269; hsa:10482; Q99799; Q9UBU9; Q9UQL2,ENSG00000162231,Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript,mRNA processing,5,0,96.82,,37.35,,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,139.25,106.25,0,40.59,10.54,nucleic acid binding activity,0,
Master Protein,High,Q9Y5K8,ATP6V1D,V-type proton ATPase subunit D OS=Homo sapiens OX=9606 GN=ATP6V1D PE=1 SV=1,1,3,0.582,2.702,4.391,0.421,-0.78,1.43,2.13,-1.25,5.76E-01,1.52E-01,2.25E-01,5.97E-01,3.56E+04,6.11E+04,1.13E+05,2.68E+05,2,1,3,1,,,2.98E+04,4.25E+04,,,,,,6.11E+04,,3.55E+04,,1.13E+05,1.17E+05,,2.68E+05,,,,,,2.91E+02,4.25E+04,,,,,,6.50E+02,,1.58E+03,,1.52E+04,2.90E+03,,7.54E+04,,,,0.001,FALSE,3.491,4,1,247,28.2,9.36,1,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf01813,51382,B2RE33; hsa:51382; Q9Y5K8; Q9Y688,ENSG00000100554,Amino acids regulate mTORC1; Neutrophil degranulation; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,Proximal tubule transport,7,0,24.73,,51.86,,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,26.33,62.85,0,4.41,2.08,transporter activity,0,
Master Protein,High,Q8NFW8,CMAS,N-acylneuraminate cytidylyltransferase OS=Homo sapiens OX=9606 GN=CMAS PE=1 SV=2,9,13,0.582,0.559,,0.478,-0.78,-0.84,,-1.06,6.65E-01,7.42E-01,,6.19E-01,3.83E+05,9.31E+04,4.38E+05,3.25E+05,3,1,3,1,3.83E+05,,,1.89E+06,2.99E+05,,,,9.31E+04,,,1.33E+05,,6.35E+05,4.38E+05,,3.25E+05,,,,1.52E+03,,,1.89E+06,1.54E+04,,,,2.62E+03,,,5.95E+03,,8.55E+04,1.09E+04,,9.12E+04,,,,0,FALSE,29.948,31,9,434,48.3,7.93,9,other metabolic processes,nucleus,Pf02348,55907,hsa:55907; Q8NFW8; Q96AX5; Q9NQZ0,ENSG00000111726,Sialic acid metabolism,Sialylation,2,0,104.52,,62.84,,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,0,116.28,,46.07,43.17,other molecular function,0,
Master Protein,High,Q96ST2,IWS1,Protein IWS1 homolog OS=Homo sapiens OX=9606 GN=IWS1 PE=1 SV=2,2,2,0.581,0.01,,0.01,-0.78,-6.64,,-6.64,6.68E-01,1.00E-17,,1.00E-17,2.30E+05,2.96E+05,,1.92E+05,4,3,,2,2.87E+06,1.52E+05,1.98E+05,2.66E+05,,2.93E+06,,1.63E+05,,2.96E+05,,,,,,,9.51E+04,,3.88E+05,,1.14E+04,5.76E+02,1.94E+03,2.66E+05,,1.04E+04,,1.51E+03,,3.15E+03,,,,,,,2.67E+04,,9.08E+03,,0,FALSE,9.787,3,2,819,91.9,4.69,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,nucleus,Pf08711,55677,hsa:55677; Q2TB65; Q6P157; Q8N3E8; Q96MI7; Q96ST2; Q9NV97; Q9NWH8,ENSG00000163166,Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,,3,0,152.94,138.05,,85.77,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,106.16,,,,8.92,,0,
Master Protein,High,P49736,MCM2,DNA replication licensing factor MCM2 OS=Homo sapiens OX=9606 GN=MCM2 PE=1 SV=4,5,15,0.581,3.065,,2.182,-0.78,1.62,,1.13,7.04E-01,3.34E-02,,3.71E-01,3.99E+05,2.68E+05,8.47E+05,7.23E+05,2,1,4,3,,,,1.32E+06,1.20E+05,,,,2.68E+05,,1.14E+06,,6.31E+05,3.77E+06,1.96E+05,,4.64E+05,,7.23E+05,9.13E+05,,,,1.32E+06,6.20E+03,,,,7.56E+03,,6.80E+03,,5.13E+03,5.08E+05,4.87E+03,,1.30E+05,,1.69E+04,9.72E+03,0,FALSE,19.486,7,5,904,101.8,5.52,5,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00493, Pf12619, Pf14551, Pf17207, Pf17855",4171,hsa:4171; P49736; Q14577; Q15023; Q8N2V1; Q969W7; Q96AE1; Q9BRM7,ENSG00000073111,Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA,Cell cycle; Ciliary landscape; G1 to S cell cycle control; DNA replication; 1p36 copy number variation syndrome,11,0,117.9,,111.92,32.23,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,0,109.19,,108.86,46.42,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P18583,SON,Protein SON OS=Homo sapiens OX=9606 GN=SON PE=1 SV=4,9,20,0.58,1.412,5.614,1.856,-0.79,0.5,2.49,0.89,7.08E-01,3.83E-01,3.19E-02,4.46E-01,2.81E+05,4.14E+05,5.59E+05,2.52E+06,5,2,5,5,2.81E+05,9.91E+04,2.41E+05,2.66E+06,8.24E+05,6.64E+05,,,,2.58E+05,4.97E+05,1.19E+06,1.56E+05,2.60E+06,5.59E+05,2.52E+06,1.72E+05,3.34E+06,5.33E+05,3.88E+06,1.11E+03,3.77E+02,2.36E+03,2.66E+06,4.25E+04,2.36E+03,,,,2.75E+03,2.97E+03,5.33E+04,1.27E+03,3.51E+05,1.39E+04,4.92E+03,4.82E+04,2.37E+04,1.25E+04,4.13E+04,0,FALSE,36.923,6,9,2426,263.7,5.64,9,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf01585, Pf14709, Pf17069",6651,D3DSF5; D3DSF6; E7ETE8; E7EU67; E7EVW3; E9PFQ2; hsa:6651; O14487; O95981; P18583; Q14120; Q6PKE0; Q9H7B1; Q9P070; Q9P072; Q9UKP9; Q9UPY0,ENSG00000159140,,,0,0,129.69,62.24,96.85,79.57,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,1,,FALSE,81.93,83.9,109.79,131.36,64.76,nucleic acid binding activity,0,
Master Protein,High,P13646,KRT13,"Keratin, type I cytoskeletal 13 OS=Homo sapiens OX=9606 GN=KRT13 PE=1 SV=4",15,158,0.579,0.87,0.463,0.927,-0.79,-0.2,-1.11,-0.11,4.71E-01,7.27E-01,2.65E-01,9.93E-01,3.69E+06,3.72E+06,1.03E+06,4.35E+06,5,5,5,5,6.98E+06,1.88E+07,3.69E+06,8.65E+05,3.32E+06,2.04E+07,1.80E+06,3.72E+06,4.88E+05,6.44E+06,1.60E+08,7.13E+05,1.03E+06,8.83E+05,1.18E+06,2.55E+07,3.68E+05,4.35E+06,1.68E+06,5.91E+06,2.77E+04,7.13E+04,3.61E+04,8.65E+05,1.71E+05,7.27E+04,3.19E+04,3.43E+04,1.38E+04,6.85E+04,9.57E+05,3.19E+04,8.39E+03,1.19E+05,2.92E+04,4.98E+04,1.03E+05,3.08E+04,3.92E+04,6.29E+04,0,FALSE,62.949,39,11,458,49.6,4.96,15,cell organization and biogenesis;stress response;other biological processes,cytosol;cytoskeleton,Pf00038,3860,hsa:3860; P13646; Q53G54; Q6AZK5; Q8N240,ENSG00000171401,Formation of the cornified envelope,Vitamin D receptor pathway,3,1,105.23,122.64,217.12,135.78,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,122.23,145.88,112.81,145.58,370.38,other molecular function,0,
Master Protein,High,A0A075B6F9,NOSIP,Nitric oxide synthase-interacting protein OS=Homo sapiens OX=9606 GN=NOSIP PE=1 SV=1,1,1,0.579,2.006,1.765,0.658,-0.79,1,0.82,-0.6,5.56E-01,2.71E-01,6.77E-01,8.60E-01,3.05E+04,5.26E+04,6.11E+04,9.29E+04,2,1,1,1,,,,5.06E+04,1.83E+04,,,5.26E+04,,,6.11E+04,,,,,,,,,9.29E+04,,,,5.06E+04,9.46E+02,,,4.86E+02,,,3.65E+02,,,,,,,,,9.89E+02,0.006,FALSE,2.443,6,1,304,33.4,8.72,1,,nucleus;other cell component,Pf15906,51070,A0A075B6F9,ENSG00000142546,,,0,0,66.12,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,78.42,78.42,0,0,3.1,other molecular function,0,
Master Protein,High,P42356,PI4KA,Phosphatidylinositol 4-kinase alpha OS=Homo sapiens OX=9606 GN=PI4KA PE=1 SV=4,1,1,0.578,0.01,0.01,,-0.79,-6.64,-6.64,,5.80E-01,1.00E-17,1.00E-17,,5.50E+04,9.53E+04,,,1,1,,,,,,5.50E+04,,,,,9.53E+04,,,,,,,,,,,,,,,5.50E+04,,,,,2.68E+03,,,,,,,,,,,,0,FALSE,4.998,1,1,2102,236.7,7.06,1,other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,"Pf00454, Pf00613, Pf19274",5297,hsa:5297; P42356; Q7Z625; Q9UPG2,ENSG00000241973,Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the ER membrane,Ectoderm differentiation; 22q11.2 copy number variation syndrome,4,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,,,,3.6,kinase activity;other molecular function,0,
Master Protein,Medium,Q9H5H4,ZNF768,Zinc finger protein 768 OS=Homo sapiens OX=9606 GN=ZNF768 PE=1 SV=2,1,1,0.578,1.041,0.01,100,-0.79,0.06,-6.64,6.64,6.82E-01,6.07E-01,1.00E-17,1.00E-17,2.66E+05,4.61E+05,2.57E+05,,2,1,3,,,,2.30E+05,3.07E+05,,,,4.61E+05,,,3.38E+05,2.57E+05,,,2.27E+05,,,,,,,,2.25E+03,3.07E+05,,,,4.25E+03,,,2.02E+03,1.15E+04,,,5.64E+03,,,,,,0.015,FALSE,2.113,2,1,540,60.2,7.97,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00096, Pf05001",79724,hsa:79724; Q569L7; Q96CX4; Q9H5H4,ENSG00000169957,,,0,0,20.22,,21.09,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,21.41,19.83,,,2.2,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A6NIW2,DOCK11,Dedicator of cytokinesis 11 OS=Homo sapiens OX=9606 GN=DOCK11 PE=1 SV=2,2,7,0.575,1.011,,0.998,-0.8,0.02,,0,6.12E-01,6.55E-01,,8.64E-01,1.83E+05,6.07E+04,1.35E+05,1.15E+05,3,2,5,4,1.83E+05,,,8.14E+04,2.45E+05,,8.38E+04,,,4.40E+04,4.37E+04,3.91E+04,1.59E+05,3.76E+05,1.35E+05,1.40E+05,,1.30E+05,1.87E+04,1.01E+05,7.28E+02,,,8.14E+04,1.27E+04,,1.49E+03,,,4.68E+02,2.61E+02,1.75E+03,1.29E+03,5.07E+04,3.36E+03,2.72E+02,,9.20E+02,4.37E+02,1.08E+03,0,FALSE,6.922,1,2,2077,237.9,7.78,2,signal transduction,,"Pf00169, Pf06920, Pf11878, Pf14429, Pf20421, Pf20422",,A6NIW2,ENSG00000147251,,,0,0,48.69,44.05,90.98,56.37,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,38.01,84.12,,79.96,16.52,enzyme regulator activity,0,
Master Protein,High,Q9Y5J7,TIMM9,Mitochondrial import inner membrane translocase subunit Tim9 OS=Homo sapiens OX=9606 GN=TIMM9 PE=1 SV=1,2,3,0.573,0.685,0.641,0.541,-0.8,-0.55,-0.64,-0.89,6.51E-01,9.75E-01,5.03E-01,7.02E-01,5.84E+05,5.18E+05,2.98E+05,5.18E+05,5,4,3,4,1.31E+06,4.61E+05,5.84E+05,1.29E+06,5.79E+05,5.69E+05,3.10E+05,4.72E+05,,2.33E+06,2.98E+05,,5.19E+05,1.18E+05,,3.70E+06,1.85E+05,4.86E+05,,5.51E+05,5.18E+03,1.75E+03,5.71E+03,1.29E+06,2.99E+04,2.02E+03,5.51E+03,4.36E+03,,2.47E+04,1.78E+03,,4.21E+03,1.59E+04,,7.21E+03,5.21E+04,3.45E+03,,5.87E+03,0,FALSE,8.83,35,2,89,10.4,7.21,2,cell organization and biogenesis;transport;other biological processes,other membranes;mitochondrion,Pf02953,26520,B2R584; hsa:26520; Q9Y5J7,ENSG00000100575,Mitochondrial protein import; Mitochondrial protein degradation,,2,0,49.51,102.69,64.45,134.38,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,82.56,73.81,72.46,66.51,8.52,other molecular function,0,
Master Protein,High,Q9GZP4,PITHD1,PITH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PITHD1 PE=1 SV=1,2,2,0.572,3.8,0.138,15.774,-0.81,1.93,-2.86,3.98,6.15E-01,5.54E-03,2.50E-02,7.26E-03,6.42E+05,1.12E+06,2.44E+06,1.55E+05,2,2,1,1,,,4.61E+05,,8.95E+05,,,,9.49E+05,1.33E+06,2.44E+06,,,,,,1.55E+05,,,,,,4.50E+03,,4.62E+04,,,,2.67E+04,1.41E+04,1.46E+04,,,,,,4.35E+04,,,,0,FALSE,5.567,18,2,211,24.2,5.74,2,other biological processes,other cell component,Pf06201,57095,B2R7J4; hsa:57095; Q5QPN6; Q5QPN7; Q9GZP4; Q9NRI8,ENSG00000057757,,,0,0,45.28,23.5,,,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,42.37,50.11,24.98,0,7.53,,0,
Master Protein,High,P41212,ETV6,Transcription factor ETV6 OS=Homo sapiens OX=9606 GN=ETV6 PE=1 SV=1,5,13,0.57,1.414,2.353,0.319,-0.81,0.5,1.23,-1.65,6.90E-01,3.45E-01,4.99E-01,3.45E-01,5.84E+05,7.28E+04,3.74E+05,1.71E+05,4,1,5,4,2.55E+05,2.98E+06,,1.34E+06,1.50E+04,,,7.28E+04,,,7.91E+04,2.53E+06,2.81E+05,3.74E+05,1.39E+06,3.84E+05,,4.52E+05,1.85E+04,7.64E+04,1.01E+03,1.13E+04,,1.34E+06,7.74E+02,,,6.72E+02,,,4.73E+02,1.13E+05,2.29E+03,5.03E+04,3.46E+04,7.49E+02,,3.20E+03,4.33E+02,8.14E+02,0,FALSE,25.645,19,5,452,53,7.43,5,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00178, Pf02198",2120,A3QVP6; A8K076; hsa:2120; P41212; Q9UMF6; Q9UMF7; Q9UMG0,ENSG00000139083,Signaling by FLT3 fusion proteins; Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,Hematopoietic stem cell gene regulation by GABP alpha/beta complex; Exercise-induced circadian regulation,4,0,117.73,,110.47,93.24,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,178.26,88.02,158.2,114.75,30.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A5F9ZI21,ARHGEF2,Rho guanine nucleotide exchange factor 2 OS=Homo sapiens OX=9606 GN=ARHGEF2 PE=1 SV=1,8,14,0.568,0.292,0.308,2.943,-0.82,-1.78,-1.7,1.56,6.16E-01,2.70E-01,1.56E-01,2.91E-01,1.08E+06,6.74E+05,2.69E+05,4.82E+04,5,5,4,4,3.50E+06,1.69E+05,2.68E+06,6.69E+05,1.08E+06,3.76E+05,9.31E+05,9.57E+05,1.47E+05,6.74E+05,1.24E+06,5.11E+05,,1.41E+05,1.05E+05,1.93E+05,1.82E+04,9.73E+04,2.39E+04,,1.39E+04,6.41E+02,2.61E+04,6.69E+05,5.56E+04,1.34E+03,1.66E+04,8.83E+03,4.15E+03,7.17E+03,7.42E+03,2.28E+04,,1.91E+04,2.61E+03,3.77E+02,5.12E+03,6.89E+02,5.58E+02,,0,FALSE,32.737,12,8,1129,126.6,7.52,8,cell cycle OR cell proliferation;stress response;developmental processes;other biological processes,cytoskeleton;ER/Golgi;other cell component,"Pf00621, Pf17838",,A0A5F9ZI21,ENSG00000116584,,,0,0,87.14,57.07,105.54,98.35,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,108.05,137.56,87.9,111.73,43.06,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q14011,CIRBP,Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1,2,4,0.566,0.962,0.682,0.799,-0.82,-0.06,-0.55,-0.32,5.41E-01,5.21E-01,5.61E-01,9.91E-01,9.57E+05,1.69E+06,9.20E+05,1.15E+06,1,3,3,3,,9.57E+05,,,,3.73E+06,6.02E+05,1.69E+06,,,,,7.58E+05,2.66E+06,9.20E+05,5.62E+06,,,2.91E+05,1.15E+06,,3.64E+03,,,,1.33E+04,1.07E+04,1.56E+04,,,,,6.16E+03,3.58E+05,2.29E+04,1.10E+04,,,6.81E+03,1.23E+04,0,FALSE,9.534,19,2,172,18.6,9.51,2,cell organization and biogenesis;stress response;other biological processes,nucleus;other cell component,Pf00076,1153,B3KT17; B4E2X2; hsa:1153; Q14011,ENSG00000099622,,,0,0,,79.17,72.84,121.48,n/a,Peak Found,n/a,High,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,95.45,31.64,117.84,102.87,16.02,nucleic acid binding activity;other molecular function,0,
Master Protein,High,H0YMW4,ANXA2,Annexin OS=Homo sapiens OX=9606 GN=ANXA2 PE=1 SV=2,12,77,0.566,4.193,1.173,0.868,-0.82,2.07,0.23,-0.2,4.85E-01,7.80E-03,9.42E-01,9.61E-01,9.12E+05,2.87E+06,9.34E+06,6.32E+06,5,5,5,5,9.12E+05,5.04E+07,8.11E+05,1.08E+06,6.96E+05,1.49E+06,2.45E+06,2.87E+06,4.15E+06,3.22E+06,2.40E+07,6.16E+06,8.92E+06,9.34E+06,1.53E+07,6.32E+06,1.09E+07,1.62E+06,5.13E+06,6.81E+06,3.62E+03,1.91E+05,7.92E+03,1.08E+06,3.59E+04,5.31E+03,4.36E+04,2.65E+04,1.17E+05,3.43E+04,1.43E+05,2.75E+05,7.25E+04,1.26E+06,3.81E+05,1.23E+04,3.08E+06,1.15E+04,1.20E+05,7.25E+04,0,FALSE,65.535,39,12,367,41.9,8.13,12,,non-structural extracellular;extracellular matrix;other membranes,Pf00191,,H0YMW4,ENSG00000182718,,,0,0,205.46,34.46,55.78,54.45,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,131.52,91.39,135.89,103.49,263.81,enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q08495,DMTN,Dematin OS=Homo sapiens OX=9606 GN=DMTN PE=1 SV=3,7,16,0.564,0.575,3.385,0.153,-0.83,-0.8,1.76,-2.71,5.32E-01,8.35E-01,1.54E-01,1.12E-01,5.13E+05,2.61E+06,4.88E+05,1.13E+07,5,5,5,5,3.66E+05,8.74E+06,2.11E+05,5.13E+05,2.31E+07,6.33E+05,5.48E+04,7.84E+06,2.61E+06,9.40E+06,3.96E+05,4.50E+05,4.88E+05,9.37E+05,1.59E+06,1.13E+07,1.22E+07,4.26E+06,2.67E+06,1.93E+07,1.45E+03,3.32E+04,2.06E+03,5.13E+05,1.19E+06,2.25E+03,9.75E+02,7.23E+04,7.34E+04,9.99E+04,2.37E+03,2.01E+04,3.97E+03,1.26E+05,3.96E+04,2.21E+04,3.44E+06,3.02E+04,6.24E+04,2.06E+05,0,FALSE,31.336,23,7,405,45.5,8.88,7,cell organization and biogenesis;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf02209, Pf16182",2039,A8K0T5; B3KP70; B3KRH3; B4DI75; E9PEJ0; hsa:2039; Q08495; Q13215; Q9BRE3,ENSG00000158856,Miscellaneous transport and binding events,,1,0,150.64,103.79,65.62,67.45,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,140.5,126.44,143.52,88.23,41.82,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,P11169,SLC2A3,"Solute carrier family 2, facilitated glucose transporter member 3 OS=Homo sapiens OX=9606 GN=SLC2A3 PE=1 SV=1",4,58,0.564,0.262,1.557,0.173,-0.83,-1.93,0.64,-2.53,4.53E-01,1.51E-01,6.64E-01,1.39E-01,5.68E+06,9.12E+06,2.08E+06,1.23E+07,5,5,5,5,1.84E+07,4.09E+07,5.14E+06,8.11E+05,5.68E+06,9.12E+06,6.39E+06,3.15E+07,2.97E+07,2.72E+06,2.55E+06,3.42E+05,2.08E+06,1.92E+06,2.68E+06,6.32E+07,6.76E+06,1.23E+07,6.45E+06,1.35E+07,7.30E+04,1.55E+05,5.02E+04,8.11E+05,2.93E+05,3.24E+04,1.14E+05,2.90E+05,8.36E+05,2.89E+04,1.52E+04,1.53E+04,1.69E+04,2.58E+05,6.67E+04,1.23E+05,1.90E+06,8.73E+04,1.51E+05,1.43E+05,0,FALSE,18.786,10,4,496,53.9,7.2,4,other metabolic processes;transport,plasma membrane;other membranes;other cell component,Pf00083,6515,B2R606; D3DUU6; hsa:6515; P11169; Q6I9U2; Q9UG15,ENSG00000059804,Neutrophil degranulation; Cellular hexose transport; Vitamin C (ascorbate) metabolism; MECP2 regulates neuronal receptors and channels,Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced HIF-1 survival signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K/AKT/mTOR - vitamin D3 signaling; Neuroinflammation and glutamatergic signaling; Chronic hyperglycemia impairment of neuron function; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,13,0,115,85.81,48.82,118.03,High,High,High,High,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,High,1,,FALSE,144.42,138.95,129.29,120.45,87.2,transporter activity;other molecular function,0,
Master Protein,High,P18859,ATP5PF,"ATP synthase-coupling factor 6, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PF PE=1 SV=1",5,20,0.563,4.311,1.784,1.173,-0.83,2.11,0.84,0.23,6.30E-01,4.25E-03,6.39E-01,7.88E-01,2.07E+05,1.71E+05,1.54E+06,1.03E+06,5,3,5,5,2.07E+05,1.21E+06,8.18E+04,2.89E+06,1.29E+05,1.08E+06,1.14E+05,1.71E+05,,,4.00E+05,7.01E+06,1.28E+06,1.54E+06,2.65E+06,7.29E+06,5.35E+05,1.93E+06,3.34E+05,1.03E+06,8.24E+02,4.60E+03,7.99E+02,2.89E+06,6.68E+03,3.82E+03,2.03E+03,1.58E+03,,,2.39E+03,3.13E+05,1.04E+04,2.07E+05,6.57E+04,1.42E+04,1.50E+05,1.36E+04,7.81E+03,1.10E+04,0,FALSE,30.192,51,5,108,12.6,9.52,5,other metabolic processes;transport,other membranes;mitochondrion,Pf05511,522,hsa:522; J3KQ83; P18859,ENSG00000154723,Mitochondrial protein degradation; Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,5,0,133.17,118.94,101.19,130.39,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,98.1,126.05,127.75,101.75,75.95,transporter activity,0,
Master Protein,High,Q02878,RPL6,60S ribosomal protein L6 OS=Homo sapiens OX=9606 GN=RPL6 PE=1 SV=3,8,31,0.563,0.599,0.87,0.375,-0.83,-0.74,-0.2,-1.42,4.52E-01,8.32E-01,7.58E-01,4.27E-01,4.90E+06,2.79E+06,1.76E+06,4.50E+06,5,4,5,5,4.90E+06,1.11E+07,3.53E+06,2.76E+06,4.98E+06,3.22E+06,9.61E+05,4.42E+06,,2.42E+06,1.40E+07,1.76E+06,6.90E+05,2.07E+06,1.36E+06,5.45E+06,5.30E+06,4.50E+06,1.29E+06,2.89E+06,1.95E+04,4.23E+04,3.45E+04,2.76E+06,2.57E+05,1.14E+04,1.71E+04,4.08E+04,,2.58E+04,8.37E+04,7.85E+04,5.61E+03,2.79E+05,3.39E+04,1.06E+04,1.49E+06,3.19E+04,3.02E+04,3.08E+04,0,FALSE,35.209,28,8,288,32.7,10.58,8,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,"Pf01159, Pf03868",6128,hsa:6128; Q02878; Q2M3Q3; Q8WW97,ENSG00000089009,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Cytoplasmic ribosomal proteins,14,0,60.58,52.66,141.49,45.54,High,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,112.62,117.97,102.28,122.38,83.53,nucleic acid binding activity;other molecular function,0,
Master Protein,High,F5GYQ1,ATP6V0D1,V-type proton ATPase subunit OS=Homo sapiens OX=9606 GN=ATP6V0D1 PE=1 SV=1,3,3,0.562,0.01,0.01,,-0.83,-6.64,-6.64,,6.34E-01,1.00E-17,1.00E-17,,5.34E+05,9.50E+05,,,1,2,,,,,,5.34E+05,,9.33E+05,,,,9.68E+05,,,,,,,,,,,,,,5.34E+05,,3.32E+03,,,,1.03E+04,,,,,,,,,,,0,FALSE,11.709,12,3,392,44.6,5.14,3,transport,other membranes;other cytoplasmic organelle,Pf01992,,F5GYQ1,ENSG00000159720,,,0,0,,2.64,,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,2.77,,,,9.41,transporter activity,0,
Master Protein,High,P51659,HSD17B4,Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens OX=9606 GN=HSD17B4 PE=1 SV=3,13,33,0.561,0.892,0.838,0.98,-0.83,-0.16,-0.26,-0.03,4.67E-01,7.07E-01,8.66E-01,9.19E-01,3.28E+06,6.00E+05,2.65E+06,1.56E+06,5,4,5,4,5.99E+06,4.32E+06,1.66E+06,3.28E+06,3.26E+05,,1.32E+05,5.78E+05,6.22E+05,8.21E+06,3.27E+06,8.82E+04,2.65E+06,7.42E+06,1.29E+06,5.02E+05,4.51E+06,6.25E+05,3.87E+06,,2.38E+04,1.64E+04,1.62E+04,3.28E+06,1.68E+04,,2.34E+03,5.34E+03,1.75E+04,8.73E+04,1.95E+04,3.94E+03,2.15E+04,1.00E+06,3.22E+04,9.79E+02,1.27E+06,4.43E+03,9.06E+04,,0,FALSE,45.818,29,13,736,79.6,8.84,13,other metabolic processes;developmental processes,cytosol;other cytoplasmic organelle,"Pf00106, Pf01575, Pf02036",3295,B4DNV1; B4DVS5; E9PB82; F5HE57; hsa:3295; P51659,ENSG00000133835,TYSND1 cleaves peroxisomal proteins; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol; alpha-linolenic acid (ALA) metabolism; Beta-oxidation of pristanoyl-CoA; Beta-oxidation of very long chain fatty acids,Androgen receptor network in prostate cancer; Steroid biosynthesis; Disorders of bile acid synthesis and biliary transport; Primary ovarian insufficiency,10,0,71.11,163.04,94.71,88.81,High,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,n/a,1,,FALSE,128.92,91.65,118.99,83.96,100.05,other molecular function,0,
Master Protein,High,Q9UPT8,ZC3H4,Zinc finger CCCH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=ZC3H4 PE=1 SV=3,5,7,0.561,0.525,0.977,0.344,-0.83,-0.93,-0.03,-1.54,5.85E-01,7.26E-01,9.12E-01,4.99E-01,7.53E+04,1.36E+05,1.82E+05,1.33E+05,4,1,4,1,3.25E+04,7.62E+04,,9.97E+05,7.43E+04,1.36E+05,,,,,2.01E+05,1.64E+05,,2.56E+05,2.94E+04,1.33E+05,,,,,1.29E+02,2.90E+02,,9.97E+05,3.83E+03,4.83E+02,,,,,1.20E+03,7.35E+03,,3.45E+04,7.30E+02,2.59E+02,,,,,0,FALSE,20.899,7,5,1303,140.2,6.27,5,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00642, Pf14608, Pf18044",23211,hsa:23211; Q9UPT8; Q9Y420,ENSG00000130749,,,0,0,158.79,,59.29,,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,108.6,91.51,0,45.57,21.37,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q562E7,WDR81,WD repeat-containing protein 81 OS=Homo sapiens OX=9606 GN=WDR81 PE=1 SV=2,4,6,0.561,1.194,0.29,5.497,-0.83,0.26,-1.79,2.46,6.27E-01,5.34E-01,2.41E-01,9.11E-02,2.06E+05,1.76E+05,5.55E+04,6.39E+04,2,4,2,2,,,,6.27E+04,6.77E+05,1.43E+05,,6.05E+04,2.16E+05,1.58E+06,4.15E+04,,,7.42E+04,,,9.87E+04,,4.14E+04,,,,,6.27E+04,3.49E+04,5.09E+02,,5.59E+02,6.09E+03,1.68E+04,2.48E+02,,,9.99E+03,,,2.77E+04,,9.70E+02,,0,FALSE,17.618,3,4,1941,211.6,5.58,4,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,other membranes;cytosol;mitochondrion;other cytoplasmic organelle,"Pf00400, Pf02138",124997,B3KW16; B3KXU1; B7Z579; E9PHG7; hsa:124997; Q24JP6; Q562E7; Q8N277; Q8N3F3; Q8TEL1,ENSG00000167716; ENSG00000276021,CDC42 GTPase cycle,,1,0,117.46,144.72,39.89,57.78,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,13.16,134.66,76.15,0,18.15,enzyme regulator activity;other molecular function,0,
Master Protein,High,H3BQK9,MACF1,Microtubule actin crosslinking factor 1 OS=Homo sapiens OX=9606 GN=MACF1 PE=1 SV=1,36,54,0.559,0.753,0.216,1.228,-0.84,-0.41,-2.21,0.3,5.22E-01,9.03E-01,8.57E-02,7.40E-01,1.85E+06,1.18E+06,2.80E+06,7.15E+05,5,5,5,5,6.51E+05,5.39E+06,3.19E+05,4.16E+06,1.85E+06,1.65E+06,1.26E+06,1.18E+06,7.45E+05,1.17E+06,1.62E+06,3.69E+06,1.75E+06,2.80E+06,4.97E+06,5.00E+05,7.15E+05,2.94E+06,5.51E+05,3.64E+06,2.59E+03,2.05E+04,3.11E+03,4.16E+06,9.55E+04,5.87E+03,2.24E+04,1.09E+04,2.10E+04,1.24E+04,9.71E+03,1.65E+05,1.42E+04,3.78E+05,1.23E+05,9.74E+02,2.01E+05,2.08E+04,1.29E+04,3.87E+04,0,FALSE,146.487,7,36,7592,860.5,5.38,36,cell organization and biogenesis,other membranes;cytoskeleton;other cell component,"Pf00307, Pf00435, Pf00681, Pf02187, Pf13499, Pf17902, Pf18373, Pf21019, Pf21020, Pf21097",,H3BQK9,ENSG00000127603,,Mesodermal commitment pathway; Mesodermal commitment pathway,2,0,89.68,26.8,47.16,89.97,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,103.69,91.05,127.54,132.17,164.93,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9P2X0,DPM3,Dolichol-phosphate mannosyltransferase subunit 3 OS=Homo sapiens OX=9606 GN=DPM3 PE=1 SV=2,1,3,0.559,0.297,4.817,0.049,-0.84,-1.75,2.27,-4.34,6.51E-01,3.27E-01,6.23E-02,1.50E-02,3.01E+05,5.39E+05,8.94E+04,1.84E+06,1,5,2,3,,3.01E+05,,,,2.09E+05,5.48E+05,5.39E+05,3.77E+05,5.66E+05,,6.44E+04,,1.24E+05,,1.20E+06,,2.73E+06,,1.84E+06,,1.15E+03,,,,7.42E+02,9.74E+03,4.98E+03,1.06E+04,6.02E+03,,2.88E+03,,1.67E+04,,2.34E+03,,1.93E+04,,1.96E+04,0.001,FALSE,3.17,11,1,92,10.1,5.94,1,protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi;other cell component,Pf08285,54344,hsa:54344; Q5SR62; Q5SR63; Q9BXN4; Q9BXN5; Q9P2X0,ENSG00000179085,Synthesis of dolichyl-phosphate mannose; Defective DPM1 causes DPM1-CDG; Defective DPM3 causes DPM3-CDG; Defective DPM2 causes DPM2-CDG,N-glycan biosynthesis,5,0,,34.3,44.71,39.87,n/a,Peak Found,n/a,High,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,7.25,49.41,48.16,50.28,7.51,enzyme regulator activity,0,
Master Protein,High,Q15149,PLEC,Plectin OS=Homo sapiens OX=9606 GN=PLEC PE=1 SV=3,25,44,0.556,0.813,1.232,0.664,-0.85,-0.3,0.3,-0.59,4.57E-01,8.12E-01,9.21E-01,8.48E-01,3.49E+06,6.69E+05,1.49E+06,6.83E+05,5,5,5,5,1.40E+06,3.63E+06,4.90E+05,3.49E+06,3.70E+06,5.34E+05,9.31E+05,1.56E+06,4.78E+05,6.69E+05,1.24E+06,1.49E+06,9.62E+05,1.08E+07,3.00E+06,5.89E+06,3.55E+04,2.00E+05,6.83E+05,3.12E+06,5.56E+03,1.38E+04,4.79E+03,3.49E+06,1.91E+05,1.90E+03,1.66E+04,1.44E+04,1.35E+04,7.11E+03,7.42E+03,6.68E+04,7.82E+03,1.46E+06,7.45E+04,1.15E+04,9.97E+03,1.42E+03,1.60E+04,3.32E+04,0,FALSE,88.813,7,25,4684,531.5,5.96,25,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;other cell component,"Pf00307, Pf00681, Pf03501, Pf17902, Pf18373, Pf21019, Pf21020, Pf21097",5339,hsa:5339; Q15148; Q15149; Q16640; Q6S376; Q6S377; Q6S378; Q6S379; Q6S380; Q6S381; Q6S382; Q6S383,ENSG00000178209,Assembly of collagen fibrils and other multimeric structures; Caspase-mediated cleavage of cytoskeletal proteins; Type I hemidesmosome assembly,Envelope proteins and their potential roles in EDMD physiopathology,4,0,58.81,53.11,118.89,126.46,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,117.56,97.24,115.58,132.43,133.61,cytoskeletal activity;other molecular function,0,
Master Protein,High,F5GXJ1,NDUFS7,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS7 PE=1 SV=1",1,2,0.555,0.808,0.398,1.144,-0.85,-0.31,-1.33,0.19,5.21E-01,7.48E-01,3.05E-01,7.39E-01,9.40E+05,1.53E+06,7.47E+05,6.31E+05,4,4,4,2,,9.56E+05,2.55E+05,1.27E+06,9.24E+05,1.91E+06,1.22E+06,2.07E+06,,1.21E+06,4.98E+05,7.35E+05,1.04E+06,,7.58E+05,9.09E+05,4.37E+05,,,,,3.63E+03,2.49E+03,1.27E+06,4.77E+04,6.78E+03,2.17E+04,1.91E+04,,1.29E+04,2.98E+03,3.28E+04,8.49E+03,,1.88E+04,1.77E+03,1.23E+05,,,,0.007,FALSE,2.365,4,1,236,25.4,9.89,1,transport,other membranes;mitochondrion,Pf01058,,F5GXJ1,ENSG00000115286,,,0,0,50.18,28.12,29.45,49.55,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,41.78,55.64,46.85,56.53,4.9,transporter activity;other molecular function,0,
Master Protein,High,P63220,RPS21,40S ribosomal protein S21 OS=Homo sapiens OX=9606 GN=RPS21 PE=1 SV=1,3,13,0.554,0.474,0.786,0.267,-0.85,-1.08,-0.35,-1.91,6.25E-01,6.32E-01,7.05E-01,2.94E-01,7.77E+05,6.98E+05,1.25E+05,6.48E+05,4,5,2,5,,6.15E+05,4.64E+04,9.92E+05,9.80E+05,7.10E+05,1.21E+05,6.98E+05,1.31E+05,8.87E+05,,4.23E+04,,3.72E+05,,1.33E+06,6.48E+05,4.35E+05,5.49E+04,1.39E+06,,2.34E+03,4.53E+02,9.92E+05,5.06E+04,2.53E+03,2.15E+03,6.44E+03,3.69E+03,9.43E+03,,1.89E+03,,5.01E+04,,2.60E+03,1.82E+05,3.08E+03,1.28E+03,1.48E+04,0,FALSE,18.766,34,3,83,9.1,8.5,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;ER/Golgi;translational apparatus;nucleus;other cell component,Pf01249,6227,hsa:6227; P35265; P63220,ENSG00000171858,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,67.41,70.28,112.51,75.03,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,High,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,84.9,107.96,108.53,76.1,42.3,other molecular function,0,
Master Protein,High,A0A994J7P9,FXR2,FMR1 autosomal homolog 2 OS=Homo sapiens OX=9606 GN=FXR2 PE=4 SV=1,3,3,0.553,0.113,0.267,0.409,-0.85,-3.14,-1.91,-1.29,6.31E-01,2.74E-02,2.04E-01,5.88E-01,3.08E+05,2.03E+05,1.19E+04,5.41E+04,4,1,2,3,9.80E+04,5.36E+05,,3.78E+05,2.51E+05,,,,,2.03E+05,,,,7.18E+03,1.97E+04,,1.05E+04,,5.41E+04,8.07E+04,3.90E+02,2.04E+03,,3.78E+05,1.29E+04,,,,,2.16E+03,,,,9.67E+02,4.89E+02,,2.94E+03,,1.27E+03,8.59E+02,0,FALSE,11.859,7,2,746,80.8,7.14,3,other biological processes,other cell component,,,A0A994J7P9,ENSG00000129245,,,0,1,58.95,,65.83,73.2,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,59.6,77.98,0,108.1,8.43,nucleic acid binding activity,0,
Master Protein,High,Q96T37,RBM15,RNA-binding protein 15 OS=Homo sapiens OX=9606 GN=RBM15 PE=1 SV=2,3,3,0.553,0.093,0.339,0.148,-0.86,-3.42,-1.56,-2.76,6.27E-01,2.24E-02,2.96E-01,1.77E-01,2.22E+05,2.33E+05,1.09E+04,4.50E+04,2,3,2,3,,,,2.18E+05,2.27E+05,,,4.33E+05,5.25E+04,2.33E+05,,5.65E+03,,2.09E+04,,,8.43E+03,3.11E+05,,4.50E+04,,,,2.18E+05,1.17E+04,,,4.00E+03,1.48E+03,2.48E+03,,2.52E+02,,2.81E+03,,,2.37E+03,2.21E+03,,4.79E+02,0,FALSE,11.706,5,3,977,107.1,10.08,3,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,other membranes;nucleus;other cell component,"Pf00076, Pf07744",64783,A1A693; hsa:64783; Q3ZB86; Q4V760; Q5D058; Q5T613; Q86VW9; Q96PE4; Q96SC5; Q96SC6; Q96SC9; Q96SD0; Q96T37; Q96T38; Q9BRA5; Q9H6R8; Q9H9Y0,ENSG00000162775,,,0,0,3.08,79.47,81.16,135.96,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,89.04,57.67,152.58,68.91,8.57,nucleic acid binding activity,0,
Master Protein,High,Q9UK76,JPT1,Jupiter microtubule associated homolog 1 OS=Homo sapiens OX=9606 GN=JPT1 PE=1 SV=3,1,3,0.552,0.384,1.435,0.32,-0.86,-1.38,0.52,-1.65,5.81E-01,5.63E-01,8.44E-01,4.59E-01,5.67E+04,1.26E+05,2.53E+04,7.92E+04,3,5,2,4,,5.67E+04,,4.10E+04,7.25E+05,1.27E+05,1.42E+05,1.26E+05,1.91E+04,1.03E+05,,1.85E+04,,3.46E+04,,1.82E+05,3.44E+04,6.36E+05,3.46E+04,,,2.15E+02,,4.10E+04,3.74E+04,4.53E+02,2.52E+03,1.16E+03,5.38E+02,1.09E+03,,8.26E+02,,4.67E+03,,3.54E+02,9.67E+03,4.51E+03,8.09E+02,,0.001,FALSE,3.86,10,1,154,16,5.6,1,,cytosol;cytoskeleton;nucleus;other cell component,Pf17054,51155,B2R6K3; hsa:51155; Q53FG7; Q7Z2D2; Q7Z2F0; Q9UK76,ENSG00000189159,,,0,0,142.37,47.54,42.95,128.51,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,110.16,68.04,120.12,101.11,8.01,,0,
Master Protein,High,P16070,CD44,CD44 antigen OS=Homo sapiens OX=9606 GN=CD44 PE=1 SV=3,3,34,0.551,0.483,0.682,0.534,-0.86,-1.05,-0.55,-0.9,4.41E-01,6.42E-01,5.35E-01,6.31E-01,1.03E+06,3.38E+06,2.04E+06,3.58E+06,5,4,5,4,4.09E+06,1.15E+07,1.03E+06,8.70E+04,3.44E+05,8.13E+06,1.40E+06,8.05E+05,,6.07E+07,7.59E+05,2.04E+06,5.28E+06,4.16E+06,1.78E+06,3.60E+06,3.57E+06,1.25E+05,4.19E+06,,1.62E+04,4.38E+04,1.01E+04,8.70E+04,1.77E+04,2.89E+04,2.50E+04,7.43E+03,,6.46E+05,4.54E+03,9.13E+04,4.29E+04,5.60E+05,4.43E+04,7.01E+03,1.00E+06,8.83E+02,9.80E+04,,0,FALSE,11.508,5,3,742,81.5,5.33,3,cell adhesion;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,Pf00193,960,A5YRN9; B6EAT9; D3DR12; D3DR13; hsa:960; O95370; P16070; P22511; Q04858; Q13419; Q13957; Q13958; Q13959; Q13960; Q13961; Q13967; Q13968; Q13980; Q15861; Q16064; Q16065; Q16066; Q16208; Q16522; Q86T72; Q86Z27; Q8N694; Q92493; Q96J24; Q9H5A5; Q9UC28; Q9UC29; Q9UC30; Q9UCB0; Q9UJ36,ENSG00000026508,Integrin cell surface interactions; Cell surface interactions at the vascular wall; Neutrophil degranulation; Degradation of the extracellular matrix; Interferon gamma signaling; Hyaluronan uptake and degradation,Hepatitis C and hepatocellular carcinoma; Wnt signaling pathway and pluripotency; Hippo-Merlin signaling dysregulation; Gastrin signaling pathway; Pleural mesothelioma; CCL18 signaling pathway,12,0,140.75,162.3,66.15,64.54,Peak Found,High,High,High,High,High,Peak Found,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,139.87,144.89,110.92,82.57,60.99,other molecular function,0,
Master Protein,High,P35658,NUP214,Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214 PE=1 SV=2,7,7,0.551,0.67,0.331,1.037,-0.86,-0.58,-1.6,0.05,6.34E-01,9.71E-01,1.92E-01,8.31E-01,5.97E+05,3.95E+05,1.02E+05,1.31E+05,1,2,3,2,,,,5.97E+05,,,,2.94E+05,,5.32E+05,,8.82E+04,,5.22E+05,1.02E+05,,,1.96E+05,8.72E+04,,,,,5.97E+05,,,,2.71E+03,,5.66E+03,,3.94E+03,,7.03E+04,2.54E+03,,,1.39E+03,2.04E+03,,0,FALSE,24.085,6,7,2090,213.5,7.47,7,other metabolic processes;transport;other biological processes,cytosol;nucleus,Pf18617,8021,A6NFQ0; hsa:8021; P35658; Q15010; Q3KQZ0; Q5JUP7; Q75R47; Q86XD3,ENSG00000126883,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; HuR (ELAVL1) binds and stabilizes mRNA,TGF-beta signaling pathway,30,0,,40.81,103.85,54.35,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,44.69,70.43,45.85,46.48,20.36,other molecular function,0,
Master Protein,High,P62820,RAB1A,Ras-related protein Rab-1A OS=Homo sapiens OX=9606 GN=RAB1A PE=1 SV=3,5,57,0.55,0.142,0.616,0.786,-0.86,-2.82,-0.7,-0.35,6.40E-01,6.60E-02,4.90E-01,9.89E-01,2.16E+05,6.31E+05,3.34E+04,8.75E+04,5,5,4,5,2.54E+05,2.16E+05,1.05E+05,1.27E+05,8.86E+05,2.35E+05,8.98E+05,1.36E+06,4.67E+05,6.31E+05,3.60E+04,7.61E+03,,4.61E+04,3.09E+04,8.75E+04,6.43E+03,5.96E+05,9.68E+03,8.78E+05,1.01E+03,8.22E+02,1.02E+03,1.27E+05,4.57E+04,8.37E+02,1.60E+04,1.25E+04,1.32E+04,6.71E+03,2.15E+02,3.40E+02,,6.21E+03,7.67E+02,1.71E+02,1.81E+03,4.22E+03,2.27E+02,9.34E+03,0,FALSE,21.43,31,3,205,22.7,6.21,5,cell adhesion;cell-cell signaling;cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes,other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,5861,hsa:5861; P11476; P62820; Q6FIE7; Q96N61; Q9Y3T2,ENSG00000138069,COPI-dependent Golgi-to-ER retrograde traffic; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; COPI-mediated anterograde transport; COPII-mediated vesicle transport; Golgi Cisternae Pericentriolar Stack Reorganization,,6,0,101.87,60.08,54.07,126.37,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,113.71,87.7,99.64,140.52,136.47,other molecular function,0,
Master Protein,High,A0A7P0TA35,P4HB,Protein disulfide-isomerase OS=Homo sapiens OX=9606 GN=P4HB PE=1 SV=1,27,430,0.55,0.797,1.76,0.394,-0.86,-0.33,0.82,-1.34,4.36E-01,8.34E-01,5.55E-01,4.53E-01,3.57E+07,1.66E+08,5.71E+07,2.13E+08,5,5,5,5,3.57E+07,2.00E+08,6.14E+06,2.74E+07,1.52E+08,1.32E+08,1.66E+08,1.91E+08,5.52E+07,3.62E+08,1.14E+07,1.39E+07,8.16E+07,6.54E+07,5.71E+07,2.13E+08,6.24E+07,5.82E+08,1.54E+08,6.84E+08,1.42E+05,7.60E+05,6.00E+04,2.74E+07,7.85E+06,4.68E+05,2.94E+06,1.76E+06,1.56E+06,3.85E+06,6.81E+04,6.21E+05,6.63E+05,8.81E+06,1.42E+06,4.15E+05,1.75E+07,4.12E+06,3.61E+06,7.29E+06,0,FALSE,139.568,59,27,542,61,5.01,27,,ER/Golgi,"Pf00085, Pf13848",,A0A7P0TA35,ENSG00000185624,,Type I collagen synthesis in the context of osteogenesis imperfecta,1,0,102.27,62.55,68.89,81.42,High,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,133.68,132.02,130.7,122.45,1036.88,other molecular function,0,
Master Protein,Medium,A8MW95,BECN2,Beclin-2 OS=Homo sapiens OX=9606 GN=BECN2 PE=1 SV=2,1,2,0.549,1.526,0.445,1.675,-0.86,0.61,-1.17,0.74,5.54E-01,2.21E-01,3.62E-01,5.18E-01,5.37E+05,1.32E+06,7.51E+05,5.85E+05,4,2,3,2,,8.98E+05,1.32E+05,3.21E+05,9.37E+06,,,,3.75E+05,4.62E+06,,,7.51E+05,3.20E+05,3.01E+06,,1.86E+05,,1.84E+06,,,3.41E+03,1.29E+03,3.21E+05,4.83E+05,,,,1.06E+04,4.91E+04,,,6.10E+03,4.31E+04,7.47E+04,,5.23E+04,,4.31E+04,,0.019,FALSE,2.003,2,1,431,48.1,4.87,1,cell organization and biogenesis;other metabolic processes;stress response;transport,other membranes;other cell component,"Pf04111, Pf17675",441925,A8MW95; E9KNW0; hsa:441925,ENSG00000196289,,Alzheimer's disease and miRNA effects; Alzheimer's disease,2,0,166.84,120.18,106.19,115.43,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,129.62,128.78,76.02,122.51,4.18,,0,
Master Protein,High,C9JCC6,DRAP1,DR1 associated protein 1 OS=Homo sapiens OX=9606 GN=DRAP1 PE=1 SV=1,2,2,0.549,0.295,0.492,0.417,-0.87,-1.76,-1.02,-1.26,6.39E-01,3.22E-01,3.58E-01,6.12E-01,3.09E+05,4.45E+05,9.11E+04,2.19E+05,5,3,1,3,6.29E+04,5.12E+05,3.33E+04,3.09E+05,7.11E+05,4.45E+05,1.30E+06,,1.03E+05,,,,,9.11E+04,,,1.88E+04,,2.19E+05,5.91E+06,2.50E+02,1.94E+03,3.25E+02,3.09E+05,3.67E+04,1.58E+03,2.30E+04,,2.91E+03,,,,,1.23E+04,,,5.28E+03,,5.12E+03,6.30E+04,0,FALSE,5.636,15,2,212,23.2,5.27,2,,,Pf00808,,C9JCC6,ENSG00000175550,,,0,0,89.29,99.92,,163.25,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,121.03,118.06,146.99,135.51,5.58,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A7I2V5R6,GNAS,GNAS complex locus OS=Homo sapiens OX=9606 GN=GNAS PE=1 SV=2,4,46,0.547,1.097,0.619,0.982,-0.87,0.13,-0.69,-0.03,5.06E-01,5.41E-01,4.72E-01,8.66E-01,2.97E+05,2.51E+06,2.65E+05,7.78E+05,5,3,3,3,3.82E+05,2.97E+05,3.12E+05,1.50E+05,1.14E+05,,6.94E+04,6.75E+06,,2.51E+06,1.30E+06,,2.65E+05,1.62E+05,,2.43E+06,7.45E+05,,,7.78E+05,1.52E+03,1.13E+03,3.05E+03,1.50E+05,5.88E+03,,1.23E+03,6.23E+04,,2.67E+04,7.79E+03,,2.15E+03,2.18E+04,,4.74E+03,2.09E+05,,,8.28E+03,0,FALSE,15.271,6,3,1038,111,5.03,4,signal transduction,other membranes,Pf00503,2778,A0A7I2V5R6,ENSG00000087460,,Thyroid stimulating hormone (TSH) signaling pathway; Endothelin pathways; Corticotropin-releasing hormone signaling pathway; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; G protein signaling pathways; Thermogenesis; Hippo signaling regulation pathways; Purinergic signaling; GPR143 in melanocytes and retinal pigment epithelium cells; Vasopressin-regulated water reabsorption; Prostaglandin and leukotriene metabolism in senescence ; Primary ovarian insufficiency; Prostaglandin and leukotriene metabolism in senescence ; Calcium regulation in cardiac cells; Estrogen signaling pathway; Serotonin receptor 4/6/7 and NR3C signaling,17,0,45.35,108.72,109.45,73.18,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,n/a,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,103.97,87.5,133.82,68.11,104.94,other molecular function,0,
Master Protein,High,P01023,A2M,Alpha-2-macroglobulin OS=Homo sapiens OX=9606 GN=A2M PE=1 SV=3,6,52,0.547,4.286,1.369,1.677,-0.87,2.1,0.45,0.75,4.33E-01,5.29E-02,7.88E-01,5.54E-01,2.76E+04,6.20E+06,1.44E+05,1.05E+05,2,1,3,3,,7.35E+04,,1.04E+04,,,,,,6.20E+06,,,6.68E+04,1.44E+05,2.10E+05,,2.02E+05,5.56E+04,,1.05E+05,,2.79E+02,,1.04E+04,,,,,,6.59E+04,,,5.43E+02,1.94E+04,5.21E+03,,5.68E+04,3.94E+02,,1.11E+03,0,FALSE,19.515,4,2,1474,163.2,6.46,6,stress response;developmental processes;other biological processes,non-structural extracellular;other cell component,"Pf00207, Pf01835, Pf07677, Pf07678, Pf07703, Pf17789, Pf17791",2,hsa:2; P01023; Q13677; Q59F47; Q5QTS0; Q68DN2; Q6PIY3; Q6PN97,ENSG00000175899,Degradation of the extracellular matrix; Platelet degranulation ; HDL assembly; Intrinsic Pathway of Fibrin Clot Formation,Complement system; Dengue-2 interactions with complement and coagulation cascades; Complement and coagulation cascades,7,0,106.45,,51.01,61.72,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,169.52,98.68,56.12,67.65,119.8,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q86VP6,CAND1,Cullin-associated NEDD8-dissociated protein 1 OS=Homo sapiens OX=9606 GN=CAND1 PE=1 SV=2,7,10,0.546,0.251,4.15,0.143,-0.87,-2,2.05,-2.8,6.22E-01,1.68E-01,8.90E-02,9.71E-02,4.41E+05,3.82E+05,3.53E+05,2.74E+06,5,2,4,5,4.41E+05,4.13E+05,1.39E+05,6.77E+05,1.10E+06,,,8.55E+05,1.71E+05,,8.55E+05,5.24E+03,,1.02E+06,1.46E+05,2.74E+06,3.85E+05,5.27E+06,9.23E+05,4.59E+06,1.75E+03,1.57E+03,1.36E+03,6.77E+05,5.69E+04,,,7.89E+03,4.82E+03,,5.11E+03,2.34E+02,,1.37E+05,3.62E+03,5.35E+03,1.08E+05,3.73E+04,2.16E+04,4.89E+04,0,FALSE,21.078,7,7,1230,136.3,5.78,7,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;ER/Golgi;nucleus;other cell component,"Pf08623, Pf13513",55832,B2RAU3; hsa:55832; O94918; Q6PIY4; Q86VP6; Q8NDJ4; Q96JZ9; Q96T19; Q9BTC4; Q9H0G2; Q9P0H7; Q9UF85,ENSG00000111530,Neddylation; Neutrophil degranulation; Iron uptake and transport,Endoderm differentiation,4,0,65.08,94.31,99.76,77.65,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,102.21,129.59,118.75,124.75,29.58,other molecular function,0,
Master Protein,High,O75348,ATP6V1G1,V-type proton ATPase subunit G 1 OS=Homo sapiens OX=9606 GN=ATP6V1G1 PE=1 SV=3,3,6,0.546,0.479,0.275,0.223,-0.87,-1.06,-1.86,-2.17,5.07E-01,6.73E-01,1.04E-01,2.19E-01,1.17E+06,1.95E+06,2.72E+05,5.95E+05,3,2,2,4,,1.17E+06,,3.37E+05,4.52E+06,,,2.36E+06,,1.61E+06,,,,1.02E+06,7.21E+04,,1.22E+06,2.54E+05,3.13E+05,1.13E+06,,4.46E+03,,3.37E+05,2.33E+05,,,2.18E+04,,1.71E+04,,,,1.38E+05,1.79E+03,,3.44E+05,1.80E+03,7.33E+03,1.20E+04,0,FALSE,9.014,29,3,118,13.7,8.79,3,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf03179,9550,hsa:9550; O75348; Q6IB33,ENSG00000136888,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,Osteoclast signaling; Proximal tubule transport,7,0,110.08,26.84,122.82,70.91,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,108.7,126.65,113.34,126.25,16.12,transporter activity;other molecular function,0,
Master Protein,High,A0A024R571,EHD1,EH domain containing 1 OS=Homo sapiens OX=9606 GN=EHD1 PE=1 SV=1,4,9,0.545,1.023,3.055,0.082,-0.88,0.03,1.61,-3.6,6.23E-01,6.10E-01,1.96E-01,3.24E-02,3.42E+05,9.33E+05,1.28E+05,5.18E+06,5,4,2,5,4.17E+05,7.97E+05,2.11E+05,3.17E+05,3.42E+05,2.20E+06,3.22E+06,3.96E+05,,1.93E+05,,,,8.08E+04,2.02E+05,5.18E+06,1.35E+06,5.26E+06,2.56E+06,7.67E+06,1.66E+03,3.03E+03,2.06E+03,3.17E+05,1.76E+04,7.82E+03,5.73E+04,3.65E+03,,2.05E+03,,,,1.09E+04,5.01E+03,1.01E+04,3.80E+05,3.73E+04,5.99E+04,8.16E+04,0,FALSE,16.637,10,2,548,61.9,6.71,4,,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00350, Pf12763, Pf16880, Pf18150",10938,A0A024R571,ENSG00000110047,,Insulin signaling,1,2,53.99,97.1,60.51,56.43,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,High,High,High,1,,FALSE,94.18,70.19,87.44,70.19,20.03,other molecular function,0,
Master Protein,High,P51571,SSR4,Translocon-associated protein subunit delta OS=Homo sapiens OX=9606 GN=SSR4 PE=1 SV=1,2,9,0.542,1.425,0.352,1.863,-0.88,0.51,-1.51,0.9,5.03E-01,2.20E-01,1.51E-01,4.48E-01,1.18E+06,2.24E+06,1.98E+06,7.88E+05,2,1,5,2,,,,1.15E+06,1.21E+06,2.24E+06,,,,,1.98E+06,3.92E+06,1.73E+06,1.26E+06,3.21E+06,1.45E+06,,,4.28E+05,,,,,1.15E+06,6.26E+04,7.96E+03,,,,,1.18E+04,1.75E+05,1.41E+04,1.69E+05,7.97E+04,2.83E+03,,,1.00E+04,,0,FALSE,6.994,17,2,173,19,6.15,2,,other membranes;ER/Golgi;other cell component,Pf05404,6748,A8K378; hsa:6748; P51571; Q53XY1,ENSG00000180879,SRP-dependent cotranslational protein targeting to membrane,VEGFA-VEGFR2 signaling,2,0,3.97,,45.68,76.97,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,High,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,0,40.56,96.19,82.33,25.96,,0,
Master Protein,High,P46100,ATRX,Transcriptional regulator ATRX OS=Homo sapiens OX=9606 GN=ATRX PE=1 SV=6,15,21,0.542,0.542,0.367,0.418,-0.88,-0.88,-1.44,-1.26,5.51E-01,7.87E-01,2.17E-01,5.19E-01,1.50E+06,3.75E+05,3.61E+05,3.18E+05,4,5,5,4,1.17E+06,2.14E+07,,1.93E+06,2.85E+05,1.24E+05,3.96E+06,5.25E+06,3.75E+05,2.93E+05,2.52E+06,3.45E+05,1.77E+05,1.69E+06,3.61E+05,,1.75E+04,3.23E+07,2.53E+05,4.00E+05,4.64E+03,8.13E+04,,1.93E+06,1.47E+04,4.41E+02,7.05E+04,4.84E+04,1.06E+04,3.12E+03,1.51E+04,1.54E+04,1.44E+03,2.27E+05,8.96E+03,,4.91E+03,2.29E+05,5.93E+03,4.26E+03,0,FALSE,55.555,9,15,2492,282.4,6.55,15,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf00176, Pf00271, Pf17981",546,D3DTE2; P46100; P51068; Q15886; Q59FB5; Q59H31; Q5H9A2; Q5JWI4; Q7Z2J1; Q9H0Z1; Q9NTS3,ENSG00000085224,Inhibition of DNA recombination at telomere; Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations; Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations,Pathways affected in adenoid cystic carcinoma,4,0,163.93,121.07,101.82,194.57,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,132.95,106.82,122.1,111.41,59.64,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P00738,HP,Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1,6,18,0.542,0.555,0.289,0.662,-0.88,-0.85,-1.79,-0.6,4.26E-01,7.49E-01,8.60E-02,7.72E-01,2.55E+06,3.83E+06,1.89E+06,9.17E+06,5,4,5,5,2.55E+06,1.26E+07,3.07E+05,2.73E+04,9.17E+06,,9.36E+05,3.52E+06,4.17E+06,6.45E+06,5.17E+06,1.11E+05,2.46E+06,1.89E+06,5.78E+05,9.17E+06,9.37E+05,1.86E+07,1.55E+06,1.53E+07,1.01E+04,4.80E+04,3.00E+03,2.73E+04,4.73E+05,,1.66E+04,3.25E+04,1.18E+05,6.86E+04,3.09E+04,4.94E+03,2.00E+04,2.55E+05,1.44E+04,1.79E+04,2.63E+05,1.32E+05,3.63E+04,1.62E+05,0,FALSE,20.562,24,6,406,45.2,6.58,6,stress response;other biological processes,non-structural extracellular;other cell component,Pf00089,3240,B0AZL5; hsa:3240; P00737; P00738; Q0VAC4; Q0VAC5; Q2PP15; Q3B7J0; Q6LBY9; Q9UC67,ENSG00000257017,Scavenging of heme from plasma; Neutrophil degranulation,Network map of SARS-CoV-2 signaling pathway,3,0,114.75,60.16,97.43,87.19,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,Peak Found,High,1,,FALSE,113.4,134.42,109.1,134.63,52.04,other molecular function,0,
Master Protein,Medium,Q15650,TRIP4,Activating signal cointegrator 1 OS=Homo sapiens OX=9606 GN=TRIP4 PE=1 SV=4,1,1,0.541,1.452,0.727,1.1,-0.89,0.54,-0.46,0.14,5.23E-01,4.52E-01,7.23E-01,7.54E-01,4.30E+04,7.81E+04,6.24E+04,5.68E+04,4,2,1,1,6.50E+04,,2.20E+04,7.67E+04,2.85E+04,,,,1.31E+05,4.68E+04,6.24E+04,,,,,,,5.68E+04,,,2.58E+02,,2.15E+02,7.67E+04,1.47E+03,,,,3.68E+03,4.97E+02,3.73E+02,,,,,,,4.02E+02,,,0.022,FALSE,1.958,1,1,581,66.1,7.85,1,cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf04266, Pf06221",9325,B2RAS0; hsa:9325; Q15650; Q96ED7; Q9UKH0,ENSG00000103671,,VEGFA-VEGFR2 signaling,1,0,56,66.81,,,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,56.44,70.48,79.46,0,1.82,other molecular function,0,
Master Protein,High,P55081,MFAP1,Microfibrillar-associated protein 1 OS=Homo sapiens OX=9606 GN=MFAP1 PE=1 SV=2,2,4,0.541,0.01,3.193,0.01,-0.89,-6.64,1.68,-6.64,5.69E-01,1.00E-17,3.21E-01,1.00E-17,6.91E+04,1.28E+05,,4.08E+05,2,1,,1,,,,2.73E+04,1.75E+05,,,,,1.28E+05,,,,,,,,,,4.08E+05,,,,2.73E+04,9.03E+03,,,,,1.36E+03,,,,,,,,,,4.35E+03,0,FALSE,8.056,8,2,439,51.9,4.98,2,RNA metabolism OR transcription;other metabolic processes,extracellular matrix;cytoskeleton;nucleus,Pf06991,4236,hsa:4236; P55081; Q86TG6,ENSG00000140259,mRNA Splicing - Major Pathway,Canonical and non-canonical Notch signaling; Ciliary landscape,3,0,103.28,,,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,158.51,,0,,12.58,,0,
Master Protein,High,Q96BR5,COA7,Cytochrome c oxidase assembly factor 7 OS=Homo sapiens OX=9606 GN=COA7 PE=1 SV=2,2,6,0.54,5.422,0.01,100,-0.89,2.44,-6.64,6.64,6.13E-01,6.69E-03,1.00E-17,1.00E-17,4.76E+05,7.99E+04,2.34E+05,,1,2,2,,,,,4.76E+05,,1.14E+05,,,,5.60E+04,,2.19E+05,,2.49E+05,,,,,,,,,,4.76E+05,,4.06E+02,,,,5.95E+02,,9.80E+03,,3.36E+04,,,,,,,0,FALSE,19.997,18,2,231,25.7,6.02,2,,mitochondrion;nucleus,Pf08238,65260,hsa:65260; Q0P6I7; Q96BR5; Q9H9Z9,ENSG00000162377,,,0,0,,48.3,9.04,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,53.88,9.49,,,19.25,,0,
Master Protein,High,Q14203,DCTN1,Dynactin subunit 1 OS=Homo sapiens OX=9606 GN=DCTN1 PE=1 SV=3,8,10,0.539,0.286,0.622,0.342,-0.89,-1.8,-0.69,-1.55,6.20E-01,3.12E-01,4.83E-01,4.28E-01,2.17E+05,5.43E+05,1.85E+05,2.43E+05,5,4,4,5,7.41E+05,2.17E+05,4.08E+04,6.00E+04,3.96E+05,,1.36E+05,3.91E+05,7.54E+05,1.50E+06,,4.59E+05,7.12E+04,1.78E+05,1.93E+05,1.37E+05,7.74E+05,6.94E+04,4.45E+05,2.43E+05,2.94E+03,8.24E+02,3.99E+02,6.00E+04,2.04E+04,,2.42E+03,3.61E+03,2.12E+04,1.60E+04,,2.05E+04,5.79E+02,2.40E+04,4.80E+03,2.68E+02,2.18E+05,4.92E+02,1.04E+04,2.58E+03,0,FALSE,20.954,8,8,1278,141.6,5.81,8,cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf01302, Pf12455",1639,A8MY36; B4DM45; E9PFS5; E9PGE1; G5E9H4; hsa:1639; O95296; Q14203; Q6IQ37; Q9BRM9; Q9UIU1; Q9UIU2,ENSG00000204843,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Signaling by ALK fusions and activated point mutants; XBP1(S) activates chaperone genes,Vasopressin-regulated water reabsorption; HDAC6 interactions in the central nervous system,8,0,99.49,85.42,73.17,85.17,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,73.7,85.42,87.99,73.47,22.13,cytoskeletal activity;other molecular function,0,
Master Protein,High,P50995,ANXA11,Annexin A11 OS=Homo sapiens OX=9606 GN=ANXA11 PE=1 SV=1,9,47,0.539,2.43,0.643,2.282,-0.89,1.28,-0.64,1.19,4.63E-01,6.36E-02,4.87E-01,4.19E-01,1.38E+06,2.36E+06,1.30E+07,2.64E+06,3,5,4,5,1.09E+06,,,6.56E+06,1.38E+06,2.36E+06,3.27E+06,5.95E+06,8.36E+05,2.27E+06,,8.99E+06,1.21E+07,1.40E+07,1.95E+07,9.69E+05,3.87E+06,2.64E+06,2.98E+06,6.71E+05,4.32E+03,,,6.56E+06,7.12E+04,8.41E+03,5.82E+04,5.49E+04,2.36E+04,2.42E+04,,4.01E+05,9.79E+04,1.89E+06,4.84E+05,1.89E+03,1.09E+06,1.87E+04,6.97E+04,7.15E+03,0,FALSE,37.718,25,9,505,54.4,7.65,9,cell cycle OR cell proliferation;transport;other biological processes,cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf00191,311,B4DVE7; hsa:311; P50995,ENSG00000122359,,,0,0,102.34,64.46,32.37,61.3,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,75.07,68.87,80.92,81.7,135.26,other molecular function,0,
Master Protein,High,Q9Y490,TLN1,Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3,64,321,0.537,0.479,1.056,0.244,-0.9,-1.06,0.08,-2.04,4.20E-01,5.87E-01,9.50E-01,2.40E-01,2.69E+07,4.16E+07,1.81E+07,7.66E+07,5,5,5,5,8.14E+07,2.38E+07,3.59E+07,5.70E+06,2.69E+07,6.64E+07,3.47E+07,4.16E+07,5.78E+07,2.04E+07,2.17E+07,7.16E+06,6.43E+06,6.23E+07,1.81E+07,1.36E+08,7.66E+07,1.40E+08,3.99E+07,4.48E+07,3.23E+05,9.03E+04,3.51E+05,5.70E+06,1.39E+06,2.36E+05,6.16E+05,3.84E+05,1.63E+06,2.17E+05,1.30E+05,3.20E+05,5.22E+04,8.39E+06,4.50E+05,2.65E+05,2.15E+07,9.93E+05,9.33E+05,4.77E+05,0,FALSE,335.655,36,64,2541,269.6,6.07,64,cell adhesion;cell organization and biogenesis;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00373, Pf01608, Pf08913, Pf09141, Pf16511, Pf21692",7094,A0A1S5UZ07; A6NMY0; hsa:7094; Q86YD0; Q9NZQ2; Q9UHH8; Q9UPX3; Q9Y490,ENSG00000137076,Platelet degranulation ; Signaling by BRAF and RAF1 fusions; XBP1(S) activates chaperone genes; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion; Smooth Muscle Contraction; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins,Integrin-mediated cell adhesion; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; TROP2 regulatory signaling,18,0,81.43,41.45,98.89,55.2,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,119.1,124.21,128.15,122.57,970.38,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9P2W9,STX18,Syntaxin-18 OS=Homo sapiens OX=9606 GN=STX18 PE=1 SV=1,3,10,0.537,0.169,0.433,0.209,-0.9,-2.56,-1.21,-2.26,6.00E-01,1.25E-01,2.94E-01,2.77E-01,1.29E+05,3.54E+05,2.18E+04,2.15E+05,3,5,5,4,9.45E+04,,,1.29E+05,2.06E+05,3.83E+05,4.91E+04,3.54E+05,9.49E+04,4.19E+05,9.64E+05,7.80E+03,4.43E+04,1.32E+04,2.18E+04,,2.91E+05,4.24E+05,1.60E+05,1.38E+05,3.75E+02,,,1.29E+05,1.06E+04,1.36E+03,8.72E+02,3.26E+03,2.67E+03,4.45E+03,5.77E+03,3.48E+02,3.60E+02,1.79E+03,5.40E+02,,8.17E+04,3.00E+03,3.73E+03,1.47E+03,0,FALSE,12.652,12,3,335,38.7,5.49,3,cell organization and biogenesis;transport;other biological processes,other membranes;ER/Golgi,Pf10496,53407,hsa:53407; Q596L3; Q5TZP5; Q9P2W9,ENSG00000168818,COPI-dependent Golgi-to-ER retrograde traffic,,1,0,39.85,66.88,200.56,52.24,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,High,1,,FALSE,106.92,95.15,107.11,142.54,29.79,other molecular function,0,
Master Protein,High,Q08722,CD47,Leukocyte surface antigen CD47 OS=Homo sapiens OX=9606 GN=CD47 PE=1 SV=1,3,38,0.537,0.776,0.365,1.239,-0.9,-0.37,-1.45,0.31,4.20E-01,8.65E-01,1.57E-01,7.90E-01,9.05E+06,1.93E+07,9.75E+06,5.69E+06,5,5,5,5,9.05E+06,4.73E+07,3.16E+06,7.10E+06,1.15E+07,1.93E+07,1.51E+06,1.96E+07,1.15E+07,1.97E+07,1.05E+07,4.90E+06,6.88E+06,9.75E+06,1.04E+07,3.45E+07,5.69E+06,1.29E+06,7.99E+06,4.07E+05,3.60E+04,1.80E+05,3.09E+04,7.10E+06,5.94E+05,6.86E+04,2.69E+04,1.81E+05,3.24E+05,2.10E+05,6.26E+04,2.19E+05,5.59E+04,1.31E+06,2.60E+05,6.74E+04,1.60E+06,9.11E+03,1.87E+05,4.33E+03,0,FALSE,7.574,9,3,323,35.2,7.21,3,cell adhesion;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf04549, Pf08204",961,A8K198; D3DN59; hsa:961; Q08722; Q53Y71; Q96A60,ENSG00000196776,Neutrophil degranulation; Cell surface interactions at the vascular wall; Integrin cell surface interactions; Signal regulatory protein family interactions,Spinal cord injury; Pleural mesothelioma,6,0,114.91,55.62,29.37,141.07,High,High,Peak Found,High,High,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,116.41,118.26,127.81,116.68,75.35,other molecular function,0,
Master Protein,High,Q9UNX4,WDR3,WD repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=WDR3 PE=1 SV=1,2,2,0.536,2.33,5.371,0.203,-0.9,1.22,2.43,-2.3,5.14E-01,2.02E-01,1.36E-01,2.12E-01,3.61E+04,6.74E+04,8.41E+04,3.62E+05,1,3,4,5,,,,3.61E+04,,,6.74E+04,5.77E+04,,1.37E+05,7.98E+04,,9.74E+05,8.87E+04,1.21E+04,1.03E+06,1.82E+05,3.62E+05,5.22E+06,6.53E+04,,,,3.61E+04,,,1.20E+03,5.33E+02,,1.46E+03,4.77E+02,,7.91E+03,1.20E+04,3.00E+02,2.01E+03,5.12E+04,2.56E+03,1.22E+05,6.95E+02,0,FALSE,5.796,4,2,943,106,6.64,2,RNA metabolism OR transcription;other metabolic processes;other biological processes,other membranes;nucleus;other cell component,"Pf00400, Pf04003, Pf12894",10885,hsa:10885; Q9UNX4,ENSG00000065183,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,,2,0,,49.49,158.72,159.14,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,21.21,67.54,117.02,139.86,6.46,nucleic acid binding activity,0,
Master Protein,High,P61158,ACTR3,Actin-related protein 3 OS=Homo sapiens OX=9606 GN=ACTR3 PE=1 SV=3,4,7,0.536,0.994,0.369,1.135,-0.9,-0.01,-1.44,0.18,6.17E-01,5.98E-01,3.13E-01,7.35E-01,6.18E+05,2.78E+05,4.72E+05,9.11E+04,3,3,5,4,3.00E+05,,,1.05E+06,6.18E+05,,4.32E+04,2.78E+05,,5.58E+05,4.72E+05,1.84E+05,8.80E+04,9.92E+05,6.31E+05,2.21E+05,,3.76E+04,1.59E+04,2.32E+05,1.19E+03,,,1.05E+06,3.19E+04,,7.68E+02,2.56E+03,,5.94E+03,2.82E+03,8.21E+03,7.15E+02,1.34E+05,1.57E+04,4.31E+02,,2.66E+02,3.73E+02,2.47E+03,0,FALSE,15.856,14,4,418,47.3,5.88,4,cell cycle OR cell proliferation;cell organization and biogenesis;stress response;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf00022,10096,hsa:10096; P32391; P61158; Q53QM2,ENSG00000115091,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,Physico-chemical features and toxicity-associated pathways,6,0,57.12,87.99,76.64,91.43,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,150.32,129.48,137.56,111.04,22.88,cytoskeletal activity;other molecular function,0,
Master Protein,High,O15144,ARPC2,Actin-related protein 2/3 complex subunit 2 OS=Homo sapiens OX=9606 GN=ARPC2 PE=1 SV=1,4,13,0.536,1.24,2.772,0.82,-0.9,0.31,1.47,-0.29,6.12E-01,3.89E-01,2.46E-01,9.91E-01,5.98E+05,5.64E+05,6.12E+05,1.32E+06,5,5,4,4,1.10E+05,7.54E+05,1.41E+06,5.98E+05,5.47E+05,1.04E+05,1.42E+06,1.45E+06,3.24E+05,5.64E+05,3.12E+05,,2.54E+05,1.67E+06,1.20E+06,1.58E+06,1.09E+06,2.43E+06,5.47E+05,,4.35E+02,2.86E+03,1.38E+04,5.98E+05,2.82E+04,3.69E+02,2.53E+04,1.33E+04,9.13E+03,6.00E+03,1.86E+03,,2.06E+03,2.26E+05,2.99E+04,3.09E+03,3.07E+05,1.72E+04,1.28E+04,,0,FALSE,17.231,17,4,300,34.3,7.36,4,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf04045,10109,hsa:10109; O15144; Q92801; Q9P1D4,ENSG00000163466,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,Pathogenic Escherichia coli infection,6,0,68.87,81.12,80.75,56.56,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,High,Peak Found,High,High,Peak Found,n/a,1,,FALSE,105.91,100.99,129.94,98.16,34.07,cytoskeletal activity,0,
Master Protein,High,P51970,NDUFA8,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 OS=Homo sapiens OX=9606 GN=NDUFA8 PE=1 SV=3,3,6,0.535,0.995,2.547,0.134,-0.9,-0.01,1.35,-2.89,6.17E-01,6.36E-01,2.87E-01,1.15E-01,2.38E+05,9.82E+05,2.79E+05,1.77E+06,5,4,4,2,1.64E+05,5.14E+05,9.64E+04,9.55E+05,2.38E+05,1.27E+06,8.53E+05,,6.37E+05,1.13E+06,1.88E+05,,3.58E+05,9.07E+05,2.17E+05,2.09E+06,,1.50E+06,,,6.50E+02,1.95E+03,9.42E+02,9.55E+05,1.23E+04,4.50E+03,1.52E+04,,1.79E+04,1.20E+04,1.12E+03,,2.91E+03,1.22E+05,5.38E+03,4.07E+03,,1.06E+04,,,0,FALSE,15.558,26,3,172,20.1,7.65,3,cell organization and biogenesis;other metabolic processes;transport,other membranes;mitochondrion,Pf06747,4702,B1AM93; hsa:4702; P51970; Q9Y6N0,ENSG00000119421,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,5,0,89.46,29.01,80.22,23.13,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,88.98,80.14,67.59,87.77,19.05,transporter activity;other molecular function,0,
Master Protein,High,P38919,EIF4A3,Eukaryotic initiation factor 4A-III OS=Homo sapiens OX=9606 GN=EIF4A3 PE=1 SV=4,6,18,0.535,0.247,1.134,0.806,-0.9,-2.02,0.18,-0.31,4.18E-01,1.29E-01,9.57E-01,9.52E-01,3.51E+06,2.11E+06,2.08E+06,1.38E+06,5,3,5,3,5.55E+06,1.48E+06,3.51E+06,6.04E+06,5.71E+05,1.71E+07,,2.11E+06,6.99E+05,,2.42E+06,2.08E+06,6.47E+05,3.04E+06,6.62E+05,8.27E+06,5.64E+04,1.38E+06,,,2.20E+04,5.63E+03,3.43E+04,6.04E+06,2.95E+04,6.10E+04,,1.95E+04,1.97E+04,,1.45E+04,9.31E+04,5.26E+03,4.10E+05,1.64E+04,1.61E+04,1.58E+04,9.76E+03,,,0,FALSE,22.436,24,5,411,46.8,6.73,6,RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00270, Pf00271",9775,hsa:9775; P38919; Q15033; Q6IBQ2; Q96A18,ENSG00000141543; ENSG00000291508,Regulation of expression of SLITs and ROBOs; Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; ISG15 antiviral mechanism; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Z-decay: degradation of maternal mRNAs by zygotically expressed factors,TAR syndrome,11,1,70.34,137.05,60.73,136.34,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,136.17,102.84,123.49,138.11,53.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,C9JFV4,PELP1,"Proline-, glutamic acid- and leucine-rich protein 1 OS=Homo sapiens OX=9606 GN=PELP1 PE=1 SV=2",8,23,0.534,0.479,,0.705,-0.9,-1.06,,-0.5,4.92E-01,6.30E-01,,8.83E-01,2.29E+06,5.04E+05,4.44E+05,1.97E+05,5,3,5,1,1.01E+07,8.81E+05,2.33E+06,2.29E+06,9.44E+05,9.65E+05,,5.04E+05,,8.11E+04,4.83E+06,4.44E+05,2.22E+05,5.77E+05,1.12E+05,,,,1.97E+05,,4.01E+04,3.35E+03,2.28E+04,2.29E+06,4.87E+04,3.43E+03,,4.65E+03,,8.62E+02,2.89E+04,1.98E+04,1.80E+03,7.78E+04,2.77E+03,,,,4.61E+03,,0,FALSE,35.091,12,8,1180,124.9,4.41,8,,nucleus;other cell component,"Pf08166, Pf08167",27043,C9JFV4; hsa:27043; I3L3A8,ENSG00000141456,,,0,0,116.6,85.59,163.06,,High,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,109.57,114.71,,72.08,72.29,,0,
Master Protein,High,H0Y459,NCOR1,Nuclear receptor corepressor 1 OS=Homo sapiens OX=9606 GN=NCOR1 PE=1 SV=2,3,5,0.533,0.658,0.01,100,-0.91,-0.6,-6.64,6.64,5.29E-01,9.71E-01,1.00E-17,1.00E-17,5.04E+04,9.46E+04,7.53E+04,,3,1,3,,,,5.04E+04,4.63E+05,4.18E+04,9.46E+04,,,,,,1.70E+05,,7.53E+04,3.32E+04,,,,,,,,4.93E+02,4.63E+05,2.16E+03,3.36E+02,,,,,,7.59E+03,,1.01E+04,8.25E+02,,,,,,0,FALSE,11.484,2,3,2514,277.8,7.12,3,,cytosol;nucleus,,9611,H0Y459,ENSG00000141027,,Androgen receptor signaling pathway; Adipogenesis; Ovarian infertility; MECP2 and associated Rett syndrome; Pathways affected in adenoid cystic carcinoma; Rett syndrome; 22q11.2 copy number variation syndrome; Notch signaling pathway,8,0,130.06,,75.47,,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,83.59,92.93,,,14.79,,0,
Master Protein,High,P27824,CANX,Calnexin OS=Homo sapiens OX=9606 GN=CANX PE=1 SV=2,28,311,0.533,0.936,1.164,0.573,-0.91,-0.1,0.22,-0.8,4.15E-01,6.55E-01,9.50E-01,6.76E-01,5.63E+07,7.53E+07,5.20E+07,1.90E+08,5,5,5,5,4.36E+07,1.50E+08,8.91E+06,5.63E+07,8.95E+07,5.60E+07,1.13E+08,2.11E+08,4.24E+07,7.53E+07,6.06E+07,3.60E+07,6.69E+07,4.52E+07,5.20E+07,1.90E+08,1.95E+07,2.34E+08,4.78E+07,2.26E+08,1.73E+05,5.72E+05,8.71E+04,5.63E+07,4.62E+06,1.99E+05,2.01E+06,1.95E+06,1.19E+06,8.01E+05,3.63E+05,1.61E+06,5.43E+05,6.09E+06,1.29E+06,3.70E+05,5.49E+06,1.66E+06,1.12E+06,2.41E+06,0,FALSE,152.009,54,28,592,67.5,4.6,28,protein metabolism;other metabolic processes;transport;other biological processes,other membranes;ER/Golgi;nucleus;other cell component,Pf00262,821,B2R5V8; B4DGP8; B4E2T8; D3DWQ3; D6R9K3; hsa:821; P27824,ENSG00000127022; ENSG00000283777,"MHC class II antigen presentation; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Interleukin-35 Signalling; Interleukin-27 signaling; Assembly of Viral Components at the Budding Site; Maturation of spike protein; Calnexin/calreticulin cycle; Maturation of spike protein",15q11q13 copy number variation,9,0,76.77,68.14,23.46,71.19,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,130.77,128.91,139.05,134.05,761.67,other molecular function,0,
Master Protein,High,Q9UBS4,DNAJB11,DnaJ homolog subfamily B member 11 OS=Homo sapiens OX=9606 GN=DNAJB11 PE=1 SV=1,6,49,0.531,0.561,0.57,0.695,-0.91,-0.83,-0.81,-0.53,4.13E-01,7.58E-01,3.96E-01,8.05E-01,5.92E+06,4.15E+06,3.86E+06,1.40E+07,4,5,4,5,4.40E+05,2.93E+07,,3.84E+06,9.12E+06,4.15E+06,8.67E+06,1.65E+07,2.91E+06,3.03E+06,,2.54E+06,4.05E+06,4.39E+06,3.68E+06,1.40E+07,1.12E+06,1.57E+07,3.03E+06,1.87E+07,1.75E+03,1.11E+05,,3.84E+06,4.70E+05,1.47E+04,1.54E+05,1.53E+05,8.21E+04,3.22E+04,,1.13E+05,3.29E+04,5.92E+05,9.14E+04,2.73E+04,3.14E+05,1.11E+05,7.10E+04,2.00E+05,0,FALSE,26.93,22,6,358,40.5,6.18,6,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,non-structural extracellular;ER/Golgi;nucleus;other cell component,"Pf00226, Pf01556",51726,hsa:51726; Q542Y5; Q542Y9; Q6IAQ8; Q96JC6; Q9UBS4,ENSG00000090520,XBP1(S) activates chaperone genes,Photodynamic therapy-induced unfolded protein response,2,0,120.96,82.1,22.01,75.33,Peak Found,High,n/a,High,Peak Found,Peak Found,High,High,High,High,n/a,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,131.17,116.81,133.97,130.26,139.12,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P37235,HPCAL1,Hippocalcin-like protein 1 OS=Homo sapiens OX=9606 GN=HPCAL1 PE=1 SV=3,2,7,0.531,1.633,0.618,1.411,-0.91,0.71,-0.69,0.5,4.94E-01,1.69E-01,4.51E-01,6.84E-01,1.24E+06,2.07E+06,2.77E+06,1.66E+06,2,4,4,5,,,,1.29E+06,1.20E+06,,8.61E+05,3.46E+06,1.24E+06,4.66E+06,,4.28E+05,3.06E+06,3.66E+06,2.51E+06,2.09E+06,3.76E+05,1.19E+06,1.66E+06,2.95E+06,,,,1.29E+06,6.20E+04,,1.53E+04,3.19E+04,3.49E+04,4.95E+04,,1.91E+04,2.48E+04,4.93E+05,6.23E+04,4.07E+03,1.06E+05,8.43E+03,3.89E+04,3.14E+04,0.001,FALSE,3.846,10,2,193,22.3,5.35,2,,other membranes,Pf13499,3241,hsa:3241; P37235; Q969S5,ENSG00000115756,,,0,0,4.74,70.91,58.19,58.35,n/a,n/a,n/a,High,High,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,86.39,99.86,110.12,97.79,13.64,other molecular function,0,
Master Protein,High,Q86Y39,NDUFA11,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 OS=Homo sapiens OX=9606 GN=NDUFA11 PE=1 SV=3,2,23,0.53,1.423,0.897,1.131,-0.92,0.51,-0.16,0.18,4.12E-01,2.87E-01,7.88E-01,8.53E-01,2.55E+06,3.12E+06,3.24E+06,3.11E+06,5,5,5,3,2.55E+06,9.54E+06,6.10E+05,4.10E+05,9.37E+06,2.69E+06,1.82E+05,3.12E+06,5.60E+06,1.80E+07,4.34E+06,2.71E+05,3.24E+06,5.79E+06,2.91E+06,4.09E+06,8.80E+05,,3.11E+06,,1.01E+04,3.62E+04,5.96E+03,4.10E+05,4.84E+05,9.57E+03,3.23E+03,2.88E+04,1.58E+05,1.91E+05,2.59E+04,1.21E+04,2.63E+04,7.80E+05,7.23E+04,7.98E+03,2.47E+05,,7.27E+04,,0,FALSE,11.816,24,2,141,14.8,8.72,2,cell organization and biogenesis;other metabolic processes,other membranes;mitochondrion,,126328,C9JT23; hsa:126328; Q6ZS66; Q86Y39,ENSG00000174886; ENSG00000292058,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,5,0,102.42,118.59,61.56,61.1,High,High,High,High,High,Peak Found,Peak Found,High,High,High,High,High,High,High,High,High,High,n/a,High,n/a,1,,FALSE,123.17,127.38,81.58,81.72,80.23,,0,
Master Protein,High,Q96GQ7,DDX27,Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=2,5,5,0.529,0.518,0.01,100,-0.92,-0.95,-6.64,6.64,5.65E-01,7.26E-01,1.00E-17,1.00E-17,1.16E+06,5.78E+05,3.39E+04,,2,4,3,,,,,6.37E+05,2.11E+06,4.91E+05,3.84E+04,6.81E+05,,1.42E+06,,3.02E+04,3.39E+04,1.42E+05,,,,,,,,,,6.37E+05,1.09E+05,1.74E+03,6.83E+02,6.28E+03,,1.51E+04,,1.35E+03,2.75E+02,1.91E+04,,,,,,,0,FALSE,13.087,6,5,796,89.8,9.28,5,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00270, Pf00271",55661,A0AVB6; B7ZLY1; Q5VXM7; Q8WYG4; Q969N7; Q96F57; Q96GQ7; Q96L97; Q9BWY9; Q9BXF0; Q9H990; Q9NWU3; Q9P0C2; Q9UGD6,,,,0,0,75.99,87.47,92.35,,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,121.8,88.2,,,14.94,other molecular function,0,
Master Protein,High,A0A499FIZ0,WDR26,WD repeat domain 26 OS=Homo sapiens OX=9606 GN=WDR26 PE=1 SV=2,4,8,0.527,0.443,1.811,0.276,-0.92,-1.17,0.86,-1.86,6.23E-01,5.86E-01,6.62E-01,3.17E-01,5.84E+05,9.22E+04,7.18E+04,4.29E+05,3,1,4,3,2.19E+06,,5.84E+05,1.88E+05,,,,9.22E+04,,,7.63E+04,,3.66E+04,6.77E+04,2.31E+05,4.29E+05,5.52E+05,3.37E+05,,,8.70E+03,,5.70E+03,1.88E+05,,,,8.51E+02,,,4.56E+02,,2.98E+02,9.12E+03,5.74E+03,8.36E+02,1.55E+05,2.39E+03,,,0,FALSE,14.306,7,4,761,81.3,6.25,4,,cytosol;mitochondrion;nucleus,"Pf00400, Pf17814",,A0A499FIZ0,ENSG00000162923,,Ciliary landscape,1,0,107.37,,84.6,24.6,High,n/a,Peak Found,High,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,33.97,93.96,101.21,98.58,18.48,,0,
Master Protein,High,A0A087WWU8,TPM3,Tropomyosin 3 OS=Homo sapiens OX=9606 GN=TPM3 PE=1 SV=1,16,82,0.525,0.82,2.609,0.197,-0.93,-0.29,1.38,-2.34,4.07E-01,8.02E-01,2.75E-01,1.73E-01,3.76E+06,5.82E+06,7.83E+06,5.22E+07,5,5,5,5,3.76E+06,3.43E+06,8.01E+05,5.51E+06,7.53E+07,5.90E+07,5.82E+06,1.89E+07,3.92E+06,5.33E+06,4.59E+06,5.60E+06,7.83E+06,1.53E+07,1.26E+07,5.22E+07,2.48E+07,1.34E+08,3.86E+07,2.09E+08,1.50E+04,1.30E+04,7.83E+03,5.51E+06,3.88E+06,2.10E+05,1.03E+05,1.74E+05,1.10E+05,5.67E+04,2.75E+04,2.50E+05,6.36E+04,2.06E+06,3.14E+05,1.02E+05,6.97E+06,9.52E+05,9.03E+05,2.22E+06,0,FALSE,52.918,49,4,227,26.4,4.78,16,,cytoskeleton,Pf00261,7170,A0A087WWU8,ENSG00000143549,,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Striated muscle contraction pathway; VEGFA-VEGFR2 signaling,3,11,181.35,125.84,50.21,85.13,n/a,n/a,n/a,High,High,Peak Found,n/a,n/a,High,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,135.93,131.23,137.53,118.9,207.85,cytoskeletal activity,0,
Master Protein,High,Q9Y5L4,TIMM13,Mitochondrial import inner membrane translocase subunit Tim13 OS=Homo sapiens OX=9606 GN=TIMM13 PE=1 SV=1,2,3,0.525,1.891,1.7,0.985,-0.93,0.92,0.77,-0.02,5.96E-01,1.17E-01,6.26E-01,8.44E-01,4.21E+05,5.90E+05,1.11E+06,1.00E+06,1,1,1,3,,,,4.21E+05,,,,5.90E+05,,,,,,1.11E+06,,,5.88E+04,3.11E+06,,1.00E+06,,,,4.21E+05,,,,5.45E+03,,,,,,1.50E+05,,,1.65E+04,2.20E+04,,1.07E+04,0,FALSE,5.561,19,2,95,10.5,8.18,2,cell organization and biogenesis;transport;other biological processes,other membranes;mitochondrion;nucleus,Pf02953,26517,hsa:26517; P62206; Q9UHL8; Q9WTL1; Q9Y5L4,ENSG00000099800,Mitochondrial protein import,,1,0,,,,112.3,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,0,81.05,139.57,139.57,7.36,other molecular function,0,
Master Protein,High,P27105,STOM,Stomatin OS=Homo sapiens OX=9606 GN=STOM PE=1 SV=3,9,175,0.524,0.177,0.531,0.33,-0.93,-2.5,-0.91,-1.6,4.05E-01,4.41E-02,3.48E-01,3.64E-01,4.25E+07,3.34E+07,3.26E+06,1.50E+07,5,5,5,5,1.66E+08,1.01E+08,4.25E+07,5.19E+05,3.01E+07,1.05E+08,6.76E+06,3.34E+07,2.34E+07,9.56E+07,5.05E+07,1.30E+06,4.77E+06,3.26E+06,2.44E+06,6.83E+07,1.01E+07,1.50E+07,5.22E+06,2.16E+07,6.59E+05,3.83E+05,4.15E+05,5.19E+05,1.55E+06,3.73E+05,1.20E+05,3.08E+05,6.60E+05,1.02E+06,3.02E+05,5.82E+04,3.87E+04,4.40E+05,6.07E+04,1.33E+05,2.83E+06,1.07E+05,1.22E+05,2.30E+05,0,FALSE,53.62,43,9,288,31.7,7.88,9,other biological processes,plasma membrane;other membranes;cytoskeleton;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component,Pf01145,2040,B1AM77; hsa:2040; P27105; Q14087; Q15609; Q5VX96; Q96FK4,ENSG00000148175,Neutrophil degranulation; RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; Stimuli-sensing channels; RHOQ GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle; RHOH GTPase cycle,Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; Ciliary landscape,12,0,96.76,84.19,171.08,105.95,High,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,1,,FALSE,137.36,146.25,118.78,142.91,387.77,other molecular function,0,
Master Protein,High,L0R6Q1,SLC35A4,SLC35A4 upstream open reading frame protein OS=Homo sapiens OX=9606 GN=SLC35A4 PE=3 SV=1,3,9,0.522,0.938,0.681,0.591,-0.94,-0.09,-0.55,-0.76,4.51E-01,5.46E-01,5.34E-01,7.61E-01,1.33E+06,2.34E+06,8.75E+05,2.06E+06,5,4,5,3,9.94E+04,2.17E+06,3.88E+04,1.33E+06,3.42E+06,,1.84E+05,3.85E+06,1.41E+06,7.10E+06,4.47E+05,2.82E+05,8.75E+05,2.51E+06,1.53E+06,,3.91E+05,,2.06E+06,5.82E+06,3.95E+02,8.26E+03,3.79E+02,1.33E+06,1.77E+05,,3.27E+03,3.56E+04,3.99E+04,7.55E+04,2.67E+03,1.26E+04,7.10E+03,3.38E+05,3.81E+04,,1.10E+05,,4.81E+04,6.19E+04,0,FALSE,12.144,40,3,103,11.1,8.1,3,stress response,other membranes,Pf15054,,L0R6Q1,ENSG00000176087,,,0,0,101.54,97.17,80.63,100.89,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,131.44,130.66,104.29,110.01,34.17,,0,
Master Protein,High,G3XAA4,JADE2,Jade family PHD finger 2 OS=Homo sapiens OX=9606 GN=JADE2 PE=1 SV=1,1,1,0.521,0.376,0.78,0.275,-0.94,-1.41,-0.36,-1.86,4.81E-01,5.81E-01,7.88E-01,3.95E-01,2.30E+04,4.03E+04,8.64E+03,3.14E+04,3,2,3,1,,,1.90E+04,2.30E+04,2.32E+04,,,5.12E+04,,3.17E+04,,7.07E+03,,8.64E+03,1.01E+04,,,,3.14E+04,,,,1.86E+02,2.30E+04,1.20E+03,,,4.73E+02,,3.37E+02,,3.16E+02,,1.16E+03,2.52E+02,,,,7.35E+02,,0.007,FALSE,2.355,1,1,834,92.1,5.6,1,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf10513, Pf13831, Pf13832",23338,D6R9B8; G3XAA4,ENSG00000043143,,,0,0,10.73,33.36,17.78,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,32.88,21.86,35.99,21.86,2.36,other molecular function,0,
Master Protein,High,D6RDA2,DEK,DEK proto-oncogene (Fragment) OS=Homo sapiens OX=9606 GN=DEK PE=1 SV=1,8,44,0.521,1.439,0.186,1.38,-0.94,0.53,-2.43,0.46,5.81E-01,2.38E-01,6.13E-02,6.35E-01,1.09E+05,1.36E+06,1.58E+06,5.96E+05,5,5,1,4,1.09E+05,1.74E+07,8.43E+04,5.44E+04,2.71E+07,1.06E+06,7.85E+05,1.36E+06,1.99E+06,1.78E+07,,,,1.58E+06,,1.34E+06,2.53E+05,,2.65E+05,1.34E+06,4.34E+02,6.60E+04,8.24E+02,5.44E+04,1.40E+06,3.78E+03,1.40E+04,1.25E+04,5.61E+04,1.89E+05,,,,2.12E+05,,2.61E+03,7.11E+04,,6.21E+03,1.43E+04,0,FALSE,30.775,54,2,122,14.1,9.95,8,cell organization and biogenesis,,Pf02037,,D6RDA2,ENSG00000124795,,10q11.21q11.23 copy number variation syndrome,1,0,140.97,160.61,,78.03,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,146.8,1486.47,112.29,21.81,116.88,nucleic acid binding activity,0,
Master Protein,High,P31948,STIP1,Stress-induced-phosphoprotein 1 OS=Homo sapiens OX=9606 GN=STIP1 PE=1 SV=1,9,15,0.52,0.191,0.8,0.236,-0.94,-2.39,-0.32,-2.09,4.86E-01,6.50E-02,8.14E-01,2.97E-01,1.29E+06,8.49E+05,3.40E+05,1.37E+06,5,3,4,5,5.43E+05,2.54E+06,4.11E+05,1.29E+06,1.40E+06,8.49E+05,,1.32E+06,4.60E+05,,,3.39E+05,1.46E+05,9.02E+05,3.41E+05,2.99E+06,2.10E+06,1.37E+06,5.23E+05,9.16E+05,2.16E+03,9.66E+03,4.02E+03,1.29E+06,7.24E+04,3.02E+03,,1.22E+04,1.30E+04,,,1.51E+04,1.19E+03,1.22E+05,8.47E+03,5.83E+03,5.91E+05,9.73E+03,1.22E+04,9.75E+03,0,FALSE,33.408,20,9,543,62.6,6.8,9,other biological processes,cytosol;ER/Golgi;nucleus;other cell component,"Pf00515, Pf13181, Pf17830",10963,B4DM70; F5H0T1; G3XAD8; hsa:10963; P31948; Q3ZCU9; Q5TZU9,ENSG00000168439,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; RND1 GTPase cycle,VEGFA-VEGFR2 signaling,3,0,68.77,49.17,75.56,62.11,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,106.42,110.89,108.53,96.92,49.26,other molecular function,0,
Master Protein,High,P12429,ANXA3,Annexin A3 OS=Homo sapiens OX=9606 GN=ANXA3 PE=1 SV=3,6,25,0.519,1.187,0.489,0.363,-0.95,0.25,-1.03,-1.46,4.78E-01,3.40E-01,2.97E-01,4.11E-01,2.42E+05,2.41E+06,1.60E+06,4.17E+06,4,4,4,5,,3.78E+05,1.54E+05,5.79E+04,1.00E+07,1.26E+06,,1.95E+06,6.61E+06,2.99E+06,6.45E+05,,3.29E+06,3.46E+06,7.76E+05,4.17E+06,5.17E+05,2.64E+05,8.39E+06,5.78E+06,,1.44E+03,1.51E+03,5.79E+04,5.16E+05,4.47E+03,,1.80E+04,1.86E+05,3.18E+04,3.86E+03,,2.67E+04,4.66E+05,1.93E+04,8.14E+03,1.45E+05,1.87E+03,1.96E+05,6.15E+04,0,FALSE,21.574,25,6,323,36.4,5.92,6,stress response;transport;developmental processes;other biological processes,plasma membrane;other membranes;other cell component,Pf00191,306,B2R9W6; hsa:306; P12429; Q6LET2,ENSG00000138772,,Prostaglandin synthesis and regulation,1,0,185.21,74.45,75.42,90.96,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,118.22,139.42,73.4,120.92,74.5,enzyme regulator activity;other molecular function,0,
Master Protein,High,P21333,FLNA,Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4,71,533,0.519,0.292,1.07,0.228,-0.95,-1.78,0.1,-2.13,3.98E-01,2.03E-01,9.64E-01,2.17E-01,5.58E+07,7.33E+07,1.75E+07,1.22E+08,5,5,5,5,6.26E+07,2.20E+08,4.27E+07,8.91E+06,5.58E+07,4.85E+07,7.33E+07,3.70E+08,1.68E+08,4.06E+07,4.67E+06,6.76E+06,1.75E+07,3.37E+07,2.88E+07,3.94E+08,6.74E+07,1.43E+08,4.54E+07,1.22E+08,2.49E+05,8.37E+05,4.18E+05,8.91E+06,2.88E+06,1.73E+05,1.30E+06,3.41E+06,4.73E+06,4.32E+05,2.80E+04,3.02E+05,1.42E+05,4.54E+06,7.15E+05,7.69E+05,1.89E+07,1.01E+06,1.06E+06,1.29E+06,0,FALSE,343.919,37,66,2647,280.6,6.06,71,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,"Pf00307, Pf00630",2316,E9KL45; hsa:2316; P21333; Q5HY53; Q5HY55; Q8NF52,ENSG00000196924,OAS antiviral response; Platelet degranulation ; RHO GTPases activate PAKs; GP1b-IX-V activation signalling; Cell-extracellular matrix interactions,Androgen receptor signaling pathway; Prolactin signaling pathway; Focal adhesion; Hypothesized pathways in pathogenesis of cardiovascular disease; MAPK signaling pathway; IL-4 signaling pathway; Ebola virus infection in host; Joubert syndrome; NPHP1 deletion syndrome,14,5,105.25,98.61,70.63,90.67,High,High,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,1,,FALSE,134.78,134.72,137.52,123.76,1407.32,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q6P4A8,PLBD1,Phospholipase B-like 1 OS=Homo sapiens OX=9606 GN=PLBD1 PE=1 SV=2,5,43,0.519,0.127,5.102,0.022,-0.95,-2.98,2.35,-5.53,3.98E-01,1.03E-02,5.15E-02,8.96E-04,2.10E+06,7.84E+06,9.00E+04,2.94E+07,5,4,4,5,5.03E+06,2.10E+06,5.47E+05,9.21E+05,1.81E+07,2.18E+06,4.70E+06,1.31E+07,,1.39E+07,3.62E+04,,4.31E+04,1.45E+06,1.88E+05,4.72E+07,4.74E+05,3.75E+07,6.97E+06,2.94E+07,2.00E+04,7.99E+03,5.34E+03,9.21E+05,9.32E+05,7.74E+03,8.36E+04,1.21E+05,,1.47E+05,2.16E+02,,3.50E+02,1.95E+05,4.67E+03,9.21E+04,1.33E+05,2.66E+05,1.63E+05,3.13E+05,0,FALSE,16.792,10,5,553,63.2,9.06,5,other metabolic processes,non-structural extracellular;cytosol;other cytoplasmic organelle,Pf04916,79887,A8K4E9; hsa:79887; Q6P4A8; Q9BVV3; Q9H625,ENSG00000121316,Acyl chain remodelling of PC; Acyl chain remodelling of PE; Acyl chain remodelling of PI; Hydrolysis of LPC,,4,0,137.48,69.69,159.32,82.11,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,n/a,High,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,High,High,High,1,,FALSE,125.56,95.86,115.58,147.34,75.54,other molecular function,0,
Master Protein,High,Q9HBI1,PARVB,Beta-parvin OS=Homo sapiens OX=9606 GN=PARVB PE=1 SV=1,2,5,0.518,1.424,6.053,0.121,-0.95,0.51,2.6,-3.05,5.93E-01,4.18E-01,5.51E-02,1.13E-01,1.03E+05,4.69E+05,1.47E+05,1.22E+06,4,3,2,4,3.11E+06,,2.60E+05,1.49E+04,4.11E+04,4.69E+05,6.28E+04,5.37E+05,,,,,,1.08E+05,2.00E+05,,3.04E+06,3.62E+06,3.01E+05,4.89E+05,1.23E+04,,2.54E+03,1.49E+04,2.12E+03,1.67E+03,1.12E+03,4.96E+03,,,,,,1.46E+04,4.98E+03,,8.54E+05,2.56E+04,7.04E+03,5.21E+03,0,FALSE,7.728,8,2,364,41.7,6.73,2,cell adhesion;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf00307,29780,B0QYM8; B0QYN1; B2R9X6; hsa:29780; Q5TGJ5; Q86X93; Q96PN1; Q9HBI1; Q9NSP7; Q9UGT3; Q9Y368; Q9Y3L6; Q9Y3L7,ENSG00000188677,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Focal adhesion,3,0,175.82,71.98,42.26,91.95,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,141.68,143.09,82.65,122.31,11.36,cytoskeletal activity,0,
Master Protein,High,Q86UE4,MTDH,Protein LYRIC OS=Homo sapiens OX=9606 GN=MTDH PE=1 SV=2,6,14,0.518,1.081,1.554,0.365,-0.95,0.11,0.64,-1.45,5.61E-01,4.69E-01,6.36E-01,4.38E-01,3.56E+05,1.29E+06,9.65E+05,2.11E+06,5,3,5,4,5.75E+05,7.33E+06,2.04E+05,3.56E+05,2.57E+05,1.29E+06,,1.79E+06,2.75E+05,,3.25E+05,1.42E+06,1.37E+06,7.90E+05,9.65E+05,3.24E+06,3.11E+05,1.89E+06,,2.35E+06,2.28E+03,2.79E+04,1.99E+03,3.56E+05,1.32E+04,4.58E+03,,1.65E+04,7.75E+03,,1.94E+03,6.33E+04,1.11E+04,1.06E+05,2.40E+04,6.31E+03,8.75E+04,1.34E+04,,2.51E+04,0,FALSE,22.873,14,6,582,63.8,9.32,6,signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cell component,Pf15686,92140,hsa:92140; Q05DH2; Q52QU9; Q6PK07; Q86UE4; Q8TCX3,ENSG00000147649,,Gastric cancer network 2; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; CCL18 signaling pathway,3,0,179.22,69.05,46.16,62.98,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,n/a,Peak Found,1,,FALSE,132.14,112.39,87.27,128.01,43.04,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8Q3WKV4,CDCA7,Cell division cycle associated 7 OS=Homo sapiens OX=9606 GN=CDCA7 PE=1 SV=1,1,1,0.518,0.01,1.543,0.01,-0.95,-6.64,0.63,-6.64,5.00E-01,1.00E-17,7.73E-01,1.00E-17,4.17E+04,9.28E+04,,7.86E+04,2,3,,2,,,,3.48E+04,5.01E+04,1.01E+05,,,2.34E+04,9.28E+04,,,,,,1.49E+05,,,,4.14E+04,,,,3.48E+04,2.58E+03,3.58E+02,,,6.59E+02,9.86E+02,,,,,,2.91E+02,,,,4.41E+02,0.001,FALSE,3.86,3,1,449,51.3,8.18,1,other biological processes,nucleus;other cell component,Pf10497,,A0A8Q3WKV4,ENSG00000144354,,,0,0,25.5,58.83,,79.99,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,65.4,,63.54,,2.38,,0,
Master Protein,High,Q9NSD9,FARSB,Phenylalanine--tRNA ligase beta subunit OS=Homo sapiens OX=9606 GN=FARSB PE=1 SV=3,5,8,0.518,1.022,0.981,0.984,-0.95,0.03,-0.03,-0.02,6.09E-01,6.40E-01,8.64E-01,8.69E-01,4.00E+05,1.94E+05,4.69E+05,6.67E+05,4,1,5,3,6.81E+06,2.98E+05,,5.36E+05,2.69E+05,1.94E+05,,,,,4.03E+05,8.82E+05,2.70E+05,1.03E+06,4.69E+05,,2.85E+06,6.67E+05,4.98E+05,,2.71E+04,1.13E+03,,5.36E+05,1.39E+04,6.91E+02,,,,,2.41E+03,3.94E+04,2.20E+03,1.39E+05,1.17E+04,,8.00E+05,4.73E+03,1.17E+04,,0,FALSE,13.992,10,5,589,66.1,6.84,5,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;other cell component,"Pf03483, Pf03484, Pf17759, Pf18262",10056,B4DFM0; hsa:10056; O95708; Q4ZFX1; Q57ZJ5; Q9NSD9; Q9NZZ6,ENSG00000116120,Cytosolic tRNA aminoacylation,VEGFA-VEGFR2 signaling; Amino acid metabolism,3,0,162.96,,53.75,97.94,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,65.39,88.77,128.34,115.39,17.99,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P23276,KEL,Kell blood group glycoprotein OS=Homo sapiens OX=9606 GN=KEL PE=1 SV=2,5,11,0.517,0.645,0.552,0.209,-0.95,-0.63,-0.86,-2.26,5.63E-01,9.39E-01,4.35E-01,2.58E-01,4.05E+05,1.27E+06,1.22E+05,1.37E+06,4,4,4,5,3.71E+06,,1.96E+05,3.22E+04,8.38E+05,7.71E+05,,1.21E+06,1.38E+06,1.32E+06,1.06E+05,,1.73E+05,1.40E+05,6.53E+04,2.72E+05,2.76E+06,1.37E+06,2.08E+06,7.02E+05,1.47E+04,,1.92E+03,3.22E+04,4.32E+04,2.74E+03,,1.12E+04,3.90E+04,1.40E+04,6.33E+02,,1.40E+03,1.88E+04,1.62E+03,5.31E+02,7.75E+05,9.71E+03,4.86E+04,7.47E+03,0,FALSE,19.307,11,5,732,82.8,7.9,5,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus,"Pf01431, Pf05649",3792,B2RBV4; hsa:3792; P23276; Q96RS8; Q99885,ENSG00000197993; ENSG00000276615,Peptide ligand-binding receptors,,1,0,143.43,23.6,38.1,70.13,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,135.46,137.99,116,82.37,24.37,other molecular function,0,
Master Protein,High,Q92504,SLC39A7,Zinc transporter SLC39A7 OS=Homo sapiens OX=9606 GN=SLC39A7 PE=1 SV=2,1,5,0.516,0.046,0.332,0.083,-0.95,-4.45,-1.59,-3.59,6.00E-01,9.74E-04,1.87E-01,7.06E-02,3.00E+05,4.94E+05,1.38E+04,1.65E+05,4,4,3,4,,1.44E+06,5.21E+04,1.14E+05,7.89E+05,,5.76E+05,1.00E+06,3.37E+05,4.24E+05,,1.02E+04,,1.83E+04,1.38E+04,1.25E+05,,2.18E+05,3.77E+04,2.05E+06,,5.48E+03,5.09E+02,1.14E+05,4.07E+04,,1.03E+04,9.24E+03,9.48E+03,4.50E+03,,4.57E+02,,2.47E+03,3.42E+02,2.45E+02,,1.54E+03,8.83E+02,2.19E+04,0,FALSE,6.596,3,1,469,50.1,6.87,1,transport;other biological processes,other membranes;ER/Golgi;nucleus,Pf02535,7922,B0UXF6; hsa:7922; Q5STP8; Q92504; Q9UIQ0,ENSG00000112473; ENSG00000206288; ENSG00000224399; ENSG00000226614; ENSG00000227402; ENSG00000229802,Zinc influx into cells by the SLC39 gene family,Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis,4,0,109.08,50.51,28.65,158.76,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,128.11,136.36,129.34,107.93,15.09,transporter activity,0,
Master Protein,High,P07602,PSAP,Prosaposin OS=Homo sapiens OX=9606 GN=PSAP PE=1 SV=2,9,95,0.516,0.975,0.781,0.459,-0.96,-0.04,-0.36,-1.12,3.95E-01,6.13E-01,6.55E-01,5.39E-01,1.59E+06,3.31E+07,5.04E+06,1.86E+07,5,5,5,5,1.21E+06,3.02E+07,1.59E+06,1.26E+06,1.77E+07,1.35E+07,4.36E+07,4.07E+07,3.52E+06,3.31E+07,9.79E+05,2.81E+06,5.04E+06,1.50E+07,9.46E+06,3.81E+07,3.14E+06,3.74E+06,2.78E+07,1.86E+07,4.82E+03,1.15E+05,1.56E+04,1.26E+06,9.10E+05,4.81E+04,7.75E+05,3.75E+05,9.91E+04,3.52E+05,5.86E+03,1.25E+05,4.10E+04,2.02E+06,2.35E+05,7.44E+04,8.83E+05,2.65E+04,6.51E+05,1.98E+05,0,FALSE,38.074,20,9,524,58.1,5.17,9,other metabolic processes;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle;other cell component,"Pf02199, Pf03489, Pf05184",5660,hsa:5660; P07292; P07602; P15793; P78538; P78541; P78546; P78547; P78558; Q53Y86; Q6IBQ6; Q92739; Q92740; Q92741; Q92742,ENSG00000197746,Neutrophil degranulation; G alpha (i) signalling events; Platelet degranulation ; Peptide ligand-binding receptors; Glycosphingolipid catabolism,"Degradation pathway of sphingolipids, including diseases",6,0,126.47,65.27,84.58,83.2,Peak Found,High,Peak Found,High,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,1,Phospho [T428],FALSE,135.76,127.61,137.32,119.75,210.08,enzyme regulator activity;other molecular function,1,Phospho [T428]
Master Protein,High,Q6DKK2,TTC19,"Tetratricopeptide repeat protein 19, mitochondrial OS=Homo sapiens OX=9606 GN=TTC19 PE=1 SV=4",1,1,0.515,1.211,0.873,0.948,-0.96,0.28,-0.2,-0.08,6.04E-01,4.64E-01,7.69E-01,8.75E-01,3.01E+05,5.39E+05,2.48E+05,3.17E+05,5,2,3,3,3.44E+05,3.01E+05,4.19E+06,1.35E+05,1.92E+05,,,9.29E+05,,3.13E+05,1.84E+06,,2.33E+05,2.48E+05,,3.17E+05,,1.94E+06,,2.35E+05,1.37E+03,1.14E+03,4.09E+04,1.35E+05,9.90E+03,,,8.57E+03,,3.33E+03,1.10E+04,,1.89E+03,3.34E+04,,6.19E+02,,1.37E+04,,2.50E+03,0,FALSE,6.466,5,1,380,42.4,5.77,1,cell cycle OR cell proliferation;cell organization and biogenesis,other membranes;cytoskeleton;mitochondrion;other cell component,"Pf13374, Pf13424",54902,A8MZ52; B3KP62; B4DN65; hsa:54902; Q2M248; Q6DKK2; Q7L3U8; Q9H6G3; Q9NXB2,ENSG00000011295,,Mitochondrial complex III assembly,1,0,171.16,70.17,119.38,115.73,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,83.3,75.9,106.83,43.4,3.65,,0,
Master Protein,High,P61254,RPL26,60S ribosomal protein L26 OS=Homo sapiens OX=9606 GN=RPL26 PE=1 SV=1,2,5,0.515,0.244,3.218,0.358,-0.96,-2.04,1.69,-1.48,5.35E-01,2.52E-01,3.08E-01,5.18E-01,1.15E+05,1.13E+05,5.54E+04,3.21E+05,5,4,5,5,5.81E+04,1.15E+05,1.01E+05,2.32E+05,1.85E+05,1.38E+05,,9.24E+04,3.36E+04,1.80E+05,4.59E+05,3.02E+04,1.88E+05,5.54E+04,2.73E+04,3.21E+05,4.11E+05,3.54E+06,6.75E+04,1.35E+05,2.31E+02,4.38E+02,9.87E+02,2.32E+05,9.53E+03,4.90E+02,,8.53E+02,9.46E+02,1.91E+03,2.75E+03,1.35E+03,1.53E+03,7.46E+03,6.79E+02,6.25E+02,1.16E+05,2.51E+04,1.58E+03,1.44E+03,0,FALSE,4.435,11,2,145,17.2,10.55,2,cell cycle OR cell proliferation;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;translational apparatus;nucleus;other cell component,"Pf00467, Pf16906",6154,B2R4F0; D3DTR8; hsa:6154; P61254; Q02877; Q6IPY2,ENSG00000161970,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),VEGFA-VEGFR2 signaling; Cytoplasmic ribosomal proteins,15,0,50.22,56.55,121.07,165.93,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,96.09,126.1,137.5,127.51,12.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9BVK6,TMED9,Transmembrane emp24 domain-containing protein 9 OS=Homo sapiens OX=9606 GN=TMED9 PE=1 SV=2,5,41,0.515,0.982,0.436,1.435,-0.96,-0.03,-1.2,0.52,3.93E-01,6.05E-01,2.34E-01,6.91E-01,8.46E+06,6.89E+06,7.91E+06,3.27E+06,5,5,5,5,2.27E+06,1.16E+07,1.13E+06,8.46E+06,1.14E+07,6.89E+06,1.77E+06,1.80E+07,5.37E+06,9.68E+06,2.16E+06,4.39E+06,8.51E+06,1.02E+07,7.91E+06,2.40E+07,3.27E+06,6.81E+05,5.83E+06,3.10E+06,9.02E+03,4.42E+04,1.10E+04,8.46E+06,5.89E+05,2.45E+04,3.14E+04,1.66E+05,1.51E+05,1.03E+05,1.29E+04,1.96E+05,6.92E+04,1.37E+06,1.96E+05,4.69E+04,9.19E+05,4.83E+03,1.37E+05,3.30E+04,0,FALSE,17.597,24,5,235,27.3,8.02,5,cell organization and biogenesis;transport;other biological processes,other membranes;ER/Golgi;other cell component,Pf01105,54732,hsa:54732; Q14437; Q8WZ61; Q9BVK6,ENSG00000184840,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,5q35 copy number variation,3,0,71.61,73.23,49.4,128.49,Peak Found,High,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,91.23,98.02,127.6,88.01,106.31,other molecular function,0,
Master Protein,High,Q9UBB5,MBD2,Methyl-CpG-binding domain protein 2 OS=Homo sapiens OX=9606 GN=MBD2 PE=1 SV=1,2,6,0.513,0.901,2.241,0.85,-0.96,-0.15,1.16,-0.23,5.80E-01,7.13E-01,5.08E-01,9.63E-01,2.58E+05,2.67E+05,1.70E+05,2.19E+05,3,2,5,3,2.58E+05,,5.09E+04,6.92E+05,,,,1.92E+05,,3.72E+05,2.15E+05,1.70E+05,9.93E+04,1.12E+06,1.10E+04,,1.80E+03,2.19E+05,1.64E+06,,1.03E+03,,4.98E+02,6.92E+05,,,,1.77E+03,,3.96E+03,1.29E+03,7.57E+03,8.07E+02,1.51E+05,2.73E+02,,5.06E+02,1.55E+03,3.83E+04,,0,FALSE,7.397,3,2,411,43.2,10.04,2,cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,"Pf01429, Pf14048, Pf16564",8932,hsa:8932; O95242; Q9UBB5; Q9UIS8,ENSG00000134046,NoRC negatively regulates rRNA expression; RNA Polymerase I Promoter Opening,Effect of progerin on genes involved in progeria,3,0,98.02,45.04,139.84,143.41,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,71.97,105.06,126.25,145.35,23.38,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P35612,ADD2,Beta-adducin OS=Homo sapiens OX=9606 GN=ADD2 PE=1 SV=3,14,41,0.512,0.385,2.577,0.077,-0.97,-1.38,1.37,-3.7,4.02E-01,4.16E-01,2.82E-01,2.78E-02,1.20E+06,3.20E+06,2.01E+06,2.01E+07,5,5,5,5,4.32E+05,2.88E+06,2.30E+05,1.20E+06,4.56E+06,1.20E+07,2.23E+06,7.05E+06,4.41E+05,3.20E+06,1.65E+06,2.01E+06,1.38E+07,2.08E+06,7.19E+05,9.72E+06,2.01E+07,2.54E+07,5.43E+06,3.08E+07,1.72E+03,1.09E+04,2.24E+03,1.20E+06,2.35E+05,4.25E+04,3.97E+04,6.50E+04,1.24E+04,3.40E+04,9.86E+03,8.98E+04,1.12E+05,2.81E+05,1.79E+04,1.89E+04,5.65E+06,1.80E+05,1.27E+05,3.28E+05,0,FALSE,61.086,26,13,726,80.8,5.92,14,cell adhesion;cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf00596,119,A8K4P2; B4DM17; D6W5G7; D6W5G8; hsa:119; P35612; Q13482; Q16412; Q59G82; Q5U5P4; Q6P0P2; Q6PGQ4; Q7Z688; Q7Z689; Q7Z690; Q7Z691,ENSG00000075340,Miscellaneous transport and binding events,,1,1,98.58,92.26,135.1,57.98,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,1,,FALSE,127.92,127.97,103,122.23,118.9,cytoskeletal activity;other molecular function,0,
Master Protein,High,O43660,PLRG1,Pleiotropic regulator 1 OS=Homo sapiens OX=9606 GN=PLRG1 PE=1 SV=1,4,9,0.511,0.448,0.01,100,-0.97,-1.16,-6.64,6.64,4.75E-01,6.04E-01,1.00E-17,1.00E-17,6.24E+05,1.48E+06,8.28E+05,,3,1,3,,,,8.42E+04,7.55E+05,6.24E+05,,,,,1.48E+06,,1.73E+04,8.28E+05,8.33E+05,,,,,,,,,8.23E+02,7.55E+05,3.22E+04,,,,,1.57E+04,,7.74E+02,6.73E+03,1.12E+05,,,,,,,0,FALSE,22.417,13,4,514,57.2,9.17,4,RNA metabolism OR transcription;other metabolic processes;other biological processes,other membranes;nucleus;other cell component,Pf00400,5356,B3KMK4; hsa:5356; O43660; Q3KQY5; Q8WUD8,ENSG00000171566,mRNA Splicing - Major Pathway,,1,0,72.9,,83.92,,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,0,132.56,,,31.21,,0,
Master Protein,Medium,Q9NQL2,RRAGD,Ras-related GTP-binding protein D OS=Homo sapiens OX=9606 GN=RRAGD PE=1 SV=1,1,1,0.511,0.883,3.062,0.168,-0.97,-0.18,1.61,-2.57,5.26E-01,8.09E-01,3.29E-01,1.16E-01,9.76E+04,1.67E+05,8.62E+04,5.12E+05,4,3,2,1,5.54E+05,1.25E+05,,2.13E+04,7.63E+04,,1.67E+05,3.68E+05,,1.34E+05,,,6.81E+04,1.09E+05,,,,5.12E+05,,,2.20E+03,4.74E+02,,2.13E+04,3.94E+03,,2.97E+03,3.39E+03,,1.42E+03,,,5.53E+02,1.47E+04,,,,3.63E+03,,,0.015,FALSE,2.111,3,1,400,45.6,4.92,1,stress response;other biological processes,other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf04670,58528,A8K184; hsa:58528; Q7L8F9; Q9NPG0; Q9NQL2,ENSG00000025039,Amino acids regulate mTORC1; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK,Target of rapamycin signaling; 2q37 copy number variation syndrome,9,0,125.5,56.78,32.82,,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,111.72,99.58,37.23,35.37,2.11,other molecular function,0,
Master Protein,High,P52209,PGD,"6-phosphogluconate dehydrogenase, decarboxylating OS=Homo sapiens OX=9606 GN=PGD PE=1 SV=3",7,17,0.51,0.976,0.768,0.399,-0.97,-0.03,-0.38,-1.33,5.66E-01,6.68E-01,6.65E-01,5.40E-01,4.77E+05,1.11E+06,2.92E+05,1.71E+06,3,1,5,2,,4.77E+05,,3.71E+05,1.52E+06,,,,,1.11E+06,2.92E+05,2.08E+05,2.32E+05,1.01E+06,5.70E+05,,1.85E+06,,1.59E+06,,,1.81E+03,,3.71E+05,7.84E+04,,,,,1.19E+04,1.75E+03,9.28E+03,1.88E+03,1.37E+05,1.42E+04,,5.19E+05,,3.71E+04,,0,FALSE,31.903,20,7,483,53.1,7.23,7,other metabolic processes,cytosol,"Pf00393, Pf03446",5226,A8K2Y9; B4DQJ8; hsa:5226; P52209; Q9BWD8,ENSG00000142657,NFE2L2 regulates pentose phosphate pathway genes; Pentose phosphate pathway,Pentose phosphate metabolism; Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling; Metabolic reprogramming in colon cancer,7,0,80.43,,73.37,10.78,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,High,High,Peak Found,1,,FALSE,170.42,142.82,0,83.83,60.09,other molecular function,0,
Master Protein,High,A0A8I5KZ38,MYH10,Myosin heavy chain 10 OS=Homo sapiens OX=9606 GN=MYH10 PE=1 SV=1,49,310,0.509,0.433,0.873,0.277,-0.97,-1.21,-0.2,-1.85,3.87E-01,4.90E-01,7.61E-01,2.88E-01,1.66E+07,2.71E+07,3.20E+06,2.90E+07,5,5,5,5,1.66E+07,5.55E+07,7.80E+06,6.35E+06,3.30E+07,3.88E+07,1.13E+07,2.71E+07,2.08E+07,3.06E+07,2.99E+06,2.69E+06,1.25E+07,3.20E+06,1.23E+07,1.35E+07,3.70E+07,2.00E+07,2.90E+07,3.63E+07,6.60E+04,2.11E+05,7.63E+04,6.35E+06,1.70E+06,1.38E+05,2.01E+05,2.50E+05,5.85E+05,3.25E+05,1.79E+04,1.20E+05,1.01E+05,4.31E+05,3.04E+05,2.64E+04,1.04E+07,1.42E+05,6.79E+05,3.86E+05,0,FALSE,259.503,31,38,1986,230,5.57,49,,cytoskeleton,"Pf00063, Pf00612, Pf01576, Pf02736",,A0A8I5KZ38,ENSG00000133026,,,0,0,86.48,40.29,76.75,37.7,Peak Found,High,High,High,High,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,120.06,117.93,121.06,109.89,810.49,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9NY93,DDX56,Probable ATP-dependent RNA helicase DDX56 OS=Homo sapiens OX=9606 GN=DDX56 PE=1 SV=1,1,1,0.509,0.899,0.01,100,-0.98,-0.15,-6.64,6.64,5.23E-01,8.10E-01,1.00E-17,1.00E-17,7.50E+04,1.47E+05,6.74E+04,,1,2,1,,,,,7.50E+04,,,1.11E+05,1.96E+05,,,,6.74E+04,,,,,,,,,,,,7.50E+04,,,1.97E+03,1.81E+03,,,,3.01E+03,,,,,,,,,0.004,FALSE,2.617,3,1,547,61.6,9.26,1,RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;nucleus,"Pf00270, Pf00271",54606,A4D2K9; C9JV95; hsa:54606; Q6IAE2; Q9H9I8; Q9NY93,ENSG00000136271,,,0,0,,39.22,,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,42.79,0,,,2.72,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9HAV7,GRPEL1,"GrpE protein homolog 1, mitochondrial OS=Homo sapiens OX=9606 GN=GRPEL1 PE=1 SV=2",4,6,0.509,1.433,0.124,2.997,-0.98,0.52,-3.02,1.58,4.84E-01,2.27E-01,1.49E-02,2.60E-01,1.37E+06,7.22E+05,1.44E+06,4.18E+05,3,2,5,3,,7.89E+04,,1.37E+06,1.71E+06,,,7.02E+04,,7.41E+06,3.76E+04,7.52E+05,4.16E+06,2.18E+06,1.44E+06,,9.76E+05,1.02E+05,4.18E+05,,,3.00E+02,,1.37E+06,8.80E+04,,,6.48E+02,,7.88E+04,2.25E+02,3.36E+04,3.38E+04,2.93E+05,3.58E+04,,2.74E+05,7.21E+02,9.77E+03,,0,FALSE,14.41,18,4,217,24.3,8.12,4,protein metabolism;other metabolic processes;transport,other membranes;mitochondrion;nucleus,Pf01025,80273,B2R783; hsa:80273; Q549M6; Q9HAV7,ENSG00000109519,Mitochondrial protein import,,1,0,81.71,138.77,92.25,88.82,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,149.09,106.13,135.61,79.76,17.51,other molecular function,0,
Master Protein,High,P26038,MSN,Moesin OS=Homo sapiens OX=9606 GN=MSN PE=1 SV=3,22,146,0.509,0.648,1.037,0.331,-0.98,-0.63,0.05,-1.6,3.86E-01,9.23E-01,9.32E-01,3.65E-01,1.31E+07,2.88E+07,9.23E+06,5.99E+07,5,5,5,5,9.71E+06,3.08E+07,1.26E+06,1.31E+07,5.29E+07,2.88E+07,2.51E+07,5.47E+07,1.59E+07,5.31E+07,6.78E+06,7.21E+06,9.23E+06,4.92E+07,2.05E+07,5.99E+07,4.89E+06,1.20E+08,1.37E+07,1.15E+08,3.86E+04,1.17E+05,1.23E+04,1.31E+07,2.73E+06,1.02E+05,4.47E+05,5.05E+05,4.48E+05,5.65E+05,4.06E+04,3.22E+05,7.50E+04,6.63E+06,5.09E+05,1.17E+05,1.37E+06,8.48E+05,3.21E+05,1.23E+06,0,FALSE,104.27,37,16,577,67.8,6.4,22,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00373, Pf00769, Pf09379, Pf09380, Pf20492",4478,hsa:4478; P26038,ENSG00000147065,Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Signaling by ALK fusions and activated point mutants,Glial cell differentiation; AGE/RAGE pathway; Measles virus infection; 16p11.2 proximal deletion syndrome; Regulation of actin cytoskeleton,10,6,95.36,49.07,96.92,86.45,High,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,133.83,122.76,134.82,138.97,368.89,signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A7I2V3S3,EIF3E,Eukaryotic translation initiation factor 3 subunit E OS=Homo sapiens OX=9606 GN=EIF3E PE=1 SV=1,8,11,0.508,0.447,0.995,0.29,-0.98,-1.16,-0.01,-1.79,4.60E-01,6.13E-01,9.99E-01,3.46E-01,1.09E+06,1.57E+06,3.12E+05,7.03E+05,5,2,5,5,1.32E+06,1.09E+06,4.89E+05,3.67E+05,1.45E+06,,,,8.25E+05,3.00E+06,5.00E+05,3.12E+05,5.45E+05,2.02E+05,1.76E+05,2.41E+06,5.19E+06,7.03E+05,7.01E+05,1.06E+05,5.25E+03,4.13E+03,4.78E+03,3.67E+05,7.46E+04,,,,2.32E+04,3.19E+04,2.99E+03,1.39E+04,4.43E+03,2.72E+04,4.38E+03,4.69E+03,1.46E+06,4.98E+03,1.64E+04,1.13E+03,0,FALSE,22.836,18,8,507,59.3,5.88,8,cell organization and biogenesis;protein metabolism;other metabolic processes,cytosol;translational apparatus;nucleus;other cell component,"Pf01399, Pf09440, Pf21357",,A0A7I2V3S3,ENSG00000104408,,,0,0,51.88,80.48,48.71,113.64,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,76.01,93.76,62.37,119.37,33.4,nucleic acid binding activity,0,
Master Protein,High,B4DUT8,CNN2,Calponin OS=Homo sapiens OX=9606 GN=CNN2 PE=1 SV=1,1,4,0.507,0.208,0.785,0.263,-0.98,-2.26,-0.35,-1.93,5.02E-01,2.30E-01,7.58E-01,3.69E-01,5.55E+04,1.09E+05,2.25E+04,8.58E+04,5,1,4,2,2.34E+05,3.39E+05,5.12E+04,5.55E+04,3.35E+04,1.09E+05,,,,,4.79E+04,7.01E+03,,2.49E+05,1.06E+04,,1.53E+05,,4.80E+04,,9.31E+02,1.29E+03,5.00E+02,5.55E+04,1.73E+03,3.89E+02,,,,,2.86E+02,3.13E+02,,3.36E+04,2.63E+02,,4.31E+04,,1.12E+03,,0,FALSE,6.156,5,1,330,35.9,7.3,1,cell organization and biogenesis,,"Pf00307, Pf00402",1265,B4DUT8,ENSG00000064666,,Myometrial relaxation and contraction pathways; Burn wound healing,2,0,95.83,,146.4,74.01,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,97.65,113.86,91.06,121.27,12.63,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A2R8YEL0,AGPS,Alkylglycerone-phosphate synthase OS=Homo sapiens OX=9606 GN=AGPS PE=1 SV=2,4,11,0.507,1.382,0.997,1.224,-0.98,0.47,0,0.29,4.41E-01,2.41E-01,9.06E-01,7.35E-01,1.41E+06,2.16E+06,1.62E+06,1.83E+06,3,2,3,2,,3.22E+06,,1.41E+06,8.28E+05,4.42E+06,,1.06E+06,,,,,2.93E+06,1.62E+06,5.99E+05,,,,1.56E+06,2.15E+06,,1.22E+04,,1.41E+06,4.27E+04,1.57E+04,,9.76E+03,,,,,2.38E+04,2.18E+05,1.49E+04,,,,3.65E+04,2.29E+04,0,FALSE,17.751,9,4,676,75.1,6.95,4,other metabolic processes,other cytoplasmic organelle,"Pf01565, Pf02913",,A0A2R8YEL0,ENSG00000018510,,,0,0,68.56,86.78,68.17,22.69,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,High,High,Peak Found,n/a,High,n/a,High,Peak Found,1,,FALSE,94.43,108.48,115.22,33.88,35.4,other molecular function,0,
Master Protein,High,A0A087WVM2,CD177,CD177 molecule OS=Homo sapiens OX=9606 GN=CD177 PE=1 SV=1,3,8,0.506,0.635,1.694,1.801,-0.98,-0.65,0.76,0.85,5.56E-01,9.85E-01,7.00E-01,4.68E-01,1.21E+06,3.96E+05,9.25E+05,7.34E+05,3,4,4,5,,,4.92E+04,1.04E+07,1.21E+06,2.16E+05,,1.03E+07,7.86E+04,7.26E+05,5.09E+05,1.16E+06,7.38E+05,2.33E+06,,5.17E+05,4.66E+05,7.34E+05,1.92E+07,1.02E+06,,,4.81E+02,1.04E+07,6.24E+04,7.68E+02,,9.50E+04,2.22E+03,7.72E+03,3.04E+03,5.18E+04,5.99E+03,3.13E+05,,1.01E+03,1.31E+05,5.20E+03,4.48E+05,1.09E+04,0,FALSE,9.982,8,3,437,46.4,6.01,3,,,Pf00021,57126,A0A087WVM2; hsa:57126,ENSG00000204936,,,0,0,145.98,176.23,68.32,188.72,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,163.94,141.7,143.29,124.19,13.55,,0,
Master Protein,High,Q9Y4B4,RAD54L2,Helicase ARIP4 OS=Homo sapiens OX=9606 GN=RAD54L2 PE=1 SV=4,2,2,0.504,0.518,0.01,100,-0.99,-0.95,-6.64,6.64,4.61E-01,8.18E-01,1.00E-17,1.00E-17,2.50E+04,4.95E+04,1.29E+04,,2,2,2,,,,,5.13E+04,1.22E+04,9.93E+04,2.47E+04,,,,,3.41E+03,,,4.91E+04,,,,,,,,,5.13E+04,6.28E+02,3.53E+02,4.39E+02,,,,,1.53E+02,,,1.22E+03,,,,,,0,FALSE,5.547,2,2,1467,162.7,6.09,2,cell organization and biogenesis,nucleus,"Pf00176, Pf00271",23132,hsa:23132; Q8TB57; Q9BV54; Q9Y4B4,ENSG00000164080,,DYRK1A involvement regarding cell proliferation in brain development,1,0,87.23,85.08,123.03,,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,57.95,127.33,,,7.33,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A1W2PR68,ME2,Malic enzyme OS=Homo sapiens OX=9606 GN=ME2 PE=1 SV=1,8,36,0.504,1.415,0.92,1.047,-0.99,0.5,-0.12,0.07,3.90E-01,2.90E-01,8.13E-01,9.07E-01,2.35E+06,1.60E+06,3.59E+06,3.22E+06,5,5,5,5,7.65E+05,2.35E+06,1.47E+05,4.73E+06,2.41E+06,3.35E+06,1.22E+06,1.35E+06,1.60E+06,1.65E+06,1.05E+06,3.03E+06,5.72E+06,6.97E+06,3.59E+06,5.63E+06,9.00E+05,5.45E+06,6.52E+05,3.22E+06,3.04E+03,8.94E+03,1.44E+03,4.73E+06,1.24E+05,1.19E+04,2.17E+04,1.24E+04,4.51E+04,1.76E+04,6.28E+03,1.35E+05,4.64E+04,9.39E+05,8.92E+04,1.10E+04,2.53E+05,3.86E+04,1.52E+04,3.43E+04,0,FALSE,30.464,24,8,530,59.9,8.1,8,,mitochondrion;other cell component,"Pf00390, Pf03949",,A0A1W2PR68,ENSG00000082212,,TCA cycle in senescence,1,0,85.55,47.13,57.01,75.2,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,1,,FALSE,111.33,102.86,120.95,139.7,108.63,other molecular function,0,
Master Protein,High,B3KY94,CDIPT,CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Homo sapiens OX=9606 GN=CDIPT PE=1 SV=1,3,4,0.5,0.902,0.535,0.149,-1,-0.15,-0.9,-2.74,5.66E-01,7.69E-01,4.36E-01,1.15E-01,5.66E+05,4.41E+05,2.93E+05,4.10E+05,5,4,4,2,5.71E+05,5.66E+05,6.99E+04,1.00E+06,2.49E+05,,2.60E+05,7.48E+05,1.48E+05,1.54E+06,1.30E+06,1.10E+05,,7.78E+05,3.66E+04,6.53E+05,,2.58E+05,,,2.27E+03,2.15E+03,6.83E+02,1.00E+06,1.28E+04,,4.63E+03,6.90E+03,4.18E+03,1.63E+04,7.76E+03,4.93E+03,,1.05E+05,9.10E+02,1.27E+03,,1.83E+03,,,0,FALSE,11.875,14,3,237,25.9,8.22,3,,other membranes,,,B3KY94,ENSG00000103502,,Glycerolipids and glycerophospholipids; 16p11.2 proximal deletion syndrome,2,0,72.56,93.76,107.36,61.28,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,93.23,78.46,100.75,89.97,9.23,other molecular function,0,
Master Protein,High,Q9BVI0,PHF20,PHD finger protein 20 OS=Homo sapiens OX=9606 GN=PHF20 PE=1 SV=2,3,3,0.5,0.159,1.46,0.087,-1,-2.65,0.55,-3.52,4.86E-01,1.34E-01,8.02E-01,6.77E-02,6.67E+04,8.39E+04,1.84E+04,6.52E+04,3,1,2,3,,,4.20E+04,6.67E+04,7.92E+04,,,,,8.39E+04,,1.27E+04,,2.67E+04,,2.30E+05,6.39E+04,,,6.52E+04,,,4.10E+02,6.67E+04,4.09E+03,,,,,8.92E+02,,5.67E+02,,3.59E+03,,4.49E+02,1.80E+04,,,6.94E+02,0,FALSE,9.204,4,3,1012,115.3,6.99,3,cell organization and biogenesis;other biological processes,other membranes;cytosol;nucleus;other cell component,"Pf12618, Pf18115, Pf20826",51230,A7E235; B2RB56; E1P5S3; hsa:51230; Q566Q2; Q5JWY9; Q66K49; Q9BVI0; Q9BWV4; Q9BXA3; Q9BZW3; Q9H421; Q9H4J6; Q9NZ22,ENSG00000025293,Formation of WDR5-containing histone-modifying complexes; HATs acetylate histones; Regulation of TP53 Degradation; Stabilization of p53; Regulation of TP53 Activity through Association with Co-factors,IL-18 signaling pathway,6,0,30.22,,50.16,79.94,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,69.29,29.51,100.02,70.08,7.86,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q5HYK3,COQ5,"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial OS=Homo sapiens OX=9606 GN=COQ5 PE=1 SV=2",2,7,0.5,1.043,1.208,0.719,-1,0.06,0.27,-0.48,5.61E-01,5.93E-01,9.98E-01,9.41E-01,1.22E+05,3.32E+05,3.36E+05,2.72E+05,4,4,4,5,,6.65E+05,7.46E+04,4.15E+04,2.00E+05,,1.24E+06,8.94E+04,2.24E+07,4.75E+04,,2.10E+05,2.52E+05,6.83E+05,4.48E+05,3.03E+06,7.87E+04,2.72E+05,2.16E+05,3.10E+05,,2.53E+03,7.29E+02,4.15E+04,1.03E+04,,2.20E+04,8.24E+02,6.30E+05,5.05E+02,,9.36E+03,2.05E+03,9.21E+04,1.11E+04,5.91E+03,2.21E+04,1.93E+03,5.06E+03,3.30E+03,0,FALSE,7.796,8,2,327,37.1,6.95,2,other metabolic processes,other membranes;mitochondrion;other cell component,Pf01209,84274,B2RDU9; B3GK62; B4DEJ4; hsa:84274; Q32Q28; Q53HH0; Q5HYK3; Q96LV1; Q9BSP8,ENSG00000110871,Ubiquinol biosynthesis,,1,0,117.41,184.81,54.4,161.28,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,140.64,114.4,147.45,89.91,22.55,other molecular function,0,
Master Protein,High,Q12789,GTF3C1,General transcription factor 3C polypeptide 1 OS=Homo sapiens OX=9606 GN=GTF3C1 PE=1 SV=4,3,3,0.5,2.868,0.01,100,-1,1.52,-6.64,6.64,4.66E-01,1.35E-01,1.00E-17,1.00E-17,4.35E+04,8.71E+04,1.25E+05,,2,2,1,,,,3.65E+04,5.18E+04,,,,,3.47E+04,2.18E+05,,,,1.25E+05,,,,,,,,,3.57E+02,5.18E+04,,,,,9.78E+02,2.32E+03,,,,1.68E+04,,,,,,,0,FALSE,12.937,2,3,2109,238.7,7.3,3,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf04182,2975,B2RP21; hsa:2975; Q12789; Q12838; Q6DKN9; Q9Y4W9,ENSG00000077235,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter,,3,0,24.38,102.61,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,131.34,25.95,,,11.03,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UHQ9,CYB5R1,NADH-cytochrome b5 reductase 1 OS=Homo sapiens OX=9606 GN=CYB5R1 PE=1 SV=1,3,4,0.498,1.881,1.341,0.917,-1,0.91,0.42,-0.13,5.44E-01,2.02E-01,9.02E-01,9.17E-01,4.04E+05,1.37E+05,4.66E+05,5.68E+05,3,1,4,3,2.37E+05,,4.04E+05,8.10E+05,,,,,1.37E+05,,,2.34E+05,4.53E+04,1.53E+06,9.29E+05,5.68E+05,,,1.12E+06,1.84E+05,9.40E+02,,3.95E+03,8.10E+05,,,,,3.87E+03,,,1.04E+04,3.68E+02,2.06E+05,2.31E+04,1.11E+03,,,2.63E+04,1.96E+03,0,FALSE,8.048,13,3,305,34.1,9.38,3,other metabolic processes;transport,plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi,"Pf00175, Pf00970",51706,A0PK21; B2R8E0; hsa:51706; O95329; Q53F73; Q8NCL5; Q9UHJ1; Q9UHQ9,ENSG00000159348,Platelet degranulation ; Erythrocytes take up carbon dioxide and release oxygen,Oxidation by cytochrome P450,3,0,60.98,,99.31,75.52,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,0,96.06,0,58.87,9.01,other molecular function,0,
Master Protein,High,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4,10,23,0.498,0.815,1.048,0.274,-1.01,-0.3,0.07,-1.87,4.26E-01,7.29E-01,9.43E-01,2.84E-01,2.45E+06,1.15E+06,1.27E+06,4.16E+06,3,5,5,5,2.45E+06,,,8.23E+05,3.07E+06,1.40E+07,1.15E+06,9.51E+05,1.19E+05,1.47E+06,5.19E+05,2.40E+05,2.03E+06,1.27E+06,1.33E+06,4.16E+06,6.12E+06,3.64E+05,2.04E+06,6.56E+06,9.72E+03,,,8.23E+05,1.59E+05,4.96E+04,2.04E+04,8.77E+03,3.36E+03,1.56E+04,3.10E+03,1.07E+04,1.65E+04,1.71E+05,3.29E+04,8.11E+03,1.72E+06,2.58E+03,4.78E+04,6.99E+04,0,FALSE,31.833,7,8,1599,175.4,5.33,10,protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes,cytosol;translational apparatus;nucleus;other cell component,"Pf02020, Pf02847, Pf02854",1981,D3DNT2; D3DNT4; D3DNT5; E9PFM1; G5E9S1; hsa:1981; O43177; O95066; Q04637; Q5HYG0; Q6ZN21; Q8N102,ENSG00000114867,AUF1 (hnRNP D0) binds and destabilizes mRNA; Regulation of expression of SLITs and ROBOs; ISG15 antiviral mechanism; Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Z-decay: degradation of maternal mRNAs by zygotically expressed factors,Translation factors; VEGFA-VEGFR2 signaling; Acute viral myocarditis; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Pleural mesothelioma,20,1,54.95,165.84,65.96,68.77,Peak Found,n/a,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,1,,FALSE,135.03,90.31,118.6,91.01,52.15,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P26639,TARS1,"Threonine--tRNA ligase 1, cytoplasmic OS=Homo sapiens OX=9606 GN=TARS1 PE=1 SV=3",8,9,0.493,0.084,1.503,0.047,-1.02,-3.57,0.59,-4.4,5.63E-01,2.45E-02,8.12E-01,2.36E-02,1.67E+05,4.34E+05,1.65E+04,2.89E+05,3,2,1,5,,2.28E+05,,8.04E+04,1.67E+05,,,1.01E+06,,1.87E+05,,,,1.65E+04,,2.51E+05,1.40E+06,7.14E+05,4.81E+04,2.89E+05,,8.66E+02,,8.04E+04,8.62E+03,,,9.28E+03,,1.99E+03,,,,2.22E+03,,4.89E+02,3.94E+05,5.06E+03,1.12E+03,3.08E+03,0,FALSE,21.904,16,8,723,83.4,6.67,8,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol,"Pf00587, Pf02824, Pf03129, Pf07973",6897,A8K8I1; B4DEG8; hsa:6897; P26639; Q96FP5; Q9BWA6,ENSG00000113407,Cytosolic tRNA aminoacylation,,1,0,46.79,96.99,,99.72,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,136.36,23.07,111.38,73.76,27.16,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P25788,PSMA3,Proteasome subunit alpha type-3 OS=Homo sapiens OX=9606 GN=PSMA3 PE=1 SV=2,5,18,0.492,0.75,0.683,0.257,-1.02,-0.41,-0.55,-1.96,4.45E-01,8.25E-01,5.37E-01,2.58E-01,1.10E+06,2.16E+06,3.37E+05,6.14E+06,5,4,5,5,1.10E+06,1.12E+06,1.32E+05,5.77E+05,3.87E+07,,1.87E+05,1.06E+06,4.40E+06,6.58E+06,3.01E+06,8.48E+04,3.37E+05,1.25E+06,3.29E+05,6.14E+06,3.58E+06,1.53E+07,2.06E+06,1.28E+07,4.36E+03,4.27E+03,1.29E+03,5.77E+05,2.00E+06,,3.32E+03,9.78E+03,1.24E+05,7.00E+04,1.80E+04,3.79E+03,2.74E+03,1.69E+05,8.18E+03,1.20E+04,1.00E+06,1.08E+05,4.82E+04,1.36E+05,0,FALSE,15.259,20,5,255,28.4,5.33,5,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00227, Pf10584",5684,B2RCK6; hsa:5684; P25788; Q86U83; Q8N1D8; Q9BS70,ENSG00000100567,ER-Phagosome pathway; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,62,0,204,97.13,120.45,72.75,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,132.11,131.84,104.24,99.75,42.9,other molecular function,0,
Master Protein,High,P22894,MMP8,Neutrophil collagenase OS=Homo sapiens OX=9606 GN=MMP8 PE=1 SV=1,2,18,0.491,0.847,1.094,0.183,-1.03,-0.24,0.13,-2.45,3.64E-01,7.40E-01,9.86E-01,1.52E-01,4.54E+05,4.73E+06,7.00E+05,4.61E+06,5,4,4,4,4.54E+05,1.84E+06,7.23E+04,2.91E+04,4.82E+06,3.54E+06,,6.31E+06,5.30E+05,1.46E+07,1.76E+05,,1.58E+06,1.48E+06,3.31E+05,1.44E+07,,4.05E+06,2.49E+06,5.25E+06,1.80E+03,7.00E+03,7.07E+02,2.91E+04,2.49E+05,1.26E+04,,5.82E+04,1.49E+04,1.55E+05,1.05E+03,,1.29E+04,1.99E+05,8.23E+03,2.80E+04,,2.87E+04,5.82E+04,5.59E+04,0,FALSE,11.811,7,2,467,53.4,6.87,2,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,non-structural extracellular;other cell component,"Pf00045, Pf00413, Pf01471",4317,hsa:4317; P22894; Q45F99,ENSG00000118113,Neutrophil degranulation; Collagen degradation; Activation of Matrix Metalloproteinases,Matrix metalloproteinases; Cell migration and invasion through p75NTR; Neural crest cell migration during development; Neural crest cell migration in cancer; IL-18 signaling pathway; Chronic hyperglycemia impairment of neuron function,10,0,140.36,96.76,83.11,81.74,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,Peak Found,High,Peak Found,High,n/a,High,High,High,1,,FALSE,137.98,139.42,122.28,130.98,40.96,other molecular function,0,
Master Protein,High,P51610,HCFC1,Host cell factor 1 OS=Homo sapiens OX=9606 GN=HCFC1 PE=1 SV=2,16,32,0.49,0.316,1.374,1.905,-1.03,-1.66,0.46,0.93,4.83E-01,2.51E-01,8.43E-01,4.50E-01,9.75E+05,8.76E+05,1.16E+06,3.61E+05,3,1,5,5,,,6.63E+04,7.47E+06,9.75E+05,,,,,8.76E+05,2.46E+05,1.62E+06,1.16E+06,4.33E+06,6.28E+05,1.65E+05,9.20E+04,1.21E+06,3.61E+05,1.39E+06,,,6.48E+02,7.47E+06,5.03E+04,,,,,9.31E+03,1.47E+03,7.26E+04,9.39E+03,5.83E+05,1.56E+04,3.21E+02,2.59E+04,8.61E+03,8.45E+03,1.48E+04,0,FALSE,75.382,14,16,2035,208.6,7.46,16,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf01344, Pf13415, Pf13854",3054,hsa:3054; P51610; Q6P4G5,ENSG00000172534,UCH proteinases; Formation of WDR5-containing histone-modifying complexes; Transcriptional activation of mitochondrial biogenesis; HATs acetylate histones,Mitochondrial gene expression; Pleural mesothelioma,6,0,142.31,,101.08,94.84,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,0,94.42,1.38,66.13,103.57,other molecular function,0,
Master Protein,Medium,Q10589,BST2,Bone marrow stromal antigen 2 OS=Homo sapiens OX=9606 GN=BST2 PE=1 SV=1,1,1,0.489,0.086,0.199,0.44,-1.03,-3.54,-2.33,-1.18,5.52E-01,8.10E-03,6.87E-02,6.20E-01,5.46E+05,4.41E+05,3.30E+04,1.19E+05,3,3,3,2,,5.79E+05,,1.21E+05,5.46E+05,,,4.41E+05,3.01E+05,1.18E+06,2.64E+05,1.03E+04,,,3.30E+04,,,,3.05E+04,4.63E+05,,2.20E+03,,1.21E+05,2.82E+04,,,4.07E+03,8.49E+03,1.26E+04,1.58E+03,4.62E+02,,,8.20E+02,,,,7.14E+02,4.93E+03,0.015,FALSE,2.101,6,1,180,19.8,5.6,1,stress response;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf16716,684,A8K4Y4; hsa:684; Q10589; Q53G07,ENSG00000130303,Neutrophil degranulation; Interferon alpha/beta signaling; SARS-CoV-1 activates/modulates innate immune responses,Ebola virus infection in host; Host-pathogen interaction of human coronaviruses - MAPK signaling,5,0,61.57,73.91,137.06,123.92,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,93.04,120.41,135.98,114.31,2.4,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q86V48,LUZP1,Leucine zipper protein 1 OS=Homo sapiens OX=9606 GN=LUZP1 PE=1 SV=2,1,2,0.488,0.572,0.01,100,-1.03,-0.81,-6.64,6.64,4.72E-01,8.76E-01,1.00E-17,1.00E-17,4.93E+04,1.01E+05,2.82E+04,,2,1,1,,4.76E+04,,,5.10E+04,,,,,,1.01E+05,,,2.82E+04,,,,,,,,1.89E+02,,,5.10E+04,,,,,,1.07E+03,,,2.29E+02,,,,,,,,0.001,FALSE,3.662,1,1,1076,120.2,8.5,1,developmental processes,cytoskeleton;nucleus;other cell component,,7798,hsa:7798; Q5TH93; Q86V48; Q8N4X3; Q8TEH1,ENSG00000169641,,Orexin receptor pathway,1,0,4.95,,,,Peak Found,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,5.2,5.2,,,5.32,,0,
Master Protein,High,Q5JRX3,PITRM1,"Presequence protease, mitochondrial OS=Homo sapiens OX=9606 GN=PITRM1 PE=1 SV=3",10,21,0.488,0.848,0.623,1.282,-1.03,-0.24,-0.68,0.36,4.97E-01,7.62E-01,6.10E-01,6.77E-01,7.68E+04,1.26E+05,9.41E+05,1.47E+05,4,4,4,4,9.88E+04,,5.96E+04,8.33E+05,4.47E+04,9.41E+04,1.30E+05,1.49E+06,1.22E+05,,,1.54E+06,3.34E+05,2.07E+06,5.77E+05,9.05E+04,1.75E+05,,2.35E+05,1.24E+05,3.93E+02,,5.83E+02,8.33E+05,2.30E+03,3.35E+02,2.32E+03,1.37E+04,3.44E+03,,,6.86E+04,2.72E+03,2.79E+05,1.43E+04,1.77E+02,4.92E+04,,5.51E+03,1.32E+03,0,FALSE,42.362,16,10,1037,117.3,6.92,10,protein metabolism;other metabolic processes;other biological processes,mitochondrion,"Pf00675, Pf05193, Pf08367",10531,B3KMJ6; B4E0J8; C9JSL2; E7ES23; hsa:10531; O95204; Q2M2G6; Q4VBR1; Q5JRW7; Q5JRX3; Q7L5Z7; Q9BSI6; Q9BVJ5; Q9UPP8,ENSG00000107959,Mitochondrial protein import,,1,0,147.99,149.73,72.08,40.43,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,119.96,69.74,96.09,117.15,56.78,enzyme regulator activity;other molecular function,0,
Master Protein,High,H0YBA1,PCM1,Pericentriolar material 1 OS=Homo sapiens OX=9606 GN=PCM1 PE=1 SV=2,2,2,0.486,0.508,0.01,100,-1.04,-0.98,-6.64,6.64,5.57E-01,7.22E-01,1.00E-17,1.00E-17,2.42E+05,4.97E+05,1.23E+05,,2,1,2,,,,3.33E+05,1.76E+05,,,,,,4.97E+05,,,,1.30E+05,1.16E+05,,,,,,,,3.25E+03,1.76E+05,,,,,,5.29E+03,,,,1.75E+04,2.87E+03,,,,,,0,FALSE,8.283,2,2,2043,230.5,5.05,2,cell organization and biogenesis;other biological processes,other membranes;cytosol;cytoskeleton;nucleus,Pf15717,,H0YBA1,ENSG00000078674,,Prader-Willi and Angelman syndrome; Joubert syndrome,2,0,43.74,,8.37,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,48.22,45.44,,,5.46,,0,
Master Protein,High,Q8WWP7,GIMAP1,GTPase IMAP family member 1 OS=Homo sapiens OX=9606 GN=GIMAP1 PE=1 SV=1,10,27,0.485,0.257,0.428,0.328,-1.04,-1.96,-1.22,-1.61,3.58E-01,1.44E-01,2.25E-01,3.62E-01,5.93E+06,7.76E+06,1.49E+06,1.76E+07,5,5,5,5,7.88E+05,1.07E+07,1.06E+06,5.93E+06,6.53E+06,7.76E+06,7.20E+07,6.10E+07,4.83E+06,6.99E+06,8.55E+05,2.05E+06,6.58E+05,1.81E+06,1.49E+06,2.29E+07,2.92E+05,4.38E+07,1.17E+06,1.76E+07,3.13E+03,4.07E+04,1.04E+04,5.93E+06,3.37E+05,2.76E+04,1.28E+06,5.63E+05,1.36E+05,7.44E+04,5.11E+03,9.16E+04,5.35E+03,2.44E+05,3.69E+04,4.47E+04,8.20E+04,3.10E+05,2.74E+04,1.88E+05,0,FALSE,48.644,45,5,306,34.3,8.87,10,,other membranes;ER/Golgi,Pf04548,170575,B2RCI3; hsa:170575; Q8NAZ0; Q8WWP7,ENSG00000213203,,,0,5,83.03,108.45,43.8,104.33,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,128.31,105.32,133.9,138,81.42,other molecular function,0,
Master Protein,High,P46977,STT3A,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A OS=Homo sapiens OX=9606 GN=STT3A PE=1 SV=2,5,12,0.485,0.286,0.431,0.594,-1.05,-1.8,-1.21,-0.75,5.02E-01,1.91E-01,3.21E-01,7.64E-01,1.42E+06,3.86E+05,1.13E+06,1.20E+06,4,4,5,4,,3.15E+06,1.58E+05,6.41E+05,1.67E+07,2.68E+05,2.08E+05,,5.56E+05,4.15E+06,3.05E+05,2.72E+04,1.64E+06,1.13E+06,1.63E+06,,6.84E+05,3.61E+05,2.11E+06,1.35E+07,,1.20E+04,1.54E+03,6.41E+05,8.64E+05,9.53E+02,3.69E+03,,1.57E+04,4.42E+04,1.82E+03,1.21E+03,1.34E+04,1.52E+05,4.06E+04,,1.92E+05,2.56E+03,4.93E+04,1.44E+05,0,FALSE,18.767,7,5,705,80.5,8.07,5,protein metabolism;other metabolic processes,other membranes;ER/Golgi,"Pf02516, Pf21436",3703,B4DJ24; E9PNQ1; hsa:3703; P46977; Q86XU9; Q8TE35; Q8WUB4,ENSG00000134910,Asparagine N-linked glycosylation; Maturation of spike protein,N-glycan biosynthesis,3,0,151.29,147.41,79.09,150.75,n/a,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,111.21,132.73,135.8,107.48,29.53,other molecular function,0,
Master Protein,High,P17568,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 OS=Homo sapiens OX=9606 GN=NDUFB7 PE=1 SV=4,4,7,0.483,0.039,0.059,0.684,-1.05,-4.68,-4.08,-0.55,5.56E-01,4.00E-04,2.17E-03,9.05E-01,2.82E+05,5.73E+05,5.14E+04,7.02E+04,4,4,3,3,,7.85E+05,4.57E+04,1.01E+05,9.01E+05,,3.89E+05,8.46E+05,3.63E+05,9.36E+05,,6.49E+03,5.14E+04,,3.31E+05,,7.56E+03,,7.02E+04,1.71E+06,,2.98E+03,4.47E+02,1.01E+05,4.65E+04,,6.91E+03,7.80E+03,1.02E+04,9.95E+03,,2.90E+02,4.17E+02,,8.23E+03,,2.12E+03,,1.64E+03,1.82E+04,0,FALSE,21.506,46,4,137,16.4,8.92,4,cell organization and biogenesis;other metabolic processes;transport,other membranes;mitochondrion,Pf05676,4713,hsa:4713; P17568; Q6ICN9; Q9UI16,ENSG00000099795,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,5,0,97.64,47.33,135.65,162.01,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,118.38,124.58,145.09,121.7,23.31,transporter activity,0,
Master Protein,High,P55809,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=OXCT1 PE=1 SV=1",7,32,0.483,3.936,1.281,0.782,-1.05,1.98,0.36,-0.36,5.48E-01,1.03E-02,7.68E-01,8.87E-01,6.79E+05,5.53E+05,4.25E+06,1.53E+06,4,4,5,5,4.95E+05,,4.14E+04,1.09E+06,9.32E+05,,1.77E+05,1.73E+06,1.19E+05,1.84E+06,3.25E+04,3.15E+06,5.61E+06,5.13E+06,4.25E+06,4.13E+05,1.19E+06,1.53E+06,2.43E+06,3.10E+06,1.97E+03,,4.04E+02,1.09E+06,4.81E+04,,3.15E+03,1.60E+04,3.34E+03,1.96E+04,1.94E+02,1.41E+05,4.56E+04,6.92E+05,1.06E+05,8.05E+02,3.34E+05,1.09E+04,5.70E+04,3.30E+04,0,FALSE,33.154,20,7,520,56.1,7.46,7,other metabolic processes,mitochondrion,Pf01144,5019,B2R5V2; B7Z528; hsa:5019; P55809,ENSG00000083720,Mitochondrial protein degradation; Utilization of Ketone Bodies,Ketone bodies synthesis and degradation,3,0,73.63,97.97,61.11,60.71,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,134.03,114.53,122.32,93.94,88.39,other molecular function,0,
Master Protein,High,P33992,MCM5,DNA replication licensing factor MCM5 OS=Homo sapiens OX=9606 GN=MCM5 PE=1 SV=5,7,14,0.482,0.47,0.731,0.302,-1.05,-1.09,-0.45,-1.73,3.65E-01,6.00E-01,6.36E-01,3.47E-01,2.89E+06,1.19E+06,8.82E+05,1.55E+06,5,4,5,3,6.94E+06,1.96E+06,2.89E+06,3.31E+06,1.26E+06,1.02E+06,1.01E+06,2.48E+06,1.39E+06,,2.06E+06,6.35E+05,7.58E+05,3.80E+06,8.82E+05,7.06E+05,,,1.55E+06,1.90E+06,2.76E+04,7.45E+03,2.83E+04,3.31E+06,6.50E+04,3.62E+03,1.80E+04,2.29E+04,3.91E+04,,1.23E+04,2.84E+04,6.16E+03,5.12E+05,2.19E+04,1.38E+03,,,3.63E+04,2.03E+04,0,FALSE,20.538,13,7,734,82.2,8.37,7,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00493, Pf14551, Pf17207, Pf17855",4174,hsa:4174; O60785; P33992; Q14578; Q9BTJ4; Q9BWL8,ENSG00000100297,Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA,Cell cycle; Ciliary landscape; G1 to S cell cycle control; DNA replication,10,0,67.19,46.98,82.51,44.36,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,74.4,107.62,62.51,86.97,39.7,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A804HKF9,ERCC4,"ERCC excision repair 4, endonuclease catalytic subunit OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=1",2,2,0.481,1.927,1.684,1.302,-1.06,0.95,0.75,0.38,4.48E-01,2.82E-01,6.91E-01,6.47E-01,7.79E+04,4.02E+04,3.57E+04,6.76E+04,2,1,3,1,,,8.93E+04,6.80E+04,,,,,4.02E+04,,3.96E+05,,3.57E+04,2.57E+04,,,,,6.76E+04,,,,8.72E+02,6.80E+04,,,,,1.13E+03,,2.37E+03,,2.90E+02,3.47E+03,,,,,1.58E+03,,0,FALSE,5.064,4,2,962,109.6,7.05,2,DNA metabolism;other metabolic processes;stress response,nucleus,Pf02732,2072,A0A804HKF9,ENSG00000175595,,"Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",3,0,19.11,,138.33,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,116.86,0,152.48,4.92,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q02447,SP3,Transcription factor Sp3 OS=Homo sapiens OX=9606 GN=SP3 PE=1 SV=3,3,6,0.48,0.171,0.358,0.113,-1.06,-2.54,-1.48,-3.14,5.49E-01,5.94E-02,2.06E-01,7.65E-02,5.47E+05,6.62E+05,3.02E+05,1.44E+05,2,1,3,2,,,,9.72E+05,3.08E+05,,,,,6.62E+05,,1.76E+04,,4.92E+05,3.02E+05,,,,3.77E+04,5.48E+05,,,,9.72E+05,1.59E+04,,,,,7.04E+03,,7.88E+02,,6.63E+04,7.51E+03,,,,8.82E+02,5.84E+03,0,FALSE,15.278,6,3,781,81.9,5.26,3,developmental processes;other biological processes,cytosol;nucleus;other cell component,Pf00096,6670,A0AVL9; B4E2B7; hsa:6670; Q02447; Q69B26; Q69B27; Q8TD56; Q8WWU4; Q9BQR1,ENSG00000172845,SUMOylation of transcription factors,"Selenium metabolism and selenoproteins; MECP2 and associated Rett syndrome; Non-genomic actions of 1,25 dihydroxyvitamin D3; Sudden infant death syndrome (SIDS) susceptibility pathways",5,0,73.36,,88.22,123.23,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,55.57,100.62,263.34,129.4,13.23,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q13330,MTA1,Metastasis-associated protein MTA1 OS=Homo sapiens OX=9606 GN=MTA1 PE=1 SV=2,4,15,0.479,0.585,0.01,100,-1.06,-0.77,-6.64,6.64,4.99E-01,8.49E-01,1.00E-17,1.00E-17,8.79E+05,9.03E+05,2.91E+05,,3,4,4,,1.35E+06,8.79E+05,,3.86E+05,,1.06E+06,7.67E+05,,2.61E+05,1.31E+06,,1.50E+05,1.26E+05,1.58E+06,5.66E+05,,,,,,5.36E+03,3.34E+03,,3.86E+05,,3.78E+03,1.36E+04,,7.36E+03,1.40E+04,,6.68E+03,1.02E+03,2.14E+05,1.41E+04,,,,,,0,FALSE,12.387,7,3,715,80.7,9.26,4,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf00249, Pf00320, Pf01426, Pf01448, Pf17226",9112,A5PLK4; hsa:9112; Q13330; Q86SW2; Q8NFI8; Q96GI8,ENSG00000182979,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; SUMOylation of transcription factors,Effect of progerin on genes involved in progeria; TAR syndrome,8,0,55.22,53.14,112.58,,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,78.39,113.13,,,39.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q02252,ALDH6A1,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial OS=Homo sapiens OX=9606 GN=ALDH6A1 PE=1 SV=2",9,29,0.479,0.632,1.511,0.722,-1.06,-0.66,0.6,-0.47,5.41E-01,9.37E-01,8.13E-01,9.04E-01,3.50E+05,4.72E+05,8.02E+05,2.02E+05,3,2,4,4,2.02E+05,,,4.31E+06,3.50E+05,5.66E+05,,,3.94E+05,,,1.17E+06,5.52E+05,5.07E+06,5.46E+05,4.65E+05,4.16E+06,6.43E+04,8.78E+04,,8.02E+02,,,4.31E+06,1.81E+04,2.01E+03,,,1.11E+04,,,5.20E+04,4.49E+03,6.83E+05,1.36E+04,9.07E+02,1.17E+06,4.56E+02,2.05E+03,,0,FALSE,47.737,18,9,535,57.8,8.5,9,other metabolic processes;other biological processes,mitochondrion;nucleus,Pf00171,4329,B2R609; B4DFS8; hsa:4329; J3KNU8; Q02252; Q9UKM8,ENSG00000119711,Branched-chain amino acid catabolism,,1,0,143.76,25.3,118.74,166.22,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,142.37,101.02,46.85,82.88,81.82,other molecular function,0,
Master Protein,High,Q14966,ZNF638,Zinc finger protein 638 OS=Homo sapiens OX=9606 GN=ZNF638 PE=1 SV=2,7,12,0.479,0.662,0.01,100,-1.06,-0.6,-6.64,6.64,5.43E-01,9.16E-01,1.00E-17,1.00E-17,4.83E+05,8.02E+05,3.13E+05,,2,1,3,,,,,5.07E+05,4.60E+05,,,,,8.02E+05,,3.13E+05,,5.05E+05,1.51E+05,,,,,,,,,5.07E+05,2.37E+04,,,,,8.53E+03,,1.40E+04,,6.80E+04,3.75E+03,,,,,,0,FALSE,27.004,6,7,1978,220.5,6.38,7,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00076, Pf12171",27332,A0A096LPH6; B5MDV1; B7ZLD1; hsa:27332; Q14966; Q53R34; Q5XJ05; Q68DP3; Q6P2H2; Q7Z3T7; Q8NF92; Q8TCA1; Q9H2G1; Q9NP37,ENSG00000075292,Transcriptional regulation of white adipocyte differentiation,,1,0,6.85,,54.94,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,27.17,56.57,,,35.95,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9HD89,RETN,Resistin OS=Homo sapiens OX=9606 GN=RETN PE=1 SV=1,1,3,0.478,2.615,1.267,0.986,-1.07,1.39,0.34,-0.02,4.49E-01,1.56E-01,9.08E-01,8.94E-01,3.51E+04,7.34E+04,9.18E+04,9.30E+04,2,1,2,2,,,,1.50E+04,8.21E+04,7.34E+04,,,,,,,5.41E+04,1.56E+05,,,,7.95E+04,1.09E+05,,,,,1.50E+04,4.24E+03,2.61E+02,,,,,,,4.40E+02,2.10E+04,,,,5.64E+02,2.55E+03,,0.001,FALSE,3.442,17,1,108,11.4,6.86,1,signal transduction;other biological processes,non-structural extracellular;other cytoplasmic organelle;other cell component,Pf06954,56729,D6W649; hsa:56729; Q540D9; Q76B53; Q9HD89,ENSG00000104918,"Neutrophil degranulation; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",Adipogenesis; Resistin as a regulator of inflammation,4,0,97.75,,68.41,22.02,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,141.82,83.65,23.37,70.04,8.37,signal transduction activity or receptor binding,0,
Master Protein,High,Q8WXX5,DNAJC9,DnaJ homolog subfamily C member 9 OS=Homo sapiens OX=9606 GN=DNAJC9 PE=1 SV=1,7,16,0.478,1.459,0.08,4.385,-1.07,0.55,-3.64,2.13,3.60E-01,2.63E-01,3.94E-03,1.37E-01,2.54E+06,1.36E+06,2.09E+06,2.87E+05,3,2,5,4,,2.54E+06,,4.24E+06,1.11E+06,,,1.31E+06,1.41E+06,,1.96E+06,1.86E+06,2.09E+06,8.99E+06,4.52E+06,,1.02E+06,1.09E+05,7.57E+05,1.08E+05,,9.64E+03,,4.24E+06,5.73E+04,,,1.21E+04,3.96E+04,,1.17E+04,8.30E+04,1.70E+04,1.21E+06,1.12E+05,,2.86E+05,7.71E+02,1.77E+04,1.15E+03,0,FALSE,31.031,33,7,260,29.9,5.73,7,cell organization and biogenesis;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf00226,23234,B2RMW6; hsa:23234; Q8WXX5,ENSG00000213551,,,0,0,59.63,4.88,78.85,92.9,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,High,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,111.61,101.22,0,40.31,53.2,other molecular function,0,
Master Protein,High,F1LLU8,HPS4,HPS4 biogenesis of lysosomal organelles complex 3 subunit 2 OS=Homo sapiens OX=9606 GN=HPS4 PE=1 SV=2,2,2,0.477,0.608,0.257,1.126,-1.07,-0.72,-1.96,0.17,4.58E-01,9.36E-01,2.14E-01,7.93E-01,4.68E+04,9.81E+04,2.84E+04,2.53E+04,1,1,1,1,,,,4.68E+04,,9.81E+04,,,,,,,2.84E+04,,,,,,2.53E+04,,,,,4.68E+04,,3.49E+02,,,,,,,2.31E+02,,,,,,5.91E+02,,0,FALSE,6.933,4,2,726,79.1,5.68,2,transport,,"Pf19031, Pf19033",,F1LLU8,ENSG00000100099,,,0,0,,,,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,0,0,0,5.95,,0,
Master Protein,High,Q16644,MAPKAPK3,MAP kinase-activated protein kinase 3 OS=Homo sapiens OX=9606 GN=MAPKAPK3 PE=1 SV=1,1,3,0.477,1.874,1.581,0.565,-1.07,0.91,0.66,-0.82,4.41E-01,8.09E-02,6.26E-01,6.90E-01,6.78E+05,1.42E+06,1.27E+06,2.25E+06,2,2,1,1,,1.21E+06,,,3.81E+05,,1.41E+06,1.43E+06,,,,,1.27E+06,,,2.25E+06,,,,,,4.59E+03,,,1.96E+04,,2.52E+04,1.32E+04,,,,,1.03E+04,,,4.38E+03,,,,,0,FALSE,5.075,8,1,382,43,7.28,1,protein metabolism;other metabolic processes;transport;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf00069,7867,B5BU67; hsa:7867; Q16644,ENSG00000114738,Oxidative Stress Induced Senescence; VEGFA-VEGFR2 Pathway; p38MAPK events; activated TAK1 mediates p38 MAPK activation,Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; Serotonin HTR1 group and FOS pathway,7,0,73.61,0.72,,,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,High,1,Acetyl [N-Term],FALSE,89.91,90.37,0.76,0,9.03,kinase activity;other molecular function,0,
Master Protein,High,G0XQ39,STIM1,STIM1L OS=Homo sapiens OX=9606 GN=STIM1 PE=1 SV=1,7,30,0.477,1.231,1.336,0.522,-1.07,0.3,0.42,-0.94,3.57E-01,3.24E-01,8.12E-01,6.17E-01,1.07E+06,3.20E+06,1.56E+06,3.88E+06,5,5,5,5,5.19E+05,5.76E+06,4.30E+05,1.07E+06,1.27E+06,3.20E+06,8.67E+05,5.02E+06,2.44E+06,3.51E+06,5.22E+05,1.06E+06,1.56E+06,1.84E+06,3.58E+06,2.50E+07,1.30E+06,4.06E+06,2.83E+06,3.88E+06,2.06E+03,2.19E+04,4.20E+03,1.07E+06,6.53E+04,1.14E+04,1.54E+04,4.63E+04,6.87E+04,3.73E+04,3.12E+03,4.73E+04,1.27E+04,2.48E+05,8.90E+04,4.88E+04,3.66E+05,2.88E+04,6.63E+04,4.13E+04,0,FALSE,21.458,9,7,791,88.6,6.64,7,transport;other biological processes,other membranes;ER/Golgi,"Pf07647, Pf16533",6786,G0XQ39,ENSG00000167323,,CAMKK2 pathway; Affected pathways in Duchenne muscular dystrophy,2,0,123.75,50.58,67.68,133.47,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,114.61,99.05,127.26,115.29,52.01,other molecular function,0,
Master Protein,High,Q04917,YWHAH,14-3-3 protein eta OS=Homo sapiens OX=9606 GN=YWHAH PE=1 SV=4,5,39,0.475,1.394,2.724,0.252,-1.07,0.48,1.45,-1.99,4.89E-01,4.60E-01,4.08E-01,2.36E-01,7.80E+04,1.64E+05,1.09E+05,4.47E+05,3,1,3,5,7.80E+04,,,4.11E+04,4.43E+05,,,1.64E+05,,,,,8.40E+04,1.09E+05,2.13E+05,3.00E+05,4.47E+05,4.16E+05,4.64E+05,8.48E+05,3.10E+02,,,4.11E+04,2.28E+04,,,1.51E+03,,,,,6.82E+02,1.46E+04,5.30E+03,5.85E+02,1.26E+05,2.95E+03,1.09E+04,9.02E+03,0,FALSE,16.759,22,2,246,28.2,4.84,5,other metabolic processes;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,Pf00244,7533,hsa:7533; Q04917,ENSG00000128245,Translocation of SLC2A4 (GLUT4) to the plasma membrane; TP53 Regulates Metabolic Genes; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Activation of BAD and translocation to mitochondria,Cell cycle; Myometrial relaxation and contraction pathways; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,11,0,118.54,,50.71,41.87,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,122.15,122.15,10.2,50.14,66.89,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,B0QY89,EIF3L,Eukaryotic translation initiation factor 3 subunit L OS=Homo sapiens OX=9606 GN=EIF3L PE=1 SV=1,6,11,0.475,2.04,0.861,0.29,-1.07,1.03,-0.22,-1.78,5.31E-01,5.95E-02,7.66E-01,3.08E-01,8.25E+05,5.57E+05,1.11E+06,2.80E+06,5,5,4,5,8.25E+05,3.22E+06,1.13E+05,2.74E+05,1.30E+06,6.52E+06,3.75E+05,3.24E+05,5.57E+05,3.01E+06,,2.97E+06,1.42E+06,2.13E+05,8.76E+05,8.69E+07,2.80E+06,5.34E+06,8.05E+05,1.04E+06,3.28E+03,1.22E+04,1.10E+03,2.74E+05,6.70E+04,2.32E+04,6.67E+03,2.99E+03,1.57E+04,3.20E+04,,1.33E+05,1.15E+04,2.86E+04,2.18E+04,1.69E+05,7.87E+05,3.78E+04,1.88E+04,1.10E+04,0,FALSE,24.096,11,6,607,70.9,6.65,6,cell organization and biogenesis;protein metabolism;other metabolic processes,translational apparatus;other cell component,Pf10255,,B0QY89; E9PB84,ENSG00000100129,,,0,0,109.12,124.51,85.94,195.03,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,124.1,139.45,144.27,121.42,33.91,nucleic acid binding activity,0,
Master Protein,High,P61088,UBE2N,Ubiquitin-conjugating enzyme E2 N OS=Homo sapiens OX=9606 GN=UBE2N PE=1 SV=1,2,11,0.475,0.302,3.281,1.297,-1.07,-1.73,1.71,0.38,3.95E-01,2.28E-01,2.75E-01,6.66E-01,3.17E+06,4.15E+05,7.59E+05,4.32E+05,3,2,4,5,4.17E+06,,3.17E+06,7.38E+05,,6.20E+05,,,,2.77E+05,1.21E+06,2.49E+05,,9.51E+05,6.05E+05,7.36E+05,3.81E+05,2.51E+06,1.43E+05,4.32E+05,1.66E+04,,3.10E+04,7.38E+05,,2.21E+03,,,,2.95E+03,7.21E+03,1.11E+04,,1.28E+05,1.50E+04,1.44E+03,1.07E+05,1.78E+04,3.35E+03,4.60E+03,0,FALSE,10.313,20,2,152,17.1,6.57,2,protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf00179,7334,hsa:7334; P61088; Q16781; Q53Y81,ENSG00000177889,"FCERI mediated NF-kB activation; Downstream TCR signaling; E3 ubiquitin ligases ubiquitinate target proteins; Antigen processing: Ubiquitination & Proteasome degradation; CLEC7A (Dectin-1) signaling; Aggrephagy; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; IKK complex recruitment mediated by RIP1; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; TAK1-dependent IKK and NF-kappa-B activation  ; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; activated TAK1 mediates p38 MAPK activation; Nonhomologous End-Joining (NHEJ); Formation of Incision Complex in GG-NER; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling",IL-1 signaling pathway; Interleukin-1 induced activation of NF-kB; MYD88 distinct input-output pathway; Prader-Willi and Angelman syndrome; 3q29 copy number variation syndrome,28,0,65.56,54.07,55.32,113.93,High,n/a,High,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,52.54,66.38,64.73,140.64,37.49,enzyme regulator activity;other molecular function,0,
Master Protein,High,P22314,UBA1,Ubiquitin-like modifier-activating enzyme 1 OS=Homo sapiens OX=9606 GN=UBA1 PE=1 SV=3,9,20,0.473,1.025,,12.018,-1.08,0.04,,3.59,5.14E-01,6.09E-01,,1.23E-02,1.19E+05,3.07E+05,4.84E+05,1.90E+04,5,2,5,1,4.52E+04,4.32E+04,1.19E+05,2.03E+06,1.19E+05,5.19E+05,,,1.81E+05,,4.84E+05,5.70E+05,8.91E+04,2.58E+06,4.20E+05,,1.90E+04,,,,1.80E+02,1.64E+02,1.16E+03,2.03E+06,6.12E+03,1.85E+03,,,5.10E+03,,2.89E+03,2.55E+04,7.23E+02,3.48E+05,1.04E+04,,5.35E+03,,,,0,FALSE,39.476,13,9,1058,117.8,5.76,9,protein metabolism;other metabolic processes;stress response,cytosol;mitochondrion;nucleus;other cell component,"Pf00899, Pf09358, Pf10585, Pf16190, Pf16191",7317,hsa:7317; P22314; Q5JRR8; Q96E13,ENSG00000130985,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,Proteasome degradation; Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway,5,0,185.15,68.33,120.3,,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,78.12,87.58,,32.36,65.96,other molecular function,0,
Master Protein,High,Q96DI7,SNRNP40,U5 small nuclear ribonucleoprotein 40 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP40 PE=1 SV=1,3,3,0.473,0.439,0.501,0.274,-1.08,-1.19,-1,-1.87,5.41E-01,5.75E-01,4.61E-01,3.84E-01,4.13E+05,3.19E+05,8.44E+04,6.76E+04,2,2,4,5,,3.52E+05,,4.84E+05,,,1.11E+05,,,9.17E+05,2.00E+05,,1.55E+05,3.50E+04,4.60E+04,7.32E+05,1.97E+05,6.76E+04,4.33E+04,5.66E+04,,1.34E+03,,4.84E+05,,,1.97E+03,,,9.75E+03,1.20E+03,,1.26E+03,4.71E+03,1.14E+03,1.43E+03,5.53E+04,4.79E+02,1.01E+03,6.03E+02,0,FALSE,8.805,15,3,357,39.3,8.1,3,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf00400,9410,B4DQJ1; hsa:9410; O75938; O95320; Q96DI7,ENSG00000060688,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing,3,0,22.38,110.88,74.64,133.71,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,102.03,117.62,121.7,117.57,8.1,,0,
Master Protein,High,P07384,CAPN1,Calpain-1 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN1 PE=1 SV=1,7,26,0.472,0.522,2.411,0.312,-1.08,-0.94,1.27,-1.68,4.12E-01,7.37E-01,3.06E-01,3.52E-01,1.95E+06,9.50E+05,1.24E+06,1.50E+06,4,2,5,5,4.64E+06,,2.83E+06,9.07E+05,1.34E+06,,2.23E+06,,4.05E+05,,5.13E+04,1.24E+06,2.14E+05,1.34E+06,1.28E+06,1.50E+06,2.16E+06,1.65E+05,1.27E+06,3.50E+06,1.84E+04,,2.77E+04,9.07E+05,6.89E+04,,3.96E+04,,1.14E+04,,3.07E+02,5.54E+04,1.74E+03,1.81E+05,3.17E+04,2.92E+03,6.08E+05,1.17E+03,2.98E+04,3.72E+04,0,FALSE,26.695,15,7,714,81.8,5.67,7,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;mitochondrion;other cytoplasmic organelle;other cell component,"Pf00648, Pf01067, Pf13833",823,P07384; Q2TTR0; Q6DHV4,ENSG00000014216,Formation of the cornified envelope; Degradation of the extracellular matrix; Neutrophil degranulation; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,Integrin-mediated cell adhesion; Alzheimer's disease and miRNA effects; Alzheimer's disease,7,0,69.56,97.96,77.06,71.37,High,n/a,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,107.8,135.87,93.17,85.9,86.82,other molecular function,0,
Master Protein,High,P50991,CCT4,T-complex protein 1 subunit delta OS=Homo sapiens OX=9606 GN=CCT4 PE=1 SV=4,5,23,0.472,0.356,0.911,0.358,-1.08,-1.49,-0.13,-1.48,3.92E-01,3.47E-01,8.03E-01,4.06E-01,1.18E+06,2.42E+06,9.58E+05,3.93E+06,5,5,5,5,1.18E+06,6.01E+06,6.31E+05,5.73E+05,1.28E+07,4.97E+06,6.37E+05,1.38E+06,2.42E+06,2.66E+07,3.97E+05,2.73E+05,2.34E+06,2.11E+06,9.58E+05,6.70E+06,8.03E+06,3.02E+06,3.93E+06,2.30E+06,4.70E+03,2.28E+04,6.16E+03,5.73E+05,6.60E+05,1.77E+04,1.13E+04,1.27E+04,6.82E+04,2.83E+05,2.38E+03,1.22E+04,1.90E+04,2.85E+05,2.38E+04,1.31E+04,2.26E+06,2.14E+04,9.19E+04,2.44E+04,0,FALSE,21.822,12,4,539,57.9,7.83,5,protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf00118,10575,B2R6I3; B7Z8B1; F5H5W3; hsa:10575; O14870; P50991; Q53QP9; Q96C51,ENSG00000115484,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,16p11.2 proximal deletion syndrome,7,0,124.96,152.32,79.05,51.35,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,135.49,128.55,97.81,124.98,60.75,other molecular function,0,
Master Protein,High,O15173,PGRMC2,Membrane-associated progesterone receptor component 2 OS=Homo sapiens OX=9606 GN=PGRMC2 PE=1 SV=1,3,9,0.471,0.709,0.255,1.159,-1.09,-0.5,-1.97,0.21,3.41E-01,9.10E-01,6.07E-02,7.38E-01,1.74E+06,3.54E+06,1.09E+06,9.01E+05,2,1,5,1,,,,3.07E+06,9.88E+05,,,,,3.54E+06,1.04E+06,1.12E+06,1.56E+06,1.09E+06,9.91E+05,,9.01E+05,,,,,,,3.07E+06,5.10E+04,,,,,3.76E+04,6.24E+03,4.99E+04,1.27E+04,1.47E+05,2.46E+04,,2.53E+05,,,,0,FALSE,16.66,26,3,223,23.8,4.88,3,transport;signal transduction;other biological processes,ER/Golgi;nucleus;other cell component,Pf00173,10424,hsa:10424; O15173; Q569H1,ENSG00000164040,RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Heme signaling,Ciliary landscape,7,0,72.51,,19.56,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,80.95,49.35,0,7.56,26.48,transporter activity;other molecular function,0,
Master Protein,High,O43707,ACTN4,Alpha-actinin-4 OS=Homo sapiens OX=9606 GN=ACTN4 PE=1 SV=2,22,107,0.471,1.127,1.49,0.343,-1.09,0.17,0.58,-1.54,3.40E-01,4.71E-01,7.06E-01,3.83E-01,2.28E+07,5.47E+07,8.37E+06,3.17E+07,5,5,5,5,2.28E+07,2.47E+07,8.45E+06,3.07E+06,6.99E+07,5.47E+07,3.06E+07,6.39E+07,8.38E+07,2.91E+07,6.82E+06,5.10E+06,8.37E+06,1.85E+07,9.18E+06,1.20E+08,2.54E+07,1.56E+08,3.17E+07,2.60E+07,9.06E+04,9.40E+04,8.25E+04,3.07E+06,3.61E+06,1.95E+05,5.45E+05,5.90E+05,2.36E+06,3.09E+05,4.08E+04,2.28E+05,6.80E+04,2.49E+06,2.28E+05,2.34E+05,7.12E+06,1.10E+06,7.41E+05,2.77E+05,0,FALSE,97.23,33,12,911,104.8,5.44,22,cell organization and biogenesis;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,"Pf00307, Pf00435, Pf08726",81,A4K467; D6PXK4; hsa:81; O43707; O76048,ENSG00000130402; ENSG00000282844,Platelet degranulation ; Nephrin family interactions,Arrhythmogenic right ventricular cardiomyopathy; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; Striated muscle contraction pathway; Ebola virus infection in host; Nephrotic syndrome; Alstrom syndrome,9,10,102.09,44.14,54.26,85.99,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,120.7,125.63,119.34,98.98,306.07,signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A994J6B4,FIP1L1,Factor interacting with PAPOLA and CPSF1 OS=Homo sapiens OX=9606 GN=FIP1L1 PE=4 SV=1,3,5,0.47,0.245,,1.24,-1.09,-2.03,,0.31,5.29E-01,1.69E-01,,7.08E-01,1.19E+06,2.34E+05,2.50E+05,2.01E+05,3,1,2,2,,6.26E+05,,1.19E+06,1.78E+06,,2.34E+05,,,,,,,5.64E+05,1.11E+05,,,2.06E+05,1.97E+05,,,2.38E+03,,1.19E+06,9.18E+04,,4.16E+03,,,,,,,7.59E+04,2.75E+03,,,1.46E+03,4.62E+03,,0,FALSE,15.991,10,3,603,67.4,5.59,3,,nucleus,,,A0A994J6B4,ENSG00000145216,,,0,0,48.08,,95,2.94,n/a,Peak Found,n/a,High,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,0,82.7,,131.69,18.13,,0,
Master Protein,High,P61006,RAB8A,Ras-related protein Rab-8A OS=Homo sapiens OX=9606 GN=RAB8A PE=1 SV=1,6,61,0.468,1.383,1.368,0.427,-1.1,0.47,0.45,-1.23,4.98E-01,2.42E-01,7.42E-01,5.42E-01,1.09E+06,5.61E+05,1.53E+06,1.40E+06,5,3,5,4,1.09E+06,2.77E+06,7.39E+05,5.37E+05,1.98E+06,,,6.38E+05,4.86E+05,5.61E+05,3.31E+06,1.12E+06,1.53E+06,7.18E+05,2.45E+06,1.45E+06,1.34E+06,,2.29E+05,2.00E+06,4.32E+03,1.05E+04,7.22E+03,5.37E+05,1.02E+05,,,5.89E+03,1.37E+04,5.97E+03,1.98E+04,5.01E+04,1.24E+04,9.68E+04,6.08E+04,2.83E+03,3.77E+05,,5.36E+03,2.13E+04,0,FALSE,30.478,28,2,207,23.7,9.07,6,cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,4218,B4DEK7; hsa:4218; P24407; P61006; Q6FHV5,ENSG00000167461,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of PLK1 Activity at G2/M Transition; Anchoring of the basal body to the plasma membrane; VxPx cargo-targeting to cilium; TBC/RABGAPs,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Ciliary landscape; Joubert syndrome,10,1,65.6,13.59,57.42,59.17,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,126.7,118.38,106.71,123.51,138.42,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9C0C9,UBE2O,(E3-independent) E2 ubiquitin-conjugating enzyme OS=Homo sapiens OX=9606 GN=UBE2O PE=1 SV=3,6,8,0.467,1.604,0.787,0.536,-1.1,0.68,-0.35,-0.9,4.30E-01,3.68E-01,7.35E-01,7.37E-01,1.45E+04,1.11E+05,2.15E+04,3.66E+05,2,4,3,2,,,,5.91E+03,3.55E+04,,3.29E+05,2.48E+05,1.94E+04,4.98E+04,,,2.15E+04,2.00E+04,1.30E+05,,1.11E+06,,1.21E+05,,,,,5.91E+03,1.83E+03,,5.84E+03,2.29E+03,5.46E+02,5.29E+02,,,1.74E+02,2.70E+03,3.23E+03,,3.12E+05,,2.83E+03,,0,FALSE,34.822,9,6,1292,141.2,5.12,6,protein metabolism;other metabolic processes;transport;other biological processes,cytosol;nucleus;other cell component,Pf00179,63893,A6NDU5; hsa:63893; Q69YP4; Q6PIZ2; Q86UA4; Q8N425; Q8TBN1; Q9BSW1; Q9C0C9; Q9H6E6; Q9H7E4; Q9H9B2,ENSG00000175931,Antigen processing: Ubiquitination & Proteasome degradation,,1,0,101.08,93.31,110.41,113.63,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,94.52,130.47,102.78,53.88,28.09,other molecular function,0,
Master Protein,High,Q9BSH4,TACO1,Translational activator of cytochrome c oxidase 1 OS=Homo sapiens OX=9606 GN=TACO1 PE=1 SV=1,4,11,0.466,1.649,2.277,2.171,-1.1,0.72,1.19,1.12,5.11E-01,2.28E-01,5.28E-01,3.57E-01,4.82E+05,3.24E+05,5.28E+05,2.67E+05,2,3,5,4,,,,8.93E+05,2.60E+05,,,3.24E+05,4.29E+05,1.98E+05,5.23E+05,5.28E+05,5.35E+05,1.29E+06,4.79E+05,2.08E+05,3.42E+05,,1.65E+05,7.39E+05,,,,8.93E+05,1.34E+04,,,2.99E+03,1.21E+04,2.11E+03,3.13E+03,2.36E+04,4.35E+03,1.74E+05,1.19E+04,4.06E+02,9.61E+04,,3.86E+03,7.87E+03,0,FALSE,16.317,22,4,297,32.5,8.13,4,cell organization and biogenesis;other biological processes,mitochondrion,"Pf01709, Pf20772",51204,B2RD21; hsa:51204; Q8N3N6; Q9BSH4; Q9UI60,ENSG00000136463,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,Mitochondrial complex IV assembly,4,0,77.62,36.4,51.65,71.89,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,n/a,High,Peak Found,1,,FALSE,47.56,46.54,36.01,49.96,32.51,translation activity;nucleic acid binding activity,0,
Master Protein,High,Q92506,HSD17B8,(3R)-3-hydroxyacyl-CoA dehydrogenase OS=Homo sapiens OX=9606 GN=HSD17B8 PE=1 SV=2,3,5,0.466,0.532,1.346,0.127,-1.1,-0.91,0.43,-2.98,5.28E-01,7.30E-01,8.42E-01,1.10E-01,5.27E+05,4.97E+05,2.20E+05,9.20E+05,3,4,5,5,,5.27E+05,,2.85E+05,1.09E+06,4.31E+06,2.58E+05,4.65E+05,,5.30E+05,3.05E+05,2.25E+05,2.20E+05,1.16E+05,1.63E+05,2.43E+06,1.30E+04,9.20E+05,2.06E+05,1.64E+06,,2.00E+03,,2.85E+05,5.61E+04,1.53E+04,4.58E+03,4.29E+03,,5.64E+03,1.82E+03,1.00E+04,1.79E+03,1.56E+04,4.05E+03,4.74E+03,3.66E+03,6.52E+03,4.83E+03,1.75E+04,0,FALSE,8.043,15,3,261,27,6.54,3,cell organization and biogenesis;other metabolic processes,plasma membrane;other membranes;mitochondrion;other cell component,Pf13561,7923,A6NLX7; hsa:7923; Q5STP7; Q92506; Q9UIQ1,ENSG00000112474; ENSG00000204228; ENSG00000225312; ENSG00000228357; ENSG00000228712; ENSG00000232357,Fatty acyl-CoA biosynthesis,,1,0,64.99,140.21,34.58,96.66,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,103.84,80.67,146.72,114.99,14.38,other molecular function,0,
Master Protein,High,P16220,CREB1,Cyclic AMP-responsive element-binding protein 1 OS=Homo sapiens OX=9606 GN=CREB1 PE=1 SV=3,3,5,0.464,0.05,,3.378,-1.11,-4.31,,1.76,4.02E-01,3.28E-05,,2.17E-01,1.98E+06,7.85E+05,3.60E+05,3.53E+04,2,1,5,2,,2.91E+06,,1.34E+06,,,7.85E+05,,,,1.47E+05,3.60E+05,1.12E+05,4.83E+05,8.57E+05,,8.33E+03,,1.49E+05,,,1.11E+04,,1.34E+06,,,1.40E+04,,,,8.78E+02,1.61E+04,9.10E+02,6.51E+04,2.13E+04,,2.34E+03,,3.49E+03,,0,FALSE,19.551,16,3,327,35.1,5.27,3,cell-cell signaling;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf00170, Pf02173",1385,hsa:1385; P16220; P21934; Q6V963; Q9UMA7,ENSG00000118260,FCGR3A-mediated IL10 synthesis; HCMV Early Events; ADORA2B mediated anti-inflammatory cytokines production; AKT phosphorylates targets in the nucleus; Constitutive Signaling by AKT1 E17K in Cancer; NGF-stimulated transcription; Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; MECP2 regulates transcription of neuronal ligands; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; NCAM signaling for neurite out-growth; Regulation of MECP2 expression and activity; Transcriptional regulation of granulopoiesis; CREB phosphorylation; Gastrin-CREB signalling pathway via PKC and MAPK; NOTCH2 intracellular domain regulates transcription; MECP2 regulates neuronal receptors and channels; CaMK IV-mediated phosphorylation of CREB; CREB1 phosphorylation through the activation of Adenylate Cyclase; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde; PKA-mediated phosphorylation of CREB; CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling; MECP2 regulates transcription factors,Androgen receptor signaling pathway; miRNA regulation of DNA damage response; Energy metabolism; miRNAs involved in DNA damage response; Folate-alcohol and cancer pathway hypotheses; Sterol regulatory element-binding proteins (SREBP) signaling; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; ATM signaling pathway; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; MFAP5-mediated ovarian cancer cell motility and invasiveness; Ovarian infertility; MECP2 and associated Rett syndrome; Transcription factor regulation in adipogenesis; BDNF-TrkB signaling; ERK pathway in Huntington's disease; VEGFA-VEGFR2 signaling; Mitochondrial gene expression; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; p38 MAPK signaling pathway; NO/cGMP/PKG mediated neuroprotection; White fat cell differentiation; PI3K-Akt signaling pathway; Phosphodiesterases in neuronal function; Acute viral myocarditis; Thermogenesis; EGF/EGFR signaling pathway; G1 to S cell cycle control; Fragile X syndrome; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; Hepatitis B infection; Melanoma; mBDNF and proBDNF regulation of GABA neurotransmission; CAMKK2 pathway; GPR143 in melanocytes and retinal pigment epithelium cells; Galanin receptor pathway; Neuroinflammation and glutamatergic signaling; Vasopressin-regulated water reabsorption; Pleural mesothelioma; CCL18 signaling pathway; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; Rubinstein-Taybi syndrome 1; Smith-Magenis and Potocki-Lupski syndrome copy number variation; Interferon type I signaling pathways; T-cell receptor signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response; Estrogen signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 4/6/7 and NR3C signaling,85,0,52.18,,77.01,126.48,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,0,63.27,,137.93,17.22,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P25686,DNAJB2,DnaJ homolog subfamily B member 2 OS=Homo sapiens OX=9606 GN=DNAJB2 PE=1 SV=3,2,3,0.464,0.097,0.772,0.055,-1.11,-3.36,-0.37,-4.18,4.06E-01,5.72E-02,7.65E-01,3.63E-02,2.06E+04,3.99E+04,2.01E+03,3.65E+04,3,3,1,2,,,2.06E+04,8.33E+03,7.88E+04,,,3.99E+04,2.45E+04,1.70E+05,,,,2.01E+03,,,,,2.42E+04,5.53E+04,,,2.02E+02,8.33E+03,4.07E+03,,,3.68E+02,6.92E+02,1.81E+03,,,,2.71E+02,,,,,5.66E+02,5.88E+02,0,FALSE,8.795,10,2,324,35.6,5.95,2,protein metabolism;other metabolic processes;stress response;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cell component,Pf00226,3300,A8K9P6; hsa:3300; P25686; Q53QD7; Q8IUK1; Q8IUK2; Q96F52,ENSG00000135924,,,0,0,104.81,102.28,,55.37,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,113.48,88.43,81.51,63.08,9.4,other molecular function,0,
Master Protein,High,A0A804HLJ9,MCCC2,methylcrotonoyl-CoA carboxylase OS=Homo sapiens OX=9606 GN=MCCC2 PE=1 SV=1,3,6,0.463,0.263,1.472,0.089,-1.11,-1.93,0.56,-3.48,5.32E-01,1.98E-01,7.87E-01,6.73E-02,5.41E+05,2.90E+05,2.80E+05,1.20E+05,2,2,3,4,,,,4.32E+05,6.77E+05,8.35E+04,,,1.00E+06,,,8.47E+04,,2.80E+05,8.15E+05,1.23E+05,1.17E+05,,1.13E+05,1.38E+05,,,,4.32E+05,3.49E+04,2.97E+02,,,2.83E+04,,,3.78E+03,,3.77E+04,2.03E+04,2.40E+02,3.29E+04,,2.65E+03,1.47E+03,0,FALSE,11.609,10,3,606,66.3,7.87,3,other metabolic processes,mitochondrion,Pf01039,,A0A804HLJ9,ENSG00000131844,,,0,0,31.27,119.71,96.19,8.99,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,31.96,103.65,20.86,136.18,20.46,other molecular function,0,
Master Protein,High,Q9H1B7,IRF2BPL,Probable E3 ubiquitin-protein ligase IRF2BPL OS=Homo sapiens OX=9606 GN=IRF2BPL PE=1 SV=1,2,2,0.463,0.238,0.367,0.37,-1.11,-2.07,-1.45,-1.43,4.78E-01,2.74E-01,3.12E-01,5.35E-01,9.23E+04,2.28E+05,2.20E+04,5.93E+04,2,3,2,2,,1.17E+05,,7.27E+04,,2.81E+05,,2.28E+05,,9.31E+04,,,3.42E+04,,1.41E+04,1.21E+05,2.90E+04,,,,,4.45E+02,,7.27E+04,,9.98E+02,,2.10E+03,,9.90E+02,,,2.78E+02,,3.50E+02,2.37E+02,8.14E+03,,,,0,FALSE,8.884,4,1,796,82.6,8.24,2,protein metabolism;other metabolic processes;developmental processes;other biological processes,nucleus,Pf11261,64207,hsa:64207; Q8NDQ2; Q96JG2; Q9H1B7; Q9H3I7,ENSG00000119669,,,0,0,33.03,48.25,58.94,86.98,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,63.58,53.58,76.4,74.19,5.85,other molecular function,0,
Master Protein,High,P07948,LYN,Tyrosine-protein kinase Lyn OS=Homo sapiens OX=9606 GN=LYN PE=1 SV=3,2,5,0.462,1.338,0.458,1.194,-1.11,0.42,-1.13,0.26,4.03E-01,2.32E-01,3.20E-01,7.18E-01,7.75E+05,1.68E+06,1.13E+06,8.79E+05,2,1,4,3,,4.08E+06,,1.47E+05,,,,1.68E+06,,,,1.88E+06,5.72E+05,1.32E+06,9.64E+05,,8.79E+05,,9.90E+05,6.56E+05,,1.55E+04,,1.47E+05,,,,1.55E+04,,,,8.40E+04,4.65E+03,1.78E+05,2.39E+04,,2.47E+05,,2.32E+04,6.98E+03,0,FALSE,4.482,5,1,512,58.5,7.11,2,cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00017, Pf00018, Pf07714",4067,A0AVQ5; hsa:4067; P07948,ENSG00000254087,"FCGR activation; FCGR3A-mediated IL10 synthesis; FCGR3A-mediated phagocytosis; Regulation of signaling by CBL; EPHB-mediated forward signaling; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Regulation of KIT signaling; EPH-ephrin mediated repulsion of cells; EPHA-mediated growth cone collapse; Signaling by CSF1 (M-CSF) in myeloid cells; CD28 co-stimulation; PECAM1 interactions; CTLA4 inhibitory signaling; Role of LAT2/NTAL/LAB on calcium mobilization; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; FCERI mediated NF-kB activation; CD22 mediated BCR regulation; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Erythropoietin activates Phosphoinositide-3-kinase (PI3K); GPVI-mediated activation cascade; Cyclin D associated events in G1; Growth hormone receptor signaling; Inactivation of CSF3 (G-CSF) signaling; Erythropoietin activates Phospholipase C gamma (PLCG); Erythropoietin activates STAT5; Erythropoietin activates RAS; Platelet Adhesion to exposed collagen; CD209 (DC-SIGN) signaling; Dectin-2 family",IL-5 signaling pathway; RANKL/RANK signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Chemokine signaling pathway; Microglia pathogen phagocytosis pathway; GDNF signaling,45,1,131.57,,46.92,20.21,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,376.17,207.51,25.49,56.11,8.88,signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function,0,
Master Protein,High,Q9NZD4,AHSP,Alpha-hemoglobin-stabilizing protein OS=Homo sapiens OX=9606 GN=AHSP PE=1 SV=1,3,9,0.461,,1.437,0.628,-1.12,,0.52,-0.67,5.14E-01,,8.16E-01,8.15E-01,2.20E+05,3.45E+05,5.13E+05,5.94E+05,1,2,1,4,,,,,2.20E+05,6.70E+05,1.78E+05,,,,,5.13E+05,,,,3.29E+05,1.07E+06,5.14E+06,,3.05E+05,,,,,1.13E+04,2.38E+03,3.17E+03,,,,,2.29E+04,,,,6.42E+02,3.02E+05,3.65E+04,,3.24E+03,0,FALSE,7.376,34,3,102,11.8,5,3,protein metabolism;other metabolic processes;other biological processes,cytosol;other cell component,Pf09236,51327,hsa:51327; Q8TD01; Q9NZD4,ENSG00000169877,,,0,0,,82.01,,135.16,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,High,1,,FALSE,105.52,,107.59,0,22.02,other molecular function,0,
Master Protein,High,J3KMX1,NUP88,Nucleoporin 88 OS=Homo sapiens OX=9606 GN=NUP88 PE=1 SV=2,6,11,0.461,0.84,0.082,3.702,-1.12,-0.25,-3.6,1.89,4.39E-01,8.36E-01,2.27E-02,2.20E-01,9.06E+04,5.47E+04,1.17E+05,1.22E+05,3,1,4,2,8.26E+04,,,1.08E+06,9.06E+04,,,,5.47E+04,,4.54E+04,1.67E+05,,9.37E+05,8.16E+04,,2.11E+04,7.12E+05,,,3.28E+02,,,1.08E+06,4.67E+03,,,,1.54E+03,,2.72E+02,7.48E+03,,1.26E+05,2.03E+03,,5.92E+03,5.04E+03,,,0,FALSE,27.939,12,6,757,85.5,5.81,6,transport,nucleus,Pf10168,4927,J3KMX1,ENSG00000108559,,Ciliary landscape,1,0,137.39,,137.26,133.29,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,0,84.72,0,56.97,37.9,other molecular function,0,
Master Protein,High,P13796,LCP1,Plastin-2 OS=Homo sapiens OX=9606 GN=LCP1 PE=1 SV=6,22,96,0.461,0.649,0.776,0.339,-1.12,-0.62,-0.37,-1.56,3.28E-01,9.25E-01,6.49E-01,3.77E-01,1.17E+07,3.40E+07,4.59E+06,4.40E+07,5,5,5,5,1.17E+07,1.18E+07,1.91E+05,2.29E+06,8.21E+07,1.38E+07,4.48E+07,5.23E+07,3.07E+05,3.40E+07,3.83E+06,2.69E+06,4.59E+06,1.19E+07,5.92E+06,4.40E+07,3.99E+06,9.55E+07,2.19E+07,8.27E+07,4.63E+04,4.49E+04,1.87E+03,2.29E+06,4.24E+06,4.89E+04,7.97E+05,4.82E+05,8.65E+03,3.62E+05,2.29E+04,1.20E+05,3.73E+04,1.61E+06,1.47E+05,8.58E+04,1.12E+06,6.77E+05,5.11E+05,8.80E+05,0,FALSE,84.312,48,22,627,70.2,5.43,22,cell organization and biogenesis;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00036, Pf00307",3936,B2R613; B4DUA0; hsa:3936; P13796; Q5TBN4,ENSG00000136167,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,,1,0,158.4,74.51,62.6,78.61,Peak Found,High,Peak Found,High,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,High,High,High,High,High,High,High,1,,FALSE,119.12,131.84,125.04,137.26,233.46,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,E9PKQ8,LCK,Tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=LCK PE=1 SV=2,2,8,0.46,0.671,0.407,0.864,-1.12,-0.57,-1.3,-0.21,4.99E-01,9.67E-01,3.53E-01,9.56E-01,1.14E+05,2.48E+05,7.65E+04,1.29E+05,3,3,3,2,,3.33E+05,1.14E+05,7.12E+04,,,5.00E+04,2.48E+05,,9.16E+05,,2.05E+04,7.65E+04,2.76E+05,,,4.35E+05,,3.83E+04,,,1.27E+03,1.11E+03,7.12E+04,,,8.90E+02,2.29E+03,,9.74E+03,,9.18E+02,6.22E+02,3.72E+04,,,1.22E+05,,8.96E+02,,0,FALSE,11.292,6,2,567,64.2,5.66,2,other metabolic processes,plasma membrane;other membranes;cytosol,"Pf00017, Pf00018, Pf07714",,E9PKQ8,ENSG00000182866,,T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Cancer immunotherapy by PD-1 blockade; Modulators of TCR signaling and T cell activation; Th17 cell differentiation pathway; Calcium mediated T-cell apoptosis involved in inclusion body myositis; TAR syndrome,6,0,81.36,112.16,107.94,118.54,n/a,Peak Found,Peak Found,High,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,100.38,122.54,131.67,110.36,29.12,kinase activity;other molecular function,0,
Master Protein,High,P06400,RB1,Retinoblastoma-associated protein OS=Homo sapiens OX=9606 GN=RB1 PE=1 SV=2,2,3,0.46,2.26,1.293,0.723,-1.12,1.18,0.37,-0.47,4.26E-01,2.15E-01,8.93E-01,9.03E-01,3.64E+04,7.92E+04,7.40E+04,1.02E+05,2,2,4,3,,,,1.85E+04,7.15E+04,1.38E+05,,,,4.55E+04,,6.74E+04,3.84E+04,1.76E+05,8.13E+04,3.84E+05,,,2.32E+04,1.02E+05,,,,1.85E+04,3.69E+03,4.90E+02,,,,4.83E+02,,3.01E+03,3.12E+02,2.38E+04,2.02E+03,7.50E+02,,,5.42E+02,1.09E+03,0,FALSE,6.673,3,2,928,106.1,7.94,2,cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf01857, Pf01858, Pf08934, Pf11934",5925,A8K5E3; hsa:5925; P06400; P78499; Q5VW46; Q8IZL4,ENSG00000139687,"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Oncogene Induced Senescence; Cyclin D associated events in G1; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3); Aberrant regulation of mitotic exit in cancer due to RB1 defects; RUNX2 regulates osteoblast differentiation; Condensation of Prophase Chromosomes; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes; Cyclin A:Cdk2-associated events at S phase entry; Formation of Senescence-Associated Heterochromatin Foci (SAHF); Inhibition of replication initiation of damaged DNA by RB1/E2F1; Defective translocation of RB1 mutants to the nucleus; Replication of the SARS-CoV-1 genome; Replication of the SARS-CoV-2 genome; Nuclear events stimulated by ALK signaling in cancer",Androgen receptor signaling pathway; miRNA regulation of DNA damage response; Cell cycle; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; Adipogenesis; Spinal cord injury; Retinoblastoma gene in cancer; Aryl hydrocarbon receptor pathway; Bladder cancer; Fas ligand pathway and stress induction of heat shock proteins; Photodynamic therapy-induced AP-1 survival signaling; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; Tumor suppressor activity of SMARCB1; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Effect of progerin on genes involved in progeria; Ciliary landscape; G1 to S cell cycle control; Small cell lung cancer; Head and neck squamous cell carcinoma; Melanoma; Overlap between signal transduction pathways contributing to LMNA laminopathies; 7q11.23 copy number variation syndrome; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis in senescence; Sphingolipid metabolism in senescence; Prostaglandin and leukotriene metabolism in senescence ; ID signaling pathway; TROP2 regulatory signaling; Prostaglandin and leukotriene metabolism in senescence ; 8q11.23 (RB1CC1) copy number variation; Omega-6-fatty acids in senescence; DNA damage response,51,0,83.17,71.26,65.75,111.71,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,61.92,88.34,119.43,114.56,9.23,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P07996,THBS1,Thrombospondin-1 OS=Homo sapiens OX=9606 GN=THBS1 PE=1 SV=2,26,134,0.459,0.153,0.922,0.095,-1.12,-2.71,-0.12,-3.4,3.26E-01,2.61E-02,8.14E-01,4.43E-02,1.41E+07,9.40E+06,5.56E+05,2.18E+07,5,5,5,5,1.73E+07,1.77E+07,4.37E+06,2.14E+06,1.41E+07,9.40E+06,6.80E+06,3.70E+07,1.53E+07,4.45E+06,5.56E+05,1.60E+05,2.77E+06,1.24E+06,2.45E+05,1.99E+08,2.18E+07,7.10E+06,3.30E+06,2.36E+07,6.88E+04,6.73E+04,4.27E+04,2.14E+06,7.29E+05,3.34E+04,1.21E+05,3.41E+05,4.31E+05,4.73E+04,3.33E+03,7.16E+03,2.25E+04,1.67E+05,6.09E+03,3.89E+05,6.12E+06,5.03E+04,7.72E+04,2.51E+05,0,FALSE,137.901,32,21,1170,129.3,4.94,26,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,"Pf00090, Pf00093, Pf02412, Pf05735",7057,A8K6H4; B4E3J7; B9EGH6; hsa:7057; P07996; Q15667; Q59E99,ENSG00000137801,Platelet degranulation ; Defective B3GALTL causes PpS; O-glycosylation of TSR domain-containing proteins; Signaling by PDGF; Integrin cell surface interactions; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Syndecan interactions,Complement system; Bladder cancer; Apoptosis-related network due to altered Notch3 in ovarian cancer; miRNA targets in ECM and membrane receptors; Focal adhesion; TGF-beta signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Inflammatory response pathway; Male infertility; TGF-beta receptor signaling in skeletal dysplasias; p53 transcriptional gene network; TGF-beta receptor signaling,20,5,66.16,90.25,108.64,163.44,High,High,High,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,Peak Found,1,,FALSE,124.74,121.86,134.41,135.68,384.54,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,X6R8F3,LCN2,Lipocalin 2 OS=Homo sapiens OX=9606 GN=LCN2 PE=1 SV=1,9,123,0.458,0.668,1.346,0.107,-1.13,-0.58,0.43,-3.23,3.25E-01,9.50E-01,8.04E-01,5.62E-02,9.97E+05,1.17E+07,1.31E+06,2.50E+07,5,5,5,5,9.97E+05,1.77E+07,8.78E+05,2.04E+05,4.01E+07,1.28E+07,3.93E+06,1.17E+07,9.75E+05,5.08E+07,1.31E+06,1.46E+05,4.39E+06,4.50E+06,9.87E+05,1.75E+07,1.82E+05,3.80E+07,2.50E+07,3.83E+07,3.96E+03,6.73E+04,8.58E+03,2.04E+05,2.07E+06,4.55E+04,6.99E+04,1.08E+05,2.75E+04,5.40E+05,7.85E+03,6.51E+03,3.57E+04,6.06E+05,2.45E+04,3.41E+04,5.10E+04,2.69E+05,5.85E+05,4.07E+05,0,FALSE,38.585,58,9,200,22.8,8.5,9,,non-structural extracellular,Pf00061,,X6R8F3,ENSG00000148346,,miRNA role in immune response in sepsis; Ciliary landscape,2,0,144.94,125.1,89.71,66.84,Peak Found,High,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,High,1,,FALSE,145.94,141.48,138.99,136.31,362.5,other molecular function,0,
Master Protein,High,Q96RS6,NUDCD1,NudC domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NUDCD1 PE=1 SV=2,2,2,0.458,0.01,4.204,0.01,-1.13,-6.64,2.07,-6.64,4.29E-01,1.00E-17,2.14E-01,1.00E-17,4.40E+04,9.63E+04,,4.05E+05,2,2,,1,,,,2.20E+04,8.84E+04,,9.26E+04,1.00E+05,,,,,,,,,,4.05E+05,,,,,,2.20E+04,4.56E+03,,1.65E+03,9.24E+02,,,,,,,,,,2.87E+03,,,0.001,FALSE,3.868,4,2,583,66.7,5.11,2,other biological processes,cytosol;nucleus,Pf04969,84955,B4DVX6; hsa:84955; Q4G130; Q8NDQ5; Q8NG18; Q96RS6; Q96SI4; Q9BVR5,ENSG00000120526,,,0,0,85.12,5.52,,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,107.46,,5.79,,5.36,,0,
Master Protein,High,Q9NVJ2,ARL8B,ADP-ribosylation factor-like protein 8B OS=Homo sapiens OX=9606 GN=ARL8B PE=1 SV=1,4,10,0.457,0.557,1.726,0.138,-1.13,-0.85,0.79,-2.86,3.70E-01,8.13E-01,5.63E-01,9.38E-02,1.61E+06,2.00E+06,7.51E+05,2.22E+06,5,4,5,5,2.60E+06,1.61E+06,4.45E+05,7.55E+05,1.96E+06,,1.78E+06,2.25E+06,6.25E+05,1.15E+07,7.51E+05,4.67E+05,2.49E+05,1.26E+06,7.99E+05,2.22E+06,5.83E+05,5.38E+06,1.25E+06,7.74E+06,1.03E+04,6.11E+03,4.35E+03,7.55E+05,1.01E+05,,3.16E+04,2.08E+04,1.76E+04,1.22E+05,4.49E+03,2.08E+04,2.02E+03,1.70E+05,1.99E+04,4.33E+03,1.64E+05,3.81E+04,2.93E+04,8.24E+04,0,FALSE,12.345,35,4,186,21.5,8.43,4,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes,other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component,Pf00025,55207,B4DI85; hsa:55207; Q9NVJ2,ENSG00000134108,,Ciliary landscape,1,0,59.75,124.12,54.29,88.2,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,86.88,94.64,125.57,121.54,29.11,cytoskeletal activity;other molecular function,0,
Master Protein,Medium,E9PHZ5,CTSB,Cathepsin B OS=Homo sapiens OX=9606 GN=CTSB PE=1 SV=9,1,2,0.456,0.481,1.031,0.212,-1.13,-1.06,0.04,-2.23,5.12E-01,6.51E-01,9.38E-01,2.26E-01,3.35E+05,7.36E+05,1.61E+05,7.59E+05,2,3,2,4,,4.62E+05,,,2.44E+05,,,7.36E+05,6.48E+04,1.51E+06,1.70E+05,,1.53E+05,,,,2.78E+05,6.53E+05,8.82E+05,9.76E+05,,1.75E+03,,,1.26E+04,,,6.79E+03,1.83E+03,1.60E+04,1.01E+03,,1.24E+03,,,,7.81E+04,4.62E+03,2.06E+04,1.04E+04,0.022,FALSE,1.944,3,1,371,41.3,6.58,1,protein metabolism,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00112, Pf08127",,E9PHZ5; E9PJ67,ENSG00000164733,,Ebola virus infection in host; 8p23.1 copy number variation syndrome,2,0,43.76,93.85,7.27,44.59,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,101.35,45.82,90,33.07,4.57,other molecular function,0,
Master Protein,High,P62328,TMSB4X,Thymosin beta-4 OS=Homo sapiens OX=9606 GN=TMSB4X PE=1 SV=2,4,68,0.454,0.303,4.188,0.098,-1.14,-1.72,2.07,-3.36,3.20E-01,2.26E-01,8.99E-02,4.68E-02,1.31E+06,6.51E+06,1.24E+06,4.43E+07,5,5,5,5,1.31E+06,1.53E+07,3.64E+05,1.23E+06,5.68E+07,3.46E+06,6.51E+06,1.42E+07,4.71E+06,2.00E+07,2.12E+04,1.24E+06,1.73E+06,4.69E+06,1.11E+06,4.43E+07,8.27E+05,8.35E+07,1.27E+06,1.40E+08,5.20E+03,5.80E+04,3.56E+03,1.23E+06,2.93E+06,1.23E+04,1.16E+05,1.31E+05,1.33E+05,2.13E+05,1.27E+02,5.54E+04,1.40E+04,6.31E+05,2.75E+04,8.64E+04,2.32E+05,5.91E+05,2.98E+04,1.49E+06,0,FALSE,33.987,45,4,44,5.1,5.06,4,cell organization and biogenesis;signal transduction;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf01290,7114,hsa:7114; P01253; P01254; P62328; Q546P5; Q63576; Q9UE55,ENSG00000205542,Platelet degranulation,Genes targeted by miRNAs in adipocytes; VEGFA-VEGFR2 signaling; IL-18 signaling pathway; Regulation of actin cytoskeleton,5,0,161.29,72.35,99.77,109.42,Peak Found,High,Peak Found,High,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,1,,FALSE,145.9,141.94,146.34,144.24,210.94,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9BZF1,OSBPL8,Oxysterol-binding protein-related protein 8 OS=Homo sapiens OX=9606 GN=OSBPL8 PE=1 SV=3,7,14,0.454,1.649,0.542,1.225,-1.14,0.72,-0.88,0.29,4.76E-01,1.26E-01,5.12E-01,7.09E-01,5.67E+05,1.07E+06,1.89E+06,1.08E+06,5,3,5,4,2.42E+05,5.67E+05,4.25E+05,9.07E+05,2.45E+06,1.95E+05,1.07E+06,,,1.72E+06,1.89E+06,4.30E+06,6.04E+05,2.51E+06,1.04E+06,,1.02E+06,9.34E+05,1.44E+06,1.15E+06,9.63E+02,2.16E+03,4.15E+03,9.07E+05,1.27E+05,6.94E+02,1.89E+04,,,1.83E+04,1.13E+04,1.92E+05,4.91E+03,3.39E+05,2.58E+04,,2.86E+05,6.62E+03,3.38E+04,1.22E+04,0,FALSE,26.687,12,7,889,101.1,6.96,7,cell organization and biogenesis;other metabolic processes;transport;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cell component,"Pf00169, Pf01237",114882,A8K1T2; E9PE66; E9PE68; hsa:114882; Q52LQ3; Q68D75; Q8WXP8; Q9BZF1; Q9P277,ENSG00000091039,Acyl chain remodelling of PS,,1,0,97.01,77.04,70.06,19.62,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,58.76,99.26,81.13,88.59,37.18,transporter activity;other molecular function,0,
Master Protein,High,O15371,EIF3D,Eukaryotic translation initiation factor 3 subunit D OS=Homo sapiens OX=9606 GN=EIF3D PE=1 SV=1,5,15,0.452,0.953,0.7,0.387,-1.15,-0.07,-0.51,-1.37,5.19E-01,6.58E-01,5.73E-01,5.03E-01,2.62E+05,3.83E+05,1.54E+05,3.09E+05,4,1,4,2,9.41E+04,3.82E+05,,5.13E+05,1.79E+05,,,,3.83E+05,,,1.39E+05,5.19E+04,3.19E+05,1.70E+05,,1.61E+06,,5.92E+04,,3.74E+02,1.45E+03,,5.13E+05,9.25E+03,,,,1.08E+04,,,6.22E+03,4.21E+02,4.30E+04,4.22E+03,,4.52E+05,,1.38E+03,,0,FALSE,16.297,14,5,548,63.9,6.05,5,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;translational apparatus;other cell component,Pf05091,8664,A8MWD3; B2R7D4; B4DTF8; B4DVY1; hsa:8664; O15371; Q3MJD9; Q5M9Q6,ENSG00000100353,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",Translation factors; VEGFA-VEGFR2 signaling; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,9,0,65.18,,65.41,131.4,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,35.74,107.4,319.24,46.13,42.13,nucleic acid binding activity,0,
Master Protein,High,P07359,GP1BA,Platelet glycoprotein Ib alpha chain OS=Homo sapiens OX=9606 GN=GP1BA PE=1 SV=2,7,23,0.452,0.343,0.951,0.288,-1.15,-1.54,-0.07,-1.8,3.70E-01,3.05E-01,8.45E-01,3.23E-01,1.82E+06,1.75E+06,6.11E+05,2.76E+06,5,5,5,4,2.74E+06,2.50E+06,1.82E+06,2.11E+05,1.62E+06,1.75E+06,9.65E+04,8.03E+06,4.29E+06,1.24E+05,6.11E+05,1.99E+05,2.16E+05,6.76E+05,1.18E+06,5.83E+07,4.15E+06,,1.84E+06,1.11E+06,1.09E+04,9.52E+03,1.78E+04,2.11E+05,8.36E+04,6.22E+03,1.72E+03,7.41E+04,1.21E+05,1.32E+03,3.65E+03,8.89E+03,1.76E+03,9.11E+04,2.93E+04,1.14E+05,1.17E+06,,4.31E+04,1.18E+04,0,FALSE,28.996,13,7,652,71.5,6.29,7,cell adhesion;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes,"Pf01462, Pf13855",2811,E7ES66; hsa:2811; P07359; Q14441; Q16469; Q8N1F3; Q8NG39; Q9HDC7; Q9UEK1; Q9UQS4,ENSG00000185245,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Platelet Adhesion to exposed collagen; Intrinsic Pathway of Fibrin Clot Formation; Platelet Aggregation (Plug Formation); Defective F9 activation; GP1b-IX-V activation signalling; Enhanced binding of GP1BA variant to VWF multimer:collagen ; Defective binding of VWF variant to GPIb:IX:V,22q11.2 copy number variation syndrome,9,0,55.7,117.52,69.79,171.22,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,n/a,Peak Found,Peak Found,1,,FALSE,136.35,97.15,142.81,127.58,45.54,other molecular function,0,
Master Protein,High,A0A1B0GW77,ALDH7A1,aldehyde dehydrogenase (NAD(+)) OS=Homo sapiens OX=9606 GN=ALDH7A1 PE=1 SV=1,7,7,0.452,0.472,2.669,0.205,-1.15,-1.08,1.42,-2.28,5.06E-01,6.30E-01,4.07E-01,2.84E-01,7.87E+05,4.98E+05,1.17E+05,1.90E+05,4,3,4,4,,1.65E+06,1.93E+05,1.38E+06,4.50E+05,,1.31E+06,4.54E+05,,4.98E+05,1.85E+05,,7.46E+04,7.48E+05,5.18E+04,2.00E+05,1.10E+05,1.80E+05,,2.66E+05,,6.29E+03,1.88E+03,1.38E+06,2.32E+04,,2.33E+04,4.19E+03,,5.29E+03,1.10E+03,,6.06E+02,1.01E+05,1.29E+03,3.90E+02,3.08E+04,1.28E+03,,2.83E+03,0,FALSE,17.121,18,7,554,60,8.18,7,,cytosol;mitochondrion,Pf00171,,A0A1B0GW77,ENSG00000164904,,"Amino acid metabolism; Vitamin B6-dependent and responsive disorders; Cerebral organic acidurias, including diseases; Diet-dependent trimethylamine/trimethylamine N-oxide metabolism ; Metabolic Epileptic Disorders",5,0,76.93,63.92,123.64,34.02,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,82.72,84.15,40.44,75.46,18.51,other molecular function,0,
Master Protein,High,P00390,GSR,"Glutathione reductase, mitochondrial OS=Homo sapiens OX=9606 GN=GSR PE=1 SV=2",5,18,0.45,0.437,0.098,1.46,-1.15,-1.2,-3.35,0.55,3.15E-01,4.97E-01,1.51E-03,6.01E-01,4.05E+06,3.77E+06,4.34E+05,4.06E+05,3,3,5,3,,4.05E+06,,1.58E+06,4.59E+06,,,3.77E+06,1.88E+05,1.01E+07,2.56E+06,4.34E+05,1.21E+05,1.24E+06,1.44E+05,,4.06E+05,,3.99E+05,1.09E+07,,1.54E+04,,1.58E+06,2.37E+05,,,3.48E+04,5.29E+03,1.08E+05,1.53E+04,1.94E+04,9.85E+02,1.67E+05,3.59E+03,,1.14E+05,,9.34E+03,1.16E+05,0,FALSE,29.603,18,5,522,56.2,8.5,5,other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion,"Pf00070, Pf02852",2936,C8KIL8; C8KIL9; C8KIM0; D3DSV3; hsa:2936; P00390; Q7Z5C9; Q9NP63,ENSG00000104687,,"Glutathione metabolism; Selenium micronutrient network; Trans-sulfuration, one-carbon metabolism and related pathways; Nuclear receptors meta-pathway; NRF2 pathway; Amino acid metabolism; One-carbon metabolism and related pathways; Oxidative stress response; Vitamin D-sensitive calcium signaling in depression; Sulfation biotransformation reaction; Metapathway biotransformation Phase I and II",11,0,47.1,107.21,114.76,155.39,n/a,Peak Found,n/a,High,High,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,134.95,86.54,128.07,61.68,60.54,other molecular function,0,
Master Protein,High,P61160,ACTR2,Actin-related protein 2 OS=Homo sapiens OX=9606 GN=ACTR2 PE=1 SV=1,3,14,0.45,0.392,0.711,0.267,-1.15,-1.35,-0.49,-1.9,3.15E-01,3.99E-01,5.71E-01,2.54E-01,3.88E+06,6.46E+06,5.48E+05,3.78E+06,4,5,4,5,5.94E+06,,2.73E+06,5.22E+05,5.51E+06,1.29E+07,2.67E+06,6.81E+06,6.46E+06,1.48E+06,,1.41E+05,3.08E+05,9.77E+05,1.42E+06,4.97E+06,4.30E+05,5.68E+06,1.28E+06,3.78E+06,2.36E+04,,2.66E+04,5.22E+05,2.84E+05,4.58E+04,4.76E+04,6.28E+04,1.82E+05,1.57E+04,,6.29E+03,2.50E+03,1.32E+05,3.54E+04,9.69E+03,1.21E+05,4.03E+04,3.00E+04,4.02E+04,0,FALSE,15.789,10,3,394,44.7,6.74,3,cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;other biological processes,non-structural extracellular;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf00022,10097,B2RCP5; D6W5F4; E9PF41; hsa:10097; O15142; P61160; Q96C82,ENSG00000138071,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Neutrophil degranulation; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,Physico-chemical features and toxicity-associated pathways; Embryonic stem cell pluripotency pathways,8,0,69.1,73.67,83.74,70.94,High,n/a,Peak Found,Peak Found,High,High,High,High,High,Peak Found,n/a,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,97.4,127.48,101.05,93.41,37.71,cytoskeletal activity;other molecular function,0,
Master Protein,High,P02787,TF,Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=4,37,180,0.45,0.464,1.603,0.115,-1.15,-1.11,0.68,-3.12,3.15E-01,5.55E-01,6.38E-01,6.59E-02,2.40E+06,2.89E+07,6.47E+06,3.44E+07,5,5,5,5,4.13E+05,8.24E+06,1.75E+05,2.40E+06,1.95E+07,2.12E+07,3.11E+06,4.66E+07,2.89E+07,5.26E+07,1.25E+07,2.27E+07,4.48E+06,6.47E+06,5.01E+06,3.21E+07,1.22E+08,3.97E+07,1.50E+07,3.44E+07,1.64E+03,3.13E+04,1.71E+03,2.40E+06,1.01E+06,7.54E+04,5.53E+04,4.30E+05,8.15E+05,5.60E+05,7.48E+04,1.01E+06,3.64E+04,8.72E+05,1.25E+05,6.25E+04,3.42E+07,2.81E+05,3.51E+05,3.66E+05,0,FALSE,211.142,60,35,698,77,7.12,37,cell organization and biogenesis;stress response;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00405,7018,hsa:7018; O43890; P02787; Q1HBA5; Q9NQB8; Q9UHV0,ENSG00000091513,Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Cargo recognition for clathrin-mediated endocytosis; Transferrin endocytosis and recycling,Iron metabolism in placenta; Pluripotent stem cell differentiation pathway; Ferroptosis; IL-18 signaling pathway; 3q29 copy number variation syndrome; Iron metabolism disorders; Sudden infant death syndrome (SIDS) susceptibility pathways,14,0,132.46,65.32,74.84,86.27,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,1,,FALSE,133.97,133.95,131.56,134.73,542.83,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q6IN85,PPP4R3A,Serine/threonine-protein phosphatase 4 regulatory subunit 3A OS=Homo sapiens OX=9606 GN=PPP4R3A PE=1 SV=1,2,2,0.449,0.723,0.01,100,-1.16,-0.47,-6.64,6.64,4.51E-01,9.86E-01,1.00E-17,1.00E-17,8.32E+04,2.57E+05,6.02E+04,,3,2,1,,2.47E+05,,8.32E+04,5.38E+04,,,8.95E+04,,7.38E+05,,,,,6.02E+04,,,,,,,9.83E+02,,8.13E+02,5.38E+04,,,1.59E+03,,2.08E+04,,,,,8.11E+03,,,,,,,0,FALSE,5.955,4,2,833,95.3,4.94,2,stress response,cytosol;cytoskeleton;nucleus;other cell component,Pf04802,55671,hsa:55671; Q69YK6; Q6IN85; Q86U23; Q86YI7; Q8IVG1; Q9H3F1; Q9H7U8; Q9NV01; Q9NWP1,ENSG00000100796,,16p11.2 proximal deletion syndrome,1,0,81.42,110.83,,,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,100.43,52.42,,,5.31,enzyme regulator activity,0,
Master Protein,High,A0A0A0MQR2,RTF2,Replication termination factor 2 OS=Homo sapiens OX=9606 GN=RTF2 PE=1 SV=1,3,3,0.449,0.195,,0.028,-1.16,-2.36,,-5.18,3.94E-01,2.14E-01,,7.59E-03,4.34E+04,5.04E+04,7.17E+03,2.59E+05,4,1,1,2,,5.88E+04,3.67E+04,5.13E+04,3.14E+04,,,,,5.04E+04,,,,7.17E+03,,3.20E+05,,2.10E+05,,,,2.23E+02,3.58E+02,5.13E+04,1.62E+03,,,,,5.35E+02,,,,9.66E+02,,6.25E+02,,1.49E+03,,,0,FALSE,9.272,12,3,336,37.5,8.44,3,cell cycle OR cell proliferation;DNA metabolism;other metabolic processes,nucleus,Pf04641,51507,A0A0A0MQR2,ENSG00000022277,,,0,0,28.43,,,29.42,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,91.28,4.9,,31.54,8.52,,0,
Master Protein,High,A0A994J5J1,RPN2,Ribophorin II OS=Homo sapiens OX=9606 GN=RPN2 PE=4 SV=1,10,128,0.448,1.39,0.303,1.557,-1.16,0.47,-1.72,0.64,3.13E-01,3.03E-01,9.79E-02,6.39E-01,1.09E+07,1.69E+07,2.06E+07,1.33E+07,5,5,5,5,1.78E+07,8.65E+07,1.09E+07,1.09E+07,9.42E+06,4.27E+07,4.88E+06,5.93E+07,1.69E+07,9.92E+06,5.79E+07,8.57E+06,1.81E+07,2.06E+07,2.21E+07,1.94E+07,7.27E+06,1.33E+07,1.67E+07,1.56E+06,7.06E+04,3.29E+05,1.07E+05,1.09E+07,4.86E+05,1.52E+05,8.68E+04,5.47E+05,4.77E+05,1.05E+05,3.46E+05,3.83E+05,1.47E+05,2.77E+06,5.49E+05,3.79E+04,2.04E+06,9.42E+04,3.91E+05,1.66E+04,0,FALSE,80.738,29,4,654,72.1,5.91,10,protein metabolism;other metabolic processes,other membranes;ER/Golgi,,,A0A994J5J1,ENSG00000118705,,N-glycan biosynthesis,1,7,123,87.14,74.2,62.11,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,n/a,n/a,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,127.17,102.51,115.98,118.85,414.3,,0,
Master Protein,High,P35610,SOAT1,Sterol O-acyltransferase 1 OS=Homo sapiens OX=9606 GN=SOAT1 PE=1 SV=3,1,4,0.447,3.212,0.45,3.335,-1.16,1.68,-1.15,1.74,4.47E-01,6.19E-02,4.33E-01,2.51E-01,7.14E+04,1.60E+05,2.54E+05,7.19E+04,4,2,4,4,7.92E+04,6.44E+04,,2.42E+05,5.39E+04,1.42E+05,,,,1.80E+05,,2.50E+05,1.05E+05,4.51E+05,2.59E+05,1.13E+05,4.57E+04,,1.27E+05,3.35E+04,3.15E+02,2.45E+02,,2.42E+05,2.78E+03,5.05E+02,,,,1.91E+03,,1.12E+04,8.55E+02,6.07E+04,6.44E+03,2.21E+02,1.28E+04,,2.98E+03,3.56E+02,0,FALSE,5.222,3,1,550,64.7,8.94,1,cell organization and biogenesis;other metabolic processes;transport;other biological processes,other membranes;ER/Golgi,Pf03062,6646,A6NC40; A8K3P4; A9Z1V7; B4DU95; hsa:6646; P35610; Q5T0X4; Q8N1E4,ENSG00000057252,LDL clearance,Statin inhibition of cholesterol production; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol metabolism,4,0,80.62,16.52,53.25,59.08,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,33.04,73.17,69.16,77.87,12.87,other molecular function,0,
Master Protein,High,P33993,MCM7,DNA replication licensing factor MCM7 OS=Homo sapiens OX=9606 GN=MCM7 PE=1 SV=4,10,28,0.446,0.531,0.639,1.32,-1.16,-0.91,-0.65,0.4,3.11E-01,6.96E-01,5.37E-01,6.71E-01,4.43E+06,6.15E+05,2.14E+06,6.01E+05,5,5,3,4,4.82E+07,4.43E+06,6.66E+06,1.28E+06,2.99E+06,2.41E+05,1.43E+06,2.80E+06,4.53E+05,6.15E+05,3.53E+06,,,2.14E+06,4.59E+05,,1.04E+05,7.10E+05,5.09E+05,1.79E+06,1.92E+05,1.68E+04,6.50E+04,1.28E+06,1.54E+05,8.56E+02,2.55E+04,2.58E+04,1.28E+04,6.54E+03,2.11E+04,,,2.89E+05,1.14E+04,,2.93E+04,5.03E+03,1.19E+04,1.90E+04,0,FALSE,36.982,22,10,719,81.3,6.46,10,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,"Pf00493, Pf14551, Pf17207, Pf17855",4176,A4D2A1; A4D2A2; E9PGN9; hsa:4176; P33993; Q15076; Q96D34; Q96GL1,ENSG00000166508,Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA,miRNA regulation of DNA damage response; Cell cycle; Retinoblastoma gene in cancer; Ciliary landscape; G1 to S cell cycle control; DNA replication,12,0,156.92,94.47,75.24,92.4,High,High,High,High,High,Peak Found,High,High,High,Peak Found,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,1,,FALSE,135.55,143.24,116.12,141.37,76.46,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A669KBJ7,ADNP,Activity dependent neuroprotector homeobox OS=Homo sapiens OX=9606 GN=ADNP PE=1 SV=1,11,18,0.445,0.64,1.047,0.267,-1.17,-0.64,0.07,-1.91,3.73E-01,9.73E-01,9.47E-01,3.53E-01,2.35E+06,4.64E+05,5.72E+05,9.58E+05,5,4,5,4,1.30E+07,2.14E+06,7.33E+06,2.35E+06,1.61E+06,1.21E+06,3.17E+05,,2.36E+05,6.78E+05,8.98E+06,3.26E+05,5.72E+05,2.04E+06,3.44E+05,1.49E+06,,9.12E+04,6.16E+05,1.79E+06,5.17E+04,8.14E+03,7.16E+04,2.35E+06,8.28E+04,4.30E+03,5.64E+03,,6.66E+03,7.21E+03,5.37E+04,1.46E+04,4.65E+03,2.75E+05,8.54E+03,2.90E+03,,6.46E+02,1.44E+04,1.91E+04,0,FALSE,40.37,14,11,1174,131.4,7.17,11,,nucleus,"Pf00046, Pf19627",,A0A669KBJ7,ENSG00000101126,,,0,0,92.65,72.58,151.57,78.55,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,91.89,112.18,74.51,78.6,46.59,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9H165,BCL11A,B-cell lymphoma/leukemia 11A OS=Homo sapiens OX=9606 GN=BCL11A PE=1 SV=2,8,9,0.444,0.193,1.343,0.112,-1.17,-2.37,0.43,-3.16,4.94E-01,8.75E-02,8.56E-01,6.72E-02,6.98E+05,5.95E+05,9.90E+04,7.31E+05,4,5,3,5,,3.58E+05,8.50E+04,1.85E+06,1.36E+06,4.35E+05,2.59E+06,1.27E+06,2.14E+05,5.95E+05,,9.90E+04,7.41E+04,1.38E+06,,7.31E+05,1.75E+05,7.77E+06,1.95E+05,3.63E+06,,1.36E+03,8.31E+02,1.85E+06,7.03E+04,1.55E+03,4.60E+04,1.17E+04,6.04E+03,6.33E+03,,4.42E+03,6.02E+02,1.86E+05,,1.43E+03,4.93E+04,5.50E+04,4.57E+03,3.86E+04,0,FALSE,36.162,21,8,835,91.1,6.61,8,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf00096,53335,D6W5D7; hsa:53335; Q66LN6; Q86W14; Q8WU92; Q96JL6; Q9H163; Q9H164; Q9H165; Q9H3G9; Q9NWA7,ENSG00000119866,ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants,Prion disease pathway,3,0,90.93,94.13,144.31,130.95,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,131.35,77.21,145.46,115.2,28.57,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O96006,ZBED1,E3 SUMO-protein ligase ZBED1 OS=Homo sapiens OX=9606 GN=ZBED1 PE=1 SV=1,2,2,0.443,0.631,0.01,100,-1.17,-0.66,-6.64,6.64,4.00E-01,9.48E-01,1.00E-17,1.00E-17,4.88E+04,6.83E+04,2.98E+04,,3,4,1,,,,2.26E+04,8.61E+04,4.88E+04,3.24E+05,3.14E+04,1.38E+05,3.37E+04,,,,,2.98E+04,,,,,,,,,2.21E+02,8.61E+04,2.52E+03,1.15E+03,5.59E+02,1.28E+03,9.50E+02,,,,,4.01E+03,,,,,,,0,FALSE,4.884,4,2,694,78.1,6.1,2,protein metabolism;other metabolic processes;other biological processes,other membranes;cytoskeleton;nucleus;other cell component,"Pf02892, Pf05699",9189,hsa:9189; O96006; Q96BY4,ENSG00000214717; ENSG00000292345,SUMOylation of chromatin organization proteins,,1,0,60.77,104.21,,,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,95.43,5.08,,,2.45,nucleic acid binding activity;other molecular function,0,
Master Protein,High,O95071,UBR5,E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2,2,2,0.443,0.242,0.01,100,-1.17,-2.05,-6.64,6.64,4.97E-01,1.87E-01,1.00E-17,1.00E-17,6.05E+05,1.91E+05,3.69E+04,,4,3,2,,2.08E+06,,2.11E+06,1.76E+05,8.73E+04,,3.00E+05,1.91E+05,1.23E+05,,,2.21E+04,,,6.16E+04,,,,,,8.26E+03,,2.06E+04,1.76E+05,4.50E+03,,5.34E+03,1.77E+03,3.47E+03,,,9.86E+02,,,1.53E+03,,,,,,0,FALSE,4.743,1,2,2799,309.2,5.85,2,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus;other cell component,"Pf00632, Pf00658, Pf11547",51366,B2RP24; hsa:51366; J3KMW7; O94970; O95071; Q9NPL3,ENSG00000104517,,Mesodermal commitment pathway,1,0,101.87,43.5,66.74,,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,52.75,54.53,,,4.74,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P56385,ATP5ME,"ATP synthase subunit e, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5ME PE=1 SV=2",1,38,0.442,0.916,1.091,0.442,-1.18,-0.13,0.13,-1.18,3.06E-01,6.79E-01,9.84E-01,5.17E-01,5.01E+06,1.23E+07,4.87E+06,1.09E+07,5,5,5,5,9.51E+05,2.49E+07,1.61E+06,5.01E+06,1.19E+07,1.23E+07,3.65E+06,1.31E+07,5.46E+06,1.67E+07,8.71E+05,4.87E+06,7.50E+06,5.41E+06,4.83E+06,3.22E+07,2.04E+06,1.43E+07,6.03E+06,1.09E+07,3.78E+03,9.44E+04,1.58E+04,5.01E+06,6.16E+05,4.36E+04,6.49E+04,1.21E+05,1.54E+05,1.77E+05,5.21E+03,2.18E+05,6.09E+04,7.29E+05,1.20E+05,6.28E+04,5.74E+05,1.01E+05,1.41E+05,1.16E+05,0.001,FALSE,4.22,14,1,69,7.9,9.35,1,other metabolic processes;transport,other membranes;mitochondrion,Pf05680,521,hsa:521; P56385; Q0D2L9,ENSG00000169020,Cristae formation; Formation of ATP by chemiosmotic coupling,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,4,0,112.03,53.54,51.1,89,Peak Found,High,High,High,High,High,High,Peak Found,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,113.8,121.74,99.12,95.55,90.52,transporter activity,0,
Master Protein,High,C9J9C1,PPP2R1A,Protein phosphatase 2 scaffold subunit Aalpha OS=Homo sapiens OX=9606 GN=PPP2R1A PE=1 SV=3,6,16,0.441,0.537,1,1.015,-1.18,-0.9,0,0.02,4.92E-01,7.68E-01,9.99E-01,8.39E-01,5.71E+05,5.76E+05,1.93E+06,1.20E+06,5,5,5,4,4.88E+04,5.71E+05,3.50E+04,2.93E+06,8.07E+05,1.60E+05,5.76E+05,6.09E+05,1.01E+05,1.78E+06,1.66E+06,1.93E+06,1.89E+06,3.54E+06,2.70E+06,9.32E+04,1.51E+06,,1.15E+06,1.26E+06,1.94E+02,2.17E+03,3.42E+02,2.93E+06,4.16E+04,5.68E+02,1.02E+04,5.62E+03,2.85E+03,1.89E+04,9.95E+03,8.64E+04,1.53E+04,4.76E+05,6.71E+04,1.82E+02,4.23E+05,,2.70E+04,1.34E+04,0,FALSE,23.236,15,6,629,69.3,5.45,6,,,Pf02985,,C9J9C1,ENSG00000105568,,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; 16p11.2 proximal deletion syndrome; Cohesin complex - Cornelia de Lange syndrome,4,0,136.07,104.55,32.93,62.26,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,n/a,High,Peak Found,1,,FALSE,115.06,83.56,136.21,112.91,53.41,,0,
Master Protein,High,P51553,IDH3G,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial OS=Homo sapiens OX=9606 GN=IDH3G PE=1 SV=1",3,5,0.439,0.918,0.01,100,-1.19,-0.12,-6.64,6.64,3.78E-01,5.96E-01,1.00E-17,1.00E-17,1.26E+06,1.29E+06,1.38E+06,,2,2,3,,,,,7.82E+05,2.02E+06,1.59E+06,,,,1.05E+06,,,4.38E+05,2.29E+06,1.38E+06,,,,,,,,,7.82E+05,1.04E+05,5.64E+03,,,,1.11E+04,,,3.55E+03,3.08E+05,3.44E+04,,,,,,0,FALSE,12.202,14,3,393,42.8,8.5,3,other metabolic processes,mitochondrion;nucleus,Pf00180,3421,E9PDD5; hsa:3421; P51553; Q9BUU5,ENSG00000067829,Citric acid cycle (TCA cycle); Mitochondrial protein import,TCA cycle (aka Krebs or citric acid cycle),3,0,62.46,28.92,67.51,,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,97.15,103.1,,,15.79,other molecular function,0,
Master Protein,High,P49720,PSMB3,Proteasome subunit beta type-3 OS=Homo sapiens OX=9606 GN=PSMB3 PE=1 SV=2,3,8,0.439,2.429,0.903,1.681,-1.19,1.28,-0.15,0.75,4.92E-01,4.71E-02,8.31E-01,5.71E-01,4.61E+05,5.77E+05,3.55E+06,1.05E+06,5,4,5,4,4.15E+06,1.29E+06,2.79E+05,4.61E+05,1.22E+05,2.10E+05,3.12E+05,1.07E+06,,5.31E+06,3.78E+06,9.06E+05,3.55E+06,5.95E+05,5.68E+06,2.05E+06,1.72E+06,5.77E+05,6.37E+05,,1.65E+04,4.89E+03,2.72E+03,4.61E+05,6.30E+03,7.47E+02,5.55E+03,9.86E+03,,5.64E+04,2.26E+04,4.05E+04,2.89E+04,8.02E+04,1.41E+05,3.99E+03,4.82E+05,4.09E+03,1.49E+04,,0,FALSE,16.095,25,3,205,22.9,6.55,3,protein metabolism;other metabolic processes,cytosol;nucleus;other cell component,Pf00227,5691,hsa:5691; P31147; P49720; Q0P6J7; Q96E27,ENSG00000275903; ENSG00000277791,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,62,0,133.08,140.28,73.53,60.19,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,128.89,139.23,216.48,137.31,22.39,,0,
Master Protein,Medium,Q8WWA1,TMEM40,Transmembrane protein 40 OS=Homo sapiens OX=9606 GN=TMEM40 PE=1 SV=2,1,1,0.439,0.01,2.019,0.01,-1.19,-6.64,1.01,-6.64,4.99E-01,1.00E-17,5.31E-01,1.00E-17,2.23E+05,5.09E+05,,1.03E+06,2,2,,1,,5.61E+05,,8.87E+04,,6.88E+05,,,3.76E+05,,,,,,,1.03E+06,,,,,,2.13E+03,,8.87E+04,,2.44E+03,,,1.06E+04,,,,,,,2.00E+03,,,,,0.029,FALSE,1.845,6,1,233,25.5,5.59,1,,other membranes,Pf15817,55287,C9JID5; hsa:55287; Q8NAL4; Q8WWA1; Q9NUZ4,ENSG00000088726,,,0,0,102.81,41.42,,,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,116.09,,45.41,,2.16,,0,
Master Protein,High,P53618,COPB1,Coatomer subunit beta OS=Homo sapiens OX=9606 GN=COPB1 PE=1 SV=3,6,11,0.437,0.456,0.436,0.361,-1.19,-1.13,-1.2,-1.47,4.60E-01,6.32E-01,3.17E-01,5.07E-01,3.36E+05,1.42E+05,1.28E+05,1.45E+06,2,1,4,3,1.71E+05,,,6.61E+05,,1.42E+05,,,,,1.45E+05,1.14E+05,,2.79E+05,5.99E+04,,1.53E+06,,1.45E+06,4.35E+04,6.78E+02,,,6.61E+05,,5.04E+02,,,,,8.65E+02,5.10E+03,,3.76E+04,1.49E+03,,4.29E+05,,3.39E+04,4.63E+02,0,FALSE,24.303,10,6,953,107.1,6.05,6,transport,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,"Pf01602, Pf07718, Pf14806",1315,D3DQX0; hsa:1315; P53618; Q6GTT7; Q9NTK2; Q9UNW7,ENSG00000129083,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Neutrophil degranulation,,3,0,83.38,,62.41,82.95,Peak Found,n/a,High,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,0,68.57,53.25,83.11,35.53,other molecular function,0,
Master Protein,High,O96000,NDUFB10,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 OS=Homo sapiens OX=9606 GN=NDUFB10 PE=1 SV=3,6,29,0.437,0.708,1.322,0.589,-1.19,-0.5,0.4,-0.76,2.99E-01,9.73E-01,8.22E-01,6.94E-01,5.80E+06,2.13E+06,2.46E+06,5.81E+06,5,5,5,5,3.12E+06,7.12E+06,4.05E+05,5.80E+06,1.25E+07,2.00E+06,1.70E+06,4.29E+06,2.13E+06,7.67E+06,1.20E+06,4.10E+06,2.46E+06,2.16E+06,2.62E+06,3.49E+06,1.46E+06,6.63E+06,5.81E+06,8.07E+06,1.24E+04,2.71E+04,3.96E+03,5.80E+06,6.46E+05,7.11E+03,3.02E+04,3.96E+04,6.01E+04,8.16E+04,7.17E+03,1.83E+05,2.00E+04,2.91E+05,6.51E+04,6.80E+03,4.09E+05,4.69E+04,1.36E+05,8.59E+04,0,FALSE,19.788,43,6,172,20.8,8.48,6,cell organization and biogenesis;other metabolic processes;transport,other membranes;mitochondrion,Pf10249,4716,hsa:4716; O96000; Q96II6,ENSG00000140990; ENSG00000291930,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Modulators of TCR signaling and T cell activation; Oxidative phosphorylation,6,0,78.77,70.73,41.71,51.56,High,High,Peak Found,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.36,126.72,106.98,127.37,64.51,transporter activity,0,
Master Protein,High,Q9BTD8,RBM42,RNA-binding protein 42 OS=Homo sapiens OX=9606 GN=RBM42 PE=1 SV=1,1,1,0.437,1.282,0.446,0.735,-1.2,0.36,-1.16,-0.44,3.87E-01,5.21E-01,4.31E-01,9.65E-01,4.01E+04,9.19E+04,5.14E+04,6.99E+04,2,2,3,4,,,3.85E+04,4.18E+04,,1.78E+05,,4.76E+04,,,5.14E+04,,,3.24E+04,5.70E+04,8.53E+04,,7.36E+04,1.93E+04,6.63E+04,,,3.76E+02,4.18E+04,,6.31E+02,,4.39E+02,,,3.08E+02,,,4.37E+03,1.42E+03,1.66E+02,,5.22E+02,4.51E+02,7.06E+02,0,FALSE,4.693,4,1,480,50.4,9.63,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf00076,79171,hsa:79171; O00320; Q8N5R7; Q9BTD8; Q9BU66,ENSG00000126254,mRNA Splicing - Major Pathway,,1,0,5.93,81.65,27.43,47.39,n/a,n/a,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,100.52,16.28,64.82,53.58,3.87,nucleic acid binding activity,0,
Master Protein,High,Q6P2E9,EDC4,Enhancer of mRNA-decapping protein 4 OS=Homo sapiens OX=9606 GN=EDC4 PE=1 SV=1,5,7,0.436,0.564,0.33,0.138,-1.2,-0.83,-1.6,-2.85,4.02E-01,8.04E-01,1.71E-01,1.07E-01,2.21E+05,1.78E+06,3.75E+05,6.52E+05,4,3,4,4,3.58E+05,,1.37E+05,1.55E+06,1.47E+04,,1.78E+06,1.50E+06,,3.08E+06,5.81E+06,3.00E+04,,1.19E+06,1.18E+05,,3.46E+04,1.86E+06,5.29E+05,8.04E+05,1.42E+03,,1.34E+03,1.55E+06,7.57E+02,,3.17E+04,1.39E+04,,3.28E+04,3.47E+04,1.34E+03,,1.60E+05,2.94E+03,,9.73E+03,1.32E+04,1.24E+04,8.55E+03,0,FALSE,24.07,6,5,1401,151.6,5.86,5,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,"Pf16529, Pf21289",23644,A6NGM1; A8K4T4; hsa:23644; Q13025; Q13826; Q6P2E9; Q6ZR12; Q7Z6H7,ENSG00000038358,mRNA decay by 5' to 3' exoribonuclease,,1,0,136.81,39.76,153.05,95.68,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,99.07,124.11,67.27,131.85,20.94,,0,
Master Protein,High,P13473,LAMP2,Lysosome-associated membrane glycoprotein 2 OS=Homo sapiens OX=9606 GN=LAMP2 PE=1 SV=2,3,44,0.436,0.693,0.365,1.263,-1.2,-0.53,-1.45,0.34,2.99E-01,9.98E-01,1.57E-01,7.77E-01,4.34E+06,1.66E+07,3.99E+06,3.50E+06,5,5,5,5,4.21E+06,3.28E+07,9.26E+05,4.34E+06,6.57E+06,1.66E+07,2.14E+06,2.80E+07,1.76E+06,3.95E+07,2.81E+06,2.83E+06,4.19E+06,9.84E+06,3.99E+06,1.18E+07,2.09E+06,2.24E+06,3.50E+06,5.20E+06,1.67E+04,1.24E+05,9.05E+03,4.34E+06,3.39E+05,5.91E+04,3.80E+04,2.59E+05,4.96E+04,4.20E+05,1.68E+04,1.26E+05,3.40E+04,1.33E+06,9.91E+04,2.30E+04,5.88E+05,1.59E+04,8.18E+04,5.54E+04,0,FALSE,7.985,6,3,410,44.9,5.63,3,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf01299, Pf21222",3920,A8K4X5; D3DTF0; hsa:3920; P13473; Q16641; Q6Q3G8; Q96J30; Q99534; Q9UD93,ENSG00000005893,Platelet degranulation ; Neutrophil degranulation; Chaperone Mediated Autophagy,"Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; Clock-controlled autophagy in bone metabolism",5,0,133.32,93.26,61.87,80.82,Peak Found,High,Peak Found,High,High,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,128.09,128.11,146.57,137.35,67.15,other molecular function,0,
Master Protein,High,P34932,HSPA4,Heat shock 70 kDa protein 4 OS=Homo sapiens OX=9606 GN=HSPA4 PE=1 SV=4,9,22,0.434,0.613,0.634,0.513,-1.2,-0.7,-0.66,-0.96,3.69E-01,9.40E-01,5.23E-01,6.85E-01,1.77E+06,3.89E+05,3.05E+05,1.33E+05,2,4,3,4,,,,7.53E+05,4.16E+06,1.29E+06,4.72E+05,,3.14E+05,3.20E+05,,3.05E+05,,1.17E+06,1.73E+05,,1.50E+06,6.97E+04,2.24E+05,7.85E+04,,,,7.53E+05,2.14E+05,4.60E+03,8.40E+03,,8.85E+03,3.40E+03,,1.36E+04,,1.57E+05,4.30E+03,,4.20E+05,4.94E+02,5.25E+03,8.36E+02,0,FALSE,34.044,16,9,840,94.3,5.19,9,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport,non-structural extracellular;cytosol;mitochondrion;nucleus,Pf00012,3308,hsa:3308; O95756; P34932; Q2TAL4; Q9BUK9,ENSG00000170606,Regulation of HSF1-mediated heat shock response,Parkin-ubiquitin proteasomal system pathway; HDAC6 interactions in the central nervous system,3,0,98.05,77.98,98.42,147.61,n/a,n/a,n/a,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,149.16,99.58,71.12,116.7,70.6,other molecular function,0,
Master Protein,Medium,Q9BYW2,SETD2,Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens OX=9606 GN=SETD2 PE=1 SV=3,1,1,0.433,0.098,0.01,100,-1.21,-3.35,-6.64,6.64,3.89E-01,5.52E-02,1.00E-17,1.00E-17,3.92E+04,9.05E+04,3.85E+03,,2,2,1,,,,,1.47E+04,1.05E+05,,1.39E+05,,,5.90E+04,,,,3.85E+03,,,,,,,,,,1.47E+04,5.39E+03,,2.47E+03,,,6.28E+02,,,,5.19E+02,,,,,,,0.024,FALSE,1.906,0,1,2564,287.4,6.14,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf00397, Pf00856, Pf08236, Pf17907",29072,hsa:29072; O75397; O75405; Q17RW8; Q5BKS9; Q5QGN2; Q69YI5; Q6IN64; Q6ZN53; Q6ZS25; Q8N3R0; Q8TCN0; Q9BYW2; Q9C0D1; Q9H696; Q9NZW9,ENSG00000181555,PKMTs methylate histone lysines,Histone modifications; Mesodermal commitment pathway; Mesodermal commitment pathway; Pathways affected in adenoid cystic carcinoma; Clear cell renal cell carcinoma pathways; Type 2 papillary renal cell carcinoma; Pleural mesothelioma,8,0,106.6,56.98,,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,110.95,170.08,,,1.86,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A6Q8PGB0,POLR2A,DNA-directed RNA polymerase subunit OS=Homo sapiens OX=9606 GN=POLR2A PE=1 SV=2,10,10,0.431,0.702,,1.714,-1.21,-0.51,,0.78,4.89E-01,9.55E-01,,5.36E-01,2.26E+05,4.56E+05,2.24E+05,5.96E+04,4,1,5,4,1.06E+05,3.39E+05,,7.51E+05,1.50E+05,4.56E+05,,,,,3.36E+05,2.24E+05,7.13E+04,5.19E+05,5.91E+04,1.56E+05,6.75E+03,,3.50E+04,1.01E+05,4.22E+02,1.29E+03,,7.51E+05,7.75E+03,1.62E+03,,,,,2.01E+03,1.00E+04,5.79E+02,7.00E+04,1.47E+03,3.05E+02,1.90E+03,,8.20E+02,1.08E+03,0,FALSE,54.183,9,10,1970,217.1,7.37,10,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00623, Pf04983, Pf04990, Pf04992, Pf04997, Pf04998, Pf05000, Pf05001",,A0A6Q8PGB0,ENSG00000181222,,22q11.2 copy number variation syndrome,1,0,87.37,,79.7,89.82,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,Acetyl [N-Term],FALSE,85.06,125.05,,103.36,37.15,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q15008,PSMD6,26S proteasome non-ATPase regulatory subunit 6 OS=Homo sapiens OX=9606 GN=PSMD6 PE=1 SV=1,1,1,0.431,0.01,1.037,0.01,-1.21,-6.64,0.05,-6.64,3.86E-01,1.00E-17,9.64E-01,1.00E-17,3.04E+04,7.04E+04,,6.56E+04,1,2,,3,,,,,3.04E+04,,,1.92E+05,,2.58E+04,,,,,,,1.03E+05,5.17E+04,,6.56E+04,,,,,1.57E+03,,,1.77E+03,,2.74E+02,,,,,,,2.90E+04,3.66E+02,,6.99E+02,0.03,FALSE,1.831,2,1,389,45.5,5.62,1,protein metabolism;other metabolic processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf01399, Pf10602, Pf21154",9861,A8K2E0; E9PHI9; hsa:9861; Q15008; Q6UV22,ENSG00000163636,Neutrophil degranulation; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,64,0,,108,,36.19,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,175.39,,124.19,,2.47,,0,
Master Protein,High,Q15003,NCAPH,Condensin complex subunit 2 OS=Homo sapiens OX=9606 GN=NCAPH PE=1 SV=3,1,1,0.431,0.154,0.028,2.414,-1.22,-2.69,-5.18,1.27,4.12E-01,1.41E-01,1.34E-03,4.03E-01,5.07E+04,1.18E+05,7.83E+03,3.24E+03,2,1,2,1,7.62E+04,,,3.37E+04,,1.18E+05,,,,,,9.81E+03,,6.25E+03,,,3.24E+03,,,,3.03E+02,,,3.37E+04,,4.18E+02,,,,,,4.38E+02,,8.42E+02,,,9.11E+02,,,,0,FALSE,5.335,3,1,741,82.5,5.06,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,Pf05786,23397,B4E189; hsa:23397; Q15003; Q8TB87,ENSG00000121152,Condensation of Prometaphase Chromosomes,2q11.2 copy number variation syndrome,2,0,54.71,,31.37,,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,62.2,49.64,0,33.73,3.21,other molecular function,0,
Master Protein,High,P25815,S100P,Protein S100-P OS=Homo sapiens OX=9606 GN=S100P PE=1 SV=2,1,18,0.43,0.546,6.055,0.026,-1.22,-0.87,2.6,-5.27,2.91E-01,7.86E-01,3.03E-02,1.54E-03,1.65E+06,3.43E+06,8.66E+05,2.07E+07,5,5,5,5,1.65E+06,1.89E+06,9.81E+05,3.24E+04,1.94E+07,3.43E+06,3.36E+06,1.08E+07,1.83E+06,4.39E+06,5.36E+05,5.85E+04,1.99E+06,1.50E+06,8.66E+05,2.07E+07,1.46E+05,3.88E+08,1.06E+07,1.58E+08,6.56E+03,7.18E+03,9.59E+03,3.24E+04,9.99E+05,1.22E+04,5.97E+04,9.97E+04,5.16E+04,4.67E+04,3.21E+03,2.61E+03,1.62E+04,2.02E+05,2.15E+04,4.05E+04,4.09E+04,2.75E+06,2.47E+05,1.69E+06,0.001,FALSE,3.525,11,1,95,10.4,4.88,1,other biological processes,non-structural extracellular;plasma membrane;other membranes;nucleus;other cell component,Pf01023,6286,hsa:6286; P25815; Q5J7W2,ENSG00000163993,Neutrophil degranulation,Gastric cancer network 1; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway,4,0,171.04,73.52,77.45,143.14,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,High,1,,FALSE,133.8,137.01,147.22,147.98,37.84,other molecular function,0,
Master Protein,High,P19784,CSNK2A2,Casein kinase II subunit alpha' OS=Homo sapiens OX=9606 GN=CSNK2A2 PE=1 SV=1,2,5,0.43,0.777,0.188,1.793,-1.22,-0.36,-2.41,0.84,2.81E-01,8.31E-01,4.98E-02,4.62E-01,3.89E+06,5.37E+05,2.46E+05,2.42E+05,4,3,5,1,2.27E+07,,4.35E+07,6.67E+05,6.13E+04,5.37E+05,2.03E+05,1.29E+06,,,3.02E+06,2.46E+05,1.79E+05,6.13E+05,8.87E+04,,2.42E+05,,,,9.01E+04,,4.25E+05,6.67E+05,3.16E+03,1.91E+03,3.61E+03,1.19E+04,,,1.81E+04,1.10E+04,1.45E+03,8.26E+04,2.20E+03,,6.81E+04,,,,0,FALSE,6.282,8,2,350,41.2,8.56,2,cell-cell signaling;cell cycle OR cell proliferation;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf00069,1459,hsa:1459; P19784,ENSG00000070770,Regulation of PTEN stability and activity; KEAP1-NFE2L2 pathway; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of TP53 Activity through Phosphorylation; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; WNT mediated activation of DVL; Signal transduction by L1; Maturation of hRSV A proteins; Receptor Mediated Mitophagy; Condensation of Prometaphase Chromosomes; Synthesis of PC,Alzheimer's disease and miRNA effects; Allograft rejection; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Measles virus infection; Pleural mesothelioma; Alzheimer's disease; HDAC6 interactions in the central nervous system,21,0,123.86,82.13,149.67,,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,144.65,108.75,0,81.93,12.79,kinase activity;other molecular function,0,
Master Protein,High,Q9BPX3,NCAPG,Condensin complex subunit 3 OS=Homo sapiens OX=9606 GN=NCAPG PE=1 SV=1,1,4,0.427,1.453,9.008,0.06,-1.23,0.54,3.17,-4.06,4.23E-01,4.43E-01,2.76E-02,2.97E-02,5.87E+04,1.38E+05,7.43E+04,1.24E+06,3,1,4,1,,2.14E+05,,2.48E+04,5.87E+04,,,,,1.38E+05,5.83E+04,,4.10E+04,2.81E+05,9.46E+04,,1.24E+06,,,,,8.15E+02,,2.48E+04,3.03E+03,,,,,1.46E+03,3.49E+02,,3.33E+02,3.79E+04,2.35E+03,,3.48E+05,,,,0,FALSE,4.531,1,1,1015,114.3,5.59,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,Pf12719,64151,hsa:64151; Q3MJE0; Q96SV9; Q9BPX3; Q9BUR3; Q9BVY1; Q9H914; Q9H9Z6; Q9HBI9,ENSG00000109805,Condensation of Prometaphase Chromosomes,,1,0,101.8,,93.02,,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,107.64,97.47,0,74.83,11.26,,0,
Master Protein,High,P17980,PSMC3,26S proteasome regulatory subunit 6A OS=Homo sapiens OX=9606 GN=PSMC3 PE=1 SV=3,5,9,0.426,0.663,0.919,0.828,-1.23,-0.59,-0.12,-0.27,4.83E-01,9.41E-01,7.82E-01,9.83E-01,1.64E+05,6.75E+05,1.11E+05,4.56E+05,5,4,5,2,1.64E+05,4.95E+05,1.28E+05,6.79E+05,1.01E+05,1.34E+06,3.40E+05,1.60E+06,1.61E+05,,1.11E+05,2.03E+05,4.98E+04,2.52E+05,8.13E+04,,7.85E+05,,2.65E+05,,6.52E+02,1.88E+03,1.25E+03,6.79E+05,5.20E+03,4.76E+03,6.05E+03,1.47E+04,4.54E+03,,6.63E+02,9.05E+03,4.05E+02,3.40E+04,2.02E+03,,2.21E+05,,6.21E+03,,0,FALSE,20.702,19,5,439,49.2,5.24,5,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf00004, Pf16450, Pf17862",5702,B2R8V1; hsa:5702; P17980; Q3B757; Q3B865; Q53HU5; Q6GPG8; Q6IBS1; Q96HD3,ENSG00000165916,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,64,0,82.69,83.12,61.04,69.98,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,102.17,93.35,144.36,145.23,25.16,other molecular function,0,
Master Protein,High,P16284,PECAM1,Platelet endothelial cell adhesion molecule OS=Homo sapiens OX=9606 GN=PECAM1 PE=1 SV=2,2,11,0.425,0.772,0.719,0.682,-1.23,-0.37,-0.48,-0.55,3.28E-01,7.94E-01,5.80E-01,9.10E-01,1.08E+06,2.54E+06,3.70E+05,1.30E+06,3,3,3,4,,1.08E+06,,2.42E+05,1.93E+06,,2.54E+06,1.82E+07,3.66E+05,,8.85E+05,,,3.70E+05,3.17E+05,1.57E+07,3.46E+05,1.52E+06,1.10E+06,,,4.10E+03,,2.42E+05,9.97E+04,,4.51E+04,1.68E+05,1.03E+04,,5.29E+03,,,4.99E+04,7.89E+03,3.05E+04,9.72E+04,1.08E+04,2.58E+04,,0,FALSE,8.363,5,2,738,82.5,6.99,2,cell adhesion;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf13895, Pf13927, Pf17736",5175,A0A075B738; A8K3S7; D3DU31; hsa:5175; P16284; Q6LDA9; Q8TBH1; Q96RF5; Q96RF6; Q9NP65; Q9NPB7; Q9NPG9; Q9NQS9; Q9NQT0; Q9NQT1; Q9NQT2,ENSG00000261371,Integrin cell surface interactions; Neutrophil degranulation; Platelet degranulation ; Platelet sensitization by LDL; PECAM1 interactions,Markers of kidney cell lineage; TROP2 regulatory signaling; Cell lineage map for neuronal differentiation,9,0,77.93,138.31,59.81,157.81,n/a,Peak Found,n/a,High,Peak Found,n/a,High,High,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,High,High,Peak Found,Peak Found,n/a,1,,FALSE,128.12,95.12,126.82,67.29,29.87,other molecular function,0,
Master Protein,High,Q16854,DGUOK,"Deoxyguanosine kinase, mitochondrial OS=Homo sapiens OX=9606 GN=DGUOK PE=1 SV=2",2,2,0.422,2.641,2.203,0.515,-1.25,1.4,1.14,-0.96,4.15E-01,1.15E-01,5.48E-01,6.51E-01,7.80E+04,1.85E+05,2.10E+05,4.07E+05,2,1,3,1,,,,5.86E+04,1.04E+05,,,,,1.85E+05,,6.92E+04,,3.58E+05,2.10E+05,,,,,4.07E+05,,,,5.86E+04,5.35E+03,,,,,1.97E+03,,3.09E+03,,4.82E+04,5.21E+03,,,,,4.33E+03,0,FALSE,7.281,12,2,277,32,8.66,2,other metabolic processes;other biological processes,cytosol;mitochondrion;other cell component,Pf01712,1716,hsa:1716; P78532; Q16759; Q16854; Q4ZG09; Q7L1W9; Q96BC1,ENSG00000114956,Purine salvage,Genetic causes of porto-sinusoidal vascular disease,2,0,39.28,,68.02,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,42.86,67.25,0,61.4,7.5,kinase activity;other molecular function,0,
Master Protein,High,Q13315,ATM,Serine-protein kinase ATM OS=Homo sapiens OX=9606 GN=ATM PE=1 SV=4,8,13,0.421,0.524,0.184,2.453,-1.25,-0.93,-2.45,1.29,4.07E-01,7.56E-01,5.70E-02,2.74E-01,1.11E+06,6.96E+05,4.05E+05,1.71E+05,5,5,5,5,2.16E+06,2.69E+05,3.16E+06,4.85E+05,1.11E+06,6.96E+05,2.81E+05,1.62E+05,1.90E+06,1.70E+06,6.46E+05,2.17E+05,2.47E+05,8.18E+05,4.05E+05,1.71E+05,1.64E+05,4.04E+05,2.56E+05,1.34E+05,8.59E+03,1.02E+03,3.08E+04,4.85E+05,5.74E+04,2.47E+03,5.00E+03,1.50E+03,5.36E+04,1.81E+04,3.86E+03,9.70E+03,2.01E+03,1.10E+05,1.01E+04,3.34E+02,4.61E+04,2.86E+03,5.99E+03,1.43E+03,0,FALSE,33.421,4,8,3056,350.5,6.81,8,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,"Pf00454, Pf02259, Pf02260, Pf11640",472,B2RNX5; hsa:472; O15429; Q12758; Q13315; Q16551; Q93007; Q9NP02; Q9UCX7,ENSG00000149311,Meiotic recombination; DNA Damage/Telomere Stress Induced Senescence; TP53 Regulates Transcription of DNA Repair Genes; Resolution of D-loop Structures through Holliday Junction Intermediates; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of HSF1-mediated heat shock response; Regulation of TP53 Degradation; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Regulation of TP53 Activity through Phosphorylation; TP53 Regulates Transcription of Caspase Activators and Caspases; Regulation of TP53 Activity through Methylation; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA); Defective homologous recombination repair (HRR) due to BRCA1 loss of function; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function; Impaired BRCA2 binding to PALB2; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Nonhomologous End-Joining (NHEJ); Sensing of DNA Double Strand Breaks; Pexophagy,"miRNA regulation of DNA damage response; miRNAs involved in DNA damage response; TP53 network; Cell cycle; Homologous recombination; Glioblastoma signaling pathways; ATM signaling pathway; DDX1 as a regulatory component of the Drosha microprocessor; Ovarian infertility; Pathways affected in adenoid cystic carcinoma; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; ATM signaling in development and disease ; DNA IR-double strand breaks and cellular response via ATM; miRNA regulation of p53 pathway in prostate cancer; DNA IR-damage and cellular response via ATR; Breast cancer pathway; G1 to S cell cycle control; Joubert syndrome; Male infertility; DNA repair pathways, full network; Pleural mesothelioma; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; NIPBL role in DNA damage - Cornelia de Lange syndrome; Primary ovarian insufficiency; DNA damage response; DNA damage response (only ATM dependent)",54,0,84.17,85.05,55.69,48.37,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,109.38,109.21,91.85,84.79,36.82,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,E5RI56,,S-phase kinase-associated protein 1 OS=Homo sapiens OX=9606 PE=3 SV=2,4,29,0.42,0.405,1.366,0.212,-1.25,-1.3,0.45,-2.24,3.43E-01,4.58E-01,7.65E-01,2.31E-01,1.85E+06,1.36E+06,2.83E+05,1.98E+06,5,5,5,5,7.11E+05,3.23E+06,3.87E+05,1.85E+06,3.94E+06,2.27E+06,1.22E+06,1.36E+06,4.15E+05,1.46E+06,1.05E+06,1.35E+05,2.83E+05,2.55E+06,2.60E+05,1.98E+06,1.89E+06,9.36E+06,5.01E+05,6.66E+06,2.83E+03,1.23E+04,3.78E+03,1.85E+06,2.03E+05,8.07E+03,2.16E+04,1.25E+04,1.17E+04,1.55E+04,6.29E+03,6.05E+03,2.30E+03,3.43E+05,6.46E+03,3.86E+03,5.30E+05,6.64E+04,1.17E+04,7.09E+04,0,FALSE,18.934,34,4,197,22.7,4.55,4,protein metabolism;other metabolic processes,other cell component,"Pf01466, Pf03931",,,,,,0,0,76.42,49.23,118.33,92.25,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,1,,FALSE,122.03,107.36,108.29,118.01,85.29,,0,
Master Protein,High,P05165,PCCA,"Propionyl-CoA carboxylase alpha chain, mitochondrial OS=Homo sapiens OX=9606 GN=PCCA PE=1 SV=4",1,3,0.419,0.01,0.795,0.01,-1.25,-6.64,-0.33,-6.64,4.02E-01,1.00E-17,7.73E-01,1.00E-17,5.02E+04,1.22E+05,,9.20E+04,3,3,,4,5.02E+04,1.41E+05,2.20E+04,,,2.40E+05,1.22E+05,,5.24E+04,,,,,,,1.21E+05,7.00E+04,,3.33E+04,6.21E+05,1.99E+02,5.35E+02,2.14E+02,,,8.53E+02,2.17E+03,,1.48E+03,,,,,,,2.36E+02,1.97E+04,,7.80E+02,6.61E+03,0,FALSE,5.9,2,1,728,80,7.52,1,other metabolic processes,cytosol;mitochondrion;other cell component,"Pf00289, Pf00364, Pf02785, Pf02786, Pf18140",5095,B4DKY8; B4DPF9; C9JPQ8; hsa:5095; P05165; Q15979; Q8WXQ7,ENSG00000175198,Biotin transport and metabolism; Defective HLCS causes multiple carboxylase deficiency; Propionyl-CoA catabolism,Primary ovarian insufficiency,4,0,87.5,68.68,,130.34,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,94.55,,99.99,,9.17,other molecular function,0,
Master Protein,High,Q9P0U3,SENP1,Sentrin-specific protease 1 OS=Homo sapiens OX=9606 GN=SENP1 PE=1 SV=2,1,2,0.419,1.356,0.118,4.123,-1.26,0.44,-3.08,2.04,3.93E-01,4.85E-01,5.48E-02,1.60E-01,4.66E+04,1.23E+05,5.98E+04,1.45E+04,3,2,4,1,1.71E+05,,,4.66E+04,1.54E+04,,,,2.14E+04,7.01E+05,,2.80E+04,4.92E+04,2.02E+05,7.26E+04,,,,1.45E+04,,6.80E+02,,,4.66E+04,7.94E+02,,,,6.04E+02,7.45E+03,,1.25E+03,4.00E+02,2.72E+04,1.80E+03,,,,3.39E+02,,0,FALSE,5.272,2,1,644,73.4,8.47,1,protein metabolism;other metabolic processes;signal transduction;other biological processes,other membranes;nucleus;other cell component,Pf02902,29843,A8K7P5; hsa:29843; Q86XC8; Q9P0U3,ENSG00000079387,RHOF GTPase cycle; SUMO is proteolytically processed,,2,0,106.01,133.03,88.94,,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,130.1,109.35,410.88,55.28,6.16,other molecular function,0,
Master Protein,High,Q6UW68,TMEM205,Transmembrane protein 205 OS=Homo sapiens OX=9606 GN=TMEM205 PE=1 SV=1,3,51,0.419,0.494,1.344,0.237,-1.26,-1.02,0.43,-2.08,2.78E-01,6.61E-01,8.06E-01,2.30E-01,1.88E+06,3.49E+06,1.18E+06,5.16E+06,5,5,5,5,5.29E+05,7.98E+06,6.87E+05,1.88E+06,2.03E+06,3.49E+06,4.84E+06,7.31E+06,1.21E+06,3.48E+06,4.16E+05,7.90E+05,1.18E+06,1.65E+06,1.32E+06,8.93E+06,3.20E+05,5.16E+06,1.86E+06,1.51E+07,2.10E+03,3.03E+04,6.71E+03,1.88E+06,1.05E+05,1.24E+04,8.61E+04,6.75E+04,3.42E+04,3.70E+04,2.49E+03,3.53E+04,9.60E+03,2.22E+05,3.27E+04,1.74E+04,9.00E+04,3.65E+04,4.36E+04,1.61E+05,0,FALSE,10.797,22,3,189,21.2,8.62,3,,other membranes,Pf13664,374882,hsa:374882; Q6UW68,ENSG00000105518,,,0,0,117.19,54.92,44.62,94.81,Peak Found,High,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,High,High,High,High,High,High,High,1,,FALSE,116.58,98.02,130.46,127.64,95.56,,0,
Master Protein,Medium,Q8IX19,MCEMP1,Mast cell-expressed membrane protein 1 OS=Homo sapiens OX=9606 GN=MCEMP1 PE=1 SV=1,1,1,0.418,1.754,1.093,0.671,-1.26,0.81,0.13,-0.58,3.90E-01,3.39E-01,9.96E-01,8.86E-01,5.39E+04,1.11E+05,9.45E+04,1.41E+05,2,3,2,2,,9.99E+04,,2.91E+04,,,9.43E+04,1.76E+05,,1.11E+05,,4.21E+04,,2.12E+05,,,3.61E+04,,5.49E+05,,,3.79E+02,,2.91E+04,,,1.68E+03,1.62E+03,,1.18E+03,,1.88E+03,,2.86E+04,,,1.01E+04,,1.29E+04,,0.017,FALSE,2.037,5,1,187,21.2,8.87,1,,plasma membrane;other membranes,,199675,hsa:199675; Q8IX19; Q8IX20,ENSG00000183019,Neutrophil degranulation,,1,0,77.62,33.93,94.54,123.98,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,84.1,71.92,197.67,120.42,2.05,other molecular function,0,
Master Protein,High,P61224,RAP1B,Ras-related protein Rap-1b OS=Homo sapiens OX=9606 GN=RAP1B PE=1 SV=1,12,115,0.418,0.193,0.621,0.269,-1.26,-2.38,-0.69,-1.89,2.77E-01,5.91E-02,4.60E-01,2.77E-01,3.10E+07,2.47E+07,5.24E+06,2.26E+07,5,5,5,5,7.74E+07,7.29E+07,3.10E+07,2.13E+06,2.09E+07,1.22E+07,2.47E+07,1.09E+08,3.84E+07,2.11E+07,2.09E+07,4.04E+06,2.72E+06,6.78E+06,5.24E+06,1.48E+08,8.09E+06,3.65E+07,4.83E+06,2.26E+07,3.08E+05,2.77E+05,3.03E+05,2.13E+06,1.08E+06,4.33E+04,4.39E+05,1.01E+06,1.08E+06,2.24E+05,1.25E+05,1.80E+05,2.21E+04,9.14E+05,1.30E+05,2.89E+05,2.27E+06,2.59E+05,1.13E+05,2.41E+05,0,FALSE,48.686,78,12,184,20.8,5.78,12,cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf00071,5908,B2R5Z2; B4DQI8; B4DW74; B4DW94; hsa:5908; P09526; P61224; Q502X3; Q5TZR4; Q6DCA1; Q6LES0,ENSG00000127314,Neutrophil degranulation; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Signaling by BRAF and RAF1 fusions; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Rap1 signalling; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins; MET activates RAP1 and RAC1,Integrin-mediated cell adhesion; Thyroid stimulating hormone (TSH) signaling pathway; Androgen receptor network in prostate cancer; Corticotropin-releasing hormone signaling pathway; Common pathways underlying drug addiction; Focal adhesion; Hepatocyte growth factor receptor signaling; MAPK signaling pathway; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; MET in type 1 papillary renal cell carcinoma; Ras signaling,26,0,80.81,95.56,93.25,135.32,High,High,High,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,High,High,High,Peak Found,High,High,1,,FALSE,130.61,134.04,130.4,134.36,240.88,other molecular function,0,
Master Protein,High,Q6IAA8,LAMTOR1,Ragulator complex protein LAMTOR1 OS=Homo sapiens OX=9606 GN=LAMTOR1 PE=1 SV=2,4,11,0.416,0.569,,0.288,-1.26,-0.81,,-1.8,3.35E-01,8.27E-01,,3.11E-01,1.15E+06,1.80E+06,1.47E+06,1.03E+06,2,2,4,1,,,,3.16E+06,4.18E+05,,1.73E+06,,1.88E+06,,,2.06E+06,5.76E+05,1.35E+06,1.59E+06,,,1.03E+06,,,,,,3.16E+06,2.15E+04,,3.07E+04,,5.31E+04,,,9.18E+04,4.68E+03,1.82E+05,3.96E+04,,,7.32E+03,,,0,FALSE,18.398,37,4,161,17.7,5.15,4,cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf15454,55004,hsa:55004; Q6IAA8; Q8WZ09; Q9NWT0,ENSG00000149357,Regulation of PTEN gene transcription; Neutrophil degranulation; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; Amino acids regulate mTORC1; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; RHOH GTPase cycle,"Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins",17,0,108.43,6.13,44.33,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,High,High,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,6.44,38.52,,10.74,32.94,other molecular function,0,
Master Protein,High,O15143,ARPC1B,Actin-related protein 2/3 complex subunit 1B OS=Homo sapiens OX=9606 GN=ARPC1B PE=1 SV=3,4,13,0.415,0.565,0.971,0.213,-1.27,-0.82,-0.04,-2.23,3.46E-01,8.10E-01,9.37E-01,2.54E-01,8.17E+05,1.31E+06,3.72E+05,1.27E+06,5,4,5,5,7.12E+05,8.17E+05,1.32E+05,1.04E+06,3.01E+06,1.19E+06,7.89E+05,1.74E+06,,1.43E+06,2.98E+05,3.93E+05,2.70E+05,4.42E+05,3.72E+05,5.30E+06,2.74E+05,2.39E+06,4.45E+05,1.27E+06,2.83E+03,3.10E+03,1.28E+03,1.04E+06,1.55E+05,4.24E+03,1.40E+04,1.60E+04,,1.53E+04,1.78E+03,1.76E+04,2.19E+03,5.96E+04,9.25E+03,1.03E+04,7.70E+04,1.69E+04,1.04E+04,1.35E+04,0,FALSE,19.889,16,4,372,40.9,8.35,4,cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,Pf00400,10095,hsa:10095; O15143; Q9BU00,ENSG00000130429,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; EPHB-mediated forward signaling,Pathogenic Escherichia coli infection; Microglia pathogen phagocytosis pathway,6,0,96.02,31.11,19.89,106.38,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,n/a,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,High,Peak Found,1,,FALSE,93.74,62.94,108.27,116.1,39.04,cytoskeletal activity;other molecular function,0,
Master Protein,High,P00352,ALDH1A1,Aldehyde dehydrogenase 1A1 OS=Homo sapiens OX=9606 GN=ALDH1A1 PE=1 SV=2,3,17,0.415,1.15,17.879,0.107,-1.27,0.2,4.16,-3.22,4.24E-01,5.04E-01,3.89E-04,5.66E-02,3.07E+05,1.38E+06,6.22E+05,1.80E+07,5,4,5,5,2.51E+05,5.23E+05,3.07E+05,2.75E+05,3.19E+06,3.18E+06,6.28E+05,,1.21E+05,3.04E+06,1.15E+06,2.16E+05,9.98E+05,6.18E+05,6.22E+05,1.80E+07,2.46E+06,1.05E+08,3.79E+06,5.56E+07,9.98E+02,1.99E+03,3.00E+03,2.75E+05,1.64E+05,1.13E+04,1.12E+04,,3.41E+03,3.23E+04,6.89E+03,9.64E+03,8.11E+03,8.33E+04,1.54E+04,3.51E+04,6.92E+05,7.43E+05,8.87E+04,5.92E+05,0,FALSE,11.58,9,3,501,54.8,6.73,3,other metabolic processes;other biological processes,cytosol;other cell component,Pf00171,216,hsa:216; O00768; P00352; Q5SYR1,ENSG00000165092,RA biosynthesis pathway; Ethanol oxidation; Fructose catabolism,Folate-alcohol and cancer pathway hypotheses; Fatty acid omega-oxidation; Dopaminergic neurogenesis; Amino acid metabolism; Ethanol effects on histone modifications; Disorders of fructose metabolism; Omega-6-fatty acids in senescence; Vitamin A and carotenoid metabolism,11,0,140.64,91.47,50.88,118.05,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,1,,FALSE,135.07,123.9,134.8,137.68,40.46,enzyme regulator activity;other molecular function,0,
Master Protein,High,P04083,ANXA1,Annexin A1 OS=Homo sapiens OX=9606 GN=ANXA1 PE=1 SV=2,17,213,0.412,5.396,1.647,1.228,-1.28,2.43,0.72,0.3,2.70E-01,2.42E-03,6.14E-01,7.96E-01,4.58E+06,8.36E+06,3.81E+07,9.70E+07,5,5,5,5,4.58E+06,9.35E+06,2.22E+06,2.38E+06,4.25E+07,8.36E+06,6.22E+06,1.82E+07,4.59E+06,1.01E+08,5.23E+07,6.14E+06,4.41E+07,3.81E+07,2.39E+07,1.47E+07,1.54E+07,2.85E+08,9.70E+07,4.71E+08,1.82E+04,3.55E+04,2.17E+04,2.38E+06,2.19E+06,2.97E+04,1.11E+05,1.68E+05,1.29E+05,1.08E+06,3.13E+05,2.74E+05,3.58E+05,5.13E+06,5.94E+05,2.86E+04,4.34E+06,2.02E+06,2.27E+06,5.02E+06,0,FALSE,82.174,51,17,346,38.7,7.02,17,cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf00191,301,B5BU38; hsa:301; P04083,ENSG00000135046,G alpha (q) signalling events; G alpha (i) signalling events; Interleukin-4 and Interleukin-13 signaling; Smooth Muscle Contraction; Formyl peptide receptors bind formyl peptides and many other ligands,Spinal cord injury; VEGFA-VEGFR2 signaling; Prostaglandin synthesis and regulation,8,0,140.81,149.57,55.33,112.16,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,144.75,128.59,134.99,144.79,678.15,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,P98171,ARHGAP4,Rho GTPase-activating protein 4 OS=Homo sapiens OX=9606 GN=ARHGAP4 PE=1 SV=2,6,15,0.411,0.543,0.131,1.007,-1.28,-0.88,-2.93,0.01,2.69E-01,7.72E-01,6.47E-03,8.80E-01,2.33E+06,1.97E+07,1.38E+06,2.22E+06,4,3,4,3,7.24E+06,1.57E+07,7.51E+05,1.04E+05,,1.97E+07,1.31E+06,2.28E+07,,,1.85E+06,4.13E+05,,3.49E+06,1.03E+06,2.22E+06,3.28E+05,2.49E+06,,,2.88E+04,5.97E+04,7.34E+03,1.04E+05,,7.01E+04,2.33E+04,2.11E+05,,,1.11E+04,1.85E+04,,4.71E+05,2.55E+04,4.33E+03,9.21E+04,1.76E+04,,,0,FALSE,21.539,11,6,946,105,6.34,6,cell organization and biogenesis;developmental processes;signal transduction;other biological processes,cytosol;cytoskeleton;nucleus;other cell component,"Pf00611, Pf00620, Pf14604",393,hsa:393; P98171; Q14144; Q86UY3,ENSG00000089820,RAC1 GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle,Clock-controlled autophagy in bone metabolism,4,0,121.99,79.57,78.75,70.13,High,High,Peak Found,High,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,1,,FALSE,140.16,143.22,95.26,100.13,45.45,enzyme regulator activity;other molecular function,0,
Master Protein,High,P14780,MMP9,Matrix metalloproteinase-9 OS=Homo sapiens OX=9606 GN=MMP9 PE=1 SV=3,11,108,0.411,0.568,2.387,0.126,-1.28,-0.82,1.26,-2.99,2.68E-01,7.71E-01,3.28E-01,7.83E-02,6.84E+06,2.38E+07,2.38E+06,6.95E+07,5,5,5,5,6.84E+06,2.60E+07,4.17E+05,2.14E+06,2.85E+07,2.43E+07,1.93E+07,9.71E+07,3.68E+06,2.38E+07,2.38E+06,3.43E+05,1.16E+07,8.06E+06,1.42E+06,2.22E+08,9.98E+05,6.95E+07,6.59E+07,1.53E+08,2.72E+04,9.88E+04,4.08E+03,2.14E+06,1.47E+06,8.63E+04,3.43E+05,8.96E+05,1.04E+05,2.53E+05,1.42E+04,1.53E+04,9.46E+04,1.09E+06,3.54E+04,4.32E+05,2.80E+05,4.93E+05,1.54E+06,1.63E+06,0,FALSE,54.486,19,11,707,78.4,6.06,11,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;other cell component,"Pf00040, Pf00045, Pf00413",4318,B2R7V9; hsa:4318; P14780; Q3LR70; Q8N725; Q9H4Z1; Q9UCJ9; Q9UCL1; Q9UDK2,ENSG00000100985,Neutrophil degranulation; Collagen degradation; Assembly of collagen fibrils and other multimeric structures; Extra-nuclear estrogen signaling; Signaling by SCF-KIT; Interleukin-4 and Interleukin-13 signaling; EPH-ephrin mediated repulsion of cells; Activation of Matrix Metalloproteinases,Matrix metalloproteinases; Osteopontin signaling; Angiogenesis; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; AGE/RAGE pathway; Spinal cord injury; Mammary gland development pathway - Involution (Stage 4 of 4); Bladder cancer; IL1 and megakaryocytes in obesity; Photodynamic therapy-induced NF-kB survival signaling; Lung fibrosis; Epithelial to mesenchymal transition in colorectal cancer; Acute viral myocarditis; Extracellular vesicles in the crosstalk of cardiac cells; Neovascularization processes; Fragile X syndrome; Cell migration and invasion through p75NTR; Neural crest cell migration during development; Neural crest cell migration in cancer; Hepatitis B infection; Male infertility; Endochondral ossification; IL-18 signaling pathway; Endochondral ossification with skeletal dysplasias; Kisspeptin/kisspeptin receptor system in the ovary; Pleural mesothelioma; Prostaglandin signaling; Overview of proinflammatory and profibrotic mediators; CCL18 signaling pathway; Urotensin-II-mediated signaling pathway; Chronic hyperglycemia impairment of neuron function; Immune infiltration in pancreatic cancer; IL-26 signaling pathways; Macrophage-stimulating protein (MSP) signaling network map,43,0,105.23,108.35,101.94,83.97,Peak Found,High,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,High,High,1,,FALSE,135.95,138.16,144.09,144.58,264.37,other molecular function,0,
Master Protein,High,H7C5A2,EMC1,ER membrane protein complex subunit 1 OS=Homo sapiens OX=9606 GN=EMC1 PE=1 SV=2,3,7,0.41,2.269,,1.469,-1.29,1.18,,0.55,4.44E-01,9.59E-02,,6.11E-01,2.77E+05,3.07E+05,7.84E+05,3.30E+05,3,2,4,2,,2.76E+06,,2.77E+05,2.66E+05,,,2.86E+05,,3.30E+05,2.63E+06,,6.44E+05,9.54E+05,5.46E+05,,2.11E+05,,5.16E+05,,,1.05E+04,,2.77E+05,1.37E+04,,,2.64E+03,,3.51E+03,1.57E+04,,5.23E+03,1.28E+05,1.36E+04,,5.92E+04,,1.21E+04,,0,FALSE,18.385,5,3,996,112,7.66,3,,other membranes;ER/Golgi,"Pf07774, Pf13360",,H7C5A2,ENSG00000127463,,,0,0,130.42,10.01,81.57,59.38,n/a,High,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,16.31,86.06,,82.32,25.02,,0,
Master Protein,High,A0A7I2V383,BCL2L2-PABPN1,BCL2L2-PABPN1 readthrough OS=Homo sapiens OX=9606 GN=BCL2L2-PABPN1 PE=1 SV=1,3,7,0.41,0.319,0.096,1.824,-1.29,-1.65,-3.38,0.87,2.67E-01,2.63E-01,1.82E-03,4.66E-01,1.32E+06,4.50E+06,7.26E+05,4.33E+05,2,1,3,2,,,,2.91E+06,5.95E+05,4.50E+06,,,,,,7.26E+05,,2.21E+06,2.00E+05,1.49E+06,1.26E+05,,,,,,,2.91E+06,3.07E+04,1.60E+04,,,,,,3.24E+04,,2.98E+05,4.98E+03,2.91E+03,3.53E+04,,,,0,FALSE,11.097,13,3,365,40.5,5.78,3,other biological processes,other membranes;mitochondrion,"Pf00076, Pf00452, Pf02180",,A0A7I2V383,ENSG00000258643,,,0,0,93.45,,99.71,119.5,n/a,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,0,86.24,234.27,164.97,21.69,nucleic acid binding activity,0,
Master Protein,High,Q16795,NDUFA9,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFA9 PE=1 SV=2",7,29,0.408,2.47,2.003,2.175,-1.29,1.3,1,1.12,3.34E-01,6.02E-02,5.05E-01,4.44E-01,1.92E+06,2.45E+05,5.83E+06,1.38E+06,5,5,5,5,3.07E+06,2.98E+05,2.35E+06,1.92E+06,4.23E+05,4.76E+05,1.33E+05,1.62E+05,2.45E+05,2.09E+06,2.31E+07,1.35E+05,2.98E+06,5.83E+06,6.29E+06,1.38E+06,1.59E+06,1.18E+06,3.76E+05,1.97E+06,1.22E+04,1.13E+03,2.30E+04,1.92E+06,2.18E+04,1.69E+03,2.36E+03,1.49E+03,6.90E+03,2.22E+04,1.38E+05,6.05E+03,2.42E+04,7.86E+05,1.56E+05,2.70E+03,4.45E+05,8.37E+03,8.81E+03,2.10E+04,0,FALSE,26.39,25,7,377,42.5,9.8,7,cell organization and biogenesis;other metabolic processes;transport;other biological processes,other membranes;mitochondrion,Pf01370,4704,hsa:4704; Q14076; Q16795; Q2NKX0,ENSG00000139180,Complex I biogenesis,Electron transport chain: OXPHOS system in mitochondria; Ciliary landscape; Nonalcoholic fatty liver disease; Oxidative phosphorylation,6,0,75.45,133.94,117.06,45.59,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,116.67,123.34,117.44,117.3,86.03,transporter activity;other molecular function,0,
Master Protein,High,Q99805,TM9SF2,Transmembrane 9 superfamily member 2 OS=Homo sapiens OX=9606 GN=TM9SF2 PE=1 SV=1,3,11,0.406,1.183,0.969,0.568,-1.3,0.24,-0.04,-0.82,4.15E-01,4.89E-01,8.23E-01,7.18E-01,1.39E+05,2.84E+05,3.01E+05,3.63E+05,5,5,5,4,1.39E+05,2.87E+05,2.51E+04,2.29E+05,1.28E+05,1.89E+06,5.87E+04,6.85E+04,2.84E+05,6.15E+06,1.49E+05,1.09E+04,3.01E+05,9.68E+05,3.58E+05,5.44E+05,1.66E+05,,5.15E+05,2.55E+05,5.52E+02,1.09E+03,2.45E+02,2.29E+05,6.60E+03,6.70E+03,1.04E+03,6.32E+02,8.01E+03,6.54E+04,8.90E+02,4.86E+02,2.45E+03,1.30E+05,8.91E+03,1.06E+03,4.68E+04,,1.21E+04,2.72E+03,0,FALSE,11.41,6,3,663,75.7,7.44,3,other metabolic processes;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle,Pf02990,9375,A8K399; hsa:9375; Q2TAY5; Q99805,ENSG00000125304,,,0,0,62.3,154.38,102.77,50.78,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,135.32,104.69,128.43,120.09,34.91,,0,
Master Protein,High,P23634,ATP2B4,Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens OX=9606 GN=ATP2B4 PE=1 SV=2,10,20,0.404,0.458,0.264,0.496,-1.31,-1.13,-1.92,-1.01,2.60E-01,5.89E-01,6.75E-02,6.76E-01,1.16E+06,5.45E+06,3.64E+05,1.52E+06,5,4,5,4,1.16E+06,1.23E+06,4.08E+05,9.60E+05,2.07E+06,4.35E+06,6.83E+06,8.46E+06,,2.30E+06,3.64E+05,3.23E+05,3.42E+05,2.26E+06,5.30E+05,4.39E+06,1.10E+06,2.10E+06,,4.24E+05,4.61E+03,4.69E+03,3.99E+03,9.60E+05,1.07E+05,1.55E+04,1.21E+05,7.81E+04,,2.44E+04,2.18E+03,1.44E+04,2.78E+03,3.05E+05,1.32E+04,8.56E+03,3.10E+05,1.49E+04,,4.51E+03,0,FALSE,35.331,12,10,1241,137.8,6.6,10,stress response;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytoskeleton;other cell component,"Pf00122, Pf00689, Pf00690, Pf00702, Pf12424, Pf13246",493,B1APW5; B1APW6; hsa:493; P23634; Q13450; Q13452; Q13455; Q16817; Q7Z3S1,ENSG00000058668,Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels,Vitamin D-sensitive calcium signaling in depression,4,0,51.51,49.49,110.08,86.4,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,111.88,77.69,106.67,125.63,53.29,transporter activity;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q96EL3,MRPL53,"39S ribosomal protein L53, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL53 PE=1 SV=1",2,4,0.402,0.01,0.01,,-1.32,-6.64,-6.64,,3.72E-01,1.00E-17,1.00E-17,,5.41E+04,1.14E+05,,,2,2,,,,,,1.88E+05,1.56E+04,,,,4.56E+05,2.87E+04,,,,,,,,,,,,,,1.88E+05,8.05E+02,,,,1.28E+04,3.06E+02,,,,,,,,,,,0,FALSE,9.913,29,2,112,12.1,8.76,2,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf10780,116540,hsa:116540; Q96EL3,ENSG00000204822,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,119.71,124.64,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,38.6,,,,11.36,,0,
Master Protein,High,Q9NYU2,UGGT1,UDP-glucose:glycoprotein glucosyltransferase 1 OS=Homo sapiens OX=9606 GN=UGGT1 PE=1 SV=3,18,42,0.402,1.135,1.091,0.783,-1.32,0.18,0.13,-0.35,4.42E-01,4.65E-01,9.80E-01,8.88E-01,6.89E+05,5.42E+05,4.92E+06,2.15E+06,5,5,5,5,6.89E+05,1.72E+05,5.58E+05,6.90E+06,5.13E+06,9.17E+05,5.42E+05,1.79E+06,5.20E+04,1.64E+05,3.70E+05,9.75E+05,4.92E+06,6.17E+06,7.50E+06,2.15E+06,6.75E+06,1.71E+06,2.09E+06,4.53E+06,2.74E+03,6.52E+02,5.45E+03,6.90E+06,2.65E+05,3.26E+03,9.64E+03,1.65E+04,1.46E+03,1.74E+03,2.21E+03,4.36E+04,4.00E+04,8.31E+05,1.86E+05,4.18E+03,1.90E+06,1.21E+04,4.90E+04,4.82E+04,0,FALSE,68.025,15,18,1555,177.1,5.63,18,protein metabolism;other metabolic processes,ER/Golgi;other cell component,"Pf06427, Pf18400, Pf18401, Pf18402, Pf18403, Pf18404",56886,hsa:56886; Q53QP2; Q53SL3; Q8IW30; Q9H8I4; Q9NYU2,ENSG00000136731,ER Quality Control Compartment (ERQC),IL-18 signaling pathway,2,0,115.44,101.22,79.44,62.6,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,120.64,104.33,97.6,112.12,117.22,other molecular function,0,
Master Protein,High,A5YKK6,CNOT1,CCR4-NOT transcription complex subunit 1 OS=Homo sapiens OX=9606 GN=CNOT1 PE=1 SV=2,4,7,0.401,0.22,0.48,,-1.32,-2.18,-1.06,,3.89E-01,2.41E-01,4.75E-01,,1.02E+05,1.34E+05,3.30E+03,8.38E+04,3,4,1,3,,,1.57E+04,1.02E+05,1.21E+06,1.88E+05,2.25E+04,9.61E+04,1.91E+05,,,,,3.30E+03,,,1.74E+04,2.67E+05,8.38E+04,,,,1.53E+02,1.02E+05,6.23E+04,6.67E+02,3.99E+02,8.87E+02,5.37E+03,,,,,4.45E+02,,,4.90E+03,1.89E+03,1.96E+03,,0,FALSE,15.493,3,4,2376,266.8,7.11,4,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf04054, Pf12842, Pf16415, Pf16417, Pf16418",23019,A5YKK6; hsa:23019; Q68DX7; Q7Z3K2; Q8IWB8; Q8TB53; Q9BVZ6; Q9UFR8; Q9UI27; Q9Y2L0,ENSG00000125107,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain; M-decay: degradation of maternal mRNAs by maternally stored factors,Ciliary landscape,4,0,150.46,65.03,,105.32,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,138.87,6.63,105.52,,19.96,other molecular function,0,
Master Protein,High,A0A2R8Y5S7,RDX,Radixin OS=Homo sapiens OX=9606 GN=RDX PE=1 SV=1,7,30,0.4,0.065,0.738,0.036,-1.32,-3.94,-0.44,-4.81,3.86E-01,1.74E-02,7.24E-01,9.52E-03,6.85E+04,1.32E+05,3.48E+03,9.75E+04,3,5,2,3,,6.85E+04,,2.01E+04,1.41E+05,3.65E+05,3.89E+04,3.53E+05,1.32E+05,1.06E+05,,,,1.88E+03,6.42E+03,9.75E+04,,4.71E+05,2.35E+04,,,2.60E+02,,2.01E+04,7.29E+03,1.30E+03,6.92E+02,3.26E+03,3.72E+03,1.12E+03,,,,2.54E+02,1.60E+02,1.90E+02,,3.34E+03,5.50E+02,,0,FALSE,25.922,10,1,590,69.3,6.27,7,,plasma membrane;other membranes;cytoskeleton;other cell component,"Pf00373, Pf00769, Pf09379, Pf09380, Pf20492",,A0A2R8Y5S7,ENSG00000137710,,,0,0,79.6,75.42,77.3,121.55,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,1,,FALSE,114.5,91.19,123.68,127.23,58.89,cytoskeletal activity,0,
Master Protein,High,A0A182DWH4,HLA-DRB3,"HLA class II histocompatibility antigen, DR beta 3 chain OS=Homo sapiens OX=9606 GN=HLA-DRB3 PE=1 SV=1",5,44,0.4,1.292,0.01,100,-1.32,0.37,-6.64,6.64,4.50E-01,4.21E-01,1.00E-17,1.00E-17,1.31E+05,5.58E+05,5.11E+05,,5,2,5,,1.00E+05,1.16E+05,2.15E+06,1.31E+05,7.74E+05,3.08E+05,1.01E+06,,,,1.94E+05,2.52E+06,4.06E+04,5.11E+05,1.68E+06,,,,,,3.98E+02,4.39E+02,2.10E+04,1.31E+05,3.99E+04,1.09E+03,1.80E+04,,,,1.16E+03,1.13E+05,3.29E+02,6.89E+04,4.18E+04,,,,,,0,FALSE,42.995,32,2,266,29.9,7.84,5,other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00969, Pf07654",,A0A182DWH4,ENSG00000230463,,,0,0,135.05,75.47,108.25,,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,93.43,108.54,,,127.48,,0,
Master Protein,High,O75069,TMCC2,Transmembrane and coiled-coil domains protein 2 OS=Homo sapiens OX=9606 GN=TMCC2 PE=1 SV=3,6,21,0.4,0.86,3.605,0.059,-1.32,-0.22,1.85,-4.09,4.30E-01,7.83E-01,1.36E-01,2.22E-02,1.97E+05,7.00E+05,1.46E+05,1.50E+06,4,5,1,4,4.30E+05,2.29E+05,,1.49E+05,1.70E+05,7.00E+05,1.29E+06,1.21E+06,4.58E+05,5.25E+05,,,,1.46E+05,,3.39E+06,7.49E+06,6.65E+05,,3.33E+05,1.71E+03,8.69E+02,,1.49E+05,8.77E+03,2.49E+03,2.30E+04,1.11E+04,1.29E+04,5.58E+03,,,,1.97E+04,,6.61E+03,2.10E+06,4.72E+03,,3.54E+03,0,FALSE,26.626,12,6,709,77.4,6.81,6,protein metabolism;other metabolic processes,other membranes;ER/Golgi;other cell component,Pf10267,9911,A2RRH3; B2RAX5; B3KTM7; B7Z1P7; hsa:9911; O75069; Q6ZN09; Q7Z6C6,ENSG00000133069,,,0,0,52.32,46.42,,111.44,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,33.36,27.23,88.54,1.69,60.46,,0,
Master Protein,High,P35613,BSG,Basigin OS=Homo sapiens OX=9606 GN=BSG PE=1 SV=2,7,127,0.399,0.628,1.032,0.306,-1.33,-0.67,0.05,-1.71,2.54E-01,8.86E-01,9.28E-01,3.30E-01,2.62E+06,1.08E+07,3.46E+06,1.14E+07,5,5,5,5,5.20E+06,3.64E+07,5.81E+05,2.08E+06,2.62E+06,2.06E+07,1.08E+07,4.07E+07,8.65E+06,1.23E+06,4.53E+06,2.07E+06,4.14E+06,3.46E+06,3.17E+06,4.51E+07,1.18E+07,8.52E+06,9.86E+06,1.14E+07,2.07E+04,1.38E+05,5.68E+03,2.08E+06,1.35E+05,7.32E+04,1.93E+05,3.76E+05,2.44E+05,1.31E+04,2.71E+04,9.24E+04,3.36E+04,4.66E+05,7.88E+04,8.80E+04,3.32E+06,6.04E+04,2.31E+05,1.21E+05,0,FALSE,40.779,22,7,385,42.2,5.66,7,developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf13927,682,A6NJW1; D3YLG5; hsa:682; P35613; Q7Z796; Q8IZL7,ENSG00000172270,Degradation of the extracellular matrix; Integrin cell surface interactions; Pyruvate metabolism; Aspirin ADME; Basigin interactions; Proton-coupled monocarboxylate transport; Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),Matrix metalloproteinases; VEGFA-VEGFR2 signaling; IL-18 signaling pathway,10,0,162.09,92.96,27.38,89.83,Peak Found,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,135.16,122.35,130.79,111.6,424.32,other molecular function,0,
Master Protein,High,Q9Y6N5,SQOR,"Sulfide:quinone oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=SQOR PE=1 SV=1",12,30,0.399,0.603,0.556,0.842,-1.33,-0.73,-0.85,-0.25,3.01E-01,9.09E-01,4.54E-01,9.99E-01,1.45E+06,2.07E+06,1.95E+06,4.20E+05,5,5,5,4,3.38E+05,1.45E+06,1.81E+05,2.60E+06,6.32E+06,8.60E+04,1.09E+06,3.66E+06,2.07E+06,1.46E+07,2.92E+05,3.72E+06,5.81E+05,3.79E+06,1.95E+06,4.76E+05,2.37E+06,2.07E+05,3.69E+05,,1.34E+03,5.53E+03,1.77E+03,2.60E+06,3.26E+05,3.06E+02,1.95E+04,3.38E+04,5.83E+04,1.55E+05,1.75E+03,1.66E+05,4.72E+03,5.11E+05,4.84E+04,9.29E+02,6.66E+05,1.47E+03,8.64E+03,,0,FALSE,51.935,36,12,450,49.9,9.11,12,other metabolic processes,other membranes;mitochondrion,Pf07992,58472,hsa:58472; Q9UQM8; Q9Y6N5,ENSG00000137767,Sulfide oxidation to sulfate,,1,0,115.2,137.15,80.52,118.7,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,n/a,1,,FALSE,121.59,106.44,129.78,64.5,79.61,other molecular function,0,
Master Protein,High,P09382,LGALS1,Galectin-1 OS=Homo sapiens OX=9606 GN=LGALS1 PE=1 SV=2,2,4,0.396,0.018,0.178,0.041,-1.34,-5.78,-2.49,-4.62,2.54E-01,7.93E-07,1.70E-02,2.65E-03,1.19E+06,2.99E+06,2.16E+04,5.31E+05,1,5,1,3,,,,,1.19E+06,2.99E+06,5.20E+06,4.09E+06,1.98E+06,1.97E+06,,,,2.16E+04,,5.31E+05,1.55E+04,1.75E+06,,,,,,,6.12E+04,1.06E+04,9.25E+04,3.78E+04,5.59E+04,2.10E+04,,,,2.92E+03,,1.04E+03,4.35E+03,1.24E+04,,,0,FALSE,5.555,16,2,135,14.7,5.5,2,cell adhesion;other biological processes,cytosol;ER/Golgi;other cell component,Pf00337,3956,B2R5E8; hsa:3956; P09382; Q9UDK5,ENSG00000100097,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,Immune infiltration in pancreatic cancer,3,0,,43.06,,116.27,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,High,n/a,n/a,1,,FALSE,50.47,0,109.62,143.94,9.72,other molecular function,0,
Master Protein,High,A0A8C8KBU6,IL16,Pro-interleukin-16 OS=Homo sapiens OX=9606 GN=IL16 PE=1 SV=1,1,1,0.396,1.872,0.01,100,-1.34,0.9,-6.64,6.64,4.30E-01,1.87E-01,1.00E-17,1.00E-17,3.31E+05,8.35E+05,6.19E+05,,2,1,4,,,,,3.51E+05,3.12E+05,,8.35E+05,,,,1.47E+06,1.04E+06,,3.70E+05,1.53E+05,,,,,,,,,3.51E+05,1.61E+04,,1.48E+04,,,,8.81E+03,4.62E+04,,4.99E+04,3.80E+03,,,,,,0.001,FALSE,3.108,1,1,1378,147,8.53,1,signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf00595,,A0A8C8KBU6,ENSG00000172349,,,0,0,8.34,,80.07,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,8.76,111.6,,,2.12,signal transduction activity or receptor binding,0,
Master Protein,Medium,Q7L1Q6,BZW1,eIF5-mimic protein 2 OS=Homo sapiens OX=9606 GN=BZW1 PE=1 SV=1,1,1,0.396,0.899,0.897,0.876,-1.34,-0.15,-0.16,-0.19,4.14E-01,7.62E-01,7.56E-01,9.48E-01,1.55E+05,4.02E+05,1.40E+05,3.61E+05,4,3,5,5,1.51E+05,,7.99E+04,1.60E+05,2.70E+05,6.84E+05,,4.02E+05,9.51E+04,,6.62E+05,1.40E+05,1.21E+06,4.50E+04,4.33E+04,3.61E+05,3.62E+05,6.71E+05,4.94E+04,2.43E+05,6.01E+02,,7.80E+02,1.60E+05,1.39E+04,2.43E+03,,3.71E+03,2.68E+03,,3.96E+03,6.24E+03,9.79E+03,6.07E+03,1.08E+03,7.04E+02,1.02E+05,4.76E+03,1.16E+03,2.59E+03,0.011,FALSE,2.267,2,1,419,48,5.92,1,other biological processes,other cell component,Pf02020,9689,B4DLZ8; B4DWF7; hsa:9689; Q14281; Q15394; Q7L1Q6; Q9BUY0,ENSG00000082153,,,0,0,47.53,74.79,121.47,67.02,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,107.27,124.5,103.76,138.56,1.79,,0,
Master Protein,High,Q9NWQ8,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 OS=Homo sapiens OX=9606 GN=PAG1 PE=1 SV=2,6,11,0.395,0.214,0.01,100,-1.34,-2.22,-6.64,6.64,3.79E-01,1.67E-01,1.00E-17,1.00E-17,8.08E+04,1.07E+05,3.35E+05,,4,5,1,,,5.83E+04,1.85E+04,1.21E+06,1.12E+05,1.68E+05,5.64E+04,5.53E+05,1.63E+04,1.07E+05,,,,3.35E+05,,,,,,,,2.21E+02,1.81E+02,1.21E+06,5.78E+03,5.97E+02,1.00E+03,5.10E+03,4.59E+02,1.14E+03,,,,4.52E+04,,,,,,,0,FALSE,32.451,27,6,432,47,4.65,6,signal transduction;other biological processes,plasma membrane;other membranes,Pf15347,55824,A8K1A3; hsa:55824; Q2M1Z9; Q5BKU4; Q9NWQ8; Q9NYK0,ENSG00000076641,Phosphorylation of CD3 and TCR zeta chains; GAB1 signalosome,,2,0,164.33,119.97,,,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,114.71,84.65,,,36.7,other molecular function,0,
Master Protein,High,K7EM18,EIF1,Eukaryotic translation initiation factor 1 OS=Homo sapiens OX=9606 GN=EIF1 PE=1 SV=1,3,7,0.394,0.724,0.245,0.322,-1.34,-0.47,-2.03,-1.63,4.20E-01,9.93E-01,9.46E-02,3.87E-01,3.92E+05,5.14E+05,4.26E+05,4.28E+05,2,3,3,2,,,,3.63E+05,4.22E+05,1.14E+05,,,7.13E+05,5.14E+05,,4.26E+05,,9.99E+05,2.74E+05,,1.38E+06,,1.33E+05,,,,,3.63E+05,2.18E+04,4.04E+02,,,2.01E+04,5.46E+03,,1.90E+04,,1.35E+05,6.81E+03,,3.87E+05,,3.12E+03,,0,FALSE,11.803,36,3,121,13.6,7.9,3,protein metabolism;other metabolic processes,,Pf01253,,K7EM18,ENSG00000173812,,,0,0,10.61,68.32,67.53,116.48,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,63.44,57.72,46.24,108.51,20.07,nucleic acid binding activity,0,
Master Protein,High,Q3SY77,UGT3A2,UDP-glucuronosyltransferase 3A2 OS=Homo sapiens OX=9606 GN=UGT3A2 PE=2 SV=1,3,11,0.394,4.155,0.605,8.14,-1.34,2.05,-0.72,3.02,3.98E-01,3.86E-03,6.01E-01,3.21E-02,3.70E+05,4.82E+04,2.78E+06,1.66E+05,3,2,4,2,1.74E+06,,3.70E+05,1.22E+05,,,5.58E+04,,,4.16E+04,4.52E+06,,7.39E+06,1.71E+06,2.35E+05,2.84E+05,9.66E+04,,,,6.92E+03,,3.62E+03,1.22E+05,,,9.92E+02,,,4.43E+02,2.70E+04,,6.00E+04,2.31E+05,5.85E+03,5.54E+02,2.71E+04,,,,0,FALSE,11.578,10,3,523,59.5,8.31,3,other biological processes,other membranes;ER/Golgi,Pf00201,167127,B4DUQ7; E9PFK7; hsa:167127; Q3SY77; Q6UXC4; Q8NBP2,ENSG00000168671,Aspirin ADME; Glucuronidation,,2,0,117.11,20.55,91.28,69.7,High,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,21.77,129.11,617.64,144.88,28.83,other molecular function,0,
Master Protein,High,Q9P0W2,HMG20B,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related OS=Homo sapiens OX=9606 GN=HMG20B PE=1 SV=1,2,2,0.393,0.475,0.254,1.644,-1.35,-1.07,-1.98,0.72,3.75E-01,6.76E-01,2.01E-01,5.89E-01,6.86E+04,1.81E+05,1.13E+05,5.19E+04,3,2,5,3,6.86E+04,,,1.28E+05,4.24E+04,1.87E+05,,,1.74E+05,,1.77E+05,7.67E+04,3.28E+05,9.47E+04,1.13E+05,,5.19E+04,4.15E+04,1.39E+05,,2.73E+02,,,1.28E+05,2.19E+03,6.67E+02,,,4.91E+03,,1.06E+03,3.42E+03,2.66E+03,1.28E+04,2.80E+03,,1.46E+04,2.94E+02,3.26E+03,,0,FALSE,5.642,8,2,317,35.8,9.35,2,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,nucleus;other cell component,Pf00505,10362,A6NMS5; D6W616; hsa:10362; Q6IBP8; Q8NBD5; Q9HD21; Q9P0W2; Q9Y491; Q9Y4A2,ENSG00000064961,Factors involved in megakaryocyte development and platelet production; Potential therapeutics for SARS; HDACs deacetylate histones,,3,0,55.06,5.1,64.89,69.2,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,68.86,68.86,29.85,116.64,5.96,nucleic acid binding activity,0,
Master Protein,High,A0A0A0MTJ9,NCEH1,Neutral cholesterol ester hydrolase 1 OS=Homo sapiens OX=9606 GN=NCEH1 PE=1 SV=1,3,11,0.392,3.19,0.916,0.347,-1.35,1.67,-0.13,-1.53,3.95E-01,4.22E-02,9.15E-01,4.40E-01,5.48E+05,1.09E+06,1.53E+05,9.50E+05,3,4,4,3,,8.45E+05,,8.42E+03,5.48E+05,1.33E+05,,4.14E+06,7.46E+05,1.61E+06,,3.18E+04,1.76E+05,1.40E+05,1.66E+05,,9.18E+05,3.79E+06,9.50E+05,,,3.21E+03,,8.42E+03,2.82E+04,4.74E+02,,3.82E+04,2.10E+04,1.71E+04,,1.42E+03,1.43E+03,1.89E+04,4.13E+03,,2.58E+05,2.69E+04,2.22E+04,,0,FALSE,13.621,9,3,448,49.9,7.21,3,,other membranes,Pf07859,57552,A0A0A0MTJ9,ENSG00000144959,,,0,0,90.82,106.4,51.5,87.48,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,77.6,87.07,123.23,120.45,25.2,other molecular function,0,
Master Protein,High,A0A994J5B1,EPB41L2,Erythrocyte membrane protein band 4.1 like 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=4 SV=1,3,5,0.39,0.338,2.147,0.119,-1.36,-1.57,1.1,-3.07,3.98E-01,3.81E-01,5.15E-01,7.03E-02,1.96E+05,2.72E+05,8.24E+04,6.95E+05,4,2,2,1,1.59E+05,,3.69E+04,2.41E+05,2.41E+06,,,,2.67E+05,2.77E+05,,,,9.37E+04,7.24E+04,,,,,6.95E+05,6.31E+02,,3.61E+02,2.41E+05,1.25E+05,,,,7.53E+03,2.95E+03,,,,1.26E+04,1.80E+03,,,,,7.40E+03,0,FALSE,7.461,4,3,1057,118.4,5.49,3,cell organization and biogenesis,cytoskeleton,,,A0A994J5B1,ENSG00000079819,,Splicing factor NOVA regulated synaptic proteins,1,0,159.55,2.59,18.1,,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,107.43,121.04,2.71,36.26,11.39,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A2R8YD14,RPS24,40S ribosomal protein S24 OS=Homo sapiens OX=9606 GN=RPS24 PE=1 SV=1,2,2,0.39,1.426,2.1,0.46,-1.36,0.51,1.07,-1.12,3.75E-01,3.79E-01,5.42E-01,6.11E-01,1.96E+05,1.32E+05,1.31E+05,2.83E+05,1,1,4,2,,,,1.96E+05,,,,,,1.32E+05,,1.67E+05,1.28E+05,1.34E+05,5.28E+04,2.78E+05,2.89E+05,,,,,,,1.96E+05,,,,,,1.41E+03,,7.45E+03,1.04E+03,1.80E+04,1.31E+03,5.42E+02,8.12E+04,,,,0,FALSE,5.639,16,2,165,19.2,10.98,2,protein metabolism;other metabolic processes,translational apparatus,Pf01282,,A0A2R8YD14,ENSG00000138326,,,0,0,,,40.07,2.82,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,0,117.45,0.09,36.17,6.34,other molecular function,0,
Master Protein,High,P50895,BCAM,Basal cell adhesion molecule OS=Homo sapiens OX=9606 GN=BCAM PE=1 SV=2,6,10,0.389,0.847,1.287,0.273,-1.36,-0.24,0.36,-1.87,4.28E-01,7.89E-01,9.10E-01,3.04E-01,2.10E+05,5.20E+05,1.62E+05,6.75E+05,2,1,3,3,,,,1.29E+05,3.42E+05,5.20E+05,,,,,1.62E+05,,,1.84E+05,1.60E+05,,1.74E+06,,6.69E+05,6.75E+05,,,,1.29E+05,1.76E+04,1.85E+03,,,,,9.69E+02,,,2.48E+04,3.97E+03,,4.89E+05,,1.57E+04,7.18E+03,0,FALSE,26.608,18,6,628,67.4,5.81,6,cell adhesion;signal transduction,plasma membrane;other membranes,"Pf07686, Pf08205, Pf13895, Pf13927",4059,A8MYF9; A9YWT5; A9YWT6; hsa:4059; P50895; Q86VC7,ENSG00000187244,,,0,0,64.06,,7.94,60.04,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,81.16,75.64,1.15,21.13,31.28,other molecular function,0,
Master Protein,High,Q9H939,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2 OS=Homo sapiens OX=9606 GN=PSTPIP2 PE=1 SV=4,2,3,0.389,0.836,1.689,0.363,-1.36,-0.26,0.76,-1.46,3.71E-01,8.54E-01,7.19E-01,5.18E-01,6.98E+04,1.79E+05,5.83E+04,1.61E+05,1,3,2,3,,,,,6.98E+04,,,1.79E+05,1.98E+05,3.91E+04,,,,7.91E+04,4.30E+04,,1.61E+05,,6.60E+04,4.38E+05,,,,,3.60E+03,,,1.66E+03,5.59E+03,4.16E+02,,,,1.07E+04,1.07E+03,,4.51E+04,,1.55E+03,4.67E+03,0,FALSE,8.462,13,2,334,38.8,8.48,2,cell organization and biogenesis,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf00611,9050,hsa:9050; Q9H939,ENSG00000152229,,,0,0,,62.62,41.78,87.3,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,15.77,45.84,77.21,84.47,9.68,cytoskeletal activity,0,
Master Protein,High,A0A5F9UY30,TGOLN2,Trans-golgi network protein 2 OS=Homo sapiens OX=9606 GN=TGOLN2 PE=1 SV=1,3,13,0.387,0.01,1.715,0.01,-1.37,-6.64,0.78,-6.64,4.19E-01,1.00E-17,5.43E-01,1.00E-17,4.96E+05,8.50E+05,,2.06E+06,3,5,,4,,4.96E+05,,9.84E+04,1.28E+06,8.06E+05,6.55E+05,2.96E+06,8.50E+05,2.19E+06,,,,,,1.34E+06,1.10E+05,5.76E+06,,3.17E+06,,1.88E+03,,9.84E+04,6.58E+04,2.87E+03,1.16E+04,2.73E+04,2.39E+04,2.33E+04,,,,,,2.61E+03,3.10E+04,4.08E+04,,3.37E+04,0,FALSE,13.669,10,3,453,47.7,5.97,3,,other membranes;ER/Golgi;nucleus,Pf17818,,A0A5F9UY30,ENSG00000152291,,,0,0,96.11,68.86,,94.63,n/a,Peak Found,n/a,High,High,Peak Found,High,High,High,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,High,1,,FALSE,111.09,,130.12,,35.61,,0,
Master Protein,High,P08397,HMBS,Porphobilinogen deaminase OS=Homo sapiens OX=9606 GN=HMBS PE=1 SV=2,5,11,0.387,1.089,5.992,0.067,-1.37,0.12,2.58,-3.9,4.30E-01,5.53E-01,3.66E-02,2.87E-02,2.34E+05,4.66E+05,3.39E+05,1.71E+06,5,3,4,5,2.34E+05,3.48E+05,1.63E+05,1.42E+05,2.07E+06,1.17E+06,4.66E+05,,,2.99E+04,,2.59E+04,5.49E+05,3.48E+05,3.31E+05,4.35E+05,1.11E+07,1.60E+06,1.71E+06,2.91E+06,9.31E+02,1.32E+03,1.60E+03,1.42E+05,1.07E+05,4.15E+03,8.29E+03,,,3.18E+02,,1.15E+03,4.46E+03,4.69E+04,8.21E+03,8.48E+02,3.12E+06,1.13E+04,4.00E+04,3.10E+04,0,FALSE,21.595,14,5,361,39.3,7.18,5,other metabolic processes,cytosol;other cell component,"Pf01379, Pf03900",3145,A8K2L0; G3V1P4; G5EA58; hsa:3145; P08396; P08397; Q16012,ENSG00000256269,Heme biosynthesis,Hemesynthesis defects and porphyrias; Heme biosynthesis,3,0,140.3,103.43,68.86,121.52,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,1,,FALSE,116.21,112.35,135.45,126.47,29.12,other molecular function,0,
Master Protein,High,Q9BVG8,KIFC3,Kinesin-like protein KIFC3 OS=Homo sapiens OX=9606 GN=KIFC3 PE=1 SV=4,1,1,0.386,2.054,4.904,0.159,-1.37,1.04,2.29,-2.65,3.91E-01,1.61E-01,1.17E-01,1.70E-01,1.01E+05,2.63E+05,3.10E+05,1.29E+06,5,1,3,4,1.51E+05,1.18E+06,4.99E+04,6.44E+04,1.01E+05,,2.63E+05,,,,,,3.10E+05,4.15E+05,1.02E+05,2.73E+06,8.49E+04,,6.08E+05,3.07E+07,6.00E+02,4.48E+03,4.87E+02,6.44E+04,5.23E+03,,4.67E+03,,,,,,2.52E+03,5.59E+04,2.52E+03,5.33E+03,2.39E+04,,1.42E+04,3.27E+05,0.002,FALSE,2.822,1,1,833,92.7,7.69,1,cell adhesion;cell organization and biogenesis;other biological processes,other membranes;cytoskeleton;ER/Golgi;other cell component,Pf00225,3801,A8K6S2; B7Z484; hsa:3801; O75299; Q49A29; Q49AQ0; Q59G19; Q8IUT3; Q96HW6; Q9BVG8,ENSG00000140859,,Ectoderm differentiation; IL-18 signaling pathway,2,0,157.74,,57.92,173.77,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,1,,FALSE,84.89,122.81,152.32,135.15,2.12,cytoskeletal activity;other molecular function,0,
Master Protein,High,M0R0P8,MYO9B,Myosin IXB OS=Homo sapiens OX=9606 GN=MYO9B PE=1 SV=1,2,3,0.382,0.313,,,-1.39,-1.67,,,3.60E-01,3.89E-01,,,1.39E+05,1.24E+05,5.05E+04,7.77E+05,4,2,1,2,1.63E+05,3.90E+06,,1.18E+05,9.22E+03,,,4.25E+05,,3.59E+04,5.05E+04,,,,,,,1.23E+06,4.91E+05,,6.48E+02,1.48E+04,,1.18E+05,4.76E+02,,,3.92E+03,,3.82E+02,3.02E+02,,,,,,,8.72E+03,1.15E+04,,0,FALSE,4.687,2,2,2157,243.2,8.78,2,signal transduction;other biological processes,cytosol;cytoskeleton,"Pf00063, Pf00612, Pf00620, Pf00788",,M0R0P8,ENSG00000099331,,,0,0,181.62,119.36,,60.82,Peak Found,High,n/a,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,103.9,1.76,,,8.37,enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,P28676,GCA,Grancalcin OS=Homo sapiens OX=9606 GN=GCA PE=1 SV=2,4,43,0.381,0.428,4.575,0.086,-1.39,-1.22,2.19,-3.53,2.33E-01,4.79E-01,7.05E-02,3.60E-02,3.55E+06,7.93E+06,1.89E+06,3.02E+07,4,5,4,5,3.37E+06,3.75E+06,,7.34E+05,9.61E+06,1.28E+07,7.93E+06,1.15E+07,4.19E+05,1.64E+06,,5.84E+05,2.66E+06,2.19E+06,1.63E+06,3.02E+07,1.72E+06,3.23E+07,2.90E+07,1.04E+08,1.34E+04,1.42E+04,,7.34E+05,4.96E+05,4.55E+04,1.41E+05,1.06E+05,1.18E+04,1.74E+04,,2.61E+04,2.16E+04,2.95E+05,4.04E+04,5.89E+04,4.82E+05,2.29E+05,6.79E+05,1.10E+06,0,FALSE,19.11,20,4,217,24,5.21,4,cell organization and biogenesis,non-structural extracellular;plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf13202,25801,B2R5X3; hsa:25801; P28676; Q53TB5; Q59EP3,ENSG00000115271,Neutrophil degranulation,,1,0,85.79,82.1,50.59,96.69,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,High,High,Peak Found,High,High,High,High,High,1,,FALSE,128.77,144.04,146.64,140.42,86.48,other molecular function,0,
Master Protein,High,Q68CP9,ARID2,AT-rich interactive domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ARID2 PE=1 SV=2,3,4,0.38,1.52,1.818,0.757,-1.39,0.6,0.86,-0.4,3.79E-01,3.37E-01,6.58E-01,9.45E-01,1.78E+05,2.50E+05,1.59E+05,4.54E+05,3,1,5,3,5.55E+04,,,2.74E+05,1.78E+05,,,,,2.50E+05,3.40E+04,1.59E+05,7.99E+04,6.22E+05,2.64E+05,,8.38E+04,4.54E+05,,6.01E+05,2.21E+02,,,2.74E+05,9.18E+03,,,,,2.66E+03,2.03E+02,7.12E+03,6.49E+02,8.39E+04,6.56E+03,,2.35E+04,3.22E+03,,6.40E+03,0,FALSE,16.046,3,3,1835,197.3,7.42,3,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf01388, Pf02257",196528,Q15KG9; Q5EB51; Q645I3; Q68CP9; Q6ZRY5; Q7Z3I5; Q86T28; Q96SJ6; Q9HCL5,ENSG00000189079,RMTs methylate histone arginines; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,,2,0,64.67,,101.35,70.21,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,7.3,105.75,47.8,47.8,14.19,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P50552,VASP,Vasodilator-stimulated phosphoprotein OS=Homo sapiens OX=9606 GN=VASP PE=1 SV=3,5,22,0.379,0.251,0.334,0.258,-1.4,-2,-1.58,-1.96,2.31E-01,1.34E-01,1.26E-01,2.60E-01,7.86E+06,1.59E+07,1.84E+06,4.00E+06,5,5,4,5,9.05E+06,7.96E+06,2.17E+06,3.62E+05,7.86E+06,1.27E+07,3.91E+06,1.59E+07,1.95E+07,2.00E+07,,2.01E+04,1.57E+06,2.52E+06,2.17E+06,6.03E+06,1.43E+06,5.98E+05,6.20E+06,4.00E+06,3.60E+04,3.02E+04,2.12E+04,3.62E+05,4.05E+05,4.51E+04,6.95E+04,1.47E+05,5.50E+05,2.13E+05,,8.98E+02,1.27E+04,3.39E+05,5.39E+04,1.18E+04,4.03E+05,4.24E+03,1.45E+05,4.26E+04,0,FALSE,17.746,17,5,380,39.8,8.94,5,cell organization and biogenesis;developmental processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00568, Pf08776",7408,B2RBT9; hsa:7408; P50552; Q6PIZ1; Q93035,ENSG00000125753,Generation of second messenger molecules; Signaling by ROBO receptors; Cell-extracellular matrix interactions,Integrin-mediated cell adhesion; Focal adhesion,5,0,71.67,45.64,70.4,70.47,High,High,High,High,High,Peak Found,Peak Found,High,High,High,n/a,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,104.59,108.7,122.82,105.52,64.51,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9H299,SH3BGRL3,SH3 domain-binding glutamic acid-rich-like protein 3 OS=Homo sapiens OX=9606 GN=SH3BGRL3 PE=1 SV=1,1,1,0.378,0.307,0.01,100,-1.4,-1.7,-6.64,6.64,4.13E-01,3.26E-01,1.00E-17,1.00E-17,2.14E+05,4.93E+05,5.58E+04,,4,2,4,,1.11E+05,2.48E+05,1.85E+05,3.07E+05,,3.33E+05,,7.31E+05,,,,4.55E+04,6.65E+04,1.08E+05,4.68E+04,,,,,,4.40E+02,9.44E+02,1.81E+03,3.07E+05,,1.18E+03,,6.74E+03,,,,2.03E+03,5.41E+02,1.45E+04,1.16E+03,,,,,,0.002,FALSE,2.907,11,1,93,10.4,4.93,1,cell organization and biogenesis,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf04908,83442,hsa:83442; Q5T122; Q9H299,ENSG00000142669,,VEGFA-VEGFR2 signaling,1,0,39.65,52.9,43.66,,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,60.28,52.61,,,2.53,,0,
Master Protein,Medium,P12018,VPREB1,Immunoglobulin iota chain OS=Homo sapiens OX=9606 GN=VPREB1 PE=1 SV=2,1,1,0.378,0.606,3.902,0.026,-1.4,-0.72,1.96,-5.28,3.05E-01,9.39E-01,2.32E-01,5.04E-04,3.50E+04,9.26E+04,2.12E+04,5.74E+05,1,3,3,2,,,,3.50E+04,,1.11E+06,9.26E+04,,,2.58E+04,,9.53E+03,,2.12E+04,2.29E+04,1.91E+05,,1.73E+06,,,,,,3.50E+04,,3.95E+03,1.65E+03,,,2.74E+02,,4.25E+02,,2.86E+03,5.68E+02,3.72E+02,,1.22E+04,,,0.03,FALSE,1.825,6,1,145,16.6,6.76,1,other biological processes,non-structural extracellular;ER/Golgi,Pf07686,7441,B5MCG2; hsa:7441; P12018,ENSG00000169575,Cell surface interactions at the vascular wall,,1,0,,148.41,40.68,113.3,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,106.98,10.75,137.23,128.14,1.97,,0,
Master Protein,High,Q92598,HSPH1,Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,1,1,0.376,0.696,0.993,0.348,-1.41,-0.52,-0.01,-1.52,3.59E-01,9.79E-01,9.20E-01,5.06E-01,8.60E+04,2.29E+05,5.99E+04,1.70E+05,1,3,4,4,,,,,8.60E+04,2.29E+05,,2.31E+05,,1.01E+05,9.16E+04,,6.59E+04,5.44E+04,5.17E+04,1.84E+05,1.48E+05,2.83E+05,,1.57E+05,,,,,4.43E+03,8.13E+02,,2.13E+03,,1.08E+03,5.48E+02,,5.36E+02,7.33E+03,1.29E+03,3.59E+02,4.16E+04,2.01E+03,,1.67E+03,0.003,FALSE,2.727,2,1,858,96.8,5.39,1,protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;cytosol;cytoskeleton;nucleus;other cell component,Pf00012,10808,B4DYH1; hsa:10808; O95739; Q5TBM6; Q5TBM7; Q5TBM8; Q92598; Q9UPC4,ENSG00000120694,Regulation of HSF1-mediated heat shock response; Scavenging by Class F Receptors,,2,0,,39.74,27.62,32.04,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,1.51,19.16,59.72,29.23,2.56,cytoskeletal activity;other molecular function,0,
Master Protein,High,O43815,STRN,Striatin OS=Homo sapiens OX=9606 GN=STRN PE=1 SV=4,5,7,0.375,0.332,0.245,0.246,-1.41,-1.59,-2.03,-2.03,4.05E-01,3.47E-01,9.15E-02,3.37E-01,3.29E+05,5.64E+05,1.64E+05,1.69E+05,5,4,4,5,3.29E+05,3.19E+05,6.54E+05,6.03E+05,2.21E+05,5.39E+05,4.62E+04,5.90E+05,3.66E+06,,,1.97E+05,1.32E+05,1.57E+05,1.71E+05,2.30E+05,1.69E+05,8.86E+04,9.07E+04,1.63E+06,1.31E+03,1.21E+03,6.39E+03,6.03E+05,1.14E+04,1.92E+03,8.21E+02,5.45E+03,1.03E+05,,,8.81E+03,1.07E+03,2.12E+04,4.26E+03,4.48E+02,4.74E+04,6.28E+02,2.12E+03,1.74E+04,0,FALSE,15.726,11,5,780,86.1,5.27,5,cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf00400, Pf08232",6801,hsa:6801; O43815; Q3KP65; Q53TQ8; Q9NP38,ENSG00000115808,"Extra-nuclear estrogen signaling; PIP3 activates AKT signaling; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Signaling by cytosolic PDGFRA and PDGFRB fusion proteins",MET in type 1 papillary renal cell carcinoma,8,0,44.92,136.69,16.7,151.15,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,127.47,80.6,111.71,82.21,19.5,other molecular function,0,
Master Protein,High,Q8NFH4,NUP37,Nucleoporin Nup37 OS=Homo sapiens OX=9606 GN=NUP37 PE=1 SV=1,2,2,0.375,0.748,3.091,0.027,-1.42,-0.42,1.63,-5.23,3.75E-01,9.12E-01,1.59E-01,1.08E-03,2.21E+05,2.27E+05,1.25E+05,3.65E+06,2,3,4,3,,,,2.91E+05,1.67E+05,1.25E+06,,2.27E+05,,1.90E+05,,1.03E+05,4.07E+04,2.92E+05,1.52E+05,,1.78E+05,3.88E+06,,3.65E+06,,,,2.91E+05,8.61E+03,4.46E+03,,2.10E+03,,2.02E+03,,4.60E+03,3.30E+02,3.94E+04,3.78E+03,,5.01E+04,2.75E+04,,3.89E+04,0,FALSE,6.116,9,2,326,36.7,5.92,2,cell cycle OR cell proliferation;transport;other biological processes,cytosol;nucleus;other cell component,Pf00400,79023,hsa:79023; Q8NFH4; Q9H644,ENSG00000075188,Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; ISG15 antiviral mechanism; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Vpr-mediated nuclear import of PICs; tRNA processing in the nucleus; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,,35,0,38.36,108.43,72.78,80.71,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,60.33,58.55,141.44,110.76,7.55,,0,
Master Protein,High,O75923,DYSF,Dysferlin OS=Homo sapiens OX=9606 GN=DYSF PE=1 SV=1,4,24,0.374,0.67,1.423,0.147,-1.42,-0.58,0.51,-2.77,2.90E-01,9.98E-01,7.51E-01,1.04E-01,6.64E+05,1.72E+06,3.27E+05,2.40E+06,4,5,5,5,7.55E+05,1.51E+06,,1.01E+04,5.83E+05,2.97E+06,1.72E+06,3.23E+06,2.30E+05,5.89E+05,6.20E+05,5.13E+04,9.82E+05,3.27E+05,1.24E+05,5.37E+06,1.13E+06,4.83E+06,1.77E+06,2.40E+06,3.00E+03,5.72E+03,,1.01E+04,3.01E+04,1.06E+04,3.07E+04,2.98E+04,6.49E+03,6.27E+03,3.71E+03,2.29E+03,7.97E+03,4.40E+04,3.07E+03,1.05E+04,3.17E+05,3.42E+04,4.15E+04,2.55E+04,0,FALSE,16.275,3,4,2080,237.1,5.64,4,other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00168, Pf08150, Pf08151, Pf08165, Pf16165",8291,A0FK00; B1PZ70; B1PZ71; B1PZ72; B1PZ73; B1PZ74; B1PZ75; B1PZ76; B1PZ77; B1PZ78; B1PZ79; B1PZ80; B1PZ81; B3KQB9; hsa:8291; O75696; O75923; Q09EX5; Q0H395; Q53QY3; Q53TD2; Q8TEL8; Q9UEN7,ENSG00000135636,Smooth Muscle Contraction,,1,0,86.44,77.42,91.11,60.98,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,126.47,140.66,124.68,112.32,62.22,other molecular function,0,
Master Protein,High,Q99536,VAT1,Synaptic vesicle membrane protein VAT-1 homolog OS=Homo sapiens OX=9606 GN=VAT1 PE=1 SV=2,4,19,0.373,0.344,0.226,0.154,-1.42,-1.54,-2.15,-2.7,2.24E-01,3.02E-01,4.23E-02,1.13E-01,5.26E+06,1.39E+07,4.92E+05,5.41E+06,3,5,4,4,,5.26E+06,,2.43E+05,5.83E+06,1.39E+07,6.97E+06,2.03E+08,5.85E+06,6.64E+07,,2.30E+05,3.06E+05,2.47E+06,7.91E+05,2.13E+06,3.88E+05,2.30E+07,,1.37E+07,,2.00E+04,,2.43E+05,3.01E+05,4.94E+04,1.24E+05,1.87E+06,1.65E+05,7.06E+05,,1.03E+04,2.49E+03,3.33E+05,1.97E+04,4.15E+03,1.09E+05,1.63E+05,,1.46E+05,0,FALSE,17.747,16,4,393,41.9,6.29,4,other biological processes,non-structural extracellular;other membranes;mitochondrion;other cytoplasmic organelle,"Pf08240, Pf13602",10493,A8K345; B0AZP7; B4DPX4; hsa:10493; Q13035; Q5BKZ7; Q96A39; Q99536; Q9BUT8,ENSG00000108828,Neutrophil degranulation,,1,0,81.39,142.16,110.05,108.07,n/a,High,n/a,High,High,Peak Found,Peak Found,High,High,High,n/a,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,138.98,132.39,139.86,131.91,44.94,other molecular function,0,
Master Protein,High,Q5T760,SRSF11,Serine and arginine rich splicing factor 11 OS=Homo sapiens OX=9606 GN=SRSF11 PE=1 SV=2,2,7,0.372,0.104,0.658,0.391,-1.43,-3.26,-0.6,-1.36,2.84E-01,7.76E-03,5.21E-01,5.65E-01,1.59E+06,7.10E+05,6.99E+04,3.29E+05,5,1,5,4,2.43E+06,1.98E+05,1.59E+06,1.67E+06,5.82E+05,,,,,7.10E+05,4.67E+05,6.99E+04,4.03E+04,9.90E+04,3.32E+04,1.69E+06,1.29E+05,8.39E+05,,9.37E+04,9.66E+03,7.53E+02,1.55E+04,1.67E+06,3.00E+04,,,,,7.55E+03,2.79E+03,3.12E+03,3.28E+02,1.33E+04,8.24E+02,3.30E+03,3.62E+04,5.94E+03,,9.97E+02,0,FALSE,7.632,5,2,491,54.3,10.45,2,RNA metabolism OR transcription;other metabolic processes,nucleus,Pf00076,,Q5T760,ENSG00000116754,,,0,0,69.43,,129.44,109.28,Peak Found,Peak Found,High,High,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,104.54,104.38,248.3,115.08,9.53,nucleic acid binding activity,0,
Master Protein,High,O14602,EIF1AY,"Eukaryotic translation initiation factor 1A, Y-chromosomal OS=Homo sapiens OX=9606 GN=EIF1AY PE=1 SV=4",2,4,0.372,0.307,0.918,0.067,-1.43,-1.7,-0.12,-3.89,2.89E-01,2.95E-01,8.21E-01,2.77E-02,5.46E+05,2.10E+06,1.68E+05,1.92E+06,2,3,2,3,,,,3.82E+05,7.79E+05,,,3.41E+06,1.31E+06,2.10E+06,,2.91E+05,,9.66E+04,,3.90E+07,1.15E+06,,1.92E+06,,,,,3.82E+05,4.02E+04,,,3.14E+04,3.69E+04,2.23E+04,,1.30E+04,,1.30E+04,,7.61E+04,3.24E+05,,4.50E+04,,0,FALSE,6.744,18,2,144,16.4,5.24,2,protein metabolism;other metabolic processes,other cell component,Pf01176,9086,hsa:9086; O14602; Q9BS77,ENSG00000198692,,Translation factors,1,0,48.4,46.7,70.95,154.25,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,55.7,153.92,118.96,98.06,11.96,nucleic acid binding activity,0,
Master Protein,High,Q9Y333,LSM2,U6 snRNA-associated Sm-like protein LSm2 OS=Homo sapiens OX=9606 GN=LSM2 PE=1 SV=1,3,7,0.371,1.773,0.053,12.928,-1.43,0.83,-4.25,3.69,2.31E-01,2.24E-01,6.79E-05,1.08E-02,2.95E+05,3.84E+06,3.54E+05,1.30E+05,3,1,2,2,,,1.07E+05,2.95E+05,7.27E+06,,,,,3.84E+06,6.38E+05,,,1.96E+05,,,5.31E+04,,3.18E+05,,,,1.05E+03,2.95E+05,3.75E+05,,,,,4.08E+04,3.82E+03,,,2.64E+04,,,1.49E+04,,7.45E+03,,0,FALSE,12.931,60,3,95,10.8,6.52,3,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf01423,57819,hsa:57819; Q6FGG1; Q9Y333,ENSG00000172850; ENSG00000204392; ENSG00000224979; ENSG00000225998; ENSG00000231502; ENSG00000236826,mRNA Splicing - Major Pathway; mRNA decay by 5' to 3' exoribonuclease,mRNA processing,3,0,159.64,,74.89,100.97,n/a,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,132.09,94.46,239.59,92.56,24.84,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P56589,PEX3,Peroxisomal biogenesis factor 3 OS=Homo sapiens OX=9606 GN=PEX3 PE=1 SV=1,1,1,0.37,0.723,3.105,0.086,-1.43,-0.47,1.63,-3.54,3.44E-01,9.82E-01,3.10E-01,3.66E-02,7.90E+04,2.13E+05,5.71E+04,6.62E+05,2,2,2,1,,,,7.14E+04,8.73E+04,1.79E+05,,,,2.54E+05,1.28E+05,,,2.55E+04,,,,6.62E+05,,,,,,7.14E+04,4.50E+03,6.36E+02,,,,2.70E+03,7.64E+02,,,3.44E+03,,,,4.69E+03,,,0.001,FALSE,3.285,3,1,373,42.1,8.15,1,cell organization and biogenesis;transport,other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf04882,8504,hsa:8504; P56589; Q6FGP5,ENSG00000034693,Class I peroxisomal membrane protein import; ABC transporters in lipid homeostasis,,2,0,14.21,24.61,94.38,,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,23.69,120.11,26.2,132.85,2.73,other molecular function,0,
Master Protein,High,P43246,MSH2,DNA mismatch repair protein Msh2 OS=Homo sapiens OX=9606 GN=MSH2 PE=1 SV=1,7,11,0.37,0.774,0.475,0.518,-1.44,-0.37,-1.07,-0.95,3.52E-01,8.52E-01,2.98E-01,6.93E-01,3.03E+05,1.42E+06,9.25E+04,1.83E+06,5,3,5,5,1.12E+05,1.81E+05,3.03E+05,7.06E+05,7.30E+06,1.42E+06,3.01E+06,4.39E+05,,,5.73E+05,6.91E+04,1.10E+06,6.25E+04,9.25E+04,1.83E+06,1.63E+05,2.12E+06,5.28E+04,4.55E+06,4.44E+02,6.89E+02,2.96E+03,7.06E+05,3.77E+05,5.06E+03,5.35E+04,4.05E+03,,,3.42E+03,3.08E+03,8.91E+03,8.43E+03,2.30E+03,3.56E+03,4.57E+04,1.50E+04,1.24E+03,4.84E+04,0,FALSE,30.208,11,7,934,104.7,5.77,7,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,nucleus,"Pf00488, Pf01624, Pf05188, Pf05190, Pf05192",4436,B4E2Z2; hsa:4436; O75488; P43246,ENSG00000095002,TP53 Regulates Transcription of DNA Repair Genes; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta); Defective Mismatch Repair Associated With MSH3; Defective Mismatch Repair Associated With MSH2; Defective Mismatch Repair Associated With MSH6,"RAC1/PAK1/p38/MMP2 pathway; Chromosomal and microsatellite instability in colorectal cancer ; Ciliary landscape; DNA repair pathways, full network; p53 transcriptional gene network; DNA mismatch repair",12,0,181.78,79.84,120.35,105.02,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,129.85,106.62,103.43,92.28,34.56,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9UKX7,NUP50,Nuclear pore complex protein Nup50 OS=Homo sapiens OX=9606 GN=NUP50 PE=1 SV=2,4,6,0.369,1.944,0.432,0.769,-1.44,0.96,-1.21,-0.38,4.12E-01,1.85E-01,2.80E-01,9.54E-01,1.40E+05,5.13E+05,2.69E+05,2.66E+05,3,5,3,3,,1.37E+05,1.40E+05,5.78E+05,,1.44E+06,3.78E+05,6.23E+05,2.70E+05,5.13E+05,1.04E+07,8.45E+04,,2.69E+05,,,,3.61E+05,1.44E+05,2.66E+05,,5.20E+02,1.37E+03,5.78E+05,,5.10E+03,6.73E+03,5.74E+03,7.62E+03,5.45E+03,6.22E+04,3.77E+03,,3.62E+04,,,,2.56E+03,3.38E+03,2.83E+03,0,FALSE,17.356,15,4,468,50.1,7.06,4,transport,other membranes;nucleus,"Pf00638, Pf08911",10762,B1AHA4; B2RB15; hsa:10762; O75644; Q8N6V5; Q9NPM9; Q9NPR6; Q9P1K5; Q9UKX7,ENSG00000093000,Rev-mediated nuclear export of HIV RNA; SUMOylation of DNA replication proteins; HCMV Early Events; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses,,28,0,89.12,71.79,164.69,42.14,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,56.17,56.69,38.83,157.2,20.77,,0,
Master Protein,High,F5GYJ8,OTUB1,ubiquitinyl hydrolase 1 OS=Homo sapiens OX=9606 GN=OTUB1 PE=1 SV=1,2,4,0.368,1.949,0.483,1.564,-1.44,0.96,-1.05,0.65,3.47E-01,2.10E-01,4.29E-01,5.43E-01,1.13E+05,1.46E+05,2.40E+05,1.46E+05,5,2,5,4,2.06E+06,5.87E+04,4.59E+05,1.13E+05,3.49E+04,,,,8.40E+04,2.53E+05,1.14E+05,3.06E+04,4.87E+05,3.12E+05,2.40E+05,,2.94E+05,4.27E+05,3.74E+04,7.22E+04,8.18E+03,2.23E+02,4.48E+03,1.13E+05,1.80E+03,,,,2.37E+03,2.69E+03,6.84E+02,1.37E+03,3.95E+03,4.20E+04,5.96E+03,,8.25E+04,3.02E+03,8.76E+02,7.68E+02,0,FALSE,9.165,7,2,286,32.3,4.96,2,protein metabolism,,Pf10275,,F5GYJ8,ENSG00000167770,,,0,0,158.45,70.82,74.85,89.17,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,73.54,120.25,83.73,126.36,7.33,other molecular function,0,
Master Protein,High,Q96RQ3,MCCC1,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=MCCC1 PE=1 SV=3",8,18,0.368,0.613,0.793,0.324,-1.44,-0.71,-0.33,-1.62,2.73E-01,9.47E-01,6.70E-01,3.56E-01,1.17E+06,1.77E+06,8.69E+05,4.51E+06,3,3,4,4,3.24E+06,1.01E+06,,1.17E+06,,,6.95E+05,1.77E+06,,1.17E+07,2.04E+06,,8.23E+05,9.16E+05,4.69E+05,,1.82E+07,7.77E+06,2.61E+06,1.27E+06,1.29E+04,3.84E+03,,1.17E+06,,,1.24E+04,1.63E+04,,1.24E+05,1.22E+04,,6.69E+03,1.23E+05,1.17E+04,,5.10E+06,5.50E+04,6.12E+04,1.35E+04,0,FALSE,45.161,20,8,725,80.4,7.78,8,other metabolic processes,cytosol;mitochondrion;other cell component,"Pf00289, Pf00364, Pf02785, Pf02786",56922,hsa:56922; Q59ES4; Q96RQ3; Q9H959; Q9NS97,ENSG00000078070,Biotin transport and metabolism; Branched-chain amino acid catabolism; Defective HLCS causes multiple carboxylase deficiency,Amino acid metabolism,4,0,68.72,128.47,63.99,102.9,High,Peak Found,High,High,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,91.28,77.48,137.32,93.99,55.35,other molecular function,0,
Master Protein,High,P02647,APOA1,Apolipoprotein A-I OS=Homo sapiens OX=9606 GN=APOA1 PE=1 SV=1,5,7,0.365,0.804,1.773,0.904,-1.45,-0.31,0.83,-0.15,2.15E-01,7.43E-01,5.49E-01,9.23E-01,2.88E+06,7.26E+06,3.28E+05,1.76E+05,5,5,5,4,5.35E+06,2.83E+05,2.91E+06,1.94E+04,2.88E+06,7.26E+06,1.56E+06,8.87E+06,1.10E+06,1.28E+07,8.20E+04,1.63E+05,3.28E+05,1.66E+06,6.80E+05,3.42E+05,3.74E+06,9.07E+04,,7.05E+04,2.12E+04,1.08E+03,2.84E+04,1.94E+04,1.49E+05,2.58E+04,2.77E+04,8.18E+04,3.11E+04,1.37E+05,4.90E+02,7.30E+03,2.66E+03,2.23E+05,1.69E+04,6.68E+02,1.05E+06,6.43E+02,,7.51E+02,0,FALSE,14.16,23,5,267,30.8,5.76,5,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf01442,335,A8K866; hsa:335; P02647; Q6LDN9; Q6Q785; Q9UCS8; Q9UCT8,ENSG00000118137,Platelet degranulation ; Scavenging of heme from plasma; PPARA activates gene expression; Amyloid fiber formation; Scavenging by Class B Receptors; Heme signaling; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Retinoid metabolism and transport; HDL clearance; Defective ABCA1 causes TGD; HDL assembly; Scavenging by Class A Receptors; ABC transporters in lipid homeostasis; Chylomicron assembly; Chylomicron remodeling; HDL remodeling,Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; Complement system; PPAR-alpha pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Statin inhibition of cholesterol production; Familial  hyperlipidemia type 1; Familial hyperlipidemia type 2; Familial hyperlipidemia type 3; Familial hyperlipidemia type 4; Familial hyperlipidemia type 5; Cholesterol metabolism; Enterocyte cholesterol metabolism,32,0,95.9,78.93,110.52,168.78,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,97.78,120.02,108.12,106.78,22.72,signal transduction activity or receptor binding;transporter activity;enzyme regulator activity;other molecular function,0,
Master Protein,High,I3L504,EIF5A,Eukaryotic translation initiation factor 5A OS=Homo sapiens OX=9606 GN=EIF5A PE=1 SV=1,7,45,0.363,0.298,1.033,0.076,-1.46,-1.75,0.05,-3.71,2.13E-01,2.24E-01,9.29E-01,2.74E-02,3.29E+06,7.17E+06,7.55E+05,2.00E+07,4,5,5,5,3.01E+05,5.18E+06,,2.09E+06,1.38E+07,7.17E+06,3.16E+07,3.73E+07,4.09E+06,3.36E+06,1.53E+05,1.23E+06,3.69E+05,2.64E+06,7.55E+05,2.00E+07,3.99E+06,5.93E+07,4.70E+06,3.41E+07,1.19E+03,1.97E+04,,2.09E+06,7.12E+05,2.55E+04,5.62E+05,3.44E+05,1.15E+05,3.57E+04,9.15E+02,5.52E+04,3.00E+03,3.56E+05,1.88E+04,3.91E+04,1.12E+06,4.20E+05,1.10E+05,3.63E+05,0,FALSE,32.987,30,7,186,20.5,5.25,7,protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi,"Pf01287, Pf21485",,I3L504,ENSG00000132507,,eIF5A regulation in response to inhibition of the nuclear export system,1,0,112.01,98.1,96.07,94.59,Peak Found,Peak Found,n/a,High,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,1,,FALSE,128.45,128.88,130.78,145.58,106.84,translation activity;nucleic acid binding activity,0,
Master Protein,High,Q49A26,GLYR1,Cytokine-like nuclear factor N-PAC OS=Homo sapiens OX=9606 GN=GLYR1 PE=1 SV=4,7,27,0.363,0.883,1.242,0.792,-1.46,-0.18,0.31,-0.34,2.13E-01,6.40E-01,8.84E-01,9.68E-01,1.92E+06,9.43E+06,1.76E+06,5.88E+05,5,3,4,5,1.92E+06,6.78E+05,1.34E+05,4.12E+06,2.01E+06,1.82E+07,,2.42E+05,,9.43E+06,,1.74E+06,1.71E+06,3.53E+06,1.79E+06,8.52E+05,4.25E+04,5.88E+05,4.44E+05,1.18E+06,7.65E+03,2.58E+03,1.31E+03,4.12E+06,1.04E+05,6.46E+04,,2.23E+03,,1.00E+05,,7.76E+04,1.39E+04,4.76E+05,4.45E+04,1.66E+03,1.19E+04,4.17E+03,1.04E+04,1.26E+04,0,FALSE,43.897,20,7,553,60.5,9.17,7,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,"Pf00855, Pf03446, Pf14833",84656,B4DL47; C9JJ40; C9JJ60; hsa:84656; Q49A26; Q5U632; Q6P1Q2; Q6V3W7; Q9BTI1; Q9BXK2,ENSG00000140632,,,0,0,86.78,96.58,40.77,68.96,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,88.41,96.81,116.94,79.65,91.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A7P0TAU8,OAS3,2'-5' oligoadenylate synthase OS=Homo sapiens OX=9606 GN=OAS3 PE=1 SV=1,1,1,0.359,0.973,0.01,100,-1.48,-0.04,-6.64,6.64,2.91E-01,6.80E-01,1.00E-17,1.00E-17,3.12E+04,8.69E+04,3.04E+04,,2,1,1,,,,4.64E+04,2.10E+04,,,,,8.69E+04,,,,,3.04E+04,,,,,,,,,4.53E+02,2.10E+04,,,,,2.45E+03,,,,,4.09E+03,,,,,,,0.003,FALSE,2.68,2,1,1130,125.9,8,1,stress response,plasma membrane;other membranes;cytosol;nucleus,"Pf01909, Pf10421",,A0A7P0TAU8,ENSG00000111331,,Measles virus infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction,3,0,53.42,,,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,60.48,60.48,,,3.32,other molecular function,0,
Master Protein,High,A0A994J439,ITIH3,Inter-alpha-trypsin inhibitor heavy chain 3 OS=Homo sapiens OX=9606 GN=ITIH3 PE=4 SV=1,2,3,0.359,1.478,0.074,4.63,-1.48,0.56,-3.75,2.21,3.76E-01,3.40E-01,4.18E-03,1.64E-01,2.85E+05,7.95E+05,1.95E+05,5.91E+04,2,2,5,2,,,,1.03E+05,7.86E+05,8.31E+05,,,,7.61E+05,2.36E+06,2.13E+05,1.55E+05,1.95E+05,1.50E+05,,3.30E+04,,,1.06E+05,,,,1.03E+05,4.05E+04,2.95E+03,,,,8.09E+03,1.41E+04,9.52E+03,1.26E+03,2.63E+04,3.73E+03,,9.27E+03,,,1.13E+03,0,FALSE,5.493,3,2,927,103.7,5.94,2,other metabolic processes,non-structural extracellular,,,A0A994J439,ENSG00000162267,,Network map of SARS-CoV-2 signaling pathway,1,0,108.54,6.23,158.76,74.23,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,169.84,122.2,87.49,86.54,8.39,enzyme regulator activity,0,
Master Protein,High,A0A8I5KWT8,MYH9,Myosin heavy chain 9 OS=Homo sapiens OX=9606 GN=MYH9 PE=1 SV=1,108,2636,0.358,0.363,0.653,0.321,-1.48,-1.46,-0.61,-1.64,2.07E-01,3.40E-01,5.00E-01,3.51E-01,5.44E+08,1.06E+09,1.96E+08,1.12E+09,5,5,5,5,5.56E+08,1.18E+09,1.86E+08,7.85E+07,5.44E+08,1.49E+09,8.60E+08,3.11E+09,1.06E+09,5.23E+08,1.22E+08,6.45E+07,2.20E+08,2.01E+08,1.96E+08,2.09E+09,2.83E+08,1.33E+09,3.44E+08,1.12E+09,2.21E+06,4.48E+06,1.82E+06,7.85E+07,2.81E+07,5.29E+06,1.53E+07,2.87E+07,2.98E+07,5.56E+06,7.31E+05,2.88E+06,1.79E+06,2.70E+07,4.86E+06,4.07E+06,7.96E+07,9.40E+06,8.05E+06,1.19E+07,0,FALSE,752.696,50,97,1981,229,5.64,108,,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus,"Pf00063, Pf01576, Pf02736",,A0A8I5KWT8,ENSG00000100345,,Primary focal segmental glomerulosclerosis (FSGS); HDAC6 interactions in the central nervous system,2,12,84.69,72.05,40.67,72.61,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,134.2,127.97,134.17,131.51,7662.14,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q96C36,PYCR2,Pyrroline-5-carboxylate reductase 2 OS=Homo sapiens OX=9606 GN=PYCR2 PE=1 SV=1,2,2,0.358,0.933,6.217,0.061,-1.48,-0.1,2.64,-4.03,3.25E-01,7.76E-01,6.92E-02,2.93E-02,6.38E+04,2.08E+05,7.89E+04,1.29E+06,3,2,3,1,2.54E+05,6.38E+04,,4.84E+04,,,2.78E+05,1.55E+05,,,1.36E+05,4.52E+04,,,7.89E+04,,,,,1.29E+06,1.01E+03,2.42E+02,,4.84E+04,,,4.94E+03,1.43E+03,,,8.11E+02,2.02E+03,,,1.96E+03,,,,,1.37E+04,0,FALSE,7.049,10,2,320,33.6,7.77,2,other metabolic processes;stress response,mitochondrion,"Pf03807, Pf14748",29920,A8K798; hsa:29920; Q7Z515; Q96C36; Q9Y5J4,ENSG00000143811,Glutamate and glutamine metabolism,Metabolic reprogramming in colon cancer,2,0,93.85,40.04,52.8,,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,1,,FALSE,86.59,83.19,43.76,62.04,2.1,other molecular function,0,
Master Protein,High,P62258,YWHAE,14-3-3 protein epsilon OS=Homo sapiens OX=9606 GN=YWHAE PE=1 SV=1,8,51,0.358,0.506,0.691,0.517,-1.48,-0.98,-0.53,-0.95,2.26E-01,6.54E-01,5.47E-01,6.11E-01,2.45E+06,1.26E+06,2.32E+06,5.58E+06,4,1,5,4,1.73E+07,9.02E+05,3.10E+06,1.94E+06,,1.26E+06,,,,,4.92E+06,9.53E+05,1.71E+06,6.92E+06,2.32E+06,,6.86E+06,8.32E+06,1.45E+06,4.53E+06,6.89E+04,3.43E+03,3.03E+04,1.94E+06,,4.46E+03,,,,,2.94E+04,4.26E+04,1.39E+04,9.32E+05,5.77E+04,,1.93E+06,5.89E+04,3.40E+04,4.83E+04,0,FALSE,28.444,31,6,255,29.2,4.74,8,stress response;developmental processes;signal transduction;other biological processes,other membranes;cytosol;mitochondrion;nucleus;other cell component,Pf00244,7531,B3KY71; D3DTH5; hsa:7531; P29360; P42655; P62258; Q4VJB6; Q53XZ5; Q63631; Q7M4R4,ENSG00000108953; ENSG00000274474,RAB GEFs exchange GTP for GDP on RABs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Recruitment of NuMA to mitotic centrosomes; Regulation of HSF1-mediated heat shock response; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; TP53 Regulates Metabolic Genes; Signaling by Hippo; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; HSF1 activation; NADE modulates death signalling; Activation of BAD and translocation to mitochondria,Cell cycle; Myometrial relaxation and contraction pathways; VEGFA-VEGFR2 signaling; Calcium regulation in cardiac cells; 17p13.3 (YWHAE) copy number variation; Sudden infant death syndrome (SIDS) susceptibility pathways,26,0,132.84,,73.8,56.62,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,0,88.96,17.76,100.18,102.88,other molecular function,0,
Master Protein,High,P11215,ITGAM,Integrin alpha-M OS=Homo sapiens OX=9606 GN=ITGAM PE=1 SV=2,6,98,0.356,0.401,0.46,0.251,-1.49,-1.32,-1.12,-1.99,2.05E-01,4.21E-01,2.62E-01,2.51E-01,8.81E+06,1.69E+07,1.71E+06,1.36E+07,5,5,5,5,8.81E+06,1.50E+07,4.49E+05,7.20E+04,1.92E+07,4.16E+07,1.62E+07,1.69E+07,1.02E+07,4.27E+07,1.01E+06,2.55E+05,4.99E+06,3.91E+06,1.71E+06,2.13E+07,9.50E+05,6.73E+06,1.36E+07,1.44E+07,3.50E+04,5.72E+04,4.38E+03,7.20E+04,9.92E+05,1.48E+05,2.88E+05,1.56E+05,2.88E+05,4.54E+05,6.03E+03,1.14E+04,4.05E+04,5.27E+05,4.24E+04,4.15E+04,2.67E+05,4.77E+04,3.18E+05,1.53E+05,0,FALSE,28.031,5,6,1152,127.1,7.23,6,cell adhesion;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf00092, Pf00357, Pf01839, Pf08441, Pf20805, Pf21520",3684,hsa:3684; P11215; Q4VAK0; Q4VAK1; Q4VAK2,ENSG00000169896,Cell surface interactions at the vascular wall; Integrin cell surface interactions; Neutrophil degranulation; Toll Like Receptor 4 (TLR4) Cascade; Interleukin-4 and Interleukin-13 signaling,Integrin-mediated cell adhesion; Vitamin D receptor pathway; Microglia pathogen phagocytosis pathway; TYROBP causal network in microglia; Fibrin complement receptor 3 signaling pathway; Complement system in neuronal development and plasticity; Acute myeloid leukemia,12,0,98.25,60.37,84.25,68.35,Peak Found,High,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,High,High,Peak Found,High,High,High,High,High,1,,FALSE,121.26,143.58,141.29,143.24,224.87,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,C9JRZ6,CHCHD3,Coiled-coil-helix-coiled-coil-helix domain containing 3 OS=Homo sapiens OX=9606 GN=CHCHD3 PE=1 SV=2,10,57,0.355,0.615,0.742,0.962,-1.49,-0.7,-0.43,-0.06,2.04E-01,8.63E-01,6.09E-01,9.67E-01,5.21E+06,6.75E+06,2.77E+06,2.37E+06,5,5,5,5,7.67E+05,1.16E+07,5.29E+05,5.21E+06,5.32E+06,1.32E+07,2.47E+06,7.27E+06,9.14E+05,6.75E+06,2.95E+05,2.77E+06,1.23E+06,3.54E+06,4.20E+06,4.58E+06,1.05E+06,1.55E+06,2.37E+06,2.50E+06,3.05E+03,4.40E+04,5.17E+03,5.21E+06,2.74E+05,4.69E+04,4.39E+04,6.71E+04,2.58E+04,7.18E+04,1.76E+03,1.24E+05,9.99E+03,4.78E+05,1.04E+05,8.94E+03,2.95E+05,1.10E+04,5.56E+04,2.67E+04,0,FALSE,37.017,41,10,232,26.7,7.75,10,,other membranes;mitochondrion,Pf05300,54927,C9JRZ6,ENSG00000106554,,,0,0,96.04,78.46,67.24,56.08,Peak Found,High,Peak Found,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,121.91,115.94,132.11,114.93,147.2,,0,
Master Protein,High,Q14520,HABP2,Hyaluronan-binding protein 2 OS=Homo sapiens OX=9606 GN=HABP2 PE=1 SV=1,6,9,0.354,,0.35,2.861,-1.5,,-1.52,1.52,2.65E-01,,1.32E-01,2.60E-01,4.62E+05,1.86E+06,1.01E+05,1.96E+06,4,4,1,1,1.57E+05,4.13E+06,1.14E+05,1.36E+06,,9.50E+06,4.04E+04,3.63E+05,2.01E+07,,1.01E+05,,,,,,,,,1.96E+06,6.24E+02,1.57E+04,1.11E+03,1.36E+06,,3.38E+04,7.18E+02,3.35E+03,5.67E+05,,6.02E+02,,,,,,,,,2.09E+04,0,FALSE,23.264,12,6,560,62.6,6.54,6,cell adhesion;protein metabolism,non-structural extracellular,"Pf00008, Pf00051, Pf00089",3026,A8K467; B7Z8U5; F5H5M6; hsa:3026; O00663; Q14520,ENSG00000148702,,,0,0,130.82,126.36,,,Peak Found,Peak Found,Peak Found,High,n/a,High,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,145.12,,184.13,0,21.12,other molecular function,0,
Master Protein,High,A0A669KAV7,WIZ,WIZ zinc finger OS=Homo sapiens OX=9606 GN=WIZ PE=1 SV=1,5,9,0.349,0.348,0.01,100,-1.52,-1.52,-6.64,6.64,3.70E-01,3.93E-01,1.00E-17,1.00E-17,4.08E+05,8.29E+05,1.48E+05,,2,1,3,,,,,3.74E+05,4.45E+05,8.29E+05,,,,,,1.48E+05,,1.51E+05,1.36E+04,,,,,,,,,3.74E+05,2.30E+04,2.95E+03,,,,,,6.63E+03,,2.03E+04,3.38E+02,,,,,,0,FALSE,24.241,5,5,1889,203.4,7.05,5,,nucleus;other cell component,,,A0A669KAV7,ENSG00000011451,,,0,0,12.37,,75.3,,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,65.75,48.57,,,30.49,,0,
Master Protein,High,P24844,MYL9,Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4,7,99,0.349,0.524,0.359,0.509,-1.52,-0.93,-1.48,-0.97,2.86E-01,6.91E-01,2.67E-01,6.54E-01,5.13E+05,1.47E+06,2.69E+05,5.29E+05,1,2,1,2,,5.13E+05,,,,,,4.86E+05,4.45E+06,,,,2.69E+05,,,,1.61E+06,,1.74E+05,,,1.95E+03,,,,,,4.48E+03,1.25E+05,,,,2.19E+03,,,,4.51E+05,,4.07E+03,,0,FALSE,58.999,44,1,172,19.8,4.92,7,cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;other cell component,Pf13499,10398,E1P5T6; hsa:10398; P24844; Q9BQL9; Q9BUF9; Q9H136,ENSG00000101335,RHO GTPases activate CIT; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; Smooth Muscle Contraction; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs,Focal adhesion; Striated muscle contraction pathway,10,0,,113.59,,113.8,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,199.92,0,66.38,200.96,300.64,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q15436,SEC23A,Protein transport protein Sec23A OS=Homo sapiens OX=9606 GN=SEC23A PE=1 SV=2,2,4,0.348,0.396,0.559,0.221,-1.52,-1.34,-0.84,-2.18,2.03E-01,4.53E-01,3.83E-01,2.19E-01,1.04E+06,3.12E+06,5.20E+05,2.35E+06,4,5,5,5,7.31E+04,1.46E+06,,7.37E+05,5.37E+06,2.86E+06,3.12E+06,7.81E+06,1.25E+06,3.64E+06,6.41E+05,1.64E+06,5.20E+05,3.53E+05,1.85E+05,2.21E+07,1.90E+05,7.46E+06,5.14E+04,2.35E+06,2.90E+02,5.53E+03,,7.37E+05,2.77E+05,1.02E+04,5.55E+04,7.21E+04,3.51E+04,3.87E+04,3.83E+03,7.34E+04,4.22E+03,4.76E+04,4.59E+03,4.31E+04,5.33E+04,5.29E+04,1.20E+03,2.50E+04,0,FALSE,4.55,4,2,765,86.1,7.08,2,cell organization and biogenesis;transport;other biological processes,other membranes;cytosol;ER/Golgi;other cell component,"Pf00626, Pf04810, Pf04811, Pf04815, Pf08033",10484,B2R5P4; B3KXI2; hsa:10484; Q15436; Q8NE16,ENSG00000100934,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC; MHC class II antigen presentation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; COPII-mediated vesicle transport; Cargo concentration in the ER; Regulation of cholesterol biosynthesis by SREBP (SREBF)",Sterol regulatory element-binding proteins (SREBP) signaling,7,0,124.42,65.54,85.48,143.99,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,109.15,124.19,136.56,144.72,10.7,enzyme regulator activity;other molecular function,0,
Master Protein,High,P02792,FTL,Ferritin light chain OS=Homo sapiens OX=9606 GN=FTL PE=1 SV=2,4,14,0.348,0.702,2.204,0.108,-1.52,-0.51,1.14,-3.2,3.42E-01,9.76E-01,4.96E-01,7.26E-02,3.53E+05,1.01E+05,2.44E+05,8.18E+05,5,4,5,5,1.07E+05,5.18E+05,5.22E+04,4.27E+05,3.53E+05,2.01E+05,,5.05E+04,1.62E+04,1.69E+06,2.84E+05,4.62E+04,2.53E+05,2.40E+05,2.44E+05,1.64E+05,3.28E+06,8.18E+05,4.83E+06,9.43E+04,4.23E+02,1.97E+03,5.10E+02,4.27E+05,1.82E+04,7.15E+02,,4.66E+02,4.56E+02,1.80E+04,1.70E+03,2.07E+03,2.06E+03,3.23E+04,6.06E+03,3.19E+02,9.22E+05,5.80E+03,1.13E+05,1.00E+03,0,FALSE,19.958,26,4,175,20,5.78,4,transport;other biological processes,non-structural extracellular;cytosol;other cytoplasmic organelle;other cell component,Pf00210,2512,B2R4B9; hsa:2512; P02792; Q6IBT7; Q7Z2W1; Q86WI9; Q8WU07; Q96AU9; Q96CU0; Q9BTZ8,ENSG00000087086,Scavenging by Class A Receptors; Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Iron uptake and transport,Nuclear receptors meta-pathway; NRF2 pathway; Ferroptosis; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Iron metabolism disorders,9,0,69.69,164.36,44.55,115.2,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,144.94,83.78,126.61,94.76,35.34,other molecular function,0,
Master Protein,High,P62195,PSMC5,26S proteasome regulatory subunit 8 OS=Homo sapiens OX=9606 GN=PSMC5 PE=1 SV=1,4,10,0.347,0.459,0.724,0.248,-1.53,-1.12,-0.47,-2.01,3.58E-01,6.41E-01,6.01E-01,2.60E-01,3.49E+05,4.12E+05,1.08E+05,5.77E+05,4,5,2,5,,6.81E+05,1.79E+05,1.33E+04,6.85E+05,4.12E+05,1.04E+06,1.45E+06,3.69E+05,2.02E+05,,8.31E+04,,1.41E+05,,3.91E+05,9.62E+05,5.77E+05,4.92E+04,1.47E+06,,2.59E+03,1.75E+03,1.33E+04,3.53E+04,1.46E+03,1.86E+04,1.33E+04,1.04E+04,2.15E+03,,3.71E+03,,1.89E+04,,7.63E+02,2.70E+05,4.09E+03,1.15E+03,1.56E+04,0,FALSE,21.404,15,4,406,45.6,7.55,4,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00004, Pf16450, Pf17862",5705,A8K3Z3; A8K763; hsa:5705; O35051; O43208; P47210; P52915; P52916; P62195,ENSG00000087191,Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Pregnane X receptor pathway; Nuclear receptors meta-pathway; Alzheimer's disease,65,0,88.71,76.06,36.36,79.13,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,120.51,54.27,127.85,35.4,31.96,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,A0A804HJX8,HECTD4,HECT domain E3 ubiquitin protein ligase 4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=1,6,10,0.344,0.234,0.115,0.312,-1.54,-2.1,-3.12,-1.68,3.60E-01,1.68E-01,1.42E-02,4.36E-01,5.24E+05,6.48E+05,6.75E+04,7.45E+04,2,1,3,4,,,,2.16E+05,1.27E+06,6.48E+05,,,,,4.50E+04,8.15E+04,,,6.75E+04,9.06E+04,4.53E+05,5.54E+04,6.13E+04,,,,,2.16E+05,6.55E+04,2.31E+03,,,,,2.69E+02,3.64E+03,,,1.68E+03,1.77E+02,1.27E+05,3.92E+02,1.43E+03,,0,FALSE,18.744,2,6,4418,484.3,6.02,6,,,Pf00632,,A0A804HJX8,ENSG00000173064,,,0,0,100.27,,28.44,116.71,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,372.3,66.36,0,84.98,25.89,other molecular function,0,
Master Protein,High,Q6I9Y2,THOC7,THO complex subunit 7 homolog OS=Homo sapiens OX=9606 GN=THOC7 PE=1 SV=3,2,3,0.344,0.513,,1.531,-1.54,-0.96,,0.61,2.52E-01,7.04E-01,,6.36E-01,6.43E+05,1.69E+06,9.08E+04,7.46E+04,3,1,2,3,,4.88E+04,,8.02E+05,6.43E+05,1.69E+06,,,,,,,,1.99E+05,4.15E+04,,,7.46E+04,7.58E+04,4.64E+04,,1.85E+02,,8.02E+05,3.32E+04,6.01E+03,,,,,,,,2.68E+04,1.03E+03,,,5.29E+02,1.77E+03,4.94E+02,0.001,FALSE,4.113,10,2,204,23.7,5.67,2,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,cytosol;nucleus;other cell component,Pf05615,80145,hsa:80145; Q6I9Y2; Q6P1L3; Q8WUF2; Q9H5H0,ENSG00000163634,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,,3,0,79.73,,92.55,25.35,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,0,113.71,,100.43,6.52,nucleic acid binding activity,0,
Master Protein,High,E9PF49,NDUFB9,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 OS=Homo sapiens OX=9606 GN=NDUFB9 PE=1 SV=1,3,7,0.343,0.723,0.451,2.179,-1.55,-0.47,-1.15,1.12,1.90E-01,8.42E-01,2.52E-01,3.96E-01,1.13E+06,3.87E+06,8.42E+05,1.05E+06,4,4,5,5,,6.32E+07,2.61E+05,6.72E+05,1.89E+06,,3.87E+06,1.29E+07,1.18E+06,3.88E+06,4.10E+04,7.92E+05,1.72E+06,1.39E+06,8.42E+05,2.32E+06,1.94E+05,8.23E+06,3.33E+05,1.05E+06,,2.40E+05,2.55E+03,6.72E+05,9.75E+04,,6.88E+04,1.19E+05,3.32E+04,4.12E+04,2.45E+02,3.54E+04,1.40E+04,1.87E+05,2.09E+04,4.53E+03,5.45E+04,5.83E+04,7.80E+03,1.12E+04,0,FALSE,12.85,19,3,221,26.6,8.87,3,other metabolic processes,other membranes;mitochondrion,Pf05347,,E9PF49,ENSG00000147684,,Mitochondrial immune response to SARS-CoV-2,1,0,188.64,93.77,67.05,138.15,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,145.15,69.3,116.76,133.4,22.46,,0,
Master Protein,High,Q92835,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 OS=Homo sapiens OX=9606 GN=INPP5D PE=1 SV=2",7,16,0.34,1.037,,1.488,-1.56,0.05,,0.57,3.34E-01,4.49E-01,,5.65E-01,1.20E+06,3.49E+05,1.03E+06,6.72E+05,5,2,3,4,5.92E+06,3.21E+05,1.92E+06,1.20E+06,8.92E+05,,3.20E+05,3.82E+05,,,,1.31E+06,,1.03E+06,7.24E+05,7.18E+05,4.02E+05,,7.87E+05,6.30E+05,2.35E+04,1.22E+03,1.88E+04,1.20E+06,4.60E+04,,5.69E+03,3.52E+03,,,,5.85E+04,,1.39E+05,1.80E+04,1.40E+03,1.13E+05,,1.84E+04,6.70E+03,0,FALSE,28.32,10,7,1189,133.2,7.59,7,other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton,Pf00017,3635,hsa:3635; O00145; Q13544; Q13545; Q6P5A4; Q92656; Q92835; Q9UE80,ENSG00000168918; ENSG00000281614,Downstream TCR signaling; Synthesis of PIPs at the plasma membrane; Interleukin receptor SHC signaling; Synthesis of IP3 and IP4 in the cytosol; Signaling by CSF1 (M-CSF) in myeloid cells; PECAM1 interactions,B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; IL-4 signaling pathway; EGF/EGFR signaling pathway; Netrin-UNC5B signaling pathway; 5q35 copy number variation,13,0,109.27,12.38,28.7,26.46,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,High,n/a,High,High,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,158.28,99.15,,47.06,47.98,other molecular function,0,
Master Protein,High,Q9HCD5,NCOA5,Nuclear receptor coactivator 5 OS=Homo sapiens OX=9606 GN=NCOA5 PE=1 SV=2,6,11,0.337,0.766,0.103,0.575,-1.57,-0.38,-3.28,-0.8,2.68E-01,8.74E-01,8.69E-03,7.97E-01,8.64E+05,1.13E+06,2.56E+05,1.06E+06,4,4,5,5,5.86E+04,,7.92E+05,1.54E+06,9.44E+05,3.85E+05,,8.55E+05,1.48E+06,2.35E+06,5.82E+04,2.06E+05,2.56E+05,1.60E+06,3.36E+05,1.06E+06,7.64E+04,6.17E+06,3.99E+05,7.04E+06,2.33E+02,,7.74E+03,1.54E+06,4.87E+04,1.37E+03,,7.89E+03,4.18E+04,2.50E+04,3.48E+02,9.19E+03,2.08E+03,2.16E+05,8.35E+03,2.06E+03,2.15E+04,4.38E+04,9.33E+03,7.50E+04,0,FALSE,34.417,17,6,579,65.5,9.6,6,signal transduction;other biological processes,cytoskeleton;nucleus,,57727,B2RTV9; E1P5R0; Q6HA99; Q9H1F2; Q9H2T2; Q9H4Y9; Q9HCD5,ENSG00000124160,,,0,0,73.14,66.94,127.97,114.35,Peak Found,n/a,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,94.23,107.51,84.41,104.94,38.64,other molecular function,0,
Master Protein,High,P53597,SUCLG1,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=SUCLG1 PE=1 SV=4",4,7,0.337,0.56,3.029,1.409,-1.57,-0.84,1.6,0.5,3.49E-01,7.92E-01,3.17E-01,6.36E-01,5.30E+05,7.46E+05,4.13E+05,3.00E+05,5,2,5,2,5.30E+05,2.46E+05,5.39E+04,1.98E+06,1.42E+06,6.71E+05,,,,8.29E+05,1.05E+05,4.13E+05,8.45E+04,1.77E+06,4.75E+05,6.42E+05,,,1.40E+05,,2.11E+03,9.35E+02,5.26E+02,1.98E+06,7.35E+04,2.39E+03,,,,8.82E+03,6.27E+02,1.85E+04,6.86E+02,2.39E+05,1.18E+04,1.25E+03,,,3.28E+03,,0,FALSE,13.65,13,4,346,36.2,8.79,4,other metabolic processes,mitochondrion;other cell component,"Pf00549, Pf02629",8802,hsa:8802; P53597; Q9BWB0; Q9UNP6,ENSG00000163541,Citric acid cycle (TCA cycle),Amino acid metabolism; TCA cycle (aka Krebs or citric acid cycle),3,0,97.16,14.89,121.88,90.66,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,137.58,102.09,123.85,81.99,16.96,other molecular function,0,
Master Protein,High,A0A994J5A3,EPS15,Epidermal growth factor receptor pathway substrate 15 OS=Homo sapiens OX=9606 GN=EPS15 PE=4 SV=1,5,10,0.336,0.651,1.549,0.392,-1.57,-0.62,0.63,-1.35,2.65E-01,9.96E-01,7.63E-01,5.88E-01,3.35E+04,8.31E+04,3.02E+04,2.66E+05,3,3,5,3,1.01E+05,,,3.35E+04,1.04E+04,6.72E+04,3.30E+05,,,8.31E+04,3.35E+04,6.05E+03,1.25E+05,2.70E+04,3.02E+04,,1.49E+06,2.66E+05,3.62E+04,,4.00E+02,,,3.35E+04,5.37E+02,2.39E+02,5.87E+03,,,8.83E+02,2.00E+02,2.70E+02,1.02E+03,3.64E+03,7.51E+02,,4.19E+05,1.89E+03,8.47E+02,,0,FALSE,18.342,10,5,933,102.4,4.7,5,,,,,A0A994J5A3,ENSG00000085832,,Ebola virus infection in host,1,0,97.24,92.1,104.6,130.85,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,125.66,111.54,110.74,132.23,31.2,other molecular function,0,
Master Protein,High,P82909,KGD4,Alpha-ketoglutarate dehydrogenase component 4 OS=Homo sapiens OX=9606 GN=MRPS36 PE=1 SV=2,2,6,0.335,2.52,0.583,0.758,-1.58,1.33,-0.78,-0.4,3.45E-01,8.98E-02,4.62E-01,9.39E-01,1.99E+05,5.93E+05,4.98E+05,3.46E+05,4,2,4,2,9.00E+04,4.39E+05,3.56E+04,5.61E+05,,8.95E+05,,3.93E+05,,,,6.05E+05,4.09E+05,2.04E+05,1.50E+06,8.40E+05,,,1.43E+05,,3.58E+02,1.67E+03,3.47E+02,5.61E+05,,3.18E+03,,3.63E+03,,,,2.70E+04,3.32E+03,2.75E+04,3.73E+04,1.64E+03,,,3.34E+03,,0,FALSE,9.068,24,2,103,11.5,9.99,2,other metabolic processes,other membranes;mitochondrion,,92259,hsa:92259; P82909; Q9H2H4,ENSG00000134056; ENSG00000278461,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,91.75,55.07,83.96,100.38,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,106.82,115.88,99.04,116.36,17.96,,0,
Master Protein,High,Q9NVT9,ARMC1,Armadillo repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=ARMC1 PE=1 SV=1,2,4,0.335,0.496,0.409,2.167,-1.58,-1.01,-1.29,1.12,3.49E-01,6.81E-01,2.51E-01,4.18E-01,1.81E+05,5.31E+05,6.84E+04,2.17E+05,3,1,4,1,,,4.18E+04,3.38E+05,1.81E+05,,5.31E+05,,,,7.93E+04,1.19E+04,,6.07E+05,5.91E+04,,2.17E+05,,,,,,4.09E+02,3.38E+05,9.35E+03,,9.44E+03,,,,4.74E+02,5.29E+02,,8.19E+04,1.47E+03,,6.10E+04,,,,0,FALSE,10.617,16,2,282,31.3,5.74,2,cell organization and biogenesis,other membranes;cytosol;mitochondrion,Pf00514,55156,B4E2W7; hsa:55156; Q9H018; Q9H820; Q9NVT9,ENSG00000104442,,,0,0,79.16,,147.9,,n/a,n/a,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,0,96.19,0,0,17.6,other molecular function,0,
Master Protein,High,Q15427,SF3B4,Splicing factor 3B subunit 4 OS=Homo sapiens OX=9606 GN=SF3B4 PE=1 SV=1,3,6,0.332,0.222,,0.289,-1.59,-2.17,,-1.79,3.43E-01,1.13E-01,,3.58E-01,6.69E+05,5.92E+05,4.66E+05,1.61E+06,1,1,5,4,,,,6.69E+05,,,,5.92E+05,,,4.66E+05,1.00E+05,9.71E+05,6.22E+05,2.61E+05,4.18E+05,1.88E+06,1.38E+06,4.51E+06,,,,,6.69E+05,,,,5.46E+03,,,2.78E+03,4.48E+03,7.89E+03,8.38E+04,6.49E+03,8.14E+02,5.29E+05,9.78E+03,1.06E+05,,0,FALSE,18.582,13,3,424,44.4,8.56,3,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf00076,10262,hsa:10262; Q15427; Q5SZ63,ENSG00000143368,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,mRNA processing; 10q22q23 copy number variation,4,0,,,69.57,85.53,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,0,0,,105.35,23.46,other molecular function,0,
Master Protein,High,P09960,LTA4H,Leukotriene A-4 hydrolase OS=Homo sapiens OX=9606 GN=LTA4H PE=1 SV=2,2,4,0.331,1.842,1.258,0.768,-1.6,0.88,0.33,-0.38,3.10E-01,2.66E-01,9.60E-01,9.57E-01,9.03E+04,2.73E+05,1.66E+05,4.63E+05,1,1,3,4,,,,9.03E+04,,,,2.73E+05,,,,,1.66E+05,1.52E+05,4.57E+05,2.07E+05,2.64E+05,,8.12E+05,1.25E+06,,,,9.03E+04,,,,2.52E+03,,,,,1.35E+03,2.05E+04,1.14E+04,4.04E+02,7.43E+04,,1.90E+04,1.33E+04,0,FALSE,7.054,4,2,611,69.2,6.18,2,protein metabolism;other metabolic processes;developmental processes;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf01433, Pf09127, Pf17900",4048,B4DNQ9; F8VV40; hsa:4048; P09960; Q6IAT6; Q9UCT7,ENSG00000111144,Neutrophil degranulation; Biosynthesis of protectins; Synthesis of Leukotrienes (LT) and Eoxins (EX); Biosynthesis of D-series resolvins; Biosynthesis of E-series 18(S)-resolvins; Biosynthesis of aspirin-triggered D-series resolvins; Biosynthesis of E-series 18(R)-resolvins,Eicosanoid metabolism via lipooxygenases (LOX); Prostaglandin and leukotriene metabolism in senescence ; Leukotriene metabolic pathway; Prostaglandin and leukotriene metabolism in senescence ; Omega-6-fatty acids in senescence,12,0,,,66.61,77.91,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,0,12.81,78.14,51.77,13.05,other molecular function,0,
Master Protein,High,Q9UH73,EBF1,Transcription factor COE1 OS=Homo sapiens OX=9606 GN=EBF1 PE=1 SV=2,8,13,0.33,1.501,0.148,0.157,-1.6,0.59,-2.76,-2.67,3.37E-01,3.36E-01,5.45E-02,1.09E-01,3.97E+05,2.86E+05,3.95E+05,1.39E+05,3,5,4,4,,,1.11E+05,5.47E+05,3.97E+05,2.86E+05,3.01E+04,3.05E+05,2.70E+05,1.15E+06,,4.51E+05,3.49E+05,3.85E+05,4.06E+05,2.01E+05,,6.00E+05,4.00E+04,9.66E+04,,,1.08E+03,5.47E+05,2.05E+04,1.02E+03,5.36E+02,2.81E+03,7.62E+03,1.22E+04,,2.02E+04,2.83E+03,5.19E+04,1.01E+04,3.92E+02,,4.25E+03,9.37E+02,1.03E+03,0,FALSE,31.872,20,8,591,64.4,8.76,8,other biological processes,nucleus;other cell component,"Pf01833, Pf16422, Pf16423",1879,hsa:1879; Q8IW11; Q9UH73,ENSG00000164330,Transcriptional regulation of white adipocyte differentiation; Expression and translocation of olfactory receptors,Adipogenesis; Prion disease pathway; White fat cell differentiation,5,0,63.07,105.04,10.79,107.8,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,114.56,113.08,8.82,139.79,37.97,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q93033,CD101,Immunoglobulin superfamily member 2 OS=Homo sapiens OX=9606 GN=CD101 PE=1 SV=2,1,1,0.328,0.196,0.01,100,-1.61,-2.35,-6.64,6.64,2.94E-01,1.14E-01,1.00E-17,1.00E-17,4.24E+05,1.29E+06,8.31E+04,,2,1,2,,,1.19E+05,,,1.51E+06,,,,,1.29E+06,1.46E+05,,,,4.74E+04,,,,,,,4.54E+02,,,7.78E+04,,,,,1.38E+04,8.73E+02,,,,1.18E+03,,,,,,0.017,FALSE,2.04,2,1,1021,115,6.96,1,signal transduction;other biological processes,plasma membrane;other membranes,Pf07686,9398,hsa:9398; Q15856; Q93033,ENSG00000134256,Generation of second messenger molecules,,1,0,120.68,,72.1,,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,242.64,138.25,,,2.19,other molecular function,0,
Master Protein,High,A0A1W2PRS1,SCARB2,Scavenger receptor class B member 2 (Fragment) OS=Homo sapiens OX=9606 GN=SCARB2 PE=1 SV=1,5,8,0.327,1.11,,3.634,-1.61,0.15,,1.86,3.36E-01,4.49E-01,,1.79E-01,7.15E+05,1.59E+05,5.63E+05,3.43E+05,5,1,5,2,8.12E+05,7.15E+05,6.87E+05,1.70E+06,2.36E+04,1.59E+05,,,,,3.19E+05,5.63E+05,2.84E+05,1.90E+06,1.26E+06,,2.26E+05,,5.21E+05,,3.22E+03,2.72E+03,6.71E+03,1.70E+06,1.22E+03,5.64E+02,,,,,1.91E+03,2.52E+04,2.31E+03,2.56E+05,3.14E+04,,6.35E+04,,1.22E+04,,0,FALSE,22.3,15,5,519,58.1,5.15,5,transport,other membranes;other cytoplasmic organelle,Pf01130,,A0A1W2PRS1,ENSG00000138760,,Primary focal segmental glomerulosclerosis (FSGS),1,0,76.01,,80.68,55.79,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,156.06,100.51,,115.64,22.65,other molecular function,0,
Master Protein,High,Q9Y487,ATP6V0A2,V-type proton ATPase 116 kDa subunit a 2 OS=Homo sapiens OX=9606 GN=ATP6V0A2 PE=1 SV=2,1,3,0.327,0.644,0.208,1.679,-1.61,-0.64,-2.26,0.75,2.65E-01,9.57E-01,1.50E-01,5.40E-01,4.04E+04,1.24E+05,4.33E+04,2.58E+04,3,2,5,1,,,4.77E+05,4.04E+04,1.55E+04,1.84E+05,,,,8.34E+04,5.59E+04,1.00E+04,4.33E+04,6.61E+04,1.32E+04,,,,2.58E+04,,,,4.66E+03,4.04E+04,8.02E+02,6.52E+02,,,,8.87E+02,3.34E+02,4.47E+02,3.52E+02,8.90E+03,3.28E+02,,,,6.03E+02,,0,FALSE,4.507,2,1,856,98,6.61,1,transport;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf01496,23545,A8K026; hsa:23545; Q6NUM0; Q9Y487,ENSG00000185344,ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,,4,0,146.09,53.05,66.79,,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,120.55,125.81,59.99,78.1,8.7,transporter activity;other molecular function,0,
Master Protein,High,O00584,RNASET2,Ribonuclease T2 OS=Homo sapiens OX=9606 GN=RNASET2 PE=1 SV=2,4,7,0.327,1.1,0.97,1.82,-1.61,0.14,-0.04,0.86,3.01E-01,4.25E-01,9.11E-01,4.86E-01,1.57E+06,8.29E+04,1.23E+06,1.56E+05,2,2,4,4,,2.62E+06,,9.37E+05,,,,1.86E+05,,3.70E+04,,1.58E+06,2.75E+06,8.96E+05,9.58E+05,,5.58E+05,8.64E+04,2.82E+05,7.48E+04,,9.97E+03,,9.37E+05,,,,1.71E+03,,3.93E+02,,7.06E+04,2.23E+04,1.21E+05,2.38E+04,,1.57E+05,6.12E+02,6.60E+03,7.97E+02,0,FALSE,13.401,20,4,256,29.5,7.08,4,RNA metabolism OR transcription;other metabolic processes;stress response,non-structural extracellular;mitochondrion;ER/Golgi;other cytoplasmic organelle,Pf00445,8635,B2RDA7; E1P5C3; hsa:8635; O00584; Q5T8Q0; Q8TCU2; Q9BZ46; Q9BZ47,ENSG00000026297,Neutrophil degranulation,,1,0,66.95,94.45,55.57,90.32,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,133.04,91.75,123.82,86.39,22.74,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P22090,RPS4Y1,"40S ribosomal protein S4, Y isoform 1 OS=Homo sapiens OX=9606 GN=RPS4Y1 PE=1 SV=2",3,6,0.326,0.01,0.01,,-1.62,-6.64,-6.64,,2.93E-01,1.00E-17,1.00E-17,,7.82E+04,2.40E+05,,,1,1,,,,,,7.82E+04,,,,2.40E+05,,,,,,,,,,,,,,,,7.82E+04,,,,2.21E+03,,,,,,,,,,,,,0,FALSE,12.323,12,1,263,29.4,10.24,3,protein metabolism;other metabolic processes,cytosol;translational apparatus;nucleus,"Pf00467, Pf00900, Pf08071, Pf16121",6192,A8K9V4; hsa:6192; P22090,ENSG00000129824,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",Cytoplasmic ribosomal proteins,19,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,,,,19.55,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P14854,COX6B1,Cytochrome c oxidase subunit 6B1 OS=Homo sapiens OX=9606 GN=COX6B1 PE=1 SV=2,4,15,0.326,0.765,0.578,0.967,-1.62,-0.39,-0.79,-0.05,1.72E-01,8.76E-01,4.02E-01,8.44E-01,7.26E+05,3.21E+06,3.59E+05,9.18E+05,5,4,5,4,1.22E+05,5.36E+06,1.38E+05,7.26E+05,8.50E+06,,5.22E+06,1.97E+06,4.01E+05,1.72E+07,6.65E+04,1.25E+06,2.44E+05,3.59E+05,1.76E+06,,7.10E+05,5.03E+06,1.84E+05,1.19E+06,4.83E+02,2.04E+04,1.34E+03,7.26E+05,4.39E+05,,9.29E+04,1.82E+04,1.13E+04,1.83E+05,3.98E+02,5.59E+04,1.98E+03,4.84E+04,4.37E+04,,1.99E+05,3.57E+04,4.30E+03,1.26E+04,0,FALSE,15.605,51,4,86,10.2,7.05,4,other metabolic processes;transport,other membranes;mitochondrion,Pf02297,1340,B2R5C9; hsa:1340; P14854; Q6IBL4,ENSG00000126267,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly; 5q35 copy number variation,7,0,127.68,122.67,99.45,124.16,Peak Found,Peak Found,Peak Found,High,High,n/a,High,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,High,1,,FALSE,134.36,118.14,128.77,134.58,31.68,transporter activity,0,
Master Protein,High,A0A6Q8PH20,CAST,Calpastatin OS=Homo sapiens OX=9606 GN=CAST PE=1 SV=1,9,14,0.323,1.059,2.113,0.102,-1.63,0.08,1.08,-3.3,3.01E-01,6.52E-01,4.19E-01,8.06E-02,8.38E+04,3.68E+05,1.34E+05,1.46E+06,1,4,4,5,,,,,8.38E+04,5.60E+05,1.29E+05,2.42E+05,,3.46E+06,1.97E+05,,2.66E+05,9.16E+04,8.80E+04,7.06E+05,2.89E+06,1.46E+06,6.62E+05,2.62E+06,,,,,4.32E+03,1.99E+03,2.29E+03,2.24E+03,,3.68E+04,1.18E+03,,2.16E+03,1.23E+04,2.19E+03,1.38E+03,8.11E+05,1.03E+04,1.55E+04,2.79E+04,0,FALSE,38.922,18,9,754,81,5.1,9,,cytosol;ER/Golgi,Pf00748,,A0A6Q8PH20,ENSG00000153113,,,0,0,,144.47,53.86,62.79,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,0,136.79,79.81,72.55,43.5,enzyme regulator activity,0,
Master Protein,High,Q2TAY7,SMU1,WD40 repeat-containing protein SMU1 OS=Homo sapiens OX=9606 GN=SMU1 PE=1 SV=2,3,6,0.323,0.469,0.01,100,-1.63,-1.09,-6.64,6.64,3.29E-01,5.99E-01,1.00E-17,1.00E-17,7.86E+05,3.67E+05,2.63E+05,,2,3,5,,,,5.41E+05,1.14E+06,,,7.54E+05,2.92E+05,3.67E+05,,1.34E+06,1.54E+05,2.63E+05,7.51E+05,7.36E+04,,,,,,,,5.29E+03,1.14E+06,,,1.34E+04,2.69E+03,1.03E+04,,8.03E+03,6.87E+03,2.14E+03,1.01E+05,1.83E+03,,,,,,0,FALSE,9.355,9,3,513,57.5,7.18,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,"Pf00400, Pf17814",55234,B4E3L0; hsa:55234; Q2TAY7; Q9BU59; Q9HA96; Q9NVD1,ENSG00000122692,mRNA Splicing - Major Pathway,,1,0,50.45,52.73,102.85,,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,30.41,95.9,,,19.21,,0,
Master Protein,High,P57740,NUP107,Nuclear pore complex protein Nup107 OS=Homo sapiens OX=9606 GN=NUP107 PE=1 SV=1,8,10,0.321,0.754,0.329,0.259,-1.64,-0.41,-1.6,-1.95,1.66E-01,8.01E-01,1.21E-01,3.30E-01,1.12E+06,7.29E+06,1.11E+06,6.29E+05,4,1,5,5,,8.23E+05,4.28E+05,1.85E+06,1.54E+06,7.29E+06,,,,,3.72E+05,1.11E+06,4.52E+05,1.97E+06,3.19E+06,7.42E+06,5.23E+05,6.67E+06,6.11E+05,6.29E+05,,3.13E+03,4.19E+03,1.85E+06,7.93E+04,2.59E+04,,,,,2.22E+03,4.94E+04,3.67E+03,2.65E+05,7.93E+04,1.45E+04,1.47E+05,4.73E+04,1.43E+04,6.70E+03,0,FALSE,24.998,13,8,925,106.3,5.43,8,cell organization and biogenesis;other metabolic processes;transport;developmental processes,other membranes;cytosol;nucleus;other cell component,Pf04121,57122,B4DZ67; hsa:57122; P57740; Q6PJE1,ENSG00000111581,HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,Gastric cancer network 1; Primary ovarian insufficiency,37,0,55.97,,83.25,111.88,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,62.13,81.64,246.15,88.5,28.84,other molecular function,0,
Master Protein,High,Q15691,MAPRE1,Microtubule-associated protein RP/EB family member 1 OS=Homo sapiens OX=9606 GN=MAPRE1 PE=1 SV=3,6,8,0.321,0.786,0.537,0.83,-1.64,-0.35,-0.9,-0.27,3.29E-01,7.79E-01,4.38E-01,9.70E-01,4.43E+05,7.91E+05,1.07E+06,9.35E+05,3,3,5,4,,,3.91E+05,4.43E+05,5.17E+05,7.91E+05,,,9.85E+05,3.01E+05,1.87E+05,1.74E+04,1.24E+06,1.39E+06,1.07E+06,,1.31E+06,3.19E+05,1.56E+06,6.70E+05,,,3.82E+03,4.43E+05,2.67E+04,2.81E+03,,,2.78E+04,3.20E+03,1.12E+03,7.79E+02,1.01E+04,1.87E+05,2.66E+04,,3.67E+05,2.26E+03,3.64E+04,7.13E+03,0,FALSE,28.895,43,6,268,30,5.14,6,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component,"Pf00307, Pf03271",22919,B2R6I7; E1P5M8; hsa:22919; Q15691; Q3KQS8,ENSG00000101367,Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Resolution of Sister Chromatid Cohesion; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Microtubule cytoskeleton regulation; HDAC6 interactions in the central nervous system,16,0,14.08,50.91,81.01,59.09,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,111.68,135.71,97.62,44.47,28.48,cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A8I5KXR3,KMT2A,Histone-lysine N-methyltransferase OS=Homo sapiens OX=9606 GN=KMT2A PE=1 SV=1,1,1,0.319,0.01,0.614,0.01,-1.65,-6.64,-0.7,-6.64,3.16E-01,1.00E-17,4.76E-01,1.00E-17,2.19E+05,4.56E+05,,2.80E+05,3,3,,1,,2.31E+05,,1.38E+04,2.19E+05,,,4.56E+05,2.32E+05,7.23E+05,,,,,,,,,,2.80E+05,,8.76E+02,,1.38E+04,1.13E+04,,,4.21E+03,6.52E+03,7.68E+03,,,,,,,,,,2.98E+03,0.004,FALSE,2.657,0,1,3996,434.4,9.07,1,cell organization and biogenesis;other metabolic processes;other biological processes,cytosol;nucleus,"Pf00628, Pf00856, Pf02008, Pf05964, Pf05965, Pf13771",,A0A8I5KXR3,ENSG00000118058,,Histone modifications,1,0,78.93,52.29,,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,98.34,,73.02,,1.88,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P13612,ITGA4,Integrin alpha-4 OS=Homo sapiens OX=9606 GN=ITGA4 PE=1 SV=3,4,7,0.319,1.279,0.532,1.033,-1.65,0.36,-0.91,0.05,3.11E-01,3.73E-01,5.00E-01,8.03E-01,4.02E+05,1.12E+06,7.41E+05,6.98E+05,2,1,3,3,,2.02E+05,,8.00E+05,,,1.12E+06,,,,,5.44E+05,,9.09E+05,7.41E+05,2.76E+05,8.52E+05,,6.98E+05,,,7.69E+02,,8.00E+05,,,1.99E+04,,,,,2.43E+04,,1.23E+05,1.84E+04,5.38E+02,2.39E+05,,1.63E+04,,0,FALSE,17.525,7,4,1032,114.8,6.48,4,cell adhesion;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,"Pf01839, Pf08441, Pf20805, Pf20806",3676,D3DPG4; hsa:3676; P13612; Q7Z4L6,ENSG00000115232,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Cell surface interactions at the vascular wall; Potential therapeutics for SARS; Integrin cell surface interactions; RUNX3 Regulates Immune Response and Cell Migration,Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Cells and molecules involved in local acute inflammatory response ; Pleural mesothelioma; 11p11.2 copy number variation syndrome,14,0,84.3,,24.99,49.05,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,0,52.36,0.4,62.23,21.87,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P31146,CORO1A,Coronin-1A OS=Homo sapiens OX=9606 GN=CORO1A PE=1 SV=4,11,41,0.319,0.431,0.2,0.404,-1.65,-1.22,-2.32,-1.31,1.64E-01,4.84E-01,2.88E-02,4.85E-01,5.91E+06,3.69E+06,1.47E+06,2.14E+06,5,5,5,5,2.01E+07,2.18E+06,5.91E+06,2.01E+06,1.67E+07,2.55E+06,3.69E+06,1.29E+07,9.82E+05,1.46E+07,5.72E+05,1.47E+06,9.85E+05,5.58E+06,2.45E+06,4.35E+06,1.86E+06,2.14E+06,3.52E+06,2.55E+05,7.97E+04,8.28E+03,5.78E+04,2.01E+06,8.59E+05,9.05E+03,6.56E+04,1.19E+05,2.77E+04,1.56E+05,3.42E+03,6.59E+04,8.00E+03,7.52E+05,6.10E+04,8.49E+03,5.23E+05,1.52E+04,8.23E+04,2.72E+03,0,FALSE,44.232,23,11,461,51,6.68,11,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component,"Pf00400, Pf08953, Pf08954, Pf16300",11151,B2RBL1; hsa:11151; P31146; Q2YD73,ENSG00000102879,Prevention of phagosomal-lysosomal fusion,16p11.2 proximal deletion syndrome,2,0,90.19,91.04,90.74,65.27,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,127.12,118.96,116.16,114,102.51,cytoskeletal activity;other molecular function,0,
Master Protein,High,P06702,S100A9,Protein S100-A9 OS=Homo sapiens OX=9606 GN=S100A9 PE=1 SV=1,4,183,0.317,0.295,0.647,0.129,-1.66,-1.76,-0.63,-2.95,1.62E-01,2.09E-01,4.92E-01,8.18E-02,5.63E+06,3.61E+07,4.48E+06,3.58E+07,5,5,5,5,5.63E+06,7.88E+07,2.59E+06,1.67E+05,3.68E+07,5.91E+07,3.61E+07,9.55E+07,1.60E+07,1.40E+07,1.32E+06,7.47E+05,4.48E+06,7.84E+06,1.32E+07,7.45E+07,1.79E+05,3.58E+07,1.91E+07,4.19E+07,2.24E+04,3.00E+05,2.53E+04,1.67E+05,1.90E+06,2.10E+05,6.41E+05,8.81E+05,4.50E+05,1.49E+05,7.91E+03,3.34E+04,3.64E+04,1.06E+06,3.29E+05,1.45E+05,5.04E+04,2.54E+05,4.46E+05,4.46E+05,0,FALSE,25.648,43,4,114,13.2,6.13,4,cell adhesion;cell-cell signaling;protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf01023,6280,D3DV36; hsa:6280; P06702; Q6FGA1; Q9NYM0; Q9UCJ1,ENSG00000163220,ER-Phagosome pathway; Neutrophil degranulation; MyD88:MAL(TIRAP) cascade initiated on plasma membrane; MyD88 deficiency (TLR2/4); IRAK4 deficiency (TLR2/4); Regulation of TLR by endogenous ligand; Metal sequestration by antimicrobial proteins; RHO GTPases Activate NADPH Oxidases,IL1 and megakaryocytes in obesity; Vitamin D receptor pathway,10,0,135.71,77.07,93.36,80.83,High,High,High,Peak Found,High,High,High,High,High,High,Peak Found,Peak Found,High,High,High,High,Peak Found,High,High,High,1,,FALSE,139.19,144.74,135.39,146.96,582.93,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,P82094,TMF1,TATA element modulatory factor OS=Homo sapiens OX=9606 GN=TMF1 PE=1 SV=2,1,2,0.317,0.252,0.234,0.341,-1.66,-1.99,-2.09,-1.55,2.75E-01,3.08E-01,1.57E-01,4.95E-01,7.71E+04,2.43E+05,1.94E+04,5.69E+04,1,2,1,1,,,,7.71E+04,,,,,1.38E+05,4.28E+05,,1.94E+04,,,,,5.69E+04,,,,,,,7.71E+04,,,,,3.89E+03,4.55E+03,,8.67E+02,,,,,1.60E+04,,,,0.002,FALSE,2.8,1,1,1093,122.8,4.92,1,cell-cell signaling;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,other membranes;cytosol;ER/Golgi;nucleus,"Pf12325, Pf12329",7110,B7ZLJ2; hsa:7110; P82094; Q17R87; Q59GK0,ENSG00000144747,Retrograde transport at the Trans-Golgi-Network,,1,0,,72.52,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,88.56,0,88.56,0,6.12,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96EY7,PTCD3,"Pentatricopeptide repeat domain-containing protein 3, mitochondrial OS=Homo sapiens OX=9606 GN=PTCD3 PE=1 SV=3",4,5,0.317,2.077,,3.82,-1.66,1.05,,1.93,2.87E-01,1.62E-01,,1.92E-01,2.25E+05,1.91E+05,2.31E+05,6.83E+04,3,1,4,2,,,6.07E+04,2.25E+05,1.15E+06,,,1.91E+05,,,,1.56E+05,2.20E+05,2.43E+05,5.64E+05,,1.84E+04,,2.53E+05,,,,5.93E+02,2.25E+05,5.92E+04,,,1.77E+03,,,,6.96E+03,1.79E+03,3.27E+04,1.40E+04,,5.17E+03,,5.93E+03,,0,FALSE,12.666,8,4,689,78.5,6.42,4,protein metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;translational apparatus;nucleus,"Pf13041, Pf13812",55037,A6NHD2; D6W5M1; hsa:55037; Q597H0; Q658Y9; Q96EY7; Q9BUZ8; Q9NWL0,ENSG00000132300,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,122.6,,61.75,122.25,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,140.42,46.51,,152.29,10.99,translation activity;nucleic acid binding activity,0,
Master Protein,High,Q5JTZ9,AARS2,"Alanine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=AARS2 PE=1 SV=1",5,9,0.316,0.925,0.488,0.397,-1.66,-0.11,-1.04,-1.33,2.94E-01,7.10E-01,3.89E-01,5.05E-01,7.82E+04,1.49E+06,4.16E+05,8.97E+04,3,3,5,4,7.82E+04,,,9.29E+05,3.81E+04,1.49E+06,,1.73E+06,,1.00E+06,4.16E+05,7.72E+05,3.51E+04,3.98E+05,7.20E+05,,4.34E+05,8.38E+04,6.61E+04,9.60E+04,3.11E+02,,,9.29E+05,1.96E+03,5.31E+03,,1.60E+04,,1.06E+04,2.49E+03,3.45E+04,2.85E+02,5.36E+04,1.79E+04,,1.22E+05,5.94E+02,1.55E+03,1.02E+03,0,FALSE,21.933,8,5,985,107.3,6.27,5,protein metabolism;RNA metabolism OR transcription;other metabolic processes,mitochondrion,"Pf01411, Pf07973",57505,A2RRN5; hsa:57505; Q5JTZ9; Q8N198; Q96D02; Q9ULF0,ENSG00000124608,Mitochondrial tRNA aminoacylation,Primary ovarian insufficiency,2,0,144.41,26.47,63.25,103.76,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,61.49,52.09,50.93,65.74,30.1,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P12814,ACTN1,Alpha-actinin-1 OS=Homo sapiens OX=9606 GN=ACTN1 PE=1 SV=2,19,124,0.316,0.452,0.462,0.206,-1.66,-1.15,-1.11,-2.28,1.61E-01,5.58E-01,2.65E-01,1.86E-01,2.76E+06,1.02E+07,1.23E+06,6.14E+06,5,5,5,5,2.76E+06,2.40E+07,1.35E+05,1.16E+05,5.65E+06,6.75E+06,1.02E+07,4.23E+07,2.99E+07,5.98E+06,8.16E+04,6.65E+05,1.30E+06,3.17E+06,1.23E+06,1.85E+06,6.14E+06,8.69E+06,3.61E+06,2.56E+07,1.10E+04,9.13E+04,1.32E+03,1.16E+05,2.91E+05,2.40E+04,1.81E+05,3.90E+05,8.41E+05,6.36E+04,4.88E+02,2.97E+04,1.05E+04,4.27E+05,3.05E+04,3.61E+03,1.73E+06,6.16E+04,8.44E+04,2.72E+05,0,FALSE,91.028,28,9,892,103,5.41,19,cell adhesion;cell organization and biogenesis;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00307, Pf00435, Pf08726",87,B3V8S3; B4DHH3; B7TY16; hsa:87; P12814; Q1HE25; Q9BTN1,ENSG00000072110,RHOD GTPase cycle; RHOF GTPase cycle; Platelet degranulation ; Nephrin family interactions; Syndecan interactions; RHOBTB2 GTPase cycle; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Arrhythmogenic right ventricular cardiomyopathy; Focal adhesion; Ebola virus infection in host; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Regulation of actin cytoskeleton,12,0,153.61,85.48,90.02,103.87,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,131.73,142.58,131.85,130.04,363.49,signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P28068,HLA-DMB,"HLA class II histocompatibility antigen, DM beta chain OS=Homo sapiens OX=9606 GN=HLA-DMB PE=1 SV=2",1,1,0.315,1.067,0.01,100,-1.67,0.09,-6.64,6.64,2.78E-01,6.30E-01,1.00E-17,1.00E-17,1.31E+05,3.55E+05,1.40E+05,,3,2,3,,,8.99E+04,,1.39E+05,1.31E+05,,,,2.30E+05,5.50E+05,1.72E+05,,6.91E+04,1.40E+05,,,,,,,,3.42E+02,,1.39E+05,6.75E+03,,,,6.47E+03,5.85E+03,1.03E+03,,5.61E+02,1.88E+04,,,,,,,0.002,FALSE,3.079,9,1,263,28.9,7.44,1,cell organization and biogenesis;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,"Pf00969, Pf07654",3109,hsa:3109; O77936; P28068; Q13012; Q29751; Q58ZE2; Q5SNZ8; Q5STC4; Q9XRX2,ENSG00000226264; ENSG00000234154; ENSG00000239329; ENSG00000241296; ENSG00000241674; ENSG00000242092; ENSG00000242386; ENSG00000242574,MHC class II antigen presentation,Allograft rejection; Ebola virus infection in host; 11p11.2 copy number variation syndrome,4,0,21.87,58.09,41.44,,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,57.07,41.49,,,3.63,other molecular function,0,
Master Protein,High,P17213,BPI,Bactericidal permeability-increasing protein OS=Homo sapiens OX=9606 GN=BPI PE=1 SV=4,7,25,0.314,0.549,0.5,0.233,-1.67,-0.86,-1,-2.1,1.59E-01,7.54E-01,3.10E-01,2.24E-01,3.44E+06,1.67E+07,6.82E+05,2.85E+06,5,5,5,5,3.44E+06,5.45E+06,8.24E+05,3.15E+05,1.45E+07,2.03E+07,1.89E+06,6.45E+06,1.67E+07,1.42E+08,1.71E+06,6.82E+05,2.85E+05,1.61E+06,1.61E+05,2.86E+06,9.01E+05,2.58E+06,5.42E+06,2.85E+06,1.37E+04,2.07E+04,8.05E+03,3.15E+05,7.47E+05,7.23E+04,3.36E+04,5.95E+04,4.72E+05,1.51E+06,1.02E+04,3.05E+04,2.31E+03,2.16E+05,4.00E+03,5.58E+03,2.53E+05,1.83E+04,1.27E+05,3.03E+04,0,FALSE,20.865,16,7,487,53.9,9.38,7,stress response;signal transduction;other biological processes,non-structural extracellular;other membranes;other cytoplasmic organelle;other cell component,"Pf01273, Pf02886",671,B2RCY2; hsa:671; P17213; Q1ZZU8; Q5JRW0; Q8IW58; Q9BYZ9; Q9H1L2; Q9H1M8; Q9H203; Q9UCT4; Q9UD65,ENSG00000101425,Neutrophil degranulation; Toll Like Receptor 4 (TLR4) Cascade; Antimicrobial peptides,,3,0,117.11,157.13,81.98,55.31,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,1,,FALSE,127.91,93.02,129.13,110.71,63.95,other molecular function,0,
Master Protein,High,A0A140T913,HLA-A,"HLA class I histocompatibility antigen, A alpha chain OS=Homo sapiens OX=9606 GN=HLA-A PE=1 SV=1",10,131,0.313,0.378,1.527,0.238,-1.68,-1.4,0.61,-2.07,2.11E-01,4.29E-01,6.83E-01,2.31E-01,3.46E+05,1.94E+06,8.92E+05,2.99E+06,5,5,4,4,9.62E+04,1.65E+07,3.46E+05,7.49E+03,3.07E+06,9.31E+05,4.19E+06,1.46E+07,1.14E+06,1.94E+06,2.05E+06,1.47E+04,3.88E+05,4.69E+06,,2.38E+07,,3.70E+06,2.42E+06,1.69E+06,3.82E+02,6.28E+04,3.38E+03,7.49E+03,1.58E+05,3.31E+03,7.44E+04,1.35E+05,3.22E+04,2.06E+04,1.22E+04,6.55E+02,3.16E+03,6.32E+05,,4.63E+04,,2.62E+04,5.67E+04,1.80E+04,0,FALSE,57.611,36,5,371,41.4,6.99,10,other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00129, Pf06623, Pf07654",,A0A140T913,ENSG00000235657,,,0,0,177.38,126.26,119.23,134.5,Peak Found,High,Peak Found,High,High,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,1,,FALSE,136.6,143.03,104.8,103.82,352.44,,0,
Master Protein,High,P18206,VCL,Vinculin OS=Homo sapiens OX=9606 GN=VCL PE=1 SV=4,21,154,0.313,0.346,0.521,0.3,-1.68,-1.53,-0.94,-1.74,1.57E-01,3.07E-01,3.35E-01,3.22E-01,6.59E+06,2.83E+07,2.38E+06,1.61E+07,5,5,5,5,6.59E+06,4.79E+07,2.97E+06,1.55E+06,2.70E+07,1.75E+07,2.32E+07,1.38E+08,4.73E+07,2.83E+07,1.36E+06,9.31E+05,2.38E+06,4.81E+06,2.74E+06,1.14E+08,3.28E+06,1.61E+07,5.91E+06,2.42E+07,2.62E+04,1.82E+05,2.90E+04,1.55E+06,1.39E+06,6.23E+04,4.12E+05,1.28E+06,1.33E+06,3.01E+05,8.13E+03,4.16E+04,1.93E+04,6.49E+05,6.80E+04,2.22E+05,9.21E+05,1.14E+05,1.38E+05,2.57E+05,0,FALSE,91.835,21,21,1134,123.7,5.66,21,cell adhesion;cell organization and biogenesis;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf01044,7414,hsa:7414; P18206; Q16450; Q5SWX2; Q7Z3B8; Q8IXU7,ENSG00000035403,Platelet degranulation ; Neutrophil degranulation; Signaling by BRAF and RAF1 fusions; Signaling by ALK fusions and activated point mutants; Smooth Muscle Contraction; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants,Integrin-mediated cell adhesion; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; VEGFA-VEGFR2 signaling; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Melanoma; Regulation of actin cytoskeleton,18,0,116.28,98.47,61.93,141.23,High,High,High,Peak Found,High,High,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,1,,FALSE,133.03,128.62,137.53,137.08,454.91,cytoskeletal activity;other molecular function,0,
Master Protein,High,P60842,EIF4A1,Eukaryotic initiation factor 4A-I OS=Homo sapiens OX=9606 GN=EIF4A1 PE=1 SV=1,3,14,0.312,1.616,0.119,0.625,-1.68,0.69,-3.07,-0.68,1.57E-01,2.95E-01,4.41E-03,7.83E-01,1.33E+05,4.66E+06,2.41E+05,4.58E+05,3,3,4,4,2.65E+06,,8.27E+04,1.33E+05,,7.96E+06,2.65E+05,4.66E+06,,,3.32E+05,,1.75E+05,6.17E+05,1.64E+05,8.93E+05,8.96E+04,3.56E+05,5.88E+05,,1.05E+04,,8.08E+02,1.33E+05,,2.83E+04,4.71E+03,4.30E+04,,,1.99E+03,,1.42E+03,8.32E+04,4.08E+03,1.74E+03,2.52E+04,2.52E+03,1.38E+04,,0,FALSE,11.619,10,2,406,46.1,5.48,3,protein metabolism;other metabolic processes,cytosol;translational apparatus;other cell component,"Pf00270, Pf00271",1973,B2R6L8; D3DTP9; hsa:1973; J3QLC4; P04765; P60842; Q5U018; Q61516,ENSG00000161960,Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; ISG15 antiviral mechanism; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Z-decay: degradation of maternal mRNAs by zygotically expressed factors,Translation factors; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Interferon type I signaling pathways,13,0,153.69,89.9,65.57,70.91,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,n/a,1,,FALSE,143.64,131.83,115.64,99.23,38.87,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A669KB53,STAT1,Signal transducer and activator of transcription OS=Homo sapiens OX=9606 GN=STAT1 PE=1 SV=1,2,4,0.311,1.211,1.986,0.216,-1.68,0.28,0.99,-2.21,2.06E-01,3.74E-01,4.57E-01,1.81E-01,5.75E+05,1.88E+06,7.91E+05,3.67E+06,4,3,2,2,,9.08E+05,3.64E+05,2.15E+05,2.40E+06,,2.07E+06,1.65E+06,,1.88E+06,,,,3.17E+05,1.97E+06,,,2.54E+06,,5.30E+06,,3.45E+03,3.56E+03,2.15E+05,1.24E+05,,3.68E+04,1.52E+04,,1.99E+04,,,,4.28E+04,4.91E+04,,,1.80E+04,,5.64E+04,0,FALSE,5.58,3,2,791,91.1,6.14,2,signal transduction;other biological processes,cytosol;nucleus,"Pf00017, Pf01017, Pf02864, Pf02865, Pf12162, Pf21354",,A0A669KB53,ENSG00000115415,,"Allograft rejection; Endoderm differentiation; Chemokine signaling pathway; PDGFR-beta pathway; Immune response to tuberculosis; Ebola virus infection in host; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Non-genomic actions of 1,25 dihydroxyvitamin D3; Measles virus infection; Tryptophan metabolism; Hepatitis B infection; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Pleural mesothelioma; Th17 cell differentiation pathway; Inflammatory bowel disease signaling; 2q13 copy number variation syndrome",22,0,102.66,11.29,102.25,49.79,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,1,,FALSE,110.31,111.77,51.93,107.43,10.64,nucleic acid binding activity;other molecular function,0,
Master Protein,High,J3QQJ0,SAP30BP,SAP30 binding protein (Fragment) OS=Homo sapiens OX=9606 GN=SAP30BP PE=1 SV=1,2,2,0.31,0.691,0.757,0.38,-1.69,-0.53,-0.4,-1.39,2.16E-01,9.19E-01,7.52E-01,5.34E-01,7.74E+05,1.33E+06,5.68E+05,1.01E+06,3,1,1,1,,1.11E+06,1.88E+05,7.74E+05,,,,1.33E+06,,,,,,5.68E+05,,1.01E+06,,,,,,4.23E+03,1.83E+03,7.74E+05,,,,1.23E+04,,,,,,7.66E+04,,1.96E+03,,,,,0,FALSE,9.505,10,2,325,35.9,4.98,2,other biological processes,cytoskeleton;nucleus,Pf07818,,J3QQJ0,ENSG00000161526,,,0,0,67.7,,,,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,93.32,74.39,0,0,6.8,,0,
Master Protein,High,P11177,PDHB,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=PDHB PE=1 SV=3",11,37,0.31,0.614,0.272,0.647,-1.69,-0.7,-1.88,-0.63,1.54E-01,8.67E-01,7.28E-02,7.87E-01,1.10E+06,6.92E+06,3.42E+06,7.67E+05,5,4,5,5,1.10E+06,3.01E+05,6.74E+05,7.43E+06,7.28E+06,,9.97E+05,8.66E+06,1.10E+07,5.52E+06,6.36E+05,7.13E+06,2.42E+05,3.88E+06,3.42E+06,7.67E+05,2.98E+05,8.97E+06,2.13E+05,3.29E+06,4.37E+03,1.14E+03,6.58E+03,7.43E+06,3.75E+05,,1.77E+04,7.99E+04,3.11E+05,5.87E+04,3.81E+03,3.18E+05,1.96E+03,5.23E+05,8.49E+04,1.50E+03,8.38E+04,6.35E+04,4.99E+03,3.50E+04,0,FALSE,41.563,44,11,359,39.2,6.65,11,other metabolic processes,mitochondrion;nucleus;other cell component,"Pf02779, Pf02780",5162,B2R7L0; B4DDD7; hsa:5162; P11177; Q6FH45; Q9BQ27; Q9UFK3,ENSG00000168291,Glyoxylate metabolism and glycine degradation; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid; Mitochondrial protein degradation,Hereditary leiomyomatosis and renal cell carcinoma pathway; Metabolic reprogramming in colon cancer; Orexin receptor pathway,8,0,109.06,66.19,91.2,137.38,Peak Found,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,88.34,95.53,139.47,144.41,82.74,other molecular function,0,
Master Protein,High,Q12931,TRAP1,"Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens OX=9606 GN=TRAP1 PE=1 SV=3",8,41,0.309,1.794,0.967,0.432,-1.69,0.84,-0.05,-1.21,1.97E-01,1.20E-01,8.58E-01,5.14E-01,1.03E+06,2.01E+06,1.90E+06,2.06E+06,5,3,4,5,3.33E+05,3.00E+06,2.42E+05,1.03E+06,1.44E+06,8.63E+05,,,2.01E+06,2.93E+06,,8.16E+05,1.72E+06,2.10E+06,4.42E+06,2.06E+06,4.81E+06,2.76E+05,4.99E+06,5.24E+04,1.32E+03,1.14E+04,2.36E+03,1.03E+06,7.44E+04,3.07E+03,,,5.68E+04,3.11E+04,,3.64E+04,1.40E+04,2.83E+05,1.10E+05,4.02E+03,1.35E+06,1.96E+03,1.17E+05,5.58E+02,0,FALSE,46.954,16,7,704,80.1,8.21,8,protein metabolism;other metabolic processes;other biological processes,other membranes;mitochondrion;nucleus;other cell component,Pf00183,10131,B4DR68; D3DUC8; F5H897; hsa:10131; O43642; O75235; Q12931; Q9UHL5,ENSG00000126602,Respiratory electron transport,TNF-alpha signaling pathway; TGF-beta signaling pathway; Clock-controlled autophagy in bone metabolism,4,0,92.44,53.5,67.79,97.57,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,High,n/a,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,120.05,103.48,36.66,64.77,118.83,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P07954,FH,"Fumarate hydratase, mitochondrial OS=Homo sapiens OX=9606 GN=FH PE=1 SV=3",7,31,0.308,0.534,1.98,1.148,-1.7,-0.9,0.99,0.2,1.52E-01,7.04E-01,4.59E-01,8.42E-01,3.38E+06,2.17E+06,4.30E+06,4.90E+06,2,1,4,2,,,,4.33E+06,2.64E+06,,,,,2.17E+06,2.73E+05,4.65E+06,,3.97E+06,7.52E+06,,4.97E+06,,4.83E+06,,,,,4.33E+06,1.36E+05,,,,,2.31E+04,1.63E+03,2.08E+05,,5.35E+05,1.87E+05,,1.40E+06,,1.13E+05,,0,FALSE,32.868,26,7,510,54.6,8.76,7,DNA metabolism;other metabolic processes;stress response;other biological processes,cytosol;mitochondrion;nucleus;other cell component,"Pf00206, Pf10415",2271,B1ANK7; hsa:2271; P07954,ENSG00000091483,Citric acid cycle (TCA cycle); Mitochondrial protein degradation,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Krebs cycle disorders; Type 2 papillary renal cell carcinoma; Metabolic reprogramming in colon cancer; TCA cycle in senescence; TCA cycle (aka Krebs or citric acid cycle),9,0,34.33,,72.66,2.02,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,High,High,n/a,High,n/a,High,n/a,1,,FALSE,0,96.42,17.5,44.37,119.42,other molecular function,0,
Master Protein,High,Q9UI26,IPO11,Importin-11 OS=Homo sapiens OX=9606 GN=IPO11 PE=1 SV=1,1,1,0.308,68.507,0.733,28.744,-1.7,6.1,-0.45,4.85,2.36E-01,2.09E-14,7.14E-01,1.45E-03,3.38E+04,1.10E+05,2.31E+06,8.05E+04,1,1,1,1,,,,3.38E+04,,,1.10E+05,,,,,,2.31E+06,,,,8.05E+04,,,,,,,3.38E+04,,,1.95E+03,,,,,,1.88E+04,,,,2.26E+04,,,,0.003,FALSE,2.715,1,1,975,112.5,5.25,1,transport,cytosol;nucleus,Pf03810,51194,A6NGJ5; B4DZ73; D3DW98; hsa:51194; Q8N5R2; Q9NSJ6; Q9NVB1; Q9UI26,ENSG00000086200,,,0,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,0,0,0,0,2.41,other molecular function,0,
Master Protein,High,P05106,ITGB3,Integrin beta-3 OS=Homo sapiens OX=9606 GN=ITGB3 PE=1 SV=2,19,219,0.307,0.26,0.737,0.283,-1.7,-1.95,-0.44,-1.82,1.52E-01,1.48E-01,6.02E-01,2.97E-01,9.30E+06,3.27E+07,6.63E+06,1.52E+07,5,5,5,5,1.02E+07,1.22E+08,9.30E+06,7.86E+05,6.73E+06,3.27E+07,1.69E+07,2.06E+08,7.45E+07,2.44E+06,1.08E+06,6.63E+06,2.75E+05,7.87E+06,1.45E+07,3.79E+08,1.42E+07,9.76E+06,1.52E+07,2.14E+07,4.06E+04,4.65E+05,9.09E+04,7.86E+05,3.47E+05,1.16E+05,3.00E+05,1.90E+06,2.10E+06,2.60E+04,6.45E+03,2.96E+05,2.24E+03,1.06E+06,3.61E+05,7.39E+05,3.99E+06,6.92E+04,3.55E+05,2.28E+05,0,FALSE,111.602,34,19,788,87,5.24,19,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf00362, Pf07965, Pf07974, Pf08725, Pf17205, Pf18372",3690,A0PJW2; D3DXJ8; hsa:3690; O15495; P05106; Q12806; Q13413; Q14648; Q16499,ENSG00000259207,Integrin cell surface interactions; ECM proteoglycans; Platelet degranulation ; Signaling by BRAF and RAF1 fusions; VEGFA-VEGFR2 Pathway; Signal transduction by L1; Syndecan interactions; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Molecules associated with elastic fibres; TGF-beta receptor signaling activates SMADs; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins; PECAM1 interactions,Osteoclast signaling; Osteopontin signaling; Serotonin transporter activity; Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; Primary focal segmental glomerulosclerosis (FSGS); Complement system; Hematopoietic stem cell differentiation; Focal adhesion; Osteoblast signaling; MFAP5-mediated ovarian cancer cell motility and invasiveness; TGF-beta signaling pathway; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Thyroid hormones production and peripheral downstream signaling effects; Pleural mesothelioma; Complement system in neuronal development and plasticity; GDNF signaling; 2q37 copy number variation syndrome; Monoamine transport,44,0,173.43,124.08,95.07,185.2,High,High,High,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,High,High,1,,FALSE,141.48,120.44,141.81,131.33,531.24,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,A0A0A6YYL6,RPL17-C18orf32,60S ribosomal protein L17 OS=Homo sapiens OX=9606 GN=RPL17-C18orf32 PE=3 SV=1,6,49,0.304,0.281,2.354,0.418,-1.72,-1.83,1.24,-1.26,1.48E-01,1.84E-01,3.05E-01,4.94E-01,6.17E+06,1.14E+06,2.10E+06,1.80E+06,5,5,5,5,7.11E+04,1.36E+05,6.17E+06,8.24E+06,7.41E+06,9.22E+05,1.14E+06,1.38E+06,1.36E+05,2.76E+06,2.25E+06,2.10E+06,9.94E+05,2.94E+06,1.33E+06,1.80E+06,1.25E+06,5.22E+06,1.30E+06,7.94E+06,2.83E+02,5.17E+02,6.03E+04,8.24E+06,3.82E+05,3.28E+03,2.03E+04,1.27E+04,3.84E+03,2.93E+04,1.35E+04,9.38E+04,8.08E+03,3.97E+05,3.31E+04,3.51E+03,3.52E+05,3.70E+04,3.04E+04,8.46E+04,0,FALSE,42.87,30,6,228,26.4,10.1,6,protein metabolism;other metabolic processes,translational apparatus,Pf00237,100526842,A0A0A6YYL6; hsa:100526842,ENSG00000215472,,,0,0,90.7,75.32,40.2,85.04,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,High,High,Peak Found,High,1,,FALSE,135.39,86.75,127.41,140.48,139.12,other molecular function,0,
Master Protein,High,P35914,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial OS=Homo sapiens OX=9606 GN=HMGCL PE=1 SV=2",3,5,0.303,0.517,0.877,,-1.72,-0.95,-0.19,,2.76E-01,7.61E-01,7.62E-01,,1.05E+06,5.03E+05,2.90E+05,4.41E+05,5,1,5,1,1.28E+05,2.57E+06,6.40E+04,1.30E+06,1.05E+06,5.03E+05,,,,,3.17E+04,4.68E+05,1.39E+05,2.90E+05,3.72E+05,4.41E+05,,,,,5.10E+02,9.76E+03,6.25E+02,1.30E+06,5.42E+04,1.79E+03,,,,,1.90E+02,2.09E+04,1.13E+03,3.91E+04,9.24E+03,8.60E+02,,,,,0,FALSE,8.246,7,3,325,34.3,8.54,3,cell organization and biogenesis;other metabolic processes,cytosol;mitochondrion;other cytoplasmic organelle;other cell component,Pf00682,3155,B4DUP4; B7UCC6; D3Y5K7; hsa:3155; P35914; Q6IBC0; Q96FP8,ENSG00000117305,Peroxisomal protein import; Synthesis of Ketone Bodies,Ketone bodies synthesis and degradation; Amino acid metabolism,4,0,100.1,,67.6,,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,70.64,119.88,0,,12.67,other molecular function,0,
Master Protein,High,Q96C19,EFHD2,EF-hand domain-containing protein D2 OS=Homo sapiens OX=9606 GN=EFHD2 PE=1 SV=1,3,9,0.302,0.81,0.093,1.027,-1.73,-0.3,-3.42,0.04,1.92E-01,8.27E-01,5.87E-03,8.11E-01,4.97E+05,2.22E+06,4.65E+05,1.08E+05,5,1,4,4,1.34E+06,9.06E+05,4.97E+05,1.37E+05,1.02E+05,2.22E+06,,,,,1.61E+05,,3.16E+05,8.79E+05,6.85E+05,,3.04E+04,8.98E+04,1.45E+06,1.30E+05,5.32E+03,3.44E+03,4.85E+03,1.37E+05,5.25E+03,7.91E+03,,,,,9.61E+02,,2.57E+03,1.18E+05,1.70E+04,,8.54E+03,6.36E+02,3.38E+04,1.39E+03,0,FALSE,7.496,15,3,240,26.7,5.2,3,,other membranes,Pf21008,79180,hsa:79180; Q5JYW9; Q96C19,ENSG00000142634,RHOD GTPase cycle,,1,0,88.49,,64.67,160.92,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,High,n/a,High,Peak Found,High,Peak Found,1,,FALSE,62.96,86,494.06,131.82,13.55,other molecular function,0,
Master Protein,High,Q99460,PSMD1,26S proteasome non-ATPase regulatory subunit 1 OS=Homo sapiens OX=9606 GN=PSMD1 PE=1 SV=2,6,9,0.301,2.013,0.653,1.367,-1.73,1.01,-0.61,0.45,3.00E-01,1.77E-01,5.14E-01,6.45E-01,1.77E+05,5.16E+05,2.74E+05,5.72E+05,3,4,2,4,,,1.77E+05,1.78E+05,2.30E+04,2.48E+05,,1.54E+06,1.02E+06,2.62E+05,,,,3.22E+05,2.34E+05,1.25E+05,7.71E+05,,4.24E+05,9.77E+05,,,1.73E+03,1.78E+05,1.18E+03,8.80E+02,,1.42E+04,2.86E+04,2.79E+03,,,,4.34E+04,5.81E+03,2.43E+02,2.17E+05,,9.92E+03,1.04E+04,0,FALSE,21.025,7,6,953,105.8,5.39,6,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf01851, Pf13646, Pf18004, Pf21505",5707,B8ZZH9; hsa:5707; Q24JU0; Q53TI2; Q6GMU5; Q6P2P4; Q6PJM7; Q6PKG9; Q86VU1; Q8IV79; Q99460,ENSG00000173692,Neutrophil degranulation; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,64,0,70.81,81.96,22.5,65.62,n/a,n/a,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,Phospho [Y426],FALSE,135.27,23.89,198.36,20.54,27.96,enzyme regulator activity;other molecular function,1,Phospho [Y426]
Master Protein,High,O95347,SMC2,Structural maintenance of chromosomes protein 2 OS=Homo sapiens OX=9606 GN=SMC2 PE=1 SV=2,4,6,0.301,0.409,0.612,0.201,-1.73,-1.29,-0.71,-2.32,1.86E-01,5.08E-01,4.64E-01,2.47E-01,7.62E+05,2.09E+06,2.57E+05,1.21E+06,2,1,1,5,,,,2.64E+05,2.20E+06,2.09E+06,,,,,,,,2.57E+05,,1.63E+06,3.88E+05,1.21E+06,8.88E+05,1.49E+06,,,,2.64E+05,1.13E+05,7.43E+03,,,,,,,,3.46E+04,,3.18E+03,1.09E+05,8.60E+03,2.08E+04,1.59E+04,0,FALSE,13.434,4,4,1197,135.6,8.43,4,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,"Pf02463, Pf06470",10592,hsa:10592; O95347; Q6IEE0; Q9P1P2,ENSG00000136824,Condensation of Prophase Chromosomes; Condensation of Prometaphase Chromosomes,Retinoblastoma gene in cancer,3,0,111.06,,,44.53,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,238.05,238.05,14.69,16.48,18.29,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P31937,HIBADH,"3-hydroxyisobutyrate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=HIBADH PE=1 SV=2",3,8,0.299,0.616,0.226,0.605,-1.74,-0.7,-2.15,-0.72,2.93E-01,8.94E-01,8.63E-02,7.61E-01,5.41E+05,7.45E+05,4.09E+05,1.32E+05,2,1,4,2,,,,1.68E+06,1.74E+05,,,,,7.45E+05,,1.82E+06,1.30E+05,6.79E+05,2.47E+05,,,,4.50E+04,3.85E+05,,,,1.68E+06,8.99E+03,,,,,7.92E+03,,8.11E+04,1.05E+03,9.15E+04,6.14E+03,,,,1.05E+03,4.10E+03,0,FALSE,14.409,13,3,336,35.3,8.13,3,other metabolic processes,mitochondrion,"Pf03446, Pf14833",11112,hsa:11112; P31937; Q546Z2; Q9UDN3,ENSG00000106049,Branched-chain amino acid catabolism,Amino acid metabolism,2,0,114.78,,107.14,111.82,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,143.75,66.31,191.46,117.49,21.39,other molecular function,0,
Master Protein,High,A0A087X2I1,PSMC6,"Proteasome 26S subunit, ATPase 6 OS=Homo sapiens OX=9606 GN=PSMC6 PE=1 SV=1",2,4,0.299,2.409,1.193,0.156,-1.74,1.27,0.25,-2.68,2.49E-01,1.49E-01,9.45E-01,1.51E-01,5.70E+04,1.68E+05,2.20E+05,2.01E+05,2,2,1,2,,,,1.09E+05,2.98E+04,,,,4.84E+05,5.85E+04,,,,2.20E+05,,,1.41E+06,,,2.86E+04,,,,1.09E+05,1.54E+03,,,,1.37E+04,6.22E+02,,,,2.97E+04,,,3.96E+05,,,3.04E+02,0,FALSE,9.806,9,2,403,45.8,7.78,2,,other cell component,"Pf00004, Pf16450, Pf17862",5706,A0A087X2I1; hsa:5706,ENSG00000100519,,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,5,0,80.76,110.96,,135.81,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,Peak Found,1,,FALSE,61.18,0,150.58,0,14.29,other molecular function,0,
Master Protein,High,P78417,GSTO1,Glutathione S-transferase omega-1 OS=Homo sapiens OX=9606 GN=GSTO1 PE=1 SV=2,2,14,0.298,1.013,2.146,0.134,-1.75,0.02,1.1,-2.9,2.92E-01,6.19E-01,3.77E-01,9.89E-02,2.18E+05,4.52E+05,3.81E+05,1.98E+06,4,4,4,5,2.16E+05,8.40E+04,,2.20E+05,1.86E+06,2.33E+05,2.45E+05,1.48E+06,8.34E+05,,,1.39E+05,3.25E+05,1.27E+06,4.46E+05,1.98E+06,2.20E+06,1.46E+06,5.20E+06,1.88E+06,8.60E+02,3.19E+02,,2.20E+05,9.57E+04,8.27E+02,4.35E+03,1.37E+04,2.35E+04,,,6.20E+03,2.64E+03,1.71E+05,1.11E+04,3.86E+03,6.18E+05,1.03E+04,1.22E+05,2.00E+04,0,FALSE,7.271,8,2,241,27.5,6.6,2,other metabolic processes;signal transduction;other biological processes,cytosol;other cell component,"Pf13409, Pf14497",9446,D3DRA3; F5H7H0; hsa:9446; P78417; Q5TA03; Q7Z3T2,ENSG00000148834,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Glutathione conjugation; Vitamin C (ascorbate) metabolism; Methylation,Myometrial relaxation and contraction pathways; Arsenic metabolism and reactive oxygen species generation; Metapathway biotransformation Phase I and II,7,0,142.01,85.01,91.66,59.37,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,120.42,102.25,78.25,120,28.77,other molecular function,0,
Master Protein,High,Q9Y6C2,EMILIN1,EMILIN-1 OS=Homo sapiens OX=9606 GN=EMILIN1 PE=1 SV=3,6,10,0.293,0.99,0.943,0.322,-1.77,-0.01,-0.08,-1.64,2.48E-01,7.21E-01,7.96E-01,4.56E-01,9.28E+04,4.01E+05,4.46E+04,3.58E+05,4,4,3,3,,2.17E+05,3.96E+04,9.11E+03,1.67E+06,1.21E+05,,1.00E+06,2.06E+06,1.60E+05,,1.79E+04,,6.92E+04,4.46E+04,7.96E+06,3.58E+05,,1.49E+05,,,8.26E+02,3.87E+02,9.11E+03,8.63E+04,4.29E+02,,9.25E+03,5.79E+04,1.70E+03,,7.99E+02,,9.33E+03,1.11E+03,1.55E+04,1.01E+05,,3.48E+03,,0,FALSE,20.729,10,6,1016,106.6,5.17,6,cell adhesion;cell organization and biogenesis;developmental processes;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;other cell component,"Pf00386, Pf01391, Pf07546",11117,A0A0C4DFX3; A5PL03; H0Y7A0; hsa:11117; Q53SY9; Q96G58; Q96IH6; Q9UG76; Q9Y6C2,ENSG00000138080,Molecules associated with elastic fibres,,1,0,164.5,109.01,58.47,157.7,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,1,,FALSE,125.66,115.69,140.55,77.64,22.34,signal transduction activity or receptor binding;extracellular structural activity;other molecular function,0,
Master Protein,High,Q9H0U4,RAB1B,Ras-related protein Rab-1B OS=Homo sapiens OX=9606 GN=RAB1B PE=1 SV=1,6,90,0.291,0.337,1.148,0.397,-1.78,-1.57,0.2,-1.33,1.35E-01,3.06E-01,9.64E-01,4.57E-01,1.42E+06,4.31E+06,2.08E+06,6.56E+06,5,5,5,5,3.33E+06,2.74E+06,1.42E+06,1.85E+05,1.38E+06,4.31E+06,1.63E+06,4.40E+06,6.44E+06,2.94E+06,2.28E+06,2.08E+06,1.65E+05,4.79E+06,1.31E+06,2.06E+07,6.56E+06,7.49E+06,1.44E+06,4.33E+06,1.32E+04,1.04E+04,1.39E+04,1.85E+05,7.10E+04,1.53E+04,2.91E+04,4.06E+04,1.81E+05,3.13E+04,1.36E+04,9.28E+04,1.34E+03,6.45E+05,3.26E+04,4.02E+04,1.84E+06,5.31E+04,3.38E+04,4.61E+04,0,FALSE,31.774,38,4,201,22.2,5.73,6,cell organization and biogenesis;other metabolic processes;transport;other biological processes,other membranes;cytosol;ER/Golgi;other cell component,Pf00071,81876,A8K7S1; hsa:81876; Q9H0U4,ENSG00000174903,COPI-mediated anterograde transport; COPI-dependent Golgi-to-ER retrograde traffic; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; COPII-mediated vesicle transport; Golgi Cisternae Pericentriolar Stack Reorganization,,6,0,68.61,45.49,80.23,91.28,High,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,1,,FALSE,128.79,140.71,147.39,142.71,245.44,other molecular function,0,
Master Protein,Medium,Q9UKF5,ADAM29,Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens OX=9606 GN=ADAM29 PE=1 SV=3,1,1,0.289,0.247,0.01,7.341,-1.79,-2.02,-6.64,2.88,2.58E-01,2.67E-01,1.00E-17,9.01E-02,1.35E+05,4.37E+05,9.61E+03,1.31E+03,4,4,2,1,1.82E+05,1.29E+05,1.41E+05,2.79E+03,,1.75E+05,,5.59E+05,5.52E+05,3.45E+05,3.96E+04,,,2.33E+03,,,1.31E+03,,,,7.23E+02,4.91E+02,1.38E+03,2.79E+03,,6.21E+02,,5.16E+03,1.56E+04,3.67E+03,2.37E+02,,,3.14E+02,,,3.68E+02,,,,0.025,FALSE,1.892,2,1,820,92.7,7.4,1,protein metabolism;developmental processes;other biological processes,plasma membrane;other membranes,"Pf00200, Pf01421, Pf01562, Pf08516",11086,hsa:11086; Q4W5F3; Q9UHP1; Q9UKF3; Q9UKF4; Q9UKF5,ENSG00000168594,,,0,0,67.98,45.25,125.7,,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,Phospho [S286],FALSE,55.44,125.11,40.48,287.58,2.93,other molecular function,1,Phospho [S286]
Master Protein,High,O75351,VPS4B,Vacuolar protein sorting-associated protein 4B OS=Homo sapiens OX=9606 GN=VPS4B PE=1 SV=2,1,1,0.288,1.295,0.124,2.473,-1.8,0.37,-3.01,1.31,2.44E-01,4.92E-01,2.78E-02,3.76E-01,8.52E+04,4.47E+05,1.37E+05,5.55E+04,3,2,4,1,1.14E+06,,,8.52E+04,8.44E+04,6.77E+05,,,,2.95E+05,2.48E+05,1.61E+05,1.17E+05,1.03E+05,,,5.55E+04,,,,4.53E+03,,,8.52E+04,4.36E+03,2.41E+03,,,,3.13E+03,1.48E+03,7.20E+03,9.50E+02,1.39E+04,,,1.56E+04,,,,0.002,FALSE,3.001,4,1,444,49.3,7.23,1,cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,"Pf00004, Pf04212, Pf09336, Pf17862",9525,hsa:9525; O75351; Q69HW4; Q9GZS7,ENSG00000119541,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT),,2,0,139.57,55.62,41.48,,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,130.09,96.86,63.43,31.36,2.99,other molecular function,0,
Master Protein,High,Q8N5Y2,MSL3,Male-specific lethal 3 homolog OS=Homo sapiens OX=9606 GN=MSL3 PE=1 SV=1,1,1,0.286,0.01,0.43,0.01,-1.8,-6.64,-1.22,-6.64,2.66E-01,1.00E-17,2.83E-01,1.00E-17,1.65E+05,5.76E+05,,2.48E+05,2,3,,2,,,,6.33E+04,4.32E+05,,4.13E+05,,5.76E+05,8.08E+05,,,,,,9.38E+05,6.56E+04,,,,,,,6.33E+04,2.23E+04,,7.34E+03,,1.62E+04,8.59E+03,,,,,,1.83E+03,1.84E+04,,,,0.004,FALSE,2.609,3,1,521,59.8,8.21,1,cell organization and biogenesis;other biological processes,nucleus;other cell component,"Pf05712, Pf11717",10943,A6NCU2; A6NHW8; A8K165; B4DUV8; B7Z227; hsa:10943; Q8N5Y2; Q9UG70; Q9Y5Z8,ENSG00000005302,HATs acetylate histones,,1,0,105.28,33.13,,122.94,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,118.19,,186.44,,3.28,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q96EH3,MALSU1,Mitochondrial assembly of ribosomal large subunit protein 1 OS=Homo sapiens OX=9606 GN=MALSU1 PE=1 SV=1,1,1,0.285,0.01,0.01,,-1.81,-6.64,-6.64,,2.31E-01,1.00E-17,1.00E-17,,7.37E+04,2.58E+05,,,2,1,,,,,,2.33E+04,2.33E+05,,,,,2.58E+05,,,,,,,,,,,,,,2.33E+04,1.20E+04,,,,,2.75E+03,,,,,,,,,,,0.001,FALSE,3.1,9,1,234,26.2,5.49,1,other biological processes,cytosol;mitochondrion,Pf02410,115416,A4D154; hsa:115416; Q96EH3,ENSG00000156928,,,0,0,115.69,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,210.87,,,,0,translation activity,0,
Master Protein,High,Q9UL25,RAB21,Ras-related protein Rab-21 OS=Homo sapiens OX=9606 GN=RAB21 PE=1 SV=3,2,5,0.285,0.836,0.891,0.184,-1.81,-0.26,-0.17,-2.44,2.03E-01,8.02E-01,8.94E-01,2.20E-01,3.73E+05,1.53E+06,5.35E+05,7.49E+05,4,3,5,4,3.41E+05,,1.48E+05,4.07E+05,9.70E+05,,5.68E+05,1.53E+06,,1.80E+06,1.18E+06,5.32E+04,5.35E+05,7.06E+05,6.83E+04,,5.42E+05,2.48E+06,1.58E+05,1.03E+06,1.35E+03,,1.44E+03,4.07E+05,5.00E+04,,1.01E+04,1.41E+04,,1.92E+04,7.05E+03,2.38E+03,4.34E+03,9.51E+04,1.70E+03,,1.52E+05,1.76E+04,3.70E+03,1.10E+04,0,FALSE,5.901,10,2,225,24.3,7.94,2,cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00071,23011,hsa:23011; Q14466; Q569H3; Q9UL25,ENSG00000080371,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation,Ciliary landscape,3,0,75.7,49.89,92.82,96.39,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,54.52,87.41,94.58,96.4,13.23,other molecular function,0,
Master Protein,High,A0A494C0X7,ITGB2,Integrin beta OS=Homo sapiens OX=9606 GN=ITGB2 PE=1 SV=1,15,138,0.284,0.505,0.942,0.308,-1.82,-0.98,-0.09,-1.7,1.28E-01,6.43E-01,8.35E-01,3.33E-01,7.24E+06,7.44E+07,6.21E+06,3.81E+07,5,5,5,5,7.24E+06,8.43E+07,9.55E+05,1.53E+05,1.35E+07,8.91E+07,7.44E+07,1.09E+08,1.22E+07,2.48E+07,6.21E+06,2.51E+06,1.01E+07,1.08E+07,4.31E+06,1.06E+08,1.96E+06,3.81E+07,1.12E+07,7.31E+07,2.88E+04,3.20E+05,9.33E+03,1.53E+05,6.94E+05,3.17E+05,1.32E+06,1.00E+06,3.43E+05,2.64E+05,3.71E+04,1.12E+05,8.21E+04,1.45E+06,1.07E+05,2.08E+05,5.50E+05,2.70E+05,2.61E+05,7.78E+05,0,FALSE,58.626,27,15,769,84.7,6.98,15,cell adhesion;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,"Pf00362, Pf07965, Pf08725, Pf17205",3689,A0A494C0X7; hsa:3689,ENSG00000160255,,Integrin-mediated cell adhesion; Complement system; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Microglia pathogen phagocytosis pathway; TYROBP causal network in microglia; Fibrin complement receptor 3 signaling pathway; Acute viral myocarditis; Cells and molecules involved in local acute inflammatory response ; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Pleural mesothelioma; Complement system in neuronal development and plasticity; CCL18 signaling pathway; Extrafollicular and follicular B cell activation by SARS-CoV-2; 11p11.2 copy number variation syndrome,14,0,168.07,67.3,52.95,94.46,High,High,Peak Found,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,141.86,144.03,135.34,140.71,302.05,other molecular function,0,
Master Protein,High,P13716,ALAD,Delta-aminolevulinic acid dehydratase OS=Homo sapiens OX=9606 GN=ALAD PE=1 SV=1,9,59,0.284,1.41,3.013,0.11,-1.82,0.5,1.59,-3.19,1.67E-01,2.02E-01,2.02E-01,5.98E-02,6.24E+05,2.33E+06,1.28E+06,1.78E+07,5,5,5,5,1.28E+06,1.04E+05,6.24E+05,4.02E+05,1.09E+07,2.33E+06,7.12E+06,1.99E+06,4.62E+05,2.34E+07,1.28E+06,3.74E+05,1.04E+07,2.14E+06,3.09E+05,7.70E+06,1.78E+07,2.57E+07,1.78E+07,1.48E+07,5.07E+03,3.97E+02,6.10E+03,4.02E+05,5.60E+05,8.27E+03,1.27E+05,1.83E+04,1.30E+04,2.49E+05,7.63E+03,1.67E+04,8.43E+04,2.89E+05,7.69E+03,1.50E+04,4.99E+06,1.82E+05,4.16E+05,1.58E+05,0,FALSE,46.04,35,9,330,36.3,6.79,9,cell organization and biogenesis;other metabolic processes;stress response;other biological processes,non-structural extracellular;cytosol;other cell component,Pf00490,210,A8K375; B2R6F2; hsa:210; P13716; Q16870; Q16871; Q9BVQ9,ENSG00000148218,Neutrophil degranulation; Heme biosynthesis,Hemesynthesis defects and porphyrias; Heme biosynthesis,4,0,173.7,134.07,146.7,38.7,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,High,High,1,Acetyl [N-Term],FALSE,143.46,146.28,121.5,127.98,132.11,other molecular function,0,
Master Protein,High,Q96FV9,THOC1,THO complex subunit 1 OS=Homo sapiens OX=9606 GN=THOC1 PE=1 SV=1,7,7,0.283,0.776,,0.345,-1.82,-0.37,,-1.54,2.66E-01,8.77E-01,,3.89E-01,4.14E+05,2.99E+05,1.57E+05,3.86E+05,3,2,4,3,,4.14E+05,,6.88E+05,2.30E+05,,,,2.45E+05,3.65E+05,,4.16E+04,1.82E+05,3.79E+05,1.35E+05,3.01E+05,,3.86E+05,,5.27E+05,,1.57E+03,,6.88E+05,1.19E+04,,,,6.89E+03,3.88E+03,,1.86E+03,1.48E+03,5.11E+04,3.35E+03,5.86E+02,,2.74E+03,,5.62E+03,0,FALSE,25.269,19,7,657,75.6,4.98,7,DNA metabolism;RNA metabolism OR transcription;other metabolic processes;transport;signal transduction;other biological processes,nucleus;other cell component,"Pf00531, Pf11957",9984,B2RBP6; hsa:9984; Q15219; Q64I72; Q64I73; Q96FV9,ENSG00000079134,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,,3,0,51.93,27.86,77.24,28.3,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,29.79,95.43,,62.12,22.71,nucleic acid binding activity,0,
Master Protein,High,P50336,PPOX,Protoporphyrinogen oxidase OS=Homo sapiens OX=9606 GN=PPOX PE=1 SV=1,5,10,0.281,0.681,1.226,0.233,-1.83,-0.56,0.29,-2.1,2.36E-01,9.74E-01,9.81E-01,2.33E-01,2.42E+05,1.65E+05,1.70E+05,6.26E+05,4,3,5,5,2.46E+05,,1.25E+05,5.18E+05,2.38E+05,6.22E+05,,1.45E+05,,1.65E+05,1.74E+05,7.01E+04,1.30E+05,2.47E+05,1.70E+05,1.42E+05,3.46E+06,5.81E+05,6.86E+05,6.26E+05,9.77E+02,,1.22E+03,5.18E+05,1.23E+04,2.21E+03,,1.34E+03,,1.76E+03,1.04E+03,3.13E+03,1.05E+03,3.33E+04,4.22E+03,2.78E+02,9.71E+05,4.11E+03,1.61E+04,6.66E+03,0,FALSE,21.655,17,5,477,50.7,8.16,5,other metabolic processes,other membranes;mitochondrion,Pf01593,5498,D3DVG0; hsa:5498; P50336; Q5VTW8,ENSG00000143224,Heme biosynthesis,Orexin receptor pathway; Hemesynthesis defects and porphyrias; Heme biosynthesis,4,0,59.13,86.7,41.04,121.63,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,90.54,36.04,91.82,100.05,26.12,other molecular function,0,
Master Protein,High,Q9NVH6,TMLHE,"Trimethyllysine dioxygenase, mitochondrial OS=Homo sapiens OX=9606 GN=TMLHE PE=1 SV=1",3,9,0.28,1.816,0.01,100,-1.84,0.86,-6.64,6.64,2.00E-01,9.02E-02,1.00E-17,1.00E-17,9.41E+05,9.51E+05,1.50E+06,,3,2,3,,,,2.50E+05,9.41E+05,1.17E+06,,,8.29E+05,,1.09E+06,,,1.50E+06,3.66E+06,1.08E+06,,,,,,,,2.44E+03,9.41E+05,6.05E+04,,,7.65E+03,,1.16E+04,,,1.22E+04,4.93E+05,2.69E+04,,,,,,0,FALSE,15.489,11,3,421,49.5,7.72,3,other metabolic processes;other biological processes,mitochondrion,"Pf02668, Pf06155",55217,A8K6M9; B4E3R3; hsa:55217; Q5TZB5; Q6IA90; Q8TBT0; Q9NVH6,ENSG00000185973,Carnitine synthesis,,1,0,60.92,19.38,66.35,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,51.84,63.96,,,31.71,other molecular function,0,
Master Protein,Medium,P04196,HRG,Histidine-rich glycoprotein OS=Homo sapiens OX=9606 GN=HRG PE=1 SV=1,1,2,0.277,0.01,0.041,0.01,-1.85,-6.64,-4.62,-6.64,1.39E-01,1.00E-17,2.39E-05,1.00E-17,8.02E+05,2.90E+06,,1.21E+05,1,4,,2,,8.02E+05,,,,8.16E+06,,1.13E+06,7.45E+06,1.09E+06,,,,,,,3.23E+04,,,4.50E+05,,3.05E+03,,,,2.90E+04,,1.04E+04,2.10E+05,1.15E+04,,,,,,,9.09E+03,,,4.79E+03,0.019,FALSE,2.014,2,1,525,59.5,7.5,1,stress response;transport;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf00031,3273,B9EK35; D3DNU7; hsa:3273; P04196,ENSG00000113905,Platelet degranulation ; Dissolution of Fibrin Clot,,2,0,,87.03,,122.46,n/a,Peak Found,n/a,n/a,n/a,High,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,162.78,,97.21,,1.9,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q9H7M9,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation OS=Homo sapiens OX=9606 GN=VSIR PE=1 SV=3,1,3,0.276,0.412,0.237,0.422,-1.86,-1.28,-2.08,-1.24,2.35E-01,5.55E-01,1.14E-01,5.96E-01,1.13E+05,4.08E+05,4.64E+04,9.65E+04,3,1,2,5,,1.13E+05,,1.58E+04,3.47E+05,4.08E+05,,,,,,,,7.79E+04,2.76E+04,9.69E+06,1.29E+04,9.65E+04,2.18E+05,5.55E+04,,4.28E+02,,1.58E+04,1.79E+04,1.45E+03,,,,,,,,1.05E+04,6.87E+02,1.89E+04,3.63E+03,6.84E+02,5.10E+03,5.91E+02,0.002,FALSE,2.84,4,1,311,33.9,6.95,1,protein metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes,Pf07686,64115,A1L0X9; A4ZYV1; A8MVH5; hsa:64115; Q6UXF3; Q8WUG3; Q8WYZ8; Q9H7M9,ENSG00000107738,,,0,0,107.44,,67.32,213.03,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,100.13,118.57,109.69,111.33,7.38,enzyme regulator activity;other molecular function,0,
Master Protein,Medium,Q9NYP7,ELOVL5,Elongation of very long chain fatty acids protein 5 OS=Homo sapiens OX=9606 GN=ELOVL5 PE=1 SV=1,1,1,0.274,0.01,0.446,0.01,-1.87,-6.64,-1.16,-6.64,2.14E-01,1.00E-17,4.19E-01,1.00E-17,7.33E+04,1.79E+05,,1.05E+05,4,4,,2,4.07E+04,1.32E+05,,2.29E+04,1.51E+05,,1.49E+05,2.14E+05,8.32E+04,6.70E+05,,,,,,,2.49E+03,4.46E+06,,,1.62E+02,5.02E+02,,2.29E+04,7.76E+03,,2.65E+03,1.98E+03,2.34E+03,7.12E+03,,,,,,,6.99E+02,3.16E+04,,,0.016,FALSE,2.09,3,1,299,35.3,9.42,1,other metabolic processes;other biological processes,other membranes;ER/Golgi;other cell component,Pf01151,60481,B4DZJ2; F6SH78; hsa:60481; Q59EL3; Q5TGH5; Q6NXE7; Q7L2S5; Q8NCG4; Q9NYP7; Q9UI22,ENSG00000012660,Synthesis of very long-chain fatty acyl-CoAs; alpha-linolenic acid (ALA) metabolism; Linoleic acid (LA) metabolism,Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-3 / omega-6 fatty acid synthesis; Omega-9 fatty acid synthesis; Linoleic acid metabolism affected by SARS-CoV-2; Omega-6-fatty acids in senescence,8,0,74.07,95.33,,141.26,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,96.43,,1105.13,,0,other molecular function,0,
Master Protein,High,Q92542,NCSTN,Nicastrin OS=Homo sapiens OX=9606 GN=NCSTN PE=1 SV=2,2,3,0.274,0.966,1.161,0.281,-1.87,-0.05,0.22,-1.83,2.49E-01,6.47E-01,9.37E-01,3.66E-01,1.96E+05,7.16E+05,1.90E+05,1.00E+06,1,3,4,4,,,1.96E+05,,,7.16E+05,1.45E+06,,,3.59E+05,2.97E+05,1.21E+05,,9.05E+04,3.42E+05,,1.45E+05,1.42E+06,1.24E+06,8.10E+05,,,1.92E+03,,,2.55E+03,2.58E+04,,,3.82E+03,1.78E+03,5.39E+03,,1.22E+04,8.50E+03,,4.07E+04,1.01E+04,2.90E+04,8.63E+03,0,FALSE,6.61,5,2,709,78.4,5.99,2,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf05450, Pf18266",23385,hsa:23385; Q5T207; Q5T208; Q86VV5; Q92542,ENSG00000162736,Neutrophil degranulation; Amyloid fiber formation; Degradation of the extracellular matrix; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; Nuclear signaling by ERBB4; EPH-ephrin mediated repulsion of cells; NOTCH4 Activation and Transmission of Signal to the Nucleus; NRIF signals cell death from the nucleus; Regulated proteolysis of p75NTR; Noncanonical activation of NOTCH3,Alzheimer's disease and miRNA effects; Notch signaling; Inclusion body myositis; Alzheimer's disease; DYRK1A involvement regarding cell proliferation in brain development; Notch signaling pathway,20,0,,66.12,59.04,62.72,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,73.96,69.12,76.93,89.91,10.71,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P13284,IFI30,Gamma-interferon-inducible lysosomal thiol reductase OS=Homo sapiens OX=9606 GN=IFI30 PE=1 SV=3,1,7,0.273,1.235,0.838,0.573,-1.87,0.3,-0.25,-0.8,1.63E-01,2.69E-01,7.29E-01,7.13E-01,5.10E+05,1.87E+06,1.47E+06,1.93E+06,2,1,3,3,,,,4.00E+05,6.51E+05,,,1.87E+06,,,,1.47E+06,,8.63E+05,4.86E+06,,1.92E+05,,1.93E+06,2.16E+06,,,,4.00E+05,3.36E+04,,,1.73E+04,,,,6.57E+04,,1.16E+05,1.21E+05,,5.40E+04,,4.52E+04,2.30E+04,0,FALSE,19.884,10,1,250,27.9,4.88,1,other biological processes,non-structural extracellular;cytosol;other cytoplasmic organelle;other cell component,Pf03227,10437,hsa:10437; P13284; Q76MF9; Q8NEI4; Q8WU77; Q9UL08,ENSG00000216490,MHC class II antigen presentation; Interferon gamma signaling,,2,0,33.82,,89.8,75.35,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,High,High,High,High,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,36.52,47.3,6.1,97.79,28.26,other molecular function,0,
Master Protein,High,Q8NG06,TRIM58,E3 ubiquitin-protein ligase TRIM58 OS=Homo sapiens OX=9606 GN=TRIM58 PE=2 SV=2,4,6,0.273,0.212,3.024,0.047,-1.87,-2.24,1.6,-4.42,2.63E-01,1.91E-01,1.93E-01,1.46E-02,1.61E+05,7.08E+05,4.56E+04,1.53E+06,1,3,3,5,,,1.61E+05,,,7.08E+05,,1.87E+06,1.38E+05,,,3.42E+04,,5.76E+04,4.56E+04,1.07E+06,1.53E+06,8.06E+06,1.27E+05,3.37E+06,,,1.58E+03,,,2.52E+03,,1.73E+04,3.90E+03,,,1.53E+03,,7.76E+03,1.13E+03,2.08E+03,4.29E+05,5.71E+04,2.97E+03,3.59E+04,0,FALSE,9.862,10,4,486,54.7,6.19,4,protein metabolism;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,"Pf00622, Pf00643, Pf13765, Pf15227",25893,hsa:25893; Q6B0H9; Q8NG06,ENSG00000162722,,,0,0,,97.58,25.56,111.41,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,84.27,0,126.83,97.27,13.67,other molecular function,0,
Master Protein,Medium,P32780,GTF2H1,General transcription factor IIH subunit 1 OS=Homo sapiens OX=9606 GN=GTF2H1 PE=1 SV=1,1,1,0.272,1.436,0.621,0.63,-1.88,0.52,-0.69,-0.67,1.63E-01,4.30E-01,6.23E-01,8.47E-01,1.72E+04,6.31E+04,2.47E+04,3.92E+04,1,2,5,1,,,,1.72E+04,,1.20E+05,,,3.32E+04,,9.16E+04,4.26E+03,2.47E+04,3.06E+04,2.10E+04,,,3.92E+04,,,,,,1.72E+04,,4.27E+02,,,9.34E+02,,5.48E+02,1.90E+02,2.01E+02,4.12E+03,5.23E+02,,,2.77E+02,,,0.022,FALSE,1.948,2,1,548,62,8.66,1,DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,nucleus,"Pf03909, Pf08567",2965,B3KXE0; D3DQY2; hsa:2965; P32780; Q6I9Y7; Q9H5K5; Q9NQD9,ENSG00000110768; ENSG00000288114,NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Dual Incision in GG-NER,"Eukaryotic transcription initiation; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",33,0,,80.21,97.08,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,102.11,35.29,102.11,28.5,2.21,other molecular function,0,
Master Protein,High,O75694,NUP155,Nuclear pore complex protein Nup155 OS=Homo sapiens OX=9606 GN=NUP155 PE=1 SV=1,7,9,0.272,0.305,1.484,0.14,-1.88,-1.71,0.57,-2.84,2.25E-01,2.67E-01,7.70E-01,1.06E-01,1.13E+06,4.97E+05,7.66E+04,8.83E+05,5,5,5,4,1.99E+06,2.30E+05,3.76E+06,1.13E+06,6.33E+05,4.97E+05,3.82E+05,6.29E+05,2.03E+05,6.42E+05,5.15E+04,1.32E+04,3.72E+05,6.71E+05,7.66E+04,9.20E+04,,1.34E+06,5.80E+05,2.80E+06,7.89E+03,8.73E+02,3.67E+04,1.13E+06,3.27E+04,1.77E+03,6.80E+03,5.81E+03,5.73E+03,6.83E+03,3.08E+02,5.88E+02,3.02E+03,9.05E+04,1.90E+03,1.79E+02,,9.52E+03,1.36E+04,2.99E+04,0,FALSE,28.719,8,7,1391,155.1,6.16,7,cell-cell signaling;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,other membranes;cytosol;nucleus,Pf08801,9631,hsa:9631; O75694; Q9UBE9; Q9UFL5,ENSG00000113569,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,,29,0,90.39,38.95,118.86,98.27,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,99.04,101.25,137.17,113.02,29.35,other molecular function,0,
Master Protein,High,Q9BUQ8,DDX23,Probable ATP-dependent RNA helicase DDX23 OS=Homo sapiens OX=9606 GN=DDX23 PE=1 SV=3,9,20,0.27,0.478,3.239,0.103,-1.89,-1.06,1.7,-3.29,2.34E-01,6.78E-01,1.71E-01,3.76E-02,7.66E+05,6.92E+05,5.39E+05,3.81E+06,3,4,2,1,,7.66E+05,,2.15E+06,2.36E+05,,5.41E+06,2.09E+05,2.30E+06,8.00E+04,8.42E+05,,,3.45E+05,,3.81E+06,,,,,,2.91E+03,,2.15E+06,1.22E+04,,9.63E+04,1.92E+03,6.47E+04,8.51E+02,5.03E+03,,,4.65E+04,,7.42E+03,,,,,0,FALSE,41.966,19,9,820,95.5,9.55,9,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf00270, Pf00271",9416,B2R600; B4DH15; hsa:9416; O43188; Q9BUQ8,ENSG00000174243,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,,2,0,94.04,124.66,59.16,,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,140.94,75.04,158.38,34.2,54.88,other molecular function,0,
Master Protein,High,O75381,PEX14,Peroxisomal membrane protein PEX14 OS=Homo sapiens OX=9606 GN=PEX14 PE=1 SV=1,4,6,0.269,0.68,1.192,6.687,-1.89,-0.56,0.25,2.74,2.51E-01,9.99E-01,9.94E-01,3.39E-02,2.28E+05,4.25E+05,1.44E+05,4.13E+05,4,1,5,3,1.82E+05,,4.16E+04,8.43E+05,2.86E+05,,,,,4.25E+05,1.19E+05,1.38E+05,3.25E+05,3.56E+05,1.44E+05,6.36E+05,4.13E+05,,1.85E+04,,7.22E+02,,4.07E+02,8.43E+05,1.48E+04,,,,,4.52E+03,7.10E+02,6.17E+03,2.64E+03,4.79E+04,3.57E+03,1.24E+03,1.16E+05,,4.32E+02,,0,FALSE,12.655,11,4,377,41.2,4.94,4,cell organization and biogenesis;stress response;transport;other biological processes,other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf04695,5195,B2R7N1; B3KML6; B7Z1N2; hsa:5195; O75381; Q8WX51,ENSG00000142655,E3 ubiquitin ligases ubiquitinate target proteins; Peroxisomal protein import; Class I peroxisomal membrane protein import,,3,0,103.91,,52.83,87.89,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,155.49,107.39,33.87,147.85,14.58,signal transduction activity or receptor binding;transporter activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,P13489,RNH1,Ribonuclease inhibitor OS=Homo sapiens OX=9606 GN=RNH1 PE=1 SV=2,5,15,0.269,0.208,0.691,0.284,-1.9,-2.27,-0.53,-1.82,1.58E-01,7.16E-02,5.73E-01,3.78E-01,1.76E+06,1.58E+06,1.11E+05,1.43E+06,4,4,4,5,2.91E+06,1.73E+06,,3.86E+05,1.80E+06,1.77E+06,5.64E+05,1.42E+06,,3.87E+06,,6.39E+04,9.43E+04,5.86E+05,1.31E+05,1.43E+06,1.29E+06,1.76E+06,5.49E+05,2.79E+06,1.16E+04,6.58E+03,,3.86E+05,9.27E+04,6.28E+03,1.00E+04,1.31E+04,,4.11E+04,,2.85E+03,7.66E+02,7.89E+04,3.25E+03,2.79E+03,3.63E+05,1.25E+04,1.28E+04,2.97E+04,0,FALSE,21.784,16,5,461,49.9,4.82,5,RNA metabolism OR transcription;other metabolic processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf13516, Pf18779",6050,hsa:6050; P13489; Q8IZK8; Q96FD7; Q9BQ80; Q9UDK6,ENSG00000023191; ENSG00000276230,,,0,0,60.51,73.75,112.58,52.09,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,High,High,1,,FALSE,106.22,86.93,115.71,97.12,43.24,enzyme regulator activity,0,
Master Protein,High,Q96DZ9,CMTM5,CKLF-like MARVEL transmembrane domain-containing protein 5 OS=Homo sapiens OX=9606 GN=CMTM5 PE=1 SV=2,1,3,0.267,0.572,0.702,0.218,-1.9,-0.81,-0.51,-2.2,2.42E-01,8.14E-01,5.69E-01,1.96E-01,1.84E+05,6.90E+05,1.05E+05,4.84E+05,1,2,1,1,,,,,1.84E+05,,,,4.05E+06,1.17E+05,,,,,1.05E+05,,4.84E+05,,,,,,,,9.51E+03,,,,1.14E+05,1.25E+03,,,,,2.62E+03,,1.36E+05,,,,0,FALSE,7.678,9,1,223,24.6,6.62,1,signal transduction;other biological processes,non-structural extracellular;other membranes,Pf01284,116173,E9PH91; hsa:116173; Q5PY48; Q96DZ9,ENSG00000166091,,,0,0,,133.45,,,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,422.69,0,422.69,0,11.12,signal transduction activity or receptor binding,0,
Master Protein,High,P25490,YY1,Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2,4,15,0.267,2.134,0.261,2.602,-1.91,1.09,-1.94,1.38,1.11E-01,8.13E-02,6.54E-02,3.02E-01,1.71E+06,6.41E+06,2.46E+06,1.14E+06,3,3,5,5,,1.71E+06,,2.80E+06,3.73E+05,5.20E+06,3.73E+07,6.41E+06,,,9.38E+04,1.57E+06,3.29E+06,4.53E+06,2.46E+06,2.33E+06,1.66E+05,5.60E+05,1.14E+06,4.07E+06,,6.50E+03,,2.80E+06,1.92E+04,1.85E+04,6.63E+05,5.91E+04,,,5.61E+02,7.03E+04,2.67E+04,6.11E+05,6.10E+04,4.54E+03,4.66E+04,3.97E+03,2.68E+04,4.33E+04,0,FALSE,25.963,18,4,414,44.7,6.25,4,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,Pf00096,7528,hsa:7528; P25490; Q14935,ENSG00000100811,UCH proteinases; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; DNA Damage Recognition in GG-NER; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,Sterol regulatory element-binding proteins (SREBP) signaling; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Pleural mesothelioma,8,0,74.71,111.6,70.48,95.44,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,101.3,130.58,110.11,115.84,51.67,nucleic acid binding activity;other molecular function,0,
Master Protein,High,H0Y8C6,IPO5,Importin 5 (Fragment) OS=Homo sapiens OX=9606 GN=IPO5 PE=1 SV=1,5,9,0.266,2.007,2.337,0.807,-1.91,1,1.22,-0.31,2.06E-01,1.80E-01,4.84E-01,9.85E-01,2.53E+05,4.29E+04,2.07E+05,3.34E+05,5,3,3,5,2.00E+06,3.85E+05,2.53E+05,5.40E+04,6.03E+03,1.45E+06,,,4.29E+04,3.88E+04,5.07E+05,,1.81E+05,2.07E+05,,2.44E+05,7.68E+05,4.57E+04,3.34E+05,3.52E+05,7.95E+03,1.46E+03,2.47E+03,5.40E+04,3.11E+02,5.15E+03,,,1.21E+03,4.12E+02,3.03E+03,,1.47E+03,2.79E+04,,4.76E+02,2.16E+05,3.24E+02,7.80E+03,3.75E+03,0,FALSE,18.441,7,5,1099,123.8,5.06,5,transport,nucleus;other cell component,"Pf02985, Pf13513, Pf18808, Pf18816, Pf18829",,H0Y8C6,ENSG00000065150,,,0,0,153.97,159.32,60.73,75.68,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,n/a,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,130.19,102.39,143.86,34.11,24.06,other molecular function,0,
Master Protein,High,P11279,LAMP1,Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,6,100,0.265,2.014,0.512,1.811,-1.92,1.01,-0.97,0.86,1.09E-01,1.15E-01,3.24E-01,5.46E-01,6.68E+06,1.24E+07,8.64E+06,2.08E+06,5,5,5,5,6.68E+06,1.58E+07,2.20E+06,4.34E+06,1.57E+07,1.24E+07,1.76E+06,3.41E+07,1.04E+07,8.67E+07,1.35E+07,4.02E+06,6.92E+06,1.30E+07,8.64E+06,3.38E+07,2.08E+06,1.15E+06,1.58E+07,3.29E+05,2.65E+04,6.01E+04,2.15E+04,4.34E+06,8.07E+05,4.42E+04,3.12E+04,3.15E+05,2.93E+05,9.21E+05,8.05E+04,1.79E+05,5.62E+04,1.75E+06,2.15E+05,6.60E+04,5.86E+05,8.17E+03,3.70E+05,3.51E+03,0,FALSE,18.797,13,6,417,44.9,8.75,6,cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf01299, Pf21222",3916,B4DWL3; hsa:3916; P11279; Q8WU33; Q96I40; Q9BRD2; Q9NP13,ENSG00000185896,Neutrophil degranulation,,1,0,71.67,118.1,43.79,135.67,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,139.25,122.35,136.06,124.66,165.77,other molecular function,0,
Master Protein,High,Q96EE3,SEH1L,Nucleoporin SEH1 OS=Homo sapiens OX=9606 GN=SEH1L PE=1 SV=3,6,9,0.264,0.798,0.361,1.133,-1.92,-0.32,-1.47,0.18,2.48E-01,8.46E-01,1.76E-01,7.82E-01,4.81E+05,8.57E+05,4.25E+05,1.93E+06,3,3,5,1,5.94E+04,,,4.81E+05,1.09E+06,5.47E+05,,5.08E+06,,8.57E+05,1.22E+06,6.82E+04,1.44E+05,1.97E+06,4.25E+05,,,,1.93E+06,,2.36E+02,,,4.81E+05,5.65E+04,1.94E+03,,4.68E+04,,9.11E+03,7.27E+03,3.05E+03,1.17E+03,2.66E+05,1.06E+04,,,,4.51E+04,,0,FALSE,27.46,26,6,360,39.6,8.09,6,cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;other biological processes,other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf00400,81929,A8K5B1; hsa:81929; Q8NFU6; Q96EE3; Q96MH3; Q9C069,ENSG00000085415,Amino acids regulate mTORC1,,1,0,95.5,117.15,106.36,,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,113.43,87.57,545.4,119.16,28.66,other molecular function,0,
Master Protein,High,P49116,NR2C2,Nuclear receptor subfamily 2 group C member 2 OS=Homo sapiens OX=9606 GN=NR2C2 PE=1 SV=1,4,4,0.264,0.439,0.328,0.322,-1.92,-1.19,-1.61,-1.63,2.24E-01,5.59E-01,1.85E-01,3.91E-01,3.86E+05,1.22E+06,1.27E+05,3.74E+05,2,3,2,2,,,,4.31E+05,3.45E+05,,1.40E+06,,1.22E+06,2.86E+05,,1.55E+05,,1.04E+05,,,,,1.89E+05,7.41E+05,,,,4.31E+05,1.78E+04,,2.50E+04,,3.44E+04,3.04E+03,,6.92E+03,,1.40E+04,,,,,4.43E+03,7.88E+03,0,FALSE,14.531,9,4,596,65.4,6.28,4,developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf00104, Pf00105",7182,A8K3H5; B6ZGT8; hsa:7182; P49116; P55092,ENSG00000177463,Nuclear Receptor transcription pathway,Androgen receptor signaling pathway; Nuclear receptors; Hypothesized pathways in pathogenesis of cardiovascular disease; Epithelial to mesenchymal transition in colorectal cancer,5,0,15.55,61.8,28,83.85,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,67.57,11.89,109.72,0,12.15,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8V8TMC8,STIM2,Stromal interaction molecule 2 OS=Homo sapiens OX=9606 GN=STIM2 PE=1 SV=1,3,4,0.259,0.137,,,-1.95,-2.87,,,2.00E-01,5.22E-02,,,1.95E+05,3.58E+05,1.01E+05,1.57E+05,3,3,3,3,,9.29E+04,,5.98E+05,1.95E+05,,1.23E+06,7.72E+04,3.58E+05,,,,1.01E+05,4.77E+05,6.30E+04,1.88E+05,7.11E+03,,1.57E+05,,,3.53E+02,,5.98E+05,1.00E+04,,2.20E+04,7.12E+02,1.01E+04,,,,8.20E+02,6.43E+04,1.57E+03,3.67E+02,2.00E+03,,3.68E+03,,0,FALSE,9.084,4,3,833,93,7.49,3,transport;other biological processes,other membranes;ER/Golgi,"Pf07647, Pf16533",,A0A8V8TMC8,ENSG00000109689,,Calcium regulation in cardiac cells,1,0,90.52,108.49,107.13,82.41,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,128.78,85.34,,,10.77,other molecular function,0,
Master Protein,High,Q86UP2,KTN1,Kinectin OS=Homo sapiens OX=9606 GN=KTN1 PE=1 SV=1,8,20,0.259,1.261,,1.996,-1.95,0.33,,1,2.28E-01,4.74E-01,,3.48E-01,4.10E+05,3.27E+05,4.12E+05,1.91E+05,1,1,5,2,,,,4.10E+05,,3.27E+05,,,,,2.74E+05,5.65E+05,4.54E+05,3.00E+05,4.12E+05,,5.05E+05,,7.20E+04,,,,,4.10E+05,,1.16E+03,,,,,1.64E+03,2.52E+04,3.69E+03,4.05E+04,1.02E+04,,1.42E+05,,1.69E+03,,0,FALSE,28.779,9,8,1357,156.2,5.64,8,transport;other biological processes,plasma membrane;other membranes;ER/Golgi,Pf05104,3895,B4DZ88; hsa:3895; Q13999; Q14707; Q15387; Q17RZ5; Q5GGW3; Q86UP2; Q86W57,ENSG00000126777,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RND2 GTPase cycle; RHOG GTPase cycle; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; RND3 GTPase cycle; RHO GTPases activate KTN1,Glucocorticoid receptor pathway; Nuclear receptors meta-pathway,11,0,,,29.58,106.13,n/a,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,32,,63.34,53.42,cytoskeletal activity,0,
Master Protein,High,P40306,PSMB10,Proteasome subunit beta type-10 OS=Homo sapiens OX=9606 GN=PSMB10 PE=1 SV=1,2,4,0.259,1.242,4.502,0.034,-1.95,0.31,2.17,-4.87,2.39E-01,3.22E-01,1.83E-01,9.00E-03,7.78E+05,7.62E+04,1.01E+06,3.43E+05,2,3,2,2,,,,4.20E+05,1.44E+06,,6.15E+04,7.62E+04,,5.35E+06,,,,1.19E+06,8.57E+05,,,3.41E+05,,3.46E+05,,,,4.20E+05,7.44E+04,,1.09E+03,7.03E+02,,5.69E+04,,,,1.61E+05,2.13E+04,,,2.41E+03,,3.68E+03,0,FALSE,9.339,11,2,273,28.9,7.81,2,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00227, Pf12465",5699,B2R5J4; hsa:5699; P40306; Q5U098,ENSG00000205220,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation,60,0,77.64,166.69,23.13,1,n/a,n/a,n/a,High,High,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,146.23,124.47,35.59,1.05,14.99,other molecular function,0,
Master Protein,High,Q13228,SELENBP1,Methanethiol oxidase OS=Homo sapiens OX=9606 GN=SELENBP1 PE=1 SV=2,5,6,0.259,1.117,0.476,0.738,-1.95,0.16,-1.07,-0.44,2.11E-01,5.65E-01,4.20E-01,9.51E-01,3.76E+05,1.23E+06,4.20E+05,7.74E+05,3,4,2,3,,6.64E+05,3.76E+05,9.95E+04,,8.22E+05,,1.83E+06,3.05E+05,2.70E+07,5.40E+05,,,3.26E+05,,7.74E+05,3.04E+06,,4.44E+05,,,2.52E+03,3.67E+03,9.95E+04,,2.92E+03,,1.69E+04,8.60E+03,2.87E+05,3.23E+03,,,4.40E+04,,1.51E+03,8.55E+05,,1.04E+04,,0,FALSE,18.573,15,5,472,52.4,6.37,5,transport,other membranes;cytosol;nucleus,Pf05694,8991,A6NML9; A6PVW9; B2RDR3; B4DKP6; B4E1F3; hsa:8991; Q13228; Q49AQ8; Q96GX7,ENSG00000143416,,Selenium metabolism and selenoproteins; IL1 and megakaryocytes in obesity,2,0,74.35,173.86,34.81,99.63,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,123.88,62.68,110.03,33.48,19.93,other molecular function,0,
Master Protein,High,P04004,VTN,Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,4,35,0.257,0.139,0.617,0.067,-1.96,-2.85,-0.7,-3.9,1.02E-01,1.43E-02,4.55E-01,2.02E-02,1.89E+06,8.08E+06,3.98E+05,1.26E+07,3,5,2,5,9.34E+05,1.42E+07,,,1.89E+06,2.45E+07,7.34E+06,2.13E+07,8.08E+06,1.55E+06,,,,1.84E+05,8.62E+05,2.44E+07,4.03E+05,1.26E+07,9.79E+05,1.31E+07,3.71E+03,5.41E+04,,,9.74E+04,8.70E+04,1.30E+05,1.96E+05,2.28E+05,1.65E+04,,,,2.48E+04,2.14E+04,4.77E+04,1.13E+05,8.93E+04,2.29E+04,1.40E+05,0,FALSE,21.25,8,1,478,54.3,5.8,4,cell adhesion;cell organization and biogenesis;transport;developmental processes;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;ER/Golgi;other cell component,"Pf00045, Pf01033",7448,B2R7G0; hsa:7448; P01141; P04004; Q9BSH7,ENSG00000109072,Regulation of Complement cascade; Integrin cell surface interactions; ECM proteoglycans; Syndecan interactions; Molecules associated with elastic fibres,Primary focal segmental glomerulosclerosis (FSGS); Complement system; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Epithelial to mesenchymal transition in colorectal cancer; Inflammatory response pathway; Complement system in neuronal development and plasticity,13,0,130.48,78.35,91.65,96.74,Peak Found,High,n/a,n/a,High,High,High,High,High,Peak Found,n/a,n/a,n/a,High,Peak Found,High,Peak Found,High,Peak Found,High,1,,FALSE,128.59,114.61,120.78,135.16,98.94,signal transduction activity or receptor binding;extracellular structural activity;other molecular function,0,
Master Protein,High,O00267,SUPT5H,Transcription elongation factor SPT5 OS=Homo sapiens OX=9606 GN=SUPT5H PE=1 SV=1,8,17,0.257,0.971,,2.679,-1.96,-0.04,,1.42,2.36E-01,6.50E-01,,2.93E-01,2.05E+05,1.08E+06,2.39E+05,2.14E+05,3,2,5,4,,,3.61E+04,1.64E+06,2.05E+05,,,8.01E+05,,1.45E+06,1.14E+05,2.39E+05,6.71E+04,1.54E+06,5.06E+05,1.41E+05,,3.24E+05,3.89E+04,4.89E+05,,,3.53E+02,1.64E+06,1.06E+04,,,7.39E+03,,1.54E+04,6.80E+02,1.07E+04,5.45E+02,2.07E+05,1.26E+04,2.75E+02,,2.29E+03,9.11E+02,5.20E+03,0,FALSE,44.621,13,8,1087,120.9,5.06,8,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,"Pf00467, Pf03439, Pf11942",6829,hsa:6829; O00267; O43279; Q59G52; Q99639,ENSG00000196235,Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE,Initiation of transcription and translation elongation at the HIV-1 LTR; mRNA processing,20,0,140.56,40.63,123.5,80.19,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,44.47,84.39,,16.13,58.7,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q6PJT7,ZC3H14,Zinc finger CCCH domain-containing protein 14 OS=Homo sapiens OX=9606 GN=ZC3H14 PE=1 SV=1,3,4,0.256,0.884,0.01,100,-1.97,-0.18,-6.64,6.64,1.90E-01,8.19E-01,1.00E-17,1.00E-17,1.00E+05,1.02E+05,6.64E+04,,2,1,2,,,,,2.79E+05,3.60E+04,,,,,1.02E+05,,,,1.91E+05,2.31E+04,,,,,,,,,2.79E+05,1.86E+03,,,,,1.08E+03,,,,2.57E+04,5.73E+02,,,,,,0,FALSE,11.744,6,3,736,82.8,7.31,3,other biological processes,nucleus;other cell component,Pf14608,79882,A8MY46; B4DXU8; B4DZW7; B4E2H4; G3V5R4; hsa:79882; Q6MZU4; Q6PJ32; Q6PJT7; Q6PUI6; Q6PUI8; Q86TQ5; Q86TW0; Q86TW1; Q8NCT6; Q8NCZ3; Q8TDE2; Q9HAC9; Q9Y5A0,ENSG00000100722,,,0,0,109.11,,110.97,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,48.65,103.16,,,12.05,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A8V8TLM6,TFRC,Transferrin receptor protein 1 OS=Homo sapiens OX=9606 GN=TFRC PE=1 SV=1,37,382,0.255,0.934,1.645,0.075,-1.97,-0.1,0.72,-3.74,1.01E-01,6.58E-01,6.15E-01,2.62E-02,1.05E+07,1.29E+08,7.17E+06,1.74E+08,5,5,5,5,1.41E+07,1.05E+07,7.65E+06,2.78E+06,3.73E+07,6.86E+07,1.66E+07,1.45E+08,1.29E+08,3.12E+08,5.36E+06,2.77E+06,2.34E+07,1.78E+07,7.17E+06,9.87E+07,5.87E+08,1.64E+08,1.74E+08,2.19E+08,5.59E+04,4.00E+04,7.47E+04,2.78E+06,1.92E+06,2.44E+05,2.96E+05,1.34E+06,3.63E+06,3.32E+06,3.20E+04,1.24E+05,1.90E+05,2.40E+06,1.78E+05,1.92E+05,1.65E+08,1.16E+06,4.06E+06,2.33E+06,0,FALSE,215.765,51,37,795,88.6,6.57,37,transport;other biological processes,plasma membrane;other membranes;other cell component,"Pf02225, Pf04253, Pf04389",,A0A8V8TLM6,ENSG00000072274,,Iron metabolism in placenta; Ferroptosis; 3q29 copy number variation syndrome; Iron metabolism disorders,4,0,92.77,83.22,78.44,78.15,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,High,High,High,1,,FALSE,139.56,119.28,135.26,125.46,1105.91,other molecular function,0,
Master Protein,High,A0A3B3IT31,LMBRD1,LMBR1 domain containing 1 OS=Homo sapiens OX=9606 GN=LMBRD1 PE=1 SV=1,1,2,0.253,0.655,0.935,0.163,-1.98,-0.61,-0.1,-2.62,1.52E-01,9.59E-01,8.52E-01,1.65E-01,3.94E+05,1.70E+06,2.58E+05,1.59E+06,3,2,2,3,6.54E+05,,,2.82E+05,3.94E+05,,,3.32E+06,,8.66E+05,,,,2.38E+05,2.80E+05,,3.54E+05,,1.59E+06,1.24E+07,2.60E+03,,,2.82E+05,2.03E+04,,,3.06E+04,,9.21E+03,,,,3.20E+04,6.97E+03,,9.95E+04,,3.71E+04,1.32E+05,0.002,FALSE,2.892,3,1,562,63.8,8.16,1,,other membranes;other cell component,Pf04791,,A0A3B3IT31,ENSG00000168216,,,0,0,43.03,82.92,11.65,138.61,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,82.11,41.7,140.31,115.05,6.72,,0,
Master Protein,High,A0A087WY85,UBE2D3,Ubiquitin conjugating enzyme E2 D3 OS=Homo sapiens OX=9606 GN=UBE2D3 PE=1 SV=1,2,6,0.252,0.568,,1.507,-1.99,-0.82,,0.59,2.06E-01,8.51E-01,,5.80E-01,1.22E+06,3.74E+05,5.70E+05,3.43E+05,4,1,1,1,1.73E+06,4.40E+06,8.67E+05,3.99E+05,,3.74E+05,,,,,,,,5.70E+05,,,3.43E+05,,,,6.87E+03,1.67E+04,8.47E+03,3.99E+05,,1.33E+03,,,,,,,,7.68E+04,,,9.63E+04,,,,0,FALSE,11.246,28,2,148,16.8,8.44,2,protein metabolism;other metabolic processes,,Pf00179,,A0A087WY85,ENSG00000109332,,,0,0,96.69,,,,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,0,98.63,,0,24.41,other molecular function,0,
Master Protein,High,Q96HY7,DHTKD1,2-oxoadipate dehydrogenase complex component E1 OS=Homo sapiens OX=9606 GN=DHTKD1 PE=1 SV=2,3,4,0.252,0.748,1.405,0.754,-1.99,-0.42,0.49,-0.41,1.95E-01,9.06E-01,8.72E-01,9.64E-01,2.03E+05,3.36E+05,3.83E+05,2.10E+05,5,2,5,3,5.74E+05,1.27E+06,2.03E+05,1.20E+04,1.30E+05,8.05E+05,1.40E+05,,,,4.05E+05,3.75E+05,3.83E+05,5.26E+05,2.05E+05,2.10E+05,,,1.16E+06,1.85E+05,2.28E+03,4.81E+03,1.98E+03,1.20E+04,6.71E+03,2.86E+03,2.49E+03,,,,2.42E+03,1.68E+04,3.11E+03,7.09E+04,5.10E+03,4.09E+02,,,2.72E+04,1.97E+03,0,FALSE,14.421,6,3,919,103,6.93,3,other metabolic processes;other biological processes,mitochondrion,"Pf00676, Pf02779, Pf16870",55526,hsa:55526; Q68CU5; Q96HY7; Q9BUM8; Q9HCE2,ENSG00000181192,Glyoxylate metabolism and glycine degradation,,1,0,116.44,99.52,30.24,107.46,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,95.86,123.16,18.94,71.58,11.07,other molecular function,0,
Master Protein,High,Q99832,CCT7,T-complex protein 1 subunit eta OS=Homo sapiens OX=9606 GN=CCT7 PE=1 SV=2,7,14,0.252,1.031,0.536,0.294,-1.99,0.04,-0.9,-1.77,1.79E-01,4.46E-01,5.03E-01,3.19E-01,1.59E+06,2.19E+05,9.18E+05,1.64E+06,5,3,2,4,2.95E+06,1.59E+06,5.55E+05,1.79E+05,2.03E+06,2.19E+05,,,1.94E+05,7.59E+06,2.27E+06,,,3.70E+05,,6.99E+06,2.81E+06,7.22E+05,9.60E+05,,1.17E+04,6.04E+03,5.43E+03,1.79E+05,1.04E+05,7.80E+02,,,5.48E+03,8.07E+04,1.36E+04,,,4.99E+04,,1.36E+04,7.90E+05,5.12E+03,2.25E+04,,0,FALSE,28.578,16,7,543,59.3,7.65,7,protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;other cell component,Pf00118,10574,A8K7E6; A8MWI8; B7WNW9; B7Z4T9; B7Z4Z7; hsa:10574; O14871; Q6FI26; Q99832,ENSG00000135624,Formation of tubulin folding intermediates by CCT/TriC; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle; Folding of actin by CCT/TriC,VEGFA-VEGFR2 signaling; 16p11.2 proximal deletion syndrome,9,0,76.71,159.78,101.81,101.04,High,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,High,Peak Found,High,n/a,1,,FALSE,91.93,124.2,124.12,113.68,48.38,other molecular function,0,
Master Protein,High,A0A5F9ZHJ0,ACAT1,Acetyl-CoA acetyltransferase 1 OS=Homo sapiens OX=9606 GN=ACAT1 PE=1 SV=1,7,24,0.251,0.467,0.371,0.331,-1.99,-1.1,-1.43,-1.59,1.29E-01,5.82E-01,1.69E-01,4.30E-01,5.66E+05,2.25E+06,2.51E+05,8.35E+05,3,1,4,3,,5.66E+05,4.59E+04,,1.50E+06,,,,,2.25E+06,1.72E+05,1.84E+05,,5.42E+05,3.41E+05,8.35E+05,6.34E+04,,,2.02E+06,,2.15E+03,4.48E+02,,7.72E+04,,,,,2.40E+04,1.03E+03,8.23E+03,,7.30E+04,8.48E+03,1.63E+03,1.78E+04,,,2.15E+04,0,FALSE,29.254,30,1,337,35.5,7.37,7,,mitochondrion,"Pf00108, Pf02803",,A0A5F9ZHJ0,ENSG00000075239,,SARS-CoV-2 and COVID-19 pathway,1,0,104.58,,55.67,101.29,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,92.19,130.43,86.94,130.81,67.42,other molecular function,0,
Master Protein,High,Q6NVY1,HIBCH,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial OS=Homo sapiens OX=9606 GN=HIBCH PE=1 SV=2",6,14,0.251,4.18,0.736,0.932,-1.99,2.06,-0.44,-0.1,1.32E-01,6.48E-03,6.74E-01,9.81E-01,1.51E+06,1.14E+06,2.86E+06,1.46E+06,2,1,4,3,,,,2.50E+06,9.16E+05,1.14E+06,,,,,,7.69E+05,2.31E+06,7.11E+06,3.53E+06,2.36E+06,8.67E+05,,1.46E+06,,,,,2.50E+06,4.72E+04,4.06E+03,,,,,,3.43E+04,1.88E+04,9.59E+05,8.76E+04,4.61E+03,2.44E+05,,3.42E+04,,0,FALSE,24.535,15,6,386,43.5,8.19,6,other metabolic processes,mitochondrion,Pf16113,26275,D3DPI4; hsa:26275; Q53GA8; Q53GF2; Q53RF7; Q53TC6; Q6NVY1; Q92931; Q9BS94,ENSG00000198130,Branched-chain amino acid catabolism,Amino acid metabolism,2,0,65.68,,78.77,48.16,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,17.82,69.37,182.26,108.01,45.45,other molecular function,0,
Master Protein,High,Q6UX06,OLFM4,Olfactomedin-4 OS=Homo sapiens OX=9606 GN=OLFM4 PE=1 SV=1,4,37,0.251,0.208,0.287,0.948,-2,-2.27,-1.8,-0.08,9.64E-02,1.05E-01,8.44E-02,9.61E-01,4.76E+05,1.20E+07,9.73E+05,3.06E+06,5,5,2,5,4.76E+05,7.55E+06,2.47E+05,4.55E+04,7.56E+06,1.20E+07,5.75E+06,2.97E+07,7.95E+05,3.52E+07,,,1.75E+06,,5.41E+05,2.17E+07,7.13E+04,3.06E+06,1.44E+06,5.68E+06,1.89E+03,2.87E+04,2.41E+03,4.55E+04,3.90E+05,4.28E+04,1.02E+05,2.74E+05,2.24E+04,3.74E+05,,,1.42E+04,,1.34E+04,4.24E+04,2.00E+04,2.17E+04,3.37E+04,6.05E+04,0,FALSE,17.69,11,4,510,57.2,5.69,4,cell adhesion;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component,Pf02191,10562,hsa:10562; O95362; Q5VWG0; Q6UX06; Q86T22,ENSG00000102837,Neutrophil degranulation,,1,0,125.98,90.09,74.66,137.95,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,n/a,n/a,High,n/a,High,High,Peak Found,Peak Found,Peak Found,High,1,,FALSE,138.24,117.65,133.36,99.88,103.7,other molecular function,0,
Master Protein,High,P07919,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial OS=Homo sapiens OX=9606 GN=UQCRH PE=1 SV=2",2,65,0.249,0.5,0.24,0.641,-2.01,-1,-2.06,-0.64,9.48E-02,6.33E-01,5.10E-02,7.50E-01,3.87E+06,8.62E+06,3.69E+06,3.46E+06,5,5,5,4,3.87E+06,5.23E+07,6.00E+05,4.80E+06,1.73E+06,9.73E+06,8.32E+05,8.62E+06,1.77E+07,2.28E+06,6.86E+05,3.69E+06,3.91E+06,7.45E+06,2.67E+06,7.79E+06,5.80E+06,,6.97E+05,2.06E+06,1.54E+04,1.99E+05,5.86E+03,4.80E+06,8.94E+04,3.46E+04,1.48E+04,7.95E+04,4.98E+05,2.42E+04,4.10E+03,1.65E+05,3.17E+04,1.00E+06,6.64E+04,1.52E+04,1.63E+06,,1.63E+04,2.20E+04,0,FALSE,22.115,29,2,91,10.7,4.44,2,other metabolic processes;transport,other membranes;mitochondrion,Pf02320,7388,B2R4V9; D3DQ18; hsa:7388; P07919; Q5TDF6; Q6LDB8; Q9BQ91,ENSG00000173660,Respiratory electron transport,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,4,0,175.49,85.89,66.91,80.17,High,High,Peak Found,High,High,High,Peak Found,High,High,High,Peak Found,High,High,High,High,High,High,n/a,Peak Found,Peak Found,1,,FALSE,138.34,136.78,113.73,111.59,226.47,transporter activity,0,
Master Protein,High,Q5UIP0,RIF1,Telomere-associated protein RIF1 OS=Homo sapiens OX=9606 GN=RIF1 PE=1 SV=2,4,4,0.248,0.454,0.179,0.64,-2.01,-1.14,-2.48,-0.64,1.34E-01,5.48E-01,5.12E-02,8.29E-01,5.51E+05,1.84E+06,2.35E+05,2.03E+05,4,1,4,4,1.42E+06,8.99E+05,3.37E+05,1.38E+05,,,1.84E+06,,,,,2.37E+05,4.97E+04,3.77E+05,2.34E+05,1.03E+06,4.32E+03,2.65E+05,1.55E+05,,5.62E+03,3.42E+03,3.29E+03,1.38E+05,,,3.28E+04,,,,,1.06E+04,4.04E+02,5.07E+04,5.81E+03,2.01E+03,1.21E+03,1.88E+03,3.63E+03,,0,FALSE,20.028,3,4,2472,274.3,5.52,4,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,Pf12231,55183,A6NC27; C9JBR1; hsa:55183; Q5H9R3; Q5UIP0; Q5UIP2; Q66YK6; Q6PRU2; Q8TE94; Q99772; Q9H830; Q9H9B9; Q9NVP5; Q9Y4R4,ENSG00000080345,Nonhomologous End-Joining (NHEJ),ATM signaling in development and disease ; 10q11.21q11.23 copy number variation syndrome,3,0,82.76,,59.77,125.78,Peak Found,Peak Found,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,73.28,89.35,153.53,133.68,12.92,,0,
Master Protein,High,Q0VD83,APOBR,Apolipoprotein B receptor OS=Homo sapiens OX=9606 GN=APOBR PE=1 SV=3,1,9,0.246,0.01,1.1,0.01,-2.02,-6.64,0.14,-6.64,9.23E-02,1.00E-17,9.92E-01,1.00E-17,8.97E+05,3.64E+06,,4.74E+06,1,4,,3,,8.97E+05,,,,2.52E+06,5.26E+06,5.48E+06,7.26E+05,,,,,,,1.43E+06,,4.74E+06,,5.91E+06,,3.41E+03,,,,8.97E+03,9.36E+04,5.06E+04,2.05E+04,,,,,,,2.79E+03,,3.36E+04,,6.29E+04,0,FALSE,8.146,1,1,1097,115.6,4.4,1,other metabolic processes;transport,non-structural extracellular;plasma membrane;other membranes,,55911,H3BU97; hsa:55911; Q0VD81; Q0VD83; Q8NC15; Q9NPJ9,ENSG00000184730,VLDL clearance,,1,0,,65.35,,57.7,n/a,High,n/a,n/a,n/a,High,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,High,1,,FALSE,70.31,,108.47,,26.85,other molecular function,0,
Master Protein,High,Q15286,RAB35,Ras-related protein Rab-35 OS=Homo sapiens OX=9606 GN=RAB35 PE=1 SV=1,5,54,0.244,1.427,0.163,1.014,-2.04,0.51,-2.62,0.02,1.83E-01,3.64E-01,3.33E-02,8.54E-01,4.43E+04,3.72E+05,4.77E+05,3.63E+05,4,2,5,5,,1.04E+05,3.72E+04,4.31E+04,4.56E+04,,,,1.69E+05,8.22E+05,1.32E+06,2.59E+04,8.83E+05,4.77E+05,2.42E+05,6.27E+05,3.91E+05,3.63E+05,1.52E+05,1.27E+05,,3.94E+02,3.63E+02,4.31E+04,2.35E+03,,,,4.75E+03,8.74E+03,7.88E+03,1.16E+03,7.18E+03,6.42E+04,6.02E+03,1.22E+03,1.10E+05,2.57E+03,3.56E+03,1.36E+03,0,FALSE,22.935,31,3,201,23,8.29,5,cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf00071,11021,B2R6E0; B4E390; hsa:11021; Q15286,ENSG00000111737,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; TBC/RABGAPs,,3,0,54.17,93.32,87.7,61.33,n/a,High,Peak Found,High,High,n/a,n/a,n/a,Peak Found,High,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,1,,FALSE,29.5,87.51,24.23,128.14,131.03,other molecular function,0,
Master Protein,High,P82970,HMGN5,High mobility group nucleosome-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=HMGN5 PE=1 SV=1,3,5,0.243,0.982,0.639,0.029,-2.04,-0.03,-0.65,-5.13,1.80E-01,6.60E-01,5.45E-01,7.14E-04,1.73E+05,1.96E+05,3.11E+05,2.53E+05,3,2,4,3,,,5.60E+04,1.73E+05,3.52E+05,,,,6.65E+04,5.77E+05,,6.34E+03,3.36E+05,5.40E+05,2.88E+05,2.53E+05,1.26E+04,,,5.38E+05,,,5.47E+02,1.73E+05,1.81E+04,,,,1.87E+03,6.14E+03,,2.83E+02,2.73E+03,7.28E+04,7.17E+03,4.93E+02,3.55E+03,,,5.73E+03,0,FALSE,11.541,9,3,282,31.5,4.55,3,cell organization and biogenesis;other biological processes,mitochondrion;nucleus;other cell component,Pf01101,79366,hsa:79366; P82970; Q5JSL1,ENSG00000198157,,,0,0,76.9,112.19,75.14,98.25,n/a,n/a,Peak Found,High,High,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,1,,FALSE,182.33,102.61,129.93,134.37,13.27,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P28074,PSMB5,Proteasome subunit beta type-5 OS=Homo sapiens OX=9606 GN=PSMB5 PE=1 SV=3,1,1,0.243,1.996,0.558,0.871,-2.04,1,-0.84,-0.2,1.78E-01,2.01E-01,4.27E-01,9.48E-01,1.07E+05,4.40E+05,2.14E+05,2.45E+05,1,1,2,2,,,,1.07E+05,,,,,,4.40E+05,,,,1.77E+05,2.58E+05,5.08E+05,1.19E+05,,,,,,,1.07E+05,,,,,,4.68E+03,,,,2.38E+04,6.41E+03,9.90E+02,3.33E+04,,,,0,FALSE,4.83,5,1,263,28.5,6.92,1,protein metabolism;other metabolic processes;stress response,cytosol;cytoskeleton;nucleus;other cell component,Pf00227,5693,B2R4N9; B4DUM9; D3DS43; E9PAV2; hsa:5693; P28074; Q16242; Q6PEW2; Q7Z3B5; Q86T01; Q9TNN9,ENSG00000100804,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,62,0,,,26.31,87.86,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,1,,FALSE,0,28.07,117.54,97.37,3.3,other molecular function,0,
Master Protein,High,K7EMV4,ELOF1,Transcription elongation factor 1 homolog OS=Homo sapiens OX=9606 GN=ELOF1 PE=1 SV=1,1,1,0.242,0.419,1.225,0.083,-2.05,-1.26,0.29,-3.59,1.44E-01,5.35E-01,8.76E-01,3.99E-02,3.92E+05,1.62E+06,1.64E+05,1.98E+06,2,1,1,3,,,,3.64E+05,4.22E+05,,,,,1.62E+06,,,,1.64E+05,,,,2.12E+06,1.96E+05,1.98E+06,,,,3.64E+05,2.18E+04,,,,,1.72E+04,,,,2.21E+04,,,,1.50E+04,4.59E+03,2.11E+04,0.005,FALSE,2.468,15,1,120,13.3,8.85,1,,nucleus,Pf05129,,K7EMV4,ENSG00000130165,,,0,0,10.48,,,74.9,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,11.02,11.02,10.26,10.26,2.87,other molecular function,0,
Master Protein,High,P20645,M6PR,Cation-dependent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=M6PR PE=1 SV=1,3,17,0.241,0.23,0.186,0.061,-2.05,-2.12,-2.42,-4.04,8.75E-02,9.48E-02,2.30E-02,1.47E-02,1.44E+06,1.03E+07,4.53E+05,2.59E+06,5,4,5,5,1.44E+06,1.16E+07,4.41E+05,8.72E+05,4.99E+06,,4.53E+06,1.93E+07,5.45E+06,1.95E+07,1.80E+06,4.42E+05,4.53E+05,1.06E+06,3.41E+05,4.14E+06,4.33E+04,2.59E+06,3.15E+05,4.57E+06,5.71E+03,4.40E+04,4.31E+03,8.72E+05,2.57E+05,,8.06E+04,1.78E+05,1.54E+05,2.08E+05,1.08E+04,1.97E+04,3.68E+03,1.42E+05,8.48E+03,8.07E+03,1.22E+04,1.84E+04,7.38E+03,4.87E+04,0,FALSE,12.645,14,3,277,31,5.83,3,transport,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf02157,4074,A8K528; D3DUV5; hsa:4074; P20645,ENSG00000003056,Lysosome Vesicle Biogenesis; Cargo recognition for clathrin-mediated endocytosis; Retrograde transport at the Trans-Golgi-Network; Glycosphingolipid catabolism,,5,0,120.98,68.31,75.39,90.1,Peak Found,High,Peak Found,High,High,n/a,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,130.58,124.71,116.88,142.54,41.93,other molecular function,0,
Master Protein,High,H0YJ66,DHRS7,Dehydrogenase/reductase 7 (Fragment) OS=Homo sapiens OX=9606 GN=DHRS7 PE=1 SV=1,1,2,0.241,0.349,1.574,0.053,-2.06,-1.52,0.65,-4.23,1.69E-01,4.08E-01,6.23E-01,1.20E-02,3.51E+05,1.46E+06,1.22E+05,2.29E+06,3,1,1,1,,,4.18E+05,2.61E+05,3.51E+05,,,,1.46E+06,,,,,,1.22E+05,,,,2.29E+06,,,,4.08E+03,2.61E+05,1.81E+04,,,,4.10E+04,,,,,,3.04E+03,,,,5.37E+04,,0.005,FALSE,2.485,6,1,399,44.8,9.03,1,,,Pf00106,,H0YJ66,ENSG00000100612,,,0,0,22.88,,,,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,23.88,28.46,0,0,2.59,other molecular function,0,
Master Protein,High,Q9HAN9,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 OS=Homo sapiens OX=9606 GN=NMNAT1 PE=1 SV=1,2,2,0.24,4.533,0.46,2.363,-2.06,2.18,-1.12,1.24,1.49E-01,4.89E-02,4.40E-01,3.87E-01,3.06E+04,1.28E+05,1.39E+05,5.87E+04,1,1,5,1,,,,3.06E+04,,,,,,1.28E+05,7.33E+05,1.39E+05,9.14E+04,3.54E+05,7.17E+04,,5.87E+04,,,,,,,3.06E+04,,,,,,1.36E+03,4.38E+03,6.20E+03,7.42E+02,4.78E+04,1.78E+03,,1.65E+04,,,,0,FALSE,7.096,14,2,279,31.9,8.87,2,other metabolic processes;stress response;other biological processes,nucleus;other cell component,Pf01467,64802,B1AN63; hsa:64802; Q8TAE9; Q9H247; Q9H6B6; Q9HAN9,ENSG00000173614,Nicotinate metabolism,NAD biosynthesis II (from tryptophan); NAD+ metabolism; NAD+ biosynthetic pathways,4,0,,,100.13,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,0,71.64,0,71.64,3.75,other molecular function,0,
Master Protein,High,Q8NFH5,NUP35,Nucleoporin NUP35 OS=Homo sapiens OX=9606 GN=NUP35 PE=1 SV=1,2,2,0.239,0.807,0.01,100,-2.07,-0.31,-6.64,6.64,2.13E-01,8.59E-01,1.00E-17,1.00E-17,2.16E+05,4.85E+05,1.06E+05,,1,1,2,,,,,2.16E+05,,,,,4.85E+05,,,1.38E+05,,,8.07E+04,,,,,,,,,2.16E+05,,,,,1.37E+04,,,6.16E+03,,,2.01E+03,,,,,,0,FALSE,5.979,10,2,326,34.8,9.09,2,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;nucleus,Pf05172,129401,B4DP57; B4DYB4; hsa:129401; Q4ZFZ9; Q53S95; Q8NFH5; Q8TDJ1,ENSG00000163002,HCMV Early Events; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,,29,0,,,37.03,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,34.55,,,5.84,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q9HAY6,BCO1,"Beta,beta-carotene 15,15'-dioxygenase OS=Homo sapiens OX=9606 GN=BCO1 PE=1 SV=1",1,2,0.239,12.562,1.313,1.615,-2.07,3.65,0.39,0.69,1.67E-01,9.79E-05,9.28E-01,5.33E-01,7.36E+04,2.66E+05,9.15E+05,3.39E+05,4,3,2,3,1.17E+05,6.44E+04,4.52E+04,,8.42E+04,2.66E+05,2.16E+05,,4.97E+05,,2.22E+06,,,3.77E+05,,,3.39E+05,1.13E+06,,2.83E+05,4.66E+02,2.45E+02,4.42E+02,,4.34E+03,9.47E+02,3.84E+03,,1.40E+04,,1.33E+04,,,5.07E+04,,,9.53E+04,8.02E+03,,3.02E+03,0.022,FALSE,1.954,1,1,547,62.6,6.67,1,other metabolic processes,cytosol,Pf03055,53630,A0AV48; A0AV50; hsa:53630; Q9HAY6; Q9NVH5,ENSG00000135697,Retinoid metabolism and transport,Vitamin A and carotenoid metabolism,2,0,39.55,45.84,100.44,81.15,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,n/a,High,Peak Found,n/a,Peak Found,1,Acetyl [N-Term],FALSE,58.9,102.92,71.09,82.03,4.69,other molecular function,0,
Master Protein,High,P13987,CD59,CD59 glycoprotein OS=Homo sapiens OX=9606 GN=CD59 PE=1 SV=1,4,10,0.238,0.813,0.67,0.565,-2.07,-0.3,-0.58,-0.82,1.96E-01,7.50E-01,5.70E-01,7.22E-01,6.46E+05,2.70E+05,9.52E+05,2.41E+06,5,5,5,5,3.42E+06,1.01E+07,6.32E+05,1.84E+05,6.46E+05,6.07E+06,1.54E+05,2.70E+05,4.59E+05,1.07E+05,1.76E+06,1.75E+05,1.37E+06,9.52E+05,5.20E+05,1.96E+06,2.49E+06,2.42E+06,2.36E+06,2.41E+06,1.36E+04,3.83E+04,6.17E+03,1.84E+05,3.33E+04,2.16E+04,2.73E+03,2.49E+03,1.29E+04,1.14E+03,1.05E+04,7.81E+03,1.11E+04,1.28E+05,1.29E+04,3.82E+03,7.00E+05,1.72E+04,5.52E+04,2.56E+04,0,FALSE,10.862,25,4,128,14.2,6.48,4,stress response;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,Pf00021,966,E9PR17; hsa:966; P13987,ENSG00000085063,Regulation of Complement cascade; COPI-mediated anterograde transport; Neutrophil degranulation; COPII-mediated vesicle transport; Cargo concentration in the ER,Complement system; Complement system in neuronal development and plasticity,7,0,139.16,184.66,66.5,9.06,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,140.63,136.18,78.47,58.05,25.15,other molecular function,0,
Master Protein,High,Q9H4L4,SENP3,Sentrin-specific protease 3 OS=Homo sapiens OX=9606 GN=SENP3 PE=1 SV=2,1,1,0.238,0.01,3.877,0.01,-2.07,-6.64,1.95,-6.64,1.77E-01,1.00E-17,1.64E-01,1.00E-17,7.77E+04,3.27E+05,,1.27E+06,1,1,,1,,,,7.77E+04,,,,,,3.27E+05,,,,,,,,,,1.27E+06,,,,7.77E+04,,,,,,3.47E+03,,,,,,,,,,1.35E+04,0,FALSE,5.49,3,1,574,65,8.56,1,protein metabolism;other metabolic processes;other biological processes,nucleus;other cell component,"Pf02902, Pf19722",26168,hsa:26168; Q66K15; Q86VS7; Q96PS4; Q9H4L4; Q9Y3W9,ENSG00000161956,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,0,,0,,3.93,other molecular function,0,
Master Protein,High,E9PCR7,OGDH,oxoglutarate dehydrogenase (succinyl-transferring) OS=Homo sapiens OX=9606 GN=OGDH PE=1 SV=1,9,15,0.237,2.218,0.881,0.833,-2.08,1.15,-0.18,-0.26,2.11E-01,1.08E-01,9.11E-01,9.63E-01,7.90E+04,1.16E+06,9.62E+05,9.94E+05,5,3,5,5,7.21E+04,7.90E+04,7.06E+04,2.18E+06,1.99E+05,3.05E+06,2.35E+04,1.16E+06,,,3.95E+05,9.62E+05,7.57E+05,2.43E+06,1.47E+06,1.45E+06,9.94E+05,5.80E+05,7.72E+05,4.09E+06,2.87E+02,3.00E+02,6.90E+02,2.18E+06,1.03E+04,1.08E+04,4.19E+02,1.07E+04,,,2.36E+03,4.30E+04,6.15E+03,3.27E+05,3.65E+04,2.82E+03,2.79E+05,4.11E+03,1.81E+04,4.35E+04,0,FALSE,25.946,13,9,1038,117.6,6.92,9,other metabolic processes,mitochondrion,"Pf00676, Pf02779, Pf16078, Pf16870",4967,E9PCR7,ENSG00000105953,,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Thiamine metabolic pathways; 7q11.23 copy number variation syndrome; TCA cycle (aka Krebs or citric acid cycle),5,0,178.71,108.28,65.53,91.42,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,87.65,104.42,97.24,82.88,30.69,other molecular function,0,
Master Protein,High,P15144,ANPEP,Aminopeptidase N OS=Homo sapiens OX=9606 GN=ANPEP PE=1 SV=4,2,6,0.237,2.118,0.09,1.176,-2.08,1.08,-3.48,0.23,2.03E-01,1.62E-01,7.01E-03,6.86E-01,1.80E+05,1.20E+06,2.91E+05,3.12E+05,4,4,3,3,4.31E+05,1.18E+05,,4.11E+04,2.76E+05,7.54E+05,1.92E+06,,4.70E+05,3.47E+06,5.84E+05,,2.91E+05,1.45E+05,,4.97E+05,2.91E+04,,3.12E+05,,1.71E+03,4.47E+02,,4.11E+04,1.42E+04,2.68E+03,3.41E+04,,1.33E+04,3.70E+04,3.49E+03,,2.36E+03,1.96E+04,,9.69E+02,8.19E+03,,7.30E+03,,0,FALSE,5.443,3,2,967,109.5,5.48,2,protein metabolism;other metabolic processes;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component,"Pf01433, Pf11838, Pf17900",290,hsa:290; P15144; Q16728; Q6GT90; Q8IUK3; Q8IVH3; Q9UCE0,ENSG00000166825,Neutrophil degranulation; Metabolism of Angiotensinogen to Angiotensins,Glutathione metabolism; Cardiac progenitor differentiation,4,0,80.07,82.55,65.77,84.34,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,87.57,74.5,128.06,89.57,15.3,other molecular function,0,
Master Protein,High,A6NHR9,SMCHD1,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SMCHD1 PE=1 SV=2,12,18,0.236,0.8,,1.259,-2.09,-0.32,,0.33,1.07E-01,7.20E-01,,6.94E-01,1.07E+06,2.45E+06,8.50E+05,1.85E+05,5,3,5,4,5.22E+05,1.34E+06,1.07E+06,2.48E+06,4.03E+05,4.91E+06,,1.20E+06,,2.45E+06,4.86E+06,9.75E+04,3.27E+05,2.58E+06,8.50E+05,2.88E+05,,3.58E+05,5.28E+04,1.19E+05,2.07E+03,5.08E+03,1.04E+04,2.48E+06,2.08E+04,1.74E+04,,1.11E+04,,2.60E+04,2.90E+04,4.35E+03,2.66E+03,3.48E+05,2.11E+04,5.62E+02,,2.54E+03,1.24E+03,1.27E+03,0,FALSE,46.623,9,12,2005,226.2,7.3,12,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,nucleus;other cell component,"Pf06470, Pf13589",23347,A6NHR9; O75141; Q6AHX6; Q6ZTQ8; Q9H6Q2; Q9UG39,ENSG00000101596,,,0,0,71.61,66.12,114.43,69.66,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,92.01,91.82,,69.05,54.49,nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q9BUR5,APOO,MICOS complex subunit MIC26 OS=Homo sapiens OX=9606 GN=APOO PE=1 SV=1,1,2,0.236,2.462,0.01,100,-2.09,1.3,-6.64,6.64,2.01E-01,1.05E-01,1.00E-17,1.00E-17,2.62E+05,1.11E+06,6.74E+05,,2,1,3,,,,1.67E+05,4.10E+05,,,,,,1.11E+06,,6.74E+05,,5.80E+05,7.17E+05,,,,,,,,1.64E+03,4.10E+05,,,,,,1.18E+04,,3.01E+04,,7.81E+04,1.78E+04,,,,,,0.017,FALSE,2.061,6,1,198,22.3,9.13,1,cell organization and biogenesis;transport,non-structural extracellular;other membranes;cytosol;mitochondrion;ER/Golgi,Pf09769,79135,B2R4K9; hsa:79135; Q9BUR5; Q9H3J9,ENSG00000184831,Cristae formation,,1,0,59.4,,10.68,,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,68.61,61.7,,,4.63,,0,
Master Protein,High,Q8ND76,CCNY,Cyclin-Y OS=Homo sapiens OX=9606 GN=CCNY PE=1 SV=2,1,1,0.235,1.275,0.01,100,-2.09,0.35,-6.64,6.64,1.39E-01,4.56E-01,1.00E-17,1.00E-17,3.72E+05,1.58E+06,4.74E+05,,1,1,1,,,,,3.72E+05,,,,,1.58E+06,,,,,4.74E+05,,,,,,,,,,3.72E+05,,,,,4.45E+04,,,,,6.39E+04,,,,,,,0.001,FALSE,3.874,4,1,341,39.3,7.2,1,cell-cell signaling;cell cycle OR cell proliferation;signal transduction;other biological processes,plasma membrane;other membranes;nucleus;other cell component,Pf00134,219771,B7ZKX9; D3DRY9; hsa:219771; Q2M3V4; Q2TU96; Q6NT86; Q7Z4U7; Q8ND76; Q8TEX2; Q8TEX3; Q96M99; Q96P45,ENSG00000108100,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,0,,,3.19,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q7L5N7,LPCAT2,Lysophosphatidylcholine acyltransferase 2 OS=Homo sapiens OX=9606 GN=LPCAT2 PE=1 SV=1,3,4,0.234,0.606,,0.304,-2.09,-0.72,,-1.72,2.02E-01,8.74E-01,,3.63E-01,3.41E+05,9.12E+05,3.72E+05,3.97E+05,4,2,5,2,1.77E+05,,5.79E+04,6.56E+05,6.90E+05,,,3.49E+05,,2.39E+06,3.72E+05,4.60E+04,4.44E+05,3.85E+05,2.37E+05,,,,1.16E+05,1.37E+06,7.05E+02,,5.66E+02,6.56E+05,3.56E+04,,,3.22E+03,,2.54E+04,2.23E+03,2.05E+03,3.60E+03,5.19E+04,5.90E+03,,,,2.70E+03,1.45E+04,0,FALSE,12.723,8,3,544,60.2,6.55,3,cell organization and biogenesis;other metabolic processes,plasma membrane;other membranes;ER/Golgi;other cell component,"Pf01553, Pf13202, Pf13499",54947,A3KBM1; hsa:54947; Q6MZJ6; Q7L5N7; Q9NX23,ENSG00000087253,Acyl chain remodelling of PC,,1,0,82.13,105.33,53.66,119.35,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,1,,FALSE,137.36,98.55,,184.59,12.47,other molecular function,0,
Master Protein,High,F5GXT1,CD9,Tetraspanin OS=Homo sapiens OX=9606 GN=CD9 PE=1 SV=10,2,26,0.234,1.952,0.24,1.705,-2.1,0.96,-2.06,0.77,8.16E-02,1.26E-01,5.11E-02,5.82E-01,4.08E+06,9.12E+06,5.24E+06,2.87E+06,4,1,5,3,1.36E+07,,5.47E+06,3.05E+06,1.52E+06,,,,9.12E+06,,3.63E+07,3.74E+06,5.24E+06,6.60E+06,4.03E+06,3.98E+06,2.10E+06,,2.87E+06,,5.41E+04,,5.35E+04,3.05E+06,7.84E+04,,,,2.57E+05,,2.17E+05,1.67E+05,4.26E+04,8.89E+05,1.00E+05,7.77E+03,5.89E+05,,6.72E+04,,0,FALSE,16.282,13,2,270,29.9,7.52,2,other biological processes,non-structural extracellular;plasma membrane;other membranes,Pf00335,,F5GXT1,ENSG00000010278,,,0,0,91.08,,125.94,31.78,High,High,High,High,Peak Found,n/a,n/a,n/a,High,Peak Found,High,Peak Found,High,High,High,Peak Found,High,n/a,High,n/a,1,,FALSE,51.15,82.58,6.74,66.69,103.78,,0,
Master Protein,High,A0A7I2V3L8,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 OS=Homo sapiens OX=9606 GN=NDUFA5 PE=1 SV=1,2,24,0.234,1.346,0.299,1.549,-2.1,0.43,-1.74,0.63,8.14E-02,3.26E-01,9.45E-02,6.42E-01,3.65E+06,8.61E+06,3.87E+06,2.73E+06,3,1,5,3,,,2.17E+06,3.65E+06,4.54E+06,,,,,8.61E+06,3.09E+06,2.71E+06,5.63E+06,3.87E+06,6.29E+06,2.57E+06,2.74E+06,,2.73E+06,,,,2.12E+04,3.65E+06,2.34E+05,,,,,9.15E+04,1.85E+04,1.21E+05,4.57E+04,5.22E+05,1.56E+05,5.02E+03,7.69E+05,,6.39E+04,,0,FALSE,22.627,25,2,145,16.6,5.6,2,other metabolic processes,other membranes;mitochondrion,Pf04716,,A0A7I2V3L8,ENSG00000128609,,Ciliary landscape,1,0,34.68,,36.47,3.49,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,High,High,Peak Found,High,High,High,Peak Found,High,n/a,High,n/a,1,,FALSE,6.01,57.47,8.7,44.88,80.85,,0,
Master Protein,High,P10301,RRAS,Ras-related protein R-Ras OS=Homo sapiens OX=9606 GN=RRAS PE=1 SV=1,1,2,0.233,0.01,1.021,0.01,-2.1,-6.64,0.03,-6.64,1.65E-01,1.00E-17,8.70E-01,1.00E-17,7.98E+04,3.43E+05,,3.51E+05,1,1,,1,,,,7.98E+04,,,,3.43E+05,,,,,,,,3.51E+05,,,,,,,,7.98E+04,,,,3.17E+03,,,,,,,,6.84E+02,,,,,0,FALSE,4.653,9,1,218,23.5,6.93,1,developmental processes;signal transduction;other biological processes,plasma membrane;other membranes,Pf00071,6237,hsa:6237; P10301; Q6FH12,ENSG00000126458,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion; Sema4D mediated inhibition of cell attachment and migration,G protein signaling pathways; MAPK signaling pathway; Canonical and non-canonical Notch signaling; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; MAPK cascade; Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; EGFR tyrosine kinase inhibitor resistance; Angiotensin II receptor type 1 pathway; Regulation of actin cytoskeleton,13,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,0,,0,,6.07,other molecular function,0,
Master Protein,High,P05546,SERPIND1,Heparin cofactor 2 OS=Homo sapiens OX=9606 GN=SERPIND1 PE=1 SV=3,4,7,0.233,5.189,,0.679,-2.1,2.38,,-0.56,1.42E-01,4.00E-02,,8.95E-01,4.27E+04,1.16E+05,5.88E+04,3.95E+05,2,1,5,1,,,,2.01E+04,9.05E+04,1.16E+05,,,,,5.42E+04,1.52E+04,5.88E+04,4.30E+05,3.36E+06,,,,,3.95E+05,,,,2.01E+04,4.67E+03,4.11E+02,,,,,3.24E+02,6.80E+02,4.78E+02,5.80E+04,8.36E+04,,,,,4.20E+03,0,FALSE,10.721,8,4,499,57,6.9,4,stress response;other biological processes,non-structural extracellular;ER/Golgi,Pf00079,3053,B2RAI1; D3DX34; hsa:3053; P05546; Q6IBZ5,ENSG00000099937,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Intrinsic Pathway of Fibrin Clot Formation; Common Pathway of Fibrin Clot Formation,Dengue-2 interactions with complement and coagulation cascades; 22q11.2 copy number variation syndrome; Complement and coagulation cascades,7,0,89.95,,185.05,,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,0,132.08,,253.8,11.78,enzyme regulator activity;other molecular function,0,
Master Protein,High,O00602,FCN1,Ficolin-1 OS=Homo sapiens OX=9606 GN=FCN1 PE=1 SV=2,3,5,0.231,2.423,1.852,6.122,-2.11,1.28,0.89,2.61,1.37E-01,1.16E-01,5.14E-01,6.89E-02,2.21E+05,1.68E+06,5.85E+05,1.31E+05,2,5,4,3,,2.96E+05,,,1.65E+05,1.86E+06,3.03E+06,1.68E+06,1.41E+05,6.34E+05,1.14E+05,,6.03E+05,5.69E+05,1.07E+06,,3.37E+04,,1.31E+05,2.38E+06,,1.12E+03,,,8.51E+03,6.63E+03,5.39E+04,1.55E+04,3.96E+03,6.74E+03,6.81E+02,,4.90E+03,7.66E+04,2.65E+04,,9.46E+03,,3.06E+03,2.53E+04,0,FALSE,11.301,10,3,326,35.1,6.86,3,protein metabolism;stress response;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf00147, Pf01391",2219,hsa:2219; O00602; Q5VYV5; Q92596,ENSG00000085265,Initial triggering of complement; Neutrophil degranulation; Ficolins bind to repetitive carbohydrate structures on the target cell surface,Complement system; Complement system in neuronal development and plasticity,6,0,40.13,76.84,66.2,156.49,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,High,1,,FALSE,111.25,61.89,141.43,96.78,12.82,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P14859,POU2F1,"POU domain, class 2, transcription factor 1 OS=Homo sapiens OX=9606 GN=POU2F1 PE=1 SV=2",2,4,0.23,1.532,0.479,2.413,-2.12,0.62,-1.06,1.27,1.97E-01,2.16E-01,3.75E-01,3.35E-01,3.42E+05,1.00E+06,1.05E+06,4.79E+05,2,1,4,1,,,,9.59E+04,1.22E+06,,,,1.00E+06,,,6.86E+04,9.48E+05,1.87E+06,1.16E+06,,,,4.79E+05,,,,,9.59E+04,6.31E+04,,,,2.82E+04,,,3.07E+03,7.70E+03,2.53E+05,2.87E+04,,,,1.12E+04,,0,FALSE,11.793,5,2,743,76.4,6.81,2,other biological processes,ER/Golgi;nucleus;other cell component,"Pf00046, Pf00157, Pf19536",5451,B1AL91; B1AL93; B4E029; hsa:5451; J3KP77; P14859; Q5TBT7; Q6PK46; Q8NEU9; Q9BPV1,ENSG00000143190,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 3 Promoter; RNA polymerase II transcribes snRNA genes; Estrogen-dependent gene expression; Interleukin-4 and Interleukin-13 signaling,Integrated cancer pathway,6,0,120.85,,73.47,,n/a,n/a,n/a,High,High,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,380.97,73.24,0,26.68,18.26,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q6KC79,NIPBL,Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,10,13,0.228,0.561,,1.233,-2.13,-0.83,,0.3,1.97E-01,8.08E-01,,7.00E-01,9.73E+05,2.15E+05,2.08E+05,8.31E+04,4,1,5,3,3.13E+06,,1.20E+06,7.91E+05,8.03E+04,,,,,2.15E+05,1.15E+06,8.80E+04,2.58E+04,1.18E+06,2.08E+05,,1.29E+05,,7.21E+04,8.31E+04,1.25E+04,,1.17E+04,7.91E+05,4.14E+03,,,,,2.28E+03,6.90E+03,3.93E+03,2.09E+02,1.59E+05,5.17E+03,,3.63E+04,,1.69E+03,8.84E+02,0,FALSE,36.974,5,10,2804,315.9,7.91,10,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;stress response;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf12765, Pf12830",25836,hsa:25836; Q6KC79; Q6KCD6; Q6N080; Q6ZT92; Q7Z2E6; Q8N4M5; Q9Y6Y3; Q9Y6Y4,ENSG00000164190,Cohesin Loading onto Chromatin,Cohesin complex - Cornelia de Lange syndrome; NIPBL role in DNA damage - Cornelia de Lange syndrome,3,0,100.45,,109.96,31.96,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,0,103.27,,108.16,38.27,other molecular function,0,
Master Protein,High,P49721,PSMB2,Proteasome subunit beta type-2 OS=Homo sapiens OX=9606 GN=PSMB2 PE=1 SV=1,3,4,0.228,0.804,0.111,1.43,-2.13,-0.32,-3.17,0.52,7.71E-02,8.59E-01,3.32E-03,5.83E-01,3.79E+05,4.35E+06,1.40E+05,4.82E+05,3,1,2,1,2.60E+06,,3.79E+05,5.65E+04,,,,,,4.35E+06,,7.70E+05,,2.56E+04,,,,,4.82E+05,,1.03E+04,,3.70E+03,5.65E+04,,,,,,4.62E+04,,3.44E+04,,3.45E+03,,,,,1.13E+04,,0,FALSE,6.852,24,3,201,22.8,7.02,3,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf00227,5690,D3DPS0; hsa:5690; P31145; P49721; Q9BWZ9,ENSG00000126067,Ub-specific processing proteases; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,62,0,136.91,,132.33,,High,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,1,,FALSE,166.03,98.86,0,0,12.07,,0,
Master Protein,High,P28065,PSMB9,Proteasome subunit beta type-9 OS=Homo sapiens OX=9606 GN=PSMB9 PE=1 SV=2,2,10,0.228,0.136,0.023,1.333,-2.13,-2.88,-5.46,0.41,1.93E-01,3.66E-02,2.66E-05,6.46E-01,2.76E+05,9.71E+05,4.16E+05,3.37E+05,4,2,3,2,,8.01E+04,1.94E+05,3.92E+05,2.09E+07,6.63E+05,,,,1.42E+06,,2.15E+04,,4.55E+05,4.16E+05,,3.98E+05,,2.85E+05,,,3.04E+02,1.90E+03,3.92E+05,1.08E+06,2.36E+03,,,,1.51E+04,,9.60E+02,,6.14E+04,1.03E+04,,1.12E+05,,6.66E+03,,0,FALSE,10.662,11,2,219,23.3,5.03,2,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf00227,5698,B0V0T1; hsa:5698; P28065; Q16523; Q5JNW4,ENSG00000239836; ENSG00000240065; ENSG00000240118; ENSG00000240508; ENSG00000242711; ENSG00000243067; ENSG00000243594; ENSG00000243958,Ub-specific processing proteases; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Type II interferon signaling,61,0,191.78,51.45,80.62,23.43,n/a,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,115.85,109.27,57.91,31.91,28.2,other molecular function,0,
Master Protein,High,O95782,AP2A1,AP-2 complex subunit alpha-1 OS=Homo sapiens OX=9606 GN=AP2A1 PE=1 SV=3,10,21,0.227,0.463,0.896,0.226,-2.14,-1.11,-0.16,-2.15,1.12E-01,6.20E-01,7.87E-01,2.15E-01,2.13E+05,1.95E+06,4.73E+05,3.23E+06,3,4,3,3,1.81E+05,3.27E+06,,2.13E+05,,1.55E+07,,3.41E+06,2.69E+05,1.12E+06,9.08E+04,,7.30E+05,4.73E+05,,,8.69E+06,3.23E+06,2.51E+06,,7.20E+02,1.24E+04,,2.13E+05,,5.50E+04,,3.14E+04,7.57E+03,1.19E+04,5.43E+02,,5.93E+03,6.38E+04,,,2.44E+06,2.29E+04,5.87E+04,,0,FALSE,35.05,15,6,977,107.5,7.03,10,transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf01602, Pf02296, Pf02883",160,hsa:160; O95782; Q96CI7; Q96PP6; Q96PP7; Q9H070,ENSG00000196961,"Potential therapeutics for SARS; Recycling pathway of L1; MHC class II antigen presentation; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Trafficking of GluR2-containing AMPA receptors; Nef Mediated CD4 Down-regulation; Retrograde neurotrophin signalling; Nef Mediated CD8 Down-regulation; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation",Synaptic vesicle pathway; VEGFA-VEGFR2 signaling; GABA receptor signaling; EGF/EGFR signaling pathway; Fragile X syndrome; mBDNF and proBDNF regulation of GABA neurotransmission; Cell lineage map for neuronal differentiation,21,3,145.24,139.33,74.55,70.27,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,n/a,n/a,High,Peak Found,High,n/a,1,,FALSE,121.83,128.18,109.52,107.78,58.97,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q15366,PCBP2,Poly(rC)-binding protein 2 OS=Homo sapiens OX=9606 GN=PCBP2 PE=1 SV=1,4,21,0.226,0.787,0.783,0.479,-2.15,-0.35,-0.35,-1.06,1.61E-01,7.77E-01,6.70E-01,6.09E-01,4.37E+05,1.26E+06,1.08E+06,2.14E+06,5,1,5,4,9.01E+05,1.85E+05,4.37E+05,2.65E+06,1.63E+05,1.26E+06,,,,,5.02E+06,1.10E+05,3.18E+05,2.05E+06,1.08E+06,2.90E+06,1.90E+06,2.41E+06,,1.93E+05,3.58E+03,7.03E+02,4.26E+03,2.65E+06,8.41E+03,4.49E+03,,,,,3.00E+04,4.93E+03,2.58E+03,2.76E+05,2.68E+04,5.66E+03,5.35E+05,1.71E+04,,2.05E+03,0,FALSE,16.361,18,3,365,38.6,6.79,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,Pf00013,5094,A8K7X6; B4DXP5; F8VYL7; G3V0E8; hsa:5094; I6L8F9; Q15366; Q32Q82; Q59HD4; Q68Y55; Q6IPF4; Q6PKG5,ENSG00000197111,mRNA Splicing - Major Pathway; Negative regulators of DDX58/IFIH1 signaling; Processing of Capped Intron-Containing Pre-mRNA; SARS-CoV-1 activates/modulates innate immune responses,mRNA processing; Ferroptosis; Modulators of TCR signaling and T cell activation,7,0,119.93,,116.52,63.65,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,80.29,80.29,155.87,111.76,56.71,nucleic acid binding activity;other molecular function,0,
Master Protein,High,B4DUC8,MTAP,S-methyl-5'-thioadenosine phosphorylase OS=Homo sapiens OX=9606 GN=MTAP PE=1 SV=1,1,6,0.225,0.478,0.072,1.489,-2.15,-1.06,-3.79,0.57,1.09E-01,6.38E-01,2.28E-03,5.91E-01,4.84E+05,2.15E+06,2.32E+05,1.55E+05,4,1,4,1,7.99E+05,,3.79E+04,2.93E+05,3.13E+06,,,,,2.15E+06,9.39E+05,1.49E+05,,3.59E+05,8.76E+04,,,,1.55E+05,,3.17E+03,,3.71E+02,2.93E+05,1.61E+05,,,,,2.28E+04,5.61E+03,6.66E+03,,4.84E+04,2.18E+03,,,,3.64E+03,,0,FALSE,5.457,6,1,300,33.2,7.46,1,other metabolic processes,cytosol;nucleus,Pf01048,,B4DUC8,ENSG00000099810,,Methionine de novo and salvage pathway,1,0,132.57,,101.08,,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,110.87,128.16,0,87.02,16.67,other molecular function,0,
Master Protein,High,Q9H1A4,ANAPC1,Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1,1,1,0.225,0.01,1.402,0.01,-2.15,-6.64,0.49,-6.64,1.49E-01,1.00E-17,8.70E-01,1.00E-17,6.47E+04,2.87E+05,,4.03E+05,2,1,,1,,1.97E+05,,2.12E+04,,2.87E+05,,,,,,,,,,,,,4.03E+05,,,7.48E+02,,2.12E+04,,1.02E+03,,,,,,,,,,,,,9.42E+03,,0.001,FALSE,3.935,1,1,1944,216.4,6.3,1,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus,"Pf12859, Pf18122, Pf20518, Pf21282",64682,hsa:64682; Q2M3H8; Q9BSE6; Q9H1A4; Q9H8D0,ENSG00000153107,Separation of Sister Chromatids; Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,Cell cycle; 2q13 copy number variation syndrome,20,0,113.87,,,,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,201.31,,0,,2.49,other molecular function,0,
Master Protein,High,P45974,USP5,Ubiquitin carboxyl-terminal hydrolase 5 OS=Homo sapiens OX=9606 GN=USP5 PE=1 SV=2,3,7,0.223,0.762,0.057,0.552,-2.16,-0.39,-4.14,-0.86,7.28E-02,8.06E-01,1.48E-04,7.39E-01,1.74E+06,1.21E+07,7.15E+04,3.37E+05,3,1,2,2,4.65E+06,,1.74E+06,1.23E+05,,1.21E+07,,,,,9.53E+04,,,5.36E+04,,,8.02E+05,,1.42E+05,,1.85E+04,,1.70E+04,1.23E+05,,4.29E+04,,,,,5.70E+02,,,7.23E+03,,,2.25E+05,,3.32E+03,,0,FALSE,14.282,6,3,858,95.7,5.03,3,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cytoplasmic organelle,"Pf00443, Pf00627, Pf02148, Pf17807",8078,D3DUS7; D3DUS8; hsa:8078; P45974; Q96J22,ENSG00000111667,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Ub-specific processing proteases,IL-18 signaling pathway,3,0,105.57,,39.58,98.92,High,n/a,High,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,74.91,62.71,0,39.46,23.61,other molecular function,0,
Master Protein,High,E9PH57,TCF4,Transcription factor 4 OS=Homo sapiens OX=9606 GN=TCF4 PE=1 SV=2,3,4,0.221,0.51,2.112,0.293,-2.18,-0.97,1.08,-1.77,1.87E-01,7.46E-01,5.38E-01,4.14E-01,8.87E+05,1.52E+05,4.50E+05,9.46E+05,4,1,2,2,2.60E+06,5.65E+06,,3.02E+05,2.87E+05,1.52E+05,,,,,1.69E+06,,,1.20E+05,,,3.24E+05,,,2.76E+06,1.03E+04,2.15E+04,,3.02E+05,1.48E+04,5.40E+02,,,,,1.01E+04,,,1.61E+04,,,9.10E+04,,,2.94E+04,0,FALSE,9.778,5,2,773,83.4,7.47,3,,,Pf00010,6925,E9PH57,ENSG00000196628,,Neural crest differentiation; Corticotropin-releasing hormone signaling pathway; Mesodermal commitment pathway; Wnt signaling pathway; Regulation of Wnt / B-catenin signaling by small molecule compounds; Development of pulmonary dendritic cells and macrophage subsets; Rett syndrome; Gastrin signaling pathway; Neurogenesis regulation in the olfactory epithelium,9,1,114.82,,122.73,111.75,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,51.23,89.92,0,139.94,9.38,other molecular function,0,
Master Protein,High,E7EVH7,,Kinesin light chain OS=Homo sapiens OX=9606 PE=3 SV=2,1,1,0.221,1.934,0.559,0.706,-2.18,0.95,-0.84,-0.5,1.46E-01,2.87E-01,5.15E-01,9.16E-01,6.01E+04,2.72E+05,1.07E+05,1.52E+05,2,1,3,2,1.36E+05,,2.66E+04,,,,,,,2.72E+05,2.76E+05,,1.07E+05,,4.91E+04,,1.27E+05,,1.82E+05,,5.40E+02,,2.60E+02,,,,,,,2.89E+03,1.65E+03,,8.73E+02,,1.22E+03,,3.58E+04,,4.25E+03,,0.001,FALSE,3.337,2,1,719,82.4,7.06,1,signal transduction,other membranes;cytoskeleton;mitochondrion,"Pf10231, Pf13374, Pf13424",,,,,,0,0,95.14,,81.66,24.92,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,134.81,104.14,26.54,89.56,3.75,,0,
Master Protein,High,Q92576,PHF3,PHD finger protein 3 OS=Homo sapiens OX=9606 GN=PHF3 PE=1 SV=3,5,5,0.221,0.433,,2.506,-2.18,-1.21,,1.33,7.08E-02,5.53E-01,,3.88E-01,4.33E+05,4.72E+06,1.62E+05,1.55E+04,1,1,3,1,,,,4.33E+05,,,,,,4.72E+06,,1.66E+05,,1.31E+05,1.62E+05,,,,1.55E+04,,,,,4.33E+05,,,,,,5.02E+04,,7.42E+03,,1.77E+04,4.03E+03,,,,3.62E+02,,0,FALSE,19.079,4,5,2039,229.3,6.96,5,RNA metabolism OR transcription;other metabolic processes,nucleus,"Pf00628, Pf07500, Pf07744",23469,A3KFI8; hsa:23469; Q14CR5; Q5CZI1; Q5T1T6; Q92576; Q9NQ16; Q9UI45,ENSG00000118482,,,0,0,,,12.47,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,575.46,35.88,,8.64,13.26,other molecular function,0,
Master Protein,High,Q7KZF4,SND1,Staphylococcal nuclease domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SND1 PE=1 SV=1,3,7,0.218,1.022,0.171,0.813,-2.2,0.03,-2.55,-0.3,1.48E-01,6.75E-01,4.62E-02,9.89E-01,1.04E+05,4.25E+05,1.42E+05,1.37E+05,3,5,2,3,1.04E+05,,,4.07E+04,5.74E+05,4.25E+05,6.90E+05,1.99E+05,1.20E+06,3.90E+05,,,,2.75E+05,7.29E+04,2.22E+05,1.25E+05,,1.37E+05,,4.14E+02,,,4.07E+04,2.96E+04,1.51E+03,1.23E+04,1.84E+03,3.38E+04,4.15E+03,,,,3.70E+04,1.81E+03,4.33E+02,3.51E+04,,3.21E+03,,0,FALSE,9.106,5,3,910,101.9,7.17,3,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00565, Pf00567",27044,hsa:27044; Q13122; Q7KZF4; Q96AG0,ENSG00000197157,Signaling by BRAF and RAF1 fusions,VEGFA-VEGFR2 signaling,2,0,121.59,66.7,82.1,32.76,Peak Found,n/a,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,83.67,122.53,93.56,96.08,19.34,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P30536,TSPO,Translocator protein OS=Homo sapiens OX=9606 GN=TSPO PE=1 SV=3,1,17,0.218,0.597,0.603,0.144,-2.2,-0.74,-0.73,-2.79,6.11E-02,8.12E-01,4.38E-01,1.02E-01,4.51E+05,4.02E+06,3.54E+05,2.45E+06,4,5,5,5,8.82E+05,3.27E+06,2.31E+05,,1.63E+05,4.09E+06,2.22E+06,4.02E+06,6.34E+05,1.07E+07,5.85E+05,1.24E+05,3.54E+05,3.31E+05,4.56E+05,6.45E+06,1.99E+05,3.83E+07,3.60E+04,2.45E+06,3.51E+03,1.24E+04,2.25E+03,,8.42E+03,1.45E+04,3.95E+04,3.71E+04,1.79E+04,1.14E+05,3.50E+03,5.54E+03,2.87E+03,4.47E+04,1.13E+04,1.26E+04,5.58E+04,2.71E+05,8.43E+02,2.61E+04,0.002,FALSE,2.908,5,1,169,18.8,9.36,1,cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes,other membranes;cytosol;mitochondrion;ER/Golgi;other cell component,Pf03073,706,hsa:706; P30536; Q53Y59; Q6ICF9; Q96TF6,ENSG00000100300,Pregnenolone biosynthesis,NO/cGMP/PKG mediated neuroprotection; Cholesterol metabolism,3,0,128.31,88.43,45.97,171.96,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,High,Peak Found,High,1,,FALSE,134.16,106.06,139.46,146.08,28.43,transporter activity;other molecular function,0,
Master Protein,High,Q15019,SEPTIN2,Septin-2 OS=Homo sapiens OX=9606 GN=SEPTIN2 PE=1 SV=1,5,11,0.217,2.076,0.53,0.893,-2.2,1.05,-0.91,-0.16,6.82E-02,7.52E-02,3.47E-01,8.97E-01,1.74E+06,3.98E+06,1.04E+06,4.56E+05,1,1,3,3,,,,1.74E+06,,,,,3.98E+06,,,1.02E+05,1.04E+06,5.86E+06,,4.01E+05,2.89E+06,,4.56E+05,,,,,1.74E+06,,,,,1.12E+05,,,4.57E+03,8.46E+03,7.90E+05,,7.81E+02,8.11E+05,,1.07E+04,,0,FALSE,25.084,25,5,361,41.5,6.6,5,cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component,Pf00735,4735,B4DGE8; hsa:4735; Q14132; Q15019; Q53QU3; Q8IUK9; Q96CB0,ENSG00000168385,Anchoring of the basal body to the plasma membrane,2q37 copy number variation syndrome,2,0,,,132.33,113.76,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,n/a,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,15.63,95.63,315.71,144.01,36.49,other molecular function,0,
Master Protein,High,O00287,RFXAP,Regulatory factor X-associated protein OS=Homo sapiens OX=9606 GN=RFXAP PE=1 SV=1,2,2,0.216,0.01,0.01,,-2.21,-6.64,-6.64,,1.75E-01,1.00E-17,1.00E-17,,1.97E+05,9.12E+05,,,1,2,,,,,,1.97E+05,,,,,1.20E+06,6.91E+05,,,,,,,,,,,,,,1.97E+05,,,,,3.39E+04,7.35E+03,,,,,,,,,,,0,FALSE,7.497,8,2,272,28.2,5.54,2,other biological processes,nucleus,Pf15289,5994,B2R9T8; hsa:5994; O00287; Q5VZM6; Q8TC40,ENSG00000133111,,,0,0,,38.28,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,41.69,,,,6.42,nucleic acid binding activity,0,
Master Protein,High,Q16775,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial OS=Homo sapiens OX=9606 GN=HAGH PE=1 SV=2",3,8,0.215,1.878,0.976,0.689,-2.22,0.91,-0.03,-0.54,1.74E-01,1.95E-01,9.05E-01,9.04E-01,1.79E+05,8.33E+05,3.65E+05,8.23E+05,4,1,4,4,,1.90E+05,1.30E+05,1.68E+06,1.68E+05,,,,,8.33E+05,3.36E+05,1.85E+05,,1.34E+06,3.97E+05,,1.59E+06,4.64E+05,1.46E+06,2.82E+05,,7.21E+02,1.27E+03,1.68E+06,8.69E+03,,,,,8.85E+03,2.01E+03,8.26E+03,,1.81E+05,9.87E+03,,4.46E+05,3.28E+03,3.42E+04,3.00E+03,0,FALSE,13.29,15,3,308,33.8,8.12,3,other metabolic processes,cytosol;mitochondrion;other cell component,"Pf00753, Pf16123",3029,A8K290; B4DP33; B4DRA7; E7EN93; hsa:3029; Q16775,ENSG00000063854,,,0,0,140.11,,93.12,70.75,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,32.65,78.25,88.76,110.44,21.94,other molecular function,0,
Master Protein,High,J3KNA0,OXA1L,OXA1L mitochondrial inner membrane protein OS=Homo sapiens OX=9606 GN=OXA1L PE=1 SV=1,1,6,0.214,0.162,0.039,1.105,-2.22,-2.62,-4.67,0.14,6.57E-02,3.22E-02,2.03E-05,8.57E-01,5.43E+06,1.36E+08,2.40E+06,2.07E+06,5,5,5,4,3.06E+06,1.00E+08,2.73E+06,5.43E+06,7.27E+08,1.43E+07,1.36E+08,1.77E+08,2.39E+07,1.95E+08,6.16E+05,4.97E+05,2.40E+06,1.06E+07,6.55E+06,4.14E+05,8.23E+04,,1.04E+07,8.15E+08,1.22E+04,3.81E+05,2.67E+04,5.43E+06,3.75E+07,5.09E+04,2.42E+06,1.63E+06,6.73E+05,2.08E+06,3.68E+03,2.22E+04,1.95E+04,1.43E+06,1.63E+05,8.08E+02,2.31E+04,,2.43E+05,8.68E+06,0.004,FALSE,2.582,2,1,495,55.2,9.69,1,other biological processes,other membranes;mitochondrion,Pf02096,5018,hsa:5018; J3KNA0,ENSG00000155463,,,0,0,188.09,77.93,105.57,196.5,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,High,1,,FALSE,142.33,137.01,148.12,148.01,12.69,other molecular function,0,
Master Protein,High,Q7Z6Z7,HUWE1,E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens OX=9606 GN=HUWE1 PE=1 SV=3,4,7,0.213,0.579,0.464,0.464,-2.23,-0.79,-1.11,-1.11,1.30E-01,9.04E-01,4.49E-01,6.63E-01,3.70E+04,1.74E+05,2.14E+04,4.61E+04,2,2,2,3,,,,5.15E+04,2.66E+04,9.30E+04,,,,3.25E+05,,,,2.08E+04,2.21E+04,,2.31E+05,4.61E+04,,4.05E+04,,,,5.15E+04,1.37E+03,3.31E+02,,,,3.45E+03,,,,2.80E+03,5.49E+02,,6.48E+04,3.27E+02,,4.31E+02,0,FALSE,20.757,2,4,4374,481.6,5.22,4,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf00627, Pf00632, Pf02825, Pf06012, Pf06025, Pf14377",10075,hsa:10075; O15029; Q4G2Z2; Q5H961; Q6P4D0; Q7Z6Z7; Q8NG67; Q9BUI0; Q9HCJ4; Q9NSL6; Q9P0A9,ENSG00000086758,Antigen processing: Ubiquitination & Proteasome degradation; Neutrophil degranulation,,2,0,45.05,78.41,4.33,102.32,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,71.01,48.32,85.93,18.23,25.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q15648,MED1,Mediator of RNA polymerase II transcription subunit 1 OS=Homo sapiens OX=9606 GN=MED1 PE=1 SV=4,4,4,0.213,0.01,0.01,,-2.23,-6.64,-6.64,,1.43E-01,1.00E-17,1.00E-17,,1.28E+05,3.30E+05,,,1,1,,,,,,1.28E+05,,,3.30E+05,,,,,,,,,,,,,,,,,1.28E+05,,,5.87E+03,,,,,,,,,,,,,,0,FALSE,16.934,4,4,1581,168.4,8.73,4,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,nucleus;other cell component,Pf10744,5469,A2RRQ6; hsa:5469; O43810; O75447; Q15648; Q6P9H7; Q6PK58; Q9HD39,ENSG00000125686,"Estrogen-dependent gene expression; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; RSV-host interactions; Heme signaling; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Transcriptional activation of mitochondrial biogenesis; Nuclear Receptor transcription pathway; Cytoprotection by HMOX1; Activation of gene expression by SREBF (SREBP); RORA activates gene expression","Energy metabolism; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; Non-genomic actions of 1,25 dihydroxyvitamin D3; 17q12 copy number variation syndrome",18,0,,,,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,,,,11.52,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,High,O00170,AIP,AH receptor-interacting protein OS=Homo sapiens OX=9606 GN=AIP PE=1 SV=3,2,2,0.211,0.246,0.529,0.085,-2.24,-2.02,-0.92,-3.55,1.32E-01,3.15E-01,4.84E-01,7.16E-02,6.06E+04,2.78E+05,1.25E+04,1.47E+05,3,1,2,1,6.06E+04,,5.88E+04,1.35E+05,,2.78E+05,,,,,,6.52E+03,2.42E+04,,,1.47E+05,,,,,2.41E+02,,5.74E+02,1.35E+05,,9.88E+02,,,,,,2.91E+02,1.96E+02,,,2.87E+02,,,,,0,FALSE,6.442,8,2,330,37.6,6.42,2,protein metabolism;other metabolic processes;other biological processes,other membranes;cytosol;nucleus;other cell component,Pf00254,9049,A0SZW3; A0SZW4; A0SZW5; A0SZW6; G9I2H4; hsa:9049; O00170; Q2M3Q2; Q99606,ENSG00000110711,Aryl hydrocarbon receptor signalling; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Aryl hydrocarbon receptor pathway; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway,5,0,51.27,,81.32,,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,4.51,87.52,0,104.21,6.11,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9NXV6,CDKN2AIP,CDKN2A-interacting protein OS=Homo sapiens OX=9606 GN=CDKN2AIP PE=1 SV=3,4,4,0.211,0.358,6.465,0.01,-2.24,-1.48,2.69,-6.64,1.47E-01,5.07E-01,2.53E-02,1.00E-17,7.08E+04,3.85E+05,1.98E+04,2.42E+06,1,2,1,1,,,,7.08E+04,,,5.38E+05,,2.75E+05,,,,,,1.98E+04,,,,,2.42E+06,,,,7.08E+04,,,9.57E+03,,7.76E+03,,,,,,4.92E+02,,,,,2.58E+04,0,FALSE,15.673,12,4,580,61.1,9.01,4,stress response;other biological processes,nucleus,Pf11952,55602,hsa:55602; Q8TBM5; Q9NXV6; Q9NYH0,ENSG00000168564,,,0,0,,45.68,,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,120.46,0,54.63,0,11.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P02649,APOE,Apolipoprotein E OS=Homo sapiens OX=9606 GN=APOE PE=1 SV=1,4,10,0.211,0.697,0.453,0.325,-2.24,-0.52,-1.14,-1.62,1.61E-01,9.79E-01,2.99E-01,4.92E-01,1.15E+05,5.47E+05,4.30E+04,2.48E+05,2,2,3,2,,,,3.12E+04,4.28E+05,,4.24E+05,,7.04E+05,,,3.84E+04,,1.69E+05,4.30E+04,,1.15E+05,,,5.32E+05,,,,3.12E+04,2.21E+04,,7.55E+03,,1.98E+04,,,1.71E+03,,2.27E+04,1.07E+03,,3.24E+04,,,5.66E+03,0,FALSE,10.195,12,2,317,36.1,5.73,4,cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf01442,348,B2RC15; C0JYY5; hsa:348; P02649; Q9P2S4,ENSG00000130203,Amyloid fiber formation; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Retinoid metabolism and transport; Nuclear signaling by ERBB4; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; Chylomicron clearance; Scavenging by Class A Receptors; Chylomicron assembly; Chylomicron remodeling; HDL remodeling; Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Vitamin B12 metabolism; Alzheimer's disease and miRNA effects; Apoptosis-related network due to altered Notch3 in ovarian cancer; ApoE and miR-146 in inflammation and atherosclerosis; Statin inhibition of cholesterol production; Familial hyperlipidemia type 3; Alzheimer's disease; Cholesterol metabolism; Fatty acids and lipoproteins transport in hepatocytes; HDAC6 interactions in the central nervous system,22,0,122.23,35.1,88.69,91.1,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,Peak Found,1,,FALSE,197.74,121.53,96.9,67.29,20.96,signal transduction activity or receptor binding;transporter activity;enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A8Q3SHY7,MIPOL1,Mirror-image polydactyly 1 OS=Homo sapiens OX=9606 GN=MIPOL1 PE=1 SV=1,1,1,0.21,0.01,0.161,0.01,-2.25,-6.64,-2.64,-6.64,1.55E-01,1.00E-17,3.55E-02,1.00E-17,8.78E+04,7.95E+05,,1.28E+05,2,3,,1,,,1.67E+05,4.60E+04,,7.97E+05,7.95E+05,,,1.24E+05,,,,,,,,,1.28E+05,,,,1.64E+03,4.60E+04,,2.83E+03,1.41E+04,,,1.32E+03,,,,,,,,,2.99E+03,,0.003,FALSE,2.703,4,1,519,59.4,6.11,1,,,,,A0A8Q3SHY7,ENSG00000151338,,,0,0,80.43,67.85,,,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,Phospho [S294],FALSE,94.77,,0.37,,2.52,,1,Phospho [S294]
Master Protein,High,Q6UWZ7,ABRAXAS1,BRCA1-A complex subunit Abraxas 1 OS=Homo sapiens OX=9606 GN=ABRAXAS1 PE=1 SV=2,2,3,0.21,1.459,,0.617,-2.25,0.55,,-0.7,1.10E-01,4.47E-01,,8.31E-01,5.08E+04,5.66E+04,9.99E+04,1.60E+05,1,1,2,1,,,,5.08E+04,,,,,,5.66E+04,,5.67E+04,,1.76E+05,,,,,1.60E+05,,,,,5.08E+04,,,,,,6.02E+02,,2.53E+03,,2.37E+04,,,,,3.74E+03,,0,FALSE,5.158,7,2,409,46.6,7.05,2,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,nucleus,Pf21125,84142,A5JJ07; hsa:84142; Q6UWZ7; Q9H8I1; Q9H9N4,ENSG00000163322,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Metalloprotease DUBs; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ),5q35 copy number variation,6,0,,,72.39,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,107.56,,85.97,9.04,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q8WYP5,AHCTF1,Protein ELYS OS=Homo sapiens OX=9606 GN=AHCTF1 PE=1 SV=3,7,8,0.21,0.197,4.586,,-2.25,-2.34,2.2,,8.88E-02,6.54E-02,7.00E-02,,2.64E+06,7.72E+05,5.83E+05,3.54E+06,4,1,3,1,3.96E+06,7.74E+06,1.76E+06,7.41E+05,,7.72E+05,,,,,,5.83E+05,6.81E+05,,3.15E+05,3.54E+06,,,,,1.57E+04,2.94E+04,1.72E+04,7.41E+05,,2.74E+03,,,,,,2.60E+04,5.53E+03,,7.84E+03,6.90E+03,,,,,0,FALSE,25.68,5,7,2266,252.3,6.6,7,cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes,other membranes;cytosol;nucleus;other cell component,"Pf13934, Pf16687",25909,A6NGM0; A8MSG9; A8MZ86; hsa:25909; Q7Z4E3; Q8IZA4; Q8WYP5; Q96EH9; Q9Y4Q6,ENSG00000153207,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,Gastric cancer network 2,8,0,87.33,,35.95,,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,0,100.48,0,,22.12,nucleic acid binding activity,0,
Master Protein,High,Q7Z7H5,TMED4,Transmembrane emp24 domain-containing protein 4 OS=Homo sapiens OX=9606 GN=TMED4 PE=1 SV=1,5,27,0.21,1.176,0.317,0.624,-2.25,0.23,-1.66,-0.68,1.41E-01,5.21E-01,2.22E-01,8.08E-01,4.40E+05,1.25E+06,3.58E+05,5.46E+05,5,5,5,3,4.40E+05,5.27E+06,8.98E+04,1.37E+06,3.97E+04,8.42E+05,1.89E+05,1.39E+06,1.25E+06,1.93E+06,1.28E+06,3.58E+05,1.97E+05,1.69E+06,2.92E+05,1.97E+06,7.00E+04,,5.46E+05,,1.75E+03,2.00E+04,8.78E+02,1.37E+06,2.05E+03,2.99E+03,3.36E+03,1.28E+04,3.53E+04,2.05E+04,7.67E+03,1.60E+04,1.60E+03,2.28E+05,7.26E+03,3.83E+03,1.97E+04,,1.28E+04,,0,FALSE,17.504,27,5,227,25.9,8.28,5,cell organization and biogenesis;transport,other membranes;ER/Golgi;other cell component,Pf01105,222068,A4D2K8; B4DFJ4; hsa:222068; Q56VW3; Q7Z432; Q7Z7H5; Q8N2P6,ENSG00000158604,,,0,0,152.87,57.93,88.69,114.63,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,147.08,128.76,125.99,130.4,52.06,,0,
Master Protein,High,Q8NBS9,TXNDC5,Thioredoxin domain-containing protein 5 OS=Homo sapiens OX=9606 GN=TXNDC5 PE=1 SV=2,4,19,0.21,0.638,0.407,0.261,-2.25,-0.65,-1.3,-1.94,6.23E-02,9.55E-01,2.01E-01,2.65E-01,1.38E+06,5.78E+06,2.56E+06,4.70E+06,5,5,5,5,7.41E+05,3.46E+06,1.15E+06,1.38E+06,2.91E+06,5.78E+06,4.99E+06,9.24E+06,3.19E+06,2.05E+07,2.90E+06,1.34E+06,2.56E+06,4.03E+06,1.99E+06,5.53E+06,5.12E+06,2.78E+06,1.32E+06,4.70E+06,2.95E+03,1.31E+04,1.13E+04,1.38E+06,1.50E+05,2.06E+04,8.88E+04,8.52E+04,8.99E+04,2.18E+05,1.74E+04,5.97E+04,2.08E+04,5.43E+05,4.93E+04,1.08E+04,1.44E+06,1.97E+04,3.09E+04,5.00E+04,0,FALSE,20.201,15,4,432,47.6,5.97,4,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;ER/Golgi;other cytoplasmic organelle,Pf00085,81567,B2RDM2; hsa:81567; Q5TCQ0; Q8NBS9; Q8ND33; Q8TCT2; Q9BVH9,ENSG00000239264,Neutrophil degranulation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis,VEGFA-VEGFR2 signaling,4,0,61.42,79.19,39.53,45.81,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,100.9,102.73,107.21,105.82,52.93,other molecular function,0,
Master Protein,High,Q9UBC2,EPS15L1,Epidermal growth factor receptor substrate 15-like 1 OS=Homo sapiens OX=9606 GN=EPS15L1 PE=1 SV=1,2,2,0.209,0.73,0.344,0.444,-2.26,-0.45,-1.54,-1.17,1.42E-01,9.72E-01,2.17E-01,6.23E-01,7.91E+04,3.78E+05,5.77E+04,1.30E+05,1,1,1,3,7.91E+04,,,,,,,,,3.78E+05,,,,,5.77E+04,1.30E+05,1.39E+06,,7.56E+04,,3.14E+02,,,,,,,,,4.02E+03,,,,,1.43E+03,2.53E+02,3.90E+05,,1.77E+03,,0,FALSE,5.656,4,2,864,94.2,5.11,2,transport,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf12763,58513,A2RRF3; A5PL29; B4DKA3; hsa:58513; Q9UBC2,ENSG00000127527,Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation,EGF/EGFR signaling pathway,4,0,,,,139.8,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,0,0,106.83,62.09,5.43,other molecular function,0,
Master Protein,Medium,I3L0A0,PEDS1-UBE2V1,HCG2044781 OS=Homo sapiens OX=9606 GN=PEDS1-UBE2V1 PE=3 SV=1,1,1,0.209,2.191,1.355,0.338,-2.26,1.13,0.44,-1.57,1.14E-01,2.29E-01,8.74E-01,4.83E-01,2.66E+04,1.27E+05,5.82E+04,1.73E+05,2,1,3,3,,,2.71E+04,,2.61E+04,1.27E+05,,,,,5.82E+04,,7.18E+04,,2.16E+04,2.04E+05,1.73E+05,1.58E+05,,,,,2.65E+02,,1.35E+03,4.53E+02,,,,,3.48E+02,,5.83E+02,,5.38E+02,3.98E+02,4.85E+04,1.12E+03,,,0.029,FALSE,1.841,2,1,370,42.2,6.71,1,other metabolic processes,other membranes;nucleus,"Pf00179, Pf10520",,I3L0A0,ENSG00000124208,,,0,0,2.58,,51.31,13.23,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,2.7,34.59,12.28,28.02,1.9,,0,
Master Protein,High,O76095,JTB,Protein JTB OS=Homo sapiens OX=9606 GN=JTB PE=1 SV=1,1,1,0.206,0.01,6.269,0.01,-2.28,-6.64,2.65,-6.64,1.30E-01,1.00E-17,2.42E-02,1.00E-17,8.15E+04,3.96E+05,,2.48E+06,1,1,,2,,,,8.15E+04,,3.96E+05,,,,,,,,,,4.84E+05,,1.27E+07,,,,,,8.15E+04,,1.41E+03,,,,,,,,,,9.44E+02,,9.00E+04,,,0.001,FALSE,3.929,9,1,146,16.3,8.28,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytoskeleton;mitochondrion;other cell component,Pf05439,10899,hsa:10899; O76095; O95442; Q6IB19; Q9P0Q4,ENSG00000143543,,,0,0,,,,131.03,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,0,,365.12,,2.65,other molecular function,0,
Master Protein,High,P60903,S100A10,Protein S100-A10 OS=Homo sapiens OX=9606 GN=S100A10 PE=1 SV=2,1,11,0.206,3.243,0.693,1.087,-2.28,1.7,-0.53,0.12,1.57E-01,4.73E-02,6.36E-01,7.72E-01,1.65E+05,9.28E+05,7.17E+05,6.43E+05,5,4,5,4,7.77E+05,1.65E+05,2.21E+05,4.36E+04,4.86E+04,2.28E+06,2.88E+04,6.99E+05,,1.23E+06,1.49E+05,1.05E+05,1.41E+06,7.17E+05,8.73E+05,,1.33E+06,5.31E+05,7.79E+05,9.04E+04,3.09E+03,6.28E+02,2.16E+03,4.36E+04,2.50E+03,8.11E+03,5.11E+02,6.45E+03,,1.31E+04,8.90E+02,4.71E+03,1.14E+04,9.66E+04,2.17E+04,,3.75E+05,3.76E+03,1.82E+04,9.63E+02,0,FALSE,6.525,18,1,97,11.2,7.37,1,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;nucleus;other cell component,Pf01023,6281,A8K4V8; hsa:6281; P08206; P60903; Q5T1C5,ENSG00000197747,Dissolution of Fibrin Clot,8p23.1 copy number variation syndrome; Prostaglandin synthesis and regulation,3,0,120.94,89.69,83.42,75.88,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,High,Peak Found,1,,FALSE,143.62,117.48,129.14,104.16,29.46,other molecular function,0,
Master Protein,High,P01857,IGHG1,Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,4,20,0.205,1.166,0.293,0.825,-2.29,0.22,-1.77,-0.28,5.87E-02,4.26E-01,8.95E-02,9.25E-01,1.08E+06,6.09E+06,3.35E+06,1.92E+06,3,5,5,5,1.08E+06,,,6.25E+05,1.58E+07,2.13E+07,5.28E+06,6.86E+06,1.85E+06,6.09E+06,6.11E+05,1.26E+06,5.28E+06,3.35E+06,4.08E+06,2.14E+07,1.92E+06,4.53E+06,1.22E+06,1.55E+06,4.30E+03,,,6.25E+05,8.13E+05,7.58E+04,9.40E+04,6.33E+04,5.22E+04,6.48E+04,3.65E+03,5.64E+04,4.29E+04,4.52E+05,1.01E+05,4.18E+04,5.38E+05,3.21E+04,2.84E+04,1.65E+04,0,FALSE,15.575,15,3,399,43.9,6.96,4,stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,Pf07654,,A0A0A0MS08; P01857,ENSG00000211896; ENSG00000277633,Initial triggering of complement; Classical antibody-mediated complement activation; FCGR activation; Regulation of actin dynamics for phagocytic cup formation; Role of phospholipids in phagocytosis; FCGR3A-mediated IL10 synthesis; FCGR3A-mediated phagocytosis; Regulation of Complement cascade; Interleukin-4 and Interleukin-13 signaling,Interactions of natural killer cells in pancreatic cancer,10,0,147.85,90.99,66.79,141.2,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,1,,FALSE,135.03,138.07,94.9,108.5,57.56,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9NRX5,SERINC1,Serine incorporator 1 OS=Homo sapiens OX=9606 GN=SERINC1 PE=1 SV=1,1,1,0.204,0.104,0.078,0.191,-2.3,-3.26,-3.68,-2.39,1.53E-01,4.42E-02,4.72E-03,2.43E-01,1.19E+05,8.32E+05,1.24E+04,6.50E+04,4,4,1,1,6.01E+04,2.50E+05,,2.12E+04,2.36E+05,1.11E+05,6.39E+05,1.19E+06,,1.08E+06,,,,1.24E+04,,,,,6.50E+04,,2.39E+02,9.48E+02,,2.12E+04,1.22E+04,3.95E+02,1.14E+04,1.10E+04,,1.15E+04,,,,1.67E+03,,,,,1.52E+03,,0.001,FALSE,3.119,3,1,453,50.5,5.85,1,other metabolic processes;other biological processes,plasma membrane;other membranes;ER/Golgi,Pf03348,57515,B3KY69; E1P565; hsa:57515; O75655; Q7Z2F5; Q8TAG1; Q9NRX5; Q9NTH8; Q9ULG7,ENSG00000111897,Serine biosynthesis,Sphingolipid pathway,2,0,83.16,65.06,,,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,113.26,133.54,54.33,0,3.22,other molecular function,0,
Master Protein,High,Q9Y2Z4,YARS2,"Tyrosine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=YARS2 PE=1 SV=2",1,7,0.2,1.646,0.078,5.389,-2.32,0.72,-3.69,2.43,1.23E-01,3.22E-01,6.34E-03,1.30E-01,8.34E+04,4.17E+05,1.74E+05,3.23E+04,2,1,4,1,,,,2.53E+05,2.76E+04,,,,4.17E+05,,,3.01E+05,6.28E+04,1.34E+05,2.26E+05,,3.23E+04,,,,,,,2.53E+05,1.42E+03,,,,1.17E+04,,,1.34E+04,5.10E+02,1.81E+04,5.61E+03,,9.08E+03,,,,0,FALSE,7.216,4,1,477,53.2,8.98,1,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;mitochondrion;nucleus,Pf00579,51067,D3DUW8; hsa:51067; Q9H817; Q9Y2Z4,ENSG00000139131,Mitochondrial tRNA aminoacylation,Orexin receptor pathway,2,0,113.59,,57.51,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,199.92,113.14,0,69.43,22.15,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P06241,FYN,Tyrosine-protein kinase Fyn OS=Homo sapiens OX=9606 GN=FYN PE=1 SV=3,2,5,0.193,3.409,2.827,0.233,-2.37,1.77,1.5,-2.1,1.14E-01,7.58E-02,3.41E-01,2.49E-01,4.97E+04,2.57E+05,1.70E+05,7.27E+05,1,3,3,1,,,,4.97E+04,,,2.57E+05,,2.18E+05,4.70E+05,6.04E+05,,,1.70E+05,6.91E+04,,,7.27E+05,,,,,,4.97E+04,,,4.57E+03,,6.15E+03,5.00E+03,3.61E+03,,,2.28E+04,1.72E+03,,,5.15E+03,,,0,FALSE,5.16,5,1,537,60.7,6.67,2,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00017, Pf00018, Pf07714",2534,B5BU57; E1P557; H0UI48; hsa:2534; P06241; Q16248; Q5R3A6; Q5R3A7; Q8N5D7,ENSG00000010810,"FCGR activation; Role of LAT2/NTAL/LAB on calcium mobilization; FCGR3A-mediated IL10 synthesis; FCGR3A-mediated phagocytosis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Regulation of signaling by CBL; Nephrin family interactions; EPHB-mediated forward signaling; RAF/MAP kinase cascade; GPVI-mediated activation cascade; DAP12 signaling; CD28 dependent PI3K/Akt signaling; VEGFA-VEGFR2 Pathway; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Ephrin signaling; Regulation of KIT signaling; Signaling by ERBB2; CRMPs in Sema3A signaling; EPH-ephrin mediated repulsion of cells; Sema3A PAK dependent Axon repulsion; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion; EPHA-mediated growth cone collapse; NCAM signaling for neurite out-growth; Signaling by CSF1 (M-CSF) in myeloid cells; Reelin signalling pathway; Platelet Adhesion to exposed collagen; CD209 (DC-SIGN) signaling; CD28 dependent Vav1 pathway; Dectin-2 family; Nef and signal transduction; PECAM1 interactions; CTLA4 inhibitory signaling; FLT3 signaling through SRC family kinases",Integrin-mediated cell adhesion; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Pathogenic Escherichia coli infection; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); T cell receptor and co-stimulatory signaling; Ectoderm differentiation; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Ectoderm differentiation; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling; Prion disease pathway; Acute viral myocarditis; NRF2-ARE regulation; Fragile X syndrome; Gastrin signaling pathway; Netrin-UNC5B signaling pathway; Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; IL-2 signaling pathway; 15q13.3 copy number variation syndrome; Congenital generalized lipodystrophy; Network map of SARS-CoV-2 signaling pathway; GDNF signaling; Interferon type I signaling pathways; T-cell receptor signaling pathway,72,0,,43.08,101.21,,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,22.36,87.8,26.34,106.64,8.79,signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function,0,
Master Protein,High,P10909,CLU,Clusterin OS=Homo sapiens OX=9606 GN=CLU PE=1 SV=1,3,27,0.193,0.347,0.517,0.367,-2.38,-1.53,-0.95,-1.44,5.00E-02,3.50E-01,3.31E-01,4.27E-01,1.10E+06,5.05E+06,6.31E+05,2.96E+06,5,5,4,5,1.10E+06,1.56E+07,2.05E+05,8.02E+04,2.11E+07,2.56E+06,4.00E+06,1.02E+07,7.74E+06,5.05E+06,1.71E+05,,1.04E+06,3.82E+05,3.07E+06,4.95E+07,5.38E+05,2.96E+06,7.25E+05,3.48E+07,4.38E+03,5.93E+04,2.00E+03,8.02E+04,1.09E+06,9.10E+03,7.12E+04,9.44E+04,2.18E+05,5.37E+04,1.02E+03,,8.47E+03,5.15E+04,7.62E+04,9.65E+04,1.51E+05,2.10E+04,1.70E+04,3.70E+05,0,FALSE,12.04,8,3,449,52.5,6.27,3,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component,Pf01093,1191,B2R9Q1; B3KSE6; hsa:1191; P10909; P11380; P11381; Q2TU75; Q5HYC1; Q7Z5B9,ENSG00000120885,Regulation of Complement cascade; Platelet degranulation ; Antimicrobial peptides; Terminal pathway of complement,Dengue-2 interactions with complement and coagulation cascades; Male infertility; Complement system in neuronal development and plasticity; Complement and coagulation cascades,8,0,131.26,51.82,113.28,129.53,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,1,,FALSE,143.22,144.47,142.34,140.16,77.42,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A8I5KNN2,DDX21,RNA helicase OS=Homo sapiens OX=9606 GN=DDX21 PE=1 SV=1,9,17,0.192,0.591,,1.396,-2.38,-0.76,,0.48,1.29E-01,8.71E-01,,6.28E-01,8.89E+05,5.64E+05,6.82E+05,3.56E+05,4,3,5,3,,1.45E+07,5.74E+04,2.49E+06,3.17E+05,3.82E+05,,5.64E+05,,6.77E+05,3.46E+05,9.38E+05,4.16E+04,2.94E+06,6.82E+05,3.90E+06,4.56E+03,,3.56E+05,,,5.49E+04,5.61E+02,2.49E+06,1.64E+04,1.36E+03,,5.20E+03,,7.20E+03,2.07E+03,4.19E+04,3.38E+02,3.97E+05,1.69E+04,7.61E+03,1.28E+03,,8.33E+03,,0,FALSE,26.508,16,8,808,89.9,9.19,9,,nucleus;other cell component,"Pf00270, Pf00271, Pf08152",,A0A8I5KNN2,ENSG00000165732,,10q11.21q11.23 copy number variation syndrome; Rubinstein-Taybi syndrome 1,2,1,157.92,27.56,115.44,151.73,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,29.84,100.77,,132.35,42.07,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A2U3TZU2,GPI,Glucose-6-phosphate isomerase OS=Homo sapiens OX=9606 GN=GPI PE=1 SV=1,2,12,0.192,0.446,0.748,0.227,-2.38,-1.16,-0.42,-2.14,4.94E-02,5.74E-01,6.16E-01,2.13E-01,7.00E+05,4.89E+06,5.27E+05,3.66E+06,5,3,5,5,5.91E+05,1.03E+06,7.00E+05,5.00E+05,9.50E+06,1.05E+06,,4.89E+06,,6.33E+06,1.23E+06,2.82E+04,5.11E+05,1.03E+06,5.27E+05,3.66E+06,9.74E+05,1.07E+07,2.73E+06,7.17E+06,2.35E+03,3.93E+03,6.84E+03,5.00E+05,4.90E+05,3.73E+03,,4.51E+04,,6.73E+04,7.34E+03,1.26E+03,4.15E+03,1.39E+05,1.31E+04,7.14E+03,2.74E+05,7.57E+04,6.40E+04,7.63E+04,0,FALSE,9.196,4,2,597,67.2,8.97,2,other metabolic processes;signal transduction,non-structural extracellular,Pf00342,2821,A0A2U3TZU2,ENSG00000105220,,Cori cycle; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; N-glycan biosynthesis; Disorders of fructose metabolism; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; UDP-derived sugars synthesis in fibroblasts,9,0,159.74,66.74,71.32,76.87,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,High,n/a,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,1,,FALSE,131.48,127.3,116.49,135.82,28.15,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q15942,ZYX,Zyxin OS=Homo sapiens OX=9606 GN=ZYX PE=1 SV=1,2,7,0.191,0.01,0.538,0.01,-2.39,-6.64,-0.89,-6.64,1.43E-01,1.00E-17,4.14E-01,1.00E-17,2.02E+05,6.64E+05,,2.67E+05,2,2,,2,,2.20E+05,,1.85E+05,,,5.42E+05,8.14E+05,,,,,,,,,2.00E+05,,,3.57E+05,,8.38E+02,,1.85E+05,,,9.64E+03,7.51E+03,,,,,,,,,5.61E+04,,,3.80E+03,0,FALSE,12.428,8,2,572,61.2,6.67,2,cell adhesion;cell-cell signaling;cell organization and biogenesis;stress response;signal transduction,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf00412,7791,A4D2G6; B4DQX7; hsa:7791; Q15942; Q6I9S4,ENSG00000159840; ENSG00000285443,,Integrin-mediated cell adhesion; Focal adhesion,2,0,12.29,28.42,,39.98,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,High,n/a,High,1,,FALSE,70.08,,30.41,,17.34,other molecular function,0,
Master Protein,High,P02679,FGG,Fibrinogen gamma chain OS=Homo sapiens OX=9606 GN=FGG PE=1 SV=3,23,612,0.19,0.382,0.189,0.657,-2.4,-1.39,-2.4,-0.61,4.80E-02,3.81E-01,2.42E-02,7.67E-01,3.15E+07,2.80E+07,2.07E+07,2.60E+07,5,5,5,5,3.66E+07,6.16E+07,2.62E+07,1.09E+06,3.15E+07,2.51E+07,1.31E+09,2.80E+07,4.49E+09,2.79E+07,5.10E+06,1.54E+06,4.61E+07,2.07E+07,2.96E+07,2.60E+07,2.49E+07,3.30E+07,2.41E+06,3.76E+07,1.45E+05,2.34E+05,2.56E+05,1.09E+06,1.63E+06,8.94E+04,2.33E+07,2.58E+05,1.26E+08,2.96E+05,3.05E+04,6.90E+04,3.74E+05,2.79E+06,7.36E+05,5.08E+04,6.98E+06,2.34E+05,5.64E+04,4.00E+05,0,FALSE,147.455,60,23,453,51.5,5.62,23,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component,"Pf00147, Pf08702",2266,A8K057; hsa:2266; P02679; P04469; P04470; Q53Y18; Q96A14; Q96KJ3; Q9UC62; Q9UC63; Q9UCF3,ENSG00000171557,ER-Phagosome pathway; Integrin cell surface interactions; Platelet degranulation ; Signaling by BRAF and RAF1 fusions; MyD88:MAL(TIRAP) cascade initiated on plasma membrane; MyD88 deficiency (TLR2/4); IRAK4 deficiency (TLR2/4); Regulation of TLR by endogenous ligand; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Common Pathway of Fibrin Clot Formation; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins,"Selenium micronutrient network; Folate metabolism; Blood clotting cascade; Complement system; VEGFA-VEGFR2 signaling; Fibrin complement receptor 3 signaling pathway; COVID-19, thrombosis and anticoagulation; Network map of SARS-CoV-2 signaling pathway",28,0,69.17,164.43,88.64,54.63,High,High,High,High,High,Peak Found,High,Peak Found,High,High,Peak Found,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,1,,FALSE,142.35,134.81,144.98,134.67,1656.47,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q15223,NECTIN1,Nectin-1 OS=Homo sapiens OX=9606 GN=NECTIN1 PE=1 SV=3,1,2,0.185,4.997,5.642,0.164,-2.43,2.32,2.5,-2.61,6.45E-02,4.13E-02,1.46E-01,1.88E-01,2.95E+03,1.59E+04,1.47E+04,8.98E+04,1,1,1,2,,,,2.95E+03,,,,,1.59E+04,,,,,,1.47E+04,,2.80E+05,,2.88E+04,,,,,2.95E+03,,,,,4.48E+02,,,,,,3.66E+02,,7.87E+04,,6.74E+02,,0.005,FALSE,2.521,3,1,517,57.1,6.1,1,cell adhesion;cell organization and biogenesis;transport;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf07686, Pf08205, Pf13927",5818,hsa:5818; O75465; Q15223; Q2M3D3; Q9HBE6; Q9HBW2,ENSG00000110400,Nectin/Necl  trans heterodimerization,,2,0,,,,115.06,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,0,207.47,207.47,5.55,other molecular function,0,
Master Protein,High,A0A7P0Z4P5,SLC3A2,Solute carrier family 3 member 2 OS=Homo sapiens OX=9606 GN=SLC3A2 PE=1 SV=1,10,46,0.185,2.007,0.835,0.618,-2.44,1.01,-0.26,-0.69,6.71E-02,8.65E-02,7.18E-01,7.26E-01,1.26E+06,1.32E+06,2.57E+06,5.66E+06,5,4,5,5,2.84E+06,1.71E+06,1.17E+05,1.26E+06,1.09E+05,6.33E+05,8.76E+05,1.98E+06,,4.14E+06,1.26E+07,2.57E+06,2.03E+06,2.21E+06,4.91E+06,1.60E+06,8.84E+06,5.66E+06,1.89E+06,1.78E+07,1.13E+04,6.51E+03,1.14E+03,1.26E+06,5.63E+03,2.25E+03,1.56E+04,1.83E+04,,4.40E+04,7.51E+04,1.15E+05,1.65E+04,2.97E+05,1.22E+05,3.12E+03,2.48E+06,4.01E+04,4.41E+04,1.90E+05,0,FALSE,47.165,23,10,654,70.4,5.21,10,other metabolic processes;transport,plasma membrane;other membranes;nucleus,"Pf00128, Pf16028",,A0A7P0Z4P5,ENSG00000168003,,"mRNA, protein, and metabolite inducation pathway by cyclosporin A; Ferroptosis; Proximal tubule transport; Pleural mesothelioma",4,0,95.42,83.84,91.85,92.98,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,n/a,High,High,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,90.23,114.6,87.76,117.05,149.83,,0,
Master Protein,High,Q9UBB9,TFIP11,Tuftelin-interacting protein 11 OS=Homo sapiens OX=9606 GN=TFIP11 PE=1 SV=1,1,1,0.184,1.096,0.01,100,-2.44,0.13,-6.64,6.64,1.10E-01,6.51E-01,1.00E-17,1.00E-17,7.21E+04,3.92E+05,9.07E+04,,3,5,2,,,,6.94E+04,9.87E+04,7.21E+04,8.32E+05,9.10E+04,1.13E+05,3.92E+05,1.57E+06,1.44E+05,,,5.73E+04,,,,,,,,,6.78E+02,9.87E+04,3.72E+03,2.96E+03,1.62E+03,1.04E+03,1.10E+04,1.67E+04,8.60E+02,,,7.72E+03,,,,,,,0.001,FALSE,3.391,1,1,837,96.8,5.67,1,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,extracellular matrix;nucleus;other cell component,"Pf01585, Pf07842, Pf12457",24144,hsa:24144; O95908; Q20WL0; Q5H8V8; Q9UBB9; Q9UGV7; Q9Y2Q8,ENSG00000100109,mRNA Splicing - Major Pathway,,1,0,20.23,103.23,60.88,,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,113.8,59.29,,,3.03,nucleic acid binding activity,0,
Master Protein,High,H3BSH7,UTP4,UTP4 small subunit processome component (Fragment) OS=Homo sapiens OX=9606 GN=UTP4 PE=1 SV=1,1,1,0.182,0.01,0.01,,-2.46,-6.64,-6.64,,1.06E-01,1.00E-17,1.00E-17,,8.10E+04,4.45E+05,,,1,1,,,,,,8.10E+04,,4.45E+05,,,,,,,,,,,,,,,,,,8.10E+04,,1.58E+03,,,,,,,,,,,,,,,0.002,FALSE,3.02,2,1,700,77.9,8.72,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,Pf00400,,H3BSH7,ENSG00000141076,,,0,0,,,,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,,,,2.78,,0,
Master Protein,High,P36222,CHI3L1,Chitinase-3-like protein 1 OS=Homo sapiens OX=9606 GN=CHI3L1 PE=1 SV=2,1,7,0.182,0.01,1.061,0.01,-2.46,-6.64,0.08,-6.64,4.31E-02,1.00E-17,9.55E-01,1.00E-17,7.31E+05,4.23E+06,,2.97E+06,2,4,,3,,1.00E+06,,,5.34E+05,2.36E+06,5.57E+06,5.42E+06,,3.30E+06,,,,,,2.94E+06,,7.21E+06,,2.97E+06,,3.80E+03,,,2.75E+04,8.38E+03,9.91E+04,5.00E+04,,3.51E+04,,,,,,5.74E+03,,5.11E+04,,3.17E+04,0,FALSE,4.979,3,1,383,42.6,8.46,1,other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;extracellular matrix;ER/Golgi;other cell component,Pf00704,1116,B2R7B0; hsa:1116; P30923; P36222; Q8IVA4; Q96HI7,ENSG00000133048,Neutrophil degranulation,Mammary gland development pathway - Involution (Stage 4 of 4),2,0,43.03,38.16,,56.07,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,High,High,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,1,,FALSE,44.12,,54.57,,17.64,extracellular structural activity;other molecular function,0,
Master Protein,High,Q9H410,DSN1,Kinetochore-associated protein DSN1 homolog OS=Homo sapiens OX=9606 GN=DSN1 PE=1 SV=2,3,5,0.182,1.067,0.584,0.578,-2.46,0.09,-0.78,-0.79,1.27E-01,5.60E-01,4.70E-01,7.29E-01,2.21E+05,4.35E+05,1.79E+05,4.76E+05,3,3,4,5,,3.22E+05,4.22E+04,2.21E+05,,,4.35E+05,2.63E+05,,7.11E+05,,6.08E+04,1.62E+05,1.98E+05,3.18E+05,3.94E+05,1.00E+04,2.24E+06,4.76E+05,6.45E+05,,1.22E+03,4.12E+02,2.21E+05,,,7.73E+03,2.42E+03,,7.56E+03,,2.72E+03,1.32E+03,2.67E+04,7.89E+03,7.67E+02,2.81E+03,1.59E+04,1.11E+04,6.86E+03,0,FALSE,13.79,14,3,356,40,7.05,3,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,non-structural extracellular;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf08202,79980,B4DWT2; E1P5U9; hsa:79980; Q5JW55; Q5JW56; Q9H410; Q9H8P4,ENSG00000149636,Neutrophil degranulation; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,7,0,72.57,48.15,57.4,114.65,n/a,Peak Found,Peak Found,High,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,68.86,112.22,134.77,133.58,18.17,,0,
Master Protein,High,P55347,PKNOX1,Homeobox protein PKNOX1 OS=Homo sapiens OX=9606 GN=PKNOX1 PE=1 SV=3,1,1,0.179,0.789,0.01,100,-2.48,-0.34,-6.64,6.64,1.32E-01,8.98E-01,1.00E-17,1.00E-17,1.57E+05,8.75E+05,1.24E+05,,2,1,2,,,,,1.72E+05,1.43E+05,,,,8.75E+05,,,,,2.33E+05,6.55E+04,,,,,,,,,1.72E+05,7.39E+03,,,,2.47E+04,,,,,3.14E+04,1.63E+03,,,,,,0.001,FALSE,3.124,4,1,436,47.6,4.91,1,RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,"Pf05920, Pf16493",5316,hsa:5316; O00528; P55347; Q8IWT7,ENSG00000160199,Activation of anterior HOX genes in hindbrain development during early embryogenesis,Sudden infant death syndrome (SIDS) susceptibility pathways,2,0,12.75,,79.38,,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,13.42,91.87,,,2.75,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q08380,LGALS3BP,Galectin-3-binding protein OS=Homo sapiens OX=9606 GN=LGALS3BP PE=1 SV=1,1,5,0.177,3.311,0.129,4.416,-2.5,1.73,-2.95,2.14,1.02E-01,1.89E-02,2.12E-02,1.34E-01,2.49E+05,1.41E+06,1.03E+06,1.82E+05,2,1,5,2,,8.17E+05,,7.57E+04,,,,,,1.41E+06,5.06E+05,4.73E+05,1.27E+06,1.03E+06,1.43E+06,,1.14E+05,,2.88E+05,,,3.10E+03,,7.57E+04,,,,,,1.49E+04,3.03E+03,2.11E+04,1.03E+04,1.39E+05,3.56E+04,,3.21E+04,,6.75E+03,,0.004,FALSE,2.627,3,1,585,65.3,5.27,1,cell adhesion;stress response;transport;signal transduction,non-structural extracellular;other membranes;other cell component,"Pf00530, Pf07707",3959,hsa:3959; Q08380; Q7M4S0; Q9UCH8; Q9UCH9; Q9UCI0,ENSG00000108679,Platelet degranulation,Network map of SARS-CoV-2 signaling pathway; 11p11.2 copy number variation syndrome,3,0,117.42,,46.44,61.12,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,High,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,220.85,126.88,71.05,58.73,12.61,other molecular function,0,
Master Protein,High,Q9P0J1,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PDP1 PE=1 SV=3",6,9,0.177,3.538,,3.787,-2.5,1.82,,1.92,1.05E-01,3.70E-02,,1.31E-01,3.81E+05,1.24E+06,4.79E+05,6.32E+04,2,1,4,3,,,,6.85E+05,2.12E+05,,,,,1.24E+06,7.78E+05,4.42E+05,1.56E+05,5.18E+05,,,6.32E+04,1.96E+05,4.12E+04,,,,,6.85E+05,1.10E+04,,,,,1.32E+04,4.65E+03,1.98E+04,1.27E+03,6.98E+04,,,1.78E+04,1.39E+03,9.64E+02,,0,FALSE,21.725,22,6,537,61,6.67,6,protein metabolism;other metabolic processes,mitochondrion;other cell component,Pf00481,54704,B3KX71; hsa:54704; J3KPU0; Q5U5K1; Q9P0J1,ENSG00000164951,Regulation of pyruvate dehydrogenase (PDH) complex,Orexin receptor pathway; Glucose metabolism in triple-negative breast cancer cells,3,0,74.48,,54.03,83.64,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,0,93.95,,117.1,30.28,enzyme regulator activity;other molecular function,0,
Master Protein,High,P61081,UBE2M,NEDD8-conjugating enzyme Ubc12 OS=Homo sapiens OX=9606 GN=UBE2M PE=1 SV=1,1,4,0.176,9.444,0.869,2.662,-2.51,3.24,-0.2,1.41,7.34E-02,5.49E-03,8.38E-01,3.33E-01,1.51E+04,8.60E+04,1.43E+05,7.47E+04,1,1,3,2,,,,,1.51E+04,8.60E+04,,,,,,1.43E+05,,4.83E+05,1.39E+05,1.05E+05,,5.29E+04,,,,,,,7.79E+02,3.06E+02,,,,,,6.37E+03,,6.50E+04,3.45E+03,2.06E+02,,3.75E+02,,,0.002,FALSE,2.967,3,1,183,20.9,7.69,1,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus,Pf00179,9040,hsa:9040; O76069; P61081; Q8VC50,ENSG00000130725,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation; Dectin-1 mediated noncanonical NF-kB signaling; NIK-->noncanonical NF-kB signaling; TGF-beta receptor signaling activates SMADs,,5,0,,,77.45,46.92,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,0,3.76,52.14,73.86,3.35,other molecular function,0,
Master Protein,High,Q14315,FLNC,Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,5,56,0.176,9.139,1.354,0.942,-2.51,3.19,0.44,-0.09,1.12E-01,6.54E-04,8.35E-01,8.79E-01,9.47E+04,5.39E+05,8.65E+05,9.19E+05,1,3,1,2,,,,9.47E+04,,1.81E+06,5.39E+05,,2.55E+05,,,8.65E+05,,,,6.79E+06,1.24E+05,,,,,,,9.47E+04,,6.42E+03,9.59E+03,,7.19E+03,,,3.86E+04,,,,1.32E+04,3.49E+04,,,,0,FALSE,12.916,2,1,2725,290.8,5.97,5,cell organization and biogenesis,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00307, Pf00630",2318,B2ZZ88; hsa:2318; O95303; Q07985; Q14315; Q9NS12; Q9NYE5; Q9UMR8; Q9Y503,ENSG00000128591,Cell-extracellular matrix interactions,Focal adhesion; MAPK signaling pathway; Ebola virus infection in host; NPHP1 deletion syndrome; 13q12.12 copy number variation,6,0,,95.27,,136.34,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,1,,FALSE,78.16,0,202.17,538.06,106,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q7LBC6,KDM3B,Lysine-specific demethylase 3B OS=Homo sapiens OX=9606 GN=KDM3B PE=1 SV=2,8,9,0.175,0.278,0.307,1.019,-2.52,-1.85,-1.71,0.03,1.14E-01,2.56E-01,2.50E-01,7.98E-01,4.19E+05,3.09E+05,5.79E+04,4.82E+04,3,4,5,3,4.19E+05,,,6.21E+05,3.34E+05,,1.75E+05,5.47E+05,1.12E+05,6.34E+05,3.00E+04,7.34E+03,2.34E+05,3.77E+05,5.79E+04,,1.10E+04,4.82E+04,1.81E+05,,1.66E+03,,,6.21E+05,1.72E+04,,3.11E+03,5.05E+03,3.16E+03,6.75E+03,1.80E+02,3.28E+02,1.90E+03,5.08E+04,1.44E+03,,3.09E+03,3.42E+02,4.23E+03,,0,FALSE,34.633,8,8,1761,191.5,7.18,8,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf02373,51780,A6H8X7; hsa:51780; Q7LBC6; Q9BVH6; Q9BW93; Q9BZ52; Q9NYF4; Q9UPS0,ENSG00000120733,HDMs demethylate histones,Thermogenesis,2,0,32.19,71.34,112.73,111.5,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,56.43,97.65,10.97,87.58,27.62,nucleic acid binding activity;other molecular function,0,
Master Protein,High,J3KNB4,CAMP,Cathelicidin antimicrobial peptide OS=Homo sapiens OX=9606 GN=CAMP PE=1 SV=1,7,158,0.174,0.119,0.522,0.052,-2.52,-3.07,-0.94,-4.27,3.82E-02,9.33E-03,3.36E-01,1.07E-02,1.63E+07,1.40E+08,3.70E+06,1.49E+08,5,5,5,5,1.63E+07,1.90E+08,4.11E+06,3.45E+05,7.03E+07,2.58E+08,3.43E+08,1.40E+08,2.74E+07,6.45E+07,2.22E+06,4.57E+05,1.87E+07,3.70E+06,4.11E+06,1.49E+08,1.70E+06,1.74E+08,3.34E+07,1.65E+08,6.46E+04,7.23E+05,4.01E+04,3.45E+05,3.63E+06,9.17E+05,6.10E+06,1.29E+06,7.72E+05,6.86E+05,1.33E+04,2.04E+04,1.52E+05,4.98E+05,1.02E+05,2.90E+05,4.76E+05,1.23E+06,7.82E+05,1.76E+06,0,FALSE,34.539,30,7,173,19.6,9.41,7,stress response,non-structural extracellular;other cell component,"Pf00666, Pf12153",820,hsa:820; J3KNB4,ENSG00000164047,,"Sterol regulatory element-binding proteins (SREBP) signaling; Vitamin D receptor pathway; Non-genomic actions of 1,25 dihydroxyvitamin D3",3,0,142.21,79.36,125.72,77.17,Peak Found,High,High,Peak Found,High,High,High,High,High,High,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,High,High,1,,FALSE,141.71,145.86,137.17,138.11,351.76,,0,
Master Protein,Medium,A0A8I5KXK0,PNKD,PNKD metallo-beta-lactamase domain containing OS=Homo sapiens OX=9606 GN=PNKD PE=1 SV=1,1,2,0.173,1.654,2.381,0.12,-2.53,0.73,1.25,-3.06,8.49E-02,3.61E-01,4.73E-01,6.74E-02,4.09E+04,2.37E+05,4.51E+04,5.64E+05,2,1,3,4,,,,1.62E+04,1.03E+05,2.37E+05,,,,,,3.25E+04,,1.41E+05,4.51E+04,4.62E+06,1.83E+04,,2.89E+05,1.10E+06,,,,1.62E+04,5.33E+03,8.43E+02,,,,,,1.45E+03,,1.90E+04,1.12E+03,9.01E+03,5.14E+03,,6.75E+03,1.18E+04,0.015,FALSE,2.116,2,1,424,47.3,9.31,1,other metabolic processes,other membranes;mitochondrion,"Pf00753, Pf15932, Pf16123",,A0A8I5KXK0,ENSG00000127838,,Mitochondrial complex IV assembly,1,0,103.11,,81.36,141,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,1,,FALSE,157.96,105.32,142.59,143.5,0,other molecular function,0,
Master Protein,High,Q7Z2T5,TRMT1L,TRMT1-like protein OS=Homo sapiens OX=9606 GN=TRMT1L PE=1 SV=2,1,2,0.171,2.435,0.015,26.979,-2.55,1.28,-6.02,4.75,1.10E-01,1.18E-01,6.25E-06,3.55E-03,1.16E+05,6.78E+05,2.83E+05,1.05E+04,2,1,1,1,,1.04E+05,,1.30E+05,,,,,,6.78E+05,,,,2.83E+05,,,1.05E+04,,,,,3.96E+02,,1.30E+05,,,,,,7.21E+03,,,,3.81E+04,,,2.95E+03,,,,0.001,FALSE,3.686,2,1,733,81.7,7.88,1,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf02005,81627,hsa:81627; Q5TEN0; Q6ZMX0; Q7Z2T5; Q8IWH5; Q8NC68; Q9BZQ1,ENSG00000121486,,,0,0,15.37,,,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,16.21,16.21,0,0,6.13,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y2S7,POLDIP2,Polymerase delta-interacting protein 2 OS=Homo sapiens OX=9606 GN=POLDIP2 PE=1 SV=1,1,2,0.171,8.686,2.545,1.056,-2.55,3.12,1.35,0.08,5.49E-02,7.01E-03,4.65E-01,8.32E-01,1.33E+04,5.14E+04,1.43E+05,1.30E+05,2,3,4,4,,,,7.69E+03,2.29E+04,,5.14E+04,3.93E+04,,2.25E+05,1.50E+05,,1.37E+05,7.45E+03,2.64E+05,1.29E+05,1.00E+05,7.72E+05,,1.31E+05,,,,7.69E+03,1.18E+03,,9.15E+02,3.63E+02,,2.39E+03,8.95E+02,,1.11E+03,1.00E+03,6.55E+03,2.51E+02,2.81E+04,5.47E+03,,1.40E+03,0.001,FALSE,3.64,4,1,368,42,8.63,1,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,cytoskeleton;mitochondrion;nucleus;other cell component,"Pf04379, Pf08755",26073,B2R846; hsa:26073; Q96JE4; Q9Y2S7,ENSG00000004142,,,0,0,70.28,98.73,75.15,115.32,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,96.22,137.2,48.63,122.17,4.08,nucleic acid binding activity,0,
Master Protein,Medium,P06737,PYGL,"Glycogen phosphorylase, liver form OS=Homo sapiens OX=9606 GN=PYGL PE=1 SV=4",1,1,0.171,0.01,0.21,0.01,-2.55,-6.64,-2.25,-6.64,1.21E-01,1.00E-17,6.67E-02,1.00E-17,1.67E+05,9.76E+05,,2.05E+05,1,2,,1,,1.67E+05,,,,1.01E+06,,9.45E+05,,,,,,,,,,2.05E+05,,,,6.34E+02,,,,3.58E+03,,8.72E+03,,,,,,,,,,1.46E+03,,,0.01,FALSE,2.269,2,1,847,97.1,7.17,1,other metabolic processes;other biological processes,non-structural extracellular;cytosol;other cell component,Pf00343,5836,A6NDQ4; B4DUB7; F5H816; hsa:5836; O60567; O60752; O60913; P06737; Q501V9; Q641R5; Q96G82,ENSG00000100504,Neutrophil degranulation; Glycogen breakdown (glycogenolysis),TNF-alpha signaling pathway; Glycogen synthesis and degradation; Disorders of galactose metabolism,5,0,,4.49,,,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,4.71,,4.71,,2.63,other molecular function,0,
Master Protein,High,O75746,SLC25A12,"Electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A12 PE=1 SV=2",3,4,0.168,0.628,0.01,100,-2.57,-0.67,-6.64,6.64,8.78E-02,9.42E-01,1.00E-17,1.00E-17,2.25E+05,1.54E+06,2.08E+05,,2,3,3,,,,3.86E+05,1.31E+05,,2.78E+06,,1.54E+06,,2.53E+05,,,2.08E+05,2.29E+05,5.97E+04,,,,,,,,3.77E+03,1.31E+05,,9.89E+03,,1.42E+04,,2.69E+03,,,1.69E+03,3.08E+04,1.48E+03,,,,,,0,FALSE,11.646,8,3,678,74.7,8.38,3,other metabolic processes;transport;other biological processes,other membranes;mitochondrion,Pf00153,8604,B3KR64; hsa:8604; O75746; Q96AM8,ENSG00000115840; ENSG00000292099,Gluconeogenesis; Mitochondrial protein import; Aspartate and asparagine metabolism,,3,0,69.67,82.94,55.71,,n/a,n/a,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,111.5,63.43,,,10.56,transporter activity;other molecular function,0,
Master Protein,High,K7EJB9,CALR,Calreticulin OS=Homo sapiens OX=9606 GN=CALR PE=1 SV=2,16,659,0.168,0.15,0.315,0.073,-2.57,-2.73,-1.67,-3.78,3.45E-02,4.87E-02,1.08E-01,4.89E-02,6.20E+05,5.07E+06,9.33E+04,1.25E+06,4,5,2,5,1.62E+05,2.37E+06,,1.59E+04,9.33E+06,1.16E+06,5.07E+06,6.35E+06,1.73E+06,1.18E+07,,,,1.77E+05,4.91E+04,1.25E+06,1.95E+04,8.72E+06,3.64E+05,3.39E+07,6.44E+02,9.02E+03,,1.59E+04,4.81E+05,4.11E+03,9.02E+04,5.86E+04,4.86E+04,1.26E+05,,,,2.39E+04,1.22E+03,2.45E+03,5.47E+03,6.18E+04,8.53E+03,3.60E+05,0,FALSE,147.159,56,1,349,40.5,4.41,16,protein metabolism;other metabolic processes,ER/Golgi,Pf00262,,K7EJB9,ENSG00000179218,,Complement system,1,0,147.26,82.02,80,163.18,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,139.89,148.42,141.27,145.53,2417.22,other molecular function,0,
Master Protein,High,Q8IWX8,CHERP,Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3,3,4,0.165,0.01,0.01,,-2.6,-6.64,-6.64,,9.51E-02,1.00E-17,1.00E-17,,8.34E+05,6.20E+05,,,1,2,,,,,,8.34E+05,,,,4.92E+05,,7.80E+05,,,,,,,,,,,,,,8.34E+05,,,,4.54E+03,,8.29E+03,,,,,,,,,,,0,FALSE,15.557,7,3,916,103.6,9.04,3,RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cell component,"Pf01585, Pf01805, Pf04818",10523,hsa:10523; O00302; Q4G0Y5; Q8IWX8; Q8WU30; Q99492,ENSG00000085872,mRNA Splicing - Major Pathway,,1,0,,31.99,,,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,34.43,,,,15.22,other molecular function,0,
Master Protein,High,P26572,MGAT1,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT1 PE=1 SV=2",1,5,0.164,1.392,0.442,0.516,-2.61,0.48,-1.18,-0.96,9.10E-02,4.27E-01,2.84E-01,6.71E-01,1.15E+05,7.03E+05,1.60E+05,3.11E+05,1,4,5,3,,,,,1.15E+05,7.79E+05,3.88E+05,6.46E+05,,7.66E+05,1.60E+05,8.11E+04,1.93E+05,1.78E+05,9.96E+04,1.61E+06,1.14E+05,,3.11E+05,,,,,,5.95E+03,2.77E+03,6.90E+03,5.96E+03,,8.15E+03,9.59E+02,3.62E+03,1.57E+03,2.40E+04,2.48E+03,3.14E+03,3.21E+04,,7.28E+03,,0.001,FALSE,4.252,3,1,445,50.8,9.16,1,protein metabolism;other metabolic processes;developmental processes;other biological processes,other membranes;ER/Golgi;other cell component,Pf03071,4245,A8K404; B3KRU8; D3DWR1; hsa:4245; P26572; Q6IBE3,ENSG00000131446,Maturation of spike protein; Maturation of spike protein; N-glycan trimming and elongation in the cis-Golgi,N-glycan biosynthesis; Cholesterol metabolism; Enterocyte cholesterol metabolism,6,0,,28.12,34.65,119.85,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,High,n/a,1,,FALSE,14.56,29.86,116.83,99.38,14.11,other molecular function,0,
Master Protein,High,P50570,DNM2,Dynamin-2 OS=Homo sapiens OX=9606 GN=DNM2 PE=1 SV=2,9,20,0.163,1.118,0.724,0.641,-2.62,0.16,-0.47,-0.64,9.23E-02,4.70E-01,5.99E-01,8.23E-01,7.40E+05,7.43E+05,4.94E+05,2.69E+05,4,2,5,4,3.71E+06,1.62E+05,3.38E+06,1.36E+05,,6.30E+05,,,,8.76E+05,1.57E+06,4.32E+05,1.01E+05,1.38E+06,4.94E+05,1.56E+05,1.25E+06,,1.58E+05,4.56E+05,1.47E+04,6.16E+02,3.30E+04,1.36E+05,,2.24E+03,,,,9.31E+03,9.39E+03,1.93E+04,8.17E+02,1.86E+05,1.23E+04,3.04E+02,3.52E+05,,3.71E+03,4.85E+03,0,FALSE,29.977,13,9,870,98,7.44,9,cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00169, Pf00350, Pf01031, Pf02212",1785,A8K1B6; E7EV30; E9PEQ4; hsa:1785; K7ESI9; P50570; Q5I0Y0; Q7Z5S3; Q9UPH4,ENSG00000079805,Clathrin-mediated endocytosis; Recycling pathway of L1; MHC class II antigen presentation; Lysosome Vesicle Biogenesis; NGF-stimulated transcription; Golgi Associated Vesicle Biogenesis; Toll Like Receptor 4 (TLR4) Cascade; NOSTRIN mediated eNOS trafficking; Retrograde neurotrophin signalling; Formation of annular gap junctions,Synaptic vesicle pathway; Fragile X syndrome; Intracellular trafficking proteins involved in CMT neuropathy,14,0,106.4,23.11,80.7,102.37,High,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,54.43,128.47,31.21,92.94,58.16,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q5SRE5,NUP188,Nucleoporin NUP188 OS=Homo sapiens OX=9606 GN=NUP188 PE=1 SV=1,2,4,0.163,1.567,1.56,0.365,-2.62,0.65,0.64,-1.45,1.10E-01,2.90E-01,6.42E-01,4.71E-01,1.78E+05,1.05E+06,5.60E+05,1.64E+06,3,2,4,2,,,4.18E+04,1.78E+05,3.31E+05,,7.35E+05,,,1.50E+06,,1.03E+06,6.80E+05,4.61E+05,3.68E+04,1.44E+07,1.87E+05,,,,,,4.08E+02,1.78E+05,1.71E+04,,1.31E+04,,,1.60E+04,,4.61E+04,5.53E+03,6.21E+04,9.13E+02,2.81E+04,5.24E+04,,,,0,FALSE,7.703,2,2,1749,195.9,6.73,2,transport,cytosol;nucleus,"Pf10487, Pf21093, Pf21094",23511,hsa:23511; Q14675; Q2TA87; Q5SRE5; Q7Z3K8; Q8IWF1,ENSG00000095319,Vpr-mediated nuclear import of PICs; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,,29,0,78.83,48.61,75.37,137.8,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,73.59,109.29,449.09,379.36,10.49,other molecular function,0,
Master Protein,High,Q96DX5,ASB9,Ankyrin repeat and SOCS box protein 9 OS=Homo sapiens OX=9606 GN=ASB9 PE=1 SV=1,1,2,0.162,1.701,0.424,0.65,-2.62,0.77,-1.24,-0.62,7.85E-02,3.50E-01,2.94E-01,8.67E-01,5.85E+04,3.61E+05,9.95E+04,1.53E+05,2,1,2,1,,,,2.07E+04,1.65E+05,3.61E+05,,,,,,3.77E+04,,2.63E+05,,,,,,1.53E+05,,,,2.07E+04,8.52E+03,1.28E+03,,,,,,1.68E+03,,3.54E+04,,,,,,1.63E+03,0.001,FALSE,3.859,6,1,294,31.8,6.98,1,protein metabolism;other metabolic processes;signal transduction;other biological processes,cytosol;mitochondrion,"Pf07525, Pf12796",140462,A8K8A5; hsa:140462; Q96DX5; Q9BVF5; Q9NWS5; Q9Y4T3,ENSG00000102048,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation,,2,0,109.86,,105.94,,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,182.92,69.27,0,167.67,6.91,,0,
Master Protein,High,P01889,HLA-B,"HLA class I histocompatibility antigen, B alpha chain OS=Homo sapiens OX=9606 GN=HLA-B PE=1 SV=3",10,127,0.159,1.439,0.01,100,-2.66,0.52,-6.64,6.64,1.01E-01,3.55E-01,1.00E-17,1.00E-17,1.96E+05,1.23E+06,3.17E+05,,3,1,4,,,1.96E+05,,6.10E+05,9.98E+04,,,,,1.23E+06,,1.36E+05,3.46E+05,8.53E+05,2.90E+05,,,,,,,7.44E+02,,6.10E+05,5.15E+03,,,,,1.31E+04,,6.08E+03,2.81E+03,1.15E+05,7.21E+03,,,,,,0,FALSE,58.701,36,1,362,40.4,5.85,10,stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00129, Pf06623, Pf07654",3106,A0A2I6Q7B5; B0V0B8; G3GN01; hsa:3106; O02862; O02956; O02957; O02960; O19555; O19556; O19595; O19615; O19624; O19625; O19627; O19641; O19651; O19675; O19692; O19758; O19779; O19783; O46702; O62897; O62901; O62915; O62917; O62919; O77933; O77959; O78053; O78138; O78160; O78163; O78172; O78173; O78180; O78217; O95730; O98140; P01889; P01890; P03989; P10317; P10318; P10319; P10320; P18463; P18464; P18465; P19373; P30460; P30461; P30462; P30463; P30464; P30465; P30466; P30467; P30468; P30469; P30470; P30471; P30472; P30473; P30474; P30475; P30476; P30477; P30478; P30479; P30480; P30481; P30482; P30483; P30484; P30485; P30486; P30487; P30488; P30489; P30490; P30491; P30492; P30493; P30494; P30495; P30496; P30497; P30498; P30513; P30685; P79489; P79490; P79496; P79504; P79523; P79524; P79542; P79555; Q04826; Q08136; Q29633; Q29636; Q29638; Q29661; Q29665; Q29678; Q29679; Q29681; Q29693; Q29695; Q29697; Q29718; Q29742; Q29749; Q29762; Q29764; Q29829; Q29836; Q29842; Q29845; Q29846; Q29847; Q29848; Q29850; Q29851; Q29852; Q29854; Q29855; Q29857; Q29858; Q29861; Q29924; Q29925; Q29933; Q29935; Q29936; Q29940; Q29953; Q29961; Q29982; Q30173; Q30198; Q31603; Q31610; Q31612; Q31613; Q546L8; Q546M4; Q5JP37; Q5QT24; Q5RIP1; Q5SRJ2; Q5TK76; Q5TK77; Q860I4; Q861B5; Q8HWF0; Q8MGQ3; Q8MHN4; Q8SNC5; Q95343; Q95344; Q95365; Q95369; Q95392; Q95HA3; Q95HA8; Q95HM9; Q95IA6; Q95IB8; Q95IH5; Q95J00; Q96IT9; Q9BCM6; Q9BCM7; Q9BCM8; Q9BD06; Q9BD38; Q9BD43; Q9GIL3; Q9GIM3; Q9GIX1; Q9GIY5; Q9GIZ0; Q9GIZ9; Q9GJ00; Q9GJ17; Q9GJ20; Q9GJ23; Q9GJ31; Q9GJF0; Q9GJM7; Q9MX21; Q9MY37; Q9MY42; Q9MY43; Q9MY61; Q9MY75; Q9MY78; Q9MY79; Q9MY84; Q9MY92; Q9MY93; Q9MY94; Q9MYB8; Q9MYC3; Q9MYC7; Q9MYF4; Q9MYG1; Q9TP35; Q9TP36; Q9TP37; Q9TP95; Q9TPQ7; Q9TPQ9; Q9TPR2; Q9TPR4; Q9TPS6; Q9TPT2; Q9TPT4; Q9TPT6; Q9TPV2; Q9TQG1; Q9TQH3; Q9TQH6; Q9TQH7; Q9TQH8; Q9TQH9; Q9TQM2; Q9TQN4; Q9TQN6; Q9UQS8; Q9UQT0,ENSG00000234745,"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; ER-Phagosome pathway; DAP12 interactions; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Neutrophil degranulation; Interferon gamma signaling; Interferon alpha/beta signaling; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Endosomal/Vacuolar pathway",Proteasome degradation; Allograft rejection; Ebola virus infection in host; TAR syndrome; Type II interferon signaling,14,0,89.8,,76.44,,n/a,High,n/a,High,Peak Found,n/a,n/a,n/a,High,High,n/a,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,100.65,94.53,,,335.27,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,A0A8V8TMV2,KPNA5,Importin subunit alpha OS=Homo sapiens OX=9606 GN=KPNA5 PE=1 SV=1,2,3,0.158,2.032,1.092,0.916,-2.66,1.02,0.13,-0.13,7.42E-02,2.50E-01,9.53E-01,8.84E-01,4.18E+04,1.41E+05,1.47E+05,1.54E+05,2,1,3,2,8.63E+04,,,2.02E+04,,1.41E+05,,,,,6.18E+05,1.47E+05,,1.83E+04,,3.21E+05,7.39E+04,,,,3.43E+02,,,2.02E+04,,5.02E+02,,,,,3.69E+03,6.55E+03,,2.47E+03,,6.26E+02,2.08E+04,,,,0,FALSE,7.269,5,2,559,63.1,5.76,2,transport,other cell component,"Pf00514, Pf01749, Pf16186",,A0A8V8TMV2,ENSG00000196911,,,0,0,87.69,,120.97,88.51,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,267.96,132.62,118.98,146.41,8.57,other molecular function,0,
Master Protein,High,Q9Y228,TRAF3IP3,TRAF3-interacting JNK-activating modulator OS=Homo sapiens OX=9606 GN=TRAF3IP3 PE=1 SV=2,4,10,0.157,1.974,0.454,1.939,-2.67,0.98,-1.14,0.95,5.80E-02,1.30E-01,3.80E-01,4.41E-01,3.84E+05,1.65E+06,8.76E+05,2.25E+05,3,2,4,3,7.63E+05,,,3.84E+05,8.64E+04,,4.95E+05,,,5.53E+06,,9.28E+05,8.27E+05,1.18E+06,6.69E+05,1.09E+06,2.25E+05,,2.21E+05,,3.03E+03,,,3.84E+05,4.46E+03,,8.81E+03,,,5.88E+04,,4.14E+04,6.71E+03,1.59E+05,1.66E+04,2.12E+03,6.31E+04,,5.18E+03,,0,FALSE,20.054,13,4,551,63.6,8.51,4,other biological processes,plasma membrane;other membranes;mitochondrion;ER/Golgi;other cytoplasmic organelle,,80342,A1L464; A6NIU9; hsa:80342; Q2YDB5; Q4VY06; Q7Z706; Q9Y228,ENSG00000009790,,,0,0,82.51,118.15,23.74,97.74,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,High,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,133.13,83.38,106.74,57.57,33.14,other molecular function,0,
Master Protein,High,Q9BVP2,GNL3,Guanine nucleotide-binding protein-like 3 OS=Homo sapiens OX=9606 GN=GNL3 PE=1 SV=2,3,3,0.157,1.349,0.01,100,-2.67,0.43,-6.64,6.64,7.64E-02,4.95E-01,1.00E-17,1.00E-17,7.33E+04,3.92E+05,1.09E+05,,4,3,3,,,8.12E+04,6.62E+04,2.49E+05,5.74E+04,1.30E+06,,3.92E+05,,2.84E+05,,,7.77E+04,1.31E+05,1.09E+05,,,,,,,3.09E+02,6.47E+02,2.49E+05,2.96E+03,4.62E+03,,3.62E+03,,3.02E+03,,,6.31E+02,1.76E+04,2.71E+03,,,,,,0,FALSE,11.031,6,3,549,62,9.16,3,other biological processes,nucleus;other cell component,"Pf01926, Pf08701",26354,B2RDC1; hsa:26354; Q5PU80; Q96SV6; Q96SV7; Q9BVP2; Q9UJY0,ENSG00000163938,Major pathway of rRNA processing in the nucleolus and cytosol,,1,0,80.04,84.68,25.22,,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,42.03,38,,,10.9,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P19823,ITIH2,Inter-alpha-trypsin inhibitor heavy chain H2 OS=Homo sapiens OX=9606 GN=ITIH2 PE=1 SV=2,4,9,0.157,0.561,0.06,1.464,-2.67,-0.83,-4.05,0.55,9.83E-02,8.01E-01,1.79E-03,5.59E-01,3.43E+05,1.01E+06,3.24E+05,2.57E+05,4,1,4,2,3.22E+05,,3.65E+04,1.92E+06,3.66E+05,,,,,1.01E+06,,2.33E+06,8.16E+04,5.86E+05,1.79E+05,,4.03E+05,,1.64E+05,,1.28E+03,,3.56E+02,1.92E+06,1.89E+04,,,,,1.08E+04,,1.04E+05,6.63E+02,7.89E+04,4.45E+03,,1.13E+05,,3.84E+03,,0,FALSE,11.569,6,4,946,106.4,6.86,4,other metabolic processes,non-structural extracellular;ER/Golgi,"Pf00092, Pf06668, Pf08487",3698,hsa:3698; P19823; Q14659; Q15484; Q5T986,ENSG00000151655,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,,2,0,128.9,,131.9,59.54,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,83.88,110.89,0,13.88,19.24,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q99808,SLC29A1,Equilibrative nucleoside transporter 1 OS=Homo sapiens OX=9606 GN=SLC29A1 PE=1 SV=3,5,15,0.156,0.198,1.305,0.019,-2.68,-2.33,0.38,-5.74,4.54E-02,1.26E-01,8.35E-01,3.62E-04,3.79E+05,2.24E+06,9.40E+04,3.79E+06,5,5,4,5,3.79E+05,1.81E+06,1.44E+05,9.93E+03,1.42E+06,5.95E+06,6.76E+05,1.97E+06,2.24E+06,2.63E+06,2.42E+05,,1.28E+05,3.62E+04,6.90E+04,3.79E+06,1.35E+06,6.70E+07,1.86E+05,4.55E+06,1.51E+03,6.88E+03,1.41E+03,9.93E+03,7.34E+04,2.12E+04,1.20E+04,1.82E+04,6.30E+04,2.80E+04,1.45E+03,,1.04E+03,4.87E+03,1.71E+03,7.40E+03,3.80E+05,4.75E+05,4.35E+03,4.84E+04,0,FALSE,12.72,13,5,456,50.2,8.29,5,cell-cell signaling;other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,Pf01733,2030,B3KQV7; B3KQY5; hsa:2030; Q5T9W9; Q99808; Q9UJY2,ENSG00000112759,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane; Azathioprine ADME; Ribavirin ADME,Fluoropyrimidine activity,4,0,107.63,72.89,76.29,188.05,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,1,,FALSE,124.89,132.21,127.46,131.01,31.76,transporter activity,0,
Master Protein,High,Q9UK45,LSM7,U6 snRNA-associated Sm-like protein LSm7 OS=Homo sapiens OX=9606 GN=LSM7 PE=1 SV=1,1,3,0.155,1.204,0.026,7.155,-2.69,0.27,-5.26,2.84,2.75E-02,3.41E-01,1.73E-06,5.93E-02,8.29E+05,5.35E+06,9.98E+05,1.39E+05,1,2,1,1,,,,8.29E+05,,2.73E+07,1.05E+06,,,,,,,9.98E+05,,,1.39E+05,,,,,,,8.29E+05,,9.70E+04,1.86E+04,,,,,,,1.34E+05,,,3.92E+04,,,,0,FALSE,5.225,24,1,103,11.6,5.27,1,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,Pf01423,51690,hsa:51690; Q9UK45,ENSG00000130332,mRNA Splicing - Major Pathway; mRNA decay by 5' to 3' exoribonuclease,mRNA processing,3,0,,130.97,,,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,364,0,364,0,11.61,nucleic acid binding activity,0,
Master Protein,Medium,P08962,CD63,CD63 antigen OS=Homo sapiens OX=9606 GN=CD63 PE=1 SV=2,1,10,0.155,0.04,0.752,0.017,-2.69,-4.65,-0.41,-5.87,3.68E-02,2.45E-04,6.21E-01,9.41E-04,7.16E+05,2.77E+06,2.86E+04,1.68E+06,4,5,1,5,,2.22E+06,3.29E+05,1.54E+04,1.56E+06,2.25E+05,1.10E+07,1.31E+07,5.38E+05,2.77E+06,,,,2.86E+04,,1.68E+06,2.87E+03,9.84E+06,2.52E+05,1.92E+07,,8.44E+03,3.22E+03,1.54E+04,8.03E+04,8.00E+02,1.96E+05,1.21E+05,1.52E+04,2.95E+04,,,,3.85E+03,,3.27E+03,8.05E+02,6.97E+04,5.90E+03,2.04E+05,0.017,FALSE,2.035,3,1,238,25.6,7.81,1,cell adhesion;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;nucleus;other cytoplasmic organelle;other cell component,Pf00335,967,F8VZE2; hsa:967; P08962; Q5TZP3; Q8N6Z9; Q9UCG6,ENSG00000135404,Platelet degranulation ; Neutrophil degranulation,Extracellular vesicles in the crosstalk of cardiac cells; 11p11.2 copy number variation syndrome,4,0,100.49,109.98,,134.15,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,141.51,159.6,145.13,148.01,18.84,,0,
Master Protein,High,Q14119,VEZF1,Vascular endothelial zinc finger 1 OS=Homo sapiens OX=9606 GN=VEZF1 PE=1 SV=2,2,5,0.154,0.542,0.01,100,-2.69,-0.88,-6.64,6.64,9.26E-02,7.70E-01,1.00E-17,1.00E-17,8.13E+05,3.02E+05,4.45E+05,,1,2,5,,,,,8.13E+05,,,3.96E+05,,2.31E+05,,2.46E+05,6.70E+05,3.40E+05,4.56E+05,4.45E+05,,,,,,,,,8.13E+05,,,7.05E+03,,6.50E+03,,1.47E+03,2.99E+04,2.76E+03,6.15E+04,1.11E+04,,,,,,0,FALSE,8.93,6,2,521,56.9,9.52,2,stress response;developmental processes;other biological processes,nucleus,"Pf00096, Pf13894",7716,hsa:7716; Q14119,ENSG00000136451,,,0,0,,37.33,36.71,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,40.58,32.82,,,15.05,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P28799,GRN,Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2,4,15,0.154,0.573,1.119,0.054,-2.7,-0.8,0.16,-4.22,4.55E-02,8.35E-01,9.71E-01,1.25E-02,6.66E+05,1.61E+06,5.40E+05,1.87E+06,3,5,1,5,,1.06E+06,,2.43E+05,6.66E+05,1.61E+06,1.15E+07,1.04E+07,3.21E+05,9.23E+05,,,,5.40E+05,,3.42E+06,1.54E+04,1.70E+06,1.87E+06,7.09E+06,,4.03E+03,,2.43E+05,3.44E+04,5.72E+03,2.04E+05,9.60E+04,9.03E+03,9.82E+03,,,,7.28E+04,,6.68E+03,4.33E+03,1.20E+04,4.38E+04,7.55E+04,0,FALSE,22.238,13,4,593,63.5,6.83,4,cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle,Pf00396,2896,D3DX55; hsa:2896; P23781; P23782; P23783; P23784; P28799; Q53HQ8; Q53Y88; Q540U8; Q9BWE7; Q9H8S1; Q9UCH0,ENSG00000030582,Neutrophil degranulation,IL-18 signaling pathway,2,0,62.27,111.29,,94.92,n/a,Peak Found,n/a,High,High,Peak Found,High,High,Peak Found,High,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,112.43,249.43,137.01,202.66,41.35,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9P107,GMIP,GEM-interacting protein OS=Homo sapiens OX=9606 GN=GMIP PE=1 SV=2,1,1,0.152,0.01,0.452,0.01,-2.72,-6.64,-1.15,-6.64,6.42E-02,1.00E-17,4.33E-01,1.00E-17,2.31E+04,1.52E+05,,6.86E+04,1,4,,2,,,,,2.31E+04,,2.46E+05,3.89E+05,2.89E+04,9.35E+04,,,,,,,,5.10E+04,,9.21E+04,,,,,1.19E+03,,4.38E+03,3.59E+03,8.13E+02,9.94E+02,,,,,,,,3.62E+02,,9.80E+02,0.004,FALSE,2.595,2,1,970,106.6,5.72,1,signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus,Pf00620,51291,A0AVN9; B7ZLZ0; hsa:51291; Q9P107,ENSG00000089639,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle,,3,0,,85.17,,40.55,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,106.24,,118.82,,2.46,enzyme regulator activity;other molecular function,0,
Master Protein,High,P28072,PSMB6,Proteasome subunit beta type-6 OS=Homo sapiens OX=9606 GN=PSMB6 PE=1 SV=4,4,8,0.151,0.01,,0.01,-2.73,-6.64,,-6.64,8.76E-02,1.00E-17,,1.00E-17,1.28E+05,8.51E+05,,9.21E+05,1,2,,3,,1.28E+05,,,,,,2.44E+05,,2.97E+06,,,,,,9.21E+05,6.35E+05,2.26E+06,,,,4.88E+02,,,,,,2.25E+03,,3.15E+04,,,,,,1.80E+03,1.78E+05,1.60E+04,,,0,FALSE,19.329,29,4,239,25.3,4.92,4,protein metabolism;other metabolic processes,cytosol;mitochondrion;nucleus;other cell component,Pf00227,5694,hsa:5694; P28072; Q96J55,ENSG00000142507,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,62,0,,119.9,,68.12,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,237.05,,,,21.86,other molecular function,0,
Master Protein,Medium,A0A3B3ISV4,VKORC1L1,vitamin-K-epoxide reductase (warfarin-sensitive) OS=Homo sapiens OX=9606 GN=VKORC1L1 PE=1 SV=1,1,2,0.15,0.904,0.218,0.62,-2.74,-0.15,-2.2,-0.69,4.14E-02,7.03E-01,5.06E-02,7.98E-01,2.89E+05,2.24E+06,2.66E+05,4.88E+05,3,2,4,2,,5.82E+05,,1.93E+05,2.89E+05,,1.20E+06,4.19E+06,,,,2.01E+05,3.47E+05,4.56E+05,2.04E+05,,,8.52E+05,2.80E+05,,,2.21E+03,,1.93E+05,1.49E+04,,2.13E+04,3.87E+04,,,,8.98E+03,2.82E+03,6.15E+04,5.06E+03,,,6.04E+03,6.55E+03,,0.029,FALSE,1.838,4,1,223,23.5,9.26,1,other metabolic processes,other membranes;ER/Golgi,Pf07884,,A0A3B3ISV4,ENSG00000196715,,,0,0,57.1,78.65,40.88,71.52,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,79.55,53.88,56.84,75.97,4.56,other molecular function,0,
Master Protein,High,Q96AG4,LRRC59,Leucine-rich repeat-containing protein 59 OS=Homo sapiens OX=9606 GN=LRRC59 PE=1 SV=1,3,13,0.149,0.367,0.973,0.346,-2.74,-1.44,-0.04,-1.53,3.64E-02,3.66E-01,8.80E-01,4.21E-01,9.72E+05,2.01E+06,9.17E+05,2.02E+06,5,5,4,5,1.93E+05,2.00E+06,9.41E+04,1.05E+06,9.72E+05,2.10E+06,1.70E+06,4.79E+06,6.30E+05,2.01E+06,,2.65E+04,6.44E+05,1.31E+06,1.66E+06,2.02E+06,6.31E+05,4.66E+06,4.53E+05,2.25E+07,7.67E+02,7.61E+03,9.20E+02,1.05E+06,5.02E+04,7.45E+03,3.02E+04,4.42E+04,1.77E+04,2.14E+04,,1.18E+03,5.23E+03,1.76E+05,4.13E+04,3.94E+03,1.77E+05,3.30E+04,1.06E+04,2.40E+05,0,FALSE,13.244,15,3,307,34.9,9.57,3,signal transduction,other membranes;mitochondrion;ER/Golgi;nucleus;other cell component,Pf13855,55379,B2RE83; D3DTX8; hsa:55379; Q96AG4; Q9P189,ENSG00000108829,,VEGFA-VEGFR2 signaling,1,0,89.57,68.44,79.62,154.48,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,102.36,118.42,137.37,134.75,40.67,,0,
Master Protein,High,P02671,FGA,Fibrinogen alpha chain OS=Homo sapiens OX=9606 GN=FGA PE=1 SV=2,28,766,0.149,0.651,0.185,0.509,-2.75,-0.62,-2.43,-0.98,2.44E-02,9.29E-01,2.24E-02,6.01E-01,2.94E+07,4.22E+08,2.26E+07,3.58E+07,5,5,5,5,2.88E+07,8.82E+07,3.14E+07,9.87E+06,2.94E+07,8.57E+07,5.57E+09,1.07E+08,7.87E+09,4.22E+08,1.90E+07,5.51E+06,5.45E+07,2.59E+07,2.26E+07,1.14E+08,2.09E+07,4.89E+07,6.80E+06,3.58E+07,1.15E+05,3.35E+05,3.06E+05,9.87E+06,1.51E+06,3.05E+05,9.90E+07,9.92E+05,2.22E+08,4.48E+06,1.14E+05,2.46E+05,4.43E+05,3.50E+06,5.62E+05,2.22E+05,5.86E+06,3.46E+05,1.59E+05,3.81E+05,0,FALSE,179.132,30,26,866,94.9,6.01,28,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component,"Pf00147, Pf08702, Pf12160",2243,A8K3E4; D3DP14; D3DP15; hsa:2243; P02671; Q4QQH7; Q9BX62; Q9UCH2,ENSG00000171560,Amyloid fiber formation; ER-Phagosome pathway; Integrin cell surface interactions; Platelet degranulation ; Signaling by BRAF and RAF1 fusions; MyD88:MAL(TIRAP) cascade initiated on plasma membrane; MyD88 deficiency (TLR2/4); IRAK4 deficiency (TLR2/4); Regulation of TLR by endogenous ligand; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Common Pathway of Fibrin Clot Formation; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins,"Selenium micronutrient network; Folate metabolism; Blood clotting cascade; Complement system; VEGFA-VEGFR2 signaling; Fibrin complement receptor 3 signaling pathway; COVID-19, thrombosis and anticoagulation; Network map of SARS-CoV-2 signaling pathway",29,2,78.94,130.28,70.44,91.63,Peak Found,High,High,High,High,Peak Found,High,High,High,High,Peak Found,Peak Found,High,High,High,High,High,Peak Found,Peak Found,Peak Found,1,,FALSE,142.91,136.83,142.77,135.07,1941.93,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,E9PDY4,CR1,Complement C3b/C4b receptor 1 (Knops blood group) OS=Homo sapiens OX=9606 GN=CR1 PE=1 SV=1,2,2,0.148,0.236,0.01,100,-2.76,-2.08,-6.64,6.64,3.52E-02,2.01E-01,1.00E-17,1.00E-17,3.60E+05,2.44E+06,8.51E+04,,1,1,4,,,,,,3.60E+05,,,,2.44E+06,,,4.61E+04,1.44E+05,5.02E+04,2.61E+05,,,,,,,,,,1.86E+04,,,,6.87E+04,,,2.06E+03,1.17E+03,6.77E+03,6.49E+03,,,,,,0,FALSE,4.393,3,2,2489,272.7,6.98,2,,other membranes,Pf00084,1378,E9PDY4,ENSG00000203710,,Primary focal segmental glomerulosclerosis (FSGS); Complement system; Dengue-2 interactions with complement and coagulation cascades; Complement system in neuronal development and plasticity; Extrafollicular and follicular B cell activation by SARS-CoV-2; Complement and coagulation cascades,6,0,,,80.69,,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,0,101.49,,,5.48,,0,
Master Protein,High,Q6NUQ1,RINT1,RAD50-interacting protein 1 OS=Homo sapiens OX=9606 GN=RINT1 PE=1 SV=1,1,1,0.146,0.663,0.499,0.308,-2.77,-0.59,-1,-1.7,6.01E-02,9.88E-01,4.61E-01,4.34E-01,3.68E+04,2.51E+05,2.44E+04,1.25E+05,1,1,2,4,,,,,3.68E+04,,,2.51E+05,,,,,4.20E+04,1.41E+04,,,1.16E+05,1.37E+05,1.87E+04,1.36E+05,,,,,1.90E+03,,,2.32E+03,,,,,3.41E+02,1.91E+03,,,3.25E+04,9.73E+02,4.37E+02,1.45E+03,0.001,FALSE,3.244,2,1,792,90.6,5.45,1,cell cycle OR cell proliferation;stress response;transport;signal transduction;other biological processes,other membranes;cytosol;ER/Golgi,Pf04437,60561,hsa:60561; Q6NUQ1; Q75MG9; Q75MH0; Q96IW8; Q9H229; Q9HAD9,ENSG00000135249,COPI-dependent Golgi-to-ER retrograde traffic,,1,0,,,70.16,55.28,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,0,84.7,12.53,108,2.46,,0,
Master Protein,Medium,Q14761,PTPRCAP,Protein tyrosine phosphatase receptor type C-associated protein OS=Homo sapiens OX=9606 GN=PTPRCAP PE=1 SV=1,1,3,0.143,2.513,0.103,2.505,-2.8,1.33,-3.28,1.32,4.64E-02,9.42E-02,1.08E-02,2.78E-01,1.07E+05,1.74E+06,4.50E+05,1.80E+05,3,2,2,2,,7.07E+05,1.07E+05,8.85E+04,,,,3.24E+05,,9.37E+06,,,,8.26E+05,2.45E+05,,5.78E+04,,,5.59E+05,,2.69E+03,1.05E+03,8.85E+04,,,,2.99E+03,,9.97E+04,,,,1.11E+05,6.09E+03,,1.62E+04,,,5.95E+03,0.018,FALSE,2.027,4,1,206,21.2,4.55,1,stress response,plasma membrane;other membranes,Pf15713,5790,B2R512; hsa:5790; O00643; Q14761; Q6I9S6,ENSG00000213402,,TNF-alpha signaling pathway,1,0,116.86,131.96,76.75,114.91,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,n/a,Peak Found,1,,FALSE,136.12,103.54,123.71,112.52,7.09,,0,
Master Protein,High,P59665,DEFA1; DEFA1B,Neutrophil defensin 1 OS=Homo sapiens OX=9606 GN=DEFA1 PE=1 SV=1,3,326,0.143,0.564,0.465,0.319,-2.8,-0.83,-1.1,-1.65,2.18E-02,7.63E-01,2.68E-01,3.49E-01,7.93E+07,5.31E+08,2.05E+07,1.05E+08,5,5,5,5,7.93E+07,1.12E+09,5.08E+06,1.78E+06,1.35E+08,2.17E+09,4.50E+08,1.95E+09,4.72E+08,5.31E+08,7.04E+06,4.10E+06,7.74E+07,5.12E+07,2.05E+07,9.16E+08,2.77E+07,1.05E+08,3.17E+08,8.25E+07,3.15E+05,4.25E+06,4.96E+04,1.78E+06,6.95E+06,7.72E+06,8.01E+06,1.80E+07,1.33E+07,5.64E+06,4.21E+04,1.83E+05,6.29E+05,6.90E+06,5.10E+05,1.79E+06,7.77E+06,7.44E+05,7.42E+06,8.78E+05,0,FALSE,10.757,20,3,94,10.2,6.99,3,stress response;signal transduction;other biological processes,non-structural extracellular;ER/Golgi;other cytoplasmic organelle,"Pf00323, Pf00879",1667; 728358,hsa:1667; hsa:728358; P11479; P59665; Q14125; Q6EZF6,ENSG00000206047; ENSG00000240247; ENSG00000284983; ENSG00000285176,Neutrophil degranulation; Alpha-defensins,,3,0,178.71,77.78,98.2,126.72,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,144.91,139.92,134.1,127.54,798.47,other molecular function,0,
Master Protein,Medium,P33121,ACSL1,Long-chain-fatty-acid--CoA ligase 1 OS=Homo sapiens OX=9606 GN=ACSL1 PE=1 SV=1,1,1,0.141,0.126,0.156,0.115,-2.82,-2.99,-2.68,-3.12,6.89E-02,8.26E-02,3.75E-02,1.08E-01,7.62E+04,5.34E+05,9.59E+03,8.35E+04,4,4,1,4,3.97E+04,1.46E+05,,1.53E+04,4.54E+05,,6.91E+05,1.21E+06,2.39E+05,4.13E+05,,,,9.59E+03,,9.55E+04,,7.29E+04,7.98E+03,3.14E+06,1.58E+02,5.56E+02,,1.53E+04,2.34E+04,,1.23E+04,1.12E+04,6.74E+03,4.40E+03,,,,1.29E+03,,1.86E+02,,5.17E+02,1.87E+02,3.34E+04,0.017,FALSE,2.029,1,1,698,77.9,7.15,1,other metabolic processes;transport;signal transduction;other biological processes,other membranes;mitochondrion;ER/Golgi;other cytoplasmic organelle,Pf00501,2180,B7Z452; D3DP57; hsa:2180; P33121; P41215; Q8N8V7; Q8TA99,ENSG00000151726,PPARA activates gene expression; Synthesis of very long-chain fatty acyl-CoAs; alpha-linolenic acid (ALA) metabolism; Linoleic acid (LA) metabolism,Fatty acid beta-oxidation; Fatty acid biosynthesis; Mitochondrial long chain fatty acid beta-oxidation; PPAR signaling pathway; Ferroptosis; Thermogenesis; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-3 / omega-6 fatty acid synthesis; Omega-9 fatty acid synthesis; Fatty acid transporters; Mitochondrial fatty acid oxidation disorders; Fatty acids and lipoproteins transport in hepatocytes; Cholesterol biosynthesis pathway in hepatocytes,17,0,123.05,66.54,,185.85,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,122.73,127.51,144.18,77.74,1.94,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q5QPL9,RALY,RALY heterogeneous nuclear ribonucleoprotein (Fragment) OS=Homo sapiens OX=9606 GN=RALY PE=1 SV=1,10,51,0.141,0.332,0.01,100,-2.83,-1.59,-6.64,6.64,4.53E-02,5.01E-01,1.00E-17,1.00E-17,1.07E+04,1.10E+05,4.57E+03,,3,3,3,,,,1.07E+04,2.51E+04,8.96E+03,1.10E+05,1.78E+05,,,3.50E+04,,8.34E+03,,2.82E+03,4.57E+03,,,,,,,,1.05E+02,2.51E+04,4.62E+02,3.91E+02,3.17E+03,,,3.72E+02,,3.72E+02,,3.80E+02,1.13E+02,,,,,,0,FALSE,29.135,38,1,237,24.7,10.49,10,,,Pf00076,,Q5QPL9,ENSG00000125970,,,0,0,59.32,66.53,53.79,,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,80.2,51.73,,,112.83,nucleic acid binding activity,0,
Master Protein,High,O15498,YKT6,Synaptobrevin homolog YKT6 OS=Homo sapiens OX=9606 GN=YKT6 PE=1 SV=1,1,4,0.139,0.715,0.177,0.291,-2.85,-0.48,-2.5,-1.78,6.70E-02,9.67E-01,4.12E-02,4.11E-01,9.26E+04,6.67E+05,3.43E+04,1.18E+05,3,1,4,1,,,1.17E+05,9.26E+04,1.10E+04,6.67E+05,,,,,,3.69E+04,3.11E+04,1.50E+05,3.18E+04,,1.18E+05,,,,,,1.15E+03,9.26E+04,5.65E+02,2.37E+03,,,,,,1.65E+03,2.53E+02,2.03E+04,7.90E+02,,3.31E+04,,,,0,FALSE,5.767,7,1,198,22.4,6.92,1,cell organization and biogenesis;transport,plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00957, Pf13774",10652,B4DR94; hsa:10652; O15498; Q53F01; Q6FGU9; Q6IB15,ENSG00000106636,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; COPI-mediated anterograde transport; RAC3 GTPase cycle; Intra-Golgi traffic; COPII-mediated vesicle transport,,8,0,75.59,,93.73,,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,31.19,129.07,0,13.38,14.73,other molecular function,0,
Master Protein,High,Q02952,AKAP12,A-kinase anchor protein 12 OS=Homo sapiens OX=9606 GN=AKAP12 PE=1 SV=4,11,17,0.139,0.58,0.462,0.744,-2.85,-0.79,-1.11,-0.43,3.57E-02,8.85E-01,4.04E-01,9.58E-01,9.48E+05,1.27E+06,3.61E+05,8.77E+05,3,2,3,3,7.90E+04,,,1.78E+06,9.48E+05,,,,4.08E+05,3.93E+06,,2.66E+04,,2.09E+06,3.61E+05,,3.90E+05,1.56E+06,8.77E+05,,3.14E+02,,,1.78E+06,4.89E+04,,,,1.15E+04,4.17E+04,,1.19E+03,,2.82E+05,8.97E+03,,1.10E+05,1.10E+04,2.05E+04,,0,FALSE,56.141,12,11,1782,191.4,4.41,11,signal transduction;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf03832, Pf10522",9590,hsa:9590; O00310; O00498; Q02952; Q4LE68; Q5SZ80; Q5TGN1; Q68D82; Q99970,ENSG00000131016,RHOD GTPase cycle; RHOF GTPase cycle,G protein signaling pathways,3,0,90.9,114.8,134.09,62.3,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,High,High,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,206.09,125.13,137.52,82.24,56.01,other molecular function,0,
Master Protein,High,P24158,PRTN3,Myeloblastin OS=Homo sapiens OX=9606 GN=PRTN3 PE=1 SV=3,5,83,0.139,0.941,1.167,0.126,-2.85,-0.09,0.22,-2.98,1.98E-02,6.49E-01,9.48E-01,7.86E-02,2.77E+06,4.65E+07,8.32E+06,1.63E+08,5,5,5,5,2.43E+07,2.41E+08,1.13E+06,1.46E+06,2.77E+06,4.65E+07,5.41E+08,1.61E+08,7.37E+06,2.02E+07,4.11E+05,1.22E+06,1.17E+07,8.32E+06,1.04E+07,3.78E+08,2.47E+07,1.63E+08,1.16E+08,4.62E+08,9.64E+04,9.16E+05,1.10E+04,1.46E+06,1.43E+05,1.65E+05,9.62E+06,1.48E+06,2.08E+05,2.15E+05,2.46E+03,5.45E+04,9.50E+04,1.12E+06,2.58E+05,7.37E+05,6.93E+06,1.16E+06,2.72E+06,4.92E+06,0,FALSE,30.789,31,5,256,27.8,8.35,5,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component,Pf00089,5657,hsa:5657; P15637; P18078; P24158; Q4VB08; Q4VB09; Q6LBM7; Q6LBN2; Q9UD25; Q9UQD8,ENSG00000196415; ENSG00000277804,Neutrophil degranulation; Antimicrobial peptides; Common Pathway of Fibrin Clot Formation; Other interleukin signaling,,4,0,193.85,144.42,81.97,80.41,High,High,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,High,High,High,High,High,High,1,,FALSE,144.46,143.03,141.97,136.58,214.54,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P07099,EPHX1,Epoxide hydrolase 1 OS=Homo sapiens OX=9606 GN=EPHX1 PE=1 SV=1,1,1,0.138,0.179,0.014,1.824,-2.86,-2.48,-6.21,0.87,3.92E-02,1.05E-01,3.81E-06,5.03E-01,2.46E+05,1.78E+06,4.40E+04,2.41E+04,1,1,2,2,2.46E+05,,,,,,,,,1.78E+06,,,5.13E+04,,3.78E+04,,1.10E+04,,5.31E+04,,9.79E+02,,,,,,,,,1.90E+04,,,4.17E+02,,9.39E+02,,3.08E+03,,1.24E+03,,0.001,FALSE,3.202,4,1,455,52.9,7.25,1,other metabolic processes;other biological processes,other membranes;ER/Golgi,Pf00561,2052,B2R8N0; hsa:2052; P07099; Q5VTJ6; Q9NP75; Q9NPE7; Q9NQU6; Q9NQU7; Q9NQU8; Q9NQU9; Q9NQV0; Q9NQV1; Q9NQV2,ENSG00000143819,Phase I - Functionalization of compounds,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Benzene metabolism; Benzo(a)pyrene metabolism; Aflatoxin B1 metabolism; Metapathway biotransformation Phase I and II,6,0,,,21.4,93.03,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,0,22.69,129.48,111.17,3.05,other molecular function,0,
Master Protein,Medium,Q6N022,TENM4,Teneurin-4 OS=Homo sapiens OX=9606 GN=TENM4 PE=1 SV=2,1,1,0.137,0.908,0.01,100,-2.87,-0.14,-6.64,6.64,5.69E-02,7.30E-01,1.00E-17,1.00E-17,2.91E+04,2.13E+05,2.65E+04,,1,1,2,,,,,2.91E+04,,,,,2.13E+05,,,,5.08E+04,,1.38E+04,,,,,,,,,2.91E+04,,,,,5.99E+03,,,,4.13E+02,,3.43E+02,,,,,,0.019,FALSE,2.009,1,1,2769,307.8,6.55,1,cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf05593, Pf06484, Pf07974, Pf15636",26011,A6ND26; hsa:26011; Q6N022; Q7Z3C7; Q96MS6; Q9P2P4; Q9Y4S2,ENSG00000149256,,,0,0,,,81.09,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,103.77,,,2.48,other molecular function,0,
Master Protein,High,Q96A72,MAGOHB,Protein mago nashi homolog 2 OS=Homo sapiens OX=9606 GN=MAGOHB PE=1 SV=1,7,18,0.136,0.55,0.207,0.359,-2.88,-0.86,-2.27,-1.48,1.75E-02,7.80E-01,7.76E-02,4.65E-01,2.27E+06,1.60E+06,5.09E+05,4.32E+05,5,4,4,4,8.33E+04,2.27E+06,7.23E+04,2.44E+06,6.74E+06,,1.50E+06,2.25E+06,5.22E+05,1.70E+06,,6.18E+05,4.59E+04,9.61E+05,4.19E+05,4.40E+05,7.48E+04,,4.24E+05,9.07E+06,3.31E+02,8.61E+03,7.07E+02,2.44E+06,3.48E+05,,2.67E+04,2.07E+04,1.47E+04,1.81E+04,,2.76E+04,3.73E+02,1.30E+05,1.04E+04,8.58E+02,2.10E+04,,9.92E+03,9.65E+04,0,FALSE,22.229,47,7,148,17.3,6.39,7,RNA metabolism OR transcription;other metabolic processes;transport;other biological processes,cytosol;nucleus;other cell component,Pf02792,55110,hsa:55110; Q96A72,ENSG00000111196,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),,6,0,117.24,48.23,74.85,175.12,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,145.99,117.26,137.19,126.01,53.46,,0,
Master Protein,High,P43155,CRAT,Carnitine O-acetyltransferase OS=Homo sapiens OX=9606 GN=CRAT PE=1 SV=5,2,2,0.136,1.623,0.264,3.383,-2.88,0.7,-1.92,1.76,1.75E-02,2.36E-01,5.84E-02,1.96E-01,6.27E+05,3.78E+06,3.93E+05,3.40E+05,3,4,3,2,,,4.18E+05,6.62E+05,6.27E+05,2.48E+06,1.73E+09,7.63E+05,5.74E+06,,,3.93E+05,,4.56E+05,2.02E+05,,1.16E+05,9.96E+05,,,,,4.08E+03,6.62E+05,3.24E+04,8.83E+03,3.08E+07,7.04E+03,1.62E+05,,,1.76E+04,,6.15E+04,5.02E+03,,3.26E+04,7.06E+03,,,0,FALSE,4.895,5,2,626,70.8,8.44,2,other metabolic processes,other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle,Pf00755,1384,P43155; Q5T952; Q9BW16,ENSG00000095321,Peroxisomal protein import; Beta-oxidation of pristanoyl-CoA,Fatty acid beta-oxidation,3,0,23.25,198.62,37.73,111.88,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,1,,FALSE,117.8,23.76,97.75,23.76,5.35,other molecular function,0,
Master Protein,High,Q13155,AIMP2,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 OS=Homo sapiens OX=9606 GN=AIMP2 PE=1 SV=2,2,5,0.135,1.224,,,-2.89,0.29,,,5.04E-02,5.18E-01,,,2.54E+04,1.88E+05,3.65E+04,9.86E+05,3,1,4,1,8.50E+04,,2.00E+04,2.54E+04,,,,,,1.88E+05,4.78E+04,2.72E+04,,2.79E+04,6.40E+04,,9.86E+05,,,,3.38E+02,,1.95E+02,2.54E+04,,,,,,2.00E+03,2.86E+02,1.21E+03,,3.76E+03,1.59E+03,,2.77E+05,,,,0,FALSE,12.137,10,2,320,35.3,8.22,2,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00043, Pf16780, Pf18569",7965,F8W950; hsa:7965; Q13155; Q75MR1; Q96CZ5; Q9P1L2,ENSG00000106305,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,Osteoclast signaling; Transcriptional activation by NRF2 in response to phytochemicals; NRF2-ARE regulation,5,0,83.04,,42.28,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,High,n/a,High,n/a,1,,FALSE,40.47,79.98,,,16.1,other molecular function,0,
Master Protein,High,P11678,EPX,Eosinophil peroxidase OS=Homo sapiens OX=9606 GN=EPX PE=1 SV=2,14,374,0.135,0.155,0.757,0.028,-2.89,-2.69,-0.4,-5.16,1.82E-02,2.74E-02,6.27E-01,1.97E-03,3.82E+06,9.62E+07,1.50E+06,4.84E+07,5,5,5,5,3.82E+06,5.24E+08,1.28E+06,3.52E+05,6.73E+07,9.62E+07,2.61E+08,2.25E+08,1.63E+07,3.76E+07,6.26E+06,3.98E+05,2.84E+06,1.50E+06,7.04E+05,2.06E+08,4.82E+05,5.83E+08,7.30E+06,4.84E+07,1.52E+04,1.99E+06,1.25E+04,3.52E+05,3.47E+06,3.42E+05,4.64E+06,2.07E+06,4.59E+05,4.00E+05,3.74E+04,1.78E+04,2.31E+04,2.03E+05,1.75E+04,4.02E+05,1.35E+05,4.13E+06,1.71E+05,5.15E+05,0,FALSE,59.505,21,10,715,81,10.29,14,other metabolic processes;stress response;other biological processes,non-structural extracellular;other cell component,Pf03098,8288,hsa:8288; P11678; Q4TVP3,ENSG00000121053,Neutrophil degranulation,,1,0,190.99,86.73,101.89,145.47,Peak Found,High,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,1,,FALSE,147.46,143.78,140.83,145.96,914.12,other molecular function,0,
Master Protein,High,A0A024R0K5,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=1,1,1,0.133,2.145,2.591,0.11,-2.91,1.1,1.37,-3.18,5.33E-02,1.47E-01,2.79E-01,4.95E-02,2.09E+05,1.57E+06,4.48E+05,4.06E+06,1,1,3,1,,,,,2.09E+05,1.57E+06,,,,,,,5.00E+05,4.48E+05,4.45E+05,,,,4.06E+06,,,,,,1.08E+04,5.57E+03,,,,,,,4.06E+03,6.04E+04,1.11E+04,,,,9.51E+04,,0.004,FALSE,2.671,1,1,702,76.7,5.69,1,,plasma membrane;other membranes,"Pf07686, Pf13895, Pf13927",1048,A0A024R0K5; hsa:1048,ENSG00000105388,,,0,0,,,6.65,,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,High,n/a,1,,FALSE,0,1.24,0,1.25,2.36,,0,
Master Protein,High,F8WF69,CLTA,Clathrin light chain OS=Homo sapiens OX=9606 GN=CLTA PE=1 SV=1,3,4,0.133,1.617,1.618,0.07,-2.91,0.69,0.69,-3.83,3.23E-02,2.86E-01,6.29E-01,2.28E-02,3.20E+05,1.82E+06,6.30E+04,2.46E+07,3,4,5,5,3.20E+05,,,1.70E+05,4.76E+07,2.20E+07,8.51E+04,2.49E+06,,1.33E+06,6.30E+04,7.77E+03,6.41E+05,4.68E+05,3.11E+04,2.46E+07,1.42E+06,3.94E+07,1.89E+06,6.53E+07,1.27E+03,,,1.70E+05,2.46E+06,7.82E+04,1.51E+03,2.30E+04,,1.42E+04,3.77E+02,3.47E+02,5.20E+03,6.31E+04,7.74E+02,4.79E+04,3.98E+05,2.79E+05,4.42E+04,6.95E+05,0,FALSE,6.689,8,3,260,27.8,4.91,3,transport,plasma membrane;other membranes;ER/Golgi,Pf01086,,F8WF69,ENSG00000122705,,Synaptic vesicle pathway; Ebola virus infection in host; Fragile X syndrome,3,0,170.56,160.49,120.64,101.75,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,1,,FALSE,139.72,124.12,142.22,138.44,9.24,other molecular function,0,
Master Protein,High,P09661,SNRPA1,U2 small nuclear ribonucleoprotein A' OS=Homo sapiens OX=9606 GN=SNRPA1 PE=1 SV=2,5,9,0.133,0.601,0.026,1.055,-2.92,-0.73,-5.28,0.08,5.54E-02,8.68E-01,3.45E-05,8.33E-01,5.02E+05,1.17E+06,1.79E+05,5.43E+05,4,4,5,4,1.07E+05,1.04E+06,,8.98E+05,2.81E+05,6.36E+05,1.06E+06,1.68E+06,1.30E+06,,4.47E+05,1.57E+05,1.79E+05,5.51E+05,1.48E+05,,3.03E+04,8.38E+05,3.51E+05,3.10E+06,4.26E+02,3.97E+03,,8.98E+05,1.45E+04,2.26E+03,1.88E+04,1.55E+04,3.67E+04,,2.67E+03,7.00E+03,1.45E+03,7.42E+04,3.68E+03,,8.50E+03,5.94E+03,8.22E+03,3.30E+04,0,FALSE,18.759,33,5,255,28.4,8.62,5,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus,Pf14580,6627,B2R5I6; hsa:6627; P09661; Q8TBD2,ENSG00000131876,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; mRNA Splicing - Major Pathway,mRNA processing,3,0,78.62,37.58,63.75,128.37,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,1,,FALSE,103.43,122.59,40.46,149.68,26.02,nucleic acid binding activity,0,
Master Protein,High,Q7KZ85,SUPT6H,Transcription elongation factor SPT6 OS=Homo sapiens OX=9606 GN=SUPT6H PE=1 SV=2,12,18,0.13,1.369,,1.124,-2.95,0.45,,0.17,5.14E-02,3.26E-01,,7.72E-01,2.26E+05,1.44E+06,8.90E+05,1.28E+05,4,1,5,4,,2.24E+05,1.77E+05,9.79E+05,2.27E+05,,1.44E+06,,,,4.98E+05,4.43E+04,1.33E+06,8.90E+05,2.28E+06,,5.31E+04,1.60E+05,5.48E+06,1.03E+05,,8.51E+02,1.73E+03,9.79E+05,1.17E+04,,2.56E+04,,,,2.98E+03,1.98E+03,1.08E+04,1.20E+05,5.65E+04,,1.49E+04,1.13E+03,1.28E+05,1.10E+03,0,FALSE,62.885,12,12,1726,198.9,4.91,12,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes,nucleus,"Pf00575, Pf14632, Pf14633, Pf14635, Pf14639, Pf14641, Pf17674",6830,A7E2B4; hsa:6830; Q15737; Q6GMQ4; Q7KYW9; Q7KZ85; Q7LDK4; Q8N526; Q92775; Q96AH3; Q9BTH9; Q9BTI2,ENSG00000109111,Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,,3,0,95.9,,84.67,185.48,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,7.51,107.04,,105.55,61.43,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A669KBF1,PRX,Periaxin OS=Homo sapiens OX=9606 GN=PRX PE=1 SV=1,4,6,0.129,1.848,0.839,0.177,-2.95,0.89,-0.25,-2.5,5.74E-02,2.79E-01,7.10E-01,2.27E-01,1.03E+05,6.76E+05,1.22E+05,1.29E+05,3,3,4,4,,2.01E+05,,1.03E+05,5.62E+04,9.83E+05,2.96E+05,,,6.76E+05,,3.15E+05,2.24E+05,1.62E+03,6.64E+04,,3.75E+04,3.06E+06,1.72E+04,4.43E+05,,7.65E+02,,1.03E+05,2.90E+03,3.49E+03,5.27E+03,,,7.19E+03,,1.41E+04,1.82E+03,2.19E+02,1.65E+03,,1.05E+04,2.17E+04,4.03E+02,4.72E+03,0,FALSE,14.813,7,4,1556,164.7,8.03,4,,,,,A0A669KBF1,ENSG00000105227,,,0,0,61.49,52.77,94.48,164.19,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,85.52,126.95,110.51,117,18.34,,0,
Master Protein,High,P13984,GTF2F2,General transcription factor IIF subunit 2 OS=Homo sapiens OX=9606 GN=GTF2F2 PE=1 SV=2,4,7,0.128,2.038,0.695,1.999,-2.97,1.03,-0.52,1,4.67E-02,2.11E-01,5.62E-01,4.03E-01,1.34E+05,2.70E+05,1.41E+05,6.78E+05,4,4,4,3,8.02E+04,,2.23E+05,8.90E+05,3.93E+04,4.44E+05,1.64E+05,,1.24E+05,6.30E+05,4.03E+04,,1.73E+05,2.81E+05,1.14E+05,7.15E+05,,6.78E+05,5.85E+04,,3.19E+02,,2.18E+03,8.90E+05,2.03E+03,1.58E+03,2.91E+03,,3.48E+03,6.70E+03,2.41E+02,,1.41E+03,3.79E+04,2.83E+03,1.40E+03,,4.80E+03,1.37E+03,,0,FALSE,30.225,24,4,249,28.4,9.23,4,RNA metabolism OR transcription;other metabolic processes;other biological processes,cytoskeleton;nucleus,"Pf02270, Pf17683",2963,A6NNS5; hsa:2963; P13984; Q5W0H3,ENSG00000188342,Viral Messenger RNA Synthesis; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; Estrogen-dependent gene expression; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM,Eukaryotic transcription initiation,33,0,128.46,70.52,66.82,76.24,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,1,,FALSE,109.58,84.78,135.4,37.48,24.29,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P00747,PLG,Plasminogen OS=Homo sapiens OX=9606 GN=PLG PE=1 SV=2,23,361,0.127,0.189,0.07,0.391,-2.98,-2.4,-3.84,-1.35,1.52E-02,4.60E-02,4.19E-04,4.49E-01,7.27E+05,2.48E+07,1.20E+06,8.41E+06,5,5,5,5,6.08E+05,2.26E+07,4.68E+05,7.27E+05,6.12E+06,1.11E+07,6.70E+08,2.48E+07,5.74E+08,1.61E+07,2.36E+06,3.89E+05,1.69E+06,1.20E+06,1.05E+06,8.41E+06,9.00E+05,9.92E+06,1.13E+06,9.18E+06,2.41E+03,8.59E+04,4.57E+03,7.27E+05,3.16E+05,3.96E+04,1.19E+07,2.29E+05,1.62E+07,1.72E+05,1.41E+04,1.74E+04,1.37E+04,1.62E+05,2.62E+04,1.64E+04,2.53E+05,7.03E+04,2.65E+04,9.77E+04,0,FALSE,147.325,35,19,810,90.5,7.24,23,cell-cell signaling;cell organization and biogenesis;protein metabolism;stress response;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf00024, Pf00051, Pf00089",5340,hsa:5340; P00747; Q15146; Q5TEH4; Q6PA00,ENSG00000122194,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Signaling by PDGF; Platelet degranulation ; Activation of Matrix Metalloproteinases; Dissolution of Fibrin Clot,Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; Blood clotting cascade; Complement system; Dengue-2 interactions with complement and coagulation cascades; Fibrin complement receptor 3 signaling pathway; Complement and coagulation cascades,14,3,156.07,128.45,55.01,76.14,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,139.18,123.87,141.63,119.78,1121.72,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q8N4V1,MMGT1,ER membrane protein complex subunit 5 OS=Homo sapiens OX=9606 GN=MMGT1 PE=1 SV=1,1,1,0.126,0.863,0.01,100,-2.99,-0.21,-6.64,6.64,2.61E-02,7.70E-01,1.00E-17,1.00E-17,3.71E+05,2.94E+06,3.20E+05,,1,1,1,,,,,,3.71E+05,,,,,2.94E+06,,3.20E+05,,,,,,,,,,,,,1.91E+04,,,,,3.13E+04,,1.43E+04,,,,,,,,,0.001,FALSE,3.592,18,1,131,14.7,9.16,1,cell organization and biogenesis;transport,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle,Pf10270,93380,B2R625; B4DIY3; D3DWG7; hsa:93380; Q5JPP7; Q8N4V1,ENSG00000169446,Miscellaneous transport and binding events,,1,0,,,,,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,0,,,4.07,transporter activity,0,
Master Protein,High,Q709C8,VPS13C,Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,4,6,0.125,0.897,0.01,100,-3,-0.16,-6.64,6.64,1.43E-02,6.89E-01,1.00E-17,1.00E-17,1.07E+06,8.92E+06,1.19E+05,,5,3,4,,6.93E+06,1.07E+06,1.24E+06,1.98E+05,1.87E+04,8.92E+06,,1.31E+06,1.12E+07,,1.61E+06,2.56E+04,4.52E+04,3.11E+05,,,,,,,2.75E+04,4.08E+03,1.21E+04,1.98E+05,9.64E+02,3.17E+04,,1.20E+04,3.15E+05,,9.62E+03,1.14E+03,3.67E+02,4.19E+04,,,,,,,0,FALSE,16.431,2,4,3753,422.1,6.83,4,cell organization and biogenesis;transport;other biological processes,other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf06650, Pf09333, Pf12624, Pf16908, Pf16909, Pf16910, Pf21679",54832,hsa:54832; Q6ISR4; Q702P2; Q702P3; Q709C8; Q709C9; Q9NXN8; Q9P2C6,ENSG00000129003,,,0,0,151.48,72.51,151.13,,High,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,124.26,126.19,,,17.06,,0,
Master Protein,High,O00391,QSOX1,Sulfhydryl oxidase 1 OS=Homo sapiens OX=9606 GN=QSOX1 PE=1 SV=3,3,6,0.123,0.496,0.349,0.435,-3.02,-1.01,-1.52,-1.2,1.12E-02,7.05E-01,1.41E-01,5.95E-01,8.68E+05,3.57E+06,6.06E+05,1.26E+06,3,2,4,5,1.37E+06,,,5.95E+05,8.68E+05,,3.92E+06,,,3.26E+06,,1.88E+05,2.30E+06,3.57E+05,1.03E+06,1.26E+06,1.23E+05,2.27E+06,2.07E+06,8.12E+05,5.43E+03,,,5.95E+05,4.48E+04,,6.97E+04,,,3.47E+04,,8.41E+03,1.87E+04,4.81E+04,2.55E+04,2.46E+03,3.47E+04,1.61E+04,4.84E+04,8.65E+03,0,FALSE,16.475,5,3,747,82.5,8.92,3,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;other membranes;ER/Golgi;other cell component,"Pf00085, Pf04777, Pf18108, Pf18371",5768,hsa:5768; O00391; Q59G29; Q5T2X0; Q8TDL6; Q8WVP4,ENSG00000116260,Neutrophil degranulation; Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,,4,0,41.42,13.01,99.07,67.91,Peak Found,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,0,61.35,62.69,120.91,16.86,other molecular function,0,
Master Protein,High,A0A7I2YQE1,KPNA2,Importin subunit alpha OS=Homo sapiens OX=9606 GN=KPNA2 PE=1 SV=1,2,2,0.123,1.524,0.133,,-3.03,0.61,-2.91,,5.73E-02,3.16E-01,1.73E-02,,2.57E+05,8.53E+05,2.32E+05,1.14E+05,1,1,1,1,,,,2.57E+05,,8.53E+05,,,,,,2.32E+05,,,,,,,1.14E+05,,,,,2.57E+05,,3.03E+03,,,,,,1.04E+04,,,,,,,2.66E+03,,0,FALSE,7.177,8,2,529,57.8,5.67,2,transport,cytosol;nucleus,"Pf00514, Pf01749, Pf16186",,A0A7I2YQE1,ENSG00000182481,,,0,0,,,,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,0,0,,7.45,other molecular function,0,
Master Protein,Medium,Q8TE82,SH3TC1,SH3 domain and tetratricopeptide repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=SH3TC1 PE=1 SV=3,1,1,0.122,1.562,0.01,100,-3.03,0.64,-6.64,6.64,4.00E-02,3.67E-01,1.00E-17,1.00E-17,2.26E+04,1.85E+05,3.53E+04,,1,3,2,,,,,2.26E+04,,1.24E+05,1.85E+05,,7.74E+05,,4.77E+04,,,2.61E+04,,,,,,,,,,2.26E+04,,4.40E+02,3.29E+03,,2.18E+04,,2.85E+02,,,3.52E+03,,,,,,,0.021,FALSE,1.961,1,1,1336,146.9,6.25,1,,,Pf00018,54436,hsa:54436; Q4W5G5; Q8TE82,ENSG00000125089,,,0,0,,99.49,41.24,,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,49.06,45.2,,,1.81,,0,
Master Protein,High,Q15024,EXOSC7,Exosome complex component RRP42 OS=Homo sapiens OX=9606 GN=EXOSC7 PE=1 SV=3,2,3,0.122,2.61,0.819,0.331,-3.03,1.38,-0.29,-1.59,4.93E-02,1.22E-01,7.06E-01,3.87E-01,5.30E+04,5.36E+05,2.08E+05,4.39E+05,2,2,4,2,,,,6.54E+04,4.30E+04,1.32E+06,,2.17E+05,,,3.85E+05,,1.12E+05,6.34E+05,6.94E+04,,,3.77E+05,,5.10E+05,,,,6.54E+04,2.22E+03,4.69E+03,,2.01E+03,,,2.30E+03,,9.11E+02,8.54E+04,1.72E+03,,,2.67E+03,,5.43E+03,0,FALSE,7.594,10,2,291,31.8,5.19,2,RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf01138, Pf03725",23016,hsa:23016; Q15024; Q96E72,ENSG00000075914,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",Ciliary landscape,7,0,29.26,101.43,87.56,21.17,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,152.61,56.57,131.24,22.45,9.83,nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A1W2PRX1,HLA-C,"HLA class I histocompatibility antigen, C alpha chain OS=Homo sapiens OX=9606 GN=HLA-C PE=1 SV=1",8,105,0.121,0.58,0.912,0.094,-3.04,-0.79,-0.13,-3.41,1.32E-02,8.51E-01,8.03E-01,3.47E-02,8.00E+05,6.77E+06,2.09E+05,4.03E+06,3,3,4,2,1.13E+06,,4.17E+05,8.00E+05,,8.21E+06,,6.77E+06,3.04E+06,,,1.16E+05,7.10E+05,3.77E+05,4.82E+04,2.19E+06,,7.45E+06,,,4.49E+03,,4.08E+03,8.00E+05,,2.92E+04,,6.24E+04,8.58E+04,,,5.20E+03,5.77E+03,5.08E+04,1.20E+03,4.26E+03,,5.28E+04,,,0,FALSE,36.504,48,3,244,26.9,5.47,8,other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf00129, Pf06623, Pf07654",,A0A1W2PRX1,ENSG00000228299,,,0,0,45.64,44.39,96,77.24,Peak Found,n/a,Peak Found,High,n/a,High,n/a,High,High,n/a,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,1,,FALSE,66.96,88.59,110.33,98.8,315.09,,0,
Master Protein,High,Q9Y276,BCS1L,Mitochondrial chaperone BCS1 OS=Homo sapiens OX=9606 GN=BCS1L PE=1 SV=1,1,2,0.12,1.099,0.01,100,-3.06,0.14,-6.64,6.64,2.84E-02,5.45E-01,1.00E-17,1.00E-17,2.07E+05,1.72E+06,2.27E+05,,2,2,2,,,,,9.99E+04,4.29E+05,3.51E+06,,,8.45E+05,,,,,2.15E+05,2.41E+05,,,,,,,,,9.99E+04,2.21E+04,1.25E+04,,,2.38E+04,,,,,2.89E+04,5.99E+03,,,,,,0,FALSE,4.783,5,1,419,47.5,8.5,1,cell organization and biogenesis,other membranes;mitochondrion,"Pf00004, Pf08740",617,B3KTW9; hsa:617; Q7Z2V7; Q9Y276,ENSG00000074582,Mitochondrial protein import,Mitochondrial complex III assembly; Mitochondrial immune response to SARS-CoV-2; Iron metabolism disorders; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction; 4p16.3 copy number variation,6,0,88.01,86.48,8.13,,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,57.87,111.28,,,7.51,other molecular function,0,
Master Protein,High,P52907,CAPZA1,F-actin-capping protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=CAPZA1 PE=1 SV=3,5,20,0.118,0.441,0.15,1.32,-3.08,-1.18,-2.74,0.4,1.13E-02,5.59E-01,1.10E-02,6.67E-01,1.61E+06,2.58E+06,4.24E+05,3.57E+05,3,3,4,2,,,2.41E+06,1.61E+06,6.76E+05,2.58E+06,6.37E+06,7.45E+05,,,6.34E+05,9.19E+05,,1.31E+05,2.83E+05,,,8.86E+05,1.44E+05,,,,2.36E+04,1.61E+06,3.49E+04,9.17E+03,1.13E+05,6.87E+03,,,3.79E+03,4.11E+04,,1.76E+04,7.03E+03,,,6.28E+03,3.37E+03,,0,FALSE,26.731,31,4,286,32.9,5.69,5,cell organization and biogenesis,non-structural extracellular;cytosol;cytoskeleton;other cell component,Pf01267,829,hsa:829; P52907; Q53FQ6; Q6FHD5,ENSG00000116489,Sensory processing of sound by inner hair cells of the cochlea; MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Factors involved in megakaryocyte development and platelet production; Advanced glycosylation endproduct receptor signaling,,8,0,55.56,88.74,72.09,101.9,n/a,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,High,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,105.43,83.07,106.53,0,66.63,cytoskeletal activity,0,
Master Protein,High,Q7Z4W1,DCXR,L-xylulose reductase OS=Homo sapiens OX=9606 GN=DCXR PE=1 SV=2,3,4,0.116,1.579,0.382,1.578,-3.11,0.66,-1.39,0.66,4.60E-02,2.28E-01,2.21E-01,5.51E-01,2.63E+05,3.70E+05,9.54E+05,3.85E+05,3,3,4,3,2.63E+05,9.40E+05,,4.29E+04,,9.01E+05,1.22E+05,3.70E+05,,,,5.91E+05,9.83E+05,1.01E+06,9.25E+05,,3.85E+05,,2.05E+05,5.86E+05,1.04E+03,3.57E+03,,4.29E+04,,3.20E+03,2.17E+03,3.42E+03,,,,2.64E+04,7.98E+03,1.36E+05,2.30E+04,,1.08E+05,,4.81E+03,6.24E+03,0,FALSE,7.396,12,3,244,25.9,8.1,3,other metabolic processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf13561,51181,hsa:51181; Q7Z4W1; Q9BTZ3; Q9UHY9,ENSG00000169738,Formation of xylulose-5-phosphate; Essential pentosuria,,2,0,112.62,85.71,22.08,48.59,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,Acetyl [N-Term],FALSE,99.38,95.2,88.94,83.21,8.52,other molecular function,0,
Master Protein,High,P02675,FGB,Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2,24,800,0.116,0.844,0.238,0.541,-3.11,-0.24,-2.07,-0.89,1.14E-02,7.69E-01,4.98E-02,6.39E-01,1.60E+07,4.76E+07,1.06E+07,3.53E+07,5,5,5,5,1.60E+07,4.14E+07,1.10E+07,1.47E+06,2.08E+07,1.77E+07,4.71E+09,4.76E+07,5.27E+09,3.91E+07,7.87E+06,1.61E+06,4.19E+07,1.06E+07,1.52E+07,1.10E+08,1.80E+07,3.59E+07,5.69E+06,3.53E+07,6.37E+04,1.57E+05,1.08E+05,1.47E+06,1.07E+06,6.30E+04,8.38E+07,4.39E+05,1.48E+08,4.16E+05,4.71E+04,7.20E+04,3.41E+05,1.43E+06,3.78E+05,2.15E+05,5.05E+06,2.54E+05,1.33E+05,3.76E+05,0,FALSE,203.537,54,20,491,55.9,8.27,24,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component,"Pf00147, Pf08702",2244,A0JLR9; B2R7G3; hsa:2244; P02675; Q32Q65; Q3KPF2,ENSG00000171564,ER-Phagosome pathway; Integrin cell surface interactions; Platelet degranulation ; Signaling by BRAF and RAF1 fusions; MyD88:MAL(TIRAP) cascade initiated on plasma membrane; MyD88 deficiency (TLR2/4); IRAK4 deficiency (TLR2/4); Regulation of TLR by endogenous ligand; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Common Pathway of Fibrin Clot Formation; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins,"Selenium micronutrient network; Folate metabolism; Blood clotting cascade; Complement system; VEGFA-VEGFR2 signaling; Dengue-2 interactions with complement and coagulation cascades; Fibrin complement receptor 3 signaling pathway; COVID-19, thrombosis and anticoagulation; Network map of SARS-CoV-2 signaling pathway; Complement and coagulation cascades",28,4,81.83,134.92,101.04,99.35,Peak Found,High,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,1,,FALSE,143.69,130.51,144.27,131.95,2467.7,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9UPU5,USP24,Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3,1,5,0.116,0.182,0.227,0.144,-3.11,-2.45,-2.14,-2.79,4.44E-02,1.76E-01,8.06E-02,1.66E-01,6.90E+04,5.96E+05,1.95E+04,1.35E+05,3,1,2,2,8.01E+05,,6.90E+04,4.91E+04,,5.96E+05,,,,,,,,3.57E+04,1.06E+04,,2.03E+05,,,9.02E+04,3.18E+03,,6.74E+02,4.91E+04,,2.12E+03,,,,,,,,4.82E+03,2.64E+02,,5.69E+04,,,9.60E+02,0.001,FALSE,3.183,1,1,2620,294.2,6.14,1,protein metabolism,cytosol;nucleus,Pf00443,23358,hsa:23358; Q6ZSY2; Q8N2Y4; Q9NXD1; Q9UPU5,ENSG00000162402,Ub-specific processing proteases,,1,0,139.87,,76.66,54.3,Peak Found,n/a,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,n/a,Peak Found,1,,FALSE,60.13,103.59,61.65,63.8,9.74,other molecular function,0,
Master Protein,High,A0A0A0MTH3,ILK,Integrin-linked protein kinase OS=Homo sapiens OX=9606 GN=ILK PE=1 SV=1,1,1,0.113,0.033,0.014,0.198,-3.14,-4.93,-6.11,-2.34,1.06E-02,6.71E-06,3.08E-08,1.75E-01,4.96E+06,4.37E+07,1.62E+05,6.31E+05,2,1,2,3,,6.15E+07,3.99E+05,,,,4.37E+07,,,,,,,9.79E+04,2.69E+05,8.53E+06,6.31E+05,,3.88E+05,,,2.34E+05,3.90E+03,,,,7.77E+05,,,,,,,1.32E+04,6.69E+03,1.66E+04,1.77E+05,,9.09E+03,,0.002,FALSE,2.903,2,1,483,54.6,7.97,1,,cytosol;cytoskeleton;other cell component,"Pf07714, Pf12796",,A0A0A0MTH3,ENSG00000166333,,Primary focal segmental glomerulosclerosis (FSGS); Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; PPAR signaling pathway; Endometrial cancer; Acute viral myocarditis; Genes controlling nephrogenesis; Development of ureteric collection system; 2q37 copy number variation syndrome,8,0,139.6,,66.01,145.51,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,913.99,551.09,92.76,92.76,2.65,kinase activity;other molecular function,0,
Master Protein,High,P40121,CAPG,Macrophage-capping protein OS=Homo sapiens OX=9606 GN=CAPG PE=1 SV=2,3,8,0.112,0.622,0.829,0.036,-3.16,-0.68,-0.27,-4.78,4.68E-02,9.05E-01,7.11E-01,4.21E-03,3.48E+05,7.73E+05,1.26E+05,8.24E+06,5,5,2,5,3.32E+05,4.18E+05,1.72E+05,3.48E+05,4.20E+06,6.12E+05,1.92E+06,2.64E+06,5.18E+04,7.73E+05,,,5.38E+05,2.94E+04,,1.54E+07,4.98E+04,4.79E+07,3.57E+05,8.24E+06,1.32E+03,1.59E+03,1.68E+03,3.48E+05,2.17E+05,2.18E+03,3.41E+04,2.44E+04,1.46E+03,8.22E+03,,,4.37E+03,3.96E+03,,3.01E+04,1.40E+04,3.40E+05,8.35E+03,8.77E+04,0,FALSE,11.155,10,3,348,38.5,6.19,3,cell organization and biogenesis;developmental processes;other biological processes,cytoskeleton;nucleus;other cell component,Pf00626,822,B8ZZS7; D6W5K8; hsa:822; P40121; Q53SA7,ENSG00000042493,,TYROBP causal network in microglia,1,0,158.95,87.89,126.78,137.39,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,1,,FALSE,142.33,106.48,129.46,106.61,22.42,cytoskeletal activity;other molecular function,0,
Master Protein,High,P05164,MPO,Myeloperoxidase OS=Homo sapiens OX=9606 GN=MPO PE=1 SV=1,41,1648,0.109,0.852,0.407,0.111,-3.19,-0.23,-1.3,-3.17,9.43E-03,7.58E-01,2.02E-01,6.14E-02,5.05E+07,2.38E+09,6.72E+07,1.46E+09,5,5,5,5,5.05E+07,1.86E+09,1.63E+07,7.20E+06,6.28E+08,2.18E+09,2.38E+09,3.23E+09,4.63E+08,2.91E+09,6.72E+07,2.68E+07,2.28E+08,4.42E+07,1.07E+08,1.56E+09,1.29E+08,1.56E+09,1.46E+09,8.14E+08,2.01E+05,7.06E+06,1.59E+05,7.20E+06,3.24E+07,7.74E+06,4.23E+07,2.98E+07,1.30E+07,3.09E+07,4.02E+05,1.20E+06,1.85E+06,5.96E+06,2.65E+06,3.04E+06,3.62E+07,1.10E+07,3.42E+07,8.67E+06,0,FALSE,278.86,58,32,745,83.8,8.97,41,cell organization and biogenesis;other metabolic processes;stress response;other biological processes,non-structural extracellular;nucleus;other cytoplasmic organelle;other cell component,Pf03098,4353,A1L4B8; hsa:4353; P05164; Q14862; Q4PJH5; Q9UCL7,ENSG00000005381,Neutrophil degranulation; Events associated with phagocytolytic activity of PMN cells,Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; Benzene metabolism; Acute myeloid leukemia; Affected pathways in Duchenne muscular dystrophy,8,10,155.58,48.09,85.02,56.84,High,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,143.78,140.18,125.21,134.27,4379.48,other molecular function,0,
Master Protein,High,A0A669KBG8,GBF1,Golgi brefeldin A resistant guanine nucleotide exchange factor 1 OS=Homo sapiens OX=9606 GN=GBF1 PE=1 SV=1,2,3,0.108,0.188,0.104,0.196,-3.21,-2.41,-3.27,-2.35,2.96E-02,1.87E-01,2.23E-02,2.62E-01,8.74E+04,3.90E+05,7.91E+03,4.05E+04,2,1,1,1,,,,1.80E+04,4.25E+05,,,,3.90E+05,,,,,7.91E+03,,,4.05E+04,,,,,,,1.80E+04,2.19E+04,,,,1.10E+04,,,,,1.07E+03,,,1.14E+04,,,,0,FALSE,6.023,1,2,1892,210,5.78,2,transport;other biological processes,ER/Golgi,"Pf01369, Pf12783",,A0A669KBG8,ENSG00000107862,,,0,0,129.95,,,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,740.27,740.27,0,0,10.19,enzyme regulator activity,0,
Master Protein,High,O15427,SLC16A3,Monocarboxylate transporter 4 OS=Homo sapiens OX=9606 GN=SLC16A3 PE=1 SV=1,1,7,0.108,0.656,0.297,0.22,-3.21,-0.61,-1.75,-2.19,4.69E-02,9.31E-01,1.43E-01,2.92E-01,6.96E+04,9.97E+05,7.93E+04,2.96E+05,2,5,3,5,,,,3.34E+04,1.45E+05,1.48E+05,9.97E+05,1.82E+06,2.05E+06,2.27E+05,7.93E+04,,1.15E+05,1.08E+04,,4.71E+06,1.06E+04,2.41E+05,2.96E+05,5.21E+05,,,,3.34E+04,7.49E+03,5.28E+02,1.77E+04,1.68E+04,5.78E+04,2.41E+03,4.74E+02,,9.31E+02,1.46E+03,,9.18E+03,2.99E+03,1.71E+03,6.93E+03,5.55E+03,0,FALSE,6.543,3,1,465,49.4,7.96,1,protein metabolism;other metabolic processes;transport,plasma membrane;other membranes;nucleus;other cell component,,9123,B3KXG8; hsa:9123; O15427; Q2M1P8,ENSG00000141526,Pyruvate metabolism; Basigin interactions; Proton-coupled monocarboxylate transport,Metabolic reprogramming in colon cancer,4,0,88.58,83.77,77.33,172.57,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,1,,FALSE,100.34,113.62,131.24,143.89,12.68,transporter activity,0,
Master Protein,Medium,Q3YEC7,RABL6,Rab-like protein 6 OS=Homo sapiens OX=9606 GN=RABL6 PE=1 SV=2,1,1,0.108,0.894,0.418,0.5,-3.21,-0.16,-1.26,-1,2.23E-02,7.45E-01,4.05E-01,7.14E-01,3.19E+04,9.45E+04,2.85E+04,5.73E+04,2,3,2,3,1.82E+05,,,5.58E+03,,1.50E+06,,9.45E+04,,5.82E+04,,,7.29E+04,,1.11E+04,,1.33E+05,5.73E+04,2.43E+04,,7.24E+02,,,5.58E+03,,5.34E+03,,8.72E+02,,6.19E+02,,,5.92E+02,,2.77E+02,,3.74E+04,4.06E+02,5.70E+02,,0.011,FALSE,2.262,2,1,729,79.5,5.22,1,,cytosol;cytoskeleton;nucleus;other cell component,Pf08477,55684,A8QVZ7; A8QVZ8; C6K8I4; C6K8I5; hsa:55684; Q3YEC7; Q4F968; Q5T5R7; Q8IWK1; Q8TCL4; Q8WU94; Q96SR8; Q9BU21; Q9H935,ENSG00000196642,,,0,0,133.02,149.27,103.95,77.94,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,131.24,160.53,104.28,106.72,2.01,other molecular function,0,
Master Protein,High,Q9HB71,CACYBP,Calcyclin-binding protein OS=Homo sapiens OX=9606 GN=CACYBP PE=1 SV=2,1,3,0.105,4.763,0.387,1.287,-3.26,2.25,-1.37,0.36,2.59E-02,2.43E-02,2.52E-01,6.86E-01,4.60E+04,4.40E+05,2.19E+05,1.70E+05,1,2,4,2,,,,4.60E+04,,,,2.67E+05,,7.25E+05,1.41E+06,9.55E+04,2.44E+05,1.96E+05,,,2.14E+05,,1.35E+05,,,,,4.60E+04,,,,2.46E+03,,7.71E+03,8.45E+03,4.26E+03,1.98E+03,2.65E+04,,,6.02E+04,,3.16E+03,,0,FALSE,7.249,9,1,228,26.2,8.25,1,developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf04969, Pf05002, Pf09032",27101,B2ZWH2; B3KSF1; hsa:27101; O60666; Q5R370; Q5R371; Q9HB71,ENSG00000116161,,Gastric cancer network 2,1,0,,65.34,127.31,32.13,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,77.24,50.34,61.29,63.43,10.21,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9Y6X0,SETBP1,SET-binding protein OS=Homo sapiens OX=9606 GN=SETBP1 PE=1 SV=3,1,19,0.104,4.765,0.108,5.907,-3.26,2.25,-3.22,2.56,7.99E-03,4.38E-03,2.93E-03,9.85E-02,2.35E+08,2.26E+09,1.26E+09,1.58E+08,4,5,5,5,,1.58E+07,4.81E+09,2.80E+08,1.98E+08,3.78E+09,2.58E+08,3.81E+09,2.26E+09,5.84E+08,1.42E+09,2.42E+09,1.26E+09,8.22E+08,2.98E+08,4.32E+09,4.43E+05,5.30E+07,4.10E+08,1.58E+08,,6.00E+04,4.70E+07,2.80E+08,1.02E+07,1.34E+07,4.59E+06,3.51E+07,6.37E+07,6.21E+06,8.48E+06,1.08E+08,1.02E+07,1.11E+08,7.40E+06,8.42E+06,1.25E+05,3.76E+05,9.58E+06,1.68E+06,0.004,FALSE,2.653,1,1,1596,174.9,9.74,1,cell organization and biogenesis;other biological processes,cytosol;nucleus,,26040,A6H8W5; hsa:26040; Q6P6C3; Q9UEF3; Q9Y6X0,ENSG00000152217,,Histone modifications,1,0,175.37,79.1,63.4,189.18,High,High,Peak Found,High,Peak Found,Peak Found,High,High,High,High,High,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,1,Phospho [S838; S840],FALSE,136.1,135.85,139.91,140.95,49.09,nucleic acid binding activity;other molecular function,2,Phospho [S838; S840]
Master Protein,High,J3QSF7,MPO,Myeloperoxidase (Fragment) OS=Homo sapiens OX=9606 GN=MPO PE=1 SV=8,7,362,0.104,0.128,0.299,0.014,-3.27,-2.97,-1.74,-6.16,7.85E-03,2.61E-02,9.48E-02,2.06E-04,6.01E+05,1.70E+07,1.52E+05,5.75E+06,4,5,4,5,2.46E+05,1.47E+06,,4.98E+04,1.60E+07,2.29E+07,2.55E+07,1.70E+07,1.10E+06,1.66E+06,,8.07E+04,2.65E+05,1.03E+05,2.26E+05,5.75E+06,7.67E+04,1.06E+08,3.56E+05,6.42E+07,9.77E+02,5.58E+03,,4.98E+04,8.25E+05,8.13E+04,4.54E+05,1.56E+05,3.10E+04,1.76E+04,,3.60E+03,2.15E+03,1.38E+04,5.61E+03,1.12E+04,2.16E+04,7.53E+05,8.34E+03,6.83E+05,0,FALSE,36.582,70,1,86,9.8,9.72,7,stress response;other biological processes,,Pf03098,,J3QSF7,ENSG00000005381,,Acute myeloid leukemia; Affected pathways in Duchenne muscular dystrophy,2,0,174.06,85.17,53.75,135.82,Peak Found,Peak Found,n/a,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,1,,FALSE,143.3,143.45,146.21,146.99,849.06,other molecular function,0,
Master Protein,High,Q3MIX3,ADCK5,Uncharacterized aarF domain-containing protein kinase 5 OS=Homo sapiens OX=9606 GN=ADCK5 PE=1 SV=3,1,1,0.101,0.01,0.01,,-3.31,-6.64,-6.64,,2.63E-02,1.00E-17,1.00E-17,,2.42E+04,2.39E+05,,,1,1,,,,,,2.42E+04,,2.39E+05,,,,,,,,,,,,,,,,,,2.42E+04,,8.50E+02,,,,,,,,,,,,,,,0.001,FALSE,4.077,4,1,580,65.8,8.87,1,other metabolic processes,other membranes,Pf03109,203054,B3KS46; hsa:203054; Q3MIX3; Q5U4P1; Q6P2S4; Q8N5V3,ENSG00000173137; ENSG00000285451,,,0,0,,,,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,,,,3.08,kinase activity,0,
Master Protein,Medium,P11216,PYGB,"Glycogen phosphorylase, brain form OS=Homo sapiens OX=9606 GN=PYGB PE=1 SV=5",1,2,0.1,0.01,0.483,0.01,-3.32,-6.64,-1.05,-6.64,1.60E-02,1.00E-17,4.89E-01,1.00E-17,8.68E+03,8.64E+04,,4.17E+04,1,1,,1,,,,8.68E+03,,8.64E+04,,,,,,,,,,,4.17E+04,,,,,,,8.68E+03,,3.07E+02,,,,,,,,,,,1.17E+04,,,,0.023,FALSE,1.919,2,1,843,96.6,6.86,1,other metabolic processes,non-structural extracellular;other cytoplasmic organelle;other cell component,Pf00343,5834,hsa:5834; P11216; Q96AK1; Q9NPX8,ENSG00000100994,Neutrophil degranulation; Glycogen breakdown (glycogenolysis),IL-18 signaling pathway; Glycogen synthesis and degradation,4,0,,,,,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,0,,0,,2.5,other molecular function,0,
Master Protein,High,C9J6P4,ZC3HAV1,"Zinc finger CCCH-type containing, antiviral 1 OS=Homo sapiens OX=9606 GN=ZC3HAV1 PE=1 SV=1",3,5,0.099,0.541,0.381,0.634,-3.33,-0.89,-1.39,-0.66,3.89E-02,7.74E-01,2.97E-01,8.26E-01,3.15E+05,1.05E+06,1.52E+05,7.71E+05,2,4,3,4,,5.02E+05,,1.97E+05,,,6.67E+05,4.16E+06,1.01E+06,1.08E+06,,1.52E+05,2.77E+05,9.71E+04,,,6.33E+05,9.40E+05,4.58E+05,1.84E+06,,1.91E+03,,1.97E+05,,,1.19E+04,3.84E+04,2.85E+04,1.15E+04,,6.77E+03,2.25E+03,1.31E+04,,,1.78E+05,6.66E+03,1.07E+04,1.96E+04,0,FALSE,13.997,5,3,1024,114,8.56,3,,cytosol,"Pf00644, Pf02825, Pf18606, Pf18633",,C9J6P4,ENSG00000105939,,,0,0,61.68,94.31,52.6,63.61,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,0,73.4,89.75,67.08,16.35,other molecular function,0,
Master Protein,High,P41218,MNDA,Myeloid cell nuclear differentiation antigen OS=Homo sapiens OX=9606 GN=MNDA PE=1 SV=1,4,27,0.099,0.914,0.927,0.287,-3.34,-0.13,-0.11,-1.8,6.73E-03,5.65E-01,8.20E-01,3.19E-01,1.37E+06,1.86E+07,5.71E+05,2.73E+06,5,5,5,4,5.36E+05,6.40E+07,1.78E+06,1.49E+05,1.37E+06,2.30E+07,9.78E+06,4.09E+07,1.14E+07,1.86E+07,1.62E+06,4.45E+05,3.47E+06,5.71E+05,5.32E+05,3.87E+07,4.49E+05,,1.67E+07,3.90E+05,2.13E+03,2.43E+05,1.74E+04,1.49E+05,7.07E+04,8.19E+04,1.74E+05,3.77E+05,3.20E+05,1.98E+05,9.71E+03,1.99E+04,2.82E+04,7.69E+04,1.32E+04,7.54E+04,1.26E+05,,3.90E+05,4.15E+03,0,FALSE,11.051,10,4,407,45.8,9.76,4,stress response;signal transduction;other biological processes,non-structural extracellular;cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf02758, Pf02760",4332,P41218,ENSG00000163563,Neutrophil degranulation,,1,0,207.86,60.18,97.11,129.04,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,n/a,High,Peak Found,1,,FALSE,145.55,130.35,106.54,136.16,40.77,nucleic acid binding activity,0,
Master Protein,High,Q7Z2W9,MRPL21,"39S ribosomal protein L21, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL21 PE=1 SV=2",1,3,0.097,2.523,0.086,2.86,-3.36,1.34,-3.54,1.52,1.20E-02,1.10E-01,2.50E-03,2.47E-01,2.32E+05,2.39E+06,5.86E+05,2.05E+05,1,2,1,1,,,,2.32E+05,,,4.52E+06,,1.26E+06,,,,,5.86E+05,,,2.05E+05,,,,,,,2.32E+05,,,8.04E+04,,3.56E+04,,,,,7.90E+04,,,5.76E+04,,,,0,FALSE,4.265,9,1,205,22.8,9.89,1,protein metabolism;other metabolic processes,other membranes;mitochondrion;translational apparatus,Pf00829,219927,A6NKU0; C9JPR2; hsa:219927; Q7Z2W9,ENSG00000197345,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,79.72,,,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,High,High,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,101.18,0,101.18,0,9.51,other molecular function,0,
Master Protein,High,Q14157,UBAP2L,Ubiquitin-associated protein 2-like OS=Homo sapiens OX=9606 GN=UBAP2L PE=1 SV=2,3,12,0.095,0.862,,1.539,-3.39,-0.21,,0.62,3.47E-02,6.72E-01,,5.66E-01,9.13E+05,8.67E+04,5.89E+05,7.44E+05,4,1,5,2,9.09E+05,,1.00E+06,9.17E+05,7.37E+04,,,,8.67E+04,,7.44E+05,1.03E+06,1.64E+05,5.87E+05,5.89E+05,,1.32E+05,4.20E+06,,,3.61E+03,,9.79E+03,9.17E+05,3.80E+03,,,,2.44E+03,,4.45E+03,4.59E+04,1.33E+03,7.91E+04,1.46E+04,,3.70E+04,2.97E+04,,,0,FALSE,14.782,5,3,1087,114.5,7.11,3,cell organization and biogenesis;other biological processes,nucleus;other cell component,Pf12478,9898,B4E0U8; hsa:9898; Q14157; Q5VU75; Q5VU76; Q9BTU3; Q9UGL2; Q9UGL3; Q9UGL4; Q9UGL5,ENSG00000143569,,VEGFA-VEGFR2 signaling,1,0,60.17,,50.26,132.82,Peak Found,n/a,High,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,0,125.26,,139.45,31.97,,0,
Master Protein,Medium,Q8TCD5,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type OS=Homo sapiens OX=9606 GN=NT5C PE=1 SV=2",1,1,0.095,1.135,0.041,3.021,-3.4,0.18,-4.61,1.6,2.20E-02,6.17E-01,7.87E-04,2.71E-01,4.59E+04,4.86E+05,6.03E+04,2.00E+04,2,4,3,1,,,,6.36E+04,3.32E+04,1.17E+05,,8.93E+05,1.30E+06,2.64E+05,,2.51E+04,8.63E+04,,6.03E+04,,,,2.00E+04,,,,,6.36E+04,1.71E+03,4.17E+02,,8.24E+03,3.66E+04,2.81E+03,,1.12E+03,7.01E+02,,1.50E+03,,,,4.67E+02,,0.015,FALSE,2.109,6,1,201,23.4,6.64,1,other metabolic processes,cytosol;nucleus;other cell component,Pf06941,30833,hsa:30833; Q8TCD5; Q96HS6; Q9NP82,ENSG00000125458,Purine catabolism; Pyrimidine catabolism,Pyrimidine metabolism,3,0,44.44,85.71,53.67,,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,110.55,69.32,118.39,63.93,3.53,other molecular function,0,
Master Protein,High,E9PQ56,PUF60,Poly(U)-binding-splicing factor PUF60 OS=Homo sapiens OX=9606 GN=PUF60 PE=1 SV=9,6,10,0.093,0.549,1.863,0.753,-3.42,-0.87,0.9,-0.41,5.51E-03,7.73E-01,5.08E-01,9.83E-01,3.41E+05,9.61E+06,2.81E+05,1.05E+05,4,5,4,3,2.30E+05,2.96E+05,,2.93E+06,3.94E+05,2.11E+06,9.61E+06,3.34E+07,7.74E+06,1.17E+07,,1.56E+05,1.50E+05,7.94E+05,5.03E+05,,6.17E+03,1.05E+05,,8.11E+05,9.13E+02,1.12E+03,,2.93E+06,2.03E+04,7.50E+03,1.71E+05,3.08E+05,2.18E+05,1.24E+05,,6.99E+03,1.22E+03,1.07E+05,1.25E+04,,1.73E+03,7.46E+02,,8.63E+03,0,FALSE,33.478,17,6,541,58,5.35,6,RNA metabolism OR transcription;other metabolic processes;other biological processes,nucleus;other cell component,Pf00076,22827,E9PQ56,ENSG00000179950,,,0,0,136.5,92.88,77.22,142.71,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,138.93,105.51,77.02,134.76,34.8,nucleic acid binding activity,0,
Master Protein,High,Q8N5N7,MRPL50,"39S ribosomal protein L50, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL50 PE=1 SV=2",2,14,0.093,2.921,0.215,2.965,-3.43,1.55,-2.22,1.57,1.25E-02,3.89E-02,7.86E-02,2.60E-01,3.37E+05,1.76E+06,9.29E+05,4.84E+05,4,2,5,2,1.82E+05,,7.82E+05,6.26E+05,6.57E+04,,,1.10E+06,2.82E+06,,3.38E+05,6.84E+05,1.86E+06,9.29E+05,1.16E+06,,1.07E+06,,2.19E+05,,7.22E+02,,7.64E+03,6.26E+05,3.39E+03,,,1.02E+04,7.94E+04,,2.02E+03,3.06E+04,1.51E+04,1.25E+05,2.89E+04,,3.00E+05,,5.13E+03,,0,FALSE,19.009,22,2,158,18.3,7.88,2,protein metabolism;other metabolic processes,other membranes;cytosol;mitochondrion;translational apparatus,Pf10501,54534,B7Z358; hsa:54534; Q5T7E0; Q8N5N7; Q9NX15,ENSG00000136897,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,83.17,61.78,57.58,93.22,Peak Found,n/a,High,High,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,109.21,116.86,92.32,105.79,48.31,,0,
Master Protein,High,P00488,F13A1,Coagulation factor XIII A chain OS=Homo sapiens OX=9606 GN=F13A1 PE=1 SV=5,4,7,0.092,0.144,10.167,,-3.44,-2.8,3.35,,3.03E-02,4.48E-02,8.11E-03,,1.19E+05,1.28E+06,6.16E+05,7.79E+05,5,4,2,3,2.56E+07,1.19E+05,1.16E+07,3.25E+04,1.18E+05,,8.49E+05,1.98E+06,1.94E+06,7.66E+04,2.48E+06,,,1.53E+05,,7.79E+05,5.22E+04,,,1.11E+06,1.02E+05,4.51E+02,1.13E+05,3.25E+04,6.08E+03,,1.51E+04,1.83E+04,5.48E+04,8.15E+02,1.48E+04,,,2.07E+04,,1.52E+03,1.47E+04,,,1.18E+04,0,FALSE,13.947,7,3,732,83.2,6,4,protein metabolism;other metabolic processes;stress response,non-structural extracellular;other cell component,"Pf00868, Pf00927, Pf01841",2162,hsa:2162; P00488; Q59HA7; Q8N6X2; Q96P24; Q9BX29,ENSG00000124491,Platelet degranulation ; Interleukin-4 and Interleukin-13 signaling; Common Pathway of Fibrin Clot Formation,Complement system,4,0,150.57,76,124.93,83.6,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,1,,FALSE,78.22,145.86,62.85,,18.89,other molecular function,0,
Master Protein,High,Q8TDB6,DTX3L,E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1,4,5,0.092,0.921,0.095,0.543,-3.44,-0.12,-3.39,-0.88,4.41E-03,5.39E-01,2.51E-03,7.04E-01,1.73E+06,2.21E+06,2.53E+05,5.73E+05,3,2,4,3,1.83E+06,,1.73E+06,2.80E+05,,1.93E+07,2.53E+05,,,,9.35E+05,1.03E+05,,3.47E+05,1.84E+05,,6.45E+04,2.32E+06,5.73E+05,,7.27E+03,,1.69E+04,2.80E+05,,6.87E+04,4.51E+03,,,,5.59E+03,4.61E+03,,4.68E+04,4.58E+03,,1.81E+04,1.64E+04,1.34E+04,,0,FALSE,16.001,10,4,740,83.5,8.06,4,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf13923, Pf18102, Pf21717, Pf21718",151636,B3KWH6; Q53ZZ3; Q5MJP7; Q8TDB6,ENSG00000163840,Antigen processing: Ubiquitination & Proteasome degradation,Notch signaling,2,0,67.75,137.76,95.8,119.95,Peak Found,n/a,High,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,67.6,104.27,140.81,61.41,16.07,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q68E01,INTS3,Integrator complex subunit 3 OS=Homo sapiens OX=9606 GN=INTS3 PE=1 SV=1,5,7,0.092,2.258,0.01,100,-3.44,1.17,-6.64,6.64,9.40E-03,1.26E-01,1.00E-17,1.00E-17,2.89E+05,3.13E+06,6.52E+05,,1,1,1,,,,,2.89E+05,,3.13E+06,,,,,,,,6.52E+05,,,,,,,,,,2.89E+05,,1.11E+04,,,,,,,,8.78E+04,,,,,,,0,FALSE,23.031,9,5,1043,118,5.8,5,cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,nucleus;other cell component,Pf10189,65123,A8K1W0; B4DQC8; B4E3U9; D3DV57; hsa:65123; Q4G0E5; Q5VUQ5; Q5VUQ6; Q5VUR0; Q5VUR1; Q68DJ1; Q68E01; Q69YR5; Q6AI57; Q6DKG7; Q6MZQ4; Q6MZZ9; Q8NC46; Q8TB23; Q9H6S9,ENSG00000143624; ENSG00000262826,RNA polymerase II transcribes snRNA genes,,1,0,,,,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,0,,,21.38,,0,
Master Protein,High,Q15744,CEBPE,CCAAT/enhancer-binding protein epsilon OS=Homo sapiens OX=9606 GN=CEBPE PE=1 SV=2,1,15,0.091,2.538,0.771,0.33,-3.46,1.34,-0.37,-1.6,3.67E-03,9.06E-02,6.44E-01,3.87E-01,2.06E+05,4.21E+06,5.23E+05,2.86E+06,3,4,4,3,2.06E+05,,,2.95E+04,2.31E+06,6.86E+06,4.72E+06,3.75E+06,1.97E+05,,1.43E+06,,2.34E+05,1.17E+06,2.23E+05,2.86E+06,2.31E+05,,,5.35E+06,8.18E+02,,,2.95E+04,1.19E+05,2.44E+04,8.40E+04,3.46E+04,5.55E+03,,8.53E+03,,1.90E+03,1.57E+05,5.55E+03,5.57E+03,6.50E+04,,,5.70E+04,0.002,FALSE,2.976,5,1,281,30.6,8.98,1,RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes,plasma membrane;other membranes;nucleus;other cell component,Pf07716,1053,hsa:1053; Q15744; Q15745; Q8IYI2; Q99803,ENSG00000092067,Transcriptional regulation of granulopoiesis,Acute myeloid leukemia,2,0,149.54,71.59,82.04,91.01,Peak Found,High,n/a,Peak Found,High,High,High,High,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,High,High,High,n/a,High,1,,FALSE,141.25,162.74,97.22,119.25,45.78,nucleic acid binding activity;other molecular function,0,
Master Protein,High,E5RFV3,SREK1,Splicing regulatory glutamic acid and lysine rich protein 1 OS=Homo sapiens OX=9606 GN=SREK1 PE=1 SV=1,1,1,0.091,0.793,0.01,100,-3.47,-0.34,-6.64,6.64,1.94E-02,8.45E-01,1.00E-17,1.00E-17,3.69E+04,4.08E+05,2.93E+04,,1,1,3,,,,,3.69E+04,,,,,4.08E+05,,8.55E+04,,2.93E+04,5.60E+03,,,,,,,,,,3.69E+04,,,,,1.15E+04,,5.11E+02,,2.38E+02,7.55E+02,,,,,,,0.002,FALSE,2.907,10,1,132,14.3,7.21,1,,,Pf00076,,E5RFV3,ENSG00000153914,,,0,0,,,102.29,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,97.5,,,2.78,nucleic acid binding activity,0,
Master Protein,High,P33908,MAN1A1,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA OS=Homo sapiens OX=9606 GN=MAN1A1 PE=1 SV=3",3,3,0.089,0.379,0.01,100,-3.48,-1.4,-6.64,6.64,2.91E-02,4.43E-01,1.00E-17,1.00E-17,3.72E+05,9.44E+05,1.09E+05,,1,1,3,,,,,3.72E+05,,,,,,9.44E+05,,9.89E+04,2.64E+05,1.09E+05,,,,,,,,,,3.72E+05,,,,,,1.00E+04,,4.42E+03,2.14E+03,1.47E+04,,,,,,,0,FALSE,11.862,7,3,653,72.9,6.47,3,protein metabolism;other metabolic processes;stress response;other biological processes,other membranes;cytosol;ER/Golgi;other cell component,Pf01532,4121,E7EU32; hsa:4121; P33908; Q6P052; Q9NU44; Q9UJI3,ENSG00000111885,"Intra-Golgi traffic; Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",N-glycan biosynthesis,3,0,,,58.81,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,14.79,,,8.76,other molecular function,0,
Master Protein,High,J3KN67,TPM3,Tropomyosin 3 OS=Homo sapiens OX=9606 GN=TPM3 PE=1 SV=1,13,64,0.089,2.292,1.545,0.132,-3.49,1.2,0.63,-2.92,2.27E-02,2.14E-01,7.01E-01,1.05E-01,5.55E+04,6.22E+05,1.27E+05,9.61E+05,1,3,2,2,,,,5.55E+04,,6.22E+05,,2.74E+05,8.74E+06,,,,3.87E+05,4.18E+04,,1.32E+06,6.99E+05,,,,,,,5.55E+04,,2.21E+03,,2.53E+03,2.46E+05,,,,3.15E+03,5.64E+03,,2.58E+03,1.96E+05,,,,0,FALSE,42.831,34,1,285,33.2,4.77,13,,cytosol;cytoskeleton,Pf00261,,J3KN67,ENSG00000143549,,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),1,0,,149.14,113.85,43.62,n/a,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,82.91,201.18,115.02,146.26,154.56,cytoskeletal activity,0,
Master Protein,High,P47897,QARS1,Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1,4,4,0.083,2.741,4.58,,-3.58,1.45,2.2,,1.26E-02,1.45E-01,1.81E-01,,1.15E+04,1.47E+05,3.15E+04,3.12E+05,2,2,2,1,,,,1.39E+04,9.47E+03,,,,5.78E+05,3.72E+04,8.55E+04,,,1.16E+04,,,3.12E+05,,,,,,,1.39E+04,4.88E+02,,,,1.63E+04,3.96E+02,5.11E+02,,,1.56E+03,,,8.76E+04,,,,0,FALSE,9.998,8,4,775,87.7,7.15,4,protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;mitochondrion;other cell component,"Pf00749, Pf03950, Pf04557, Pf04558, Pf20974",5859,B4DWJ2; hsa:5859; P47897,ENSG00000172053,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation; Mitochondrial tRNA aminoacylation,,3,0,26.99,124.32,107.65,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,209.72,143.43,0,,13.21,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q13619,CUL4A,Cullin-4A OS=Homo sapiens OX=9606 GN=CUL4A PE=1 SV=3,2,2,0.081,4.756,0.213,1.803,-3.63,2.25,-2.23,0.85,7.02E-03,6.20E-03,3.76E-02,4.73E-01,1.87E+05,2.32E+06,8.90E+05,6.63E+05,2,1,2,1,1.08E+06,,,3.24E+04,,,,,,2.32E+06,,,5.37E+05,,1.48E+06,,6.63E+05,,,,4.29E+03,,,3.24E+04,,,,,,2.46E+04,,,4.36E+03,,3.67E+04,,1.86E+05,,,,0,FALSE,9.415,4,2,759,87.6,8.13,2,cell cycle OR cell proliferation;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,nucleus;other cell component,"Pf00888, Pf10557",8451,A2A2W2; hsa:8451; O75834; Q13619; Q589T6; Q5TC62; Q6UP08; Q9UP17,ENSG00000139842,Neddylation; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; DNA Damage Recognition in GG-NER; Dual Incision in GG-NER,"Hippo-Merlin signaling dysregulation; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",13,0,133.17,,65.91,,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,414.9,250.38,0,78.1,6.66,other molecular function,0,
Master Protein,High,Q15388,TOMM20,Mitochondrial import receptor subunit TOM20 homolog OS=Homo sapiens OX=9606 GN=TOMM20 PE=1 SV=1,1,9,0.081,5.21,0.062,6.115,-3.63,2.38,-4.02,2.61,3.29E-03,2.87E-03,2.28E-04,9.24E-02,7.50E+05,9.30E+06,4.80E+06,5.73E+05,2,1,3,2,,,1.18E+06,4.78E+05,,,,,9.30E+06,,,,7.84E+06,1.57E+06,4.80E+06,1.05E+06,,,3.13E+05,,,,1.15E+04,4.78E+05,,,,,2.62E+05,,,,6.37E+04,2.11E+05,1.19E+05,2.04E+03,,,7.33E+03,,0,FALSE,9.661,14,1,145,16.3,8.6,1,cell organization and biogenesis;transport;other biological processes,other membranes;cytoskeleton;mitochondrion;other cell component,Pf02064,9804,A8K195; hsa:9804; Q15388; Q498B3; Q6IBT4,ENSG00000173726,Ub-specific processing proteases; Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy,,3,0,59.7,,66.24,76.34,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,High,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,69.04,82.67,95.07,74.67,43.32,transporter activity;other molecular function,0,
Master Protein,High,P20160,AZU1,Azurocidin OS=Homo sapiens OX=9606 GN=AZU1 PE=1 SV=3,6,255,0.081,0.368,0.406,0.135,-3.63,-1.44,-1.3,-2.89,3.28E-03,3.51E-01,2.00E-01,8.91E-02,7.59E+06,7.92E+08,5.19E+06,6.34E+08,5,5,5,5,7.59E+06,5.49E+08,3.01E+06,1.07E+06,1.48E+08,8.58E+08,7.92E+08,1.14E+09,9.16E+07,5.07E+08,1.11E+06,2.27E+06,3.01E+07,1.27E+07,5.19E+06,7.10E+08,6.12E+06,6.34E+08,4.50E+07,7.01E+08,3.02E+04,2.09E+06,2.94E+04,1.07E+06,7.63E+06,3.05E+06,1.41E+07,1.05E+07,2.58E+06,5.39E+06,6.63E+03,1.01E+05,2.45E+05,1.72E+06,1.29E+05,1.38E+06,1.72E+06,4.49E+06,1.05E+06,7.47E+06,0,FALSE,24.348,29,6,251,26.9,9.5,6,protein metabolism;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;other membranes;other cytoplasmic organelle;other cell component,Pf00089,566,hsa:566; P20160; P80014; Q52LG4; Q9UCM1; Q9UCT5,ENSG00000172232; ENSG00000278624,Neutrophil degranulation,,1,0,166.57,58.62,116.49,86.06,Peak Found,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,137.74,138.03,135.03,139.42,541.13,other molecular function,0,
Master Protein,High,Q8NEH6,MNS1,Meiosis-specific nuclear structural protein 1 OS=Homo sapiens OX=9606 GN=MNS1 PE=1 SV=2,1,5,0.08,0.285,1.7,0.012,-3.64,-1.81,0.77,-6.36,3.20E-03,1.99E-01,5.85E-01,1.25E-04,2.34E+06,9.89E+06,3.56E+05,3.93E+07,3,3,2,4,,4.31E+06,,1.58E+05,2.34E+06,,1.98E+06,6.75E+07,9.89E+06,,,,9.04E+05,1.40E+05,,8.31E+07,5.43E+05,2.32E+07,,6.65E+07,,1.64E+04,,1.58E+05,1.21E+05,,3.52E+04,6.23E+05,2.79E+05,,,,7.35E+03,1.89E+04,,1.62E+05,1.52E+05,1.65E+05,,7.08E+05,0.002,FALSE,2.964,2,1,495,60.5,7.12,1,cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes,cytoskeleton;nucleus,Pf13868,55329,hsa:55329; Q8IYT6; Q8NEH6; Q9NUP4,ENSG00000138587,,,0,0,91.53,135.21,103.46,87.91,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,High,1,,FALSE,138.23,120.74,145.52,144.23,11.59,other molecular function,0,
Master Protein,High,P02766,TTR,Transthyretin OS=Homo sapiens OX=9606 GN=TTR PE=1 SV=1,2,2,0.08,2.139,0.01,100,-3.64,1.1,-6.64,6.64,3.18E-03,1.43E-01,1.00E-17,1.00E-17,2.36E+05,7.64E+06,5.04E+05,,2,1,2,,,,,3.52E+04,1.58E+06,,,,,7.64E+06,1.33E+06,,,1.91E+05,,,,,,,,,,3.52E+04,8.13E+04,,,,,8.12E+04,7.96E+03,,,2.57E+04,,,,,,,0,FALSE,6.577,19,2,147,15.9,5.76,2,other metabolic processes;signal transduction,non-structural extracellular;other cytoplasmic organelle,Pf00576,7276,hsa:7276; P02766; Q549C7; Q6IB96; Q9UBZ6; Q9UCM9,ENSG00000118271,Amyloid fiber formation; Neutrophil degranulation; Non-integrin membrane-ECM interactions; Retinoid metabolism and transport; The canonical retinoid cycle in rods (twilight vision); Retinoid cycle disease events,,6,0,135.24,,105.98,,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,484.97,183.56,,,8.04,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,Medium,A0A804HL87,RAPGEF1,Rap guanine nucleotide exchange factor 1 OS=Homo sapiens OX=9606 GN=RAPGEF1 PE=1 SV=1,1,1,0.076,0.01,0.613,0.01,-3.71,-6.64,-0.71,-6.64,2.06E-02,1.00E-17,5.25E-01,1.00E-17,7.61E+04,9.96E+05,,6.11E+05,2,2,,2,8.17E+04,,,,7.09E+04,,6.30E+05,1.58E+06,,,,,,,,3.26E+05,,,,1.15E+06,3.25E+02,,,,3.66E+03,,1.12E+04,1.45E+04,,,,,,,,6.35E+02,,,,1.22E+04,0.02,FALSE,1.97,1,1,1263,139.7,5.87,1,cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;developmental processes;signal transduction;other biological processes,other membranes;other cell component,"Pf00617, Pf00618",,A0A804HL87,ENSG00000107263,,MET in type 1 papillary renal cell carcinoma,1,0,9.99,60.62,,78.78,Peak Found,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,1,,FALSE,65.53,,62.89,,1.95,enzyme regulator activity,0,
Master Protein,High,C9JIF9,APEH,Acylamino-acid-releasing enzyme OS=Homo sapiens OX=9606 GN=APEH PE=1 SV=1,3,3,0.074,,0.498,1.164,-3.75,,-1,0.22,6.70E-03,,4.26E-01,7.28E-01,1.37E+05,1.82E+06,3.04E+05,2.50E+05,2,3,1,3,,1.82E+05,,,1.04E+05,2.14E+06,1.82E+06,,,1.77E+06,,,,3.04E+05,,,2.06E+06,,8.54E+04,2.50E+05,,6.93E+02,,,5.34E+03,7.60E+03,3.23E+04,,,1.88E+04,,,,4.09E+04,,,5.78E+05,,2.00E+03,2.66E+03,0,FALSE,7.38,4,3,737,81.6,5.54,3,protein metabolism,other membranes;cytosol;nucleus,"Pf00326, Pf19283",,C9JIF9,ENSG00000164062,,,0,0,39.02,10.44,,137.21,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,36.93,,100.82,0,6.35,other molecular function,0,
Master Protein,High,A0A087WW23,ALOX5AP,Arachidonate 5-lipoxygenase activating protein OS=Homo sapiens OX=9606 GN=ALOX5AP PE=1 SV=1,1,23,0.072,0.498,0.12,0.142,-3.79,-1,-3.06,-2.81,2.19E-03,6.82E-01,4.50E-03,9.83E-02,7.96E+05,1.08E+07,7.74E+05,4.60E+06,5,5,5,4,7.80E+05,1.09E+07,2.30E+05,7.96E+05,3.67E+06,2.83E+06,4.93E+08,9.37E+06,8.41E+08,1.08E+07,3.97E+05,9.09E+04,8.37E+05,3.31E+06,7.74E+05,1.72E+07,6.16E+05,7.32E+06,2.89E+06,,3.10E+03,4.15E+04,2.25E+03,7.96E+05,1.89E+05,1.01E+04,8.77E+06,8.65E+04,2.37E+07,1.15E+05,2.37E+03,4.06E+03,6.80E+03,4.45E+05,1.92E+04,3.35E+04,1.73E+05,5.19E+04,6.77E+04,,0.009,FALSE,2.313,4,1,218,24.2,8.18,1,other metabolic processes,other membranes;ER/Golgi,Pf01124,241,A0A087WW23,ENSG00000132965,,Selenium micronutrient network; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; Prostaglandin and leukotriene metabolism in senescence ; Leukotriene metabolic pathway; Prostaglandin and leukotriene metabolism in senescence ; Omega-6-fatty acids in senescence,7,0,136.59,140.58,118.38,104.75,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,High,High,High,High,Peak Found,High,n/a,1,,FALSE,145.49,130.47,143.38,130.64,42.9,enzyme regulator activity,0,
Master Protein,High,A0A1B0GU45,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=1",5,6,0.07,1.438,0.14,0.129,-3.83,0.52,-2.83,-2.95,5.29E-03,3.54E-01,1.20E-02,1.30E-01,3.18E+05,1.69E+06,4.48E+05,9.77E+05,3,2,4,4,,,7.95E+04,3.18E+05,6.26E+05,1.25E+06,,2.30E+06,,,,4.04E+05,4.81E+05,6.24E+05,4.17E+05,5.96E+05,,3.55E+06,1.55E+05,1.60E+06,,,7.77E+02,3.18E+05,3.23E+04,4.44E+03,,2.12E+04,,,,1.80E+04,3.90E+03,8.41E+04,1.04E+04,1.16E+03,,2.52E+04,3.63E+03,1.70E+04,0,FALSE,13.64,6,5,1454,164.9,5.52,5,,other membranes;other cell component,"Pf05781, Pf14658, Pf14662",,A0A1B0GU45,ENSG00000118308,,,0,0,80.32,41.93,20.92,102.36,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,88.41,72.52,48.01,85.04,13.47,,0,
Master Protein,High,A6NC48,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Homo sapiens OX=9606 GN=BST1 PE=1 SV=1,4,11,0.07,0.463,2.211,0.038,-3.84,-1.11,1.14,-4.74,1.90E-03,6.12E-01,3.78E-01,4.58E-03,5.25E+05,1.24E+07,7.25E+05,3.20E+07,5,5,4,5,5.25E+05,5.90E+06,7.77E+04,1.24E+05,6.17E+06,1.51E+07,1.24E+07,1.32E+07,1.78E+06,3.48E+06,,5.15E+04,1.37E+06,1.14E+06,4.61E+05,3.20E+07,6.59E+04,6.85E+07,8.75E+06,6.08E+07,2.09E+03,2.24E+04,7.59E+02,1.24E+05,3.18E+05,5.36E+04,2.21E+05,1.22E+05,5.01E+04,3.70E+04,,2.30E+03,1.11E+04,1.53E+05,1.15E+04,6.24E+04,1.85E+04,4.85E+05,2.05E+05,6.47E+05,0,FALSE,14.376,18,4,333,37.5,7.97,4,,other membranes,Pf02267,,A6NC48,ENSG00000109743,,NAD+ biosynthetic pathways,1,0,124.22,66.35,80.39,89.4,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,1,,FALSE,127.78,140.71,147.9,147.65,25.31,other molecular function,0,
Master Protein,High,Q8NG11,TSPAN14,Tetraspanin-14 OS=Homo sapiens OX=9606 GN=TSPAN14 PE=1 SV=1,1,3,0.069,2.259,0.378,0.478,-3.86,1.18,-1.4,-1.07,1.11E-02,1.74E-01,2.92E-01,6.02E-01,1.00E+05,1.45E+06,1.71E+05,5.49E+05,2,1,5,2,,,6.56E+04,1.53E+05,,,,,,1.45E+06,1.28E+05,6.73E+04,1.71E+05,5.36E+05,6.90E+05,,2.92E+05,,1.03E+06,,,,6.41E+02,1.53E+05,,,,,,1.54E+04,7.67E+02,3.01E+03,1.39E+03,7.22E+04,1.71E+04,,8.21E+04,,2.41E+04,,0.001,FALSE,3.916,6,1,270,30.7,6.84,1,protein metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,Pf00335,81619,A6NHE1; B4DHY6; D3DWD7; D3DWD8; hsa:81619; Q567U7; Q8NG11; Q9BU34; Q9H0U1,ENSG00000108219,Neutrophil degranulation; Amyloid fiber formation,10q22q23 copy number variation,3,0,56.38,,86.84,78.96,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,64.45,87.59,99.77,113.96,9.73,other molecular function,0,
Master Protein,High,Q658P3,STEAP3,Metalloreductase STEAP3 OS=Homo sapiens OX=9606 GN=STEAP3 PE=1 SV=2,2,5,0.065,0.01,0.368,0.01,-3.95,-6.64,-1.44,-6.64,3.30E-03,1.00E-17,1.78E-01,1.00E-17,1.33E+05,2.05E+06,,7.55E+05,1,2,,1,1.33E+05,,,,,,,,1.27E+06,3.30E+06,,,,,,,,,,7.55E+05,5.27E+02,,,,,,,,3.58E+04,3.51E+04,,,,,,,,,,8.03E+03,0,FALSE,6.655,5,2,488,54.6,8.6,2,cell cycle OR cell proliferation;transport;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,"Pf01794, Pf03807",55240,A8K6E3; hsa:55240; Q4VBR2; Q4ZG36; Q53SQ8; Q658P3; Q7Z389; Q86SF6; Q8NEW6; Q8TDP3; Q8TF03; Q9NVB5,ENSG00000115107,Transferrin endocytosis and recycling; CDC42 GTPase cycle; RHOQ GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,Iron metabolism in placenta; Copper homeostasis; Ferroptosis; Iron metabolism disorders,11,0,,62.77,,,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,73.44,,73.44,,13.76,other molecular function,0,
Master Protein,High,E7ENX8,,ABC-type antigen peptide transporter (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1,5,14,0.064,0.239,0.042,0.253,-3.96,-2.06,-4.57,-1.98,1.40E-03,1.56E-01,3.01E-05,2.70E-01,1.20E+06,6.94E+06,2.48E+05,5.53E+05,5,1,5,4,2.04E+06,5.57E+05,2.74E+06,1.20E+06,4.77E+05,,6.94E+06,,,,7.36E+06,2.48E+05,8.37E+04,2.42E+05,5.93E+05,5.43E+05,,5.64E+05,1.96E+05,2.32E+07,8.12E+03,2.12E+03,2.68E+04,1.20E+06,2.46E+04,,1.23E+05,,,,4.40E+04,1.11E+04,6.80E+02,3.27E+04,1.47E+04,1.06E+03,,3.99E+03,4.59E+03,2.47E+05,0,FALSE,20.853,7,1,843,92.9,7.24,5,transport;other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle,"Pf00005, Pf00664, Pf00969, Pf07654",,,,,,0,5,69.57,,185.63,185.82,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,29.42,116.6,136.65,96.99,29.58,signal transduction activity or receptor binding;transporter activity;other molecular function,0,
Master Protein,High,Q96C86,DCPS,m7GpppX diphosphatase OS=Homo sapiens OX=9606 GN=DCPS PE=1 SV=2,1,2,0.064,0.615,0.068,0.562,-3.97,-0.7,-3.87,-0.83,1.07E-02,8.75E-01,2.55E-03,7.54E-01,9.51E+04,1.49E+06,6.33E+04,1.02E+05,3,2,4,2,,1.29E+07,,9.51E+04,3.70E+04,,,1.38E+06,,1.60E+06,6.91E+04,2.29E+04,,8.91E+04,5.81E+04,1.40E+05,,,7.39E+04,,,4.91E+04,,9.51E+04,1.91E+03,,,1.27E+04,,1.70E+04,4.13E+02,1.02E+03,,1.20E+04,1.44E+03,2.72E+02,,,1.73E+03,,0.001,FALSE,4.252,4,1,337,38.6,6.38,1,RNA metabolism OR transcription;other metabolic processes,cytosol;mitochondrion;nucleus;other cell component,"Pf05652, Pf11969",28960,hsa:28960; Q8NHL8; Q96C86; Q9Y2S5,ENSG00000110063,mRNA decay by 3' to 5' exoribonuclease,,1,0,170.58,10.68,46.38,43.51,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,1,,FALSE,147.17,104.89,44.44,55.54,3.5,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P28070,PSMB4,Proteasome subunit beta type-4 OS=Homo sapiens OX=9606 GN=PSMB4 PE=1 SV=4,3,9,0.063,0.336,0.121,0.415,-3.99,-1.58,-3.05,-1.27,1.28E-03,3.53E-01,4.69E-03,5.73E-01,5.69E+05,4.14E+06,1.55E+05,1.09E+06,5,2,5,3,5.69E+05,4.37E+05,2.38E+05,8.05E+05,7.68E+06,,,,8.99E+05,1.91E+07,1.05E+05,1.70E+05,7.68E+04,1.41E+06,1.55E+05,,1.09E+06,1.37E+07,1.09E+06,,2.26E+03,1.66E+03,2.33E+03,8.05E+05,3.96E+05,,,,2.53E+04,2.03E+05,6.27E+02,7.59E+03,6.24E+02,1.90E+05,3.84E+03,,3.07E+05,9.69E+04,2.56E+04,,0,FALSE,15.861,16,3,264,29.2,5.97,3,protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;mitochondrion;nucleus;other cell component,Pf00227,5692,B2R9L3; hsa:5692; P28070; P31148; Q5SZS5; Q6IBI4; Q969L6,ENSG00000159377,Regulation of PTEN stability and activity; KEAP1-NFE2L2 pathway; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,62,0,165.03,128.71,150.13,137.39,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,90.51,63.75,131.06,86.78,27.84,other molecular function,0,
Master Protein,High,Q5TGY3,AHDC1,Transcription factor Gibbin OS=Homo sapiens OX=9606 GN=AHDC1 PE=1 SV=1,5,6,0.062,1.469,,,-4.02,0.55,,,1.18E-03,3.25E-01,,,4.20E+05,5.41E+06,4.89E+05,2.19E+06,1,1,2,1,,,,4.20E+05,,,,,,5.41E+06,,,4.64E+05,5.16E+05,,,,2.19E+06,,,,,,4.20E+05,,,,,,5.75E+04,,,3.77E+03,6.95E+04,,,,1.55E+04,,,0,FALSE,14.217,5,5,1603,168.2,9.04,5,developmental processes;other biological processes,nucleus;other cell component,Pf15735,27245,hsa:27245; Q5TGY3; Q5TGY4; Q6PJK1; Q6ZUQ6; Q99769; Q9NUF5,ENSG00000126705,,Mesodermal commitment pathway,1,0,,,7.53,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,0,7.91,,,15.97,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NRG7,SDR39U1,Epimerase family protein SDR39U1 OS=Homo sapiens OX=9606 GN=SDR39U1 PE=1 SV=3,2,4,0.061,0.792,0.01,100,-4.03,-0.34,-6.64,6.64,1.10E-03,8.53E-01,1.00E-17,1.00E-17,6.77E+05,3.44E+06,2.80E+05,,1,1,5,,,,,6.77E+05,,,,,,3.44E+06,1.23E+06,2.80E+05,6.46E+04,5.65E+05,1.33E+05,,,,,,,,,6.77E+05,,,,,,3.66E+04,7.37E+03,1.25E+04,5.25E+02,7.62E+04,3.30E+03,,,,,,0,FALSE,10.629,10,2,293,31.1,9.04,2,,,"Pf01370, Pf08338",56948,hsa:56948; Q6ZW71; Q9BVQ3; Q9NRG7,ENSG00000100445,,,0,0,,,104.46,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,89.84,,,10.85,other molecular function,0,
Master Protein,High,Q12769,NUP160,Nuclear pore complex protein Nup160 OS=Homo sapiens OX=9606 GN=NUP160 PE=1 SV=3,3,5,0.058,5.368,,0.482,-4.12,2.42,,-1.05,6.60E-03,7.45E-03,,6.45E-01,2.88E+05,1.20E+06,6.55E+05,4.39E+05,2,1,4,1,,,,1.00E+05,8.27E+05,,1.20E+06,,,,3.25E+05,,8.23E+05,1.17E+06,5.21E+05,,,,4.39E+05,,,,,1.00E+05,4.26E+04,,2.13E+04,,,,1.94E+03,,6.69E+03,1.58E+05,1.30E+04,,,,1.03E+04,,0,FALSE,11.076,4,3,1436,162,5.5,3,other metabolic processes;transport;developmental processes,cytosol;nucleus,Pf11715,23279,B4DYE8; B4E2J9; hsa:23279; Q08AD3; Q12769; Q7Z5X6; Q96GB3; Q9H660,ENSG00000030066,Rev-mediated nuclear export of HIV RNA; Nuclear import of Rev protein; Postmitotic nuclear pore complex (NPC) reformation; SUMOylation of DNA damage response and repair proteins; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,35,0,110.86,,52.06,,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,140.01,,0,17.74,other molecular function,0,
Master Protein,Medium,Q7Z553,MDGA2,MAM domain-containing glycosylphosphatidylinositol anchor protein 2 OS=Homo sapiens OX=9606 GN=MDGA2 PE=1 SV=2,1,1,0.057,2.64,2.039,0.049,-4.14,1.4,1.03,-4.37,6.49E-03,1.60E-01,4.11E-01,7.37E-03,3.29E+04,5.77E+05,8.67E+04,2.51E+06,1,4,4,4,,,3.29E+04,,,2.71E+05,3.21E+06,1.23E+06,2.29E+05,,2.65E+05,3.50E+04,6.17E+04,1.22E+05,,2.63E+06,,3.28E+06,1.27E+05,2.40E+06,,,3.21E+02,,,9.62E+02,5.71E+04,1.14E+04,6.46E+03,,1.58E+03,1.56E+03,5.01E+02,1.64E+04,,5.14E+03,,2.33E+04,2.96E+03,2.55E+04,0.027,FALSE,1.857,1,1,956,107.4,7.2,1,developmental processes,non-structural extracellular;plasma membrane;other membranes,"Pf00629, Pf07679, Pf13927",161357,F6W3S7; hsa:161357; J3KPX6; Q7Z553,ENSG00000139915,Post-translational modification: synthesis of GPI-anchored proteins,,1,0,,112.98,84.96,65.12,n/a,n/a,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,128.77,74.29,127.49,132.31,1.75,,0,
Master Protein,High,Q9H9J2,MRPL44,"39S ribosomal protein L44, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL44 PE=1 SV=1",2,3,0.056,2.302,0.03,4.324,-4.15,1.2,-5.06,2.11,9.22E-03,1.83E-01,7.68E-05,2.01E-01,6.04E+04,1.07E+06,1.39E+05,3.22E+04,1,2,1,1,,,,6.04E+04,,1.44E+06,,7.94E+05,,,,,,1.39E+05,,,3.22E+04,,,,,,,6.04E+04,,5.12E+03,,7.33E+03,,,,,,1.87E+04,,,9.04E+03,,,,0,FALSE,8.563,10,2,332,37.5,8.4,2,protein metabolism;RNA metabolism OR transcription;other metabolic processes,plasma membrane;other membranes;mitochondrion;translational apparatus;nucleus,,65080,hsa:65080; Q53S16; Q6IA62; Q9H821; Q9H9J2,ENSG00000135900,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,,3,0,,40.94,,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,44.85,0,44.85,0,9.06,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q7Z7A1,CNTRL,Centriolin OS=Homo sapiens OX=9606 GN=CNTRL PE=1 SV=2,1,1,0.042,0.763,0.051,1.152,-4.56,-0.39,-4.3,0.2,3.71E-03,9.37E-01,1.12E-03,7.76E-01,5.70E+04,1.35E+06,7.89E+04,6.85E+04,3,1,4,1,,5.31E+05,,2.97E+04,5.70E+04,,,,1.35E+06,,9.59E+04,1.52E+04,6.49E+04,,1.17E+05,,,,6.85E+04,,,2.02E+03,,2.97E+04,2.94E+03,,,,3.80E+04,,5.73E+02,6.80E+02,5.27E+02,,2.92E+03,,,,1.60E+03,,0.002,FALSE,3.029,1,1,2325,268.7,5.55,1,cell cycle OR cell proliferation;developmental processes;other biological processes,cytosol;cytoskeleton;other cell component,Pf14580,11064,A2A2Y1; B2RP67; hsa:11064; Q3MN79; Q5FWF8; Q5JVD0; Q6MZR3; Q6PKC1; Q7Z7A1; Q8TEP3; Q9Y489,ENSG00000119397,Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,,7,0,136.9,,60.43,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,132.35,116.36,0,52.14,2.09,,0,
Master Protein,High,P35251,RFC1,Replication factor C subunit 1 OS=Homo sapiens OX=9606 GN=RFC1 PE=1 SV=4,3,5,0.039,0.595,,0.626,-4.7,-0.75,,-0.67,1.62E-04,8.83E-01,,8.38E-01,1.93E+06,6.66E+06,7.33E+05,4.92E+05,3,1,5,3,,1.93E+06,2.22E+06,2.96E+04,,6.66E+06,,,,,2.21E+06,5.13E+04,4.07E+05,1.10E+06,7.33E+05,4.92E+05,8.94E+04,1.18E+06,,,,7.35E+03,2.17E+04,2.96E+04,,2.37E+04,,,,,1.32E+04,2.29E+03,3.31E+03,1.48E+05,1.82E+04,9.60E+02,2.51E+04,8.33E+03,,,0,FALSE,8.989,3,3,1148,128.2,9.36,3,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes,nucleus;other cell component,"Pf00004, Pf00533, Pf08519",5981,A8K6E7; hsa:5981; P35251; Q5XKF5; Q6PKU0; Q86V41; Q86V46,ENSG00000035928,Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,"miRNA regulation of DNA damage response; DNA replication; Male infertility; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair; DNA damage response",22,0,85.39,,92.01,93.73,n/a,Peak Found,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,1,,FALSE,633.94,144.83,,121.34,12.8,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P08246,ELANE,Neutrophil elastase OS=Homo sapiens OX=9606 GN=ELANE PE=1 SV=1,7,455,0.037,0.929,0.25,0.155,-4.76,-0.11,-2,-2.69,1.36E-04,6.63E-01,5.74E-02,1.14E-01,8.79E+06,5.66E+08,1.07E+07,1.58E+08,5,5,5,5,8.79E+06,5.50E+08,2.47E+06,2.48E+06,6.07E+07,1.01E+09,5.66E+08,8.56E+08,1.08E+08,1.80E+08,7.49E+06,3.44E+06,2.87E+07,1.07E+07,1.75E+07,8.56E+08,1.02E+07,1.58E+08,1.79E+08,8.10E+07,3.49E+04,2.09E+06,2.42E+04,2.48E+06,3.13E+06,3.59E+06,1.01E+07,7.89E+06,3.03E+06,1.92E+06,4.48E+04,1.54E+05,2.33E+05,1.44E+06,4.35E+05,1.67E+06,2.86E+06,1.12E+06,4.19E+06,8.63E+05,0,FALSE,56.029,32,7,267,28.5,9.35,7,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,non-structural extracellular;cytosol;other cytoplasmic organelle;other cell component,Pf00089,1991,hsa:1991; P08246; P09649; Q6B0D9; Q6LDP5,ENSG00000197561; ENSG00000277571,Neutrophil degranulation; Antimicrobial peptides; Regulation of Complement cascade; Collagen degradation; Pyroptosis; Activation of Matrix Metalloproteinases,Complement system; miRNA role in immune response in sepsis; Affected pathways in Duchenne muscular dystrophy,10,0,191.3,73.39,72.94,132.94,Peak Found,High,Peak Found,High,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,138.79,133.29,127.8,136.91,983.29,other molecular function,0,
Master Protein,High,Q99653,CHP1,Calcineurin B homologous protein 1 OS=Homo sapiens OX=9606 GN=CHP1 PE=1 SV=3,1,2,0.032,1.073,0.01,100,-4.98,0.1,-6.64,6.64,6.56E-05,4.59E-01,1.00E-17,1.00E-17,7.23E+05,2.28E+07,7.76E+05,,2,1,2,,1.59E+06,,,3.29E+05,,,,,,2.28E+07,,,,9.76E+05,6.17E+05,,,,,,6.32E+03,,,3.29E+05,,,,,,2.43E+05,,,,1.32E+05,1.53E+04,,,,,,0.009,FALSE,2.311,6,1,195,22.4,5.1,1,cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component,Pf00036,11261,B2R6H9; hsa:11261; Q6FHZ9; Q99653,ENSG00000187446,Hyaluronan uptake and degradation,T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection,2,0,93.02,,31.93,,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,129.47,102.89,,,5.66,transporter activity;enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q9UN36,NDRG2,Protein NDRG2 OS=Homo sapiens OX=9606 GN=NDRG2 PE=1 SV=2,1,11,0.03,0.473,0.017,0.309,-5.08,-1.08,-5.87,-1.69,4.71E-05,6.69E-01,1.04E-07,3.99E-01,3.43E+05,2.38E+07,1.18E+05,3.39E+05,4,5,5,2,1.20E+05,9.75E+05,,7.31E+03,1.01E+06,2.38E+07,3.36E+07,3.23E+07,1.36E+06,1.24E+07,5.30E+04,1.18E+05,2.07E+05,1.29E+04,5.14E+05,5.65E+05,,,2.03E+05,,4.78E+02,3.71E+03,,7.31E+03,5.21E+04,8.46E+04,5.97E+05,2.98E+05,3.82E+04,1.31E+05,3.17E+02,5.26E+03,1.68E+03,1.74E+03,1.28E+04,1.10E+03,,,4.76E+03,,0.009,FALSE,2.301,2,1,371,40.8,5.21,1,cell-cell signaling;cell cycle OR cell proliferation;signal transduction;other biological processes,cytosol;ER/Golgi;nucleus;other cell component,Pf03096,57447,B3KUE3; B4DE86; B7WP11; B7WPD5; D3DS07; D3DS10; hsa:57447; Q567T1; Q68DW2; Q86U08; Q86U46; Q96FD3; Q96FT0; Q96JU0; Q96PN0; Q9BQH5; Q9ULH2; Q9UN36,ENSG00000165795,,,0,0,101.92,66.4,110.63,66.52,Peak Found,Peak Found,n/a,Peak Found,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,1,,FALSE,142.27,146.52,111.99,100.61,6.7,,0,
Master Protein,High,P06127,CD5,T-cell surface glycoprotein CD5 OS=Homo sapiens OX=9606 GN=CD5 PE=1 SV=2,2,3,0.028,5.168,2.662,0.055,-5.14,2.37,1.41,-4.19,3.80E-04,3.73E-02,4.20E-01,1.75E-02,4.12E+03,1.46E+05,2.13E+04,3.88E+05,1,2,2,1,,,,4.12E+03,,,,,4.65E+04,4.57E+05,,,7.43E+04,6.11E+03,,,,3.88E+05,,,,,,4.12E+03,,,,,1.31E+03,4.86E+03,,,6.03E+02,8.23E+02,,,,2.75E+03,,,0,FALSE,4.494,5,2,495,54.5,8.21,2,signal transduction;other biological processes,plasma membrane;other membranes,Pf00530,921,A0N0P4; A8K9I3; hsa:921; P06127,ENSG00000110448,,Modulators of TCR signaling and T cell activation,1,0,,115.33,119.93,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,208.89,237.25,208.89,237.25,8.08,other molecular function,0,
Master Protein,High,P53634,CTSC,Dipeptidyl peptidase 1 OS=Homo sapiens OX=9606 GN=CTSC PE=1 SV=2,3,16,0.026,4.555,0.084,2.169,-5.27,2.19,-3.57,1.12,5.18E-04,2.96E-02,4.58E-03,3.68E-01,9.00E+04,1.39E+06,1.67E+05,3.02E+05,4,4,4,5,1.28E+05,,2.95E+04,6.32E+04,1.74E+06,1.02E+06,,1.26E+06,1.54E+06,5.97E+06,8.92E+04,,1.56E+05,1.15E+06,1.79E+05,2.25E+06,3.02E+05,4.11E+04,3.36E+05,3.85E+04,5.09E+02,,2.88E+02,6.32E+04,8.96E+04,3.62E+03,,1.16E+04,4.34E+04,6.35E+04,5.33E+02,,1.27E+03,1.55E+05,4.45E+03,4.39E+03,8.50E+04,2.91E+02,7.87E+03,4.10E+02,0,FALSE,15.134,11,3,463,51.8,6.99,3,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;other membranes;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00112, Pf08773",1075,A8K7V2; B5MDD5; hsa:1075; P53634; Q2HIY8; Q53G93; Q71E75; Q71E76; Q7M4N9; Q7Z3G7; Q7Z5U7; Q8WY99; Q8WYA7; Q8WYA8,ENSG00000109861,Neutrophil degranulation; MHC class II antigen presentation; COPII-mediated vesicle transport; Cargo concentration in the ER,,4,0,170.13,96.28,128.69,157.83,Peak Found,High,Peak Found,High,High,Peak Found,n/a,High,High,High,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,139.93,131.77,141.93,121.56,17.25,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q9P013,CWC15,Spliceosome-associated protein CWC15 homolog OS=Homo sapiens OX=9606 GN=CWC15 PE=1 SV=2,1,2,0.026,2.88,0.124,0.601,-5.27,1.53,-3.01,-0.73,2.49E-05,4.40E-02,5.26E-03,7.89E-01,2.77E+05,1.07E+07,7.99E+05,1.33E+06,1,2,1,2,,,,2.77E+05,,1.74E+07,,6.57E+06,,,,,,7.99E+05,,,,3.13E+06,5.64E+05,,,,,2.77E+05,,6.17E+04,,6.07E+04,,,,,,1.08E+05,,,,2.22E+04,1.32E+04,,0,FALSE,5.592,10,1,229,26.6,5.71,1,RNA metabolism OR transcription;other metabolic processes,mitochondrion;nucleus;other cell component,Pf04889,51503,B2RC17; hsa:51503; Q05BV9; Q05DM1; Q9P013; Q9UI29,ENSG00000150316,mRNA Splicing - Major Pathway,,1,0,,63.74,,98.21,n/a,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,1,,FALSE,74.86,0,88.05,143.1,7.63,nucleic acid binding activity,0,
Master Protein,High,P43405,SYK,Tyrosine-protein kinase SYK OS=Homo sapiens OX=9606 GN=SYK PE=1 SV=1,3,5,0.025,0.465,0.058,0.222,-5.3,-1.11,-4.1,-2.17,1.93E-05,6.62E-01,1.74E-04,3.04E-01,1.24E+05,4.03E+06,4.46E+04,2.81E+05,3,1,5,5,,2.98E+06,,1.20E+05,1.24E+05,4.03E+06,,,,,4.46E+04,3.45E+04,2.02E+05,6.42E+04,1.23E+04,9.97E+05,1.14E+05,4.23E+05,2.17E+04,2.81E+05,,1.13E+04,,1.20E+05,6.40E+03,1.43E+04,,,,,2.67E+02,1.54E+03,1.64E+03,8.65E+03,3.05E+02,1.94E+03,3.20E+04,3.00E+03,5.09E+02,2.99E+03,0,FALSE,11.403,8,3,635,72,8.25,3,cell adhesion;cell-cell signaling;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00017, Pf07714",6850,hsa:6850; P43405,ENSG00000165025,FCGR activation; Regulation of actin dynamics for phagocytic cup formation; Role of phospholipids in phagocytosis; Role of LAT2/NTAL/LAB on calcium mobilization; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; FCGR3A-mediated phagocytosis; Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; CLEC7A (Dectin-1) signaling; Regulation of signaling by CBL; GPVI-mediated activation cascade; DAP12 signaling; Inactivation of CSF3 (G-CSF) signaling; Integrin signaling; Interleukin-2 signaling; Dectin-2 family; FLT3 signaling through SRC family kinases,IL-5 signaling pathway; RANKL/RANK signaling pathway; B cell receptor signaling pathway; IL-3 signaling pathway; Microglia pathogen phagocytosis pathway; Fibrin complement receptor 3 signaling pathway; PI3K-Akt signaling pathway; IL-2 signaling pathway; Extrafollicular and follicular B cell activation by SARS-CoV-2,30,0,153.51,,105.32,104.63,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,143.17,104.55,69.2,72.51,11.7,signal transduction activity or receptor binding;kinase activity;other molecular function,0,
Master Protein,High,Q86X76,NIT1,Deaminated glutathione amidase OS=Homo sapiens OX=9606 GN=NIT1 PE=1 SV=2,3,19,0.021,0.931,0.148,0.917,-5.54,-0.1,-2.76,-0.12,9.45E-06,6.98E-01,1.02E-02,1.00E+00,4.12E+05,1.87E+07,2.25E+05,5.08E+06,5,4,5,5,2.80E+05,4.12E+05,1.08E+05,8.41E+05,3.07E+06,4.43E+07,2.72E+07,1.29E+07,,4.09E+06,8.09E+04,2.25E+05,9.75E+04,8.80E+05,3.31E+05,6.48E+06,2.31E+05,5.08E+06,3.64E+05,1.12E+07,1.11E+03,1.56E+03,1.05E+03,8.41E+05,1.59E+05,1.57E+05,4.83E+05,1.19E+05,,4.35E+04,4.84E+02,1.00E+04,7.92E+02,1.19E+05,8.21E+03,1.26E+04,6.48E+04,3.60E+04,8.51E+03,1.20E+05,0,FALSE,11.941,12,3,327,35.9,7.74,3,other metabolic processes,mitochondrion;other cell component,Pf00795,4817,B1AQP3; D3DVF4; hsa:4817; O76091; Q86X76,ENSG00000158793,,,0,0,129.57,79.52,101.48,98.47,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,1,,FALSE,127.3,92.34,129.23,134.08,20.03,other molecular function,0,
Master Protein,Medium,Q9ULV0,MYO5B,Unconventional myosin-Vb OS=Homo sapiens OX=9606 GN=MYO5B PE=1 SV=3,1,9,0.018,0.453,1.629,0.013,-5.8,-1.14,0.7,-6.29,3.70E-06,5.99E-01,6.23E-01,1.49E-04,1.89E+05,1.41E+07,1.43E+05,4.20E+07,5,5,4,5,1.89E+05,3.70E+06,5.72E+04,1.30E+05,7.63E+05,3.64E+07,1.05E+07,3.87E+07,1.41E+07,3.67E+06,4.07E+05,4.75E+04,1.06E+06,5.01E+04,,2.24E+08,2.00E+06,6.31E+07,2.59E+06,4.20E+07,7.51E+02,1.41E+04,5.59E+02,1.30E+05,3.94E+04,1.29E+05,1.87E+05,3.57E+05,3.97E+05,3.91E+04,2.44E+03,2.12E+03,8.63E+03,6.75E+03,,4.37E+05,5.62E+05,4.47E+05,6.07E+04,4.48E+05,0.02,FALSE,1.972,0,1,1848,213.5,7.2,1,cell organization and biogenesis;transport;other biological processes,other membranes;cytoskeleton;other cell component,"Pf00063, Pf00612, Pf01843",4645,B0I1R3; hsa:4645; Q0P656; Q9H6Y6; Q9ULV0,ENSG00000167306,Vasopressin regulates renal water homeostasis via Aquaporins,Alstrom syndrome,2,0,160.48,76.8,121.97,137.49,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,High,1,,FALSE,135.41,123.09,142.17,144.17,16.88,cytoskeletal activity;other molecular function,0,
Master Protein,High,P02745,C1QA,Complement C1q subcomponent subunit A OS=Homo sapiens OX=9606 GN=C1QA PE=1 SV=2,1,4,0.018,1.551,0.3,0.096,-5.82,0.63,-1.74,-3.38,3.44E-06,3.73E-01,9.58E-02,6.27E-02,1.13E+05,6.38E+06,1.32E+05,1.92E+06,3,5,5,3,1.72E+05,,8.48E+04,1.13E+05,,1.98E+07,5.27E+05,1.33E+07,6.38E+06,1.34E+05,1.18E+06,1.80E+04,4.36E+05,1.32E+05,1.31E+05,1.92E+06,,3.61E+06,,1.37E+06,6.83E+02,,8.28E+02,1.13E+05,,7.03E+04,9.37E+03,1.23E+05,1.80E+05,1.43E+03,7.03E+03,8.02E+02,3.55E+03,1.78E+04,3.27E+03,3.73E+03,,2.56E+04,,1.45E+04,0.009,FALSE,2.302,4,1,245,26,9.11,1,cell-cell signaling;cell organization and biogenesis;stress response;developmental processes;other biological processes,non-structural extracellular;other cell component,"Pf00386, Pf01391",712,B2R4X2; hsa:712; P02745; Q5T963,ENSG00000173372,Initial triggering of complement; Classical antibody-mediated complement activation; Regulation of Complement cascade,Allograft rejection; Dengue-2 interactions with complement and coagulation cascades; Microglia pathogen phagocytosis pathway; Oxidative damage response; Complement system in neuronal development and plasticity; Complement activation; Complement and coagulation cascades,10,0,36.02,105.57,124.59,50.99,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,144.09,128.01,141.77,104.42,6.61,other molecular function,0,
Master Protein,High,Q9P2I0,CPSF2,Cleavage and polyadenylation specificity factor subunit 2 OS=Homo sapiens OX=9606 GN=CPSF2 PE=1 SV=2,1,1,0.015,0.01,0.01,,-6.05,-6.64,-6.64,,1.38E-06,1.00E-17,1.00E-17,,7.86E+04,5.22E+06,,,1,1,,,,,,7.86E+04,,,,,,5.22E+06,,,,,,,,,,,,,,7.86E+04,,,,,,5.55E+04,,,,,,,,,,,0.003,FALSE,2.724,2,1,782,88.4,5.11,1,RNA metabolism OR transcription;other metabolic processes,nucleus;other cell component,"Pf07521, Pf10996, Pf13299, Pf16661",53981,B3KME1; hsa:53981; Q6NSJ1; Q9H3W7; Q9P2I0,ENSG00000165934,Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,mRNA processing,6,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,0,,,,2.8,nucleic acid binding activity,0,
Master Protein,High,Q92688,ANP32B,Acidic leucine-rich nuclear phosphoprotein 32 family member B OS=Homo sapiens OX=9606 GN=ANP32B PE=1 SV=1,4,9,0.014,0.571,,0.18,-6.14,-0.81,,-2.47,3.09E-06,8.10E-01,,1.58E-01,6.97E+05,2.75E+06,2.66E+05,2.22E+05,3,2,5,1,,,3.92E+04,4.63E+06,6.97E+05,,1.63E+07,,,4.66E+05,2.08E+05,2.66E+05,3.15E+05,2.39E+06,1.94E+05,,,,2.22E+05,,,,3.83E+02,4.63E+06,3.60E+04,,2.89E+05,,,4.96E+03,1.24E+03,1.19E+04,2.56E+03,3.23E+05,4.82E+03,,,,5.20E+03,,0,FALSE,15.222,19,3,251,28.8,4.06,4,cell organization and biogenesis;developmental processes;other biological processes,nucleus;other cell component,Pf12799,10541,B2R9C7; hsa:10541; O00655; P78458; P78459; Q92688,ENSG00000136938,,,0,0,138.8,133.53,142.46,,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,425.07,131.64,,97.44,24.23,other molecular function,0,
Master Protein,High,Q5T9B7,AK1,Adenylate kinase isoenzyme 1 OS=Homo sapiens OX=9606 GN=AK1 PE=1 SV=1,2,5,0.013,0.528,0.017,0.325,-6.23,-0.92,-5.88,-1.62,3.43E-07,7.45E-01,4.77E-08,4.11E-01,1.59E+05,3.77E+06,5.41E+04,4.03E+05,5,1,4,4,1.59E+05,3.21E+05,8.79E+04,9.22E+04,6.44E+05,3.77E+06,,,,,4.79E+04,,4.74E+04,6.12E+04,2.11E+05,,2.16E+05,2.20E+06,1.60E+05,7.53E+05,6.32E+02,1.22E+03,8.59E+02,9.22E+04,3.32E+04,1.34E+04,,,,,2.86E+02,,3.85E+02,8.25E+03,5.24E+03,,6.07E+04,1.56E+04,3.74E+03,8.02E+03,0,FALSE,6.404,11,2,210,23.4,8.6,2,other metabolic processes,cytosol,Pf00406,203,Q5T9B7,ENSG00000106992,,,0,0,89.74,,86.65,114.2,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,67.97,86.04,72.24,97.27,12.64,kinase activity;other molecular function,0,
Master Protein,High,Q10472,GALNT1,Polypeptide N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=GALNT1 PE=1 SV=1,3,4,0.011,1.074,1.363,0.01,-6.55,0.1,0.45,-6.64,1.83E-07,5.83E-01,7.92E-01,1.00E-17,1.31E+05,1.23E+07,2.33E+05,1.68E+07,2,4,2,2,1.18E+05,,,1.46E+05,,,1.08E+07,2.02E+07,5.82E+06,1.40E+07,,,2.00E+05,2.71E+05,,,,1.72E+07,,1.63E+07,4.67E+02,,,1.46E+05,,,1.92E+05,1.86E+05,1.64E+05,1.49E+05,,,1.62E+03,3.65E+04,,,,1.22E+05,,1.74E+05,0,FALSE,16.315,9,3,559,64.2,7.72,3,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;other membranes;ER/Golgi;other cell component,"Pf00535, Pf00652",2589,hsa:2589; Q10472; Q86TJ7; Q9UM86,ENSG00000141429,COPI-independent Golgi-to-ER retrograde traffic; O-linked glycosylation of mucins; Maturation of protein 3a; Maturation of protein 3a,Metabolism of sphingolipids in ER and Golgi apparatus,5,0,15.44,47.42,21.4,3.85,Peak Found,n/a,n/a,High,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,55.11,47.31,40.48,51.38,15.69,other molecular function,0,
Master Protein,High,P38571,LIPA,Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens OX=9606 GN=LIPA PE=1 SV=2,1,1,0.01,100,0.4,1.412,-6.64,6.64,-1.32,0.5,1.00E-17,1.00E-17,2.91E-01,6.02E-01,,1.13E+06,6.36E+05,4.50E+05,,1,3,1,,,,,,1.13E+06,,,,,,,1.66E+05,1.14E+06,6.36E+05,,,,4.50E+05,,,,,,,4.00E+03,,,,,,,1.35E+03,1.54E+05,1.58E+04,,,,1.05E+04,,0.002,FALSE,3.087,4,1,399,45.4,6.92,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf00561,3988,B2RBH5; D3DR29; hsa:3988; P38571; Q16529; Q53H21; Q5T074; Q5T771; Q96EJ0,ENSG00000107798,LDL clearance,"Phase I biotransformations, non-P450; Degradation pathway of sphingolipids, including diseases; Cholesterol metabolism",4,0,,,75.27,,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,,0,109.44,3.32,other molecular function,0,
Master Protein,High,P61019,RAB2A,Ras-related protein Rab-2A OS=Homo sapiens OX=9606 GN=RAB2A PE=1 SV=1,2,3,0.01,,0.192,0.01,-6.64,,-2.38,-6.64,1.00E-17,,6.44E-02,1.00E-17,,4.46E+05,,8.58E+04,,1,,2,,,,,,,,,4.46E+05,,,,,,,,1.36E+05,,5.41E+04,,,,,,,,,,1.26E+04,,,,,,,,3.82E+04,,1.26E+03,,0,FALSE,4.913,13,1,212,23.5,6.54,2,cell organization and biogenesis;transport,other membranes;cytosol;ER/Golgi;other cell component,Pf00071,5862,B2R5W8; B4DMQ5; hsa:5862; P08886; P61019,ENSG00000104388,RAB geranylgeranylation; Golgi Cisternae Pericentriolar Stack Reorganization,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Ciliary landscape,4,0,,,,61,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,70.89,,8.01,other molecular function,0,
Master Protein,High,Q16853,AOC3,Membrane primary amine oxidase OS=Homo sapiens OX=9606 GN=AOC3 PE=1 SV=3,1,3,0.01,100,0.01,100,-6.64,6.64,-6.64,6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,,5.64E+05,5.09E+05,,,2,1,,,,,,,,,3.74E+05,,8.49E+05,,,,5.09E+05,,,,,,,,,,,,,,3.45E+03,,9.03E+03,,,,6.87E+04,,,,,,,0.002,FALSE,2.797,2,1,763,84.6,6.52,1,cell adhesion;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,"Pf01179, Pf02727, Pf02728",8639,B2RCI5; hsa:8639; K7ESB3; L0L8N9; Q16853; Q45F94,ENSG00000131471,Phase I - Functionalization of compounds,Amino acid metabolism,2,0,,54.89,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,8.95,other molecular function,0,
Master Protein,High,B7Z596,TPM1,Tropomyosin 1 OS=Homo sapiens OX=9606 GN=TPM1 PE=1 SV=1,10,41,0.01,100,0.627,0.076,-6.64,6.64,-0.67,-3.72,1.00E-17,1.00E-17,4.68E-01,4.75E-02,,3.47E+06,6.64E+04,1.45E+06,,5,4,5,,,,,,1.98E+06,8.85E+06,3.47E+06,4.67E+06,4.42E+05,,1.97E+04,1.22E+05,7.35E+04,6.00E+04,1.85E+06,1.45E+06,1.52E+06,4.04E+05,7.00E+05,,,,,,7.04E+03,1.57E+05,3.20E+04,1.31E+05,4.70E+03,,8.78E+02,9.93E+02,9.90E+03,1.49E+03,3.61E+03,4.07E+05,1.08E+04,9.46E+03,7.46E+03,0,FALSE,33.686,29,4,275,31.7,4.89,10,,other membranes;cytosol;cytoskeleton,Pf00261,,B7Z596,ENSG00000140416,,Cell lineage map for neuronal differentiation,1,0,,82.38,61.46,51.15,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,,,121.3,111.67,107.33,cytoskeletal activity,0,
Master Protein,High,Q9UMX5,NENF,Neudesin OS=Homo sapiens OX=9606 GN=NENF PE=1 SV=1,2,2,0.01,,1.977,0.01,-6.64,,0.98,-6.64,1.00E-17,,6.14E-01,1.00E-17,,1.67E+05,,3.31E+05,,1,,1,,,,,,,1.67E+05,,,,,,,,,,3.31E+05,,,,,,,,,,2.98E+03,,,,,,,,,,9.30E+04,,,,0.001,FALSE,3.958,26,2,172,18.8,5.69,2,signal transduction;other biological processes,non-structural extracellular;other membranes;mitochondrion;ER/Golgi;other cell component,Pf00173,29937,A1KYQ8; hsa:29937; Q53FZ6; Q5TM90; Q9UMX5,ENSG00000117691,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,0,,5.94,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,Medium,A0A8V8TR89,DHDDS,"ditrans,polycis-polyprenyl diphosphate synthase [(2E,6E)-farnesyldiphosphate specific] OS=Homo sapiens OX=9606 GN=DHDDS PE=1 SV=1",1,1,0.01,,0.317,0.01,-6.64,,-1.66,-6.64,1.00E-17,,2.76E-01,1.00E-17,,5.67E+04,,1.79E+04,,2,,1,,,,,,,,8.24E+04,,3.90E+04,,,,,,,1.79E+04,,,,,,,,,,,7.60E+02,,4.15E+02,,,,,,,5.04E+03,,,,0.012,FALSE,2.212,7,1,260,30.4,8.54,1,,,Pf01255,,A0A8V8TR89,ENSG00000117682,,,0,0,,50.56,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,Phospho [S102],FALSE,,,56.75,,2.97,other molecular function,1,Phospho [S102]
Master Protein,High,Q9BRB3,PIGQ,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Homo sapiens OX=9606 GN=PIGQ PE=1 SV=3,1,1,0.01,100,0.46,3.92,-6.64,6.64,-1.12,1.97,1.00E-17,1.00E-17,4.34E-01,1.22E-01,,2.44E+05,4.40E+05,1.12E+05,,1,1,2,,,,,,,2.44E+05,,,,4.40E+05,,,,,,2.14E+05,,5.87E+04,,,,,,,,4.34E+03,,,,2.63E+03,,,,,,6.02E+04,,1.37E+03,,0.002,FALSE,3.016,2,1,760,84,8.05,1,protein metabolism;other metabolic processes,other membranes;ER/Golgi,Pf05024,9091,A2IDE1; D3DU52; hsa:9091; O14927; Q96G00; Q96S22; Q9BRB3; Q9UJH4,ENSG00000007541,,,0,0,,,,80.64,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,102.91,102.91,2.87,,0,
Master Protein,High,A0A2R8Y6I8,ENO1,Enolase 1 (Fragment) OS=Homo sapiens OX=9606 GN=ENO1 PE=1 SV=1,2,4,0.01,100,6.46,0.251,-6.64,6.64,2.69,-2,1.00E-17,1.00E-17,2.04E-02,2.45E-01,,4.82E+05,7.80E+05,3.11E+06,,1,1,2,,,,,,,,,,4.82E+05,,,7.80E+05,,,5.74E+05,,1.69E+07,,,,,,,,,,,,5.12E+03,,,6.34E+03,,,1.12E+03,,1.20E+05,,,0,FALSE,5.532,30,1,33,3.6,9.7,2,,,,,A0A2R8Y6I8,ENSG00000074800,,Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer,2,0,,,,132.11,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,High,n/a,n/a,1,,FALSE,,,388.05,388.05,11.74,,0,
Master Protein,High,P08571,CD14,Monocyte differentiation antigen CD14 OS=Homo sapiens OX=9606 GN=CD14 PE=1 SV=2,1,1,0.01,100,2.991,0.015,-6.64,6.64,1.58,-6.06,1.00E-17,1.00E-17,1.96E-01,4.66E-04,,6.16E+05,2.82E+04,1.89E+06,,5,1,2,,,,,,1.95E+06,7.42E+05,6.16E+05,1.00E+05,5.38E+05,,,,,2.82E+04,,,1.62E+06,,2.21E+06,,,,,,6.92E+03,1.32E+04,5.69E+03,2.83E+03,5.72E+03,,,,,7.01E+02,,,1.15E+04,,2.35E+04,0.004,FALSE,2.589,4,1,375,40.1,6.23,1,stress response;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle,Pf13516,929,hsa:929; P08571; Q53XT5; Q96FR6; Q96L99; Q9UNS3,ENSG00000170458,"Neutrophil degranulation; RSV-host interactions; ER-Phagosome pathway; Caspase activation via Death Receptors in the presence of ligand; MyD88:MAL(TIRAP) cascade initiated on plasma membrane; MyD88-independent TLR4 cascade ; TRIF-mediated programmed cell death; MyD88 deficiency (TLR2/4); IRAK4 deficiency (TLR2/4); Regulation of TLR by endogenous ligand; Activation of IRF3, IRF7 mediated by TBK1, IKBKE; IKK complex recruitment mediated by RIP1; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Respiratory syncytial virus (RSV) attachment and entry; Transfer of LPS from LBP carrier to CD14",Pathogenic Escherichia coli infection; Vitamin D receptor pathway; MAPK signaling pathway; Fibrin complement receptor 3 signaling pathway; Macrophage markers; LTF danger signal response pathway; Regulation of actin cytoskeleton; Network map of SARS-CoV-2 signaling pathway; Acute myeloid leukemia; Toll-like receptor signaling pathway,29,0,,87.58,,21.93,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,,47.88,23.27,3.17,other molecular function,0,
Master Protein,Medium,A0A0U1RQC9,TP53,Cellular tumor antigen p53 OS=Homo sapiens OX=9606 GN=TP53 PE=1 SV=1,1,3,0.01,2.233,0.347,0.012,-6.64,1.16,-1.53,-6.37,1.00E-17,2.06E-01,1.39E-01,7.46E-05,1.23E+04,1.05E+07,4.40E+04,3.64E+06,2,5,4,5,,,,3.33E+03,4.58E+04,1.05E+07,9.05E+06,1.57E+07,1.40E+06,3.90E+07,,9.79E+03,7.76E+04,4.29E+04,4.51E+04,3.64E+06,2.76E+03,3.62E+07,1.93E+05,4.38E+07,,,,3.33E+03,2.36E+03,3.72E+04,1.61E+05,1.45E+05,3.94E+04,4.14E+05,,4.37E+02,6.30E+02,5.79E+03,1.12E+03,7.09E+03,7.75E+02,2.57E+05,4.52E+03,4.67E+05,0.03,FALSE,1.825,1,1,410,45.9,7.2,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,other membranes;nucleus;other cell component,"Pf00870, Pf07710, Pf18521",,A0A0U1RQC9,ENSG00000141510,,AMP-activated protein kinase signaling; miRNA regulation of DNA damage response; Cell cycle; Metastatic brain tumor; Glioblastoma signaling pathways; Spinal cord injury; ATM signaling pathway; Copper homeostasis; RAC1/PAK1/p38/MMP2 pathway; Hepatitis C and hepatocellular carcinoma; Pathways affected in adenoid cystic carcinoma; lncRNA-mediated mechanisms of therapeutic resistance; miRNA regulation of prostate cancer signaling pathways; miRNA regulation of p53 pathway in prostate cancer; Endometrial cancer; PI3K-Akt signaling pathway; Caloric restriction and aging; Hereditary leiomyomatosis and renal cell carcinoma pathway; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer; Ferroptosis; Effect of progerin on genes involved in progeria; MicroRNA network associated with chronic lymphocytic leukemia; Measles virus infection; 22q11.2 copy number variation syndrome; Small cell lung cancer; Head and neck squamous cell carcinoma; Melanoma; Thyroid hormones production and peripheral downstream signaling effects; Unfolded protein response; 16p11.2 proximal deletion syndrome; Pentose phosphate pathway in senescent cells; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis in senescence; TCA cycle in senescence; Pleural mesothelioma; Lipid metabolism in senescent cells; DYRK1A involvement regarding cell proliferation in brain development; 2q37 copy number variation syndrome; Autophagy in pancreatic ductal adenocarcinoma; 11p11.2 copy number variation syndrome ; 8q11.23 (RB1CC1) copy number variation; Omega-6-fatty acids in senescence; DNA damage response; DNA damage response (only ATM dependent),49,0,122.26,94.38,63.15,127.81,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,1,,FALSE,119.95,110.02,146.27,148.17,0,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q969X1,TMBIM1,Protein lifeguard 3 OS=Homo sapiens OX=9606 GN=TMBIM1 PE=1 SV=2,1,2,0.01,100,1.565,0.367,-6.64,6.64,0.65,-1.45,1.00E-17,1.00E-17,7.64E-01,5.20E-01,,8.16E+04,4.68E+04,1.28E+05,,1,1,5,,,,,,8.16E+04,,,,,4.68E+04,,,,,1.80E+05,1.28E+05,1.74E+05,4.53E+04,6.23E+04,,,,,,2.90E+02,,,,,2.80E+02,,,,,3.51E+02,3.59E+04,1.23E+03,1.06E+03,6.63E+02,0,FALSE,5.263,5,1,311,34.6,7.72,1,other biological processes,plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component,Pf01027,64114,B3KQY6; hsa:64114; Q8N1R3; Q8TAM3; Q969X1; Q96K13,ENSG00000135926,Neutrophil degranulation,,1,0,,,,52.72,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,,60.7,60.7,6.84,signal transduction activity or receptor binding,0,
Master Protein,High,A0A590UJB6,KCNAB2,Voltage-gated potassium channel subunit beta-2 OS=Homo sapiens OX=9606 GN=KCNAB2 PE=1 SV=1,1,3,0.01,100,0.01,100,-6.64,6.64,-6.64,6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,,9.99E+06,4.30E+05,,,1,1,,,,,,,,,,,9.99E+06,,,,4.30E+05,,,,,,,,,,,,,,,,1.06E+05,,,,5.80E+04,,,,,,,0,FALSE,7.62,5,1,398,44.1,9.14,1,transport,plasma membrane;other membranes;cytoskeleton;other cell component,Pf00248,,A0A590UJB6,ENSG00000069424,,Metapathway biotransformation Phase I and II,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,9.2,transporter activity,0,
Master Protein,High,P05154,SERPINA5,Plasma serine protease inhibitor OS=Homo sapiens OX=9606 GN=SERPINA5 PE=1 SV=3,1,3,0.01,,0.01,,-6.64,,-6.64,,1.00E-17,,1.00E-17,,,2.24E+07,,,,2,,,,,,,,2.98E+07,,1.68E+07,,,,,,,,,,,,,,,,,,1.06E+05,,1.55E+05,,,,,,,,,,,,,0,FALSE,7.61,7,1,406,45.6,9.26,1,cell organization and biogenesis;transport;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,Pf00079,5104,hsa:5104; P05154; Q07616; Q9UG30,ENSG00000188488,Intrinsic Pathway of Fibrin Clot Formation; Common Pathway of Fibrin Clot Formation,Dengue-2 interactions with complement and coagulation cascades; Complement and coagulation cascades,4,0,,39.39,,,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,11.41,enzyme regulator activity;other molecular function,0,
Master Protein,High,P06132,UROD,Uroporphyrinogen decarboxylase OS=Homo sapiens OX=9606 GN=UROD PE=1 SV=2,3,3,0.01,,0.067,0.01,-6.64,,-3.91,-6.64,1.00E-17,,3.34E-04,1.00E-17,,8.19E+06,,1.50E+06,,1,,3,,,,,,,,,,8.19E+06,,,,,,,1.50E+06,2.59E+06,,1.26E+06,,,,,,,,,,8.71E+04,,,,,,,4.22E+05,1.84E+04,,1.34E+04,0,FALSE,9.017,13,3,367,40.8,6.14,3,other metabolic processes,cytosol;nucleus,Pf01208,7389,A8K762; hsa:7389; P06132; Q16863; Q16883; Q53YB8; Q53ZP6; Q6IB28; Q9BUZ0,ENSG00000126088,Heme biosynthesis,Hemesynthesis defects and porphyrias; Heme biosynthesis,3,0,,,,39.67,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,,,161.77,,10.07,other molecular function,0,
Master Protein,High,P31151,S100A7,Protein S100-A7 OS=Homo sapiens OX=9606 GN=S100A7 PE=1 SV=4,1,1,0.01,100,0.01,100,-6.64,6.64,-6.64,6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,,5.32E+06,3.17E+06,,,2,1,,,,,,,,2.21E+07,1.28E+06,,,,,3.17E+06,,,,,,,,,,,,,,3.92E+05,1.18E+04,,,,,2.57E+04,,,,,,,,0,FALSE,4.439,20,1,101,11.5,6.77,1,stress response;developmental processes;other biological processes,non-structural extracellular;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf01023,6278,hsa:6278; P31151; Q5SY67; Q6FGE3; Q9H1E2,ENSG00000143556,Neutrophil degranulation; Metal sequestration by antimicrobial proteins,,2,0,,125.88,,,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.36,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q00013,MPP1,55 kDa erythrocyte membrane protein OS=Homo sapiens OX=9606 GN=MPP1 PE=1 SV=2,3,7,0.01,100,6.583,0.157,-6.64,6.64,2.72,-2.67,1.00E-17,1.00E-17,1.88E-02,1.24E-01,,3.20E+05,3.60E+05,2.57E+06,,3,1,2,,,,,,1.04E+05,1.12E+06,,3.20E+05,,,3.60E+05,,,,,3.11E+06,2.13E+06,,,,,,,,3.70E+02,1.98E+04,,9.02E+03,,,1.61E+04,,,,,8.73E+05,1.51E+04,,,0,FALSE,10.411,11,3,466,52.3,7.37,3,other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;other cell component,"Pf00018, Pf00595, Pf00625",4354,B4DZV5; G3XAI1; hsa:4354; Q00013; Q2TSB6; Q5J7V5,ENSG00000130830,Sensory processing of sound by outer hair cells of the cochlea,MECP2 and associated Rett syndrome,2,0,,103.8,,26.47,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,,69.76,11.46,18.88,signal transduction activity or receptor binding;kinase activity,0,
Master Protein,High,F6WQW2,RANBP1,RAN binding protein 1 OS=Homo sapiens OX=9606 GN=RANBP1 PE=1 SV=1,2,2,0.01,,0.659,0.01,-6.64,,-0.6,-6.64,1.00E-17,,6.56E-01,1.00E-17,,1.30E+05,,8.56E+04,,1,,1,,,,,,,,,1.30E+05,,,,,,,,8.56E+04,,,,,,,,,,,,3.66E+03,,,,,,,,2.41E+04,,,,0,FALSE,7.28,16,2,278,31.9,8.75,2,cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes,cytosol;cytoskeleton,Pf00638,5902,F6WQW2,ENSG00000099901,,22q11.2 copy number variation syndrome,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,0,,7.01,,0,
Master Protein,High,P28289,TMOD1,Tropomodulin-1 OS=Homo sapiens OX=9606 GN=TMOD1 PE=1 SV=1,3,3,0.01,100,0.238,0.455,-6.64,6.64,-2.07,-1.14,1.00E-17,1.00E-17,4.56E-02,6.08E-01,,3.45E+06,3.74E+05,5.63E+05,,1,1,3,,,,,,,,,,3.45E+06,,,,,3.74E+05,2.64E+05,2.39E+06,,5.63E+05,,,,,,,,,,,3.67E+04,,,,,9.30E+03,5.16E+02,6.70E+05,,1.32E+04,,0,FALSE,12.554,17,3,359,40.5,5.1,3,cell organization and biogenesis;developmental processes;other biological processes,other membranes;cytosol;cytoskeleton,Pf03250,7111,B2RB77; hsa:7111; P28289; Q5T7W3; Q9BUF1,ENSG00000136842,Striated Muscle Contraction,Striated muscle contraction pathway; VEGFA-VEGFR2 signaling,3,0,,,,107.19,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,,,57.48,57.48,11.09,cytoskeletal activity,0,
Master Protein,High,Q8NFQ8,TOR1AIP2,Torsin-1A-interacting protein 2 OS=Homo sapiens OX=9606 GN=TOR1AIP2 PE=1 SV=1,2,4,0.01,100,9.338,0.18,-6.64,6.64,3.22,-2.47,1.00E-17,1.00E-17,7.35E-02,2.29E-01,,1.93E+04,3.25E+04,1.80E+05,,2,2,4,,,,,,,,,1.43E+04,2.60E+04,,1.38E+04,,7.63E+04,,,7.28E+04,4.45E+05,4.80E+04,7.07E+05,,,,,,,,,4.03E+02,2.76E+02,,6.17E+02,,1.03E+04,,,2.04E+04,3.15E+03,1.12E+03,7.53E+03,0,FALSE,7.3,5,1,470,51.2,4.96,2,cell organization and biogenesis;other biological processes,other membranes;ER/Golgi;nucleus,"Pf05609, Pf20443",163590,hsa:163590; Q8NFQ8,ENSG00000169905,,,0,0,,40.93,98.05,99.47,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,,121.45,111.21,10.15,other molecular function,0,
Master Protein,Medium,Q8WUB8,PHF10,PHD finger protein 10 OS=Homo sapiens OX=9606 GN=PHF10 PE=1 SV=3,1,1,0.01,100,0.776,0.491,-6.64,6.64,-0.37,-1.03,1.00E-17,1.00E-17,7.79E-01,6.98E-01,,1.09E+06,4.17E+05,8.49E+05,,1,1,2,,,,,,,,1.09E+06,,,,,,4.17E+05,,,8.75E+05,,,8.24E+05,,,,,,,,1.01E+04,,,,,,5.62E+04,,,2.46E+05,,,8.77E+03,0.026,FALSE,1.865,2,1,498,56,6.62,1,cell organization and biogenesis;developmental processes;other biological processes,nucleus;other cell component,Pf00628,55274,hsa:55274; Q2YDA3; Q53HG8; Q8WUB8; Q9BXD2; Q9NV26,ENSG00000130024,,,0,0,,,,4.19,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,1,,FALSE,,,4.39,4.39,2.07,other molecular function,0,
Master Protein,High,P12314,FCGR1A,High affinity immunoglobulin gamma Fc receptor I OS=Homo sapiens OX=9606 GN=FCGR1A PE=1 SV=2,1,2,0.01,,0.01,,-6.64,,-6.64,,1.00E-17,,1.00E-17,,,9.62E+05,,,,2,,,,,,,,7.42E+05,,,,1.25E+06,,,,,,,,,,,,,,,,2.64E+03,,,,1.33E+04,,,,,,,,,,,0,FALSE,4.832,5,1,374,42.6,7.97,1,cell organization and biogenesis;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00047, Pf13895, Pf13927",2209,hsa:2209; P12314; P12315; Q5QNW7; Q92495; Q92663,ENSG00000150337,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; FCGR activation; Regulation of actin dynamics for phagocytic cup formation; Role of phospholipids in phagocytosis; FCGR3A-mediated IL10 synthesis; Cross-presentation of soluble exogenous antigens (endosomes); Interferon gamma signaling,Microglia pathogen phagocytosis pathway; Acute myeloid leukemia,9,0,,35.93,,,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,8.05,other molecular function,0,
Master Protein,High,P25774,CTSS,Cathepsin S OS=Homo sapiens OX=9606 GN=CTSS PE=1 SV=3,1,1,0.01,,0.63,0.01,-6.64,,-0.67,-6.64,1.00E-17,,6.00E-01,1.00E-17,,1.25E+06,,7.89E+05,,2,,1,,,,,,,,5.07E+05,,3.09E+06,,,,,,,,,,7.89E+05,,,,,,,,4.68E+03,,3.29E+04,,,,,,,,,,8.40E+03,0,FALSE,4.465,4,1,331,37.5,8.34,1,cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes,non-structural extracellular;other cytoplasmic organelle;other cell component,"Pf00112, Pf08246",1520,B4DWC9; D3DV05; hsa:1520; P25774; Q5T5I0; Q6FHS5; Q9BUG3,ENSG00000163131,Neutrophil degranulation; Degradation of the extracellular matrix; MHC class II antigen presentation; Assembly of collagen fibrils and other multimeric structures; Trafficking and processing of endosomal TLR; Endosomal/Vacuolar pathway,,6,0,,101.55,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,1,,FALSE,,,152.95,,3.74,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q6Q759,SPAG17,Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1,1,1,0.01,100,0.101,3.5,-6.64,6.64,-3.3,1.81,1.00E-17,1.00E-17,2.29E-03,2.35E-01,,2.91E+07,8.25E+07,2.95E+06,,1,5,5,,,,,,2.91E+07,,,,,5.09E+06,1.34E+08,1.76E+08,8.99E+06,8.25E+07,9.14E+07,2.95E+06,1.45E+06,6.18E+07,1.27E+06,,,,,,1.03E+05,,,,,3.04E+04,5.98E+06,1.43E+06,1.21E+06,2.05E+06,1.78E+05,8.29E+05,1.03E+04,1.45E+06,1.35E+04,0.001,FALSE,3.191,1,1,2223,251.6,6.24,1,cell organization and biogenesis;transport;other biological processes,non-structural extracellular;cytoskeleton;ER/Golgi;other cell component,Pf14874,200162,Q6Q759; Q8NAZ1; Q9NT21,ENSG00000155761,,,0,0,,,92.75,132.97,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,,,143.48,144.1,3.05,,0,
Master Protein,High,Q9GZT6,CCDC90B,"Coiled-coil domain-containing protein 90B, mitochondrial OS=Homo sapiens OX=9606 GN=CCDC90B PE=1 SV=2",2,4,0.01,100,0.305,0.924,-6.64,6.64,-1.71,-0.11,1.00E-17,1.00E-17,1.00E-01,9.15E-01,,5.18E+06,1.46E+06,1.58E+06,,1,3,3,,,,,,5.18E+06,,,,,1.53E+06,,,2.76E+05,1.46E+06,,2.41E+05,,1.58E+06,3.55E+06,,,,,,1.84E+04,,,,,9.15E+03,,,3.72E+04,3.63E+04,,6.76E+04,,3.70E+04,3.78E+04,0,FALSE,4.954,13,2,254,29.5,7.55,2,,other membranes;mitochondrion,Pf07798,60492,A8K8I4; B3KP87; B4E3L2; hsa:60492; Q3B781; Q9GZT6; Q9GZU6,ENSG00000137500,,,0,0,,,64.72,92.92,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,High,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,,,82.17,126.71,13.89,,0,
Master Protein,High,Q05682,CALD1,Caldesmon OS=Homo sapiens OX=9606 GN=CALD1 PE=1 SV=3,2,2,0.01,,1.162,0.01,-6.64,,0.22,-6.64,1.00E-17,,9.58E-01,1.00E-17,,3.84E+04,,4.46E+04,,3,,2,,,,,,,3.84E+04,,2.11E+04,4.66E+04,,,,,,,4.37E+04,,4.55E+04,,,,,,,,6.82E+02,,5.94E+02,4.96E+02,,,,,,,1.23E+04,,1.06E+03,,0,FALSE,4.515,5,2,793,93.2,5.66,2,cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton,Pf02029,800,A8K0X1; hsa:800; Q05682; Q13978; Q13979; Q14741; Q14742; Q9UD91,ENSG00000122786,Smooth Muscle Contraction,Myometrial relaxation and contraction pathways,2,0,,36.83,,2.92,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,26.16,,5.65,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q86YW5,TREML1,Trem-like transcript 1 protein OS=Homo sapiens OX=9606 GN=TREML1 PE=1 SV=2,1,1,0.01,,0.557,0.01,-6.64,,-0.84,-6.64,1.00E-17,,5.25E-01,1.00E-17,,2.48E+05,,1.38E+05,,1,,4,,,,,,,,2.48E+05,,,,,,,,,2.34E+05,1.82E+05,2.29E+04,1.05E+05,,,,,,,,2.29E+03,,,,,,,,,6.57E+04,1.29E+03,5.36E+02,1.12E+03,0.004,FALSE,2.549,5,1,311,32.7,6.05,1,stress response;signal transduction,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component,,340205,hsa:340205; Q496B3; Q86YW5; Q8IWY1; Q8IWY2,ENSG00000161911,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,,1,0,,,,67.79,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,,53.88,,3.15,,0,
Master Protein,High,P61201,COPS2,COP9 signalosome complex subunit 2 OS=Homo sapiens OX=9606 GN=COPS2 PE=1 SV=1,1,1,0.01,,1.027,0.01,-6.64,,0.04,-6.64,1.00E-17,,8.69E-01,1.00E-17,,3.94E+05,,4.05E+05,,3,,1,,,,,,3.94E+05,,5.26E+05,,2.38E+05,,,,,,,4.05E+05,,,,,,,,,1.40E+03,,4.86E+03,,2.53E+03,,,,,,,1.14E+05,,,,0.005,FALSE,2.533,3,1,443,51.6,5.53,1,cell cycle OR cell proliferation;protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes,cytosol;nucleus;other cell component,Pf01399,9318,hsa:9318; O88950; P61201; Q15647; Q6FGP4; Q9BY54; Q9R249; Q9UNI2; Q9UNQ5,ENSG00000166200,Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; RHOBTB1 GTPase cycle; DNA Damage Recognition in GG-NER,Ciliary landscape,6,0,,37.31,,,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,37.19,,2.63,other molecular function,0,
Master Protein,High,P23229,ITGA6,Integrin alpha-6 OS=Homo sapiens OX=9606 GN=ITGA6 PE=1 SV=5,2,3,0.01,,0.083,0.01,-6.64,,-3.59,-6.64,1.00E-17,,6.38E-03,1.00E-17,,5.96E+05,,4.96E+04,,3,,1,,,,,,,5.96E+05,3.99E+05,1.75E+07,,,,,,,,4.96E+04,,,,,,,,,,1.06E+04,3.69E+03,4.92E+05,,,,,,,,1.39E+04,,,,0,FALSE,6.929,4,2,1130,126.5,6.61,2,cell adhesion;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,"Pf01839, Pf08441, Pf20805, Pf20806",3655,B2RMU9; B4DG69; B4DKB8; C4AM96; G5E9H1; hsa:3655; P23229; Q08443; Q0MRC7; Q14646; Q16508; Q53RX7; Q59HB7; Q86VL6; Q9UCT1; Q9UN03,ENSG00000091409,Assembly of collagen fibrils and other multimeric structures; Integrin cell surface interactions; Syndecan interactions; Laminin interactions; Basigin interactions; Type I hemidesmosome assembly,Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; Alpha 6 beta 4 signaling pathway; Mammary gland development pathway - Embryonic development (Stage 1 of 4); Focal adhesion; Regulation of apoptosis by parathyroid hormone-related protein; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Small cell lung cancer; Pleural mesothelioma; GDNF signaling; 11p11.2 copy number variation syndrome ; Cell lineage map for neuronal differentiation,20,0,,159.2,,,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,48.96,,10.12,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9Y6X5,ENPP4,Bis(5'-adenosyl)-triphosphatase ENPP4 OS=Homo sapiens OX=9606 GN=ENPP4 PE=1 SV=3,1,2,0.01,,0.01,,-6.64,,-6.64,,1.00E-17,,1.00E-17,,,6.96E+06,,,,1,,,,,,,,,,,,6.96E+06,,,,,,,,,,,,,,,,,,,,7.40E+04,,,,,,,,,,,0.002,FALSE,2.992,3,1,453,51.6,6.15,1,other metabolic processes;stress response;other biological processes,plasma membrane;other membranes,Pf01663,22875,A8K5G1; hsa:22875; Q7L2N1; Q9Y6X5,ENSG00000001561,Neutrophil degranulation,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.92,other molecular function,0,
Master Protein,High,Q9Y5K6,CD2AP,CD2-associated protein OS=Homo sapiens OX=9606 GN=CD2AP PE=1 SV=1,5,7,0.01,100,1.495,0.405,-6.64,6.64,0.58,-1.3,1.00E-17,1.00E-17,6.51E-01,5.62E-01,,3.80E+05,1.10E+05,1.50E+06,,3,1,1,,,,,,,,3.80E+05,4.24E+04,6.63E+05,,,,1.10E+05,,,1.50E+06,,,,,,,,,,,3.51E+03,1.19E+03,7.05E+03,,,,1.48E+04,,,4.21E+05,,,,0,FALSE,19.056,9,5,639,71.4,6.4,5,cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytoskeleton;nucleus;other cell component,"Pf00018, Pf07653, Pf14604",23607,A6NL34; hsa:23607; Q5VYA3; Q9UG97; Q9Y5K6,ENSG00000198087,Nephrin family interactions,Primary focal segmental glomerulosclerosis (FSGS); Nephrotic syndrome; Genes controlling nephrogenesis; GDNF signaling,5,0,,85.89,,,n/a,n/a,n/a,High,High,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,121.34,0,22.92,cytoskeletal activity;other molecular function,0,
Master Protein,High,P27701,CD82,CD82 antigen OS=Homo sapiens OX=9606 GN=CD82 PE=1 SV=1,4,10,0.01,17.661,0.282,0.47,-6.64,4.14,-1.83,-1.09,1.00E-17,1.65E-04,1.62E-01,6.02E-01,1.79E+04,1.37E+06,2.41E+05,5.79E+05,1,4,3,5,,,,1.79E+04,,,9.58E+05,1.96E+06,4.35E+05,2.31E+06,,4.13E+04,,6.13E+05,2.41E+05,4.34E+05,5.79E+05,8.76E+05,1.01E+05,9.40E+05,,,,1.79E+04,,,1.70E+04,1.81E+04,1.22E+04,2.46E+04,,1.84E+03,,8.26E+04,5.98E+03,8.46E+02,1.63E+05,6.21E+03,2.37E+03,1.00E+04,0,FALSE,16.837,22,4,267,29.6,5.24,4,,plasma membrane;other membranes,Pf00335,3732,D3DQN6; E9PC70; hsa:3732; P27701; Q7Z2D4; Q7Z5N2,ENSG00000085117,,16p11.2 distal deletion syndrome; Extrafollicular and follicular B cell activation by SARS-CoV-2; 11p11.2 copy number variation syndrome,3,0,,61.47,97.28,58.36,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,82.55,155.5,106.1,126.92,26.8,,0,
Master Protein,Medium,A0A0G2JK05,LY6G6F-LY6G6D,LY6G6F-LY6G6D readthrough OS=Homo sapiens OX=9606 GN=LY6G6F-LY6G6D PE=4 SV=1,1,4,0.01,100,1.428,0.385,-6.64,6.64,0.51,-1.38,1.00E-17,1.00E-17,7.57E-01,5.54E-01,,7.01E+05,3.85E+05,1.00E+06,,1,2,3,,,,,,7.01E+05,,,,,,,,5.02E+05,2.95E+05,2.35E+07,3.02E+05,,1.00E+06,,,,,,,2.49E+03,,,,,,,,6.77E+04,7.33E+03,4.59E+04,8.50E+04,,2.34E+04,,0.019,FALSE,2.005,2,1,382,40.9,7.81,1,,plasma membrane;other membranes,Pf07686,,A0A0G2JK05,ENSG00000258880,,,0,0,,,36.74,159.62,n/a,High,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,1,,FALSE,,,103.45,101.86,1.66,,0,
Master Protein,High,Q96IL0,COA8,Cytochrome c oxidase assembly factor 8 OS=Homo sapiens OX=9606 GN=COA8 PE=1 SV=3,1,1,0.01,,0.038,0.01,-6.64,,-4.73,-6.64,1.00E-17,,2.73E-04,1.00E-17,,6.97E+05,,2.62E+04,,5,,1,,,,,,4.76E+05,1.83E+07,3.26E+05,5.80E+06,6.97E+05,,,,,,,,,2.62E+04,,,,,,,1.69E+03,3.26E+05,3.00E+03,1.64E+05,7.41E+03,,,,,,,,,6.13E+02,,0.005,FALSE,2.464,4,1,206,24.1,9.96,1,cell organization and biogenesis;stress response;signal transduction;other biological processes,other membranes;mitochondrion,Pf10231,84334,H7C2Z1; hsa:84334; Q53G28; Q96IL0,ENSG00000256053,,,0,0,,150.79,,,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,,78.99,,2.08,,0,
Master Protein,High,A0A2R8YEL6,GCLC,Glutamate--cysteine ligase (Fragment) OS=Homo sapiens OX=9606 GN=GCLC PE=1 SV=1,2,3,0.01,100,0.598,0.285,-6.64,6.64,-0.74,-1.81,1.00E-17,1.00E-17,5.92E-01,4.02E-01,,1.10E+05,1.83E+04,6.43E+04,,3,2,3,,,,,,1.19E+05,2.08E+04,,1.10E+05,,,2.15E+04,,1.56E+04,,,2.01E+05,6.43E+04,1.24E+04,,,,,,,4.23E+02,3.69E+02,,3.09E+03,,,9.58E+02,,2.11E+03,,,5.63E+04,4.56E+02,2.91E+02,,0,FALSE,8.463,5,2,639,72.9,6.09,2,other metabolic processes,,Pf03074,,A0A2R8YEL6,ENSG00000001084,,"Trans-sulfuration, one-carbon metabolism and related pathways; Nuclear receptors meta-pathway; NRF2 pathway; One-carbon metabolism and related pathways; Ferroptosis; Vitamin D-sensitive calcium signaling in depression",6,0,,65.19,22.16,105.12,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,,99.68,119.25,10.38,other molecular function,0,
Master Protein,High,Q9NT62,ATG3,Ubiquitin-like-conjugating enzyme ATG3 OS=Homo sapiens OX=9606 GN=ATG3 PE=1 SV=1,1,1,0.01,,3.063,0.01,-6.64,,1.61,-6.64,1.00E-17,,3.00E-01,1.00E-17,,2.88E+05,,8.82E+05,,3,,4,,,,,,1.53E+06,1.54E+05,2.88E+05,,,,,,,,8.92E+05,3.33E+05,8.30E+06,,8.71E+05,,,,,,5.44E+03,2.75E+03,2.66E+03,,,,,,,,1.74E+03,9.36E+04,5.88E+04,,9.28E+03,0.003,FALSE,2.706,4,1,314,35.8,4.74,1,cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;other cell component,Pf03987,64422,hsa:64422; Q6PKC5; Q9H6L9; Q9NT62,ENSG00000144848,Macroautophagy,Nanoparticle triggered autophagic cell death; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Autophagy; Clock-controlled autophagy in bone metabolism; ADHD and autism (ASD) linked metabolic pathways and SNP,6,0,,115.43,,146.55,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,,,120.39,,2.8,other molecular function,0,
Master Protein,High,Q9NZK5,ADA2,Adenosine deaminase 2 OS=Homo sapiens OX=9606 GN=ADA2 PE=1 SV=2,1,1,0.01,,0.33,0.01,-6.64,,-1.6,-6.64,1.00E-17,,1.78E-01,1.00E-17,,5.11E+05,,1.69E+05,,2,,1,,,,,,,,9.60E+04,,2.72E+06,,,,,,,,1.69E+05,,,,,,,,,,8.85E+02,,2.89E+04,,,,,,,,1.19E+03,,,0.001,FALSE,4.13,4,1,511,58.9,7.91,1,other metabolic processes;signal transduction,non-structural extracellular;other cytoplasmic organelle,"Pf00962, Pf08451",51816,A8K9H4; hsa:51816; Q6ICF1; Q86UB6; Q8NCJ2; Q96K41; Q9NZK5,ENSG00000093072,Neutrophil degranulation; Surfactant metabolism,,2,0,,131.79,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,,380.93,,3.19,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9UKY7,CDV3,Protein CDV3 homolog OS=Homo sapiens OX=9606 GN=CDV3 PE=1 SV=1,2,3,0.01,,5.394,0.01,-6.64,,2.43,-6.64,1.00E-17,,1.12E-01,1.00E-17,,1.14E+05,,6.17E+05,,1,,2,,,,,,,,,,1.14E+05,,,,,,,3.01E+05,1.26E+06,,,,,,,,,,,,1.22E+03,,,,,,,8.47E+04,8.94E+03,,,0,FALSE,5.65,15,2,258,27.3,6.4,2,,plasma membrane;other membranes;cytosol;other cell component,Pf15359,55573,B3KUC2; hsa:55573; Q96IP9; Q9UKY7,ENSG00000091527,,,0,0,,,,86.87,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,,115.42,,10.22,,0,
Master Protein,High,Q9BSL1,UBAC1,Ubiquitin-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBAC1 PE=1 SV=1,4,4,0.01,,0.528,0.01,-6.64,,-0.92,-6.64,1.00E-17,,3.98E-01,1.00E-17,,6.07E+05,,5.81E+05,,1,,1,,,,,,,,6.07E+05,,,,,,,,,5.81E+05,,,,,,,,,,,5.60E+03,,,,,,,,,1.63E+05,,,,0,FALSE,23.46,19,4,405,45.3,4.92,4,protein metabolism;other metabolic processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,Pf00627,10422,hsa:10422; O75500; Q9BSL1; Q9UMW7,ENSG00000130560,Antigen processing: Ubiquitination & Proteasome degradation,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,0,,17.24,other molecular function,0,
Master Protein,High,Q9UDY6,TRIM10,Tripartite motif-containing protein 10 OS=Homo sapiens OX=9606 GN=TRIM10 PE=1 SV=3,2,2,0.01,,2.524,0.01,-6.64,,1.34,-6.64,1.00E-17,,4.54E-01,1.00E-17,,1.02E+05,,2.58E+05,,1,,2,,,,,,,1.02E+05,,,,,,,,,,2.16E+05,,,3.09E+05,,,,,,,1.82E+03,,,,,,,,,,6.06E+04,,,3.29E+03,0,FALSE,11.454,7,2,481,55,5.97,2,protein metabolism;other metabolic processes;stress response;other biological processes,other cell component,"Pf00097, Pf00622, Pf00643, Pf13765",10107,A6NF84; hsa:10107; Q5SRJ5; Q5SRK8; Q86Z08; Q96QB6; Q9C023; Q9C024; Q9UDY6,ENSG00000137394; ENSG00000204613; ENSG00000227472; ENSG00000229346; ENSG00000229381; ENSG00000235025; ENSG00000237192; ENSG00000237703,Interferon gamma signaling,,1,0,,,,25.2,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,1,,FALSE,,,26.85,,7.2,other molecular function,0,
Master Protein,Medium,O43866,CD5L,CD5 antigen-like OS=Homo sapiens OX=9606 GN=CD5L PE=1 SV=1,1,1,0.01,,0.01,,-6.64,,-6.64,,1.00E-17,,1.00E-17,,,3.54E+05,,,,1,,,,,,,,,,,3.54E+05,,,,,,,,,,,,,,,,,,,,9.96E+03,,,,,,,,,,,,0.011,FALSE,2.256,6,1,347,38.1,5.47,1,protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,Pf00530,922,A8K7M5; hsa:922; O43866; Q6UX63,ENSG00000073754,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.87,other molecular function,0,
Master Protein,High,P15309,ACP3,Prostatic acid phosphatase OS=Homo sapiens OX=9606 GN=ACP3 PE=1 SV=3,2,2,0.01,100,0.201,2.034,-6.64,6.64,-2.32,1.02,1.00E-17,1.00E-17,1.41E-01,4.72E-01,,7.98E+04,3.26E+04,1.60E+04,,2,3,1,,,,,,,4.41E+04,1.44E+05,,,,5.99E+03,3.28E+04,3.26E+04,,,,,1.60E+04,,,,,,,,7.85E+02,1.33E+03,,,,2.68E+02,2.66E+02,4.39E+03,,,,,3.75E+02,,0.001,FALSE,3.693,8,2,386,44.5,6.24,2,cell organization and biogenesis;other metabolic processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00328,55,D3DNC6; hsa:55; P15309; Q5FBY0; Q96KY0; Q96QK9; Q96QM0,ENSG00000014257,Neutrophil degranulation,,1,0,,75.15,64.78,,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,93,0.85,5,other molecular function,0,
Master Protein,High,Q96P20,NLRP3,"NACHT, LRR and PYD domains-containing protein 3 OS=Homo sapiens OX=9606 GN=NLRP3 PE=1 SV=3",1,1,0.01,100,0.056,0.152,-6.64,6.64,-4.16,-2.72,1.00E-17,1.00E-17,1.03E-04,1.80E-01,,3.42E+06,2.91E+04,1.91E+05,,1,2,1,,,,,,,3.42E+06,,,,,,,2.96E+04,2.85E+04,,,,1.91E+05,,,,,,,,6.09E+04,,,,,,,3.99E+03,7.09E+02,,,,4.47E+03,,0.007,FALSE,2.412,2,1,1036,118.1,6.65,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,non-structural extracellular;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf02758, Pf05729, Pf13516, Pf14484, Pf17776, Pf17779",114548,A0A024R5Q0; B2RC97; B7ZKS9; B7ZKT2; B7ZKT3; hsa:114548; O75434; Q17RS2; Q59H68; Q5JQS8; Q5JQS9; Q6TG35; Q8TCW0; Q8TEU9; Q8WXH9; Q96P20,,SARS-CoV-2 activates/modulates innate and adaptive immune responses; SARS-CoV-1 activates/modulates innate immune responses; Cytoprotection by HMOX1; Metalloprotease DUBs; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection,IL1 and megakaryocytes in obesity,7,0,,,2.68,,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,,0,2.81,2.59,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q08554,DSC1,Desmocollin-1 OS=Homo sapiens OX=9606 GN=DSC1 PE=1 SV=2,3,5,0.01,100,0.597,0.238,-6.64,6.64,-0.74,-2.07,1.00E-17,1.00E-17,4.51E-01,2.39E-01,,2.08E+06,6.67E+04,8.03E+05,,1,5,4,,,,,,2.08E+06,,,,,2.94E+06,6.67E+04,1.95E+05,5.25E+04,3.95E+04,3.12E+06,,1.62E+06,1.50E+05,3.98E+05,,,,,,7.40E+03,,,,,1.76E+04,2.98E+03,1.58E+03,7.08E+03,9.80E+02,6.09E+03,,1.15E+04,3.50E+03,4.23E+03,0,FALSE,8.157,5,3,894,99.9,5.43,3,cell adhesion,plasma membrane;other membranes;other cell component,"Pf00028, Pf08758",1823,hsa:1823; Q08554; Q9HB01,ENSG00000134765,Neutrophil degranulation; Formation of the cornified envelope,VEGFA-VEGFR2 signaling,4,0,,,193.87,102.97,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,,,82.78,129.6,8.59,other molecular function,0,
Master Protein,Medium,G5E948,MAP4K4,Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP4K4 PE=1 SV=3,1,1,0.01,100,2.976,0.091,-6.64,6.64,1.57,-3.46,1.00E-17,1.00E-17,3.40E-01,8.51E-02,,1.37E+04,3.72E+03,4.08E+04,,1,1,1,,,,,,,,,,1.37E+04,,,,3.72E+03,,,4.08E+04,,,,,,,,,,,,,1.46E+02,,,,5.01E+02,,,1.15E+04,,,,0.025,FALSE,1.876,1,1,1384,157.7,7.37,1,other biological processes,,"Pf00069, Pf00780",,G5E948,ENSG00000071054,,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-YAP signaling; Pleural mesothelioma,3,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,0,0,0,kinase activity;other molecular function,0,
Master Protein,Medium,P10124,SRGN,Serglycin OS=Homo sapiens OX=9606 GN=SRGN PE=1 SV=3,1,2,0.01,,0.819,0.01,-6.64,,-0.29,-6.64,1.00E-17,,8.22E-01,1.00E-17,,1.30E+06,,1.07E+06,,1,,3,,,,,,1.30E+06,,,,,,,,,,1.07E+06,1.82E+05,,1.68E+06,,,,,,,4.63E+03,,,,,,,,,,2.08E+03,5.10E+04,,3.92E+04,,0.015,FALSE,2.111,8,1,158,17.6,4.96,1,cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes,non-structural extracellular;ER/Golgi;other cytoplasmic organelle;other cell component,Pf04360,5552,B2R4L7; hsa:5552; P10124; Q5VW06,ENSG00000122862,Platelet degranulation,Glucocorticoid receptor pathway; Nuclear receptors meta-pathway,3,0,,,,77.09,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,1,,FALSE,,,53.86,,4.77,,0,
Master Protein,High,A0A8V8TMY4,PFKP,ATP-dependent 6-phosphofructokinase OS=Homo sapiens OX=9606 GN=PFKP PE=1 SV=1,1,1,0.01,,0.844,0.01,-6.64,,-0.24,-6.64,1.00E-17,,8.11E-01,1.00E-17,,1.22E+05,,1.03E+05,,1,,4,,,,,,1.22E+05,,,,,,,,,,,5.28E+04,9.47E+04,2.95E+05,1.12E+05,,,,,,4.33E+02,,,,,,,,,,,1.48E+04,6.71E+02,6.90E+03,1.19E+03,0.001,FALSE,3.813,2,1,835,90.8,7.11,1,other metabolic processes,other cell component,Pf00365,,A0A8V8TMY4,ENSG00000067057,,Cori cycle; Clear cell renal cell carcinoma pathways,2,0,,,,77.29,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,,54.61,,3.21,kinase activity;other molecular function,0,
Master Protein,High,P48426,PIP4K2A,Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Homo sapiens OX=9606 GN=PIP4K2A PE=1 SV=2,2,2,0.01,,0.01,,-6.64,,-6.64,,1.00E-17,,1.00E-17,,,1.92E+05,,,,4,,,,,,,,,2.12E+05,5.94E+05,1.62E+05,1.74E+05,,,,,,,,,,,,,,,,,3.78E+03,5.48E+03,4.56E+03,1.85E+03,,,,,,,,,,,0,FALSE,5.081,6,2,406,46.2,6.99,2,cell organization and biogenesis;other metabolic processes;transport;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf01504,5305,B0YJ66; B4DGX2; D3DRV1; hsa:5305; P48426; P53807; Q5VUX3,ENSG00000150867,"Synthesis of PIPs at the plasma membrane; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; PI5P Regulates TP53 Acetylation; Synthesis of PIPs in the nucleus",Regulation of actin cytoskeleton; G13 signaling pathway,6,0,,72.47,,,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,2.31,kinase activity;other molecular function,0,
Master Protein,High,O60763,USO1,General vesicular transport factor p115 OS=Homo sapiens OX=9606 GN=USO1 PE=1 SV=2,3,5,0.01,0.892,0.041,0.408,-6.64,-0.17,-4.6,-1.29,1.00E-17,8.05E-01,1.54E-05,5.21E-01,1.01E+05,3.04E+06,5.11E+04,4.39E+05,5,2,2,4,2.53E+05,1.31E+05,9.95E+04,3.57E+04,1.01E+05,,,1.20E+05,,7.69E+07,,,1.41E+05,,1.85E+04,,2.33E+05,8.28E+05,2.13E+05,1.71E+06,1.00E+03,4.99E+02,9.72E+02,3.57E+04,5.18E+03,,,1.11E+03,,8.18E+05,,,1.15E+03,,4.59E+02,,6.54E+04,5.86E+03,4.99E+03,1.82E+04,0,FALSE,12.529,7,3,962,107.8,4.91,3,cell organization and biogenesis;transport;signal transduction;other biological processes,other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,"Pf04869, Pf04871, Pf18770",8615,B2RAQ0; hsa:8615; O60763; Q6PK63; Q86TB8; Q8N592,ENSG00000138768,COPI-mediated anterograde transport; COPII-mediated vesicle transport; Golgi Cisternae Pericentriolar Stack Reorganization,,3,0,64.53,140.98,108.75,94.35,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,High,Peak Found,High,1,,FALSE,118.03,101.47,1098.93,86.34,10.45,,0,
Master Protein,High,P35998,PSMC2,26S proteasome regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMC2 PE=1 SV=3,2,2,0.01,100,0.744,0.211,-6.64,6.64,-0.43,-2.25,1.00E-17,1.00E-17,6.12E-01,1.89E-01,,5.96E+05,9.33E+04,4.43E+05,,2,3,1,,,,,,,,1.39E+06,,2.55E+05,2.46E+05,,,9.33E+04,6.60E+04,,4.43E+05,,,,,,,,,,,1.28E+04,,2.71E+03,1.47E+03,,,1.26E+04,1.64E+03,,1.25E+05,,,,0,FALSE,5.59,6,2,433,48.6,5.95,2,protein metabolism;other metabolic processes;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf00004, Pf17862, Pf21236",5701,A4D0Q1; B7Z5E2; hsa:5701; P35998; Q3LIA5; Q9UDI3,ENSG00000161057,Downstream TCR signaling; FCERI mediated NF-kB activation; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,64,0,,97.57,71.86,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,,141.31,61.22,5.9,other molecular function,0,
Master Protein,High,G3V1A6,GSDMD,"Gasdermin domain containing 1, isoform CRA_d OS=Homo sapiens OX=9606 GN=GSDMD PE=1 SV=1",1,1,0.01,,7.141,0.01,-6.64,,2.84,-6.64,1.00E-17,,2.53E-02,1.00E-17,,2.62E+05,,1.87E+06,,1,,3,,,,,,,,,,2.62E+05,,,,,,,7.43E+05,1.87E+06,,1.90E+06,,,,,,,,,,2.78E+03,,,,,,,2.09E+05,1.32E+04,,2.02E+04,0.002,FALSE,2.797,3,1,532,57.7,5.39,1,other biological processes,plasma membrane;other membranes;nucleus,"Pf04598, Pf17708",,G3V1A6,ENSG00000104518; ENSG00000278718,,STING pathway in Kawasaki-like disease and COVID-19,1,0,,,,43.85,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,1,,FALSE,,,2.5,,2.17,,0,
Master Protein,High,H3BTB6,CMC2,COX assembly mitochondrial protein OS=Homo sapiens OX=9606 GN=CMC2 PE=1 SV=1,1,1,0.01,100,0.143,1.142,-6.64,6.64,-2.81,0.19,1.00E-17,1.00E-17,2.28E-02,7.64E-01,,1.03E+06,2.63E+05,1.47E+05,,2,3,3,,,,,,,,1.08E+06,,9.79E+05,,,2.63E+05,5.83E+05,7.03E+04,6.66E+05,6.15E+04,,1.47E+05,,,,,,,,,1.00E+04,,1.04E+04,,,2.14E+03,7.86E+04,1.75E+03,1.30E+03,1.73E+04,,3.44E+03,,0.001,FALSE,3.175,24,1,93,10.6,8.27,1,,mitochondrion,Pf08583,,H3BTB6,ENSG00000103121,,,0,0,,7.22,84.75,112.23,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,,115.51,96.93,2.82,,0,
Master Protein,Medium,E5RH38,TMEM67,Transmembrane protein 67 OS=Homo sapiens OX=9606 GN=TMEM67 PE=1 SV=1,1,1,0.01,100,0.01,100,-6.64,6.64,-6.64,6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,,4.54E+05,2.35E+05,,,2,3,,,,,,,,3.40E+05,,6.05E+05,,,,2.35E+05,1.15E+06,1.67E+05,,,,,,,,,,,,6.05E+03,,1.70E+04,,,,1.91E+03,1.55E+05,4.14E+03,,,,,,0.026,FALSE,1.868,9,1,119,12.8,8.41,1,cell organization and biogenesis,other cell component,,,E5RH38,ENSG00000164953,,Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome,3,0,,39.62,106.16,,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.83,,0,
Master Protein,High,Q9P2J5,LARS1,"Leucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=LARS1 PE=1 SV=2",3,3,0.01,,1.233,0.01,-6.64,,0.3,-6.64,1.00E-17,,9.27E-01,1.00E-17,,1.28E+05,,2.05E+05,,4,,5,,,,,,1.34E+05,,1.33E+05,3.13E+04,1.24E+05,,,,,,4.83E+05,2.05E+05,1.32E+06,1.44E+04,1.38E+05,,,,,,4.75E+02,,1.22E+03,8.82E+02,1.32E+03,,,,,,9.41E+02,5.77E+04,9.35E+03,3.37E+02,1.47E+03,0,FALSE,13.665,3,3,1176,134.4,7.3,3,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00133, Pf08264",51520,A2RRR4; A7E266; B4DJ10; hsa:51520; Q2TU79; Q9NSE1; Q9P2J5,ENSG00000133706,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,,2,0,,47.04,,121.52,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,,135.25,,8.21,enzyme regulator activity;other molecular function,0,
Master Protein,High,G3V0E4,PMPCB,"Peptidase (Mitochondrial processing) beta, isoform CRA_c OS=Homo sapiens OX=9606 GN=PMPCB PE=1 SV=1",4,5,0.01,100,0.01,100,-6.64,6.64,-6.64,6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,,6.44E+05,4.63E+05,,,2,2,,,,,,,1.06E+06,,3.91E+05,,,,,,5.23E+05,4.11E+05,,,,,,,,,,,3.76E+03,,3.61E+03,,,,,,7.05E+04,1.02E+04,,,,,,0,FALSE,10.671,10,4,490,54.2,6.83,4,protein metabolism,mitochondrion,"Pf00675, Pf05193",,G3V0E4,ENSG00000105819,,,0,0,,65.08,17,,n/a,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,12,other molecular function,0,
Master Protein,High,P18084,ITGB5,Integrin beta-5 OS=Homo sapiens OX=9606 GN=ITGB5 PE=1 SV=1,1,1,0.01,,0.01,,-6.64,,-6.64,,1.00E-17,,1.00E-17,,,1.23E+06,,,,1,,,,,,,,,,1.23E+06,,,,,,,,,,,,,,,,,,,,1.13E+04,,,,,,,,,,,,,0,FALSE,5.921,3,1,799,88,6.06,1,cell adhesion;cell organization and biogenesis;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,"Pf00362, Pf07965, Pf08725, Pf17205, Pf18372",3693,B0LPF8; B2RD70; hsa:3693; P18084,ENSG00000082781,Integrin cell surface interactions; ECM proteoglycans; Syndecan interactions; Smooth Muscle Contraction; Molecules associated with elastic fibres; TGF-beta receptor signaling activates SMADs; Cross-presentation of particulate exogenous antigens (phagosomes),Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; miRNA targets in ECM and membrane receptors; Focal adhesion; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms,15,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.8,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q14019,COTL1,Coactosin-like protein OS=Homo sapiens OX=9606 GN=COTL1 PE=1 SV=3,1,2,0.01,100,0.033,1.874,-6.64,6.64,-4.91,0.91,1.00E-17,1.00E-17,7.65E-06,4.50E-01,,9.01E+06,5.61E+05,2.99E+05,,1,1,1,,,,,,,,,,9.01E+06,,,,,5.61E+05,,2.99E+05,,,,,,,,,,,,,9.58E+04,,,,,1.39E+04,,8.41E+04,,,,0.001,FALSE,4.175,19,1,142,15.9,5.67,1,cell organization and biogenesis;stress response,non-structural extracellular;cytosol;cytoskeleton;nucleus;other cell component,Pf00241,23406,B2RDU3; D3DUL9; hsa:23406; Q14019; Q86XM5,ENSG00000103187,Neutrophil degranulation,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,,0,0,6.25,cytoskeletal activity;other molecular function,0,
Master Protein,High,P68036,UBE2L3,Ubiquitin-conjugating enzyme E2 L3 OS=Homo sapiens OX=9606 GN=UBE2L3 PE=1 SV=1,1,2,0.01,100,0.48,1.779,-6.64,6.64,-1.06,0.83,1.00E-17,1.00E-17,3.50E-01,4.73E-01,,3.63E+05,3.10E+05,1.74E+05,,1,1,1,,,,,,,,,3.63E+05,,,,,3.10E+05,,,1.74E+05,,,,,,,,,,,,1.02E+04,,,,,4.18E+04,,,4.90E+04,,,,0.001,FALSE,3.779,16,1,154,17.9,8.51,1,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,Pf00179,7332,B2R4A7; B4DDG1; B4DSZ4; E7EWS7; hsa:7332; P51966; P68036; P70653; Q9HAV1,ENSG00000185651,E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; Regulation of necroptotic cell death; Regulation of TNFR1 signaling,Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway,7,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,0,0,7.79,enzyme regulator activity;other molecular function,0,
Master Protein,Medium,Q5VY43,PEAR1,Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1,1,1,0.01,,0.824,0.01,-6.64,,-0.28,-6.64,1.00E-17,,7.03E-01,1.00E-17,,3.91E+05,,3.22E+05,,2,,1,,,,,,,,1.07E+06,1.43E+05,,,,,,,3.22E+05,,,,,,,,,,,,9.89E+03,4.02E+03,,,,,,,6.28E+02,,,,,0.023,FALSE,1.938,2,1,1037,110.6,6.81,1,cell adhesion;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;other cell component,Pf00053,375033,hsa:375033; Q5VY43; Q8TEK2,ENSG00000187800,,,0,0,,108.2,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,1,,FALSE,,,176.14,,3.25,other molecular function,0,
Master Protein,High,Q06787,FMR1,Fragile X messenger ribonucleoprotein 1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1,2,2,0.01,100,15.985,0.1,-6.64,6.64,4,-3.33,1.00E-17,1.00E-17,4.58E-03,7.57E-02,,1.03E+05,1.45E+05,1.47E+06,,3,2,3,,,,,,,,1.20E+05,4.65E+04,1.03E+05,9.32E+04,,,2.27E+05,,7.43E+05,,1.47E+06,,2.88E+06,,,,,,,,1.11E+03,1.31E+03,1.10E+03,5.57E+02,,,3.06E+04,,1.45E+03,,1.04E+04,,3.06E+04,0,FALSE,7.209,5,1,632,71.1,7.42,2,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00013, Pf05641, Pf12235, Pf16098, Pf17904, Pf18336",2332,A6NNH4; D3DWT0; D3DWT1; D3DWT2; G8JL90; hsa:2332; Q06787; Q16578; Q5PQZ6; Q99054,ENSG00000102081,,Ovarian infertility; Serotonin and anxiety; Prader-Willi and Angelman syndrome; Fragile X syndrome; Disruption of postsynaptic signaling by CNV; 15q11.2 copy number variation syndrome; Primary ovarian insufficiency,7,0,,42.86,59.16,63.87,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,1,,FALSE,,,81.37,68.74,5.17,cytoskeletal activity;translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P61221,ABCE1,ATP-binding cassette sub-family E member 1 OS=Homo sapiens OX=9606 GN=ABCE1 PE=1 SV=1,2,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,3.84E+05,,,,1,,,,,,,,,,,,,,,,,3.84E+05,,,,,,,,,,,,,,,,,,,,1.08E+05,,,,0,FALSE,10.125,6,2,599,67.3,8.34,2,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,cytosol;mitochondrion;translational apparatus;other cell component,"Pf00005, Pf00037, Pf04068",6059,hsa:6059; O88793; P61221; Q13181; Q13864; Q6NR76; Q96AL0; Q96B10; Q99K66,ENSG00000164163,OAS antiviral response; Interferon alpha/beta signaling,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,10.89,enzyme regulator activity;translation activity;other molecular function,0,
Master Protein,High,P31949,S100A11,Protein S100-A11 OS=Homo sapiens OX=9606 GN=S100A11 PE=1 SV=2,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.82E+05,,,,1,,,,,,,,,,,,,,,,,2.82E+05,,,,,,,,,,,,,,,,,,,,7.91E+04,,,,0,FALSE,6.255,30,1,105,11.7,7.12,1,signal transduction;other biological processes,nucleus;other cell component,"Pf00036, Pf01023",6282,hsa:6282; P31949; Q5VTK0,ENSG00000163191,Neutrophil degranulation,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,5.36,other molecular function,0,
Master Protein,High,O43772,SLC25A20,Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens OX=9606 GN=SLC25A20 PE=1 SV=1,1,1,,100,100,0.312,,6.64,6.64,-1.68,,1.00E-17,1.00E-17,4.47E-01,,,3.05E+05,9.77E+05,,,2,2,,,,,,,,,,,,,,5.82E+05,1.60E+05,6.75E+06,1.41E+05,,,,,,,,,,,,,,,,,7.84E+04,3.97E+03,1.32E+04,3.97E+04,,,,0.001,FALSE,3.572,8,1,301,32.9,9.41,1,transport;developmental processes,other membranes;cytosol;mitochondrion,Pf00153,788,B2R7F4; hsa:788; O43772; Q9UIQ2,ENSG00000178537,Carnitine metabolism,Fatty acid beta-oxidation; Mitochondrial long chain fatty acid beta-oxidation; Thermogenesis,4,0,,,80.49,135.62,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,1,,FALSE,,,,262.7,3.89,transporter activity,0,
Master Protein,Medium,P01042,KNG1,Kininogen-1 OS=Homo sapiens OX=9606 GN=KNG1 PE=1 SV=2,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,3.70E+04,,,,2,,,,,,,,,,,,,,,4.14E+04,3.30E+04,,,,,,,,,,,,,,,,,,,5.58E+03,8.21E+02,,,,,,0.012,FALSE,2.199,3,1,644,71.9,6.81,1,stress response;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,Pf00031,3827,A8K474; B2RCR2; C9JEX1; hsa:3827; P01042; P01043; Q53EQ0; Q6PAU9; Q7M4P1,ENSG00000113889,G alpha (q) signalling events; G alpha (i) signalling events; Platelet degranulation ; Peptide ligand-binding receptors; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Intrinsic Pathway of Fibrin Clot Formation,Vitamin D receptor pathway; Dengue-2 interactions with complement and coagulation cascades; Cells and molecules involved in local acute inflammatory response ; RAS and bradykinin pathways in COVID-19; ACE inhibitor pathway; Complement and coagulation cascades,13,0,,,15.88,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.54,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,P20061,TCN1,Transcobalamin-1 OS=Homo sapiens OX=9606 GN=TCN1 PE=1 SV=2,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,2.79E+05,,,,2,,,,,,,,,,,,,,4.40E+05,1.77E+05,,,,,,,,,,,,,,,,,,,3.57E+03,2.38E+04,,,,,,,0.001,FALSE,3.17,3,1,433,48.2,5.03,1,transport,non-structural extracellular;other cell component,"Pf01122, Pf14478",6947,A8KAC5; hsa:6947; P20061; Q8WV77,ENSG00000134827,Neutrophil degranulation; Uptake of dietary cobalamins into enterocytes; Transport of RCbl within the body,Vitamin B12 metabolism,4,0,,,60.35,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.91,other molecular function,0,
Master Protein,High,A0A2R8Y891,PFKM,ATP-dependent 6-phosphofructokinase OS=Homo sapiens OX=9606 GN=PFKM PE=1 SV=1,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.92E+04,,,,1,,,,,,,,,,,,,,,,,2.92E+04,,,,,,,,,,,,,,,,,,,,8.20E+03,,,,0.002,FALSE,2.998,2,1,883,96.8,8.12,1,other metabolic processes,other cell component,Pf00365,5213,A0A2R8Y891,ENSG00000152556,,Clear cell renal cell carcinoma pathways; Aerobic glycolysis; Insulin signaling; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,5,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,2.9,kinase activity;other molecular function,0,
Master Protein,High,Q13616,CUL1,Cullin-1 OS=Homo sapiens OX=9606 GN=CUL1 PE=1 SV=2,3,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,3.04E+04,,,,1,,,,,,,,,,,,,,,,,3.04E+04,,,,,,,,,,,,,,,,,,,,8.55E+03,,,,0,FALSE,10.5,7,3,776,89.6,8,3,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00888, Pf10557",8454,D3DWG3; hsa:8454; O60719; Q08AL6; Q13616; Q8IYW1,ENSG00000055130,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; SCF-beta-TrCP mediated degradation of Emi1; Degradation of beta-catenin by the destruction complex; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; NIK-->noncanonical NF-kB signaling; Orc1 removal from chromatin; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Neddylation; Regulation of PLK1 Activity at G2/M Transition; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; SCF(Skp2)-mediated degradation of p27/p21; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Circadian Clock; Cyclin D associated events in G1; Regulation of BACH1 activity; MAP3K8 (TPL2)-dependent MAPK1/3 activation; NOTCH1 Intracellular Domain Regulates Transcription; Prolactin receptor signaling; Iron uptake and transport; Nuclear events stimulated by ALK signaling in cancer; Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,Cell cycle; TNF-alpha signaling pathway; Parkin-ubiquitin proteasomal system pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; TGF-beta signaling pathway; Pleural mesothelioma; Notch signaling pathway,41,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,9.64,other molecular function,0,
Master Protein,High,Q9H3Z4,DNAJC5,DnaJ homolog subfamily C member 5 OS=Homo sapiens OX=9606 GN=DNAJC5 PE=1 SV=1,2,2,,100,100,0.226,,6.64,6.64,-2.15,,1.00E-17,1.00E-17,2.94E-01,,,2.46E+05,1.09E+06,,,4,1,,,,,,,,,,,2.49E+05,,4.94E+05,2.33E+05,2.44E+05,,,,1.09E+06,,,,,,,,,,,,1.49E+03,,4.02E+03,3.13E+04,6.06E+03,,,,2.55E+04,,0,FALSE,4.462,8,2,198,22.1,5.07,2,cell-cell signaling;protein metabolism;other metabolic processes;transport;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00226,80331,A8K0M0; B3KY68; E1P5G8; hsa:80331; Q9H3Z4; Q9H3Z5; Q9H7H2,ENSG00000101152,"Neutrophil degranulation; Sensory processing of sound by inner hair cells of the cochlea; GABA synthesis, release, reuptake and degradation",,3,0,,,41.48,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,,,5.11,2.17,other molecular function,0,
Master Protein,High,Q9NZN3,EHD3,EH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EHD3 PE=1 SV=2,3,4,,100,100,0.831,,6.64,6.64,-0.27,,1.00E-17,1.00E-17,9.94E-01,,,1.96E+05,2.36E+05,,,1,1,,,,,,,,,,,,,,,1.96E+05,,2.36E+05,,,,,,,,,,,,,,,,,,4.86E+03,,6.62E+04,,,,0,FALSE,10.292,6,1,535,60.8,6.57,3,cell organization and biogenesis;other metabolic processes;transport;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf00350, Pf12763, Pf16880, Pf18150",30845,B4DFR5; D6W574; hsa:30845; Q8N514; Q9NZB3; Q9NZN3,ENSG00000013016,Factors involved in megakaryocyte development and platelet production,Ciliary landscape,2,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,0,5.95,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y6D6,ARFGEF1,Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Homo sapiens OX=9606 GN=ARFGEF1 PE=1 SV=2,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.94E+04,,,,1,,,,,,,,,,,,,,,,,2.94E+04,,,,,,,,,,,,,,,,,,,,8.25E+03,,,,0.006,FALSE,2.457,0,1,1849,208.6,5.85,1,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,other membranes;cytosol;ER/Golgi;nucleus;other cell component,"Pf01369, Pf09324, Pf12783, Pf16213, Pf20252",10565,hsa:10565; Q9NV46; Q9UFV2; Q9UNL0; Q9Y6D6,ENSG00000066777,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,1.63,enzyme regulator activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,P33316,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial OS=Homo sapiens OX=9606 GN=DUT PE=1 SV=4",4,6,,0.459,,,,-1.12,,,,5.88E-01,,,7.27E+05,8.65E+05,9.10E+05,7.56E+04,2,1,4,1,,,,6.32E+05,8.35E+05,,,8.65E+05,,,,8.71E+05,9.51E+05,2.48E+06,7.36E+05,,,,7.56E+04,,,,,6.32E+05,4.31E+04,,,7.98E+03,,,,3.89E+04,7.73E+03,3.34E+05,1.83E+04,,,,1.77E+03,,0,FALSE,11.458,23,4,252,26.5,9.36,4,DNA metabolism;other metabolic processes;developmental processes;other biological processes,mitochondrion;nucleus,Pf00692,1854,A8K650; B4DPR5; hsa:1854; O14785; P33316; Q16708; Q16860; Q6FHN1; Q6NSA3; Q96Q81,ENSG00000128951,,Pyrimidine metabolism,1,0,19.62,,64.93,,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,133.29,,,14.83,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q13492,PICALM,Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens OX=9606 GN=PICALM PE=1 SV=2,4,5,,0.547,0.859,0.291,,-0.87,-0.22,-1.78,,7.71E-01,7.61E-01,3.09E-01,2.25E+05,1.00E+05,1.15E+05,3.33E+06,2,4,2,4,,,,2.89E+05,1.75E+05,2.10E+05,,4.80E+04,2.30E+05,3.07E+04,,,6.49E+04,2.03E+05,,5.81E+05,3.20E+06,9.87E+06,3.46E+06,,,,,2.89E+05,9.03E+03,7.47E+02,,4.43E+02,6.49E+03,3.26E+02,,,5.27E+02,2.73E+04,,1.13E+03,9.00E+05,7.00E+04,8.10E+04,,0,FALSE,20.248,8,4,652,70.7,7.9,4,cell organization and biogenesis;transport;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf07651,8301,B4DTM3; E9PN05; F8VPG7; hsa:8301; O60700; Q13492; Q4LE54; Q6GMQ6; Q86XZ9,ENSG00000073921,Golgi Associated Vesicle Biogenesis; RND3 GTPase cycle; Cargo recognition for clathrin-mediated endocytosis,,4,0,34.72,80.9,72.83,92.28,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,,22.14,115.46,113.82,16.61,signal transduction activity or receptor binding;cytoskeletal activity;other molecular function,0,
Master Protein,High,A0A2R8YDT1,GLUL,Glutamine synthetase OS=Homo sapiens OX=9606 GN=GLUL PE=1 SV=1,2,3,,100,100,0.026,,6.64,6.64,-5.25,,1.00E-17,1.00E-17,3.60E-03,,,2.18E+04,1.42E+06,,,3,4,,,,,,,,,,,6.52E+04,2.14E+04,,,2.18E+04,8.63E+06,2.17E+05,,2.34E+05,7.79E+07,,,,,,,,,,,3.90E+02,9.54E+02,,,5.42E+02,1.68E+04,6.09E+04,,5.48E+03,8.29E+05,0,FALSE,11.085,7,2,507,57.1,8.37,2,other metabolic processes;developmental processes,plasma membrane;other membranes;cytosol;mitochondrion,"Pf00120, Pf03951",,A0A2R8YDT1,ENSG00000135821,,Amino acid metabolism; Cell lineage map for neuronal differentiation,2,0,,,69.7,173.12,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,High,n/a,Peak Found,Peak Found,1,,FALSE,,,,250.96,10.61,other molecular function,0,
Master Protein,High,H0Y4W2,TRRAP,Transformation/transcription domain associated protein OS=Homo sapiens OX=9606 GN=TRRAP PE=1 SV=2,2,5,,1.19,0.01,100,,0.25,-6.64,6.64,,5.19E-01,1.00E-17,1.00E-17,5.22E+04,4.94E+05,2.65E+05,,2,1,5,,,,3.72E+04,7.34E+04,,4.94E+05,,,,,3.60E+05,2.68E+04,2.65E+05,2.61E+05,5.38E+05,,,,,,,,3.63E+02,7.34E+04,,1.76E+03,,,,,2.16E+03,1.20E+03,2.16E+03,3.52E+04,1.34E+04,,,,,,0,FALSE,11.553,1,2,3873,438.6,8.12,2,other biological processes,ER/Golgi;nucleus,"Pf00454, Pf02259, Pf20175, Pf20206",,H0Y4W2,ENSG00000196367,,Rett syndrome,1,0,46.26,,63.77,,n/a,n/a,Peak Found,High,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,80.54,,,14.51,other molecular function,0,
Master Protein,High,Q6RW13,AGTRAP,Type-1 angiotensin II receptor-associated protein OS=Homo sapiens OX=9606 GN=AGTRAP PE=1 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,1.17E+05,,,,4,,,,,,,,,,,,1.09E+05,7.61E+04,,1.26E+05,1.50E+05,,,,,,,,,,,,,,,,6.53E+02,3.40E+03,,1.69E+04,3.74E+03,,,,,,0.006,FALSE,2.427,11,1,159,17.4,6.14,1,stress response;signal transduction;other biological processes,plasma membrane;other membranes;ER/Golgi;other cell component,Pf06396,57085,A8MVQ5; hsa:57085; Q5SNV4; Q5SNV5; Q6RW13; Q96AC0; Q96PL4; Q9NRW9,ENSG00000177674,Signaling by BRAF and RAF1 fusions,,1,0,,,27.01,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.19,other molecular function,0,
Master Protein,High,P51531,SMARCA2,Probable global transcription activator SNF2L2 OS=Homo sapiens OX=9606 GN=SMARCA2 PE=1 SV=2,12,34,,0.807,1.025,1.141,,-0.31,0.04,0.19,,7.08E-01,8.60E-01,7.51E-01,1.16E+06,3.45E+05,9.34E+05,2.97E+05,1,4,5,4,,,,1.16E+06,,2.74E+05,,4.46E+05,1.40E+05,4.34E+05,5.55E+05,1.82E+06,1.45E+05,1.68E+06,9.34E+05,1.95E+05,1.69E+04,4.51E+05,5.25E+05,,,,,1.16E+06,,9.73E+02,,4.12E+03,3.94E+03,4.62E+03,3.32E+03,8.14E+04,1.17E+03,2.26E+05,2.32E+04,3.80E+02,4.76E+03,3.20E+03,1.23E+04,,0,FALSE,43.625,9,3,1590,181.2,7.2,12,cell organization and biogenesis;developmental processes;other biological processes,cytoskeleton;nucleus;other cell component,"Pf00176, Pf00271, Pf00439, Pf07529, Pf07533, Pf08880, Pf14619",6595,B1ALG3; B1ALG4; D3DRH4; D3DRH5; hsa:6595; P51531,ENSG00000080503,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,Retinoblastoma gene in cancer; Pathways affected in adenoid cystic carcinoma; VEGFA-VEGFR2 signaling; Rett syndrome; Thermogenesis; Kleefstra syndrome,8,0,,45,70.01,78.85,n/a,n/a,n/a,High,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,,84.62,87.7,88.69,89.82,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9Y4E8,USP15,Ubiquitin carboxyl-terminal hydrolase 15 OS=Homo sapiens OX=9606 GN=USP15 PE=1 SV=3,5,10,,0.075,3.082,0.063,,-3.74,1.62,-3.99,,1.95E-02,3.59E-01,3.81E-02,1.10E+05,5.88E+04,3.20E+04,1.96E+05,3,2,2,3,,1.10E+05,,1.21E+06,6.23E+04,,2.94E+04,1.18E+05,,,,,,1.14E+04,8.99E+04,,3.96E+05,1.68E+05,,1.96E+05,,4.17E+02,,1.21E+06,3.21E+03,,5.22E+02,1.09E+03,,,,,,1.53E+03,2.23E+03,,1.11E+05,1.19E+03,,2.08E+03,0,FALSE,19.982,8,5,981,112.3,5.22,5,cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes,cytosol;mitochondrion;nucleus;other cell component,"Pf00443, Pf06337, Pf14533, Pf14836",9958,hsa:9958; Q08AL5; Q9H8G9; Q9HCA6; Q9UNP0; Q9Y4E8; Q9Y5B5,ENSG00000135655,UCH proteinases; Ub-specific processing proteases; Downregulation of TGF-beta receptor signaling,,3,0,140.93,85.02,109.65,49.18,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,High,Peak Found,High,Peak Found,1,,FALSE,,0,103.47,11.55,27.73,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,B7ZC38,SH3GLB2,"SH3 domain containing GRB2 like, endophilin B2 OS=Homo sapiens OX=9606 GN=SH3GLB2 PE=1 SV=1",2,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.24E+05,,,,1,,,,,,,,,,,,,,,,,1.24E+05,,,,,,,,,,,,,,,,,,,,3.47E+04,,,,0,FALSE,5.398,8,2,400,44.3,5.82,2,,cytosol;nucleus,"Pf03114, Pf14604",56904,B7ZC38,ENSG00000148341,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,2.64,,0,
Master Protein,High,E9PK89,RAB3IL1,RAB3A interacting protein like 1 OS=Homo sapiens OX=9606 GN=RAB3IL1 PE=1 SV=9,2,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,6.22E+05,,,,2,,,,,,,,,,,,,,,,,5.86E+05,,,6.59E+05,,,,,,,,,,,,,,,,,1.65E+05,,,7.02E+03,0,FALSE,7.904,9,2,477,52.4,6.1,2,,,Pf06428,,E9PK89,ENSG00000167994,,Ciliary landscape,1,0,,,,8.35,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,1,,FALSE,,,,,7.54,enzyme regulator activity,0,
Master Protein,High,Q9NUX5,POT1,Protection of telomeres protein 1 OS=Homo sapiens OX=9606 GN=POT1 PE=1 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,1.01E+05,,,,2,,,,,,,,,,,,,,,1.32E+05,7.72E+04,,,,,,,,,,,,,,,,,,,1.78E+04,1.92E+03,,,,,,0.001,FALSE,3.19,3,1,634,71.4,6.73,1,cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes,nucleus;other cell component,"Pf02765, Pf16686, Pf21375",25913,hsa:25913; O95018; Q5MJ36; Q9H662; Q9NUX5; Q9NW19; Q9UG95,ENSG00000128513,Meiotic synapsis; Telomere Extension By Telomerase; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; Packaging Of Telomere Ends; DNA Damage/Telomere Stress Induced Senescence; Polymerase switching on the C-strand of the telomere; Telomere C-strand synthesis initiation; Removal of the Flap Intermediate from the C-strand,,14,0,,,37.3,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.05,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q6ZR08,DNAH12,Dynein axonemal heavy chain 12 OS=Homo sapiens OX=9606 GN=DNAH12 PE=2 SV=2,1,1,,100,100,0.2,,6.64,6.64,-2.32,,1.00E-17,1.00E-17,2.26E-01,,,3.17E+05,1.58E+06,,,1,2,,,,,,,,,,,,,3.17E+05,,,1.75E+06,,,1.43E+06,,,,,,,,,,,,,,2.57E+03,,,3.41E+03,,,3.34E+04,,0.02,FALSE,1.996,0,1,3092,356.7,6.19,1,other biological processes,cytoskeleton,"Pf03028, Pf08393, Pf12774, Pf12775, Pf12780, Pf17852, Pf17857, Pf18198, Pf18199",201625,A6NGI2; hsa:201625; Q6ZR08; Q6ZTR8; Q8N7R9; Q8WXK2; Q92816,ENSG00000174844,,,0,0,,,,14.22,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,High,n/a,1,,FALSE,,,,14.98,0,cytoskeletal activity;other molecular function,0,
Master Protein,High,P62256,UBE2H,Ubiquitin-conjugating enzyme E2 H OS=Homo sapiens OX=9606 GN=UBE2H PE=1 SV=1,2,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.02E+06,,,,2,,,,,,,,,,,,,,,,1.60E+06,6.50E+05,,,,,,,,,,,,,,,,,,,3.12E+03,1.83E+05,,,,0,FALSE,4.931,14,2,183,20.6,4.67,2,protein metabolism;other metabolic processes,cytosol;nucleus,Pf00179,7328,A4D1L6; C9JY93; hsa:7328; P37286; P62256; Q7Z6F4,ENSG00000186591,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,Ciliary landscape,3,0,,,,59.58,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,,,,5.34,other molecular function,0,
Master Protein,High,P54577,YARS1,"Tyrosine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=YARS1 PE=1 SV=4",3,4,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,3.62E+05,,,,1,,,,,,,,,,,,,,,,,3.62E+05,,,,,,,,,,,,,,,,,,,,1.02E+05,,,,0,FALSE,11.905,10,3,528,59.1,7.05,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf00579, Pf01588",8565,B3KWK4; D3DPQ4; hsa:8565; O43276; P54577; Q53EN1,ENSG00000134684,Cytosolic tRNA aminoacylation,Nephrotic syndrome,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,12.19,signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function,0,
Master Protein,Medium,Q86U28,ISCA2,"Iron-sulfur cluster assembly 2 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=ISCA2 PE=1 SV=2",1,2,,100,100,0.976,,6.64,6.64,-0.03,,1.00E-17,1.00E-17,8.46E-01,,,7.26E+05,7.43E+05,,,2,1,,,,,,,,,,,,,,9.63E+05,5.47E+05,,,,7.43E+05,,,,,,,,,,,,,,,1.30E+05,1.36E+04,,,,1.74E+04,,0.011,FALSE,2.24,8,1,154,16.5,5.25,1,cell organization and biogenesis;protein metabolism;other metabolic processes,mitochondrion,Pf01521,122961,A6NFF1; A8K3W3; G3V291; hsa:122961; Q86U28; Q8IYZ0; Q96BB2,ENSG00000165898,Mitochondrial iron-sulfur cluster biogenesis,,1,0,,,38.92,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,,,42.44,5.45,other molecular function,0,
Master Protein,Medium,Q4KMP7,TBC1D10B,TBC1 domain family member 10B OS=Homo sapiens OX=9606 GN=TBC1D10B PE=1 SV=3,1,1,,100,100,1.842,,6.64,6.64,0.88,,1.00E-17,1.00E-17,5.04E-01,,,3.86E+04,2.10E+04,,,1,1,,,,,,,,,,,3.86E+04,,,,,,2.10E+04,,,,,,,,,,,,,,2.31E+02,,,,,,5.89E+03,,,,0.012,FALSE,2.165,3,1,808,87.1,9.19,1,transport;other biological processes,plasma membrane;other membranes;cytosol,Pf00566,26000,B9A6L0; hsa:26000; Q4KMP7; Q6IN54; Q6P530; Q71RG7; Q86VC5; Q9H8Z2; Q9NUN6; Q9UFP2,ENSG00000169221,TBC/RABGAPs,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,0,2.59,enzyme regulator activity,0,
Master Protein,High,Q9UBU8,MORF4L1,Mortality factor 4-like protein 1 OS=Homo sapiens OX=9606 GN=MORF4L1 PE=1 SV=2,2,5,,2.379,5.121,0.119,,1.25,2.36,-3.07,,1.37E-01,5.82E-02,8.98E-02,1.62E+04,2.37E+05,2.87E+05,1.84E+06,1,2,3,4,,,,1.62E+04,,6.60E+05,,,,8.47E+04,,,2.87E+05,3.47E+05,1.97E+05,,3.15E+06,3.63E+06,2.41E+05,1.07E+06,,,,1.62E+04,,2.35E+03,,,,9.01E+02,,,2.33E+03,4.67E+04,4.90E+03,,8.84E+05,2.58E+04,5.63E+03,1.14E+04,0,FALSE,7.18,7,2,362,41.4,9.28,2,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;stress response;other biological processes,nucleus;other cell component,"Pf05712, Pf11717",10933,B4DKN6; B7Z6R1; D3DW88; hsa:10933; O95899; Q5QTS1; Q6NVX8; Q86YT7; Q9HBP6; Q9NSW5; Q9UBU8,ENSG00000185787,HATs acetylate histones,Pathways affected in adenoid cystic carcinoma,2,0,,109.27,27.19,80.43,n/a,n/a,n/a,High,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,27.38,119.52,85.5,14.17,other molecular function,0,
Master Protein,High,P54136,RARS1,"Arginine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=RARS1 PE=1 SV=2",3,7,,100,100,1.325,,6.64,6.64,0.41,,1.00E-17,1.00E-17,6.53E-01,,,3.53E+05,8.77E+05,,,1,1,,,,,,,,,,,3.53E+05,,,,,,8.77E+05,,,,,,,,,,,,,,2.11E+03,,,,,,2.46E+05,,,,0,FALSE,16.255,6,3,660,75.3,6.68,3,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol;nucleus;other cell component,"Pf00750, Pf03485, Pf05746",5917,B2RBS9; hsa:5917; P54136; Q53GY4; Q9BWA1,ENSG00000113643,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,Amino acid metabolism,3,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,0,20.8,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q7Z6P3,RAB44,Ras-related protein Rab-44 OS=Homo sapiens OX=9606 GN=RAB44 PE=1 SV=4,1,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.80E+06,,,,2,,,,,,,,,,,,,,,,,,1.83E+06,,1.78E+06,,,,,,,,,,,,,,,,,,1.30E+04,,1.90E+04,0.002,FALSE,3.014,2,1,1021,110.8,5.08,1,cell-cell signaling;stress response;transport,plasma membrane;other membranes;other cytoplasmic organelle,Pf00071,401258,A0A087WXI0; hsa:401258; Q7Z6P3,ENSG00000255587,Neutrophil degranulation; RAB geranylgeranylation,,2,0,,,,1.9,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,1,,FALSE,,,,,5.78,other molecular function,0,
Master Protein,High,O75431,MTX2,Metaxin-2 OS=Homo sapiens OX=9606 GN=MTX2 PE=1 SV=1,1,3,,100,100,1.79,,6.64,6.64,0.84,,1.00E-17,1.00E-17,4.84E-01,,,2.91E+05,1.62E+05,,,3,1,,,,,,,,,,,2.91E+05,,,1.55E+05,1.14E+06,,1.62E+05,,,,,,,,,,,,,,1.74E+03,,,2.09E+04,2.84E+04,,4.56E+04,,,,0,FALSE,6.377,8,1,263,29.7,6.29,1,cell organization and biogenesis;transport,other membranes;mitochondrion;nucleus;other cell component,"Pf10568, Pf17171",10651,A8JZZ4; hsa:10651; O75431; Q53S50; Q53SQ2; Q5M7Z6; Q8IZ68,ENSG00000128654,Mitochondrial protein import; Cristae formation,,2,0,,,101.11,,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,69.23,9.03,,0,
Master Protein,High,P14222,PRF1,Perforin-1 OS=Homo sapiens OX=9606 GN=PRF1 PE=1 SV=1,2,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,4.31E+05,,,,2,,,,,,,,,,,,,,,,,,4.75E+05,3.91E+05,,,,,,,,,,,,,,,,,,,3.37E+03,9.16E+03,,0,FALSE,6.794,6,2,555,61.3,7.83,2,cell organization and biogenesis;stress response;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;other cytoplasmic organelle,"Pf00168, Pf01823",5551,B2R6X4; hsa:5551; P14222; Q59F57; Q86WX7,ENSG00000180644,Nuclear events stimulated by ALK signaling in cancer,Allograft rejection; Nanomaterial induced apoptosis; Apoptosis,4,0,,,,13.65,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,High,n/a,1,,FALSE,,,,,10.25,transporter activity;other molecular function,0,
Master Protein,Medium,Q9NRZ7,AGPAT3,1-acyl-sn-glycerol-3-phosphate acyltransferase gamma OS=Homo sapiens OX=9606 GN=AGPAT3 PE=1 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,9.85E+04,,,,2,,,,,,,,,,,,,,,1.68E+05,5.76E+04,,,,,,,,,,,,,,,,,,,2.27E+04,1.43E+03,,,,,,0.02,FALSE,1.989,4,1,376,43.4,8.72,1,other metabolic processes,other membranes;ER/Golgi;nucleus;other cell component,"Pf01553, Pf16076",56894,D3DSL2; hsa:56894; Q3ZCU2; Q6UWP6; Q6ZUC6; Q8N3Q7; Q9NRZ6; Q9NRZ7,ENSG00000160216,COPI-independent Golgi-to-ER retrograde traffic; Synthesis of PA,Triacylglyceride synthesis,3,0,,,69.4,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.48,other molecular function,0,
Master Protein,High,Q13501,SQSTM1,Sequestosome-1 OS=Homo sapiens OX=9606 GN=SQSTM1 PE=1 SV=1,2,5,,100,100,0.267,,6.64,6.64,-1.9,,1.00E-17,1.00E-17,3.75E-01,,,1.94E+04,1.75E+05,,,2,1,,,,,,,,,,,,1.01E+04,,3.73E+04,,,1.75E+05,,,,,,,,,,,,,,,4.52E+02,,5.03E+03,,,4.93E+04,,,,0,FALSE,10.345,12,2,440,47.7,5.22,2,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;signal transduction;other biological processes,cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00564, Pf00569, Pf16577",8878,A6NFN7; B2R661; B3KUW5; hsa:8878; Q13446; Q13501; Q9BUV7; Q9BVS6; Q9UEU1,ENSG00000161011; ENSG00000284099,Neddylation; Interleukin-1 signaling; Signaling by ALK fusions and activated point mutants; p75NTR recruits signalling complexes; NF-kB is activated and signals survival; Nuclear events mediated by NFE2L2; PINK1-PRKN Mediated Mitophagy; NRIF signals cell death from the nucleus; Pexophagy,IL-1 signaling pathway; RANKL/RANK signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Nuclear receptors meta-pathway; NRF2 pathway; Interleukin-1 induced activation of NF-kB; Clear cell renal cell carcinoma pathways; CAMKK2 pathway; 7q11.23 copy number variation syndrome; Opioid receptor pathways; Clock-controlled autophagy in bone metabolism; Autophagy in pancreatic ductal adenocarcinoma; HDAC6 interactions in the central nervous system,24,0,,,81.07,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,103.73,16.96,signal transduction activity or receptor binding;kinase activity;other molecular function,0,
Master Protein,High,Q99733,NAP1L4,Nucleosome assembly protein 1-like 4 OS=Homo sapiens OX=9606 GN=NAP1L4 PE=1 SV=1,2,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,9.03E+05,,,,1,,,,,,,,,,,,,,,,,9.03E+05,,,,,,,,,,,,,,,,,,,,2.54E+05,,,,0,FALSE,9.002,12,2,375,42.8,4.69,2,cell organization and biogenesis,nucleus;other cell component,Pf00956,4676,B2R6J4; F5HFY4; hsa:4676; Q99733,ENSG00000205531; ENSG00000273562,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,13.14,other molecular function,0,
Master Protein,High,P17931,LGALS3,Galectin-3 OS=Homo sapiens OX=9606 GN=LGALS3 PE=1 SV=5,2,2,,100,100,0.137,,6.64,6.64,-2.86,,1.00E-17,1.00E-17,1.46E-01,,,1.68E+05,1.22E+06,,,4,1,,,,,,,,,,,1.88E+05,1.19E+05,1.50E+05,3.08E+05,,,1.22E+06,,,,,,,,,,,,,,1.12E+03,5.30E+03,1.22E+03,4.15E+04,,,3.44E+05,,,,0,FALSE,5.173,10,2,250,26.1,8.56,2,RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component,Pf00337,3958,B2RC38; hsa:3958; P17931; Q16005; Q6IBA7; Q96J47,ENSG00000131981,Neutrophil degranulation; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells; Advanced glycosylation endproduct receptor signaling; RUNX2 regulates genes involved in differentiation of myeloid cells,AGE/RAGE pathway; Spinal cord injury; 2q13 copy number variation syndrome; Immune infiltration in pancreatic cancer,8,0,,,43.36,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,39.46,5.19,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,B5MC82,DDT,D-dopachrome decarboxylase OS=Homo sapiens OX=9606 GN=DDT PE=3 SV=2,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,2.05E+05,,,,3,,,,,,,,,,,,,,2.05E+05,4.46E+05,1.61E+05,,,,,,,,,,,,,,,,,,1.67E+03,6.02E+04,3.99E+03,,,,,,0.002,FALSE,2.817,7,1,166,17.7,8.69,1,,,Pf01187,100037417,B5MC82; B5MCS6,ENSG00000099977; ENSG00000275003,,,0,0,,,56.77,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.11,,0,
Master Protein,High,P06331,IGHV4-34,Immunoglobulin heavy variable 4-34 OS=Homo sapiens OX=9606 GN=IGHV4-34 PE=1 SV=2,1,2,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,5.89E+05,,,,2,,,,,,,,,,,,,,,4.94E+05,7.01E+05,,,,,,,,,,,,,,,,,,,6.66E+04,1.74E+04,,,,,,0.001,FALSE,4.023,17,1,123,13.8,9.33,1,other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,Pf07686,,A0A0A0MS12; A0A0G2JP38; P06331,ENSG00000211956; ENSG00000276491,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Scavenging of heme from plasma; Initial triggering of complement; Classical antibody-mediated complement activation; Cell surface interactions at the vascular wall; FCGR activation; Regulation of actin dynamics for phagocytic cup formation; Role of phospholipids in phagocytosis; Role of LAT2/NTAL/LAB on calcium mobilization; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; FCERI mediated NF-kB activation; CD22 mediated BCR regulation; FCGR3A-mediated IL10 synthesis; FCGR3A-mediated phagocytosis; Potential therapeutics for SARS; Regulation of Complement cascade; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,Extrafollicular and follicular B cell activation by SARS-CoV-2,20,0,,,24.43,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.79,other molecular function,0,
Master Protein,High,O94915,FRYL,Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2,3,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,4.88E+05,,,,1,,,,,,,,,,,,,,,,,4.88E+05,,,,,,,,,,,,,,,,,,,,1.37E+05,,,,0,FALSE,9.475,1,3,3013,339.4,5.58,3,cell organization and biogenesis;developmental processes;other biological processes,other cell component,"Pf14222, Pf14225, Pf14228, Pf19421",285527,hsa:285527; O94915; O95640; Q8WTZ5; Q9NT40,ENSG00000075539,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,8.68,,0,
Master Protein,High,A0A286YFF8,MON2,Protein MON2 homolog OS=Homo sapiens OX=9606 GN=MON2 PE=1 SV=1,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,4.67E+04,,,,1,,,,,,,,,,,,,,,,,4.67E+04,,,,,,,,,,,,,,,,,,,,1.31E+04,,,,0.004,FALSE,2.644,0,1,1718,190.4,6.1,1,transport,,"Pf09324, Pf12783, Pf16206, Pf16213",23041,A0A286YFF8,ENSG00000061987,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,1.71,,0,
Master Protein,High,P02763,ORM1,Alpha-1-acid glycoprotein 1 OS=Homo sapiens OX=9606 GN=ORM1 PE=1 SV=2,2,10,,100,100,0.397,,6.64,6.64,-1.33,,1.00E-17,1.00E-17,4.64E-01,,,6.01E+05,2.89E+06,,,3,3,,,,,,,,,,,,,3.50E+05,3.94E+06,6.01E+05,1.56E+05,2.89E+06,,5.52E+06,,,,,,,,,,,,,,2.84E+03,5.31E+05,1.49E+04,3.04E+02,8.12E+05,,1.29E+05,,0,FALSE,8.284,15,2,201,23.5,5.11,2,stress response;other biological processes,non-structural extracellular;other cell component,Pf00061,5004,B7ZKQ5; hsa:5004; P02763; Q5T539; Q5U067; Q8TC16,ENSG00000229314,Neutrophil degranulation; Platelet degranulation,Vitamin D receptor pathway,3,0,,,122.95,93.98,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,Peak Found,High,n/a,High,n/a,1,,FALSE,,,,106.36,23.18,,0,
Master Protein,High,P04080,CSTB,Cystatin-B OS=Homo sapiens OX=9606 GN=CSTB PE=1 SV=2,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,3.62E+05,,,,1,,,,,,,,,,,,,,,3.62E+05,,,,,,,,,,,,,,,,,,,,4.87E+04,,,,,,,0,FALSE,4.652,24,1,98,11.1,7.56,1,other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,Pf00031,1476,hsa:1476; P04080,ENSG00000160213,Neutrophil degranulation,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,Acetyl [N-Term],FALSE,,,,,2.81,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q92844,TANK,TRAF family member-associated NF-kappa-B activator OS=Homo sapiens OX=9606 GN=TANK PE=1 SV=2,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.72E+05,,,,1,,,,,,,,,,,,,,,,,1.72E+05,,,,,,,,,,,,,,,,,,,,4.82E+04,,,,0.004,FALSE,2.583,4,1,425,47.8,5.68,1,stress response;signal transduction;other biological processes,cytosol;other cell component,Pf12845,10010,D3DPB5; hsa:10010; Q7Z4J6; Q92844; Q92885,ENSG00000136560,"Activation of IRF3, IRF7 mediated by TBK1, IKBKE; TICAM1-dependent activation of IRF3/IRF7; TRAF6 mediated IRF7 activation",TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; Novel intracellular components of RIG-I-like receptor pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response,7,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,2.66,enzyme regulator activity;other molecular function,0,
Master Protein,Medium,Q9ULH1,ASAP1,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ASAP1 PE=1 SV=4",1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.58E+05,,,,1,,,,,,,,,,,,,,,,,1.58E+05,,,,,,,,,,,,,,,,,,,,4.43E+04,,,,0.012,FALSE,2.147,2,1,1129,125.4,7.31,1,cell organization and biogenesis;other biological processes,other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component,"Pf00169, Pf01412, Pf12796, Pf14604, Pf16746",50807,B2RNV3; hsa:50807; Q9ULH1,ENSG00000153317,VxPx cargo-targeting to cilium,EGF/EGFR signaling pathway; CCL18 signaling pathway,3,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,3.48,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q96GM5,SMARCD1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 OS=Homo sapiens OX=9606 GN=SMARCD1 PE=1 SV=2,2,5,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,4.13E+05,,,,3,,,,,,,,,,,,,,9.50E+04,4.75E+05,4.13E+05,,,,,,,,,,,,,,,,,,7.72E+02,6.39E+04,1.03E+04,,,,,,0,FALSE,6.249,5,2,515,58.2,9.25,2,cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,nucleus;other cell component,Pf02201,6602,A6NN27; hsa:6602; Q92924; Q96GM5; Q9Y635,ENSG00000066117,RMTs methylate histone arginines; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,Androgen receptor network in prostate cancer; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome,6,0,,,62.2,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,15.98,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,Medium,O95977,S1PR4,Sphingosine 1-phosphate receptor 4 OS=Homo sapiens OX=9606 GN=S1PR4 PE=1 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,3.68E+05,,,,3,,,,,,,,,,,,3.04E+06,,,3.68E+05,2.88E+05,,,,,,,,,,,,,,,,1.82E+04,,,4.96E+04,7.16E+03,,,,,,0.02,FALSE,1.994,2,1,384,41.6,9.96,1,signal transduction;other biological processes,plasma membrane;other membranes;mitochondrion;other cell component,Pf00001,8698,D6W612; hsa:8698; O95977,ENSG00000125910,G alpha (i) signalling events; Lysosphingolipid and LPA receptors,Small ligand GPCRs; IL-18 signaling pathway,4,0,,,127.13,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,1.84,other molecular function,0,
Master Protein,High,Q9H0Z9,RBM38,RNA-binding protein 38 OS=Homo sapiens OX=9606 GN=RBM38 PE=1 SV=2,1,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,3.31E+05,,,,3,,,,,,,,,,,,,,,,,3.31E+05,7.67E+04,5.58E+05,,,,,,,,,,,,,,,,,,9.29E+04,5.43E+02,1.31E+04,,0.001,FALSE,3.471,7,1,239,25.5,8.65,1,cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes,cytosol;nucleus,Pf00076,55544,A6NDK1; A6NMU6; hsa:55544; Q15350; Q15351; Q9BYK3; Q9BYK4; Q9H0Z9,ENSG00000132819,,,0,0,,,,74.84,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,,,,8.12,nucleic acid binding activity,0,
Master Protein,High,K7N7A8,,Ubiquitin carboxyl-terminal hydrolase MINDY (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=2,1,4,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.01E+06,,,,2,,,,,,,,,,,,,,,,,1.34E+06,,7.62E+05,,,,,,,,,,,,,,,,,,3.77E+05,,1.78E+04,,0,FALSE,5.953,4,1,449,48.8,5.22,1,protein metabolism;transport,plasma membrane;other membranes,"Pf00230, Pf13898",,,,,,0,0,,,,39.02,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,1,,FALSE,,,,,13.96,transporter activity;other molecular function,0,
Master Protein,High,Q14318,FKBP8,Peptidyl-prolyl cis-trans isomerase FKBP8 OS=Homo sapiens OX=9606 GN=FKBP8 PE=1 SV=2,3,7,,1.163,8.117,2.55,,0.22,3.02,1.35,,5.13E-01,8.35E-02,3.10E-01,1.74E+05,2.31E+04,3.37E+05,1.17E+05,3,1,5,2,,1.74E+05,5.57E+04,2.57E+05,,,,,,2.31E+04,4.79E+05,1.79E+05,2.74E+05,3.37E+05,3.76E+05,,2.92E+05,,4.66E+04,,,6.60E+02,5.44E+02,2.57E+05,,,,,,2.46E+02,2.86E+03,8.02E+03,2.23E+03,4.54E+04,9.35E+03,,8.21E+04,,1.09E+03,,0,FALSE,10.266,9,3,412,44.5,4.84,3,protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes,other membranes;cytosol;mitochondrion;ER/Golgi;other cell component,Pf00254,23770,C8C9T5; hsa:23770; Q14318; Q53GU3; Q7Z349; Q86YK6,ENSG00000105701,Ub-specific processing proteases,,1,0,62.44,,33.98,102.56,n/a,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,76.72,0,65.9,13.58,other molecular function,0,
Master Protein,High,Q9UNZ2,NSFL1C,NSFL1 cofactor p47 OS=Homo sapiens OX=9606 GN=NSFL1C PE=1 SV=2,2,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.51E+05,,,,1,,,,,,,,,,,,,,,,,1.51E+05,,,,,,,,,,,,,,,,,,,,4.25E+04,,,,0,FALSE,7.294,11,2,370,40.5,5.1,2,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component,"Pf00789, Pf08059, Pf14555",55968,A2A2L1; B2RD74; hsa:55968; Q5JXA4; Q5JXA5; Q7Z533; Q9H102; Q9NVL9; Q9UI06; Q9UNZ2,ENSG00000088833,RHOH GTPase cycle,Alstrom syndrome,2,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,6.89,other molecular function,0,
Master Protein,High,Q5U5X0,LYRM7,Complex III assembly factor LYRM7 OS=Homo sapiens OX=9606 GN=LYRM7 PE=1 SV=1,1,2,,100,100,4.283,,6.64,6.64,2.1,,1.00E-17,1.00E-17,1.31E-01,,,6.90E+05,1.61E+05,,,1,2,,,,,,,,,,,,,6.90E+05,,,,1.17E+05,,2.22E+05,,,,,,,,,,,,,,5.60E+03,,,,3.28E+04,,5.19E+03,,0.004,FALSE,2.563,10,1,104,11.9,9.66,1,cell organization and biogenesis;protein metabolism;other metabolic processes,other membranes;mitochondrion,Pf05347,90624,A8MPQ9; hsa:90624; Q5U5X0; Q86Y68,ENSG00000186687,,Mitochondrial complex III assembly,1,0,,,,43.85,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,,48.36,3.86,other molecular function,0,
Master Protein,High,Q15629,TRAM1,Translocating chain-associated membrane protein 1 OS=Homo sapiens OX=9606 GN=TRAM1 PE=1 SV=3,1,2,,100,100,1.054,,6.64,6.64,0.08,,1.00E-17,1.00E-17,8.06E-01,,,5.84E+05,5.54E+05,,,1,1,,,,,,,,,,,,,,,5.84E+05,,,,5.54E+05,,,,,,,,,,,,,,,,1.45E+04,,,,1.30E+04,,0.001,FALSE,4.222,4,1,374,43,9.63,1,cell organization and biogenesis;stress response;transport;other biological processes,other membranes;ER/Golgi,Pf03798,23471,B4E0K2; hsa:23471; Q15629,ENSG00000067167,SRP-dependent cotranslational protein targeting to membrane,TLR4 signaling and tolerance,2,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,,,0,5.87,other molecular function,0,
Master Protein,High,Q5TDH0,DDI2,Protein DDI1 homolog 2 OS=Homo sapiens OX=9606 GN=DDI2 PE=1 SV=1,3,4,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.90E+05,,,,1,,,,,,,,,,,,,,,,,1.90E+05,,,,,,,,,,,,,,,,,,,,5.33E+04,,,,0,FALSE,9.017,13,3,399,44.5,5.05,3,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00240, Pf09668",84301,A8KAE1; hsa:84301; Q5TDH0; Q7RTZ0; Q9BRT1,ENSG00000197312,,,0,0,,,,,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,11.39,other molecular function,0,
Master Protein,High,P18428,LBP,Lipopolysaccharide-binding protein OS=Homo sapiens OX=9606 GN=LBP PE=1 SV=3,2,7,,2.519,2.038,0.343,,1.33,1.03,-1.55,,2.92E-02,4.29E-01,4.22E-01,1.33E+06,8.95E+05,5.39E+05,1.82E+06,4,1,5,3,1.08E+06,1.62E+06,1.85E+06,1.28E+05,,8.95E+05,,,,,2.96E+06,2.32E+05,2.52E+05,5.39E+05,6.90E+06,1.82E+06,8.88E+04,,2.30E+06,,4.30E+03,6.17E+03,1.80E+04,1.28E+05,,3.18E+03,,,,,1.77E+04,1.04E+04,2.05E+03,7.26E+04,1.71E+05,3.56E+03,2.49E+04,,5.38E+04,,0,FALSE,9.309,6,2,481,53.4,6.7,2,stress response;transport;signal transduction;other biological processes,non-structural extracellular;other membranes;other cell component,"Pf01273, Pf02886",3929,B2R938; hsa:3929; O43438; P18428; Q92672; Q9H403; Q9UD66,ENSG00000129988,Regulation of TLR by endogenous ligand; Interleukin-4 and Interleukin-13 signaling; Transfer of LPS from LBP carrier to CD14,Fibrin complement receptor 3 signaling pathway; Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; Network map of SARS-CoV-2 signaling pathway; Toll-like receptor signaling pathway,8,0,65.41,,132.14,82.87,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,87.31,38.61,182.55,24.6,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q9NYP9,MIS18A,Protein Mis18-alpha OS=Homo sapiens OX=9606 GN=MIS18A PE=1 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,3.17E+05,,,,1,,,,,,,,,,,,,,,3.17E+05,,,,,,,,,,,,,,,,,,,,4.27E+04,,,,,,,0,FALSE,5.216,9,1,233,25.8,5.2,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,Pf03226,54069,B2R562; hsa:54069; Q542Z0; Q9NYP9,ENSG00000159055,Deposition of new CENPA-containing nucleosomes at the centromere,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.91,other molecular function,0,
Master Protein,High,P23381,WARS1,"Tryptophan--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=WARS1 PE=1 SV=2",1,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,8.24E+05,,,,2,,,,,,,,,,,,,,,,,1.25E+06,,5.42E+05,,,,,,,,,,,,,,,,,,3.52E+05,,1.27E+04,,0,FALSE,4.622,3,1,471,53.1,6.23,1,protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00458, Pf00579",7453,A6NGN1; A6NID3; hsa:7453; P23381; P78535; Q502Y0; Q53XB6; Q9UDI5; Q9UDL3,ENSG00000140105,Cytosolic tRNA aminoacylation,Photodynamic therapy-induced unfolded protein response; Amino acid metabolism,3,0,,,,56.07,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,1,,FALSE,,,,,5.74,enzyme regulator activity;other molecular function,0,
Master Protein,High,P40199,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,2,2,,100,100,0.79,,6.64,6.64,-0.34,,1.00E-17,1.00E-17,9.68E-01,,,9.81E+05,1.80E+06,,,1,1,,,,,,,,,,,,,9.81E+05,,,,,,1.80E+06,,,,,,,,,,,,,,7.97E+03,,,,,,4.21E+04,,0,FALSE,6.156,11,2,344,37.2,5.82,2,cell adhesion;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle;other cell component,"Pf07686, Pf13895, Pf13927",4680,hsa:4680; P40199; Q13774; Q14920; Q53XP7,ENSG00000086548,Neutrophil degranulation; Cell surface interactions at the vascular wall; Fibronectin matrix formation,Pancreatic cancer subtypes,4,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,n/a,1,,FALSE,,,,0,7.51,other molecular function,0,
Master Protein,High,A0A8V8TMP7,CYRIB,CYFIP related Rac1 interactor B OS=Homo sapiens OX=9606 GN=CYRIB PE=1 SV=1,1,1,,100,100,0.236,,6.64,6.64,-2.08,,1.00E-17,1.00E-17,3.30E-01,,,6.70E+03,4.39E+04,,,4,2,,,,,,,,,,,,3.49E+03,3.08E+04,6.84E+03,6.55E+03,,2.67E+03,,,7.20E+05,,,,,,,,,,,,1.56E+02,2.50E+02,9.22E+02,1.63E+02,,7.51E+02,,,7.67E+03,0.002,FALSE,2.93,3,1,324,36.8,6.46,1,cell organization and biogenesis,other membranes,Pf07159,,A0A8V8TMP7,ENSG00000153310,,,0,0,,,106.29,140.38,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,High,1,,FALSE,,,,408.51,1.65,other molecular function,0,
Master Protein,High,Q13033,STRN3,Striatin-3 OS=Homo sapiens OX=9606 GN=STRN3 PE=1 SV=3,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.37E+05,,,,1,,,,,,,,,,,,,,,,,2.37E+05,,,,,,,,,,,,,,,,,,,,6.65E+04,,,,0,FALSE,7.028,3,1,797,87.2,5.36,1,other biological processes,plasma membrane;other membranes;ER/Golgi;nucleus;other cell component,"Pf00400, Pf08232",29966,A2RTX7; A6NHZ7; hsa:29966; Q13033; Q9NRA5,ENSG00000196792,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,3.97,other molecular function,0,
Master Protein,High,Q69YH5,CDCA2,Cell division cycle-associated protein 2 OS=Homo sapiens OX=9606 GN=CDCA2 PE=1 SV=2,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,1.04E+05,,,,1,,,,,,,,,,,,,,,1.04E+05,,,,,,,,,,,,,,,,,,,,1.40E+04,,,,,,,0.002,FALSE,2.942,2,1,1023,112.6,8.4,1,cell cycle OR cell proliferation;other biological processes,cytosol;nucleus;other cell component,Pf15276,157313,hsa:157313; Q3SX74; Q4G0W0; Q5RKN0; Q69YH5; Q69YI4; Q6P464; Q8N7C1,ENSG00000184661,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,2.84,,0,
Master Protein,High,Q9NUQ6,SPATS2L,SPATS2-like protein OS=Homo sapiens OX=9606 GN=SPATS2L PE=1 SV=2,2,2,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,1.02E+05,,,,3,,,,,,,,,,,,,1.02E+05,,1.51E+05,9.10E+04,,,,,,,,,,,,,,,,,4.58E+03,,2.03E+04,2.26E+03,,,,,,0,FALSE,5.201,6,2,558,61.7,9.64,2,,cytosol;nucleus;other cell component,Pf07139,26010,A8K381; B4DRE6; B4DT67; B7WNZ7; hsa:26010; Q53T22; Q8WV53; Q8WYG1; Q9NTW4; Q9NUQ6,ENSG00000196141,,,0,0,,,27.61,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.98,,0,
Master Protein,Medium,Q9BWH2,FUNDC2,FUN14 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=FUNDC2 PE=1 SV=2,1,1,,100,100,1.068,,6.64,6.64,0.09,,1.00E-17,1.00E-17,8.08E-01,,,2.56E+05,2.39E+05,,,3,1,,,,,,,,,,,9.15E+05,,2.56E+05,2.20E+05,,,2.39E+05,,,,,,,,,,,,,,5.47E+03,,2.08E+03,2.97E+04,,,6.73E+04,,,,0.028,FALSE,1.851,6,1,189,20.7,9.73,1,cell organization and biogenesis;other metabolic processes;other biological processes,other membranes;mitochondrion,Pf04930,65991,B2R7W5; D3DWY5; hsa:65991; Q8NHX8; Q9BWH2; Q9H2I6,ENSG00000165775,,,0,0,,,84.4,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,,,20.56,2.67,other molecular function,0,
Master Protein,High,P11836,MS4A1,B-lymphocyte antigen CD20 OS=Homo sapiens OX=9606 GN=MS4A1 PE=1 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,1.46E+05,,,,4,,,,,,,,,,,,1.43E+05,1.22E+05,1.50E+05,,8.95E+05,,,,,,,,,,,,,,,,8.54E+02,5.44E+03,1.21E+03,,2.22E+04,,,,,,0.01,FALSE,2.291,6,1,297,33.1,5.05,1,cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;other membranes;nucleus;other cell component,Pf04103,931,A6NMS4; B4DT24; hsa:931; P08984; P11836; Q13963,ENSG00000156738,,Extrafollicular and follicular B cell activation by SARS-CoV-2; 11p11.2 copy number variation syndrome,2,0,,,115.71,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.21,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q92673,SORL1,Sortilin-related receptor OS=Homo sapiens OX=9606 GN=SORL1 PE=1 SV=2,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,8.69E+05,,,,1,,,,,,,,,,,,,,,,,,,8.69E+05,,,,,,,,,,,,,,,,,,,,2.03E+04,,0.002,FALSE,2.934,1,1,2214,248.3,5.55,1,protein metabolism;other metabolic processes;transport;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,"Pf00041, Pf00057, Pf00058, Pf15901, Pf15902",6653,B2RNX7; hsa:6653; Q92673; Q92856,ENSG00000137642,Amyloid fiber formation,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,1,,FALSE,,,,,2.73,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q9P0M6,MACROH2A2,Core histone macro-H2A.2 OS=Homo sapiens OX=9606 GN=MACROH2A2 PE=1 SV=3,3,49,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,1.30E+05,,,,2,,,,,,,,,,,,,,3.72E+04,4.56E+05,,,,,,,,,,,,,,,,,,,3.03E+02,6.15E+04,,,,,,,0,FALSE,20.042,11,1,372,40,9.69,3,cell organization and biogenesis;developmental processes;other biological processes,nucleus;other cell component,"Pf00125, Pf01661, Pf16211",55506,hsa:55506; Q5SQT2; Q9P0M6,ENSG00000099284,,Pre-implantation embryo; lncRNA in canonical Wnt signaling and colorectal cancer; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,3,0,,,120.07,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,153.77,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q8TBP6,SLC25A40,Probable mitochondrial glutathione transporter SLC25A40 OS=Homo sapiens OX=9606 GN=SLC25A40 PE=1 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,1.32E+05,,,,3,,,,,,,,,,,,,,1.06E+05,3.03E+05,1.32E+05,,,,,,,,,,,,,,,,,,8.64E+02,4.08E+04,3.29E+03,,,,,,0.007,FALSE,2.372,4,1,338,38.1,9.35,1,transport;other biological processes,other membranes;mitochondrion,Pf00153,55972,A8K483; D6W5P6; hsa:55972; Q53GB1; Q8TBP6; Q9UHR1,ENSG00000075303,,,0,0,,,59.16,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.01,,0,
Master Protein,Medium,Q99436,PSMB7,Proteasome subunit beta type-7 OS=Homo sapiens OX=9606 GN=PSMB7 PE=1 SV=1,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,6.34E+04,,,,1,,,,,,,,,,,,,,,,,6.34E+04,,,,,,,,,,,,,,,,,,,,1.78E+04,,,,0.013,FALSE,2.139,3,1,277,29.9,7.68,1,protein metabolism;other metabolic processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf00227, Pf12465",5695,B4E0P1; hsa:5695; Q5TBG6; Q96AG8; Q99436; Q9BWA7,ENSG00000136930,Ub-specific processing proteases; Neutrophil degranulation; Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,63,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,1.99,other molecular function,0,
Master Protein,High,A0A8Q3SIS5,G6PD,Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens OX=9606 GN=G6PD PE=1 SV=1,4,5,,2.787,,1.307,,1.48,,0.39,,7.76E-02,,6.76E-01,1.39E+05,1.16E+06,2.79E+05,3.94E+05,1,4,2,2,,,,1.39E+05,,,1.17E+06,6.47E+06,4.98E+05,1.15E+06,,,,4.01E+05,1.94E+05,,,,2.56E+05,6.08E+05,,,,1.39E+05,,,2.09E+04,5.97E+04,1.40E+04,1.22E+04,,,,5.40E+04,4.83E+03,,,,5.98E+03,6.47E+03,0,FALSE,10.027,8,4,581,66.1,7.11,4,other metabolic processes,,"Pf00479, Pf02781",,A0A8Q3SIS5,ENSG00000160211,,Cori cycle; Nuclear receptors meta-pathway; NRF2 pathway; ATM signaling in development and disease ; Metabolic reprogramming in colon cancer; Vitamin D-sensitive calcium signaling in depression; Pentose phosphate pathway in senescent cells; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis in senescence; Sulfation biotransformation reaction,10,0,,119.79,49.1,57.67,n/a,n/a,n/a,High,n/a,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,High,Peak Found,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,,39.28,,37.16,9.99,other molecular function,0,
Master Protein,High,P50579,METAP2,Methionine aminopeptidase 2 OS=Homo sapiens OX=9606 GN=METAP2 PE=1 SV=1,2,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,5.16E+04,,,,1,,,,,,,,,,,,,,,,,5.16E+04,,,,,,,,,,,,,,,,,,,,1.45E+04,,,,0,FALSE,7.402,5,2,478,52.9,5.82,2,protein metabolism;other metabolic processes,plasma membrane;other membranes;cytosol;other cell component,Pf00557,10988,B2RDI8; B4DUX5; G3XA91; hsa:10988; P50579; Q8NB11,ENSG00000111142,"Inactivation, recovery and regulation of the phototransduction cascade",,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,11.41,other molecular function,0,
Master Protein,High,P78540,ARG2,"Arginase-2, mitochondrial OS=Homo sapiens OX=9606 GN=ARG2 PE=1 SV=1",1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.01E+05,,,,1,,,,,,,,,,,,,,,,,1.01E+05,,,,,,,,,,,,,,,,,,,,2.83E+04,,,,0,FALSE,6.906,7,1,354,38.6,6.47,1,other metabolic processes;stress response;developmental processes;other biological processes,mitochondrion;other cell component,Pf00491,384,B2R690; hsa:384; P78540; Q6FHY8,ENSG00000081181,Mitochondrial protein degradation; Urea cycle,Amino acid metabolism,3,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,3.85,other molecular function,0,
Master Protein,High,A0A182DWE9,HLA-DPB1,HLA class II histocompatibility antigen DP beta chain OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1,4,16,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,9.37E+05,,,,2,,,,,,,,,,,,2.94E+05,2.98E+06,,,,,,,,,,,,,,,,,,,1.76E+03,1.33E+05,,,,,,,,,0,FALSE,22.214,18,1,258,29.3,7.43,4,other biological processes,plasma membrane;other membranes;other cytoplasmic organelle,"Pf00969, Pf07654",,A0A182DWE9,ENSG00000230708,,,0,0,,,116.03,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,43.66,,0,
Master Protein,High,O95169,NDUFB8,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFB8 PE=1 SV=1",4,8,,1.121,1.947,0.501,,0.16,0.96,-1,,5.64E-01,5.48E-01,6.99E-01,3.17E+05,5.00E+05,5.29E+05,1.06E+06,1,2,4,4,,,,3.17E+05,,,,,5.42E+05,4.62E+05,,3.44E+05,4.23E+05,7.51E+05,6.60E+05,1.59E+06,2.73E+05,,7.00E+05,2.65E+06,,,,3.17E+05,,,,,1.53E+04,4.91E+03,,1.53E+04,3.44E+03,1.01E+05,1.64E+04,3.10E+03,7.67E+04,,1.64E+04,2.82E+04,0,FALSE,14.106,27,4,186,21.8,6.8,4,cell organization and biogenesis;other metabolic processes;transport,other membranes;mitochondrion;ER/Golgi,Pf05821,4714,A8K0L4; hsa:4714; O95169; Q5W143; Q5W144; Q5W145; Q9UG53; Q9UJR4; Q9UQF3,ENSG00000166136,Complex I biogenesis; Mitochondrial protein import,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,6,0,,11.24,35.33,80.7,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,High,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,1,,FALSE,,13.63,92.66,105.37,21.21,transporter activity,0,
Master Protein,Medium,O00178,GTPBP1,GTP-binding protein 1 OS=Homo sapiens OX=9606 GN=GTPBP1 PE=1 SV=3,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,6.78E+05,,,,2,,,,,,,,,,,,,,,,,1.98E+05,,,2.32E+06,,,,,,,,,,,,,,,,,5.57E+04,,,2.47E+04,0.012,FALSE,2.196,1,1,669,72.4,8.34,1,protein metabolism;other metabolic processes;signal transduction;other biological processes,cytosol;other cytoplasmic organelle,"Pf00009, Pf03144",9567,hsa:9567; O00178; Q6IC67,ENSG00000100226,,,0,0,,,,119.14,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,1,,FALSE,,,,,2.18,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P14672,SLC2A4,"Solute carrier family 2, facilitated glucose transporter member 4 OS=Homo sapiens OX=9606 GN=SLC2A4 PE=1 SV=1",1,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,8.05E+05,,,,1,,,,,,,,,,,,,,,,,8.05E+05,,,,,,,,,,,,,,,,,,,,2.26E+05,,,,0.004,FALSE,2.565,3,1,509,54.8,6.93,1,cell cycle OR cell proliferation;other metabolic processes;stress response;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00083,6517,hsa:6517; P14672; Q05BQ3; Q14CX2,ENSG00000181856; ENSG00000288174,Transcriptional regulation of white adipocyte differentiation; Cellular hexose transport; Translocation of SLC2A4 (GLUT4) to the plasma membrane,AMP-activated protein kinase signaling; Type II diabetes mellitus; Cori cycle; Adipogenesis; Vitamin D receptor pathway; Nuclear receptors meta-pathway; NRF2 pathway; Transcription factor regulation in adipogenesis; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; SCFA and skeletal muscle substrate metabolism; 22q11.2 copy number variation syndrome; Insulin signaling; Influence of laminopathies on Wnt signaling; Galanin receptor pathway; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Orexin receptor pathway; Female steroid hormones in cardiomyocyte energy metabolism; Glycolysis and gluconeogenesis; 8p23.1 copy number variation syndrome; Metabolic Epileptic Disorders,24,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,8.97,transporter activity,0,
Master Protein,High,Q15181,PPA1,Inorganic pyrophosphatase OS=Homo sapiens OX=9606 GN=PPA1 PE=1 SV=2,2,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,6.61E+04,,,,1,,,,,,,,,,,,,,,,,6.61E+04,,,,,,,,,,,,,,,,,,,,1.86E+04,,,,0,FALSE,4.276,10,1,289,32.6,5.86,2,other metabolic processes,cytosol;other cell component,Pf00719,5464,hsa:5464; Q15181; Q2M348; Q5SQT7; Q6P7P4; Q9UQJ5; Q9Y5B1,ENSG00000180817,Cytosolic tRNA aminoacylation; Pyrophosphate hydrolysis,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,5.29,other molecular function,0,
Master Protein,High,Q6P179,ERAP2,Endoplasmic reticulum aminopeptidase 2 OS=Homo sapiens OX=9606 GN=ERAP2 PE=1 SV=2,4,13,,8.027,1.153,0.773,,3,0.21,-0.37,,5.75E-04,9.67E-01,9.99E-01,5.62E+04,1.70E+05,1.07E+06,1.96E+05,2,1,3,4,,,,6.92E+03,4.56E+05,,,,,1.70E+05,,1.07E+06,,4.43E+03,4.98E+06,2.62E+05,9.04E+05,1.46E+05,1.25E+04,,,,,6.92E+03,2.35E+04,,,,,1.80E+03,,4.80E+04,,5.96E+02,1.24E+05,5.11E+02,2.54E+05,1.03E+03,2.93E+02,,0,FALSE,15.117,6,4,960,110.4,6.71,4,protein metabolism;other metabolic processes;other biological processes,other membranes;ER/Golgi;other cell component,"Pf01433, Pf11838, Pf17900",64167,hsa:64167; Q6P179; Q7Z5K1; Q8TD32; Q8WVJ4; Q9HBX2,ENSG00000164308,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",,1,0,137.2,,129.69,119.35,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,High,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,,307.04,82.01,138.11,30.04,other molecular function,0,
Master Protein,High,P30405,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial OS=Homo sapiens OX=9606 GN=PPIF PE=1 SV=1",1,2,,100,100,0.236,,6.64,6.64,-2.08,,1.00E-17,1.00E-17,2.37E-01,,,6.42E+05,1.82E+06,,,4,4,,,,,,,,,,,1.14E+05,2.81E+05,1.47E+06,,1.51E+06,8.04E+06,1.09E+06,3.03E+06,,5.27E+05,,,,,,,,,,,6.81E+02,1.26E+04,1.19E+04,,3.75E+04,1.57E+04,3.06E+05,2.15E+04,,5.61E+03,0.002,FALSE,2.776,4,1,207,22,9.38,1,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,other membranes;mitochondrion;other cell component,Pf00160,10105,hsa:10105; P30405; Q2YDB7; Q5W131,ENSG00000108179,,Alzheimer's disease and miRNA effects; Alzheimer's disease,2,0,,,88.8,107.76,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,,,,122.6,5.35,other molecular function,0,
Master Protein,High,Q9BXL5,HEMGN,Hemogen OS=Homo sapiens OX=9606 GN=HEMGN PE=1 SV=1,4,6,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,5.56E+05,,,,1,,,,,,,,,,,,,,,,,5.56E+05,,,,,,,,,,,,,,,,,,,,1.56E+05,,,,0,FALSE,14.121,14,4,484,55.3,4.87,4,other biological processes,nucleus,,55363,hsa:55363; Q6XAR3; Q86XY5; Q9BXL5; Q9NPC0,ENSG00000136929,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,1,,FALSE,,,,,19.22,,0,
Master Protein,High,P30043,BLVRB,Flavin reductase (NADPH) OS=Homo sapiens OX=9606 GN=BLVRB PE=1 SV=3,6,26,,0.655,6.4,0.376,,-0.61,2.68,-1.41,,9.58E-01,5.73E-02,5.22E-01,3.54E+05,2.34E+05,2.11E+05,1.35E+06,4,2,5,3,1.29E+06,,4.83E+05,8.18E+04,2.59E+05,,,3.94E+05,1.39E+05,,5.46E+05,2.00E+05,5.53E+05,2.11E+05,1.85E+05,,1.83E+07,3.98E+05,1.35E+06,,5.12E+03,,4.72E+03,8.18E+04,1.33E+04,,,3.64E+03,3.92E+03,,3.27E+03,8.95E+03,4.49E+03,2.84E+04,4.59E+03,,5.15E+06,2.82E+03,3.15E+04,,0,FALSE,50.002,40,6,206,22.1,7.65,6,other metabolic processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,Pf13460,645,A6NKD8; B2R5C6; hsa:645; P30043; P32078; P53005; Q32LZ2,ENSG00000090013,Cytoprotection by HMOX1; Heme degradation,Nuclear receptors meta-pathway; NRF2 pathway; IL-10 anti-inflammatory signaling pathway,5,0,100.93,67.56,56.75,150.81,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,High,n/a,1,,FALSE,,99.63,80.62,131.16,83.18,other molecular function,0,
Master Protein,High,Q9Y376,CAB39,Calcium-binding protein 39 OS=Homo sapiens OX=9606 GN=CAB39 PE=1 SV=1,2,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.30E+05,,,,2,,,,,,,,,,,,,,,,1.47E+05,3.58E+05,,,,,,,,,,,,,,,,,,,2.87E+02,1.01E+05,,,,0,FALSE,4.802,6,2,341,39.8,6.89,2,protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,non-structural extracellular;cytosol;cytoskeleton;other cell component,Pf08569,51719,A8K8L7; hsa:51719; Q9Y376,ENSG00000135932,Neutrophil degranulation; Energy dependent regulation of mTOR by LKB1-AMPK,AMP-activated protein kinase signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Endochondral ossification; Endochondral ossification with skeletal dysplasias,6,0,,,,59.06,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,,,,4.02,enzyme regulator activity;other molecular function,0,
Master Protein,High,P09972,ALDOC,Fructose-bisphosphate aldolase C OS=Homo sapiens OX=9606 GN=ALDOC PE=1 SV=2,3,16,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,3.76E+05,,,,2,,,,,,,,,,,,,4.37E+05,,3.24E+05,,,,,,,,,,,,,,,,,,1.95E+04,,4.36E+04,,,,,,,0,FALSE,18.088,17,1,364,39.4,6.87,3,other metabolic processes;other biological processes,non-structural extracellular;cytosol;cytoskeleton;other cell component,Pf00274,230,B2R5R3; hsa:230; P09972; Q3SYL3; Q6FH94; Q6P0L5,ENSG00000109107,Glycolysis; Gluconeogenesis; Neutrophil degranulation,Clear cell renal cell carcinoma pathways; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders,6,0,,,21.09,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,42.98,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q5T7Y6,S100A1,Protein S100 OS=Homo sapiens OX=9606 GN=S100A1 PE=1 SV=1,1,2,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,2.68E+05,,,,1,,,,,,,,,,,,,,,2.68E+05,,,,,,,,,,,,,,,,,,,,3.62E+04,,,,,,,0.007,FALSE,2.406,10,1,147,15.9,4.48,1,other biological processes,cytosol;mitochondrion;ER/Golgi;nucleus,"Pf00036, Pf01023",,Q5T7Y6,ENSG00000160678,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.7,other molecular function,0,
Master Protein,Medium,Q9NP72,RAB18,Ras-related protein Rab-18 OS=Homo sapiens OX=9606 GN=RAB18 PE=1 SV=1,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,6.03E+05,,,,2,,,,,,,,,,,,,,,,8.30E+05,4.39E+05,,,,,,,,,,,,,,,,,,,1.62E+03,1.23E+05,,,,0.017,FALSE,2.04,5,1,206,23,5.24,1,cell organization and biogenesis;transport;developmental processes;signal transduction,plasma membrane;other membranes;cytosol;ER/Golgi;other cell component,Pf00071,22931,B3KMC7; B7Z333; D3DRW1; hsa:22931; Q53FX8; Q56UN9; Q6FIH1; Q9NP72,ENSG00000099246,Neutrophil degranulation; RAB geranylgeranylation; RAB GEFs exchange GTP for GDP on RABs; COPI-independent Golgi-to-ER retrograde traffic,,4,0,,,,43.64,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,,,,2.55,other molecular function,0,
Master Protein,High,P12544,GZMA,Granzyme A OS=Homo sapiens OX=9606 GN=GZMA PE=1 SV=2,1,6,,100,100,2.02,,6.64,6.64,1.01,,1.00E-17,1.00E-17,4.00E-01,,,3.50E+05,1.73E+05,,,3,1,,,,,,,,,,,,,6.91E+04,4.46E+05,3.50E+05,,1.73E+05,,,,,,,,,,,,,,,,5.61E+02,6.01E+04,8.69E+03,,4.86E+04,,,,0.001,FALSE,3.302,5,1,262,29,8.91,1,protein metabolism;other metabolic processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;nucleus;other cell component,Pf00089,3001,A4PHN1; hsa:3001; P12544; Q6IB36,ENSG00000145649,,,0,0,,,67.94,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,High,High,Peak Found,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,40.79,10.68,other molecular function,0,
Master Protein,High,P30825,SLC7A1,High affinity cationic amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A1 PE=1 SV=1,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,6.56E+05,,,,1,,,,,,,,,,,,,,,,,6.56E+05,,,,,,,,,,,,,,,,,,,,1.84E+05,,,,0.007,FALSE,2.402,2,1,629,67.6,5.43,1,transport;other biological processes,plasma membrane;other membranes;other cell component,"Pf13520, Pf13906",6541,hsa:6541; P30825; Q5JR50,ENSG00000139514,Amino acid transport across the plasma membrane,VEGFA-VEGFR2 signaling,2,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,2.41,transporter activity;other molecular function,0,
Master Protein,High,P53004,BLVRA,Biliverdin reductase A OS=Homo sapiens OX=9606 GN=BLVRA PE=1 SV=2,1,2,,100,100,0.244,,6.64,6.64,-2.04,,1.00E-17,1.00E-17,3.31E-01,,,2.59E+04,1.06E+05,,,2,4,,,,,,,,,,,,,3.51E+04,,1.92E+04,8.99E+04,1.26E+05,1.85E+05,,2.71E+04,,,,,,,,,,,,,2.85E+02,,4.77E+02,1.75E+02,3.54E+04,1.31E+03,,2.88E+02,0.002,FALSE,3.063,6,1,296,33.4,6.44,1,other metabolic processes,cytosol,"Pf01408, Pf09166",644,A8K747; hsa:644; O95019; P53004; Q86UX0; Q96QL4; Q9BRW8,ENSG00000106605,Cytoprotection by HMOX1; Heme degradation,IL-10 anti-inflammatory signaling pathway,3,0,,,41.32,61.75,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,1,,FALSE,,,,72.27,6.21,other molecular function,0,
Master Protein,High,Q8WU79,SMAP2,Stromal membrane-associated protein 2 OS=Homo sapiens OX=9606 GN=SMAP2 PE=1 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,3.14E+05,,,,4,,,,,,,,,,,,,3.19E+05,2.81E+05,4.30E+05,3.09E+05,,,,,,,,,,,,,,,,,1.42E+04,2.29E+03,5.80E+04,7.69E+03,,,,,,0.003,FALSE,2.73,3,1,429,46.8,8.87,1,,cytosol;nucleus;other cell component,Pf01412,64744,B2R7T1; B7Z5B5; B7Z8V2; D3DPV2; hsa:64744; Q5QPL2; Q8WU79; Q96C93; Q9NST2; Q9UJL8,ENSG00000084070,,,0,0,,,19.56,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.23,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q15021,NCAPD2,Condensin complex subunit 1 OS=Homo sapiens OX=9606 GN=NCAPD2 PE=1 SV=3,3,5,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,7.84E+05,,,,2,,,,,,,,,,,,,,,,,6.20E+05,,9.92E+05,,,,,,,,,,,,,,,,,,1.74E+05,,2.32E+04,,0,FALSE,9.548,3,3,1401,157.1,6.61,3,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,cytosol;nucleus;other cell component,"Pf12717, Pf12922",9918,D3DUR4; hsa:9918; Q15021; Q8N6U3,ENSG00000010292,Condensation of Prometaphase Chromosomes,,1,0,,,,32.58,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,1,,FALSE,,,,,13,other molecular function,0,
Master Protein,High,Q15811,ITSN1,Intersectin-1 OS=Homo sapiens OX=9606 GN=ITSN1 PE=1 SV=3,2,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,3.96E+05,,,,1,,,,,,,,,,,,,,,,,3.96E+05,,,,,,,,,,,,,,,,,,,,1.11E+05,,,,0,FALSE,13.284,2,2,1721,195.3,7.77,2,transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,"Pf00018, Pf00168, Pf00621, Pf07653, Pf12763, Pf14604, Pf16617, Pf16652",6453,A7Y322; A8CTX8; A8CTY3; A8CTY7; A8D7D0; A8DCP3; B4DTM2; E7ERJ1; E9PE44; E9PG01; E9PHV2; hsa:6453; O95216; Q0PW94; Q0PW95; Q0PW97; Q14BD3; Q15811; Q1ED40; Q20BK3; Q9UET5; Q9UK60; Q9UNK1; Q9UNK2; Q9UQ92,ENSG00000205726,G alpha (12/13) signalling events; Cargo recognition for clathrin-mediated endocytosis; CDC42 GTPase cycle; NRAGE signals death through JNK; RHOQ GTPase cycle; RHOG GTPase cycle; EPHB-mediated forward signaling,,8,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,10.91,enzyme regulator activity;other molecular function,0,
Master Protein,Medium,Q99871,HAUS7,HAUS augmin-like complex subunit 7 OS=Homo sapiens OX=9606 GN=HAUS7 PE=1 SV=4,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.76E+04,,,,1,,,,,,,,,,,,,,,,,2.76E+04,,,,,,,,,,,,,,,,,,,,7.76E+03,,,,0.023,FALSE,1.918,4,1,358,39.8,4.75,1,cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus,,55559,B4DUH6; D3DWT9; Q96HS8; Q99871; Q9NP54; Q9UFH9,ENSG00000213397,Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,,7,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,2.82,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q6ZUX7,LHFPL2,LHFPL tetraspan subfamily member 2 protein OS=Homo sapiens OX=9606 GN=LHFPL2 PE=1 SV=2,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.12E+05,,,,1,,,,,,,,,,,,,,,,,2.12E+05,,,,,,,,,,,,,,,,,,,,5.95E+04,,,,0,FALSE,4.701,11,1,228,24.5,6.49,1,developmental processes;other biological processes,plasma membrane;other membranes,Pf10242,10184,B2RMQ6; hsa:10184; Q6ZUX7; Q7Z5P0; Q92605,ENSG00000145685,Platelet degranulation,TYROBP causal network in microglia,2,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,2.66,,0,
Master Protein,High,Q8N129,CNPY4,Protein canopy homolog 4 OS=Homo sapiens OX=9606 GN=CNPY4 PE=1 SV=1,1,2,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,2.13E+05,,,,1,,,,,,,,,,,,,,,2.13E+05,,,,,,,,,,,,,,,,,,,,2.87E+04,,,,,,,0,FALSE,5.814,6,1,248,28.3,4.64,1,other biological processes,non-structural extracellular,Pf11938,245812,hsa:245812; Q8N129; Q8WUN9,ENSG00000166997,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,9.31,signal transduction activity or receptor binding,0,
Master Protein,High,Q14232,EIF2B1,Translation initiation factor eIF-2B subunit alpha OS=Homo sapiens OX=9606 GN=EIF2B1 PE=1 SV=1,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,3.50E+05,,,,2,,,,,,,,,,,,,,,,5.13E+05,2.38E+05,,,,,,,,,,,,,,,,,,,9.99E+02,6.70E+04,,,,0.009,FALSE,2.332,3,1,305,33.7,7.33,1,protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;translational apparatus;other cell component,Pf01008,1967,A6NLY9; B4DGX0; hsa:1967; Q14232; Q3SXP4,ENSG00000111361,Recycling of eIF2:GDP,Translation factors,2,0,,,,51.62,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,n/a,1,,FALSE,,,,,3.14,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q92539,LPIN2,Phosphatidate phosphatase LPIN2 OS=Homo sapiens OX=9606 GN=LPIN2 PE=1 SV=1,1,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,4.62E+05,,,,3,,,,,,,,,,,,,,,,4.12E+05,8.45E+05,4.62E+05,,,,,,,,,,,,,,,,,,8.03E+02,2.38E+05,3.27E+03,,,0,FALSE,6.388,2,1,896,99.3,5.33,1,other metabolic processes;other biological processes,other membranes;cytosol;ER/Golgi;nucleus,"Pf04571, Pf08235, Pf16876",9663,A7MD25; D3DUH3; hsa:9663; Q92539,ENSG00000101577,Triglyceride biosynthesis; Depolymerization of the Nuclear Lamina; Synthesis of PC; Synthesis of PE,Adipogenesis; Congenital generalized lipodystrophy,6,0,,,,41.4,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,,,,,6.23,other molecular function,0,
Master Protein,High,Q9BZV1,UBXN6,UBX domain-containing protein 6 OS=Homo sapiens OX=9606 GN=UBXN6 PE=1 SV=1,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,3.34E+05,,,,1,,,,,,,,,,,,,,,,,3.34E+05,,,,,,,,,,,,,,,,,,,,9.37E+04,,,,0,FALSE,8.909,5,1,441,49.7,6.89,1,protein metabolism;other metabolic processes;stress response;transport,other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,"Pf00789, Pf09409",80700,D6W626; hsa:80700; Q96AH1; Q96IK9; Q9BZV0; Q9BZV1,ENSG00000167671,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,5.53,,0,
Master Protein,High,P28482,MAPK1,Mitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3,1,3,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,8.83E+04,,,,1,,,,,,,,,,,,,,,,,8.83E+04,,,,,,,,,,,,,,,,,,,,2.48E+04,,,,0,FALSE,4.534,5,1,360,41.4,6.98,1,cell-cell signaling;cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component,Pf00069,5594,A8CZ64; hsa:5594; P28482,ENSG00000100030,"Neutrophil degranulation; Regulation of actin dynamics for phagocytic cup formation; FCERI mediated MAPK activation; FCGR3A-mediated phagocytosis; Recycling pathway of L1; NPAS4 regulates expression of target genes; RHO GTPases Activate WASPs and WAVEs; Regulation of HSF1-mediated heat shock response; Signaling by BRAF and RAF1 fusions; Thrombin signalling through proteinase activated receptors (PARs); SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Signaling by NODAL; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Interferon gamma signaling; Oncogene Induced Senescence; Senescence-Associated Secretory Phenotype (SASP); Growth hormone receptor signaling; Regulation of the apoptosome activity; Signal transduction by L1; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; NCAM signaling for neurite out-growth; Downregulation of SMAD2/3:SMAD4 transcriptional activity; RUNX2 regulates osteoblast differentiation; RSK activation; Estrogen-stimulated signaling through PRKCZ; Spry regulation of FGF signaling; Suppression of apoptosis; MAPK1 (ERK2) activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; IFNG signaling activates MAPKs; Golgi Cisternae Pericentriolar Stack Reorganization; Signaling by Activin; Activation of the AP-1 family of transcription factors; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; Signal attenuation; Gastrin-CREB signalling pathway via PKC and MAPK; ESR-mediated signaling; Negative feedback regulation of MAPK pathway; Advanced glycosylation endproduct receptor signaling; RHO GTPases Activate NADPH Oxidases; Nuclear events stimulated by ALK signaling in cancer; ERKs are inactivated; Signaling by MAP2K mutants; phospho-PLA2 pathway; Signaling by MAPK mutants","IL-5 signaling pathway; Osteopontin signaling; Physiological and pathological hypertrophy of the heart; Angiogenesis; MicroRNAs in cardiomyocyte hypertrophy; Type II diabetes mellitus; Heart development; Integrin-mediated cell adhesion; IL-1 signaling pathway; Thyroxine (thyroid hormone) production; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; IL-17 signaling pathway; Endothelin pathways; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Glioblastoma signaling pathways; Androgen receptor network in prostate cancer; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Alpha 6 beta 4 signaling pathway; PDGF pathway; Aryl hydrocarbon receptor pathway; S1P receptor signal transduction; Ebstein-Barr virus LMP1 signaling; Common pathways underlying drug addiction; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Bladder cancer; IL-3 signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; TCA cycle nutrient use and invasiveness of ovarian cancer; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; MFAP5-mediated ovarian cancer cell motility and invasiveness; RAC1/PAK1/p38/MMP2 pathway; Wnt signaling pathway; IL6 signaling pathway; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; BDNF-TrkB signaling; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; ERK pathway in Huntington's disease; Toll-like receptor signaling related to MyD88; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; miRNA regulation of prostate cancer signaling pathways; Prion disease pathway; Endometrial cancer; PI3K-Akt signaling pathway; MET in type 1 papillary renal cell carcinoma; Chromosomal and microsatellite instability in colorectal cancer ; Ebola virus infection in host; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Neovascularization processes; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Bile acids synthesis and enterohepatic circulation ; LTF danger signal response pathway; Resistin as a regulator of inflammation; Relationship between inflammation, COX-2 and EGFR; Envelope proteins and their potential roles in EDMD physiopathology; Regulatory circuits of the STAT3 signaling pathway; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Hepatitis B infection; Melanoma; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Regucalcin in proximal tubule epithelial kidney cells; Kisspeptin/kisspeptin receptor system in the ovary; MAP3K1 role in promoting and blocking gonadal determination; CAMKK2 pathway; Disruption of postsynaptic signaling by CNV; Host-pathogen interaction of human coronaviruses - MAPK signaling; IL-2 signaling pathway; RAS and bradykinin pathways in COVID-19; Angiotensin II receptor type 1 pathway; Kallmann syndrome; Neuroinflammation and glutamatergic signaling; Pleural mesothelioma; Orexin receptor pathway; CCL18 signaling pathway; Regulation of actin cytoskeleton; Sphingolipid metabolism in senescence; Alzheimer's disease; Th17 cell differentiation pathway; GDNF signaling; 2q11.2 copy number variation syndrome; 2q13 copy number variation syndrome; Hippocampal synaptogenesis and neurogenesis; Comprehensive IL-17A signaling; Genetic causes of porto-sinusoidal vascular disease; Acute myeloid leukemia; Female steroid hormones in cardiomyocyte energy metabolism; Cardiomyocyte signaling pathways converging on titin; 8p23.1 copy number variation syndrome; IL-26 signaling pathways; Macrophage-stimulating protein (MSP) signaling network map; 4p16.3 copy number variation; Osteoarthritic chondrocyte hypertrophy; NPHP1 deletion syndrome; IL-19 signaling pathway; HDAC6 interactions in the central nervous system; GNAQ pathways in port-wine stain; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response (only ATM dependent); Estrogen signaling pathway; Vitamin A and carotenoid metabolism; Toll-like receptor signaling pathway",208,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,8.17,nucleic acid binding activity;kinase activity;other molecular function,0,
Master Protein,High,P29374,ARID4A,AT-rich interactive domain-containing protein 4A OS=Homo sapiens OX=9606 GN=ARID4A PE=1 SV=3,1,2,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,8.42E+04,,,,1,,,,,,,,,,,,,,,8.42E+04,,,,,,,,,,,,,,,,,,,,1.13E+04,,,,,,,0.001,FALSE,3.528,2,1,1257,142.7,5.1,1,cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf01388, Pf08169, Pf11717",5926,hsa:5926; P29374; Q15991; Q15992; Q15993,ENSG00000032219,Potential therapeutics for SARS; HDACs deacetylate histones,,2,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.22,nucleic acid binding activity,0,
Master Protein,High,Q9ULI0,,ATPase family AAA domain-containing protein 2B OS=Homo sapiens OX=9606 GN=ATAD2B PE=1 SV=3,2,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,3.73E+06,,,,1,,,,,,,,,,,,,,,,,3.73E+06,,,,,,,,,,,,,,,,,,,,1.05E+06,,,,0,FALSE,5.016,3,2,1458,164.8,6.8,2,,,,,,,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,Phospho [S524; S527],FALSE,,,,,7.53,,2,Phospho [S524; S527]
Master Protein,High,Q99497,PARK7,Parkinson disease protein 7 OS=Homo sapiens OX=9606 GN=PARK7 PE=1 SV=2,4,15,,2.109,2.126,0.978,,1.08,1.09,-0.03,,1.07E-01,4.97E-01,8.74E-01,1.10E+05,3.08E+05,1.10E+06,1.14E+06,3,3,5,3,1.10E+05,,,9.58E+05,4.92E+04,,,3.08E+05,1.80E+05,4.38E+06,1.47E+05,1.51E+06,1.09E+06,1.83E+06,1.10E+06,,1.95E+06,7.86E+05,,1.14E+06,4.38E+02,,,9.58E+05,2.54E+03,,,2.85E+03,5.08E+03,4.66E+04,8.80E+02,6.76E+04,8.89E+03,2.47E+05,2.74E+04,,5.48E+05,5.57E+03,,1.21E+04,0,FALSE,15.699,34,4,189,19.9,6.79,4,cell-cell signaling;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component,Pf01965,11315,B2R4Z1; hsa:11315; O14805; Q6DR95; Q7LFU2; Q99497,ENSG00000116288,Late endosomal microautophagy; Aggrephagy; SUMOylation of transcription cofactors; Chaperone Mediated Autophagy,Androgen receptor signaling pathway; Synaptic vesicle pathway; Parkinson's disease pathway; HDAC6 interactions in the central nervous system,8,0,136.37,147.19,55.66,46.25,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,n/a,High,Peak Found,n/a,Peak Found,1,,FALSE,,81.6,106.19,73.69,45.08,signal transduction activity or receptor binding;enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q9NY15,STAB1,Stabilin-1 OS=Homo sapiens OX=9606 GN=STAB1 PE=1 SV=3,1,1,,100,100,2.57,,6.64,6.64,1.36,,1.00E-17,1.00E-17,3.62E-01,,,1.90E+05,7.39E+04,,,1,1,,,,,,,,,,,,1.90E+05,,,,,7.39E+04,,,,,,,,,,,,,,,8.48E+03,,,,,2.08E+04,,,,0.006,FALSE,2.452,1,1,2570,275.3,6.49,1,cell adhesion;cell-cell signaling;stress response;transport;other biological processes,plasma membrane;other membranes,"Pf00193, Pf02469, Pf12947",23166,A7E297; hsa:23166; Q8IUH0; Q8IUH1; Q93072; Q9NY15,ENSG00000010327,Scavenging by Class H Receptors,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,,,,0,2,other molecular function,0,
Master Protein,High,Q9UJX4,ANAPC5,Anaphase-promoting complex subunit 5 OS=Homo sapiens OX=9606 GN=ANAPC5 PE=1 SV=2,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,7.79E+04,,,,1,,,,,,,,,,,,,,,,,7.79E+04,,,,,,,,,,,,,,,,,,,,2.19E+04,,,,0.002,FALSE,2.831,2,1,755,85,6.87,1,cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes,cytosol;cytoskeleton;nucleus,"Pf12862, Pf21371",51433,E9PFB2; hsa:51433; Q8N4H7; Q9BQD4; Q9UJX4,ENSG00000089053,Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,Cell cycle,19,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,0,other molecular function,0,
Master Protein,High,P25311,AZGP1,Zinc-alpha-2-glycoprotein OS=Homo sapiens OX=9606 GN=AZGP1 PE=1 SV=2,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,2.72E+05,,,,1,,,,,,,,,,,,,2.72E+05,,,,,,,,,,,,,,,,,,,,1.22E+04,,,,,,,,,0.002,FALSE,2.912,7,1,298,34.2,6.05,1,cell adhesion;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes,"Pf00129, Pf07654",563,D6W5T8; hsa:563; O60386; P25311; Q5XKQ4; Q8N4N0,ENSG00000160862,Miscellaneous transport and binding events,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,0,transporter activity;other molecular function,0,
Master Protein,High,Q96PC5,MIA2,Melanoma inhibitory activity protein 2 OS=Homo sapiens OX=9606 GN=MIA2 PE=1 SV=4,3,3,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,1.02E+05,,,,3,,,,,,,,,,,,,1.82E+05,,1.02E+05,8.46E+04,,,,,,,,,,,,,,,,,8.12E+03,,1.38E+04,2.10E+03,,,,,,0,FALSE,8.333,3,3,1412,159.7,4.69,3,transport;other biological processes,other membranes;ER/Golgi,Pf07653,4253,A0A193H6U5; A1L4H0; B3KRA6; B4DQS6; D3DSA6; G3XAC5; hsa:4253; O00169; O15320; Q6MZN2; Q6P2R8; Q86TF6; Q8IX92; Q8IX93; Q96PC5; Q9H6C1,ENSG00000150527,Cargo concentration in the ER,,1,0,,,42.19,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,8.36,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q9BY43,CHMP4A,Charged multivesicular body protein 4a OS=Homo sapiens OX=9606 GN=CHMP4A PE=1 SV=3,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.04E+05,,,,1,,,,,,,,,,,,,,,,,2.04E+05,,,,,,,,,,,,,,,,,,,,5.74E+04,,,,0.001,FALSE,3.775,7,1,222,25.1,4.7,1,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component,Pf03357,29082,hsa:29082; Q14D22; Q32Q79; Q86SZ8; Q96QJ9; Q9BY43; Q9P026,ENSG00000254505; ENSG00000285302,HCMV Late Events; Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex,,9,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,3.32,other molecular function,0,
Master Protein,Medium,Q15751,HERC1,Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.01E+05,,,,1,,,,,,,,,,,,,,,,,1.01E+05,,,,,,,,,,,,,,,,,,,,2.82E+04,,,,0.028,FALSE,1.853,0,1,4861,531.9,6.04,1,cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes,other membranes;cytosol;ER/Golgi;other cell component,"Pf00400, Pf00415, Pf00622, Pf00632",8925,hsa:8925; Q15751; Q8IW65,ENSG00000103657,Antigen processing: Ubiquitination & Proteasome degradation,,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,1.62,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q0JRZ9,FCHO2,F-BAR domain only protein 2 OS=Homo sapiens OX=9606 GN=FCHO2 PE=1 SV=2,2,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,7.49E+05,,,,1,,,,,,,,,,,,,,,,,7.49E+05,,,,,,,,,,,,,,,,,,,,2.11E+05,,,,0,FALSE,7.778,5,2,810,88.9,6.86,2,cell organization and biogenesis;transport;other biological processes,plasma membrane;other membranes;cytosol;other cell component,"Pf00611, Pf10291",115548,A8K6W7; B2RNQ9; B4DHK0; E9PG79; hsa:115548; Q0JRZ9; Q0JTJ3; Q96CF5,ENSG00000157107,Cargo recognition for clathrin-mediated endocytosis,,2,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,6.5,other molecular function,0,
Master Protein,High,Q92616,GCN1,eIF-2-alpha kinase activator GCN1 OS=Homo sapiens OX=9606 GN=GCN1 PE=1 SV=7,6,8,,0.129,0.459,0.682,,-2.96,-1.12,-0.55,,2.13E-02,3.55E-01,8.61E-01,1.08E+06,8.26E+05,1.38E+05,7.21E+05,2,2,3,2,1.40E+06,,8.27E+05,,,,,7.18E+05,9.50E+05,,1.38E+05,,,1.11E+05,6.02E+05,,7.84E+05,,6.63E+05,,5.55E+03,,8.08E+03,,,,,6.63E+03,2.68E+04,,8.26E+02,,,1.50E+04,1.50E+04,,2.20E+05,,1.55E+04,,0,FALSE,18.972,4,6,2671,292.5,7.43,6,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,cytosol;translational apparatus;other cell component,,10985,A8KAY1; hsa:10985; O95001; O95651; Q6P2S3; Q86X65; Q8N5I5; Q8WU80; Q92616; Q99736; Q9UE60,ENSG00000089154,Response of EIF2AK4 (GCN2) to amino acid deficiency,,1,0,36.23,19.66,97.22,11.76,High,n/a,High,High,n/a,n/a,n/a,Peak Found,Peak Found,n/a,Peak Found,n/a,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,39.29,75.89,80.4,19.91,enzyme regulator activity;translation activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,P26232,CTNNA2,Catenin alpha-2 OS=Homo sapiens OX=9606 GN=CTNNA2 PE=1 SV=5,1,1,,100,100,0.625,,6.64,6.64,-0.68,,1.00E-17,1.00E-17,8.41E-01,,,5.16E+04,8.24E+04,,,1,3,,,,,,,,,,,,,5.16E+04,,,1.18E+05,8.24E+04,6.33E+04,,,,,,,,,,,,,,,4.19E+02,,,2.29E+02,2.32E+04,4.48E+02,,,0.007,FALSE,2.41,1,1,953,105.2,5.71,1,cell adhesion;cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf01044,1496,B3KXE5; B7Z2W7; B7Z352; B7Z898; hsa:1496; P26232; Q4ZFW1; Q53R26; Q53R33; Q53T67; Q53T71; Q53TM8; Q7Z3L1; Q7Z3Y0,ENSG00000066032,Myogenesis,Arrhythmogenic right ventricular cardiomyopathy; Ectoderm differentiation; Ectoderm differentiation; Endometrial cancer; Pleural mesothelioma,6,0,,,,31.36,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,1,,FALSE,,,,34.49,3.09,cytoskeletal activity;other molecular function,0,
Master Protein,High,P56192,MARS1,"Methionine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=MARS1 PE=1 SV=2",5,8,,1.508,0.432,0.874,,0.59,-1.21,-0.2,,3.85E-01,2.73E-01,9.41E-01,1.46E+05,2.27E+05,6.53E+04,9.32E+05,1,2,2,1,,,,1.46E+05,,,,6.10E+05,,8.45E+04,,2.19E+05,1.94E+04,,,,9.32E+05,,,,,,,1.46E+05,,,,5.63E+03,,8.99E+02,,9.80E+03,1.58E+02,,,,2.62E+05,,,,0,FALSE,15.801,8,5,900,101.1,6.16,5,protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes,cytosol;nucleus;other cell component,"Pf00043, Pf00458, Pf09334, Pf18485, Pf19303",4141,B3KVK7; hsa:4141; P56192; Q14895; Q53H14; Q96A15; Q96BZ0; Q9NSE0,ENSG00000166986,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,,2,0,,107.03,118.44,,n/a,n/a,n/a,High,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,171.65,310.5,19.74,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q5EBM0,CMPK2,"UMP-CMP kinase 2, mitochondrial OS=Homo sapiens OX=9606 GN=CMPK2 PE=1 SV=3",1,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,5.59E+04,,,,2,,,,,,,,,,,,,,,,,3.21E+04,9.74E+04,,,,,,,,,,,,,,,,,,,9.01E+03,6.90E+02,,,0,FALSE,4.302,3,1,449,49.4,7.01,1,other metabolic processes;other biological processes,mitochondrion;nucleus;other cell component,Pf02223,129607,A2RUB0; A5D8T2; B7ZM18; hsa:129607; Q5EBM0; Q6ZRU2; Q96AL8,ENSG00000134326,,Pyrimidine metabolism,1,0,,,,71.34,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,,,,5.31,kinase activity;other molecular function,0,
Master Protein,High,Q96EY1,DNAJA3,"DnaJ homolog subfamily A member 3, mitochondrial OS=Homo sapiens OX=9606 GN=DNAJA3 PE=1 SV=2",1,1,,100,100,0.095,,6.64,6.64,-3.4,,1.00E-17,1.00E-17,4.39E-02,,,4.70E+05,4.97E+06,,,2,1,,,,,,,,,,,,,,3.15E+05,7.02E+05,,,4.97E+06,,,,,,,,,,,,,,,,4.25E+04,1.75E+04,,,3.52E+04,,,0.005,FALSE,2.474,4,1,480,52.5,9.26,1,cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component,"Pf00226, Pf00684, Pf01556",9093,B2RAJ5; B4DI33; E7ES32; hsa:9093; O75472; Q8WUJ6; Q8WXJ3; Q96D76; Q96EY1; Q96IV1; Q9NYH8,ENSG00000103423; ENSG00000276726,,,0,0,,,53.83,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,n/a,n/a,Peak Found,n/a,n/a,1,,FALSE,,,,61.03,2.32,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q5T5H1,ENSA,Endosulfine alpha OS=Homo sapiens OX=9606 GN=ENSA PE=1 SV=1,1,1,,100,100,0.685,,6.64,6.64,-0.55,,1.00E-17,1.00E-17,9.32E-01,,,4.44E+04,6.49E+04,,,1,2,,,,,,,,,,,,,,,4.44E+04,,1.01E+05,,4.18E+04,,,,,,,,,,,,,,,,1.10E+03,,2.83E+04,,9.79E+02,,0.001,FALSE,3.398,9,1,187,21,7.87,1,,,,,Q5T5H1,ENSG00000143420,,,0,0,,,,58.4,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,,67.22,2.4,,0,
Master Protein,High,P21266,GSTM3,Glutathione S-transferase Mu 3 OS=Homo sapiens OX=9606 GN=GSTM3 PE=1 SV=3,1,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.32E+05,,,,2,,,,,,,,,,,,,,,,,2.95E+05,,1.82E+05,,,,,,,,,,,,,,,,,,8.29E+04,,4.26E+03,,0.001,FALSE,4.004,8,1,225,26.5,5.54,1,other metabolic processes;stress response;developmental processes;other biological processes,cytosol;cytoskeleton;other cell component,"Pf00043, Pf02798",2947,hsa:2947; O60550; P21266; Q96HA3,ENSG00000134202,Glutathione conjugation,Nuclear receptors meta-pathway; NRF2 pathway; Exercise-induced circadian regulation; Metapathway biotransformation Phase I and II,5,0,,,,33.47,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,,,6.46,other molecular function,0,
Master Protein,High,E9PHI4,SUN1,Sad1 and UNC84 domain containing 1 OS=Homo sapiens OX=9606 GN=SUN1 PE=1 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,4.16E+05,,,,1,,,,,,,,,,,,,,,4.16E+05,,,,,,,,,,,,,,,,,,,,5.60E+04,,,,,,,0.002,FALSE,2.788,2,1,822,91.1,7.18,1,,other membranes;nucleus;other cell component,"Pf07738, Pf09387, Pf18580",,E9PHI4,ENSG00000164828,,,0,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.53,,0,
Master Protein,High,O00232,PSMD12,26S proteasome non-ATPase regulatory subunit 12 OS=Homo sapiens OX=9606 GN=PSMD12 PE=1 SV=3,4,4,,100,100,0.74,,6.64,6.64,-0.43,,1.00E-17,1.00E-17,9.32E-01,,,3.48E+05,5.72E+05,,,3,3,,,,,,,,,,,3.48E+05,,5.36E+05,,2.99E+05,,5.72E+05,3.59E+05,6.69E+05,,,,,,,,,,,,2.08E+03,,4.35E+03,,7.44E+03,,1.61E+05,2.55E+03,1.57E+04,,0,FALSE,13.976,11,4,456,52.9,7.65,4,protein metabolism;other metabolic processes,non-structural extracellular;cytosol;nucleus;other cell component,"Pf01399, Pf18098",5718,A6NP15; hsa:5718; O00232; Q53HA2; Q6P053,ENSG00000197170,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,65,0,,,31.68,29.72,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,1,,FALSE,,,,35.3,11.99,,0,
Master Protein,High,Q9Y3Z3,SAMHD1,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Homo sapiens OX=9606 GN=SAMHD1 PE=1 SV=2,3,7,,0.01,0.172,0.01,,-6.64,-2.54,-6.64,,1.00E-17,1.51E-02,1.00E-17,7.25E+05,3.29E+06,,4.36E+05,2,3,,4,7.01E+05,,7.49E+05,,,1.31E+07,1.60E+06,3.29E+06,,,,,,,,2.24E+06,1.08E+05,1.75E+06,6.24E+04,,2.79E+03,,7.32E+03,,,4.64E+04,2.84E+04,3.03E+04,,,,,,,,4.37E+03,3.04E+04,1.24E+04,1.46E+03,,0,FALSE,15.489,10,3,626,72.2,7.14,3,cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,plasma membrane;other membranes;nucleus;other cell component,"Pf01966, Pf07647",25939,B4E2A5; E1P5V2; hsa:25939; Q5JXG8; Q8N491; Q9H004; Q9H005; Q9H3U9; Q9Y3Z3,ENSG00000101347,Interferon alpha/beta signaling; Nucleotide catabolism,,2,0,4.65,103.47,,107.74,High,n/a,High,n/a,High,Peak Found,High,High,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,1,,FALSE,,,125.09,,24.58,nucleic acid binding activity;other molecular function,0,
Master Protein,High,Q460N5,PARP14,Protein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3,3,3,,3.68,0.01,100,,1.88,-6.64,6.64,,3.36E-02,1.00E-17,1.00E-17,1.04E+05,7.44E+05,3.81E+05,,1,1,4,,,,,1.04E+05,,,,,,7.44E+05,,3.51E+05,3.06E+05,4.15E+05,6.06E+05,,,,,,,,,1.04E+05,,,,,,7.91E+03,,1.57E+04,2.48E+03,5.59E+04,1.51E+04,,,,,,0,FALSE,9.351,3,3,1801,202.7,7.18,3,protein metabolism;other metabolic processes;stress response;other biological processes,plasma membrane;other membranes;cytosol;nucleus;other cell component,"Pf00644, Pf01661, Pf02825",54625,B4E2H0; hsa:54625; Q460N4; Q460N5; Q8J027; Q9H9X9; Q9NV60; Q9ULF2,ENSG00000173193,Maturation of nucleoprotein; Nicotinamide salvaging; Maturation of nucleoprotein,,3,0,,,31.52,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,112.92,,,7.68,other molecular function,0,
Master Protein,High,Q13442,PDAP1,28 kDa heat- and acid-stable phosphoprotein OS=Homo sapiens OX=9606 GN=PDAP1 PE=1 SV=1,1,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,4.53E+05,,,,1,,,,,,,,,,,,,,,,,4.53E+05,,,,,,,,,,,,,,,,,,,,1.27E+05,,,,0.001,FALSE,3.743,7,1,181,20.6,8.87,1,signal transduction,non-structural extracellular;plasma membrane;other membranes;cytosol;other cell component,Pf10252,11333,D6W5S5; hsa:11333; Q13442; Q92906,ENSG00000106244,Neutrophil degranulation,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,6.33,,0,
Master Protein,High,O60488,ACSL4,Long-chain-fatty-acid--CoA ligase 4 OS=Homo sapiens OX=9606 GN=ACSL4 PE=1 SV=2,1,2,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,3.38E+05,,,,1,,,,,,,,,,,,,,,3.38E+05,,,,,,,,,,,,,,,,,,,,4.55E+04,,,,,,,0.006,FALSE,2.44,3,1,711,79.1,8.38,1,other metabolic processes;developmental processes;other biological processes,plasma membrane;other membranes;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component,Pf00501,2182,D3DUY2; hsa:2182; O60488; O60848; O60849; Q5JWV8,ENSG00000068366,Synthesis of very long-chain fatty acyl-CoAs; Intracellular metabolism of fatty acids regulates insulin secretion,Fatty acid beta-oxidation; Fatty acid biosynthesis; Mitochondrial long chain fatty acid beta-oxidation; PPAR signaling pathway; Ferroptosis; Thermogenesis; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-3 / omega-6 fatty acid synthesis; Omega-9 fatty acid synthesis; Fatty acid transporters; Mitochondrial fatty acid oxidation disorders,13,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,5.9,other molecular function,0,
Master Protein,Medium,A0A0A0MSI8,EXOC5,Exocyst complex component 5 OS=Homo sapiens OX=9606 GN=EXOC5 PE=1 SV=1,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,3.46E+04,,,,1,,,,,,,,,,,,,,,,,3.46E+04,,,,,,,,,,,,,,,,,,,,9.73E+03,,,,0.027,FALSE,1.859,3,1,711,82.1,6.87,1,,other cell component,"Pf07393, Pf20667",,A0A0A0MSI8,ENSG00000070367,,Ciliary landscape,1,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,0,,0,
Master Protein,High,Q5VST6,ABHD17B,Alpha/beta hydrolase domain-containing protein 17B OS=Homo sapiens OX=9606 GN=ABHD17B PE=1 SV=1,1,2,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,6.79E+06,,,,1,,,,,,,,,,,,6.79E+06,,,,,,,,,,,,,,,,,,,,4.06E+04,,,,,,,,,,0,FALSE,8.397,9,1,288,32.2,6.29,1,protein metabolism;other metabolic processes;other biological processes,plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf00326,51104,A8KAJ5; hsa:51104; Q5VST6; Q5VST7; Q86YB6; Q8IY03; Q9Y377,ENSG00000107362,RAS processing,,1,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,8.01,other molecular function,0,
Master Protein,Medium,Q8WWL7,CCNB3,G2/mitotic-specific cyclin-B3 OS=Homo sapiens OX=9606 GN=CCNB3 PE=1 SV=2,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,2.27E+06,,,,1,,,,,,,,,,,,,,,,,2.27E+06,,,,,,,,,,,,,,,,,,,,6.37E+05,,,,0.021,FALSE,1.964,1,1,1395,157.8,6.68,1,cell cycle OR cell proliferation;other biological processes,cytoskeleton;nucleus;other cell component,"Pf00134, Pf02984",85417,B1AQI5; B1AQI6; hsa:85417; Q8WWL7; Q96SB5; Q96SB6; Q96SB7; Q9NT38,ENSG00000147082,,miRNA regulation of DNA damage response; Cell cycle; DNA damage response,3,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,Phospho [Y1313],FALSE,,,,,2.3,enzyme regulator activity,1,Phospho [Y1313]
Master Protein,High,Q9Y3L3,SH3BP1,SH3 domain-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3BP1 PE=1 SV=3,1,2,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,2.58E+05,,,,4,,,,,,,,,,,,3.48E+05,1.92E+05,1.67E+05,,3.93E+05,,,,,,,,,,,,,,,,2.08E+03,8.56E+03,1.35E+03,,9.77E+03,,,,,,0.001,FALSE,3.124,3,1,701,75.7,6.77,1,cell organization and biogenesis;transport;signal transduction;other biological processes,plasma membrane;cytosol;nucleus;other cell component,"Pf00620, Pf03114",23616,hsa:23616; Q5R3N0; Q6IBZ2; Q6ZVL9; Q96HQ5; Q9NSQ9; Q9Y3L3,ENSG00000100092,RAC1 GTPase cycle,,1,0,,,40.91,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,6.86,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q13310,PABPC4,Polyadenylate-binding protein 4 OS=Homo sapiens OX=9606 GN=PABPC4 PE=1 SV=1,6,14,,100,100,0.441,,6.64,6.64,-1.18,,1.00E-17,1.00E-17,5.51E-01,,,1.99E+05,4.52E+05,,,1,4,,,,,,,,,,,1.99E+05,,,,,,1.31E+05,1.07E+06,1.90E+05,1.97E+06,,,,,,,,,,,1.19E+03,,,,,,3.67E+04,7.60E+03,4.45E+03,2.10E+04,0,FALSE,37.533,12,1,644,70.7,9.26,6,protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes,cytosol;nucleus;other cell component,"Pf00076, Pf00658",8761,B1ANQ8; hsa:8761; Q13310; Q4VC03; Q6P0N3,ENSG00000090621,,,0,0,,,,103.15,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,,,154.54,53.98,nucleic acid binding activity,0,
Master Protein,High,Q9GZY6,LAT2,Linker for activation of T-cells family member 2 OS=Homo sapiens OX=9606 GN=LAT2 PE=1 SV=1,2,4,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,7.83E+04,,,,4,,,,,,,,,,,,,1.45E+06,5.71E+04,1.07E+05,2.83E+04,,,,,,,,,,,,,,,,,6.47E+04,4.64E+02,1.45E+04,7.03E+02,,,,,,0,FALSE,9.479,15,2,243,26.5,4.78,2,transport;signal transduction;other biological processes,plasma membrane;other membranes,Pf15703,7462,A6NFK6; A8K209; A8K4F1; D3DXF9; hsa:7462; Q9BXX8; Q9GZY6; Q9NZY9,ENSG00000086730,Role of LAT2/NTAL/LAB on calcium mobilization,B cell receptor signaling pathway; 7q11.23 copy number variation syndrome,3,0,,,168.9,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,13.23,other molecular function,0,
Master Protein,High,P21980,TGM2,Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens OX=9606 GN=TGM2 PE=1 SV=2,5,9,,100,100,0.095,,6.64,6.64,-3.4,,1.00E-17,1.00E-17,3.96E-02,,,5.51E+04,3.15E+06,,,3,1,,,,,,,,,,,,,7.40E+04,1.45E+04,5.51E+04,,3.15E+06,,,,,,,,,,,,,,,,6.02E+02,1.96E+03,1.37E+03,,8.86E+05,,,,0,FALSE,20.337,13,5,687,77.3,5.22,5,cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes,extracellular matrix;plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf00868, Pf00927, Pf01841",7052,E1P5V9; hsa:7052; P21980; Q16436; Q6B838; Q9BTN7; Q9H035; Q9UH35,ENSG00000198959,,IL-18 signaling pathway,1,0,,,63.48,,Peak Found,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,n/a,n/a,1,,FALSE,,,,37.83,26.95,other molecular function,0,
Master Protein,High,P23921,RRM1,Ribonucleoside-diphosphate reductase large subunit OS=Homo sapiens OX=9606 GN=RRM1 PE=1 SV=1,1,1,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,1.14E+05,,,,1,,,,,,,,,,,,,,,,,1.14E+05,,,,,,,,,,,,,,,,,,,,3.21E+04,,,,0.001,FALSE,3.287,3,1,792,90,7.15,1,cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes,cytosol;mitochondrion;nucleus;other cell component,"Pf00317, Pf02867, Pf03477",6240,hsa:6240; P23921; Q9UNN2,ENSG00000167325,Interconversion of nucleotide di- and triphosphates,Fluoropyrimidine activity; Retinoblastoma gene in cancer; Pyrimidine metabolism,4,0,,,,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,2.76,other molecular function,0,
Master Protein,High,Q9UNM6,PSMD13,26S proteasome non-ATPase regulatory subunit 13 OS=Homo sapiens OX=9606 GN=PSMD13 PE=1 SV=2,2,2,,,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,,8.84E+05,,,,1,,,,,,,,,,,,,,,,,8.84E+05,,,,,,,,,,,,,,,,,,,,2.48E+05,,,,0,FALSE,9.284,7,2,376,42.9,5.81,2,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes,non-structural extracellular;cytosol;nucleus;other cell component,Pf01399,5719,B3KT15; hsa:5719; O75831; Q53XU2; Q9UNM6; Q9UNV3,ENSG00000185627,RUNX1 regulates transcription of genes involved in differentiation of HSCs; Separation of Sister Chromatids; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,65,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,,,,6.58,other molecular function,0,
Master Protein,High,E7ETE2,HARS1,"Histidine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=HARS1 PE=1 SV=2",1,1,100,0.01,100,0.01,6.64,-6.64,6.64,-6.64,1.00E-17,1.00E-17,1.00E-17,1.00E-17,8.82E+05,,,2.36E+05,2,,,2,,1.07E+06,,,7.29E+05,,,,,,,,,,,,3.28E+05,,1.70E+05,,,4.05E+03,,,3.76E+04,,,,,,,,,,,,9.22E+04,,3.97E+03,,0.005,TRUE,2.517,2,1,512,57.8,5.88,1,protein metabolism;RNA metabolism OR transcription;other metabolic processes,cytosol,"Pf00458, Pf03129, Pf13393",,E7ETE2,ENSG00000170445,,Allograft rejection,1,0,26.58,,,45.01,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,,,,2.73,other molecular function,0,
Master Protein,High,P00441,SOD1,Superoxide dismutase [Cu-Zn] OS=Homo sapiens OX=9606 GN=SOD1 PE=1 SV=2,3,8,100,7.004,100,0.957,6.64,2.81,6.64,-0.06,1.00E-17,2.25E-04,1.00E-17,9.70E-01,3.35E+05,,2.34E+06,3.08E+06,1,,1,1,,,,3.35E+05,,,,,,,,,,2.34E+06,,,3.08E+06,,,,,,,3.35E+05,,,,,,,,,,3.16E+05,,,8.65E+05,,,,0,TRUE,24.051,58,3,154,15.9,6.13,3,cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes,non-structural extracellular;cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component,Pf00080,6647,A6NHJ0; D3DSE4; P00441; Q16669; Q16711; Q16838; Q16839; Q16840; Q6NR85,ENSG00000142168,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Platelet degranulation ; Detoxification of Reactive Oxygen Species,"Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; AGE/RAGE pathway; Dopamine metabolism; Amyotrophic lateral sclerosis (ALS); Trans-sulfuration, one-carbon metabolism and related pathways; Copper homeostasis; Physico-chemical features and toxicity-associated pathways; One-carbon metabolism and related pathways; Oxidative stress response; Extracellular vesicles in the crosstalk of cardiac cells; Arsenic metabolism and reactive oxygen species generation; HDAC6 interactions in the central nervous system",17,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,High,n/a,High,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,0,34.02,other molecular function,0,
Master Protein,High,P02753,RBP4,Retinol-binding protein 4 OS=Homo sapiens OX=9606 GN=RBP4 PE=1 SV=3,1,1,100,1.272,100,0.765,6.64,0.35,6.64,-0.39,1.00E-17,3.94E-01,1.00E-17,9.93E-01,4.58E+05,,5.83E+05,7.63E+05,1,,2,1,,,,4.58E+05,,,,,,,,,,6.25E+05,5.44E+05,,,,7.63E+05,,,,,4.58E+05,,,,,,,,,,8.42E+04,1.35E+04,,,,1.78E+04,,0.003,TRUE,2.765,5,1,201,23,6.07,1,other metabolic processes;transport;developmental processes;other biological processes,non-structural extracellular,Pf00061,5950,D3DR38; hsa:5950; O43478; O43479; P02753; Q5VY24; Q8WWA3; Q9P178,ENSG00000138207,Retinoid metabolism and transport; The canonical retinoid cycle in rods (twilight vision); Retinoid cycle disease events; Retinoid metabolism disease events,Sterol regulatory element-binding proteins (SREBP) signaling; Vitamin A and carotenoid metabolism,6,0,,,9.75,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,10.25,,10.25,2.36,transporter activity;other molecular function,0,
Master Protein,High,Q5D862,FLG2,Filaggrin-2 OS=Homo sapiens OX=9606 GN=FLG2 PE=1 SV=1,1,4,100,0.661,100,2.32,6.64,-0.6,6.64,1.21,1.00E-17,9.47E-01,1.00E-17,3.37E-01,7.58E+06,,5.39E+05,2.78E+05,3,,3,2,1.08E+07,,7.58E+06,7.68E+04,,,,,,,7.15E+06,,5.39E+05,1.71E+05,,,1.31E+05,,5.91E+05,,4.29E+04,,7.41E+04,7.68E+04,,,,,,,4.27E+04,,4.38E+03,2.30E+04,,,3.67E+04,,1.38E+04,,0.001,TRUE,3.367,0,1,2391,247.9,8.31,1,cell adhesion;other biological processes,non-structural extracellular;plasma membrane;other cell component,Pf01023,388698,hsa:388698; Q5D862; Q9H4U1,ENSG00000143520,Neutrophil degranulation,,1,0,89.44,,149.91,90.18,High,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,,147.21,,122.5,9.51,other molecular function,0,
Master Protein,High,P00167,CYB5A,Cytochrome b5 OS=Homo sapiens OX=9606 GN=CYB5A PE=1 SV=2,2,13,100,4.705,100,3.61,6.64,2.23,6.64,1.85,1.00E-17,1.28E-02,1.00E-17,1.73E-01,1.49E+05,,7.87E+05,2.57E+05,5,,5,4,9.41E+04,2.10E+05,1.09E+05,2.77E+06,1.49E+05,,,,,,5.33E+05,4.78E+05,2.97E+06,1.04E+06,7.87E+05,,4.97E+05,8.04E+04,3.11E+05,2.12E+05,3.74E+02,7.99E+02,1.06E+03,2.77E+06,7.69E+03,,,,,,3.19E+03,2.14E+04,2.41E+04,1.40E+05,1.95E+04,,1.40E+05,5.70E+02,7.28E+03,2.26E+03,0,TRUE,13.588,25,2,134,15.3,4.96,2,transport,other membranes;cytosol;mitochondrion;ER/Golgi;other cell component,Pf00173,1528,A8MV91; F8WEU4; hsa:1528; P00167; Q6IB14,ENSG00000166347,Vitamin C (ascorbate) metabolism,Oxidation by cytochrome P450,2,0,176.65,,89.01,63.8,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,Peak Found,High,High,High,High,n/a,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,113.89,,81.41,28.04,transporter activity;other molecular function,0,
Master Protein,High,P06396,GSN,Gelsolin OS=Homo sapiens OX=9606 GN=GSN PE=1 SV=1,9,36,27.133,0.895,13.457,1.092,4.76,-0.16,3.75,0.13,1.57E-03,6.00E-01,8.06E-03,7.70E-01,1.09E+06,3.39E+04,7.54E+05,9.16E+05,5,5,5,4,6.84E+05,1.32E+06,2.45E+05,1.34E+06,1.09E+06,1.65E+06,2.21E+04,3.84E+04,1.33E+04,3.39E+04,7.25E+05,2.45E+05,1.43E+06,1.09E+06,7.54E+05,1.54E+06,6.80E+05,,1.23E+06,1.60E+05,2.72E+03,5.02E+03,2.40E+03,1.34E+06,5.60E+04,5.88E+03,3.93E+02,3.54E+02,3.76E+02,3.60E+02,4.34E+03,1.09E+04,1.16E+04,1.47E+05,1.87E+04,3.01E+03,1.91E+05,,2.88E+04,1.70E+03,0,TRUE,28.368,13,2,782,85.6,6.28,9,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,Pf00626,2934,A2A418; A8MUD1; A8MYN7; B7Z373; B7Z5V1; F5H1A8; hsa:2934; P06396; Q5T0I2; Q8WVV7,ENSG00000148180,Neutrophil degranulation; Amyloid fiber formation; Sensory processing of sound by outer hair cells of the cochlea; Caspase-mediated cleavage of cytoskeletal proteins,Ebola virus infection in host; Regulation of actin cytoskeleton,6,0,49.94,206.53,52.19,67.62,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,n/a,High,Peak Found,1,,FALSE,108.64,63.05,133.05,96,92.54,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q15843,NEDD8,NEDD8 OS=Homo sapiens OX=9606 GN=NEDD8 PE=1 SV=1,1,13,5.141,0.407,2.829,0.997,2.36,-1.3,1.5,0,7.49E-02,4.89E-01,3.80E-01,8.52E-01,5.24E+05,1.02E+05,2.13E+05,2.88E+05,2,1,4,3,,,,6.78E+05,4.05E+05,1.02E+05,,,,,,1.42E+05,1.67E+05,2.73E+05,8.85E+05,,3.27E+05,1.35E+05,2.88E+05,,,,,6.78E+05,2.09E+04,3.62E+02,,,,,,6.35E+03,1.35E+03,3.68E+04,2.20E+04,,9.18E+04,9.58E+02,6.75E+03,,0,TRUE,7.013,17,1,81,9.1,8.43,1,protein metabolism;other metabolic processes;other biological processes,cytosol;nucleus,Pf00240,4738,hsa:4738; Q15843; Q3SXN8; Q6LES6,ENSG00000129559; ENSG00000285246,UCH proteinases; Neddylation; Cargo recognition for clathrin-mediated endocytosis; Iron uptake and transport; TGF-beta receptor signaling activates SMADs,EGF/EGFR signaling pathway; 2q37 copy number variation syndrome,7,0,35.68,,95.49,40.55,n/a,n/a,n/a,High,High,Peak Found,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,High,n/a,High,Peak Found,High,n/a,1,,FALSE,38.66,77.97,19.81,96.85,23.18,other molecular function,0,
Master Protein,High,P69905,HBA1; HBA2,Hemoglobin subunit alpha OS=Homo sapiens OX=9606 GN=HBA1 PE=1 SV=2,13,1286,4.412,0.869,10.942,0.254,2.14,-0.2,3.45,-1.98,1.18E-01,7.36E-01,3.49E-03,2.54E-01,9.24E+07,4.40E+07,4.15E+08,8.19E+08,5,5,5,5,1.18E+09,7.04E+07,5.33E+08,9.24E+07,6.21E+07,7.43E+07,1.55E+07,2.11E+07,4.40E+07,9.70E+07,2.56E+07,4.15E+08,4.25E+08,5.23E+08,1.11E+08,6.36E+07,5.86E+09,1.52E+09,8.19E+08,1.10E+08,4.67E+06,2.67E+05,5.21E+06,9.24E+07,3.21E+06,2.64E+05,2.76E+05,1.95E+05,1.24E+06,1.03E+06,1.53E+05,1.85E+07,3.45E+06,7.05E+07,2.77E+06,1.24E+05,1.65E+09,1.08E+07,1.92E+07,1.18E+06,0,TRUE,261.244,93,10,142,15.2,8.68,13,other metabolic processes;stress response;transport;other biological processes,non-structural extracellular;cytosol;other cell component,Pf00042,3039; 3040,hsa:3039; hsa:3040; P01922; P69905; Q1HDT5; Q3MIF5; Q53F97; Q96KF1; Q9NYR7; Q9UCM0,ENSG00000188536; ENSG00000206172,Scavenging of heme from plasma; Heme signaling; Cytoprotection by HMOX1; Erythrocytes take up carbon dioxide and release oxygen; Erythrocytes take up oxygen and release carbon dioxide,Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; Effects of nitric oxide,9,4,125.06,69.17,72.57,144.12,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,142.43,141.28,138.85,139.63,4006.91,other molecular function,0,
Master Protein,High,P62937,PPIA,Peptidyl-prolyl cis-trans isomerase A OS=Homo sapiens OX=9606 GN=PPIA PE=1 SV=2,7,65,4.231,0.824,2.452,2.114,2.08,-0.28,1.29,1.08,1.29E-01,7.96E-01,3.11E-01,4.59E-01,1.03E+07,1.04E+06,5.79E+06,7.19E+06,5,5,5,5,1.22E+07,6.13E+06,6.03E+06,1.51E+07,1.03E+07,6.26E+05,5.54E+06,9.15E+05,3.25E+06,1.04E+06,7.73E+05,1.53E+07,5.51E+06,2.98E+07,5.79E+06,5.85E+06,1.08E+07,7.19E+06,4.05E+06,1.87E+07,4.85E+04,2.33E+04,5.89E+04,1.51E+07,5.33E+05,2.23E+03,9.85E+04,8.44E+03,9.17E+04,1.11E+04,4.62E+03,6.83E+05,4.47E+04,4.02E+06,1.44E+05,1.14E+04,3.03E+06,5.10E+04,9.47E+04,1.99E+05,0,TRUE,47.619,47,7,165,18,7.81,7,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes,non-structural extracellular;nucleus;other cell component,Pf00160,5478,A8K220; hsa:5478; P05092; P62937; Q3KQW3; Q567Q0; Q6IBU5; Q96IX3; Q9BRU4; Q9BTY9; Q9UC61,ENSG00000196262,Neutrophil degranulation; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Budding and maturation of HIV virion; Platelet degranulation ; Basigin interactions; SARS-CoV-1 activates/modulates innate immune responses; Integration of provirus; APOBEC3G mediated resistance to HIV-1 infection; Calcineurin activates NFAT; Binding and entry of HIV virion; Assembly Of The HIV Virion; Uncoating of the HIV Virion; Minus-strand DNA synthesis; Plus-strand DNA synthesis,Prolactin signaling pathway,16,0,39.41,92.52,100.99,62.36,High,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,109.74,131.32,110.17,128.91,178.15,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P02533,KRT14,"Keratin, type I cytoskeletal 14 OS=Homo sapiens OX=9606 GN=KRT14 PE=1 SV=4",14,256,2.612,0.63,1.212,1.294,1.39,-0.67,0.28,0.37,3.30E-01,8.91E-01,9.10E-01,7.60E-01,2.94E+07,2.27E+06,2.75E+06,3.60E+06,5,5,5,5,4.23E+07,3.49E+07,2.94E+07,3.99E+05,8.98E+06,2.80E+07,2.08E+06,4.81E+06,6.42E+05,2.27E+06,9.60E+07,2.75E+06,6.83E+06,7.42E+05,8.00E+05,1.37E+07,2.04E+05,3.60E+06,2.44E+06,5.64E+06,1.68E+05,1.33E+05,2.87E+05,3.99E+05,4.63E+05,9.95E+04,3.70E+04,4.43E+04,1.81E+04,2.41E+04,5.74E+05,1.23E+05,5.55E+04,9.99E+04,1.99E+04,2.67E+04,5.73E+04,2.55E+04,5.71E+04,6.00E+04,0,TRUE,57.038,35,6,472,51.5,5.16,14,cell organization and biogenesis;other biological processes,plasma membrane;cytosol;cytoskeleton;nucleus;other cell component,Pf00038,3861,hsa:3861; P02533; Q14715; Q53XY3; Q9BUE3; Q9UBN2; Q9UBN3; Q9UCY4,ENSG00000186847,Formation of the cornified envelope; Type I hemidesmosome assembly,Corticotropin-releasing hormone signaling pathway,4,3,76.58,152.42,194.92,101.35,High,High,High,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,High,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,128.77,140.75,136,139.17,502.13,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q06830,PRDX1,Peroxiredoxin-1 OS=Homo sapiens OX=9606 GN=PRDX1 PE=1 SV=1,15,182,2.256,0.481,0.622,2.045,1.17,-1.06,-0.68,1.03,4.18E-01,5.91E-01,4.61E-01,4.77E-01,6.26E+07,2.41E+07,3.31E+07,2.16E+07,5,5,5,5,3.43E+07,6.26E+07,1.58E+07,6.97E+07,1.24E+08,1.49E+07,4.68E+06,3.31E+07,2.57E+07,2.41E+07,8.97E+06,2.47E+07,3.31E+07,7.12E+07,3.93E+07,2.16E+07,2.60E+07,4.70E+06,2.96E+07,1.25E+07,1.36E+05,2.38E+05,1.55E+05,6.97E+07,6.39E+06,5.30E+04,8.32E+04,3.05E+05,7.23E+05,2.57E+05,5.36E+04,1.10E+06,2.69E+05,9.60E+06,9.77E+05,4.22E+04,7.31E+06,3.33E+04,6.94E+05,1.34E+05,0,TRUE,85.149,68,12,199,22.1,8.13,15,cell cycle OR cell proliferation;other metabolic processes;stress response;developmental processes;other biological processes,cytosol;nucleus;other cell component,"Pf00578, Pf10417",5052,B5BU26; D3DPZ8; hsa:5052; P35703; Q06830; Q2V576; Q5T154; Q5T155,ENSG00000117450,Detoxification of Reactive Oxygen Species; TP53 Regulates Metabolic Genes; NFE2L2 regulating anti-oxidant/detoxification enzymes; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,Androgen receptor signaling pathway; Selenium micronutrient network; Nuclear receptors meta-pathway; NRF2 pathway; HDAC6 interactions in the central nervous system,9,3,67.25,53.45,64.89,53.91,Peak Found,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,124.36,100.94,123.99,125.17,459.23,other molecular function,0,
Master Protein,High,P08779,KRT16,"Keratin, type I cytoskeletal 16 OS=Homo sapiens OX=9606 GN=KRT16 PE=1 SV=4",9,238,2.249,0.351,,2.527,1.17,-1.51,,1.34,4.20E-01,3.16E-01,,2.96E-01,1.34E+07,5.50E+06,2.59E+06,1.99E+05,3,1,2,2,1.94E+07,,1.34E+07,,3.98E+05,5.50E+06,,,,,3.29E+07,,,2.04E+05,,,2.25E+05,,1.76E+05,,7.69E+04,,1.31E+05,,2.05E+04,1.95E+04,,,,,1.97E+05,,,2.75E+04,,,6.31E+04,,4.12E+03,,0,TRUE,40.54,18,1,473,51.2,5.05,9,cell organization and biogenesis;stress response;other biological processes,plasma membrane;cytosol;cytoskeleton,Pf00038,3868,A8K488; hsa:3868; P08779; P30654; Q16402; Q9UBG8,ENSG00000186832,Formation of the cornified envelope,Vitamin D receptor pathway,3,0,87.77,,139.67,17.14,High,n/a,High,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,1,,FALSE,44.52,317.8,,1012.6,462.36,cytoskeletal activity,0,
Master Protein,High,P68871,HBB,Hemoglobin subunit beta OS=Homo sapiens OX=9606 GN=HBB PE=1 SV=2,17,1660,2.24,1.008,13.166,0.221,1.16,0.01,3.72,-2.18,4.23E-01,5.78E-01,1.59E-03,2.06E-01,2.79E+08,1.60E+08,4.00E+08,2.69E+09,5,5,5,5,1.69E+09,2.11E+08,5.39E+08,5.42E+07,2.79E+08,2.83E+08,6.02E+07,1.60E+08,9.70E+07,4.02E+08,6.55E+07,4.00E+08,9.48E+08,7.61E+08,1.18E+08,1.62E+08,8.15E+09,2.69E+09,6.64E+09,6.56E+08,6.71E+06,8.00E+05,5.27E+06,5.42E+07,1.44E+07,1.01E+06,1.07E+06,1.48E+06,2.73E+06,4.28E+06,3.92E+05,1.79E+07,7.70E+06,1.03E+08,2.93E+06,3.16E+05,2.29E+09,1.90E+07,1.55E+08,6.98E+06,0,TRUE,218.548,91,11,147,16,7.28,17,other metabolic processes;stress response;transport;other biological processes,non-structural extracellular;cytosol;other cell component,Pf00042,3043,A4GX73; B2ZUE0; hsa:3043; P02023; P68871; Q13852; Q14481; Q14510; Q45KT0; Q549N7; Q6FI08; Q6R7N2; Q8IZI1; Q9BX96; Q9UCD6; Q9UCP8; Q9UCP9,ENSG00000244734,Neutrophil degranulation; Scavenging of heme from plasma; Late endosomal microautophagy; Heme signaling; Cytoprotection by HMOX1; Factors involved in megakaryocyte development and platelet production; Chaperone Mediated Autophagy; Erythrocytes take up carbon dioxide and release oxygen; Erythrocytes take up oxygen and release carbon dioxide,Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism,12,6,118.68,70.35,84.83,97.81,High,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,134.25,138.57,137.87,143.21,5088.34,other molecular function,0,
Master Protein,High,B0QYN7,UBE2I,Ubiquitin conjugating enzyme E2 I OS=Homo sapiens OX=9606 GN=UBE2I PE=1 SV=1,2,7,2.044,0.495,,0.972,1.03,-1.01,,-0.04,4.54E-01,6.73E-01,,8.64E-01,7.10E+05,2.66E+05,3.15E+05,3.15E+05,3,2,4,4,,,7.10E+05,1.26E+06,3.14E+05,,2.51E+05,2.81E+05,,,2.70E+05,3.67E+05,1.01E+05,8.17E+05,,6.57E+05,,3.45E+05,1.71E+05,2.88E+05,,,6.93E+03,1.26E+06,1.62E+04,,4.47E+03,2.59E+03,,,1.61E+03,1.64E+04,8.23E+02,1.10E+05,,1.28E+03,,2.44E+03,4.00E+03,3.07E+03,0,TRUE,9.379,17,2,184,20.4,8.46,2,protein metabolism;other metabolic processes,,Pf00179,7329,B0QYN7,ENSG00000103275,,Androgen receptor signaling pathway; TGF-beta signaling pathway; TAR syndrome,3,0,62.49,7.93,78.65,56.85,n/a,n/a,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,Peak Found,n/a,Peak Found,Peak Found,Peak Found,1,,FALSE,38,59.36,,88.11,20.56,other molecular function,0,
Master Protein,High,P08758,ANXA5,Annexin A5 OS=Homo sapiens OX=9606 GN=ANXA5 PE=1 SV=2,13,69,2,1.335,5.064,1.478,1,0.42,2.34,0.56,4.49E-01,3.31E-01,5.26E-02,6.72E-01,1.94E+06,1.61E+06,8.01E+06,5.30E+06,5,5,5,5,1.24E+05,4.93E+04,2.36E+06,2.11E+07,1.94E+06,1.61E+06,6.56E+05,9.18E+05,2.43E+06,2.27E+06,8.01E+06,1.16E+06,6.83E+06,2.84E+07,2.56E+07,4.95E+06,5.51E+06,1.26E+07,5.30E+06,2.64E+06,4.94E+02,1.87E+02,2.31E+04,2.11E+07,1.00E+05,5.72E+03,1.17E+04,8.47E+03,6.85E+04,2.42E+04,4.79E+04,5.19E+04,5.55E+04,3.83E+06,6.35E+05,9.65E+03,1.55E+06,8.91E+04,1.24E+05,2.81E+04,0,TRUE,62.335,51,13,320,35.9,5.05,13,stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;other cell component,Pf00191,308,D3DNW7; hsa:308; P08758; Q6FHB3; Q6FI16; Q8WV69; Q9UDH9,ENSG00000164111,Platelet degranulation,Apoptosis-related network due to altered Notch3 in ovarian cancer; Interactions between LOXL4 and oxidative stress pathway; Prostaglandin synthesis and regulation,4,0,175.82,50.08,87.04,60.5,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,113.82,135.59,96.44,130.15,200.64,enzyme regulator activity;other molecular function,0,
Master Protein,High,P60709,ACTB,"Actin, cytoplasmic 1 OS=Homo sapiens OX=9606 GN=ACTB PE=1 SV=1",23,780,1.61,0.39,1.441,0.763,0.69,-1.36,0.53,-0.39,6.67E-01,3.98E-01,7.38E-01,8.70E-01,3.46E+08,2.04E+08,1.06E+08,2.16E+08,5,5,5,5,6.85E+08,1.21E+08,3.46E+08,1.83E+08,4.24E+08,2.42E+08,1.98E+08,3.02E+08,1.03E+08,2.04E+08,1.06E+08,1.06E+08,9.48E+07,1.63E+08,1.71E+08,2.16E+08,1.48E+08,7.59E+08,1.16E+08,8.69E+08,2.72E+06,4.61E+05,3.38E+06,1.83E+08,2.19E+07,8.61E+05,3.53E+06,2.79E+06,2.92E+06,2.17E+06,6.35E+05,4.72E+06,7.70E+05,2.20E+07,4.25E+06,4.21E+05,4.15E+07,5.38E+06,2.72E+06,9.25E+06,0,TRUE,172.205,72,0,375,41.7,5.48,23,cell organization and biogenesis;developmental processes;other biological processes,plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component,Pf00022,60,hsa:60; P02570; P60709; P70514; P99021; Q11211; Q64316; Q75MN2; Q96B34; Q96HG5,ENSG00000075624,Translocation of SLC2A4 (GLUT4) to the plasma membrane; UCH proteinases; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; RHO GTPases Activate WASPs and WAVEs; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; RHOF GTPase cycle; B-WICH complex positively regulates rRNA expression; Signaling by BRAF and RAF1 fusions; Clathrin-mediated endocytosis; EPHB-mediated forward signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; EPH-ephrin mediated repulsion of cells; HATs acetylate histones; Interaction between L1 and Ankyrins; Prefoldin mediated transfer of substrate  to CCT/TriC; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Adherens junctions interactions; DNA Damage Recognition in GG-NER; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Formation of annular gap junctions; Folding of actin by CCT/TriC; Cell-extracellular matrix interactions,Arrhythmogenic right ventricular cardiomyopathy; Pathogenic Escherichia coli infection; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; Focal adhesion; Fas ligand pathway and stress induction of heat shock proteins; Ebola virus infection in host; Acute viral myocarditis; Thermogenesis; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Overlap between signal transduction pathways contributing to LMNA laminopathies; Pleural mesothelioma; Regulation of actin cytoskeleton; Network map of SARS-CoV-2 signaling pathway,47,28,63.18,34.55,28.07,85.9,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,121.41,128.81,131.62,136.37,1912.52,cytoskeletal activity;other molecular function,0,
Master Protein,High,P04264,KRT1,"Keratin, type II cytoskeletal 1 OS=Homo sapiens OX=9606 GN=KRT1 PE=1 SV=6",40,1299,1.51,0.325,0.418,1.233,0.59,-1.62,-1.26,0.3,7.21E-01,2.64E-01,2.14E-01,7.93E-01,9.06E+08,1.96E+08,1.62E+08,9.21E+07,5,5,5,5,1.66E+09,1.37E+09,9.06E+08,3.44E+07,9.81E+07,1.39E+09,1.24E+08,1.96E+08,8.33E+07,3.02E+08,2.91E+09,1.62E+08,2.15E+08,2.80E+07,3.78E+07,2.95E+08,1.54E+07,8.06E+07,9.21E+07,1.09E+08,6.60E+06,5.21E+06,8.85E+06,3.44E+07,5.06E+06,4.95E+06,2.20E+06,1.81E+06,2.35E+06,3.22E+06,1.74E+07,7.24E+06,1.74E+06,3.77E+06,9.39E+05,5.75E+05,4.32E+06,5.71E+05,2.16E+06,1.16E+06,0,TRUE,267.551,56,35,644,66,8.12,40,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component,"Pf00038, Pf16208, Pf16210",3848,B2RA01; hsa:3848; P04264; P85925; P86104; Q14720; Q6GSJ0; Q9H298,ENSG00000167768,Formation of the cornified envelope; Neutrophil degranulation,Corticotropin-releasing hormone signaling pathway,4,5,90.2,131.11,187.11,88.5,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,1,,FALSE,141.56,144.89,131.53,142.66,3349.01,"bone, tooth or skin structural activity;other molecular function",0,
Master Protein,High,P02538,KRT6A,"Keratin, type II cytoskeletal 6A OS=Homo sapiens OX=9606 GN=KRT6A PE=1 SV=3",14,211,1.498,0.923,0.266,1.68,0.58,-0.12,-1.91,0.75,6.62E-01,5.54E-01,1.07E-01,4.45E-01,1.79E+06,6.53E+05,2.31E+05,3.54E+05,5,3,4,2,1.91E+06,1.83E+06,1.79E+06,1.13E+05,1.16E+06,1.35E+06,,,6.53E+05,1.70E+05,1.03E+07,1.06E+05,5.05E+05,,2.73E+04,,1.28E+05,9.82E+05,,,7.59E+03,6.94E+03,1.75E+04,1.13E+05,6.00E+04,4.80E+03,,,1.84E+04,1.81E+03,6.14E+04,4.72E+03,4.10E+03,,6.78E+02,,3.59E+04,6.96E+03,,,0,TRUE,44.902,25,1,564,60,8,14,cell organization and biogenesis;stress response;other biological processes,cytosol;cytoskeleton,"Pf00038, Pf16208",3853,A4QPC1; hsa:3853; P02538; P48667; Q08AR4; Q6NT67; Q96CL4,ENSG00000205420,Formation of the cornified envelope,Ectoderm differentiation; Ectoderm differentiation; Pancreatic cancer subtypes,5,2,55.72,81.86,184.55,108.88,High,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,High,n/a,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,1,,FALSE,133.57,142.79,93.1,138.76,425.89,"bone, tooth or skin structural activity;cytoskeletal activity",0,
Master Protein,High,P35908,KRT2,"Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens OX=9606 GN=KRT2 PE=1 SV=2",28,470,1.427,0.302,0.314,1.589,0.51,-1.73,-1.67,0.67,7.68E-01,2.22E-01,1.08E-01,6.26E-01,1.18E+08,3.73E+07,2.79E+07,2.12E+07,5,5,5,5,1.70E+08,2.87E+08,1.18E+08,1.07E+07,1.90E+07,1.73E+08,3.73E+07,4.32E+07,3.06E+07,3.52E+07,4.87E+08,2.79E+07,2.91E+07,7.84E+06,1.03E+07,6.01E+07,1.96E+06,2.44E+07,9.71E+06,2.12E+07,6.74E+05,1.09E+06,1.15E+06,1.07E+07,9.79E+05,6.15E+05,6.63E+05,3.98E+05,8.63E+05,3.74E+05,2.91E+06,1.24E+06,2.36E+05,1.06E+06,2.57E+05,1.17E+05,5.49E+05,1.73E+05,2.27E+05,2.25E+05,0,TRUE,122.262,50,20,639,65.4,8,28,cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes,plasma membrane;cytosol;cytoskeleton;other cell component,"Pf00038, Pf16208",3849,hsa:3849; P35908; Q4VAQ2,ENSG00000172867,Formation of the cornified envelope,,2,6,94.81,95.85,186.45,95.24,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,Peak Found,Peak Found,1,,FALSE,130.86,142.84,129.37,141.01,1090.01,"bone, tooth or skin structural activity;cytoskeletal activity",0,
Master Protein,High,P13647,KRT5,"Keratin, type II cytoskeletal 5 OS=Homo sapiens OX=9606 GN=KRT5 PE=1 SV=3",16,205,1.365,0.433,1.042,0.868,0.45,-1.21,0.06,-0.2,8.07E-01,4.89E-01,9.37E-01,9.61E-01,7.44E+06,2.34E+06,5.89E+05,1.03E+07,5,5,5,5,1.16E+07,1.86E+07,5.18E+06,8.79E+05,7.44E+06,1.02E+07,1.27E+06,2.34E+06,1.36E+06,4.53E+06,4.08E+07,5.77E+05,4.04E+06,5.89E+05,2.50E+05,1.37E+07,5.33E+05,1.85E+07,4.71E+05,1.03E+07,4.60E+04,7.08E+04,5.06E+04,8.79E+05,3.84E+05,3.62E+04,2.25E+04,2.16E+04,3.83E+04,4.82E+04,2.44E+05,2.58E+04,3.28E+04,7.93E+04,6.21E+03,2.66E+04,1.50E+05,1.31E+05,1.10E+04,1.10E+05,0,TRUE,48.091,27,7,590,62.3,7.74,16,cell organization and biogenesis;other biological processes,cytosol;cytoskeleton;other cell component,"Pf00038, Pf16208",3852,hsa:3852; P13647; Q6PI71; Q6UBJ0; Q8TA91,ENSG00000186081,Formation of the cornified envelope; Type I hemidesmosome assembly,,3,2,77.15,94.79,191.37,92.39,High,High,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,138.31,144.13,139.72,145.19,412.07,"bone, tooth or skin structural activity;cytoskeletal activity;other molecular function",0,
Master Protein,High,P61769,B2M,Beta-2-microglobulin OS=Homo sapiens OX=9606 GN=B2M PE=1 SV=1,5,77,1.277,0.677,0.625,2.246,0.35,-0.56,-0.68,1.17,8.66E-01,9.75E-01,4.65E-01,4.27E-01,4.97E+07,1.56E+06,3.83E+07,4.54E+06,5,5,5,5,1.33E+08,5.29E+07,4.97E+07,1.51E+07,1.10E+07,3.38E+06,1.56E+06,1.38E+06,5.87E+06,1.46E+06,3.83E+07,1.66E+07,1.69E+07,3.92E+07,1.07E+08,4.54E+06,1.68E+07,1.36E+06,9.25E+06,1.29E+06,5.29E+05,2.01E+05,4.85E+05,1.51E+07,5.68E+05,1.20E+04,2.77E+04,1.28E+04,1.66E+05,1.55E+04,2.29E+05,7.43E+05,1.38E+05,5.28E+06,2.67E+06,8.85E+03,4.71E+06,9.65E+03,2.17E+05,1.37E+04,0,TRUE,29.291,57,1,119,13.7,6.52,5,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component,Pf07654,567,hsa:567; P01884; P61769; Q540F8; Q6IAT8; Q9UCK0; Q9UD48; Q9UDF4,ENSG00000166710; ENSG00000273686,"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Amyloid fiber formation; ER-Phagosome pathway; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Neutrophil degranulation; DAP12 signaling; Interferon gamma signaling; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Modulation by Mtb of host immune system; Nef mediated downregulation of MHC class I complex cell surface expression; Endosomal/Vacuolar pathway",IL-18 signaling pathway,13,3,93.71,71.16,85.36,98.26,High,Peak Found,High,High,High,n/a,n/a,Peak Found,n/a,n/a,High,High,High,High,High,Peak Found,High,High,High,n/a,1,,FALSE,104.09,136.95,113.76,139.48,242.3,other molecular function,0,
Master Protein,High,P35527,KRT9,"Keratin, type I cytoskeletal 9 OS=Homo sapiens OX=9606 GN=KRT9 PE=1 SV=3",32,973,1.26,0.28,0.402,0.765,0.33,-1.84,-1.32,-0.39,8.77E-01,1.82E-01,1.96E-01,8.72E-01,6.31E+08,2.40E+08,7.46E+07,8.32E+07,5,5,5,5,1.31E+09,1.64E+09,6.31E+08,2.02E+07,7.69E+07,1.37E+09,1.41E+08,2.40E+08,6.13E+07,2.49E+08,2.60E+09,7.46E+07,1.57E+08,2.20E+07,4.22E+07,4.43E+08,1.69E+07,8.32E+07,8.93E+07,8.30E+07,5.21E+06,6.22E+06,6.16E+06,2.02E+07,3.97E+06,4.86E+06,2.51E+06,2.22E+06,1.73E+06,2.65E+06,1.56E+07,3.33E+06,1.27E+06,2.96E+06,1.05E+06,8.64E+05,4.74E+06,5.89E+05,2.09E+06,8.83E+05,0,TRUE,210.146,61,31,623,62,5.24,32,cell organization and biogenesis;other biological processes,cytosol;cytoskeleton,Pf00038,3857,hsa:3857; O00109; P35527; Q0IJ47; Q14665,ENSG00000171403,Formation of the cornified envelope,,2,1,98.57,131.01,195.28,119.01,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,1,,FALSE,138.24,145.05,130.22,141.86,2591.57,cytoskeletal activity,0,
Master Protein,High,A0A1B0GVI3,KRT10,Keratin 10 OS=Homo sapiens OX=9606 GN=KRT10 PE=1 SV=2,26,864,1.153,0.444,0.367,1.609,0.21,-1.17,-1.45,0.69,9.56E-01,5.14E-01,1.58E-01,6.18E-01,5.41E+08,1.39E+08,7.29E+07,1.12E+08,5,5,5,5,5.97E+08,6.83E+08,5.41E+08,1.31E+07,9.86E+07,6.82E+08,1.39E+08,1.75E+08,5.06E+07,1.20E+08,1.88E+09,7.29E+07,2.03E+08,1.07E+07,1.87E+07,2.80E+08,2.11E+07,1.74E+08,3.67E+07,1.12E+08,2.37E+06,2.59E+06,5.29E+06,1.31E+07,5.08E+06,2.42E+06,2.47E+06,1.62E+06,1.42E+06,1.28E+06,1.13E+07,3.26E+06,1.65E+06,1.44E+06,4.65E+05,5.45E+05,5.91E+06,1.24E+06,8.58E+05,1.19E+06,0,TRUE,176.759,38,20,624,63.3,5.26,26,,cytoskeleton,Pf00038,,A0A1B0GVI3,ENSG00000186395,,,0,6,79.57,109.14,185.44,85.17,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,138.58,145.99,133.39,143.6,2350.14,other molecular function,0,
Master Protein,High,P99999,CYCS,Cytochrome c OS=Homo sapiens OX=9606 GN=CYCS PE=1 SV=2,8,169,1.088,2.721,2.942,1.262,0.12,1.44,1.56,0.34,9.91E-01,4.32E-02,2.13E-01,7.77E-01,4.28E+06,4.56E+06,1.85E+07,2.74E+07,5,5,5,5,1.30E+06,4.28E+06,2.36E+06,4.26E+07,4.91E+07,4.56E+06,4.09E+06,5.74E+06,6.38E+05,7.69E+07,4.51E+06,2.53E+07,1.46E+07,1.02E+08,1.85E+07,1.99E+07,2.74E+07,2.90E+07,9.22E+06,8.21E+07,5.15E+03,1.63E+04,2.31E+04,4.26E+07,2.53E+06,1.62E+04,7.27E+04,5.29E+04,1.80E+04,8.18E+05,2.70E+04,1.13E+06,1.19E+05,1.37E+07,4.59E+05,3.89E+04,7.71E+06,2.06E+05,2.16E+05,8.74E+05,0,TRUE,46.148,58,8,105,11.7,9.57,8,other metabolic processes;signal transduction;other biological processes,other membranes;cytosol;mitochondrion;nucleus,Pf00034,54205,A4D166; B2R4I1; hsa:54205; P00001; P99999; Q6NUR2; Q6NX69; Q96BV4,ENSG00000172115,Respiratory electron transport; Detoxification of Reactive Oxygen Species; Transcriptional activation of mitochondrial biogenesis; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1; Activation of caspases through apoptosome-mediated cleavage; SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Regulation of the apoptosome activity; Release of apoptotic factors from the mitochondria; Pyroptosis,miRNA regulation of DNA damage response; Apoptosis modulation and signaling; Alzheimer's disease and miRNA effects; AGE/RAGE pathway; Parkinson's disease pathway; Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Apoptosis modulation by HSP70; VEGFA-VEGFR2 signaling; Oxidative damage response; NO/cGMP/PKG mediated neuroprotection; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; Acute viral myocarditis; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Hepatitis B infection; IL-18 signaling pathway; Pleural mesothelioma; Complement system in neuronal development and plasticity; Alzheimer's disease; DNA damage response,36,0,119.42,178.24,119,84.18,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,135.33,139.46,145.18,123.25,360.31,other molecular function,0,
Master Protein,High,P00918,CA2,Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,11,43,0.914,0.694,5.876,0.051,-0.13,-0.53,2.55,-4.31,8.36E-01,9.02E-01,3.34E-02,1.01E-02,1.48E+06,3.58E+06,8.91E+05,7.60E+06,5,5,5,5,1.48E+06,3.24E+06,2.93E+05,1.14E+05,4.03E+06,4.05E+06,1.42E+06,9.85E+05,5.01E+06,3.58E+06,1.21E+06,8.02E+05,8.91E+05,1.98E+06,6.53E+05,5.58E+06,4.44E+07,7.60E+06,2.58E+07,4.59E+06,5.88E+03,1.23E+04,2.87E+03,1.14E+05,2.08E+05,1.44E+04,2.52E+04,9.08E+03,1.41E+05,3.81E+04,7.25E+03,3.58E+04,7.24E+03,2.67E+05,1.62E+04,1.09E+04,1.25E+07,5.39E+04,6.04E+05,4.89E+04,0,TRUE,51.22,53,11,260,29.2,7.4,11,other metabolic processes;transport;signal transduction;other biological processes,plasma membrane;other membranes;cytosol;other cell component,Pf00194,760,B2R7G8; hsa:760; P00918; Q6FI12; Q96ET9,ENSG00000104267,Reversible hydration of carbon dioxide; Erythrocytes take up carbon dioxide and release oxygen; Erythrocytes take up oxygen and release carbon dioxide,Proximal tubule transport,4,0,95.55,57.69,47.82,98.39,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,99.59,126.45,121.33,99.19,128.2,other molecular function,0,
Master Protein,High,P61626,LYZ,Lysozyme C OS=Homo sapiens OX=9606 GN=LYZ PE=1 SV=1,5,64,0.883,0.328,1.341,0.72,-0.18,-1.61,0.42,-0.47,8.06E-01,2.71E-01,8.08E-01,8.30E-01,2.87E+07,2.21E+07,7.15E+06,3.62E+07,5,5,5,5,3.25E+07,2.87E+07,1.57E+08,1.64E+06,2.37E+07,2.69E+07,8.63E+06,2.21E+07,9.20E+06,3.39E+07,1.69E+07,3.78E+06,1.48E+07,6.66E+06,7.15E+06,3.62E+07,1.16E+07,1.24E+08,4.37E+06,3.78E+07,1.29E+05,1.09E+05,1.53E+06,1.64E+06,1.22E+06,9.55E+04,1.53E+05,2.04E+05,2.59E+05,3.60E+05,1.01E+05,1.69E+05,1.20E+05,8.97E+05,1.78E+05,7.07E+04,3.25E+06,8.77E+05,1.02E+05,4.03E+05,0,TRUE,16.242,28,5,148,16.5,9.16,5,other metabolic processes;stress response;other biological processes,non-structural extracellular;other cytoplasmic organelle;other cell component,Pf00062,4069,hsa:4069; P00695; P61626; Q13170; Q9UCF8,ENSG00000090382,Amyloid fiber formation; Neutrophil degranulation; Antimicrobial peptides,Macrophage markers; Pancreatic cancer subtypes,5,0,126.67,54.97,57.44,111.4,Peak Found,High,High,High,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,High,High,High,High,High,Peak Found,High,1,,FALSE,138.14,137.22,141.11,138.16,118.59,other molecular function,0,
Master Protein,High,P62979,RPS27A,Ubiquitin-40S ribosomal protein S27a OS=Homo sapiens OX=9606 GN=RPS27A PE=1 SV=2,9,141,0.806,0.995,4.882,0.224,-0.31,-0.01,2.29,-2.16,7.28E-01,5.92E-01,5.86E-02,2.11E-01,1.12E+07,2.97E+07,2.84E+07,5.57E+07,5,5,5,5,1.12E+07,1.10E+08,8.49E+06,3.74E+06,2.92E+07,5.89E+07,1.53E+07,1.06E+08,5.42E+06,2.97E+07,7.36E+06,2.17E+06,2.86E+07,2.84E+07,5.10E+07,4.58E+07,8.79E+06,6.52E+08,5.57E+07,4.38E+08,4.43E+04,4.19E+05,8.29E+04,3.74E+06,1.51E+06,2.09E+05,2.73E+05,9.79E+05,1.53E+05,3.15E+05,4.40E+04,9.70E+04,2.32E+05,3.83E+06,1.27E+06,8.92E+04,2.47E+06,4.62E+06,1.30E+06,4.66E+06,0,TRUE,27.837,44,9,156,18,9.64,9,protein metabolism;other metabolic processes,plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;translational apparatus;nucleus;other cytoplasmic organelle;other cell component,"Pf00240, Pf01599",6233,hsa:6233; P02248; P02249; P02250; P14798; P62979; P62988; Q29120; Q6LBL4; Q6LDU5; Q8WYN8; Q91887; Q91888; Q9BQ77; Q9BWD6; Q9BX98; Q9UEF2; Q9UEG1; Q9UEK8; Q9UPK7,ENSG00000143947,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of TP53 Activity through Phosphorylation; Processing of DNA double-strand break ends; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; Dual Incision in GG-NER; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER; Regulation of expression of SLITs and ROBOs; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; SARS-CoV-2 modulates host translation machinery; SARS-CoV-1 modulates host translation machinery; E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Stimuli-sensing channels; Amyloid fiber formation; Fanconi Anemia Pathway; Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy; Aggrephagy; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Regulation of PLK1 Activity at G2/M Transition; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; NOTCH3 Activation and Transmission of Signal to the Nucleus; Peroxisomal protein import; Regulation of TP53 Degradation; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Activation of IRF3, IRF7 mediated by TBK1, IKBKE; IKK complex recruitment mediated by RIP1; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; ER Quality Control Compartment (ERQC); SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Deactivation of the beta-catenin transactivating complex; Oxidative Stress Induced Senescence; Signaling by ALK fusions and activated point mutants; Circadian Clock; Regulation of signaling by CBL; Metalloprotease DUBs; Regulation of necroptotic cell death; Oncogene Induced Senescence; Cyclin D associated events in G1; APC/C:Cdc20 mediated degradation of Cyclin B; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Negative regulation of FLT3; Downregulation of ERBB2:ERBB3 signaling; Cargo recognition for clathrin-mediated endocytosis; Interferon alpha/beta signaling; Inactivation of CSF3 (G-CSF) signaling; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; Regulation of TP53 Activity through Methylation; Regulation of BACH1 activity; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; p75NTR recruits signalling complexes; NF-kB is activated and signals survival; TAK1-dependent IKK and NF-kappa-B activation  ; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; MAP3K8 (TPL2)-dependent MAPK1/3 activation; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; Regulation of NF-kappa B signaling; Negative regulators of DDX58/IFIH1 signaling; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Prevention of phagosomal-lysosomal fusion; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity; Signaling by CSF1 (M-CSF) in myeloid cells; NOTCH1 Intracellular Domain Regulates Transcription; TICAM1-dependent activation of IRF3/IRF7; TICAM1,TRAF6-dependent induction of TAK1 complex; Glycogen synthesis; Formation of TC-NER Pre-Incision Complex; Modulation by Mtb of host immune system; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; SARS-CoV-1 activates/modulates innate immune responses; Alpha-protein kinase 1 signaling pathway; Ovarian tumor domain proteases; Spry regulation of FGF signaling; RAS processing; PINK1-PRKN Mediated Mitophagy; Josephin domain DUBs; Regulation of FZD by ubiquitination; Chaperone Mediated Autophagy; InlA-mediated entry of Listeria monocytogenes into host cells; Formation of Incision Complex in GG-NER; Iron uptake and transport; VLDLR internalisation and degradation; Myoclonic epilepsy of Lafora; Evasion by RSV of host interferon responses; DNA Damage Recognition in GG-NER; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Negative regulation of MAPK pathway; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); NRIF signals cell death from the nucleus; Assembly Of The HIV Virion; Downregulation of ERBB4 signaling; Regulation of innate immune responses to cytosolic DNA; N-glycan trimming in the ER and Calnexin/Calreticulin cycle; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1; Regulation of PTEN localization; Pexophagy; Maturation of protein E; Maturation of protein E; FLT3 signaling by CBL mutants; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling",Cytoplasmic ribosomal proteins,203,0,136.54,94.2,82.95,120.38,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,Peak Found,High,High,High,High,High,High,High,High,1,,FALSE,135.62,134.96,135.62,136.52,306.6,other molecular function,0,
Master Protein,High,P02768,ALB,Albumin OS=Homo sapiens OX=9606 GN=ALB PE=1 SV=2,42,869,0.727,1.202,0.814,1.123,-0.46,0.27,-0.3,0.17,6.43E-01,4.15E-01,6.94E-01,8.57E-01,7.00E+07,1.44E+08,6.24E+07,9.68E+07,5,5,5,5,2.10E+08,1.99E+08,3.80E+07,1.82E+07,7.00E+07,2.71E+08,3.91E+07,2.54E+08,1.12E+08,1.44E+08,6.24E+07,4.83E+07,1.67E+08,1.94E+08,5.78E+07,1.78E+08,1.30E+08,6.42E+07,4.10E+07,9.68E+07,8.33E+05,7.57E+05,3.72E+05,1.82E+07,3.61E+06,9.64E+05,6.96E+05,2.34E+06,3.16E+06,1.53E+06,3.73E+05,2.16E+06,1.36E+06,2.62E+07,1.44E+06,3.46E+05,3.64E+07,4.55E+05,9.59E+05,1.03E+06,0,TRUE,274.25,74,37,609,69.3,6.28,42,stress response;other biological processes,non-structural extracellular;ER/Golgi;other cell component,Pf00273,213,E7ESS9; hsa:213; O95574; P02768; P04277; Q13140; Q645G4; Q68DN5; Q6UXK4; Q86YG0; Q8IUK7; Q9P157; Q9P1I7; Q9UHS3; Q9UJZ0,ENSG00000163631,Cytoprotection by HMOX1; Scavenging of heme from plasma; Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Aspirin ADME; Ciprofloxacin ADME; Recycling of bile acids and salts; Prednisone ADME; Heme degradation; HDL remodeling; Heme biosynthesis,Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; Complement system; VEGFA-VEGFR2 signaling,17,0,84.95,59.61,65.2,53.01,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,124.2,124.8,121.71,119.06,2192.21,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P55957,BID,BH3-interacting domain death agonist OS=Homo sapiens OX=9606 GN=BID PE=1 SV=1,2,8,0.687,0.59,0.829,0.488,-0.54,-0.76,-0.27,-1.04,7.81E-01,8.42E-01,6.96E-01,6.16E-01,3.26E+05,5.87E+05,2.21E+05,4.53E+05,5,2,3,3,1.36E+05,1.59E+06,3.26E+05,5.12E+03,1.87E+06,6.55E+05,,5.26E+05,,,,,5.53E+05,1.18E+05,2.21E+05,3.17E+06,1.01E+05,,4.53E+05,,5.39E+02,6.03E+03,3.19E+03,5.12E+03,9.63E+04,2.33E+03,,4.85E+03,,,,,4.49E+03,1.58E+04,5.48E+03,6.18E+03,2.83E+04,,1.06E+04,,0,TRUE,8.546,14,2,195,22,5.44,2,cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes,other membranes;cytosol;mitochondrion,Pf06393,637,hsa:637; P55957; Q549M7; Q71T04; Q7Z4M9; Q8IY86,ENSG00000015475,"TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members; Activation, myristolyation of BID and translocation to mitochondria; Activation of BAD and translocation to mitochondria ; Activation and oligomerization of BAK protein; Activation, translocation and oligomerization of BAX",miRNA regulation of DNA damage response; TP53 network; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Amyotrophic lateral sclerosis (ALS); Nanomaterial induced apoptosis; Apoptosis; Photodynamic therapy-induced AP-1 survival signaling; Photodynamic therapy-induced HIF-1 survival signaling; Apoptosis modulation by HSP70; Regulation of apoptosis by parathyroid hormone-related protein; miRNA regulation of p53 pathway in prostate cancer; Non-small cell lung cancer; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Hepatitis B infection; IL-18 signaling pathway; Host-pathogen interaction of human coronaviruses - apoptosis; Unfolded protein response; Complement system in neuronal development and plasticity; Network map of SARS-CoV-2 signaling pathway; Alzheimer's disease; DNA damage response,30,0,111.44,15.41,76.56,135.32,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,n/a,n/a,n/a,High,High,High,High,High,n/a,High,n/a,1,,FALSE,92.64,145.34,64.7,129.94,25.31,signal transduction activity or receptor binding;enzyme regulator activity;other molecular function,0,
Master Protein,High,Q15323,KRT31,"Keratin, type I cuticular Ha1 OS=Homo sapiens OX=9606 GN=KRT31 PE=1 SV=3",6,46,0.666,0.543,1.577,0.183,-0.59,-0.88,0.66,-2.45,6.56E-01,7.76E-01,6.53E-01,1.34E-01,2.24E+06,1.12E+06,1.27E+06,3.28E+06,5,3,5,5,5.21E+06,2.24E+06,3.48E+04,4.85E+05,2.27E+06,7.46E+06,,,1.12E+06,7.29E+05,3.69E+05,1.13E+05,1.90E+06,1.33E+06,1.27E+06,2.58E+07,5.56E+05,3.28E+06,6.95E+04,6.45E+06,2.07E+04,8.52E+03,3.40E+02,4.85E+05,1.17E+05,2.65E+04,,,3.16E+04,7.75E+03,2.20E+03,5.06E+03,1.55E+04,1.80E+05,3.16E+04,5.03E+04,1.56E+05,2.33E+04,1.63E+03,6.86E+04,0,TRUE,21.099,15,2,416,47.2,4.88,6,cell organization and biogenesis;other biological processes,cytosol;cytoskeleton,Pf00038,3881,hsa:3881; Q15323; Q9UE12,ENSG00000094796; ENSG00000262993; ENSG00000292029,Formation of the cornified envelope,IL-18 signaling pathway,3,3,99.34,121.73,74.05,147.83,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,1,,FALSE,116.6,116.6,142.07,132.14,101.08,cytoskeletal activity,0,
Master Protein,High,P10599,TXN,Thioredoxin OS=Homo sapiens OX=9606 GN=TXN PE=1 SV=3,2,9,0.625,1.313,1.902,0.374,-0.68,0.39,0.93,-1.42,5.93E-01,3.07E-01,4.91E-01,4.36E-01,5.99E+05,2.89E+06,9.33E+05,2.83E+06,5,5,5,5,7.09E+05,5.71E+05,5.99E+05,3.36E+05,2.61E+06,3.29E+06,1.51E+06,2.89E+06,3.05E+06,1.01E+06,4.41E+05,6.51E+05,2.52E+06,3.68E+06,9.33E+05,6.03E+06,1.90E+06,5.69E+06,2.83E+06,2.11E+06,2.82E+03,2.17E+03,5.85E+03,3.36E+05,1.35E+05,1.17E+04,2.69E+04,2.66E+04,8.58E+04,1.08E+04,2.64E+03,2.91E+04,2.04E+04,4.95E+05,2.32E+04,1.18E+04,5.34E+05,4.03E+04,6.62E+04,2.25E+04,0,TRUE,9.721,24,2,105,11.7,4.92,2,other metabolic processes;stress response;other biological processes,non-structural extracellular;cytosol;nucleus;other cell component,Pf00085,7295,B1ALW1; hsa:7295; O60744; P10599; Q53X69; Q96KI3; Q9UDG5,ENSG00000136810,Detoxification of Reactive Oxygen Species; Oxidative Stress Induced Senescence; TP53 Regulates Metabolic Genes; Interconversion of nucleotide di- and triphosphates; NFE2L2 regulating anti-oxidant/detoxification enzymes; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; Regulation of FOXO transcriptional activity by acetylation; Protein repair,Selenium micronutrient network; Folic acid network; Selenium micronutrient network ; Folic acid network; Selenium micronutrient network; TNF-alpha signaling pathway; Complement system; Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling; TAR syndrome,20,0,96.32,43.34,85.12,53.72,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,112.35,105.4,114.09,112.15,25.09,other molecular function,0,
Master Protein,High,P04040,CAT,Catalase OS=Homo sapiens OX=9606 GN=CAT PE=1 SV=3,21,270,0.606,1.105,3.23,0.198,-0.72,0.14,1.69,-2.33,5.04E-01,4.89E-01,1.72E-01,1.74E-01,1.27E+07,4.43E+07,1.23E+07,1.69E+08,5,5,5,5,1.27E+07,4.01E+07,7.59E+06,1.08E+07,6.23E+07,5.48E+07,2.35E+07,4.43E+07,1.03E+07,7.71E+07,1.23E+07,7.94E+06,2.92E+07,3.77E+07,1.11E+07,1.06E+08,9.51E+07,3.24E+08,1.69E+08,2.65E+08,5.03E+04,1.52E+05,7.42E+04,1.08E+07,3.21E+06,1.95E+05,4.18E+05,4.09E+05,2.89E+05,8.20E+05,7.36E+04,3.55E+05,2.38E+05,5.08E+06,2.75E+05,2.07E+05,2.67E+07,2.29E+06,3.95E+06,2.82E+06,0,TRUE,149.25,58,21,527,59.7,7.39,21,protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes,non-structural extracellular;other membranes;cytosol;mitochondrion;other cytoplasmic organelle;other cell component,"Pf00199, Pf06628",847,A8K6C0; B2RCZ9; D3DR07; hsa:847; P04040; Q2M1U4; Q4VXX5; Q9BWT9; Q9UC85,ENSG00000121691,"Peroxisomal protein import; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Neutrophil degranulation; Detoxification of Reactive Oxygen Species",Selenium micronutrient network; Folate metabolism; Amyotrophic lateral sclerosis (ALS); Oxidative stress response; Tryptophan metabolism; Male infertility; Arsenic metabolism and reactive oxygen species generation; DNA damage response (only ATM dependent),12,0,89.03,62.43,66.46,52.08,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,131.85,121.5,124.15,109.64,827.32,other molecular function,0,
Master Protein,High,P02748,C9,Complement component C9 OS=Homo sapiens OX=9606 GN=C9 PE=1 SV=2,2,9,0.582,0.479,,1.279,-0.78,-1.06,,0.36,5.60E-01,6.41E-01,,6.65E-01,1.92E+06,4.83E+05,2.71E+05,1.22E+06,4,2,5,1,2.80E+06,2.85E+06,1.32E+06,6.16E+05,,,,,7.71E+05,3.02E+05,5.93E+04,6.34E+04,9.13E+05,2.71E+05,3.60E+06,,,,1.22E+06,,1.11E+04,1.08E+04,1.29E+04,6.16E+05,,,,,2.17E+04,3.21E+03,3.55E+02,2.83E+03,7.42E+03,3.65E+04,8.95E+04,,,,2.86E+04,,0,TRUE,5.734,4,2,559,63.1,5.59,2,cell organization and biogenesis;stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cell component,"Pf00057, Pf00090, Pf01823",735,hsa:735; P02748,ENSG00000113600,Regulation of Complement cascade; Terminal pathway of complement,Allograft rejection; Complement system; Dengue-2 interactions with complement and coagulation cascades; Complement system in neuronal development and plasticity; Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); Complement activation; Complement and coagulation cascades,9,0,58.52,61.76,153.39,,Peak Found,Peak Found,Peak Found,High,n/a,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,130.57,115.88,,98.76,16.32,,0,
Master Protein,High,P08311,CTSG,Cathepsin G OS=Homo sapiens OX=9606 GN=CTSG PE=1 SV=2,11,321,0.535,0.554,0.351,0.629,-0.9,-0.85,-1.51,-0.67,4.18E-01,7.44E-01,1.43E-01,7.38E-01,1.45E+08,1.50E+08,3.12E+07,6.58E+07,5,5,5,5,1.45E+08,8.05E+08,1.76E+07,5.77E+06,1.45E+08,4.51E+08,6.40E+07,1.50E+08,1.42E+08,3.07E+08,2.08E+07,1.79E+07,1.09E+08,5.37E+07,3.12E+07,1.08E+08,5.00E+07,1.29E+08,6.23E+07,6.58E+07,5.75E+05,3.06E+06,1.72E+05,5.77E+06,7.47E+06,1.60E+06,1.14E+06,1.39E+06,3.99E+06,3.27E+06,1.24E+05,7.98E+05,8.87E+05,7.23E+06,7.75E+05,2.10E+05,1.40E+07,9.15E+05,1.46E+06,7.00E+05,0,TRUE,72.128,46,11,255,28.8,11.19,11,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component,Pf00089,1511,hsa:1511; P08311; Q6IBJ6; Q9UCA5; Q9UCU6,ENSG00000100448,Neutrophil degranulation; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Purinergic signaling in leishmaniasis infection; Suppression of apoptosis; Activation of Matrix Metalloproteinases; Antimicrobial peptides; Metabolism of Angiotensinogen to Angiotensins; Interleukin-1 processing,Renin-angiotensin-aldosterone system (RAAS); ACE inhibitor pathway,11,0,148.39,69.62,81.12,40.68,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,139.91,142.06,124.48,133.75,782.93,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q04695,KRT17,"Keratin, type I cytoskeletal 17 OS=Homo sapiens OX=9606 GN=KRT17 PE=1 SV=2",5,126,0.47,4.793,0.01,100,-1.09,2.26,-6.64,6.64,4.14E-01,4.22E-02,1.00E-17,1.00E-17,1.94E+04,4.12E+04,9.28E+04,,1,2,3,,,,,,1.94E+04,6.43E+04,,,,2.64E+04,8.41E+05,,9.28E+04,,1.65E+04,,,,,,,,,,9.98E+02,2.29E+02,,,,2.80E+02,5.03E+03,,7.54E+02,,4.09E+02,,,,,,0,TRUE,14.183,11,2,432,48.1,5.02,5,cell organization and biogenesis;other biological processes,plasma membrane;cytosol;cytoskeleton,Pf00038,3872,A5Z1M9; A5Z1N0; A5Z1N1; A5Z1N2; A6NDV6; A6NKQ2; hsa:3872; Q04695; Q6IP98; Q8N1P6,ENSG00000128422,Formation of the cornified envelope,1p36 copy number variation syndrome; Pancreatic cancer subtypes,4,0,,59.17,143.84,,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,68.3,121.94,,,207.93,other molecular function,0,
Master Protein,High,P09211,GSTP1,Glutathione S-transferase P OS=Homo sapiens OX=9606 GN=GSTP1 PE=1 SV=2,4,6,0.313,1.453,0.335,1.325,-1.68,0.54,-1.58,0.41,2.73E-01,1.95E-01,2.09E-01,6.47E-01,6.51E+05,1.09E+06,1.21E+06,3.65E+05,4,2,5,4,3.25E+05,,2.16E+05,1.30E+06,1.34E+06,8.64E+05,,,,1.37E+06,1.22E+06,8.58E+05,7.86E+05,2.71E+06,1.21E+06,,9.54E+04,7.53E+05,3.22E+05,4.12E+05,1.29E+03,,2.11E+03,1.30E+06,6.93E+04,3.07E+03,,,,1.45E+04,7.32E+03,3.83E+04,6.38E+03,3.66E+05,3.00E+04,,2.68E+04,5.34E+03,7.54E+03,4.39E+03,0,TRUE,9.035,29,4,210,23.3,5.64,4,cell cycle OR cell proliferation;other metabolic processes;stress response;developmental processes;other biological processes,non-structural extracellular;cytosol;mitochondrion;nucleus;other cell component,"Pf02798, Pf14497",2950,hsa:2950; O00460; P09211; Q15690; Q5TZY3,ENSG00000084207,Paracetamol ADME; Neutrophil degranulation; Detoxification of Reactive Oxygen Species; Glutathione conjugation,Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Exercise-induced circadian regulation; Omega-6-fatty acids in senescence; Arachidonate epoxygenase / epoxide hydrolase; Metapathway biotransformation Phase I and II,11,0,76.54,31.79,57.72,69,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,42.37,59.69,60.34,65.26,14.24,enzyme regulator activity;other molecular function,0,
Master Protein,High,P02788,LTF,Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,33,642,0.295,0.591,0.332,0.315,-1.76,-0.76,-1.59,-1.67,1.39E-01,8.16E-01,1.24E-01,3.43E-01,6.65E+06,4.13E+08,1.85E+07,2.81E+08,5,5,5,5,6.65E+06,3.24E+08,6.31E+06,2.33E+06,2.87E+08,4.13E+08,7.42E+08,4.59E+08,5.07E+07,2.81E+08,1.85E+07,8.28E+06,6.25E+07,5.73E+07,1.84E+07,2.81E+08,1.59E+06,5.64E+08,5.30E+07,3.96E+08,2.64E+04,1.23E+06,6.16E+04,2.33E+06,1.48E+07,1.47E+06,1.32E+07,4.24E+06,1.43E+06,2.99E+06,1.11E+05,3.70E+05,5.08E+05,7.72E+06,4.57E+05,5.48E+05,4.47E+05,4.00E+06,1.24E+06,4.22E+06,0,TRUE,166.679,61,31,710,78.1,8.12,33,protein metabolism;stress response;transport;developmental processes;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle;other cell component,Pf00405,4057,A8K9U8; B2MV13; B7Z4X2; E7EQH5; hsa:4057; O00756; P02788; Q16780; Q16785; Q16786; Q16789; Q5DSM0; Q8IU92; Q8IZH6; Q8TCD2; Q96KZ4; Q96KZ5; Q9H1Z3; Q9UCY5,ENSG00000012223,Neutrophil degranulation; Amyloid fiber formation; Mtb iron assimilation by chelation; Metal sequestration by antimicrobial proteins,LTF danger signal response pathway; Male infertility,7,0,131.79,65.04,75.72,90.7,Peak Found,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,High,1,,FALSE,138.32,141.4,134.2,145.48,1741.51,enzyme regulator activity;nucleic acid binding activity;other molecular function,0,
Master Protein,High,A0A1B0GU03,,Peptidase A1 domain-containing protein OS=Homo sapiens OX=9606 PE=1 SV=1,5,10,0.246,5.442,1.194,1.331,-2.02,2.44,0.26,0.41,2.02E-01,4.87E-03,8.23E-01,6.54E-01,5.89E+05,2.13E+05,4.07E+05,1.68E+06,5,1,5,2,7.92E+05,5.89E+05,4.52E+05,1.14E+06,2.23E+05,,,,,2.13E+05,3.34E+05,1.08E+05,6.23E+05,6.44E+05,4.07E+05,,2.61E+06,,1.08E+06,,3.15E+03,2.24E+03,4.42E+03,1.14E+06,1.15E+04,,,,,2.27E+03,2.00E+03,4.83E+03,5.06E+03,8.68E+04,1.01E+04,,7.35E+05,,2.52E+04,,0,TRUE,16.048,11,5,582,62.7,7.77,5,protein metabolism,other membranes,"Pf00026, Pf04505, Pf07966",,,,,,0,0,54.53,,52.33,58.88,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,113.27,116.88,0,89.75,26.4,other molecular function,0,
Master Protein,High,P00915,CA1,Carbonic anhydrase 1 OS=Homo sapiens OX=9606 GN=CA1 PE=1 SV=2,9,98,0.104,0.519,1.753,0.051,-3.26,-0.95,0.81,-4.29,8.05E-03,7.16E-01,5.59E-01,1.04E-02,1.44E+06,1.36E+07,2.16E+06,3.11E+07,5,5,5,5,6.25E+06,1.44E+06,4.12E+05,8.26E+05,3.26E+07,1.09E+07,1.20E+07,1.36E+07,1.80E+07,9.15E+07,2.16E+06,1.45E+06,4.31E+06,1.08E+07,1.99E+05,1.03E+07,1.74E+08,3.11E+07,6.76E+07,2.56E+07,2.48E+04,5.45E+03,4.03E+03,8.26E+05,1.68E+06,3.87E+04,2.14E+05,1.26E+05,5.09E+05,9.73E+05,1.29E+04,6.48E+04,3.50E+04,1.45E+06,4.94E+03,2.01E+04,4.89E+07,2.20E+05,1.58E+06,2.72E+05,0,TRUE,70.554,46,6,261,28.9,7.12,9,other metabolic processes,cytosol,Pf00194,759,hsa:759; P00915,ENSG00000133742,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Reversible hydration of carbon dioxide; Erythrocytes take up carbon dioxide and release oxygen; Erythrocytes take up oxygen and release carbon dioxide,,4,3,165.93,119.52,110.74,107.26,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,131.09,134.24,137.4,136.39,262.48,other molecular function,0,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Master Protein,High,Q32PJ2,APOA4,Apolipoprotein A-IV OS=Bos taurus GN=APOA4 PE=2 SV=1,3,5,100,0.776,100,0.5,6.64,-0.37,6.64,-1,1.00E-17,8.03E-01,1.00E-17,6.14E-01,1.05E+06,,5.40E+05,1.97E+06,1,,4,1,,,,1.05E+06,,,,,,,,2.38E+05,4.60E+05,1.02E+06,6.35E+05,,,,1.97E+06,,,,,1.05E+06,,,,,,,,1.07E+04,3.74E+03,1.37E+05,1.58E+04,,,,4.60E+04,,0,TRUE,11.06,14,3,380,43,5.4,3,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,non-structural extracellular,Pf01442,537301,bta:537301; Q32PJ2,,,,0,0,,,55.94,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,n/a,n/a,High,n/a,1,,FALSE,,23.72,,16.79,15.74,enzyme regulator activity;other molecular function,0,
Master Protein,High,Q3SZH5,AGT,Angiotensinogen OS=Bos taurus GN=AGT PE=2 SV=1,6,24,100,1.007,100,1.578,6.64,0.01,6.64,0.66,1.00E-17,5.05E-01,1.00E-17,5.59E-01,1.76E+06,,1.14E+06,7.98E+05,2,,4,2,,,,4.41E+06,7.02E+05,,,,,,,2.76E+06,8.20E+05,5.47E+05,1.59E+06,,1.32E+06,,4.81E+05,,,,,4.41E+06,3.62E+04,,,,,,,1.23E+05,6.66E+03,7.37E+04,3.96E+04,,3.71E+05,,1.13E+04,,0,TRUE,30.723,22,6,424,45.4,9.19,6,other biological processes,non-structural extracellular,Pf00079,527114,bta:527114; Q3SZH5,ENSBTAG00000012393,,ACE inhibitor pathway; Monoamine transport; IL-6 signaling pathway; Adipogenesis,4,0,102.58,,69.26,65.91,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,55.47,,83.4,79.27,enzyme regulator activity,0,
Master Protein,High,Q2KIF2,LRG1,Leucine-rich alpha-2-glycoprotein 1 OS=Bos taurus GN=LRG1 PE=2 SV=1,1,1,100,1.076,100,0.059,6.64,0.11,6.64,-4.07,1.00E-17,5.63E-01,1.00E-17,1.25E-02,2.53E+05,,1.90E+05,3.20E+06,2,,3,3,,,,1.23E+05,5.23E+05,,,,,,4.24E+05,1.90E+05,,,1.75E+05,3.20E+06,,,1.41E+05,1.08E+08,,,,1.23E+05,2.70E+04,,,,,,2.53E+03,8.48E+03,,,4.35E+03,6.24E+03,,,3.30E+03,1.15E+06,0.001,TRUE,3.219,3,1,346,38.3,6.99,1,,,Pf13855,514663,bta:514663; Q2KIF2,,,,0,0,87.66,,53.09,165.46,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,1,,FALSE,,81.59,,141.73,2.87,,0,
Master Protein,High,Q28194,,Thrombospondin-1 (Fragment) OS=Bos taurus PE=2 SV=1,7,13,100,1.539,100,0.221,6.64,0.62,6.64,-2.18,1.00E-17,2.12E-01,1.00E-17,2.12E-01,5.58E+05,,8.59E+05,3.89E+06,1,,2,1,,,,5.58E+05,,,,,,,,,,8.21E+05,8.99E+05,,3.89E+06,,,,,,,5.58E+05,,,,,,,,,,1.11E+05,2.23E+04,,1.09E+06,,,,0,TRUE,22.959,36,2,229,25,7.97,7,,,Pf02210,,,,,,0,0,,,6.42,,Peak Found,n/a,Peak Found,High,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,n/a,1,,FALSE,,6.74,,6.74,39.78,,0,
Master Protein,High,Q2KIT0,,Protein HP-20 homolog OS=Bos taurus PE=2 SV=1,1,4,100,0.733,100,1.894,6.64,-0.45,6.64,0.92,1.00E-17,9.32E-01,1.00E-17,4.54E-01,4.29E+05,,2.82E+05,1.49E+05,2,,3,1,,9.25E+05,,1.99E+05,,,,,,,,2.82E+05,2.52E+05,3.91E+05,,,,,1.49E+05,,,3.51E+03,,1.99E+05,,,,,,,,1.26E+04,2.05E+03,5.27E+04,,,,,3.49E+03,,0.001,TRUE,4.247,8,1,191,20.6,8.59,1,,non-structural extracellular;other cell component,Pf00386,,,,,,0,0,91.37,,23.72,,n/a,Peak Found,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,n/a,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,100.74,,15.89,10.85,,0,
Master Protein,High,Q9TT36,SERPINA7,Thyroxine-binding globulin OS=Bos taurus GN=SERPINA7 PE=2 SV=1,2,5,100,1.179,100,0.838,6.64,0.24,6.64,-0.25,1.00E-17,4.84E-01,1.00E-17,9.81E-01,9.59E+04,,4.54E+05,4.48E+05,2,,4,3,,,,1.46E+05,6.27E+04,,,,,,,1.69E+05,7.56E+05,2.73E+05,1.52E+06,,4.48E+05,8.80E+04,1.37E+06,,,,,1.46E+05,3.24E+03,,,,,,,7.55E+03,6.14E+03,3.68E+04,3.77E+04,,1.26E+05,6.23E+02,3.21E+04,,0,TRUE,6.214,7,2,411,46,5.72,2,,non-structural extracellular,Pf00079,282518,bta:282518; Q9TT36,,,,0,0,56.62,,90.51,104.09,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,n/a,High,Peak Found,High,n/a,1,,FALSE,,84.94,,81.84,14.76,enzyme regulator activity,0,
Master Protein,High,Q32PI4,CFI,Complement factor I OS=Bos taurus GN=CFI PE=2 SV=1,5,15,100,0.448,100,0.753,6.64,-1.16,6.64,-0.41,1.00E-17,5.95E-01,1.00E-17,9.82E-01,7.08E+05,,8.03E+05,6.54E+05,2,,4,3,,,,2.04E+06,2.46E+05,,,,,,,4.85E+05,6.45E+05,1.47E+06,9.98E+05,,6.54E+05,6.53E+05,1.52E+06,,,,,2.04E+06,1.27E+04,,,,,,,2.17E+04,5.24E+03,1.98E+05,2.48E+04,,1.84E+05,4.63E+03,3.55E+04,,0,TRUE,24.802,11,5,618,68.9,7.74,5,protein metabolism,other membranes,"Pf00057, Pf00089, Pf00530, Pf21286, Pf21287",513197,bta:513197; Q32PI4,,,,0,0,111.05,,48.43,52.85,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,Peak Found,High,n/a,1,,FALSE,,40.82,,58.67,47.1,other molecular function,0,
Master Protein,High,ENSEMBL:ENSBTAP00000031360,,(Bos taurus) 55 kDa protein [OS=Bos taurus],1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.44E+05,,,,1,,,,,,,3.44E+05,,,,,,,,,,,,,,,,,,,,3.44E+05,,,,,,,,,,,,,,,,,0,TRUE,9.525,4,1,491,54.6,5.07,1,,,,,,,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,5.7,,0,
Master Protein,High,Q9D646,Krt34,"Keratin, type I cuticular Ha4 OS=Mus musculus GN=Krt34 PE=2 SV=1",4,12,100,0.115,100,0.072,6.64,-3.12,6.64,-3.8,1.00E-17,2.08E-02,1.00E-17,2.17E-02,5.11E+05,,5.86E+04,8.15E+05,1,,1,3,,,,,5.11E+05,,,,,,,,,5.86E+04,,8.86E+07,9.45E+04,8.15E+05,,,,,,,2.63E+04,,,,,,,,,7.90E+03,,1.73E+05,2.65E+04,5.77E+03,,,0,TRUE,14.835,10,1,392,44.5,4.79,4,cell organization and biogenesis;other biological processes,cytoskeleton,Pf00038,16672,mmu:16672; Q9D646,ENSMUSG00000043485,Formation of the cornified envelope,,2,0,,,,170.57,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,Peak Found,n/a,n/a,1,,FALSE,,0,,131.07,37.73,other molecular function,0,
Master Protein,High,Q2HJF0,LOC525947,Serotransferrin-like OS=Bos taurus GN=LOC525947 PE=2 SV=1,3,18,100,0.342,100,0.529,6.64,-1.55,6.64,-0.92,1.00E-17,3.91E-01,1.00E-17,7.50E-01,2.12E+05,,5.11E+04,4.24E+04,1,,3,1,,,,2.12E+05,,,,,,,,1.62E+05,,3.70E+04,5.11E+04,,,,4.24E+04,,,,,2.12E+05,,,,,,,,7.25E+03,,4.98E+03,1.27E+03,,,,9.92E+02,,0,TRUE,10.431,8,2,622,69.1,7.88,3,,non-structural extracellular,Pf00405,525947,bta:525947; Q2HJF0,,,,0,0,,,82.26,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,,83.02,,68.45,35.98,,0,
Master Protein,High,A5PJ69,SERPINA10,SERPINA10 protein OS=Bos taurus GN=SERPINA10 PE=2 SV=1,4,6,100,0.568,100,4.541,6.64,-0.82,6.64,2.18,1.00E-17,8.20E-01,1.00E-17,1.41E-01,8.40E+05,,3.39E+05,7.69E+03,2,,1,1,,,,3.36E+05,2.10E+06,,,,,,,,,3.39E+05,,,7.69E+03,,,,,,,3.36E+05,1.08E+05,,,,,,,,,4.57E+04,,,2.16E+03,,,,0,TRUE,17.761,13,4,452,52,6.48,4,stress response,non-structural extracellular,Pf00079,517172,A5PJ69; bta:517172,ENSBTAG00000009894,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,,2,0,102.49,,,,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,n/a,n/a,1,,FALSE,,72.42,,0,20.72,enzyme regulator activity,0,
Master Protein,High,ENSEMBL:ENSBTAP00000033053,,(Bos taurus) 15 kDa protein [OS=Bos taurus],1,1,100,0.25,,100,6.64,-2,,6.64,1.00E-17,1.70E-01,,1.00E-17,8.32E+05,,2.08E+05,,1,,1,,,,,8.32E+05,,,,,,,,,,2.08E+05,,,,,,,,,,8.32E+05,,,,,,,,,,2.81E+04,,,,,,,0,TRUE,4.295,19,1,139,14.8,9.45,1,,,,,,,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,0,,,4.94,,0,
Master Protein,High,P02676,FGB,Fibrinogen beta chain OS=Bos taurus GN=FGB PE=1 SV=2,8,242,100,2.536,100,0.375,6.64,1.34,6.64,-1.42,1.00E-17,1.73E-01,1.00E-17,5.45E-01,2.89E+04,,9.12E+04,2.35E+05,2,,4,2,,,,1.08E+04,7.75E+04,,,,,,,3.67E+04,6.01E+04,1.39E+05,2.28E+05,,1.44E+05,,3.83E+05,,,,,1.08E+04,4.00E+03,,,,,,,1.64E+03,4.88E+02,1.87E+04,5.66E+03,,4.04E+04,,8.95E+03,,0,TRUE,34.177,22,4,468,53.3,8.19,8,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;extracellular matrix,"Pf00147, Pf08702",,P02676,,,,0,0,106.97,,74.71,64.09,n/a,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,High,High,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,111.78,,79.55,643.85,signal transduction activity or receptor binding,0,
Master Protein,High,ENSEMBL:ENSBTAP00000014147,,(Bos taurus) 12 kDa protein [OS=Bos taurus],1,1,100,0.01,,,6.64,-6.64,,,1.00E-17,1.00E-17,,,3.12E+05,,,,3,,,,,1.17E+06,,3.12E+05,2.29E+05,,,,,,,,,,,,,,,,,4.43E+03,,3.12E+05,1.18E+04,,,,,,,,,,,,,,,,0,TRUE,6.27,12,1,113,11.7,6.55,1,,,,,,,,,0,0,91.11,,,,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.43,,0,
Master Protein,High,Q0VCM5,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1 OS=Bos taurus GN=ITIH1 PE=2 SV=1,2,3,100,0.435,,100,6.64,-1.2,,6.64,1.00E-17,6.74E-01,,1.00E-17,3.46E+04,,1.50E+04,,1,,1,,,,,3.46E+04,,,,,,,,1.50E+04,,,,,,,,,,,,3.46E+04,,,,,,,,6.72E+02,,,,,,,,,0,TRUE,9.011,4,2,906,101.2,7.4,2,other metabolic processes,non-structural extracellular,"Pf00092, Pf06668, Pf08487",508356,bta:508356; Q0VCM5,ENSBTAG00000007843,,,0,0,,,,,n/a,n/a,n/a,High,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,High,n/a,n/a,n/a,1,,FALSE,,0,,,13.37,enzyme regulator activity,0,
Master Protein,High,A2I7N1,SERPINA3-5,Serpin A3-5 OS=Bos taurus GN=SERPINA3-5 PE=3 SV=1,7,30,100,1.489,100,4.736,6.64,0.57,6.64,2.24,1.00E-17,3.70E-01,1.00E-17,1.59E-01,1.29E+05,,1.59E+05,3.55E+04,2,,3,2,,,,1.96E+05,8.45E+04,,,,,,,3.22E+04,,1.71E+05,1.59E+05,,1.97E+04,,6.40E+04,,,,,1.96E+05,4.36E+03,,,,,,,1.44E+03,,2.30E+04,3.96E+03,,5.54E+03,,1.50E+03,,0,TRUE,24.498,18,3,411,46.4,6.96,7,,non-structural extracellular;other cell component,Pf00079,617667,A2I7N1,,,,0,0,56.06,,63.65,74.8,n/a,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,105.96,,123.82,70.29,enzyme regulator activity,0,
Master Protein,High,Q2TBQ1,F13B,"Coagulation factor XIII, B polypeptide OS=Bos taurus GN=F13B PE=2 SV=1",5,10,100,1.043,100,1.261,6.64,0.06,6.64,0.33,1.00E-17,5.48E-01,1.00E-17,6.81E-01,8.47E+05,,2.55E+05,7.24E+05,3,,5,5,1.06E+06,,,8.47E+05,1.73E+05,,,,,,2.90E+06,2.55E+05,1.52E+05,1.95E+06,1.00E+05,2.10E+05,1.40E+06,7.24E+05,4.73E+04,1.00E+06,4.22E+03,,,8.47E+05,8.93E+03,,,,,,1.73E+04,1.14E+04,1.24E+03,2.62E+05,2.49E+03,4.10E+02,3.94E+05,5.13E+03,1.11E+03,1.07E+04,0,TRUE,21.545,14,5,661,75.1,6.76,5,protein metabolism;other metabolic processes;stress response,,Pf00084,511483,bta:511483; Q2TBQ1,ENSBTAG00000000070,Common Pathway of Fibrin Clot Formation,Steroid biosynthesis; Complement and coagulation cascades; Blood clotting cascade,4,0,66.83,,119.58,82.51,Peak Found,n/a,n/a,High,Peak Found,n/a,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,,126.29,,132.03,32.12,,0,
Master Protein,High,Q9N2I2,SERPINA5,Plasma serine protease inhibitor OS=Bos taurus GN=SERPINA5 PE=1 SV=1,3,13,100,0.789,100,3.375,6.64,-0.34,6.64,1.76,1.00E-17,7.67E-01,1.00E-17,2.17E-01,9.30E+05,,7.68E+05,3.50E+05,3,,4,1,,,2.77E+05,2.18E+06,9.30E+05,,,,,,,1.61E+06,6.17E+05,9.55E+05,4.51E+05,,,,3.50E+05,,,,2.71E+03,2.18E+06,4.80E+04,,,,,,,7.18E+04,5.02E+03,1.29E+05,1.12E+04,,,,8.19E+03,,0,TRUE,14.096,14,3,404,45.3,9.36,3,transport;other biological processes,non-structural extracellular;other membranes;other cell component,Pf00079,338050,A7E3W0; bta:338050; Q9N2I2,,,,0,0,85.61,,56.34,,n/a,n/a,Peak Found,High,High,n/a,n/a,n/a,n/a,n/a,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,,76.42,,79.38,42.6,enzyme regulator activity;other molecular function,0,
Master Protein,High,ENSEMBL:ENSBTAP00000037665,,"(Bos taurus) similar to Pregnancy zone protein, partial [OS=Bos taurus]",2,6,100,1.153,100,0.542,6.64,0.21,6.64,-0.88,1.00E-17,5.06E-01,1.00E-17,7.59E-01,4.33E+05,,5.06E+05,9.59E+05,3,,3,3,,6.03E+05,,4.15E+05,4.33E+05,,,,,,,3.86E+05,,5.06E+05,6.95E+05,,4.66E+05,,1.28E+06,9.59E+05,,2.29E+03,,4.15E+05,2.23E+04,,,,,,,1.72E+04,,6.82E+04,1.73E+04,,1.31E+05,,3.00E+04,1.02E+04,0,TRUE,6.097,6,2,578,65.2,7.01,2,,,,,,,,,0,0,21.41,,29.46,45.61,n/a,Peak Found,n/a,High,High,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,High,High,n/a,High,n/a,Peak Found,Peak Found,1,,FALSE,,33.73,,51.33,17.77,,0,
Master Protein,High,Q9R0H5,Krt71,"Keratin, type II cytoskeletal 71 OS=Mus musculus GN=Krt71 PE=1 SV=1",3,75,100,0.066,100,0.01,6.64,-3.92,6.64,-6.64,1.00E-17,1.33E-02,1.00E-17,1.00E-17,1.35E+05,,8.92E+03,1.12E+06,1,,1,2,,,,1.35E+05,,,,,,,,8.92E+03,,,,4.69E+07,,,2.69E+04,,,,,1.35E+05,,,,,,,,3.98E+02,,,,9.14E+04,,,6.29E+02,,0,TRUE,12.104,5,1,524,57.3,6.99,3,cell organization and biogenesis;other biological processes,cytoskeleton;other cell component,"Pf00038, Pf16208",56735,A0JLW9; mmu:56735; Q7TPF3; Q9D0X6; Q9R0H5,ENSMUSG00000051879,Formation of the cornified envelope,,2,0,,,,141.26,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,n/a,High,n/a,n/a,Peak Found,n/a,1,,FALSE,,0,,3093.5,145.46,"bone, tooth or skin structural activity",0,
Master Protein,High,Q3ZBS7,VTN,Uncharacterized protein OS=Bos taurus GN=VTN PE=2 SV=1,10,29,11.369,0.687,1.778,1.525,3.51,-0.54,0.83,0.61,6.63E-03,9.92E-01,5.17E-01,6.52E-01,3.41E+06,2.56E+05,2.24E+06,2.64E+06,3,3,5,4,,,1.69E+05,2.20E+07,3.41E+06,,2.56E+05,6.84E+04,,3.25E+05,1.35E+06,3.08E+06,1.96E+06,1.05E+07,2.24E+06,,2.67E+06,4.56E+05,3.45E+06,2.61E+06,,,1.65E+03,2.20E+07,1.76E+05,,4.56E+03,6.31E+02,,3.45E+03,8.08E+03,1.38E+05,1.60E+04,1.41E+06,5.57E+04,,7.51E+05,3.23E+03,8.08E+04,2.78E+04,0,TRUE,56.117,25,7,476,53.5,6.28,10,cell adhesion;cell organization and biogenesis;transport;developmental processes;other biological processes,non-structural extracellular;extracellular matrix;ER/Golgi;other cell component,"Pf00045, Pf01033",507525,bta:507525; Q3ZBS7,ENSBTAG00000016151,Molecules associated with elastic fibres; Integrin cell surface interactions; Syndecan interactions; ECM proteoglycans; Regulation of Complement cascade,Inflammatory response pathway; Focal adhesion; Primary focal segmental glomerulosclerosis (FSGS),8,3,138.16,61.31,98.58,55.98,n/a,n/a,n/a,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,n/a,High,Peak Found,High,Peak Found,1,,FALSE,145.11,114.07,129.29,130.58,95.33,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,ENSEMBL:ENSBTAP00000018229,,(Bos taurus) 54 kDa protein [OS=Bos taurus],23,235,6.53,3.015,4.517,2.63,2.71,1.59,2.18,1.4,4.07E-02,2.97E-02,1.17E-01,3.50E-01,2.13E+06,4.68E+05,6.47E+06,1.28E+06,3,4,5,2,,5.29E+05,,2.13E+06,2.65E+07,1.27E+06,4.14E+05,,6.37E+04,5.30E+05,1.34E+06,6.47E+06,6.41E+06,7.06E+06,8.49E+06,1.29E+05,,,1.28E+07,,,2.01E+03,,2.13E+06,1.37E+06,4.52E+03,7.36E+03,,1.79E+03,5.63E+03,8.04E+03,2.89E+05,5.21E+04,9.51E+05,2.11E+05,2.52E+02,,,2.99E+05,,0,TRUE,159.648,55,1,475,53.6,6.05,23,,,,,,,,,0,0,149.75,89.17,45.52,138.59,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,n/a,High,n/a,1,,FALSE,132.21,135.15,163.25,290.16,843.67,,0,
Master Protein,High,Q9TTE1,SERPINA3-1,Serpin A3-1 OS=Bos taurus GN=SERPINA3-1 PE=1 SV=3,8,104,6.456,1.597,5.723,1.888,2.69,0.68,2.52,0.92,4.01E-02,2.17E-01,3.62E-02,5.22E-01,2.68E+06,1.65E+06,2.01E+07,5.10E+06,5,5,5,5,2.68E+06,1.51E+06,7.00E+05,1.88E+07,3.44E+07,3.57E+06,1.68E+06,6.71E+05,4.88E+05,1.65E+06,4.35E+05,1.51E+07,2.18E+07,2.01E+07,2.81E+07,5.10E+06,1.31E+07,5.08E+06,4.42E+07,3.84E+06,1.06E+04,5.72E+03,6.84E+03,1.88E+07,1.78E+06,1.27E+04,2.98E+04,6.19E+03,1.38E+04,1.76E+04,2.60E+03,6.75E+05,1.77E+05,2.70E+06,6.98E+05,9.94E+03,3.68E+06,3.60E+04,1.03E+06,4.08E+04,0,TRUE,44.33,22,4,411,46.2,5.99,8,,non-structural extracellular;other cell component,Pf00079,286804,bta:286804; Q2KIQ9; Q3ZEJ7; Q9TTE1,,,,0,4,127.15,75.97,60.86,120.12,Peak Found,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,129.87,136.19,120.88,102.82,344.66,enzyme regulator activity,0,
Master Protein,High,P13717,nucA,Nuclease OS=Serratia marcescens GN=nucA PE=1 SV=2,12,108,6.382,0.269,0.819,1.155,2.67,-1.9,-0.29,0.21,4.77E-02,1.63E-01,6.99E-01,8.38E-01,1.44E+07,1.99E+06,2.68E+06,4.81E+06,5,5,5,5,1.57E+08,1.44E+07,7.63E+07,3.76E+06,7.40E+06,3.07E+06,2.04E+06,1.79E+06,5.90E+05,1.99E+06,5.00E+07,9.98E+06,2.68E+06,1.24E+06,2.38E+06,4.81E+06,1.08E+06,5.06E+06,1.25E+06,6.35E+06,6.25E+05,5.47E+04,7.45E+05,3.76E+06,3.82E+05,1.09E+04,3.62E+04,1.65E+04,1.66E+04,2.12E+04,2.99E+05,4.46E+05,2.18E+04,1.67E+05,5.92E+04,9.39E+03,3.04E+05,3.59E+04,2.92E+04,6.76E+04,0,TRUE,56.772,64,12,266,28.9,7.42,12,,non-structural extracellular,Pf01223,66715254,P13717,,,,0,0,127.32,46.63,157.15,64.57,High,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,137.59,138.13,111.49,131.06,257.07,nucleic acid binding activity;other molecular function,0,
Master Protein,High,P81644,APOA2,Apolipoprotein A-II OS=Bos taurus GN=APOA2 PE=1 SV=2,8,135,3.954,1.814,9.24,0.891,1.98,0.86,3.21,-0.17,1.49E-01,1.55E-01,6.83E-03,9.79E-01,6.15E+06,2.21E+06,1.04E+08,3.02E+07,5,5,5,5,1.15E+06,6.15E+06,6.85E+05,3.36E+07,8.59E+07,2.92E+06,8.74E+05,2.21E+06,3.94E+04,2.92E+07,4.48E+06,1.10E+08,2.99E+08,3.69E+07,1.04E+08,9.74E+06,5.08E+07,1.34E+07,2.67E+08,3.02E+07,4.55E+03,2.34E+04,6.69E+03,3.36E+07,4.43E+06,1.04E+04,1.55E+04,2.04E+04,1.11E+03,3.10E+05,2.68E+04,4.94E+06,2.43E+06,4.97E+06,2.57E+06,1.90E+04,1.43E+07,9.49E+04,6.26E+06,3.22E+05,0,TRUE,42.932,44,8,100,11.2,8.1,8,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes,non-structural extracellular,Pf04711,505394,bta:505394; P81644; Q2NKV9,ENSBTAG00000009212,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Chylomicron assembly; Chylomicron remodeling; Retinoid metabolism and transport,Statin pathway,6,0,142.71,176.34,103.02,146.92,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,High,Peak Found,1,,FALSE,144.09,140.81,130.73,141.52,393.33,signal transduction activity or receptor binding;transporter activity;enzyme regulator activity;other molecular function,0,
Master Protein,High,P01030,C4,Complement C4 (Fragments) OS=Bos taurus GN=C4 PE=1 SV=2,14,38,3.557,0.22,1.438,0.405,1.83,-2.19,0.52,-1.3,2.15E-01,1.14E-01,8.36E-01,5.02E-01,9.53E+05,2.68E+05,2.09E+05,5.69E+05,3,2,2,4,,5.48E+06,,1.67E+05,9.53E+05,,5.27E+05,,1.36E+05,,,,,2.73E+05,1.60E+05,5.86E+05,1.91E+05,7.78E+05,,5.53E+05,,2.08E+04,,1.67E+05,4.92E+04,,9.38E+03,,3.84E+03,,,,,3.68E+04,3.99E+03,1.14E+03,5.37E+04,5.51E+03,,5.89E+03,0,TRUE,69.245,21,1,920,101.8,6.58,14,stress response;other biological processes,non-structural extracellular;other cell component,,,P01030; Q27992; Q27993,,,,0,0,130.34,83.37,36.81,46.46,n/a,Peak Found,n/a,High,Peak Found,n/a,Peak Found,n/a,Peak Found,n/a,n/a,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,1,,FALSE,139.28,121.38,75.51,64.9,112.85,,0,
Master Protein,High,Q2UVX4,C3,Complement C3 OS=Bos taurus GN=C3 PE=1 SV=2,40,157,3.237,0.746,3.235,0.857,1.69,-0.42,1.69,-0.22,2.24E-01,9.11E-01,1.72E-01,9.52E-01,1.47E+07,5.55E+06,1.41E+07,7.81E+06,5,5,5,5,4.91E+06,1.47E+07,6.01E+06,2.10E+07,3.55E+07,5.55E+06,3.28E+06,4.88E+06,7.66E+06,3.07E+07,9.86E+05,1.41E+07,9.15E+06,1.75E+07,2.59E+07,6.29E+06,1.48E+07,5.84E+06,2.13E+07,7.81E+06,1.95E+04,5.57E+04,5.87E+04,2.10E+07,1.83E+06,1.97E+04,5.84E+04,4.51E+04,2.16E+05,3.26E+05,5.90E+03,6.29E+05,7.43E+04,2.36E+06,6.44E+05,1.23E+04,4.15E+06,4.14E+04,5.00E+05,8.31E+04,0,TRUE,177.024,37,37,1661,187.1,6.84,40,cell organization and biogenesis;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes,non-structural extracellular;other cell component,"Pf00207, Pf01759, Pf01821, Pf01835, Pf07677, Pf07678, Pf07703, Pf17789, Pf17790, Pf17791, Pf21308, Pf21406",280677,bta:280677; Q2KIZ4; Q2UVX4,ENSBTAG00000017280,Neutrophil degranulation; Peptide ligand-binding receptors; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; G alpha (i) signalling events; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Regulation of Complement cascade; Alternative complement activation; Activation of C3 and C5,"Complement and coagulation cascades; Complement activation, classical pathway",11,3,76.41,109.85,68.77,59.87,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,High,High,High,1,,FALSE,136.21,106.28,135.98,97.49,445.4,signal transduction activity or receptor binding;enzyme regulator activity,0,
Master Protein,High,Q2KIS7,CLEC3B,Tetranectin OS=Bos taurus GN=CLEC3B PE=2 SV=1,6,33,2.967,0.559,4.513,1.568,1.57,-0.84,2.17,0.65,2.49E-01,7.53E-01,6.75E-02,6.34E-01,3.00E+06,3.30E+05,2.48E+06,2.94E+06,3,5,5,5,,3.00E+06,,7.24E+06,2.15E+06,7.40E+04,9.34E+05,3.30E+05,1.23E+06,1.42E+05,4.96E+05,2.48E+06,3.19E+06,2.78E+06,1.92E+06,2.16E+06,2.20E+05,4.48E+07,2.94E+06,3.67E+07,,1.14E+04,,7.24E+06,1.11E+05,2.63E+02,1.66E+04,3.04E+03,3.47E+04,1.51E+03,2.96E+03,1.11E+05,2.59E+04,3.75E+05,4.76E+04,4.21E+03,6.18E+04,3.18E+05,6.88E+04,3.91E+05,0,TRUE,33.243,47,6,202,22.1,5.64,6,other biological processes,non-structural extracellular;nucleus;other cell component,Pf00059,515783,bta:515783; Q2KIS7,,,,0,0,66.01,94.62,48.17,124.19,n/a,Peak Found,n/a,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,131.5,89.87,117.77,105.78,98.99,other molecular function,0,
Master Protein,High,P00761,,Trypsin OS=Sus scrofa PE=1 SV=1,4,278,2.942,1.489,1.907,1.897,1.56,0.57,0.93,0.92,2.67E-01,2.58E-01,4.89E-01,5.19E-01,2.93E+07,2.14E+07,6.94E+07,1.80E+07,5,5,5,5,6.44E+08,2.93E+07,3.15E+08,9.55E+06,3.07E+06,2.15E+07,2.14E+07,4.63E+06,3.44E+06,2.66E+07,2.78E+08,2.82E+07,7.66E+07,6.94E+06,6.94E+07,2.09E+07,1.80E+07,4.84E+06,1.68E+08,1.76E+07,2.56E+06,1.11E+05,3.07E+06,9.55E+06,1.58E+05,7.63E+04,3.81E+05,4.27E+04,9.68E+04,2.83E+05,1.66E+06,1.26E+06,6.22E+05,9.35E+05,1.72E+06,4.07E+04,5.06E+06,3.43E+04,3.93E+06,1.88E+05,0,TRUE,34.443,25,4,231,24.4,7.18,4,protein metabolism;other biological processes,non-structural extracellular,Pf00089,,,,,,0,0,140.1,68.97,117.6,149.41,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,High,High,1,,FALSE,145.06,143.64,128.29,130.74,853.78,other molecular function,0,
Master Protein,High,P02769,ALB,Serum albumin OS=Bos taurus GN=ALB PE=1 SV=4,76,5381,2.918,2.009,5.364,1.331,1.54,1.01,2.42,0.41,2.72E-01,1.15E-01,4.43E-02,7.41E-01,7.18E+08,1.53E+08,3.75E+09,1.31E+09,5,5,5,5,7.18E+08,1.52E+08,2.78E+08,3.79E+09,3.92E+09,3.39E+08,8.63E+07,1.53E+08,8.48E+07,2.35E+09,1.65E+08,4.19E+09,3.75E+09,4.23E+09,3.56E+09,4.09E+08,2.95E+09,1.05E+09,7.32E+09,1.31E+09,2.85E+06,5.76E+05,2.72E+06,3.79E+09,2.02E+08,1.21E+06,1.54E+06,1.41E+06,2.39E+06,2.49E+07,9.84E+05,1.87E+08,3.04E+07,5.70E+08,8.84E+07,7.98E+05,8.29E+08,7.43E+06,1.71E+08,1.39E+07,0,TRUE,779.539,84,71,607,69.2,6.18,76,stress response;other biological processes,non-structural extracellular;other cell component,Pf00273,280717,A5PJX3; bta:280717; O02787; P02769; P04277; Q3SZR2,,,,0,5,108.04,162.96,53.78,107.24,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,1,,FALSE,138.7,140.43,138.04,137.3,15999.55,nucleic acid binding activity;other molecular function,0,
Master Protein,High,ENSEMBL:ENSBTAP00000024466,,(Bos taurus) 44 kDa protein [OS=Bos taurus],9,67,2.843,0.369,1.845,0.386,1.51,-1.44,0.88,-1.37,2.84E-01,3.54E-01,5.16E-01,4.42E-01,1.87E+07,1.09E+06,3.46E+06,5.99E+06,3,4,4,5,1.36E+05,,,3.20E+07,1.87E+07,1.04E+06,1.16E+06,3.56E+05,,1.84E+07,,1.19E+06,3.60E+05,1.01E+07,1.13E+07,2.14E+06,4.23E+05,5.99E+06,2.53E+07,6.57E+06,5.39E+02,,,3.20E+07,9.66E+05,3.69E+03,2.05E+04,3.28E+03,,1.96E+05,,5.33E+04,2.92E+03,1.35E+06,2.80E+05,4.18E+03,1.19E+05,4.24E+04,5.92E+05,6.99E+04,0,TRUE,54.757,35,9,401,43.9,5.35,9,,,,,,,,,0,0,94.4,167.71,100.32,123.21,Peak Found,n/a,n/a,High,High,Peak Found,Peak Found,Peak Found,n/a,High,n/a,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,123.15,114.42,146.53,134.57,239.47,,0,
Master Protein,High,Q28107,F5,Coagulation factor V OS=Bos taurus GN=F5 PE=1 SV=1,45,316,2.593,0.85,2.696,1.28,1.37,-0.23,1.43,0.36,3.34E-01,7.60E-01,2.57E-01,7.67E-01,1.10E+07,1.95E+06,6.29E+07,1.74E+07,5,5,5,5,2.38E+06,1.23E+07,6.20E+06,8.41E+07,1.10E+07,2.91E+06,3.73E+05,1.95E+06,1.23E+06,1.32E+07,4.15E+06,6.46E+07,6.29E+07,8.05E+07,1.24E+07,9.15E+06,3.19E+07,1.72E+07,2.19E+07,1.74E+07,9.47E+03,4.69E+04,6.05E+04,8.41E+07,5.67E+05,1.03E+04,6.63E+03,1.80E+04,3.47E+04,1.41E+05,2.48E+04,2.89E+06,5.11E+05,1.08E+07,3.09E+05,1.78E+04,8.96E+06,1.22E+05,5.12E+05,1.85E+05,0,TRUE,275.243,25,45,2211,248.8,5.83,45,stress response;other biological processes,non-structural extracellular;other cell component,"Pf00754, Pf06049, Pf07732",280687,bta:280687; Q28107; Q28108,,,,0,0,147.76,133.95,76.26,42.65,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,High,Peak Found,1,,FALSE,111.83,130.82,132.03,126.03,896.33,other molecular function,0,
Master Protein,High,P41361,SERPINC1,Antithrombin-III OS=Bos taurus GN=SERPINC1 PE=1 SV=2,4,13,2.591,0.697,1.947,0.861,1.37,-0.52,0.96,-0.22,2.95E-01,9.83E-01,5.62E-01,1.00E+00,3.10E+06,4.25E+05,1.67E+06,8.44E+05,2,3,5,5,,,,1.81E+06,5.31E+06,4.25E+05,5.00E+04,,,1.39E+06,1.20E+05,1.41E+06,1.67E+06,2.94E+06,3.95E+06,3.80E+05,4.99E+05,8.44E+05,8.61E+06,1.77E+06,,,,1.81E+06,2.74E+05,1.51E+03,8.89E+02,,,1.48E+04,7.16E+02,6.28E+04,1.36E+04,3.96E+05,9.80E+04,7.42E+02,1.40E+05,5.98E+03,2.02E+05,1.89E+04,0,TRUE,15.42,11,4,465,52.3,7.33,4,stress response;other biological processes,non-structural extracellular,Pf00079,540261,bta:540261; P41361; Q3SZQ7,,,,0,0,69.64,111.32,72.99,144.68,n/a,n/a,n/a,High,High,Peak Found,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,117.72,104.98,80.12,118.86,23.4,enzyme regulator activity;other molecular function,0,
Master Protein,High,P12763,AHSG,Alpha-2-HS-glycoprotein OS=Bos taurus GN=AHSG PE=1 SV=2,20,919,2.47,2.257,3.627,1.793,1.3,1.17,1.86,0.84,3.62E-01,8.08E-02,1.30E-01,5.52E-01,1.17E+08,6.27E+07,7.22E+08,3.89E+08,5,5,5,5,1.17E+08,4.67E+07,7.31E+07,6.93E+08,3.88E+08,7.99E+07,6.27E+07,2.58E+07,1.55E+07,5.21E+08,1.60E+07,1.08E+09,8.11E+08,6.05E+08,7.22E+08,2.60E+08,3.89E+08,4.01E+08,9.19E+08,1.62E+08,4.66E+05,1.78E+05,7.14E+05,6.93E+08,2.00E+07,2.84E+05,1.12E+06,2.38E+05,4.36E+05,5.54E+06,9.54E+04,4.83E+07,6.59E+06,8.16E+07,1.79E+07,5.06E+05,1.09E+08,2.84E+06,2.15E+07,1.73E+06,0,TRUE,220.325,55,17,359,38.4,5.5,20,stress response;other biological processes,non-structural extracellular;extracellular matrix;plasma membrane;other membranes;ER/Golgi;other cell component,Pf00031,280988,A6QLF7; bta:280988; P12763,ENSBTAG00000000522,Neutrophil degranulation; Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,,4,3,104.65,151.8,60.92,68.62,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,High,Peak Found,1,Phospho [S320; S323],FALSE,143.19,139.52,138.51,138.91,3024.15,enzyme regulator activity,2,Phospho [S320; S323]
Master Protein,High,REFSEQ:XP_585019,AFM,(Bos taurus) similar to afamin [OS=Bos taurus],5,12,2.442,0.631,1.256,2.071,1.29,-0.66,0.33,1.05,3.34E-01,9.37E-01,9.27E-01,4.08E-01,6.15E+05,2.27E+05,6.46E+05,8.05E+04,2,4,5,4,,,,6.80E+05,5.55E+05,5.53E+04,1.62E+05,5.73E+05,3.18E+05,,3.64E+05,2.02E+05,6.46E+05,1.36E+06,7.89E+05,6.95E+04,,3.42E+04,3.76E+05,9.33E+04,,,,6.80E+05,2.86E+04,1.97E+02,2.88E+03,5.29E+03,8.95E+03,,2.17E+03,9.03E+03,5.24E+03,1.83E+05,1.96E+04,1.36E+02,,2.42E+02,8.79E+03,9.93E+02,0,TRUE,13.604,10,5,604,69.5,5.85,5,transport;other biological processes,non-structural extracellular;other cell component,Pf00273,508264,A0A4W2D8R0; bta:508264; G3MYZ3,ENSBIXG00000025243; ENSBTAG00000047833,,,0,0,14.29,81.23,66.59,109.56,n/a,n/a,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,113.03,34.73,75.33,87.64,23.13,other molecular function,0,
Master Protein,High,P01966,HBA,Hemoglobin subunit alpha OS=Bos taurus GN=HBA PE=1 SV=2,5,658,2.35,5.957,2.194,3.018,1.23,2.57,1.13,1.59,3.64E-01,1.48E-03,3.84E-01,2.91E-01,7.21E+05,1.56E+06,1.76E+07,7.07E+06,3,5,5,3,,,7.21E+05,3.63E+07,5.88E+05,4.52E+06,3.78E+05,1.56E+06,7.78E+05,4.48E+06,3.83E+05,4.03E+07,7.67E+06,1.84E+07,1.76E+07,,1.86E+07,,7.07E+06,5.01E+05,,,7.04E+03,3.63E+07,3.03E+04,1.61E+04,6.72E+03,1.44E+04,2.19E+04,4.76E+04,2.29E+03,1.80E+06,6.23E+04,2.48E+06,4.37E+05,,5.22E+06,,1.65E+05,5.34E+03,0,TRUE,78.705,49,2,142,15.2,8.44,5,other metabolic processes;transport;other biological processes,cytosol;other cell component,Pf00042,100140149; 512439,A3KN13; bta:100140149; bta:512439; P01966; Q3SZE0; Q9TTR9; Q9TTS0; Q9TTS1,ENSBTAG00000051412,Cytoprotection by HMOX1; Scavenging of heme from plasma; Erythrocytes take up carbon dioxide and release oxygen; Heme signaling; Erythrocytes take up oxygen and release carbon dioxide,,5,0,164.17,85.88,89.41,105,Peak Found,High,High,High,High,High,Peak Found,High,High,High,High,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,137.78,142.01,138.38,130.46,1588.8,other molecular function,0,
Master Protein,High,P34955,SERPINA1,Alpha-1-antiproteinase OS=Bos taurus GN=SERPINA1 PE=1 SV=1,23,616,2.196,2.156,3.317,1.818,1.13,1.11,1.73,0.86,4.36E-01,9.33E-02,1.62E-01,5.44E-01,5.28E+07,2.85E+07,2.25E+08,1.42E+08,5,5,5,5,5.28E+07,3.60E+07,1.03E+07,3.59E+08,3.93E+08,6.68E+07,1.38E+07,2.85E+07,1.05E+07,9.65E+07,1.79E+07,2.25E+08,2.44E+08,2.21E+08,4.75E+08,6.18E+07,1.18E+08,1.42E+08,2.85E+08,2.94E+08,2.10E+05,1.37E+05,1.00E+05,3.59E+08,2.03E+07,2.37E+05,2.46E+05,2.63E+05,2.94E+05,1.03E+06,1.07E+05,1.01E+07,1.99E+06,2.98E+07,1.18E+07,1.21E+05,3.31E+07,1.00E+06,6.68E+06,3.13E+06,0,TRUE,151.928,41,23,416,46.1,6.52,23,,non-structural extracellular;ER/Golgi,Pf00079,280699,bta:280699; P34955; Q3SZS3,ENSBTAG00000018843,Neutrophil degranulation; Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Cargo concentration in the ER; COPII-mediated vesicle transport,Complement and coagulation cascades; NRF2 pathway,8,0,110.97,86.14,68.45,57.8,High,High,High,High,High,High,High,High,Peak Found,High,Peak Found,High,High,High,High,High,High,High,High,High,1,,FALSE,137.1,137.04,124.31,124.87,1744.56,enzyme regulator activity;other molecular function,0,
Master Protein,High,ENSEMBL:ENSBTAP00000034412,,(Bos taurus) similar to C4b-binding protein alpha chain [OS=Bos taurus],5,10,2.058,0.146,0.457,1,1.04,-2.78,-1.13,0,4.26E-01,2.08E-02,3.86E-01,8.50E-01,2.22E+06,1.56E+06,5.15E+05,3.67E+05,3,4,5,4,,2.22E+06,,5.66E+06,1.95E+06,3.75E+06,,3.46E+05,6.52E+05,1.16E+07,5.15E+05,4.74E+05,6.31E+05,9.51E+05,7.96E+04,2.50E+06,9.39E+04,,3.25E+05,4.14E+05,,8.43E+03,,5.66E+06,1.01E+05,1.33E+04,,3.20E+03,1.84E+04,1.24E+05,3.08E+03,2.12E+04,5.12E+03,1.28E+05,1.98E+03,4.87E+03,2.64E+04,,7.61E+03,4.40E+03,0,TRUE,21.743,32,5,199,22.3,7.49,5,,,,,,,,,0,0,63.07,128.34,59.17,134.31,n/a,Peak Found,n/a,High,High,Peak Found,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,97.28,63.91,120.38,118.5,31.05,,0,
Master Protein,High,Q3SZ57,AFP,Alpha-fetoprotein OS=Bos taurus GN=AFP PE=2 SV=1,29,330,1.929,0.962,1.881,0.908,0.95,-0.06,0.91,-0.14,5.26E-01,6.27E-01,5.00E-01,9.92E-01,9.52E+06,5.90E+06,5.30E+07,1.64E+07,5,5,5,5,9.52E+06,5.96E+05,6.63E+04,8.11E+07,6.54E+07,1.76E+07,2.89E+05,5.90E+06,3.04E+06,2.87E+07,4.17E+06,6.04E+07,2.89E+07,5.30E+07,6.70E+07,9.91E+06,4.56E+07,1.08E+07,1.06E+08,1.64E+07,3.78E+04,2.27E+03,6.48E+02,8.11E+07,3.37E+06,6.26E+04,5.14E+03,5.45E+04,8.57E+04,3.06E+05,2.49E+04,2.70E+06,2.35E+05,7.14E+06,1.66E+06,1.93E+04,1.28E+07,7.68E+04,2.48E+06,1.75E+05,0,TRUE,192.21,58,28,610,68.5,6.29,29,other metabolic processes;developmental processes;signal transduction,non-structural extracellular;other cell component,Pf00273,506011,bta:506011; Q3SZ57,ENSBTAG00000017131,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,,2,0,123.95,106.67,60.69,108.22,Peak Found,Peak Found,High,High,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,135.99,119.05,140.35,124.22,858.72,other molecular function,0,
Master Protein,High,P00978,AMBP,Protein AMBP OS=Bos taurus GN=AMBP PE=1 SV=2,6,54,1.69,0.56,1.08,0.755,0.76,-0.84,0.11,-0.41,5.18E-01,8.00E-01,9.92E-01,8.62E-01,6.14E+05,1.68E+05,3.15E+06,3.33E+06,4,5,5,5,5.90E+04,,3.57E+04,6.70E+06,6.39E+06,1.68E+05,1.00E+06,9.89E+04,6.08E+04,3.26E+07,2.74E+05,4.26E+06,2.24E+06,6.84E+06,3.15E+06,9.66E+05,3.33E+06,2.37E+06,7.11E+06,4.05E+06,2.34E+02,,3.49E+02,6.70E+06,3.29E+05,5.97E+02,1.78E+04,9.13E+02,1.71E+03,3.47E+05,1.64E+03,1.90E+05,1.82E+04,9.21E+05,7.83E+04,1.88E+03,9.35E+05,1.68E+04,1.66E+05,4.31E+04,0,TRUE,31.145,16,6,352,39.2,7.62,6,,non-structural extracellular;plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component,"Pf00014, Pf00061",280996,bta:280996; P00978; P35420; Q28020; Q3SZZ4,,,,0,0,113.88,212.75,72.63,64.33,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,129.61,85.79,136.86,102.17,217.32,enzyme regulator activity;other molecular function,0,
Master Protein,High,P00735,F2,Prothrombin OS=Bos taurus GN=F2 PE=1 SV=2,26,132,1.689,0.488,1.082,0.557,0.76,-1.03,0.11,-0.84,6.28E-01,6.07E-01,9.75E-01,6.58E-01,8.21E+06,1.18E+07,1.44E+07,1.38E+07,5,5,5,5,1.42E+06,8.21E+06,1.49E+06,5.26E+07,1.63E+07,1.18E+07,2.49E+07,2.81E+06,2.60E+06,1.31E+07,1.51E+07,1.44E+07,6.58E+06,1.80E+07,9.89E+06,2.01E+06,1.11E+07,1.67E+07,1.38E+07,3.87E+07,5.66E+03,3.12E+04,1.46E+04,5.26E+07,8.40E+05,4.19E+04,4.42E+05,2.59E+04,7.32E+04,1.40E+05,9.06E+04,6.45E+05,5.34E+04,2.43E+06,2.46E+05,3.91E+03,3.13E+06,1.19E+05,3.24E+05,4.13E+05,0,TRUE,149.972,48,26,625,70.5,6.33,26,cell organization and biogenesis;protein metabolism;stress response;other biological processes,non-structural extracellular;extracellular matrix,"Pf00051, Pf00089, Pf00594, Pf09396",280685,bta:280685; P00735; Q3MHK7,,,,0,0,133.43,82.95,35.5,82.51,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,134.87,128.98,121.12,112.41,406.64,other molecular function,0,
Master Protein,High,Q3MHN5,GC,Vitamin D-binding protein OS=Bos taurus GN=GC PE=2 SV=1,24,237,1.495,1.161,1.371,1.308,0.58,0.22,0.45,0.39,7.29E-01,4.45E-01,7.86E-01,7.53E-01,5.02E+06,6.63E+05,4.28E+07,5.77E+06,5,5,5,5,5.02E+06,1.80E+06,1.83E+06,5.02E+07,4.03E+07,2.97E+06,5.58E+05,6.63E+05,1.21E+05,6.61E+07,2.36E+06,4.28E+07,4.55E+07,5.03E+07,3.93E+07,5.77E+06,2.78E+07,5.14E+06,7.96E+07,1.32E+06,2.00E+04,6.83E+03,1.79E+04,5.02E+07,2.08E+06,1.06E+04,9.92E+03,6.12E+03,3.40E+03,7.03E+05,1.41E+04,1.91E+06,3.70E+05,6.78E+06,9.76E+05,1.13E+04,7.80E+06,3.64E+04,1.86E+06,1.41E+04,0,TRUE,161.036,57,2,474,53.3,5.52,24,transport,non-structural extracellular;other cell component,"Pf00273, Pf09164",530076,bta:530076; Q3MHN5,,,,0,21,118.52,206.64,53.43,137.24,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,132.83,113.83,141.63,109.93,853.26,transporter activity;cytoskeletal activity;other molecular function,0,
Master Protein,High,Q29443,TF,Serotransferrin OS=Bos taurus GN=TF PE=2 SV=1,57,1017,1.456,0.811,1.882,0.73,0.54,-0.3,0.91,-0.45,7.51E-01,8.14E-01,4.99E-01,8.40E-01,8.10E+07,3.12E+08,1.36E+08,1.79E+08,5,5,5,5,4.21E+07,8.10E+07,9.58E+06,2.96E+08,1.07E+09,2.32E+08,5.84E+08,3.12E+08,2.52E+07,1.13E+09,6.13E+06,2.44E+08,1.36E+08,2.26E+08,1.31E+08,1.79E+08,1.80E+08,8.03E+07,3.13E+08,1.12E+08,1.67E+05,3.08E+05,9.36E+04,2.96E+08,5.52E+07,8.24E+05,1.04E+07,2.88E+06,7.11E+05,1.20E+07,3.67E+04,1.09E+07,1.11E+06,3.04E+07,3.26E+06,3.48E+05,5.06E+07,5.69E+05,7.33E+06,1.19E+06,0,TRUE,420.62,82,52,704,77.7,7.08,57,stress response;transport;other biological processes,non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle,Pf00405,280705,bta:280705; Q0IIK2; Q29443,,,,0,5,148.44,93.19,63.58,51.75,High,Peak Found,High,High,High,Peak Found,High,Peak Found,High,High,Peak Found,High,High,High,High,Peak Found,High,High,High,High,1,,FALSE,136.64,132.66,140.79,117.4,3051,other molecular function,0,
Master Protein,High,Q05B55,IGK,IGK protein OS=Bos taurus GN=IGK PE=2 SV=1,6,22,1.418,0.228,,0.604,0.5,-2.13,,-0.73,7.07E-01,9.63E-02,,8.15E-01,2.79E+06,4.83E+05,9.20E+05,8.97E+05,2,1,4,2,,,,8.95E+06,8.68E+05,,,,,4.83E+05,,8.44E+05,4.76E+05,2.87E+06,1.00E+06,,2.69E+05,,3.00E+06,,,,,8.95E+06,4.48E+04,,,,,5.14E+03,,3.77E+04,3.86E+03,3.87E+05,2.49E+04,,7.55E+04,,7.01E+04,,0,TRUE,52.255,24,6,240,26.6,6.54,6,,,"Pf07654, Pf07686",,Q05B55,,,,0,0,116.41,,82.5,118.14,n/a,n/a,n/a,High,High,n/a,n/a,n/a,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,Peak Found,n/a,1,,FALSE,0,95.74,,115.81,77.13,,0,
Master Protein,High,P15497,APOA1,Apolipoprotein A-I OS=Bos taurus GN=APOA1 PE=1 SV=3,28,297,1.416,1.632,3.011,1.109,0.5,0.71,1.59,0.15,7.75E-01,2.05E-01,2.02E-01,8.66E-01,2.25E+07,9.17E+06,7.02E+07,3.35E+07,5,5,5,5,9.06E+06,3.13E+07,2.29E+06,7.15E+07,2.25E+07,2.28E+07,2.53E+06,8.95E+06,9.17E+06,4.53E+07,1.54E+07,6.09E+07,2.57E+08,7.02E+07,1.04E+08,3.35E+07,1.17E+08,2.76E+07,3.41E+08,2.87E+07,3.60E+04,1.19E+05,2.24E+04,7.15E+07,1.16E+06,8.09E+04,4.50E+04,8.26E+04,2.58E+05,4.82E+05,9.18E+04,2.72E+06,2.09E+06,9.46E+06,2.60E+06,6.54E+04,3.30E+07,1.95E+05,7.98E+06,3.05E+05,0,TRUE,138.1,70,28,265,30.3,5.97,28,protein metabolism;other metabolic processes;transport;other biological processes,non-structural extracellular,Pf01442,281631,A5D7M9; bta:281631; P15497; Q3SZD9,ENSBTAG00000002258,Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Chylomicron assembly; Chylomicron remodeling; HDL remodeling; Retinoid metabolism and transport; HDL clearance; HDL assembly; Heme signaling; Scavenging by Class B Receptors,Statin pathway; Folate metabolism; Vitamin B12 metabolism; Selenium micronutrient network,15,0,99.38,96.25,91.08,122.95,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,135.05,131.01,139.97,130.06,821.21,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,Q2KJF1,A1BG,Alpha-1B-glycoprotein OS=Bos taurus GN=A1BG PE=1 SV=1,7,38,1.338,0.316,1.579,0.413,0.42,-1.66,0.66,-1.28,8.25E-01,2.47E-01,6.52E-01,4.79E-01,9.55E+06,3.36E+06,5.85E+06,1.35E+07,5,3,4,5,5.92E+06,1.57E+07,4.00E+06,9.55E+06,1.49E+07,9.02E+06,,3.36E+06,,2.95E+06,,8.30E+06,5.61E+06,5.24E+06,6.09E+06,3.72E+07,3.52E+06,1.54E+07,5.67E+06,1.35E+07,2.35E+04,5.96E+04,3.91E+04,9.55E+06,7.69E+05,3.21E+04,,3.10E+04,,3.13E+04,,3.71E+05,4.56E+04,7.05E+05,1.51E+05,7.24E+04,9.89E+05,1.09E+05,1.33E+05,1.44E+05,0,TRUE,22.37,20,7,503,53.5,5.43,7,,non-structural extracellular;plasma membrane;other membranes,Pf00047,518955,bta:518955; Q2KJF1,ENSBTAG00000009735,Neutrophil degranulation; Platelet degranulation,,2,0,52.18,66.38,21.73,88.66,Peak Found,Peak Found,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,High,n/a,High,High,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,103.67,109.82,111.43,102.97,93.68,,0,
Master Protein,High,P06868,PLG,Plasminogen OS=Bos taurus GN=PLG PE=1 SV=2,17,74,1.152,0.621,1.233,0.6,0.2,-0.69,0.3,-0.74,8.81E-01,8.74E-01,8.54E-01,7.07E-01,2.29E+06,3.72E+05,2.94E+06,2.66E+06,4,4,4,5,,7.94E+05,9.17E+04,8.56E+06,6.61E+06,1.36E+06,2.42E+05,5.38E+05,,2.57E+05,,3.29E+06,2.29E+06,6.08E+06,2.62E+06,4.14E+06,2.22E+06,2.66E+06,4.56E+06,1.30E+06,,3.02E+03,8.96E+02,8.56E+06,3.41E+05,4.82E+03,4.30E+03,4.97E+03,,2.74E+03,,1.47E+05,1.86E+04,8.19E+05,6.51E+04,8.08E+03,6.24E+05,1.88E+04,1.07E+05,1.38E+04,0,TRUE,75.202,30,13,812,91.2,7.5,17,protein metabolism;stress response;other biological processes,non-structural extracellular,"Pf00024, Pf00051, Pf00089",280897,bta:280897; P06868; Q28162,,,,0,0,104.87,87.42,48.31,45.59,n/a,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,40.03,93.9,96.11,87.05,212.4,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,ENSEMBL:ENSBTAP00000024146,,(Bos taurus) similar to alpha-2-macroglobulin isoform 1 [OS=Bos taurus],52,417,1.05,0.97,1.246,0.816,0.07,-0.04,0.32,-0.29,9.59E-01,6.18E-01,8.82E-01,9.17E-01,4.96E+07,5.82E+06,6.45E+07,5.11E+07,5,5,5,5,1.71E+07,5.02E+07,5.18E+06,4.96E+07,1.77E+08,2.56E+07,3.24E+06,5.58E+06,5.82E+06,2.78E+08,7.05E+06,4.16E+07,6.45E+07,9.99E+07,8.91E+07,2.35E+07,5.11E+07,1.67E+07,1.18E+08,5.40E+07,6.79E+04,1.91E+05,5.06E+04,4.96E+07,9.12E+06,9.10E+04,5.77E+04,5.14E+04,1.64E+05,2.96E+06,4.22E+04,1.86E+06,5.24E+05,1.35E+07,2.22E+06,4.59E+04,1.44E+07,1.19E+05,2.76E+06,5.75E+05,0,TRUE,274.784,49,48,1477,164.2,6.02,52,,,,,,,,,0,4,114.34,188.81,61.94,76.03,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,138.93,116.32,139.89,93.95,1228.04,,0,
Master Protein,High,Q3T052,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus GN=ITIH4 PE=1 SV=1,17,107,1.033,1.601,1.159,1.345,0.05,0.68,0.21,0.43,9.45E-01,2.15E-01,9.55E-01,7.34E-01,2.43E+06,2.60E+06,1.61E+07,6.39E+06,5,5,5,5,8.46E+05,2.43E+06,3.31E+05,1.11E+07,8.35E+06,2.01E+06,1.47E+06,3.91E+06,2.60E+06,3.64E+07,1.27E+06,1.96E+07,1.61E+07,1.76E+07,1.51E+07,6.39E+06,8.17E+06,2.63E+06,1.16E+07,3.89E+06,3.36E+03,9.25E+03,3.24E+03,1.11E+07,4.31E+05,7.13E+03,2.62E+04,3.60E+04,7.32E+04,3.87E+05,7.58E+03,8.75E+05,1.31E+05,2.37E+06,3.75E+05,1.25E+04,2.30E+06,1.86E+04,2.71E+05,4.14E+04,0,TRUE,75.035,25,17,916,101.4,6.68,17,other metabolic processes;stress response,non-structural extracellular,"Pf00092, Pf06668, Pf08487",513700,bta:513700; Q3T052,,,,0,0,104.65,163.69,52.26,54.27,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,117.11,112.78,120.14,107.15,280.65,enzyme regulator activity,0,
Master Protein,High,Q3SX14,GSN,Gelsolin OS=Bos taurus GN=GSN PE=2 SV=1,14,56,1.022,1.149,1.418,1.318,0.03,0.2,0.5,0.4,9.35E-01,4.53E-01,7.54E-01,7.48E-01,4.85E+06,2.73E+06,7.59E+06,4.00E+06,5,5,5,5,1.82E+06,4.85E+06,2.88E+05,1.39E+07,4.88E+06,5.69E+06,2.11E+06,2.73E+06,5.20E+06,2.64E+06,5.53E+06,7.59E+06,9.58E+06,9.33E+06,6.58E+06,3.68E+06,4.00E+06,1.52E+07,5.10E+06,2.76E+06,7.24E+03,1.84E+04,2.81E+03,1.39E+07,2.52E+05,2.02E+04,3.76E+04,2.52E+04,1.46E+05,2.80E+04,3.31E+04,3.39E+05,7.78E+04,1.26E+06,1.63E+05,7.17E+03,1.12E+06,1.08E+05,1.19E+05,2.94E+04,0,TRUE,62.191,28,7,731,80.7,5.78,14,cell organization and biogenesis;developmental processes;other biological processes,non-structural extracellular;cytoskeleton;other cell component,Pf00626,535077,bta:535077; Q3SX14,,,,0,7,102.44,44.73,22.56,83.48,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,Peak Found,High,n/a,High,n/a,1,,FALSE,112,99.79,122.07,115.95,156.31,cytoskeletal activity;other molecular function,0,
Master Protein,High,Q28085,CFH,Complement factor H OS=Bos taurus GN=CFH PE=1 SV=3,15,43,0.984,0.42,0.661,0.996,-0.02,-1.25,-0.6,-0.01,9.01E-01,4.72E-01,5.33E-01,8.84E-01,2.71E+06,2.34E+06,1.54E+06,8.88E+05,5,4,5,5,3.91E+05,2.71E+06,1.43E+05,6.68E+06,4.50E+06,2.60E+06,2.11E+06,,6.19E+06,1.90E+06,9.95E+05,1.80E+06,6.78E+05,3.56E+06,1.54E+06,2.29E+06,5.67E+05,8.88E+05,2.23E+06,1.73E+05,1.55E+03,1.03E+04,1.40E+03,6.68E+06,2.32E+05,9.24E+03,3.76E+04,,1.74E+05,2.02E+04,5.95E+03,8.03E+04,5.51E+03,4.79E+05,3.83E+04,4.46E+03,1.59E+05,6.29E+03,5.23E+04,1.84E+03,0,TRUE,94.484,21,15,1236,140.3,6.81,15,stress response;other biological processes,non-structural extracellular,Pf00084,280816,bta:280816; Q28085; Q3MHF3; Q9TQZ7,,,,0,0,96.16,62.92,65.41,79.28,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,91,73.91,106.61,84.06,138.45,other molecular function,0,
Master Protein,High,Q3SZR3,ORM1,Alpha-1-acid glycoprotein OS=Bos taurus GN=ORM1 PE=2 SV=1,9,97,0.906,0.827,1.908,0.523,-0.14,-0.27,0.93,-0.93,8.29E-01,7.92E-01,4.88E-01,6.18E-01,2.27E+07,2.28E+08,1.51E+07,4.14E+07,5,5,5,5,8.66E+05,3.40E+08,2.34E+06,2.27E+07,6.08E+08,2.36E+07,2.28E+08,4.66E+08,4.80E+07,8.62E+08,1.05E+06,8.32E+06,1.51E+07,2.46E+07,2.11E+07,3.43E+06,8.74E+06,4.14E+07,5.10E+07,1.51E+09,3.44E+03,1.29E+06,2.28E+04,2.27E+07,3.13E+07,8.40E+04,4.06E+06,4.30E+06,1.35E+06,9.17E+06,6.29E+03,3.72E+05,1.23E+05,3.31E+06,5.24E+05,6.69E+03,2.46E+06,2.93E+05,1.19E+06,1.61E+07,0,TRUE,38.08,39,9,202,23.2,5.87,9,stress response;other biological processes,non-structural extracellular,Pf00061,497200,bta:497200; Q3SZR3,,,,0,0,139.67,106.98,67.87,205.58,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,High,High,Peak Found,1,,FALSE,142.28,125.78,147.21,120.7,226.03,,0,
Master Protein,High,Q95121,SERPINF1,Pigment epithelium-derived factor OS=Bos taurus GN=SERPINF1 PE=1 SV=1,10,59,0.905,0.992,1.004,0.657,-0.14,-0.01,0.01,-0.61,8.27E-01,5.95E-01,9.00E-01,7.67E-01,2.80E+06,2.00E+06,6.28E+06,2.19E+07,5,5,5,5,1.40E+06,4.89E+06,3.62E+05,1.06E+07,2.80E+06,6.55E+05,5.26E+06,2.55E+06,2.16E+05,2.00E+06,3.49E+05,8.97E+06,2.27E+07,6.28E+06,3.71E+06,3.68E+06,1.57E+06,5.51E+07,2.19E+07,6.42E+07,5.57E+03,1.86E+04,3.53E+03,1.06E+07,1.44E+05,2.33E+03,9.34E+04,2.36E+04,6.09E+03,2.13E+04,2.09E+03,4.01E+05,1.84E+05,8.46E+05,9.21E+04,7.18E+03,4.41E+05,3.90E+05,5.12E+05,6.83E+05,0,TRUE,45.584,34,10,416,46.2,7.05,10,other biological processes,non-structural extracellular;other cell component,Pf00079,281386,bta:281386; Q2KIF6; Q95121,ENSBTAG00000009705,,,0,0,100.88,93.05,102.38,99.01,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,94.49,123.71,85.89,132.85,172.95,enzyme regulator activity,0,
Master Protein,High,Q3Y5Z3,ADIPOQ,Adiponectin OS=Bos taurus GN=ADIPOQ PE=1 SV=1,2,8,0.886,5.214,1.226,2.4,-0.17,2.38,0.29,1.26,9.44E-01,9.42E-03,9.29E-01,3.15E-01,2.03E+05,7.93E+04,6.79E+05,9.72E+04,4,3,4,4,5.66E+04,1.67E+05,,2.47E+05,4.06E+05,7.93E+04,1.56E+04,,,4.87E+06,,3.30E+04,5.44E+05,1.21E+06,8.48E+05,,4.38E+04,1.26E+05,1.00E+06,7.53E+04,2.25E+02,6.35E+02,,2.47E+05,2.10E+04,2.82E+02,2.78E+02,,,5.17E+04,,1.47E+03,4.42E+03,1.63E+05,2.11E+04,,1.23E+04,8.89E+02,2.35E+04,8.02E+02,0,TRUE,10.231,11,2,240,26.1,5.74,2,other metabolic processes;stress response;signal transduction;other biological processes,non-structural extracellular;ER/Golgi;other cell component,"Pf00386, Pf01391",282865,A5D7A8; Q3Y5Z3; Q95MQ4,,,,0,0,67.12,168.24,75.6,148.15,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,n/a,n/a,High,n/a,Peak Found,Peak Found,High,High,n/a,Peak Found,Peak Found,High,Peak Found,1,,FALSE,118.33,134.59,146.78,139.01,18.88,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P02662,CSN1S1,Alpha-S1-casein OS=Bos taurus GN=CSN1S1 PE=1 SV=2,2,4,0.857,0.34,0.01,100,-0.22,-1.56,-6.64,6.64,7.79E-01,2.94E-01,1.00E-17,1.00E-17,4.17E+06,2.98E+06,1.42E+06,,3,2,1,,6.42E+06,4.19E+05,4.17E+06,,,6.04E+06,,1.47E+06,,,1.42E+06,,,,,,,,,,2.55E+04,1.59E+03,4.07E+04,,,2.15E+04,,1.36E+04,,,8.47E+03,,,,,,,,,,0,TRUE,7.147,14,2,214,24.5,5.02,2,other biological processes,non-structural extracellular;ER/Golgi,Pf00363,282208,A5YK80; A8WCP1; A8WCP2; A8WCP3; A8WCP4; A8WCP5; A8WCP6; A8WCP7; A8WCP8; A8WCP9; A8WCQ0; A8WCQ1; A8WCQ2; A8WCQ3; A8WCQ4; A8WCQ5; A8WCQ6; A8WCQ7; A8WCQ8; A8WCQ9; A8WCR0; A8WCR1; A8WCR2; A8WCR3; A8WCR4; A8WCR5; A8WCR6; A8WCR7; A8WCR8; A8WCR9; A8WCS0; A8WCS1; bta:282208; P02662; Q28048; Q28069; Q32LE8; Q7M2U6; Q9TRH5,ENSBTAG00000007695,Miscellaneous transport and binding events,,1,0,82.61,86.07,,,High,Peak Found,High,n/a,n/a,Peak Found,n/a,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,,FALSE,111.34,80,,,11.08,other molecular function,0,
Master Protein,High,ENSEMBL:ENSBTAP00000016046,FBLN1,(Bos taurus) similar to fibulin-1 C isoform 1 [OS=Bos taurus],9,14,0.856,0.356,0.389,0.662,-0.22,-1.49,-1.36,-0.6,7.79E-01,3.27E-01,1.82E-01,8.07E-01,6.46E+06,5.30E+06,3.10E+06,7.66E+05,5,5,5,3,7.02E+06,6.37E+06,7.81E+06,6.46E+06,3.15E+06,5.88E+05,5.30E+06,1.76E+07,9.51E+05,9.87E+06,4.28E+06,3.89E+06,2.37E+06,3.10E+06,2.12E+06,,2.44E+05,,7.66E+05,5.00E+06,2.79E+04,2.42E+04,7.63E+04,6.46E+06,1.63E+05,2.09E+03,9.42E+04,1.63E+05,2.68E+04,1.05E+05,2.56E+04,1.74E+05,1.93E+04,4.18E+05,5.27E+04,,6.84E+04,,1.79E+04,5.33E+04,0,TRUE,52.837,23,9,706,77.4,5.06,9,cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular;extracellular matrix,"Pf01821, Pf07645, Pf12662",,A0A4W2C0I9,ENSBIXG00000011470; ENSBIXG00005008557,,,0,0,28.83,103.43,29.59,130.22,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,n/a,Peak Found,Peak Found,1,,FALSE,105.91,84.47,118.89,76.29,47.58,signal transduction activity or receptor binding;enzyme regulator activity;extracellular structural activity;other molecular function,0,
Master Protein,High,Q03247,APOE,Apolipoprotein E OS=Bos taurus GN=APOE PE=2 SV=1,7,34,0.823,0.687,1.207,0.574,-0.28,-0.54,0.27,-0.8,7.47E-01,9.92E-01,8.88E-01,6.70E-01,2.92E+06,1.58E+06,1.99E+06,2.25E+06,5,5,5,5,2.46E+05,3.25E+06,6.91E+04,2.92E+06,3.27E+06,8.47E+05,2.30E+05,1.58E+06,2.00E+06,4.95E+06,2.91E+05,1.99E+06,3.37E+06,2.15E+06,1.56E+06,6.58E+06,1.99E+06,4.87E+06,1.66E+06,2.25E+06,9.78E+02,1.24E+04,6.75E+02,2.92E+06,1.68E+05,3.01E+03,4.10E+03,1.45E+04,5.63E+04,5.26E+04,1.74E+03,8.87E+04,2.74E+04,2.90E+05,3.87E+04,1.28E+04,5.58E+05,3.45E+04,3.88E+04,2.39E+04,0,TRUE,45.559,28,5,316,36,5.67,7,cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes,non-structural extracellular;extracellular matrix;other cytoplasmic organelle,Pf01442,281004,bta:281004; Q03247; Q3T006; Q5E967,,,,0,1,84.28,94.98,59.39,62.19,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,127.96,100.54,136.46,131.66,97.29,signal transduction activity or receptor binding;other molecular function,0,
Master Protein,High,P17690,APOH,Beta-2-glycoprotein 1 OS=Bos taurus GN=APOH PE=1 SV=4,16,129,0.801,0.305,0.682,0.614,-0.32,-1.71,-0.55,-0.7,7.22E-01,2.26E-01,5.36E-01,7.22E-01,3.07E+06,3.95E+06,8.96E+06,8.80E+06,5,5,5,5,3.50E+05,3.07E+06,3.38E+05,5.37E+07,1.47E+07,2.06E+06,8.43E+05,3.95E+06,8.30E+06,1.32E+07,6.96E+05,1.85E+07,4.44E+06,1.55E+07,8.96E+06,1.72E+06,1.00E+07,2.09E+06,8.80E+06,9.77E+06,1.39E+03,1.17E+04,3.30E+03,5.37E+07,7.60E+05,7.33E+03,1.50E+04,3.64E+04,2.34E+05,1.40E+05,4.16E+03,8.28E+05,3.61E+04,2.09E+06,2.23E+05,3.36E+03,2.82E+06,1.48E+04,2.06E+05,1.04E+05,0,TRUE,115.946,61,14,345,38.2,8.15,16,,non-structural extracellular,"Pf00084, Pf09014",281006,bta:281006; P17690; Q148G1; Q28052,,,,0,2,157.51,89.36,77.21,64.88,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,138.26,134.11,137.9,124.32,435.87,other molecular function,0,
Master Protein,High,P02070,HBB,Hemoglobin subunit beta OS=Bos taurus GN=HBB PE=1 SV=1,5,117,0.788,1.479,1.984,1.606,-0.34,0.56,0.99,0.68,7.09E-01,2.62E-01,4.58E-01,6.19E-01,9.11E+06,1.61E+06,1.91E+07,8.00E+06,5,5,4,5,9.11E+06,1.95E+06,2.05E+06,1.46E+07,1.76E+07,2.96E+06,9.48E+05,1.61E+06,7.76E+05,4.80E+06,,2.08E+07,2.49E+07,8.09E+06,1.76E+07,2.54E+06,8.65E+06,4.20E+06,1.48E+07,8.00E+06,3.62E+04,7.41E+03,2.01E+04,1.46E+07,9.09E+05,1.05E+04,1.69E+04,1.49E+04,2.19E+04,5.10E+04,,9.28E+05,2.03E+05,1.09E+06,4.37E+05,4.95E+03,2.43E+06,2.97E+04,3.47E+05,8.51E+04,0,TRUE,30.185,32,4,145,15.9,7.59,5,other metabolic processes;transport;other biological processes,cytosol;other cell component,Pf00042,280813,bta:280813; P02070,ENSBTAG00000037644,Cytoprotection by HMOX1; Neutrophil degranulation; Scavenging of heme from plasma; Erythrocytes take up carbon dioxide and release oxygen; Heme signaling; Erythrocytes take up oxygen and release carbon dioxide,Folate metabolism; Vitamin B12 metabolism; Selenium micronutrient network,9,0,78.69,75.6,40.17,62.29,High,Peak Found,High,High,High,Peak Found,Peak Found,Peak Found,High,High,n/a,High,High,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,132.08,122.12,107.03,127.73,330.22,other molecular function,0,
Master Protein,High,Q58D62,FETUB,Fetuin-B OS=Bos taurus GN=FETUB PE=2 SV=1,11,83,0.774,1.339,1.713,1.003,-0.37,0.42,0.78,0,6.94E-01,3.29E-01,5.79E-01,9.37E-01,2.57E+06,3.22E+06,2.24E+07,1.66E+07,5,5,5,5,2.23E+06,2.56E+06,2.57E+06,3.90E+07,9.92E+06,1.76E+06,5.28E+06,3.22E+06,5.41E+05,3.39E+06,1.37E+06,2.90E+07,1.62E+07,2.24E+07,3.42E+07,3.31E+06,2.00E+07,1.66E+07,3.09E+07,1.25E+07,8.86E+03,9.71E+03,2.51E+04,3.90E+07,5.11E+05,6.27E+03,9.39E+04,2.97E+04,1.52E+04,3.61E+04,8.20E+03,1.29E+06,1.32E+05,3.01E+06,8.49E+05,6.46E+03,5.63E+06,1.17E+05,7.23E+05,1.33E+05,0,TRUE,53.213,32,11,387,42.6,5.77,11,other biological processes,non-structural extracellular,Pf00031,504615,bta:504615; Q58D62,ENSBTAG00000017531,,,0,0,140.76,63.15,61.65,60.81,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,124.74,117,131.09,116.19,199.86,enzyme regulator activity,0,
Master Protein,High,REFSEQ:XP_001252647,,(Bos taurus) similar to endopin 2B [OS=Bos taurus],7,58,0.769,1.614,1.002,1.122,-0.38,0.69,0,0.17,8.60E-01,2.11E-01,8.98E-01,8.58E-01,9.04E+05,6.35E+05,1.04E+07,5.82E+06,5,4,5,4,4.36E+05,1.83E+06,4.87E+05,4.32E+06,9.04E+05,7.28E+05,,5.53E+05,2.80E+05,1.16E+06,2.85E+05,2.57E+06,1.04E+07,1.10E+07,1.62E+07,,1.12E+07,1.78E+06,1.27E+07,3.01E+06,1.73E+03,6.97E+03,4.76E+03,4.32E+06,4.66E+04,2.59E+03,,5.10E+03,7.89E+03,1.23E+04,1.70E+03,1.15E+05,8.49E+04,1.48E+06,4.02E+05,,3.16E+06,1.26E+04,2.98E+05,3.21E+04,0,TRUE,25.501,20,5,417,46.9,5.66,7,,,,,,,,,0,1,101.67,54.26,80.74,77.8,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,n/a,High,High,High,High,n/a,High,Peak Found,High,Peak Found,1,,FALSE,42.36,103.97,65.92,79.37,165.03,,0,
Master Protein,High,P02672,FGA,Fibrinogen alpha chain OS=Bos taurus GN=FGA PE=1 SV=5,8,142,0.738,0.643,0.894,0.358,-0.44,-0.64,-0.16,-1.48,6.54E-01,9.98E-01,7.84E-01,4.09E-01,1.30E+06,3.25E+06,9.49E+05,3.92E+06,4,4,4,4,2.73E+06,1.52E+06,,3.60E+05,1.11E+06,,2.65E+06,1.61E+07,3.99E+06,1.83E+06,,2.34E+05,1.10E+06,8.20E+05,1.82E+06,,7.98E+05,7.10E+06,2.17E+06,8.09E+06,1.09E+04,5.79E+03,,3.60E+05,5.74E+04,,4.71E+04,1.48E+05,1.12E+05,1.94E+04,,1.05E+04,8.92E+03,1.10E+05,4.52E+04,,2.24E+05,5.03E+04,5.07E+04,8.62E+04,0,TRUE,32.21,15,6,615,67,7.17,8,cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes,non-structural extracellular,"Pf08702, Pf12160",522039,bta:522039; O97642; P02672; Q3T049,,,,0,0,69.27,108.99,66.29,79.25,Peak Found,Peak Found,n/a,High,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,n/a,High,Peak Found,High,High,n/a,High,Peak Found,High,Peak Found,1,,FALSE,101.63,73.21,121.8,116,366.55,signal transduction activity or receptor binding,0,
Master Protein,High,ENSEMBL:ENSBTAP00000038329,,(Bos taurus) 9 kDa protein [OS=Bos taurus],2,22,0.725,0.944,4.498,0.172,-0.46,-0.08,2.17,-2.54,7.31E-01,6.47E-01,7.40E-02,1.38E-01,1.55E+06,1.03E+06,3.44E+06,1.04E+07,4,3,5,5,6.98E+05,,2.04E+05,3.46E+06,2.97E+07,1.03E+06,,9.00E+05,,7.99E+06,7.32E+04,6.24E+05,3.55E+06,3.52E+06,3.44E+06,4.64E+06,1.96E+06,2.00E+07,1.04E+07,3.42E+07,2.77E+03,,1.99E+03,3.46E+06,1.53E+06,3.67E+03,,8.30E+03,,8.50E+04,4.38E+02,2.79E+04,2.89E+04,4.74E+05,8.55E+04,9.04E+03,5.50E+05,1.42E+05,2.44E+05,3.64E+05,0,TRUE,10.063,28,1,80,8.6,5.71,2,,,,,,,,,0,0,166.71,122.67,77.6,92.14,Peak Found,n/a,Peak Found,High,High,Peak Found,n/a,Peak Found,n/a,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,High,1,,FALSE,132.4,140.18,129.13,114.56,66.18,,0,
Master Protein,High,ENSEMBL:ENSBTAP00000007350,,(Bos taurus) similar to Complement C4-A precursor [OS=Bos taurus],35,129,0.659,0.611,0.762,0.628,-0.6,-0.71,-0.39,-0.67,5.66E-01,8.54E-01,6.32E-01,7.37E-01,1.03E+07,9.32E+06,1.08E+07,1.18E+07,5,5,5,5,1.03E+07,7.46E+06,6.79E+06,1.75E+07,5.60E+07,1.51E+07,5.93E+06,9.32E+06,8.21E+05,5.02E+07,1.01E+07,4.93E+06,1.11E+07,1.08E+07,1.36E+07,1.18E+07,8.22E+06,4.89E+06,2.49E+07,2.16E+07,4.09E+04,2.83E+04,6.64E+04,1.75E+07,2.89E+06,5.37E+04,1.05E+05,8.60E+04,2.31E+04,5.34E+05,6.06E+04,2.20E+05,9.06E+04,1.46E+06,3.38E+05,2.30E+04,2.31E+06,3.46E+04,5.82E+05,2.30E+05,0,TRUE,161.199,29,21,1742,192.9,7.44,35,,,,,,,,,0,14,106.05,120.8,31.42,60.36,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,126.35,121.7,112.05,125.49,396.16,,0,
Master Protein,High,Q3KUS7,BF,Complement factor B (Fragment) OS=Bos taurus GN=BF PE=4 SV=1,1,4,0.626,0.435,1.201,0.227,-0.67,-1.2,0.26,-2.14,7.12E-01,5.64E-01,9.33E-01,2.45E-01,4.31E+05,6.89E+05,1.74E+05,8.27E+05,2,2,4,2,,5.20E+05,,,3.58E+05,,,3.86E+05,,1.23E+06,,1.51E+05,1.86E+05,1.62E+05,2.32E+05,,2.36E+05,,,2.90E+06,,1.97E+03,,,1.85E+04,,,3.56E+03,,1.31E+04,,6.76E+03,1.51E+03,2.19E+04,5.78E+03,,6.63E+04,,,3.09E+04,0,TRUE,4.54,17,1,77,9.1,8.76,1,other biological processes,non-structural extracellular,Pf00084,,Q3KUS7,,,,0,0,26.04,73.88,19.7,120.16,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,Peak Found,n/a,High,Peak Found,High,Peak Found,n/a,High,n/a,n/a,Peak Found,1,,FALSE,75.4,28.05,133.79,192.66,9.02,other molecular function,0,
Master Protein,High,P07224,PROS1,Vitamin K-dependent protein S OS=Bos taurus GN=PROS1 PE=1 SV=1,11,34,0.587,0.684,0.643,1.746,-0.77,-0.55,-0.64,0.8,4.93E-01,9.84E-01,4.88E-01,5.46E-01,1.33E+06,3.02E+06,2.79E+06,1.80E+06,4,5,5,5,3.39E+05,7.15E+05,,1.05E+07,2.48E+06,9.33E+05,1.26E+07,1.04E+06,3.02E+06,5.49E+06,1.92E+06,1.05E+07,2.79E+06,4.24E+06,2.56E+06,7.23E+06,1.11E+06,1.79E+06,1.80E+06,4.06E+06,1.35E+03,2.72E+03,,1.05E+07,1.28E+05,3.32E+03,2.24E+05,9.60E+03,8.52E+04,5.84E+04,1.15E+04,4.70E+05,2.26E+04,5.72E+05,6.36E+04,1.41E+04,3.11E+05,1.27E+04,4.21E+04,4.32E+04,0,TRUE,53.948,20,10,675,75.1,5.41,11,stress response;other biological processes,non-structural extracellular,"Pf00008, Pf00054, Pf00594, Pf02210, Pf07645, Pf12662",282006,bta:282006; P07224,ENSBTAG00000023652,Platelet degranulation ; Intrinsic Pathway of Fibrin Clot Formation; Cell surface interactions at the vascular wall; Common Pathway of Fibrin Clot Formation; Gamma-carboxylation of protein precursors; Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus; Removal of aminoterminal propeptides from gamma-carboxylated proteins,Complement and coagulation cascades,8,1,135.58,104.72,79.9,78.7,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,104.67,116.91,107.62,103.43,106.11,other molecular function,0,
Master Protein,High,P15241,,"Keratin, type II microfibrillar, component 7C OS=Ovis aries PE=1 SV=1",4,19,0.542,0.484,0.863,0.145,-0.88,-1.05,-0.21,-2.78,6.06E-01,6.50E-01,8.28E-01,1.42E-01,3.04E+05,1.19E+06,4.09E+05,1.32E+06,5,4,5,5,7.30E+04,1.59E+06,3.04E+05,5.45E+04,4.34E+06,1.86E+06,,9.01E+05,1.35E+05,1.56E+06,4.19E+04,2.93E+04,4.86E+05,4.09E+05,7.18E+05,7.70E+07,3.15E+05,2.27E+06,3.46E+05,1.32E+06,2.90E+02,6.06E+03,2.97E+03,5.45E+04,2.24E+05,6.60E+03,,8.31E+03,3.79E+03,1.66E+04,2.51E+02,1.31E+03,3.95E+03,5.51E+04,1.79E+04,1.50E+05,8.84E+04,1.61E+04,8.10E+03,1.40E+04,0,TRUE,10.522,9,3,491,53.6,5.57,4,,cytoskeleton,"Pf00038, Pf16208",,,,,,0,0,143.64,68.72,88.36,209.06,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,126.32,95,144.53,138.26,26.32,,0,
Master Protein,High,Q28065,C4BPA,C4b-binding protein alpha chain OS=Bos taurus GN=C4BPA PE=2 SV=1,11,19,0.519,0.277,0.819,1.109,-0.95,-1.85,-0.29,0.15,3.99E-01,1.87E-01,7.05E-01,7.68E-01,2.58E+06,3.42E+06,4.30E+05,8.14E+05,3,2,4,5,,,6.22E+05,3.14E+06,2.58E+06,1.32E+06,,,,8.86E+06,,3.61E+05,1.16E+05,9.54E+05,5.13E+05,8.14E+05,2.39E+04,2.02E+06,8.76E+04,2.60E+06,,,6.07E+03,3.14E+06,1.33E+05,4.68E+03,,,,9.43E+04,,1.61E+04,9.41E+02,1.29E+05,1.27E+04,1.59E+03,6.71E+03,1.43E+04,2.05E+03,2.77E+04,0,TRUE,39.321,25,11,610,68.8,6.38,11,stress response;other biological processes,non-structural extracellular;plasma membrane;other membranes,"Pf00084, Pf18453",281651,bta:281651; Q28065; Q2KJ87,ENSBTAG00000009876,,,0,0,62.53,104.82,72.5,104.4,n/a,n/a,Peak Found,High,High,Peak Found,n/a,n/a,n/a,High,n/a,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,128.98,89.05,117.29,89.05,51.78,,0,
Master Protein,High,ENSEMBL:ENSBTAP00000032840,,"(Bos taurus) similar to apolipoprotein B, partial [OS=Bos taurus]",4,8,0.487,2.077,1.473,0.968,-1.04,1.05,0.56,-0.05,5.42E-01,1.70E-01,7.99E-01,8.86E-01,1.68E+05,3.46E+05,3.52E+05,5.02E+05,3,3,5,3,,1.68E+05,,2.28E+05,1.00E+05,,,5.03E+05,2.05E+05,3.46E+05,5.50E+05,8.40E+04,3.47E+05,3.52E+05,3.61E+06,7.52E+05,2.71E+05,,5.02E+05,,,6.40E+02,,2.28E+05,5.16E+03,,,4.64E+03,5.78E+03,3.68E+03,3.29E+03,3.75E+03,2.82E+03,4.75E+04,8.96E+04,1.47E+03,7.62E+04,,1.17E+04,,0,TRUE,12.034,7,3,825,92.2,7.03,4,,,,,,,,,0,0,38.67,42.4,149.09,47.3,n/a,Peak Found,n/a,High,Peak Found,n/a,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,n/a,Peak Found,n/a,1,,FALSE,38.69,101.38,35.8,74.65,23.63,,0,
Master Protein,High,ENSEMBL:ENSBTAP00000031900,,(Bos taurus) 121 kDa protein [OS=Bos taurus],14,61,0.433,0.145,0.099,0.714,-1.21,-2.78,-3.34,-0.49,2.95E-01,1.95E-02,2.02E-03,9.00E-01,3.74E+06,5.21E+06,5.68E+05,3.14E+05,5,5,3,5,4.34E+06,1.57E+05,3.74E+06,6.10E+05,2.58E+07,1.44E+05,5.21E+06,4.62E+06,5.22E+06,6.60E+07,3.14E+04,,1.10E+06,5.68E+05,,2.15E+05,3.14E+05,1.44E+06,1.74E+05,7.35E+05,1.73E+04,5.98E+02,3.66E+04,6.10E+05,1.33E+06,5.13E+02,9.26E+04,4.26E+04,1.47E+05,7.02E+05,1.88E+02,,8.97E+03,7.66E+04,,4.20E+02,8.82E+04,1.02E+04,4.06E+03,7.83E+03,0,TRUE,63.722,18,12,1064,121.4,6.09,14,,,,,,,,,0,2,154.43,171.81,94.46,92.49,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,n/a,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,138.41,127.88,140.26,127.42,174.28,,0,
Master Protein,High,P28800,SERPINF2,Alpha-2-antiplasmin OS=Bos taurus GN=SERPINF2 PE=1 SV=2,7,28,0.306,0.867,3.881,0.299,-1.71,-0.21,1.96,-1.74,1.50E-01,7.39E-01,1.10E-01,3.21E-01,3.63E+06,5.36E+06,3.74E+06,1.41E+07,5,5,5,5,2.18E+06,4.92E+06,2.67E+05,3.63E+06,5.18E+06,1.47E+07,5.36E+06,5.68E+06,4.61E+05,3.24E+06,2.68E+05,3.81E+06,2.51E+06,4.91E+06,3.74E+06,3.89E+07,2.66E+06,1.41E+07,1.11E+07,6.88E+07,8.67E+03,1.87E+04,2.61E+03,3.63E+06,2.67E+05,5.24E+04,9.52E+04,5.24E+04,1.30E+04,3.44E+04,1.61E+03,1.70E+05,2.04E+04,6.61E+05,9.29E+04,7.58E+04,7.48E+05,1.00E+05,2.60E+05,7.32E+05,0,TRUE,37.455,14,7,492,54.7,5.72,7,stress response;other biological processes,non-structural extracellular,Pf00079,282522,bta:282522; P28800,ENSBTAG00000020859,Platelet degranulation ; Dissolution of Fibrin Clot,Complement and coagulation cascades; Blood clotting cascade,4,0,63.14,91.03,58.1,99.28,Peak Found,Peak Found,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,High,Peak Found,High,Peak Found,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,122.85,107.76,143.78,84.68,71.16,enzyme regulator activity,0,
Master Protein,High,P50448,,Factor XIIa inhibitor OS=Bos taurus PE=1 SV=1,2,10,0.297,2.657,0.879,1.404,-1.75,1.41,-0.19,0.49,1.93E-01,2.82E-02,8.44E-01,6.47E-01,1.20E+06,1.22E+06,2.30E+06,1.30E+06,2,1,4,2,,,,1.07E+06,1.35E+06,,,1.22E+06,,,,1.75E+06,2.47E+06,2.15E+06,4.93E+06,,5.08E+05,,3.35E+06,,,,,1.07E+06,6.94E+04,,,1.13E+04,,,,7.81E+04,2.01E+04,2.89E+05,1.23E+05,,1.43E+05,,7.83E+04,,0,TRUE,8.887,5,2,468,51.7,6.67,2,stress response;other biological processes,non-structural extracellular,Pf00079,,,,,,0,0,15.92,,50.83,104.16,n/a,n/a,n/a,High,Peak Found,n/a,n/a,Peak Found,n/a,n/a,n/a,Peak Found,High,High,High,n/a,High,n/a,High,n/a,1,,FALSE,9.8,75.35,121.4,69.06,32.5,enzyme regulator activity,0,
Master Protein,High,Q3SZV7,HPX,Hemopexin OS=Bos taurus GN=HPX PE=2 SV=1,9,72,0.268,0.618,0.516,0.682,-1.9,-0.69,-0.95,-0.55,1.12E-01,8.68E-01,3.30E-01,7.93E-01,3.44E+06,2.07E+06,7.91E+06,3.18E+06,5,3,5,5,3.44E+06,6.66E+05,3.72E+04,7.57E+06,1.01E+07,4.48E+05,2.07E+06,,,1.94E+07,9.13E+06,1.44E+06,4.35E+06,1.05E+07,7.91E+06,2.03E+06,8.65E+06,1.71E+06,1.79E+07,3.18E+06,1.37E+04,2.53E+03,3.63E+02,7.57E+06,5.21E+05,1.59E+03,3.68E+04,,,2.07E+05,5.46E+04,6.45E+04,3.53E+04,1.41E+06,1.97E+05,3.96E+03,2.43E+06,1.21E+04,4.19E+05,3.38E+04,0,TRUE,59.71,37,9,459,52.2,7.8,9,other metabolic processes;transport;other biological processes,non-structural extracellular,Pf00045,534509,bta:534509; Q3SZV7,,,,0,0,100.19,143.82,55.52,102.6,Peak Found,Peak Found,Peak Found,High,High,Peak Found,Peak Found,n/a,Peak Found,High,Peak Found,High,High,High,High,Peak Found,High,Peak Found,High,Peak Found,1,,FALSE,131.3,124.8,137.92,112.86,208.46,transporter activity;other molecular function,0,
Master Protein,High,P19013,,"Keratin, type II cytoskeletal 4 OS=Homo sapiens GN=KRT4 PE=1 SV=4",14,270,0.238,0.899,11.104,1.647,-2.07,-0.15,3.47,0.72,1.23E-01,5.94E-01,1.09E-02,5.21E-01,1.16E+06,1.28E+06,1.07E+06,4.77E+05,5,3,5,4,3.13E+06,2.28E+06,2.70E+05,1.14E+05,1.16E+06,1.82E+06,,9.26E+05,,1.28E+06,1.45E+08,1.67E+06,1.07E+06,1.17E+05,3.90E+05,,3.00E+04,1.67E+06,1.37E+05,1.66E+06,1.25E+04,8.68E+03,2.64E+03,1.14E+05,5.97E+04,6.48E+03,,8.54E+03,,1.36E+04,8.67E+05,7.47E+04,8.68E+03,1.57E+04,9.69E+03,,8.42E+03,1.18E+04,3.21E+03,1.77E+04,0,TRUE,54.749,36,11,534,57.3,6.61,14,,,,,,,,,0,0,93.51,33.69,217.49,104.55,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,n/a,Peak Found,High,Peak Found,Peak Found,Peak Found,Peak Found,n/a,Peak Found,Peak Found,Peak Found,Peak Found,1,,FALSE,123.73,145.65,10.01,144.57,697.95,,0,
Master Protein,High,Q1RMN8,IGL@,"Immunoglobulin light chain, lambda gene cluster OS=Bos taurus GN=IGL@ PE=2 SV=1",5,24,0.235,0.227,0.203,0.168,-2.09,-2.14,-2.3,-2.57,2.02E-01,1.70E-01,4.18E-02,1.75E-01,4.67E+05,8.32E+05,1.92E+05,1.85E+06,4,3,5,5,7.22E+04,,4.88E+04,3.02E+06,7.65E+06,,8.32E+05,5.53E+05,,1.78E+07,1.16E+05,9.17E+04,1.92E+05,8.07E+05,8.83E+05,5.39E+06,1.10E+05,3.25E+06,1.85E+06,1.13E+06,2.87E+02,,4.77E+02,3.02E+06,3.95E+05,,1.48E+04,5.10E+03,,1.89E+05,6.91E+02,4.09E+03,1.56E+03,1.09E+05,2.20E+04,1.05E+04,3.10E+04,2.30E+04,4.32E+04,1.20E+04,0,TRUE,19.832,25,5,234,24.5,7.62,5,,,"Pf07654, Pf07686",,Q1RMN8,,,,0,0,132.92,154.48,93.99,87.42,Peak Found,n/a,Peak Found,High,High,n/a,Peak Found,Peak Found,n/a,High,Peak Found,Peak Found,Peak Found,High,High,Peak Found,High,Peak Found,Peak Found,Peak Found,1,,FALSE,124.83,133.44,133.33,131.44,50.03,,0,
Master Protein,Medium,P17697,CLU,Clusterin OS=Bos taurus GN=CLU PE=1 SV=1,1,3,0.181,1.264,0.279,0.822,-2.46,0.34,-1.84,-0.28,1.18E-01,4.95E-01,1.26E-01,9.82E-01,1.18E+05,6.52E+05,1.50E+05,1.82E+05,1,1,2,1,,,1.18E+05,,,,,,6.52E+05,,,1.68E+05,,1.33E+05,,,,,1.82E+05,,,,1.16E+03,,,,,,1.84E+04,,,7.51E+03,,1.79E+04,,,,,4.26E+03,,0.015,TRUE,2.107,4,1,439,51.1,6.04,1,protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes,non-structural extracellular;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component,Pf01093,280750,A5D983; bta:280750; P17697; Q148K1,ENSBTAG00000005574,Platelet degranulation ; Regulation of Complement cascade; Terminal pathway of complement; Antimicrobial peptides,,4,0,,,16.51,,n/a,n/a,Peak Found,High,n/a,n/a,n/a,n/a,Peak Found,n/a,n/a,High,n/a,High,n/a,n/a,n/a,n/a,Peak Found,n/a,1,,FALSE,0,17.42,0,17.42,9.39,other molecular function,0,
Master Protein,High,Q2KJC7,POSTN,Periostin variant 7 OS=Bos taurus GN=POSTN PE=2 SV=1,6,10,0.173,0.831,1.026,0.621,-2.53,-0.27,0.04,-0.69,7.48E-02,7.83E-01,9.38E-01,7.87E-01,6.03E+05,1.23E+06,4.95E+05,2.56E+06,2,2,4,2,,8.49E+05,,4.29E+05,,,1.30E+06,1.17E+06,,,,3.80E+05,1.17E+06,3.41E+05,6.46E+05,,3.69E+06,,1.78E+06,,,3.23E+03,,4.29E+05,,,2.31E+04,1.08E+04,,,,1.70E+04,9.50E+03,4.60E+04,1.60E+04,,1.04E+06,,4.15E+04,,0,TRUE,18.743,12,6,779,86.8,7.5,6,cell adhesion,,Pf02469,281960,bta:281960; Q2KJC7,ENSBTAG00000012409,,,0,0,46.54,7.29,60.24,49.48,n/a,Peak Found,n/a,High,n/a,n/a,Peak Found,Peak Found,n/a,n/a,n/a,Peak Found,Peak Found,High,Peak Found,n/a,High,n/a,High,n/a,1,,FALSE,262.4,114.81,152.77,81.97,30.79,,0,
Master Protein,High,A6QPP2,SERPIND1,SERPIND1 protein OS=Bos taurus GN=SERPIND1 PE=2 SV=1,1,1,,100,,100,,6.64,,6.64,,1.00E-17,,1.00E-17,,,3.17E+05,,,,3,,,,,,,,,,,,,,3.17E+05,5.37E+05,2.35E+05,,,,,,,,,,,,,,,,,,2.58E+03,7.24E+04,5.84E+03,,,,,,0,TRUE,4.336,4,1,496,55.2,6.86,1,stress response,non-structural extracellular,Pf00079,100125764,A6QPP2; bta:100125764,,,,0,0,,,43.03,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Peak Found,High,Peak Found,n/a,n/a,n/a,n/a,n/a,1,,FALSE,,,,,3.85,enzyme regulator activity,0,
